id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
125643934|NCT01640353|451980246|FG000|Overall Study|Withdrew prior to treatment|10|||
125643935|NCT01640353|451980246|FG000|Overall Study|Withdrawn from analysis at term site|12|||
125643936|NCT01640353|451980246|FG000|Overall Study|Withdrawal by Subject|5|||
125643937|NCT01640353|451980246|FG000|Overall Study|Death|2|||
125643938|NCT01640353|451980246|FG000|Overall Study|Early site termination|3|||
125643939|NCT01640353|451980246|FG000|Overall Study|Lost to Follow-up|12|||
125643940|NCT01640353|451980246|FG000|Overall Study|Physician Decision|1|||
125643941|NCT03758612|451980247|FG000|Washout Period|Withdrawal by Subject|0|||
125643942|NCT03758612|451980248|FG001|Washout Period|Withdrawal by Subject|0|||
125643943|NCT03758612|451980249|FG002|Washout Period|Withdrawal by Subject|2|||
125643944|NCT03758612|451980250|FG003|Washout Period|Withdrawal by Subject|0|||
125643945|NCT03758612|451980251|FG004|Washout Period|Withdrawal by Subject|0|||
125643946|NCT03758612|451980252|FG005|Washout Period|Withdrawal by Subject|0|||
125643947|NCT03758612|451980253|FG006|Washout Period|Withdrawal by Subject|0|||
125643948|NCT03758612|451980254|FG007|Washout Period|Withdrawal by Subject|0|||
125643949|NCT03758612|451980255|FG008|Washout Period|Withdrawal by Subject|0|||
125643950|NCT03758612|451980256|FG009|Washout Period|Withdrawal by Subject|0|||
125643951|NCT03758612|451980257|FG010|Washout Period|Withdrawal by Subject|0|||
125643952|NCT03758612|451980258|FG011|Washout Period|Withdrawal by Subject|0|||
125643953|NCT03758612|451980247|FG000|Period 2|Protocol Violation|0|||
125643954|NCT03758612|451980248|FG001|Period 2|Protocol Violation|0|||
125643955|NCT03758612|451980249|FG002|Period 2|Protocol Violation|0|||
125643956|NCT03758612|451980250|FG003|Period 2|Protocol Violation|0|||
125643957|NCT03758612|451980251|FG004|Period 2|Protocol Violation|1|||
125643958|NCT03758612|451980252|FG005|Period 2|Protocol Violation|0|||
125643959|NCT03758612|451980253|FG006|Period 2|Protocol Violation|0|||
125643960|NCT03758612|451980254|FG007|Period 2|Protocol Violation|0|||
125643961|NCT03758612|451980255|FG008|Period 2|Protocol Violation|0|||
125643962|NCT03758612|451980256|FG009|Period 2|Protocol Violation|0|||
125643963|NCT03758612|451980257|FG010|Period 2|Protocol Violation|0|||
125643964|NCT03758612|451980258|FG011|Period 2|Protocol Violation|0|||
125643965|NCT01603615|451980260|FG000|Overall Study|Did not Receive Treatment|7|||
125643966|NCT01603615|451980260|FG000|Overall Study|Lost to Follow-up|9|||
125643967|NCT01603615|451980260|FG000|Overall Study|Personal Reasons|17|||
125643968|NCT01603615|451980260|FG000|Overall Study|Other Miscellaneous|1|||
125643969|NCT03419741|451980261|FG000|Overall Study|Adverse Event|1|||
125643970|NCT03419741|451980262|FG001|Overall Study|Adverse Event|0|||
125643971|NCT03419741|451980261|FG000|Overall Study|Withdrawal by Subject|1|||
125643972|NCT03419741|451980262|FG001|Overall Study|Withdrawal by Subject|2|||
125643973|NCT04354870|451980263|FG000|Overall Study|Lost to Follow-up|32|||
125643974|NCT04354870|451980264|FG001|Overall Study|Lost to Follow-up|12|||
125643975|NCT04354870|451980263|FG000|Overall Study|Withdrawal by Subject|10|||
125643976|NCT04354870|451980264|FG001|Overall Study|Withdrawal by Subject|16|||
125643977|NCT04354870|451980263|FG000|Overall Study|Did not complete all study visits|6|||
125643978|NCT04354870|451980264|FG001|Overall Study|Did not complete all study visits|5|||
125643979|NCT03384316|451980265|FG000|Overall Study|Screen failure|0|||
125643980|NCT03384316|451980266|FG001|Overall Study|Screen failure|1|||
125643981|NCT04450394|451980277|FG000|Overall Study|Adverse Event|2|||
125643982|NCT04450394|451980278|FG001|Overall Study|Adverse Event|0|||
125643983|NCT04450394|451980279|FG002|Overall Study|Adverse Event|0|||
125643984|NCT04450394|451980277|FG000|Overall Study|Death|0|||
125643985|NCT04450394|451980278|FG001|Overall Study|Death|1|||
125643986|NCT04450394|451980279|FG002|Overall Study|Death|0|||
125643987|NCT04450394|451980277|FG000|Overall Study|Lost to Follow-up|0|||
125643988|NCT04450394|451980278|FG001|Overall Study|Lost to Follow-up|3|||
125643989|NCT04450394|451980279|FG002|Overall Study|Lost to Follow-up|0|||
125643990|NCT04450394|451980277|FG000|Overall Study|Physician Decision|0|||
125643991|NCT04450394|451980278|FG001|Overall Study|Physician Decision|1|||
125643992|NCT04450394|451980279|FG002|Overall Study|Physician Decision|0|||
125643993|NCT04450394|451980277|FG000|Overall Study|Protocol Violation|2|||
125643994|NCT04450394|451980278|FG001|Overall Study|Protocol Violation|0|||
125643995|NCT04450394|451980279|FG002|Overall Study|Protocol Violation|0|||
125643996|NCT04450394|451980277|FG000|Overall Study|Withdrawal by Subject|6|||
125643997|NCT04450394|451980278|FG001|Overall Study|Withdrawal by Subject|9|||
125643998|NCT04450394|451980279|FG002|Overall Study|Withdrawal by Subject|0|||
125643999|NCT02194699|451980283|FG000|Randomised|Did not receive treatment|1|||
125644000|NCT02194699|451980284|FG001|Randomised|Did not receive treatment|5|||
125533106|NCT04996004|451582738|FG000|Phase I|Death|1|||
125421237|NCT03393000|451168301|FG000|Overall Study|Death|11|||
125644001|NCT02194699|451980283|FG000|Randomised|Without potential for 52 weeks of IP|5|||
125421238|NCT03393000|451168301|FG000|Overall Study|Withdrawal by Subject|2|||
125421239|NCT03393000|451168301|FG000|Overall Study|Physician Decision|1|||
125644002|NCT02194699|451980284|FG001|Randomised|Without potential for 52 weeks of IP|5|||
125644003|NCT02194699|451980283|FG000|Randomised|Duplicate patient|2|||
125644004|NCT02194699|451980284|FG001|Randomised|Duplicate patient|1|||
125644005|NCT02194699|451980283|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
125533107|NCT04996004|451582739|FG001|Phase I|Death|2|||
125644006|NCT02194699|451980284|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
125644007|NCT02194699|451980283|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
125644008|NCT02194699|451980284|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
125644009|NCT02194699|451980283|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
125644010|NCT02194699|451980284|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
125644011|NCT02194699|451980283|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
125644012|NCT02194699|451980284|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
125644013|NCT02194699|451980283|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
125644014|NCT02194699|451980284|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
125644015|NCT02194699|451980283|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
125644016|NCT02194699|451980284|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
125644017|NCT02155660|451980286|FG000|Overall Study|Other Reason|8|||
125644018|NCT02155660|451980287|FG001|Overall Study|Other Reason|6|||
125421240|NCT01773070|451168302|FG000|Overall Study|Withdrawal by Subject|24|||
125421241|NCT01773070|451168302|FG000|Overall Study|Lost to Follow-up|39|||
125421242|NCT01773070|451168302|FG000|Overall Study|Other|15|||
125421243|NCT01773070|451168302|FG000|Overall Study|Death (unrelated to study procedures)|3|||
125421244|NCT01843192|451168303|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
125421245|NCT01843192|451168304|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
125421246|NCT01843192|451168305|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
125421247|NCT01471054|451168306|FG000|Overall Study|Study terminated prematurely|4|||
125421248|NCT01471054|451168307|FG001|Overall Study|Study terminated prematurely|0|||
125421249|NCT01559844|451168308|FG000|Overall Study|Consent Withdrawn|7|||
125421250|NCT01559844|451168308|FG000|Overall Study|Death|5|||
125421251|NCT01559844|451168308|FG000|Overall Study|Efficacy Failure|10|||
125421252|NCT01559844|451168308|FG000|Overall Study|No Longer A Transplant Candidate|3|||
125421253|NCT00951041|451168309|FG000|Overall Study|Withdrawal by Subject|1|||
125421254|NCT00951041|451168310|FG001|Overall Study|Withdrawal by Subject|1|||
125421255|NCT00951041|451168309|FG000|Overall Study|Lost to Follow-up|1|||
125421256|NCT00951041|451168310|FG001|Overall Study|Lost to Follow-up|0|||
125421257|NCT00951041|451168309|FG000|Overall Study|Other|3|||
125421258|NCT00951041|451168310|FG001|Overall Study|Other|0|||
125421259|NCT01514448|451168311|FG000|Overall Study|Death|7|||
125421260|NCT01514448|451168312|FG001|Overall Study|Death|8|||
125421261|NCT01514448|451168311|FG000|Overall Study|Withdrawal by Subject|2|||
125421262|NCT01514448|451168312|FG001|Overall Study|Withdrawal by Subject|0|||
125421263|NCT01514448|451168311|FG000|Overall Study|Lost to Follow-up|2|||
125421264|NCT01514448|451168312|FG001|Overall Study|Lost to Follow-up|0|||
125421265|NCT01514448|451168311|FG000|Overall Study|New Cancer Therapy|1|||
125421266|NCT01514448|451168312|FG001|Overall Study|New Cancer Therapy|0|||
125421267|NCT02314624|451168313|FG000|Overall Study|No participating patient|16|||
125421268|NCT02314624|451168314|FG001|Overall Study|No participating patient|13|||
125421269|NCT02314624|451168313|FG000|Overall Study|Participant withdrew|7|||
125421270|NCT02314624|451168314|FG001|Overall Study|Participant withdrew|2|||
125421271|NCT02314624|451168313|FG000|Overall Study|Lost to Follow-up|2|||
125421272|NCT02314624|451168314|FG001|Overall Study|Lost to Follow-up|5|||
125421273|NCT02314624|451168313|FG000|Overall Study|Dropped/Excluded by PI|6|||
125421274|NCT02314624|451168314|FG001|Overall Study|Dropped/Excluded by PI|6|||
125421275|NCT00713648|451168319|FG000|Overall Study|Adverse Event|1|||
125421276|NCT00713648|451168319|FG000|Overall Study|Unclassified|2|||
125421277|NCT00713648|451168319|FG000|Overall Study|According to Protocol|2|||
125421278|NCT00713648|451168319|FG000|Overall Study|Development of antibodies|3|||
125421279|NCT03252587|451168320|FG000|Overall Study|Adverse Event|3|||
125421280|NCT03252587|451168321|FG001|Overall Study|Adverse Event|8|||
125421281|NCT03252587|451168322|FG002|Overall Study|Adverse Event|6|||
125421282|NCT03252587|451168323|FG003|Overall Study|Adverse Event|12|||
125421283|NCT03252587|451168320|FG000|Overall Study|Lack of Efficacy|7|||
125421284|NCT03252587|451168321|FG001|Overall Study|Lack of Efficacy|2|||
125421285|NCT03252587|451168322|FG002|Overall Study|Lack of Efficacy|2|||
125421286|NCT03252587|451168323|FG003|Overall Study|Lack of Efficacy|4|||
125421287|NCT03252587|451168320|FG000|Overall Study|Lost to Follow-up|2|||
125421288|NCT03252587|451168321|FG001|Overall Study|Lost to Follow-up|0|||
125421289|NCT03252587|451168322|FG002|Overall Study|Lost to Follow-up|0|||
125421290|NCT03252587|451168323|FG003|Overall Study|Lost to Follow-up|2|||
125421291|NCT03252587|451168320|FG000|Overall Study|Pregnancy|2|||
125421292|NCT03252587|451168321|FG001|Overall Study|Pregnancy|1|||
125421293|NCT03252587|451168322|FG002|Overall Study|Pregnancy|0|||
125421294|NCT03252587|451168323|FG003|Overall Study|Pregnancy|1|||
125421295|NCT03252587|451168320|FG000|Overall Study|Withdrawal by Subject|8|||
125421296|NCT03252587|451168321|FG001|Overall Study|Withdrawal by Subject|4|||
125421297|NCT03252587|451168322|FG002|Overall Study|Withdrawal by Subject|4|||
125421298|NCT03252587|451168323|FG003|Overall Study|Withdrawal by Subject|4|||
125421299|NCT03252587|451168320|FG000|Overall Study|Other Reasons|2|||
125421300|NCT03252587|451168321|FG001|Overall Study|Other Reasons|5|||
125421301|NCT03252587|451168322|FG002|Overall Study|Other Reasons|5|||
125533108|NCT04996004|451582740|FG002|Phase I|Death|1|||
125421302|NCT03252587|451168323|FG003|Overall Study|Other Reasons|4|||
125421303|NCT04052204|451168324|FG000|Overall Study|Death|1|||
125421304|NCT04052204|451168325|FG001|Overall Study|Death|0|||
125421305|NCT04052204|451168326|FG002|Overall Study|Death|0|||
125421306|NCT04052204|451168324|FG000|Overall Study|Progressive disease|1|||
125421307|NCT04052204|451168325|FG001|Overall Study|Progressive disease|0|||
125421308|NCT04052204|451168326|FG002|Overall Study|Progressive disease|0|||
125421309|NCT04052204|451168324|FG000|Overall Study|Other|1|||
125533109|NCT04996004|451582741|FG003|Phase I|Death|0|||
125644019|NCT02155660|451980288|FG002|Overall Study|Other Reason|10|||
125644020|NCT02155660|451980289|FG003|Overall Study|Other Reason|10|||
125644021|NCT02155660|451980286|FG000|Overall Study|Study-specific withdrawal criteria|0|||
125644022|NCT02155660|451980287|FG001|Overall Study|Study-specific withdrawal criteria|1|||
125644023|NCT02155660|451980288|FG002|Overall Study|Study-specific withdrawal criteria|1|||
125644024|NCT02155660|451980289|FG003|Overall Study|Study-specific withdrawal criteria|1|||
125644025|NCT02155660|451980286|FG000|Overall Study|Severe non-compliance|0|||
125644026|NCT02155660|451980287|FG001|Overall Study|Severe non-compliance|4|||
125644027|NCT02155660|451980288|FG002|Overall Study|Severe non-compliance|0|||
125644028|NCT02155660|451980289|FG003|Overall Study|Severe non-compliance|1|||
125644029|NCT02155660|451980286|FG000|Overall Study|Adverse Event|2|||
125644030|NCT02155660|451980287|FG001|Overall Study|Adverse Event|6|||
125644031|NCT02155660|451980288|FG002|Overall Study|Adverse Event|3|||
125198603|NCT00199797|450350976|FG000|Overall Study|Progressive Disease|1|||
125309893|NCT02871635|450761923|FG000|Overall Study|Primary lack of efficacy|4|||
125309894|NCT02871635|450761924|FG001|Overall Study|Primary lack of efficacy|4|||
125309895|NCT02871635|450761923|FG000|Overall Study|Protocol Violation|3|||
125309896|NCT02871635|450761924|FG001|Overall Study|Protocol Violation|1|||
125309897|NCT02871635|450761923|FG000|Overall Study|Lost to Follow-up|1|||
125309898|NCT02871635|450761924|FG001|Overall Study|Lost to Follow-up|2|||
125309899|NCT02871635|450761923|FG000|Overall Study|Pregnancy|0|||
125309900|NCT02871635|450761924|FG001|Overall Study|Pregnancy|2|||
125309901|NCT02871635|450761923|FG000|Overall Study|Physician Decision|1|||
125309902|NCT02871635|450761924|FG001|Overall Study|Physician Decision|1|||
125309903|NCT02871635|450761923|FG000|Overall Study|Withdrawal by Subject|3|||
125309904|NCT02871635|450761924|FG001|Overall Study|Withdrawal by Subject|4|||
125309905|NCT02871635|450761923|FG000|Overall Study|Adverse Event|4|||
125309906|NCT02871635|450761924|FG001|Overall Study|Adverse Event|4|||
125309907|NCT02871635|450761923|FG000|Overall Study|Secondary lack of efficacy|2|||
125309908|NCT02871635|450761924|FG001|Overall Study|Secondary lack of efficacy|1|||
125309909|NCT02420379|450761925|FG000|Overall Study|Withdrawal by Subject|0|||
125309910|NCT02420379|450761926|FG001|Overall Study|Withdrawal by Subject|3|||
125309911|NCT02420379|450761925|FG000|Overall Study|Unable to complete due to schooling|0|||
125309912|NCT02420379|450761926|FG001|Overall Study|Unable to complete due to schooling|1|||
125309913|NCT02420379|450761925|FG000|Overall Study|Transitioned to commercial drug|1|||
125309914|NCT02420379|450761926|FG001|Overall Study|Transitioned to commercial drug|0|||
125309915|NCT00502671|450761927|FG000|Overall Study|Disease Progression|13|||
125309916|NCT00502671|450761927|FG000|Overall Study|Personal Reasons|22|||
125309917|NCT00502671|450761927|FG000|Overall Study|Lost to Follow-up|7|||
125309918|NCT00502671|450761927|FG000|Overall Study|Protocol Violation|16|||
125309919|NCT00502671|450761927|FG000|Overall Study|Adverse Event|19|||
125309920|NCT00412893|450761936|FG000|Overall Study|Adverse Event|31|||
125309921|NCT00412893|450761937|FG001|Overall Study|Adverse Event|53|||
125309922|NCT00412893|450761936|FG000|Overall Study|Death|17|||
125309923|NCT00412893|450761937|FG001|Overall Study|Death|21|||
125309924|NCT00412893|450761936|FG000|Overall Study|Insufficient Therapeutic Response|39|||
125309925|NCT00412893|450761937|FG001|Overall Study|Insufficient Therapeutic Response|23|||
125309926|NCT00412893|450761936|FG000|Overall Study|Lost to Follow-up|2|||
125309927|NCT00412893|450761937|FG001|Overall Study|Lost to Follow-up|1|||
125309928|NCT00412893|450761936|FG000|Overall Study|Violation of Selection at Entry|17|||
125309929|NCT00412893|450761937|FG001|Overall Study|Violation of Selection at Entry|10|||
125309930|NCT00412893|450761936|FG000|Overall Study|Other Protocol Violation|10|||
125309931|NCT00412893|450761937|FG001|Overall Study|Other Protocol Violation|6|||
125309932|NCT00412893|450761936|FG000|Overall Study|Did Not Cooperate|12|||
125309933|NCT00412893|450761937|FG001|Overall Study|Did Not Cooperate|9|||
125309934|NCT00412893|450761936|FG000|Overall Study|Administrative Reason|12|||
125309935|NCT00412893|450761937|FG001|Overall Study|Administrative Reason|15|||
125309936|NCT00412893|450761936|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
125309937|NCT00412893|450761937|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
125309938|NCT00853151|450761938|FG000|Overall Study|Adverse Event|1|||
125309939|NCT00853151|450761939|FG001|Overall Study|Adverse Event|4|||
125309940|NCT00853151|450761940|FG002|Overall Study|Adverse Event|2|||
125309941|NCT00853151|450761941|FG003|Overall Study|Adverse Event|0|||
125309942|NCT00853151|450761938|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
125309943|NCT00853151|450761939|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125421310|NCT04052204|451168325|FG001|Overall Study|Other|0|||
125421311|NCT04052204|451168326|FG002|Overall Study|Other|0|||
125309944|NCT00853151|450761940|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125421312|NCT02807558|451168339|FG000|Overall Study|Consent withdrawn by participant|4|||
125644032|NCT02155660|451980289|FG003|Overall Study|Adverse Event|1|||
125644033|NCT02155660|451980286|FG000|Overall Study|Lost to Follow-up|3|||
125421313|NCT02807558|451168340|FG001|Overall Study|Consent withdrawn by participant|0|||
125421314|NCT02807558|451168341|FG002|Overall Study|Consent withdrawn by participant|4|||
125421315|NCT02807558|451168342|FG003|Overall Study|Consent withdrawn by participant|2|||
125644034|NCT02155660|451980287|FG001|Overall Study|Lost to Follow-up|6|||
125644035|NCT02155660|451980288|FG002|Overall Study|Lost to Follow-up|5|||
125421316|NCT02807558|451168343|FG004|Overall Study|Consent withdrawn by participant|1|||
125533110|NCT04996004|451582742|FG004|Phase I|Death|0|||
125533111|NCT04996004|451582743|FG005|Phase I|Death|0|||
125533112|NCT04996004|451582738|FG000|Phase I|Study terminated by sponsor|2|||
125421317|NCT02807558|451168344|FG005|Overall Study|Consent withdrawn by participant|0|||
125421318|NCT02807558|451168339|FG000|Overall Study|Non-compliance with Study Drug|0|||
125421319|NCT02807558|451168340|FG001|Overall Study|Non-compliance with Study Drug|0|||
125421320|NCT02807558|451168341|FG002|Overall Study|Non-compliance with Study Drug|1|||
125421321|NCT02807558|451168342|FG003|Overall Study|Non-compliance with Study Drug|0|||
125421322|NCT02807558|451168343|FG004|Overall Study|Non-compliance with Study Drug|0|||
125421323|NCT02807558|451168344|FG005|Overall Study|Non-compliance with Study Drug|0|||
125421324|NCT02807558|451168339|FG000|Overall Study|Adverse Event|0|||
125421325|NCT02807558|451168340|FG001|Overall Study|Adverse Event|0|||
125421326|NCT02807558|451168341|FG002|Overall Study|Adverse Event|9|||
125644036|NCT02155660|451980289|FG003|Overall Study|Lost to Follow-up|8|||
125644037|NCT02155660|451980286|FG000|Overall Study|Death|17|||
125644038|NCT02155660|451980287|FG001|Overall Study|Death|19|||
125644039|NCT02155660|451980288|FG002|Overall Study|Death|17|||
125644040|NCT02155660|451980289|FG003|Overall Study|Death|19|||
125644041|NCT02155660|451980286|FG000|Overall Study|Withdrawal by Subject|28|||
125644042|NCT02155660|451980287|FG001|Overall Study|Withdrawal by Subject|31|||
125644043|NCT02155660|451980288|FG002|Overall Study|Withdrawal by Subject|24|||
125644044|NCT02155660|451980289|FG003|Overall Study|Withdrawal by Subject|21|||
125644045|NCT00303719|451980296|FG000|Overall Study|Not evaluable, prior therapies|0|||
125644046|NCT00303719|451980297|FG001|Overall Study|Not evaluable, prior therapies|30|||
125644047|NCT00303719|451980296|FG000|Overall Study|Lost to Follow-up|0|||
125421327|NCT02807558|451168342|FG003|Overall Study|Adverse Event|0|||
125421328|NCT02807558|451168343|FG004|Overall Study|Adverse Event|0|||
125533113|NCT04996004|451582739|FG001|Phase I|Study terminated by sponsor|1|||
125533114|NCT04996004|451582740|FG002|Phase I|Study terminated by sponsor|2|||
125533115|NCT04996004|451582741|FG003|Phase I|Study terminated by sponsor|0|||
125533116|NCT04996004|451582742|FG004|Phase I|Study terminated by sponsor|0|||
125533117|NCT04996004|451582743|FG005|Phase I|Study terminated by sponsor|0|||
125533118|NCT04996004|451582738|FG000|Phase II|Study terminated by sponsor|0|||
125533119|NCT04996004|451582739|FG001|Phase II|Study terminated by sponsor|0|||
125533120|NCT04996004|451582740|FG002|Phase II|Study terminated by sponsor|0|||
125533121|NCT04996004|451582741|FG003|Phase II|Study terminated by sponsor|20|||
125533122|NCT04996004|451582742|FG004|Phase II|Study terminated by sponsor|10|||
125533123|NCT04996004|451582743|FG005|Phase II|Study terminated by sponsor|10|||
125533124|NCT04996004|451582738|FG000|Phase II|Withdrawal by Subject|0|||
125533125|NCT04996004|451582739|FG001|Phase II|Withdrawal by Subject|0|||
125533126|NCT04996004|451582740|FG002|Phase II|Withdrawal by Subject|0|||
125533127|NCT04996004|451582741|FG003|Phase II|Withdrawal by Subject|0|||
125533128|NCT04996004|451582742|FG004|Phase II|Withdrawal by Subject|1|||
125533129|NCT04996004|451582743|FG005|Phase II|Withdrawal by Subject|2|||
125533130|NCT04996004|451582738|FG000|Phase II|Death|0|||
125421329|NCT02807558|451168344|FG005|Overall Study|Adverse Event|0|||
125421330|NCT02807558|451168339|FG000|Overall Study|Death|23|||
125421331|NCT02807558|451168340|FG001|Overall Study|Death|2|||
125533131|NCT04996004|451582739|FG001|Phase II|Death|0|||
125533132|NCT04996004|451582740|FG002|Phase II|Death|0|||
125533133|NCT04996004|451582741|FG003|Phase II|Death|12|||
125533134|NCT04996004|451582742|FG004|Phase II|Death|2|||
125533135|NCT04996004|451582743|FG005|Phase II|Death|9|||
125533136|NCT04996004|451582738|FG000|Phase II|Other|0|||
125533137|NCT04996004|451582739|FG001|Phase II|Other|0|||
125533138|NCT04996004|451582740|FG002|Phase II|Other|0|||
125533139|NCT04996004|451582741|FG003|Phase II|Other|0|||
125533140|NCT04996004|451582742|FG004|Phase II|Other|0|||
125644048|NCT00303719|451980297|FG001|Overall Study|Lost to Follow-up|7|||
125644049|NCT02643420|451980318|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
125198604|NCT00199797|450350976|FG000|Overall Study|Adverse Event|1|||
125421332|NCT02807558|451168341|FG002|Overall Study|Death|3|||
125421333|NCT02807558|451168342|FG003|Overall Study|Death|43|||
125421334|NCT02807558|451168343|FG004|Overall Study|Death|24|||
125421335|NCT02807558|451168344|FG005|Overall Study|Death|15|||
125421336|NCT02807558|451168339|FG000|Overall Study|Progressive Disease|0|||
125644050|NCT02643420|451980319|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
125533141|NCT04996004|451582743|FG005|Phase II|Other|1|||
125533142|NCT02942277|451582744|FG000|Year 1|Withdrawal by Subject|0|||
125533143|NCT02942277|451582745|FG001|Year 1|Withdrawal by Subject|0|||
125533144|NCT02942277|451582746|FG002|Year 1|Withdrawal by Subject|0|||
125533145|NCT02942277|451582747|FG003|Year 1|Withdrawal by Subject|0|||
125533146|NCT02942277|451582748|FG004|Year 1|Withdrawal by Subject|1|||
125533147|NCT02942277|451582749|FG005|Year 1|Withdrawal by Subject|3|||
125644051|NCT02643420|451980318|FG000|Overall Study|Withdrawal by Subject|25|||
125421337|NCT02807558|451168340|FG001|Overall Study|Progressive Disease|0|||
125644052|NCT02643420|451980319|FG001|Overall Study|Withdrawal by Subject|19|||
125644053|NCT02643420|451980318|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
125644054|NCT02643420|451980319|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
125644055|NCT02643420|451980318|FG000|Overall Study|Lost to Follow-up|6|||
125644056|NCT02643420|451980319|FG001|Overall Study|Lost to Follow-up|10|||
125644057|NCT02643420|451980318|FG000|Overall Study|Investigator Decision|2|||
125644058|NCT02643420|451980319|FG001|Overall Study|Investigator Decision|4|||
125644059|NCT02643420|451980318|FG000|Overall Study|Sponsor decision|1|||
125644060|NCT02643420|451980319|FG001|Overall Study|Sponsor decision|1|||
125644061|NCT02643420|451980318|FG000|Overall Study|Death|0|||
125644062|NCT02643420|451980319|FG001|Overall Study|Death|2|||
125644063|NCT02643420|451980318|FG000|Overall Study|Reason not Specified|8|||
125644064|NCT02643420|451980319|FG001|Overall Study|Reason not Specified|7|||
125644065|NCT02127970|451980320|FG000|Overall Study|Adverse Event|2|||
125644066|NCT02127970|451980321|FG001|Overall Study|Adverse Event|1|||
125644067|NCT02127970|451980320|FG000|Overall Study|Death|1|||
125644068|NCT02127970|451980321|FG001|Overall Study|Death|1|||
125644069|NCT02127970|451980320|FG000|Overall Study|Lost to Follow-up|14|||
125644070|NCT02127970|451980321|FG001|Overall Study|Lost to Follow-up|14|||
125644071|NCT02127970|451980320|FG000|Overall Study|Reason not Specified|4|||
125644072|NCT02127970|451980321|FG001|Overall Study|Reason not Specified|7|||
125644073|NCT02127970|451980320|FG000|Overall Study|Pregnancy|0|||
125644074|NCT02127970|451980321|FG001|Overall Study|Pregnancy|1|||
125644075|NCT02127970|451980320|FG000|Overall Study|Subject Withdrew Consent|5|||
125644076|NCT02127970|451980321|FG001|Overall Study|Subject Withdrew Consent|3|||
125644077|NCT01710709|451980322|FG000|Overall Study|Lost to Follow-up|29|||
125644078|NCT01710709|451980322|FG000|Overall Study|Adverse Event|48|||
125644079|NCT01710709|451980322|FG000|Overall Study|Participant met withdrawal criteria|33|||
125644080|NCT01710709|451980322|FG000|Overall Study|Participant withdrawn by investigator|2|||
125644081|NCT01710709|451980322|FG000|Overall Study|Withdrawal by Subject|53|||
125644082|NCT01710709|451980322|FG000|Overall Study|Protocol Violation|5|||
125644083|NCT01710709|451980322|FG000|Overall Study|Lack of Efficacy|3|||
125644084|NCT00542321|451980324|FG000|Overall Study|Death|0|||
125644085|NCT00542321|451980325|FG001|Overall Study|Death|1|||
125644086|NCT00718887|451980338|FG000|Overall Study|Withdrawal by Subject|3|||
125644087|NCT00718887|451980339|FG001|Overall Study|Withdrawal by Subject|2|||
125644088|NCT00718887|451980338|FG000|Overall Study|Not identified|2|||
125644089|NCT00718887|451980339|FG001|Overall Study|Not identified|7|||
125644090|NCT05102734|451980340|FG000|Overall Study|Did not require vasopressors|1|||
125644091|NCT05102734|451980341|FG001|Overall Study|Did not require vasopressors|0|||
125644092|NCT05102734|451980340|FG000|Overall Study|Did not have functioning PA catheter|1|||
125644093|NCT05102734|451980341|FG001|Overall Study|Did not have functioning PA catheter|0|||
125644094|NCT05102734|451980340|FG000|Overall Study|Inadequate video quality|2|||
125644095|NCT05102734|451980341|FG001|Overall Study|Inadequate video quality|0|||
125644096|NCT03055806|451980342|FG000|Overall Study|Adverse Event|0|||
125644097|NCT03055806|451980343|FG001|Overall Study|Adverse Event|0|||
125644098|NCT03055806|451980344|FG002|Overall Study|Adverse Event|1|||
125644099|NCT03055806|451980345|FG003|Overall Study|Adverse Event|1|||
125644100|NCT03055806|451980342|FG000|Overall Study|Lost to Follow-up|0|||
125644101|NCT03055806|451980343|FG001|Overall Study|Lost to Follow-up|3|||
125644102|NCT03055806|451980344|FG002|Overall Study|Lost to Follow-up|6|||
125644103|NCT03055806|451980345|FG003|Overall Study|Lost to Follow-up|7|||
125644104|NCT03055806|451980342|FG000|Overall Study|Physician Decision|1|||
125644105|NCT03055806|451980343|FG001|Overall Study|Physician Decision|0|||
125644106|NCT03055806|451980344|FG002|Overall Study|Physician Decision|0|||
125421338|NCT02807558|451168341|FG002|Overall Study|Progressive Disease|1|||
125421339|NCT02807558|451168342|FG003|Overall Study|Progressive Disease|0|||
125421340|NCT02807558|451168343|FG004|Overall Study|Progressive Disease|0|||
125421341|NCT02807558|451168344|FG005|Overall Study|Progressive Disease|0|||
125421342|NCT02807558|451168339|FG000|Overall Study|Other than specified|1|||
125421343|NCT02807558|451168340|FG001|Overall Study|Other than specified|0|||
125421344|NCT02807558|451168341|FG002|Overall Study|Other than specified|2|||
125421345|NCT02807558|451168342|FG003|Overall Study|Other than specified|0|||
125421346|NCT02807558|451168343|FG004|Overall Study|Other than specified|1|||
125421347|NCT02807558|451168344|FG005|Overall Study|Other than specified|1|||
125421348|NCT02807558|451168339|FG000|Overall Study|Lack of Efficacy|0|||
125421349|NCT02807558|451168340|FG001|Overall Study|Lack of Efficacy|0|||
125644107|NCT03055806|451980345|FG003|Overall Study|Physician Decision|1|||
125644108|NCT03055806|451980342|FG000|Overall Study|Protocol Violation|1|||
125198605|NCT00199797|450350976|FG000|Overall Study|Physician Decision|1|||
125644109|NCT03055806|451980343|FG001|Overall Study|Protocol Violation|0|||
125644110|NCT03055806|451980344|FG002|Overall Study|Protocol Violation|0|||
125644111|NCT03055806|451980345|FG003|Overall Study|Protocol Violation|0|||
125644112|NCT03055806|451980342|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
125644113|NCT03055806|451980343|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
125644114|NCT03055806|451980344|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
125644115|NCT03055806|451980345|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
125644116|NCT03055806|451980342|FG000|Overall Study|Withdrawal of consent to continue study|2|||
125644117|NCT03055806|451980343|FG001|Overall Study|Withdrawal of consent to continue study|3|||
125644118|NCT03055806|451980344|FG002|Overall Study|Withdrawal of consent to continue study|4|||
125644119|NCT03055806|451980345|FG003|Overall Study|Withdrawal of consent to continue study|6|||
125644120|NCT03055806|451980342|FG000|Overall Study|Partner not willing to try intercourse|1|||
125644121|NCT03055806|451980343|FG001|Overall Study|Partner not willing to try intercourse|0|||
125644122|NCT03055806|451980344|FG002|Overall Study|Partner not willing to try intercourse|0|||
125644123|NCT03055806|451980345|FG003|Overall Study|Partner not willing to try intercourse|0|||
125421350|NCT02807558|451168341|FG002|Overall Study|Lack of Efficacy|9|||
125421351|NCT02807558|451168342|FG003|Overall Study|Lack of Efficacy|0|||
125421352|NCT02807558|451168343|FG004|Overall Study|Lack of Efficacy|0|||
125421353|NCT02807558|451168344|FG005|Overall Study|Lack of Efficacy|0|||
125421354|NCT04575467|451168348|FG000|Overall Study|Adverse Event|0|||
125421355|NCT04575467|451168349|FG001|Overall Study|Adverse Event|1|||
125421356|NCT04575467|451168350|FG002|Overall Study|Adverse Event|0|||
125421357|NCT04575467|451168351|FG003|Overall Study|Adverse Event|0|||
125533148|NCT02942277|451582750|FG006|Year 1|Withdrawal by Subject|0|||
125533149|NCT02942277|451582751|FG007|Year 1|Withdrawal by Subject|1|||
125421358|NCT01328574|451168352|FG000|Overall Study|Refused further treatment|1|||
125421359|NCT01483924|451168353|FG000|Overall Study|Withdrawal by Subject|2|||
125421360|NCT01483924|451168354|FG001|Overall Study|Withdrawal by Subject|0|||
125421361|NCT01483924|451168355|FG002|Overall Study|Withdrawal by Subject|0|||
125421362|NCT01483924|451168356|FG003|Overall Study|Withdrawal by Subject|1|||
125533150|NCT02942277|451582752|FG008|Year 1|Withdrawal by Subject|0|||
125644124|NCT04601194|451980346|FG000|Overall Study|Lost to Follow-up|7|||
125644125|NCT00125138|451980347|FG000|Overall Study|Adverse Event|1|||
125644126|NCT00125138|451980348|FG001|Overall Study|Adverse Event|0|||
125644127|NCT00125138|451980349|FG002|Overall Study|Adverse Event|3|||
125644128|NCT00125138|451980350|FG003|Overall Study|Adverse Event|2|||
125533151|NCT02942277|451582753|FG009|Year 1|Withdrawal by Subject|0|||
125533152|NCT02942277|451582754|FG010|Year 1|Withdrawal by Subject|3|||
125644129|NCT00125138|451980347|FG000|Overall Study|Withdrawal by Subject|2|||
125644130|NCT00125138|451980348|FG001|Overall Study|Withdrawal by Subject|3|||
125644131|NCT00125138|451980349|FG002|Overall Study|Withdrawal by Subject|1|||
125644132|NCT00125138|451980350|FG003|Overall Study|Withdrawal by Subject|1|||
125644133|NCT00125138|451980347|FG000|Overall Study|Lack of Efficacy|0|||
125644134|NCT00125138|451980348|FG001|Overall Study|Lack of Efficacy|0|||
125644135|NCT00125138|451980349|FG002|Overall Study|Lack of Efficacy|0|||
125644136|NCT00125138|451980350|FG003|Overall Study|Lack of Efficacy|1|||
125644137|NCT00125138|451980347|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
125644138|NCT00125138|451980348|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
125644139|NCT00125138|451980349|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
125644140|NCT00125138|451980350|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
125533153|NCT02942277|451582744|FG000|Year 1|Travel|0|||
125533154|NCT02942277|451582745|FG001|Year 1|Travel|1|||
125533155|NCT02942277|451582746|FG002|Year 1|Travel|0|||
125533156|NCT02942277|451582747|FG003|Year 1|Travel|0|||
125644141|NCT00348686|451980355|FG000|Overall Study|Withdrawal by Subject|45|||
125644142|NCT00348686|451980355|FG000|Overall Study|Adverse Event|5|||
125644143|NCT00348686|451980355|FG000|Overall Study|Protocol Violation|6|||
125644144|NCT00348686|451980355|FG000|Overall Study|Lost to Follow-up|2|||
125644145|NCT00348686|451980355|FG000|Overall Study|Multiple Reasons|8|||
125644146|NCT01904760|451980362|FG000|Overall Study|Protocol Violation|1|||
125644147|NCT01904760|451980363|FG001|Overall Study|Protocol Violation|0|||
125644148|NCT04249076|451980375|FG000|Overall Study|Adverse Event|1|||
125644149|NCT04249076|451980376|FG001|Overall Study|Adverse Event|1|||
125644150|NCT04249076|451980375|FG000|Overall Study|Protocol Violation|1|||
125644151|NCT04249076|451980376|FG001|Overall Study|Protocol Violation|2|||
125644152|NCT04249076|451980375|FG000|Overall Study|Lack of Efficacy|0|||
125309945|NCT00853151|450761941|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125309946|NCT00853151|450761938|FG000|Overall Study|Lost to Follow-up|2|||
125309947|NCT00853151|450761939|FG001|Overall Study|Lost to Follow-up|0|||
125421363|NCT01483924|451168357|FG004|Overall Study|Withdrawal by Subject|1|||
125421364|NCT01483924|451168353|FG000|Overall Study|Adverse Event|0|||
125421365|NCT01483924|451168354|FG001|Overall Study|Adverse Event|0|||
125421366|NCT01483924|451168355|FG002|Overall Study|Adverse Event|1|||
125421367|NCT01483924|451168356|FG003|Overall Study|Adverse Event|1|||
125644153|NCT04249076|451980376|FG001|Overall Study|Lack of Efficacy|1|||
125644154|NCT04249076|451980375|FG000|Overall Study|Withdrawal by Subject|0|||
125644155|NCT04249076|451980376|FG001|Overall Study|Withdrawal by Subject|1|||
125421368|NCT01483924|451168357|FG004|Overall Study|Adverse Event|0|||
125533157|NCT02942277|451582748|FG004|Year 1|Travel|4|||
125533158|NCT02942277|451582749|FG005|Year 1|Travel|5|||
125533159|NCT02942277|451582750|FG006|Year 1|Travel|0|||
125533160|NCT02942277|451582751|FG007|Year 1|Travel|0|||
125644156|NCT00405756|451980377|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
125644157|NCT00405756|451980378|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
125644158|NCT00405756|451980379|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
125644159|NCT00405756|451980377|FG000|Double-blind Treatment|Adverse Event|31|||
125644160|NCT00405756|451980378|FG001|Double-blind Treatment|Adverse Event|27|||
125644161|NCT00405756|451980379|FG002|Double-blind Treatment|Adverse Event|12|||
125644162|NCT00405756|451980377|FG000|Double-blind Treatment|Disease Progression|47|||
125644163|NCT00405756|451980378|FG001|Double-blind Treatment|Disease Progression|81|||
125644164|NCT00405756|451980379|FG002|Double-blind Treatment|Disease Progression|102|||
125644165|NCT00405756|451980377|FG000|Double-blind Treatment|Lack of Efficacy|1|||
125644166|NCT00405756|451980378|FG001|Double-blind Treatment|Lack of Efficacy|4|||
125644167|NCT00405756|451980379|FG002|Double-blind Treatment|Lack of Efficacy|2|||
125644168|NCT00405756|451980377|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
125644169|NCT00405756|451980378|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
125644170|NCT00405756|451980379|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
125644171|NCT00405756|451980377|FG000|Double-blind Treatment|Lost to Follow-up|1|||
125644172|NCT00405756|451980378|FG001|Double-blind Treatment|Lost to Follow-up|0|||
125644173|NCT00405756|451980379|FG002|Double-blind Treatment|Lost to Follow-up|0|||
125644174|NCT00405756|451980377|FG000|Double-blind Treatment|Death|4|||
125644175|NCT00405756|451980378|FG001|Double-blind Treatment|Death|4|||
125644176|NCT00405756|451980379|FG002|Double-blind Treatment|Death|4|||
125644177|NCT00405756|451980377|FG000|Double-blind Treatment|Protocol Violation|1|||
125644178|NCT00405756|451980378|FG001|Double-blind Treatment|Protocol Violation|0|||
125644179|NCT00405756|451980379|FG002|Double-blind Treatment|Protocol Violation|2|||
125644180|NCT00405756|451980377|FG000|Double-blind Treatment|Other|7|||
125644181|NCT00405756|451980378|FG001|Double-blind Treatment|Other|4|||
125644182|NCT00405756|451980379|FG002|Double-blind Treatment|Other|4|||
125644183|NCT00405756|451980377|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
125644184|NCT00405756|451980378|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
125644185|NCT00405756|451980379|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
125644186|NCT00405756|451980377|FG000|Open-label Extension|Adverse Event|1|||
125644187|NCT00405756|451980378|FG001|Open-label Extension|Adverse Event|3|||
125644188|NCT00405756|451980379|FG002|Open-label Extension|Adverse Event|7|||
125644189|NCT00405756|451980377|FG000|Open-label Extension|Disease Progression|8|||
125644190|NCT00405756|451980378|FG001|Open-label Extension|Disease Progression|23|||
125644191|NCT00405756|451980379|FG002|Open-label Extension|Disease Progression|26|||
125644192|NCT00405756|451980377|FG000|Open-label Extension|Withdrawal by Subject|2|||
125644193|NCT00405756|451980378|FG001|Open-label Extension|Withdrawal by Subject|3|||
125644194|NCT00405756|451980379|FG002|Open-label Extension|Withdrawal by Subject|3|||
125644195|NCT00405756|451980377|FG000|Open-label Extension|Death|1|||
125644196|NCT00405756|451980378|FG001|Open-label Extension|Death|2|||
125644197|NCT00405756|451980379|FG002|Open-label Extension|Death|4|||
125644198|NCT00405756|451980377|FG000|Open-label Extension|Other|0|||
125644199|NCT00405756|451980378|FG001|Open-label Extension|Other|1|||
125644200|NCT00405756|451980379|FG002|Open-label Extension|Other|7|||
125644201|NCT00405756|451980377|FG000|Follow-up|Ongoing in Follow-up Period|52|||
125644202|NCT00405756|451980378|FG001|Follow-up|Ongoing in Follow-up Period|51|||
125644203|NCT00405756|451980379|FG002|Follow-up|Ongoing in Follow-up Period|60|||
125644204|NCT00405756|451980377|FG000|Follow-up|Death|21|||
125644205|NCT00405756|451980378|FG001|Follow-up|Death|31|||
125644206|NCT00405756|451980379|FG002|Follow-up|Death|24|||
125644207|NCT00405756|451980377|FG000|Follow-up|Lost to Follow-up|2|||
125644208|NCT00405756|451980378|FG001|Follow-up|Lost to Follow-up|8|||
125644209|NCT00405756|451980379|FG002|Follow-up|Lost to Follow-up|4|||
125644210|NCT00089505|451980380|FG000|Overall Study|Death|4|||
125644211|NCT00089505|451980381|FG001|Overall Study|Death|1|||
125644212|NCT00089505|451980382|FG002|Overall Study|Death|5|||
125644213|NCT00089505|451980383|FG003|Overall Study|Death|8|||
125644214|NCT00089505|451980380|FG000|Overall Study|Withdrawal by Subject|3|||
125644215|NCT00089505|451980381|FG001|Overall Study|Withdrawal by Subject|0|||
125644216|NCT00089505|451980382|FG002|Overall Study|Withdrawal by Subject|6|||
125644217|NCT00089505|451980383|FG003|Overall Study|Withdrawal by Subject|6|||
125644218|NCT00089505|451980380|FG000|Overall Study|Lost to Follow-up|1|||
125644219|NCT00089505|451980381|FG001|Overall Study|Lost to Follow-up|1|||
125644220|NCT00089505|451980382|FG002|Overall Study|Lost to Follow-up|9|||
125644221|NCT00089505|451980383|FG003|Overall Study|Lost to Follow-up|7|||
125644222|NCT00089505|451980380|FG000|Overall Study|Physician Decision|1|||
125644223|NCT00089505|451980381|FG001|Overall Study|Physician Decision|0|||
125644224|NCT00089505|451980382|FG002|Overall Study|Physician Decision|0|||
125644225|NCT00089505|451980383|FG003|Overall Study|Physician Decision|0|||
125644226|NCT00089505|451980380|FG000|Overall Study|Protocol Violation|0|||
125644227|NCT00089505|451980381|FG001|Overall Study|Protocol Violation|0|||
125644228|NCT00089505|451980382|FG002|Overall Study|Protocol Violation|1|||
125644229|NCT00089505|451980383|FG003|Overall Study|Protocol Violation|0|||
125644230|NCT01117428|451980385|FG000|Overall Study|Lack of Efficacy|1|||
125644231|NCT01117428|451980386|FG001|Overall Study|Lack of Efficacy|0|||
125644232|NCT01117428|451980387|FG002|Overall Study|Lack of Efficacy|0|||
125644233|NCT01117428|451980388|FG003|Overall Study|Lack of Efficacy|0|||
125644234|NCT01117428|451980389|FG004|Overall Study|Lack of Efficacy|0|||
125644235|NCT01117428|451980390|FG005|Overall Study|Lack of Efficacy|0|||
125644236|NCT01117428|451980385|FG000|Overall Study|Adverse Event|4|||
125644237|NCT01117428|451980386|FG001|Overall Study|Adverse Event|0|||
125644238|NCT01117428|451980387|FG002|Overall Study|Adverse Event|0|||
125533161|NCT02942277|451582752|FG008|Year 1|Travel|0|||
125644239|NCT01117428|451980388|FG003|Overall Study|Adverse Event|0|||
125644240|NCT01117428|451980389|FG004|Overall Study|Adverse Event|1|||
125644241|NCT01117428|451980390|FG005|Overall Study|Adverse Event|2|||
125644242|NCT01117428|451980385|FG000|Overall Study|Death|0|||
125644243|NCT01117428|451980386|FG001|Overall Study|Death|1|||
125644244|NCT01117428|451980387|FG002|Overall Study|Death|2|||
125644245|NCT01117428|451980388|FG003|Overall Study|Death|0|||
125644246|NCT01117428|451980389|FG004|Overall Study|Death|0|||
125644247|NCT01117428|451980390|FG005|Overall Study|Death|1|||
125644248|NCT01117428|451980385|FG000|Overall Study|Physician Decision|0|||
125644249|NCT01117428|451980386|FG001|Overall Study|Physician Decision|1|||
125644250|NCT01117428|451980387|FG002|Overall Study|Physician Decision|0|||
125644251|NCT01117428|451980388|FG003|Overall Study|Physician Decision|0|||
125644252|NCT01117428|451980389|FG004|Overall Study|Physician Decision|0|||
125644253|NCT01117428|451980390|FG005|Overall Study|Physician Decision|0|||
125644254|NCT01117428|451980385|FG000|Overall Study|Withdrawal by Subject|0|||
125644255|NCT01117428|451980386|FG001|Overall Study|Withdrawal by Subject|0|||
125644256|NCT01117428|451980387|FG002|Overall Study|Withdrawal by Subject|1|||
125644257|NCT01117428|451980388|FG003|Overall Study|Withdrawal by Subject|0|||
125644258|NCT01117428|451980389|FG004|Overall Study|Withdrawal by Subject|0|||
125644259|NCT01117428|451980390|FG005|Overall Study|Withdrawal by Subject|0|||
125644260|NCT01117428|451980385|FG000|Overall Study|Progressive disease|15|||
125644261|NCT01117428|451980386|FG001|Overall Study|Progressive disease|27|||
125644262|NCT01117428|451980387|FG002|Overall Study|Progressive disease|10|||
125644263|NCT01117428|451980388|FG003|Overall Study|Progressive disease|12|||
125644264|NCT01117428|451980389|FG004|Overall Study|Progressive disease|16|||
125644265|NCT01117428|451980390|FG005|Overall Study|Progressive disease|17|||
125644266|NCT02519777|451980392|FG000|Overall Study|Death|1|||
125644267|NCT02519777|451980393|FG001|Overall Study|Death|0|||
125644268|NCT02519777|451980394|FG002|Overall Study|Death|0|||
125644269|NCT02519777|451980392|FG000|Overall Study|Lost to Follow-up|0|||
125644270|NCT02519777|451980393|FG001|Overall Study|Lost to Follow-up|4|||
125644271|NCT02519777|451980394|FG002|Overall Study|Lost to Follow-up|2|||
125644272|NCT02519777|451980392|FG000|Overall Study|Withdrawal by Subject|3|||
125644273|NCT02519777|451980393|FG001|Overall Study|Withdrawal by Subject|1|||
125644274|NCT02519777|451980394|FG002|Overall Study|Withdrawal by Subject|0|||
125644275|NCT02519777|451980392|FG000|Overall Study|Severe Debilitation|1|||
125644276|NCT02519777|451980393|FG001|Overall Study|Severe Debilitation|1|||
125644277|NCT02519777|451980394|FG002|Overall Study|Severe Debilitation|1|||
125644278|NCT02519777|451980392|FG000|Overall Study|Not able to get to clinic|1|||
125533162|NCT02942277|451582753|FG009|Year 1|Travel|0|||
125644279|NCT02519777|451980393|FG001|Overall Study|Not able to get to clinic|2|||
125644280|NCT02519777|451980394|FG002|Overall Study|Not able to get to clinic|1|||
125644281|NCT02195531|451980395|FG000|Overall Study|Withdrawal by Subject|1|||
125533163|NCT02942277|451582754|FG010|Year 1|Travel|8|||
125533164|NCT02942277|451582744|FG000|Year 1|Joined Army|0|||
125533165|NCT02942277|451582745|FG001|Year 1|Joined Army|1|||
125644282|NCT02195531|451980396|FG001|Overall Study|Withdrawal by Subject|1|||
125644283|NCT02195531|451980397|FG002|Overall Study|Withdrawal by Subject|1|||
125644284|NCT00545740|451980402|FG000|Overall Study|Lack of Efficacy|34|||
125644285|NCT00545740|451980403|FG001|Overall Study|Lack of Efficacy|35|||
125644286|NCT00545740|451980404|FG002|Overall Study|Lack of Efficacy|47|||
125644287|NCT00545740|451980405|FG003|Overall Study|Lack of Efficacy|36|||
125644288|NCT00545740|451980402|FG000|Overall Study|Withdrawal by Subject|17|||
125644289|NCT00545740|451980403|FG001|Overall Study|Withdrawal by Subject|15|||
125644290|NCT00545740|451980404|FG002|Overall Study|Withdrawal by Subject|16|||
125533166|NCT02942277|451582746|FG002|Year 1|Joined Army|0|||
125644291|NCT00545740|451980405|FG003|Overall Study|Withdrawal by Subject|18|||
125644292|NCT00545740|451980402|FG000|Overall Study|Adverse Event|10|||
125644293|NCT00545740|451980403|FG001|Overall Study|Adverse Event|18|||
125644294|NCT00545740|451980404|FG002|Overall Study|Adverse Event|19|||
125644295|NCT00545740|451980405|FG003|Overall Study|Adverse Event|9|||
125644296|NCT00545740|451980402|FG000|Overall Study|Lost to Follow-up|7|||
125533167|NCT02942277|451582747|FG003|Year 1|Joined Army|0|||
125533168|NCT02942277|451582748|FG004|Year 1|Joined Army|0|||
125533169|NCT02942277|451582749|FG005|Year 1|Joined Army|0|||
125644297|NCT00545740|451980403|FG001|Overall Study|Lost to Follow-up|5|||
125644298|NCT00545740|451980404|FG002|Overall Study|Lost to Follow-up|5|||
125644299|NCT00545740|451980405|FG003|Overall Study|Lost to Follow-up|6|||
125644300|NCT00545740|451980402|FG000|Overall Study|Protocol Violation|1|||
125644301|NCT00545740|451980403|FG001|Overall Study|Protocol Violation|3|||
125644302|NCT00545740|451980404|FG002|Overall Study|Protocol Violation|1|||
125644303|NCT00545740|451980405|FG003|Overall Study|Protocol Violation|0|||
125644304|NCT00545740|451980402|FG000|Overall Study|Non-compliance|0|||
125644305|NCT00545740|451980403|FG001|Overall Study|Non-compliance|2|||
125644306|NCT00545740|451980404|FG002|Overall Study|Non-compliance|1|||
125644307|NCT00545740|451980405|FG003|Overall Study|Non-compliance|0|||
125644308|NCT00545740|451980402|FG000|Overall Study|Moved|2|||
125644309|NCT00545740|451980403|FG001|Overall Study|Moved|0|||
125644310|NCT00545740|451980404|FG002|Overall Study|Moved|1|||
125644311|NCT00545740|451980405|FG003|Overall Study|Moved|0|||
125644312|NCT00545740|451980402|FG000|Overall Study|Diverticulitis attack|0|||
125644313|NCT00545740|451980403|FG001|Overall Study|Diverticulitis attack|0|||
125644314|NCT00545740|451980404|FG002|Overall Study|Diverticulitis attack|1|||
125644315|NCT00545740|451980405|FG003|Overall Study|Diverticulitis attack|1|||
125644316|NCT00545740|451980402|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
125644317|NCT00545740|451980403|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
125644318|NCT00545740|451980404|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
125644319|NCT00545740|451980405|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
125644320|NCT00545740|451980402|FG000|Overall Study|Site closure|1|||
125644321|NCT00545740|451980403|FG001|Overall Study|Site closure|0|||
125644322|NCT00545740|451980404|FG002|Overall Study|Site closure|0|||
125644323|NCT00545740|451980405|FG003|Overall Study|Site closure|0|||
125644324|NCT00545740|451980402|FG000|Overall Study|Missed visit|1|||
125644325|NCT00545740|451980403|FG001|Overall Study|Missed visit|0|||
125644326|NCT00545740|451980404|FG002|Overall Study|Missed visit|0|||
125644327|NCT00545740|451980405|FG003|Overall Study|Missed visit|0|||
125644328|NCT00545740|451980402|FG000|Overall Study|Physician Decision|0|||
125644329|NCT00545740|451980403|FG001|Overall Study|Physician Decision|0|||
125421369|NCT01483924|451168353|FG000|Overall Study|Non-compliance|0|||
125421370|NCT01483924|451168354|FG001|Overall Study|Non-compliance|0|||
125421371|NCT01483924|451168355|FG002|Overall Study|Non-compliance|0|||
125421372|NCT01483924|451168356|FG003|Overall Study|Non-compliance|1|||
125421373|NCT01483924|451168357|FG004|Overall Study|Non-compliance|1|||
125421374|NCT01483924|451168353|FG000|Overall Study|Sponsor concern over ECG result|0|||
125421375|NCT01483924|451168354|FG001|Overall Study|Sponsor concern over ECG result|0|||
125421376|NCT01483924|451168355|FG002|Overall Study|Sponsor concern over ECG result|0|||
125421377|NCT01483924|451168356|FG003|Overall Study|Sponsor concern over ECG result|1|||
125421378|NCT01483924|451168357|FG004|Overall Study|Sponsor concern over ECG result|0|||
125421379|NCT00003298|451168358|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
125421380|NCT00003298|451168358|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
125421381|NCT00003298|451168358|FG000|Surgery|Unresectable at surgery|3|||
125421382|NCT00003298|451168358|FG000|Surgery|Progression before surgery|2|||
125421383|NCT00003298|451168358|FG000|Surgery|Unevaluable and off study|2|||
125421384|NCT00003298|451168358|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
125421385|NCT00003298|451168358|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
125421386|NCT00003298|451168358|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
125421387|NCT00003298|451168358|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
125421388|NCT00003298|451168358|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
125421389|NCT00003298|451168358|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
125421390|NCT00003298|451168358|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
125421391|NCT00003298|451168358|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
125421392|NCT00003298|451168358|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
125421393|NCT00003298|451168358|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
125421394|NCT03565887|451168368|FG000|Overall Study|Adverse Event|1|||
125421395|NCT03565887|451168369|FG001|Overall Study|Adverse Event|0|||
125421396|NCT03565887|451168368|FG000|Overall Study|Withdrawal by Subject|0|||
125421397|NCT03565887|451168369|FG001|Overall Study|Withdrawal by Subject|2|||
125421398|NCT01994954|451168370|FG000|Overall Study|Death|1|||
125421399|NCT01994954|451168371|FG001|Overall Study|Death|0|||
125421400|NCT01994954|451168370|FG000|Overall Study|Withdrawal by Subject|9|||
125421401|NCT01994954|451168371|FG001|Overall Study|Withdrawal by Subject|14|||
125421402|NCT01994954|451168370|FG000|Overall Study|Physician Decision|2|||
125421403|NCT01994954|451168371|FG001|Overall Study|Physician Decision|2|||
125421404|NCT01994954|451168370|FG000|Overall Study|Lost to Follow-up|8|||
125421405|NCT01994954|451168371|FG001|Overall Study|Lost to Follow-up|10|||
125421406|NCT01994954|451168370|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
125421407|NCT01994954|451168371|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
125421408|NCT00449176|451168373|FG000|Overall Study|Withdrawal by Subject|39|||
125421409|NCT00449176|451168374|FG001|Overall Study|Withdrawal by Subject|43|||
125421410|NCT00449176|451168375|FG002|Overall Study|Withdrawal by Subject|59|||
125421411|NCT00449176|451168373|FG000|Overall Study|Lost to Follow-up|13|||
125421412|NCT00449176|451168374|FG001|Overall Study|Lost to Follow-up|8|||
125421413|NCT00449176|451168375|FG002|Overall Study|Lost to Follow-up|12|||
125421414|NCT00449176|451168373|FG000|Overall Study|Adverse Event|51|||
125421415|NCT00449176|451168374|FG001|Overall Study|Adverse Event|107|||
125644330|NCT00545740|451980404|FG002|Overall Study|Physician Decision|3|||
125644331|NCT00545740|451980405|FG003|Overall Study|Physician Decision|0|||
125644332|NCT00545740|451980402|FG000|Overall Study|Accepted only monthly telephone calls|1|||
125644333|NCT00545740|451980403|FG001|Overall Study|Accepted only monthly telephone calls|0|||
125644334|NCT00545740|451980404|FG002|Overall Study|Accepted only monthly telephone calls|0|||
125644335|NCT00545740|451980405|FG003|Overall Study|Accepted only monthly telephone calls|0|||
125644336|NCT00545740|451980402|FG000|Overall Study|Sponsor decision|0|||
125644337|NCT00545740|451980403|FG001|Overall Study|Sponsor decision|1|||
125644338|NCT00545740|451980404|FG002|Overall Study|Sponsor decision|0|||
125644339|NCT00545740|451980405|FG003|Overall Study|Sponsor decision|0|||
125644340|NCT00545740|451980402|FG000|Overall Study|Lack of time|0|||
125644341|NCT00545740|451980403|FG001|Overall Study|Lack of time|1|||
125644342|NCT00545740|451980404|FG002|Overall Study|Lack of time|0|||
125421416|NCT00449176|451168375|FG002|Overall Study|Adverse Event|15|||
125421417|NCT00449176|451168373|FG000|Overall Study|Lack of Efficacy|13|||
125421418|NCT00449176|451168374|FG001|Overall Study|Lack of Efficacy|7|||
125421419|NCT00449176|451168375|FG002|Overall Study|Lack of Efficacy|50|||
125644343|NCT00545740|451980405|FG003|Overall Study|Lack of time|0|||
125644344|NCT00545740|451980402|FG000|Overall Study|Non-adherence to visits|0|||
125644345|NCT00545740|451980403|FG001|Overall Study|Non-adherence to visits|1|||
125644346|NCT00545740|451980404|FG002|Overall Study|Non-adherence to visits|0|||
125644347|NCT00545740|451980405|FG003|Overall Study|Non-adherence to visits|0|||
125644348|NCT00545740|451980402|FG000|Overall Study|Patient difficulties|0|||
125644349|NCT00545740|451980403|FG001|Overall Study|Patient difficulties|1|||
125644350|NCT00545740|451980404|FG002|Overall Study|Patient difficulties|0|||
125644351|NCT00545740|451980405|FG003|Overall Study|Patient difficulties|0|||
125644352|NCT00545740|451980402|FG000|Overall Study|Husband against study|0|||
125644353|NCT00545740|451980403|FG001|Overall Study|Husband against study|0|||
125644354|NCT00545740|451980404|FG002|Overall Study|Husband against study|1|||
125644355|NCT00545740|451980405|FG003|Overall Study|Husband against study|0|||
125644356|NCT00082628|451980408|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
125644357|NCT00082628|451980409|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
125644358|NCT00082628|451980410|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
125644359|NCT00082628|451980411|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
125644360|NCT00082628|451980412|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
125421420|NCT00449176|451168373|FG000|Overall Study|Study drug non-compliant|14|||
125421421|NCT00449176|451168374|FG001|Overall Study|Study drug non-compliant|11|||
125421422|NCT00449176|451168375|FG002|Overall Study|Study drug non-compliant|11|||
125421423|NCT00449176|451168373|FG000|Overall Study|all other|22|||
125421424|NCT00449176|451168374|FG001|Overall Study|all other|19|||
125421425|NCT00449176|451168375|FG002|Overall Study|all other|20|||
125644361|NCT00082628|451980408|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
125644362|NCT00082628|451980409|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
125644363|NCT00082628|451980410|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
125644364|NCT00082628|451980411|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
125644365|NCT00082628|451980412|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
125644366|NCT00082628|451980408|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
125644367|NCT00082628|451980409|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
125644368|NCT00082628|451980410|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
125644369|NCT00082628|451980411|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
125644370|NCT00082628|451980412|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
125421426|NCT02677116|451168384|FG000|Overall Study|Adverse Event|0|||
125421427|NCT02677116|451168385|FG001|Overall Study|Adverse Event|1|||
125421428|NCT02677116|451168386|FG002|Overall Study|Adverse Event|0|||
125421429|NCT02677116|451168387|FG003|Overall Study|Adverse Event|0|||
125421430|NCT02677116|451168388|FG004|Overall Study|Adverse Event|0|||
125421431|NCT02677116|451168389|FG005|Overall Study|Adverse Event|1|||
125421432|NCT02677116|451168390|FG006|Overall Study|Adverse Event|1|||
125421433|NCT02677116|451168391|FG007|Overall Study|Adverse Event|0|||
125421434|NCT02677116|451168392|FG008|Overall Study|Adverse Event|0|||
125644371|NCT00082628|451980408|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
125644372|NCT00082628|451980409|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
125644373|NCT00082628|451980410|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
125644374|NCT00082628|451980411|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
125644375|NCT00082628|451980412|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
125644376|NCT00082628|451980408|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
125421435|NCT02677116|451168384|FG000|Overall Study|Physician Decision|0|||
125421436|NCT02677116|451168385|FG001|Overall Study|Physician Decision|2|||
125644377|NCT00082628|451980409|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
125644378|NCT00082628|451980410|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
125198606|NCT04250350|450350980|FG000|Overall Study|Withdrawal by Subject|13|||
125421437|NCT02677116|451168386|FG002|Overall Study|Physician Decision|3|||
125421438|NCT02677116|451168387|FG003|Overall Study|Physician Decision|2|||
125421439|NCT02677116|451168388|FG004|Overall Study|Physician Decision|1|||
125644379|NCT00082628|451980411|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
125644380|NCT00082628|451980412|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
125533170|NCT02942277|451582750|FG006|Year 1|Joined Army|0|||
125533171|NCT02942277|451582751|FG007|Year 1|Joined Army|0|||
125533172|NCT02942277|451582752|FG008|Year 1|Joined Army|0|||
125644381|NCT00082628|451980408|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
125644382|NCT00082628|451980409|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
125644383|NCT00082628|451980410|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
125644384|NCT00082628|451980411|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
125644385|NCT00082628|451980412|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
125644386|NCT00082628|451980408|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
125644387|NCT00082628|451980409|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
125644388|NCT00082628|451980410|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
125644389|NCT00082628|451980411|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
125644390|NCT00082628|451980412|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
125644391|NCT02177942|451980417|FG000|Overall Study|Adverse Event|1|||
125533173|NCT02942277|451582753|FG009|Year 1|Joined Army|0|||
125644392|NCT02177942|451980418|FG001|Overall Study|Adverse Event|0|||
125644393|NCT02177942|451980417|FG000|Overall Study|Lost to Follow-up|1|||
125644394|NCT02177942|451980418|FG001|Overall Study|Lost to Follow-up|1|||
125644395|NCT02177942|451980417|FG000|Overall Study|Protocol Violation|4|||
125644396|NCT02177942|451980418|FG001|Overall Study|Protocol Violation|6|||
125644397|NCT02177942|451980417|FG000|Overall Study|Withdrawal by Subject|71|||
125644398|NCT02177942|451980418|FG001|Overall Study|Withdrawal by Subject|81|||
125644399|NCT01351415|451980419|FG000|Overall Study|Withdrawal by Subject|15|||
125644400|NCT01351415|451980420|FG001|Overall Study|Withdrawal by Subject|17|||
125644401|NCT01351415|451980419|FG000|Overall Study|Trial termination by the Sponsor|28|||
125644402|NCT01351415|451980420|FG001|Overall Study|Trial termination by the Sponsor|19|||
125644403|NCT01351415|451980419|FG000|Overall Study|Lost to Follow-up|5|||
125644404|NCT01351415|451980420|FG001|Overall Study|Lost to Follow-up|7|||
125644405|NCT01351415|451980419|FG000|Overall Study|Death|190|||
125644406|NCT01351415|451980420|FG001|Overall Study|Death|187|||
125644407|NCT01351415|451980419|FG000|Overall Study|Physician Decision|2|||
125644408|NCT01351415|451980420|FG001|Overall Study|Physician Decision|3|||
125644409|NCT01351415|451980419|FG000|Overall Study|Reason unknown|0|||
125644410|NCT01351415|451980420|FG001|Overall Study|Reason unknown|2|||
125644411|NCT01351415|451980419|FG000|Overall Study|Never Started|5|||
125644412|NCT01351415|451980420|FG001|Overall Study|Never Started|5|||
125644413|NCT01234337|451980421|FG000|Overall Study|Adverse Event|58|||
125644414|NCT01234337|451980422|FG001|Overall Study|Adverse Event|21|||
125644415|NCT01234337|451980421|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
125644416|NCT01234337|451980422|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
125644417|NCT01234337|451980421|FG000|Overall Study|Investi. decision not protocol driven|5|||
125644418|NCT01234337|451980422|FG001|Overall Study|Investi. decision not protocol driven|6|||
125533174|NCT02942277|451582754|FG010|Year 1|Joined Army|0|||
125533175|NCT02942277|451582744|FG000|Year 1|Subject met withdrawal criteria|0|||
125533176|NCT02942277|451582745|FG001|Year 1|Subject met withdrawal criteria|0|||
125644419|NCT01234337|451980421|FG000|Overall Study|Non-compliant with study medication|3|||
125644420|NCT01234337|451980422|FG001|Overall Study|Non-compliant with study medication|2|||
125644421|NCT01234337|451980421|FG000|Overall Study|Randomized but not treated|6|||
125644422|NCT01234337|451980422|FG001|Overall Study|Randomized but not treated|4|||
125644423|NCT01234337|451980421|FG000|Overall Study|Lost to Follow-up|0|||
125644424|NCT01234337|451980422|FG001|Overall Study|Lost to Follow-up|1|||
125644425|NCT01234337|451980421|FG000|Overall Study|Protocol Violation|2|||
125644426|NCT01234337|451980422|FG001|Overall Study|Protocol Violation|3|||
125644427|NCT01234337|451980421|FG000|Overall Study|Withdrawal by Subject|11|||
125644428|NCT01234337|451980422|FG001|Overall Study|Withdrawal by Subject|9|||
125644429|NCT01234337|451980421|FG000|Overall Study|Death|0|||
125644430|NCT01234337|451980422|FG001|Overall Study|Death|1|||
125644431|NCT01234337|451980421|FG000|Overall Study|Switch to commercial drug|0|||
125644432|NCT01234337|451980422|FG001|Overall Study|Switch to commercial drug|1|||
125644433|NCT04118127|451980427|FG000|Overall Study|Trial terminated by sponsor|0|||
125644434|NCT04118127|451980428|FG001|Overall Study|Trial terminated by sponsor|12|||
125533177|NCT02942277|451582746|FG002|Year 1|Subject met withdrawal criteria|0|||
125644435|NCT04118127|451980427|FG000|Overall Study|Adverse Event|1|||
125644436|NCT04118127|451980428|FG001|Overall Study|Adverse Event|2|||
125644437|NCT04118127|451980427|FG000|Overall Study|Physician Decision|0|||
125533178|NCT02942277|451582747|FG003|Year 1|Subject met withdrawal criteria|1|||
125533179|NCT02942277|451582748|FG004|Year 1|Subject met withdrawal criteria|0|||
125533180|NCT02942277|451582749|FG005|Year 1|Subject met withdrawal criteria|0|||
125644438|NCT04118127|451980428|FG001|Overall Study|Physician Decision|1|||
125644439|NCT04118127|451980427|FG000|Overall Study|Withdrawal by Subject|2|||
125644440|NCT04118127|451980428|FG001|Overall Study|Withdrawal by Subject|1|||
125644441|NCT03480360|451980429|FG000|Overall Study|Death|2|||
125644442|NCT01646255|451980434|FG000|Overall Study|Adverse Event|7|||
125644443|NCT01646255|451980435|FG001|Overall Study|Adverse Event|8|||
125644444|NCT01646255|451980434|FG000|Overall Study|Lack of Efficacy|2|||
125644445|NCT01646255|451980435|FG001|Overall Study|Lack of Efficacy|0|||
125644446|NCT01646255|451980434|FG000|Overall Study|Withdrawal by Subject|10|||
125644447|NCT01646255|451980435|FG001|Overall Study|Withdrawal by Subject|6|||
125644448|NCT01646255|451980434|FG000|Overall Study|Compliance is not well|1|||
125644449|NCT01646255|451980435|FG001|Overall Study|Compliance is not well|0|||
125644450|NCT01646255|451980434|FG000|Overall Study|Inclusion Criteria Deviation|1|||
125644451|NCT01646255|451980435|FG001|Overall Study|Inclusion Criteria Deviation|0|||
125644452|NCT02380703|451980436|FG000|Overall Study|Withdrawal by Subject|12|||
125644453|NCT02380703|451980437|FG001|Overall Study|Withdrawal by Subject|9|||
125644454|NCT02380703|451980436|FG000|Overall Study|Lost to Follow-up|12|||
125644455|NCT02380703|451980437|FG001|Overall Study|Lost to Follow-up|12|||
125644456|NCT02380703|451980436|FG000|Overall Study|Caregiver death|1|||
125644457|NCT02380703|451980437|FG001|Overall Study|Caregiver death|0|||
125644458|NCT02380703|451980436|FG000|Overall Study|Person with dementia (PWD) death|7|||
125644459|NCT02380703|451980437|FG001|Overall Study|Person with dementia (PWD) death|8|||
125644460|NCT02380703|451980436|FG000|Overall Study|Entered Long-term Care|4|||
125644461|NCT02380703|451980437|FG001|Overall Study|Entered Long-term Care|7|||
125644462|NCT03480841|451980438|FG000|Overall Study|Lost to Follow-up|2|||
125644463|NCT01362049|451980439|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
125644464|NCT01362049|451980440|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
125644465|NCT01362049|451980441|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
125644466|NCT01362049|451980442|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
125644467|NCT01362049|451980439|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
125644468|NCT01362049|451980440|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
125644469|NCT01362049|451980441|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
125644470|NCT01362049|451980442|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
125533181|NCT02942277|451582750|FG006|Year 1|Subject met withdrawal criteria|0|||
125198607|NCT04250350|450350980|FG000|Overall Study|Lost to Follow-up|8|||
125198608|NCT04250350|450350980|FG000|Overall Study|Adverse Event|5|||
125198609|NCT04250350|450350980|FG000|Overall Study|Lack of Efficacy|4|||
125198610|NCT04250350|450350980|FG000|Overall Study|Physician Decision|1|||
125644471|NCT01524900|451982004|FG000|Overall Study|Lost to Follow-up|3|||
125644472|NCT01524900|451982005|FG001|Overall Study|Lost to Follow-up|12|||
125644473|NCT01524900|451982006|FG002|Overall Study|Lost to Follow-up|1|||
125644474|NCT01524900|451982007|FG003|Overall Study|Lost to Follow-up|0|||
125644475|NCT01524900|451982008|FG004|Overall Study|Lost to Follow-up|0|||
125644476|NCT01524900|451982004|FG000|Overall Study|Other reason than stated above|1|||
125644477|NCT01524900|451982005|FG001|Overall Study|Other reason than stated above|1|||
125644478|NCT01524900|451982006|FG002|Overall Study|Other reason than stated above|0|||
125644479|NCT01524900|451982007|FG003|Overall Study|Other reason than stated above|0|||
125644480|NCT01524900|451982008|FG004|Overall Study|Other reason than stated above|0|||
125644481|NCT01524900|451982004|FG000|Overall Study|No reason documented|2|||
125131279|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
125131280|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Death|1|||
125131281|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Death|0|||
125131282|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
125131283|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
125131284|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
125131285|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
125131286|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Other|6|||
125131287|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Other|10|||
125131288|NCT01864174|450108085|FG000|Off Treatment Follow-Up|Other|2|||
125131289|NCT01864174|450108086|FG001|Off Treatment Follow-Up|Other|0|||
125131290|NCT01864174|450108085|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
125131291|NCT01864174|450108086|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
125131292|NCT02739997|450108087|FG000|Overall Study|Death|1|||
125131293|NCT02739997|450108087|FG000|Overall Study|Withdrawal by Subject|1|||
125131294|NCT00468286|450108088|FG000|Overall Study|Adverse Event|1|||
125131295|NCT00468286|450108089|FG001|Overall Study|Adverse Event|6|||
125131296|NCT00468286|450108088|FG000|Overall Study|Protocol Violation|2|||
125131297|NCT00468286|450108089|FG001|Overall Study|Protocol Violation|2|||
125131298|NCT00468286|450108088|FG000|Overall Study|Withdrawal by Subject|4|||
125131299|NCT00468286|450108089|FG001|Overall Study|Withdrawal by Subject|3|||
125131300|NCT00468286|450108088|FG000|Overall Study|Physician Decision|0|||
125131301|NCT00468286|450108089|FG001|Overall Study|Physician Decision|1|||
125131302|NCT02158663|450108090|FG000|Overall Study|Withdrawal by Subject|5|||
125131303|NCT02158663|450108091|FG001|Overall Study|Withdrawal by Subject|4|||
125131304|NCT03552393|450108096|FG000|Core Period|Kidney Transplant|1|||
125131305|NCT03552393|450108096|FG000|Core Period|Prohibited Medication|1|||
125131306|NCT03552393|450108096|FG000|Safety Extension Period|Kidney Transplant|4|||
125131307|NCT02414152|450108098|FG000|Overall Study|Withdrawal by Subject|1|||
125131308|NCT02414152|450108098|FG000|Overall Study|Lack of Efficacy|1|||
125131309|NCT02601625|450108099|FG000|Overall Study|Lost to Follow-up|0|||
125131310|NCT02601625|450108100|FG001|Overall Study|Lost to Follow-up|0|||
125131311|NCT02601625|450108101|FG002|Overall Study|Lost to Follow-up|1|||
125131312|NCT02601625|450108102|FG003|Overall Study|Lost to Follow-up|1|||
125131313|NCT00359281|450108103|FG000|Overall Study|Adverse Event|1|||
125131314|NCT00359281|450108104|FG001|Overall Study|Adverse Event|0|||
125131315|NCT00359281|450108105|FG002|Overall Study|Adverse Event|0|||
125131316|NCT00359281|450108106|FG003|Overall Study|Adverse Event|0|||
125131317|NCT00359281|450108107|FG004|Overall Study|Adverse Event|0|||
125131318|NCT00359281|450108108|FG005|Overall Study|Adverse Event|0|||
125131319|NCT00359281|450108109|FG006|Overall Study|Adverse Event|1|||
125131320|NCT00359281|450108110|FG007|Overall Study|Adverse Event|0|||
125131321|NCT00359281|450108111|FG008|Overall Study|Adverse Event|0|||
125131322|NCT00359281|450108103|FG000|Overall Study|Withdrawal by Subject|0|||
125131323|NCT00359281|450108104|FG001|Overall Study|Withdrawal by Subject|0|||
125131324|NCT00359281|450108105|FG002|Overall Study|Withdrawal by Subject|0|||
125131325|NCT00359281|450108106|FG003|Overall Study|Withdrawal by Subject|0|||
125131326|NCT00359281|450108107|FG004|Overall Study|Withdrawal by Subject|0|||
125131327|NCT00359281|450108108|FG005|Overall Study|Withdrawal by Subject|0|||
125131328|NCT00359281|450108109|FG006|Overall Study|Withdrawal by Subject|1|||
125533182|NCT02942277|451582751|FG007|Year 1|Subject met withdrawal criteria|0|||
125533183|NCT02942277|451582752|FG008|Year 1|Subject met withdrawal criteria|0|||
125533184|NCT02942277|451582753|FG009|Year 1|Subject met withdrawal criteria|0|||
125131329|NCT00359281|450108110|FG007|Overall Study|Withdrawal by Subject|0|||
125131330|NCT00359281|450108111|FG008|Overall Study|Withdrawal by Subject|0|||
125131331|NCT04887415|450108112|FG000|Overall Study|Lost to Follow-up|2|||
125131332|NCT01415986|450108113|FG000|Overall Study|Lost to Follow-up|1|||
125421440|NCT02677116|451168389|FG005|Overall Study|Physician Decision|3|||
125131333|NCT03792477|450108114|FG000|Overall Study|Adverse Event|0|||
125131334|NCT03792477|450108115|FG001|Overall Study|Adverse Event|0|||
125131335|NCT03792477|450108116|FG002|Overall Study|Adverse Event|0|||
125131336|NCT03792477|450108117|FG003|Overall Study|Adverse Event|1|||
125131337|NCT03792477|450108118|FG004|Overall Study|Adverse Event|0|||
125131338|NCT03792477|450108114|FG000|Overall Study|Lost to Follow-up|0|||
125198611|NCT04250350|450350980|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
125533185|NCT02942277|451582754|FG010|Year 1|Subject met withdrawal criteria|0|||
125644482|NCT01524900|451982005|FG001|Overall Study|No reason documented|1|||
125644483|NCT01524900|451982006|FG002|Overall Study|No reason documented|0|||
125644484|NCT01524900|451982007|FG003|Overall Study|No reason documented|1|||
125644485|NCT01524900|451982008|FG004|Overall Study|No reason documented|0|||
125644486|NCT03824704|451982009|FG000|Overall Study|Study Terminated by Sponsor|1|||
125644487|NCT00298766|451982010|FG000|Overall Study|Adverse Event|18|||
125644488|NCT00298766|451982010|FG000|Overall Study|Death|2|||
125644489|NCT00298766|451982010|FG000|Overall Study|Withdrawal by Subject|9|||
125644490|NCT00298766|451982010|FG000|Overall Study|Treatment ongoing|4|||
125644491|NCT00298766|451982010|FG000|Overall Study|Progression of amyloid markers|4|||
125644492|NCT00298766|451982010|FG000|Overall Study|Deterioration in KPS and organ function|1|||
125644493|NCT00298766|451982010|FG000|Overall Study|Subjects overall condition deterioration|4|||
125644494|NCT00298766|451982010|FG000|Overall Study|Other|4|||
125644495|NCT02988115|451982012|FG000|Overall Study|Adverse Event|6|||
125644496|NCT02988115|451982013|FG001|Overall Study|Adverse Event|1|||
125644497|NCT02988115|451982012|FG000|Overall Study|Sponsor Decision|5|||
125644498|NCT02988115|451982013|FG001|Overall Study|Sponsor Decision|2|||
125644499|NCT02988115|451982012|FG000|Overall Study|Withdrawal by Subject|1|||
125644500|NCT02988115|451982013|FG001|Overall Study|Withdrawal by Subject|1|||
125644501|NCT02988115|451982012|FG000|Overall Study|Withdrawn by Mistake|1|||
125644502|NCT02988115|451982013|FG001|Overall Study|Withdrawn by Mistake|0|||
125644503|NCT02988115|451982012|FG000|Overall Study|Lost to Follow-up|1|||
125644504|NCT02988115|451982013|FG001|Overall Study|Lost to Follow-up|0|||
125644505|NCT01731951|451982014|FG000|Overall Study|Documented Disease Progression|1|||
125644506|NCT01731951|451982015|FG001|Overall Study|Documented Disease Progression|0|||
125644507|NCT01731951|451982016|FG002|Overall Study|Documented Disease Progression|0|||
125644508|NCT01731951|451982017|FG003|Overall Study|Documented Disease Progression|0|||
125644509|NCT01731951|451982018|FG004|Overall Study|Documented Disease Progression|0|||
125644510|NCT01731951|451982019|FG005|Overall Study|Documented Disease Progression|0|||
125644511|NCT01731951|451982014|FG000|Overall Study|Lost to Follow-up|2|||
125644512|NCT01731951|451982015|FG001|Overall Study|Lost to Follow-up|0|||
125644513|NCT01731951|451982016|FG002|Overall Study|Lost to Follow-up|0|||
125644514|NCT01731951|451982017|FG003|Overall Study|Lost to Follow-up|1|||
125644515|NCT01731951|451982018|FG004|Overall Study|Lost to Follow-up|3|||
125644516|NCT01731951|451982019|FG005|Overall Study|Lost to Follow-up|1|||
125644517|NCT01731951|451982014|FG000|Overall Study|Withdrawal of Consent|1|||
125644518|NCT01731951|451982015|FG001|Overall Study|Withdrawal of Consent|0|||
125644519|NCT01731951|451982016|FG002|Overall Study|Withdrawal of Consent|0|||
125644520|NCT01731951|451982017|FG003|Overall Study|Withdrawal of Consent|0|||
125644521|NCT01731951|451982018|FG004|Overall Study|Withdrawal of Consent|0|||
125644522|NCT01731951|451982019|FG005|Overall Study|Withdrawal of Consent|2|||
125309948|NCT00853151|450761940|FG002|Overall Study|Lost to Follow-up|3|||
125309949|NCT00853151|450761941|FG003|Overall Study|Lost to Follow-up|0|||
125309950|NCT00853151|450761938|FG000|Overall Study|Death|1|||
125309951|NCT00853151|450761939|FG001|Overall Study|Death|0|||
125309952|NCT00853151|450761940|FG002|Overall Study|Death|0|||
125309953|NCT00853151|450761941|FG003|Overall Study|Death|1|||
125309954|NCT00853151|450761938|FG000|Overall Study|Protocol Violation|0|||
125309955|NCT00853151|450761939|FG001|Overall Study|Protocol Violation|0|||
125309956|NCT00853151|450761940|FG002|Overall Study|Protocol Violation|0|||
125309957|NCT00853151|450761941|FG003|Overall Study|Protocol Violation|1|||
125309958|NCT00853151|450761938|FG000|Overall Study|Withdrawal by Subject|5|||
125309959|NCT00853151|450761939|FG001|Overall Study|Withdrawal by Subject|4|||
125309960|NCT00853151|450761940|FG002|Overall Study|Withdrawal by Subject|2|||
125309961|NCT00853151|450761941|FG003|Overall Study|Withdrawal by Subject|1|||
125309962|NCT00853151|450761938|FG000|Overall Study|Physician Decision|0|||
125309963|NCT00853151|450761939|FG001|Overall Study|Physician Decision|2|||
125309964|NCT00853151|450761940|FG002|Overall Study|Physician Decision|1|||
125309965|NCT00853151|450761941|FG003|Overall Study|Physician Decision|0|||
125309966|NCT00853151|450761938|FG000|Overall Study|Sponsor Decision|0|||
125309967|NCT00853151|450761939|FG001|Overall Study|Sponsor Decision|3|||
125309968|NCT00853151|450761940|FG002|Overall Study|Sponsor Decision|0|||
125309969|NCT00853151|450761941|FG003|Overall Study|Sponsor Decision|0|||
125309970|NCT00269919|450761942|FG000|Overall Study|Other|26|||
125309971|NCT00269919|450761942|FG000|Overall Study|Started but not treated|1|||
125309972|NCT04473963|450761943|FG000|Overall Study|Withdrawal by Subject|1|||
125309973|NCT04473963|450761944|FG001|Overall Study|Withdrawal by Subject|1|||
125309974|NCT04473963|450761945|FG002|Overall Study|Withdrawal by Subject|0|||
125309975|NCT04473963|450761943|FG000|Overall Study|Not inducible in AF|0|||
125309976|NCT04473963|450761944|FG001|Overall Study|Not inducible in AF|0|||
125309977|NCT04473963|450761945|FG002|Overall Study|Not inducible in AF|2|||
125309978|NCT01799226|450761948|FG000|Overall Study|Withdrawal by Subject|1|||
125309979|NCT01799226|450761949|FG001|Overall Study|Withdrawal by Subject|0|||
125644523|NCT01731951|451982014|FG000|Overall Study|Death|13|||
125309980|NCT01799226|450761948|FG000|Overall Study|Disqualified at Day 14|1|||
125309981|NCT01799226|450761949|FG001|Overall Study|Disqualified at Day 14|0|||
125309982|NCT02274792|450761950|FG000|Overall Study|Withdrawal by Subject|13|||
125309983|NCT02274792|450761950|FG000|Overall Study|Lost to Follow-up|8|||
125309984|NCT02274792|450761950|FG000|Overall Study|Protocol Specified Criteria|2|||
125309985|NCT02274792|450761950|FG000|Overall Study|Sponsor Decision|2|||
125309986|NCT03361293|450761959|FG000|Overall Study|Lost to Follow-up|0|||
125309987|NCT03361293|450761960|FG001|Overall Study|Lost to Follow-up|2|||
125309988|NCT03361293|450761959|FG000|Overall Study|Withdrawal by Subject|1|||
125309989|NCT03361293|450761960|FG001|Overall Study|Withdrawal by Subject|3|||
125309990|NCT01550757|450761964|FG000|Overall Study|Lost to Follow-up|21|||
125309991|NCT01550757|450761965|FG001|Overall Study|Lost to Follow-up|14|||
125309992|NCT01550757|450761966|FG002|Overall Study|Lost to Follow-up|42|||
125309993|NCT01550757|450761967|FG003|Overall Study|Lost to Follow-up|53|||
125309994|NCT01550757|450761964|FG000|Overall Study|Withdrawal by Subject|2|||
125309995|NCT01550757|450761965|FG001|Overall Study|Withdrawal by Subject|0|||
125309996|NCT01550757|450761966|FG002|Overall Study|Withdrawal by Subject|3|||
125309997|NCT01550757|450761967|FG003|Overall Study|Withdrawal by Subject|1|||
125309998|NCT04098809|450761969|FG000|Overall Study|Withdrawal by Subject|1|||
125309999|NCT04098809|450761970|FG001|Overall Study|Withdrawal by Subject|3|||
125310000|NCT04098809|450761969|FG000|Overall Study|Physician Decision|2|||
125310001|NCT04098809|450761970|FG001|Overall Study|Physician Decision|1|||
125310002|NCT02741596|450761971|FG000|Overall Study|Adverse Event|1|||
125644524|NCT01731951|451982015|FG001|Overall Study|Death|15|||
125310003|NCT02741596|450761972|FG001|Overall Study|Adverse Event|5|||
125310004|NCT02741596|450761971|FG000|Overall Study|Lost to Follow-up|1|||
125310005|NCT02741596|450761972|FG001|Overall Study|Lost to Follow-up|1|||
125310006|NCT02741596|450761971|FG000|Overall Study|Physician Decision|2|||
125310007|NCT02741596|450761972|FG001|Overall Study|Physician Decision|1|||
125310008|NCT02741596|450761971|FG000|Overall Study|Pregnancy|3|||
125310009|NCT02741596|450761972|FG001|Overall Study|Pregnancy|1|||
125310010|NCT02741596|450761971|FG000|Overall Study|Other (Unspecified)|0|||
125310011|NCT02741596|450761972|FG001|Overall Study|Other (Unspecified)|3|||
125310012|NCT02741596|450761971|FG000|Overall Study|Subject withdrawn-Other|17|||
125310013|NCT02741596|450761972|FG001|Overall Study|Subject withdrawn-Other|4|||
125310014|NCT02741596|450761971|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
125310015|NCT02741596|450761972|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
125310016|NCT01426958|450761973|FG000|Overall Study|Adverse Event|2|||
125310017|NCT02859246|450761976|FG000|Overall Study|Screen fails|3|||
125310018|NCT02859246|450761976|FG000|Overall Study|Adverse Event|1|||
125310019|NCT02859246|450761976|FG000|Overall Study|Withdrawal by Subject|1|||
125310020|NCT00100789|450761977|FG000|Overall Study|Adverse Event|10|||
125310021|NCT00100789|450761977|FG000|Overall Study|Withdrawal by Subject|1|||
125310022|NCT00100789|450761977|FG000|Overall Study|Progression/relapse|42|||
125310023|NCT00100789|450761977|FG000|Overall Study|Death|2|||
125310024|NCT00100789|450761977|FG000|Overall Study|Not protocol specified|5|||
125310025|NCT00100789|450761977|FG000|Overall Study|Ineligible|3|||
125310026|NCT00100789|450761977|FG000|Overall Study|Never received treatment|1|||
125310027|NCT01746368|450761978|FG000|Overall Study|Lost to Follow-up|2|||
125310028|NCT01746368|450761979|FG001|Overall Study|Lost to Follow-up|0|||
125310029|NCT01746368|450761978|FG000|Overall Study|Withdrawal by Subject|0|||
125310030|NCT01746368|450761979|FG001|Overall Study|Withdrawal by Subject|1|||
125310031|NCT05280717|450761980|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
125310032|NCT05280717|450761981|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
125310033|NCT05280717|450761982|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
125310034|NCT05280717|450761983|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
125310035|NCT05280717|450761984|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
125310036|NCT05280717|450761985|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
125310037|NCT05280717|450761986|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
125310038|NCT05280717|450761980|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
125310039|NCT05280717|450761981|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
125310040|NCT05280717|450761982|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
125310041|NCT05280717|450761983|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
125310042|NCT05280717|450761984|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
125310043|NCT05280717|450761985|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
125310044|NCT05280717|450761986|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
125310045|NCT05280717|450761980|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
125310046|NCT05280717|450761981|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
125310047|NCT05280717|450761982|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
125310048|NCT05280717|450761983|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
125310049|NCT05280717|450761984|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
125310050|NCT05280717|450761985|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
125310051|NCT05280717|450761986|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
125310052|NCT05280717|450761980|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
125378809|NCT01774968|451017299|FG001|Overall Study|Physician Decision|1|||
125533186|NCT02942277|451582744|FG000|Year 1|Lost to Follow-up|0|||
125644525|NCT01731951|451982016|FG002|Overall Study|Death|9|||
125644526|NCT01731951|451982017|FG003|Overall Study|Death|8|||
125644527|NCT01731951|451982018|FG004|Overall Study|Death|9|||
125644528|NCT01731951|451982019|FG005|Overall Study|Death|6|||
125644529|NCT03287089|451982020|FG000|Overall Study|Lost to Follow-up|0|||
125644530|NCT03287089|451982021|FG001|Overall Study|Lost to Follow-up|2|||
125644531|NCT03287089|451982020|FG000|Overall Study|Physician Decision|0|||
125644532|NCT03287089|451982021|FG001|Overall Study|Physician Decision|2|||
125644533|NCT03287089|451982020|FG000|Overall Study|Withdrawal by Subject|0|||
125644534|NCT03287089|451982021|FG001|Overall Study|Withdrawal by Subject|2|||
125644535|NCT00661362|451982022|FG000|Overall Study|Adverse Event|5|||
125644536|NCT00661362|451982023|FG001|Overall Study|Adverse Event|4|||
125644537|NCT00661362|451982022|FG000|Overall Study|Incorrect enrollment|2|||
125644538|NCT00661362|451982023|FG001|Overall Study|Incorrect enrollment|0|||
125644539|NCT00661362|451982022|FG000|Overall Study|Study specific discontinuation criteria|4|||
125644540|NCT00661362|451982023|FG001|Overall Study|Study specific discontinuation criteria|11|||
125644541|NCT00661362|451982022|FG000|Overall Study|Withdrawal by Subject|13|||
125644542|NCT00661362|451982023|FG001|Overall Study|Withdrawal by Subject|23|||
125644543|NCT00661362|451982022|FG000|Overall Study|Lost to Follow-up|3|||
125644544|NCT00661362|451982023|FG001|Overall Study|Lost to Follow-up|1|||
125644545|NCT00661362|451982022|FG000|Overall Study|Severe non-compliance to protocol|0|||
125644546|NCT00661362|451982023|FG001|Overall Study|Severe non-compliance to protocol|1|||
125644547|NCT00661362|451982022|FG000|Overall Study|Safety reasons|1|||
125644548|NCT00661362|451982023|FG001|Overall Study|Safety reasons|0|||
125644549|NCT00661362|451982022|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
125644550|NCT00661362|451982023|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
125644551|NCT00775138|451982024|FG000|Overall Study|Withdrawal by Subject|0|||
125644552|NCT00775138|451982025|FG001|Overall Study|Withdrawal by Subject|0|||
125644553|NCT00775138|451982026|FG002|Overall Study|Withdrawal by Subject|2|||
125644554|NCT00775138|451982027|FG003|Overall Study|Withdrawal by Subject|2|||
125644555|NCT00775138|451982024|FG000|Overall Study|Adverse Event|0|||
125644556|NCT00775138|451982025|FG001|Overall Study|Adverse Event|0|||
125644557|NCT00775138|451982026|FG002|Overall Study|Adverse Event|1|||
125644558|NCT00775138|451982027|FG003|Overall Study|Adverse Event|0|||
125644559|NCT04880642|451982028|FG000|Randomization|Withdrawal by Subject|2|||
125644560|NCT04880642|451982029|FG001|Randomization|Withdrawal by Subject|3|||
125644561|NCT04880642|451982028|FG000|Treatment Period|Adverse Event|0|||
125644562|NCT04880642|451982029|FG001|Treatment Period|Adverse Event|1|||
125644563|NCT04880642|451982028|FG000|Treatment Period|Death|6|||
125644564|NCT04880642|451982029|FG001|Treatment Period|Death|6|||
125644565|NCT04880642|451982028|FG000|Treatment Period|Lost to Follow-up|1|||
125644566|NCT04880642|451982029|FG001|Treatment Period|Lost to Follow-up|0|||
125644567|NCT04880642|451982028|FG000|Treatment Period|Protocol Violation|0|||
125644568|NCT04880642|451982029|FG001|Treatment Period|Protocol Violation|1|||
125644569|NCT04880642|451982028|FG000|Treatment Period|Withdrawal by Subject|5|||
125644570|NCT04880642|451982029|FG001|Treatment Period|Withdrawal by Subject|3|||
125644571|NCT04880642|451982028|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
125644572|NCT04880642|451982029|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
125644573|NCT04880642|451982028|FG000|Follow-up|Death|4|||
125644574|NCT04880642|451982029|FG001|Follow-up|Death|3|||
125644575|NCT04880642|451982028|FG000|Follow-up|Withdrawal by Subject|1|||
125644576|NCT04880642|451982029|FG001|Follow-up|Withdrawal by Subject|0|||
125644577|NCT02906644|451982030|FG000|First 2 Weeks|Withdrawal by Subject|0|||
125644578|NCT02906644|451982031|FG001|First 2 Weeks|Withdrawal by Subject|2|||
125644579|NCT02906644|451982030|FG000|First 2 Weeks|Physician Decision|1|||
125644580|NCT02906644|451982031|FG001|First 2 Weeks|Physician Decision|1|||
125644581|NCT02906644|451982030|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
125644582|NCT02906644|451982031|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
125644583|NCT02906644|451982030|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
125644584|NCT02906644|451982031|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
125644585|NCT02452034|451982032|FG000|Overall Study|Adverse Event|0|||
125644586|NCT02452034|451982033|FG001|Overall Study|Adverse Event|0|||
125644587|NCT02452034|451982034|FG002|Overall Study|Adverse Event|0|||
125644588|NCT02452034|451982035|FG003|Overall Study|Adverse Event|0|||
125644589|NCT02452034|451982036|FG004|Overall Study|Adverse Event|0|||
125644590|NCT02452034|451982037|FG005|Overall Study|Adverse Event|1|||
125644591|NCT02452034|451982032|FG000|Overall Study|Death|0|||
125644592|NCT02452034|451982033|FG001|Overall Study|Death|0|||
125644593|NCT02452034|451982034|FG002|Overall Study|Death|0|||
125644594|NCT02452034|451982035|FG003|Overall Study|Death|0|||
125644595|NCT02452034|451982036|FG004|Overall Study|Death|1|||
125644596|NCT02452034|451982037|FG005|Overall Study|Death|1|||
125644597|NCT02452034|451982032|FG000|Overall Study|Physician Decision|0|||
125644598|NCT02452034|451982033|FG001|Overall Study|Physician Decision|1|||
125644599|NCT02452034|451982034|FG002|Overall Study|Physician Decision|1|||
125644600|NCT02452034|451982035|FG003|Overall Study|Physician Decision|0|||
125644601|NCT02452034|451982036|FG004|Overall Study|Physician Decision|0|||
125644602|NCT02452034|451982037|FG005|Overall Study|Physician Decision|0|||
125644603|NCT02452034|451982032|FG000|Overall Study|Protocol Violation|0|||
125644604|NCT02452034|451982033|FG001|Overall Study|Protocol Violation|0|||
125644605|NCT02452034|451982034|FG002|Overall Study|Protocol Violation|0|||
125644606|NCT02452034|451982035|FG003|Overall Study|Protocol Violation|0|||
125644607|NCT02452034|451982036|FG004|Overall Study|Protocol Violation|0|||
125644608|NCT02452034|451982037|FG005|Overall Study|Protocol Violation|1|||
125644609|NCT02452034|451982032|FG000|Overall Study|Screen Failure|1|||
125644610|NCT02452034|451982033|FG001|Overall Study|Screen Failure|0|||
125644611|NCT02452034|451982034|FG002|Overall Study|Screen Failure|0|||
125644612|NCT02452034|451982035|FG003|Overall Study|Screen Failure|1|||
125644613|NCT02452034|451982036|FG004|Overall Study|Screen Failure|0|||
125644614|NCT02452034|451982037|FG005|Overall Study|Screen Failure|0|||
125644615|NCT02452034|451982032|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
125644616|NCT02452034|451982033|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
125644617|NCT02452034|451982034|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
125644618|NCT02452034|451982035|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
125644619|NCT02452034|451982036|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
125644620|NCT02452034|451982037|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
125644621|NCT00561795|451982038|FG000|Overall Study|Adverse Event|3|||
125644622|NCT00561795|451982039|FG001|Overall Study|Adverse Event|3|||
125644623|NCT00561795|451982040|FG002|Overall Study|Adverse Event|0|||
125644624|NCT00561795|451982041|FG003|Overall Study|Adverse Event|0|||
125644625|NCT00561795|451982038|FG000|Overall Study|Study Closed/Terminated|0|||
125644626|NCT00561795|451982039|FG001|Overall Study|Study Closed/Terminated|3|||
125644627|NCT00561795|451982040|FG002|Overall Study|Study Closed/Terminated|0|||
125644628|NCT00561795|451982041|FG003|Overall Study|Study Closed/Terminated|0|||
125644629|NCT00561795|451982038|FG000|Overall Study|Physician Decision|1|||
125644630|NCT00561795|451982039|FG001|Overall Study|Physician Decision|0|||
125644631|NCT00561795|451982040|FG002|Overall Study|Physician Decision|0|||
125644632|NCT00561795|451982041|FG003|Overall Study|Physician Decision|0|||
125644633|NCT04235959|451982043|FG000|Overall Study|Protocol Violation|0|||
125644634|NCT04235959|451982044|FG001|Overall Study|Protocol Violation|1|||
125644635|NCT04235959|451982045|FG002|Overall Study|Protocol Violation|0|||
125644636|NCT04235959|451982043|FG000|Overall Study|Adverse Event|1|||
125644637|NCT04235959|451982044|FG001|Overall Study|Adverse Event|0|||
125644638|NCT04235959|451982045|FG002|Overall Study|Adverse Event|0|||
125644639|NCT02135848|451982051|FG000|Overall Study|Adverse Event|2|||
125644640|NCT02135848|451982052|FG001|Overall Study|Adverse Event|0|||
125644641|NCT02135848|451982051|FG000|Overall Study|Withdrawal by Subject|1|||
125644642|NCT02135848|451982052|FG001|Overall Study|Withdrawal by Subject|1|||
125644643|NCT04212221|451982056|FG000|Overall Study|Remained on Treatment|0|||
125644644|NCT04212221|451982057|FG001|Overall Study|Remained on Treatment|0|||
125644645|NCT04212221|451982058|FG002|Overall Study|Remained on Treatment|0|||
125644646|NCT04212221|451982059|FG003|Overall Study|Remained on Treatment|1|||
125644647|NCT04212221|451982060|FG004|Overall Study|Remained on Treatment|0|||
125644648|NCT04212221|451982061|FG005|Overall Study|Remained on Treatment|0|||
125644649|NCT04212221|451982062|FG006|Overall Study|Remained on Treatment|3|||
125644650|NCT04212221|451982063|FG007|Overall Study|Remained on Treatment|9|||
125644651|NCT04212221|451982056|FG000|Overall Study|Adverse Event|0|||
125644652|NCT04212221|451982057|FG001|Overall Study|Adverse Event|0|||
125644653|NCT04212221|451982058|FG002|Overall Study|Adverse Event|0|||
125644654|NCT04212221|451982059|FG003|Overall Study|Adverse Event|0|||
125644655|NCT04212221|451982060|FG004|Overall Study|Adverse Event|0|||
125644656|NCT04212221|451982061|FG005|Overall Study|Adverse Event|0|||
125644657|NCT04212221|451982062|FG006|Overall Study|Adverse Event|2|||
125644658|NCT04212221|451982063|FG007|Overall Study|Adverse Event|3|||
125644659|NCT04212221|451982056|FG000|Overall Study|Death|0|||
125644660|NCT04212221|451982057|FG001|Overall Study|Death|0|||
125644661|NCT04212221|451982058|FG002|Overall Study|Death|0|||
125644662|NCT04212221|451982059|FG003|Overall Study|Death|0|||
125644663|NCT04212221|451982060|FG004|Overall Study|Death|0|||
125644664|NCT04212221|451982061|FG005|Overall Study|Death|0|||
125644665|NCT04212221|451982062|FG006|Overall Study|Death|0|||
125644666|NCT04212221|451982063|FG007|Overall Study|Death|2|||
125644667|NCT04212221|451982056|FG000|Overall Study|Disease progression according to irRECIST|1|||
125644668|NCT04212221|451982057|FG001|Overall Study|Disease progression according to irRECIST|2|||
125644669|NCT04212221|451982058|FG002|Overall Study|Disease progression according to irRECIST|3|||
125644670|NCT04212221|451982059|FG003|Overall Study|Disease progression according to irRECIST|3|||
125644671|NCT04212221|451982060|FG004|Overall Study|Disease progression according to irRECIST|2|||
125644672|NCT04212221|451982061|FG005|Overall Study|Disease progression according to irRECIST|2|||
125644673|NCT04212221|451982062|FG006|Overall Study|Disease progression according to irRECIST|21|||
125421441|NCT02677116|451168390|FG006|Overall Study|Physician Decision|1|||
125644674|NCT04212221|451982063|FG007|Overall Study|Disease progression according to irRECIST|17|||
125644675|NCT04212221|451982056|FG000|Overall Study|Global Deterioration of Health Status|0|||
125644676|NCT04212221|451982057|FG001|Overall Study|Global Deterioration of Health Status|0|||
125644677|NCT04212221|451982058|FG002|Overall Study|Global Deterioration of Health Status|0|||
125644678|NCT04212221|451982059|FG003|Overall Study|Global Deterioration of Health Status|0|||
125310053|NCT05280717|450761981|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
125310054|NCT05280717|450761982|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
125310055|NCT05280717|450761983|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
125310056|NCT05280717|450761984|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
125310057|NCT05280717|450761985|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
125310058|NCT05280717|450761986|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
125644679|NCT04212221|451982060|FG004|Overall Study|Global Deterioration of Health Status|0|||
125644680|NCT04212221|451982061|FG005|Overall Study|Global Deterioration of Health Status|0|||
125644681|NCT04212221|451982062|FG006|Overall Study|Global Deterioration of Health Status|0|||
125310059|NCT05280717|450761980|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
125310060|NCT05280717|450761981|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
125310061|NCT05280717|450761982|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
125310062|NCT05280717|450761983|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
125310063|NCT05280717|450761984|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
125310064|NCT05280717|450761985|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
125310065|NCT05280717|450761986|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
125310066|NCT05280717|450761980|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
125310067|NCT05280717|450761981|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
125310068|NCT05280717|450761982|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
125310069|NCT05280717|450761983|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
125310070|NCT05280717|450761984|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
125310071|NCT05280717|450761985|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
125310072|NCT05280717|450761986|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
125310073|NCT00080301|450761987|FG000|Overall Study|Randomized but Never Treated|5|||
125310074|NCT00080301|450761988|FG001|Overall Study|Randomized but Never Treated|10|||
125310075|NCT00080301|450761987|FG000|Overall Study|Still on Treatment as of CSR date|0|||
125310076|NCT00080301|450761988|FG001|Overall Study|Still on Treatment as of CSR date|1|||
125310077|NCT00740584|450761989|FG000|Overall Study|Withdrawal by Subject|1|||
125310078|NCT02073682|450761997|FG000|Overall Study|Low Creatinine Clearance|1|||
125310079|NCT02073682|450761998|FG001|Overall Study|Low Creatinine Clearance|2|||
125310080|NCT02073682|450761997|FG000|Overall Study|Death|86|||
125310081|NCT02073682|450761998|FG001|Overall Study|Death|100|||
125310082|NCT02073682|450761997|FG000|Overall Study|Cancer Cured|10|||
125310083|NCT02073682|450761998|FG001|Overall Study|Cancer Cured|15|||
125310084|NCT02073682|450761997|FG000|Overall Study|ID: Patient Noncompliance|1|||
125310085|NCT02073682|450761998|FG001|Overall Study|ID: Patient Noncompliance|2|||
125310086|NCT02073682|450761997|FG000|Overall Study|ID: Palliative Treatment Only|10|||
125533187|NCT02942277|451582745|FG001|Year 1|Lost to Follow-up|0|||
125644682|NCT04212221|451982063|FG007|Overall Study|Global Deterioration of Health Status|2|||
125644683|NCT04212221|451982056|FG000|Overall Study|Investigator's Decision|0|||
125644684|NCT04212221|451982057|FG001|Overall Study|Investigator's Decision|0|||
125644685|NCT04212221|451982058|FG002|Overall Study|Investigator's Decision|0|||
125644686|NCT04212221|451982059|FG003|Overall Study|Investigator's Decision|1|||
125644687|NCT04212221|451982060|FG004|Overall Study|Investigator's Decision|0|||
125644688|NCT04212221|451982061|FG005|Overall Study|Investigator's Decision|0|||
125644689|NCT04212221|451982062|FG006|Overall Study|Investigator's Decision|3|||
125644690|NCT04212221|451982063|FG007|Overall Study|Investigator's Decision|0|||
125644691|NCT04212221|451982056|FG000|Overall Study|Participant refused to continue treatment|0|||
125644692|NCT04212221|451982057|FG001|Overall Study|Participant refused to continue treatment|1|||
125644693|NCT04212221|451982058|FG002|Overall Study|Participant refused to continue treatment|0|||
125644694|NCT04212221|451982059|FG003|Overall Study|Participant refused to continue treatment|1|||
125644695|NCT04212221|451982060|FG004|Overall Study|Participant refused to continue treatment|1|||
125644696|NCT04212221|451982061|FG005|Overall Study|Participant refused to continue treatment|2|||
125644697|NCT04212221|451982062|FG006|Overall Study|Participant refused to continue treatment|4|||
125644698|NCT04212221|451982063|FG007|Overall Study|Participant refused to continue treatment|2|||
125644699|NCT04212221|451982056|FG000|Overall Study|Protocol Violation|0|||
125644700|NCT04212221|451982057|FG001|Overall Study|Protocol Violation|0|||
125644701|NCT04212221|451982058|FG002|Overall Study|Protocol Violation|0|||
125644702|NCT04212221|451982059|FG003|Overall Study|Protocol Violation|0|||
125644703|NCT04212221|451982060|FG004|Overall Study|Protocol Violation|0|||
125644704|NCT04212221|451982061|FG005|Overall Study|Protocol Violation|0|||
125644705|NCT04212221|451982062|FG006|Overall Study|Protocol Violation|0|||
125644706|NCT04212221|451982063|FG007|Overall Study|Protocol Violation|1|||
125644707|NCT00636506|451982068|FG000|Overall Study|Lost to Follow-up|8|||
125644708|NCT00636506|451982068|FG000|Overall Study|Explanted|1|||
125644709|NCT00636506|451982068|FG000|Overall Study|Withdrawal by Subject|6|||
125644710|NCT00636506|451982068|FG000|Overall Study|Procedure aborted|1|||
125644711|NCT03742271|451982069|FG000|Overall Study|Unsatisfactory Visual Response|1|||
125644712|NCT03742271|451982069|FG000|Overall Study|Withdrawal by Subject|3|||
125644713|NCT03742271|451982069|FG000|Overall Study|Lost to Follow-up|4|||
125644714|NCT03742271|451982069|FG000|Overall Study|Failed Insertion & removal|3|||
125644715|NCT03742271|451982069|FG000|Overall Study|Protocol Violation|1|||
125644716|NCT01624974|451982071|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
125644717|NCT01624974|451982072|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
125644718|NCT01624974|451982071|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
125644719|NCT01624974|451982072|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
125644720|NCT01624974|451982071|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
125644721|NCT01624974|451982072|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
125644722|NCT01624974|451982071|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
125644723|NCT01624974|451982072|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
125644724|NCT01624974|451982071|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
125644725|NCT01624974|451982072|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
125644726|NCT01624974|451982071|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
125644727|NCT01624974|451982072|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
125644728|NCT01624974|451982071|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
125644729|NCT01624974|451982072|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
125644730|NCT01624974|451982071|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
125644731|NCT01624974|451982072|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
125644732|NCT01624974|451982071|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
125644733|NCT01624974|451982072|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
125644734|NCT01624974|451982071|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
125644735|NCT01624974|451982072|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
125644736|NCT01624974|451982071|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
125644737|NCT01624974|451982072|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
125644738|NCT01624974|451982071|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
125644739|NCT01624974|451982072|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
125644740|NCT01376908|451982073|FG000|Overall Study|Protocol Violation|1|||
125644741|NCT01376908|451982074|FG001|Overall Study|Protocol Violation|1|||
125644742|NCT01376908|451982073|FG000|Overall Study|Withdrawal by Subject|1|||
125644743|NCT01376908|451982074|FG001|Overall Study|Withdrawal by Subject|2|||
125644744|NCT01468844|451982077|FG000|Overall Study|Adverse Event|1|||
125644745|NCT01468844|451982078|FG001|Overall Study|Adverse Event|0|||
125644746|NCT01468844|451982077|FG000|Overall Study|Withdrawal by Subject|1|||
125644747|NCT01468844|451982078|FG001|Overall Study|Withdrawal by Subject|0|||
125644748|NCT00266695|451982081|FG000|Overall Study|Adverse Event|1|||
125644749|NCT00266695|451982081|FG000|Overall Study|Death|9|||
125644750|NCT00266695|451982081|FG000|Overall Study|Physician Decision|1|||
125644751|NCT00266695|451982081|FG000|Overall Study|Lost to Follow-up|3|||
125644752|NCT00266695|451982081|FG000|Overall Study|Withdrawal by Subject|15|||
125644753|NCT03607994|451982082|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
125644754|NCT03607994|451982083|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
125644755|NCT02417935|451982084|FG000|Treatment Period|Adverse Event|12|||
125644756|NCT02417935|451982085|FG001|Treatment Period|Adverse Event|10|||
125644757|NCT02417935|451982084|FG000|Treatment Period|Lost to Follow-up|1|||
125644758|NCT02417935|451982085|FG001|Treatment Period|Lost to Follow-up|0|||
125644759|NCT02417935|451982084|FG000|Treatment Period|Entry Criteria not met|0|||
125644760|NCT02417935|451982085|FG001|Treatment Period|Entry Criteria not met|1|||
125644761|NCT02417935|451982084|FG000|Treatment Period|Protocol Violation|2|||
125644762|NCT02417935|451982085|FG001|Treatment Period|Protocol Violation|1|||
125644763|NCT02417935|451982084|FG000|Treatment Period|Withdrawal by Subject|3|||
125644764|NCT02417935|451982085|FG001|Treatment Period|Withdrawal by Subject|3|||
125644765|NCT02417935|451982084|FG000|Treatment Period|Physician Decision|3|||
125644766|NCT02417935|451982085|FG001|Treatment Period|Physician Decision|1|||
125644767|NCT02850276|451982086|FG000|Overall Study|screen failure|43|||
125644768|NCT02850276|451982086|FG000|Overall Study|Withdrawal by Subject|14|||
125644769|NCT02850276|451982086|FG000|Overall Study|Physician Decision|2|||
125644770|NCT02850276|451982086|FG000|Overall Study|Lost to Follow-up|2|||
125644771|NCT01899729|451982087|FG000|Overall Study|Adverse Event|1|||
125644772|NCT01899729|451982088|FG001|Overall Study|Adverse Event|0|||
125644773|NCT01899729|451982089|FG002|Overall Study|Adverse Event|0|||
125644774|NCT01899729|451982090|FG003|Overall Study|Adverse Event|0|||
125644775|NCT01899729|451982091|FG004|Overall Study|Adverse Event|1|||
125644776|NCT01899729|451982087|FG000|Overall Study|Withdrawal by Subject|1|||
125644777|NCT01899729|451982088|FG001|Overall Study|Withdrawal by Subject|2|||
125644778|NCT01899729|451982089|FG002|Overall Study|Withdrawal by Subject|0|||
125421442|NCT02677116|451168391|FG007|Overall Study|Physician Decision|1|||
125421443|NCT02677116|451168392|FG008|Overall Study|Physician Decision|2|||
125644779|NCT01899729|451982090|FG003|Overall Study|Withdrawal by Subject|0|||
125644780|NCT01899729|451982091|FG004|Overall Study|Withdrawal by Subject|0|||
125533188|NCT02942277|451582746|FG002|Year 1|Lost to Follow-up|0|||
125644781|NCT01899729|451982087|FG000|Overall Study|Lack of Efficacy|0|||
125644782|NCT01899729|451982088|FG001|Overall Study|Lack of Efficacy|0|||
125644783|NCT01899729|451982089|FG002|Overall Study|Lack of Efficacy|2|||
125644784|NCT01899729|451982090|FG003|Overall Study|Lack of Efficacy|0|||
125644785|NCT01899729|451982091|FG004|Overall Study|Lack of Efficacy|1|||
125644786|NCT01454531|451982092|FG000|Overall Study|Adverse Event|14|||
125644787|NCT01454531|451982092|FG000|Overall Study|Withdrawal by Subject|5|||
125644788|NCT01454531|451982092|FG000|Overall Study|Lost to Follow-up|1|||
125644789|NCT01454531|451982092|FG000|Overall Study|Physician Decision|1|||
125644790|NCT01454531|451982092|FG000|Overall Study|Delay in IMP administration|1|||
125644791|NCT01454531|451982092|FG000|Overall Study|Other|1|||
125644792|NCT00252499|451982103|FG000|Overall Study|Lost to Follow-up|1|||
125644793|NCT00252499|451982104|FG001|Overall Study|Lost to Follow-up|0|||
125644794|NCT00252499|451982105|FG002|Overall Study|Lost to Follow-up|0|||
125644795|NCT02646332|451982106|FG000|Overall Study|Lost to Follow-up|0|||
125644796|NCT02646332|451982107|FG001|Overall Study|Lost to Follow-up|3|||
125644797|NCT04490499|451982108|FG000|Overall Study|Withdrawal by Subject|2|||
125644798|NCT01882439|451982111|FG000|Overall Study|Adverse event related to study drug|3|||
125421444|NCT02677116|451168384|FG000|Overall Study|Withdrawal by parent or guardian|2|||
125421445|NCT02677116|451168385|FG001|Overall Study|Withdrawal by parent or guardian|1|||
125421446|NCT02677116|451168386|FG002|Overall Study|Withdrawal by parent or guardian|0|||
125421447|NCT02677116|451168387|FG003|Overall Study|Withdrawal by parent or guardian|1|||
125421448|NCT02677116|451168388|FG004|Overall Study|Withdrawal by parent or guardian|0|||
125421449|NCT02677116|451168389|FG005|Overall Study|Withdrawal by parent or guardian|0|||
125421450|NCT02677116|451168390|FG006|Overall Study|Withdrawal by parent or guardian|2|||
125421451|NCT02677116|451168391|FG007|Overall Study|Withdrawal by parent or guardian|1|||
125421452|NCT02677116|451168392|FG008|Overall Study|Withdrawal by parent or guardian|0|||
125421453|NCT02677116|451168384|FG000|Overall Study|Withdrawal by Subject|1|||
125421454|NCT02677116|451168385|FG001|Overall Study|Withdrawal by Subject|0|||
125421455|NCT02677116|451168386|FG002|Overall Study|Withdrawal by Subject|0|||
125421456|NCT02677116|451168387|FG003|Overall Study|Withdrawal by Subject|0|||
125421457|NCT02677116|451168388|FG004|Overall Study|Withdrawal by Subject|0|||
125421458|NCT02677116|451168389|FG005|Overall Study|Withdrawal by Subject|0|||
125421459|NCT02677116|451168390|FG006|Overall Study|Withdrawal by Subject|0|||
125421460|NCT02677116|451168391|FG007|Overall Study|Withdrawal by Subject|0|||
125421461|NCT02677116|451168392|FG008|Overall Study|Withdrawal by Subject|0|||
125421462|NCT03182868|451168393|FG000|Overall Study|Protocol Violation|3|||
125421463|NCT03182868|451168394|FG001|Overall Study|Protocol Violation|0|||
125421464|NCT03182868|451168395|FG002|Overall Study|Protocol Violation|4|||
125421465|NCT03182868|451168396|FG003|Overall Study|Protocol Violation|1|||
125421466|NCT03182868|451168397|FG004|Overall Study|Protocol Violation|8|||
125421467|NCT02363946|451168399|FG000|Overall Study|Lost to Follow-up|0|||
125421468|NCT02363946|451168400|FG001|Overall Study|Lost to Follow-up|0|||
125421469|NCT02363946|451168401|FG002|Overall Study|Lost to Follow-up|0|||
125421470|NCT02363946|451168402|FG003|Overall Study|Lost to Follow-up|0|||
125421471|NCT02363946|451168403|FG004|Overall Study|Lost to Follow-up|0|||
125421472|NCT02363946|451168404|FG005|Overall Study|Lost to Follow-up|0|||
125421473|NCT02363946|451168405|FG006|Overall Study|Lost to Follow-up|0|||
125421474|NCT02363946|451168406|FG007|Overall Study|Lost to Follow-up|1|||
125421475|NCT02363946|451168407|FG008|Overall Study|Lost to Follow-up|0|||
125421476|NCT02363946|451168408|FG009|Overall Study|Lost to Follow-up|0|||
125421477|NCT02363946|451168409|FG010|Overall Study|Lost to Follow-up|0|||
125421478|NCT02363946|451168410|FG011|Overall Study|Lost to Follow-up|0|||
125421479|NCT02363946|451168411|FG012|Overall Study|Lost to Follow-up|0|||
125421480|NCT01967732|451168412|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
125421481|NCT01967732|451168413|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
125421482|NCT01967732|451168414|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
125421483|NCT01967732|451168415|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
125421484|NCT01967732|451168412|FG000|First Intervention (Day 1)|Poor venous access|0|||
125421485|NCT01967732|451168413|FG001|First Intervention (Day 1)|Poor venous access|1|||
125310087|NCT02073682|450761998|FG001|Overall Study|ID: Palliative Treatment Only|7|||
125310088|NCT02073682|450761997|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
125310089|NCT02073682|450761998|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
125310090|NCT02073682|450761997|FG000|Overall Study|Platelet Count <50,000/mL|1|||
125310091|NCT02073682|450761998|FG001|Overall Study|Platelet Count <50,000/mL|2|||
125310092|NCT02073682|450761997|FG000|Overall Study|Surgery/Medical Procedure|3|||
125421486|NCT01967732|451168414|FG002|First Intervention (Day 1)|Poor venous access|0|||
125421487|NCT01967732|451168415|FG003|First Intervention (Day 1)|Poor venous access|0|||
125421488|NCT03342638|451168416|FG000|Overall Study|Withdrawal by Subject|1|||
125421489|NCT03342638|451168417|FG001|Overall Study|Withdrawal by Subject|0|||
125421490|NCT03342638|451168416|FG000|Overall Study|Physician Decision|0|||
125421491|NCT03342638|451168417|FG001|Overall Study|Physician Decision|1|||
125644799|NCT01882439|451982112|FG001|Overall Study|Adverse event related to study drug|8|||
125644800|NCT01882439|451982113|FG002|Overall Study|Adverse event related to study drug|1|||
125644801|NCT01882439|451982114|FG003|Overall Study|Adverse event related to study drug|2|||
125198612|NCT02836236|450350983|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
125421492|NCT01292239|451168433|FG000|Overall Study|Other|1|||
125421493|NCT01292239|451168434|FG001|Overall Study|Other|1|||
125421494|NCT01292239|451168433|FG000|Overall Study|Withdrawal by Subject|3|||
125421495|NCT01292239|451168434|FG001|Overall Study|Withdrawal by Subject|6|||
125421496|NCT00113568|451168435|FG000|Overall Study|Adverse Event|97|||
125421497|NCT00113568|451168435|FG000|Overall Study|Death|1|||
125421498|NCT00113568|451168435|FG000|Overall Study|Lack of Efficacy|30|||
125533189|NCT02942277|451582747|FG003|Year 1|Lost to Follow-up|0|||
125533190|NCT02942277|451582748|FG004|Year 1|Lost to Follow-up|1|||
125533191|NCT02942277|451582749|FG005|Year 1|Lost to Follow-up|0|||
125533192|NCT02942277|451582750|FG006|Year 1|Lost to Follow-up|0|||
125533193|NCT02942277|451582751|FG007|Year 1|Lost to Follow-up|0|||
125533194|NCT02942277|451582752|FG008|Year 1|Lost to Follow-up|0|||
125533195|NCT02942277|451582753|FG009|Year 1|Lost to Follow-up|0|||
125644802|NCT01882439|451982111|FG000|Overall Study|Pregnancy|0|||
125644803|NCT01882439|451982112|FG001|Overall Study|Pregnancy|1|||
125644804|NCT01882439|451982113|FG002|Overall Study|Pregnancy|0|||
125644805|NCT01882439|451982114|FG003|Overall Study|Pregnancy|0|||
125310093|NCT02073682|450761998|FG001|Overall Study|Surgery/Medical Procedure|1|||
125310094|NCT02073682|450761997|FG000|Overall Study|Withdrawal by Subject|6|||
125310095|NCT02073682|450761998|FG001|Overall Study|Withdrawal by Subject|8|||
125310096|NCT02073682|450761997|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
125310097|NCT02073682|450761998|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
125310098|NCT02073682|450761997|FG000|Overall Study|Cancer Progression|53|||
125310099|NCT02073682|450761998|FG001|Overall Study|Cancer Progression|33|||
125310100|NCT02073682|450761997|FG000|Overall Study|Protocol Violation|1|||
125310101|NCT02073682|450761998|FG001|Overall Study|Protocol Violation|0|||
125310102|NCT02073682|450761997|FG000|Overall Study|Adverse Event|79|||
125310103|NCT02073682|450761998|FG001|Overall Study|Adverse Event|62|||
125310104|NCT02073682|450761997|FG000|Overall Study|No reason provided|11|||
125310105|NCT02073682|450761998|FG001|Overall Study|No reason provided|9|||
125310106|NCT02073682|450761997|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
125310107|NCT02073682|450761998|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
125310108|NCT02073682|450761997|FG000|Overall Study|Lost to Follow-up|1|||
125310109|NCT02073682|450761998|FG001|Overall Study|Lost to Follow-up|1|||
125310110|NCT02073682|450761997|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
125310111|NCT02073682|450761998|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
125310112|NCT03461146|450761999|FG000|Overall Study|Adverse Event|2|||
125310113|NCT03461146|450761999|FG000|Overall Study|Physician Decision|1|||
125310114|NCT00181766|450762000|FG000|Overall Study|Lost to Follow-up|6|||
125310115|NCT00181766|450762000|FG000|Overall Study|Adverse Event|4|||
125310116|NCT00181766|450762000|FG000|Overall Study|non-compliance|2|||
125310117|NCT00855816|450762001|FG000|Overall Study|Withdrawal by Subject|22|||
125310118|NCT00855816|450762002|FG001|Overall Study|Withdrawal by Subject|15|||
125310119|NCT00855816|450762001|FG000|Overall Study|Lost to Follow-up|3|||
125310120|NCT00855816|450762002|FG001|Overall Study|Lost to Follow-up|5|||
125310121|NCT00855816|450762001|FG000|Overall Study|Death|1|||
125310122|NCT00855816|450762002|FG001|Overall Study|Death|0|||
125310123|NCT00855816|450762001|FG000|Overall Study|Became ineligible|0|||
125310124|NCT00855816|450762002|FG001|Overall Study|Became ineligible|1|||
125644806|NCT01882439|451982111|FG000|Overall Study|Protocol Violation|2|||
125644807|NCT01882439|451982112|FG001|Overall Study|Protocol Violation|2|||
125644808|NCT01882439|451982113|FG002|Overall Study|Protocol Violation|0|||
125644809|NCT01882439|451982114|FG003|Overall Study|Protocol Violation|1|||
125644810|NCT01882439|451982111|FG000|Overall Study|No longer willing to participate|1|||
125644811|NCT01882439|451982112|FG001|Overall Study|No longer willing to participate|4|||
125644812|NCT01882439|451982113|FG002|Overall Study|No longer willing to participate|2|||
125644813|NCT01882439|451982114|FG003|Overall Study|No longer willing to participate|3|||
125644814|NCT01882439|451982111|FG000|Overall Study|Medication error with no associated AE|0|||
125644815|NCT01882439|451982112|FG001|Overall Study|Medication error with no associated AE|0|||
125644816|NCT01882439|451982113|FG002|Overall Study|Medication error with no associated AE|2|||
125644817|NCT01882439|451982114|FG003|Overall Study|Medication error with no associated AE|0|||
125644818|NCT01882439|451982111|FG000|Overall Study|Insufficient clinical response|1|||
125644819|NCT01882439|451982112|FG001|Overall Study|Insufficient clinical response|4|||
125217402|NCT05415462|450423518|FG000|Overall Study|Lost to Follow-up|72|||
125310125|NCT01965704|450762006|FG000|Overall Study|Withdrawal by Subject|2|||
125310126|NCT01965704|450762007|FG001|Overall Study|Withdrawal by Subject|2|||
125421499|NCT00113568|451168435|FG000|Overall Study|Lost to Follow-up|156|||
125421500|NCT00113568|451168435|FG000|Overall Study|Protocol Violation|32|||
125310127|NCT01965704|450762008|FG002|Overall Study|Withdrawal by Subject|1|||
125310128|NCT01965704|450762009|FG003|Overall Study|Withdrawal by Subject|1|||
125310129|NCT01965704|450762006|FG000|Overall Study|Delivered at home|1|||
125310130|NCT01965704|450762007|FG001|Overall Study|Delivered at home|1|||
125310131|NCT01965704|450762008|FG002|Overall Study|Delivered at home|0|||
125310132|NCT01965704|450762009|FG003|Overall Study|Delivered at home|0|||
125421501|NCT00113568|451168435|FG000|Overall Study|Withdrawal by Subject|117|||
125421502|NCT00113568|451168435|FG000|Overall Study|Other|112|||
125533196|NCT02942277|451582754|FG010|Year 1|Lost to Follow-up|2|||
125533197|NCT02942277|451582744|FG000|Year 1|Protocol Violation|0|||
125533198|NCT02942277|451582745|FG001|Year 1|Protocol Violation|0|||
125310133|NCT01965704|450762006|FG000|Overall Study|Experienced complications|0|||
125310134|NCT01965704|450762007|FG001|Overall Study|Experienced complications|0|||
125310135|NCT01965704|450762008|FG002|Overall Study|Experienced complications|2|||
125310136|NCT01965704|450762009|FG003|Overall Study|Experienced complications|2|||
125310137|NCT01965704|450762006|FG000|Overall Study|Adverse Event|0|||
125310138|NCT01965704|450762007|FG001|Overall Study|Adverse Event|0|||
125310139|NCT01965704|450762008|FG002|Overall Study|Adverse Event|1|||
125310140|NCT01965704|450762009|FG003|Overall Study|Adverse Event|1|||
125310141|NCT01965704|450762006|FG000|Overall Study|Did not meet inclusion criteria|0|||
125421503|NCT00262821|451168436|FG000|Overall Study|Ineligible - wrong stage|0|||
125421504|NCT00262821|451168437|FG001|Overall Study|Ineligible - wrong stage|3|||
125421505|NCT00262821|451168436|FG000|Overall Study|Ineligible - wrong cell type|2|||
125421506|NCT00262821|451168437|FG001|Overall Study|Ineligible - wrong cell type|2|||
125421507|NCT00262821|451168436|FG000|Overall Study|Ineligible - wrong primary|0|||
125421508|NCT00262821|451168437|FG001|Overall Study|Ineligible - wrong primary|1|||
125421509|NCT00262821|451168436|FG000|Overall Study|Ineligible - inadequate pathology|1|||
125421510|NCT00262821|451168437|FG001|Overall Study|Ineligible - inadequate pathology|3|||
125421511|NCT00262821|451168436|FG000|Overall Study|Ineligible - elevated creatinine|0|||
125421512|NCT00262821|451168437|FG001|Overall Study|Ineligible - elevated creatinine|2|||
125421513|NCT00262821|451168436|FG000|Overall Study|Ineligible - required test not done|1|||
125421514|NCT00262821|451168437|FG001|Overall Study|Ineligible - required test not done|4|||
125421515|NCT00262821|451168436|FG000|Overall Study|Inevaluable - inadequate data|0|||
125421516|NCT00262821|451168437|FG001|Overall Study|Inevaluable - inadequate data|4|||
125421517|NCT01988779|451168439|FG000|Overall Study|Withdrawal by Subject|2|||
125421518|NCT01988779|451168440|FG001|Overall Study|Withdrawal by Subject|2|||
125421519|NCT01988779|451168439|FG000|Overall Study|Protocol Violation|1|||
125421520|NCT01988779|451168440|FG001|Overall Study|Protocol Violation|0|||
125421521|NCT00584727|451168441|FG000|First Intervention|Discontinuation|0|||
125421522|NCT00584727|451168442|FG001|First Intervention|Discontinuation|0|||
125421523|NCT00584727|451168443|FG002|First Intervention|Discontinuation|1|||
125421524|NCT00584727|451168444|FG003|First Intervention|Discontinuation|0|||
125421525|NCT00584727|451168445|FG004|First Intervention|Discontinuation|0|||
125421526|NCT00584727|451168446|FG005|First Intervention|Discontinuation|0|||
125421527|NCT00584727|451168441|FG000|Third Intervention|Protocol Violation|0|||
125421528|NCT00584727|451168442|FG001|Third Intervention|Protocol Violation|0|||
125421529|NCT00584727|451168443|FG002|Third Intervention|Protocol Violation|1|||
125421530|NCT00584727|451168444|FG003|Third Intervention|Protocol Violation|0|||
125421531|NCT00584727|451168445|FG004|Third Intervention|Protocol Violation|4|||
125421532|NCT00584727|451168446|FG005|Third Intervention|Protocol Violation|2|||
125421533|NCT00377403|451168448|FG000|Overall Study|Unable to contact for telephone intervie|4|||
125421534|NCT00377403|451168449|FG001|Overall Study|Unable to contact for telephone intervie|7|||
125421535|NCT01041638|451168450|FG000|Overall Study|Adverse Event|4|||
125421536|NCT01041638|451168450|FG000|Overall Study|Death|1|||
125421537|NCT01041638|451168450|FG000|Overall Study|Lack of Efficacy|7|||
125421538|NCT01041638|451168450|FG000|Overall Study|Physician Decision|4|||
125421539|NCT01041638|451168450|FG000|Overall Study|Withdrawal by Subject|11|||
125421540|NCT01687257|451168453|FG000|Overall Study|Efficacy Failure|6|||
125421541|NCT01687257|451168454|FG001|Overall Study|Efficacy Failure|0|||
125421542|NCT01687257|451168455|FG002|Overall Study|Efficacy Failure|5|||
125421543|NCT01687257|451168453|FG000|Overall Study|Subject Withdrew Consent|1|||
125421544|NCT01687257|451168454|FG001|Overall Study|Subject Withdrew Consent|1|||
125421545|NCT01687257|451168455|FG002|Overall Study|Subject Withdrew Consent|1|||
125421546|NCT01687257|451168453|FG000|Overall Study|Adverse Event|1|||
125421547|NCT01687257|451168454|FG001|Overall Study|Adverse Event|0|||
125421548|NCT01687257|451168455|FG002|Overall Study|Adverse Event|0|||
125421549|NCT01687257|451168453|FG000|Overall Study|Investigator's Discretion|0|||
125421550|NCT01687257|451168454|FG001|Overall Study|Investigator's Discretion|3|||
125421551|NCT01687257|451168455|FG002|Overall Study|Investigator's Discretion|0|||
125421552|NCT00736645|451168456|FG000|Overall Study|Adverse Event|0|||
125421553|NCT00736645|451168457|FG001|Overall Study|Adverse Event|2|||
125310142|NCT01965704|450762007|FG001|Overall Study|Did not meet inclusion criteria|0|||
125421554|NCT00736645|451168458|FG002|Overall Study|Adverse Event|0|||
125421555|NCT00736645|451168459|FG003|Overall Study|Adverse Event|0|||
125421556|NCT00295022|451168462|FG000|Overall Study|Adverse Event|1|||
125421557|NCT00295022|451168463|FG001|Overall Study|Adverse Event|1|||
125421558|NCT00295022|451168464|FG002|Overall Study|Adverse Event|2|||
125421559|NCT00295022|451168462|FG000|Overall Study|Lost to Follow-up|0|||
125421560|NCT00295022|451168463|FG001|Overall Study|Lost to Follow-up|0|||
125421561|NCT00295022|451168464|FG002|Overall Study|Lost to Follow-up|1|||
125421562|NCT00295022|451168462|FG000|Overall Study|Withdrawal by Subject|0|||
125421563|NCT00295022|451168463|FG001|Overall Study|Withdrawal by Subject|0|||
125310143|NCT01965704|450762008|FG002|Overall Study|Did not meet inclusion criteria|1|||
125310144|NCT01965704|450762009|FG003|Overall Study|Did not meet inclusion criteria|1|||
125644820|NCT01882439|451982113|FG002|Overall Study|Insufficient clinical response|4|||
125310145|NCT00687804|450762017|FG000|Core Study|Adverse Event|5|||
125421564|NCT00295022|451168464|FG002|Overall Study|Withdrawal by Subject|2|||
125310146|NCT00687804|450762018|FG001|Core Study|Adverse Event|3|||
125310147|NCT00687804|450762019|FG002|Core Study|Adverse Event|3|||
125310148|NCT00687804|450762017|FG000|Core Study|Abnormal laboratory value(s)|1|||
125310149|NCT00687804|450762018|FG001|Core Study|Abnormal laboratory value(s)|0|||
125310150|NCT00687804|450762019|FG002|Core Study|Abnormal laboratory value(s)|0|||
125310151|NCT00687804|450762017|FG000|Core Study|Lack of Efficacy|1|||
125310152|NCT00687804|450762018|FG001|Core Study|Lack of Efficacy|1|||
125310153|NCT00687804|450762019|FG002|Core Study|Lack of Efficacy|1|||
125310154|NCT00687804|450762017|FG000|Core Study|Withdrawal by Subject|4|||
125310155|NCT00687804|450762018|FG001|Core Study|Withdrawal by Subject|7|||
125310156|NCT00687804|450762019|FG002|Core Study|Withdrawal by Subject|7|||
125310157|NCT00687804|450762017|FG000|Core Study|Lost to Follow-up|0|||
125310158|NCT00687804|450762018|FG001|Core Study|Lost to Follow-up|1|||
125310159|NCT00687804|450762019|FG002|Core Study|Lost to Follow-up|0|||
125310160|NCT00687804|450762017|FG000|Core Study|Death|2|||
125310161|NCT00687804|450762018|FG001|Core Study|Death|2|||
125310162|NCT00687804|450762019|FG002|Core Study|Death|2|||
125310163|NCT00687804|450762017|FG000|Core Study|Protocol Violation|1|||
125310164|NCT00687804|450762018|FG001|Core Study|Protocol Violation|1|||
125310165|NCT00687804|450762019|FG002|Core Study|Protocol Violation|0|||
125310166|NCT00687804|450762017|FG000|Open-Label Extension Study|Adverse Event|2|||
125310167|NCT00687804|450762018|FG001|Open-Label Extension Study|Adverse Event|2|||
125310168|NCT00687804|450762019|FG002|Open-Label Extension Study|Adverse Event|2|||
125310169|NCT00687804|450762017|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
125310170|NCT00687804|450762018|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
125310171|NCT00687804|450762019|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
125644821|NCT01882439|451982114|FG003|Overall Study|Insufficient clinical response|2|||
125644822|NCT01882439|451982111|FG000|Overall Study|Adverse event unrelated to study drug|2|||
125644823|NCT01882439|451982112|FG001|Overall Study|Adverse event unrelated to study drug|2|||
125310172|NCT00687804|450762017|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
125310173|NCT00687804|450762018|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
125310174|NCT00687804|450762019|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
125310175|NCT00687804|450762017|FG000|Open-Label Extension Study|Administrative problems|1|||
125310176|NCT00687804|450762018|FG001|Open-Label Extension Study|Administrative problems|1|||
125310177|NCT00687804|450762019|FG002|Open-Label Extension Study|Administrative problems|0|||
125310178|NCT00687804|450762017|FG000|Open-Label Extension Study|Death|2|||
125310179|NCT00687804|450762018|FG001|Open-Label Extension Study|Death|3|||
125310180|NCT00687804|450762019|FG002|Open-Label Extension Study|Death|3|||
125310181|NCT04390243|450762020|FG000|Overall Study|Death|1|||
125310182|NCT04390243|450762020|FG000|Overall Study|Disease Progression|4|||
125310183|NCT04390243|450762020|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
125421565|NCT00734630|451168465|FG000|Overall Study|Lack of Efficacy|4|||
125421566|NCT00734630|451168466|FG001|Overall Study|Lack of Efficacy|4|||
125421567|NCT00734630|451168465|FG000|Overall Study|Withdrawal by Subject|7|||
125421568|NCT00734630|451168466|FG001|Overall Study|Withdrawal by Subject|9|||
125421569|NCT00734630|451168465|FG000|Overall Study|Lost to Follow-up|13|||
125421570|NCT00734630|451168466|FG001|Overall Study|Lost to Follow-up|7|||
125421571|NCT00734630|451168465|FG000|Overall Study|Protocol Violation|0|||
125421572|NCT00734630|451168466|FG001|Overall Study|Protocol Violation|3|||
125421573|NCT00734630|451168465|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
125421574|NCT00734630|451168466|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
125421575|NCT00734630|451168465|FG000|Overall Study|Adverse Event|3|||
125421576|NCT00734630|451168466|FG001|Overall Study|Adverse Event|6|||
125421577|NCT00734630|451168465|FG000|Overall Study|Randomized in Error|0|||
125421578|NCT00734630|451168466|FG001|Overall Study|Randomized in Error|1|||
125421579|NCT00734630|451168465|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
125421580|NCT00734630|451168466|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
125421581|NCT00734630|451168465|FG000|Overall Study|Poor Compliance|1|||
125421582|NCT00734630|451168466|FG001|Overall Study|Poor Compliance|1|||
125421583|NCT01922076|451168467|FG000|Overall Study|Adverse Event|0|||
125421584|NCT01922076|451168468|FG001|Overall Study|Adverse Event|0|||
125421585|NCT01922076|451168469|FG002|Overall Study|Adverse Event|0|||
125421586|NCT01922076|451168470|FG003|Overall Study|Adverse Event|0|||
125421587|NCT01922076|451168471|FG004|Overall Study|Adverse Event|1|||
125421588|NCT01922076|451168472|FG005|Overall Study|Adverse Event|0|||
125421589|NCT01922076|451168473|FG006|Overall Study|Adverse Event|0|||
125421590|NCT01922076|451168467|FG000|Overall Study|Physician Decision|0|||
125421591|NCT01922076|451168468|FG001|Overall Study|Physician Decision|0|||
125421592|NCT01922076|451168469|FG002|Overall Study|Physician Decision|1|||
125644824|NCT01882439|451982113|FG002|Overall Study|Adverse event unrelated to study drug|1|||
125644825|NCT01882439|451982114|FG003|Overall Study|Adverse event unrelated to study drug|1|||
125644826|NCT03125902|451982117|FG000|Overall Study|Adverse Event|0|||
125644827|NCT03125902|451982118|FG001|Overall Study|Adverse Event|1|||
125310184|NCT00413218|450762023|FG000|Overall Study|Randomized but didn't receive study drug|2|||
125310185|NCT00413218|450762024|FG001|Overall Study|Randomized but didn't receive study drug|8|||
125310186|NCT00413218|450762023|FG000|Overall Study|Death|57|||
125310187|NCT00413218|450762024|FG001|Overall Study|Death|56|||
125421593|NCT01922076|451168470|FG003|Overall Study|Physician Decision|0|||
125421594|NCT01922076|451168471|FG004|Overall Study|Physician Decision|0|||
125421595|NCT01922076|451168472|FG005|Overall Study|Physician Decision|0|||
125421596|NCT01922076|451168473|FG006|Overall Study|Physician Decision|0|||
125421597|NCT01922076|451168467|FG000|Overall Study|Withdrawal by Subject|0|||
125421598|NCT01922076|451168468|FG001|Overall Study|Withdrawal by Subject|0|||
125421599|NCT01922076|451168469|FG002|Overall Study|Withdrawal by Subject|0|||
125421600|NCT01922076|451168470|FG003|Overall Study|Withdrawal by Subject|1|||
125421601|NCT01922076|451168471|FG004|Overall Study|Withdrawal by Subject|0|||
125421602|NCT01922076|451168472|FG005|Overall Study|Withdrawal by Subject|1|||
125421603|NCT01922076|451168473|FG006|Overall Study|Withdrawal by Subject|1|||
125421604|NCT01018394|451168476|FG000|Overall Study|Withdrawal by Subject|5|||
125421605|NCT01018394|451168477|FG001|Overall Study|Withdrawal by Subject|5|||
125421606|NCT01018394|451168476|FG000|Overall Study|Lost to Follow-up|4|||
125421607|NCT01018394|451168477|FG001|Overall Study|Lost to Follow-up|3|||
125421608|NCT00683644|451168478|FG000|Overall Study|Withdrawal by Subject|4|||
125421609|NCT00683644|451168479|FG001|Overall Study|Withdrawal by Subject|2|||
125421610|NCT00683644|451168478|FG000|Overall Study|Lost to Follow-up|1|||
125421611|NCT00683644|451168479|FG001|Overall Study|Lost to Follow-up|4|||
125421612|NCT00683644|451168478|FG000|Overall Study|Adverse Event|1|||
125421613|NCT00683644|451168479|FG001|Overall Study|Adverse Event|2|||
125421614|NCT00683644|451168478|FG000|Overall Study|Low copper, other health problems,|7|||
125533199|NCT02942277|451582746|FG002|Year 1|Protocol Violation|0|||
125533200|NCT02942277|451582747|FG003|Year 1|Protocol Violation|0|||
125533201|NCT02942277|451582748|FG004|Year 1|Protocol Violation|1|||
125533202|NCT02942277|451582749|FG005|Year 1|Protocol Violation|1|||
125533203|NCT02942277|451582750|FG006|Year 1|Protocol Violation|0|||
125533204|NCT02942277|451582751|FG007|Year 1|Protocol Violation|0|||
125533205|NCT02942277|451582752|FG008|Year 1|Protocol Violation|0|||
125533206|NCT02942277|451582753|FG009|Year 1|Protocol Violation|0|||
125533207|NCT02942277|451582754|FG010|Year 1|Protocol Violation|2|||
125533208|NCT02942277|451582744|FG000|Year 1|Pregnancy|0|||
125533209|NCT02942277|451582745|FG001|Year 1|Pregnancy|0|||
125533210|NCT02942277|451582746|FG002|Year 1|Pregnancy|0|||
125533211|NCT02942277|451582747|FG003|Year 1|Pregnancy|0|||
125644828|NCT03125902|451982117|FG000|Overall Study|Death|119|||
125644829|NCT03125902|451982118|FG001|Overall Study|Death|229|||
125533212|NCT02942277|451582748|FG004|Year 1|Pregnancy|0|||
125533213|NCT02942277|451582749|FG005|Year 1|Pregnancy|1|||
125533214|NCT02942277|451582750|FG006|Year 1|Pregnancy|0|||
125533215|NCT02942277|451582751|FG007|Year 1|Pregnancy|0|||
125533216|NCT02942277|451582752|FG008|Year 1|Pregnancy|0|||
125533217|NCT02942277|451582753|FG009|Year 1|Pregnancy|0|||
125533218|NCT02942277|451582754|FG010|Year 1|Pregnancy|0|||
125533219|NCT02942277|451582744|FG000|Year 2|Lost to Follow-up|0|||
125533220|NCT02942277|451582745|FG001|Year 2|Lost to Follow-up|0|||
125644830|NCT03125902|451982117|FG000|Overall Study|Lost to Follow-up|4|||
125644831|NCT03125902|451982118|FG001|Overall Study|Lost to Follow-up|13|||
125644832|NCT03125902|451982117|FG000|Overall Study|Other|0|||
125644833|NCT03125902|451982118|FG001|Overall Study|Other|4|||
125644834|NCT03125902|451982117|FG000|Overall Study|Physician Decision|2|||
125644835|NCT03125902|451982118|FG001|Overall Study|Physician Decision|1|||
125644836|NCT03125902|451982117|FG000|Overall Study|Progressive Disease|0|||
125644837|NCT03125902|451982118|FG001|Overall Study|Progressive Disease|3|||
125644838|NCT03125902|451982117|FG000|Overall Study|Study Terminated By Sponsor|74|||
125198613|NCT02836236|450350984|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
125198614|NCT02836236|450350985|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
125198615|NCT02836236|450350986|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
125198616|NCT02836236|450350983|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
125198617|NCT02836236|450350984|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
125198618|NCT02836236|450350985|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
125198619|NCT02836236|450350986|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
125198620|NCT02836236|450350983|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
125198621|NCT02836236|450350984|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
125198622|NCT02836236|450350985|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
125198623|NCT02836236|450350986|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
125198624|NCT02836236|450350983|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
125198625|NCT02836236|450350984|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
125198626|NCT02836236|450350985|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
125198627|NCT02836236|450350986|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
125198628|NCT02836236|450350983|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
125198629|NCT02836236|450350984|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
125198630|NCT02836236|450350985|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
125421615|NCT00683644|451168479|FG001|Overall Study|Low copper, other health problems,|6|||
125533221|NCT02942277|451582746|FG002|Year 2|Lost to Follow-up|0|||
125533222|NCT02942277|451582747|FG003|Year 2|Lost to Follow-up|0|||
125533223|NCT02942277|451582748|FG004|Year 2|Lost to Follow-up|2|||
125533224|NCT02942277|451582749|FG005|Year 2|Lost to Follow-up|1|||
125533225|NCT02942277|451582750|FG006|Year 2|Lost to Follow-up|0|||
125644839|NCT03125902|451982118|FG001|Overall Study|Study Terminated By Sponsor|143|||
125421616|NCT03240692|451168480|FG000|Overall Study|Physician Decision|1|||
125421617|NCT03240692|451168480|FG000|Overall Study|Withdrawal by Subject|1|||
125421618|NCT04123067|451168482|FG000|Overall Study|Lost to Follow-up|0|||
125421619|NCT04123067|451168483|FG001|Overall Study|Lost to Follow-up|1|||
125421620|NCT00843167|451168484|FG000|Treatment Period|Adverse Event|1|||
125421621|NCT00843167|451168485|FG001|Treatment Period|Adverse Event|5|||
125421622|NCT00843167|451168484|FG000|Treatment Period|Withdrawal by Subject|2|||
125421623|NCT00843167|451168485|FG001|Treatment Period|Withdrawal by Subject|3|||
125421624|NCT00127101|451168486|FG000|Base Protocol|Adverse Event|0|||
125421625|NCT00127101|451168487|FG001|Base Protocol|Adverse Event|2|||
125421626|NCT00127101|451168488|FG002|Base Protocol|Adverse Event|1|||
125421627|NCT00127101|451168489|FG003|Base Protocol|Adverse Event|0|||
125421628|NCT00127101|451168490|FG004|Base Protocol|Adverse Event|0|||
125421629|NCT00127101|451168491|FG005|Base Protocol|Adverse Event|0|||
125421630|NCT00127101|451168486|FG000|Base Protocol|Lack of Efficacy|1|||
125421631|NCT00127101|451168487|FG001|Base Protocol|Lack of Efficacy|0|||
125421632|NCT00127101|451168488|FG002|Base Protocol|Lack of Efficacy|0|||
125421633|NCT00127101|451168489|FG003|Base Protocol|Lack of Efficacy|0|||
125421634|NCT00127101|451168490|FG004|Base Protocol|Lack of Efficacy|2|||
125421635|NCT00127101|451168491|FG005|Base Protocol|Lack of Efficacy|0|||
125421636|NCT00127101|451168486|FG000|Base Protocol|Withdrawal by Subject|1|||
125421637|NCT00127101|451168487|FG001|Base Protocol|Withdrawal by Subject|2|||
125421638|NCT00127101|451168488|FG002|Base Protocol|Withdrawal by Subject|1|||
125421639|NCT00127101|451168489|FG003|Base Protocol|Withdrawal by Subject|0|||
125421640|NCT00127101|451168490|FG004|Base Protocol|Withdrawal by Subject|0|||
125421641|NCT00127101|451168491|FG005|Base Protocol|Withdrawal by Subject|1|||
125421642|NCT00127101|451168486|FG000|Continuation Phase|Adverse Event|0|||
125421643|NCT00127101|451168487|FG001|Continuation Phase|Adverse Event|0|||
125421644|NCT00127101|451168488|FG002|Continuation Phase|Adverse Event|0|||
125421645|NCT00127101|451168489|FG003|Continuation Phase|Adverse Event|0|||
125421646|NCT00127101|451168490|FG004|Continuation Phase|Adverse Event|1|||
125421647|NCT00127101|451168491|FG005|Continuation Phase|Adverse Event|1|||
125421648|NCT00127101|451168486|FG000|Continuation Phase|Lack of Efficacy|0|||
125421649|NCT00127101|451168487|FG001|Continuation Phase|Lack of Efficacy|0|||
125421650|NCT00127101|451168488|FG002|Continuation Phase|Lack of Efficacy|0|||
125421651|NCT00127101|451168489|FG003|Continuation Phase|Lack of Efficacy|0|||
125421652|NCT00127101|451168490|FG004|Continuation Phase|Lack of Efficacy|0|||
125421653|NCT00127101|451168491|FG005|Continuation Phase|Lack of Efficacy|1|||
125421654|NCT00127101|451168486|FG000|Continuation Phase|Withdrawal by Subject|0|||
125421655|NCT00127101|451168487|FG001|Continuation Phase|Withdrawal by Subject|0|||
125421656|NCT00127101|451168488|FG002|Continuation Phase|Withdrawal by Subject|1|||
125421657|NCT00127101|451168489|FG003|Continuation Phase|Withdrawal by Subject|0|||
125421658|NCT00127101|451168490|FG004|Continuation Phase|Withdrawal by Subject|2|||
125421659|NCT00127101|451168491|FG005|Continuation Phase|Withdrawal by Subject|1|||
125421660|NCT01565707|451168492|FG000|Overall Study|Adverse Event|1|||
125421661|NCT01565707|451168493|FG001|Overall Study|Adverse Event|6|||
125421662|NCT01565707|451168494|FG002|Overall Study|Adverse Event|2|||
125421663|NCT01565707|451168495|FG003|Overall Study|Adverse Event|1|||
125533226|NCT02942277|451582751|FG007|Year 2|Lost to Follow-up|0|||
125533227|NCT02942277|451582752|FG008|Year 2|Lost to Follow-up|0|||
125533228|NCT02942277|451582753|FG009|Year 2|Lost to Follow-up|0|||
125533229|NCT02942277|451582754|FG010|Year 2|Lost to Follow-up|0|||
125533230|NCT02942277|451582744|FG000|Year 2|Did not rescreen|0|||
125533231|NCT02942277|451582745|FG001|Year 2|Did not rescreen|0|||
125533232|NCT02942277|451582746|FG002|Year 2|Did not rescreen|1|||
125533233|NCT02942277|451582747|FG003|Year 2|Did not rescreen|1|||
125533234|NCT02942277|451582748|FG004|Year 2|Did not rescreen|9|||
125533235|NCT02942277|451582749|FG005|Year 2|Did not rescreen|6|||
125533236|NCT02942277|451582750|FG006|Year 2|Did not rescreen|0|||
125533237|NCT02942277|451582751|FG007|Year 2|Did not rescreen|1|||
125533238|NCT02942277|451582752|FG008|Year 2|Did not rescreen|0|||
125533239|NCT02942277|451582753|FG009|Year 2|Did not rescreen|0|||
125533240|NCT02942277|451582754|FG010|Year 2|Did not rescreen|21|||
125533241|NCT02942277|451582744|FG000|Year 2|Met withdrawal criteria|0|||
125533242|NCT02942277|451582745|FG001|Year 2|Met withdrawal criteria|0|||
125533243|NCT02942277|451582746|FG002|Year 2|Met withdrawal criteria|0|||
125533244|NCT02942277|451582747|FG003|Year 2|Met withdrawal criteria|0|||
125533245|NCT02942277|451582748|FG004|Year 2|Met withdrawal criteria|1|||
125533246|NCT02942277|451582749|FG005|Year 2|Met withdrawal criteria|2|||
125533247|NCT02942277|451582750|FG006|Year 2|Met withdrawal criteria|0|||
125533248|NCT02942277|451582751|FG007|Year 2|Met withdrawal criteria|0|||
125533249|NCT02942277|451582752|FG008|Year 2|Met withdrawal criteria|0|||
125533250|NCT02942277|451582753|FG009|Year 2|Met withdrawal criteria|0|||
125533251|NCT02942277|451582754|FG010|Year 2|Met withdrawal criteria|1|||
125533252|NCT02942277|451582744|FG000|Year 2|Travel|0|||
125421664|NCT01565707|451168492|FG000|Overall Study|Lost to Follow-up|1|||
125421665|NCT01565707|451168493|FG001|Overall Study|Lost to Follow-up|0|||
125421666|NCT01565707|451168494|FG002|Overall Study|Lost to Follow-up|0|||
125421667|NCT01565707|451168495|FG003|Overall Study|Lost to Follow-up|0|||
125533253|NCT02942277|451582745|FG001|Year 2|Travel|1|||
125533254|NCT02942277|451582746|FG002|Year 2|Travel|0|||
125533255|NCT02942277|451582747|FG003|Year 2|Travel|0|||
125533256|NCT02942277|451582748|FG004|Year 2|Travel|0|||
125533257|NCT02942277|451582749|FG005|Year 2|Travel|1|||
125533258|NCT02942277|451582750|FG006|Year 2|Travel|0|||
125533259|NCT02942277|451582751|FG007|Year 2|Travel|0|||
125533260|NCT02942277|451582752|FG008|Year 2|Travel|0|||
125533261|NCT02942277|451582753|FG009|Year 2|Travel|1|||
125533262|NCT02942277|451582754|FG010|Year 2|Travel|3|||
125533263|NCT02942277|451582744|FG000|Year 2|Non-compliant|0|||
125533264|NCT02942277|451582745|FG001|Year 2|Non-compliant|0|||
125533265|NCT02942277|451582746|FG002|Year 2|Non-compliant|0|||
125533266|NCT02942277|451582747|FG003|Year 2|Non-compliant|0|||
125198631|NCT02836236|450350986|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
125421668|NCT01565707|451168492|FG000|Overall Study|Protocol Violation|1|||
125421669|NCT01565707|451168493|FG001|Overall Study|Protocol Violation|0|||
125421670|NCT01565707|451168494|FG002|Overall Study|Protocol Violation|0|||
125421671|NCT01565707|451168495|FG003|Overall Study|Protocol Violation|1|||
125421672|NCT01565707|451168492|FG000|Overall Study|Withdrawal by Subject|3|||
125421673|NCT01565707|451168493|FG001|Overall Study|Withdrawal by Subject|1|||
125421674|NCT01565707|451168494|FG002|Overall Study|Withdrawal by Subject|1|||
125421675|NCT01565707|451168495|FG003|Overall Study|Withdrawal by Subject|1|||
125421676|NCT01565707|451168492|FG000|Overall Study|Randomized but not evaluable|2|||
125421677|NCT01565707|451168493|FG001|Overall Study|Randomized but not evaluable|0|||
125421678|NCT01565707|451168494|FG002|Overall Study|Randomized but not evaluable|0|||
125421679|NCT01565707|451168495|FG003|Overall Study|Randomized but not evaluable|0|||
125421680|NCT01565707|451168492|FG000|Overall Study|Miscellaneous|1|||
125421681|NCT01565707|451168493|FG001|Overall Study|Miscellaneous|1|||
125421682|NCT01565707|451168494|FG002|Overall Study|Miscellaneous|0|||
125421683|NCT01565707|451168495|FG003|Overall Study|Miscellaneous|2|||
125421684|NCT03762473|451168496|FG000|Overall Study|Death|1|||
125421685|NCT03762473|451168497|FG001|Overall Study|Death|0|||
125421686|NCT00126438|451168498|FG000|Overall Study|Withdrawal due to adverse event|1|||
125421687|NCT00126438|451168499|FG001|Overall Study|Withdrawal due to adverse event|0|||
125421688|NCT00126438|451168498|FG000|Overall Study|Lost to Follow-up|22|||
125421689|NCT00126438|451168499|FG001|Overall Study|Lost to Follow-up|0|||
125421690|NCT00126438|451168498|FG000|Overall Study|Protocol Violation|8|||
125421691|NCT00126438|451168499|FG001|Overall Study|Protocol Violation|8|||
125421692|NCT00126438|451168498|FG000|Overall Study|Withdrawal by Subject|3|||
125421693|NCT00126438|451168499|FG001|Overall Study|Withdrawal by Subject|2|||
125533267|NCT02942277|451582748|FG004|Year 2|Non-compliant|1|||
125533268|NCT02942277|451582749|FG005|Year 2|Non-compliant|1|||
125533269|NCT02942277|451582750|FG006|Year 2|Non-compliant|0|||
125533270|NCT02942277|451582751|FG007|Year 2|Non-compliant|0|||
125533271|NCT02942277|451582752|FG008|Year 2|Non-compliant|0|||
125533272|NCT02942277|451582753|FG009|Year 2|Non-compliant|0|||
125533273|NCT02942277|451582754|FG010|Year 2|Non-compliant|0|||
125533274|NCT02942277|451582744|FG000|Year 2|Withdrawal by Subject|0|||
125533275|NCT02942277|451582745|FG001|Year 2|Withdrawal by Subject|0|||
125533276|NCT02942277|451582746|FG002|Year 2|Withdrawal by Subject|0|||
125533277|NCT02942277|451582747|FG003|Year 2|Withdrawal by Subject|0|||
125533278|NCT02942277|451582748|FG004|Year 2|Withdrawal by Subject|0|||
125533279|NCT02942277|451582749|FG005|Year 2|Withdrawal by Subject|0|||
125533280|NCT02942277|451582750|FG006|Year 2|Withdrawal by Subject|1|||
125533281|NCT02942277|451582751|FG007|Year 2|Withdrawal by Subject|0|||
125533282|NCT02942277|451582752|FG008|Year 2|Withdrawal by Subject|0|||
125533283|NCT02942277|451582753|FG009|Year 2|Withdrawal by Subject|0|||
125533284|NCT02942277|451582754|FG010|Year 2|Withdrawal by Subject|0|||
125533285|NCT05577715|451582755|FG000|Overall Study|Withdrawal by Subject|1|||
125533286|NCT05577715|451582755|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
125533287|NCT05577715|451582755|FG000|Overall Study|Lost to Follow-up|1|||
125533288|NCT05577715|451582755|FG000|Overall Study|Death|6|||
125533289|NCT00626197|451582762|FG000|Overall Study|Did not cooperate|2|||
125533290|NCT00626197|451582763|FG001|Overall Study|Did not cooperate|6|||
125533291|NCT00626197|451582764|FG002|Overall Study|Did not cooperate|1|||
125533292|NCT00626197|451582762|FG000|Overall Study|Failure to return|6|||
125533293|NCT00626197|451582763|FG001|Overall Study|Failure to return|5|||
125533294|NCT00626197|451582764|FG002|Overall Study|Failure to return|6|||
125533295|NCT00626197|451582762|FG000|Overall Study|Adverse event, serious fatal|3|||
125533296|NCT00626197|451582763|FG001|Overall Study|Adverse event, serious fatal|6|||
125533297|NCT00626197|451582764|FG002|Overall Study|Adverse event, serious fatal|6|||
125533298|NCT00626197|451582762|FG000|Overall Study|Adverse Event|1|||
125533299|NCT00626197|451582763|FG001|Overall Study|Adverse Event|1|||
125533300|NCT00626197|451582764|FG002|Overall Study|Adverse Event|2|||
125533301|NCT00626197|451582762|FG000|Overall Study|Withdrawal by Subject|17|||
125533302|NCT00626197|451582763|FG001|Overall Study|Withdrawal by Subject|17|||
125533303|NCT00626197|451582764|FG002|Overall Study|Withdrawal by Subject|7|||
125198632|NCT02836236|450350983|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
125533304|NCT00626197|451582762|FG000|Overall Study|Administrative reasons|15|||
125533305|NCT00626197|451582763|FG001|Overall Study|Administrative reasons|19|||
125533306|NCT00626197|451582764|FG002|Overall Study|Administrative reasons|55|||
125533307|NCT04833127|451582765|FG000|Overall Study|Lost to Follow-up|1|||
125421694|NCT02626780|451168500|FG000|Overall Study|Withdrawal by Subject|3|||
125421695|NCT03456700|451168501|FG000|Overall Study|Withdrawal by Subject|1|||
125421696|NCT02858895|451168503|FG000|Overall Study|Disease progression|31|||
125421697|NCT02858895|451168503|FG000|Overall Study|Death|2|||
125421698|NCT02858895|451168503|FG000|Overall Study|Adverse Event|1|||
125421699|NCT02858895|451168503|FG000|Overall Study|Withdrawal by Subject|3|||
125421700|NCT02858895|451168503|FG000|Overall Study|hospice,|1|||
125421701|NCT02858895|451168503|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
125421702|NCT04918784|451170245|FG000|Overall Study|Amputation - no longer eligible|1|||
125421703|NCT04918784|451170246|FG001|Overall Study|Amputation - no longer eligible|2|||
125421704|NCT04918784|451170245|FG000|Overall Study|Death|1|||
125421705|NCT04918784|451170246|FG001|Overall Study|Death|0|||
125421706|NCT04918784|451170245|FG000|Overall Study|patient non-compliance|3|||
125421707|NCT04918784|451170246|FG001|Overall Study|patient non-compliance|1|||
125421708|NCT04918784|451170245|FG000|Overall Study|Adverse Event|1|||
125421709|NCT04918784|451170246|FG001|Overall Study|Adverse Event|0|||
125421710|NCT02160314|451170247|FG000|Overall Study|Adverse Event|0|||
125421711|NCT02160314|451170248|FG001|Overall Study|Adverse Event|6|||
125421712|NCT02160314|451170247|FG000|Overall Study|Protocol Violation|0|||
125421713|NCT02160314|451170248|FG001|Overall Study|Protocol Violation|4|||
125421714|NCT02160314|451170247|FG000|Overall Study|Withdrawal by Subject|1|||
125421715|NCT02160314|451170248|FG001|Overall Study|Withdrawal by Subject|2|||
125421716|NCT02160314|451170247|FG000|Overall Study|Lost to Follow-up|0|||
125421717|NCT02160314|451170248|FG001|Overall Study|Lost to Follow-up|1|||
125421718|NCT02586025|451170257|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
125421719|NCT02586025|451170258|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
125421720|NCT02586025|451170257|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
125421721|NCT02586025|451170258|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
125421722|NCT02586025|451170257|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
125421723|NCT02586025|451170258|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
125421724|NCT02586025|451170257|FG000|Neoadjuvant Treatment|Death|1|||
125421725|NCT02586025|451170258|FG001|Neoadjuvant Treatment|Death|0|||
125421726|NCT02586025|451170257|FG000|Neoadjuvant Treatment|Adverse Event|1|||
125421727|NCT02586025|451170258|FG001|Neoadjuvant Treatment|Adverse Event|0|||
125421728|NCT02586025|451170257|FG000|Neoadjuvant Treatment|Physician Decision|2|||
125421729|NCT02586025|451170258|FG001|Neoadjuvant Treatment|Physician Decision|1|||
125421730|NCT02586025|451170257|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
125421731|NCT02586025|451170258|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
125421732|NCT02586025|451170257|FG000|Adjuvant Treatment|Recurrent Disease|4|||
125421733|NCT02586025|451170258|FG001|Adjuvant Treatment|Recurrent Disease|5|||
125421734|NCT02586025|451170257|FG000|Adjuvant Treatment|Physician Decision|0|||
125533308|NCT04833127|451582766|FG001|Overall Study|Lost to Follow-up|1|||
125533309|NCT04552899|451582769|FG000|Overall Study|Adverse Event|4|||
125533310|NCT04552899|451582770|FG001|Overall Study|Adverse Event|3|||
125533311|NCT04552899|451582769|FG000|Overall Study|Death|4|||
125533312|NCT04552899|451582770|FG001|Overall Study|Death|4|||
125533313|NCT04552899|451582769|FG000|Overall Study|Lost to Follow-up|8|||
125533314|NCT04552899|451582770|FG001|Overall Study|Lost to Follow-up|13|||
125533315|NCT04552899|451582769|FG000|Overall Study|Lung Transplant|4|||
125533316|NCT04552899|451582770|FG001|Overall Study|Lung Transplant|3|||
125533317|NCT04552899|451582769|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
125533318|NCT04552899|451582770|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
125533319|NCT04552899|451582769|FG000|Overall Study|Physician Decision|3|||
125533320|NCT04552899|451582770|FG001|Overall Study|Physician Decision|4|||
125533321|NCT04552899|451582769|FG000|Overall Study|Study Terminated By Sponsor|237|||
125533322|NCT04552899|451582770|FG001|Overall Study|Study Terminated By Sponsor|239|||
125533323|NCT04552899|451582769|FG000|Overall Study|Withdrawal by Subject|15|||
125533324|NCT04552899|451582770|FG001|Overall Study|Withdrawal by Subject|17|||
125533325|NCT05282121|451582771|FG000|Overall Study|Adverse Event|1|||
125533326|NCT05282121|451582772|FG001|Overall Study|Adverse Event|1|||
125533327|NCT05282121|451582773|FG002|Overall Study|Adverse Event|4|||
125533328|NCT05282121|451582774|FG003|Overall Study|Adverse Event|1|||
125533329|NCT05282121|451582771|FG000|Overall Study|Study Terminated by Sponsor|1|||
125533330|NCT05282121|451582772|FG001|Overall Study|Study Terminated by Sponsor|2|||
125533331|NCT05282121|451582773|FG002|Overall Study|Study Terminated by Sponsor|2|||
125533332|NCT05282121|451582774|FG003|Overall Study|Study Terminated by Sponsor|2|||
125533333|NCT05282121|451582771|FG000|Overall Study|Other than listed|0|||
125533334|NCT05282121|451582772|FG001|Overall Study|Other than listed|0|||
125533335|NCT05282121|451582773|FG002|Overall Study|Other than listed|1|||
125533336|NCT05282121|451582774|FG003|Overall Study|Other than listed|0|||
125533337|NCT05282121|451582771|FG000|Overall Study|No reason available|0|||
125421735|NCT02586025|451170258|FG001|Adjuvant Treatment|Physician Decision|1|||
125421736|NCT02586025|451170257|FG000|Adjuvant Treatment|Pregnancy|1|||
125533338|NCT05282121|451582772|FG001|Overall Study|No reason available|0|||
125533339|NCT05282121|451582773|FG002|Overall Study|No reason available|1|||
125533340|NCT05282121|451582774|FG003|Overall Study|No reason available|0|||
125421737|NCT02586025|451170258|FG001|Adjuvant Treatment|Pregnancy|0|||
125533341|NCT00461981|451582778|FG000|Overall Study|Lost to Follow-up|9|||
125533342|NCT00461981|451582779|FG001|Overall Study|Lost to Follow-up|6|||
125533343|NCT00461981|451582778|FG000|Overall Study|Withdrawal by Subject|2|||
125533344|NCT00461981|451582779|FG001|Overall Study|Withdrawal by Subject|3|||
125533345|NCT00731133|451582783|FG000|Overall Study|Withdrawal by Subject|10|||
125533346|NCT03510455|451582784|FG000|Overall Study|Physician Decision|1|||
125533347|NCT04958642|451582791|FG000|Overall Study|Transferred to OLEX program|3|||
125533348|NCT04958642|451582792|FG001|Overall Study|Transferred to OLEX program|0|||
125533349|NCT04958642|451582793|FG002|Overall Study|Transferred to OLEX program|5|||
125533350|NCT04958642|451582791|FG000|Overall Study|Death|0|||
125533351|NCT04958642|451582792|FG001|Overall Study|Death|0|||
125533352|NCT04958642|451582793|FG002|Overall Study|Death|1|||
125533353|NCT04958642|451582791|FG000|Overall Study|Withdrawal by Subject|4|||
125533354|NCT04958642|451582792|FG001|Overall Study|Withdrawal by Subject|9|||
125533355|NCT04958642|451582793|FG002|Overall Study|Withdrawal by Subject|13|||
125533356|NCT04958642|451582791|FG000|Overall Study|Investigator's Decision|0|||
125421738|NCT02586025|451170257|FG000|Treatment-Free Follow-Up|Death|11|||
125421739|NCT02586025|451170258|FG001|Treatment-Free Follow-Up|Death|11|||
125421740|NCT02586025|451170257|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
125421741|NCT02586025|451170258|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
125533357|NCT04958642|451582792|FG001|Overall Study|Investigator's Decision|0|||
125533358|NCT04958642|451582793|FG002|Overall Study|Investigator's Decision|1|||
125533359|NCT04958642|451582791|FG000|Overall Study|Adverse Event|1|||
125533360|NCT04958642|451582792|FG001|Overall Study|Adverse Event|0|||
125533361|NCT04958642|451582793|FG002|Overall Study|Adverse Event|1|||
125533362|NCT04958642|451582791|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
125533363|NCT04958642|451582792|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
125533364|NCT04958642|451582793|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
125533365|NCT04958642|451582791|FG000|Overall Study|Lost to Follow-up|1|||
125533366|NCT04958642|451582792|FG001|Overall Study|Lost to Follow-up|0|||
125533367|NCT04958642|451582793|FG002|Overall Study|Lost to Follow-up|0|||
125533368|NCT04958642|451582791|FG000|Overall Study|Transferred to EAP following study termination|0|||
125533369|NCT04958642|451582792|FG001|Overall Study|Transferred to EAP following study termination|0|||
125533370|NCT04958642|451582793|FG002|Overall Study|Transferred to EAP following study termination|1|||
125533371|NCT04958642|451582791|FG000|Overall Study|Transferred to Expanded Access Program|1|||
125533372|NCT04958642|451582792|FG001|Overall Study|Transferred to Expanded Access Program|0|||
125533373|NCT04958642|451582793|FG002|Overall Study|Transferred to Expanded Access Program|0|||
125533374|NCT03853551|451582797|FG000|Overall Study|Death|2|||
125533375|NCT03853551|451582797|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
125533376|NCT02476175|451582798|FG000|Overall Study|Adverse Event|2|||
125533377|NCT01876901|451582800|FG000|Overall Study|Protocol Violation|10|||
125533378|NCT01876901|451582801|FG001|Overall Study|Protocol Violation|2|||
125533379|NCT01876901|451582800|FG000|Overall Study|No or other surgical intervention|7|||
125533380|NCT01876901|451582801|FG001|Overall Study|No or other surgical intervention|5|||
125533381|NCT02964325|451582804|FG000|Overall Study|Lost to Follow-up|3|||
125533382|NCT02964325|451582805|FG001|Overall Study|Lost to Follow-up|3|||
125533383|NCT02964325|451582804|FG000|Overall Study|Physician Decision|5|||
125533384|NCT02964325|451582805|FG001|Overall Study|Physician Decision|4|||
125533385|NCT02964325|451582804|FG000|Overall Study|Death|1|||
125533386|NCT02964325|451582805|FG001|Overall Study|Death|3|||
125533387|NCT02964325|451582804|FG000|Overall Study|Withdrawal by Subject|2|||
125533388|NCT02964325|451582805|FG001|Overall Study|Withdrawal by Subject|1|||
125533389|NCT02964325|451582804|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
125533390|NCT02964325|451582805|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
125533391|NCT02510040|451582806|FG000|Overall Study|Deemed no longer eligible|18|||
125533392|NCT02510040|451582807|FG001|Overall Study|Deemed no longer eligible|3|||
125533393|NCT02510040|451582808|FG002|Overall Study|Deemed no longer eligible|1|||
125533394|NCT00643617|451582809|FG000|Overall Study|Death|6|||
125533395|NCT00643617|451582810|FG001|Overall Study|Death|9|||
125533396|NCT00643617|451582809|FG000|Overall Study|Lost to Follow-up|42|||
125533397|NCT00643617|451582810|FG001|Overall Study|Lost to Follow-up|51|||
125533398|NCT00534495|451582819|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
125533399|NCT00534495|451582820|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
125533400|NCT00534495|451582821|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
125533401|NCT00534495|451582819|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
125533402|NCT00534495|451582820|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
125533403|NCT00534495|451582821|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
125533404|NCT00534495|451582819|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
125533405|NCT00534495|451582820|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
125533406|NCT00534495|451582821|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
125533407|NCT00534495|451582819|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
125533408|NCT00534495|451582820|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
125533409|NCT00534495|451582821|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
125533410|NCT00534495|451582819|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
125533411|NCT00534495|451582820|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
125533412|NCT00534495|451582821|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
125533413|NCT00534495|451582819|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
125533414|NCT00534495|451582820|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
125533415|NCT00534495|451582821|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
125533416|NCT00534495|451582819|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
125533417|NCT00534495|451582820|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
125533418|NCT00534495|451582821|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
125533419|NCT00534495|451582819|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
125533420|NCT00534495|451582820|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
125533421|NCT00534495|451582821|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
125533422|NCT00534495|451582819|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
125533423|NCT00534495|451582820|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
125533424|NCT00534495|451582821|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
125533425|NCT01068665|451582822|FG000|Overall Study|Adverse Event|5|||
125533426|NCT01068665|451582823|FG001|Overall Study|Adverse Event|4|||
125533427|NCT01068665|451582822|FG000|Overall Study|Lack of Efficacy|0|||
125533428|NCT01068665|451582823|FG001|Overall Study|Lack of Efficacy|2|||
125533429|NCT01068665|451582822|FG000|Overall Study|Protocol Violation|5|||
125533430|NCT01068665|451582823|FG001|Overall Study|Protocol Violation|2|||
125533431|NCT01068665|451582822|FG000|Overall Study|Withdrawal Criteria|3|||
125533432|NCT01068665|451582823|FG001|Overall Study|Withdrawal Criteria|9|||
125533433|NCT01068665|451582822|FG000|Overall Study|Other|17|||
125533434|NCT01068665|451582823|FG001|Overall Study|Other|12|||
125533435|NCT02202785|451582825|FG000|Overall Study|Study Terminated by Sponsor|1|||
125533436|NCT02202785|451582826|FG001|Overall Study|Study Terminated by Sponsor|6|||
125533437|NCT02202785|451582827|FG002|Overall Study|Study Terminated by Sponsor|4|||
125533438|NCT02202785|451582825|FG000|Overall Study|Withdrawal by Subject|0|||
125533439|NCT02202785|451582826|FG001|Overall Study|Withdrawal by Subject|1|||
125533440|NCT02202785|451582827|FG002|Overall Study|Withdrawal by Subject|0|||
125533441|NCT02202785|451582825|FG000|Overall Study|Lost to Follow-up|0|||
125533442|NCT02202785|451582826|FG001|Overall Study|Lost to Follow-up|1|||
125533443|NCT02202785|451582827|FG002|Overall Study|Lost to Follow-up|0|||
125533444|NCT02202785|451582825|FG000|Overall Study|Reason not Specified|10|||
125533445|NCT02202785|451582826|FG001|Overall Study|Reason not Specified|7|||
125533446|NCT02202785|451582827|FG002|Overall Study|Reason not Specified|13|||
125533447|NCT02180243|451582828|FG000|Overall Study|Withdrawal by Subject|12|||
125533448|NCT02180243|451582829|FG001|Overall Study|Withdrawal by Subject|12|||
125533449|NCT02180243|451582828|FG000|Overall Study|Lost to Follow-up|12|||
125533450|NCT02180243|451582829|FG001|Overall Study|Lost to Follow-up|2|||
125533451|NCT01137578|451582831|FG000|Overall Study|Participant requested to Discontinue|3|||
125533452|NCT01137578|451582832|FG001|Overall Study|Participant requested to Discontinue|0|||
125533453|NCT01137578|451582833|FG002|Overall Study|Participant requested to Discontinue|0|||
125533454|NCT01137578|451582831|FG000|Overall Study|Withdrawal by Subject|1|||
125533455|NCT01137578|451582832|FG001|Overall Study|Withdrawal by Subject|0|||
125310188|NCT00413218|450762023|FG000|Overall Study|Lost to Follow-up|14|||
125421742|NCT02586025|451170257|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
125421743|NCT02586025|451170258|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
125421744|NCT02586025|451170257|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
125421745|NCT02586025|451170258|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
125421746|NCT02586025|451170257|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
125421747|NCT02586025|451170258|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
125421748|NCT04205630|451170259|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
125421749|NCT04205630|451170259|FG000|Overall Study|Disease clinical progression|7|||
125421750|NCT04205630|451170259|FG000|Overall Study|Withdrawal by Subject|2|||
125421751|NCT04205630|451170259|FG000|Overall Study|Adverse Event|17|||
125421752|NCT04205630|451170259|FG000|Overall Study|Other|1|||
125421753|NCT04493216|451170261|FG000|Overall Study|Study terminated by sponsor|30|||
125421754|NCT04493216|451170262|FG001|Overall Study|Study terminated by sponsor|33|||
125421755|NCT04493216|451170263|FG002|Overall Study|Study terminated by sponsor|28|||
125421756|NCT04493216|451170264|FG003|Overall Study|Study terminated by sponsor|27|||
125421757|NCT04493216|451170261|FG000|Overall Study|Withdrawal by Subject|2|||
125421758|NCT04493216|451170262|FG001|Overall Study|Withdrawal by Subject|1|||
125533456|NCT01137578|451582833|FG002|Overall Study|Withdrawal by Subject|0|||
125533457|NCT01137578|451582831|FG000|Overall Study|Other|12|||
125533458|NCT01137578|451582832|FG001|Overall Study|Other|2|||
125533459|NCT01137578|451582833|FG002|Overall Study|Other|6|||
125533460|NCT04145700|451582834|FG000|Overall Study|Withdrawal by Subject|8|||
125533461|NCT04145700|451582835|FG001|Overall Study|Withdrawal by Subject|3|||
125421759|NCT04493216|451170263|FG002|Overall Study|Withdrawal by Subject|1|||
125421760|NCT04493216|451170264|FG003|Overall Study|Withdrawal by Subject|2|||
125421761|NCT04493216|451170261|FG000|Overall Study|Protocol Violation|1|||
125421762|NCT04493216|451170262|FG001|Overall Study|Protocol Violation|2|||
125421763|NCT04493216|451170263|FG002|Overall Study|Protocol Violation|0|||
125421764|NCT04493216|451170264|FG003|Overall Study|Protocol Violation|2|||
125421765|NCT04493216|451170261|FG000|Overall Study|Physician Decision|0|||
125421766|NCT04493216|451170262|FG001|Overall Study|Physician Decision|0|||
125421767|NCT04493216|451170263|FG002|Overall Study|Physician Decision|1|||
125421768|NCT04493216|451170264|FG003|Overall Study|Physician Decision|0|||
125421769|NCT04493216|451170261|FG000|Overall Study|Lost to Follow-up|2|||
125421770|NCT04493216|451170262|FG001|Overall Study|Lost to Follow-up|1|||
125421771|NCT04493216|451170263|FG002|Overall Study|Lost to Follow-up|0|||
125421772|NCT04493216|451170264|FG003|Overall Study|Lost to Follow-up|1|||
125421773|NCT04493216|451170261|FG000|Overall Study|Adverse Event|1|||
125421774|NCT04493216|451170262|FG001|Overall Study|Adverse Event|4|||
125421775|NCT04493216|451170263|FG002|Overall Study|Adverse Event|5|||
125421776|NCT04493216|451170264|FG003|Overall Study|Adverse Event|2|||
125421777|NCT04493216|451170261|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
125421778|NCT04493216|451170262|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
125421779|NCT04493216|451170263|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
125421780|NCT04493216|451170264|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
125421781|NCT03643952|451170271|FG000|Overall Study|Lack of Efficacy|1|||
125421782|NCT01597050|451170272|FG000|Overall Study|Withdrawal by Subject|1|||
125421783|NCT01597050|451170273|FG001|Overall Study|Withdrawal by Subject|0|||
125421784|NCT00483184|451170274|FG000|Overall Study|Withdrawal by Subject|2|||
125421785|NCT00483184|451170275|FG001|Overall Study|Withdrawal by Subject|2|||
125421786|NCT00483184|451170276|FG002|Overall Study|Withdrawal by Subject|0|||
125421787|NCT00483184|451170274|FG000|Overall Study|Lost to Follow-up|1|||
125421788|NCT00483184|451170275|FG001|Overall Study|Lost to Follow-up|0|||
125421789|NCT00483184|451170276|FG002|Overall Study|Lost to Follow-up|0|||
125421790|NCT00483184|451170274|FG000|Overall Study|Adverse Event|1|||
125421791|NCT00483184|451170275|FG001|Overall Study|Adverse Event|2|||
125421792|NCT00483184|451170276|FG002|Overall Study|Adverse Event|2|||
125421793|NCT00483184|451170274|FG000|Overall Study|Protocol Violation|1|||
125421794|NCT00483184|451170275|FG001|Overall Study|Protocol Violation|0|||
125421795|NCT00483184|451170276|FG002|Overall Study|Protocol Violation|1|||
125421796|NCT00558428|451170277|FG000|Overall Study|Adverse Event|6|||
125421797|NCT00558428|451170278|FG001|Overall Study|Adverse Event|22|||
125421798|NCT00558428|451170279|FG002|Overall Study|Adverse Event|3|||
125421799|NCT00558428|451170280|FG003|Overall Study|Adverse Event|4|||
125421800|NCT00558428|451170277|FG000|Overall Study|Lost to Follow-up|0|||
125421801|NCT00558428|451170278|FG001|Overall Study|Lost to Follow-up|1|||
125421802|NCT00558428|451170279|FG002|Overall Study|Lost to Follow-up|0|||
125421803|NCT00558428|451170280|FG003|Overall Study|Lost to Follow-up|0|||
125421804|NCT00558428|451170277|FG000|Overall Study|Lack of Efficacy|0|||
125421805|NCT00558428|451170278|FG001|Overall Study|Lack of Efficacy|0|||
125421806|NCT00558428|451170279|FG002|Overall Study|Lack of Efficacy|1|||
125421807|NCT00558428|451170280|FG003|Overall Study|Lack of Efficacy|2|||
125421808|NCT00558428|451170277|FG000|Overall Study|Non compliant with protocol|1|||
125421809|NCT00558428|451170278|FG001|Overall Study|Non compliant with protocol|0|||
125421810|NCT00558428|451170279|FG002|Overall Study|Non compliant with protocol|0|||
125421811|NCT00558428|451170280|FG003|Overall Study|Non compliant with protocol|3|||
125421812|NCT00558428|451170277|FG000|Overall Study|Consent withdrawn|2|||
125421813|NCT00558428|451170278|FG001|Overall Study|Consent withdrawn|1|||
125421814|NCT00558428|451170279|FG002|Overall Study|Consent withdrawn|0|||
125421815|NCT00558428|451170280|FG003|Overall Study|Consent withdrawn|1|||
125421816|NCT00558428|451170277|FG000|Overall Study|Other|3|||
125421817|NCT00558428|451170278|FG001|Overall Study|Other|0|||
125421818|NCT00558428|451170279|FG002|Overall Study|Other|0|||
125421819|NCT00558428|451170280|FG003|Overall Study|Other|1|||
125421820|NCT05224050|451170281|FG000|Overall Study|Withdrawal by Subject|9|||
125421821|NCT05224050|451170281|FG000|Overall Study|Lost to Follow-up|3|||
125421822|NCT01292876|451170282|FG000|Overall Study|Physician Decision|4|||
125421823|NCT01627327|451170283|FG000|Overall Study|Adverse Event|6|||
125421824|NCT01627327|451170284|FG001|Overall Study|Adverse Event|12|||
125421825|NCT01627327|451170283|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
125421826|NCT01627327|451170284|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
125310189|NCT00413218|450762024|FG001|Overall Study|Lost to Follow-up|17|||
125310190|NCT00413218|450762023|FG000|Overall Study|Admin|20|||
125421827|NCT01627327|451170283|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
125421828|NCT01627327|451170284|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
125421829|NCT01627327|451170283|FG000|Overall Study|Protocol Violation|4|||
125421830|NCT01627327|451170284|FG001|Overall Study|Protocol Violation|10|||
125421831|NCT01627327|451170283|FG000|Overall Study|Lost to Follow-up|1|||
125421832|NCT01627327|451170284|FG001|Overall Study|Lost to Follow-up|3|||
125421833|NCT01627327|451170283|FG000|Overall Study|Physician Decision|1|||
125421834|NCT01627327|451170284|FG001|Overall Study|Physician Decision|0|||
125421835|NCT01627327|451170283|FG000|Overall Study|Withdrawal by Subject|3|||
125421836|NCT01627327|451170284|FG001|Overall Study|Withdrawal by Subject|3|||
125421837|NCT04528069|451170290|FG000|Overall Study|Adverse Event|1|||
125421838|NCT04528069|451170290|FG000|Overall Study|Lost to Follow-up|1|||
125533462|NCT00818779|451582836|FG000|Overall Study|Protocol Violation|1|||
125421839|NCT04528069|451170290|FG000|Overall Study|Patient Unable to Come|1|||
125421840|NCT04528069|451170290|FG000|Overall Study|Patient Unable to Attend|1|||
125421841|NCT02525874|451170293|FG000|Overall Study|Other|1|||
125421842|NCT02525874|451170293|FG000|Overall Study|Investigator Decision|1|||
125421843|NCT02525874|451170293|FG000|Overall Study|Consent withdrawn|22|||
125421844|NCT02525874|451170293|FG000|Overall Study|Non-compliance with study drug|3|||
125421845|NCT02525874|451170293|FG000|Overall Study|Adverse Event|17|||
125421846|NCT02525874|451170293|FG000|Overall Study|Lost to Follow-up|7|||
125421847|NCT02525874|451170293|FG000|Overall Study|Disease progression, defined by protocol|2|||
125421848|NCT02525874|451170293|FG000|Overall Study|Disease relapse|4|||
125421849|NCT02525874|451170293|FG000|Overall Study|Alternative Treatment for MS|2|||
125421850|NCT02525874|451170293|FG000|Overall Study|New lesions in Brain|1|||
125421851|NCT01692782|451170296|FG000|Overall Study|Adverse Event|12|||
125421852|NCT01692782|451170297|FG001|Overall Study|Adverse Event|32|||
125421853|NCT01692782|451170298|FG002|Overall Study|Adverse Event|2|||
125421854|NCT01692782|451170296|FG000|Overall Study|Lack of Efficacy|1|||
125533463|NCT00818779|451582837|FG001|Overall Study|Protocol Violation|0|||
125533464|NCT00818779|451582836|FG000|Overall Study|Lost to Follow-up|1|||
125421855|NCT01692782|451170297|FG001|Overall Study|Lack of Efficacy|2|||
125421856|NCT01692782|451170298|FG002|Overall Study|Lack of Efficacy|0|||
125421857|NCT01692782|451170296|FG000|Overall Study|Lost to Follow-up|2|||
125421858|NCT01692782|451170297|FG001|Overall Study|Lost to Follow-up|7|||
125421859|NCT01692782|451170298|FG002|Overall Study|Lost to Follow-up|1|||
125421860|NCT01692782|451170296|FG000|Overall Study|Pregnancy|1|||
125533465|NCT00818779|451582837|FG001|Overall Study|Lost to Follow-up|0|||
125533466|NCT00818779|451582836|FG000|Overall Study|Adverse Event|4|||
125421861|NCT01692782|451170297|FG001|Overall Study|Pregnancy|0|||
125421862|NCT01692782|451170298|FG002|Overall Study|Pregnancy|0|||
125421863|NCT01692782|451170296|FG000|Overall Study|Protocol Violation|1|||
125421864|NCT01692782|451170297|FG001|Overall Study|Protocol Violation|0|||
125421865|NCT01692782|451170298|FG002|Overall Study|Protocol Violation|2|||
125421866|NCT01692782|451170296|FG000|Overall Study|Non-complance with study drug|0|||
125421867|NCT01692782|451170297|FG001|Overall Study|Non-complance with study drug|4|||
125421868|NCT01692782|451170298|FG002|Overall Study|Non-complance with study drug|1|||
125421869|NCT01692782|451170296|FG000|Overall Study|Non-compliant with study visits|0|||
125421870|NCT01692782|451170297|FG001|Overall Study|Non-compliant with study visits|0|||
125421871|NCT01692782|451170298|FG002|Overall Study|Non-compliant with study visits|1|||
125421872|NCT01692782|451170296|FG000|Overall Study|SAE not related to study drug|0|||
125421873|NCT01692782|451170297|FG001|Overall Study|SAE not related to study drug|1|||
125421874|NCT01692782|451170298|FG002|Overall Study|SAE not related to study drug|0|||
125421875|NCT01692782|451170296|FG000|Overall Study|Withdrawal by Subject|3|||
125421876|NCT01692782|451170297|FG001|Overall Study|Withdrawal by Subject|10|||
125421877|NCT01692782|451170298|FG002|Overall Study|Withdrawal by Subject|3|||
125421878|NCT03945188|451170299|FG000|Overall Study|Protocol Violation|1|||
125421879|NCT03945188|451170300|FG001|Overall Study|Protocol Violation|0|||
125421880|NCT03945188|451170299|FG000|Overall Study|Disease worsening|79|||
125421881|NCT03945188|451170300|FG001|Overall Study|Disease worsening|73|||
125421882|NCT03945188|451170299|FG000|Overall Study|Physician Decision|2|||
125421883|NCT03945188|451170300|FG001|Overall Study|Physician Decision|2|||
125421884|NCT03945188|451170299|FG000|Overall Study|Lack of Efficacy|7|||
125421885|NCT03945188|451170300|FG001|Overall Study|Lack of Efficacy|4|||
125421886|NCT03945188|451170299|FG000|Overall Study|Pregnancy|2|||
125421887|NCT03945188|451170300|FG001|Overall Study|Pregnancy|0|||
125421888|NCT03945188|451170299|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
125421889|NCT03945188|451170300|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
125421890|NCT03945188|451170299|FG000|Overall Study|Adverse Event|10|||
125421891|NCT03945188|451170300|FG001|Overall Study|Adverse Event|5|||
125421892|NCT03945188|451170299|FG000|Overall Study|Other|2|||
125421893|NCT03945188|451170300|FG001|Overall Study|Other|2|||
125421894|NCT03945188|451170299|FG000|Overall Study|Lost to Follow-up|1|||
125421895|NCT03945188|451170300|FG001|Overall Study|Lost to Follow-up|2|||
125421896|NCT01618162|451170319|FG000|Overall Study|Protocol Violation|13|||
125421897|NCT01618162|451170320|FG001|Overall Study|Protocol Violation|10|||
125421898|NCT01618162|451170319|FG000|Overall Study|Adverse Event|9|||
125421899|NCT01618162|451170320|FG001|Overall Study|Adverse Event|2|||
125421900|NCT01618162|451170319|FG000|Overall Study|Withdrawal Criteria|2|||
125421901|NCT01618162|451170320|FG001|Overall Study|Withdrawal Criteria|10|||
125421902|NCT01618162|451170319|FG000|Overall Study|Unclassified|14|||
125421903|NCT01618162|451170320|FG001|Overall Study|Unclassified|13|||
125421904|NCT04124926|451170321|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
125421905|NCT04124926|451170322|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
125421906|NCT04124926|451170323|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
125421907|NCT04124926|451170324|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
125421908|NCT04124926|451170325|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
125421909|NCT04124926|451170321|FG000|Healing Phase|Protocol Violation|0|||
125421910|NCT04124926|451170322|FG001|Healing Phase|Protocol Violation|1|||
125533467|NCT00818779|451582837|FG001|Overall Study|Adverse Event|1|||
125421911|NCT04124926|451170323|FG002|Healing Phase|Protocol Violation|0|||
125421912|NCT04124926|451170324|FG003|Healing Phase|Protocol Violation|0|||
125421913|NCT04124926|451170325|FG004|Healing Phase|Protocol Violation|0|||
125421914|NCT04124926|451170321|FG000|Healing Phase|Lost to Follow-up|5|||
125421915|NCT04124926|451170322|FG001|Healing Phase|Lost to Follow-up|4|||
125421916|NCT04124926|451170323|FG002|Healing Phase|Lost to Follow-up|0|||
125421917|NCT04124926|451170324|FG003|Healing Phase|Lost to Follow-up|0|||
125421918|NCT04124926|451170325|FG004|Healing Phase|Lost to Follow-up|0|||
125421919|NCT04124926|451170321|FG000|Healing Phase|Voluntary Withdrawal|10|||
125421920|NCT04124926|451170322|FG001|Healing Phase|Voluntary Withdrawal|7|||
125421921|NCT04124926|451170323|FG002|Healing Phase|Voluntary Withdrawal|0|||
125421922|NCT04124926|451170324|FG003|Healing Phase|Voluntary Withdrawal|0|||
125421923|NCT04124926|451170325|FG004|Healing Phase|Voluntary Withdrawal|0|||
125421924|NCT04124926|451170321|FG000|Healing Phase|Withdrawal of Consent|5|||
125421925|NCT04124926|451170322|FG001|Healing Phase|Withdrawal of Consent|3|||
125421926|NCT04124926|451170323|FG002|Healing Phase|Withdrawal of Consent|0|||
125421927|NCT04124926|451170324|FG003|Healing Phase|Withdrawal of Consent|0|||
125421928|NCT04124926|451170325|FG004|Healing Phase|Withdrawal of Consent|0|||
125421929|NCT04124926|451170321|FG000|Healing Phase|Miscellaneous|8|||
125421930|NCT04124926|451170322|FG001|Healing Phase|Miscellaneous|7|||
125421931|NCT04124926|451170323|FG002|Healing Phase|Miscellaneous|0|||
125421932|NCT04124926|451170324|FG003|Healing Phase|Miscellaneous|0|||
125421933|NCT04124926|451170325|FG004|Healing Phase|Miscellaneous|0|||
125421934|NCT04124926|451170321|FG000|Healing Phase|Randomized but not Treated|0|||
125421935|NCT04124926|451170322|FG001|Healing Phase|Randomized but not Treated|3|||
125421936|NCT04124926|451170323|FG002|Healing Phase|Randomized but not Treated|0|||
125421937|NCT04124926|451170324|FG003|Healing Phase|Randomized but not Treated|0|||
125421938|NCT04124926|451170325|FG004|Healing Phase|Randomized but not Treated|0|||
125421939|NCT04124926|451170321|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
125421940|NCT04124926|451170322|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
125421941|NCT04124926|451170323|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
125421942|NCT04124926|451170324|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
125421943|NCT04124926|451170325|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
125421944|NCT04124926|451170321|FG000|Maintenance Phase|Protocol Violation|0|||
125421945|NCT04124926|451170322|FG001|Maintenance Phase|Protocol Violation|0|||
125421946|NCT04124926|451170323|FG002|Maintenance Phase|Protocol Violation|3|||
125421947|NCT04124926|451170324|FG003|Maintenance Phase|Protocol Violation|0|||
125421948|NCT04124926|451170325|FG004|Maintenance Phase|Protocol Violation|0|||
125421949|NCT04124926|451170321|FG000|Maintenance Phase|Lost to Follow-up|0|||
125421950|NCT04124926|451170322|FG001|Maintenance Phase|Lost to Follow-up|0|||
125421951|NCT04124926|451170323|FG002|Maintenance Phase|Lost to Follow-up|7|||
125421952|NCT04124926|451170324|FG003|Maintenance Phase|Lost to Follow-up|8|||
125421953|NCT04124926|451170325|FG004|Maintenance Phase|Lost to Follow-up|9|||
125421954|NCT04124926|451170321|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
125421955|NCT04124926|451170322|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
125421956|NCT04124926|451170323|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
125421957|NCT04124926|451170324|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
125421958|NCT04124926|451170325|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
125421959|NCT04124926|451170321|FG000|Maintenance Phase|Pregnancy|0|||
125421960|NCT04124926|451170322|FG001|Maintenance Phase|Pregnancy|0|||
125421961|NCT04124926|451170323|FG002|Maintenance Phase|Pregnancy|0|||
125421962|NCT04124926|451170324|FG003|Maintenance Phase|Pregnancy|1|||
125421963|NCT04124926|451170325|FG004|Maintenance Phase|Pregnancy|0|||
125421964|NCT04124926|451170321|FG000|Maintenance Phase|Lack of Efficacy|0|||
125421965|NCT04124926|451170322|FG001|Maintenance Phase|Lack of Efficacy|0|||
125421966|NCT04124926|451170323|FG002|Maintenance Phase|Lack of Efficacy|0|||
125421967|NCT04124926|451170324|FG003|Maintenance Phase|Lack of Efficacy|0|||
125421968|NCT04124926|451170325|FG004|Maintenance Phase|Lack of Efficacy|1|||
125421969|NCT04124926|451170321|FG000|Maintenance Phase|Withdrawal of Consent|0|||
125421970|NCT04124926|451170322|FG001|Maintenance Phase|Withdrawal of Consent|0|||
125421971|NCT04124926|451170323|FG002|Maintenance Phase|Withdrawal of Consent|5|||
125421972|NCT04124926|451170324|FG003|Maintenance Phase|Withdrawal of Consent|5|||
125421973|NCT04124926|451170325|FG004|Maintenance Phase|Withdrawal of Consent|5|||
125421974|NCT04124926|451170321|FG000|Maintenance Phase|Miscellaneous|0|||
125421975|NCT04124926|451170322|FG001|Maintenance Phase|Miscellaneous|0|||
125421976|NCT04124926|451170323|FG002|Maintenance Phase|Miscellaneous|1|||
125421977|NCT04124926|451170324|FG003|Maintenance Phase|Miscellaneous|2|||
125421978|NCT04124926|451170325|FG004|Maintenance Phase|Miscellaneous|4|||
125421979|NCT04124926|451170321|FG000|Maintenance Phase|Randomized but not Treated|0|||
125421980|NCT04124926|451170322|FG001|Maintenance Phase|Randomized but not Treated|0|||
125421981|NCT04124926|451170323|FG002|Maintenance Phase|Randomized but not Treated|2|||
125421982|NCT04124926|451170324|FG003|Maintenance Phase|Randomized but not Treated|2|||
125421983|NCT04124926|451170325|FG004|Maintenance Phase|Randomized but not Treated|0|||
125421984|NCT04867369|451170328|FG000|Overall Study|Withdrawal by Subject|1|||
125421985|NCT04867369|451170329|FG001|Overall Study|Withdrawal by Subject|0|||
125421986|NCT04435366|451170330|FG000|Year 1 (12 Months)|Adverse Event|3|||
125421987|NCT04435366|451170331|FG001|Year 1 (12 Months)|Adverse Event|0|||
125421988|NCT04435366|451170332|FG002|Year 1 (12 Months)|Adverse Event|2|||
125421989|NCT04435366|451170330|FG000|Year 1 (12 Months)|Death|2|||
125421990|NCT04435366|451170331|FG001|Year 1 (12 Months)|Death|0|||
125421991|NCT04435366|451170332|FG002|Year 1 (12 Months)|Death|1|||
125421992|NCT04435366|451170330|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
125421993|NCT04435366|451170331|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
125421994|NCT04435366|451170332|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
125421995|NCT04435366|451170330|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
125421996|NCT04435366|451170331|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
125421997|NCT04435366|451170332|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
125421998|NCT04435366|451170330|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
125421999|NCT04435366|451170331|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
125422000|NCT04435366|451170332|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
125422001|NCT04435366|451170330|FG000|Year 1 (12 Months)|Not treated|0|||
125422002|NCT04435366|451170331|FG001|Year 1 (12 Months)|Not treated|0|||
125422003|NCT04435366|451170332|FG002|Year 1 (12 Months)|Not treated|1|||
125422004|NCT04435366|451170330|FG000|Year 2 (12 Months)|Death|1|||
125422005|NCT04435366|451170331|FG001|Year 2 (12 Months)|Death|4|||
125422006|NCT04435366|451170332|FG002|Year 2 (12 Months)|Death|6|||
125422007|NCT04435366|451170330|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
125422008|NCT04435366|451170331|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
125422009|NCT04435366|451170332|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
125422010|NCT04435366|451170330|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
125422011|NCT04435366|451170331|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
125422012|NCT04435366|451170332|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
125422013|NCT04435366|451170330|FG000|Year 2 (12 Months)|Adverse Event|2|||
125422014|NCT04435366|451170331|FG001|Year 2 (12 Months)|Adverse Event|1|||
125422015|NCT04435366|451170332|FG002|Year 2 (12 Months)|Adverse Event|6|||
125422016|NCT02477111|451170333|FG000|Overall Study|Death|28|||
125422017|NCT02477111|451170333|FG000|Overall Study|Withdrawal by Subject|19|||
125422018|NCT02477111|451170333|FG000|Overall Study|Lost to Follow-up|4|||
125422019|NCT03492281|451170338|FG000|Overall Study|Withdrawal by Subject|21|||
125422020|NCT03492281|451170339|FG001|Overall Study|Withdrawal by Subject|14|||
125422021|NCT03492281|451170340|FG002|Overall Study|Withdrawal by Subject|13|||
125422022|NCT03492281|451170338|FG000|Overall Study|Lost to Follow-up|14|||
125422023|NCT03492281|451170339|FG001|Overall Study|Lost to Follow-up|15|||
125422024|NCT03492281|451170340|FG002|Overall Study|Lost to Follow-up|10|||
125422025|NCT03492281|451170338|FG000|Overall Study|Adverse Event|6|||
125422026|NCT03492281|451170339|FG001|Overall Study|Adverse Event|8|||
125422027|NCT03492281|451170340|FG002|Overall Study|Adverse Event|13|||
125422028|NCT03492281|451170338|FG000|Overall Study|Lack of Efficacy|3|||
125422029|NCT03492281|451170339|FG001|Overall Study|Lack of Efficacy|0|||
125422030|NCT03492281|451170340|FG002|Overall Study|Lack of Efficacy|1|||
125422031|NCT03492281|451170338|FG000|Overall Study|Physician Decision|1|||
125422032|NCT03492281|451170339|FG001|Overall Study|Physician Decision|0|||
125422033|NCT03492281|451170340|FG002|Overall Study|Physician Decision|3|||
125422034|NCT03492281|451170338|FG000|Overall Study|Protocol Violation|0|||
125422035|NCT03492281|451170339|FG001|Overall Study|Protocol Violation|2|||
125422036|NCT03492281|451170340|FG002|Overall Study|Protocol Violation|1|||
125422037|NCT03492281|451170338|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
125422038|NCT03492281|451170339|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
125422039|NCT03492281|451170340|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
125422040|NCT03492281|451170338|FG000|Overall Study|Death|0|||
125422041|NCT03492281|451170339|FG001|Overall Study|Death|0|||
125422042|NCT03492281|451170340|FG002|Overall Study|Death|1|||
125422043|NCT03492281|451170338|FG000|Overall Study|Captured as Other in Database|8|||
125422044|NCT03492281|451170339|FG001|Overall Study|Captured as Other in Database|6|||
125422045|NCT03492281|451170340|FG002|Overall Study|Captured as Other in Database|3|||
125422046|NCT01506193|451170341|FG000|Overall Study|Protocol Violation|1|||
125310191|NCT00413218|450762024|FG001|Overall Study|Admin|14|||
125310192|NCT00413218|450762023|FG000|Overall Study|Missing|1|||
125310193|NCT00413218|450762024|FG001|Overall Study|Missing|0|||
125422047|NCT01506193|451170342|FG001|Overall Study|Protocol Violation|0|||
125422048|NCT01506193|451170343|FG002|Overall Study|Protocol Violation|1|||
125422049|NCT01506193|451170341|FG000|Overall Study|Migrated/moved from study area|0|||
125422050|NCT01506193|451170342|FG001|Overall Study|Migrated/moved from study area|0|||
125422051|NCT01506193|451170343|FG002|Overall Study|Migrated/moved from study area|1|||
125422052|NCT01506193|451170341|FG000|Overall Study|Adverse event, non-fatal|0|||
125422053|NCT01506193|451170342|FG001|Overall Study|Adverse event, non-fatal|0|||
125422054|NCT01506193|451170343|FG002|Overall Study|Adverse event, non-fatal|1|||
125422055|NCT01506193|451170341|FG000|Overall Study|Withdrawal by Subject|5|||
125310194|NCT00413218|450762023|FG000|Overall Study|Withdrawal by Subject|9|||
125533468|NCT04978493|451582838|FG000|Overall Study|No reason available|0|||
125422056|NCT01506193|451170342|FG001|Overall Study|Withdrawal by Subject|1|||
125422057|NCT01506193|451170343|FG002|Overall Study|Withdrawal by Subject|8|||
125422058|NCT01506193|451170341|FG000|Overall Study|Lost to Follow-up|8|||
125422059|NCT01506193|451170342|FG001|Overall Study|Lost to Follow-up|3|||
125422060|NCT01506193|451170343|FG002|Overall Study|Lost to Follow-up|3|||
125310195|NCT00413218|450762024|FG001|Overall Study|Withdrawal by Subject|1|||
125310196|NCT01196026|450762026|FG000|Overall Study|Withdrawal by Subject|1|||
125310197|NCT01196026|450762027|FG001|Overall Study|Withdrawal by Subject|4|||
125310198|NCT01196026|450762028|FG002|Overall Study|Withdrawal by Subject|0|||
125310199|NCT01196026|450762029|FG003|Overall Study|Withdrawal by Subject|0|||
125310200|NCT01196026|450762030|FG004|Overall Study|Withdrawal by Subject|0|||
125310201|NCT01196026|450762031|FG005|Overall Study|Withdrawal by Subject|0|||
125310202|NCT01196026|450762026|FG000|Overall Study|Lost to Follow-up|0|||
125310203|NCT01196026|450762027|FG001|Overall Study|Lost to Follow-up|3|||
125422061|NCT01454583|451170344|FG000|1st Year|Lost to Follow-up|1057|||
125422062|NCT01454583|451170345|FG001|1st Year|Lost to Follow-up|318|||
125422063|NCT01454583|451170346|FG002|1st Year|Lost to Follow-up|180|||
125422064|NCT01454583|451170344|FG000|2nd Year|Lost to Follow-up|3965|||
125422065|NCT01454583|451170345|FG001|2nd Year|Lost to Follow-up|1049|||
125422066|NCT01454583|451170346|FG002|2nd Year|Lost to Follow-up|737|||
125422067|NCT01454583|451170344|FG000|3rd Year|Lost to Follow-up|1959|||
125422068|NCT01454583|451170345|FG001|3rd Year|Lost to Follow-up|512|||
125422069|NCT01454583|451170346|FG002|3rd Year|Lost to Follow-up|297|||
125422070|NCT00827918|451170347|FG000|Overall Study|Adverse Event|4|||
125422071|NCT00827918|451170348|FG001|Overall Study|Adverse Event|0|||
125422072|NCT00827918|451170349|FG002|Overall Study|Adverse Event|0|||
125422073|NCT00827918|451170347|FG000|Overall Study|Lack of Efficacy|16|||
125422074|NCT00827918|451170348|FG001|Overall Study|Lack of Efficacy|4|||
125422075|NCT00827918|451170349|FG002|Overall Study|Lack of Efficacy|15|||
125422076|NCT00827918|451170347|FG000|Overall Study|Physician Decision|1|||
125422077|NCT00827918|451170348|FG001|Overall Study|Physician Decision|0|||
125422078|NCT00827918|451170349|FG002|Overall Study|Physician Decision|0|||
125422079|NCT00827918|451170347|FG000|Overall Study|Pregnancy|0|||
125422080|NCT00827918|451170348|FG001|Overall Study|Pregnancy|1|||
125422081|NCT00827918|451170349|FG002|Overall Study|Pregnancy|0|||
125422082|NCT00827918|451170347|FG000|Overall Study|Progressive Disease|1|||
125422083|NCT00827918|451170348|FG001|Overall Study|Progressive Disease|1|||
125422084|NCT00827918|451170349|FG002|Overall Study|Progressive Disease|0|||
125422085|NCT00827918|451170347|FG000|Overall Study|Protocol Violation|0|||
125422086|NCT00827918|451170348|FG001|Overall Study|Protocol Violation|1|||
125422087|NCT00827918|451170349|FG002|Overall Study|Protocol Violation|0|||
125422088|NCT00827918|451170347|FG000|Overall Study|Withdrawal by Subject|6|||
125422089|NCT00827918|451170348|FG001|Overall Study|Withdrawal by Subject|2|||
125422090|NCT00827918|451170349|FG002|Overall Study|Withdrawal by Subject|6|||
125422091|NCT04302350|451170353|FG000|Overall Study|Physician Decision|1|||
125422092|NCT04302350|451170354|FG001|Overall Study|Physician Decision|1|||
125422093|NCT04302350|451170355|FG002|Overall Study|Physician Decision|2|||
125422094|NCT04302350|451170353|FG000|Overall Study|Lack of Efficacy|1|||
125422095|NCT04302350|451170354|FG001|Overall Study|Lack of Efficacy|1|||
125422096|NCT04302350|451170355|FG002|Overall Study|Lack of Efficacy|4|||
125422097|NCT04302350|451170353|FG000|Overall Study|Adverse Event|0|||
125422098|NCT04302350|451170354|FG001|Overall Study|Adverse Event|1|||
125422099|NCT04302350|451170355|FG002|Overall Study|Adverse Event|2|||
125422100|NCT02012491|451170358|FG000|Overall Study|Lost to Follow-up|1|||
125422101|NCT02012491|451170359|FG001|Overall Study|Lost to Follow-up|0|||
125422102|NCT02012491|451170358|FG000|Overall Study|Protocol Violation|0|||
125422103|NCT02012491|451170359|FG001|Overall Study|Protocol Violation|1|||
125422104|NCT02012491|451170358|FG000|Overall Study|Withdrawal by Subject|1|||
125422105|NCT02012491|451170359|FG001|Overall Study|Withdrawal by Subject|0|||
125533469|NCT04978493|451582839|FG001|Overall Study|No reason available|1|||
125533470|NCT04978493|451582838|FG000|Overall Study|Adverse Event|1|||
125422106|NCT02137369|451170360|FG000|Overall Study|Withdrawal by Subject|3|||
125422107|NCT02137369|451170361|FG001|Overall Study|Withdrawal by Subject|2|||
125422108|NCT02137369|451170360|FG000|Overall Study|Adverse Event|2|||
125422109|NCT02137369|451170361|FG001|Overall Study|Adverse Event|0|||
125422110|NCT02137369|451170360|FG000|Overall Study|Lost to Follow-up|1|||
125422111|NCT02137369|451170361|FG001|Overall Study|Lost to Follow-up|0|||
125310204|NCT01196026|450762028|FG002|Overall Study|Lost to Follow-up|0|||
125310205|NCT01196026|450762029|FG003|Overall Study|Lost to Follow-up|0|||
125422112|NCT02137369|451170360|FG000|Overall Study|Moved away|2|||
125422113|NCT02137369|451170361|FG001|Overall Study|Moved away|0|||
125422114|NCT01667432|451170362|FG000|Overall Study|Premature Study Termination|26|||
125422115|NCT01667432|451170362|FG000|Overall Study|Failure to Return|10|||
125422116|NCT01667432|451170362|FG000|Overall Study|Moved to Another Center|3|||
125310206|NCT01196026|450762030|FG004|Overall Study|Lost to Follow-up|1|||
125422117|NCT01667432|451170362|FG000|Overall Study|Lost to Follow-up|3|||
125422118|NCT01667432|451170362|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
125422119|NCT01667432|451170362|FG000|Overall Study|Insufficient Therapeutic Response|4|||
125422120|NCT01667432|451170362|FG000|Overall Study|Adverse Event|1|||
125533471|NCT04978493|451582839|FG001|Overall Study|Adverse Event|0|||
125310207|NCT01196026|450762031|FG005|Overall Study|Lost to Follow-up|0|||
125310208|NCT01196026|450762026|FG000|Overall Study|Other|0|||
125422121|NCT01667432|451170362|FG000|Overall Study|Protocol Deviation|2|||
125422122|NCT01667432|451170362|FG000|Overall Study|Principal Investigator Decision|1|||
125422123|NCT01667432|451170362|FG000|Overall Study|Reason Not Specified|2|||
125422124|NCT01667432|451170362|FG000|Overall Study|Missing Information|4|||
125422125|NCT02077166|451170363|FG000|Overall Study|Death|6|||
125422126|NCT02077166|451170364|FG001|Overall Study|Death|7|||
125422127|NCT02077166|451170365|FG002|Overall Study|Death|5|||
125422128|NCT02077166|451170366|FG003|Overall Study|Death|6|||
125422129|NCT02077166|451170367|FG004|Overall Study|Death|4|||
125422130|NCT02077166|451170368|FG005|Overall Study|Death|32|||
125422131|NCT02077166|451170369|FG006|Overall Study|Death|22|||
125422132|NCT02077166|451170363|FG000|Overall Study|Study Closure by Sponsor|3|||
125422133|NCT02077166|451170364|FG001|Overall Study|Study Closure by Sponsor|0|||
125422134|NCT02077166|451170365|FG002|Overall Study|Study Closure by Sponsor|2|||
125422135|NCT02077166|451170366|FG003|Overall Study|Study Closure by Sponsor|2|||
125422136|NCT02077166|451170367|FG004|Overall Study|Study Closure by Sponsor|2|||
125422137|NCT02077166|451170368|FG005|Overall Study|Study Closure by Sponsor|12|||
125422138|NCT02077166|451170369|FG006|Overall Study|Study Closure by Sponsor|4|||
125422139|NCT02077166|451170363|FG000|Overall Study|Lost to Follow-up|0|||
125422140|NCT02077166|451170364|FG001|Overall Study|Lost to Follow-up|0|||
125422141|NCT02077166|451170365|FG002|Overall Study|Lost to Follow-up|0|||
125422142|NCT02077166|451170366|FG003|Overall Study|Lost to Follow-up|0|||
125422143|NCT02077166|451170367|FG004|Overall Study|Lost to Follow-up|0|||
125422144|NCT02077166|451170368|FG005|Overall Study|Lost to Follow-up|1|||
125422145|NCT02077166|451170369|FG006|Overall Study|Lost to Follow-up|0|||
125422146|NCT02077166|451170363|FG000|Overall Study|Withdrawal by Subject|3|||
125422147|NCT02077166|451170364|FG001|Overall Study|Withdrawal by Subject|0|||
125422148|NCT02077166|451170365|FG002|Overall Study|Withdrawal by Subject|1|||
125422149|NCT02077166|451170366|FG003|Overall Study|Withdrawal by Subject|1|||
125422150|NCT02077166|451170367|FG004|Overall Study|Withdrawal by Subject|1|||
125422151|NCT02077166|451170368|FG005|Overall Study|Withdrawal by Subject|3|||
125422152|NCT02077166|451170369|FG006|Overall Study|Withdrawal by Subject|0|||
125422153|NCT02077166|451170363|FG000|Overall Study|Other, Not Specified|0|||
125422154|NCT02077166|451170364|FG001|Overall Study|Other, Not Specified|0|||
125422155|NCT02077166|451170365|FG002|Overall Study|Other, Not Specified|1|||
125422156|NCT02077166|451170366|FG003|Overall Study|Other, Not Specified|0|||
125422157|NCT02077166|451170367|FG004|Overall Study|Other, Not Specified|1|||
125422158|NCT02077166|451170368|FG005|Overall Study|Other, Not Specified|7|||
125422159|NCT02077166|451170369|FG006|Overall Study|Other, Not Specified|8|||
125422160|NCT03519854|451170370|FG000|Overall Study|Technical Error|0|||
125422161|NCT03519854|451170371|FG001|Overall Study|Technical Error|0|||
125422162|NCT03519854|451170372|FG002|Overall Study|Technical Error|1|||
125422163|NCT03519854|451170373|FG003|Overall Study|Technical Error|0|||
125422164|NCT03519854|451170374|FG004|Overall Study|Technical Error|0|||
125422165|NCT03519854|451170375|FG005|Overall Study|Technical Error|0|||
125422166|NCT03519854|451170376|FG006|Overall Study|Technical Error|0|||
125310209|NCT01196026|450762027|FG001|Overall Study|Other|1|||
125310210|NCT01196026|450762028|FG002|Overall Study|Other|0|||
125310211|NCT01196026|450762029|FG003|Overall Study|Other|0|||
125310212|NCT01196026|450762030|FG004|Overall Study|Other|0|||
125310213|NCT01196026|450762031|FG005|Overall Study|Other|0|||
125310214|NCT01687296|450762032|FG000|Overall Study|Lack of Efficacy|1|||
125310215|NCT01687296|450762033|FG001|Overall Study|Lack of Efficacy|1|||
125310216|NCT01687296|450762032|FG000|Overall Study|Protocol Violation|0|||
125310217|NCT01687296|450762033|FG001|Overall Study|Protocol Violation|1|||
125310218|NCT01687296|450762032|FG000|Overall Study|Withdrawal by Subject|6|||
125310219|NCT01687296|450762033|FG001|Overall Study|Withdrawal by Subject|3|||
125310220|NCT03672292|450762037|FG000|Overall Study|Adverse Event|3|||
125310221|NCT03672292|450762038|FG001|Overall Study|Adverse Event|1|||
125310222|NCT03672292|450762037|FG000|Overall Study|Physician Decision|0|||
125310223|NCT03672292|450762038|FG001|Overall Study|Physician Decision|1|||
125310224|NCT03672292|450762037|FG000|Overall Study|Withdrawal by Subject|1|||
125310225|NCT03672292|450762038|FG001|Overall Study|Withdrawal by Subject|2|||
125310226|NCT00799903|450762039|FG000|Overall Study|Investigator Site Closed|25|||
125310227|NCT00799903|450762040|FG001|Overall Study|Investigator Site Closed|23|||
125310228|NCT00799903|450762039|FG000|Overall Study|Withdrawal by Subject|179|||
125422167|NCT03519854|451170377|FG007|Overall Study|Technical Error|0|||
125422168|NCT03519854|451170378|FG008|Overall Study|Technical Error|0|||
125422169|NCT03519854|451170379|FG009|Overall Study|Technical Error|0|||
125422170|NCT03519854|451170380|FG010|Overall Study|Technical Error|0|||
125422171|NCT03519854|451170381|FG011|Overall Study|Technical Error|0|||
125422172|NCT03519854|451170382|FG012|Overall Study|Technical Error|0|||
125422173|NCT03519854|451170383|FG013|Overall Study|Technical Error|0|||
125422174|NCT03519854|451170384|FG014|Overall Study|Technical Error|0|||
125310229|NCT00799903|450762040|FG001|Overall Study|Withdrawal by Subject|175|||
125310230|NCT00799903|450762039|FG000|Overall Study|Lost to Follow-up|69|||
125310231|NCT00799903|450762040|FG001|Overall Study|Lost to Follow-up|80|||
125310232|NCT02518971|450762041|FG000|Overall Study|Lost to Follow-up|0|||
125310233|NCT02518971|450762042|FG001|Overall Study|Lost to Follow-up|1|||
125422175|NCT03519854|451170385|FG015|Overall Study|Technical Error|0|||
125422176|NCT03519854|451170386|FG016|Overall Study|Technical Error|0|||
125310234|NCT02518971|450762041|FG000|Overall Study|Physician Decision|6|||
125422177|NCT03519854|451170387|FG017|Overall Study|Technical Error|0|||
125422178|NCT00818753|451170394|FG000|Overall Study|Protocol Violation|1|||
125422179|NCT00818753|451170395|FG001|Overall Study|Protocol Violation|0|||
125422180|NCT00818753|451170396|FG002|Overall Study|Protocol Violation|0|||
125422181|NCT00818753|451170394|FG000|Overall Study|Other reason (not specified)|0|||
125422182|NCT00818753|451170395|FG001|Overall Study|Other reason (not specified)|0|||
125422183|NCT00818753|451170396|FG002|Overall Study|Other reason (not specified)|1|||
125422184|NCT00818753|451170394|FG000|Overall Study|Randomised and not treated|2|||
125422185|NCT00818753|451170395|FG001|Overall Study|Randomised and not treated|0|||
125422186|NCT00818753|451170396|FG002|Overall Study|Randomised and not treated|0|||
125422187|NCT01389973|451170399|FG000|Overall Study|Lost to Follow-up|1|||
125422188|NCT01389973|451170399|FG000|Overall Study|Trial Stopped by Sponsor|9|||
125422189|NCT01389973|451170399|FG000|Overall Study|Other|10|||
125422190|NCT04154787|451170400|FG000|Overall Study|Adverse Event|0|||
125422191|NCT04154787|451170401|FG001|Overall Study|Adverse Event|1|||
125422192|NCT04154787|451170402|FG002|Overall Study|Adverse Event|0|||
125422193|NCT04154787|451170400|FG000|Overall Study|Patient Requires Other Treatment|0|||
125422194|NCT04154787|451170401|FG001|Overall Study|Patient Requires Other Treatment|1|||
125422195|NCT04154787|451170402|FG002|Overall Study|Patient Requires Other Treatment|0|||
125422196|NCT04154787|451170400|FG000|Overall Study|Study Terminated By Sponsor|0|||
125422197|NCT04154787|451170401|FG001|Overall Study|Study Terminated By Sponsor|6|||
125422198|NCT04154787|451170402|FG002|Overall Study|Study Terminated By Sponsor|1|||
125422199|NCT04154787|451170400|FG000|Overall Study|Subject Decision|0|||
125422200|NCT04154787|451170401|FG001|Overall Study|Subject Decision|1|||
125422201|NCT04154787|451170402|FG002|Overall Study|Subject Decision|0|||
125422202|NCT04154787|451170400|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
125422203|NCT04154787|451170401|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
125422204|NCT04154787|451170402|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
125422205|NCT02277444|451170406|FG000|Overall Study|Adverse Event|10|||
125422206|NCT02277444|451170406|FG000|Overall Study|Withdrawal by Subject|3|||
125533472|NCT01254747|451582840|FG000|Overall Study|Unacceptable subjective vision|0|||
125533473|NCT01254747|451582841|FG001|Overall Study|Unacceptable subjective vision|0|||
125533474|NCT01254747|451582842|FG002|Overall Study|Unacceptable subjective vision|0|||
125533475|NCT01254747|451582843|FG003|Overall Study|Unacceptable subjective vision|2|||
125533476|NCT01254747|451582840|FG000|Overall Study|Difficult removal handling|0|||
125533477|NCT01254747|451582841|FG001|Overall Study|Difficult removal handling|0|||
125422207|NCT02277444|451170406|FG000|Overall Study|Other|1|||
125422208|NCT02277444|451170406|FG000|Overall Study|Enrolled and not Treated|3|||
125422209|NCT02277444|451170406|FG000|Overall Study|Ongoing|113|||
125436493|NCT00675506|451224413|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
125436494|NCT00675506|451224414|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
125436495|NCT00675506|451224413|FG000|Overall Study|Elevated IGF-1|2|||
125436496|NCT00675506|451224414|FG001|Overall Study|Elevated IGF-1|0|||
125436497|NCT00675506|451224413|FG000|Overall Study|Hypersensitivity Reaction|1|||
125436498|NCT00675506|451224414|FG001|Overall Study|Hypersensitivity Reaction|0|||
125436499|NCT00675506|451224413|FG000|Overall Study|Disclosed history of cancer|1|||
125436500|NCT00675506|451224414|FG001|Overall Study|Disclosed history of cancer|0|||
125436501|NCT00675506|451224413|FG000|Overall Study|Declined participation|1|||
125436502|NCT00675506|451224414|FG001|Overall Study|Declined participation|0|||
125436503|NCT00675506|451224413|FG000|Overall Study|Schedule conflict|0|||
125436504|NCT00675506|451224414|FG001|Overall Study|Schedule conflict|1|||
125436505|NCT00936221|451224415|FG000|Overall Study|Withdrawal by Subject|1|||
125436506|NCT00936221|451224416|FG001|Overall Study|Withdrawal by Subject|1|||
125436507|NCT03820323|451224417|FG000|Overall Study|Lost to Follow-up|2|||
125436508|NCT03820323|451224418|FG001|Overall Study|Lost to Follow-up|1|||
125436509|NCT03820323|451224417|FG000|Overall Study|Missed 12-month visit|22|||
125436510|NCT03820323|451224418|FG001|Overall Study|Missed 12-month visit|14|||
125436511|NCT03820323|451224417|FG000|Overall Study|Death|2|||
125436512|NCT03820323|451224418|FG001|Overall Study|Death|1|||
125436513|NCT03820323|451224417|FG000|Overall Study|Transferred out|13|||
125436514|NCT03820323|451224418|FG001|Overall Study|Transferred out|11|||
125436515|NCT03820323|451224417|FG000|Overall Study|Terminated|0|||
125436516|NCT03820323|451224418|FG001|Overall Study|Terminated|3|||
125436517|NCT03820323|451224417|FG000|Overall Study|Withdrawal by Subject|1|||
125436518|NCT03820323|451224418|FG001|Overall Study|Withdrawal by Subject|6|||
125436519|NCT03151395|451224419|FG000|Overall Study|Adverse Event|2|||
125436520|NCT03151395|451224419|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
125436521|NCT03151395|451224419|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
125436522|NCT03151395|451224419|FG000|Overall Study|Unspecified reason|4|||
125436523|NCT00879996|451224420|FG000|Overall Study|Lost to Follow-up|7|||
125436524|NCT00879996|451224421|FG001|Overall Study|Lost to Follow-up|6|||
125436525|NCT00879996|451224420|FG000|Overall Study|non-compliance|6|||
125436526|NCT00879996|451224421|FG001|Overall Study|non-compliance|4|||
125436527|NCT00879996|451224420|FG000|Overall Study|Physician Decision|1|||
125436528|NCT00879996|451224421|FG001|Overall Study|Physician Decision|2|||
125436529|NCT00879996|451224420|FG000|Overall Study|psychiatric problem|0|||
125436530|NCT00879996|451224421|FG001|Overall Study|psychiatric problem|1|||
125436531|NCT00879996|451224420|FG000|Overall Study|put on parole|1|||
125422210|NCT01712009|451172755|FG000|Overall Study|Withdrawal by Subject|24|||
125422211|NCT01712009|451172756|FG001|Overall Study|Withdrawal by Subject|15|||
125422212|NCT01712009|451172757|FG002|Overall Study|Withdrawal by Subject|8|||
125422213|NCT01712009|451172755|FG000|Overall Study|Lost to Follow-up|2|||
125422214|NCT01712009|451172756|FG001|Overall Study|Lost to Follow-up|0|||
125422215|NCT01712009|451172757|FG002|Overall Study|Lost to Follow-up|1|||
125422216|NCT01712009|451172755|FG000|Overall Study|Decision by Sponsor|12|||
125422217|NCT01712009|451172756|FG001|Overall Study|Decision by Sponsor|14|||
125422218|NCT01712009|451172757|FG002|Overall Study|Decision by Sponsor|12|||
125422219|NCT00593567|451172758|FG000|Overall Study|Adverse Event|2|||
125422220|NCT00593567|451172759|FG001|Overall Study|Adverse Event|0|||
125422221|NCT00593567|451172758|FG000|Overall Study|Physician Decision|2|||
125422222|NCT00593567|451172759|FG001|Overall Study|Physician Decision|0|||
125422223|NCT00593567|451172758|FG000|Overall Study|Protocol Violation|13|||
125422224|NCT00593567|451172759|FG001|Overall Study|Protocol Violation|7|||
125422225|NCT00593567|451172758|FG000|Overall Study|Lack of Efficacy|2|||
125422226|NCT00593567|451172759|FG001|Overall Study|Lack of Efficacy|1|||
125422227|NCT00593567|451172758|FG000|Overall Study|Withdrawal by Subject|1|||
125422228|NCT00593567|451172759|FG001|Overall Study|Withdrawal by Subject|2|||
125533478|NCT01254747|451582842|FG002|Overall Study|Difficult removal handling|1|||
125533479|NCT01254747|451582843|FG003|Overall Study|Difficult removal handling|0|||
125533480|NCT01254747|451582840|FG000|Overall Study|Symptoms and problems|0|||
125533481|NCT01254747|451582841|FG001|Overall Study|Symptoms and problems|2|||
125533482|NCT01254747|451582842|FG002|Overall Study|Symptoms and problems|1|||
125533483|NCT01254747|451582843|FG003|Overall Study|Symptoms and problems|0|||
125533484|NCT01254747|451582840|FG000|Overall Study|Lost to Follow-up|0|||
125533485|NCT01254747|451582841|FG001|Overall Study|Lost to Follow-up|0|||
125533486|NCT01254747|451582842|FG002|Overall Study|Lost to Follow-up|1|||
125533487|NCT01254747|451582843|FG003|Overall Study|Lost to Follow-up|0|||
125533488|NCT01254747|451582840|FG000|Overall Study|Biomicroscopy|0|||
125533489|NCT01254747|451582841|FG001|Overall Study|Biomicroscopy|0|||
125533490|NCT01254747|451582842|FG002|Overall Study|Biomicroscopy|1|||
125533491|NCT01254747|451582843|FG003|Overall Study|Biomicroscopy|0|||
125533492|NCT01254747|451582840|FG000|Overall Study|Discomfort|0|||
125533493|NCT01254747|451582841|FG001|Overall Study|Discomfort|4|||
125533494|NCT01254747|451582842|FG002|Overall Study|Discomfort|0|||
125533495|NCT01254747|451582843|FG003|Overall Study|Discomfort|0|||
125533496|NCT00245960|451582844|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
125533497|NCT00245960|451582845|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
125533498|NCT00245960|451582844|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
125533499|NCT00245960|451582845|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
125533500|NCT00245960|451582844|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
125533501|NCT00245960|451582845|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
125533502|NCT00245960|451582844|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
125533503|NCT00245960|451582845|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
125533504|NCT00245960|451582844|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
125533505|NCT00245960|451582845|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
125533506|NCT00245960|451582844|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
125533507|NCT00245960|451582845|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
125533508|NCT00245960|451582844|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
125533509|NCT00245960|451582845|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
125533510|NCT00245960|451582844|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
125533511|NCT00245960|451582845|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
125198633|NCT02836236|450350984|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
125533512|NCT00245960|451582844|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
125533513|NCT00245960|451582845|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
125533514|NCT00245960|451582844|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
125533515|NCT00245960|451582845|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
125533516|NCT00245960|451582844|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
125533517|NCT00245960|451582845|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
125533518|NCT00245960|451582844|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
125533519|NCT00245960|451582845|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
125533520|NCT00316017|451582850|FG000|Overall Study|Protocol Violation|11|||
125533521|NCT00316017|451582851|FG001|Overall Study|Protocol Violation|13|||
125533522|NCT00316017|451582852|FG002|Overall Study|Protocol Violation|19|||
125533523|NCT05235269|451582857|FG000|Overall Study|Adverse Event|1|||
125533524|NCT05235269|451582857|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
125533525|NCT05235269|451582857|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
125533526|NCT03570892|451582861|FG000|Overall Study|Death|51|||
125533527|NCT03570892|451582862|FG001|Overall Study|Death|45|||
125533528|NCT03570892|451582861|FG000|Overall Study|Subject decision|5|||
125533529|NCT03570892|451582862|FG001|Overall Study|Subject decision|3|||
125533530|NCT03570892|451582861|FG000|Overall Study|Protocol Violation|1|||
125533531|NCT03570892|451582862|FG001|Overall Study|Protocol Violation|4|||
125533532|NCT03570892|451582861|FG000|Overall Study|Physician Decision|0|||
125533533|NCT03570892|451582862|FG001|Overall Study|Physician Decision|2|||
125637158|NCT03073200|451952839|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125637159|NCT03073200|451952840|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125637160|NCT03073200|451952841|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125637161|NCT03073200|451952842|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125637162|NCT03073200|451952843|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125637163|NCT03073200|451952844|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125637164|NCT03073200|451952845|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125637165|NCT03073200|451952846|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125637166|NCT03073200|451952832|FG000|Extension Period|Lost to Follow-up|0|||
125637167|NCT03073200|451952833|FG001|Extension Period|Lost to Follow-up|0|||
125637168|NCT03073200|451952834|FG002|Extension Period|Lost to Follow-up|0|||
125637169|NCT03073200|451952835|FG003|Extension Period|Lost to Follow-up|0|||
125637170|NCT03073200|451952836|FG004|Extension Period|Lost to Follow-up|0|||
125637171|NCT03073200|451952837|FG005|Extension Period|Lost to Follow-up|0|||
125637172|NCT03073200|451952838|FG006|Extension Period|Lost to Follow-up|1|||
125637173|NCT03073200|451952839|FG007|Extension Period|Lost to Follow-up|1|||
125637174|NCT03073200|451952840|FG008|Extension Period|Lost to Follow-up|0|||
125637175|NCT03073200|451952841|FG009|Extension Period|Lost to Follow-up|0|||
125637176|NCT03073200|451952842|FG010|Extension Period|Lost to Follow-up|0|||
125637177|NCT03073200|451952843|FG011|Extension Period|Lost to Follow-up|0|||
125637178|NCT03073200|451952844|FG012|Extension Period|Lost to Follow-up|0|||
125637179|NCT03073200|451952845|FG013|Extension Period|Lost to Follow-up|0|||
125637180|NCT03073200|451952846|FG014|Extension Period|Lost to Follow-up|0|||
125637181|NCT03073200|451952832|FG000|Extension Period|Sponsor Decision|0|||
125637182|NCT03073200|451952833|FG001|Extension Period|Sponsor Decision|0|||
125637183|NCT03073200|451952834|FG002|Extension Period|Sponsor Decision|0|||
125637184|NCT03073200|451952835|FG003|Extension Period|Sponsor Decision|0|||
125637185|NCT03073200|451952836|FG004|Extension Period|Sponsor Decision|0|||
125637186|NCT03073200|451952837|FG005|Extension Period|Sponsor Decision|0|||
125637187|NCT03073200|451952838|FG006|Extension Period|Sponsor Decision|0|||
125637188|NCT03073200|451952839|FG007|Extension Period|Sponsor Decision|0|||
125637189|NCT03073200|451952840|FG008|Extension Period|Sponsor Decision|1|||
125637190|NCT03073200|451952841|FG009|Extension Period|Sponsor Decision|0|||
125637191|NCT03073200|451952842|FG010|Extension Period|Sponsor Decision|0|||
125637192|NCT03073200|451952843|FG011|Extension Period|Sponsor Decision|0|||
125637193|NCT03073200|451952844|FG012|Extension Period|Sponsor Decision|0|||
125637194|NCT03073200|451952845|FG013|Extension Period|Sponsor Decision|0|||
125198634|NCT02836236|450350985|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
125198635|NCT02836236|450350986|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
125198636|NCT02836236|450350983|FG000|Open-Label TAF Treatment Phase|Death|0|||
125198637|NCT02836236|450350984|FG001|Open-Label TAF Treatment Phase|Death|0|||
125198638|NCT02836236|450350985|FG002|Open-Label TAF Treatment Phase|Death|1|||
125198639|NCT02836236|450350986|FG003|Open-Label TAF Treatment Phase|Death|1|||
125198640|NCT02836236|450350983|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
125198641|NCT02836236|450350984|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
125198642|NCT02836236|450350985|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
125198643|NCT02836236|450350986|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
125198644|NCT01806961|450350987|FG000|Overall Study|sponsor decision|16|||
125198645|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
125198646|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
125198647|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
125198648|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
125198649|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Death|0|||
125198650|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Death|0|||
125198651|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Death|1|||
125198652|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Death|0|||
125198653|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
125198654|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
125198655|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
125198656|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
125198657|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
125198658|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
125198659|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
125198660|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
125198661|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
125198662|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
125198663|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
125198664|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
125198665|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
125217403|NCT05415462|450423519|FG001|Overall Study|Lost to Follow-up|64|||
125637195|NCT03073200|451952846|FG014|Extension Period|Sponsor Decision|0|||
125533534|NCT01876082|451584758|FG000|Overall Study|Withdrawal by Subject|0|||
125533535|NCT01876082|451584759|FG001|Overall Study|Withdrawal by Subject|2|||
125533536|NCT01876082|451584758|FG000|Overall Study|Protocol Violation|1|||
125533537|NCT01876082|451584759|FG001|Overall Study|Protocol Violation|0|||
125533538|NCT01876082|451584758|FG000|Overall Study|Adverse Event|1|||
125533539|NCT01876082|451584759|FG001|Overall Study|Adverse Event|1|||
125533540|NCT01876082|451584758|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
125533541|NCT01876082|451584759|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
125533542|NCT04427280|451584761|FG000|Overall Study|Withdrawal by Subject|0|||
125533543|NCT04427280|451584762|FG001|Overall Study|Withdrawal by Subject|2|||
125533544|NCT03829501|451584765|FG000|Overall Study|Withdrawal of Consent|2|||
125533545|NCT03829501|451584766|FG001|Overall Study|Withdrawal of Consent|0|||
125533546|NCT03829501|451584767|FG002|Overall Study|Withdrawal of Consent|3|||
125533547|NCT03829501|451584768|FG003|Overall Study|Withdrawal of Consent|0|||
125533548|NCT03829501|451584769|FG004|Overall Study|Withdrawal of Consent|1|||
125533549|NCT03829501|451584770|FG005|Overall Study|Withdrawal of Consent|1|||
125533550|NCT03829501|451584771|FG006|Overall Study|Withdrawal of Consent|0|||
125644840|NCT03125902|451982117|FG000|Overall Study|Withdrawal by Subject|21|||
125644841|NCT03125902|451982118|FG001|Overall Study|Withdrawal by Subject|37|||
125644842|NCT02269709|451982119|FG000|Time of Enrollment|Withdrawal by Subject|3|||
125644843|NCT02269709|451982119|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
125644844|NCT02269709|451982119|FG000|Six Month Follow-up|Lost to Follow-up|12|||
125644845|NCT02504424|451982122|FG000|Overall Study|Withdrawal by Subject|2|||
125644846|NCT00440232|451982123|FG000|Overall Study|Lost to Follow-up|1|||
125644847|NCT00440232|451982124|FG001|Overall Study|Lost to Follow-up|1|||
125644848|NCT00440232|451982123|FG000|Overall Study|Unable to treat within allowed time|0|||
125644849|NCT00440232|451982124|FG001|Overall Study|Unable to treat within allowed time|1|||
125644850|NCT00440232|451982123|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
125644851|NCT00440232|451982124|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
125644852|NCT00426842|451982125|FG000|Overall Study|Lost to Follow-up|1|||
125644853|NCT00362297|451982126|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
125131339|NCT03792477|450108115|FG001|Overall Study|Lost to Follow-up|0|||
125131340|NCT03792477|450108116|FG002|Overall Study|Lost to Follow-up|2|||
125198666|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
125198667|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
125131341|NCT03792477|450108117|FG003|Overall Study|Lost to Follow-up|0|||
125198668|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
125198669|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
125198670|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
125198671|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
125198672|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
125198673|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
125198674|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
125198675|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
125198676|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
125198677|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
125198678|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
125198679|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125198680|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125217404|NCT05415462|450423518|FG000|Overall Study|Physician Decision|5|||
125644854|NCT00362297|451982127|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
125131342|NCT03792477|450108118|FG004|Overall Study|Lost to Follow-up|0|||
125131343|NCT03792477|450108114|FG000|Overall Study|Other|0|||
125131344|NCT03792477|450108115|FG001|Overall Study|Other|0|||
125131345|NCT03792477|450108116|FG002|Overall Study|Other|0|||
125131346|NCT03792477|450108117|FG003|Overall Study|Other|0|||
125131347|NCT03792477|450108118|FG004|Overall Study|Other|1|||
125131348|NCT00840411|450108120|FG000|First Intervention|Adverse Event|1|||
125131349|NCT00840411|450108121|FG001|First Intervention|Adverse Event|0|||
125131350|NCT00840411|450108120|FG000|Washout|Withdrawal by Subject|1|||
125131351|NCT00840411|450108121|FG001|Washout|Withdrawal by Subject|0|||
125131352|NCT00576056|450108126|FG000|Overall Study|Adverse Event|1|||
125131353|NCT00576056|450108126|FG000|Overall Study|Death|1|||
125131354|NCT00576056|450108126|FG000|Overall Study|Lack of Efficacy|1|||
125131355|NCT00576056|450108126|FG000|Overall Study|Withdrawal by Subject|2|||
125131356|NCT00576056|450108126|FG000|Overall Study|did not meet eligibility criteria|8|||
125131357|NCT00576056|450108126|FG000|Overall Study|Physician Decision|1|||
125131358|NCT01854047|450108127|FG000|Overall Study|Lack of Efficacy|1|||
125131359|NCT01854047|450108128|FG001|Overall Study|Lack of Efficacy|0|||
125131360|NCT01854047|450108129|FG002|Overall Study|Lack of Efficacy|0|||
125131361|NCT01854047|450108130|FG003|Overall Study|Lack of Efficacy|0|||
125131362|NCT01854047|450108131|FG004|Overall Study|Lack of Efficacy|0|||
125310235|NCT02518971|450762042|FG001|Overall Study|Physician Decision|6|||
125310236|NCT02518971|450762041|FG000|Overall Study|Protocol Violation|6|||
125310237|NCT02518971|450762042|FG001|Overall Study|Protocol Violation|4|||
125310238|NCT02518971|450762041|FG000|Overall Study|Withdrawal by Subject|4|||
125310239|NCT02518971|450762042|FG001|Overall Study|Withdrawal by Subject|5|||
125310240|NCT02518971|450762041|FG000|Overall Study|Side effects|1|||
125310241|NCT02518971|450762042|FG001|Overall Study|Side effects|0|||
125533551|NCT03829501|451584772|FG007|Overall Study|Withdrawal of Consent|10|||
125533552|NCT03829501|451584773|FG008|Overall Study|Withdrawal of Consent|10|||
125533553|NCT03829501|451584774|FG009|Overall Study|Withdrawal of Consent|3|||
125533554|NCT03829501|451584775|FG010|Overall Study|Withdrawal of Consent|4|||
125533555|NCT03829501|451584776|FG011|Overall Study|Withdrawal of Consent|4|||
125310242|NCT02518971|450762041|FG000|Overall Study|medication lost in mail|0|||
125310243|NCT02518971|450762042|FG001|Overall Study|medication lost in mail|1|||
125310244|NCT02518971|450762041|FG000|Overall Study|eligibility criteria no longer met|6|||
125310245|NCT02518971|450762042|FG001|Overall Study|eligibility criteria no longer met|3|||
125310246|NCT02336230|450762043|FG000|Overall Study|Adverse Event|1|||
125198681|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
125198682|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
125198683|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
125198684|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
125198685|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
125198686|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
125198687|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
125198688|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
125310247|NCT02336230|450762043|FG000|Overall Study|Withdrawal of consent|1|||
125198689|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Other|8|||
125198690|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Other|14|||
125310248|NCT02336230|450762043|FG000|Overall Study|Death|9|||
125310249|NCT02336230|450762043|FG000|Overall Study|Dose not received due to shipping delay|1|||
125310250|NCT02336230|450762043|FG000|Overall Study|Discontinuation of MSC infusion|1|||
125310251|NCT02524171|450762044|FG000|6-month Follow-up|Lost to Follow-up|53|||
125310252|NCT02524171|450762045|FG001|6-month Follow-up|Lost to Follow-up|45|||
125533556|NCT03829501|451584777|FG012|Overall Study|Withdrawal of Consent|4|||
125533557|NCT03829501|451584778|FG013|Overall Study|Withdrawal of Consent|0|||
125533558|NCT03829501|451584779|FG014|Overall Study|Withdrawal of Consent|3|||
125533559|NCT03829501|451584780|FG015|Overall Study|Withdrawal of Consent|0|||
125533560|NCT03829501|451584781|FG016|Overall Study|Withdrawal of Consent|1|||
125533561|NCT03829501|451584782|FG017|Overall Study|Withdrawal of Consent|1|||
125533562|NCT03829501|451584783|FG018|Overall Study|Withdrawal of Consent|0|||
125533563|NCT03829501|451584784|FG019|Overall Study|Withdrawal of Consent|0|||
125533564|NCT03829501|451584785|FG020|Overall Study|Withdrawal of Consent|3|||
125533565|NCT03829501|451584786|FG021|Overall Study|Withdrawal of Consent|0|||
125533566|NCT03829501|451584787|FG022|Overall Study|Withdrawal of Consent|1|||
125533567|NCT03829501|451584765|FG000|Overall Study|PD|0|||
125533568|NCT03829501|451584766|FG001|Overall Study|PD|0|||
125533569|NCT03829501|451584767|FG002|Overall Study|PD|0|||
125198691|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Other|8|||
125198692|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Other|23|||
125198693|NCT01106677|450350991|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
125198694|NCT01106677|450350992|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
125198695|NCT01106677|450350993|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
125198696|NCT01106677|450350994|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
125198697|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
125198698|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
125198699|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
125198700|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
125198701|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Death|0|||
125198702|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Death|0|||
125198703|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Death|0|||
125198704|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Death|1|||
125198705|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
125310253|NCT02524171|450762044|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
125310254|NCT02524171|450762045|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
125310255|NCT00757237|450762048|FG000|Overall Study|Lost to Follow-up|0|||
125310256|NCT00757237|450762049|FG001|Overall Study|Lost to Follow-up|1|||
125310257|NCT00757237|450762048|FG000|Overall Study|Protocol Violation|0|||
125533570|NCT03829501|451584768|FG003|Overall Study|PD|2|||
125533571|NCT03829501|451584769|FG004|Overall Study|PD|0|||
125533572|NCT03829501|451584770|FG005|Overall Study|PD|0|||
125533573|NCT03829501|451584771|FG006|Overall Study|PD|0|||
125533574|NCT03829501|451584772|FG007|Overall Study|PD|0|||
125533575|NCT03829501|451584773|FG008|Overall Study|PD|0|||
125533576|NCT03829501|451584774|FG009|Overall Study|PD|0|||
125533577|NCT03829501|451584775|FG010|Overall Study|PD|0|||
125533578|NCT03829501|451584776|FG011|Overall Study|PD|0|||
125533579|NCT03829501|451584777|FG012|Overall Study|PD|0|||
125533580|NCT03829501|451584778|FG013|Overall Study|PD|0|||
125533581|NCT03829501|451584779|FG014|Overall Study|PD|0|||
125198706|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
125198707|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
125198708|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
125198709|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125198710|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
125198711|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
125198712|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
125198713|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
125198714|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
125198715|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
125198716|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
125198717|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
125198718|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125198719|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125198720|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125198721|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125198722|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
125198723|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
125198724|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125198725|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
125198726|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
125198727|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
125533582|NCT03829501|451584780|FG015|Overall Study|PD|1|||
125533583|NCT03829501|451584781|FG016|Overall Study|PD|0|||
125533584|NCT03829501|451584782|FG017|Overall Study|PD|0|||
125533585|NCT03829501|451584783|FG018|Overall Study|PD|0|||
125533586|NCT03829501|451584784|FG019|Overall Study|PD|0|||
125533587|NCT03829501|451584785|FG020|Overall Study|PD|1|||
125533588|NCT03829501|451584786|FG021|Overall Study|PD|0|||
125533589|NCT03829501|451584787|FG022|Overall Study|PD|0|||
125533590|NCT03829501|451584765|FG000|Overall Study|Study Terminated by Sponsor|0|||
125533591|NCT03829501|451584766|FG001|Overall Study|Study Terminated by Sponsor|0|||
125533592|NCT03829501|451584767|FG002|Overall Study|Study Terminated by Sponsor|0|||
125533593|NCT03829501|451584768|FG003|Overall Study|Study Terminated by Sponsor|0|||
125533594|NCT03829501|451584769|FG004|Overall Study|Study Terminated by Sponsor|0|||
125533595|NCT03829501|451584770|FG005|Overall Study|Study Terminated by Sponsor|0|||
125533596|NCT03829501|451584771|FG006|Overall Study|Study Terminated by Sponsor|0|||
125198728|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
125198729|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125198730|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125198731|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125198732|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
125198733|NCT01106677|450350991|FG000|Extension Period: Week 26 to Week 52|Other|6|||
125533597|NCT03829501|451584772|FG007|Overall Study|Study Terminated by Sponsor|3|||
125533598|NCT03829501|451584773|FG008|Overall Study|Study Terminated by Sponsor|1|||
125533599|NCT03829501|451584774|FG009|Overall Study|Study Terminated by Sponsor|0|||
125533600|NCT03829501|451584775|FG010|Overall Study|Study Terminated by Sponsor|0|||
125533601|NCT03829501|451584776|FG011|Overall Study|Study Terminated by Sponsor|0|||
125533602|NCT03829501|451584777|FG012|Overall Study|Study Terminated by Sponsor|0|||
125198734|NCT01106677|450350992|FG001|Extension Period: Week 26 to Week 52|Other|5|||
125533603|NCT03829501|451584778|FG013|Overall Study|Study Terminated by Sponsor|0|||
125533604|NCT03829501|451584779|FG014|Overall Study|Study Terminated by Sponsor|3|||
125533605|NCT03829501|451584780|FG015|Overall Study|Study Terminated by Sponsor|2|||
125533606|NCT03829501|451584781|FG016|Overall Study|Study Terminated by Sponsor|2|||
125533607|NCT03829501|451584782|FG017|Overall Study|Study Terminated by Sponsor|0|||
125533608|NCT03829501|451584783|FG018|Overall Study|Study Terminated by Sponsor|0|||
125533609|NCT03829501|451584784|FG019|Overall Study|Study Terminated by Sponsor|0|||
125533610|NCT03829501|451584785|FG020|Overall Study|Study Terminated by Sponsor|1|||
125533611|NCT03829501|451584786|FG021|Overall Study|Study Terminated by Sponsor|0|||
125533612|NCT03829501|451584787|FG022|Overall Study|Study Terminated by Sponsor|3|||
125533613|NCT03829501|451584765|FG000|Overall Study|Lost to Follow Up|0|||
125533614|NCT03829501|451584766|FG001|Overall Study|Lost to Follow Up|0|||
125533615|NCT03829501|451584767|FG002|Overall Study|Lost to Follow Up|0|||
125533616|NCT03829501|451584768|FG003|Overall Study|Lost to Follow Up|0|||
125533617|NCT03829501|451584769|FG004|Overall Study|Lost to Follow Up|1|||
125533618|NCT03829501|451584770|FG005|Overall Study|Lost to Follow Up|0|||
125533619|NCT03829501|451584771|FG006|Overall Study|Lost to Follow Up|0|||
125533620|NCT03829501|451584772|FG007|Overall Study|Lost to Follow Up|2|||
125533621|NCT03829501|451584773|FG008|Overall Study|Lost to Follow Up|2|||
125533622|NCT03829501|451584774|FG009|Overall Study|Lost to Follow Up|0|||
125533623|NCT03829501|451584775|FG010|Overall Study|Lost to Follow Up|2|||
125533624|NCT03829501|451584776|FG011|Overall Study|Lost to Follow Up|1|||
125533625|NCT03829501|451584777|FG012|Overall Study|Lost to Follow Up|0|||
125533626|NCT03829501|451584778|FG013|Overall Study|Lost to Follow Up|1|||
125533627|NCT03829501|451584779|FG014|Overall Study|Lost to Follow Up|1|||
125533628|NCT03829501|451584780|FG015|Overall Study|Lost to Follow Up|0|||
125533629|NCT03829501|451584781|FG016|Overall Study|Lost to Follow Up|0|||
125533630|NCT03829501|451584782|FG017|Overall Study|Lost to Follow Up|0|||
125533631|NCT03829501|451584783|FG018|Overall Study|Lost to Follow Up|0|||
125533632|NCT03829501|451584784|FG019|Overall Study|Lost to Follow Up|0|||
125533633|NCT03829501|451584785|FG020|Overall Study|Lost to Follow Up|0|||
125533634|NCT03829501|451584786|FG021|Overall Study|Lost to Follow Up|0|||
125533635|NCT03829501|451584787|FG022|Overall Study|Lost to Follow Up|1|||
125533636|NCT03829501|451584765|FG000|Overall Study|Death|2|||
125533637|NCT03829501|451584766|FG001|Overall Study|Death|4|||
125533638|NCT03829501|451584767|FG002|Overall Study|Death|5|||
125533639|NCT03829501|451584768|FG003|Overall Study|Death|6|||
125533640|NCT03829501|451584769|FG004|Overall Study|Death|5|||
125533641|NCT03829501|451584770|FG005|Overall Study|Death|4|||
125533642|NCT03829501|451584771|FG006|Overall Study|Death|5|||
125533643|NCT03829501|451584772|FG007|Overall Study|Death|24|||
125533644|NCT03829501|451584773|FG008|Overall Study|Death|22|||
125533645|NCT03829501|451584774|FG009|Overall Study|Death|6|||
125533646|NCT03829501|451584775|FG010|Overall Study|Death|3|||
125533647|NCT03829501|451584776|FG011|Overall Study|Death|10|||
125533648|NCT03829501|451584777|FG012|Overall Study|Death|10|||
125533649|NCT03829501|451584778|FG013|Overall Study|Death|5|||
125533650|NCT03829501|451584779|FG014|Overall Study|Death|7|||
125533651|NCT03829501|451584780|FG015|Overall Study|Death|2|||
125533652|NCT03829501|451584781|FG016|Overall Study|Death|2|||
125533653|NCT03829501|451584782|FG017|Overall Study|Death|1|||
125533654|NCT03829501|451584783|FG018|Overall Study|Death|1|||
125533655|NCT03829501|451584784|FG019|Overall Study|Death|1|||
125533656|NCT03829501|451584785|FG020|Overall Study|Death|1|||
125533657|NCT03829501|451584786|FG021|Overall Study|Death|2|||
125533658|NCT03829501|451584787|FG022|Overall Study|Death|3|||
125533659|NCT03829501|451584765|FG000|Overall Study|Miscellaneous|0|||
125198735|NCT01106677|450350993|FG002|Extension Period: Week 26 to Week 52|Other|8|||
125198736|NCT01106677|450350994|FG003|Extension Period: Week 26 to Week 52|Other|5|||
125198737|NCT03937908|450350996|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
125198738|NCT03937908|450350997|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
125198739|NCT03205761|450350998|FG000|Overall Study|Withdrawal by Subject|1|||
125198740|NCT03205761|450350998|FG000|Overall Study|Progressive Disease|10|||
125198741|NCT04420585|450350999|FG000|Overall Study|Adverse Event|1|||
125198742|NCT04420585|450350999|FG000|Overall Study|Never initiated medication|2|||
125198743|NCT00972816|450351000|FG000|Overall Study|Adverse Event|0|||
125198744|NCT00972816|450351001|FG001|Overall Study|Adverse Event|0|||
125198745|NCT00972816|450351002|FG002|Overall Study|Adverse Event|1|||
125198746|NCT00972816|450351003|FG003|Overall Study|Adverse Event|0|||
125198747|NCT00972816|450351004|FG004|Overall Study|Adverse Event|0|||
125198748|NCT00972816|450351005|FG005|Overall Study|Adverse Event|0|||
125198749|NCT00972816|450351006|FG006|Overall Study|Adverse Event|0|||
125198750|NCT00972816|450351007|FG007|Overall Study|Adverse Event|0|||
125198751|NCT00972816|450351000|FG000|Overall Study|Withdrawal by Subject|4|||
125198752|NCT00972816|450351001|FG001|Overall Study|Withdrawal by Subject|2|||
125198753|NCT00972816|450351002|FG002|Overall Study|Withdrawal by Subject|1|||
125198754|NCT00972816|450351003|FG003|Overall Study|Withdrawal by Subject|3|||
125198755|NCT00972816|450351004|FG004|Overall Study|Withdrawal by Subject|0|||
125198756|NCT00972816|450351005|FG005|Overall Study|Withdrawal by Subject|1|||
125198757|NCT00972816|450351006|FG006|Overall Study|Withdrawal by Subject|1|||
125198758|NCT00972816|450351007|FG007|Overall Study|Withdrawal by Subject|2|||
125533660|NCT03829501|451584766|FG001|Overall Study|Miscellaneous|0|||
125533661|NCT03829501|451584767|FG002|Overall Study|Miscellaneous|1|||
125533662|NCT03829501|451584768|FG003|Overall Study|Miscellaneous|0|||
125533663|NCT03829501|451584769|FG004|Overall Study|Miscellaneous|0|||
125198759|NCT00972816|450351000|FG000|Overall Study|Lost to Follow-up|11|||
125198760|NCT00972816|450351001|FG001|Overall Study|Lost to Follow-up|9|||
125198761|NCT00972816|450351002|FG002|Overall Study|Lost to Follow-up|7|||
125533664|NCT03829501|451584770|FG005|Overall Study|Miscellaneous|0|||
125198762|NCT00972816|450351003|FG003|Overall Study|Lost to Follow-up|5|||
125198763|NCT00972816|450351004|FG004|Overall Study|Lost to Follow-up|11|||
125198764|NCT00972816|450351005|FG005|Overall Study|Lost to Follow-up|10|||
125198765|NCT00972816|450351006|FG006|Overall Study|Lost to Follow-up|7|||
125533665|NCT03829501|451584771|FG006|Overall Study|Miscellaneous|0|||
125533666|NCT03829501|451584772|FG007|Overall Study|Miscellaneous|1|||
125533667|NCT03829501|451584773|FG008|Overall Study|Miscellaneous|0|||
125533668|NCT03829501|451584774|FG009|Overall Study|Miscellaneous|0|||
125533669|NCT03829501|451584775|FG010|Overall Study|Miscellaneous|0|||
125533670|NCT03829501|451584776|FG011|Overall Study|Miscellaneous|0|||
125533671|NCT03829501|451584777|FG012|Overall Study|Miscellaneous|0|||
125310258|NCT00757237|450762049|FG001|Overall Study|Protocol Violation|2|||
125310259|NCT00757237|450762048|FG000|Overall Study|Physician Decision|2|||
125310260|NCT00757237|450762049|FG001|Overall Study|Physician Decision|3|||
125310261|NCT00757237|450762048|FG000|Overall Study|Withdrawal by Subject|8|||
125310262|NCT00757237|450762049|FG001|Overall Study|Withdrawal by Subject|12|||
125310263|NCT00757237|450762048|FG000|Overall Study|Safety or Tolerability|3|||
125310264|NCT00757237|450762049|FG001|Overall Study|Safety or Tolerability|5|||
125310265|NCT00757237|450762048|FG000|Overall Study|Other|0|||
125310266|NCT00757237|450762049|FG001|Overall Study|Other|2|||
125310267|NCT05150990|450762050|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
125310268|NCT05150990|450762051|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
125310269|NCT05150990|450762050|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
125310270|NCT05150990|450762051|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
125533672|NCT03829501|451584778|FG013|Overall Study|Miscellaneous|0|||
125422229|NCT00590902|451172762|FG000|Overall Study|Death|1|||
125422230|NCT00785291|451172764|FG000|Overall Study|Never began treatment|8|||
125422231|NCT00785291|451172765|FG001|Overall Study|Never began treatment|4|||
125422232|NCT00785291|451172766|FG002|Overall Study|Never began treatment|4|||
125422233|NCT00785291|451172764|FG000|Overall Study|Adverse Event|39|||
125422234|NCT00785291|451172765|FG001|Overall Study|Adverse Event|70|||
125422235|NCT00785291|451172766|FG002|Overall Study|Adverse Event|56|||
125310271|NCT05150990|450762050|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
125310272|NCT05150990|450762051|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
125310273|NCT05150990|450762050|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
125310274|NCT05150990|450762051|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
125310275|NCT05150990|450762050|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
125310276|NCT05150990|450762051|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
125310277|NCT05150990|450762050|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
125310278|NCT05150990|450762051|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
125310279|NCT05150990|450762050|FG000|Overall Study|Death (unrelated to the intervention)|1|||
125310280|NCT05150990|450762051|FG001|Overall Study|Death (unrelated to the intervention)|2|||
125422236|NCT00785291|451172764|FG000|Overall Study|Death|7|||
125422237|NCT00785291|451172765|FG001|Overall Study|Death|4|||
125422238|NCT00785291|451172766|FG002|Overall Study|Death|3|||
125422239|NCT00785291|451172764|FG000|Overall Study|Withdrawal by Subject|35|||
125422240|NCT00785291|451172765|FG001|Overall Study|Withdrawal by Subject|36|||
125422241|NCT00785291|451172766|FG002|Overall Study|Withdrawal by Subject|17|||
125422242|NCT00785291|451172764|FG000|Overall Study|Alternative Therapy|12|||
125422243|NCT00785291|451172765|FG001|Overall Study|Alternative Therapy|6|||
125422244|NCT00785291|451172766|FG002|Overall Study|Alternative Therapy|7|||
125422245|NCT00785291|451172764|FG000|Overall Study|Complicating illness|6|||
125422246|NCT00785291|451172765|FG001|Overall Study|Complicating illness|4|||
125422247|NCT00785291|451172766|FG002|Overall Study|Complicating illness|4|||
125422248|NCT00785291|451172764|FG000|Overall Study|Other Medical Reasons|29|||
125422249|NCT00785291|451172765|FG001|Overall Study|Other Medical Reasons|25|||
125422250|NCT00785291|451172766|FG002|Overall Study|Other Medical Reasons|15|||
125422251|NCT00844857|451172767|FG000|Overall Study|Adverse Event|24|||
125422252|NCT00844857|451172768|FG001|Overall Study|Adverse Event|5|||
125422253|NCT00844857|451172767|FG000|Overall Study|Sponsor Decision|1|||
125422254|NCT00844857|451172768|FG001|Overall Study|Sponsor Decision|1|||
125422255|NCT00844857|451172767|FG000|Overall Study|Physician Decision|2|||
125422256|NCT00844857|451172768|FG001|Overall Study|Physician Decision|0|||
125422257|NCT00844857|451172767|FG000|Overall Study|Parent/Caregiver Decision|6|||
125422258|NCT00844857|451172768|FG001|Overall Study|Parent/Caregiver Decision|2|||
125422259|NCT00844857|451172767|FG000|Overall Study|Withdrawal by Subject|8|||
125533673|NCT03829501|451584779|FG014|Overall Study|Miscellaneous|0|||
125533674|NCT03829501|451584780|FG015|Overall Study|Miscellaneous|0|||
125533675|NCT03829501|451584781|FG016|Overall Study|Miscellaneous|0|||
125533676|NCT03829501|451584782|FG017|Overall Study|Miscellaneous|0|||
125533677|NCT03829501|451584783|FG018|Overall Study|Miscellaneous|0|||
125533678|NCT03829501|451584784|FG019|Overall Study|Miscellaneous|0|||
125533679|NCT03829501|451584785|FG020|Overall Study|Miscellaneous|0|||
125533680|NCT03829501|451584786|FG021|Overall Study|Miscellaneous|0|||
125533681|NCT03829501|451584787|FG022|Overall Study|Miscellaneous|1|||
125533682|NCT01123070|451584788|FG000|Part B Double Blind Period|Protocol Violation|0|||
125533683|NCT01123070|451584789|FG001|Part B Double Blind Period|Protocol Violation|0|||
125533684|NCT01123070|451584790|FG002|Part B Double Blind Period|Protocol Violation|0|||
125533685|NCT01123070|451584791|FG003|Part B Double Blind Period|Protocol Violation|1|||
125533686|NCT01123070|451584788|FG000|Part B Double Blind Period|Adverse Event|0|||
125310281|NCT00466921|450762052|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
125533687|NCT01123070|451584789|FG001|Part B Double Blind Period|Adverse Event|0|||
125533688|NCT01123070|451584790|FG002|Part B Double Blind Period|Adverse Event|2|||
125310282|NCT00466921|450762052|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
125533689|NCT01123070|451584791|FG003|Part B Double Blind Period|Adverse Event|0|||
125533690|NCT01123070|451584788|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
125422260|NCT00844857|451172768|FG001|Overall Study|Withdrawal by Subject|7|||
125422261|NCT00844857|451172767|FG000|Overall Study|Protocol Violation|6|||
125422262|NCT00844857|451172768|FG001|Overall Study|Protocol Violation|0|||
125422263|NCT00844857|451172767|FG000|Overall Study|Lack of Efficacy|5|||
125422264|NCT00844857|451172768|FG001|Overall Study|Lack of Efficacy|5|||
125422265|NCT00844857|451172767|FG000|Overall Study|Clinical Relapse|0|||
125422266|NCT00844857|451172768|FG001|Overall Study|Clinical Relapse|1|||
125422267|NCT00844857|451172767|FG000|Overall Study|Entry Criteria Not Met|0|||
125422268|NCT00844857|451172768|FG001|Overall Study|Entry Criteria Not Met|1|||
125422269|NCT00844857|451172767|FG000|Overall Study|Lost to Follow-up|2|||
125422270|NCT00844857|451172768|FG001|Overall Study|Lost to Follow-up|3|||
125422271|NCT00844857|451172767|FG000|Overall Study|Did Not Take Study Drug|3|||
125422272|NCT00844857|451172768|FG001|Overall Study|Did Not Take Study Drug|1|||
125422273|NCT00844857|451172767|FG000|Overall Study|Good Clinical Practice Violations|21|||
125422274|NCT00844857|451172768|FG001|Overall Study|Good Clinical Practice Violations|11|||
125422275|NCT00570674|451172769|FG000|Overall Study|Withdrawal by Subject|0|||
125422276|NCT00570674|451172770|FG001|Overall Study|Withdrawal by Subject|0|||
125422277|NCT00570674|451172771|FG002|Overall Study|Withdrawal by Subject|1|||
125422278|NCT00570674|451172772|FG003|Overall Study|Withdrawal by Subject|0|||
125422279|NCT00570674|451172773|FG004|Overall Study|Withdrawal by Subject|0|||
125422280|NCT00570674|451172774|FG005|Overall Study|Withdrawal by Subject|0|||
125422281|NCT00570674|451172775|FG006|Overall Study|Withdrawal by Subject|0|||
125422282|NCT02979639|451172777|FG000|Overall Study|Withdrawal based on medical judgement|1|||
125422283|NCT02979639|451172777|FG000|Overall Study|Lost to Follow-up|8|||
125422284|NCT02979639|451172777|FG000|Overall Study|Withdrawal by Subject|3|||
125422285|NCT02979639|451172777|FG000|Overall Study|Adverse Event|2|||
125422286|NCT04050865|451172781|FG000|Overall Study|Adverse Event|1|||
125422287|NCT04050865|451172782|FG001|Overall Study|Adverse Event|0|||
125422288|NCT04050865|451172781|FG000|Overall Study|no insert|1|||
125422289|NCT04050865|451172782|FG001|Overall Study|no insert|0|||
125422290|NCT04050865|451172781|FG000|Overall Study|Only 1 insert|2|||
125422291|NCT04050865|451172782|FG001|Overall Study|Only 1 insert|3|||
125422292|NCT04050865|451172781|FG000|Overall Study|Physician Decision|0|||
125422293|NCT04050865|451172782|FG001|Overall Study|Physician Decision|1|||
125422294|NCT04050865|451172781|FG000|Overall Study|Withdrawal by Subject|0|||
125422295|NCT04050865|451172782|FG001|Overall Study|Withdrawal by Subject|1|||
125422296|NCT00175825|451172789|FG000|Overall Study|Adverse Event|3|||
125422297|NCT00175825|451172790|FG001|Overall Study|Adverse Event|2|||
125422298|NCT00175825|451172791|FG002|Overall Study|Adverse Event|1|||
125422299|NCT00175825|451172792|FG003|Overall Study|Adverse Event|1|||
125422300|NCT00175825|451172789|FG000|Overall Study|Lost to Follow-up|1|||
125422301|NCT00175825|451172790|FG001|Overall Study|Lost to Follow-up|2|||
125422302|NCT00175825|451172791|FG002|Overall Study|Lost to Follow-up|0|||
125422303|NCT00175825|451172792|FG003|Overall Study|Lost to Follow-up|0|||
125422304|NCT00175825|451172789|FG000|Overall Study|Withdrawal by Subject|1|||
125422305|NCT00175825|451172790|FG001|Overall Study|Withdrawal by Subject|0|||
125422306|NCT00175825|451172791|FG002|Overall Study|Withdrawal by Subject|0|||
125422307|NCT00175825|451172792|FG003|Overall Study|Withdrawal by Subject|0|||
125422308|NCT00608582|451172793|FG000|Overall Study|Lost to Follow-up|2|||
125422309|NCT00608582|451172794|FG001|Overall Study|Lost to Follow-up|0|||
125422310|NCT00608582|451172793|FG000|Overall Study|No Best Response in Phase 1 located|1|||
125422311|NCT00608582|451172794|FG001|Overall Study|No Best Response in Phase 1 located|1|||
125422312|NCT00608582|451172793|FG000|Overall Study|Illicit Drug Use|1|||
125422313|NCT00608582|451172794|FG001|Overall Study|Illicit Drug Use|0|||
125422314|NCT00608582|451172793|FG000|Overall Study|Early stage Design Change|0|||
125422315|NCT00608582|451172794|FG001|Overall Study|Early stage Design Change|3|||
125422316|NCT02450331|451172797|FG000|Overall Study|Death|162|||
125422317|NCT02450331|451172798|FG001|Overall Study|Death|171|||
125422318|NCT02450331|451172797|FG000|Overall Study|Lost to Follow-up|14|||
125422319|NCT02450331|451172798|FG001|Overall Study|Lost to Follow-up|12|||
125422320|NCT02450331|451172797|FG000|Overall Study|Withdrawal by Subject|55|||
125422321|NCT02450331|451172798|FG001|Overall Study|Withdrawal by Subject|44|||
125422322|NCT02450331|451172797|FG000|Overall Study|Non-specified other|1|||
125422323|NCT02450331|451172798|FG001|Overall Study|Non-specified other|1|||
125422324|NCT03232983|451172799|FG000|Period 1|Physician Decision|0|||
125533691|NCT01123070|451584789|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
125533692|NCT01123070|451584790|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
125533693|NCT01123070|451584791|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
125533694|NCT03284229|451584792|FG000|Overall Study|Lost to Follow-up|3|||
125533695|NCT01332630|451584793|FG000|Overall Study|Withdrawal by Subject|3|||
125533696|NCT03140280|451584794|FG000|Overall Study|Physician Decision|5|||
125533697|NCT01977677|451584807|FG000|Overall Study|Unrelated Adverse Event|0|||
125422325|NCT03232983|451172800|FG001|Period 1|Physician Decision|0|||
125422326|NCT03232983|451172801|FG002|Period 1|Physician Decision|1|||
125422327|NCT03232983|451172802|FG003|Period 1|Physician Decision|0|||
125644855|NCT01070381|451982128|FG000|Period 2, 1 Week of Wear|Handling|0|||
125422328|NCT03232983|451172799|FG000|Washout Period 2|Physician Decision|0|||
125422329|NCT03232983|451172800|FG001|Washout Period 2|Physician Decision|0|||
125422330|NCT03232983|451172801|FG002|Washout Period 2|Physician Decision|1|||
125422331|NCT03232983|451172802|FG003|Washout Period 2|Physician Decision|0|||
125422332|NCT03232983|451172799|FG000|Washout Period 2|Withdrawal by Subject|0|||
125422333|NCT03232983|451172800|FG001|Washout Period 2|Withdrawal by Subject|0|||
125422334|NCT03232983|451172801|FG002|Washout Period 2|Withdrawal by Subject|0|||
125422335|NCT03232983|451172802|FG003|Washout Period 2|Withdrawal by Subject|1|||
125422336|NCT03232983|451172799|FG000|Period 4|Withdrawal by Subject|1|||
125422337|NCT03232983|451172800|FG001|Period 4|Withdrawal by Subject|0|||
125422338|NCT03232983|451172801|FG002|Period 4|Withdrawal by Subject|0|||
125422339|NCT03232983|451172802|FG003|Period 4|Withdrawal by Subject|0|||
125422340|NCT00815295|451172805|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
125422341|NCT00815295|451172806|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
125422342|NCT00815295|451172807|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
125422343|NCT00530855|451172808|FG000|Overall Study|Lack of Efficacy|20|||
125422344|NCT00530855|451172808|FG000|Overall Study|Withdrawal by Subject|30|||
125422345|NCT00530855|451172808|FG000|Overall Study|Fatal Serious AE|3|||
125422346|NCT00530855|451172808|FG000|Overall Study|Non Fatal Serious AE|7|||
125422347|NCT00530855|451172808|FG000|Overall Study|Non Fatal Non Serious AE|12|||
125422348|NCT00530855|451172808|FG000|Overall Study|Protocol Violation|3|||
125422349|NCT00530855|451172808|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
125422350|NCT00530855|451172808|FG000|Overall Study|Lost to Follow-up|9|||
125422351|NCT00530855|451172808|FG000|Overall Study|Other reason for premature termination|17|||
125422352|NCT01137474|451172809|FG000|Overall Study|Adverse Event|3|||
125422353|NCT01137474|451172810|FG001|Overall Study|Adverse Event|5|||
125422354|NCT01137474|451172811|FG002|Overall Study|Adverse Event|1|||
125422355|NCT01137474|451172812|FG003|Overall Study|Adverse Event|3|||
125422356|NCT01137474|451172809|FG000|Overall Study|Withdrawal by Subject|7|||
125422357|NCT01137474|451172810|FG001|Overall Study|Withdrawal by Subject|2|||
125422358|NCT01137474|451172811|FG002|Overall Study|Withdrawal by Subject|6|||
125422359|NCT01137474|451172812|FG003|Overall Study|Withdrawal by Subject|9|||
125422360|NCT01137474|451172809|FG000|Overall Study|No longer met study criteria|6|||
125422361|NCT01137474|451172810|FG001|Overall Study|No longer met study criteria|1|||
125422362|NCT01137474|451172811|FG002|Overall Study|No longer met study criteria|0|||
125422363|NCT01137474|451172812|FG003|Overall Study|No longer met study criteria|5|||
125422364|NCT01137474|451172809|FG000|Overall Study|Lost to Follow-up|5|||
125422365|NCT01137474|451172810|FG001|Overall Study|Lost to Follow-up|1|||
125422366|NCT01137474|451172811|FG002|Overall Study|Lost to Follow-up|0|||
125422367|NCT01137474|451172812|FG003|Overall Study|Lost to Follow-up|2|||
125422368|NCT01137474|451172809|FG000|Overall Study|Lack of Efficacy|0|||
125422369|NCT01137474|451172810|FG001|Overall Study|Lack of Efficacy|0|||
125422370|NCT01137474|451172811|FG002|Overall Study|Lack of Efficacy|0|||
125422371|NCT01137474|451172812|FG003|Overall Study|Lack of Efficacy|2|||
125422372|NCT01137474|451172809|FG000|Overall Study|Other|3|||
125422373|NCT01137474|451172810|FG001|Overall Study|Other|1|||
125422374|NCT01137474|451172811|FG002|Overall Study|Other|0|||
125422375|NCT01137474|451172812|FG003|Overall Study|Other|0|||
125422376|NCT01137474|451172809|FG000|Overall Study|Pregnancy|0|||
125422377|NCT01137474|451172810|FG001|Overall Study|Pregnancy|1|||
125422378|NCT01137474|451172811|FG002|Overall Study|Pregnancy|0|||
125422379|NCT01137474|451172812|FG003|Overall Study|Pregnancy|0|||
125422380|NCT01137474|451172809|FG000|Overall Study|Administrative reason by sponsor|0|||
125422381|NCT01137474|451172810|FG001|Overall Study|Administrative reason by sponsor|1|||
125422382|NCT01137474|451172811|FG002|Overall Study|Administrative reason by sponsor|0|||
125422383|NCT01137474|451172812|FG003|Overall Study|Administrative reason by sponsor|0|||
125422384|NCT02219048|451172813|FG000|Overall Study|Adverse Event|2|||
125422385|NCT02219048|451172814|FG001|Overall Study|Adverse Event|5|||
125422386|NCT02219048|451172813|FG000|Overall Study|No longer meets eligibility criteria|1|||
125422387|NCT02219048|451172814|FG001|Overall Study|No longer meets eligibility criteria|0|||
125422388|NCT02219048|451172813|FG000|Overall Study|Study terminated by sponsor|16|||
125422389|NCT02219048|451172814|FG001|Overall Study|Study terminated by sponsor|15|||
125422390|NCT02219048|451172813|FG000|Overall Study|Withdrawal by Subject|2|||
125422391|NCT02219048|451172814|FG001|Overall Study|Withdrawal by Subject|0|||
125422392|NCT02219048|451172813|FG000|Overall Study|Other|0|||
125422393|NCT02219048|451172814|FG001|Overall Study|Other|1|||
125422394|NCT04794803|451172815|FG000|Overall Study|Death|1|||
125422395|NCT04794803|451172816|FG001|Overall Study|Death|3|||
125422396|NCT04794803|451172815|FG000|Overall Study|Lost to Follow-up|2|||
125422397|NCT04794803|451172816|FG001|Overall Study|Lost to Follow-up|2|||
125422398|NCT04794803|451172815|FG000|Overall Study|Withdrawal by Subject|1|||
125422399|NCT04794803|451172816|FG001|Overall Study|Withdrawal by Subject|0|||
125422400|NCT04794803|451172815|FG000|Overall Study|Physician Decision|1|||
125422401|NCT04794803|451172816|FG001|Overall Study|Physician Decision|1|||
125422402|NCT04794803|451172815|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
125422403|NCT04794803|451172816|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
125422404|NCT04794803|451172815|FG000|Overall Study|Refused to continue the treatment|1|||
125422405|NCT04794803|451172816|FG001|Overall Study|Refused to continue the treatment|0|||
125422406|NCT04794803|451172815|FG000|Overall Study|Patient admitted to ICU|0|||
125422407|NCT04794803|451172816|FG001|Overall Study|Patient admitted to ICU|1|||
125422408|NCT00911534|451172819|FG000|Overall Study|Adverse Event|4|||
125422409|NCT00911534|451172820|FG001|Overall Study|Adverse Event|4|||
125422410|NCT00911534|451172819|FG000|Overall Study|Lost to Follow-up|2|||
125422411|NCT00911534|451172820|FG001|Overall Study|Lost to Follow-up|4|||
125422412|NCT00911534|451172819|FG000|Overall Study|Withdrawal by Subject|2|||
125422413|NCT00911534|451172820|FG001|Overall Study|Withdrawal by Subject|1|||
125422414|NCT00911534|451172819|FG000|Overall Study|Lack of Efficacy|4|||
125422415|NCT00911534|451172820|FG001|Overall Study|Lack of Efficacy|1|||
125422416|NCT00911534|451172819|FG000|Overall Study|Withdrawal of consent|1|||
125422417|NCT00911534|451172820|FG001|Overall Study|Withdrawal of consent|4|||
125422418|NCT00911534|451172819|FG000|Overall Study|Other|2|||
125422419|NCT00911534|451172820|FG001|Overall Study|Other|2|||
125422420|NCT03152526|451172821|FG000|Overall Study|Withdrawal by Subject|0|||
125422421|NCT03152526|451172822|FG001|Overall Study|Withdrawal by Subject|1|||
125422422|NCT05711641|451172823|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
125422423|NCT05711641|451172824|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
125422424|NCT05711641|451172823|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
125422425|NCT05711641|451172824|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
125422426|NCT00162370|451172825|FG000|Efficacy Population|Lost to Follow-up|51|||
125422427|NCT04040751|451172826|FG000|Overall Study|Withdrawal by Subject|2|||
125422428|NCT04040751|451172827|FG001|Overall Study|Withdrawal by Subject|0|||
125422429|NCT04040751|451172828|FG002|Overall Study|Withdrawal by Subject|2|||
125422430|NCT04040751|451172829|FG003|Overall Study|Withdrawal by Subject|0|||
125422431|NCT03896035|451172830|FG000|Overall Study|Lost to Follow-up|2|||
125422432|NCT03896035|451172831|FG001|Overall Study|Lost to Follow-up|6|||
125422433|NCT03896035|451172830|FG000|Overall Study|Withdrawal by Subject|0|||
125422434|NCT03896035|451172831|FG001|Overall Study|Withdrawal by Subject|1|||
125422435|NCT03896035|451172830|FG000|Overall Study|Health/family health issues during COVID|0|||
125422436|NCT03896035|451172831|FG001|Overall Study|Health/family health issues during COVID|4|||
125422437|NCT00743366|451172832|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
125422438|NCT00743366|451172833|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
125422439|NCT03206203|451172834|FG000|Treatment|Death|38|||
125198766|NCT00972816|450351007|FG007|Overall Study|Lost to Follow-up|7|||
125198767|NCT00972816|450351000|FG000|Overall Study|Inappropriate enrolment|0|||
125198768|NCT00972816|450351001|FG001|Overall Study|Inappropriate enrolment|0|||
125198769|NCT00972816|450351002|FG002|Overall Study|Inappropriate enrolment|0|||
125198770|NCT00972816|450351003|FG003|Overall Study|Inappropriate enrolment|0|||
125198771|NCT00972816|450351004|FG004|Overall Study|Inappropriate enrolment|0|||
125198772|NCT00972816|450351005|FG005|Overall Study|Inappropriate enrolment|0|||
125198773|NCT00972816|450351006|FG006|Overall Study|Inappropriate enrolment|2|||
125198774|NCT00972816|450351007|FG007|Overall Study|Inappropriate enrolment|0|||
125198775|NCT00972816|450351000|FG000|Overall Study|Unable to classify|2|||
125198776|NCT00972816|450351001|FG001|Overall Study|Unable to classify|0|||
125198777|NCT00972816|450351002|FG002|Overall Study|Unable to classify|0|||
125198778|NCT00972816|450351003|FG003|Overall Study|Unable to classify|0|||
125198779|NCT00972816|450351004|FG004|Overall Study|Unable to classify|1|||
125198780|NCT00972816|450351005|FG005|Overall Study|Unable to classify|0|||
125198781|NCT00972816|450351006|FG006|Overall Study|Unable to classify|0|||
125198782|NCT00972816|450351007|FG007|Overall Study|Unable to classify|0|||
125198783|NCT04114357|450351008|FG000|Baseline-Randomization|Adverse Event|2|||
125198784|NCT04114357|450351009|FG001|Baseline-Randomization|Adverse Event|1|||
125198785|NCT04114357|450351008|FG000|Baseline-Randomization|Lost to Follow-up|1|||
125198786|NCT04114357|450351009|FG001|Baseline-Randomization|Lost to Follow-up|1|||
125198787|NCT04114357|450351008|FG000|Cross-over|Adverse Event|0|||
125198788|NCT04114357|450351009|FG001|Cross-over|Adverse Event|1|||
125198789|NCT02163226|450351010|FG000|Overall Study|Death|2|||
125198790|NCT02163226|450351011|FG001|Overall Study|Death|1|||
125198791|NCT02163226|450351010|FG000|Overall Study|Withdrawal by Subject|5|||
125198792|NCT02163226|450351011|FG001|Overall Study|Withdrawal by Subject|2|||
125198793|NCT02163226|450351010|FG000|Overall Study|Returned home, local radiotherapy|3|||
125422440|NCT03206203|451172835|FG001|Treatment|Death|26|||
125422441|NCT03206203|451172836|FG002|Treatment|Death|0|||
125422442|NCT03206203|451172834|FG000|Treatment|Withdrawal by Subject|1|||
125422443|NCT03206203|451172835|FG001|Treatment|Withdrawal by Subject|0|||
125422444|NCT03206203|451172836|FG002|Treatment|Withdrawal by Subject|0|||
125422445|NCT03206203|451172834|FG000|Treatment|Lost to Follow-up|4|||
125422446|NCT03206203|451172835|FG001|Treatment|Lost to Follow-up|0|||
125422447|NCT03206203|451172836|FG002|Treatment|Lost to Follow-up|0|||
125422448|NCT03206203|451172834|FG000|Treatment|N/A in Follow-Up|8|||
125422449|NCT03206203|451172835|FG001|Treatment|N/A in Follow-Up|1|||
125198794|NCT02163226|450351011|FG001|Overall Study|Returned home, local radiotherapy|0|||
125198795|NCT02163226|450351010|FG000|Overall Study|Repeat imaging showed no disease|2|||
125198796|NCT02163226|450351011|FG001|Overall Study|Repeat imaging showed no disease|0|||
125422450|NCT03206203|451172836|FG002|Treatment|N/A in Follow-Up|0|||
125422451|NCT03206203|451172834|FG000|Treatment|Disease progression|0|||
125422452|NCT03206203|451172835|FG001|Treatment|Disease progression|1|||
125198797|NCT02163226|450351010|FG000|Overall Study|Incomplete radiotherapy|3|||
125198798|NCT02163226|450351011|FG001|Overall Study|Incomplete radiotherapy|0|||
125198799|NCT02163226|450351010|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
125198800|NCT02163226|450351011|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
125198801|NCT02163226|450351010|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
125198802|NCT02163226|450351011|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
125198803|NCT02163226|450351010|FG000|Overall Study|ineligible|0|||
125198804|NCT02163226|450351011|FG001|Overall Study|ineligible|3|||
125198805|NCT00477750|450351012|FG000|Overall Study|Currently Receiving Treatment|11|||
125198806|NCT03558152|450351014|FG000|Overall Study|Adverse Event|0|||
125198807|NCT03558152|450351015|FG001|Overall Study|Adverse Event|0|||
125198808|NCT03558152|450351016|FG002|Overall Study|Adverse Event|1|||
125198809|NCT03558152|450351017|FG003|Overall Study|Adverse Event|1|||
125198810|NCT03558152|450351018|FG004|Overall Study|Adverse Event|2|||
125198811|NCT03558152|450351019|FG005|Overall Study|Adverse Event|1|||
125198812|NCT03558152|450351020|FG006|Overall Study|Adverse Event|1|||
125198813|NCT03558152|450351021|FG007|Overall Study|Adverse Event|0|||
125198814|NCT03558152|450351014|FG000|Overall Study|Death|0|||
125198815|NCT03558152|450351015|FG001|Overall Study|Death|0|||
125198816|NCT03558152|450351016|FG002|Overall Study|Death|0|||
125198817|NCT03558152|450351017|FG003|Overall Study|Death|0|||
125198818|NCT03558152|450351018|FG004|Overall Study|Death|1|||
125198819|NCT03558152|450351019|FG005|Overall Study|Death|0|||
125198820|NCT03558152|450351020|FG006|Overall Study|Death|0|||
125198821|NCT03558152|450351021|FG007|Overall Study|Death|0|||
125198822|NCT03558152|450351014|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
125198823|NCT03558152|450351015|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198824|NCT03558152|450351016|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198825|NCT03558152|450351017|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198826|NCT03558152|450351018|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198827|NCT03558152|450351019|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198828|NCT03558152|450351020|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198829|NCT03558152|450351021|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
125198830|NCT03558152|450351014|FG000|Overall Study|Miscalculation in mmcs|0|||
125198831|NCT03558152|450351015|FG001|Overall Study|Miscalculation in mmcs|0|||
125198832|NCT03558152|450351016|FG002|Overall Study|Miscalculation in mmcs|0|||
125198833|NCT03558152|450351017|FG003|Overall Study|Miscalculation in mmcs|0|||
125198834|NCT03558152|450351018|FG004|Overall Study|Miscalculation in mmcs|0|||
125198835|NCT03558152|450351019|FG005|Overall Study|Miscalculation in mmcs|0|||
125198836|NCT03558152|450351020|FG006|Overall Study|Miscalculation in mmcs|1|||
125198837|NCT03558152|450351021|FG007|Overall Study|Miscalculation in mmcs|0|||
125198838|NCT03558152|450351014|FG000|Overall Study|Mistake in calculation|0|||
125198839|NCT03558152|450351015|FG001|Overall Study|Mistake in calculation|0|||
125422453|NCT03206203|451172836|FG002|Treatment|Disease progression|0|||
125422454|NCT03206203|451172834|FG000|Treatment|Refused follow-up|0|||
125422455|NCT03206203|451172835|FG001|Treatment|Refused follow-up|1|||
125422456|NCT03206203|451172836|FG002|Treatment|Refused follow-up|0|||
125422457|NCT03206203|451172834|FG000|Treatment|Cross over to Arm 1|0|||
125422458|NCT03206203|451172835|FG001|Treatment|Cross over to Arm 1|19|||
125422459|NCT03206203|451172836|FG002|Treatment|Cross over to Arm 1|0|||
125422460|NCT03206203|451172834|FG000|Optional Cross-Over|Death|0|||
125422461|NCT03206203|451172835|FG001|Optional Cross-Over|Death|0|||
125422462|NCT03206203|451172836|FG002|Optional Cross-Over|Death|14|||
125422463|NCT03206203|451172834|FG000|Optional Cross-Over|Refused follow-up|0|||
125422464|NCT03206203|451172835|FG001|Optional Cross-Over|Refused follow-up|0|||
125422465|NCT03206203|451172836|FG002|Optional Cross-Over|Refused follow-up|2|||
125422466|NCT00335322|451172837|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
125422467|NCT00335322|451172838|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
125422468|NCT00335322|451172839|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
125422469|NCT01152580|451172842|FG000|Overall Study|Withdrawal by Subject|0|||
125533698|NCT01977677|451584808|FG001|Overall Study|Unrelated Adverse Event|0|||
125533699|NCT01977677|451584809|FG002|Overall Study|Unrelated Adverse Event|1|||
125533700|NCT01498887|451584810|FG000|Overall Study|Administrative problems|1|||
125533701|NCT01498887|451584811|FG001|Overall Study|Administrative problems|0|||
125533702|NCT01498887|451584810|FG000|Overall Study|Lost to Follow-up|1|||
125533703|NCT01498887|451584811|FG001|Overall Study|Lost to Follow-up|1|||
125533704|NCT01498887|451584810|FG000|Overall Study|Withdrawal by Subject|1|||
125533705|NCT01498887|451584811|FG001|Overall Study|Withdrawal by Subject|0|||
125533706|NCT01498887|451584810|FG000|Overall Study|Protocol Violation|1|||
125533707|NCT01498887|451584811|FG001|Overall Study|Protocol Violation|3|||
125533708|NCT01498887|451584810|FG000|Overall Study|Lack of Efficacy|5|||
125533709|NCT01498887|451584811|FG001|Overall Study|Lack of Efficacy|3|||
125533710|NCT01498887|451584810|FG000|Overall Study|Abnormal result from test procedure|1|||
125198840|NCT03558152|450351016|FG002|Overall Study|Mistake in calculation|0|||
125198841|NCT03558152|450351017|FG003|Overall Study|Mistake in calculation|1|||
125198842|NCT03558152|450351018|FG004|Overall Study|Mistake in calculation|0|||
125198843|NCT03558152|450351019|FG005|Overall Study|Mistake in calculation|0|||
125198844|NCT03558152|450351020|FG006|Overall Study|Mistake in calculation|0|||
125198845|NCT03558152|450351021|FG007|Overall Study|Mistake in calculation|0|||
125198846|NCT03558152|450351014|FG000|Overall Study|Mistake in evaluation of disease status|0|||
125198847|NCT03558152|450351015|FG001|Overall Study|Mistake in evaluation of disease status|0|||
125198848|NCT03558152|450351016|FG002|Overall Study|Mistake in evaluation of disease status|0|||
125198849|NCT03558152|450351017|FG003|Overall Study|Mistake in evaluation of disease status|0|||
125198850|NCT03558152|450351018|FG004|Overall Study|Mistake in evaluation of disease status|0|||
125198851|NCT03558152|450351019|FG005|Overall Study|Mistake in evaluation of disease status|0|||
125198852|NCT03558152|450351020|FG006|Overall Study|Mistake in evaluation of disease status|0|||
125198853|NCT03558152|450351021|FG007|Overall Study|Mistake in evaluation of disease status|1|||
125198854|NCT03558152|450351014|FG000|Overall Study|Physician Decision|0|||
125198855|NCT03558152|450351015|FG001|Overall Study|Physician Decision|0|||
125198856|NCT03558152|450351016|FG002|Overall Study|Physician Decision|0|||
125198857|NCT03558152|450351017|FG003|Overall Study|Physician Decision|0|||
125198858|NCT03558152|450351018|FG004|Overall Study|Physician Decision|0|||
125198859|NCT03558152|450351019|FG005|Overall Study|Physician Decision|0|||
125198860|NCT03558152|450351020|FG006|Overall Study|Physician Decision|1|||
125198861|NCT03558152|450351021|FG007|Overall Study|Physician Decision|0|||
125198862|NCT03558152|450351014|FG000|Overall Study|Withdrawal by Subject|2|||
125198863|NCT03558152|450351015|FG001|Overall Study|Withdrawal by Subject|3|||
125198864|NCT03558152|450351016|FG002|Overall Study|Withdrawal by Subject|2|||
125198865|NCT03558152|450351017|FG003|Overall Study|Withdrawal by Subject|1|||
125198866|NCT03558152|450351018|FG004|Overall Study|Withdrawal by Subject|1|||
125198867|NCT03558152|450351019|FG005|Overall Study|Withdrawal by Subject|1|||
125198868|NCT03558152|450351020|FG006|Overall Study|Withdrawal by Subject|3|||
125198869|NCT03558152|450351021|FG007|Overall Study|Withdrawal by Subject|2|||
125198870|NCT03558152|450351014|FG000|Overall Study|Lack of Efficacy|11|||
125198871|NCT03558152|450351015|FG001|Overall Study|Lack of Efficacy|11|||
125198872|NCT03558152|450351016|FG002|Overall Study|Lack of Efficacy|10|||
125198873|NCT03558152|450351017|FG003|Overall Study|Lack of Efficacy|11|||
125198874|NCT03558152|450351018|FG004|Overall Study|Lack of Efficacy|14|||
125198875|NCT03558152|450351019|FG005|Overall Study|Lack of Efficacy|12|||
125198876|NCT03558152|450351020|FG006|Overall Study|Lack of Efficacy|14|||
125198877|NCT03558152|450351021|FG007|Overall Study|Lack of Efficacy|13|||
125198878|NCT03558152|450351014|FG000|Overall Study|Protocol Violation|1|||
125198879|NCT03558152|450351015|FG001|Overall Study|Protocol Violation|1|||
125198880|NCT03558152|450351016|FG002|Overall Study|Protocol Violation|0|||
125198881|NCT03558152|450351017|FG003|Overall Study|Protocol Violation|1|||
125198882|NCT03558152|450351018|FG004|Overall Study|Protocol Violation|1|||
125198883|NCT03558152|450351019|FG005|Overall Study|Protocol Violation|0|||
125198884|NCT03558152|450351020|FG006|Overall Study|Protocol Violation|2|||
125198885|NCT03558152|450351021|FG007|Overall Study|Protocol Violation|0|||
125198886|NCT03693612|450351022|FG000|Overall Study|Lost to Follow-up|0|||
125198887|NCT03693612|450351023|FG001|Overall Study|Lost to Follow-up|0|||
125198888|NCT03693612|450351024|FG002|Overall Study|Lost to Follow-up|0|||
125198889|NCT03693612|450351025|FG003|Overall Study|Lost to Follow-up|0|||
125198890|NCT03693612|450351026|FG004|Overall Study|Lost to Follow-up|1|||
125198891|NCT03693612|450351027|FG005|Overall Study|Lost to Follow-up|0|||
125198892|NCT03693612|450351028|FG006|Overall Study|Lost to Follow-up|0|||
125198893|NCT03693612|450351022|FG000|Overall Study|Withdrawal by Subject|0|||
125198894|NCT03693612|450351023|FG001|Overall Study|Withdrawal by Subject|0|||
125198895|NCT03693612|450351024|FG002|Overall Study|Withdrawal by Subject|1|||
125198896|NCT03693612|450351025|FG003|Overall Study|Withdrawal by Subject|0|||
125198897|NCT03693612|450351026|FG004|Overall Study|Withdrawal by Subject|2|||
125198898|NCT03693612|450351027|FG005|Overall Study|Withdrawal by Subject|0|||
125198899|NCT03693612|450351028|FG006|Overall Study|Withdrawal by Subject|0|||
125198900|NCT03693612|450351022|FG000|Overall Study|Study Terminated by Sponsor|0|||
125198901|NCT03693612|450351023|FG001|Overall Study|Study Terminated by Sponsor|1|||
125198902|NCT03693612|450351024|FG002|Overall Study|Study Terminated by Sponsor|0|||
125198903|NCT03693612|450351025|FG003|Overall Study|Study Terminated by Sponsor|0|||
125198904|NCT03693612|450351026|FG004|Overall Study|Study Terminated by Sponsor|3|||
125198905|NCT03693612|450351027|FG005|Overall Study|Study Terminated by Sponsor|0|||
125198906|NCT03693612|450351028|FG006|Overall Study|Study Terminated by Sponsor|0|||
125198907|NCT05318092|450351031|FG000|Overall Study|Lost to Follow-up|3|||
125198908|NCT05318092|450351031|FG000|Overall Study|Withdrawal by Subject|1|||
125198909|NCT00601172|450351032|FG000|Overall Study|Adverse Event|43|||
125198910|NCT00601172|450351033|FG001|Overall Study|Adverse Event|32|||
125198911|NCT00601172|450351032|FG000|Overall Study|Lack of Efficacy|11|||
125198912|NCT00601172|450351033|FG001|Overall Study|Lack of Efficacy|12|||
125198913|NCT00601172|450351032|FG000|Overall Study|Protocol Violation|2|||
125198914|NCT00601172|450351033|FG001|Overall Study|Protocol Violation|5|||
125198915|NCT00601172|450351032|FG000|Overall Study|Lost to Follow-up|4|||
125198916|NCT00601172|450351033|FG001|Overall Study|Lost to Follow-up|3|||
125198917|NCT00601172|450351032|FG000|Overall Study|Physician Decision|27|||
125198918|NCT00601172|450351033|FG001|Overall Study|Physician Decision|28|||
125198919|NCT00601172|450351032|FG000|Overall Study|Withdrawal by Subject|35|||
125198920|NCT00601172|450351033|FG001|Overall Study|Withdrawal by Subject|27|||
125198921|NCT00601172|450351032|FG000|Overall Study|Did not meet continuation criteria|19|||
125198922|NCT00601172|450351033|FG001|Overall Study|Did not meet continuation criteria|20|||
125198923|NCT03030989|450351037|FG000|Overall Study|Fever|2|||
125198924|NCT03030989|450351038|FG001|Overall Study|Fever|2|||
125198925|NCT03030989|450351037|FG000|Overall Study|Rash|2|||
125198926|NCT03030989|450351038|FG001|Overall Study|Rash|1|||
125533711|NCT01498887|451584811|FG001|Overall Study|Abnormal result from test procedure|1|||
125533712|NCT01498887|451584810|FG000|Overall Study|Abnormal laboratory value|2|||
125533713|NCT01498887|451584811|FG001|Overall Study|Abnormal laboratory value|2|||
125533714|NCT01498887|451584810|FG000|Overall Study|Adverse Event|4|||
125533715|NCT01498887|451584811|FG001|Overall Study|Adverse Event|1|||
125533716|NCT00667225|451584814|FG000|Overall Study|Subject had no more lesions to treat.|1|||
125533717|NCT00667225|451584815|FG001|Overall Study|Subject had no more lesions to treat.|0|||
125533718|NCT00667225|451584814|FG000|Overall Study|Lost to Follow-up|0|||
125533719|NCT00667225|451584815|FG001|Overall Study|Lost to Follow-up|1|||
125533720|NCT02993406|451584816|FG000|Overall Study|Withdrawal by Subject|170|||
125533721|NCT02993406|451584817|FG001|Overall Study|Withdrawal by Subject|196|||
125533722|NCT02993406|451584816|FG000|Overall Study|Physician Decision|3|||
125533723|NCT02993406|451584817|FG001|Overall Study|Physician Decision|5|||
125533724|NCT02993406|451584816|FG000|Overall Study|Lost to Follow-up|12|||
125533725|NCT02993406|451584817|FG001|Overall Study|Lost to Follow-up|13|||
125533726|NCT02993406|451584816|FG000|Overall Study|Unclassifiable Response|105|||
125533727|NCT02993406|451584817|FG001|Overall Study|Unclassifiable Response|139|||
125533728|NCT02993406|451584816|FG000|Overall Study|Administrative decision|1|||
125533729|NCT02993406|451584817|FG001|Overall Study|Administrative decision|0|||
125533730|NCT02993406|451584816|FG000|Overall Study|Sponsor decision|4|||
125533731|NCT02993406|451584817|FG001|Overall Study|Sponsor decision|5|||
125533732|NCT02248818|451584818|FG000|Screening|Protocol Violation|0|||
125533733|NCT02248818|451584819|FG001|Screening|Protocol Violation|0|||
125533734|NCT02248818|451584820|FG002|Screening|Protocol Violation|0|||
125533735|NCT02248818|451584821|FG003|Screening|Protocol Violation|0|||
125533736|NCT02248818|451584822|FG004|Screening|Protocol Violation|0|||
125533737|NCT02248818|451584823|FG005|Screening|Protocol Violation|0|||
125533738|NCT02248818|451584824|FG006|Screening|Protocol Violation|0|||
125533739|NCT02248818|451584825|FG007|Screening|Protocol Violation|0|||
125533740|NCT02248818|451584826|FG008|Screening|Protocol Violation|7|||
125533741|NCT02248818|451584818|FG000|Screening|Study fully enrolled|0|||
125533742|NCT02248818|451584819|FG001|Screening|Study fully enrolled|0|||
125533743|NCT02248818|451584820|FG002|Screening|Study fully enrolled|0|||
125533744|NCT02248818|451584821|FG003|Screening|Study fully enrolled|0|||
125533745|NCT02248818|451584822|FG004|Screening|Study fully enrolled|0|||
125533746|NCT02248818|451584823|FG005|Screening|Study fully enrolled|0|||
125533747|NCT02248818|451584824|FG006|Screening|Study fully enrolled|0|||
125533748|NCT02248818|451584825|FG007|Screening|Study fully enrolled|0|||
125533749|NCT02248818|451584826|FG008|Screening|Study fully enrolled|14|||
125533750|NCT02248818|451584818|FG000|Screening|Physician Decision|0|||
125533751|NCT02248818|451584819|FG001|Screening|Physician Decision|0|||
125533752|NCT02248818|451584820|FG002|Screening|Physician Decision|0|||
125533753|NCT02248818|451584821|FG003|Screening|Physician Decision|0|||
125533754|NCT02248818|451584822|FG004|Screening|Physician Decision|0|||
125198927|NCT03030989|450351037|FG000|Overall Study|Fatigue/Overwhelmed|1|||
125198928|NCT03030989|450351038|FG001|Overall Study|Fatigue/Overwhelmed|5|||
125198929|NCT03030989|450351037|FG000|Overall Study|Positive Blood Cultures|2|||
125198930|NCT03030989|450351038|FG001|Overall Study|Positive Blood Cultures|1|||
125198931|NCT03030989|450351037|FG000|Overall Study|Line Removed|0|||
125198932|NCT03030989|450351038|FG001|Overall Study|Line Removed|2|||
125198933|NCT03030989|450351037|FG000|Overall Study|No longer interested|5|||
125198934|NCT03030989|450351038|FG001|Overall Study|No longer interested|3|||
125533755|NCT02248818|451584823|FG005|Screening|Physician Decision|0|||
125533756|NCT02248818|451584824|FG006|Screening|Physician Decision|0|||
125533757|NCT02248818|451584825|FG007|Screening|Physician Decision|0|||
125533758|NCT02248818|451584826|FG008|Screening|Physician Decision|73|||
125533759|NCT02248818|451584818|FG000|Screening|Withdrawal by Subject|0|||
125533760|NCT02248818|451584819|FG001|Screening|Withdrawal by Subject|0|||
125533761|NCT02248818|451584820|FG002|Screening|Withdrawal by Subject|0|||
125533762|NCT02248818|451584821|FG003|Screening|Withdrawal by Subject|0|||
125533763|NCT02248818|451584822|FG004|Screening|Withdrawal by Subject|0|||
125533764|NCT02248818|451584823|FG005|Screening|Withdrawal by Subject|0|||
125533765|NCT02248818|451584824|FG006|Screening|Withdrawal by Subject|0|||
125533766|NCT02248818|451584825|FG007|Screening|Withdrawal by Subject|0|||
125533767|NCT02248818|451584826|FG008|Screening|Withdrawal by Subject|6|||
125533768|NCT02248818|451584818|FG000|Screening|Lost to Follow-up|0|||
125533769|NCT02248818|451584819|FG001|Screening|Lost to Follow-up|0|||
125533770|NCT02248818|451584820|FG002|Screening|Lost to Follow-up|0|||
125533771|NCT02248818|451584821|FG003|Screening|Lost to Follow-up|0|||
125198935|NCT03917472|450351039|FG000|Overall Study|Physician Decision|4|||
125198936|NCT03917472|450351040|FG001|Overall Study|Physician Decision|0|||
125198937|NCT03917472|450351039|FG000|Overall Study|Adverse Event|3|||
125198938|NCT03917472|450351040|FG001|Overall Study|Adverse Event|1|||
125198939|NCT03917472|450351039|FG000|Overall Study|Death|7|||
125198940|NCT03917472|450351040|FG001|Overall Study|Death|5|||
125198941|NCT03917472|450351039|FG000|Overall Study|Withdrawal by Subject|11|||
125198942|NCT03917472|450351040|FG001|Overall Study|Withdrawal by Subject|4|||
125198943|NCT03917472|450351039|FG000|Overall Study|Lost to Follow-up|10|||
125198944|NCT03917472|450351040|FG001|Overall Study|Lost to Follow-up|5|||
125198945|NCT02706886|450351041|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
125198946|NCT02706886|450351042|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
125198947|NCT02706886|450351043|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
125198948|NCT02706886|450351044|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
125198949|NCT02706886|450351045|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
125198950|NCT02706886|450351046|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
125198951|NCT02706886|450351047|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
125198952|NCT02706886|450351048|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
125533772|NCT02248818|451584822|FG004|Screening|Lost to Follow-up|0|||
125533773|NCT02248818|451584823|FG005|Screening|Lost to Follow-up|0|||
125533774|NCT02248818|451584824|FG006|Screening|Lost to Follow-up|0|||
125533775|NCT02248818|451584825|FG007|Screening|Lost to Follow-up|0|||
125533776|NCT02248818|451584826|FG008|Screening|Lost to Follow-up|7|||
125533777|NCT02248818|451584818|FG000|Randomised Study|Administrative - randomization error|0|||
125533778|NCT02248818|451584819|FG001|Randomised Study|Administrative - randomization error|0|||
125533779|NCT02248818|451584820|FG002|Randomised Study|Administrative - randomization error|0|||
125533780|NCT02248818|451584821|FG003|Randomised Study|Administrative - randomization error|0|||
125533781|NCT02248818|451584822|FG004|Randomised Study|Administrative - randomization error|0|||
125533782|NCT02248818|451584823|FG005|Randomised Study|Administrative - randomization error|8|||
125533783|NCT02248818|451584824|FG006|Randomised Study|Administrative - randomization error|0|||
125533784|NCT02248818|451584825|FG007|Randomised Study|Administrative - randomization error|0|||
125533785|NCT02248818|451584826|FG008|Randomised Study|Administrative - randomization error|0|||
125533786|NCT05262517|451584827|FG000|Overall Study|Randomized but not treated|5|||
125533787|NCT05262517|451584828|FG001|Overall Study|Randomized but not treated|11|||
125533788|NCT04325282|451584829|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
125533789|NCT04325282|451584830|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
125533790|NCT04325282|451584829|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
125533791|NCT04325282|451584830|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
125533792|NCT00527787|451584832|FG000|Overall Study|Adverse Event|14|||
125533793|NCT00527787|451584833|FG001|Overall Study|Adverse Event|24|||
125533794|NCT00527787|451584832|FG000|Overall Study|Withdrawal by Subject|13|||
125533795|NCT00527787|451584833|FG001|Overall Study|Withdrawal by Subject|25|||
125533796|NCT00527787|451584832|FG000|Overall Study|Lost to Follow-up|5|||
125533797|NCT00527787|451584833|FG001|Overall Study|Lost to Follow-up|2|||
125533798|NCT00527787|451584832|FG000|Overall Study|Duodenal Ulcer|1|||
125533799|NCT00527787|451584833|FG001|Overall Study|Duodenal Ulcer|10|||
125533800|NCT00527787|451584832|FG000|Overall Study|misc|5|||
125533801|NCT00527787|451584833|FG001|Overall Study|misc|2|||
125533802|NCT03330405|451584834|FG000|Overall Study|Other|1|||
125533803|NCT03330405|451584835|FG001|Overall Study|Other|3|||
125533804|NCT03330405|451584836|FG002|Overall Study|Other|1|||
125533805|NCT03330405|451584837|FG003|Overall Study|Other|0|||
125533806|NCT03330405|451584838|FG004|Overall Study|Other|2|||
125533807|NCT03330405|451584839|FG005|Overall Study|Other|0|||
125533808|NCT03330405|451584840|FG006|Overall Study|Other|1|||
125533809|NCT03330405|451584841|FG007|Overall Study|Other|0|||
125533810|NCT03330405|451584842|FG008|Overall Study|Other|0|||
125533811|NCT03330405|451584843|FG009|Overall Study|Other|0|||
125533812|NCT03330405|451584844|FG010|Overall Study|Other|0|||
125533813|NCT03330405|451584834|FG000|Overall Study|Progressive disease|8|||
125533814|NCT03330405|451584835|FG001|Overall Study|Progressive disease|27|||
125533815|NCT03330405|451584836|FG002|Overall Study|Progressive disease|4|||
125533816|NCT03330405|451584837|FG003|Overall Study|Progressive disease|18|||
125533817|NCT03330405|451584838|FG004|Overall Study|Progressive disease|16|||
125533818|NCT03330405|451584839|FG005|Overall Study|Progressive disease|14|||
125533819|NCT03330405|451584840|FG006|Overall Study|Progressive disease|7|||
125533820|NCT03330405|451584841|FG007|Overall Study|Progressive disease|29|||
125533821|NCT03330405|451584842|FG008|Overall Study|Progressive disease|9|||
125533822|NCT03330405|451584843|FG009|Overall Study|Progressive disease|11|||
125198953|NCT02706886|450351049|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
125198954|NCT04434469|450351056|FG000|Overall Study|Death|2|||
125198955|NCT04434469|450351057|FG001|Overall Study|Death|3|||
125198956|NCT04434469|450351058|FG002|Overall Study|Death|2|||
125198957|NCT04434469|450351059|FG003|Overall Study|Death|2|||
125533823|NCT03330405|451584844|FG010|Overall Study|Progressive disease|5|||
125533824|NCT03330405|451584834|FG000|Overall Study|Withdrawal by Subject|1|||
125533825|NCT03330405|451584835|FG001|Overall Study|Withdrawal by Subject|4|||
125533826|NCT03330405|451584836|FG002|Overall Study|Withdrawal by Subject|0|||
125533827|NCT03330405|451584837|FG003|Overall Study|Withdrawal by Subject|1|||
125533828|NCT03330405|451584838|FG004|Overall Study|Withdrawal by Subject|1|||
125533829|NCT03330405|451584839|FG005|Overall Study|Withdrawal by Subject|1|||
125533830|NCT03330405|451584840|FG006|Overall Study|Withdrawal by Subject|0|||
125533831|NCT03330405|451584841|FG007|Overall Study|Withdrawal by Subject|2|||
125533832|NCT03330405|451584842|FG008|Overall Study|Withdrawal by Subject|2|||
125533833|NCT03330405|451584843|FG009|Overall Study|Withdrawal by Subject|1|||
125533834|NCT03330405|451584844|FG010|Overall Study|Withdrawal by Subject|1|||
125533835|NCT03330405|451584834|FG000|Overall Study|Global deterioration of health status|2|||
125533836|NCT03330405|451584835|FG001|Overall Study|Global deterioration of health status|3|||
125533837|NCT03330405|451584836|FG002|Overall Study|Global deterioration of health status|0|||
125533838|NCT03330405|451584837|FG003|Overall Study|Global deterioration of health status|2|||
125533839|NCT03330405|451584838|FG004|Overall Study|Global deterioration of health status|3|||
125533840|NCT03330405|451584839|FG005|Overall Study|Global deterioration of health status|3|||
125533841|NCT03330405|451584840|FG006|Overall Study|Global deterioration of health status|0|||
125533842|NCT03330405|451584841|FG007|Overall Study|Global deterioration of health status|2|||
125533843|NCT03330405|451584842|FG008|Overall Study|Global deterioration of health status|8|||
125533844|NCT03330405|451584843|FG009|Overall Study|Global deterioration of health status|4|||
125533845|NCT03330405|451584844|FG010|Overall Study|Global deterioration of health status|1|||
125533846|NCT03330405|451584834|FG000|Overall Study|Adverse Event|0|||
125533847|NCT03330405|451584835|FG001|Overall Study|Adverse Event|1|||
125533848|NCT03330405|451584836|FG002|Overall Study|Adverse Event|0|||
125533849|NCT03330405|451584837|FG003|Overall Study|Adverse Event|1|||
125533850|NCT03330405|451584838|FG004|Overall Study|Adverse Event|1|||
125533851|NCT03330405|451584839|FG005|Overall Study|Adverse Event|1|||
125533852|NCT03330405|451584840|FG006|Overall Study|Adverse Event|3|||
125533853|NCT03330405|451584841|FG007|Overall Study|Adverse Event|4|||
125533854|NCT03330405|451584842|FG008|Overall Study|Adverse Event|2|||
125533855|NCT03330405|451584843|FG009|Overall Study|Adverse Event|2|||
125533856|NCT03330405|451584844|FG010|Overall Study|Adverse Event|2|||
125533857|NCT03330405|451584834|FG000|Overall Study|Death|0|||
125533858|NCT03330405|451584835|FG001|Overall Study|Death|4|||
125533859|NCT03330405|451584836|FG002|Overall Study|Death|0|||
125533860|NCT03330405|451584837|FG003|Overall Study|Death|0|||
125533861|NCT03330405|451584838|FG004|Overall Study|Death|0|||
125533862|NCT03330405|451584839|FG005|Overall Study|Death|1|||
125533863|NCT03330405|451584840|FG006|Overall Study|Death|0|||
125533864|NCT03330405|451584841|FG007|Overall Study|Death|2|||
125533865|NCT03330405|451584842|FG008|Overall Study|Death|0|||
125533866|NCT03330405|451584843|FG009|Overall Study|Death|0|||
125533867|NCT03330405|451584844|FG010|Overall Study|Death|0|||
125533868|NCT03330405|451584834|FG000|Overall Study|Physician Decision|0|||
125533869|NCT03330405|451584835|FG001|Overall Study|Physician Decision|0|||
125533870|NCT03330405|451584836|FG002|Overall Study|Physician Decision|0|||
125533871|NCT03330405|451584837|FG003|Overall Study|Physician Decision|0|||
125533872|NCT03330405|451584838|FG004|Overall Study|Physician Decision|0|||
125533873|NCT03330405|451584839|FG005|Overall Study|Physician Decision|0|||
125533874|NCT03330405|451584840|FG006|Overall Study|Physician Decision|0|||
125533875|NCT03330405|451584841|FG007|Overall Study|Physician Decision|1|||
125533876|NCT03330405|451584842|FG008|Overall Study|Physician Decision|0|||
125533877|NCT03330405|451584843|FG009|Overall Study|Physician Decision|0|||
125533878|NCT03330405|451584844|FG010|Overall Study|Physician Decision|0|||
125533879|NCT02643303|451584845|FG000|Overall Study|Progressive Disease|4|||
125533880|NCT02643303|451584846|FG001|Overall Study|Progressive Disease|4|||
125533881|NCT02643303|451584847|FG002|Overall Study|Progressive Disease|1|||
125533882|NCT02643303|451584848|FG003|Overall Study|Progressive Disease|12|||
125533883|NCT02643303|451584849|FG004|Overall Study|Progressive Disease|6|||
125533884|NCT02643303|451584850|FG005|Overall Study|Progressive Disease|4|||
125533885|NCT02643303|451584851|FG006|Overall Study|Progressive Disease|8|||
125533886|NCT02643303|451584852|FG007|Overall Study|Progressive Disease|2|||
125533887|NCT02643303|451584853|FG008|Overall Study|Progressive Disease|6|||
125533888|NCT02643303|451584845|FG000|Overall Study|Adverse Event|0|||
125533889|NCT02643303|451584846|FG001|Overall Study|Adverse Event|1|||
125533890|NCT02643303|451584847|FG002|Overall Study|Adverse Event|0|||
125533891|NCT02643303|451584848|FG003|Overall Study|Adverse Event|0|||
125533892|NCT02643303|451584849|FG004|Overall Study|Adverse Event|1|||
125533893|NCT02643303|451584850|FG005|Overall Study|Adverse Event|0|||
125533894|NCT02643303|451584851|FG006|Overall Study|Adverse Event|0|||
125533895|NCT02643303|451584852|FG007|Overall Study|Adverse Event|0|||
125198958|NCT04434469|450351060|FG004|Overall Study|Death|2|||
125533896|NCT02643303|451584853|FG008|Overall Study|Adverse Event|0|||
125533897|NCT02643303|451584845|FG000|Overall Study|Withdrawal by Subject|0|||
125533898|NCT02643303|451584846|FG001|Overall Study|Withdrawal by Subject|0|||
125533899|NCT02643303|451584847|FG002|Overall Study|Withdrawal by Subject|0|||
125533900|NCT02643303|451584848|FG003|Overall Study|Withdrawal by Subject|1|||
125533901|NCT02643303|451584849|FG004|Overall Study|Withdrawal by Subject|0|||
125533902|NCT02643303|451584850|FG005|Overall Study|Withdrawal by Subject|0|||
125198959|NCT04434469|450351061|FG005|Overall Study|Death|0|||
125533903|NCT02643303|451584851|FG006|Overall Study|Withdrawal by Subject|1|||
125533904|NCT02643303|451584852|FG007|Overall Study|Withdrawal by Subject|1|||
125533905|NCT02643303|451584853|FG008|Overall Study|Withdrawal by Subject|1|||
125533906|NCT02383940|451584856|FG000|Overall Study|Adverse Event|1|||
125533907|NCT02383940|451584857|FG001|Overall Study|Adverse Event|0|||
125533908|NCT02383940|451584856|FG000|Overall Study|Lost to Follow-up|2|||
125533909|NCT02383940|451584857|FG001|Overall Study|Lost to Follow-up|2|||
125533910|NCT02383940|451584856|FG000|Overall Study|Physician Decision|2|||
125533911|NCT02383940|451584857|FG001|Overall Study|Physician Decision|0|||
125533912|NCT02383940|451584856|FG000|Overall Study|Withdrawal by Subject|1|||
125533913|NCT02383940|451584857|FG001|Overall Study|Withdrawal by Subject|1|||
125533914|NCT02383940|451584856|FG000|Overall Study|Randomized but not treated|2|||
125533915|NCT02383940|451584857|FG001|Overall Study|Randomized but not treated|0|||
125533916|NCT02383940|451584856|FG000|Overall Study|Other than specified above|1|||
125533917|NCT02383940|451584857|FG001|Overall Study|Other than specified above|0|||
125533918|NCT02672852|451584859|FG000|Part A1|Disease Worsening|1|||
125533919|NCT02672852|451584860|FG001|Part A1|Disease Worsening|0|||
125533920|NCT02672852|451584861|FG002|Part A1|Disease Worsening|0|||
125533921|NCT02672852|451584862|FG003|Part A1|Disease Worsening|0|||
125533922|NCT02672852|451584863|FG004|Part A1|Disease Worsening|0|||
125533923|NCT02672852|451584864|FG005|Part A1|Disease Worsening|0|||
125533924|NCT02672852|451584865|FG006|Part A1|Disease Worsening|0|||
125533925|NCT02672852|451584859|FG000|Part A1|Adverse Event|0|||
125533926|NCT02672852|451584860|FG001|Part A1|Adverse Event|1|||
125533927|NCT02672852|451584861|FG002|Part A1|Adverse Event|0|||
125533928|NCT02672852|451584862|FG003|Part A1|Adverse Event|0|||
125533929|NCT02672852|451584863|FG004|Part A1|Adverse Event|0|||
125533930|NCT02672852|451584864|FG005|Part A1|Adverse Event|0|||
125533931|NCT02672852|451584865|FG006|Part A1|Adverse Event|0|||
125533932|NCT02672852|451584859|FG000|Part A1|Lost to Follow-up|1|||
125533933|NCT02672852|451584860|FG001|Part A1|Lost to Follow-up|2|||
125533934|NCT02672852|451584861|FG002|Part A1|Lost to Follow-up|0|||
125533935|NCT02672852|451584862|FG003|Part A1|Lost to Follow-up|0|||
125533936|NCT02672852|451584863|FG004|Part A1|Lost to Follow-up|0|||
125533937|NCT02672852|451584864|FG005|Part A1|Lost to Follow-up|0|||
125533938|NCT02672852|451584865|FG006|Part A1|Lost to Follow-up|0|||
125533939|NCT02672852|451584859|FG000|Part A1|Withdrawal by Subject|1|||
125533940|NCT02672852|451584860|FG001|Part A1|Withdrawal by Subject|1|||
125533941|NCT02672852|451584861|FG002|Part A1|Withdrawal by Subject|0|||
125533942|NCT02672852|451584862|FG003|Part A1|Withdrawal by Subject|0|||
125533943|NCT02672852|451584863|FG004|Part A1|Withdrawal by Subject|0|||
125533944|NCT02672852|451584864|FG005|Part A1|Withdrawal by Subject|0|||
125533945|NCT02672852|451584865|FG006|Part A1|Withdrawal by Subject|0|||
125533946|NCT02672852|451584859|FG000|Part A2|Disease worsening|0|||
125533947|NCT02672852|451584860|FG001|Part A2|Disease worsening|0|||
125533948|NCT02672852|451584861|FG002|Part A2|Disease worsening|1|||
125533949|NCT02672852|451584862|FG003|Part A2|Disease worsening|0|||
125533950|NCT02672852|451584863|FG004|Part A2|Disease worsening|0|||
125533951|NCT02672852|451584864|FG005|Part A2|Disease worsening|0|||
125533952|NCT02672852|451584865|FG006|Part A2|Disease worsening|0|||
125533953|NCT02672852|451584859|FG000|Part A2|Adverse Event|0|||
125533954|NCT02672852|451584860|FG001|Part A2|Adverse Event|0|||
125533955|NCT02672852|451584861|FG002|Part A2|Adverse Event|3|||
125533956|NCT02672852|451584862|FG003|Part A2|Adverse Event|0|||
125533957|NCT02672852|451584863|FG004|Part A2|Adverse Event|0|||
125533958|NCT02672852|451584864|FG005|Part A2|Adverse Event|0|||
125533959|NCT02672852|451584865|FG006|Part A2|Adverse Event|0|||
125533960|NCT02672852|451584859|FG000|Part A2|Lost to Follow-up|0|||
125533961|NCT02672852|451584860|FG001|Part A2|Lost to Follow-up|0|||
125533962|NCT02672852|451584861|FG002|Part A2|Lost to Follow-up|2|||
125533963|NCT02672852|451584862|FG003|Part A2|Lost to Follow-up|0|||
125533964|NCT02672852|451584863|FG004|Part A2|Lost to Follow-up|0|||
125533965|NCT02672852|451584864|FG005|Part A2|Lost to Follow-up|0|||
125533966|NCT02672852|451584865|FG006|Part A2|Lost to Follow-up|0|||
125533967|NCT02672852|451584859|FG000|Part A2|Withdrawal by Subject|0|||
125533968|NCT02672852|451584860|FG001|Part A2|Withdrawal by Subject|0|||
125533969|NCT02672852|451584861|FG002|Part A2|Withdrawal by Subject|1|||
125533970|NCT02672852|451584862|FG003|Part A2|Withdrawal by Subject|0|||
125533971|NCT02672852|451584863|FG004|Part A2|Withdrawal by Subject|0|||
125533972|NCT02672852|451584864|FG005|Part A2|Withdrawal by Subject|0|||
125533973|NCT02672852|451584865|FG006|Part A2|Withdrawal by Subject|0|||
125533974|NCT02672852|451584859|FG000|Part A2|Other|0|||
125533975|NCT02672852|451584860|FG001|Part A2|Other|0|||
125533976|NCT02672852|451584861|FG002|Part A2|Other|3|||
125533977|NCT02672852|451584862|FG003|Part A2|Other|0|||
125533978|NCT02672852|451584863|FG004|Part A2|Other|0|||
125198960|NCT04434469|450351056|FG000|Overall Study|Lost to Follow-up|0|||
125533979|NCT02672852|451584864|FG005|Part A2|Other|0|||
125533980|NCT02672852|451584865|FG006|Part A2|Other|0|||
125533981|NCT02672852|451584859|FG000|Part A2|Not entered in Part B|0|||
125533982|NCT02672852|451584860|FG001|Part A2|Not entered in Part B|0|||
125533983|NCT02672852|451584861|FG002|Part A2|Not entered in Part B|0|||
125533984|NCT02672852|451584862|FG003|Part A2|Not entered in Part B|4|||
125533985|NCT02672852|451584863|FG004|Part A2|Not entered in Part B|0|||
125533986|NCT02672852|451584864|FG005|Part A2|Not entered in Part B|0|||
125533987|NCT02672852|451584865|FG006|Part A2|Not entered in Part B|0|||
125533988|NCT02672852|451584859|FG000|Part B|Disease worsening|0|||
125533989|NCT02672852|451584860|FG001|Part B|Disease worsening|0|||
125533990|NCT02672852|451584861|FG002|Part B|Disease worsening|0|||
125533991|NCT02672852|451584862|FG003|Part B|Disease worsening|0|||
125533992|NCT02672852|451584863|FG004|Part B|Disease worsening|1|||
125533993|NCT02672852|451584864|FG005|Part B|Disease worsening|0|||
125533994|NCT02672852|451584865|FG006|Part B|Disease worsening|1|||
125533995|NCT02672852|451584859|FG000|Part B|Worsening pre-existing condition|0|||
125533996|NCT02672852|451584860|FG001|Part B|Worsening pre-existing condition|0|||
125533997|NCT02672852|451584861|FG002|Part B|Worsening pre-existing condition|0|||
125533998|NCT02672852|451584862|FG003|Part B|Worsening pre-existing condition|0|||
125533999|NCT02672852|451584863|FG004|Part B|Worsening pre-existing condition|0|||
125534000|NCT02672852|451584864|FG005|Part B|Worsening pre-existing condition|1|||
125534001|NCT02672852|451584865|FG006|Part B|Worsening pre-existing condition|0|||
125534002|NCT02672852|451584859|FG000|Part B|Other adverse event|0|||
125534003|NCT02672852|451584860|FG001|Part B|Other adverse event|0|||
125534004|NCT02672852|451584861|FG002|Part B|Other adverse event|0|||
125534005|NCT02672852|451584862|FG003|Part B|Other adverse event|0|||
125534006|NCT02672852|451584863|FG004|Part B|Other adverse event|3|||
125534007|NCT02672852|451584864|FG005|Part B|Other adverse event|5|||
125534008|NCT02672852|451584865|FG006|Part B|Other adverse event|1|||
125534009|NCT02672852|451584859|FG000|Part B|Lost to Follow-up|0|||
125534010|NCT02672852|451584860|FG001|Part B|Lost to Follow-up|0|||
125534011|NCT02672852|451584861|FG002|Part B|Lost to Follow-up|0|||
125534012|NCT02672852|451584862|FG003|Part B|Lost to Follow-up|0|||
125534013|NCT02672852|451584863|FG004|Part B|Lost to Follow-up|3|||
125534014|NCT02672852|451584864|FG005|Part B|Lost to Follow-up|4|||
125534015|NCT02672852|451584865|FG006|Part B|Lost to Follow-up|1|||
125534016|NCT02672852|451584859|FG000|Part B|Withdrawal by Subject|0|||
125534017|NCT02672852|451584860|FG001|Part B|Withdrawal by Subject|0|||
125534018|NCT02672852|451584861|FG002|Part B|Withdrawal by Subject|0|||
125534019|NCT02672852|451584862|FG003|Part B|Withdrawal by Subject|0|||
125534020|NCT02672852|451584863|FG004|Part B|Withdrawal by Subject|5|||
125534021|NCT02672852|451584864|FG005|Part B|Withdrawal by Subject|0|||
125534022|NCT02672852|451584865|FG006|Part B|Withdrawal by Subject|7|||
125534023|NCT02672852|451584859|FG000|Part B|Other|0|||
125534024|NCT02672852|451584860|FG001|Part B|Other|0|||
125534025|NCT02672852|451584861|FG002|Part B|Other|0|||
125534026|NCT02672852|451584862|FG003|Part B|Other|0|||
125534027|NCT02672852|451584863|FG004|Part B|Other|4|||
125534028|NCT02672852|451584864|FG005|Part B|Other|1|||
125534029|NCT02672852|451584865|FG006|Part B|Other|2|||
125534030|NCT04308590|451584866|FG000|Overall Study|Adverse Event|12|||
125534031|NCT04308590|451584867|FG001|Overall Study|Adverse Event|2|||
125534032|NCT04308590|451584866|FG000|Overall Study|Withdrawal by Subject|10|||
125534033|NCT04308590|451584867|FG001|Overall Study|Withdrawal by Subject|4|||
125534034|NCT04308590|451584866|FG000|Overall Study|Death|1|||
125534035|NCT04308590|451584867|FG001|Overall Study|Death|0|||
125534036|NCT04308590|451584866|FG000|Overall Study|Lost to Follow-up|1|||
125534037|NCT04308590|451584867|FG001|Overall Study|Lost to Follow-up|1|||
125534038|NCT04308590|451584866|FG000|Overall Study|Physician Decision|1|||
125534039|NCT04308590|451584867|FG001|Overall Study|Physician Decision|0|||
125534040|NCT04308590|451584866|FG000|Overall Study|Subject does not want to continue with Pi|0|||
125534041|NCT04308590|451584867|FG001|Overall Study|Subject does not want to continue with Pi|1|||
125534042|NCT05487586|451584868|FG000|Overall Study|Death|22|||
125534043|NCT05487586|451584868|FG000|Overall Study|Physician Decision|1|||
125534044|NCT05487586|451584868|FG000|Overall Study|Transfer to another hospital|4|||
125534045|NCT05487586|451584868|FG000|Overall Study|Other|1|||
125534046|NCT04798781|451584869|FG000|Overall Study|Withdrawal by Subject|1|||
125534047|NCT02175641|451584871|FG000|Overall Study|Death|3|||
125534048|NCT02175641|451584872|FG001|Overall Study|Death|4|||
125534049|NCT02175641|451584871|FG000|Overall Study|Lost to Follow-up|4|||
125534050|NCT02175641|451584872|FG001|Overall Study|Lost to Follow-up|4|||
125534051|NCT02175641|451584871|FG000|Overall Study|Withdrawal by Subject|7|||
125534052|NCT02175641|451584872|FG001|Overall Study|Withdrawal by Subject|4|||
125534053|NCT02175641|451584871|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
125534054|NCT02175641|451584872|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
125534055|NCT02175641|451584871|FG000|Overall Study|Developed Contraindicated Condition|8|||
125534056|NCT02175641|451584872|FG001|Overall Study|Developed Contraindicated Condition|0|||
125534057|NCT03921723|451584873|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
125534058|NCT03921723|451584873|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
125422470|NCT01152580|451172843|FG001|Overall Study|Withdrawal by Subject|1|||
125534059|NCT01598662|451584874|FG000|Overall Study|Lost to Follow-up|10|||
125534060|NCT01598662|451584875|FG001|Overall Study|Lost to Follow-up|17|||
125422471|NCT03364751|451172844|FG000|Overall Study|Withdrawal by Subject|1|||
125534061|NCT01598662|451584874|FG000|Overall Study|Physician Decision|1|||
125534062|NCT01598662|451584875|FG001|Overall Study|Physician Decision|2|||
125534063|NCT01598662|451584874|FG000|Overall Study|IUD expelled before month 6|0|||
125534064|NCT01598662|451584875|FG001|Overall Study|IUD expelled before month 6|2|||
125534065|NCT02683785|451584876|FG000|Overall Study|Withdrawal by Subject|1|||
125534066|NCT02683785|451584877|FG001|Overall Study|Withdrawal by Subject|1|||
125534067|NCT02683785|451584876|FG000|Overall Study|Lost to Follow-up|0|||
125534068|NCT02683785|451584877|FG001|Overall Study|Lost to Follow-up|1|||
125534069|NCT02683785|451584876|FG000|Overall Study|Adverse Event|0|||
125534070|NCT02683785|451584877|FG001|Overall Study|Adverse Event|2|||
125534071|NCT02233803|451584882|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
125534072|NCT02233803|451584883|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
125534073|NCT02233803|451584882|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
125644856|NCT01070381|451982129|FG001|Period 2, 1 Week of Wear|Handling|1|||
125644857|NCT01070381|451982128|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
125644858|NCT01070381|451982129|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
125644859|NCT03512028|451982131|FG000|Overall Study|Withdrawal by Subject|2|||
125644860|NCT03512028|451982132|FG001|Overall Study|Withdrawal by Subject|0|||
125644861|NCT03512028|451982131|FG000|Overall Study|Protocol Violation|2|||
125644862|NCT03512028|451982132|FG001|Overall Study|Protocol Violation|0|||
125644863|NCT01259388|451982133|FG000|Overall Study|Adverse Event|3|||
125644864|NCT01259388|451982134|FG001|Overall Study|Adverse Event|0|||
125644865|NCT01259388|451982133|FG000|Overall Study|Withdrawal by Subject|1|||
125644866|NCT01259388|451982134|FG001|Overall Study|Withdrawal by Subject|1|||
125644867|NCT01259388|451982133|FG000|Overall Study|Physician Decision|1|||
125644868|NCT01259388|451982134|FG001|Overall Study|Physician Decision|0|||
125644869|NCT02743494|451982137|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
125644870|NCT02743494|451982138|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
125644871|NCT02743494|451982137|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
125644872|NCT02743494|451982138|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
125644873|NCT02743494|451982137|FG000|Treatment Period|Completed treatment|229|||
125644874|NCT02743494|451982138|FG001|Treatment Period|Completed treatment|99|||
125644875|NCT02743494|451982137|FG000|Treatment Period|Disease recurrence|149|||
125644876|NCT02743494|451982138|FG001|Treatment Period|Disease recurrence|113|||
125644877|NCT02743494|451982137|FG000|Treatment Period|Study drug toxicity|57|||
125644878|NCT02743494|451982138|FG001|Treatment Period|Study drug toxicity|8|||
125644879|NCT02743494|451982137|FG000|Treatment Period|Death|1|||
125644880|NCT02743494|451982138|FG001|Treatment Period|Death|0|||
125644881|NCT02743494|451982137|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
125644882|NCT02743494|451982138|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
125644883|NCT02743494|451982137|FG000|Treatment Period|Participant request to discontinue treatment|30|||
125644884|NCT02743494|451982138|FG001|Treatment Period|Participant request to discontinue treatment|5|||
125644885|NCT02743494|451982137|FG000|Treatment Period|Participant withdrew consent|12|||
125644886|NCT02743494|451982138|FG001|Treatment Period|Participant withdrew consent|4|||
125644887|NCT02743494|451982137|FG000|Treatment Period|Lost to Follow-up|0|||
125644888|NCT02743494|451982138|FG001|Treatment Period|Lost to Follow-up|1|||
125644889|NCT02743494|451982137|FG000|Treatment Period|Poor/Non-compliance|1|||
125644890|NCT02743494|451982138|FG001|Treatment Period|Poor/Non-compliance|0|||
125644891|NCT02743494|451982137|FG000|Treatment Period|Other reasons|7|||
125644892|NCT02743494|451982138|FG001|Treatment Period|Other reasons|2|||
125644893|NCT03529162|451982139|FG000|Overall Study|Lost to Follow-up|2|||
125644894|NCT03529162|451982140|FG001|Overall Study|Lost to Follow-up|2|||
125644895|NCT00983827|451982141|FG000|Overall Study|Withdrawal by Subject|1|||
125644896|NCT01521494|451982142|FG000|Overall Study|Adverse Event|1|||
125644897|NCT01521494|451982143|FG001|Overall Study|Adverse Event|2|||
125644898|NCT01521494|451982144|FG002|Overall Study|Adverse Event|9|||
125644899|NCT01521494|451982145|FG003|Overall Study|Adverse Event|6|||
125644900|NCT01521494|451982146|FG004|Overall Study|Adverse Event|2|||
125644901|NCT01521494|451982142|FG000|Overall Study|Lack of Efficacy|0|||
125644902|NCT01521494|451982143|FG001|Overall Study|Lack of Efficacy|0|||
125644903|NCT01521494|451982144|FG002|Overall Study|Lack of Efficacy|0|||
125644904|NCT01521494|451982145|FG003|Overall Study|Lack of Efficacy|0|||
125644905|NCT01521494|451982146|FG004|Overall Study|Lack of Efficacy|2|||
125644906|NCT01521494|451982142|FG000|Overall Study|Withdrawal by Subject|1|||
125644907|NCT01521494|451982143|FG001|Overall Study|Withdrawal by Subject|1|||
125534074|NCT02233803|451584883|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
125534075|NCT02233803|451584882|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
125534076|NCT02233803|451584883|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
125534077|NCT02233803|451584882|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
125644908|NCT01521494|451982144|FG002|Overall Study|Withdrawal by Subject|0|||
125644909|NCT01521494|451982145|FG003|Overall Study|Withdrawal by Subject|2|||
125644910|NCT01521494|451982146|FG004|Overall Study|Withdrawal by Subject|0|||
125644911|NCT01521494|451982142|FG000|Overall Study|Decrease in serum phosphate|0|||
125644912|NCT01521494|451982143|FG001|Overall Study|Decrease in serum phosphate|2|||
125644913|NCT01521494|451982144|FG002|Overall Study|Decrease in serum phosphate|3|||
125644914|NCT01521494|451982145|FG003|Overall Study|Decrease in serum phosphate|12|||
125644915|NCT01521494|451982146|FG004|Overall Study|Decrease in serum phosphate|0|||
125644916|NCT01521494|451982142|FG000|Overall Study|Decrease in serum calcium|0|||
125644917|NCT01521494|451982143|FG001|Overall Study|Decrease in serum calcium|0|||
125644918|NCT01521494|451982144|FG002|Overall Study|Decrease in serum calcium|0|||
125534078|NCT02233803|451584883|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
125534079|NCT02233803|451584882|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
125534080|NCT02233803|451584883|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
125534081|NCT02233803|451584882|FG000|Washout Period (4-Wks)|Physician Decision|1|||
125534082|NCT02233803|451584883|FG001|Washout Period (4-Wks)|Physician Decision|0|||
125534083|NCT02233803|451584882|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
125534084|NCT02233803|451584883|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
125534085|NCT02233803|451584882|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
125534086|NCT02233803|451584883|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
125198961|NCT04434469|450351057|FG001|Overall Study|Lost to Follow-up|0|||
125198962|NCT04434469|450351058|FG002|Overall Study|Lost to Follow-up|0|||
125198963|NCT04434469|450351059|FG003|Overall Study|Lost to Follow-up|1|||
125198964|NCT04434469|450351060|FG004|Overall Study|Lost to Follow-up|1|||
125198965|NCT04434469|450351061|FG005|Overall Study|Lost to Follow-up|0|||
125198966|NCT04434469|450351056|FG000|Overall Study|Study terminated by sponsor|1|||
125198967|NCT04434469|450351057|FG001|Overall Study|Study terminated by sponsor|1|||
125198968|NCT04434469|450351058|FG002|Overall Study|Study terminated by sponsor|1|||
125198969|NCT04434469|450351059|FG003|Overall Study|Study terminated by sponsor|2|||
125198970|NCT04434469|450351060|FG004|Overall Study|Study terminated by sponsor|3|||
125198971|NCT04434469|450351061|FG005|Overall Study|Study terminated by sponsor|3|||
125198972|NCT04434469|450351056|FG000|Overall Study|Withdrawal by Subject|0|||
125198973|NCT04434469|450351057|FG001|Overall Study|Withdrawal by Subject|0|||
125198974|NCT04434469|450351058|FG002|Overall Study|Withdrawal by Subject|1|||
125198975|NCT04434469|450351059|FG003|Overall Study|Withdrawal by Subject|0|||
125198976|NCT04434469|450351060|FG004|Overall Study|Withdrawal by Subject|0|||
125198977|NCT04434469|450351061|FG005|Overall Study|Withdrawal by Subject|0|||
125198978|NCT01669174|450351062|FG000|Overall Study|Subject withdrew consent|2|||
125198979|NCT01669174|450351063|FG001|Overall Study|Subject withdrew consent|2|||
125198980|NCT01669174|450351062|FG000|Overall Study|Lost to Follow-up|1|||
125198981|NCT01669174|450351063|FG001|Overall Study|Lost to Follow-up|0|||
125198982|NCT01669174|450351062|FG000|Overall Study|Adverse Event|2|||
125198983|NCT01669174|450351063|FG001|Overall Study|Adverse Event|2|||
125198984|NCT01669174|450351062|FG000|Overall Study|Administrative problems|1|||
125198985|NCT01669174|450351063|FG001|Overall Study|Administrative problems|2|||
125198986|NCT01953601|450351067|FG000|Part 1 (Base Study)|Adverse Event|24|||
125198987|NCT01953601|450351068|FG001|Part 1 (Base Study)|Adverse Event|37|||
125198988|NCT01953601|450351069|FG002|Part 1 (Base Study)|Adverse Event|15|||
125198989|NCT01953601|450351067|FG000|Part 1 (Base Study)|Death|2|||
125198990|NCT01953601|450351068|FG001|Part 1 (Base Study)|Death|0|||
125198991|NCT01953601|450351069|FG002|Part 1 (Base Study)|Death|3|||
125198992|NCT01953601|450351067|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
125198993|NCT01953601|450351068|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
125198994|NCT01953601|450351069|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
125198995|NCT01953601|450351067|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
125198996|NCT01953601|450351068|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
125198997|NCT01953601|450351069|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
125198998|NCT01953601|450351067|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
125198999|NCT01953601|450351068|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
125199000|NCT01953601|450351069|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
125199001|NCT01953601|450351067|FG000|Part 1 (Base Study)|Physician Decision|3|||
125199002|NCT01953601|450351068|FG001|Part 1 (Base Study)|Physician Decision|7|||
125199003|NCT01953601|450351069|FG002|Part 1 (Base Study)|Physician Decision|4|||
125199004|NCT01953601|450351067|FG000|Part 1 (Base Study)|Screen failure|1|||
125199005|NCT01953601|450351068|FG001|Part 1 (Base Study)|Screen failure|0|||
125199006|NCT01953601|450351069|FG002|Part 1 (Base Study)|Screen failure|1|||
125199007|NCT01953601|450351067|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
125199008|NCT01953601|450351068|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
125199009|NCT01953601|450351069|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
125199010|NCT01953601|450351067|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
125199011|NCT01953601|450351068|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
125199012|NCT01953601|450351069|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
125199013|NCT01953601|450351067|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
125199014|NCT01953601|450351068|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
125199015|NCT01953601|450351069|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
125199016|NCT01953601|450351067|FG000|Part 1 (Base Study)|Subject moved|2|||
125199017|NCT01953601|450351068|FG001|Part 1 (Base Study)|Subject moved|2|||
125199018|NCT01953601|450351069|FG002|Part 1 (Base Study)|Subject moved|1|||
125199019|NCT01953601|450351067|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
125199020|NCT01953601|450351068|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
125199021|NCT01953601|450351069|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
125199022|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Adverse Event|1|||
125199023|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Adverse Event|1|||
125199024|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Adverse Event|10|||
125199025|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Death|0|||
125199026|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Death|3|||
125199027|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Death|0|||
125199028|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
125199029|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
125199030|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
125199031|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
125199032|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
125199033|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
125199034|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Physician Decision|2|||
125199035|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Physician Decision|0|||
125199036|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Physician Decision|2|||
125199037|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
125199038|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
125534087|NCT02233803|451584882|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
125534088|NCT02233803|451584883|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
125534089|NCT03635099|451584884|FG000|Period 1|Adverse Event|1|||
125534090|NCT03635099|451584885|FG001|Period 1|Adverse Event|0|||
125534091|NCT03635099|451584886|FG002|Period 1|Adverse Event|0|||
125534092|NCT03635099|451584887|FG003|Period 1|Adverse Event|1|||
125534093|NCT03635099|451584888|FG004|Period 1|Adverse Event|0|||
125534094|NCT03635099|451584889|FG005|Period 1|Adverse Event|0|||
125534095|NCT03635099|451584890|FG006|Period 1|Adverse Event|0|||
125534096|NCT03635099|451584891|FG007|Period 1|Adverse Event|0|||
125534097|NCT03635099|451584884|FG000|Period 1|Protocol Violation|0|||
125534098|NCT03635099|451584885|FG001|Period 1|Protocol Violation|0|||
125534099|NCT03635099|451584886|FG002|Period 1|Protocol Violation|1|||
125534100|NCT03635099|451584887|FG003|Period 1|Protocol Violation|0|||
125534101|NCT03635099|451584888|FG004|Period 1|Protocol Violation|0|||
125534102|NCT03635099|451584889|FG005|Period 1|Protocol Violation|0|||
125199039|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
125199040|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
125199041|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
125199042|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
125199043|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
125199044|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
125199045|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
125199046|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Subject moved|0|||
125199047|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Subject moved|0|||
125199048|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Subject moved|1|||
125199049|NCT01953601|450351067|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
125199050|NCT01953601|450351068|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
125199051|NCT01953601|450351069|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
125199052|NCT01154296|450351075|FG000|Randomization and Intervention|Decided to decline|1|||
125199053|NCT01154296|450351076|FG001|Randomization and Intervention|Decided to decline|1|||
125199054|NCT01154296|450351075|FG000|Randomization and Intervention|Declined by staff|1|||
125199055|NCT01154296|450351076|FG001|Randomization and Intervention|Declined by staff|0|||
125199056|NCT01154296|450351075|FG000|Randomization and Intervention|Did not return|1|||
125199057|NCT01154296|450351076|FG001|Randomization and Intervention|Did not return|0|||
125199058|NCT01154296|450351075|FG000|Randomization and Intervention|Left before test|0|||
125199059|NCT01154296|450351076|FG001|Randomization and Intervention|Left before test|1|||
125199060|NCT01154296|450351075|FG000|Randomization and Intervention|Left clinic early|2|||
125199061|NCT01154296|450351076|FG001|Randomization and Intervention|Left clinic early|0|||
125199062|NCT01154296|450351075|FG000|6-month Follow-up|Lost contact|269|||
125199063|NCT01154296|450351076|FG001|6-month Follow-up|Lost contact|275|||
125199064|NCT01154296|450351075|FG000|6-month Follow-up|Incarcerated|37|||
125199065|NCT01154296|450351076|FG001|6-month Follow-up|Incarcerated|32|||
125199066|NCT01154296|450351075|FG000|6-month Follow-up|Withdrew consent|14|||
125199067|NCT01154296|450351076|FG001|6-month Follow-up|Withdrew consent|15|||
125199068|NCT01154296|450351075|FG000|6-month Follow-up|Death|3|||
125199069|NCT01154296|450351076|FG001|6-month Follow-up|Death|2|||
125199070|NCT01154296|450351075|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
125199071|NCT01154296|450351076|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
125199072|NCT04310397|450351079|FG000|Overall Study|Lack of Efficacy|3|||
125199073|NCT04310397|450351079|FG000|Overall Study|Withdrawal by Subject|1|||
125199074|NCT00664859|450351106|FG000|Overall Study|Adverse Event|2|||
125199075|NCT00664859|450351107|FG001|Overall Study|Adverse Event|1|||
125199076|NCT00664859|450351108|FG002|Overall Study|Adverse Event|3|||
125199077|NCT00664859|450351106|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
125199078|NCT00664859|450351107|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
125199079|NCT00664859|450351108|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
125199080|NCT00664859|450351106|FG000|Overall Study|Noncompliance with protocol|1|||
125199081|NCT00664859|450351107|FG001|Overall Study|Noncompliance with protocol|0|||
125534103|NCT03635099|451584890|FG006|Period 1|Protocol Violation|0|||
125534104|NCT03635099|451584891|FG007|Period 1|Protocol Violation|0|||
125199082|NCT00664859|450351108|FG002|Overall Study|Noncompliance with protocol|4|||
125217405|NCT05415462|450423519|FG001|Overall Study|Physician Decision|5|||
125534105|NCT03635099|451584884|FG000|Period 1|Lost to Follow-up|0|||
125534106|NCT03635099|451584885|FG001|Period 1|Lost to Follow-up|0|||
125534107|NCT03635099|451584886|FG002|Period 1|Lost to Follow-up|1|||
125534108|NCT03635099|451584887|FG003|Period 1|Lost to Follow-up|2|||
125534109|NCT03635099|451584888|FG004|Period 1|Lost to Follow-up|1|||
125534110|NCT03635099|451584889|FG005|Period 1|Lost to Follow-up|0|||
125534111|NCT03635099|451584890|FG006|Period 1|Lost to Follow-up|1|||
125534112|NCT03635099|451584891|FG007|Period 1|Lost to Follow-up|2|||
125534113|NCT03635099|451584884|FG000|Period 1|Withdrawal by Subject|3|||
125534114|NCT03635099|451584885|FG001|Period 1|Withdrawal by Subject|3|||
125534115|NCT03635099|451584886|FG002|Period 1|Withdrawal by Subject|5|||
125534116|NCT03635099|451584887|FG003|Period 1|Withdrawal by Subject|2|||
125534117|NCT03635099|451584888|FG004|Period 1|Withdrawal by Subject|2|||
125534118|NCT03635099|451584889|FG005|Period 1|Withdrawal by Subject|0|||
125534119|NCT03635099|451584890|FG006|Period 1|Withdrawal by Subject|3|||
125534120|NCT03635099|451584891|FG007|Period 1|Withdrawal by Subject|0|||
125534121|NCT03635099|451584884|FG000|Period 1|History of suicidal ideation|0|||
125534122|NCT03635099|451584885|FG001|Period 1|History of suicidal ideation|0|||
125534123|NCT03635099|451584886|FG002|Period 1|History of suicidal ideation|1|||
125534124|NCT03635099|451584887|FG003|Period 1|History of suicidal ideation|0|||
125534125|NCT03635099|451584888|FG004|Period 1|History of suicidal ideation|0|||
125534126|NCT03635099|451584889|FG005|Period 1|History of suicidal ideation|0|||
125534127|NCT03635099|451584890|FG006|Period 1|History of suicidal ideation|0|||
125534128|NCT03635099|451584891|FG007|Period 1|History of suicidal ideation|0|||
125534129|NCT03635099|451584884|FG000|Period 1|pursue other treatment options|0|||
125534130|NCT03635099|451584885|FG001|Period 1|pursue other treatment options|0|||
125534131|NCT03635099|451584886|FG002|Period 1|pursue other treatment options|0|||
125534132|NCT03635099|451584887|FG003|Period 1|pursue other treatment options|0|||
125534133|NCT03635099|451584888|FG004|Period 1|pursue other treatment options|0|||
125534134|NCT03635099|451584889|FG005|Period 1|pursue other treatment options|1|||
125534135|NCT03635099|451584890|FG006|Period 1|pursue other treatment options|0|||
125534136|NCT03635099|451584891|FG007|Period 1|pursue other treatment options|0|||
125534137|NCT03635099|451584884|FG000|Not Eligible for Period 2|Pregnancy|0|||
125534138|NCT03635099|451584885|FG001|Not Eligible for Period 2|Pregnancy|0|||
125534139|NCT03635099|451584886|FG002|Not Eligible for Period 2|Pregnancy|0|||
125534140|NCT03635099|451584887|FG003|Not Eligible for Period 2|Pregnancy|1|||
125534141|NCT03635099|451584888|FG004|Not Eligible for Period 2|Pregnancy|0|||
125534142|NCT03635099|451584889|FG005|Not Eligible for Period 2|Pregnancy|0|||
125534143|NCT03635099|451584890|FG006|Not Eligible for Period 2|Pregnancy|0|||
125534144|NCT03635099|451584891|FG007|Not Eligible for Period 2|Pregnancy|0|||
125534145|NCT03635099|451584884|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
125534146|NCT03635099|451584885|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
125534147|NCT03635099|451584886|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
125534148|NCT03635099|451584887|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
125534149|NCT03635099|451584888|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
125534150|NCT03635099|451584889|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
125534151|NCT03635099|451584890|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
125534152|NCT03635099|451584891|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
125534153|NCT03635099|451584884|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
125534154|NCT03635099|451584885|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
125534155|NCT03635099|451584886|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
125534156|NCT03635099|451584887|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
125534157|NCT03635099|451584888|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
125534158|NCT03635099|451584889|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
125534159|NCT03635099|451584890|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
125534160|NCT03635099|451584891|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
125534161|NCT03635099|451584884|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
125534162|NCT03635099|451584885|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
125534163|NCT03635099|451584886|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
125534164|NCT03635099|451584887|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
125534165|NCT03635099|451584888|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
125534166|NCT03635099|451584889|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
125534167|NCT03635099|451584890|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
125534168|NCT03635099|451584891|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
125534169|NCT03635099|451584884|FG000|Period 2|Adverse Event|0|||
125534170|NCT03635099|451584885|FG001|Period 2|Adverse Event|0|||
125534171|NCT03635099|451584886|FG002|Period 2|Adverse Event|1|||
125534172|NCT03635099|451584887|FG003|Period 2|Adverse Event|0|||
125534173|NCT03635099|451584888|FG004|Period 2|Adverse Event|1|||
125534174|NCT03635099|451584889|FG005|Period 2|Adverse Event|0|||
125534175|NCT03635099|451584890|FG006|Period 2|Adverse Event|0|||
125534176|NCT03635099|451584891|FG007|Period 2|Adverse Event|0|||
125534177|NCT03635099|451584884|FG000|Period 2|Lost to Follow-up|0|||
125534178|NCT03635099|451584885|FG001|Period 2|Lost to Follow-up|0|||
125534179|NCT03635099|451584886|FG002|Period 2|Lost to Follow-up|1|||
125199083|NCT00664859|450351106|FG000|Overall Study|Laboratory abnormality|2|||
125199084|NCT00664859|450351107|FG001|Overall Study|Laboratory abnormality|1|||
125199085|NCT00664859|450351108|FG002|Overall Study|Laboratory abnormality|4|||
125199086|NCT00664859|450351106|FG000|Overall Study|Withdrawal by Subject|4|||
125199087|NCT00664859|450351107|FG001|Overall Study|Withdrawal by Subject|1|||
125199088|NCT00664859|450351108|FG002|Overall Study|Withdrawal by Subject|3|||
125199089|NCT00664859|450351106|FG000|Overall Study|Lost to Follow-up|2|||
125199090|NCT00664859|450351107|FG001|Overall Study|Lost to Follow-up|2|||
125534180|NCT03635099|451584887|FG003|Period 2|Lost to Follow-up|0|||
125534181|NCT03635099|451584888|FG004|Period 2|Lost to Follow-up|4|||
125534182|NCT03635099|451584889|FG005|Period 2|Lost to Follow-up|0|||
125534183|NCT03635099|451584890|FG006|Period 2|Lost to Follow-up|0|||
125534184|NCT03635099|451584891|FG007|Period 2|Lost to Follow-up|0|||
125534185|NCT03635099|451584884|FG000|Period 2|Withdrawal by Subject|0|||
125534186|NCT03635099|451584885|FG001|Period 2|Withdrawal by Subject|0|||
125534187|NCT03635099|451584886|FG002|Period 2|Withdrawal by Subject|7|||
125199091|NCT00664859|450351108|FG002|Overall Study|Lost to Follow-up|1|||
125199092|NCT00664859|450351106|FG000|Overall Study|Other|0|||
125199093|NCT00664859|450351107|FG001|Overall Study|Other|1|||
125199094|NCT00664859|450351108|FG002|Overall Study|Other|2|||
125199095|NCT01943851|450351109|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199096|NCT01943851|450351110|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199097|NCT01943851|450351111|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199098|NCT01943851|450351112|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
125199099|NCT01943851|450351113|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199100|NCT01943851|450351114|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199101|NCT01943851|450351115|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
125199102|NCT01943851|450351116|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
125199103|NCT01943851|450351117|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
125199104|NCT01943851|450351118|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199105|NCT01943851|450351119|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199106|NCT01943851|450351120|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199107|NCT01943851|450351121|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199108|NCT01943851|450351122|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199109|NCT01943851|450351123|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199110|NCT01943851|450351124|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199111|NCT01943851|450351125|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199112|NCT01943851|450351126|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
125199113|NCT01943851|450351109|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199114|NCT01943851|450351110|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199115|NCT01943851|450351111|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199116|NCT01943851|450351112|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199117|NCT01943851|450351113|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
125199118|NCT01943851|450351114|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199119|NCT01943851|450351115|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199120|NCT01943851|450351116|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
125199121|NCT01943851|450351117|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199122|NCT01943851|450351118|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199123|NCT01943851|450351119|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199124|NCT01943851|450351120|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199125|NCT01943851|450351121|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199126|NCT01943851|450351122|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199127|NCT01943851|450351123|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125534188|NCT03635099|451584887|FG003|Period 2|Withdrawal by Subject|4|||
125534189|NCT03635099|451584888|FG004|Period 2|Withdrawal by Subject|7|||
125534190|NCT03635099|451584889|FG005|Period 2|Withdrawal by Subject|0|||
125534191|NCT03635099|451584890|FG006|Period 2|Withdrawal by Subject|0|||
125534192|NCT03635099|451584891|FG007|Period 2|Withdrawal by Subject|0|||
125534193|NCT04191616|451584893|FG000|Pre-assignment Period|Did not receive study treatment|2|||
125534194|NCT04191616|451584893|FG000|Treatment Period|Death|37|||
125534195|NCT04191616|451584893|FG000|Treatment Period|Sponsor decision|11|||
125199128|NCT01943851|450351124|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199129|NCT01943851|450351125|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199130|NCT01943851|450351126|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
125199131|NCT01943851|450351109|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199132|NCT01943851|450351110|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199133|NCT01943851|450351111|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125534196|NCT04191616|451584893|FG000|Treatment Period|Withdrawal by Subject|4|||
125534197|NCT04230122|451584894|FG000|Overall Study|Lost to Follow-up|1|||
125534198|NCT04230122|451584895|FG001|Overall Study|Lost to Follow-up|0|||
125534199|NCT01840410|451584898|FG000|Overall Study|Physician Decision|1|||
125199134|NCT01943851|450351112|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199135|NCT01943851|450351113|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199136|NCT01943851|450351114|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199137|NCT01943851|450351115|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199138|NCT01943851|450351116|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199139|NCT01943851|450351117|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199140|NCT01943851|450351118|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199141|NCT01943851|450351119|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199142|NCT01943851|450351120|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199143|NCT01943851|450351121|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199144|NCT01943851|450351122|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
125199145|NCT01943851|450351123|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199146|NCT01943851|450351124|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199147|NCT01943851|450351125|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199148|NCT01943851|450351126|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
125199149|NCT01943851|450351109|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199150|NCT01943851|450351110|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199151|NCT01943851|450351111|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199152|NCT01943851|450351112|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199153|NCT01943851|450351113|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199154|NCT01943851|450351114|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199155|NCT01943851|450351115|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199156|NCT01943851|450351116|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199157|NCT01943851|450351117|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199158|NCT01943851|450351118|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199159|NCT01943851|450351119|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199160|NCT01943851|450351120|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199161|NCT01943851|450351121|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199162|NCT01943851|450351122|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199163|NCT01943851|450351123|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199164|NCT01943851|450351124|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
125199165|NCT01943851|450351125|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199166|NCT01943851|450351126|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
125199167|NCT01943851|450351109|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199168|NCT01943851|450351110|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199169|NCT01943851|450351111|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199170|NCT01943851|450351112|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199171|NCT01943851|450351113|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199172|NCT01943851|450351114|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199173|NCT01943851|450351115|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199174|NCT01943851|450351116|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199175|NCT01943851|450351117|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199176|NCT01943851|450351118|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199177|NCT01943851|450351119|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199178|NCT01943851|450351120|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199179|NCT01943851|450351121|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199180|NCT01943851|450351122|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199181|NCT01943851|450351123|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
125199182|NCT01943851|450351124|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
125199183|NCT01943851|450351125|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
125199184|NCT01943851|450351126|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
125199185|NCT00900757|450351127|FG000|Overall Study|screen failure|19|||
125199186|NCT03320850|450351128|FG000|Overall Study|Lost to Follow-up|0|||
125199187|NCT03320850|450351129|FG001|Overall Study|Lost to Follow-up|0|||
125199188|NCT03320850|450351130|FG002|Overall Study|Lost to Follow-up|0|||
125199189|NCT03320850|450351131|FG003|Overall Study|Lost to Follow-up|0|||
125199190|NCT03320850|450351132|FG004|Overall Study|Lost to Follow-up|1|||
125199191|NCT03320850|450351133|FG005|Overall Study|Lost to Follow-up|2|||
125199192|NCT03320850|450351134|FG006|Overall Study|Lost to Follow-up|2|||
125199193|NCT03320850|450351135|FG007|Overall Study|Lost to Follow-up|0|||
125199194|NCT03320850|450351136|FG008|Overall Study|Lost to Follow-up|6|||
125199195|NCT03320850|450351137|FG009|Overall Study|Lost to Follow-up|4|||
125199196|NCT03320850|450351128|FG000|Overall Study|Withdrawal by Subject|0|||
125199197|NCT03320850|450351129|FG001|Overall Study|Withdrawal by Subject|0|||
125199198|NCT03320850|450351130|FG002|Overall Study|Withdrawal by Subject|0|||
125199199|NCT03320850|450351131|FG003|Overall Study|Withdrawal by Subject|0|||
125199200|NCT03320850|450351132|FG004|Overall Study|Withdrawal by Subject|1|||
125199201|NCT03320850|450351133|FG005|Overall Study|Withdrawal by Subject|2|||
125199202|NCT03320850|450351134|FG006|Overall Study|Withdrawal by Subject|4|||
125199203|NCT03320850|450351135|FG007|Overall Study|Withdrawal by Subject|5|||
125310283|NCT00466921|450762052|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
125199204|NCT03320850|450351136|FG008|Overall Study|Withdrawal by Subject|2|||
125199205|NCT03320850|450351137|FG009|Overall Study|Withdrawal by Subject|1|||
125199206|NCT03320850|450351128|FG000|Overall Study|Lack of Efficacy|0|||
125199207|NCT03320850|450351129|FG001|Overall Study|Lack of Efficacy|0|||
125199208|NCT03320850|450351130|FG002|Overall Study|Lack of Efficacy|0|||
125199209|NCT03320850|450351131|FG003|Overall Study|Lack of Efficacy|1|||
125199210|NCT03320850|450351132|FG004|Overall Study|Lack of Efficacy|0|||
125199211|NCT03320850|450351133|FG005|Overall Study|Lack of Efficacy|1|||
125199212|NCT03320850|450351134|FG006|Overall Study|Lack of Efficacy|0|||
125199213|NCT03320850|450351135|FG007|Overall Study|Lack of Efficacy|2|||
125199214|NCT03320850|450351136|FG008|Overall Study|Lack of Efficacy|0|||
125199215|NCT03320850|450351137|FG009|Overall Study|Lack of Efficacy|3|||
125199216|NCT03320850|450351128|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
125199217|NCT03320850|450351129|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
125199218|NCT03320850|450351130|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
125199219|NCT03320850|450351131|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
125199220|NCT03320850|450351132|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
125199221|NCT03320850|450351133|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
125199222|NCT03320850|450351134|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
125199223|NCT03320850|450351135|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
125199224|NCT03320850|450351136|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
125199225|NCT03320850|450351137|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
125199226|NCT03320850|450351128|FG000|Overall Study|Adverse Event|0|||
125199227|NCT03320850|450351129|FG001|Overall Study|Adverse Event|0|||
125199228|NCT03320850|450351130|FG002|Overall Study|Adverse Event|0|||
125199229|NCT03320850|450351131|FG003|Overall Study|Adverse Event|0|||
125199230|NCT03320850|450351132|FG004|Overall Study|Adverse Event|0|||
125199231|NCT03320850|450351133|FG005|Overall Study|Adverse Event|2|||
125199232|NCT03320850|450351134|FG006|Overall Study|Adverse Event|1|||
125199233|NCT03320850|450351135|FG007|Overall Study|Adverse Event|0|||
125199234|NCT03320850|450351136|FG008|Overall Study|Adverse Event|2|||
125199235|NCT03320850|450351137|FG009|Overall Study|Adverse Event|0|||
125199236|NCT03320850|450351128|FG000|Overall Study|Reason Not Specified|0|||
125199237|NCT03320850|450351129|FG001|Overall Study|Reason Not Specified|0|||
125199238|NCT03320850|450351130|FG002|Overall Study|Reason Not Specified|0|||
125199239|NCT03320850|450351131|FG003|Overall Study|Reason Not Specified|0|||
125199240|NCT03320850|450351132|FG004|Overall Study|Reason Not Specified|0|||
125199241|NCT03320850|450351133|FG005|Overall Study|Reason Not Specified|1|||
125199242|NCT03320850|450351134|FG006|Overall Study|Reason Not Specified|0|||
125199243|NCT03320850|450351135|FG007|Overall Study|Reason Not Specified|0|||
125199244|NCT03320850|450351136|FG008|Overall Study|Reason Not Specified|0|||
125199245|NCT03320850|450351137|FG009|Overall Study|Reason Not Specified|1|||
125199246|NCT00546117|450351138|FG000|Overall Study|Withdrawal by Subject|3|||
125199247|NCT00546117|450351139|FG001|Overall Study|Withdrawal by Subject|0|||
125199248|NCT00546117|450351138|FG000|Overall Study|Inability to schedule follow-up visit|1|||
125199249|NCT00546117|450351139|FG001|Overall Study|Inability to schedule follow-up visit|0|||
125199250|NCT01609543|450351155|FG000|Overall Study|Disease Progression|28|||
125199251|NCT01609543|450351155|FG000|Overall Study|Adverse Event|5|||
125199252|NCT01609543|450351155|FG000|Overall Study|Withdrawal by Subject|1|||
125199253|NCT01609543|450351155|FG000|Overall Study|Protocol Violation|1|||
125199254|NCT01609543|450351155|FG000|Overall Study|Death|7|||
125199255|NCT00507819|450351156|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
125199256|NCT00507819|450351157|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
125199257|NCT03452488|450351158|FG000|Overall Study|Adverse Event|4|||
125199258|NCT03452488|450351159|FG001|Overall Study|Adverse Event|6|||
125199259|NCT03452488|450351160|FG002|Overall Study|Adverse Event|1|||
125199260|NCT03452488|450351158|FG000|Overall Study|Death|0|||
125199261|NCT03452488|450351159|FG001|Overall Study|Death|0|||
125199262|NCT03452488|450351160|FG002|Overall Study|Death|1|||
125199263|NCT03452488|450351158|FG000|Overall Study|Lost to Follow-up|1|||
125199264|NCT03452488|450351159|FG001|Overall Study|Lost to Follow-up|2|||
125199265|NCT03452488|450351160|FG002|Overall Study|Lost to Follow-up|0|||
125199266|NCT03452488|450351158|FG000|Overall Study|PI Decision|1|||
125199267|NCT03452488|450351159|FG001|Overall Study|PI Decision|0|||
125199268|NCT03452488|450351160|FG002|Overall Study|PI Decision|0|||
125199269|NCT03452488|450351158|FG000|Overall Study|Withdrew consent|4|||
125199270|NCT03452488|450351159|FG001|Overall Study|Withdrew consent|2|||
125199271|NCT03452488|450351160|FG002|Overall Study|Withdrew consent|2|||
125199272|NCT03452488|450351158|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
125199273|NCT03452488|450351159|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
125199274|NCT03452488|450351160|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
125199275|NCT03452488|450351158|FG000|Overall Study|Other|0|||
125199276|NCT03452488|450351159|FG001|Overall Study|Other|2|||
125199277|NCT03452488|450351160|FG002|Overall Study|Other|2|||
125199278|NCT01254318|450351161|FG000|Overall Study|Lost to Follow-up|5|||
125199279|NCT01254318|450351161|FG000|Overall Study|Death|47|||
125199280|NCT00782184|450351168|FG000|Overall Study|Adverse Event|1|||
125199281|NCT00782184|450351169|FG001|Overall Study|Adverse Event|2|||
125199282|NCT00782184|450351168|FG000|Overall Study|Protocol Violation|0|||
125199283|NCT00782184|450351169|FG001|Overall Study|Protocol Violation|1|||
125199284|NCT00782184|450351168|FG000|Overall Study|Withdrawal by Subject|3|||
125199285|NCT00782184|450351169|FG001|Overall Study|Withdrawal by Subject|2|||
125199286|NCT01992653|450351172|FG000|Overall Study|Death|0|||
125199287|NCT01992653|450351173|FG001|Overall Study|Death|0|||
125199288|NCT01992653|450351174|FG002|Overall Study|Death|1|||
125199289|NCT01992653|450351175|FG003|Overall Study|Death|0|||
125199290|NCT01992653|450351176|FG004|Overall Study|Death|1|||
125199291|NCT01992653|450351177|FG005|Overall Study|Death|0|||
125199292|NCT01992653|450351178|FG006|Overall Study|Death|4|||
125199293|NCT01992653|450351179|FG007|Overall Study|Death|2|||
125199294|NCT01992653|450351172|FG000|Overall Study|Lost to Follow-up|0|||
125199295|NCT01992653|450351173|FG001|Overall Study|Lost to Follow-up|0|||
125199296|NCT01992653|450351174|FG002|Overall Study|Lost to Follow-up|0|||
125199297|NCT01992653|450351175|FG003|Overall Study|Lost to Follow-up|0|||
125199298|NCT01992653|450351176|FG004|Overall Study|Lost to Follow-up|0|||
125199299|NCT01992653|450351177|FG005|Overall Study|Lost to Follow-up|0|||
125199300|NCT01992653|450351178|FG006|Overall Study|Lost to Follow-up|0|||
125199301|NCT01992653|450351179|FG007|Overall Study|Lost to Follow-up|1|||
125199302|NCT01992653|450351172|FG000|Overall Study|Study Completed|0|||
125199303|NCT01992653|450351173|FG001|Overall Study|Study Completed|0|||
125199304|NCT01992653|450351174|FG002|Overall Study|Study Completed|0|||
125199305|NCT01992653|450351175|FG003|Overall Study|Study Completed|0|||
125199306|NCT01992653|450351176|FG004|Overall Study|Study Completed|0|||
125199307|NCT01992653|450351177|FG005|Overall Study|Study Completed|0|||
125199308|NCT01992653|450351178|FG006|Overall Study|Study Completed|0|||
125199309|NCT01992653|450351179|FG007|Overall Study|Study Completed|1|||
125199310|NCT01992653|450351172|FG000|Overall Study|Disease Progression|0|||
125199311|NCT01992653|450351173|FG001|Overall Study|Disease Progression|0|||
125199312|NCT01992653|450351174|FG002|Overall Study|Disease Progression|0|||
125199313|NCT01992653|450351175|FG003|Overall Study|Disease Progression|0|||
125199314|NCT01992653|450351176|FG004|Overall Study|Disease Progression|0|||
125199315|NCT01992653|450351177|FG005|Overall Study|Disease Progression|0|||
125199316|NCT01992653|450351178|FG006|Overall Study|Disease Progression|4|||
125199317|NCT01992653|450351179|FG007|Overall Study|Disease Progression|0|||
125199318|NCT02572076|450351180|FG000|Overall Study|Protocol Violation|1|||
125199319|NCT03395184|450351185|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
125199320|NCT03395184|450351186|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
125199321|NCT03395184|450351187|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
125199322|NCT03395184|450351188|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
125199323|NCT03395184|450351189|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
125199324|NCT03395184|450351190|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
125199325|NCT03395184|450351191|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
125199326|NCT03395184|450351185|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
125199327|NCT03395184|450351186|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
125199328|NCT03395184|450351187|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
125199329|NCT03395184|450351188|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
125199330|NCT03395184|450351189|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
125199331|NCT03395184|450351190|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
125199332|NCT03395184|450351191|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
125199333|NCT03395184|450351185|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
125199334|NCT03395184|450351186|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
125199335|NCT03395184|450351187|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
125199336|NCT03395184|450351188|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
125199337|NCT03395184|450351189|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
125199338|NCT03395184|450351190|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
125199339|NCT03395184|450351191|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
125199340|NCT03395184|450351185|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
125199341|NCT03395184|450351186|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
125199342|NCT03395184|450351187|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
125199343|NCT03395184|450351188|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
125199344|NCT03395184|450351189|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
125199345|NCT03395184|450351190|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
125199346|NCT03395184|450351191|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
125199347|NCT03395184|450351185|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
125199348|NCT03395184|450351186|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125199349|NCT03395184|450351187|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
125199350|NCT03395184|450351188|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125199351|NCT03395184|450351189|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125199352|NCT03395184|450351190|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125199353|NCT03395184|450351191|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125199354|NCT03395184|450351185|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
125199355|NCT03395184|450351186|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
125199356|NCT03395184|450351187|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
125378810|NCT01774968|451017298|FG000|Overall Study|Protocol Violation|14|||
125422472|NCT03364751|451172845|FG001|Overall Study|Withdrawal by Subject|0|||
125422473|NCT03364751|451172846|FG002|Overall Study|Withdrawal by Subject|0|||
125422474|NCT03364751|451172847|FG003|Overall Study|Withdrawal by Subject|0|||
125199357|NCT03395184|450351188|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
125199358|NCT03395184|450351189|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
125199359|NCT03395184|450351190|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
125199360|NCT03395184|450351191|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
125199361|NCT03395184|450351185|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
125199362|NCT03395184|450351186|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
125199363|NCT03395184|450351187|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
125199364|NCT03395184|450351188|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
125199365|NCT03395184|450351189|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
125199366|NCT03395184|450351190|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
125199367|NCT03395184|450351191|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
125199368|NCT03395184|450351185|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
125199369|NCT03395184|450351186|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
125199370|NCT03395184|450351187|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
125199371|NCT03395184|450351188|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
125199372|NCT03395184|450351189|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
125199373|NCT03395184|450351190|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
125199374|NCT03395184|450351191|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
125199375|NCT03395184|450351185|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
125199376|NCT03395184|450351186|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
125199377|NCT03395184|450351187|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
125199378|NCT03395184|450351188|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
125199379|NCT03395184|450351189|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
125199380|NCT03395184|450351190|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
125199381|NCT03395184|450351191|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
125199382|NCT03395184|450351185|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
125199383|NCT03395184|450351186|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
125199384|NCT03395184|450351187|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
125199385|NCT03395184|450351188|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
125199386|NCT03395184|450351189|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
125199387|NCT03395184|450351190|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
125199388|NCT03395184|450351191|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
125199389|NCT03395184|450351185|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
125199390|NCT03395184|450351186|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
125199391|NCT03395184|450351187|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
125199392|NCT03395184|450351188|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
125199393|NCT03395184|450351189|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
125199394|NCT03395184|450351190|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
125199395|NCT03395184|450351191|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
125199396|NCT03395184|450351185|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
125199397|NCT03395184|450351186|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
125199398|NCT03395184|450351187|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
125199399|NCT03395184|450351188|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
125199400|NCT03395184|450351189|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
125199401|NCT03395184|450351190|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
125199402|NCT03395184|450351191|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
125217406|NCT05415462|450423518|FG000|Overall Study|Protocol Deviation|1|||
125217407|NCT05415462|450423519|FG001|Overall Study|Protocol Deviation|0|||
125217408|NCT05415462|450423518|FG000|Overall Study|Withdrawal by Subject|129|||
125217409|NCT05415462|450423519|FG001|Overall Study|Withdrawal by Subject|101|||
125217410|NCT05415462|450423518|FG000|Overall Study|Other Than Specified|8|||
125217411|NCT05415462|450423519|FG001|Overall Study|Other Than Specified|8|||
125217412|NCT01348100|450423520|FG000|Overall Study|Subject Withdrew Consent|0|||
125217413|NCT01348100|450423521|FG001|Overall Study|Subject Withdrew Consent|0|||
125217414|NCT01348100|450423522|FG002|Overall Study|Subject Withdrew Consent|2|||
125217415|NCT01348100|450423523|FG003|Overall Study|Subject Withdrew Consent|0|||
125217416|NCT01348100|450423524|FG004|Overall Study|Subject Withdrew Consent|1|||
125217417|NCT01348100|450423525|FG005|Overall Study|Subject Withdrew Consent|0|||
125217418|NCT01348100|450423526|FG006|Overall Study|Subject Withdrew Consent|1|||
125217419|NCT01348100|450423520|FG000|Overall Study|Protocol Deviation|0|||
125217420|NCT01348100|450423521|FG001|Overall Study|Protocol Deviation|0|||
125217421|NCT01348100|450423522|FG002|Overall Study|Protocol Deviation|0|||
125217422|NCT01348100|450423523|FG003|Overall Study|Protocol Deviation|1|||
125217423|NCT01348100|450423524|FG004|Overall Study|Protocol Deviation|0|||
125217424|NCT01348100|450423525|FG005|Overall Study|Protocol Deviation|0|||
125217425|NCT01348100|450423526|FG006|Overall Study|Protocol Deviation|0|||
125217433|NCT01348100|450423520|FG000|Overall Study|Lost to Follow-up|0|||
125199403|NCT01397786|450352961|FG000|Phase A|Lost to Follow-up|0|||
125199404|NCT01397786|450352962|FG001|Phase A|Lost to Follow-up|0|||
125199405|NCT01397786|450352963|FG002|Phase A|Lost to Follow-up|6|||
125199406|NCT01397786|450352961|FG000|Phase A|Adverse Event|0|||
125199407|NCT01397786|450352962|FG001|Phase A|Adverse Event|0|||
125199408|NCT01397786|450352963|FG002|Phase A|Adverse Event|8|||
125199409|NCT01397786|450352961|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
125199410|NCT01397786|450352962|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
125199411|NCT01397786|450352963|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
125199412|NCT01397786|450352961|FG000|Phase A|Physician Decision|0|||
125199413|NCT01397786|450352962|FG001|Phase A|Physician Decision|0|||
125199414|NCT01397786|450352963|FG002|Phase A|Physician Decision|1|||
125199415|NCT01397786|450352961|FG000|Phase A|Withdrawal by Subject|0|||
125199416|NCT01397786|450352962|FG001|Phase A|Withdrawal by Subject|0|||
125199417|NCT01397786|450352963|FG002|Phase A|Withdrawal by Subject|5|||
125199418|NCT01397786|450352961|FG000|Phase A|Lack of Efficacy|0|||
125199419|NCT01397786|450352962|FG001|Phase A|Lack of Efficacy|0|||
125199420|NCT01397786|450352963|FG002|Phase A|Lack of Efficacy|1|||
125199421|NCT01397786|450352961|FG000|Phase B|Lost to Follow-up|22|||
125199422|NCT01397786|450352962|FG001|Phase B|Lost to Follow-up|12|||
125199423|NCT01397786|450352963|FG002|Phase B|Lost to Follow-up|22|||
125199424|NCT01397786|450352961|FG000|Phase B|Adverse Event|109|||
125199425|NCT01397786|450352962|FG001|Phase B|Adverse Event|23|||
125199426|NCT01397786|450352963|FG002|Phase B|Adverse Event|27|||
125199427|NCT01397786|450352961|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
125199428|NCT01397786|450352962|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
125199429|NCT01397786|450352963|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
125199430|NCT01397786|450352961|FG000|Phase B|Physician Decision|9|||
125199431|NCT01397786|450352962|FG001|Phase B|Physician Decision|1|||
125199432|NCT01397786|450352963|FG002|Phase B|Physician Decision|3|||
125199433|NCT01397786|450352961|FG000|Phase B|Withdrawal by Subject|102|||
125199434|NCT01397786|450352962|FG001|Phase B|Withdrawal by Subject|45|||
125199435|NCT01397786|450352963|FG002|Phase B|Withdrawal by Subject|30|||
125199436|NCT01397786|450352961|FG000|Phase B|Protocol Deviation|1|||
125199437|NCT01397786|450352962|FG001|Phase B|Protocol Deviation|2|||
125199438|NCT01397786|450352963|FG002|Phase B|Protocol Deviation|4|||
125199439|NCT01397786|450352961|FG000|Phase B|Lack of Efficacy|22|||
125199440|NCT01397786|450352962|FG001|Phase B|Lack of Efficacy|7|||
125199441|NCT01397786|450352963|FG002|Phase B|Lack of Efficacy|14|||
125199442|NCT00784550|450352964|FG000|Overall Study|Adverse Event|12|||
125199443|NCT00784550|450352965|FG001|Overall Study|Adverse Event|10|||
125199444|NCT00784550|450352964|FG000|Overall Study|Lack of Efficacy|0|||
125199445|NCT00784550|450352965|FG001|Overall Study|Lack of Efficacy|1|||
125199446|NCT00784550|450352964|FG000|Overall Study|Protocol Violation|10|||
125199447|NCT00784550|450352965|FG001|Overall Study|Protocol Violation|10|||
125199448|NCT00784550|450352964|FG000|Overall Study|Lost to Follow-up|8|||
125199449|NCT00784550|450352965|FG001|Overall Study|Lost to Follow-up|5|||
125199450|NCT00784550|450352964|FG000|Overall Study|Physician Decision|2|||
125199451|NCT00784550|450352965|FG001|Overall Study|Physician Decision|3|||
125199452|NCT00784550|450352964|FG000|Overall Study|Withdrawal by Subject|4|||
125199453|NCT00784550|450352965|FG001|Overall Study|Withdrawal by Subject|13|||
125199454|NCT00688701|450352966|FG000|Overall Study|Adverse Event|1|||
125199455|NCT00688701|450352967|FG001|Overall Study|Adverse Event|0|||
125199456|NCT00688701|450352968|FG002|Overall Study|Adverse Event|5|||
125199457|NCT00688701|450352969|FG003|Overall Study|Adverse Event|3|||
125199458|NCT00688701|450352966|FG000|Overall Study|Lack of Efficacy|0|||
125199459|NCT00688701|450352967|FG001|Overall Study|Lack of Efficacy|1|||
125199460|NCT00688701|450352968|FG002|Overall Study|Lack of Efficacy|0|||
125199461|NCT00688701|450352969|FG003|Overall Study|Lack of Efficacy|0|||
125199462|NCT00688701|450352966|FG000|Overall Study|Withdrawal by Subject|3|||
125199463|NCT00688701|450352967|FG001|Overall Study|Withdrawal by Subject|3|||
125199464|NCT00688701|450352968|FG002|Overall Study|Withdrawal by Subject|4|||
125199465|NCT00688701|450352969|FG003|Overall Study|Withdrawal by Subject|8|||
125199466|NCT00688701|450352966|FG000|Overall Study|Poor compliance to protocol|0|||
125199467|NCT00688701|450352967|FG001|Overall Study|Poor compliance to protocol|1|||
125199468|NCT00688701|450352968|FG002|Overall Study|Poor compliance to protocol|1|||
125199469|NCT00688701|450352969|FG003|Overall Study|Poor compliance to protocol|0|||
125199470|NCT03875092|450352975|FG000|Overall Study|Adverse Event|2|||
125199471|NCT03875092|450352976|FG001|Overall Study|Adverse Event|5|||
125199472|NCT03875092|450352975|FG000|Overall Study|Death|44|||
125199473|NCT03875092|450352976|FG001|Overall Study|Death|51|||
125199474|NCT03875092|450352975|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
125199475|NCT03875092|450352976|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
125199476|NCT00784238|450352977|FG000|Overall Study|Adverse Event|14|||
125199477|NCT00784238|450352977|FG000|Overall Study|Death|2|||
125199478|NCT00784238|450352977|FG000|Overall Study|Lack of Efficacy|33|||
125199479|NCT00784238|450352977|FG000|Overall Study|Lost to Follow-up|29|||
125199480|NCT00784238|450352977|FG000|Overall Study|Pregnancy|1|||
125422475|NCT03364751|451172844|FG000|Overall Study|Lost to Follow-up|0|||
125199481|NCT00784238|450352977|FG000|Overall Study|Withdrawal by Subject|26|||
125199482|NCT00784238|450352977|FG000|Overall Study|Other|14|||
125199483|NCT02759055|450352978|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
125199484|NCT02759055|450352979|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
125199485|NCT00723255|450352980|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
125199486|NCT00723255|450352980|FG000|Overall Study|Ineligible: Second primary|1|||
125199487|NCT00723255|450352980|FG000|Overall Study|Ineligible: Wrong Primary|2|||
125199488|NCT00614523|450352981|FG000|Overall Study|Adverse Event|4|||
125199489|NCT00614523|450352982|FG001|Overall Study|Adverse Event|20|||
125199490|NCT00614523|450352981|FG000|Overall Study|Death|5|||
125199491|NCT00614523|450352982|FG001|Overall Study|Death|8|||
125199492|NCT00614523|450352981|FG000|Overall Study|Lack of Efficacy|9|||
125199493|NCT00614523|450352982|FG001|Overall Study|Lack of Efficacy|11|||
125199494|NCT00614523|450352981|FG000|Overall Study|Lost to Follow-up|0|||
125199495|NCT00614523|450352982|FG001|Overall Study|Lost to Follow-up|1|||
125199496|NCT00614523|450352981|FG000|Overall Study|Protocol Violation|3|||
125199497|NCT00614523|450352982|FG001|Overall Study|Protocol Violation|2|||
125199498|NCT00614523|450352981|FG000|Overall Study|Withdrawal by Subject|12|||
125199499|NCT00614523|450352982|FG001|Overall Study|Withdrawal by Subject|22|||
125199500|NCT00614523|450352981|FG000|Overall Study|Other|6|||
125199501|NCT00614523|450352982|FG001|Overall Study|Other|11|||
125199502|NCT00614523|450352981|FG000|Overall Study|Ineligibility Determined|1|||
125199503|NCT00614523|450352982|FG001|Overall Study|Ineligibility Determined|2|||
125199504|NCT00614523|450352981|FG000|Overall Study|Disease Progression|0|||
125199505|NCT00614523|450352982|FG001|Overall Study|Disease Progression|8|||
125199506|NCT00614523|450352981|FG000|Overall Study|Administrative Decision|23|||
125199507|NCT00614523|450352982|FG001|Overall Study|Administrative Decision|46|||
125199508|NCT03692325|450352983|FG000|Overall Study|Adverse Event|2|||
125199509|NCT03692325|450352983|FG000|Overall Study|Progression/Recurrence|2|||
125199510|NCT02461524|450352984|FG000|Overall Study|Death|16|||
125199511|NCT02461524|450352984|FG000|Overall Study|Withdrawal by Subject|4|||
125199512|NCT02461524|450352984|FG000|Overall Study|Device Explanted|5|||
125199513|NCT02461524|450352984|FG000|Overall Study|Missed Visit|6|||
125199514|NCT04481191|450352995|FG000|Overall Study|Withdrawn by parent/guardian|15|||
125199515|NCT04481191|450352996|FG001|Overall Study|Withdrawn by parent/guardian|10|||
125199516|NCT02487771|450352997|FG000|Overall Study|Lost to Follow-up|2|||
125199517|NCT02487771|450352998|FG001|Overall Study|Lost to Follow-up|3|||
125199518|NCT02487771|450352997|FG000|Overall Study|Moved out of area|5|||
125199519|NCT02487771|450352998|FG001|Overall Study|Moved out of area|6|||
125199520|NCT02487771|450352997|FG000|Overall Study|Withdrawal by Subject|3|||
125199521|NCT02487771|450352998|FG001|Overall Study|Withdrawal by Subject|5|||
125199522|NCT02002533|450352999|FG000|Overall Study|Withdrawal by Subject|6|||
125199523|NCT02002533|450353000|FG001|Overall Study|Withdrawal by Subject|13|||
125199524|NCT02002533|450352999|FG000|Overall Study|Protocol Violation|0|||
125199525|NCT02002533|450353000|FG001|Overall Study|Protocol Violation|1|||
125199526|NCT02002533|450352999|FG000|Overall Study|Adverse Event|0|||
125199527|NCT02002533|450353000|FG001|Overall Study|Adverse Event|3|||
125199528|NCT02002533|450352999|FG000|Overall Study|Lost to Follow-up|0|||
125199529|NCT02002533|450353000|FG001|Overall Study|Lost to Follow-up|1|||
125199530|NCT04984278|450353005|FG000|Period 1|Withdrawal by Subject|1|||
125199531|NCT04984278|450353006|FG001|Period 1|Withdrawal by Subject|0|||
125199532|NCT04984278|450353005|FG000|Period 1|Other|0|||
125199533|NCT04984278|450353006|FG001|Period 1|Other|1|||
125199534|NCT04984278|450353005|FG000|Period 2|Adverse Event|1|||
125199535|NCT04984278|450353006|FG001|Period 2|Adverse Event|0|||
125199536|NCT04984278|450353005|FG000|Period 2|Other|0|||
125199537|NCT04984278|450353006|FG001|Period 2|Other|1|||
125199538|NCT01482065|450353007|FG000|Overall Study|Withdrawal by Subject|0|||
125199539|NCT01482065|450353008|FG001|Overall Study|Withdrawal by Subject|1|||
125199540|NCT00425061|450353009|FG000|Overall Study|Adverse Event|1|||
125199541|NCT00425061|450353010|FG001|Overall Study|Adverse Event|0|||
125199542|NCT00425061|450353011|FG002|Overall Study|Adverse Event|0|||
125199543|NCT00425061|450353012|FG003|Overall Study|Adverse Event|2|||
125199544|NCT00425061|450353013|FG004|Overall Study|Adverse Event|2|||
125199545|NCT00425061|450353014|FG005|Overall Study|Adverse Event|0|||
125199546|NCT00425061|450353015|FG006|Overall Study|Adverse Event|0|||
125199547|NCT00425061|450353009|FG000|Overall Study|Lost to Follow-up|0|||
125199548|NCT00425061|450353010|FG001|Overall Study|Lost to Follow-up|1|||
125199549|NCT00425061|450353011|FG002|Overall Study|Lost to Follow-up|0|||
125199550|NCT00425061|450353012|FG003|Overall Study|Lost to Follow-up|0|||
125199551|NCT00425061|450353013|FG004|Overall Study|Lost to Follow-up|0|||
125199552|NCT00425061|450353014|FG005|Overall Study|Lost to Follow-up|0|||
125199553|NCT00425061|450353015|FG006|Overall Study|Lost to Follow-up|0|||
125199554|NCT00425061|450353009|FG000|Overall Study|Protocol Violation|1|||
125199555|NCT00425061|450353010|FG001|Overall Study|Protocol Violation|0|||
125199556|NCT00425061|450353011|FG002|Overall Study|Protocol Violation|0|||
125199557|NCT00425061|450353012|FG003|Overall Study|Protocol Violation|0|||
125199558|NCT00425061|450353013|FG004|Overall Study|Protocol Violation|0|||
125199559|NCT00425061|450353014|FG005|Overall Study|Protocol Violation|0|||
125199560|NCT00425061|450353015|FG006|Overall Study|Protocol Violation|0|||
125199561|NCT00425061|450353009|FG000|Overall Study|Withdrawal by Subject|0|||
125199562|NCT00425061|450353010|FG001|Overall Study|Withdrawal by Subject|1|||
125199563|NCT00425061|450353011|FG002|Overall Study|Withdrawal by Subject|0|||
125199564|NCT00425061|450353012|FG003|Overall Study|Withdrawal by Subject|0|||
125199565|NCT00425061|450353013|FG004|Overall Study|Withdrawal by Subject|1|||
125199566|NCT00425061|450353014|FG005|Overall Study|Withdrawal by Subject|0|||
125199567|NCT00425061|450353015|FG006|Overall Study|Withdrawal by Subject|3|||
125199568|NCT00425061|450353009|FG000|Overall Study|Sponsor's request|0|||
125199569|NCT00425061|450353010|FG001|Overall Study|Sponsor's request|0|||
125199570|NCT00425061|450353011|FG002|Overall Study|Sponsor's request|0|||
125199571|NCT00425061|450353012|FG003|Overall Study|Sponsor's request|0|||
125199572|NCT00425061|450353013|FG004|Overall Study|Sponsor's request|19|||
125199573|NCT00425061|450353014|FG005|Overall Study|Sponsor's request|4|||
125199574|NCT00425061|450353015|FG006|Overall Study|Sponsor's request|15|||
125199575|NCT00425061|450353009|FG000|Overall Study|Physician Decision|0|||
125199576|NCT00425061|450353010|FG001|Overall Study|Physician Decision|0|||
125199577|NCT00425061|450353011|FG002|Overall Study|Physician Decision|0|||
125199578|NCT00425061|450353012|FG003|Overall Study|Physician Decision|0|||
125199579|NCT00425061|450353013|FG004|Overall Study|Physician Decision|1|||
125199580|NCT00425061|450353014|FG005|Overall Study|Physician Decision|0|||
125199581|NCT00425061|450353015|FG006|Overall Study|Physician Decision|0|||
125199582|NCT00425061|450353009|FG000|Overall Study|Other|0|||
125199583|NCT00425061|450353010|FG001|Overall Study|Other|0|||
125199584|NCT00425061|450353011|FG002|Overall Study|Other|0|||
125199585|NCT00425061|450353012|FG003|Overall Study|Other|0|||
125199586|NCT00425061|450353013|FG004|Overall Study|Other|3|||
125199587|NCT00425061|450353014|FG005|Overall Study|Other|0|||
125199588|NCT00425061|450353015|FG006|Overall Study|Other|1|||
125199589|NCT02137850|450353018|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
125199590|NCT02137850|450353019|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
125199591|NCT02137850|450353020|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
125199592|NCT02137850|450353018|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
125199593|NCT02137850|450353019|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
125199594|NCT02137850|450353020|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
125199595|NCT02137850|450353018|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
125199596|NCT02137850|450353019|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
125199597|NCT02137850|450353020|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
125199598|NCT02137850|450353018|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
125199599|NCT02137850|450353019|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
125199600|NCT02137850|450353020|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
125199601|NCT02137850|450353018|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
125199602|NCT02137850|450353019|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
125199603|NCT02137850|450353020|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
125199604|NCT02137850|450353018|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
125199605|NCT02137850|450353019|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
125199606|NCT02137850|450353020|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
125199607|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
125199608|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
125199609|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
125199610|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
125199611|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
125199612|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
125199613|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
125199614|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
125199615|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
125199616|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
125199617|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
125199618|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
125199619|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Other|0|||
125199620|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Other|1|||
125199621|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Other|0|||
125199622|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
125199623|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
125199624|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
125199625|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Early site closure|0|||
125199626|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Early site closure|2|||
125199627|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Early site closure|0|||
125199628|NCT02137850|450353018|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
125199629|NCT02137850|450353019|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
125199630|NCT02137850|450353020|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
125199631|NCT02137850|450353018|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
125199632|NCT02137850|450353019|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
125199633|NCT02137850|450353020|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
125199634|NCT02137850|450353018|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
125199635|NCT02137850|450353019|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
125199636|NCT02137850|450353020|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
125199637|NCT02137850|450353018|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
125199638|NCT02137850|450353019|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
125199639|NCT02137850|450353020|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
125199640|NCT02137850|450353018|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
125199641|NCT02137850|450353019|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
125199642|NCT02137850|450353020|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
125199643|NCT02137850|450353018|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
125199644|NCT02137850|450353019|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
125199645|NCT02137850|450353020|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
125199646|NCT02137850|450353018|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
125199647|NCT02137850|450353019|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
125199648|NCT02137850|450353020|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
125199649|NCT02137850|450353018|FG000|Extension Phase: Prophylaxis|Other|0|||
125199650|NCT02137850|450353019|FG001|Extension Phase: Prophylaxis|Other|1|||
125199651|NCT02137850|450353020|FG002|Extension Phase: Prophylaxis|Other|0|||
125199652|NCT02137850|450353018|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
125199653|NCT02137850|450353019|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
125199654|NCT02137850|450353020|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
125199655|NCT02651155|450353021|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
125199656|NCT02651155|450353022|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
125199657|NCT02651155|450353021|FG000|Overall Study|Voluntary Withdrawal|5|||
125199658|NCT02651155|450353022|FG001|Overall Study|Voluntary Withdrawal|0|||
125199659|NCT04533412|450353023|FG000|Overall Study|Withdrawal by Subject|1|||
125199660|NCT04533412|450353024|FG001|Overall Study|Withdrawal by Subject|1|||
125199661|NCT04533412|450353023|FG000|Overall Study|Lost to Follow-up|1|||
125199662|NCT04533412|450353024|FG001|Overall Study|Lost to Follow-up|4|||
125199663|NCT00968981|450353030|FG000|Overall Study|Adverse Event|2|||
125199664|NCT00968981|450353031|FG001|Overall Study|Adverse Event|0|||
125199665|NCT00968981|450353032|FG002|Overall Study|Adverse Event|0|||
125199666|NCT00968981|450353030|FG000|Overall Study|Disease Progression|14|||
125199667|NCT00968981|450353031|FG001|Overall Study|Disease Progression|16|||
125199668|NCT00968981|450353032|FG002|Overall Study|Disease Progression|13|||
125199669|NCT00968981|450353030|FG000|Overall Study|Lost to Follow-up|0|||
125199670|NCT00968981|450353031|FG001|Overall Study|Lost to Follow-up|0|||
125199671|NCT00968981|450353032|FG002|Overall Study|Lost to Follow-up|1|||
125199672|NCT00968981|450353030|FG000|Overall Study|Physician Decision|5|||
125199673|NCT00968981|450353031|FG001|Overall Study|Physician Decision|3|||
125199674|NCT00968981|450353032|FG002|Overall Study|Physician Decision|5|||
125199675|NCT00968981|450353030|FG000|Overall Study|Withdrawal by Subject|1|||
125199676|NCT00968981|450353031|FG001|Overall Study|Withdrawal by Subject|3|||
125199677|NCT00968981|450353032|FG002|Overall Study|Withdrawal by Subject|3|||
125199678|NCT01489254|450353035|FG000|Double-blind Part|Adverse Event|7|||
125199679|NCT01489254|450353036|FG001|Double-blind Part|Adverse Event|2|||
125199680|NCT01489254|450353037|FG002|Double-blind Part|Adverse Event|2|||
125199681|NCT01489254|450353038|FG003|Double-blind Part|Adverse Event|0|||
125199682|NCT01489254|450353035|FG000|Double-blind Part|Pregnancy|1|||
125199683|NCT01489254|450353036|FG001|Double-blind Part|Pregnancy|3|||
125199684|NCT01489254|450353037|FG002|Double-blind Part|Pregnancy|0|||
125199685|NCT01489254|450353038|FG003|Double-blind Part|Pregnancy|0|||
125199686|NCT01489254|450353035|FG000|Double-blind Part|Withdrawal by Subject|12|||
125199687|NCT01489254|450353036|FG001|Double-blind Part|Withdrawal by Subject|20|||
125199688|NCT01489254|450353037|FG002|Double-blind Part|Withdrawal by Subject|1|||
125199689|NCT01489254|450353038|FG003|Double-blind Part|Withdrawal by Subject|0|||
125199690|NCT01489254|450353035|FG000|Double-blind Part|Lost to Follow-up|1|||
125199691|NCT01489254|450353036|FG001|Double-blind Part|Lost to Follow-up|2|||
125199692|NCT01489254|450353037|FG002|Double-blind Part|Lost to Follow-up|0|||
125199693|NCT01489254|450353038|FG003|Double-blind Part|Lost to Follow-up|0|||
125199694|NCT01489254|450353035|FG000|Double-blind Part|Other reasons for not completing study|4|||
125199695|NCT01489254|450353036|FG001|Double-blind Part|Other reasons for not completing study|6|||
125199696|NCT01489254|450353037|FG002|Double-blind Part|Other reasons for not completing study|0|||
125199697|NCT01489254|450353038|FG003|Double-blind Part|Other reasons for not completing study|0|||
125199698|NCT01489254|450353035|FG000|Open-label Extension Part|Adverse Event|0|||
125199699|NCT01489254|450353036|FG001|Open-label Extension Part|Adverse Event|0|||
125199700|NCT01489254|450353037|FG002|Open-label Extension Part|Adverse Event|0|||
125199701|NCT01489254|450353038|FG003|Open-label Extension Part|Adverse Event|10|||
125199702|NCT01489254|450353035|FG000|Open-label Extension Part|Pregnancy|0|||
125199703|NCT01489254|450353036|FG001|Open-label Extension Part|Pregnancy|0|||
125199704|NCT01489254|450353037|FG002|Open-label Extension Part|Pregnancy|0|||
125199705|NCT01489254|450353038|FG003|Open-label Extension Part|Pregnancy|3|||
125199706|NCT01489254|450353035|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
125644919|NCT01521494|451982145|FG003|Overall Study|Decrease in serum calcium|1|||
125199707|NCT01489254|450353036|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
125199708|NCT01489254|450353037|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
125199709|NCT01489254|450353038|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
125199710|NCT01489254|450353035|FG000|Open-label Extension Part|Protocol Violation|0|||
125199711|NCT01489254|450353036|FG001|Open-label Extension Part|Protocol Violation|0|||
125199712|NCT01489254|450353037|FG002|Open-label Extension Part|Protocol Violation|0|||
125199713|NCT01489254|450353038|FG003|Open-label Extension Part|Protocol Violation|1|||
125199714|NCT01489254|450353035|FG000|Open-label Extension Part|Lost to Follow-up|0|||
125199715|NCT01489254|450353036|FG001|Open-label Extension Part|Lost to Follow-up|0|||
125199716|NCT01489254|450353037|FG002|Open-label Extension Part|Lost to Follow-up|0|||
125199717|NCT01489254|450353038|FG003|Open-label Extension Part|Lost to Follow-up|9|||
125199718|NCT01489254|450353035|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
125199719|NCT01489254|450353036|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
125199720|NCT01489254|450353037|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
125199721|NCT01489254|450353038|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
125199722|NCT01878084|450353040|FG000|Overall Study|Physician Decision|2|||
125199723|NCT00749684|450353041|FG000|Overall Study|Death|1|||
125199724|NCT00749684|450353041|FG000|Overall Study|Adverse Event|27|||
125199725|NCT00749684|450353041|FG000|Overall Study|Participant's Wish|10|||
125310284|NCT00466921|450762052|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
125310285|NCT00466921|450762052|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
125310286|NCT00466921|450762052|FG000|Follow up for a Minimum of 1 Year|Death|6|||
125310287|NCT02864901|450762053|FG000|Overall Study|Withdrawal by Subject|1|||
125310288|NCT02864901|450762054|FG001|Overall Study|Withdrawal by Subject|0|||
125310289|NCT01219985|450762055|FG000|Overall Study|Physician Decision|20|||
125310290|NCT04797780|450762056|FG000|Overall Study|Lost to Follow-up|1|||
125310291|NCT04797780|450762057|FG001|Overall Study|Lost to Follow-up|1|||
125310292|NCT04797780|450762056|FG000|Overall Study|Withdrawal by Subject|14|||
125310293|NCT04797780|450762057|FG001|Overall Study|Withdrawal by Subject|9|||
125310294|NCT04797780|450762056|FG000|Overall Study|Death|49|||
125310295|NCT04797780|450762057|FG001|Overall Study|Death|20|||
125310296|NCT04669301|450762058|FG000|Overall Study|Lost to Follow-up|0|||
125310297|NCT04669301|450762059|FG001|Overall Study|Lost to Follow-up|1|||
125310298|NCT04669301|450762060|FG002|Overall Study|Lost to Follow-up|0|||
125310299|NCT04669301|450762058|FG000|Overall Study|Withdrawal by Subject|3|||
125310300|NCT04669301|450762059|FG001|Overall Study|Withdrawal by Subject|2|||
125310301|NCT04669301|450762060|FG002|Overall Study|Withdrawal by Subject|0|||
125310302|NCT02863328|450762061|FG000|Overall Study|Lost to Follow-up|4|||
125310303|NCT02863328|450762062|FG001|Overall Study|Lost to Follow-up|10|||
125310304|NCT02863328|450762061|FG000|Overall Study|Withdrawal by Subject|7|||
125310305|NCT02863328|450762062|FG001|Overall Study|Withdrawal by Subject|12|||
125310306|NCT02863328|450762061|FG000|Overall Study|Died|0|||
125310307|NCT02863328|450762062|FG001|Overall Study|Died|1|||
125310308|NCT00398320|450762063|FG000|Overall Study|Death|1|||
125310309|NCT00398320|450762063|FG000|Overall Study|Adverse Event|4|||
125310310|NCT00398320|450762063|FG000|Overall Study|Physician Decision|1|||
125310311|NCT00163020|450762067|FG000|Overall Study|Lost to Follow-up|0|||
125310312|NCT00163020|450762068|FG001|Overall Study|Lost to Follow-up|2|||
125310313|NCT03553758|450763250|FG000|Overall Study|Lost to Follow-up|1|||
125310314|NCT00447226|450763252|FG000|12-Week Open-label Phase|Adverse Event|0|||
125310315|NCT00447226|450763253|FG001|12-Week Open-label Phase|Adverse Event|3|||
125310316|NCT00447226|450763252|FG000|12-Week Open-label Phase|Protocol Violation|0|||
125310317|NCT00447226|450763253|FG001|12-Week Open-label Phase|Protocol Violation|1|||
125310318|NCT00447226|450763252|FG000|12-Week Open-label Phase|Disease Progression|0|||
125310319|NCT00447226|450763253|FG001|12-Week Open-label Phase|Disease Progression|20|||
125310320|NCT00447226|450763252|FG000|12-Week Open-label Phase|Physician Decision|0|||
125310321|NCT00447226|450763253|FG001|12-Week Open-label Phase|Physician Decision|1|||
125310322|NCT00447226|450763252|FG000|Double-blind Phase|Disease Progression|4|||
125310323|NCT00447226|450763253|FG001|Double-blind Phase|Disease Progression|3|||
125310324|NCT01388907|450763267|FG000|Overall Study|Adverse Event|2|||
125310325|NCT01388907|450763268|FG001|Overall Study|Adverse Event|0|||
125310326|NCT03187132|450763269|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
125310327|NCT03187132|450763270|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
125310328|NCT03187132|450763269|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
125534200|NCT01840410|451584899|FG001|Overall Study|Physician Decision|2|||
125534201|NCT01840410|451584898|FG000|Overall Study|Pregnancy|1|||
125534202|NCT01840410|451584899|FG001|Overall Study|Pregnancy|0|||
125534203|NCT01840410|451584898|FG000|Overall Study|Protocol deviation|1|||
125534204|NCT01840410|451584899|FG001|Overall Study|Protocol deviation|0|||
125534205|NCT01840410|451584898|FG000|Overall Study|Lost to Follow-up|1|||
125534206|NCT01840410|451584899|FG001|Overall Study|Lost to Follow-up|0|||
125310329|NCT03187132|450763270|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
125310330|NCT03187132|450763269|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
125310331|NCT03187132|450763270|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
125310332|NCT03187132|450763269|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
125378811|NCT01774968|451017299|FG001|Overall Study|Protocol Violation|13|||
125534207|NCT01840410|451584898|FG000|Overall Study|Withdrawal by Subject|2|||
125199726|NCT00749684|450353041|FG000|Overall Study|Not Documented|1|||
125199727|NCT00749684|450353041|FG000|Overall Study|Progressive Desease|31|||
125199728|NCT00749684|450353041|FG000|Overall Study|Therapy according to protocol + AE|2|||
125199729|NCT00749684|450353041|FG000|Overall Study|AE+discontinuation on participants wish|1|||
125199730|NCT00749684|450353041|FG000|Overall Study|Missing|9|||
125199731|NCT02892422|450353043|FG000|Overall Study|Enrolled not treated|4|||
125199732|NCT02892422|450353043|FG000|Overall Study|Adverse Event|38|||
125199733|NCT02892422|450353043|FG000|Overall Study|Lack of Efficacy|32|||
125199734|NCT02892422|450353043|FG000|Overall Study|Non-compliance with study drug|11|||
125199735|NCT02892422|450353043|FG000|Overall Study|Protocol Violation|4|||
125199736|NCT02892422|450353043|FG000|Overall Study|Withdrawal by Subject|56|||
125199737|NCT02892422|450353043|FG000|Overall Study|Lost to Follow-up|5|||
125199738|NCT02892422|450353043|FG000|Overall Study|sponsor information 16159A results|21|||
125199739|NCT02892422|450353043|FG000|Overall Study|withdrawal of consent|13|||
125199740|NCT02892422|450353043|FG000|Overall Study|exclusion criteria met|3|||
125199741|NCT02892422|450353043|FG000|Overall Study|moving elsewhere|4|||
125199742|NCT02892422|450353043|FG000|Overall Study|non-compliance|10|||
125199743|NCT02892422|450353043|FG000|Overall Study|patient legally incapable|1|||
125199744|NCT02892422|450353043|FG000|Overall Study|patient decision|7|||
125199745|NCT02892422|450353043|FG000|Overall Study|Investigator decision|1|||
125199746|NCT01023256|450353044|FG000|Overall Study|Protocol Violation|2|||
125199747|NCT01023256|450353045|FG001|Overall Study|Protocol Violation|3|||
125199748|NCT01023256|450353046|FG002|Overall Study|Protocol Violation|0|||
125199749|NCT01023256|450353047|FG003|Overall Study|Protocol Violation|0|||
125199750|NCT01023256|450353044|FG000|Overall Study|Randomized but not treated|1|||
125199751|NCT01023256|450353045|FG001|Overall Study|Randomized but not treated|0|||
125199752|NCT01023256|450353046|FG002|Overall Study|Randomized but not treated|1|||
125199753|NCT01023256|450353047|FG003|Overall Study|Randomized but not treated|0|||
125199754|NCT01023256|450353044|FG000|Overall Study|Other|1|||
125199755|NCT01023256|450353045|FG001|Overall Study|Other|0|||
125199756|NCT01023256|450353046|FG002|Overall Study|Other|0|||
125199757|NCT01023256|450353047|FG003|Overall Study|Other|2|||
125199758|NCT01023256|450353044|FG000|Overall Study|Adverse Event|0|||
125199759|NCT01023256|450353045|FG001|Overall Study|Adverse Event|0|||
125199760|NCT01023256|450353046|FG002|Overall Study|Adverse Event|0|||
125199761|NCT01023256|450353047|FG003|Overall Study|Adverse Event|1|||
125199762|NCT01023256|450353044|FG000|Overall Study|Withdrawal by Subject|0|||
125199763|NCT01023256|450353045|FG001|Overall Study|Withdrawal by Subject|0|||
125199764|NCT01023256|450353046|FG002|Overall Study|Withdrawal by Subject|0|||
125199765|NCT01023256|450353047|FG003|Overall Study|Withdrawal by Subject|2|||
125199766|NCT03155178|450353048|FG000|Overall Study|Did not meet treatment day baseline|7|||
125199767|NCT03155178|450353049|FG001|Overall Study|Did not meet treatment day baseline|7|||
125199768|NCT03155178|450353050|FG002|Overall Study|Did not meet treatment day baseline|7|||
125199769|NCT03155178|450353051|FG003|Overall Study|Did not meet treatment day baseline|7|||
125199770|NCT03089697|450353052|FG000|Overall Study|Adverse Event|1|||
125199771|NCT03089697|450353053|FG001|Overall Study|Adverse Event|2|||
125199772|NCT03089697|450353052|FG000|Overall Study|Withdrawal by Subject|1|||
125199773|NCT03089697|450353053|FG001|Overall Study|Withdrawal by Subject|0|||
125199774|NCT03613649|450353054|FG000|Second Treatment|Lost to Follow-up|0|||
125199775|NCT03613649|450353055|FG001|Second Treatment|Lost to Follow-up|0|||
125199776|NCT03613649|450353056|FG002|Second Treatment|Lost to Follow-up|1|||
125199777|NCT03613649|450353057|FG003|Second Treatment|Lost to Follow-up|0|||
125199778|NCT03613649|450353058|FG004|Second Treatment|Lost to Follow-up|0|||
125199779|NCT03613649|450353059|FG005|Second Treatment|Lost to Follow-up|0|||
125199780|NCT03613649|450353060|FG006|Second Treatment|Lost to Follow-up|0|||
125199781|NCT03613649|450353061|FG007|Second Treatment|Lost to Follow-up|0|||
125199782|NCT03613649|450353062|FG008|Second Treatment|Lost to Follow-up|0|||
125199783|NCT03613649|450353063|FG009|Second Treatment|Lost to Follow-up|0|||
125199784|NCT03613649|450353064|FG010|Second Treatment|Lost to Follow-up|0|||
125199785|NCT03613649|450353065|FG011|Second Treatment|Lost to Follow-up|0|||
125422476|NCT03364751|451172845|FG001|Overall Study|Lost to Follow-up|1|||
125422477|NCT03364751|451172846|FG002|Overall Study|Lost to Follow-up|0|||
125422478|NCT03364751|451172847|FG003|Overall Study|Lost to Follow-up|0|||
125422479|NCT00675766|451172848|FG000|Overall Study|Lost to Follow-up|6|||
125422480|NCT00675766|451172849|FG001|Overall Study|Lost to Follow-up|5|||
125422481|NCT00675766|451172850|FG002|Overall Study|Lost to Follow-up|21|||
125422482|NCT00675766|451172851|FG003|Overall Study|Lost to Follow-up|26|||
125422483|NCT02275065|451172853|FG000|Overall Study|Randomized but not treated|1|||
125422484|NCT02275065|451172854|FG001|Overall Study|Randomized but not treated|0|||
125422485|NCT02275065|451172855|FG002|Overall Study|Randomized but not treated|1|||
125422486|NCT02275065|451172856|FG003|Overall Study|Randomized but not treated|1|||
125422487|NCT02275065|451172857|FG004|Overall Study|Randomized but not treated|0|||
125422488|NCT03213158|451172858|FG000|Overall Study|Withdrawal by Subject|1|||
125422489|NCT03213158|451172858|FG000|Overall Study|Physician Decision|2|||
125422490|NCT01207102|451172861|FG000|Overall Study|Withdrawal by Subject|5|||
125422491|NCT01207102|451172861|FG000|Overall Study|Adverse Event|2|||
125422492|NCT01207102|451172861|FG000|Overall Study|progression|2|||
125436532|NCT00879996|451224421|FG001|Overall Study|put on parole|0|||
125534208|NCT01840410|451584899|FG001|Overall Study|Withdrawal by Subject|1|||
125534209|NCT01840410|451584898|FG000|Overall Study|Adverse Event|1|||
125534210|NCT01840410|451584899|FG001|Overall Study|Adverse Event|1|||
125534211|NCT02671500|451584911|FG000|Overall Study|Lack of Efficacy|12|||
125534212|NCT02671500|451584911|FG000|Overall Study|Lost to Follow-up|2|||
125534213|NCT00798434|451584916|FG000|Double-Blind|Adverse Event|22|||
125534214|NCT00798434|451584917|FG001|Double-Blind|Adverse Event|46|||
125534215|NCT00798434|451584916|FG000|Double-Blind|Death|0|||
125534216|NCT00798434|451584917|FG001|Double-Blind|Death|1|||
125199786|NCT03613649|450353054|FG000|Second Treatment|Withdrawal by Subject|0|||
125199787|NCT03613649|450353055|FG001|Second Treatment|Withdrawal by Subject|0|||
125199788|NCT03613649|450353056|FG002|Second Treatment|Withdrawal by Subject|0|||
125199789|NCT03613649|450353057|FG003|Second Treatment|Withdrawal by Subject|0|||
125199790|NCT03613649|450353058|FG004|Second Treatment|Withdrawal by Subject|1|||
125199791|NCT03613649|450353059|FG005|Second Treatment|Withdrawal by Subject|0|||
125199792|NCT03613649|450353060|FG006|Second Treatment|Withdrawal by Subject|0|||
125199793|NCT03613649|450353061|FG007|Second Treatment|Withdrawal by Subject|0|||
125199794|NCT03613649|450353062|FG008|Second Treatment|Withdrawal by Subject|0|||
125199795|NCT03613649|450353063|FG009|Second Treatment|Withdrawal by Subject|0|||
125199796|NCT03613649|450353064|FG010|Second Treatment|Withdrawal by Subject|0|||
125199797|NCT03613649|450353065|FG011|Second Treatment|Withdrawal by Subject|0|||
125199798|NCT03613649|450353054|FG000|Third Treatment|Lost to Follow-up|0|||
125199799|NCT03613649|450353055|FG001|Third Treatment|Lost to Follow-up|0|||
125199800|NCT03613649|450353056|FG002|Third Treatment|Lost to Follow-up|0|||
125199801|NCT03613649|450353057|FG003|Third Treatment|Lost to Follow-up|0|||
125199802|NCT03613649|450353058|FG004|Third Treatment|Lost to Follow-up|1|||
125199803|NCT03613649|450353059|FG005|Third Treatment|Lost to Follow-up|0|||
125199804|NCT03613649|450353060|FG006|Third Treatment|Lost to Follow-up|0|||
125199805|NCT03613649|450353061|FG007|Third Treatment|Lost to Follow-up|0|||
125199806|NCT03613649|450353062|FG008|Third Treatment|Lost to Follow-up|0|||
125199807|NCT03613649|450353063|FG009|Third Treatment|Lost to Follow-up|0|||
125199808|NCT03613649|450353064|FG010|Third Treatment|Lost to Follow-up|0|||
125199809|NCT03613649|450353065|FG011|Third Treatment|Lost to Follow-up|1|||
125199810|NCT03613649|450353054|FG000|Third Treatment|Protocol Violation|0|||
125199811|NCT03613649|450353055|FG001|Third Treatment|Protocol Violation|0|||
125199812|NCT03613649|450353056|FG002|Third Treatment|Protocol Violation|0|||
125199813|NCT03613649|450353057|FG003|Third Treatment|Protocol Violation|0|||
125199814|NCT03613649|450353058|FG004|Third Treatment|Protocol Violation|0|||
125199815|NCT03613649|450353059|FG005|Third Treatment|Protocol Violation|0|||
125199816|NCT03613649|450353060|FG006|Third Treatment|Protocol Violation|1|||
125199817|NCT03613649|450353061|FG007|Third Treatment|Protocol Violation|0|||
125199818|NCT03613649|450353062|FG008|Third Treatment|Protocol Violation|0|||
125199819|NCT03613649|450353063|FG009|Third Treatment|Protocol Violation|0|||
125199820|NCT03613649|450353064|FG010|Third Treatment|Protocol Violation|0|||
125199821|NCT03613649|450353065|FG011|Third Treatment|Protocol Violation|1|||
125199822|NCT03613649|450353054|FG000|Fourth Treatment|Protocol Violation|1|||
125199823|NCT03613649|450353055|FG001|Fourth Treatment|Protocol Violation|0|||
125199824|NCT03613649|450353056|FG002|Fourth Treatment|Protocol Violation|0|||
125199825|NCT03613649|450353057|FG003|Fourth Treatment|Protocol Violation|0|||
125199826|NCT03613649|450353058|FG004|Fourth Treatment|Protocol Violation|1|||
125199827|NCT03613649|450353059|FG005|Fourth Treatment|Protocol Violation|0|||
125199828|NCT03613649|450353060|FG006|Fourth Treatment|Protocol Violation|0|||
125199829|NCT03613649|450353061|FG007|Fourth Treatment|Protocol Violation|0|||
125199830|NCT03613649|450353062|FG008|Fourth Treatment|Protocol Violation|0|||
125199831|NCT03613649|450353063|FG009|Fourth Treatment|Protocol Violation|0|||
125199832|NCT03613649|450353064|FG010|Fourth Treatment|Protocol Violation|0|||
125199833|NCT03613649|450353065|FG011|Fourth Treatment|Protocol Violation|0|||
125199834|NCT03613649|450353054|FG000|Fourth Treatment|Physician Decision|0|||
125199835|NCT03613649|450353055|FG001|Fourth Treatment|Physician Decision|0|||
125199836|NCT03613649|450353056|FG002|Fourth Treatment|Physician Decision|0|||
125199837|NCT03613649|450353057|FG003|Fourth Treatment|Physician Decision|0|||
125199838|NCT03613649|450353058|FG004|Fourth Treatment|Physician Decision|0|||
125534217|NCT00798434|451584916|FG000|Double-Blind|Lost to Follow-up|1|||
125534218|NCT00798434|451584917|FG001|Double-Blind|Lost to Follow-up|0|||
125534219|NCT00798434|451584916|FG000|Double-Blind|Lack of Efficacy|8|||
125199839|NCT03613649|450353059|FG005|Fourth Treatment|Physician Decision|0|||
125199840|NCT03613649|450353060|FG006|Fourth Treatment|Physician Decision|1|||
125199841|NCT03613649|450353061|FG007|Fourth Treatment|Physician Decision|0|||
125199842|NCT03613649|450353062|FG008|Fourth Treatment|Physician Decision|0|||
125199843|NCT03613649|450353063|FG009|Fourth Treatment|Physician Decision|0|||
125199844|NCT03613649|450353064|FG010|Fourth Treatment|Physician Decision|0|||
125199845|NCT03613649|450353065|FG011|Fourth Treatment|Physician Decision|0|||
125199846|NCT00675428|450353066|FG000|Overall Study|Disease Progression|2|||
125199847|NCT00675428|450353067|FG001|Overall Study|Disease Progression|2|||
125199848|NCT00675428|450353066|FG000|Overall Study|No Disease Response After Cycle 6|0|||
125199849|NCT00675428|450353067|FG001|Overall Study|No Disease Response After Cycle 6|1|||
125199850|NCT00675428|450353066|FG000|Overall Study|Physician Decision|1|||
125199851|NCT00675428|450353067|FG001|Overall Study|Physician Decision|0|||
125199852|NCT00319592|450353068|FG000|Overall Study|Protocol Violation|1|||
125199853|NCT00319592|450353069|FG001|Overall Study|Protocol Violation|0|||
125199854|NCT00319592|450353068|FG000|Overall Study|Physician Decision|0|||
125199855|NCT00319592|450353069|FG001|Overall Study|Physician Decision|1|||
125199856|NCT01500187|450353072|FG000|Overall Study|Lost to Follow-up|6|||
125199857|NCT01500187|450353073|FG001|Overall Study|Lost to Follow-up|0|||
125199858|NCT02537431|450353074|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
125199859|NCT02727777|450353075|FG000|Overall Study|Screen Failure|2|||
125199860|NCT02727777|450353076|FG001|Overall Study|Screen Failure|0|||
125199861|NCT02727777|450353077|FG002|Overall Study|Screen Failure|0|||
125199862|NCT02727777|450353075|FG000|Overall Study|Progressive disease|2|||
125199863|NCT02727777|450353076|FG001|Overall Study|Progressive disease|0|||
125199864|NCT02727777|450353077|FG002|Overall Study|Progressive disease|0|||
125199865|NCT01340027|450353079|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
125199866|NCT01340027|450353080|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
125199867|NCT01340027|450353081|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
125199868|NCT01340027|450353082|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
125199869|NCT01340027|450353083|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
125199870|NCT01340027|450353084|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
125199871|NCT01340027|450353085|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
125199872|NCT01340027|450353086|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
125199873|NCT01340027|450353087|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
125199874|NCT01340027|450353088|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
125199875|NCT01340027|450353089|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
125199876|NCT01340027|450353090|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
125199877|NCT01340027|450353079|FG000|Overall Study|Adverse Event|0|||
125199878|NCT01340027|450353080|FG001|Overall Study|Adverse Event|1|||
125199879|NCT01340027|450353081|FG002|Overall Study|Adverse Event|2|||
125199880|NCT01340027|450353082|FG003|Overall Study|Adverse Event|0|||
125199881|NCT01340027|450353083|FG004|Overall Study|Adverse Event|1|||
125199882|NCT01340027|450353084|FG005|Overall Study|Adverse Event|2|||
125199883|NCT01340027|450353085|FG006|Overall Study|Adverse Event|2|||
125199884|NCT01340027|450353086|FG007|Overall Study|Adverse Event|1|||
125199885|NCT01340027|450353087|FG008|Overall Study|Adverse Event|4|||
125199886|NCT01340027|450353088|FG009|Overall Study|Adverse Event|1|||
125199887|NCT01340027|450353089|FG010|Overall Study|Adverse Event|1|||
125199888|NCT01340027|450353090|FG011|Overall Study|Adverse Event|3|||
125199889|NCT01340027|450353079|FG000|Overall Study|Lack of Efficacy|0|||
125199890|NCT01340027|450353080|FG001|Overall Study|Lack of Efficacy|0|||
125199891|NCT01340027|450353081|FG002|Overall Study|Lack of Efficacy|0|||
125199892|NCT01340027|450353082|FG003|Overall Study|Lack of Efficacy|0|||
125199893|NCT01340027|450353083|FG004|Overall Study|Lack of Efficacy|0|||
125199894|NCT01340027|450353084|FG005|Overall Study|Lack of Efficacy|0|||
125199895|NCT01340027|450353085|FG006|Overall Study|Lack of Efficacy|1|||
125199896|NCT01340027|450353086|FG007|Overall Study|Lack of Efficacy|1|||
125199897|NCT01340027|450353087|FG008|Overall Study|Lack of Efficacy|1|||
125199898|NCT01340027|450353088|FG009|Overall Study|Lack of Efficacy|0|||
125199899|NCT01340027|450353089|FG010|Overall Study|Lack of Efficacy|0|||
125199900|NCT01340027|450353090|FG011|Overall Study|Lack of Efficacy|0|||
125199901|NCT01340027|450353079|FG000|Overall Study|Lost to Follow-up|0|||
125199902|NCT01340027|450353080|FG001|Overall Study|Lost to Follow-up|1|||
125199903|NCT01340027|450353081|FG002|Overall Study|Lost to Follow-up|0|||
125199904|NCT01340027|450353082|FG003|Overall Study|Lost to Follow-up|0|||
125199905|NCT01340027|450353083|FG004|Overall Study|Lost to Follow-up|0|||
125199906|NCT01340027|450353084|FG005|Overall Study|Lost to Follow-up|0|||
125199907|NCT01340027|450353085|FG006|Overall Study|Lost to Follow-up|1|||
125199908|NCT01340027|450353086|FG007|Overall Study|Lost to Follow-up|0|||
125199909|NCT01340027|450353087|FG008|Overall Study|Lost to Follow-up|0|||
125199910|NCT01340027|450353088|FG009|Overall Study|Lost to Follow-up|1|||
125199911|NCT01340027|450353089|FG010|Overall Study|Lost to Follow-up|0|||
125199912|NCT01340027|450353090|FG011|Overall Study|Lost to Follow-up|0|||
125199913|NCT01340027|450353079|FG000|Overall Study|Protocol Violation|1|||
125199914|NCT01340027|450353080|FG001|Overall Study|Protocol Violation|2|||
125199915|NCT01340027|450353081|FG002|Overall Study|Protocol Violation|0|||
125199916|NCT01340027|450353082|FG003|Overall Study|Protocol Violation|0|||
125199917|NCT01340027|450353083|FG004|Overall Study|Protocol Violation|6|||
125199918|NCT01340027|450353084|FG005|Overall Study|Protocol Violation|0|||
125199919|NCT01340027|450353085|FG006|Overall Study|Protocol Violation|0|||
125199920|NCT01340027|450353086|FG007|Overall Study|Protocol Violation|1|||
125199921|NCT01340027|450353087|FG008|Overall Study|Protocol Violation|2|||
125199922|NCT01340027|450353088|FG009|Overall Study|Protocol Violation|2|||
125199923|NCT01340027|450353089|FG010|Overall Study|Protocol Violation|0|||
125199924|NCT01340027|450353090|FG011|Overall Study|Protocol Violation|0|||
125199925|NCT01340027|450353079|FG000|Overall Study|Withdrawal by Subject|4|||
125199926|NCT01340027|450353080|FG001|Overall Study|Withdrawal by Subject|3|||
125199927|NCT01340027|450353081|FG002|Overall Study|Withdrawal by Subject|1|||
125199928|NCT01340027|450353082|FG003|Overall Study|Withdrawal by Subject|3|||
125199929|NCT01340027|450353083|FG004|Overall Study|Withdrawal by Subject|3|||
125199930|NCT01340027|450353084|FG005|Overall Study|Withdrawal by Subject|2|||
125199931|NCT01340027|450353085|FG006|Overall Study|Withdrawal by Subject|3|||
125199932|NCT01340027|450353086|FG007|Overall Study|Withdrawal by Subject|4|||
125199933|NCT01340027|450353087|FG008|Overall Study|Withdrawal by Subject|1|||
125199934|NCT01340027|450353088|FG009|Overall Study|Withdrawal by Subject|2|||
125199935|NCT01340027|450353089|FG010|Overall Study|Withdrawal by Subject|0|||
125199936|NCT01340027|450353090|FG011|Overall Study|Withdrawal by Subject|1|||
125199937|NCT01340027|450353079|FG000|Overall Study|Miscellaneous|0|||
125199938|NCT01340027|450353080|FG001|Overall Study|Miscellaneous|0|||
125199939|NCT01340027|450353081|FG002|Overall Study|Miscellaneous|0|||
125199940|NCT01340027|450353082|FG003|Overall Study|Miscellaneous|1|||
125199941|NCT01340027|450353083|FG004|Overall Study|Miscellaneous|0|||
125199942|NCT01340027|450353084|FG005|Overall Study|Miscellaneous|0|||
125199943|NCT01340027|450353085|FG006|Overall Study|Miscellaneous|0|||
125199944|NCT01340027|450353086|FG007|Overall Study|Miscellaneous|0|||
125199945|NCT01340027|450353087|FG008|Overall Study|Miscellaneous|0|||
125199946|NCT01340027|450353088|FG009|Overall Study|Miscellaneous|0|||
125199947|NCT01340027|450353089|FG010|Overall Study|Miscellaneous|1|||
125199948|NCT01340027|450353090|FG011|Overall Study|Miscellaneous|0|||
125199949|NCT01758731|450353091|FG000|Overall Study|Physician Decision|1|||
125199950|NCT04687072|450353092|FG000|Overall Study|Adverse Event|2|||
125199951|NCT04687072|450353093|FG001|Overall Study|Adverse Event|0|||
125199952|NCT04687072|450353092|FG000|Overall Study|Death|1|||
125199953|NCT04687072|450353093|FG001|Overall Study|Death|0|||
125199954|NCT04687072|450353092|FG000|Overall Study|Lack of Efficacy|2|||
125199955|NCT04687072|450353093|FG001|Overall Study|Lack of Efficacy|1|||
125199956|NCT04687072|450353092|FG000|Overall Study|Physician Decision|1|||
125199957|NCT04687072|450353093|FG001|Overall Study|Physician Decision|0|||
125199958|NCT04687072|450353092|FG000|Overall Study|Pregnancy|1|||
125199959|NCT04687072|450353093|FG001|Overall Study|Pregnancy|0|||
125199960|NCT04687072|450353092|FG000|Overall Study|Requires Prohibited Medication|2|||
125199961|NCT04687072|450353093|FG001|Overall Study|Requires Prohibited Medication|0|||
125199962|NCT04687072|450353092|FG000|Overall Study|Withdrawal of Consent|11|||
125199963|NCT04687072|450353093|FG001|Overall Study|Withdrawal of Consent|6|||
125199964|NCT04687072|450353092|FG000|Overall Study|Miscellaneous|4|||
125199965|NCT04687072|450353093|FG001|Overall Study|Miscellaneous|1|||
125199966|NCT00915876|450353094|FG000|Overall Study|Adverse Event|0|||
125199967|NCT00915876|450353095|FG001|Overall Study|Adverse Event|1|||
125199968|NCT01300338|450354918|FG000|Overall Study|Lost to Follow-up|5|||
125199969|NCT01300338|450354919|FG001|Overall Study|Lost to Follow-up|0|||
125199970|NCT01895270|450354920|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
125199971|NCT01895270|450354921|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
125199972|NCT01895270|450354920|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
125199973|NCT01895270|450354921|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
125199974|NCT01895270|450354920|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
125199975|NCT01895270|450354921|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
125199976|NCT01895270|450354920|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
125199977|NCT01895270|450354921|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
125199978|NCT01895270|450354920|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
125199979|NCT01895270|450354921|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
125199980|NCT01895270|450354920|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
125199981|NCT01895270|450354921|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
125199982|NCT01895270|450354920|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
125199983|NCT01895270|450354921|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
125199984|NCT00976820|450354922|FG000|Overall Study|Lost to Follow-up|5|||
125199985|NCT00976820|450354923|FG001|Overall Study|Lost to Follow-up|16|||
125199986|NCT00976820|450354924|FG002|Overall Study|Lost to Follow-up|2|||
125199987|NCT00976820|450354925|FG003|Overall Study|Lost to Follow-up|3|||
125199988|NCT00976820|450354922|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
125199989|NCT00976820|450354923|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
125199990|NCT00976820|450354924|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
125199991|NCT00976820|450354925|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
125199992|NCT00976820|450354922|FG000|Overall Study|Withdrawal by Subject|2|||
125534220|NCT00798434|451584917|FG001|Double-Blind|Lack of Efficacy|12|||
125534221|NCT00798434|451584916|FG000|Double-Blind|Withdrawal by Subject|17|||
125199993|NCT00976820|450354923|FG001|Overall Study|Withdrawal by Subject|4|||
125199994|NCT00976820|450354924|FG002|Overall Study|Withdrawal by Subject|1|||
125199995|NCT00976820|450354925|FG003|Overall Study|Withdrawal by Subject|4|||
125534222|NCT00798434|451584917|FG001|Double-Blind|Withdrawal by Subject|14|||
125534223|NCT00798434|451584916|FG000|Double-Blind|Protocol Violation|1|||
125199996|NCT03261674|450354931|FG000|Overall Study|Lost to Follow-up|6|||
125199997|NCT03261674|450354932|FG001|Overall Study|Lost to Follow-up|7|||
125644920|NCT01521494|451982146|FG004|Overall Study|Decrease in serum calcium|1|||
125644921|NCT01521494|451982142|FG000|Overall Study|Physician Decision|0|||
125199998|NCT03261674|450354931|FG000|Overall Study|Protocol Violation|1|||
125199999|NCT03261674|450354932|FG001|Overall Study|Protocol Violation|4|||
125200000|NCT03261674|450354931|FG000|Overall Study|Withdrawal by Subject|1|||
125200001|NCT03261674|450354932|FG001|Overall Study|Withdrawal by Subject|4|||
125200002|NCT03261674|450354931|FG000|Overall Study|Physician Decision|1|||
125200003|NCT03261674|450354932|FG001|Overall Study|Physician Decision|0|||
125200004|NCT00623935|450354935|FG000|Overall Study|Death|1|||
125200005|NCT00623935|450354935|FG000|Overall Study|Patient Declined Transplant|1|||
125200006|NCT00747474|450354940|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200007|NCT00747474|450354941|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200008|NCT00747474|450354942|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200009|NCT00747474|450354943|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200010|NCT00747474|450354944|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200011|NCT00747474|450354945|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200012|NCT00747474|450354946|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200013|NCT00747474|450354947|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
125200014|NCT00747474|450354948|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200015|NCT00747474|450354949|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200016|NCT00747474|450354950|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200017|NCT00747474|450354951|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
125200018|NCT04507256|450354952|FG000|Overall Study|Withdrawal by Subject|1|||
125200019|NCT04507256|450354953|FG001|Overall Study|Withdrawal by Subject|0|||
125200020|NCT04507256|450354954|FG002|Overall Study|Withdrawal by Subject|0|||
125200021|NCT04507256|450354955|FG003|Overall Study|Withdrawal by Subject|1|||
125200022|NCT04507256|450354956|FG004|Overall Study|Withdrawal by Subject|0|||
125200023|NCT04507256|450354957|FG005|Overall Study|Withdrawal by Subject|0|||
125200024|NCT00631410|450354958|FG000|Overall Study|Adverse Event|1|||
125200025|NCT00631410|450354959|FG001|Overall Study|Adverse Event|3|||
125200026|NCT00631410|450354958|FG000|Overall Study|Objective Progression or Relapse|4|||
125200027|NCT00631410|450354959|FG001|Overall Study|Objective Progression or Relapse|3|||
125200028|NCT00631410|450354958|FG000|Overall Study|Surgery|1|||
125200029|NCT00631410|450354959|FG001|Overall Study|Surgery|0|||
125200030|NCT00890084|450354960|FG000|Overall Study|Adverse Event|16|||
125200031|NCT00890084|450354960|FG000|Overall Study|Lost to Follow-up|126|||
125200032|NCT02980341|450354965|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
125200033|NCT02980341|450354966|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
125200034|NCT02980341|450354967|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
125200035|NCT02980341|450354968|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
125200036|NCT02980341|450354969|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
125200037|NCT02980341|450354970|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
125200038|NCT02980341|450354971|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
125200039|NCT02980341|450354972|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
125200040|NCT02980341|450354973|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
125200041|NCT02980341|450354974|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
125200042|NCT02980341|450354975|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
125200043|NCT02980341|450354965|FG000|Dose Escalation|Clinical progression|0|||
125200044|NCT02980341|450354966|FG001|Dose Escalation|Clinical progression|0|||
125200045|NCT02980341|450354967|FG002|Dose Escalation|Clinical progression|2|||
125200046|NCT02980341|450354968|FG003|Dose Escalation|Clinical progression|1|||
125310333|NCT03187132|450763270|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
125310334|NCT03187132|450763269|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
125310335|NCT03187132|450763270|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
125310336|NCT03187132|450763269|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
125310337|NCT03187132|450763270|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
125310338|NCT03187132|450763269|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
125310339|NCT03187132|450763270|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
125310340|NCT03187132|450763269|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
125310341|NCT03187132|450763270|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
125310342|NCT03187132|450763269|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
125310343|NCT03187132|450763270|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
125310344|NCT03187132|450763269|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
125310345|NCT03187132|450763270|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
125310346|NCT03187132|450763269|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
125310347|NCT03187132|450763270|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
125310348|NCT03594773|450763271|FG000|Overall Study|Withdrawal by Subject|3|||
125310349|NCT03594773|450763272|FG001|Overall Study|Withdrawal by Subject|2|||
125310350|NCT03594773|450763271|FG000|Overall Study|Lost to Follow-up|3|||
125310351|NCT03594773|450763272|FG001|Overall Study|Lost to Follow-up|4|||
125310352|NCT00991939|450763276|FG000|Overall Study|Lost to Follow-up|0|||
125310353|NCT00991939|450763277|FG001|Overall Study|Lost to Follow-up|1|||
125310354|NCT00991939|450763276|FG000|Overall Study|Withdrawal by Subject|1|||
125310355|NCT00991939|450763277|FG001|Overall Study|Withdrawal by Subject|0|||
125310356|NCT00991939|450763276|FG000|Overall Study|Entire study terminated|4|||
125310357|NCT00991939|450763277|FG001|Overall Study|Entire study terminated|1|||
125310358|NCT00714415|450763280|FG000|Overall Study|Lack of Efficacy|1|||
125310359|NCT00714415|450763281|FG001|Overall Study|Lack of Efficacy|0|||
125310360|NCT00714415|450763280|FG000|Overall Study|Death|1|||
125310361|NCT00714415|450763281|FG001|Overall Study|Death|0|||
125310362|NCT01461707|450763284|FG000|Overall Study|Withdrawal by Subject|1|||
125310363|NCT01461707|450763285|FG001|Overall Study|Withdrawal by Subject|0|||
125310364|NCT01100320|450763302|FG000|Period 1|Withdrawal by Subject|2|||
125310365|NCT01100320|450763303|FG001|Period 1|Withdrawal by Subject|4|||
125310366|NCT01100320|450763302|FG000|Period 1|Positive Drug Screen|1|||
125310367|NCT01100320|450763303|FG001|Period 1|Positive Drug Screen|1|||
125310368|NCT01100320|450763302|FG000|Period 1|Adverse Event|2|||
125310369|NCT01100320|450763303|FG001|Period 1|Adverse Event|2|||
125310370|NCT01100320|450763302|FG000|Period 2|Withdrawal by Subject|1|||
125310371|NCT01100320|450763303|FG001|Period 2|Withdrawal by Subject|1|||
125310372|NCT03797586|450763304|FG000|Overall Study|Lost to Follow-up|3|||
125310373|NCT03797586|450763305|FG001|Overall Study|Lost to Follow-up|6|||
125310374|NCT03797586|450763304|FG000|Overall Study|Death|1|||
125310375|NCT03797586|450763305|FG001|Overall Study|Death|1|||
125310376|NCT03797586|450763304|FG000|Overall Study|Adverse Event|0|||
125310377|NCT03797586|450763305|FG001|Overall Study|Adverse Event|2|||
125310378|NCT04980612|450763306|FG000|Overall Study|Withdrawal by Subject|7|||
125310379|NCT04980612|450763307|FG001|Overall Study|Withdrawal by Subject|5|||
125310380|NCT05730387|450763308|FG000|Overall Study|Stillbirth|0|||
125310381|NCT05730387|450763309|FG001|Overall Study|Stillbirth|262|||
125310382|NCT05730387|450763308|FG000|Overall Study|Died during or after delivery|2|||
125310383|NCT05730387|450763309|FG001|Overall Study|Died during or after delivery|85|||
125310384|NCT05730387|450763308|FG000|Overall Study|Died after being admitted|0|||
125310385|NCT05730387|450763309|FG001|Overall Study|Died after being admitted|44|||
125310386|NCT05730387|450763308|FG000|Overall Study|Lost to Follow-up|69|||
125310387|NCT05730387|450763309|FG001|Overall Study|Lost to Follow-up|77|||
125310388|NCT01369784|450763312|FG000|Overall Study|Protocol Violation|12|||
125310389|NCT02680665|450763313|FG000|Overall Study|No visit after the first prescription|5|||
125310390|NCT00596752|450763314|FG000|Overall Study|Other Reason|44|||
125310391|NCT00596752|450763315|FG001|Overall Study|Other Reason|49|||
125310392|NCT00596752|450763314|FG000|Overall Study|Adverse Event|34|||
125310393|NCT00596752|450763315|FG001|Overall Study|Adverse Event|34|||
125534224|NCT00798434|451584917|FG001|Double-Blind|Protocol Violation|4|||
125310394|NCT00596752|450763314|FG000|Overall Study|Lost to Follow-up|22|||
125310395|NCT00596752|450763315|FG001|Overall Study|Lost to Follow-up|38|||
125310396|NCT00596752|450763314|FG000|Overall Study|Withdrawal by Subject|12|||
125310397|NCT00596752|450763315|FG001|Overall Study|Withdrawal by Subject|9|||
125310398|NCT00596752|450763314|FG000|Overall Study|Unsatisfactory Compliance|9|||
125310399|NCT00596752|450763315|FG001|Overall Study|Unsatisfactory Compliance|6|||
125310400|NCT00596752|450763314|FG000|Overall Study|Lack of Efficacy|4|||
125310401|NCT00596752|450763315|FG001|Overall Study|Lack of Efficacy|7|||
125310402|NCT00596752|450763314|FG000|Overall Study|Protocol Violation|1|||
125310403|NCT00596752|450763315|FG001|Overall Study|Protocol Violation|0|||
125310404|NCT05973006|450763316|FG000|Overall Study|Early termination|3|||
125310405|NCT05973006|450763317|FG001|Overall Study|Early termination|9|||
125310406|NCT04378270|450763319|FG000|Overall Study|Lack of Efficacy|1|||
125310407|NCT04378270|450763319|FG000|Overall Study|Withdrawal by Subject|1|||
125310408|NCT04378270|450763319|FG000|Overall Study|Screen Failure|1|||
125310409|NCT04378270|450763319|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
125310410|NCT01327599|450763320|FG000|Overall Study|Adverse Event|1|||
125310411|NCT01327599|450763320|FG000|Overall Study|Could Not Attend Visit|1|||
125310412|NCT01327599|450763320|FG000|Overall Study|Withdrawal of Consent|1|||
125310413|NCT04544956|450763323|FG000|Overall Study|Withdrawal by Subject|1|||
125310414|NCT00548145|450763326|FG000|Overall Study|Death|0|||
125310415|NCT00548145|450763327|FG001|Overall Study|Death|1|||
125310416|NCT00548145|450763326|FG000|Overall Study|Withdrawal by Subject|0|||
125310417|NCT00548145|450763327|FG001|Overall Study|Withdrawal by Subject|2|||
125310418|NCT00548145|450763326|FG000|Overall Study|Physician Decision|1|||
125310419|NCT00548145|450763327|FG001|Overall Study|Physician Decision|1|||
125310420|NCT02119663|450763328|FG000|Overall Study|Disease progression|26|||
125310421|NCT02119663|450763329|FG001|Overall Study|Disease progression|27|||
125310422|NCT02119663|450763328|FG000|Overall Study|Adverse Event|5|||
125310423|NCT02119663|450763329|FG001|Overall Study|Adverse Event|5|||
125310424|NCT02119663|450763328|FG000|Overall Study|Death|3|||
125310425|NCT02119663|450763329|FG001|Overall Study|Death|2|||
125310426|NCT02119663|450763328|FG000|Overall Study|Physician Decision|1|||
125310427|NCT02119663|450763329|FG001|Overall Study|Physician Decision|2|||
125310428|NCT02119663|450763328|FG000|Overall Study|Other unspecified|2|||
125310429|NCT02119663|450763329|FG001|Overall Study|Other unspecified|0|||
125310430|NCT02119663|450763328|FG000|Overall Study|Subject decision|0|||
125310431|NCT02119663|450763329|FG001|Overall Study|Subject decision|1|||
125310432|NCT02119663|450763328|FG000|Overall Study|Study Terminated by the Sponsor|3|||
125644922|NCT01521494|451982143|FG001|Overall Study|Physician Decision|0|||
125310433|NCT02119663|450763329|FG001|Overall Study|Study Terminated by the Sponsor|4|||
125310434|NCT00892775|450763330|FG000|Overall Study|Protocol Violation|1|||
125310435|NCT00892775|450763331|FG001|Overall Study|Protocol Violation|0|||
125310436|NCT00892775|450763330|FG000|Overall Study|Subject difficulties with blood drawing|1|||
125310437|NCT00892775|450763331|FG001|Overall Study|Subject difficulties with blood drawing|0|||
125310438|NCT00892775|450763330|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
125310439|NCT00892775|450763331|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
125310440|NCT00892775|450763330|FG000|Overall Study|Migrated/ moved from study area|1|||
125310441|NCT00892775|450763331|FG001|Overall Study|Migrated/ moved from study area|0|||
125310442|NCT00892775|450763330|FG000|Overall Study|Withdrawal by Subject|0|||
125310443|NCT00892775|450763331|FG001|Overall Study|Withdrawal by Subject|1|||
125310444|NCT00892775|450763330|FG000|Overall Study|Lost to Follow-up|1|||
125310445|NCT00892775|450763331|FG001|Overall Study|Lost to Follow-up|0|||
125310446|NCT00699660|450763332|FG000|Overall Study|Lost to Follow-up|4|||
125310447|NCT00699660|450763333|FG001|Overall Study|Lost to Follow-up|2|||
125310448|NCT00699660|450763332|FG000|Overall Study|missing reports and recording failures|10|||
125310449|NCT00699660|450763333|FG001|Overall Study|missing reports and recording failures|6|||
125310450|NCT00064792|450763334|FG000|Overall Study|Withdrawal by Subject|2|||
125310451|NCT00064792|450763335|FG001|Overall Study|Withdrawal by Subject|0|||
125310452|NCT00064792|450763334|FG000|Overall Study|Adverse Event|3|||
125310453|NCT00064792|450763335|FG001|Overall Study|Adverse Event|0|||
125310454|NCT03301350|450763336|FG000|Overall Study|Withdrawal by Subject|4|||
125310455|NCT03301350|450763336|FG000|Overall Study|Adverse Event|1|||
125310456|NCT03301350|450763336|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
125310457|NCT03301350|450763336|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
125310458|NCT03301350|450763336|FG000|Overall Study|no detail provided|1|||
125310459|NCT01248949|450763339|FG000|Overall Study|Lost to Follow-up|2|||
125310460|NCT01248949|450763340|FG001|Overall Study|Lost to Follow-up|2|||
125310461|NCT01248949|450763341|FG002|Overall Study|Lost to Follow-up|2|||
125310462|NCT01248949|450763342|FG003|Overall Study|Lost to Follow-up|1|||
125310463|NCT01248949|450763343|FG004|Overall Study|Lost to Follow-up|0|||
125310464|NCT01248949|450763339|FG000|Overall Study|Withdrawal by Subject|5|||
125310465|NCT01248949|450763340|FG001|Overall Study|Withdrawal by Subject|3|||
125310466|NCT01248949|450763341|FG002|Overall Study|Withdrawal by Subject|11|||
125310467|NCT01248949|450763342|FG003|Overall Study|Withdrawal by Subject|3|||
125310468|NCT01248949|450763343|FG004|Overall Study|Withdrawal by Subject|1|||
125310469|NCT01248949|450763339|FG000|Overall Study|Death|22|||
125310470|NCT01248949|450763340|FG001|Overall Study|Death|7|||
125310471|NCT01248949|450763341|FG002|Overall Study|Death|21|||
125310472|NCT01248949|450763342|FG003|Overall Study|Death|6|||
125310473|NCT01248949|450763343|FG004|Overall Study|Death|2|||
125310474|NCT01248949|450763339|FG000|Overall Study|Alternative Therapy|1|||
125310475|NCT01248949|450763340|FG001|Overall Study|Alternative Therapy|0|||
125310476|NCT01248949|450763341|FG002|Overall Study|Alternative Therapy|0|||
125310477|NCT01248949|450763342|FG003|Overall Study|Alternative Therapy|0|||
125310478|NCT01248949|450763343|FG004|Overall Study|Alternative Therapy|0|||
125310479|NCT01248949|450763339|FG000|Overall Study|Alternative Therapy.|1|||
125310480|NCT01248949|450763340|FG001|Overall Study|Alternative Therapy.|0|||
125310481|NCT01248949|450763341|FG002|Overall Study|Alternative Therapy.|0|||
125310482|NCT01248949|450763342|FG003|Overall Study|Alternative Therapy.|0|||
125310483|NCT01248949|450763343|FG004|Overall Study|Alternative Therapy.|0|||
125310484|NCT01248949|450763339|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
125310485|NCT01248949|450763340|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
125310486|NCT01248949|450763341|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
125310487|NCT01248949|450763342|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
125310488|NCT01248949|450763343|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
125310489|NCT01248949|450763339|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
125310490|NCT01248949|450763340|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
125310491|NCT01248949|450763341|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
125310492|NCT01248949|450763342|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
125310493|NCT01248949|450763343|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
125310494|NCT01248949|450763339|FG000|Overall Study|Participant Went To Hospice|0|||
125310495|NCT01248949|450763340|FG001|Overall Study|Participant Went To Hospice|0|||
125310496|NCT01248949|450763341|FG002|Overall Study|Participant Went To Hospice|1|||
125310497|NCT01248949|450763342|FG003|Overall Study|Participant Went To Hospice|0|||
125310498|NCT01248949|450763343|FG004|Overall Study|Participant Went To Hospice|0|||
125310499|NCT01248949|450763339|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
125310500|NCT01248949|450763340|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
125644923|NCT01521494|451982144|FG002|Overall Study|Physician Decision|0|||
125310501|NCT01248949|450763341|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
125310502|NCT01248949|450763342|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
125310503|NCT01248949|450763343|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
125310504|NCT01248949|450763339|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
125378812|NCT01774968|451017298|FG000|Overall Study|Sponsor Decision|0|||
125310505|NCT01248949|450763340|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
125310506|NCT01248949|450763341|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
125310507|NCT01248949|450763342|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
125310508|NCT01248949|450763343|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
125310509|NCT01248949|450763339|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
125310510|NCT01248949|450763340|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
125310511|NCT01248949|450763341|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
125310512|NCT01248949|450763342|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
125310513|NCT01248949|450763343|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
125310514|NCT01248949|450763339|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
125310515|NCT01248949|450763340|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
125310516|NCT01248949|450763341|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
125310517|NCT01248949|450763342|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
125310518|NCT01248949|450763343|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
125310519|NCT03915470|450763346|FG000|Overall Study|Death|3|||
125310520|NCT03915470|450763347|FG001|Overall Study|Death|1|||
125310521|NCT03915470|450763346|FG000|Overall Study|Adverse Event|1|||
125310522|NCT03915470|450763347|FG001|Overall Study|Adverse Event|0|||
125310523|NCT03915470|450763346|FG000|Overall Study|Physician Decision|1|||
125310524|NCT03915470|450763347|FG001|Overall Study|Physician Decision|0|||
125310525|NCT03915470|450763346|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
125310526|NCT03915470|450763347|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
125310527|NCT03245775|450763350|FG000|Overall Study|Lost to Follow-up|25|||
125310528|NCT03245775|450763351|FG001|Overall Study|Lost to Follow-up|26|||
125310529|NCT03245775|450763352|FG002|Overall Study|Lost to Follow-up|16|||
125310530|NCT03245775|450763353|FG003|Overall Study|Lost to Follow-up|16|||
125310531|NCT02713828|450763354|FG000|Overall Study|Death|2|||
125310532|NCT02713828|450763355|FG001|Overall Study|Death|0|||
125310533|NCT02713828|450763354|FG000|Overall Study|Withdrawal by Subject|1|||
125310534|NCT02713828|450763355|FG001|Overall Study|Withdrawal by Subject|0|||
125310535|NCT02713828|450763354|FG000|Overall Study|study terminated but patient allowed to|2|||
125310536|NCT02713828|450763355|FG001|Overall Study|study terminated but patient allowed to|0|||
125310537|NCT00434109|450763356|FG000|Overall Study|Physician Decision|9|||
125310538|NCT00434109|450763356|FG000|Overall Study|Adverse Event|5|||
125310539|NCT00434109|450763356|FG000|Overall Study|Protocol Violation|1|||
125310540|NCT00434109|450763356|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
125310541|NCT02978833|450763359|FG000|Overall Study|Study terminated|1|||
125310542|NCT02978833|450763360|FG001|Overall Study|Study terminated|1|||
125310543|NCT00103740|450763361|FG000|Period 1 - Core|Adverse Event|1|||
125310544|NCT00103740|450763362|FG001|Period 1 - Core|Adverse Event|0|||
125310545|NCT00103740|450763361|FG000|Period 1 - Core|Protocol Violation|3|||
125310546|NCT00103740|450763362|FG001|Period 1 - Core|Protocol Violation|2|||
125310547|NCT00103740|450763361|FG000|Period 1 - Core|Patient withdrew consent|3|||
125310548|NCT00103740|450763362|FG001|Period 1 - Core|Patient withdrew consent|2|||
125310549|NCT00103740|450763361|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
125310550|NCT00103740|450763362|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
125310551|NCT00103740|450763361|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
125310552|NCT00103740|450763362|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
125310553|NCT00103740|450763361|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
125310554|NCT00103740|450763362|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
125310555|NCT00103740|450763361|FG000|Period 2 - Extended Observation Period|Death|6|||
125310556|NCT00103740|450763362|FG001|Period 2 - Extended Observation Period|Death|2|||
125310557|NCT00103740|450763361|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
125310558|NCT00103740|450763362|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
125310559|NCT00291486|450763367|FG000|Overall Study|Adverse Event|0|||
125310560|NCT00291486|450763368|FG001|Overall Study|Adverse Event|3|||
125310561|NCT00291486|450763369|FG002|Overall Study|Adverse Event|0|||
125310562|NCT00291486|450763370|FG003|Overall Study|Adverse Event|1|||
125310563|NCT00291486|450763371|FG004|Overall Study|Adverse Event|0|||
125310564|NCT00291486|450763367|FG000|Overall Study|Withdrawal by Subject|0|||
125310565|NCT00291486|450763368|FG001|Overall Study|Withdrawal by Subject|0|||
125310566|NCT00291486|450763369|FG002|Overall Study|Withdrawal by Subject|0|||
125310567|NCT00291486|450763370|FG003|Overall Study|Withdrawal by Subject|0|||
125310568|NCT00291486|450763371|FG004|Overall Study|Withdrawal by Subject|1|||
125310569|NCT00291486|450763367|FG000|Overall Study|Disease progression|1|||
125310570|NCT00291486|450763368|FG001|Overall Study|Disease progression|0|||
125310571|NCT00291486|450763369|FG002|Overall Study|Disease progression|1|||
125310572|NCT00291486|450763370|FG003|Overall Study|Disease progression|0|||
125310573|NCT00291486|450763371|FG004|Overall Study|Disease progression|0|||
125310574|NCT01099397|450763372|FG000|Overall Study|Lost to Follow-up|4|||
125310575|NCT01099397|450763372|FG000|Overall Study|Protocol Violation|4|||
125310576|NCT01099397|450763372|FG000|Overall Study|Withdrawal by Subject|5|||
125310577|NCT01900652|450763375|FG000|Overall Study|Progressive Disease|1|||
125310578|NCT01900652|450763376|FG001|Overall Study|Progressive Disease|0|||
125310579|NCT01900652|450763375|FG000|Overall Study|Consent withdrawn by subject|1|||
125310580|NCT01900652|450763376|FG001|Overall Study|Consent withdrawn by subject|1|||
125310581|NCT01900652|450763375|FG000|Overall Study|Death|3|||
125310582|NCT01900652|450763376|FG001|Overall Study|Death|0|||
125310583|NCT01900652|450763375|FG000|Overall Study|Adverse Event|2|||
125310584|NCT01900652|450763376|FG001|Overall Study|Adverse Event|1|||
125310585|NCT01900652|450763375|FG000|Overall Study|Physician Decision|1|||
125310586|NCT01900652|450763376|FG001|Overall Study|Physician Decision|1|||
125310587|NCT02663622|450763379|FG000|Overall Study|Death|3|||
125310588|NCT02663622|450763380|FG001|Overall Study|Death|1|||
125310589|NCT02663622|450763381|FG002|Overall Study|Death|1|||
125310590|NCT02663622|450763382|FG003|Overall Study|Death|8|||
125310591|NCT02663622|450763379|FG000|Overall Study|Protocol Violation|0|||
125310592|NCT02663622|450763380|FG001|Overall Study|Protocol Violation|0|||
125310593|NCT02663622|450763381|FG002|Overall Study|Protocol Violation|0|||
125310594|NCT02663622|450763382|FG003|Overall Study|Protocol Violation|1|||
125310595|NCT01792115|450763383|FG000|Overall Study|Lost to Follow-up|0|||
125310596|NCT01792115|450763384|FG001|Overall Study|Lost to Follow-up|1|||
125310597|NCT01792115|450763385|FG002|Overall Study|Lost to Follow-up|0|||
125310598|NCT00900029|450763386|FG000|Overall Study|Lost to Follow-up|0|||
125310599|NCT00900029|450763387|FG001|Overall Study|Lost to Follow-up|2|||
125310600|NCT00900029|450763388|FG002|Overall Study|Lost to Follow-up|1|||
125310601|NCT00900029|450763389|FG003|Overall Study|Lost to Follow-up|4|||
125310602|NCT00900029|450763390|FG004|Overall Study|Lost to Follow-up|4|||
125310603|NCT00900029|450763386|FG000|Overall Study|Withdrawal by Subject|2|||
125310604|NCT00900029|450763387|FG001|Overall Study|Withdrawal by Subject|2|||
125310605|NCT00900029|450763388|FG002|Overall Study|Withdrawal by Subject|1|||
125310606|NCT00900029|450763389|FG003|Overall Study|Withdrawal by Subject|1|||
125310607|NCT00900029|450763390|FG004|Overall Study|Withdrawal by Subject|1|||
125310608|NCT00900029|450763386|FG000|Overall Study|Adverse Event|0|||
125310609|NCT00900029|450763387|FG001|Overall Study|Adverse Event|0|||
125310610|NCT00900029|450763388|FG002|Overall Study|Adverse Event|1|||
125310611|NCT00900029|450763389|FG003|Overall Study|Adverse Event|1|||
125310612|NCT00900029|450763390|FG004|Overall Study|Adverse Event|1|||
125310613|NCT00900029|450763386|FG000|Overall Study|Death|1|||
125310614|NCT00900029|450763387|FG001|Overall Study|Death|0|||
125310615|NCT00900029|450763388|FG002|Overall Study|Death|0|||
125310616|NCT00900029|450763389|FG003|Overall Study|Death|1|||
125310617|NCT00900029|450763390|FG004|Overall Study|Death|0|||
125378813|NCT01774968|451017299|FG001|Overall Study|Sponsor Decision|2|||
125378814|NCT01774968|451017298|FG000|Overall Study|Withdrawal by Subject|6|||
125378815|NCT01774968|451017299|FG001|Overall Study|Withdrawal by Subject|11|||
125378816|NCT01937559|451017308|FG000|Overall Study|Physician Decision|3|||
125378817|NCT01937559|451017309|FG001|Overall Study|Physician Decision|3|||
125378818|NCT01937559|451017310|FG002|Overall Study|Physician Decision|0|||
125378819|NCT01937559|451017308|FG000|Overall Study|Withdrawal by Subject|6|||
125378820|NCT01937559|451017309|FG001|Overall Study|Withdrawal by Subject|4|||
125378821|NCT01937559|451017310|FG002|Overall Study|Withdrawal by Subject|0|||
125378822|NCT01937559|451017308|FG000|Overall Study|screen fail|2|||
125378823|NCT01937559|451017309|FG001|Overall Study|screen fail|4|||
125378824|NCT01937559|451017310|FG002|Overall Study|screen fail|0|||
125378825|NCT04203238|451019163|FG000|Overall Study|Withdrawal by Subject|1|||
125378826|NCT04203238|451019164|FG001|Overall Study|Withdrawal by Subject|1|||
125378827|NCT04203238|451019163|FG000|Overall Study|Covid-19|3|||
125378828|NCT04203238|451019164|FG001|Overall Study|Covid-19|0|||
125378829|NCT01955733|451019165|FG000|Period 1|Lost to Follow-up|1|||
125378830|NCT01955733|451019166|FG001|Period 1|Lost to Follow-up|0|||
125378831|NCT01955733|451019167|FG002|Period 1|Lost to Follow-up|0|||
125378832|NCT01955733|451019165|FG000|Period 2|Adverse Event|1|||
125378833|NCT01955733|451019166|FG001|Period 2|Adverse Event|0|||
125378834|NCT01955733|451019167|FG002|Period 2|Adverse Event|0|||
125378835|NCT01955733|451019165|FG000|Period 2|Physician Decision|0|||
125378836|NCT01955733|451019166|FG001|Period 2|Physician Decision|0|||
125378837|NCT01955733|451019167|FG002|Period 2|Physician Decision|1|||
125378838|NCT01955733|451019165|FG000|Period 2|Withdrawal by Subject|1|||
125378839|NCT01955733|451019166|FG001|Period 2|Withdrawal by Subject|3|||
125378840|NCT01955733|451019167|FG002|Period 2|Withdrawal by Subject|2|||
125378841|NCT01955733|451019165|FG000|Period 2|Study terminated by sponsor|8|||
125378842|NCT01955733|451019166|FG001|Period 2|Study terminated by sponsor|14|||
125534225|NCT00798434|451584916|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
125378843|NCT01955733|451019167|FG002|Period 2|Study terminated by sponsor|16|||
125378844|NCT01955733|451019165|FG000|Period 2|Lost to Follow-up|2|||
125378845|NCT01955733|451019166|FG001|Period 2|Lost to Follow-up|0|||
125378846|NCT01955733|451019167|FG002|Period 2|Lost to Follow-up|0|||
125378847|NCT01955733|451019165|FG000|Period 2|Other not defined above|0|||
125378848|NCT01955733|451019166|FG001|Period 2|Other not defined above|2|||
125378849|NCT01955733|451019167|FG002|Period 2|Other not defined above|2|||
125378850|NCT00733408|451019168|FG000|Overall Study|Adverse Event|4|||
125378851|NCT01134783|451019170|FG000|Overall Study|Pregnancy|16|||
125310618|NCT01594931|450766468|FG000|Overall Study|Adverse Event|3|||
125310619|NCT01594931|450766469|FG001|Overall Study|Adverse Event|1|||
125310620|NCT01594931|450766470|FG002|Overall Study|Adverse Event|1|||
125310621|NCT01594931|450766468|FG000|Overall Study|Withdrawal by Subject|2|||
125310622|NCT01594931|450766469|FG001|Overall Study|Withdrawal by Subject|1|||
125310623|NCT01594931|450766470|FG002|Overall Study|Withdrawal by Subject|1|||
125310624|NCT01594931|450766468|FG000|Overall Study|Lack of Efficacy|7|||
125310625|NCT01594931|450766469|FG001|Overall Study|Lack of Efficacy|2|||
125310626|NCT01594931|450766470|FG002|Overall Study|Lack of Efficacy|2|||
125310627|NCT01594931|450766468|FG000|Overall Study|Lost to Follow-up|4|||
125310628|NCT01594931|450766469|FG001|Overall Study|Lost to Follow-up|3|||
125310629|NCT01594931|450766470|FG002|Overall Study|Lost to Follow-up|3|||
125310630|NCT01594931|450766468|FG000|Overall Study|Protocol Violation|2|||
125310631|NCT01594931|450766469|FG001|Overall Study|Protocol Violation|1|||
125310632|NCT01594931|450766470|FG002|Overall Study|Protocol Violation|0|||
125310633|NCT01594931|450766468|FG000|Overall Study|No defiined|11|||
125310634|NCT01594931|450766469|FG001|Overall Study|No defiined|4|||
125310635|NCT01594931|450766470|FG002|Overall Study|No defiined|7|||
125310636|NCT02936635|450766479|FG000|Overall Study|Adverse Event|43|||
125310637|NCT02936635|450766480|FG001|Overall Study|Adverse Event|25|||
125310638|NCT02936635|450766479|FG000|Overall Study|Progressive Disease|10|||
125310639|NCT02936635|450766480|FG001|Overall Study|Progressive Disease|18|||
125310640|NCT02936635|450766479|FG000|Overall Study|Sponsor Discretion|10|||
125310641|NCT02936635|450766480|FG001|Overall Study|Sponsor Discretion|16|||
125310642|NCT02936635|450766479|FG000|Overall Study|Death|9|||
125310643|NCT02936635|450766480|FG001|Overall Study|Death|15|||
125310644|NCT02936635|450766479|FG000|Overall Study|Withdrawal by Subject|8|||
125310645|NCT02936635|450766480|FG001|Overall Study|Withdrawal by Subject|15|||
125310646|NCT02936635|450766479|FG000|Overall Study|Physician Decision|2|||
125310647|NCT02936635|450766480|FG001|Overall Study|Physician Decision|9|||
125310648|NCT02936635|450766479|FG000|Overall Study|Lost to Follow-up|1|||
125310649|NCT02936635|450766480|FG001|Overall Study|Lost to Follow-up|2|||
125310650|NCT02936635|450766479|FG000|Overall Study|Protocol Violation|1|||
125310651|NCT02936635|450766480|FG001|Overall Study|Protocol Violation|0|||
125310652|NCT02936635|450766479|FG000|Overall Study|Lack of effect/Entry into other study|31|||
125310653|NCT02936635|450766480|FG001|Overall Study|Lack of effect/Entry into other study|65|||
125310654|NCT01633788|450766481|FG000|Overall Study|Adverse Event|1|||
125310655|NCT01633788|450766482|FG001|Overall Study|Adverse Event|3|||
125310656|NCT01633788|450766483|FG002|Overall Study|Adverse Event|3|||
125310657|NCT01633788|450766484|FG003|Overall Study|Adverse Event|3|||
125310658|NCT01633788|450766481|FG000|Overall Study|Lost to Follow-up|2|||
125310659|NCT01633788|450766482|FG001|Overall Study|Lost to Follow-up|2|||
125310660|NCT01633788|450766483|FG002|Overall Study|Lost to Follow-up|2|||
125310661|NCT01633788|450766484|FG003|Overall Study|Lost to Follow-up|0|||
125310662|NCT01633788|450766481|FG000|Overall Study|Personal Reasons|3|||
125310663|NCT01633788|450766482|FG001|Overall Study|Personal Reasons|1|||
125310664|NCT01633788|450766483|FG002|Overall Study|Personal Reasons|1|||
125310665|NCT01633788|450766484|FG003|Overall Study|Personal Reasons|3|||
125310666|NCT01633788|450766481|FG000|Overall Study|Protocol Violation|1|||
125310667|NCT01633788|450766482|FG001|Overall Study|Protocol Violation|0|||
125310668|NCT01633788|450766483|FG002|Overall Study|Protocol Violation|1|||
125310669|NCT01633788|450766484|FG003|Overall Study|Protocol Violation|0|||
125310670|NCT01633788|450766481|FG000|Overall Study|Other Reasons|0|||
125310671|NCT01633788|450766482|FG001|Overall Study|Other Reasons|2|||
125310672|NCT01633788|450766483|FG002|Overall Study|Other Reasons|3|||
125310673|NCT01633788|450766484|FG003|Overall Study|Other Reasons|7|||
125310674|NCT01929226|450766485|FG000|Overall Study|Lost to Follow-up|4|||
125310675|NCT01929226|450766486|FG001|Overall Study|Lost to Follow-up|0|||
125310676|NCT01929226|450766485|FG000|Overall Study|Withdrawal by Subject|1|||
125310677|NCT01929226|450766486|FG001|Overall Study|Withdrawal by Subject|1|||
125310678|NCT01473732|450766488|FG000|Overall Study|Adverse Event|1|||
125310679|NCT01473732|450766489|FG001|Overall Study|Adverse Event|0|||
125310680|NCT01473732|450766488|FG000|Overall Study|Death|1|||
125310681|NCT01473732|450766489|FG001|Overall Study|Death|0|||
125310682|NCT01217944|450766496|FG000|Overall Study|Protocol Violation|1|||
125310683|NCT01217944|450766497|FG001|Overall Study|Protocol Violation|1|||
125310684|NCT01217944|450766498|FG002|Overall Study|Protocol Violation|0|||
125310685|NCT01217944|450766496|FG000|Overall Study|Lost to Follow-up|3|||
125310686|NCT01217944|450766497|FG001|Overall Study|Lost to Follow-up|1|||
125310687|NCT01217944|450766498|FG002|Overall Study|Lost to Follow-up|0|||
125310688|NCT01217944|450766496|FG000|Overall Study|Withdrawal by Subject|1|||
125310689|NCT01217944|450766497|FG001|Overall Study|Withdrawal by Subject|2|||
125310690|NCT01217944|450766498|FG002|Overall Study|Withdrawal by Subject|0|||
125310691|NCT01217944|450766496|FG000|Overall Study|Lack of Efficacy|1|||
125310692|NCT01217944|450766497|FG001|Overall Study|Lack of Efficacy|0|||
125310693|NCT01217944|450766498|FG002|Overall Study|Lack of Efficacy|0|||
125310694|NCT03579940|450766499|FG000|Period 2|Withdrawal by Subject|0|||
125310695|NCT03579940|450766500|FG001|Period 2|Withdrawal by Subject|0|||
125310696|NCT03579940|450766501|FG002|Period 2|Withdrawal by Subject|1|||
125310697|NCT03579940|450766502|FG003|Period 2|Withdrawal by Subject|0|||
125310698|NCT03579940|450766503|FG004|Period 2|Withdrawal by Subject|0|||
125310699|NCT03579940|450766504|FG005|Period 2|Withdrawal by Subject|0|||
125310700|NCT03579940|450766505|FG006|Period 2|Withdrawal by Subject|0|||
125310701|NCT03579940|450766506|FG007|Period 2|Withdrawal by Subject|0|||
125310702|NCT03579940|450766507|FG008|Period 2|Withdrawal by Subject|0|||
125310703|NCT03579940|450766508|FG009|Period 2|Withdrawal by Subject|0|||
125310704|NCT03579940|450766509|FG010|Period 2|Withdrawal by Subject|0|||
125310705|NCT00671034|450766510|FG000|Overall Study|Adverse Event|5|||
125310706|NCT00671034|450766511|FG001|Overall Study|Adverse Event|7|||
125310707|NCT00671034|450766512|FG002|Overall Study|Adverse Event|1|||
125310708|NCT00671034|450766510|FG000|Overall Study|Death|3|||
125310709|NCT00671034|450766511|FG001|Overall Study|Death|2|||
125310710|NCT00671034|450766512|FG002|Overall Study|Death|1|||
125310711|NCT00671034|450766510|FG000|Overall Study|Physician Decision|12|||
125310712|NCT00671034|450766511|FG001|Overall Study|Physician Decision|4|||
125310713|NCT00671034|450766512|FG002|Overall Study|Physician Decision|5|||
125310714|NCT00671034|450766510|FG000|Overall Study|VHR ALL feature|8|||
125310715|NCT00671034|450766511|FG001|Overall Study|VHR ALL feature|3|||
125310716|NCT00671034|450766512|FG002|Overall Study|VHR ALL feature|5|||
125310717|NCT00671034|450766510|FG000|Overall Study|Refusal|5|||
125310718|NCT00671034|450766511|FG001|Overall Study|Refusal|3|||
125310719|NCT00671034|450766512|FG002|Overall Study|Refusal|5|||
125310720|NCT00671034|450766510|FG000|Overall Study|includes Alternative therapy, etc.|6|||
125310721|NCT00671034|450766511|FG001|Overall Study|includes Alternative therapy, etc.|1|||
125310722|NCT00671034|450766512|FG002|Overall Study|includes Alternative therapy, etc.|7|||
125310723|NCT01751984|450766513|FG000|Overall Study|Adverse Event|5|||
125310724|NCT01751984|450766514|FG001|Overall Study|Adverse Event|3|||
125310725|NCT01751984|450766513|FG000|Overall Study|Withdrawal by Subject|0|||
125310726|NCT01751984|450766514|FG001|Overall Study|Withdrawal by Subject|1|||
125310727|NCT01751984|450766513|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
125310728|NCT01751984|450766514|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
125310729|NCT01797263|450766515|FG000|Overall Study|Withdrawal by Subject|21|||
125310730|NCT01797263|450766516|FG001|Overall Study|Withdrawal by Subject|25|||
125310731|NCT01797263|450766515|FG000|Overall Study|Death|1|||
125310732|NCT01797263|450766516|FG001|Overall Study|Death|0|||
125310733|NCT01797263|450766515|FG000|Overall Study|Lost to Follow-up|15|||
125310734|NCT01797263|450766516|FG001|Overall Study|Lost to Follow-up|15|||
125310735|NCT02045095|450766517|FG000|Overall Study|Other|0|||
125310736|NCT02045095|450766518|FG001|Overall Study|Other|0|||
125310737|NCT02045095|450766519|FG002|Overall Study|Other|1|||
125310738|NCT02045095|450766520|FG003|Overall Study|Other|0|||
125310739|NCT02045095|450766521|FG004|Overall Study|Other|0|||
125310740|NCT02045095|450766522|FG005|Overall Study|Other|2|||
125310741|NCT02045095|450766523|FG006|Overall Study|Other|0|||
125310742|NCT02045095|450766517|FG000|Overall Study|Progressive Disease|3|||
125310743|NCT02045095|450766518|FG001|Overall Study|Progressive Disease|3|||
125310744|NCT02045095|450766519|FG002|Overall Study|Progressive Disease|2|||
125310745|NCT02045095|450766520|FG003|Overall Study|Progressive Disease|4|||
125310746|NCT02045095|450766521|FG004|Overall Study|Progressive Disease|2|||
125310747|NCT02045095|450766522|FG005|Overall Study|Progressive Disease|4|||
125310748|NCT02045095|450766523|FG006|Overall Study|Progressive Disease|1|||
125310749|NCT02045095|450766517|FG000|Overall Study|Withdrawal by Subject|0|||
125310750|NCT02045095|450766518|FG001|Overall Study|Withdrawal by Subject|0|||
125310751|NCT02045095|450766519|FG002|Overall Study|Withdrawal by Subject|0|||
125310752|NCT02045095|450766520|FG003|Overall Study|Withdrawal by Subject|0|||
125310753|NCT02045095|450766521|FG004|Overall Study|Withdrawal by Subject|3|||
125310754|NCT02045095|450766522|FG005|Overall Study|Withdrawal by Subject|0|||
125310755|NCT02045095|450766523|FG006|Overall Study|Withdrawal by Subject|0|||
125310756|NCT02045095|450766517|FG000|Overall Study|Adverse Event|0|||
125310757|NCT02045095|450766518|FG001|Overall Study|Adverse Event|1|||
125310758|NCT02045095|450766519|FG002|Overall Study|Adverse Event|1|||
125310759|NCT02045095|450766520|FG003|Overall Study|Adverse Event|0|||
125310760|NCT02045095|450766521|FG004|Overall Study|Adverse Event|0|||
125310761|NCT02045095|450766522|FG005|Overall Study|Adverse Event|2|||
125310762|NCT02045095|450766523|FG006|Overall Study|Adverse Event|0|||
125310763|NCT01450761|450766524|FG000|Randomization|Subject no longer meets study criteria|1|||
125310764|NCT01450761|450766525|FG001|Randomization|Subject no longer meets study criteria|2|||
125310765|NCT01450761|450766524|FG000|Randomization|Withdrawal by Subject|2|||
125310766|NCT01450761|450766525|FG001|Randomization|Withdrawal by Subject|0|||
125310767|NCT01450761|450766524|FG000|Randomization|Disease progression|0|||
125310768|NCT01450761|450766525|FG001|Randomization|Disease progression|2|||
125310769|NCT01450761|450766524|FG000|Randomization|Adverse Event unrelated to study drug|1|||
125310770|NCT01450761|450766525|FG001|Randomization|Adverse Event unrelated to study drug|0|||
125310771|NCT01450761|450766524|FG000|Randomization|Other|0|||
125310772|NCT01450761|450766525|FG001|Randomization|Other|1|||
125310773|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Disease progression|33|||
125310774|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Disease progression|32|||
125310775|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
125310776|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
125310777|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
125310778|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
125310779|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
125310780|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
125310781|NCT01450761|450766524|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
125310782|NCT01450761|450766525|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
125310783|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Death|3|||
125310784|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Death|3|||
125310785|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Other|2|||
125310786|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Other|2|||
125310787|NCT01450761|450766524|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
125310788|NCT01450761|450766525|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
125310789|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
125310790|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
125310791|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
125310792|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
125310793|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
125310794|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
125310795|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
125310796|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
125310797|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
125310798|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
125310799|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Death|5|||
125310800|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Death|6|||
125310801|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
125310802|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
125310803|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
125310804|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
125310805|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
125310806|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
125310807|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
125310808|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
125310809|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
125310810|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
125310811|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
125310812|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
125310813|NCT01450761|450766524|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
125310814|NCT01450761|450766525|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
125310815|NCT00337207|450766526|FG000|Overall Study|Withdrawal by Subject|3|||
125310816|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
125310817|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
125310818|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
125310819|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
125310820|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
125310821|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
125310822|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
125310823|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
125310824|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
125310825|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
125310826|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
125310827|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
125310828|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
125310829|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
125310830|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
125310831|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
125310832|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
125310833|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
125310834|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
125310835|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
125310836|NCT03573323|450766527|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
125310837|NCT03573323|450766528|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
125310838|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
125310839|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
125310840|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
125310841|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
125310842|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
125534226|NCT00798434|451584917|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
125534227|NCT00798434|451584916|FG000|Double-Blind|Other|1|||
125534228|NCT00798434|451584917|FG001|Double-Blind|Other|0|||
125534229|NCT00798434|451584916|FG000|Double-Blind|Not Treated|3|||
125534230|NCT00798434|451584917|FG001|Double-Blind|Not Treated|6|||
125534231|NCT00798434|451584916|FG000|Open-Label|Adverse Event|33|||
125310843|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
125310844|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
125310845|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
125310846|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
125310847|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
125310848|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
125310849|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
125310850|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
125310851|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
125310852|NCT03573323|450766527|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
125310853|NCT03573323|450766528|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
125310854|NCT00837213|450766532|FG000|Overall Study|Lost to Follow-up|3|||
125310855|NCT00837213|450766533|FG001|Overall Study|Lost to Follow-up|2|||
125310856|NCT00837213|450766532|FG000|Overall Study|Withdrawal by Subject|2|||
125310857|NCT00837213|450766533|FG001|Overall Study|Withdrawal by Subject|2|||
125310858|NCT00837213|450766532|FG000|Overall Study|not stated|1|||
125310859|NCT00837213|450766533|FG001|Overall Study|not stated|1|||
125310860|NCT02698826|450766535|FG000|Overall Study|Death|13|||
125310861|NCT02698826|450766535|FG000|Overall Study|Adverse Event|1|||
125310862|NCT00216671|450766541|FG000|Overall Study|Adverse Event|4|||
125310863|NCT00216671|450766542|FG001|Overall Study|Adverse Event|9|||
125310864|NCT00216671|450766541|FG000|Overall Study|Pregnancy|0|||
125310865|NCT00216671|450766542|FG001|Overall Study|Pregnancy|1|||
125310866|NCT00216671|450766541|FG000|Overall Study|Withdrawal by Subject|4|||
125310867|NCT00216671|450766542|FG001|Overall Study|Withdrawal by Subject|2|||
125310868|NCT00216671|450766541|FG000|Overall Study|Refused Injections|3|||
125310869|NCT00216671|450766542|FG001|Overall Study|Refused Injections|13|||
125310870|NCT00216671|450766541|FG000|Overall Study|No Need to Continue Medication|1|||
125310871|NCT00216671|450766542|FG001|Overall Study|No Need to Continue Medication|1|||
125310872|NCT00216671|450766541|FG000|Overall Study|Insufficient Response|9|||
125310873|NCT00216671|450766542|FG001|Overall Study|Insufficient Response|4|||
125534232|NCT00798434|451584917|FG001|Open-Label|Adverse Event|11|||
125310874|NCT00216671|450766541|FG000|Overall Study|Lost to Follow-up|3|||
125310875|NCT00216671|450766542|FG001|Overall Study|Lost to Follow-up|5|||
125310876|NCT00216671|450766541|FG000|Overall Study|Non compliant|2|||
125310877|NCT00216671|450766542|FG001|Overall Study|Non compliant|2|||
125310878|NCT00216671|450766541|FG000|Overall Study|Ineligible|0|||
125310879|NCT00216671|450766542|FG001|Overall Study|Ineligible|2|||
125310880|NCT00216671|450766541|FG000|Overall Study|Physician Decision|1|||
125310881|NCT00216671|450766542|FG001|Overall Study|Physician Decision|1|||
125310882|NCT00216671|450766541|FG000|Overall Study|Protocol Violation|3|||
125310883|NCT00216671|450766542|FG001|Overall Study|Protocol Violation|5|||
125310884|NCT00216671|450766541|FG000|Overall Study|Relapse|1|||
125310885|NCT00216671|450766542|FG001|Overall Study|Relapse|0|||
125310886|NCT00216671|450766541|FG000|Overall Study|Investigator Illness|0|||
125310887|NCT00216671|450766542|FG001|Overall Study|Investigator Illness|1|||
125310888|NCT00216671|450766541|FG000|Overall Study|Patient Moved|0|||
125310889|NCT00216671|450766542|FG001|Overall Study|Patient Moved|1|||
125310890|NCT00216671|450766541|FG000|Overall Study|Ineligible, no efficacy data|2|||
125310891|NCT00216671|450766542|FG001|Overall Study|Ineligible, no efficacy data|2|||
125310892|NCT00216671|450766541|FG000|Overall Study|Insufficient Response Adverse Event|2|||
125310893|NCT00216671|450766542|FG001|Overall Study|Insufficient Response Adverse Event|1|||
125310894|NCT04961541|450766543|FG000|Overall Study|Adverse Event|0|||
125310895|NCT04961541|450766544|FG001|Overall Study|Adverse Event|0|||
125200047|NCT02980341|450354969|FG004|Dose Escalation|Clinical progression|0|||
125200048|NCT02980341|450354970|FG005|Dose Escalation|Clinical progression|0|||
125200049|NCT02980341|450354971|FG006|Dose Escalation|Clinical progression|0|||
125200050|NCT02980341|450354972|FG007|Dose Escalation|Clinical progression|0|||
125200051|NCT02980341|450354973|FG008|Dose Escalation|Clinical progression|0|||
125200052|NCT02980341|450354974|FG009|Dose Escalation|Clinical progression|0|||
125200053|NCT02980341|450354975|FG010|Dose Escalation|Clinical progression|0|||
125200054|NCT02980341|450354965|FG000|Dose Escalation|Adverse Event|0|||
125200055|NCT02980341|450354966|FG001|Dose Escalation|Adverse Event|0|||
125534233|NCT00798434|451584916|FG000|Open-Label|Lack of Efficacy|5|||
125200056|NCT02980341|450354967|FG002|Dose Escalation|Adverse Event|1|||
125310896|NCT04961541|450766545|FG002|Overall Study|Adverse Event|0|||
125310897|NCT04961541|450766546|FG003|Overall Study|Adverse Event|0|||
125310898|NCT04961541|450766547|FG004|Overall Study|Adverse Event|0|||
125310899|NCT04961541|450766548|FG005|Overall Study|Adverse Event|1|||
125200057|NCT02980341|450354968|FG003|Dose Escalation|Adverse Event|2|||
125200058|NCT02980341|450354969|FG004|Dose Escalation|Adverse Event|2|||
125200059|NCT02980341|450354970|FG005|Dose Escalation|Adverse Event|0|||
125200060|NCT02980341|450354971|FG006|Dose Escalation|Adverse Event|0|||
125200061|NCT02980341|450354972|FG007|Dose Escalation|Adverse Event|0|||
125200062|NCT02980341|450354973|FG008|Dose Escalation|Adverse Event|0|||
125200063|NCT02980341|450354974|FG009|Dose Escalation|Adverse Event|0|||
125200064|NCT02980341|450354975|FG010|Dose Escalation|Adverse Event|0|||
125200065|NCT02980341|450354965|FG000|Dose Escalation|Withdrawal by Subject|0|||
125200066|NCT02980341|450354966|FG001|Dose Escalation|Withdrawal by Subject|0|||
125200067|NCT02980341|450354967|FG002|Dose Escalation|Withdrawal by Subject|1|||
125200068|NCT02980341|450354968|FG003|Dose Escalation|Withdrawal by Subject|0|||
125200069|NCT02980341|450354969|FG004|Dose Escalation|Withdrawal by Subject|0|||
125310900|NCT04961541|450766549|FG006|Overall Study|Adverse Event|0|||
125310901|NCT04961541|450766550|FG007|Overall Study|Adverse Event|0|||
125310902|NCT04961541|450766551|FG008|Overall Study|Adverse Event|0|||
125310903|NCT04961541|450766552|FG009|Overall Study|Adverse Event|0|||
125310904|NCT04961541|450766553|FG010|Overall Study|Adverse Event|0|||
125310905|NCT04961541|450766554|FG011|Overall Study|Adverse Event|0|||
125310906|NCT04961541|450766555|FG012|Overall Study|Adverse Event|0|||
125310907|NCT04961541|450766556|FG013|Overall Study|Adverse Event|0|||
125310908|NCT04961541|450766543|FG000|Overall Study|Lost to Follow-up|0|||
125310909|NCT04961541|450766544|FG001|Overall Study|Lost to Follow-up|0|||
125310910|NCT04961541|450766545|FG002|Overall Study|Lost to Follow-up|3|||
125310911|NCT04961541|450766546|FG003|Overall Study|Lost to Follow-up|0|||
125310912|NCT04961541|450766547|FG004|Overall Study|Lost to Follow-up|0|||
125310913|NCT04961541|450766548|FG005|Overall Study|Lost to Follow-up|0|||
125310914|NCT04961541|450766549|FG006|Overall Study|Lost to Follow-up|1|||
125310915|NCT04961541|450766550|FG007|Overall Study|Lost to Follow-up|1|||
125310916|NCT04961541|450766551|FG008|Overall Study|Lost to Follow-up|0|||
125310917|NCT04961541|450766552|FG009|Overall Study|Lost to Follow-up|1|||
125310918|NCT04961541|450766553|FG010|Overall Study|Lost to Follow-up|0|||
125310919|NCT04961541|450766554|FG011|Overall Study|Lost to Follow-up|0|||
125310920|NCT04961541|450766555|FG012|Overall Study|Lost to Follow-up|1|||
125310921|NCT04961541|450766556|FG013|Overall Study|Lost to Follow-up|0|||
125310922|NCT04961541|450766543|FG000|Overall Study|Withdrawal by Subject|0|||
125310923|NCT04961541|450766544|FG001|Overall Study|Withdrawal by Subject|0|||
125310924|NCT04961541|450766545|FG002|Overall Study|Withdrawal by Subject|1|||
125310925|NCT04961541|450766546|FG003|Overall Study|Withdrawal by Subject|1|||
125310926|NCT04961541|450766547|FG004|Overall Study|Withdrawal by Subject|0|||
125310927|NCT04961541|450766548|FG005|Overall Study|Withdrawal by Subject|0|||
125310928|NCT04961541|450766549|FG006|Overall Study|Withdrawal by Subject|0|||
125310929|NCT04961541|450766550|FG007|Overall Study|Withdrawal by Subject|0|||
125310930|NCT04961541|450766551|FG008|Overall Study|Withdrawal by Subject|0|||
125310931|NCT04961541|450766552|FG009|Overall Study|Withdrawal by Subject|1|||
125310932|NCT04961541|450766553|FG010|Overall Study|Withdrawal by Subject|0|||
125310933|NCT04961541|450766554|FG011|Overall Study|Withdrawal by Subject|0|||
125310934|NCT04961541|450766555|FG012|Overall Study|Withdrawal by Subject|0|||
125310935|NCT04961541|450766556|FG013|Overall Study|Withdrawal by Subject|0|||
125310936|NCT01843023|450766558|FG000|Overall Study|Death|1|||
125310937|NCT01843023|450766559|FG001|Overall Study|Death|0|||
125310938|NCT01843023|450766558|FG000|Overall Study|Lost to Follow-up|24|||
125310939|NCT01843023|450766559|FG001|Overall Study|Lost to Follow-up|29|||
125310940|NCT01843023|450766558|FG000|Overall Study|Withdrawal by Subject|8|||
125310941|NCT01843023|450766559|FG001|Overall Study|Withdrawal by Subject|6|||
125310942|NCT03305770|450766560|FG000|Overall Study|Physician Decision - prior to dispense|0|||
125310943|NCT03305770|450766561|FG001|Overall Study|Physician Decision - prior to dispense|1|||
125310944|NCT03305770|450766560|FG000|Overall Study|Subject moved|1|||
125310945|NCT03305770|450766561|FG001|Overall Study|Subject moved|0|||
125310946|NCT03539601|450766562|FG000|Overall Study|Withdraw by parent/guardian|1|||
125310947|NCT03539601|450766563|FG001|Overall Study|Withdraw by parent/guardian|0|||
125310948|NCT03539601|450766564|FG002|Overall Study|Withdraw by parent/guardian|1|||
125310949|NCT03539601|450766565|FG003|Overall Study|Withdraw by parent/guardian|0|||
125310950|NCT03539601|450766562|FG000|Overall Study|Adverse Event|0|||
125310951|NCT03539601|450766563|FG001|Overall Study|Adverse Event|2|||
125310952|NCT03539601|450766564|FG002|Overall Study|Adverse Event|0|||
125310953|NCT03539601|450766565|FG003|Overall Study|Adverse Event|0|||
125310954|NCT03539601|450766562|FG000|Overall Study|Lost to Follow-up|2|||
125310955|NCT03539601|450766563|FG001|Overall Study|Lost to Follow-up|4|||
125310956|NCT03539601|450766564|FG002|Overall Study|Lost to Follow-up|5|||
125310957|NCT03539601|450766565|FG003|Overall Study|Lost to Follow-up|0|||
125310958|NCT03539601|450766562|FG000|Overall Study|Withdrawal by Subject|2|||
125310959|NCT03539601|450766563|FG001|Overall Study|Withdrawal by Subject|0|||
125310960|NCT03539601|450766564|FG002|Overall Study|Withdrawal by Subject|0|||
125310961|NCT03539601|450766565|FG003|Overall Study|Withdrawal by Subject|1|||
125310962|NCT03539601|450766562|FG000|Overall Study|Randomized but not treated|1|||
125310963|NCT03539601|450766563|FG001|Overall Study|Randomized but not treated|1|||
125200070|NCT02980341|450354970|FG005|Dose Escalation|Withdrawal by Subject|0|||
125310964|NCT03539601|450766564|FG002|Overall Study|Randomized but not treated|0|||
125310965|NCT03539601|450766565|FG003|Overall Study|Randomized but not treated|0|||
125310966|NCT01970306|450766566|FG000|Overall Study|Not eligible|3|||
125310967|NCT01970306|450766566|FG000|Overall Study|Not able to be treated|9|||
125310968|NCT00226811|450766567|FG000|Overall Study|Death|8|||
125310969|NCT00226811|450766567|FG000|Overall Study|Adverse Event|11|||
125310970|NCT00226811|450766567|FG000|Overall Study|Lack of Efficacy|55|||
125310971|NCT00226811|450766567|FG000|Overall Study|Withdrawal by Subject|2|||
125310972|NCT02741635|450766568|FG000|Overall Study|Withdrawal by Subject|1|||
125310973|NCT01427933|450766569|FG000|Overall Study|Withdrawal by Subject|5|||
125310974|NCT01427933|450766570|FG001|Overall Study|Withdrawal by Subject|8|||
125310975|NCT01427933|450766569|FG000|Overall Study|Lost to Follow-up|1|||
125310976|NCT01427933|450766570|FG001|Overall Study|Lost to Follow-up|5|||
125310977|NCT01427933|450766569|FG000|Overall Study|Other|1|||
125310978|NCT01427933|450766570|FG001|Overall Study|Other|0|||
125310979|NCT01427933|450766569|FG000|Overall Study|Investigator's Decision|1|||
125310980|NCT01427933|450766570|FG001|Overall Study|Investigator's Decision|0|||
125310981|NCT01633541|450766571|FG000|Overall Study|Death|1|||
125310982|NCT01633541|450766572|FG001|Overall Study|Death|0|||
125310983|NCT03472326|450766575|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
125310984|NCT03472326|450766576|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
125310985|NCT03472326|450766577|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
125310986|NCT03472326|450766578|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
125310987|NCT03472326|450766575|FG000|Part 2: Combination Therapy|Pregnancy|0|||
125310988|NCT03472326|450766576|FG001|Part 2: Combination Therapy|Pregnancy|0|||
125310989|NCT03472326|450766577|FG002|Part 2: Combination Therapy|Pregnancy|0|||
125310990|NCT03472326|450766578|FG003|Part 2: Combination Therapy|Pregnancy|1|||
125310991|NCT01010971|450766579|FG000|Overall Study|Adverse Event|2|||
125310992|NCT01010971|450766580|FG001|Overall Study|Adverse Event|4|||
125310993|NCT01010971|450766581|FG002|Overall Study|Adverse Event|3|||
125310994|NCT01010971|450766579|FG000|Overall Study|Withdrawal by Subject|0|||
125310995|NCT01010971|450766580|FG001|Overall Study|Withdrawal by Subject|2|||
125310996|NCT01010971|450766581|FG002|Overall Study|Withdrawal by Subject|5|||
125310997|NCT01010971|450766579|FG000|Overall Study|Lost to Follow-up|0|||
125310998|NCT01010971|450766580|FG001|Overall Study|Lost to Follow-up|2|||
125310999|NCT01010971|450766581|FG002|Overall Study|Lost to Follow-up|3|||
125311000|NCT01010971|450766579|FG000|Overall Study|Other|1|||
125311001|NCT01010971|450766580|FG001|Overall Study|Other|0|||
125311002|NCT01010971|450766581|FG002|Overall Study|Other|2|||
125311003|NCT03386721|450766582|FG000|Overall Study|Death|12|||
125311004|NCT03386721|450766583|FG001|Overall Study|Death|21|||
125311005|NCT03386721|450766584|FG002|Overall Study|Death|2|||
125311006|NCT03386721|450766585|FG003|Overall Study|Death|5|||
125311007|NCT03386721|450766586|FG004|Overall Study|Death|1|||
125311008|NCT03386721|450766587|FG005|Overall Study|Death|12|||
125311009|NCT03386721|450766588|FG006|Overall Study|Death|1|||
125311010|NCT03386721|450766589|FG007|Overall Study|Death|1|||
125311011|NCT03386721|450766590|FG008|Overall Study|Death|12|||
125311012|NCT03386721|450766591|FG009|Overall Study|Death|20|||
125311013|NCT03386721|450766592|FG010|Overall Study|Death|21|||
125311014|NCT03386721|450766593|FG011|Overall Study|Death|21|||
125311015|NCT03386721|450766594|FG012|Overall Study|Death|14|||
125311016|NCT03386721|450766595|FG013|Overall Study|Death|2|||
125311017|NCT03386721|450766596|FG014|Overall Study|Death|1|||
125311018|NCT03386721|450766582|FG000|Overall Study|Lost to Follow-up|1|||
125311019|NCT03386721|450766583|FG001|Overall Study|Lost to Follow-up|3|||
125311020|NCT03386721|450766584|FG002|Overall Study|Lost to Follow-up|0|||
125311021|NCT03386721|450766585|FG003|Overall Study|Lost to Follow-up|0|||
125311022|NCT03386721|450766586|FG004|Overall Study|Lost to Follow-up|0|||
125311023|NCT03386721|450766587|FG005|Overall Study|Lost to Follow-up|2|||
125311024|NCT03386721|450766588|FG006|Overall Study|Lost to Follow-up|1|||
125311025|NCT03386721|450766589|FG007|Overall Study|Lost to Follow-up|0|||
125311026|NCT03386721|450766590|FG008|Overall Study|Lost to Follow-up|1|||
125311027|NCT03386721|450766591|FG009|Overall Study|Lost to Follow-up|2|||
125311028|NCT03386721|450766592|FG010|Overall Study|Lost to Follow-up|1|||
125311029|NCT03386721|450766593|FG011|Overall Study|Lost to Follow-up|0|||
125311030|NCT03386721|450766594|FG012|Overall Study|Lost to Follow-up|0|||
125311031|NCT03386721|450766595|FG013|Overall Study|Lost to Follow-up|0|||
125311032|NCT03386721|450766596|FG014|Overall Study|Lost to Follow-up|0|||
125311033|NCT03386721|450766582|FG000|Overall Study|Reason not specified|3|||
125311034|NCT03386721|450766583|FG001|Overall Study|Reason not specified|0|||
125311035|NCT03386721|450766584|FG002|Overall Study|Reason not specified|0|||
125311036|NCT03386721|450766585|FG003|Overall Study|Reason not specified|0|||
125311037|NCT03386721|450766586|FG004|Overall Study|Reason not specified|0|||
125311038|NCT03386721|450766587|FG005|Overall Study|Reason not specified|3|||
125311039|NCT03386721|450766588|FG006|Overall Study|Reason not specified|1|||
125311040|NCT03386721|450766589|FG007|Overall Study|Reason not specified|0|||
125311041|NCT03386721|450766590|FG008|Overall Study|Reason not specified|0|||
125311042|NCT03386721|450766591|FG009|Overall Study|Reason not specified|1|||
125311043|NCT03386721|450766592|FG010|Overall Study|Reason not specified|2|||
125311044|NCT03386721|450766593|FG011|Overall Study|Reason not specified|6|||
125311045|NCT03386721|450766594|FG012|Overall Study|Reason not specified|1|||
125311046|NCT03386721|450766595|FG013|Overall Study|Reason not specified|0|||
125311047|NCT03386721|450766596|FG014|Overall Study|Reason not specified|0|||
125311048|NCT03386721|450766582|FG000|Overall Study|Progressive Disease|0|||
125311049|NCT03386721|450766583|FG001|Overall Study|Progressive Disease|0|||
125311050|NCT03386721|450766584|FG002|Overall Study|Progressive Disease|1|||
125311051|NCT03386721|450766585|FG003|Overall Study|Progressive Disease|0|||
125311052|NCT03386721|450766586|FG004|Overall Study|Progressive Disease|0|||
125311053|NCT03386721|450766587|FG005|Overall Study|Progressive Disease|1|||
125311054|NCT03386721|450766588|FG006|Overall Study|Progressive Disease|0|||
125311055|NCT03386721|450766589|FG007|Overall Study|Progressive Disease|0|||
125311056|NCT03386721|450766590|FG008|Overall Study|Progressive Disease|2|||
125311057|NCT03386721|450766591|FG009|Overall Study|Progressive Disease|1|||
125311058|NCT03386721|450766592|FG010|Overall Study|Progressive Disease|1|||
125311059|NCT03386721|450766593|FG011|Overall Study|Progressive Disease|0|||
125311060|NCT03386721|450766594|FG012|Overall Study|Progressive Disease|1|||
125311061|NCT03386721|450766595|FG013|Overall Study|Progressive Disease|0|||
125311062|NCT03386721|450766596|FG014|Overall Study|Progressive Disease|0|||
125311063|NCT03386721|450766582|FG000|Overall Study|Site Terminated by Sponsor|5|||
125311064|NCT03386721|450766583|FG001|Overall Study|Site Terminated by Sponsor|5|||
125311065|NCT03386721|450766584|FG002|Overall Study|Site Terminated by Sponsor|0|||
125311066|NCT03386721|450766585|FG003|Overall Study|Site Terminated by Sponsor|0|||
125311067|NCT03386721|450766586|FG004|Overall Study|Site Terminated by Sponsor|1|||
125311068|NCT03386721|450766587|FG005|Overall Study|Site Terminated by Sponsor|3|||
125311069|NCT03386721|450766588|FG006|Overall Study|Site Terminated by Sponsor|0|||
125311070|NCT03386721|450766589|FG007|Overall Study|Site Terminated by Sponsor|1|||
125311071|NCT03386721|450766590|FG008|Overall Study|Site Terminated by Sponsor|4|||
125311072|NCT03386721|450766591|FG009|Overall Study|Site Terminated by Sponsor|5|||
125311073|NCT03386721|450766592|FG010|Overall Study|Site Terminated by Sponsor|3|||
125311074|NCT03386721|450766593|FG011|Overall Study|Site Terminated by Sponsor|11|||
125311075|NCT03386721|450766594|FG012|Overall Study|Site Terminated by Sponsor|6|||
125311076|NCT03386721|450766595|FG013|Overall Study|Site Terminated by Sponsor|0|||
125311077|NCT03386721|450766596|FG014|Overall Study|Site Terminated by Sponsor|0|||
125311078|NCT03386721|450766582|FG000|Overall Study|Symptomatic Deterioration|0|||
125311079|NCT03386721|450766583|FG001|Overall Study|Symptomatic Deterioration|0|||
125311080|NCT03386721|450766584|FG002|Overall Study|Symptomatic Deterioration|0|||
125311081|NCT03386721|450766585|FG003|Overall Study|Symptomatic Deterioration|0|||
125311082|NCT03386721|450766586|FG004|Overall Study|Symptomatic Deterioration|0|||
125311083|NCT03386721|450766587|FG005|Overall Study|Symptomatic Deterioration|0|||
125311084|NCT03386721|450766588|FG006|Overall Study|Symptomatic Deterioration|0|||
125311085|NCT03386721|450766589|FG007|Overall Study|Symptomatic Deterioration|0|||
125311086|NCT03386721|450766590|FG008|Overall Study|Symptomatic Deterioration|1|||
125311087|NCT03386721|450766591|FG009|Overall Study|Symptomatic Deterioration|0|||
125311088|NCT03386721|450766592|FG010|Overall Study|Symptomatic Deterioration|0|||
125311089|NCT03386721|450766593|FG011|Overall Study|Symptomatic Deterioration|1|||
125311090|NCT03386721|450766594|FG012|Overall Study|Symptomatic Deterioration|0|||
125311091|NCT03386721|450766595|FG013|Overall Study|Symptomatic Deterioration|0|||
125311092|NCT03386721|450766596|FG014|Overall Study|Symptomatic Deterioration|0|||
125311093|NCT03386721|450766582|FG000|Overall Study|Withdrawal by Subject|1|||
125311094|NCT03386721|450766583|FG001|Overall Study|Withdrawal by Subject|2|||
125311095|NCT03386721|450766584|FG002|Overall Study|Withdrawal by Subject|0|||
125311096|NCT03386721|450766585|FG003|Overall Study|Withdrawal by Subject|0|||
125311097|NCT03386721|450766586|FG004|Overall Study|Withdrawal by Subject|0|||
125311098|NCT03386721|450766587|FG005|Overall Study|Withdrawal by Subject|0|||
125311099|NCT03386721|450766588|FG006|Overall Study|Withdrawal by Subject|0|||
125311100|NCT03386721|450766589|FG007|Overall Study|Withdrawal by Subject|0|||
125311101|NCT03386721|450766590|FG008|Overall Study|Withdrawal by Subject|2|||
125311102|NCT03386721|450766591|FG009|Overall Study|Withdrawal by Subject|1|||
125311103|NCT03386721|450766592|FG010|Overall Study|Withdrawal by Subject|3|||
125311104|NCT03386721|450766593|FG011|Overall Study|Withdrawal by Subject|2|||
125311105|NCT03386721|450766594|FG012|Overall Study|Withdrawal by Subject|3|||
125311106|NCT03386721|450766595|FG013|Overall Study|Withdrawal by Subject|0|||
125311107|NCT03386721|450766596|FG014|Overall Study|Withdrawal by Subject|0|||
125311108|NCT03081884|450766597|FG000|Overall Study|deferred prostate cancer treatment|1|||
125311109|NCT03081884|450766597|FG000|Overall Study|metastasis managed with systemic therapy|3|||
125311110|NCT03948334|450766599|FG000|Overall Study|Adverse Event|1|||
125311111|NCT03948334|450766600|FG001|Overall Study|Adverse Event|4|||
125311112|NCT03948334|450766599|FG000|Overall Study|Lack of Efficacy|2|||
125311113|NCT03948334|450766600|FG001|Overall Study|Lack of Efficacy|0|||
125311114|NCT03948334|450766599|FG000|Overall Study|Lost to Follow-up|1|||
125311115|NCT03948334|450766600|FG001|Overall Study|Lost to Follow-up|0|||
125311116|NCT03948334|450766599|FG000|Overall Study|Physician Decision|1|||
125311117|NCT03948334|450766600|FG001|Overall Study|Physician Decision|0|||
125311118|NCT03948334|450766599|FG000|Overall Study|Pregnancy|0|||
125311119|NCT03948334|450766600|FG001|Overall Study|Pregnancy|1|||
125311120|NCT03948334|450766599|FG000|Overall Study|Protocol Deviation|1|||
125311121|NCT03948334|450766600|FG001|Overall Study|Protocol Deviation|0|||
125311122|NCT03948334|450766599|FG000|Overall Study|Study terminated by Sponsor|50|||
125311123|NCT03948334|450766600|FG001|Overall Study|Study terminated by Sponsor|51|||
125311124|NCT03948334|450766599|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
125311125|NCT03948334|450766600|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
125311126|NCT05114473|450766601|FG000|Overall Study|Lost to Follow-up|2|||
125311127|NCT05114473|450766602|FG001|Overall Study|Lost to Follow-up|2|||
125311128|NCT05114473|450766603|FG002|Overall Study|Lost to Follow-up|0|||
125311129|NCT00700713|450766604|FG000|Overall Study|Protocol Violation|1|||
125311130|NCT00700713|450766605|FG001|Overall Study|Protocol Violation|0|||
125311131|NCT00700713|450766606|FG002|Overall Study|Protocol Violation|1|||
125311132|NCT00700713|450766604|FG000|Overall Study|Withdrawal by Subject|0|||
125311133|NCT00700713|450766605|FG001|Overall Study|Withdrawal by Subject|0|||
125311134|NCT00700713|450766606|FG002|Overall Study|Withdrawal by Subject|1|||
125311135|NCT00550953|450766608|FG000|Overall Study|Adverse Event|4|||
125311136|NCT00550953|450766609|FG001|Overall Study|Adverse Event|3|||
125311137|NCT00550953|450766608|FG000|Overall Study|Not able to visit the site|2|||
125311138|NCT00550953|450766609|FG001|Overall Study|Not able to visit the site|3|||
125311139|NCT02446717|450766610|FG000|Overall Study|Adverse Event|0|||
125311140|NCT02446717|450766611|FG001|Overall Study|Adverse Event|0|||
125311141|NCT02446717|450766612|FG002|Overall Study|Adverse Event|1|||
125311142|NCT02446717|450766613|FG003|Overall Study|Adverse Event|0|||
125311143|NCT02446717|450766614|FG004|Overall Study|Adverse Event|0|||
125311144|NCT02446717|450766610|FG000|Overall Study|Lost to Follow-up|0|||
125311145|NCT02446717|450766611|FG001|Overall Study|Lost to Follow-up|1|||
125311146|NCT02446717|450766612|FG002|Overall Study|Lost to Follow-up|1|||
125311147|NCT02446717|450766613|FG003|Overall Study|Lost to Follow-up|0|||
125311148|NCT02446717|450766614|FG004|Overall Study|Lost to Follow-up|1|||
125311149|NCT02446717|450766610|FG000|Overall Study|Withdrew consent|0|||
125311150|NCT02446717|450766611|FG001|Overall Study|Withdrew consent|0|||
125311151|NCT02446717|450766612|FG002|Overall Study|Withdrew consent|0|||
125311152|NCT02446717|450766613|FG003|Overall Study|Withdrew consent|1|||
125311153|NCT02446717|450766614|FG004|Overall Study|Withdrew consent|0|||
125311154|NCT02905266|450766615|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
125311155|NCT02905266|450766616|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
125311156|NCT02905266|450766615|FG000|Treatment Phase Part 1|Disease Progression|6|||
125311157|NCT02905266|450766616|FG001|Treatment Phase Part 1|Disease Progression|7|||
125311158|NCT02905266|450766615|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
125311159|NCT02905266|450766616|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
125311160|NCT02905266|450766615|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
125311161|NCT02905266|450766616|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
125311162|NCT02905266|450766615|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
125311163|NCT02905266|450766616|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
125311164|NCT02905266|450766615|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
125311165|NCT02905266|450766616|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
125311166|NCT02905266|450766615|FG000|Transition From Part 1 to Part 2|Death|0|||
125311167|NCT02905266|450766616|FG001|Transition From Part 1 to Part 2|Death|1|||
125311168|NCT02905266|450766615|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
125311169|NCT02905266|450766616|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
125311170|NCT02905266|450766615|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
125311171|NCT02905266|450766616|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
125311172|NCT02905266|450766615|FG000|Maintenance Phase Part 2|Disease Progression|9|||
125311173|NCT02905266|450766616|FG001|Maintenance Phase Part 2|Disease Progression|2|||
125311174|NCT02905266|450766615|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
125311175|NCT02905266|450766616|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
125311176|NCT02905266|450766615|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
125311177|NCT02905266|450766616|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
125311178|NCT02777827|450766622|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
125311179|NCT02777827|450766623|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
125311180|NCT02777827|450766624|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
125311181|NCT02777827|450766625|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
125311182|NCT02777827|450766626|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
125311183|NCT02777827|450766627|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
125311184|NCT03160898|450766628|FG000|Overall Study|Adverse Event|4|||
125311185|NCT03160898|450766629|FG001|Overall Study|Adverse Event|8|||
125311186|NCT03160898|450766630|FG002|Overall Study|Adverse Event|7|||
125311187|NCT03160898|450766631|FG003|Overall Study|Adverse Event|10|||
125311188|NCT03160898|450766628|FG000|Overall Study|Death|1|||
125644924|NCT01521494|451982145|FG003|Overall Study|Physician Decision|0|||
125311189|NCT03160898|450766629|FG001|Overall Study|Death|0|||
125311190|NCT03160898|450766630|FG002|Overall Study|Death|0|||
125311191|NCT03160898|450766631|FG003|Overall Study|Death|1|||
125311192|NCT03160898|450766628|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
125311193|NCT03160898|450766629|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
125311194|NCT03160898|450766630|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
125311195|NCT03160898|450766631|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
125311196|NCT03160898|450766628|FG000|Overall Study|Lost to Follow-up|1|||
125311197|NCT03160898|450766629|FG001|Overall Study|Lost to Follow-up|1|||
125311198|NCT03160898|450766630|FG002|Overall Study|Lost to Follow-up|1|||
125311199|NCT03160898|450766631|FG003|Overall Study|Lost to Follow-up|2|||
125311200|NCT03160898|450766628|FG000|Overall Study|Physician Decision|1|||
125311201|NCT03160898|450766629|FG001|Overall Study|Physician Decision|0|||
125311202|NCT03160898|450766630|FG002|Overall Study|Physician Decision|0|||
125311203|NCT03160898|450766631|FG003|Overall Study|Physician Decision|1|||
125311204|NCT03160898|450766628|FG000|Overall Study|Progressive Disease|4|||
125311205|NCT03160898|450766629|FG001|Overall Study|Progressive Disease|1|||
125311206|NCT03160898|450766630|FG002|Overall Study|Progressive Disease|2|||
125311207|NCT03160898|450766631|FG003|Overall Study|Progressive Disease|1|||
125311208|NCT03160898|450766628|FG000|Overall Study|Protocol Violation|1|||
125311209|NCT03160898|450766629|FG001|Overall Study|Protocol Violation|0|||
125311210|NCT03160898|450766630|FG002|Overall Study|Protocol Violation|2|||
125311211|NCT03160898|450766631|FG003|Overall Study|Protocol Violation|0|||
125311212|NCT03160898|450766628|FG000|Overall Study|Sponsor Discretion|2|||
125311213|NCT03160898|450766629|FG001|Overall Study|Sponsor Discretion|0|||
125311214|NCT03160898|450766630|FG002|Overall Study|Sponsor Discretion|0|||
125311215|NCT03160898|450766631|FG003|Overall Study|Sponsor Discretion|0|||
125311216|NCT03160898|450766628|FG000|Overall Study|Withdrawal by Subject|1|||
125311217|NCT03160898|450766629|FG001|Overall Study|Withdrawal by Subject|3|||
125311218|NCT03160898|450766630|FG002|Overall Study|Withdrawal by Subject|2|||
125311219|NCT03160898|450766631|FG003|Overall Study|Withdrawal by Subject|1|||
125311220|NCT03160898|450766628|FG000|Overall Study|Other|2|||
125311221|NCT03160898|450766629|FG001|Overall Study|Other|0|||
125311222|NCT03160898|450766630|FG002|Overall Study|Other|2|||
125311223|NCT03160898|450766631|FG003|Overall Study|Other|2|||
125311224|NCT04178720|450766638|FG000|Overall Study|Withdrawal by Subject|2|||
125311225|NCT04178720|450766639|FG001|Overall Study|Withdrawal by Subject|0|||
125311226|NCT04178720|450766638|FG000|Overall Study|Relocation|0|||
125311227|NCT04178720|450766639|FG001|Overall Study|Relocation|1|||
125311228|NCT04177212|450766641|FG000|Overall Study|Withdrawal by Subject|9|||
125311229|NCT04177212|450766642|FG001|Overall Study|Withdrawal by Subject|7|||
125311230|NCT04177212|450766641|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
125311231|NCT04177212|450766642|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
125311232|NCT04177212|450766641|FG000|Overall Study|Physician Decision|1|||
125311233|NCT04177212|450766642|FG001|Overall Study|Physician Decision|0|||
125311234|NCT04177212|450766641|FG000|Overall Study|Lost to Follow-up|0|||
125311235|NCT04177212|450766642|FG001|Overall Study|Lost to Follow-up|3|||
125311236|NCT04177212|450766641|FG000|Overall Study|Adverse Event|0|||
125311237|NCT04177212|450766642|FG001|Overall Study|Adverse Event|1|||
125311238|NCT04177212|450766641|FG000|Overall Study|Other|1|||
125311239|NCT04177212|450766642|FG001|Overall Study|Other|2|||
125311240|NCT04725500|450766643|FG000|Screening|Screen Failure|26|||
125311241|NCT04725500|450766643|FG000|Screening|Withdrawal by Subject|1|||
125311242|NCT04725500|450766643|FG000|2 Week Take Home|Screen Fail|5|||
125311243|NCT04618744|450766645|FG000|Overall Study|Adverse Event|0|||
125311244|NCT04618744|450766646|FG001|Overall Study|Adverse Event|1|||
125311245|NCT04618744|450766645|FG000|Overall Study|Withdrawal by Subject|0|||
125311246|NCT04618744|450766646|FG001|Overall Study|Withdrawal by Subject|1|||
125311247|NCT00930930|450766647|FG000|Overall Study|Death|1|||
125311248|NCT00930930|450766648|FG001|Overall Study|Death|0|||
125311249|NCT00930930|450766647|FG000|Overall Study|Physician Decision|1|||
125311250|NCT00930930|450766648|FG001|Overall Study|Physician Decision|0|||
125311251|NCT00930930|450766647|FG000|Overall Study|Adverse Event|13|||
125311252|NCT00930930|450766648|FG001|Overall Study|Adverse Event|3|||
125311253|NCT00930930|450766647|FG000|Overall Study|Withdrawal by Subject|3|||
125311254|NCT00930930|450766648|FG001|Overall Study|Withdrawal by Subject|1|||
125311255|NCT00930930|450766647|FG000|Overall Study|Disease progression|2|||
125311256|NCT00930930|450766648|FG001|Overall Study|Disease progression|3|||
125311257|NCT00930930|450766647|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
125311258|NCT00930930|450766648|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
125311259|NCT00930930|450766647|FG000|Overall Study|patients not compliant|1|||
125311260|NCT00930930|450766648|FG001|Overall Study|patients not compliant|1|||
125311261|NCT02709330|450766649|FG000|Overall Study|Death|5|||
125311262|NCT02709330|450766650|FG001|Overall Study|Death|0|||
125311263|NCT02709330|450766649|FG000|Overall Study|Lost to Follow-up|2|||
125311264|NCT02709330|450766650|FG001|Overall Study|Lost to Follow-up|0|||
125311265|NCT02709330|450766649|FG000|Overall Study|Physician Decision|2|||
125534234|NCT00798434|451584917|FG001|Open-Label|Lack of Efficacy|11|||
125311266|NCT02709330|450766650|FG001|Overall Study|Physician Decision|0|||
125311267|NCT02709330|450766649|FG000|Overall Study|Withdrawal by Subject|4|||
125311268|NCT02709330|450766650|FG001|Overall Study|Withdrawal by Subject|0|||
125311269|NCT01172535|450768631|FG000|Overall Study|Death|3|||
125311270|NCT01172535|450768631|FG000|Overall Study|Withdrawal by Subject|2|||
125311271|NCT01172535|450768631|FG000|Overall Study|Lost to Follow-up|1|||
125534235|NCT00798434|451584916|FG000|Open-Label|Withdrawal by Subject|2|||
125311272|NCT01172535|450768631|FG000|Overall Study|Ineligible at study entry|1|||
125311273|NCT01172535|450768631|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
125311274|NCT00988598|450768632|FG000|Overall Study|Withdrawal by Subject|2|||
125311275|NCT00988598|450768633|FG001|Overall Study|Withdrawal by Subject|0|||
125311276|NCT04317040|450768634|FG000|Overall Study|Lost to Follow-up|2|||
125311277|NCT04317040|450768635|FG001|Overall Study|Lost to Follow-up|0|||
125311278|NCT04317040|450768634|FG000|Overall Study|Death|16|||
125311279|NCT04317040|450768635|FG001|Overall Study|Death|18|||
125311280|NCT04317040|450768634|FG000|Overall Study|Withdrawal by Subject|0|||
125311281|NCT04317040|450768635|FG001|Overall Study|Withdrawal by Subject|1|||
125311282|NCT04317040|450768634|FG000|Overall Study|Incomplete assessments|0|||
125311283|NCT04317040|450768635|FG001|Overall Study|Incomplete assessments|1|||
125311284|NCT01177007|450768636|FG000|Overall Study|Lost to Follow-up|2|||
125311285|NCT01177007|450768636|FG000|Overall Study|Death|4|||
125311286|NCT01177007|450768636|FG000|Overall Study|Entered hospice care|5|||
125311287|NCT01177007|450768636|FG000|Overall Study|Required additional Y90 treatment|6|||
125311288|NCT01177007|450768636|FG000|Overall Study|Change in treatment modality|21|||
125311289|NCT02366195|450768648|FG000|Overall Study|Protocol-specified criteria|3|||
125311290|NCT02366195|450768648|FG000|Overall Study|Withdrawal by Subject|9|||
125311291|NCT02366195|450768648|FG000|Overall Study|Lost to Follow-up|1|||
125311292|NCT02366195|450768648|FG000|Overall Study|Death|41|||
125311293|NCT01338818|450768649|FG000|Overall Study|Adverse Event|8|||
125311294|NCT01338818|450768649|FG000|Overall Study|Lack of Efficacy|5|||
125311295|NCT01338818|450768649|FG000|Overall Study|no longer require study drug|1|||
125311296|NCT01338818|450768649|FG000|Overall Study|Withdrawal by Subject|11|||
125311297|NCT01338818|450768649|FG000|Overall Study|Lost to Follow-up|4|||
125311298|NCT01338818|450768649|FG000|Overall Study|Administrative problems|3|||
125311299|NCT01338818|450768649|FG000|Overall Study|Protocol Deviation|4|||
125311300|NCT00556998|450768654|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
125311301|NCT00556998|450768654|FG000|Voriconazole Intravenous (IV)|Other|4|||
125311302|NCT00556998|450768654|FG000|Voriconazole Oral|Adverse Event|1|||
125311303|NCT00556998|450768654|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
125311304|NCT03030417|450768663|FG000|Dose Expansion|Disease progression before treatment|0|||
125311305|NCT03030417|450768664|FG001|Dose Expansion|Disease progression before treatment|0|||
125311306|NCT03030417|450768665|FG002|Dose Expansion|Disease progression before treatment|0|||
125311307|NCT03030417|450768666|FG003|Dose Expansion|Disease progression before treatment|0|||
125311308|NCT03030417|450768667|FG004|Dose Expansion|Disease progression before treatment|0|||
125311309|NCT03030417|450768668|FG005|Dose Expansion|Disease progression before treatment|0|||
125311310|NCT03030417|450768669|FG006|Dose Expansion|Disease progression before treatment|0|||
125311311|NCT03030417|450768670|FG007|Dose Expansion|Disease progression before treatment|0|||
125311312|NCT03030417|450768671|FG008|Dose Expansion|Disease progression before treatment|0|||
125311313|NCT03030417|450768672|FG009|Dose Expansion|Disease progression before treatment|0|||
125311314|NCT03030417|450768673|FG010|Dose Expansion|Disease progression before treatment|0|||
125311315|NCT03030417|450768674|FG011|Dose Expansion|Disease progression before treatment|0|||
125311316|NCT03030417|450768675|FG012|Dose Expansion|Disease progression before treatment|1|||
125311317|NCT01684202|450768676|FG000|Dose-escalation Period|Adverse Event|0|||
125311318|NCT01684202|450768677|FG001|Dose-escalation Period|Adverse Event|1|||
125311319|NCT01684202|450768678|FG002|Dose-escalation Period|Adverse Event|0|||
125311320|NCT01684202|450768679|FG003|Dose-escalation Period|Adverse Event|0|||
125311321|NCT01684202|450768676|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
125311322|NCT01684202|450768677|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
125311323|NCT01684202|450768678|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
125311324|NCT01684202|450768679|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
125311325|NCT01684202|450768676|FG000|Maintenance Period|Adverse Event|1|||
125311326|NCT01684202|450768677|FG001|Maintenance Period|Adverse Event|1|||
125311327|NCT01684202|450768678|FG002|Maintenance Period|Adverse Event|1|||
125311328|NCT01684202|450768679|FG003|Maintenance Period|Adverse Event|1|||
125311329|NCT01684202|450768676|FG000|Maintenance Period|Physician Decision|0|||
125311330|NCT01684202|450768677|FG001|Maintenance Period|Physician Decision|1|||
125311331|NCT01684202|450768678|FG002|Maintenance Period|Physician Decision|0|||
125311332|NCT01684202|450768679|FG003|Maintenance Period|Physician Decision|0|||
125311333|NCT01684202|450768676|FG000|Maintenance Period|Withdrawal by Subject|0|||
125311334|NCT01684202|450768677|FG001|Maintenance Period|Withdrawal by Subject|1|||
125311335|NCT01684202|450768678|FG002|Maintenance Period|Withdrawal by Subject|0|||
125311336|NCT01684202|450768679|FG003|Maintenance Period|Withdrawal by Subject|0|||
125311337|NCT00191308|450768680|FG000|Overall Study|Adverse Event|1|||
125311338|NCT00779025|450768681|FG000|Overall Study|Withdrawal by Subject|1|||
125311339|NCT03710642|450768682|FG000|Overall Study|Adverse Event|5|||
125311340|NCT03710642|450768683|FG001|Overall Study|Adverse Event|1|||
125311341|NCT03710642|450768682|FG000|Overall Study|non-site physician recommendation|1|||
125311342|NCT03710642|450768683|FG001|Overall Study|non-site physician recommendation|0|||
125311343|NCT03710642|450768682|FG000|Overall Study|Participant unwilling or unable to participate|1|||
125311344|NCT03710642|450768683|FG001|Overall Study|Participant unwilling or unable to participate|1|||
125378852|NCT01134783|451019171|FG001|Overall Study|Pregnancy|8|||
125311345|NCT03710642|450768682|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
125311346|NCT03710642|450768683|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
125311347|NCT03710642|450768682|FG000|Overall Study|NA-no code provided|1|||
125311348|NCT03710642|450768683|FG001|Overall Study|NA-no code provided|0|||
125311349|NCT03710642|450768682|FG000|Overall Study|Withdrawal by Subject|1|||
125311350|NCT03710642|450768683|FG001|Overall Study|Withdrawal by Subject|0|||
125311351|NCT00782717|450768684|FG000|Overall Study|Adverse Event|2|||
125311352|NCT00782717|450768685|FG001|Overall Study|Adverse Event|5|||
125311353|NCT00782717|450768684|FG000|Overall Study|Patient decision unrelated to AE|6|||
125311354|NCT00782717|450768685|FG001|Overall Study|Patient decision unrelated to AE|3|||
125311355|NCT00782717|450768684|FG000|Overall Study|Noncompliance|2|||
125311356|NCT00782717|450768685|FG001|Overall Study|Noncompliance|1|||
125311357|NCT00782717|450768684|FG000|Overall Study|Treatment failure|3|||
125311358|NCT00782717|450768685|FG001|Overall Study|Treatment failure|14|||
125311359|NCT00782717|450768684|FG000|Overall Study|Enrollment close prior to surgery|1|||
125311360|NCT00782717|450768685|FG001|Overall Study|Enrollment close prior to surgery|0|||
125311361|NCT00782717|450768684|FG000|Overall Study|Did not meet entrance criteria|1|||
125311362|NCT00782717|450768685|FG001|Overall Study|Did not meet entrance criteria|3|||
125311363|NCT00782717|450768684|FG000|Overall Study|Exited in error|0|||
125311364|NCT00782717|450768685|FG001|Overall Study|Exited in error|2|||
125311365|NCT02292719|450768686|FG000|Overall Study|Withdrawal by Subject|0|||
125311366|NCT02292719|450768687|FG001|Overall Study|Withdrawal by Subject|0|||
125311367|NCT02292719|450768688|FG002|Overall Study|Withdrawal by Subject|0|||
125311368|NCT02292719|450768689|FG003|Overall Study|Withdrawal by Subject|1|||
125311369|NCT02292719|450768690|FG004|Overall Study|Withdrawal by Subject|1|||
125311370|NCT02292719|450768691|FG005|Overall Study|Withdrawal by Subject|0|||
125311371|NCT02292719|450768686|FG000|Overall Study|Subject enrolled in new study.|0|||
125311372|NCT02292719|450768687|FG001|Overall Study|Subject enrolled in new study.|0|||
125311373|NCT02292719|450768688|FG002|Overall Study|Subject enrolled in new study.|1|||
125311374|NCT02292719|450768689|FG003|Overall Study|Subject enrolled in new study.|0|||
125311375|NCT02292719|450768690|FG004|Overall Study|Subject enrolled in new study.|0|||
125311376|NCT02292719|450768691|FG005|Overall Study|Subject enrolled in new study.|0|||
125311377|NCT02586727|450768697|FG000|Overall Study|Lost to Follow-up|1|||
125311378|NCT02586727|450768698|FG001|Overall Study|Lost to Follow-up|0|||
125311379|NCT04628780|450768703|FG000|Overall Study|Death|0|||
125311380|NCT04628780|450768704|FG001|Overall Study|Death|1|||
125311381|NCT04628780|450768705|FG002|Overall Study|Death|0|||
125311382|NCT04628780|450768706|FG003|Overall Study|Death|0|||
125311383|NCT04628780|450768707|FG004|Overall Study|Death|1|||
125311384|NCT04628780|450768708|FG005|Overall Study|Death|0|||
125311385|NCT04628780|450768703|FG000|Overall Study|Physician Decision|2|||
125311386|NCT04628780|450768704|FG001|Overall Study|Physician Decision|0|||
125311387|NCT04628780|450768705|FG002|Overall Study|Physician Decision|0|||
125311388|NCT04628780|450768706|FG003|Overall Study|Physician Decision|0|||
125311389|NCT04628780|450768707|FG004|Overall Study|Physician Decision|2|||
125311390|NCT04628780|450768708|FG005|Overall Study|Physician Decision|0|||
125311391|NCT04628780|450768703|FG000|Overall Study|Progressive disease|2|||
125311392|NCT04628780|450768704|FG001|Overall Study|Progressive disease|2|||
125311393|NCT04628780|450768705|FG002|Overall Study|Progressive disease|2|||
125311394|NCT04628780|450768706|FG003|Overall Study|Progressive disease|3|||
125311395|NCT04628780|450768707|FG004|Overall Study|Progressive disease|9|||
125311396|NCT04628780|450768708|FG005|Overall Study|Progressive disease|4|||
125311397|NCT04628780|450768703|FG000|Overall Study|Withdrawal by Subject|0|||
125311398|NCT04628780|450768704|FG001|Overall Study|Withdrawal by Subject|1|||
125311399|NCT04628780|450768705|FG002|Overall Study|Withdrawal by Subject|2|||
125311400|NCT04628780|450768706|FG003|Overall Study|Withdrawal by Subject|0|||
125311401|NCT04628780|450768707|FG004|Overall Study|Withdrawal by Subject|3|||
125311402|NCT04628780|450768708|FG005|Overall Study|Withdrawal by Subject|1|||
125422493|NCT01207102|451172861|FG000|Overall Study|Withdrawal by Treating Physician|1|||
125422494|NCT01777854|451172862|FG000|Overall Study|Physician Decision|3|||
125311403|NCT04628780|450768703|FG000|Overall Study|Global deterioration of health status|0|||
125311404|NCT04628780|450768704|FG001|Overall Study|Global deterioration of health status|0|||
125311405|NCT04628780|450768705|FG002|Overall Study|Global deterioration of health status|0|||
125422495|NCT01777854|451172863|FG001|Overall Study|Physician Decision|3|||
125422496|NCT01239030|451172868|FG000|Double Blind|Adverse Event|0|||
125422497|NCT01239030|451172869|FG001|Double Blind|Adverse Event|1|||
125422498|NCT01239030|451172870|FG002|Double Blind|Adverse Event|0|||
125422499|NCT01239030|451172871|FG003|Double Blind|Adverse Event|2|||
125422500|NCT01239030|451172872|FG004|Double Blind|Adverse Event|0|||
125422501|NCT01239030|451172868|FG000|Double Blind|Withdrawal by Subject|0|||
125422502|NCT01239030|451172869|FG001|Double Blind|Withdrawal by Subject|1|||
125422503|NCT01239030|451172870|FG002|Double Blind|Withdrawal by Subject|1|||
125422504|NCT01239030|451172871|FG003|Double Blind|Withdrawal by Subject|0|||
125422505|NCT01239030|451172872|FG004|Double Blind|Withdrawal by Subject|1|||
125422506|NCT01239030|451172868|FG000|Double Blind|Lost to Follow-up|1|||
125422507|NCT01239030|451172869|FG001|Double Blind|Lost to Follow-up|1|||
125422508|NCT01239030|451172870|FG002|Double Blind|Lost to Follow-up|0|||
125534236|NCT00798434|451584917|FG001|Open-Label|Withdrawal by Subject|7|||
125534237|NCT00798434|451584916|FG000|Open-Label|Protocol Violation|1|||
125534238|NCT00798434|451584917|FG001|Open-Label|Protocol Violation|0|||
125534239|NCT00798434|451584916|FG000|Open-Label|Other|1|||
125534240|NCT00798434|451584917|FG001|Open-Label|Other|2|||
125534241|NCT00798434|451584916|FG000|Open-Label|Not Treated|0|||
125534242|NCT00798434|451584917|FG001|Open-Label|Not Treated|1|||
125534243|NCT03898167|451584918|FG000|Overall Study|Terminated phone call early|7|||
125534244|NCT03898167|451584919|FG001|Overall Study|Terminated phone call early|0|||
125534245|NCT03898167|451584920|FG002|Overall Study|Terminated phone call early|0|||
125534246|NCT03898167|451584918|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
125534247|NCT03898167|451584919|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
125534248|NCT03898167|451584920|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
125534249|NCT05292586|451584921|FG000|Overall Study|Withdrawal by Subject|3|||
125534250|NCT05292586|451584922|FG001|Overall Study|Withdrawal by Subject|10|||
125534251|NCT05292586|451584921|FG000|Overall Study|Randomization error|3|||
125534252|NCT05292586|451584922|FG001|Overall Study|Randomization error|7|||
125534253|NCT05292586|451584921|FG000|Overall Study|Adverse Event|3|||
125534254|NCT05292586|451584922|FG001|Overall Study|Adverse Event|0|||
125534255|NCT05292586|451584921|FG000|Overall Study|Lost to Follow-up|0|||
125534256|NCT05292586|451584922|FG001|Overall Study|Lost to Follow-up|1|||
125422509|NCT01239030|451172871|FG003|Double Blind|Lost to Follow-up|0|||
125422510|NCT01239030|451172872|FG004|Double Blind|Lost to Follow-up|0|||
125422511|NCT01239030|451172868|FG000|Double Blind|Physician Decision|0|||
125534257|NCT05292586|451584921|FG000|Overall Study|Patient refused treatment|1|||
125534258|NCT05292586|451584922|FG001|Overall Study|Patient refused treatment|0|||
125534259|NCT05292586|451584921|FG000|Overall Study|Patient could not travel to the study site|1|||
125422512|NCT01239030|451172869|FG001|Double Blind|Physician Decision|1|||
125422513|NCT01239030|451172870|FG002|Double Blind|Physician Decision|0|||
125422514|NCT01239030|451172871|FG003|Double Blind|Physician Decision|0|||
125422515|NCT01239030|451172872|FG004|Double Blind|Physician Decision|0|||
125422516|NCT01239030|451172868|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
125422517|NCT01239030|451172869|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
125422518|NCT01239030|451172870|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
125422519|NCT01239030|451172871|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
125422520|NCT01239030|451172872|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
125422521|NCT01239030|451172868|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
125422522|NCT01239030|451172869|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
125311406|NCT04628780|450768706|FG003|Overall Study|Global deterioration of health status|0|||
125311407|NCT04628780|450768707|FG004|Overall Study|Global deterioration of health status|1|||
125311408|NCT04628780|450768708|FG005|Overall Study|Global deterioration of health status|1|||
125311409|NCT03622814|450768710|FG000|Overall Study|Lost to Follow-up|8|||
125311410|NCT03622814|450768711|FG001|Overall Study|Lost to Follow-up|14|||
125311411|NCT01288989|450768714|FG000|Overall Study|Death|0|||
125311412|NCT01288989|450768715|FG001|Overall Study|Death|0|||
125311413|NCT01288989|450768716|FG002|Overall Study|Death|0|||
125311414|NCT01288989|450768717|FG003|Overall Study|Death|1|||
125311415|NCT01288989|450768718|FG004|Overall Study|Death|0|||
125311416|NCT01288989|450768714|FG000|Overall Study|Dose limiting toxicity|1|||
125311417|NCT01288989|450768715|FG001|Overall Study|Dose limiting toxicity|0|||
125311418|NCT01288989|450768716|FG002|Overall Study|Dose limiting toxicity|0|||
125311419|NCT01288989|450768717|FG003|Overall Study|Dose limiting toxicity|0|||
125311420|NCT01288989|450768718|FG004|Overall Study|Dose limiting toxicity|0|||
125311421|NCT01288989|450768714|FG000|Overall Study|Adverse Event|0|||
125311422|NCT01288989|450768715|FG001|Overall Study|Adverse Event|0|||
125311423|NCT01288989|450768716|FG002|Overall Study|Adverse Event|0|||
125311424|NCT01288989|450768717|FG003|Overall Study|Adverse Event|0|||
125311425|NCT01288989|450768718|FG004|Overall Study|Adverse Event|2|||
125311426|NCT01288989|450768714|FG000|Overall Study|Physician Decision|0|||
125311427|NCT01288989|450768715|FG001|Overall Study|Physician Decision|0|||
125311428|NCT01288989|450768716|FG002|Overall Study|Physician Decision|0|||
125311429|NCT01288989|450768717|FG003|Overall Study|Physician Decision|0|||
125311430|NCT01288989|450768718|FG004|Overall Study|Physician Decision|1|||
125311431|NCT01288989|450768714|FG000|Overall Study|Withdrawal by Subject|0|||
125311432|NCT01288989|450768715|FG001|Overall Study|Withdrawal by Subject|0|||
125311433|NCT01288989|450768716|FG002|Overall Study|Withdrawal by Subject|0|||
125311434|NCT01288989|450768717|FG003|Overall Study|Withdrawal by Subject|0|||
125534260|NCT05292586|451584922|FG001|Overall Study|Patient could not travel to the study site|0|||
125534261|NCT05292586|451584921|FG000|Overall Study|Technical issues with the masterscope|0|||
125534262|NCT05292586|451584922|FG001|Overall Study|Technical issues with the masterscope|3|||
125311435|NCT01288989|450768718|FG004|Overall Study|Withdrawal by Subject|3|||
125311436|NCT01156714|450768719|FG000|Overall Study|Withdrawal by Subject|9|||
125311437|NCT01156714|450768720|FG001|Overall Study|Withdrawal by Subject|4|||
125534263|NCT05292586|451584921|FG000|Overall Study|Patient moved to a different state|0|||
125422523|NCT01239030|451172870|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
125534264|NCT05292586|451584922|FG001|Overall Study|Patient moved to a different state|1|||
125311438|NCT01156714|450768721|FG002|Overall Study|Withdrawal by Subject|3|||
125311439|NCT01132313|450768722|FG000|Overall Study|Lack of Efficacy|1|||
125311440|NCT01132313|450768723|FG001|Overall Study|Lack of Efficacy|0|||
125311441|NCT01132313|450768724|FG002|Overall Study|Lack of Efficacy|0|||
125311442|NCT01132313|450768725|FG003|Overall Study|Lack of Efficacy|0|||
125311443|NCT01132313|450768726|FG004|Overall Study|Lack of Efficacy|0|||
125311444|NCT01132313|450768727|FG005|Overall Study|Lack of Efficacy|0|||
125311445|NCT01132313|450768728|FG006|Overall Study|Lack of Efficacy|0|||
125311446|NCT01132313|450768729|FG007|Overall Study|Lack of Efficacy|3|||
125311447|NCT01132313|450768730|FG008|Overall Study|Lack of Efficacy|14|||
125422524|NCT01239030|451172871|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
125422525|NCT01239030|451172872|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
125422526|NCT01239030|451172868|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
125422527|NCT01239030|451172869|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
125311448|NCT01132313|450768731|FG009|Overall Study|Lack of Efficacy|16|||
125311449|NCT01132313|450768732|FG010|Overall Study|Lack of Efficacy|0|||
125311450|NCT01132313|450768733|FG011|Overall Study|Lack of Efficacy|0|||
125311451|NCT01132313|450768722|FG000|Overall Study|Not treated|2|||
125311452|NCT01132313|450768723|FG001|Overall Study|Not treated|0|||
125311453|NCT01132313|450768724|FG002|Overall Study|Not treated|0|||
125311454|NCT01132313|450768725|FG003|Overall Study|Not treated|0|||
125311455|NCT01132313|450768726|FG004|Overall Study|Not treated|2|||
125311456|NCT01132313|450768727|FG005|Overall Study|Not treated|1|||
125311457|NCT01132313|450768728|FG006|Overall Study|Not treated|3|||
125311458|NCT01132313|450768729|FG007|Overall Study|Not treated|0|||
125311459|NCT01132313|450768730|FG008|Overall Study|Not treated|0|||
125311460|NCT01132313|450768731|FG009|Overall Study|Not treated|0|||
125311461|NCT01132313|450768732|FG010|Overall Study|Not treated|0|||
125311462|NCT01132313|450768733|FG011|Overall Study|Not treated|0|||
125311463|NCT01132313|450768722|FG000|Overall Study|Adverse Event|0|||
125311464|NCT01132313|450768723|FG001|Overall Study|Adverse Event|0|||
125311465|NCT01132313|450768724|FG002|Overall Study|Adverse Event|4|||
125311466|NCT01132313|450768725|FG003|Overall Study|Adverse Event|10|||
125311467|NCT01132313|450768726|FG004|Overall Study|Adverse Event|19|||
125311468|NCT01132313|450768727|FG005|Overall Study|Adverse Event|6|||
125311469|NCT01132313|450768728|FG006|Overall Study|Adverse Event|5|||
125311470|NCT01132313|450768729|FG007|Overall Study|Adverse Event|3|||
125311471|NCT01132313|450768730|FG008|Overall Study|Adverse Event|7|||
125311472|NCT01132313|450768731|FG009|Overall Study|Adverse Event|2|||
125311473|NCT01132313|450768732|FG010|Overall Study|Adverse Event|0|||
125311474|NCT01132313|450768733|FG011|Overall Study|Adverse Event|0|||
125311475|NCT01132313|450768722|FG000|Overall Study|Protocol Violation|0|||
125311476|NCT01132313|450768723|FG001|Overall Study|Protocol Violation|0|||
125311477|NCT01132313|450768724|FG002|Overall Study|Protocol Violation|0|||
125311478|NCT01132313|450768725|FG003|Overall Study|Protocol Violation|1|||
125311479|NCT01132313|450768726|FG004|Overall Study|Protocol Violation|0|||
125311480|NCT01132313|450768727|FG005|Overall Study|Protocol Violation|0|||
125311481|NCT01132313|450768728|FG006|Overall Study|Protocol Violation|0|||
125311482|NCT01132313|450768729|FG007|Overall Study|Protocol Violation|0|||
125311483|NCT01132313|450768730|FG008|Overall Study|Protocol Violation|0|||
125422528|NCT01239030|451172870|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
125422529|NCT01239030|451172871|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
125422530|NCT01239030|451172872|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
125422531|NCT01239030|451172868|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
125422532|NCT01239030|451172869|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
125422533|NCT01239030|451172870|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
125422534|NCT01239030|451172871|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
125422535|NCT01239030|451172872|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
125422536|NCT03792126|451172880|FG000|Overall Study|Adverse Event|1|||
125422537|NCT03792126|451172881|FG001|Overall Study|Adverse Event|2|||
125422538|NCT03792126|451172880|FG000|Overall Study|Death|0|||
125422539|NCT03792126|451172881|FG001|Overall Study|Death|1|||
125422540|NCT03792126|451172880|FG000|Overall Study|Lost to Follow-up|1|||
125422541|NCT03792126|451172881|FG001|Overall Study|Lost to Follow-up|0|||
125311484|NCT01132313|450768731|FG009|Overall Study|Protocol Violation|0|||
125311485|NCT01132313|450768732|FG010|Overall Study|Protocol Violation|0|||
125311486|NCT01132313|450768733|FG011|Overall Study|Protocol Violation|0|||
125311487|NCT01132313|450768722|FG000|Overall Study|Lost to Follow-up|0|||
125311488|NCT01132313|450768723|FG001|Overall Study|Lost to Follow-up|0|||
125311489|NCT01132313|450768724|FG002|Overall Study|Lost to Follow-up|1|||
125311490|NCT01132313|450768725|FG003|Overall Study|Lost to Follow-up|0|||
125311491|NCT01132313|450768726|FG004|Overall Study|Lost to Follow-up|0|||
125311492|NCT01132313|450768727|FG005|Overall Study|Lost to Follow-up|0|||
125311493|NCT01132313|450768728|FG006|Overall Study|Lost to Follow-up|0|||
125311494|NCT01132313|450768729|FG007|Overall Study|Lost to Follow-up|1|||
125311495|NCT01132313|450768730|FG008|Overall Study|Lost to Follow-up|0|||
125311496|NCT01132313|450768731|FG009|Overall Study|Lost to Follow-up|0|||
125311497|NCT01132313|450768732|FG010|Overall Study|Lost to Follow-up|0|||
125311498|NCT01132313|450768733|FG011|Overall Study|Lost to Follow-up|0|||
125311499|NCT01132313|450768722|FG000|Overall Study|Withdrawal by Subject|0|||
125422542|NCT03792126|451172880|FG000|Overall Study|Withdrawal by Subject|0|||
125422543|NCT03792126|451172881|FG001|Overall Study|Withdrawal by Subject|1|||
125422544|NCT03792126|451172880|FG000|Overall Study|COVID-19 Restrictions|1|||
125422545|NCT03792126|451172881|FG001|Overall Study|COVID-19 Restrictions|3|||
125422546|NCT03792126|451172880|FG000|Overall Study|Symptoms resolved|0|||
125422547|NCT03792126|451172881|FG001|Overall Study|Symptoms resolved|3|||
125422548|NCT02300220|451172882|FG000|Overall Study|Lost to Follow-up|1|||
125422549|NCT02300220|451172883|FG001|Overall Study|Lost to Follow-up|2|||
125422550|NCT02300220|451172882|FG000|Overall Study|Death|1|||
125422551|NCT02300220|451172883|FG001|Overall Study|Death|1|||
125422552|NCT02300220|451172882|FG000|Overall Study|Adverse Event|1|||
125422553|NCT02300220|451172883|FG001|Overall Study|Adverse Event|1|||
125422554|NCT02300220|451172882|FG000|Overall Study|Protocol Violation|1|||
125311500|NCT01132313|450768723|FG001|Overall Study|Withdrawal by Subject|0|||
125311501|NCT01132313|450768724|FG002|Overall Study|Withdrawal by Subject|3|||
125311502|NCT01132313|450768725|FG003|Overall Study|Withdrawal by Subject|3|||
125311503|NCT01132313|450768726|FG004|Overall Study|Withdrawal by Subject|6|||
125311504|NCT01132313|450768727|FG005|Overall Study|Withdrawal by Subject|0|||
125311505|NCT01132313|450768728|FG006|Overall Study|Withdrawal by Subject|1|||
125311506|NCT01132313|450768729|FG007|Overall Study|Withdrawal by Subject|0|||
125311507|NCT01132313|450768730|FG008|Overall Study|Withdrawal by Subject|0|||
125311508|NCT01132313|450768731|FG009|Overall Study|Withdrawal by Subject|2|||
125311509|NCT01132313|450768732|FG010|Overall Study|Withdrawal by Subject|0|||
125311510|NCT01132313|450768733|FG011|Overall Study|Withdrawal by Subject|0|||
125311511|NCT01132313|450768722|FG000|Overall Study|Lack of antiviral response|0|||
125311512|NCT01132313|450768723|FG001|Overall Study|Lack of antiviral response|0|||
125311513|NCT01132313|450768724|FG002|Overall Study|Lack of antiviral response|12|||
125311514|NCT01132313|450768725|FG003|Overall Study|Lack of antiviral response|18|||
125311515|NCT01132313|450768726|FG004|Overall Study|Lack of antiviral response|18|||
125311516|NCT01132313|450768727|FG005|Overall Study|Lack of antiviral response|18|||
125311517|NCT01132313|450768728|FG006|Overall Study|Lack of antiviral response|21|||
125311518|NCT01132313|450768729|FG007|Overall Study|Lack of antiviral response|0|||
125311519|NCT01132313|450768730|FG008|Overall Study|Lack of antiviral response|0|||
125311520|NCT01132313|450768731|FG009|Overall Study|Lack of antiviral response|0|||
125311521|NCT01132313|450768732|FG010|Overall Study|Lack of antiviral response|1|||
125311522|NCT01132313|450768733|FG011|Overall Study|Lack of antiviral response|0|||
125311523|NCT01132313|450768722|FG000|Overall Study|Other reason not defined above|0|||
125311524|NCT01132313|450768723|FG001|Overall Study|Other reason not defined above|0|||
125311525|NCT01132313|450768724|FG002|Overall Study|Other reason not defined above|0|||
125311526|NCT01132313|450768725|FG003|Overall Study|Other reason not defined above|0|||
125311527|NCT01132313|450768726|FG004|Overall Study|Other reason not defined above|0|||
125311528|NCT01132313|450768727|FG005|Overall Study|Other reason not defined above|0|||
125311529|NCT01132313|450768728|FG006|Overall Study|Other reason not defined above|0|||
125311530|NCT01132313|450768729|FG007|Overall Study|Other reason not defined above|1|||
125311531|NCT01132313|450768730|FG008|Overall Study|Other reason not defined above|0|||
125311532|NCT01132313|450768731|FG009|Overall Study|Other reason not defined above|0|||
125311533|NCT01132313|450768732|FG010|Overall Study|Other reason not defined above|0|||
125311534|NCT01132313|450768733|FG011|Overall Study|Other reason not defined above|0|||
125311535|NCT00165672|450768734|FG000|Overall Study|Adverse Event|0|||
125311536|NCT00165672|450768735|FG001|Overall Study|Adverse Event|1|||
125311537|NCT02715609|450768741|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
125311538|NCT02715609|450768742|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
125311539|NCT02715609|450768743|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
125311540|NCT02715609|450768741|FG000|Overall Study|Withdrawal by Subject|0|||
125311541|NCT02715609|450768742|FG001|Overall Study|Withdrawal by Subject|0|||
125311542|NCT02715609|450768743|FG002|Overall Study|Withdrawal by Subject|1|||
125311543|NCT03201419|450768744|FG000|Overall Study|Adverse Event|3|||
125311544|NCT03201419|450768745|FG001|Overall Study|Adverse Event|1|||
125311545|NCT03201419|450768746|FG002|Overall Study|Adverse Event|0|||
125311546|NCT03201419|450768747|FG003|Overall Study|Adverse Event|0|||
125311547|NCT03201419|450768748|FG004|Overall Study|Adverse Event|1|||
125311548|NCT03201419|450768749|FG005|Overall Study|Adverse Event|1|||
125311549|NCT03201419|450768750|FG006|Overall Study|Adverse Event|5|||
125311550|NCT03201419|450768751|FG007|Overall Study|Adverse Event|0|||
125311551|NCT03201419|450768752|FG008|Overall Study|Adverse Event|0|||
125311552|NCT03201419|450768744|FG000|Overall Study|Lost to Follow-up|1|||
125311553|NCT03201419|450768745|FG001|Overall Study|Lost to Follow-up|0|||
125311554|NCT03201419|450768746|FG002|Overall Study|Lost to Follow-up|0|||
125311555|NCT03201419|450768747|FG003|Overall Study|Lost to Follow-up|0|||
125311556|NCT03201419|450768748|FG004|Overall Study|Lost to Follow-up|0|||
125311557|NCT03201419|450768749|FG005|Overall Study|Lost to Follow-up|0|||
125311558|NCT03201419|450768750|FG006|Overall Study|Lost to Follow-up|0|||
125311559|NCT03201419|450768751|FG007|Overall Study|Lost to Follow-up|0|||
125422555|NCT02300220|451172883|FG001|Overall Study|Protocol Violation|0|||
125311560|NCT03201419|450768752|FG008|Overall Study|Lost to Follow-up|0|||
125422556|NCT02300220|451172882|FG000|Overall Study|Withdrawal by Subject|0|||
125422557|NCT02300220|451172883|FG001|Overall Study|Withdrawal by Subject|2|||
125422558|NCT02300220|451172882|FG000|Overall Study|Did not tolerate IMP|0|||
125534265|NCT05177354|451584923|FG000|Implant to 30-day Visit|Physician Decision|1|||
125534266|NCT05177354|451584923|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
125534267|NCT05177354|451584923|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
125534268|NCT05177354|451584923|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
125534269|NCT03548220|451584925|FG000|Overall Study|Lost to Follow-up|1|||
125534270|NCT03548220|451584926|FG001|Overall Study|Lost to Follow-up|0|||
125534271|NCT03548220|451584927|FG002|Overall Study|Lost to Follow-up|0|||
125534272|NCT03548220|451584928|FG003|Overall Study|Lost to Follow-up|0|||
125534273|NCT01099215|451586238|FG000|Overall Study|Withdrawal by Subject|1|||
125534274|NCT01099215|451586239|FG001|Overall Study|Withdrawal by Subject|0|||
125534275|NCT01099215|451586238|FG000|Overall Study|Adverse Event|0|||
125534276|NCT01099215|451586239|FG001|Overall Study|Adverse Event|1|||
125534277|NCT00747227|451586241|FG000|Overall Study|Death|3|||
125534278|NCT00747227|451586242|FG001|Overall Study|Death|1|||
125534279|NCT00747227|451586241|FG000|Overall Study|Withdrawal by Subject|1|||
125534280|NCT00747227|451586242|FG001|Overall Study|Withdrawal by Subject|0|||
125534281|NCT00747227|451586241|FG000|Overall Study|Lost to Follow-up|1|||
125534282|NCT00747227|451586242|FG001|Overall Study|Lost to Follow-up|2|||
125534283|NCT00747227|451586241|FG000|Overall Study|Illness|1|||
125534284|NCT00747227|451586242|FG001|Overall Study|Illness|1|||
125534285|NCT03554629|451586243|FG000|Overall Study|Inadequate data|6|||
125534286|NCT00515671|451586252|FG000|Overall Study|Lost to Follow-up|13|||
125534287|NCT00515671|451586253|FG001|Overall Study|Lost to Follow-up|10|||
125534288|NCT00515671|451586252|FG000|Overall Study|Withdrawal by Subject|3|||
125534289|NCT00515671|451586253|FG001|Overall Study|Withdrawal by Subject|5|||
125534290|NCT00515671|451586252|FG000|Overall Study|incarcerated|1|||
125534291|NCT00515671|451586253|FG001|Overall Study|incarcerated|2|||
125534292|NCT00288639|451586256|FG000|Overall Study|Adverse Event|5|||
125534293|NCT00288639|451586256|FG000|Overall Study|Lack of Efficacy|4|||
125422559|NCT02300220|451172883|FG001|Overall Study|Did not tolerate IMP|1|||
125422560|NCT04322682|451172884|FG000|Overall Study|Withdrawal by Subject|33|||
125422561|NCT04322682|451172885|FG001|Overall Study|Withdrawal by Subject|47|||
125422562|NCT04322682|451172884|FG000|Overall Study|Death|5|||
125422563|NCT04322682|451172885|FG001|Overall Study|Death|9|||
125422564|NCT04322682|451172884|FG000|Overall Study|Lost to Follow-up|4|||
125422565|NCT04322682|451172885|FG001|Overall Study|Lost to Follow-up|8|||
125422566|NCT04322682|451172884|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
125534294|NCT00288639|451586256|FG000|Overall Study|Withdrawal by Subject|2|||
125534295|NCT00288639|451586256|FG000|Overall Study|Other|1|||
125534296|NCT01014208|451586265|FG000|Overall Study|Lost to Follow-up|2|||
125534297|NCT01014208|451586266|FG001|Overall Study|Lost to Follow-up|5|||
125534298|NCT01014208|451586265|FG000|Overall Study|Participant Withdrew Consent|12|||
125534299|NCT01014208|451586266|FG001|Overall Study|Participant Withdrew Consent|12|||
125534300|NCT01014208|451586265|FG000|Overall Study|Did Not Receive Study Drug|2|||
125534301|NCT01014208|451586266|FG001|Overall Study|Did Not Receive Study Drug|0|||
125534302|NCT01014208|451586265|FG000|Overall Study|Study Closed/terminated|78|||
125534303|NCT01014208|451586266|FG001|Overall Study|Study Closed/terminated|83|||
125534304|NCT04165031|451586267|FG000|Overall Study|Adverse Event|1|||
125534305|NCT04165031|451586268|FG001|Overall Study|Adverse Event|1|||
125534306|NCT04165031|451586269|FG002|Overall Study|Adverse Event|0|||
125534307|NCT04165031|451586270|FG003|Overall Study|Adverse Event|0|||
125534308|NCT04165031|451586271|FG004|Overall Study|Adverse Event|0|||
125534309|NCT04165031|451586272|FG005|Overall Study|Adverse Event|0|||
125534310|NCT04165031|451586267|FG000|Overall Study|Withdrawal by Subject|0|||
125534311|NCT04165031|451586268|FG001|Overall Study|Withdrawal by Subject|0|||
125534312|NCT04165031|451586269|FG002|Overall Study|Withdrawal by Subject|1|||
125534313|NCT04165031|451586270|FG003|Overall Study|Withdrawal by Subject|0|||
125534314|NCT04165031|451586271|FG004|Overall Study|Withdrawal by Subject|0|||
125534315|NCT04165031|451586272|FG005|Overall Study|Withdrawal by Subject|0|||
125534316|NCT00663702|451586275|FG000|Overall Study|Adverse Event|8|||
125534317|NCT00663702|451586276|FG001|Overall Study|Adverse Event|4|||
125534318|NCT00663702|451586275|FG000|Overall Study|Withdrawal by Subject|3|||
125534319|NCT00663702|451586276|FG001|Overall Study|Withdrawal by Subject|1|||
125422567|NCT04322682|451172885|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
125422568|NCT02238379|451172886|FG000|Overall Study|Lost to Follow-up|1|||
125422569|NCT02238379|451172887|FG001|Overall Study|Lost to Follow-up|0|||
125534320|NCT00663702|451586275|FG000|Overall Study|Pregnancy|0|||
125534321|NCT00663702|451586276|FG001|Overall Study|Pregnancy|1|||
125534322|NCT00663702|451586275|FG000|Overall Study|Lost to Follow-up|3|||
125422570|NCT00441090|451172888|FG000|Overall Study|Adverse Event|0|||
125534323|NCT00663702|451586276|FG001|Overall Study|Lost to Follow-up|0|||
125534324|NCT00663702|451586275|FG000|Overall Study|Death|1|||
125534325|NCT00663702|451586276|FG001|Overall Study|Death|1|||
125534326|NCT00663702|451586275|FG000|Overall Study|Lack of Efficacy|3|||
125534327|NCT00663702|451586276|FG001|Overall Study|Lack of Efficacy|3|||
125534328|NCT01283152|451586279|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
125534329|NCT01283152|451586280|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
125534330|NCT01283152|451586279|FG000|Overall Study|Refused HESA|1|||
125534331|NCT01283152|451586280|FG001|Overall Study|Refused HESA|0|||
125534332|NCT04020185|451586285|FG000|Overall Study|Death|0|||
125534333|NCT04020185|451586286|FG001|Overall Study|Death|0|||
125534334|NCT04020185|451586287|FG002|Overall Study|Death|1|||
125534335|NCT04020185|451586288|FG003|Overall Study|Death|2|||
125534336|NCT04020185|451586289|FG004|Overall Study|Death|1|||
125534337|NCT04020185|451586290|FG005|Overall Study|Death|0|||
125534338|NCT04020185|451586291|FG006|Overall Study|Death|1|||
125534339|NCT04020185|451586292|FG007|Overall Study|Death|0|||
125534340|NCT04020185|451586285|FG000|Overall Study|Consent withdrawn|1|||
125534341|NCT04020185|451586286|FG001|Overall Study|Consent withdrawn|0|||
125534342|NCT04020185|451586287|FG002|Overall Study|Consent withdrawn|0|||
125534343|NCT04020185|451586288|FG003|Overall Study|Consent withdrawn|0|||
125311561|NCT03201419|450768744|FG000|Overall Study|Protocol Deviation|0|||
125311562|NCT03201419|450768745|FG001|Overall Study|Protocol Deviation|0|||
125311563|NCT03201419|450768746|FG002|Overall Study|Protocol Deviation|0|||
125311564|NCT03201419|450768747|FG003|Overall Study|Protocol Deviation|0|||
125311565|NCT03201419|450768748|FG004|Overall Study|Protocol Deviation|0|||
125534344|NCT04020185|451586289|FG004|Overall Study|Consent withdrawn|2|||
125534345|NCT04020185|451586290|FG005|Overall Study|Consent withdrawn|0|||
125534346|NCT04020185|451586291|FG006|Overall Study|Consent withdrawn|1|||
125534347|NCT04020185|451586292|FG007|Overall Study|Consent withdrawn|1|||
125534348|NCT04020185|451586285|FG000|Overall Study|Patient in hospice|0|||
125534349|NCT04020185|451586286|FG001|Overall Study|Patient in hospice|1|||
125534350|NCT04020185|451586287|FG002|Overall Study|Patient in hospice|0|||
125534351|NCT04020185|451586288|FG003|Overall Study|Patient in hospice|0|||
125534352|NCT04020185|451586289|FG004|Overall Study|Patient in hospice|0|||
125534353|NCT04020185|451586290|FG005|Overall Study|Patient in hospice|0|||
125534354|NCT04020185|451586291|FG006|Overall Study|Patient in hospice|0|||
125534355|NCT04020185|451586292|FG007|Overall Study|Patient in hospice|0|||
125422571|NCT00441090|451172889|FG001|Overall Study|Adverse Event|1|||
125422572|NCT00441090|451172890|FG002|Overall Study|Adverse Event|1|||
125422573|NCT00441090|451172891|FG003|Overall Study|Adverse Event|0|||
125422574|NCT00441090|451172892|FG004|Overall Study|Adverse Event|0|||
125422575|NCT00441090|451172888|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
125422576|NCT00441090|451172889|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
125311566|NCT03201419|450768749|FG005|Overall Study|Protocol Deviation|0|||
125311567|NCT03201419|450768750|FG006|Overall Study|Protocol Deviation|1|||
125311568|NCT03201419|450768751|FG007|Overall Study|Protocol Deviation|0|||
125311569|NCT03201419|450768752|FG008|Overall Study|Protocol Deviation|0|||
125311570|NCT03201419|450768744|FG000|Overall Study|Withdrawal by Subject|4|||
125311571|NCT03201419|450768745|FG001|Overall Study|Withdrawal by Subject|2|||
125311572|NCT03201419|450768746|FG002|Overall Study|Withdrawal by Subject|1|||
125311573|NCT03201419|450768747|FG003|Overall Study|Withdrawal by Subject|0|||
125311574|NCT03201419|450768748|FG004|Overall Study|Withdrawal by Subject|0|||
125311575|NCT03201419|450768749|FG005|Overall Study|Withdrawal by Subject|0|||
125311576|NCT03201419|450768750|FG006|Overall Study|Withdrawal by Subject|0|||
125311577|NCT03201419|450768751|FG007|Overall Study|Withdrawal by Subject|1|||
125311578|NCT03201419|450768752|FG008|Overall Study|Withdrawal by Subject|2|||
125311579|NCT03201419|450768744|FG000|Overall Study|Other|0|||
125311580|NCT03201419|450768745|FG001|Overall Study|Other|0|||
125311581|NCT03201419|450768746|FG002|Overall Study|Other|1|||
125311582|NCT03201419|450768747|FG003|Overall Study|Other|0|||
125311583|NCT03201419|450768748|FG004|Overall Study|Other|0|||
125311584|NCT03201419|450768749|FG005|Overall Study|Other|0|||
125311585|NCT03201419|450768750|FG006|Overall Study|Other|0|||
125311586|NCT03201419|450768751|FG007|Overall Study|Other|0|||
125311587|NCT03201419|450768752|FG008|Overall Study|Other|0|||
125422577|NCT00441090|451172890|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
125422578|NCT00441090|451172891|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
125422579|NCT00441090|451172892|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
125422580|NCT00441090|451172888|FG000|Overall Study|Withdrawal by Subject|1|||
125422581|NCT00441090|451172889|FG001|Overall Study|Withdrawal by Subject|0|||
125422582|NCT00441090|451172890|FG002|Overall Study|Withdrawal by Subject|1|||
125422583|NCT00441090|451172891|FG003|Overall Study|Withdrawal by Subject|0|||
125422584|NCT00441090|451172892|FG004|Overall Study|Withdrawal by Subject|0|||
125422585|NCT00441090|451172888|FG000|Overall Study|Lack of Efficacy|1|||
125422586|NCT00441090|451172889|FG001|Overall Study|Lack of Efficacy|0|||
125422587|NCT00441090|451172890|FG002|Overall Study|Lack of Efficacy|0|||
125422588|NCT00441090|451172891|FG003|Overall Study|Lack of Efficacy|0|||
125422589|NCT00441090|451172892|FG004|Overall Study|Lack of Efficacy|0|||
125422590|NCT01441102|451172893|FG000|Overall Study|Adverse Event|1|||
125422591|NCT01441102|451172893|FG000|Overall Study|Withdrawal by Subject|2|||
125422592|NCT03085485|451172894|FG000|Overall Study|Death|1|||
125422593|NCT03085485|451172895|FG001|Overall Study|Death|0|||
125422594|NCT03085485|451172894|FG000|Overall Study|Lost to Follow-up|1|||
125422595|NCT03085485|451172895|FG001|Overall Study|Lost to Follow-up|0|||
125534356|NCT04020185|451586285|FG000|Overall Study|Continuing on expanded access|0|||
125311588|NCT05907395|450768755|FG000|Period 1|No longer met eligibility criteria|0|||
125311589|NCT05907395|450768756|FG001|Period 1|No longer met eligibility criteria|1|||
125311590|NCT05907395|450768757|FG002|Period 1|No longer met eligibility criteria|0|||
125534357|NCT04020185|451586286|FG001|Overall Study|Continuing on expanded access|0|||
125534358|NCT04020185|451586287|FG002|Overall Study|Continuing on expanded access|0|||
125534359|NCT04020185|451586288|FG003|Overall Study|Continuing on expanded access|0|||
125534360|NCT04020185|451586289|FG004|Overall Study|Continuing on expanded access|0|||
125534361|NCT04020185|451586290|FG005|Overall Study|Continuing on expanded access|0|||
125534362|NCT04020185|451586291|FG006|Overall Study|Continuing on expanded access|1|||
125534363|NCT04020185|451586292|FG007|Overall Study|Continuing on expanded access|1|||
125534364|NCT03433677|451586294|FG000|Period 1|Protocol Violation|1|||
125534365|NCT03433677|451586295|FG001|Period 1|Protocol Violation|0|||
125534366|NCT03433677|451586294|FG000|Period 2|Withdrawal by Subject|1|||
125534367|NCT03433677|451586295|FG001|Period 2|Withdrawal by Subject|1|||
125534368|NCT01499303|451586296|FG000|Overall Study|Ongoing|2|||
125534369|NCT01499303|451586297|FG001|Overall Study|Ongoing|1|||
125534370|NCT01499303|451586296|FG000|Overall Study|Withdrawal by Subject|0|||
125534371|NCT01499303|451586297|FG001|Overall Study|Withdrawal by Subject|1|||
125534372|NCT01499303|451586296|FG000|Overall Study|Adverse Event|1|||
125534373|NCT01499303|451586297|FG001|Overall Study|Adverse Event|4|||
125534374|NCT01499303|451586296|FG000|Overall Study|Other|0|||
125534375|NCT01499303|451586297|FG001|Overall Study|Other|1|||
125534376|NCT04939701|451586300|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
125534377|NCT04939701|451586301|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
125534378|NCT04939701|451586302|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
125534379|NCT04939701|451586300|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
125534380|NCT04939701|451586301|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
125534381|NCT04939701|451586302|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
125534382|NCT04939701|451586300|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
125534383|NCT04939701|451586301|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
125534384|NCT04939701|451586302|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
125534385|NCT04939701|451586300|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
125534386|NCT04939701|451586301|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
125534387|NCT04939701|451586302|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
125534388|NCT04939701|451586300|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
125534389|NCT04939701|451586301|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
125534390|NCT04939701|451586302|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
125534391|NCT04939701|451586300|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
125311591|NCT05907395|450768758|FG003|Period 1|No longer met eligibility criteria|0|||
125311592|NCT05907395|450768759|FG004|Period 1|No longer met eligibility criteria|0|||
125311593|NCT05907395|450768760|FG005|Period 1|No longer met eligibility criteria|1|||
125311594|NCT05907395|450768761|FG006|Period 1|No longer met eligibility criteria|1|||
125311595|NCT05907395|450768762|FG007|Period 1|No longer met eligibility criteria|0|||
125311596|NCT05907395|450768763|FG008|Period 1|No longer met eligibility criteria|0|||
125311597|NCT05907395|450768764|FG009|Period 1|No longer met eligibility criteria|0|||
125311598|NCT05907395|450768765|FG010|Period 1|No longer met eligibility criteria|0|||
125311599|NCT05907395|450768766|FG011|Period 1|No longer met eligibility criteria|0|||
125311600|NCT05907395|450768755|FG000|Period 2|Adverse Event|0|||
125311601|NCT05907395|450768756|FG001|Period 2|Adverse Event|0|||
125311602|NCT05907395|450768757|FG002|Period 2|Adverse Event|0|||
125311603|NCT05907395|450768758|FG003|Period 2|Adverse Event|1|||
125311604|NCT05907395|450768759|FG004|Period 2|Adverse Event|0|||
125311605|NCT05907395|450768760|FG005|Period 2|Adverse Event|0|||
125311606|NCT05907395|450768761|FG006|Period 2|Adverse Event|0|||
125311607|NCT05907395|450768762|FG007|Period 2|Adverse Event|1|||
125311608|NCT05907395|450768763|FG008|Period 2|Adverse Event|0|||
125311609|NCT05907395|450768764|FG009|Period 2|Adverse Event|0|||
125311610|NCT05907395|450768765|FG010|Period 2|Adverse Event|0|||
125311611|NCT05907395|450768766|FG011|Period 2|Adverse Event|0|||
125311612|NCT05907395|450768755|FG000|Period 2|Personal reason|0|||
125311613|NCT05907395|450768756|FG001|Period 2|Personal reason|0|||
125311614|NCT05907395|450768757|FG002|Period 2|Personal reason|0|||
125311615|NCT05907395|450768758|FG003|Period 2|Personal reason|0|||
125311616|NCT05907395|450768759|FG004|Period 2|Personal reason|0|||
125311617|NCT05907395|450768760|FG005|Period 2|Personal reason|0|||
125311618|NCT05907395|450768761|FG006|Period 2|Personal reason|0|||
125311619|NCT05907395|450768762|FG007|Period 2|Personal reason|0|||
125311620|NCT05907395|450768763|FG008|Period 2|Personal reason|0|||
125311621|NCT05907395|450768764|FG009|Period 2|Personal reason|1|||
125311622|NCT05907395|450768765|FG010|Period 2|Personal reason|0|||
125311623|NCT05907395|450768766|FG011|Period 2|Personal reason|0|||
125311624|NCT05907395|450768755|FG000|Period 3|Adverse Event|0|||
125311625|NCT05907395|450768756|FG001|Period 3|Adverse Event|0|||
125311626|NCT05907395|450768757|FG002|Period 3|Adverse Event|0|||
125311627|NCT05907395|450768758|FG003|Period 3|Adverse Event|0|||
125311628|NCT05907395|450768759|FG004|Period 3|Adverse Event|1|||
125534392|NCT04939701|451586301|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
125534393|NCT04939701|451586302|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
125534394|NCT04939701|451586300|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
125534395|NCT04939701|451586301|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
125534396|NCT04939701|451586302|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
125534397|NCT00565773|451586303|FG000|Overall Study|Withdrawal by Subject|1|||
125534398|NCT00565773|451586303|FG000|Overall Study|Physician Decision|1|||
125534399|NCT00702962|451586304|FG000|Overall Study|Progressive disease|0|||
125534400|NCT00702962|451586305|FG001|Overall Study|Progressive disease|1|||
125534401|NCT00702962|451586304|FG000|Overall Study|Hospitalized for other health disorder|1|||
125534402|NCT00702962|451586305|FG001|Overall Study|Hospitalized for other health disorder|0|||
125534403|NCT01923467|451586307|FG000|Overall Study|Lost to Follow-up|62|||
125534404|NCT01923467|451586307|FG000|Overall Study|Subject non-interest|479|||
125534405|NCT03015129|451586308|FG000|Overall Study|Death|2|||
125534406|NCT03015129|451586309|FG001|Overall Study|Death|2|||
125534407|NCT03015129|451586308|FG000|Overall Study|Lost to Follow-up|0|||
125534408|NCT03015129|451586309|FG001|Overall Study|Lost to Follow-up|1|||
125534409|NCT03015129|451586308|FG000|Overall Study|Progression of disease|38|||
125534410|NCT03015129|451586309|FG001|Overall Study|Progression of disease|33|||
125534411|NCT03015129|451586308|FG000|Overall Study|Adverse Event|0|||
125534412|NCT03015129|451586309|FG001|Overall Study|Adverse Event|4|||
125534413|NCT02242097|451586310|FG000|Ibrutinib Treatment|Adverse Event|16|||
125534414|NCT02242097|451586310|FG000|Ibrutinib Treatment|Physician Decision|1|||
125534415|NCT02242097|451586310|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
125534416|NCT02242097|451586310|FG000|Ibrutinib Treatment|Death|1|||
125534417|NCT02242097|451586310|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
125534418|NCT02242097|451586310|FG000|Post Therapy Follow Up|Death|3|||
125534419|NCT02242097|451586310|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
125534420|NCT01075958|451586311|FG000|Overall Study|Blood sample could not be obtained|44|||
125534421|NCT03733314|451586313|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
125534422|NCT03733314|451586314|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
125534423|NCT03733314|451586313|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
125311629|NCT05907395|450768760|FG005|Period 3|Adverse Event|0|||
125311630|NCT05907395|450768761|FG006|Period 3|Adverse Event|0|||
125311631|NCT05907395|450768762|FG007|Period 3|Adverse Event|0|||
125311632|NCT05907395|450768763|FG008|Period 3|Adverse Event|0|||
125311633|NCT05907395|450768764|FG009|Period 3|Adverse Event|0|||
125311634|NCT05907395|450768765|FG010|Period 3|Adverse Event|0|||
125311635|NCT05907395|450768766|FG011|Period 3|Adverse Event|0|||
125311636|NCT04896593|450768767|FG000|Overall Study|Withdrawal by Subject|2|||
125311637|NCT04896593|450768767|FG000|Overall Study|Lost to Follow-up|1|||
125311638|NCT04896593|450768767|FG000|Overall Study|Did not complete onboarding|2|||
125311639|NCT00369577|450768769|FG000|Overall Study|Withdrawal by Subject|0|||
125311640|NCT00369577|450768770|FG001|Overall Study|Withdrawal by Subject|0|||
125311641|NCT00369577|450768771|FG002|Overall Study|Withdrawal by Subject|1|||
125311642|NCT02360228|450768780|FG000|Overall Study|Withdrawal by Subject|1|||
125311643|NCT02360228|450768781|FG001|Overall Study|Withdrawal by Subject|0|||
125311644|NCT02360228|450768782|FG002|Overall Study|Withdrawal by Subject|0|||
125311645|NCT02360228|450768780|FG000|Overall Study|Self-discontinued medication|0|||
125311646|NCT02360228|450768781|FG001|Overall Study|Self-discontinued medication|1|||
125311647|NCT02360228|450768782|FG002|Overall Study|Self-discontinued medication|0|||
125311648|NCT02360228|450768780|FG000|Overall Study|Unstable symptoms during screening|0|||
125311649|NCT02360228|450768781|FG001|Overall Study|Unstable symptoms during screening|0|||
125311650|NCT02360228|450768782|FG002|Overall Study|Unstable symptoms during screening|1|||
125311651|NCT01059318|450768783|FG000|Core Study (26 Week)|Adverse Event|3|||
125311652|NCT01059318|450768783|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
125311653|NCT01059318|450768783|FG000|Extension (36 Week)|Adverse Event|3|||
125311654|NCT03790917|450768786|FG000|Overall Study|Death|1|||
125311655|NCT04186871|450768787|FG000|Overall Study|Lack of Efficacy|0|||
125311656|NCT04186871|450768788|FG001|Overall Study|Lack of Efficacy|1|||
125311657|NCT04186871|450768789|FG002|Overall Study|Lack of Efficacy|0|||
125311658|NCT04186871|450768790|FG003|Overall Study|Lack of Efficacy|0|||
125311659|NCT04186871|450768791|FG004|Overall Study|Lack of Efficacy|1|||
125311660|NCT04186871|450768792|FG005|Overall Study|Lack of Efficacy|1|||
125311661|NCT04186871|450768787|FG000|Overall Study|Adverse Event|1|||
125311662|NCT04186871|450768788|FG001|Overall Study|Adverse Event|1|||
125311663|NCT04186871|450768789|FG002|Overall Study|Adverse Event|0|||
125311664|NCT04186871|450768790|FG003|Overall Study|Adverse Event|0|||
125311665|NCT04186871|450768791|FG004|Overall Study|Adverse Event|0|||
125311666|NCT04186871|450768792|FG005|Overall Study|Adverse Event|2|||
125311667|NCT04186871|450768787|FG000|Overall Study|Study terminated by sponsor|1|||
125311668|NCT04186871|450768788|FG001|Overall Study|Study terminated by sponsor|2|||
125534424|NCT03733314|451586314|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
125311669|NCT04186871|450768789|FG002|Overall Study|Study terminated by sponsor|0|||
125311670|NCT04186871|450768790|FG003|Overall Study|Study terminated by sponsor|1|||
125644925|NCT01521494|451982146|FG004|Overall Study|Physician Decision|2|||
125311671|NCT04186871|450768791|FG004|Overall Study|Study terminated by sponsor|0|||
125534425|NCT03733314|451586313|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
125534426|NCT03733314|451586314|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
125534427|NCT03733314|451586313|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
125534428|NCT03733314|451586314|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
125534429|NCT03733314|451586313|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
125534430|NCT03733314|451586314|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
125534431|NCT03733314|451586313|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
125534432|NCT03733314|451586314|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
125534433|NCT01240915|451586315|FG000|Overall Study|Adverse Event|0|||
125534434|NCT01240915|451586316|FG001|Overall Study|Adverse Event|0|||
125534435|NCT01240915|451586317|FG002|Overall Study|Adverse Event|0|||
125534436|NCT01240915|451586318|FG003|Overall Study|Adverse Event|1|||
125534437|NCT01240915|451586319|FG004|Overall Study|Adverse Event|0|||
125534438|NCT01240915|451586320|FG005|Overall Study|Adverse Event|2|||
125534439|NCT01240915|451586321|FG006|Overall Study|Adverse Event|0|||
125534440|NCT01240915|451586322|FG007|Overall Study|Adverse Event|0|||
125534441|NCT01240915|451586323|FG008|Overall Study|Adverse Event|1|||
125534442|NCT01240915|451586315|FG000|Overall Study|Lost to Follow-up|0|||
125534443|NCT01240915|451586316|FG001|Overall Study|Lost to Follow-up|0|||
125534444|NCT01240915|451586317|FG002|Overall Study|Lost to Follow-up|0|||
125534445|NCT01240915|451586318|FG003|Overall Study|Lost to Follow-up|0|||
125534446|NCT01240915|451586319|FG004|Overall Study|Lost to Follow-up|1|||
125534447|NCT01240915|451586320|FG005|Overall Study|Lost to Follow-up|1|||
125534448|NCT01240915|451586321|FG006|Overall Study|Lost to Follow-up|0|||
125534449|NCT01240915|451586322|FG007|Overall Study|Lost to Follow-up|1|||
125534450|NCT01240915|451586323|FG008|Overall Study|Lost to Follow-up|1|||
125534451|NCT01240915|451586315|FG000|Overall Study|Withdrawal by Subject|2|||
125534452|NCT01240915|451586316|FG001|Overall Study|Withdrawal by Subject|1|||
125534453|NCT01240915|451586317|FG002|Overall Study|Withdrawal by Subject|0|||
125534454|NCT01240915|451586318|FG003|Overall Study|Withdrawal by Subject|2|||
125534455|NCT01240915|451586319|FG004|Overall Study|Withdrawal by Subject|0|||
125534456|NCT01240915|451586320|FG005|Overall Study|Withdrawal by Subject|4|||
125534457|NCT01240915|451586321|FG006|Overall Study|Withdrawal by Subject|2|||
125534458|NCT01240915|451586322|FG007|Overall Study|Withdrawal by Subject|3|||
125534459|NCT01240915|451586323|FG008|Overall Study|Withdrawal by Subject|3|||
125534460|NCT01240915|451586315|FG000|Overall Study|Other|0|||
125534461|NCT01240915|451586316|FG001|Overall Study|Other|0|||
125534462|NCT01240915|451586317|FG002|Overall Study|Other|0|||
125534463|NCT01240915|451586318|FG003|Overall Study|Other|0|||
125534464|NCT01240915|451586319|FG004|Overall Study|Other|2|||
125534465|NCT01240915|451586320|FG005|Overall Study|Other|0|||
125534466|NCT01240915|451586321|FG006|Overall Study|Other|0|||
125534467|NCT01240915|451586322|FG007|Overall Study|Other|0|||
125534468|NCT01240915|451586323|FG008|Overall Study|Other|0|||
125534469|NCT01240915|451586315|FG000|Overall Study|Insufficient Clinical Response|0|||
125534470|NCT01240915|451586316|FG001|Overall Study|Insufficient Clinical Response|0|||
125534471|NCT01240915|451586317|FG002|Overall Study|Insufficient Clinical Response|0|||
125534472|NCT01240915|451586318|FG003|Overall Study|Insufficient Clinical Response|0|||
125534473|NCT01240915|451586319|FG004|Overall Study|Insufficient Clinical Response|1|||
125534474|NCT01240915|451586320|FG005|Overall Study|Insufficient Clinical Response|3|||
125534475|NCT01240915|451586321|FG006|Overall Study|Insufficient Clinical Response|6|||
125534476|NCT01240915|451586322|FG007|Overall Study|Insufficient Clinical Response|0|||
125534477|NCT01240915|451586323|FG008|Overall Study|Insufficient Clinical Response|3|||
125534478|NCT02574845|451586325|FG000|Overall Study|Consent withdrawn further participation|0|||
125534479|NCT02574845|451586326|FG001|Overall Study|Consent withdrawn further participation|0|||
125534480|NCT02574845|451586327|FG002|Overall Study|Consent withdrawn further participation|0|||
125534481|NCT02574845|451586328|FG003|Overall Study|Consent withdrawn further participation|0|||
125534482|NCT02574845|451586329|FG004|Overall Study|Consent withdrawn further participation|1|||
125534483|NCT02574845|451586330|FG005|Overall Study|Consent withdrawn further participation|0|||
125534484|NCT02574845|451586325|FG000|Overall Study|Adverse Event|0|||
125534485|NCT02574845|451586326|FG001|Overall Study|Adverse Event|1|||
125534486|NCT02574845|451586327|FG002|Overall Study|Adverse Event|0|||
125534487|NCT02574845|451586328|FG003|Overall Study|Adverse Event|0|||
125534488|NCT02574845|451586329|FG004|Overall Study|Adverse Event|0|||
125534489|NCT02574845|451586330|FG005|Overall Study|Adverse Event|1|||
125534490|NCT03435692|451586332|FG000|Overall Study|Lack of Efficacy|2|||
125534491|NCT03435692|451586333|FG001|Overall Study|Lack of Efficacy|2|||
125534492|NCT03435692|451586334|FG002|Overall Study|Lack of Efficacy|0|||
125534493|NCT00821587|451586339|FG000|Overall Study|Physician Decision|0|||
125534494|NCT00821587|451586340|FG001|Overall Study|Physician Decision|1|||
125534495|NCT02906007|451586343|FG000|Overall Study|Physician Decision|0|||
125534496|NCT02906007|451586344|FG001|Overall Study|Physician Decision|0|||
125534497|NCT02906007|451586345|FG002|Overall Study|Physician Decision|1|||
125534498|NCT02906007|451586343|FG000|Overall Study|Died|1|||
125534499|NCT02906007|451586344|FG001|Overall Study|Died|0|||
125534500|NCT02906007|451586345|FG002|Overall Study|Died|0|||
125644926|NCT02728804|451982154|FG000|Overall Study|Ineligible|3|||
125534501|NCT01946529|451586348|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
125534502|NCT01946529|451586349|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
125534503|NCT01946529|451586350|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
125534504|NCT01946529|451586348|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
125534505|NCT01946529|451586349|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
125534506|NCT01946529|451586350|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
125534507|NCT06655558|451586354|FG000|Overall Study|Protocol Violation|1|||
125534508|NCT06748729|451586363|FG000|Overall Study|Withdrawal by Subject|1|||
125534509|NCT01253135|451588118|FG000|Original Protocol|Protocol Amendment|15|||
125534510|NCT01253135|451588118|FG000|Amended Protocol|Non-compliance|1|||
125534511|NCT01901432|451588123|FG000|Overall Study|Adverse Event|0|||
125534512|NCT01901432|451588124|FG001|Overall Study|Adverse Event|1|||
125534513|NCT01901432|451588125|FG002|Overall Study|Adverse Event|1|||
125534514|NCT01901432|451588126|FG003|Overall Study|Adverse Event|0|||
125534515|NCT01901432|451588127|FG004|Overall Study|Adverse Event|1|||
125534516|NCT01901432|451588123|FG000|Overall Study|Withdrawal by Subject|0|||
125534517|NCT01901432|451588124|FG001|Overall Study|Withdrawal by Subject|0|||
125534518|NCT01901432|451588125|FG002|Overall Study|Withdrawal by Subject|1|||
125534519|NCT01901432|451588126|FG003|Overall Study|Withdrawal by Subject|0|||
125534520|NCT01901432|451588127|FG004|Overall Study|Withdrawal by Subject|5|||
125534521|NCT01901432|451588123|FG000|Overall Study|Physician Decision|0|||
125534522|NCT01901432|451588124|FG001|Overall Study|Physician Decision|0|||
125534523|NCT01901432|451588125|FG002|Overall Study|Physician Decision|0|||
125534524|NCT01901432|451588126|FG003|Overall Study|Physician Decision|0|||
125534525|NCT01901432|451588127|FG004|Overall Study|Physician Decision|2|||
125534526|NCT01901432|451588123|FG000|Overall Study|Patient decision to stop study drug|0|||
125534527|NCT01901432|451588124|FG001|Overall Study|Patient decision to stop study drug|0|||
125534528|NCT01901432|451588125|FG002|Overall Study|Patient decision to stop study drug|0|||
125534529|NCT01901432|451588126|FG003|Overall Study|Patient decision to stop study drug|0|||
125534530|NCT01901432|451588127|FG004|Overall Study|Patient decision to stop study drug|1|||
125534531|NCT00379288|451588130|FG000|Overall Study|Adverse Event|5|||
125534532|NCT00379288|451588131|FG001|Overall Study|Adverse Event|6|||
125534533|NCT00379288|451588132|FG002|Overall Study|Adverse Event|2|||
125534534|NCT00379288|451588133|FG003|Overall Study|Adverse Event|0|||
125534535|NCT00379288|451588130|FG000|Overall Study|Treatment Failure|0|||
125534536|NCT00379288|451588131|FG001|Overall Study|Treatment Failure|1|||
125534537|NCT00379288|451588132|FG002|Overall Study|Treatment Failure|0|||
125534538|NCT00379288|451588133|FG003|Overall Study|Treatment Failure|1|||
125534539|NCT00379288|451588130|FG000|Overall Study|Lost to Follow-up|3|||
125534540|NCT00379288|451588131|FG001|Overall Study|Lost to Follow-up|3|||
125534541|NCT00379288|451588132|FG002|Overall Study|Lost to Follow-up|2|||
125534542|NCT00379288|451588133|FG003|Overall Study|Lost to Follow-up|0|||
125534543|NCT00379288|451588130|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
125534544|NCT00379288|451588131|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
125534545|NCT00379288|451588132|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
125534546|NCT00379288|451588133|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
125534547|NCT00379288|451588130|FG000|Overall Study|Subject withdrew-related to study drug|1|||
125534548|NCT00379288|451588131|FG001|Overall Study|Subject withdrew-related to study drug|0|||
125534549|NCT00379288|451588132|FG002|Overall Study|Subject withdrew-related to study drug|0|||
125534550|NCT00379288|451588133|FG003|Overall Study|Subject withdrew-related to study drug|1|||
125534551|NCT00379288|451588130|FG000|Overall Study|Noncompliance with protocol|8|||
125534552|NCT00379288|451588131|FG001|Overall Study|Noncompliance with protocol|6|||
125534553|NCT00379288|451588132|FG002|Overall Study|Noncompliance with protocol|2|||
125534554|NCT00379288|451588133|FG003|Overall Study|Noncompliance with protocol|1|||
125534555|NCT00379288|451588130|FG000|Overall Study|Did not meet protocol eligibility|0|||
125534556|NCT00379288|451588131|FG001|Overall Study|Did not meet protocol eligibility|1|||
125534557|NCT00379288|451588132|FG002|Overall Study|Did not meet protocol eligibility|0|||
125534558|NCT00379288|451588133|FG003|Overall Study|Did not meet protocol eligibility|2|||
125534559|NCT00379288|451588130|FG000|Overall Study|Administrative|2|||
125534560|NCT00379288|451588131|FG001|Overall Study|Administrative|2|||
125534561|NCT00379288|451588132|FG002|Overall Study|Administrative|0|||
125534562|NCT00379288|451588133|FG003|Overall Study|Administrative|1|||
125534563|NCT00918879|451588134|FG000|Overall Study|Withdrawal by Subject|4|||
125534564|NCT00918879|451588135|FG001|Overall Study|Withdrawal by Subject|4|||
125534565|NCT00918879|451588134|FG000|Overall Study|Lost to Follow-up|1|||
125534566|NCT00918879|451588135|FG001|Overall Study|Lost to Follow-up|1|||
125534567|NCT00918879|451588134|FG000|Overall Study|Severe non-compliance to protocol|1|||
125534568|NCT00918879|451588135|FG001|Overall Study|Severe non-compliance to protocol|1|||
125534569|NCT00833261|451588138|FG000|Overall Study|Withdrawal by Subject|4|||
125534570|NCT00357110|451588139|FG000|Overall Study|Early study termination|5|||
125534571|NCT00357110|451588140|FG001|Overall Study|Early study termination|5|||
125534572|NCT05602727|451588143|FG000|Overall Study|Physician Decision|0|||
125534573|NCT05602727|451588144|FG001|Overall Study|Physician Decision|1|||
125534574|NCT05602727|451588145|FG002|Overall Study|Physician Decision|0|||
125534575|NCT05602727|451588143|FG000|Overall Study|Randomized by mistake without study medication|1|||
125534576|NCT05602727|451588144|FG001|Overall Study|Randomized by mistake without study medication|0|||
125534577|NCT05602727|451588145|FG002|Overall Study|Randomized by mistake without study medication|0|||
125534578|NCT05602727|451588143|FG000|Overall Study|Study termination by Sponsor|18|||
125534579|NCT05602727|451588144|FG001|Overall Study|Study termination by Sponsor|15|||
125534580|NCT05602727|451588145|FG002|Overall Study|Study termination by Sponsor|19|||
125534581|NCT05602727|451588143|FG000|Overall Study|Withdrawal by Subject|2|||
125534582|NCT05602727|451588144|FG001|Overall Study|Withdrawal by Subject|1|||
125534583|NCT05602727|451588145|FG002|Overall Study|Withdrawal by Subject|1|||
125534584|NCT05602727|451588143|FG000|Overall Study|Various reasons|1|||
125534585|NCT05602727|451588144|FG001|Overall Study|Various reasons|6|||
125534586|NCT05602727|451588145|FG002|Overall Study|Various reasons|1|||
125534587|NCT03889704|451588146|FG000|Overall Study|Study terminated due to pandemic|1|||
125534588|NCT03482466|451588147|FG000|Overall Study|Protocol Violation|2|||
125534589|NCT02060370|451588152|FG000|Overall Study|Physician Decision|1|||
125534590|NCT01493427|451588153|FG000|Overall Study|Adverse Event|10|||
125534591|NCT01493427|451588153|FG000|Overall Study|Personal Reasons|4|||
125534592|NCT01493427|451588153|FG000|Overall Study|Lost to Follow-up|2|||
125534593|NCT01493427|451588153|FG000|Overall Study|Inability to Follow Instructions|2|||
125534594|NCT01493427|451588153|FG000|Overall Study|Other|2|||
125534595|NCT01461811|451588154|FG000|Overall Study|Adverse Event|2|||
125534596|NCT01461811|451588155|FG001|Overall Study|Adverse Event|1|||
125534597|NCT01461811|451588154|FG000|Overall Study|Subject decision unrelated to an AE|1|||
125534598|NCT01461811|451588155|FG001|Overall Study|Subject decision unrelated to an AE|1|||
125534599|NCT01461811|451588154|FG000|Overall Study|Noncompliance|1|||
125534600|NCT01461811|451588155|FG001|Overall Study|Noncompliance|1|||
125534601|NCT02781090|451588156|FG000|3-Month Follow-Up|Missed Visit|20|||
125534602|NCT02781090|451588157|FG001|3-Month Follow-Up|Missed Visit|20|||
125534603|NCT02781090|451588156|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
125534604|NCT02781090|451588157|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
125534605|NCT02781090|451588156|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
125534606|NCT02781090|451588157|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
125534607|NCT02781090|451588156|FG000|3-Month Follow-Up|Death|1|||
125534608|NCT02781090|451588157|FG001|3-Month Follow-Up|Death|0|||
125534609|NCT02781090|451588156|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
125534610|NCT02781090|451588157|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
125534611|NCT02781090|451588156|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
125534612|NCT02781090|451588157|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
125534613|NCT02781090|451588156|FG000|6-Month Follow-Up|Death|0|||
125534614|NCT02781090|451588157|FG001|6-Month Follow-Up|Death|1|||
125534615|NCT01712061|451588158|FG000|Overall Study|Adverse Event|4|||
125534616|NCT01712061|451588159|FG001|Overall Study|Adverse Event|9|||
125534617|NCT01712061|451588160|FG002|Overall Study|Adverse Event|5|||
125534618|NCT01712061|451588158|FG000|Overall Study|Death|0|||
125534619|NCT01712061|451588159|FG001|Overall Study|Death|0|||
125534620|NCT01712061|451588160|FG002|Overall Study|Death|1|||
125534621|NCT01712061|451588158|FG000|Overall Study|Lost to Follow-up|1|||
125534622|NCT01712061|451588159|FG001|Overall Study|Lost to Follow-up|0|||
125534623|NCT01712061|451588160|FG002|Overall Study|Lost to Follow-up|1|||
125534624|NCT01712061|451588158|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
125534625|NCT01712061|451588159|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
125534626|NCT01712061|451588160|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
125534627|NCT01712061|451588158|FG000|Overall Study|Medication Error Without Associated AE|0|||
125534628|NCT01712061|451588159|FG001|Overall Study|Medication Error Without Associated AE|1|||
125534629|NCT01712061|451588160|FG002|Overall Study|Medication Error Without Associated AE|0|||
125534630|NCT01712061|451588158|FG000|Overall Study|Withdrawal by Subject|1|||
125534631|NCT01712061|451588159|FG001|Overall Study|Withdrawal by Subject|7|||
125534632|NCT01712061|451588160|FG002|Overall Study|Withdrawal by Subject|1|||
125534633|NCT01712061|451588158|FG000|Overall Study|Other|0|||
125534634|NCT01712061|451588159|FG001|Overall Study|Other|3|||
125534635|NCT01712061|451588160|FG002|Overall Study|Other|0|||
125534636|NCT00879775|451588163|FG000|Overall Study|Lost to Follow-up|2|||
125534637|NCT00879775|451588164|FG001|Overall Study|Lost to Follow-up|1|||
125534638|NCT01195623|451588165|FG000|Overall Study|Lost to Follow-up|35|||
125534639|NCT01195623|451588166|FG001|Overall Study|Lost to Follow-up|37|||
125644927|NCT02728804|451982154|FG000|Overall Study|Did not complete baseline questionnaire|9|||
125644928|NCT02728804|451982154|FG000|Overall Study|Death|99|||
125644929|NCT01854918|451982155|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
125644930|NCT01854918|451982156|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
125644931|NCT01854918|451982155|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
125534640|NCT01401153|451588168|FG000|First Test Day|Learning disabilities; illness|1|||
125534641|NCT01401153|451588169|FG001|First Test Day|Learning disabilities; illness|10|||
125534642|NCT01401153|451588168|FG000|Second Test Day|illness|0|||
125534643|NCT01401153|451588169|FG001|Second Test Day|illness|5|||
125534644|NCT01677767|451588170|FG000|Overall Study|Adverse Event|1|||
125534645|NCT01677767|451588170|FG000|Overall Study|Death|4|||
125534646|NCT01677767|451588170|FG000|Overall Study|Protocol Violation|4|||
125644932|NCT01854918|451982156|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
125644933|NCT01854918|451982155|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
125644934|NCT01854918|451982156|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
125644935|NCT01854918|451982155|FG000|SOC-controlled Period (Year 1)|Death|5|||
125644936|NCT01854918|451982156|FG001|SOC-controlled Period (Year 1)|Death|5|||
125644937|NCT01854918|451982155|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
125644938|NCT01854918|451982156|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
125644939|NCT01854918|451982155|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
125644940|NCT01854918|451982156|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
125644941|NCT01854918|451982155|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
125644942|NCT01854918|451982156|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
125644943|NCT01854918|451982155|FG000|All-IP Period (Years 2 and 3)|Death|5|||
125644944|NCT01854918|451982156|FG001|All-IP Period (Years 2 and 3)|Death|16|||
125644945|NCT02146352|451982161|FG000|Overall Study|Death|1|||
125644946|NCT02146352|451982161|FG000|Overall Study|Patient entered hospice care|1|||
125644947|NCT02918006|451982162|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
125644948|NCT02918006|451982163|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
125644949|NCT02918006|451982164|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
125644950|NCT02918006|451982162|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
125644951|NCT02918006|451982163|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
125644952|NCT02918006|451982164|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
125644953|NCT02918006|451982162|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
125644954|NCT02918006|451982163|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
125644955|NCT02918006|451982164|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
125644956|NCT02918006|451982162|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
125644957|NCT02918006|451982163|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
125644958|NCT02918006|451982164|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
125644959|NCT02918006|451982162|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
125644960|NCT02918006|451982163|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
125644961|NCT02918006|451982164|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
125644962|NCT02918006|451982162|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
125644963|NCT02918006|451982163|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
125644964|NCT02918006|451982164|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
125644965|NCT02918006|451982162|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
125644966|NCT02918006|451982163|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
125644967|NCT02918006|451982164|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
125644968|NCT02918006|451982162|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
125644969|NCT02918006|451982163|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
125644970|NCT02918006|451982164|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
125644971|NCT02918006|451982162|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
125644972|NCT02918006|451982163|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
125644973|NCT02918006|451982164|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
125644974|NCT02475564|451982166|FG000|Overall Study|Withdrawal by Subject|1|||
125644975|NCT02475564|451982167|FG001|Overall Study|Withdrawal by Subject|0|||
125644976|NCT02475564|451982166|FG000|Overall Study|Lost to Follow-up|2|||
125644977|NCT02475564|451982167|FG001|Overall Study|Lost to Follow-up|1|||
125644978|NCT02475564|451982166|FG000|Overall Study|Intense Menstrual bleeding|1|||
125644979|NCT02475564|451982167|FG001|Overall Study|Intense Menstrual bleeding|0|||
125644980|NCT01156012|451982168|FG000|Overall Study|Adverse Event|3|||
125644981|NCT01156012|451982169|FG001|Overall Study|Adverse Event|1|||
125644982|NCT01156012|451982168|FG000|Overall Study|Lost to Follow-up|1|||
125644983|NCT01156012|451982169|FG001|Overall Study|Lost to Follow-up|0|||
125644984|NCT01156012|451982168|FG000|Overall Study|Withdrawal by Subject|1|||
125644985|NCT01156012|451982169|FG001|Overall Study|Withdrawal by Subject|0|||
125644986|NCT01156012|451982168|FG000|Overall Study|use of commercial drug instead of study|0|||
125644987|NCT01156012|451982169|FG001|Overall Study|use of commercial drug instead of study|1|||
125644988|NCT01156012|451982168|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
125644989|NCT01156012|451982169|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
125644990|NCT00939094|451982171|FG000|Overall Study|Adverse Event|9|||
125644991|NCT00939094|451982172|FG001|Overall Study|Adverse Event|0|||
125644992|NCT00939094|451982171|FG000|Overall Study|Withdrawal by Subject|1|||
125644993|NCT00939094|451982172|FG001|Overall Study|Withdrawal by Subject|6|||
125644994|NCT00939094|451982171|FG000|Overall Study|Lost to Follow-up|1|||
125644995|NCT00939094|451982172|FG001|Overall Study|Lost to Follow-up|1|||
125644996|NCT00939094|451982171|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125644997|NCT00939094|451982172|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125644998|NCT00939094|451982171|FG000|Overall Study|Severe non-compliance to protocol|0|||
125644999|NCT00939094|451982172|FG001|Overall Study|Severe non-compliance to protocol|1|||
125645000|NCT00939094|451982171|FG000|Overall Study|Study stopped by sponsor|0|||
125645001|NCT00939094|451982172|FG001|Overall Study|Study stopped by sponsor|2|||
125645002|NCT00939094|451982171|FG000|Overall Study|Abnormal ECG findings|1|||
125645003|NCT00939094|451982172|FG001|Overall Study|Abnormal ECG findings|0|||
125645004|NCT01906489|451982173|FG000|Overall Study|Adverse Event|10|||
125645005|NCT01906489|451982174|FG001|Overall Study|Adverse Event|3|||
125645006|NCT01906489|451982173|FG000|Overall Study|Worsening of CKD|6|||
125645007|NCT01906489|451982174|FG001|Overall Study|Worsening of CKD|4|||
125645008|NCT01906489|451982173|FG000|Overall Study|Withdrawal by Subject|5|||
125645009|NCT01906489|451982174|FG001|Overall Study|Withdrawal by Subject|0|||
125645010|NCT01906489|451982173|FG000|Overall Study|Worsening of Anemia|1|||
125645011|NCT01906489|451982174|FG001|Overall Study|Worsening of Anemia|0|||
125645012|NCT01906489|451982173|FG000|Overall Study|Protocol Violation|0|||
125645013|NCT01906489|451982174|FG001|Overall Study|Protocol Violation|1|||
125645014|NCT01906489|451982173|FG000|Overall Study|Non- Compliance|1|||
125645015|NCT01906489|451982174|FG001|Overall Study|Non- Compliance|0|||
125645016|NCT01906489|451982173|FG000|Overall Study|Sponsor Decision|1|||
125645017|NCT01906489|451982174|FG001|Overall Study|Sponsor Decision|0|||
125645018|NCT01906489|451982173|FG000|Overall Study|Lost to Follow-up|1|||
125645019|NCT01906489|451982174|FG001|Overall Study|Lost to Follow-up|1|||
125645020|NCT01906489|451982173|FG000|Overall Study|Other|1|||
125645021|NCT01906489|451982174|FG001|Overall Study|Other|0|||
125645022|NCT01503229|451984222|FG000|Overall Study|Withdrew consent|1|||
125645023|NCT00240331|451984223|FG000|Overall Study|Withdrawal by Subject|125|||
125645024|NCT00240331|451984224|FG001|Overall Study|Withdrawal by Subject|132|||
125645025|NCT00240331|451984223|FG000|Overall Study|Option selected by investigator|1|||
125645026|NCT00240331|451984224|FG001|Overall Study|Option selected by investigator|2|||
125645027|NCT02551874|451984225|FG000|Overall Study|Lost to Follow-up|0|||
125645028|NCT02551874|451984226|FG001|Overall Study|Lost to Follow-up|2|||
125645029|NCT02551874|451984225|FG000|Overall Study|Pregnancy|0|||
125645030|NCT02551874|451984226|FG001|Overall Study|Pregnancy|1|||
125645031|NCT02551874|451984225|FG000|Overall Study|Reason not reported|10|||
125645032|NCT02551874|451984226|FG001|Overall Study|Reason not reported|4|||
125645033|NCT02551874|451984225|FG000|Overall Study|Did not receive randomized treatment|0|||
125645034|NCT02551874|451984226|FG001|Overall Study|Did not receive randomized treatment|7|||
125645035|NCT02551874|451984225|FG000|Overall Study|Did not enter long-term study|18|||
125645036|NCT02551874|451984226|FG001|Overall Study|Did not enter long-term study|25|||
125645037|NCT02491463|451984227|FG000|Overall Study|Withdrawal by Subject|1|||
125645038|NCT02491463|451984228|FG001|Overall Study|Withdrawal by Subject|2|||
125645039|NCT02491463|451984229|FG002|Overall Study|Withdrawal by Subject|0|||
125645040|NCT02491463|451984230|FG003|Overall Study|Withdrawal by Subject|0|||
125645041|NCT02491463|451984227|FG000|Overall Study|Migrated/moved from study area|1|||
125645042|NCT02491463|451984228|FG001|Overall Study|Migrated/moved from study area|5|||
125645043|NCT02491463|451984229|FG002|Overall Study|Migrated/moved from study area|1|||
125645044|NCT02491463|451984230|FG003|Overall Study|Migrated/moved from study area|1|||
125645045|NCT02491463|451984227|FG000|Overall Study|Lost to Follow-up|0|||
125645046|NCT02491463|451984228|FG001|Overall Study|Lost to Follow-up|3|||
125645047|NCT02491463|451984229|FG002|Overall Study|Lost to Follow-up|3|||
125645048|NCT02491463|451984230|FG003|Overall Study|Lost to Follow-up|0|||
125645049|NCT01491802|451984231|FG000|Overall Study|Adverse Event|1|||
125645050|NCT01491802|451984232|FG001|Overall Study|Adverse Event|1|||
125645051|NCT01491802|451984231|FG000|Overall Study|Withdrawal by Subject|0|||
125645052|NCT01491802|451984232|FG001|Overall Study|Withdrawal by Subject|1|||
125645053|NCT00386152|451984237|FG000|Overall Study|Adverse Event|6|||
125645054|NCT00386152|451984238|FG001|Overall Study|Adverse Event|5|||
125645055|NCT00386152|451984239|FG002|Overall Study|Adverse Event|4|||
125645056|NCT00386152|451984237|FG000|Overall Study|Chang from original chemo stratification|4|||
125645057|NCT00386152|451984238|FG001|Overall Study|Chang from original chemo stratification|5|||
125645058|NCT00386152|451984239|FG002|Overall Study|Chang from original chemo stratification|6|||
125645059|NCT00386152|451984237|FG000|Overall Study|Death|3|||
125645060|NCT00386152|451984238|FG001|Overall Study|Death|0|||
125645061|NCT00386152|451984239|FG002|Overall Study|Death|1|||
125645062|NCT00386152|451984237|FG000|Overall Study|Disease progression|7|||
125645063|NCT00386152|451984238|FG001|Overall Study|Disease progression|4|||
125645064|NCT00386152|451984239|FG002|Overall Study|Disease progression|5|||
125645065|NCT00386152|451984237|FG000|Overall Study|Physician Decision|13|||
125645066|NCT00386152|451984238|FG001|Overall Study|Physician Decision|10|||
125645067|NCT00386152|451984239|FG002|Overall Study|Physician Decision|4|||
125645068|NCT00386152|451984237|FG000|Overall Study|Lost to Follow-up|1|||
125645069|NCT00386152|451984238|FG001|Overall Study|Lost to Follow-up|0|||
125645070|NCT00386152|451984239|FG002|Overall Study|Lost to Follow-up|0|||
125645071|NCT00386152|451984237|FG000|Overall Study|Completed chemotherapy|4|||
125645072|NCT00386152|451984238|FG001|Overall Study|Completed chemotherapy|5|||
125645073|NCT00386152|451984239|FG002|Overall Study|Completed chemotherapy|1|||
125645074|NCT00386152|451984237|FG000|Overall Study|Protocol Violation|3|||
125645075|NCT00386152|451984238|FG001|Overall Study|Protocol Violation|5|||
125645076|NCT00386152|451984239|FG002|Overall Study|Protocol Violation|2|||
125645077|NCT00386152|451984237|FG000|Overall Study|Withdrawal by Subject|3|||
125645078|NCT00386152|451984238|FG001|Overall Study|Withdrawal by Subject|6|||
125645079|NCT00386152|451984239|FG002|Overall Study|Withdrawal by Subject|10|||
125645080|NCT00508872|451984243|FG000|Overall Study|Lost to Follow-up|1|||
125534647|NCT01677767|451588170|FG000|Overall Study|Withdrawal by Subject|10|||
125534648|NCT01677767|451588170|FG000|Overall Study|Non-compliance by the participants|3|||
125534649|NCT03846453|451588171|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
125311672|NCT04186871|450768792|FG005|Overall Study|Study terminated by sponsor|0|||
125311673|NCT04186871|450768787|FG000|Overall Study|Other reasons|0|||
125311674|NCT04186871|450768788|FG001|Overall Study|Other reasons|0|||
125311675|NCT04186871|450768789|FG002|Overall Study|Other reasons|0|||
125534650|NCT03846453|451588172|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
125534651|NCT03846453|451588173|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
125534652|NCT03846453|451588171|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
125534653|NCT03846453|451588172|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
125534654|NCT03846453|451588173|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
125534655|NCT03846453|451588171|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
125534656|NCT03846453|451588172|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
125534657|NCT03846453|451588173|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
125534658|NCT03846453|451588171|FG000|Placebo Run-in (14 Days)|Other|2|||
125534659|NCT03846453|451588172|FG001|Placebo Run-in (14 Days)|Other|0|||
125534660|NCT03846453|451588173|FG002|Placebo Run-in (14 Days)|Other|0|||
125534661|NCT03846453|451588171|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
125534662|NCT03846453|451588172|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
125534663|NCT03846453|451588173|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
125534664|NCT03846453|451588171|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
125534665|NCT03846453|451588172|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
125534666|NCT03846453|451588173|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
125534667|NCT03846453|451588171|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
125534668|NCT03846453|451588172|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
125534669|NCT03846453|451588173|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
125534670|NCT03846453|451588171|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
125534671|NCT03846453|451588172|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
125534672|NCT03846453|451588173|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
125534673|NCT03846453|451588171|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
125534674|NCT03846453|451588172|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
125534675|NCT03846453|451588173|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
125534676|NCT00757627|451588174|FG000|Overall Study|Adverse Event|15|||
125534677|NCT00757627|451588174|FG000|Overall Study|Lack of Efficacy|10|||
125534678|NCT00757627|451588174|FG000|Overall Study|Lost to Follow-up|28|||
125534679|NCT00757627|451588174|FG000|Overall Study|Withdrawal by Subject|27|||
125534680|NCT00757627|451588174|FG000|Overall Study|Other|1|||
125534681|NCT00468143|451588175|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
125534682|NCT00468143|451588176|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
125534683|NCT00468143|451588175|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
125534684|NCT00468143|451588176|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
125534685|NCT01606670|451588179|FG000|Overall Study|Adverse Event|6|||
125534686|NCT01606670|451588179|FG000|Overall Study|Lack of Efficacy|2|||
125534687|NCT01606670|451588179|FG000|Overall Study|Lost to Follow-up|3|||
125534688|NCT01606670|451588179|FG000|Overall Study|Withdrawal by Subject|3|||
125534689|NCT01606670|451588179|FG000|Overall Study|Other Reason|2|||
125534690|NCT02636725|451588181|FG000|Overall Study|Adverse Event|1|||
125534691|NCT00403767|451588182|FG000|Overall Study|Adverse Event|993|||
125534692|NCT00403767|451588183|FG001|Overall Study|Adverse Event|919|||
125534693|NCT00403767|451588182|FG000|Overall Study|Non-compliant with study medication|134|||
125534694|NCT00403767|451588183|FG001|Overall Study|Non-compliant with study medication|164|||
125534695|NCT00403767|451588182|FG000|Overall Study|Consent withdrawn|671|||
125534696|NCT00403767|451588183|FG001|Overall Study|Consent withdrawn|673|||
125534697|NCT00403767|451588182|FG000|Overall Study|Investigator dec./not protocol-related|191|||
125534698|NCT00403767|451588183|FG001|Overall Study|Investigator dec./not protocol-related|178|||
125534699|NCT00403767|451588182|FG000|Overall Study|Lost to Follow-up|6|||
125534700|NCT00403767|451588183|FG001|Overall Study|Lost to Follow-up|8|||
125534701|NCT00403767|451588182|FG000|Overall Study|Protocol Violation|142|||
125534702|NCT00403767|451588183|FG001|Overall Study|Protocol Violation|124|||
125534703|NCT00403767|451588182|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
125534704|NCT00403767|451588183|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
125534705|NCT00403767|451588182|FG000|Overall Study|Study terminated by sponsor|82|||
125534706|NCT00403767|451588183|FG001|Overall Study|Study terminated by sponsor|69|||
125534707|NCT00403767|451588182|FG000|Overall Study|Missing/incomplete data|1|||
125534708|NCT00403767|451588183|FG001|Overall Study|Missing/incomplete data|1|||
125534709|NCT05330676|451588184|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
125534710|NCT05330676|451588185|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
125534711|NCT00436605|451588186|FG000|Overall Study|Protocol Violation|3|||
125645081|NCT00508872|451984243|FG000|Overall Study|Physician Decision|1|||
125645082|NCT03007472|451984244|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
125645083|NCT03007472|451984244|FG000|Overall Study|Death|2|||
125645084|NCT03007472|451984244|FG000|Overall Study|Loss to Follow Up|1|||
125645085|NCT01977651|451984247|FG000|4 Month Treatment Period|Adverse Event|34|||
125645086|NCT01977651|451984247|FG000|4 Month Treatment Period|Death|3|||
125645087|NCT01977651|451984247|FG000|4 Month Treatment Period|Progressive Disease|43|||
125645088|NCT01977651|451984247|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
125645089|NCT01977651|451984247|FG000|4 Month Treatment Period|Physician Decision|4|||
125645090|NCT01977651|451984247|FG000|1 Year Extension Period|Adverse Event|14|||
125645091|NCT01977651|451984247|FG000|1 Year Extension Period|Death|10|||
125645092|NCT01977651|451984247|FG000|1 Year Extension Period|Lost to Follow-up|2|||
125645093|NCT01977651|451984247|FG000|1 Year Extension Period|Progressive Disease|86|||
125645094|NCT01977651|451984247|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
125645095|NCT01977651|451984247|FG000|1 Year Extension Period|Physician Decision|6|||
125645096|NCT01977651|451984247|FG000|1 Year Extension Period|Miscellaneous|1|||
125645097|NCT01977651|451984247|FG000|Post 1 Year Extension Period|Adverse Event|5|||
125645098|NCT01977651|451984247|FG000|Post 1 Year Extension Period|Death|13|||
125645099|NCT01977651|451984247|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
125645100|NCT01977651|451984247|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
125645101|NCT01977651|451984247|FG000|Post 1 Year Extension Period|Physician Decision|4|||
125645102|NCT01977651|451984247|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
125534712|NCT01559129|451588190|FG000|Treatment Phase|Adverse Event|0|||
125534713|NCT01559129|451588191|FG001|Treatment Phase|Adverse Event|2|||
125534714|NCT01559129|451588190|FG000|Treatment Phase|Progressive Disease|1|||
125534715|NCT01559129|451588191|FG001|Treatment Phase|Progressive Disease|1|||
125534716|NCT01559129|451588190|FG000|Treatment Phase|Lack of Efficacy|0|||
125534717|NCT01559129|451588191|FG001|Treatment Phase|Lack of Efficacy|1|||
125534718|NCT01559129|451588190|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
125534719|NCT01559129|451588191|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
125534720|NCT01559129|451588190|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
125534721|NCT01559129|451588191|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
125534722|NCT01559129|451588190|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
125534723|NCT01559129|451588191|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
125534724|NCT01559129|451588190|FG000|Open-label Extension Period|Adverse Event|1|||
125534725|NCT01559129|451588191|FG001|Open-label Extension Period|Adverse Event|0|||
125534726|NCT01559129|451588190|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
125534727|NCT01559129|451588191|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
125534728|NCT00368927|451588192|FG000|Overall Study|Lost to Follow-up|2|||
125534729|NCT00368927|451588193|FG001|Overall Study|Lost to Follow-up|0|||
125534730|NCT00368927|451588192|FG000|Overall Study|Adverse Event|1|||
125534731|NCT00368927|451588193|FG001|Overall Study|Adverse Event|1|||
125534732|NCT00368927|451588192|FG000|Overall Study|Withdrawal by Subject|1|||
125534733|NCT00368927|451588193|FG001|Overall Study|Withdrawal by Subject|2|||
125534734|NCT00368927|451588192|FG000|Overall Study|Physician Decision|1|||
125534735|NCT00368927|451588193|FG001|Overall Study|Physician Decision|0|||
125534736|NCT03525392|451588194|FG000|Overall Study|Adverse Event|1|||
125534737|NCT03525392|451588195|FG001|Overall Study|Adverse Event|0|||
125534738|NCT03525392|451588196|FG002|Overall Study|Adverse Event|2|||
125534739|NCT03525392|451588197|FG003|Overall Study|Adverse Event|0|||
125534740|NCT03525392|451588198|FG004|Overall Study|Adverse Event|0|||
125534741|NCT03525392|451588194|FG000|Overall Study|Progressive disease|0|||
125534742|NCT03525392|451588195|FG001|Overall Study|Progressive disease|1|||
125534743|NCT03525392|451588196|FG002|Overall Study|Progressive disease|1|||
125534744|NCT03525392|451588197|FG003|Overall Study|Progressive disease|3|||
125534745|NCT03525392|451588198|FG004|Overall Study|Progressive disease|1|||
125534746|NCT03284203|451588201|FG000|Overall Study|Lost to Follow-up|3|||
125534747|NCT02229851|451588202|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
125534748|NCT02229851|451588203|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
125534749|NCT02229851|451588204|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
125534750|NCT02229851|451588205|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
125534751|NCT02229851|451588206|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
125534752|NCT02229851|451588207|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
125534753|NCT02229851|451588208|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
125534754|NCT02229851|451588202|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
125534755|NCT02229851|451588203|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
125534756|NCT02229851|451588204|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
125534757|NCT02229851|451588205|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
125534758|NCT02229851|451588206|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
125534759|NCT02229851|451588207|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
125534760|NCT02229851|451588208|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
125534761|NCT02229851|451588202|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
125534762|NCT02229851|451588203|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
125534763|NCT02229851|451588204|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
125534764|NCT02229851|451588205|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
125534765|NCT02229851|451588206|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
125534766|NCT02229851|451588207|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
125534767|NCT02229851|451588208|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
125534768|NCT02229851|451588202|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
125534769|NCT02229851|451588203|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
125534770|NCT02229851|451588204|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
125534771|NCT02229851|451588205|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
125534772|NCT02229851|451588206|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
125534773|NCT02229851|451588207|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
125534774|NCT02229851|451588208|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
125534775|NCT02229851|451588202|FG000|Main Phase (Double-blind Phase)|Death|1|||
125534776|NCT02229851|451588203|FG001|Main Phase (Double-blind Phase)|Death|1|||
125534777|NCT02229851|451588204|FG002|Main Phase (Double-blind Phase)|Death|0|||
125534778|NCT02229851|451588205|FG003|Main Phase (Double-blind Phase)|Death|0|||
125534779|NCT02229851|451588206|FG004|Main Phase (Double-blind Phase)|Death|0|||
125534780|NCT02229851|451588207|FG005|Main Phase (Double-blind Phase)|Death|0|||
125534781|NCT02229851|451588208|FG006|Main Phase (Double-blind Phase)|Death|0|||
125534782|NCT02229851|451588202|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
125534783|NCT02229851|451588203|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
125534784|NCT02229851|451588204|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
125534785|NCT02229851|451588205|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
125534786|NCT02229851|451588206|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
125645103|NCT00253747|451984248|FG000|Overall Study|Lost to Follow-up|13|||
125645104|NCT00253747|451984249|FG001|Overall Study|Lost to Follow-up|14|||
125645105|NCT00253747|451984248|FG000|Overall Study|Withdrawal by Subject|10|||
125645106|NCT00253747|451984249|FG001|Overall Study|Withdrawal by Subject|11|||
125645107|NCT00253747|451984248|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
125645108|NCT00253747|451984249|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
125645109|NCT00104299|451984250|FG000|Overall Study|Adverse Event|3|||
125645110|NCT00104299|451984251|FG001|Overall Study|Adverse Event|1|||
125645111|NCT00104299|451984250|FG000|Overall Study|Death|2|||
125645112|NCT00104299|451984251|FG001|Overall Study|Death|2|||
125645113|NCT00104299|451984250|FG000|Overall Study|Withdrawal by Subject|2|||
125645114|NCT00104299|451984251|FG001|Overall Study|Withdrawal by Subject|6|||
125645115|NCT00104299|451984250|FG000|Overall Study|Physician Decision|1|||
125645116|NCT00104299|451984251|FG001|Overall Study|Physician Decision|1|||
125645117|NCT00104299|451984250|FG000|Overall Study|To have renal transplant|1|||
125645118|NCT00104299|451984251|FG001|Overall Study|To have renal transplant|0|||
125645119|NCT03672006|451984253|FG000|Overall Study|exclusion criteria met|0|||
125645120|NCT03672006|451984254|FG001|Overall Study|exclusion criteria met|1|||
125645121|NCT00608426|451984255|FG000|Overall Study|Death|32|||
125645122|NCT00608426|451984256|FG001|Overall Study|Death|36|||
125645123|NCT00608426|451984255|FG000|Overall Study|Lost to Follow-up|485|||
125645124|NCT00608426|451984256|FG001|Overall Study|Lost to Follow-up|521|||
125645125|NCT00608426|451984255|FG000|Overall Study|refused, health issues, wrong address|319|||
125645126|NCT00608426|451984256|FG001|Overall Study|refused, health issues, wrong address|348|||
125534787|NCT02229851|451588207|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
125534788|NCT02229851|451588208|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
125534789|NCT02229851|451588202|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
125534790|NCT02229851|451588203|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
125645127|NCT02630459|451984260|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
125645128|NCT02630459|451984261|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
125645129|NCT02630459|451984262|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
125645130|NCT02630459|451984263|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
125645131|NCT02630459|451984264|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
125645132|NCT02630459|451984265|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
125645133|NCT02630459|451984266|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
125645134|NCT02630459|451984267|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
125645135|NCT02630459|451984260|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125645136|NCT02630459|451984261|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125645137|NCT02630459|451984262|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
125645138|NCT02630459|451984263|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125645139|NCT02630459|451984264|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125645140|NCT02630459|451984265|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125645141|NCT02630459|451984266|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125645142|NCT02630459|451984267|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
125645143|NCT02630459|451984260|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
125645144|NCT02630459|451984261|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
125645145|NCT02630459|451984262|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
125645146|NCT02630459|451984263|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
125645147|NCT02630459|451984264|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
125645148|NCT02630459|451984265|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
125311676|NCT04186871|450768790|FG003|Overall Study|Other reasons|0|||
125311677|NCT04186871|450768791|FG004|Overall Study|Other reasons|0|||
125311678|NCT04186871|450768792|FG005|Overall Study|Other reasons|1|||
125311679|NCT04186871|450768787|FG000|Overall Study|Withdrawal by Subject|0|||
125311680|NCT04186871|450768788|FG001|Overall Study|Withdrawal by Subject|0|||
125311681|NCT04186871|450768789|FG002|Overall Study|Withdrawal by Subject|0|||
125311682|NCT04186871|450768790|FG003|Overall Study|Withdrawal by Subject|0|||
125311683|NCT04186871|450768791|FG004|Overall Study|Withdrawal by Subject|0|||
125311684|NCT04186871|450768792|FG005|Overall Study|Withdrawal by Subject|1|||
125311685|NCT04186871|450768787|FG000|Overall Study|Lost to Follow-up|0|||
125311686|NCT04186871|450768788|FG001|Overall Study|Lost to Follow-up|0|||
125311687|NCT04186871|450768789|FG002|Overall Study|Lost to Follow-up|0|||
125311688|NCT04186871|450768790|FG003|Overall Study|Lost to Follow-up|0|||
125311689|NCT04186871|450768791|FG004|Overall Study|Lost to Follow-up|0|||
125311690|NCT04186871|450768792|FG005|Overall Study|Lost to Follow-up|1|||
125311691|NCT02464410|450768793|FG000|Overall Study|Death|3|||
125311692|NCT02464410|450768794|FG001|Overall Study|Death|4|||
125311693|NCT02464410|450768793|FG000|Overall Study|Lost to Follow-up|7|||
125311694|NCT02464410|450768794|FG001|Overall Study|Lost to Follow-up|9|||
125311695|NCT02464410|450768793|FG000|Overall Study|Withdrawal by Subject|12|||
125311696|NCT02464410|450768794|FG001|Overall Study|Withdrawal by Subject|3|||
125311697|NCT00176462|450768798|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
125311698|NCT00176462|450768799|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
125311699|NCT00176462|450768798|FG000|Induction (4 Weeks)|Death|1|||
125311700|NCT00176462|450768799|FG001|Induction (4 Weeks)|Death|2|||
125311701|NCT00176462|450768798|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
125311702|NCT00176462|450768799|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
125311703|NCT00176462|450768798|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
125311704|NCT00176462|450768799|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
125311705|NCT00176462|450768798|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
125422596|NCT00605280|451172896|FG000|Year 1|Protocol Violation|0|||
125534791|NCT02229851|451588204|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
125534792|NCT02229851|451588205|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
125534793|NCT02229851|451588206|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
125534794|NCT02229851|451588207|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
125534795|NCT02229851|451588208|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
125534796|NCT02229851|451588202|FG000|Extension Phase (Open-label Phase)|Death|0|||
125534797|NCT02229851|451588203|FG001|Extension Phase (Open-label Phase)|Death|0|||
125534798|NCT02229851|451588204|FG002|Extension Phase (Open-label Phase)|Death|0|||
125534799|NCT02229851|451588205|FG003|Extension Phase (Open-label Phase)|Death|1|||
125534800|NCT02229851|451588206|FG004|Extension Phase (Open-label Phase)|Death|0|||
125534801|NCT02229851|451588207|FG005|Extension Phase (Open-label Phase)|Death|1|||
125534802|NCT02229851|451588208|FG006|Extension Phase (Open-label Phase)|Death|1|||
125534803|NCT01111240|451588209|FG000|Overall Study|Adverse Event|190|||
125534804|NCT01111240|451588209|FG000|Overall Study|Lack of Efficacy|545|||
125534805|NCT01111240|451588209|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
125534806|NCT01111240|451588209|FG000|Overall Study|Other|312|||
125534807|NCT02206061|451588210|FG000|Overall Study|Withdrawal by Subject|4|||
125534808|NCT02206061|451588211|FG001|Overall Study|Withdrawal by Subject|7|||
125534809|NCT02206061|451588212|FG002|Overall Study|Withdrawal by Subject|1|||
125534810|NCT02206061|451588210|FG000|Overall Study|Lost to Follow-up|14|||
125534811|NCT02206061|451588211|FG001|Overall Study|Lost to Follow-up|7|||
125534812|NCT02206061|451588212|FG002|Overall Study|Lost to Follow-up|20|||
125534813|NCT04187326|451588213|FG000|Overall Study|Lost to Follow-up|2|||
125534814|NCT04187326|451588214|FG001|Overall Study|Lost to Follow-up|1|||
125534815|NCT04187326|451588213|FG000|Overall Study|Computer error- task was only partially completed.|0|||
125534816|NCT04187326|451588214|FG001|Overall Study|Computer error- task was only partially completed.|1|||
125534817|NCT01607476|451588215|FG000|Overall Study|Withdrawal by Subject|1|||
125534818|NCT01607476|451588216|FG001|Overall Study|Withdrawal by Subject|0|||
125534819|NCT01607476|451588217|FG002|Overall Study|Withdrawal by Subject|1|||
125534820|NCT01607476|451588215|FG000|Overall Study|Lost to Follow-up|0|||
125534821|NCT01607476|451588216|FG001|Overall Study|Lost to Follow-up|0|||
125534822|NCT01607476|451588217|FG002|Overall Study|Lost to Follow-up|2|||
125534823|NCT04958200|451588224|FG000|Overall Study|Withdrawal by Subject|0|||
125534824|NCT04958200|451588225|FG001|Overall Study|Withdrawal by Subject|2|||
125534825|NCT04958200|451588224|FG000|Overall Study|Lost to Follow-up|3|||
125645149|NCT02630459|451984266|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
125645150|NCT02630459|451984267|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
125645151|NCT02630459|451984260|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
125645152|NCT02630459|451984261|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125534826|NCT04958200|451588225|FG001|Overall Study|Lost to Follow-up|2|||
125534827|NCT02145468|451588226|FG000|Overall Study|Withdrawal by Subject|5|||
125534828|NCT02145468|451588227|FG001|Overall Study|Withdrawal by Subject|8|||
125534829|NCT00623805|451588228|FG000|Overall Study|Adverse Event|9|||
125534830|NCT00623805|451588229|FG001|Overall Study|Adverse Event|6|||
125534831|NCT00623805|451588228|FG000|Overall Study|Death|2|||
125534832|NCT00623805|451588229|FG001|Overall Study|Death|0|||
125534833|NCT00623805|451588228|FG000|Overall Study|Lack of Efficacy|3|||
125534834|NCT00623805|451588229|FG001|Overall Study|Lack of Efficacy|7|||
125534835|NCT00623805|451588228|FG000|Overall Study|Lost to Follow-up|2|||
125534836|NCT00623805|451588229|FG001|Overall Study|Lost to Follow-up|2|||
125534837|NCT00623805|451588228|FG000|Overall Study|Protocol Violation|1|||
125534838|NCT00623805|451588229|FG001|Overall Study|Protocol Violation|1|||
125534839|NCT00623805|451588228|FG000|Overall Study|Reason not Specified|3|||
125534840|NCT00623805|451588229|FG001|Overall Study|Reason not Specified|6|||
125534841|NCT04655027|451588233|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
125534842|NCT04655027|451588234|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
125534843|NCT03519997|451588237|FG000|Overall Study|Adverse Event|4|||
125534844|NCT03519997|451588237|FG000|Overall Study|Withdrawal by Subject|2|||
125534845|NCT03519997|451588237|FG000|Overall Study|Protocol Violation|1|||
125534846|NCT03820947|451588238|FG000|Overall Study|Physician Decision|0|||
125534847|NCT03820947|451588239|FG001|Overall Study|Physician Decision|1|||
125534848|NCT03820947|451588240|FG002|Overall Study|Physician Decision|1|||
125534849|NCT03820947|451588241|FG003|Overall Study|Physician Decision|0|||
125534850|NCT03820947|451588242|FG004|Overall Study|Physician Decision|3|||
125645153|NCT02630459|451984262|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125645154|NCT02630459|451984263|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125645155|NCT02630459|451984264|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125645156|NCT02630459|451984265|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125645157|NCT02630459|451984266|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125645158|NCT02630459|451984267|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
125645159|NCT02630459|451984260|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
125645160|NCT02630459|451984261|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
125645161|NCT02630459|451984262|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
125645162|NCT02630459|451984263|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
125645163|NCT02630459|451984264|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
125645164|NCT02630459|451984265|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
125645165|NCT02630459|451984266|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
125645166|NCT02630459|451984267|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
125645167|NCT02630459|451984260|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
125645168|NCT02630459|451984261|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
125645169|NCT02630459|451984262|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
125645170|NCT02630459|451984263|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
125645171|NCT02630459|451984264|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
125645172|NCT02630459|451984265|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
125645173|NCT02630459|451984266|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
125645174|NCT02630459|451984267|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
125645175|NCT02630459|451984260|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125645176|NCT02630459|451984261|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125645177|NCT02630459|451984262|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125645178|NCT02630459|451984263|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125645179|NCT02630459|451984264|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
125645180|NCT02630459|451984265|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125645181|NCT02630459|451984266|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125645182|NCT02630459|451984267|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
125645183|NCT01453439|451984268|FG000|Treatment Phase|Withdrawal by Subject|13|||
125645184|NCT01453439|451984269|FG001|Treatment Phase|Withdrawal by Subject|10|||
125645185|NCT01453439|451984268|FG000|Treatment Phase|Suicidal Ideation|2|||
125645186|NCT01453439|451984269|FG001|Treatment Phase|Suicidal Ideation|0|||
125645187|NCT01453439|451984268|FG000|Treatment Phase|Need for higher level of care|1|||
125645188|NCT01453439|451984269|FG001|Treatment Phase|Need for higher level of care|1|||
125645189|NCT01453439|451984268|FG000|Treatment Phase|Therapist conflict of interest|1|||
125645190|NCT01453439|451984269|FG001|Treatment Phase|Therapist conflict of interest|0|||
125645191|NCT01453439|451984268|FG000|Follow-up|Withdrawal by Subject|0|||
125645192|NCT01453439|451984269|FG001|Follow-up|Withdrawal by Subject|1|||
125645193|NCT01453439|451984268|FG000|Follow-up|Lost to Follow-up|5|||
125645194|NCT01453439|451984269|FG001|Follow-up|Lost to Follow-up|10|||
125645195|NCT01014442|451984270|FG000|Overall Study|Adverse Event|0|||
125645196|NCT01014442|451984271|FG001|Overall Study|Adverse Event|8|||
125645197|NCT01014442|451984270|FG000|Overall Study|Withdrawal by Subject|4|||
125645198|NCT01014442|451984271|FG001|Overall Study|Withdrawal by Subject|4|||
125645199|NCT01014442|451984270|FG000|Overall Study|Protocol Violation|2|||
125645200|NCT01014442|451984271|FG001|Overall Study|Protocol Violation|5|||
125645201|NCT01014442|451984270|FG000|Overall Study|Lack of Compliance|0|||
125645202|NCT01014442|451984271|FG001|Overall Study|Lack of Compliance|1|||
125645203|NCT01014442|451984270|FG000|Overall Study|Unspecified Reason|1|||
125645204|NCT01014442|451984271|FG001|Overall Study|Unspecified Reason|1|||
125645205|NCT01220024|451984279|FG000|Overall Study|Lost to Follow-up|1|||
125645206|NCT01220024|451984280|FG001|Overall Study|Lost to Follow-up|1|||
125645207|NCT00174460|451984281|FG000|Overall Study|Withdrawal by Subject|0|||
125645208|NCT00174460|451984282|FG001|Overall Study|Withdrawal by Subject|1|||
125645209|NCT00490815|451984285|FG000|Overall Study|Adverse Event|2|||
125645210|NCT00490815|451984286|FG001|Overall Study|Adverse Event|3|||
125645211|NCT00490815|451984285|FG000|Overall Study|Withdrawal by Subject|4|||
125645212|NCT00490815|451984286|FG001|Overall Study|Withdrawal by Subject|0|||
125645213|NCT00490815|451984285|FG000|Overall Study|Lost to Follow-up|1|||
125645214|NCT00490815|451984286|FG001|Overall Study|Lost to Follow-up|3|||
125645215|NCT00490815|451984285|FG000|Overall Study|Death|1|||
125645216|NCT00490815|451984286|FG001|Overall Study|Death|3|||
125645217|NCT00579059|451984288|FG000|Overall Study|Study Canceled at 1 Year|21|||
125645218|NCT00579059|451984289|FG001|Overall Study|Study Canceled at 1 Year|10|||
125645219|NCT04047472|451984290|FG000|Overall Study|Adverse Event|3|||
125645220|NCT04047472|451984291|FG001|Overall Study|Adverse Event|3|||
125645221|NCT04047472|451984290|FG000|Overall Study|Death|0|||
125645222|NCT04047472|451984291|FG001|Overall Study|Death|1|||
125645223|NCT04047472|451984290|FG000|Overall Study|Lost to Follow-up|1|||
125645224|NCT04047472|451984291|FG001|Overall Study|Lost to Follow-up|0|||
125645225|NCT04047472|451984290|FG000|Overall Study|Physician Decision|1|||
125645226|NCT04047472|451984291|FG001|Overall Study|Physician Decision|2|||
125645227|NCT04047472|451984290|FG000|Overall Study|Protocol Violation|1|||
125645228|NCT04047472|451984291|FG001|Overall Study|Protocol Violation|0|||
125645229|NCT04047472|451984290|FG000|Overall Study|Withdrawal by Subject|10|||
125645230|NCT04047472|451984291|FG001|Overall Study|Withdrawal by Subject|10|||
125645231|NCT02030067|451984292|FG000|Overall Study|Disease Progression|1|||
125645232|NCT02030067|451984293|FG001|Overall Study|Disease Progression|1|||
125645233|NCT02030067|451984294|FG002|Overall Study|Disease Progression|2|||
125645234|NCT02030067|451984295|FG003|Overall Study|Disease Progression|2|||
125645235|NCT02030067|451984296|FG004|Overall Study|Disease Progression|3|||
125645236|NCT02030067|451984297|FG005|Overall Study|Disease Progression|2|||
125645237|NCT02030067|451984298|FG006|Overall Study|Disease Progression|3|||
125645238|NCT02030067|451984299|FG007|Overall Study|Disease Progression|3|||
125645239|NCT02030067|451984300|FG008|Overall Study|Disease Progression|4|||
125645240|NCT02030067|451984301|FG009|Overall Study|Disease Progression|3|||
125645241|NCT02030067|451984302|FG010|Overall Study|Disease Progression|7|||
125645242|NCT02030067|451984303|FG011|Overall Study|Disease Progression|2|||
125645243|NCT02030067|451984304|FG012|Overall Study|Disease Progression|59|||
125645244|NCT02030067|451984292|FG000|Overall Study|Withdrawal by Subject|0|||
125645245|NCT02030067|451984293|FG001|Overall Study|Withdrawal by Subject|0|||
125645246|NCT02030067|451984294|FG002|Overall Study|Withdrawal by Subject|0|||
125645247|NCT02030067|451984295|FG003|Overall Study|Withdrawal by Subject|1|||
125645248|NCT02030067|451984296|FG004|Overall Study|Withdrawal by Subject|0|||
125645249|NCT02030067|451984297|FG005|Overall Study|Withdrawal by Subject|0|||
125645250|NCT02030067|451984298|FG006|Overall Study|Withdrawal by Subject|0|||
125645251|NCT02030067|451984299|FG007|Overall Study|Withdrawal by Subject|1|||
125645252|NCT02030067|451984300|FG008|Overall Study|Withdrawal by Subject|0|||
125645253|NCT02030067|451984301|FG009|Overall Study|Withdrawal by Subject|0|||
125645254|NCT02030067|451984302|FG010|Overall Study|Withdrawal by Subject|3|||
125645255|NCT02030067|451984303|FG011|Overall Study|Withdrawal by Subject|0|||
125645256|NCT02030067|451984304|FG012|Overall Study|Withdrawal by Subject|6|||
125645257|NCT02030067|451984292|FG000|Overall Study|Physician Decision|0|||
125645258|NCT02030067|451984293|FG001|Overall Study|Physician Decision|0|||
125645259|NCT02030067|451984294|FG002|Overall Study|Physician Decision|0|||
125645260|NCT02030067|451984295|FG003|Overall Study|Physician Decision|0|||
125645261|NCT02030067|451984296|FG004|Overall Study|Physician Decision|0|||
125645262|NCT02030067|451984297|FG005|Overall Study|Physician Decision|0|||
125645263|NCT02030067|451984298|FG006|Overall Study|Physician Decision|0|||
125645264|NCT02030067|451984299|FG007|Overall Study|Physician Decision|0|||
125645265|NCT02030067|451984300|FG008|Overall Study|Physician Decision|0|||
125645266|NCT02030067|451984301|FG009|Overall Study|Physician Decision|0|||
125645267|NCT02030067|451984302|FG010|Overall Study|Physician Decision|1|||
125645268|NCT02030067|451984303|FG011|Overall Study|Physician Decision|0|||
125645269|NCT02030067|451984304|FG012|Overall Study|Physician Decision|3|||
125645270|NCT02030067|451984292|FG000|Overall Study|other reasons|0|||
125645271|NCT02030067|451984293|FG001|Overall Study|other reasons|0|||
125645272|NCT02030067|451984294|FG002|Overall Study|other reasons|0|||
125645273|NCT02030067|451984295|FG003|Overall Study|other reasons|0|||
125645274|NCT02030067|451984296|FG004|Overall Study|other reasons|0|||
125645275|NCT02030067|451984297|FG005|Overall Study|other reasons|1|||
125645276|NCT02030067|451984298|FG006|Overall Study|other reasons|0|||
125645277|NCT02030067|451984299|FG007|Overall Study|other reasons|0|||
125645278|NCT02030067|451984300|FG008|Overall Study|other reasons|2|||
125645279|NCT02030067|451984301|FG009|Overall Study|other reasons|0|||
125645280|NCT02030067|451984302|FG010|Overall Study|other reasons|0|||
125645281|NCT02030067|451984303|FG011|Overall Study|other reasons|0|||
125645282|NCT02030067|451984304|FG012|Overall Study|other reasons|4|||
125645283|NCT02030067|451984292|FG000|Overall Study|Adverse Event|0|||
125645284|NCT02030067|451984293|FG001|Overall Study|Adverse Event|0|||
125645285|NCT02030067|451984294|FG002|Overall Study|Adverse Event|0|||
125645286|NCT02030067|451984295|FG003|Overall Study|Adverse Event|0|||
125645287|NCT02030067|451984296|FG004|Overall Study|Adverse Event|0|||
125645288|NCT02030067|451984297|FG005|Overall Study|Adverse Event|0|||
125645289|NCT02030067|451984298|FG006|Overall Study|Adverse Event|0|||
125645290|NCT02030067|451984299|FG007|Overall Study|Adverse Event|0|||
125645291|NCT02030067|451984300|FG008|Overall Study|Adverse Event|0|||
125645292|NCT02030067|451984301|FG009|Overall Study|Adverse Event|0|||
125645293|NCT02030067|451984302|FG010|Overall Study|Adverse Event|0|||
125645294|NCT02030067|451984303|FG011|Overall Study|Adverse Event|1|||
125645295|NCT02030067|451984304|FG012|Overall Study|Adverse Event|8|||
125645296|NCT01756846|451984305|FG000|Overall Study|Lost to Follow-up|5|||
125645297|NCT01756846|451984306|FG001|Overall Study|Lost to Follow-up|10|||
125645298|NCT01756846|451984305|FG000|Overall Study|Withdrawal by Subject|1|||
125645299|NCT01756846|451984306|FG001|Overall Study|Withdrawal by Subject|2|||
125645300|NCT01284127|451984307|FG000|Overall Study|Adverse Event|2|||
125645301|NCT01284127|451984307|FG000|Overall Study|Withdrawal by Subject|4|||
125645302|NCT01284127|451984307|FG000|Overall Study|Physician Decision|1|||
125645303|NCT00699582|451984310|FG000|Overall Study|Adverse Event|4|||
125645304|NCT00699582|451984311|FG001|Overall Study|Adverse Event|11|||
125645305|NCT00699582|451984312|FG002|Overall Study|Adverse Event|23|||
125645306|NCT00699582|451984310|FG000|Overall Study|Withdrawal by Subject|6|||
125645307|NCT00699582|451984311|FG001|Overall Study|Withdrawal by Subject|7|||
125645308|NCT00699582|451984312|FG002|Overall Study|Withdrawal by Subject|4|||
125645309|NCT00699582|451984310|FG000|Overall Study|Lack of Efficacy|1|||
125645310|NCT00699582|451984311|FG001|Overall Study|Lack of Efficacy|0|||
125645311|NCT00699582|451984312|FG002|Overall Study|Lack of Efficacy|1|||
125645312|NCT00699582|451984310|FG000|Overall Study|Progressive Disease|1|||
125645313|NCT00699582|451984311|FG001|Overall Study|Progressive Disease|0|||
125645314|NCT00699582|451984312|FG002|Overall Study|Progressive Disease|0|||
125645315|NCT00699582|451984310|FG000|Overall Study|Administrative/Other|4|||
125645316|NCT00699582|451984311|FG001|Overall Study|Administrative/Other|3|||
125645317|NCT00699582|451984312|FG002|Overall Study|Administrative/Other|0|||
125645318|NCT00699582|451984310|FG000|Overall Study|Randomized, Not Treated|2|||
125645319|NCT00699582|451984311|FG001|Overall Study|Randomized, Not Treated|1|||
125645320|NCT00699582|451984312|FG002|Overall Study|Randomized, Not Treated|0|||
125645321|NCT01843933|451984318|FG000|Overall Study|Data lost|6|||
125645322|NCT01843933|451984319|FG001|Overall Study|Data lost|4|||
125645323|NCT02909504|451984320|FG000|Overall Study|Adverse Event|2|||
125645324|NCT02909504|451984320|FG000|Overall Study|Lack of Efficacy|3|||
125645325|NCT02909504|451984320|FG000|Overall Study|Withdrawal by Subject|4|||
125645326|NCT02909504|451984320|FG000|Overall Study|Pregnancy|1|||
125645327|NCT02909504|451984320|FG000|Overall Study|Subject moved|1|||
125645328|NCT02909504|451984320|FG000|Overall Study|Lost to Follow-up|1|||
125645329|NCT04411472|451984321|FG000|Overall Study|Adverse Event|5|||
125645330|NCT04411472|451984322|FG001|Overall Study|Adverse Event|10|||
125645331|NCT04411472|451984323|FG002|Overall Study|Adverse Event|1|||
125645332|NCT04411472|451984324|FG003|Overall Study|Adverse Event|0|||
125645333|NCT04411472|451984325|FG004|Overall Study|Adverse Event|0|||
125645334|NCT04411472|451984326|FG005|Overall Study|Adverse Event|0|||
125645335|NCT04411472|451984321|FG000|Overall Study|Protocol Violation|1|||
125645336|NCT04411472|451984322|FG001|Overall Study|Protocol Violation|0|||
125645337|NCT04411472|451984323|FG002|Overall Study|Protocol Violation|0|||
125645338|NCT04411472|451984324|FG003|Overall Study|Protocol Violation|0|||
125645339|NCT04411472|451984325|FG004|Overall Study|Protocol Violation|0|||
125645340|NCT04411472|451984326|FG005|Overall Study|Protocol Violation|0|||
125645341|NCT04411472|451984321|FG000|Overall Study|Withdrawal by Subject|0|||
125645342|NCT04411472|451984322|FG001|Overall Study|Withdrawal by Subject|1|||
125645343|NCT04411472|451984323|FG002|Overall Study|Withdrawal by Subject|0|||
125645344|NCT04411472|451984324|FG003|Overall Study|Withdrawal by Subject|1|||
125645345|NCT04411472|451984325|FG004|Overall Study|Withdrawal by Subject|0|||
125645346|NCT04411472|451984326|FG005|Overall Study|Withdrawal by Subject|0|||
125645347|NCT04411472|451984321|FG000|Overall Study|Physician Decision|1|||
125645348|NCT04411472|451984322|FG001|Overall Study|Physician Decision|0|||
125645349|NCT04411472|451984323|FG002|Overall Study|Physician Decision|0|||
125645350|NCT04411472|451984324|FG003|Overall Study|Physician Decision|0|||
125645351|NCT04411472|451984325|FG004|Overall Study|Physician Decision|0|||
125645352|NCT04411472|451984326|FG005|Overall Study|Physician Decision|0|||
125645353|NCT04411472|451984321|FG000|Overall Study|Study terminated by sponsor|17|||
125645354|NCT04411472|451984322|FG001|Overall Study|Study terminated by sponsor|20|||
125645355|NCT04411472|451984323|FG002|Overall Study|Study terminated by sponsor|3|||
125645356|NCT04411472|451984324|FG003|Overall Study|Study terminated by sponsor|0|||
125645357|NCT04411472|451984325|FG004|Overall Study|Study terminated by sponsor|0|||
125645358|NCT04411472|451984326|FG005|Overall Study|Study terminated by sponsor|0|||
125645359|NCT01747655|451984328|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
125645360|NCT01747655|451984329|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
125645361|NCT01747655|451984328|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
125645362|NCT01747655|451984329|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
125645363|NCT01747655|451984328|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
125645364|NCT01747655|451984329|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
125645365|NCT00982111|451984330|FG000|Overall Study|Adverse Event|1|||
125645366|NCT00982111|451984331|FG001|Overall Study|Adverse Event|1|||
125645367|NCT00982111|451984330|FG000|Overall Study|Progressive Disease|46|||
125645368|NCT00982111|451984331|FG001|Overall Study|Progressive Disease|39|||
125645369|NCT00982111|451984330|FG000|Overall Study|Lost to Follow-up|9|||
125645370|NCT00982111|451984331|FG001|Overall Study|Lost to Follow-up|6|||
125645371|NCT00982111|451984330|FG000|Overall Study|New Anti-Cancer Therapy|5|||
125645372|NCT00982111|451984331|FG001|Overall Study|New Anti-Cancer Therapy|5|||
125645373|NCT00982111|451984330|FG000|Overall Study|Medical Decision|1|||
125645374|NCT00982111|451984331|FG001|Overall Study|Medical Decision|0|||
125645375|NCT00982111|451984330|FG000|Overall Study|Withdrawal by Subject|17|||
125645376|NCT00982111|451984331|FG001|Overall Study|Withdrawal by Subject|19|||
125645377|NCT00982111|451984330|FG000|Overall Study|Global Study End|0|||
125645378|NCT00982111|451984331|FG001|Overall Study|Global Study End|1|||
125645379|NCT00982111|451984330|FG000|Overall Study|Sponsor's Decision|0|||
125645380|NCT00982111|451984331|FG001|Overall Study|Sponsor's Decision|1|||
125645381|NCT01482598|451984332|FG000|Overall Study|Death|7|||
125645382|NCT01482598|451984333|FG001|Overall Study|Death|10|||
125645383|NCT01482598|451984332|FG000|Overall Study|Physician Decision|0|||
125645384|NCT01482598|451984333|FG001|Overall Study|Physician Decision|3|||
125645385|NCT01482598|451984332|FG000|Overall Study|Withdrawal by Subject|4|||
125645386|NCT01482598|451984333|FG001|Overall Study|Withdrawal by Subject|5|||
125645387|NCT01482598|451984332|FG000|Overall Study|Lost to Follow-up|5|||
125645388|NCT01482598|451984333|FG001|Overall Study|Lost to Follow-up|4|||
125645389|NCT03769753|451984334|FG000|Overall Study|Not Treated|6|||
125200071|NCT02980341|450354971|FG006|Dose Escalation|Withdrawal by Subject|0|||
125200072|NCT02980341|450354972|FG007|Dose Escalation|Withdrawal by Subject|0|||
125645390|NCT03769753|451984334|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
125645391|NCT01373294|451984335|FG000|Overall Study|Adverse Event|1|||
125645392|NCT01373294|451984336|FG001|Overall Study|Adverse Event|0|||
125645393|NCT01657903|451984338|FG000|Overall Study|Lost to Follow-up|1|||
125645394|NCT01657903|451984338|FG000|Overall Study|Withdrawal by Subject|1|||
125645395|NCT01920061|451984341|FG000|Overall Study|Death|1|||
125311706|NCT00176462|450768799|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
125311707|NCT00176462|450768798|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
125311708|NCT00176462|450768799|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
125311709|NCT00176462|450768798|FG000|Consolidation (12 Weeks)|Not documented|0|||
125311710|NCT00176462|450768799|FG001|Consolidation (12 Weeks)|Not documented|1|||
125311711|NCT00176462|450768798|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
125311712|NCT00176462|450768799|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
125311713|NCT00176462|450768798|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
125311714|NCT00176462|450768799|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
125311715|NCT01408459|450768800|FG000|Overall Study|Withdrawal by Subject|1|||
125311716|NCT01408459|450768801|FG001|Overall Study|Withdrawal by Subject|1|||
125311717|NCT01657292|450768806|FG000|Overall Study|Adverse Event|6|||
125311718|NCT01657292|450768806|FG000|Overall Study|Withdrawal by Subject|2|||
125311719|NCT01657292|450768806|FG000|Overall Study|Violation of eligibility criteria|1|||
125311720|NCT01657292|450768806|FG000|Overall Study|Change of therapy|1|||
125311721|NCT00650845|450768807|FG000|Overall Study|Withdrawal by Subject|5|||
125311722|NCT00650845|450768808|FG001|Overall Study|Withdrawal by Subject|0|||
125311723|NCT00650845|450768807|FG000|Overall Study|Protocol Violation|0|||
125311724|NCT00650845|450768808|FG001|Overall Study|Protocol Violation|13|||
125645396|NCT01920061|451984342|FG001|Overall Study|Death|1|||
125645397|NCT01920061|451984343|FG002|Overall Study|Death|0|||
125645398|NCT01920061|451984344|FG003|Overall Study|Death|1|||
125645399|NCT01920061|451984345|FG004|Overall Study|Death|1|||
125311725|NCT03932760|450768809|FG000|Overall Study|Became Ineligible|2|||
125645400|NCT01920061|451984346|FG005|Overall Study|Death|0|||
125645401|NCT01920061|451984347|FG006|Overall Study|Death|0|||
125645402|NCT01920061|451984348|FG007|Overall Study|Death|1|||
125645403|NCT01920061|451984349|FG008|Overall Study|Death|0|||
125311726|NCT03932760|450768810|FG001|Overall Study|Became Ineligible|5|||
125645404|NCT01920061|451984350|FG009|Overall Study|Death|1|||
125311727|NCT03932760|450768809|FG000|Overall Study|Withdrawal by Subject|6|||
125311728|NCT03932760|450768810|FG001|Overall Study|Withdrawal by Subject|6|||
125311729|NCT01301833|450768811|FG000|Overall Study|Adverse Event|7|||
125311730|NCT01301833|450768812|FG001|Overall Study|Adverse Event|5|||
125311731|NCT01301833|450768813|FG002|Overall Study|Adverse Event|5|||
125645405|NCT01920061|451984351|FG010|Overall Study|Death|0|||
125645406|NCT01920061|451984352|FG011|Overall Study|Death|1|||
125645407|NCT01920061|451984353|FG012|Overall Study|Death|0|||
125645408|NCT01920061|451984354|FG013|Overall Study|Death|2|||
125645409|NCT01920061|451984355|FG014|Overall Study|Death|0|||
125645410|NCT01920061|451984356|FG015|Overall Study|Death|0|||
125645411|NCT01920061|451984357|FG016|Overall Study|Death|0|||
125645412|NCT01920061|451984358|FG017|Overall Study|Death|0|||
125645413|NCT01920061|451984359|FG018|Overall Study|Death|1|||
125645414|NCT01920061|451984360|FG019|Overall Study|Death|0|||
125645415|NCT01920061|451984341|FG000|Overall Study|Lost to Follow-up|0|||
125645416|NCT01920061|451984342|FG001|Overall Study|Lost to Follow-up|2|||
125645417|NCT01920061|451984343|FG002|Overall Study|Lost to Follow-up|0|||
125645418|NCT01920061|451984344|FG003|Overall Study|Lost to Follow-up|0|||
125645419|NCT01920061|451984345|FG004|Overall Study|Lost to Follow-up|0|||
125645420|NCT01920061|451984346|FG005|Overall Study|Lost to Follow-up|0|||
125645421|NCT01920061|451984347|FG006|Overall Study|Lost to Follow-up|1|||
125645422|NCT01920061|451984348|FG007|Overall Study|Lost to Follow-up|0|||
125645423|NCT01920061|451984349|FG008|Overall Study|Lost to Follow-up|0|||
125645424|NCT01920061|451984350|FG009|Overall Study|Lost to Follow-up|0|||
125645425|NCT01920061|451984351|FG010|Overall Study|Lost to Follow-up|3|||
125645426|NCT01920061|451984352|FG011|Overall Study|Lost to Follow-up|0|||
125645427|NCT01920061|451984353|FG012|Overall Study|Lost to Follow-up|0|||
125645428|NCT01920061|451984354|FG013|Overall Study|Lost to Follow-up|0|||
125645429|NCT01920061|451984355|FG014|Overall Study|Lost to Follow-up|0|||
125645430|NCT01920061|451984356|FG015|Overall Study|Lost to Follow-up|0|||
125645431|NCT01920061|451984357|FG016|Overall Study|Lost to Follow-up|0|||
125645432|NCT01920061|451984358|FG017|Overall Study|Lost to Follow-up|1|||
125645433|NCT01920061|451984359|FG018|Overall Study|Lost to Follow-up|4|||
125645434|NCT01920061|451984360|FG019|Overall Study|Lost to Follow-up|3|||
125645435|NCT01920061|451984341|FG000|Overall Study|Other|1|||
125645436|NCT01920061|451984342|FG001|Overall Study|Other|1|||
125645437|NCT01920061|451984343|FG002|Overall Study|Other|2|||
125645438|NCT01920061|451984344|FG003|Overall Study|Other|1|||
125645439|NCT01920061|451984345|FG004|Overall Study|Other|0|||
125645440|NCT01920061|451984346|FG005|Overall Study|Other|1|||
125645441|NCT01920061|451984347|FG006|Overall Study|Other|0|||
125645442|NCT01920061|451984348|FG007|Overall Study|Other|0|||
125645443|NCT01920061|451984349|FG008|Overall Study|Other|0|||
125645444|NCT01920061|451984350|FG009|Overall Study|Other|1|||
125645445|NCT01920061|451984351|FG010|Overall Study|Other|1|||
125645446|NCT01920061|451984352|FG011|Overall Study|Other|2|||
125645447|NCT01920061|451984353|FG012|Overall Study|Other|1|||
125645448|NCT01920061|451984354|FG013|Overall Study|Other|4|||
125645449|NCT01920061|451984355|FG014|Overall Study|Other|0|||
125645450|NCT01920061|451984356|FG015|Overall Study|Other|1|||
125645451|NCT01920061|451984357|FG016|Overall Study|Other|1|||
125645452|NCT01920061|451984358|FG017|Overall Study|Other|0|||
125645453|NCT01920061|451984359|FG018|Overall Study|Other|1|||
125645454|NCT01920061|451984360|FG019|Overall Study|Other|1|||
125645455|NCT01920061|451984341|FG000|Overall Study|Participant refused further follow-up|0|||
125645456|NCT01920061|451984342|FG001|Overall Study|Participant refused further follow-up|0|||
125645457|NCT01920061|451984343|FG002|Overall Study|Participant refused further follow-up|0|||
125645458|NCT01920061|451984344|FG003|Overall Study|Participant refused further follow-up|0|||
125645459|NCT01920061|451984345|FG004|Overall Study|Participant refused further follow-up|1|||
125645460|NCT01920061|451984346|FG005|Overall Study|Participant refused further follow-up|1|||
125645461|NCT01920061|451984347|FG006|Overall Study|Participant refused further follow-up|0|||
125645462|NCT01920061|451984348|FG007|Overall Study|Participant refused further follow-up|0|||
125645463|NCT01920061|451984349|FG008|Overall Study|Participant refused further follow-up|1|||
125645464|NCT01920061|451984350|FG009|Overall Study|Participant refused further follow-up|0|||
125645465|NCT01920061|451984351|FG010|Overall Study|Participant refused further follow-up|1|||
125645466|NCT01920061|451984352|FG011|Overall Study|Participant refused further follow-up|0|||
125645467|NCT01920061|451984353|FG012|Overall Study|Participant refused further follow-up|1|||
125645468|NCT01920061|451984354|FG013|Overall Study|Participant refused further follow-up|0|||
125645469|NCT01920061|451984355|FG014|Overall Study|Participant refused further follow-up|1|||
125645470|NCT01920061|451984356|FG015|Overall Study|Participant refused further follow-up|2|||
125645471|NCT01920061|451984357|FG016|Overall Study|Participant refused further follow-up|1|||
125645472|NCT01920061|451984358|FG017|Overall Study|Participant refused further follow-up|1|||
125645473|NCT01920061|451984359|FG018|Overall Study|Participant refused further follow-up|0|||
125645474|NCT01920061|451984360|FG019|Overall Study|Participant refused further follow-up|0|||
125645475|NCT00517634|451984361|FG000|Second Treatment Period|Withdrawal by Subject|0|||
125645476|NCT00517634|451984362|FG001|Second Treatment Period|Withdrawal by Subject|0|||
125645477|NCT00517634|451984363|FG002|Second Treatment Period|Withdrawal by Subject|0|||
125645478|NCT00517634|451984364|FG003|Second Treatment Period|Withdrawal by Subject|0|||
125645479|NCT00517634|451984365|FG004|Second Treatment Period|Withdrawal by Subject|1|||
125645480|NCT00517634|451984366|FG005|Second Treatment Period|Withdrawal by Subject|0|||
125645481|NCT03091920|451984367|FG000|Overall Study|Adverse Event|0|||
125645482|NCT03091920|451984368|FG001|Overall Study|Adverse Event|1|||
125645483|NCT03091920|451984369|FG002|Overall Study|Adverse Event|0|||
125645484|NCT03143855|451984370|FG000|Overall Study|Withdrawal by Subject|4|||
125645485|NCT03143855|451984371|FG001|Overall Study|Withdrawal by Subject|3|||
125645486|NCT03143855|451984370|FG000|Overall Study|Protocol Violation|1|||
125645487|NCT03143855|451984371|FG001|Overall Study|Protocol Violation|0|||
125645488|NCT03143855|451984370|FG000|Overall Study|Participant experienced withdrawal|0|||
125645489|NCT03143855|451984371|FG001|Overall Study|Participant experienced withdrawal|1|||
125645490|NCT00453349|451984373|FG000|Randomized|Adverse Event|12|||
125645491|NCT00453349|451984374|FG001|Randomized|Adverse Event|11|||
125645492|NCT00453349|451984373|FG000|Randomized|Lack of Efficacy|2|||
125645493|NCT00453349|451984374|FG001|Randomized|Lack of Efficacy|1|||
125645494|NCT00453349|451984373|FG000|Randomized|Lost to Follow-up|7|||
125311732|NCT01301833|450768814|FG003|Overall Study|Adverse Event|5|||
125311733|NCT01301833|450768811|FG000|Overall Study|Lack of Efficacy|1|||
125645495|NCT00453349|451984374|FG001|Randomized|Lost to Follow-up|5|||
125645496|NCT00453349|451984373|FG000|Randomized|Protocol Violation|1|||
125645497|NCT00453349|451984374|FG001|Randomized|Protocol Violation|1|||
125645498|NCT00453349|451984373|FG000|Randomized|Withdrawal by Subject|3|||
125645499|NCT00453349|451984374|FG001|Randomized|Withdrawal by Subject|5|||
125645500|NCT00453349|451984373|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
125645501|NCT00453349|451984374|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
125200073|NCT02980341|450354973|FG008|Dose Escalation|Withdrawal by Subject|0|||
125200074|NCT02980341|450354974|FG009|Dose Escalation|Withdrawal by Subject|0|||
125200075|NCT02980341|450354975|FG010|Dose Escalation|Withdrawal by Subject|0|||
125200076|NCT02980341|450354965|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200077|NCT02980341|450354966|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200078|NCT02980341|450354967|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200079|NCT02980341|450354968|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
125200080|NCT02980341|450354969|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
125217434|NCT01348100|450423521|FG001|Overall Study|Lost to Follow-up|0|||
125311734|NCT01301833|450768812|FG001|Overall Study|Lack of Efficacy|1|||
125645502|NCT00453349|451984373|FG000|Completed Study|Adverse Event|12|||
125645503|NCT00453349|451984374|FG001|Completed Study|Adverse Event|11|||
125645504|NCT00453349|451984373|FG000|Completed Study|Lack of Efficacy|2|||
125645505|NCT00453349|451984374|FG001|Completed Study|Lack of Efficacy|1|||
125645506|NCT00453349|451984373|FG000|Completed Study|Lost to Follow-up|7|||
125645507|NCT00453349|451984374|FG001|Completed Study|Lost to Follow-up|5|||
125645508|NCT00453349|451984373|FG000|Completed Study|Protocol Violation|1|||
125645509|NCT00453349|451984374|FG001|Completed Study|Protocol Violation|1|||
125645510|NCT00453349|451984373|FG000|Completed Study|Withdrawal by Subject|3|||
125645511|NCT00453349|451984374|FG001|Completed Study|Withdrawal by Subject|5|||
125645512|NCT00453349|451984373|FG000|Completed Study|Lost to follow up after study treatment|2|||
125645513|NCT00453349|451984374|FG001|Completed Study|Lost to follow up after study treatment|11|||
125645514|NCT04369742|451984375|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
125645515|NCT04369742|451984376|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
125645516|NCT04369742|451984375|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
125645517|NCT04369742|451984376|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
125645518|NCT00695318|451984381|FG000|Overall Study|Lost to Follow-up|1|||
125645519|NCT00695318|451984382|FG001|Overall Study|Lost to Follow-up|0|||
125645520|NCT00695318|451984381|FG000|Overall Study|Withdrawal by Subject|2|||
125645521|NCT00695318|451984382|FG001|Overall Study|Withdrawal by Subject|0|||
125645522|NCT00695318|451984381|FG000|Overall Study|Death|1|||
125645523|NCT00695318|451984382|FG001|Overall Study|Death|1|||
125645524|NCT00695318|451984381|FG000|Overall Study|Study Terminated|1|||
125645525|NCT00695318|451984382|FG001|Overall Study|Study Terminated|0|||
125645526|NCT02098733|451984383|FG000|Overall Study|Data Not Available|5|||
125645527|NCT02098733|451984383|FG000|Overall Study|Lost to Follow-up|5|||
125645528|NCT00434876|451984384|FG000|Overall Study|Lost to Follow-up|1|||
125645529|NCT00434876|451984385|FG001|Overall Study|Lost to Follow-up|1|||
125645530|NCT01078389|451986253|FG000|Overall Study|Adverse Event|10|||
125645531|NCT01078389|451986254|FG001|Overall Study|Adverse Event|6|||
125645532|NCT01078389|451986253|FG000|Overall Study|Major Protocol Deviation|2|||
125645533|NCT01078389|451986254|FG001|Overall Study|Major Protocol Deviation|0|||
125645534|NCT01078389|451986253|FG000|Overall Study|Lost to Follow-up|23|||
125645535|NCT01078389|451986254|FG001|Overall Study|Lost to Follow-up|23|||
125645536|NCT01078389|451986253|FG000|Overall Study|Voluntary Withdrawal|20|||
125645537|NCT01078389|451986254|FG001|Overall Study|Voluntary Withdrawal|36|||
125645538|NCT01078389|451986253|FG000|Overall Study|Other|9|||
125645539|NCT01078389|451986254|FG001|Overall Study|Other|2|||
125645540|NCT01002573|451986255|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
125645541|NCT01002573|451986256|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
125645542|NCT02028182|451986257|FG000|Overall Study|Protocol Violation|2|||
125645543|NCT02198040|451986260|FG000|Overall Study|Work reasons|0|||
125645544|NCT02198040|451986261|FG001|Overall Study|Work reasons|1|||
125645545|NCT02198040|451986262|FG002|Overall Study|Work reasons|0|||
125645546|NCT02198040|451986260|FG000|Overall Study|Withdrawal by Subject|0|||
125645547|NCT02198040|451986261|FG001|Overall Study|Withdrawal by Subject|0|||
125645548|NCT02198040|451986262|FG002|Overall Study|Withdrawal by Subject|1|||
125645549|NCT04524663|451986263|FG000|Overall Study|Withdrawal by Subject|0|||
125311735|NCT01301833|450768813|FG002|Overall Study|Lack of Efficacy|0|||
125311736|NCT01301833|450768814|FG003|Overall Study|Lack of Efficacy|0|||
125311737|NCT01301833|450768811|FG000|Overall Study|Physician Decision|3|||
125311738|NCT01301833|450768812|FG001|Overall Study|Physician Decision|1|||
125311739|NCT01301833|450768813|FG002|Overall Study|Physician Decision|1|||
125311740|NCT01301833|450768814|FG003|Overall Study|Physician Decision|0|||
125311741|NCT01301833|450768811|FG000|Overall Study|Withdrawal by Subject|3|||
125311742|NCT01301833|450768812|FG001|Overall Study|Withdrawal by Subject|1|||
125311743|NCT01301833|450768813|FG002|Overall Study|Withdrawal by Subject|1|||
125311744|NCT01301833|450768814|FG003|Overall Study|Withdrawal by Subject|2|||
125311745|NCT01301833|450768811|FG000|Overall Study|Personal matter|1|||
125311746|NCT01301833|450768812|FG001|Overall Study|Personal matter|0|||
125311747|NCT01301833|450768813|FG002|Overall Study|Personal matter|0|||
125311748|NCT01301833|450768814|FG003|Overall Study|Personal matter|0|||
125311749|NCT03922620|450768815|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
125311750|NCT03922620|450768816|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
125311751|NCT03566082|450768817|FG000|Overall Study|Death|7|||
125422597|NCT00605280|451172897|FG001|Year 1|Protocol Violation|0|||
125422598|NCT00605280|451172898|FG002|Year 1|Protocol Violation|0|||
125422599|NCT00605280|451172899|FG003|Year 1|Protocol Violation|1|||
125422600|NCT00605280|451172896|FG000|Year 1|Adverse Event|3|||
125422601|NCT00605280|451172897|FG001|Year 1|Adverse Event|1|||
125422602|NCT00605280|451172898|FG002|Year 1|Adverse Event|1|||
125422603|NCT00605280|451172899|FG003|Year 1|Adverse Event|5|||
125422604|NCT00605280|451172896|FG000|Year 1|Physician Decision|7|||
125422605|NCT00605280|451172897|FG001|Year 1|Physician Decision|4|||
125422606|NCT00605280|451172898|FG002|Year 1|Physician Decision|0|||
125422607|NCT00605280|451172899|FG003|Year 1|Physician Decision|6|||
125422608|NCT00605280|451172896|FG000|Year 1|Withdrawal by Subject|2|||
125422609|NCT00605280|451172897|FG001|Year 1|Withdrawal by Subject|4|||
125422610|NCT00605280|451172898|FG002|Year 1|Withdrawal by Subject|0|||
125422611|NCT00605280|451172899|FG003|Year 1|Withdrawal by Subject|4|||
125422612|NCT00605280|451172896|FG000|Year 1|Other|2|||
125422613|NCT00605280|451172897|FG001|Year 1|Other|1|||
125422614|NCT00605280|451172898|FG002|Year 1|Other|0|||
125422615|NCT00605280|451172899|FG003|Year 1|Other|1|||
125422616|NCT00605280|451172896|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
125422617|NCT00605280|451172897|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
125422618|NCT00605280|451172898|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
125422619|NCT00605280|451172899|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
125422620|NCT00605280|451172896|FG000|Year 2|Adverse Event|4|||
125422621|NCT00605280|451172897|FG001|Year 2|Adverse Event|0|||
125422622|NCT00605280|451172898|FG002|Year 2|Adverse Event|2|||
125422623|NCT00605280|451172899|FG003|Year 2|Adverse Event|4|||
125422624|NCT00605280|451172896|FG000|Year 2|Physician Decision|11|||
125422625|NCT00605280|451172897|FG001|Year 2|Physician Decision|6|||
125422626|NCT00605280|451172898|FG002|Year 2|Physician Decision|4|||
125422627|NCT00605280|451172899|FG003|Year 2|Physician Decision|11|||
125422628|NCT00605280|451172896|FG000|Year 2|Withdrawal by Subject|4|||
125645550|NCT04524663|451986264|FG001|Overall Study|Withdrawal by Subject|2|||
125645551|NCT00337935|451986265|FG000|Overall Study|Adverse Event|2|||
125645552|NCT00337935|451986266|FG001|Overall Study|Adverse Event|5|||
125645553|NCT00337935|451986265|FG000|Overall Study|Death|2|||
125645554|NCT00337935|451986266|FG001|Overall Study|Death|8|||
125645555|NCT00337935|451986265|FG000|Overall Study|Physician Decision|1|||
125645556|NCT00337935|451986266|FG001|Overall Study|Physician Decision|1|||
125645557|NCT00337935|451986265|FG000|Overall Study|Lost to Follow-up|0|||
125645558|NCT00337935|451986266|FG001|Overall Study|Lost to Follow-up|1|||
125645559|NCT00337935|451986265|FG000|Overall Study|Protocol Violation|4|||
125645560|NCT00337935|451986266|FG001|Overall Study|Protocol Violation|3|||
125645561|NCT00337935|451986265|FG000|Overall Study|Withdrawal by Subject|1|||
125422629|NCT00605280|451172897|FG001|Year 2|Withdrawal by Subject|0|||
125422630|NCT00605280|451172898|FG002|Year 2|Withdrawal by Subject|0|||
125422631|NCT00605280|451172899|FG003|Year 2|Withdrawal by Subject|4|||
125645562|NCT00337935|451986266|FG001|Overall Study|Withdrawal by Subject|7|||
125645563|NCT00337935|451986265|FG000|Overall Study|Other|0|||
125645564|NCT00337935|451986266|FG001|Overall Study|Other|1|||
125645565|NCT00337935|451986265|FG000|Overall Study|Lack of Efficacy|0|||
125422632|NCT00605280|451172896|FG000|Year 2|Other|1|||
125422633|NCT00605280|451172897|FG001|Year 2|Other|0|||
125422634|NCT00605280|451172898|FG002|Year 2|Other|0|||
125422635|NCT00605280|451172899|FG003|Year 2|Other|1|||
125422636|NCT00605280|451172896|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
125422637|NCT00605280|451172897|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
125422638|NCT00605280|451172898|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
125422639|NCT00605280|451172899|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
125422640|NCT00605280|451172896|FG000|Year 3 Extension|Adverse Event|2|||
125645566|NCT00337935|451986266|FG001|Overall Study|Lack of Efficacy|1|||
125645567|NCT01884675|451986267|FG000|Overall Study|Study closed/terminated|3|||
125422641|NCT00605280|451172897|FG001|Year 3 Extension|Adverse Event|0|||
125645568|NCT01884675|451986268|FG001|Overall Study|Study closed/terminated|2|||
125645569|NCT02361307|451986269|FG000|Overall Study|Unstable medical condition.|0|||
125645570|NCT02361307|451986270|FG001|Overall Study|Unstable medical condition.|1|||
125645571|NCT00711009|451986271|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
125645572|NCT00711009|451986272|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
125645573|NCT00711009|451986271|FG000|Overall Study|Withdrawal by Subject|4|||
125645574|NCT00711009|451986272|FG001|Overall Study|Withdrawal by Subject|2|||
125645575|NCT00711009|451986271|FG000|Overall Study|Lost to Follow-up|3|||
125645576|NCT00711009|451986272|FG001|Overall Study|Lost to Follow-up|9|||
125645577|NCT00711009|451986271|FG000|Overall Study|Participant Noncompliant|0|||
125645578|NCT00711009|451986272|FG001|Overall Study|Participant Noncompliant|1|||
125645579|NCT00711009|451986271|FG000|Overall Study|Virologic Failure|2|||
125645580|NCT00711009|451986272|FG001|Overall Study|Virologic Failure|1|||
125645581|NCT00711009|451986271|FG000|Overall Study|Pregnancy|1|||
125645582|NCT00711009|451986272|FG001|Overall Study|Pregnancy|0|||
125645583|NCT00711009|451986271|FG000|Overall Study|Site closing|0|||
125645584|NCT00711009|451986272|FG001|Overall Study|Site closing|1|||
125645585|NCT00711009|451986271|FG000|Overall Study|Dose adjustment|1|||
125645586|NCT00711009|451986272|FG001|Overall Study|Dose adjustment|0|||
125645587|NCT03359811|451986273|FG000|Overall Study|Protocol Violation|2|||
125645588|NCT03359811|451986274|FG001|Overall Study|Protocol Violation|0|||
125645589|NCT01682876|451986275|FG000|Overall Study|Administrative reason|4|||
125645590|NCT01682876|451986276|FG001|Overall Study|Administrative reason|4|||
125422642|NCT00605280|451172898|FG002|Year 3 Extension|Adverse Event|0|||
125422643|NCT00605280|451172899|FG003|Year 3 Extension|Adverse Event|2|||
125422644|NCT00605280|451172896|FG000|Year 3 Extension|Physician Decision|0|||
125422645|NCT00605280|451172897|FG001|Year 3 Extension|Physician Decision|0|||
125422646|NCT00605280|451172898|FG002|Year 3 Extension|Physician Decision|0|||
125422647|NCT00605280|451172899|FG003|Year 3 Extension|Physician Decision|2|||
125422648|NCT00605280|451172896|FG000|Year 3 Extension|Withdrawal by Subject|2|||
125422649|NCT00605280|451172897|FG001|Year 3 Extension|Withdrawal by Subject|0|||
125422650|NCT00605280|451172898|FG002|Year 3 Extension|Withdrawal by Subject|0|||
125422651|NCT00605280|451172899|FG003|Year 3 Extension|Withdrawal by Subject|5|||
125422652|NCT00605280|451172896|FG000|Year 3 Extension|Other|2|||
125422653|NCT00605280|451172897|FG001|Year 3 Extension|Other|0|||
125422654|NCT00605280|451172898|FG002|Year 3 Extension|Other|0|||
125422655|NCT00605280|451172899|FG003|Year 3 Extension|Other|0|||
125422656|NCT00605280|451172896|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
125422657|NCT00605280|451172897|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
125422658|NCT00605280|451172898|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
125422659|NCT00605280|451172899|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
125422660|NCT01775904|451172903|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
125422661|NCT01775904|451172903|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
125422662|NCT00518115|451172904|FG000|Overall Study|Adverse Event|6|||
125422663|NCT00518115|451172905|FG001|Overall Study|Adverse Event|1|||
125422664|NCT00518115|451172906|FG002|Overall Study|Adverse Event|5|||
125422665|NCT00518115|451172907|FG003|Overall Study|Adverse Event|6|||
125422666|NCT00518115|451172908|FG004|Overall Study|Adverse Event|5|||
125422667|NCT00518115|451172909|FG005|Overall Study|Adverse Event|5|||
125422668|NCT00518115|451172910|FG006|Overall Study|Adverse Event|5|||
125422669|NCT00518115|451172911|FG007|Overall Study|Adverse Event|10|||
125422670|NCT00518115|451172912|FG008|Overall Study|Adverse Event|2|||
125422671|NCT00518115|451172913|FG009|Overall Study|Adverse Event|9|||
125422672|NCT00518115|451172904|FG000|Overall Study|Lost to Follow-up|0|||
125422673|NCT00518115|451172905|FG001|Overall Study|Lost to Follow-up|0|||
125422674|NCT00518115|451172906|FG002|Overall Study|Lost to Follow-up|2|||
125422675|NCT00518115|451172907|FG003|Overall Study|Lost to Follow-up|3|||
125422676|NCT00518115|451172908|FG004|Overall Study|Lost to Follow-up|1|||
125422677|NCT00518115|451172909|FG005|Overall Study|Lost to Follow-up|3|||
125422678|NCT00518115|451172910|FG006|Overall Study|Lost to Follow-up|0|||
125422679|NCT00518115|451172911|FG007|Overall Study|Lost to Follow-up|1|||
125645591|NCT01682876|451986277|FG002|Overall Study|Administrative reason|0|||
125645592|NCT01682876|451986278|FG003|Overall Study|Administrative reason|3|||
125645593|NCT01682876|451986275|FG000|Overall Study|Adverse Event|0|||
125422680|NCT00518115|451172912|FG008|Overall Study|Lost to Follow-up|1|||
125422681|NCT00518115|451172913|FG009|Overall Study|Lost to Follow-up|1|||
125422682|NCT00518115|451172904|FG000|Overall Study|Protocol Violation|1|||
125422683|NCT00518115|451172905|FG001|Overall Study|Protocol Violation|3|||
125422684|NCT00518115|451172906|FG002|Overall Study|Protocol Violation|1|||
125422685|NCT00518115|451172907|FG003|Overall Study|Protocol Violation|0|||
125422686|NCT00518115|451172908|FG004|Overall Study|Protocol Violation|0|||
125422687|NCT00518115|451172909|FG005|Overall Study|Protocol Violation|0|||
125422688|NCT00518115|451172910|FG006|Overall Study|Protocol Violation|0|||
125422689|NCT00518115|451172911|FG007|Overall Study|Protocol Violation|0|||
125422690|NCT00518115|451172912|FG008|Overall Study|Protocol Violation|0|||
125645594|NCT01682876|451986276|FG001|Overall Study|Adverse Event|0|||
125645595|NCT01682876|451986277|FG002|Overall Study|Adverse Event|0|||
125645596|NCT01682876|451986278|FG003|Overall Study|Adverse Event|1|||
125645597|NCT01682876|451986275|FG000|Overall Study|Lost to Follow-up|11|||
125645598|NCT01682876|451986276|FG001|Overall Study|Lost to Follow-up|15|||
125422691|NCT00518115|451172913|FG009|Overall Study|Protocol Violation|0|||
125422692|NCT00518115|451172904|FG000|Overall Study|Withdrawal by Subject|1|||
125422693|NCT00518115|451172905|FG001|Overall Study|Withdrawal by Subject|1|||
125422694|NCT00518115|451172906|FG002|Overall Study|Withdrawal by Subject|5|||
125422695|NCT00518115|451172907|FG003|Overall Study|Withdrawal by Subject|0|||
125422696|NCT00518115|451172908|FG004|Overall Study|Withdrawal by Subject|2|||
125422697|NCT00518115|451172909|FG005|Overall Study|Withdrawal by Subject|1|||
125422698|NCT00518115|451172910|FG006|Overall Study|Withdrawal by Subject|0|||
125422699|NCT00518115|451172911|FG007|Overall Study|Withdrawal by Subject|2|||
125422700|NCT00518115|451172912|FG008|Overall Study|Withdrawal by Subject|1|||
125422701|NCT00518115|451172913|FG009|Overall Study|Withdrawal by Subject|3|||
125422702|NCT00518115|451172904|FG000|Overall Study|Lack of Efficacy|1|||
125422703|NCT00518115|451172905|FG001|Overall Study|Lack of Efficacy|0|||
125422704|NCT00518115|451172906|FG002|Overall Study|Lack of Efficacy|1|||
125422705|NCT00518115|451172907|FG003|Overall Study|Lack of Efficacy|1|||
125422706|NCT00518115|451172908|FG004|Overall Study|Lack of Efficacy|0|||
125422707|NCT00518115|451172909|FG005|Overall Study|Lack of Efficacy|0|||
125422708|NCT00518115|451172910|FG006|Overall Study|Lack of Efficacy|0|||
125422709|NCT00518115|451172911|FG007|Overall Study|Lack of Efficacy|1|||
125422710|NCT00518115|451172912|FG008|Overall Study|Lack of Efficacy|0|||
125422711|NCT00518115|451172913|FG009|Overall Study|Lack of Efficacy|0|||
125422712|NCT00518115|451172904|FG000|Overall Study|Non-Compliance|1|||
125422713|NCT00518115|451172905|FG001|Overall Study|Non-Compliance|0|||
125422714|NCT00518115|451172906|FG002|Overall Study|Non-Compliance|1|||
125422715|NCT00518115|451172907|FG003|Overall Study|Non-Compliance|0|||
125422716|NCT00518115|451172908|FG004|Overall Study|Non-Compliance|1|||
125422717|NCT00518115|451172909|FG005|Overall Study|Non-Compliance|1|||
125422718|NCT00518115|451172910|FG006|Overall Study|Non-Compliance|1|||
125422719|NCT00518115|451172911|FG007|Overall Study|Non-Compliance|1|||
125422720|NCT00518115|451172912|FG008|Overall Study|Non-Compliance|0|||
125422721|NCT00518115|451172913|FG009|Overall Study|Non-Compliance|1|||
125422722|NCT00518115|451172904|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
125422723|NCT00518115|451172905|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
125422724|NCT00518115|451172906|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125422725|NCT00518115|451172907|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125422726|NCT00518115|451172908|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125422727|NCT00518115|451172909|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
125422728|NCT00518115|451172910|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125422729|NCT00518115|451172911|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125422730|NCT00518115|451172912|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125422731|NCT00518115|451172913|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125422732|NCT00518115|451172904|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
125422733|NCT00518115|451172905|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125422734|NCT00518115|451172906|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125422735|NCT00518115|451172907|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125422736|NCT00518115|451172908|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125422737|NCT00518115|451172909|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125422738|NCT00518115|451172910|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125422739|NCT00518115|451172911|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125422740|NCT00518115|451172912|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125422741|NCT00518115|451172913|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
125422742|NCT00518115|451172904|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
125422743|NCT00518115|451172905|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
125422744|NCT00518115|451172906|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
125422745|NCT00518115|451172907|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
125422746|NCT00518115|451172908|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
125422747|NCT00518115|451172909|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
125422748|NCT00518115|451172910|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
125422749|NCT00518115|451172911|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
125422750|NCT00518115|451172912|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
125422751|NCT00518115|451172913|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
125422752|NCT00518115|451172904|FG000|Overall Study|Wrong Monotherapy Administered|0|||
125422753|NCT00518115|451172905|FG001|Overall Study|Wrong Monotherapy Administered|0|||
125422754|NCT00518115|451172906|FG002|Overall Study|Wrong Monotherapy Administered|1|||
125422755|NCT00518115|451172907|FG003|Overall Study|Wrong Monotherapy Administered|0|||
125645599|NCT01682876|451986277|FG002|Overall Study|Lost to Follow-up|9|||
125422756|NCT00518115|451172908|FG004|Overall Study|Wrong Monotherapy Administered|0|||
125422757|NCT00518115|451172909|FG005|Overall Study|Wrong Monotherapy Administered|0|||
125422758|NCT00518115|451172910|FG006|Overall Study|Wrong Monotherapy Administered|1|||
125422759|NCT00518115|451172911|FG007|Overall Study|Wrong Monotherapy Administered|0|||
125422760|NCT00518115|451172912|FG008|Overall Study|Wrong Monotherapy Administered|0|||
125422761|NCT00518115|451172913|FG009|Overall Study|Wrong Monotherapy Administered|0|||
125422762|NCT00518115|451172904|FG000|Overall Study|Violation of Exclusion Criteria|0|||
125422763|NCT00518115|451172905|FG001|Overall Study|Violation of Exclusion Criteria|0|||
125422764|NCT00518115|451172906|FG002|Overall Study|Violation of Exclusion Criteria|0|||
125422765|NCT00518115|451172907|FG003|Overall Study|Violation of Exclusion Criteria|1|||
125422766|NCT00518115|451172908|FG004|Overall Study|Violation of Exclusion Criteria|0|||
125422767|NCT00518115|451172909|FG005|Overall Study|Violation of Exclusion Criteria|0|||
125422768|NCT00518115|451172910|FG006|Overall Study|Violation of Exclusion Criteria|1|||
125422769|NCT00518115|451172911|FG007|Overall Study|Violation of Exclusion Criteria|0|||
125422770|NCT00518115|451172912|FG008|Overall Study|Violation of Exclusion Criteria|0|||
125422771|NCT00518115|451172913|FG009|Overall Study|Violation of Exclusion Criteria|0|||
125422772|NCT00518115|451172904|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
125422773|NCT00518115|451172905|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
125422774|NCT00518115|451172906|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
125422775|NCT00518115|451172907|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
125422776|NCT00518115|451172908|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
125422777|NCT00518115|451172909|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
125422778|NCT00518115|451172910|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
125422779|NCT00518115|451172911|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
125422780|NCT00518115|451172912|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
125422781|NCT00518115|451172913|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
125422782|NCT00518115|451172904|FG000|Overall Study|Withdrew Consent|0|||
125422783|NCT00518115|451172905|FG001|Overall Study|Withdrew Consent|0|||
125422784|NCT00518115|451172906|FG002|Overall Study|Withdrew Consent|0|||
125422785|NCT00518115|451172907|FG003|Overall Study|Withdrew Consent|0|||
125422786|NCT00518115|451172908|FG004|Overall Study|Withdrew Consent|0|||
125422787|NCT00518115|451172909|FG005|Overall Study|Withdrew Consent|1|||
125422788|NCT00518115|451172910|FG006|Overall Study|Withdrew Consent|0|||
125422789|NCT00518115|451172911|FG007|Overall Study|Withdrew Consent|0|||
125422790|NCT00518115|451172912|FG008|Overall Study|Withdrew Consent|0|||
125422791|NCT00518115|451172913|FG009|Overall Study|Withdrew Consent|0|||
125422792|NCT00518115|451172904|FG000|Overall Study|Moved Out of State|0|||
125422793|NCT00518115|451172905|FG001|Overall Study|Moved Out of State|0|||
125422794|NCT00518115|451172906|FG002|Overall Study|Moved Out of State|0|||
125422795|NCT00518115|451172907|FG003|Overall Study|Moved Out of State|0|||
125422796|NCT00518115|451172908|FG004|Overall Study|Moved Out of State|0|||
125422797|NCT00518115|451172909|FG005|Overall Study|Moved Out of State|0|||
125422798|NCT00518115|451172910|FG006|Overall Study|Moved Out of State|0|||
125422799|NCT00518115|451172911|FG007|Overall Study|Moved Out of State|0|||
125422800|NCT00518115|451172912|FG008|Overall Study|Moved Out of State|0|||
125422801|NCT00518115|451172913|FG009|Overall Study|Moved Out of State|1|||
125422802|NCT04891419|451172914|FG000|Overall Study|Withdrawal by Subject|4|||
125422803|NCT04891419|451172915|FG001|Overall Study|Withdrawal by Subject|0|||
125422804|NCT04891419|451172914|FG000|Overall Study|Lost to Follow-up|1|||
125422805|NCT04891419|451172915|FG001|Overall Study|Lost to Follow-up|3|||
125422806|NCT02291614|451172916|FG000|Overall Study|Lost to Follow-up|0|||
125422807|NCT02291614|451172917|FG001|Overall Study|Lost to Follow-up|0|||
125422808|NCT02291614|451172918|FG002|Overall Study|Lost to Follow-up|0|||
125422809|NCT02291614|451172919|FG003|Overall Study|Lost to Follow-up|0|||
125422810|NCT02291614|451172920|FG004|Overall Study|Lost to Follow-up|0|||
125422811|NCT02291614|451172921|FG005|Overall Study|Lost to Follow-up|0|||
125422812|NCT02291614|451172922|FG006|Overall Study|Lost to Follow-up|0|||
125422813|NCT02291614|451172923|FG007|Overall Study|Lost to Follow-up|1|||
125422814|NCT02291614|451172924|FG008|Overall Study|Lost to Follow-up|0|||
125422815|NCT02291614|451172925|FG009|Overall Study|Lost to Follow-up|0|||
125422816|NCT02291614|451172926|FG010|Overall Study|Lost to Follow-up|0|||
125422817|NCT02291614|451172916|FG000|Overall Study|Withdrawal by Subject|0|||
125422818|NCT02291614|451172917|FG001|Overall Study|Withdrawal by Subject|1|||
125422819|NCT02291614|451172918|FG002|Overall Study|Withdrawal by Subject|0|||
125422820|NCT02291614|451172919|FG003|Overall Study|Withdrawal by Subject|0|||
125422821|NCT02291614|451172920|FG004|Overall Study|Withdrawal by Subject|0|||
125422822|NCT02291614|451172921|FG005|Overall Study|Withdrawal by Subject|0|||
125422823|NCT02291614|451172922|FG006|Overall Study|Withdrawal by Subject|0|||
125422824|NCT02291614|451172923|FG007|Overall Study|Withdrawal by Subject|0|||
125422825|NCT02291614|451172924|FG008|Overall Study|Withdrawal by Subject|0|||
125422826|NCT02291614|451172925|FG009|Overall Study|Withdrawal by Subject|2|||
125422827|NCT02291614|451172926|FG010|Overall Study|Withdrawal by Subject|2|||
125422828|NCT02291614|451172916|FG000|Overall Study|Decision by sponsor|0|||
125422829|NCT02291614|451172917|FG001|Overall Study|Decision by sponsor|0|||
125422830|NCT02291614|451172918|FG002|Overall Study|Decision by sponsor|0|||
125422831|NCT02291614|451172919|FG003|Overall Study|Decision by sponsor|1|||
125422832|NCT02291614|451172920|FG004|Overall Study|Decision by sponsor|0|||
125422833|NCT02291614|451172921|FG005|Overall Study|Decision by sponsor|0|||
125422834|NCT02291614|451172922|FG006|Overall Study|Decision by sponsor|0|||
125422835|NCT02291614|451172923|FG007|Overall Study|Decision by sponsor|0|||
125422836|NCT02291614|451172924|FG008|Overall Study|Decision by sponsor|0|||
125422837|NCT02291614|451172925|FG009|Overall Study|Decision by sponsor|0|||
125422838|NCT02291614|451172926|FG010|Overall Study|Decision by sponsor|0|||
125422839|NCT02291614|451172916|FG000|Overall Study|Death|0|||
125422840|NCT02291614|451172917|FG001|Overall Study|Death|0|||
125422841|NCT02291614|451172918|FG002|Overall Study|Death|1|||
125422842|NCT02291614|451172919|FG003|Overall Study|Death|0|||
125422843|NCT02291614|451172920|FG004|Overall Study|Death|1|||
125422844|NCT02291614|451172921|FG005|Overall Study|Death|1|||
125422845|NCT02291614|451172922|FG006|Overall Study|Death|1|||
125422846|NCT02291614|451172923|FG007|Overall Study|Death|0|||
125422847|NCT02291614|451172924|FG008|Overall Study|Death|0|||
125422848|NCT02291614|451172925|FG009|Overall Study|Death|0|||
125422849|NCT02291614|451172926|FG010|Overall Study|Death|0|||
125422850|NCT01662310|451172927|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
125422851|NCT01662310|451172928|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
125422852|NCT01662310|451172929|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
125422853|NCT01662310|451172930|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
125422854|NCT01662310|451172931|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
125422855|NCT01662310|451172927|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
125422856|NCT01662310|451172928|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
125422857|NCT01662310|451172929|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
125422858|NCT01662310|451172930|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
125422859|NCT01662310|451172931|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
125422860|NCT01662310|451172927|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
125422861|NCT01662310|451172928|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
125422862|NCT01662310|451172929|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
125422863|NCT01662310|451172930|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
125422864|NCT01662310|451172931|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
125422865|NCT01662310|451172927|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
125422866|NCT01662310|451172928|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
125422867|NCT01662310|451172929|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
125422868|NCT01662310|451172930|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
125422869|NCT01662310|451172931|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
125422870|NCT01662310|451172927|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
125422871|NCT01662310|451172928|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
125422872|NCT01662310|451172929|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
125422873|NCT01662310|451172930|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
125422874|NCT01662310|451172931|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
125422875|NCT01662310|451172927|FG000|Run-In or Stabilization Phase|Other|1|||
125422876|NCT01662310|451172928|FG001|Run-In or Stabilization Phase|Other|0|||
125422877|NCT01662310|451172929|FG002|Run-In or Stabilization Phase|Other|0|||
125422878|NCT01662310|451172930|FG003|Run-In or Stabilization Phase|Other|0|||
125422879|NCT01662310|451172931|FG004|Run-In or Stabilization Phase|Other|0|||
125422880|NCT01662310|451172927|FG000|Double-Blind Phase|Adverse Event|0|||
125422881|NCT01662310|451172928|FG001|Double-Blind Phase|Adverse Event|0|||
125422882|NCT01662310|451172929|FG002|Double-Blind Phase|Adverse Event|1|||
125422883|NCT01662310|451172930|FG003|Double-Blind Phase|Adverse Event|0|||
125422884|NCT01662310|451172931|FG004|Double-Blind Phase|Adverse Event|0|||
125422885|NCT01662310|451172927|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125422886|NCT01662310|451172928|FG001|Double-Blind Phase|Lost to Follow-up|3|||
125422887|NCT01662310|451172929|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125422888|NCT01662310|451172930|FG003|Double-Blind Phase|Lost to Follow-up|0|||
125422889|NCT01662310|451172931|FG004|Double-Blind Phase|Lost to Follow-up|0|||
125422890|NCT01662310|451172927|FG000|Double-Blind Phase|Pregnancy|0|||
125422891|NCT01662310|451172928|FG001|Double-Blind Phase|Pregnancy|2|||
125422892|NCT01662310|451172929|FG002|Double-Blind Phase|Pregnancy|0|||
125422893|NCT01662310|451172930|FG003|Double-Blind Phase|Pregnancy|0|||
125422894|NCT01662310|451172931|FG004|Double-Blind Phase|Pregnancy|0|||
125422895|NCT01662310|451172927|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
125422896|NCT01662310|451172928|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
125422897|NCT01662310|451172929|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
125422898|NCT01662310|451172930|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
125422899|NCT01662310|451172931|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
125422900|NCT01662310|451172927|FG000|Double-Blind Phase|Other|0|||
125422901|NCT01662310|451172928|FG001|Double-Blind Phase|Other|0|||
125422902|NCT01662310|451172929|FG002|Double-Blind Phase|Other|1|||
125422903|NCT01662310|451172930|FG003|Double-Blind Phase|Other|0|||
125422904|NCT01662310|451172931|FG004|Double-Blind Phase|Other|0|||
125422905|NCT01662310|451172927|FG000|Double-Blind Phase|Randomized but not treated|0|||
125422906|NCT01662310|451172928|FG001|Double-Blind Phase|Randomized but not treated|1|||
125422907|NCT01662310|451172929|FG002|Double-Blind Phase|Randomized but not treated|0|||
125422908|NCT01662310|451172930|FG003|Double-Blind Phase|Randomized but not treated|0|||
125422909|NCT01662310|451172931|FG004|Double-Blind Phase|Randomized but not treated|0|||
125534851|NCT03820947|451588238|FG000|Overall Study|Withdrawal by Subject|6|||
125422910|NCT01662310|451172927|FG000|Open-Label Extension Phase|Adverse Event|0|||
125422911|NCT01662310|451172928|FG001|Open-Label Extension Phase|Adverse Event|0|||
125534852|NCT03820947|451588239|FG001|Overall Study|Withdrawal by Subject|10|||
125645600|NCT01682876|451986278|FG003|Overall Study|Lost to Follow-up|11|||
125645601|NCT01682876|451986275|FG000|Overall Study|Protocol Violation|1|||
125645602|NCT01682876|451986276|FG001|Overall Study|Protocol Violation|1|||
125645603|NCT01682876|451986277|FG002|Overall Study|Protocol Violation|1|||
125645604|NCT01682876|451986278|FG003|Overall Study|Protocol Violation|1|||
125645605|NCT01682876|451986275|FG000|Overall Study|Withdrawal by Subject|4|||
125645606|NCT01682876|451986276|FG001|Overall Study|Withdrawal by Subject|0|||
125645607|NCT01682876|451986277|FG002|Overall Study|Withdrawal by Subject|0|||
125645608|NCT01682876|451986278|FG003|Overall Study|Withdrawal by Subject|2|||
125645609|NCT01682876|451986275|FG000|Overall Study|Other|1|||
125645610|NCT01682876|451986276|FG001|Overall Study|Other|0|||
125645611|NCT01682876|451986277|FG002|Overall Study|Other|1|||
125645612|NCT01682876|451986278|FG003|Overall Study|Other|1|||
125645613|NCT02534324|451986280|FG000|Overall Study|Protocol Violation|4|||
125645614|NCT02534324|451986281|FG001|Overall Study|Protocol Violation|1|||
125645615|NCT02534324|451986280|FG000|Overall Study|Lost to Follow-up|20|||
125645616|NCT02534324|451986281|FG001|Overall Study|Lost to Follow-up|7|||
125645617|NCT02534324|451986280|FG000|Overall Study|Adverse Event|1|||
125645618|NCT02534324|451986281|FG001|Overall Study|Adverse Event|0|||
125645619|NCT01459016|451986284|FG000|Overall Study|Withdrawal by Subject|11|||
125645620|NCT01459016|451986284|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
125645621|NCT00303602|451986288|FG000|Overall Study|Adverse Event|2|||
125645622|NCT00303602|451986289|FG001|Overall Study|Adverse Event|2|||
125645623|NCT00303602|451986288|FG000|Overall Study|Withdrawal by Subject|5|||
125645624|NCT00303602|451986289|FG001|Overall Study|Withdrawal by Subject|6|||
125645625|NCT00303602|451986288|FG000|Overall Study|Lost to Follow-up|5|||
125645626|NCT00303602|451986289|FG001|Overall Study|Lost to Follow-up|2|||
125645627|NCT00303602|451986288|FG000|Overall Study|Protocol entry criteria not met|2|||
125645628|NCT00303602|451986289|FG001|Overall Study|Protocol entry criteria not met|2|||
125645629|NCT00303602|451986288|FG000|Overall Study|Physician Decision|2|||
125645630|NCT00303602|451986289|FG001|Overall Study|Physician Decision|1|||
125645631|NCT00303602|451986288|FG000|Overall Study|Noncompliance|2|||
125645632|NCT00303602|451986289|FG001|Overall Study|Noncompliance|2|||
125645633|NCT00303602|451986288|FG000|Overall Study|Protocol Violation|1|||
125645634|NCT00303602|451986289|FG001|Overall Study|Protocol Violation|0|||
125645635|NCT00663208|451986294|FG000|Treatment Period|Lost to Follow-up|0|||
125645636|NCT00663208|451986295|FG001|Treatment Period|Lost to Follow-up|1|||
125645637|NCT00663208|451986296|FG002|Treatment Period|Lost to Follow-up|0|||
125645638|NCT00663208|451986297|FG003|Treatment Period|Lost to Follow-up|0|||
125645639|NCT00663208|451986298|FG004|Treatment Period|Lost to Follow-up|0|||
125645640|NCT00663208|451986299|FG005|Treatment Period|Lost to Follow-up|0|||
125645641|NCT00663208|451986300|FG006|Treatment Period|Lost to Follow-up|0|||
125645642|NCT00663208|451986294|FG000|Follow-up Period|Lost to Follow-up|2|||
125645643|NCT00663208|451986295|FG001|Follow-up Period|Lost to Follow-up|0|||
125645644|NCT00663208|451986296|FG002|Follow-up Period|Lost to Follow-up|3|||
125645645|NCT00663208|451986297|FG003|Follow-up Period|Lost to Follow-up|2|||
125645646|NCT00663208|451986298|FG004|Follow-up Period|Lost to Follow-up|0|||
125645647|NCT00663208|451986299|FG005|Follow-up Period|Lost to Follow-up|0|||
125645648|NCT00663208|451986300|FG006|Follow-up Period|Lost to Follow-up|0|||
125645649|NCT00663208|451986294|FG000|Follow-up Period|Other reason|1|||
125645650|NCT00663208|451986295|FG001|Follow-up Period|Other reason|0|||
125645651|NCT00663208|451986296|FG002|Follow-up Period|Other reason|0|||
125645652|NCT00663208|451986297|FG003|Follow-up Period|Other reason|0|||
125645653|NCT00663208|451986298|FG004|Follow-up Period|Other reason|0|||
125645654|NCT00663208|451986299|FG005|Follow-up Period|Other reason|0|||
125645655|NCT00663208|451986300|FG006|Follow-up Period|Other reason|1|||
125645656|NCT04563845|451986302|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125645657|NCT04563845|451986303|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125645658|NCT04563845|451986304|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125645659|NCT04563845|451986305|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125645660|NCT04563845|451986306|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125645661|NCT04563845|451986307|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125645662|NCT04563845|451986308|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125645663|NCT04563845|451986309|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
125645664|NCT04563845|451986310|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125645665|NCT04563845|451986311|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125645666|NCT04563845|451986312|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125645667|NCT04563845|451986313|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125645668|NCT04563845|451986314|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125645669|NCT04563845|451986315|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
125645670|NCT04563845|451986302|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125645671|NCT04563845|451986303|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125645672|NCT04563845|451986304|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125645673|NCT04563845|451986305|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125422912|NCT01662310|451172929|FG002|Open-Label Extension Phase|Adverse Event|0|||
125422913|NCT01662310|451172930|FG003|Open-Label Extension Phase|Adverse Event|3|||
125422914|NCT01662310|451172931|FG004|Open-Label Extension Phase|Adverse Event|0|||
125422915|NCT01662310|451172927|FG000|Open-Label Extension Phase|Death|0|||
125422916|NCT01662310|451172928|FG001|Open-Label Extension Phase|Death|0|||
125422917|NCT01662310|451172929|FG002|Open-Label Extension Phase|Death|0|||
125422918|NCT01662310|451172930|FG003|Open-Label Extension Phase|Death|1|||
125422919|NCT01662310|451172931|FG004|Open-Label Extension Phase|Death|0|||
125422920|NCT01662310|451172927|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
125422921|NCT01662310|451172928|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
125422922|NCT01662310|451172929|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
125422923|NCT01662310|451172930|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
125422924|NCT01662310|451172931|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
125422925|NCT01662310|451172927|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
125422926|NCT01662310|451172928|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
125422927|NCT01662310|451172929|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
125422928|NCT01662310|451172930|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
125422929|NCT01662310|451172931|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
125422930|NCT01662310|451172927|FG000|Open-Label Extension Phase|Pregnancy|0|||
125422931|NCT01662310|451172928|FG001|Open-Label Extension Phase|Pregnancy|0|||
125422932|NCT01662310|451172929|FG002|Open-Label Extension Phase|Pregnancy|0|||
125422933|NCT01662310|451172930|FG003|Open-Label Extension Phase|Pregnancy|1|||
125422934|NCT01662310|451172931|FG004|Open-Label Extension Phase|Pregnancy|0|||
125422935|NCT01662310|451172927|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
125422936|NCT01662310|451172928|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
125422937|NCT01662310|451172929|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
125422938|NCT01662310|451172930|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
125422939|NCT01662310|451172931|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
125422940|NCT01302847|451172935|FG000|Overall Study|Death|0|||
125422941|NCT01302847|451172936|FG001|Overall Study|Death|1|||
125422942|NCT01302847|451172937|FG002|Overall Study|Death|0|||
125422943|NCT01302847|451172938|FG003|Overall Study|Death|0|||
125422944|NCT01302847|451172939|FG004|Overall Study|Death|0|||
125422945|NCT01302847|451172940|FG005|Overall Study|Death|1|||
125422946|NCT01302847|451172941|FG006|Overall Study|Death|1|||
125422947|NCT01302847|451172942|FG007|Overall Study|Death|0|||
125422948|NCT01302847|451172935|FG000|Overall Study|Pregnancy|2|||
125422949|NCT01302847|451172936|FG001|Overall Study|Pregnancy|0|||
125422950|NCT01302847|451172937|FG002|Overall Study|Pregnancy|0|||
125422951|NCT01302847|451172938|FG003|Overall Study|Pregnancy|0|||
125422952|NCT01302847|451172939|FG004|Overall Study|Pregnancy|0|||
125422953|NCT01302847|451172940|FG005|Overall Study|Pregnancy|0|||
125422954|NCT01302847|451172941|FG006|Overall Study|Pregnancy|0|||
125422955|NCT01302847|451172942|FG007|Overall Study|Pregnancy|0|||
125422956|NCT01302847|451172935|FG000|Overall Study|Virologic failure|0|||
125422957|NCT01302847|451172936|FG001|Overall Study|Virologic failure|2|||
125422958|NCT01302847|451172937|FG002|Overall Study|Virologic failure|0|||
125422959|NCT01302847|451172938|FG003|Overall Study|Virologic failure|2|||
125422960|NCT01302847|451172939|FG004|Overall Study|Virologic failure|1|||
125422961|NCT01302847|451172940|FG005|Overall Study|Virologic failure|3|||
125422962|NCT01302847|451172941|FG006|Overall Study|Virologic failure|1|||
125422963|NCT01302847|451172942|FG007|Overall Study|Virologic failure|2|||
125422964|NCT01302847|451172935|FG000|Overall Study|Severe debilitation, unable to continue|0|||
125422965|NCT01302847|451172936|FG001|Overall Study|Severe debilitation, unable to continue|0|||
125422966|NCT01302847|451172937|FG002|Overall Study|Severe debilitation, unable to continue|0|||
125422967|NCT01302847|451172938|FG003|Overall Study|Severe debilitation, unable to continue|0|||
125422968|NCT01302847|451172939|FG004|Overall Study|Severe debilitation, unable to continue|0|||
125422969|NCT01302847|451172940|FG005|Overall Study|Severe debilitation, unable to continue|1|||
125422970|NCT01302847|451172941|FG006|Overall Study|Severe debilitation, unable to continue|1|||
125422971|NCT01302847|451172942|FG007|Overall Study|Severe debilitation, unable to continue|0|||
125422972|NCT01302847|451172935|FG000|Overall Study|Not able to get to clinic|1|||
125422973|NCT01302847|451172936|FG001|Overall Study|Not able to get to clinic|1|||
125422974|NCT01302847|451172937|FG002|Overall Study|Not able to get to clinic|0|||
125645674|NCT04563845|451986306|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
125645675|NCT04563845|451986307|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125645676|NCT04563845|451986308|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125422975|NCT01302847|451172938|FG003|Overall Study|Not able to get to clinic|0|||
125422976|NCT01302847|451172939|FG004|Overall Study|Not able to get to clinic|0|||
125422977|NCT01302847|451172940|FG005|Overall Study|Not able to get to clinic|0|||
125422978|NCT01302847|451172941|FG006|Overall Study|Not able to get to clinic|0|||
125422979|NCT01302847|451172942|FG007|Overall Study|Not able to get to clinic|0|||
125422980|NCT01302847|451172935|FG000|Overall Study|Site closing|2|||
125645677|NCT04563845|451986309|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125422981|NCT01302847|451172936|FG001|Overall Study|Site closing|2|||
125422982|NCT01302847|451172937|FG002|Overall Study|Site closing|0|||
125422983|NCT01302847|451172938|FG003|Overall Study|Site closing|0|||
125422984|NCT01302847|451172939|FG004|Overall Study|Site closing|0|||
125422985|NCT01302847|451172940|FG005|Overall Study|Site closing|0|||
125422986|NCT01302847|451172941|FG006|Overall Study|Site closing|0|||
125422987|NCT01302847|451172942|FG007|Overall Study|Site closing|0|||
125422988|NCT01302847|451172935|FG000|Overall Study|Withdrawal by Subject|1|||
125422989|NCT01302847|451172936|FG001|Overall Study|Withdrawal by Subject|0|||
125422990|NCT01302847|451172937|FG002|Overall Study|Withdrawal by Subject|0|||
125422991|NCT01302847|451172938|FG003|Overall Study|Withdrawal by Subject|0|||
125422992|NCT01302847|451172939|FG004|Overall Study|Withdrawal by Subject|1|||
125422993|NCT01302847|451172940|FG005|Overall Study|Withdrawal by Subject|0|||
125422994|NCT01302847|451172941|FG006|Overall Study|Withdrawal by Subject|0|||
125422995|NCT01302847|451172942|FG007|Overall Study|Withdrawal by Subject|1|||
125422996|NCT01302847|451172935|FG000|Overall Study|Not willing to adhere to requirements|5|||
125422997|NCT01302847|451172936|FG001|Overall Study|Not willing to adhere to requirements|0|||
125422998|NCT01302847|451172937|FG002|Overall Study|Not willing to adhere to requirements|1|||
125422999|NCT01302847|451172938|FG003|Overall Study|Not willing to adhere to requirements|0|||
125423000|NCT01302847|451172939|FG004|Overall Study|Not willing to adhere to requirements|0|||
125423001|NCT01302847|451172940|FG005|Overall Study|Not willing to adhere to requirements|0|||
125423002|NCT01302847|451172941|FG006|Overall Study|Not willing to adhere to requirements|0|||
125423003|NCT01302847|451172942|FG007|Overall Study|Not willing to adhere to requirements|2|||
125423004|NCT01302847|451172935|FG000|Overall Study|Site unable to contact participant|2|||
125423005|NCT01302847|451172936|FG001|Overall Study|Site unable to contact participant|1|||
125423006|NCT01302847|451172937|FG002|Overall Study|Site unable to contact participant|0|||
125423007|NCT01302847|451172938|FG003|Overall Study|Site unable to contact participant|0|||
125423008|NCT01302847|451172939|FG004|Overall Study|Site unable to contact participant|0|||
125423009|NCT01302847|451172940|FG005|Overall Study|Site unable to contact participant|0|||
125423010|NCT01302847|451172941|FG006|Overall Study|Site unable to contact participant|2|||
125423011|NCT01302847|451172942|FG007|Overall Study|Site unable to contact participant|0|||
125423012|NCT00374322|451172944|FG000|Overall Study|Lost to Follow-up|92|||
125423013|NCT00374322|451172945|FG001|Overall Study|Lost to Follow-up|90|||
125423014|NCT00374322|451172944|FG000|Overall Study|Protocol Violation|8|||
125423015|NCT00374322|451172945|FG001|Overall Study|Protocol Violation|3|||
125423016|NCT00374322|451172944|FG000|Overall Study|Withdrawal by Subject|235|||
125423017|NCT00374322|451172945|FG001|Overall Study|Withdrawal by Subject|167|||
125423018|NCT00374322|451172944|FG000|Overall Study|Sponsor Terminated Study|866|||
125423019|NCT00374322|451172945|FG001|Overall Study|Sponsor Terminated Study|990|||
125423020|NCT00374322|451172944|FG000|Overall Study|Physician Decision|36|||
125423021|NCT00374322|451172945|FG001|Overall Study|Physician Decision|32|||
125423022|NCT00374322|451172944|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
125423023|NCT00374322|451172945|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
125423024|NCT00374322|451172944|FG000|Overall Study|Sponsor Decision|2|||
125423025|NCT00374322|451172945|FG001|Overall Study|Sponsor Decision|3|||
125423026|NCT00374322|451172944|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
125423027|NCT00374322|451172945|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
125423028|NCT00374322|451172944|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
125423029|NCT00374322|451172945|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
125423030|NCT00374322|451172944|FG000|Overall Study|Severe Toxicity|1|||
125423031|NCT00374322|451172945|FG001|Overall Study|Severe Toxicity|0|||
125423032|NCT00374322|451172944|FG000|Overall Study|Site Closed|2|||
125423033|NCT00374322|451172945|FG001|Overall Study|Site Closed|2|||
125423034|NCT00374322|451172944|FG000|Overall Study|Participant Changed Physician|1|||
125423035|NCT00374322|451172945|FG001|Overall Study|Participant Changed Physician|0|||
125423036|NCT00374322|451172944|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
125423037|NCT00374322|451172945|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
125423038|NCT00374322|451172944|FG000|Overall Study|Noncompliance with Study Requirements|0|||
125423039|NCT00374322|451172945|FG001|Overall Study|Noncompliance with Study Requirements|1|||
125423040|NCT00374322|451172944|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
125423041|NCT00374322|451172945|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
125423042|NCT00374322|451172944|FG000|Overall Study|Did Not Receive Study Medication|8|||
125423043|NCT00374322|451172945|FG001|Overall Study|Did Not Receive Study Medication|6|||
125423044|NCT00450411|451172946|FG000|Overall Study|Protocol Violation|6|||
125423045|NCT00450411|451172946|FG000|Overall Study|No protocol treatment|2|||
125423046|NCT03969719|451172957|FG000|Overall Study|Other reasons not specified|1|||
125423047|NCT03969719|451172958|FG001|Overall Study|Other reasons not specified|1|||
125423048|NCT03969719|451172959|FG002|Overall Study|Other reasons not specified|3|||
125423049|NCT03969719|451172957|FG000|Overall Study|Withdrawal by Subject|2|||
125423050|NCT03969719|451172958|FG001|Overall Study|Withdrawal by Subject|3|||
125423051|NCT03969719|451172959|FG002|Overall Study|Withdrawal by Subject|2|||
125423052|NCT03969719|451172957|FG000|Overall Study|Protocol Violation|1|||
125423053|NCT03969719|451172958|FG001|Overall Study|Protocol Violation|2|||
125423054|NCT03969719|451172959|FG002|Overall Study|Protocol Violation|0|||
125423055|NCT03969719|451172957|FG000|Overall Study|Adverse Event|0|||
125423056|NCT03969719|451172958|FG001|Overall Study|Adverse Event|2|||
125423057|NCT03969719|451172959|FG002|Overall Study|Adverse Event|0|||
125423058|NCT03969719|451172957|FG000|Overall Study|Lost to Follow-up|0|||
125423059|NCT03969719|451172958|FG001|Overall Study|Lost to Follow-up|1|||
125423060|NCT03969719|451172959|FG002|Overall Study|Lost to Follow-up|0|||
125423061|NCT02130193|451172963|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
125423062|NCT02130193|451172964|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
125423063|NCT02130193|451172965|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
125423064|NCT02130193|451172963|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
125423065|NCT02130193|451172964|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
125423066|NCT02130193|451172965|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
125423067|NCT02130193|451172963|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
125423068|NCT02130193|451172964|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
125423069|NCT02130193|451172965|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
125423070|NCT02130193|451172963|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
125423071|NCT02130193|451172964|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
125423072|NCT02130193|451172965|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
125423073|NCT01297959|451172966|FG000|Overall Study|Adverse Event|0|||
125423074|NCT01297959|451172967|FG001|Overall Study|Adverse Event|1|||
125423075|NCT01297959|451172966|FG000|Overall Study|Protocol Violation|2|||
125423076|NCT01297959|451172967|FG001|Overall Study|Protocol Violation|1|||
125423077|NCT01297959|451172966|FG000|Overall Study|Withdrawal by Subject|5|||
125423078|NCT01297959|451172967|FG001|Overall Study|Withdrawal by Subject|4|||
125423079|NCT01297959|451172966|FG000|Overall Study|Physician Decision|0|||
125423080|NCT01297959|451172967|FG001|Overall Study|Physician Decision|1|||
125423081|NCT01297959|451172966|FG000|Overall Study|Unrelated medical illness / complication|0|||
125423082|NCT01297959|451172967|FG001|Overall Study|Unrelated medical illness / complication|2|||
125423083|NCT01297959|451172966|FG000|Overall Study|Other|13|||
125423084|NCT01297959|451172967|FG001|Overall Study|Other|7|||
125423085|NCT00707031|451172972|FG000|Overall Study|Adverse Event|45|||
125423086|NCT00707031|451172973|FG001|Overall Study|Adverse Event|45|||
125423087|NCT00707031|451172972|FG000|Overall Study|Lack of Efficacy|19|||
125423088|NCT00707031|451172973|FG001|Overall Study|Lack of Efficacy|6|||
125423089|NCT00707031|451172972|FG000|Overall Study|Lost to Follow-up|2|||
125423090|NCT00707031|451172973|FG001|Overall Study|Lost to Follow-up|1|||
125423091|NCT00707031|451172972|FG000|Overall Study|Protocol Violation|1|||
125423092|NCT00707031|451172973|FG001|Overall Study|Protocol Violation|0|||
125423093|NCT00707031|451172972|FG000|Overall Study|Withdrawal by Subject|7|||
125423094|NCT00707031|451172973|FG001|Overall Study|Withdrawal by Subject|8|||
125423095|NCT00707031|451172972|FG000|Overall Study|Poor Compliance to Protocol|7|||
125423096|NCT00707031|451172973|FG001|Overall Study|Poor Compliance to Protocol|13|||
125423097|NCT00707031|451172972|FG000|Overall Study|Familial or Personal Reasons|12|||
125423098|NCT00707031|451172973|FG001|Overall Study|Familial or Personal Reasons|15|||
125423099|NCT00707031|451172972|FG000|Overall Study|Serious Noncompliance|2|||
125423100|NCT00707031|451172973|FG001|Overall Study|Serious Noncompliance|3|||
125423101|NCT00707031|451172972|FG000|Overall Study|Sponsor Decision|9|||
125423102|NCT00707031|451172973|FG001|Overall Study|Sponsor Decision|8|||
125423103|NCT02747238|451172978|FG000|Overall Study|Lack of Efficacy|0|||
125423104|NCT02747238|451172979|FG001|Overall Study|Lack of Efficacy|1|||
125423105|NCT02747238|451172978|FG000|Overall Study|Data lost|3|||
125423106|NCT02747238|451172979|FG001|Overall Study|Data lost|5|||
125423107|NCT02085252|451172982|FG000|Overall Study|Withdrawal of Consent|1|||
125423108|NCT02085252|451172983|FG001|Overall Study|Withdrawal of Consent|0|||
125423109|NCT02085252|451172982|FG000|Overall Study|Adverse Event|0|||
125423110|NCT02085252|451172983|FG001|Overall Study|Adverse Event|1|||
125423111|NCT02085252|451172982|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
125423112|NCT02085252|451172983|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
125423113|NCT02085252|451172982|FG000|Overall Study|Reason Not Specified|0|||
125423114|NCT02085252|451172983|FG001|Overall Study|Reason Not Specified|1|||
125423115|NCT02085252|451172982|FG000|Overall Study|Reason Unknown|0|||
125423116|NCT02085252|451172983|FG001|Overall Study|Reason Unknown|1|||
125423117|NCT00951275|451172985|FG000|Overall Study|Administrative Reason|1|||
125423118|NCT00951275|451172985|FG000|Overall Study|Adverse Event|7|||
125423119|NCT00951275|451172985|FG000|Overall Study|Withdrawal by Subject|4|||
125423120|NCT00951275|451172985|FG000|Overall Study|Protocol Violation|1|||
125423121|NCT01475136|451172986|FG000|Overall Study|Sponsor Decision|0|||
125423122|NCT01475136|451172987|FG001|Overall Study|Sponsor Decision|1|||
125423123|NCT01475136|451172988|FG002|Overall Study|Sponsor Decision|0|||
125423124|NCT01475136|451172989|FG003|Overall Study|Sponsor Decision|0|||
125423125|NCT01475136|451172986|FG000|Overall Study|Entry Criteria Not Met|0|||
125423126|NCT01475136|451172987|FG001|Overall Study|Entry Criteria Not Met|2|||
125423127|NCT01475136|451172988|FG002|Overall Study|Entry Criteria Not Met|3|||
125423128|NCT01475136|451172989|FG003|Overall Study|Entry Criteria Not Met|1|||
125423129|NCT01475136|451172986|FG000|Overall Study|Withdrawal by Subject|0|||
125423130|NCT01475136|451172987|FG001|Overall Study|Withdrawal by Subject|0|||
125423131|NCT01475136|451172988|FG002|Overall Study|Withdrawal by Subject|0|||
125423132|NCT01475136|451172989|FG003|Overall Study|Withdrawal by Subject|2|||
125423133|NCT01475136|451172986|FG000|Overall Study|Adverse Event|1|||
125423134|NCT01475136|451172987|FG001|Overall Study|Adverse Event|0|||
125423135|NCT01475136|451172988|FG002|Overall Study|Adverse Event|0|||
125423136|NCT01475136|451172989|FG003|Overall Study|Adverse Event|1|||
125423137|NCT01475136|451172986|FG000|Overall Study|Death|0|||
125423138|NCT01475136|451172987|FG001|Overall Study|Death|0|||
125423139|NCT01475136|451172988|FG002|Overall Study|Death|0|||
125423140|NCT01475136|451172989|FG003|Overall Study|Death|1|||
125423141|NCT03355326|451172992|FG000|Overall Study|Protocol Violation|3|||
125423142|NCT03355326|451172993|FG001|Overall Study|Protocol Violation|3|||
125423143|NCT00003508|451175029|FG000|Overall Study|Not evaluable|5|||
125423144|NCT01377480|451175030|FG000|Overall Study|Protocol Violation|0|||
125423145|NCT01377480|451175031|FG001|Overall Study|Protocol Violation|0|||
125423146|NCT01377480|451175032|FG002|Overall Study|Protocol Violation|0|||
125423147|NCT01377480|451175033|FG003|Overall Study|Protocol Violation|4|||
125423148|NCT01377480|451175030|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
125423149|NCT01377480|451175031|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
125423150|NCT01377480|451175032|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
125423151|NCT01377480|451175033|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
125423152|NCT01377480|451175030|FG000|Overall Study|Withdrawal by Subject|0|||
125423153|NCT01377480|451175031|FG001|Overall Study|Withdrawal by Subject|0|||
125423154|NCT01377480|451175032|FG002|Overall Study|Withdrawal by Subject|1|||
125423155|NCT01377480|451175033|FG003|Overall Study|Withdrawal by Subject|0|||
125423156|NCT01377480|451175030|FG000|Overall Study|Serious adverse event|0|||
125423157|NCT01377480|451175031|FG001|Overall Study|Serious adverse event|0|||
125423158|NCT01377480|451175032|FG002|Overall Study|Serious adverse event|1|||
125423159|NCT01377480|451175033|FG003|Overall Study|Serious adverse event|1|||
125423160|NCT01377480|451175030|FG000|Overall Study|Other|0|||
125423161|NCT01377480|451175031|FG001|Overall Study|Other|0|||
125423162|NCT01377480|451175032|FG002|Overall Study|Other|7|||
125423163|NCT01377480|451175033|FG003|Overall Study|Other|6|||
125423164|NCT03576768|451175035|FG000|Overall Study|Lost to Follow-up|3|||
125423165|NCT03576768|451175036|FG001|Overall Study|Lost to Follow-up|3|||
125423166|NCT03576768|451175037|FG002|Overall Study|Lost to Follow-up|0|||
125423167|NCT03576768|451175038|FG003|Overall Study|Lost to Follow-up|0|||
125423168|NCT01986881|451175041|FG000|Overall Study|Death|228|||
125423169|NCT01986881|451175042|FG001|Overall Study|Death|233|||
125423170|NCT01986881|451175043|FG002|Overall Study|Death|247|||
125423171|NCT01986881|451175041|FG000|Overall Study|Lost to Follow-up|51|||
125423172|NCT01986881|451175042|FG001|Overall Study|Lost to Follow-up|44|||
125423173|NCT01986881|451175043|FG002|Overall Study|Lost to Follow-up|55|||
125423174|NCT01986881|451175041|FG000|Overall Study|Physician Decision|7|||
125423175|NCT01986881|451175042|FG001|Overall Study|Physician Decision|4|||
125423176|NCT01986881|451175043|FG002|Overall Study|Physician Decision|6|||
125423177|NCT01986881|451175041|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
125423178|NCT01986881|451175042|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
125423179|NCT01986881|451175043|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
125423180|NCT01986881|451175041|FG000|Overall Study|Withdrawal by Subject|41|||
125423181|NCT01986881|451175042|FG001|Overall Study|Withdrawal by Subject|60|||
125423182|NCT01986881|451175043|FG002|Overall Study|Withdrawal by Subject|45|||
125423183|NCT01986881|451175041|FG000|Overall Study|Subject Moved|0|||
125423184|NCT01986881|451175042|FG001|Overall Study|Subject Moved|1|||
125423185|NCT01986881|451175043|FG002|Overall Study|Subject Moved|0|||
125423186|NCT01986881|451175041|FG000|Overall Study|Other|1|||
125423187|NCT01986881|451175042|FG001|Overall Study|Other|2|||
125423188|NCT01986881|451175043|FG002|Overall Study|Other|2|||
125423189|NCT04179175|451175048|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
125423190|NCT04179175|451175049|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
125423191|NCT04179175|451175050|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
125423192|NCT04179175|451175051|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
125423193|NCT04179175|451175052|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
125423194|NCT04179175|451175053|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
125423195|NCT04179175|451175048|FG000|Overall Study|Adverse Event|5|||
125423196|NCT04179175|451175049|FG001|Overall Study|Adverse Event|3|||
125423197|NCT04179175|451175050|FG002|Overall Study|Adverse Event|3|||
125423198|NCT04179175|451175051|FG003|Overall Study|Adverse Event|4|||
125423199|NCT04179175|451175052|FG004|Overall Study|Adverse Event|6|||
125423200|NCT04179175|451175053|FG005|Overall Study|Adverse Event|6|||
125423201|NCT04179175|451175048|FG000|Overall Study|Lack of Efficacy|5|||
125423202|NCT04179175|451175049|FG001|Overall Study|Lack of Efficacy|1|||
125423203|NCT04179175|451175050|FG002|Overall Study|Lack of Efficacy|3|||
125423204|NCT04179175|451175051|FG003|Overall Study|Lack of Efficacy|2|||
125423205|NCT04179175|451175052|FG004|Overall Study|Lack of Efficacy|18|||
125423206|NCT04179175|451175053|FG005|Overall Study|Lack of Efficacy|7|||
125423207|NCT04179175|451175048|FG000|Overall Study|Lost to Follow-up|5|||
125423208|NCT04179175|451175049|FG001|Overall Study|Lost to Follow-up|3|||
125423209|NCT04179175|451175050|FG002|Overall Study|Lost to Follow-up|2|||
125423210|NCT04179175|451175051|FG003|Overall Study|Lost to Follow-up|2|||
125423211|NCT04179175|451175052|FG004|Overall Study|Lost to Follow-up|4|||
125423212|NCT04179175|451175053|FG005|Overall Study|Lost to Follow-up|5|||
125423213|NCT04179175|451175048|FG000|Overall Study|Physician Decision|2|||
125423214|NCT04179175|451175049|FG001|Overall Study|Physician Decision|0|||
125423215|NCT04179175|451175050|FG002|Overall Study|Physician Decision|2|||
125423216|NCT04179175|451175051|FG003|Overall Study|Physician Decision|3|||
125423217|NCT04179175|451175052|FG004|Overall Study|Physician Decision|1|||
125423218|NCT04179175|451175053|FG005|Overall Study|Physician Decision|1|||
125423219|NCT04179175|451175048|FG000|Overall Study|Pregnancy|3|||
125423220|NCT04179175|451175049|FG001|Overall Study|Pregnancy|0|||
125423221|NCT04179175|451175050|FG002|Overall Study|Pregnancy|3|||
125423222|NCT04179175|451175051|FG003|Overall Study|Pregnancy|0|||
125423223|NCT04179175|451175052|FG004|Overall Study|Pregnancy|1|||
125423224|NCT04179175|451175053|FG005|Overall Study|Pregnancy|2|||
125423225|NCT04179175|451175048|FG000|Overall Study|Withdrawal by Subject|22|||
125423226|NCT04179175|451175049|FG001|Overall Study|Withdrawal by Subject|10|||
125423227|NCT04179175|451175050|FG002|Overall Study|Withdrawal by Subject|12|||
125423228|NCT04179175|451175051|FG003|Overall Study|Withdrawal by Subject|8|||
125423229|NCT04179175|451175052|FG004|Overall Study|Withdrawal by Subject|23|||
125423230|NCT04179175|451175053|FG005|Overall Study|Withdrawal by Subject|31|||
125423231|NCT04179175|451175048|FG000|Overall Study|Technical problems|0|||
125645678|NCT04563845|451986310|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125645679|NCT04563845|451986311|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125645680|NCT04563845|451986312|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125645681|NCT04563845|451986313|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125645682|NCT04563845|451986314|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125645683|NCT04563845|451986315|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
125645684|NCT02146274|451986316|FG000|Overall Study|Protocol Violation|73|||
125645685|NCT01539720|451986317|FG000|Overall Study|Screen Fail|15|||
125645686|NCT01539720|451986318|FG001|Overall Study|Screen Fail|3|||
125645687|NCT01539720|451986317|FG000|Overall Study|Lost to Follow-up|14|||
125645688|NCT01539720|451986318|FG001|Overall Study|Lost to Follow-up|7|||
125645689|NCT03938857|451986322|FG000|Overall Study|Physician Decision|1|||
125645690|NCT03938857|451986323|FG001|Overall Study|Physician Decision|0|||
125645691|NCT03938857|451986324|FG002|Overall Study|Physician Decision|0|||
125645692|NCT03938857|451986325|FG003|Overall Study|Physician Decision|0|||
125645693|NCT02516605|451986326|FG000|Overall Study|Protocol Violation|0|||
125645694|NCT02516605|451986327|FG001|Overall Study|Protocol Violation|0|||
125645695|NCT02516605|451986328|FG002|Overall Study|Protocol Violation|0|||
125645696|NCT02516605|451986329|FG003|Overall Study|Protocol Violation|0|||
125645697|NCT02516605|451986330|FG004|Overall Study|Protocol Violation|1|||
125645698|NCT02516605|451986326|FG000|Overall Study|Withdrawal by Subject|0|||
125645699|NCT02516605|451986327|FG001|Overall Study|Withdrawal by Subject|0|||
125645700|NCT02516605|451986328|FG002|Overall Study|Withdrawal by Subject|0|||
125645701|NCT02516605|451986329|FG003|Overall Study|Withdrawal by Subject|1|||
125645702|NCT02516605|451986330|FG004|Overall Study|Withdrawal by Subject|0|||
125645703|NCT02577107|451986331|FG000|Overall Study|Protocol deviation|0|||
125645704|NCT02577107|451986332|FG001|Overall Study|Protocol deviation|1|||
125645705|NCT00577382|451986333|FG000|Overall Study|Adverse Event|0|||
125645706|NCT00577382|451986334|FG001|Overall Study|Adverse Event|6|||
125645707|NCT00577382|451986333|FG000|Overall Study|Withdrawal by Subject|0|||
125645708|NCT00577382|451986334|FG001|Overall Study|Withdrawal by Subject|1|||
125645709|NCT00577382|451986333|FG000|Overall Study|Progressive Disease|17|||
125645710|NCT00577382|451986334|FG001|Overall Study|Progressive Disease|19|||
125645711|NCT00577382|451986333|FG000|Overall Study|Intercurrent Illness|1|||
125645712|NCT00577382|451986334|FG001|Overall Study|Intercurrent Illness|2|||
125645713|NCT00577382|451986333|FG000|Overall Study|Death|1|||
125645714|NCT00577382|451986334|FG001|Overall Study|Death|1|||
125645715|NCT00577382|451986333|FG000|Overall Study|Lost to Follow-up|2|||
125645716|NCT00577382|451986334|FG001|Overall Study|Lost to Follow-up|2|||
125645717|NCT02839330|451986335|FG000|Overall Study|Adverse Event|0|||
125645718|NCT02839330|451986336|FG001|Overall Study|Adverse Event|1|||
125645719|NCT02839330|451986337|FG002|Overall Study|Adverse Event|2|||
125645720|NCT02839330|451986338|FG003|Overall Study|Adverse Event|2|||
125423232|NCT04179175|451175049|FG001|Overall Study|Technical problems|0|||
125423233|NCT04179175|451175050|FG002|Overall Study|Technical problems|1|||
125423234|NCT04179175|451175051|FG003|Overall Study|Technical problems|1|||
125645721|NCT02839330|451986335|FG000|Overall Study|Death|4|||
125645722|NCT02839330|451986336|FG001|Overall Study|Death|6|||
125645723|NCT02839330|451986337|FG002|Overall Study|Death|1|||
125645724|NCT02839330|451986338|FG003|Overall Study|Death|1|||
125645725|NCT02839330|451986335|FG000|Overall Study|Withdrawal by Subject|27|||
125645726|NCT02839330|451986336|FG001|Overall Study|Withdrawal by Subject|19|||
125645727|NCT02839330|451986337|FG002|Overall Study|Withdrawal by Subject|11|||
125645728|NCT02839330|451986338|FG003|Overall Study|Withdrawal by Subject|13|||
125645729|NCT02839330|451986335|FG000|Overall Study|Lost to Follow-up|22|||
125423235|NCT04179175|451175052|FG004|Overall Study|Technical problems|0|||
125423236|NCT04179175|451175053|FG005|Overall Study|Technical problems|0|||
125645730|NCT02839330|451986336|FG001|Overall Study|Lost to Follow-up|27|||
125423237|NCT02030015|451175059|FG000|Overall Study|Withdrawal by Subject|3|||
125423238|NCT02030015|451175059|FG000|Overall Study|Death|13|||
125423239|NCT03014674|451175061|FG000|Overall Study|Withdrawal by Subject|1|||
125423240|NCT03014674|451175062|FG001|Overall Study|Withdrawal by Subject|0|||
125423241|NCT03014674|451175063|FG002|Overall Study|Withdrawal by Subject|0|||
125423242|NCT03224182|451175076|FG000|Overall Study|Study Drug Not Instilled|6|||
125423243|NCT03224182|451175077|FG001|Overall Study|Study Drug Not Instilled|1|||
125423244|NCT03224182|451175076|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
125423245|NCT03224182|451175077|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
125423246|NCT03224182|451175076|FG000|Overall Study|Withdrew of Consent|4|||
125423247|NCT03224182|451175077|FG001|Overall Study|Withdrew of Consent|2|||
125423248|NCT03224182|451175076|FG000|Overall Study|Investigator Decision|3|||
125423249|NCT03224182|451175077|FG001|Overall Study|Investigator Decision|1|||
125423250|NCT03224182|451175076|FG000|Overall Study|Sponsor Decision|26|||
125423251|NCT03224182|451175077|FG001|Overall Study|Sponsor Decision|12|||
125423252|NCT03224182|451175076|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
125423253|NCT03224182|451175077|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
125423254|NCT03224182|451175076|FG000|Overall Study|Lost to Follow-up|1|||
125423255|NCT03224182|451175077|FG001|Overall Study|Lost to Follow-up|0|||
125423256|NCT03224182|451175076|FG000|Overall Study|Participant Had Recurrence|11|||
125423257|NCT03224182|451175077|FG001|Overall Study|Participant Had Recurrence|5|||
125423258|NCT03224182|451175076|FG000|Overall Study|Death|0|||
125423259|NCT03224182|451175077|FG001|Overall Study|Death|1|||
125423260|NCT03224182|451175076|FG000|Overall Study|Reason not Specified|3|||
125423261|NCT03224182|451175077|FG001|Overall Study|Reason not Specified|3|||
125423262|NCT03224182|451175076|FG000|Overall Study|Other|1|||
125423263|NCT03224182|451175077|FG001|Overall Study|Other|0|||
125423264|NCT02822222|451175078|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
125423265|NCT02822222|451175079|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
125423266|NCT04279314|451175080|FG000|Overall Study|Adverse Event|55|||
125423267|NCT04279314|451175080|FG000|Overall Study|Withdrawal by Subject|5|||
125423268|NCT04279314|451175080|FG000|Overall Study|Lack of Efficacy|5|||
125423269|NCT04279314|451175080|FG000|Overall Study|Protocol Violation|3|||
125423270|NCT04279314|451175080|FG000|Overall Study|Other (not COVID-19 related)|2|||
125423271|NCT02481310|451175081|FG000|Follow up|Still in follow up|0|||
125423272|NCT02481310|451175082|FG001|Follow up|Still in follow up|3|||
125423273|NCT02481310|451175083|FG002|Follow up|Still in follow up|0|||
125423274|NCT00160680|451175084|FG000|Overall Study|Adverse Event|0|||
125423275|NCT00160680|451175085|FG001|Overall Study|Adverse Event|1|||
125423276|NCT00160680|451175084|FG000|Overall Study|Lack of Efficacy|2|||
125423277|NCT00160680|451175085|FG001|Overall Study|Lack of Efficacy|1|||
125423278|NCT00160680|451175084|FG000|Overall Study|Lost to Follow-up|3|||
125423279|NCT00160680|451175085|FG001|Overall Study|Lost to Follow-up|2|||
125423280|NCT00160680|451175084|FG000|Overall Study|Withdrawal by Subject|4|||
125423281|NCT00160680|451175085|FG001|Overall Study|Withdrawal by Subject|9|||
125423282|NCT00985725|451175089|FG000|Overall Study|Adverse Event|4|||
125423283|NCT00985725|451175090|FG001|Overall Study|Adverse Event|1|||
125423284|NCT00985725|451175089|FG000|Overall Study|Protocol Violation|1|||
125423285|NCT00985725|451175090|FG001|Overall Study|Protocol Violation|3|||
125423286|NCT00985725|451175089|FG000|Overall Study|Withdrawal by Subject|4|||
125423287|NCT00985725|451175090|FG001|Overall Study|Withdrawal by Subject|4|||
125423288|NCT00985725|451175089|FG000|Overall Study|Lost to Follow-up|1|||
125423289|NCT00985725|451175090|FG001|Overall Study|Lost to Follow-up|1|||
125423290|NCT00985725|451175089|FG000|Overall Study|Lack of Efficacy|0|||
125423291|NCT00985725|451175090|FG001|Overall Study|Lack of Efficacy|1|||
125423292|NCT00985725|451175089|FG000|Overall Study|Non-compliance|1|||
125423293|NCT00985725|451175090|FG001|Overall Study|Non-compliance|2|||
125423294|NCT00985725|451175089|FG000|Overall Study|Out-of-window visits|0|||
125423295|NCT00985725|451175090|FG001|Overall Study|Out-of-window visits|1|||
125423296|NCT01410474|451175094|FG000|Overall Study|Withdrawal by Subject|0|||
125423297|NCT01410474|451175095|FG001|Overall Study|Withdrawal by Subject|1|||
125423298|NCT02428296|451175096|FG000|Overall Study|Adverse Event|7|||
125423299|NCT02428296|451175096|FG000|Overall Study|Withdrawal by Subject|2|||
125423300|NCT02723864|451175097|FG000|Overall Study|Refused further treatment|1|||
125423301|NCT02723864|451175098|FG001|Overall Study|Refused further treatment|0|||
125423302|NCT02723864|451175099|FG002|Overall Study|Refused further treatment|0|||
125423303|NCT02723864|451175100|FG003|Overall Study|Refused further treatment|0|||
125423304|NCT02723864|451175101|FG004|Overall Study|Refused further treatment|1|||
125423305|NCT02723864|451175102|FG005|Overall Study|Refused further treatment|2|||
125423306|NCT02723864|451175103|FG006|Overall Study|Refused further treatment|0|||
125423307|NCT02723864|451175097|FG000|Overall Study|Exceed treatment hold time|0|||
125423308|NCT02723864|451175098|FG001|Overall Study|Exceed treatment hold time|1|||
125423309|NCT02723864|451175099|FG002|Overall Study|Exceed treatment hold time|0|||
125423310|NCT02723864|451175100|FG003|Overall Study|Exceed treatment hold time|0|||
125423311|NCT02723864|451175101|FG004|Overall Study|Exceed treatment hold time|0|||
125423312|NCT02723864|451175102|FG005|Overall Study|Exceed treatment hold time|0|||
125423313|NCT02723864|451175103|FG006|Overall Study|Exceed treatment hold time|0|||
125423314|NCT02723864|451175097|FG000|Overall Study|Clinical progression|0|||
125423315|NCT02723864|451175098|FG001|Overall Study|Clinical progression|0|||
125423316|NCT02723864|451175099|FG002|Overall Study|Clinical progression|1|||
125423317|NCT02723864|451175100|FG003|Overall Study|Clinical progression|0|||
125423318|NCT02723864|451175101|FG004|Overall Study|Clinical progression|0|||
125423319|NCT02723864|451175102|FG005|Overall Study|Clinical progression|3|||
125423320|NCT02723864|451175103|FG006|Overall Study|Clinical progression|1|||
125423321|NCT02723864|451175097|FG000|Overall Study|Physician Decision|0|||
125423322|NCT02723864|451175098|FG001|Overall Study|Physician Decision|0|||
125423323|NCT02723864|451175099|FG002|Overall Study|Physician Decision|0|||
125423324|NCT02723864|451175100|FG003|Overall Study|Physician Decision|0|||
125423325|NCT02723864|451175101|FG004|Overall Study|Physician Decision|0|||
125423326|NCT02723864|451175102|FG005|Overall Study|Physician Decision|0|||
125423327|NCT02723864|451175103|FG006|Overall Study|Physician Decision|1|||
125423328|NCT02723864|451175097|FG000|Overall Study|Changes in patient condition|0|||
125423329|NCT02723864|451175098|FG001|Overall Study|Changes in patient condition|0|||
125423330|NCT02723864|451175099|FG002|Overall Study|Changes in patient condition|0|||
125423331|NCT02723864|451175100|FG003|Overall Study|Changes in patient condition|0|||
125423332|NCT02723864|451175101|FG004|Overall Study|Changes in patient condition|0|||
125423333|NCT02723864|451175102|FG005|Overall Study|Changes in patient condition|1|||
125423334|NCT02723864|451175103|FG006|Overall Study|Changes in patient condition|0|||
125423335|NCT02723864|451175097|FG000|Overall Study|Patient choice|0|||
125423336|NCT02723864|451175098|FG001|Overall Study|Patient choice|0|||
125423337|NCT02723864|451175099|FG002|Overall Study|Patient choice|0|||
125423338|NCT02723864|451175100|FG003|Overall Study|Patient choice|0|||
125423339|NCT02723864|451175101|FG004|Overall Study|Patient choice|0|||
125423340|NCT02723864|451175102|FG005|Overall Study|Patient choice|1|||
125423341|NCT02723864|451175103|FG006|Overall Study|Patient choice|0|||
125423342|NCT02723864|451175097|FG000|Overall Study|Adverse Event|0|||
125423343|NCT02723864|451175098|FG001|Overall Study|Adverse Event|0|||
125423344|NCT02723864|451175099|FG002|Overall Study|Adverse Event|0|||
125423345|NCT02723864|451175100|FG003|Overall Study|Adverse Event|0|||
125423346|NCT02723864|451175101|FG004|Overall Study|Adverse Event|0|||
125423347|NCT02723864|451175102|FG005|Overall Study|Adverse Event|1|||
125423348|NCT02723864|451175103|FG006|Overall Study|Adverse Event|0|||
125423349|NCT02723864|451175097|FG000|Overall Study|Started new treatment|0|||
125423350|NCT02723864|451175098|FG001|Overall Study|Started new treatment|0|||
125423351|NCT02723864|451175099|FG002|Overall Study|Started new treatment|0|||
125423352|NCT02723864|451175100|FG003|Overall Study|Started new treatment|0|||
125423353|NCT02723864|451175101|FG004|Overall Study|Started new treatment|0|||
125423354|NCT02723864|451175102|FG005|Overall Study|Started new treatment|1|||
125423355|NCT02723864|451175103|FG006|Overall Study|Started new treatment|0|||
125423356|NCT02723864|451175097|FG000|Overall Study|Switched to alternative treatment|0|||
125423357|NCT02723864|451175098|FG001|Overall Study|Switched to alternative treatment|0|||
125423358|NCT02723864|451175099|FG002|Overall Study|Switched to alternative treatment|0|||
125423359|NCT02723864|451175100|FG003|Overall Study|Switched to alternative treatment|0|||
125423360|NCT02723864|451175101|FG004|Overall Study|Switched to alternative treatment|0|||
125423361|NCT02723864|451175102|FG005|Overall Study|Switched to alternative treatment|1|||
125423362|NCT02723864|451175103|FG006|Overall Study|Switched to alternative treatment|0|||
125423363|NCT02723864|451175097|FG000|Overall Study|Late determination of ineligibility|0|||
125423364|NCT02723864|451175098|FG001|Overall Study|Late determination of ineligibility|0|||
125423365|NCT02723864|451175099|FG002|Overall Study|Late determination of ineligibility|0|||
125423366|NCT02723864|451175100|FG003|Overall Study|Late determination of ineligibility|0|||
125423367|NCT02723864|451175101|FG004|Overall Study|Late determination of ineligibility|0|||
125423368|NCT02723864|451175102|FG005|Overall Study|Late determination of ineligibility|1|||
125423369|NCT02723864|451175103|FG006|Overall Study|Late determination of ineligibility|0|||
125423370|NCT00828984|451175104|FG000|Overall Study|Adverse Event|2|||
125423371|NCT00828984|451175105|FG001|Overall Study|Adverse Event|3|||
125423372|NCT00828984|451175106|FG002|Overall Study|Adverse Event|0|||
125423373|NCT00828984|451175104|FG000|Overall Study|Lost to Follow-up|5|||
125423374|NCT00828984|451175105|FG001|Overall Study|Lost to Follow-up|3|||
125423375|NCT00828984|451175106|FG002|Overall Study|Lost to Follow-up|1|||
125423376|NCT00828984|451175104|FG000|Overall Study|Withdrawal by Subject|4|||
125423377|NCT00828984|451175105|FG001|Overall Study|Withdrawal by Subject|4|||
125423378|NCT00828984|451175106|FG002|Overall Study|Withdrawal by Subject|4|||
125423379|NCT00828984|451175104|FG000|Overall Study|Ineligable|1|||
125423380|NCT00828984|451175105|FG001|Overall Study|Ineligable|2|||
125423381|NCT00828984|451175106|FG002|Overall Study|Ineligable|0|||
125423382|NCT00828984|451175104|FG000|Overall Study|Medical Contraindication|0|||
125423383|NCT00828984|451175105|FG001|Overall Study|Medical Contraindication|1|||
125423384|NCT00828984|451175106|FG002|Overall Study|Medical Contraindication|0|||
125645731|NCT02839330|451986337|FG002|Overall Study|Lost to Follow-up|29|||
125423385|NCT00828984|451175104|FG000|Overall Study|Noncompliant|1|||
125423386|NCT00828984|451175105|FG001|Overall Study|Noncompliant|2|||
125423387|NCT00828984|451175106|FG002|Overall Study|Noncompliant|3|||
125423388|NCT00828984|451175104|FG000|Overall Study|ConMed|1|||
125423389|NCT00828984|451175105|FG001|Overall Study|ConMed|1|||
125423390|NCT00828984|451175106|FG002|Overall Study|ConMed|1|||
125423391|NCT04465357|451175107|FG000|Overall Study|Adverse Event|2|||
125423392|NCT04465357|451175107|FG000|Overall Study|Lack of Efficacy|1|||
125423393|NCT04465357|451175107|FG000|Overall Study|Lost to Follow-up|2|||
125423394|NCT04465357|451175107|FG000|Overall Study|Withdrawal by Subject|6|||
125423395|NCT04465357|451175107|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
125423396|NCT02548455|451175108|FG000|Overall Study|Withdrawal by Subject|27|||
125423397|NCT02548455|451175108|FG000|Overall Study|Death|26|||
125423398|NCT02548455|451175108|FG000|Overall Study|Lost to Follow-up|14|||
125423399|NCT02548455|451175108|FG000|Overall Study|Visit not completed|173|||
125423400|NCT02261493|451175109|FG000|Overall Study|Noncompliance|0|||
125423401|NCT02261493|451175110|FG001|Overall Study|Noncompliance|0|||
125423402|NCT02261493|451175111|FG002|Overall Study|Noncompliance|2|||
125423403|NCT02261493|451175109|FG000|Overall Study|Physician Decision|0|||
125423404|NCT02261493|451175110|FG001|Overall Study|Physician Decision|1|||
125423405|NCT02261493|451175111|FG002|Overall Study|Physician Decision|0|||
125423406|NCT02261493|451175109|FG000|Overall Study|Undisclosed alcohol abuse|0|||
125423407|NCT02261493|451175110|FG001|Overall Study|Undisclosed alcohol abuse|1|||
125423408|NCT02261493|451175111|FG002|Overall Study|Undisclosed alcohol abuse|0|||
125423409|NCT02261493|451175109|FG000|Overall Study|Protocol Violation|1|||
125423410|NCT02261493|451175110|FG001|Overall Study|Protocol Violation|0|||
125423411|NCT02261493|451175111|FG002|Overall Study|Protocol Violation|0|||
125423412|NCT02261493|451175109|FG000|Overall Study|Personal Reasons|14|||
125423413|NCT02261493|451175110|FG001|Overall Study|Personal Reasons|14|||
125423414|NCT02261493|451175111|FG002|Overall Study|Personal Reasons|16|||
125423415|NCT02261493|451175109|FG000|Overall Study|Lost to Follow-up|14|||
125423416|NCT02261493|451175110|FG001|Overall Study|Lost to Follow-up|27|||
125423417|NCT02261493|451175111|FG002|Overall Study|Lost to Follow-up|8|||
125423418|NCT02261493|451175109|FG000|Overall Study|Pregnancy|1|||
125423419|NCT02261493|451175110|FG001|Overall Study|Pregnancy|2|||
125423420|NCT02261493|451175111|FG002|Overall Study|Pregnancy|0|||
125423421|NCT02261493|451175109|FG000|Overall Study|Lack of Efficacy|0|||
125423422|NCT02261493|451175110|FG001|Overall Study|Lack of Efficacy|1|||
125423423|NCT02261493|451175111|FG002|Overall Study|Lack of Efficacy|0|||
125423424|NCT02261493|451175109|FG000|Overall Study|Adverse Event|0|||
125423425|NCT02261493|451175110|FG001|Overall Study|Adverse Event|1|||
125423426|NCT02261493|451175111|FG002|Overall Study|Adverse Event|0|||
125423427|NCT03624504|451175114|FG000|Overall Study|Unsuccessful Implant|1|||
125423428|NCT02862457|451175115|FG000|Overall Study|Death|1|||
125423429|NCT02862457|451175116|FG001|Overall Study|Death|3|||
125423430|NCT02862457|451175117|FG002|Overall Study|Death|2|||
125423431|NCT02862457|451175118|FG003|Overall Study|Death|3|||
125423432|NCT02862457|451175119|FG004|Overall Study|Death|0|||
125423433|NCT02862457|451175120|FG005|Overall Study|Death|2|||
125423434|NCT02862457|451175121|FG006|Overall Study|Death|1|||
125423435|NCT02862457|451175115|FG000|Overall Study|Lost to Follow-up|1|||
125423436|NCT02862457|451175116|FG001|Overall Study|Lost to Follow-up|0|||
125423437|NCT02862457|451175117|FG002|Overall Study|Lost to Follow-up|0|||
125423438|NCT02862457|451175118|FG003|Overall Study|Lost to Follow-up|1|||
125423439|NCT02862457|451175119|FG004|Overall Study|Lost to Follow-up|0|||
125423440|NCT02862457|451175120|FG005|Overall Study|Lost to Follow-up|0|||
125423441|NCT02862457|451175121|FG006|Overall Study|Lost to Follow-up|0|||
125423442|NCT02862457|451175115|FG000|Overall Study|Withdrawal by Subject|0|||
125423443|NCT02862457|451175116|FG001|Overall Study|Withdrawal by Subject|0|||
125423444|NCT02862457|451175117|FG002|Overall Study|Withdrawal by Subject|1|||
125423445|NCT02862457|451175118|FG003|Overall Study|Withdrawal by Subject|0|||
125423446|NCT02862457|451175119|FG004|Overall Study|Withdrawal by Subject|0|||
125423447|NCT02862457|451175120|FG005|Overall Study|Withdrawal by Subject|1|||
125423448|NCT02862457|451175121|FG006|Overall Study|Withdrawal by Subject|0|||
125423449|NCT01388816|451175122|FG000|Overall Study|Adverse Event|0|||
125423450|NCT01388816|451175123|FG001|Overall Study|Adverse Event|2|||
125423451|NCT01388816|451175124|FG002|Overall Study|Adverse Event|0|||
125423452|NCT01388816|451175125|FG003|Overall Study|Adverse Event|0|||
125423453|NCT01388816|451175122|FG000|Overall Study|Lost to Follow-up|0|||
125423454|NCT01388816|451175123|FG001|Overall Study|Lost to Follow-up|1|||
125423455|NCT01388816|451175124|FG002|Overall Study|Lost to Follow-up|0|||
125423456|NCT01388816|451175125|FG003|Overall Study|Lost to Follow-up|0|||
125423457|NCT01388816|451175122|FG000|Overall Study|Withdrawal by Subject|2|||
125423458|NCT01388816|451175123|FG001|Overall Study|Withdrawal by Subject|1|||
125423459|NCT01388816|451175124|FG002|Overall Study|Withdrawal by Subject|1|||
125423460|NCT01388816|451175125|FG003|Overall Study|Withdrawal by Subject|0|||
125423461|NCT01388816|451175122|FG000|Overall Study|Protocol Violation|0|||
125423462|NCT01388816|451175123|FG001|Overall Study|Protocol Violation|0|||
125423463|NCT01388816|451175124|FG002|Overall Study|Protocol Violation|2|||
125423464|NCT01388816|451175125|FG003|Overall Study|Protocol Violation|0|||
125423465|NCT00951483|451175128|FG000|Overall Study|Physician Decision|4|||
125423466|NCT00951483|451175129|FG001|Overall Study|Physician Decision|0|||
125423467|NCT00951483|451175128|FG000|Overall Study|Withdrawal by Subject|15|||
125423468|NCT00951483|451175129|FG001|Overall Study|Withdrawal by Subject|0|||
125423469|NCT00765674|451175130|FG000|Overall Study|Adverse Event|7|||
125423470|NCT00765674|451175131|FG001|Overall Study|Adverse Event|2|||
125423471|NCT00765674|451175132|FG002|Overall Study|Adverse Event|8|||
125423472|NCT00765674|451175133|FG003|Overall Study|Adverse Event|11|||
125423473|NCT00765674|451175130|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
125423474|NCT00765674|451175131|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
125423475|NCT00765674|451175132|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
125423476|NCT00765674|451175133|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
125423477|NCT00765674|451175130|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
125423478|NCT00765674|451175131|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
125423479|NCT00765674|451175132|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
125423480|NCT00765674|451175133|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
125423481|NCT00765674|451175130|FG000|Overall Study|Lack of Efficacy|2|||
125423482|NCT00765674|451175131|FG001|Overall Study|Lack of Efficacy|3|||
125423483|NCT00765674|451175132|FG002|Overall Study|Lack of Efficacy|1|||
125423484|NCT00765674|451175133|FG003|Overall Study|Lack of Efficacy|2|||
125423485|NCT00765674|451175130|FG000|Overall Study|Protocol Violation|2|||
125423486|NCT00765674|451175131|FG001|Overall Study|Protocol Violation|0|||
125423487|NCT00765674|451175132|FG002|Overall Study|Protocol Violation|1|||
125423488|NCT00765674|451175133|FG003|Overall Study|Protocol Violation|0|||
125423489|NCT00765674|451175130|FG000|Overall Study|Withdrawal by Subject|5|||
125423490|NCT00765674|451175131|FG001|Overall Study|Withdrawal by Subject|7|||
125423491|NCT00765674|451175132|FG002|Overall Study|Withdrawal by Subject|3|||
125423492|NCT00765674|451175133|FG003|Overall Study|Withdrawal by Subject|8|||
125423493|NCT00765674|451175130|FG000|Overall Study|Lost to Follow-up|4|||
125423494|NCT00765674|451175131|FG001|Overall Study|Lost to Follow-up|6|||
125423495|NCT00765674|451175132|FG002|Overall Study|Lost to Follow-up|2|||
125423496|NCT00765674|451175133|FG003|Overall Study|Lost to Follow-up|1|||
125423497|NCT00765674|451175130|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
125423498|NCT00765674|451175131|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
125423499|NCT00765674|451175132|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
125423500|NCT00765674|451175133|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
125423501|NCT01813474|451175134|FG000|Overall Study|Withdrawal by Subject|0|||
125423502|NCT01813474|451175135|FG001|Overall Study|Withdrawal by Subject|0|||
125423503|NCT01813474|451175136|FG002|Overall Study|Withdrawal by Subject|1|||
125423504|NCT01813474|451175134|FG000|Overall Study|Adverse Event|1|||
125423505|NCT01813474|451175135|FG001|Overall Study|Adverse Event|1|||
125423506|NCT01813474|451175136|FG002|Overall Study|Adverse Event|0|||
125423507|NCT01813474|451175134|FG000|Overall Study|Lack of Efficacy|2|||
125423508|NCT01813474|451175135|FG001|Overall Study|Lack of Efficacy|6|||
125423509|NCT01813474|451175136|FG002|Overall Study|Lack of Efficacy|9|||
125423510|NCT01813474|451175134|FG000|Overall Study|Death|0|||
125423511|NCT01813474|451175135|FG001|Overall Study|Death|0|||
125423512|NCT01813474|451175136|FG002|Overall Study|Death|1|||
125423513|NCT03015402|451175137|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
125423514|NCT03015402|451175138|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
125423515|NCT03015402|451175137|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
125423516|NCT03015402|451175138|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
125423517|NCT01995461|451175145|FG000|Overall Study|Death|1|||
125423518|NCT01995461|451175145|FG000|Overall Study|Lost to Follow-up|2|||
125423519|NCT01995461|451175145|FG000|Overall Study|Withdrawal by Subject|2|||
125423520|NCT00540124|451175148|FG000|Overall Study|Adverse Event|0|||
125423521|NCT00540124|451175149|FG001|Overall Study|Adverse Event|2|||
125423522|NCT00540124|451175150|FG002|Overall Study|Adverse Event|1|||
125423523|NCT00540124|451175148|FG000|Overall Study|Entry Criteria Not Met|2|||
125423524|NCT00540124|451175149|FG001|Overall Study|Entry Criteria Not Met|0|||
125423525|NCT00540124|451175150|FG002|Overall Study|Entry Criteria Not Met|0|||
125423526|NCT00540124|451175148|FG000|Overall Study|Lack of Efficacy|1|||
125423527|NCT00540124|451175149|FG001|Overall Study|Lack of Efficacy|0|||
125423528|NCT00540124|451175150|FG002|Overall Study|Lack of Efficacy|0|||
125423529|NCT00540124|451175148|FG000|Overall Study|Withdrawal by Subject|1|||
125423530|NCT00540124|451175149|FG001|Overall Study|Withdrawal by Subject|1|||
125423531|NCT00540124|451175150|FG002|Overall Study|Withdrawal by Subject|0|||
125423532|NCT01212770|451175152|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
125423533|NCT01212770|451175153|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
125423534|NCT01212770|451175154|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
125423535|NCT01212770|451175155|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125423536|NCT01212770|451175156|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125423537|NCT01212770|451175157|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125423538|NCT01212770|451175158|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125423539|NCT01212770|451175159|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125423540|NCT01212770|451175160|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125423541|NCT01212770|451175152|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
125423542|NCT01212770|451175153|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
125423543|NCT01212770|451175154|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
125423544|NCT01212770|451175155|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125423545|NCT01212770|451175156|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125423546|NCT01212770|451175157|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125423547|NCT01212770|451175158|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125423548|NCT01212770|451175159|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125423549|NCT01212770|451175160|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125423550|NCT01212770|451175152|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
125423551|NCT01212770|451175153|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
125423552|NCT01212770|451175154|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
125423553|NCT01212770|451175155|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125423554|NCT01212770|451175156|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125423555|NCT01212770|451175157|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125423556|NCT01212770|451175158|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125423557|NCT01212770|451175159|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125423558|NCT01212770|451175160|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125423559|NCT01212770|451175152|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
125423560|NCT01212770|451175153|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125423561|NCT01212770|451175154|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
125423562|NCT01212770|451175155|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125423563|NCT01212770|451175156|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125423564|NCT01212770|451175157|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125423565|NCT01212770|451175158|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125423566|NCT01212770|451175159|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125423567|NCT01212770|451175160|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125423568|NCT01212770|451175152|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125423569|NCT01212770|451175153|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125423570|NCT01212770|451175154|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
125423571|NCT01212770|451175155|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125423572|NCT01212770|451175156|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125423573|NCT01212770|451175157|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125423574|NCT01212770|451175158|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125423575|NCT01212770|451175159|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125423576|NCT01212770|451175160|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125423577|NCT01212770|451175152|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
125423578|NCT01212770|451175153|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
125423579|NCT01212770|451175154|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
125423580|NCT01212770|451175155|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
125423581|NCT01212770|451175156|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
125423582|NCT01212770|451175157|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
125423583|NCT01212770|451175158|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
125423584|NCT01212770|451175159|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
125423585|NCT01212770|451175160|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
125423586|NCT01212770|451175152|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
125423587|NCT01212770|451175153|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
125423588|NCT01212770|451175154|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
125423589|NCT01212770|451175155|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
125423590|NCT01212770|451175156|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
125423591|NCT01212770|451175157|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
125423592|NCT01212770|451175158|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
125423593|NCT01212770|451175159|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
125423594|NCT01212770|451175160|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
125423595|NCT01212770|451175152|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
125423596|NCT01212770|451175153|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
125423597|NCT01212770|451175154|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
125423598|NCT01212770|451175155|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
125423599|NCT01212770|451175156|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
125423600|NCT01212770|451175157|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
125423601|NCT01212770|451175158|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
125423602|NCT01212770|451175159|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
125423603|NCT01212770|451175160|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
125423604|NCT01212770|451175152|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
125423605|NCT01212770|451175153|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
125423606|NCT01212770|451175154|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
125423607|NCT01212770|451175155|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
125423608|NCT01212770|451175156|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
125645732|NCT02839330|451986338|FG003|Overall Study|Lost to Follow-up|25|||
125423609|NCT01212770|451175157|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
125423610|NCT01212770|451175158|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
125423611|NCT01212770|451175159|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
125423612|NCT01212770|451175160|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
125423613|NCT01212770|451175152|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125423614|NCT01212770|451175153|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125423615|NCT01212770|451175154|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
125423616|NCT01212770|451175155|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125423617|NCT01212770|451175156|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125423618|NCT01212770|451175157|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125423619|NCT01212770|451175158|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125423620|NCT01212770|451175159|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125423621|NCT01212770|451175160|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
125423622|NCT01212770|451175152|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125423623|NCT01212770|451175153|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125423624|NCT01212770|451175154|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125423625|NCT01212770|451175155|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
125423626|NCT01212770|451175156|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125423627|NCT01212770|451175157|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125423628|NCT01212770|451175158|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125423629|NCT01212770|451175159|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125423630|NCT01212770|451175160|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
125423631|NCT01212770|451175152|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125423632|NCT01212770|451175153|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125423633|NCT01212770|451175154|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
125423634|NCT01212770|451175155|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
125423635|NCT01212770|451175156|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125423636|NCT01212770|451175157|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125423637|NCT01212770|451175158|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125423638|NCT01212770|451175159|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125423639|NCT01212770|451175160|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
125423640|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125423641|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
125423642|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
125423643|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125423644|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125423645|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125423646|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125423647|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125423648|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
125423649|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125423650|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
125423651|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
125423652|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125423653|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125423654|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125423655|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125423656|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
125423657|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
125423658|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125423659|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
125423660|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125423661|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125423662|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125423663|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125423664|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125423665|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125423666|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
125423667|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125423668|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
125423669|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
125423670|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125423671|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125423672|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125534853|NCT03820947|451588240|FG002|Overall Study|Withdrawal by Subject|3|||
125534854|NCT03820947|451588241|FG003|Overall Study|Withdrawal by Subject|8|||
125423673|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125423674|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
125423675|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
125423676|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
125423677|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
125423678|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
125423679|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
125423680|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
125423681|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
125423682|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
125423683|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
125423684|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
125423685|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125423686|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
125423687|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
125423688|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125423689|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125423690|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125423691|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125423692|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125423693|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
125423694|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125423695|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
125423696|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
125423697|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125423698|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125423699|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125423700|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125423701|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
125423702|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
125423703|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125423704|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
125423705|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
125423706|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125423707|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125423708|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125423709|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125423710|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
125423711|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
125423712|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125423713|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
125423714|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
125423715|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125423716|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125423717|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125423718|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125423719|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
125423720|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
125423721|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125423722|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
125423723|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125423724|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125423725|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125423726|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125423727|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125423728|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125423729|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125423730|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125423731|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125423732|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125423733|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125423734|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125423735|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125423736|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125423737|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
125423738|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
125423739|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125423740|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
125423741|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
125423742|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125423743|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125423744|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125423745|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125423746|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
125423747|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
125423748|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125423749|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
125423750|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
125423751|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125423752|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125423753|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125423754|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125423755|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125423756|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
125423757|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125423758|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
125423759|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
125423760|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125423761|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125423762|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125423763|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125423764|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
125423765|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125423766|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125423767|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
125423768|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
125423769|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125423770|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125423771|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125423772|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125423773|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
125423774|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
125423775|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125423776|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
125423777|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
125423778|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125423779|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125423780|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125423781|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125423782|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125423783|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125423784|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125423785|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125423786|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
125423787|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125423788|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125423789|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125423790|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125423791|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125423792|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125423793|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125423794|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
125423795|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125423796|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125423797|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125423798|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125423799|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125423800|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125423801|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
125423802|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
125423803|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
125423804|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
125423805|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
125423806|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
125423807|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
125534855|NCT03820947|451588242|FG004|Overall Study|Withdrawal by Subject|5|||
125534856|NCT03820947|451588238|FG000|Overall Study|Procedure Not Attempted|0|||
125423808|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
125423809|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
125423810|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
125423811|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125423812|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125423813|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
125423814|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125423815|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125423816|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125423817|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125423818|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125423819|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125423820|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125423821|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125423822|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
125423823|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125423824|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125423825|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125423826|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125423827|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125423828|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
125423829|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125423830|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125423831|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
125423832|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125423833|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125423834|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125423835|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125423836|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125423837|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125423838|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125423839|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
125423840|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
125423841|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125423842|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125423843|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125423844|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125423845|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
125423846|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125423847|NCT01212770|451175152|FG000|Long-term Safety Phase (Year 5)|Death|0|||
125423848|NCT01212770|451175153|FG001|Long-term Safety Phase (Year 5)|Death|0|||
125423849|NCT01212770|451175154|FG002|Long-term Safety Phase (Year 5)|Death|0|||
125423850|NCT01212770|451175155|FG003|Long-term Safety Phase (Year 5)|Death|0|||
125423851|NCT01212770|451175156|FG004|Long-term Safety Phase (Year 5)|Death|0|||
125423852|NCT01212770|451175157|FG005|Long-term Safety Phase (Year 5)|Death|0|||
125423853|NCT01212770|451175158|FG006|Long-term Safety Phase (Year 5)|Death|0|||
125423854|NCT01212770|451175159|FG007|Long-term Safety Phase (Year 5)|Death|1|||
125423855|NCT01212770|451175160|FG008|Long-term Safety Phase (Year 5)|Death|0|||
125423856|NCT00829387|451175161|FG000|Overall Study|Withdrawal by Subject|2|||
125423857|NCT00829387|451175162|FG001|Overall Study|Withdrawal by Subject|3|||
125423858|NCT00829387|451175161|FG000|Overall Study|Disqualified by PI|1|||
125423859|NCT00829387|451175162|FG001|Overall Study|Disqualified by PI|0|||
125423860|NCT01112579|451175170|FG000|Overall Study|Missed Visit|1|||
125423861|NCT01112579|451175171|FG001|Overall Study|Missed Visit|1|||
125423862|NCT01112579|451175170|FG000|Overall Study|Death|0|||
125423863|NCT01112579|451175171|FG001|Overall Study|Death|2|||
125423864|NCT04304833|451175172|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
125423865|NCT04304833|451175173|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
125423866|NCT01951625|451175174|FG000|Treatment Period|Protocol Violation|2|||
125423867|NCT01951625|451175175|FG001|Treatment Period|Protocol Violation|0|||
125423868|NCT01951625|451175176|FG002|Treatment Period|Protocol Violation|1|||
125423869|NCT01951625|451175177|FG003|Treatment Period|Protocol Violation|3|||
125423870|NCT01951625|451175178|FG004|Treatment Period|Protocol Violation|2|||
125423871|NCT01951625|451175174|FG000|Treatment Period|Physician Decision|0|||
125423872|NCT01951625|451175175|FG001|Treatment Period|Physician Decision|0|||
125423873|NCT01951625|451175176|FG002|Treatment Period|Physician Decision|0|||
125423874|NCT01951625|451175177|FG003|Treatment Period|Physician Decision|0|||
125423875|NCT01951625|451175178|FG004|Treatment Period|Physician Decision|1|||
125423876|NCT01951625|451175174|FG000|Treatment Period|Protocol driven decision point|0|||
125423877|NCT01951625|451175175|FG001|Treatment Period|Protocol driven decision point|5|||
125423878|NCT01951625|451175176|FG002|Treatment Period|Protocol driven decision point|0|||
125423879|NCT01951625|451175177|FG003|Treatment Period|Protocol driven decision point|2|||
125423880|NCT01951625|451175178|FG004|Treatment Period|Protocol driven decision point|1|||
125423881|NCT01951625|451175174|FG000|Treatment Period|Non compliance with study drug|1|||
125423882|NCT01951625|451175175|FG001|Treatment Period|Non compliance with study drug|2|||
125423883|NCT01951625|451175176|FG002|Treatment Period|Non compliance with study drug|2|||
125423884|NCT01951625|451175177|FG003|Treatment Period|Non compliance with study drug|0|||
125423885|NCT01951625|451175178|FG004|Treatment Period|Non compliance with study drug|0|||
125423886|NCT01951625|451175174|FG000|Treatment Period|Death|3|||
125423887|NCT01951625|451175175|FG001|Treatment Period|Death|2|||
125423888|NCT01951625|451175176|FG002|Treatment Period|Death|2|||
125423889|NCT01951625|451175177|FG003|Treatment Period|Death|1|||
125423890|NCT01951625|451175178|FG004|Treatment Period|Death|2|||
125423891|NCT01951625|451175174|FG000|Treatment Period|Adverse Event|7|||
125423892|NCT01951625|451175175|FG001|Treatment Period|Adverse Event|10|||
125423893|NCT01951625|451175176|FG002|Treatment Period|Adverse Event|9|||
125423894|NCT01951625|451175177|FG003|Treatment Period|Adverse Event|8|||
125423895|NCT01951625|451175178|FG004|Treatment Period|Adverse Event|8|||
125423896|NCT01951625|451175174|FG000|Treatment Period|Withdrawal by Subject|5|||
125423897|NCT01951625|451175175|FG001|Treatment Period|Withdrawal by Subject|2|||
125423898|NCT01951625|451175176|FG002|Treatment Period|Withdrawal by Subject|1|||
125423899|NCT01951625|451175177|FG003|Treatment Period|Withdrawal by Subject|7|||
125423900|NCT01951625|451175178|FG004|Treatment Period|Withdrawal by Subject|3|||
125423901|NCT01951625|451175174|FG000|Treatment Period|Lost to Follow-up|1|||
125423902|NCT01951625|451175175|FG001|Treatment Period|Lost to Follow-up|0|||
125423903|NCT01951625|451175176|FG002|Treatment Period|Lost to Follow-up|0|||
125423904|NCT01951625|451175177|FG003|Treatment Period|Lost to Follow-up|1|||
125423905|NCT01951625|451175178|FG004|Treatment Period|Lost to Follow-up|0|||
125423906|NCT01951625|451175174|FG000|Follow Up Period|Non-compliance with study drug|1|||
125423907|NCT01951625|451175175|FG001|Follow Up Period|Non-compliance with study drug|0|||
125423908|NCT01951625|451175176|FG002|Follow Up Period|Non-compliance with study drug|0|||
125423909|NCT01951625|451175177|FG003|Follow Up Period|Non-compliance with study drug|0|||
125423910|NCT01951625|451175178|FG004|Follow Up Period|Non-compliance with study drug|0|||
125423911|NCT01951625|451175174|FG000|Follow Up Period|Death|1|||
125423912|NCT01951625|451175175|FG001|Follow Up Period|Death|3|||
125423913|NCT01951625|451175176|FG002|Follow Up Period|Death|2|||
125423914|NCT01951625|451175177|FG003|Follow Up Period|Death|2|||
125423915|NCT01951625|451175178|FG004|Follow Up Period|Death|1|||
125423916|NCT01951625|451175174|FG000|Follow Up Period|Logistical difficulties|1|||
125423917|NCT01951625|451175175|FG001|Follow Up Period|Logistical difficulties|2|||
125423918|NCT01951625|451175176|FG002|Follow Up Period|Logistical difficulties|0|||
125423919|NCT01951625|451175177|FG003|Follow Up Period|Logistical difficulties|0|||
125423920|NCT01951625|451175178|FG004|Follow Up Period|Logistical difficulties|0|||
125423921|NCT01951625|451175174|FG000|Follow Up Period|Adverse Event|0|||
125423922|NCT01951625|451175175|FG001|Follow Up Period|Adverse Event|3|||
125423923|NCT01951625|451175176|FG002|Follow Up Period|Adverse Event|2|||
125423924|NCT01951625|451175177|FG003|Follow Up Period|Adverse Event|3|||
125423925|NCT01951625|451175178|FG004|Follow Up Period|Adverse Event|5|||
125423926|NCT01951625|451175174|FG000|Follow Up Period|Withdrawal by Subject|4|||
125423927|NCT01951625|451175175|FG001|Follow Up Period|Withdrawal by Subject|1|||
125423928|NCT01951625|451175176|FG002|Follow Up Period|Withdrawal by Subject|0|||
125423929|NCT01951625|451175177|FG003|Follow Up Period|Withdrawal by Subject|5|||
125423930|NCT01951625|451175178|FG004|Follow Up Period|Withdrawal by Subject|3|||
125423931|NCT01951625|451175174|FG000|Follow Up Period|Lost to Follow-up|1|||
125423932|NCT01951625|451175175|FG001|Follow Up Period|Lost to Follow-up|0|||
125423933|NCT01951625|451175176|FG002|Follow Up Period|Lost to Follow-up|0|||
125423934|NCT01951625|451175177|FG003|Follow Up Period|Lost to Follow-up|1|||
125423935|NCT01951625|451175178|FG004|Follow Up Period|Lost to Follow-up|1|||
125423936|NCT02459574|451175179|FG000|Overall Study|Withdrawal by Subject|6|||
125423937|NCT02459574|451175180|FG001|Overall Study|Withdrawal by Subject|6|||
125423938|NCT02459574|451175181|FG002|Overall Study|Withdrawal by Subject|2|||
125423939|NCT02459574|451175179|FG000|Overall Study|Lost to Follow-up|1|||
125423940|NCT02459574|451175180|FG001|Overall Study|Lost to Follow-up|1|||
125423941|NCT02459574|451175181|FG002|Overall Study|Lost to Follow-up|0|||
125423942|NCT02459574|451175179|FG000|Overall Study|Death|0|||
125423943|NCT02459574|451175180|FG001|Overall Study|Death|1|||
125423944|NCT02459574|451175181|FG002|Overall Study|Death|0|||
125423945|NCT00251745|451175182|FG000|Overall Study|Adverse Event|7|||
125423946|NCT00251745|451175183|FG001|Overall Study|Adverse Event|9|||
125423947|NCT00251745|451175184|FG002|Overall Study|Adverse Event|11|||
125423948|NCT00251745|451175182|FG000|Overall Study|Lost to Follow-up|4|||
125423949|NCT00251745|451175183|FG001|Overall Study|Lost to Follow-up|2|||
125423950|NCT00251745|451175184|FG002|Overall Study|Lost to Follow-up|5|||
125423951|NCT00251745|451175182|FG000|Overall Study|Withdrawal by Subject|13|||
125423952|NCT00251745|451175183|FG001|Overall Study|Withdrawal by Subject|7|||
125423953|NCT00251745|451175184|FG002|Overall Study|Withdrawal by Subject|3|||
125423954|NCT00251745|451175182|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
125423955|NCT00251745|451175183|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
125423956|NCT00251745|451175184|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
125423957|NCT00251745|451175182|FG000|Overall Study|Lack of Efficacy|3|||
125423958|NCT00251745|451175183|FG001|Overall Study|Lack of Efficacy|0|||
125423959|NCT00251745|451175184|FG002|Overall Study|Lack of Efficacy|0|||
125423960|NCT00251745|451175182|FG000|Overall Study|Noncompliant|0|||
125423961|NCT00251745|451175183|FG001|Overall Study|Noncompliant|2|||
125423962|NCT00251745|451175184|FG002|Overall Study|Noncompliant|2|||
125423963|NCT00251745|451175182|FG000|Overall Study|Pregnancy|0|||
125423964|NCT00251745|451175183|FG001|Overall Study|Pregnancy|1|||
125423965|NCT00251745|451175184|FG002|Overall Study|Pregnancy|0|||
125423966|NCT00251745|451175182|FG000|Overall Study|Per Subject Request|0|||
125423967|NCT00251745|451175183|FG001|Overall Study|Per Subject Request|0|||
125423968|NCT00251745|451175184|FG002|Overall Study|Per Subject Request|1|||
125423969|NCT00251745|451175182|FG000|Overall Study|Per Investigator Request|1|||
125423970|NCT00251745|451175183|FG001|Overall Study|Per Investigator Request|0|||
125423971|NCT00251745|451175184|FG002|Overall Study|Per Investigator Request|0|||
125423972|NCT04508699|451175187|FG000|Overall Study|Lack of Efficacy|2|||
125423973|NCT04508699|451175188|FG001|Overall Study|Lack of Efficacy|15|||
125423974|NCT04508699|451175187|FG000|Overall Study|Withdrawal by Subject|0|||
125423975|NCT04508699|451175188|FG001|Overall Study|Withdrawal by Subject|2|||
125423976|NCT04866017|451175189|FG000|Overall Study|Study Terminated by Sponsor|13|||
125423977|NCT04866017|451175190|FG001|Overall Study|Study Terminated by Sponsor|14|||
125423978|NCT04866017|451175191|FG002|Overall Study|Study Terminated by Sponsor|13|||
125423979|NCT04866017|451175189|FG000|Overall Study|Death|8|||
125423980|NCT04866017|451175190|FG001|Overall Study|Death|4|||
125423981|NCT04866017|451175191|FG002|Overall Study|Death|8|||
125423982|NCT04866017|451175189|FG000|Overall Study|Withdrawal by Subject|1|||
125423983|NCT04866017|451175190|FG001|Overall Study|Withdrawal by Subject|0|||
125423984|NCT04866017|451175191|FG002|Overall Study|Withdrawal by Subject|1|||
125423985|NCT04866017|451175189|FG000|Overall Study|Physician Decision|0|||
125423986|NCT04866017|451175190|FG001|Overall Study|Physician Decision|1|||
125423987|NCT04866017|451175191|FG002|Overall Study|Physician Decision|0|||
125423988|NCT00833560|451176785|FG000|Overall Study|Toxicity|13|||
125423989|NCT00833560|451176785|FG000|Overall Study|Adverse Event|11|||
125423990|NCT00833560|451176785|FG000|Overall Study|Protocol Violation|6|||
125423991|NCT00833560|451176785|FG000|Overall Study|Lack of Efficacy|4|||
125423992|NCT00833560|451176785|FG000|Overall Study|Death|2|||
125423993|NCT00833560|451176785|FG000|Overall Study|Pregression of other disease|1|||
125423994|NCT00833560|451176785|FG000|Overall Study|Other|5|||
125423995|NCT00643916|451176786|FG000|Overall Study|Protocol Violation|0|||
125423996|NCT00643916|451176787|FG001|Overall Study|Protocol Violation|1|||
125423997|NCT00643916|451176788|FG002|Overall Study|Protocol Violation|1|||
125423998|NCT00643916|451176789|FG003|Overall Study|Protocol Violation|1|||
125423999|NCT00643916|451176790|FG004|Overall Study|Protocol Violation|0|||
125424000|NCT00643916|451176791|FG005|Overall Study|Protocol Violation|0|||
125424001|NCT00643916|451176786|FG000|Overall Study|Lost to Follow-up|0|||
125424002|NCT00643916|451176787|FG001|Overall Study|Lost to Follow-up|1|||
125424003|NCT00643916|451176788|FG002|Overall Study|Lost to Follow-up|0|||
125424004|NCT00643916|451176789|FG003|Overall Study|Lost to Follow-up|0|||
125424005|NCT00643916|451176790|FG004|Overall Study|Lost to Follow-up|0|||
125424006|NCT00643916|451176791|FG005|Overall Study|Lost to Follow-up|0|||
125424007|NCT00643916|451176786|FG000|Overall Study|Withdrawal by Subject|2|||
125424008|NCT00643916|451176787|FG001|Overall Study|Withdrawal by Subject|2|||
125424009|NCT00643916|451176788|FG002|Overall Study|Withdrawal by Subject|2|||
125424010|NCT00643916|451176789|FG003|Overall Study|Withdrawal by Subject|1|||
125424011|NCT00643916|451176790|FG004|Overall Study|Withdrawal by Subject|0|||
125424012|NCT00643916|451176791|FG005|Overall Study|Withdrawal by Subject|1|||
125424013|NCT00643916|451176786|FG000|Overall Study|Not Vaccinated|2|||
125424014|NCT00643916|451176787|FG001|Overall Study|Not Vaccinated|2|||
125424015|NCT00643916|451176788|FG002|Overall Study|Not Vaccinated|3|||
125424016|NCT00643916|451176789|FG003|Overall Study|Not Vaccinated|0|||
125424017|NCT00643916|451176790|FG004|Overall Study|Not Vaccinated|2|||
125424018|NCT00643916|451176791|FG005|Overall Study|Not Vaccinated|0|||
125424019|NCT00499031|451176792|FG000|Overall Study|Improper pre-protocol treatment|1|||
125424020|NCT00499031|451176792|FG000|Overall Study|Required test not done|1|||
125424021|NCT00499031|451176792|FG000|Overall Study|Never treated|1|||
125424022|NCT01791725|451176798|FG000|Overall Study|Withdrawal by Subject|0|||
125424023|NCT01791725|451176799|FG001|Overall Study|Withdrawal by Subject|1|||
125424024|NCT01791725|451176800|FG002|Overall Study|Withdrawal by Subject|0|||
125424025|NCT00512148|451176801|FG000|Primay Study Period|Withdrawal by Subject|1|||
125424026|NCT00677833|451176802|FG000|Overall Study|Withdrawal by Subject|4|||
125424027|NCT00677833|451176803|FG001|Overall Study|Withdrawal by Subject|0|||
125424028|NCT00677833|451176804|FG002|Overall Study|Withdrawal by Subject|1|||
125424029|NCT00677833|451176805|FG003|Overall Study|Withdrawal by Subject|3|||
125424030|NCT00677833|451176802|FG000|Overall Study|Lost to Follow-up|0|||
125424031|NCT00677833|451176803|FG001|Overall Study|Lost to Follow-up|0|||
125424032|NCT00677833|451176804|FG002|Overall Study|Lost to Follow-up|1|||
125424033|NCT00677833|451176805|FG003|Overall Study|Lost to Follow-up|0|||
125424034|NCT02001194|451176811|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
125424035|NCT02001194|451176812|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
125424036|NCT02001194|451176813|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
125424037|NCT02001194|451176814|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
125424038|NCT02001194|451176811|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
125424039|NCT02001194|451176812|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
125424040|NCT02001194|451176813|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
125424041|NCT02001194|451176814|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
125424042|NCT02606279|451176815|FG000|Overall Study|Lost to Follow-up|0|||
125424043|NCT02606279|451176816|FG001|Overall Study|Lost to Follow-up|1|||
125424044|NCT02690974|451176818|FG000|Overall Study|Adverse Event|16|||
125424045|NCT02690974|451176818|FG000|Overall Study|Death|9|||
125424046|NCT02690974|451176818|FG000|Overall Study|Subject/guardian decision|4|||
125424047|NCT02690974|451176818|FG000|Overall Study|Lost to Follow-up|3|||
125424048|NCT02690974|451176818|FG000|Overall Study|Withdrawal of Informed Consent|3|||
125424049|NCT02690974|451176818|FG000|Overall Study|Physician Decision|2|||
125424050|NCT02690974|451176818|FG000|Overall Study|Non-compliance with study treatment|1|||
125424051|NCT02690974|451176818|FG000|Overall Study|Protocol-defined stopping criteria|1|||
125424052|NCT02690974|451176818|FG000|Overall Study|Protocol Deviation|1|||
125424053|NCT02184611|451176823|FG000|Overall Study|Lack of Efficacy|11|||
125424054|NCT02184611|451176824|FG001|Overall Study|Lack of Efficacy|15|||
125424055|NCT02184611|451176823|FG000|Overall Study|Withdrawal by Subject|5|||
125424056|NCT02184611|451176824|FG001|Overall Study|Withdrawal by Subject|6|||
125424057|NCT02184611|451176823|FG000|Overall Study|Adverse Event|4|||
125424058|NCT02184611|451176824|FG001|Overall Study|Adverse Event|5|||
125424059|NCT02184611|451176823|FG000|Overall Study|Protocol Violation|1|||
125424060|NCT02184611|451176824|FG001|Overall Study|Protocol Violation|1|||
125424061|NCT02184611|451176823|FG000|Overall Study|Protocol defined stopping criteria|0|||
125424062|NCT02184611|451176824|FG001|Overall Study|Protocol defined stopping criteria|1|||
125424063|NCT01666951|451176825|FG000|Overall Study|Not dosed|1|||
125424064|NCT01666951|451176826|FG001|Overall Study|Not dosed|1|||
125424065|NCT00522301|451176827|FG000|Overall Study|Withdrawal by Subject|1|||
125424066|NCT00522301|451176827|FG000|Overall Study|Adverse Event|5|||
125424067|NCT02366910|451176828|FG000|Overall Study|Withdrawal by Subject|2|||
125424068|NCT02366910|451176828|FG000|Overall Study|Screen Failure|3|||
125424069|NCT02623322|451176831|FG000|Overall Study|Lost to Follow-up|2|||
125424070|NCT02623322|451176832|FG001|Overall Study|Lost to Follow-up|1|||
125424071|NCT02623322|451176833|FG002|Overall Study|Lost to Follow-up|0|||
125424072|NCT03563716|451176834|FG000|Overall Study|Death|20|||
125424073|NCT03563716|451176835|FG001|Overall Study|Death|14|||
125424074|NCT03563716|451176834|FG000|Overall Study|Withdrawal by Subject|3|||
125424075|NCT03563716|451176835|FG001|Overall Study|Withdrawal by Subject|3|||
125424076|NCT03563716|451176834|FG000|Overall Study|Still on Study|45|||
125424077|NCT03563716|451176835|FG001|Overall Study|Still on Study|50|||
125424078|NCT04605978|451176839|FG000|Overall Study|Adverse Event|2|||
125424079|NCT04605978|451176840|FG001|Overall Study|Adverse Event|1|||
125424080|NCT04605978|451176839|FG000|Overall Study|Withdrawal nonmedical reason|1|||
125424081|NCT04605978|451176840|FG001|Overall Study|Withdrawal nonmedical reason|1|||
125424082|NCT03813238|451176841|FG000|Overall Study|Adverse Event|0|||
125424083|NCT03813238|451176842|FG001|Overall Study|Adverse Event|6|||
125424084|NCT03813238|451176841|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125424085|NCT03813238|451176842|FG001|Overall Study|Withdrawal by parent/guardian|2|||
125424086|NCT03813238|451176841|FG000|Overall Study|Lost to Follow-up|0|||
125424087|NCT03813238|451176842|FG001|Overall Study|Lost to Follow-up|1|||
125424088|NCT03813238|451176841|FG000|Overall Study|Other than specified|1|||
125424089|NCT03813238|451176842|FG001|Overall Study|Other than specified|2|||
125424090|NCT02583425|451176843|FG000|Screening|Did not meet entry criteria|12|||
125424091|NCT02583425|451176843|FG000|Baseline|Did not meet continued criteria|5|||
125424092|NCT02583425|451176843|FG000|Treatment Period|Adverse Event|1|||
125424093|NCT03318523|451176844|FG000|PC Period: Up to Year 1|Adverse Event|1|||
125424094|NCT03318523|451176845|FG001|PC Period: Up to Year 1|Adverse Event|0|||
125424095|NCT03318523|451176846|FG002|PC Period: Up to Year 1|Adverse Event|2|||
125424096|NCT03318523|451176847|FG003|PC Period: Up to Year 1|Adverse Event|0|||
125424097|NCT03318523|451176848|FG004|PC Period: Up to Year 1|Adverse Event|0|||
125424098|NCT03318523|451176849|FG005|PC Period: Up to Year 1|Adverse Event|0|||
125424099|NCT03318523|451176850|FG006|PC Period: Up to Year 1|Adverse Event|0|||
125424100|NCT03318523|451176851|FG007|PC Period: Up to Year 1|Adverse Event|0|||
125424101|NCT03318523|451176852|FG008|PC Period: Up to Year 1|Adverse Event|0|||
125424102|NCT03318523|451176853|FG009|PC Period: Up to Year 1|Adverse Event|0|||
125424103|NCT03318523|451176844|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
125424104|NCT03318523|451176845|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
125424105|NCT03318523|451176846|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
125424106|NCT03318523|451176847|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
125424107|NCT03318523|451176848|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
125424108|NCT03318523|451176849|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
125424109|NCT03318523|451176850|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
125424110|NCT03318523|451176851|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
125424111|NCT03318523|451176852|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
125424112|NCT03318523|451176853|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
125424113|NCT03318523|451176844|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125424114|NCT03318523|451176845|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125424115|NCT03318523|451176846|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125424116|NCT03318523|451176847|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125424117|NCT03318523|451176848|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
125424118|NCT03318523|451176849|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125424119|NCT03318523|451176850|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125424120|NCT03318523|451176851|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
125424121|NCT03318523|451176852|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
125424122|NCT03318523|451176853|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
125424123|NCT03318523|451176844|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
125424124|NCT03318523|451176845|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
125424125|NCT03318523|451176846|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
125424126|NCT03318523|451176847|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
125424127|NCT03318523|451176848|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
125424128|NCT03318523|451176849|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
125424129|NCT03318523|451176850|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
125424130|NCT03318523|451176851|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
125424131|NCT03318523|451176852|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
125424132|NCT03318523|451176853|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
125424133|NCT03318523|451176844|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125424134|NCT03318523|451176845|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125424135|NCT03318523|451176846|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125424136|NCT03318523|451176847|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125424137|NCT03318523|451176848|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125424138|NCT03318523|451176849|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
125424139|NCT03318523|451176850|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125424140|NCT03318523|451176851|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125424141|NCT03318523|451176852|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125424142|NCT03318523|451176853|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
125424143|NCT03318523|451176844|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125424144|NCT03318523|451176845|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125424145|NCT03318523|451176846|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125424146|NCT03318523|451176847|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125424147|NCT03318523|451176848|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125424148|NCT03318523|451176849|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125424149|NCT03318523|451176850|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125424150|NCT03318523|451176851|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125424151|NCT03318523|451176852|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
125424152|NCT03318523|451176853|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
125424153|NCT03318523|451176844|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
125424154|NCT03318523|451176845|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
125424155|NCT03318523|451176846|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
125424156|NCT03318523|451176847|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
125424157|NCT03318523|451176848|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
125424158|NCT03318523|451176849|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
125424159|NCT03318523|451176850|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
125424160|NCT03318523|451176851|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
125424161|NCT03318523|451176852|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
125424162|NCT03318523|451176853|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
125424163|NCT03318523|451176844|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125424164|NCT03318523|451176845|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125424165|NCT03318523|451176846|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125424166|NCT03318523|451176847|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125424167|NCT03318523|451176848|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
125424168|NCT03318523|451176849|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125424169|NCT03318523|451176850|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125534857|NCT03820947|451588239|FG001|Overall Study|Procedure Not Attempted|2|||
125534858|NCT03820947|451588240|FG002|Overall Study|Procedure Not Attempted|1|||
125424170|NCT03318523|451176851|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
125424171|NCT03318523|451176852|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
125424172|NCT03318523|451176853|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
125424173|NCT03581981|451176854|FG000|Overall Study|Withdrawal by Subject|12|||
125424174|NCT03581981|451176855|FG001|Overall Study|Withdrawal by Subject|13|||
125424175|NCT03581981|451176854|FG000|Overall Study|Physician Decision|1|||
125424176|NCT03581981|451176855|FG001|Overall Study|Physician Decision|2|||
125645733|NCT02839330|451986335|FG000|Overall Study|Administrative Reason|0|||
125424177|NCT03581981|451176854|FG000|Overall Study|Lost to Follow-up|0|||
125424178|NCT03581981|451176855|FG001|Overall Study|Lost to Follow-up|4|||
125424179|NCT02080871|451176856|FG000|Overall Study|Death|1|||
125424180|NCT02080871|451176856|FG000|Overall Study|Lost to Follow-up|1|||
125424181|NCT00234052|451176857|FG000|Treatment|Withdrawal by Subject|3|||
125424182|NCT00234052|451176857|FG000|Treatment|Adverse Event|5|||
125424183|NCT00234052|451176857|FG000|Treatment|Death|2|||
125424184|NCT00234052|451176857|FG000|Treatment|Progressive Disease|11|||
125424185|NCT00234052|451176857|FG000|Follow-up for 5 Years|Death|41|||
125424186|NCT00234052|451176857|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
125424187|NCT00234052|451176857|FG000|Follow-up for 5 Years|Other|7|||
125424188|NCT01615328|451176860|FG000|Overall Study|Lost to Follow-up|3|||
125424189|NCT01615328|451176861|FG001|Overall Study|Lost to Follow-up|5|||
125424190|NCT03338894|451176862|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
125424191|NCT00626028|451176865|FG000|Overall Study|Adverse Event|1|||
125424192|NCT00626028|451176866|FG001|Overall Study|Adverse Event|1|||
125424193|NCT00626028|451176865|FG000|Overall Study|Device Failure|0|||
125424194|NCT00626028|451176866|FG001|Overall Study|Device Failure|1|||
125424195|NCT00626028|451176865|FG000|Overall Study|Physician Decision|2|||
125424196|NCT00626028|451176866|FG001|Overall Study|Physician Decision|1|||
125424197|NCT00626028|451176865|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
125424198|NCT00626028|451176866|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
125424199|NCT00831779|451176867|FG000|Overall Study|Lost to Follow-up|1|||
125424200|NCT00831779|451176868|FG001|Overall Study|Lost to Follow-up|0|||
125424201|NCT00831779|451176867|FG000|Overall Study|No longer met criteria|0|||
125424202|NCT00831779|451176868|FG001|Overall Study|No longer met criteria|1|||
125424203|NCT02436330|451176869|FG000|Cohort 1|Lost to Follow-up|5|||
125424204|NCT02436330|451176870|FG001|Cohort 1|Lost to Follow-up|2|||
125424205|NCT02436330|451176869|FG000|Cohort 1|Withdrawal by Subject|0|||
125424206|NCT02436330|451176870|FG001|Cohort 1|Withdrawal by Subject|1|||
125424207|NCT02436330|451176869|FG000|Cohort 2|Lost to Follow-up|2|||
125424208|NCT02436330|451176870|FG001|Cohort 2|Lost to Follow-up|0|||
125424209|NCT02436330|451176869|FG000|Cohort 2|Withdrawal by Subject|2|||
125424210|NCT02436330|451176870|FG001|Cohort 2|Withdrawal by Subject|3|||
125424211|NCT02436330|451176869|FG000|Cohort 3|Lost to Follow-up|1|||
125424212|NCT02436330|451176870|FG001|Cohort 3|Lost to Follow-up|0|||
125424213|NCT02436330|451176869|FG000|Cohort 3|Withdrawal by Subject|4|||
125424214|NCT02436330|451176870|FG001|Cohort 3|Withdrawal by Subject|0|||
125424215|NCT02436330|451176869|FG000|Cohort 4|Lost to Follow-up|1|||
125424216|NCT02436330|451176870|FG001|Cohort 4|Lost to Follow-up|0|||
125424217|NCT02436330|451176869|FG000|Cohort 4|Withdrawal by Subject|1|||
125424218|NCT02436330|451176870|FG001|Cohort 4|Withdrawal by Subject|0|||
125424219|NCT02436330|451176869|FG000|Cohort 5|Lost to Follow-up|3|||
125424220|NCT02436330|451176870|FG001|Cohort 5|Lost to Follow-up|2|||
125424221|NCT02436330|451176869|FG000|Cohort 5|Withdrawal by Subject|3|||
125424222|NCT02436330|451176870|FG001|Cohort 5|Withdrawal by Subject|2|||
125424223|NCT02436330|451176869|FG000|Cohort 6|Lost to Follow-up|2|||
125424224|NCT02436330|451176870|FG001|Cohort 6|Lost to Follow-up|0|||
125424225|NCT02436330|451176869|FG000|Cohort 6|Withdrawal by Subject|1|||
125424226|NCT02436330|451176870|FG001|Cohort 6|Withdrawal by Subject|1|||
125424227|NCT02230956|451176871|FG000|Overall Study|Adverse Event|1|||
125424228|NCT02230956|451176872|FG001|Overall Study|Adverse Event|1|||
125424229|NCT02230956|451176873|FG002|Overall Study|Adverse Event|0|||
125424230|NCT02230956|451176871|FG000|Overall Study|Lack of Efficacy|1|||
125424231|NCT02230956|451176872|FG001|Overall Study|Lack of Efficacy|1|||
125424232|NCT02230956|451176873|FG002|Overall Study|Lack of Efficacy|1|||
125424233|NCT02230956|451176871|FG000|Overall Study|Lost to Follow-up|1|||
125424234|NCT02230956|451176872|FG001|Overall Study|Lost to Follow-up|1|||
125424235|NCT02230956|451176873|FG002|Overall Study|Lost to Follow-up|2|||
125424236|NCT02230956|451176871|FG000|Overall Study|Personal Reasons|2|||
125424237|NCT02230956|451176872|FG001|Overall Study|Personal Reasons|1|||
125424238|NCT02230956|451176873|FG002|Overall Study|Personal Reasons|1|||
125424239|NCT02230956|451176871|FG000|Overall Study|Protocol Violation|0|||
125645734|NCT02839330|451986336|FG001|Overall Study|Administrative Reason|0|||
125645735|NCT02839330|451986337|FG002|Overall Study|Administrative Reason|0|||
125645736|NCT02839330|451986338|FG003|Overall Study|Administrative Reason|1|||
125424240|NCT02230956|451176872|FG001|Overall Study|Protocol Violation|1|||
125424241|NCT02230956|451176873|FG002|Overall Study|Protocol Violation|1|||
125424242|NCT02230956|451176871|FG000|Overall Study|Other Miscellaneous Reason|0|||
125424243|NCT02230956|451176872|FG001|Overall Study|Other Miscellaneous Reason|1|||
125424244|NCT02230956|451176873|FG002|Overall Study|Other Miscellaneous Reason|2|||
125424245|NCT00338884|451176874|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
125424246|NCT00338884|451176874|FG000|Overall Study|Adverse Event|14|||
125424247|NCT00338884|451176874|FG000|Overall Study|Death|8|||
125424248|NCT00338884|451176874|FG000|Overall Study|Other|4|||
125424249|NCT00338884|451176874|FG000|Overall Study|Global Deterioration of Health Status|3|||
125424250|NCT00338884|451176874|FG000|Overall Study|Withdrawal by Subject|3|||
125424251|NCT00338884|451176874|FG000|Overall Study|Lost to Follow-up|1|||
125424252|NCT00338884|451176874|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
125424253|NCT01970982|451176876|FG000|Overall Study|Withdrawal by Subject|0|||
125424254|NCT01970982|451176877|FG001|Overall Study|Withdrawal by Subject|0|||
125424255|NCT01970982|451176878|FG002|Overall Study|Withdrawal by Subject|2|||
125424256|NCT01984684|451176883|FG000|Overall Study|Lost to Follow-up|25|||
125424257|NCT01984684|451176884|FG001|Overall Study|Lost to Follow-up|24|||
125424258|NCT01984684|451176883|FG000|Overall Study|Adverse Event|8|||
125424259|NCT01984684|451176884|FG001|Overall Study|Adverse Event|12|||
125424260|NCT01984684|451176883|FG000|Overall Study|Withdrawal by Subject|9|||
125424261|NCT01984684|451176884|FG001|Overall Study|Withdrawal by Subject|9|||
125424262|NCT01984684|451176883|FG000|Overall Study|Lack of Efficacy|3|||
125424263|NCT01984684|451176884|FG001|Overall Study|Lack of Efficacy|6|||
125424264|NCT01984684|451176883|FG000|Overall Study|Physician Decision|4|||
125424265|NCT01984684|451176884|FG001|Overall Study|Physician Decision|2|||
125424266|NCT01984684|451176883|FG000|Overall Study|Protocol Violation|4|||
125424267|NCT01984684|451176884|FG001|Overall Study|Protocol Violation|2|||
125424268|NCT01984684|451176883|FG000|Overall Study|Death|0|||
125424269|NCT01984684|451176884|FG001|Overall Study|Death|1|||
125424270|NCT01984684|451176883|FG000|Overall Study|Noncompliance with study drug|2|||
125424271|NCT01984684|451176884|FG001|Overall Study|Noncompliance with study drug|1|||
125424272|NCT01984684|451176883|FG000|Overall Study|Subject incarcerated|1|||
125424273|NCT01984684|451176884|FG001|Overall Study|Subject incarcerated|0|||
125424274|NCT01984684|451176883|FG000|Overall Study|Study drug not available at site|1|||
125424275|NCT01984684|451176884|FG001|Overall Study|Study drug not available at site|1|||
125424276|NCT01984684|451176883|FG000|Overall Study|Subject had inadequate IV access|0|||
125424277|NCT01984684|451176884|FG001|Overall Study|Subject had inadequate IV access|1|||
125424278|NCT04575051|451176885|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
125424279|NCT04575051|451176886|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
125424280|NCT04575051|451176887|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
125424281|NCT04575051|451176888|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
125424282|NCT04575051|451176889|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
125424283|NCT04575051|451176885|FG000|Time Period 1|Missing follow up|1|||
125424284|NCT04575051|451176886|FG001|Time Period 1|Missing follow up|3|||
125424285|NCT04575051|451176887|FG002|Time Period 1|Missing follow up|1|||
125424286|NCT04575051|451176888|FG003|Time Period 1|Missing follow up|3|||
125424287|NCT04575051|451176889|FG004|Time Period 1|Missing follow up|2|||
125424288|NCT04575051|451176885|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
125424289|NCT04575051|451176886|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
125424290|NCT04575051|451176887|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
125424291|NCT04575051|451176888|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
125424292|NCT04575051|451176889|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
125424293|NCT04575051|451176885|FG000|Time Period 2|Missing follow up|1|||
125424294|NCT04575051|451176886|FG001|Time Period 2|Missing follow up|8|||
125424295|NCT04575051|451176887|FG002|Time Period 2|Missing follow up|7|||
125424296|NCT04575051|451176888|FG003|Time Period 2|Missing follow up|0|||
125424297|NCT04575051|451176889|FG004|Time Period 2|Missing follow up|1|||
125424298|NCT04575051|451176885|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
125424299|NCT04575051|451176886|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
125424300|NCT04575051|451176887|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
125424301|NCT04575051|451176888|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
125424302|NCT04575051|451176889|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
125424303|NCT04575051|451176885|FG000|Time Period 3|Missing follow up|8|||
125424304|NCT04575051|451176886|FG001|Time Period 3|Missing follow up|6|||
125424305|NCT04575051|451176887|FG002|Time Period 3|Missing follow up|4|||
125424306|NCT04575051|451176888|FG003|Time Period 3|Missing follow up|3|||
125424307|NCT04575051|451176889|FG004|Time Period 3|Missing follow up|0|||
125424308|NCT04575051|451176885|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
125424309|NCT04575051|451176886|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
125424310|NCT04575051|451176887|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
125424311|NCT04575051|451176888|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
125424312|NCT04575051|451176889|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
125424313|NCT04575051|451176885|FG000|Time Period 4|Missing follow up|17|||
125424314|NCT04575051|451176886|FG001|Time Period 4|Missing follow up|3|||
125424315|NCT04575051|451176887|FG002|Time Period 4|Missing follow up|4|||
125424316|NCT04575051|451176888|FG003|Time Period 4|Missing follow up|2|||
125424317|NCT04575051|451176889|FG004|Time Period 4|Missing follow up|1|||
125424318|NCT04575051|451176885|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
125424319|NCT04575051|451176886|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
125424320|NCT04575051|451176887|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
125424321|NCT04575051|451176888|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
125424322|NCT04575051|451176889|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
125424323|NCT04575051|451176885|FG000|Time Period 5|Missing follow up|11|||
125424324|NCT04575051|451176886|FG001|Time Period 5|Missing follow up|8|||
125424325|NCT04575051|451176887|FG002|Time Period 5|Missing follow up|12|||
125424326|NCT04575051|451176888|FG003|Time Period 5|Missing follow up|3|||
125424327|NCT04575051|451176889|FG004|Time Period 5|Missing follow up|11|||
125424328|NCT03583554|451176892|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
125424329|NCT03583554|451176893|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
125424330|NCT03583554|451176894|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
125424331|NCT03178266|451176895|FG000|Overall Study|Death|0|||
125424332|NCT03178266|451176896|FG001|Overall Study|Death|1|||
125424333|NCT03178266|451176895|FG000|Overall Study|Disont. Early|0|||
125424334|NCT03178266|451176896|FG001|Overall Study|Disont. Early|1|||
125424335|NCT03178266|451176895|FG000|Overall Study|Withdrawal by Subject|0|||
125424336|NCT03178266|451176896|FG001|Overall Study|Withdrawal by Subject|2|||
125424337|NCT02472964|451176897|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
125424338|NCT02472964|451176898|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
125424339|NCT02472964|451176897|FG000|Part 1 (up to Week 24)|disease progression|58|||
125424340|NCT02472964|451176898|FG001|Part 1 (up to Week 24)|disease progression|47|||
125424341|NCT02472964|451176897|FG000|Part 1 (up to Week 24)|Death|3|||
125424342|NCT02472964|451176898|FG001|Part 1 (up to Week 24)|Death|6|||
125424343|NCT02472964|451176897|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
125424344|NCT02472964|451176898|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
125424345|NCT02472964|451176897|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
125424346|NCT02472964|451176898|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
125424347|NCT02472964|451176897|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
125424348|NCT02472964|451176898|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
125424349|NCT02472964|451176897|FG000|Part 1 (up to Week 24)|Other|2|||
125424350|NCT02472964|451176898|FG001|Part 1 (up to Week 24)|Other|1|||
125424351|NCT02472964|451176897|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
125424352|NCT02472964|451176898|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
125424353|NCT02472964|451176897|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
125424354|NCT02472964|451176898|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
125424355|NCT02472964|451176897|FG000|Part 2 (Week 24-week 48)|Death|0|||
125424356|NCT02472964|451176898|FG001|Part 2 (Week 24-week 48)|Death|1|||
125424357|NCT02472964|451176897|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
125424358|NCT02472964|451176898|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
125424359|NCT02472964|451176897|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
125424360|NCT02472964|451176898|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
125424361|NCT02472964|451176897|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
125424362|NCT02472964|451176898|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
125424363|NCT02472964|451176897|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
125424364|NCT02472964|451176898|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
125424365|NCT04672941|451176904|FG000|Overall Study|Investigator decision|1|||
125424366|NCT04672941|451176904|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
125424367|NCT04672941|451176904|FG000|Overall Study|COVID-19 related but no adverse event|1|||
125424368|NCT04672941|451176904|FG000|Overall Study|Adverse Event|2|||
125424369|NCT04672941|451176904|FG000|Overall Study|Lost to Follow-up|2|||
125424370|NCT00765388|451176906|FG000|Period 1|Lack of Efficacy|1|||
125424371|NCT00765388|451176907|FG001|Period 1|Lack of Efficacy|2|||
125424372|NCT00765388|451176906|FG000|Period 1|Lost to Follow-up|0|||
125424373|NCT00765388|451176907|FG001|Period 1|Lost to Follow-up|1|||
125424374|NCT00765388|451176906|FG000|Period 1|Herpes Zoster|0|||
125424375|NCT00765388|451176907|FG001|Period 1|Herpes Zoster|1|||
125424376|NCT00765388|451176906|FG000|Period 1|Hip operation|0|||
125424377|NCT00765388|451176907|FG001|Period 1|Hip operation|1|||
125424378|NCT02342886|451176908|FG000|Overall Study|Treatment non-compliance|1|||
125424379|NCT02342886|451176909|FG001|Overall Study|Treatment non-compliance|0|||
125424380|NCT02342886|451176910|FG002|Overall Study|Treatment non-compliance|0|||
125424381|NCT02342886|451176911|FG003|Overall Study|Treatment non-compliance|1|||
125424382|NCT02342886|451176912|FG004|Overall Study|Treatment non-compliance|0|||
125424383|NCT02342886|451176908|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
125424384|NCT02342886|451176909|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
125424385|NCT02342886|451176910|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
125424386|NCT02342886|451176911|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
125424387|NCT02342886|451176912|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
125424388|NCT02342886|451176908|FG000|Overall Study|Adverse event/specific toxicity|4|||
125424389|NCT02342886|451176909|FG001|Overall Study|Adverse event/specific toxicity|3|||
125424390|NCT02342886|451176910|FG002|Overall Study|Adverse event/specific toxicity|11|||
125424391|NCT02342886|451176911|FG003|Overall Study|Adverse event/specific toxicity|2|||
125424392|NCT02342886|451176912|FG004|Overall Study|Adverse event/specific toxicity|1|||
125424393|NCT02342886|451176908|FG000|Overall Study|Lost to Follow-up|1|||
125424394|NCT02342886|451176909|FG001|Overall Study|Lost to Follow-up|0|||
125424395|NCT02342886|451176910|FG002|Overall Study|Lost to Follow-up|0|||
125424396|NCT02342886|451176911|FG003|Overall Study|Lost to Follow-up|0|||
125424397|NCT02342886|451176912|FG004|Overall Study|Lost to Follow-up|0|||
125424398|NCT02342886|451176908|FG000|Overall Study|Death|1|||
125424399|NCT02342886|451176909|FG001|Overall Study|Death|2|||
125424400|NCT02342886|451176910|FG002|Overall Study|Death|1|||
125424401|NCT02342886|451176911|FG003|Overall Study|Death|0|||
125424402|NCT02342886|451176912|FG004|Overall Study|Death|1|||
125534859|NCT03820947|451588241|FG003|Overall Study|Procedure Not Attempted|0|||
125534860|NCT03820947|451588242|FG004|Overall Study|Procedure Not Attempted|0|||
125424403|NCT02342886|451176908|FG000|Overall Study|Withdrawal by Subject|0|||
125424404|NCT02342886|451176909|FG001|Overall Study|Withdrawal by Subject|1|||
125424405|NCT02342886|451176910|FG002|Overall Study|Withdrawal by Subject|0|||
125424406|NCT02342886|451176911|FG003|Overall Study|Withdrawal by Subject|1|||
125424407|NCT02342886|451176912|FG004|Overall Study|Withdrawal by Subject|0|||
125424408|NCT02342886|451176908|FG000|Overall Study|Investigator/sponsor decision|0|||
125534861|NCT03820947|451588238|FG000|Overall Study|Other Exit|1|||
125534862|NCT03820947|451588239|FG001|Overall Study|Other Exit|3|||
125534863|NCT03820947|451588240|FG002|Overall Study|Other Exit|3|||
125534864|NCT03820947|451588241|FG003|Overall Study|Other Exit|3|||
125534865|NCT03820947|451588242|FG004|Overall Study|Other Exit|0|||
125534866|NCT03820947|451588238|FG000|Overall Study|Follow-up Not Done|10|||
125534867|NCT03820947|451588239|FG001|Overall Study|Follow-up Not Done|13|||
125534868|NCT03820947|451588240|FG002|Overall Study|Follow-up Not Done|2|||
125534869|NCT03820947|451588241|FG003|Overall Study|Follow-up Not Done|3|||
125534870|NCT03820947|451588242|FG004|Overall Study|Follow-up Not Done|12|||
125534871|NCT03820947|451588238|FG000|Overall Study|Death|0|||
125534872|NCT03820947|451588239|FG001|Overall Study|Death|0|||
125534873|NCT03820947|451588240|FG002|Overall Study|Death|0|||
125534874|NCT03820947|451588241|FG003|Overall Study|Death|0|||
125534875|NCT03820947|451588242|FG004|Overall Study|Death|9|||
125534876|NCT03820947|451588238|FG000|Overall Study|Lost to Follow-up|4|||
125534877|NCT03820947|451588239|FG001|Overall Study|Lost to Follow-up|6|||
125534878|NCT03820947|451588240|FG002|Overall Study|Lost to Follow-up|0|||
125424409|NCT02342886|451176909|FG001|Overall Study|Investigator/sponsor decision|2|||
125424410|NCT02342886|451176910|FG002|Overall Study|Investigator/sponsor decision|0|||
125424411|NCT02342886|451176911|FG003|Overall Study|Investigator/sponsor decision|3|||
125424412|NCT02342886|451176912|FG004|Overall Study|Investigator/sponsor decision|1|||
125424413|NCT02342886|451176908|FG000|Overall Study|Pregnancy|0|||
125424414|NCT02342886|451176909|FG001|Overall Study|Pregnancy|0|||
125424415|NCT02342886|451176910|FG002|Overall Study|Pregnancy|2|||
125424416|NCT02342886|451176911|FG003|Overall Study|Pregnancy|0|||
125424417|NCT02342886|451176912|FG004|Overall Study|Pregnancy|0|||
125424418|NCT02342886|451176908|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
125424419|NCT02342886|451176909|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
125424420|NCT02342886|451176910|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
125424421|NCT02342886|451176911|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
125424422|NCT02342886|451176912|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
125424423|NCT02342886|451176908|FG000|Overall Study|Protocol Violation|0|||
125424424|NCT02342886|451176909|FG001|Overall Study|Protocol Violation|0|||
125424425|NCT02342886|451176910|FG002|Overall Study|Protocol Violation|0|||
125424426|NCT02342886|451176911|FG003|Overall Study|Protocol Violation|2|||
125424427|NCT02342886|451176912|FG004|Overall Study|Protocol Violation|0|||
125534879|NCT03820947|451588241|FG003|Overall Study|Lost to Follow-up|0|||
125534880|NCT03820947|451588242|FG004|Overall Study|Lost to Follow-up|9|||
125534881|NCT03578887|451588243|FG000|Overall Study|Withdrawal by Subject|7|||
125424428|NCT01328080|451176913|FG000|Overall Study|Lost to Follow-up|5|||
125424429|NCT00862134|451176914|FG000|Overall Study|Death|1|||
125424430|NCT00862134|451176915|FG001|Overall Study|Death|0|||
125424431|NCT00862134|451176914|FG000|Overall Study|Physician Decision|0|||
125424432|NCT00862134|451176915|FG001|Overall Study|Physician Decision|1|||
125424433|NCT00862134|451176914|FG000|Overall Study|Withdrawal by Subject|1|||
125424434|NCT00862134|451176915|FG001|Overall Study|Withdrawal by Subject|2|||
125424435|NCT00862134|451176914|FG000|Overall Study|Sponsor terminated study|5|||
125424436|NCT00862134|451176915|FG001|Overall Study|Sponsor terminated study|7|||
125424437|NCT00862134|451176914|FG000|Overall Study|Adverse Event|2|||
125424438|NCT00862134|451176915|FG001|Overall Study|Adverse Event|2|||
125424439|NCT00862134|451176914|FG000|Overall Study|Withdrew prior to dosing|2|||
125424440|NCT00862134|451176915|FG001|Overall Study|Withdrew prior to dosing|0|||
125424441|NCT02191267|451176916|FG000|Overall Study|Withdrawal by Subject|1|||
125424442|NCT02191267|451176917|FG001|Overall Study|Withdrawal by Subject|0|||
125424443|NCT02191267|451176918|FG002|Overall Study|Withdrawal by Subject|0|||
125424444|NCT00316082|451176919|FG000|Overall Study|Lack of Efficacy|2|||
125424445|NCT00316082|451176920|FG001|Overall Study|Lack of Efficacy|3|||
125424446|NCT00316082|451176921|FG002|Overall Study|Lack of Efficacy|3|||
125424447|NCT00316082|451176922|FG003|Overall Study|Lack of Efficacy|4|||
125424448|NCT00316082|451176923|FG004|Overall Study|Lack of Efficacy|6|||
125424449|NCT00316082|451176919|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
125534882|NCT03578887|451588244|FG001|Overall Study|Withdrawal by Subject|2|||
125534883|NCT03578887|451588245|FG002|Overall Study|Withdrawal by Subject|1|||
125534884|NCT03578887|451588243|FG000|Overall Study|Lost to Follow-up|13|||
125424450|NCT00316082|451176920|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
125424451|NCT00316082|451176921|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
125424452|NCT00316082|451176922|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
125424453|NCT00316082|451176923|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
125424454|NCT00316082|451176919|FG000|Overall Study|Lost to Follow-up|7|||
125424455|NCT00316082|451176920|FG001|Overall Study|Lost to Follow-up|6|||
125424456|NCT00316082|451176921|FG002|Overall Study|Lost to Follow-up|7|||
125424457|NCT00316082|451176922|FG003|Overall Study|Lost to Follow-up|8|||
125424458|NCT00316082|451176923|FG004|Overall Study|Lost to Follow-up|6|||
125534885|NCT03578887|451588244|FG001|Overall Study|Lost to Follow-up|1|||
125534886|NCT03578887|451588245|FG002|Overall Study|Lost to Follow-up|4|||
125534887|NCT03578887|451588243|FG000|Overall Study|Physician Decision|0|||
125534888|NCT03578887|451588244|FG001|Overall Study|Physician Decision|1|||
125534889|NCT03578887|451588245|FG002|Overall Study|Physician Decision|1|||
125534890|NCT00387426|451589667|FG000|Overall Study|Lack of Response|7|||
125424459|NCT00316082|451176919|FG000|Overall Study|Poor/noncompliance|6|||
125424460|NCT00316082|451176920|FG001|Overall Study|Poor/noncompliance|1|||
125424461|NCT00316082|451176921|FG002|Overall Study|Poor/noncompliance|4|||
125424462|NCT00316082|451176922|FG003|Overall Study|Poor/noncompliance|1|||
125424463|NCT00316082|451176923|FG004|Overall Study|Poor/noncompliance|4|||
125424464|NCT00316082|451176919|FG000|Overall Study|Adverse Event|4|||
125424465|NCT00316082|451176920|FG001|Overall Study|Adverse Event|2|||
125424466|NCT00316082|451176921|FG002|Overall Study|Adverse Event|5|||
125424467|NCT00316082|451176922|FG003|Overall Study|Adverse Event|1|||
125424468|NCT00316082|451176923|FG004|Overall Study|Adverse Event|3|||
125424469|NCT00316082|451176919|FG000|Overall Study|Subject no longer meets study criteria|3|||
125424470|NCT00316082|451176920|FG001|Overall Study|Subject no longer meets study criteria|1|||
125424471|NCT00316082|451176921|FG002|Overall Study|Subject no longer meets study criteria|2|||
125424472|NCT00316082|451176922|FG003|Overall Study|Subject no longer meets study criteria|2|||
125424473|NCT00316082|451176923|FG004|Overall Study|Subject no longer meets study criteria|1|||
125424474|NCT00316082|451176919|FG000|Overall Study|Physician Decision|1|||
125424475|NCT00316082|451176920|FG001|Overall Study|Physician Decision|1|||
125424476|NCT00316082|451176921|FG002|Overall Study|Physician Decision|2|||
125424477|NCT00316082|451176922|FG003|Overall Study|Physician Decision|1|||
125424478|NCT00316082|451176923|FG004|Overall Study|Physician Decision|1|||
125424479|NCT00316082|451176919|FG000|Overall Study|Death|0|||
125534891|NCT00387426|451589667|FG000|Overall Study|Toxicities|4|||
125534892|NCT00387426|451589667|FG000|Overall Study|Disease Progression|3|||
125534893|NCT02218606|451589668|FG000|Overall Study|Adverse Event|1|||
125534894|NCT02218606|451589669|FG001|Overall Study|Adverse Event|1|||
125534895|NCT02218606|451589668|FG000|Overall Study|Death|15|||
125534896|NCT02218606|451589669|FG001|Overall Study|Death|28|||
125534897|NCT02218606|451589668|FG000|Overall Study|Physician Decision|0|||
125534898|NCT02218606|451589669|FG001|Overall Study|Physician Decision|1|||
125534899|NCT02218606|451589668|FG000|Overall Study|Withdrawal by Subject|4|||
125534900|NCT02218606|451589669|FG001|Overall Study|Withdrawal by Subject|0|||
125534901|NCT02218606|451589668|FG000|Overall Study|Noncompliance|1|||
125534902|NCT02218606|451589669|FG001|Overall Study|Noncompliance|0|||
125534903|NCT02218606|451589668|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
125534904|NCT02218606|451589669|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
125534905|NCT02218606|451589668|FG000|Overall Study|Other|2|||
125534906|NCT02218606|451589669|FG001|Overall Study|Other|1|||
125534907|NCT02218606|451589668|FG000|Overall Study|Never started treatment|0|||
125534908|NCT02218606|451589669|FG001|Overall Study|Never started treatment|1|||
125534909|NCT03203473|451589670|FG000|Induction Phase|Never started primary treatment|2|||
125534910|NCT03203473|451589671|FG001|Induction Phase|Never started primary treatment|0|||
125534911|NCT03203473|451589672|FG002|Induction Phase|Never started primary treatment|0|||
125534912|NCT03203473|451589670|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
125534913|NCT03203473|451589671|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
125534914|NCT03203473|451589672|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
125534915|NCT03203473|451589670|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
125534916|NCT03203473|451589671|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
125534917|NCT03203473|451589672|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
125534918|NCT03203473|451589670|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
125534919|NCT03203473|451589671|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
125534920|NCT03203473|451589672|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
125534921|NCT03203473|451589670|FG000|Arm Allocation Phase|started salvage therapy|0|||
125534922|NCT03203473|451589671|FG001|Arm Allocation Phase|started salvage therapy|5|||
125534923|NCT03203473|451589672|FG002|Arm Allocation Phase|started salvage therapy|0|||
125534924|NCT03203473|451589670|FG000|Arm Allocation Phase|Disease progression|0|||
125534925|NCT03203473|451589671|FG001|Arm Allocation Phase|Disease progression|0|||
125534926|NCT03203473|451589672|FG002|Arm Allocation Phase|Disease progression|37|||
125534927|NCT03203473|451589670|FG000|Arm Allocation Phase|Adverse Event|0|||
125534928|NCT03203473|451589671|FG001|Arm Allocation Phase|Adverse Event|0|||
125534929|NCT03203473|451589672|FG002|Arm Allocation Phase|Adverse Event|11|||
125534930|NCT03203473|451589670|FG000|Arm Allocation Phase|Physician Decision|0|||
125534931|NCT03203473|451589671|FG001|Arm Allocation Phase|Physician Decision|0|||
125534932|NCT03203473|451589672|FG002|Arm Allocation Phase|Physician Decision|3|||
125534933|NCT03203473|451589670|FG000|Arm Allocation Phase|Death|0|||
125534934|NCT03203473|451589671|FG001|Arm Allocation Phase|Death|0|||
125534935|NCT03203473|451589672|FG002|Arm Allocation Phase|Death|1|||
125534936|NCT03203473|451589670|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
125534937|NCT03203473|451589671|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
125534938|NCT03203473|451589672|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
125534939|NCT03203473|451589670|FG000|Arm Allocation Phase|Intercurrent illness|0|||
125534940|NCT03203473|451589671|FG001|Arm Allocation Phase|Intercurrent illness|0|||
125534941|NCT03203473|451589672|FG002|Arm Allocation Phase|Intercurrent illness|1|||
125534942|NCT03203473|451589670|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
125534943|NCT03203473|451589671|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
125534944|NCT03203473|451589672|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
125534945|NCT00890695|451589673|FG000|Overall Study|Protocol Violation|1|||
125534946|NCT00890695|451589674|FG001|Overall Study|Protocol Violation|0|||
125534947|NCT00568178|451589675|FG000|Double Blind Base Study|Adverse Event|0|||
125534948|NCT00568178|451589676|FG001|Double Blind Base Study|Adverse Event|2|||
125534949|NCT00568178|451589677|FG002|Double Blind Base Study|Adverse Event|1|||
125534950|NCT00568178|451589678|FG003|Double Blind Base Study|Adverse Event|2|||
125534951|NCT00568178|451589679|FG004|Double Blind Base Study|Adverse Event|0|||
125534952|NCT00568178|451589680|FG005|Double Blind Base Study|Adverse Event|0|||
125534953|NCT00568178|451589675|FG000|Double Blind Base Study|Lost to Follow-up|1|||
125534954|NCT00568178|451589676|FG001|Double Blind Base Study|Lost to Follow-up|0|||
125534955|NCT00568178|451589677|FG002|Double Blind Base Study|Lost to Follow-up|0|||
125534956|NCT00568178|451589678|FG003|Double Blind Base Study|Lost to Follow-up|1|||
125534957|NCT00568178|451589679|FG004|Double Blind Base Study|Lost to Follow-up|0|||
125534958|NCT00568178|451589680|FG005|Double Blind Base Study|Lost to Follow-up|0|||
125534959|NCT00568178|451589675|FG000|Double Blind Base Study|Physician Decision|1|||
125534960|NCT00568178|451589676|FG001|Double Blind Base Study|Physician Decision|1|||
125534961|NCT00568178|451589677|FG002|Double Blind Base Study|Physician Decision|0|||
125534962|NCT00568178|451589678|FG003|Double Blind Base Study|Physician Decision|1|||
125534963|NCT00568178|451589679|FG004|Double Blind Base Study|Physician Decision|0|||
125534964|NCT00568178|451589680|FG005|Double Blind Base Study|Physician Decision|0|||
125534965|NCT00568178|451589675|FG000|Double Blind Base Study|Protocol Violation|3|||
125534966|NCT00568178|451589676|FG001|Double Blind Base Study|Protocol Violation|2|||
125534967|NCT00568178|451589677|FG002|Double Blind Base Study|Protocol Violation|0|||
125534968|NCT00568178|451589678|FG003|Double Blind Base Study|Protocol Violation|0|||
125534969|NCT00568178|451589679|FG004|Double Blind Base Study|Protocol Violation|0|||
125534970|NCT00568178|451589680|FG005|Double Blind Base Study|Protocol Violation|0|||
125534971|NCT00568178|451589675|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
125534972|NCT00568178|451589676|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
125534973|NCT00568178|451589677|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
125534974|NCT00568178|451589678|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
125534975|NCT00568178|451589679|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
125534976|NCT00568178|451589680|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
125534977|NCT00568178|451589675|FG000|Double Blind Base Study|Progressive Disease|0|||
125534978|NCT00568178|451589676|FG001|Double Blind Base Study|Progressive Disease|0|||
125534979|NCT00568178|451589677|FG002|Double Blind Base Study|Progressive Disease|0|||
125534980|NCT00568178|451589678|FG003|Double Blind Base Study|Progressive Disease|1|||
125534981|NCT00568178|451589679|FG004|Double Blind Base Study|Progressive Disease|0|||
125534982|NCT00568178|451589680|FG005|Double Blind Base Study|Progressive Disease|0|||
125534983|NCT00568178|451589675|FG000|Open Label Extension|Adverse Event|0|||
125534984|NCT00568178|451589676|FG001|Open Label Extension|Adverse Event|0|||
125534985|NCT00568178|451589677|FG002|Open Label Extension|Adverse Event|0|||
125534986|NCT00568178|451589678|FG003|Open Label Extension|Adverse Event|0|||
125534987|NCT00568178|451589679|FG004|Open Label Extension|Adverse Event|11|||
125534988|NCT00568178|451589680|FG005|Open Label Extension|Adverse Event|8|||
125534989|NCT00568178|451589675|FG000|Open Label Extension|Protocol Violation|0|||
125534990|NCT00568178|451589676|FG001|Open Label Extension|Protocol Violation|0|||
125534991|NCT00568178|451589677|FG002|Open Label Extension|Protocol Violation|0|||
125534992|NCT00568178|451589678|FG003|Open Label Extension|Protocol Violation|0|||
125534993|NCT00568178|451589679|FG004|Open Label Extension|Protocol Violation|1|||
125534994|NCT00568178|451589680|FG005|Open Label Extension|Protocol Violation|0|||
125534995|NCT00568178|451589675|FG000|Open Label Extension|Lost to Follow-up|0|||
125534996|NCT00568178|451589676|FG001|Open Label Extension|Lost to Follow-up|0|||
125534997|NCT00568178|451589677|FG002|Open Label Extension|Lost to Follow-up|0|||
125534998|NCT00568178|451589678|FG003|Open Label Extension|Lost to Follow-up|0|||
125534999|NCT00568178|451589679|FG004|Open Label Extension|Lost to Follow-up|6|||
125535000|NCT00568178|451589680|FG005|Open Label Extension|Lost to Follow-up|11|||
125535001|NCT00568178|451589675|FG000|Open Label Extension|Physician Decision|0|||
125645737|NCT02839330|451986335|FG000|Overall Study|Protocol Violation|1|||
125645738|NCT02839330|451986336|FG001|Overall Study|Protocol Violation|2|||
125645739|NCT02839330|451986337|FG002|Overall Study|Protocol Violation|2|||
125645740|NCT02839330|451986338|FG003|Overall Study|Protocol Violation|3|||
125645741|NCT02839330|451986335|FG000|Overall Study|Other reason, not specified|4|||
125645742|NCT02839330|451986336|FG001|Overall Study|Other reason, not specified|3|||
125645743|NCT02839330|451986337|FG002|Overall Study|Other reason, not specified|3|||
125645744|NCT02839330|451986338|FG003|Overall Study|Other reason, not specified|6|||
125645745|NCT03802331|451986340|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
125645746|NCT03802331|451986341|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
125645747|NCT02074059|451986342|FG000|Overall Study|Death|0|||
125645748|NCT02074059|451986343|FG001|Overall Study|Death|0|||
125645749|NCT02074059|451986344|FG002|Overall Study|Death|0|||
125645750|NCT02074059|451986345|FG003|Overall Study|Death|0|||
125645751|NCT02074059|451986346|FG004|Overall Study|Death|1|||
125645752|NCT02074059|451986347|FG005|Overall Study|Death|1|||
125645753|NCT00779506|451986349|FG000|Overall Study|Screening Failed|2|||
125645754|NCT00779506|451986349|FG000|Overall Study|Adverse Event|4|||
125645755|NCT00779506|451986349|FG000|Overall Study|Lack of Efficacy|11|||
125645756|NCT00779506|451986349|FG000|Overall Study|Protocol Violation|5|||
125645757|NCT00779506|451986349|FG000|Overall Study|Withdrawal by Subject|6|||
125645758|NCT00779506|451986349|FG000|Overall Study|Lost to Follow-up|1|||
125645759|NCT01632345|451986352|FG000|Treatment: Part I|Adverse Event|1|||
125645760|NCT01632345|451986353|FG001|Treatment: Part I|Adverse Event|4|||
125645761|NCT01632345|451986354|FG002|Treatment: Part I|Adverse Event|2|||
125645762|NCT01632345|451986355|FG003|Treatment: Part I|Adverse Event|1|||
125645763|NCT01632345|451986356|FG004|Treatment: Part I|Adverse Event|3|||
125645764|NCT01632345|451986357|FG005|Treatment: Part I|Adverse Event|0|||
125645765|NCT01632345|451986358|FG006|Treatment: Part I|Adverse Event|0|||
125645766|NCT01632345|451986352|FG000|Treatment: Part I|Lack of Efficacy|0|||
125645767|NCT01632345|451986353|FG001|Treatment: Part I|Lack of Efficacy|1|||
125645768|NCT01632345|451986354|FG002|Treatment: Part I|Lack of Efficacy|0|||
125645769|NCT01632345|451986355|FG003|Treatment: Part I|Lack of Efficacy|1|||
125645770|NCT01632345|451986356|FG004|Treatment: Part I|Lack of Efficacy|1|||
125645771|NCT01632345|451986357|FG005|Treatment: Part I|Lack of Efficacy|0|||
125645772|NCT01632345|451986358|FG006|Treatment: Part I|Lack of Efficacy|0|||
125645773|NCT01632345|451986352|FG000|Treatment: Part I|Lost to Follow-up|3|||
125645774|NCT01632345|451986353|FG001|Treatment: Part I|Lost to Follow-up|2|||
125645775|NCT01632345|451986354|FG002|Treatment: Part I|Lost to Follow-up|1|||
125645776|NCT01632345|451986355|FG003|Treatment: Part I|Lost to Follow-up|3|||
125645777|NCT01632345|451986356|FG004|Treatment: Part I|Lost to Follow-up|4|||
125645778|NCT01632345|451986357|FG005|Treatment: Part I|Lost to Follow-up|0|||
125645779|NCT01632345|451986358|FG006|Treatment: Part I|Lost to Follow-up|0|||
125645780|NCT01632345|451986352|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
125645781|NCT01632345|451986353|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
125645782|NCT01632345|451986354|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
125645783|NCT01632345|451986355|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
125645784|NCT01632345|451986356|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
125645785|NCT01632345|451986357|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
125645786|NCT01632345|451986358|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
125645787|NCT01632345|451986352|FG000|Treatment: Part I|Physician Decision|2|||
125645788|NCT01632345|451986353|FG001|Treatment: Part I|Physician Decision|1|||
125645789|NCT01632345|451986354|FG002|Treatment: Part I|Physician Decision|0|||
125645790|NCT01632345|451986355|FG003|Treatment: Part I|Physician Decision|0|||
125645791|NCT01632345|451986356|FG004|Treatment: Part I|Physician Decision|1|||
125645792|NCT01632345|451986357|FG005|Treatment: Part I|Physician Decision|0|||
125645793|NCT01632345|451986358|FG006|Treatment: Part I|Physician Decision|0|||
125645794|NCT01632345|451986352|FG000|Treatment: Part I|Pregnancy|0|||
125645795|NCT01632345|451986353|FG001|Treatment: Part I|Pregnancy|1|||
125645796|NCT01632345|451986354|FG002|Treatment: Part I|Pregnancy|0|||
125645797|NCT01632345|451986355|FG003|Treatment: Part I|Pregnancy|0|||
125645798|NCT01632345|451986356|FG004|Treatment: Part I|Pregnancy|0|||
125645799|NCT01632345|451986357|FG005|Treatment: Part I|Pregnancy|0|||
125645800|NCT01632345|451986358|FG006|Treatment: Part I|Pregnancy|0|||
125645801|NCT01632345|451986352|FG000|Treatment: Part I|Protocol Deviation|0|||
125645802|NCT01632345|451986353|FG001|Treatment: Part I|Protocol Deviation|0|||
125645803|NCT01632345|451986354|FG002|Treatment: Part I|Protocol Deviation|1|||
125645804|NCT01632345|451986355|FG003|Treatment: Part I|Protocol Deviation|1|||
125645805|NCT01632345|451986356|FG004|Treatment: Part I|Protocol Deviation|0|||
125645806|NCT01632345|451986357|FG005|Treatment: Part I|Protocol Deviation|0|||
125645807|NCT01632345|451986358|FG006|Treatment: Part I|Protocol Deviation|0|||
125645808|NCT01632345|451986352|FG000|Treatment: Part I|Withdrawal by Subject|3|||
125645809|NCT01632345|451986353|FG001|Treatment: Part I|Withdrawal by Subject|4|||
125645810|NCT01632345|451986354|FG002|Treatment: Part I|Withdrawal by Subject|4|||
125645811|NCT01632345|451986355|FG003|Treatment: Part I|Withdrawal by Subject|1|||
125645812|NCT01632345|451986356|FG004|Treatment: Part I|Withdrawal by Subject|4|||
125645813|NCT01632345|451986357|FG005|Treatment: Part I|Withdrawal by Subject|0|||
125645814|NCT01632345|451986358|FG006|Treatment: Part I|Withdrawal by Subject|0|||
125645815|NCT01632345|451986352|FG000|Treatment: Part II|Adverse Event|0|||
125535002|NCT00568178|451589676|FG001|Open Label Extension|Physician Decision|0|||
125535003|NCT00568178|451589677|FG002|Open Label Extension|Physician Decision|0|||
125535004|NCT00568178|451589678|FG003|Open Label Extension|Physician Decision|0|||
125535005|NCT00568178|451589679|FG004|Open Label Extension|Physician Decision|9|||
125535006|NCT00568178|451589680|FG005|Open Label Extension|Physician Decision|8|||
125535007|NCT00568178|451589675|FG000|Open Label Extension|Pregnancy|0|||
125424480|NCT00316082|451176920|FG001|Overall Study|Death|0|||
125424481|NCT00316082|451176921|FG002|Overall Study|Death|1|||
125535008|NCT00568178|451589676|FG001|Open Label Extension|Pregnancy|0|||
125535009|NCT00568178|451589677|FG002|Open Label Extension|Pregnancy|0|||
125535010|NCT00568178|451589678|FG003|Open Label Extension|Pregnancy|0|||
125535011|NCT00568178|451589679|FG004|Open Label Extension|Pregnancy|0|||
125535012|NCT00568178|451589680|FG005|Open Label Extension|Pregnancy|1|||
125535013|NCT00568178|451589675|FG000|Open Label Extension|Progressive Disease|0|||
125535014|NCT00568178|451589676|FG001|Open Label Extension|Progressive Disease|0|||
125535015|NCT00568178|451589677|FG002|Open Label Extension|Progressive Disease|0|||
125535016|NCT00568178|451589678|FG003|Open Label Extension|Progressive Disease|0|||
125424482|NCT00316082|451176922|FG003|Overall Study|Death|0|||
125424483|NCT00316082|451176923|FG004|Overall Study|Death|0|||
125424484|NCT00316082|451176919|FG000|Overall Study|Administrative reason by sponsor|0|||
125424485|NCT00316082|451176920|FG001|Overall Study|Administrative reason by sponsor|0|||
125424486|NCT00316082|451176921|FG002|Overall Study|Administrative reason by sponsor|1|||
125424487|NCT00316082|451176922|FG003|Overall Study|Administrative reason by sponsor|0|||
125424488|NCT00316082|451176923|FG004|Overall Study|Administrative reason by sponsor|0|||
125424489|NCT00528775|451176924|FG000|Overall Study|Other not specified|1|||
125424490|NCT00587964|451176927|FG000|Overall Study|Withdrawal by Subject|1|||
125424491|NCT00587964|451176927|FG000|Overall Study|Lost to Follow-up|1|||
125424492|NCT00587964|451176927|FG000|Overall Study|Patient found to be ineligible|1|||
125424493|NCT00587964|451176927|FG000|Overall Study|Patient did not receive intervention|5|||
125424494|NCT00587964|451176927|FG000|Overall Study|Progression of Disease|4|||
125424495|NCT01569438|451176931|FG000|Overall Study|Lack of Efficacy|1|||
125424496|NCT01569438|451176932|FG001|Overall Study|Lack of Efficacy|2|||
125424497|NCT01569438|451176931|FG000|Overall Study|Withdrawal by Subject|0|||
125424498|NCT01569438|451176932|FG001|Overall Study|Withdrawal by Subject|3|||
125424499|NCT01569438|451176931|FG000|Overall Study|Adverse Event|2|||
125424500|NCT01569438|451176932|FG001|Overall Study|Adverse Event|15|||
125424501|NCT01569438|451176931|FG000|Overall Study|Protocol Violation|2|||
125424502|NCT01569438|451176932|FG001|Overall Study|Protocol Violation|0|||
125424503|NCT01569438|451176931|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
125424504|NCT01569438|451176932|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
125424505|NCT01569438|451176931|FG000|Overall Study|Sponsor/Physician decision|1|||
125424506|NCT01569438|451176932|FG001|Overall Study|Sponsor/Physician decision|1|||
125424507|NCT01569438|451176931|FG000|Overall Study|Unable to adhere to study schedule|0|||
125424508|NCT01569438|451176932|FG001|Overall Study|Unable to adhere to study schedule|1|||
125424509|NCT03649230|451176933|FG000|Overall Study|Adverse Event|12|||
125424510|NCT03649230|451176933|FG000|Overall Study|Death|8|||
125424511|NCT03649230|451176933|FG000|Overall Study|Withdrawal by Subject|6|||
125424512|NCT03649230|451176933|FG000|Overall Study|Physician Decision|5|||
125424513|NCT03649230|451176933|FG000|Overall Study|Disease progression|5|||
125424514|NCT03649230|451176933|FG000|Overall Study|Switched to non-HEC|5|||
125424515|NCT03649230|451176933|FG000|Overall Study|Chemotherapy discontinued|4|||
125424516|NCT03649230|451176933|FG000|Overall Study|Received only 3 HEC cycles|4|||
125424517|NCT03649230|451176933|FG000|Overall Study|Screen Failure|3|||
125424518|NCT03649230|451176933|FG000|Overall Study|Patient stopped treatment|2|||
125424519|NCT03649230|451176933|FG000|Overall Study|Protocol Violation|1|||
125424520|NCT03649230|451176933|FG000|Overall Study|Non-compliance|1|||
125424521|NCT03649230|451176933|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
125424522|NCT01693068|451176935|FG000|Randomization Period|On-study|2|||
125424523|NCT01693068|451176936|FG001|Randomization Period|On-study|5|||
125424524|NCT01693068|451176937|FG002|Randomization Period|On-study|0|||
125424525|NCT01693068|451176935|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
125424526|NCT01693068|451176936|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
125424527|NCT01693068|451176937|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
125424528|NCT00977665|451176943|FG000|Overall Study|Withdrawal by Subject|1|||
125424529|NCT00977665|451176944|FG001|Overall Study|Withdrawal by Subject|3|||
125645816|NCT01632345|451986353|FG001|Treatment: Part II|Adverse Event|0|||
125645817|NCT01632345|451986354|FG002|Treatment: Part II|Adverse Event|0|||
125424530|NCT00977665|451176943|FG000|Overall Study|Physician Decision|2|||
125424531|NCT00977665|451176944|FG001|Overall Study|Physician Decision|1|||
125535017|NCT00568178|451589679|FG004|Open Label Extension|Progressive Disease|3|||
125645818|NCT01632345|451986355|FG003|Treatment: Part II|Adverse Event|0|||
125645819|NCT01632345|451986356|FG004|Treatment: Part II|Adverse Event|0|||
125535018|NCT00568178|451589680|FG005|Open Label Extension|Progressive Disease|1|||
125535019|NCT00568178|451589675|FG000|Open Label Extension|Termination of Trial|0|||
125645820|NCT01632345|451986357|FG005|Treatment: Part II|Adverse Event|3|||
125424532|NCT00977665|451176943|FG000|Overall Study|Sponsor requested withdrawal|0|||
125535020|NCT00568178|451589676|FG001|Open Label Extension|Termination of Trial|0|||
125424533|NCT00977665|451176944|FG001|Overall Study|Sponsor requested withdrawal|1|||
125424534|NCT00977665|451176943|FG000|Overall Study|Lost to Follow-up|1|||
125424535|NCT00977665|451176944|FG001|Overall Study|Lost to Follow-up|0|||
125424536|NCT00977665|451176943|FG000|Overall Study|Death|3|||
125424537|NCT00977665|451176944|FG001|Overall Study|Death|2|||
125424538|NCT00977665|451176943|FG000|Overall Study|Adverse Event|14|||
125424539|NCT00977665|451176944|FG001|Overall Study|Adverse Event|7|||
125424540|NCT00977665|451176943|FG000|Overall Study|Treatment failure|0|||
125424541|NCT00977665|451176944|FG001|Overall Study|Treatment failure|1|||
125424542|NCT02432105|451176951|FG000|Overall Study|Lost to Follow-up|1|||
125424543|NCT02432105|451176952|FG001|Overall Study|Lost to Follow-up|1|||
125424544|NCT02432105|451176953|FG002|Overall Study|Lost to Follow-up|0|||
125424545|NCT02432105|451176951|FG000|Overall Study|Withdrawal by Subject|1|||
125424546|NCT02432105|451176952|FG001|Overall Study|Withdrawal by Subject|0|||
125424547|NCT02432105|451176953|FG002|Overall Study|Withdrawal by Subject|1|||
125424548|NCT02432105|451176951|FG000|Overall Study|Culture positive for yeast|0|||
125424549|NCT02432105|451176952|FG001|Overall Study|Culture positive for yeast|1|||
125424550|NCT02432105|451176953|FG002|Overall Study|Culture positive for yeast|0|||
125424551|NCT02432105|451176951|FG000|Overall Study|Randomized in error|0|||
125424552|NCT02432105|451176952|FG001|Overall Study|Randomized in error|0|||
125424553|NCT02432105|451176953|FG002|Overall Study|Randomized in error|2|||
125424554|NCT01400503|451176954|FG000|Overall Study|Withdrawal by Subject|1|||
125424555|NCT01400503|451176954|FG000|Overall Study|Study Terminated by Sponsor|58|||
125424556|NCT01400503|451176954|FG000|Overall Study|Other|1|||
125424557|NCT00058123|451176955|FG000|Overall Study|Wrong histology|9|||
125424558|NCT00058123|451176955|FG000|Overall Study|Received >3 prior treatments|1|||
125424559|NCT03053050|451176956|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
125424560|NCT03053050|451176957|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
125424561|NCT03053050|451176958|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
125424562|NCT03053050|451176959|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
125424563|NCT03053050|451176956|FG000|Randomized Phase|Withdrew Consent|16|||
125424564|NCT03053050|451176957|FG001|Randomized Phase|Withdrew Consent|8|||
125424565|NCT03053050|451176958|FG002|Randomized Phase|Withdrew Consent|9|||
125424566|NCT03053050|451176959|FG003|Randomized Phase|Withdrew Consent|0|||
125424567|NCT03053050|451176956|FG000|Randomized Phase|Investigator's Discretion|6|||
125424568|NCT03053050|451176957|FG001|Randomized Phase|Investigator's Discretion|6|||
125424569|NCT03053050|451176958|FG002|Randomized Phase|Investigator's Discretion|3|||
125424570|NCT03053050|451176959|FG003|Randomized Phase|Investigator's Discretion|0|||
125424571|NCT03053050|451176956|FG000|Randomized Phase|Lost to Follow-up|5|||
125424572|NCT03053050|451176957|FG001|Randomized Phase|Lost to Follow-up|1|||
125424573|NCT03053050|451176958|FG002|Randomized Phase|Lost to Follow-up|1|||
125424574|NCT03053050|451176959|FG003|Randomized Phase|Lost to Follow-up|0|||
125424575|NCT03053050|451176956|FG000|Randomized Phase|Adverse Event|0|||
125424576|NCT03053050|451176957|FG001|Randomized Phase|Adverse Event|1|||
125424577|NCT03053050|451176958|FG002|Randomized Phase|Adverse Event|0|||
125424578|NCT03053050|451176959|FG003|Randomized Phase|Adverse Event|0|||
125424579|NCT03053050|451176956|FG000|Randomized Phase|Randomized but Never Treated|2|||
125424580|NCT03053050|451176957|FG001|Randomized Phase|Randomized but Never Treated|2|||
125424581|NCT03053050|451176958|FG002|Randomized Phase|Randomized but Never Treated|2|||
125424582|NCT03053050|451176959|FG003|Randomized Phase|Randomized but Never Treated|0|||
125424583|NCT03053050|451176956|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
125424584|NCT03053050|451176957|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
125424585|NCT03053050|451176958|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
125424586|NCT03053050|451176959|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
125424587|NCT03053050|451176956|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
125535021|NCT00568178|451589677|FG002|Open Label Extension|Termination of Trial|0|||
125535022|NCT00568178|451589678|FG003|Open Label Extension|Termination of Trial|0|||
125535023|NCT00568178|451589679|FG004|Open Label Extension|Termination of Trial|45|||
125535024|NCT00568178|451589680|FG005|Open Label Extension|Termination of Trial|47|||
125535025|NCT00568178|451589675|FG000|Open Label Extension|Withdrawal by Subject|0|||
125535026|NCT00568178|451589676|FG001|Open Label Extension|Withdrawal by Subject|0|||
125535027|NCT00568178|451589677|FG002|Open Label Extension|Withdrawal by Subject|0|||
125535028|NCT00568178|451589678|FG003|Open Label Extension|Withdrawal by Subject|0|||
125535029|NCT00568178|451589679|FG004|Open Label Extension|Withdrawal by Subject|4|||
125535030|NCT00568178|451589680|FG005|Open Label Extension|Withdrawal by Subject|4|||
125535031|NCT01531673|451589681|FG000|Overall Study|Non-Compliance|0|||
125535032|NCT01531673|451589682|FG001|Overall Study|Non-Compliance|0|||
125535033|NCT01531673|451589683|FG002|Overall Study|Non-Compliance|0|||
125645821|NCT01632345|451986358|FG006|Treatment: Part II|Adverse Event|8|||
125424588|NCT03053050|451176957|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
125424589|NCT03053050|451176958|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
125424590|NCT03053050|451176959|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
125424591|NCT03053050|451176956|FG000|Open-label Phase|Withdrew Consent|0|||
125535034|NCT01531673|451589684|FG003|Overall Study|Non-Compliance|0|||
125535035|NCT01531673|451589685|FG004|Overall Study|Non-Compliance|0|||
125535036|NCT01531673|451589686|FG005|Overall Study|Non-Compliance|1|||
125535037|NCT01531673|451589687|FG006|Overall Study|Non-Compliance|0|||
125535038|NCT01531673|451589688|FG007|Overall Study|Non-Compliance|0|||
125535039|NCT01531673|451589689|FG008|Overall Study|Non-Compliance|0|||
125535040|NCT01531673|451589690|FG009|Overall Study|Non-Compliance|0|||
125535041|NCT01531673|451589691|FG010|Overall Study|Non-Compliance|0|||
125535042|NCT01531673|451589692|FG011|Overall Study|Non-Compliance|0|||
125535043|NCT01531673|451589693|FG012|Overall Study|Non-Compliance|0|||
125535044|NCT01531673|451589681|FG000|Overall Study|Adverse Event|0|||
125535045|NCT01531673|451589682|FG001|Overall Study|Adverse Event|1|||
125535046|NCT01531673|451589683|FG002|Overall Study|Adverse Event|0|||
125535047|NCT01531673|451589684|FG003|Overall Study|Adverse Event|0|||
125535048|NCT01531673|451589685|FG004|Overall Study|Adverse Event|0|||
125535049|NCT01531673|451589686|FG005|Overall Study|Adverse Event|0|||
125535050|NCT01531673|451589687|FG006|Overall Study|Adverse Event|0|||
125535051|NCT01531673|451589688|FG007|Overall Study|Adverse Event|0|||
125535052|NCT01531673|451589689|FG008|Overall Study|Adverse Event|0|||
125535053|NCT01531673|451589690|FG009|Overall Study|Adverse Event|0|||
125535054|NCT01531673|451589691|FG010|Overall Study|Adverse Event|0|||
125535055|NCT01531673|451589692|FG011|Overall Study|Adverse Event|0|||
125535056|NCT01531673|451589693|FG012|Overall Study|Adverse Event|0|||
125535057|NCT01531673|451589681|FG000|Overall Study|Lost to Follow-up|0|||
125535058|NCT01531673|451589682|FG001|Overall Study|Lost to Follow-up|0|||
125535059|NCT01531673|451589683|FG002|Overall Study|Lost to Follow-up|0|||
125535060|NCT01531673|451589684|FG003|Overall Study|Lost to Follow-up|0|||
125535061|NCT01531673|451589685|FG004|Overall Study|Lost to Follow-up|1|||
125535062|NCT01531673|451589686|FG005|Overall Study|Lost to Follow-up|0|||
125535063|NCT01531673|451589687|FG006|Overall Study|Lost to Follow-up|0|||
125535064|NCT01531673|451589688|FG007|Overall Study|Lost to Follow-up|0|||
125535065|NCT01531673|451589689|FG008|Overall Study|Lost to Follow-up|0|||
125535066|NCT01531673|451589690|FG009|Overall Study|Lost to Follow-up|0|||
125535067|NCT01531673|451589691|FG010|Overall Study|Lost to Follow-up|0|||
125535068|NCT01531673|451589692|FG011|Overall Study|Lost to Follow-up|0|||
125535069|NCT01531673|451589693|FG012|Overall Study|Lost to Follow-up|0|||
125535070|NCT01531673|451589681|FG000|Overall Study|Other|0|||
125535071|NCT01531673|451589682|FG001|Overall Study|Other|0|||
125535072|NCT01531673|451589683|FG002|Overall Study|Other|0|||
125535073|NCT01531673|451589684|FG003|Overall Study|Other|1|||
125535074|NCT01531673|451589685|FG004|Overall Study|Other|0|||
125535075|NCT01531673|451589686|FG005|Overall Study|Other|0|||
125535076|NCT01531673|451589687|FG006|Overall Study|Other|0|||
125535077|NCT01531673|451589688|FG007|Overall Study|Other|0|||
125535078|NCT01531673|451589689|FG008|Overall Study|Other|0|||
125535079|NCT01531673|451589690|FG009|Overall Study|Other|1|||
125535080|NCT01531673|451589691|FG010|Overall Study|Other|0|||
125535081|NCT01531673|451589692|FG011|Overall Study|Other|0|||
125535082|NCT01531673|451589693|FG012|Overall Study|Other|0|||
125535083|NCT01008553|451589694|FG000|Period 1 (Titration Period)|Physician Decision|2|||
125535084|NCT01008553|451589695|FG001|Period 1 (Titration Period)|Physician Decision|0|||
125535085|NCT01008553|451589696|FG002|Period 1 (Titration Period)|Physician Decision|0|||
125535086|NCT01008553|451589694|FG000|Period 1 (Titration Period)|Adverse Event|33|||
125535087|NCT01008553|451589695|FG001|Period 1 (Titration Period)|Adverse Event|0|||
125535088|NCT01008553|451589696|FG002|Period 1 (Titration Period)|Adverse Event|0|||
125535089|NCT01008553|451589694|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
125535090|NCT01008553|451589695|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
125535091|NCT01008553|451589696|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
125535092|NCT01008553|451589694|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
125535093|NCT01008553|451589695|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
125535094|NCT01008553|451589696|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
125535095|NCT01008553|451589694|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
125424592|NCT03053050|451176957|FG001|Open-label Phase|Withdrew Consent|0|||
125424593|NCT03053050|451176958|FG002|Open-label Phase|Withdrew Consent|0|||
125424594|NCT03053050|451176959|FG003|Open-label Phase|Withdrew Consent|6|||
125424595|NCT03053050|451176956|FG000|Open-label Phase|Investigator's Discretion|0|||
125424596|NCT03053050|451176957|FG001|Open-label Phase|Investigator's Discretion|0|||
125424597|NCT03053050|451176958|FG002|Open-label Phase|Investigator's Discretion|0|||
125424598|NCT03053050|451176959|FG003|Open-label Phase|Investigator's Discretion|4|||
125424599|NCT03703466|451176960|FG000|Overall Study|Death|2|||
125424600|NCT03703466|451176961|FG001|Overall Study|Death|1|||
125424601|NCT03703466|451176962|FG002|Overall Study|Death|0|||
125424602|NCT03703466|451176960|FG000|Overall Study|Withdrawal by Subject|0|||
125424603|NCT03703466|451176961|FG001|Overall Study|Withdrawal by Subject|3|||
125424604|NCT03703466|451176962|FG002|Overall Study|Withdrawal by Subject|0|||
125424605|NCT03703466|451176960|FG000|Overall Study|Completed < 3 Cycles|2|||
125424606|NCT03703466|451176961|FG001|Overall Study|Completed < 3 Cycles|2|||
125424607|NCT03703466|451176962|FG002|Overall Study|Completed < 3 Cycles|2|||
125424608|NCT05338333|451176963|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
125535096|NCT01008553|451589695|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
125535097|NCT01008553|451589696|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
125424609|NCT05338333|451176964|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
125424610|NCT05073133|451176968|FG000|Overall Study|Death|2|||
125424611|NCT03751631|451178641|FG000|Overall Study|Withdrawal by Subject|0|||
125424612|NCT03751631|451178642|FG001|Overall Study|Withdrawal by Subject|0|||
125424613|NCT03751631|451178643|FG002|Overall Study|Withdrawal by Subject|1|||
125424614|NCT03751631|451178644|FG003|Overall Study|Withdrawal by Subject|1|||
125535098|NCT01008553|451589694|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
125535099|NCT01008553|451589695|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
125535100|NCT01008553|451589696|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
125535101|NCT01008553|451589694|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
125535102|NCT01008553|451589695|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
125535103|NCT01008553|451589696|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
125535104|NCT01008553|451589694|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
125535105|NCT01008553|451589695|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
125535106|NCT01008553|451589696|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
125424615|NCT03751631|451178645|FG004|Overall Study|Withdrawal by Subject|0|||
125535107|NCT01008553|451589694|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
125535108|NCT01008553|451589695|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
125535109|NCT01008553|451589696|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
125535110|NCT01008553|451589694|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
125535111|NCT01008553|451589695|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
125535112|NCT01008553|451589696|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
125535113|NCT01008553|451589694|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
125535114|NCT01008553|451589695|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
125535115|NCT01008553|451589696|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
125535116|NCT01008553|451589694|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
125535117|NCT01008553|451589695|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
125535118|NCT01008553|451589696|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
125535119|NCT01008553|451589694|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
125535120|NCT01008553|451589695|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
125535121|NCT01008553|451589696|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
125535122|NCT01008553|451589694|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
125535123|NCT01008553|451589695|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
125535124|NCT01008553|451589696|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
125535125|NCT03563157|451589703|FG000|Overall Study|Progressive Disease|2|||
125535126|NCT02187159|451589704|FG000|Overall Study|Protocol Violation|4|||
125535127|NCT02187159|451589705|FG001|Overall Study|Protocol Violation|6|||
125535128|NCT02187159|451589706|FG002|Overall Study|Protocol Violation|3|||
125535129|NCT02187159|451589707|FG003|Overall Study|Protocol Violation|4|||
125535130|NCT02187159|451589704|FG000|Overall Study|Lack of Efficacy|10|||
125535131|NCT02187159|451589705|FG001|Overall Study|Lack of Efficacy|5|||
125535132|NCT02187159|451589706|FG002|Overall Study|Lack of Efficacy|4|||
125535133|NCT02187159|451589707|FG003|Overall Study|Lack of Efficacy|7|||
125535134|NCT02187159|451589704|FG000|Overall Study|Adverse Event|28|||
125535135|NCT02187159|451589705|FG001|Overall Study|Adverse Event|33|||
125535136|NCT02187159|451589706|FG002|Overall Study|Adverse Event|42|||
125535137|NCT02187159|451589707|FG003|Overall Study|Adverse Event|50|||
125535138|NCT02187159|451589704|FG000|Overall Study|Withdrawal by Subject|24|||
125535139|NCT02187159|451589705|FG001|Overall Study|Withdrawal by Subject|28|||
125535140|NCT02187159|451589706|FG002|Overall Study|Withdrawal by Subject|25|||
125535141|NCT02187159|451589707|FG003|Overall Study|Withdrawal by Subject|26|||
125535142|NCT02187159|451589704|FG000|Overall Study|Other|3|||
125535143|NCT02187159|451589705|FG001|Overall Study|Other|7|||
125535144|NCT02187159|451589706|FG002|Overall Study|Other|3|||
125424616|NCT03751631|451178646|FG005|Overall Study|Withdrawal by Subject|0|||
125424617|NCT00428090|451178648|FG000|Overall Study|Adverse Event|10|||
125424618|NCT00428090|451178649|FG001|Overall Study|Adverse Event|8|||
125424619|NCT00428090|451178650|FG002|Overall Study|Adverse Event|10|||
125424620|NCT00428090|451178651|FG003|Overall Study|Adverse Event|11|||
125424621|NCT00428090|451178648|FG000|Overall Study|Lost to Follow-up|3|||
125424622|NCT00428090|451178649|FG001|Overall Study|Lost to Follow-up|6|||
125424623|NCT00428090|451178650|FG002|Overall Study|Lost to Follow-up|1|||
125424624|NCT00428090|451178651|FG003|Overall Study|Lost to Follow-up|4|||
125424625|NCT00428090|451178648|FG000|Overall Study|Protocol Violation|3|||
125424626|NCT00428090|451178649|FG001|Overall Study|Protocol Violation|1|||
125424627|NCT00428090|451178650|FG002|Overall Study|Protocol Violation|3|||
125424628|NCT00428090|451178651|FG003|Overall Study|Protocol Violation|3|||
125424629|NCT00428090|451178648|FG000|Overall Study|Withdrawal by Subject|10|||
125424630|NCT00428090|451178649|FG001|Overall Study|Withdrawal by Subject|12|||
125424631|NCT00428090|451178650|FG002|Overall Study|Withdrawal by Subject|15|||
125424632|NCT00428090|451178651|FG003|Overall Study|Withdrawal by Subject|5|||
125424633|NCT00428090|451178648|FG000|Overall Study|Sponsor terminated study|0|||
125535145|NCT02187159|451589707|FG003|Overall Study|Other|9|||
125535146|NCT00567567|451589708|FG000|Overall Study|Adverse Event|0|||
125535147|NCT00567567|451589709|FG001|Overall Study|Adverse Event|2|||
125535148|NCT00567567|451589710|FG002|Overall Study|Adverse Event|5|||
125535149|NCT00567567|451589708|FG000|Overall Study|Death|8|||
125535150|NCT00567567|451589709|FG001|Overall Study|Death|1|||
125535151|NCT00567567|451589710|FG002|Overall Study|Death|5|||
125535152|NCT00567567|451589708|FG000|Overall Study|Lack of Efficacy|16|||
125535153|NCT00567567|451589709|FG001|Overall Study|Lack of Efficacy|17|||
125535154|NCT00567567|451589710|FG002|Overall Study|Lack of Efficacy|48|||
125535155|NCT00567567|451589708|FG000|Overall Study|Lost to Follow-up|0|||
125535156|NCT00567567|451589709|FG001|Overall Study|Lost to Follow-up|0|||
125535157|NCT00567567|451589710|FG002|Overall Study|Lost to Follow-up|1|||
125535158|NCT00567567|451589708|FG000|Overall Study|Physician Decision|16|||
125535159|NCT00567567|451589709|FG001|Overall Study|Physician Decision|18|||
125535160|NCT00567567|451589710|FG002|Overall Study|Physician Decision|84|||
125535161|NCT00567567|451589708|FG000|Overall Study|Withdrawal by Subject|0|||
125535162|NCT00567567|451589709|FG001|Overall Study|Withdrawal by Subject|0|||
125535163|NCT00567567|451589710|FG002|Overall Study|Withdrawal by Subject|2|||
125535164|NCT00567567|451589708|FG000|Overall Study|Ineligible|4|||
125535165|NCT00567567|451589709|FG001|Overall Study|Ineligible|0|||
125535166|NCT00567567|451589710|FG002|Overall Study|Ineligible|9|||
125535167|NCT00567567|451589708|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
125535168|NCT00567567|451589709|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
125535169|NCT00567567|451589710|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
125535170|NCT00567567|451589708|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
125535171|NCT00567567|451589709|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
125535172|NCT00567567|451589710|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
125535173|NCT00567567|451589708|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
125535174|NCT00567567|451589709|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
125535175|NCT00567567|451589710|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
125535176|NCT04335591|451589711|FG000|Overall Study|Adverse Event|5|||
125535177|NCT04335591|451589712|FG001|Overall Study|Adverse Event|2|||
125535178|NCT04335591|451589713|FG002|Overall Study|Adverse Event|3|||
125535179|NCT04335591|451589714|FG003|Overall Study|Adverse Event|2|||
125535180|NCT04335591|451589711|FG000|Overall Study|Protocol Violation|1|||
125535181|NCT04335591|451589712|FG001|Overall Study|Protocol Violation|0|||
125535182|NCT04335591|451589713|FG002|Overall Study|Protocol Violation|0|||
125535183|NCT04335591|451589714|FG003|Overall Study|Protocol Violation|0|||
125535184|NCT04335591|451589711|FG000|Overall Study|Withdrawal by Subject|8|||
125535185|NCT04335591|451589712|FG001|Overall Study|Withdrawal by Subject|4|||
125535186|NCT04335591|451589713|FG002|Overall Study|Withdrawal by Subject|4|||
125535187|NCT04335591|451589714|FG003|Overall Study|Withdrawal by Subject|5|||
125535188|NCT04335591|451589711|FG000|Overall Study|Subject planning pregnancy|0|||
125535189|NCT04335591|451589712|FG001|Overall Study|Subject planning pregnancy|1|||
125535190|NCT04335591|451589713|FG002|Overall Study|Subject planning pregnancy|0|||
125535191|NCT04335591|451589714|FG003|Overall Study|Subject planning pregnancy|0|||
125535192|NCT04335591|451589711|FG000|Overall Study|Ukrainian Russian war conflict|4|||
125535193|NCT04335591|451589712|FG001|Overall Study|Ukrainian Russian war conflict|5|||
125535194|NCT04335591|451589713|FG002|Overall Study|Ukrainian Russian war conflict|2|||
125535195|NCT04335591|451589714|FG003|Overall Study|Ukrainian Russian war conflict|0|||
125535196|NCT03268603|451589715|FG000|Overall Study|Withdrawal by Subject|6|||
125535197|NCT03268603|451589715|FG000|Overall Study|Physician Decision|1|||
125535198|NCT03268603|451589715|FG000|Overall Study|Withdrawn due to disease progression|2|||
125535199|NCT00356408|451589716|FG000|Overall Study|Adverse Event|9|||
125535200|NCT00356408|451589716|FG000|Overall Study|Lack of Efficacy|36|||
125535201|NCT00356408|451589716|FG000|Overall Study|Lost to Follow-up|2|||
125535202|NCT00356408|451589716|FG000|Overall Study|Withdrawal by Subject|6|||
125535203|NCT00356408|451589716|FG000|Overall Study|Other: Principal investigator discretion|3|||
125535204|NCT00356408|451589716|FG000|Overall Study|Other: Sponsor request|1|||
125535205|NCT00356408|451589716|FG000|Overall Study|Other: Azathioprine stopped|1|||
125535206|NCT00356408|451589716|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
125535207|NCT00356408|451589716|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
125535208|NCT05775991|451589718|FG000|Overall Study|Withdrawal by Subject|0|||
125535209|NCT05775991|451589719|FG001|Overall Study|Withdrawal by Subject|0|||
125535210|NCT05775991|451589720|FG002|Overall Study|Withdrawal by Subject|2|||
125535211|NCT04514510|451589721|FG000|Overall Study|Lost to Follow-up|0|||
125535212|NCT04514510|451589722|FG001|Overall Study|Lost to Follow-up|1|||
125535213|NCT04514510|451589721|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
125535214|NCT04514510|451589722|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
125535215|NCT00406692|451589723|FG000|Overall Study|Withdrawal by Subject|4|||
125535216|NCT00406692|451589723|FG000|Overall Study|Physician Decision|1|||
125535217|NCT00406692|451589723|FG000|Overall Study|Adverse Event|1|||
125535218|NCT00406692|451589723|FG000|Overall Study|Lack of Efficacy|1|||
125535219|NCT01145898|451589724|FG000|3-year Treatment|medication change by treating physician|3|||
125645822|NCT01632345|451986352|FG000|Treatment: Part II|Lost to Follow-up|0|||
125535220|NCT01145898|451589725|FG001|3-year Treatment|medication change by treating physician|16|||
125535221|NCT00214019|451589728|FG000|Overall Study|Lost to Follow-up|11|||
125535222|NCT00214019|451589728|FG000|Overall Study|Withdrawal by Subject|2|||
125535223|NCT00214019|451589728|FG000|Overall Study|Screen Failed prior to randomization|17|||
125535224|NCT00842244|451589729|FG000|Overall Study|Death|3|||
125535225|NCT00842244|451589729|FG000|Overall Study|Withdrawal by Subject|1|||
125535226|NCT00842244|451589729|FG000|Overall Study|Other|17|||
125535227|NCT01696045|451589735|FG000|Overall Study|Study drug toxicity|1|||
125535228|NCT01696045|451589736|FG001|Overall Study|Study drug toxicity|5|||
125535229|NCT01696045|451589735|FG000|Overall Study|Disease progression|2|||
125535230|NCT01696045|451589736|FG001|Overall Study|Disease progression|2|||
125535231|NCT04445987|451589737|FG000|Overall Study|Adverse Event|0|||
125535232|NCT04445987|451589738|FG001|Overall Study|Adverse Event|0|||
125535233|NCT04445987|451589739|FG002|Overall Study|Adverse Event|1|||
125535234|NCT04445987|451589740|FG003|Overall Study|Adverse Event|0|||
125535235|NCT04445987|451589741|FG004|Overall Study|Adverse Event|4|||
125535236|NCT04445987|451589742|FG005|Overall Study|Adverse Event|0|||
125535237|NCT04445987|451589737|FG000|Overall Study|Lost to Follow-up|4|||
125535238|NCT04445987|451589738|FG001|Overall Study|Lost to Follow-up|3|||
125535239|NCT04445987|451589739|FG002|Overall Study|Lost to Follow-up|1|||
125535240|NCT04445987|451589740|FG003|Overall Study|Lost to Follow-up|1|||
125535241|NCT04445987|451589741|FG004|Overall Study|Lost to Follow-up|29|||
125535242|NCT04445987|451589742|FG005|Overall Study|Lost to Follow-up|0|||
125535243|NCT04445987|451589737|FG000|Overall Study|Physician Decision|0|||
125535244|NCT04445987|451589738|FG001|Overall Study|Physician Decision|0|||
125535245|NCT04445987|451589739|FG002|Overall Study|Physician Decision|0|||
125535246|NCT04445987|451589740|FG003|Overall Study|Physician Decision|0|||
125535247|NCT04445987|451589741|FG004|Overall Study|Physician Decision|1|||
125535248|NCT04445987|451589742|FG005|Overall Study|Physician Decision|0|||
125645823|NCT01632345|451986353|FG001|Treatment: Part II|Lost to Follow-up|0|||
125645824|NCT01632345|451986354|FG002|Treatment: Part II|Lost to Follow-up|0|||
125645825|NCT01632345|451986355|FG003|Treatment: Part II|Lost to Follow-up|0|||
125645826|NCT01632345|451986356|FG004|Treatment: Part II|Lost to Follow-up|0|||
125645827|NCT01632345|451986357|FG005|Treatment: Part II|Lost to Follow-up|3|||
125645828|NCT01632345|451986358|FG006|Treatment: Part II|Lost to Follow-up|1|||
125645829|NCT01632345|451986352|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
125645830|NCT01632345|451986353|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
125645831|NCT01632345|451986354|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
125645832|NCT01632345|451986355|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
125645833|NCT01632345|451986356|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
125645834|NCT01632345|451986357|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
125645835|NCT01632345|451986358|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
125645836|NCT01632345|451986352|FG000|Treatment: Part II|Withdrawal by Subject|0|||
125645837|NCT01632345|451986353|FG001|Treatment: Part II|Withdrawal by Subject|0|||
125645838|NCT01632345|451986354|FG002|Treatment: Part II|Withdrawal by Subject|0|||
125645839|NCT01632345|451986355|FG003|Treatment: Part II|Withdrawal by Subject|0|||
125645840|NCT01632345|451986356|FG004|Treatment: Part II|Withdrawal by Subject|0|||
125645841|NCT01632345|451986357|FG005|Treatment: Part II|Withdrawal by Subject|2|||
125645842|NCT01632345|451986358|FG006|Treatment: Part II|Withdrawal by Subject|2|||
125645843|NCT02853318|451986362|FG000|Overall Study|Withdrawal by Subject|1|||
125645844|NCT01997333|451986363|FG000|Randomization and Treatment|Disease Progression|70|||
125645845|NCT01997333|451986364|FG001|Randomization and Treatment|Disease Progression|159|||
125645846|NCT01997333|451986363|FG000|Randomization and Treatment|Adverse Event|10|||
125645847|NCT01997333|451986364|FG001|Randomization and Treatment|Adverse Event|32|||
125645848|NCT01997333|451986363|FG000|Randomization and Treatment|Physician Decision|0|||
125645849|NCT01997333|451986364|FG001|Randomization and Treatment|Physician Decision|4|||
125645850|NCT01997333|451986363|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
125645851|NCT01997333|451986364|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
125645852|NCT01997333|451986363|FG000|Randomization and Treatment|Did not receive treatment|17|||
125645853|NCT01997333|451986364|FG001|Randomization and Treatment|Did not receive treatment|5|||
125645854|NCT01997333|451986363|FG000|Survival Follow up|Withdrawal by Subject|15|||
125645855|NCT01997333|451986364|FG001|Survival Follow up|Withdrawal by Subject|6|||
125645856|NCT01997333|451986363|FG000|Survival Follow up|Lost to Follow-up|0|||
125645857|NCT01997333|451986364|FG001|Survival Follow up|Lost to Follow-up|6|||
125645858|NCT01997333|451986363|FG000|Survival Follow up|Various|1|||
125645859|NCT01997333|451986364|FG001|Survival Follow up|Various|2|||
125645860|NCT05060003|451986365|FG000|Overall Study|ctDNA negative|7|||
125645861|NCT01535638|451986366|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
125645862|NCT01535638|451986367|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
125645863|NCT01535638|451986368|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
125200081|NCT02980341|450354970|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
125535249|NCT04445987|451589737|FG000|Overall Study|Protocol Violation|1|||
125535250|NCT04445987|451589738|FG001|Overall Study|Protocol Violation|0|||
125535251|NCT04445987|451589739|FG002|Overall Study|Protocol Violation|0|||
125535252|NCT04445987|451589740|FG003|Overall Study|Protocol Violation|0|||
125535253|NCT04445987|451589741|FG004|Overall Study|Protocol Violation|2|||
125535254|NCT04445987|451589742|FG005|Overall Study|Protocol Violation|0|||
125535255|NCT04445987|451589737|FG000|Overall Study|Withdrawal by Subject|4|||
125535256|NCT04445987|451589738|FG001|Overall Study|Withdrawal by Subject|0|||
125535257|NCT04445987|451589739|FG002|Overall Study|Withdrawal by Subject|1|||
125535258|NCT04445987|451589740|FG003|Overall Study|Withdrawal by Subject|0|||
125535259|NCT04445987|451589741|FG004|Overall Study|Withdrawal by Subject|18|||
125535260|NCT04445987|451589742|FG005|Overall Study|Withdrawal by Subject|1|||
125535261|NCT04445987|451589737|FG000|Overall Study|Other reason|0|||
125535262|NCT04445987|451589738|FG001|Overall Study|Other reason|0|||
125535263|NCT04445987|451589739|FG002|Overall Study|Other reason|1|||
125535264|NCT04445987|451589740|FG003|Overall Study|Other reason|0|||
125535265|NCT04445987|451589741|FG004|Overall Study|Other reason|2|||
125535266|NCT04445987|451589742|FG005|Overall Study|Other reason|0|||
125535267|NCT04531098|451589748|FG000|Stage I|Adverse Event|0|||
125535268|NCT04531098|451589749|FG001|Stage I|Adverse Event|0|||
125535269|NCT04531098|451589750|FG002|Stage I|Adverse Event|3|||
125535270|NCT04531098|451589748|FG000|Stage I|Protocol Violation|0|||
125535271|NCT04531098|451589749|FG001|Stage I|Protocol Violation|0|||
125535272|NCT04531098|451589750|FG002|Stage I|Protocol Violation|5|||
125535273|NCT04531098|451589748|FG000|Stage I|Withdrawal by Subject|0|||
125535274|NCT04531098|451589749|FG001|Stage I|Withdrawal by Subject|5|||
125535275|NCT04531098|451589750|FG002|Stage I|Withdrawal by Subject|10|||
125535276|NCT04531098|451589748|FG000|Stage II|Adverse Event|1|||
125535277|NCT04531098|451589749|FG001|Stage II|Adverse Event|2|||
125535278|NCT04531098|451589750|FG002|Stage II|Adverse Event|0|||
125535279|NCT04531098|451589748|FG000|Stage II|Protocol Violation|1|||
125535280|NCT04531098|451589749|FG001|Stage II|Protocol Violation|2|||
125535281|NCT04531098|451589750|FG002|Stage II|Protocol Violation|0|||
125535282|NCT04531098|451589748|FG000|Stage II|Withdrawal by Subject|3|||
125535283|NCT04531098|451589749|FG001|Stage II|Withdrawal by Subject|1|||
125535284|NCT04531098|451589750|FG002|Stage II|Withdrawal by Subject|0|||
125535285|NCT04531098|451589748|FG000|Stage II|Moved from study area|8|||
125535286|NCT04531098|451589749|FG001|Stage II|Moved from study area|5|||
125535287|NCT04531098|451589750|FG002|Stage II|Moved from study area|0|||
125535288|NCT02628028|451589751|FG000|Dosing Period|Withdrawal by Subject|0|||
125535289|NCT02628028|451589752|FG001|Dosing Period|Withdrawal by Subject|0|||
125535290|NCT02628028|451589753|FG002|Dosing Period|Withdrawal by Subject|1|||
125535291|NCT02628028|451589754|FG003|Dosing Period|Withdrawal by Subject|0|||
125535292|NCT02628028|451589755|FG004|Dosing Period|Withdrawal by Subject|2|||
125535293|NCT02628028|451589756|FG005|Dosing Period|Withdrawal by Subject|4|||
125535294|NCT02628028|451589757|FG006|Dosing Period|Withdrawal by Subject|1|||
125535295|NCT02628028|451589758|FG007|Dosing Period|Withdrawal by Subject|1|||
125535296|NCT02628028|451589751|FG000|Dosing Period|Adverse Event|0|||
125535297|NCT02628028|451589752|FG001|Dosing Period|Adverse Event|0|||
125535298|NCT02628028|451589753|FG002|Dosing Period|Adverse Event|0|||
125535299|NCT02628028|451589754|FG003|Dosing Period|Adverse Event|0|||
125535300|NCT02628028|451589755|FG004|Dosing Period|Adverse Event|2|||
125535301|NCT02628028|451589756|FG005|Dosing Period|Adverse Event|1|||
125535302|NCT02628028|451589757|FG006|Dosing Period|Adverse Event|3|||
125535303|NCT02628028|451589758|FG007|Dosing Period|Adverse Event|2|||
125535304|NCT02628028|451589751|FG000|Dosing Period|Death|0|||
125535305|NCT02628028|451589752|FG001|Dosing Period|Death|0|||
125535306|NCT02628028|451589753|FG002|Dosing Period|Death|0|||
125535307|NCT02628028|451589754|FG003|Dosing Period|Death|0|||
125535308|NCT02628028|451589755|FG004|Dosing Period|Death|0|||
125535309|NCT02628028|451589756|FG005|Dosing Period|Death|0|||
125535310|NCT02628028|451589757|FG006|Dosing Period|Death|0|||
125535311|NCT02628028|451589758|FG007|Dosing Period|Death|1|||
125535312|NCT02628028|451589751|FG000|Dosing Period|Lack of Efficacy|0|||
125535313|NCT02628028|451589752|FG001|Dosing Period|Lack of Efficacy|0|||
125535314|NCT02628028|451589753|FG002|Dosing Period|Lack of Efficacy|0|||
125535315|NCT02628028|451589754|FG003|Dosing Period|Lack of Efficacy|0|||
125535316|NCT02628028|451589755|FG004|Dosing Period|Lack of Efficacy|3|||
125535317|NCT02628028|451589756|FG005|Dosing Period|Lack of Efficacy|0|||
125535318|NCT02628028|451589757|FG006|Dosing Period|Lack of Efficacy|1|||
125535319|NCT02628028|451589758|FG007|Dosing Period|Lack of Efficacy|0|||
125535320|NCT02628028|451589751|FG000|Dosing Period|Study Terminated by Sponsor|0|||
125535321|NCT02628028|451589752|FG001|Dosing Period|Study Terminated by Sponsor|0|||
125535322|NCT02628028|451589753|FG002|Dosing Period|Study Terminated by Sponsor|0|||
125535323|NCT02628028|451589754|FG003|Dosing Period|Study Terminated by Sponsor|0|||
125535324|NCT02628028|451589755|FG004|Dosing Period|Study Terminated by Sponsor|7|||
125535325|NCT02628028|451589756|FG005|Dosing Period|Study Terminated by Sponsor|6|||
125535326|NCT02628028|451589757|FG006|Dosing Period|Study Terminated by Sponsor|7|||
125535327|NCT02628028|451589758|FG007|Dosing Period|Study Terminated by Sponsor|7|||
125535328|NCT02628028|451589751|FG000|Dosing Period|Physician Decision|0|||
125535329|NCT02628028|451589752|FG001|Dosing Period|Physician Decision|0|||
125535330|NCT02628028|451589753|FG002|Dosing Period|Physician Decision|0|||
125535331|NCT02628028|451589754|FG003|Dosing Period|Physician Decision|0|||
125535332|NCT02628028|451589755|FG004|Dosing Period|Physician Decision|0|||
125535333|NCT02628028|451589756|FG005|Dosing Period|Physician Decision|1|||
125535334|NCT02628028|451589757|FG006|Dosing Period|Physician Decision|0|||
125645864|NCT01535638|451986369|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
125645865|NCT01535638|451986370|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
125645866|NCT01535638|451986371|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
125645867|NCT01535638|451986366|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
125535335|NCT02628028|451589758|FG007|Dosing Period|Physician Decision|0|||
125535336|NCT02628028|451589751|FG000|Dosing Period|Site Terminated by Sponsor|0|||
125535337|NCT02628028|451589752|FG001|Dosing Period|Site Terminated by Sponsor|0|||
125535338|NCT02628028|451589753|FG002|Dosing Period|Site Terminated by Sponsor|0|||
125535339|NCT02628028|451589754|FG003|Dosing Period|Site Terminated by Sponsor|0|||
125535340|NCT02628028|451589755|FG004|Dosing Period|Site Terminated by Sponsor|0|||
125535341|NCT02628028|451589756|FG005|Dosing Period|Site Terminated by Sponsor|1|||
125535342|NCT02628028|451589757|FG006|Dosing Period|Site Terminated by Sponsor|1|||
125535343|NCT02628028|451589758|FG007|Dosing Period|Site Terminated by Sponsor|0|||
125535344|NCT02628028|451589751|FG000|Dosing Period|Lost to Follow-up|0|||
125535345|NCT02628028|451589752|FG001|Dosing Period|Lost to Follow-up|0|||
125535346|NCT02628028|451589753|FG002|Dosing Period|Lost to Follow-up|0|||
125535347|NCT02628028|451589754|FG003|Dosing Period|Lost to Follow-up|0|||
125535348|NCT02628028|451589755|FG004|Dosing Period|Lost to Follow-up|0|||
125535349|NCT02628028|451589756|FG005|Dosing Period|Lost to Follow-up|0|||
125535350|NCT02628028|451589757|FG006|Dosing Period|Lost to Follow-up|1|||
125535351|NCT02628028|451589758|FG007|Dosing Period|Lost to Follow-up|0|||
125535352|NCT02628028|451589751|FG000|Dosing Period|Other|0|||
125645868|NCT01535638|451986367|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
125645869|NCT01535638|451986368|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
125645870|NCT01535638|451986369|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
125645871|NCT01535638|451986370|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
125645872|NCT01535638|451986371|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
125645873|NCT00819052|451986372|FG000|Overall Study|Adverse Event|0|||
125645874|NCT00819052|451986373|FG001|Overall Study|Adverse Event|5|||
125645875|NCT00819052|451986372|FG000|Overall Study|Protocol Violation|1|||
125645876|NCT00819052|451986373|FG001|Overall Study|Protocol Violation|2|||
125645877|NCT00819052|451986372|FG000|Overall Study|Lost to Follow-up|1|||
125645878|NCT00819052|451986373|FG001|Overall Study|Lost to Follow-up|2|||
125645879|NCT00819052|451986372|FG000|Overall Study|Withdrawal by Subject|1|||
125645880|NCT00819052|451986373|FG001|Overall Study|Withdrawal by Subject|2|||
125645881|NCT00819052|451986372|FG000|Overall Study|Lack of Efficacy|1|||
125645882|NCT00819052|451986373|FG001|Overall Study|Lack of Efficacy|1|||
125645883|NCT00819052|451986372|FG000|Overall Study|Pregnancy|1|||
125645884|NCT00819052|451986373|FG001|Overall Study|Pregnancy|2|||
125645885|NCT00819052|451986372|FG000|Overall Study|Death or events leading to death|1|||
125645886|NCT00819052|451986373|FG001|Overall Study|Death or events leading to death|0|||
125645887|NCT01277666|451986378|FG000|Overall Study|Adverse Event|26|||
125645888|NCT01277666|451986379|FG001|Overall Study|Adverse Event|25|||
125645889|NCT01277666|451986380|FG002|Overall Study|Adverse Event|20|||
125645890|NCT01277666|451986378|FG000|Overall Study|Lack of Efficacy|8|||
125645891|NCT01277666|451986379|FG001|Overall Study|Lack of Efficacy|20|||
125645892|NCT01277666|451986380|FG002|Overall Study|Lack of Efficacy|12|||
125645893|NCT01277666|451986378|FG000|Overall Study|Protocol Violation|2|||
125645894|NCT01277666|451986379|FG001|Overall Study|Protocol Violation|3|||
125645895|NCT01277666|451986380|FG002|Overall Study|Protocol Violation|2|||
125645896|NCT01277666|451986378|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
125645897|NCT01277666|451986379|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
125645898|NCT01277666|451986380|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
125645899|NCT01277666|451986378|FG000|Overall Study|Lost to Follow-up|1|||
125645900|NCT01277666|451986379|FG001|Overall Study|Lost to Follow-up|1|||
125645901|NCT01277666|451986380|FG002|Overall Study|Lost to Follow-up|2|||
125645902|NCT01277666|451986378|FG000|Overall Study|Withdrawal by Subject|7|||
125645903|NCT01277666|451986379|FG001|Overall Study|Withdrawal by Subject|8|||
125645904|NCT01277666|451986380|FG002|Overall Study|Withdrawal by Subject|6|||
125645905|NCT01277666|451986378|FG000|Overall Study|Death|0|||
125645906|NCT01277666|451986379|FG001|Overall Study|Death|0|||
125645907|NCT01277666|451986380|FG002|Overall Study|Death|1|||
125645908|NCT03702166|451986381|FG000|Overall Study|Lost to Follow-up|1|||
125645909|NCT03702166|451986381|FG000|Overall Study|Withdrawal by Subject|1|||
125645910|NCT00620815|451986382|FG000|Overall Study|Adverse Event|1|||
125645911|NCT00620815|451986383|FG001|Overall Study|Adverse Event|1|||
125535353|NCT02628028|451589752|FG001|Dosing Period|Other|0|||
125535354|NCT02628028|451589753|FG002|Dosing Period|Other|0|||
125535355|NCT02628028|451589754|FG003|Dosing Period|Other|0|||
125645912|NCT00620815|451986384|FG002|Overall Study|Adverse Event|2|||
125645913|NCT00620815|451986382|FG000|Overall Study|Withdrawal by Subject|1|||
125645914|NCT00620815|451986383|FG001|Overall Study|Withdrawal by Subject|2|||
125645915|NCT00620815|451986384|FG002|Overall Study|Withdrawal by Subject|0|||
125645916|NCT00620815|451986382|FG000|Overall Study|Lost to Follow-up|1|||
125645917|NCT00620815|451986383|FG001|Overall Study|Lost to Follow-up|6|||
125645918|NCT00620815|451986384|FG002|Overall Study|Lost to Follow-up|3|||
125645919|NCT00620815|451986382|FG000|Overall Study|Inappropriate enrolment|0|||
125535356|NCT02628028|451589755|FG004|Dosing Period|Other|2|||
125535357|NCT02628028|451589756|FG005|Dosing Period|Other|1|||
125535358|NCT02628028|451589757|FG006|Dosing Period|Other|2|||
125535359|NCT02628028|451589758|FG007|Dosing Period|Other|4|||
125535360|NCT02628028|451589751|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
125535361|NCT02628028|451589752|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
125535362|NCT02628028|451589753|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
125535363|NCT02628028|451589754|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
125535364|NCT02628028|451589755|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
125535365|NCT02628028|451589756|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
125535366|NCT02628028|451589757|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
125535367|NCT02628028|451589758|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
125535368|NCT02628028|451589751|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
125535369|NCT02628028|451589752|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
125535370|NCT02628028|451589753|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
125535371|NCT02628028|451589754|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
125535372|NCT02628028|451589755|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
125535373|NCT02628028|451589756|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
125535374|NCT02628028|451589757|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
125535375|NCT02628028|451589758|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
125535376|NCT02628028|451589751|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
125535377|NCT02628028|451589752|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
125535378|NCT02628028|451589753|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
125535379|NCT02628028|451589754|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
125535380|NCT02628028|451589755|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
125535381|NCT02628028|451589756|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
125535382|NCT02628028|451589757|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
125535383|NCT02628028|451589758|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
125535384|NCT02628028|451589751|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
125535385|NCT02628028|451589752|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
125535386|NCT02628028|451589753|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
125535387|NCT02628028|451589754|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
125535388|NCT02628028|451589755|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
125535389|NCT02628028|451589756|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
125535390|NCT02628028|451589757|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
125535391|NCT02628028|451589758|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
125535392|NCT02628028|451589751|FG000|Long-term Extension (LTE) Period|Other|0|||
125535393|NCT02628028|451589752|FG001|Long-term Extension (LTE) Period|Other|0|||
125535394|NCT02628028|451589753|FG002|Long-term Extension (LTE) Period|Other|0|||
125535395|NCT02628028|451589754|FG003|Long-term Extension (LTE) Period|Other|0|||
125535396|NCT02628028|451589755|FG004|Long-term Extension (LTE) Period|Other|0|||
125535397|NCT02628028|451589756|FG005|Long-term Extension (LTE) Period|Other|3|||
125535398|NCT02628028|451589757|FG006|Long-term Extension (LTE) Period|Other|4|||
125535399|NCT02628028|451589758|FG007|Long-term Extension (LTE) Period|Other|3|||
125535400|NCT04157400|451589759|FG000|Overall Study|Withdrawal by Subject|1|||
125535401|NCT04157400|451589759|FG000|Overall Study|Lost to Follow-up|3|||
125535402|NCT05543707|451589761|FG000|Overall Study|Study drug non-compliance/|5|||
125535403|NCT05543707|451589762|FG001|Overall Study|Study drug non-compliance/|0|||
125535404|NCT05543707|451589761|FG000|Overall Study|Withdrawal by Subject|1|||
125535405|NCT05543707|451589762|FG001|Overall Study|Withdrawal by Subject|1|||
125535406|NCT05543707|451589761|FG000|Overall Study|Adverse Event|1|||
125535407|NCT05543707|451589762|FG001|Overall Study|Adverse Event|0|||
125535408|NCT05543707|451589761|FG000|Overall Study|concurrent illness|0|||
125535409|NCT05543707|451589762|FG001|Overall Study|concurrent illness|1|||
125535410|NCT05543707|451589761|FG000|Overall Study|Pregnancy|1|||
125535411|NCT05543707|451589762|FG001|Overall Study|Pregnancy|1|||
125535412|NCT00186888|451589763|FG000|Overall Study|Toxicity|0|||
125535413|NCT00186888|451589764|FG001|Overall Study|Toxicity|1|||
125535414|NCT00186888|451589765|FG002|Overall Study|Toxicity|0|||
125535415|NCT00186888|451589763|FG000|Overall Study|Relapse or progression of disease|4|||
125535416|NCT00186888|451589764|FG001|Overall Study|Relapse or progression of disease|2|||
125535417|NCT00186888|451589765|FG002|Overall Study|Relapse or progression of disease|0|||
125645920|NCT00620815|451986383|FG001|Overall Study|Inappropriate enrolment|0|||
125645921|NCT00620815|451986384|FG002|Overall Study|Inappropriate enrolment|1|||
125645922|NCT00620815|451986382|FG000|Overall Study|Protocol Violation|1|||
125645923|NCT00620815|451986383|FG001|Overall Study|Protocol Violation|2|||
125645924|NCT00620815|451986384|FG002|Overall Study|Protocol Violation|1|||
125535418|NCT02108964|451589766|FG000|Overall Study|Progressive disease|15|||
125535419|NCT02108964|451589767|FG001|Overall Study|Progressive disease|31|||
125535420|NCT02108964|451589768|FG002|Overall Study|Progressive disease|54|||
125535421|NCT02108964|451589769|FG003|Overall Study|Progressive disease|7|||
125535422|NCT02108964|451589770|FG004|Overall Study|Progressive disease|20|||
125535423|NCT02108964|451589771|FG005|Overall Study|Progressive disease|4|||
125645925|NCT01888367|451986387|FG000|Overall Study|Physician Decision|3|||
125645926|NCT01888367|451986388|FG001|Overall Study|Physician Decision|4|||
125645927|NCT01888367|451986389|FG002|Overall Study|Physician Decision|2|||
125645928|NCT01888367|451986387|FG000|Overall Study|Death|2|||
125645929|NCT01888367|451986388|FG001|Overall Study|Death|0|||
125645930|NCT01888367|451986389|FG002|Overall Study|Death|1|||
125645931|NCT01888367|451986387|FG000|Overall Study|Withdrawal by Subject|1|||
125645932|NCT01888367|451986388|FG001|Overall Study|Withdrawal by Subject|0|||
125645933|NCT01888367|451986389|FG002|Overall Study|Withdrawal by Subject|1|||
125645934|NCT01888367|451986387|FG000|Overall Study|Lost to Follow-up|1|||
125645935|NCT01888367|451986388|FG001|Overall Study|Lost to Follow-up|1|||
125645936|NCT01888367|451986389|FG002|Overall Study|Lost to Follow-up|0|||
125645937|NCT01888367|451986387|FG000|Overall Study|Protocol Violation|0|||
125645938|NCT01888367|451986388|FG001|Overall Study|Protocol Violation|0|||
125645939|NCT01888367|451986389|FG002|Overall Study|Protocol Violation|1|||
125645940|NCT01888367|451986387|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
125645941|NCT01888367|451986388|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
125645942|NCT01888367|451986389|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
125645943|NCT00842829|451986393|FG000|Dose Titration Period|Adverse Event|11|||
125645944|NCT00842829|451986394|FG001|Dose Titration Period|Adverse Event|10|||
125645945|NCT00842829|451986395|FG002|Dose Titration Period|Adverse Event|0|||
125645946|NCT00842829|451986393|FG000|Dose Titration Period|Lack of Efficacy|4|||
125645947|NCT00842829|451986394|FG001|Dose Titration Period|Lack of Efficacy|1|||
125645948|NCT00842829|451986395|FG002|Dose Titration Period|Lack of Efficacy|0|||
125645949|NCT00842829|451986393|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
125645950|NCT00842829|451986394|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
125645951|NCT00842829|451986395|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
125645952|NCT00842829|451986393|FG000|Dose Titration Period|Withdrawal by Subject|2|||
125645953|NCT00842829|451986394|FG001|Dose Titration Period|Withdrawal by Subject|6|||
125645954|NCT00842829|451986395|FG002|Dose Titration Period|Withdrawal by Subject|0|||
125645955|NCT00842829|451986393|FG000|Dose Titration Period|Other|5|||
125645956|NCT00842829|451986394|FG001|Dose Titration Period|Other|4|||
125645957|NCT00842829|451986395|FG002|Dose Titration Period|Other|0|||
125645958|NCT00842829|451986393|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
125645959|NCT00842829|451986394|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
125645960|NCT00842829|451986395|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
125645961|NCT00842829|451986393|FG000|Dose Titration Period|Non-compliance to study drug|2|||
125645962|NCT00842829|451986394|FG001|Dose Titration Period|Non-compliance to study drug|1|||
125645963|NCT00842829|451986395|FG002|Dose Titration Period|Non-compliance to study drug|0|||
125645964|NCT00842829|451986393|FG000|Treatment Period|Adverse Event|0|||
125645965|NCT00842829|451986394|FG001|Treatment Period|Adverse Event|0|||
125645966|NCT00842829|451986395|FG002|Treatment Period|Adverse Event|15|||
125645967|NCT00842829|451986393|FG000|Treatment Period|Lack of Efficacy|0|||
125645968|NCT00842829|451986394|FG001|Treatment Period|Lack of Efficacy|0|||
125645969|NCT00842829|451986395|FG002|Treatment Period|Lack of Efficacy|6|||
125645970|NCT00842829|451986393|FG000|Treatment Period|Unstable persistent cancer pain|0|||
125645971|NCT00842829|451986394|FG001|Treatment Period|Unstable persistent cancer pain|0|||
125645972|NCT00842829|451986395|FG002|Treatment Period|Unstable persistent cancer pain|5|||
125645973|NCT00842829|451986393|FG000|Treatment Period|Withdrawal by Subject|0|||
125645974|NCT00842829|451986394|FG001|Treatment Period|Withdrawal by Subject|0|||
125645975|NCT00842829|451986395|FG002|Treatment Period|Withdrawal by Subject|11|||
125645976|NCT00842829|451986393|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
125645977|NCT00842829|451986394|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
125645978|NCT00842829|451986395|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
125645979|NCT00842829|451986393|FG000|Treatment Period|Protocol Violation|0|||
125645980|NCT00842829|451986394|FG001|Treatment Period|Protocol Violation|0|||
125645981|NCT00842829|451986395|FG002|Treatment Period|Protocol Violation|2|||
125645982|NCT00842829|451986393|FG000|Treatment Period|Other|0|||
125645983|NCT00842829|451986394|FG001|Treatment Period|Other|0|||
125645984|NCT00842829|451986395|FG002|Treatment Period|Other|18|||
125645985|NCT00842829|451986393|FG000|Treatment Period|Non-compliance to study procedures|0|||
125645986|NCT00842829|451986394|FG001|Treatment Period|Non-compliance to study procedures|0|||
125535424|NCT02108964|451589772|FG006|Overall Study|Progressive disease|6|||
125535425|NCT02108964|451589773|FG007|Overall Study|Progressive disease|33|||
125535426|NCT02108964|451589766|FG000|Overall Study|Physician Decision|1|||
125535427|NCT02108964|451589767|FG001|Overall Study|Physician Decision|5|||
125535428|NCT02108964|451589768|FG002|Overall Study|Physician Decision|7|||
125535429|NCT02108964|451589769|FG003|Overall Study|Physician Decision|1|||
125645987|NCT00842829|451986395|FG002|Treatment Period|Non-compliance to study procedures|4|||
125645988|NCT00842829|451986393|FG000|Treatment Period|Unclear completion status|0|||
125645989|NCT00842829|451986394|FG001|Treatment Period|Unclear completion status|0|||
125645990|NCT00842829|451986395|FG002|Treatment Period|Unclear completion status|1|||
125645991|NCT00842829|451986393|FG000|Continuation Period|Adverse Event|0|||
125645992|NCT00842829|451986394|FG001|Continuation Period|Adverse Event|0|||
125645993|NCT00842829|451986395|FG002|Continuation Period|Adverse Event|32|||
125645994|NCT00842829|451986393|FG000|Continuation Period|Lack of Efficacy|0|||
125645995|NCT00842829|451986394|FG001|Continuation Period|Lack of Efficacy|0|||
125645996|NCT00842829|451986395|FG002|Continuation Period|Lack of Efficacy|6|||
125645997|NCT00842829|451986393|FG000|Continuation Period|Unstable persistent cancer pain|0|||
125645998|NCT00842829|451986394|FG001|Continuation Period|Unstable persistent cancer pain|0|||
125645999|NCT00842829|451986395|FG002|Continuation Period|Unstable persistent cancer pain|3|||
125646000|NCT00842829|451986393|FG000|Continuation Period|Withdrawal by Subject|0|||
125646001|NCT00842829|451986394|FG001|Continuation Period|Withdrawal by Subject|0|||
125646002|NCT00842829|451986395|FG002|Continuation Period|Withdrawal by Subject|10|||
125646003|NCT00842829|451986393|FG000|Continuation Period|Other|0|||
125535430|NCT02108964|451589770|FG004|Overall Study|Physician Decision|2|||
125646004|NCT00842829|451986394|FG001|Continuation Period|Other|0|||
125646005|NCT00842829|451986395|FG002|Continuation Period|Other|7|||
125646006|NCT00842829|451986393|FG000|Continuation Period|Non-compliance to study procedures|0|||
125646007|NCT00842829|451986394|FG001|Continuation Period|Non-compliance to study procedures|0|||
125646008|NCT00842829|451986395|FG002|Continuation Period|Non-compliance to study procedures|2|||
125646009|NCT00842829|451986393|FG000|Continuation Period|Non-compliance to study drug|0|||
125646010|NCT00842829|451986394|FG001|Continuation Period|Non-compliance to study drug|0|||
125646011|NCT00842829|451986395|FG002|Continuation Period|Non-compliance to study drug|1|||
125646012|NCT03969589|451986396|FG000|Overall Study|Lost to Follow-up|3|||
125646013|NCT03969589|451986397|FG001|Overall Study|Lost to Follow-up|2|||
125646014|NCT03969589|451986396|FG000|Overall Study|Declined Follow-Up|0|||
125646015|NCT03969589|451986397|FG001|Overall Study|Declined Follow-Up|1|||
125646016|NCT03417999|451986400|FG000|Overall Study|Withdrawal by Subject|1|||
125646017|NCT03417999|451986401|FG001|Overall Study|Withdrawal by Subject|0|||
125646018|NCT03417999|451986402|FG002|Overall Study|Withdrawal by Subject|0|||
125646019|NCT03417999|451986400|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
125535431|NCT02108964|451589771|FG005|Overall Study|Physician Decision|1|||
125535432|NCT02108964|451589772|FG006|Overall Study|Physician Decision|1|||
125535433|NCT02108964|451589773|FG007|Overall Study|Physician Decision|3|||
125535434|NCT02108964|451589766|FG000|Overall Study|Adverse Event|0|||
125535435|NCT02108964|451589767|FG001|Overall Study|Adverse Event|0|||
125535436|NCT02108964|451589768|FG002|Overall Study|Adverse Event|4|||
125535437|NCT02108964|451589769|FG003|Overall Study|Adverse Event|0|||
125535438|NCT02108964|451589770|FG004|Overall Study|Adverse Event|1|||
125535439|NCT02108964|451589771|FG005|Overall Study|Adverse Event|0|||
125535440|NCT02108964|451589772|FG006|Overall Study|Adverse Event|3|||
125535441|NCT02108964|451589773|FG007|Overall Study|Adverse Event|2|||
125535442|NCT02108964|451589766|FG000|Overall Study|Death|1|||
125535443|NCT02108964|451589767|FG001|Overall Study|Death|1|||
125535444|NCT02108964|451589768|FG002|Overall Study|Death|4|||
125535445|NCT02108964|451589769|FG003|Overall Study|Death|0|||
125535446|NCT02108964|451589770|FG004|Overall Study|Death|3|||
125535447|NCT02108964|451589771|FG005|Overall Study|Death|0|||
125535448|NCT02108964|451589772|FG006|Overall Study|Death|0|||
125535449|NCT02108964|451589773|FG007|Overall Study|Death|2|||
125535450|NCT02108964|451589766|FG000|Overall Study|Subject/Guardian decision|0|||
125535451|NCT02108964|451589767|FG001|Overall Study|Subject/Guardian decision|1|||
125535452|NCT02108964|451589768|FG002|Overall Study|Subject/Guardian decision|4|||
125535453|NCT02108964|451589769|FG003|Overall Study|Subject/Guardian decision|0|||
125535454|NCT02108964|451589770|FG004|Overall Study|Subject/Guardian decision|2|||
125535455|NCT02108964|451589771|FG005|Overall Study|Subject/Guardian decision|0|||
125535456|NCT02108964|451589772|FG006|Overall Study|Subject/Guardian decision|1|||
125535457|NCT02108964|451589773|FG007|Overall Study|Subject/Guardian decision|2|||
125535458|NCT02108964|451589766|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
125535459|NCT02108964|451589767|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
125535460|NCT02108964|451589768|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
125535461|NCT02108964|451589769|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
125535462|NCT02108964|451589770|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
125535463|NCT02108964|451589771|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
125535464|NCT02108964|451589772|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
125535465|NCT02108964|451589773|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
125535466|NCT01214642|451589776|FG000|Overall Study|Progressive Disease|3|||
125535467|NCT01214642|451589777|FG001|Overall Study|Progressive Disease|2|||
125535468|NCT01214642|451589778|FG002|Overall Study|Progressive Disease|3|||
125535469|NCT01214642|451589779|FG003|Overall Study|Progressive Disease|5|||
125535470|NCT01214642|451589780|FG004|Overall Study|Progressive Disease|5|||
125646020|NCT03417999|451986401|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
125535471|NCT01214642|451589781|FG005|Overall Study|Progressive Disease|3|||
125535472|NCT01214642|451589782|FG006|Overall Study|Progressive Disease|5|||
125535473|NCT01214642|451589783|FG007|Overall Study|Progressive Disease|3|||
125535474|NCT01214642|451589784|FG008|Overall Study|Progressive Disease|10|||
125535475|NCT01214642|451589785|FG009|Overall Study|Progressive Disease|2|||
125535476|NCT01214642|451589786|FG010|Overall Study|Progressive Disease|1|||
125535477|NCT01214642|451589787|FG011|Overall Study|Progressive Disease|4|||
125535478|NCT01214642|451589776|FG000|Overall Study|Adverse Event|0|||
125535479|NCT01214642|451589777|FG001|Overall Study|Adverse Event|1|||
125535480|NCT01214642|451589778|FG002|Overall Study|Adverse Event|0|||
125535481|NCT01214642|451589779|FG003|Overall Study|Adverse Event|0|||
125535482|NCT01214642|451589780|FG004|Overall Study|Adverse Event|0|||
125535483|NCT01214642|451589781|FG005|Overall Study|Adverse Event|0|||
125535484|NCT01214642|451589782|FG006|Overall Study|Adverse Event|1|||
125535485|NCT01214642|451589783|FG007|Overall Study|Adverse Event|0|||
125535486|NCT01214642|451589784|FG008|Overall Study|Adverse Event|0|||
125535487|NCT01214642|451589785|FG009|Overall Study|Adverse Event|1|||
125535488|NCT01214642|451589786|FG010|Overall Study|Adverse Event|1|||
125535489|NCT01214642|451589787|FG011|Overall Study|Adverse Event|0|||
125535490|NCT01214642|451589776|FG000|Overall Study|Death|0|||
125535491|NCT01214642|451589777|FG001|Overall Study|Death|0|||
125535492|NCT01214642|451589778|FG002|Overall Study|Death|1|||
125535493|NCT01214642|451589779|FG003|Overall Study|Death|0|||
125535494|NCT01214642|451589780|FG004|Overall Study|Death|0|||
125535495|NCT01214642|451589781|FG005|Overall Study|Death|0|||
125535496|NCT01214642|451589782|FG006|Overall Study|Death|0|||
125535497|NCT01214642|451589783|FG007|Overall Study|Death|0|||
125535498|NCT01214642|451589784|FG008|Overall Study|Death|0|||
125535499|NCT01214642|451589785|FG009|Overall Study|Death|0|||
125535500|NCT01214642|451589786|FG010|Overall Study|Death|1|||
125535501|NCT01214642|451589787|FG011|Overall Study|Death|0|||
125535502|NCT01214642|451589776|FG000|Overall Study|Withdrawal by Subject|0|||
125535503|NCT01214642|451589777|FG001|Overall Study|Withdrawal by Subject|0|||
125535504|NCT01214642|451589778|FG002|Overall Study|Withdrawal by Subject|1|||
125535505|NCT01214642|451589779|FG003|Overall Study|Withdrawal by Subject|0|||
125535506|NCT01214642|451589780|FG004|Overall Study|Withdrawal by Subject|0|||
125535507|NCT01214642|451589781|FG005|Overall Study|Withdrawal by Subject|0|||
125535508|NCT01214642|451589782|FG006|Overall Study|Withdrawal by Subject|0|||
125535509|NCT01214642|451589783|FG007|Overall Study|Withdrawal by Subject|0|||
125535510|NCT01214642|451589784|FG008|Overall Study|Withdrawal by Subject|3|||
125535511|NCT01214642|451589785|FG009|Overall Study|Withdrawal by Subject|1|||
125535512|NCT01214642|451589786|FG010|Overall Study|Withdrawal by Subject|1|||
125535513|NCT01214642|451589787|FG011|Overall Study|Withdrawal by Subject|0|||
125535514|NCT01214642|451589776|FG000|Overall Study|Physician Decision|0|||
125535515|NCT01214642|451589777|FG001|Overall Study|Physician Decision|0|||
125535516|NCT01214642|451589778|FG002|Overall Study|Physician Decision|1|||
125535517|NCT01214642|451589779|FG003|Overall Study|Physician Decision|1|||
125535518|NCT01214642|451589780|FG004|Overall Study|Physician Decision|1|||
125535519|NCT01214642|451589781|FG005|Overall Study|Physician Decision|0|||
125535520|NCT01214642|451589782|FG006|Overall Study|Physician Decision|0|||
125535521|NCT01214642|451589783|FG007|Overall Study|Physician Decision|0|||
125535522|NCT01214642|451589784|FG008|Overall Study|Physician Decision|0|||
125535523|NCT01214642|451589785|FG009|Overall Study|Physician Decision|0|||
125535524|NCT01214642|451589786|FG010|Overall Study|Physician Decision|0|||
125535525|NCT01214642|451589787|FG011|Overall Study|Physician Decision|2|||
125535526|NCT02336451|451589788|FG000|Overall Study|Adverse Event|1|||
125535527|NCT02336451|451589789|FG001|Overall Study|Adverse Event|2|||
125535528|NCT02336451|451589790|FG002|Overall Study|Adverse Event|0|||
125535529|NCT02336451|451589791|FG003|Overall Study|Adverse Event|6|||
125535530|NCT02336451|451589792|FG004|Overall Study|Adverse Event|4|||
125535531|NCT02336451|451589788|FG000|Overall Study|Death|6|||
125535532|NCT02336451|451589789|FG001|Overall Study|Death|2|||
125535533|NCT02336451|451589790|FG002|Overall Study|Death|3|||
125535534|NCT02336451|451589791|FG003|Overall Study|Death|6|||
125535535|NCT02336451|451589792|FG004|Overall Study|Death|6|||
125535536|NCT02336451|451589788|FG000|Overall Study|Physician Decision|9|||
125535537|NCT02336451|451589789|FG001|Overall Study|Physician Decision|6|||
125535538|NCT02336451|451589790|FG002|Overall Study|Physician Decision|7|||
125535539|NCT02336451|451589791|FG003|Overall Study|Physician Decision|16|||
125535540|NCT02336451|451589792|FG004|Overall Study|Physician Decision|3|||
125535541|NCT02336451|451589788|FG000|Overall Study|Progressive disease|23|||
125535542|NCT02336451|451589789|FG001|Overall Study|Progressive disease|26|||
125535543|NCT02336451|451589790|FG002|Overall Study|Progressive disease|2|||
125535544|NCT02336451|451589791|FG003|Overall Study|Progressive disease|14|||
125535545|NCT02336451|451589792|FG004|Overall Study|Progressive disease|4|||
125535546|NCT02336451|451589788|FG000|Overall Study|Protocol Violation|1|||
125535547|NCT02336451|451589789|FG001|Overall Study|Protocol Violation|0|||
125535548|NCT02336451|451589790|FG002|Overall Study|Protocol Violation|0|||
125535549|NCT02336451|451589791|FG003|Overall Study|Protocol Violation|0|||
125535550|NCT02336451|451589792|FG004|Overall Study|Protocol Violation|0|||
125535551|NCT02336451|451589788|FG000|Overall Study|Patient/guardian decision|2|||
125535552|NCT02336451|451589789|FG001|Overall Study|Patient/guardian decision|4|||
125535553|NCT02336451|451589790|FG002|Overall Study|Patient/guardian decision|0|||
125535554|NCT02336451|451589791|FG003|Overall Study|Patient/guardian decision|2|||
125535555|NCT02336451|451589792|FG004|Overall Study|Patient/guardian decision|1|||
125646021|NCT03417999|451986402|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
125646022|NCT03417999|451986400|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
125646023|NCT03417999|451986401|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
125646024|NCT03417999|451986402|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
125646025|NCT03417999|451986400|FG000|Overall Study|Inadequate study staff available to process samples|0|||
125646026|NCT03417999|451986401|FG001|Overall Study|Inadequate study staff available to process samples|0|||
125646027|NCT03417999|451986402|FG002|Overall Study|Inadequate study staff available to process samples|1|||
125646028|NCT00039377|451988144|FG000|Initial Registration|Adverse Event|2|||
125646029|NCT00039377|451988145|FG001|Initial Registration|Adverse Event|0|||
125646030|NCT00039377|451988146|FG002|Initial Registration|Adverse Event|0|||
125646031|NCT00039377|451988147|FG003|Initial Registration|Adverse Event|0|||
125646032|NCT00039377|451988144|FG000|Initial Registration|Relapsed|6|||
125646033|NCT00039377|451988145|FG001|Initial Registration|Relapsed|0|||
125646034|NCT00039377|451988146|FG002|Initial Registration|Relapsed|0|||
125646035|NCT00039377|451988147|FG003|Initial Registration|Relapsed|0|||
125646036|NCT00039377|451988144|FG000|Initial Registration|Received non-protocol therapy|11|||
125646037|NCT00039377|451988145|FG001|Initial Registration|Received non-protocol therapy|0|||
125646038|NCT00039377|451988146|FG002|Initial Registration|Received non-protocol therapy|0|||
125646039|NCT00039377|451988147|FG003|Initial Registration|Received non-protocol therapy|0|||
125646040|NCT00039377|451988144|FG000|Initial Registration|Withdrawal by Subject|3|||
125646041|NCT00039377|451988145|FG001|Initial Registration|Withdrawal by Subject|0|||
125646042|NCT00039377|451988146|FG002|Initial Registration|Withdrawal by Subject|0|||
125646043|NCT00039377|451988147|FG003|Initial Registration|Withdrawal by Subject|0|||
125646044|NCT04067310|451988151|FG000|Overall Study|Physician Decision|2|||
125646045|NCT04067310|451988152|FG001|Overall Study|Physician Decision|6|||
125646046|NCT04067310|451988151|FG000|Overall Study|Lost to Follow-up|0|||
125646047|NCT04067310|451988152|FG001|Overall Study|Lost to Follow-up|1|||
125200082|NCT02980341|450354971|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200083|NCT02980341|450354972|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200084|NCT02980341|450354973|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200085|NCT02980341|450354974|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200086|NCT02980341|450354975|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
125200087|NCT02980341|450354965|FG000|Dose Escalation|Due to investigator's decision|0|||
125200088|NCT02980341|450354966|FG001|Dose Escalation|Due to investigator's decision|0|||
125200089|NCT02980341|450354967|FG002|Dose Escalation|Due to investigator's decision|0|||
125200090|NCT02980341|450354968|FG003|Dose Escalation|Due to investigator's decision|0|||
125200091|NCT02980341|450354969|FG004|Dose Escalation|Due to investigator's decision|1|||
125200092|NCT02980341|450354970|FG005|Dose Escalation|Due to investigator's decision|0|||
125200093|NCT02980341|450354971|FG006|Dose Escalation|Due to investigator's decision|0|||
125200094|NCT02980341|450354972|FG007|Dose Escalation|Due to investigator's decision|0|||
125200095|NCT02980341|450354973|FG008|Dose Escalation|Due to investigator's decision|0|||
125200096|NCT02980341|450354974|FG009|Dose Escalation|Due to investigator's decision|0|||
125200097|NCT02980341|450354975|FG010|Dose Escalation|Due to investigator's decision|0|||
125200098|NCT02980341|450354965|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200099|NCT02980341|450354966|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200100|NCT02980341|450354967|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200101|NCT02980341|450354968|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
125535556|NCT02344290|451589797|FG000|Overall Study|Withdrawal by Subject|315|||
125535557|NCT02344290|451589798|FG001|Overall Study|Withdrawal by Subject|324|||
125535558|NCT02344290|451589797|FG000|Overall Study|Lost to Follow-up|258|||
125535559|NCT02344290|451589798|FG001|Overall Study|Lost to Follow-up|249|||
125535560|NCT02344290|451589797|FG000|Overall Study|Unable to get to clinic|69|||
125535561|NCT02344290|451589798|FG001|Overall Study|Unable to get to clinic|60|||
125535562|NCT02344290|451589797|FG000|Overall Study|Physician Decision|25|||
125535563|NCT02344290|451589798|FG001|Overall Study|Physician Decision|25|||
125200102|NCT02980341|450354969|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200103|NCT02980341|450354970|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
125200104|NCT02980341|450354971|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
125200105|NCT02980341|450354972|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200106|NCT02980341|450354973|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200107|NCT02980341|450354974|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200108|NCT02980341|450354975|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
125200109|NCT02980341|450354965|FG000|Dose Finding|Adverse Event|0|||
125200110|NCT02980341|450354966|FG001|Dose Finding|Adverse Event|0|||
125200111|NCT02980341|450354967|FG002|Dose Finding|Adverse Event|0|||
125200112|NCT02980341|450354968|FG003|Dose Finding|Adverse Event|0|||
125200113|NCT02980341|450354969|FG004|Dose Finding|Adverse Event|0|||
125200114|NCT02980341|450354970|FG005|Dose Finding|Adverse Event|3|||
125200115|NCT02980341|450354971|FG006|Dose Finding|Adverse Event|0|||
125535564|NCT02344290|451589797|FG000|Overall Study|Site Closure|15|||
125535565|NCT02344290|451589798|FG001|Overall Study|Site Closure|19|||
125535566|NCT02344290|451589797|FG000|Overall Study|Other|5|||
125535567|NCT02344290|451589798|FG001|Overall Study|Other|3|||
125535568|NCT04998812|451589799|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
125535569|NCT04998812|451589800|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
125535570|NCT04998812|451589799|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
125535571|NCT04998812|451589800|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
125535572|NCT04998812|451589799|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
125535573|NCT04998812|451589800|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
125535574|NCT04998812|451589799|FG000|Vaccination Period|Ongoing in study|23|||
125535575|NCT04998812|451589800|FG001|Vaccination Period|Ongoing in study|23|||
125535576|NCT03826030|451589801|FG000|Overall Study|Withdrawal by Subject|2|||
125535577|NCT03826030|451589802|FG001|Overall Study|Withdrawal by Subject|0|||
125535578|NCT03826030|451589803|FG002|Overall Study|Withdrawal by Subject|1|||
125535579|NCT03826030|451589801|FG000|Overall Study|Lost to Follow-up|1|||
125535580|NCT03826030|451589802|FG001|Overall Study|Lost to Follow-up|1|||
125535581|NCT03826030|451589803|FG002|Overall Study|Lost to Follow-up|1|||
125535582|NCT03826030|451589801|FG000|Overall Study|Too busy to return for visits|1|||
125535583|NCT03826030|451589802|FG001|Overall Study|Too busy to return for visits|0|||
125535584|NCT03826030|451589803|FG002|Overall Study|Too busy to return for visits|0|||
125535585|NCT04893460|451589808|FG000|Overall Study|Lost to Follow-up|18|||
125535586|NCT05718466|451591652|FG000|Overall Study|Withdrawal by Subject|1|||
125535587|NCT05718466|451591653|FG001|Overall Study|Withdrawal by Subject|2|||
125535588|NCT05718466|451591652|FG000|Overall Study|Death|0|||
125535589|NCT05718466|451591653|FG001|Overall Study|Death|1|||
125535590|NCT01732822|451591658|FG000|Overall Study|Withdrawal by Subject|123|||
125535591|NCT01732822|451591659|FG001|Overall Study|Withdrawal by Subject|113|||
125535592|NCT01183260|451591660|FG000|Overall Study|Intraop screen failure|2|||
125535593|NCT01183260|451591661|FG001|Overall Study|Intraop screen failure|0|||
125535594|NCT01183260|451591660|FG000|Overall Study|Withdrawal by Subject|1|||
125535595|NCT01183260|451591661|FG001|Overall Study|Withdrawal by Subject|1|||
125535596|NCT01183260|451591660|FG000|Overall Study|Revised within 30 days|0|||
125535597|NCT01183260|451591661|FG001|Overall Study|Revised within 30 days|1|||
125535598|NCT01183260|451591660|FG000|Overall Study|Death|1|||
125535599|NCT01183260|451591661|FG001|Overall Study|Death|0|||
125535600|NCT02815579|451591664|FG000|Overall Study|Non-payment of loan down-payment|16|||
125535601|NCT02815579|451591665|FG001|Overall Study|Non-payment of loan down-payment|0|||
125535602|NCT02815579|451591664|FG000|Overall Study|Withdrawal by Subject|7|||
125535603|NCT02815579|451591665|FG001|Overall Study|Withdrawal by Subject|1|||
125535604|NCT02815579|451591664|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
125535605|NCT02815579|451591665|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
125535606|NCT02815579|451591664|FG000|Overall Study|Lost to Follow-up|7|||
125535607|NCT02815579|451591665|FG001|Overall Study|Lost to Follow-up|4|||
125535608|NCT02815579|451591664|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
125535609|NCT02815579|451591665|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
125535610|NCT02815579|451591664|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
125535611|NCT02815579|451591665|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
125535612|NCT02815579|451591664|FG000|Overall Study|Death|5|||
125535613|NCT02815579|451591665|FG001|Overall Study|Death|4|||
125535614|NCT02815579|451591664|FG000|Overall Study|Imprisoned|0|||
125535615|NCT02815579|451591665|FG001|Overall Study|Imprisoned|2|||
125535616|NCT02815579|451591664|FG000|Overall Study|Did not meet enrollment criteria|0|||
125535617|NCT02815579|451591665|FG001|Overall Study|Did not meet enrollment criteria|1|||
125535618|NCT00264303|451591666|FG000|Overall Study|Adverse Event|4|||
125535619|NCT00264303|451591667|FG001|Overall Study|Adverse Event|3|||
125535620|NCT00264303|451591666|FG000|Overall Study|Lack of Efficacy|10|||
125535621|NCT00264303|451591667|FG001|Overall Study|Lack of Efficacy|13|||
125535622|NCT00264303|451591666|FG000|Overall Study|Lost to Follow-up|3|||
125535623|NCT00264303|451591667|FG001|Overall Study|Lost to Follow-up|3|||
125535624|NCT00264303|451591666|FG000|Overall Study|Withdrawal by Subject|2|||
125535625|NCT00264303|451591667|FG001|Overall Study|Withdrawal by Subject|3|||
125535626|NCT00264303|451591666|FG000|Overall Study|Various reasons listed in study report|6|||
125535627|NCT00264303|451591667|FG001|Overall Study|Various reasons listed in study report|7|||
125535628|NCT02389452|451591668|FG000|Overall Study|Lost to Follow-up|13|||
125535629|NCT02389452|451591668|FG000|Overall Study|Adverse Event|1|||
125535630|NCT02389452|451591668|FG000|Overall Study|Withdrawal by Subject|5|||
125535631|NCT02389452|451591668|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
125535632|NCT02311673|451591669|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
125535633|NCT02311673|451591670|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
125535634|NCT02311673|451591671|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
125535635|NCT02311673|451591672|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
125535636|NCT00414908|451591678|FG000|Overall Study|Protocol Violation|1|||
125535637|NCT00414908|451591679|FG001|Overall Study|Protocol Violation|1|||
125200116|NCT02980341|450354972|FG007|Dose Finding|Adverse Event|0|||
125200117|NCT02980341|450354973|FG008|Dose Finding|Adverse Event|0|||
125535638|NCT00818168|451591680|FG000|Overall Study|Lack of Efficacy|18|||
125535639|NCT00818168|451591680|FG000|Overall Study|Pregnancy|2|||
125535640|NCT00818168|451591680|FG000|Overall Study|Withdrawal by Subject|16|||
125535641|NCT00818168|451591680|FG000|Overall Study|Lost to Follow-up|7|||
125535642|NCT00818168|451591680|FG000|Overall Study|Adverse Event|19|||
125535643|NCT00818168|451591680|FG000|Overall Study|Reason for Non-completion Not reported|6|||
125535644|NCT00818168|451591680|FG000|Overall Study|Participant Moved|2|||
125535645|NCT02040259|451591681|FG000|Overall Study|Death|280|||
125535646|NCT02040259|451591681|FG000|Overall Study|Lost to Follow-up|76|||
125535647|NCT02040259|451591681|FG000|Overall Study|Assessment not completed|3|||
125535648|NCT02040259|451591681|FG000|Overall Study|Withdrawal by Subject|4|||
125535649|NCT04476251|451591682|FG000|Overall Study|Not treated|1|||
125535650|NCT00316602|451591692|FG000|Overall Study|Withdrawal by Subject|3|||
125535651|NCT00316602|451591693|FG001|Overall Study|Withdrawal by Subject|2|||
125200118|NCT02980341|450354974|FG009|Dose Finding|Adverse Event|0|||
125200119|NCT02980341|450354975|FG010|Dose Finding|Adverse Event|0|||
125200120|NCT02980341|450354965|FG000|Dose Finding|Withdrawal by Subject|0|||
125200121|NCT02980341|450354966|FG001|Dose Finding|Withdrawal by Subject|0|||
125200122|NCT02980341|450354967|FG002|Dose Finding|Withdrawal by Subject|0|||
125200123|NCT02980341|450354968|FG003|Dose Finding|Withdrawal by Subject|0|||
125200124|NCT02980341|450354969|FG004|Dose Finding|Withdrawal by Subject|0|||
125200125|NCT02980341|450354970|FG005|Dose Finding|Withdrawal by Subject|1|||
125200126|NCT02980341|450354971|FG006|Dose Finding|Withdrawal by Subject|1|||
125200127|NCT02980341|450354972|FG007|Dose Finding|Withdrawal by Subject|0|||
125200128|NCT02980341|450354973|FG008|Dose Finding|Withdrawal by Subject|0|||
125200129|NCT02980341|450354974|FG009|Dose Finding|Withdrawal by Subject|0|||
125200130|NCT02980341|450354975|FG010|Dose Finding|Withdrawal by Subject|0|||
125200131|NCT02980341|450354965|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
125200132|NCT02980341|450354966|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
125200133|NCT02980341|450354967|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
125200134|NCT02980341|450354968|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
125200135|NCT02980341|450354969|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
125535652|NCT00316602|451591692|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
125535653|NCT00316602|451591693|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
125535654|NCT00316602|451591692|FG000|Overall Study|Adverse Event|1|||
125535655|NCT00316602|451591693|FG001|Overall Study|Adverse Event|0|||
125535656|NCT00316602|451591692|FG000|Overall Study|Other|3|||
125535657|NCT00316602|451591693|FG001|Overall Study|Other|6|||
125535658|NCT00626990|451591694|FG000|Overall Study|Lack of Efficacy|6|||
125535659|NCT00626990|451591695|FG001|Overall Study|Lack of Efficacy|7|||
125535660|NCT00626990|451591696|FG002|Overall Study|Lack of Efficacy|49|||
125535661|NCT00626990|451591697|FG003|Overall Study|Lack of Efficacy|40|||
125535662|NCT00626990|451591694|FG000|Overall Study|Adverse Event|1|||
125535663|NCT00626990|451591695|FG001|Overall Study|Adverse Event|7|||
125200136|NCT02980341|450354970|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
125200137|NCT02980341|450354971|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
125200138|NCT02980341|450354972|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
125200139|NCT02980341|450354973|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
125200140|NCT02980341|450354974|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
125200141|NCT02980341|450354975|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
125200142|NCT02980341|450354965|FG000|Dose Expansion|Clinical progression|0|||
125200143|NCT02980341|450354966|FG001|Dose Expansion|Clinical progression|0|||
125200144|NCT02980341|450354967|FG002|Dose Expansion|Clinical progression|0|||
125200145|NCT02980341|450354968|FG003|Dose Expansion|Clinical progression|0|||
125200146|NCT02980341|450354969|FG004|Dose Expansion|Clinical progression|0|||
125200147|NCT02980341|450354970|FG005|Dose Expansion|Clinical progression|0|||
125200148|NCT02980341|450354971|FG006|Dose Expansion|Clinical progression|0|||
125200149|NCT02980341|450354972|FG007|Dose Expansion|Clinical progression|4|||
125200150|NCT02980341|450354973|FG008|Dose Expansion|Clinical progression|3|||
125200151|NCT02980341|450354974|FG009|Dose Expansion|Clinical progression|1|||
125200152|NCT02980341|450354975|FG010|Dose Expansion|Clinical progression|4|||
125200153|NCT02980341|450354965|FG000|Dose Expansion|Adverse Event|0|||
125200154|NCT02980341|450354966|FG001|Dose Expansion|Adverse Event|0|||
125200155|NCT02980341|450354967|FG002|Dose Expansion|Adverse Event|0|||
125200156|NCT02980341|450354968|FG003|Dose Expansion|Adverse Event|0|||
125200157|NCT02980341|450354969|FG004|Dose Expansion|Adverse Event|0|||
125535664|NCT00626990|451591696|FG002|Overall Study|Adverse Event|14|||
125535665|NCT00626990|451591697|FG003|Overall Study|Adverse Event|28|||
125535666|NCT00626990|451591694|FG000|Overall Study|Death|0|||
125535667|NCT00626990|451591695|FG001|Overall Study|Death|1|||
125200158|NCT02980341|450354970|FG005|Dose Expansion|Adverse Event|0|||
125200159|NCT02980341|450354971|FG006|Dose Expansion|Adverse Event|0|||
125535668|NCT00626990|451591696|FG002|Overall Study|Death|0|||
125535669|NCT00626990|451591697|FG003|Overall Study|Death|0|||
125200160|NCT02980341|450354972|FG007|Dose Expansion|Adverse Event|3|||
125535670|NCT00626990|451591694|FG000|Overall Study|Withdrawal by Subject|3|||
125535671|NCT00626990|451591695|FG001|Overall Study|Withdrawal by Subject|1|||
125535672|NCT00626990|451591696|FG002|Overall Study|Withdrawal by Subject|5|||
125535673|NCT00626990|451591697|FG003|Overall Study|Withdrawal by Subject|11|||
125535674|NCT00626990|451591694|FG000|Overall Study|Protocol Violation|0|||
125535675|NCT00626990|451591695|FG001|Overall Study|Protocol Violation|1|||
125535676|NCT00626990|451591696|FG002|Overall Study|Protocol Violation|1|||
125535677|NCT00626990|451591697|FG003|Overall Study|Protocol Violation|0|||
125535678|NCT00626990|451591694|FG000|Overall Study|Various different reasons/missing|4|||
125535679|NCT00626990|451591695|FG001|Overall Study|Various different reasons/missing|8|||
125535680|NCT00626990|451591696|FG002|Overall Study|Various different reasons/missing|8|||
125535681|NCT00626990|451591697|FG003|Overall Study|Various different reasons/missing|16|||
125535682|NCT04138576|451591702|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
125535683|NCT01008410|451591704|FG000|Overall Study|Adverse Event|13|||
125535684|NCT01008410|451591705|FG001|Overall Study|Adverse Event|7|||
125535685|NCT01008410|451591704|FG000|Overall Study|Withdrawal by Subject|6|||
125535686|NCT01008410|451591705|FG001|Overall Study|Withdrawal by Subject|2|||
125535687|NCT01008410|451591704|FG000|Overall Study|Lost to Follow-up|1|||
125535688|NCT01008410|451591705|FG001|Overall Study|Lost to Follow-up|0|||
125535689|NCT01008410|451591704|FG000|Overall Study|Noncompliance|1|||
125535690|NCT01008410|451591705|FG001|Overall Study|Noncompliance|0|||
125535691|NCT01008410|451591704|FG000|Overall Study|Low Cortisol|2|||
125535692|NCT01008410|451591705|FG001|Overall Study|Low Cortisol|0|||
125535693|NCT01008410|451591704|FG000|Overall Study|Lack of Efficacy|2|||
125535694|NCT01008410|451591705|FG001|Overall Study|Lack of Efficacy|6|||
125535695|NCT01008410|451591704|FG000|Overall Study|Met Exclusion Criterion|0|||
125535696|NCT01008410|451591705|FG001|Overall Study|Met Exclusion Criterion|1|||
125535697|NCT03056300|451591706|FG000|Overall Study|Surgical reason per study protocol|3|||
125535698|NCT03248882|451591707|FG000|Overall Study|Adverse Event|3|||
125535699|NCT03248882|451591708|FG001|Overall Study|Adverse Event|3|||
125535700|NCT03248882|451591709|FG002|Overall Study|Adverse Event|2|||
125535701|NCT03248882|451591710|FG003|Overall Study|Adverse Event|6|||
125535702|NCT03248882|451591711|FG004|Overall Study|Adverse Event|9|||
125535703|NCT03248882|451591707|FG000|Overall Study|Lost to Follow-up|0|||
125535704|NCT03248882|451591708|FG001|Overall Study|Lost to Follow-up|0|||
125535705|NCT03248882|451591709|FG002|Overall Study|Lost to Follow-up|0|||
125535706|NCT03248882|451591710|FG003|Overall Study|Lost to Follow-up|0|||
125535707|NCT03248882|451591711|FG004|Overall Study|Lost to Follow-up|1|||
125535708|NCT03248882|451591707|FG000|Overall Study|Protocol Violation|2|||
125535709|NCT03248882|451591708|FG001|Overall Study|Protocol Violation|0|||
125535710|NCT03248882|451591709|FG002|Overall Study|Protocol Violation|2|||
125535711|NCT03248882|451591710|FG003|Overall Study|Protocol Violation|0|||
125535712|NCT03248882|451591711|FG004|Overall Study|Protocol Violation|1|||
125535713|NCT03248882|451591707|FG000|Overall Study|Withdrawal by Subject|2|||
125535714|NCT03248882|451591708|FG001|Overall Study|Withdrawal by Subject|2|||
125535715|NCT03248882|451591709|FG002|Overall Study|Withdrawal by Subject|3|||
125535716|NCT03248882|451591710|FG003|Overall Study|Withdrawal by Subject|4|||
125535717|NCT03248882|451591711|FG004|Overall Study|Withdrawal by Subject|2|||
125535718|NCT01656200|451591712|FG000|Overall Study|Withdrawal by Subject|1|||
125535719|NCT03174431|451591713|FG000|Overall Study|Withdrawal by Subject|14|||
125535720|NCT03174431|451591714|FG001|Overall Study|Withdrawal by Subject|11|||
125535721|NCT03174431|451591713|FG000|Overall Study|alternative treatment|2|||
125535722|NCT03174431|451591714|FG001|Overall Study|alternative treatment|0|||
125535723|NCT03174431|451591713|FG000|Overall Study|Lost to Follow-up|1|||
125535724|NCT03174431|451591714|FG001|Overall Study|Lost to Follow-up|5|||
125535725|NCT01867333|451591715|FG000|Overall Study|Withdrawal by Subject|1|||
125535726|NCT01867333|451591716|FG001|Overall Study|Withdrawal by Subject|0|||
125535727|NCT01867333|451591715|FG000|Overall Study|Adverse Event|1|||
125535728|NCT01867333|451591716|FG001|Overall Study|Adverse Event|0|||
125535729|NCT01867333|451591715|FG000|Overall Study|Participant choice|1|||
125535730|NCT01867333|451591716|FG001|Overall Study|Participant choice|2|||
125535731|NCT01867333|451591715|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
125535732|NCT01867333|451591716|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
125535733|NCT01867333|451591715|FG000|Overall Study|Death|0|||
125535734|NCT01867333|451591716|FG001|Overall Study|Death|1|||
125535735|NCT01867333|451591715|FG000|Overall Study|Physician Decision|3|||
125535736|NCT01867333|451591716|FG001|Overall Study|Physician Decision|2|||
125200161|NCT02980341|450354973|FG008|Dose Expansion|Adverse Event|0|||
125535737|NCT01867333|451591715|FG000|Overall Study|Switched to alternative treatment|1|||
125535738|NCT01867333|451591716|FG001|Overall Study|Switched to alternative treatment|0|||
125535739|NCT00951015|451591719|FG000|Randomization Phase 96 Week|Adverse Event|1|||
125535740|NCT00951015|451591720|FG001|Randomization Phase 96 Week|Adverse Event|1|||
125535741|NCT00951015|451591721|FG002|Randomization Phase 96 Week|Adverse Event|2|||
125535742|NCT00951015|451591722|FG003|Randomization Phase 96 Week|Adverse Event|5|||
125535743|NCT00951015|451591723|FG004|Randomization Phase 96 Week|Adverse Event|0|||
125535744|NCT00951015|451591719|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
125200162|NCT02980341|450354974|FG009|Dose Expansion|Adverse Event|1|||
125200163|NCT02980341|450354975|FG010|Dose Expansion|Adverse Event|3|||
125200164|NCT02980341|450354965|FG000|Dose Expansion|Death|0|||
125200165|NCT02980341|450354966|FG001|Dose Expansion|Death|0|||
125200166|NCT02980341|450354967|FG002|Dose Expansion|Death|0|||
125200167|NCT02980341|450354968|FG003|Dose Expansion|Death|0|||
125200168|NCT02980341|450354969|FG004|Dose Expansion|Death|0|||
125200169|NCT02980341|450354970|FG005|Dose Expansion|Death|0|||
125200170|NCT02980341|450354971|FG006|Dose Expansion|Death|0|||
125200171|NCT02980341|450354972|FG007|Dose Expansion|Death|0|||
125200172|NCT02980341|450354973|FG008|Dose Expansion|Death|2|||
125200173|NCT02980341|450354974|FG009|Dose Expansion|Death|1|||
125200174|NCT02980341|450354975|FG010|Dose Expansion|Death|0|||
125200175|NCT02980341|450354965|FG000|Dose Expansion|Withdrawal by Subject|0|||
125200176|NCT02980341|450354966|FG001|Dose Expansion|Withdrawal by Subject|0|||
125200177|NCT02980341|450354967|FG002|Dose Expansion|Withdrawal by Subject|0|||
125200178|NCT02980341|450354968|FG003|Dose Expansion|Withdrawal by Subject|0|||
125200179|NCT02980341|450354969|FG004|Dose Expansion|Withdrawal by Subject|0|||
125200180|NCT02980341|450354970|FG005|Dose Expansion|Withdrawal by Subject|0|||
125200181|NCT02980341|450354971|FG006|Dose Expansion|Withdrawal by Subject|0|||
125200182|NCT02980341|450354972|FG007|Dose Expansion|Withdrawal by Subject|2|||
125200183|NCT02980341|450354973|FG008|Dose Expansion|Withdrawal by Subject|0|||
125200184|NCT02980341|450354974|FG009|Dose Expansion|Withdrawal by Subject|1|||
125200185|NCT02980341|450354975|FG010|Dose Expansion|Withdrawal by Subject|0|||
125200186|NCT02980341|450354965|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200187|NCT02980341|450354966|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200188|NCT02980341|450354967|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200189|NCT02980341|450354968|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200190|NCT02980341|450354969|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200191|NCT02980341|450354970|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200192|NCT02980341|450354971|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200193|NCT02980341|450354972|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
125200194|NCT02980341|450354973|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200195|NCT02980341|450354974|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200196|NCT02980341|450354975|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
125200197|NCT02980341|450354965|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200198|NCT02980341|450354966|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200199|NCT02980341|450354967|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200200|NCT02980341|450354968|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200201|NCT02980341|450354969|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200202|NCT02980341|450354970|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200203|NCT02980341|450354971|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200204|NCT02980341|450354972|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200205|NCT02980341|450354973|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
125200206|NCT02980341|450354974|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125200207|NCT02980341|450354975|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
125535745|NCT00951015|451591720|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
125535746|NCT00951015|451591721|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
125535747|NCT00951015|451591722|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
125535748|NCT00951015|451591723|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
125535749|NCT00951015|451591719|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
125535750|NCT00951015|451591720|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
125535751|NCT00951015|451591721|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
125535752|NCT00951015|451591722|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
125535753|NCT00951015|451591723|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
125535754|NCT00951015|451591719|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
125535755|NCT00951015|451591720|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
125535756|NCT00951015|451591721|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
125535757|NCT00951015|451591722|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
125535758|NCT00951015|451591723|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
125535759|NCT00951015|451591719|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
125535760|NCT00951015|451591720|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
125535761|NCT00951015|451591721|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
125535762|NCT00951015|451591722|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
125535763|NCT00951015|451591723|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
125535764|NCT00951015|451591719|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
125535765|NCT00951015|451591720|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
125535766|NCT00951015|451591721|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
125535767|NCT00951015|451591722|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
125535768|NCT00951015|451591723|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
125535769|NCT00951015|451591719|FG000|Open-label Phase|Adverse Event|0|||
125535770|NCT00951015|451591720|FG001|Open-label Phase|Adverse Event|0|||
125535771|NCT00951015|451591721|FG002|Open-label Phase|Adverse Event|0|||
125535772|NCT00951015|451591722|FG003|Open-label Phase|Adverse Event|0|||
125535773|NCT00951015|451591723|FG004|Open-label Phase|Adverse Event|3|||
125535774|NCT00951015|451591719|FG000|Open-label Phase|Lack of Efficacy|0|||
125535775|NCT00951015|451591720|FG001|Open-label Phase|Lack of Efficacy|0|||
125535776|NCT00951015|451591721|FG002|Open-label Phase|Lack of Efficacy|0|||
125535777|NCT00951015|451591722|FG003|Open-label Phase|Lack of Efficacy|0|||
125535778|NCT00951015|451591723|FG004|Open-label Phase|Lack of Efficacy|1|||
125535779|NCT00951015|451591719|FG000|Open-label Phase|Protocol Violation|0|||
125535780|NCT00951015|451591720|FG001|Open-label Phase|Protocol Violation|0|||
125535781|NCT00951015|451591721|FG002|Open-label Phase|Protocol Violation|0|||
125535782|NCT00951015|451591722|FG003|Open-label Phase|Protocol Violation|0|||
125535783|NCT00951015|451591723|FG004|Open-label Phase|Protocol Violation|12|||
125535784|NCT00951015|451591719|FG000|Open-label Phase|Lost to Follow-up|0|||
125535785|NCT00951015|451591720|FG001|Open-label Phase|Lost to Follow-up|0|||
125535786|NCT00951015|451591721|FG002|Open-label Phase|Lost to Follow-up|0|||
125535787|NCT00951015|451591722|FG003|Open-label Phase|Lost to Follow-up|0|||
125535788|NCT00951015|451591723|FG004|Open-label Phase|Lost to Follow-up|12|||
125535789|NCT00951015|451591719|FG000|Open-label Phase|Withdrawal by Subject|0|||
125535790|NCT00951015|451591720|FG001|Open-label Phase|Withdrawal by Subject|0|||
125535791|NCT00951015|451591721|FG002|Open-label Phase|Withdrawal by Subject|0|||
125535792|NCT00951015|451591722|FG003|Open-label Phase|Withdrawal by Subject|0|||
125535793|NCT00951015|451591723|FG004|Open-label Phase|Withdrawal by Subject|14|||
125535794|NCT00951015|451591719|FG000|Open-label Phase|Physician Decision|0|||
125535795|NCT00951015|451591720|FG001|Open-label Phase|Physician Decision|0|||
125535796|NCT00951015|451591721|FG002|Open-label Phase|Physician Decision|0|||
125535797|NCT00951015|451591722|FG003|Open-label Phase|Physician Decision|0|||
125535798|NCT00951015|451591723|FG004|Open-label Phase|Physician Decision|8|||
125535799|NCT03819634|451591725|FG000|Overall Study|Physician Decision|2|||
125535800|NCT01208103|451591726|FG000|Overall Study|Adverse Event|1|||
125535801|NCT01208103|451591726|FG000|Overall Study|Withdrawal by Subject|1|||
125535802|NCT00299494|451591727|FG000|Overall Study|Withdrawal by Subject|0|||
125535803|NCT00299494|451591728|FG001|Overall Study|Withdrawal by Subject|0|||
125535804|NCT00299494|451591729|FG002|Overall Study|Withdrawal by Subject|0|||
125535805|NCT00299494|451591730|FG003|Overall Study|Withdrawal by Subject|3|||
125535806|NCT00299494|451591731|FG004|Overall Study|Withdrawal by Subject|1|||
125535807|NCT00299494|451591732|FG005|Overall Study|Withdrawal by Subject|4|||
125535808|NCT00299494|451591727|FG000|Overall Study|Physician Decision|0|||
125535809|NCT00299494|451591728|FG001|Overall Study|Physician Decision|0|||
125535810|NCT00299494|451591729|FG002|Overall Study|Physician Decision|0|||
125535811|NCT00299494|451591730|FG003|Overall Study|Physician Decision|0|||
125535812|NCT00299494|451591731|FG004|Overall Study|Physician Decision|1|||
125535813|NCT00299494|451591732|FG005|Overall Study|Physician Decision|0|||
125535814|NCT00299494|451591727|FG000|Overall Study|Death|3|||
125535815|NCT00299494|451591728|FG001|Overall Study|Death|1|||
125535816|NCT00299494|451591729|FG002|Overall Study|Death|4|||
125535817|NCT00299494|451591730|FG003|Overall Study|Death|6|||
125535818|NCT00299494|451591731|FG004|Overall Study|Death|18|||
125535819|NCT00299494|451591732|FG005|Overall Study|Death|19|||
125535820|NCT00299494|451591727|FG000|Overall Study|Lost to Follow-up|0|||
125535821|NCT00299494|451591728|FG001|Overall Study|Lost to Follow-up|0|||
125535822|NCT00299494|451591729|FG002|Overall Study|Lost to Follow-up|0|||
125535823|NCT00299494|451591730|FG003|Overall Study|Lost to Follow-up|0|||
125535824|NCT00299494|451591731|FG004|Overall Study|Lost to Follow-up|3|||
125535825|NCT00299494|451591732|FG005|Overall Study|Lost to Follow-up|1|||
125535826|NCT00299494|451591727|FG000|Overall Study|Other - Unspecified|0|||
125535827|NCT00299494|451591728|FG001|Overall Study|Other - Unspecified|0|||
125535828|NCT00299494|451591729|FG002|Overall Study|Other - Unspecified|0|||
125535829|NCT00299494|451591730|FG003|Overall Study|Other - Unspecified|0|||
125535830|NCT00299494|451591731|FG004|Overall Study|Other - Unspecified|3|||
125535831|NCT00299494|451591732|FG005|Overall Study|Other - Unspecified|1|||
125535832|NCT00299494|451591727|FG000|Overall Study|Other - site closure|0|||
125535833|NCT00299494|451591728|FG001|Overall Study|Other - site closure|0|||
125535834|NCT00299494|451591729|FG002|Overall Study|Other - site closure|0|||
125535835|NCT00299494|451591730|FG003|Overall Study|Other - site closure|1|||
125535836|NCT00299494|451591731|FG004|Overall Study|Other - site closure|1|||
125535837|NCT00299494|451591732|FG005|Overall Study|Other - site closure|1|||
125535838|NCT00416195|451591733|FG000|Overall Study|Adverse Event|1|||
125535839|NCT00416195|451591734|FG001|Overall Study|Adverse Event|2|||
125535840|NCT00416195|451591733|FG000|Overall Study|Protocol Violation|1|||
125535841|NCT00416195|451591734|FG001|Overall Study|Protocol Violation|1|||
125535842|NCT00416195|451591733|FG000|Overall Study|Other|0|||
125535843|NCT00416195|451591734|FG001|Overall Study|Other|1|||
125535844|NCT01417104|451591739|FG000|Overall Study|Withdrawal by Subject|5|||
125535845|NCT01417104|451591740|FG001|Overall Study|Withdrawal by Subject|1|||
125535846|NCT01417104|451591739|FG000|Overall Study|Failure to make contact|0|||
125535847|NCT01417104|451591740|FG001|Overall Study|Failure to make contact|1|||
125535848|NCT01417104|451591739|FG000|Overall Study|Adverse Event|1|||
125535849|NCT01417104|451591740|FG001|Overall Study|Adverse Event|0|||
125535850|NCT03101462|451591741|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
125535851|NCT03101462|451591742|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
125535852|NCT00635661|451591743|FG000|Overall Study|Withdrawal by Subject|4|||
125535853|NCT01696955|451591746|FG000|Main Study|Protocol Violation|1|||
125535854|NCT01696955|451591747|FG001|Main Study|Protocol Violation|0|||
125535855|NCT01696955|451591746|FG000|Main Study|Withdrawal by Subject|1|||
125535856|NCT01696955|451591747|FG001|Main Study|Withdrawal by Subject|1|||
125535857|NCT03192475|451591748|FG000|Overall Study|Death|0|||
125535858|NCT03192475|451591749|FG001|Overall Study|Death|1|||
125535859|NCT03192475|451591748|FG000|Overall Study|Lost to Follow-up|13|||
125535860|NCT03192475|451591749|FG001|Overall Study|Lost to Follow-up|8|||
125535861|NCT00573859|451591752|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
125535862|NCT00573859|451591752|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
125535863|NCT03541200|451591761|FG000|Overall Study|Adverse Event|19|||
125535864|NCT03541200|451591761|FG000|Overall Study|Death|1|||
125535865|NCT03541200|451591761|FG000|Overall Study|Lost to Follow-up|10|||
125200208|NCT02980341|450354965|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200209|NCT02980341|450354966|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200210|NCT02980341|450354967|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200211|NCT02980341|450354968|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200212|NCT02980341|450354969|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200213|NCT02980341|450354970|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200214|NCT02980341|450354971|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200215|NCT02980341|450354972|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200216|NCT02980341|450354973|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
125200217|NCT02980341|450354974|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200218|NCT02980341|450354975|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
125200219|NCT02980341|450354965|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200220|NCT02980341|450354966|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200221|NCT02980341|450354967|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200222|NCT02980341|450354968|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200223|NCT02980341|450354969|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125535866|NCT03541200|451591761|FG000|Overall Study|Physician Decision|1|||
125535867|NCT03541200|451591761|FG000|Overall Study|Protocol Violation|51|||
125535868|NCT03541200|451591761|FG000|Overall Study|Withdrawal by Subject|23|||
125535869|NCT03541200|451591761|FG000|Overall Study|other|8|||
125535870|NCT01204710|451591763|FG000|Randomization Treatment|Lost to Follow-up|1|||
125535871|NCT01204710|451591764|FG001|Randomization Treatment|Lost to Follow-up|0|||
125535872|NCT01204710|451591763|FG000|Randomization Treatment|Withdrawal by Subject|6|||
125535873|NCT01204710|451591764|FG001|Randomization Treatment|Withdrawal by Subject|5|||
125535874|NCT01204710|451591763|FG000|Randomization Treatment|Physician Decision|3|||
125535875|NCT01204710|451591764|FG001|Randomization Treatment|Physician Decision|2|||
125535876|NCT01204710|451591763|FG000|Randomization Treatment|Entry criteria not met|0|||
125535877|NCT01204710|451591764|FG001|Randomization Treatment|Entry criteria not met|1|||
125535878|NCT01204710|451591763|FG000|Randomization Treatment|Adverse Event|4|||
125535879|NCT01204710|451591764|FG001|Randomization Treatment|Adverse Event|2|||
125535880|NCT01204710|451591763|FG000|Randomization Treatment|Sponsor Decision|0|||
125535881|NCT01204710|451591764|FG001|Randomization Treatment|Sponsor Decision|1|||
125535882|NCT01204710|451591763|FG000|Randomization Treatment|Worsening of General condition|0|||
125535883|NCT01204710|451591764|FG001|Randomization Treatment|Worsening of General condition|1|||
125200224|NCT02980341|450354970|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200225|NCT02980341|450354971|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200226|NCT02980341|450354972|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200227|NCT02980341|450354973|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125535884|NCT01204710|451591763|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
125535885|NCT01204710|451591764|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
125535886|NCT01204710|451591763|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
125535887|NCT01204710|451591764|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
125535888|NCT01204710|451591763|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
125535889|NCT01204710|451591764|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
125535890|NCT01204710|451591763|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
125535891|NCT01204710|451591764|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
125535892|NCT01276379|451591765|FG000|Overall Study|Screening failure|40|||
125535893|NCT00864253|451591766|FG000|Overall Study|Adverse Event|56|||
125535894|NCT00864253|451591767|FG001|Overall Study|Adverse Event|11|||
125535895|NCT00864253|451591766|FG000|Overall Study|Unrelated Adverse Event|3|||
125535896|NCT00864253|451591767|FG001|Overall Study|Unrelated Adverse Event|1|||
125535897|NCT00864253|451591766|FG000|Overall Study|Physician Decision|11|||
125535898|NCT00864253|451591767|FG001|Overall Study|Physician Decision|15|||
125535899|NCT00864253|451591766|FG000|Overall Study|Protocol Violation|0|||
125535900|NCT00864253|451591767|FG001|Overall Study|Protocol Violation|2|||
125535901|NCT00864253|451591766|FG000|Overall Study|Lost to Follow-up|1|||
125535902|NCT00864253|451591767|FG001|Overall Study|Lost to Follow-up|1|||
125535903|NCT00864253|451591766|FG000|Overall Study|Withdrawal by Subject|18|||
125535904|NCT00864253|451591767|FG001|Overall Study|Withdrawal by Subject|18|||
125200228|NCT02980341|450354974|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
125200229|NCT02980341|450354975|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
125200230|NCT01647516|450354976|FG000|Induction Period (IP)|Physician Decision|2|||
125200231|NCT01647516|450354977|FG001|Induction Period (IP)|Physician Decision|0|||
125200232|NCT01647516|450354978|FG002|Induction Period (IP)|Physician Decision|0|||
125200233|NCT01647516|450354979|FG003|Induction Period (IP)|Physician Decision|0|||
125200234|NCT01647516|450354980|FG004|Induction Period (IP)|Physician Decision|0|||
125200235|NCT01647516|450354981|FG005|Induction Period (IP)|Physician Decision|0|||
125200236|NCT01647516|450354976|FG000|Induction Period (IP)|Adverse Event|1|||
125200237|NCT01647516|450354977|FG001|Induction Period (IP)|Adverse Event|2|||
125200238|NCT01647516|450354978|FG002|Induction Period (IP)|Adverse Event|0|||
125200239|NCT01647516|450354979|FG003|Induction Period (IP)|Adverse Event|0|||
125200240|NCT01647516|450354980|FG004|Induction Period (IP)|Adverse Event|0|||
125200241|NCT01647516|450354981|FG005|Induction Period (IP)|Adverse Event|0|||
125200242|NCT01647516|450354976|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
125200243|NCT01647516|450354977|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
125200244|NCT01647516|450354978|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
125200245|NCT01647516|450354979|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
125200246|NCT01647516|450354980|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
125200247|NCT01647516|450354981|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
125200248|NCT01647516|450354976|FG000|Induction Period (IP)|Participant Choice|0|||
125200249|NCT01647516|450354977|FG001|Induction Period (IP)|Participant Choice|0|||
125200250|NCT01647516|450354978|FG002|Induction Period (IP)|Participant Choice|1|||
125200251|NCT01647516|450354979|FG003|Induction Period (IP)|Participant Choice|0|||
125200252|NCT01647516|450354980|FG004|Induction Period (IP)|Participant Choice|0|||
125200253|NCT01647516|450354981|FG005|Induction Period (IP)|Participant Choice|0|||
125200254|NCT01647516|450354976|FG000|Induction Period (IP)|Lack of Efficacy|1|||
125200255|NCT01647516|450354977|FG001|Induction Period (IP)|Lack of Efficacy|0|||
125200256|NCT01647516|450354978|FG002|Induction Period (IP)|Lack of Efficacy|0|||
125200257|NCT01647516|450354979|FG003|Induction Period (IP)|Lack of Efficacy|0|||
125200258|NCT01647516|450354980|FG004|Induction Period (IP)|Lack of Efficacy|0|||
125200259|NCT01647516|450354981|FG005|Induction Period (IP)|Lack of Efficacy|0|||
125200260|NCT01647516|450354976|FG000|Induction Period (IP)|No study drug received|1|||
125200261|NCT01647516|450354977|FG001|Induction Period (IP)|No study drug received|1|||
125200262|NCT01647516|450354978|FG002|Induction Period (IP)|No study drug received|0|||
125200263|NCT01647516|450354979|FG003|Induction Period (IP)|No study drug received|0|||
125200264|NCT01647516|450354980|FG004|Induction Period (IP)|No study drug received|0|||
125200265|NCT01647516|450354981|FG005|Induction Period (IP)|No study drug received|0|||
125200266|NCT01647516|450354976|FG000|Maintenance Period (MP)|Adverse Event|2|||
125200267|NCT01647516|450354977|FG001|Maintenance Period (MP)|Adverse Event|1|||
125200268|NCT01647516|450354978|FG002|Maintenance Period (MP)|Adverse Event|0|||
125200269|NCT01647516|450354979|FG003|Maintenance Period (MP)|Adverse Event|0|||
125200270|NCT01647516|450354980|FG004|Maintenance Period (MP)|Adverse Event|0|||
125200271|NCT01647516|450354981|FG005|Maintenance Period (MP)|Adverse Event|0|||
125200272|NCT01647516|450354976|FG000|Maintenance Period (MP)|Non-compliance|1|||
125200273|NCT01647516|450354977|FG001|Maintenance Period (MP)|Non-compliance|0|||
125200274|NCT01647516|450354978|FG002|Maintenance Period (MP)|Non-compliance|0|||
125200275|NCT01647516|450354979|FG003|Maintenance Period (MP)|Non-compliance|0|||
125200276|NCT01647516|450354980|FG004|Maintenance Period (MP)|Non-compliance|0|||
125200277|NCT01647516|450354981|FG005|Maintenance Period (MP)|Non-compliance|0|||
125200278|NCT01647516|450354976|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
125535905|NCT00864253|451591766|FG000|Overall Study|Death|1|||
125535906|NCT00864253|451591767|FG001|Overall Study|Death|0|||
125200279|NCT01647516|450354977|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
125200280|NCT01647516|450354978|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
125200281|NCT01647516|450354979|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
125200282|NCT01647516|450354980|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
125200283|NCT01647516|450354981|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
125535907|NCT00864253|451591766|FG000|Overall Study|Ongoing|2|||
125535908|NCT00864253|451591767|FG001|Overall Study|Ongoing|3|||
125535909|NCT00864253|451591766|FG000|Overall Study|Untreated|7|||
125535910|NCT00864253|451591767|FG001|Overall Study|Untreated|7|||
125535911|NCT01896726|451591768|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
125535912|NCT01896726|451591768|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
125535913|NCT01128114|451591769|FG000|Overall Study|Treatment Withdrawn|6|||
125535914|NCT01128114|451591769|FG000|Overall Study|Screening Failed|2|||
125535915|NCT00208325|451591770|FG000|Overall Study|Death|18|||
125200284|NCT01647516|450354976|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
125200285|NCT01647516|450354977|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
125200286|NCT01647516|450354978|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
125200287|NCT01647516|450354979|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
125200288|NCT01647516|450354980|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
125200289|NCT01647516|450354981|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
125200290|NCT01647516|450354976|FG000|Open-Label Period|Adverse Event|0|||
125200291|NCT01647516|450354977|FG001|Open-Label Period|Adverse Event|0|||
125200292|NCT01647516|450354978|FG002|Open-Label Period|Adverse Event|0|||
125200293|NCT01647516|450354979|FG003|Open-Label Period|Adverse Event|5|||
125200294|NCT01647516|450354980|FG004|Open-Label Period|Adverse Event|6|||
125200295|NCT01647516|450354981|FG005|Open-Label Period|Adverse Event|3|||
125200296|NCT01647516|450354976|FG000|Open-Label Period|Pregnancy|0|||
125200297|NCT01647516|450354977|FG001|Open-Label Period|Pregnancy|0|||
125200298|NCT01647516|450354978|FG002|Open-Label Period|Pregnancy|0|||
125200299|NCT01647516|450354979|FG003|Open-Label Period|Pregnancy|0|||
125200300|NCT01647516|450354980|FG004|Open-Label Period|Pregnancy|0|||
125200301|NCT01647516|450354981|FG005|Open-Label Period|Pregnancy|1|||
125200302|NCT01647516|450354976|FG000|Open-Label Period|Non-compliance|0|||
125200303|NCT01647516|450354977|FG001|Open-Label Period|Non-compliance|0|||
125200304|NCT01647516|450354978|FG002|Open-Label Period|Non-compliance|0|||
125200305|NCT01647516|450354979|FG003|Open-Label Period|Non-compliance|1|||
125200306|NCT01647516|450354980|FG004|Open-Label Period|Non-compliance|0|||
125200307|NCT01647516|450354981|FG005|Open-Label Period|Non-compliance|1|||
125200308|NCT01647516|450354976|FG000|Open-Label Period|Physician Decision|0|||
125200309|NCT01647516|450354977|FG001|Open-Label Period|Physician Decision|0|||
125200310|NCT01647516|450354978|FG002|Open-Label Period|Physician Decision|0|||
125200311|NCT01647516|450354979|FG003|Open-Label Period|Physician Decision|1|||
125200312|NCT01647516|450354980|FG004|Open-Label Period|Physician Decision|1|||
125200313|NCT01647516|450354981|FG005|Open-Label Period|Physician Decision|0|||
125200314|NCT01647516|450354976|FG000|Open-Label Period|Withdrawal by Subject|0|||
125200315|NCT01647516|450354977|FG001|Open-Label Period|Withdrawal by Subject|0|||
125200316|NCT01647516|450354978|FG002|Open-Label Period|Withdrawal by Subject|0|||
125200317|NCT01647516|450354979|FG003|Open-Label Period|Withdrawal by Subject|9|||
125200318|NCT01647516|450354980|FG004|Open-Label Period|Withdrawal by Subject|11|||
125200319|NCT01647516|450354981|FG005|Open-Label Period|Withdrawal by Subject|6|||
125200320|NCT01647516|450354976|FG000|Open-Label Period|Lost to Follow-up|0|||
125200321|NCT01647516|450354977|FG001|Open-Label Period|Lost to Follow-up|0|||
125200322|NCT01647516|450354978|FG002|Open-Label Period|Lost to Follow-up|0|||
125200323|NCT01647516|450354979|FG003|Open-Label Period|Lost to Follow-up|1|||
125200324|NCT01647516|450354980|FG004|Open-Label Period|Lost to Follow-up|0|||
125200325|NCT01647516|450354981|FG005|Open-Label Period|Lost to Follow-up|1|||
125200326|NCT01647516|450354976|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
125200327|NCT01647516|450354977|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
125200328|NCT01647516|450354978|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
125200329|NCT01647516|450354979|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
125535916|NCT00208325|451591771|FG001|Overall Study|Death|19|||
125535917|NCT00208325|451591772|FG002|Overall Study|Death|7|||
125535918|NCT00208325|451591773|FG003|Overall Study|Death|5|||
125535919|NCT00208325|451591770|FG000|Overall Study|Withdrawal by Subject|0|||
125535920|NCT00208325|451591771|FG001|Overall Study|Withdrawal by Subject|1|||
125535921|NCT00208325|451591772|FG002|Overall Study|Withdrawal by Subject|0|||
125535922|NCT00208325|451591773|FG003|Overall Study|Withdrawal by Subject|0|||
125535923|NCT00208325|451591770|FG000|Overall Study|Revision|4|||
125200330|NCT01647516|450354980|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
125200331|NCT01647516|450354981|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
125200332|NCT01647516|450354976|FG000|Open-Label Period|Lack of Efficacy|0|||
125200333|NCT01647516|450354977|FG001|Open-Label Period|Lack of Efficacy|0|||
125200334|NCT01647516|450354978|FG002|Open-Label Period|Lack of Efficacy|0|||
125200335|NCT01647516|450354979|FG003|Open-Label Period|Lack of Efficacy|7|||
125200336|NCT01647516|450354980|FG004|Open-Label Period|Lack of Efficacy|9|||
125200337|NCT01647516|450354981|FG005|Open-Label Period|Lack of Efficacy|10|||
125200338|NCT01647516|450354976|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
125200339|NCT01647516|450354977|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
125200340|NCT01647516|450354978|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
125535924|NCT00208325|451591771|FG001|Overall Study|Revision|1|||
125535925|NCT00208325|451591772|FG002|Overall Study|Revision|0|||
125535926|NCT00208325|451591773|FG003|Overall Study|Revision|4|||
125535927|NCT00208325|451591770|FG000|Overall Study|Lost to Follow-up|1|||
125535928|NCT00208325|451591771|FG001|Overall Study|Lost to Follow-up|0|||
125535929|NCT00208325|451591772|FG002|Overall Study|Lost to Follow-up|2|||
125535930|NCT00208325|451591773|FG003|Overall Study|Lost to Follow-up|0|||
125535931|NCT00208325|451591770|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
125535932|NCT00208325|451591771|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
125535933|NCT00208325|451591772|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
125535934|NCT00208325|451591773|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
125535935|NCT00208325|451591770|FG000|Overall Study|Does not wish to Continue in Study|5|||
125535936|NCT00208325|451591771|FG001|Overall Study|Does not wish to Continue in Study|8|||
125535937|NCT00208325|451591772|FG002|Overall Study|Does not wish to Continue in Study|3|||
125535938|NCT00208325|451591773|FG003|Overall Study|Does not wish to Continue in Study|2|||
125535939|NCT00208325|451591770|FG000|Overall Study|Other|2|||
125535940|NCT00208325|451591771|FG001|Overall Study|Other|1|||
125535941|NCT00208325|451591772|FG002|Overall Study|Other|1|||
125535942|NCT00208325|451591773|FG003|Overall Study|Other|0|||
125535943|NCT00208325|451591770|FG000|Overall Study|Mis-Randomized|17|||
125535944|NCT00208325|451591771|FG001|Overall Study|Mis-Randomized|20|||
125535945|NCT00208325|451591772|FG002|Overall Study|Mis-Randomized|0|||
125535946|NCT00208325|451591773|FG003|Overall Study|Mis-Randomized|0|||
125535947|NCT00586612|451591774|FG000|Primary Phase|Protocol Violation|1|||
125535948|NCT00586612|451591775|FG001|Primary Phase|Protocol Violation|0|||
125535949|NCT00586612|451591774|FG000|Primary Phase|Lost to Follow-up|0|||
125535950|NCT00586612|451591775|FG001|Primary Phase|Lost to Follow-up|1|||
125535951|NCT00586612|451591774|FG000|Primary Phase|Withdrawal by Subject|0|||
125535952|NCT00586612|451591775|FG001|Primary Phase|Withdrawal by Subject|2|||
125535953|NCT00586612|451591774|FG000|Booster Phase|Lost to Follow-up|3|||
125535954|NCT00586612|451591775|FG001|Booster Phase|Lost to Follow-up|1|||
125535955|NCT02001064|451591778|FG000|Overall Study|Withdrawal by Subject|2|||
125535956|NCT02001064|451591779|FG001|Overall Study|Withdrawal by Subject|1|||
125535957|NCT01609062|451591780|FG000|Extension Phase|Terminated by Sponsor|14|||
125535958|NCT01609062|451591781|FG001|Extension Phase|Terminated by Sponsor|9|||
125535959|NCT01609062|451591780|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
125535960|NCT01609062|451591781|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
125535961|NCT01609062|451591780|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
125535962|NCT01609062|451591781|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
125535963|NCT02738853|451591782|FG000|Enrollment|Inclusion/Exclusion not met|21|||
125535964|NCT02738853|451591782|FG000|Enrollment|Withdrawal by Subject|3|||
125535965|NCT02738853|451591782|FG000|Enrollment|Subject treated with commercially available device|6|||
125535966|NCT02738853|451591782|FG000|Enrollment|Study Enrollment Closed|3|||
125535967|NCT02738853|451591782|FG000|Procedure|Death|1|||
125535968|NCT02738853|451591782|FG000|1 Month|Death|2|||
125535969|NCT02738853|451591782|FG000|6 Month|Death|4|||
125535970|NCT02738853|451591782|FG000|6 Month|Withdrawal by Subject|2|||
125535971|NCT02738853|451591782|FG000|1 Year|Death|6|||
125535972|NCT02738853|451591782|FG000|1 Year|Withdrawal by Subject|1|||
125535973|NCT02738853|451591782|FG000|2 Year|Death|2|||
125535974|NCT02738853|451591782|FG000|2 Year|Lost to Follow-up|1|||
125535975|NCT02738853|451591782|FG000|3 Year|Death|2|||
125535976|NCT02738853|451591782|FG000|3 Year|Withdrawal by Subject|1|||
125535977|NCT02738853|451591782|FG000|4 Year|Death|9|||
125535978|NCT02738853|451591782|FG000|5 Year|Lost to Follow-up|4|||
125535979|NCT01803282|451591783|FG000|Overall Study|Progressive Disease|4|||
125535980|NCT01803282|451591784|FG001|Overall Study|Progressive Disease|3|||
125535981|NCT01803282|451591785|FG002|Overall Study|Progressive Disease|6|||
125535982|NCT01803282|451591786|FG003|Overall Study|Progressive Disease|22|||
125535983|NCT01803282|451591787|FG004|Overall Study|Progressive Disease|5|||
125535984|NCT01803282|451591788|FG005|Overall Study|Progressive Disease|8|||
125535985|NCT01803282|451591789|FG006|Overall Study|Progressive Disease|23|||
125535986|NCT01803282|451591790|FG007|Overall Study|Progressive Disease|24|||
125535987|NCT01803282|451591791|FG008|Overall Study|Progressive Disease|3|||
125535988|NCT01803282|451591792|FG009|Overall Study|Progressive Disease|29|||
125535989|NCT01803282|451591793|FG010|Overall Study|Progressive Disease|6|||
125535990|NCT01803282|451591794|FG011|Overall Study|Progressive Disease|11|||
125535991|NCT01803282|451591783|FG000|Overall Study|Death|0|||
125535992|NCT01803282|451591784|FG001|Overall Study|Death|0|||
125535993|NCT01803282|451591785|FG002|Overall Study|Death|0|||
125535994|NCT01803282|451591786|FG003|Overall Study|Death|0|||
125535995|NCT01803282|451591787|FG004|Overall Study|Death|2|||
125535996|NCT01803282|451591788|FG005|Overall Study|Death|1|||
125535997|NCT01803282|451591789|FG006|Overall Study|Death|1|||
125535998|NCT01803282|451591790|FG007|Overall Study|Death|5|||
125535999|NCT01803282|451591791|FG008|Overall Study|Death|1|||
125536000|NCT01803282|451591792|FG009|Overall Study|Death|1|||
125536001|NCT01803282|451591793|FG010|Overall Study|Death|0|||
125536002|NCT01803282|451591794|FG011|Overall Study|Death|0|||
125536003|NCT01803282|451591783|FG000|Overall Study|Withdrew Consent|0|||
125200341|NCT01647516|450354979|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
125536004|NCT01803282|451591784|FG001|Overall Study|Withdrew Consent|0|||
125536005|NCT01803282|451591785|FG002|Overall Study|Withdrew Consent|0|||
125536006|NCT01803282|451591786|FG003|Overall Study|Withdrew Consent|6|||
125536007|NCT01803282|451591787|FG004|Overall Study|Withdrew Consent|1|||
125200342|NCT01647516|450354980|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
125200343|NCT01647516|450354981|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
125200344|NCT01647516|450354976|FG000|Open-Label Period|No completion / discontinuation visit|0|||
125200345|NCT01647516|450354977|FG001|Open-Label Period|No completion / discontinuation visit|0|||
125200346|NCT01647516|450354978|FG002|Open-Label Period|No completion / discontinuation visit|0|||
125200347|NCT01647516|450354979|FG003|Open-Label Period|No completion / discontinuation visit|0|||
125200348|NCT01647516|450354980|FG004|Open-Label Period|No completion / discontinuation visit|2|||
125200349|NCT01647516|450354981|FG005|Open-Label Period|No completion / discontinuation visit|1|||
125200350|NCT03193801|450354986|FG000|Overall Study|Physician Decision|2|||
125200351|NCT03193801|450354986|FG000|Overall Study|Withdrawal by Subject|1|||
125200352|NCT04964544|450354987|FG000|Overall Study|Screen failure or other uncategorised|10|||
125200353|NCT04964544|450354987|FG000|Overall Study|Physician Decision|4|||
125200354|NCT04964544|450354987|FG000|Overall Study|Lost to Follow-up|9|||
125200355|NCT04964544|450354987|FG000|Overall Study|Withdrawal by Subject|18|||
125200356|NCT04964544|450354987|FG000|Overall Study|Death|1|||
125200357|NCT01613222|450354990|FG000|Overall Study|Physician Decision|1|||
125200358|NCT01613222|450354990|FG000|Overall Study|Unable to place arterial line|1|||
125200359|NCT01613222|450354990|FG000|Overall Study|Reused disposable sensors|10|||
125200360|NCT03696108|450354991|FG000|Overall Study|Physician Decision|1|||
125200361|NCT03696108|450354992|FG001|Overall Study|Physician Decision|0|||
125200362|NCT03696108|450354991|FG000|Overall Study|Withdrawal by Subject|3|||
125200363|NCT03696108|450354992|FG001|Overall Study|Withdrawal by Subject|6|||
125200364|NCT02833844|450354996|FG000|Double-Blind Period|Withdrawal by Subject|2|||
125200365|NCT02833844|450354997|FG001|Double-Blind Period|Withdrawal by Subject|3|||
125200366|NCT02833844|450354996|FG000|Double-Blind Period|Protocol Violation|0|||
125200367|NCT02833844|450354997|FG001|Double-Blind Period|Protocol Violation|4|||
125200368|NCT02833844|450354996|FG000|Open-Label Period|Death|0|||
125200369|NCT02833844|450354997|FG001|Open-Label Period|Death|2|||
125200370|NCT02833844|450354996|FG000|Open-Label Period|Lost to Follow-up|1|||
125200371|NCT02833844|450354997|FG001|Open-Label Period|Lost to Follow-up|0|||
125200372|NCT02833844|450354996|FG000|Open-Label Period|Withdrawal by Subject|1|||
125200373|NCT02833844|450354997|FG001|Open-Label Period|Withdrawal by Subject|0|||
125200374|NCT01899742|450354998|FG000|Overall Study|Adverse Event|5|||
125200375|NCT01899742|450354999|FG001|Overall Study|Adverse Event|4|||
125200376|NCT01899742|450354998|FG000|Overall Study|Lack of Efficacy|1|||
125200377|NCT01899742|450354999|FG001|Overall Study|Lack of Efficacy|5|||
125200378|NCT01899742|450354998|FG000|Overall Study|Protocol Violation|2|||
125200379|NCT01899742|450354999|FG001|Overall Study|Protocol Violation|2|||
125200380|NCT01899742|450354998|FG000|Overall Study|Withdrawal by Subject|9|||
125200381|NCT01899742|450354999|FG001|Overall Study|Withdrawal by Subject|5|||
125200382|NCT02662764|450355000|FG000|Overall Study|Adverse Event|6|||
125200383|NCT02662764|450355000|FG000|Overall Study|Lack of Efficacy|8|||
125200384|NCT02662764|450355000|FG000|Overall Study|Protocol Violation|1|||
125200385|NCT02662764|450355000|FG000|Overall Study|Withdrawal by Subject|5|||
125200386|NCT02662764|450355000|FG000|Overall Study|Device failure|4|||
125200387|NCT02662764|450355000|FG000|Overall Study|Patient changed treatment|1|||
125200388|NCT02662764|450355000|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
125200389|NCT04323306|450355001|FG000|Overall Study|Physician Decision|1|||
125200390|NCT04323306|450355002|FG001|Overall Study|Physician Decision|0|||
125200391|NCT04323306|450355003|FG002|Overall Study|Physician Decision|0|||
125200392|NCT04323306|450355004|FG003|Overall Study|Physician Decision|0|||
125200393|NCT04323306|450355005|FG004|Overall Study|Physician Decision|0|||
125200394|NCT04323306|450355006|FG005|Overall Study|Physician Decision|0|||
125200395|NCT04323306|450355007|FG006|Overall Study|Physician Decision|0|||
125200396|NCT04323306|450355008|FG007|Overall Study|Physician Decision|0|||
125200397|NCT04323306|450355009|FG008|Overall Study|Physician Decision|0|||
125200398|NCT04323306|450355001|FG000|Overall Study|Withdrawal by Subject|0|||
125200399|NCT04323306|450355002|FG001|Overall Study|Withdrawal by Subject|0|||
125200400|NCT04323306|450355003|FG002|Overall Study|Withdrawal by Subject|0|||
125200401|NCT04323306|450355004|FG003|Overall Study|Withdrawal by Subject|0|||
125200402|NCT04323306|450355005|FG004|Overall Study|Withdrawal by Subject|0|||
125200403|NCT04323306|450355006|FG005|Overall Study|Withdrawal by Subject|1|||
125200404|NCT04323306|450355007|FG006|Overall Study|Withdrawal by Subject|3|||
125200405|NCT04323306|450355008|FG007|Overall Study|Withdrawal by Subject|0|||
125200406|NCT04323306|450355009|FG008|Overall Study|Withdrawal by Subject|1|||
125200407|NCT00089778|450355010|FG000|Overall Study|Protocol Violation|0|||
125536008|NCT01803282|451591788|FG005|Overall Study|Withdrew Consent|0|||
125200408|NCT00089778|450355011|FG001|Overall Study|Protocol Violation|0|||
125200409|NCT00089778|450355012|FG002|Overall Study|Protocol Violation|1|||
125200410|NCT01154088|450355015|FG000|Overall Study|Lost to Follow-up|4|||
125200411|NCT01154088|450355016|FG001|Overall Study|Lost to Follow-up|6|||
125200412|NCT01154088|450355017|FG002|Overall Study|Lost to Follow-up|7|||
125200413|NCT05129137|450355018|FG000|Second Period|Adverse Event|1|||
125200414|NCT05129137|450355019|FG001|Second Period|Adverse Event|0|||
125200415|NCT05129137|450355020|FG002|Second Period|Adverse Event|0|||
125200416|NCT05129137|450355021|FG003|Second Period|Adverse Event|0|||
125536009|NCT01803282|451591789|FG006|Overall Study|Withdrew Consent|8|||
125536010|NCT01803282|451591790|FG007|Overall Study|Withdrew Consent|3|||
125536011|NCT01803282|451591791|FG008|Overall Study|Withdrew Consent|1|||
125536012|NCT01803282|451591792|FG009|Overall Study|Withdrew Consent|5|||
125536013|NCT01803282|451591793|FG010|Overall Study|Withdrew Consent|0|||
125536014|NCT01803282|451591794|FG011|Overall Study|Withdrew Consent|1|||
125536015|NCT01803282|451591783|FG000|Overall Study|Investigator's Discretion|0|||
125536016|NCT01803282|451591784|FG001|Overall Study|Investigator's Discretion|0|||
125536017|NCT01803282|451591785|FG002|Overall Study|Investigator's Discretion|0|||
125536018|NCT01803282|451591786|FG003|Overall Study|Investigator's Discretion|7|||
125536019|NCT01803282|451591787|FG004|Overall Study|Investigator's Discretion|2|||
125536020|NCT01803282|451591788|FG005|Overall Study|Investigator's Discretion|1|||
125536021|NCT01803282|451591789|FG006|Overall Study|Investigator's Discretion|7|||
125536022|NCT01803282|451591790|FG007|Overall Study|Investigator's Discretion|10|||
125536023|NCT01803282|451591791|FG008|Overall Study|Investigator's Discretion|6|||
125536024|NCT01803282|451591792|FG009|Overall Study|Investigator's Discretion|7|||
125536025|NCT01803282|451591793|FG010|Overall Study|Investigator's Discretion|1|||
125536026|NCT01803282|451591794|FG011|Overall Study|Investigator's Discretion|0|||
125536027|NCT01803282|451591783|FG000|Overall Study|Adverse Event|0|||
125536028|NCT01803282|451591784|FG001|Overall Study|Adverse Event|0|||
125200417|NCT05129137|450355018|FG000|Second Period|Protocol Violation|0|||
125200418|NCT05129137|450355019|FG001|Second Period|Protocol Violation|0|||
125200419|NCT05129137|450355020|FG002|Second Period|Protocol Violation|0|||
125200420|NCT05129137|450355021|FG003|Second Period|Protocol Violation|1|||
125200421|NCT05129137|450355018|FG000|Third Period|Protocol Violation|0|||
125200422|NCT05129137|450355019|FG001|Third Period|Protocol Violation|0|||
125200423|NCT05129137|450355020|FG002|Third Period|Protocol Violation|0|||
125200424|NCT05129137|450355021|FG003|Third Period|Protocol Violation|1|||
125200425|NCT05129137|450355018|FG000|Forth Period|Protocol Violation|0|||
125200426|NCT05129137|450355019|FG001|Forth Period|Protocol Violation|1|||
125200427|NCT05129137|450355020|FG002|Forth Period|Protocol Violation|0|||
125200428|NCT05129137|450355021|FG003|Forth Period|Protocol Violation|0|||
125200429|NCT05129137|450355018|FG000|Forth Period|Withdrawal by Subject|0|||
125200430|NCT05129137|450355019|FG001|Forth Period|Withdrawal by Subject|0|||
125200431|NCT05129137|450355020|FG002|Forth Period|Withdrawal by Subject|1|||
125200432|NCT05129137|450355021|FG003|Forth Period|Withdrawal by Subject|0|||
125200433|NCT01104246|450355022|FG000|Overall Study|Withdrawal by Subject|1|||
125200434|NCT01104246|450355022|FG000|Overall Study|did not meet inclusion criteria|4|||
125200435|NCT05178641|450355033|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
125200436|NCT05178641|450355034|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
125200437|NCT05178641|450355033|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
125200438|NCT05178641|450355034|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
125200439|NCT01869699|450355035|FG000|Overall Study|Withdrawal by Subject|1|||
125200440|NCT01869699|450355036|FG001|Overall Study|Withdrawal by Subject|0|||
125200441|NCT01475851|450355037|FG000|Overall Study|Protocol defined stopping criteria|1|||
125200442|NCT01475851|450355038|FG001|Overall Study|Protocol defined stopping criteria|0|||
125200443|NCT01867294|450355039|FG000|Overall Study|Withdrawal by Subject|1|||
125200444|NCT01867294|450355040|FG001|Overall Study|Withdrawal by Subject|1|||
125200445|NCT01867294|450355041|FG002|Overall Study|Withdrawal by Subject|0|||
125200446|NCT01867294|450355042|FG003|Overall Study|Withdrawal by Subject|0|||
125200447|NCT02017912|450355045|FG000|Overall Study|Withdrawal by Subject|2|||
125200448|NCT02017912|450355046|FG001|Overall Study|Withdrawal by Subject|1|||
125200449|NCT02017912|450355045|FG000|Overall Study|miscellaneous|1|||
125200450|NCT02017912|450355046|FG001|Overall Study|miscellaneous|1|||
125200451|NCT01508130|450355050|FG000|Overall Study|Adverse Event|81|||
125200452|NCT01508130|450355051|FG001|Overall Study|Adverse Event|28|||
125200453|NCT01508130|450355050|FG000|Overall Study|Death|3|||
125200454|NCT01508130|450355051|FG001|Overall Study|Death|1|||
125200455|NCT01508130|450355050|FG000|Overall Study|Protocol Violation|2|||
125200456|NCT01508130|450355051|FG001|Overall Study|Protocol Violation|0|||
125200457|NCT01508130|450355050|FG000|Overall Study|Lost to Follow-up|25|||
125200458|NCT01508130|450355051|FG001|Overall Study|Lost to Follow-up|2|||
125200459|NCT01508130|450355050|FG000|Overall Study|Withdrawal by Subject|3|||
125200460|NCT01508130|450355051|FG001|Overall Study|Withdrawal by Subject|3|||
125200461|NCT01508130|450355050|FG000|Overall Study|Subject's substantial non-compliance|25|||
125200462|NCT01508130|450355051|FG001|Overall Study|Subject's substantial non-compliance|9|||
125200463|NCT01508130|450355050|FG000|Overall Study|Insufficient therapeutic response|74|||
125200464|NCT01508130|450355051|FG001|Overall Study|Insufficient therapeutic response|23|||
125200465|NCT01508130|450355050|FG000|Overall Study|Administrative|14|||
125200466|NCT01508130|450355051|FG001|Overall Study|Administrative|3|||
125536029|NCT01803282|451591785|FG002|Overall Study|Adverse Event|0|||
125536030|NCT01803282|451591786|FG003|Overall Study|Adverse Event|0|||
125536031|NCT01803282|451591787|FG004|Overall Study|Adverse Event|0|||
125536032|NCT01803282|451591788|FG005|Overall Study|Adverse Event|0|||
125536033|NCT01803282|451591789|FG006|Overall Study|Adverse Event|1|||
125536034|NCT01803282|451591790|FG007|Overall Study|Adverse Event|2|||
125536035|NCT01803282|451591791|FG008|Overall Study|Adverse Event|0|||
125200467|NCT01680159|450355052|FG000|Screening Period|Not meet criteria for dose-up period|7|||
125200468|NCT01680159|450355052|FG000|Increased Dose Period|Adverse Event|6|||
125200469|NCT01680159|450355052|FG000|Increased Dose Period|Withdrawal by Subject|2|||
125200470|NCT03429244|450355057|FG000|Overall Study|Withdrawal by Subject|2|||
125200471|NCT03429244|450355058|FG001|Overall Study|Withdrawal by Subject|1|||
125200472|NCT03429244|450355059|FG002|Overall Study|Withdrawal by Subject|1|||
125200473|NCT03403751|450355060|FG000|Overall Study|Death|5|||
125200474|NCT03403751|450355061|FG001|Overall Study|Death|6|||
125200475|NCT03403751|450355060|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
125200476|NCT03403751|450355061|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
125200477|NCT00750139|450355062|FG000|Overall Study|Adverse Event|1|||
125536036|NCT01803282|451591792|FG009|Overall Study|Adverse Event|1|||
125536037|NCT01803282|451591793|FG010|Overall Study|Adverse Event|0|||
125200478|NCT00750139|450355063|FG001|Overall Study|Adverse Event|2|||
125200479|NCT00750139|450355064|FG002|Overall Study|Adverse Event|0|||
125200480|NCT00750139|450355065|FG003|Overall Study|Adverse Event|1|||
125536038|NCT01803282|451591794|FG011|Overall Study|Adverse Event|3|||
125200481|NCT00750139|450355062|FG000|Overall Study|Lost to Follow-up|17|||
125200482|NCT00750139|450355063|FG001|Overall Study|Lost to Follow-up|12|||
125200483|NCT00750139|450355064|FG002|Overall Study|Lost to Follow-up|15|||
125200484|NCT00750139|450355065|FG003|Overall Study|Lost to Follow-up|6|||
125200485|NCT00750139|450355062|FG000|Overall Study|Withdrawal by Subject|3|||
125200486|NCT00750139|450355063|FG001|Overall Study|Withdrawal by Subject|2|||
125200487|NCT00750139|450355064|FG002|Overall Study|Withdrawal by Subject|6|||
125200488|NCT00750139|450355065|FG003|Overall Study|Withdrawal by Subject|2|||
125200489|NCT00750139|450355062|FG000|Overall Study|Physician Decision|1|||
125200490|NCT00750139|450355063|FG001|Overall Study|Physician Decision|1|||
125200491|NCT00750139|450355064|FG002|Overall Study|Physician Decision|0|||
125200492|NCT00750139|450355065|FG003|Overall Study|Physician Decision|0|||
125200493|NCT00750139|450355062|FG000|Overall Study|Non-compliance|1|||
125200494|NCT00750139|450355063|FG001|Overall Study|Non-compliance|0|||
125200495|NCT00750139|450355064|FG002|Overall Study|Non-compliance|1|||
125200496|NCT00750139|450355065|FG003|Overall Study|Non-compliance|3|||
125200497|NCT00750139|450355062|FG000|Overall Study|Termination by sponsor|4|||
125200498|NCT00750139|450355063|FG001|Overall Study|Termination by sponsor|0|||
125200499|NCT00750139|450355064|FG002|Overall Study|Termination by sponsor|0|||
125200500|NCT00750139|450355065|FG003|Overall Study|Termination by sponsor|1|||
125536039|NCT01803282|451591783|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125536040|NCT01803282|451591784|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125536041|NCT01803282|451591785|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125536042|NCT01803282|451591786|FG003|Overall Study|Non-Compliance with Study Drug|1|||
125536043|NCT01803282|451591787|FG004|Overall Study|Non-Compliance with Study Drug|0|||
125536044|NCT01803282|451591788|FG005|Overall Study|Non-Compliance with Study Drug|0|||
125536045|NCT01803282|451591789|FG006|Overall Study|Non-Compliance with Study Drug|0|||
125536046|NCT01803282|451591790|FG007|Overall Study|Non-Compliance with Study Drug|0|||
125536047|NCT01803282|451591791|FG008|Overall Study|Non-Compliance with Study Drug|0|||
125536048|NCT01803282|451591792|FG009|Overall Study|Non-Compliance with Study Drug|0|||
125536049|NCT01803282|451591793|FG010|Overall Study|Non-Compliance with Study Drug|0|||
125536050|NCT01803282|451591794|FG011|Overall Study|Non-Compliance with Study Drug|0|||
125536051|NCT01803282|451591783|FG000|Overall Study|Unknown Reason|0|||
125536052|NCT01803282|451591784|FG001|Overall Study|Unknown Reason|0|||
125536053|NCT01803282|451591785|FG002|Overall Study|Unknown Reason|0|||
125536054|NCT01803282|451591786|FG003|Overall Study|Unknown Reason|0|||
125536055|NCT01803282|451591787|FG004|Overall Study|Unknown Reason|0|||
125536056|NCT01803282|451591788|FG005|Overall Study|Unknown Reason|0|||
125536057|NCT01803282|451591789|FG006|Overall Study|Unknown Reason|0|||
125536058|NCT01803282|451591790|FG007|Overall Study|Unknown Reason|1|||
125536059|NCT01803282|451591791|FG008|Overall Study|Unknown Reason|0|||
125536060|NCT01803282|451591792|FG009|Overall Study|Unknown Reason|0|||
125536061|NCT01803282|451591793|FG010|Overall Study|Unknown Reason|0|||
125536062|NCT01803282|451591794|FG011|Overall Study|Unknown Reason|0|||
125536063|NCT01803282|451591783|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
125536064|NCT01803282|451591784|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
125536065|NCT01803282|451591785|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
125536066|NCT01803282|451591786|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
125536067|NCT01803282|451591787|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
125536068|NCT01803282|451591788|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
125200501|NCT00750139|450355062|FG000|Overall Study|Non-specific|62|||
125200502|NCT00750139|450355063|FG001|Overall Study|Non-specific|42|||
125200503|NCT00750139|450355064|FG002|Overall Study|Non-specific|79|||
125200504|NCT00750139|450355065|FG003|Overall Study|Non-specific|33|||
125200505|NCT00658775|450355068|FG000|Overall Study|Adverse Event|4|||
125200506|NCT00658775|450355069|FG001|Overall Study|Adverse Event|6|||
125200507|NCT00658775|450355068|FG000|Overall Study|Lost to Follow-up|17|||
125200508|NCT00658775|450355069|FG001|Overall Study|Lost to Follow-up|18|||
125536069|NCT01803282|451591789|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
125536070|NCT01803282|451591790|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
125536071|NCT01803282|451591791|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
125536072|NCT01803282|451591792|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
125536073|NCT01803282|451591793|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
125536074|NCT01803282|451591794|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
125536075|NCT01803282|451591783|FG000|Overall Study|Enrolled but Never Treated|0|||
125536076|NCT01803282|451591784|FG001|Overall Study|Enrolled but Never Treated|0|||
125536077|NCT01803282|451591785|FG002|Overall Study|Enrolled but Never Treated|0|||
125200509|NCT00658775|450355068|FG000|Overall Study|Withdrawal by Subject|6|||
125200510|NCT00658775|450355069|FG001|Overall Study|Withdrawal by Subject|4|||
125200511|NCT00658775|450355068|FG000|Overall Study|Withdrawal of consent|8|||
125200512|NCT00658775|450355069|FG001|Overall Study|Withdrawal of consent|7|||
125200513|NCT00658775|450355068|FG000|Overall Study|Other|7|||
125200514|NCT00658775|450355069|FG001|Overall Study|Other|8|||
125200515|NCT05033262|450355070|FG000|Overall Study|Lost to Follow-up|1|||
125200516|NCT05033262|450355071|FG001|Overall Study|Lost to Follow-up|0|||
125200517|NCT05033262|450355072|FG002|Overall Study|Lost to Follow-up|0|||
125200518|NCT05033262|450355073|FG003|Overall Study|Lost to Follow-up|1|||
125200519|NCT04413552|450355075|FG000|Overall Study|Adverse Event|0|||
125200520|NCT04413552|450355076|FG001|Overall Study|Adverse Event|0|||
125200521|NCT04413552|450355077|FG002|Overall Study|Adverse Event|0|||
125200522|NCT04413552|450355078|FG003|Overall Study|Adverse Event|0|||
125200523|NCT04413552|450355079|FG004|Overall Study|Adverse Event|0|||
125200524|NCT04413552|450355080|FG005|Overall Study|Adverse Event|0|||
125200525|NCT04413552|450355081|FG006|Overall Study|Adverse Event|1|||
125200526|NCT04413552|450355082|FG007|Overall Study|Adverse Event|0|||
125200527|NCT04413552|450355083|FG008|Overall Study|Adverse Event|0|||
125200528|NCT04413552|450355084|FG009|Overall Study|Adverse Event|0|||
125200529|NCT01741792|450357534|FG000|Overall Study|Death|6|||
125200530|NCT01741792|450357535|FG001|Overall Study|Death|1|||
125200531|NCT01741792|450357536|FG002|Overall Study|Death|12|||
125200532|NCT02222545|450357537|FG000|Overall Study|Adverse Event|1|||
125200533|NCT02222545|450357538|FG001|Overall Study|Adverse Event|0|||
125200534|NCT02222545|450357539|FG002|Overall Study|Adverse Event|2|||
125200535|NCT02222545|450357537|FG000|Overall Study|Death|0|||
125200536|NCT02222545|450357538|FG001|Overall Study|Death|0|||
125200537|NCT02222545|450357539|FG002|Overall Study|Death|9|||
125200538|NCT02222545|450357537|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
125200539|NCT02222545|450357538|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
125200540|NCT02222545|450357539|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
125200541|NCT02222545|450357537|FG000|Overall Study|Withdrawal by Subject|0|||
125200542|NCT02222545|450357538|FG001|Overall Study|Withdrawal by Subject|0|||
125200543|NCT02222545|450357539|FG002|Overall Study|Withdrawal by Subject|3|||
125200544|NCT02222545|450357537|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
125200545|NCT02222545|450357538|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
125200546|NCT02222545|450357539|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
125200547|NCT00761280|450357540|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
125200548|NCT00761280|450357541|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
125200549|NCT00761280|450357540|FG000|Randomization to First Dose|Sponsor decision|1|||
125200550|NCT00761280|450357541|FG001|Randomization to First Dose|Sponsor decision|0|||
125200551|NCT00761280|450357540|FG000|Randomization to First Dose|Other|1|||
125200552|NCT00761280|450357541|FG001|Randomization to First Dose|Other|0|||
125200553|NCT00761280|450357540|FG000|First Dose to End of Study|End of trial|5|||
125200554|NCT00761280|450357541|FG001|First Dose to End of Study|End of trial|5|||
125200555|NCT00761280|450357540|FG000|First Dose to End of Study|Progressive disease|5|||
125200556|NCT00761280|450357541|FG001|First Dose to End of Study|Progressive disease|3|||
125200557|NCT00761280|450357540|FG000|First Dose to End of Study|Sponsor decision|1|||
125200558|NCT00761280|450357541|FG001|First Dose to End of Study|Sponsor decision|2|||
125200559|NCT00761280|450357540|FG000|First Dose to End of Study|Death|1|||
125200560|NCT00761280|450357541|FG001|First Dose to End of Study|Death|0|||
125200561|NCT00761280|450357540|FG000|First Dose to End of Study|Lost to Follow-up|0|||
125200562|NCT00761280|450357541|FG001|First Dose to End of Study|Lost to Follow-up|1|||
125200563|NCT01938430|450357542|FG000|Overall Study|Randomized but Not Treated|0|||
125200564|NCT01938430|450357543|FG001|Overall Study|Randomized but Not Treated|0|||
125200565|NCT01938430|450357544|FG002|Overall Study|Randomized but Not Treated|0|||
125200566|NCT01938430|450357545|FG003|Overall Study|Randomized but Not Treated|0|||
125200567|NCT01938430|450357546|FG004|Overall Study|Randomized but Not Treated|0|||
125200568|NCT01938430|450357547|FG005|Overall Study|Randomized but Not Treated|0|||
125200569|NCT01938430|450357548|FG006|Overall Study|Randomized but Not Treated|0|||
125200570|NCT01938430|450357549|FG007|Overall Study|Randomized but Not Treated|0|||
125200571|NCT01938430|450357550|FG008|Overall Study|Randomized but Not Treated|0|||
125200572|NCT01938430|450357551|FG009|Overall Study|Randomized but Not Treated|0|||
125536078|NCT01803282|451591786|FG003|Overall Study|Enrolled but Never Treated|0|||
125536079|NCT01803282|451591787|FG004|Overall Study|Enrolled but Never Treated|1|||
125536080|NCT01803282|451591788|FG005|Overall Study|Enrolled but Never Treated|0|||
125536081|NCT01803282|451591789|FG006|Overall Study|Enrolled but Never Treated|1|||
125536082|NCT01803282|451591790|FG007|Overall Study|Enrolled but Never Treated|1|||
125536083|NCT01803282|451591791|FG008|Overall Study|Enrolled but Never Treated|0|||
125536084|NCT01803282|451591792|FG009|Overall Study|Enrolled but Never Treated|1|||
125536085|NCT01803282|451591793|FG010|Overall Study|Enrolled but Never Treated|0|||
125536086|NCT01803282|451591794|FG011|Overall Study|Enrolled but Never Treated|0|||
125536087|NCT01743989|451591795|FG000|Treatment Phase|Unstable MR4.0|0|||
125536088|NCT01743989|451591796|FG001|Treatment Phase|Unstable MR4.0|6|||
125536089|NCT01743989|451591797|FG002|Treatment Phase|Unstable MR4.0|263|||
125536090|NCT01743989|451591795|FG000|Treatment Phase|Adverse Event|0|||
125536091|NCT01743989|451591796|FG001|Treatment Phase|Adverse Event|4|||
125536092|NCT01743989|451591797|FG002|Treatment Phase|Adverse Event|67|||
125536093|NCT01743989|451591795|FG000|Treatment Phase|Withdrawal by Subject|1|||
125536094|NCT01743989|451591796|FG001|Treatment Phase|Withdrawal by Subject|3|||
125536095|NCT01743989|451591797|FG002|Treatment Phase|Withdrawal by Subject|28|||
125536096|NCT01743989|451591795|FG000|Treatment Phase|Death|0|||
125536097|NCT01743989|451591796|FG001|Treatment Phase|Death|1|||
125536098|NCT01743989|451591797|FG002|Treatment Phase|Death|3|||
125536099|NCT01743989|451591795|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
125536100|NCT01743989|451591796|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
125536101|NCT01743989|451591797|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
125536102|NCT01743989|451591795|FG000|Treatment Phase|Protocol deviation|0|||
125536103|NCT01743989|451591796|FG001|Treatment Phase|Protocol deviation|0|||
125536104|NCT01743989|451591797|FG002|Treatment Phase|Protocol deviation|3|||
125536105|NCT01743989|451591795|FG000|Treatment Phase|Pregnancy|0|||
125536106|NCT01743989|451591796|FG001|Treatment Phase|Pregnancy|0|||
125536107|NCT01743989|451591797|FG002|Treatment Phase|Pregnancy|2|||
125536108|NCT01743989|451591795|FG000|Treatment Phase|Lost to Follow-up|0|||
125536109|NCT01743989|451591796|FG001|Treatment Phase|Lost to Follow-up|0|||
125536110|NCT01743989|451591797|FG002|Treatment Phase|Lost to Follow-up|2|||
125536111|NCT01743989|451591795|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
125536112|NCT01743989|451591796|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
125536113|NCT01743989|451591797|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
125536114|NCT01743989|451591795|FG000|Treatment Phase|Administrative problems|0|||
125536115|NCT01743989|451591796|FG001|Treatment Phase|Administrative problems|0|||
125536116|NCT01743989|451591797|FG002|Treatment Phase|Administrative problems|1|||
125536117|NCT01743989|451591795|FG000|Treatment Phase|New cancer (CML) therapy|0|||
125536118|NCT01743989|451591796|FG001|Treatment Phase|New cancer (CML) therapy|1|||
125536119|NCT01743989|451591797|FG002|Treatment Phase|New cancer (CML) therapy|0|||
125536120|NCT01743989|451591795|FG000|Treatment Phase|Physician Decision|0|||
125536121|NCT01743989|451591796|FG001|Treatment Phase|Physician Decision|0|||
125536122|NCT01743989|451591797|FG002|Treatment Phase|Physician Decision|3|||
125536123|NCT01743989|451591795|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
125536124|NCT01743989|451591796|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
125536125|NCT01743989|451591797|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
125536126|NCT01743989|451591795|FG000|Treatment Phase|Not randomized by mistake|0|||
125536127|NCT01743989|451591796|FG001|Treatment Phase|Not randomized by mistake|0|||
125536128|NCT01743989|451591797|FG002|Treatment Phase|Not randomized by mistake|1|||
125536129|NCT01743989|451591795|FG000|Treatment Phase|Included by mistake|0|||
125536130|NCT01743989|451591796|FG001|Treatment Phase|Included by mistake|0|||
125536131|NCT01743989|451591797|FG002|Treatment Phase|Included by mistake|1|||
125536132|NCT01743989|451591795|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
125536133|NCT01743989|451591796|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
125536134|NCT01743989|451591797|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
125536135|NCT01743989|451591795|FG000|TFR Phase|Adverse Event|0|||
125536136|NCT01743989|451591796|FG001|TFR Phase|Adverse Event|1|||
125536137|NCT01743989|451591797|FG002|TFR Phase|Adverse Event|0|||
125536138|NCT01743989|451591795|FG000|TFR Phase|Lost to Follow-up|0|||
125536139|NCT01743989|451591796|FG001|TFR Phase|Lost to Follow-up|2|||
125536140|NCT01743989|451591797|FG002|TFR Phase|Lost to Follow-up|0|||
125536141|NCT01743989|451591795|FG000|TFR Phase|Physician Decision|0|||
125536142|NCT01743989|451591796|FG001|TFR Phase|Physician Decision|1|||
125536143|NCT01743989|451591797|FG002|TFR Phase|Physician Decision|0|||
125536144|NCT01743989|451591795|FG000|TFR Phase|Logistical problems|0|||
125200573|NCT01938430|450357552|FG010|Overall Study|Randomized but Not Treated|1|||
125200574|NCT01938430|450357553|FG011|Overall Study|Randomized but Not Treated|0|||
125200575|NCT01938430|450357554|FG012|Overall Study|Randomized but Not Treated|0|||
125536145|NCT01743989|451591796|FG001|TFR Phase|Logistical problems|2|||
125536146|NCT01743989|451591797|FG002|TFR Phase|Logistical problems|0|||
125536147|NCT01743989|451591795|FG000|TFR Phase|Protocol deviation|0|||
125536148|NCT01743989|451591796|FG001|TFR Phase|Protocol deviation|1|||
125536149|NCT01743989|451591797|FG002|TFR Phase|Protocol deviation|0|||
125536150|NCT01743989|451591795|FG000|TFR Phase|Withdrawal by Subject|0|||
125536151|NCT01743989|451591796|FG001|TFR Phase|Withdrawal by Subject|2|||
125536152|NCT01743989|451591797|FG002|TFR Phase|Withdrawal by Subject|0|||
125536153|NCT01743989|451591795|FG000|Re-treatment Phase|Adverse Event|8|||
125536154|NCT01743989|451591796|FG001|Re-treatment Phase|Adverse Event|4|||
125536155|NCT01743989|451591797|FG002|Re-treatment Phase|Adverse Event|0|||
125536156|NCT01743989|451591795|FG000|Re-treatment Phase|Death|1|||
125536157|NCT01743989|451591796|FG001|Re-treatment Phase|Death|1|||
125536158|NCT01743989|451591797|FG002|Re-treatment Phase|Death|0|||
125536159|NCT01743989|451591795|FG000|Re-treatment Phase|Administrative problems|1|||
125536160|NCT01743989|451591796|FG001|Re-treatment Phase|Administrative problems|1|||
125536161|NCT01743989|451591797|FG002|Re-treatment Phase|Administrative problems|0|||
125536162|NCT01743989|451591795|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
125536163|NCT01743989|451591796|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
125536164|NCT01743989|451591797|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
125536165|NCT01743989|451591795|FG000|Re-treatment Phase|Unstable MR|1|||
125536166|NCT01743989|451591796|FG001|Re-treatment Phase|Unstable MR|0|||
125536167|NCT01743989|451591797|FG002|Re-treatment Phase|Unstable MR|0|||
125536168|NCT01743989|451591795|FG000|Re-treatment Phase|Physician Decision|0|||
125536169|NCT01743989|451591796|FG001|Re-treatment Phase|Physician Decision|1|||
125536170|NCT01743989|451591797|FG002|Re-treatment Phase|Physician Decision|0|||
125536171|NCT01743989|451591795|FG000|Re-treatment Phase|Lost to Follow-up|0|||
125536172|NCT01743989|451591796|FG001|Re-treatment Phase|Lost to Follow-up|1|||
125536173|NCT01743989|451591797|FG002|Re-treatment Phase|Lost to Follow-up|0|||
125536174|NCT02235311|451591804|FG000|Overall Study|Lost to Follow-up|0|||
125536175|NCT02235311|451591805|FG001|Overall Study|Lost to Follow-up|1|||
125536176|NCT02235311|451591804|FG000|Overall Study|Protocol Violation|0|||
125536177|NCT02235311|451591805|FG001|Overall Study|Protocol Violation|1|||
125536178|NCT03006848|451591806|FG000|Overall Study|Adverse Event|1|||
125536179|NCT03006848|451591806|FG000|Overall Study|Physician Decision|1|||
125536180|NCT03006848|451591806|FG000|Overall Study|Lack of Efficacy|16|||
125536181|NCT00384397|451591808|FG000|Overall Study|Adverse Event|0|||
125536182|NCT00384397|451591809|FG001|Overall Study|Adverse Event|1|||
125536183|NCT00384397|451591810|FG002|Overall Study|Adverse Event|2|||
125536184|NCT00384397|451591808|FG000|Overall Study|Protocol Violation|7|||
125536185|NCT00384397|451591809|FG001|Overall Study|Protocol Violation|15|||
125536186|NCT00384397|451591810|FG002|Overall Study|Protocol Violation|13|||
125536187|NCT00384397|451591808|FG000|Overall Study|Lost to Follow-up|11|||
125536188|NCT00384397|451591809|FG001|Overall Study|Lost to Follow-up|13|||
125536189|NCT00384397|451591810|FG002|Overall Study|Lost to Follow-up|3|||
125536190|NCT00384397|451591808|FG000|Overall Study|Withdrawal by Subject|14|||
125536191|NCT00384397|451591809|FG001|Overall Study|Withdrawal by Subject|17|||
125536192|NCT00384397|451591810|FG002|Overall Study|Withdrawal by Subject|15|||
125536193|NCT04372121|451591815|FG000|Overall Study|Lost to Follow-up|0|||
125536194|NCT04372121|451591816|FG001|Overall Study|Lost to Follow-up|0|||
125536195|NCT04372121|451591817|FG002|Overall Study|Lost to Follow-up|0|||
125536196|NCT04372121|451591818|FG003|Overall Study|Lost to Follow-up|1|||
125536197|NCT04372121|451591815|FG000|Overall Study|Protocol Violation|0|||
125536198|NCT04372121|451591816|FG001|Overall Study|Protocol Violation|0|||
125536199|NCT04372121|451591817|FG002|Overall Study|Protocol Violation|1|||
125536200|NCT04372121|451591818|FG003|Overall Study|Protocol Violation|0|||
125536201|NCT04372121|451591815|FG000|Overall Study|Withdrawal by Subject|3|||
125536202|NCT04372121|451591816|FG001|Overall Study|Withdrawal by Subject|1|||
125536203|NCT04372121|451591817|FG002|Overall Study|Withdrawal by Subject|0|||
125536204|NCT04372121|451591818|FG003|Overall Study|Withdrawal by Subject|0|||
125536205|NCT04372121|451591815|FG000|Overall Study|Study termination|6|||
125536206|NCT04372121|451591816|FG001|Overall Study|Study termination|5|||
125536207|NCT04372121|451591817|FG002|Overall Study|Study termination|1|||
125536208|NCT04372121|451591818|FG003|Overall Study|Study termination|1|||
125536209|NCT04372121|451591815|FG000|Overall Study|Hysterectomy planned|1|||
125536210|NCT04372121|451591816|FG001|Overall Study|Hysterectomy planned|0|||
125536211|NCT04372121|451591817|FG002|Overall Study|Hysterectomy planned|0|||
125536212|NCT04372121|451591818|FG003|Overall Study|Hysterectomy planned|0|||
125536213|NCT03345576|451591819|FG000|Overall Study|Withdrawal by Subject|2|||
125536214|NCT03345576|451591820|FG001|Overall Study|Withdrawal by Subject|2|||
125536215|NCT03345576|451591819|FG000|Overall Study|Adverse Event|1|||
125536216|NCT03345576|451591820|FG001|Overall Study|Adverse Event|0|||
125536217|NCT02314780|451594046|FG000|Overall Study|organizational reasons|0|||
125536218|NCT02314780|451594047|FG001|Overall Study|organizational reasons|2|||
125536219|NCT02314780|451594048|FG002|Overall Study|organizational reasons|0|||
125536220|NCT02314780|451594046|FG000|Overall Study|Adverse Event|0|||
125536221|NCT02314780|451594047|FG001|Overall Study|Adverse Event|1|||
125536222|NCT02314780|451594048|FG002|Overall Study|Adverse Event|0|||
125536223|NCT00215137|451594052|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
125536224|NCT00215137|451594053|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
125536225|NCT00215137|451594054|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
125536226|NCT00215137|451594052|FG000|Randomization Period|Lost to Follow-up|0|||
125536227|NCT00215137|451594053|FG001|Randomization Period|Lost to Follow-up|1|||
125536228|NCT00215137|451594054|FG002|Randomization Period|Lost to Follow-up|0|||
125536229|NCT00215137|451594052|FG000|Randomization Period|Withdrawal by Subject|0|||
125536230|NCT00215137|451594053|FG001|Randomization Period|Withdrawal by Subject|1|||
125536231|NCT00215137|451594054|FG002|Randomization Period|Withdrawal by Subject|0|||
125536232|NCT01255631|451594056|FG000|Overall Study|poor enrollment, no data analyzed|9|||
125536233|NCT01255631|451594057|FG001|Overall Study|poor enrollment, no data analyzed|6|||
125536234|NCT01076153|451594070|FG000|Overall Study|Symptoms improved/resolved|10|||
125536235|NCT01076153|451594070|FG000|Overall Study|Adverse Event|1|||
125536236|NCT01142232|451594074|FG000|Overall Study|Adverse Event|1|||
125536237|NCT01142232|451594075|FG001|Overall Study|Adverse Event|2|||
125536238|NCT01142232|451594076|FG002|Overall Study|Adverse Event|1|||
125536239|NCT01142232|451594077|FG003|Overall Study|Adverse Event|0|||
125536240|NCT01142232|451594078|FG004|Overall Study|Adverse Event|4|||
125536241|NCT01142232|451594074|FG000|Overall Study|Death|0|||
125536242|NCT01142232|451594075|FG001|Overall Study|Death|0|||
125536243|NCT01142232|451594076|FG002|Overall Study|Death|0|||
125536244|NCT01142232|451594077|FG003|Overall Study|Death|0|||
125536245|NCT01142232|451594078|FG004|Overall Study|Death|1|||
125536246|NCT01142232|451594074|FG000|Overall Study|Disease Progression|2|||
125536247|NCT01142232|451594075|FG001|Overall Study|Disease Progression|0|||
125536248|NCT01142232|451594076|FG002|Overall Study|Disease Progression|1|||
125536249|NCT01142232|451594077|FG003|Overall Study|Disease Progression|2|||
125536250|NCT01142232|451594078|FG004|Overall Study|Disease Progression|12|||
125536251|NCT01142232|451594074|FG000|Overall Study|Withdrawal by Subject|0|||
125536252|NCT01142232|451594075|FG001|Overall Study|Withdrawal by Subject|0|||
125536253|NCT01142232|451594076|FG002|Overall Study|Withdrawal by Subject|0|||
125536254|NCT01142232|451594077|FG003|Overall Study|Withdrawal by Subject|1|||
125536255|NCT01142232|451594078|FG004|Overall Study|Withdrawal by Subject|3|||
125536256|NCT01142232|451594074|FG000|Overall Study|Physician Decision|0|||
125536257|NCT01142232|451594075|FG001|Overall Study|Physician Decision|1|||
125536258|NCT01142232|451594076|FG002|Overall Study|Physician Decision|0|||
125536259|NCT01142232|451594077|FG003|Overall Study|Physician Decision|2|||
125536260|NCT01142232|451594078|FG004|Overall Study|Physician Decision|10|||
125536261|NCT01142232|451594074|FG000|Overall Study|Alternative Therapy|0|||
125536262|NCT01142232|451594075|FG001|Overall Study|Alternative Therapy|1|||
125536263|NCT01142232|451594076|FG002|Overall Study|Alternative Therapy|1|||
125536264|NCT01142232|451594077|FG003|Overall Study|Alternative Therapy|0|||
125536265|NCT01142232|451594078|FG004|Overall Study|Alternative Therapy|1|||
125536266|NCT01142232|451594074|FG000|Overall Study|Off Trt for other complicating disease|0|||
125536267|NCT01142232|451594075|FG001|Overall Study|Off Trt for other complicating disease|0|||
125536268|NCT01142232|451594076|FG002|Overall Study|Off Trt for other complicating disease|0|||
125536269|NCT01142232|451594077|FG003|Overall Study|Off Trt for other complicating disease|0|||
125536270|NCT01142232|451594078|FG004|Overall Study|Off Trt for other complicating disease|1|||
125536271|NCT01142232|451594074|FG000|Overall Study|Noncompliance|0|||
125536272|NCT01142232|451594075|FG001|Overall Study|Noncompliance|0|||
125536273|NCT01142232|451594076|FG002|Overall Study|Noncompliance|0|||
125536274|NCT01142232|451594077|FG003|Overall Study|Noncompliance|0|||
125536275|NCT01142232|451594078|FG004|Overall Study|Noncompliance|2|||
125536276|NCT00297427|451594083|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
125536277|NCT00297427|451594084|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
125536278|NCT00297427|451594083|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
125536279|NCT00297427|451594084|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
125536280|NCT00297427|451594083|FG000|Phase 1: Initial Intervention|Death|0|||
125536281|NCT00297427|451594084|FG001|Phase 1: Initial Intervention|Death|1|||
125536282|NCT00297427|451594083|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
125536283|NCT00297427|451594084|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
125536284|NCT00297427|451594083|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
125536285|NCT00297427|451594084|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
125536286|NCT00297427|451594083|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
125536287|NCT00297427|451594084|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
125536288|NCT00297427|451594083|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
125536289|NCT00297427|451594084|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
125536290|NCT00297427|451594083|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
125536291|NCT00297427|451594084|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
125536292|NCT00574873|451594086|FG000|Overall Study|Withdrawal by Subject|18|||
125536293|NCT00574873|451594087|FG001|Overall Study|Withdrawal by Subject|19|||
125536294|NCT00574873|451594086|FG000|Overall Study|Investigator request|18|||
125536295|NCT00574873|451594087|FG001|Overall Study|Investigator request|8|||
125536296|NCT00574873|451594086|FG000|Overall Study|Death|15|||
125536297|NCT00574873|451594087|FG001|Overall Study|Death|14|||
125536298|NCT00574873|451594086|FG000|Overall Study|Lost to Follow-up|14|||
125536299|NCT00574873|451594087|FG001|Overall Study|Lost to Follow-up|5|||
125536300|NCT00574873|451594086|FG000|Overall Study|Other|40|||
125536301|NCT00574873|451594087|FG001|Overall Study|Other|4|||
125536302|NCT00574873|451594086|FG000|Overall Study|Discontinuation of study by sponsor|5|||
125536303|NCT00574873|451594087|FG001|Overall Study|Discontinuation of study by sponsor|199|||
125536304|NCT00574873|451594086|FG000|Overall Study|Blank, site closed per local regulations|2|||
125536305|NCT00574873|451594087|FG001|Overall Study|Blank, site closed per local regulations|2|||
125536306|NCT00574873|451594086|FG000|Overall Study|Extension Study|126|||
125536307|NCT00574873|451594087|FG001|Overall Study|Extension Study|0|||
125536308|NCT00201643|451594089|FG000|Overall Study|Withdrawal by Subject|5|||
125536309|NCT00201643|451594090|FG001|Overall Study|Withdrawal by Subject|4|||
125536310|NCT02787044|451594097|FG000|Overall Study|Lost to Follow-up|15|||
125536311|NCT02787044|451594098|FG001|Overall Study|Lost to Follow-up|19|||
125536312|NCT02182947|451594099|FG000|Overall Study|Withdrawal by Subject|7|||
125536313|NCT02182947|451594099|FG000|Overall Study|Lost to Follow-up|3|||
125536314|NCT02182947|451594099|FG000|Overall Study|Failed screening activities|8|||
125536315|NCT02236988|451594102|FG000|Overall Study|Lost to Follow-up|0|||
125536316|NCT02236988|451594103|FG001|Overall Study|Lost to Follow-up|0|||
125536317|NCT02236988|451594104|FG002|Overall Study|Lost to Follow-up|0|||
125536318|NCT02236988|451594105|FG003|Overall Study|Lost to Follow-up|1|||
125536319|NCT02236988|451594102|FG000|Overall Study|Unable to Comply with Study Visits|0|||
125536320|NCT02236988|451594103|FG001|Overall Study|Unable to Comply with Study Visits|0|||
125536321|NCT02236988|451594104|FG002|Overall Study|Unable to Comply with Study Visits|0|||
125536322|NCT02236988|451594105|FG003|Overall Study|Unable to Comply with Study Visits|2|||
125536323|NCT00730275|451594106|FG000|Overall Study|Withdrawal by Subject|0|||
125536324|NCT00730275|451594107|FG001|Overall Study|Withdrawal by Subject|0|||
125536325|NCT00730275|451594108|FG002|Overall Study|Withdrawal by Subject|0|||
125536326|NCT00730275|451594109|FG003|Overall Study|Withdrawal by Subject|1|||
125536327|NCT04032613|451594111|FG000|Overall Study|Did not complete post-program assessment|5|||
125536328|NCT04032613|451594112|FG001|Overall Study|Did not complete post-program assessment|2|||
125536329|NCT03053518|451594117|FG000|Overall Study|Withdrawal by Subject|3|||
125536330|NCT03053518|451594117|FG000|Overall Study|Lost to Follow-up|2|||
125536331|NCT03053518|451594117|FG000|Overall Study|Ineligible|5|||
125536332|NCT01156376|451594118|FG000|Overall Study|Adverse Event|1|||
125536333|NCT01156376|451594119|FG001|Overall Study|Adverse Event|0|||
125536334|NCT01156376|451594120|FG002|Overall Study|Adverse Event|1|||
125536335|NCT01156376|451594118|FG000|Overall Study|Withdrawal by Subject|0|||
125536336|NCT01156376|451594119|FG001|Overall Study|Withdrawal by Subject|0|||
125536337|NCT01156376|451594120|FG002|Overall Study|Withdrawal by Subject|3|||
125536338|NCT02071290|451594121|FG000|Overall Study|Death|1|||
125536339|NCT02071290|451594122|FG001|Overall Study|Death|0|||
125536340|NCT02071290|451594121|FG000|Overall Study|Withdrawal by Subject|0|||
125536341|NCT02071290|451594122|FG001|Overall Study|Withdrawal by Subject|1|||
125536342|NCT02071290|451594121|FG000|Overall Study|Protocol Violation|3|||
125536343|NCT02071290|451594122|FG001|Overall Study|Protocol Violation|5|||
125536344|NCT02071290|451594121|FG000|Overall Study|Physician Decision|0|||
125536345|NCT02071290|451594122|FG001|Overall Study|Physician Decision|1|||
125536346|NCT04488770|451594125|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
125536347|NCT04488770|451594126|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
125536348|NCT04488770|451594127|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
125536349|NCT04488770|451594128|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
125536350|NCT04488770|451594129|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
125536351|NCT04488770|451594130|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
125536352|NCT04488770|451594131|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
125536353|NCT04488770|451594132|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
125536354|NCT04488770|451594133|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
125536355|NCT04488770|451594134|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
125536356|NCT04488770|451594135|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
125536357|NCT04488770|451594136|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
125536358|NCT04488770|451594137|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
125536359|NCT04488770|451594125|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
125536360|NCT04488770|451594126|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
125536361|NCT04488770|451594127|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
125536362|NCT04488770|451594128|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
125536363|NCT04488770|451594129|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
125536364|NCT04488770|451594130|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
125536365|NCT04488770|451594131|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
125200576|NCT01938430|450357555|FG013|Overall Study|Randomized but Not Treated|1|||
125200577|NCT01938430|450357542|FG000|Overall Study|Adverse Event|0|||
125200578|NCT01938430|450357543|FG001|Overall Study|Adverse Event|0|||
125536366|NCT04488770|451594132|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
125536367|NCT04488770|451594133|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
125536368|NCT04488770|451594134|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
125536369|NCT04488770|451594135|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
125536370|NCT04488770|451594136|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
125536371|NCT04488770|451594137|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
125536372|NCT04488770|451594125|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125536373|NCT04488770|451594126|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125536374|NCT04488770|451594127|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125536375|NCT04488770|451594128|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125536376|NCT04488770|451594129|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125536377|NCT04488770|451594130|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
125536378|NCT04488770|451594131|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
125536379|NCT04488770|451594132|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125536380|NCT04488770|451594133|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125536381|NCT04488770|451594134|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125536382|NCT04488770|451594135|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125536383|NCT04488770|451594136|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125536384|NCT04488770|451594137|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125536385|NCT04488770|451594125|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
125536386|NCT04488770|451594126|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
125536387|NCT04488770|451594127|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
125536388|NCT04488770|451594128|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
125536389|NCT04488770|451594129|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
125536390|NCT04488770|451594130|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
125646048|NCT04067310|451988151|FG000|Overall Study|Withdrawal by Subject|3|||
125646049|NCT04067310|451988152|FG001|Overall Study|Withdrawal by Subject|0|||
125646050|NCT01249404|451988153|FG000|Overall Study|Study treatment not received|0|||
125646051|NCT01249404|451988154|FG001|Overall Study|Study treatment not received|1|||
125646052|NCT01249404|451988155|FG002|Overall Study|Study treatment not received|2|||
125646053|NCT01249404|451988153|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
125646054|NCT01249404|451988154|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
125646055|NCT01249404|451988155|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
125646056|NCT01249404|451988153|FG000|Overall Study|Adverse Event|2|||
125646057|NCT01249404|451988154|FG001|Overall Study|Adverse Event|2|||
125646058|NCT01249404|451988155|FG002|Overall Study|Adverse Event|2|||
125646059|NCT01249404|451988153|FG000|Overall Study|Withdrawal by Subject|2|||
125646060|NCT01249404|451988154|FG001|Overall Study|Withdrawal by Subject|2|||
125646061|NCT01249404|451988155|FG002|Overall Study|Withdrawal by Subject|0|||
125646062|NCT01249404|451988153|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
125646063|NCT01249404|451988154|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
125646064|NCT01249404|451988155|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
125646065|NCT01249404|451988153|FG000|Overall Study|Non compliance to visit schedule|0|||
125646066|NCT01249404|451988154|FG001|Overall Study|Non compliance to visit schedule|1|||
125646067|NCT01249404|451988155|FG002|Overall Study|Non compliance to visit schedule|0|||
125646068|NCT01020812|451988156|FG000|Overall Study|Physician Decision|1|||
125646069|NCT01020812|451988156|FG000|Overall Study|Withdrawal by Subject|1|||
125646070|NCT01020812|451988156|FG000|Overall Study|Protocol Violation|1|||
125646071|NCT02927990|451988157|FG000|Overall Study|Protocol Violation|4|||
125646072|NCT02927990|451988157|FG000|Overall Study|Physician Decision|9|||
125646073|NCT02927990|451988157|FG000|Overall Study|Room switched and therefore no study device available|15|||
125646074|NCT02927990|451988157|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
125646075|NCT00960323|451988158|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
125646076|NCT02719028|451988165|FG000|Overall Study|Adverse Event|2|||
125646077|NCT02719028|451988166|FG001|Overall Study|Adverse Event|1|||
125646078|NCT02719028|451988167|FG002|Overall Study|Adverse Event|4|||
125646079|NCT02719028|451988168|FG003|Overall Study|Adverse Event|8|||
125646080|NCT02719028|451988165|FG000|Overall Study|Physician Decision|0|||
125646081|NCT02719028|451988166|FG001|Overall Study|Physician Decision|1|||
125646082|NCT02719028|451988167|FG002|Overall Study|Physician Decision|1|||
125646083|NCT02719028|451988168|FG003|Overall Study|Physician Decision|1|||
125646084|NCT02719028|451988165|FG000|Overall Study|Use of prohibited medication|0|||
125646085|NCT02719028|451988166|FG001|Overall Study|Use of prohibited medication|0|||
125646086|NCT02719028|451988167|FG002|Overall Study|Use of prohibited medication|1|||
125646087|NCT02719028|451988168|FG003|Overall Study|Use of prohibited medication|0|||
125646088|NCT02719028|451988165|FG000|Overall Study|Protocol Violation|0|||
125646089|NCT02719028|451988166|FG001|Overall Study|Protocol Violation|0|||
125646090|NCT02719028|451988167|FG002|Overall Study|Protocol Violation|0|||
125646091|NCT02719028|451988168|FG003|Overall Study|Protocol Violation|1|||
125646092|NCT03287960|451988169|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
125646093|NCT03287960|451988169|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
125646094|NCT03730987|451988170|FG000|Overall Study|Lost to Follow-up|2|||
125646095|NCT03730987|451988171|FG001|Overall Study|Lost to Follow-up|0|||
125646096|NCT03730987|451988172|FG002|Overall Study|Lost to Follow-up|2|||
125646097|NCT03730987|451988173|FG003|Overall Study|Lost to Follow-up|0|||
125646098|NCT01667731|451988179|FG000|Overall Study|Enrolled but not treated|0|||
125646099|NCT01667731|451988180|FG001|Overall Study|Enrolled but not treated|0|||
125646100|NCT01667731|451988181|FG002|Overall Study|Enrolled but not treated|0|||
125646101|NCT01667731|451988182|FG003|Overall Study|Enrolled but not treated|0|||
125646102|NCT01667731|451988183|FG004|Overall Study|Enrolled but not treated|1|||
125646103|NCT01667731|451988179|FG000|Overall Study|Efficacy Failure|1|||
125536391|NCT04488770|451594131|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
125536392|NCT04488770|451594132|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
125536393|NCT04488770|451594133|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
125536394|NCT04488770|451594134|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
125536395|NCT04488770|451594135|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
125536396|NCT04488770|451594136|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
125536397|NCT04488770|451594137|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
125536398|NCT02075073|451594138|FG000|Overall Study|Withdrawal by Subject|0|||
125536399|NCT02075073|451594139|FG001|Overall Study|Withdrawal by Subject|1|||
125536400|NCT02075073|451594140|FG002|Overall Study|Withdrawal by Subject|0|||
125536401|NCT02797080|451594146|FG000|Overall Study|Lost to Follow-up|1|||
125536402|NCT02797080|451594146|FG000|Overall Study|Withdrawal by Subject|1|||
125536403|NCT01305408|451594147|FG000|Overall Study|Adverse Event|10|||
125536404|NCT01305408|451594148|FG001|Overall Study|Adverse Event|7|||
125536405|NCT01305408|451594147|FG000|Overall Study|Lack of Efficacy|3|||
125536406|NCT01305408|451594148|FG001|Overall Study|Lack of Efficacy|4|||
125536407|NCT01305408|451594147|FG000|Overall Study|Withdrawal by Subject|9|||
125536408|NCT01305408|451594148|FG001|Overall Study|Withdrawal by Subject|9|||
125536409|NCT01305408|451594147|FG000|Overall Study|Protocol Violation|4|||
125536410|NCT01305408|451594148|FG001|Overall Study|Protocol Violation|6|||
125536411|NCT01305408|451594147|FG000|Overall Study|Lost to Follow-up|5|||
125536412|NCT01305408|451594148|FG001|Overall Study|Lost to Follow-up|3|||
125536413|NCT01305408|451594147|FG000|Overall Study|Noncompliance with study medication|0|||
125536414|NCT01305408|451594148|FG001|Overall Study|Noncompliance with study medication|1|||
125536415|NCT01305408|451594147|FG000|Overall Study|Noncompliance with study procedures|0|||
125536416|NCT01305408|451594148|FG001|Overall Study|Noncompliance with study procedures|1|||
125536417|NCT01305408|451594147|FG000|Overall Study|Other|1|||
125536418|NCT01305408|451594148|FG001|Overall Study|Other|0|||
125536419|NCT02530970|451594149|FG000|Overall Study|Adverse Event|8|||
125536420|NCT02530970|451594149|FG000|Overall Study|Lost to Follow-up|88|||
125536421|NCT02530970|451594149|FG000|Overall Study|Physician Decision|5|||
125536422|NCT02530970|451594149|FG000|Overall Study|Withdrawal by Subject|14|||
125536423|NCT02530970|451594149|FG000|Overall Study|Death|6|||
125536424|NCT02530970|451594149|FG000|Overall Study|Hospitalization|1|||
125536425|NCT02530970|451594149|FG000|Overall Study|Insurance|2|||
125536426|NCT02530970|451594149|FG000|Overall Study|Explant|2|||
125536427|NCT02530970|451594149|FG000|Overall Study|Change in Provider|5|||
125536428|NCT02530970|451594149|FG000|Overall Study|Relocation|3|||
125536429|NCT01365481|451594156|FG000|Overall Study|Adverse Event|6|||
125536430|NCT01365481|451594157|FG001|Overall Study|Adverse Event|9|||
125536431|NCT01365481|451594158|FG002|Overall Study|Adverse Event|0|||
125536432|NCT01365481|451594159|FG003|Overall Study|Adverse Event|2|||
125536433|NCT01365481|451594156|FG000|Overall Study|Withdrawal by Subject|0|||
125536434|NCT01365481|451594157|FG001|Overall Study|Withdrawal by Subject|2|||
125536435|NCT01365481|451594158|FG002|Overall Study|Withdrawal by Subject|1|||
125536436|NCT01365481|451594159|FG003|Overall Study|Withdrawal by Subject|1|||
125536437|NCT01365481|451594156|FG000|Overall Study|Lost to Follow-up|1|||
125536438|NCT01365481|451594157|FG001|Overall Study|Lost to Follow-up|1|||
125536439|NCT01365481|451594158|FG002|Overall Study|Lost to Follow-up|2|||
125536440|NCT01365481|451594159|FG003|Overall Study|Lost to Follow-up|3|||
125536441|NCT01365481|451594156|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125536442|NCT01365481|451594157|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125536443|NCT01365481|451594158|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125536444|NCT01365481|451594159|FG003|Overall Study|Abnormal laboratory value(s)|0|||
125536445|NCT01365481|451594156|FG000|Overall Study|Administrative problems|0|||
125536446|NCT01365481|451594157|FG001|Overall Study|Administrative problems|1|||
125536447|NCT01365481|451594158|FG002|Overall Study|Administrative problems|0|||
125536448|NCT01365481|451594159|FG003|Overall Study|Administrative problems|0|||
125536449|NCT01365481|451594156|FG000|Overall Study|Protocol deviation|0|||
125536450|NCT01365481|451594157|FG001|Overall Study|Protocol deviation|1|||
125536451|NCT01365481|451594158|FG002|Overall Study|Protocol deviation|0|||
125536452|NCT01365481|451594159|FG003|Overall Study|Protocol deviation|1|||
125536453|NCT01365481|451594156|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125536454|NCT01365481|451594157|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125536455|NCT01365481|451594158|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
125536456|NCT01365481|451594159|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
125536457|NCT01641159|451594170|FG000|Overall Study|Lost to Follow-up|2|||
125536458|NCT01641159|451594171|FG001|Overall Study|Lost to Follow-up|1|||
125536459|NCT01641159|451594170|FG000|Overall Study|Withdrawal by Subject|0|||
125536460|NCT01641159|451594171|FG001|Overall Study|Withdrawal by Subject|1|||
125536461|NCT03653208|451594175|FG000|Overall Study|Withdrawal by Subject|0|||
125536462|NCT03653208|451594176|FG001|Overall Study|Withdrawal by Subject|0|||
125536463|NCT03653208|451594177|FG002|Overall Study|Withdrawal by Subject|0|||
125536464|NCT03653208|451594178|FG003|Overall Study|Withdrawal by Subject|0|||
125536465|NCT03653208|451594179|FG004|Overall Study|Withdrawal by Subject|1|||
125536466|NCT03653208|451594180|FG005|Overall Study|Withdrawal by Subject|0|||
125536467|NCT03653208|451594181|FG006|Overall Study|Withdrawal by Subject|0|||
125536468|NCT03653208|451594182|FG007|Overall Study|Withdrawal by Subject|1|||
125536469|NCT03653208|451594183|FG008|Overall Study|Withdrawal by Subject|1|||
125536470|NCT03752970|451594185|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
125536471|NCT03752970|451594186|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
125536472|NCT03752970|451594187|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
125536473|NCT03752970|451594185|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
125536474|NCT03752970|451594186|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
125536475|NCT03752970|451594187|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
125536476|NCT03752970|451594185|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
125536477|NCT03752970|451594186|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
125536478|NCT03752970|451594187|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
125536479|NCT03752970|451594185|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
125536480|NCT03752970|451594186|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
125536481|NCT03752970|451594187|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
125536482|NCT03752970|451594185|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
125536483|NCT03752970|451594186|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
125536484|NCT03752970|451594187|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
125536485|NCT01152814|451594189|FG000|Overall Study|Lost to Follow-up|2|||
125536486|NCT01669577|451594193|FG000|Overall Study|Death|22|||
125536487|NCT01669577|451594193|FG000|Overall Study|Lost to Follow-up|78|||
125536488|NCT01669577|451594193|FG000|Overall Study|Physician Decision|34|||
125536489|NCT01283516|451594194|FG000|Overall Study|Adverse Event|0|||
125536490|NCT01283516|451594195|FG001|Overall Study|Adverse Event|0|||
125536491|NCT01283516|451594196|FG002|Overall Study|Adverse Event|0|||
125536492|NCT01283516|451594197|FG003|Overall Study|Adverse Event|0|||
125536493|NCT01283516|451594198|FG004|Overall Study|Adverse Event|0|||
125536494|NCT01283516|451594199|FG005|Overall Study|Adverse Event|0|||
125536495|NCT01283516|451594200|FG006|Overall Study|Adverse Event|2|||
125536496|NCT01283516|451594201|FG007|Overall Study|Adverse Event|0|||
125536497|NCT01283516|451594202|FG008|Overall Study|Adverse Event|28|||
125536498|NCT01283516|451594194|FG000|Overall Study|Death|0|||
125536499|NCT01283516|451594195|FG001|Overall Study|Death|0|||
125536500|NCT01283516|451594196|FG002|Overall Study|Death|0|||
125536501|NCT01283516|451594197|FG003|Overall Study|Death|0|||
125536502|NCT01283516|451594198|FG004|Overall Study|Death|0|||
125536503|NCT01283516|451594199|FG005|Overall Study|Death|1|||
125536504|NCT01283516|451594200|FG006|Overall Study|Death|0|||
125536505|NCT01283516|451594201|FG007|Overall Study|Death|1|||
125536506|NCT01283516|451594202|FG008|Overall Study|Death|12|||
125536507|NCT01283516|451594194|FG000|Overall Study|Disease Progression|2|||
125536508|NCT01283516|451594195|FG001|Overall Study|Disease Progression|2|||
125536509|NCT01283516|451594196|FG002|Overall Study|Disease Progression|3|||
125536510|NCT01283516|451594197|FG003|Overall Study|Disease Progression|3|||
125536511|NCT01283516|451594198|FG004|Overall Study|Disease Progression|13|||
125536512|NCT01283516|451594199|FG005|Overall Study|Disease Progression|8|||
125536513|NCT01283516|451594200|FG006|Overall Study|Disease Progression|6|||
125536514|NCT01283516|451594201|FG007|Overall Study|Disease Progression|3|||
125536515|NCT01283516|451594202|FG008|Overall Study|Disease Progression|139|||
125536516|NCT01283516|451594194|FG000|Overall Study|Withdrawal by Subject|0|||
125536517|NCT01283516|451594195|FG001|Overall Study|Withdrawal by Subject|0|||
125536518|NCT01283516|451594196|FG002|Overall Study|Withdrawal by Subject|0|||
125536519|NCT01283516|451594197|FG003|Overall Study|Withdrawal by Subject|0|||
125536520|NCT01283516|451594198|FG004|Overall Study|Withdrawal by Subject|1|||
125536521|NCT01283516|451594199|FG005|Overall Study|Withdrawal by Subject|0|||
125536522|NCT01283516|451594200|FG006|Overall Study|Withdrawal by Subject|1|||
125536523|NCT01283516|451594201|FG007|Overall Study|Withdrawal by Subject|0|||
125536524|NCT01283516|451594202|FG008|Overall Study|Withdrawal by Subject|36|||
125536525|NCT01283516|451594194|FG000|Overall Study|Administrative problems|0|||
125536526|NCT01283516|451594195|FG001|Overall Study|Administrative problems|0|||
125536527|NCT01283516|451594196|FG002|Overall Study|Administrative problems|0|||
125536528|NCT01283516|451594197|FG003|Overall Study|Administrative problems|0|||
125536529|NCT01283516|451594198|FG004|Overall Study|Administrative problems|0|||
125536530|NCT01283516|451594199|FG005|Overall Study|Administrative problems|1|||
125536531|NCT01283516|451594200|FG006|Overall Study|Administrative problems|1|||
125536532|NCT01283516|451594201|FG007|Overall Study|Administrative problems|1|||
125536533|NCT01283516|451594202|FG008|Overall Study|Administrative problems|39|||
125536534|NCT01283516|451594194|FG000|Overall Study|Lost to Follow-up|0|||
125200579|NCT01938430|450357544|FG002|Overall Study|Adverse Event|0|||
125200580|NCT01938430|450357545|FG003|Overall Study|Adverse Event|0|||
125536535|NCT01283516|451594195|FG001|Overall Study|Lost to Follow-up|0|||
125536536|NCT01283516|451594196|FG002|Overall Study|Lost to Follow-up|0|||
125536537|NCT01283516|451594197|FG003|Overall Study|Lost to Follow-up|0|||
125200581|NCT01938430|450357546|FG004|Overall Study|Adverse Event|0|||
125200582|NCT01938430|450357547|FG005|Overall Study|Adverse Event|0|||
125536538|NCT01283516|451594198|FG004|Overall Study|Lost to Follow-up|0|||
125536539|NCT01283516|451594199|FG005|Overall Study|Lost to Follow-up|0|||
125536540|NCT01283516|451594200|FG006|Overall Study|Lost to Follow-up|0|||
125536541|NCT01283516|451594201|FG007|Overall Study|Lost to Follow-up|0|||
125536542|NCT01283516|451594202|FG008|Overall Study|Lost to Follow-up|1|||
125536543|NCT00132873|451594206|FG000|Overall Study|Adverse Event|3|||
125536544|NCT00132873|451594206|FG000|Overall Study|Lost to Follow-up|1|||
125536545|NCT00132873|451594206|FG000|Overall Study|Lack of Efficacy|1|||
125536546|NCT00132873|451594206|FG000|Overall Study|Withdrawal by Subject|3|||
125536547|NCT00132873|451594206|FG000|Overall Study|Planned Pregnancy|1|||
125536548|NCT00444275|451594207|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
125536549|NCT00444275|451594208|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
125536550|NCT00444275|451594209|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
125536551|NCT00444275|451594210|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
125536552|NCT00444275|451594211|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
125536553|NCT00444275|451594207|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
125536554|NCT00444275|451594208|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
125536555|NCT00444275|451594209|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
125536556|NCT00444275|451594210|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
125536557|NCT00444275|451594211|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
125536558|NCT00444275|451594207|FG000|Maintenance Treatment Phase|Adverse Event|0|||
125536559|NCT00444275|451594208|FG001|Maintenance Treatment Phase|Adverse Event|0|||
125536560|NCT00444275|451594209|FG002|Maintenance Treatment Phase|Adverse Event|3|||
125536561|NCT00444275|451594210|FG003|Maintenance Treatment Phase|Adverse Event|2|||
125536562|NCT00444275|451594211|FG004|Maintenance Treatment Phase|Adverse Event|13|||
125536563|NCT00444275|451594207|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
125536564|NCT00444275|451594208|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
125536565|NCT00444275|451594209|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
125536566|NCT00444275|451594210|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
125536567|NCT00444275|451594211|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
125536568|NCT00444275|451594207|FG000|Maintenance Treatment Phase|Patient's wish|0|||
125536569|NCT00444275|451594208|FG001|Maintenance Treatment Phase|Patient's wish|0|||
125536570|NCT00444275|451594209|FG002|Maintenance Treatment Phase|Patient's wish|19|||
125536571|NCT00444275|451594210|FG003|Maintenance Treatment Phase|Patient's wish|9|||
125536572|NCT00444275|451594211|FG004|Maintenance Treatment Phase|Patient's wish|20|||
125536573|NCT00444275|451594207|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
125536574|NCT00444275|451594208|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
125536575|NCT00444275|451594209|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
125536576|NCT00444275|451594210|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
125536577|NCT00444275|451594211|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
125536578|NCT00444275|451594207|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
125536579|NCT00444275|451594208|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
125536580|NCT00444275|451594209|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
125536581|NCT00444275|451594210|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
125536582|NCT00444275|451594211|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
125536583|NCT02045875|451594212|FG000|Overall Study|Lost to Follow-up|3|||
125536584|NCT02045875|451594213|FG001|Overall Study|Lost to Follow-up|0|||
125536585|NCT02045875|451594212|FG000|Overall Study|Withdrawal by Subject|4|||
125536586|NCT02045875|451594213|FG001|Overall Study|Withdrawal by Subject|3|||
125536587|NCT01114880|451594217|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
125536588|NCT01114880|451594218|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
125536589|NCT01114880|451594217|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
125536590|NCT01114880|451594218|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
125536591|NCT01114880|451594217|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
125536592|NCT01114880|451594218|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
125536593|NCT01114880|451594217|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
125536594|NCT01114880|451594218|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
125536595|NCT01114880|451594217|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
125536596|NCT01114880|451594218|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
125536597|NCT01114880|451594217|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
125536598|NCT01114880|451594218|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
125536599|NCT02626455|451594219|FG000|Overall Study|Other|1|||
125536600|NCT02626455|451594220|FG001|Overall Study|Other|1|||
125536601|NCT02626455|451594221|FG002|Overall Study|Other|0|||
125536602|NCT02626455|451594222|FG003|Overall Study|Other|0|||
125536603|NCT02626455|451594223|FG004|Overall Study|Other|0|||
125200583|NCT01938430|450357548|FG006|Overall Study|Adverse Event|1|||
125200584|NCT01938430|450357549|FG007|Overall Study|Adverse Event|0|||
125536604|NCT02626455|451594224|FG005|Overall Study|Other|17|||
125536605|NCT02626455|451594225|FG006|Overall Study|Other|23|||
125536606|NCT02626455|451594219|FG000|Overall Study|Withdrawal by Subject|1|||
125200585|NCT01938430|450357550|FG008|Overall Study|Adverse Event|0|||
125200586|NCT01938430|450357551|FG009|Overall Study|Adverse Event|0|||
125200587|NCT01938430|450357552|FG010|Overall Study|Adverse Event|0|||
125200588|NCT01938430|450357553|FG011|Overall Study|Adverse Event|0|||
125200589|NCT01938430|450357554|FG012|Overall Study|Adverse Event|0|||
125424634|NCT00428090|451178649|FG001|Overall Study|Sponsor terminated study|1|||
125424635|NCT00428090|451178650|FG002|Overall Study|Sponsor terminated study|0|||
125424636|NCT00428090|451178651|FG003|Overall Study|Sponsor terminated study|0|||
125424637|NCT00428090|451178648|FG000|Overall Study|Non-compliance|4|||
125424638|NCT00428090|451178649|FG001|Overall Study|Non-compliance|0|||
125424639|NCT00428090|451178650|FG002|Overall Study|Non-compliance|1|||
125424640|NCT00428090|451178651|FG003|Overall Study|Non-compliance|3|||
125424641|NCT00428090|451178648|FG000|Overall Study|Par. did not returned to visit|1|||
125424642|NCT00428090|451178649|FG001|Overall Study|Par. did not returned to visit|0|||
125424643|NCT00428090|451178650|FG002|Overall Study|Par. did not returned to visit|0|||
125424644|NCT00428090|451178651|FG003|Overall Study|Par. did not returned to visit|1|||
125424645|NCT00428090|451178648|FG000|Overall Study|Follow-Up visit not possible|1|||
125424646|NCT00428090|451178649|FG001|Overall Study|Follow-Up visit not possible|0|||
125424647|NCT00428090|451178650|FG002|Overall Study|Follow-Up visit not possible|0|||
125424648|NCT00428090|451178651|FG003|Overall Study|Follow-Up visit not possible|0|||
125424649|NCT00428090|451178648|FG000|Overall Study|Prohibited medication used for SAE|1|||
125424650|NCT00428090|451178649|FG001|Overall Study|Prohibited medication used for SAE|0|||
125424651|NCT00428090|451178650|FG002|Overall Study|Prohibited medication used for SAE|0|||
125424652|NCT00428090|451178651|FG003|Overall Study|Prohibited medication used for SAE|0|||
125424653|NCT00428090|451178648|FG000|Overall Study|Death of par.|1|||
125424654|NCT00428090|451178649|FG001|Overall Study|Death of par.|0|||
125424655|NCT00428090|451178650|FG002|Overall Study|Death of par.|1|||
125424656|NCT00428090|451178651|FG003|Overall Study|Death of par.|0|||
125424657|NCT00428090|451178648|FG000|Overall Study|Visit 7 exceed the visit window|0|||
125424658|NCT00428090|451178649|FG001|Overall Study|Visit 7 exceed the visit window|1|||
125424659|NCT00428090|451178650|FG002|Overall Study|Visit 7 exceed the visit window|0|||
125424660|NCT00428090|451178651|FG003|Overall Study|Visit 7 exceed the visit window|0|||
125424661|NCT00428090|451178648|FG000|Overall Study|Medical monitor terminated par.|0|||
125424662|NCT00428090|451178649|FG001|Overall Study|Medical monitor terminated par.|1|||
125424663|NCT00428090|451178650|FG002|Overall Study|Medical monitor terminated par.|0|||
125424664|NCT00428090|451178651|FG003|Overall Study|Medical monitor terminated par.|0|||
125424665|NCT00428090|451178648|FG000|Overall Study|Mental status of par. was|0|||
125424666|NCT00428090|451178649|FG001|Overall Study|Mental status of par. was|1|||
125424667|NCT00428090|451178650|FG002|Overall Study|Mental status of par. was|0|||
125424668|NCT00428090|451178651|FG003|Overall Study|Mental status of par. was|0|||
125424669|NCT00428090|451178648|FG000|Overall Study|Worsening of AD|0|||
125424670|NCT00428090|451178649|FG001|Overall Study|Worsening of AD|0|||
125424671|NCT00428090|451178650|FG002|Overall Study|Worsening of AD|1|||
125424672|NCT00428090|451178651|FG003|Overall Study|Worsening of AD|0|||
125424673|NCT00428090|451178648|FG000|Overall Study|Excluded for concerning QTc value|0|||
125424674|NCT00428090|451178649|FG001|Overall Study|Excluded for concerning QTc value|0|||
125424675|NCT00428090|451178650|FG002|Overall Study|Excluded for concerning QTc value|1|||
125424676|NCT00428090|451178651|FG003|Overall Study|Excluded for concerning QTc value|0|||
125424677|NCT00428090|451178648|FG000|Overall Study|Insufficient AD documentation|0|||
125424678|NCT00428090|451178649|FG001|Overall Study|Insufficient AD documentation|0|||
125424679|NCT00428090|451178650|FG002|Overall Study|Insufficient AD documentation|1|||
125424680|NCT00428090|451178651|FG003|Overall Study|Insufficient AD documentation|0|||
125424681|NCT00428090|451178648|FG000|Overall Study|High MMSE scores|0|||
125424682|NCT00428090|451178649|FG001|Overall Study|High MMSE scores|0|||
125424683|NCT00428090|451178650|FG002|Overall Study|High MMSE scores|1|||
125424684|NCT00428090|451178651|FG003|Overall Study|High MMSE scores|0|||
125424685|NCT00428090|451178648|FG000|Overall Study|Deterioration of cognitive status|0|||
125424686|NCT00428090|451178649|FG001|Overall Study|Deterioration of cognitive status|0|||
125424687|NCT00428090|451178650|FG002|Overall Study|Deterioration of cognitive status|1|||
125424688|NCT00428090|451178651|FG003|Overall Study|Deterioration of cognitive status|0|||
125424689|NCT00428090|451178648|FG000|Overall Study|Serious adverse event|0|||
125424690|NCT00428090|451178649|FG001|Overall Study|Serious adverse event|0|||
125424691|NCT00428090|451178650|FG002|Overall Study|Serious adverse event|1|||
125424692|NCT00428090|451178651|FG003|Overall Study|Serious adverse event|0|||
125424693|NCT00428090|451178648|FG000|Overall Study|Excluded for heart insufficiency|0|||
125424694|NCT00428090|451178649|FG001|Overall Study|Excluded for heart insufficiency|0|||
125424695|NCT00428090|451178650|FG002|Overall Study|Excluded for heart insufficiency|1|||
125424696|NCT00428090|451178651|FG003|Overall Study|Excluded for heart insufficiency|0|||
125424697|NCT00428090|451178648|FG000|Overall Study|Raised Creatinine Value|0|||
125424698|NCT00428090|451178649|FG001|Overall Study|Raised Creatinine Value|0|||
125424699|NCT00428090|451178650|FG002|Overall Study|Raised Creatinine Value|0|||
125424700|NCT00428090|451178651|FG003|Overall Study|Raised Creatinine Value|1|||
125424701|NCT03409666|451178652|FG000|Overall Study|Physician Decision|0|||
125424702|NCT03409666|451178653|FG001|Overall Study|Physician Decision|1|||
125424703|NCT03409666|451178652|FG000|Overall Study|Protocol Violation|0|||
125536607|NCT02626455|451594220|FG001|Overall Study|Withdrawal by Subject|0|||
125536608|NCT02626455|451594221|FG002|Overall Study|Withdrawal by Subject|0|||
125536609|NCT02626455|451594222|FG003|Overall Study|Withdrawal by Subject|0|||
125536610|NCT02626455|451594223|FG004|Overall Study|Withdrawal by Subject|0|||
125536611|NCT02626455|451594224|FG005|Overall Study|Withdrawal by Subject|10|||
125536612|NCT02626455|451594225|FG006|Overall Study|Withdrawal by Subject|6|||
125536613|NCT02626455|451594219|FG000|Overall Study|Physician Decision|0|||
125536614|NCT02626455|451594220|FG001|Overall Study|Physician Decision|2|||
125536615|NCT02626455|451594221|FG002|Overall Study|Physician Decision|2|||
125536616|NCT02626455|451594222|FG003|Overall Study|Physician Decision|2|||
125536617|NCT02626455|451594223|FG004|Overall Study|Physician Decision|1|||
125536618|NCT02626455|451594224|FG005|Overall Study|Physician Decision|10|||
125536619|NCT02626455|451594225|FG006|Overall Study|Physician Decision|3|||
125536620|NCT02626455|451594219|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
125536621|NCT02626455|451594220|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
125536622|NCT02626455|451594221|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
125536623|NCT02626455|451594222|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
125536624|NCT02626455|451594223|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
125536625|NCT02626455|451594224|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
125536626|NCT02626455|451594225|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
125536627|NCT02626455|451594219|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
125536628|NCT02626455|451594220|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
125536629|NCT02626455|451594221|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
125536630|NCT02626455|451594222|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
125536631|NCT02626455|451594223|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
125536632|NCT02626455|451594224|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
125536633|NCT02626455|451594225|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
125536634|NCT02626455|451594219|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
125536635|NCT02626455|451594220|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
125536636|NCT02626455|451594221|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
125536637|NCT02626455|451594222|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
125536638|NCT02626455|451594223|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
125536639|NCT02626455|451594224|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
125536640|NCT02626455|451594225|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
125536641|NCT02626455|451594219|FG000|Overall Study|Patient decision|0|||
125536642|NCT02626455|451594220|FG001|Overall Study|Patient decision|1|||
125536643|NCT02626455|451594221|FG002|Overall Study|Patient decision|0|||
125536644|NCT02626455|451594222|FG003|Overall Study|Patient decision|0|||
125536645|NCT02626455|451594223|FG004|Overall Study|Patient decision|1|||
125536646|NCT02626455|451594224|FG005|Overall Study|Patient decision|36|||
125536647|NCT02626455|451594225|FG006|Overall Study|Patient decision|22|||
125536648|NCT02626455|451594219|FG000|Overall Study|Protocol Violation|0|||
125536649|NCT02626455|451594220|FG001|Overall Study|Protocol Violation|0|||
125536650|NCT02626455|451594221|FG002|Overall Study|Protocol Violation|0|||
125536651|NCT02626455|451594222|FG003|Overall Study|Protocol Violation|0|||
125536652|NCT02626455|451594223|FG004|Overall Study|Protocol Violation|0|||
125536653|NCT02626455|451594224|FG005|Overall Study|Protocol Violation|0|||
125536654|NCT02626455|451594225|FG006|Overall Study|Protocol Violation|1|||
125536655|NCT02626455|451594219|FG000|Overall Study|Progressive disease - radiological progression|0|||
125536656|NCT02626455|451594220|FG001|Overall Study|Progressive disease - radiological progression|0|||
125536657|NCT02626455|451594221|FG002|Overall Study|Progressive disease - radiological progression|0|||
125536658|NCT02626455|451594222|FG003|Overall Study|Progressive disease - radiological progression|0|||
125536659|NCT02626455|451594223|FG004|Overall Study|Progressive disease - radiological progression|0|||
125536660|NCT02626455|451594224|FG005|Overall Study|Progressive disease - radiological progression|11|||
125536661|NCT02626455|451594225|FG006|Overall Study|Progressive disease - radiological progression|22|||
125536662|NCT02626455|451594219|FG000|Overall Study|Progressive disease - clinical progression|0|||
125536663|NCT02626455|451594220|FG001|Overall Study|Progressive disease - clinical progression|0|||
125536664|NCT02626455|451594221|FG002|Overall Study|Progressive disease - clinical progression|0|||
125536665|NCT02626455|451594222|FG003|Overall Study|Progressive disease - clinical progression|0|||
125536666|NCT02626455|451594223|FG004|Overall Study|Progressive disease - clinical progression|0|||
125536667|NCT02626455|451594224|FG005|Overall Study|Progressive disease - clinical progression|1|||
125536668|NCT02626455|451594225|FG006|Overall Study|Progressive disease - clinical progression|2|||
125536669|NCT02626455|451594219|FG000|Overall Study|Lost to Follow-up|0|||
125536670|NCT02626455|451594220|FG001|Overall Study|Lost to Follow-up|0|||
125536671|NCT02626455|451594221|FG002|Overall Study|Lost to Follow-up|0|||
125536672|NCT02626455|451594222|FG003|Overall Study|Lost to Follow-up|0|||
125536673|NCT02626455|451594223|FG004|Overall Study|Lost to Follow-up|0|||
125536674|NCT02626455|451594224|FG005|Overall Study|Lost to Follow-up|1|||
125536675|NCT02626455|451594225|FG006|Overall Study|Lost to Follow-up|0|||
125536676|NCT02626455|451594219|FG000|Overall Study|AE not associated with clinical disease progression|1|||
125536677|NCT02626455|451594220|FG001|Overall Study|AE not associated with clinical disease progression|1|||
125536678|NCT02626455|451594221|FG002|Overall Study|AE not associated with clinical disease progression|0|||
125536679|NCT02626455|451594222|FG003|Overall Study|AE not associated with clinical disease progression|2|||
125536680|NCT02626455|451594223|FG004|Overall Study|AE not associated with clinical disease progression|1|||
125536681|NCT02626455|451594224|FG005|Overall Study|AE not associated with clinical disease progression|65|||
125536682|NCT02626455|451594225|FG006|Overall Study|AE not associated with clinical disease progression|21|||
125536683|NCT02626455|451594219|FG000|Overall Study|AE associated with clinical disease progression|0|||
125536684|NCT02626455|451594220|FG001|Overall Study|AE associated with clinical disease progression|0|||
125536685|NCT02626455|451594221|FG002|Overall Study|AE associated with clinical disease progression|0|||
125536686|NCT02626455|451594222|FG003|Overall Study|AE associated with clinical disease progression|0|||
125536687|NCT02626455|451594223|FG004|Overall Study|AE associated with clinical disease progression|0|||
125536688|NCT02626455|451594224|FG005|Overall Study|AE associated with clinical disease progression|1|||
125536689|NCT02626455|451594225|FG006|Overall Study|AE associated with clinical disease progression|2|||
125536690|NCT02626455|451594219|FG000|Overall Study|Study intervention never administered|0|||
125536691|NCT02626455|451594220|FG001|Overall Study|Study intervention never administered|0|||
125536692|NCT02626455|451594221|FG002|Overall Study|Study intervention never administered|0|||
125536693|NCT02626455|451594222|FG003|Overall Study|Study intervention never administered|0|||
125536694|NCT02626455|451594223|FG004|Overall Study|Study intervention never administered|0|||
125536695|NCT02626455|451594224|FG005|Overall Study|Study intervention never administered|1|||
125536696|NCT02626455|451594225|FG006|Overall Study|Study intervention never administered|3|||
125536697|NCT04500769|451595760|FG000|Overall Study|Withdrawal by Subject|5|||
125536698|NCT01967147|451595761|FG000|Overall Study|Adverse Event|5|||
125536699|NCT01967147|451595762|FG001|Overall Study|Adverse Event|2|||
125536700|NCT01967147|451595761|FG000|Overall Study|Lack of Efficacy|1|||
125536701|NCT01967147|451595762|FG001|Overall Study|Lack of Efficacy|4|||
125536702|NCT01967147|451595761|FG000|Overall Study|Lost to Follow-up|1|||
125536703|NCT01967147|451595762|FG001|Overall Study|Lost to Follow-up|2|||
125536704|NCT01967147|451595761|FG000|Overall Study|Withdrawal by Subject|2|||
125536705|NCT01967147|451595762|FG001|Overall Study|Withdrawal by Subject|4|||
125536706|NCT01967147|451595761|FG000|Overall Study|Non-compliance with Study Drug|0|||
125536707|NCT01967147|451595762|FG001|Overall Study|Non-compliance with Study Drug|3|||
125536708|NCT01967147|451595761|FG000|Overall Study|Other|4|||
125536709|NCT01967147|451595762|FG001|Overall Study|Other|5|||
125536710|NCT03002220|451595767|FG000|Overall Study|Lack of Efficacy|2|||
125536711|NCT03002220|451595767|FG000|Overall Study|Withdrawal by Subject|3|||
125536712|NCT03002220|451595767|FG000|Overall Study|Adverse Event|2|||
125536713|NCT03002220|451595767|FG000|Overall Study|Disease progression|13|||
125536714|NCT03002220|451595767|FG000|Overall Study|Physician Decision|1|||
125536715|NCT01015560|451595770|FG000|Overall Study|Adverse Event|1|||
125536716|NCT01015560|451595770|FG000|Overall Study|Not protocol specified|1|||
125536717|NCT01015560|451595770|FG000|Overall Study|Withdrawal by Subject|1|||
125536718|NCT00640133|451595771|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
125536719|NCT00640133|451595772|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
125536720|NCT00640133|451595771|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
125536721|NCT00640133|451595772|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
125536722|NCT00640133|451595771|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
125536723|NCT00640133|451595772|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
125536724|NCT00128102|451595773|FG000|Overall Study|Site Discontinued|3|||
125536725|NCT00128102|451595774|FG001|Overall Study|Site Discontinued|6|||
125536726|NCT00128102|451595773|FG000|Overall Study|Other|0|||
125536727|NCT00128102|451595774|FG001|Overall Study|Other|1|||
125536728|NCT00128102|451595773|FG000|Overall Study|Progressive Disease|255|||
125536729|NCT00128102|451595774|FG001|Overall Study|Progressive Disease|285|||
125536730|NCT00128102|451595773|FG000|Overall Study|Adverse Event|34|||
125536731|NCT00128102|451595774|FG001|Overall Study|Adverse Event|11|||
125536732|NCT00128102|451595773|FG000|Overall Study|Death|12|||
125536733|NCT00128102|451595774|FG001|Overall Study|Death|13|||
125536734|NCT00128102|451595773|FG000|Overall Study|Physician Decision|3|||
125536735|NCT00128102|451595774|FG001|Overall Study|Physician Decision|3|||
125536736|NCT00128102|451595773|FG000|Overall Study|Withdrawal by Subject|19|||
125536737|NCT00128102|451595774|FG001|Overall Study|Withdrawal by Subject|11|||
125536738|NCT00128102|451595773|FG000|Overall Study|Protocol Violation|2|||
125536739|NCT00128102|451595774|FG001|Overall Study|Protocol Violation|2|||
125536740|NCT01202903|451595776|FG000|Overall Study|Administrative Probelms|1|||
125536741|NCT01202903|451595777|FG001|Overall Study|Administrative Probelms|4|||
125536742|NCT01202903|451595776|FG000|Overall Study|Protocol Violation|0|||
125536743|NCT01202903|451595777|FG001|Overall Study|Protocol Violation|1|||
125536744|NCT01202903|451595776|FG000|Overall Study|Death|1|||
125536745|NCT01202903|451595777|FG001|Overall Study|Death|0|||
125536746|NCT01202903|451595776|FG000|Overall Study|Lost to Follow-up|1|||
125536747|NCT01202903|451595777|FG001|Overall Study|Lost to Follow-up|1|||
125536748|NCT01202903|451595776|FG000|Overall Study|Lack of Efficacy|1|||
125536749|NCT01202903|451595777|FG001|Overall Study|Lack of Efficacy|3|||
125536750|NCT01202903|451595776|FG000|Overall Study|Adverse Event|3|||
125536751|NCT01202903|451595777|FG001|Overall Study|Adverse Event|3|||
125536752|NCT01202903|451595776|FG000|Overall Study|Withdrawal by Subject|4|||
125536753|NCT01202903|451595777|FG001|Overall Study|Withdrawal by Subject|4|||
125536754|NCT01302080|451595778|FG000|Overall Study|Withdrew Consent|92|||
125536755|NCT01302080|451595779|FG001|Overall Study|Withdrew Consent|39|||
125536756|NCT01302080|451595778|FG000|Overall Study|Patient/Family Moved|28|||
125536757|NCT01302080|451595779|FG001|Overall Study|Patient/Family Moved|3|||
125536758|NCT01302080|451595778|FG000|Overall Study|Lost to Follow-up|192|||
125536759|NCT01302080|451595779|FG001|Overall Study|Lost to Follow-up|93|||
125536760|NCT01302080|451595778|FG000|Overall Study|Death|1|||
125536761|NCT01302080|451595779|FG001|Overall Study|Death|0|||
125536762|NCT01302080|451595778|FG000|Overall Study|Other|52|||
125536763|NCT01302080|451595779|FG001|Overall Study|Other|8|||
125536764|NCT01302080|451595778|FG000|Overall Study|Reason Missing For Discontinuation|1|||
125536765|NCT01302080|451595779|FG001|Overall Study|Reason Missing For Discontinuation|0|||
125536766|NCT00490490|451595784|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
125536767|NCT00490490|451595784|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
125536768|NCT01638429|451595785|FG000|Overall Study|Withdrawal by Subject|1|||
125536769|NCT03207451|451595787|FG000|Overall Study|scheduling conflict|1|||
125536770|NCT03207451|451595788|FG001|Overall Study|scheduling conflict|0|||
125536771|NCT03207451|451595789|FG002|Overall Study|scheduling conflict|2|||
125536772|NCT03207451|451595790|FG003|Overall Study|scheduling conflict|2|||
125536773|NCT03207451|451595787|FG000|Overall Study|Adverse Event|0|||
125536774|NCT03207451|451595788|FG001|Overall Study|Adverse Event|0|||
125536775|NCT03207451|451595789|FG002|Overall Study|Adverse Event|0|||
125536776|NCT03207451|451595790|FG003|Overall Study|Adverse Event|1|||
125536777|NCT02040584|451595792|FG000|Overall Study|Adverse Event|13|||
125536778|NCT02040584|451595793|FG001|Overall Study|Adverse Event|6|||
125536779|NCT02040584|451595792|FG000|Overall Study|Protocol Violation|9|||
125536780|NCT02040584|451595793|FG001|Overall Study|Protocol Violation|11|||
125536781|NCT02040584|451595792|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125536782|NCT02040584|451595793|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125536783|NCT02040584|451595792|FG000|Overall Study|Death|6|||
125536784|NCT02040584|451595793|FG001|Overall Study|Death|3|||
125536785|NCT02040584|451595792|FG000|Overall Study|Transplant rejection/retransplant|0|||
125536786|NCT02040584|451595793|FG001|Overall Study|Transplant rejection/retransplant|1|||
125536787|NCT02040584|451595792|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
125536788|NCT02040584|451595793|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
125536789|NCT00996476|451595794|FG000|Overall Study|Withdrawal by Subject|1|||
125536790|NCT00996476|451595795|FG001|Overall Study|Withdrawal by Subject|2|||
125536791|NCT00996476|451595796|FG002|Overall Study|Withdrawal by Subject|1|||
125536792|NCT00996476|451595797|FG003|Overall Study|Withdrawal by Subject|0|||
125536793|NCT00996476|451595798|FG004|Overall Study|Withdrawal by Subject|1|||
125536794|NCT00996476|451595794|FG000|Overall Study|Adverse Event|0|||
125536795|NCT00996476|451595795|FG001|Overall Study|Adverse Event|1|||
125536796|NCT00996476|451595796|FG002|Overall Study|Adverse Event|0|||
125536797|NCT00996476|451595797|FG003|Overall Study|Adverse Event|0|||
125536798|NCT00996476|451595798|FG004|Overall Study|Adverse Event|1|||
125536799|NCT05540717|451595799|FG000|Overall Study|Lost to Follow-up|2|||
125536800|NCT05540717|451595800|FG001|Overall Study|Lost to Follow-up|5|||
125536801|NCT05540717|451595799|FG000|Overall Study|Withdrawal by Subject|6|||
125536802|NCT05540717|451595800|FG001|Overall Study|Withdrawal by Subject|6|||
125536803|NCT05540717|451595799|FG000|Overall Study|Sponsor request|1|||
125536804|NCT05540717|451595800|FG001|Overall Study|Sponsor request|0|||
125536805|NCT05540717|451595799|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
125536806|NCT05540717|451595800|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
125536807|NCT05540717|451595799|FG000|Overall Study|Other|0|||
125536808|NCT05540717|451595800|FG001|Overall Study|Other|1|||
125536809|NCT00473265|451595801|FG000|Overall Study|Unrelated adverse event|5|||
125536810|NCT00473265|451595801|FG000|Overall Study|Off treatment early|15|||
125536811|NCT01802567|451595802|FG000|Overall Study|Withdrawal by Subject|2|||
125536812|NCT01802567|451595802|FG000|Overall Study|Physician Decision|1|||
125536813|NCT01802567|451595802|FG000|Overall Study|Lack of Efficacy|7|||
125200590|NCT01938430|450357555|FG013|Overall Study|Adverse Event|0|||
125536814|NCT01802567|451595802|FG000|Overall Study|Consented but did not start therapy|7|||
125200591|NCT01938430|450357542|FG000|Overall Study|Death|1|||
125536815|NCT01802567|451595802|FG000|Overall Study|Protocol Violation|1|||
125536816|NCT01940939|451595805|FG000|Overall Study|Withdrawal by Subject|2|||
125536817|NCT01940939|451595806|FG001|Overall Study|Withdrawal by Subject|8|||
125536818|NCT01470001|451595807|FG000|Overall Study|Lost to Follow-up|1|||
125536819|NCT01470001|451595808|FG001|Overall Study|Lost to Follow-up|1|||
125536820|NCT01470001|451595807|FG000|Overall Study|Physician Decision|2|||
125536821|NCT01470001|451595808|FG001|Overall Study|Physician Decision|0|||
125536822|NCT01470001|451595807|FG000|Overall Study|Withdrawal by Subject|2|||
125536823|NCT01470001|451595808|FG001|Overall Study|Withdrawal by Subject|1|||
125536824|NCT01895101|451595809|FG000|Overall Study|OPCAB procedure|1|||
125200592|NCT01938430|450357543|FG001|Overall Study|Death|2|||
125536825|NCT01895101|451595810|FG001|Overall Study|OPCAB procedure|1|||
125536826|NCT01895101|451595811|FG002|Overall Study|OPCAB procedure|3|||
125536827|NCT01895101|451595809|FG000|Overall Study|Withdrawal by Subject|0|||
125536828|NCT01895101|451595810|FG001|Overall Study|Withdrawal by Subject|1|||
125536829|NCT01895101|451595811|FG002|Overall Study|Withdrawal by Subject|2|||
125536830|NCT01895101|451595809|FG000|Overall Study|another study, enrolled in other study|0|||
125536831|NCT01895101|451595810|FG001|Overall Study|another study, enrolled in other study|1|||
125536832|NCT01895101|451595811|FG002|Overall Study|another study, enrolled in other study|0|||
125536833|NCT01895101|451595809|FG000|Overall Study|Death|0|||
125536834|NCT01895101|451595810|FG001|Overall Study|Death|1|||
125536835|NCT01895101|451595811|FG002|Overall Study|Death|0|||
125536836|NCT01895101|451595809|FG000|Overall Study|coagulation disorder|0|||
125536837|NCT01895101|451595810|FG001|Overall Study|coagulation disorder|1|||
125536838|NCT01895101|451595811|FG002|Overall Study|coagulation disorder|0|||
125536839|NCT02591953|451595814|FG000|Overall Study|Lost to Follow-up|6|||
125536840|NCT02591953|451595815|FG001|Overall Study|Lost to Follow-up|6|||
125536841|NCT03167359|451595818|FG000|Overall Study|Physician Decision|1|||
125536842|NCT03167359|451595818|FG000|Overall Study|Lost to Follow-up|1|||
125536843|NCT01896557|451595819|FG000|Clopidogrel Alone|Adverse Event|1|||
125536844|NCT01896557|451595820|FG001|Clopidogrel Alone|Adverse Event|0|||
125536845|NCT01896557|451595819|FG000|Clopidogrel + GI Protector|low adherence|1|||
125536846|NCT01896557|451595820|FG001|Clopidogrel + GI Protector|low adherence|1|||
125536847|NCT01896557|451595819|FG000|Clopidogrel + GI Protector|Reading error|1|||
125536848|NCT01896557|451595820|FG001|Clopidogrel + GI Protector|Reading error|3|||
125536849|NCT01517295|451595821|FG000|Overall Study|Physician Decision|1|||
125536850|NCT01517295|451595822|FG001|Overall Study|Physician Decision|0|||
125536851|NCT01659853|451595823|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
125536852|NCT01659853|451595824|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
125536853|NCT01659853|451595823|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
125536854|NCT01659853|451595824|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
125536855|NCT05560243|451595826|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
125536856|NCT00939822|451595829|FG000|Overall Study|Lost to Follow-up|1|||
125536857|NCT00939822|451595830|FG001|Overall Study|Lost to Follow-up|0|||
125536858|NCT00939822|451595829|FG000|Overall Study|withdrew from study due to busy schedule|1|||
125536859|NCT00939822|451595830|FG001|Overall Study|withdrew from study due to busy schedule|1|||
125536860|NCT00939822|451595829|FG000|Overall Study|Mental health issues|0|||
125536861|NCT00939822|451595830|FG001|Overall Study|Mental health issues|2|||
125536862|NCT01232738|451595831|FG000|Overall Study|Death|3|||
125536863|NCT01232738|451595831|FG000|Overall Study|Physician Decision|2|||
125536864|NCT01232738|451595831|FG000|Overall Study|Lost to Follow-up|1|||
125536865|NCT01232738|451595831|FG000|Overall Study|Withdrawal by Subject|2|||
125536866|NCT01232738|451595831|FG000|Overall Study|Adverse Event|5|||
125536867|NCT03046121|451595832|FG000|Overall Study|Death|32|||
125536868|NCT03046121|451595833|FG001|Overall Study|Death|60|||
125536869|NCT03046121|451595832|FG000|Overall Study|Withdrawal by Subject|14|||
125536870|NCT03046121|451595833|FG001|Overall Study|Withdrawal by Subject|12|||
125536871|NCT04155047|451595836|FG000|Overall Study|Adverse Event|1|||
125536872|NCT04155047|451595837|FG001|Overall Study|Adverse Event|0|||
125536873|NCT04155047|451595836|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
125536874|NCT04155047|451595837|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
125536875|NCT03361605|451595844|FG000|Overall Study|Analyzable data not available|3|||
125536876|NCT02770612|451595845|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
125536877|NCT00958841|451595848|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125536878|NCT00958841|451595848|FG000|Overall Study|Abnormal test procedure result(s)|3|||
125536879|NCT00958841|451595848|FG000|Overall Study|Administrative problems|1|||
125536880|NCT00958841|451595848|FG000|Overall Study|Adverse Event|8|||
125536881|NCT00958841|451595848|FG000|Overall Study|New cancer therapy|5|||
125536882|NCT00958841|451595848|FG000|Overall Study|Withdrawal by Subject|1|||
125536883|NCT00958841|451595848|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
125536884|NCT00958841|451595848|FG000|Overall Study|Completed M6/did not enter extension|27|||
125536885|NCT00958841|451595848|FG000|Overall Study|Discontinued prior to M*|28|||
125536886|NCT03014011|451595850|FG000|First Intervention|Withdrawal by Subject|1|||
125536887|NCT03014011|451595851|FG001|First Intervention|Withdrawal by Subject|0|||
125536888|NCT03014011|451595850|FG000|Washout|Withdrawal by Subject|1|||
125536889|NCT03014011|451595851|FG001|Washout|Withdrawal by Subject|0|||
125536890|NCT02416453|451595852|FG000|Overall Study|Adverse Event|0|||
125536891|NCT02416453|451595853|FG001|Overall Study|Adverse Event|0|||
125536892|NCT02416453|451595854|FG002|Overall Study|Adverse Event|0|||
125536893|NCT02416453|451595855|FG003|Overall Study|Adverse Event|2|||
125536894|NCT02416453|451595856|FG004|Overall Study|Adverse Event|0|||
125536895|NCT02416453|451595857|FG005|Overall Study|Adverse Event|1|||
125536896|NCT02416453|451595858|FG006|Overall Study|Adverse Event|0|||
125536897|NCT02416453|451595859|FG007|Overall Study|Adverse Event|0|||
125536898|NCT02416453|451595860|FG008|Overall Study|Adverse Event|0|||
125536899|NCT02416453|451595861|FG009|Overall Study|Adverse Event|0|||
125536900|NCT02416453|451595862|FG010|Overall Study|Adverse Event|0|||
125536901|NCT02416453|451595852|FG000|Overall Study|Lost to Follow-up|1|||
125536902|NCT02416453|451595853|FG001|Overall Study|Lost to Follow-up|3|||
125536903|NCT02416453|451595854|FG002|Overall Study|Lost to Follow-up|0|||
125536904|NCT02416453|451595855|FG003|Overall Study|Lost to Follow-up|8|||
125536905|NCT02416453|451595856|FG004|Overall Study|Lost to Follow-up|0|||
125536906|NCT02416453|451595857|FG005|Overall Study|Lost to Follow-up|5|||
125536907|NCT02416453|451595858|FG006|Overall Study|Lost to Follow-up|1|||
125536908|NCT02416453|451595859|FG007|Overall Study|Lost to Follow-up|3|||
125536909|NCT02416453|451595860|FG008|Overall Study|Lost to Follow-up|1|||
125536910|NCT02416453|451595861|FG009|Overall Study|Lost to Follow-up|0|||
125536911|NCT02416453|451595862|FG010|Overall Study|Lost to Follow-up|0|||
125536912|NCT02416453|451595852|FG000|Overall Study|Physician Decision|0|||
125536913|NCT02416453|451595853|FG001|Overall Study|Physician Decision|0|||
125536914|NCT02416453|451595854|FG002|Overall Study|Physician Decision|0|||
125536915|NCT02416453|451595855|FG003|Overall Study|Physician Decision|0|||
125536916|NCT02416453|451595856|FG004|Overall Study|Physician Decision|0|||
125536917|NCT02416453|451595857|FG005|Overall Study|Physician Decision|1|||
125536918|NCT02416453|451595858|FG006|Overall Study|Physician Decision|1|||
125536919|NCT02416453|451595859|FG007|Overall Study|Physician Decision|1|||
125536920|NCT02416453|451595860|FG008|Overall Study|Physician Decision|0|||
125536921|NCT02416453|451595861|FG009|Overall Study|Physician Decision|0|||
125536922|NCT02416453|451595862|FG010|Overall Study|Physician Decision|0|||
125536923|NCT02416453|451595852|FG000|Overall Study|Withdrawal by Subject|2|||
125536924|NCT02416453|451595853|FG001|Overall Study|Withdrawal by Subject|0|||
125536925|NCT02416453|451595854|FG002|Overall Study|Withdrawal by Subject|0|||
125536926|NCT02416453|451595855|FG003|Overall Study|Withdrawal by Subject|5|||
125536927|NCT02416453|451595856|FG004|Overall Study|Withdrawal by Subject|1|||
125536928|NCT02416453|451595857|FG005|Overall Study|Withdrawal by Subject|8|||
125536929|NCT02416453|451595858|FG006|Overall Study|Withdrawal by Subject|0|||
125536930|NCT02416453|451595859|FG007|Overall Study|Withdrawal by Subject|8|||
125536931|NCT02416453|451595860|FG008|Overall Study|Withdrawal by Subject|4|||
125536932|NCT02416453|451595861|FG009|Overall Study|Withdrawal by Subject|0|||
125536933|NCT02416453|451595862|FG010|Overall Study|Withdrawal by Subject|0|||
125536934|NCT02416453|451595852|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
125536935|NCT02416453|451595853|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
125536936|NCT02416453|451595854|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
125536937|NCT02416453|451595855|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
125536938|NCT02416453|451595856|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
125536939|NCT02416453|451595857|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
125536940|NCT02416453|451595858|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
125536941|NCT02416453|451595859|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
125536942|NCT02416453|451595860|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
125536943|NCT02416453|451595861|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
125536944|NCT02416453|451595862|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
125536945|NCT02416453|451595852|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
125536946|NCT02416453|451595853|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
125536947|NCT02416453|451595854|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
125536948|NCT02416453|451595855|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
125536949|NCT02416453|451595856|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
125536950|NCT02416453|451595857|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
125536951|NCT02416453|451595858|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
125536952|NCT02416453|451595859|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
125536953|NCT02416453|451595860|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
125536954|NCT02416453|451595861|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
125536955|NCT02416453|451595862|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
125536956|NCT00831129|451595870|FG000|Overall Study|Adverse Event|0|||
125536957|NCT00831129|451595871|FG001|Overall Study|Adverse Event|1|||
125536958|NCT00831129|451595870|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
125536959|NCT00831129|451595871|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
125536960|NCT01877239|451595872|FG000|Overall Study|Adverse Event|4|||
125536961|NCT01877239|451595872|FG000|Overall Study|Disease Remission|1|||
125536962|NCT01877239|451595872|FG000|Overall Study|Withdrawal by Subject|4|||
125536963|NCT01877239|451595872|FG000|Overall Study|Other|2|||
125536964|NCT01877239|451595872|FG000|Overall Study|Lack of Efficacy|4|||
125536965|NCT01877239|451595872|FG000|Overall Study|Data not available|35|||
125536966|NCT00743431|451595878|FG000|Overall Study|Toxicity|6|||
125536967|NCT00743431|451595878|FG000|Overall Study|Tumor progression|56|||
125536968|NCT00743431|451595878|FG000|Overall Study|Withdrawal by Subject|13|||
125536969|NCT00743431|451595878|FG000|Overall Study|Death|9|||
125536970|NCT00743431|451595878|FG000|Overall Study|Reason for discontinuation not specified|29|||
125536971|NCT00743431|451595878|FG000|Overall Study|No documentation available|13|||
125536972|NCT03291288|451595879|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
125536973|NCT03291288|451595880|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
125536974|NCT03291288|451595879|FG000|Drug-drug Interaction Phase|Disease progression|1|||
125536975|NCT03291288|451595880|FG001|Drug-drug Interaction Phase|Disease progression|0|||
125536976|NCT03291288|451595879|FG000|Drug-drug Interaction Phase|Other|3|||
125536977|NCT03291288|451595880|FG001|Drug-drug Interaction Phase|Other|0|||
125536978|NCT03291288|451595879|FG000|Pexidartinib Only|Ongoing|0|||
125536979|NCT03291288|451595880|FG001|Pexidartinib Only|Ongoing|2|||
125536980|NCT04276415|451595881|FG000|Overall Study|Adverse Event|0|||
125536981|NCT04276415|451595882|FG001|Overall Study|Adverse Event|0|||
125536982|NCT04276415|451595883|FG002|Overall Study|Adverse Event|0|||
125536983|NCT04276415|451595884|FG003|Overall Study|Adverse Event|3|||
125536984|NCT04276415|451595885|FG004|Overall Study|Adverse Event|0|||
125536985|NCT04276415|451595886|FG005|Overall Study|Adverse Event|0|||
125536986|NCT04276415|451595881|FG000|Overall Study|Clinical progression|1|||
125536987|NCT04276415|451595882|FG001|Overall Study|Clinical progression|1|||
125536988|NCT04276415|451595883|FG002|Overall Study|Clinical progression|0|||
125536989|NCT04276415|451595884|FG003|Overall Study|Clinical progression|0|||
125536990|NCT04276415|451595885|FG004|Overall Study|Clinical progression|1|||
125536991|NCT04276415|451595886|FG005|Overall Study|Clinical progression|0|||
125536992|NCT04276415|451595881|FG000|Overall Study|Other|0|||
125536993|NCT04276415|451595882|FG001|Overall Study|Other|0|||
125536994|NCT04276415|451595883|FG002|Overall Study|Other|0|||
125536995|NCT04276415|451595884|FG003|Overall Study|Other|1|||
125536996|NCT04276415|451595885|FG004|Overall Study|Other|0|||
125536997|NCT04276415|451595886|FG005|Overall Study|Other|0|||
125536998|NCT04276415|451595881|FG000|Overall Study|Physician Decision|0|||
125536999|NCT04276415|451595882|FG001|Overall Study|Physician Decision|0|||
125537000|NCT04276415|451595883|FG002|Overall Study|Physician Decision|1|||
125537001|NCT04276415|451595884|FG003|Overall Study|Physician Decision|3|||
125537002|NCT04276415|451595885|FG004|Overall Study|Physician Decision|2|||
125537003|NCT04276415|451595886|FG005|Overall Study|Physician Decision|0|||
125537004|NCT04276415|451595881|FG000|Overall Study|Progressive disease|3|||
125537005|NCT04276415|451595882|FG001|Overall Study|Progressive disease|3|||
125537006|NCT04276415|451595883|FG002|Overall Study|Progressive disease|4|||
125537007|NCT04276415|451595884|FG003|Overall Study|Progressive disease|5|||
125537008|NCT04276415|451595885|FG004|Overall Study|Progressive disease|1|||
125537009|NCT04276415|451595886|FG005|Overall Study|Progressive disease|2|||
125537010|NCT04276415|451595881|FG000|Overall Study|Withdrawal by patient|0|||
125537011|NCT04276415|451595882|FG001|Overall Study|Withdrawal by patient|0|||
125537012|NCT04276415|451595883|FG002|Overall Study|Withdrawal by patient|0|||
125537013|NCT04276415|451595884|FG003|Overall Study|Withdrawal by patient|1|||
125537014|NCT04276415|451595885|FG004|Overall Study|Withdrawal by patient|2|||
125537015|NCT04276415|451595886|FG005|Overall Study|Withdrawal by patient|0|||
125537016|NCT03309813|451595887|FG000|Main Randomized Study|Withdrawal by Subject|1|||
125537017|NCT03309813|451595888|FG001|Main Randomized Study|Withdrawal by Subject|0|||
125537018|NCT01989169|451595891|FG000|Period 2|Adverse Event|0|||
125537019|NCT01989169|451595892|FG001|Period 2|Adverse Event|1|||
125537020|NCT02406677|451595893|FG000|Overall Study|Death|16|||
125537021|NCT02406677|451595894|FG001|Overall Study|Death|8|||
125537022|NCT02406677|451595893|FG000|Overall Study|Discharged without P2Y12|1|||
125537023|NCT02406677|451595894|FG001|Overall Study|Discharged without P2Y12|3|||
125537024|NCT02406677|451595893|FG000|Overall Study|Discharged on prasugrel|283|||
125537025|NCT02406677|451595894|FG001|Overall Study|Discharged on prasugrel|587|||
125537026|NCT02406677|451595893|FG000|Overall Study|Withdrawal by Subject|1|||
125537027|NCT02406677|451595894|FG001|Overall Study|Withdrawal by Subject|0|||
125537028|NCT04531904|451595895|FG000|Overall Study|Lost to Follow-up|1|||
125537029|NCT04531904|451595895|FG000|Overall Study|Death|14|||
125537030|NCT00283244|451595896|FG000|Overall Study|Adverse Event|0|||
125537031|NCT00283244|451595897|FG001|Overall Study|Adverse Event|8|||
125537032|NCT00283244|451595898|FG002|Overall Study|Adverse Event|11|||
125537033|NCT00283244|451595896|FG000|Overall Study|Death|4|||
125537034|NCT00283244|451595897|FG001|Overall Study|Death|3|||
125537035|NCT00283244|451595898|FG002|Overall Study|Death|2|||
125537036|NCT00283244|451595896|FG000|Overall Study|Lack of Efficacy|8|||
125537037|NCT00283244|451595897|FG001|Overall Study|Lack of Efficacy|32|||
125537038|NCT00283244|451595898|FG002|Overall Study|Lack of Efficacy|26|||
125537039|NCT00283244|451595896|FG000|Overall Study|Withdrawal by Subject|1|||
125537040|NCT00283244|451595897|FG001|Overall Study|Withdrawal by Subject|2|||
125537041|NCT00283244|451595898|FG002|Overall Study|Withdrawal by Subject|2|||
125537042|NCT00283244|451595896|FG000|Overall Study|Physician Decision|0|||
125537043|NCT00283244|451595897|FG001|Overall Study|Physician Decision|0|||
125537044|NCT00283244|451595898|FG002|Overall Study|Physician Decision|1|||
125537045|NCT00283244|451595896|FG000|Overall Study|Medical illness (other complicating dz)|4|||
125537046|NCT00283244|451595897|FG001|Overall Study|Medical illness (other complicating dz)|3|||
125537047|NCT00283244|451595898|FG002|Overall Study|Medical illness (other complicating dz)|6|||
125537048|NCT00283244|451595896|FG000|Overall Study|Clinical deterioration|1|||
125537049|NCT00283244|451595897|FG001|Overall Study|Clinical deterioration|3|||
125537050|NCT00283244|451595898|FG002|Overall Study|Clinical deterioration|3|||
125537051|NCT00658788|451595899|FG000|Overall Study|Adverse Event|11|||
125537052|NCT00658788|451595899|FG000|Overall Study|Withdrawal by Subject|13|||
125537053|NCT00658788|451595899|FG000|Overall Study|Lost to Follow-up|18|||
125537054|NCT00658788|451595899|FG000|Overall Study|Treatment Discontinuation|32|||
125537055|NCT00653523|451595900|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
125537056|NCT00653523|451595900|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
125537057|NCT00653523|451595900|FG000|Overall Study|Adverse Event|7|||
125537058|NCT00653523|451595900|FG000|Overall Study|Withdrawal by Subject|6|||
125537059|NCT00653523|451595900|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
125537060|NCT00653523|451595900|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
125537061|NCT05384938|451595901|FG000|Overall Study|Withdrawal by Subject|8|||
125537062|NCT05384938|451595901|FG000|Overall Study|Lost to Follow-up|6|||
125537063|NCT05384938|451595901|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
125537064|NCT03843554|451597327|FG000|Overall Study|Physician Decision|0|||
125537065|NCT03843554|451597328|FG001|Overall Study|Physician Decision|2|||
125537066|NCT04396366|451597329|FG000|Overall Study|Adverse Event|1|||
125537067|NCT04396366|451597330|FG001|Overall Study|Adverse Event|0|||
125537068|NCT00166712|451597332|FG000|Overall Study|Death|0|||
125537069|NCT00166712|451597333|FG001|Overall Study|Death|1|||
125537070|NCT00166712|451597332|FG000|Overall Study|Adverse Event|1|||
125537071|NCT00166712|451597333|FG001|Overall Study|Adverse Event|0|||
125537072|NCT00166712|451597332|FG000|Overall Study|Withdrawal by Subject|1|||
125537073|NCT00166712|451597333|FG001|Overall Study|Withdrawal by Subject|2|||
125537074|NCT00166712|451597332|FG000|Overall Study|Physician Decision|0|||
125537075|NCT00166712|451597333|FG001|Overall Study|Physician Decision|2|||
125537076|NCT03986944|451597334|FG000|Overall Study|Adverse Event|1|||
125537077|NCT03986944|451597335|FG001|Overall Study|Adverse Event|2|||
125537078|NCT03986944|451597336|FG002|Overall Study|Adverse Event|3|||
125537079|NCT03986944|451597334|FG000|Overall Study|Protocol Violation|0|||
125537080|NCT03986944|451597335|FG001|Overall Study|Protocol Violation|1|||
125537081|NCT03986944|451597336|FG002|Overall Study|Protocol Violation|1|||
125537082|NCT03986944|451597334|FG000|Overall Study|Withdrawal by Subject|3|||
125537083|NCT03986944|451597335|FG001|Overall Study|Withdrawal by Subject|5|||
125537084|NCT03986944|451597336|FG002|Overall Study|Withdrawal by Subject|5|||
125537085|NCT03986944|451597334|FG000|Overall Study|Study termination|10|||
125537086|NCT03986944|451597335|FG001|Overall Study|Study termination|10|||
125537087|NCT03986944|451597336|FG002|Overall Study|Study termination|10|||
125537088|NCT03986944|451597334|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
125537089|NCT03986944|451597335|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
125537090|NCT03986944|451597336|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
125537091|NCT03986944|451597334|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
125537092|NCT03986944|451597335|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
125537093|NCT03986944|451597336|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
125537094|NCT03339245|451597340|FG000|Overall Study|Adverse Event|1|||
125537095|NCT03339245|451597341|FG001|Overall Study|Adverse Event|1|||
125537096|NCT03339245|451597340|FG000|Overall Study|Withdrawal by Subject|1|||
125537097|NCT03339245|451597341|FG001|Overall Study|Withdrawal by Subject|0|||
125537098|NCT00837694|451597342|FG000|Overall Study|Lost to Follow-up|2|||
125537099|NCT00837694|451597343|FG001|Overall Study|Lost to Follow-up|0|||
125537100|NCT00837694|451597344|FG002|Overall Study|Lost to Follow-up|2|||
125537101|NCT00837694|451597345|FG003|Overall Study|Lost to Follow-up|1|||
125537102|NCT00837694|451597346|FG004|Overall Study|Lost to Follow-up|1|||
125537103|NCT00837694|451597347|FG005|Overall Study|Lost to Follow-up|1|||
125537104|NCT00306670|451597354|FG000|Overall Study|patients recruited; Genentech, the st|0|||
125537105|NCT00306670|451597355|FG001|Overall Study|patients recruited; Genentech, the st|2|||
125537106|NCT00503139|451597356|FG000|Overall Study|Case Report Forms were not collected|4|||
125537107|NCT00503139|451597356|FG000|Overall Study|Protocol Violation|4|||
125537108|NCT02735577|451597357|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
125537109|NCT02735577|451597357|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
125537110|NCT02731690|451597358|FG000|Overall Study|Adverse Event|1|||
125537111|NCT02731690|451597358|FG000|Overall Study|Withdrawal by Subject|3|||
125537112|NCT02731690|451597358|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
125537113|NCT00833833|451597359|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
125537114|NCT00833833|451597360|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
125537115|NCT00833833|451597361|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
125537116|NCT00833833|451597362|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
125537117|NCT00833833|451597363|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
125537118|NCT00833833|451597364|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
125537119|NCT00833833|451597359|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
125537120|NCT00833833|451597360|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
125537121|NCT00833833|451597361|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
125537122|NCT00833833|451597362|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
125537123|NCT00833833|451597363|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
125537124|NCT00833833|451597364|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
125537125|NCT00833833|451597359|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
125537126|NCT00833833|451597360|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
125537127|NCT00833833|451597361|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
125537128|NCT00833833|451597362|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
125537129|NCT00833833|451597363|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
125537130|NCT00833833|451597364|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
125537131|NCT00833833|451597359|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
125537132|NCT00833833|451597360|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
125537133|NCT00833833|451597361|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
125537134|NCT00833833|451597362|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
125537135|NCT00833833|451597363|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
125537136|NCT00833833|451597364|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
125537137|NCT00833833|451597359|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
125537138|NCT00833833|451597360|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
125537139|NCT00833833|451597361|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
125537140|NCT00833833|451597362|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
125537141|NCT00833833|451597363|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
125537142|NCT00833833|451597364|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
125537143|NCT00833833|451597359|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
125537144|NCT00833833|451597360|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
125537145|NCT00833833|451597361|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
125537146|NCT00833833|451597362|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
125537147|NCT00833833|451597363|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
125537148|NCT00833833|451597364|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
125537149|NCT00833833|451597359|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
125537150|NCT00833833|451597360|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
125537151|NCT00833833|451597361|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
125537152|NCT00833833|451597362|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
125537153|NCT00833833|451597363|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
125537154|NCT00833833|451597364|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
125537155|NCT00833833|451597359|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
125537156|NCT00833833|451597360|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
125537157|NCT00833833|451597361|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
125537158|NCT00833833|451597362|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
125537159|NCT00833833|451597363|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
125537160|NCT00833833|451597364|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
125537161|NCT00833833|451597359|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
125537162|NCT00833833|451597360|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
125537163|NCT00833833|451597361|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
125537164|NCT00833833|451597362|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
125537165|NCT00833833|451597363|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
125537166|NCT00833833|451597364|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
125537167|NCT00833833|451597359|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
125537168|NCT00833833|451597360|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
125537169|NCT00833833|451597361|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
125537170|NCT00833833|451597362|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
125537171|NCT00833833|451597363|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
125537172|NCT00833833|451597364|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
125537173|NCT00833833|451597359|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
125537174|NCT00833833|451597360|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
125537175|NCT00833833|451597361|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
125537176|NCT00833833|451597362|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
125537177|NCT00833833|451597363|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
125537178|NCT00833833|451597364|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
125537179|NCT00833833|451597359|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
125537180|NCT00833833|451597360|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
125537181|NCT00833833|451597361|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
125537182|NCT00833833|451597362|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
125537183|NCT00833833|451597363|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
125537184|NCT00833833|451597364|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
125537185|NCT00833833|451597359|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
125537186|NCT00833833|451597360|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
125537187|NCT00833833|451597361|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
125537188|NCT00833833|451597362|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
125537189|NCT00833833|451597363|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
125537190|NCT00833833|451597364|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
125537191|NCT01994837|451597365|FG000|Overall Study|Progressive disease per protocol|23|||
125537192|NCT01994837|451597365|FG000|Overall Study|Adv event related to progressive disease|3|||
125537193|NCT01994837|451597365|FG000|Overall Study|Fatal progressive disease|2|||
125537194|NCT01994837|451597365|FG000|Overall Study|Adverse event not related to progression|1|||
125537195|NCT01994837|451597365|FG000|Overall Study|Chose palliative care|1|||
125537196|NCT01994837|451597365|FG000|Overall Study|Proceeded to transplant|1|||
125537197|NCT01994837|451597365|FG000|Overall Study|Removed from study due to no response|1|||
125537198|NCT01127893|451597366|FG000|Overall Study|Study Termination by the Sponsor|1|||
125537199|NCT01262677|451597367|FG000|Overall Study|Does not meet entrance criteria|0|||
125537200|NCT01262677|451597368|FG001|Overall Study|Does not meet entrance criteria|2|||
125537201|NCT01262677|451597369|FG002|Overall Study|Does not meet entrance criteria|0|||
125537202|NCT01262677|451597367|FG000|Overall Study|Insufficient clinical response|0|||
125537203|NCT01262677|451597368|FG001|Overall Study|Insufficient clinical response|0|||
125537204|NCT01262677|451597369|FG002|Overall Study|Insufficient clinical response|1|||
125537205|NCT01262677|451597367|FG000|Overall Study|Lost to Follow-up|1|||
125537206|NCT01262677|451597368|FG001|Overall Study|Lost to Follow-up|0|||
125537207|NCT01262677|451597369|FG002|Overall Study|Lost to Follow-up|2|||
125537208|NCT01262677|451597367|FG000|Overall Study|No longer willing to participate|3|||
125537209|NCT01262677|451597368|FG001|Overall Study|No longer willing to participate|3|||
125537210|NCT01262677|451597369|FG002|Overall Study|No longer willing to participate|2|||
125537211|NCT01262677|451597367|FG000|Overall Study|Reason not provided|2|||
125537212|NCT01262677|451597368|FG001|Overall Study|Reason not provided|1|||
125537213|NCT01262677|451597369|FG002|Overall Study|Reason not provided|3|||
125537214|NCT01262677|451597367|FG000|Overall Study|Protocol Violation|0|||
125537215|NCT01262677|451597368|FG001|Overall Study|Protocol Violation|1|||
125537216|NCT01262677|451597369|FG002|Overall Study|Protocol Violation|1|||
125537217|NCT01262677|451597367|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
125537218|NCT01262677|451597368|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
125537219|NCT01262677|451597369|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
125537220|NCT03446781|451597379|FG000|Overall Study|Lost to Follow-up|11|||
125537221|NCT03446781|451597380|FG001|Overall Study|Lost to Follow-up|5|||
125537222|NCT03446781|451597379|FG000|Overall Study|Withdrawal by Subject|9|||
125537223|NCT03446781|451597380|FG001|Overall Study|Withdrawal by Subject|7|||
125537224|NCT03446781|451597379|FG000|Overall Study|Adverse Event|8|||
125537225|NCT03446781|451597380|FG001|Overall Study|Adverse Event|2|||
125537226|NCT03446781|451597379|FG000|Overall Study|Protocol Violation|0|||
125537227|NCT03446781|451597380|FG001|Overall Study|Protocol Violation|3|||
125537228|NCT03339583|451597389|FG000|First Intervention (14 Days)|Adverse Event|1|||
125537229|NCT03339583|451597390|FG001|First Intervention (14 Days)|Adverse Event|0|||
125537230|NCT03339583|451597389|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
125537231|NCT03339583|451597390|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
125537232|NCT03339583|451597389|FG000|Second Intervention (14 Days)|Adverse Event|0|||
125537233|NCT03339583|451597390|FG001|Second Intervention (14 Days)|Adverse Event|1|||
125537234|NCT03339583|451597389|FG000|Follow-up (14 Days)|Physician Decision|6|||
125537235|NCT03339583|451597390|FG001|Follow-up (14 Days)|Physician Decision|3|||
125537236|NCT00734591|451597391|FG000|Screening for Prospective Period|Site did not participate|1604|||
125537237|NCT00734591|451597392|FG001|Screening for Prospective Period|Site did not participate|1488|||
125537238|NCT00734591|451597391|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
125537239|NCT00734591|451597392|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
125537240|NCT00734591|451597391|FG000|Prospective Period|Withdrawal by Subject|11|||
125537241|NCT00734591|451597392|FG001|Prospective Period|Withdrawal by Subject|9|||
125537242|NCT00734591|451597391|FG000|Prospective Period|Lost to Follow-up|37|||
125537243|NCT00734591|451597392|FG001|Prospective Period|Lost to Follow-up|33|||
125537244|NCT00734591|451597391|FG000|Prospective Period|Study Terminated|1|||
125537245|NCT00734591|451597392|FG001|Prospective Period|Study Terminated|0|||
125537246|NCT00734591|451597391|FG000|Prospective Period|Other|2|||
125537247|NCT00734591|451597392|FG001|Prospective Period|Other|2|||
125537248|NCT01072630|451597401|FG000|Overall Study|Adverse Event|11|||
125537249|NCT01072630|451597402|FG001|Overall Study|Adverse Event|19|||
125537250|NCT01072630|451597403|FG002|Overall Study|Adverse Event|2|||
125537251|NCT01072630|451597401|FG000|Overall Study|Lack of Efficacy|10|||
125537252|NCT01072630|451597402|FG001|Overall Study|Lack of Efficacy|10|||
125537253|NCT01072630|451597403|FG002|Overall Study|Lack of Efficacy|1|||
125537254|NCT01072630|451597401|FG000|Overall Study|Withdrawal by Subject|8|||
125537255|NCT01072630|451597402|FG001|Overall Study|Withdrawal by Subject|7|||
125537256|NCT01072630|451597403|FG002|Overall Study|Withdrawal by Subject|2|||
125537257|NCT01072630|451597401|FG000|Overall Study|Protocol Violation|10|||
125537258|NCT01072630|451597402|FG001|Overall Study|Protocol Violation|8|||
125537259|NCT01072630|451597403|FG002|Overall Study|Protocol Violation|4|||
125537260|NCT01072630|451597401|FG000|Overall Study|Lost to Follow-up|11|||
125537261|NCT01072630|451597402|FG001|Overall Study|Lost to Follow-up|11|||
125537262|NCT01072630|451597403|FG002|Overall Study|Lost to Follow-up|1|||
125537263|NCT01072630|451597401|FG000|Overall Study|Noncompliance with study medication|1|||
125537264|NCT01072630|451597402|FG001|Overall Study|Noncompliance with study medication|1|||
125537265|NCT01072630|451597403|FG002|Overall Study|Noncompliance with study medication|1|||
125537266|NCT01072630|451597401|FG000|Overall Study|Noncompliance with study procedures|1|||
125537267|NCT01072630|451597402|FG001|Overall Study|Noncompliance with study procedures|2|||
125537268|NCT01072630|451597403|FG002|Overall Study|Noncompliance with study procedures|1|||
125537269|NCT01072630|451597401|FG000|Overall Study|Other|3|||
125537270|NCT01072630|451597402|FG001|Overall Study|Other|2|||
125537271|NCT01072630|451597403|FG002|Overall Study|Other|1|||
125537272|NCT00338962|451597404|FG000|Overall Study|Lost to Follow-up|3|||
125537273|NCT00338962|451597405|FG001|Overall Study|Lost to Follow-up|3|||
125537274|NCT00338962|451597406|FG002|Overall Study|Lost to Follow-up|2|||
125537275|NCT00338962|451597407|FG003|Overall Study|Lost to Follow-up|3|||
125537276|NCT00338962|451597404|FG000|Overall Study|Withdrawal by Subject|1|||
125537277|NCT00338962|451597405|FG001|Overall Study|Withdrawal by Subject|0|||
125537278|NCT00338962|451597406|FG002|Overall Study|Withdrawal by Subject|0|||
125537279|NCT00338962|451597407|FG003|Overall Study|Withdrawal by Subject|0|||
125537280|NCT00338962|451597404|FG000|Overall Study|No Transportation|2|||
125537281|NCT00338962|451597405|FG001|Overall Study|No Transportation|0|||
125537282|NCT00338962|451597406|FG002|Overall Study|No Transportation|0|||
125537283|NCT00338962|451597407|FG003|Overall Study|No Transportation|0|||
125537284|NCT00338962|451597404|FG000|Overall Study|Time Constraint|2|||
125537285|NCT00338962|451597405|FG001|Overall Study|Time Constraint|0|||
125537286|NCT00338962|451597406|FG002|Overall Study|Time Constraint|0|||
125537287|NCT00338962|451597407|FG003|Overall Study|Time Constraint|0|||
125537288|NCT00338962|451597404|FG000|Overall Study|Moved|0|||
125537289|NCT00338962|451597405|FG001|Overall Study|Moved|1|||
125537290|NCT00338962|451597406|FG002|Overall Study|Moved|0|||
125537291|NCT00338962|451597407|FG003|Overall Study|Moved|0|||
125537292|NCT00338962|451597404|FG000|Overall Study|Adverse Event|0|||
125537293|NCT00338962|451597405|FG001|Overall Study|Adverse Event|0|||
125537294|NCT00338962|451597406|FG002|Overall Study|Adverse Event|2|||
125537295|NCT00338962|451597407|FG003|Overall Study|Adverse Event|0|||
125537296|NCT00338962|451597404|FG000|Overall Study|Poor Compliance|0|||
125537297|NCT00338962|451597405|FG001|Overall Study|Poor Compliance|0|||
125537298|NCT00338962|451597406|FG002|Overall Study|Poor Compliance|2|||
125537299|NCT00338962|451597407|FG003|Overall Study|Poor Compliance|0|||
125537300|NCT03214640|451597408|FG000|Overall Study|Protocol Violation|1|||
125537301|NCT03214640|451597409|FG001|Overall Study|Protocol Violation|2|||
125537302|NCT03214640|451597410|FG002|Overall Study|Protocol Violation|1|||
125537303|NCT03214640|451597411|FG003|Overall Study|Protocol Violation|4|||
125537304|NCT00910039|451597412|FG000|Overall Study|Physician Decision|1|||
125537305|NCT03547739|451597420|FG000|Overall Study|Death|0|||
125537306|NCT03547739|451597421|FG001|Overall Study|Death|1|||
125537307|NCT03547739|451597422|FG002|Overall Study|Death|5|||
125537308|NCT03547739|451597420|FG000|Overall Study|Adverse Event|24|||
125537309|NCT03547739|451597421|FG001|Overall Study|Adverse Event|11|||
125537310|NCT03547739|451597422|FG002|Overall Study|Adverse Event|13|||
125537311|NCT03547739|451597420|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
125537312|NCT03547739|451597421|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
125537313|NCT03547739|451597422|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
125537314|NCT03547739|451597420|FG000|Overall Study|Lost to Follow-up|80|||
125537315|NCT03547739|451597421|FG001|Overall Study|Lost to Follow-up|84|||
125537316|NCT03547739|451597422|FG002|Overall Study|Lost to Follow-up|116|||
125537317|NCT04035499|451597425|FG000|Overall Study|Death|2|||
125537318|NCT04035499|451597425|FG000|Overall Study|Withdrawal by Subject|1|||
125537319|NCT02003222|451597426|FG000|Induction|Never started treatment|0|||
125537320|NCT02003222|451597427|FG001|Induction|Never started treatment|0|||
125537321|NCT02003222|451597428|FG002|Induction|Never started treatment|0|||
125537322|NCT02003222|451597429|FG003|Induction|Never started treatment|0|||
125537323|NCT02003222|451597430|FG004|Induction|Never started treatment|8|||
125537324|NCT02003222|451597426|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
125537325|NCT02003222|451597427|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
125537326|NCT02003222|451597428|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
125537327|NCT02003222|451597429|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
125537328|NCT02003222|451597430|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
125200593|NCT01938430|450357544|FG002|Overall Study|Death|2|||
125537329|NCT02003222|451597426|FG000|Induction|Adverse Event|0|||
125200594|NCT01938430|450357545|FG003|Overall Study|Death|1|||
125537330|NCT02003222|451597427|FG001|Induction|Adverse Event|0|||
125537331|NCT02003222|451597428|FG002|Induction|Adverse Event|0|||
125537332|NCT02003222|451597429|FG003|Induction|Adverse Event|0|||
125537333|NCT02003222|451597430|FG004|Induction|Adverse Event|13|||
125537334|NCT02003222|451597426|FG000|Induction|Alternative therapy|0|||
125537335|NCT02003222|451597427|FG001|Induction|Alternative therapy|0|||
125537336|NCT02003222|451597428|FG002|Induction|Alternative therapy|0|||
125537337|NCT02003222|451597429|FG003|Induction|Alternative therapy|0|||
125537338|NCT02003222|451597430|FG004|Induction|Alternative therapy|12|||
125537339|NCT02003222|451597426|FG000|Induction|Disease progression|0|||
125537340|NCT02003222|451597427|FG001|Induction|Disease progression|0|||
125537341|NCT02003222|451597428|FG002|Induction|Disease progression|0|||
125537342|NCT02003222|451597429|FG003|Induction|Disease progression|0|||
125537343|NCT02003222|451597430|FG004|Induction|Disease progression|22|||
125537344|NCT02003222|451597426|FG000|Induction|Death|0|||
125200595|NCT01938430|450357546|FG004|Overall Study|Death|0|||
125424704|NCT03409666|451178653|FG001|Overall Study|Protocol Violation|3|||
125424705|NCT03255824|451178657|FG000|Overall Study|Under-sedation|2|||
125424706|NCT03255824|451178658|FG001|Overall Study|Under-sedation|1|||
125424707|NCT03432364|451178661|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
125424708|NCT03320018|451178665|FG000|Treatment Period|Withdrawal by Subject|1|||
125424709|NCT03320018|451178666|FG001|Treatment Period|Withdrawal by Subject|0|||
125424710|NCT03320018|451178665|FG000|Day 90 Follow up|Death|0|||
125424711|NCT03320018|451178666|FG001|Day 90 Follow up|Death|1|||
125424712|NCT03284788|451178670|FG000|Overall Study|Withdrawal by Subject|2|||
125424713|NCT03104699|451178675|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
125424714|NCT03104699|451178676|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
125424715|NCT03104699|451178677|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
125424716|NCT03104699|451178678|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
125424717|NCT03104699|451178679|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
125424718|NCT03104699|451178680|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125424719|NCT03104699|451178675|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
125424720|NCT03104699|451178676|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
125424721|NCT03104699|451178677|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
125424722|NCT03104699|451178678|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
125424723|NCT03104699|451178679|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
125424724|NCT03104699|451178680|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
125424725|NCT03104699|451178675|FG000|Phase 1: Dose Escalation|Death|6|||
125424726|NCT03104699|451178676|FG001|Phase 1: Dose Escalation|Death|3|||
125424727|NCT03104699|451178677|FG002|Phase 1: Dose Escalation|Death|0|||
125424728|NCT03104699|451178678|FG003|Phase 1: Dose Escalation|Death|1|||
125424729|NCT03104699|451178679|FG004|Phase 1: Dose Escalation|Death|1|||
125424730|NCT03104699|451178680|FG005|Phase 1: Dose Escalation|Death|0|||
125424731|NCT03104699|451178675|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
125424732|NCT03104699|451178676|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
125424733|NCT03104699|451178677|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
125424734|NCT03104699|451178678|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
125424735|NCT03104699|451178679|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
125424736|NCT03104699|451178680|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
125424737|NCT03104699|451178675|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
125424738|NCT03104699|451178676|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
125424739|NCT03104699|451178677|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
125424740|NCT03104699|451178678|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
125424741|NCT03104699|451178679|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
125424742|NCT03104699|451178680|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
125424743|NCT03104699|451178675|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
125424744|NCT03104699|451178676|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
125424745|NCT03104699|451178677|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
125424746|NCT03104699|451178678|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
125424747|NCT03104699|451178679|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
125424748|NCT03104699|451178680|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
125424749|NCT03104699|451178675|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
125424750|NCT03104699|451178676|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
125424751|NCT03104699|451178677|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
125424752|NCT03104699|451178678|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
125424753|NCT03104699|451178679|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
125424754|NCT03104699|451178680|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
125424755|NCT03104699|451178675|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
125424756|NCT03104699|451178676|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
125424757|NCT03104699|451178677|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
125424758|NCT03104699|451178678|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
125424759|NCT03104699|451178679|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
125424760|NCT03104699|451178680|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
125424761|NCT03104699|451178675|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125424762|NCT03104699|451178676|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125424763|NCT03104699|451178677|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125424764|NCT03104699|451178678|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125424765|NCT03104699|451178679|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125424766|NCT03104699|451178680|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
125424767|NCT03104699|451178675|FG000|Phase 2: Dose Expansion|Death|0|||
125424768|NCT03104699|451178676|FG001|Phase 2: Dose Expansion|Death|0|||
125424769|NCT03104699|451178677|FG002|Phase 2: Dose Expansion|Death|0|||
125424770|NCT03104699|451178678|FG003|Phase 2: Dose Expansion|Death|0|||
125424771|NCT03104699|451178679|FG004|Phase 2: Dose Expansion|Death|0|||
125424772|NCT03104699|451178680|FG005|Phase 2: Dose Expansion|Death|107|||
125424773|NCT03104699|451178675|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
125424774|NCT03104699|451178676|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
125537345|NCT02003222|451597427|FG001|Induction|Death|0|||
125537346|NCT02003222|451597428|FG002|Induction|Death|0|||
125537347|NCT02003222|451597429|FG003|Induction|Death|0|||
125537348|NCT02003222|451597430|FG004|Induction|Death|3|||
125537349|NCT02003222|451597426|FG000|Induction|Withdrawal by Subject|0|||
125537350|NCT02003222|451597427|FG001|Induction|Withdrawal by Subject|0|||
125537351|NCT02003222|451597428|FG002|Induction|Withdrawal by Subject|0|||
125537352|NCT02003222|451597429|FG003|Induction|Withdrawal by Subject|0|||
125537353|NCT02003222|451597430|FG004|Induction|Withdrawal by Subject|8|||
125537354|NCT02003222|451597426|FG000|Induction|Other reasons|0|||
125537355|NCT02003222|451597427|FG001|Induction|Other reasons|0|||
125537356|NCT02003222|451597428|FG002|Induction|Other reasons|0|||
125537357|NCT02003222|451597429|FG003|Induction|Other reasons|0|||
125537358|NCT02003222|451597430|FG004|Induction|Other reasons|22|||
125537359|NCT02003222|451597426|FG000|Intensification|Never started treatment|0|||
125537360|NCT02003222|451597427|FG001|Intensification|Never started treatment|0|||
125537361|NCT02003222|451597428|FG002|Intensification|Never started treatment|0|||
125537362|NCT02003222|451597429|FG003|Intensification|Never started treatment|0|||
125537363|NCT02003222|451597430|FG004|Intensification|Never started treatment|2|||
125537364|NCT02003222|451597426|FG000|Intensification|Adverse Event|0|||
125537365|NCT02003222|451597427|FG001|Intensification|Adverse Event|0|||
125537366|NCT02003222|451597428|FG002|Intensification|Adverse Event|0|||
125537367|NCT02003222|451597429|FG003|Intensification|Adverse Event|0|||
125537368|NCT02003222|451597430|FG004|Intensification|Adverse Event|6|||
125537369|NCT02003222|451597426|FG000|Intensification|Alternative therapy|0|||
125537370|NCT02003222|451597427|FG001|Intensification|Alternative therapy|0|||
125537371|NCT02003222|451597428|FG002|Intensification|Alternative therapy|0|||
125537372|NCT02003222|451597429|FG003|Intensification|Alternative therapy|0|||
125537373|NCT02003222|451597430|FG004|Intensification|Alternative therapy|8|||
125537374|NCT02003222|451597426|FG000|Intensification|Disease progression|0|||
125537375|NCT02003222|451597427|FG001|Intensification|Disease progression|0|||
125537376|NCT02003222|451597428|FG002|Intensification|Disease progression|0|||
125537377|NCT02003222|451597429|FG003|Intensification|Disease progression|0|||
125537378|NCT02003222|451597430|FG004|Intensification|Disease progression|18|||
125537379|NCT02003222|451597426|FG000|Intensification|Withdrawal by Subject|0|||
125537380|NCT02003222|451597427|FG001|Intensification|Withdrawal by Subject|0|||
125537381|NCT02003222|451597428|FG002|Intensification|Withdrawal by Subject|0|||
125537382|NCT02003222|451597429|FG003|Intensification|Withdrawal by Subject|0|||
125537383|NCT02003222|451597430|FG004|Intensification|Withdrawal by Subject|5|||
125537384|NCT02003222|451597426|FG000|Intensification|Other reasons|0|||
125537385|NCT02003222|451597427|FG001|Intensification|Other reasons|0|||
125537386|NCT02003222|451597428|FG002|Intensification|Other reasons|0|||
125537387|NCT02003222|451597429|FG003|Intensification|Other reasons|0|||
125537388|NCT02003222|451597430|FG004|Intensification|Other reasons|8|||
125537389|NCT01280357|451597431|FG000|Overall Study|Excluded no internal monitoring|14|||
125537390|NCT01280357|451597431|FG000|Overall Study|IInsufficient data/No data supplied|12|||
125537391|NCT00886795|451597432|FG000|Overall Study|Lack of Efficacy|1|||
125537392|NCT01259089|451597433|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
125537393|NCT01259089|451597434|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
125537394|NCT01259089|451597435|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
125537395|NCT01259089|451597436|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
125537396|NCT01259089|451597437|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
125537397|NCT01259089|451597438|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
125537398|NCT01259089|451597433|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
125537399|NCT01259089|451597434|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
125537400|NCT01259089|451597435|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
125537401|NCT01259089|451597436|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
125537402|NCT01259089|451597437|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
125537403|NCT01259089|451597438|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
125537404|NCT01259089|451597433|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
125537405|NCT01259089|451597434|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
125537406|NCT01259089|451597435|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
125537407|NCT01259089|451597436|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
125537408|NCT01259089|451597437|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
125537409|NCT01259089|451597438|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
125537410|NCT01259089|451597433|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
125537411|NCT01259089|451597434|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
125537412|NCT01259089|451597435|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
125537413|NCT01259089|451597436|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
125537414|NCT01259089|451597437|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
125537415|NCT01259089|451597438|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
125646104|NCT01667731|451988180|FG001|Overall Study|Efficacy Failure|12|||
125537416|NCT01259089|451597433|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
125537417|NCT01259089|451597434|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
125646105|NCT01667731|451988181|FG002|Overall Study|Efficacy Failure|0|||
125537418|NCT01259089|451597435|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
125537419|NCT01259089|451597436|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
125537420|NCT01259089|451597437|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
125537421|NCT01259089|451597438|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
125537422|NCT01259089|451597433|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
125537423|NCT01259089|451597434|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
125537424|NCT01259089|451597435|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
125537425|NCT01259089|451597436|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
125537426|NCT01259089|451597437|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
125537427|NCT01259089|451597438|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
125537428|NCT01259089|451597433|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
125537429|NCT01259089|451597434|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
125537430|NCT01259089|451597435|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
125537431|NCT01259089|451597436|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
125537432|NCT01259089|451597437|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
125537433|NCT01259089|451597438|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
125537434|NCT01259089|451597433|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
125537435|NCT01259089|451597434|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
125537436|NCT01259089|451597435|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
125537437|NCT01259089|451597436|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
125537438|NCT01259089|451597437|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
125537439|NCT01259089|451597438|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
125537440|NCT01259089|451597433|FG000|Survival Follow up for Two Years|Death|3|||
125537441|NCT01259089|451597434|FG001|Survival Follow up for Two Years|Death|2|||
125537442|NCT01259089|451597435|FG002|Survival Follow up for Two Years|Death|2|||
125537443|NCT01259089|451597436|FG003|Survival Follow up for Two Years|Death|3|||
125537444|NCT01259089|451597437|FG004|Survival Follow up for Two Years|Death|6|||
125537445|NCT01259089|451597438|FG005|Survival Follow up for Two Years|Death|13|||
125537446|NCT01259089|451597433|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
125537447|NCT01259089|451597434|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
125537448|NCT01259089|451597435|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
125537449|NCT01259089|451597436|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
125537450|NCT01259089|451597437|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
125537451|NCT01259089|451597438|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
125537452|NCT01259089|451597433|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
125537453|NCT01259089|451597434|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
125537454|NCT01259089|451597435|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
125537455|NCT01259089|451597436|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
125537456|NCT01259089|451597437|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
125537457|NCT01259089|451597438|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
125537458|NCT02310100|451597443|FG000|Overall Study|Physician Decision|3|||
125537459|NCT02310100|451597443|FG000|Overall Study|Withdrawal by Subject|10|||
125537460|NCT02310100|451597443|FG000|Overall Study|Enrollment closure|1|||
125537461|NCT02310100|451597443|FG000|Overall Study|Unapproved ablation operator|1|||
125537462|NCT02310100|451597443|FG000|Overall Study|Visit compliance|1|||
125537463|NCT02310100|451597443|FG000|Overall Study|Lost to Follow-up|2|||
125537464|NCT00688870|451597446|FG000|Infant Series|Parent or legal guardian request|4|||
125537465|NCT00688870|451597447|FG001|Infant Series|Parent or legal guardian request|0|||
125537466|NCT01253018|451597458|FG000|Overall Study|Lost to Follow-up|1|||
125537467|NCT01253018|451597459|FG001|Overall Study|Lost to Follow-up|1|||
125200596|NCT01938430|450357547|FG005|Overall Study|Death|0|||
125200597|NCT01938430|450357548|FG006|Overall Study|Death|1|||
125200598|NCT01938430|450357549|FG007|Overall Study|Death|1|||
125537468|NCT01253018|451597458|FG000|Overall Study|Robot Repair Issues|2|||
125537469|NCT01253018|451597459|FG001|Overall Study|Robot Repair Issues|0|||
125537470|NCT01253018|451597458|FG000|Overall Study|Withdrawal by Subject|1|||
125537471|NCT01253018|451597459|FG001|Overall Study|Withdrawal by Subject|1|||
125537472|NCT03449901|451597460|FG000|Overall Study|Progression|57|||
125537473|NCT03449901|451597461|FG001|Overall Study|Progression|12|||
125537474|NCT03449901|451597460|FG000|Overall Study|Adverse Event|3|||
125537475|NCT03449901|451597461|FG001|Overall Study|Adverse Event|0|||
125537476|NCT03449901|451597460|FG000|Overall Study|Death|6|||
125537477|NCT03449901|451597461|FG001|Overall Study|Death|2|||
125537478|NCT03449901|451597460|FG000|Overall Study|Withdrawal by Subject|12|||
125537479|NCT03449901|451597461|FG001|Overall Study|Withdrawal by Subject|1|||
125537480|NCT03449901|451597460|FG000|Overall Study|Physician Decision|1|||
125537481|NCT03449901|451597461|FG001|Overall Study|Physician Decision|0|||
125537482|NCT03449901|451597460|FG000|Overall Study|Patient elected for surgical intervention|1|||
125537483|NCT03449901|451597461|FG001|Overall Study|Patient elected for surgical intervention|0|||
125537484|NCT03449901|451597460|FG000|Overall Study|Patient off for other complicating disease|1|||
125200599|NCT01938430|450357550|FG008|Overall Study|Death|2|||
125537485|NCT03449901|451597461|FG001|Overall Study|Patient off for other complicating disease|0|||
125537486|NCT03466073|451597462|FG000|Overall Study|Death|1|||
125537487|NCT03466073|451597463|FG001|Overall Study|Death|0|||
125537488|NCT03466073|451597464|FG002|Overall Study|Death|0|||
125537489|NCT03466073|451597465|FG003|Overall Study|Death|0|||
125537490|NCT03466073|451597466|FG004|Overall Study|Death|0|||
125537491|NCT03466073|451597467|FG005|Overall Study|Death|1|||
125537492|NCT00744757|451597468|FG000|Overall Study|Objective disease progression|7|||
125537493|NCT00744757|451597468|FG000|Overall Study|Physician Decision|5|||
125537494|NCT00744757|451597468|FG000|Overall Study|Withdrawal by Subject|1|||
125537495|NCT00744757|451597468|FG000|Overall Study|Death|6|||
125646106|NCT01667731|451988182|FG003|Overall Study|Efficacy Failure|1|||
125646107|NCT01667731|451988183|FG004|Overall Study|Efficacy Failure|24|||
125646108|NCT01667731|451988179|FG000|Overall Study|Lost to Follow-up|2|||
125646109|NCT01667731|451988180|FG001|Overall Study|Lost to Follow-up|3|||
125646110|NCT01667731|451988181|FG002|Overall Study|Lost to Follow-up|1|||
125646111|NCT01667731|451988182|FG003|Overall Study|Lost to Follow-up|1|||
125646112|NCT01667731|451988183|FG004|Overall Study|Lost to Follow-up|2|||
125646113|NCT01667731|451988179|FG000|Overall Study|Subject Withdrew Consent|2|||
125646114|NCT01667731|451988180|FG001|Overall Study|Subject Withdrew Consent|0|||
125646115|NCT01667731|451988181|FG002|Overall Study|Subject Withdrew Consent|1|||
125646116|NCT01667731|451988182|FG003|Overall Study|Subject Withdrew Consent|0|||
125646117|NCT01667731|451988183|FG004|Overall Study|Subject Withdrew Consent|1|||
125646118|NCT01667731|451988179|FG000|Overall Study|Death|0|||
125646119|NCT01667731|451988180|FG001|Overall Study|Death|1|||
125646120|NCT01667731|451988181|FG002|Overall Study|Death|0|||
125646121|NCT01667731|451988182|FG003|Overall Study|Death|0|||
125646122|NCT01667731|451988183|FG004|Overall Study|Death|0|||
125646123|NCT01425268|451988184|FG000|Overall Study|Withdrawal by Subject|2|||
125646124|NCT01425268|451988185|FG001|Overall Study|Withdrawal by Subject|0|||
125646125|NCT01425268|451988184|FG000|Overall Study|Sponsor Decision|5|||
125646126|NCT01425268|451988185|FG001|Overall Study|Sponsor Decision|0|||
125646127|NCT01425268|451988184|FG000|Overall Study|Physician Decision|1|||
125646128|NCT01425268|451988185|FG001|Overall Study|Physician Decision|0|||
125646129|NCT03633461|451988186|FG000|Overall Study|Lost to Follow-up|0|||
125646130|NCT03633461|451988187|FG001|Overall Study|Lost to Follow-up|1|||
125646131|NCT01345162|451988192|FG000|Overall Study|Protocol Violation|2|||
125646132|NCT01345162|451988193|FG001|Overall Study|Protocol Violation|4|||
125646133|NCT01871870|451988194|FG000|Overall Study|Hardware issues|7|||
125646134|NCT01871870|451988194|FG000|Overall Study|hyperglycemia|2|||
125646135|NCT00883896|451988196|FG000|Overall Study|Lost to Follow-up|0|||
125646136|NCT00883896|451988197|FG001|Overall Study|Lost to Follow-up|0|||
125646137|NCT00883896|451988198|FG002|Overall Study|Lost to Follow-up|0|||
125646138|NCT00883896|451988199|FG003|Overall Study|Lost to Follow-up|2|||
125646139|NCT00883896|451988196|FG000|Overall Study|Withdrawal by Subject|5|||
125646140|NCT00883896|451988197|FG001|Overall Study|Withdrawal by Subject|0|||
125646141|NCT00883896|451988198|FG002|Overall Study|Withdrawal by Subject|1|||
125646142|NCT00883896|451988199|FG003|Overall Study|Withdrawal by Subject|3|||
125646143|NCT00883896|451988196|FG000|Overall Study|Lack of Efficacy|0|||
125646144|NCT00883896|451988197|FG001|Overall Study|Lack of Efficacy|0|||
125646145|NCT00883896|451988198|FG002|Overall Study|Lack of Efficacy|0|||
125646146|NCT00883896|451988199|FG003|Overall Study|Lack of Efficacy|2|||
125646147|NCT00883896|451988196|FG000|Overall Study|Other|1|||
125646148|NCT00883896|451988197|FG001|Overall Study|Other|0|||
125646149|NCT00883896|451988198|FG002|Overall Study|Other|0|||
125646150|NCT00883896|451988199|FG003|Overall Study|Other|0|||
125646151|NCT01856920|451988209|FG000|Overall Study|Disease Progression On Study|3|||
125646152|NCT01856920|451988210|FG001|Overall Study|Disease Progression On Study|4|||
125646153|NCT01856920|451988209|FG000|Overall Study|Disease Progression before Treatment|1|||
125646154|NCT01856920|451988210|FG001|Overall Study|Disease Progression before Treatment|0|||
125646155|NCT01856920|451988209|FG000|Overall Study|Ineligible|0|||
125646156|NCT01856920|451988210|FG001|Overall Study|Ineligible|1|||
125646157|NCT01856920|451988209|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
125646158|NCT01856920|451988210|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
125646159|NCT01856920|451988209|FG000|Overall Study|Refused further Treatment|5|||
125646160|NCT01856920|451988210|FG001|Overall Study|Refused further Treatment|1|||
125646161|NCT01856920|451988209|FG000|Overall Study|Other Reasons|0|||
125646162|NCT01856920|451988210|FG001|Overall Study|Other Reasons|1|||
125200600|NCT01938430|450357551|FG009|Overall Study|Death|3|||
125646163|NCT01856920|451988209|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
125646164|NCT01856920|451988210|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
125646165|NCT01716585|451988216|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
125646166|NCT01716585|451988217|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
125646167|NCT01716585|451988216|FG000|Double-blind Treatment|Adverse Event|2|||
125646168|NCT01716585|451988217|FG001|Double-blind Treatment|Adverse Event|1|||
125646169|NCT01716585|451988216|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
125537496|NCT00744757|451597468|FG000|Overall Study|Adverse Event|2|||
125537497|NCT03682302|451597469|FG000|Overall Study|Lost to Follow-up|1|||
125537498|NCT03682302|451597470|FG001|Overall Study|Lost to Follow-up|2|||
125537499|NCT03682302|451597471|FG002|Overall Study|Lost to Follow-up|0|||
125537500|NCT03682302|451597472|FG003|Overall Study|Lost to Follow-up|1|||
125537501|NCT03682302|451597469|FG000|Overall Study|Study drug was not administered|0|||
125537502|NCT03682302|451597470|FG001|Overall Study|Study drug was not administered|0|||
125537503|NCT03682302|451597471|FG002|Overall Study|Study drug was not administered|1|||
125537504|NCT03682302|451597472|FG003|Overall Study|Study drug was not administered|1|||
125537505|NCT05051462|451597473|FG000|Overall Study|Lost to Follow-up|1|||
125537506|NCT05051462|451597474|FG001|Overall Study|Lost to Follow-up|8|||
125537507|NCT05051462|451597473|FG000|Overall Study|Withdrawal by Subject|1|||
125537508|NCT05051462|451597474|FG001|Overall Study|Withdrawal by Subject|0|||
125537509|NCT05051462|451597473|FG000|Overall Study|Protocol Violation|0|||
125537510|NCT05051462|451597474|FG001|Overall Study|Protocol Violation|2|||
125537511|NCT02425904|451597475|FG000|Overall Study|Lost to Follow-up|1|||
125537512|NCT02425904|451597476|FG001|Overall Study|Lost to Follow-up|0|||
125537513|NCT02425904|451597475|FG000|Overall Study|Withdrawal by Subject|2|||
125537514|NCT02425904|451597476|FG001|Overall Study|Withdrawal by Subject|0|||
125537515|NCT02425904|451597475|FG000|Overall Study|Death|0|||
125537516|NCT02425904|451597476|FG001|Overall Study|Death|3|||
125537517|NCT05260021|451597481|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
125537518|NCT05260021|451597482|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
125537519|NCT05260021|451597483|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
125537520|NCT05260021|451597481|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
125537521|NCT05260021|451597482|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
125537522|NCT05260021|451597483|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
125537523|NCT05260021|451597481|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
125537524|NCT05260021|451597482|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
125537525|NCT05260021|451597483|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
125537526|NCT05260021|451597481|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
125537527|NCT05260021|451597482|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
125537528|NCT05260021|451597483|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
125537529|NCT05260021|451597481|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
125537530|NCT05260021|451597482|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
125537531|NCT05260021|451597483|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
125537532|NCT03568318|451598422|FG000|Overall Study|Adverse Event|3|||
125537533|NCT03568318|451598423|FG001|Overall Study|Adverse Event|1|||
125537534|NCT03568318|451598424|FG002|Overall Study|Adverse Event|1|||
125537535|NCT03568318|451598425|FG003|Overall Study|Adverse Event|0|||
125537536|NCT03568318|451598426|FG004|Overall Study|Adverse Event|1|||
125537537|NCT03568318|451598427|FG005|Overall Study|Adverse Event|0|||
125537538|NCT03568318|451598422|FG000|Overall Study|Withdrawal by Subject|6|||
125537539|NCT03568318|451598423|FG001|Overall Study|Withdrawal by Subject|5|||
125537540|NCT03568318|451598424|FG002|Overall Study|Withdrawal by Subject|2|||
125537541|NCT03568318|451598425|FG003|Overall Study|Withdrawal by Subject|1|||
125537542|NCT03568318|451598426|FG004|Overall Study|Withdrawal by Subject|0|||
125537543|NCT03568318|451598427|FG005|Overall Study|Withdrawal by Subject|0|||
125537544|NCT03568318|451598422|FG000|Overall Study|Lost to Follow-up|3|||
125537545|NCT03568318|451598423|FG001|Overall Study|Lost to Follow-up|2|||
125537546|NCT03568318|451598424|FG002|Overall Study|Lost to Follow-up|2|||
125537547|NCT03568318|451598425|FG003|Overall Study|Lost to Follow-up|2|||
125537548|NCT03568318|451598426|FG004|Overall Study|Lost to Follow-up|1|||
125537549|NCT03568318|451598427|FG005|Overall Study|Lost to Follow-up|0|||
125537550|NCT03568318|451598422|FG000|Overall Study|Other|3|||
125537551|NCT03568318|451598423|FG001|Overall Study|Other|1|||
125537552|NCT03568318|451598424|FG002|Overall Study|Other|3|||
125537553|NCT03568318|451598425|FG003|Overall Study|Other|0|||
125537554|NCT03568318|451598426|FG004|Overall Study|Other|0|||
125537555|NCT03568318|451598427|FG005|Overall Study|Other|0|||
125537556|NCT03568318|451598422|FG000|Overall Study|Ongoing at Time of Analysis|5|||
125537557|NCT03568318|451598423|FG001|Overall Study|Ongoing at Time of Analysis|3|||
125537558|NCT03568318|451598424|FG002|Overall Study|Ongoing at Time of Analysis|2|||
125537559|NCT03568318|451598425|FG003|Overall Study|Ongoing at Time of Analysis|1|||
125537560|NCT03568318|451598426|FG004|Overall Study|Ongoing at Time of Analysis|0|||
125537561|NCT03568318|451598427|FG005|Overall Study|Ongoing at Time of Analysis|0|||
125537562|NCT05870228|451598432|FG000|Overall Study|Lost to Follow-up|2|||
125537563|NCT05870228|451598433|FG001|Overall Study|Lost to Follow-up|0|||
125537564|NCT05870228|451598432|FG000|Overall Study|Withdrawal by Subject|1|||
125537565|NCT05870228|451598433|FG001|Overall Study|Withdrawal by Subject|0|||
125537566|NCT04662931|451598434|FG000|Overall Study|Withdrawal by Subject|17|||
125537567|NCT04662931|451598434|FG000|Overall Study|Death|3|||
125537568|NCT04662931|451598434|FG000|Overall Study|Lost to Follow-up|3|||
125537569|NCT04662931|451598434|FG000|Overall Study|Guardian Decision|1|||
125537570|NCT03842358|451598436|FG000|Overall Study|Poor DOT probe contact with breast|2|||
125537571|NCT03842358|451598436|FG000|Overall Study|DOT system problem|1|||
125537572|NCT03842358|451598436|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
125537573|NCT03842358|451598436|FG000|Overall Study|No biopsy after physician review|4|||
125537574|NCT03842358|451598436|FG000|Overall Study|Patient withdrew|2|||
125537575|NCT06665919|451598437|FG000|Overall Study|Withdrawal by Subject|4|||
125537576|NCT06665919|451598438|FG001|Overall Study|Withdrawal by Subject|4|||
125537577|NCT06665919|451598439|FG002|Overall Study|Withdrawal by Subject|4|||
125537578|NCT06665919|451598437|FG000|Overall Study|Non-compliance to Treatment|4|||
125537579|NCT06665919|451598438|FG001|Overall Study|Non-compliance to Treatment|1|||
125537580|NCT06665919|451598439|FG002|Overall Study|Non-compliance to Treatment|6|||
125537581|NCT06665919|451598437|FG000|Overall Study|Lost to Follow-up|3|||
125537582|NCT06665919|451598438|FG001|Overall Study|Lost to Follow-up|0|||
125537583|NCT06665919|451598439|FG002|Overall Study|Lost to Follow-up|2|||
125537584|NCT06665919|451598437|FG000|Overall Study|Physician Decision|4|||
125537585|NCT06665919|451598438|FG001|Overall Study|Physician Decision|0|||
125537586|NCT06665919|451598439|FG002|Overall Study|Physician Decision|1|||
125537587|NCT04150068|451598440|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
125537588|NCT04150068|451598441|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
125537589|NCT04150068|451598442|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
125537590|NCT04150068|451598440|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
125537591|NCT04150068|451598441|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
125537592|NCT04150068|451598442|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
125537593|NCT05316701|451598443|FG000|Overall Study|Adverse Event|0|||
125537594|NCT05316701|451598444|FG001|Overall Study|Adverse Event|1|||
125537595|NCT05316701|451598443|FG000|Overall Study|Death|3|||
125537596|NCT05316701|451598444|FG001|Overall Study|Death|9|||
125537597|NCT05316701|451598443|FG000|Overall Study|Lost to Follow-up|1|||
125537598|NCT05316701|451598444|FG001|Overall Study|Lost to Follow-up|0|||
125537599|NCT05316701|451598443|FG000|Overall Study|Physician Decision|1|||
125537600|NCT05316701|451598444|FG001|Overall Study|Physician Decision|4|||
125537601|NCT05316701|451598443|FG000|Overall Study|Withdrawal by Subject|3|||
125537602|NCT05316701|451598444|FG001|Overall Study|Withdrawal by Subject|5|||
125537603|NCT05316701|451598443|FG000|Overall Study|Progression/Relapse|14|||
125537604|NCT05316701|451598444|FG001|Overall Study|Progression/Relapse|9|||
125537605|NCT05316701|451598443|FG000|Overall Study|Received Standard of Care|1|||
125537606|NCT05316701|451598444|FG001|Overall Study|Received Standard of Care|0|||
125537607|NCT05316701|451598443|FG000|Overall Study|Ongoing|70|||
125537608|NCT05316701|451598444|FG001|Overall Study|Ongoing|64|||
125537609|NCT04696653|451598445|FG000|Overall Study|left organization|18|||
125537610|NCT04696653|451598445|FG000|Overall Study|Lost to Follow-up|3|||
125537611|NCT04625413|451598446|FG000|Overall Study|Hospice|2|||
125537612|NCT04625413|451598446|FG000|Overall Study|Distress|1|||
125537613|NCT04625413|451598446|FG000|Overall Study|Not feeling well|1|||
125537614|NCT04679935|451598447|FG000|Overall Study|Death|0|||
125537615|NCT04679935|451598448|FG001|Overall Study|Death|1|||
125537616|NCT02993146|451598449|FG000|Overall Study|Withdrawal by Subject|0|||
125537617|NCT02993146|451598450|FG001|Overall Study|Withdrawal by Subject|0|||
125537618|NCT02993146|451598451|FG002|Overall Study|Withdrawal by Subject|1|||
125537619|NCT02993146|451598452|FG003|Overall Study|Withdrawal by Subject|1|||
125537620|NCT04362189|451598453|FG000|Overall Study|Lost to Follow-up|0|||
125537621|NCT04362189|451598454|FG001|Overall Study|Lost to Follow-up|1|||
125537622|NCT04362189|451598453|FG000|Overall Study|Withdrawal by Subject|1|||
125537623|NCT04362189|451598454|FG001|Overall Study|Withdrawal by Subject|0|||
125537624|NCT04362189|451598453|FG000|Overall Study|FDA Clinical Hold|7|||
125537625|NCT04362189|451598454|FG001|Overall Study|FDA Clinical Hold|2|||
125537626|NCT04362189|451598453|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
125537627|NCT04362189|451598454|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
125537628|NCT04362189|451598453|FG000|Overall Study|Adverse Event|0|||
125537629|NCT04362189|451598454|FG001|Overall Study|Adverse Event|2|||
125537630|NCT04362189|451598453|FG000|Overall Study|Death|4|||
125537631|NCT04362189|451598454|FG001|Overall Study|Death|1|||
125537632|NCT02111681|451598455|FG000|Overall Study|Death|5|||
125537633|NCT02111681|451598455|FG000|Overall Study|Lack of Efficacy|2|||
125537634|NCT02111681|451598455|FG000|Overall Study|Progression of disease|4|||
125537635|NCT04349631|451598462|FG000|Overall Study|Lost to Follow-up|3|||
125537636|NCT04349631|451598462|FG000|Overall Study|Withdrawal by Subject|7|||
125537637|NCT01982448|451598463|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
125537638|NCT01982448|451598464|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
125537639|NCT01982448|451598463|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
125537640|NCT01982448|451598464|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
125537641|NCT01982448|451598463|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
125537642|NCT01982448|451598464|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
125537643|NCT01982448|451598463|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
125537644|NCT01982448|451598464|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
125537645|NCT02898077|451600105|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
125537646|NCT02898077|451600106|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
125537647|NCT02898077|451600105|FG000|Overall Study|Lost to Follow-up|4|||
125537648|NCT02898077|451600106|FG001|Overall Study|Lost to Follow-up|3|||
125537649|NCT02898077|451600105|FG000|Overall Study|Physician Decision|0|||
125424775|NCT03104699|451178677|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
125424776|NCT03104699|451178678|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
125424777|NCT03104699|451178679|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
125424778|NCT03104699|451178680|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
125424779|NCT03104699|451178675|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
125424780|NCT03104699|451178676|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
125424781|NCT03104699|451178677|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
125424782|NCT03104699|451178678|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
125424783|NCT03104699|451178679|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
125424784|NCT03104699|451178680|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
125424785|NCT03104699|451178675|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125424786|NCT03104699|451178676|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125424787|NCT03104699|451178677|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125424788|NCT03104699|451178678|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125424789|NCT03104699|451178679|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125424790|NCT03104699|451178680|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
125424791|NCT03104699|451178675|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
125424792|NCT03104699|451178676|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
125424793|NCT03104699|451178677|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
125424794|NCT03104699|451178678|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
125424795|NCT03104699|451178679|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
125424796|NCT03104699|451178680|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
125424797|NCT00152464|451178681|FG000|Overall Study|Adverse Event|3|||
125424798|NCT00152464|451178682|FG001|Overall Study|Adverse Event|6|||
125424799|NCT00152464|451178681|FG000|Overall Study|Lost to Follow-up|8|||
125424800|NCT00152464|451178682|FG001|Overall Study|Lost to Follow-up|4|||
125424801|NCT00152464|451178681|FG000|Overall Study|Protocol Violation|3|||
125424802|NCT00152464|451178682|FG001|Overall Study|Protocol Violation|1|||
125424803|NCT00152464|451178681|FG000|Overall Study|Withdrawal by Subject|21|||
125424804|NCT00152464|451178682|FG001|Overall Study|Withdrawal by Subject|22|||
125424805|NCT00152464|451178681|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
125424806|NCT00152464|451178682|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
125424807|NCT00152464|451178681|FG000|Overall Study|Eczema deterioration|0|||
125424808|NCT00152464|451178682|FG001|Overall Study|Eczema deterioration|1|||
125424809|NCT00152464|451178681|FG000|Overall Study|Parent decision|1|||
125424810|NCT00152464|451178682|FG001|Overall Study|Parent decision|1|||
125424811|NCT00152464|451178681|FG000|Overall Study|Investigator decision|1|||
125424812|NCT00152464|451178682|FG001|Overall Study|Investigator decision|0|||
125424813|NCT00152464|451178681|FG000|Overall Study|Lack of Efficacy|1|||
125424814|NCT00152464|451178682|FG001|Overall Study|Lack of Efficacy|0|||
125424815|NCT00152464|451178681|FG000|Overall Study|Eczema poorly controlled|1|||
125424816|NCT00152464|451178682|FG001|Overall Study|Eczema poorly controlled|0|||
125424817|NCT00152464|451178681|FG000|Overall Study|Patient relocated|1|||
125424818|NCT00152464|451178682|FG001|Overall Study|Patient relocated|0|||
125424819|NCT01690130|451178683|FG000|Overall Study|Subject have cancelled visit.|1|||
125424820|NCT01690130|451178684|FG001|Overall Study|Subject have cancelled visit.|0|||
125424821|NCT01644734|451178685|FG000|Overall Study|Adverse Event|4|||
125424822|NCT01644734|451178685|FG000|Overall Study|Lost to Follow-up|17|||
125424823|NCT01644734|451178685|FG000|Overall Study|Reasons other than stated above|7|||
125424824|NCT01644734|451178685|FG000|Overall Study|Missing documentation|238|||
125424825|NCT05159622|451178686|FG000|Overall Study|Lost to Follow-up|4|||
125424826|NCT05159622|451178687|FG001|Overall Study|Lost to Follow-up|5|||
125424827|NCT00863655|451178693|FG000|Overall Study|Protocol Violation|4|||
125424828|NCT00863655|451178694|FG001|Overall Study|Protocol Violation|0|||
125424829|NCT00863655|451178693|FG000|Overall Study|Adverse Event|52|||
125424830|NCT00863655|451178694|FG001|Overall Study|Adverse Event|8|||
125424831|NCT00863655|451178693|FG000|Overall Study|Withdrawal by Subject|47|||
125424832|NCT00863655|451178694|FG001|Overall Study|Withdrawal by Subject|7|||
125424833|NCT00863655|451178693|FG000|Overall Study|Administrative problems|1|||
125424834|NCT00863655|451178694|FG001|Overall Study|Administrative problems|0|||
125424835|NCT00863655|451178693|FG000|Overall Study|Death|7|||
125424836|NCT00863655|451178694|FG001|Overall Study|Death|1|||
125424837|NCT00863655|451178693|FG000|Overall Study|New cancer therapy|5|||
125424838|NCT00863655|451178694|FG001|Overall Study|New cancer therapy|1|||
125424839|NCT00863655|451178693|FG000|Overall Study|Disease progression|364|||
125424840|NCT00863655|451178694|FG001|Overall Study|Disease progression|221|||
125424841|NCT00863655|451178693|FG000|Overall Study|Treatment completed as per protocol|5|||
125424842|NCT00863655|451178694|FG001|Overall Study|Treatment completed as per protocol|1|||
125424843|NCT02157779|451178695|FG000|Overall Study|Logistical|9|||
125424844|NCT02157779|451178696|FG001|Overall Study|Logistical|3|||
125424845|NCT02157779|451178695|FG000|Overall Study|Stopped attending, reason unknown|11|||
125424846|NCT02157779|451178696|FG001|Overall Study|Stopped attending, reason unknown|7|||
125424847|NCT02157779|451178695|FG000|Overall Study|No response to outreach after Baseline|1|||
125424848|NCT02157779|451178696|FG001|Overall Study|No response to outreach after Baseline|1|||
125200601|NCT01938430|450357552|FG010|Overall Study|Death|0|||
125200602|NCT01938430|450357553|FG011|Overall Study|Death|0|||
125200603|NCT01938430|450357554|FG012|Overall Study|Death|0|||
125200604|NCT01938430|450357555|FG013|Overall Study|Death|0|||
125200605|NCT01938430|450357542|FG000|Overall Study|Investigator's Discretion|0|||
125200606|NCT01938430|450357543|FG001|Overall Study|Investigator's Discretion|0|||
125537650|NCT02898077|451600106|FG001|Overall Study|Physician Decision|2|||
125537651|NCT02898077|451600105|FG000|Overall Study|Sponsor Decision|32|||
125537652|NCT02898077|451600106|FG001|Overall Study|Sponsor Decision|13|||
125537653|NCT02898077|451600105|FG000|Overall Study|Withdrawal by Subject|6|||
125537654|NCT02898077|451600106|FG001|Overall Study|Withdrawal by Subject|3|||
125537655|NCT02898077|451600105|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
125537656|NCT02898077|451600106|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
125537657|NCT02898077|451600105|FG000|Overall Study|Ended extension period|3|||
125537658|NCT02898077|451600106|FG001|Overall Study|Ended extension period|0|||
125537659|NCT04410523|451600107|FG000|Overall Study|Study terminated by sponsor|1|||
125537660|NCT04410523|451600108|FG001|Overall Study|Study terminated by sponsor|3|||
125537661|NCT04410523|451600109|FG002|Overall Study|Study terminated by sponsor|2|||
125537662|NCT04410523|451600110|FG003|Overall Study|Study terminated by sponsor|6|||
125537663|NCT04410523|451600111|FG004|Overall Study|Study terminated by sponsor|3|||
125537664|NCT04410523|451600112|FG005|Overall Study|Study terminated by sponsor|4|||
125537665|NCT04410523|451600107|FG000|Overall Study|Adverse Event|1|||
125537666|NCT04410523|451600108|FG001|Overall Study|Adverse Event|0|||
125537667|NCT04410523|451600109|FG002|Overall Study|Adverse Event|0|||
125537668|NCT04410523|451600110|FG003|Overall Study|Adverse Event|0|||
125537669|NCT04410523|451600111|FG004|Overall Study|Adverse Event|0|||
125537670|NCT04410523|451600112|FG005|Overall Study|Adverse Event|2|||
125537671|NCT04410523|451600107|FG000|Overall Study|Lost to Follow-up|0|||
125537672|NCT04410523|451600108|FG001|Overall Study|Lost to Follow-up|1|||
125537673|NCT04410523|451600109|FG002|Overall Study|Lost to Follow-up|0|||
125537674|NCT04410523|451600110|FG003|Overall Study|Lost to Follow-up|0|||
125537675|NCT04410523|451600111|FG004|Overall Study|Lost to Follow-up|0|||
125537676|NCT04410523|451600112|FG005|Overall Study|Lost to Follow-up|0|||
125537677|NCT04410523|451600107|FG000|Overall Study|Physician Decision|0|||
125537678|NCT04410523|451600108|FG001|Overall Study|Physician Decision|1|||
125537679|NCT04410523|451600109|FG002|Overall Study|Physician Decision|0|||
125537680|NCT04410523|451600110|FG003|Overall Study|Physician Decision|0|||
125537681|NCT04410523|451600111|FG004|Overall Study|Physician Decision|0|||
125537682|NCT04410523|451600112|FG005|Overall Study|Physician Decision|0|||
125537683|NCT04410523|451600107|FG000|Overall Study|Pregnancy|0|||
125537684|NCT04410523|451600108|FG001|Overall Study|Pregnancy|0|||
125537685|NCT04410523|451600109|FG002|Overall Study|Pregnancy|0|||
125537686|NCT04410523|451600110|FG003|Overall Study|Pregnancy|0|||
125537687|NCT04410523|451600111|FG004|Overall Study|Pregnancy|0|||
125537688|NCT04410523|451600112|FG005|Overall Study|Pregnancy|1|||
125537689|NCT04410523|451600107|FG000|Overall Study|Protocol deviation|0|||
125537690|NCT04410523|451600108|FG001|Overall Study|Protocol deviation|0|||
125537691|NCT04410523|451600109|FG002|Overall Study|Protocol deviation|0|||
125537692|NCT04410523|451600110|FG003|Overall Study|Protocol deviation|0|||
125537693|NCT04410523|451600111|FG004|Overall Study|Protocol deviation|0|||
125537694|NCT04410523|451600112|FG005|Overall Study|Protocol deviation|2|||
125537695|NCT04410523|451600107|FG000|Overall Study|Subject decision|2|||
125537696|NCT04410523|451600108|FG001|Overall Study|Subject decision|0|||
125537697|NCT04410523|451600109|FG002|Overall Study|Subject decision|0|||
125537698|NCT04410523|451600110|FG003|Overall Study|Subject decision|1|||
125537699|NCT04410523|451600111|FG004|Overall Study|Subject decision|0|||
125537700|NCT04410523|451600112|FG005|Overall Study|Subject decision|1|||
125537701|NCT00621777|451600113|FG000|Open Phase|Adverse Event|20|||
125537702|NCT00621777|451600114|FG001|Open Phase|Adverse Event|0|||
125537703|NCT00621777|451600113|FG000|Open Phase|Did not abstain during open phase|56|||
125537704|NCT00621777|451600114|FG001|Open Phase|Did not abstain during open phase|0|||
125537705|NCT00621777|451600113|FG000|Open Phase|Withdrawal by Subject|17|||
125537706|NCT00621777|451600114|FG001|Open Phase|Withdrawal by Subject|0|||
125537707|NCT00621777|451600113|FG000|Open Phase|administrative|13|||
125537708|NCT00621777|451600114|FG001|Open Phase|administrative|0|||
125537709|NCT00621777|451600113|FG000|Open Phase|Lost to Follow-up|10|||
125537710|NCT00621777|451600114|FG001|Open Phase|Lost to Follow-up|0|||
125537711|NCT00621777|451600113|FG000|Randomized Phase|Adverse Event|3|||
125537712|NCT00621777|451600114|FG001|Randomized Phase|Adverse Event|3|||
125537713|NCT00621777|451600113|FG000|Randomized Phase|Lost to Follow-up|3|||
125537714|NCT00621777|451600114|FG001|Randomized Phase|Lost to Follow-up|3|||
125537715|NCT00621777|451600113|FG000|Randomized Phase|Withdrawal by Subject|1|||
125200607|NCT01938430|450357544|FG002|Overall Study|Investigator's Discretion|1|||
125537716|NCT00621777|451600114|FG001|Randomized Phase|Withdrawal by Subject|9|||
125537717|NCT00621777|451600113|FG000|Randomized Phase|administrative|0|||
125537718|NCT00621777|451600114|FG001|Randomized Phase|administrative|3|||
125537719|NCT00621777|451600113|FG000|Randomized Phase|Death|0|||
125537720|NCT00621777|451600114|FG001|Randomized Phase|Death|1|||
125537721|NCT01239043|451600115|FG000|Overall Study|Protocol Violation|2|||
125537722|NCT01239043|451600116|FG001|Overall Study|Protocol Violation|1|||
125537723|NCT01519089|451600117|FG000|Overall Study|Adverse Event|4|||
125537724|NCT01519089|451600118|FG001|Overall Study|Adverse Event|4|||
125537725|NCT01519089|451600117|FG000|Overall Study|Lack of Efficacy|0|||
125537726|NCT01519089|451600118|FG001|Overall Study|Lack of Efficacy|2|||
125537727|NCT01519089|451600117|FG000|Overall Study|Lost to Follow-up|1|||
125537728|NCT01519089|451600118|FG001|Overall Study|Lost to Follow-up|0|||
125537729|NCT01519089|451600117|FG000|Overall Study|Withdrawal by Subject|0|||
125537730|NCT01519089|451600118|FG001|Overall Study|Withdrawal by Subject|2|||
125537731|NCT01519089|451600117|FG000|Overall Study|Other|2|||
125537732|NCT01519089|451600118|FG001|Overall Study|Other|6|||
125537733|NCT01519089|451600117|FG000|Overall Study|Not received study drug|0|||
125537734|NCT01519089|451600118|FG001|Overall Study|Not received study drug|1|||
125537735|NCT00127205|451600119|FG000|Overall Study|Adverse Event|228|||
125537736|NCT00127205|451600120|FG001|Overall Study|Adverse Event|387|||
125537737|NCT00127205|451600121|FG002|Overall Study|Adverse Event|273|||
125537738|NCT00127205|451600119|FG000|Overall Study|Death|8|||
125537739|NCT00127205|451600120|FG001|Overall Study|Death|6|||
125537740|NCT00127205|451600121|FG002|Overall Study|Death|5|||
125537741|NCT00127205|451600119|FG000|Overall Study|Withdrawal by Subject|318|||
125537742|NCT00127205|451600120|FG001|Overall Study|Withdrawal by Subject|310|||
125537743|NCT00127205|451600121|FG002|Overall Study|Withdrawal by Subject|172|||
125537744|NCT00127205|451600119|FG000|Overall Study|Other-non protocol specified|142|||
125537745|NCT00127205|451600120|FG001|Overall Study|Other-non protocol specified|129|||
125537746|NCT00127205|451600121|FG002|Overall Study|Other-non protocol specified|77|||
125537747|NCT00127205|451600119|FG000|Overall Study|Data not reported|6|||
125537748|NCT00127205|451600120|FG001|Overall Study|Data not reported|10|||
125537749|NCT00127205|451600121|FG002|Overall Study|Data not reported|1|||
125537750|NCT00127205|451600119|FG000|Overall Study|Progression|127|||
125537751|NCT00127205|451600120|FG001|Overall Study|Progression|131|||
125537752|NCT00127205|451600121|FG002|Overall Study|Progression|84|||
125537753|NCT00224887|451600125|FG000|Overall Study|Pregnancy|6|||
125537754|NCT00224887|451600126|FG001|Overall Study|Pregnancy|6|||
125537755|NCT03582943|451600131|FG000|Allocated to Groups|Withdrawal by Subject|1|||
125537756|NCT03582943|451600132|FG001|Allocated to Groups|Withdrawal by Subject|1|||
125537757|NCT03582943|451600131|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
125537758|NCT03582943|451600132|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
125537759|NCT03582943|451600131|FG000|Analyzed|Protocol Violation|4|||
125537760|NCT03582943|451600132|FG001|Analyzed|Protocol Violation|1|||
125537761|NCT05032872|451600133|FG000|Overall Study|Adverse Event|1|||
125537762|NCT05032872|451600134|FG001|Overall Study|Adverse Event|0|||
125537763|NCT05032872|451600133|FG000|Overall Study|Lost to Follow-up|2|||
125537764|NCT05032872|451600134|FG001|Overall Study|Lost to Follow-up|4|||
125537765|NCT05032872|451600133|FG000|Overall Study|Withdrawal by Subject|4|||
125537766|NCT05032872|451600134|FG001|Overall Study|Withdrawal by Subject|3|||
125537767|NCT00488475|451600135|FG000|Overall Study|Other|1754|||
125537768|NCT00798590|451600156|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
125537769|NCT00798590|451600157|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
125537770|NCT01163292|451600163|FG000|Overall Study|Lack of Efficacy|9|||
125537771|NCT01163292|451600164|FG001|Overall Study|Lack of Efficacy|0|||
125537772|NCT01163292|451600163|FG000|Overall Study|Adverse Event|6|||
125537773|NCT01163292|451600164|FG001|Overall Study|Adverse Event|0|||
125537774|NCT01163292|451600163|FG000|Overall Study|Initiation of biological therapy|0|||
125537775|NCT01163292|451600164|FG001|Overall Study|Initiation of biological therapy|15|||
125537776|NCT01163292|451600163|FG000|Overall Study|Sufficient response to adalimumab|8|||
125537777|NCT01163292|451600164|FG001|Overall Study|Sufficient response to adalimumab|0|||
125537778|NCT01163292|451600163|FG000|Overall Study|Refusal to receive adalimumab|7|||
125537779|NCT01163292|451600164|FG001|Overall Study|Refusal to receive adalimumab|0|||
125537780|NCT01163292|451600163|FG000|Overall Study|Economic reasons|6|||
125537781|NCT01163292|451600164|FG001|Overall Study|Economic reasons|0|||
125537782|NCT01163292|451600163|FG000|Overall Study|No further visits|5|||
125537783|NCT01163292|451600164|FG001|Overall Study|No further visits|7|||
125537784|NCT03223662|451600165|FG000|Overall Study|Physician Decision|1|||
125537785|NCT03223662|451600165|FG000|Overall Study|Study closure|1|||
125200608|NCT01938430|450357545|FG003|Overall Study|Investigator's Discretion|0|||
125200609|NCT01938430|450357546|FG004|Overall Study|Investigator's Discretion|0|||
125537786|NCT02217475|451600166|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
125537787|NCT02217475|451600167|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
125537788|NCT02217475|451600168|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
125537789|NCT02217475|451600166|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
125537790|NCT02217475|451600167|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
125537791|NCT02217475|451600168|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
125537792|NCT02217475|451600166|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
125537793|NCT02217475|451600167|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
125537794|NCT02217475|451600168|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
125537795|NCT02217475|451600166|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
125200610|NCT01938430|450357547|FG005|Overall Study|Investigator's Discretion|0|||
125537796|NCT02217475|451600167|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
125537797|NCT02217475|451600168|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
125537798|NCT02217475|451600166|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
125537799|NCT02217475|451600167|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
125537800|NCT02217475|451600168|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
125537801|NCT02217475|451600166|FG000|Discontinued After Period 1|Adverse Event|1|||
125537802|NCT02217475|451600167|FG001|Discontinued After Period 1|Adverse Event|2|||
125537803|NCT02217475|451600168|FG002|Discontinued After Period 1|Adverse Event|0|||
125537804|NCT02217475|451600166|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
125537805|NCT02217475|451600167|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
125537806|NCT02217475|451600168|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
125537807|NCT02217475|451600166|FG000|Discontinued After Period 1|Physician Decision|0|||
125537808|NCT02217475|451600167|FG001|Discontinued After Period 1|Physician Decision|0|||
125537809|NCT02217475|451600168|FG002|Discontinued After Period 1|Physician Decision|1|||
125537810|NCT02217475|451600166|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
125537811|NCT02217475|451600167|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
125537812|NCT02217475|451600168|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
125537813|NCT02217475|451600166|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
125537814|NCT02217475|451600167|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
125537815|NCT02217475|451600168|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
125537816|NCT02217475|451600166|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
125537817|NCT02217475|451600167|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
125537818|NCT02217475|451600168|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
125537819|NCT02217475|451600166|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
125537820|NCT02217475|451600167|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
125537821|NCT02217475|451600168|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
125537822|NCT02217475|451600166|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
125537823|NCT02217475|451600167|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
125537824|NCT02217475|451600168|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
125537825|NCT02643472|451600169|FG000|Overall Study|Death|2|||
125537826|NCT02643472|451600170|FG001|Overall Study|Death|5|||
125537827|NCT02643472|451600169|FG000|Overall Study|Withdrawal by Subject|3|||
125537828|NCT02643472|451600170|FG001|Overall Study|Withdrawal by Subject|2|||
125537829|NCT02643472|451600169|FG000|Overall Study|Protocol Violation|0|||
125537830|NCT02643472|451600170|FG001|Overall Study|Protocol Violation|1|||
125537831|NCT02643472|451600169|FG000|Overall Study|Lost to Follow-up|22|||
125537832|NCT02643472|451600170|FG001|Overall Study|Lost to Follow-up|26|||
125537833|NCT01215188|451600171|FG000|Overall Study|Lost to Follow-up|22|||
125537834|NCT01215188|451600172|FG001|Overall Study|Lost to Follow-up|22|||
125537835|NCT01215188|451600173|FG002|Overall Study|Lost to Follow-up|16|||
125537836|NCT01215188|451600171|FG000|Overall Study|Adverse Event|1|||
125537837|NCT01215188|451600172|FG001|Overall Study|Adverse Event|1|||
125537838|NCT01215188|451600173|FG002|Overall Study|Adverse Event|3|||
125537839|NCT01215188|451600171|FG000|Overall Study|Physician Decision|2|||
125537840|NCT01215188|451600172|FG001|Overall Study|Physician Decision|1|||
125537841|NCT01215188|451600173|FG002|Overall Study|Physician Decision|0|||
125537842|NCT01215188|451600171|FG000|Overall Study|Lack of Efficacy|0|||
125537843|NCT01215188|451600172|FG001|Overall Study|Lack of Efficacy|0|||
125537844|NCT01215188|451600173|FG002|Overall Study|Lack of Efficacy|1|||
125537845|NCT01215188|451600171|FG000|Overall Study|Protocol Violation|1|||
125537846|NCT01215188|451600172|FG001|Overall Study|Protocol Violation|1|||
125537847|NCT01215188|451600173|FG002|Overall Study|Protocol Violation|1|||
125537848|NCT01215188|451600171|FG000|Overall Study|Withdrawal by Subject|32|||
125200611|NCT01938430|450357548|FG006|Overall Study|Investigator's Discretion|0|||
125200612|NCT01938430|450357549|FG007|Overall Study|Investigator's Discretion|0|||
125200613|NCT01938430|450357550|FG008|Overall Study|Investigator's Discretion|0|||
125200614|NCT01938430|450357551|FG009|Overall Study|Investigator's Discretion|0|||
125200615|NCT01938430|450357552|FG010|Overall Study|Investigator's Discretion|0|||
125200616|NCT01938430|450357553|FG011|Overall Study|Investigator's Discretion|0|||
125200617|NCT01938430|450357554|FG012|Overall Study|Investigator's Discretion|0|||
125200618|NCT01938430|450357555|FG013|Overall Study|Investigator's Discretion|0|||
125200619|NCT01938430|450357542|FG000|Overall Study|Lack of Efficacy|3|||
125200620|NCT01938430|450357543|FG001|Overall Study|Lack of Efficacy|1|||
125200621|NCT01938430|450357544|FG002|Overall Study|Lack of Efficacy|1|||
125200622|NCT01938430|450357545|FG003|Overall Study|Lack of Efficacy|1|||
125200623|NCT01938430|450357546|FG004|Overall Study|Lack of Efficacy|0|||
125200624|NCT01938430|450357547|FG005|Overall Study|Lack of Efficacy|0|||
125200625|NCT01938430|450357548|FG006|Overall Study|Lack of Efficacy|0|||
125200626|NCT01938430|450357549|FG007|Overall Study|Lack of Efficacy|0|||
125200627|NCT01938430|450357550|FG008|Overall Study|Lack of Efficacy|1|||
125200628|NCT01938430|450357551|FG009|Overall Study|Lack of Efficacy|0|||
125200629|NCT01938430|450357552|FG010|Overall Study|Lack of Efficacy|2|||
125537849|NCT01215188|451600172|FG001|Overall Study|Withdrawal by Subject|34|||
125537850|NCT01215188|451600173|FG002|Overall Study|Withdrawal by Subject|31|||
125537851|NCT01012414|451600174|FG000|Overall Study|Withdrawal by Subject|2|||
125200630|NCT01938430|450357553|FG011|Overall Study|Lack of Efficacy|1|||
125200631|NCT01938430|450357554|FG012|Overall Study|Lack of Efficacy|0|||
125200632|NCT01938430|450357555|FG013|Overall Study|Lack of Efficacy|0|||
125200633|NCT01938430|450357542|FG000|Overall Study|Lost to Follow-up|0|||
125200634|NCT01938430|450357543|FG001|Overall Study|Lost to Follow-up|0|||
125200635|NCT01938430|450357544|FG002|Overall Study|Lost to Follow-up|1|||
125200636|NCT01938430|450357545|FG003|Overall Study|Lost to Follow-up|0|||
125200637|NCT01938430|450357546|FG004|Overall Study|Lost to Follow-up|0|||
125200638|NCT01938430|450357547|FG005|Overall Study|Lost to Follow-up|1|||
125200639|NCT01938430|450357548|FG006|Overall Study|Lost to Follow-up|0|||
125200640|NCT01938430|450357549|FG007|Overall Study|Lost to Follow-up|0|||
125200641|NCT01938430|450357550|FG008|Overall Study|Lost to Follow-up|0|||
125200642|NCT01938430|450357551|FG009|Overall Study|Lost to Follow-up|0|||
125200643|NCT01938430|450357552|FG010|Overall Study|Lost to Follow-up|0|||
125200644|NCT01938430|450357553|FG011|Overall Study|Lost to Follow-up|0|||
125200645|NCT01938430|450357554|FG012|Overall Study|Lost to Follow-up|0|||
125200646|NCT01938430|450357555|FG013|Overall Study|Lost to Follow-up|0|||
125200647|NCT01938430|450357542|FG000|Overall Study|Withdrew Consent|0|||
125200648|NCT01938430|450357543|FG001|Overall Study|Withdrew Consent|0|||
125200649|NCT01938430|450357544|FG002|Overall Study|Withdrew Consent|0|||
125200650|NCT01938430|450357545|FG003|Overall Study|Withdrew Consent|0|||
125200651|NCT01938430|450357546|FG004|Overall Study|Withdrew Consent|0|||
125200652|NCT01938430|450357547|FG005|Overall Study|Withdrew Consent|0|||
125200653|NCT01938430|450357548|FG006|Overall Study|Withdrew Consent|0|||
125200654|NCT01938430|450357549|FG007|Overall Study|Withdrew Consent|0|||
125200655|NCT01938430|450357550|FG008|Overall Study|Withdrew Consent|1|||
125200656|NCT01938430|450357551|FG009|Overall Study|Withdrew Consent|0|||
125200657|NCT01938430|450357552|FG010|Overall Study|Withdrew Consent|0|||
125200658|NCT01938430|450357553|FG011|Overall Study|Withdrew Consent|0|||
125200659|NCT01938430|450357554|FG012|Overall Study|Withdrew Consent|0|||
125200660|NCT01938430|450357555|FG013|Overall Study|Withdrew Consent|0|||
125200661|NCT03875482|450357556|FG000|Overall Study|Adverse Event|0|||
125200662|NCT03875482|450357557|FG001|Overall Study|Adverse Event|1|||
125200663|NCT03875482|450357556|FG000|Overall Study|Withdrew consent|5|||
125200664|NCT03875482|450357557|FG001|Overall Study|Withdrew consent|6|||
125200665|NCT03875482|450357556|FG000|Overall Study|Lost to Follow-up|8|||
125200666|NCT03875482|450357557|FG001|Overall Study|Lost to Follow-up|2|||
125200667|NCT03875482|450357556|FG000|Overall Study|Lack of Efficacy|0|||
125200668|NCT03875482|450357557|FG001|Overall Study|Lack of Efficacy|11|||
125200669|NCT02111785|450357559|FG000|Overall Study|Death|0|||
125200670|NCT02111785|450357560|FG001|Overall Study|Death|1|||
125200671|NCT02111785|450357561|FG002|Overall Study|Death|0|||
125200672|NCT02111785|450357562|FG003|Overall Study|Death|0|||
125200673|NCT02738879|450357569|FG000|Overall Study|Adverse Event|1|||
125200674|NCT02738879|450357570|FG001|Overall Study|Adverse Event|1|||
125200675|NCT02738879|450357569|FG000|Overall Study|Death|0|||
125200676|NCT02738879|450357570|FG001|Overall Study|Death|2|||
125200677|NCT02738879|450357569|FG000|Overall Study|Lost to Follow-up|1|||
125200678|NCT02738879|450357570|FG001|Overall Study|Lost to Follow-up|5|||
125200679|NCT02738879|450357569|FG000|Overall Study|Protocol Violation|1|||
125200680|NCT02738879|450357570|FG001|Overall Study|Protocol Violation|3|||
125200681|NCT02738879|450357569|FG000|Overall Study|Physician Decision|3|||
125200682|NCT02738879|450357570|FG001|Overall Study|Physician Decision|4|||
125200683|NCT02738879|450357569|FG000|Overall Study|Pregnancy|0|||
125200684|NCT02738879|450357570|FG001|Overall Study|Pregnancy|1|||
125200685|NCT02738879|450357569|FG000|Overall Study|Screen Failure|1|||
125200686|NCT02738879|450357570|FG001|Overall Study|Screen Failure|2|||
125200687|NCT02738879|450357569|FG000|Overall Study|Site Discontinued Study Participation|1|||
125200688|NCT02738879|450357570|FG001|Overall Study|Site Discontinued Study Participation|0|||
125200689|NCT02738879|450357569|FG000|Overall Study|Withdrawal by Subject|5|||
125200690|NCT02738879|450357570|FG001|Overall Study|Withdrawal by Subject|7|||
125200691|NCT01438294|450357571|FG000|Overall Study|Lost to Follow-up|3|||
125200692|NCT01438294|450357572|FG001|Overall Study|Lost to Follow-up|7|||
125200693|NCT01346189|450357575|FG000|Overall Study|Withdrawal by Subject|7|||
125200694|NCT01346189|450357576|FG001|Overall Study|Withdrawal by Subject|5|||
125200695|NCT01346189|450357577|FG002|Overall Study|Withdrawal by Subject|3|||
125200696|NCT01346189|450357578|FG003|Overall Study|Withdrawal by Subject|5|||
125200697|NCT01346189|450357575|FG000|Overall Study|Physician Decision|4|||
125200698|NCT01346189|450357576|FG001|Overall Study|Physician Decision|0|||
125200699|NCT01346189|450357577|FG002|Overall Study|Physician Decision|0|||
125200700|NCT01346189|450357578|FG003|Overall Study|Physician Decision|0|||
125200701|NCT01346189|450357575|FG000|Overall Study|Moved|3|||
125200702|NCT01346189|450357576|FG001|Overall Study|Moved|0|||
125200703|NCT01346189|450357577|FG002|Overall Study|Moved|4|||
125200704|NCT01346189|450357578|FG003|Overall Study|Moved|0|||
125200705|NCT01346189|450357575|FG000|Overall Study|Other|2|||
125200706|NCT01346189|450357576|FG001|Overall Study|Other|4|||
125200707|NCT01346189|450357577|FG002|Overall Study|Other|7|||
125200708|NCT01346189|450357578|FG003|Overall Study|Other|3|||
125200709|NCT01346189|450357575|FG000|Overall Study|Death|0|||
125200710|NCT01346189|450357576|FG001|Overall Study|Death|3|||
125200711|NCT01346189|450357577|FG002|Overall Study|Death|0|||
125200712|NCT01346189|450357578|FG003|Overall Study|Death|0|||
125200713|NCT01346189|450357575|FG000|Overall Study|Non-health system primary care physician|0|||
125200714|NCT01346189|450357576|FG001|Overall Study|Non-health system primary care physician|5|||
125200715|NCT01346189|450357577|FG002|Overall Study|Non-health system primary care physician|0|||
125200716|NCT01346189|450357578|FG003|Overall Study|Non-health system primary care physician|0|||
125200717|NCT01346189|450357575|FG000|Overall Study|Travel|0|||
125200718|NCT01346189|450357576|FG001|Overall Study|Travel|0|||
125200719|NCT01346189|450357577|FG002|Overall Study|Travel|0|||
125200720|NCT01346189|450357578|FG003|Overall Study|Travel|3|||
125200721|NCT01730534|450357585|FG000|Overall Study|Withdrawal by Subject|97|||
125200722|NCT01730534|450357586|FG001|Overall Study|Withdrawal by Subject|127|||
125200723|NCT01730534|450357585|FG000|Overall Study|Lost to Follow-up|12|||
125200724|NCT01730534|450357586|FG001|Overall Study|Lost to Follow-up|18|||
125200725|NCT01676896|450357587|FG000|Overall Study|Withdrawal by Subject|12|||
125200726|NCT01676896|450357588|FG001|Overall Study|Withdrawal by Subject|7|||
125200727|NCT01676896|450357589|FG002|Overall Study|Withdrawal by Subject|19|||
125200728|NCT02256982|450357590|FG000|Overall Study|Disease Progression|0|||
125200729|NCT02256982|450357591|FG001|Overall Study|Disease Progression|1|||
125200730|NCT00655733|450357595|FG000|Overall Study|Lost to Follow-up|2|||
125200731|NCT00655733|450357596|FG001|Overall Study|Lost to Follow-up|2|||
125200732|NCT00655733|450357595|FG000|Overall Study|Adverse Event|2|||
125200733|NCT00655733|450357596|FG001|Overall Study|Adverse Event|2|||
125200734|NCT00655733|450357595|FG000|Overall Study|Withdrawal by Subject|3|||
125200735|NCT00655733|450357596|FG001|Overall Study|Withdrawal by Subject|3|||
125200736|NCT00655733|450357595|FG000|Overall Study|Physician Decision|0|||
125200737|NCT00655733|450357596|FG001|Overall Study|Physician Decision|1|||
125200738|NCT02658734|450357597|FG000|Overall Study|Adverse Event|2|||
125200739|NCT02658734|450357597|FG000|Overall Study|Death|4|||
125200740|NCT02658734|450357597|FG000|Overall Study|Lost to Follow-up|7|||
125200741|NCT02658734|450357597|FG000|Overall Study|Withdrawal of Consent|16|||
125200742|NCT02658734|450357597|FG000|Overall Study|Disease Progression|28|||
125200743|NCT00459706|450357598|FG000|Overall Study|Adverse Event|19|||
125200744|NCT00459706|450357599|FG001|Overall Study|Adverse Event|13|||
125200745|NCT00459706|450357598|FG000|Overall Study|Withdrawal by Subject|1|||
125200746|NCT00459706|450357599|FG001|Overall Study|Withdrawal by Subject|6|||
125200747|NCT00459706|450357598|FG000|Overall Study|Physician Decision|2|||
125200748|NCT00459706|450357599|FG001|Overall Study|Physician Decision|0|||
125200749|NCT00459706|450357598|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
125200750|NCT00459706|450357599|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
125200751|NCT00459706|450357598|FG000|Overall Study|Protocol Violation|2|||
125200752|NCT00459706|450357599|FG001|Overall Study|Protocol Violation|1|||
125200753|NCT00459706|450357598|FG000|Overall Study|Failed to Return|1|||
125200754|NCT00459706|450357599|FG001|Overall Study|Failed to Return|0|||
125200755|NCT00459706|450357598|FG000|Overall Study|Other|0|||
125200756|NCT00459706|450357599|FG001|Overall Study|Other|1|||
125200757|NCT02447497|450357600|FG000|Overall Study|Did not meet treatment day baseline.|6|||
125200758|NCT02447497|450357601|FG001|Overall Study|Did not meet treatment day baseline.|5|||
125200759|NCT02447497|450357602|FG002|Overall Study|Did not meet treatment day baseline.|2|||
125200760|NCT02447497|450357603|FG003|Overall Study|Did not meet treatment day baseline.|2|||
125200761|NCT02447497|450357600|FG000|Overall Study|Dressing was compromised|0|||
125200762|NCT02447497|450357601|FG001|Overall Study|Dressing was compromised|1|||
125200763|NCT02447497|450357602|FG002|Overall Study|Dressing was compromised|0|||
125200764|NCT02447497|450357603|FG003|Overall Study|Dressing was compromised|0|||
125200765|NCT01322035|450357604|FG000|Overall Study|Lost to Follow-up|8|||
125200766|NCT01322035|450357605|FG001|Overall Study|Lost to Follow-up|3|||
125200767|NCT00732758|450357606|FG000|Overall Study|Lost to Follow-up|8|||
125200768|NCT00732758|450357607|FG001|Overall Study|Lost to Follow-up|16|||
125200769|NCT04240457|450357610|FG000|Overall Study|Lost to Follow-up|5|||
125200770|NCT04240457|450357611|FG001|Overall Study|Lost to Follow-up|1|||
125200771|NCT01252563|450357613|FG000|Overall Study|Contract Deviation|41|||
125200772|NCT01252563|450357613|FG000|Overall Study|Centralized Registration Deviation|30|||
125200773|NCT01252563|450357613|FG000|Overall Study|Lost to Follow-up|161|||
125200774|NCT01252563|450357613|FG000|Overall Study|No visit after first day of treatment|194|||
125200775|NCT01252563|450357613|FG000|Overall Study|No drug administration|6|||
125200776|NCT01880086|450357614|FG000|Overall Study|Lost to Follow-up|1|||
125200777|NCT01880086|450357615|FG001|Overall Study|Lost to Follow-up|1|||
125200778|NCT03843632|450357621|FG000|Overall Study|Withdrawal by Subject|1|||
125200779|NCT03843632|450357622|FG001|Overall Study|Withdrawal by Subject|0|||
125200780|NCT03843632|450357623|FG002|Overall Study|Withdrawal by Subject|0|||
125200781|NCT03843632|450357624|FG003|Overall Study|Withdrawal by Subject|0|||
125200782|NCT01820572|450357626|FG000|Randomization|Not Treated|2|||
125200783|NCT01820572|450357627|FG001|Randomization|Not Treated|1|||
125200784|NCT01820572|450357626|FG000|Treatment Period|Adverse Event|12|||
125200785|NCT01820572|450357627|FG001|Treatment Period|Adverse Event|7|||
125200786|NCT01820572|450357626|FG000|Treatment Period|Death|3|||
125200787|NCT01820572|450357627|FG001|Treatment Period|Death|3|||
125200788|NCT01820572|450357626|FG000|Treatment Period|Lack of Efficacy|1|||
125200789|NCT01820572|450357627|FG001|Treatment Period|Lack of Efficacy|0|||
125200790|NCT01820572|450357626|FG000|Treatment Period|poor/non compliance|0|||
125200791|NCT01820572|450357627|FG001|Treatment Period|poor/non compliance|3|||
125200792|NCT01820572|450357626|FG000|Treatment Period|request to discontinue|6|||
125200793|NCT01820572|450357627|FG001|Treatment Period|request to discontinue|11|||
125200794|NCT01820572|450357626|FG000|Treatment Period|No longer meets study criteria|3|||
125200795|NCT01820572|450357627|FG001|Treatment Period|No longer meets study criteria|10|||
125200796|NCT01820572|450357626|FG000|Treatment Period|withdrew consent|1|||
125200797|NCT01820572|450357627|FG001|Treatment Period|withdrew consent|2|||
125200798|NCT05036668|450357631|FG000|Overall Study|lost to follow Up|0|||
125200799|NCT05036668|450357632|FG001|Overall Study|lost to follow Up|0|||
125200800|NCT05036668|450357633|FG002|Overall Study|lost to follow Up|1|||
125200801|NCT00387010|450357634|FG000|Dose Titration Period|Adverse Event|12|||
125200802|NCT00387010|450357634|FG000|Dose Titration Period|Lack of Efficacy|5|||
125200803|NCT00387010|450357634|FG000|Dose Titration Period|Withdrawal by Subject|3|||
125200804|NCT00387010|450357634|FG000|Dose Titration Period|Protocol Violation|1|||
125200805|NCT00387010|450357634|FG000|Dose Titration Period|Lost to Follow-up|2|||
125200806|NCT00387010|450357634|FG000|Dose Titration Period|Noncompliance with study medication|8|||
125200807|NCT00387010|450357634|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
125200808|NCT00387010|450357634|FG000|Treatment Period|Adverse Event|4|||
125200809|NCT00387010|450357634|FG000|Treatment Period|Withdrawal by Subject|1|||
125200810|NCT00387010|450357634|FG000|Treatment Period|Noncompliance with study medication|2|||
125200811|NCT00387010|450357634|FG000|Treatment Period|Noncompliance with study procedures|3|||
125200812|NCT00387010|450357634|FG000|Treatment Period|Participant reported study drug stolen|1|||
125200813|NCT00520481|450357635|FG000|Overall Study|Adverse Event|4|||
125200814|NCT00520481|450357636|FG001|Overall Study|Adverse Event|1|||
125200815|NCT00520481|450357635|FG000|Overall Study|Withdrawal by Subject|3|||
125200816|NCT00520481|450357636|FG001|Overall Study|Withdrawal by Subject|0|||
125200817|NCT01190267|450357641|FG000|Overall Study|Adverse Event|10|||
125200818|NCT01190267|450357642|FG001|Overall Study|Adverse Event|0|||
125200819|NCT01190267|450357641|FG000|Overall Study|Treatment Failure|8|||
125200820|NCT01190267|450357642|FG001|Overall Study|Treatment Failure|2|||
125200821|NCT01190267|450357641|FG000|Overall Study|Lost to Follow-up|2|||
125200822|NCT01190267|450357642|FG001|Overall Study|Lost to Follow-up|0|||
125200823|NCT01190267|450357641|FG000|Overall Study|Withdrawal by Subject|13|||
125200824|NCT01190267|450357642|FG001|Overall Study|Withdrawal by Subject|1|||
125200825|NCT01190267|450357641|FG000|Overall Study|Protocol Violation|8|||
125200826|NCT01190267|450357642|FG001|Overall Study|Protocol Violation|1|||
125200827|NCT01931956|450357643|FG000|Overall Study|Death|42|||
125200828|NCT01931956|450357644|FG001|Overall Study|Death|7|||
125200829|NCT01931956|450357645|FG002|Overall Study|Death|379|||
125200830|NCT01931956|450357646|FG003|Overall Study|Death|96|||
125200831|NCT01931956|450357643|FG000|Overall Study|Withdrawal by Subject|5|||
125200832|NCT01931956|450357644|FG001|Overall Study|Withdrawal by Subject|0|||
125200833|NCT01931956|450357645|FG002|Overall Study|Withdrawal by Subject|70|||
125200834|NCT01931956|450357646|FG003|Overall Study|Withdrawal by Subject|30|||
125200835|NCT01931956|450357643|FG000|Overall Study|Lost to Follow-up|2|||
125200836|NCT01931956|450357644|FG001|Overall Study|Lost to Follow-up|0|||
125200837|NCT01931956|450357645|FG002|Overall Study|Lost to Follow-up|11|||
125200838|NCT01931956|450357646|FG003|Overall Study|Lost to Follow-up|7|||
125200839|NCT01931956|450357643|FG000|Overall Study|Expected|2|||
125200840|NCT01931956|450357644|FG001|Overall Study|Expected|0|||
125200841|NCT01931956|450357645|FG002|Overall Study|Expected|6|||
125200842|NCT01931956|450357646|FG003|Overall Study|Expected|0|||
125200843|NCT01931956|450357643|FG000|Overall Study|Not due|0|||
125200844|NCT01931956|450357644|FG001|Overall Study|Not due|0|||
125200845|NCT01931956|450357645|FG002|Overall Study|Not due|21|||
125200846|NCT01931956|450357646|FG003|Overall Study|Not due|0|||
125200847|NCT02847494|450357647|FG000|Overall Study|Lost to Follow-up|8|||
125200848|NCT02847494|450357648|FG001|Overall Study|Lost to Follow-up|5|||
125200849|NCT02841280|450357651|FG000|Overall Study|Adverse Event|2|||
125200850|NCT02841280|450357652|FG001|Overall Study|Adverse Event|1|||
125200851|NCT02841280|450357651|FG000|Overall Study|Death|1|||
125200852|NCT02841280|450357652|FG001|Overall Study|Death|0|||
125200853|NCT02841280|450357651|FG000|Overall Study|Lost to Follow-up|2|||
125200854|NCT02841280|450357652|FG001|Overall Study|Lost to Follow-up|2|||
125200855|NCT02841280|450357651|FG000|Overall Study|Withdrawal by Subject|7|||
125200856|NCT02841280|450357652|FG001|Overall Study|Withdrawal by Subject|3|||
125200857|NCT02841280|450357651|FG000|Overall Study|Stop Point: BP above threshold|2|||
125200858|NCT02841280|450357652|FG001|Overall Study|Stop Point: BP above threshold|0|||
125200859|NCT01738503|450357653|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
125200860|NCT01738503|450357654|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
125200861|NCT01738503|450357655|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
125200862|NCT01738503|450357656|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
125200863|NCT01738503|450357657|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
125200864|NCT01738503|450357658|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
125200865|NCT01738503|450357659|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
125200866|NCT01738503|450357653|FG000|Treatment Period|Adverse Event|0|||
125200867|NCT01738503|450357654|FG001|Treatment Period|Adverse Event|1|||
125200868|NCT01738503|450357655|FG002|Treatment Period|Adverse Event|0|||
125200869|NCT01738503|450357656|FG003|Treatment Period|Adverse Event|1|||
125200870|NCT01738503|450357657|FG004|Treatment Period|Adverse Event|2|||
125200871|NCT01738503|450357658|FG005|Treatment Period|Adverse Event|2|||
125200872|NCT01738503|450357659|FG006|Treatment Period|Adverse Event|2|||
125200873|NCT01738503|450357653|FG000|Treatment Period|Lost to Follow-up|0|||
125200874|NCT01738503|450357654|FG001|Treatment Period|Lost to Follow-up|0|||
125200875|NCT01738503|450357655|FG002|Treatment Period|Lost to Follow-up|3|||
125200876|NCT01738503|450357656|FG003|Treatment Period|Lost to Follow-up|4|||
125200877|NCT01738503|450357657|FG004|Treatment Period|Lost to Follow-up|1|||
125200878|NCT01738503|450357658|FG005|Treatment Period|Lost to Follow-up|1|||
125200879|NCT01738503|450357659|FG006|Treatment Period|Lost to Follow-up|5|||
125200880|NCT01738503|450357653|FG000|Treatment Period|Withdrawal by Subject|0|||
125200881|NCT01738503|450357654|FG001|Treatment Period|Withdrawal by Subject|1|||
125200882|NCT01738503|450357655|FG002|Treatment Period|Withdrawal by Subject|0|||
125200883|NCT01738503|450357656|FG003|Treatment Period|Withdrawal by Subject|1|||
125200884|NCT01738503|450357657|FG004|Treatment Period|Withdrawal by Subject|1|||
125200885|NCT01738503|450357658|FG005|Treatment Period|Withdrawal by Subject|1|||
125200886|NCT01738503|450357659|FG006|Treatment Period|Withdrawal by Subject|1|||
125200887|NCT01738503|450357653|FG000|Treatment Period|Protocol Violation|0|||
125200888|NCT01738503|450357654|FG001|Treatment Period|Protocol Violation|3|||
125200889|NCT01738503|450357655|FG002|Treatment Period|Protocol Violation|1|||
125200890|NCT01738503|450357656|FG003|Treatment Period|Protocol Violation|0|||
125200891|NCT01738503|450357657|FG004|Treatment Period|Protocol Violation|4|||
125200892|NCT01738503|450357658|FG005|Treatment Period|Protocol Violation|2|||
125200893|NCT01738503|450357659|FG006|Treatment Period|Protocol Violation|0|||
125200894|NCT01738503|450357653|FG000|Treatment Period|Other|0|||
125200895|NCT01738503|450357654|FG001|Treatment Period|Other|0|||
125200896|NCT01738503|450357655|FG002|Treatment Period|Other|1|||
125200897|NCT01738503|450357656|FG003|Treatment Period|Other|0|||
125200898|NCT01738503|450357657|FG004|Treatment Period|Other|0|||
125200899|NCT01738503|450357658|FG005|Treatment Period|Other|0|||
125200900|NCT01738503|450357659|FG006|Treatment Period|Other|0|||
125200901|NCT01738503|450357653|FG000|PET Imaging Sub-study|Adverse Event|0|||
125200902|NCT01738503|450357654|FG001|PET Imaging Sub-study|Adverse Event|0|||
125200903|NCT01738503|450357655|FG002|PET Imaging Sub-study|Adverse Event|0|||
125200904|NCT01738503|450357656|FG003|PET Imaging Sub-study|Adverse Event|0|||
125200905|NCT01738503|450357657|FG004|PET Imaging Sub-study|Adverse Event|0|||
125200906|NCT01738503|450357658|FG005|PET Imaging Sub-study|Adverse Event|1|||
125200907|NCT01738503|450357659|FG006|PET Imaging Sub-study|Adverse Event|0|||
125200908|NCT01738503|450357653|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
125200909|NCT01738503|450357654|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
125200910|NCT01738503|450357655|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
125200911|NCT01738503|450357656|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
125200912|NCT01738503|450357657|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
125200913|NCT01738503|450357658|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
125200914|NCT01738503|450357659|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
125200915|NCT03005327|450357660|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
125200916|NCT03005327|450357661|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
125200917|NCT03005327|450357662|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
125200918|NCT03005327|450357663|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
125200919|NCT03005327|450357660|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125200920|NCT03005327|450357661|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
125200921|NCT03005327|450357662|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125200922|NCT03005327|450357663|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125200923|NCT02496091|450357667|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125200924|NCT02272842|450357668|FG000|Overall Study|Lost to Follow-up|8|||
125200925|NCT02272842|450357669|FG001|Overall Study|Lost to Follow-up|8|||
125200926|NCT02272842|450357668|FG000|Overall Study|Withdrawal by Subject|8|||
125200927|NCT02272842|450357669|FG001|Overall Study|Withdrawal by Subject|2|||
125200928|NCT01493284|450357671|FG000|Overall Study|Death|29|||
125200929|NCT01493284|450357671|FG000|Overall Study|Withdrawal by Subject|32|||
125200930|NCT00519428|450357672|FG000|Overall Study|Adverse Event|5|||
125200931|NCT00519428|450357673|FG001|Overall Study|Adverse Event|2|||
125200932|NCT00519428|450357674|FG002|Overall Study|Adverse Event|10|||
125200933|NCT00519428|450357672|FG000|Overall Study|Lost to Follow-up|7|||
125200934|NCT00519428|450357673|FG001|Overall Study|Lost to Follow-up|7|||
125200935|NCT00519428|450357674|FG002|Overall Study|Lost to Follow-up|6|||
125200936|NCT00519428|450357672|FG000|Overall Study|Withdrawal by Subject|8|||
125200937|NCT00519428|450357673|FG001|Overall Study|Withdrawal by Subject|3|||
125200938|NCT00519428|450357674|FG002|Overall Study|Withdrawal by Subject|7|||
125200939|NCT00519428|450357672|FG000|Overall Study|unstated|1|||
125200940|NCT00519428|450357673|FG001|Overall Study|unstated|3|||
125200941|NCT00519428|450357674|FG002|Overall Study|unstated|2|||
125200942|NCT00325156|450357675|FG000|Overall Study|Protocol Violation|8|||
125200943|NCT00325156|450357675|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
125200944|NCT00325156|450357675|FG000|Overall Study|Migrated/moved from study area|12|||
125200945|NCT00325156|450357675|FG000|Overall Study|Adverse event, non-fatal|3|||
125200946|NCT00325156|450357675|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
125200947|NCT00325156|450357675|FG000|Overall Study|Other|1|||
125200948|NCT00325156|450357675|FG000|Overall Study|Withdrawal by Subject|31|||
125200949|NCT03626363|450357676|FG000|Overall Study|Protocol Violation|4|||
125200950|NCT03626363|450357677|FG001|Overall Study|Protocol Violation|0|||
125200951|NCT03626363|450357676|FG000|Overall Study|Lost to Follow-up|5|||
125200952|NCT03626363|450357677|FG001|Overall Study|Lost to Follow-up|7|||
125200953|NCT00533702|450357680|FG000|Overall Study|Withdrawal by Subject|3|||
125200954|NCT00533702|450357681|FG001|Overall Study|Withdrawal by Subject|1|||
125200955|NCT00533702|450357680|FG000|Overall Study|Found ineligible after randomization|2|||
125200956|NCT00533702|450357681|FG001|Overall Study|Found ineligible after randomization|1|||
125200957|NCT03053063|450357684|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
125200958|NCT03053063|450357685|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
125200959|NCT03053063|450357686|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
125200960|NCT03053063|450357687|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
125200961|NCT03053063|450357684|FG000|Randomized Phase|Withdrew consent|8|||
125200962|NCT03053063|450357685|FG001|Randomized Phase|Withdrew consent|11|||
125200963|NCT03053063|450357686|FG002|Randomized Phase|Withdrew consent|5|||
125200964|NCT03053063|450357687|FG003|Randomized Phase|Withdrew consent|0|||
125200965|NCT03053063|450357684|FG000|Randomized Phase|Investigator's Discretion|8|||
125200966|NCT03053063|450357685|FG001|Randomized Phase|Investigator's Discretion|6|||
125200967|NCT03053063|450357686|FG002|Randomized Phase|Investigator's Discretion|2|||
125200968|NCT03053063|450357687|FG003|Randomized Phase|Investigator's Discretion|0|||
125200969|NCT03053063|450357684|FG000|Randomized Phase|Lost to Follow-up|3|||
125200970|NCT03053063|450357685|FG001|Randomized Phase|Lost to Follow-up|5|||
125200971|NCT03053063|450357686|FG002|Randomized Phase|Lost to Follow-up|1|||
125200972|NCT03053063|450357687|FG003|Randomized Phase|Lost to Follow-up|0|||
125200973|NCT03053063|450357684|FG000|Randomized Phase|Adverse Event|0|||
125200974|NCT03053063|450357685|FG001|Randomized Phase|Adverse Event|1|||
125200975|NCT03053063|450357686|FG002|Randomized Phase|Adverse Event|0|||
125200976|NCT03053063|450357687|FG003|Randomized Phase|Adverse Event|0|||
125200977|NCT03053063|450357684|FG000|Randomized Phase|Randomized but Never Treated|1|||
125200978|NCT03053063|450357685|FG001|Randomized Phase|Randomized but Never Treated|3|||
125200979|NCT03053063|450357686|FG002|Randomized Phase|Randomized but Never Treated|2|||
125200980|NCT03053063|450357687|FG003|Randomized Phase|Randomized but Never Treated|0|||
125200981|NCT03053063|450357684|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
125200982|NCT03053063|450357685|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
125200983|NCT03053063|450357686|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
125200984|NCT03053063|450357687|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
125200985|NCT03053063|450357684|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
125200986|NCT03053063|450357685|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
125200987|NCT03053063|450357686|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
125200988|NCT03053063|450357687|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
125200989|NCT03053063|450357684|FG000|Open-Label Phase|Death|0|||
125200990|NCT03053063|450357685|FG001|Open-Label Phase|Death|0|||
125200991|NCT03053063|450357686|FG002|Open-Label Phase|Death|0|||
125200992|NCT03053063|450357687|FG003|Open-Label Phase|Death|2|||
125200993|NCT03053063|450357684|FG000|Open-Label Phase|Investigator's discretion|0|||
125200994|NCT03053063|450357685|FG001|Open-Label Phase|Investigator's discretion|0|||
125200995|NCT03053063|450357686|FG002|Open-Label Phase|Investigator's discretion|0|||
125200996|NCT03053063|450357687|FG003|Open-Label Phase|Investigator's discretion|2|||
125200997|NCT02600845|450357688|FG000|Overall Study|Reason Not Specified|3|||
125200998|NCT02600845|450357688|FG000|Overall Study|Non-compliance with Study Procedures|10|||
125200999|NCT02600845|450357688|FG000|Overall Study|Consent Withdrawal|5|||
125201000|NCT02100670|450357691|FG000|Overall Study|Adverse Event|10|||
125201001|NCT02100670|450357692|FG001|Overall Study|Adverse Event|3|||
125201002|NCT02100670|450357693|FG002|Overall Study|Adverse Event|3|||
125201003|NCT02100670|450357694|FG003|Overall Study|Adverse Event|0|||
125201004|NCT02100670|450357691|FG000|Overall Study|Lost to Follow-up|1|||
125201005|NCT02100670|450357692|FG001|Overall Study|Lost to Follow-up|0|||
125201006|NCT02100670|450357693|FG002|Overall Study|Lost to Follow-up|0|||
125201007|NCT02100670|450357694|FG003|Overall Study|Lost to Follow-up|0|||
125201008|NCT02100670|450357691|FG000|Overall Study|Protocol Violation|0|||
125201009|NCT02100670|450357692|FG001|Overall Study|Protocol Violation|1|||
125201010|NCT02100670|450357693|FG002|Overall Study|Protocol Violation|0|||
125201011|NCT02100670|450357694|FG003|Overall Study|Protocol Violation|1|||
125201012|NCT02100670|450357691|FG000|Overall Study|Withdrawal of Consent|0|||
125201013|NCT02100670|450357692|FG001|Overall Study|Withdrawal of Consent|1|||
125201014|NCT02100670|450357693|FG002|Overall Study|Withdrawal of Consent|1|||
125201015|NCT02100670|450357694|FG003|Overall Study|Withdrawal of Consent|0|||
125201016|NCT02100670|450357691|FG000|Overall Study|No swelling no pain|1|||
125201017|NCT02100670|450357692|FG001|Overall Study|No swelling no pain|0|||
125201018|NCT02100670|450357693|FG002|Overall Study|No swelling no pain|0|||
125201019|NCT02100670|450357694|FG003|Overall Study|No swelling no pain|0|||
125201020|NCT02100670|450357691|FG000|Overall Study|Poor Efficacy|0|||
125201021|NCT02100670|450357692|FG001|Overall Study|Poor Efficacy|1|||
125201022|NCT02100670|450357693|FG002|Overall Study|Poor Efficacy|0|||
125201023|NCT02100670|450357694|FG003|Overall Study|Poor Efficacy|0|||
125201024|NCT02100670|450357691|FG000|Overall Study|Physician Decision|0|||
125201025|NCT02100670|450357692|FG001|Overall Study|Physician Decision|1|||
125201026|NCT02100670|450357693|FG002|Overall Study|Physician Decision|0|||
125201027|NCT02100670|450357694|FG003|Overall Study|Physician Decision|0|||
125201028|NCT02100670|450357691|FG000|Overall Study|Withdrawal by Subject|1|||
125201029|NCT02100670|450357692|FG001|Overall Study|Withdrawal by Subject|0|||
125201030|NCT02100670|450357693|FG002|Overall Study|Withdrawal by Subject|0|||
125201031|NCT02100670|450357694|FG003|Overall Study|Withdrawal by Subject|0|||
125201032|NCT04852679|450357695|FG000|Main Intervention Period|Withdrawal by Subject|3|||
125201033|NCT04852679|450357695|FG000|Main Intervention Period|Adverse Event|1|||
125201034|NCT04852679|450357695|FG000|Main Intervention Period|Progressive Disease|16|||
125201035|NCT04852679|450357695|FG000|Main Intervention Period|Refused study visit|1|||
125201036|NCT04852679|450357695|FG000|Independent Injection Period|Missed study visit|1|||
125201037|NCT01294696|450357696|FG000|Overall Study|Screening failures|7|||
125201038|NCT01294696|450357696|FG000|Overall Study|Protocol Violation|8|||
125201039|NCT01294696|450357696|FG000|Overall Study|Missing BPI Response|7|||
125201040|NCT01294696|450357696|FG000|Overall Study|Site closure|52|||
125201041|NCT03339726|450359577|FG000|Overall Study|Withdrawal by Subject|1|||
125201042|NCT03339726|450359578|FG001|Overall Study|Withdrawal by Subject|0|||
125201043|NCT03339726|450359579|FG002|Overall Study|Withdrawal by Subject|0|||
125201044|NCT03339726|450359577|FG000|Overall Study|Lost to Follow-up|0|||
125201045|NCT03339726|450359578|FG001|Overall Study|Lost to Follow-up|1|||
125201046|NCT03339726|450359579|FG002|Overall Study|Lost to Follow-up|0|||
125201047|NCT01275755|450359580|FG000|Double-blind Treatment Period|Adverse Event|0|||
125201048|NCT01275755|450359581|FG001|Double-blind Treatment Period|Adverse Event|2|||
125201049|NCT01275755|450359580|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
125201050|NCT01275755|450359581|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
125201051|NCT01275755|450359580|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
125201052|NCT01275755|450359581|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
125201053|NCT01275755|450359580|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
125201054|NCT01275755|450359581|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
125201055|NCT00636194|450359587|FG000|Overall Study|Study related symptoms and complaints|1|||
125201056|NCT00636194|450359588|FG001|Overall Study|Study related symptoms and complaints|0|||
125201057|NCT00636194|450359587|FG000|Overall Study|Protocol Violation|2|||
125201058|NCT00636194|450359588|FG001|Overall Study|Protocol Violation|0|||
125201059|NCT04934189|450359593|FG000|Overall Study|Lost to Follow-up|4|||
125201060|NCT04934189|450359593|FG000|Overall Study|Withdrawal by Subject|17|||
125201061|NCT03962790|450359594|FG000|Period 1|Adverse Event|0|||
125201062|NCT03962790|450359595|FG001|Period 1|Adverse Event|1|||
125201063|NCT03962790|450359594|FG000|Period 1|Failed to meet all eligibility criteria|1|||
125201064|NCT03962790|450359595|FG001|Period 1|Failed to meet all eligibility criteria|1|||
125201065|NCT03962790|450359594|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
125201066|NCT03962790|450359595|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
125201067|NCT03962790|450359594|FG000|Period 1|Withdrawal by Subject|1|||
125201068|NCT03962790|450359595|FG001|Period 1|Withdrawal by Subject|0|||
125201069|NCT01286168|450359597|FG000|Overall Study|Withdrawal by Subject|1|||
125201070|NCT01286168|450359597|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
125201071|NCT04598451|450359598|FG000|Overall Study|Adverse Event|3|||
125201072|NCT04598451|450359599|FG001|Overall Study|Adverse Event|2|||
125201073|NCT04598451|450359598|FG000|Overall Study|Withdrawal by Subject|3|||
125201074|NCT04598451|450359599|FG001|Overall Study|Withdrawal by Subject|7|||
125201075|NCT04598451|450359598|FG000|Overall Study|Lost to Follow-up|2|||
125201076|NCT04598451|450359599|FG001|Overall Study|Lost to Follow-up|0|||
125201077|NCT04598451|450359598|FG000|Overall Study|Physician Decision|4|||
125201078|NCT04598451|450359599|FG001|Overall Study|Physician Decision|1|||
125201079|NCT04598451|450359598|FG000|Overall Study|Requires Prohibited Medication|1|||
125201080|NCT04598451|450359599|FG001|Overall Study|Requires Prohibited Medication|0|||
125201081|NCT04598451|450359598|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
125201082|NCT04598451|450359599|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
125201083|NCT04594941|450359605|FG000|Overall Study|Other|0|||
125201084|NCT04594941|450359606|FG001|Overall Study|Other|3|||
125201085|NCT04594941|450359607|FG002|Overall Study|Other|1|||
125201086|NCT04594941|450359608|FG003|Overall Study|Other|0|||
125201087|NCT03535194|450359609|FG000|Induction Period|Adverse Event|2|||
125201088|NCT03535194|450359610|FG001|Induction Period|Adverse Event|2|||
125201089|NCT03535194|450359611|FG002|Induction Period|Adverse Event|1|||
125201090|NCT03535194|450359612|FG003|Induction Period|Adverse Event|3|||
125201091|NCT03535194|450359613|FG004|Induction Period|Adverse Event|0|||
125201092|NCT03535194|450359609|FG000|Induction Period|Death|0|||
125201093|NCT03535194|450359610|FG001|Induction Period|Death|1|||
125201094|NCT03535194|450359611|FG002|Induction Period|Death|0|||
125201095|NCT03535194|450359612|FG003|Induction Period|Death|0|||
125201096|NCT03535194|450359613|FG004|Induction Period|Death|0|||
125201097|NCT03535194|450359609|FG000|Induction Period|Lack of Efficacy|1|||
125201098|NCT03535194|450359610|FG001|Induction Period|Lack of Efficacy|3|||
125201099|NCT03535194|450359611|FG002|Induction Period|Lack of Efficacy|2|||
125201100|NCT03535194|450359612|FG003|Induction Period|Lack of Efficacy|2|||
125201101|NCT03535194|450359613|FG004|Induction Period|Lack of Efficacy|0|||
125201102|NCT03535194|450359609|FG000|Induction Period|Lost to Follow-up|3|||
125201103|NCT03535194|450359610|FG001|Induction Period|Lost to Follow-up|5|||
125201104|NCT03535194|450359611|FG002|Induction Period|Lost to Follow-up|2|||
125201105|NCT03535194|450359612|FG003|Induction Period|Lost to Follow-up|3|||
125201106|NCT03535194|450359613|FG004|Induction Period|Lost to Follow-up|0|||
125201107|NCT03535194|450359609|FG000|Induction Period|Physician Decision|1|||
125201108|NCT03535194|450359610|FG001|Induction Period|Physician Decision|1|||
125201109|NCT03535194|450359611|FG002|Induction Period|Physician Decision|0|||
125201110|NCT03535194|450359612|FG003|Induction Period|Physician Decision|0|||
125201111|NCT03535194|450359613|FG004|Induction Period|Physician Decision|0|||
125201112|NCT03535194|450359609|FG000|Induction Period|Protocol Violation|1|||
125201113|NCT03535194|450359610|FG001|Induction Period|Protocol Violation|0|||
125201114|NCT03535194|450359611|FG002|Induction Period|Protocol Violation|0|||
125201115|NCT03535194|450359612|FG003|Induction Period|Protocol Violation|1|||
125201116|NCT03535194|450359613|FG004|Induction Period|Protocol Violation|0|||
125201117|NCT03535194|450359609|FG000|Induction Period|Screen Failure|0|||
125201118|NCT03535194|450359610|FG001|Induction Period|Screen Failure|1|||
125201119|NCT03535194|450359611|FG002|Induction Period|Screen Failure|0|||
125201120|NCT03535194|450359612|FG003|Induction Period|Screen Failure|0|||
125201121|NCT03535194|450359613|FG004|Induction Period|Screen Failure|0|||
125201122|NCT03535194|450359609|FG000|Induction Period|Withdrawal by Subject|3|||
125201123|NCT03535194|450359610|FG001|Induction Period|Withdrawal by Subject|4|||
125201124|NCT03535194|450359611|FG002|Induction Period|Withdrawal by Subject|3|||
125201125|NCT03535194|450359612|FG003|Induction Period|Withdrawal by Subject|2|||
125201126|NCT03535194|450359613|FG004|Induction Period|Withdrawal by Subject|0|||
125201127|NCT03535194|450359609|FG000|Maintenance Period|Adverse Event|6|||
125201128|NCT03535194|450359610|FG001|Maintenance Period|Adverse Event|5|||
125201129|NCT03535194|450359611|FG002|Maintenance Period|Adverse Event|1|||
125201130|NCT03535194|450359612|FG003|Maintenance Period|Adverse Event|11|||
125201131|NCT03535194|450359613|FG004|Maintenance Period|Adverse Event|4|||
125201132|NCT03535194|450359609|FG000|Maintenance Period|Lack of Efficacy|3|||
125201133|NCT03535194|450359610|FG001|Maintenance Period|Lack of Efficacy|2|||
125201134|NCT03535194|450359611|FG002|Maintenance Period|Lack of Efficacy|5|||
125201135|NCT03535194|450359612|FG003|Maintenance Period|Lack of Efficacy|9|||
125201136|NCT03535194|450359613|FG004|Maintenance Period|Lack of Efficacy|0|||
125201137|NCT03535194|450359609|FG000|Maintenance Period|Lost to Follow-up|4|||
125201138|NCT03535194|450359610|FG001|Maintenance Period|Lost to Follow-up|2|||
125201139|NCT03535194|450359611|FG002|Maintenance Period|Lost to Follow-up|1|||
125201140|NCT03535194|450359612|FG003|Maintenance Period|Lost to Follow-up|5|||
125201141|NCT03535194|450359613|FG004|Maintenance Period|Lost to Follow-up|2|||
125201142|NCT03535194|450359609|FG000|Maintenance Period|Other|1|||
125201143|NCT03535194|450359610|FG001|Maintenance Period|Other|2|||
125201144|NCT03535194|450359611|FG002|Maintenance Period|Other|0|||
125201145|NCT03535194|450359612|FG003|Maintenance Period|Other|0|||
125201146|NCT03535194|450359613|FG004|Maintenance Period|Other|0|||
125201147|NCT03535194|450359609|FG000|Maintenance Period|Physician Decision|1|||
125201148|NCT03535194|450359610|FG001|Maintenance Period|Physician Decision|2|||
125201149|NCT03535194|450359611|FG002|Maintenance Period|Physician Decision|0|||
125201150|NCT03535194|450359612|FG003|Maintenance Period|Physician Decision|2|||
125201151|NCT03535194|450359613|FG004|Maintenance Period|Physician Decision|0|||
125201152|NCT03535194|450359609|FG000|Maintenance Period|Pregnancy|0|||
125201153|NCT03535194|450359610|FG001|Maintenance Period|Pregnancy|0|||
125201154|NCT03535194|450359611|FG002|Maintenance Period|Pregnancy|0|||
125201155|NCT03535194|450359612|FG003|Maintenance Period|Pregnancy|2|||
125201156|NCT03535194|450359613|FG004|Maintenance Period|Pregnancy|0|||
125201157|NCT03535194|450359609|FG000|Maintenance Period|Protocol Violation|0|||
125201158|NCT03535194|450359610|FG001|Maintenance Period|Protocol Violation|1|||
125201159|NCT03535194|450359611|FG002|Maintenance Period|Protocol Violation|0|||
125201160|NCT03535194|450359612|FG003|Maintenance Period|Protocol Violation|0|||
125201161|NCT03535194|450359613|FG004|Maintenance Period|Protocol Violation|0|||
125201162|NCT03535194|450359609|FG000|Maintenance Period|Withdrawal by Subject|7|||
125201163|NCT03535194|450359610|FG001|Maintenance Period|Withdrawal by Subject|2|||
125201164|NCT03535194|450359611|FG002|Maintenance Period|Withdrawal by Subject|1|||
125201165|NCT03535194|450359612|FG003|Maintenance Period|Withdrawal by Subject|8|||
125201166|NCT03535194|450359613|FG004|Maintenance Period|Withdrawal by Subject|0|||
125201167|NCT03535194|450359609|FG000|Post-Treatment Followup Period|Adverse Event|4|||
125201168|NCT03535194|450359610|FG001|Post-Treatment Followup Period|Adverse Event|5|||
125201169|NCT03535194|450359611|FG002|Post-Treatment Followup Period|Adverse Event|1|||
125201170|NCT03535194|450359612|FG003|Post-Treatment Followup Period|Adverse Event|8|||
125217435|NCT01348100|450423522|FG002|Overall Study|Lost to Follow-up|0|||
125201171|NCT03535194|450359613|FG004|Post-Treatment Followup Period|Adverse Event|0|||
125201172|NCT03535194|450359609|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
125201173|NCT03535194|450359610|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
125201174|NCT03535194|450359611|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
125201175|NCT03535194|450359612|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
125201176|NCT03535194|450359613|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
125201177|NCT03535194|450359609|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
125201178|NCT03535194|450359610|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
125201179|NCT03535194|450359611|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
125201180|NCT03535194|450359612|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
125201181|NCT03535194|450359613|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
125201182|NCT03535194|450359609|FG000|Post-Treatment Followup Period|Other|1|||
125201183|NCT03535194|450359610|FG001|Post-Treatment Followup Period|Other|0|||
125201184|NCT03535194|450359611|FG002|Post-Treatment Followup Period|Other|0|||
125201185|NCT03535194|450359612|FG003|Post-Treatment Followup Period|Other|5|||
125201186|NCT03535194|450359613|FG004|Post-Treatment Followup Period|Other|0|||
125201187|NCT03535194|450359609|FG000|Post-Treatment Followup Period|Physician Decision|0|||
125201188|NCT03535194|450359610|FG001|Post-Treatment Followup Period|Physician Decision|2|||
125201189|NCT03535194|450359611|FG002|Post-Treatment Followup Period|Physician Decision|1|||
125201190|NCT03535194|450359612|FG003|Post-Treatment Followup Period|Physician Decision|1|||
125201191|NCT03535194|450359613|FG004|Post-Treatment Followup Period|Physician Decision|0|||
125201192|NCT03535194|450359609|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
125201193|NCT03535194|450359610|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
125201194|NCT03535194|450359611|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
125201195|NCT03535194|450359612|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
125201196|NCT03535194|450359613|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125201197|NCT02091960|450359614|FG000|Overall Study|Death|7|||
125201198|NCT02091960|450359614|FG000|Overall Study|Withdrawal by Subject|1|||
125201199|NCT02091960|450359614|FG000|Overall Study|Miscellaneous Reasons|37|||
125201200|NCT02424630|450359627|FG000|Overall Study|No rotator cuff tear|1|||
125201201|NCT02424630|450359628|FG001|Overall Study|No rotator cuff tear|2|||
125201202|NCT02424630|450359627|FG000|Overall Study|Open procedure|0|||
125201203|NCT02424630|450359628|FG001|Overall Study|Open procedure|1|||
125201204|NCT02703272|450359629|FG000|Overall Study|Death|4|||
125201205|NCT02703272|450359630|FG001|Overall Study|Death|9|||
125201206|NCT02703272|450359631|FG002|Overall Study|Death|19|||
125201207|NCT02703272|450359632|FG003|Overall Study|Death|10|||
125201208|NCT02703272|450359629|FG000|Overall Study|Withdrawal by Subject|0|||
125201209|NCT02703272|450359630|FG001|Overall Study|Withdrawal by Subject|0|||
125201210|NCT02703272|450359631|FG002|Overall Study|Withdrawal by Subject|4|||
125201211|NCT02703272|450359632|FG003|Overall Study|Withdrawal by Subject|2|||
125201212|NCT02703272|450359629|FG000|Overall Study|Study Terminated by Sponsor|6|||
125201213|NCT02703272|450359630|FG001|Overall Study|Study Terminated by Sponsor|1|||
125201214|NCT02703272|450359631|FG002|Overall Study|Study Terminated by Sponsor|12|||
125201215|NCT02703272|450359632|FG003|Overall Study|Study Terminated by Sponsor|4|||
125201216|NCT02703272|450359629|FG000|Overall Study|Other|1|||
125201217|NCT02703272|450359630|FG001|Overall Study|Other|0|||
125201218|NCT02703272|450359631|FG002|Overall Study|Other|0|||
125201219|NCT02703272|450359632|FG003|Overall Study|Other|0|||
125201220|NCT02637895|450359635|FG000|Overall Study|Lost to Follow-up|4|||
125201221|NCT02637895|450359636|FG001|Overall Study|Lost to Follow-up|0|||
125201222|NCT02637895|450359635|FG000|Overall Study|Protocol Violation|0|||
125201223|NCT02637895|450359636|FG001|Overall Study|Protocol Violation|1|||
125201224|NCT02637895|450359635|FG000|Overall Study|Lack of Efficacy|1|||
125201225|NCT02637895|450359636|FG001|Overall Study|Lack of Efficacy|0|||
125201226|NCT02637895|450359635|FG000|Overall Study|Withdrawal by Subject|1|||
125201227|NCT02637895|450359636|FG001|Overall Study|Withdrawal by Subject|1|||
125201228|NCT02637895|450359635|FG000|Overall Study|Abnormal baseline lab|0|||
125201229|NCT02637895|450359636|FG001|Overall Study|Abnormal baseline lab|1|||
125201230|NCT02005692|450359637|FG000|Overall Study|Protocol Violation|1|||
125201231|NCT02005692|450359637|FG000|Overall Study|Withdrawal by Subject|1|||
125201232|NCT02005692|450359637|FG000|Overall Study|Discharged earlier than anticipated|5|||
125201233|NCT02091375|450359639|FG000|Overall Study|Adverse Event|8|||
125201234|NCT02091375|450359640|FG001|Overall Study|Adverse Event|1|||
125201235|NCT02091375|450359639|FG000|Overall Study|Lost to Follow-up|0|||
125201236|NCT02091375|450359640|FG001|Overall Study|Lost to Follow-up|1|||
125201237|NCT02091375|450359639|FG000|Overall Study|Withdrawal by Subject|0|||
125201238|NCT02091375|450359640|FG001|Overall Study|Withdrawal by Subject|1|||
125201239|NCT02091375|450359639|FG000|Overall Study|Withdrawn by the investigator|1|||
125201240|NCT02091375|450359640|FG001|Overall Study|Withdrawn by the investigator|0|||
125201241|NCT02682823|450359641|FG000|Overall Study|Withdrawal by Subject|0|||
125201242|NCT02682823|450359642|FG001|Overall Study|Withdrawal by Subject|0|||
125201243|NCT02682823|450359643|FG002|Overall Study|Withdrawal by Subject|1|||
125201244|NCT02682823|450359644|FG003|Overall Study|Withdrawal by Subject|0|||
125201245|NCT02682823|450359645|FG004|Overall Study|Withdrawal by Subject|1|||
125201246|NCT02682823|450359641|FG000|Overall Study|Protocol Deviation|0|||
125201247|NCT02682823|450359642|FG001|Overall Study|Protocol Deviation|1|||
125201248|NCT02682823|450359643|FG002|Overall Study|Protocol Deviation|0|||
125201249|NCT02682823|450359644|FG003|Overall Study|Protocol Deviation|0|||
125201250|NCT02682823|450359645|FG004|Overall Study|Protocol Deviation|0|||
125201251|NCT02682823|450359641|FG000|Overall Study|Adverse Event|0|||
125201252|NCT02682823|450359642|FG001|Overall Study|Adverse Event|0|||
125201253|NCT02682823|450359643|FG002|Overall Study|Adverse Event|0|||
125201254|NCT02682823|450359644|FG003|Overall Study|Adverse Event|1|||
125201255|NCT02682823|450359645|FG004|Overall Study|Adverse Event|0|||
125201256|NCT02122770|450359649|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
125201257|NCT02122770|450359650|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
125201258|NCT02122770|450359651|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
125201259|NCT02122770|450359652|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
125201260|NCT02122770|450359653|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
125201261|NCT02122770|450359654|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
125201262|NCT02122770|450359649|FG000|Part A: Drug-drug Interaction 2|Other|0|||
125201263|NCT02122770|450359650|FG001|Part A: Drug-drug Interaction 2|Other|0|||
125201264|NCT02122770|450359651|FG002|Part A: Drug-drug Interaction 2|Other|1|||
125201265|NCT02122770|450359652|FG003|Part A: Drug-drug Interaction 2|Other|0|||
125201266|NCT02122770|450359653|FG004|Part A: Drug-drug Interaction 2|Other|0|||
125201267|NCT02122770|450359654|FG005|Part A: Drug-drug Interaction 2|Other|0|||
125201268|NCT02122770|450359649|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
125201269|NCT02122770|450359650|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
125201270|NCT02122770|450359651|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
125201271|NCT02122770|450359652|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
125201272|NCT02122770|450359653|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
125201273|NCT02122770|450359654|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
125201274|NCT02122770|450359649|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
125201275|NCT02122770|450359650|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
125201276|NCT02122770|450359651|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
125201277|NCT02122770|450359652|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
125201278|NCT02122770|450359653|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
125201279|NCT02122770|450359654|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
125201280|NCT02122770|450359649|FG000|Part B: Standard of Care|Adverse Event|0|||
125201281|NCT02122770|450359650|FG001|Part B: Standard of Care|Adverse Event|0|||
125201282|NCT02122770|450359651|FG002|Part B: Standard of Care|Adverse Event|0|||
125201283|NCT02122770|450359652|FG003|Part B: Standard of Care|Adverse Event|0|||
125201284|NCT02122770|450359653|FG004|Part B: Standard of Care|Adverse Event|4|||
125201285|NCT02122770|450359654|FG005|Part B: Standard of Care|Adverse Event|1|||
125201286|NCT02122770|450359649|FG000|Part B: Standard of Care|Other|0|||
125201287|NCT02122770|450359650|FG001|Part B: Standard of Care|Other|0|||
125201288|NCT02122770|450359651|FG002|Part B: Standard of Care|Other|0|||
125201289|NCT02122770|450359652|FG003|Part B: Standard of Care|Other|0|||
125201290|NCT02122770|450359653|FG004|Part B: Standard of Care|Other|0|||
125201291|NCT02122770|450359654|FG005|Part B: Standard of Care|Other|2|||
125201292|NCT02122770|450359649|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
125201293|NCT02122770|450359650|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
125201294|NCT02122770|450359651|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
125201295|NCT02122770|450359652|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
125201296|NCT02122770|450359653|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
125201297|NCT02122770|450359654|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
125201298|NCT02122770|450359649|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
125201299|NCT02122770|450359650|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
125201300|NCT02122770|450359651|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
125201301|NCT02122770|450359652|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
125201302|NCT02122770|450359653|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
125201303|NCT02122770|450359654|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
125201304|NCT02122770|450359649|FG000|Part B: Standard of Care|Progressive Disease|0|||
125201305|NCT02122770|450359650|FG001|Part B: Standard of Care|Progressive Disease|0|||
125201306|NCT02122770|450359651|FG002|Part B: Standard of Care|Progressive Disease|0|||
125201307|NCT02122770|450359652|FG003|Part B: Standard of Care|Progressive Disease|0|||
125201308|NCT02122770|450359653|FG004|Part B: Standard of Care|Progressive Disease|10|||
125201309|NCT02122770|450359654|FG005|Part B: Standard of Care|Progressive Disease|8|||
125201310|NCT00189306|450359656|FG000|Treatment Period|Withdrawal by Subject|2|||
125201311|NCT00189306|450359656|FG000|Treatment Period|Adverse Event|2|||
125201312|NCT00189306|450359656|FG000|Treatment Period|Protocol Violation|1|||
125201313|NCT00189306|450359656|FG000|Posttreatment Period|Death|1|||
125201314|NCT00189306|450359656|FG000|Posttreatment Period|Withdrawal by Subject|2|||
125201315|NCT00189306|450359656|FG000|Posttreatment Period|Noncompliance|1|||
125201316|NCT00189306|450359656|FG000|Posttreatment Period|Target lesion excised|1|||
125201317|NCT00189306|450359656|FG000|Posttreatment Period|Protocol Violation|1|||
125201318|NCT00189306|450359656|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
125201319|NCT00189306|450359656|FG000|Posttreatment Period|Local skin reaction/sign|1|||
125201320|NCT00189306|450359656|FG000|Long-Term Follow-up|Adverse Event|2|||
125201321|NCT00189306|450359656|FG000|Long-Term Follow-up|Death|4|||
125201322|NCT00189306|450359656|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
125201323|NCT00189306|450359656|FG000|Long-Term Follow-up|Intercurrent disease|2|||
125201324|NCT00189306|450359656|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
125201325|NCT00189306|450359656|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
125201326|NCT03640481|450359657|FG000|Overall Study|Death|14|||
125201327|NCT03640481|450359658|FG001|Overall Study|Death|14|||
125201328|NCT03640481|450359659|FG002|Overall Study|Death|0|||
125201329|NCT03640481|450359660|FG003|Overall Study|Death|0|||
125201330|NCT03640481|450359657|FG000|Overall Study|Lost to Follow-up|2|||
125201331|NCT03640481|450359658|FG001|Overall Study|Lost to Follow-up|0|||
125201332|NCT03640481|450359659|FG002|Overall Study|Lost to Follow-up|0|||
125201333|NCT03640481|450359660|FG003|Overall Study|Lost to Follow-up|0|||
125201334|NCT03640481|450359657|FG000|Overall Study|Site terminated by sponsor|1|||
125201335|NCT03640481|450359658|FG001|Overall Study|Site terminated by sponsor|3|||
125201336|NCT03640481|450359659|FG002|Overall Study|Site terminated by sponsor|0|||
125201337|NCT03640481|450359660|FG003|Overall Study|Site terminated by sponsor|0|||
125201338|NCT03640481|450359657|FG000|Overall Study|Study terminated by sponsor|29|||
125201339|NCT03640481|450359658|FG001|Overall Study|Study terminated by sponsor|42|||
125201340|NCT03640481|450359659|FG002|Overall Study|Study terminated by sponsor|1|||
125201341|NCT03640481|450359660|FG003|Overall Study|Study terminated by sponsor|0|||
125201342|NCT03640481|450359657|FG000|Overall Study|Withdrawal by Subject|5|||
125201343|NCT03640481|450359658|FG001|Overall Study|Withdrawal by Subject|4|||
125201344|NCT03640481|450359659|FG002|Overall Study|Withdrawal by Subject|0|||
125201345|NCT03640481|450359660|FG003|Overall Study|Withdrawal by Subject|1|||
125201346|NCT03640481|450359657|FG000|Overall Study|Other|26|||
125201347|NCT03640481|450359658|FG001|Overall Study|Other|12|||
125201348|NCT03640481|450359659|FG002|Overall Study|Other|1|||
125201349|NCT03640481|450359660|FG003|Overall Study|Other|0|||
125201350|NCT03640481|450359657|FG000|Overall Study|Randomized, but not treated|1|||
125201351|NCT03640481|450359658|FG001|Overall Study|Randomized, but not treated|3|||
125201352|NCT03640481|450359659|FG002|Overall Study|Randomized, but not treated|0|||
125201353|NCT03640481|450359660|FG003|Overall Study|Randomized, but not treated|0|||
125201354|NCT00535847|450359661|FG000|Overall Study|Adverse Event|5|||
125201355|NCT00535847|450359662|FG001|Overall Study|Adverse Event|3|||
125201356|NCT00535847|450359663|FG002|Overall Study|Adverse Event|2|||
125201357|NCT00535847|450359661|FG000|Overall Study|Non compliance|1|||
125201358|NCT00535847|450359662|FG001|Overall Study|Non compliance|1|||
125201359|NCT00535847|450359663|FG002|Overall Study|Non compliance|0|||
125201360|NCT00535847|450359661|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
125201361|NCT00535847|450359662|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
125201362|NCT00535847|450359663|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
125201363|NCT00727844|450359664|FG000|Initial Randomization|Physician Decision|2|||
125201364|NCT00727844|450359665|FG001|Initial Randomization|Physician Decision|0|||
125201365|NCT00727844|450359666|FG002|Initial Randomization|Physician Decision|0|||
125201366|NCT00727844|450359667|FG003|Initial Randomization|Physician Decision|0|||
125201367|NCT04569968|450359668|FG000|Overall Study|Lost to Follow-up|2|||
125201368|NCT04569968|450359669|FG001|Overall Study|Lost to Follow-up|5|||
125201369|NCT04569968|450359668|FG000|Overall Study|Story of head and/or neck surgery|2|||
125201370|NCT04569968|450359669|FG001|Overall Study|Story of head and/or neck surgery|2|||
125201371|NCT04569968|450359668|FG000|Overall Study|Time of stroke onset|8|||
125201372|NCT04569968|450359669|FG001|Overall Study|Time of stroke onset|7|||
125201373|NCT04569968|450359668|FG000|Overall Study|Type of strokr|12|||
125201374|NCT04569968|450359669|FG001|Overall Study|Type of strokr|8|||
125201375|NCT04569968|450359668|FG000|Overall Study|Cooperation|8|||
125201376|NCT04569968|450359669|FG001|Overall Study|Cooperation|8|||
125201377|NCT04569968|450359668|FG000|Overall Study|Age interval|17|||
125201378|NCT04569968|450359669|FG001|Overall Study|Age interval|6|||
125201379|NCT04569968|450359668|FG000|Overall Study|Denial of participation to the study|0|||
125201380|NCT04569968|450359669|FG001|Overall Study|Denial of participation to the study|3|||
125201381|NCT04569968|450359668|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
125201382|NCT04569968|450359669|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
125201383|NCT04569968|450359668|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
125201384|NCT04569968|450359669|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
125201385|NCT04569968|450359668|FG000|Overall Study|Quarantine|1|||
125201386|NCT04569968|450359669|FG001|Overall Study|Quarantine|0|||
125201387|NCT04569968|450359668|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
125201388|NCT04569968|450359669|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
125201389|NCT04569968|450359668|FG000|Overall Study|Repetitive stroke|8|||
125201390|NCT04569968|450359669|FG001|Overall Study|Repetitive stroke|0|||
125201391|NCT04569968|450359668|FG000|Overall Study|Insufficient mastication|1|||
125201392|NCT04569968|450359669|FG001|Overall Study|Insufficient mastication|0|||
125201393|NCT04569968|450359668|FG000|Overall Study|Infection|1|||
125201394|NCT04569968|450359669|FG001|Overall Study|Infection|0|||
125201395|NCT00373958|450359670|FG000|Infant Series|Withdrawal by Subject|13|||
125201396|NCT00373958|450359671|FG001|Infant Series|Withdrawal by Subject|15|||
125201397|NCT00373958|450359670|FG000|Infant Series|Failed to return|8|||
125201398|NCT00373958|450359671|FG001|Infant Series|Failed to return|13|||
125201399|NCT00373958|450359670|FG000|Infant Series|Lost to Follow-up|6|||
125201400|NCT00373958|450359671|FG001|Infant Series|Lost to Follow-up|5|||
125201401|NCT00373958|450359670|FG000|Infant Series|Protocol Violation|3|||
125201402|NCT00373958|450359671|FG001|Infant Series|Protocol Violation|7|||
125201403|NCT00373958|450359670|FG000|Infant Series|Lost Kaiser coverage|4|||
125201404|NCT00373958|450359671|FG001|Infant Series|Lost Kaiser coverage|0|||
125201405|NCT00373958|450359670|FG000|Infant Series|Child relocated|1|||
125201406|NCT00373958|450359671|FG001|Infant Series|Child relocated|0|||
125201407|NCT00373958|450359670|FG000|Infant Series|Consent was not received|1|||
125201408|NCT00373958|450359671|FG001|Infant Series|Consent was not received|0|||
125201409|NCT00373958|450359670|FG000|Infant Series|Adverse Event|3|||
125201410|NCT00373958|450359671|FG001|Infant Series|Adverse Event|1|||
125201411|NCT00373958|450359670|FG000|Infant Series|Physician Decision|1|||
125201412|NCT00373958|450359671|FG001|Infant Series|Physician Decision|1|||
125201413|NCT00373958|450359670|FG000|Toddler Dose|Lost to Follow-up|5|||
125201414|NCT00373958|450359671|FG001|Toddler Dose|Lost to Follow-up|8|||
125201415|NCT00373958|450359670|FG000|Toddler Dose|Withdrawal by Subject|2|||
125201416|NCT00373958|450359671|FG001|Toddler Dose|Withdrawal by Subject|2|||
125201417|NCT00373958|450359670|FG000|Toddler Dose|Failed to return|1|||
125201418|NCT00373958|450359671|FG001|Toddler Dose|Failed to return|2|||
125201419|NCT00373958|450359670|FG000|Toddler Dose|Protocol Violation|0|||
125201420|NCT00373958|450359671|FG001|Toddler Dose|Protocol Violation|1|||
125201421|NCT00373958|450359670|FG000|Toddler Dose|Withdrawn after infant series|22|||
125201422|NCT00373958|450359671|FG001|Toddler Dose|Withdrawn after infant series|25|||
125201423|NCT05007041|450359672|FG000|Overall Study|Missing Diary Entries|0|||
125201424|NCT05007041|450359673|FG001|Overall Study|Missing Diary Entries|1|||
125201425|NCT01552915|450359674|FG000|Overall Study|Adverse Event|3|||
125201426|NCT01552915|450359675|FG001|Overall Study|Adverse Event|14|||
125201427|NCT01552915|450359676|FG002|Overall Study|Adverse Event|3|||
125201428|NCT01552915|450359674|FG000|Overall Study|Lost to Follow-up|4|||
125201429|NCT01552915|450359675|FG001|Overall Study|Lost to Follow-up|6|||
125201430|NCT01552915|450359676|FG002|Overall Study|Lost to Follow-up|5|||
125201431|NCT01552915|450359674|FG000|Overall Study|Withdrawal by Subject|6|||
125201432|NCT01552915|450359675|FG001|Overall Study|Withdrawal by Subject|4|||
125201433|NCT01552915|450359676|FG002|Overall Study|Withdrawal by Subject|5|||
125201434|NCT01552915|450359674|FG000|Overall Study|Protocol Violation|0|||
125201435|NCT01552915|450359675|FG001|Overall Study|Protocol Violation|4|||
125201436|NCT01552915|450359676|FG002|Overall Study|Protocol Violation|4|||
125201437|NCT01552915|450359674|FG000|Overall Study|Lack of Efficacy|8|||
125201438|NCT01552915|450359675|FG001|Overall Study|Lack of Efficacy|1|||
125201439|NCT01552915|450359676|FG002|Overall Study|Lack of Efficacy|4|||
125201440|NCT01552915|450359674|FG000|Overall Study|Other|2|||
125201441|NCT01552915|450359675|FG001|Overall Study|Other|0|||
125201442|NCT01552915|450359676|FG002|Overall Study|Other|6|||
125201443|NCT02850016|450359679|FG000|Overall Study|Withdrawal by Subject|1|||
125201444|NCT02850016|450359680|FG001|Overall Study|Withdrawal by Subject|2|||
125201445|NCT02457832|450359681|FG000|Training|Lost to Follow-up|10|||
125201446|NCT02457832|450359682|FG001|Training|Lost to Follow-up|6|||
125201447|NCT02457832|450359683|FG002|Training|Lost to Follow-up|3|||
125201448|NCT02457832|450359681|FG000|One Month Washout|Lost to Follow-up|0|||
125201449|NCT02457832|450359682|FG001|One Month Washout|Lost to Follow-up|1|||
125201450|NCT02457832|450359683|FG002|One Month Washout|Lost to Follow-up|1|||
125201451|NCT00423189|450359684|FG000|Overall Study|Death|0|||
125201452|NCT00423189|450359685|FG001|Overall Study|Death|1|||
125201453|NCT00423189|450359686|FG002|Overall Study|Death|0|||
125201454|NCT03973918|450359691|FG000|Overall Study|Adverse Event|0|||
125201455|NCT03973918|450359692|FG001|Overall Study|Adverse Event|0|||
125201456|NCT03973918|450359693|FG002|Overall Study|Adverse Event|0|||
125201457|NCT03973918|450359694|FG003|Overall Study|Adverse Event|1|||
125201458|NCT03973918|450359691|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
125201459|NCT03973918|450359692|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
125201460|NCT03973918|450359693|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
125201461|NCT03973918|450359694|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
125201462|NCT02951533|450359698|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
125201463|NCT02951533|450359699|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
125201464|NCT02951533|450359700|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
125201465|NCT02951533|450359698|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
125201466|NCT02951533|450359699|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
125201467|NCT02951533|450359700|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
125201468|NCT02951533|450359698|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
125201469|NCT02951533|450359699|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
125201470|NCT02951533|450359700|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
125201471|NCT02951533|450359698|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
125201472|NCT02951533|450359699|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
125201473|NCT02951533|450359700|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
125201474|NCT02951533|450359698|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
125201475|NCT02951533|450359699|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
125201476|NCT02951533|450359700|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
125201477|NCT02951533|450359698|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
125201478|NCT02951533|450359699|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
125201479|NCT02951533|450359700|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
125201480|NCT02951533|450359698|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
125201481|NCT02951533|450359699|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
125201482|NCT02951533|450359700|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
125201483|NCT02951533|450359698|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
125201484|NCT02951533|450359699|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
125201485|NCT02951533|450359700|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
125201486|NCT02951533|450359698|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
125201487|NCT02951533|450359699|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
125201488|NCT02951533|450359700|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
125201489|NCT02951533|450359698|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
125201490|NCT02951533|450359699|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
125201491|NCT02951533|450359700|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
125201492|NCT02951533|450359698|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
125201493|NCT02951533|450359699|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
125201494|NCT02951533|450359700|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
125201495|NCT01446237|450359709|FG000|Overall Study|Adverse Event|1|||
125201496|NCT01446237|450359709|FG000|Overall Study|Lost to Follow-up|2|||
125201497|NCT01446237|450359709|FG000|Overall Study|Withdrawal by Subject|7|||
125201498|NCT00742508|450359712|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
125201499|NCT00742508|450359713|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
125201500|NCT00742508|450359712|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
125201501|NCT00742508|450359713|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
125201502|NCT00742508|450359712|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
125201503|NCT00742508|450359713|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
125201504|NCT00742508|450359712|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
125201505|NCT00742508|450359713|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
125201506|NCT00742508|450359712|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
125201507|NCT00742508|450359713|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
125201508|NCT04017832|450359714|FG000|Overall Study|Withdrawal by Subject|13|||
125201509|NCT04017832|450359715|FG001|Overall Study|Withdrawal by Subject|12|||
125201510|NCT04017832|450359716|FG002|Overall Study|Withdrawal by Subject|21|||
125201511|NCT04017832|450359717|FG003|Overall Study|Withdrawal by Subject|7|||
125201512|NCT04017832|450359714|FG000|Overall Study|Lost to Follow-up|0|||
125201513|NCT04017832|450359715|FG001|Overall Study|Lost to Follow-up|3|||
125201514|NCT04017832|450359716|FG002|Overall Study|Lost to Follow-up|3|||
125201515|NCT04017832|450359717|FG003|Overall Study|Lost to Follow-up|1|||
125201516|NCT04017832|450359714|FG000|Overall Study|Physician Decision|1|||
125201517|NCT04017832|450359715|FG001|Overall Study|Physician Decision|1|||
125201518|NCT04017832|450359716|FG002|Overall Study|Physician Decision|1|||
125201519|NCT04017832|450359717|FG003|Overall Study|Physician Decision|1|||
125201520|NCT04017832|450359714|FG000|Overall Study|Death|2|||
125201521|NCT04017832|450359715|FG001|Overall Study|Death|2|||
125201522|NCT04017832|450359716|FG002|Overall Study|Death|1|||
125201523|NCT04017832|450359717|FG003|Overall Study|Death|0|||
125201524|NCT01901653|450359723|FG000|Overall Study|Death|2|||
125201525|NCT01901653|450359724|FG001|Overall Study|Death|1|||
125201526|NCT01901653|450359725|FG002|Overall Study|Death|8|||
125201527|NCT01901653|450359726|FG003|Overall Study|Death|3|||
125201528|NCT01901653|450359727|FG004|Overall Study|Death|2|||
125201529|NCT01901653|450359728|FG005|Overall Study|Death|2|||
125201530|NCT01901653|450359729|FG006|Overall Study|Death|6|||
125201531|NCT01901653|450359730|FG007|Overall Study|Death|9|||
125201532|NCT01901653|450359731|FG008|Overall Study|Death|1|||
125201533|NCT01901653|450359732|FG009|Overall Study|Death|16|||
125201534|NCT01901653|450359733|FG010|Overall Study|Death|2|||
125201535|NCT01901653|450359734|FG011|Overall Study|Death|15|||
125201536|NCT01901653|450359735|FG012|Overall Study|Death|4|||
125201537|NCT01901653|450359723|FG000|Overall Study|Lost to Follow-up|1|||
125201538|NCT01901653|450359724|FG001|Overall Study|Lost to Follow-up|0|||
125201539|NCT01901653|450359725|FG002|Overall Study|Lost to Follow-up|2|||
125201540|NCT01901653|450359726|FG003|Overall Study|Lost to Follow-up|0|||
125201541|NCT01901653|450359727|FG004|Overall Study|Lost to Follow-up|0|||
125424849|NCT02157779|451178695|FG000|Overall Study|Moved|1|||
125201542|NCT01901653|450359728|FG005|Overall Study|Lost to Follow-up|1|||
125201543|NCT01901653|450359729|FG006|Overall Study|Lost to Follow-up|0|||
125201544|NCT01901653|450359730|FG007|Overall Study|Lost to Follow-up|1|||
125201545|NCT01901653|450359731|FG008|Overall Study|Lost to Follow-up|0|||
125201546|NCT01901653|450359732|FG009|Overall Study|Lost to Follow-up|0|||
125201547|NCT01901653|450359733|FG010|Overall Study|Lost to Follow-up|0|||
125201548|NCT01901653|450359734|FG011|Overall Study|Lost to Follow-up|0|||
125201549|NCT01901653|450359735|FG012|Overall Study|Lost to Follow-up|0|||
125201550|NCT01901653|450359723|FG000|Overall Study|Withdrawal by Subject|0|||
125201551|NCT01901653|450359724|FG001|Overall Study|Withdrawal by Subject|0|||
125201552|NCT01901653|450359725|FG002|Overall Study|Withdrawal by Subject|0|||
125201553|NCT01901653|450359726|FG003|Overall Study|Withdrawal by Subject|0|||
125201554|NCT01901653|450359727|FG004|Overall Study|Withdrawal by Subject|0|||
125201555|NCT01901653|450359728|FG005|Overall Study|Withdrawal by Subject|0|||
125201556|NCT01901653|450359729|FG006|Overall Study|Withdrawal by Subject|1|||
125201557|NCT01901653|450359730|FG007|Overall Study|Withdrawal by Subject|0|||
125201558|NCT01901653|450359731|FG008|Overall Study|Withdrawal by Subject|0|||
125201559|NCT01901653|450359732|FG009|Overall Study|Withdrawal by Subject|0|||
125201560|NCT01901653|450359733|FG010|Overall Study|Withdrawal by Subject|0|||
125201561|NCT01901653|450359734|FG011|Overall Study|Withdrawal by Subject|0|||
125201562|NCT01901653|450359735|FG012|Overall Study|Withdrawal by Subject|0|||
125201563|NCT01901653|450359723|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
125201564|NCT01901653|450359724|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
125201565|NCT01901653|450359725|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
125201566|NCT01901653|450359726|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
125201567|NCT01901653|450359727|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
125201568|NCT01901653|450359728|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
125201569|NCT01901653|450359729|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
125201570|NCT01901653|450359730|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
125201571|NCT01901653|450359731|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
125201572|NCT01901653|450359732|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
125201573|NCT01901653|450359733|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
125201574|NCT01901653|450359734|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
125201575|NCT01901653|450359735|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
125201576|NCT02091986|450359736|FG000|Overall Study|7 rand in error 1 patient decision|2|||
125201577|NCT02091986|450359737|FG001|Overall Study|7 rand in error 1 patient decision|3|||
125201578|NCT02091986|450359738|FG002|Overall Study|7 rand in error 1 patient decision|3|||
125201579|NCT02091986|450359736|FG000|Overall Study|Lost to Follow-up|1|||
125201580|NCT02091986|450359737|FG001|Overall Study|Lost to Follow-up|0|||
125201581|NCT02091986|450359738|FG002|Overall Study|Lost to Follow-up|0|||
125201582|NCT02091986|450359736|FG000|Overall Study|Withdrawal by Subject|4|||
125201583|NCT02091986|450359737|FG001|Overall Study|Withdrawal by Subject|8|||
125201584|NCT02091986|450359738|FG002|Overall Study|Withdrawal by Subject|3|||
125201585|NCT02091986|450359736|FG000|Overall Study|Adverse Event|0|||
125201586|NCT02091986|450359737|FG001|Overall Study|Adverse Event|0|||
125201587|NCT02091986|450359738|FG002|Overall Study|Adverse Event|2|||
125201588|NCT00957268|450359742|FG000|Overall Study|Voluntary Withdrawal|0|||
125201589|NCT00957268|450359743|FG001|Overall Study|Voluntary Withdrawal|0|||
125201590|NCT00957268|450359744|FG002|Overall Study|Voluntary Withdrawal|1|||
125201591|NCT00957268|450359745|FG003|Overall Study|Voluntary Withdrawal|0|||
125201592|NCT00957268|450359746|FG004|Overall Study|Voluntary Withdrawal|0|||
125201593|NCT00794040|450359747|FG000|Overall Study|Withdrawal by Subject|3|||
125201594|NCT00794040|450359748|FG001|Overall Study|Withdrawal by Subject|4|||
125201595|NCT00794040|450359747|FG000|Overall Study|Physician Decision|0|||
125201596|NCT00794040|450359748|FG001|Overall Study|Physician Decision|1|||
125201597|NCT02396420|450359749|FG000|Overall Study|Death|1|||
125201598|NCT01273623|450359750|FG000|Overall Study|did not meet IVUS criteria|29|||
125201599|NCT04064411|450359751|FG000|Overall Study|Adverse Event|29|||
125201600|NCT04064411|450359752|FG001|Overall Study|Adverse Event|19|||
125201601|NCT04064411|450359751|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
125201602|NCT04064411|450359752|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
125201603|NCT04064411|450359751|FG000|Overall Study|Protocol Deviation|0|||
125201604|NCT04064411|450359752|FG001|Overall Study|Protocol Deviation|2|||
125201605|NCT04064411|450359751|FG000|Overall Study|Withdrawal by Subject|25|||
125201606|NCT04064411|450359752|FG001|Overall Study|Withdrawal by Subject|29|||
125201607|NCT04064411|450359751|FG000|Overall Study|Lost to Follow-up|5|||
125201608|NCT04064411|450359752|FG001|Overall Study|Lost to Follow-up|2|||
125201609|NCT04064411|450359751|FG000|Overall Study|Other than Specified|4|||
125201610|NCT04064411|450359752|FG001|Overall Study|Other than Specified|1|||
125201611|NCT04064411|450359751|FG000|Overall Study|Death|1|||
125201612|NCT04064411|450359752|FG001|Overall Study|Death|0|||
125201613|NCT01970475|450359761|FG000|Overall Study|Withdrawal by Subject|11|||
125201614|NCT01970475|450359762|FG001|Overall Study|Withdrawal by Subject|6|||
125201615|NCT01970475|450359761|FG000|Overall Study|Adverse Event|7|||
125201616|NCT01970475|450359762|FG001|Overall Study|Adverse Event|3|||
125201617|NCT01970475|450359761|FG000|Overall Study|Lost to Follow-up|2|||
125201618|NCT01970475|450359762|FG001|Overall Study|Lost to Follow-up|2|||
125201619|NCT01970475|450359761|FG000|Overall Study|Protocol Violation|1|||
125201620|NCT01970475|450359762|FG001|Overall Study|Protocol Violation|0|||
125201621|NCT00381238|450361465|FG000|Overall Study|Adverse Event|3|||
125201622|NCT00381238|450361465|FG000|Overall Study|Protocol Violation|1|||
125201623|NCT00381238|450361465|FG000|Overall Study|Withdrawal by Subject|4|||
125201624|NCT00381238|450361465|FG000|Overall Study|Lack of Efficacy|2|||
125201625|NCT00381238|450361465|FG000|Overall Study|Withdrew by physician|1|||
125201626|NCT00381238|450361465|FG000|Overall Study|Disease progression|1|||
125201627|NCT02086448|450361469|FG000|Overall Study|Withdrawal by Subject|1|||
125201628|NCT02086448|450361470|FG001|Overall Study|Withdrawal by Subject|0|||
125201629|NCT02086448|450361471|FG002|Overall Study|Withdrawal by Subject|0|||
125201630|NCT02086448|450361472|FG003|Overall Study|Withdrawal by Subject|2|||
125201631|NCT00843037|450361473|FG000|Overall Study|Lost to Follow-up|1|||
125201632|NCT01871402|450361476|FG000|Overall Study|Lost to Follow-up|1|||
125201633|NCT01871402|450361477|FG001|Overall Study|Lost to Follow-up|0|||
125201634|NCT01871402|450361476|FG000|Overall Study|Withdrawal by Subject|0|||
125201635|NCT01871402|450361477|FG001|Overall Study|Withdrawal by Subject|2|||
125201636|NCT01871402|450361476|FG000|Overall Study|Non-compliance|0|||
125201637|NCT01871402|450361477|FG001|Overall Study|Non-compliance|1|||
125201638|NCT05896527|450361480|FG000|Overall Study|Withdrawal by Subject|11|||
125201639|NCT05896527|450361481|FG001|Overall Study|Withdrawal by Subject|10|||
125201640|NCT05896527|450361482|FG002|Overall Study|Withdrawal by Subject|4|||
125201641|NCT05896527|450361483|FG003|Overall Study|Withdrawal by Subject|3|||
125201642|NCT05896527|450361484|FG004|Overall Study|Withdrawal by Subject|2|||
125201643|NCT05896527|450361480|FG000|Overall Study|Lost to Follow-up|0|||
125201644|NCT05896527|450361481|FG001|Overall Study|Lost to Follow-up|2|||
125201645|NCT05896527|450361482|FG002|Overall Study|Lost to Follow-up|2|||
125201646|NCT05896527|450361483|FG003|Overall Study|Lost to Follow-up|2|||
125201647|NCT05896527|450361484|FG004|Overall Study|Lost to Follow-up|1|||
125201648|NCT05896527|450361480|FG000|Overall Study|Significant protocol noncompliance|0|||
125201649|NCT05896527|450361481|FG001|Overall Study|Significant protocol noncompliance|1|||
125201650|NCT05896527|450361482|FG002|Overall Study|Significant protocol noncompliance|0|||
125201651|NCT05896527|450361483|FG003|Overall Study|Significant protocol noncompliance|0|||
125201652|NCT05896527|450361484|FG004|Overall Study|Significant protocol noncompliance|0|||
125201653|NCT05896527|450361480|FG000|Overall Study|Eligibility criteria not met|1|||
125201654|NCT05896527|450361481|FG001|Overall Study|Eligibility criteria not met|0|||
125201655|NCT05896527|450361482|FG002|Overall Study|Eligibility criteria not met|0|||
125201656|NCT05896527|450361483|FG003|Overall Study|Eligibility criteria not met|0|||
125201657|NCT05896527|450361484|FG004|Overall Study|Eligibility criteria not met|0|||
125201658|NCT05896527|450361480|FG000|Overall Study|Sponsor's decision|0|||
125201659|NCT05896527|450361481|FG001|Overall Study|Sponsor's decision|0|||
125201660|NCT05896527|450361482|FG002|Overall Study|Sponsor's decision|0|||
125201661|NCT05896527|450361483|FG003|Overall Study|Sponsor's decision|1|||
125201662|NCT05896527|450361484|FG004|Overall Study|Sponsor's decision|0|||
125201663|NCT05896527|450361480|FG000|Overall Study|Investigator's decision|0|||
125201664|NCT05896527|450361481|FG001|Overall Study|Investigator's decision|1|||
125201665|NCT05896527|450361482|FG002|Overall Study|Investigator's decision|0|||
125201666|NCT05896527|450361483|FG003|Overall Study|Investigator's decision|0|||
125201667|NCT05896527|450361484|FG004|Overall Study|Investigator's decision|0|||
125201668|NCT05896527|450361480|FG000|Overall Study|Pregnancy of his partner|0|||
125201669|NCT05896527|450361481|FG001|Overall Study|Pregnancy of his partner|0|||
125201670|NCT05896527|450361482|FG002|Overall Study|Pregnancy of his partner|0|||
125201671|NCT05896527|450361483|FG003|Overall Study|Pregnancy of his partner|1|||
125201672|NCT05896527|450361484|FG004|Overall Study|Pregnancy of his partner|0|||
125201673|NCT01279070|450361485|FG000|Overall Study|Withdrawal by Subject|2|||
125201674|NCT01279070|450361486|FG001|Overall Study|Withdrawal by Subject|3|||
125201675|NCT01279070|450361485|FG000|Overall Study|Acute exacerbation|3|||
125201676|NCT01279070|450361486|FG001|Overall Study|Acute exacerbation|1|||
125201677|NCT03781583|450361487|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
125201678|NCT03781583|450361488|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
125201679|NCT03781583|450361489|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
125201680|NCT03781583|450361490|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
125201681|NCT03781583|450361487|FG000|Overall Study|Technology did not work for that person in that environment|1|||
125201682|NCT03781583|450361488|FG001|Overall Study|Technology did not work for that person in that environment|0|||
125201683|NCT03781583|450361489|FG002|Overall Study|Technology did not work for that person in that environment|0|||
125201684|NCT03781583|450361490|FG003|Overall Study|Technology did not work for that person in that environment|0|||
125201685|NCT03781583|450361487|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
125201686|NCT03781583|450361488|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
125201687|NCT03781583|450361489|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
125201688|NCT03781583|450361490|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
125201689|NCT03781583|450361487|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
125201690|NCT03781583|450361488|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
125201691|NCT03781583|450361489|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
125201692|NCT03781583|450361490|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
125201693|NCT05139303|450361491|FG000|Overall Study|Lost to Follow-up|3|||
125201694|NCT05139303|450361492|FG001|Overall Study|Lost to Follow-up|0|||
125201695|NCT05139303|450361491|FG000|Overall Study|Adverse Event|1|||
125201696|NCT05139303|450361492|FG001|Overall Study|Adverse Event|0|||
125201697|NCT02045862|450361493|FG000|Overall Study|Death|0|||
125201698|NCT02045862|450361494|FG001|Overall Study|Death|0|||
125201699|NCT02045862|450361495|FG002|Overall Study|Death|1|||
125201700|NCT02045862|450361493|FG000|Overall Study|Miscellaneous|5|||
125201701|NCT02045862|450361494|FG001|Overall Study|Miscellaneous|0|||
125201702|NCT02045862|450361495|FG002|Overall Study|Miscellaneous|8|||
125201703|NCT02045862|450361493|FG000|Overall Study|Withdrawal by Patient|18|||
125201704|NCT02045862|450361494|FG001|Overall Study|Withdrawal by Patient|27|||
125201705|NCT02045862|450361495|FG002|Overall Study|Withdrawal by Patient|57|||
125201706|NCT02045862|450361493|FG000|Overall Study|Protocol Violation|0|||
125201707|NCT02045862|450361494|FG001|Overall Study|Protocol Violation|0|||
125201708|NCT02045862|450361495|FG002|Overall Study|Protocol Violation|6|||
125201709|NCT02045862|450361493|FG000|Overall Study|Lack of Efficacy|8|||
125201710|NCT02045862|450361494|FG001|Overall Study|Lack of Efficacy|4|||
125646170|NCT01716585|451988217|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
125646171|NCT01716585|451988216|FG000|Double-blind Treatment|Lost to Follow-up|2|||
125646172|NCT01716585|451988217|FG001|Double-blind Treatment|Lost to Follow-up|0|||
125646173|NCT01716585|451988216|FG000|Double-blind Treatment|Subject Noncompliant|1|||
125646174|NCT01716585|451988217|FG001|Double-blind Treatment|Subject Noncompliant|0|||
125646175|NCT01716585|451988216|FG000|Double-blind Treatment|Other|1|||
125646176|NCT01716585|451988217|FG001|Double-blind Treatment|Other|0|||
125646177|NCT01716585|451988216|FG000|Open-label Treatment|Adverse Event|0|||
125646178|NCT01716585|451988217|FG001|Open-label Treatment|Adverse Event|2|||
125646179|NCT01716585|451988216|FG000|Open-label Treatment|Virologic Failure|0|||
125646180|NCT01716585|451988217|FG001|Open-label Treatment|Virologic Failure|2|||
125646181|NCT01716585|451988216|FG000|Open-label Treatment|Withdrawal by Subject|0|||
125646182|NCT01716585|451988217|FG001|Open-label Treatment|Withdrawal by Subject|3|||
125646183|NCT00504595|451988218|FG000|Overall Study|Lack of Efficacy|1|||
125646184|NCT00504595|451988219|FG001|Overall Study|Lack of Efficacy|0|||
125646185|NCT00504595|451988220|FG002|Overall Study|Lack of Efficacy|0|||
125646186|NCT00504595|451988221|FG003|Overall Study|Lack of Efficacy|0|||
125646187|NCT00504595|451988218|FG000|Overall Study|Other|0|||
125646188|NCT00504595|451988219|FG001|Overall Study|Other|0|||
125646189|NCT00504595|451988220|FG002|Overall Study|Other|2|||
125646190|NCT00504595|451988221|FG003|Overall Study|Other|0|||
125646191|NCT02764229|451988222|FG000|Overall Study|Withdrawal by Subject|15|||
125646192|NCT02764229|451988222|FG000|Overall Study|Adverse Event|9|||
125646193|NCT02764229|451988222|FG000|Overall Study|Physician Decision|5|||
125646194|NCT02764229|451988222|FG000|Overall Study|Lost to Follow-up|3|||
125646195|NCT02764229|451988222|FG000|Overall Study|Lack of Efficacy|1|||
125646196|NCT02764229|451988222|FG000|Overall Study|Study Stopped by Sponsor|69|||
125646197|NCT00851721|451988224|FG000|Overall Study|planned surgery|1|||
125646198|NCT00851721|451988225|FG001|Overall Study|planned surgery|0|||
125646199|NCT00851721|451988224|FG000|Overall Study|Death|1|||
125646200|NCT00851721|451988225|FG001|Overall Study|Death|0|||
125646201|NCT00851721|451988224|FG000|Overall Study|Adverse Event|0|||
125646202|NCT00851721|451988225|FG001|Overall Study|Adverse Event|1|||
125646203|NCT03451630|451988230|FG000|Overall Study|Death|15|||
125646204|NCT03451630|451988231|FG001|Overall Study|Death|16|||
125646205|NCT03451630|451988232|FG002|Overall Study|Death|11|||
125646206|NCT03451630|451988230|FG000|Overall Study|Lost to Follow-up|9|||
125646207|NCT03451630|451988231|FG001|Overall Study|Lost to Follow-up|0|||
125646208|NCT03451630|451988232|FG002|Overall Study|Lost to Follow-up|4|||
125646209|NCT03451630|451988230|FG000|Overall Study|Withdrawal by Subject|0|||
125646210|NCT03451630|451988231|FG001|Overall Study|Withdrawal by Subject|3|||
125646211|NCT03451630|451988232|FG002|Overall Study|Withdrawal by Subject|0|||
125646212|NCT03451630|451988230|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
125646213|NCT03451630|451988231|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
125646214|NCT03451630|451988232|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
125646215|NCT03370133|451988237|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
125646216|NCT03370133|451988238|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
125646217|NCT03370133|451988239|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
125646218|NCT03370133|451988240|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
125201711|NCT02045862|450361495|FG002|Overall Study|Lack of Efficacy|13|||
125201712|NCT02045862|450361493|FG000|Overall Study|Randomized but not Received Study Drug|0|||
125201713|NCT02045862|450361494|FG001|Overall Study|Randomized but not Received Study Drug|2|||
125201714|NCT02045862|450361495|FG002|Overall Study|Randomized but not Received Study Drug|8|||
125201715|NCT02045862|450361493|FG000|Overall Study|Adverse Event|7|||
125201716|NCT02045862|450361494|FG001|Overall Study|Adverse Event|5|||
125201717|NCT02045862|450361495|FG002|Overall Study|Adverse Event|27|||
125201718|NCT02045862|450361493|FG000|Overall Study|Lost to Follow-up|1|||
125201719|NCT02045862|450361494|FG001|Overall Study|Lost to Follow-up|2|||
125201720|NCT02045862|450361495|FG002|Overall Study|Lost to Follow-up|6|||
125201721|NCT03164564|450361496|FG000|Overall Study|Death|3|||
125201722|NCT03164564|450361497|FG001|Overall Study|Death|0|||
125201723|NCT03164564|450361496|FG000|Overall Study|Withdrawal by Subject|20|||
125201724|NCT03164564|450361497|FG001|Overall Study|Withdrawal by Subject|15|||
125201725|NCT03164564|450361496|FG000|Overall Study|Lost to Follow-up|2|||
125201726|NCT03164564|450361497|FG001|Overall Study|Lost to Follow-up|0|||
125201727|NCT03164564|450361496|FG000|Overall Study|Physician Decision|0|||
125201728|NCT03164564|450361497|FG001|Overall Study|Physician Decision|1|||
125201729|NCT03164564|450361496|FG000|Overall Study|Adverse Event|0|||
125201730|NCT03164564|450361497|FG001|Overall Study|Adverse Event|1|||
125201731|NCT03164564|450361496|FG000|Overall Study|Ongoing|1586|||
125201732|NCT03164564|450361497|FG001|Overall Study|Ongoing|1586|||
125201733|NCT02691013|450361498|FG000|Overall Study|Withdrawal by Subject|3|||
125201734|NCT02691013|450361499|FG001|Overall Study|Withdrawal by Subject|0|||
125201735|NCT01075646|450361503|FG000|Overall Study|Lost to Follow-up|4|||
125201736|NCT01075646|450361504|FG001|Overall Study|Lost to Follow-up|3|||
125201737|NCT01075646|450361505|FG002|Overall Study|Lost to Follow-up|1|||
125201738|NCT01075646|450361506|FG003|Overall Study|Lost to Follow-up|2|||
125201739|NCT01895608|450361507|FG000|Overall Study|change in health status|0|||
125201740|NCT01895608|450361508|FG001|Overall Study|change in health status|1|||
125201741|NCT01895608|450361509|FG002|Overall Study|change in health status|1|||
125201742|NCT01895608|450361510|FG003|Overall Study|change in health status|0|||
125201743|NCT01895608|450361507|FG000|Overall Study|Withdrawal by Subject|0|||
125201744|NCT01895608|450361508|FG001|Overall Study|Withdrawal by Subject|0|||
125201745|NCT01895608|450361509|FG002|Overall Study|Withdrawal by Subject|2|||
125201746|NCT01895608|450361510|FG003|Overall Study|Withdrawal by Subject|0|||
125201747|NCT03505593|450361514|FG000|Overall Study|Withdrawal by Subject|1|||
125201748|NCT03505593|450361514|FG000|Overall Study|Died before procedure|1|||
125201749|NCT03505593|450361514|FG000|Overall Study|Anatomical abnormality|1|||
125201750|NCT03505593|450361514|FG000|Overall Study|Unable to pass through esophagus|1|||
125201751|NCT03505593|450361514|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
125201752|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Adverse Event|6|||
125201753|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Adverse Event|14|||
125201754|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Death|3|||
125201755|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Death|1|||
125201756|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
125201757|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
125201758|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
125201759|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
125201760|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
125201761|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
125201762|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
125201763|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
125201764|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
125201765|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
125201766|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Physician Decision|2|||
125201767|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Physician Decision|4|||
125201768|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Pregnancy|2|||
125201769|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Pregnancy|1|||
125201770|NCT02275780|450361515|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
125201771|NCT02275780|450361516|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
125201772|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
125201773|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
125201774|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
125201775|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
125201776|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
125201777|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
125201778|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
125201779|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
125201780|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
125201781|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
125201782|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
125201783|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
125201784|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
125201785|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
125217436|NCT01348100|450423523|FG003|Overall Study|Lost to Follow-up|0|||
125201786|NCT02275780|450361515|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
125201787|NCT02275780|450361516|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
125201788|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
125201789|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
125201790|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
125201791|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
125201792|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
125201793|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
125201794|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
125201795|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
125201796|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
125201797|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
125201798|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
125201799|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
125201800|NCT02275780|450361515|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
125201801|NCT02275780|450361516|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
125201802|NCT02275780|450361515|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
125201803|NCT02275780|450361516|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
125201804|NCT02275780|450361515|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
125201805|NCT02275780|450361516|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
125201806|NCT02275780|450361515|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
125201807|NCT02275780|450361516|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
125201808|NCT02275780|450361515|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
125201809|NCT02275780|450361516|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
125201810|NCT02275780|450361515|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
125201811|NCT02275780|450361516|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
125201812|NCT02275780|450361515|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
125201813|NCT02275780|450361516|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
125201814|NCT02855359|450361521|FG000|Overall Study|Death|2|||
125201815|NCT02855359|450361522|FG001|Overall Study|Death|2|||
125201816|NCT02855359|450361523|FG002|Overall Study|Death|0|||
125201817|NCT02855359|450361524|FG003|Overall Study|Death|0|||
125201818|NCT02855359|450361521|FG000|Overall Study|Study Termination by Sponsor|9|||
125201819|NCT02855359|450361522|FG001|Overall Study|Study Termination by Sponsor|11|||
125201820|NCT02855359|450361523|FG002|Overall Study|Study Termination by Sponsor|0|||
125201821|NCT02855359|450361524|FG003|Overall Study|Study Termination by Sponsor|0|||
125201822|NCT00738881|450361529|FG000|Overall Study|Withdrawal by Subject|0|||
125201823|NCT00738881|450361530|FG001|Overall Study|Withdrawal by Subject|2|||
125201824|NCT00348790|450361531|FG000|Completed Treatment|Withdrawal by Subject|4|||
125201825|NCT00348790|450361531|FG000|Completed Treatment|Disease progression|14|||
125201826|NCT00348790|450361531|FG000|Completed Treatment|Adverse Event|4|||
125201827|NCT00348790|450361531|FG000|Completed Treatment|Required surgery|2|||
125201828|NCT00348790|450361531|FG000|Completed Treatment|Unable to travel to study site|1|||
125201829|NCT01044290|450361532|FG000|Follow-up 1|Death|3|||
125201830|NCT01044290|450361533|FG001|Follow-up 1|Death|3|||
125201831|NCT01044290|450361534|FG002|Follow-up 1|Death|1|||
125201832|NCT01044290|450361532|FG000|Follow-up 1|Withdrawal by Subject|2|||
125201833|NCT01044290|450361533|FG001|Follow-up 1|Withdrawal by Subject|2|||
125201834|NCT01044290|450361534|FG002|Follow-up 1|Withdrawal by Subject|0|||
125201835|NCT01044290|450361532|FG000|Follow-Up 2|Death|0|||
125201836|NCT01044290|450361533|FG001|Follow-Up 2|Death|1|||
125201837|NCT01044290|450361534|FG002|Follow-Up 2|Death|1|||
125201838|NCT01044290|450361532|FG000|Follow-Up 2|Withdrawal by Subject|0|||
125201839|NCT01044290|450361533|FG001|Follow-Up 2|Withdrawal by Subject|1|||
125201840|NCT01044290|450361534|FG002|Follow-Up 2|Withdrawal by Subject|1|||
125201841|NCT00759785|450361540|FG000|Overall Study|Participant sample not evaluable|11|||
125201842|NCT00759785|450361541|FG001|Overall Study|Participant sample not evaluable|2|||
125201843|NCT00759785|450361540|FG000|Overall Study|Participant sample lost|0|||
125201844|NCT00759785|450361541|FG001|Overall Study|Participant sample lost|1|||
125201845|NCT00759785|450361540|FG000|Overall Study|Protocol Violation|1|||
125201846|NCT00759785|450361541|FG001|Overall Study|Protocol Violation|0|||
125201847|NCT00759785|450361540|FG000|Overall Study|Physician Decision|0|||
125201848|NCT00759785|450361541|FG001|Overall Study|Physician Decision|1|||
125201849|NCT00759785|450361540|FG000|Overall Study|Withdrawal by Subject|0|||
125201850|NCT00759785|450361541|FG001|Overall Study|Withdrawal by Subject|1|||
125201851|NCT01646021|450361542|FG000|Overall Study|Death|77|||
125201852|NCT01646021|450361543|FG001|Overall Study|Death|83|||
125201853|NCT01646021|450361542|FG000|Overall Study|Study Terminated by Sponsor|50|||
125201854|NCT01646021|450361543|FG001|Overall Study|Study Terminated by Sponsor|41|||
125201855|NCT01646021|450361542|FG000|Overall Study|Lost to Follow-up|2|||
125201856|NCT01646021|450361543|FG001|Overall Study|Lost to Follow-up|2|||
125201857|NCT01646021|450361542|FG000|Overall Study|Withdrawal by Subject|10|||
125201858|NCT01646021|450361543|FG001|Overall Study|Withdrawal by Subject|15|||
125201859|NCT04712019|450361544|FG000|Overall Study|Withdrawal by Subject|2|||
125201860|NCT04712019|450361545|FG001|Overall Study|Withdrawal by Subject|2|||
125201861|NCT04712019|450361544|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
125201862|NCT04712019|450361545|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
125201863|NCT04521621|450361546|FG000|Overall Study|Death|17|||
125201864|NCT04521621|450361547|FG001|Overall Study|Death|8|||
125201865|NCT04521621|450361548|FG002|Overall Study|Death|8|||
125201866|NCT04521621|450361549|FG003|Overall Study|Death|5|||
125201867|NCT04521621|450361550|FG004|Overall Study|Death|2|||
125201868|NCT04521621|450361551|FG005|Overall Study|Death|7|||
125201869|NCT04521621|450361552|FG006|Overall Study|Death|0|||
125201870|NCT04521621|450361553|FG007|Overall Study|Death|0|||
125201871|NCT04521621|450361546|FG000|Overall Study|Study Terminated by Sponsor|4|||
125201872|NCT04521621|450361547|FG001|Overall Study|Study Terminated by Sponsor|6|||
125201873|NCT04521621|450361548|FG002|Overall Study|Study Terminated by Sponsor|8|||
125201874|NCT04521621|450361549|FG003|Overall Study|Study Terminated by Sponsor|0|||
125201875|NCT04521621|450361550|FG004|Overall Study|Study Terminated by Sponsor|1|||
125201876|NCT04521621|450361551|FG005|Overall Study|Study Terminated by Sponsor|7|||
125201877|NCT04521621|450361552|FG006|Overall Study|Study Terminated by Sponsor|0|||
125201878|NCT04521621|450361553|FG007|Overall Study|Study Terminated by Sponsor|0|||
125201879|NCT04521621|450361546|FG000|Overall Study|Withdrawal by Subject|0|||
125201880|NCT04521621|450361547|FG001|Overall Study|Withdrawal by Subject|0|||
125201881|NCT04521621|450361548|FG002|Overall Study|Withdrawal by Subject|1|||
125201882|NCT04521621|450361549|FG003|Overall Study|Withdrawal by Subject|1|||
125201883|NCT04521621|450361550|FG004|Overall Study|Withdrawal by Subject|0|||
125201884|NCT04521621|450361551|FG005|Overall Study|Withdrawal by Subject|0|||
125201885|NCT04521621|450361552|FG006|Overall Study|Withdrawal by Subject|0|||
125201886|NCT04521621|450361553|FG007|Overall Study|Withdrawal by Subject|0|||
125201887|NCT04521621|450361546|FG000|Overall Study|Allocated in error without study intervention|1|||
125201888|NCT04521621|450361547|FG001|Overall Study|Allocated in error without study intervention|0|||
125201889|NCT04521621|450361548|FG002|Overall Study|Allocated in error without study intervention|0|||
125201890|NCT04521621|450361549|FG003|Overall Study|Allocated in error without study intervention|0|||
125201891|NCT04521621|450361550|FG004|Overall Study|Allocated in error without study intervention|0|||
125201892|NCT04521621|450361551|FG005|Overall Study|Allocated in error without study intervention|0|||
125201893|NCT04521621|450361552|FG006|Overall Study|Allocated in error without study intervention|0|||
125201894|NCT04521621|450361553|FG007|Overall Study|Allocated in error without study intervention|0|||
125201895|NCT01282164|450361554|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
125201896|NCT01282164|450361555|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
125201897|NCT01967706|450361570|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
125201898|NCT01967706|450361571|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
125201899|NCT01967706|450361572|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
125201900|NCT01967706|450361573|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
125201901|NCT02777970|450361574|FG000|Overall Study|Lost to Follow-up|0|||
125201902|NCT02777970|450361575|FG001|Overall Study|Lost to Follow-up|1|||
125201903|NCT02777970|450361576|FG002|Overall Study|Lost to Follow-up|0|||
125201904|NCT02777970|450361574|FG000|Overall Study|Protocol Violation|1|||
125201905|NCT02777970|450361575|FG001|Overall Study|Protocol Violation|0|||
125201906|NCT02777970|450361576|FG002|Overall Study|Protocol Violation|0|||
125201907|NCT02347891|450361580|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
125201908|NCT02347891|450361581|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
125201909|NCT02347891|450361580|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
125201910|NCT02347891|450361581|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
125201911|NCT05845567|450361582|FG000|Overall Study|Withdrawal by Subject|1|||
125201912|NCT02541669|450361583|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
125201913|NCT02541669|450361584|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
125201914|NCT02541669|450361585|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
125201915|NCT02541669|450361586|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
125201916|NCT02541669|450361587|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
125201917|NCT00725608|450361588|FG000|Overall Study|Lost to Follow-up|60|||
125201918|NCT00725608|450361588|FG000|Overall Study|Adverse Event|14|||
125201919|NCT00725608|450361588|FG000|Overall Study|Individual reasons|86|||
125201920|NCT00725608|450361588|FG000|Overall Study|Other|7|||
125201921|NCT03409107|450361589|FG000|Overall Study|Withdrawal by Subject|4|||
125201922|NCT03409107|450361590|FG001|Overall Study|Withdrawal by Subject|2|||
125201923|NCT03409107|450361589|FG000|Overall Study|Physician Decision|1|||
125201924|NCT03409107|450361590|FG001|Overall Study|Physician Decision|0|||
125201925|NCT03409107|450361589|FG000|Overall Study|Lost to Follow-up|7|||
125201926|NCT03409107|450361590|FG001|Overall Study|Lost to Follow-up|2|||
125201927|NCT03409107|450361589|FG000|Overall Study|Adverse Event|5|||
125201928|NCT03409107|450361590|FG001|Overall Study|Adverse Event|3|||
125201929|NCT01084668|450361592|FG000|Overall Study|Lack of Efficacy|5|||
125201930|NCT01084668|450361592|FG000|Overall Study|Withdrawal by Subject|2|||
125201931|NCT01084668|450361592|FG000|Overall Study|Pregnancy|1|||
125201932|NCT01084668|450361592|FG000|Overall Study|Non-compliance|1|||
125201933|NCT01083186|450361594|FG000|Overall Study|Lost to Follow-up|48|||
125201934|NCT01083186|450361594|FG000|Overall Study|Consent Withdrawal|7|||
125201935|NCT01083186|450361594|FG000|Overall Study|Death|3|||
125201936|NCT01083186|450361594|FG000|Overall Study|Adverse Event|3|||
125201937|NCT01083186|450361594|FG000|Overall Study|Lack of Efficacy|2|||
125201938|NCT01083186|450361594|FG000|Overall Study|Hemodialysis Initiation|28|||
125201939|NCT01083186|450361594|FG000|Overall Study|Administrative Reasons|2|||
125201940|NCT01083186|450361594|FG000|Overall Study|Non-compliance to Study Treatment|1|||
125201941|NCT01258075|450361615|FG000|Overall Study|Adverse Event|8|||
125201942|NCT01258075|450361616|FG001|Overall Study|Adverse Event|3|||
125201943|NCT01258075|450361615|FG000|Overall Study|Lost to Follow-up|11|||
125201944|NCT01258075|450361616|FG001|Overall Study|Lost to Follow-up|6|||
125201945|NCT01258075|450361615|FG000|Overall Study|Withdrawal by Subject|10|||
125201946|NCT01258075|450361616|FG001|Overall Study|Withdrawal by Subject|7|||
125201947|NCT01258075|450361615|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
125201948|NCT01258075|450361616|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
125201949|NCT01258075|450361615|FG000|Overall Study|Other|12|||
125201950|NCT01258075|450361616|FG001|Overall Study|Other|5|||
125201951|NCT01500213|450361617|FG000|Overall Study|Adverse Event|35|||
125201952|NCT01500213|450361618|FG001|Overall Study|Adverse Event|35|||
125201953|NCT01500213|450361617|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
125201954|NCT01500213|450361618|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
125201955|NCT01500213|450361617|FG000|Overall Study|Withdrawal by Subject|28|||
125201956|NCT01500213|450361618|FG001|Overall Study|Withdrawal by Subject|37|||
125201957|NCT01500213|450361617|FG000|Overall Study|Death|7|||
125201958|NCT01500213|450361618|FG001|Overall Study|Death|3|||
125201959|NCT01500213|450361617|FG000|Overall Study|Disease Progression|13|||
125201960|NCT01500213|450361618|FG001|Overall Study|Disease Progression|21|||
125201961|NCT01500213|450361617|FG000|Overall Study|Protocol Violation|19|||
125201962|NCT01500213|450361618|FG001|Overall Study|Protocol Violation|19|||
125201963|NCT01500213|450361617|FG000|Overall Study|Physician Decision|12|||
125201964|NCT01500213|450361618|FG001|Overall Study|Physician Decision|10|||
125201965|NCT01500213|450361617|FG000|Overall Study|Lack of Efficacy|9|||
125201966|NCT01500213|450361618|FG001|Overall Study|Lack of Efficacy|7|||
125201967|NCT01500213|450361617|FG000|Overall Study|Lost to Follow-up|3|||
125201968|NCT01500213|450361618|FG001|Overall Study|Lost to Follow-up|6|||
125201969|NCT01500213|450361617|FG000|Overall Study|Other Reasons|7|||
125201970|NCT01500213|450361618|FG001|Overall Study|Other Reasons|5|||
125201971|NCT03197870|450361623|FG000|Overall Study|Adverse Event|9|||
125201972|NCT03197870|450361624|FG001|Overall Study|Adverse Event|4|||
125201973|NCT03197870|450361625|FG002|Overall Study|Adverse Event|6|||
125201974|NCT03197870|450361623|FG000|Overall Study|Withdrawal by Subject|2|||
125201975|NCT03197870|450361624|FG001|Overall Study|Withdrawal by Subject|3|||
125201976|NCT03197870|450361625|FG002|Overall Study|Withdrawal by Subject|0|||
125201977|NCT03197870|450361623|FG000|Overall Study|Lost to Follow-up|2|||
125201978|NCT03197870|450361624|FG001|Overall Study|Lost to Follow-up|2|||
125201979|NCT03197870|450361625|FG002|Overall Study|Lost to Follow-up|0|||
125201980|NCT03197870|450361623|FG000|Overall Study|data not available|1|||
125201981|NCT03197870|450361624|FG001|Overall Study|data not available|1|||
125201982|NCT03197870|450361625|FG002|Overall Study|data not available|0|||
125201983|NCT01618019|450361627|FG000|Overall Study|Withdrawal by Subject|14|||
125201984|NCT01618019|450361628|FG001|Overall Study|Withdrawal by Subject|14|||
125201985|NCT05174949|450361629|FG000|Overall Study|Physician Decision|1|||
125201986|NCT05174949|450361630|FG001|Overall Study|Physician Decision|2|||
125201987|NCT05174949|450361631|FG002|Overall Study|Physician Decision|0|||
125201988|NCT05174949|450361632|FG003|Overall Study|Physician Decision|1|||
125201989|NCT05174949|450361633|FG004|Overall Study|Physician Decision|0|||
125201990|NCT05174949|450361634|FG005|Overall Study|Physician Decision|0|||
125201991|NCT05174949|450361629|FG000|Overall Study|Withdrawal by Subject|0|||
125201992|NCT05174949|450361630|FG001|Overall Study|Withdrawal by Subject|1|||
125201993|NCT05174949|450361631|FG002|Overall Study|Withdrawal by Subject|0|||
125201994|NCT05174949|450361632|FG003|Overall Study|Withdrawal by Subject|0|||
125201995|NCT05174949|450361633|FG004|Overall Study|Withdrawal by Subject|0|||
125201996|NCT05174949|450361634|FG005|Overall Study|Withdrawal by Subject|0|||
125201997|NCT05174949|450361629|FG000|Overall Study|Lost to Follow-up|0|||
125201998|NCT05174949|450361630|FG001|Overall Study|Lost to Follow-up|0|||
125201999|NCT05174949|450361631|FG002|Overall Study|Lost to Follow-up|0|||
125202000|NCT05174949|450361632|FG003|Overall Study|Lost to Follow-up|1|||
125202001|NCT05174949|450361633|FG004|Overall Study|Lost to Follow-up|0|||
125202002|NCT05174949|450361634|FG005|Overall Study|Lost to Follow-up|0|||
125202003|NCT02880865|450361635|FG000|Overall Study|Adverse Event|1|||
125202004|NCT02880865|450361636|FG001|Overall Study|Adverse Event|0|||
125202005|NCT02880865|450361635|FG000|Overall Study|Withdrawal by Subject|0|||
125202006|NCT02880865|450361636|FG001|Overall Study|Withdrawal by Subject|2|||
125202007|NCT02880865|450361635|FG000|Overall Study|Physician Decision|0|||
125202008|NCT02880865|450361636|FG001|Overall Study|Physician Decision|1|||
125217437|NCT01348100|450423524|FG004|Overall Study|Lost to Follow-up|0|||
125202009|NCT00860249|450363556|FG000|Overall Study|trial was terminated prior to completion|21|||
125202010|NCT00860249|450363557|FG001|Overall Study|trial was terminated prior to completion|18|||
125202011|NCT00860249|450363558|FG002|Overall Study|trial was terminated prior to completion|21|||
125202012|NCT00174967|450363559|FG000|Overall Study|Adverse Event|1|||
125202013|NCT00174967|450363560|FG001|Overall Study|Adverse Event|2|||
125202014|NCT00174967|450363561|FG002|Overall Study|Adverse Event|2|||
125202015|NCT00174967|450363562|FG003|Overall Study|Adverse Event|1|||
125202016|NCT00174967|450363559|FG000|Overall Study|Gout Flare|0|||
125202017|NCT00174967|450363560|FG001|Overall Study|Gout Flare|0|||
125202018|NCT00174967|450363561|FG002|Overall Study|Gout Flare|0|||
125202019|NCT00174967|450363562|FG003|Overall Study|Gout Flare|1|||
125202020|NCT00174967|450363559|FG000|Overall Study|Other|0|||
125202021|NCT00174967|450363560|FG001|Overall Study|Other|1|||
125202022|NCT00174967|450363561|FG002|Overall Study|Other|0|||
125202023|NCT00174967|450363562|FG003|Overall Study|Other|0|||
125202024|NCT02031640|450363563|FG000|Screening Period|Adverse Event|1|||
125202025|NCT02031640|450363564|FG001|Screening Period|Adverse Event|0|||
125202026|NCT02031640|450363565|FG002|Screening Period|Adverse Event|0|||
125202027|NCT02031640|450363566|FG003|Screening Period|Adverse Event|0|||
125202028|NCT02031640|450363567|FG004|Screening Period|Adverse Event|0|||
125202029|NCT02031640|450363568|FG005|Screening Period|Adverse Event|0|||
125202030|NCT02031640|450363563|FG000|Screening Period|Withdrawal by Subject|29|||
125202031|NCT02031640|450363564|FG001|Screening Period|Withdrawal by Subject|0|||
125202032|NCT02031640|450363565|FG002|Screening Period|Withdrawal by Subject|0|||
125202033|NCT02031640|450363566|FG003|Screening Period|Withdrawal by Subject|0|||
125202034|NCT02031640|450363567|FG004|Screening Period|Withdrawal by Subject|0|||
125202035|NCT02031640|450363568|FG005|Screening Period|Withdrawal by Subject|0|||
125202036|NCT02031640|450363563|FG000|Screening Period|Inclusion criteria not met|312|||
125202037|NCT02031640|450363564|FG001|Screening Period|Inclusion criteria not met|0|||
125202038|NCT02031640|450363565|FG002|Screening Period|Inclusion criteria not met|0|||
125202039|NCT02031640|450363566|FG003|Screening Period|Inclusion criteria not met|0|||
125202040|NCT02031640|450363567|FG004|Screening Period|Inclusion criteria not met|0|||
125202041|NCT02031640|450363568|FG005|Screening Period|Inclusion criteria not met|0|||
125202042|NCT02031640|450363563|FG000|Screening Period|Exclusion criteria met|30|||
125202043|NCT02031640|450363564|FG001|Screening Period|Exclusion criteria met|0|||
125202044|NCT02031640|450363565|FG002|Screening Period|Exclusion criteria met|0|||
125202045|NCT02031640|450363566|FG003|Screening Period|Exclusion criteria met|0|||
125202046|NCT02031640|450363567|FG004|Screening Period|Exclusion criteria met|0|||
125202047|NCT02031640|450363568|FG005|Screening Period|Exclusion criteria met|0|||
125202048|NCT02031640|450363563|FG000|Screening Period|Lost to Follow-up|14|||
125202049|NCT02031640|450363564|FG001|Screening Period|Lost to Follow-up|0|||
125202050|NCT02031640|450363565|FG002|Screening Period|Lost to Follow-up|0|||
125202051|NCT02031640|450363566|FG003|Screening Period|Lost to Follow-up|0|||
125202052|NCT02031640|450363567|FG004|Screening Period|Lost to Follow-up|0|||
125202053|NCT02031640|450363568|FG005|Screening Period|Lost to Follow-up|0|||
125202054|NCT02031640|450363563|FG000|Screening Period|Enrollment closed|26|||
125202055|NCT02031640|450363564|FG001|Screening Period|Enrollment closed|0|||
125202056|NCT02031640|450363565|FG002|Screening Period|Enrollment closed|0|||
125202057|NCT02031640|450363566|FG003|Screening Period|Enrollment closed|0|||
125202058|NCT02031640|450363567|FG004|Screening Period|Enrollment closed|0|||
125202059|NCT02031640|450363568|FG005|Screening Period|Enrollment closed|0|||
125202060|NCT02031640|450363563|FG000|Run-In Period|Adverse Event|4|||
125202061|NCT02031640|450363564|FG001|Run-In Period|Adverse Event|0|||
125202062|NCT02031640|450363565|FG002|Run-In Period|Adverse Event|0|||
125202063|NCT02031640|450363566|FG003|Run-In Period|Adverse Event|0|||
125202064|NCT02031640|450363567|FG004|Run-In Period|Adverse Event|0|||
125202065|NCT02031640|450363568|FG005|Run-In Period|Adverse Event|0|||
125202066|NCT02031640|450363563|FG000|Run-In Period|Withdrawal by Subject|17|||
125202067|NCT02031640|450363564|FG001|Run-In Period|Withdrawal by Subject|0|||
125202068|NCT02031640|450363565|FG002|Run-In Period|Withdrawal by Subject|0|||
125202069|NCT02031640|450363566|FG003|Run-In Period|Withdrawal by Subject|0|||
125202070|NCT02031640|450363567|FG004|Run-In Period|Withdrawal by Subject|0|||
125202071|NCT02031640|450363568|FG005|Run-In Period|Withdrawal by Subject|0|||
125202072|NCT02031640|450363563|FG000|Run-In Period|Inclusion criteria not met|38|||
125202073|NCT02031640|450363564|FG001|Run-In Period|Inclusion criteria not met|0|||
125202074|NCT02031640|450363565|FG002|Run-In Period|Inclusion criteria not met|0|||
125202075|NCT02031640|450363566|FG003|Run-In Period|Inclusion criteria not met|0|||
125202076|NCT02031640|450363567|FG004|Run-In Period|Inclusion criteria not met|0|||
125202077|NCT02031640|450363568|FG005|Run-In Period|Inclusion criteria not met|0|||
125202078|NCT02031640|450363563|FG000|Run-In Period|Exclusion criteria met|8|||
125202079|NCT02031640|450363564|FG001|Run-In Period|Exclusion criteria met|0|||
125202080|NCT02031640|450363565|FG002|Run-In Period|Exclusion criteria met|0|||
125202081|NCT02031640|450363566|FG003|Run-In Period|Exclusion criteria met|0|||
125202082|NCT02031640|450363567|FG004|Run-In Period|Exclusion criteria met|0|||
125202083|NCT02031640|450363568|FG005|Run-In Period|Exclusion criteria met|0|||
125202084|NCT02031640|450363563|FG000|Run-In Period|Randomization criteria not met|85|||
125217438|NCT01348100|450423525|FG005|Overall Study|Lost to Follow-up|0|||
125202085|NCT02031640|450363564|FG001|Run-In Period|Randomization criteria not met|0|||
125202086|NCT02031640|450363565|FG002|Run-In Period|Randomization criteria not met|0|||
125202087|NCT02031640|450363566|FG003|Run-In Period|Randomization criteria not met|0|||
125202088|NCT02031640|450363567|FG004|Run-In Period|Randomization criteria not met|0|||
125202089|NCT02031640|450363568|FG005|Run-In Period|Randomization criteria not met|0|||
125202090|NCT02031640|450363563|FG000|Run-In Period|Various administrative reasons|17|||
125202091|NCT02031640|450363564|FG001|Run-In Period|Various administrative reasons|0|||
125202092|NCT02031640|450363565|FG002|Run-In Period|Various administrative reasons|0|||
125202093|NCT02031640|450363566|FG003|Run-In Period|Various administrative reasons|0|||
125202094|NCT02031640|450363567|FG004|Run-In Period|Various administrative reasons|0|||
125202095|NCT02031640|450363568|FG005|Run-In Period|Various administrative reasons|0|||
125202096|NCT02031640|450363563|FG000|Double-blind Treatment Period|Protocol deviation|0|||
125202097|NCT02031640|450363564|FG001|Double-blind Treatment Period|Protocol deviation|2|||
125202098|NCT02031640|450363565|FG002|Double-blind Treatment Period|Protocol deviation|0|||
125202099|NCT02031640|450363566|FG003|Double-blind Treatment Period|Protocol deviation|1|||
125202100|NCT02031640|450363567|FG004|Double-blind Treatment Period|Protocol deviation|3|||
125202101|NCT02031640|450363568|FG005|Double-blind Treatment Period|Protocol deviation|1|||
125202102|NCT02031640|450363563|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
125202103|NCT02031640|450363564|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
125202104|NCT02031640|450363565|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
125202105|NCT02031640|450363566|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
125202106|NCT02031640|450363567|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
125202107|NCT02031640|450363568|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
125202108|NCT02031640|450363563|FG000|Double-blind Treatment Period|Non-compliance|0|||
125202109|NCT02031640|450363564|FG001|Double-blind Treatment Period|Non-compliance|1|||
125202110|NCT02031640|450363565|FG002|Double-blind Treatment Period|Non-compliance|0|||
125202111|NCT02031640|450363566|FG003|Double-blind Treatment Period|Non-compliance|1|||
125202112|NCT02031640|450363567|FG004|Double-blind Treatment Period|Non-compliance|1|||
125202113|NCT02031640|450363568|FG005|Double-blind Treatment Period|Non-compliance|0|||
125202114|NCT02031640|450363563|FG000|Double-blind Treatment Period|Adverse Event|0|||
125202115|NCT02031640|450363564|FG001|Double-blind Treatment Period|Adverse Event|0|||
125202116|NCT02031640|450363565|FG002|Double-blind Treatment Period|Adverse Event|0|||
125202117|NCT02031640|450363566|FG003|Double-blind Treatment Period|Adverse Event|2|||
125202118|NCT02031640|450363567|FG004|Double-blind Treatment Period|Adverse Event|0|||
125202119|NCT02031640|450363568|FG005|Double-blind Treatment Period|Adverse Event|0|||
125202120|NCT02031640|450363563|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
125202121|NCT02031640|450363564|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
125202122|NCT02031640|450363565|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
125202123|NCT02031640|450363566|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
125202124|NCT02031640|450363567|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
125202125|NCT02031640|450363568|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
125202126|NCT02031640|450363563|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
125202127|NCT02031640|450363564|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
125202128|NCT02031640|450363565|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
125202129|NCT02031640|450363566|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
125202130|NCT02031640|450363567|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
125202131|NCT02031640|450363568|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
125202132|NCT03085238|450363571|FG000|Overall Study|Adverse Event|2|||
125202133|NCT03085238|450363571|FG000|Overall Study|Death|2|||
125202134|NCT02822573|450363580|FG000|Overall Study|Lost to Follow-up|5|||
125202135|NCT02822573|450363581|FG001|Overall Study|Lost to Follow-up|3|||
125202136|NCT02822573|450363580|FG000|Overall Study|Physician Decision|1|||
125202137|NCT02822573|450363581|FG001|Overall Study|Physician Decision|1|||
125202138|NCT02822573|450363580|FG000|Overall Study|Withdrawal by Subject|9|||
125202139|NCT02822573|450363581|FG001|Overall Study|Withdrawal by Subject|5|||
125202140|NCT02822573|450363580|FG000|Overall Study|Protocol Violation|6|||
125202141|NCT02822573|450363581|FG001|Overall Study|Protocol Violation|4|||
125202142|NCT02822573|450363580|FG000|Overall Study|Too sick or ill|2|||
125202143|NCT02822573|450363581|FG001|Overall Study|Too sick or ill|1|||
125202144|NCT02822573|450363580|FG000|Overall Study|Disease Progression|1|||
125202145|NCT02822573|450363581|FG001|Overall Study|Disease Progression|1|||
125202146|NCT02822573|450363580|FG000|Overall Study|No reason given|6|||
125202147|NCT02822573|450363581|FG001|Overall Study|No reason given|4|||
125202148|NCT01054300|450363582|FG000|Period 1|Adverse Event|1|||
125202149|NCT01054300|450363583|FG001|Period 1|Adverse Event|0|||
125202150|NCT01054300|450363584|FG002|Period 1|Adverse Event|0|||
125202151|NCT01054300|450363585|FG003|Period 1|Adverse Event|0|||
125202152|NCT01054300|450363582|FG000|Period 2|Withdrawal by Subject|0|||
125202153|NCT01054300|450363583|FG001|Period 2|Withdrawal by Subject|0|||
125202154|NCT01054300|450363584|FG002|Period 2|Withdrawal by Subject|1|||
125202155|NCT01054300|450363585|FG003|Period 2|Withdrawal by Subject|0|||
125202156|NCT00308087|450363586|FG000|Overall Study|Progressive Disease|19|||
125202157|NCT00308087|450363587|FG001|Overall Study|Progressive Disease|21|||
125202158|NCT00308087|450363586|FG000|Overall Study|Study Closure|11|||
125202159|NCT00308087|450363587|FG001|Overall Study|Study Closure|12|||
125202160|NCT00308087|450363586|FG000|Overall Study|Withdrawal by Subject|2|||
125202161|NCT00308087|450363587|FG001|Overall Study|Withdrawal by Subject|1|||
125202162|NCT00308087|450363586|FG000|Overall Study|Other|4|||
125202163|NCT00308087|450363587|FG001|Overall Study|Other|3|||
125202164|NCT04186806|450363592|FG000|Period 1: 7 Days|Adverse Event|1|||
125202165|NCT04186806|450363593|FG001|Period 1: 7 Days|Adverse Event|0|||
125202166|NCT00177307|450363596|FG000|Overall Study|Withdrawal by Subject|1|||
125202167|NCT01459718|450363597|FG000|Overall Study|Physician Decision|1|||
125202168|NCT01459718|450363597|FG000|Overall Study|Lost to Follow-up|1|||
125202169|NCT01459718|450363597|FG000|Overall Study|Adverse Event|1|||
125202170|NCT01542034|450363600|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
125202171|NCT01542034|450363601|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
125202172|NCT01542034|450363600|FG000|Overall Study|Administrative decision|0|||
125202173|NCT01542034|450363601|FG001|Overall Study|Administrative decision|3|||
125202174|NCT01542034|450363600|FG000|Overall Study|Subject Noncompliance|1|||
125202175|NCT01542034|450363601|FG001|Overall Study|Subject Noncompliance|0|||
125202176|NCT01542034|450363600|FG000|Overall Study|Adverse Event|2|||
125202177|NCT01542034|450363601|FG001|Overall Study|Adverse Event|2|||
125202178|NCT01542034|450363600|FG000|Overall Study|Lost to Follow-up|7|||
125202179|NCT01542034|450363601|FG001|Overall Study|Lost to Follow-up|6|||
125202180|NCT02612610|450363602|FG000|Overall Study|Withdrawal by Subject|1|||
125202181|NCT02612610|450363603|FG001|Overall Study|Withdrawal by Subject|1|||
125202182|NCT02612610|450363604|FG002|Overall Study|Withdrawal by Subject|0|||
125202183|NCT02612610|450363605|FG003|Overall Study|Withdrawal by Subject|2|||
125202184|NCT02612610|450363602|FG000|Overall Study|Adverse Event|2|||
125202185|NCT02612610|450363603|FG001|Overall Study|Adverse Event|2|||
125202186|NCT02612610|450363604|FG002|Overall Study|Adverse Event|3|||
125202187|NCT02612610|450363605|FG003|Overall Study|Adverse Event|10|||
125202188|NCT02612610|450363602|FG000|Overall Study|Lost to Follow-up|0|||
125202189|NCT02612610|450363603|FG001|Overall Study|Lost to Follow-up|1|||
125202190|NCT02612610|450363604|FG002|Overall Study|Lost to Follow-up|0|||
125202191|NCT02612610|450363605|FG003|Overall Study|Lost to Follow-up|0|||
125202192|NCT02612610|450363602|FG000|Overall Study|Protocol Violation|0|||
125202193|NCT02612610|450363603|FG001|Overall Study|Protocol Violation|1|||
125202194|NCT02612610|450363604|FG002|Overall Study|Protocol Violation|1|||
125202195|NCT02612610|450363605|FG003|Overall Study|Protocol Violation|0|||
125202196|NCT02612610|450363602|FG000|Overall Study|Lack of Efficacy|1|||
125202197|NCT02612610|450363603|FG001|Overall Study|Lack of Efficacy|2|||
125202198|NCT02612610|450363604|FG002|Overall Study|Lack of Efficacy|0|||
125202199|NCT02612610|450363605|FG003|Overall Study|Lack of Efficacy|1|||
125202200|NCT02612610|450363602|FG000|Overall Study|Physician Decision|0|||
125202201|NCT02612610|450363603|FG001|Overall Study|Physician Decision|1|||
125202202|NCT02612610|450363604|FG002|Overall Study|Physician Decision|0|||
125202203|NCT02612610|450363605|FG003|Overall Study|Physician Decision|0|||
125202204|NCT02612610|450363602|FG000|Overall Study|Noncompliance|1|||
125202205|NCT02612610|450363603|FG001|Overall Study|Noncompliance|0|||
125202206|NCT02612610|450363604|FG002|Overall Study|Noncompliance|0|||
125202207|NCT02612610|450363605|FG003|Overall Study|Noncompliance|0|||
125202208|NCT02612610|450363602|FG000|Overall Study|Cough Improvement|0|||
125202209|NCT02612610|450363603|FG001|Overall Study|Cough Improvement|0|||
125202210|NCT02612610|450363604|FG002|Overall Study|Cough Improvement|1|||
125202211|NCT02612610|450363605|FG003|Overall Study|Cough Improvement|0|||
125202212|NCT00176644|450363606|FG000|Overall Study|Withdrawal by Subject|1|||
125202213|NCT01801280|450363607|FG000|Period 1|Withdrawal by Subject|0|||
125202214|NCT01801280|450363608|FG001|Period 1|Withdrawal by Subject|1|||
125202215|NCT01801280|450363609|FG002|Period 1|Withdrawal by Subject|0|||
125202216|NCT01801280|450363610|FG003|Period 1|Withdrawal by Subject|0|||
125202217|NCT01801280|450363607|FG000|Period 2|Withdrawal by Subject|1|||
125202218|NCT01801280|450363608|FG001|Period 2|Withdrawal by Subject|0|||
125202219|NCT01801280|450363609|FG002|Period 2|Withdrawal by Subject|0|||
125202220|NCT01801280|450363610|FG003|Period 2|Withdrawal by Subject|0|||
125202221|NCT01801280|450363607|FG000|Period 4|Protocol Violation|0|||
125202222|NCT01801280|450363608|FG001|Period 4|Protocol Violation|0|||
125202223|NCT01801280|450363609|FG002|Period 4|Protocol Violation|1|||
125202224|NCT01801280|450363610|FG003|Period 4|Protocol Violation|0|||
125202225|NCT02783729|450363611|FG000|Overall Study|Lack of Efficacy|1|||
125202226|NCT02783729|450363612|FG001|Overall Study|Lack of Efficacy|0|||
125202227|NCT02783729|450363613|FG002|Overall Study|Lack of Efficacy|0|||
125202228|NCT02783729|450363614|FG003|Overall Study|Lack of Efficacy|0|||
125202229|NCT02783729|450363611|FG000|Overall Study|Adverse Event|2|||
125202230|NCT02783729|450363612|FG001|Overall Study|Adverse Event|6|||
125202231|NCT02783729|450363613|FG002|Overall Study|Adverse Event|2|||
125202232|NCT02783729|450363614|FG003|Overall Study|Adverse Event|3|||
125424850|NCT02157779|451178696|FG001|Overall Study|Moved|0|||
125202233|NCT02783729|450363611|FG000|Overall Study|Other|1|||
125424851|NCT02157779|451178695|FG000|Overall Study|Medical|1|||
125424852|NCT02157779|451178696|FG001|Overall Study|Medical|0|||
125202234|NCT02783729|450363612|FG001|Overall Study|Other|6|||
125202235|NCT02783729|450363613|FG002|Overall Study|Other|2|||
125202236|NCT02783729|450363614|FG003|Overall Study|Other|3|||
125202237|NCT02783729|450363611|FG000|Overall Study|Withdrawal by Subject|2|||
125202238|NCT02783729|450363612|FG001|Overall Study|Withdrawal by Subject|3|||
125202239|NCT02783729|450363613|FG002|Overall Study|Withdrawal by Subject|1|||
125202240|NCT02783729|450363614|FG003|Overall Study|Withdrawal by Subject|2|||
125202241|NCT02783729|450363611|FG000|Overall Study|Participant's choice|2|||
125202242|NCT02783729|450363612|FG001|Overall Study|Participant's choice|1|||
125202243|NCT02783729|450363613|FG002|Overall Study|Participant's choice|2|||
125202244|NCT02783729|450363614|FG003|Overall Study|Participant's choice|1|||
125202245|NCT02783729|450363611|FG000|Overall Study|Lost to Follow-up|2|||
125202246|NCT02783729|450363612|FG001|Overall Study|Lost to Follow-up|1|||
125202247|NCT02783729|450363613|FG002|Overall Study|Lost to Follow-up|1|||
125202248|NCT02783729|450363614|FG003|Overall Study|Lost to Follow-up|0|||
125202249|NCT02693171|450363615|FG000|Overall Study|Adverse Event|1|||
125202250|NCT02693171|450363615|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
125202251|NCT01866657|450363623|FG000|Overall Study|Surgery canceled|2|||
125202252|NCT01866657|450363624|FG001|Overall Study|Surgery canceled|0|||
125202253|NCT02288091|450363631|FG000|Overall Study|Lost to Follow-up|1|||
125202254|NCT02288091|450363631|FG000|Overall Study|Screen fail|7|||
125202255|NCT04021121|450363633|FG000|Overall Study|Death|3|||
125202256|NCT04021121|450363634|FG001|Overall Study|Death|3|||
125202257|NCT04021121|450363635|FG002|Overall Study|Death|5|||
125202258|NCT04021121|450363636|FG003|Overall Study|Death|4|||
125202259|NCT00978250|450363640|FG000|Overall Study|Late determination of ineligibility|0|||
125202260|NCT00978250|450363641|FG001|Overall Study|Late determination of ineligibility|1|||
125202261|NCT00978250|450363642|FG002|Overall Study|Late determination of ineligibility|0|||
125202262|NCT00978250|450363643|FG003|Overall Study|Late determination of ineligibility|1|||
125202263|NCT02029989|450363646|FG000|Overall Study|Withdrawal by Subject|1|||
125202264|NCT02029989|450363647|FG001|Overall Study|Withdrawal by Subject|0|||
125537852|NCT01012414|451600174|FG000|Overall Study|Lost to Follow-up|1|||
125537853|NCT01012414|451600174|FG000|Overall Study|Trial was stopped before completed|7|||
125537854|NCT00506441|451600175|FG000|Period 1; Open-label Period|Adverse Event|21|||
125537855|NCT00506441|451600176|FG001|Period 1; Open-label Period|Adverse Event|0|||
125537856|NCT00506441|451600175|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
125537857|NCT00506441|451600176|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
125537858|NCT00506441|451600175|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
125537859|NCT00506441|451600176|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
125537860|NCT00506441|451600175|FG000|Period 1; Open-label Period|Physician Decision|5|||
125537861|NCT00506441|451600176|FG001|Period 1; Open-label Period|Physician Decision|0|||
125537862|NCT00506441|451600175|FG000|Period 1; Open-label Period|Protocol Violation|9|||
125537863|NCT00506441|451600176|FG001|Period 1; Open-label Period|Protocol Violation|0|||
125537864|NCT00506441|451600175|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
125537865|NCT00506441|451600176|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
125537866|NCT00506441|451600175|FG000|Period 1; Open-label Period|Other Reasons|13|||
125537867|NCT00506441|451600176|FG001|Period 1; Open-label Period|Other Reasons|0|||
125537868|NCT00506441|451600175|FG000|Period 2; Double-blind Period|Adverse Event|0|||
125202265|NCT02029989|450363646|FG000|Overall Study|Withdrawal: Fear of needles|1|||
125202266|NCT02029989|450363647|FG001|Overall Study|Withdrawal: Fear of needles|0|||
125202267|NCT02029989|450363646|FG000|Overall Study|Change of location|2|||
125202268|NCT02029989|450363647|FG001|Overall Study|Change of location|3|||
125202269|NCT02029989|450363646|FG000|Overall Study|Physician Decision|2|||
125202270|NCT02029989|450363647|FG001|Overall Study|Physician Decision|0|||
125202271|NCT02029989|450363646|FG000|Overall Study|Lost to Follow-up|9|||
125202272|NCT02029989|450363647|FG001|Overall Study|Lost to Follow-up|7|||
125202273|NCT02029989|450363646|FG000|Overall Study|Death|0|||
125202274|NCT02029989|450363647|FG001|Overall Study|Death|1|||
125202275|NCT02029989|450363646|FG000|Overall Study|Protocol Violation|1|||
125202276|NCT02029989|450363647|FG001|Overall Study|Protocol Violation|0|||
125202277|NCT04351373|450363648|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
125424853|NCT02157779|451178695|FG000|Overall Study|Legal issue|1|||
125424854|NCT02157779|451178696|FG001|Overall Study|Legal issue|0|||
125424855|NCT00430248|451178699|FG000|Overall Study|Adverse Event|49|||
125424856|NCT00430248|451178700|FG001|Overall Study|Adverse Event|61|||
125424857|NCT00430248|451178701|FG002|Overall Study|Adverse Event|64|||
125424858|NCT00430248|451178699|FG000|Overall Study|Protocol Violation|10|||
125424859|NCT00430248|451178700|FG001|Overall Study|Protocol Violation|2|||
125424860|NCT00430248|451178701|FG002|Overall Study|Protocol Violation|4|||
125424861|NCT00430248|451178699|FG000|Overall Study|Personal Reasons|12|||
125424862|NCT00430248|451178700|FG001|Overall Study|Personal Reasons|24|||
125424863|NCT00430248|451178701|FG002|Overall Study|Personal Reasons|9|||
125424864|NCT00430248|451178699|FG000|Overall Study|Lost to Follow-up|28|||
125424865|NCT00430248|451178700|FG001|Overall Study|Lost to Follow-up|33|||
125424866|NCT00430248|451178701|FG002|Overall Study|Lost to Follow-up|28|||
125424867|NCT00430248|451178699|FG000|Overall Study|Therapeutic Failure|1|||
125424868|NCT00430248|451178700|FG001|Overall Study|Therapeutic Failure|1|||
125424869|NCT00430248|451178701|FG002|Overall Study|Therapeutic Failure|1|||
125537869|NCT00506441|451600176|FG001|Period 2; Double-blind Period|Adverse Event|1|||
125537870|NCT00506441|451600175|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
125537871|NCT00506441|451600176|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
125537872|NCT00506441|451600175|FG000|Period 2; Double-blind Period|Physician Decision|1|||
125537873|NCT00506441|451600176|FG001|Period 2; Double-blind Period|Physician Decision|1|||
125537874|NCT00506441|451600175|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
125537875|NCT00506441|451600176|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
125537876|NCT00506441|451600175|FG000|Period 2; Double-blind Period|Other Reason|1|||
125537877|NCT00506441|451600176|FG001|Period 2; Double-blind Period|Other Reason|1|||
125537878|NCT02601300|451600177|FG000|Induction Phase|Lack of Efficacy|2|||
125537879|NCT02601300|451600177|FG000|Induction Phase|Protocol Violation|1|||
125537880|NCT02601300|451600177|FG000|Extension Phase|Withdrawal by Subject|3|||
125537881|NCT02601300|451600177|FG000|Extension Phase|Adverse Event|4|||
125537882|NCT02601300|451600177|FG000|Extension Phase|Lack of Efficacy|10|||
125537883|NCT00528931|451600181|FG000|Overall Study|Lost to Follow-up|1|||
125537884|NCT00992225|451600182|FG000|Overall Study|Entry Criteria Not Met|8|||
125537885|NCT00992225|451600182|FG000|Overall Study|Adverse Event|2|||
125537886|NCT00291642|451600185|FG000|Overall Study|Adverse Event|1|||
125537887|NCT00291642|451600186|FG001|Overall Study|Adverse Event|0|||
125537888|NCT00291642|451600187|FG002|Overall Study|Adverse Event|1|||
125537889|NCT00291642|451600188|FG003|Overall Study|Adverse Event|0|||
125537890|NCT00291642|451600189|FG004|Overall Study|Adverse Event|1|||
125537891|NCT00291642|451600185|FG000|Overall Study|Patient missed visit|0|||
125537892|NCT00291642|451600186|FG001|Overall Study|Patient missed visit|0|||
125537893|NCT00291642|451600187|FG002|Overall Study|Patient missed visit|1|||
125537894|NCT00291642|451600188|FG003|Overall Study|Patient missed visit|0|||
125537895|NCT00291642|451600189|FG004|Overall Study|Patient missed visit|0|||
125537896|NCT00291642|451600185|FG000|Overall Study|Intake of prohibited medication|1|||
125537897|NCT00291642|451600186|FG001|Overall Study|Intake of prohibited medication|0|||
125537898|NCT00291642|451600187|FG002|Overall Study|Intake of prohibited medication|0|||
125537899|NCT00291642|451600188|FG003|Overall Study|Intake of prohibited medication|0|||
125537900|NCT00291642|451600189|FG004|Overall Study|Intake of prohibited medication|0|||
125537901|NCT02576587|451600194|FG000|Baseline|Equipment failure|0|||
125537902|NCT02576587|451600195|FG001|Baseline|Equipment failure|1|||
125537903|NCT02576587|451600194|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
125537904|NCT02576587|451600195|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
125537905|NCT02576587|451600194|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
125537906|NCT02576587|451600195|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
125537907|NCT02576587|451600194|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
125537908|NCT02576587|451600195|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
125537909|NCT00532493|451600196|FG000|Overall Study|Death|1|||
125537910|NCT00532493|451600197|FG001|Overall Study|Death|1|||
125537911|NCT00532493|451600196|FG000|Overall Study|Lost to Follow-up|10|||
125537912|NCT00532493|451600197|FG001|Overall Study|Lost to Follow-up|7|||
125537913|NCT00532493|451600196|FG000|Overall Study|Withdrawal by Subject|7|||
125537914|NCT00532493|451600197|FG001|Overall Study|Withdrawal by Subject|9|||
125537915|NCT00532493|451600196|FG000|Overall Study|Physician Decision|1|||
125537916|NCT00532493|451600197|FG001|Overall Study|Physician Decision|6|||
125537917|NCT00532493|451600196|FG000|Overall Study|Adverse Event|6|||
125537918|NCT00532493|451600197|FG001|Overall Study|Adverse Event|5|||
125537919|NCT00532493|451600196|FG000|Overall Study|Protocol Deviation|1|||
125537920|NCT00532493|451600197|FG001|Overall Study|Protocol Deviation|0|||
125537921|NCT00532493|451600196|FG000|Overall Study|Subject Moved Away|3|||
125537922|NCT00532493|451600197|FG001|Overall Study|Subject Moved Away|1|||
125537923|NCT00532493|451600196|FG000|Overall Study|Contraindicative Medication|1|||
125537924|NCT00532493|451600197|FG001|Overall Study|Contraindicative Medication|0|||
125537925|NCT00738894|451600200|FG000|Overall Study|Lost to Follow-up|23|||
125537926|NCT00738894|451600201|FG001|Overall Study|Lost to Follow-up|13|||
125537927|NCT00738894|451600200|FG000|Overall Study|Withdrawal by Subject|10|||
125537928|NCT00738894|451600201|FG001|Overall Study|Withdrawal by Subject|15|||
125537929|NCT00738894|451600200|FG000|Overall Study|Physician Decision|4|||
125202278|NCT00471718|450363660|FG000|Overall Study|Adverse Event|3|||
125202279|NCT00471718|450363660|FG000|Overall Study|other complicating disease|1|||
125202280|NCT00471718|450363660|FG000|Overall Study|disease progression|22|||
125537930|NCT00738894|451600201|FG001|Overall Study|Physician Decision|5|||
125537931|NCT00738894|451600200|FG000|Overall Study|Death|2|||
125537932|NCT00738894|451600201|FG001|Overall Study|Death|0|||
125537933|NCT02546921|451600208|FG000|Overall Study|Adverse Event|0|||
125537934|NCT02546921|451600209|FG001|Overall Study|Adverse Event|5|||
125537935|NCT02546921|451600210|FG002|Overall Study|Adverse Event|2|||
125537936|NCT02546921|451600211|FG003|Overall Study|Adverse Event|0|||
125537937|NCT02546921|451600212|FG004|Overall Study|Adverse Event|0|||
125537938|NCT02546921|451600213|FG005|Overall Study|Adverse Event|0|||
125537939|NCT02546921|451600214|FG006|Overall Study|Adverse Event|0|||
125202281|NCT00471718|450363660|FG000|Overall Study|Withdrawal by Subject|1|||
125202282|NCT01597375|450363663|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
125537940|NCT02546921|451600208|FG000|Overall Study|Evidence of Disease Progression|1|||
125537941|NCT02546921|451600209|FG001|Overall Study|Evidence of Disease Progression|0|||
125537942|NCT02546921|451600210|FG002|Overall Study|Evidence of Disease Progression|0|||
125537943|NCT02546921|451600211|FG003|Overall Study|Evidence of Disease Progression|0|||
125537944|NCT02546921|451600212|FG004|Overall Study|Evidence of Disease Progression|1|||
125537945|NCT02546921|451600213|FG005|Overall Study|Evidence of Disease Progression|0|||
125537946|NCT02546921|451600214|FG006|Overall Study|Evidence of Disease Progression|0|||
125537947|NCT02546921|451600208|FG000|Overall Study|Patient Choice|0|||
125537948|NCT02546921|451600209|FG001|Overall Study|Patient Choice|1|||
125537949|NCT02546921|451600210|FG002|Overall Study|Patient Choice|0|||
125537950|NCT02546921|451600211|FG003|Overall Study|Patient Choice|0|||
125537951|NCT02546921|451600212|FG004|Overall Study|Patient Choice|0|||
125537952|NCT02546921|451600213|FG005|Overall Study|Patient Choice|1|||
125537953|NCT02546921|451600214|FG006|Overall Study|Patient Choice|0|||
125537954|NCT00680992|451600218|FG000|Overall Study|Complete Resection (as per protocol)|25|||
125537955|NCT00680992|451600219|FG001|Overall Study|Complete Resection (as per protocol)|121|||
125537956|NCT00680992|451600220|FG002|Overall Study|Complete Resection (as per protocol)|0|||
125537957|NCT00680992|451600218|FG000|Overall Study|Administrative Decision|83|||
125537958|NCT00680992|451600219|FG001|Overall Study|Administrative Decision|42|||
125537959|NCT00680992|451600220|FG002|Overall Study|Administrative Decision|5|||
125537960|NCT00680992|451600218|FG000|Overall Study|End of Trial|32|||
125537961|NCT00680992|451600219|FG001|Overall Study|End of Trial|12|||
125537962|NCT00680992|451600220|FG002|Overall Study|End of Trial|3|||
125537963|NCT00680992|451600218|FG000|Overall Study|Withdrawal by Subject|33|||
125537964|NCT00680992|451600219|FG001|Overall Study|Withdrawal by Subject|11|||
125537965|NCT00680992|451600220|FG002|Overall Study|Withdrawal by Subject|1|||
125537966|NCT00680992|451600218|FG000|Overall Study|Adverse Event|21|||
125537967|NCT00680992|451600219|FG001|Overall Study|Adverse Event|19|||
125537968|NCT00680992|451600220|FG002|Overall Study|Adverse Event|1|||
125537969|NCT00680992|451600218|FG000|Overall Study|Other|19|||
125537970|NCT00680992|451600219|FG001|Overall Study|Other|14|||
125537971|NCT00680992|451600220|FG002|Overall Study|Other|1|||
125537972|NCT00680992|451600218|FG000|Overall Study|Disease Progression|21|||
125537973|NCT00680992|451600219|FG001|Overall Study|Disease Progression|9|||
125537974|NCT00680992|451600220|FG002|Overall Study|Disease Progression|0|||
125537975|NCT00680992|451600218|FG000|Overall Study|Lost to Follow-up|12|||
125537976|NCT00680992|451600219|FG001|Overall Study|Lost to Follow-up|14|||
125537977|NCT00680992|451600220|FG002|Overall Study|Lost to Follow-up|0|||
125537978|NCT00680992|451600218|FG000|Overall Study|Noncompliance|4|||
125537979|NCT00680992|451600219|FG001|Overall Study|Noncompliance|6|||
125537980|NCT00680992|451600220|FG002|Overall Study|Noncompliance|0|||
125537981|NCT00680992|451600218|FG000|Overall Study|Requirement for Alternative Therapy|8|||
125537982|NCT00680992|451600219|FG001|Overall Study|Requirement for Alternative Therapy|2|||
125537983|NCT00680992|451600220|FG002|Overall Study|Requirement for Alternative Therapy|0|||
125537984|NCT00680992|451600218|FG000|Overall Study|Pregnancy|5|||
125537985|NCT00680992|451600219|FG001|Overall Study|Pregnancy|0|||
125537986|NCT00680992|451600220|FG002|Overall Study|Pregnancy|1|||
125537987|NCT00680992|451600218|FG000|Overall Study|Death|5|||
125537988|NCT00680992|451600219|FG001|Overall Study|Death|1|||
125537989|NCT00680992|451600220|FG002|Overall Study|Death|0|||
125537990|NCT00680992|451600218|FG000|Overall Study|Ineligibility Determined|0|||
125537991|NCT00680992|451600219|FG001|Overall Study|Ineligibility Determined|1|||
125537992|NCT00680992|451600220|FG002|Overall Study|Ineligibility Determined|0|||
125537993|NCT01585155|451600221|FG000|Overall Study|Adverse Event|1|||
125537994|NCT01585155|451600221|FG000|Overall Study|Lack of Efficacy|2|||
125537995|NCT01585155|451600221|FG000|Overall Study|Worsening ulcerative colitis|2|||
125537996|NCT01397422|451600226|FG000|Overall Study|Adverse Event|0|||
125537997|NCT01397422|451600227|FG001|Overall Study|Adverse Event|3|||
125537998|NCT01397422|451600228|FG002|Overall Study|Adverse Event|3|||
125537999|NCT01397422|451600229|FG003|Overall Study|Adverse Event|8|||
125538000|NCT01397422|451600226|FG000|Overall Study|Withdrawal by Subject|1|||
125538001|NCT01397422|451600227|FG001|Overall Study|Withdrawal by Subject|0|||
125538002|NCT01397422|451600228|FG002|Overall Study|Withdrawal by Subject|0|||
125538003|NCT01397422|451600229|FG003|Overall Study|Withdrawal by Subject|0|||
125538004|NCT01397422|451600226|FG000|Overall Study|Increased bradykinesia related to PD|1|||
125538005|NCT01397422|451600227|FG001|Overall Study|Increased bradykinesia related to PD|0|||
125538006|NCT01397422|451600228|FG002|Overall Study|Increased bradykinesia related to PD|0|||
125538007|NCT01397422|451600229|FG003|Overall Study|Increased bradykinesia related to PD|0|||
125538008|NCT03772587|451600230|FG000|Overall Study|COVID-19|0|||
125538009|NCT03772587|451600231|FG001|Overall Study|COVID-19|0|||
125538010|NCT03772587|451600232|FG002|Overall Study|COVID-19|1|||
125538011|NCT03772587|451600233|FG003|Overall Study|COVID-19|1|||
125538012|NCT03772587|451600234|FG004|Overall Study|COVID-19|0|||
125538013|NCT03772587|451600230|FG000|Overall Study|Withdrawal by Subject|1|||
125538014|NCT03772587|451600231|FG001|Overall Study|Withdrawal by Subject|0|||
125538015|NCT03772587|451600232|FG002|Overall Study|Withdrawal by Subject|0|||
125538016|NCT03772587|451600233|FG003|Overall Study|Withdrawal by Subject|0|||
125538017|NCT03772587|451600234|FG004|Overall Study|Withdrawal by Subject|0|||
125538018|NCT00513305|451600235|FG000|Overall Study|Adverse Event|6|||
125538019|NCT00513305|451600236|FG001|Overall Study|Adverse Event|2|||
125538020|NCT00513305|451600235|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
125538021|NCT00513305|451600236|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
125538022|NCT00513305|451600235|FG000|Overall Study|Lack of Efficacy|8|||
125538023|NCT00513305|451600236|FG001|Overall Study|Lack of Efficacy|13|||
125538024|NCT00513305|451600235|FG000|Overall Study|Withdrawal by Subject|1|||
125538025|NCT00513305|451600236|FG001|Overall Study|Withdrawal by Subject|2|||
125538026|NCT00513305|451600235|FG000|Overall Study|Disease progression|8|||
125538027|NCT00513305|451600236|FG001|Overall Study|Disease progression|5|||
125538028|NCT00513305|451600235|FG000|Overall Study|Eligible for stem cell transplant|1|||
125538029|NCT00513305|451600236|FG001|Overall Study|Eligible for stem cell transplant|0|||
125538030|NCT00513305|451600235|FG000|Overall Study|Hematologic counts did not recover|1|||
125538031|NCT00513305|451600236|FG001|Overall Study|Hematologic counts did not recover|0|||
125538032|NCT00513305|451600235|FG000|Overall Study|Physician Decision|1|||
125538033|NCT00513305|451600236|FG001|Overall Study|Physician Decision|0|||
125538034|NCT00513305|451600235|FG000|Overall Study|Persistent hypocellularity|0|||
125538035|NCT00513305|451600236|FG001|Overall Study|Persistent hypocellularity|1|||
125538036|NCT00513305|451600235|FG000|Overall Study|Sponsor Decision|0|||
125538037|NCT00513305|451600236|FG001|Overall Study|Sponsor Decision|2|||
125538038|NCT03798691|451600237|FG000|Overall Study|Lost to Follow-up|2|||
125538039|NCT03798691|451600238|FG001|Overall Study|Lost to Follow-up|2|||
125538040|NCT05148962|451600239|FG000|Overall Study|Withdrawal by Subject|1|||
125538041|NCT05148962|451600240|FG001|Overall Study|Withdrawal by Subject|1|||
125538042|NCT05148962|451600241|FG002|Overall Study|Withdrawal by Subject|0|||
125538043|NCT05148962|451600242|FG003|Overall Study|Withdrawal by Subject|1|||
125538044|NCT05148962|451600243|FG004|Overall Study|Withdrawal by Subject|0|||
125538045|NCT05148962|451600239|FG000|Overall Study|Participant was early terminated per protocol|0|||
125538046|NCT05148962|451600240|FG001|Overall Study|Participant was early terminated per protocol|0|||
125538047|NCT05148962|451600241|FG002|Overall Study|Participant was early terminated per protocol|3|||
125538048|NCT05148962|451600242|FG003|Overall Study|Participant was early terminated per protocol|5|||
125538049|NCT05148962|451600243|FG004|Overall Study|Participant was early terminated per protocol|2|||
125538050|NCT05148962|451600239|FG000|Overall Study|Miscellaneous|0|||
125538051|NCT05148962|451600240|FG001|Overall Study|Miscellaneous|0|||
125538052|NCT05148962|451600241|FG002|Overall Study|Miscellaneous|0|||
125538053|NCT05148962|451600242|FG003|Overall Study|Miscellaneous|1|||
125538054|NCT05148962|451600243|FG004|Overall Study|Miscellaneous|0|||
125538055|NCT01525238|451600246|FG000|Overall Study|Withdrawal by Subject|1|||
125538056|NCT01525238|451600247|FG001|Overall Study|Withdrawal by Subject|0|||
125538057|NCT01525238|451600248|FG002|Overall Study|Withdrawal by Subject|0|||
125538058|NCT00151281|451600249|FG000|Overall Study|Not evaluable|3|||
125538059|NCT01133418|451600250|FG000|Overall Study|Lost to Follow-up|5|||
125538060|NCT01133418|451600251|FG001|Overall Study|Lost to Follow-up|6|||
125538061|NCT01077271|451602432|FG000|Overall Study|Parental desire|8|||
125538062|NCT01077271|451602432|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
125538063|NCT01077271|451602432|FG000|Overall Study|Noncompliance|2|||
125538064|NCT01077271|451602432|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
125538065|NCT01077271|451602432|FG000|Overall Study|Changed doctors|2|||
125538066|NCT01077271|451602432|FG000|Overall Study|Parents thought too many injections|2|||
125538067|NCT01077271|451602432|FG000|Overall Study|End of RSV season nearly reached|1|||
125538068|NCT01077271|451602432|FG000|Overall Study|Mother unconvinced of the necessity|1|||
125538069|NCT03333876|451602433|FG000|Screening Period|Screen Failure|4|||
125538070|NCT03333876|451602433|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
125538071|NCT03333876|451602433|FG000|Mandibular Advancement|Adverse Event|2|||
125538072|NCT03333876|451602433|FG000|Mandibular Advancement|Product Damage|2|||
125538073|NCT00095498|451602434|FG000|Overall Study|Physician Decision|9|||
125538074|NCT00095498|451602435|FG001|Overall Study|Physician Decision|10|||
125538075|NCT00095498|451602436|FG002|Overall Study|Physician Decision|8|||
125538076|NCT00095498|451602434|FG000|Overall Study|Adverse Event|1|||
125538077|NCT00095498|451602435|FG001|Overall Study|Adverse Event|0|||
125538078|NCT00095498|451602436|FG002|Overall Study|Adverse Event|1|||
125538079|NCT00095498|451602434|FG000|Overall Study|Withdrawal by Subject|15|||
125538080|NCT00095498|451602435|FG001|Overall Study|Withdrawal by Subject|16|||
125538081|NCT00095498|451602436|FG002|Overall Study|Withdrawal by Subject|15|||
125538082|NCT00095498|451602434|FG000|Overall Study|Disease progression|0|||
125202283|NCT01597375|450363664|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
125202284|NCT01597375|450363663|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
125202285|NCT01597375|450363664|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
125538083|NCT00095498|451602435|FG001|Overall Study|Disease progression|1|||
125538084|NCT00095498|451602436|FG002|Overall Study|Disease progression|1|||
125538085|NCT00095498|451602434|FG000|Overall Study|Ineligibility determined|3|||
125538086|NCT00095498|451602435|FG001|Overall Study|Ineligibility determined|0|||
125538087|NCT00095498|451602436|FG002|Overall Study|Ineligibility determined|2|||
125538088|NCT00095498|451602434|FG000|Overall Study|Lost to Follow-up|1|||
125538089|NCT00095498|451602435|FG001|Overall Study|Lost to Follow-up|1|||
125538090|NCT00095498|451602436|FG002|Overall Study|Lost to Follow-up|2|||
125538091|NCT00095498|451602434|FG000|Overall Study|Noncompliance|1|||
125538092|NCT00095498|451602435|FG001|Overall Study|Noncompliance|0|||
125538093|NCT00095498|451602436|FG002|Overall Study|Noncompliance|1|||
125538094|NCT00095498|451602434|FG000|Overall Study|Other|6|||
125538095|NCT00095498|451602435|FG001|Overall Study|Other|7|||
125538096|NCT00095498|451602436|FG002|Overall Study|Other|6|||
125538097|NCT00095498|451602434|FG000|Overall Study|Protocol Violation|0|||
125538098|NCT00095498|451602435|FG001|Overall Study|Protocol Violation|0|||
125538099|NCT00095498|451602436|FG002|Overall Study|Protocol Violation|1|||
125538100|NCT00095498|451602434|FG000|Overall Study|Requirement for alternative therapy|1|||
125538101|NCT00095498|451602435|FG001|Overall Study|Requirement for alternative therapy|0|||
125538102|NCT00095498|451602436|FG002|Overall Study|Requirement for alternative therapy|2|||
125538103|NCT05020327|451602437|FG000|Overall Study|Physician Decision|3|||
125538104|NCT05020327|451602438|FG001|Overall Study|Physician Decision|0|||
125538105|NCT05020327|451602439|FG002|Overall Study|Physician Decision|0|||
125538106|NCT05020327|451602437|FG000|Overall Study|Withdrawal by Subject|1|||
125538107|NCT05020327|451602438|FG001|Overall Study|Withdrawal by Subject|1|||
125538108|NCT05020327|451602439|FG002|Overall Study|Withdrawal by Subject|0|||
125538109|NCT05020327|451602437|FG000|Overall Study|personal/cultural, ineligible|12|||
125538110|NCT05020327|451602438|FG001|Overall Study|personal/cultural, ineligible|0|||
125538111|NCT05020327|451602439|FG002|Overall Study|personal/cultural, ineligible|0|||
125538112|NCT04684394|451602440|FG000|Overall Study|Death|1|||
125538113|NCT04684394|451602441|FG001|Overall Study|Death|2|||
125538114|NCT04684394|451602440|FG000|Overall Study|Lost to Follow-up|1|||
125538115|NCT04684394|451602441|FG001|Overall Study|Lost to Follow-up|0|||
125538116|NCT04684394|451602440|FG000|Overall Study|Withdrawal by Subject|2|||
125538117|NCT04684394|451602441|FG001|Overall Study|Withdrawal by Subject|0|||
125538118|NCT04684394|451602440|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
125538119|NCT04684394|451602441|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
125538120|NCT00591370|451602443|FG000|Overall Study|Not Treated|2|||
125538121|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
125538122|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
125538123|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
125538124|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
125538125|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
125538126|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
125538127|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
125538128|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
125538129|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
125538130|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
125538131|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
125538132|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
125538133|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Death|1|||
125538134|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Death|2|||
125538135|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Death|2|||
125538136|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Death|0|||
125538137|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Death|0|||
125538138|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Death|0|||
125538139|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
125538140|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
125538141|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
125538142|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
125538143|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
125538144|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
125538145|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
125538146|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
125538147|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
125538148|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
125538149|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
125538150|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
125538151|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
125538152|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
125538153|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
125538154|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
125538155|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
125538156|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
125538157|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
125637196|NCT03073200|451952832|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
125538158|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
125538159|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
125538160|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
125538161|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
125538162|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
125538163|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
125538164|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
125538165|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
125538166|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
125538167|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
125538168|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
125538169|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
125538170|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
125538171|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
125538172|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
125538173|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
125538174|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
125538175|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
125538176|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
125538177|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
125538178|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
125538179|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
125538180|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
125538181|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Site closure|0|||
125538182|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Site closure|0|||
125538183|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Site closure|1|||
125538184|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Site closure|0|||
125538185|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Site closure|0|||
125538186|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Site closure|0|||
125538187|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
125538188|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
125538189|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
125538190|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
125538191|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
125538192|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
125538193|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
125538194|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
125538195|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
125538196|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
125538197|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
125538198|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
125538199|NCT03439254|451602444|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
125538200|NCT03439254|451602445|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
125538201|NCT03439254|451602446|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
125538202|NCT03439254|451602447|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
125538203|NCT03439254|451602448|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
125538204|NCT03439254|451602449|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
125538205|NCT03439254|451602444|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
125538206|NCT03439254|451602445|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
125538207|NCT03439254|451602446|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
125538208|NCT03439254|451602447|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
125538209|NCT03439254|451602448|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
125538210|NCT03439254|451602449|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
125538211|NCT03439254|451602444|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
125538212|NCT03439254|451602445|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
125538213|NCT03439254|451602446|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
125538214|NCT03439254|451602447|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
125538215|NCT03439254|451602448|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
125538216|NCT03439254|451602449|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
125538217|NCT03439254|451602444|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
125538218|NCT03439254|451602445|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
125538219|NCT03439254|451602446|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
125538220|NCT03439254|451602447|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
125538221|NCT03439254|451602448|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
125538222|NCT03439254|451602449|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
125538223|NCT03439254|451602444|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
125538224|NCT03439254|451602445|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
125538225|NCT03439254|451602446|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
125538226|NCT03439254|451602447|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
125538227|NCT03439254|451602448|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
125538228|NCT03439254|451602449|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
125538229|NCT03439254|451602444|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
125538230|NCT03439254|451602445|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
125538231|NCT03439254|451602446|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
125538232|NCT03439254|451602447|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
125538233|NCT03439254|451602448|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
125538234|NCT03439254|451602449|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
125538235|NCT03439254|451602444|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
125538236|NCT03439254|451602445|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
125538237|NCT03439254|451602446|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
125538238|NCT03439254|451602447|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
125538239|NCT03439254|451602448|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
125538240|NCT03439254|451602449|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
125538241|NCT03439254|451602444|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
125538242|NCT03439254|451602445|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
125538243|NCT03439254|451602446|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
125538244|NCT03439254|451602447|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
125538245|NCT03439254|451602448|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
125538246|NCT03439254|451602449|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
125538247|NCT03439254|451602444|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
125538248|NCT03439254|451602445|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
125538249|NCT03439254|451602446|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
125538250|NCT03439254|451602447|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
125538251|NCT03439254|451602448|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
125538252|NCT03439254|451602449|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
125538253|NCT03439254|451602444|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
125538254|NCT03439254|451602445|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
125538255|NCT03439254|451602446|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
125538256|NCT03439254|451602447|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
125538257|NCT03439254|451602448|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
125538258|NCT03439254|451602449|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
125538259|NCT02075476|451602451|FG000|Overall Study|Death|2|||
125538260|NCT02075476|451602452|FG001|Overall Study|Death|2|||
125538261|NCT02075476|451602451|FG000|Overall Study|Lost to Follow-up|1|||
125538262|NCT02075476|451602452|FG001|Overall Study|Lost to Follow-up|3|||
125538263|NCT00095056|451602453|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
125538264|NCT00095056|451602454|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
125538265|NCT00095056|451602453|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
125538266|NCT00095056|451602454|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
125538267|NCT00095056|451602453|FG000|Phase A (Weeks 0-12)|Death|1|||
125538268|NCT00095056|451602454|FG001|Phase A (Weeks 0-12)|Death|0|||
125538269|NCT00095056|451602453|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
125538270|NCT00095056|451602454|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
125538271|NCT00095056|451602453|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
125538272|NCT00095056|451602454|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
125538273|NCT00095056|451602453|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
125538274|NCT00095056|451602454|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
125538275|NCT00095056|451602453|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
125538276|NCT00095056|451602454|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
125538277|NCT00095056|451602453|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
125538278|NCT00095056|451602454|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
125538279|NCT00095056|451602453|FG000|Phase B (Weeks 12-54)|Death|3|||
125538280|NCT00095056|451602454|FG001|Phase B (Weeks 12-54)|Death|1|||
125538281|NCT00095056|451602453|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
125538282|NCT00095056|451602454|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
125538283|NCT00095056|451602453|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
125538284|NCT00095056|451602454|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
125538285|NCT00923260|451602460|FG000|Overall Study|Lost to Follow-up|1|||
125538286|NCT00923260|451602461|FG001|Overall Study|Lost to Follow-up|1|||
125538287|NCT00836745|451602465|FG000|Overall Study|Death|2|||
125538288|NCT00836745|451602465|FG000|Overall Study|Lost to Follow-up|10|||
125538289|NCT00836745|451602465|FG000|Overall Study|Adverse Event|3|||
125538290|NCT00836745|451602465|FG000|Overall Study|Objective progression or relapse|4|||
125538291|NCT00836745|451602465|FG000|Overall Study|Other|2|||
125538292|NCT02121301|451602467|FG000|Overall Study|Protocol Violation|1|||
125538293|NCT02121301|451602468|FG001|Overall Study|Protocol Violation|4|||
125538294|NCT02121301|451602469|FG002|Overall Study|Protocol Violation|1|||
125538295|NCT00436852|451602475|FG000|Overall Study|Death|23|||
125538296|NCT00436852|451602476|FG001|Overall Study|Death|34|||
125538297|NCT00436852|451602475|FG000|Overall Study|Lack of Efficacy|9|||
125538298|NCT00436852|451602476|FG001|Overall Study|Lack of Efficacy|7|||
125538299|NCT00436852|451602475|FG000|Overall Study|Withdrawal by Subject|2|||
125538300|NCT00436852|451602476|FG001|Overall Study|Withdrawal by Subject|4|||
125538301|NCT00436852|451602475|FG000|Overall Study|Ineligible|1|||
125538302|NCT00436852|451602476|FG001|Overall Study|Ineligible|0|||
125538303|NCT00370682|451602477|FG000|Overall Study|Moved from area|0|||
125538304|NCT00370682|451602478|FG001|Overall Study|Moved from area|2|||
125538305|NCT00370682|451602479|FG002|Overall Study|Moved from area|0|||
125538306|NCT00370682|451602477|FG000|Overall Study|Lost to Follow-up|0|||
125538307|NCT00370682|451602478|FG001|Overall Study|Lost to Follow-up|1|||
125538308|NCT00370682|451602479|FG002|Overall Study|Lost to Follow-up|1|||
125538309|NCT00943852|451602480|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
125538310|NCT00943852|451602481|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
125538311|NCT00943852|451602482|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
125538312|NCT00943852|451602483|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
125538313|NCT00943852|451602484|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
125538314|NCT00943852|451602485|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
125538315|NCT00943852|451602486|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
125538316|NCT00943852|451602487|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
125538317|NCT00943852|451602488|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
125538318|NCT00943852|451602489|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
125538319|NCT00943852|451602480|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
125538320|NCT00943852|451602481|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
125538321|NCT00943852|451602482|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
125538322|NCT00943852|451602483|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
125538323|NCT00943852|451602484|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
125538324|NCT00943852|451602485|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
125538325|NCT00943852|451602486|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
125538326|NCT00943852|451602487|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
125538327|NCT00943852|451602488|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
125538328|NCT00943852|451602489|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
125538329|NCT00943852|451602480|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
125538330|NCT00943852|451602481|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
125538331|NCT00943852|451602482|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
125538332|NCT00943852|451602483|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
125538333|NCT00943852|451602484|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
125538334|NCT00943852|451602485|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
125538335|NCT00943852|451602486|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
125538336|NCT00943852|451602487|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
125538337|NCT00943852|451602488|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
125538338|NCT00943852|451602489|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
125538339|NCT00943852|451602480|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
125538340|NCT00943852|451602481|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
125538341|NCT00943852|451602482|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
125538342|NCT00943852|451602483|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
125538343|NCT00943852|451602484|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
125538344|NCT00943852|451602485|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
125538345|NCT00943852|451602486|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
125646219|NCT03370133|451988241|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
125202286|NCT01597375|450363663|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
125202287|NCT01597375|450363664|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
125202288|NCT01597375|450363663|FG000|Washout (2 Weeks)|Adverse Event|1|||
125538346|NCT00943852|451602487|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
125538347|NCT00943852|451602488|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
125538348|NCT00943852|451602489|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
125538349|NCT00943852|451602480|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
125538350|NCT00943852|451602481|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
125538351|NCT00943852|451602482|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
125538352|NCT00943852|451602483|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
125538353|NCT00943852|451602484|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
125538354|NCT00943852|451602485|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
125538355|NCT00943852|451602486|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
125538356|NCT00943852|451602487|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
125538357|NCT00943852|451602488|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
125538358|NCT00943852|451602489|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
125538359|NCT02141620|451602490|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
125538360|NCT02141620|451602491|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
125538361|NCT03651622|451602492|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
125538362|NCT03651622|451602493|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
125538363|NCT03651622|451602494|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
125538364|NCT03651622|451602492|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
125538365|NCT03651622|451602493|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
125538366|NCT03651622|451602494|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
125538367|NCT03651622|451602492|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
125538368|NCT03651622|451602493|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
125538369|NCT03651622|451602494|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
125538370|NCT03651622|451602492|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
125538371|NCT03651622|451602493|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
125538372|NCT03651622|451602494|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
125538373|NCT03651622|451602492|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
125538374|NCT03651622|451602493|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
125538375|NCT03651622|451602494|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
125538376|NCT03377699|451602495|FG000|Overall Study|Withdrawal by Subject|2|||
125538377|NCT03377699|451602496|FG001|Overall Study|Withdrawal by Subject|9|||
125538378|NCT03377699|451602495|FG000|Overall Study|Lost to Follow-up|1|||
125538379|NCT03377699|451602496|FG001|Overall Study|Lost to Follow-up|1|||
125538380|NCT03377699|451602495|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
125538381|NCT03377699|451602496|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
125538382|NCT03377699|451602495|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
125538383|NCT03377699|451602496|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
125538384|NCT03377699|451602495|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
125538385|NCT03377699|451602496|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
125538386|NCT03377699|451602495|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
125538387|NCT03377699|451602496|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
125538388|NCT00307684|451602497|FG000|Open Label Phase|Lack of Efficacy|0|||
125538389|NCT00307684|451602498|FG001|Open Label Phase|Lack of Efficacy|0|||
125538390|NCT00307684|451602499|FG002|Open Label Phase|Lack of Efficacy|3|||
125538391|NCT00307684|451602497|FG000|Open Label Phase|Adverse Event|0|||
125538392|NCT00307684|451602498|FG001|Open Label Phase|Adverse Event|0|||
125538393|NCT00307684|451602499|FG002|Open Label Phase|Adverse Event|16|||
125538394|NCT00307684|451602497|FG000|Open Label Phase|Withdrawal by Subject|0|||
125538395|NCT00307684|451602498|FG001|Open Label Phase|Withdrawal by Subject|0|||
125538396|NCT00307684|451602499|FG002|Open Label Phase|Withdrawal by Subject|15|||
125538397|NCT00307684|451602497|FG000|Open Label Phase|Lost to Follow-up|0|||
125538398|NCT00307684|451602498|FG001|Open Label Phase|Lost to Follow-up|0|||
125538399|NCT00307684|451602499|FG002|Open Label Phase|Lost to Follow-up|11|||
125538400|NCT00307684|451602497|FG000|Open Label Phase|non compliance|0|||
125538401|NCT00307684|451602498|FG001|Open Label Phase|non compliance|0|||
125538402|NCT00307684|451602499|FG002|Open Label Phase|non compliance|5|||
125538403|NCT00307684|451602497|FG000|Open Label Phase|other|0|||
125538404|NCT00307684|451602498|FG001|Open Label Phase|other|0|||
125538405|NCT00307684|451602499|FG002|Open Label Phase|other|6|||
125538406|NCT00307684|451602497|FG000|Double Blind Phase|Lack of Efficacy|2|||
125538407|NCT00307684|451602498|FG001|Double Blind Phase|Lack of Efficacy|5|||
125538408|NCT00307684|451602499|FG002|Double Blind Phase|Lack of Efficacy|0|||
125538409|NCT02580305|451602500|FG000|Overall Study|Adverse Event|15|||
125538410|NCT02580305|451602501|FG001|Overall Study|Adverse Event|19|||
125202289|NCT01597375|450363664|FG001|Washout (2 Weeks)|Adverse Event|0|||
125202290|NCT01597375|450363663|FG000|Second Intervention|Failed to react at both Aspirin|1|||
125202291|NCT01597375|450363664|FG001|Second Intervention|Failed to react at both Aspirin|1|||
125202292|NCT02294175|450363669|FG000|Overall Study|Withdrawal by Subject|1|||
125202293|NCT02294175|450363670|FG001|Overall Study|Withdrawal by Subject|2|||
125202294|NCT02294175|450363669|FG000|Overall Study|pt taking excluded medication|3|||
125202295|NCT02294175|450363670|FG001|Overall Study|pt taking excluded medication|1|||
125202296|NCT02294175|450363669|FG000|Overall Study|Protocol Violation|1|||
125202297|NCT02294175|450363670|FG001|Overall Study|Protocol Violation|0|||
125202298|NCT02294175|450363669|FG000|Overall Study|Lost to Follow-up|0|||
125202299|NCT02294175|450363670|FG001|Overall Study|Lost to Follow-up|1|||
125202300|NCT02294175|450363669|FG000|Overall Study|wound healed|0|||
125202301|NCT02294175|450363670|FG001|Overall Study|wound healed|2|||
125202302|NCT04696354|450363674|FG000|Overall Study|Study termination|6|||
125202303|NCT04696354|450363675|FG001|Overall Study|Study termination|6|||
125202304|NCT05238025|450363676|FG000|Overall Study|Adverse Event|2|||
125202305|NCT05238025|450363677|FG001|Overall Study|Adverse Event|2|||
125202306|NCT05238025|450363676|FG000|Overall Study|Lost to Follow-up|334|||
125202307|NCT05238025|450363677|FG001|Overall Study|Lost to Follow-up|339|||
125202308|NCT05238025|450363676|FG000|Overall Study|Withdrawal by Subject|203|||
125202309|NCT05238025|450363677|FG001|Overall Study|Withdrawal by Subject|222|||
125202310|NCT05238025|450363676|FG000|Overall Study|Physician Decision|20|||
125202311|NCT05238025|450363677|FG001|Overall Study|Physician Decision|8|||
125202312|NCT05238025|450363676|FG000|Overall Study|Protocol Violation|6|||
125202313|NCT05238025|450363677|FG001|Overall Study|Protocol Violation|2|||
125202314|NCT05238025|450363676|FG000|Overall Study|Death|38|||
125202315|NCT05238025|450363677|FG001|Overall Study|Death|32|||
125202316|NCT05238025|450363676|FG000|Overall Study|Study terminated by Sponsor|6358|||
125202317|NCT05238025|450363677|FG001|Overall Study|Study terminated by Sponsor|6358|||
125202318|NCT05238025|450363676|FG000|Overall Study|Other Reason|669|||
125202319|NCT05238025|450363677|FG001|Overall Study|Other Reason|690|||
125202320|NCT03814720|450363679|FG000|Overall Study|Lost to Follow-up|0|||
125202321|NCT03814720|450363680|FG001|Overall Study|Lost to Follow-up|1|||
125202322|NCT03814720|450363681|FG002|Overall Study|Lost to Follow-up|0|||
125202323|NCT03814720|450363682|FG003|Overall Study|Lost to Follow-up|0|||
125202324|NCT03814720|450363683|FG004|Overall Study|Lost to Follow-up|0|||
125202325|NCT03197324|450363684|FG000|Overall Study|Adverse Event|0|||
125202326|NCT03197324|450363685|FG001|Overall Study|Adverse Event|1|||
125202327|NCT00965341|450363686|FG000|Overall Study|Withdrew consent|1|||
125202328|NCT00965341|450363687|FG001|Overall Study|Withdrew consent|5|||
125202329|NCT00965341|450363686|FG000|Overall Study|Lost to Follow-up|1|||
125202330|NCT00965341|450363687|FG001|Overall Study|Lost to Follow-up|0|||
125202331|NCT00965341|450363686|FG000|Overall Study|Transportation issues|4|||
125202332|NCT00965341|450363687|FG001|Overall Study|Transportation issues|3|||
125202333|NCT03057054|450363693|FG000|Overall Study|Death|4|||
125202334|NCT03057054|450363694|FG001|Overall Study|Death|4|||
125202335|NCT03057054|450363693|FG000|Overall Study|Withdrawal by Subject|6|||
125202336|NCT03057054|450363694|FG001|Overall Study|Withdrawal by Subject|3|||
125202337|NCT03057054|450363693|FG000|Overall Study|Ineligible|1|||
125202338|NCT03057054|450363694|FG001|Overall Study|Ineligible|1|||
125202339|NCT01077739|450363695|FG000|Overall Study|Premature withdrawal|1|||
125202340|NCT01077739|450363696|FG001|Overall Study|Premature withdrawal|3|||
125202341|NCT01077739|450363695|FG000|Overall Study|Withdrawal by Subject|1|||
125202342|NCT01077739|450363696|FG001|Overall Study|Withdrawal by Subject|0|||
125202343|NCT01077739|450363695|FG000|Overall Study|Death|0|||
125202344|NCT01077739|450363696|FG001|Overall Study|Death|3|||
125202345|NCT01077739|450363695|FG000|Overall Study|Unacceptable toxicity|1|||
125202346|NCT01077739|450363696|FG001|Overall Study|Unacceptable toxicity|2|||
125202347|NCT01077739|450363695|FG000|Overall Study|Other|2|||
125202348|NCT01077739|450363696|FG001|Overall Study|Other|2|||
125202349|NCT00960986|450363697|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
125202350|NCT00960986|450363698|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
125202351|NCT00960986|450363699|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
125202352|NCT00960986|450363700|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
125202353|NCT00960986|450363697|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
125202354|NCT00960986|450363698|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
125202355|NCT00960986|450363699|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
125202356|NCT00960986|450363700|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
125202357|NCT00960986|450363697|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
125202358|NCT00960986|450363698|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
125202359|NCT00960986|450363699|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
125202360|NCT00960986|450363700|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
125202361|NCT00960986|450363697|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
125202362|NCT00960986|450363698|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
125202363|NCT00960986|450363699|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
125202364|NCT00960986|450363700|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
125202365|NCT00960986|450363697|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
125538411|NCT02580305|451602502|FG002|Overall Study|Adverse Event|10|||
125538412|NCT02580305|451602500|FG000|Overall Study|Lack of Efficacy|5|||
125538413|NCT02580305|451602501|FG001|Overall Study|Lack of Efficacy|0|||
125538414|NCT02580305|451602502|FG002|Overall Study|Lack of Efficacy|2|||
125538415|NCT02580305|451602500|FG000|Overall Study|Protocol Violation|4|||
125538416|NCT02580305|451602501|FG001|Overall Study|Protocol Violation|9|||
125538417|NCT02580305|451602502|FG002|Overall Study|Protocol Violation|6|||
125538418|NCT02580305|451602500|FG000|Overall Study|Lost to Follow-up|4|||
125538419|NCT02580305|451602501|FG001|Overall Study|Lost to Follow-up|4|||
125538420|NCT02580305|451602502|FG002|Overall Study|Lost to Follow-up|2|||
125538421|NCT02580305|451602500|FG000|Overall Study|Withdrawal by Subject|11|||
125538422|NCT02580305|451602501|FG001|Overall Study|Withdrawal by Subject|9|||
125538423|NCT02580305|451602502|FG002|Overall Study|Withdrawal by Subject|7|||
125538424|NCT02580305|451602500|FG000|Overall Study|Randomized in error and never treated|4|||
125538425|NCT02580305|451602501|FG001|Overall Study|Randomized in error and never treated|8|||
125538426|NCT02580305|451602502|FG002|Overall Study|Randomized in error and never treated|5|||
125538427|NCT00941070|451602504|FG000|Overall Study|Patient non-compliant|1|||
125538428|NCT01416389|451602507|FG000|Overall Study|Lost to Follow-up|1|||
125538429|NCT01416389|451602508|FG001|Overall Study|Lost to Follow-up|0|||
125538430|NCT01416389|451602507|FG000|Overall Study|Started New Therapy|2|||
125538431|NCT01416389|451602508|FG001|Overall Study|Started New Therapy|0|||
125538432|NCT01125514|451602509|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
125538433|NCT01125514|451602509|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
125538434|NCT01125514|451602509|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
125538435|NCT01125514|451602509|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
125538436|NCT01125514|451602509|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
125538437|NCT01125514|451602509|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
125538438|NCT02755818|451602512|FG000|Overall Study|Withdrawal by Subject|0|||
125538439|NCT02755818|451602513|FG001|Overall Study|Withdrawal by Subject|0|||
125538440|NCT02755818|451602514|FG002|Overall Study|Withdrawal by Subject|0|||
125538441|NCT02755818|451602515|FG003|Overall Study|Withdrawal by Subject|2|||
125538442|NCT02755818|451602512|FG000|Overall Study|withdrawal by PI|0|||
125538443|NCT02755818|451602513|FG001|Overall Study|withdrawal by PI|0|||
125538444|NCT02755818|451602514|FG002|Overall Study|withdrawal by PI|1|||
125538445|NCT02755818|451602515|FG003|Overall Study|withdrawal by PI|1|||
125538446|NCT02535091|451602516|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
125538447|NCT02535091|451602517|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
125538448|NCT02535091|451602518|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
125538449|NCT02535091|451602516|FG000|Overall Study|Withdrawal by Subject|14|||
125538450|NCT02535091|451602517|FG001|Overall Study|Withdrawal by Subject|5|||
125538451|NCT02535091|451602518|FG002|Overall Study|Withdrawal by Subject|121|||
125538452|NCT02535091|451602516|FG000|Overall Study|Adverse Event|9|||
125538453|NCT02535091|451602517|FG001|Overall Study|Adverse Event|4|||
125538454|NCT02535091|451602518|FG002|Overall Study|Adverse Event|170|||
125538455|NCT02535091|451602516|FG000|Overall Study|Other|4|||
125538456|NCT02535091|451602517|FG001|Overall Study|Other|3|||
125538457|NCT02535091|451602518|FG002|Overall Study|Other|81|||
125538458|NCT02535091|451602516|FG000|Overall Study|Lost to Follow-up|0|||
125538459|NCT02535091|451602517|FG001|Overall Study|Lost to Follow-up|1|||
125538460|NCT02535091|451602518|FG002|Overall Study|Lost to Follow-up|19|||
125538461|NCT02535091|451602516|FG000|Overall Study|Protocol Violation|0|||
125538462|NCT02535091|451602517|FG001|Overall Study|Protocol Violation|1|||
125538463|NCT02535091|451602518|FG002|Overall Study|Protocol Violation|11|||
125538464|NCT02535091|451602516|FG000|Overall Study|Pregnancy|0|||
125538465|NCT02535091|451602517|FG001|Overall Study|Pregnancy|0|||
125538466|NCT02535091|451602518|FG002|Overall Study|Pregnancy|7|||
125538467|NCT01127763|451602519|FG000|Overall Study|Adverse Event|2|||
125538468|NCT01127763|451602519|FG000|Overall Study|Withdrawal by Subject|1|||
125538469|NCT01127763|451602519|FG000|Overall Study|Physician Decision|2|||
125538470|NCT01769326|451602520|FG000|Overall Study|Lost to Follow-up|1|||
125538471|NCT01769326|451602521|FG001|Overall Study|Lost to Follow-up|2|||
125538472|NCT01769326|451602522|FG002|Overall Study|Lost to Follow-up|0|||
125538473|NCT01769326|451602523|FG003|Overall Study|Lost to Follow-up|0|||
125538474|NCT01769326|451602520|FG000|Overall Study|unrelated injry|1|||
125538475|NCT01769326|451602521|FG001|Overall Study|unrelated injry|1|||
125538476|NCT01769326|451602522|FG002|Overall Study|unrelated injry|0|||
125538477|NCT01769326|451602523|FG003|Overall Study|unrelated injry|0|||
125538478|NCT01769326|451602520|FG000|Overall Study|got a job|0|||
125538479|NCT01769326|451602521|FG001|Overall Study|got a job|1|||
125202366|NCT00960986|450363698|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
125202367|NCT00960986|450363699|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
125538480|NCT01769326|451602522|FG002|Overall Study|got a job|0|||
125538481|NCT01769326|451602523|FG003|Overall Study|got a job|0|||
125538482|NCT01769326|451602520|FG000|Overall Study|Got sick and could not complete study|0|||
125538483|NCT01769326|451602521|FG001|Overall Study|Got sick and could not complete study|0|||
125538484|NCT01769326|451602522|FG002|Overall Study|Got sick and could not complete study|1|||
125538485|NCT01769326|451602523|FG003|Overall Study|Got sick and could not complete study|0|||
125538486|NCT01036438|451602524|FG000|Overall Study|Adverse Event|7|||
125538487|NCT01036438|451602525|FG001|Overall Study|Adverse Event|8|||
125538488|NCT01036438|451602524|FG000|Overall Study|Death|0|||
125538489|NCT01036438|451602525|FG001|Overall Study|Death|1|||
125538490|NCT01036438|451602524|FG000|Overall Study|No effect of study treatment|3|||
125538491|NCT01036438|451602525|FG001|Overall Study|No effect of study treatment|1|||
125538492|NCT02153073|451602526|FG000|Overall Study|Case Report Forms Uncollected|230|||
125538493|NCT02153073|451602526|FG000|Overall Study|Protocol Deviation|68|||
125538494|NCT03702231|451602527|FG000|Overall Study|Withdrawal by Subject|1|||
125538495|NCT03702231|451602528|FG001|Overall Study|Withdrawal by Subject|0|||
125538496|NCT03702231|451602529|FG002|Overall Study|Withdrawal by Subject|0|||
125538497|NCT03702231|451602527|FG000|Overall Study|Protocol Violation|0|||
125538498|NCT03702231|451602528|FG001|Overall Study|Protocol Violation|0|||
125538499|NCT03702231|451602529|FG002|Overall Study|Protocol Violation|1|||
125538500|NCT03702231|451602527|FG000|Overall Study|Change in CLL Treatment|0|||
125538501|NCT03702231|451602528|FG001|Overall Study|Change in CLL Treatment|0|||
125538502|NCT03702231|451602529|FG002|Overall Study|Change in CLL Treatment|1|||
125538503|NCT03702231|451602527|FG000|Overall Study|COVID Pandemic|1|||
125538504|NCT03702231|451602528|FG001|Overall Study|COVID Pandemic|4|||
125538505|NCT03702231|451602529|FG002|Overall Study|COVID Pandemic|1|||
125538506|NCT03702231|451602527|FG000|Overall Study|Non-compliance|0|||
125538507|NCT03702231|451602528|FG001|Overall Study|Non-compliance|0|||
125538508|NCT03702231|451602529|FG002|Overall Study|Non-compliance|1|||
125538509|NCT01278173|451602530|FG000|Overall Study|Lack of Efficacy|13|||
125538510|NCT01278173|451602530|FG000|Overall Study|Adverse Event|8|||
125538511|NCT01278173|451602530|FG000|Overall Study|Administrative or other reason|4|||
125538512|NCT01278173|451602530|FG000|Overall Study|Protocol Violation|1|||
125538513|NCT01278173|451602530|FG000|Overall Study|Withdrawal by Subject|1|||
125538514|NCT03590366|451602531|FG000|Overall Study|Adverse Event|0|||
125538515|NCT03590366|451602532|FG001|Overall Study|Adverse Event|3|||
125538516|NCT03590366|451602531|FG000|Overall Study|Lost to Follow-up|3|||
125538517|NCT03590366|451602532|FG001|Overall Study|Lost to Follow-up|3|||
125538518|NCT03590366|451602531|FG000|Overall Study|Withdrawal by Subject|0|||
125538519|NCT03590366|451602532|FG001|Overall Study|Withdrawal by Subject|2|||
125538520|NCT01468181|451602533|FG000|Overall Study|Adverse Event|8|||
125538521|NCT01468181|451602534|FG001|Overall Study|Adverse Event|1|||
125538522|NCT01468181|451602535|FG002|Overall Study|Adverse Event|6|||
125538523|NCT01468181|451602536|FG003|Overall Study|Adverse Event|2|||
125538524|NCT01468181|451602537|FG004|Overall Study|Adverse Event|2|||
125538525|NCT01468181|451602533|FG000|Overall Study|Protocol Violation|2|||
125538526|NCT01468181|451602534|FG001|Overall Study|Protocol Violation|0|||
125538527|NCT01468181|451602535|FG002|Overall Study|Protocol Violation|1|||
125538528|NCT01468181|451602536|FG003|Overall Study|Protocol Violation|0|||
125538529|NCT01468181|451602537|FG004|Overall Study|Protocol Violation|1|||
125202368|NCT00960986|450363700|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
125202369|NCT00960986|450363697|FG000|Period 3 (7-week Therapy Period)|Death|0|||
125202370|NCT00960986|450363698|FG001|Period 3 (7-week Therapy Period)|Death|0|||
125202371|NCT00960986|450363699|FG002|Period 3 (7-week Therapy Period)|Death|1|||
125202372|NCT00960986|450363700|FG003|Period 3 (7-week Therapy Period)|Death|0|||
125202373|NCT00960986|450363697|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
125538530|NCT01468181|451602533|FG000|Overall Study|Physician Decision|0|||
125538531|NCT01468181|451602534|FG001|Overall Study|Physician Decision|0|||
125538532|NCT01468181|451602535|FG002|Overall Study|Physician Decision|0|||
125538533|NCT01468181|451602536|FG003|Overall Study|Physician Decision|1|||
125538534|NCT01468181|451602537|FG004|Overall Study|Physician Decision|1|||
125538535|NCT01468181|451602533|FG000|Overall Study|Lost to Follow-up|0|||
125538536|NCT01468181|451602534|FG001|Overall Study|Lost to Follow-up|0|||
125538537|NCT01468181|451602535|FG002|Overall Study|Lost to Follow-up|1|||
125538538|NCT01468181|451602536|FG003|Overall Study|Lost to Follow-up|0|||
125202374|NCT00960986|450363698|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
125202375|NCT00960986|450363699|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
125202376|NCT00960986|450363700|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
125202377|NCT00960986|450363697|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
125202378|NCT00960986|450363698|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
125217439|NCT01348100|450423526|FG006|Overall Study|Lost to Follow-up|1|||
125538539|NCT01468181|451602537|FG004|Overall Study|Lost to Follow-up|1|||
125538540|NCT01468181|451602533|FG000|Overall Study|Withdrawal by Subject|0|||
125538541|NCT01468181|451602534|FG001|Overall Study|Withdrawal by Subject|1|||
125538542|NCT01468181|451602535|FG002|Overall Study|Withdrawal by Subject|0|||
125538543|NCT01468181|451602536|FG003|Overall Study|Withdrawal by Subject|0|||
125538544|NCT01468181|451602537|FG004|Overall Study|Withdrawal by Subject|0|||
125538545|NCT02297139|451602546|FG000|Overall Study|Disease progression|0|||
125538546|NCT02297139|451602547|FG001|Overall Study|Disease progression|1|||
125538547|NCT02297139|451602546|FG000|Overall Study|Study drug toxicity|0|||
125538548|NCT02297139|451602547|FG001|Overall Study|Study drug toxicity|4|||
125538549|NCT02297139|451602546|FG000|Overall Study|Participant request to discontinue study treatment|0|||
125538550|NCT02297139|451602547|FG001|Overall Study|Participant request to discontinue study treatment|1|||
125538551|NCT02297139|451602546|FG000|Overall Study|Maximum clinical benefit|1|||
125538552|NCT02297139|451602547|FG001|Overall Study|Maximum clinical benefit|0|||
125538553|NCT02297139|451602546|FG000|Overall Study|Administrative reason by sponsor|0|||
125538554|NCT02297139|451602547|FG001|Overall Study|Administrative reason by sponsor|2|||
125538555|NCT02297139|451602546|FG000|Overall Study|Other reasons|0|||
125538556|NCT02297139|451602547|FG001|Overall Study|Other reasons|8|||
125538557|NCT05597787|451602550|FG000|Overall Study|Withdrawal by Subject|0|||
125538558|NCT05597787|451602551|FG001|Overall Study|Withdrawal by Subject|0|||
125538559|NCT05597787|451602552|FG002|Overall Study|Withdrawal by Subject|1|||
125538560|NCT01934790|451602553|FG000|Treatment|Adverse Event|3|||
125538561|NCT01934790|451602553|FG000|Treatment|Clinical progression|6|||
125538562|NCT01934790|451602553|FG000|Treatment|Radiological progression|4|||
125538563|NCT01934790|451602553|FG000|Treatment|Withdrawal by Subject|2|||
125538564|NCT01934790|451602553|FG000|Treatment|Study drug never administered|1|||
125538565|NCT01934790|451602553|FG000|Active Follow up|Death|20|||
125538566|NCT01934790|451602553|FG000|Active Follow up|Physician Decision|2|||
125538567|NCT01934790|451602553|FG000|Active Follow up|Progressive disease|1|||
125538568|NCT01934790|451602553|FG000|Active Follow up|Other reason|1|||
125538569|NCT01144377|451602558|FG000|52 Week Treatment Period|Adverse Event|0|||
125538570|NCT01144377|451602559|FG001|52 Week Treatment Period|Adverse Event|0|||
125538571|NCT01144377|451602560|FG002|52 Week Treatment Period|Adverse Event|3|||
125538572|NCT01144377|451602561|FG003|52 Week Treatment Period|Adverse Event|2|||
125538573|NCT01144377|451602562|FG004|52 Week Treatment Period|Adverse Event|1|||
125538574|NCT01144377|451602558|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
125538575|NCT01144377|451602559|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
125538576|NCT01144377|451602560|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
125538577|NCT01144377|451602561|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
125538578|NCT01144377|451602562|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
125538579|NCT01144377|451602558|FG000|52 Week Treatment Period|Protocol Violation|0|||
125538580|NCT01144377|451602559|FG001|52 Week Treatment Period|Protocol Violation|0|||
125538581|NCT01144377|451602560|FG002|52 Week Treatment Period|Protocol Violation|0|||
125538582|NCT01144377|451602561|FG003|52 Week Treatment Period|Protocol Violation|0|||
125538583|NCT01144377|451602562|FG004|52 Week Treatment Period|Protocol Violation|1|||
125538584|NCT01144377|451602558|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
125538585|NCT01144377|451602559|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
125538586|NCT01144377|451602560|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
125538587|NCT01144377|451602561|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
125538588|NCT01144377|451602562|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
125538589|NCT01144377|451602558|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
125538590|NCT01144377|451602559|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
125538591|NCT01144377|451602560|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
125538592|NCT01144377|451602561|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
125538593|NCT01144377|451602562|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
125538594|NCT01144377|451602558|FG000|52 Week Treatment Period|Sponsor Decision|0|||
125538595|NCT01144377|451602559|FG001|52 Week Treatment Period|Sponsor Decision|0|||
125538596|NCT01144377|451602560|FG002|52 Week Treatment Period|Sponsor Decision|0|||
125538597|NCT01144377|451602561|FG003|52 Week Treatment Period|Sponsor Decision|0|||
125538598|NCT01144377|451602562|FG004|52 Week Treatment Period|Sponsor Decision|1|||
125538599|NCT01144377|451602558|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
125538600|NCT01144377|451602559|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
125538601|NCT01144377|451602560|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
125538602|NCT01144377|451602561|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
125538603|NCT01144377|451602562|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
125538604|NCT01144377|451602558|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
125538605|NCT01144377|451602559|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
125538606|NCT01144377|451602560|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
125538607|NCT01144377|451602561|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
125538608|NCT01144377|451602562|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
125538609|NCT01144377|451602558|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
125538610|NCT01144377|451602559|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
125538611|NCT01144377|451602560|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
125538612|NCT01144377|451602561|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
125538613|NCT01144377|451602562|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
125202379|NCT00960986|450363699|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
125202380|NCT00960986|450363700|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
125538614|NCT00607724|451602566|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
125538615|NCT00607724|451602567|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
125538616|NCT00607724|451602568|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
125538617|NCT00607724|451602569|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
125538618|NCT00607724|451602570|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
125538619|NCT00607724|451602571|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
125538620|NCT00607724|451602572|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
125538621|NCT00607724|451602566|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
125538622|NCT00607724|451602567|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
125538623|NCT00607724|451602568|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
125538624|NCT00607724|451602569|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
125538625|NCT00607724|451602570|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
125538626|NCT00607724|451602571|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
125538627|NCT00607724|451602572|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
125538628|NCT00607724|451602566|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
125538629|NCT00607724|451602567|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
125538630|NCT00607724|451602568|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
125538631|NCT00607724|451602569|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
125538632|NCT00607724|451602570|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
125538633|NCT00607724|451602571|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
125538634|NCT00607724|451602572|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
125538635|NCT00607724|451602566|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
125538636|NCT00607724|451602567|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
125538637|NCT00607724|451602568|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
125538638|NCT00607724|451602569|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
125538639|NCT00607724|451602570|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
125538640|NCT00607724|451602571|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
125538641|NCT00607724|451602572|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
125538642|NCT00607724|451602566|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
125538643|NCT00607724|451602567|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
125538644|NCT00607724|451602568|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
125538645|NCT00607724|451602569|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
125538646|NCT00607724|451602570|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
125538647|NCT00607724|451602571|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
125538648|NCT00607724|451602572|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
125538649|NCT03738423|451602573|FG000|Overall Study|Withdrawal by Subject|9|||
125538650|NCT03738423|451602574|FG001|Overall Study|Withdrawal by Subject|12|||
125538651|NCT03738423|451602575|FG002|Overall Study|Withdrawal by Subject|9|||
125538652|NCT03738423|451602576|FG003|Overall Study|Withdrawal by Subject|12|||
125538653|NCT03738423|451602577|FG004|Overall Study|Withdrawal by Subject|10|||
125538654|NCT03738423|451602573|FG000|Overall Study|Lack of Efficacy|3|||
125538655|NCT03738423|451602574|FG001|Overall Study|Lack of Efficacy|1|||
125538656|NCT03738423|451602575|FG002|Overall Study|Lack of Efficacy|1|||
125538657|NCT03738423|451602576|FG003|Overall Study|Lack of Efficacy|1|||
125538658|NCT03738423|451602577|FG004|Overall Study|Lack of Efficacy|2|||
125538659|NCT03738423|451602573|FG000|Overall Study|Lost to Follow-up|1|||
125538660|NCT03738423|451602574|FG001|Overall Study|Lost to Follow-up|0|||
125538661|NCT03738423|451602575|FG002|Overall Study|Lost to Follow-up|1|||
125538662|NCT03738423|451602576|FG003|Overall Study|Lost to Follow-up|1|||
125538663|NCT03738423|451602577|FG004|Overall Study|Lost to Follow-up|0|||
125538664|NCT03738423|451602573|FG000|Overall Study|Protocol Violation|1|||
125538665|NCT03738423|451602574|FG001|Overall Study|Protocol Violation|0|||
125538666|NCT03738423|451602575|FG002|Overall Study|Protocol Violation|0|||
125538667|NCT03738423|451602576|FG003|Overall Study|Protocol Violation|0|||
125538668|NCT03738423|451602577|FG004|Overall Study|Protocol Violation|1|||
125538669|NCT03738423|451602573|FG000|Overall Study|Physician Decision|0|||
125538670|NCT03738423|451602574|FG001|Overall Study|Physician Decision|0|||
125538671|NCT03738423|451602575|FG002|Overall Study|Physician Decision|1|||
125538672|NCT03738423|451602576|FG003|Overall Study|Physician Decision|0|||
125538673|NCT03738423|451602577|FG004|Overall Study|Physician Decision|1|||
125538674|NCT03738423|451602573|FG000|Overall Study|Death|0|||
125538675|NCT03738423|451602574|FG001|Overall Study|Death|0|||
125538676|NCT03738423|451602575|FG002|Overall Study|Death|0|||
125538677|NCT03738423|451602576|FG003|Overall Study|Death|0|||
125538678|NCT03738423|451602577|FG004|Overall Study|Death|1|||
125538679|NCT03738423|451602573|FG000|Overall Study|Randomized but never treated|0|||
125538680|NCT03738423|451602574|FG001|Overall Study|Randomized but never treated|0|||
125538681|NCT03738423|451602575|FG002|Overall Study|Randomized but never treated|1|||
125538682|NCT03738423|451602576|FG003|Overall Study|Randomized but never treated|1|||
125538683|NCT03738423|451602577|FG004|Overall Study|Randomized but never treated|0|||
125538684|NCT01241604|451602578|FG000|Screening Period|Screen Failure|3|||
125538685|NCT01241604|451602579|FG001|Screening Period|Screen Failure|0|||
125538686|NCT01241604|451602580|FG002|Screening Period|Screen Failure|0|||
125538687|NCT01593787|451602581|FG000|Overall Study|Adverse Event|1|||
125538688|NCT01593787|451602582|FG001|Overall Study|Adverse Event|0|||
125538689|NCT01593787|451602583|FG002|Overall Study|Adverse Event|0|||
125538690|NCT01865747|451602584|FG000|Overall Study (ITT)|Adverse Event|32|||
125538691|NCT01865747|451602585|FG001|Overall Study (ITT)|Adverse Event|31|||
125538692|NCT01865747|451602584|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
125538693|NCT01865747|451602585|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
125538694|NCT01865747|451602584|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
125538695|NCT01865747|451602585|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
125538696|NCT01865747|451602584|FG000|Overall Study (ITT)|Protocol Violation|1|||
125538697|NCT01865747|451602585|FG001|Overall Study (ITT)|Protocol Violation|1|||
125538698|NCT01865747|451602584|FG000|Overall Study (ITT)|Physician Decision|5|||
125538699|NCT01865747|451602585|FG001|Overall Study (ITT)|Physician Decision|2|||
125538700|NCT01865747|451602584|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
125538701|NCT01865747|451602585|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
125538702|NCT01865747|451602584|FG000|Overall Study (ITT)|Sponsor Decision|0|||
125538703|NCT01865747|451602585|FG001|Overall Study (ITT)|Sponsor Decision|1|||
125538704|NCT01865747|451602584|FG000|Overall Study (ITT)|Progressive Disease|122|||
125538705|NCT01865747|451602585|FG001|Overall Study (ITT)|Progressive Disease|158|||
125538706|NCT01865747|451602584|FG000|Overall Study (ITT)|Reason Not Provided|0|||
125538707|NCT01865747|451602585|FG001|Overall Study (ITT)|Reason Not Provided|1|||
125538708|NCT01865747|451602584|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
125538709|NCT01865747|451602585|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
125538710|NCT01865747|451602584|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
125538711|NCT01865747|451602585|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
125538712|NCT01865747|451602584|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
125538713|NCT01865747|451602585|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
125538714|NCT01865747|451602584|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
125538715|NCT01865747|451602585|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
125538716|NCT01865747|451602584|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
125538717|NCT01865747|451602585|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
125538718|NCT01865747|451602584|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
125538719|NCT01865747|451602585|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
125538720|NCT01865747|451602584|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
125538721|NCT01865747|451602585|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
125538722|NCT01865747|451602584|FG000|Primary Intent to Treat (PITT)|Other|0|||
125538723|NCT01865747|451602585|FG001|Primary Intent to Treat (PITT)|Other|1|||
125538724|NCT02592876|451602586|FG000|Overall Study|Withdrawal by Subject|3|||
125538725|NCT02592876|451602587|FG001|Overall Study|Withdrawal by Subject|3|||
125538726|NCT02592876|451602586|FG000|Overall Study|Study Termination by Sponsor|32|||
125538727|NCT02592876|451602587|FG001|Overall Study|Study Termination by Sponsor|27|||
125538728|NCT02592876|451602586|FG000|Overall Study|Lost to Follow-up|0|||
125538729|NCT02592876|451602587|FG001|Overall Study|Lost to Follow-up|1|||
125538730|NCT02592876|451602586|FG000|Overall Study|Death|6|||
125538731|NCT02592876|451602587|FG001|Overall Study|Death|9|||
125538732|NCT00611975|451602590|FG000|Overall Study|Withdrawal by Subject|3|||
125538733|NCT00611975|451602591|FG001|Overall Study|Withdrawal by Subject|7|||
125538734|NCT00611975|451602590|FG000|Overall Study|Pregnancy|2|||
125538735|NCT00611975|451602591|FG001|Overall Study|Pregnancy|1|||
125538736|NCT01305200|451602593|FG000|Overall Study|Physician Decision|4|||
125538737|NCT01305200|451602594|FG001|Overall Study|Physician Decision|6|||
125538738|NCT01305200|451602595|FG002|Overall Study|Physician Decision|1|||
125538739|NCT01305200|451602593|FG000|Overall Study|Withdrawal by Subject|24|||
125538740|NCT01305200|451602594|FG001|Overall Study|Withdrawal by Subject|21|||
125538741|NCT01305200|451602595|FG002|Overall Study|Withdrawal by Subject|1|||
125538742|NCT01305200|451602593|FG000|Overall Study|Ineligible|1|||
125538743|NCT01305200|451602594|FG001|Overall Study|Ineligible|2|||
125538744|NCT01305200|451602595|FG002|Overall Study|Ineligible|1|||
125538745|NCT01305200|451602593|FG000|Overall Study|Death|0|||
125538746|NCT01305200|451602594|FG001|Overall Study|Death|2|||
125538747|NCT01305200|451602595|FG002|Overall Study|Death|0|||
125538748|NCT04075994|451604071|FG000|Overall Study|Withdrawal by Subject|8|||
125538749|NCT04075994|451604072|FG001|Overall Study|Withdrawal by Subject|9|||
125538750|NCT04075994|451604071|FG000|Overall Study|Adverse Event|2|||
125538751|NCT04075994|451604072|FG001|Overall Study|Adverse Event|2|||
125538752|NCT04075994|451604071|FG000|Overall Study|Investigator withdrew|3|||
125538753|NCT04075994|451604072|FG001|Overall Study|Investigator withdrew|1|||
125538754|NCT01941719|451604076|FG000|Overall Study|Lost to Follow-up|20|||
125538755|NCT01941719|451604077|FG001|Overall Study|Lost to Follow-up|19|||
125538756|NCT01744392|451604080|FG000|Overall Study|Physician Decision|1|||
125538757|NCT00858364|451604087|FG000|Overall Study|Administrative Decision|3|||
125538758|NCT00858364|451604088|FG001|Overall Study|Administrative Decision|2|||
125538759|NCT00858364|451604087|FG000|Overall Study|Adverse Event|5|||
125538760|NCT00858364|451604088|FG001|Overall Study|Adverse Event|2|||
125538761|NCT00858364|451604087|FG000|Overall Study|Withdrawal by Subject|44|||
125538762|NCT00858364|451604088|FG001|Overall Study|Withdrawal by Subject|118|||
125538763|NCT00858364|451604087|FG000|Overall Study|Ineligibility Determined|1|||
125538764|NCT00858364|451604088|FG001|Overall Study|Ineligibility Determined|10|||
125538765|NCT00858364|451604087|FG000|Overall Study|Lost to Follow-up|24|||
125538766|NCT00858364|451604088|FG001|Overall Study|Lost to Follow-up|54|||
125538767|NCT00858364|451604087|FG000|Overall Study|Noncompliance|3|||
125538768|NCT00858364|451604088|FG001|Overall Study|Noncompliance|4|||
125538769|NCT00858364|451604087|FG000|Overall Study|Protocol Deviation|0|||
125538770|NCT00858364|451604088|FG001|Overall Study|Protocol Deviation|2|||
125538771|NCT00858364|451604087|FG000|Overall Study|Other|9|||
125538772|NCT00858364|451604088|FG001|Overall Study|Other|17|||
125538773|NCT00858364|451604087|FG000|Overall Study|Missing|1|||
125538774|NCT00858364|451604088|FG001|Overall Study|Missing|1|||
125538775|NCT00858364|451604087|FG000|Overall Study|Still on-study|114|||
125538776|NCT00858364|451604088|FG001|Overall Study|Still on-study|247|||
125538777|NCT03980808|451604089|FG000|Overall Study|Lost to Follow-up|2|||
125538778|NCT03980808|451604090|FG001|Overall Study|Lost to Follow-up|2|||
125538779|NCT01655693|451604091|FG000|Overall Study|Progression of Disease|92|||
125538780|NCT01655693|451604092|FG001|Overall Study|Progression of Disease|76|||
125538781|NCT01655693|451604093|FG002|Overall Study|Progression of Disease|58|||
125538782|NCT01655693|451604091|FG000|Overall Study|Death|8|||
125538783|NCT01655693|451604092|FG001|Overall Study|Death|9|||
125538784|NCT01655693|451604093|FG002|Overall Study|Death|12|||
125538785|NCT01655693|451604091|FG000|Overall Study|Serious Adverse Event|3|||
125538786|NCT01655693|451604092|FG001|Overall Study|Serious Adverse Event|15|||
125538787|NCT01655693|451604093|FG002|Overall Study|Serious Adverse Event|11|||
125538788|NCT01655693|451604091|FG000|Overall Study|Withdrawal by Subject|3|||
125538789|NCT01655693|451604092|FG001|Overall Study|Withdrawal by Subject|2|||
125538790|NCT01655693|451604093|FG002|Overall Study|Withdrawal by Subject|20|||
125538791|NCT01655693|451604091|FG000|Overall Study|Adverse Event|3|||
125538792|NCT01655693|451604092|FG001|Overall Study|Adverse Event|11|||
125538793|NCT01655693|451604093|FG002|Overall Study|Adverse Event|3|||
125538794|NCT01655693|451604091|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
125538795|NCT01655693|451604092|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
125538796|NCT01655693|451604093|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
125538797|NCT01655693|451604091|FG000|Overall Study|Non-Compliance|0|||
125538798|NCT01655693|451604092|FG001|Overall Study|Non-Compliance|0|||
125538799|NCT01655693|451604093|FG002|Overall Study|Non-Compliance|7|||
125538800|NCT01655693|451604091|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
125538801|NCT01655693|451604092|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
125538802|NCT01655693|451604093|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
125538803|NCT01655693|451604091|FG000|Overall Study|Protocol Violation|1|||
125538804|NCT01655693|451604092|FG001|Overall Study|Protocol Violation|0|||
125538805|NCT01655693|451604093|FG002|Overall Study|Protocol Violation|3|||
125538806|NCT01655693|451604091|FG000|Overall Study|Lost to Follow-up|1|||
125538807|NCT01655693|451604092|FG001|Overall Study|Lost to Follow-up|0|||
125538808|NCT01655693|451604093|FG002|Overall Study|Lost to Follow-up|1|||
125538809|NCT01655693|451604091|FG000|Overall Study|Screening Failure|1|||
125538810|NCT01655693|451604092|FG001|Overall Study|Screening Failure|0|||
125538811|NCT01655693|451604093|FG002|Overall Study|Screening Failure|0|||
125538812|NCT01655693|451604091|FG000|Overall Study|Other|8|||
125538813|NCT01655693|451604092|FG001|Overall Study|Other|6|||
125538814|NCT01655693|451604093|FG002|Overall Study|Other|15|||
125538815|NCT00929110|451604098|FG000|Overall Study|Adverse Event|40|||
125538816|NCT00929110|451604099|FG001|Overall Study|Adverse Event|29|||
125538817|NCT00929110|451604100|FG002|Overall Study|Adverse Event|18|||
125538818|NCT00929110|451604098|FG000|Overall Study|Subject withdrew consent|40|||
125538819|NCT00929110|451604099|FG001|Overall Study|Subject withdrew consent|23|||
125538820|NCT00929110|451604100|FG002|Overall Study|Subject withdrew consent|26|||
125538821|NCT00929110|451604098|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
125538822|NCT00929110|451604099|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
125538823|NCT00929110|451604100|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
125538824|NCT00929110|451604098|FG000|Overall Study|Lost to Follow-up|7|||
125538825|NCT00929110|451604099|FG001|Overall Study|Lost to Follow-up|7|||
125538826|NCT00929110|451604100|FG002|Overall Study|Lost to Follow-up|3|||
125538827|NCT00929110|451604098|FG000|Overall Study|Protocol deviation|5|||
125538828|NCT00929110|451604099|FG001|Overall Study|Protocol deviation|2|||
125538829|NCT00929110|451604100|FG002|Overall Study|Protocol deviation|4|||
125538830|NCT00929110|451604098|FG000|Overall Study|Administrative problems|4|||
125538831|NCT00929110|451604099|FG001|Overall Study|Administrative problems|1|||
125538832|NCT00929110|451604100|FG002|Overall Study|Administrative problems|2|||
125538833|NCT00929110|451604098|FG000|Overall Study|Death|2|||
125538834|NCT00929110|451604099|FG001|Overall Study|Death|2|||
125538835|NCT00929110|451604100|FG002|Overall Study|Death|2|||
125538836|NCT00929110|451604098|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125538837|NCT00929110|451604099|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125538838|NCT00929110|451604100|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125538839|NCT00929110|451604098|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125538840|NCT00929110|451604099|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125538841|NCT00929110|451604100|FG002|Overall Study|Abnormal test procedure result(s)|1|||
125538842|NCT00929110|451604098|FG000|Overall Study|Patient inability to use the device|0|||
125538843|NCT00929110|451604099|FG001|Overall Study|Patient inability to use the device|1|||
125538844|NCT00929110|451604100|FG002|Overall Study|Patient inability to use the device|0|||
125538845|NCT02703259|451604101|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
125538846|NCT02703259|451604102|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
125538847|NCT02703259|451604101|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
125538848|NCT02703259|451604102|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
125538849|NCT02703259|451604101|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
125538850|NCT02703259|451604102|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
125538851|NCT02285153|451604108|FG000|Overall Study|Adverse Event|1|||
125538852|NCT02285153|451604109|FG001|Overall Study|Adverse Event|0|||
125538853|NCT02544451|451604111|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
125538854|NCT02544451|451604112|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
125538855|NCT02544451|451604113|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
125538856|NCT02544451|451604114|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
125538857|NCT02544451|451604111|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
125538858|NCT02544451|451604112|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
125538859|NCT02544451|451604113|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
125538860|NCT02544451|451604114|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
125538861|NCT02544451|451604111|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
125538862|NCT02544451|451604112|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
125538863|NCT02544451|451604113|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
125538864|NCT02544451|451604114|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
125538865|NCT02544451|451604111|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
125538866|NCT02544451|451604112|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
125538867|NCT02544451|451604113|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
125538868|NCT02544451|451604114|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
125538869|NCT02544451|451604111|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
125538870|NCT02544451|451604112|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
125538871|NCT02544451|451604113|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
125538872|NCT02544451|451604114|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
125538873|NCT02544451|451604111|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
125538874|NCT02544451|451604112|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
125538875|NCT02544451|451604113|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
125538876|NCT02544451|451604114|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
125538877|NCT01489891|451604117|FG000|Overall Study|Endoscopy failure|1|||
125538878|NCT01489891|451604118|FG001|Overall Study|Endoscopy failure|0|||
125538879|NCT00998790|451604119|FG000|Overall Study|Withdrawal by Subject|21|||
125538880|NCT03001076|451604120|FG000|Overall Study|Withdrawal by patient|2|||
125538881|NCT03001076|451604121|FG001|Overall Study|Withdrawal by patient|0|||
125538882|NCT03001076|451604120|FG000|Overall Study|Other|1|||
125538883|NCT03001076|451604121|FG001|Overall Study|Other|0|||
125538884|NCT03001076|451604120|FG000|Overall Study|Adverse Event|3|||
125538885|NCT03001076|451604121|FG001|Overall Study|Adverse Event|3|||
125538886|NCT03001076|451604120|FG000|Overall Study|Sponsor decision|1|||
125538887|NCT03001076|451604121|FG001|Overall Study|Sponsor decision|0|||
125538888|NCT03001076|451604120|FG000|Overall Study|Lost to Follow-up|0|||
125538889|NCT03001076|451604121|FG001|Overall Study|Lost to Follow-up|2|||
125538890|NCT00948766|451604122|FG000|Core Study|Adverse Event|73|||
125538891|NCT00948766|451604123|FG001|Core Study|Adverse Event|51|||
125538892|NCT00948766|451604122|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
125538893|NCT00948766|451604123|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
125538894|NCT00948766|451604122|FG000|Core Study|Patient Withdrew Consent|27|||
125538895|NCT00948766|451604123|FG001|Core Study|Patient Withdrew Consent|46|||
125538896|NCT00948766|451604122|FG000|Core Study|Lost to Follow-up|3|||
125538897|NCT00948766|451604123|FG001|Core Study|Lost to Follow-up|2|||
125538898|NCT00948766|451604122|FG000|Core Study|Administrative Problems|2|||
125538899|NCT00948766|451604123|FG001|Core Study|Administrative Problems|2|||
125538900|NCT00948766|451604122|FG000|Core Study|Death|1|||
125538901|NCT00948766|451604123|FG001|Core Study|Death|1|||
125538902|NCT00948766|451604122|FG000|Core Study|Protocol Deviation|8|||
125538903|NCT00948766|451604123|FG001|Core Study|Protocol Deviation|10|||
125538904|NCT00948766|451604122|FG000|Extension Study|Adverse Event|43|||
125538905|NCT00948766|451604123|FG001|Extension Study|Adverse Event|0|||
125538906|NCT00948766|451604122|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
125538907|NCT00948766|451604123|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
125538908|NCT00948766|451604122|FG000|Extension Study|Study Drug No Longer Required|1|||
125538909|NCT00948766|451604123|FG001|Extension Study|Study Drug No Longer Required|0|||
125538910|NCT00948766|451604122|FG000|Extension Study|Patient Withdrew Consent|32|||
125538911|NCT00948766|451604123|FG001|Extension Study|Patient Withdrew Consent|0|||
125538912|NCT00948766|451604122|FG000|Extension Study|Lost to Follow-up|8|||
125538913|NCT00948766|451604123|FG001|Extension Study|Lost to Follow-up|0|||
125538914|NCT00948766|451604122|FG000|Extension Study|Administrative Problems|1|||
125538915|NCT00948766|451604123|FG001|Extension Study|Administrative Problems|0|||
125538916|NCT00948766|451604122|FG000|Extension Study|Death|4|||
125538917|NCT00948766|451604123|FG001|Extension Study|Death|0|||
125538918|NCT03459443|451604127|FG000|Overall Study|Lack of Efficacy|3|||
125538919|NCT03459443|451604127|FG000|Overall Study|Adverse Event|1|||
125538920|NCT03459443|451604127|FG000|Overall Study|Sponsor's decision to close the study|18|||
125538921|NCT01081665|451604128|FG000|Overall Study|Death|41|||
125538922|NCT01081665|451604128|FG000|Overall Study|Lost to Follow-up|18|||
125538923|NCT01081665|451604128|FG000|Overall Study|Withdrawal by Subject|17|||
125538924|NCT01081665|451604128|FG000|Overall Study|Change of dialysis unit|10|||
125538925|NCT01081665|451604128|FG000|Overall Study|Regulation of iPTH|5|||
125538926|NCT01081665|451604128|FG000|Overall Study|Change in renal replacement therapy|2|||
125538927|NCT01081665|451604128|FG000|Overall Study|Adverse Event|1|||
125538928|NCT01081665|451604128|FG000|Overall Study|Lack of Efficacy|1|||
125538929|NCT03406078|451604133|FG000|Overall Study|Death|1|||
125538930|NCT03406078|451604134|FG001|Overall Study|Death|0|||
125538931|NCT03406078|451604133|FG000|Overall Study|Lost to Follow-up|0|||
125538932|NCT03406078|451604134|FG001|Overall Study|Lost to Follow-up|1|||
125538933|NCT03406078|451604133|FG000|Overall Study|Withdrawal by Subject|5|||
125538934|NCT03406078|451604134|FG001|Overall Study|Withdrawal by Subject|2|||
125538935|NCT01413503|451604135|FG000|Overall Study|Lost to Follow-up|1|||
125538936|NCT01373151|451604136|FG000|Period 1|Lack of Efficacy|3|||
125538937|NCT01373151|451604137|FG001|Period 1|Lack of Efficacy|0|||
125538938|NCT01373151|451604138|FG002|Period 1|Lack of Efficacy|0|||
125538939|NCT01373151|451604139|FG003|Period 1|Lack of Efficacy|0|||
125538940|NCT01373151|451604140|FG004|Period 1|Lack of Efficacy|1|||
125538941|NCT01373151|451604141|FG005|Period 1|Lack of Efficacy|0|||
125538942|NCT01373151|451604142|FG006|Period 1|Lack of Efficacy|0|||
125538943|NCT01373151|451604136|FG000|Period 1|Adverse Event|0|||
125538944|NCT01373151|451604137|FG001|Period 1|Adverse Event|0|||
125538945|NCT01373151|451604138|FG002|Period 1|Adverse Event|1|||
125538946|NCT01373151|451604139|FG003|Period 1|Adverse Event|0|||
125538947|NCT01373151|451604140|FG004|Period 1|Adverse Event|4|||
125538948|NCT01373151|451604141|FG005|Period 1|Adverse Event|3|||
125538949|NCT01373151|451604142|FG006|Period 1|Adverse Event|0|||
125538950|NCT01373151|451604136|FG000|Period 1|Withdrawal by Subject|2|||
125538951|NCT01373151|451604137|FG001|Period 1|Withdrawal by Subject|0|||
125538952|NCT01373151|451604138|FG002|Period 1|Withdrawal by Subject|3|||
125538953|NCT01373151|451604139|FG003|Period 1|Withdrawal by Subject|1|||
125538954|NCT01373151|451604140|FG004|Period 1|Withdrawal by Subject|0|||
125538955|NCT01373151|451604141|FG005|Period 1|Withdrawal by Subject|1|||
125538956|NCT01373151|451604142|FG006|Period 1|Withdrawal by Subject|0|||
125538957|NCT01373151|451604136|FG000|Period 2|Lack of Efficacy|9|||
125538958|NCT01373151|451604137|FG001|Period 2|Lack of Efficacy|0|||
125538959|NCT01373151|451604138|FG002|Period 2|Lack of Efficacy|0|||
125538960|NCT01373151|451604139|FG003|Period 2|Lack of Efficacy|1|||
125538961|NCT01373151|451604140|FG004|Period 2|Lack of Efficacy|2|||
125538962|NCT01373151|451604141|FG005|Period 2|Lack of Efficacy|0|||
125538963|NCT01373151|451604142|FG006|Period 2|Lack of Efficacy|3|||
125538964|NCT01373151|451604136|FG000|Period 2|Adverse Event|0|||
125538965|NCT01373151|451604137|FG001|Period 2|Adverse Event|0|||
125538966|NCT01373151|451604138|FG002|Period 2|Adverse Event|3|||
125538967|NCT01373151|451604139|FG003|Period 2|Adverse Event|3|||
125538968|NCT01373151|451604140|FG004|Period 2|Adverse Event|0|||
125538969|NCT01373151|451604141|FG005|Period 2|Adverse Event|0|||
125538970|NCT01373151|451604142|FG006|Period 2|Adverse Event|1|||
125538971|NCT01373151|451604136|FG000|Period 2|subject request to discontinue|0|||
125538972|NCT01373151|451604137|FG001|Period 2|subject request to discontinue|1|||
125538973|NCT01373151|451604138|FG002|Period 2|subject request to discontinue|0|||
125538974|NCT01373151|451604139|FG003|Period 2|subject request to discontinue|0|||
125538975|NCT01373151|451604140|FG004|Period 2|subject request to discontinue|0|||
125538976|NCT01373151|451604141|FG005|Period 2|subject request to discontinue|0|||
125538977|NCT01373151|451604142|FG006|Period 2|subject request to discontinue|0|||
125538978|NCT01373151|451604136|FG000|Period 2|Withdrawal by Subject|0|||
125538979|NCT01373151|451604137|FG001|Period 2|Withdrawal by Subject|0|||
125538980|NCT01373151|451604138|FG002|Period 2|Withdrawal by Subject|0|||
125538981|NCT01373151|451604139|FG003|Period 2|Withdrawal by Subject|1|||
125538982|NCT01373151|451604140|FG004|Period 2|Withdrawal by Subject|0|||
125538983|NCT01373151|451604141|FG005|Period 2|Withdrawal by Subject|0|||
125538984|NCT01373151|451604142|FG006|Period 2|Withdrawal by Subject|0|||
125538985|NCT01373151|451604136|FG000|Period 2|Other|0|||
125538986|NCT01373151|451604137|FG001|Period 2|Other|0|||
125538987|NCT01373151|451604138|FG002|Period 2|Other|1|||
125202381|NCT00960986|450363697|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
125202382|NCT00960986|450363698|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
125538988|NCT01373151|451604139|FG003|Period 2|Other|0|||
125538989|NCT01373151|451604140|FG004|Period 2|Other|0|||
125538990|NCT01373151|451604141|FG005|Period 2|Other|0|||
125538991|NCT01373151|451604142|FG006|Period 2|Other|1|||
125538992|NCT03026075|451604146|FG000|Overall Study|Physician Decision|1|||
125202383|NCT00960986|450363699|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
125538993|NCT00293059|451604147|FG000|Overall Study|Adverse Event|12|||
125538994|NCT00293059|451604148|FG001|Overall Study|Adverse Event|4|||
125538995|NCT00293059|451604147|FG000|Overall Study|Lack of Efficacy|2|||
125538996|NCT00293059|451604148|FG001|Overall Study|Lack of Efficacy|0|||
125538997|NCT00293059|451604147|FG000|Overall Study|Lost to Follow-up|2|||
125538998|NCT00293059|451604148|FG001|Overall Study|Lost to Follow-up|3|||
125538999|NCT00293059|451604147|FG000|Overall Study|Pregnancy|1|||
125539000|NCT00293059|451604148|FG001|Overall Study|Pregnancy|1|||
125539001|NCT00293059|451604147|FG000|Overall Study|Protocol Violation|2|||
125539002|NCT00293059|451604148|FG001|Overall Study|Protocol Violation|0|||
125539003|NCT00293059|451604147|FG000|Overall Study|Withdrawal by Subject|11|||
125539004|NCT00293059|451604148|FG001|Overall Study|Withdrawal by Subject|5|||
125539005|NCT00293059|451604147|FG000|Overall Study|Participant moved out of state|1|||
125539006|NCT00293059|451604148|FG001|Overall Study|Participant moved out of state|0|||
125539007|NCT00293059|451604147|FG000|Overall Study|Participant stopped study drug|1|||
125539008|NCT00293059|451604148|FG001|Overall Study|Participant stopped study drug|0|||
125539009|NCT00293059|451604147|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
125539010|NCT00293059|451604148|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
125539011|NCT00293059|451604147|FG000|Overall Study|missing|3|||
125539012|NCT00293059|451604148|FG001|Overall Study|missing|5|||
125539013|NCT00438672|451604150|FG000|Overall Study|Lost to Follow-up|7|||
125539014|NCT00438672|451604151|FG001|Overall Study|Lost to Follow-up|9|||
125539015|NCT02712905|451604152|FG000|Monotherapy|Death|2|||
125539016|NCT02712905|451604153|FG001|Monotherapy|Death|5|||
125539017|NCT02712905|451604154|FG002|Monotherapy|Death|0|||
125539018|NCT02712905|451604155|FG003|Monotherapy|Death|3|||
125539019|NCT02712905|451604156|FG004|Monotherapy|Death|15|||
125539020|NCT02712905|451604157|FG005|Monotherapy|Death|1|||
125539021|NCT02712905|451604158|FG006|Monotherapy|Death|3|||
125539022|NCT02712905|451604159|FG007|Monotherapy|Death|3|||
125539023|NCT02712905|451604160|FG008|Monotherapy|Death|0|||
125539024|NCT02712905|451604161|FG009|Monotherapy|Death|27|||
125539025|NCT02712905|451604162|FG010|Monotherapy|Death|2|||
125539026|NCT02712905|451604163|FG011|Monotherapy|Death|5|||
125539027|NCT02712905|451604164|FG012|Monotherapy|Death|0|||
125539028|NCT02712905|451604165|FG013|Monotherapy|Death|0|||
125539029|NCT02712905|451604166|FG014|Monotherapy|Death|0|||
125539030|NCT02712905|451604167|FG015|Monotherapy|Death|0|||
125539031|NCT02712905|451604168|FG016|Monotherapy|Death|0|||
125539032|NCT02712905|451604169|FG017|Monotherapy|Death|0|||
125539033|NCT02712905|451604152|FG000|Monotherapy|Lost to Follow-up|0|||
125539034|NCT02712905|451604153|FG001|Monotherapy|Lost to Follow-up|1|||
125539035|NCT02712905|451604154|FG002|Monotherapy|Lost to Follow-up|0|||
125539036|NCT02712905|451604155|FG003|Monotherapy|Lost to Follow-up|1|||
125539037|NCT02712905|451604156|FG004|Monotherapy|Lost to Follow-up|0|||
125539038|NCT02712905|451604157|FG005|Monotherapy|Lost to Follow-up|0|||
125539039|NCT02712905|451604158|FG006|Monotherapy|Lost to Follow-up|0|||
125539040|NCT02712905|451604159|FG007|Monotherapy|Lost to Follow-up|0|||
125539041|NCT02712905|451604160|FG008|Monotherapy|Lost to Follow-up|0|||
125539042|NCT02712905|451604161|FG009|Monotherapy|Lost to Follow-up|2|||
125539043|NCT02712905|451604162|FG010|Monotherapy|Lost to Follow-up|0|||
125539044|NCT02712905|451604163|FG011|Monotherapy|Lost to Follow-up|0|||
125539045|NCT02712905|451604164|FG012|Monotherapy|Lost to Follow-up|0|||
125539046|NCT02712905|451604165|FG013|Monotherapy|Lost to Follow-up|0|||
125539047|NCT02712905|451604166|FG014|Monotherapy|Lost to Follow-up|0|||
125539048|NCT02712905|451604167|FG015|Monotherapy|Lost to Follow-up|0|||
125539049|NCT02712905|451604168|FG016|Monotherapy|Lost to Follow-up|0|||
125539050|NCT02712905|451604169|FG017|Monotherapy|Lost to Follow-up|0|||
125539051|NCT02712905|451604152|FG000|Monotherapy|Physician Decision|1|||
125539052|NCT02712905|451604153|FG001|Monotherapy|Physician Decision|0|||
125539053|NCT02712905|451604154|FG002|Monotherapy|Physician Decision|0|||
125539054|NCT02712905|451604155|FG003|Monotherapy|Physician Decision|1|||
125539055|NCT02712905|451604156|FG004|Monotherapy|Physician Decision|0|||
125539056|NCT02712905|451604157|FG005|Monotherapy|Physician Decision|0|||
125539057|NCT02712905|451604158|FG006|Monotherapy|Physician Decision|0|||
125539058|NCT02712905|451604159|FG007|Monotherapy|Physician Decision|0|||
125539059|NCT02712905|451604160|FG008|Monotherapy|Physician Decision|0|||
125539060|NCT02712905|451604161|FG009|Monotherapy|Physician Decision|1|||
125539061|NCT02712905|451604162|FG010|Monotherapy|Physician Decision|0|||
125539062|NCT02712905|451604163|FG011|Monotherapy|Physician Decision|0|||
125539063|NCT02712905|451604164|FG012|Monotherapy|Physician Decision|0|||
125539064|NCT02712905|451604165|FG013|Monotherapy|Physician Decision|0|||
125539065|NCT02712905|451604166|FG014|Monotherapy|Physician Decision|0|||
125539066|NCT02712905|451604167|FG015|Monotherapy|Physician Decision|0|||
125539067|NCT02712905|451604168|FG016|Monotherapy|Physician Decision|0|||
125539068|NCT02712905|451604169|FG017|Monotherapy|Physician Decision|0|||
125539069|NCT02712905|451604152|FG000|Monotherapy|Study Terminated by Sponsor|0|||
125539070|NCT02712905|451604153|FG001|Monotherapy|Study Terminated by Sponsor|0|||
125539071|NCT02712905|451604154|FG002|Monotherapy|Study Terminated by Sponsor|0|||
125539072|NCT02712905|451604155|FG003|Monotherapy|Study Terminated by Sponsor|0|||
125539073|NCT02712905|451604156|FG004|Monotherapy|Study Terminated by Sponsor|1|||
125539074|NCT02712905|451604157|FG005|Monotherapy|Study Terminated by Sponsor|0|||
125539075|NCT02712905|451604158|FG006|Monotherapy|Study Terminated by Sponsor|0|||
125539076|NCT02712905|451604159|FG007|Monotherapy|Study Terminated by Sponsor|0|||
125539077|NCT02712905|451604160|FG008|Monotherapy|Study Terminated by Sponsor|0|||
125539078|NCT02712905|451604161|FG009|Monotherapy|Study Terminated by Sponsor|2|||
125539079|NCT02712905|451604162|FG010|Monotherapy|Study Terminated by Sponsor|0|||
125539080|NCT02712905|451604163|FG011|Monotherapy|Study Terminated by Sponsor|0|||
125539081|NCT02712905|451604164|FG012|Monotherapy|Study Terminated by Sponsor|0|||
125539082|NCT02712905|451604165|FG013|Monotherapy|Study Terminated by Sponsor|0|||
125539083|NCT02712905|451604166|FG014|Monotherapy|Study Terminated by Sponsor|0|||
125539084|NCT02712905|451604167|FG015|Monotherapy|Study Terminated by Sponsor|0|||
125539085|NCT02712905|451604168|FG016|Monotherapy|Study Terminated by Sponsor|0|||
125539086|NCT02712905|451604169|FG017|Monotherapy|Study Terminated by Sponsor|0|||
125539087|NCT02712905|451604152|FG000|Monotherapy|Withdrawal by Subject|0|||
125539088|NCT02712905|451604153|FG001|Monotherapy|Withdrawal by Subject|0|||
125539089|NCT02712905|451604154|FG002|Monotherapy|Withdrawal by Subject|1|||
125539090|NCT02712905|451604155|FG003|Monotherapy|Withdrawal by Subject|0|||
125539091|NCT02712905|451604156|FG004|Monotherapy|Withdrawal by Subject|2|||
125539092|NCT02712905|451604157|FG005|Monotherapy|Withdrawal by Subject|0|||
125539093|NCT02712905|451604158|FG006|Monotherapy|Withdrawal by Subject|0|||
125539094|NCT02712905|451604159|FG007|Monotherapy|Withdrawal by Subject|0|||
125539095|NCT02712905|451604160|FG008|Monotherapy|Withdrawal by Subject|0|||
125539096|NCT02712905|451604161|FG009|Monotherapy|Withdrawal by Subject|4|||
125539097|NCT02712905|451604162|FG010|Monotherapy|Withdrawal by Subject|1|||
125539098|NCT02712905|451604163|FG011|Monotherapy|Withdrawal by Subject|2|||
125539099|NCT02712905|451604164|FG012|Monotherapy|Withdrawal by Subject|0|||
125539100|NCT02712905|451604165|FG013|Monotherapy|Withdrawal by Subject|0|||
125539101|NCT02712905|451604166|FG014|Monotherapy|Withdrawal by Subject|0|||
125539102|NCT02712905|451604167|FG015|Monotherapy|Withdrawal by Subject|0|||
125539103|NCT02712905|451604168|FG016|Monotherapy|Withdrawal by Subject|0|||
125539104|NCT02712905|451604169|FG017|Monotherapy|Withdrawal by Subject|0|||
125539105|NCT02712905|451604152|FG000|Monotherapy|Started New Cancer Drug|0|||
125539106|NCT02712905|451604153|FG001|Monotherapy|Started New Cancer Drug|0|||
125539107|NCT02712905|451604154|FG002|Monotherapy|Started New Cancer Drug|0|||
125539108|NCT02712905|451604155|FG003|Monotherapy|Started New Cancer Drug|0|||
125539109|NCT02712905|451604156|FG004|Monotherapy|Started New Cancer Drug|0|||
125539110|NCT02712905|451604157|FG005|Monotherapy|Started New Cancer Drug|1|||
125539111|NCT02712905|451604158|FG006|Monotherapy|Started New Cancer Drug|0|||
125539112|NCT02712905|451604159|FG007|Monotherapy|Started New Cancer Drug|0|||
125539113|NCT02712905|451604160|FG008|Monotherapy|Started New Cancer Drug|0|||
125539114|NCT02712905|451604161|FG009|Monotherapy|Started New Cancer Drug|0|||
125539115|NCT02712905|451604162|FG010|Monotherapy|Started New Cancer Drug|0|||
125539116|NCT02712905|451604163|FG011|Monotherapy|Started New Cancer Drug|0|||
125539117|NCT02712905|451604164|FG012|Monotherapy|Started New Cancer Drug|0|||
125539118|NCT02712905|451604165|FG013|Monotherapy|Started New Cancer Drug|0|||
125539119|NCT02712905|451604166|FG014|Monotherapy|Started New Cancer Drug|0|||
125539120|NCT02712905|451604167|FG015|Monotherapy|Started New Cancer Drug|0|||
125539121|NCT02712905|451604168|FG016|Monotherapy|Started New Cancer Drug|0|||
125539122|NCT02712905|451604169|FG017|Monotherapy|Started New Cancer Drug|0|||
125539123|NCT02712905|451604152|FG000|Monotherapy|Adverse Event|0|||
125539124|NCT02712905|451604153|FG001|Monotherapy|Adverse Event|0|||
125539125|NCT02712905|451604154|FG002|Monotherapy|Adverse Event|0|||
125539126|NCT02712905|451604155|FG003|Monotherapy|Adverse Event|0|||
125539127|NCT02712905|451604156|FG004|Monotherapy|Adverse Event|0|||
125539128|NCT02712905|451604157|FG005|Monotherapy|Adverse Event|0|||
125539129|NCT02712905|451604158|FG006|Monotherapy|Adverse Event|0|||
125539130|NCT02712905|451604159|FG007|Monotherapy|Adverse Event|0|||
125539131|NCT02712905|451604160|FG008|Monotherapy|Adverse Event|1|||
125539132|NCT02712905|451604161|FG009|Monotherapy|Adverse Event|0|||
125539133|NCT02712905|451604162|FG010|Monotherapy|Adverse Event|0|||
125539134|NCT02712905|451604163|FG011|Monotherapy|Adverse Event|0|||
125539135|NCT02712905|451604164|FG012|Monotherapy|Adverse Event|0|||
125539136|NCT02712905|451604165|FG013|Monotherapy|Adverse Event|0|||
125539137|NCT02712905|451604166|FG014|Monotherapy|Adverse Event|0|||
125539138|NCT02712905|451604167|FG015|Monotherapy|Adverse Event|0|||
125539139|NCT02712905|451604168|FG016|Monotherapy|Adverse Event|0|||
125539140|NCT02712905|451604169|FG017|Monotherapy|Adverse Event|0|||
125539141|NCT02712905|451604152|FG000|Combination Therapy|Death|0|||
125539142|NCT02712905|451604153|FG001|Combination Therapy|Death|0|||
125539143|NCT02712905|451604154|FG002|Combination Therapy|Death|0|||
125539144|NCT02712905|451604155|FG003|Combination Therapy|Death|0|||
125539145|NCT02712905|451604156|FG004|Combination Therapy|Death|0|||
125539146|NCT02712905|451604157|FG005|Combination Therapy|Death|0|||
125539147|NCT02712905|451604158|FG006|Combination Therapy|Death|0|||
125539148|NCT02712905|451604159|FG007|Combination Therapy|Death|0|||
125539149|NCT02712905|451604160|FG008|Combination Therapy|Death|0|||
125539150|NCT02712905|451604161|FG009|Combination Therapy|Death|0|||
125539151|NCT02712905|451604162|FG010|Combination Therapy|Death|0|||
125539152|NCT02712905|451604163|FG011|Combination Therapy|Death|0|||
125539153|NCT02712905|451604164|FG012|Combination Therapy|Death|5|||
125539154|NCT02712905|451604165|FG013|Combination Therapy|Death|6|||
125539155|NCT02712905|451604166|FG014|Combination Therapy|Death|1|||
125539156|NCT02712905|451604167|FG015|Combination Therapy|Death|3|||
125539157|NCT02712905|451604168|FG016|Combination Therapy|Death|1|||
125539158|NCT02712905|451604169|FG017|Combination Therapy|Death|3|||
125539159|NCT02712905|451604152|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
125539160|NCT02712905|451604153|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
125539161|NCT02712905|451604154|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
125539162|NCT02712905|451604155|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
125539163|NCT02712905|451604156|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
125539164|NCT02712905|451604157|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
125539165|NCT02712905|451604158|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
125539166|NCT02712905|451604159|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
125539167|NCT02712905|451604160|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
125539168|NCT02712905|451604161|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
125539169|NCT02712905|451604162|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
125539170|NCT02712905|451604163|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
125539171|NCT02712905|451604164|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
125539172|NCT02712905|451604165|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
125539173|NCT02712905|451604166|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
125539174|NCT02712905|451604167|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
125539175|NCT02712905|451604168|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
125539176|NCT02712905|451604169|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
125539177|NCT02712905|451604152|FG000|Combination Therapy|Withdrawal by Subject|0|||
125539178|NCT02712905|451604153|FG001|Combination Therapy|Withdrawal by Subject|0|||
125539179|NCT02712905|451604154|FG002|Combination Therapy|Withdrawal by Subject|0|||
125539180|NCT02712905|451604155|FG003|Combination Therapy|Withdrawal by Subject|0|||
125539181|NCT02712905|451604156|FG004|Combination Therapy|Withdrawal by Subject|0|||
125539182|NCT02712905|451604157|FG005|Combination Therapy|Withdrawal by Subject|0|||
125539183|NCT02712905|451604158|FG006|Combination Therapy|Withdrawal by Subject|0|||
125539184|NCT02712905|451604159|FG007|Combination Therapy|Withdrawal by Subject|0|||
125539185|NCT02712905|451604160|FG008|Combination Therapy|Withdrawal by Subject|0|||
125539186|NCT02712905|451604161|FG009|Combination Therapy|Withdrawal by Subject|0|||
125539187|NCT02712905|451604162|FG010|Combination Therapy|Withdrawal by Subject|0|||
125539188|NCT02712905|451604163|FG011|Combination Therapy|Withdrawal by Subject|0|||
125539189|NCT02712905|451604164|FG012|Combination Therapy|Withdrawal by Subject|0|||
125539190|NCT02712905|451604165|FG013|Combination Therapy|Withdrawal by Subject|0|||
125539191|NCT02712905|451604166|FG014|Combination Therapy|Withdrawal by Subject|0|||
125539192|NCT02712905|451604167|FG015|Combination Therapy|Withdrawal by Subject|1|||
125539193|NCT02712905|451604168|FG016|Combination Therapy|Withdrawal by Subject|0|||
125539194|NCT02712905|451604169|FG017|Combination Therapy|Withdrawal by Subject|2|||
125539195|NCT02712905|451604152|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539196|NCT02712905|451604153|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539197|NCT02712905|451604154|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539198|NCT02712905|451604155|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539199|NCT02712905|451604156|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539200|NCT02712905|451604157|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539201|NCT02712905|451604158|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539202|NCT02712905|451604159|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539203|NCT02712905|451604160|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539204|NCT02712905|451604161|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539205|NCT02712905|451604162|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539206|NCT02712905|451604163|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539207|NCT02712905|451604164|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539208|NCT02712905|451604165|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539209|NCT02712905|451604166|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539210|NCT02712905|451604167|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
125539211|NCT02712905|451604168|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539212|NCT02712905|451604169|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
125539213|NCT01942785|451604176|FG000|Overall Study|Adverse Event|2|||
125539214|NCT01942785|451604176|FG000|Overall Study|Withdrawal by Subject|1|||
125539215|NCT01942785|451604176|FG000|Overall Study|Protocol Violation|1|||
125539216|NCT02227199|451604177|FG000|Overall Study|Physician Decision|0|||
125539217|NCT02227199|451604178|FG001|Overall Study|Physician Decision|0|||
125539218|NCT02227199|451604179|FG002|Overall Study|Physician Decision|1|||
125539219|NCT02227199|451604177|FG000|Overall Study|Adverse Event|0|||
125539220|NCT02227199|451604178|FG001|Overall Study|Adverse Event|0|||
125539221|NCT02227199|451604179|FG002|Overall Study|Adverse Event|3|||
125539222|NCT05453201|451604181|FG000|Overall Study|Withdrawal by Subject|1|||
125539223|NCT00552929|451604182|FG000|Overall Study|Lost to Follow-up|0|||
125539224|NCT00552929|451604183|FG001|Overall Study|Lost to Follow-up|0|||
125539225|NCT00552929|451604184|FG002|Overall Study|Lost to Follow-up|0|||
125202384|NCT00960986|450363700|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
125202385|NCT00960986|450363697|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
125539226|NCT00552929|451604185|FG003|Overall Study|Lost to Follow-up|0|||
125539227|NCT00552929|451604186|FG004|Overall Study|Lost to Follow-up|0|||
125539228|NCT00552929|451604187|FG005|Overall Study|Lost to Follow-up|0|||
125539229|NCT00552929|451604188|FG006|Overall Study|Lost to Follow-up|0|||
125539230|NCT00552929|451604189|FG007|Overall Study|Lost to Follow-up|0|||
125539231|NCT00552929|451604190|FG008|Overall Study|Lost to Follow-up|1|||
125539232|NCT00552929|451604191|FG009|Overall Study|Lost to Follow-up|0|||
125539233|NCT00552929|451604182|FG000|Overall Study|Not Eligible|0|||
125539234|NCT00552929|451604183|FG001|Overall Study|Not Eligible|0|||
125539235|NCT00552929|451604184|FG002|Overall Study|Not Eligible|0|||
125539236|NCT00552929|451604185|FG003|Overall Study|Not Eligible|0|||
125539237|NCT00552929|451604186|FG004|Overall Study|Not Eligible|0|||
125539238|NCT00552929|451604187|FG005|Overall Study|Not Eligible|1|||
125539239|NCT00552929|451604188|FG006|Overall Study|Not Eligible|0|||
125539240|NCT00552929|451604189|FG007|Overall Study|Not Eligible|0|||
125539241|NCT00552929|451604190|FG008|Overall Study|Not Eligible|0|||
125539242|NCT00552929|451604191|FG009|Overall Study|Not Eligible|0|||
125539243|NCT01200290|451604192|FG000|Treatment Period|Adverse Event|1|||
125539244|NCT01200290|451604192|FG000|Post-Treatment Follow-Up Period|Death|2|||
125539245|NCT02489968|451604199|FG000|Open-label Treatment Period|Adverse Event|14|||
125539246|NCT02489968|451604200|FG001|Open-label Treatment Period|Adverse Event|7|||
125539247|NCT02489968|451604201|FG002|Open-label Treatment Period|Adverse Event|0|||
125539248|NCT02489968|451604202|FG003|Open-label Treatment Period|Adverse Event|0|||
125539249|NCT02489968|451604203|FG004|Open-label Treatment Period|Adverse Event|0|||
125539250|NCT02489968|451604204|FG005|Open-label Treatment Period|Adverse Event|0|||
125539251|NCT02489968|451604199|FG000|Open-label Treatment Period|Protocol Violation|2|||
125539252|NCT02489968|451604200|FG001|Open-label Treatment Period|Protocol Violation|2|||
125539253|NCT02489968|451604201|FG002|Open-label Treatment Period|Protocol Violation|0|||
125539254|NCT02489968|451604202|FG003|Open-label Treatment Period|Protocol Violation|0|||
125539255|NCT02489968|451604203|FG004|Open-label Treatment Period|Protocol Violation|0|||
125539256|NCT02489968|451604204|FG005|Open-label Treatment Period|Protocol Violation|0|||
125539257|NCT02489968|451604199|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
125539258|NCT02489968|451604200|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
125539259|NCT02489968|451604201|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
125539260|NCT02489968|451604202|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
125539261|NCT02489968|451604203|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
125539262|NCT02489968|451604204|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
125539263|NCT02489968|451604199|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
125539264|NCT02489968|451604200|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
125539265|NCT02489968|451604201|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
125539266|NCT02489968|451604202|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
125539267|NCT02489968|451604203|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
125539268|NCT02489968|451604204|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
125539269|NCT02489968|451604199|FG000|Open-label Treatment Period|Other than specified above|204|||
125539270|NCT02489968|451604200|FG001|Open-label Treatment Period|Other than specified above|189|||
125539271|NCT02489968|451604201|FG002|Open-label Treatment Period|Other than specified above|0|||
125539272|NCT02489968|451604202|FG003|Open-label Treatment Period|Other than specified above|0|||
125539273|NCT02489968|451604203|FG004|Open-label Treatment Period|Other than specified above|0|||
125539274|NCT02489968|451604204|FG005|Open-label Treatment Period|Other than specified above|0|||
125539275|NCT02489968|451604199|FG000|Double-blind Treatment Period|Adverse Event|0|||
125539276|NCT02489968|451604200|FG001|Double-blind Treatment Period|Adverse Event|0|||
125539277|NCT02489968|451604201|FG002|Double-blind Treatment Period|Adverse Event|2|||
125539278|NCT02489968|451604202|FG003|Double-blind Treatment Period|Adverse Event|6|||
125539279|NCT02489968|451604203|FG004|Double-blind Treatment Period|Adverse Event|4|||
125539280|NCT02489968|451604204|FG005|Double-blind Treatment Period|Adverse Event|5|||
125539281|NCT02489968|451604199|FG000|Double-blind Treatment Period|Protocol Violation|0|||
125539282|NCT02489968|451604200|FG001|Double-blind Treatment Period|Protocol Violation|0|||
125539283|NCT02489968|451604201|FG002|Double-blind Treatment Period|Protocol Violation|0|||
125539284|NCT02489968|451604202|FG003|Double-blind Treatment Period|Protocol Violation|0|||
125539285|NCT02489968|451604203|FG004|Double-blind Treatment Period|Protocol Violation|1|||
125539286|NCT02489968|451604204|FG005|Double-blind Treatment Period|Protocol Violation|1|||
125539287|NCT02489968|451604199|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
125539288|NCT02489968|451604200|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
125539289|NCT02489968|451604201|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125539290|NCT02489968|451604202|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
125539291|NCT02489968|451604203|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
125202386|NCT00960986|450363698|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
125539292|NCT02489968|451604204|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
125539293|NCT02489968|451604199|FG000|Double-blind Treatment Period|Other than specified above|0|||
125539294|NCT02489968|451604200|FG001|Double-blind Treatment Period|Other than specified above|0|||
125539295|NCT02489968|451604201|FG002|Double-blind Treatment Period|Other than specified above|0|||
125539296|NCT02489968|451604202|FG003|Double-blind Treatment Period|Other than specified above|0|||
125539297|NCT02489968|451604203|FG004|Double-blind Treatment Period|Other than specified above|1|||
125539298|NCT02489968|451604204|FG005|Double-blind Treatment Period|Other than specified above|0|||
125539299|NCT04577001|451604205|FG000|Overall Study|Subject became ineligible|0|||
125539300|NCT04577001|451604206|FG001|Overall Study|Subject became ineligible|1|||
125539301|NCT03465904|451604209|FG000|Overall Study|Withdrawal by Subject|9|||
125539302|NCT03465904|451604210|FG001|Overall Study|Withdrawal by Subject|5|||
125539303|NCT03465904|451604209|FG000|Overall Study|Lost to Follow-up|11|||
125539304|NCT03465904|451604210|FG001|Overall Study|Lost to Follow-up|9|||
125539305|NCT03465904|451604209|FG000|Overall Study|Protocol Violation|20|||
125539306|NCT03465904|451604210|FG001|Overall Study|Protocol Violation|15|||
125539307|NCT01022112|451604213|FG000|Overall Study|Adverse Event|1|||
125539308|NCT01022112|451604214|FG001|Overall Study|Adverse Event|2|||
125539309|NCT01022112|451604215|FG002|Overall Study|Adverse Event|0|||
125539310|NCT01022112|451604216|FG003|Overall Study|Adverse Event|1|||
125202387|NCT00960986|450363699|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
125202388|NCT00960986|450363700|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
125202389|NCT00877071|450363701|FG000|Overall Study|disease progression|2|||
125202390|NCT01984892|450363702|FG000|Overall Study|Progressive disease|7|||
125202391|NCT04464720|450363703|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
125202392|NCT05723328|450363709|FG000|Overall Study|Investigator's Decision|5|||
125202393|NCT05723328|450363710|FG001|Overall Study|Investigator's Decision|2|||
125202394|NCT00954512|450363714|FG000|Overall Study|Withdrawal by Subject|0|||
125202395|NCT00954512|450363715|FG001|Overall Study|Withdrawal by Subject|0|||
125202396|NCT00954512|450363716|FG002|Overall Study|Withdrawal by Subject|0|||
125202397|NCT00954512|450363717|FG003|Overall Study|Withdrawal by Subject|0|||
125539311|NCT01022112|451604217|FG004|Overall Study|Adverse Event|0|||
125539312|NCT01022112|451604213|FG000|Overall Study|Lack of Efficacy|1|||
125539313|NCT01022112|451604214|FG001|Overall Study|Lack of Efficacy|0|||
125539314|NCT01022112|451604215|FG002|Overall Study|Lack of Efficacy|0|||
125539315|NCT01022112|451604216|FG003|Overall Study|Lack of Efficacy|0|||
125539316|NCT01022112|451604217|FG004|Overall Study|Lack of Efficacy|1|||
125539317|NCT01022112|451604213|FG000|Overall Study|Physician Decision|0|||
125539318|NCT01022112|451604214|FG001|Overall Study|Physician Decision|0|||
125539319|NCT01022112|451604215|FG002|Overall Study|Physician Decision|1|||
125539320|NCT01022112|451604216|FG003|Overall Study|Physician Decision|0|||
125539321|NCT01022112|451604217|FG004|Overall Study|Physician Decision|1|||
125539322|NCT01022112|451604213|FG000|Overall Study|Withdrawal by Subject|0|||
125539323|NCT01022112|451604214|FG001|Overall Study|Withdrawal by Subject|1|||
125539324|NCT01022112|451604215|FG002|Overall Study|Withdrawal by Subject|2|||
125539325|NCT01022112|451604216|FG003|Overall Study|Withdrawal by Subject|2|||
125539326|NCT01022112|451604217|FG004|Overall Study|Withdrawal by Subject|1|||
125539327|NCT01022112|451604213|FG000|Overall Study|Fasting plasma glucose level increased|1|||
125539328|NCT01022112|451604214|FG001|Overall Study|Fasting plasma glucose level increased|0|||
125539329|NCT01022112|451604215|FG002|Overall Study|Fasting plasma glucose level increased|0|||
125539330|NCT01022112|451604216|FG003|Overall Study|Fasting plasma glucose level increased|0|||
125539331|NCT01022112|451604217|FG004|Overall Study|Fasting plasma glucose level increased|7|||
125539332|NCT00925353|451604218|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
125539333|NCT01198756|451605766|FG000|Overall Study|Adverse Event|0|||
125539334|NCT01198756|451605767|FG001|Overall Study|Adverse Event|0|||
125539335|NCT01198756|451605768|FG002|Overall Study|Adverse Event|0|||
125539336|NCT01198756|451605769|FG003|Overall Study|Adverse Event|1|||
125539337|NCT01198756|451605766|FG000|Overall Study|Protocol Violation|0|||
125539338|NCT01198756|451605767|FG001|Overall Study|Protocol Violation|0|||
125539339|NCT01198756|451605768|FG002|Overall Study|Protocol Violation|0|||
125539340|NCT01198756|451605769|FG003|Overall Study|Protocol Violation|2|||
125539341|NCT01198756|451605766|FG000|Overall Study|Withdrawal by Subject|9|||
125539342|NCT01198756|451605767|FG001|Overall Study|Withdrawal by Subject|4|||
125539343|NCT01198756|451605768|FG002|Overall Study|Withdrawal by Subject|7|||
125539344|NCT01198756|451605769|FG003|Overall Study|Withdrawal by Subject|5|||
125539345|NCT01198756|451605766|FG000|Overall Study|Lost to Follow-up|29|||
125539346|NCT01198756|451605767|FG001|Overall Study|Lost to Follow-up|36|||
125539347|NCT01198756|451605768|FG002|Overall Study|Lost to Follow-up|23|||
125539348|NCT01198756|451605769|FG003|Overall Study|Lost to Follow-up|18|||
125539349|NCT01290315|451605771|FG000|Overall Study|Adverse Event|0|||
125202398|NCT00954512|450363718|FG004|Overall Study|Withdrawal by Subject|0|||
125202399|NCT00954512|450363719|FG005|Overall Study|Withdrawal by Subject|1|||
125202400|NCT00954512|450363714|FG000|Overall Study|Adverse Event|0|||
125539350|NCT01290315|451605772|FG001|Overall Study|Adverse Event|0|||
125539351|NCT01290315|451605773|FG002|Overall Study|Adverse Event|0|||
125539352|NCT01290315|451605774|FG003|Overall Study|Adverse Event|3|||
125539353|NCT01290315|451605771|FG000|Overall Study|Selection criteria/compliance|2|||
125539354|NCT01290315|451605772|FG001|Overall Study|Selection criteria/compliance|1|||
125539355|NCT01290315|451605773|FG002|Overall Study|Selection criteria/compliance|0|||
125539356|NCT01290315|451605774|FG003|Overall Study|Selection criteria/compliance|2|||
125539357|NCT01290315|451605771|FG000|Overall Study|Lost to Follow-up|0|||
125539358|NCT01290315|451605772|FG001|Overall Study|Lost to Follow-up|1|||
125539359|NCT01290315|451605773|FG002|Overall Study|Lost to Follow-up|0|||
125539360|NCT01290315|451605774|FG003|Overall Study|Lost to Follow-up|0|||
125539361|NCT01290315|451605771|FG000|Overall Study|Withdrawal by Subject|1|||
125539362|NCT01290315|451605772|FG001|Overall Study|Withdrawal by Subject|1|||
125539363|NCT01290315|451605773|FG002|Overall Study|Withdrawal by Subject|0|||
125539364|NCT01290315|451605774|FG003|Overall Study|Withdrawal by Subject|0|||
125539365|NCT00591721|451605775|FG000|Overall Study|Withdrawal by Subject|10|||
125539366|NCT00591721|451605776|FG001|Overall Study|Withdrawal by Subject|10|||
125539367|NCT00591721|451605775|FG000|Overall Study|Lost to Follow-up|1|||
125539368|NCT00591721|451605776|FG001|Overall Study|Lost to Follow-up|4|||
125539369|NCT00591721|451605775|FG000|Overall Study|Intervention not received|10|||
125539370|NCT00591721|451605776|FG001|Overall Study|Intervention not received|8|||
125539371|NCT00901186|451605781|FG000|Overall Study|Lack of Efficacy|0|||
125539372|NCT00901186|451605782|FG001|Overall Study|Lack of Efficacy|1|||
125539373|NCT00901186|451605781|FG000|Overall Study|Abnormal laboratory values|0|||
125539374|NCT00901186|451605782|FG001|Overall Study|Abnormal laboratory values|1|||
125539375|NCT00901186|451605781|FG000|Overall Study|Lost to Follow-up|2|||
125539376|NCT00901186|451605782|FG001|Overall Study|Lost to Follow-up|0|||
125539377|NCT00901186|451605781|FG000|Overall Study|Adverse Event|2|||
125539378|NCT00901186|451605782|FG001|Overall Study|Adverse Event|4|||
125539379|NCT00901186|451605781|FG000|Overall Study|Administration problems|0|||
125539380|NCT00901186|451605782|FG001|Overall Study|Administration problems|1|||
125539381|NCT00901186|451605781|FG000|Overall Study|Protocol deviations|5|||
125539382|NCT00901186|451605782|FG001|Overall Study|Protocol deviations|4|||
125539383|NCT00581555|451605785|FG000|Overall Study|Adverse Event|4|||
125539384|NCT00581555|451605786|FG001|Overall Study|Adverse Event|3|||
125539385|NCT00581555|451605785|FG000|Overall Study|Physician Decision|3|||
125539386|NCT00581555|451605786|FG001|Overall Study|Physician Decision|2|||
125539387|NCT00581555|451605785|FG000|Overall Study|Withdrawal by Subject|18|||
125539388|NCT00581555|451605786|FG001|Overall Study|Withdrawal by Subject|9|||
125539389|NCT00581555|451605785|FG000|Overall Study|Lost to Follow-up|2|||
125539390|NCT00581555|451605786|FG001|Overall Study|Lost to Follow-up|2|||
125539391|NCT00581555|451605785|FG000|Overall Study|Other reasons|16|||
125539392|NCT00581555|451605786|FG001|Overall Study|Other reasons|4|||
125539393|NCT03828747|451605787|FG000|Double-Blind Treatment Period|Adverse Event|6|||
125539394|NCT03828747|451605788|FG001|Double-Blind Treatment Period|Adverse Event|6|||
125539395|NCT03828747|451605787|FG000|Double-Blind Treatment Period|Death|1|||
125539396|NCT03828747|451605788|FG001|Double-Blind Treatment Period|Death|1|||
125539397|NCT03828747|451605787|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125539398|NCT03828747|451605788|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
125539399|NCT03828747|451605787|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
125539400|NCT03828747|451605788|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
125539401|NCT03828747|451605787|FG000|Double-Blind Treatment Period|Physician Decision|1|||
125539402|NCT03828747|451605788|FG001|Double-Blind Treatment Period|Physician Decision|4|||
125539403|NCT03828747|451605787|FG000|Double-Blind Treatment Period|Various reasons|5|||
125539404|NCT03828747|451605788|FG001|Double-Blind Treatment Period|Various reasons|3|||
125539405|NCT03828747|451605787|FG000|Open-Label Extension|Adverse Event|9|||
125539406|NCT03828747|451605788|FG001|Open-Label Extension|Adverse Event|7|||
125539407|NCT03828747|451605787|FG000|Open-Label Extension|Death|0|||
125539408|NCT03828747|451605788|FG001|Open-Label Extension|Death|2|||
125539409|NCT03828747|451605787|FG000|Open-Label Extension|Lost to Follow-up|4|||
125539410|NCT03828747|451605788|FG001|Open-Label Extension|Lost to Follow-up|0|||
125539411|NCT03828747|451605787|FG000|Open-Label Extension|Withdrawal by Subject|31|||
125539412|NCT03828747|451605788|FG001|Open-Label Extension|Withdrawal by Subject|30|||
125539413|NCT03828747|451605787|FG000|Open-Label Extension|Various reasons|4|||
125539414|NCT03828747|451605788|FG001|Open-Label Extension|Various reasons|4|||
125539415|NCT03828747|451605787|FG000|Open-Label Extension|Physician Decision|6|||
125539416|NCT03828747|451605788|FG001|Open-Label Extension|Physician Decision|2|||
125539417|NCT05816330|451605789|FG000|Overall Study|Withdrawal by Subject|4|||
125539418|NCT05816330|451605790|FG001|Overall Study|Withdrawal by Subject|1|||
125539419|NCT03900416|451605791|FG000|Six Week Follow-up|Lost to Follow-up|1|||
125539420|NCT03900416|451605792|FG001|Six Week Follow-up|Lost to Follow-up|0|||
125539421|NCT03900416|451605791|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
125539422|NCT03900416|451605792|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
125539423|NCT03900416|451605791|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
125539424|NCT03900416|451605792|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
125539425|NCT03900416|451605791|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
125539426|NCT03900416|451605792|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
125539427|NCT03900416|451605791|FG000|Twelve Week Follow-up|Adverse Event|1|||
125539428|NCT03900416|451605792|FG001|Twelve Week Follow-up|Adverse Event|1|||
125539429|NCT03900416|451605791|FG000|Six Month Follow-up|Lost to Follow-up|4|||
125539430|NCT03900416|451605792|FG001|Six Month Follow-up|Lost to Follow-up|3|||
125539431|NCT03900416|451605791|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
125539432|NCT03900416|451605792|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
125539433|NCT02663518|451605798|FG000|Part 1: Phase 1a Escalation|Death|0|||
125539434|NCT02663518|451605799|FG001|Part 1: Phase 1a Escalation|Death|0|||
125539435|NCT02663518|451605800|FG002|Part 1: Phase 1a Escalation|Death|1|||
125539436|NCT02663518|451605801|FG003|Part 1: Phase 1a Escalation|Death|0|||
125539437|NCT02663518|451605802|FG004|Part 1: Phase 1a Escalation|Death|0|||
125539438|NCT02663518|451605803|FG005|Part 1: Phase 1a Escalation|Death|0|||
125539439|NCT02663518|451605804|FG006|Part 1: Phase 1a Escalation|Death|0|||
125539440|NCT02663518|451605805|FG007|Part 1: Phase 1a Escalation|Death|0|||
125539441|NCT02663518|451605806|FG008|Part 1: Phase 1a Escalation|Death|0|||
125539442|NCT02663518|451605807|FG009|Part 1: Phase 1a Escalation|Death|0|||
125539443|NCT02663518|451605808|FG010|Part 1: Phase 1a Escalation|Death|0|||
125539444|NCT02663518|451605809|FG011|Part 1: Phase 1a Escalation|Death|0|||
125539445|NCT02663518|451605810|FG012|Part 1: Phase 1a Escalation|Death|0|||
125539446|NCT02663518|451605811|FG013|Part 1: Phase 1a Escalation|Death|0|||
125539447|NCT02663518|451605798|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
125539448|NCT02663518|451605799|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
125539449|NCT02663518|451605800|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
125539450|NCT02663518|451605801|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
125539451|NCT02663518|451605802|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
125539452|NCT02663518|451605803|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
125539453|NCT02663518|451605804|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
125539454|NCT02663518|451605805|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
125539455|NCT02663518|451605806|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
125539456|NCT02663518|451605807|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
125539457|NCT02663518|451605808|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
125539458|NCT02663518|451605809|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
125539459|NCT02663518|451605810|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
125539460|NCT02663518|451605811|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
125539461|NCT02663518|451605798|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
125539462|NCT02663518|451605799|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
125539463|NCT02663518|451605800|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
125539464|NCT02663518|451605801|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
125539465|NCT02663518|451605802|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
125539466|NCT02663518|451605803|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
125539467|NCT02663518|451605804|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
125539468|NCT02663518|451605805|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
125539469|NCT02663518|451605806|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
125539470|NCT02663518|451605807|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
125539471|NCT02663518|451605808|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
125539472|NCT02663518|451605809|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
125539473|NCT02663518|451605810|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
125539474|NCT02663518|451605811|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
125539475|NCT02663518|451605798|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
125539476|NCT02663518|451605799|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
125539477|NCT02663518|451605800|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
125539478|NCT02663518|451605801|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
125539479|NCT02663518|451605802|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
125539480|NCT02663518|451605803|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
125539481|NCT02663518|451605804|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
125539482|NCT02663518|451605805|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
125539483|NCT02663518|451605806|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
125539484|NCT02663518|451605807|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
125539485|NCT02663518|451605808|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
125539486|NCT02663518|451605809|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
125539487|NCT02663518|451605810|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
125539488|NCT02663518|451605811|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
125539489|NCT02663518|451605798|FG000|Part 1: Phase 1a Escalation|Other|0|||
125539490|NCT02663518|451605799|FG001|Part 1: Phase 1a Escalation|Other|0|||
125539491|NCT02663518|451605800|FG002|Part 1: Phase 1a Escalation|Other|2|||
125539492|NCT02663518|451605801|FG003|Part 1: Phase 1a Escalation|Other|0|||
125539493|NCT02663518|451605802|FG004|Part 1: Phase 1a Escalation|Other|0|||
125539494|NCT02663518|451605803|FG005|Part 1: Phase 1a Escalation|Other|0|||
125539495|NCT02663518|451605804|FG006|Part 1: Phase 1a Escalation|Other|0|||
125202401|NCT00954512|450363715|FG001|Overall Study|Adverse Event|0|||
125202402|NCT00954512|450363716|FG002|Overall Study|Adverse Event|0|||
125202403|NCT00954512|450363717|FG003|Overall Study|Adverse Event|0|||
125202404|NCT00954512|450363718|FG004|Overall Study|Adverse Event|1|||
125539496|NCT02663518|451605805|FG007|Part 1: Phase 1a Escalation|Other|0|||
125539497|NCT02663518|451605806|FG008|Part 1: Phase 1a Escalation|Other|0|||
125539498|NCT02663518|451605807|FG009|Part 1: Phase 1a Escalation|Other|0|||
125539499|NCT02663518|451605808|FG010|Part 1: Phase 1a Escalation|Other|0|||
125539500|NCT02663518|451605809|FG011|Part 1: Phase 1a Escalation|Other|0|||
125539501|NCT02663518|451605810|FG012|Part 1: Phase 1a Escalation|Other|0|||
125539502|NCT02663518|451605811|FG013|Part 1: Phase 1a Escalation|Other|0|||
125539503|NCT02663518|451605798|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
125539504|NCT02663518|451605799|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
125539505|NCT02663518|451605800|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
125539506|NCT02663518|451605801|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
125539507|NCT02663518|451605802|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
125539508|NCT02663518|451605803|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
125539509|NCT02663518|451605804|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
125539510|NCT02663518|451605805|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
125539511|NCT02663518|451605806|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
125539512|NCT02663518|451605807|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
125539513|NCT02663518|451605808|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
125539514|NCT02663518|451605809|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
125539515|NCT02663518|451605810|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
125539516|NCT02663518|451605811|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
125539517|NCT02663518|451605798|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
125539518|NCT02663518|451605799|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
125646220|NCT03370133|451988242|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
125646221|NCT03370133|451988237|FG000|Initial Treatment Period (WK 16)|Death|1|||
125646222|NCT03370133|451988238|FG001|Initial Treatment Period (WK 16)|Death|1|||
125646223|NCT03370133|451988239|FG002|Initial Treatment Period (WK 16)|Death|1|||
125646224|NCT03370133|451988240|FG003|Initial Treatment Period (WK 16)|Death|0|||
125646225|NCT03370133|451988241|FG004|Initial Treatment Period (WK 16)|Death|0|||
125646226|NCT03370133|451988242|FG005|Initial Treatment Period (WK 16)|Death|0|||
125646227|NCT03370133|451988237|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
125646228|NCT03370133|451988238|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
125646229|NCT03370133|451988239|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
125646230|NCT03370133|451988240|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
125646231|NCT03370133|451988241|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
125646232|NCT03370133|451988242|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
125646233|NCT03370133|451988237|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
125646234|NCT03370133|451988238|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
125646235|NCT03370133|451988239|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
125646236|NCT03370133|451988240|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
125646237|NCT03370133|451988241|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
125646238|NCT03370133|451988242|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
125646239|NCT03370133|451988237|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
125646240|NCT03370133|451988238|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
125646241|NCT03370133|451988239|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
125646242|NCT03370133|451988240|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
125646243|NCT03370133|451988241|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
125646244|NCT03370133|451988242|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
125646245|NCT03370133|451988237|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
125646246|NCT03370133|451988238|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
125646247|NCT03370133|451988239|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
125646248|NCT03370133|451988240|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
125646249|NCT03370133|451988241|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
125646250|NCT03370133|451988242|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
125646251|NCT03370133|451988237|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
125539519|NCT02663518|451605800|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
125539520|NCT02663518|451605801|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
125539521|NCT02663518|451605802|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
125539522|NCT02663518|451605803|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
125539523|NCT02663518|451605804|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
125539524|NCT02663518|451605805|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
125539525|NCT02663518|451605806|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
125539526|NCT02663518|451605807|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
125539527|NCT02663518|451605808|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
125539528|NCT02663518|451605809|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
125539529|NCT02663518|451605810|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
125202405|NCT00954512|450363719|FG005|Overall Study|Adverse Event|2|||
125539530|NCT02663518|451605811|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
125539531|NCT02663518|451605798|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
125539532|NCT02663518|451605799|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
125539533|NCT02663518|451605800|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
125539534|NCT02663518|451605801|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
125539535|NCT02663518|451605802|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
125539536|NCT02663518|451605803|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
125539537|NCT02663518|451605804|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
125539538|NCT02663518|451605805|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
125539539|NCT02663518|451605806|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
125539540|NCT02663518|451605807|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
125539541|NCT02663518|451605808|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
125539542|NCT02663518|451605809|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
125539543|NCT02663518|451605810|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
125539544|NCT02663518|451605811|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
125539545|NCT02663518|451605798|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
125539546|NCT02663518|451605799|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
125539547|NCT02663518|451605800|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
125539548|NCT02663518|451605801|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
125539549|NCT02663518|451605802|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
125539550|NCT02663518|451605803|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
125539551|NCT02663518|451605804|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
125539552|NCT02663518|451605805|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
125539553|NCT02663518|451605806|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
125539554|NCT02663518|451605807|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
125539555|NCT02663518|451605808|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
125539556|NCT02663518|451605809|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
125539557|NCT02663518|451605810|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
125539558|NCT02663518|451605811|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
125539559|NCT02663518|451605798|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
125539560|NCT02663518|451605799|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
125539561|NCT02663518|451605800|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
125539562|NCT02663518|451605801|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
125539563|NCT02663518|451605802|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
125539564|NCT02663518|451605803|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
125539565|NCT02663518|451605804|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
125539566|NCT02663518|451605805|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
125539567|NCT02663518|451605806|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
125539568|NCT02663518|451605807|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
125539569|NCT02663518|451605808|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
125539570|NCT02663518|451605809|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
125539571|NCT02663518|451605810|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
125539572|NCT02663518|451605811|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
125539573|NCT02663518|451605798|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
125539574|NCT02663518|451605799|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
125539575|NCT02663518|451605800|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
125539576|NCT02663518|451605801|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
125539577|NCT02663518|451605802|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
125539578|NCT02663518|451605803|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
125539579|NCT02663518|451605804|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
125539580|NCT02663518|451605805|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
125539581|NCT02663518|451605806|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
125539582|NCT02663518|451605807|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
125539583|NCT02663518|451605808|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
125539584|NCT02663518|451605809|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
125539585|NCT02663518|451605810|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
125539586|NCT02663518|451605811|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
125539587|NCT02663518|451605798|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
125539588|NCT02663518|451605799|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
125539589|NCT02663518|451605800|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
125539590|NCT02663518|451605801|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
125539591|NCT02663518|451605802|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
125539592|NCT02663518|451605803|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
125539593|NCT02663518|451605804|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
125539594|NCT02663518|451605805|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
125539595|NCT02663518|451605806|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
125539596|NCT02663518|451605807|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
125539597|NCT02663518|451605808|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
125539598|NCT02663518|451605809|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
125539599|NCT02663518|451605810|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
125539600|NCT02663518|451605811|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
125539601|NCT02663518|451605798|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
125539602|NCT02663518|451605799|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
125539603|NCT02663518|451605800|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
125539604|NCT02663518|451605801|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
125539605|NCT02663518|451605802|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
125539606|NCT02663518|451605803|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
125539607|NCT02663518|451605804|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
125539608|NCT02663518|451605805|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
125539609|NCT02663518|451605806|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
125539610|NCT02663518|451605807|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
125539611|NCT02663518|451605808|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
125539612|NCT02663518|451605809|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
125539613|NCT02663518|451605810|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
125539614|NCT02663518|451605811|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
125646252|NCT03370133|451988238|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
125646253|NCT03370133|451988239|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
125646254|NCT03370133|451988240|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
125646255|NCT03370133|451988241|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
125646256|NCT03370133|451988242|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
125646257|NCT03370133|451988237|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
125646258|NCT03370133|451988238|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
125646259|NCT03370133|451988239|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
125646260|NCT03370133|451988240|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
125646261|NCT03370133|451988241|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
125646262|NCT03370133|451988242|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
125646263|NCT03370133|451988237|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
125646264|NCT03370133|451988238|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
125646265|NCT03370133|451988239|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
125539615|NCT02663518|451605798|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125539616|NCT02663518|451605799|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125539617|NCT02663518|451605800|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125539618|NCT02663518|451605801|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125539619|NCT02663518|451605802|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125539620|NCT02663518|451605803|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125539621|NCT02663518|451605804|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125539622|NCT02663518|451605805|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125539623|NCT02663518|451605806|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125539624|NCT02663518|451605807|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125539625|NCT02663518|451605808|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125539626|NCT02663518|451605809|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
125646266|NCT03370133|451988240|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
125646267|NCT03370133|451988241|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
125646268|NCT03370133|451988242|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
125646269|NCT03370133|451988237|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
125646270|NCT03370133|451988238|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
125646271|NCT03370133|451988239|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
125646272|NCT03370133|451988240|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
125539627|NCT02663518|451605810|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125539628|NCT02663518|451605811|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
125539629|NCT02663518|451605798|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
125539630|NCT02663518|451605799|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
125539631|NCT02663518|451605800|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
125539632|NCT02663518|451605801|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
125539633|NCT02663518|451605802|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
125539634|NCT02663518|451605803|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
125539635|NCT02663518|451605804|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
125539636|NCT02663518|451605805|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
125539637|NCT02663518|451605806|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
125539638|NCT02663518|451605807|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
125539639|NCT02663518|451605808|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
125539640|NCT02663518|451605809|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
125539641|NCT02663518|451605810|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
125539642|NCT02663518|451605811|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
125539643|NCT02663518|451605798|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
125202406|NCT00954512|450363714|FG000|Overall Study|Physician Decision|0|||
125202407|NCT00954512|450363715|FG001|Overall Study|Physician Decision|1|||
125202408|NCT00954512|450363716|FG002|Overall Study|Physician Decision|0|||
125539644|NCT02663518|451605799|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
125539645|NCT02663518|451605800|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
125539646|NCT02663518|451605801|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
125202409|NCT00954512|450363717|FG003|Overall Study|Physician Decision|1|||
125539647|NCT02663518|451605802|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
125539648|NCT02663518|451605803|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
125539649|NCT02663518|451605804|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
125539650|NCT02663518|451605805|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
125539651|NCT02663518|451605806|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
125539652|NCT02663518|451605807|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
125539653|NCT02663518|451605808|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
125539654|NCT02663518|451605809|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
125539655|NCT02663518|451605810|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
125539656|NCT02663518|451605811|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
125539657|NCT02663518|451605798|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
125539658|NCT02663518|451605799|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
125539659|NCT02663518|451605800|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
125539660|NCT02663518|451605801|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
125539661|NCT02663518|451605802|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
125539662|NCT02663518|451605803|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
125539663|NCT02663518|451605804|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
125539664|NCT02663518|451605805|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
125539665|NCT02663518|451605806|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
125539666|NCT02663518|451605807|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
125539667|NCT02663518|451605808|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
125539668|NCT02663518|451605809|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
125539669|NCT02663518|451605810|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
125539670|NCT02663518|451605811|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
125539671|NCT03896152|451605812|FG000|Overall Study|Patient/guardian decision|1|||
125539672|NCT03896152|451605813|FG001|Overall Study|Patient/guardian decision|1|||
125539673|NCT03896152|451605812|FG000|Overall Study|Adverse Event|0|||
125539674|NCT03896152|451605813|FG001|Overall Study|Adverse Event|1|||
125539675|NCT03896152|451605812|FG000|Overall Study|Physician Decision|1|||
125539676|NCT03896152|451605813|FG001|Overall Study|Physician Decision|0|||
125539677|NCT03896152|451605812|FG000|Overall Study|Technical problems|1|||
125539678|NCT03896152|451605813|FG001|Overall Study|Technical problems|0|||
125539679|NCT00772330|451605814|FG000|Overall Study|Lost to Follow-up|3|||
125539680|NCT01353859|451605815|FG000|Overall Study|Adverse Event|3|||
125539681|NCT01353859|451605815|FG000|Overall Study|Lack of Efficacy|1|||
125539682|NCT00700427|451605816|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
125539683|NCT00700427|451605817|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
125539684|NCT00700427|451605818|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
125539685|NCT00700427|451605819|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
125539686|NCT00700427|451605820|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
125539687|NCT00700427|451605816|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
125539688|NCT00700427|451605817|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
125539689|NCT00700427|451605818|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
125539690|NCT00700427|451605819|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
125539691|NCT00700427|451605820|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
125539692|NCT00700427|451605816|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
125539693|NCT00700427|451605817|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
125539694|NCT00700427|451605818|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
125539695|NCT00700427|451605819|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
125646273|NCT03370133|451988241|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
125646274|NCT03370133|451988242|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
125646275|NCT03370133|451988237|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
125646276|NCT03370133|451988238|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
125646277|NCT03370133|451988239|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
125646278|NCT03370133|451988240|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
125646279|NCT03370133|451988241|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
125646280|NCT03370133|451988242|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
125646281|NCT03370133|451988237|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
125646282|NCT03370133|451988238|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
125646283|NCT03370133|451988239|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
125646284|NCT03370133|451988240|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
125646285|NCT03370133|451988241|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
125646286|NCT03370133|451988242|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
125646287|NCT03370133|451988237|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
125646288|NCT03370133|451988238|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
125646289|NCT03370133|451988239|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
125202410|NCT00954512|450363718|FG004|Overall Study|Physician Decision|0|||
125539696|NCT00700427|451605820|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
125539697|NCT00700427|451605816|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
125539698|NCT00700427|451605817|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
125539699|NCT00700427|451605818|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
125539700|NCT00700427|451605819|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
125539701|NCT00700427|451605820|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
125539702|NCT00700427|451605816|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
125539703|NCT00700427|451605817|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
125539704|NCT00700427|451605818|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
125539705|NCT00700427|451605819|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
125539706|NCT00700427|451605820|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
125539707|NCT00700427|451605816|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
125539708|NCT00700427|451605817|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
125539709|NCT00700427|451605818|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
125539710|NCT00700427|451605819|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
125539711|NCT00700427|451605820|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
125539712|NCT00700427|451605816|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
125539713|NCT00700427|451605817|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
125539714|NCT00700427|451605818|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
125539715|NCT00700427|451605819|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
125539716|NCT00700427|451605820|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
125539717|NCT00700427|451605816|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
125539718|NCT00700427|451605817|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
125539719|NCT00700427|451605818|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
125539720|NCT00700427|451605819|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
125539721|NCT00700427|451605820|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
125646290|NCT03370133|451988240|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
125646291|NCT03370133|451988241|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
125646292|NCT03370133|451988242|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
125646293|NCT03370133|451988237|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
125646294|NCT03370133|451988238|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
125646295|NCT03370133|451988239|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
125646296|NCT03370133|451988240|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
125646297|NCT03370133|451988241|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
125646298|NCT03370133|451988242|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
125646299|NCT03370133|451988237|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
125646300|NCT03370133|451988238|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
125646301|NCT03370133|451988239|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
125646302|NCT03370133|451988240|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
125646303|NCT03370133|451988241|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
125646304|NCT03370133|451988242|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
125646305|NCT01365468|451988243|FG000|Overall Study|Physician Decision|1|||
125646306|NCT01365468|451988244|FG001|Overall Study|Physician Decision|0|||
125646307|NCT01365468|451988243|FG000|Overall Study|Disease progression|1|||
125646308|NCT01365468|451988244|FG001|Overall Study|Disease progression|0|||
125646309|NCT01365468|451988243|FG000|Overall Study|Lost to Follow-up|2|||
125646310|NCT01365468|451988244|FG001|Overall Study|Lost to Follow-up|0|||
125646311|NCT03524664|451988245|FG000|Overall Study|Withdrawal by Subject|1|||
125646312|NCT03524664|451988246|FG001|Overall Study|Withdrawal by Subject|2|||
125646313|NCT03524664|451988245|FG000|Overall Study|Lost to Follow-up|4|||
125646314|NCT03524664|451988246|FG001|Overall Study|Lost to Follow-up|13|||
125646315|NCT02694562|451988247|FG000|Overall Study|Death|8|||
125646316|NCT02694562|451988247|FG000|Overall Study|Protocol Violation|4|||
125646317|NCT02694562|451988247|FG000|Overall Study|Lost to Follow-up|3|||
125646318|NCT02694562|451988247|FG000|Overall Study|Screen Failure|2|||
125646319|NCT02694562|451988247|FG000|Overall Study|Physician Decision|1|||
125646320|NCT00423267|451988248|FG000|Period A|Withdrawal by Subject|0|||
125646321|NCT00423267|451988249|FG001|Period A|Withdrawal by Subject|1|||
125646322|NCT00423267|451988248|FG000|Period A|Non-compliance with protocol|1|||
125646323|NCT00423267|451988249|FG001|Period A|Non-compliance with protocol|0|||
125646324|NCT00423267|451988248|FG000|Period A|Administrative|1|||
125646325|NCT00423267|451988249|FG001|Period A|Administrative|0|||
125646326|NCT01333865|451988250|FG000|Overall Study|Adverse Event|2|||
125646327|NCT00684073|451988251|FG000|Selection|Selection/non-selection criteria|3|||
125646328|NCT00684073|451988251|FG000|Selection|Death|1|||
125646329|NCT00684073|451988251|FG000|Selection|noncompliance|1|||
125646330|NCT00684073|451988251|FG000|Selection|Lost to Follow-up|1|||
125646331|NCT00684073|451988251|FG000|Selection|request of the sponsor|1|||
125646332|NCT00684073|451988251|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
125646333|NCT00591786|451988254|FG000|Overall Study|Withdrawal of Informed Consent|0|||
125646334|NCT00591786|451988255|FG001|Overall Study|Withdrawal of Informed Consent|0|||
125646335|NCT00591786|451988256|FG002|Overall Study|Withdrawal of Informed Consent|1|||
125646336|NCT00591786|451988257|FG003|Overall Study|Withdrawal of Informed Consent|0|||
125646337|NCT00591786|451988258|FG004|Overall Study|Withdrawal of Informed Consent|0|||
125646338|NCT00591786|451988259|FG005|Overall Study|Withdrawal of Informed Consent|0|||
125646339|NCT00591786|451988260|FG006|Overall Study|Withdrawal of Informed Consent|0|||
125646340|NCT00591786|451988261|FG007|Overall Study|Withdrawal of Informed Consent|0|||
125646341|NCT00591786|451988262|FG008|Overall Study|Withdrawal of Informed Consent|0|||
125646342|NCT00591786|451988263|FG009|Overall Study|Withdrawal of Informed Consent|0|||
125646343|NCT00554229|451988264|FG000|Overall Study|Lost to Follow-up|3|||
125646344|NCT00554229|451988265|FG001|Overall Study|Lost to Follow-up|6|||
125646345|NCT00554229|451988264|FG000|Overall Study|Withdrawal by Subject|29|||
125646346|NCT00554229|451988265|FG001|Overall Study|Withdrawal by Subject|37|||
125539722|NCT00700427|451605816|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
125539723|NCT00700427|451605817|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
125539724|NCT00700427|451605818|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
125539725|NCT00700427|451605819|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
125539726|NCT00700427|451605820|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
125539727|NCT00700427|451605816|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
125539728|NCT00700427|451605817|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
125539729|NCT00700427|451605818|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
125539730|NCT00700427|451605819|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
125539731|NCT00700427|451605820|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
125646347|NCT00554229|451988264|FG000|Overall Study|Adverse Event|71|||
125646348|NCT00554229|451988265|FG001|Overall Study|Adverse Event|39|||
125646349|NCT00554229|451988264|FG000|Overall Study|Protocol Violation|3|||
125646350|NCT00554229|451988265|FG001|Overall Study|Protocol Violation|3|||
125646351|NCT00554229|451988264|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
125646352|NCT00554229|451988265|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
125646353|NCT00554229|451988264|FG000|Overall Study|Randomised but no treatment received|1|||
125646354|NCT00554229|451988265|FG001|Overall Study|Randomised but no treatment received|0|||
125646355|NCT01140646|451988266|FG000|Overall Study|Adverse Event|4|||
125646356|NCT01140646|451988266|FG000|Overall Study|Refused Further Treatment|5|||
125646357|NCT00689728|451988268|FG000|Double-Blind Treatment|Adverse Event|1|||
125646358|NCT00689728|451988269|FG001|Double-Blind Treatment|Adverse Event|0|||
125646359|NCT00689728|451988270|FG002|Double-Blind Treatment|Adverse Event|0|||
125646360|NCT00689728|451988268|FG000|Double-Blind Treatment|Protocol Violation|0|||
125646361|NCT00689728|451988269|FG001|Double-Blind Treatment|Protocol Violation|0|||
125646362|NCT00689728|451988270|FG002|Double-Blind Treatment|Protocol Violation|1|||
125646363|NCT00689728|451988268|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
125646364|NCT00689728|451988269|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
125646365|NCT00689728|451988270|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
125646366|NCT00689728|451988268|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
125646367|NCT00689728|451988269|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
125646368|NCT00689728|451988270|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
125646369|NCT00689728|451988268|FG000|Rescue|Adverse Event|0|||
125646370|NCT00689728|451988269|FG001|Rescue|Adverse Event|1|||
125646371|NCT00689728|451988270|FG002|Rescue|Adverse Event|0|||
125646372|NCT00689728|451988268|FG000|Rescue|Withdrawal by Subject|1|||
125646373|NCT00689728|451988269|FG001|Rescue|Withdrawal by Subject|1|||
125646374|NCT00689728|451988270|FG002|Rescue|Withdrawal by Subject|1|||
125646375|NCT00689728|451988268|FG000|Optional Follow-Up|Adverse Event|1|||
125646376|NCT00689728|451988269|FG001|Optional Follow-Up|Adverse Event|0|||
125646377|NCT00689728|451988270|FG002|Optional Follow-Up|Adverse Event|0|||
125646378|NCT00689728|451988268|FG000|Optional Follow-Up|Lack of Efficacy|0|||
125646379|NCT00689728|451988269|FG001|Optional Follow-Up|Lack of Efficacy|1|||
125646380|NCT00689728|451988270|FG002|Optional Follow-Up|Lack of Efficacy|1|||
125646381|NCT00689728|451988268|FG000|Optional Follow-Up|Lost to Follow-up|0|||
125646382|NCT00689728|451988269|FG001|Optional Follow-Up|Lost to Follow-up|1|||
125646383|NCT00689728|451988270|FG002|Optional Follow-Up|Lost to Follow-up|1|||
125646384|NCT00689728|451988268|FG000|Optional Follow-Up|Protocol Violation|0|||
125646385|NCT00689728|451988269|FG001|Optional Follow-Up|Protocol Violation|0|||
125646386|NCT00689728|451988270|FG002|Optional Follow-Up|Protocol Violation|1|||
125646387|NCT00689728|451988268|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
125646388|NCT00689728|451988269|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
125646389|NCT00689728|451988270|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
125646390|NCT00784836|451988275|FG000|Overall Study|Early Study Termination|3|||
125646391|NCT00660829|451988277|FG000|Overall Study|Adverse Event|3|||
125646392|NCT00660829|451988278|FG001|Overall Study|Adverse Event|4|||
125646393|NCT00660829|451988277|FG000|Overall Study|Lack of Efficacy|2|||
125646394|NCT00660829|451988278|FG001|Overall Study|Lack of Efficacy|3|||
125202411|NCT00954512|450363719|FG005|Overall Study|Physician Decision|0|||
125202412|NCT00954512|450363714|FG000|Overall Study|Symptomatic Deterioration|0|||
125202413|NCT00954512|450363715|FG001|Overall Study|Symptomatic Deterioration|1|||
125202414|NCT00954512|450363716|FG002|Overall Study|Symptomatic Deterioration|0|||
125202415|NCT00954512|450363717|FG003|Overall Study|Symptomatic Deterioration|0|||
125202416|NCT00954512|450363718|FG004|Overall Study|Symptomatic Deterioration|2|||
125202417|NCT00954512|450363719|FG005|Overall Study|Symptomatic Deterioration|0|||
125202418|NCT00954512|450363714|FG000|Overall Study|Progression of Disease|2|||
125202419|NCT00954512|450363715|FG001|Overall Study|Progression of Disease|1|||
125202420|NCT00954512|450363716|FG002|Overall Study|Progression of Disease|0|||
125202421|NCT00954512|450363717|FG003|Overall Study|Progression of Disease|1|||
125202422|NCT00954512|450363718|FG004|Overall Study|Progression of Disease|1|||
125202423|NCT00954512|450363719|FG005|Overall Study|Progression of Disease|1|||
125202424|NCT01794793|450363720|FG000|Treatment Period|Withdrawal by Subject|24|||
125202425|NCT01794793|450363720|FG000|Treatment Period|Lack of Efficacy|22|||
125202426|NCT01794793|450363720|FG000|Treatment Period|Adverse Event|17|||
125202427|NCT01794793|450363720|FG000|Treatment Period|Physician Decision|14|||
125202428|NCT01794793|450363720|FG000|Treatment Period|Lost to Follow-up|7|||
125202429|NCT01794793|450363720|FG000|Treatment Period|Death|6|||
125202430|NCT01794793|450363720|FG000|Treatment Period|Protocol Violation|5|||
125202431|NCT01794793|450363720|FG000|Treatment Period|administrative problem|3|||
125202432|NCT01794793|450363720|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
125202433|NCT01794793|450363720|FG000|Post-treatment Follow-up|Adverse Event|8|||
125202434|NCT01794793|450363720|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
125202435|NCT01794793|450363720|FG000|Post-treatment Follow-up|administrative problem|5|||
125202436|NCT01794793|450363720|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
125202437|NCT01794793|450363720|FG000|Post-treatment Follow-up|Protocol Violation|3|||
125202438|NCT03495154|450363721|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
125202439|NCT03495154|450363721|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
125202440|NCT03495154|450363721|FG000|Overall Study|Screen Failures During Surgery|6|||
125202441|NCT03495154|450363721|FG000|Overall Study|Death|2|||
125202442|NCT03495154|450363721|FG000|Overall Study|Lost to Follow-up|16|||
125202443|NCT03495154|450363721|FG000|Overall Study|Withdrawal by Subject|2|||
125202444|NCT03495154|450363721|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
125202445|NCT05685732|450363722|FG000|Overall Study|Withdrawal by Subject|2|||
125202446|NCT05685732|450363723|FG001|Overall Study|Withdrawal by Subject|0|||
125202447|NCT05685732|450363724|FG002|Overall Study|Withdrawal by Subject|2|||
125202448|NCT05685732|450363725|FG003|Overall Study|Withdrawal by Subject|3|||
125202449|NCT05685732|450363722|FG000|Overall Study|Protocol Violation|1|||
125202450|NCT05685732|450363723|FG001|Overall Study|Protocol Violation|2|||
125202451|NCT05685732|450363724|FG002|Overall Study|Protocol Violation|4|||
125202452|NCT05685732|450363725|FG003|Overall Study|Protocol Violation|1|||
125202453|NCT05685732|450363722|FG000|Overall Study|Lost to Follow-up|5|||
125202454|NCT05685732|450363723|FG001|Overall Study|Lost to Follow-up|1|||
125202455|NCT05685732|450363724|FG002|Overall Study|Lost to Follow-up|3|||
125202456|NCT05685732|450363725|FG003|Overall Study|Lost to Follow-up|1|||
125202457|NCT05685732|450363722|FG000|Overall Study|Adverse Event|2|||
125202458|NCT05685732|450363723|FG001|Overall Study|Adverse Event|1|||
125202459|NCT05685732|450363724|FG002|Overall Study|Adverse Event|0|||
125202460|NCT05685732|450363725|FG003|Overall Study|Adverse Event|0|||
125202461|NCT05685732|450363722|FG000|Overall Study|Physician Decision|1|||
125202462|NCT05685732|450363723|FG001|Overall Study|Physician Decision|0|||
125202463|NCT05685732|450363724|FG002|Overall Study|Physician Decision|0|||
125202464|NCT05685732|450363725|FG003|Overall Study|Physician Decision|0|||
125202465|NCT02640404|450363726|FG000|Overall Study|Protocol Violation|1|||
125539732|NCT00700427|451605816|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
125539733|NCT00700427|451605817|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
125539734|NCT00700427|451605818|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
125539735|NCT00700427|451605819|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
125539736|NCT00700427|451605820|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
125539737|NCT00700427|451605816|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
125539738|NCT00700427|451605817|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
125539739|NCT00700427|451605818|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
125539740|NCT00700427|451605819|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
125539741|NCT00700427|451605820|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
125539742|NCT00700427|451605816|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
125539743|NCT00700427|451605817|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
125539744|NCT00700427|451605818|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
125539745|NCT00700427|451605819|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
125539746|NCT00700427|451605820|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
125539747|NCT00700427|451605816|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
125539748|NCT00700427|451605817|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
125646395|NCT00660829|451988277|FG000|Overall Study|Non-Compliance|0|||
125202466|NCT02640404|450363727|FG001|Overall Study|Protocol Violation|0|||
125202467|NCT02640404|450363726|FG000|Overall Study|Withdrawal by Subject|1|||
125202468|NCT02640404|450363727|FG001|Overall Study|Withdrawal by Subject|0|||
125202469|NCT05397171|450363728|FG000|Overall Study|Death|2|||
125202470|NCT05397171|450363729|FG001|Overall Study|Death|3|||
125202471|NCT05397171|450363730|FG002|Overall Study|Death|3|||
125202472|NCT05397171|450363728|FG000|Overall Study|Study Terminated By Sponsor|1|||
125202473|NCT05397171|450363729|FG001|Overall Study|Study Terminated By Sponsor|2|||
125202474|NCT05397171|450363730|FG002|Overall Study|Study Terminated By Sponsor|3|||
125202475|NCT05397171|450363728|FG000|Overall Study|Withdrawal by Subject|0|||
125202476|NCT05397171|450363729|FG001|Overall Study|Withdrawal by Subject|1|||
125202477|NCT05397171|450363730|FG002|Overall Study|Withdrawal by Subject|1|||
125202478|NCT02234596|450363731|FG000|Overall Study|Participant not treated|2|||
125202479|NCT03634033|450365398|FG000|Overall Study|Did not have a post-assessment|384|||
125202480|NCT03634033|450365399|FG001|Overall Study|Did not have a post-assessment|291|||
125202481|NCT03634033|450365400|FG002|Overall Study|Did not have a post-assessment|114|||
125202482|NCT03634033|450365401|FG003|Overall Study|Did not have a post-assessment|161|||
125202483|NCT03634033|450365402|FG004|Overall Study|Did not have a post-assessment|5|||
125202484|NCT03634033|450365403|FG005|Overall Study|Did not have a post-assessment|0|||
125202485|NCT03634033|450365404|FG006|Overall Study|Did not have a post-assessment|0|||
125202486|NCT03634033|450365398|FG000|Overall Study|Death|0|||
125202487|NCT03634033|450365399|FG001|Overall Study|Death|0|||
125202488|NCT03634033|450365400|FG002|Overall Study|Death|0|||
125202489|NCT03634033|450365401|FG003|Overall Study|Death|0|||
125202490|NCT03634033|450365402|FG004|Overall Study|Death|0|||
125202491|NCT03634033|450365403|FG005|Overall Study|Death|7|||
125202492|NCT03634033|450365404|FG006|Overall Study|Death|7|||
125202493|NCT03634033|450365398|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
125202494|NCT03634033|450365399|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
125202495|NCT03634033|450365400|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
125202496|NCT03634033|450365401|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
125202497|NCT03634033|450365402|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
125202498|NCT03634033|450365403|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
125202499|NCT03634033|450365404|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
125202500|NCT03634033|450365398|FG000|Overall Study|Lost to Follow-up|0|||
125202501|NCT03634033|450365399|FG001|Overall Study|Lost to Follow-up|0|||
125202502|NCT03634033|450365400|FG002|Overall Study|Lost to Follow-up|0|||
125202503|NCT03634033|450365401|FG003|Overall Study|Lost to Follow-up|0|||
125202504|NCT03634033|450365402|FG004|Overall Study|Lost to Follow-up|0|||
125202505|NCT03634033|450365403|FG005|Overall Study|Lost to Follow-up|1|||
125202506|NCT03634033|450365404|FG006|Overall Study|Lost to Follow-up|2|||
125202507|NCT03634033|450365398|FG000|Overall Study|Withdrawal by Subject|0|||
125202508|NCT03634033|450365399|FG001|Overall Study|Withdrawal by Subject|0|||
125202509|NCT03634033|450365400|FG002|Overall Study|Withdrawal by Subject|0|||
125202510|NCT03634033|450365401|FG003|Overall Study|Withdrawal by Subject|0|||
125202511|NCT03634033|450365402|FG004|Overall Study|Withdrawal by Subject|0|||
125202512|NCT03634033|450365403|FG005|Overall Study|Withdrawal by Subject|0|||
125202513|NCT03634033|450365404|FG006|Overall Study|Withdrawal by Subject|1|||
125202514|NCT06366087|450365405|FG000|Overall Study|Withdrawal by Subject|0|||
125202515|NCT06366087|450365406|FG001|Overall Study|Withdrawal by Subject|1|||
125202516|NCT01944670|450365410|FG000|Overall Study|Lost to Follow-up|2|||
125202517|NCT00743288|450365411|FG000|Overall Study|Adverse Event|1|||
125202518|NCT00743288|450365412|FG001|Overall Study|Adverse Event|1|||
125202519|NCT00743288|450365413|FG002|Overall Study|Adverse Event|2|||
125202520|NCT00743288|450365414|FG003|Overall Study|Adverse Event|2|||
125202521|NCT00743288|450365415|FG004|Overall Study|Adverse Event|1|||
125202522|NCT00743288|450365416|FG005|Overall Study|Adverse Event|1|||
125202523|NCT00743288|450365417|FG006|Overall Study|Adverse Event|2|||
125202524|NCT00743288|450365411|FG000|Overall Study|Withdrawal by Subject|0|||
125202525|NCT00743288|450365412|FG001|Overall Study|Withdrawal by Subject|0|||
125202526|NCT00743288|450365413|FG002|Overall Study|Withdrawal by Subject|1|||
125202527|NCT00743288|450365414|FG003|Overall Study|Withdrawal by Subject|0|||
125202528|NCT00743288|450365415|FG004|Overall Study|Withdrawal by Subject|0|||
125202529|NCT00743288|450365416|FG005|Overall Study|Withdrawal by Subject|1|||
125202530|NCT00743288|450365417|FG006|Overall Study|Withdrawal by Subject|1|||
125202531|NCT00743288|450365411|FG000|Overall Study|Progressive disease (PD)|2|||
125202532|NCT00743288|450365412|FG001|Overall Study|Progressive disease (PD)|0|||
125202533|NCT00743288|450365413|FG002|Overall Study|Progressive disease (PD)|1|||
125202534|NCT00743288|450365414|FG003|Overall Study|Progressive disease (PD)|4|||
125646396|NCT00660829|451988278|FG001|Overall Study|Non-Compliance|4|||
125202535|NCT00743288|450365415|FG004|Overall Study|Progressive disease (PD)|5|||
125202536|NCT00743288|450365416|FG005|Overall Study|Progressive disease (PD)|3|||
125202537|NCT00743288|450365417|FG006|Overall Study|Progressive disease (PD)|6|||
125202538|NCT00743288|450365411|FG000|Overall Study|Worsening of condition (Not PD)|0|||
125202539|NCT00743288|450365412|FG001|Overall Study|Worsening of condition (Not PD)|2|||
125202540|NCT00743288|450365413|FG002|Overall Study|Worsening of condition (Not PD)|1|||
125202541|NCT00743288|450365414|FG003|Overall Study|Worsening of condition (Not PD)|1|||
125202542|NCT00743288|450365415|FG004|Overall Study|Worsening of condition (Not PD)|0|||
125202543|NCT00743288|450365416|FG005|Overall Study|Worsening of condition (Not PD)|0|||
125202544|NCT00743288|450365417|FG006|Overall Study|Worsening of condition (Not PD)|0|||
125202545|NCT05903924|450365418|FG000|Overall Study|Lost to Follow-up|1|||
125202546|NCT05903924|450365419|FG001|Overall Study|Lost to Follow-up|0|||
125202547|NCT05903924|450365420|FG002|Overall Study|Lost to Follow-up|0|||
125202548|NCT04338269|450365421|FG000|Overall Study|Death|86|||
125202549|NCT04338269|450365422|FG001|Overall Study|Death|89|||
125202550|NCT04338269|450365421|FG000|Overall Study|Lost to Follow-up|1|||
125202551|NCT04338269|450365422|FG001|Overall Study|Lost to Follow-up|2|||
125202552|NCT04338269|450365421|FG000|Overall Study|Physician Decision|1|||
125202553|NCT04338269|450365422|FG001|Overall Study|Physician Decision|0|||
125202554|NCT04338269|450365421|FG000|Overall Study|Withdrawal by Subject|14|||
125202555|NCT04338269|450365422|FG001|Overall Study|Withdrawal by Subject|11|||
125202556|NCT04166591|450365427|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
125202557|NCT04166591|450365428|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
125202558|NCT04166591|450365429|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
125202559|NCT04166591|450365430|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
125202560|NCT04166591|450365427|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
125202561|NCT04166591|450365428|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
125202562|NCT04166591|450365429|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
125202563|NCT04166591|450365430|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
125202564|NCT02730377|450365431|FG000|Overall Study|Other|5|||
125202565|NCT02730377|450365432|FG001|Overall Study|Other|4|||
125202566|NCT02730377|450365431|FG000|Overall Study|Death|1|||
125202567|NCT02730377|450365432|FG001|Overall Study|Death|8|||
125202568|NCT02730377|450365431|FG000|Overall Study|Inadequate glycaemic control|368|||
125202569|NCT02730377|450365432|FG001|Overall Study|Inadequate glycaemic control|473|||
125202570|NCT02730377|450365431|FG000|Overall Study|Adverse Event|79|||
125202571|NCT02730377|450365432|FG001|Overall Study|Adverse Event|41|||
125202572|NCT02730377|450365431|FG000|Overall Study|Protocol Violation|23|||
125202573|NCT02730377|450365432|FG001|Overall Study|Protocol Violation|30|||
125202574|NCT02730377|450365431|FG000|Overall Study|Lack of Efficacy|4|||
125202575|NCT02730377|450365432|FG001|Overall Study|Lack of Efficacy|13|||
125202576|NCT02730377|450365431|FG000|Overall Study|Pregnancy|0|||
125202577|NCT02730377|450365432|FG001|Overall Study|Pregnancy|1|||
125202578|NCT02730377|450365431|FG000|Overall Study|Withdrawal by Subject|45|||
125202579|NCT02730377|450365432|FG001|Overall Study|Withdrawal by Subject|42|||
125202580|NCT02730377|450365431|FG000|Overall Study|Lost to Follow-up|25|||
125202581|NCT02730377|450365432|FG001|Overall Study|Lost to Follow-up|21|||
125202582|NCT02203851|450365435|FG000|Overall Study|Lost to Follow-up|4|||
125202583|NCT02203851|450365435|FG000|Overall Study|Withdrawal by Subject|6|||
125202584|NCT02203851|450365435|FG000|Overall Study|Other|1|||
125202585|NCT04045132|450365438|FG000|Overall Study|Lost to Follow-up|3|||
125202586|NCT04045132|450365439|FG001|Overall Study|Lost to Follow-up|6|||
125202587|NCT02677038|450365445|FG000|Overall Study|Physician Decision|1|||
125202588|NCT02677038|450365445|FG000|Overall Study|Withdrawal by Subject|1|||
125202589|NCT03671564|450365447|FG000|Overall Study|Progressive Disease|3|||
125202590|NCT03671564|450365448|FG001|Overall Study|Progressive Disease|5|||
125202591|NCT03671564|450365449|FG002|Overall Study|Progressive Disease|3|||
125202592|NCT03671564|450365447|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
125646397|NCT00660829|451988277|FG000|Overall Study|Withdrawal by Subject|1|||
125646398|NCT00660829|451988278|FG001|Overall Study|Withdrawal by Subject|2|||
125646399|NCT00660829|451988277|FG000|Overall Study|Lost to Follow-up|3|||
125646400|NCT00660829|451988278|FG001|Overall Study|Lost to Follow-up|2|||
125646401|NCT00660829|451988277|FG000|Overall Study|Other|9|||
125646402|NCT00660829|451988278|FG001|Overall Study|Other|4|||
125646403|NCT03590613|451988279|FG000|Period 2, 4 Days|Physician Decision|0|||
125646404|NCT03590613|451988280|FG001|Period 2, 4 Days|Physician Decision|0|||
125646405|NCT03590613|451988281|FG002|Period 2, 4 Days|Physician Decision|0|||
125646406|NCT03590613|451988282|FG003|Period 2, 4 Days|Physician Decision|1|||
125646407|NCT00280059|451988283|FG000|Efficacy Assessment Phase|Death|2|||
125646408|NCT00280059|451988284|FG001|Efficacy Assessment Phase|Death|0|||
125646409|NCT00280059|451988283|FG000|Efficacy Assessment Phase|Adverse Event|33|||
125202593|NCT03671564|450365448|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
125202594|NCT03671564|450365449|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
125202595|NCT03671564|450365447|FG000|Overall Study|Withdrawal by Subject|1|||
125202596|NCT03671564|450365448|FG001|Overall Study|Withdrawal by Subject|1|||
125202597|NCT03671564|450365449|FG002|Overall Study|Withdrawal by Subject|0|||
125202598|NCT04739722|450365452|FG000|Overall Study|Lost to Follow-up|5301|||
125202599|NCT04739722|450365452|FG000|Overall Study|Withdrawal by Subject|42|||
125202600|NCT04739722|450365452|FG000|Overall Study|Non Average-risk|1157|||
125202601|NCT01185509|450365456|FG000|Overall Study|Progression/Relapse|9|||
125202602|NCT01185509|450365457|FG001|Overall Study|Progression/Relapse|15|||
125646410|NCT00280059|451988284|FG001|Efficacy Assessment Phase|Adverse Event|31|||
125646411|NCT00280059|451988283|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
125646412|NCT00280059|451988284|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
125646413|NCT00280059|451988283|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
125646414|NCT00280059|451988284|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
125202603|NCT01185509|450365456|FG000|Overall Study|Physician Decision|2|||
125202604|NCT01185509|450365457|FG001|Overall Study|Physician Decision|2|||
125202605|NCT01185509|450365456|FG000|Overall Study|Withdrawal by Subject|0|||
125202606|NCT01185509|450365457|FG001|Overall Study|Withdrawal by Subject|1|||
125202607|NCT01185509|450365456|FG000|Overall Study|Death|0|||
125202608|NCT01185509|450365457|FG001|Overall Study|Death|1|||
125202609|NCT01185509|450365456|FG000|Overall Study|Intercurrent Illness|0|||
125202610|NCT01185509|450365457|FG001|Overall Study|Intercurrent Illness|1|||
125202611|NCT03687372|450365458|FG000|Overall Study|Lost to Follow-up|12|||
125202612|NCT03687372|450365459|FG001|Overall Study|Lost to Follow-up|21|||
125202613|NCT03687372|450365458|FG000|Overall Study|Withdrawal by Subject|4|||
125202614|NCT03687372|450365459|FG001|Overall Study|Withdrawal by Subject|17|||
125202615|NCT03687372|450365458|FG000|Overall Study|Investigator Decision|1|||
125202616|NCT03687372|450365459|FG001|Overall Study|Investigator Decision|1|||
125202617|NCT00878969|450365465|FG000|Overall Study|Physician Decision|5|||
125202618|NCT00878969|450365466|FG001|Overall Study|Physician Decision|3|||
125202619|NCT00878969|450365467|FG002|Overall Study|Physician Decision|2|||
125202620|NCT00878969|450365465|FG000|Overall Study|Withdrawal by Subject|1|||
125202621|NCT00878969|450365466|FG001|Overall Study|Withdrawal by Subject|6|||
125202622|NCT00878969|450365467|FG002|Overall Study|Withdrawal by Subject|3|||
125202623|NCT00878969|450365465|FG000|Overall Study|kidney transplant|2|||
125202624|NCT00878969|450365466|FG001|Overall Study|kidney transplant|3|||
125202625|NCT00878969|450365467|FG002|Overall Study|kidney transplant|2|||
125202626|NCT00878969|450365465|FG000|Overall Study|Adverse Event|3|||
125202627|NCT00878969|450365466|FG001|Overall Study|Adverse Event|1|||
125202628|NCT00878969|450365467|FG002|Overall Study|Adverse Event|2|||
125202629|NCT00878969|450365465|FG000|Overall Study|Lost to Follow-up|2|||
125202630|NCT00878969|450365466|FG001|Overall Study|Lost to Follow-up|1|||
125202631|NCT00878969|450365467|FG002|Overall Study|Lost to Follow-up|0|||
125202632|NCT00878969|450365465|FG000|Overall Study|Protocol Violation|2|||
125202633|NCT00878969|450365466|FG001|Overall Study|Protocol Violation|0|||
125202634|NCT00878969|450365467|FG002|Overall Study|Protocol Violation|0|||
125202635|NCT00878969|450365465|FG000|Overall Study|Death|0|||
125202636|NCT00878969|450365466|FG001|Overall Study|Death|0|||
125202637|NCT00878969|450365467|FG002|Overall Study|Death|2|||
125202638|NCT00878969|450365465|FG000|Overall Study|Pregnancy|0|||
125202639|NCT00878969|450365466|FG001|Overall Study|Pregnancy|1|||
125202640|NCT00878969|450365467|FG002|Overall Study|Pregnancy|0|||
125202641|NCT02083185|450365470|FG000|Overall Study|Lost to Follow-up|0|||
125202642|NCT02083185|450365471|FG001|Overall Study|Lost to Follow-up|3|||
125202643|NCT02083185|450365472|FG002|Overall Study|Lost to Follow-up|0|||
125202644|NCT02083185|450365470|FG000|Overall Study|Withdrawal by Subject|9|||
125646415|NCT00280059|451988283|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
125646416|NCT00280059|451988284|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
125646417|NCT00280059|451988283|FG000|Efficacy Assessment Phase|Other|7|||
125646418|NCT00280059|451988284|FG001|Efficacy Assessment Phase|Other|8|||
125646419|NCT00280059|451988283|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
125646420|NCT00280059|451988284|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
125646421|NCT01130831|451988287|FG000|Overall Study|Withdrawal by Subject|7|||
125646422|NCT01130831|451988287|FG000|Overall Study|Death|4|||
125646423|NCT01130831|451988287|FG000|Overall Study|Information was missing|3|||
125646424|NCT00951912|451988288|FG000|Overall Study|Lack of Efficacy|1|||
125646425|NCT00951912|451988289|FG001|Overall Study|Lack of Efficacy|0|||
125646426|NCT00951912|451988290|FG002|Overall Study|Lack of Efficacy|0|||
125646427|NCT00951912|451988288|FG000|Overall Study|Adverse Event|0|||
125646428|NCT00951912|451988289|FG001|Overall Study|Adverse Event|1|||
125646429|NCT00951912|451988290|FG002|Overall Study|Adverse Event|1|||
125646430|NCT00951912|451988288|FG000|Overall Study|Lost to Follow-up|2|||
125646431|NCT00951912|451988289|FG001|Overall Study|Lost to Follow-up|2|||
125646432|NCT00951912|451988290|FG002|Overall Study|Lost to Follow-up|0|||
125202645|NCT02083185|450365471|FG001|Overall Study|Withdrawal by Subject|15|||
125202646|NCT02083185|450365472|FG002|Overall Study|Withdrawal by Subject|1|||
125202647|NCT02083185|450365470|FG000|Overall Study|Death|2|||
125646433|NCT00951912|451988288|FG000|Overall Study|Physician Decision|1|||
125646434|NCT00951912|451988289|FG001|Overall Study|Physician Decision|0|||
125646435|NCT00951912|451988290|FG002|Overall Study|Physician Decision|1|||
125202648|NCT02083185|450365471|FG001|Overall Study|Death|2|||
125202649|NCT02083185|450365472|FG002|Overall Study|Death|1|||
125202650|NCT02083185|450365470|FG000|Overall Study|Reason not Specified|9|||
125202651|NCT02083185|450365471|FG001|Overall Study|Reason not Specified|6|||
125202652|NCT02083185|450365472|FG002|Overall Study|Reason not Specified|5|||
125202653|NCT02083185|450365470|FG000|Overall Study|Study Terminated by Sponsor|0|||
125202654|NCT02083185|450365471|FG001|Overall Study|Study Terminated by Sponsor|1|||
125202655|NCT02083185|450365472|FG002|Overall Study|Study Terminated by Sponsor|0|||
125646436|NCT00951912|451988288|FG000|Overall Study|Withdrawal by Subject|1|||
125202656|NCT02083185|450365470|FG000|Overall Study|Did not Receive Study Drug|0|||
125202657|NCT02083185|450365471|FG001|Overall Study|Did not Receive Study Drug|2|||
125202658|NCT02083185|450365472|FG002|Overall Study|Did not Receive Study Drug|0|||
125202659|NCT03419598|450365473|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
125202660|NCT01740128|450365474|FG000|Overall Study|Pregnancy|0|||
125202661|NCT01740128|450365475|FG001|Overall Study|Pregnancy|1|||
125202662|NCT01740128|450365474|FG000|Overall Study|Protocol Violation|1|||
125202663|NCT01740128|450365475|FG001|Overall Study|Protocol Violation|2|||
125202664|NCT01740128|450365474|FG000|Overall Study|Lost to Follow-up|2|||
125202665|NCT01740128|450365475|FG001|Overall Study|Lost to Follow-up|2|||
125202666|NCT01740128|450365474|FG000|Overall Study|Withdrawal by Subject|1|||
125202667|NCT01740128|450365475|FG001|Overall Study|Withdrawal by Subject|0|||
125646437|NCT00951912|451988289|FG001|Overall Study|Withdrawal by Subject|1|||
125646438|NCT00951912|451988290|FG002|Overall Study|Withdrawal by Subject|0|||
125646439|NCT00951912|451988288|FG000|Overall Study|Other:Depression|1|||
125646440|NCT00951912|451988289|FG001|Overall Study|Other:Depression|0|||
125646441|NCT00951912|451988290|FG002|Overall Study|Other:Depression|0|||
125646442|NCT00951912|451988288|FG000|Overall Study|Other: Colon cancer|1|||
125646443|NCT00951912|451988289|FG001|Overall Study|Other: Colon cancer|0|||
125646444|NCT00951912|451988290|FG002|Overall Study|Other: Colon cancer|0|||
125646445|NCT00951912|451988288|FG000|Overall Study|Other: Stroke|0|||
125646446|NCT00951912|451988289|FG001|Overall Study|Other: Stroke|1|||
125646447|NCT00951912|451988290|FG002|Overall Study|Other: Stroke|0|||
125646448|NCT01513460|451988291|FG000|Overall Study|Death|0|||
125646449|NCT01513460|451988292|FG001|Overall Study|Death|0|||
125646450|NCT01513460|451988293|FG002|Overall Study|Death|1|||
125646451|NCT01513460|451988291|FG000|Overall Study|Lost to Follow-up|0|||
125646452|NCT01513460|451988292|FG001|Overall Study|Lost to Follow-up|0|||
125646453|NCT01513460|451988293|FG002|Overall Study|Lost to Follow-up|2|||
125646454|NCT01513460|451988291|FG000|Overall Study|Abnormal laboratory value|1|||
125646455|NCT01513460|451988292|FG001|Overall Study|Abnormal laboratory value|0|||
125646456|NCT01513460|451988293|FG002|Overall Study|Abnormal laboratory value|1|||
125646457|NCT01513460|451988291|FG000|Overall Study|Lack of Efficacy|1|||
125646458|NCT01513460|451988292|FG001|Overall Study|Lack of Efficacy|2|||
125646459|NCT01513460|451988293|FG002|Overall Study|Lack of Efficacy|5|||
125646460|NCT01513460|451988291|FG000|Overall Study|Protocol deviations|3|||
125646461|NCT01513460|451988292|FG001|Overall Study|Protocol deviations|4|||
125646462|NCT01513460|451988293|FG002|Overall Study|Protocol deviations|3|||
125646463|NCT01513460|451988291|FG000|Overall Study|Withdrawal by Subject|7|||
125646464|NCT01513460|451988292|FG001|Overall Study|Withdrawal by Subject|8|||
125646465|NCT01513460|451988293|FG002|Overall Study|Withdrawal by Subject|21|||
125646466|NCT01513460|451988291|FG000|Overall Study|Adverse Event|16|||
125646467|NCT01513460|451988292|FG001|Overall Study|Adverse Event|18|||
125646468|NCT01513460|451988293|FG002|Overall Study|Adverse Event|23|||
125646469|NCT01513460|451988291|FG000|Overall Study|Abnormal test procedure|1|||
125646470|NCT01513460|451988292|FG001|Overall Study|Abnormal test procedure|0|||
125646471|NCT01513460|451988293|FG002|Overall Study|Abnormal test procedure|0|||
125646472|NCT00489216|451988297|FG000|Overall Study|Adverse Event|1|||
125646473|NCT02612194|451988302|FG000|Overall Study|Death|5|||
125646474|NCT02612194|451988303|FG001|Overall Study|Death|0|||
125646475|NCT02612194|451988304|FG002|Overall Study|Death|2|||
125646476|NCT02612194|451988302|FG000|Overall Study|Early Study Termination|1|||
125646477|NCT02612194|451988303|FG001|Overall Study|Early Study Termination|0|||
125646478|NCT02612194|451988304|FG002|Overall Study|Early Study Termination|0|||
125646479|NCT02539160|451988305|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
125646480|NCT02539160|451988306|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
125646481|NCT02539160|451988307|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
125646482|NCT02539160|451988308|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
125646483|NCT02539160|451988305|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
125646484|NCT02539160|451988306|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
125646485|NCT02539160|451988307|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
125646486|NCT02539160|451988308|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
125646487|NCT02539160|451988305|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
125646488|NCT02539160|451988306|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
125646489|NCT02539160|451988307|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
125646490|NCT02539160|451988308|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
125646491|NCT01681004|451988309|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
125646492|NCT01681004|451988310|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
125646493|NCT01681004|451988309|FG000|Study Completion|Lost to Follow-up|8|||
125646494|NCT01681004|451988310|FG001|Study Completion|Lost to Follow-up|3|||
125646495|NCT01681004|451988309|FG000|Study Completion|Physician Decision|1|||
125646496|NCT01681004|451988310|FG001|Study Completion|Physician Decision|3|||
125646497|NCT01681004|451988309|FG000|Study Completion|Site Termination|2|||
125646498|NCT01681004|451988310|FG001|Study Completion|Site Termination|1|||
125646499|NCT01681004|451988309|FG000|Study Completion|Death|1|||
125646500|NCT01681004|451988310|FG001|Study Completion|Death|1|||
125646501|NCT00372905|451988311|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
125646502|NCT00372905|451988312|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
125202668|NCT01740128|450365474|FG000|Overall Study|Insufficient protocol compliance|2|||
125202669|NCT01740128|450365475|FG001|Overall Study|Insufficient protocol compliance|2|||
125202670|NCT02474589|450365476|FG000|Overall Study|Adverse Event|6|||
125202671|NCT02474589|450365477|FG001|Overall Study|Adverse Event|2|||
125202672|NCT02474589|450365476|FG000|Overall Study|Lost to Follow-up|6|||
125202673|NCT02474589|450365477|FG001|Overall Study|Lost to Follow-up|1|||
125202674|NCT02474589|450365476|FG000|Overall Study|Protocol Violation|4|||
125202675|NCT02474589|450365477|FG001|Overall Study|Protocol Violation|1|||
125202676|NCT02474589|450365476|FG000|Overall Study|Withdrawal by Subject|4|||
125202677|NCT02474589|450365477|FG001|Overall Study|Withdrawal by Subject|0|||
125202678|NCT02474589|450365476|FG000|Overall Study|Inability to complete study procedures|5|||
125202679|NCT02474589|450365477|FG001|Overall Study|Inability to complete study procedures|1|||
125202680|NCT01041976|450365478|FG000|Overall Study|Withdrawal by Subject|3|||
125202681|NCT01041976|450365479|FG001|Overall Study|Withdrawal by Subject|0|||
125202682|NCT01041976|450365478|FG000|Overall Study|Incarceration|2|||
125202683|NCT01041976|450365479|FG001|Overall Study|Incarceration|0|||
125202684|NCT01041976|450365478|FG000|Overall Study|Death|0|||
125202685|NCT01041976|450365479|FG001|Overall Study|Death|4|||
125202686|NCT00380081|450365480|FG000|Overall Study|Withdrawal by Subject|0|||
125202687|NCT00380081|450365481|FG001|Overall Study|Withdrawal by Subject|0|||
125202688|NCT00380081|450365482|FG002|Overall Study|Withdrawal by Subject|0|||
125202689|NCT00380081|450365483|FG003|Overall Study|Withdrawal by Subject|0|||
125202690|NCT00380081|450365484|FG004|Overall Study|Withdrawal by Subject|1|||
125202691|NCT00380081|450365485|FG005|Overall Study|Withdrawal by Subject|0|||
125202692|NCT00380081|450365480|FG000|Overall Study|Family Emergency|0|||
125202693|NCT00380081|450365481|FG001|Overall Study|Family Emergency|0|||
125202694|NCT00380081|450365482|FG002|Overall Study|Family Emergency|0|||
125202695|NCT00380081|450365483|FG003|Overall Study|Family Emergency|0|||
125202696|NCT00380081|450365484|FG004|Overall Study|Family Emergency|0|||
125202697|NCT00380081|450365485|FG005|Overall Study|Family Emergency|1|||
125202698|NCT02231879|450365486|FG000|Overall Study|Adverse Event|2|||
125202699|NCT02231879|450365487|FG001|Overall Study|Adverse Event|1|||
125202700|NCT02231879|450365486|FG000|Overall Study|Lack of Efficacy|0|||
125202701|NCT02231879|450365487|FG001|Overall Study|Lack of Efficacy|1|||
125202702|NCT01546168|450365490|FG000|Overall Study|Lost to Follow-up|1|||
125202703|NCT01546168|450365491|FG001|Overall Study|Lost to Follow-up|0|||
125202704|NCT01546168|450365490|FG000|Overall Study|Withdrawal by Subject|1|||
125202705|NCT01546168|450365491|FG001|Overall Study|Withdrawal by Subject|0|||
125202706|NCT01546168|450365490|FG000|Overall Study|ineligible after signing consent|2|||
125202707|NCT01546168|450365491|FG001|Overall Study|ineligible after signing consent|0|||
125202708|NCT02370667|450365492|FG000|Overall Study|Lost to Follow-up|0|||
125202709|NCT02370667|450365493|FG001|Overall Study|Lost to Follow-up|1|||
125202710|NCT02370667|450365494|FG002|Overall Study|Lost to Follow-up|0|||
125646503|NCT00372905|451988313|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
125646504|NCT00372905|451988314|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
125646505|NCT00372905|451988311|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
125646506|NCT00372905|451988312|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
125646507|NCT00372905|451988313|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
125646508|NCT00372905|451988314|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
125646509|NCT00372905|451988311|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
125646510|NCT00372905|451988312|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
125646511|NCT00372905|451988313|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
125646512|NCT00372905|451988314|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
125646513|NCT00372905|451988311|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
125646514|NCT00372905|451988312|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
125646515|NCT00372905|451988313|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
125646516|NCT00372905|451988314|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
125646517|NCT00372905|451988311|FG000|Follow up Until Relapse or Progression|Study closed|0|||
125646518|NCT00372905|451988312|FG001|Follow up Until Relapse or Progression|Study closed|0|||
125646519|NCT00372905|451988313|FG002|Follow up Until Relapse or Progression|Study closed|0|||
125646520|NCT00372905|451988314|FG003|Follow up Until Relapse or Progression|Study closed|3|||
125646521|NCT00372905|451988311|FG000|Follow up Until Relapse or Progression|Other|0|||
125646522|NCT00372905|451988312|FG001|Follow up Until Relapse or Progression|Other|1|||
125646523|NCT00372905|451988313|FG002|Follow up Until Relapse or Progression|Other|0|||
125646524|NCT00372905|451988314|FG003|Follow up Until Relapse or Progression|Other|0|||
125202711|NCT02954653|450365495|FG000|Overall Study|Death|3|||
125202712|NCT02954653|450365496|FG001|Overall Study|Death|1|||
125202713|NCT02954653|450365497|FG002|Overall Study|Death|0|||
125202714|NCT02954653|450365498|FG003|Overall Study|Death|0|||
125646525|NCT02312934|451988315|FG000|Overall Study|Lost to Follow-up|1|||
125646526|NCT02312934|451988316|FG001|Overall Study|Lost to Follow-up|0|||
125202715|NCT02954653|450365499|FG004|Overall Study|Death|0|||
125202716|NCT02954653|450365500|FG005|Overall Study|Death|0|||
125202717|NCT02954653|450365501|FG006|Overall Study|Death|0|||
125202718|NCT02954653|450365502|FG007|Overall Study|Death|0|||
125202719|NCT02954653|450365503|FG008|Overall Study|Death|0|||
125202720|NCT02954653|450365495|FG000|Overall Study|Randomized but did not receive treatment|1|||
125202721|NCT02954653|450365496|FG001|Overall Study|Randomized but did not receive treatment|0|||
125202722|NCT02954653|450365497|FG002|Overall Study|Randomized but did not receive treatment|0|||
125202723|NCT02954653|450365498|FG003|Overall Study|Randomized but did not receive treatment|0|||
125202724|NCT02954653|450365499|FG004|Overall Study|Randomized but did not receive treatment|0|||
125202725|NCT02954653|450365500|FG005|Overall Study|Randomized but did not receive treatment|0|||
125202726|NCT02954653|450365501|FG006|Overall Study|Randomized but did not receive treatment|0|||
125202727|NCT02954653|450365502|FG007|Overall Study|Randomized but did not receive treatment|0|||
125202728|NCT02954653|450365503|FG008|Overall Study|Randomized but did not receive treatment|0|||
125202729|NCT02954653|450365495|FG000|Overall Study|Started another anti-cancer therapy|0|||
125202730|NCT02954653|450365496|FG001|Overall Study|Started another anti-cancer therapy|1|||
125202731|NCT02954653|450365497|FG002|Overall Study|Started another anti-cancer therapy|0|||
125202732|NCT02954653|450365498|FG003|Overall Study|Started another anti-cancer therapy|0|||
125202733|NCT02954653|450365499|FG004|Overall Study|Started another anti-cancer therapy|0|||
125202734|NCT02954653|450365500|FG005|Overall Study|Started another anti-cancer therapy|0|||
125202735|NCT02954653|450365501|FG006|Overall Study|Started another anti-cancer therapy|0|||
125202736|NCT02954653|450365502|FG007|Overall Study|Started another anti-cancer therapy|0|||
125202737|NCT02954653|450365503|FG008|Overall Study|Started another anti-cancer therapy|0|||
125202738|NCT02954653|450365495|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
125202739|NCT02954653|450365496|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
125202740|NCT02954653|450365497|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
125202741|NCT02954653|450365498|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
125202742|NCT02954653|450365499|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
125202743|NCT02954653|450365500|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
125202744|NCT02954653|450365501|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
125202745|NCT02954653|450365502|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
125202746|NCT02954653|450365503|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
125202747|NCT03054064|450365504|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
125202748|NCT03054064|450365504|FG000|Overall Study|Investigator Decision|2|||
125202749|NCT03054064|450365504|FG000|Overall Study|Bladder Issue|1|||
125202750|NCT03054064|450365504|FG000|Overall Study|High Blood Pressure|1|||
125202751|NCT03054064|450365504|FG000|Overall Study|Change in Status|1|||
125202752|NCT03787303|450365506|FG000|Overall Study|Death|1|||
125202753|NCT03787303|450365506|FG000|Overall Study|Premature Termination of Study|1|||
125202754|NCT01210495|450365507|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
125202755|NCT01210495|450365508|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
125202756|NCT01210495|450365509|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
125202757|NCT01210495|450365510|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
125202758|NCT01210495|450365507|FG000|Overall Study|Death|14|||
125202759|NCT01210495|450365508|FG001|Overall Study|Death|7|||
125202760|NCT01210495|450365509|FG002|Overall Study|Death|112|||
125202761|NCT01210495|450365510|FG003|Overall Study|Death|54|||
125202762|NCT01210495|450365507|FG000|Overall Study|Study Terminated by Sponsor|0|||
125202763|NCT01210495|450365508|FG001|Overall Study|Study Terminated by Sponsor|0|||
125202764|NCT01210495|450365509|FG002|Overall Study|Study Terminated by Sponsor|4|||
125202765|NCT01210495|450365510|FG003|Overall Study|Study Terminated by Sponsor|11|||
125202766|NCT01210495|450365507|FG000|Overall Study|Lost to Follow-up|0|||
125202767|NCT01210495|450365508|FG001|Overall Study|Lost to Follow-up|0|||
125202768|NCT01210495|450365509|FG002|Overall Study|Lost to Follow-up|1|||
125202769|NCT01210495|450365510|FG003|Overall Study|Lost to Follow-up|1|||
125202770|NCT01210495|450365507|FG000|Overall Study|Other unspecified|0|||
125202771|NCT01210495|450365508|FG001|Overall Study|Other unspecified|0|||
125202772|NCT01210495|450365509|FG002|Overall Study|Other unspecified|6|||
125202773|NCT01210495|450365510|FG003|Overall Study|Other unspecified|0|||
125202774|NCT00985959|450365520|FG000|Overall Study|Adverse Event|0|||
125202775|NCT00985959|450365521|FG001|Overall Study|Adverse Event|0|||
125202776|NCT00985959|450365522|FG002|Overall Study|Adverse Event|19|||
125202777|NCT00985959|450365520|FG000|Overall Study|Withdrawal by Subject|0|||
125202778|NCT00985959|450365521|FG001|Overall Study|Withdrawal by Subject|0|||
125202779|NCT00985959|450365522|FG002|Overall Study|Withdrawal by Subject|8|||
125202780|NCT00985959|450365520|FG000|Overall Study|Progressive disease|1|||
125202781|NCT00985959|450365521|FG001|Overall Study|Progressive disease|2|||
125202782|NCT00985959|450365522|FG002|Overall Study|Progressive disease|8|||
125202783|NCT00985959|450365520|FG000|Overall Study|Unrecovered toxicity|0|||
125202784|NCT00985959|450365521|FG001|Overall Study|Unrecovered toxicity|0|||
125202785|NCT00985959|450365522|FG002|Overall Study|Unrecovered toxicity|7|||
125202786|NCT00985959|450365520|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
125202787|NCT00985959|450365521|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
125202788|NCT00985959|450365522|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
125202789|NCT00985959|450365520|FG000|Overall Study|Complete response observed over 2 cycles|0|||
125202790|NCT00985959|450365521|FG001|Overall Study|Complete response observed over 2 cycles|1|||
125202791|NCT00985959|450365522|FG002|Overall Study|Complete response observed over 2 cycles|4|||
125202792|NCT00985959|450365520|FG000|Overall Study|Other|0|||
125202793|NCT00985959|450365521|FG001|Overall Study|Other|0|||
125202794|NCT00985959|450365522|FG002|Overall Study|Other|11|||
125202795|NCT00976209|450365523|FG000|Treatment Period 1|Protocol Violation|1|||
125202796|NCT00976209|450365524|FG001|Treatment Period 1|Protocol Violation|0|||
125202797|NCT00976209|450365523|FG000|Treatment Period 1|Lost to Follow-up|2|||
125202798|NCT00976209|450365524|FG001|Treatment Period 1|Lost to Follow-up|0|||
125202799|NCT00976209|450365523|FG000|Treatment Period 1|Other|0|||
125202800|NCT00976209|450365524|FG001|Treatment Period 1|Other|1|||
125202801|NCT00976209|450365523|FG000|Wash-out Period|Adverse Event|1|||
125202802|NCT00976209|450365524|FG001|Wash-out Period|Adverse Event|2|||
125202803|NCT00976209|450365523|FG000|Wash-out Period|Lost to Follow-up|1|||
125202804|NCT00976209|450365524|FG001|Wash-out Period|Lost to Follow-up|0|||
125202805|NCT00976209|450365523|FG000|Wash-out Period|Protocol Violation|1|||
125202806|NCT00976209|450365524|FG001|Wash-out Period|Protocol Violation|0|||
125202807|NCT00976209|450365523|FG000|Wash-out Period|Other|1|||
125202808|NCT00976209|450365524|FG001|Wash-out Period|Other|0|||
125202809|NCT00976209|450365523|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125202810|NCT00976209|450365524|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125202811|NCT00976209|450365523|FG000|Treatment Period 2|Lost to Follow-up|0|||
125202812|NCT00976209|450365524|FG001|Treatment Period 2|Lost to Follow-up|1|||
125202813|NCT00979420|450365525|FG000|Overall Study|Adverse Event|1|||
125202814|NCT00979420|450365526|FG001|Overall Study|Adverse Event|0|||
125202815|NCT00979420|450365527|FG002|Overall Study|Adverse Event|0|||
125202816|NCT00979420|450365528|FG003|Overall Study|Adverse Event|0|||
125202817|NCT00979420|450365525|FG000|Overall Study|Lack of Efficacy|3|||
125202818|NCT00979420|450365526|FG001|Overall Study|Lack of Efficacy|0|||
125202819|NCT00979420|450365527|FG002|Overall Study|Lack of Efficacy|1|||
125202820|NCT00979420|450365528|FG003|Overall Study|Lack of Efficacy|1|||
125202821|NCT00979420|450365525|FG000|Overall Study|Other reasons not related to Viramune|3|||
125202822|NCT00979420|450365526|FG001|Overall Study|Other reasons not related to Viramune|0|||
125202823|NCT00979420|450365527|FG002|Overall Study|Other reasons not related to Viramune|0|||
125202824|NCT00979420|450365528|FG003|Overall Study|Other reasons not related to Viramune|1|||
125202825|NCT00574249|450365529|FG000|Overall Study|Adverse Event|6|||
125202826|NCT00574249|450365530|FG001|Overall Study|Adverse Event|18|||
125202827|NCT00574249|450365529|FG000|Overall Study|Lack of Efficacy|5|||
125202828|NCT00574249|450365530|FG001|Overall Study|Lack of Efficacy|3|||
125202829|NCT00574249|450365529|FG000|Overall Study|Lost to Follow-up|4|||
125202830|NCT00574249|450365530|FG001|Overall Study|Lost to Follow-up|3|||
125202831|NCT00574249|450365529|FG000|Overall Study|Protocol Violation|5|||
125202832|NCT00574249|450365530|FG001|Overall Study|Protocol Violation|2|||
125202833|NCT00574249|450365529|FG000|Overall Study|History of carcinoma|1|||
125202834|NCT00574249|450365530|FG001|Overall Study|History of carcinoma|0|||
125202835|NCT00574249|450365529|FG000|Overall Study|Withdrawal by Subject|3|||
125202836|NCT00574249|450365530|FG001|Overall Study|Withdrawal by Subject|0|||
125202837|NCT00574249|450365529|FG000|Overall Study|Physician Decision|1|||
125202838|NCT00574249|450365530|FG001|Overall Study|Physician Decision|0|||
125202839|NCT00574249|450365529|FG000|Overall Study|Pregnancy|1|||
125202840|NCT00574249|450365530|FG001|Overall Study|Pregnancy|0|||
125202841|NCT00574249|450365529|FG000|Overall Study|Excluded by company|0|||
125202842|NCT00574249|450365530|FG001|Overall Study|Excluded by company|1|||
125202843|NCT00574249|450365529|FG000|Overall Study|PPD test taken twice|0|||
125202844|NCT00574249|450365530|FG001|Overall Study|PPD test taken twice|1|||
125202845|NCT01259375|450365531|FG000|Overall Study|Adverse Event|1|||
125202846|NCT00478699|450365536|FG000|Overall Study|Inclusion Error|1|||
125202847|NCT00478699|450365537|FG001|Overall Study|Inclusion Error|7|||
125202848|NCT00478699|450365536|FG000|Overall Study|Not receive study treatment|6|||
125202849|NCT00478699|450365537|FG001|Overall Study|Not receive study treatment|30|||
125202850|NCT00656851|450365539|FG000|Overall Study|Withdrawal by Subject|0|||
125646527|NCT02312934|451988315|FG000|Overall Study|Physician Decision|1|||
125646528|NCT02312934|451988316|FG001|Overall Study|Physician Decision|0|||
125202851|NCT00656851|450365540|FG001|Overall Study|Withdrawal by Subject|4|||
125202852|NCT01123941|450365541|FG000|Overall Study|Lost to Follow-up|2|||
125202853|NCT01123941|450365542|FG001|Overall Study|Lost to Follow-up|1|||
125202854|NCT04601103|450365543|FG000|Overall Study|Needed crown & cleaning|0|||
125202855|NCT04601103|450365544|FG001|Overall Study|Needed crown & cleaning|0|||
125202856|NCT04601103|450365545|FG002|Overall Study|Needed crown & cleaning|1|||
125202857|NCT04601103|450365543|FG000|Overall Study|study was terminated|18|||
125202858|NCT04601103|450365544|FG001|Overall Study|study was terminated|18|||
125202859|NCT04601103|450365545|FG002|Overall Study|study was terminated|16|||
125202860|NCT06011161|450365548|FG000|Overall Study|Withdrawal by Subject|2|||
125202861|NCT06011161|450365548|FG000|Overall Study|Lost to Follow-up|5|||
125202862|NCT04713592|450365551|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
125202863|NCT04713592|450365552|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
125202864|NCT04713592|450365553|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
125202865|NCT04713592|450365554|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
125202866|NCT04713592|450365551|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
125646529|NCT00701064|451988318|FG000|Overall Study|Protocol Violation|1|||
125646530|NCT00701064|451988319|FG001|Overall Study|Protocol Violation|1|||
125646531|NCT00701064|451988318|FG000|Overall Study|Withdrawal by Subject|1|||
125646532|NCT00701064|451988319|FG001|Overall Study|Withdrawal by Subject|1|||
125646533|NCT00701064|451988318|FG000|Overall Study|initiated other PTSD treatment|2|||
125646534|NCT00701064|451988319|FG001|Overall Study|initiated other PTSD treatment|2|||
125646535|NCT00689299|451988320|FG000|Overall Study|Adverse Event|2|||
125646536|NCT00689299|451988321|FG001|Overall Study|Adverse Event|1|||
125646537|NCT00689299|451988322|FG002|Overall Study|Adverse Event|1|||
125646538|NCT00689299|451988320|FG000|Overall Study|Lost to Follow-up|0|||
125646539|NCT00689299|451988321|FG001|Overall Study|Lost to Follow-up|1|||
125646540|NCT00689299|451988322|FG002|Overall Study|Lost to Follow-up|1|||
125646541|NCT00689299|451988320|FG000|Overall Study|Withdrawal by Subject|4|||
125646542|NCT00689299|451988321|FG001|Overall Study|Withdrawal by Subject|1|||
125646543|NCT00689299|451988322|FG002|Overall Study|Withdrawal by Subject|3|||
125646544|NCT00689299|451988320|FG000|Overall Study|Protocol Violation|1|||
125646545|NCT00689299|451988321|FG001|Overall Study|Protocol Violation|0|||
125646546|NCT00689299|451988322|FG002|Overall Study|Protocol Violation|0|||
125646547|NCT02613910|451988325|FG000|Overall Study|Termination of study|1|||
125646548|NCT03395704|451988326|FG000|Overall Study|Adverse Event|2|||
125646549|NCT03395704|451988327|FG001|Overall Study|Adverse Event|1|||
125646550|NCT03395704|451988326|FG000|Overall Study|Withdrawal by Subject|2|||
125646551|NCT03395704|451988327|FG001|Overall Study|Withdrawal by Subject|1|||
125646552|NCT03395704|451988326|FG000|Overall Study|Physician Decision|0|||
125646553|NCT03395704|451988327|FG001|Overall Study|Physician Decision|1|||
125646554|NCT00758394|451988328|FG000|2nd Intervention Order|Lost to Follow-up|0|||
125646555|NCT00758394|451988329|FG001|2nd Intervention Order|Lost to Follow-up|1|||
125646556|NCT00758394|451988330|FG002|2nd Intervention Order|Lost to Follow-up|0|||
125646557|NCT00758394|451988331|FG003|2nd Intervention Order|Lost to Follow-up|0|||
125646558|NCT00758394|451988328|FG000|3rd Intervention|Lost to Follow-up|1|||
125646559|NCT00758394|451988329|FG001|3rd Intervention|Lost to Follow-up|0|||
125646560|NCT00758394|451988330|FG002|3rd Intervention|Lost to Follow-up|0|||
125646561|NCT00758394|451988331|FG003|3rd Intervention|Lost to Follow-up|1|||
125646562|NCT04823494|451990073|FG000|Overall Study|Programming software malfunction.|1|||
125646563|NCT04823494|451990074|FG001|Overall Study|Programming software malfunction.|0|||
125646564|NCT04823494|451990073|FG000|Overall Study|Withdrawal by Subject|1|||
125646565|NCT04823494|451990074|FG001|Overall Study|Withdrawal by Subject|0|||
125646566|NCT04823494|451990073|FG000|Overall Study|Devices lost|0|||
125646567|NCT04823494|451990074|FG001|Overall Study|Devices lost|1|||
125646568|NCT03726320|451990075|FG000|Overall Study|Lost to Follow-up|2|||
125646569|NCT03726320|451990076|FG001|Overall Study|Lost to Follow-up|4|||
125646570|NCT03726320|451990077|FG002|Overall Study|Lost to Follow-up|0|||
125646571|NCT03726320|451990075|FG000|Overall Study|Time Constraints|4|||
125646572|NCT03726320|451990076|FG001|Overall Study|Time Constraints|1|||
125646573|NCT03726320|451990077|FG002|Overall Study|Time Constraints|0|||
125646574|NCT03726320|451990075|FG000|Overall Study|Ineligible after enrollment|3|||
125646575|NCT03726320|451990076|FG001|Overall Study|Ineligible after enrollment|3|||
125646576|NCT03726320|451990077|FG002|Overall Study|Ineligible after enrollment|0|||
125646577|NCT03726320|451990075|FG000|Overall Study|Clinic / insurance issue|2|||
125646578|NCT03726320|451990076|FG001|Overall Study|Clinic / insurance issue|0|||
125646579|NCT03726320|451990077|FG002|Overall Study|Clinic / insurance issue|0|||
125646580|NCT03726320|451990075|FG000|Overall Study|Language barrier|1|||
125646581|NCT03726320|451990076|FG001|Overall Study|Language barrier|0|||
125646582|NCT03726320|451990077|FG002|Overall Study|Language barrier|0|||
125646583|NCT03726320|451990075|FG000|Overall Study|Provider left the clinic|0|||
125646584|NCT03726320|451990076|FG001|Overall Study|Provider left the clinic|0|||
125646585|NCT03726320|451990077|FG002|Overall Study|Provider left the clinic|1|||
125646586|NCT01684930|451990080|FG000|Overall Study|Withdrawal by Subject|3|||
125646587|NCT01684930|451990081|FG001|Overall Study|Withdrawal by Subject|1|||
125646588|NCT00313716|451990091|FG000|Overall Study|Death|3|||
125646589|NCT00313716|451990092|FG001|Overall Study|Death|2|||
125646590|NCT00313716|451990093|FG002|Overall Study|Death|9|||
125646591|NCT00313716|451990094|FG003|Overall Study|Death|3|||
125646592|NCT00313716|451990095|FG004|Overall Study|Death|5|||
125646593|NCT00313716|451990096|FG005|Overall Study|Death|9|||
125646594|NCT00313716|451990091|FG000|Overall Study|Lost to Follow-up|2|||
125646595|NCT00313716|451990092|FG001|Overall Study|Lost to Follow-up|5|||
125646596|NCT00313716|451990093|FG002|Overall Study|Lost to Follow-up|2|||
125646597|NCT00313716|451990094|FG003|Overall Study|Lost to Follow-up|1|||
125646598|NCT00313716|451990095|FG004|Overall Study|Lost to Follow-up|0|||
125646599|NCT00313716|451990096|FG005|Overall Study|Lost to Follow-up|4|||
125646600|NCT00313716|451990091|FG000|Overall Study|Withdrawal by Subject|0|||
125646601|NCT00313716|451990092|FG001|Overall Study|Withdrawal by Subject|1|||
125646602|NCT00313716|451990093|FG002|Overall Study|Withdrawal by Subject|1|||
125646603|NCT00313716|451990094|FG003|Overall Study|Withdrawal by Subject|0|||
125646604|NCT00313716|451990095|FG004|Overall Study|Withdrawal by Subject|1|||
125646605|NCT00313716|451990096|FG005|Overall Study|Withdrawal by Subject|0|||
125646606|NCT01041027|451990098|FG000|Overall Study|Withdrawal by Subject|2|||
125202867|NCT04713592|450365552|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
125202868|NCT04713592|450365553|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
125202869|NCT04713592|450365554|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
125202870|NCT04713592|450365551|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
125202871|NCT04713592|450365552|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
125202872|NCT04713592|450365553|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
125202873|NCT04713592|450365554|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
125202874|NCT04713592|450365551|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125202875|NCT04713592|450365552|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125202876|NCT04713592|450365553|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
125202877|NCT04713592|450365554|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
125202878|NCT04713592|450365551|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
125202879|NCT04713592|450365552|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
125202880|NCT04713592|450365553|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
125202881|NCT04713592|450365554|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
125202882|NCT04713592|450365551|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125202883|NCT04713592|450365552|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125202884|NCT04713592|450365553|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
125202885|NCT04713592|450365554|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
125202886|NCT04713592|450365551|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
125202887|NCT04713592|450365552|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
125202888|NCT04713592|450365553|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
125202889|NCT04713592|450365554|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
125202890|NCT02548351|450365560|FG000|Overall Study|Withdrawal by Subject|149|||
125202891|NCT02548351|450365561|FG001|Overall Study|Withdrawal by Subject|154|||
125202892|NCT02548351|450365562|FG002|Overall Study|Withdrawal by Subject|152|||
125202893|NCT02548351|450365560|FG000|Overall Study|Death|11|||
125202894|NCT02548351|450365561|FG001|Overall Study|Death|15|||
125202895|NCT02548351|450365562|FG002|Overall Study|Death|12|||
125202896|NCT02548351|450365560|FG000|Overall Study|Adverse Event|22|||
125202897|NCT02548351|450365561|FG001|Overall Study|Adverse Event|56|||
125202898|NCT02548351|450365562|FG002|Overall Study|Adverse Event|36|||
125202899|NCT02548351|450365560|FG000|Overall Study|Study Terminated by Sponsor|549|||
125202900|NCT02548351|450365561|FG001|Overall Study|Study Terminated by Sponsor|509|||
125202901|NCT02548351|450365562|FG002|Overall Study|Study Terminated by Sponsor|528|||
125202902|NCT02548351|450365560|FG000|Overall Study|Site Closure|14|||
125202903|NCT02548351|450365561|FG001|Overall Study|Site Closure|5|||
125202904|NCT02548351|450365562|FG002|Overall Study|Site Closure|7|||
125202905|NCT02548351|450365560|FG000|Overall Study|Non-compliance with Study Drug|4|||
125202906|NCT02548351|450365561|FG001|Overall Study|Non-compliance with Study Drug|2|||
125202907|NCT02548351|450365562|FG002|Overall Study|Non-compliance with Study Drug|0|||
125202908|NCT02548351|450365560|FG000|Overall Study|Protocol Violation|2|||
125202909|NCT02548351|450365561|FG001|Overall Study|Protocol Violation|1|||
125202910|NCT02548351|450365562|FG002|Overall Study|Protocol Violation|2|||
125202911|NCT02548351|450365560|FG000|Overall Study|Physician Decision|11|||
125202912|NCT02548351|450365561|FG001|Overall Study|Physician Decision|18|||
125202913|NCT02548351|450365562|FG002|Overall Study|Physician Decision|11|||
125202914|NCT02548351|450365560|FG000|Overall Study|Lost to Follow-up|43|||
125202915|NCT02548351|450365561|FG001|Overall Study|Lost to Follow-up|50|||
125202916|NCT02548351|450365562|FG002|Overall Study|Lost to Follow-up|57|||
125202917|NCT02548351|450365560|FG000|Overall Study|Other|19|||
125202918|NCT02548351|450365561|FG001|Overall Study|Other|16|||
125202919|NCT02548351|450365562|FG002|Overall Study|Other|20|||
125202920|NCT02548351|450365560|FG000|Overall Study|Missing|1|||
125202921|NCT02548351|450365561|FG001|Overall Study|Missing|1|||
125202922|NCT02548351|450365562|FG002|Overall Study|Missing|0|||
125202923|NCT00125242|450365563|FG000|Overall Study|did not qualify|7|||
125202924|NCT00125242|450365564|FG001|Overall Study|did not qualify|2|||
125202925|NCT01664949|450365565|FG000|Overall Study|Adverse Event|11|||
125202926|NCT01664949|450365566|FG001|Overall Study|Adverse Event|12|||
125202927|NCT01664949|450365565|FG000|Overall Study|Lack of Efficacy|1|||
125202928|NCT01664949|450365566|FG001|Overall Study|Lack of Efficacy|1|||
125202929|NCT01664949|450365565|FG000|Overall Study|Lost to Follow-up|1|||
125202930|NCT01664949|450365566|FG001|Overall Study|Lost to Follow-up|2|||
125202931|NCT01664949|450365565|FG000|Overall Study|Personal Reasons|3|||
125202932|NCT01664949|450365566|FG001|Overall Study|Personal Reasons|4|||
125202933|NCT01664949|450365565|FG000|Overall Study|Protocol Violation|5|||
125202934|NCT01664949|450365566|FG001|Overall Study|Protocol Violation|5|||
125202935|NCT01664949|450365565|FG000|Overall Study|Other Miscellaneous Reasons|3|||
125202936|NCT01664949|450365566|FG001|Overall Study|Other Miscellaneous Reasons|1|||
125202937|NCT03003494|450365567|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
125202938|NCT01632150|450366867|FG000|Overall Study|Disease progression|27|||
125202939|NCT01632150|450366867|FG000|Overall Study|Study drug toxicity|1|||
125202940|NCT01632150|450366867|FG000|Overall Study|Unrelated adverse event|7|||
125202941|NCT01632150|450366867|FG000|Overall Study|Withdrawal by Subject|2|||
125202942|NCT01632150|450366867|FG000|Overall Study|Patient underwent autologous transplant|1|||
125202943|NCT01632150|450366867|FG000|Overall Study|Moved to compassionate program|2|||
125202944|NCT02143791|450366868|FG000|Enrolled|Withdrawal by Subject|4|||
125202945|NCT02143791|450366868|FG000|Trial Stimulation|Lack of Efficacy|21|||
125202946|NCT02143791|450366868|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
125202947|NCT02143791|450366868|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
125202948|NCT02143791|450366868|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
125202949|NCT02143791|450366868|FG000|Any Programming (3-6 Months)|Missing Data|1|||
125202950|NCT02143791|450366868|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
125202951|NCT00401544|450366871|FG000|Overall Study|Adverse Event|5|||
125202952|NCT00401544|450366872|FG001|Overall Study|Adverse Event|1|||
125202953|NCT00401544|450366873|FG002|Overall Study|Adverse Event|1|||
125202954|NCT00401544|450366874|FG003|Overall Study|Adverse Event|1|||
125202955|NCT00401544|450366871|FG000|Overall Study|Death|3|||
125202956|NCT00401544|450366872|FG001|Overall Study|Death|6|||
125202957|NCT00401544|450366873|FG002|Overall Study|Death|2|||
125202958|NCT00401544|450366874|FG003|Overall Study|Death|5|||
125202959|NCT00401544|450366871|FG000|Overall Study|Lost to Follow-up|2|||
125202960|NCT00401544|450366872|FG001|Overall Study|Lost to Follow-up|0|||
125202961|NCT00401544|450366873|FG002|Overall Study|Lost to Follow-up|1|||
125202962|NCT00401544|450366874|FG003|Overall Study|Lost to Follow-up|1|||
125202963|NCT00401544|450366871|FG000|Overall Study|Withdrawal by Subject|7|||
125202964|NCT00401544|450366872|FG001|Overall Study|Withdrawal by Subject|6|||
125202965|NCT00401544|450366873|FG002|Overall Study|Withdrawal by Subject|6|||
125202966|NCT00401544|450366874|FG003|Overall Study|Withdrawal by Subject|5|||
125202967|NCT00401544|450366871|FG000|Overall Study|Physician Decision|1|||
125202968|NCT00401544|450366872|FG001|Overall Study|Physician Decision|3|||
125202969|NCT00401544|450366873|FG002|Overall Study|Physician Decision|0|||
125202970|NCT00401544|450366874|FG003|Overall Study|Physician Decision|0|||
125202971|NCT00401544|450366871|FG000|Overall Study|Ineligibility determined|0|||
125202972|NCT00401544|450366872|FG001|Overall Study|Ineligibility determined|1|||
125202973|NCT00401544|450366873|FG002|Overall Study|Ineligibility determined|0|||
125202974|NCT00401544|450366874|FG003|Overall Study|Ineligibility determined|2|||
125202975|NCT00401544|450366871|FG000|Overall Study|Disease progression|0|||
125202976|NCT00401544|450366872|FG001|Overall Study|Disease progression|1|||
125202977|NCT00401544|450366873|FG002|Overall Study|Disease progression|0|||
125202978|NCT00401544|450366874|FG003|Overall Study|Disease progression|0|||
125202979|NCT00401544|450366871|FG000|Overall Study|Other|0|||
125202980|NCT00401544|450366872|FG001|Overall Study|Other|0|||
125202981|NCT00401544|450366873|FG002|Overall Study|Other|2|||
125202982|NCT00401544|450366874|FG003|Overall Study|Other|2|||
125202983|NCT02339155|450366882|FG000|Overall Study|Adverse Event|0|||
125202984|NCT02339155|450366883|FG001|Overall Study|Adverse Event|6|||
125202985|NCT02339155|450366882|FG000|Overall Study|Death|1|||
125202986|NCT02339155|450366883|FG001|Overall Study|Death|1|||
125202987|NCT02339155|450366882|FG000|Overall Study|Lost to Follow-up|8|||
125202988|NCT02339155|450366883|FG001|Overall Study|Lost to Follow-up|9|||
125202989|NCT02339155|450366882|FG000|Overall Study|Physician Decision|2|||
125202990|NCT02339155|450366883|FG001|Overall Study|Physician Decision|1|||
125202991|NCT02339155|450366882|FG000|Overall Study|Withdrawal by Subject|4|||
125202992|NCT02339155|450366883|FG001|Overall Study|Withdrawal by Subject|4|||
125202993|NCT01214252|450366884|FG000|Overall Study|Not eligible per protocol|82|||
125202994|NCT04327661|450366887|FG000|Overall Study|Withdrawal by Subject|1|||
125202995|NCT04327661|450366888|FG001|Overall Study|Withdrawal by Subject|0|||
125202996|NCT04327661|450366889|FG002|Overall Study|Withdrawal by Subject|0|||
125202997|NCT01877551|450366892|FG000|Overall Study|Physician Decision|0|||
125202998|NCT01877551|450366893|FG001|Overall Study|Physician Decision|1|||
125202999|NCT02659514|450366896|FG000|Overall Study|Adverse Event|3|||
125203000|NCT02659514|450366897|FG001|Overall Study|Adverse Event|12|||
125203001|NCT02659514|450366896|FG000|Overall Study|Disease Progression|23|||
125203002|NCT02659514|450366897|FG001|Overall Study|Disease Progression|13|||
125203003|NCT02659514|450366896|FG000|Overall Study|Withdrawal by Subject|0|||
125203004|NCT02659514|450366897|FG001|Overall Study|Withdrawal by Subject|4|||
125203005|NCT02659514|450366896|FG000|Overall Study|Lost to Follow-up|0|||
125203006|NCT02659514|450366897|FG001|Overall Study|Lost to Follow-up|1|||
125203007|NCT02659514|450366896|FG000|Overall Study|Death|6|||
125203008|NCT02659514|450366897|FG001|Overall Study|Death|1|||
125203009|NCT02659514|450366896|FG000|Overall Study|Reason Unspecified|0|||
125203010|NCT02659514|450366897|FG001|Overall Study|Reason Unspecified|3|||
125203011|NCT01968707|450366903|FG000|Overall Study|Did not meet treatment day baseline|49|||
125203012|NCT01968707|450366904|FG001|Overall Study|Did not meet treatment day baseline|12|||
125203013|NCT01968707|450366905|FG002|Overall Study|Did not meet treatment day baseline|41|||
125203014|NCT01968707|450366906|FG003|Overall Study|Did not meet treatment day baseline|44|||
125203015|NCT01968707|450366907|FG004|Overall Study|Did not meet treatment day baseline|36|||
125203016|NCT01968707|450366908|FG005|Overall Study|Did not meet treatment day baseline|11|||
125203017|NCT01968707|450366909|FG006|Overall Study|Did not meet treatment day baseline|34|||
125203018|NCT01968707|450366910|FG007|Overall Study|Did not meet treatment day baseline|35|||
125646607|NCT01041027|451990098|FG000|Overall Study|Protocol Violation|1|||
125646608|NCT01041027|451990098|FG000|Overall Study|Delayed Radiation Therapy|1|||
125646609|NCT01041027|451990098|FG000|Overall Study|Adverse Event|4|||
125646610|NCT01347931|451990099|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
125646611|NCT02493712|451990100|FG000|Overall Study|Withdrawal by Subject|1|||
125646612|NCT02493712|451990101|FG001|Overall Study|Withdrawal by Subject|0|||
125646613|NCT02493712|451990102|FG002|Overall Study|Withdrawal by Subject|2|||
125646614|NCT02493712|451990100|FG000|Overall Study|Protocol Violation|0|||
125646615|NCT02493712|451990101|FG001|Overall Study|Protocol Violation|0|||
125646616|NCT02493712|451990102|FG002|Overall Study|Protocol Violation|1|||
125646617|NCT02493712|451990100|FG000|Overall Study|Lost to Follow-up|1|||
125646618|NCT02493712|451990101|FG001|Overall Study|Lost to Follow-up|0|||
125646619|NCT02493712|451990102|FG002|Overall Study|Lost to Follow-up|0|||
125646620|NCT02493712|451990100|FG000|Overall Study|Physician Decision|0|||
125646621|NCT02493712|451990101|FG001|Overall Study|Physician Decision|1|||
125646622|NCT02493712|451990102|FG002|Overall Study|Physician Decision|0|||
125646623|NCT02493712|451990100|FG000|Overall Study|Lack of Efficacy|0|||
125646624|NCT02493712|451990101|FG001|Overall Study|Lack of Efficacy|5|||
125646625|NCT02493712|451990102|FG002|Overall Study|Lack of Efficacy|3|||
125646626|NCT02528643|451990103|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
125646627|NCT02528643|451990104|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
125646628|NCT02528643|451990103|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
125646629|NCT02528643|451990104|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
125646630|NCT02528643|451990103|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
125646631|NCT02528643|451990104|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
125646632|NCT02528643|451990103|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
125646633|NCT02528643|451990104|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
125646634|NCT02528643|451990103|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
125646635|NCT02528643|451990104|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
125646636|NCT02528643|451990103|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
125646637|NCT02528643|451990104|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
125646638|NCT02528643|451990103|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
125646639|NCT02528643|451990104|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
125646640|NCT04120116|451990105|FG000|Overall Study|Lost to Follow-up|0|||
125646641|NCT04120116|451990106|FG001|Overall Study|Lost to Follow-up|1|||
125646642|NCT04120116|451990107|FG002|Overall Study|Lost to Follow-up|0|||
125646643|NCT04120116|451990108|FG003|Overall Study|Lost to Follow-up|2|||
125646644|NCT04120116|451990105|FG000|Overall Study|Withdrawal by Subject|1|||
125646645|NCT04120116|451990106|FG001|Overall Study|Withdrawal by Subject|0|||
125646646|NCT04120116|451990107|FG002|Overall Study|Withdrawal by Subject|1|||
125646647|NCT04120116|451990108|FG003|Overall Study|Withdrawal by Subject|1|||
125646648|NCT04120116|451990105|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
125646649|NCT04120116|451990106|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
125646650|NCT04120116|451990107|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
125646651|NCT04120116|451990108|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
125646652|NCT02087085|451990109|FG000|Overall Study|Adverse Event|10|||
125646653|NCT02087085|451990110|FG001|Overall Study|Adverse Event|14|||
125646654|NCT02087085|451990109|FG000|Overall Study|Lack of Efficacy|4|||
125646655|NCT02087085|451990110|FG001|Overall Study|Lack of Efficacy|3|||
125646656|NCT02087085|451990109|FG000|Overall Study|Lost to Follow-up|6|||
125646657|NCT02087085|451990110|FG001|Overall Study|Lost to Follow-up|4|||
125646658|NCT02087085|451990109|FG000|Overall Study|Withdrawal by Subject|9|||
125646659|NCT02087085|451990110|FG001|Overall Study|Withdrawal by Subject|11|||
125646660|NCT02087085|451990109|FG000|Overall Study|Protocol Violation|1|||
125646661|NCT02087085|451990110|FG001|Overall Study|Protocol Violation|0|||
125646662|NCT02087085|451990109|FG000|Overall Study|Study Terminated by Sponsor|87|||
125646663|NCT02087085|451990110|FG001|Overall Study|Study Terminated by Sponsor|80|||
125646664|NCT02087085|451990109|FG000|Overall Study|Other Miscellaneous Reasons|3|||
125646665|NCT02087085|451990110|FG001|Overall Study|Other Miscellaneous Reasons|4|||
125646666|NCT01191190|451990111|FG000|Overall Study|Withdrawal by Subject|1|||
125646667|NCT02545270|451990119|FG000|Overall Study|technical difficulties|0|||
125646668|NCT02545270|451990120|FG001|Overall Study|technical difficulties|1|||
125646669|NCT02545270|451990121|FG002|Overall Study|technical difficulties|0|||
125646670|NCT02545270|451990119|FG000|Overall Study|Videos being too similar to other|0|||
125646671|NCT02545270|451990120|FG001|Overall Study|Videos being too similar to other|0|||
125646672|NCT02545270|451990121|FG002|Overall Study|Videos being too similar to other|2|||
125646673|NCT00761891|451990122|FG000|Overall Study|Withdrawal by Subject|10|||
125646674|NCT01707667|451990123|FG000|Period 1|expulsion of colonic sensor catheter|1|||
125646675|NCT01707667|451990124|FG001|Period 1|expulsion of colonic sensor catheter|0|||
125646676|NCT04382066|451990132|FG000|Overall Study|Adverse Event|1|||
125646677|NCT04382066|451990133|FG001|Overall Study|Adverse Event|0|||
125646678|NCT04382066|451990134|FG002|Overall Study|Adverse Event|0|||
125203019|NCT00916344|450366911|FG000|Overall Study|Death|2|||
125203020|NCT00916344|450366911|FG000|Overall Study|ICD upgrade|1|||
125203021|NCT00916344|450366911|FG000|Overall Study|Drop-out|5|||
125203022|NCT00108485|450366915|FG000|Overall Study|Withdrawal by Subject|3|||
125203023|NCT00108485|450366916|FG001|Overall Study|Withdrawal by Subject|0|||
125203024|NCT00108485|450366915|FG000|Overall Study|Lost to Follow-up|0|||
125203025|NCT00108485|450366916|FG001|Overall Study|Lost to Follow-up|2|||
125203026|NCT01097421|450366917|FG000|Overall Study|Adverse Event|8|||
125203027|NCT01097421|450366917|FG000|Overall Study|Protocol Violation|2|||
125203028|NCT01097421|450366917|FG000|Overall Study|Lost to Follow-up|1|||
125203029|NCT01097421|450366917|FG000|Overall Study|Withdrawal by Subject|3|||
125203030|NCT01701193|450366922|FG000|Overall Study|Withdrawal by Subject|2|||
125203031|NCT01701193|450366923|FG001|Overall Study|Withdrawal by Subject|2|||
125203032|NCT01701193|450366924|FG002|Overall Study|Withdrawal by Subject|1|||
125203033|NCT01701193|450366925|FG003|Overall Study|Withdrawal by Subject|2|||
125203034|NCT01701193|450366922|FG000|Overall Study|Adverse Event|1|||
125203035|NCT01701193|450366923|FG001|Overall Study|Adverse Event|0|||
125203036|NCT01701193|450366924|FG002|Overall Study|Adverse Event|0|||
125203037|NCT01701193|450366925|FG003|Overall Study|Adverse Event|0|||
125203038|NCT02062944|450366926|FG000|Overall Study|Lost to Follow-up|1|||
125203039|NCT02062944|450366926|FG000|Overall Study|New hemotological disorder identified|1|||
125203040|NCT02062944|450366926|FG000|Overall Study|Uncontrolled Hypertension|1|||
125203041|NCT02062944|450366926|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
125203042|NCT00278148|450366927|FG000|Phase II - Expansion Phase|Disease progression|0|||
125203043|NCT00278148|450366928|FG001|Phase II - Expansion Phase|Disease progression|0|||
125203044|NCT00278148|450366929|FG002|Phase II - Expansion Phase|Disease progression|4|||
125203045|NCT00278148|450366927|FG000|Phase II - Expansion Phase|Adverse Event|0|||
125203046|NCT00278148|450366928|FG001|Phase II - Expansion Phase|Adverse Event|0|||
125203047|NCT00278148|450366929|FG002|Phase II - Expansion Phase|Adverse Event|2|||
125203048|NCT02035748|450366930|FG000|Overall Study|Adverse Event|5|||
125203049|NCT02035748|450366930|FG000|Overall Study|Death|3|||
125203050|NCT02035748|450366930|FG000|Overall Study|Lost to Follow-up|2|||
125203051|NCT02035748|450366930|FG000|Overall Study|Physician Decision|3|||
125203052|NCT02035748|450366930|FG000|Overall Study|Withdrawal by Subject|6|||
125203053|NCT02035748|450366930|FG000|Overall Study|Progressive Disease|1|||
125203054|NCT01088243|450366932|FG000|Overall Study|Adverse Event|1|||
125203055|NCT01088243|450366933|FG001|Overall Study|Adverse Event|0|||
125203056|NCT00454818|450366936|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
125203057|NCT00454818|450366937|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
125203058|NCT00454818|450366938|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
125203059|NCT00454818|450366939|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
125203060|NCT00454818|450366940|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
125203061|NCT00454818|450366936|FG000|Phase I: Open-label Dose-escalation|Death|0|||
125203062|NCT00454818|450366937|FG001|Phase I: Open-label Dose-escalation|Death|1|||
125203063|NCT00454818|450366938|FG002|Phase I: Open-label Dose-escalation|Death|0|||
125203064|NCT00454818|450366939|FG003|Phase I: Open-label Dose-escalation|Death|0|||
125203065|NCT00454818|450366940|FG004|Phase I: Open-label Dose-escalation|Death|0|||
125203066|NCT00454818|450366936|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
125203067|NCT00454818|450366937|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
125203068|NCT00454818|450366938|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
125203069|NCT00454818|450366939|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
125203070|NCT00454818|450366940|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
125203071|NCT00454818|450366936|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
125203072|NCT00454818|450366937|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
125203073|NCT00454818|450366938|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
125203074|NCT00454818|450366939|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
125203075|NCT00454818|450366940|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
125203076|NCT00454818|450366936|FG000|Phase 2: Randomized Double-blind|Death|0|||
125203077|NCT00454818|450366937|FG001|Phase 2: Randomized Double-blind|Death|1|||
125203078|NCT00454818|450366938|FG002|Phase 2: Randomized Double-blind|Death|0|||
125203079|NCT00454818|450366939|FG003|Phase 2: Randomized Double-blind|Death|0|||
125203080|NCT00454818|450366940|FG004|Phase 2: Randomized Double-blind|Death|1|||
125203081|NCT00454818|450366936|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
125203082|NCT00454818|450366937|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
125203083|NCT00454818|450366938|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
125203084|NCT00454818|450366939|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
125203085|NCT00454818|450366940|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
125203086|NCT00454818|450366936|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
125203087|NCT00454818|450366937|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
125203088|NCT00454818|450366938|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
125203089|NCT00454818|450366939|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
125203090|NCT00454818|450366940|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
125203091|NCT01384019|450366941|FG000|Overall Study|Withdrawal by Subject|3|||
125203092|NCT01384019|450366942|FG001|Overall Study|Withdrawal by Subject|0|||
125203093|NCT01384019|450366941|FG000|Overall Study|Death|1|||
125203094|NCT01384019|450366942|FG001|Overall Study|Death|0|||
125203095|NCT01384019|450366941|FG000|Overall Study|MRI refusal|6|||
125203096|NCT01384019|450366942|FG001|Overall Study|MRI refusal|6|||
125203097|NCT00767039|450366943|FG000|Overall Study|Death|5|||
125203098|NCT00767039|450366944|FG001|Overall Study|Death|2|||
125203099|NCT01826370|450366945|FG000|Overall Study|Protocol Violation|6|||
125203100|NCT01826370|450366945|FG000|Overall Study|Lost to Follow-up|12|||
125203101|NCT01826370|450366945|FG000|Overall Study|Other reason not defined above|2|||
125203102|NCT04416737|450366947|FG000|Week 1 (First Injection)|Physician Decision|0|||
125203103|NCT04416737|450366948|FG001|Week 1 (First Injection)|Physician Decision|1|||
125203104|NCT03332628|450366949|FG000|Overall Study|Physician Decision|2|||
125203105|NCT01472757|450366950|FG000|Overall Study|Withdrawal by Subject|1|||
125203106|NCT01472757|450366951|FG001|Overall Study|Withdrawal by Subject|2|||
125203107|NCT01472757|450366952|FG002|Overall Study|Withdrawal by Subject|2|||
125203108|NCT01472757|450366953|FG003|Overall Study|Withdrawal by Subject|0|||
125203109|NCT01472757|450366950|FG000|Overall Study|Asthma exacerbation|4|||
125203110|NCT01472757|450366951|FG001|Overall Study|Asthma exacerbation|1|||
125203111|NCT01472757|450366952|FG002|Overall Study|Asthma exacerbation|2|||
125203112|NCT01472757|450366953|FG003|Overall Study|Asthma exacerbation|1|||
125203113|NCT01472757|450366950|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
125203114|NCT01472757|450366951|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
125203115|NCT01472757|450366952|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
125203116|NCT01472757|450366953|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
125203117|NCT01472757|450366950|FG000|Overall Study|Protocol Violation|3|||
125203118|NCT01472757|450366951|FG001|Overall Study|Protocol Violation|2|||
125203119|NCT01472757|450366952|FG002|Overall Study|Protocol Violation|4|||
125203120|NCT01472757|450366953|FG003|Overall Study|Protocol Violation|4|||
125203121|NCT01472757|450366950|FG000|Overall Study|Other reasons|1|||
125203122|NCT01472757|450366951|FG001|Overall Study|Other reasons|0|||
125203123|NCT01472757|450366952|FG002|Overall Study|Other reasons|2|||
125203124|NCT01472757|450366953|FG003|Overall Study|Other reasons|2|||
125203125|NCT04489381|450366954|FG000|Overall Study|Lost to Follow-up|2|||
125203126|NCT04489381|450366955|FG001|Overall Study|Lost to Follow-up|3|||
125203127|NCT04489381|450366954|FG000|Overall Study|Withdrawal by Subject|1|||
125203128|NCT04489381|450366955|FG001|Overall Study|Withdrawal by Subject|0|||
125203129|NCT00070018|450366958|FG000|Overall Study|Adverse Event|2|||
125203130|NCT00070018|450366958|FG000|Overall Study|Lack of Efficacy|1|||
125203131|NCT00070018|450366958|FG000|Overall Study|Withdrawal by Subject|1|||
125203132|NCT02939716|450366962|FG000|Overall Study|scanner failure|0|||
125203133|NCT02939716|450366963|FG001|Overall Study|scanner failure|0|||
125203134|NCT02939716|450366964|FG002|Overall Study|scanner failure|0|||
125203135|NCT02939716|450366965|FG003|Overall Study|scanner failure|1|||
125203136|NCT02939716|450366966|FG004|Overall Study|scanner failure|1|||
125203137|NCT02939716|450366967|FG005|Overall Study|scanner failure|1|||
125203138|NCT02543892|450366970|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
125203139|NCT02543892|450366971|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
125203140|NCT02543892|450366972|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
125203141|NCT02543892|450366973|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
125203142|NCT02543892|450366974|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
125203143|NCT02543892|450366975|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
125203144|NCT02543892|450366976|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
125203145|NCT02543892|450366977|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
125203146|NCT02543892|450366970|FG000|Received Vaccination 2|Physician Decision|0|||
125203147|NCT02543892|450366971|FG001|Received Vaccination 2|Physician Decision|0|||
125203148|NCT02543892|450366972|FG002|Received Vaccination 2|Physician Decision|0|||
125203149|NCT02543892|450366973|FG003|Received Vaccination 2|Physician Decision|0|||
125203150|NCT02543892|450366974|FG004|Received Vaccination 2|Physician Decision|0|||
125203151|NCT02543892|450366975|FG005|Received Vaccination 2|Physician Decision|1|||
125203152|NCT02543892|450366976|FG006|Received Vaccination 2|Physician Decision|0|||
125203153|NCT02543892|450366977|FG007|Received Vaccination 2|Physician Decision|0|||
125203154|NCT02543892|450366970|FG000|Received Vaccination 2|Adverse Event|0|||
125203155|NCT02543892|450366971|FG001|Received Vaccination 2|Adverse Event|1|||
125203156|NCT02543892|450366972|FG002|Received Vaccination 2|Adverse Event|0|||
125203157|NCT02543892|450366973|FG003|Received Vaccination 2|Adverse Event|0|||
125203158|NCT02543892|450366974|FG004|Received Vaccination 2|Adverse Event|0|||
125203159|NCT02543892|450366975|FG005|Received Vaccination 2|Adverse Event|0|||
125203160|NCT02543892|450366976|FG006|Received Vaccination 2|Adverse Event|0|||
125203161|NCT02543892|450366977|FG007|Received Vaccination 2|Adverse Event|0|||
125203162|NCT02543892|450366970|FG000|Had Immunology Data|Withdrawal by Subject|0|||
125203163|NCT02543892|450366971|FG001|Had Immunology Data|Withdrawal by Subject|0|||
125203164|NCT02543892|450366972|FG002|Had Immunology Data|Withdrawal by Subject|0|||
125203165|NCT02543892|450366973|FG003|Had Immunology Data|Withdrawal by Subject|0|||
125203166|NCT02543892|450366974|FG004|Had Immunology Data|Withdrawal by Subject|0|||
125203167|NCT02543892|450366975|FG005|Had Immunology Data|Withdrawal by Subject|0|||
125203168|NCT02543892|450366976|FG006|Had Immunology Data|Withdrawal by Subject|1|||
125203169|NCT02543892|450366977|FG007|Had Immunology Data|Withdrawal by Subject|0|||
125203170|NCT00785213|450366978|FG000|Quinine Sulfate Alone|Adverse Event|4|||
125203171|NCT00785213|450366978|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
125203172|NCT00525902|450366979|FG000|Overall Study|Lack of Efficacy|1|||
125203173|NCT00844480|450366986|FG000|Overall Study|Withdrawal by Subject|2|||
125203174|NCT00844480|450366987|FG001|Overall Study|Withdrawal by Subject|3|||
125203175|NCT02858180|450366988|FG000|Overall Study|Lost to Follow-up|0|||
125203176|NCT02858180|450366989|FG001|Overall Study|Lost to Follow-up|2|||
125203177|NCT00526331|450366990|FG000|Overall Study|Sponsor Termination|55|||
125203178|NCT01043705|450366993|FG000|Overall Study|Death|28|||
125203179|NCT01043705|450366994|FG001|Overall Study|Death|60|||
125203180|NCT01043705|450366995|FG002|Overall Study|Death|26|||
125203181|NCT01043705|450366993|FG000|Overall Study|Lost to Follow-up|27|||
125203182|NCT01043705|450366994|FG001|Overall Study|Lost to Follow-up|12|||
125203183|NCT01043705|450366995|FG002|Overall Study|Lost to Follow-up|0|||
125203184|NCT01043705|450366993|FG000|Overall Study|Multiple Reasons|4|||
125203185|NCT01043705|450366994|FG001|Overall Study|Multiple Reasons|7|||
125203186|NCT01043705|450366995|FG002|Overall Study|Multiple Reasons|0|||
125203187|NCT01043705|450366993|FG000|Overall Study|Protocol Violation|2|||
125203188|NCT01043705|450366994|FG001|Overall Study|Protocol Violation|1|||
125203189|NCT01043705|450366995|FG002|Overall Study|Protocol Violation|0|||
125203190|NCT01043705|450366993|FG000|Overall Study|Withdrawal by Subject|8|||
125203191|NCT01043705|450366994|FG001|Overall Study|Withdrawal by Subject|6|||
125203192|NCT01043705|450366995|FG002|Overall Study|Withdrawal by Subject|0|||
125203193|NCT01043705|450366993|FG000|Overall Study|Site Closure|8|||
125203194|NCT01043705|450366994|FG001|Overall Study|Site Closure|0|||
125203195|NCT01043705|450366995|FG002|Overall Study|Site Closure|0|||
125203196|NCT01043705|450366993|FG000|Overall Study|Subsequent Procedure|9|||
125203197|NCT01043705|450366994|FG001|Overall Study|Subsequent Procedure|24|||
125203198|NCT01043705|450366995|FG002|Overall Study|Subsequent Procedure|29|||
125203199|NCT01043705|450366993|FG000|Overall Study|Adverse Event|0|||
125203200|NCT01043705|450366994|FG001|Overall Study|Adverse Event|2|||
125203201|NCT01043705|450366995|FG002|Overall Study|Adverse Event|0|||
125203202|NCT01043705|450366993|FG000|Overall Study|Screen Fail|21|||
125203203|NCT01043705|450366994|FG001|Overall Study|Screen Fail|0|||
125203204|NCT01043705|450366995|FG002|Overall Study|Screen Fail|0|||
125203205|NCT01043705|450366993|FG000|Overall Study|Other|0|||
125203206|NCT01043705|450366994|FG001|Overall Study|Other|19|||
125203207|NCT01043705|450366995|FG002|Overall Study|Other|25|||
125203208|NCT00581542|450366997|FG000|Overall Study|they met an exclusion criteria|2|||
125203209|NCT00581542|450366998|FG001|Overall Study|they met an exclusion criteria|2|||
125203210|NCT00581542|450366997|FG000|Overall Study|Lost to Follow-up|9|||
125203211|NCT00581542|450366998|FG001|Overall Study|Lost to Follow-up|21|||
125203212|NCT03099694|450367000|FG000|Overall Study|Withdrawal by Subject|11|||
125203213|NCT03099694|450367001|FG001|Overall Study|Withdrawal by Subject|13|||
125203214|NCT03099694|450367000|FG000|Overall Study|Lost to Follow-up|9|||
125646679|NCT04382066|451990132|FG000|Overall Study|Death|1|||
125203215|NCT03099694|450367001|FG001|Overall Study|Lost to Follow-up|5|||
125203216|NCT02291601|450367002|FG000|Abdomen|Did not qualify|333|||
125203217|NCT02291601|450367003|FG001|Abdomen|Did not qualify|54|||
125203218|NCT02291601|450367004|FG002|Abdomen|Did not qualify|339|||
125203219|NCT02291601|450367002|FG000|Groin|Did not qualify|183|||
125203220|NCT02291601|450367003|FG001|Groin|Did not qualify|30|||
125203221|NCT02291601|450367004|FG002|Groin|Did not qualify|177|||
125203222|NCT00381043|450367005|FG000|Overall Study|Lost to Follow-up|8|||
125203223|NCT00381043|450367006|FG001|Overall Study|Lost to Follow-up|6|||
125203224|NCT00381043|450367005|FG000|Overall Study|Withdrawal by Subject|3|||
125203225|NCT00381043|450367006|FG001|Overall Study|Withdrawal by Subject|1|||
125203226|NCT00381043|450367005|FG000|Overall Study|wanted more care|0|||
125203227|NCT00381043|450367006|FG001|Overall Study|wanted more care|1|||
125203228|NCT00381043|450367005|FG000|Overall Study|incarcerated|1|||
125203229|NCT00381043|450367006|FG001|Overall Study|incarcerated|0|||
125646680|NCT04382066|451990133|FG001|Overall Study|Death|0|||
125203230|NCT03045276|450367007|FG000|Intervention Phase|Withdrawal by Subject|7|||
125203231|NCT03045276|450367008|FG001|Intervention Phase|Withdrawal by Subject|2|||
125203232|NCT03045276|450367009|FG002|Intervention Phase|Withdrawal by Subject|3|||
125203233|NCT03045276|450367010|FG003|Intervention Phase|Withdrawal by Subject|7|||
125203234|NCT03045276|450367007|FG000|Intervention Phase|Developed exclusionary criteria|3|||
125646681|NCT04382066|451990134|FG002|Overall Study|Death|1|||
125203235|NCT03045276|450367008|FG001|Intervention Phase|Developed exclusionary criteria|3|||
125203236|NCT03045276|450367009|FG002|Intervention Phase|Developed exclusionary criteria|0|||
125203237|NCT03045276|450367010|FG003|Intervention Phase|Developed exclusionary criteria|0|||
125203238|NCT03045276|450367007|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
125203239|NCT03045276|450367008|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
125646682|NCT03326323|451990137|FG000|Overall Study|Unable to receive ANH protocol|3|||
125203240|NCT03045276|450367009|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
125203241|NCT03045276|450367010|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
125203242|NCT03045276|450367007|FG000|Follow-Up Phase|Lost to Follow-up|0|||
125203243|NCT03045276|450367008|FG001|Follow-Up Phase|Lost to Follow-up|1|||
125203244|NCT03045276|450367009|FG002|Follow-Up Phase|Lost to Follow-up|0|||
125203245|NCT03045276|450367010|FG003|Follow-Up Phase|Lost to Follow-up|1|||
125203246|NCT03045276|450367007|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
125203247|NCT03045276|450367008|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
125203248|NCT03045276|450367009|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
125203249|NCT03045276|450367010|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
125203250|NCT00347919|450367011|FG000|Overall Study|Lost to Follow-up|11|||
125203251|NCT00347919|450367012|FG001|Overall Study|Lost to Follow-up|13|||
125203252|NCT00347919|450367013|FG002|Overall Study|Lost to Follow-up|0|||
125203253|NCT00347919|450367011|FG000|Overall Study|Withdrawal by Subject|6|||
125203254|NCT00347919|450367012|FG001|Overall Study|Withdrawal by Subject|8|||
125203255|NCT00347919|450367013|FG002|Overall Study|Withdrawal by Subject|0|||
125203256|NCT00347919|450367011|FG000|Overall Study|Physician Decision|1|||
125203257|NCT00347919|450367012|FG001|Overall Study|Physician Decision|1|||
125203258|NCT00347919|450367013|FG002|Overall Study|Physician Decision|0|||
125203259|NCT00347919|450367011|FG000|Overall Study|Sponsor terminated study|15|||
125203260|NCT00347919|450367012|FG001|Overall Study|Sponsor terminated study|10|||
125203261|NCT00347919|450367013|FG002|Overall Study|Sponsor terminated study|16|||
125203262|NCT00347919|450367011|FG000|Overall Study|Death|35|||
125203263|NCT00347919|450367012|FG001|Overall Study|Death|42|||
125203264|NCT00347919|450367013|FG002|Overall Study|Death|19|||
125203265|NCT00347919|450367011|FG000|Overall Study|Par. Started Other Treatment|1|||
125203266|NCT00347919|450367012|FG001|Overall Study|Par. Started Other Treatment|1|||
125203267|NCT00347919|450367013|FG002|Overall Study|Par. Started Other Treatment|1|||
125203268|NCT00347919|450367011|FG000|Overall Study|Missing|2|||
125203269|NCT00347919|450367012|FG001|Overall Study|Missing|1|||
125203270|NCT00347919|450367013|FG002|Overall Study|Missing|2|||
125203271|NCT03379753|450367014|FG000|Overall Study|Withdrawal by Subject|2|||
125203272|NCT03379753|450367015|FG001|Overall Study|Withdrawal by Subject|1|||
125203273|NCT03379753|450367014|FG000|Overall Study|not having correct procedure|1|||
125203274|NCT03379753|450367015|FG001|Overall Study|not having correct procedure|2|||
125203275|NCT03379753|450367014|FG000|Overall Study|No primary outcome|12|||
125203276|NCT03379753|450367015|FG001|Overall Study|No primary outcome|22|||
125203277|NCT01032239|450367016|FG000|Overall Study|Lost to Follow-up|3|||
125203278|NCT01032239|450367017|FG001|Overall Study|Lost to Follow-up|2|||
125203279|NCT01032239|450367016|FG000|Overall Study|Withdrawal by Subject|2|||
125203280|NCT01032239|450367017|FG001|Overall Study|Withdrawal by Subject|3|||
125203281|NCT01032239|450367016|FG000|Overall Study|Death|1|||
125203282|NCT01032239|450367017|FG001|Overall Study|Death|0|||
125203283|NCT01032239|450367016|FG000|Overall Study|Protocol Violation|1|||
125203284|NCT01032239|450367017|FG001|Overall Study|Protocol Violation|0|||
125203285|NCT01940900|450367024|FG000|Overall Study|Physician Decision|4|||
125203286|NCT01940900|450367025|FG001|Overall Study|Physician Decision|0|||
125203287|NCT01940900|450367024|FG000|Overall Study|Adverse Event|10|||
125203288|NCT01940900|450367025|FG001|Overall Study|Adverse Event|15|||
125203289|NCT01940900|450367024|FG000|Overall Study|Withdrawal by Subject|11|||
125203290|NCT01940900|450367025|FG001|Overall Study|Withdrawal by Subject|15|||
125203291|NCT01940900|450367024|FG000|Overall Study|Lost to Follow-up|1|||
125203292|NCT01940900|450367025|FG001|Overall Study|Lost to Follow-up|0|||
125203293|NCT01940900|450367024|FG000|Overall Study|Sponsor Decision|1|||
125203294|NCT01940900|450367025|FG001|Overall Study|Sponsor Decision|0|||
125203295|NCT01940900|450367024|FG000|Overall Study|subject non-compliance|1|||
125203296|NCT01940900|450367025|FG001|Overall Study|subject non-compliance|1|||
125203297|NCT01940900|450367024|FG000|Overall Study|other|1|||
125203298|NCT01940900|450367025|FG001|Overall Study|other|0|||
125203299|NCT02225366|450367026|FG000|Overall Study|Lack of Efficacy|1|||
125203300|NCT02225366|450367027|FG001|Overall Study|Lack of Efficacy|0|||
125203301|NCT03782298|450367039|FG000|Overall Study|Protocol Deviation|4|||
125203302|NCT01382225|450367040|FG000|Overall Study|Adverse Event|3|||
125203303|NCT01382225|450367041|FG001|Overall Study|Adverse Event|2|||
125203304|NCT01382225|450367040|FG000|Overall Study|Protocol Violation|2|||
125203305|NCT01382225|450367041|FG001|Overall Study|Protocol Violation|1|||
125203306|NCT01382225|450367040|FG000|Overall Study|Subject Withdrew Consent|5|||
125203307|NCT01382225|450367041|FG001|Overall Study|Subject Withdrew Consent|2|||
125203308|NCT01382225|450367040|FG000|Overall Study|Other|4|||
125203309|NCT01382225|450367041|FG001|Overall Study|Other|2|||
125203310|NCT01797081|450367044|FG000|Overall Study|Adverse Event|1|||
125203311|NCT01797081|450367045|FG001|Overall Study|Adverse Event|0|||
125203312|NCT01797081|450367046|FG002|Overall Study|Adverse Event|1|||
125203313|NCT01797081|450367047|FG003|Overall Study|Adverse Event|0|||
125203314|NCT01797081|450367044|FG000|Overall Study|Pregnancy|1|||
125203315|NCT01797081|450367045|FG001|Overall Study|Pregnancy|0|||
125203316|NCT01797081|450367046|FG002|Overall Study|Pregnancy|0|||
125203317|NCT01797081|450367047|FG003|Overall Study|Pregnancy|0|||
125203318|NCT01797081|450367044|FG000|Overall Study|Personal Reasons|12|||
125203319|NCT01797081|450367045|FG001|Overall Study|Personal Reasons|4|||
125203320|NCT01797081|450367046|FG002|Overall Study|Personal Reasons|4|||
125203321|NCT01797081|450367047|FG003|Overall Study|Personal Reasons|8|||
125203322|NCT01797081|450367044|FG000|Overall Study|Protocol Violation|0|||
125203323|NCT01797081|450367045|FG001|Overall Study|Protocol Violation|0|||
125203324|NCT01797081|450367046|FG002|Overall Study|Protocol Violation|0|||
125203325|NCT01797081|450367047|FG003|Overall Study|Protocol Violation|1|||
125203326|NCT03617861|450368707|FG000|Second Intervention (1 Day)|Adverse Event|0|||
125203327|NCT03617861|450368708|FG001|Second Intervention (1 Day)|Adverse Event|0|||
125203328|NCT03617861|450368709|FG002|Second Intervention (1 Day)|Adverse Event|1|||
125203329|NCT03617861|450368710|FG003|Second Intervention (1 Day)|Adverse Event|0|||
125203330|NCT00623597|450368711|FG000|Overall Study|Failed to return|1|||
125203331|NCT00623597|450368712|FG001|Overall Study|Failed to return|0|||
125203332|NCT02515994|450368713|FG000|Overall Study|Protocol Violation|3|||
125203333|NCT02515994|450368714|FG001|Overall Study|Protocol Violation|5|||
125203334|NCT02515994|450368713|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
125203335|NCT02515994|450368714|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
125203336|NCT02515994|450368713|FG000|Overall Study|Adverse Event|3|||
125203337|NCT02515994|450368714|FG001|Overall Study|Adverse Event|1|||
125203338|NCT02515994|450368713|FG000|Overall Study|Withdrawal by Subject|2|||
125203339|NCT02515994|450368714|FG001|Overall Study|Withdrawal by Subject|0|||
125203340|NCT01668966|450368724|FG000|Overall Study|Withdrawal by Subject|1|||
125203341|NCT01668966|450368724|FG000|Overall Study|Death|1|||
125203342|NCT01668966|450368724|FG000|Overall Study|Not treated|2|||
125203343|NCT00552032|450368726|FG000|Overall Study|Withdrawal by Subject|2|||
125203344|NCT00552032|450368727|FG001|Overall Study|Withdrawal by Subject|2|||
125203345|NCT00552032|450368726|FG000|Overall Study|Protocol Violation|7|||
125203346|NCT00552032|450368727|FG001|Overall Study|Protocol Violation|12|||
125203347|NCT00552032|450368726|FG000|Overall Study|Lost to Follow-up|8|||
125203348|NCT00552032|450368727|FG001|Overall Study|Lost to Follow-up|5|||
125203349|NCT00345878|450368728|FG000|Overall Study|Adverse Event|1|||
125203350|NCT00345878|450368729|FG001|Overall Study|Adverse Event|0|||
125203351|NCT00345878|450368728|FG000|Overall Study|Lost to Follow-up|2|||
125203352|NCT00345878|450368729|FG001|Overall Study|Lost to Follow-up|1|||
125203353|NCT00345878|450368728|FG000|Overall Study|Other|1|||
125203354|NCT00345878|450368729|FG001|Overall Study|Other|0|||
125203355|NCT01643798|450368730|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
125203356|NCT01643798|450368731|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
125203357|NCT00984061|450368737|FG000|Clarithromycin Alone|Protocol Violation|1|||
125203358|NCT00614120|450368739|FG000|Overall Study|Adverse Event|9|||
125203359|NCT00614120|450368740|FG001|Overall Study|Adverse Event|22|||
125203360|NCT00614120|450368741|FG002|Overall Study|Adverse Event|30|||
125203361|NCT00614120|450368742|FG003|Overall Study|Adverse Event|3|||
125203362|NCT00614120|450368739|FG000|Overall Study|Lack of Efficacy|3|||
125203363|NCT00614120|450368740|FG001|Overall Study|Lack of Efficacy|3|||
125203364|NCT00614120|450368741|FG002|Overall Study|Lack of Efficacy|2|||
125203365|NCT00614120|450368742|FG003|Overall Study|Lack of Efficacy|2|||
125203366|NCT00614120|450368739|FG000|Overall Study|Protocol Violation|2|||
125203367|NCT00614120|450368740|FG001|Overall Study|Protocol Violation|5|||
125203368|NCT00614120|450368741|FG002|Overall Study|Protocol Violation|3|||
125203369|NCT00614120|450368742|FG003|Overall Study|Protocol Violation|1|||
125203370|NCT00614120|450368739|FG000|Overall Study|Withdrawal criteria|1|||
125203371|NCT00614120|450368740|FG001|Overall Study|Withdrawal criteria|0|||
125203372|NCT00614120|450368741|FG002|Overall Study|Withdrawal criteria|0|||
125203373|NCT00614120|450368742|FG003|Overall Study|Withdrawal criteria|0|||
125203374|NCT00614120|450368739|FG000|Overall Study|Withdrawal by Subject|9|||
125203375|NCT00614120|450368740|FG001|Overall Study|Withdrawal by Subject|10|||
125203376|NCT00614120|450368741|FG002|Overall Study|Withdrawal by Subject|16|||
125203377|NCT00614120|450368742|FG003|Overall Study|Withdrawal by Subject|3|||
125203378|NCT00614120|450368739|FG000|Overall Study|Did not meet trial criteria|0|||
125203379|NCT00614120|450368740|FG001|Overall Study|Did not meet trial criteria|1|||
125203380|NCT00614120|450368741|FG002|Overall Study|Did not meet trial criteria|1|||
125203381|NCT00614120|450368742|FG003|Overall Study|Did not meet trial criteria|1|||
125203382|NCT00614120|450368739|FG000|Overall Study|hCG positive (not pregnant)|0|||
125203383|NCT00614120|450368740|FG001|Overall Study|hCG positive (not pregnant)|0|||
125203384|NCT00614120|450368741|FG002|Overall Study|hCG positive (not pregnant)|1|||
125203385|NCT00614120|450368742|FG003|Overall Study|hCG positive (not pregnant)|0|||
125203386|NCT00614120|450368739|FG000|Overall Study|Hypoglycaemia|0|||
125203387|NCT00614120|450368740|FG001|Overall Study|Hypoglycaemia|0|||
125203388|NCT00614120|450368741|FG002|Overall Study|Hypoglycaemia|0|||
125203389|NCT00614120|450368742|FG003|Overall Study|Hypoglycaemia|1|||
125203390|NCT00614120|450368739|FG000|Overall Study|Lack of trial product|3|||
125203391|NCT00614120|450368740|FG001|Overall Study|Lack of trial product|3|||
125203392|NCT00614120|450368741|FG002|Overall Study|Lack of trial product|2|||
125203393|NCT00614120|450368742|FG003|Overall Study|Lack of trial product|0|||
125203394|NCT00614120|450368739|FG000|Overall Study|Late syphilis, latent|1|||
125203395|NCT00614120|450368740|FG001|Overall Study|Late syphilis, latent|0|||
125203396|NCT00614120|450368741|FG002|Overall Study|Late syphilis, latent|0|||
125203397|NCT00614120|450368742|FG003|Overall Study|Late syphilis, latent|0|||
125203398|NCT00614120|450368739|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
125203399|NCT00614120|450368740|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
125203400|NCT00614120|450368741|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
125203401|NCT00614120|450368742|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
125203402|NCT00614120|450368739|FG000|Overall Study|Lost to Follow-up|1|||
125203403|NCT00614120|450368740|FG001|Overall Study|Lost to Follow-up|2|||
125203404|NCT00614120|450368741|FG002|Overall Study|Lost to Follow-up|3|||
125203405|NCT00614120|450368742|FG003|Overall Study|Lost to Follow-up|4|||
125203406|NCT03602391|450368749|FG000|Overall Study|COVID-19|7|||
125203407|NCT03602391|450368750|FG001|Overall Study|COVID-19|6|||
125203408|NCT00819780|450368755|FG000|Overall Study|Did not receive study drug|3|||
125203409|NCT00819780|450368756|FG001|Overall Study|Did not receive study drug|4|||
125203410|NCT00819780|450368755|FG000|Overall Study|Still in treatment|25|||
125203411|NCT00819780|450368756|FG001|Overall Study|Still in treatment|17|||
125203412|NCT01793688|450368757|FG000|Overall Study|Protocol Violation|2|||
125203413|NCT02484651|450368760|FG000|Overall Study|Patients' data files were corrupted.|1|||
125203414|NCT02484651|450368761|FG001|Overall Study|Patients' data files were corrupted.|1|||
125203415|NCT02484651|450368760|FG000|Overall Study|BIS monitoring failed.|1|||
125203416|NCT02484651|450368761|FG001|Overall Study|BIS monitoring failed.|1|||
125203417|NCT02484651|450368760|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
125203418|NCT02484651|450368761|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
125203419|NCT00150800|450368762|FG000|Overall Study|Adverse Event|89|||
125203420|NCT00150800|450368762|FG000|Overall Study|Death|18|||
125203421|NCT00150800|450368762|FG000|Overall Study|Lack of Efficacy|166|||
125203422|NCT00150800|450368762|FG000|Overall Study|Lost to Follow-up|58|||
125203423|NCT00150800|450368762|FG000|Overall Study|Subject's choice|90|||
125203424|NCT00150800|450368762|FG000|Overall Study|No compliance|18|||
125203425|NCT00150800|450368762|FG000|Overall Study|IP misshandling|1|||
125203426|NCT00150800|450368762|FG000|Overall Study|Site closure|24|||
125203427|NCT00150800|450368762|FG000|Overall Study|Protocol non-adherence|2|||
125203428|NCT00150800|450368762|FG000|Overall Study|Nobody to accompany patient|1|||
125203429|NCT00150800|450368762|FG000|Overall Study|Distance too long for patient|1|||
125203430|NCT00150800|450368762|FG000|Overall Study|Neurosurgery|2|||
125203431|NCT00150800|450368762|FG000|Overall Study|BRV monotherapy|1|||
125203432|NCT00150800|450368762|FG000|Overall Study|Visit refusal|3|||
125203433|NCT00150800|450368762|FG000|Overall Study|Sponsor's request|2|||
125203434|NCT00150800|450368762|FG000|Overall Study|Generalized Epilepsy|1|||
125203435|NCT00150800|450368762|FG000|Overall Study|Moved from area/country|8|||
125203436|NCT00150800|450368762|FG000|Overall Study|PI retiring|2|||
125203437|NCT00150800|450368762|FG000|Overall Study|PI leaving site|2|||
125203438|NCT00150800|450368762|FG000|Overall Study|Patient insurance|1|||
125203439|NCT00150800|450368762|FG000|Overall Study|Surgical intervention|4|||
125203440|NCT00150800|450368762|FG000|Overall Study|Pregnancy planned|1|||
125203441|NCT00150800|450368762|FG000|Overall Study|PI discontinuation request|1|||
125203442|NCT01698879|450368763|FG000|Overall Study|Withdrawal by Subject|1|||
125203443|NCT01698879|450368764|FG001|Overall Study|Withdrawal by Subject|0|||
125203444|NCT01698879|450368765|FG002|Overall Study|Withdrawal by Subject|0|||
125203445|NCT04972968|450368766|FG000|Overall Study|Adverse Event|3|||
125203446|NCT04972968|450368767|FG001|Overall Study|Adverse Event|1|||
125203447|NCT04972968|450368768|FG002|Overall Study|Adverse Event|1|||
125203448|NCT04972968|450368769|FG003|Overall Study|Adverse Event|7|||
125203449|NCT04972968|450368766|FG000|Overall Study|Lack of Efficacy|2|||
125203450|NCT04972968|450368767|FG001|Overall Study|Lack of Efficacy|1|||
125203451|NCT04972968|450368768|FG002|Overall Study|Lack of Efficacy|0|||
125203452|NCT04972968|450368769|FG003|Overall Study|Lack of Efficacy|0|||
125203453|NCT04972968|450368766|FG000|Overall Study|Withdrawal by Subject|7|||
125203454|NCT04972968|450368767|FG001|Overall Study|Withdrawal by Subject|4|||
125203455|NCT04972968|450368768|FG002|Overall Study|Withdrawal by Subject|3|||
125203456|NCT04972968|450368769|FG003|Overall Study|Withdrawal by Subject|2|||
125203457|NCT04972968|450368766|FG000|Overall Study|Study Terminated by Sponsor|25|||
125203458|NCT04972968|450368767|FG001|Overall Study|Study Terminated by Sponsor|28|||
125203459|NCT04972968|450368768|FG002|Overall Study|Study Terminated by Sponsor|32|||
125203460|NCT04972968|450368769|FG003|Overall Study|Study Terminated by Sponsor|27|||
125203461|NCT04972968|450368766|FG000|Overall Study|Other|1|||
125203462|NCT04972968|450368767|FG001|Overall Study|Other|0|||
125203463|NCT04972968|450368768|FG002|Overall Study|Other|1|||
125203464|NCT04972968|450368769|FG003|Overall Study|Other|1|||
125203465|NCT02375555|450368777|FG000|Induction Period|Adverse Event|7|||
125203466|NCT02375555|450368777|FG000|Induction Period|Withdrawal by Subject|2|||
125203467|NCT02375555|450368777|FG000|Induction Period|Other|1|||
125203468|NCT02375555|450368777|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
125203469|NCT02375555|450368777|FG000|Maintenance Period|Adverse Event|2|||
125203470|NCT02375555|450368777|FG000|Maintenance Period|Withdrawal by Subject|4|||
125203471|NCT02375555|450368777|FG000|Maintenance Period|Death|1|||
125203472|NCT02375555|450368777|FG000|Maintenance Period|Disease Progression|5|||
125203473|NCT02375555|450368777|FG000|Maintenance Period|Patient Non-compliance|1|||
125203474|NCT02375555|450368777|FG000|Maintenance Period|Still on maintenance|16|||
125203475|NCT01744184|450368789|FG000|Overall Study|Adverse Event|1|||
125203476|NCT01744184|450368790|FG001|Overall Study|Adverse Event|0|||
125203477|NCT01744184|450368789|FG000|Overall Study|Withdrawal by Subject|0|||
125203478|NCT01744184|450368790|FG001|Overall Study|Withdrawal by Subject|1|||
125203479|NCT01263782|450368798|FG000|Overall Study|Death|0|||
125203480|NCT01263782|450368799|FG001|Overall Study|Death|0|||
125203481|NCT01263782|450368800|FG002|Overall Study|Death|1|||
125203482|NCT01263782|450368801|FG003|Overall Study|Death|0|||
125203483|NCT01263782|450368798|FG000|Overall Study|Progressive disease|0|||
125203484|NCT01263782|450368799|FG001|Overall Study|Progressive disease|0|||
125203485|NCT01263782|450368800|FG002|Overall Study|Progressive disease|0|||
125203486|NCT01263782|450368801|FG003|Overall Study|Progressive disease|1|||
125203487|NCT01263782|450368798|FG000|Overall Study|Too early|0|||
125203488|NCT01263782|450368799|FG001|Overall Study|Too early|0|||
125203489|NCT01263782|450368800|FG002|Overall Study|Too early|1|||
125203490|NCT01263782|450368801|FG003|Overall Study|Too early|0|||
125203491|NCT01263782|450368798|FG000|Overall Study|Inevaluable|0|||
125203492|NCT01263782|450368799|FG001|Overall Study|Inevaluable|0|||
125203493|NCT01263782|450368800|FG002|Overall Study|Inevaluable|1|||
125203494|NCT01263782|450368801|FG003|Overall Study|Inevaluable|0|||
125203495|NCT04545567|450368803|FG000|Overall Study|tested positive for SARS-co-V2|1|||
125203496|NCT04545567|450368804|FG001|Overall Study|tested positive for SARS-co-V2|1|||
125203497|NCT04545567|450368803|FG000|Overall Study|Withdrawal by Subject|0|||
125203498|NCT04545567|450368804|FG001|Overall Study|Withdrawal by Subject|1|||
125203499|NCT02419612|450368811|FG000|Short-term Treatment Period|Adverse Event|1|||
125203500|NCT02419612|450368812|FG001|Short-term Treatment Period|Adverse Event|1|||
125203501|NCT02419612|450368811|FG000|Short-term Treatment Period|Death|0|||
125203502|NCT02419612|450368812|FG001|Short-term Treatment Period|Death|2|||
125203503|NCT02419612|450368811|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
125203504|NCT02419612|450368812|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
125203505|NCT02419612|450368811|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
125203506|NCT02419612|450368812|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
125203507|NCT02419612|450368811|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
125203508|NCT02419612|450368812|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
125203509|NCT02419612|450368811|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
125203510|NCT02419612|450368812|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
125203511|NCT02419612|450368811|FG000|Short-term Treatment Period|Worsening of liver function|0|||
125203512|NCT02419612|450368812|FG001|Short-term Treatment Period|Worsening of liver function|1|||
125203513|NCT02419612|450368811|FG000|Short-term Treatment Period|Subject moved out of state|0|||
125203514|NCT02419612|450368812|FG001|Short-term Treatment Period|Subject moved out of state|1|||
125203515|NCT02419612|450368811|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
125203516|NCT02419612|450368812|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
125203517|NCT02419612|450368811|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
125203518|NCT02419612|450368812|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
125203519|NCT02419612|450368811|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
125203520|NCT02419612|450368812|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
125203521|NCT02419612|450368811|FG000|Long-term Treatment Period|Death|0|||
125203522|NCT02419612|450368812|FG001|Long-term Treatment Period|Death|1|||
125203523|NCT02419612|450368811|FG000|Long-term Treatment Period|Adverse Event|0|||
125203524|NCT02419612|450368812|FG001|Long-term Treatment Period|Adverse Event|5|||
125203525|NCT02419612|450368811|FG000|Long-term Treatment Period|Other|4|||
125203526|NCT02419612|450368812|FG001|Long-term Treatment Period|Other|4|||
125203527|NCT02419612|450368811|FG000|Long-term Treatment Period|Subject Decision|2|||
125203528|NCT02419612|450368812|FG001|Long-term Treatment Period|Subject Decision|4|||
125203529|NCT02419612|450368811|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
125203530|NCT02419612|450368812|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
125203531|NCT01095978|450368813|FG000|Overall Study|Did not take Klacid SR|2|||
125203532|NCT01095978|450368813|FG000|Overall Study|Adverse Event|1|||
125203533|NCT02135107|450368814|FG000|Treatment Period|Withdrawal by Subject|11|||
125203534|NCT02135107|450368815|FG001|Treatment Period|Withdrawal by Subject|0|||
125203535|NCT02135107|450368816|FG002|Treatment Period|Withdrawal by Subject|0|||
125203536|NCT02135107|450368817|FG003|Treatment Period|Withdrawal by Subject|0|||
125203537|NCT02135107|450368814|FG000|Treatment Period|Adverse Event|5|||
125203538|NCT02135107|450368815|FG001|Treatment Period|Adverse Event|2|||
125203539|NCT02135107|450368816|FG002|Treatment Period|Adverse Event|0|||
125203540|NCT02135107|450368817|FG003|Treatment Period|Adverse Event|0|||
125203541|NCT02135107|450368814|FG000|Treatment Period|Pregnancy|1|||
125203542|NCT02135107|450368815|FG001|Treatment Period|Pregnancy|0|||
125203543|NCT02135107|450368816|FG002|Treatment Period|Pregnancy|0|||
125203544|NCT02135107|450368817|FG003|Treatment Period|Pregnancy|0|||
125203545|NCT02135107|450368814|FG000|Treatment Period|Other|115|||
125203546|NCT02135107|450368815|FG001|Treatment Period|Other|24|||
125203547|NCT02135107|450368816|FG002|Treatment Period|Other|0|||
125203548|NCT02135107|450368817|FG003|Treatment Period|Other|0|||
125203549|NCT02135107|450368814|FG000|Maintenance Therapy Period|Adverse Event|0|||
125203550|NCT02135107|450368815|FG001|Maintenance Therapy Period|Adverse Event|0|||
125646683|NCT04225026|451990139|FG000|Overall Study|Withdrawal by Subject|4|||
125646684|NCT04225026|451990139|FG000|Overall Study|Adverse Event|1|||
125646685|NCT04225026|451990139|FG000|Overall Study|Other|1|||
125646686|NCT04225026|451990139|FG000|Overall Study|Death|11|||
125646687|NCT04225026|451990139|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
125646688|NCT00779142|451990140|FG000|Overall Study|Screen Failures|3|||
125646689|NCT00672490|451990141|FG000|Overall Study|Withdrawal by Subject|8|||
125646690|NCT00672490|451990142|FG001|Overall Study|Withdrawal by Subject|8|||
125646691|NCT00672490|451990141|FG000|Overall Study|Lack of Compliance|2|||
125646692|NCT00672490|451990142|FG001|Overall Study|Lack of Compliance|7|||
125646693|NCT00672490|451990141|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
125646694|NCT00672490|451990142|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
125646695|NCT00672490|451990141|FG000|Overall Study|Adverse Event|5|||
125646696|NCT00672490|451990142|FG001|Overall Study|Adverse Event|8|||
125646697|NCT00672490|451990141|FG000|Overall Study|Violation of Concomitant Medicine|1|||
125646698|NCT00672490|451990142|FG001|Overall Study|Violation of Concomitant Medicine|0|||
125646699|NCT00672490|451990141|FG000|Overall Study|Intolerance|0|||
125646700|NCT00672490|451990142|FG001|Overall Study|Intolerance|2|||
125646701|NCT00672490|451990141|FG000|Overall Study|Lost to Follow-up|1|||
125646702|NCT00672490|451990142|FG001|Overall Study|Lost to Follow-up|5|||
125646703|NCT00672490|451990141|FG000|Overall Study|No reason was provided|6|||
125646704|NCT00672490|451990142|FG001|Overall Study|No reason was provided|2|||
125646705|NCT04533204|451990145|FG000|Overall Study|Unable to understand training instructions|1|||
125646706|NCT04533204|451990146|FG001|Overall Study|Unable to understand training instructions|1|||
125646707|NCT03982069|451990147|FG000|Overall Study|Lost to Follow-up|5|||
125646708|NCT03982069|451990148|FG001|Overall Study|Lost to Follow-up|5|||
125646709|NCT03982069|451990149|FG002|Overall Study|Lost to Follow-up|3|||
125646710|NCT03982069|451990150|FG003|Overall Study|Lost to Follow-up|5|||
125646711|NCT03982069|451990147|FG000|Overall Study|Physician Decision|0|||
125646712|NCT03982069|451990148|FG001|Overall Study|Physician Decision|1|||
125646713|NCT03982069|451990149|FG002|Overall Study|Physician Decision|0|||
125646714|NCT03982069|451990150|FG003|Overall Study|Physician Decision|0|||
125646715|NCT03982069|451990147|FG000|Overall Study|Withdrawal by Subject|2|||
125646716|NCT03982069|451990148|FG001|Overall Study|Withdrawal by Subject|1|||
125646717|NCT03982069|451990149|FG002|Overall Study|Withdrawal by Subject|5|||
125646718|NCT03982069|451990150|FG003|Overall Study|Withdrawal by Subject|2|||
125646719|NCT03982069|451990147|FG000|Overall Study|Specimen loss|3|||
125646720|NCT03982069|451990148|FG001|Overall Study|Specimen loss|3|||
125646721|NCT03982069|451990149|FG002|Overall Study|Specimen loss|1|||
125646722|NCT03982069|451990150|FG003|Overall Study|Specimen loss|1|||
125646723|NCT01218477|451990151|FG000|Overall Study|Disease progression|2|||
125203551|NCT02135107|450368816|FG002|Maintenance Therapy Period|Adverse Event|3|||
125203552|NCT02135107|450368817|FG003|Maintenance Therapy Period|Adverse Event|7|||
125203553|NCT02135107|450368814|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
125203554|NCT02135107|450368815|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
125646724|NCT01218477|451990152|FG001|Overall Study|Disease progression|3|||
125646725|NCT01218477|451990153|FG002|Overall Study|Disease progression|6|||
125646726|NCT01218477|451990154|FG003|Overall Study|Disease progression|2|||
125646727|NCT01218477|451990151|FG000|Overall Study|Study drug toxicity|0|||
125646728|NCT01218477|451990152|FG001|Overall Study|Study drug toxicity|2|||
125646729|NCT01218477|451990153|FG002|Overall Study|Study drug toxicity|5|||
125646730|NCT01218477|451990154|FG003|Overall Study|Study drug toxicity|0|||
125646731|NCT01218477|451990151|FG000|Overall Study|No longer meets study criteria|1|||
125646732|NCT01218477|451990152|FG001|Overall Study|No longer meets study criteria|0|||
125646733|NCT01218477|451990153|FG002|Overall Study|No longer meets study criteria|0|||
125646734|NCT01218477|451990154|FG003|Overall Study|No longer meets study criteria|0|||
125646735|NCT01218477|451990151|FG000|Overall Study|Withdrawal by Subject|0|||
125646736|NCT01218477|451990152|FG001|Overall Study|Withdrawal by Subject|0|||
125646737|NCT01218477|451990153|FG002|Overall Study|Withdrawal by Subject|1|||
125646738|NCT01218477|451990154|FG003|Overall Study|Withdrawal by Subject|0|||
125646739|NCT01218477|451990151|FG000|Overall Study|Prepared for cell transplantation|0|||
125646740|NCT01218477|451990152|FG001|Overall Study|Prepared for cell transplantation|1|||
125646741|NCT01218477|451990153|FG002|Overall Study|Prepared for cell transplantation|1|||
125646742|NCT01218477|451990154|FG003|Overall Study|Prepared for cell transplantation|0|||
125646743|NCT01218477|451990151|FG000|Overall Study|Administrative reason by sponsor|0|||
125203555|NCT02135107|450368816|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
125203556|NCT02135107|450368817|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
125203557|NCT02135107|450368814|FG000|Maintenance Therapy Period|Pregnancy|0|||
125203558|NCT02135107|450368815|FG001|Maintenance Therapy Period|Pregnancy|0|||
125646744|NCT01218477|451990152|FG001|Overall Study|Administrative reason by sponsor|0|||
125646745|NCT01218477|451990153|FG002|Overall Study|Administrative reason by sponsor|1|||
125646746|NCT01218477|451990154|FG003|Overall Study|Administrative reason by sponsor|0|||
125646747|NCT01218477|451990151|FG000|Overall Study|Maximum clinical benefit|0|||
125646748|NCT01218477|451990152|FG001|Overall Study|Maximum clinical benefit|2|||
125646749|NCT01218477|451990153|FG002|Overall Study|Maximum clinical benefit|0|||
125646750|NCT01218477|451990154|FG003|Overall Study|Maximum clinical benefit|0|||
125203559|NCT02135107|450368816|FG002|Maintenance Therapy Period|Pregnancy|0|||
125203560|NCT02135107|450368817|FG003|Maintenance Therapy Period|Pregnancy|1|||
125203561|NCT02135107|450368814|FG000|Maintenance Therapy Period|Other|0|||
125203562|NCT02135107|450368815|FG001|Maintenance Therapy Period|Other|0|||
125203563|NCT02135107|450368816|FG002|Maintenance Therapy Period|Other|7|||
125203564|NCT02135107|450368817|FG003|Maintenance Therapy Period|Other|8|||
125203565|NCT00474045|450368818|FG000|Overall Study|Adverse Event|18|||
125203566|NCT00474045|450368819|FG001|Overall Study|Adverse Event|8|||
125203567|NCT00474045|450368818|FG000|Overall Study|Unclassified|1|||
125203568|NCT00474045|450368819|FG001|Overall Study|Unclassified|3|||
125203569|NCT00474045|450368818|FG000|Overall Study|Lack of Efficacy|0|||
125203570|NCT00474045|450368819|FG001|Overall Study|Lack of Efficacy|9|||
125203571|NCT00474045|450368818|FG000|Overall Study|Lost to Follow-up|1|||
125203572|NCT00474045|450368819|FG001|Overall Study|Lost to Follow-up|1|||
125203573|NCT00474045|450368818|FG000|Overall Study|Protocol Violation|10|||
125203574|NCT00474045|450368819|FG001|Overall Study|Protocol Violation|12|||
125203575|NCT00474045|450368818|FG000|Overall Study|Withdrawal by Subject|16|||
125203576|NCT00474045|450368819|FG001|Overall Study|Withdrawal by Subject|18|||
125203577|NCT00474045|450368818|FG000|Overall Study|Withdrawal criteria|60|||
125203578|NCT00474045|450368819|FG001|Overall Study|Withdrawal criteria|50|||
125203579|NCT02009397|450368827|FG000|Overall Study|Protocol Violation|6|||
125203580|NCT02009397|450368827|FG000|Overall Study|Death|8|||
125203581|NCT02009397|450368827|FG000|Overall Study|Lost to Follow-up|6|||
125203582|NCT02278120|450368829|FG000|Treatment Period|Progressive disease|234|||
125203583|NCT02278120|450368830|FG001|Treatment Period|Progressive disease|260|||
125203584|NCT02278120|450368829|FG000|Treatment Period|Subject/guardian decision|23|||
125203585|NCT02278120|450368830|FG001|Treatment Period|Subject/guardian decision|20|||
125203586|NCT02278120|450368829|FG000|Treatment Period|Adverse Event|16|||
125203587|NCT02278120|450368830|FG001|Treatment Period|Adverse Event|14|||
125203588|NCT02278120|450368829|FG000|Treatment Period|Physician Decision|14|||
125203589|NCT02278120|450368830|FG001|Treatment Period|Physician Decision|27|||
125203590|NCT02278120|450368829|FG000|Treatment Period|Death|3|||
125203591|NCT02278120|450368830|FG001|Treatment Period|Death|3|||
125203592|NCT02278120|450368829|FG000|Treatment Period|Lost to Follow-up|2|||
125203593|NCT02278120|450368830|FG001|Treatment Period|Lost to Follow-up|0|||
125203594|NCT02278120|450368829|FG000|Treatment Period|Protocol deviation|0|||
125203595|NCT02278120|450368830|FG001|Treatment Period|Protocol deviation|2|||
125203596|NCT02278120|450368829|FG000|Treatment Period|Study terminated as per protocol|43|||
125203597|NCT02278120|450368830|FG001|Treatment Period|Study terminated as per protocol|11|||
125203598|NCT02278120|450368829|FG000|Post-treatment Efficacy Follow-up|Death|0|||
125203599|NCT02278120|450368830|FG001|Post-treatment Efficacy Follow-up|Death|1|||
125203600|NCT02278120|450368829|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
125203601|NCT02278120|450368830|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
125203602|NCT02278120|450368829|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
125203603|NCT02278120|450368830|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
125203604|NCT02278120|450368829|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
125203605|NCT02278120|450368830|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
125203606|NCT02278120|450368829|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125203607|NCT02278120|450368830|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125203608|NCT01966068|450368834|FG000|Overall Study|Withdrawal by Subject|57|||
125203609|NCT01966068|450368834|FG000|Overall Study|Lost to Follow-up|81|||
125203610|NCT00808639|450368837|FG000|Overall Study|Disease progression before surgery.|1|||
125203611|NCT00191282|450368842|FG000|Overall Study|Adverse Event|5|||
125203612|NCT00191282|450368843|FG001|Overall Study|Adverse Event|6|||
125203613|NCT00191282|450368842|FG000|Overall Study|Death|51|||
125203614|NCT00191282|450368843|FG001|Overall Study|Death|51|||
125203615|NCT00191282|450368842|FG000|Overall Study|Lack of Efficacy|11|||
125203616|NCT00191282|450368843|FG001|Overall Study|Lack of Efficacy|6|||
125203617|NCT00191282|450368842|FG000|Overall Study|Noncompliance|14|||
125203618|NCT00191282|450368843|FG001|Overall Study|Noncompliance|17|||
125203619|NCT00191282|450368842|FG000|Overall Study|Patient moved|11|||
125203620|NCT00191282|450368843|FG001|Overall Study|Patient moved|14|||
125203621|NCT00191282|450368842|FG000|Overall Study|Withdrawal by Subject|59|||
125203622|NCT00191282|450368843|FG001|Overall Study|Withdrawal by Subject|44|||
125203623|NCT00191282|450368842|FG000|Overall Study|Physician Decision|18|||
125203624|NCT00191282|450368843|FG001|Overall Study|Physician Decision|15|||
125203625|NCT00191282|450368842|FG000|Overall Study|Protocol entry criteria not met|14|||
125203626|NCT00191282|450368843|FG001|Overall Study|Protocol entry criteria not met|9|||
125203627|NCT00191282|450368842|FG000|Overall Study|Protocol Violation|9|||
125203628|NCT00191282|450368843|FG001|Overall Study|Protocol Violation|12|||
125203629|NCT00191282|450368842|FG000|Overall Study|Severity of outcome|2|||
125203630|NCT00191282|450368843|FG001|Overall Study|Severity of outcome|5|||
125203631|NCT00191282|450368842|FG000|Overall Study|Sponsor's decision|2|||
125203632|NCT00191282|450368843|FG001|Overall Study|Sponsor's decision|2|||
125203633|NCT00191282|450368842|FG000|Overall Study|Lost to Follow-up|24|||
125203634|NCT00191282|450368843|FG001|Overall Study|Lost to Follow-up|31|||
125203635|NCT00102531|450368844|FG000|Overall Study|Adverse Event|0|||
125203636|NCT00102531|450368845|FG001|Overall Study|Adverse Event|1|||
125203637|NCT00102531|450368844|FG000|Overall Study|Disease Progression|5|||
125203638|NCT00102531|450368845|FG001|Overall Study|Disease Progression|9|||
125203639|NCT00102531|450368844|FG000|Overall Study|Physician Decision|0|||
125203640|NCT00102531|450368845|FG001|Overall Study|Physician Decision|1|||
125203641|NCT04756154|450368847|FG000|Overall Study|Did not meet treatment day baseline|30|||
125203642|NCT04756154|450368848|FG001|Overall Study|Did not meet treatment day baseline|28|||
125203643|NCT04756154|450368849|FG002|Overall Study|Did not meet treatment day baseline|7|||
125203644|NCT04756154|450368847|FG000|Overall Study|Did not return for final sample collection|1|||
125203645|NCT04756154|450368848|FG001|Overall Study|Did not return for final sample collection|1|||
125203646|NCT04756154|450368849|FG002|Overall Study|Did not return for final sample collection|0|||
125203647|NCT01790828|450368851|FG000|Overall Study|Other|34|||
125203648|NCT03026530|450368856|FG000|Overall Study|Lost to Follow-up|19|||
125203649|NCT03026530|450368857|FG001|Overall Study|Lost to Follow-up|24|||
125203650|NCT03026530|450368856|FG000|Overall Study|Protocol Violation|2|||
125203651|NCT03026530|450368857|FG001|Overall Study|Protocol Violation|5|||
125203652|NCT03721835|450368858|FG000|Overall Study|Participant not able to return|1|||
125203653|NCT03721835|450368858|FG000|Overall Study|Lost to Follow-up|1|||
125203654|NCT03721835|450368858|FG000|Overall Study|Revision of the components of the study device|2|||
125203655|NCT03721835|450368858|FG000|Overall Study|Sponsor terminated study|6|||
125203656|NCT03721835|450368858|FG000|Overall Study|Death|1|||
125203657|NCT03721835|450368858|FG000|Overall Study|Sponsor decision|1|||
125203658|NCT05072964|450368863|FG000|Overall Study|Withdrawal by Subject|4|||
125203659|NCT05072964|450368863|FG000|Overall Study|Death|1|||
125203660|NCT03055494|450370218|FG000|Overall Study|Lost to Follow-up|6|||
125203661|NCT03055494|450370219|FG001|Overall Study|Lost to Follow-up|0|||
125203662|NCT03055494|450370218|FG000|Overall Study|Physician Decision|2|||
125203663|NCT03055494|450370219|FG001|Overall Study|Physician Decision|0|||
125203664|NCT03055494|450370218|FG000|Overall Study|Withdrawal by Subject|1|||
125203665|NCT03055494|450370219|FG001|Overall Study|Withdrawal by Subject|0|||
125203666|NCT03055494|450370218|FG000|Overall Study|Adverse Event|0|||
125203667|NCT03055494|450370219|FG001|Overall Study|Adverse Event|1|||
125203668|NCT03055494|450370218|FG000|Overall Study|Non-compliance with study treatment|1|||
125203669|NCT03055494|450370219|FG001|Overall Study|Non-compliance with study treatment|0|||
125203670|NCT05079750|450370220|FG000|Overall Study|Lost to Follow-up|0|||
125203671|NCT05079750|450370221|FG001|Overall Study|Lost to Follow-up|0|||
125203672|NCT05079750|450370222|FG002|Overall Study|Lost to Follow-up|1|||
125203673|NCT05897827|450370223|FG000|Overall Study|Lost to Follow-up|33|||
125203674|NCT05897827|450370224|FG001|Overall Study|Lost to Follow-up|14|||
125203675|NCT05897827|450370223|FG000|Overall Study|Withdrawal by Subject|1|||
125203676|NCT05897827|450370224|FG001|Overall Study|Withdrawal by Subject|1|||
125203677|NCT00197002|450370225|FG000|Overall Study|Adverse Event|0|||
125203678|NCT00197002|450370226|FG001|Overall Study|Adverse Event|1|||
125203679|NCT00197002|450370227|FG002|Overall Study|Adverse Event|0|||
125203680|NCT00197002|450370225|FG000|Overall Study|Protocol Violation|1|||
125203681|NCT00197002|450370226|FG001|Overall Study|Protocol Violation|0|||
125203682|NCT00197002|450370227|FG002|Overall Study|Protocol Violation|2|||
125203683|NCT00197002|450370225|FG000|Overall Study|Withdrawal by Subject|9|||
125203684|NCT00197002|450370226|FG001|Overall Study|Withdrawal by Subject|5|||
125203685|NCT00197002|450370227|FG002|Overall Study|Withdrawal by Subject|7|||
125203686|NCT00197002|450370225|FG000|Overall Study|Migrated/moved from study area|3|||
125203687|NCT00197002|450370226|FG001|Overall Study|Migrated/moved from study area|5|||
125203688|NCT00197002|450370227|FG002|Overall Study|Migrated/moved from study area|1|||
125203689|NCT00197002|450370225|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
125203690|NCT00197002|450370226|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
125203691|NCT00197002|450370227|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
125203692|NCT00197002|450370225|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
125203693|NCT00197002|450370226|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
125203694|NCT00197002|450370227|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
125203695|NCT00197002|450370225|FG000|Overall Study|Others|3|||
125203696|NCT00197002|450370226|FG001|Overall Study|Others|1|||
125203697|NCT00197002|450370227|FG002|Overall Study|Others|1|||
125203698|NCT02017717|450370228|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203699|NCT02017717|450370229|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203700|NCT02017717|450370230|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203701|NCT02017717|450370231|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203702|NCT02017717|450370232|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203703|NCT02017717|450370233|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203704|NCT02017717|450370234|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203705|NCT02017717|450370235|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
125203706|NCT02017717|450370236|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
125203707|NCT02017717|450370228|FG000|Before Treatment Period|Participant request to stop therapy|0|||
125203708|NCT02017717|450370229|FG001|Before Treatment Period|Participant request to stop therapy|0|||
125203709|NCT02017717|450370230|FG002|Before Treatment Period|Participant request to stop therapy|0|||
125203710|NCT02017717|450370231|FG003|Before Treatment Period|Participant request to stop therapy|0|||
125203711|NCT02017717|450370232|FG004|Before Treatment Period|Participant request to stop therapy|0|||
125203712|NCT02017717|450370233|FG005|Before Treatment Period|Participant request to stop therapy|0|||
125203713|NCT02017717|450370234|FG006|Before Treatment Period|Participant request to stop therapy|0|||
125203714|NCT02017717|450370235|FG007|Before Treatment Period|Participant request to stop therapy|0|||
125203715|NCT02017717|450370236|FG008|Before Treatment Period|Participant request to stop therapy|5|||
125203716|NCT02017717|450370228|FG000|Before Treatment Period|Participant withdrew consent|0|||
125203717|NCT02017717|450370229|FG001|Before Treatment Period|Participant withdrew consent|0|||
125203718|NCT02017717|450370230|FG002|Before Treatment Period|Participant withdrew consent|0|||
125203719|NCT02017717|450370231|FG003|Before Treatment Period|Participant withdrew consent|0|||
125203720|NCT02017717|450370232|FG004|Before Treatment Period|Participant withdrew consent|0|||
125203721|NCT02017717|450370233|FG005|Before Treatment Period|Participant withdrew consent|0|||
125203722|NCT02017717|450370234|FG006|Before Treatment Period|Participant withdrew consent|2|||
125203723|NCT02017717|450370235|FG007|Before Treatment Period|Participant withdrew consent|0|||
125203724|NCT02017717|450370236|FG008|Before Treatment Period|Participant withdrew consent|11|||
125203725|NCT02017717|450370228|FG000|Before Treatment Period|Lost to Follow-up|0|||
125203726|NCT02017717|450370229|FG001|Before Treatment Period|Lost to Follow-up|0|||
125203727|NCT02017717|450370230|FG002|Before Treatment Period|Lost to Follow-up|0|||
125203728|NCT02017717|450370231|FG003|Before Treatment Period|Lost to Follow-up|0|||
125203729|NCT02017717|450370232|FG004|Before Treatment Period|Lost to Follow-up|0|||
125203730|NCT02017717|450370233|FG005|Before Treatment Period|Lost to Follow-up|0|||
125203731|NCT02017717|450370234|FG006|Before Treatment Period|Lost to Follow-up|0|||
125203732|NCT02017717|450370235|FG007|Before Treatment Period|Lost to Follow-up|0|||
125203733|NCT02017717|450370236|FG008|Before Treatment Period|Lost to Follow-up|1|||
125203734|NCT02017717|450370228|FG000|Before Treatment Period|Participant no longer met criteria|0|||
125203735|NCT02017717|450370229|FG001|Before Treatment Period|Participant no longer met criteria|0|||
125203736|NCT02017717|450370230|FG002|Before Treatment Period|Participant no longer met criteria|0|||
125203737|NCT02017717|450370231|FG003|Before Treatment Period|Participant no longer met criteria|0|||
125203738|NCT02017717|450370232|FG004|Before Treatment Period|Participant no longer met criteria|0|||
125203739|NCT02017717|450370233|FG005|Before Treatment Period|Participant no longer met criteria|1|||
125203740|NCT02017717|450370234|FG006|Before Treatment Period|Participant no longer met criteria|0|||
125203741|NCT02017717|450370235|FG007|Before Treatment Period|Participant no longer met criteria|1|||
125203742|NCT02017717|450370236|FG008|Before Treatment Period|Participant no longer met criteria|2|||
125203743|NCT02017717|450370228|FG000|Before Treatment Period|other reason|0|||
125203744|NCT02017717|450370229|FG001|Before Treatment Period|other reason|0|||
125203745|NCT02017717|450370230|FG002|Before Treatment Period|other reason|0|||
125203746|NCT02017717|450370231|FG003|Before Treatment Period|other reason|0|||
125203747|NCT02017717|450370232|FG004|Before Treatment Period|other reason|0|||
125203748|NCT02017717|450370233|FG005|Before Treatment Period|other reason|0|||
125203749|NCT02017717|450370234|FG006|Before Treatment Period|other reason|0|||
125203750|NCT02017717|450370235|FG007|Before Treatment Period|other reason|0|||
125203751|NCT02017717|450370236|FG008|Before Treatment Period|other reason|1|||
125203752|NCT02017717|450370228|FG000|Treatment Period|Disease progression|7|||
125203753|NCT02017717|450370229|FG001|Treatment Period|Disease progression|9|||
125203754|NCT02017717|450370230|FG002|Treatment Period|Disease progression|12|||
125203755|NCT02017717|450370231|FG003|Treatment Period|Disease progression|20|||
125203756|NCT02017717|450370232|FG004|Treatment Period|Disease progression|26|||
125203757|NCT02017717|450370233|FG005|Treatment Period|Disease progression|16|||
125203758|NCT02017717|450370234|FG006|Treatment Period|Disease progression|22|||
125203759|NCT02017717|450370235|FG007|Treatment Period|Disease progression|165|||
125203760|NCT02017717|450370236|FG008|Treatment Period|Disease progression|135|||
125203761|NCT02017717|450370228|FG000|Treatment Period|Study drug toxicity|3|||
125203762|NCT02017717|450370229|FG001|Treatment Period|Study drug toxicity|0|||
125203763|NCT02017717|450370230|FG002|Treatment Period|Study drug toxicity|1|||
125203764|NCT02017717|450370231|FG003|Treatment Period|Study drug toxicity|4|||
125203765|NCT02017717|450370232|FG004|Treatment Period|Study drug toxicity|4|||
125203766|NCT02017717|450370233|FG005|Treatment Period|Study drug toxicity|5|||
125203767|NCT02017717|450370234|FG006|Treatment Period|Study drug toxicity|3|||
125203768|NCT02017717|450370235|FG007|Treatment Period|Study drug toxicity|7|||
125203769|NCT02017717|450370236|FG008|Treatment Period|Study drug toxicity|11|||
125203770|NCT02017717|450370228|FG000|Treatment Period|Death|0|||
125203771|NCT02017717|450370229|FG001|Treatment Period|Death|0|||
125203772|NCT02017717|450370230|FG002|Treatment Period|Death|1|||
125203773|NCT02017717|450370231|FG003|Treatment Period|Death|0|||
125203774|NCT02017717|450370232|FG004|Treatment Period|Death|0|||
125203775|NCT02017717|450370233|FG005|Treatment Period|Death|2|||
125203776|NCT02017717|450370234|FG006|Treatment Period|Death|0|||
125203777|NCT02017717|450370235|FG007|Treatment Period|Death|0|||
125203778|NCT02017717|450370236|FG008|Treatment Period|Death|0|||
125203779|NCT02017717|450370228|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
125203780|NCT02017717|450370229|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
125203781|NCT02017717|450370230|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
125203782|NCT02017717|450370231|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
125203783|NCT02017717|450370232|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
125203784|NCT02017717|450370233|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
125203785|NCT02017717|450370234|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
125203786|NCT02017717|450370235|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
125203787|NCT02017717|450370236|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
125203788|NCT02017717|450370228|FG000|Treatment Period|Participant request to stop therapy|0|||
125203789|NCT02017717|450370229|FG001|Treatment Period|Participant request to stop therapy|0|||
125203790|NCT02017717|450370230|FG002|Treatment Period|Participant request to stop therapy|3|||
125203791|NCT02017717|450370231|FG003|Treatment Period|Participant request to stop therapy|6|||
125203792|NCT02017717|450370232|FG004|Treatment Period|Participant request to stop therapy|0|||
125203793|NCT02017717|450370233|FG005|Treatment Period|Participant request to stop therapy|2|||
125203794|NCT02017717|450370234|FG006|Treatment Period|Participant request to stop therapy|1|||
125203795|NCT02017717|450370235|FG007|Treatment Period|Participant request to stop therapy|4|||
125203796|NCT02017717|450370236|FG008|Treatment Period|Participant request to stop therapy|7|||
125203797|NCT02017717|450370228|FG000|Treatment Period|Participant withdrew consent|0|||
125203798|NCT02017717|450370229|FG001|Treatment Period|Participant withdrew consent|0|||
125203799|NCT02017717|450370230|FG002|Treatment Period|Participant withdrew consent|1|||
125203800|NCT02017717|450370231|FG003|Treatment Period|Participant withdrew consent|0|||
125203801|NCT02017717|450370232|FG004|Treatment Period|Participant withdrew consent|0|||
125203802|NCT02017717|450370233|FG005|Treatment Period|Participant withdrew consent|2|||
125203803|NCT02017717|450370234|FG006|Treatment Period|Participant withdrew consent|0|||
125203804|NCT02017717|450370235|FG007|Treatment Period|Participant withdrew consent|1|||
125203805|NCT02017717|450370236|FG008|Treatment Period|Participant withdrew consent|4|||
125203806|NCT02017717|450370228|FG000|Treatment Period|Participant no longer met criteria|0|||
125203807|NCT02017717|450370229|FG001|Treatment Period|Participant no longer met criteria|0|||
125203808|NCT02017717|450370230|FG002|Treatment Period|Participant no longer met criteria|0|||
125203809|NCT02017717|450370231|FG003|Treatment Period|Participant no longer met criteria|0|||
125203810|NCT02017717|450370232|FG004|Treatment Period|Participant no longer met criteria|0|||
125203811|NCT02017717|450370233|FG005|Treatment Period|Participant no longer met criteria|0|||
125203812|NCT02017717|450370234|FG006|Treatment Period|Participant no longer met criteria|0|||
125203813|NCT02017717|450370235|FG007|Treatment Period|Participant no longer met criteria|0|||
125203814|NCT02017717|450370236|FG008|Treatment Period|Participant no longer met criteria|1|||
125203815|NCT02017717|450370228|FG000|Treatment Period|Other reasons|0|||
125203816|NCT02017717|450370229|FG001|Treatment Period|Other reasons|0|||
125203817|NCT02017717|450370230|FG002|Treatment Period|Other reasons|0|||
125203818|NCT02017717|450370231|FG003|Treatment Period|Other reasons|1|||
125203819|NCT02017717|450370232|FG004|Treatment Period|Other reasons|0|||
125203820|NCT02017717|450370233|FG005|Treatment Period|Other reasons|1|||
125203821|NCT02017717|450370234|FG006|Treatment Period|Other reasons|1|||
125203822|NCT02017717|450370235|FG007|Treatment Period|Other reasons|1|||
125203823|NCT02017717|450370236|FG008|Treatment Period|Other reasons|1|||
125203824|NCT02017717|450370228|FG000|Treatment Period|Maximum clinical benefit|0|||
125203825|NCT02017717|450370229|FG001|Treatment Period|Maximum clinical benefit|0|||
125646751|NCT03137433|451990155|FG000|Overall Study|Withdrawal by Subject|11|||
125203826|NCT02017717|450370230|FG002|Treatment Period|Maximum clinical benefit|0|||
125203827|NCT02017717|450370231|FG003|Treatment Period|Maximum clinical benefit|0|||
125203828|NCT02017717|450370232|FG004|Treatment Period|Maximum clinical benefit|0|||
125203829|NCT02017717|450370233|FG005|Treatment Period|Maximum clinical benefit|0|||
125203830|NCT02017717|450370234|FG006|Treatment Period|Maximum clinical benefit|0|||
125203831|NCT02017717|450370235|FG007|Treatment Period|Maximum clinical benefit|0|||
125203832|NCT02017717|450370236|FG008|Treatment Period|Maximum clinical benefit|1|||
125203833|NCT02017717|450370228|FG000|Treatment Period|Not reported|0|||
125203834|NCT02017717|450370229|FG001|Treatment Period|Not reported|1|||
125203835|NCT02017717|450370230|FG002|Treatment Period|Not reported|0|||
125203836|NCT02017717|450370231|FG003|Treatment Period|Not reported|0|||
125203837|NCT02017717|450370232|FG004|Treatment Period|Not reported|0|||
125203838|NCT02017717|450370233|FG005|Treatment Period|Not reported|0|||
125203839|NCT02017717|450370234|FG006|Treatment Period|Not reported|0|||
125203840|NCT02017717|450370235|FG007|Treatment Period|Not reported|0|||
125646752|NCT03137433|451990156|FG001|Overall Study|Withdrawal by Subject|11|||
125646753|NCT03137433|451990155|FG000|Overall Study|Lost to Follow-up|5|||
125203841|NCT02017717|450370236|FG008|Treatment Period|Not reported|0|||
125646754|NCT03137433|451990156|FG001|Overall Study|Lost to Follow-up|6|||
125203842|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
125203843|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
125203844|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
125203845|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
125203846|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
125203847|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
125203848|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
125203849|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
125203850|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
125203851|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
125203852|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
125203853|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
125203854|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
125203855|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
125203856|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
125203857|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
125203858|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
125203859|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
125203860|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
125203861|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
125203862|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
125203863|NCT04488419|450370241|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
125203864|NCT04488419|450370242|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
125203865|NCT04488419|450370243|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
125203866|NCT04488419|450370241|FG000|Primary Analysis Population|Adverse Event|6|||
125203867|NCT04488419|450370242|FG001|Primary Analysis Population|Adverse Event|9|||
125203868|NCT04488419|450370243|FG002|Primary Analysis Population|Adverse Event|0|||
125203869|NCT04488419|450370241|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
125203870|NCT04488419|450370242|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
125203871|NCT04488419|450370243|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
125203872|NCT04488419|450370241|FG000|Primary Analysis Population|Protocol Violation|1|||
125203873|NCT04488419|450370242|FG001|Primary Analysis Population|Protocol Violation|1|||
125203874|NCT04488419|450370243|FG002|Primary Analysis Population|Protocol Violation|0|||
125203875|NCT04488419|450370241|FG000|Primary Analysis Population|Undetermined|7|||
125203876|NCT04488419|450370242|FG001|Primary Analysis Population|Undetermined|3|||
125203877|NCT04488419|450370243|FG002|Primary Analysis Population|Undetermined|0|||
125203878|NCT04488419|450370241|FG000|Primary Analysis Population|>1 Reason|2|||
125203879|NCT04488419|450370242|FG001|Primary Analysis Population|>1 Reason|4|||
125203880|NCT04488419|450370243|FG002|Primary Analysis Population|>1 Reason|0|||
125203881|NCT02276053|450370246|FG000|Overall Study|Death|2|||
125203882|NCT02276053|450370246|FG000|Overall Study|Adverse Event|5|||
125203883|NCT02276053|450370246|FG000|Overall Study|Lack of Efficacy|2|||
125203884|NCT02276053|450370246|FG000|Overall Study|Withdrawal by Subject|1|||
125203885|NCT02276053|450370246|FG000|Overall Study|Patient does not meet selection criteria|3|||
125203886|NCT02276053|450370246|FG000|Overall Study|Patient needs to increase baseline AED|1|||
125203887|NCT04542499|450370249|FG000|Overall Study|Adverse Event|23|||
125203888|NCT04542499|450370250|FG001|Overall Study|Adverse Event|43|||
125203889|NCT04542499|450370249|FG000|Overall Study|Lack of Efficacy|5|||
125203890|NCT04542499|450370250|FG001|Overall Study|Lack of Efficacy|2|||
125203891|NCT04542499|450370249|FG000|Overall Study|Lost to Follow-up|3|||
125203892|NCT04542499|450370250|FG001|Overall Study|Lost to Follow-up|4|||
125203893|NCT04542499|450370249|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
125203894|NCT04542499|450370250|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
125203895|NCT04542499|450370249|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
125203896|NCT04542499|450370250|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
125203897|NCT04542499|450370249|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125203898|NCT04542499|450370250|FG001|Overall Study|Non-Compliance with Study Drug|2|||
125203899|NCT04542499|450370249|FG000|Overall Study|Physician Decision|0|||
125203900|NCT04542499|450370250|FG001|Overall Study|Physician Decision|1|||
125203901|NCT04542499|450370249|FG000|Overall Study|Site Terminated by Sponsor|3|||
125203902|NCT04542499|450370250|FG001|Overall Study|Site Terminated by Sponsor|5|||
125203903|NCT04542499|450370249|FG000|Overall Study|Withdrawal by Subject|12|||
125203904|NCT04542499|450370250|FG001|Overall Study|Withdrawal by Subject|33|||
125203905|NCT04542499|450370249|FG000|Overall Study|Other|2|||
125203906|NCT04542499|450370250|FG001|Overall Study|Other|2|||
125203907|NCT04161079|450370255|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
125203908|NCT03427268|450370259|FG000|Overall Study|Progressive disease|25|||
125203909|NCT03427268|450370259|FG000|Overall Study|Never treated|2|||
125203910|NCT03427268|450370259|FG000|Overall Study|Compassionate use|1|||
125203911|NCT03427268|450370259|FG000|Overall Study|Withdrawal by Subject|1|||
125203912|NCT03427268|450370259|FG000|Overall Study|Adverse Event|3|||
125203913|NCT03391232|450370260|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
125646755|NCT03137433|451990155|FG000|Overall Study|Physician Decision|2|||
125424870|NCT00430248|451178699|FG000|Overall Study|Withdrawal by Subject|14|||
125203914|NCT03391232|450370261|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
125203915|NCT03391232|450370260|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
125203916|NCT03391232|450370261|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
125203917|NCT01995175|450370262|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
125203918|NCT01995175|450370262|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
125203919|NCT01995175|450370262|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
125203920|NCT01995175|450370262|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
125203921|NCT01995175|450370262|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
125203922|NCT01995175|450370262|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
125203923|NCT01995175|450370262|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
125203924|NCT01995175|450370262|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
125203925|NCT01995175|450370262|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
125203926|NCT03047720|450370266|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
125203927|NCT03047720|450370267|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
125203928|NCT03729570|450370272|FG000|Overall Study|Lost to Follow-up|16|||
125203929|NCT03729570|450370273|FG001|Overall Study|Lost to Follow-up|20|||
125203930|NCT03729570|450370272|FG000|Overall Study|Seroconversion|5|||
125203931|NCT03729570|450370273|FG001|Overall Study|Seroconversion|0|||
125203932|NCT03729570|450370272|FG000|Overall Study|Moved out of the city|1|||
125203933|NCT03729570|450370273|FG001|Overall Study|Moved out of the city|0|||
125203934|NCT03729570|450370272|FG000|Overall Study|Time Conflict|1|||
125203935|NCT03729570|450370273|FG001|Overall Study|Time Conflict|0|||
125203936|NCT03729570|450370272|FG000|Overall Study|Time Commitment|2|||
125203937|NCT03729570|450370273|FG001|Overall Study|Time Commitment|0|||
125203938|NCT03729570|450370272|FG000|Overall Study|Bad Experience|0|||
125203939|NCT03729570|450370273|FG001|Overall Study|Bad Experience|1|||
125203940|NCT03729570|450370272|FG000|Overall Study|No reason provided|2|||
125203941|NCT03729570|450370273|FG001|Overall Study|No reason provided|1|||
125203942|NCT03729570|450370272|FG000|Overall Study|Family Conflict|0|||
125203943|NCT03729570|450370273|FG001|Overall Study|Family Conflict|1|||
125203944|NCT03729570|450370272|FG000|Overall Study|Did not want to continue taking medications|0|||
125203945|NCT03729570|450370273|FG001|Overall Study|Did not want to continue taking medications|1|||
125203946|NCT03729570|450370272|FG000|Overall Study|Found another PrEP provider|1|||
125203947|NCT03729570|450370273|FG001|Overall Study|Found another PrEP provider|0|||
125203948|NCT03729570|450370272|FG000|Overall Study|Did not enjoy being in the control group|0|||
125203949|NCT03729570|450370273|FG001|Overall Study|Did not enjoy being in the control group|1|||
125203950|NCT01482962|450370277|FG000|Overall Study|Progressive Disease|65|||
125203951|NCT01482962|450370278|FG001|Overall Study|Progressive Disease|53|||
125203952|NCT01482962|450370277|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
125203953|NCT01482962|450370278|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
125203954|NCT01482962|450370277|FG000|Overall Study|Adverse Event|18|||
125203955|NCT01482962|450370278|FG001|Overall Study|Adverse Event|22|||
125203956|NCT01482962|450370277|FG000|Overall Study|Withdrawal by Participant|8|||
125203957|NCT01482962|450370278|FG001|Overall Study|Withdrawal by Participant|13|||
125203958|NCT01482962|450370277|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
125203959|NCT01482962|450370278|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
125203960|NCT01482962|450370277|FG000|Overall Study|Other Reason|1|||
125203961|NCT01482962|450370278|FG001|Overall Study|Other Reason|5|||
125203962|NCT01482962|450370277|FG000|Overall Study|Study Terminated by Sponsor|5|||
125203963|NCT01482962|450370278|FG001|Overall Study|Study Terminated by Sponsor|2|||
125203964|NCT01482962|450370277|FG000|Overall Study|Did not Receive Study Drug|1|||
125203965|NCT01482962|450370278|FG001|Overall Study|Did not Receive Study Drug|6|||
125203966|NCT02407457|450370279|FG000|1 Month|Death|3|||
125203967|NCT02407457|450370280|FG001|1 Month|Death|0|||
125203968|NCT02407457|450370279|FG000|1 Month|Lost to Follow-up|1|||
125203969|NCT02407457|450370280|FG001|1 Month|Lost to Follow-up|1|||
125203970|NCT02407457|450370279|FG000|1 Month|missed visit|2|||
125203971|NCT02407457|450370280|FG001|1 Month|missed visit|5|||
125203972|NCT02407457|450370279|FG000|6-Month|Death|2|||
125203973|NCT02407457|450370280|FG001|6-Month|Death|8|||
125203974|NCT02407457|450370279|FG000|6-Month|Lost to Follow-up|2|||
125203975|NCT02407457|450370280|FG001|6-Month|Lost to Follow-up|2|||
125203976|NCT02407457|450370279|FG000|6-Month|missed visit|16|||
125203977|NCT02407457|450370280|FG001|6-Month|missed visit|14|||
125203978|NCT02407457|450370279|FG000|6-Month|Open Repair|0|||
125203979|NCT02407457|450370280|FG001|6-Month|Open Repair|1|||
125203980|NCT02407457|450370279|FG000|1 Year|Death|6|||
125203981|NCT02407457|450370280|FG001|1 Year|Death|11|||
125203982|NCT02407457|450370279|FG000|1 Year|Lost to Follow-up|3|||
125203983|NCT02407457|450370280|FG001|1 Year|Lost to Follow-up|2|||
125203984|NCT02407457|450370279|FG000|1 Year|Missed Visit|24|||
125203985|NCT02407457|450370280|FG001|1 Year|Missed Visit|14|||
125203986|NCT02407457|450370279|FG000|1 Year|Open Repair|0|||
125203987|NCT02407457|450370280|FG001|1 Year|Open Repair|1|||
125203988|NCT02407457|450370279|FG000|2-year|Death|14|||
125203989|NCT02407457|450370280|FG001|2-year|Death|8|||
125203990|NCT02407457|450370279|FG000|2-year|Lost to Follow-up|7|||
125203991|NCT02407457|450370280|FG001|2-year|Lost to Follow-up|10|||
125203992|NCT02407457|450370279|FG000|2-year|Missed Visit|13|||
125203993|NCT02407457|450370280|FG001|2-year|Missed Visit|15|||
125203994|NCT02407457|450370279|FG000|2-year|Open Repair|0|||
125203995|NCT02407457|450370280|FG001|2-year|Open Repair|2|||
125203996|NCT02407457|450370279|FG000|3-year|Death|11|||
125203997|NCT02407457|450370280|FG001|3-year|Death|10|||
125203998|NCT02407457|450370279|FG000|3-year|Lost to Follow-up|9|||
125203999|NCT02407457|450370280|FG001|3-year|Lost to Follow-up|10|||
125204000|NCT02407457|450370279|FG000|3-year|Missed Visit|19|||
125204001|NCT02407457|450370280|FG001|3-year|Missed Visit|16|||
125204002|NCT02407457|450370279|FG000|4-year|Death|18|||
125204003|NCT02407457|450370280|FG001|4-year|Death|10|||
125204004|NCT02407457|450370279|FG000|4-year|Lost to Follow-up|10|||
125204005|NCT02407457|450370280|FG001|4-year|Lost to Follow-up|12|||
125204006|NCT02407457|450370279|FG000|4-year|Missed Visit|18|||
125204007|NCT02407457|450370280|FG001|4-year|Missed Visit|16|||
125204008|NCT02407457|450370279|FG000|5-year|Death|10|||
125204009|NCT02407457|450370280|FG001|5-year|Death|3|||
125204010|NCT02407457|450370279|FG000|5-year|Lost to Follow-up|22|||
125204011|NCT02407457|450370280|FG001|5-year|Lost to Follow-up|13|||
125204012|NCT02407457|450370279|FG000|5-year|Missed Visit|9|||
125204013|NCT02407457|450370280|FG001|5-year|Missed Visit|1|||
125204014|NCT04495816|450370281|FG000|Overall Study|Lost to Follow-up|10|||
125204015|NCT04495816|450370282|FG001|Overall Study|Lost to Follow-up|4|||
125204016|NCT04495816|450370281|FG000|Overall Study|Withdrawal by Subject|3|||
125204017|NCT04495816|450370282|FG001|Overall Study|Withdrawal by Subject|5|||
125204018|NCT00558896|450370283|FG000|Overall Study|Adverse Event|1|||
125204019|NCT00558896|450370284|FG001|Overall Study|Adverse Event|1|||
125204020|NCT00558896|450370285|FG002|Overall Study|Adverse Event|1|||
125204021|NCT00558896|450370286|FG003|Overall Study|Adverse Event|3|||
125204022|NCT00558896|450370287|FG004|Overall Study|Adverse Event|4|||
125204023|NCT00558896|450370288|FG005|Overall Study|Adverse Event|10|||
125204024|NCT00558896|450370289|FG006|Overall Study|Adverse Event|3|||
125204025|NCT00558896|450370283|FG000|Overall Study|Death|3|||
125204026|NCT00558896|450370284|FG001|Overall Study|Death|0|||
125204027|NCT00558896|450370285|FG002|Overall Study|Death|2|||
125204028|NCT00558896|450370286|FG003|Overall Study|Death|3|||
125204029|NCT00558896|450370287|FG004|Overall Study|Death|2|||
125204030|NCT00558896|450370288|FG005|Overall Study|Death|2|||
125204031|NCT00558896|450370289|FG006|Overall Study|Death|6|||
125204032|NCT00558896|450370283|FG000|Overall Study|Withdrawal by Subject|2|||
125204033|NCT00558896|450370284|FG001|Overall Study|Withdrawal by Subject|1|||
125204034|NCT00558896|450370285|FG002|Overall Study|Withdrawal by Subject|1|||
125204035|NCT00558896|450370286|FG003|Overall Study|Withdrawal by Subject|1|||
125204036|NCT00558896|450370287|FG004|Overall Study|Withdrawal by Subject|1|||
125204037|NCT00558896|450370288|FG005|Overall Study|Withdrawal by Subject|5|||
125204038|NCT00558896|450370289|FG006|Overall Study|Withdrawal by Subject|5|||
125204039|NCT00558896|450370283|FG000|Overall Study|Alternative Treatment|2|||
125204040|NCT00558896|450370284|FG001|Overall Study|Alternative Treatment|2|||
125204041|NCT00558896|450370285|FG002|Overall Study|Alternative Treatment|0|||
125204042|NCT00558896|450370286|FG003|Overall Study|Alternative Treatment|2|||
125204043|NCT00558896|450370287|FG004|Overall Study|Alternative Treatment|6|||
125204044|NCT00558896|450370288|FG005|Overall Study|Alternative Treatment|7|||
125204045|NCT00558896|450370289|FG006|Overall Study|Alternative Treatment|1|||
125204046|NCT00558896|450370283|FG000|Overall Study|Physician discretion|3|||
125204047|NCT00558896|450370284|FG001|Overall Study|Physician discretion|2|||
125204048|NCT00558896|450370285|FG002|Overall Study|Physician discretion|1|||
125204049|NCT00558896|450370286|FG003|Overall Study|Physician discretion|2|||
125204050|NCT00558896|450370287|FG004|Overall Study|Physician discretion|1|||
125204051|NCT00558896|450370288|FG005|Overall Study|Physician discretion|3|||
125204052|NCT00558896|450370289|FG006|Overall Study|Physician discretion|3|||
125204053|NCT00558896|450370283|FG000|Overall Study|Continues on treatment|10|||
125204054|NCT00558896|450370284|FG001|Overall Study|Continues on treatment|1|||
125204055|NCT00558896|450370285|FG002|Overall Study|Continues on treatment|0|||
125204056|NCT00558896|450370286|FG003|Overall Study|Continues on treatment|1|||
125204057|NCT00558896|450370287|FG004|Overall Study|Continues on treatment|9|||
125204058|NCT00558896|450370288|FG005|Overall Study|Continues on treatment|25|||
125204059|NCT00558896|450370289|FG006|Overall Study|Continues on treatment|6|||
125204060|NCT04329091|450370292|FG000|Overall Study|Physician Decision|5|||
125204061|NCT01527487|450370293|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
125204062|NCT01527487|450370294|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
125204063|NCT01527487|450370293|FG000|Overall Study|Disease Progression|4|||
125204064|NCT01527487|450370294|FG001|Overall Study|Disease Progression|1|||
125204065|NCT01527487|450370293|FG000|Overall Study|Adverse Event|1|||
125204066|NCT01527487|450370294|FG001|Overall Study|Adverse Event|1|||
125204067|NCT01527487|450370293|FG000|Overall Study|Death|0|||
125204068|NCT01527487|450370294|FG001|Overall Study|Death|1|||
125204069|NCT02258542|450370301|FG000|Overall Study|eg. not made to the visit|7|||
125204070|NCT02258542|450370302|FG001|Overall Study|eg. not made to the visit|4|||
125646756|NCT03137433|451990156|FG001|Overall Study|Physician Decision|0|||
125204071|NCT02258542|450370303|FG002|Overall Study|eg. not made to the visit|0|||
125204072|NCT02258542|450370304|FG003|Overall Study|eg. not made to the visit|1|||
125204073|NCT02258542|450370301|FG000|Overall Study|study specific discount. criteria|1|||
125204074|NCT02258542|450370302|FG001|Overall Study|study specific discount. criteria|1|||
125204075|NCT02258542|450370303|FG002|Overall Study|study specific discount. criteria|0|||
125204076|NCT02258542|450370304|FG003|Overall Study|study specific discount. criteria|0|||
125204077|NCT02258542|450370301|FG000|Overall Study|Withdrawal by Subject|20|||
125204078|NCT02258542|450370302|FG001|Overall Study|Withdrawal by Subject|20|||
125204079|NCT02258542|450370303|FG002|Overall Study|Withdrawal by Subject|7|||
125204080|NCT02258542|450370304|FG003|Overall Study|Withdrawal by Subject|1|||
125204081|NCT02258542|450370301|FG000|Overall Study|Lost to Follow-up|5|||
125204082|NCT02258542|450370302|FG001|Overall Study|Lost to Follow-up|12|||
125204083|NCT02258542|450370303|FG002|Overall Study|Lost to Follow-up|1|||
125204084|NCT02258542|450370304|FG003|Overall Study|Lost to Follow-up|2|||
125204085|NCT02258542|450370301|FG000|Overall Study|Death|5|||
125204086|NCT02258542|450370302|FG001|Overall Study|Death|4|||
125204087|NCT02258542|450370303|FG002|Overall Study|Death|0|||
125204088|NCT02258542|450370304|FG003|Overall Study|Death|1|||
125204089|NCT02258542|450370301|FG000|Overall Study|Adverse Event|3|||
125204090|NCT02258542|450370302|FG001|Overall Study|Adverse Event|4|||
125204091|NCT02258542|450370303|FG002|Overall Study|Adverse Event|0|||
125204092|NCT02258542|450370304|FG003|Overall Study|Adverse Event|0|||
125204093|NCT02258542|450370301|FG000|Overall Study|Protocol Violation|1|||
125204094|NCT02258542|450370302|FG001|Overall Study|Protocol Violation|2|||
125204095|NCT02258542|450370303|FG002|Overall Study|Protocol Violation|0|||
125204096|NCT02258542|450370304|FG003|Overall Study|Protocol Violation|0|||
125204097|NCT02258542|450370301|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125204098|NCT02258542|450370302|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
125204099|NCT02258542|450370303|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
125204100|NCT02258542|450370304|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
125204101|NCT00986986|450370305|FG000|Overall Study|Lost to Follow-up|0|||
125204102|NCT00986986|450370306|FG001|Overall Study|Lost to Follow-up|1|||
125204103|NCT03589976|450370313|FG000|Overall Study|Death|5|||
125204104|NCT03589976|450370314|FG001|Overall Study|Death|1|||
125204105|NCT03589976|450370313|FG000|Overall Study|Adverse Event|5|||
125204106|NCT03589976|450370314|FG001|Overall Study|Adverse Event|1|||
125204107|NCT03589976|450370313|FG000|Overall Study|Withdrawal by Subject|4|||
125204108|NCT03589976|450370314|FG001|Overall Study|Withdrawal by Subject|1|||
125204109|NCT03589976|450370313|FG000|Overall Study|Lost to Follow-up|1|||
125204110|NCT03589976|450370314|FG001|Overall Study|Lost to Follow-up|0|||
125204111|NCT03589976|450370313|FG000|Overall Study|Other|4|||
125204112|NCT03589976|450370314|FG001|Overall Study|Other|3|||
125204113|NCT00514904|450370315|FG000|Overall Study|Withdrawal by Subject|3|||
125204114|NCT00514904|450370316|FG001|Overall Study|Withdrawal by Subject|2|||
125204115|NCT00514904|450370315|FG000|Overall Study|Lost to Follow-up|21|||
125204116|NCT00514904|450370316|FG001|Overall Study|Lost to Follow-up|3|||
125204117|NCT03430895|450370317|FG000|Overall Study|Not Treated|2|||
125204118|NCT00084318|450370318|FG000|Overall Study|Withdrawal by Subject|5|||
125204119|NCT00084318|450370319|FG001|Overall Study|Withdrawal by Subject|2|||
125204120|NCT00084318|450370318|FG000|Overall Study|Protocol Violation|15|||
125204121|NCT00084318|450370319|FG001|Overall Study|Protocol Violation|11|||
125204122|NCT00084318|450370318|FG000|Overall Study|No protocol treatment|2|||
125204123|NCT00084318|450370319|FG001|Overall Study|No protocol treatment|0|||
125204124|NCT01317797|450370322|FG000|Overall Study|Other|0|||
125204125|NCT01317797|450370323|FG001|Overall Study|Other|1|||
125204126|NCT01317797|450370324|FG002|Overall Study|Other|0|||
125204127|NCT01317797|450370322|FG000|Overall Study|Withdrawal of Patient|0|||
125204128|NCT01317797|450370323|FG001|Overall Study|Withdrawal of Patient|0|||
125646757|NCT03137433|451990155|FG000|Overall Study|Moved out of study area|1|||
125204129|NCT01317797|450370324|FG002|Overall Study|Withdrawal of Patient|1|||
125646758|NCT03137433|451990156|FG001|Overall Study|Moved out of study area|0|||
125646759|NCT03137433|451990155|FG000|Overall Study|Too far out of window due to COVID|0|||
125646760|NCT03137433|451990156|FG001|Overall Study|Too far out of window due to COVID|1|||
125646761|NCT00265382|451990157|FG000|Overall Study|Adverse Event|21|||
125204130|NCT01645891|450370329|FG000|Overall Study|Adverse Event|6|||
125646762|NCT00265382|451990157|FG000|Overall Study|Laboratory Abnormality|1|||
125646763|NCT00265382|451990157|FG000|Overall Study|Lost to Follow-up|3|||
125204131|NCT01645891|450370330|FG001|Overall Study|Adverse Event|10|||
125204132|NCT01645891|450370329|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
125204133|NCT01645891|450370330|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
125204134|NCT01645891|450370329|FG000|Overall Study|Withdrawal by Subject|3|||
125646764|NCT00265382|451990157|FG000|Overall Study|Lack of Efficacy|6|||
125204135|NCT01645891|450370330|FG001|Overall Study|Withdrawal by Subject|3|||
125204136|NCT01645891|450370329|FG000|Overall Study|Protocol Violation|4|||
125204137|NCT01645891|450370330|FG001|Overall Study|Protocol Violation|0|||
125204138|NCT01645891|450370329|FG000|Overall Study|Lost to Follow-up|4|||
125204139|NCT01645891|450370330|FG001|Overall Study|Lost to Follow-up|1|||
125204140|NCT01645891|450370329|FG000|Overall Study|Death|0|||
125204141|NCT01645891|450370330|FG001|Overall Study|Death|2|||
125204142|NCT00138073|450370333|FG000|Overall Study|lack of resources|55|||
125204143|NCT03301740|450370334|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
125204144|NCT03301740|450370335|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
125204145|NCT03301740|450370334|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
125204146|NCT03301740|450370335|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
125204147|NCT02342548|450370341|FG000|Overall Study|Adverse Event|12|||
125646765|NCT00265382|451990157|FG000|Overall Study|Miscellaneous|6|||
125646766|NCT00265382|451990157|FG000|Overall Study|Withdrawal by Subject|13|||
125646767|NCT00265382|451990157|FG000|Overall Study|Study terminated by sponsor|94|||
125646768|NCT00265382|451990157|FG000|Overall Study|Death|1|||
125646769|NCT00760994|451990158|FG000|Overall Study|Lost to Follow-up|4|||
125646770|NCT00760994|451990159|FG001|Overall Study|Lost to Follow-up|4|||
125646771|NCT00760994|451990160|FG002|Overall Study|Lost to Follow-up|3|||
125646772|NCT01853397|451990161|FG000|Overall Study|Withdrawal by Subject|0|||
125646773|NCT01853397|451990162|FG001|Overall Study|Withdrawal by Subject|0|||
125646774|NCT01853397|451990163|FG002|Overall Study|Withdrawal by Subject|0|||
125646775|NCT01853397|451990164|FG003|Overall Study|Withdrawal by Subject|1|||
125646776|NCT01853397|451990161|FG000|Overall Study|Subject Noncompliance|0|||
125646777|NCT01853397|451990162|FG001|Overall Study|Subject Noncompliance|0|||
125646778|NCT01853397|451990163|FG002|Overall Study|Subject Noncompliance|0|||
125646779|NCT01853397|451990164|FG003|Overall Study|Subject Noncompliance|1|||
125646780|NCT02132312|451990165|FG000|Overall Study|Adverse Event|2|||
125646781|NCT02132312|451990166|FG001|Overall Study|Adverse Event|0|||
125646782|NCT02132312|451990165|FG000|Overall Study|Physician Decision|1|||
125646783|NCT02132312|451990166|FG001|Overall Study|Physician Decision|1|||
125646784|NCT02132312|451990165|FG000|Overall Study|Protocol Violation|0|||
125646785|NCT02132312|451990166|FG001|Overall Study|Protocol Violation|1|||
125646786|NCT02132312|451990165|FG000|Overall Study|Withdrawal by Subject|1|||
125646787|NCT02132312|451990166|FG001|Overall Study|Withdrawal by Subject|0|||
125646788|NCT02132312|451990165|FG000|Overall Study|Lost to Follow-up|2|||
125646789|NCT02132312|451990166|FG001|Overall Study|Lost to Follow-up|1|||
125646790|NCT01724021|451990169|FG000|Overall Study|Adverse Event|11|||
125646791|NCT01724021|451990170|FG001|Overall Study|Adverse Event|6|||
125646792|NCT01724021|451990169|FG000|Overall Study|Death|46|||
125646793|NCT01724021|451990170|FG001|Overall Study|Death|58|||
125646794|NCT01724021|451990169|FG000|Overall Study|Participant request/ Withdrew consent|18|||
125646795|NCT01724021|451990170|FG001|Overall Study|Participant request/ Withdrew consent|14|||
125204148|NCT02342548|450370342|FG001|Overall Study|Adverse Event|17|||
125204149|NCT02342548|450370343|FG002|Overall Study|Adverse Event|13|||
125204150|NCT02342548|450370341|FG000|Overall Study|Lost to Follow-up|0|||
125204151|NCT02342548|450370342|FG001|Overall Study|Lost to Follow-up|1|||
125204152|NCT02342548|450370343|FG002|Overall Study|Lost to Follow-up|0|||
125204153|NCT02342548|450370341|FG000|Overall Study|Study terminated by sponsor|20|||
125204154|NCT02342548|450370342|FG001|Overall Study|Study terminated by sponsor|39|||
125204155|NCT02342548|450370343|FG002|Overall Study|Study terminated by sponsor|25|||
125204156|NCT02342548|450370341|FG000|Overall Study|Protocol Violation|0|||
125646796|NCT01724021|451990169|FG000|Overall Study|Lost to Follow-up|15|||
125646797|NCT01724021|451990170|FG001|Overall Study|Lost to Follow-up|15|||
125646798|NCT01724021|451990169|FG000|Overall Study|Reason Not Specified|36|||
125646799|NCT01724021|451990170|FG001|Overall Study|Reason Not Specified|39|||
125646800|NCT01724021|451990169|FG000|Overall Study|Missing|1|||
125646801|NCT01724021|451990170|FG001|Overall Study|Missing|1|||
125646802|NCT02452892|451990173|FG000|Week 1 Initial Randommization|Adverse Event|1|||
125646803|NCT02452892|451990174|FG001|Week 1 Initial Randommization|Adverse Event|0|||
125646804|NCT02452892|451990175|FG002|Week 1 Initial Randommization|Adverse Event|0|||
125646805|NCT02452892|451990176|FG003|Week 1 Initial Randommization|Adverse Event|0|||
125646806|NCT02452892|451990173|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
125646807|NCT02452892|451990174|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
125646808|NCT02452892|451990175|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
125646809|NCT02452892|451990176|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
125646810|NCT02452892|451990173|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
125646811|NCT02452892|451990174|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
125646812|NCT02452892|451990175|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
125646813|NCT02452892|451990176|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
125646814|NCT02452892|451990173|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
125646815|NCT02452892|451990174|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
125646816|NCT02452892|451990175|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
125646817|NCT02452892|451990176|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
125646818|NCT02452892|451990173|FG000|Follow-up|Withdrawal by Subject|0|||
125646819|NCT02452892|451990174|FG001|Follow-up|Withdrawal by Subject|0|||
125646820|NCT02452892|451990175|FG002|Follow-up|Withdrawal by Subject|0|||
125646821|NCT02452892|451990176|FG003|Follow-up|Withdrawal by Subject|1|||
125646822|NCT02452892|451990173|FG000|Follow-up|Subject left town on Day 42|1|||
125646823|NCT02452892|451990174|FG001|Follow-up|Subject left town on Day 42|0|||
125204157|NCT02342548|450370342|FG001|Overall Study|Protocol Violation|1|||
125204158|NCT02342548|450370343|FG002|Overall Study|Protocol Violation|0|||
125204159|NCT02342548|450370341|FG000|Overall Study|Withdrawal by Subject|1|||
125204160|NCT02342548|450370342|FG001|Overall Study|Withdrawal by Subject|3|||
125646824|NCT02452892|451990175|FG002|Follow-up|Subject left town on Day 42|0|||
125646825|NCT02452892|451990176|FG003|Follow-up|Subject left town on Day 42|0|||
125646826|NCT00486720|451990177|FG000|Overall Study|Adverse Event|1|||
125646827|NCT00486720|451990178|FG001|Overall Study|Adverse Event|2|||
125646828|NCT00486720|451990177|FG000|Overall Study|Lack of Efficacy|4|||
125646829|NCT00486720|451990178|FG001|Overall Study|Lack of Efficacy|6|||
125646830|NCT00486720|451990177|FG000|Overall Study|Physician Decision|1|||
125646831|NCT00486720|451990178|FG001|Overall Study|Physician Decision|2|||
125646832|NCT00486720|451990177|FG000|Overall Study|Protocol Violation|1|||
125646833|NCT00486720|451990178|FG001|Overall Study|Protocol Violation|0|||
125646834|NCT00486720|451990177|FG000|Overall Study|Withdrawal by Subject|3|||
125646835|NCT00486720|451990178|FG001|Overall Study|Withdrawal by Subject|1|||
125646836|NCT00486720|451990177|FG000|Overall Study|Progressive Disease|0|||
125646837|NCT00486720|451990178|FG001|Overall Study|Progressive Disease|1|||
125646838|NCT00955682|451990180|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
125646839|NCT00955682|451990181|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
125646840|NCT02041533|451990182|FG000|Pre-Treatment Period|Disease Progression|1|||
125646841|NCT02041533|451990183|FG001|Pre-Treatment Period|Disease Progression|1|||
125646842|NCT02041533|451990182|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
125646843|NCT02041533|451990183|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
125646844|NCT02041533|451990182|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
125646845|NCT02041533|451990183|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
125646846|NCT02041533|451990182|FG000|Treatment Period|Disease progression|189|||
125646847|NCT02041533|451990183|FG001|Treatment Period|Disease progression|146|||
125646848|NCT02041533|451990182|FG000|Treatment Period|Study drug toxicity|30|||
125646849|NCT02041533|451990183|FG001|Treatment Period|Study drug toxicity|34|||
125646850|NCT02041533|451990182|FG000|Treatment Period|Death|1|||
125646851|NCT02041533|451990183|FG001|Treatment Period|Death|0|||
125646852|NCT02041533|451990182|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
125646853|NCT02041533|451990183|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
125646854|NCT02041533|451990182|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
125646855|NCT02041533|451990183|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
125646856|NCT02041533|451990182|FG000|Treatment Period|Participant withdrew consent|2|||
125646857|NCT02041533|451990183|FG001|Treatment Period|Participant withdrew consent|2|||
125646858|NCT02041533|451990182|FG000|Treatment Period|Maximum clinical benefit|0|||
125646859|NCT02041533|451990183|FG001|Treatment Period|Maximum clinical benefit|18|||
125646860|NCT02041533|451990182|FG000|Treatment Period|Poor/Non-compliance|1|||
125646861|NCT02041533|451990183|FG001|Treatment Period|Poor/Non-compliance|0|||
125646862|NCT02041533|451990182|FG000|Treatment Period|Administrative reason by sponsor|1|||
125646863|NCT02041533|451990183|FG001|Treatment Period|Administrative reason by sponsor|0|||
125646864|NCT02041533|451990182|FG000|Treatment Period|Other reasons|9|||
125646865|NCT02041533|451990183|FG001|Treatment Period|Other reasons|2|||
125646866|NCT02041533|451990182|FG000|Treatment Period|Not Reported|0|||
125646867|NCT02041533|451990183|FG001|Treatment Period|Not Reported|1|||
125646868|NCT02117024|451990184|FG000|Overall Study|Progressive Disease|26|||
125646869|NCT02117024|451990185|FG001|Overall Study|Progressive Disease|9|||
125646870|NCT02117024|451990184|FG000|Overall Study|Significant Clinical Progression|7|||
125646871|NCT02117024|451990185|FG001|Overall Study|Significant Clinical Progression|4|||
125646872|NCT02117024|451990184|FG000|Overall Study|Death|5|||
125646873|NCT02117024|451990185|FG001|Overall Study|Death|0|||
125646874|NCT02117024|451990184|FG000|Overall Study|Withdrawal by Subject|3|||
125646875|NCT02117024|451990185|FG001|Overall Study|Withdrawal by Subject|1|||
125646876|NCT02117024|451990184|FG000|Overall Study|Protocol Violation|1|||
125646877|NCT02117024|451990185|FG001|Overall Study|Protocol Violation|0|||
125646878|NCT02117024|451990184|FG000|Overall Study|Adverse Event|1|||
125646879|NCT02117024|451990185|FG001|Overall Study|Adverse Event|2|||
125646880|NCT02117024|451990184|FG000|Overall Study|Randomized in Error|1|||
125646881|NCT02117024|451990185|FG001|Overall Study|Randomized in Error|0|||
125646882|NCT02117024|451990184|FG000|Overall Study|Patient returned to primary oncologist|0|||
125646883|NCT02117024|451990185|FG001|Overall Study|Patient returned to primary oncologist|1|||
125646884|NCT02117024|451990184|FG000|Overall Study|Patient took treatment break|0|||
125646885|NCT02117024|451990185|FG001|Overall Study|Patient took treatment break|1|||
125204161|NCT02342548|450370343|FG002|Overall Study|Withdrawal by Subject|4|||
125646886|NCT02117024|451990184|FG000|Overall Study|Physician Decision|0|||
125204162|NCT02342548|450370341|FG000|Overall Study|Other|1|||
125646887|NCT02117024|451990185|FG001|Overall Study|Physician Decision|2|||
125646888|NCT00565721|451990188|FG000|Overall Study|Screen Failure|2|||
125646889|NCT00565721|451990188|FG000|Overall Study|Lost to Follow-up|6|||
125646890|NCT00565721|451990188|FG000|Overall Study|Technical Problems|1|||
125646891|NCT00565721|451990188|FG000|Overall Study|Physician Decision|2|||
125646892|NCT00565721|451990188|FG000|Overall Study|Other reasons|6|||
125646893|NCT02813681|451990191|FG000|Overall Study|Physician Decision|5|||
125646894|NCT02813681|451990192|FG001|Overall Study|Physician Decision|5|||
125646895|NCT02813681|451990193|FG002|Overall Study|Physician Decision|0|||
125646896|NCT02813681|451990191|FG000|Overall Study|Lost to Follow-up|0|||
125204163|NCT02342548|450370342|FG001|Overall Study|Other|1|||
125646897|NCT02813681|451990192|FG001|Overall Study|Lost to Follow-up|1|||
125646898|NCT02813681|451990193|FG002|Overall Study|Lost to Follow-up|0|||
125646899|NCT02500706|451990194|FG000|Overall Study|Adverse Event|0|||
125646900|NCT02500706|451990195|FG001|Overall Study|Adverse Event|0|||
125646901|NCT02500706|451990196|FG002|Overall Study|Adverse Event|1|||
125646902|NCT02500706|451990194|FG000|Overall Study|Lost to Follow-up|0|||
125646903|NCT02500706|451990195|FG001|Overall Study|Lost to Follow-up|1|||
125646904|NCT02500706|451990196|FG002|Overall Study|Lost to Follow-up|1|||
125646905|NCT02500706|451990194|FG000|Overall Study|Withdrawal by Subject|4|||
125646906|NCT02500706|451990195|FG001|Overall Study|Withdrawal by Subject|6|||
125646907|NCT02500706|451990196|FG002|Overall Study|Withdrawal by Subject|4|||
125646908|NCT02500706|451990194|FG000|Overall Study|Unclassified|0|||
125646909|NCT02500706|451990195|FG001|Overall Study|Unclassified|0|||
125646910|NCT02500706|451990196|FG002|Overall Study|Unclassified|1|||
125646911|NCT00529152|451990197|FG000|Overall Study|Adverse Event|2|||
125646912|NCT00529152|451990197|FG000|Overall Study|Withdrawal by Subject|2|||
125646913|NCT00529152|451990197|FG000|Overall Study|Lost to Follow-up|1|||
125646914|NCT01497899|451990202|FG000|Double-Blind Phase|Randomized but not Treated|1|||
125646915|NCT01497899|451990203|FG001|Double-Blind Phase|Randomized but not Treated|0|||
125646916|NCT01497899|451990204|FG002|Double-Blind Phase|Randomized but not Treated|0|||
125646917|NCT01497899|451990205|FG003|Double-Blind Phase|Randomized but not Treated|0|||
125646918|NCT01497899|451990202|FG000|Double-Blind Phase|Adverse Event|1|||
125646919|NCT01497899|451990203|FG001|Double-Blind Phase|Adverse Event|0|||
125646920|NCT01497899|451990204|FG002|Double-Blind Phase|Adverse Event|0|||
125646921|NCT01497899|451990205|FG003|Double-Blind Phase|Adverse Event|0|||
125646922|NCT01497899|451990202|FG000|Double-Blind Phase|Lack of Efficacy|0|||
125646923|NCT01497899|451990203|FG001|Double-Blind Phase|Lack of Efficacy|1|||
125646924|NCT01497899|451990204|FG002|Double-Blind Phase|Lack of Efficacy|0|||
125646925|NCT01497899|451990205|FG003|Double-Blind Phase|Lack of Efficacy|0|||
125646926|NCT01497899|451990202|FG000|Double-Blind Phase|Investigator's Discretion|1|||
125646927|NCT01497899|451990203|FG001|Double-Blind Phase|Investigator's Discretion|0|||
125646928|NCT01497899|451990204|FG002|Double-Blind Phase|Investigator's Discretion|0|||
125646929|NCT01497899|451990205|FG003|Double-Blind Phase|Investigator's Discretion|0|||
125646930|NCT01497899|451990202|FG000|Double-Blind Phase|Withdrew Consent|0|||
125646931|NCT01497899|451990203|FG001|Double-Blind Phase|Withdrew Consent|1|||
125646932|NCT01497899|451990204|FG002|Double-Blind Phase|Withdrew Consent|0|||
125646933|NCT01497899|451990205|FG003|Double-Blind Phase|Withdrew Consent|0|||
125646934|NCT01497899|451990202|FG000|Double-Blind Phase|Lost to Follow-up|3|||
125646935|NCT01497899|451990203|FG001|Double-Blind Phase|Lost to Follow-up|2|||
125646936|NCT01497899|451990204|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125646937|NCT01497899|451990205|FG003|Double-Blind Phase|Lost to Follow-up|0|||
125646938|NCT01497899|451990202|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
125646939|NCT01497899|451990203|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
125646940|NCT01497899|451990204|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
125646941|NCT01497899|451990205|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
125646942|NCT01497899|451990202|FG000|Open-Label Extension Phase|Adverse Event|1|||
125646943|NCT01497899|451990203|FG001|Open-Label Extension Phase|Adverse Event|0|||
125646944|NCT01497899|451990204|FG002|Open-Label Extension Phase|Adverse Event|0|||
125646945|NCT01497899|451990205|FG003|Open-Label Extension Phase|Adverse Event|0|||
125646946|NCT01497899|451990202|FG000|Open-Label Extension Phase|Death|1|||
125646947|NCT01497899|451990203|FG001|Open-Label Extension Phase|Death|0|||
125646948|NCT01497899|451990204|FG002|Open-Label Extension Phase|Death|0|||
125646949|NCT01497899|451990205|FG003|Open-Label Extension Phase|Death|0|||
125646950|NCT01497899|451990202|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
125646951|NCT01497899|451990203|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
125646952|NCT01497899|451990204|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
125646953|NCT01497899|451990205|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
125646954|NCT01497899|451990202|FG000|Open-Label Extension Phase|Pregnancy|0|||
125646955|NCT01497899|451990203|FG001|Open-Label Extension Phase|Pregnancy|1|||
125646956|NCT01497899|451990204|FG002|Open-Label Extension Phase|Pregnancy|1|||
125646957|NCT01497899|451990205|FG003|Open-Label Extension Phase|Pregnancy|0|||
125646958|NCT01497899|451990202|FG000|Open-Label Extension Phase|Protocol Violation|0|||
125646959|NCT01497899|451990203|FG001|Open-Label Extension Phase|Protocol Violation|0|||
125646960|NCT01497899|451990204|FG002|Open-Label Extension Phase|Protocol Violation|1|||
125646961|NCT01497899|451990205|FG003|Open-Label Extension Phase|Protocol Violation|0|||
125646962|NCT01497899|451990202|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
125646963|NCT01497899|451990203|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
125646964|NCT01497899|451990204|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
125646965|NCT01497899|451990205|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
125646966|NCT05047601|451990207|FG000|Overall Study|Lost to Follow-up|9|||
125646967|NCT05047601|451990208|FG001|Overall Study|Lost to Follow-up|11|||
125646968|NCT05047601|451990209|FG002|Overall Study|Lost to Follow-up|7|||
125646969|NCT05047601|451990207|FG000|Overall Study|Withdrawal by Subject|25|||
125646970|NCT05047601|451990208|FG001|Overall Study|Withdrawal by Subject|36|||
125204164|NCT02342548|450370343|FG002|Overall Study|Other|1|||
125646971|NCT05047601|451990209|FG002|Overall Study|Withdrawal by Subject|23|||
125646972|NCT05047601|451990207|FG000|Overall Study|Other|10|||
125646973|NCT05047601|451990208|FG001|Overall Study|Other|6|||
125646974|NCT05047601|451990209|FG002|Overall Study|Other|5|||
125646975|NCT00286234|451990210|FG000|Overall Study|Protocol Violation|1|||
125646976|NCT00286234|451990211|FG001|Overall Study|Protocol Violation|2|||
125646977|NCT00286234|451990212|FG002|Overall Study|Protocol Violation|0|||
125646978|NCT00286234|451990213|FG003|Overall Study|Protocol Violation|1|||
125646979|NCT00286234|451990210|FG000|Overall Study|Physician Decision|1|||
125646980|NCT00286234|451990211|FG001|Overall Study|Physician Decision|0|||
125646981|NCT00286234|451990212|FG002|Overall Study|Physician Decision|0|||
125646982|NCT00286234|451990213|FG003|Overall Study|Physician Decision|1|||
125646983|NCT00286234|451990210|FG000|Overall Study|Adverse Event|0|||
125646984|NCT00286234|451990211|FG001|Overall Study|Adverse Event|0|||
125646985|NCT00286234|451990212|FG002|Overall Study|Adverse Event|0|||
125646986|NCT00286234|451990213|FG003|Overall Study|Adverse Event|1|||
125646987|NCT00286234|451990210|FG000|Overall Study|Adverse Event|0|||
125646988|NCT00286234|451990211|FG001|Overall Study|Adverse Event|0|||
125646989|NCT00286234|451990212|FG002|Overall Study|Adverse Event|0|||
125646990|NCT00286234|451990213|FG003|Overall Study|Adverse Event|1|||
125646991|NCT01874288|451990221|FG000|Overall Study|Withdrawal by Subject|1|||
125646992|NCT01874288|451990222|FG001|Overall Study|Withdrawal by Subject|0|||
125646993|NCT01874288|451990223|FG002|Overall Study|Withdrawal by Subject|2|||
125646994|NCT01874288|451990224|FG003|Overall Study|Withdrawal by Subject|1|||
125646995|NCT01874288|451990225|FG004|Overall Study|Withdrawal by Subject|1|||
125646996|NCT01874288|451990221|FG000|Overall Study|Physician Decision|0|||
125646997|NCT01874288|451990222|FG001|Overall Study|Physician Decision|0|||
125646998|NCT01874288|451990223|FG002|Overall Study|Physician Decision|0|||
125646999|NCT01874288|451990224|FG003|Overall Study|Physician Decision|1|||
125647000|NCT01874288|451990225|FG004|Overall Study|Physician Decision|0|||
125647001|NCT01874288|451990221|FG000|Overall Study|Progressive disease|2|||
125647002|NCT01874288|451990222|FG001|Overall Study|Progressive disease|0|||
125647003|NCT01874288|451990223|FG002|Overall Study|Progressive disease|3|||
125647004|NCT01874288|451990224|FG003|Overall Study|Progressive disease|5|||
125647005|NCT01874288|451990225|FG004|Overall Study|Progressive disease|1|||
125647006|NCT00283062|451990226|FG000|Overall Study|Did not receive any study medication|5|||
125647007|NCT00283062|451990227|FG001|Overall Study|Did not receive any study medication|4|||
125647008|NCT00283062|451990228|FG002|Overall Study|Did not receive any study medication|36|||
125647009|NCT00283062|451990229|FG003|Overall Study|Did not receive any study medication|45|||
125647010|NCT00283062|451990226|FG000|Overall Study|Adverse Event|2|||
125647011|NCT00283062|451990227|FG001|Overall Study|Adverse Event|0|||
125647012|NCT00283062|451990228|FG002|Overall Study|Adverse Event|1|||
125647013|NCT00283062|451990229|FG003|Overall Study|Adverse Event|0|||
125647014|NCT00283062|451990226|FG000|Overall Study|Lost to Follow-up|1|||
125647015|NCT00283062|451990227|FG001|Overall Study|Lost to Follow-up|0|||
125647016|NCT00283062|451990228|FG002|Overall Study|Lost to Follow-up|1|||
125647017|NCT00283062|451990229|FG003|Overall Study|Lost to Follow-up|0|||
125647018|NCT00283062|451990226|FG000|Overall Study|Progressive disease|0|||
125647019|NCT00283062|451990227|FG001|Overall Study|Progressive disease|0|||
125647020|NCT00283062|451990228|FG002|Overall Study|Progressive disease|1|||
125647021|NCT00283062|451990229|FG003|Overall Study|Progressive disease|0|||
125647022|NCT00283062|451990226|FG000|Overall Study|Participant did not wish to continue|3|||
125647023|NCT00283062|451990227|FG001|Overall Study|Participant did not wish to continue|2|||
125647024|NCT00283062|451990228|FG002|Overall Study|Participant did not wish to continue|1|||
125647025|NCT00283062|451990229|FG003|Overall Study|Participant did not wish to continue|0|||
125647026|NCT00283062|451990226|FG000|Overall Study|Undefined|0|||
125647027|NCT00283062|451990227|FG001|Overall Study|Undefined|1|||
125647028|NCT00283062|451990228|FG002|Overall Study|Undefined|1|||
125647029|NCT00283062|451990229|FG003|Overall Study|Undefined|4|||
125647030|NCT00283062|451990226|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
125647031|NCT00283062|451990227|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
125647032|NCT00283062|451990228|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
125647033|NCT00283062|451990229|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
125204165|NCT01047332|450370344|FG000|Overall Study|SEMS Obstruction|11|||
125204166|NCT01047332|450370345|FG001|Overall Study|SEMS Obstruction|20|||
125647034|NCT00827112|451990232|FG000|Overall Study|Adverse Event|2|||
125647035|NCT00827112|451990233|FG001|Overall Study|Adverse Event|0|||
125647036|NCT00827112|451990232|FG000|Overall Study|Lack of Efficacy|2|||
125647037|NCT00827112|451990233|FG001|Overall Study|Lack of Efficacy|0|||
125647038|NCT00827112|451990232|FG000|Overall Study|Lost to Follow-up|3|||
125647039|NCT00827112|451990233|FG001|Overall Study|Lost to Follow-up|2|||
125647040|NCT00827112|451990232|FG000|Overall Study|Pregnancy|0|||
125647041|NCT00827112|451990233|FG001|Overall Study|Pregnancy|1|||
125647042|NCT00827112|451990232|FG000|Overall Study|Protocol Violation|0|||
125647043|NCT00827112|451990233|FG001|Overall Study|Protocol Violation|2|||
125204167|NCT01047332|450370344|FG000|Overall Study|Died Unobstructed|38|||
125647044|NCT00827112|451990232|FG000|Overall Study|Withdrawal by Subject|2|||
125647045|NCT00827112|451990233|FG001|Overall Study|Withdrawal by Subject|1|||
125647046|NCT00827112|451990232|FG000|Overall Study|Randomized but not treated|5|||
125647047|NCT00827112|451990233|FG001|Overall Study|Randomized but not treated|3|||
125647048|NCT00827112|451990232|FG000|Overall Study|Other|1|||
125647049|NCT00827112|451990233|FG001|Overall Study|Other|3|||
125647050|NCT01475214|451990234|FG000|Overall Study|Lost to Follow-up|1|||
125647051|NCT01475214|451990235|FG001|Overall Study|Lost to Follow-up|0|||
125647052|NCT01475214|451990236|FG002|Overall Study|Lost to Follow-up|1|||
125647053|NCT01475214|451990234|FG000|Overall Study|Physician Decision|2|||
125647054|NCT01475214|451990235|FG001|Overall Study|Physician Decision|0|||
125647055|NCT01475214|451990236|FG002|Overall Study|Physician Decision|0|||
125647056|NCT01475214|451990234|FG000|Overall Study|Withdrawal by Subject|2|||
125647057|NCT01475214|451990235|FG001|Overall Study|Withdrawal by Subject|4|||
125647058|NCT01475214|451990236|FG002|Overall Study|Withdrawal by Subject|1|||
125647059|NCT00877929|451990239|FG000|Overall Study|Adverse Event|11|||
125647060|NCT00877929|451990240|FG001|Overall Study|Adverse Event|20|||
125647061|NCT00877929|451990239|FG000|Overall Study|Protocol Violation|3|||
125647062|NCT00877929|451990240|FG001|Overall Study|Protocol Violation|3|||
125647063|NCT00877929|451990239|FG000|Overall Study|Lost to Follow-up|0|||
125647064|NCT00877929|451990240|FG001|Overall Study|Lost to Follow-up|1|||
125647065|NCT00877929|451990239|FG000|Overall Study|Withdrawal by Subject|4|||
125647066|NCT00877929|451990240|FG001|Overall Study|Withdrawal by Subject|4|||
125647067|NCT00877929|451990239|FG000|Overall Study|Lack of Efficacy|0|||
125647068|NCT00877929|451990240|FG001|Overall Study|Lack of Efficacy|1|||
125647069|NCT00877929|451990239|FG000|Overall Study|Other reason (not specified)|2|||
125647070|NCT00877929|451990240|FG001|Overall Study|Other reason (not specified)|6|||
125647071|NCT02127931|451990243|FG000|Overall Study|Glitch in Game|1|||
125647072|NCT00422942|451990244|FG000|Overall Study|Study terminated by Sponsor|3|||
125647073|NCT02828982|451990245|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125647074|NCT02828982|451990246|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125647075|NCT03691831|451991505|FG000|Overall Study|Lost to Follow-up|16|||
125647076|NCT03691831|451991506|FG001|Overall Study|Lost to Follow-up|12|||
125647077|NCT03691831|451991505|FG000|Overall Study|Withdrawal by Subject|9|||
125647078|NCT03691831|451991506|FG001|Overall Study|Withdrawal by Subject|17|||
125647079|NCT03691831|451991505|FG000|Overall Study|Investigator Decision|2|||
125647080|NCT03691831|451991506|FG001|Overall Study|Investigator Decision|2|||
125647081|NCT03922945|451991507|FG000|Overall Study|Adverse Event|1|||
125647082|NCT03922945|451991508|FG001|Overall Study|Adverse Event|1|||
125647083|NCT03922945|451991509|FG002|Overall Study|Adverse Event|2|||
125647084|NCT03922945|451991507|FG000|Overall Study|Lost to Follow-up|13|||
125647085|NCT03922945|451991508|FG001|Overall Study|Lost to Follow-up|9|||
125647086|NCT03922945|451991509|FG002|Overall Study|Lost to Follow-up|20|||
125647087|NCT03922945|451991507|FG000|Overall Study|Lack of Efficacy|2|||
125647088|NCT03922945|451991508|FG001|Overall Study|Lack of Efficacy|0|||
125647089|NCT03922945|451991509|FG002|Overall Study|Lack of Efficacy|1|||
125647090|NCT03922945|451991507|FG000|Overall Study|Protocol Non-Compliance|0|||
125647091|NCT03922945|451991508|FG001|Overall Study|Protocol Non-Compliance|0|||
125647092|NCT03922945|451991509|FG002|Overall Study|Protocol Non-Compliance|1|||
125647093|NCT03922945|451991507|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
125647094|NCT03922945|451991508|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
125647095|NCT03922945|451991509|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
125647096|NCT03922945|451991507|FG000|Overall Study|All Other Personal Reasons|1|||
125647097|NCT03922945|451991508|FG001|Overall Study|All Other Personal Reasons|1|||
125647098|NCT03922945|451991509|FG002|Overall Study|All Other Personal Reasons|2|||
125647099|NCT02079077|451991515|FG000|Overall Study|Lost to Follow-up|5|||
125647100|NCT02079077|451991516|FG001|Overall Study|Lost to Follow-up|7|||
125647101|NCT02079077|451991515|FG000|Overall Study|Became STIs Positive|1|||
125647102|NCT02079077|451991516|FG001|Overall Study|Became STIs Positive|2|||
125647103|NCT00772031|451991517|FG000|Overall Study|Early termination of trial|12|||
125647104|NCT00772031|451991518|FG001|Overall Study|Early termination of trial|10|||
125647105|NCT00772031|451991517|FG000|Overall Study|Lost to Follow-up|20|||
125647106|NCT00772031|451991518|FG001|Overall Study|Lost to Follow-up|33|||
125647107|NCT02681094|451991519|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
125647108|NCT02681094|451991520|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
125647109|NCT02681094|451991521|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
125647110|NCT02681094|451991519|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
125647111|NCT02681094|451991520|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
125647112|NCT02681094|451991521|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
125647113|NCT02681094|451991519|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
125647114|NCT02681094|451991520|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
125647115|NCT02681094|451991521|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
125647116|NCT02681094|451991519|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
125647117|NCT02681094|451991520|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
125647118|NCT02681094|451991521|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
125647119|NCT02681094|451991519|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
125647120|NCT02681094|451991520|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
125647121|NCT02681094|451991521|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
125647122|NCT02681094|451991519|FG000|1 -Modified Enrolled Participants Set|Other|6|||
125647123|NCT02681094|451991520|FG001|1 -Modified Enrolled Participants Set|Other|6|||
125647124|NCT02681094|451991521|FG002|1 -Modified Enrolled Participants Set|Other|7|||
125647125|NCT02681094|451991519|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
125647126|NCT02681094|451991520|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
125647127|NCT02681094|451991521|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
125647128|NCT02681094|451991519|FG000|2 - Enrolled Participants Set|Participant decision|7|||
125647129|NCT02681094|451991520|FG001|2 - Enrolled Participants Set|Participant decision|10|||
125647130|NCT02681094|451991521|FG002|2 - Enrolled Participants Set|Participant decision|9|||
125647131|NCT02681094|451991519|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
125647132|NCT02681094|451991520|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
125647133|NCT02681094|451991521|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
125647134|NCT02681094|451991519|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
125647135|NCT02681094|451991520|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
125647136|NCT02681094|451991521|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
125647137|NCT02681094|451991519|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
125647138|NCT02681094|451991520|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
125647139|NCT02681094|451991521|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
125647140|NCT02681094|451991519|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
125647141|NCT02681094|451991520|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
125647142|NCT02681094|451991521|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
125647143|NCT02681094|451991519|FG000|2 - Enrolled Participants Set|Other|6|||
125647144|NCT02681094|451991520|FG001|2 - Enrolled Participants Set|Other|6|||
125647145|NCT02681094|451991521|FG002|2 - Enrolled Participants Set|Other|7|||
125647146|NCT02681094|451991519|FG000|2 - Enrolled Participants Set|No treatment given|0|||
125647147|NCT02681094|451991520|FG001|2 - Enrolled Participants Set|No treatment given|1|||
125647148|NCT02681094|451991521|FG002|2 - Enrolled Participants Set|No treatment given|1|||
125647149|NCT00310440|451991522|FG000|Overall Study|Lost to Follow-up|17|||
125647150|NCT00310440|451991523|FG001|Overall Study|Lost to Follow-up|8|||
125647151|NCT00310440|451991522|FG000|Overall Study|Withdrawal by Subject|2|||
125647152|NCT00310440|451991523|FG001|Overall Study|Withdrawal by Subject|1|||
125647153|NCT00310440|451991522|FG000|Overall Study|Missed 12 Month Visit|7|||
125647154|NCT00310440|451991523|FG001|Overall Study|Missed 12 Month Visit|4|||
125647155|NCT01098266|451991524|FG000|Overall Study|Physician Decision|1|||
125647156|NCT01098266|451991525|FG001|Overall Study|Physician Decision|0|||
125647157|NCT01098266|451991524|FG000|Overall Study|Death|3|||
125647158|NCT01098266|451991525|FG001|Overall Study|Death|2|||
125647159|NCT01098266|451991524|FG000|Overall Study|Withdrawal by Subject|3|||
125647160|NCT01098266|451991525|FG001|Overall Study|Withdrawal by Subject|5|||
125647161|NCT03339999|451991526|FG000|Overall Study|Adverse Event|1|||
125647162|NCT03339999|451991527|FG001|Overall Study|Adverse Event|2|||
125647163|NCT03339999|451991528|FG002|Overall Study|Adverse Event|2|||
125647164|NCT03339999|451991529|FG003|Overall Study|Adverse Event|1|||
125647165|NCT03339999|451991526|FG000|Overall Study|Lack of Efficacy|0|||
125647166|NCT03339999|451991527|FG001|Overall Study|Lack of Efficacy|1|||
125647167|NCT03339999|451991528|FG002|Overall Study|Lack of Efficacy|0|||
125647168|NCT03339999|451991529|FG003|Overall Study|Lack of Efficacy|0|||
125647169|NCT03339999|451991526|FG000|Overall Study|Lost to Follow-up|0|||
125647170|NCT03339999|451991527|FG001|Overall Study|Lost to Follow-up|0|||
125647171|NCT03339999|451991528|FG002|Overall Study|Lost to Follow-up|0|||
125647172|NCT03339999|451991529|FG003|Overall Study|Lost to Follow-up|1|||
125647173|NCT03339999|451991526|FG000|Overall Study|Study Terminated by Sponsor|6|||
125647174|NCT03339999|451991527|FG001|Overall Study|Study Terminated by Sponsor|3|||
125647175|NCT03339999|451991528|FG002|Overall Study|Study Terminated by Sponsor|4|||
125647176|NCT03339999|451991529|FG003|Overall Study|Study Terminated by Sponsor|3|||
125647177|NCT00525499|451991530|FG000|Overall Study|Lost to Follow-up|2|||
125647178|NCT00525499|451991531|FG001|Overall Study|Lost to Follow-up|4|||
125647179|NCT00525499|451991532|FG002|Overall Study|Lost to Follow-up|1|||
125647180|NCT00525499|451991533|FG003|Overall Study|Lost to Follow-up|4|||
125647181|NCT00525499|451991530|FG000|Overall Study|Adverse Event|0|||
125647182|NCT00525499|451991531|FG001|Overall Study|Adverse Event|1|||
125647183|NCT00525499|451991532|FG002|Overall Study|Adverse Event|0|||
125647184|NCT00525499|451991533|FG003|Overall Study|Adverse Event|1|||
125647185|NCT00525499|451991530|FG000|Overall Study|Withdrawal by Subject|5|||
125647186|NCT00525499|451991531|FG001|Overall Study|Withdrawal by Subject|1|||
125647187|NCT00525499|451991532|FG002|Overall Study|Withdrawal by Subject|5|||
125647188|NCT00525499|451991533|FG003|Overall Study|Withdrawal by Subject|2|||
125204168|NCT01047332|450370345|FG001|Overall Study|Died Unobstructed|41|||
125647189|NCT00525499|451991530|FG000|Overall Study|Protocol Violation|0|||
125647190|NCT00525499|451991531|FG001|Overall Study|Protocol Violation|1|||
125647191|NCT00525499|451991532|FG002|Overall Study|Protocol Violation|1|||
125647192|NCT00525499|451991533|FG003|Overall Study|Protocol Violation|0|||
125647193|NCT01733758|451991534|FG000|Overall Study|Adverse Event|5|||
125647194|NCT01733758|451991535|FG001|Overall Study|Adverse Event|7|||
125647195|NCT01733758|451991536|FG002|Overall Study|Adverse Event|8|||
125647196|NCT01733758|451991537|FG003|Overall Study|Adverse Event|1|||
125647197|NCT01733758|451991534|FG000|Overall Study|Withdrawal by Subject|1|||
125647198|NCT01733758|451991535|FG001|Overall Study|Withdrawal by Subject|1|||
125647199|NCT01733758|451991536|FG002|Overall Study|Withdrawal by Subject|5|||
125647200|NCT01733758|451991537|FG003|Overall Study|Withdrawal by Subject|3|||
125647201|NCT01733758|451991534|FG000|Overall Study|Persistent Hyperglycemia|3|||
125647202|NCT01733758|451991535|FG001|Overall Study|Persistent Hyperglycemia|2|||
125647203|NCT01733758|451991536|FG002|Overall Study|Persistent Hyperglycemia|0|||
125647204|NCT01733758|451991537|FG003|Overall Study|Persistent Hyperglycemia|0|||
125647205|NCT01733758|451991534|FG000|Overall Study|Protocol Violation|0|||
125647206|NCT01733758|451991535|FG001|Overall Study|Protocol Violation|1|||
125647207|NCT01733758|451991536|FG002|Overall Study|Protocol Violation|2|||
125647208|NCT01733758|451991537|FG003|Overall Study|Protocol Violation|2|||
125647209|NCT01733758|451991534|FG000|Overall Study|Non-compliance|1|||
125647210|NCT01733758|451991535|FG001|Overall Study|Non-compliance|0|||
125647211|NCT01733758|451991536|FG002|Overall Study|Non-compliance|0|||
125647212|NCT01733758|451991537|FG003|Overall Study|Non-compliance|0|||
125647213|NCT01733758|451991534|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
125647214|NCT01733758|451991535|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
125647215|NCT01733758|451991536|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
125647216|NCT01733758|451991537|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
125647217|NCT01733758|451991534|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
125647218|NCT01733758|451991535|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
125647219|NCT01733758|451991536|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
125647220|NCT01733758|451991537|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
125647221|NCT03380091|451991542|FG000|Overall Study|Withdrawal by Subject|2|||
125647222|NCT03380091|451991543|FG001|Overall Study|Withdrawal by Subject|1|||
125647223|NCT05602818|451991544|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
125647224|NCT05602818|451991545|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
125647225|NCT05602818|451991546|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
125647226|NCT05602818|451991547|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
125647227|NCT05602818|451991548|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
125647228|NCT05602818|451991549|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
125647229|NCT05602818|451991550|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
125647230|NCT05602818|451991551|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
125647231|NCT05602818|451991552|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
125647232|NCT05602818|451991553|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
125647233|NCT05602818|451991554|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
125647234|NCT05602818|451991555|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
125647235|NCT05602818|451991544|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
125647236|NCT05602818|451991545|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
125647237|NCT05602818|451991546|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125647238|NCT05602818|451991547|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125647239|NCT05602818|451991548|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125647240|NCT05602818|451991549|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125647241|NCT05602818|451991550|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125647242|NCT05602818|451991551|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125647243|NCT05602818|451991552|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125647244|NCT05602818|451991553|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125647245|NCT05602818|451991554|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125647246|NCT05602818|451991555|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
125647247|NCT05602818|451991544|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
125204169|NCT01047332|450370344|FG000|Overall Study|Lost to Follow-up|8|||
125204170|NCT01047332|450370345|FG001|Overall Study|Lost to Follow-up|3|||
125204171|NCT03521817|450370350|FG000|Overall Study|Protocol Violation|0|||
125204172|NCT03521817|450370351|FG001|Overall Study|Protocol Violation|1|||
125204173|NCT01390428|450371935|FG000|Overall Study|Elective Surgery|0|||
125204174|NCT01390428|450371936|FG001|Overall Study|Elective Surgery|0|||
125204175|NCT01390428|450371937|FG002|Overall Study|Elective Surgery|0|||
125204176|NCT01390428|450371938|FG003|Overall Study|Elective Surgery|0|||
125204177|NCT01390428|450371939|FG004|Overall Study|Elective Surgery|1|||
125204178|NCT01390428|450371940|FG005|Overall Study|Elective Surgery|0|||
125204179|NCT01390428|450371935|FG000|Overall Study|Withdrawal by Subject|0|||
125647248|NCT05602818|451991545|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125647249|NCT05602818|451991546|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125647250|NCT05602818|451991547|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125647251|NCT05602818|451991548|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125647252|NCT05602818|451991549|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125204180|NCT01390428|450371936|FG001|Overall Study|Withdrawal by Subject|0|||
125204181|NCT01390428|450371937|FG002|Overall Study|Withdrawal by Subject|1|||
125204182|NCT01390428|450371938|FG003|Overall Study|Withdrawal by Subject|0|||
125204183|NCT01390428|450371939|FG004|Overall Study|Withdrawal by Subject|0|||
125204184|NCT01390428|450371940|FG005|Overall Study|Withdrawal by Subject|0|||
125204185|NCT04322539|450371949|FG000|Overall Study|Adverse Event|2|||
125204186|NCT04322539|450371950|FG001|Overall Study|Adverse Event|0|||
125204187|NCT04322539|450371949|FG000|Overall Study|Death|411|||
125647253|NCT05602818|451991550|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125647254|NCT05602818|451991551|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125647255|NCT05602818|451991552|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125647256|NCT05602818|451991553|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125647257|NCT05602818|451991554|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125647258|NCT05602818|451991555|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
125647259|NCT05602818|451991544|FG000|Qualification Phase (3 Days)|Other|1|||
125647260|NCT05602818|451991545|FG001|Qualification Phase (3 Days)|Other|0|||
125647261|NCT05602818|451991546|FG002|Qualification Phase (3 Days)|Other|0|||
125204188|NCT04322539|450371950|FG001|Overall Study|Death|203|||
125204189|NCT04322539|450371949|FG000|Overall Study|Lost to Follow-up|3|||
125204190|NCT04322539|450371950|FG001|Overall Study|Lost to Follow-up|1|||
125204191|NCT04322539|450371949|FG000|Overall Study|Withdrawal of consent|14|||
125647262|NCT05602818|451991547|FG003|Qualification Phase (3 Days)|Other|0|||
125647263|NCT05602818|451991548|FG004|Qualification Phase (3 Days)|Other|0|||
125647264|NCT05602818|451991549|FG005|Qualification Phase (3 Days)|Other|0|||
125647265|NCT05602818|451991550|FG006|Qualification Phase (3 Days)|Other|0|||
125647266|NCT05602818|451991551|FG007|Qualification Phase (3 Days)|Other|0|||
125647267|NCT05602818|451991552|FG008|Qualification Phase (3 Days)|Other|0|||
125647268|NCT05602818|451991553|FG009|Qualification Phase (3 Days)|Other|0|||
125647269|NCT05602818|451991554|FG010|Qualification Phase (3 Days)|Other|0|||
125647270|NCT05602818|451991555|FG011|Qualification Phase (3 Days)|Other|0|||
125647271|NCT05602818|451991544|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125647272|NCT05602818|451991545|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
125647273|NCT05602818|451991546|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125647274|NCT05602818|451991547|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125647275|NCT05602818|451991548|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125647276|NCT05602818|451991549|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125647277|NCT05602818|451991550|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125647278|NCT05602818|451991551|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125647279|NCT05602818|451991552|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125647280|NCT05602818|451991553|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125647281|NCT05602818|451991554|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125647282|NCT05602818|451991555|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
125647283|NCT05602818|451991544|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
125647284|NCT05602818|451991545|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
125647285|NCT05602818|451991546|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
125647286|NCT05602818|451991547|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
125647287|NCT05602818|451991548|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
125647288|NCT05602818|451991549|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
125647289|NCT05602818|451991550|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
125647290|NCT05602818|451991551|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
125647291|NCT05602818|451991552|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
125647292|NCT05602818|451991553|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
125647293|NCT05602818|451991554|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
125647294|NCT05602818|451991555|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
125647295|NCT05602818|451991544|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125647296|NCT05602818|451991545|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125647297|NCT05602818|451991546|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125647298|NCT05602818|451991547|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125647299|NCT05602818|451991548|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125647300|NCT05602818|451991549|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125647301|NCT05602818|451991550|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125647302|NCT05602818|451991551|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125204192|NCT04322539|450371950|FG001|Overall Study|Withdrawal of consent|8|||
125204193|NCT04322539|450371949|FG000|Overall Study|Radiological Disease Progression|6|||
125204194|NCT04322539|450371950|FG001|Overall Study|Radiological Disease Progression|0|||
125647303|NCT05602818|451991552|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125204195|NCT04322539|450371949|FG000|Overall Study|Sponsor Decision|19|||
125424871|NCT00430248|451178700|FG001|Overall Study|Withdrawal by Subject|20|||
125424872|NCT00430248|451178701|FG002|Overall Study|Withdrawal by Subject|16|||
125647304|NCT05602818|451991553|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
125647305|NCT05602818|451991554|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
125647306|NCT05602818|451991555|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
125647307|NCT05602818|451991544|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
125647308|NCT05602818|451991545|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
125647309|NCT05602818|451991546|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
125647310|NCT05602818|451991547|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
125647311|NCT05602818|451991548|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
125647312|NCT05602818|451991549|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
125647313|NCT05602818|451991550|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
125647314|NCT05602818|451991551|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
125647315|NCT05602818|451991552|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
125647316|NCT05602818|451991553|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
125647317|NCT05602818|451991554|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
125647318|NCT05602818|451991555|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
125647319|NCT04594213|451991560|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
125647320|NCT04594213|451991561|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
125647321|NCT04594213|451991562|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
125647322|NCT04594213|451991563|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
125647323|NCT04594213|451991564|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
125647324|NCT04594213|451991565|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
125647325|NCT04594213|451991560|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
125647326|NCT04594213|451991561|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
125647327|NCT04594213|451991562|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
125647328|NCT04594213|451991563|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
125647329|NCT04594213|451991564|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
125647330|NCT04594213|451991565|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
125647331|NCT04594213|451991560|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
125647332|NCT04594213|451991561|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125647333|NCT04594213|451991562|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
125647334|NCT04594213|451991563|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125647335|NCT04594213|451991564|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125647336|NCT04594213|451991565|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125647337|NCT04594213|451991560|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125647338|NCT04594213|451991561|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125647339|NCT04594213|451991562|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125647340|NCT04594213|451991563|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125647341|NCT04594213|451991564|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
125647342|NCT04594213|451991565|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125647343|NCT04594213|451991560|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
125647344|NCT04594213|451991561|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
125647345|NCT04594213|451991562|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
125647346|NCT04594213|451991563|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
125647347|NCT04594213|451991564|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
125647348|NCT04594213|451991565|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
125647349|NCT04594213|451991560|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125647350|NCT04594213|451991561|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125647351|NCT04594213|451991562|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125647352|NCT04594213|451991563|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125647353|NCT04594213|451991564|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125647354|NCT04594213|451991565|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
125647355|NCT04594213|451991560|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125647356|NCT04594213|451991561|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125647357|NCT04594213|451991562|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125647358|NCT04594213|451991563|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
125647359|NCT04594213|451991564|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125647360|NCT04594213|451991565|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125647361|NCT04594213|451991560|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
125647362|NCT04594213|451991561|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
125647363|NCT04594213|451991562|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
125647364|NCT04594213|451991563|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
125647365|NCT04594213|451991564|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
125647366|NCT04594213|451991565|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
125647367|NCT04594213|451991560|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
125647368|NCT04594213|451991561|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
125647369|NCT04594213|451991562|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
125647370|NCT04594213|451991563|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
125647371|NCT04594213|451991564|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
125647372|NCT04594213|451991565|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
125647373|NCT04594213|451991560|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
125647374|NCT04594213|451991561|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
125647375|NCT04594213|451991562|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
125647376|NCT04594213|451991563|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
125647377|NCT04594213|451991564|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
125647378|NCT04594213|451991565|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
125647379|NCT04594213|451991560|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
125647380|NCT04594213|451991561|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
125647381|NCT04594213|451991562|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
125647382|NCT04594213|451991563|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
125647383|NCT04594213|451991564|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
125647384|NCT04594213|451991565|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
125647385|NCT03814499|451991567|FG000|Overall Study|Lost to Follow-up|3|||
125647386|NCT01589185|451991568|FG000|Overall Study|Death|1|||
125647387|NCT01589185|451991569|FG001|Overall Study|Death|2|||
125647388|NCT01589185|451991570|FG002|Overall Study|Death|2|||
125647389|NCT01589185|451991571|FG003|Overall Study|Death|0|||
125647390|NCT01589185|451991572|FG004|Overall Study|Death|1|||
125647391|NCT01589185|451991568|FG000|Overall Study|Lost to Follow-up|1|||
125647392|NCT01589185|451991569|FG001|Overall Study|Lost to Follow-up|0|||
125647393|NCT01589185|451991570|FG002|Overall Study|Lost to Follow-up|2|||
125647394|NCT01589185|451991571|FG003|Overall Study|Lost to Follow-up|3|||
125647395|NCT01589185|451991572|FG004|Overall Study|Lost to Follow-up|0|||
125647396|NCT02046993|451991573|FG000|Overall Study|Withdrawal by Subject|2|||
125647397|NCT02046993|451991574|FG001|Overall Study|Withdrawal by Subject|10|||
125647398|NCT02046993|451991573|FG000|Overall Study|Lost to Follow-up|1|||
125647399|NCT02046993|451991574|FG001|Overall Study|Lost to Follow-up|1|||
125647400|NCT00598442|451991577|FG000|Overall Study|Adverse Event|3|||
125647401|NCT00598442|451991578|FG001|Overall Study|Adverse Event|0|||
125647402|NCT00598442|451991579|FG002|Overall Study|Adverse Event|0|||
125647403|NCT00598442|451991577|FG000|Overall Study|Death|19|||
125647404|NCT00598442|451991578|FG001|Overall Study|Death|11|||
125647405|NCT00598442|451991579|FG002|Overall Study|Death|11|||
125647406|NCT00598442|451991577|FG000|Overall Study|Lost to Follow-up|4|||
125647407|NCT00598442|451991578|FG001|Overall Study|Lost to Follow-up|3|||
125647408|NCT00598442|451991579|FG002|Overall Study|Lost to Follow-up|3|||
125647409|NCT00598442|451991577|FG000|Overall Study|Physician Decision|2|||
125647410|NCT00598442|451991578|FG001|Overall Study|Physician Decision|1|||
125647411|NCT00598442|451991579|FG002|Overall Study|Physician Decision|1|||
125647412|NCT00598442|451991577|FG000|Overall Study|Withdrawal by Subject|8|||
125647413|NCT00598442|451991578|FG001|Overall Study|Withdrawal by Subject|16|||
125647414|NCT00598442|451991579|FG002|Overall Study|Withdrawal by Subject|6|||
125647415|NCT00598442|451991577|FG000|Overall Study|Noncompliance|0|||
125647416|NCT00598442|451991578|FG001|Overall Study|Noncompliance|2|||
125647417|NCT00598442|451991579|FG002|Overall Study|Noncompliance|1|||
125647418|NCT00598442|451991577|FG000|Overall Study|Relocation|1|||
125647419|NCT00598442|451991578|FG001|Overall Study|Relocation|4|||
125647420|NCT00598442|451991579|FG002|Overall Study|Relocation|0|||
125647421|NCT00598442|451991577|FG000|Overall Study|Renal transplant|0|||
125647422|NCT00598442|451991578|FG001|Overall Study|Renal transplant|0|||
125647423|NCT00598442|451991579|FG002|Overall Study|Renal transplant|1|||
125647424|NCT00598442|451991577|FG000|Overall Study|Site closed by sponsor|5|||
125647425|NCT00598442|451991578|FG001|Overall Study|Site closed by sponsor|2|||
125647426|NCT00598442|451991579|FG002|Overall Study|Site closed by sponsor|1|||
125647427|NCT00598442|451991577|FG000|Overall Study|Started dialysis|1|||
125647428|NCT00598442|451991578|FG001|Overall Study|Started dialysis|0|||
125647429|NCT00598442|451991579|FG002|Overall Study|Started dialysis|0|||
125647430|NCT01729559|451991585|FG000|Overall Study|Protocol Violation|31|||
125647431|NCT01729559|451991586|FG001|Overall Study|Protocol Violation|28|||
125647432|NCT03764813|451991591|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
125647433|NCT03764813|451991592|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
125647434|NCT03764813|451991593|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
125647435|NCT03764813|451991594|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
125647436|NCT01654666|451991599|FG000|Overall Study|Protocol Violation|7|||
125647437|NCT01654666|451991600|FG001|Overall Study|Protocol Violation|4|||
125647438|NCT01654666|451991601|FG002|Overall Study|Protocol Violation|8|||
125647439|NCT01654666|451991599|FG000|Overall Study|Lost to Follow-up|4|||
125647440|NCT01654666|451991600|FG001|Overall Study|Lost to Follow-up|5|||
125647441|NCT01654666|451991601|FG002|Overall Study|Lost to Follow-up|5|||
125647442|NCT01654666|451991599|FG000|Overall Study|Withdrawal by Subject|4|||
125647443|NCT01654666|451991600|FG001|Overall Study|Withdrawal by Subject|4|||
125647444|NCT01654666|451991601|FG002|Overall Study|Withdrawal by Subject|1|||
125647445|NCT00535262|451991602|FG000|Overall Study|No funding|3|||
125647446|NCT02898662|451991603|FG000|Overall Study|Adverse Event|1|||
125647447|NCT02898662|451991604|FG001|Overall Study|Adverse Event|0|||
125647448|NCT02898662|451991603|FG000|Overall Study|Loss of asthma control|23|||
125647449|NCT02898662|451991604|FG001|Overall Study|Loss of asthma control|24|||
125647450|NCT02898662|451991603|FG000|Overall Study|Withdrawal by Subject|4|||
125647451|NCT02898662|451991604|FG001|Overall Study|Withdrawal by Subject|1|||
125647452|NCT02898662|451991603|FG000|Overall Study|Technical issue|0|||
125647453|NCT02898662|451991604|FG001|Overall Study|Technical issue|1|||
125647454|NCT02898662|451991603|FG000|Overall Study|Randomized in error|0|||
125647455|NCT02898662|451991604|FG001|Overall Study|Randomized in error|1|||
125647456|NCT02898662|451991603|FG000|Overall Study|Subject decision|1|||
125647457|NCT02898662|451991604|FG001|Overall Study|Subject decision|0|||
125647458|NCT02898662|451991603|FG000|Overall Study|Other|0|||
125647459|NCT02898662|451991604|FG001|Overall Study|Other|1|||
125647460|NCT00917553|451991605|FG000|Overall Study|Lost to Follow-up|2|||
125647461|NCT00917553|451991606|FG001|Overall Study|Lost to Follow-up|1|||
125647462|NCT01616173|451991607|FG000|Overall Study|Lost to Follow-up|0|||
125647463|NCT01616173|451991608|FG001|Overall Study|Lost to Follow-up|2|||
125647464|NCT01616173|451991609|FG002|Overall Study|Lost to Follow-up|0|||
125647465|NCT03432819|451991612|FG000|Overall Study|Lost to Follow-up|2|||
125647466|NCT03432819|451991613|FG001|Overall Study|Lost to Follow-up|2|||
125647467|NCT03432819|451991612|FG000|Overall Study|Withdrawal by Subject|5|||
125647468|NCT03432819|451991613|FG001|Overall Study|Withdrawal by Subject|3|||
125647469|NCT04738123|451991616|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
125647470|NCT04738123|451991617|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
125647471|NCT04738123|451991616|FG000|Overall Study|Progressive Disease|0|||
125647472|NCT04738123|451991617|FG001|Overall Study|Progressive Disease|4|||
125647473|NCT04738123|451991616|FG000|Overall Study|Adverse Event|8|||
125647474|NCT04738123|451991617|FG001|Overall Study|Adverse Event|7|||
125647475|NCT04738123|451991616|FG000|Overall Study|Other Reasons|0|||
125647476|NCT04738123|451991617|FG001|Overall Study|Other Reasons|1|||
125647477|NCT04738123|451991616|FG000|Overall Study|Suicidal or assaultive behavior|0|||
125647478|NCT04738123|451991617|FG001|Overall Study|Suicidal or assaultive behavior|2|||
125647479|NCT04738123|451991616|FG000|Overall Study|Protocol Violation|2|||
125647480|NCT04738123|451991617|FG001|Overall Study|Protocol Violation|2|||
125647481|NCT04738123|451991616|FG000|Overall Study|Consent Withdrawn|35|||
125647482|NCT04738123|451991617|FG001|Overall Study|Consent Withdrawn|22|||
125647483|NCT03604159|451991618|FG000|Overall Study|Lost to Follow-up|6|||
125647484|NCT03604159|451991619|FG001|Overall Study|Lost to Follow-up|7|||
125647485|NCT00787527|451991622|FG000|Overall Study|Toxicity|3|||
125647486|NCT00083616|451991625|FG000|Overall Study|Disease Progression|16|||
125647487|NCT00083616|451991625|FG000|Overall Study|Lost to Follow-up|1|||
125647488|NCT00083616|451991625|FG000|Overall Study|Physician Decision|2|||
125647489|NCT00083616|451991625|FG000|Overall Study|Withdrawal by Subject|3|||
125647490|NCT00083616|451991625|FG000|Overall Study|Ineligibility determined|2|||
125647491|NCT00083616|451991625|FG000|Overall Study|Non-compliance|1|||
125647492|NCT00083616|451991625|FG000|Overall Study|Other|6|||
125647493|NCT01474993|451991628|FG000|Overall Study|Lost to Follow-up|1|||
125647494|NCT01474993|451991629|FG001|Overall Study|Lost to Follow-up|2|||
125647495|NCT01474993|451991628|FG000|Overall Study|Adverse Event|0|||
125647496|NCT01474993|451991629|FG001|Overall Study|Adverse Event|1|||
125647497|NCT03258710|451991630|FG000|Overall Study|Adverse Event|1|||
125647498|NCT03258710|451991630|FG000|Overall Study|Protocol-defined stopping criteria|1|||
125647499|NCT03258710|451991630|FG000|Overall Study|Physician Decision|1|||
125647500|NCT02242305|451991631|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
125647501|NCT02242305|451991632|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
125647502|NCT02242305|451991631|FG000|Overall Study|Adverse Event|1|||
125647503|NCT02242305|451991632|FG001|Overall Study|Adverse Event|0|||
125647504|NCT02242305|451991631|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
125647505|NCT02242305|451991632|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
125647506|NCT02242305|451991631|FG000|Overall Study|Subject withdraws inform consent|0|||
125647507|NCT02242305|451991632|FG001|Overall Study|Subject withdraws inform consent|4|||
125647508|NCT02242305|451991631|FG000|Overall Study|Lost to Follow-up|2|||
125647509|NCT02242305|451991632|FG001|Overall Study|Lost to Follow-up|0|||
125647510|NCT03137173|451991633|FG000|Overall Study|Withdrawal by Subject|8|||
125647511|NCT03137173|451991634|FG001|Overall Study|Withdrawal by Subject|13|||
125647512|NCT03137173|451991633|FG000|Overall Study|Death|1|||
125647513|NCT03137173|451991634|FG001|Overall Study|Death|3|||
125647514|NCT03137173|451991633|FG000|Overall Study|Physician Decision|1|||
125647515|NCT03137173|451991634|FG001|Overall Study|Physician Decision|0|||
125647516|NCT03137173|451991633|FG000|Overall Study|Lost to Follow-up|13|||
125647517|NCT03137173|451991634|FG001|Overall Study|Lost to Follow-up|18|||
125647518|NCT03137173|451991633|FG000|Overall Study|Other reasons|3|||
125647519|NCT03137173|451991634|FG001|Overall Study|Other reasons|2|||
125647520|NCT03044730|451991645|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
125647521|NCT03044730|451991645|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
125647522|NCT03044730|451991645|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
125647523|NCT03044730|451991645|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
125647524|NCT03044730|451991645|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
125647525|NCT03044730|451991645|FG000|Cycles 4 and Beyond|Adverse Event|1|||
125647526|NCT03044730|451991645|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
125647527|NCT03044730|451991645|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
125647528|NCT03044730|451991645|FG000|On Follow-up for 2 Years|Death|17|||
125647529|NCT00690612|451993471|FG000|Overall Study|Adverse Event|1|||
125647530|NCT00690612|451993471|FG000|Overall Study|Withdrawal by Subject|2|||
125647531|NCT00911508|451993472|FG000|Overall Study|Lost to Follow-up|27|||
125647532|NCT00911508|451993473|FG001|Overall Study|Lost to Follow-up|18|||
125647533|NCT00911508|451993472|FG000|Overall Study|Withdrawal by Subject|79|||
125647534|NCT00911508|451993473|FG001|Overall Study|Withdrawal by Subject|112|||
125647535|NCT01409382|451993474|FG000|Overall Study|Lost to Follow-up|1|||
125647536|NCT01409382|451993475|FG001|Overall Study|Lost to Follow-up|1|||
125647537|NCT01409382|451993474|FG000|Overall Study|Protocol Violation|0|||
125647538|NCT01409382|451993475|FG001|Overall Study|Protocol Violation|3|||
125647539|NCT01409382|451993474|FG000|Overall Study|Multiple pregnancy|2|||
125647540|NCT01409382|451993475|FG001|Overall Study|Multiple pregnancy|4|||
125647541|NCT01409382|451993474|FG000|Overall Study|Still pregnant when study ended|13|||
125647542|NCT01409382|451993475|FG001|Overall Study|Still pregnant when study ended|2|||
125647543|NCT01409382|451993474|FG000|Overall Study|Did not manage to get pregnant|64|||
125647544|NCT01409382|451993475|FG001|Overall Study|Did not manage to get pregnant|70|||
125647545|NCT01409382|451993474|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
125647546|NCT01409382|451993475|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
125647547|NCT01233076|451993476|FG000|Period 2, One Week|Lost to Follow-up|1|||
125647548|NCT01233076|451993477|FG001|Period 2, One Week|Lost to Follow-up|0|||
125647549|NCT01786707|451993479|FG000|Overall Study|Lost to Follow-up|1|||
125647550|NCT01786707|451993480|FG001|Overall Study|Lost to Follow-up|1|||
125647551|NCT02058940|451993482|FG000|Overall Study|Discharged from Critical Care Unit|1|||
125647552|NCT01519700|451993483|FG000|Overall Study|Death|1|||
125647553|NCT01519700|451993484|FG001|Overall Study|Death|0|||
125647554|NCT01519700|451993485|FG002|Overall Study|Death|0|||
125647555|NCT01519700|451993486|FG003|Overall Study|Death|0|||
125647556|NCT01519700|451993483|FG000|Overall Study|Lost to Follow-up|0|||
125647557|NCT01519700|451993484|FG001|Overall Study|Lost to Follow-up|0|||
125647558|NCT01519700|451993485|FG002|Overall Study|Lost to Follow-up|1|||
125647559|NCT01519700|451993486|FG003|Overall Study|Lost to Follow-up|1|||
125647560|NCT01519700|451993483|FG000|Overall Study|Physician Decision|1|||
125647561|NCT01519700|451993484|FG001|Overall Study|Physician Decision|1|||
125647562|NCT01519700|451993485|FG002|Overall Study|Physician Decision|3|||
125647563|NCT01519700|451993486|FG003|Overall Study|Physician Decision|0|||
125647564|NCT01519700|451993483|FG000|Overall Study|Withdrawal by Subject|5|||
125647565|NCT01519700|451993484|FG001|Overall Study|Withdrawal by Subject|3|||
125647566|NCT01519700|451993485|FG002|Overall Study|Withdrawal by Subject|3|||
125647567|NCT01519700|451993486|FG003|Overall Study|Withdrawal by Subject|2|||
125647568|NCT01519700|451993483|FG000|Overall Study|Other Reason|2|||
125647569|NCT01519700|451993484|FG001|Overall Study|Other Reason|2|||
125647570|NCT01519700|451993485|FG002|Overall Study|Other Reason|0|||
125647571|NCT01519700|451993486|FG003|Overall Study|Other Reason|4|||
125647572|NCT01789476|451993492|FG000|Overall Study|Lack of Efficacy|6|||
125647573|NCT01789476|451993493|FG001|Overall Study|Lack of Efficacy|2|||
125647574|NCT01789476|451993492|FG000|Overall Study|Adverse Event|1|||
125647575|NCT01789476|451993493|FG001|Overall Study|Adverse Event|0|||
125647576|NCT01789476|451993492|FG000|Overall Study|Unable to get IV access|1|||
125647577|NCT01789476|451993493|FG001|Overall Study|Unable to get IV access|0|||
125647578|NCT00965458|451993494|FG000|Overall Study|Adverse Event|1|||
125647579|NCT00965458|451993495|FG001|Overall Study|Adverse Event|0|||
125647580|NCT00965458|451993494|FG000|Overall Study|Lost to Follow-up|1|||
125647581|NCT00965458|451993495|FG001|Overall Study|Lost to Follow-up|3|||
125647582|NCT00965458|451993494|FG000|Overall Study|Withdrawal by Subject|0|||
125647583|NCT00965458|451993495|FG001|Overall Study|Withdrawal by Subject|1|||
125647584|NCT04177862|451993502|FG000|Overall Study|Protocol Violation|2|||
125647585|NCT04177862|451993503|FG001|Overall Study|Protocol Violation|7|||
125647586|NCT00379639|451993504|FG000|Overall Study|Disease Progression|3|||
125647587|NCT00379639|451993505|FG001|Overall Study|Disease Progression|3|||
125647588|NCT00379639|451993506|FG002|Overall Study|Disease Progression|3|||
125647589|NCT00379639|451993507|FG003|Overall Study|Disease Progression|4|||
125647590|NCT00379639|451993508|FG004|Overall Study|Disease Progression|4|||
125647591|NCT00379639|451993504|FG000|Overall Study|Physician Decision|0|||
125647592|NCT00379639|451993505|FG001|Overall Study|Physician Decision|2|||
125647593|NCT00379639|451993506|FG002|Overall Study|Physician Decision|1|||
125204196|NCT04322539|450371950|FG001|Overall Study|Sponsor Decision|14|||
125204197|NCT04322539|450371949|FG000|Overall Study|Other|6|||
125647594|NCT00379639|451993507|FG003|Overall Study|Physician Decision|1|||
125647595|NCT00379639|451993508|FG004|Overall Study|Physician Decision|0|||
125647596|NCT00379639|451993504|FG000|Overall Study|Symptomatic Deterioration|0|||
125647597|NCT00379639|451993505|FG001|Overall Study|Symptomatic Deterioration|0|||
125647598|NCT00379639|451993506|FG002|Overall Study|Symptomatic Deterioration|1|||
125647599|NCT00379639|451993507|FG003|Overall Study|Symptomatic Deterioration|0|||
125647600|NCT00379639|451993508|FG004|Overall Study|Symptomatic Deterioration|1|||
125647601|NCT00379639|451993504|FG000|Overall Study|Adverse Event|0|||
125647602|NCT00379639|451993505|FG001|Overall Study|Adverse Event|0|||
125647603|NCT00379639|451993506|FG002|Overall Study|Adverse Event|1|||
125647604|NCT00379639|451993507|FG003|Overall Study|Adverse Event|0|||
125647605|NCT00379639|451993508|FG004|Overall Study|Adverse Event|1|||
125647606|NCT00379639|451993504|FG000|Overall Study|Lost to Follow-up|0|||
125647607|NCT00379639|451993505|FG001|Overall Study|Lost to Follow-up|0|||
125647608|NCT00379639|451993506|FG002|Overall Study|Lost to Follow-up|0|||
125647609|NCT00379639|451993507|FG003|Overall Study|Lost to Follow-up|1|||
125647610|NCT00379639|451993508|FG004|Overall Study|Lost to Follow-up|0|||
125647611|NCT00379639|451993504|FG000|Overall Study|Other|0|||
125647612|NCT00379639|451993505|FG001|Overall Study|Other|0|||
125647613|NCT00379639|451993506|FG002|Overall Study|Other|3|||
125647614|NCT00379639|451993507|FG003|Overall Study|Other|0|||
125647615|NCT00379639|451993508|FG004|Overall Study|Other|0|||
125647616|NCT00594958|451993509|FG000|Overall Study|Withdrawal by Subject|1|||
125647617|NCT00594958|451993510|FG001|Overall Study|Withdrawal by Subject|0|||
125647618|NCT00594958|451993511|FG002|Overall Study|Withdrawal by Subject|1|||
125647619|NCT00594958|451993509|FG000|Overall Study|Adverse Event|4|||
125647620|NCT00594958|451993510|FG001|Overall Study|Adverse Event|1|||
125647621|NCT00594958|451993511|FG002|Overall Study|Adverse Event|2|||
125647622|NCT00594958|451993509|FG000|Overall Study|Pregnancy|0|||
125647623|NCT00594958|451993510|FG001|Overall Study|Pregnancy|2|||
125647624|NCT00594958|451993511|FG002|Overall Study|Pregnancy|0|||
125647625|NCT00594958|451993509|FG000|Overall Study|Protocol Violation|1|||
125647626|NCT00594958|451993510|FG001|Overall Study|Protocol Violation|0|||
125647627|NCT00594958|451993511|FG002|Overall Study|Protocol Violation|2|||
125647628|NCT00594958|451993509|FG000|Overall Study|Lost to Follow-up|5|||
125647629|NCT00594958|451993510|FG001|Overall Study|Lost to Follow-up|0|||
125647630|NCT00594958|451993511|FG002|Overall Study|Lost to Follow-up|3|||
125647631|NCT00594958|451993509|FG000|Overall Study|administrative|3|||
125647632|NCT00594958|451993510|FG001|Overall Study|administrative|0|||
125647633|NCT00594958|451993511|FG002|Overall Study|administrative|2|||
125647634|NCT05637515|451993512|FG000|Overall Study|Withdrawal by Subject|17|||
125647635|NCT05637515|451993513|FG001|Overall Study|Withdrawal by Subject|17|||
125647636|NCT03233009|451993514|FG000|Overall Study|Lost to Follow-up|1|||
125647637|NCT00278473|451993516|FG000|Overall Study|drop out|4|||
125647638|NCT00278473|451993517|FG001|Overall Study|drop out|3|||
125647639|NCT03039686|451993518|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
125647640|NCT03039686|451993519|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
125647641|NCT03039686|451993520|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
125647642|NCT03039686|451993518|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
125647643|NCT03039686|451993519|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
125647644|NCT03039686|451993520|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
125647645|NCT03039686|451993518|FG000|Double-blind Period|Withdrawal by Subject|2|||
125647646|NCT03039686|451993519|FG001|Double-blind Period|Withdrawal by Subject|2|||
125647647|NCT03039686|451993520|FG002|Double-blind Period|Withdrawal by Subject|1|||
125647648|NCT03039686|451993518|FG000|Double-blind Period|Death|0|||
125647649|NCT03039686|451993519|FG001|Double-blind Period|Death|0|||
125647650|NCT03039686|451993520|FG002|Double-blind Period|Death|1|||
125647651|NCT03039686|451993518|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
125647652|NCT03039686|451993519|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
125647653|NCT03039686|451993520|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
125647654|NCT03039686|451993518|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
125647655|NCT03039686|451993519|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
125647656|NCT03039686|451993520|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
125647657|NCT03039686|451993518|FG000|Open Label Period|Withdrawal by Subject|0|||
125647658|NCT03039686|451993519|FG001|Open Label Period|Withdrawal by Subject|3|||
125647659|NCT03039686|451993520|FG002|Open Label Period|Withdrawal by Subject|1|||
125647660|NCT02158949|451993521|FG000|Overall Study|Withdrawal by Subject|1|||
125647661|NCT02158949|451993522|FG001|Overall Study|Withdrawal by Subject|0|||
125647662|NCT02158949|451993521|FG000|Overall Study|Lost to Follow-up|5|||
125647663|NCT02158949|451993522|FG001|Overall Study|Lost to Follow-up|11|||
125647664|NCT02322866|451993523|FG000|Overall Study|Adverse Event|6|||
125647665|NCT02322866|451993524|FG001|Overall Study|Adverse Event|11|||
125647666|NCT02322866|451993523|FG000|Overall Study|Withdrawal of Consent|16|||
125647667|NCT02322866|451993524|FG001|Overall Study|Withdrawal of Consent|25|||
125204198|NCT04322539|450371950|FG001|Overall Study|Other|4|||
125204199|NCT01702532|450371951|FG000|Overall Study|Adverse Event|0|||
125647668|NCT02322866|451993523|FG000|Overall Study|Lost to Follow-up|36|||
125647669|NCT02322866|451993524|FG001|Overall Study|Lost to Follow-up|39|||
125647670|NCT02322866|451993523|FG000|Overall Study|Protocol Violation|1|||
125647671|NCT02322866|451993524|FG001|Overall Study|Protocol Violation|0|||
125647672|NCT02322866|451993523|FG000|Overall Study|Noncompliance with Treatment|3|||
125647673|NCT02322866|451993524|FG001|Overall Study|Noncompliance with Treatment|4|||
125647674|NCT02322866|451993523|FG000|Overall Study|Lack of Efficacy|3|||
125647675|NCT02322866|451993524|FG001|Overall Study|Lack of Efficacy|1|||
125647676|NCT02322866|451993523|FG000|Overall Study|Other Miscellaneous Reasons|6|||
125647677|NCT02322866|451993524|FG001|Overall Study|Other Miscellaneous Reasons|6|||
125647678|NCT00656136|451993532|FG000|Overall Study|Progressive disease|177|||
125647679|NCT00656136|451993533|FG001|Overall Study|Progressive disease|322|||
125647680|NCT00656136|451993532|FG000|Overall Study|Other Adverse Event|5|||
125647681|NCT00656136|451993533|FG001|Overall Study|Other Adverse Event|51|||
125647682|NCT00656136|451993532|FG000|Overall Study|Protocol Violation|2|||
125647683|NCT00656136|451993533|FG001|Overall Study|Protocol Violation|3|||
125647684|NCT00656136|451993532|FG000|Overall Study|Patient refused to take study medication|7|||
125647685|NCT00656136|451993533|FG001|Overall Study|Patient refused to take study medication|10|||
125647686|NCT00656136|451993532|FG000|Overall Study|Unknown and others|4|||
125647687|NCT00656136|451993533|FG001|Overall Study|Unknown and others|4|||
125647688|NCT02505945|451993534|FG000|Overall Study|Withdrawal by Subject|13|||
125647689|NCT02505945|451993535|FG001|Overall Study|Withdrawal by Subject|2|||
125647690|NCT02505945|451993534|FG000|Overall Study|Adverse Event|1|||
125647691|NCT02505945|451993535|FG001|Overall Study|Adverse Event|0|||
125647692|NCT02505945|451993534|FG000|Overall Study|Physician Decision|2|||
125647693|NCT02505945|451993535|FG001|Overall Study|Physician Decision|1|||
125647694|NCT02505945|451993534|FG000|Overall Study|Lost to Follow-up|6|||
125647695|NCT02505945|451993535|FG001|Overall Study|Lost to Follow-up|1|||
125647696|NCT00635804|451993536|FG000|Overall Study|Adverse Event|0|||
125647697|NCT00635804|451993537|FG001|Overall Study|Adverse Event|0|||
125647698|NCT00635804|451993538|FG002|Overall Study|Adverse Event|0|||
125647699|NCT00635804|451993539|FG003|Overall Study|Adverse Event|0|||
125647700|NCT00635804|451993540|FG004|Overall Study|Adverse Event|0|||
125647701|NCT00635804|451993541|FG005|Overall Study|Adverse Event|1|||
125647702|NCT00635804|451993542|FG006|Overall Study|Adverse Event|0|||
125647703|NCT00635804|451993543|FG007|Overall Study|Adverse Event|0|||
125647704|NCT00635804|451993536|FG000|Overall Study|Withdrawal by Subject|1|||
125647705|NCT00635804|451993537|FG001|Overall Study|Withdrawal by Subject|0|||
125647706|NCT00635804|451993538|FG002|Overall Study|Withdrawal by Subject|0|||
125647707|NCT00635804|451993539|FG003|Overall Study|Withdrawal by Subject|0|||
125647708|NCT00635804|451993540|FG004|Overall Study|Withdrawal by Subject|0|||
125647709|NCT00635804|451993541|FG005|Overall Study|Withdrawal by Subject|0|||
125647710|NCT00635804|451993542|FG006|Overall Study|Withdrawal by Subject|0|||
125647711|NCT00635804|451993543|FG007|Overall Study|Withdrawal by Subject|0|||
125647712|NCT02718131|451993544|FG000|Overall Study|Withdrawal by Subject|1|||
125647713|NCT02718131|451993545|FG001|Overall Study|Withdrawal by Subject|0|||
125647714|NCT02718131|451993544|FG000|Overall Study|Adverse Event|1|||
125647715|NCT02718131|451993545|FG001|Overall Study|Adverse Event|0|||
125647716|NCT02718131|451993544|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
125647717|NCT02718131|451993545|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
125647718|NCT01097057|451993546|FG000|Overall Study|Physician Decision|3|||
125647719|NCT01101321|451993547|FG000|Period 1|Withdrawal by Subject|1|||
125647720|NCT01101321|451993548|FG001|Period 1|Withdrawal by Subject|1|||
125647721|NCT01101321|451993547|FG000|Period 1|Adverse Event|3|||
125647722|NCT01101321|451993548|FG001|Period 1|Adverse Event|3|||
125647723|NCT01270139|451993549|FG000|Overall Study|Adverse Event|8|||
125647724|NCT01270139|451993550|FG001|Overall Study|Adverse Event|17|||
125647725|NCT01270139|451993551|FG002|Overall Study|Adverse Event|18|||
125647726|NCT01270139|451993549|FG000|Overall Study|Lost to Follow-up|10|||
125647727|NCT01270139|451993550|FG001|Overall Study|Lost to Follow-up|9|||
125647728|NCT01270139|451993551|FG002|Overall Study|Lost to Follow-up|2|||
125647729|NCT02452320|451993552|FG000|Overall Study|Adverse Event|0|||
125647730|NCT02452320|451993553|FG001|Overall Study|Adverse Event|1|||
125647731|NCT03198559|451993554|FG000|Overall Study|Adverse Event|2|||
125647732|NCT01072175|451993555|FG000|Part A (Drug-Drug Interaction)|Death|1|||
125647733|NCT01072175|451993556|FG001|Part A (Drug-Drug Interaction)|Death|0|||
125647734|NCT01072175|451993557|FG002|Part A (Drug-Drug Interaction)|Death|0|||
125647735|NCT01072175|451993558|FG003|Part A (Drug-Drug Interaction)|Death|0|||
125647736|NCT01072175|451993559|FG004|Part A (Drug-Drug Interaction)|Death|0|||
125647737|NCT01072175|451993560|FG005|Part A (Drug-Drug Interaction)|Death|0|||
125647738|NCT01072175|451993561|FG006|Part A (Drug-Drug Interaction)|Death|0|||
125647739|NCT01072175|451993562|FG007|Part A (Drug-Drug Interaction)|Death|0|||
125647740|NCT01072175|451993563|FG008|Part A (Drug-Drug Interaction)|Death|0|||
125647741|NCT01072175|451993564|FG009|Part A (Drug-Drug Interaction)|Death|0|||
125647742|NCT01072175|451993565|FG010|Part A (Drug-Drug Interaction)|Death|0|||
125647743|NCT01072175|451993566|FG011|Part A (Drug-Drug Interaction)|Death|0|||
125647744|NCT01072175|451993567|FG012|Part A (Drug-Drug Interaction)|Death|0|||
125647745|NCT01072175|451993555|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
125647746|NCT01072175|451993556|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125647747|NCT01072175|451993557|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125647748|NCT01072175|451993558|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125647749|NCT01072175|451993559|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125204200|NCT01702532|450371952|FG001|Overall Study|Adverse Event|1|||
125204201|NCT01451164|450371953|FG000|Overall Study|Adverse Event|19|||
125647750|NCT01072175|451993560|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125647751|NCT01072175|451993561|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125647752|NCT01072175|451993562|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125647753|NCT01072175|451993563|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125647754|NCT01072175|451993564|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125647755|NCT01072175|451993565|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125647756|NCT01072175|451993566|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125647757|NCT01072175|451993567|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
125647758|NCT01072175|451993555|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
125647759|NCT01072175|451993556|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125647760|NCT01072175|451993557|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125647761|NCT01072175|451993558|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125647762|NCT01072175|451993559|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125647763|NCT01072175|451993560|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125647764|NCT01072175|451993561|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125647765|NCT01072175|451993562|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125647766|NCT01072175|451993563|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125647767|NCT01072175|451993564|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125647768|NCT01072175|451993565|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125647769|NCT01072175|451993566|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125647770|NCT01072175|451993567|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
125647771|NCT01072175|451993555|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
125647772|NCT01072175|451993556|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
125647773|NCT01072175|451993557|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
125647774|NCT01072175|451993558|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
125647775|NCT01072175|451993559|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
125647776|NCT01072175|451993560|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
125647777|NCT01072175|451993561|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
125647778|NCT01072175|451993562|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
125647779|NCT01072175|451993563|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
125647780|NCT01072175|451993564|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
125647781|NCT01072175|451993565|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
125647782|NCT01072175|451993566|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
125647783|NCT01072175|451993567|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
125647784|NCT01072175|451993555|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125647785|NCT01072175|451993556|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125647786|NCT01072175|451993557|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
125647787|NCT01072175|451993558|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125647788|NCT01072175|451993559|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
125647789|NCT01072175|451993560|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125647790|NCT01072175|451993561|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125647791|NCT01072175|451993562|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125647792|NCT01072175|451993563|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125647793|NCT01072175|451993564|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125647794|NCT01072175|451993565|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125647795|NCT01072175|451993566|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125647796|NCT01072175|451993567|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
125647797|NCT01072175|451993555|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125647798|NCT01072175|451993556|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
125647799|NCT01072175|451993557|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125647800|NCT01072175|451993558|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
125647801|NCT01072175|451993559|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
125647802|NCT01072175|451993560|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125647803|NCT01072175|451993561|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125647804|NCT01072175|451993562|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125647805|NCT01072175|451993563|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125647806|NCT01072175|451993564|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125647807|NCT01072175|451993565|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125647808|NCT01072175|451993566|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125647809|NCT01072175|451993567|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
125647810|NCT01072175|451993555|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125647811|NCT01072175|451993556|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125647812|NCT01072175|451993557|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
125647813|NCT01072175|451993558|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
125647814|NCT01072175|451993559|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
125647815|NCT01072175|451993560|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125647816|NCT01072175|451993561|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125647817|NCT01072175|451993562|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125647818|NCT01072175|451993563|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125647819|NCT01072175|451993564|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125647820|NCT01072175|451993565|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125647821|NCT01072175|451993566|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125647822|NCT01072175|451993567|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
125647823|NCT01072175|451993555|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125647824|NCT01072175|451993556|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
125647825|NCT01072175|451993557|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125647826|NCT01072175|451993558|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
125647827|NCT01072175|451993559|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
125647828|NCT01072175|451993560|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125647829|NCT01072175|451993561|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125647830|NCT01072175|451993562|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125647831|NCT01072175|451993563|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125647832|NCT01072175|451993564|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125647833|NCT01072175|451993565|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125647834|NCT01072175|451993566|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125647835|NCT01072175|451993567|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
125647836|NCT01072175|451993555|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
125647837|NCT01072175|451993556|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
125647838|NCT01072175|451993557|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
125647839|NCT01072175|451993558|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
125647840|NCT01072175|451993559|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
125647841|NCT01072175|451993560|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
125647842|NCT01072175|451993561|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
125647843|NCT01072175|451993562|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
125647844|NCT01072175|451993563|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
125647845|NCT01072175|451993564|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
125204202|NCT01451164|450371954|FG001|Overall Study|Adverse Event|12|||
125204203|NCT01451164|450371955|FG002|Overall Study|Adverse Event|18|||
125204204|NCT01451164|450371956|FG003|Overall Study|Adverse Event|21|||
125204205|NCT01451164|450371953|FG000|Overall Study|Withdrawal Criteria|1|||
125204206|NCT01451164|450371954|FG001|Overall Study|Withdrawal Criteria|1|||
125204207|NCT01451164|450371955|FG002|Overall Study|Withdrawal Criteria|1|||
125204208|NCT01451164|450371956|FG003|Overall Study|Withdrawal Criteria|1|||
125204209|NCT01451164|450371953|FG000|Overall Study|Physician Decision|2|||
125204210|NCT01451164|450371954|FG001|Overall Study|Physician Decision|0|||
125204211|NCT01451164|450371955|FG002|Overall Study|Physician Decision|1|||
125204212|NCT01451164|450371956|FG003|Overall Study|Physician Decision|0|||
125204213|NCT01451164|450371953|FG000|Overall Study|Withdrawal by Subject|14|||
125204214|NCT01451164|450371954|FG001|Overall Study|Withdrawal by Subject|11|||
125204215|NCT01451164|450371955|FG002|Overall Study|Withdrawal by Subject|16|||
125204216|NCT01451164|450371956|FG003|Overall Study|Withdrawal by Subject|17|||
125204217|NCT01451164|450371953|FG000|Overall Study|Protocol Violation|0|||
125539749|NCT00700427|451605818|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
125539750|NCT00700427|451605819|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
125539751|NCT00700427|451605820|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
125539752|NCT00700427|451605816|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
125539753|NCT00700427|451605817|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
125539754|NCT00700427|451605818|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
125539755|NCT00700427|451605819|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
125539756|NCT00700427|451605820|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
125539757|NCT00700427|451605816|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
125539758|NCT00700427|451605817|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
125539759|NCT00700427|451605818|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
125539760|NCT00700427|451605819|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
125539761|NCT00700427|451605820|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
125539762|NCT00700427|451605816|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
125539763|NCT00700427|451605817|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
125539764|NCT00700427|451605818|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
125539765|NCT00700427|451605819|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
125539766|NCT00700427|451605820|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
125539767|NCT00700427|451605816|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
125539768|NCT00700427|451605817|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
125539769|NCT00700427|451605818|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
125539770|NCT00700427|451605819|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
125539771|NCT00700427|451605820|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
125539772|NCT00700427|451605816|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
125539773|NCT00700427|451605817|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
125647846|NCT01072175|451993565|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
125647847|NCT01072175|451993566|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
125647848|NCT01072175|451993567|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
125647849|NCT01072175|451993555|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125647850|NCT01072175|451993556|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125647851|NCT01072175|451993557|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125647852|NCT01072175|451993558|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125647853|NCT01072175|451993559|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125647854|NCT01072175|451993560|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
125647855|NCT01072175|451993561|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
125647856|NCT01072175|451993562|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
125647857|NCT01072175|451993563|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125647858|NCT01072175|451993564|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125647859|NCT01072175|451993565|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125647860|NCT01072175|451993566|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125647861|NCT01072175|451993567|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
125647862|NCT01072175|451993555|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125647863|NCT01072175|451993556|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125647864|NCT01072175|451993557|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125647865|NCT01072175|451993558|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125647866|NCT01072175|451993559|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125647867|NCT01072175|451993560|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125647868|NCT01072175|451993561|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
125647869|NCT01072175|451993562|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
125647870|NCT01072175|451993563|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125647871|NCT01072175|451993564|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125647872|NCT01072175|451993565|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125647873|NCT01072175|451993566|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125647874|NCT01072175|451993567|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
125647875|NCT01072175|451993555|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125647876|NCT01072175|451993556|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125647877|NCT01072175|451993557|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125647878|NCT01072175|451993558|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125647879|NCT01072175|451993559|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125647880|NCT01072175|451993560|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
125647881|NCT01072175|451993561|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
125647882|NCT01072175|451993562|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
125647883|NCT01072175|451993563|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125647884|NCT01072175|451993564|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125647885|NCT01072175|451993565|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125647886|NCT01072175|451993566|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125647887|NCT01072175|451993567|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
125647888|NCT01072175|451993555|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125647889|NCT01072175|451993556|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125647890|NCT01072175|451993557|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125647891|NCT01072175|451993558|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125647892|NCT01072175|451993559|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125647893|NCT01072175|451993560|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
125647894|NCT01072175|451993561|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
125647895|NCT01072175|451993562|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125647896|NCT01072175|451993563|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125647897|NCT01072175|451993564|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125647898|NCT01072175|451993565|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125647899|NCT01072175|451993566|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125647900|NCT01072175|451993567|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
125647901|NCT01072175|451993555|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125647902|NCT01072175|451993556|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125647903|NCT01072175|451993557|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125647904|NCT01072175|451993558|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125647905|NCT01072175|451993559|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125204218|NCT01451164|450371954|FG001|Overall Study|Protocol Violation|1|||
125204219|NCT01451164|450371955|FG002|Overall Study|Protocol Violation|0|||
125647906|NCT01072175|451993560|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125204220|NCT01451164|450371956|FG003|Overall Study|Protocol Violation|0|||
125204221|NCT01451164|450371953|FG000|Overall Study|Lack of Efficacy|7|||
125204222|NCT01451164|450371954|FG001|Overall Study|Lack of Efficacy|9|||
125647907|NCT01072175|451993561|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125647908|NCT01072175|451993562|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125647909|NCT01072175|451993563|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
125647910|NCT01072175|451993564|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125647911|NCT01072175|451993565|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125647912|NCT01072175|451993566|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125647913|NCT01072175|451993567|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
125647914|NCT01072175|451993555|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125647915|NCT01072175|451993556|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125647916|NCT01072175|451993557|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125647917|NCT01072175|451993558|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125647918|NCT01072175|451993559|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125647919|NCT01072175|451993560|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125647920|NCT01072175|451993561|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125647921|NCT01072175|451993562|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125647922|NCT01072175|451993563|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
125647923|NCT01072175|451993564|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125647924|NCT01072175|451993565|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125647925|NCT01072175|451993566|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125647926|NCT01072175|451993567|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
125647927|NCT01072175|451993555|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125204223|NCT01451164|450371955|FG002|Overall Study|Lack of Efficacy|9|||
125204224|NCT01451164|450371956|FG003|Overall Study|Lack of Efficacy|7|||
125204225|NCT01846221|450371957|FG000|Overall Study|Catheter Failure|2|||
125204226|NCT01846221|450371958|FG001|Overall Study|Catheter Failure|0|||
125204227|NCT01846221|450371957|FG000|Overall Study|Age Exclusion|1|||
125204228|NCT01846221|450371958|FG001|Overall Study|Age Exclusion|0|||
125204229|NCT02879994|450371959|FG000|Overall Study|off treatment early|7|||
125204230|NCT02879994|450371959|FG000|Overall Study|Adverse Event|2|||
125204231|NCT02879994|450371959|FG000|Overall Study|Death|2|||
125204232|NCT02052596|450371960|FG000|Active Phase|Adverse Event|3|||
125204233|NCT02052596|450371961|FG001|Active Phase|Adverse Event|2|||
125204234|NCT02052596|450371960|FG000|Active Phase|Lost to Follow-up|8|||
125204235|NCT02052596|450371961|FG001|Active Phase|Lost to Follow-up|11|||
125204236|NCT02052596|450371960|FG000|Active Phase|Protocol Violation|1|||
125204237|NCT02052596|450371961|FG001|Active Phase|Protocol Violation|2|||
125204238|NCT02052596|450371960|FG000|Active Phase|Withdrawal by Subject|3|||
125204239|NCT02052596|450371961|FG001|Active Phase|Withdrawal by Subject|4|||
125204240|NCT02052596|450371960|FG000|Active Phase|Enrolled in error|1|||
125539774|NCT00700427|451605818|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
125539775|NCT00700427|451605819|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
125539776|NCT00700427|451605820|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
125539777|NCT00700427|451605816|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
125539778|NCT00700427|451605817|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
125539779|NCT00700427|451605818|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
125539780|NCT00700427|451605819|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
125539781|NCT00700427|451605820|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
125539782|NCT00700427|451605816|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
125539783|NCT00700427|451605817|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
125539784|NCT00700427|451605818|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
125539785|NCT00700427|451605819|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
125539786|NCT00700427|451605820|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
125539787|NCT00700427|451605816|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
125539788|NCT00700427|451605817|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
125539789|NCT00700427|451605818|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
125539790|NCT00700427|451605819|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
125539791|NCT00700427|451605820|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
125539792|NCT00700427|451605816|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
125539793|NCT00700427|451605817|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
125539794|NCT00700427|451605818|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
125539795|NCT00700427|451605819|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
125539796|NCT00700427|451605820|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
125539797|NCT00700427|451605816|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
125539798|NCT00700427|451605817|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
125204241|NCT02052596|450371961|FG001|Active Phase|Enrolled in error|0|||
125204242|NCT02052596|450371960|FG000|Active Phase|Lost due to Crohn's disease|0|||
125204243|NCT02052596|450371961|FG001|Active Phase|Lost due to Crohn's disease|1|||
125647928|NCT01072175|451993556|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125647929|NCT01072175|451993557|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125647930|NCT01072175|451993558|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125647931|NCT01072175|451993559|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125647932|NCT01072175|451993560|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125647933|NCT01072175|451993561|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125647934|NCT01072175|451993562|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125647935|NCT01072175|451993563|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
125647936|NCT01072175|451993564|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125647937|NCT01072175|451993565|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125647938|NCT01072175|451993566|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125204244|NCT02052596|450371960|FG000|Safety Phase|Adverse Event|6|||
125204245|NCT02052596|450371961|FG001|Safety Phase|Adverse Event|3|||
125204246|NCT02052596|450371960|FG000|Safety Phase|Lost to Follow-up|11|||
125204247|NCT02052596|450371961|FG001|Safety Phase|Lost to Follow-up|18|||
125204248|NCT02052596|450371960|FG000|Safety Phase|Protocol Violation|1|||
125204249|NCT02052596|450371961|FG001|Safety Phase|Protocol Violation|2|||
125204250|NCT02052596|450371960|FG000|Safety Phase|Withdrawal by Subject|8|||
125204251|NCT02052596|450371961|FG001|Safety Phase|Withdrawal by Subject|11|||
125204252|NCT02052596|450371960|FG000|Safety Phase|Enrolled in error|1|||
125204253|NCT02052596|450371961|FG001|Safety Phase|Enrolled in error|0|||
125204254|NCT02052596|450371960|FG000|Safety Phase|Lost due to Crohn's disease|0|||
125204255|NCT02052596|450371961|FG001|Safety Phase|Lost due to Crohn's disease|1|||
125204256|NCT00705718|450371962|FG000|Overall Study|Death|6|||
125204257|NCT00705718|450371963|FG001|Overall Study|Death|6|||
125204258|NCT00705718|450371962|FG000|Overall Study|Not due for Visit|0|||
125204259|NCT00705718|450371963|FG001|Overall Study|Not due for Visit|12|||
125204260|NCT00705718|450371962|FG000|Overall Study|Follow up not done|1|||
125204261|NCT00705718|450371963|FG001|Overall Study|Follow up not done|4|||
125204262|NCT06137703|450371965|FG000|Overall Study|Other|0|||
125204263|NCT06137703|450371966|FG001|Overall Study|Other|1|||
125204264|NCT06137703|450371967|FG002|Overall Study|Other|0|||
125204265|NCT06137703|450371968|FG003|Overall Study|Other|0|||
125204266|NCT06137703|450371965|FG000|Overall Study|Adverse Event|0|||
125204267|NCT06137703|450371966|FG001|Overall Study|Adverse Event|0|||
125204268|NCT06137703|450371967|FG002|Overall Study|Adverse Event|1|||
125204269|NCT06137703|450371968|FG003|Overall Study|Adverse Event|0|||
125204270|NCT00741091|450371971|FG000|Overall Study|Death|13|||
125204271|NCT00741091|450371971|FG000|Overall Study|Lost to Follow-up|16|||
125204272|NCT00741091|450371971|FG000|Overall Study|Withdrawal by Subject|6|||
125204273|NCT00741091|450371971|FG000|Overall Study|Missed Visit|22|||
125204274|NCT01801358|450371972|FG000|Overall Study|Adverse Event|0|||
125204275|NCT01801358|450371973|FG001|Overall Study|Adverse Event|2|||
125204276|NCT01801358|450371974|FG002|Overall Study|Adverse Event|1|||
125204277|NCT01801358|450371975|FG003|Overall Study|Adverse Event|0|||
125204278|NCT01801358|450371976|FG004|Overall Study|Adverse Event|0|||
125204279|NCT01801358|450371977|FG005|Overall Study|Adverse Event|1|||
125204280|NCT01801358|450371972|FG000|Overall Study|Physician Decision|0|||
125204281|NCT01801358|450371973|FG001|Overall Study|Physician Decision|0|||
125204282|NCT01801358|450371974|FG002|Overall Study|Physician Decision|1|||
125204283|NCT01801358|450371975|FG003|Overall Study|Physician Decision|0|||
125204284|NCT01801358|450371976|FG004|Overall Study|Physician Decision|0|||
125204285|NCT01801358|450371977|FG005|Overall Study|Physician Decision|0|||
125204286|NCT01801358|450371972|FG000|Overall Study|Progressive Disease|6|||
125204287|NCT01801358|450371973|FG001|Overall Study|Progressive Disease|4|||
125204288|NCT01801358|450371974|FG002|Overall Study|Progressive Disease|4|||
125204289|NCT01801358|450371975|FG003|Overall Study|Progressive Disease|5|||
125204290|NCT01801358|450371976|FG004|Overall Study|Progressive Disease|6|||
125204291|NCT01801358|450371977|FG005|Overall Study|Progressive Disease|5|||
125204292|NCT01801358|450371972|FG000|Overall Study|Withdrawal by Subject|0|||
125204293|NCT01801358|450371973|FG001|Overall Study|Withdrawal by Subject|0|||
125204294|NCT01801358|450371974|FG002|Overall Study|Withdrawal by Subject|0|||
125204295|NCT01801358|450371975|FG003|Overall Study|Withdrawal by Subject|1|||
125204296|NCT01801358|450371976|FG004|Overall Study|Withdrawal by Subject|0|||
125204297|NCT01801358|450371977|FG005|Overall Study|Withdrawal by Subject|2|||
125204298|NCT00723190|450371979|FG000|Overall Study|Withdrawal by Subject|45|||
125204299|NCT00723190|450371979|FG000|Overall Study|Lost to Follow-up|37|||
125647939|NCT01072175|451993567|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
125204300|NCT00723190|450371979|FG000|Overall Study|Adverse Event|18|||
125204301|NCT00723190|450371979|FG000|Overall Study|Lack of Efficacy|16|||
125204302|NCT00723190|450371979|FG000|Overall Study|Protocol Violation|15|||
125204303|NCT00723190|450371979|FG000|Overall Study|Other-Premature Discontinuation|9|||
125204304|NCT00723190|450371979|FG000|Overall Study|Other-Not included in safety population|2|||
125204305|NCT03181503|450371980|FG000|Overall Study|Adverse Event|2|||
125204306|NCT03181503|450371981|FG001|Overall Study|Adverse Event|2|||
125204307|NCT03181503|450371980|FG000|Overall Study|Protocol Violation|1|||
125204308|NCT03181503|450371981|FG001|Overall Study|Protocol Violation|0|||
125204309|NCT03181503|450371980|FG000|Overall Study|Withdrawal by Subject|3|||
125204310|NCT03181503|450371981|FG001|Overall Study|Withdrawal by Subject|0|||
125204311|NCT03181503|450371980|FG000|Overall Study|Lost to Follow-up|1|||
125204312|NCT03181503|450371981|FG001|Overall Study|Lost to Follow-up|1|||
125204313|NCT02505334|450371992|FG000|Main Treatment Period|Adverse Event|3|||
125204314|NCT02505334|450371993|FG001|Main Treatment Period|Adverse Event|3|||
125204315|NCT02505334|450371992|FG000|Main Treatment Period|Lack of Efficacy|7|||
125647940|NCT01072175|451993555|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125647941|NCT01072175|451993556|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125647942|NCT01072175|451993557|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125647943|NCT01072175|451993558|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125647944|NCT01072175|451993559|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125647945|NCT01072175|451993560|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125647946|NCT01072175|451993561|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125647947|NCT01072175|451993562|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125647948|NCT01072175|451993563|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
125647949|NCT01072175|451993564|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125647950|NCT01072175|451993565|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125647951|NCT01072175|451993566|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125647952|NCT01072175|451993567|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
125647953|NCT01072175|451993555|FG000|Part D (HPMC Capsules)|Death|0|||
125647954|NCT01072175|451993556|FG001|Part D (HPMC Capsules)|Death|0|||
125647955|NCT01072175|451993557|FG002|Part D (HPMC Capsules)|Death|0|||
125647956|NCT01072175|451993558|FG003|Part D (HPMC Capsules)|Death|0|||
125647957|NCT01072175|451993559|FG004|Part D (HPMC Capsules)|Death|0|||
125647958|NCT01072175|451993560|FG005|Part D (HPMC Capsules)|Death|0|||
125647959|NCT01072175|451993561|FG006|Part D (HPMC Capsules)|Death|0|||
125647960|NCT01072175|451993562|FG007|Part D (HPMC Capsules)|Death|0|||
125647961|NCT01072175|451993563|FG008|Part D (HPMC Capsules)|Death|0|||
125647962|NCT01072175|451993564|FG009|Part D (HPMC Capsules)|Death|10|||
125647963|NCT01072175|451993565|FG010|Part D (HPMC Capsules)|Death|12|||
125647964|NCT01072175|451993566|FG011|Part D (HPMC Capsules)|Death|28|||
125647965|NCT01072175|451993567|FG012|Part D (HPMC Capsules)|Death|26|||
125647966|NCT01072175|451993555|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
125647967|NCT01072175|451993556|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
125647968|NCT01072175|451993557|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
125647969|NCT01072175|451993558|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
125647970|NCT01072175|451993559|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
125647971|NCT01072175|451993560|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
125647972|NCT01072175|451993561|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
125647973|NCT01072175|451993562|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
125647974|NCT01072175|451993563|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
125647975|NCT01072175|451993564|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
125647976|NCT01072175|451993565|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
125647977|NCT01072175|451993566|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
125647978|NCT01072175|451993567|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
125647979|NCT01072175|451993555|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125647980|NCT01072175|451993556|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125647981|NCT01072175|451993557|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125647982|NCT01072175|451993558|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125647983|NCT01072175|451993559|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125647984|NCT01072175|451993560|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125647985|NCT01072175|451993561|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125647986|NCT01072175|451993562|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125647987|NCT01072175|451993563|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125647988|NCT01072175|451993564|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
125647989|NCT01072175|451993565|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
125647990|NCT01072175|451993566|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
125647991|NCT01072175|451993567|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
125647992|NCT01072175|451993555|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
125647993|NCT01072175|451993556|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
125647994|NCT01072175|451993557|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
125647995|NCT01072175|451993558|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
125647996|NCT01072175|451993559|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
125204316|NCT02505334|450371993|FG001|Main Treatment Period|Lack of Efficacy|17|||
125204317|NCT02505334|450371992|FG000|Main Treatment Period|Protocol Violation|0|||
125647997|NCT01072175|451993560|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
125647998|NCT01072175|451993561|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
125647999|NCT01072175|451993562|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
125648000|NCT01072175|451993563|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
125648001|NCT01072175|451993564|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
125648002|NCT01072175|451993565|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
125648003|NCT01072175|451993566|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
125648004|NCT01072175|451993567|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
125648005|NCT01072175|451993555|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125648006|NCT01072175|451993556|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125648007|NCT01072175|451993557|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125648008|NCT01072175|451993558|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125648009|NCT01072175|451993559|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125648010|NCT01072175|451993560|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125648011|NCT01072175|451993561|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125648012|NCT01072175|451993562|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125648013|NCT01072175|451993563|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125648014|NCT01072175|451993564|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125648015|NCT01072175|451993565|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
125648016|NCT01072175|451993566|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
125648017|NCT01072175|451993567|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
125648018|NCT02477215|451993570|FG000|Dose Escalation Phase|Physician Decision|1|||
125648019|NCT02477215|451993571|FG001|Dose Escalation Phase|Physician Decision|2|||
125648020|NCT02477215|451993572|FG002|Dose Escalation Phase|Physician Decision|0|||
125648021|NCT02477215|451993570|FG000|Fixed Dose Phase|Physician Decision|0|||
125648022|NCT02477215|451993571|FG001|Fixed Dose Phase|Physician Decision|7|||
125648023|NCT02477215|451993572|FG002|Fixed Dose Phase|Physician Decision|0|||
125648024|NCT02210559|451993573|FG000|Overall Study|Progressive Disease|3|||
125648025|NCT02210559|451993574|FG001|Overall Study|Progressive Disease|2|||
125648026|NCT02210559|451993573|FG000|Overall Study|Adverse Event|2|||
125648027|NCT02210559|451993574|FG001|Overall Study|Adverse Event|2|||
125648028|NCT02210559|451993573|FG000|Overall Study|Physician Decision|1|||
125648029|NCT02210559|451993574|FG001|Overall Study|Physician Decision|0|||
125648030|NCT02210559|451993573|FG000|Overall Study|Withdrawal by Subject|0|||
125648031|NCT02210559|451993574|FG001|Overall Study|Withdrawal by Subject|1|||
125648032|NCT02210559|451993573|FG000|Overall Study|Other than specified|0|||
125648033|NCT02210559|451993574|FG001|Overall Study|Other than specified|1|||
125648034|NCT01474291|451993575|FG000|Overall Study|Not Evaluable for Efficacy|26|||
125648035|NCT01474291|451993575|FG000|Overall Study|Lack of Treatment Efficacy|88|||
125648036|NCT01474291|451993575|FG000|Overall Study|Adverse Event|53|||
125648037|NCT01474291|451993575|FG000|Overall Study|Lost to Follow-up|29|||
125648038|NCT01474291|451993575|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
125648039|NCT01474291|451993575|FG000|Overall Study|No Reason Reported|10|||
125648040|NCT01474291|451993575|FG000|Overall Study|Death|2|||
125648041|NCT00438815|451993579|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
125648042|NCT00438815|451993579|FG000|Overall Study|3-month follow-up no longer required|12|||
125648043|NCT00438815|451993579|FG000|Overall Study|Noncompliance with protocol requirements|9|||
125648044|NCT00438815|451993579|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
125648045|NCT00438815|451993579|FG000|Overall Study|Lost to Follow-up|6|||
125648046|NCT00438815|451993579|FG000|Overall Study|Withdrawal by Subject|6|||
125204318|NCT02505334|450371993|FG001|Main Treatment Period|Protocol Violation|1|||
125204319|NCT02505334|450371992|FG000|Main Treatment Period|Withdrawal by Subject|1|||
125204320|NCT02505334|450371993|FG001|Main Treatment Period|Withdrawal by Subject|8|||
125204321|NCT02505334|450371992|FG000|Main Treatment Period|Unclassified|4|||
125204322|NCT02505334|450371993|FG001|Main Treatment Period|Unclassified|10|||
125204323|NCT02505334|450371992|FG000|Extension Treatment Period|Adverse Event|5|||
125204324|NCT02505334|450371993|FG001|Extension Treatment Period|Adverse Event|0|||
125204325|NCT02505334|450371992|FG000|Extension Treatment Period|Lack of Efficacy|4|||
125204326|NCT02505334|450371993|FG001|Extension Treatment Period|Lack of Efficacy|0|||
125204327|NCT02505334|450371992|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
125204328|NCT02505334|450371993|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
125204329|NCT02505334|450371992|FG000|Extension Treatment Period|Unclassified|3|||
125204330|NCT02505334|450371993|FG001|Extension Treatment Period|Unclassified|0|||
125204331|NCT03199612|450371994|FG000|Overall Study|Adverse Event|1|||
125648047|NCT00438815|451993579|FG000|Overall Study|Death|1|||
125648048|NCT00679354|451993584|FG000|Overall Study|Death|3|||
125648049|NCT00679354|451993584|FG000|Overall Study|Lack of Efficacy|22|||
125648050|NCT00679354|451993584|FG000|Overall Study|Physician Decision|4|||
125204332|NCT03199612|450371995|FG001|Overall Study|Adverse Event|0|||
125204333|NCT00081731|450372001|FG000|Overall Study|scientific integrity issue|8|||
125648051|NCT00679354|451993584|FG000|Overall Study|Ineligible|1|||
125648052|NCT00665002|451993591|FG000|Overall Study|Progression/relapse during treatment|11|||
125648053|NCT00665002|451993591|FG000|Overall Study|Cytogenetic resistance|1|||
125648054|NCT00697255|451993592|FG000|Stage 1a|Insufficient ovarian response|1|||
125204334|NCT00081731|450372002|FG001|Overall Study|scientific integrity issue|8|||
125204335|NCT02386345|450372006|FG000|Overall Study|Not treated|14|||
125204336|NCT02386345|450372006|FG000|Overall Study|Lost to Follow-up|1|||
125204337|NCT02386345|450372006|FG000|Overall Study|Adverse Event|5|||
125648055|NCT00697255|451993593|FG001|Stage 1a|Insufficient ovarian response|0|||
125648056|NCT00697255|451993592|FG000|Stage 1a|Multifollicular growth|1|||
125648057|NCT00697255|451993593|FG001|Stage 1a|Multifollicular growth|0|||
125648058|NCT00697255|451993592|FG000|Stage 1a|Not growing of dominant follicle|1|||
125648059|NCT00697255|451993593|FG001|Stage 1a|Not growing of dominant follicle|0|||
125648060|NCT00697255|451993592|FG000|Stage 1b|Not growing of dominant follicle|0|||
125648061|NCT00697255|451993593|FG001|Stage 1b|Not growing of dominant follicle|1|||
125204338|NCT02386345|450372006|FG000|Overall Study|Repeat Procedure|10|||
125204339|NCT02386345|450372006|FG000|Overall Study|Did not complete 12-month follow-up|72|||
125204340|NCT04050124|450372007|FG000|Overall Study|Death|1|||
125204341|NCT04050124|450372008|FG001|Overall Study|Death|0|||
125648062|NCT00697255|451993592|FG000|Stage 1b|Insufficient ovarian response|0|||
125648063|NCT00697255|451993593|FG001|Stage 1b|Insufficient ovarian response|1|||
125648064|NCT01303159|451993601|FG000|Overall Study|Death|16|||
125648065|NCT01303159|451993601|FG000|Overall Study|Study Termination|7|||
125648066|NCT02243306|451993602|FG000|Overall Study|Adverse Event|0|||
125648067|NCT02243306|451993603|FG001|Overall Study|Adverse Event|1|||
125648068|NCT02243306|451993602|FG000|Overall Study|Other: Reached stopping criteria|0|||
125648069|NCT02243306|451993603|FG001|Overall Study|Other: Reached stopping criteria|1|||
125648070|NCT02243306|451993602|FG000|Overall Study|Physician Decision|0|||
125648071|NCT02243306|451993603|FG001|Overall Study|Physician Decision|1|||
125648072|NCT00496782|451993607|FG000|Overall Study|Protocol Violation|1|||
125648073|NCT00496782|451993608|FG001|Overall Study|Protocol Violation|2|||
125648074|NCT01005875|451993620|FG000|Overall Study|Death|3|||
125648075|NCT00242658|451993623|FG000|Overall Study|Lost to Follow-up|22|||
125648076|NCT00242658|451993624|FG001|Overall Study|Lost to Follow-up|19|||
125648077|NCT01815099|451993625|FG000|Overall Study|Lack of Efficacy|1|||
125648078|NCT01815099|451993625|FG000|Overall Study|unable to attend study visits|1|||
125648079|NCT00643851|451993626|FG000|Overall Study|Death|0|||
125204342|NCT01537068|450372019|FG000|Overall Study|Lost to Follow-up|2|||
125204343|NCT01537068|450372020|FG001|Overall Study|Lost to Follow-up|1|||
125204344|NCT01537068|450372019|FG000|Overall Study|Adverse Event|0|||
125204345|NCT01537068|450372020|FG001|Overall Study|Adverse Event|1|||
125204346|NCT01537068|450372019|FG000|Overall Study|Withdrawal by Subject|1|||
125204347|NCT01537068|450372020|FG001|Overall Study|Withdrawal by Subject|1|||
125204348|NCT01537068|450372019|FG000|Overall Study|Lack of Efficacy|1|||
125204349|NCT01537068|450372020|FG001|Overall Study|Lack of Efficacy|0|||
125204350|NCT00483704|450372021|FG000|Randomization|Withdrawal by Subject|19|||
125204351|NCT00483704|450372022|FG001|Randomization|Withdrawal by Subject|28|||
125204352|NCT00483704|450372023|FG002|Randomization|Withdrawal by Subject|18|||
125204353|NCT00483704|450372021|FG000|Randomization|Protocol Violation|14|||
125204354|NCT00483704|450372022|FG001|Randomization|Protocol Violation|25|||
125204355|NCT00483704|450372023|FG002|Randomization|Protocol Violation|22|||
125204356|NCT00483704|450372021|FG000|Randomization|Lost to Follow-up|14|||
125204357|NCT00483704|450372022|FG001|Randomization|Lost to Follow-up|14|||
125204358|NCT00483704|450372023|FG002|Randomization|Lost to Follow-up|19|||
125204359|NCT00483704|450372021|FG000|Randomization|Pregnancy|1|||
125204360|NCT00483704|450372022|FG001|Randomization|Pregnancy|0|||
125204361|NCT00483704|450372023|FG002|Randomization|Pregnancy|0|||
125204362|NCT00483704|450372021|FG000|Randomization|Physician Decision|2|||
125204363|NCT00483704|450372022|FG001|Randomization|Physician Decision|4|||
125204364|NCT00483704|450372023|FG002|Randomization|Physician Decision|0|||
125204365|NCT00483704|450372021|FG000|Randomization|Progressive disease|0|||
125204366|NCT00483704|450372022|FG001|Randomization|Progressive disease|0|||
125204367|NCT00483704|450372023|FG002|Randomization|Progressive disease|1|||
125204368|NCT00483704|450372021|FG000|Randomization|Lack of qualifying migraines|21|||
125204369|NCT00483704|450372022|FG001|Randomization|Lack of qualifying migraines|25|||
125204370|NCT00483704|450372023|FG002|Randomization|Lack of qualifying migraines|31|||
125204371|NCT00483704|450372021|FG000|Treatment|Lack of qualifying migraines|101|||
125204372|NCT00483704|450372022|FG001|Treatment|Lack of qualifying migraines|99|||
125204373|NCT00483704|450372023|FG002|Treatment|Lack of qualifying migraines|116|||
125204374|NCT00483704|450372021|FG000|Treatment|Adverse Event|3|||
125204375|NCT00483704|450372022|FG001|Treatment|Adverse Event|5|||
125204376|NCT00483704|450372023|FG002|Treatment|Adverse Event|4|||
125204377|NCT00483704|450372021|FG000|Treatment|Withdrawal by Subject|16|||
125204378|NCT00483704|450372022|FG001|Treatment|Withdrawal by Subject|12|||
125204379|NCT00483704|450372023|FG002|Treatment|Withdrawal by Subject|21|||
125648080|NCT00643851|451993627|FG001|Overall Study|Death|1|||
125204380|NCT00483704|450372021|FG000|Treatment|Protocol Violation|6|||
125204381|NCT00483704|450372022|FG001|Treatment|Protocol Violation|3|||
125204382|NCT00483704|450372023|FG002|Treatment|Protocol Violation|5|||
125648081|NCT00643851|451993628|FG002|Overall Study|Death|0|||
125204383|NCT00483704|450372021|FG000|Treatment|Lost to Follow-up|2|||
125204384|NCT00483704|450372022|FG001|Treatment|Lost to Follow-up|7|||
125204385|NCT00483704|450372023|FG002|Treatment|Lost to Follow-up|5|||
125204386|NCT00483704|450372021|FG000|Treatment|Lack of Efficacy|1|||
125204387|NCT00483704|450372022|FG001|Treatment|Lack of Efficacy|1|||
125204388|NCT00483704|450372023|FG002|Treatment|Lack of Efficacy|1|||
125204389|NCT00483704|450372021|FG000|Treatment|Pregnancy|0|||
125204390|NCT00483704|450372022|FG001|Treatment|Pregnancy|1|||
125648082|NCT00643851|451993626|FG000|Overall Study|Lack of Efficacy|0|||
125648083|NCT00643851|451993627|FG001|Overall Study|Lack of Efficacy|1|||
125648084|NCT00643851|451993628|FG002|Overall Study|Lack of Efficacy|0|||
125204391|NCT00483704|450372023|FG002|Treatment|Pregnancy|0|||
125204392|NCT00483704|450372021|FG000|Treatment|Physician Decision|0|||
125204393|NCT00483704|450372022|FG001|Treatment|Physician Decision|1|||
125204394|NCT00483704|450372023|FG002|Treatment|Physician Decision|4|||
125204395|NCT04442269|450372024|FG000|Overall Study|Adverse Event|1|||
125204396|NCT04442269|450372025|FG001|Overall Study|Adverse Event|0|||
125204397|NCT04442269|450372024|FG000|Overall Study|Death|0|||
125204398|NCT04442269|450372025|FG001|Overall Study|Death|1|||
125204399|NCT04442269|450372024|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
125204400|NCT04442269|450372025|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
125204401|NCT04442269|450372024|FG000|Overall Study|Lost to Follow-up|1|||
125204402|NCT04442269|450372025|FG001|Overall Study|Lost to Follow-up|0|||
125648085|NCT00643851|451993626|FG000|Overall Study|Adverse Event|2|||
125648086|NCT00643851|451993627|FG001|Overall Study|Adverse Event|6|||
125648087|NCT00643851|451993628|FG002|Overall Study|Adverse Event|6|||
125648088|NCT00643851|451993626|FG000|Overall Study|Lost to Follow-up|4|||
125648089|NCT00643851|451993627|FG001|Overall Study|Lost to Follow-up|6|||
125648090|NCT00643851|451993628|FG002|Overall Study|Lost to Follow-up|9|||
125648091|NCT00643851|451993626|FG000|Overall Study|Withdrawal by Subject|8|||
125648092|NCT00643851|451993627|FG001|Overall Study|Withdrawal by Subject|15|||
125648093|NCT00643851|451993628|FG002|Overall Study|Withdrawal by Subject|9|||
125204403|NCT04442269|450372024|FG000|Overall Study|Withdrawal by Subject|3|||
125204404|NCT04442269|450372025|FG001|Overall Study|Withdrawal by Subject|2|||
125648094|NCT00643851|451993626|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
125204405|NCT04442269|450372024|FG000|Overall Study|Protocol Deviation|0|||
125204406|NCT04442269|450372025|FG001|Overall Study|Protocol Deviation|1|||
125648095|NCT00643851|451993627|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
125648096|NCT00643851|451993628|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
125648097|NCT04557189|451993631|FG000|Overall Study|Adverse Event|0|||
125648098|NCT04557189|451993632|FG001|Overall Study|Adverse Event|1|||
125648099|NCT04557189|451993631|FG000|Overall Study|Lost to Follow-up|1|||
125648100|NCT04557189|451993632|FG001|Overall Study|Lost to Follow-up|1|||
125648101|NCT04557189|451993631|FG000|Overall Study|Withdrawal by Subject|2|||
125648102|NCT04557189|451993632|FG001|Overall Study|Withdrawal by Subject|1|||
125648103|NCT04557189|451993631|FG000|Overall Study|Reason not Specified|3|||
125648104|NCT04557189|451993632|FG001|Overall Study|Reason not Specified|6|||
125648105|NCT01728454|451993633|FG000|Stage 1 and 2|Pregnancy|1|||
125648106|NCT01728454|451993634|FG001|Stage 1 and 2|Pregnancy|0|||
125648107|NCT01728454|451993635|FG002|Stage 1 and 2|Pregnancy|0|||
125648108|NCT01728454|451993633|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
125648109|NCT01728454|451993634|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
125648110|NCT01728454|451993635|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
125204407|NCT04442269|450372024|FG000|Overall Study|Travel Limitations|1|||
125204408|NCT04442269|450372025|FG001|Overall Study|Travel Limitations|1|||
125204409|NCT04450407|450372026|FG000|Overall Study|Withdrawal by Subject|10|||
125204410|NCT04450407|450372027|FG001|Overall Study|Withdrawal by Subject|1|||
125648111|NCT01728454|451993633|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
125648112|NCT01728454|451993634|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
125648113|NCT01728454|451993635|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
125648114|NCT01728454|451993633|FG000|Stage 1 and 2|Lost to Follow-up|1|||
125648115|NCT01728454|451993634|FG001|Stage 1 and 2|Lost to Follow-up|1|||
125648116|NCT01728454|451993635|FG002|Stage 1 and 2|Lost to Follow-up|0|||
125204411|NCT04450407|450372028|FG002|Overall Study|Withdrawal by Subject|4|||
125204412|NCT04450407|450372026|FG000|Overall Study|Adverse Event|0|||
125204413|NCT04450407|450372027|FG001|Overall Study|Adverse Event|0|||
125204414|NCT04450407|450372028|FG002|Overall Study|Adverse Event|1|||
125204415|NCT04450407|450372026|FG000|Overall Study|Lost to Follow-up|1|||
125204416|NCT04450407|450372027|FG001|Overall Study|Lost to Follow-up|0|||
125204417|NCT04450407|450372028|FG002|Overall Study|Lost to Follow-up|0|||
125204418|NCT04450407|450372026|FG000|Overall Study|Physician Decision|0|||
125204419|NCT04450407|450372027|FG001|Overall Study|Physician Decision|0|||
125204420|NCT04450407|450372028|FG002|Overall Study|Physician Decision|1|||
125204421|NCT04450407|450372026|FG000|Overall Study|Pregnancy|1|||
125204422|NCT04450407|450372027|FG001|Overall Study|Pregnancy|0|||
125204423|NCT04450407|450372028|FG002|Overall Study|Pregnancy|0|||
125204424|NCT04450407|450372026|FG000|Overall Study|Protocol Violation|2|||
125648117|NCT01728454|451993633|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
125648118|NCT01728454|451993634|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
125648119|NCT01728454|451993635|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
125648120|NCT01728454|451993633|FG000|Stage 3|Reason Missing|0|||
125648121|NCT01728454|451993634|FG001|Stage 3|Reason Missing|0|||
125204425|NCT04450407|450372027|FG001|Overall Study|Protocol Violation|0|||
125204426|NCT04450407|450372028|FG002|Overall Study|Protocol Violation|0|||
125204427|NCT04450407|450372026|FG000|Overall Study|Investigational site terminated by sponsor|3|||
125204428|NCT04450407|450372027|FG001|Overall Study|Investigational site terminated by sponsor|0|||
125204429|NCT04450407|450372028|FG002|Overall Study|Investigational site terminated by sponsor|2|||
125204430|NCT02089334|450372029|FG000|Overall Study|Withdrawal by Subject|0|||
125648122|NCT01728454|451993635|FG002|Stage 3|Reason Missing|1|||
125204431|NCT02089334|450372030|FG001|Overall Study|Withdrawal by Subject|0|||
125204432|NCT02089334|450372031|FG002|Overall Study|Withdrawal by Subject|0|||
125204433|NCT02089334|450372032|FG003|Overall Study|Withdrawal by Subject|2|||
125204434|NCT02089334|450372029|FG000|Overall Study|Adverse Event|0|||
125204435|NCT02089334|450372030|FG001|Overall Study|Adverse Event|0|||
125204436|NCT02089334|450372031|FG002|Overall Study|Adverse Event|0|||
125648123|NCT01728454|451993633|FG000|Stage 3|Subject Required Other Treatment|0|||
125648124|NCT01728454|451993634|FG001|Stage 3|Subject Required Other Treatment|1|||
125204437|NCT02089334|450372032|FG003|Overall Study|Adverse Event|2|||
125204438|NCT02089334|450372029|FG000|Overall Study|Progressive disease|0|||
125204439|NCT02089334|450372030|FG001|Overall Study|Progressive disease|0|||
125204440|NCT02089334|450372031|FG002|Overall Study|Progressive disease|0|||
125648125|NCT01728454|451993635|FG002|Stage 3|Subject Required Other Treatment|0|||
125648126|NCT01728454|451993633|FG000|Stage 3|Pregnancy|1|||
125648127|NCT01728454|451993634|FG001|Stage 3|Pregnancy|0|||
125648128|NCT01728454|451993635|FG002|Stage 3|Pregnancy|0|||
125648129|NCT01728454|451993633|FG000|Stage 3|Withdrew Consent|1|||
125648130|NCT01728454|451993634|FG001|Stage 3|Withdrew Consent|0|||
125648131|NCT01728454|451993635|FG002|Stage 3|Withdrew Consent|1|||
125648132|NCT01728454|451993633|FG000|Stage 3|Non-compliance with Protocol|0|||
125648133|NCT01728454|451993634|FG001|Stage 3|Non-compliance with Protocol|0|||
125648134|NCT01728454|451993635|FG002|Stage 3|Non-compliance with Protocol|1|||
125648135|NCT01728454|451993633|FG000|Stage 3|Lost to Follow-up|0|||
125648136|NCT01728454|451993634|FG001|Stage 3|Lost to Follow-up|3|||
125648137|NCT01728454|451993635|FG002|Stage 3|Lost to Follow-up|1|||
125648138|NCT01728454|451993633|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
125648139|NCT01728454|451993634|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
125648140|NCT01728454|451993635|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
125648141|NCT01190839|451993636|FG000|Overall Study|Adverse Event|32|||
125648142|NCT01190839|451993637|FG001|Overall Study|Adverse Event|41|||
125648143|NCT01190839|451993636|FG000|Overall Study|Protocol Violation|2|||
125648144|NCT01190839|451993637|FG001|Overall Study|Protocol Violation|2|||
125648145|NCT01190839|451993636|FG000|Overall Study|Lost to Follow-up|7|||
125648146|NCT01190839|451993637|FG001|Overall Study|Lost to Follow-up|1|||
125648147|NCT01190839|451993636|FG000|Overall Study|Death|1|||
125204441|NCT02089334|450372032|FG003|Overall Study|Progressive disease|2|||
125204442|NCT02089334|450372029|FG000|Overall Study|Physician Decision|0|||
125204443|NCT02089334|450372030|FG001|Overall Study|Physician Decision|0|||
125204444|NCT02089334|450372031|FG002|Overall Study|Physician Decision|1|||
125204445|NCT02089334|450372032|FG003|Overall Study|Physician Decision|1|||
125204446|NCT02832375|450372033|FG000|Overall Study|Lost to Follow-up|1|||
125204447|NCT02832375|450372034|FG001|Overall Study|Lost to Follow-up|0|||
125204448|NCT02832375|450372033|FG000|Overall Study|Withdrawal of Consent|1|||
125204449|NCT02832375|450372034|FG001|Overall Study|Withdrawal of Consent|0|||
125204450|NCT01173055|450372037|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
125204451|NCT01173055|450372038|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
125204452|NCT01173055|450372037|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
125204453|NCT01173055|450372038|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
125204454|NCT04325698|450372040|FG000|Overall Study|Study Terminated By Sponsor|1|||
125204455|NCT04325698|450372041|FG001|Overall Study|Study Terminated By Sponsor|1|||
125204456|NCT04325698|450372040|FG000|Overall Study|Withdrawal by Subject|0|||
125204457|NCT04325698|450372041|FG001|Overall Study|Withdrawal by Subject|2|||
125204458|NCT04253782|450372042|FG000|Overall Study|Death|2|||
125204459|NCT04253782|450372043|FG001|Overall Study|Death|0|||
125204460|NCT00962091|450372044|FG000|Overall Study|Withdrawal by Subject|1|||
125648148|NCT01190839|451993637|FG001|Overall Study|Death|0|||
125648149|NCT01190839|451993636|FG000|Overall Study|Trial stopped by Sponsor|71|||
125648150|NCT01190839|451993637|FG001|Overall Study|Trial stopped by Sponsor|68|||
125648151|NCT01190839|451993636|FG000|Overall Study|Undefined|35|||
125648152|NCT01190839|451993637|FG001|Overall Study|Undefined|31|||
125648153|NCT01190839|451993636|FG000|Overall Study|Randomized but not treated|2|||
125204461|NCT00962091|450372045|FG001|Overall Study|Withdrawal by Subject|2|||
125204462|NCT00962091|450372046|FG002|Overall Study|Withdrawal by Subject|1|||
125204463|NCT00962091|450372047|FG003|Overall Study|Withdrawal by Subject|1|||
125648154|NCT01190839|451993637|FG001|Overall Study|Randomized but not treated|4|||
125648155|NCT03077646|451993641|FG000|Overall Study|Lost to Follow-up|29|||
125648156|NCT03077646|451993642|FG001|Overall Study|Lost to Follow-up|30|||
125648157|NCT03077646|451993643|FG002|Overall Study|Lost to Follow-up|31|||
125648158|NCT02058966|451993644|FG000|Open-Label Methamphetamine|Adverse Event|1|||
125648159|NCT02058966|451993644|FG000|First Intervention|Withdrawal by Subject|1|||
125648160|NCT02545504|451993645|FG000|Overall Study|Death|174|||
125648161|NCT02545504|451993646|FG001|Overall Study|Death|168|||
125204464|NCT00962091|450372048|FG004|Overall Study|Withdrawal by Subject|0|||
125204465|NCT00962091|450372049|FG005|Overall Study|Withdrawal by Subject|1|||
125204466|NCT00962091|450372050|FG006|Overall Study|Withdrawal by Subject|0|||
125204467|NCT00962091|450372044|FG000|Overall Study|Adverse Event|0|||
125204468|NCT00962091|450372045|FG001|Overall Study|Adverse Event|0|||
125204469|NCT00962091|450372046|FG002|Overall Study|Adverse Event|0|||
125204470|NCT00962091|450372047|FG003|Overall Study|Adverse Event|0|||
125648162|NCT02545504|451993645|FG000|Overall Study|Unknown reason|30|||
125648163|NCT02545504|451993646|FG001|Overall Study|Unknown reason|32|||
125648164|NCT02545504|451993645|FG000|Overall Study|Withdrew consent|9|||
125648165|NCT02545504|451993646|FG001|Overall Study|Withdrew consent|11|||
125648166|NCT02545504|451993645|FG000|Overall Study|Investigator's discretion|3|||
125648167|NCT02545504|451993646|FG001|Overall Study|Investigator's discretion|1|||
125648168|NCT02545504|451993645|FG000|Overall Study|Lost to Follow-up|2|||
125648169|NCT02545504|451993646|FG001|Overall Study|Lost to Follow-up|2|||
125648170|NCT01336647|451995705|FG000|Overall Study|Lost to Follow-up|4|||
125648171|NCT01336647|451995706|FG001|Overall Study|Lost to Follow-up|1|||
125648172|NCT01336647|451995707|FG002|Overall Study|Lost to Follow-up|3|||
125648173|NCT05056311|451995708|FG000|Overall Study|Lost to Follow-up|14|||
125648174|NCT05056311|451995708|FG000|Overall Study|Withdrawal by Subject|1|||
125648175|NCT05056311|451995708|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
125648176|NCT05111548|451995709|FG000|Overall Study|Withdrawal by Subject|2|||
125648177|NCT05111548|451995710|FG001|Overall Study|Withdrawal by Subject|1|||
125648178|NCT05111548|451995709|FG000|Overall Study|Adverse Event|1|||
125648179|NCT05111548|451995710|FG001|Overall Study|Adverse Event|0|||
125648180|NCT00151775|451995721|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
125648181|NCT00151775|451995722|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
125648182|NCT00151775|451995723|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125648183|NCT00151775|451995724|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125648184|NCT00151775|451995725|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125648185|NCT00151775|451995726|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125648186|NCT00151775|451995727|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125648187|NCT00151775|451995728|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125648188|NCT00151775|451995729|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125648189|NCT00151775|451995730|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125648190|NCT00151775|451995731|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125648191|NCT00151775|451995732|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
125648192|NCT00151775|451995721|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
125648193|NCT00151775|451995722|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125648194|NCT00151775|451995723|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125648195|NCT00151775|451995724|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125648196|NCT00151775|451995725|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125648197|NCT00151775|451995726|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125648198|NCT00151775|451995727|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
125648199|NCT00151775|451995728|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125648200|NCT00151775|451995729|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125648201|NCT00151775|451995730|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125648202|NCT00151775|451995731|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
125648203|NCT00151775|451995732|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
125648204|NCT00151775|451995721|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125648205|NCT00151775|451995722|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
125648206|NCT00151775|451995723|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125648207|NCT00151775|451995724|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125648208|NCT00151775|451995725|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125648209|NCT00151775|451995726|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125648210|NCT00151775|451995727|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125648211|NCT00151775|451995728|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125648212|NCT00151775|451995729|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125648213|NCT00151775|451995730|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125648214|NCT00151775|451995731|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125648215|NCT00151775|451995732|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
125648216|NCT00151775|451995721|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
125648217|NCT00151775|451995722|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
125648218|NCT00151775|451995723|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
125648219|NCT00151775|451995724|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
125648220|NCT00151775|451995725|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
125648221|NCT00151775|451995726|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
125648222|NCT00151775|451995727|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
125648223|NCT00151775|451995728|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
125648224|NCT00151775|451995729|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
125648225|NCT00151775|451995730|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
125648226|NCT00151775|451995731|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
125648227|NCT00151775|451995732|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
125648228|NCT00151775|451995721|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125648229|NCT00151775|451995722|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125648230|NCT00151775|451995723|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125648231|NCT00151775|451995724|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125648232|NCT00151775|451995725|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125648233|NCT00151775|451995726|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
125648234|NCT00151775|451995727|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125648235|NCT00151775|451995728|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125648236|NCT00151775|451995729|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125648237|NCT00151775|451995730|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125648238|NCT00151775|451995731|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125648239|NCT00151775|451995732|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
125648240|NCT00151775|451995721|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125648241|NCT00151775|451995722|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125648242|NCT00151775|451995723|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125648243|NCT00151775|451995724|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125648244|NCT00151775|451995725|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125648245|NCT00151775|451995726|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
125648246|NCT00151775|451995727|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125648247|NCT00151775|451995728|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125648248|NCT00151775|451995729|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125648249|NCT00151775|451995730|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125648250|NCT00151775|451995731|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125648251|NCT00151775|451995732|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
125648252|NCT00151775|451995721|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125648253|NCT00151775|451995722|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125648254|NCT00151775|451995723|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125648255|NCT00151775|451995724|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125648256|NCT00151775|451995725|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125648257|NCT00151775|451995726|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125648258|NCT00151775|451995727|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
125648259|NCT00151775|451995728|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125648260|NCT00151775|451995729|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125648261|NCT00151775|451995730|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125648262|NCT00151775|451995731|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125648263|NCT00151775|451995732|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
125648264|NCT00151775|451995721|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125648265|NCT00151775|451995722|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125648266|NCT00151775|451995723|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125648267|NCT00151775|451995724|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125648268|NCT00151775|451995725|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125648269|NCT00151775|451995726|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
125648270|NCT00151775|451995727|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125648271|NCT00151775|451995728|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125648272|NCT00151775|451995729|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125648273|NCT00151775|451995730|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125648274|NCT00151775|451995731|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125648275|NCT00151775|451995732|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
125648276|NCT00151775|451995721|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
125648277|NCT00151775|451995722|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
125648278|NCT00151775|451995723|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
125648279|NCT00151775|451995724|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
125648280|NCT00151775|451995725|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
125648281|NCT00151775|451995726|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
125648282|NCT00151775|451995727|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
125648283|NCT00151775|451995728|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
125648284|NCT00151775|451995729|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
125648285|NCT00151775|451995730|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
125648286|NCT00151775|451995731|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
125648287|NCT00151775|451995732|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
125648288|NCT00151775|451995721|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125648289|NCT00151775|451995722|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125648290|NCT00151775|451995723|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125648291|NCT00151775|451995724|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125648292|NCT00151775|451995725|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125648293|NCT00151775|451995726|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125648294|NCT00151775|451995727|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
125204471|NCT00962091|450372048|FG004|Overall Study|Adverse Event|0|||
125204472|NCT00962091|450372049|FG005|Overall Study|Adverse Event|0|||
125648295|NCT00151775|451995728|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125648296|NCT00151775|451995729|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125648297|NCT00151775|451995730|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125648298|NCT00151775|451995731|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125648299|NCT00151775|451995732|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
125648300|NCT00151775|451995721|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125648301|NCT00151775|451995722|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125648302|NCT00151775|451995723|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
125648303|NCT00151775|451995724|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125648304|NCT00151775|451995725|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125648305|NCT00151775|451995726|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125648306|NCT00151775|451995727|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125648307|NCT00151775|451995728|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125648308|NCT00151775|451995729|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125648309|NCT00151775|451995730|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125648310|NCT00151775|451995731|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125648311|NCT00151775|451995732|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
125648312|NCT00151775|451995721|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125648313|NCT00151775|451995722|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125648314|NCT00151775|451995723|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
125648315|NCT00151775|451995724|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125648316|NCT00151775|451995725|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125648317|NCT00151775|451995726|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125648318|NCT00151775|451995727|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125648319|NCT00151775|451995728|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125648320|NCT00151775|451995729|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125648321|NCT00151775|451995730|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125648322|NCT00151775|451995731|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125648323|NCT00151775|451995732|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
125648324|NCT00151775|451995721|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125648325|NCT00151775|451995722|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125648326|NCT00151775|451995723|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125648327|NCT00151775|451995724|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125648328|NCT00151775|451995725|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125648329|NCT00151775|451995726|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125648330|NCT00151775|451995727|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125648331|NCT00151775|451995728|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125648332|NCT00151775|451995729|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125648333|NCT00151775|451995730|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125648334|NCT00151775|451995731|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
125648335|NCT00151775|451995732|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
125648336|NCT00151775|451995721|FG000|Period 4: Open Label|Increased blood pressure|0|||
125648337|NCT00151775|451995722|FG001|Period 4: Open Label|Increased blood pressure|0|||
125648338|NCT00151775|451995723|FG002|Period 4: Open Label|Increased blood pressure|0|||
125648339|NCT00151775|451995724|FG003|Period 4: Open Label|Increased blood pressure|0|||
125648340|NCT00151775|451995725|FG004|Period 4: Open Label|Increased blood pressure|1|||
125648341|NCT00151775|451995726|FG005|Period 4: Open Label|Increased blood pressure|0|||
125648342|NCT00151775|451995727|FG006|Period 4: Open Label|Increased blood pressure|0|||
125648343|NCT00151775|451995728|FG007|Period 4: Open Label|Increased blood pressure|0|||
125648344|NCT00151775|451995729|FG008|Period 4: Open Label|Increased blood pressure|0|||
125648345|NCT00151775|451995730|FG009|Period 4: Open Label|Increased blood pressure|1|||
125648346|NCT00151775|451995731|FG010|Period 4: Open Label|Increased blood pressure|0|||
125648347|NCT00151775|451995732|FG011|Period 4: Open Label|Increased blood pressure|0|||
125648348|NCT00151775|451995721|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
125648349|NCT00151775|451995722|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
125648350|NCT00151775|451995723|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
125648351|NCT00151775|451995724|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
125648352|NCT00151775|451995725|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
125648353|NCT00151775|451995726|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
125648354|NCT00151775|451995727|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
125648355|NCT00151775|451995728|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
125648356|NCT00151775|451995729|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
125648357|NCT00151775|451995730|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
125648358|NCT00151775|451995731|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
125204473|NCT00962091|450372050|FG006|Overall Study|Adverse Event|1|||
125424873|NCT00430248|451178699|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125648359|NCT00151775|451995732|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
125648360|NCT00151775|451995721|FG000|Period 4: Open Label|Adverse Event|0|||
125648361|NCT00151775|451995722|FG001|Period 4: Open Label|Adverse Event|0|||
125648362|NCT00151775|451995723|FG002|Period 4: Open Label|Adverse Event|0|||
125204474|NCT04216589|450372051|FG000|Overall Study|Withdrawal by Subject|2|||
125204475|NCT04216589|450372051|FG000|Overall Study|Protocol Violation|1|||
125204476|NCT04216589|450372051|FG000|Overall Study|Incarceration|1|||
125204477|NCT02326298|450372057|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204478|NCT02326298|450372058|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204479|NCT02326298|450372059|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
125204480|NCT02326298|450372060|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204481|NCT02326298|450372061|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204482|NCT02326298|450372062|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204483|NCT02326298|450372063|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204484|NCT02326298|450372064|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204485|NCT02326298|450372065|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204486|NCT02326298|450372066|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204487|NCT02326298|450372067|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125648363|NCT00151775|451995724|FG003|Period 4: Open Label|Adverse Event|0|||
125648364|NCT00151775|451995725|FG004|Period 4: Open Label|Adverse Event|1|||
125648365|NCT00151775|451995726|FG005|Period 4: Open Label|Adverse Event|0|||
125648366|NCT00151775|451995727|FG006|Period 4: Open Label|Adverse Event|0|||
125648367|NCT00151775|451995728|FG007|Period 4: Open Label|Adverse Event|0|||
125648368|NCT00151775|451995729|FG008|Period 4: Open Label|Adverse Event|0|||
125648369|NCT00151775|451995730|FG009|Period 4: Open Label|Adverse Event|2|||
125648370|NCT00151775|451995731|FG010|Period 4: Open Label|Adverse Event|0|||
125648371|NCT00151775|451995732|FG011|Period 4: Open Label|Adverse Event|0|||
125648372|NCT00151775|451995721|FG000|Period 4: Open Label|Lost to Follow-up|0|||
125648373|NCT00151775|451995722|FG001|Period 4: Open Label|Lost to Follow-up|0|||
125648374|NCT00151775|451995723|FG002|Period 4: Open Label|Lost to Follow-up|0|||
125648375|NCT00151775|451995724|FG003|Period 4: Open Label|Lost to Follow-up|0|||
125648376|NCT00151775|451995725|FG004|Period 4: Open Label|Lost to Follow-up|17|||
125648377|NCT00151775|451995726|FG005|Period 4: Open Label|Lost to Follow-up|0|||
125648378|NCT00151775|451995727|FG006|Period 4: Open Label|Lost to Follow-up|0|||
125648379|NCT00151775|451995728|FG007|Period 4: Open Label|Lost to Follow-up|0|||
125648380|NCT00151775|451995729|FG008|Period 4: Open Label|Lost to Follow-up|0|||
125648381|NCT00151775|451995730|FG009|Period 4: Open Label|Lost to Follow-up|7|||
125648382|NCT00151775|451995731|FG010|Period 4: Open Label|Lost to Follow-up|0|||
125648383|NCT00151775|451995732|FG011|Period 4: Open Label|Lost to Follow-up|0|||
125648384|NCT00151775|451995721|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
125648385|NCT00151775|451995722|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
125648386|NCT00151775|451995723|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
125648387|NCT00151775|451995724|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
125648388|NCT00151775|451995725|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
125648389|NCT00151775|451995726|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
125648390|NCT00151775|451995727|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
125648391|NCT00151775|451995728|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
125648392|NCT00151775|451995729|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
125648393|NCT00151775|451995730|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
125648394|NCT00151775|451995731|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
125648395|NCT00151775|451995732|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
125648396|NCT00151775|451995721|FG000|Period 4: Open Label|Other|0|||
125648397|NCT00151775|451995722|FG001|Period 4: Open Label|Other|0|||
125648398|NCT00151775|451995723|FG002|Period 4: Open Label|Other|0|||
125648399|NCT00151775|451995724|FG003|Period 4: Open Label|Other|0|||
125204488|NCT02326298|450372068|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204489|NCT02326298|450372069|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204490|NCT02326298|450372070|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125204491|NCT02326298|450372057|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
125204492|NCT02326298|450372058|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204493|NCT02326298|450372059|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204494|NCT02326298|450372060|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204495|NCT02326298|450372061|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204496|NCT02326298|450372062|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204497|NCT02326298|450372063|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204498|NCT02326298|450372064|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204499|NCT02326298|450372065|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204500|NCT02326298|450372066|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204501|NCT02326298|450372067|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125648400|NCT00151775|451995725|FG004|Period 4: Open Label|Other|1|||
125648401|NCT00151775|451995726|FG005|Period 4: Open Label|Other|0|||
125648402|NCT00151775|451995727|FG006|Period 4: Open Label|Other|0|||
125648403|NCT00151775|451995728|FG007|Period 4: Open Label|Other|0|||
125204502|NCT02326298|450372068|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125648404|NCT00151775|451995729|FG008|Period 4: Open Label|Other|0|||
125648405|NCT00151775|451995730|FG009|Period 4: Open Label|Other|3|||
125648406|NCT00151775|451995731|FG010|Period 4: Open Label|Other|0|||
125648407|NCT00151775|451995732|FG011|Period 4: Open Label|Other|0|||
125648408|NCT00151775|451995721|FG000|Period 4: Open Label|Physician Decision|0|||
125648409|NCT00151775|451995722|FG001|Period 4: Open Label|Physician Decision|0|||
125648410|NCT00151775|451995723|FG002|Period 4: Open Label|Physician Decision|0|||
125648411|NCT00151775|451995724|FG003|Period 4: Open Label|Physician Decision|0|||
125648412|NCT00151775|451995725|FG004|Period 4: Open Label|Physician Decision|0|||
125648413|NCT00151775|451995726|FG005|Period 4: Open Label|Physician Decision|0|||
125648414|NCT00151775|451995727|FG006|Period 4: Open Label|Physician Decision|0|||
125648415|NCT00151775|451995728|FG007|Period 4: Open Label|Physician Decision|0|||
125648416|NCT00151775|451995729|FG008|Period 4: Open Label|Physician Decision|0|||
125648417|NCT00151775|451995730|FG009|Period 4: Open Label|Physician Decision|2|||
125648418|NCT00151775|451995731|FG010|Period 4: Open Label|Physician Decision|0|||
125648419|NCT00151775|451995732|FG011|Period 4: Open Label|Physician Decision|0|||
125648420|NCT00151775|451995721|FG000|Period 4: Open Label|Protocol Violation|0|||
125648421|NCT00151775|451995722|FG001|Period 4: Open Label|Protocol Violation|0|||
125648422|NCT00151775|451995723|FG002|Period 4: Open Label|Protocol Violation|0|||
125648423|NCT00151775|451995724|FG003|Period 4: Open Label|Protocol Violation|0|||
125648424|NCT00151775|451995725|FG004|Period 4: Open Label|Protocol Violation|1|||
125648425|NCT00151775|451995726|FG005|Period 4: Open Label|Protocol Violation|0|||
125648426|NCT00151775|451995727|FG006|Period 4: Open Label|Protocol Violation|0|||
125648427|NCT00151775|451995728|FG007|Period 4: Open Label|Protocol Violation|0|||
125648428|NCT00151775|451995729|FG008|Period 4: Open Label|Protocol Violation|0|||
125648429|NCT00151775|451995730|FG009|Period 4: Open Label|Protocol Violation|0|||
125648430|NCT00151775|451995731|FG010|Period 4: Open Label|Protocol Violation|0|||
125648431|NCT00151775|451995732|FG011|Period 4: Open Label|Protocol Violation|0|||
125648432|NCT00474994|451995741|FG000|Overall Study|Patient Not treated|1|||
125648433|NCT00474994|451995741|FG000|Overall Study|Patient evaluable for toxicity only|3|||
125648434|NCT00474994|451995741|FG000|Overall Study|Patient found to be ineligible|1|||
125648435|NCT04516291|451995742|FG000|Treatment Period (24 Weeks)|Other|1|||
125648436|NCT04516291|451995743|FG001|Treatment Period (24 Weeks)|Other|0|||
125648437|NCT04516291|451995744|FG002|Treatment Period (24 Weeks)|Other|0|||
125648438|NCT04516291|451995745|FG003|Treatment Period (24 Weeks)|Other|2|||
125648439|NCT04516291|451995746|FG004|Treatment Period (24 Weeks)|Other|2|||
125648440|NCT04516291|451995747|FG005|Treatment Period (24 Weeks)|Other|4|||
125648441|NCT04516291|451995748|FG006|Treatment Period (24 Weeks)|Other|2|||
125648442|NCT04516291|451995749|FG007|Treatment Period (24 Weeks)|Other|0|||
125648443|NCT04516291|451995742|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125648444|NCT04516291|451995743|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
125648445|NCT04516291|451995744|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
125648446|NCT04516291|451995745|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125648447|NCT04516291|451995746|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
125648448|NCT04516291|451995747|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125648449|NCT04516291|451995748|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125648450|NCT04516291|451995749|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125648451|NCT04516291|451995742|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
125648452|NCT04516291|451995743|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
125648453|NCT04516291|451995744|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
125648454|NCT04516291|451995745|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
125648455|NCT04516291|451995746|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
125648456|NCT04516291|451995747|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
125648457|NCT04516291|451995748|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
125648458|NCT04516291|451995749|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
125648459|NCT04516291|451995742|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125648460|NCT04516291|451995743|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125648461|NCT04516291|451995744|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125648462|NCT04516291|451995745|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125648463|NCT04516291|451995746|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125648464|NCT04516291|451995747|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125648465|NCT04516291|451995748|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125648466|NCT04516291|451995749|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125648467|NCT04516291|451995742|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
125204503|NCT02326298|450372069|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125648468|NCT04516291|451995743|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
125648469|NCT04516291|451995744|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
125648470|NCT04516291|451995745|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
125648471|NCT04516291|451995746|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
125648472|NCT04516291|451995747|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
125648473|NCT04516291|451995748|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
125648474|NCT04516291|451995749|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
125648475|NCT04516291|451995742|FG000|Follow-up Period (12 Weeks)|Other|0|||
125648476|NCT04516291|451995743|FG001|Follow-up Period (12 Weeks)|Other|1|||
125648477|NCT04516291|451995744|FG002|Follow-up Period (12 Weeks)|Other|0|||
125648478|NCT04516291|451995745|FG003|Follow-up Period (12 Weeks)|Other|2|||
125648479|NCT04516291|451995746|FG004|Follow-up Period (12 Weeks)|Other|0|||
125648480|NCT04516291|451995747|FG005|Follow-up Period (12 Weeks)|Other|0|||
125648481|NCT04516291|451995748|FG006|Follow-up Period (12 Weeks)|Other|0|||
125648482|NCT04516291|451995749|FG007|Follow-up Period (12 Weeks)|Other|0|||
125648483|NCT04516291|451995742|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125648484|NCT04516291|451995743|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125648485|NCT04516291|451995744|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125648486|NCT04516291|451995745|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125648487|NCT04516291|451995746|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
125648488|NCT04516291|451995747|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125648489|NCT04516291|451995748|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125648490|NCT04516291|451995749|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125648491|NCT04516291|451995742|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
125648492|NCT04516291|451995743|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
125648493|NCT04516291|451995744|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
125648494|NCT04516291|451995745|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
125648495|NCT04516291|451995746|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
125648496|NCT04516291|451995747|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
125648497|NCT04516291|451995748|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
125648498|NCT04516291|451995749|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
125648499|NCT02181634|451995753|FG000|Overall Study|Lack of Efficacy|33|||
125648500|NCT02181634|451995753|FG000|Overall Study|Adverse Event|17|||
125648501|NCT02181634|451995753|FG000|Overall Study|Physician Decision|8|||
125648502|NCT02181634|451995753|FG000|Overall Study|Withdrawal by Subject|5|||
125648503|NCT02181634|451995753|FG000|Overall Study|Death|2|||
125648504|NCT02181634|451995753|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
125648505|NCT02181634|451995753|FG000|Overall Study|Ineligible|1|||
125648506|NCT02181634|451995753|FG000|Overall Study|Max number of dose reduction|1|||
125648507|NCT02181634|451995753|FG000|Overall Study|Symptomatic progression|1|||
125648508|NCT02181634|451995753|FG000|Overall Study|Patient opted to proceed to surgery|1|||
125648509|NCT01928758|451995762|FG000|Overall Study|Lost to Follow-up|14|||
125648510|NCT01928758|451995763|FG001|Overall Study|Lost to Follow-up|9|||
125648511|NCT01928758|451995762|FG000|Overall Study|Withdrawal by Subject|5|||
125648512|NCT01928758|451995763|FG001|Overall Study|Withdrawal by Subject|2|||
125648513|NCT01928758|451995762|FG000|Overall Study|Adverse Event|3|||
125648514|NCT01928758|451995763|FG001|Overall Study|Adverse Event|5|||
125648515|NCT01928758|451995762|FG000|Overall Study|Protocol Violation|3|||
125648516|NCT01928758|451995763|FG001|Overall Study|Protocol Violation|4|||
125648517|NCT00719706|451995764|FG000|Overall Study|Adverse Event|5|||
125648518|NCT00719706|451995765|FG001|Overall Study|Adverse Event|4|||
125648519|NCT00719706|451995764|FG000|Overall Study|Withdrawal by Subject|1|||
125648520|NCT00719706|451995765|FG001|Overall Study|Withdrawal by Subject|2|||
125648521|NCT00719706|451995764|FG000|Overall Study|Protocol Violation|3|||
125648522|NCT00719706|451995765|FG001|Overall Study|Protocol Violation|0|||
125648523|NCT00134563|451995768|FG000|Overall Study|Not treated due to protocol violation|0|||
125648524|NCT00134563|451995769|FG001|Overall Study|Not treated due to protocol violation|1|||
125648525|NCT00134563|451995770|FG002|Overall Study|Not treated due to protocol violation|1|||
125648526|NCT00134563|451995768|FG000|Overall Study|Adverse Event|29|||
125648527|NCT00134563|451995769|FG001|Overall Study|Adverse Event|37|||
125648528|NCT00134563|451995770|FG002|Overall Study|Adverse Event|38|||
125648529|NCT00134563|451995768|FG000|Overall Study|Lack of Efficacy|24|||
125648530|NCT00134563|451995769|FG001|Overall Study|Lack of Efficacy|14|||
125648531|NCT00134563|451995770|FG002|Overall Study|Lack of Efficacy|17|||
125648532|NCT00134563|451995768|FG000|Overall Study|Protocol Violation|3|||
125648533|NCT00134563|451995769|FG001|Overall Study|Protocol Violation|2|||
125648534|NCT00134563|451995770|FG002|Overall Study|Protocol Violation|5|||
125648535|NCT00134563|451995768|FG000|Overall Study|Lost to Follow-up|4|||
125648536|NCT00134563|451995769|FG001|Overall Study|Lost to Follow-up|0|||
125648537|NCT00134563|451995770|FG002|Overall Study|Lost to Follow-up|2|||
125648538|NCT00134563|451995768|FG000|Overall Study|progressive disease|11|||
125648539|NCT00134563|451995769|FG001|Overall Study|progressive disease|4|||
125648540|NCT00134563|451995770|FG002|Overall Study|progressive disease|2|||
125648541|NCT00134563|451995768|FG000|Overall Study|did not wish to continue|33|||
125648542|NCT00134563|451995769|FG001|Overall Study|did not wish to continue|32|||
125648543|NCT00134563|451995770|FG002|Overall Study|did not wish to continue|26|||
125648544|NCT00134563|451995768|FG000|Overall Study|Reason other than above|0|||
125648545|NCT00134563|451995769|FG001|Overall Study|Reason other than above|2|||
125648546|NCT00134563|451995770|FG002|Overall Study|Reason other than above|5|||
125648547|NCT03382639|451995774|FG000|Overall Study|Adverse Event|2|||
125648548|NCT03382639|451995775|FG001|Overall Study|Adverse Event|0|||
125648549|NCT03382639|451995776|FG002|Overall Study|Adverse Event|1|||
125648550|NCT03382639|451995777|FG003|Overall Study|Adverse Event|1|||
125648551|NCT03382639|451995774|FG000|Overall Study|Lost to Follow-up|1|||
125648552|NCT03382639|451995775|FG001|Overall Study|Lost to Follow-up|0|||
125648553|NCT03382639|451995776|FG002|Overall Study|Lost to Follow-up|0|||
125648554|NCT03382639|451995777|FG003|Overall Study|Lost to Follow-up|0|||
125648555|NCT03382639|451995774|FG000|Overall Study|Withdrawal by Subject|4|||
125648556|NCT03382639|451995775|FG001|Overall Study|Withdrawal by Subject|3|||
125648557|NCT03382639|451995776|FG002|Overall Study|Withdrawal by Subject|2|||
125204504|NCT02326298|450372070|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
125204505|NCT02326298|450372057|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
125204506|NCT02326298|450372058|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
125204507|NCT02326298|450372059|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204508|NCT02326298|450372060|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204509|NCT02326298|450372061|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204510|NCT02326298|450372062|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204511|NCT02326298|450372063|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204512|NCT02326298|450372064|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204513|NCT02326298|450372065|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204514|NCT02326298|450372066|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204515|NCT02326298|450372067|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125648558|NCT03382639|451995777|FG003|Overall Study|Withdrawal by Subject|3|||
125648559|NCT03382639|451995774|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
125648560|NCT03382639|451995775|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
125648561|NCT03382639|451995776|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
125648562|NCT03382639|451995777|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
125648563|NCT03382639|451995774|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
125648564|NCT03382639|451995775|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
125648565|NCT03382639|451995776|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
125648566|NCT03382639|451995777|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
125648567|NCT03382639|451995774|FG000|Overall Study|Other|2|||
125648568|NCT03382639|451995775|FG001|Overall Study|Other|0|||
125648569|NCT03382639|451995776|FG002|Overall Study|Other|0|||
125648570|NCT03382639|451995777|FG003|Overall Study|Other|3|||
125648571|NCT02406586|451995778|FG000|Overall Study|Lost to Follow-up|0|||
125648572|NCT02406586|451995779|FG001|Overall Study|Lost to Follow-up|4|||
125648573|NCT02406586|451995780|FG002|Overall Study|Lost to Follow-up|2|||
125648574|NCT02406586|451995778|FG000|Overall Study|Withdrawal by Subject|1|||
125648575|NCT02406586|451995779|FG001|Overall Study|Withdrawal by Subject|0|||
125648576|NCT02406586|451995780|FG002|Overall Study|Withdrawal by Subject|0|||
125648577|NCT00682539|451995783|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
125648578|NCT00682539|451995784|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
125648579|NCT00682539|451995785|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
125648580|NCT00682539|451995783|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
125648581|NCT00682539|451995784|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
125648582|NCT00682539|451995785|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
125648583|NCT01911546|451995788|FG000|Overall Study|Lost to Follow-up|1|||
125648584|NCT01911546|451995788|FG000|Overall Study|Everolimus was discontinued|5|||
125648585|NCT02546193|451995789|FG000|Overall Study|Withdrawal by Subject|2|||
125648586|NCT02546193|451995790|FG001|Overall Study|Withdrawal by Subject|0|||
125648587|NCT02546193|451995791|FG002|Overall Study|Withdrawal by Subject|1|||
125648588|NCT02546193|451995792|FG003|Overall Study|Withdrawal by Subject|0|||
125648589|NCT02546193|451995789|FG000|Overall Study|Not eligible at time of induction|4|||
125648590|NCT02546193|451995790|FG001|Overall Study|Not eligible at time of induction|6|||
125648591|NCT02546193|451995791|FG002|Overall Study|Not eligible at time of induction|1|||
125648592|NCT02546193|451995792|FG003|Overall Study|Not eligible at time of induction|0|||
125648593|NCT01287403|451995793|FG000|1st Intervention (1 Day)|Adverse Event|1|||
125648594|NCT00148109|451995794|FG000|Overall Study|Lack of Efficacy|10|||
125648595|NCT00148109|451995795|FG001|Overall Study|Lack of Efficacy|18|||
125648596|NCT00148109|451995794|FG000|Overall Study|Adverse Event|0|||
125648597|NCT00148109|451995795|FG001|Overall Study|Adverse Event|2|||
125648598|NCT00148109|451995794|FG000|Overall Study|Withdrawal by Subject|2|||
125648599|NCT00148109|451995795|FG001|Overall Study|Withdrawal by Subject|0|||
125648600|NCT00649220|451995796|FG000|Overall Study|Adverse Event|2|||
125204516|NCT02326298|450372068|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125648601|NCT00649220|451995796|FG000|Overall Study|Withdrawal by Subject|1|||
125648602|NCT01399619|451995797|FG000|Overall Study|Adverse Event|10|||
125648603|NCT01399619|451995798|FG001|Overall Study|Adverse Event|0|||
125648604|NCT01399619|451995799|FG002|Overall Study|Adverse Event|4|||
125648605|NCT01399619|451995800|FG003|Overall Study|Adverse Event|10|||
125648606|NCT01399619|451995797|FG000|Overall Study|Lack of Efficacy|9|||
125648607|NCT01399619|451995798|FG001|Overall Study|Lack of Efficacy|0|||
125648608|NCT01399619|451995799|FG002|Overall Study|Lack of Efficacy|5|||
125648609|NCT01399619|451995800|FG003|Overall Study|Lack of Efficacy|0|||
125648610|NCT01399619|451995797|FG000|Overall Study|Withdrawal by Subject|6|||
125648611|NCT01399619|451995798|FG001|Overall Study|Withdrawal by Subject|0|||
125648612|NCT01399619|451995799|FG002|Overall Study|Withdrawal by Subject|3|||
125648613|NCT01399619|451995800|FG003|Overall Study|Withdrawal by Subject|4|||
125648614|NCT01399619|451995797|FG000|Overall Study|Protocol Violation|0|||
125648615|NCT01399619|451995798|FG001|Overall Study|Protocol Violation|0|||
125648616|NCT01399619|451995799|FG002|Overall Study|Protocol Violation|0|||
125648617|NCT01399619|451995800|FG003|Overall Study|Protocol Violation|1|||
125648618|NCT01399619|451995797|FG000|Overall Study|Not treated|0|||
125648619|NCT01399619|451995798|FG001|Overall Study|Not treated|0|||
125648620|NCT01399619|451995799|FG002|Overall Study|Not treated|0|||
125648621|NCT01399619|451995800|FG003|Overall Study|Not treated|2|||
125648622|NCT02557308|451995801|FG000|Overall Study|Withdrawal by Subject|11|||
125648623|NCT02557308|451995802|FG001|Overall Study|Withdrawal by Subject|3|||
125648624|NCT02557308|451995803|FG002|Overall Study|Withdrawal by Subject|2|||
125648625|NCT02557308|451995804|FG003|Overall Study|Withdrawal by Subject|0|||
125648626|NCT02557308|451995805|FG004|Overall Study|Withdrawal by Subject|1|||
125648627|NCT02557308|451995806|FG005|Overall Study|Withdrawal by Subject|0|||
125648628|NCT02557308|451995807|FG006|Overall Study|Withdrawal by Subject|10|||
125648629|NCT02557308|451995808|FG007|Overall Study|Withdrawal by Subject|1|||
125648630|NCT02557308|451995801|FG000|Overall Study|Disease Progression|0|||
125648631|NCT02557308|451995802|FG001|Overall Study|Disease Progression|1|||
125648632|NCT02557308|451995803|FG002|Overall Study|Disease Progression|0|||
125648633|NCT02557308|451995804|FG003|Overall Study|Disease Progression|0|||
125648634|NCT02557308|451995805|FG004|Overall Study|Disease Progression|0|||
125648635|NCT02557308|451995806|FG005|Overall Study|Disease Progression|0|||
125648636|NCT02557308|451995807|FG006|Overall Study|Disease Progression|0|||
125648637|NCT02557308|451995808|FG007|Overall Study|Disease Progression|0|||
125648638|NCT02557308|451995801|FG000|Overall Study|Lack of Efficacy|3|||
125648639|NCT02557308|451995802|FG001|Overall Study|Lack of Efficacy|0|||
125648640|NCT02557308|451995803|FG002|Overall Study|Lack of Efficacy|0|||
125648641|NCT02557308|451995804|FG003|Overall Study|Lack of Efficacy|0|||
125648642|NCT02557308|451995805|FG004|Overall Study|Lack of Efficacy|0|||
125648643|NCT02557308|451995806|FG005|Overall Study|Lack of Efficacy|0|||
125648644|NCT02557308|451995807|FG006|Overall Study|Lack of Efficacy|1|||
125648645|NCT02557308|451995808|FG007|Overall Study|Lack of Efficacy|0|||
125648646|NCT02557308|451995801|FG000|Overall Study|Adverse Event|4|||
125648647|NCT02557308|451995802|FG001|Overall Study|Adverse Event|1|||
125648648|NCT02557308|451995803|FG002|Overall Study|Adverse Event|2|||
125648649|NCT02557308|451995804|FG003|Overall Study|Adverse Event|0|||
125648650|NCT02557308|451995805|FG004|Overall Study|Adverse Event|0|||
125648651|NCT02557308|451995806|FG005|Overall Study|Adverse Event|0|||
125648652|NCT02557308|451995807|FG006|Overall Study|Adverse Event|4|||
125648653|NCT02557308|451995808|FG007|Overall Study|Adverse Event|1|||
125648654|NCT02557308|451995801|FG000|Overall Study|Lost to Follow-up|2|||
125648655|NCT02557308|451995802|FG001|Overall Study|Lost to Follow-up|0|||
125648656|NCT02557308|451995803|FG002|Overall Study|Lost to Follow-up|1|||
125648657|NCT02557308|451995804|FG003|Overall Study|Lost to Follow-up|0|||
125648658|NCT02557308|451995805|FG004|Overall Study|Lost to Follow-up|0|||
125648659|NCT02557308|451995806|FG005|Overall Study|Lost to Follow-up|0|||
125648660|NCT02557308|451995807|FG006|Overall Study|Lost to Follow-up|2|||
125648661|NCT02557308|451995808|FG007|Overall Study|Lost to Follow-up|0|||
125648662|NCT02557308|451995801|FG000|Overall Study|Death|1|||
125648663|NCT02557308|451995802|FG001|Overall Study|Death|0|||
125648664|NCT02557308|451995803|FG002|Overall Study|Death|0|||
125648665|NCT02557308|451995804|FG003|Overall Study|Death|0|||
125648666|NCT02557308|451995805|FG004|Overall Study|Death|0|||
125648667|NCT02557308|451995806|FG005|Overall Study|Death|0|||
125648668|NCT02557308|451995807|FG006|Overall Study|Death|0|||
125204517|NCT02326298|450372069|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125204518|NCT02326298|450372070|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125648669|NCT02557308|451995808|FG007|Overall Study|Death|0|||
125648670|NCT02557308|451995801|FG000|Overall Study|Study Close|98|||
125648671|NCT02557308|451995802|FG001|Overall Study|Study Close|18|||
125648672|NCT02557308|451995803|FG002|Overall Study|Study Close|5|||
125648673|NCT02557308|451995804|FG003|Overall Study|Study Close|3|||
125648674|NCT02557308|451995805|FG004|Overall Study|Study Close|1|||
125648675|NCT02557308|451995806|FG005|Overall Study|Study Close|0|||
125648676|NCT02557308|451995807|FG006|Overall Study|Study Close|123|||
125648677|NCT02557308|451995808|FG007|Overall Study|Study Close|5|||
125648678|NCT02557308|451995801|FG000|Overall Study|Except for study close|5|||
125648679|NCT02557308|451995802|FG001|Overall Study|Except for study close|0|||
125648680|NCT02557308|451995803|FG002|Overall Study|Except for study close|0|||
125648681|NCT02557308|451995804|FG003|Overall Study|Except for study close|0|||
125648682|NCT02557308|451995805|FG004|Overall Study|Except for study close|3|||
125648683|NCT02557308|451995806|FG005|Overall Study|Except for study close|0|||
125648684|NCT02557308|451995807|FG006|Overall Study|Except for study close|6|||
125648685|NCT02557308|451995808|FG007|Overall Study|Except for study close|10|||
125648686|NCT00351611|451995811|FG000|Overall Study|Adverse Event|11|||
125648687|NCT00351611|451995812|FG001|Overall Study|Adverse Event|3|||
125648688|NCT00351611|451995811|FG000|Overall Study|Death|1|||
125648689|NCT00351611|451995812|FG001|Overall Study|Death|0|||
125648690|NCT00351611|451995811|FG000|Overall Study|Lost to Follow-up|1|||
125648691|NCT00351611|451995812|FG001|Overall Study|Lost to Follow-up|0|||
125648692|NCT00351611|451995811|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
125648693|NCT00351611|451995812|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
125648694|NCT00351611|451995811|FG000|Overall Study|Other|1|||
125648695|NCT00351611|451995812|FG001|Overall Study|Other|0|||
125648696|NCT00351611|451995811|FG000|Overall Study|Protocol Violation|0|||
125648697|NCT00351611|451995812|FG001|Overall Study|Protocol Violation|2|||
125648698|NCT00267202|451995813|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
125648699|NCT00267202|451995814|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
125648700|NCT00267202|451995813|FG000|Overall Study|Withdrawal by Subject|12|||
125648701|NCT00267202|451995814|FG001|Overall Study|Withdrawal by Subject|15|||
125648702|NCT00267202|451995813|FG000|Overall Study|Adverse Event|13|||
125648703|NCT00267202|451995814|FG001|Overall Study|Adverse Event|7|||
125648704|NCT00267202|451995813|FG000|Overall Study|Protocol Violation|2|||
125648705|NCT00267202|451995814|FG001|Overall Study|Protocol Violation|3|||
125648706|NCT00267202|451995813|FG000|Overall Study|Administrative problems|2|||
125648707|NCT00267202|451995814|FG001|Overall Study|Administrative problems|1|||
125648708|NCT00267202|451995813|FG000|Overall Study|Lost to Follow-up|3|||
125648709|NCT00267202|451995814|FG001|Overall Study|Lost to Follow-up|0|||
125648710|NCT00368069|451995815|FG000|Overall Study|Adverse Event|5|||
125648711|NCT00368069|451995816|FG001|Overall Study|Adverse Event|2|||
125648712|NCT00368069|451995815|FG000|Overall Study|Lack of Efficacy|0|||
125648713|NCT00368069|451995816|FG001|Overall Study|Lack of Efficacy|1|||
125648714|NCT00368069|451995815|FG000|Overall Study|Lost to Follow-up|1|||
125648715|NCT00368069|451995816|FG001|Overall Study|Lost to Follow-up|0|||
125648716|NCT00368069|451995815|FG000|Overall Study|Protocol Violation|0|||
125648717|NCT00368069|451995816|FG001|Overall Study|Protocol Violation|2|||
125648718|NCT00368069|451995815|FG000|Overall Study|Withdrawal of Consent|2|||
125648719|NCT00368069|451995816|FG001|Overall Study|Withdrawal of Consent|1|||
125648720|NCT00368069|451995815|FG000|Overall Study|no blood sampling possible|0|||
125648721|NCT00368069|451995816|FG001|Overall Study|no blood sampling possible|1|||
125648722|NCT03907072|451995820|FG000|Overall Study|Study Terminated by Sponsor|2|||
125648723|NCT03907072|451995821|FG001|Overall Study|Study Terminated by Sponsor|2|||
125648724|NCT03907072|451995822|FG002|Overall Study|Study Terminated by Sponsor|2|||
125648725|NCT01430559|451995826|FG000|Overall Study|Adverse Event|7|||
125648726|NCT01430559|451995827|FG001|Overall Study|Adverse Event|3|||
125648727|NCT01430559|451995826|FG000|Overall Study|Entry criteria not met|1|||
125648728|NCT01430559|451995827|FG001|Overall Study|Entry criteria not met|1|||
125648729|NCT01430559|451995826|FG000|Overall Study|Lost to Follow-up|1|||
125648730|NCT01430559|451995827|FG001|Overall Study|Lost to Follow-up|0|||
125648731|NCT01430559|451995826|FG000|Overall Study|Medication error|1|||
125648732|NCT01430559|451995827|FG001|Overall Study|Medication error|0|||
125648733|NCT01430559|451995826|FG000|Overall Study|Withdrawal by Subject|3|||
125204519|NCT02326298|450372057|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
125204520|NCT02326298|450372058|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
125204521|NCT02326298|450372059|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204522|NCT02326298|450372060|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204523|NCT02326298|450372061|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204524|NCT02326298|450372062|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204525|NCT02326298|450372063|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204526|NCT02326298|450372064|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204527|NCT02326298|450372065|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204528|NCT02326298|450372066|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204529|NCT02326298|450372067|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204530|NCT02326298|450372068|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204531|NCT02326298|450372069|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204532|NCT02326298|450372070|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125204533|NCT02326298|450372057|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204534|NCT02326298|450372058|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204535|NCT02326298|450372059|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
125204536|NCT02326298|450372060|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204537|NCT02326298|450372061|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204538|NCT02326298|450372062|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204539|NCT02326298|450372063|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204540|NCT02326298|450372064|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204541|NCT02326298|450372065|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204542|NCT02326298|450372066|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204543|NCT02326298|450372067|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125648734|NCT01430559|451995827|FG001|Overall Study|Withdrawal by Subject|2|||
125648735|NCT01430559|451995826|FG000|Overall Study|Protocol Violation|1|||
125648736|NCT01430559|451995827|FG001|Overall Study|Protocol Violation|0|||
125648737|NCT01430559|451995826|FG000|Overall Study|Other|3|||
125648738|NCT01430559|451995827|FG001|Overall Study|Other|3|||
125648739|NCT01430559|451995826|FG000|Overall Study|Randomized, Not Treated|3|||
125204544|NCT02326298|450372068|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204545|NCT02326298|450372069|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204546|NCT02326298|450372070|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
125204547|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204548|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204549|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204550|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204551|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204552|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125204553|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
125204554|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125204555|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125204556|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125204557|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204558|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204559|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204560|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125204561|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204562|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204563|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204564|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204565|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204566|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
125204567|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
125204568|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204569|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
125204570|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204571|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204572|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204573|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204574|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
125204575|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204576|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125424874|NCT00430248|451178700|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
125648740|NCT01430559|451995827|FG001|Overall Study|Randomized, Not Treated|3|||
125648741|NCT01177943|451995828|FG000|First Intervention|Withdrawal by Subject|2|||
125648742|NCT01177943|451995829|FG001|First Intervention|Withdrawal by Subject|0|||
125648743|NCT00808665|451995830|FG000|Overall Study|Withdrawal by Subject|1|||
125648744|NCT00808665|451995831|FG001|Overall Study|Withdrawal by Subject|0|||
125648745|NCT00808665|451995830|FG000|Overall Study|only required minimally invasive surgery|1|||
125648746|NCT00808665|451995831|FG001|Overall Study|only required minimally invasive surgery|0|||
125648747|NCT00808665|451995830|FG000|Overall Study|surgery cancelled|1|||
125648748|NCT00808665|451995831|FG001|Overall Study|surgery cancelled|0|||
125648749|NCT00808665|451995830|FG000|Overall Study|required an additional procedure|0|||
125648750|NCT00808665|451995831|FG001|Overall Study|required an additional procedure|1|||
125648751|NCT00808665|451995830|FG000|Overall Study|Physician Decision|3|||
125648752|NCT00808665|451995831|FG001|Overall Study|Physician Decision|1|||
125648753|NCT00808665|451995830|FG000|Overall Study|Medication stopped by resident|0|||
125648754|NCT00808665|451995831|FG001|Overall Study|Medication stopped by resident|1|||
125648755|NCT03319160|451995832|FG000|Overall Study|Data not available.|7|||
125648756|NCT02431559|451995833|FG000|Overall Study|Adverse Event|0|||
125648757|NCT02431559|451995834|FG001|Overall Study|Adverse Event|1|||
125648758|NCT02431559|451995835|FG002|Overall Study|Adverse Event|0|||
125648759|NCT02431559|451995836|FG003|Overall Study|Adverse Event|4|||
125648760|NCT02431559|451995833|FG000|Overall Study|Progressive disease|2|||
125648761|NCT02431559|451995834|FG001|Overall Study|Progressive disease|1|||
125648762|NCT02431559|451995835|FG002|Overall Study|Progressive disease|4|||
125648763|NCT02431559|451995836|FG003|Overall Study|Progressive disease|22|||
125648764|NCT02431559|451995833|FG000|Overall Study|Withdrawal by Subject|0|||
125648765|NCT02431559|451995834|FG001|Overall Study|Withdrawal by Subject|1|||
125648766|NCT02431559|451995835|FG002|Overall Study|Withdrawal by Subject|0|||
125648767|NCT02431559|451995836|FG003|Overall Study|Withdrawal by Subject|4|||
125648768|NCT02431559|451995833|FG000|Overall Study|Physician Decision|0|||
125648769|NCT02431559|451995834|FG001|Overall Study|Physician Decision|0|||
125648770|NCT02431559|451995835|FG002|Overall Study|Physician Decision|0|||
125648771|NCT02431559|451995836|FG003|Overall Study|Physician Decision|1|||
125648772|NCT02543918|451995837|FG000|Overall Study|Never treated|0|||
125648773|NCT02543918|451995838|FG001|Overall Study|Never treated|1|||
125648774|NCT02543918|451995837|FG000|Overall Study|Lost to Follow-up|1|||
125648775|NCT02543918|451995838|FG001|Overall Study|Lost to Follow-up|1|||
125648776|NCT02543918|451995837|FG000|Overall Study|Withdrawal by Subject|1|||
125648777|NCT02543918|451995838|FG001|Overall Study|Withdrawal by Subject|1|||
125648778|NCT02543918|451995837|FG000|Overall Study|Adverse Event|1|||
125648779|NCT02543918|451995838|FG001|Overall Study|Adverse Event|1|||
125648780|NCT01411917|451995840|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
125648781|NCT01411917|451995841|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
125648782|NCT04806334|451995848|FG000|Overall Study|Withdrawal by Subject|1|||
125648783|NCT01731600|451995851|FG000|Overall Study|Adverse Event|2|||
125648784|NCT01731600|451995852|FG001|Overall Study|Adverse Event|0|||
125648785|NCT01731600|451995851|FG000|Overall Study|Withdrawal criteria|1|||
125648786|NCT01731600|451995852|FG001|Overall Study|Withdrawal criteria|0|||
125648787|NCT01731600|451995851|FG000|Overall Study|Other reasons|3|||
125648788|NCT01731600|451995852|FG001|Overall Study|Other reasons|0|||
125648789|NCT00465894|451995853|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
125648790|NCT00465894|451995854|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
125648791|NCT00465894|451995853|FG000|Treatment For 12 Weeks|Family Issues|1|||
125648792|NCT00465894|451995854|FG001|Treatment For 12 Weeks|Family Issues|1|||
125648793|NCT00465894|451995853|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
125648794|NCT00465894|451995854|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
125648795|NCT01636076|451995855|FG000|Overall Study|Terminated by sponsor|1|||
125648796|NCT01636076|451995856|FG001|Overall Study|Terminated by sponsor|1|||
125648797|NCT01636076|451995855|FG000|Overall Study|Lack of Efficacy|0|||
125648798|NCT01636076|451995856|FG001|Overall Study|Lack of Efficacy|1|||
125648799|NCT01636076|451995855|FG000|Overall Study|Lost to Follow-up|1|||
125648800|NCT01636076|451995856|FG001|Overall Study|Lost to Follow-up|0|||
125648801|NCT01636076|451995855|FG000|Overall Study|Physician Decision|1|||
125648802|NCT01636076|451995856|FG001|Overall Study|Physician Decision|1|||
125648803|NCT01636076|451995855|FG000|Overall Study|Non-compliance with study treatment|1|||
125648804|NCT01636076|451995856|FG001|Overall Study|Non-compliance with study treatment|1|||
125648805|NCT01636076|451995855|FG000|Overall Study|Adverse Event|6|||
125648806|NCT01636076|451995856|FG001|Overall Study|Adverse Event|11|||
125648807|NCT01636076|451995855|FG000|Overall Study|Withdrawal by Subject|7|||
125648808|NCT01636076|451995856|FG001|Overall Study|Withdrawal by Subject|10|||
125648809|NCT00540228|451995857|FG000|Overall Study|Adverse Event|2|||
125648810|NCT00540228|451995858|FG001|Overall Study|Adverse Event|0|||
125648811|NCT00540228|451995859|FG002|Overall Study|Adverse Event|0|||
125648812|NCT00540228|451995860|FG003|Overall Study|Adverse Event|0|||
125648813|NCT00540228|451995861|FG004|Overall Study|Adverse Event|0|||
125648814|NCT00540228|451995857|FG000|Overall Study|Lost to Follow-up|1|||
125648815|NCT00540228|451995858|FG001|Overall Study|Lost to Follow-up|1|||
125648816|NCT00540228|451995859|FG002|Overall Study|Lost to Follow-up|0|||
125648817|NCT00540228|451995860|FG003|Overall Study|Lost to Follow-up|0|||
125648818|NCT00540228|451995861|FG004|Overall Study|Lost to Follow-up|0|||
125648819|NCT02173158|451995863|FG000|Efficacy Phase|Adverse Event|1|||
125648820|NCT00765726|451995875|FG000|Overall Study|Withdrawal by Subject|1|||
125648821|NCT00765726|451995875|FG000|Overall Study|Discontinuation of study by sponsor|8|||
125648822|NCT01265511|451995876|FG000|Overall Study|Lack of Efficacy|2|||
125648823|NCT01265511|451995877|FG001|Overall Study|Lack of Efficacy|1|||
125648824|NCT01265511|451995876|FG000|Overall Study|Met stopping rules|0|||
125648825|NCT01265511|451995877|FG001|Overall Study|Met stopping rules|2|||
125648826|NCT00323479|451995878|FG000|Overall Study|Adverse Event|2|||
125648827|NCT00323479|451995878|FG000|Overall Study|Withdrawal by Subject|2|||
125648828|NCT00323479|451995878|FG000|Overall Study|Protocol Violation|3|||
125648829|NCT00323479|451995878|FG000|Overall Study|house moving|1|||
125648830|NCT01362062|451995879|FG000|Overall Study|Adverse Event|1|||
125648831|NCT01362062|451995880|FG001|Overall Study|Adverse Event|0|||
125648832|NCT01362062|451995879|FG000|Overall Study|Lost to Follow-up|11|||
125648833|NCT01362062|451995880|FG001|Overall Study|Lost to Follow-up|0|||
125648834|NCT01362062|451995879|FG000|Overall Study|Withdrawal by Subject|2|||
125648835|NCT01362062|451995880|FG001|Overall Study|Withdrawal by Subject|0|||
125648836|NCT01362062|451995879|FG000|Overall Study|Non-compliant participant|2|||
125648837|NCT01362062|451995880|FG001|Overall Study|Non-compliant participant|0|||
125648838|NCT01362062|451995879|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
125648839|NCT01362062|451995880|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
125648840|NCT01362062|451995879|FG000|Overall Study|Had significant improvement|9|||
125648841|NCT01362062|451995880|FG001|Overall Study|Had significant improvement|0|||
125648842|NCT00967343|451995882|FG000|Overall Study|Study termination by sponsor|12|||
125648843|NCT00967343|451995882|FG000|Overall Study|Death|24|||
125648844|NCT00967343|451995882|FG000|Overall Study|Relapse|1|||
125648845|NCT00967343|451995882|FG000|Overall Study|Lost to Follow-up|1|||
125648846|NCT00950755|451995883|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
125648847|NCT00950755|451995883|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
125648848|NCT00950755|451995883|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
125648849|NCT00950755|451995883|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
125648850|NCT00950755|451995883|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
125648851|NCT00950755|451995883|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
125648852|NCT00950755|451995883|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
125648853|NCT00950755|451995883|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
125539799|NCT00700427|451605818|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
125539800|NCT00700427|451605819|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
125539801|NCT00700427|451605820|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
125539802|NCT00700427|451605816|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
125539803|NCT00700427|451605817|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
125539804|NCT00700427|451605818|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
125539805|NCT00700427|451605819|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
125539806|NCT00700427|451605820|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
125539807|NCT00700427|451605816|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
125539808|NCT00700427|451605817|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
125539809|NCT00700427|451605818|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
125539810|NCT00700427|451605819|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
125539811|NCT00700427|451605820|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
125539812|NCT00700427|451605816|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
125539813|NCT00700427|451605817|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
125539814|NCT00700427|451605818|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
125539815|NCT00700427|451605819|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
125539816|NCT00700427|451605820|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
125539817|NCT00700427|451605816|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
125539818|NCT00700427|451605817|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
125539819|NCT00700427|451605818|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
125539820|NCT00700427|451605819|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
125539821|NCT00700427|451605820|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
125539822|NCT00700427|451605816|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
125539823|NCT00700427|451605817|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
125539824|NCT00700427|451605818|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
125539825|NCT00700427|451605819|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
125539826|NCT00700427|451605820|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
125539827|NCT00700427|451605816|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
125539828|NCT00700427|451605817|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
125539829|NCT00700427|451605818|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
125539830|NCT00700427|451605819|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
125539831|NCT00700427|451605820|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
125539832|NCT00700427|451605816|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
125539833|NCT00700427|451605817|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
125539834|NCT00700427|451605818|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
125539835|NCT00700427|451605819|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
125539836|NCT00700427|451605820|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
125539837|NCT00700427|451605816|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
125539838|NCT00700427|451605817|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
125539839|NCT00700427|451605818|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
125539840|NCT00700427|451605819|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
125539841|NCT00700427|451605820|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
125539842|NCT00700427|451605816|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
125539843|NCT00700427|451605817|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
125539844|NCT00700427|451605818|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
125539845|NCT00700427|451605819|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
125539846|NCT00700427|451605820|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
125539847|NCT00700427|451605816|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
125539848|NCT00700427|451605817|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
125539849|NCT00700427|451605818|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
125539850|NCT00700427|451605819|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
125539851|NCT00700427|451605820|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
125539852|NCT00700427|451605816|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
125539853|NCT00700427|451605817|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
125539854|NCT00700427|451605818|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
125539855|NCT00700427|451605819|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
125539856|NCT00700427|451605820|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
125539857|NCT00700427|451605816|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
125539858|NCT00700427|451605817|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
125648854|NCT00950755|451995883|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
125648855|NCT00950755|451995883|FG000|Long-Term Follow-Up|Death|8|||
125648856|NCT00508820|451995884|FG000|Overall Study|Adverse Event|6|||
125648857|NCT00508820|451995885|FG001|Overall Study|Adverse Event|10|||
125648858|NCT00508820|451995884|FG000|Overall Study|Death|6|||
125648859|NCT00508820|451995885|FG001|Overall Study|Death|8|||
125648860|NCT00508820|451995884|FG000|Overall Study|Lost to Follow-up|1|||
125204577|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204578|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204579|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204580|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
125204581|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204582|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204583|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204584|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204585|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204586|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204587|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204588|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
125204589|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204590|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204591|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204592|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204593|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204594|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204595|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
125204596|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204597|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204598|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204599|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204600|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204601|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204602|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125204603|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204604|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204605|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204606|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204607|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204608|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204609|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204610|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
125204611|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204612|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204613|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204614|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204615|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204616|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
125204617|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204618|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204619|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204620|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204621|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125648861|NCT00508820|451995885|FG001|Overall Study|Lost to Follow-up|1|||
125648862|NCT00508820|451995884|FG000|Overall Study|Physician Decision|8|||
125648863|NCT00508820|451995885|FG001|Overall Study|Physician Decision|2|||
125648864|NCT00508820|451995884|FG000|Overall Study|Pregnancy|0|||
125648865|NCT00508820|451995885|FG001|Overall Study|Pregnancy|2|||
125648866|NCT00508820|451995884|FG000|Overall Study|Protocol Violation|2|||
125648867|NCT00508820|451995885|FG001|Overall Study|Protocol Violation|0|||
125648868|NCT00508820|451995884|FG000|Overall Study|Withdrawal by Subject|10|||
125648869|NCT00508820|451995885|FG001|Overall Study|Withdrawal by Subject|12|||
125648870|NCT00508820|451995884|FG000|Overall Study|Other|11|||
125648871|NCT00508820|451995885|FG001|Overall Study|Other|2|||
125648872|NCT00508820|451995884|FG000|Overall Study|Noncompliance|1|||
125648873|NCT00508820|451995885|FG001|Overall Study|Noncompliance|0|||
125648874|NCT00508820|451995884|FG000|Overall Study|Requirement for alternative therapy|7|||
125648875|NCT00508820|451995885|FG001|Overall Study|Requirement for alternative therapy|15|||
125204622|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204623|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
125204624|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
125204625|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204626|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204627|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204628|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204629|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204630|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125204631|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204632|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204633|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204634|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204635|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204636|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204637|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204638|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
125204639|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204640|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204641|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204642|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204643|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204644|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125204645|NCT02326298|450372057|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204646|NCT02326298|450372058|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204647|NCT02326298|450372059|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204648|NCT02326298|450372060|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204649|NCT02326298|450372061|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204650|NCT02326298|450372062|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
125204651|NCT02326298|450372063|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204652|NCT02326298|450372064|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204653|NCT02326298|450372065|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204654|NCT02326298|450372066|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204655|NCT02326298|450372067|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204656|NCT02326298|450372068|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204657|NCT02326298|450372069|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204658|NCT02326298|450372070|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
125204659|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
125204660|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
125204661|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
125204662|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
125204663|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
125204664|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
125204665|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
125204666|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
125204667|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
125204668|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
125204669|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
125204670|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
125204671|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
125204672|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
125204673|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204674|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204675|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204676|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204677|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204678|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204679|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204680|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204681|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204682|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204683|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125539859|NCT00700427|451605818|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
125539860|NCT00700427|451605819|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
125204684|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
125204685|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
125204686|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125204687|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204688|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204689|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204690|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204691|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204692|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204693|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204694|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204695|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204696|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204697|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204698|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
125204699|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
125204700|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125204701|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204702|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204703|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204704|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204705|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204706|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204707|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204708|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204709|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204710|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204711|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204712|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204713|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125204714|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
125204715|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204716|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204717|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204718|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204719|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204720|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204721|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204722|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204723|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204724|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204725|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125204726|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
125204727|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
125204728|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
125204729|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204730|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204731|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204732|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204733|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204734|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204735|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204736|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204737|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204738|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204739|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125204740|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
125204741|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
125204742|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
125204743|NCT02326298|450372057|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204744|NCT02326298|450372058|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204745|NCT02326298|450372059|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204746|NCT02326298|450372060|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204747|NCT02326298|450372061|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204748|NCT02326298|450372062|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204749|NCT02326298|450372063|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204750|NCT02326298|450372064|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204751|NCT02326298|450372065|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204752|NCT02326298|450372066|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204753|NCT02326298|450372067|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125204754|NCT02326298|450372068|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
125204755|NCT02326298|450372069|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
125204756|NCT02326298|450372070|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
125204757|NCT03191864|450372071|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
125204758|NCT03191864|450372072|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
125204759|NCT03191864|450372073|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
125204760|NCT03191864|450372074|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
125204761|NCT03191864|450372075|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
125204762|NCT03191864|450372076|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
125204763|NCT03191864|450372071|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
125204764|NCT03191864|450372072|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
125204765|NCT03191864|450372073|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
125204766|NCT03191864|450372074|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
125204767|NCT03191864|450372075|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
125204768|NCT03191864|450372076|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
125204769|NCT03191864|450372071|FG000|Baseline Symptom Assessment|Adverse Event|0|||
125204770|NCT03191864|450372072|FG001|Baseline Symptom Assessment|Adverse Event|0|||
125204771|NCT03191864|450372073|FG002|Baseline Symptom Assessment|Adverse Event|0|||
125204772|NCT03191864|450372074|FG003|Baseline Symptom Assessment|Adverse Event|0|||
125204773|NCT03191864|450372075|FG004|Baseline Symptom Assessment|Adverse Event|0|||
125204774|NCT03191864|450372076|FG005|Baseline Symptom Assessment|Adverse Event|2|||
125204775|NCT03191864|450372071|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
125204776|NCT03191864|450372072|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
125204777|NCT03191864|450372073|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
125204778|NCT03191864|450372074|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
125204779|NCT03191864|450372075|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
125204780|NCT03191864|450372076|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
125204781|NCT03191864|450372071|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
125204782|NCT03191864|450372072|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
125204783|NCT03191864|450372073|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
125204784|NCT03191864|450372074|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
125204785|NCT03191864|450372075|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
125204786|NCT03191864|450372076|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
125204787|NCT03191864|450372071|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
125204788|NCT03191864|450372072|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
125204789|NCT03191864|450372073|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
125204790|NCT03191864|450372074|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
125204791|NCT03191864|450372075|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
125204792|NCT03191864|450372076|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
125204793|NCT03191864|450372071|FG000|Part 1 - Induction|Adverse Event|0|||
125204794|NCT03191864|450372072|FG001|Part 1 - Induction|Adverse Event|2|||
125204795|NCT03191864|450372073|FG002|Part 1 - Induction|Adverse Event|0|||
125204796|NCT03191864|450372074|FG003|Part 1 - Induction|Adverse Event|1|||
125204797|NCT03191864|450372075|FG004|Part 1 - Induction|Adverse Event|0|||
125204798|NCT03191864|450372076|FG005|Part 1 - Induction|Adverse Event|2|||
125204799|NCT03191864|450372071|FG000|Part 1 - Induction|Randomized but never dosed|0|||
125204800|NCT03191864|450372072|FG001|Part 1 - Induction|Randomized but never dosed|0|||
125204801|NCT03191864|450372073|FG002|Part 1 - Induction|Randomized but never dosed|1|||
125204802|NCT03191864|450372074|FG003|Part 1 - Induction|Randomized but never dosed|0|||
125204803|NCT03191864|450372075|FG004|Part 1 - Induction|Randomized but never dosed|0|||
125204804|NCT03191864|450372076|FG005|Part 1 - Induction|Randomized but never dosed|0|||
125204805|NCT03191864|450372071|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
125204806|NCT03191864|450372072|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
125204807|NCT03191864|450372073|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
125204808|NCT03191864|450372074|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
125204809|NCT03191864|450372075|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
125204810|NCT03191864|450372076|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
125204811|NCT03191864|450372071|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
125204812|NCT03191864|450372072|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
125204813|NCT03191864|450372073|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
125424875|NCT00430248|451178701|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125204814|NCT03191864|450372074|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
125204815|NCT03191864|450372075|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
125204816|NCT03191864|450372076|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
125204817|NCT03191864|450372071|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
125204818|NCT03191864|450372072|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
125204819|NCT03191864|450372073|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
125204820|NCT03191864|450372074|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
125204821|NCT03191864|450372075|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
125204822|NCT03191864|450372076|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
125204823|NCT03191864|450372071|FG000|Part 2 - Maintenance|Physician Decision|1|||
125204824|NCT03191864|450372072|FG001|Part 2 - Maintenance|Physician Decision|0|||
125204825|NCT03191864|450372073|FG002|Part 2 - Maintenance|Physician Decision|0|||
125204826|NCT03191864|450372074|FG003|Part 2 - Maintenance|Physician Decision|0|||
125204827|NCT03191864|450372075|FG004|Part 2 - Maintenance|Physician Decision|0|||
125204828|NCT03191864|450372076|FG005|Part 2 - Maintenance|Physician Decision|0|||
125204829|NCT03191864|450372071|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
125204830|NCT03191864|450372072|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
125204831|NCT03191864|450372073|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
125204832|NCT03191864|450372074|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
125204833|NCT03191864|450372075|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
125204834|NCT03191864|450372076|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
125204835|NCT03191864|450372071|FG000|Part 2 - Maintenance|Adverse Event|0|||
125204836|NCT03191864|450372072|FG001|Part 2 - Maintenance|Adverse Event|0|||
125204837|NCT03191864|450372073|FG002|Part 2 - Maintenance|Adverse Event|0|||
125204838|NCT03191864|450372074|FG003|Part 2 - Maintenance|Adverse Event|0|||
125204839|NCT03191864|450372075|FG004|Part 2 - Maintenance|Adverse Event|1|||
125204840|NCT03191864|450372076|FG005|Part 2 - Maintenance|Adverse Event|0|||
125204841|NCT03191864|450372071|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
125204842|NCT03191864|450372072|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
125204843|NCT03191864|450372073|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
125204844|NCT03191864|450372074|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
125204845|NCT03191864|450372075|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
125204846|NCT03191864|450372076|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
125204847|NCT03191864|450372071|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
125204848|NCT03191864|450372072|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
125204849|NCT03191864|450372073|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
125204850|NCT03191864|450372074|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
125204851|NCT03191864|450372075|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
125204852|NCT03191864|450372076|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
125204853|NCT00787917|450372080|FG000|Blinded Treatment|Adverse Event|1|||
125204854|NCT00787917|450372081|FG001|Blinded Treatment|Adverse Event|0|||
125204855|NCT00787917|450372080|FG000|Blinded Treatment|Lack of Efficacy|1|||
125204856|NCT00787917|450372081|FG001|Blinded Treatment|Lack of Efficacy|0|||
125204857|NCT00787917|450372080|FG000|Blinded Treatment|Administrative problems|3|||
125204858|NCT00787917|450372081|FG001|Blinded Treatment|Administrative problems|2|||
125204859|NCT00787917|450372080|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
125204860|NCT00787917|450372081|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
125204861|NCT00787917|450372080|FG000|Open Label|Administrative problems|3|||
125204862|NCT00787917|450372081|FG001|Open Label|Administrative problems|0|||
125204863|NCT01328548|450372082|FG000|Overall Study|Death|3|||
125204864|NCT01328548|450372083|FG001|Overall Study|Death|0|||
125204865|NCT01328548|450372082|FG000|Overall Study|Protocol Violation|1|||
125204866|NCT01328548|450372083|FG001|Overall Study|Protocol Violation|0|||
125204867|NCT00073983|450372084|FG000|Overall Study|not evaluable|1|||
125204868|NCT03800836|450372085|FG000|Overall Study|Other|2|||
125204869|NCT03800836|450372086|FG001|Overall Study|Other|1|||
125204870|NCT03800836|450372087|FG002|Overall Study|Other|0|||
125204871|NCT03800836|450372088|FG003|Overall Study|Other|2|||
125204872|NCT03800836|450372089|FG004|Overall Study|Other|0|||
125539861|NCT00700427|451605820|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
125539862|NCT00700427|451605816|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
125539863|NCT00700427|451605817|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
125539864|NCT00700427|451605818|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
125539865|NCT00700427|451605819|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
125539866|NCT00700427|451605820|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
125539867|NCT00700427|451605816|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
125204873|NCT03800836|450372090|FG005|Overall Study|Other|1|||
125204874|NCT03800836|450372085|FG000|Overall Study|Lost to Follow-up|2|||
125204875|NCT03800836|450372086|FG001|Overall Study|Lost to Follow-up|0|||
125204876|NCT03800836|450372087|FG002|Overall Study|Lost to Follow-up|1|||
125204877|NCT03800836|450372088|FG003|Overall Study|Lost to Follow-up|1|||
125204878|NCT03800836|450372089|FG004|Overall Study|Lost to Follow-up|3|||
125204879|NCT03800836|450372090|FG005|Overall Study|Lost to Follow-up|0|||
125204880|NCT03800836|450372085|FG000|Overall Study|Withdrawal by Subject|1|||
125204881|NCT03800836|450372086|FG001|Overall Study|Withdrawal by Subject|0|||
125204882|NCT03800836|450372087|FG002|Overall Study|Withdrawal by Subject|0|||
125204883|NCT03800836|450372088|FG003|Overall Study|Withdrawal by Subject|0|||
125204884|NCT03800836|450372089|FG004|Overall Study|Withdrawal by Subject|0|||
125204885|NCT03800836|450372090|FG005|Overall Study|Withdrawal by Subject|0|||
125204886|NCT03800836|450372085|FG000|Overall Study|Physician Decision|31|||
125204887|NCT03800836|450372086|FG001|Overall Study|Physician Decision|3|||
125204888|NCT03800836|450372087|FG002|Overall Study|Physician Decision|6|||
125204889|NCT03800836|450372088|FG003|Overall Study|Physician Decision|4|||
125204890|NCT03800836|450372089|FG004|Overall Study|Physician Decision|4|||
125204891|NCT03800836|450372090|FG005|Overall Study|Physician Decision|5|||
125204892|NCT03800836|450372085|FG000|Overall Study|Death|34|||
125204893|NCT03800836|450372086|FG001|Overall Study|Death|16|||
125204894|NCT03800836|450372087|FG002|Overall Study|Death|5|||
125204895|NCT03800836|450372088|FG003|Overall Study|Death|5|||
125204896|NCT03800836|450372089|FG004|Overall Study|Death|10|||
125204897|NCT03800836|450372090|FG005|Overall Study|Death|0|||
125204898|NCT03800836|450372085|FG000|Overall Study|Symptomatic Deterioration|1|||
125204899|NCT03800836|450372086|FG001|Overall Study|Symptomatic Deterioration|0|||
125204900|NCT03800836|450372087|FG002|Overall Study|Symptomatic Deterioration|1|||
125204901|NCT03800836|450372088|FG003|Overall Study|Symptomatic Deterioration|0|||
125204902|NCT03800836|450372089|FG004|Overall Study|Symptomatic Deterioration|0|||
125204903|NCT03800836|450372090|FG005|Overall Study|Symptomatic Deterioration|0|||
125204904|NCT03197467|450373234|FG000|Overall Study|Withdrawal by Subject|1|||
125204905|NCT04599933|450373242|FG000|Overall Study|Adverse Event|4|||
125204906|NCT04599933|450373243|FG001|Overall Study|Adverse Event|1|||
125204907|NCT04599933|450373242|FG000|Overall Study|Withdrawal by Subject|4|||
125204908|NCT04599933|450373243|FG001|Overall Study|Withdrawal by Subject|2|||
125204909|NCT04599933|450373242|FG000|Overall Study|Lost to Follow-up|0|||
125204910|NCT04599933|450373243|FG001|Overall Study|Lost to Follow-up|1|||
125204911|NCT04599933|450373242|FG000|Overall Study|Physician Decision|0|||
125204912|NCT04599933|450373243|FG001|Overall Study|Physician Decision|1|||
125204913|NCT04599933|450373242|FG000|Overall Study|Screen Failure|1|||
125204914|NCT04599933|450373243|FG001|Overall Study|Screen Failure|2|||
125204915|NCT04392167|450373251|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
125204916|NCT04063657|450373252|FG000|Overall Study|Lost to Follow-up|1|||
125204917|NCT04063657|450373253|FG001|Overall Study|Lost to Follow-up|0|||
125204918|NCT03408444|450373254|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
125204919|NCT03408444|450373255|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
125204920|NCT03408444|450373256|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
125204921|NCT03408444|450373257|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
125204922|NCT03408444|450373254|FG000|Overall Study|Lens Discomfort|0|||
125204923|NCT03408444|450373255|FG001|Overall Study|Lens Discomfort|1|||
125204924|NCT03408444|450373256|FG002|Overall Study|Lens Discomfort|0|||
125204925|NCT03408444|450373257|FG003|Overall Study|Lens Discomfort|0|||
125204926|NCT03408444|450373254|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
125204927|NCT03408444|450373255|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
125204928|NCT03408444|450373256|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
125204929|NCT03408444|450373257|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
125204930|NCT03408444|450373254|FG000|Overall Study|Withdrawal by Subject|0|||
125204931|NCT03408444|450373255|FG001|Overall Study|Withdrawal by Subject|2|||
125204932|NCT03408444|450373256|FG002|Overall Study|Withdrawal by Subject|3|||
125204933|NCT03408444|450373257|FG003|Overall Study|Withdrawal by Subject|0|||
125204934|NCT03408444|450373254|FG000|Overall Study|Lost to Follow-up|0|||
125204935|NCT03408444|450373255|FG001|Overall Study|Lost to Follow-up|0|||
125204936|NCT03408444|450373256|FG002|Overall Study|Lost to Follow-up|1|||
125204937|NCT03408444|450373257|FG003|Overall Study|Lost to Follow-up|0|||
125204938|NCT03408444|450373254|FG000|Overall Study|Adverse Event|0|||
125204939|NCT03408444|450373255|FG001|Overall Study|Adverse Event|0|||
125204940|NCT03408444|450373256|FG002|Overall Study|Adverse Event|0|||
125204941|NCT03408444|450373257|FG003|Overall Study|Adverse Event|1|||
125204942|NCT03408444|450373254|FG000|Overall Study|Lens Handling Difficulties|0|||
125204943|NCT03408444|450373255|FG001|Overall Study|Lens Handling Difficulties|0|||
125204944|NCT03408444|450373256|FG002|Overall Study|Lens Handling Difficulties|1|||
125204945|NCT03408444|450373257|FG003|Overall Study|Lens Handling Difficulties|0|||
125204946|NCT03408444|450373254|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
125204947|NCT03408444|450373255|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
125204948|NCT03408444|450373256|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
125204949|NCT03408444|450373257|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
125204950|NCT04984681|450373258|FG000|Overall Study|Lost to Follow-up|3|||
125204951|NCT04984681|450373259|FG001|Overall Study|Lost to Follow-up|1|||
125204952|NCT01473394|450373260|FG000|Overall Study|Adverse Event|13|||
125204953|NCT01473394|450373261|FG001|Overall Study|Adverse Event|16|||
125204954|NCT01473394|450373260|FG000|Overall Study|Insufficient Therapeutic Response|4|||
125204955|NCT01473394|450373261|FG001|Overall Study|Insufficient Therapeutic Response|1|||
125204956|NCT01473394|450373260|FG000|Overall Study|Protocol Violation|7|||
125204957|NCT01473394|450373261|FG001|Overall Study|Protocol Violation|5|||
125204958|NCT01473394|450373260|FG000|Overall Study|Withdrew Consent|12|||
125204959|NCT01473394|450373261|FG001|Overall Study|Withdrew Consent|10|||
125204960|NCT01473394|450373260|FG000|Overall Study|Lost to Follow-up|9|||
125204961|NCT01473394|450373261|FG001|Overall Study|Lost to Follow-up|11|||
125204962|NCT03117881|450373264|FG000|Baseline|Withdrawal by Subject|21|||
125204963|NCT03117881|450373265|FG001|Baseline|Withdrawal by Subject|10|||
125204964|NCT03117881|450373266|FG002|Baseline|Withdrawal by Subject|0|||
125204965|NCT03117881|450373264|FG000|Baseline|Lost to Follow-up|22|||
125204966|NCT03117881|450373265|FG001|Baseline|Lost to Follow-up|25|||
125204967|NCT03117881|450373266|FG002|Baseline|Lost to Follow-up|0|||
125204968|NCT03117881|450373264|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
125204969|NCT03117881|450373265|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
125204970|NCT03117881|450373266|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
125204971|NCT03117881|450373264|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
125204972|NCT03117881|450373265|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
125204973|NCT03117881|450373266|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
125204974|NCT03117881|450373264|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
125204975|NCT03117881|450373265|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
125204976|NCT03117881|450373266|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
125204977|NCT03117881|450373264|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
125204978|NCT03117881|450373265|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
125204979|NCT03117881|450373266|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
125204980|NCT03117881|450373264|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
125204981|NCT03117881|450373265|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
125204982|NCT03117881|450373266|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
125204983|NCT03117881|450373264|FG000|6-Month Follow-Up|Did not complete test|53|||
125204984|NCT03117881|450373265|FG001|6-Month Follow-Up|Did not complete test|25|||
125204985|NCT03117881|450373266|FG002|6-Month Follow-Up|Did not complete test|7|||
125204986|NCT03117881|450373264|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
125204987|NCT03117881|450373265|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
125204988|NCT03117881|450373266|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
125204989|NCT03117881|450373264|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
125204990|NCT03117881|450373265|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
125204991|NCT03117881|450373266|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
125204992|NCT03117881|450373264|FG000|12-Month Follow-Up|Did not complete test|40|||
125204993|NCT03117881|450373265|FG001|12-Month Follow-Up|Did not complete test|0|||
125204994|NCT03117881|450373266|FG002|12-Month Follow-Up|Did not complete test|0|||
125204995|NCT01027897|450373267|FG000|Overall Study|Protocol Violation|1|||
125204996|NCT01027897|450373267|FG000|Overall Study|Withdrawal by Subject|1|||
125204997|NCT00473824|450373270|FG000|Overall Study|Virologic Breakthrough|1|||
125204998|NCT00473824|450373271|FG001|Overall Study|Virologic Breakthrough|0|||
125204999|NCT00473824|450373270|FG000|Overall Study|Adverse Event|1|||
125205000|NCT00473824|450373271|FG001|Overall Study|Adverse Event|0|||
125205001|NCT00473824|450373270|FG000|Overall Study|Death|1|||
125205002|NCT00473824|450373271|FG001|Overall Study|Death|0|||
125205003|NCT00473824|450373270|FG000|Overall Study|Lost to Follow-up|1|||
125205004|NCT00473824|450373271|FG001|Overall Study|Lost to Follow-up|0|||
125205005|NCT00473824|450373270|FG000|Overall Study|Withdrawal by physician|1|||
125205006|NCT00473824|450373271|FG001|Overall Study|Withdrawal by physician|0|||
125205007|NCT02560623|450373272|FG000|Overall Study|Unable to swallow sponge|0|||
125205008|NCT02560623|450373273|FG001|Overall Study|Unable to swallow sponge|1|||
125205009|NCT02560623|450373274|FG002|Overall Study|Unable to swallow sponge|0|||
125205010|NCT02560623|450373275|FG003|Overall Study|Unable to swallow sponge|0|||
125205011|NCT02560623|450373272|FG000|Overall Study|Intervention prior to sponge administration|0|||
125205012|NCT02560623|450373273|FG001|Overall Study|Intervention prior to sponge administration|1|||
125205013|NCT02560623|450373274|FG002|Overall Study|Intervention prior to sponge administration|0|||
125205014|NCT02560623|450373275|FG003|Overall Study|Intervention prior to sponge administration|0|||
125205015|NCT01661933|450373279|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
125205016|NCT01661933|450373279|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
125205017|NCT02720744|450373280|FG000|Overall Study|Protocol Violation|0|||
125205018|NCT02720744|450373281|FG001|Overall Study|Protocol Violation|2|||
125205019|NCT02720744|450373280|FG000|Overall Study|Pregnancy|2|||
125205020|NCT02720744|450373281|FG001|Overall Study|Pregnancy|0|||
125648876|NCT00508820|451995884|FG000|Overall Study|Protocol-specified Criteria|3|||
125205021|NCT02720744|450373280|FG000|Overall Study|Lack of Efficacy|2|||
125205022|NCT02720744|450373281|FG001|Overall Study|Lack of Efficacy|8|||
125648877|NCT00508820|451995885|FG001|Overall Study|Protocol-specified Criteria|12|||
125205023|NCT02720744|450373280|FG000|Overall Study|Adverse Event|21|||
125205024|NCT02720744|450373281|FG001|Overall Study|Adverse Event|3|||
125205025|NCT02720744|450373280|FG000|Overall Study|Withdrawal by Subject|11|||
125205026|NCT02720744|450373281|FG001|Overall Study|Withdrawal by Subject|11|||
125205027|NCT02720744|450373280|FG000|Overall Study|Lost to follow up|2|||
125205028|NCT02720744|450373281|FG001|Overall Study|Lost to follow up|0|||
125205029|NCT02720744|450373280|FG000|Overall Study|Non Compliance with Investigational Product|0|||
125205030|NCT02720744|450373281|FG001|Overall Study|Non Compliance with Investigational Product|1|||
125205031|NCT02720744|450373280|FG000|Overall Study|Excluded Concomitant Medication|0|||
125205032|NCT02720744|450373281|FG001|Overall Study|Excluded Concomitant Medication|1|||
125205033|NCT01447446|450373282|FG000|Overall Study|Death|6|||
125205034|NCT01447446|450373283|FG001|Overall Study|Death|3|||
125205035|NCT01447446|450373284|FG002|Overall Study|Death|2|||
125205036|NCT01447446|450373285|FG003|Overall Study|Death|1|||
125205037|NCT01447446|450373286|FG004|Overall Study|Death|7|||
125205038|NCT01447446|450373287|FG005|Overall Study|Death|0|||
125205039|NCT01447446|450373282|FG000|Overall Study|Adverse Event|3|||
125205040|NCT01447446|450373283|FG001|Overall Study|Adverse Event|0|||
125205041|NCT01447446|450373284|FG002|Overall Study|Adverse Event|1|||
125205042|NCT01447446|450373285|FG003|Overall Study|Adverse Event|0|||
125205043|NCT01447446|450373286|FG004|Overall Study|Adverse Event|2|||
125205044|NCT01447446|450373287|FG005|Overall Study|Adverse Event|0|||
125205045|NCT01447446|450373282|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
125205046|NCT01447446|450373283|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
125205047|NCT01447446|450373284|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
125205048|NCT01447446|450373285|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
125205049|NCT01447446|450373286|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
125205050|NCT01447446|450373287|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
125205051|NCT01447446|450373282|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
125205052|NCT01447446|450373283|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
125205053|NCT01447446|450373284|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
125205054|NCT01447446|450373285|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
125205055|NCT01447446|450373286|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
125205056|NCT01447446|450373287|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
125205057|NCT01447446|450373282|FG000|Overall Study|Administrative/Other|34|||
125205058|NCT01447446|450373283|FG001|Overall Study|Administrative/Other|9|||
125205059|NCT01447446|450373284|FG002|Overall Study|Administrative/Other|10|||
125205060|NCT01447446|450373285|FG003|Overall Study|Administrative/Other|2|||
125205061|NCT01447446|450373286|FG004|Overall Study|Administrative/Other|33|||
125205062|NCT01447446|450373287|FG005|Overall Study|Administrative/Other|4|||
125205063|NCT01447446|450373282|FG000|Overall Study|SVR12 Assessment|13|||
125205064|NCT01447446|450373283|FG001|Overall Study|SVR12 Assessment|1|||
125205065|NCT01447446|450373284|FG002|Overall Study|SVR12 Assessment|2|||
125205066|NCT01447446|450373285|FG003|Overall Study|SVR12 Assessment|1|||
125205067|NCT01447446|450373286|FG004|Overall Study|SVR12 Assessment|5|||
125205068|NCT01447446|450373287|FG005|Overall Study|SVR12 Assessment|5|||
125205069|NCT01447446|450373282|FG000|Overall Study|New Treatment Started|8|||
125205070|NCT01447446|450373283|FG001|Overall Study|New Treatment Started|2|||
125205071|NCT01447446|450373284|FG002|Overall Study|New Treatment Started|1|||
125205072|NCT01447446|450373285|FG003|Overall Study|New Treatment Started|0|||
125205073|NCT01447446|450373286|FG004|Overall Study|New Treatment Started|2|||
125205074|NCT01447446|450373287|FG005|Overall Study|New Treatment Started|0|||
125205075|NCT01447446|450373282|FG000|Overall Study|Reason not Specified|1|||
125205076|NCT01447446|450373283|FG001|Overall Study|Reason not Specified|1|||
125205077|NCT01447446|450373284|FG002|Overall Study|Reason not Specified|1|||
125205078|NCT01447446|450373285|FG003|Overall Study|Reason not Specified|1|||
125205079|NCT01447446|450373286|FG004|Overall Study|Reason not Specified|1|||
125205080|NCT01447446|450373287|FG005|Overall Study|Reason not Specified|0|||
125205081|NCT03536949|450373300|FG000|Overall Study|Adverse Event|4|||
125205082|NCT03536949|450373301|FG001|Overall Study|Adverse Event|0|||
125205083|NCT03536949|450373300|FG000|Overall Study|Lost to Follow-up|2|||
125205084|NCT03536949|450373301|FG001|Overall Study|Lost to Follow-up|1|||
125205085|NCT03536949|450373300|FG000|Overall Study|Withdrawal by Subject|6|||
125205086|NCT03536949|450373301|FG001|Overall Study|Withdrawal by Subject|0|||
125205087|NCT03536949|450373300|FG000|Overall Study|Non-compliance|2|||
125205088|NCT03536949|450373301|FG001|Overall Study|Non-compliance|1|||
125205089|NCT00250458|450373307|FG000|Overall Study|Lost to Follow-up|4|||
125205090|NCT00250458|450373308|FG001|Overall Study|Lost to Follow-up|2|||
125205091|NCT00250458|450373307|FG000|Overall Study|Protocol Violation|0|||
125205092|NCT00250458|450373308|FG001|Overall Study|Protocol Violation|1|||
125205093|NCT00250458|450373307|FG000|Overall Study|Withdrawal by Subject|4|||
125205094|NCT00250458|450373308|FG001|Overall Study|Withdrawal by Subject|2|||
125205095|NCT00250458|450373307|FG000|Overall Study|Lack of Migraine Attack|20|||
125205096|NCT00250458|450373308|FG001|Overall Study|Lack of Migraine Attack|9|||
125205097|NCT00250458|450373307|FG000|Overall Study|Qualifying migraine but did not treat|3|||
125205098|NCT00250458|450373308|FG001|Overall Study|Qualifying migraine but did not treat|3|||
125205099|NCT00250458|450373307|FG000|Overall Study|Other|1|||
125205100|NCT00250458|450373308|FG001|Overall Study|Other|0|||
125205101|NCT01892085|450373311|FG000|Overall Study|Death|4|||
125205102|NCT01892085|450373312|FG001|Overall Study|Death|1|||
125205103|NCT01892085|450373313|FG002|Overall Study|Death|3|||
125205104|NCT01892085|450373311|FG000|Overall Study|Withdrawal by Subject|2|||
125205105|NCT01892085|450373312|FG001|Overall Study|Withdrawal by Subject|0|||
125205106|NCT01892085|450373313|FG002|Overall Study|Withdrawal by Subject|2|||
125205107|NCT01549041|450373314|FG000|Overall Study|Lack of Efficacy|2|||
125205108|NCT01549041|450373315|FG001|Overall Study|Lack of Efficacy|4|||
125205109|NCT01549041|450373314|FG000|Overall Study|Adverse Event|0|||
125205110|NCT01549041|450373315|FG001|Overall Study|Adverse Event|4|||
125205111|NCT00597506|450373316|FG000|Overall Study|Subject is being followed for survival|1|||
125205112|NCT02609724|450373317|FG000|Overall Study|Death|2|||
125205113|NCT02609724|450373318|FG001|Overall Study|Death|0|||
125205114|NCT02609724|450373319|FG002|Overall Study|Death|1|||
125205115|NCT02609724|450373317|FG000|Overall Study|Withdrawal by Subject|1|||
125205116|NCT02609724|450373318|FG001|Overall Study|Withdrawal by Subject|2|||
125205117|NCT02609724|450373319|FG002|Overall Study|Withdrawal by Subject|3|||
125205118|NCT02609724|450373317|FG000|Overall Study|Illness|2|||
125205119|NCT02609724|450373318|FG001|Overall Study|Illness|1|||
125205120|NCT02609724|450373319|FG002|Overall Study|Illness|0|||
125205121|NCT03077659|450373320|FG000|Overall Study|Withdrawal by Subject|0|||
125205122|NCT03077659|450373321|FG001|Overall Study|Withdrawal by Subject|0|||
125205123|NCT03077659|450373322|FG002|Overall Study|Withdrawal by Subject|1|||
125205124|NCT02844907|450373323|FG000|With Dexamethasone|No IV access|1|||
125205125|NCT00426660|450373324|FG000|Overall Study|Death|14|||
125205126|NCT00426660|450373324|FG000|Overall Study|Adverse Event|23|||
125205127|NCT00426660|450373324|FG000|Overall Study|Insufficient Clinical Response|22|||
125205128|NCT00426660|450373324|FG000|Overall Study|Lost to Follow-up|15|||
125205129|NCT00426660|450373324|FG000|Overall Study|Other|23|||
125205130|NCT00426660|450373324|FG000|Overall Study|Withdrawal by Subject|18|||
125205131|NCT00426660|450373324|FG000|Overall Study|Protocol Violation|1|||
125205132|NCT00426660|450373324|FG000|Overall Study|Enrolled Not Treated|15|||
125205133|NCT04326439|450373327|FG000|Overall Study|Withdrawal by Subject|1|||
125205134|NCT04326439|450373328|FG001|Overall Study|Withdrawal by Subject|0|||
125205135|NCT04326439|450373327|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
125205136|NCT04326439|450373328|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
125205137|NCT04326439|450373327|FG000|Overall Study|Relapse after Induction 2|0|||
125205138|NCT04326439|450373328|FG001|Overall Study|Relapse after Induction 2|1|||
125205139|NCT04326439|450373327|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
125205140|NCT04326439|450373328|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
125205141|NCT00204477|450373331|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
125205142|NCT00204477|450373332|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
125205143|NCT00204477|450373331|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
125205144|NCT00204477|450373332|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
125205145|NCT04272606|450373335|FG000|Overall Study|Protocol Violation|1|||
125205146|NCT04272606|450373336|FG001|Overall Study|Protocol Violation|1|||
125205147|NCT04272606|450373335|FG000|Overall Study|Physician Decision|0|||
125205148|NCT04272606|450373336|FG001|Overall Study|Physician Decision|1|||
125205149|NCT01037127|450373337|FG000|Overall Study|Lost to Follow-up|2|||
125205150|NCT01037127|450373338|FG001|Overall Study|Lost to Follow-up|4|||
125205151|NCT01037127|450373337|FG000|Overall Study|Physician Decision|1|||
125205152|NCT01037127|450373338|FG001|Overall Study|Physician Decision|0|||
125205153|NCT01037127|450373337|FG000|Overall Study|Study Closed Terminated|2|||
125205154|NCT01037127|450373338|FG001|Overall Study|Study Closed Terminated|17|||
125205155|NCT02637713|450373342|FG000|Overall Study|Screen Failure|2|||
125205156|NCT02847182|450373343|FG000|Overall Study|Withdrawal by Subject|0|||
125205157|NCT02847182|450373344|FG001|Overall Study|Withdrawal by Subject|1|||
125205158|NCT02345889|450373345|FG000|Overall Study|Inadequate Bowel Prep|17|||
125205159|NCT02345889|450373346|FG001|Overall Study|Inadequate Bowel Prep|16|||
125205160|NCT02345889|450373347|FG002|Overall Study|Inadequate Bowel Prep|18|||
125205161|NCT02345889|450373348|FG003|Overall Study|Inadequate Bowel Prep|14|||
125205162|NCT02345889|450373345|FG000|Overall Study|Polyposis identified during procedure|1|||
125205163|NCT02345889|450373346|FG001|Overall Study|Polyposis identified during procedure|1|||
125205164|NCT02345889|450373347|FG002|Overall Study|Polyposis identified during procedure|0|||
125205165|NCT02345889|450373348|FG003|Overall Study|Polyposis identified during procedure|1|||
125205166|NCT02345889|450373345|FG000|Overall Study|Recognized ineligible post-randomization|1|||
125205167|NCT02345889|450373346|FG001|Overall Study|Recognized ineligible post-randomization|0|||
125205168|NCT02345889|450373347|FG002|Overall Study|Recognized ineligible post-randomization|2|||
125205169|NCT02345889|450373348|FG003|Overall Study|Recognized ineligible post-randomization|1|||
125205170|NCT02345889|450373345|FG000|Overall Study|Ulcerative Colitis identified|1|||
125205171|NCT02345889|450373346|FG001|Overall Study|Ulcerative Colitis identified|0|||
125205172|NCT02345889|450373347|FG002|Overall Study|Ulcerative Colitis identified|0|||
125205173|NCT02345889|450373348|FG003|Overall Study|Ulcerative Colitis identified|0|||
125205174|NCT02345889|450373345|FG000|Overall Study|Cecum not intubated|1|||
125205175|NCT02345889|450373346|FG001|Overall Study|Cecum not intubated|0|||
125205176|NCT02345889|450373347|FG002|Overall Study|Cecum not intubated|0|||
125205177|NCT02345889|450373348|FG003|Overall Study|Cecum not intubated|0|||
125205178|NCT00778102|450373349|FG000|Overall Study|Adverse Event|8|||
125205179|NCT00778102|450373350|FG001|Overall Study|Adverse Event|5|||
125205180|NCT00778102|450373349|FG000|Overall Study|Death|1|||
125205181|NCT00778102|450373350|FG001|Overall Study|Death|1|||
125205182|NCT00778102|450373349|FG000|Overall Study|Lost to Follow-up|1|||
125205183|NCT00778102|450373350|FG001|Overall Study|Lost to Follow-up|0|||
125205184|NCT00778102|450373349|FG000|Overall Study|Violation of Selection Criteria|1|||
125205185|NCT00778102|450373350|FG001|Overall Study|Violation of Selection Criteria|1|||
125205186|NCT00778102|450373349|FG000|Overall Study|Protocol Violation|0|||
125205187|NCT00778102|450373350|FG001|Overall Study|Protocol Violation|1|||
125205188|NCT00778102|450373349|FG000|Overall Study|Refused Treatment|2|||
125205189|NCT00778102|450373350|FG001|Overall Study|Refused Treatment|3|||
125205190|NCT00778102|450373349|FG000|Overall Study|Withdrawal by Subject|1|||
125205191|NCT00778102|450373350|FG001|Overall Study|Withdrawal by Subject|1|||
125205192|NCT00778102|450373349|FG000|Overall Study|Administrative Reason|7|||
125205193|NCT00778102|450373350|FG001|Overall Study|Administrative Reason|10|||
125205194|NCT02417961|450374675|FG000|Overall Study|Adverse Event|1|||
125205195|NCT02417961|450374675|FG000|Overall Study|Lost to Follow-up|1|||
125205196|NCT02417961|450374675|FG000|Overall Study|Withdrawal by Subject|2|||
125205197|NCT03666533|450374679|FG000|Overall Study|Lost to Follow-up|2|||
125205198|NCT03666533|450374680|FG001|Overall Study|Lost to Follow-up|2|||
125205199|NCT04240886|450374681|FG000|Treatment Phase|Death|4|||
125205200|NCT04240886|450374681|FG000|Treatment Phase|Discontinuation by Subject|1|||
125205201|NCT04240886|450374681|FG000|Treatment Phase|Adverse Event|5|||
125205202|NCT04240886|450374681|FG000|Follow-up Phase|Withdrawal by Subject|1|||
125205203|NCT04240886|450374681|FG000|Follow-up Phase|Discontinuation by Subject|1|||
125205204|NCT04240886|450374681|FG000|Follow-up Phase|Death|2|||
125205205|NCT04743804|450374682|FG000|Overall Study|Other|1|||
125205206|NCT04743804|450374683|FG001|Overall Study|Other|0|||
125205207|NCT04743804|450374682|FG000|Overall Study|Withdrawal by Subject|0|||
125205208|NCT04743804|450374683|FG001|Overall Study|Withdrawal by Subject|1|||
125205209|NCT04743804|450374682|FG000|Overall Study|Study Terminated by Sponsor|1|||
125205210|NCT04743804|450374683|FG001|Overall Study|Study Terminated by Sponsor|4|||
125205211|NCT04743804|450374682|FG000|Overall Study|Physician Decision|0|||
125205212|NCT04743804|450374683|FG001|Overall Study|Physician Decision|1|||
125205213|NCT04743804|450374682|FG000|Overall Study|Death|3|||
125205214|NCT04743804|450374683|FG001|Overall Study|Death|0|||
125205215|NCT01632904|450374684|FG000|Overall Study|Adverse Event|4|||
125205216|NCT01632904|450374685|FG001|Overall Study|Adverse Event|1|||
125205217|NCT01632904|450374684|FG000|Overall Study|Physician Decision|0|||
125205218|NCT01632904|450374685|FG001|Overall Study|Physician Decision|1|||
125205219|NCT01632904|450374684|FG000|Overall Study|Subject decision|3|||
125205220|NCT01632904|450374685|FG001|Overall Study|Subject decision|2|||
125205221|NCT01632904|450374684|FG000|Overall Study|Disease Progression|0|||
125205222|NCT01632904|450374685|FG001|Overall Study|Disease Progression|1|||
125205223|NCT01632904|450374684|FG000|Overall Study|Reason for discontinuation not available|0|||
125205224|NCT01632904|450374685|FG001|Overall Study|Reason for discontinuation not available|1|||
125205225|NCT02059434|450374686|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
125205226|NCT02059434|450374687|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
125205227|NCT02059434|450374688|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
125205228|NCT02059434|450374689|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
125205229|NCT02059434|450374690|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
125205230|NCT02059434|450374691|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
125205231|NCT02059434|450374692|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
125205232|NCT02059434|450374693|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
125205233|NCT02059434|450374694|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
125205234|NCT02059434|450374686|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
125205235|NCT02059434|450374687|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
125205236|NCT02059434|450374688|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
125205237|NCT02059434|450374689|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
125205238|NCT02059434|450374690|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
125205239|NCT02059434|450374691|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
125205240|NCT02059434|450374692|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
125205241|NCT02059434|450374693|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
125205242|NCT02059434|450374694|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
125205243|NCT02059434|450374686|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
125205244|NCT02059434|450374687|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
125205245|NCT02059434|450374688|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
125205246|NCT02059434|450374689|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
125205247|NCT02059434|450374690|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
125205248|NCT02059434|450374691|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
125205249|NCT02059434|450374692|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
125205250|NCT02059434|450374693|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
125205251|NCT02059434|450374694|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
125205252|NCT02059434|450374686|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
125205253|NCT02059434|450374687|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
125205254|NCT02059434|450374688|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
125205255|NCT02059434|450374689|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
125205256|NCT02059434|450374690|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
125205257|NCT02059434|450374691|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
125205258|NCT02059434|450374692|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
125205259|NCT02059434|450374693|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
125205260|NCT02059434|450374694|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
125205261|NCT02059434|450374686|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205262|NCT02059434|450374687|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205263|NCT02059434|450374688|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205264|NCT02059434|450374689|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205265|NCT02059434|450374690|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205266|NCT02059434|450374691|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205267|NCT02059434|450374692|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205268|NCT02059434|450374693|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
125205269|NCT02059434|450374694|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
125205270|NCT01004406|450374699|FG000|Overall Study|Withdrawal by Subject|2|||
125205271|NCT01004406|450374700|FG001|Overall Study|Withdrawal by Subject|0|||
125205272|NCT01004406|450374699|FG000|Overall Study|Lost to Follow-up|1|||
125205273|NCT01004406|450374700|FG001|Overall Study|Lost to Follow-up|0|||
125205274|NCT02928770|450374701|FG000|Overall Study|Withdrawal by Subject|2|||
125205275|NCT03201874|450374702|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
125205276|NCT03201874|450374703|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
125205277|NCT03201874|450374702|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
125205278|NCT03201874|450374703|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
125205279|NCT02907593|450374706|FG000|Overall Study|Withdrawal by Subject|0|||
125205280|NCT02907593|450374707|FG001|Overall Study|Withdrawal by Subject|0|||
125205281|NCT02907593|450374708|FG002|Overall Study|Withdrawal by Subject|1|||
125205282|NCT02907593|450374709|FG003|Overall Study|Withdrawal by Subject|0|||
125205283|NCT04618471|450374710|FG000|Overall Study|Screen Failure|62|||
125205284|NCT04618471|450374710|FG000|Overall Study|Withdrawal by Subject|6|||
125205285|NCT04618471|450374710|FG000|Overall Study|Physician Decision|2|||
125205286|NCT04618471|450374710|FG000|Overall Study|Lost to Follow-up|1|||
125205287|NCT04618471|450374710|FG000|Overall Study|Various other reasons|2|||
125205288|NCT04618471|450374710|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
125205289|NCT01752634|450374711|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
125205290|NCT01752634|450374712|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
125205291|NCT01752634|450374713|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
125205292|NCT01752634|450374714|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
125205293|NCT01752634|450374715|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
125205294|NCT01752634|450374716|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
125205295|NCT01752634|450374711|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
125205296|NCT01752634|450374712|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
125205297|NCT01752634|450374713|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
125205298|NCT01752634|450374714|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
125205299|NCT01752634|450374715|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
125205300|NCT01752634|450374716|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
125205301|NCT01752634|450374711|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
125205302|NCT01752634|450374712|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
125539868|NCT00700427|451605817|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
125539869|NCT00700427|451605818|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
125539870|NCT00700427|451605819|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
125539871|NCT00700427|451605820|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
125539872|NCT00424385|451605821|FG000|Cohort 0|Withdrawal by Subject|5|||
125539873|NCT00424385|451605821|FG000|Cohort 0|Physician Decision|1|||
125539874|NCT00424385|451605821|FG000|Cohort 1|Withdrawal by Subject|1|||
125539875|NCT02683876|451605822|FG000|Overall Study|samples damaged during shipping|2|||
125539876|NCT02683876|451605823|FG001|Overall Study|samples damaged during shipping|0|||
125539877|NCT03231800|451605830|FG000|Overall Study|Lost to Follow-up|0|||
125539878|NCT03231800|451605831|FG001|Overall Study|Lost to Follow-up|2|||
125539879|NCT03231800|451605830|FG000|Overall Study|Protocol Violation|1|||
125539880|NCT03231800|451605831|FG001|Overall Study|Protocol Violation|1|||
125539881|NCT03231800|451605830|FG000|Overall Study|reason not provided|2|||
125539882|NCT03231800|451605831|FG001|Overall Study|reason not provided|0|||
125539883|NCT00859222|451605832|FG000|Overall Study|Adverse Event|2|||
125539884|NCT00859222|451605833|FG001|Overall Study|Adverse Event|3|||
125539885|NCT00859222|451605834|FG002|Overall Study|Adverse Event|6|||
125205303|NCT01752634|450374713|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
125205304|NCT01752634|450374714|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
125205305|NCT01752634|450374715|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
125205306|NCT01752634|450374716|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
125205307|NCT01752634|450374711|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
125205308|NCT01752634|450374712|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
125205309|NCT01752634|450374713|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
125205310|NCT01752634|450374714|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
125205311|NCT01752634|450374715|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
125205312|NCT01752634|450374716|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
125205313|NCT01752634|450374711|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
125205314|NCT01752634|450374712|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
125205315|NCT01752634|450374713|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
125205316|NCT01752634|450374714|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
125205317|NCT01752634|450374715|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
125205318|NCT01752634|450374716|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
125205319|NCT01752634|450374711|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
125205320|NCT01752634|450374712|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
125205321|NCT01752634|450374713|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
125205322|NCT01752634|450374714|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
125648878|NCT02926833|451997428|FG000|Overall Study|Death|1|||
125648879|NCT02926833|451997429|FG001|Overall Study|Death|1|||
125205323|NCT01752634|450374715|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
125205324|NCT01752634|450374716|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
125205325|NCT01752634|450374711|FG000|Week 24 to Week 260|Physician Decision|1|||
125205326|NCT01752634|450374712|FG001|Week 24 to Week 260|Physician Decision|2|||
125205327|NCT01752634|450374713|FG002|Week 24 to Week 260|Physician Decision|4|||
125205328|NCT01752634|450374714|FG003|Week 24 to Week 260|Physician Decision|2|||
125205329|NCT01752634|450374715|FG004|Week 24 to Week 260|Physician Decision|1|||
125205330|NCT01752634|450374716|FG005|Week 24 to Week 260|Physician Decision|0|||
125205331|NCT01752634|450374711|FG000|Week 24 to Week 260|Death|0|||
125205332|NCT01752634|450374712|FG001|Week 24 to Week 260|Death|1|||
125205333|NCT01752634|450374713|FG002|Week 24 to Week 260|Death|0|||
125205334|NCT01752634|450374714|FG003|Week 24 to Week 260|Death|0|||
125205335|NCT01752634|450374715|FG004|Week 24 to Week 260|Death|0|||
125205336|NCT01752634|450374716|FG005|Week 24 to Week 260|Death|0|||
125205337|NCT01752634|450374711|FG000|Week 24 to Week 260|Pregnancy|0|||
125205338|NCT01752634|450374712|FG001|Week 24 to Week 260|Pregnancy|0|||
125205339|NCT01752634|450374713|FG002|Week 24 to Week 260|Pregnancy|1|||
125205340|NCT01752634|450374714|FG003|Week 24 to Week 260|Pregnancy|0|||
125205341|NCT01752634|450374715|FG004|Week 24 to Week 260|Pregnancy|0|||
125205342|NCT01752634|450374716|FG005|Week 24 to Week 260|Pregnancy|0|||
125205343|NCT01752634|450374711|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
125205344|NCT01752634|450374712|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
125205345|NCT01752634|450374713|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
125205346|NCT01752634|450374714|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
125205347|NCT01752634|450374715|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
125205348|NCT01752634|450374716|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
125205349|NCT01752634|450374711|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
125205350|NCT01752634|450374712|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
125205351|NCT01752634|450374713|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
125205352|NCT01752634|450374714|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
125205353|NCT01752634|450374715|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
125205354|NCT01752634|450374716|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
125205355|NCT01752634|450374711|FG000|Week 24 to Week 260|Adverse Event|4|||
125205356|NCT01752634|450374712|FG001|Week 24 to Week 260|Adverse Event|8|||
125205357|NCT01752634|450374713|FG002|Week 24 to Week 260|Adverse Event|8|||
125205358|NCT01752634|450374714|FG003|Week 24 to Week 260|Adverse Event|4|||
125205359|NCT01752634|450374715|FG004|Week 24 to Week 260|Adverse Event|2|||
125205360|NCT01752634|450374716|FG005|Week 24 to Week 260|Adverse Event|0|||
125205361|NCT01250171|450374717|FG000|Overall Study|Administrative reasons|1|||
125205362|NCT01250171|450374718|FG001|Overall Study|Administrative reasons|0|||
125205363|NCT01250171|450374719|FG002|Overall Study|Administrative reasons|0|||
125205364|NCT04557124|450374727|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
125205365|NCT04557124|450374728|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
125205366|NCT04557124|450374727|FG000|Mid-point (1 Month)|Missed testing|5|||
125205367|NCT04557124|450374728|FG001|Mid-point (1 Month)|Missed testing|4|||
125205368|NCT04557124|450374727|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
125205369|NCT04557124|450374728|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
125205370|NCT04557124|450374727|FG000|Post-testing (2 Months)|Missed testing|1|||
125205371|NCT04557124|450374728|FG001|Post-testing (2 Months)|Missed testing|5|||
125205372|NCT04557124|450374727|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
125205373|NCT04557124|450374728|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
125205374|NCT04557124|450374727|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
125648880|NCT02926833|451997430|FG002|Overall Study|Death|2|||
125205375|NCT04557124|450374728|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
125205376|NCT03226678|450374735|FG000|Part A (Core Study Phase)|Adverse Event|0|||
125205377|NCT03226678|450374736|FG001|Part A (Core Study Phase)|Adverse Event|1|||
125205378|NCT03226678|450374737|FG002|Part A (Core Study Phase)|Adverse Event|0|||
125205379|NCT03226678|450374738|FG003|Part A (Core Study Phase)|Adverse Event|0|||
125205380|NCT03226678|450374739|FG004|Part A (Core Study Phase)|Adverse Event|0|||
125205381|NCT03226678|450374740|FG005|Part A (Core Study Phase)|Adverse Event|0|||
125205382|NCT03226678|450374735|FG000|Part A (Core Study Phase)|Death|0|||
125205383|NCT03226678|450374736|FG001|Part A (Core Study Phase)|Death|0|||
125205384|NCT03226678|450374737|FG002|Part A (Core Study Phase)|Death|1|||
125205385|NCT03226678|450374738|FG003|Part A (Core Study Phase)|Death|0|||
125205386|NCT03226678|450374739|FG004|Part A (Core Study Phase)|Death|0|||
125205387|NCT03226678|450374740|FG005|Part A (Core Study Phase)|Death|0|||
125205388|NCT03226678|450374735|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
125205389|NCT03226678|450374736|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
125205390|NCT03226678|450374737|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
125205391|NCT03226678|450374738|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
125205392|NCT03226678|450374739|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
125205393|NCT03226678|450374740|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
125205394|NCT03226678|450374735|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
125205395|NCT03226678|450374736|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
125205396|NCT03226678|450374737|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
125205397|NCT03226678|450374738|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
125205398|NCT03226678|450374739|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
125205399|NCT03226678|450374740|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
125205400|NCT03226678|450374735|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
125205401|NCT03226678|450374736|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
125205402|NCT03226678|450374737|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
125205403|NCT03226678|450374738|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
125205404|NCT03226678|450374739|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
125205405|NCT03226678|450374740|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
125205406|NCT03226678|450374735|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
125205407|NCT03226678|450374736|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
125205408|NCT03226678|450374737|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
125205409|NCT03226678|450374738|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
125205410|NCT03226678|450374739|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
125205411|NCT03226678|450374740|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
125205412|NCT03226678|450374735|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
125205413|NCT03226678|450374736|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
125205414|NCT03226678|450374737|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
125205415|NCT03226678|450374738|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
125205416|NCT03226678|450374739|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
125205417|NCT03226678|450374740|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
125205418|NCT03226678|450374735|FG000|Part B (Long-Term Extension Phase)|Death|0|||
125205419|NCT03226678|450374736|FG001|Part B (Long-Term Extension Phase)|Death|0|||
125205420|NCT03226678|450374737|FG002|Part B (Long-Term Extension Phase)|Death|0|||
125205421|NCT03226678|450374738|FG003|Part B (Long-Term Extension Phase)|Death|0|||
125205422|NCT03226678|450374739|FG004|Part B (Long-Term Extension Phase)|Death|0|||
125205423|NCT03226678|450374740|FG005|Part B (Long-Term Extension Phase)|Death|1|||
125205424|NCT03226678|450374735|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
125205425|NCT03226678|450374736|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
125205426|NCT03226678|450374737|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
125205427|NCT03226678|450374738|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
125205428|NCT03226678|450374739|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
125205429|NCT03226678|450374740|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
125205430|NCT03226678|450374735|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
125205431|NCT03226678|450374736|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
125205432|NCT03226678|450374737|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
125205433|NCT03226678|450374738|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
125205434|NCT03226678|450374739|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
125205435|NCT03226678|450374740|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
125205436|NCT03226678|450374735|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
125205437|NCT03226678|450374736|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
125205438|NCT03226678|450374737|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
125205439|NCT03226678|450374738|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
125205440|NCT03226678|450374739|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
125205441|NCT03226678|450374740|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
125205442|NCT01911780|450374743|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
125424876|NCT00430248|451178699|FG000|Overall Study|Gout Flare|3|||
125205443|NCT01911780|450374744|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
125205444|NCT01911780|450374743|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
125205445|NCT01911780|450374744|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
125205446|NCT01911780|450374743|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
125205447|NCT01911780|450374744|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
125205448|NCT01911780|450374743|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
125205449|NCT01911780|450374744|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
125205450|NCT01911780|450374743|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
125205451|NCT01911780|450374744|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
125205452|NCT01911780|450374743|FG000|Extension Period (52 Weeks)|Personal reason|1|||
125205453|NCT01911780|450374744|FG001|Extension Period (52 Weeks)|Personal reason|1|||
125205454|NCT02045732|450374745|FG000|Overall Study|At the discretion of the investigator|1|||
125648881|NCT02926833|451997431|FG003|Overall Study|Death|13|||
125205455|NCT02045732|450374746|FG001|Overall Study|At the discretion of the investigator|1|||
125205456|NCT05014815|450374747|FG000|Overall Study|Death|63|||
125205457|NCT05014815|450374748|FG001|Overall Study|Death|70|||
125205458|NCT05014815|450374747|FG000|Overall Study|Withdrawal by Subject|10|||
125205459|NCT05014815|450374748|FG001|Overall Study|Withdrawal by Subject|10|||
125205460|NCT05014815|450374747|FG000|Overall Study|Lost to Follow-up|4|||
125205461|NCT05014815|450374748|FG001|Overall Study|Lost to Follow-up|2|||
125205462|NCT05014815|450374747|FG000|Overall Study|Physician Decision|2|||
125205463|NCT05014815|450374748|FG001|Overall Study|Physician Decision|4|||
125205464|NCT04247880|450374749|FG000|Overall Study|Lost to Follow-up|24|||
125205465|NCT04247880|450374750|FG001|Overall Study|Lost to Follow-up|17|||
125205466|NCT04247880|450374749|FG000|Overall Study|Withdrawal by Subject|3|||
125205467|NCT04247880|450374750|FG001|Overall Study|Withdrawal by Subject|0|||
125205468|NCT06303167|450374751|FG000|Overall Study|Ineligible|1|||
125205469|NCT06303167|450374751|FG000|Overall Study|Never start protocol therapy|2|||
125205470|NCT06303167|450374751|FG000|Overall Study|Disease progression|16|||
125205471|NCT02453282|450374752|FG000|Overall Study|Death|275|||
125205472|NCT02453282|450374753|FG001|Overall Study|Death|277|||
125205473|NCT02453282|450374754|FG002|Overall Study|Death|296|||
125205474|NCT02453282|450374752|FG000|Overall Study|Lost to Follow-up|1|||
125205475|NCT02453282|450374753|FG001|Overall Study|Lost to Follow-up|0|||
125205476|NCT02453282|450374754|FG002|Overall Study|Lost to Follow-up|2|||
125205477|NCT02453282|450374752|FG000|Overall Study|Withdrawal by Subject|12|||
125205478|NCT02453282|450374753|FG001|Overall Study|Withdrawal by Subject|10|||
125205479|NCT02453282|450374754|FG002|Overall Study|Withdrawal by Subject|11|||
125205480|NCT02453282|450374752|FG000|Overall Study|Participants ongoing at data cut-off|85|||
125205481|NCT02453282|450374753|FG001|Overall Study|Participants ongoing at data cut-off|84|||
125205482|NCT02453282|450374754|FG002|Overall Study|Participants ongoing at data cut-off|62|||
125205483|NCT02453282|450374752|FG000|Overall Study|Other|1|||
125205484|NCT02453282|450374753|FG001|Overall Study|Other|1|||
125205485|NCT02453282|450374754|FG002|Overall Study|Other|1|||
125205486|NCT03385304|450374756|FG000|Overall Study|Death|19|||
125205487|NCT03385304|450374757|FG001|Overall Study|Death|7|||
125205488|NCT03385304|450374756|FG000|Overall Study|Lost to Follow-up|17|||
125205489|NCT03385304|450374757|FG001|Overall Study|Lost to Follow-up|14|||
125205490|NCT03385304|450374756|FG000|Overall Study|Withdrawal by Subject|3|||
125205491|NCT03385304|450374757|FG001|Overall Study|Withdrawal by Subject|2|||
125205492|NCT03385304|450374756|FG000|Overall Study|Incarceration|2|||
125205493|NCT03385304|450374757|FG001|Overall Study|Incarceration|3|||
125205494|NCT01120249|450374758|FG000|Overall Study|No protocol treatment received|21|||
125205495|NCT01120249|450374759|FG001|Overall Study|No protocol treatment received|15|||
125205496|NCT01120249|450374758|FG000|Overall Study|Disease recurrence|107|||
125205497|NCT01120249|450374759|FG001|Overall Study|Disease recurrence|57|||
125205498|NCT01120249|450374758|FG000|Overall Study|Death|1|||
125205499|NCT01120249|450374759|FG001|Overall Study|Death|0|||
125205500|NCT01120249|450374758|FG000|Overall Study|Adverse Event|40|||
125205501|NCT01120249|450374759|FG001|Overall Study|Adverse Event|276|||
125205502|NCT01120249|450374758|FG000|Overall Study|Participant refusal|34|||
125205503|NCT01120249|450374759|FG001|Overall Study|Participant refusal|42|||
125205504|NCT01120249|450374758|FG000|Overall Study|Other reasons, not protocol specified|29|||
125205505|NCT01120249|450374759|FG001|Overall Study|Other reasons, not protocol specified|22|||
125205506|NCT01629823|450374765|FG000|Trial Period|Missed visit|11|||
125205507|NCT01629823|450374766|FG001|Trial Period|Missed visit|9|||
125205508|NCT01629823|450374767|FG002|Trial Period|Missed visit|8|||
125205509|NCT01629823|450374765|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
125205510|NCT01629823|450374766|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
125205511|NCT01629823|450374767|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
125205512|NCT01629823|450374765|FG000|Trial Period|Pregnancy|1|||
125205513|NCT01629823|450374766|FG001|Trial Period|Pregnancy|0|||
125205514|NCT01629823|450374767|FG002|Trial Period|Pregnancy|0|||
125205515|NCT01629823|450374765|FG000|Trial Period|Adverse Event|0|||
125205516|NCT01629823|450374766|FG001|Trial Period|Adverse Event|1|||
125205517|NCT01629823|450374767|FG002|Trial Period|Adverse Event|0|||
125205518|NCT01629823|450374765|FG000|Trial Period|Out-of-window visit|0|||
125205519|NCT01629823|450374766|FG001|Trial Period|Out-of-window visit|2|||
125205520|NCT01629823|450374767|FG002|Trial Period|Out-of-window visit|0|||
125205521|NCT01629823|450374765|FG000|Trial Period|Failed to hold medication|0|||
125205522|NCT01629823|450374766|FG001|Trial Period|Failed to hold medication|0|||
125205523|NCT01629823|450374767|FG002|Trial Period|Failed to hold medication|1|||
125205524|NCT01629823|450374765|FG000|Washout Period|Safety|2|||
125205525|NCT01629823|450374766|FG001|Washout Period|Safety|5|||
125205526|NCT01629823|450374767|FG002|Washout Period|Safety|0|||
125205527|NCT01629823|450374765|FG000|Washout Period|Pregnancy|1|||
125205528|NCT01629823|450374766|FG001|Washout Period|Pregnancy|0|||
125205529|NCT01629823|450374767|FG002|Washout Period|Pregnancy|0|||
125205530|NCT01629823|450374765|FG000|Washout Period|Protocol Violation|0|||
125205531|NCT01629823|450374766|FG001|Washout Period|Protocol Violation|1|||
125205532|NCT01629823|450374767|FG002|Washout Period|Protocol Violation|0|||
125205533|NCT00480493|450374768|FG000|Overall Study|moved|2|||
125205534|NCT00480493|450374769|FG001|Overall Study|moved|7|||
125205535|NCT00738062|450374770|FG000|Open Label Treatment|Lack of Efficacy|5|||
125205536|NCT00738062|450374771|FG001|Open Label Treatment|Lack of Efficacy|0|||
125205537|NCT00738062|450374772|FG002|Open Label Treatment|Lack of Efficacy|0|||
125205538|NCT00738062|450374770|FG000|Open Label Treatment|Adverse Event|11|||
125205539|NCT00738062|450374771|FG001|Open Label Treatment|Adverse Event|0|||
125205540|NCT00738062|450374772|FG002|Open Label Treatment|Adverse Event|0|||
125205541|NCT00738062|450374770|FG000|Open Label Treatment|Protocol Violation|2|||
125205542|NCT00738062|450374771|FG001|Open Label Treatment|Protocol Violation|0|||
125205543|NCT00738062|450374772|FG002|Open Label Treatment|Protocol Violation|0|||
125205544|NCT00738062|450374770|FG000|Open Label Treatment|Withdrawal by Subject|9|||
125205545|NCT00738062|450374771|FG001|Open Label Treatment|Withdrawal by Subject|0|||
125205546|NCT00738062|450374772|FG002|Open Label Treatment|Withdrawal by Subject|0|||
125205547|NCT00738062|450374770|FG000|Open Label Treatment|Investigator Decision|1|||
125205548|NCT00738062|450374771|FG001|Open Label Treatment|Investigator Decision|0|||
125205549|NCT00738062|450374772|FG002|Open Label Treatment|Investigator Decision|0|||
125205550|NCT00738062|450374770|FG000|Open-Label Extension|Adverse Event|5|||
125205551|NCT00738062|450374771|FG001|Open-Label Extension|Adverse Event|0|||
125205552|NCT00738062|450374772|FG002|Open-Label Extension|Adverse Event|0|||
125205553|NCT00738062|450374770|FG000|Open-Label Extension|Physician Decision|1|||
125205554|NCT00738062|450374771|FG001|Open-Label Extension|Physician Decision|0|||
125205555|NCT00738062|450374772|FG002|Open-Label Extension|Physician Decision|0|||
125205556|NCT00738062|450374770|FG000|Open-Label Extension|Lack of Efficacy|2|||
125205557|NCT00738062|450374771|FG001|Open-Label Extension|Lack of Efficacy|0|||
125205558|NCT00738062|450374772|FG002|Open-Label Extension|Lack of Efficacy|0|||
125205559|NCT00738062|450374770|FG000|Open-Label Extension|Withdrawal by Subject|6|||
125205560|NCT00738062|450374771|FG001|Open-Label Extension|Withdrawal by Subject|0|||
125205561|NCT00738062|450374772|FG002|Open-Label Extension|Withdrawal by Subject|0|||
125205562|NCT00738062|450374770|FG000|Open-Label Extension|Protocol Violation|1|||
125205563|NCT00738062|450374771|FG001|Open-Label Extension|Protocol Violation|0|||
125205564|NCT00738062|450374772|FG002|Open-Label Extension|Protocol Violation|0|||
125205565|NCT00738062|450374770|FG000|Open-Label Extension|Study Terminated|2|||
125205566|NCT00738062|450374771|FG001|Open-Label Extension|Study Terminated|0|||
125205567|NCT00738062|450374772|FG002|Open-Label Extension|Study Terminated|0|||
125205568|NCT00550862|450374773|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
125205569|NCT00550862|450374774|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
125205570|NCT00550862|450374775|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
125205571|NCT00550862|450374776|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
125205572|NCT00550862|450374777|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
125205573|NCT00550862|450374773|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
125205574|NCT00550862|450374774|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
125205575|NCT00550862|450374775|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
125205576|NCT00550862|450374776|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
125205577|NCT00550862|450374777|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
125205578|NCT00550862|450374773|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
125205579|NCT00550862|450374774|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
125205580|NCT00550862|450374775|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
125205581|NCT00550862|450374776|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
125205582|NCT00550862|450374777|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
125205583|NCT00550862|450374773|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
125205584|NCT00550862|450374774|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
125205585|NCT00550862|450374775|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
125205586|NCT00550862|450374776|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
125648882|NCT02926833|451997428|FG000|Overall Study|Lost to Follow-up|1|||
125648883|NCT02926833|451997429|FG001|Overall Study|Lost to Follow-up|2|||
125648884|NCT02926833|451997430|FG002|Overall Study|Lost to Follow-up|0|||
125648885|NCT02926833|451997431|FG003|Overall Study|Lost to Follow-up|3|||
125648886|NCT02926833|451997428|FG000|Overall Study|Full Consent Withdrawal|0|||
125648887|NCT02926833|451997429|FG001|Overall Study|Full Consent Withdrawal|0|||
125648888|NCT02926833|451997430|FG002|Overall Study|Full Consent Withdrawal|0|||
125648889|NCT02926833|451997431|FG003|Overall Study|Full Consent Withdrawal|2|||
125648890|NCT02926833|451997428|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
125648891|NCT02926833|451997429|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
125648892|NCT02926833|451997430|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
125648893|NCT02926833|451997431|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
125648894|NCT02926833|451997428|FG000|Overall Study|Investigator Decision|0|||
125648895|NCT02926833|451997429|FG001|Overall Study|Investigator Decision|1|||
125648896|NCT02926833|451997430|FG002|Overall Study|Investigator Decision|0|||
125648897|NCT02926833|451997431|FG003|Overall Study|Investigator Decision|0|||
125648898|NCT02926833|451997428|FG000|Overall Study|Adverse Event|0|||
125648899|NCT02926833|451997429|FG001|Overall Study|Adverse Event|0|||
125648900|NCT02926833|451997430|FG002|Overall Study|Adverse Event|1|||
125648901|NCT02926833|451997431|FG003|Overall Study|Adverse Event|0|||
125648902|NCT02926833|451997428|FG000|Overall Study|Partial Withdrawal of Consent|0|||
125648903|NCT02926833|451997429|FG001|Overall Study|Partial Withdrawal of Consent|0|||
125648904|NCT02926833|451997430|FG002|Overall Study|Partial Withdrawal of Consent|0|||
125648905|NCT02926833|451997431|FG003|Overall Study|Partial Withdrawal of Consent|1|||
125648906|NCT01277757|451997434|FG000|Overall Study|Disease Progression|1|||
125648907|NCT01277757|451997434|FG000|Overall Study|Withdrawal by Subject|1|||
125648908|NCT04308668|451997435|FG000|Overall Study|Lost to Follow-up|32|||
125648909|NCT04308668|451997436|FG001|Overall Study|Lost to Follow-up|38|||
125648910|NCT04308668|451997435|FG000|Overall Study|Withdrawal by Subject|4|||
125648911|NCT04308668|451997436|FG001|Overall Study|Withdrawal by Subject|4|||
125648912|NCT01945866|451997437|FG000|Overall Study|Eyes did not complete or were dropped|2|||
125648913|NCT01945866|451997438|FG001|Overall Study|Eyes did not complete or were dropped|0|||
125648914|NCT03808298|451997439|FG000|Overall Study|Adverse Event|3|||
125648915|NCT03808298|451997439|FG000|Overall Study|Physician Decision|1|||
125648916|NCT03808298|451997439|FG000|Overall Study|Withdrawal by Subject|1|||
125648917|NCT03808298|451997439|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
125648918|NCT01004822|451997440|FG000|Overall Study|Objective progression or relapse|3|||
125648919|NCT01004822|451997441|FG001|Overall Study|Objective progression or relapse|3|||
125648920|NCT01004822|451997442|FG002|Overall Study|Objective progression or relapse|0|||
125648921|NCT01004822|451997443|FG003|Overall Study|Objective progression or relapse|1|||
125648922|NCT01004822|451997444|FG004|Overall Study|Objective progression or relapse|2|||
125648923|NCT01004822|451997445|FG005|Overall Study|Objective progression or relapse|2|||
125648924|NCT01004822|451997446|FG006|Overall Study|Objective progression or relapse|1|||
125648925|NCT01004822|451997447|FG007|Overall Study|Objective progression or relapse|4|||
125648926|NCT01004822|451997440|FG000|Overall Study|Global deterioration of health status|0|||
125648927|NCT01004822|451997441|FG001|Overall Study|Global deterioration of health status|0|||
125648928|NCT01004822|451997442|FG002|Overall Study|Global deterioration of health status|0|||
125648929|NCT01004822|451997443|FG003|Overall Study|Global deterioration of health status|1|||
125648930|NCT01004822|451997444|FG004|Overall Study|Global deterioration of health status|0|||
125648931|NCT01004822|451997445|FG005|Overall Study|Global deterioration of health status|0|||
125648932|NCT01004822|451997446|FG006|Overall Study|Global deterioration of health status|1|||
125648933|NCT01004822|451997447|FG007|Overall Study|Global deterioration of health status|0|||
125648934|NCT01004822|451997440|FG000|Overall Study|No longer willing to continue|0|||
125648935|NCT01004822|451997441|FG001|Overall Study|No longer willing to continue|0|||
125648936|NCT01004822|451997442|FG002|Overall Study|No longer willing to continue|0|||
125648937|NCT01004822|451997443|FG003|Overall Study|No longer willing to continue|1|||
125648938|NCT01004822|451997444|FG004|Overall Study|No longer willing to continue|2|||
125648939|NCT01004822|451997445|FG005|Overall Study|No longer willing to continue|1|||
125648940|NCT01004822|451997446|FG006|Overall Study|No longer willing to continue|1|||
125648941|NCT01004822|451997447|FG007|Overall Study|No longer willing to continue|0|||
125648942|NCT01004822|451997440|FG000|Overall Study|Adverse Event|0|||
125648943|NCT01004822|451997441|FG001|Overall Study|Adverse Event|0|||
125648944|NCT01004822|451997442|FG002|Overall Study|Adverse Event|0|||
125648945|NCT01004822|451997443|FG003|Overall Study|Adverse Event|0|||
125648946|NCT01004822|451997444|FG004|Overall Study|Adverse Event|0|||
125648947|NCT01004822|451997445|FG005|Overall Study|Adverse Event|0|||
125648948|NCT01004822|451997446|FG006|Overall Study|Adverse Event|1|||
125648949|NCT01004822|451997447|FG007|Overall Study|Adverse Event|1|||
125648950|NCT01004822|451997440|FG000|Overall Study|Other|0|||
125648951|NCT01004822|451997441|FG001|Overall Study|Other|0|||
125648952|NCT01004822|451997442|FG002|Overall Study|Other|4|||
125648953|NCT01004822|451997443|FG003|Overall Study|Other|1|||
125648954|NCT01004822|451997444|FG004|Overall Study|Other|0|||
125648955|NCT01004822|451997445|FG005|Overall Study|Other|1|||
125648956|NCT01004822|451997446|FG006|Overall Study|Other|0|||
125205587|NCT00550862|450374777|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
125205588|NCT00550862|450374773|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
125205589|NCT00550862|450374774|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
125205590|NCT00550862|450374775|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
125205591|NCT00550862|450374776|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
125205592|NCT00550862|450374777|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
125205593|NCT00550862|450374773|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
125205594|NCT00550862|450374774|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
125205595|NCT00550862|450374775|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
125205596|NCT00550862|450374776|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
125205597|NCT00550862|450374777|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
125205598|NCT00550862|450374773|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
125205599|NCT00550862|450374774|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
125205600|NCT00550862|450374775|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
125205601|NCT00550862|450374776|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
125205602|NCT00550862|450374777|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
125205603|NCT00550862|450374773|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
125205604|NCT00550862|450374774|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
125205605|NCT00550862|450374775|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
125205606|NCT00550862|450374776|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
125205607|NCT00550862|450374777|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
125205608|NCT00550862|450374773|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
125205609|NCT00550862|450374774|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
125205610|NCT00550862|450374775|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
125205611|NCT00550862|450374776|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
125205612|NCT00550862|450374777|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
125205613|NCT00550862|450374773|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
125205614|NCT00550862|450374774|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
125205615|NCT00550862|450374775|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
125205616|NCT00550862|450374776|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
125205617|NCT00550862|450374777|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
125205618|NCT00980174|450374778|FG000|Overall Study|Withdrawal by Subject|1|||
125205619|NCT00980174|450374779|FG001|Overall Study|Withdrawal by Subject|4|||
125205620|NCT00980174|450374778|FG000|Overall Study|Adverse Event|0|||
125205621|NCT00980174|450374779|FG001|Overall Study|Adverse Event|3|||
125205622|NCT00980174|450374778|FG000|Overall Study|Ineligibility determined|2|||
125205623|NCT00980174|450374779|FG001|Overall Study|Ineligibility determined|1|||
125205624|NCT00980174|450374778|FG000|Overall Study|Death|1|||
125205625|NCT00980174|450374779|FG001|Overall Study|Death|1|||
125205626|NCT00980174|450374778|FG000|Overall Study|Other|0|||
125205627|NCT00980174|450374779|FG001|Overall Study|Other|1|||
125205628|NCT04631107|450374783|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
125205629|NCT04631107|450374783|FG000|Second Intervention (1 Night)|Adverse Event|1|||
125205630|NCT04631107|450374783|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
125205631|NCT04631107|450374783|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
125205632|NCT02003963|450374784|FG000|Overall Study|Lost to Follow-up|2|||
125205633|NCT02003963|450374785|FG001|Overall Study|Lost to Follow-up|1|||
125205634|NCT01935128|450374787|FG000|Overall Study|Death|1|||
125205635|NCT01935128|450374787|FG000|Overall Study|Adverse Event|6|||
125205636|NCT01440569|450374788|FG000|Main Study|Enrolled but not treated|1|||
125205637|NCT01440569|450374789|FG001|Main Study|Enrolled but not treated|0|||
125205638|NCT01440569|450374788|FG000|Main Study|Adverse Event|9|||
125205639|NCT01440569|450374789|FG001|Main Study|Adverse Event|0|||
125205640|NCT01440569|450374788|FG000|Main Study|Pregnancy|1|||
125205641|NCT01440569|450374789|FG001|Main Study|Pregnancy|0|||
125205642|NCT01440569|450374788|FG000|Main Study|Investigator's Discretion|1|||
125205643|NCT01440569|450374789|FG001|Main Study|Investigator's Discretion|1|||
125205644|NCT01440569|450374788|FG000|Main Study|Withdrew Consent|7|||
125205645|NCT01440569|450374789|FG001|Main Study|Withdrew Consent|1|||
125205646|NCT01440569|450374788|FG000|Main Study|Lost to Follow-up|13|||
125205647|NCT01440569|450374789|FG001|Main Study|Lost to Follow-up|2|||
125205648|NCT01440569|450374788|FG000|Main Study|Subject Non-Compliance|3|||
125205649|NCT01440569|450374789|FG001|Main Study|Subject Non-Compliance|0|||
125205650|NCT01440569|450374788|FG000|Main Study|Protocol Violation|1|||
125205651|NCT01440569|450374789|FG001|Main Study|Protocol Violation|0|||
125205652|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Adverse Event|3|||
125205653|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Adverse Event|0|||
125205654|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Pregnancy|1|||
125205655|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Pregnancy|0|||
125205656|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
125205657|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
125205658|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
125205659|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
125205660|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
125205661|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
125205662|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
125205663|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
125205664|NCT01440569|450374788|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
125205665|NCT01440569|450374789|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
125205666|NCT05020366|450374790|FG000|Overall Study|Lost to Follow-up|2|||
125205667|NCT05020366|450374791|FG001|Overall Study|Lost to Follow-up|0|||
125205668|NCT05020366|450374790|FG000|Overall Study|Withdrawal by Subject|2|||
125205669|NCT05020366|450374791|FG001|Overall Study|Withdrawal by Subject|0|||
125205670|NCT03589326|450374807|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
125205671|NCT03589326|450374808|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
125205672|NCT03589326|450374807|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
125205673|NCT03589326|450374808|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
125205674|NCT03589326|450374807|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
125205675|NCT03589326|450374808|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
125205676|NCT03589326|450374807|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
125205677|NCT03589326|450374808|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
125205678|NCT03589326|450374807|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
125205679|NCT03589326|450374808|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
125205680|NCT00435487|450374809|FG000|Overall Study|Death|3|||
125205681|NCT00435487|450374810|FG001|Overall Study|Death|4|||
125205682|NCT00435487|450374809|FG000|Overall Study|Adverse Event|0|||
125205683|NCT00435487|450374810|FG001|Overall Study|Adverse Event|3|||
125205684|NCT00435487|450374809|FG000|Overall Study|Lost to Follow-up|2|||
125205685|NCT00435487|450374810|FG001|Overall Study|Lost to Follow-up|2|||
125205686|NCT00435487|450374809|FG000|Overall Study|Other|5|||
125205687|NCT00435487|450374810|FG001|Overall Study|Other|2|||
125205688|NCT00435487|450374809|FG000|Overall Study|Withdrawal by Subject|2|||
125205689|NCT00435487|450374810|FG001|Overall Study|Withdrawal by Subject|1|||
125205690|NCT00435487|450374809|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
125205691|NCT00435487|450374810|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
125205692|NCT00435487|450374809|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
125205693|NCT00435487|450374810|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
125205694|NCT03301844|450374811|FG000|Overall Study|suspected colon cancer|1|||
125205695|NCT03301844|450374812|FG001|Overall Study|suspected colon cancer|1|||
125205696|NCT05087966|450374813|FG000|Overall Study|Lost to Follow-up|1|||
125205697|NCT05087966|450374813|FG000|Overall Study|Withdrawal by Subject|5|||
125205698|NCT00501059|450374814|FG000|Overall Study|Protocol Violation|80|||
125205699|NCT00501059|450374815|FG001|Overall Study|Protocol Violation|69|||
125205700|NCT00501059|450374814|FG000|Overall Study|Death|140|||
125205701|NCT00501059|450374815|FG001|Overall Study|Death|137|||
125205702|NCT00501059|450374814|FG000|Overall Study|Other|236|||
125205703|NCT00501059|450374815|FG001|Overall Study|Other|239|||
125205704|NCT00501059|450374814|FG000|Overall Study|Missing end-of-study page|91|||
125205705|NCT00501059|450374815|FG001|Overall Study|Missing end-of-study page|92|||
125205706|NCT00501059|450374814|FG000|Overall Study|Clinical endpoint reached|110|||
125205707|NCT00501059|450374815|FG001|Overall Study|Clinical endpoint reached|123|||
125205708|NCT00501059|450374814|FG000|Overall Study|Insufficient therapeutic effect|4|||
125205709|NCT00501059|450374815|FG001|Overall Study|Insufficient therapeutic effect|5|||
125205710|NCT00501059|450374814|FG000|Overall Study|Consent withdrawn by subject|817|||
125205711|NCT00501059|450374815|FG001|Overall Study|Consent withdrawn by subject|873|||
125205712|NCT00501059|450374814|FG000|Overall Study|Non-compliant with study treatment|23|||
125205713|NCT00501059|450374815|FG001|Overall Study|Non-compliant with study treatment|16|||
125205714|NCT00501059|450374814|FG000|Overall Study|Reason not given|3|||
125205715|NCT00501059|450374815|FG001|Overall Study|Reason not given|1|||
125205716|NCT00501059|450374814|FG000|Overall Study|Adverse Event|129|||
125205717|NCT00501059|450374815|FG001|Overall Study|Adverse Event|122|||
125205718|NCT00501059|450374814|FG000|Overall Study|Lost to Follow-up|210|||
125205719|NCT00501059|450374815|FG001|Overall Study|Lost to Follow-up|198|||
125205720|NCT00501059|450374814|FG000|Overall Study|Not treated|25|||
125205721|NCT00501059|450374815|FG001|Overall Study|Not treated|17|||
125205722|NCT00430352|450374819|FG000|Overall Study|Disease progression|58|||
125205723|NCT00430352|450374819|FG000|Overall Study|Withdrawal by Subject|11|||
125205724|NCT00430352|450374819|FG000|Overall Study|Adverse Event|16|||
125205725|NCT00430352|450374819|FG000|Overall Study|Death|5|||
125205726|NCT00430352|450374819|FG000|Overall Study|Other|48|||
125205727|NCT01785849|450374824|FG000|Overall Study|Death|7|||
125205728|NCT01785849|450374825|FG001|Overall Study|Death|9|||
125205729|NCT01785849|450374824|FG000|Overall Study|Protocol Specified Criteria|29|||
125205730|NCT01785849|450374825|FG001|Overall Study|Protocol Specified Criteria|1|||
125205731|NCT01785849|450374824|FG000|Overall Study|Withdrawal by Subject|15|||
125205732|NCT01785849|450374825|FG001|Overall Study|Withdrawal by Subject|12|||
125205733|NCT01785849|450374824|FG000|Overall Study|Sponsor Decision|0|||
125205734|NCT01785849|450374825|FG001|Overall Study|Sponsor Decision|1|||
125205735|NCT01785849|450374824|FG000|Overall Study|Lost to Follow-up|10|||
125205736|NCT01785849|450374825|FG001|Overall Study|Lost to Follow-up|11|||
125205737|NCT04550832|450377117|FG000|Overall Study|Adverse Event|0|||
125205738|NCT04550832|450377118|FG001|Overall Study|Adverse Event|0|||
125205739|NCT04550832|450377119|FG002|Overall Study|Adverse Event|2|||
125205740|NCT04550832|450377120|FG003|Overall Study|Adverse Event|0|||
125205741|NCT04550832|450377121|FG004|Overall Study|Adverse Event|1|||
125648957|NCT01004822|451997447|FG007|Overall Study|Other|0|||
125648958|NCT01858701|451997448|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
125648959|NCT01858701|451997449|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
125648960|NCT01858701|451997448|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
125648961|NCT01858701|451997449|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
125648962|NCT01858701|451997448|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
125648963|NCT01858701|451997449|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
125648964|NCT01858701|451997448|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
125205742|NCT04823130|450377122|FG000|Overall Study|Withdrawal by Subject|2|||
125205743|NCT04823130|450377123|FG001|Overall Study|Withdrawal by Subject|3|||
125205744|NCT04823130|450377122|FG000|Overall Study|Failure to meet inclusion criteria|6|||
125205745|NCT04823130|450377123|FG001|Overall Study|Failure to meet inclusion criteria|4|||
125205746|NCT04823130|450377122|FG000|Overall Study|Other-unspecified|1|||
125205747|NCT04823130|450377123|FG001|Overall Study|Other-unspecified|0|||
125205748|NCT03315455|450377124|FG000|Overall Study|Ongoing in the Study|13|||
125205749|NCT03315455|450377125|FG001|Overall Study|Ongoing in the Study|24|||
125205750|NCT03315455|450377126|FG002|Overall Study|Ongoing in the Study|17|||
125205751|NCT03315455|450377127|FG003|Overall Study|Ongoing in the Study|15|||
125205752|NCT03315455|450377124|FG000|Overall Study|Withdrawal by Subject|0|||
125205753|NCT03315455|450377125|FG001|Overall Study|Withdrawal by Subject|1|||
125205754|NCT03315455|450377126|FG002|Overall Study|Withdrawal by Subject|0|||
125205755|NCT03315455|450377127|FG003|Overall Study|Withdrawal by Subject|0|||
125205756|NCT03030118|450377131|FG000|Overall Study|Achieved SLE Diagnosis|11|||
125205757|NCT03030118|450377132|FG001|Overall Study|Achieved SLE Diagnosis|10|||
125205758|NCT03030118|450377131|FG000|Overall Study|Adverse Event|1|||
125205759|NCT03030118|450377132|FG001|Overall Study|Adverse Event|1|||
125205760|NCT03030118|450377131|FG000|Overall Study|Pregnancy|2|||
125205761|NCT03030118|450377132|FG001|Overall Study|Pregnancy|2|||
125205762|NCT03030118|450377131|FG000|Overall Study|Lost to Follow-up|5|||
125205763|NCT03030118|450377132|FG001|Overall Study|Lost to Follow-up|6|||
125205764|NCT03030118|450377131|FG000|Overall Study|Concomitant Medications|1|||
125205765|NCT03030118|450377132|FG001|Overall Study|Concomitant Medications|1|||
125205766|NCT03030118|450377131|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
125205767|NCT03030118|450377132|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
125205768|NCT03030118|450377131|FG000|Overall Study|Other|2|||
125205769|NCT03030118|450377132|FG001|Overall Study|Other|0|||
125205770|NCT03030118|450377131|FG000|Overall Study|Withdrawal by Subject|26|||
125205771|NCT03030118|450377132|FG001|Overall Study|Withdrawal by Subject|21|||
125205772|NCT03030118|450377131|FG000|Overall Study|Protocol Violation|1|||
125205773|NCT03030118|450377132|FG001|Overall Study|Protocol Violation|6|||
125205774|NCT01032070|450377133|FG000|Overall Study|Disease progression|13|||
125205775|NCT01032070|450377134|FG001|Overall Study|Disease progression|8|||
125205776|NCT01032070|450377133|FG000|Overall Study|Medical or ethical reasons|0|||
125205777|NCT01032070|450377134|FG001|Overall Study|Medical or ethical reasons|2|||
125205778|NCT01032070|450377133|FG000|Overall Study|Withdrawal by Subject|0|||
125205779|NCT01032070|450377134|FG001|Overall Study|Withdrawal by Subject|2|||
125205780|NCT03488225|450377137|FG000|Overall Study|Off Protocol Therapy|2|||
125205781|NCT03488225|450377137|FG000|Overall Study|Stem Cell Transplant|2|||
125205782|NCT00894790|450377138|FG000|Overall Study|Protocol Violation|0|||
125205783|NCT00894790|450377139|FG001|Overall Study|Protocol Violation|1|||
125205784|NCT00894790|450377138|FG000|Overall Study|Lost to Follow-up|0|||
125205785|NCT00894790|450377139|FG001|Overall Study|Lost to Follow-up|1|||
125205786|NCT00894790|450377138|FG000|Overall Study|Did not meet entrance criteria|1|||
125205787|NCT00894790|450377139|FG001|Overall Study|Did not meet entrance criteria|0|||
125205788|NCT04093492|450377140|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
125205789|NCT04093492|450377141|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
125205790|NCT04093492|450377142|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
125205791|NCT04093492|450377143|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
125205792|NCT04093492|450377140|FG000|25 Weeks Gestational Age (GA)|No response|5|||
125205793|NCT04093492|450377141|FG001|25 Weeks Gestational Age (GA)|No response|5|||
125205794|NCT04093492|450377142|FG002|25 Weeks Gestational Age (GA)|No response|5|||
125205795|NCT04093492|450377143|FG003|25 Weeks Gestational Age (GA)|No response|2|||
125205796|NCT04093492|450377140|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
125205797|NCT04093492|450377141|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
125205798|NCT04093492|450377142|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
125424877|NCT00430248|451178700|FG001|Overall Study|Gout Flare|7|||
125205799|NCT04093492|450377143|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
125205800|NCT04093492|450377140|FG000|30 Weeks GA|Delivered before assessment|1|||
125205801|NCT04093492|450377141|FG001|30 Weeks GA|Delivered before assessment|2|||
125205802|NCT04093492|450377142|FG002|30 Weeks GA|Delivered before assessment|0|||
125205803|NCT04093492|450377143|FG003|30 Weeks GA|Delivered before assessment|0|||
125205804|NCT04093492|450377140|FG000|30 Weeks GA|No response|7|||
125205805|NCT04093492|450377141|FG001|30 Weeks GA|No response|5|||
125205806|NCT04093492|450377142|FG002|30 Weeks GA|No response|5|||
125205807|NCT04093492|450377143|FG003|30 Weeks GA|No response|2|||
125205808|NCT04093492|450377140|FG000|30 Weeks GA|Lost to Follow-up|0|||
125205809|NCT04093492|450377141|FG001|30 Weeks GA|Lost to Follow-up|1|||
125205810|NCT04093492|450377142|FG002|30 Weeks GA|Lost to Follow-up|0|||
125205811|NCT04093492|450377143|FG003|30 Weeks GA|Lost to Follow-up|0|||
125205812|NCT04093492|450377140|FG000|34 Weeks GA|Delivered before assessment|6|||
125205813|NCT04093492|450377141|FG001|34 Weeks GA|Delivered before assessment|3|||
125205814|NCT04093492|450377142|FG002|34 Weeks GA|Delivered before assessment|0|||
125205815|NCT04093492|450377143|FG003|34 Weeks GA|Delivered before assessment|0|||
125205816|NCT04093492|450377140|FG000|34 Weeks GA|No response|0|||
125205817|NCT04093492|450377141|FG001|34 Weeks GA|No response|7|||
125205818|NCT04093492|450377142|FG002|34 Weeks GA|No response|5|||
125205819|NCT04093492|450377143|FG003|34 Weeks GA|No response|3|||
125205820|NCT04093492|450377140|FG000|34 Weeks GA|Lost to Follow-up|0|||
125205821|NCT04093492|450377141|FG001|34 Weeks GA|Lost to Follow-up|1|||
125205822|NCT04093492|450377142|FG002|34 Weeks GA|Lost to Follow-up|0|||
125205823|NCT04093492|450377143|FG003|34 Weeks GA|Lost to Follow-up|0|||
125205824|NCT00503997|450377148|FG000|Overall Study|disease progression|1|||
125205825|NCT00503997|450377148|FG000|Overall Study|Adverse Event|5|||
125205826|NCT00503997|450377148|FG000|Overall Study|Death|1|||
125205827|NCT00503997|450377148|FG000|Overall Study|Withdrawal by Subject|1|||
125205828|NCT01195844|450377149|FG000|Overall Study|Fecal sample not collected|40|||
125205829|NCT05385224|450377150|FG000|Overall Study|Unable to swallow capsule|2|||
125205830|NCT05385224|450377150|FG000|Overall Study|Withdrawal by Subject|2|||
125205831|NCT05385224|450377150|FG000|Overall Study|Did not meet study criteria|1|||
125205832|NCT00551161|450377151|FG000|Overall Study|Withdrawal by Subject|1|||
125205833|NCT00096993|450377152|FG000|Overall Study|Death|1|||
125205834|NCT00096993|450377153|FG001|Overall Study|Death|0|||
125205835|NCT00096993|450377152|FG000|Overall Study|Disease progression|56|||
125205836|NCT00096993|450377153|FG001|Overall Study|Disease progression|53|||
125205837|NCT00096993|450377152|FG000|Overall Study|Adverse Event|2|||
125205838|NCT00096993|450377153|FG001|Overall Study|Adverse Event|8|||
125205839|NCT00096993|450377152|FG000|Overall Study|Subject's decision|3|||
125205840|NCT00096993|450377153|FG001|Overall Study|Subject's decision|1|||
125205841|NCT00096993|450377152|FG000|Overall Study|Physician Decision|2|||
125205842|NCT00096993|450377153|FG001|Overall Study|Physician Decision|1|||
125205843|NCT00096993|450377152|FG000|Overall Study|Non-compliance|0|||
125205844|NCT00096993|450377153|FG001|Overall Study|Non-compliance|1|||
125205845|NCT00096993|450377152|FG000|Overall Study|Other unspecified|1|||
125205846|NCT00096993|450377153|FG001|Overall Study|Other unspecified|1|||
125205847|NCT00772005|450377155|FG000|Overall Study|Adverse Event|9|||
125205848|NCT00772005|450377156|FG001|Overall Study|Adverse Event|14|||
125205849|NCT00772005|450377157|FG002|Overall Study|Adverse Event|10|||
125205850|NCT00772005|450377158|FG003|Overall Study|Adverse Event|13|||
125205851|NCT00772005|450377155|FG000|Overall Study|Lack of Efficacy|0|||
125205852|NCT00772005|450377156|FG001|Overall Study|Lack of Efficacy|1|||
125205853|NCT00772005|450377157|FG002|Overall Study|Lack of Efficacy|0|||
125205854|NCT00772005|450377158|FG003|Overall Study|Lack of Efficacy|0|||
125205855|NCT00772005|450377155|FG000|Overall Study|Withdrawal by Subject|3|||
125205856|NCT00772005|450377156|FG001|Overall Study|Withdrawal by Subject|7|||
125205857|NCT00772005|450377157|FG002|Overall Study|Withdrawal by Subject|10|||
125205858|NCT00772005|450377158|FG003|Overall Study|Withdrawal by Subject|2|||
125205859|NCT00772005|450377155|FG000|Overall Study|Protocol Violation|2|||
125205860|NCT00772005|450377156|FG001|Overall Study|Protocol Violation|4|||
125205861|NCT00772005|450377157|FG002|Overall Study|Protocol Violation|1|||
125205862|NCT00772005|450377158|FG003|Overall Study|Protocol Violation|6|||
125205863|NCT00772005|450377155|FG000|Overall Study|Lost to Follow-up|7|||
125205864|NCT00772005|450377156|FG001|Overall Study|Lost to Follow-up|3|||
125205865|NCT00772005|450377157|FG002|Overall Study|Lost to Follow-up|6|||
125205866|NCT00772005|450377158|FG003|Overall Study|Lost to Follow-up|3|||
125205867|NCT00772005|450377155|FG000|Overall Study|Non-compliance with study procedures|1|||
125205868|NCT00772005|450377156|FG001|Overall Study|Non-compliance with study procedures|1|||
125205869|NCT00772005|450377157|FG002|Overall Study|Non-compliance with study procedures|0|||
125205870|NCT00772005|450377158|FG003|Overall Study|Non-compliance with study procedures|1|||
125205871|NCT00772005|450377155|FG000|Overall Study|Non-compliance with drug administration|3|||
125205872|NCT00772005|450377156|FG001|Overall Study|Non-compliance with drug administration|0|||
125205873|NCT00772005|450377157|FG002|Overall Study|Non-compliance with drug administration|1|||
125205874|NCT00772005|450377158|FG003|Overall Study|Non-compliance with drug administration|1|||
125205875|NCT01606202|450377162|FG000|Overall Study|Adverse Event|5|||
125205876|NCT01606202|450377163|FG001|Overall Study|Adverse Event|0|||
125205877|NCT01606202|450377162|FG000|Overall Study|Withdrawal by Subject|2|||
125205878|NCT01606202|450377163|FG001|Overall Study|Withdrawal by Subject|1|||
125205879|NCT01606202|450377162|FG000|Overall Study|Personal problems|0|||
125205880|NCT01606202|450377163|FG001|Overall Study|Personal problems|1|||
125205881|NCT01606202|450377162|FG000|Overall Study|Problems with administration|0|||
125205882|NCT01606202|450377163|FG001|Overall Study|Problems with administration|1|||
125205883|NCT01267201|450377164|FG000|First Intervention Period|Withdrawal by Subject|1|||
125205884|NCT01267201|450377165|FG001|First Intervention Period|Withdrawal by Subject|0|||
125205885|NCT01267201|450377166|FG002|First Intervention Period|Withdrawal by Subject|0|||
125205886|NCT01267201|450377167|FG003|First Intervention Period|Withdrawal by Subject|0|||
125205887|NCT01267201|450377168|FG004|First Intervention Period|Withdrawal by Subject|0|||
125205888|NCT01267201|450377169|FG005|First Intervention Period|Withdrawal by Subject|0|||
125205889|NCT01267201|450377164|FG000|Second Intervention Period|Withdrawal by Subject|0|||
125205890|NCT01267201|450377165|FG001|Second Intervention Period|Withdrawal by Subject|1|||
125205891|NCT01267201|450377166|FG002|Second Intervention Period|Withdrawal by Subject|0|||
125205892|NCT01267201|450377167|FG003|Second Intervention Period|Withdrawal by Subject|0|||
125205893|NCT01267201|450377168|FG004|Second Intervention Period|Withdrawal by Subject|0|||
125205894|NCT01267201|450377169|FG005|Second Intervention Period|Withdrawal by Subject|0|||
125205895|NCT00955968|450377173|FG000|Overall Study|Death|2|||
125205896|NCT00955968|450377174|FG001|Overall Study|Death|4|||
125205897|NCT00955968|450377173|FG000|Overall Study|Withdrawal by Subject|35|||
125205898|NCT00955968|450377174|FG001|Overall Study|Withdrawal by Subject|31|||
125205899|NCT00955968|450377173|FG000|Overall Study|Lost to Follow-up|45|||
125205900|NCT00955968|450377174|FG001|Overall Study|Lost to Follow-up|39|||
125205901|NCT00955968|450377173|FG000|Overall Study|Site closed|55|||
125205902|NCT00955968|450377174|FG001|Overall Study|Site closed|52|||
125205903|NCT05020899|450377176|FG000|8 Week Follow-up|Lost to Follow-up|3|||
125205904|NCT05020899|450377177|FG001|8 Week Follow-up|Lost to Follow-up|6|||
125205905|NCT05020899|450377176|FG000|12 Week Follow-up|Lost to Follow-up|1|||
125205906|NCT05020899|450377177|FG001|12 Week Follow-up|Lost to Follow-up|0|||
125205907|NCT05020899|450377176|FG000|12 Week Follow-up|Death|0|||
125205908|NCT05020899|450377177|FG001|12 Week Follow-up|Death|1|||
125205909|NCT01294371|450377178|FG000|Overall Study|Adverse Event|1|||
125205910|NCT01294371|450377178|FG000|Overall Study|Withdrawal by Subject|12|||
125205911|NCT01294371|450377178|FG000|Overall Study|Lost to Follow-up|6|||
125205912|NCT01294371|450377178|FG000|Overall Study|Administrative Reason|1|||
125205913|NCT01294371|450377178|FG000|Overall Study|Other|14|||
125205914|NCT05619536|450377179|FG000|Overall Study|Withdrawal by Subject|0|||
125205915|NCT05619536|450377180|FG001|Overall Study|Withdrawal by Subject|1|||
125205916|NCT05619536|450377181|FG002|Overall Study|Withdrawal by Subject|0|||
125205917|NCT05619536|450377182|FG003|Overall Study|Withdrawal by Subject|1|||
125205918|NCT05619536|450377179|FG000|Overall Study|Lost to Follow-up|0|||
125205919|NCT05619536|450377180|FG001|Overall Study|Lost to Follow-up|1|||
125205920|NCT05619536|450377181|FG002|Overall Study|Lost to Follow-up|1|||
125205921|NCT05619536|450377182|FG003|Overall Study|Lost to Follow-up|0|||
125205922|NCT02923245|450377183|FG000|Overall Study|ultrasound order was cancelled|2|||
125205923|NCT02923245|450377184|FG001|Overall Study|ultrasound order was cancelled|1|||
125205924|NCT02520427|450377185|FG000|Overall Study|Decision by sponsor|0|||
125205925|NCT02520427|450377186|FG001|Overall Study|Decision by sponsor|0|||
125205926|NCT02520427|450377187|FG002|Overall Study|Decision by sponsor|0|||
125205927|NCT02520427|450377188|FG003|Overall Study|Decision by sponsor|0|||
125205928|NCT02520427|450377189|FG004|Overall Study|Decision by sponsor|0|||
125205929|NCT02520427|450377190|FG005|Overall Study|Decision by sponsor|0|||
125205930|NCT02520427|450377191|FG006|Overall Study|Decision by sponsor|0|||
125205931|NCT02520427|450377192|FG007|Overall Study|Decision by sponsor|0|||
125205932|NCT02520427|450377193|FG008|Overall Study|Decision by sponsor|1|||
125205933|NCT02520427|450377194|FG009|Overall Study|Decision by sponsor|1|||
125205934|NCT02520427|450377195|FG010|Overall Study|Decision by sponsor|0|||
125205935|NCT02520427|450377196|FG011|Overall Study|Decision by sponsor|0|||
125205936|NCT02520427|450377197|FG012|Overall Study|Decision by sponsor|0|||
125205937|NCT02520427|450377198|FG013|Overall Study|Decision by sponsor|0|||
125205938|NCT02520427|450377199|FG014|Overall Study|Decision by sponsor|0|||
125205939|NCT02520427|450377200|FG015|Overall Study|Decision by sponsor|0|||
125205940|NCT02520427|450377201|FG016|Overall Study|Decision by sponsor|0|||
125205941|NCT02520427|450377202|FG017|Overall Study|Decision by sponsor|0|||
125205942|NCT02520427|450377203|FG018|Overall Study|Decision by sponsor|0|||
125205943|NCT02520427|450377204|FG019|Overall Study|Decision by sponsor|0|||
125205944|NCT02520427|450377205|FG020|Overall Study|Decision by sponsor|0|||
125205945|NCT02520427|450377206|FG021|Overall Study|Decision by sponsor|0|||
125205946|NCT02520427|450377207|FG022|Overall Study|Decision by sponsor|0|||
125205947|NCT02520427|450377208|FG023|Overall Study|Decision by sponsor|0|||
125205948|NCT02520427|450377209|FG024|Overall Study|Decision by sponsor|0|||
125205949|NCT02520427|450377210|FG025|Overall Study|Decision by sponsor|0|||
125205950|NCT02520427|450377185|FG000|Overall Study|Withdrawal by Subject|0|||
125205951|NCT02520427|450377186|FG001|Overall Study|Withdrawal by Subject|0|||
125205952|NCT02520427|450377187|FG002|Overall Study|Withdrawal by Subject|1|||
125205953|NCT02520427|450377188|FG003|Overall Study|Withdrawal by Subject|0|||
125205954|NCT02520427|450377189|FG004|Overall Study|Withdrawal by Subject|0|||
125205955|NCT02520427|450377190|FG005|Overall Study|Withdrawal by Subject|0|||
125205956|NCT02520427|450377191|FG006|Overall Study|Withdrawal by Subject|0|||
125205957|NCT02520427|450377192|FG007|Overall Study|Withdrawal by Subject|0|||
125205958|NCT02520427|450377193|FG008|Overall Study|Withdrawal by Subject|0|||
125205959|NCT02520427|450377194|FG009|Overall Study|Withdrawal by Subject|0|||
125205960|NCT02520427|450377195|FG010|Overall Study|Withdrawal by Subject|0|||
125205961|NCT02520427|450377196|FG011|Overall Study|Withdrawal by Subject|0|||
125205962|NCT02520427|450377197|FG012|Overall Study|Withdrawal by Subject|1|||
125205963|NCT02520427|450377198|FG013|Overall Study|Withdrawal by Subject|1|||
125205964|NCT02520427|450377199|FG014|Overall Study|Withdrawal by Subject|1|||
125205965|NCT02520427|450377200|FG015|Overall Study|Withdrawal by Subject|0|||
125205966|NCT02520427|450377201|FG016|Overall Study|Withdrawal by Subject|1|||
125205967|NCT02520427|450377202|FG017|Overall Study|Withdrawal by Subject|0|||
125205968|NCT02520427|450377203|FG018|Overall Study|Withdrawal by Subject|0|||
125205969|NCT02520427|450377204|FG019|Overall Study|Withdrawal by Subject|3|||
125205970|NCT02520427|450377205|FG020|Overall Study|Withdrawal by Subject|2|||
125205971|NCT02520427|450377206|FG021|Overall Study|Withdrawal by Subject|0|||
125205972|NCT02520427|450377207|FG022|Overall Study|Withdrawal by Subject|0|||
125205973|NCT02520427|450377208|FG023|Overall Study|Withdrawal by Subject|0|||
125205974|NCT02520427|450377209|FG024|Overall Study|Withdrawal by Subject|0|||
125205975|NCT02520427|450377210|FG025|Overall Study|Withdrawal by Subject|0|||
125205976|NCT02520427|450377185|FG000|Overall Study|Death|1|||
125205977|NCT02520427|450377186|FG001|Overall Study|Death|0|||
125205978|NCT02520427|450377187|FG002|Overall Study|Death|0|||
125205979|NCT02520427|450377188|FG003|Overall Study|Death|0|||
125205980|NCT02520427|450377189|FG004|Overall Study|Death|0|||
125205981|NCT02520427|450377190|FG005|Overall Study|Death|0|||
125205982|NCT02520427|450377191|FG006|Overall Study|Death|0|||
125205983|NCT02520427|450377192|FG007|Overall Study|Death|0|||
125205984|NCT02520427|450377193|FG008|Overall Study|Death|0|||
125205985|NCT02520427|450377194|FG009|Overall Study|Death|0|||
125205986|NCT02520427|450377195|FG010|Overall Study|Death|0|||
125205987|NCT02520427|450377196|FG011|Overall Study|Death|0|||
125205988|NCT02520427|450377197|FG012|Overall Study|Death|0|||
125205989|NCT02520427|450377198|FG013|Overall Study|Death|0|||
125205990|NCT02520427|450377199|FG014|Overall Study|Death|0|||
125205991|NCT02520427|450377200|FG015|Overall Study|Death|0|||
125205992|NCT02520427|450377201|FG016|Overall Study|Death|2|||
125205993|NCT02520427|450377202|FG017|Overall Study|Death|1|||
125205994|NCT02520427|450377203|FG018|Overall Study|Death|3|||
125205995|NCT02520427|450377204|FG019|Overall Study|Death|2|||
125205996|NCT02520427|450377205|FG020|Overall Study|Death|0|||
125205997|NCT02520427|450377206|FG021|Overall Study|Death|0|||
125205998|NCT02520427|450377207|FG022|Overall Study|Death|1|||
125205999|NCT02520427|450377208|FG023|Overall Study|Death|0|||
125206000|NCT02520427|450377209|FG024|Overall Study|Death|1|||
125206001|NCT02520427|450377210|FG025|Overall Study|Death|0|||
125206002|NCT00793624|450377213|FG000|Overall Study|Adverse Event|18|||
125206003|NCT00793624|450377214|FG001|Overall Study|Adverse Event|16|||
125206004|NCT00793624|450377215|FG002|Overall Study|Adverse Event|15|||
125206005|NCT00793624|450377216|FG003|Overall Study|Adverse Event|20|||
125206006|NCT00793624|450377213|FG000|Overall Study|Lost to Follow-up|2|||
125206007|NCT00793624|450377214|FG001|Overall Study|Lost to Follow-up|2|||
125206008|NCT00793624|450377215|FG002|Overall Study|Lost to Follow-up|4|||
125206009|NCT00793624|450377216|FG003|Overall Study|Lost to Follow-up|0|||
125206010|NCT00793624|450377213|FG000|Overall Study|Withdrawal by Subject|20|||
125206011|NCT00793624|450377214|FG001|Overall Study|Withdrawal by Subject|9|||
125206012|NCT00793624|450377215|FG002|Overall Study|Withdrawal by Subject|11|||
125206013|NCT00793624|450377216|FG003|Overall Study|Withdrawal by Subject|14|||
125206014|NCT00793624|450377213|FG000|Overall Study|Lack of Efficacy|9|||
125206015|NCT00793624|450377214|FG001|Overall Study|Lack of Efficacy|2|||
125206016|NCT00793624|450377215|FG002|Overall Study|Lack of Efficacy|1|||
125206017|NCT00793624|450377216|FG003|Overall Study|Lack of Efficacy|3|||
125206018|NCT00793624|450377213|FG000|Overall Study|Non compliance with protocol|2|||
125206019|NCT00793624|450377214|FG001|Overall Study|Non compliance with protocol|3|||
125206020|NCT00793624|450377215|FG002|Overall Study|Non compliance with protocol|2|||
125206021|NCT00793624|450377216|FG003|Overall Study|Non compliance with protocol|3|||
125206022|NCT00793624|450377213|FG000|Overall Study|Other reason not described above|6|||
125206023|NCT00793624|450377214|FG001|Overall Study|Other reason not described above|4|||
125206024|NCT00793624|450377215|FG002|Overall Study|Other reason not described above|6|||
125206025|NCT00793624|450377216|FG003|Overall Study|Other reason not described above|3|||
125206026|NCT00710684|450377217|FG000|Overall Study|Adverse Event|11|||
125206027|NCT00710684|450377218|FG001|Overall Study|Adverse Event|19|||
125206028|NCT00710684|450377219|FG002|Overall Study|Adverse Event|16|||
125424878|NCT00430248|451178701|FG002|Overall Study|Gout Flare|2|||
125206029|NCT00710684|450377217|FG000|Overall Study|Lack of Efficacy|4|||
125206030|NCT00710684|450377218|FG001|Overall Study|Lack of Efficacy|3|||
125206031|NCT00710684|450377219|FG002|Overall Study|Lack of Efficacy|5|||
125206032|NCT00710684|450377217|FG000|Overall Study|Protocol Violation|5|||
125206033|NCT00710684|450377218|FG001|Overall Study|Protocol Violation|5|||
125206034|NCT00710684|450377219|FG002|Overall Study|Protocol Violation|5|||
125206035|NCT00710684|450377217|FG000|Overall Study|Lost to Follow-up|4|||
125206036|NCT00710684|450377218|FG001|Overall Study|Lost to Follow-up|6|||
125206037|NCT00710684|450377219|FG002|Overall Study|Lost to Follow-up|7|||
125206038|NCT00710684|450377217|FG000|Overall Study|Physician Decision|0|||
125206039|NCT00710684|450377218|FG001|Overall Study|Physician Decision|2|||
125206040|NCT00710684|450377219|FG002|Overall Study|Physician Decision|4|||
125206041|NCT00710684|450377217|FG000|Overall Study|Withdrawal by Subject|24|||
125206042|NCT00710684|450377218|FG001|Overall Study|Withdrawal by Subject|18|||
125206043|NCT00710684|450377219|FG002|Overall Study|Withdrawal by Subject|11|||
125206044|NCT00710684|450377217|FG000|Overall Study|Missing|1|||
125206045|NCT00710684|450377218|FG001|Overall Study|Missing|0|||
125206046|NCT00710684|450377219|FG002|Overall Study|Missing|0|||
125648965|NCT01858701|451997449|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
125648966|NCT01674010|451997450|FG000|Open Treatment Phase 1|Adverse Event|10|||
125648967|NCT01674010|451997451|FG001|Open Treatment Phase 1|Adverse Event|0|||
125648968|NCT01674010|451997452|FG002|Open Treatment Phase 1|Adverse Event|0|||
125648969|NCT01674010|451997450|FG000|Open Treatment Phase 1|Death|1|||
125648970|NCT01674010|451997451|FG001|Open Treatment Phase 1|Death|0|||
125648971|NCT01674010|451997452|FG002|Open Treatment Phase 1|Death|0|||
125206047|NCT00710684|450377217|FG000|Overall Study|Did not continue after week 24|25|||
125206048|NCT00710684|450377218|FG001|Overall Study|Did not continue after week 24|21|||
125206049|NCT00710684|450377219|FG002|Overall Study|Did not continue after week 24|16|||
125206050|NCT04778059|450377220|FG000|Overall Study|Death|2|||
125206051|NCT04778059|450377221|FG001|Overall Study|Death|2|||
125206052|NCT04778059|450377222|FG002|Overall Study|Death|1|||
125206053|NCT04778059|450377223|FG003|Overall Study|Death|1|||
125206054|NCT04778059|450377224|FG004|Overall Study|Death|1|||
125206055|NCT04778059|450377220|FG000|Overall Study|Lost to Follow-up|0|||
125206056|NCT04778059|450377221|FG001|Overall Study|Lost to Follow-up|0|||
125206057|NCT04778059|450377222|FG002|Overall Study|Lost to Follow-up|0|||
125206058|NCT04778059|450377223|FG003|Overall Study|Lost to Follow-up|0|||
125206059|NCT04778059|450377224|FG004|Overall Study|Lost to Follow-up|1|||
125206060|NCT04778059|450377220|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
125206061|NCT04778059|450377221|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
125206062|NCT04778059|450377222|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
125206063|NCT04778059|450377223|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
125206064|NCT04778059|450377224|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
125206065|NCT00157248|450377229|FG000|Overall Study|Adverse Event|36|||
125206066|NCT00157248|450377230|FG001|Overall Study|Adverse Event|25|||
125206067|NCT00157248|450377231|FG002|Overall Study|Adverse Event|13|||
125206068|NCT00157248|450377232|FG003|Overall Study|Adverse Event|33|||
125206069|NCT00157248|450377229|FG000|Overall Study|Protocol Violation|4|||
125206070|NCT00157248|450377230|FG001|Overall Study|Protocol Violation|0|||
125206071|NCT00157248|450377231|FG002|Overall Study|Protocol Violation|2|||
125206072|NCT00157248|450377232|FG003|Overall Study|Protocol Violation|2|||
125206073|NCT00157248|450377229|FG000|Overall Study|Lost to Follow-up|0|||
125206074|NCT00157248|450377230|FG001|Overall Study|Lost to Follow-up|1|||
125206075|NCT00157248|450377231|FG002|Overall Study|Lost to Follow-up|0|||
125206076|NCT00157248|450377232|FG003|Overall Study|Lost to Follow-up|0|||
125206077|NCT00157248|450377229|FG000|Overall Study|Withdrawal by Subject|1|||
125206078|NCT00157248|450377230|FG001|Overall Study|Withdrawal by Subject|4|||
125206079|NCT00157248|450377231|FG002|Overall Study|Withdrawal by Subject|3|||
125206080|NCT00157248|450377232|FG003|Overall Study|Withdrawal by Subject|3|||
125206081|NCT00157248|450377229|FG000|Overall Study|site closures, subject moving|7|||
125206082|NCT00157248|450377230|FG001|Overall Study|site closures, subject moving|7|||
125206083|NCT00157248|450377231|FG002|Overall Study|site closures, subject moving|3|||
125206084|NCT00157248|450377232|FG003|Overall Study|site closures, subject moving|9|||
125206085|NCT01306045|450377237|FG000|Met General Eligibility Criteria|Screen failures|193|||
125206086|NCT01306045|450377238|FG001|Met General Eligibility Criteria|Screen failures|11|||
125206087|NCT01306045|450377239|FG002|Met General Eligibility Criteria|Screen failures|8|||
125206088|NCT02987972|450377240|FG000|Overall Study|Adverse Event|1|||
125206089|NCT02987972|450377241|FG001|Overall Study|Adverse Event|1|||
125206090|NCT02987972|450377242|FG002|Overall Study|Adverse Event|0|||
125206091|NCT02987972|450377240|FG000|Overall Study|Death|1|||
125648972|NCT01674010|451997450|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
125648973|NCT01674010|451997451|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
125206092|NCT02987972|450377241|FG001|Overall Study|Death|0|||
125648974|NCT01674010|451997452|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
125206093|NCT02987972|450377242|FG002|Overall Study|Death|0|||
125206094|NCT02987972|450377240|FG000|Overall Study|Lack of Efficacy|9|||
125206095|NCT02987972|450377241|FG001|Overall Study|Lack of Efficacy|12|||
125206096|NCT02987972|450377242|FG002|Overall Study|Lack of Efficacy|12|||
125206097|NCT02987972|450377240|FG000|Overall Study|Lost to Follow-up|7|||
125206098|NCT02987972|450377241|FG001|Overall Study|Lost to Follow-up|8|||
125206099|NCT02987972|450377242|FG002|Overall Study|Lost to Follow-up|4|||
125648975|NCT01674010|451997450|FG000|Open Treatment Phase 1|Physician Decision|9|||
125206100|NCT02987972|450377240|FG000|Overall Study|Physician Decision|1|||
125206101|NCT02987972|450377241|FG001|Overall Study|Physician Decision|6|||
125206102|NCT02987972|450377242|FG002|Overall Study|Physician Decision|0|||
125206103|NCT02987972|450377240|FG000|Overall Study|Protocol Violation|2|||
125206104|NCT02987972|450377241|FG001|Overall Study|Protocol Violation|1|||
125206105|NCT02987972|450377242|FG002|Overall Study|Protocol Violation|5|||
125206106|NCT02987972|450377240|FG000|Overall Study|Withdrawal by Subject|22|||
125206107|NCT02987972|450377241|FG001|Overall Study|Withdrawal by Subject|17|||
125206108|NCT02987972|450377242|FG002|Overall Study|Withdrawal by Subject|21|||
125206109|NCT05128773|450378343|FG000|Overall Study|Sponsor decision to terminate study|3|||
125206110|NCT04250714|450378345|FG000|Overall Study|Treatment - withdrawal by subject|14|||
125206111|NCT04250714|450378345|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
125206112|NCT04250714|450378345|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
125206113|NCT04250714|450378345|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
125206114|NCT04250714|450378345|FG000|Overall Study|Treatment - Death|1|||
125206115|NCT04250714|450378345|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
125206116|NCT04250714|450378345|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
125206117|NCT04250714|450378345|FG000|Overall Study|Attempt|2|||
125206118|NCT04250714|450378345|FG000|Overall Study|Intent|7|||
125206119|NCT04676412|450378346|FG000|Overall Study|Death|28|||
125206120|NCT04676412|450378347|FG001|Overall Study|Death|31|||
125206121|NCT04676412|450378346|FG000|Overall Study|Lost to Follow-up|1|||
125206122|NCT04676412|450378347|FG001|Overall Study|Lost to Follow-up|2|||
125206123|NCT04676412|450378346|FG000|Overall Study|Sponsor Decision|20|||
125206124|NCT04676412|450378347|FG001|Overall Study|Sponsor Decision|23|||
125206125|NCT04676412|450378346|FG000|Overall Study|Withdrawal by Subject|0|||
125206126|NCT04676412|450378347|FG001|Overall Study|Withdrawal by Subject|2|||
125206127|NCT04697056|450378348|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
125206128|NCT04697056|450378349|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
125206129|NCT04439357|450378351|FG000|Overall Study|Disease Progression|4|||
125206130|NCT05906836|450378357|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
125206131|NCT05906836|450378357|FG000|Overall Study|Lost to Follow-up|1|||
125206132|NCT02542293|450378358|FG000|Overall Study|Death|367|||
125206133|NCT02542293|450378359|FG001|Overall Study|Death|377|||
125206134|NCT02542293|450378358|FG000|Overall Study|Withdrawal by Subject|8|||
125206135|NCT02542293|450378359|FG001|Overall Study|Withdrawal by Subject|19|||
125206136|NCT04529850|450378360|FG000|Overall Study|Death|2|||
125206137|NCT04529850|450378360|FG000|Overall Study|Physician Decision|1|||
125206138|NCT04529850|450378360|FG000|Overall Study|Withdrawal by Subject|2|||
125206139|NCT01458951|450378363|FG000|Overall Study|Other|1|||
125206140|NCT01458951|450378364|FG001|Overall Study|Other|0|||
125206141|NCT01458951|450378365|FG002|Overall Study|Other|0|||
125206142|NCT01458951|450378363|FG000|Overall Study|Protocol Violation|5|||
125206143|NCT01458951|450378364|FG001|Overall Study|Protocol Violation|1|||
125206144|NCT01458951|450378365|FG002|Overall Study|Protocol Violation|0|||
125206145|NCT01458951|450378363|FG000|Overall Study|Withdrawal by Subject|2|||
125206146|NCT01458951|450378364|FG001|Overall Study|Withdrawal by Subject|0|||
125206147|NCT01458951|450378365|FG002|Overall Study|Withdrawal by Subject|2|||
125206148|NCT01458951|450378363|FG000|Overall Study|Adverse Event|7|||
125206149|NCT01458951|450378364|FG001|Overall Study|Adverse Event|0|||
125206150|NCT01458951|450378365|FG002|Overall Study|Adverse Event|2|||
125206151|NCT01458951|450378363|FG000|Overall Study|Insufficient Clinical Response|17|||
125206152|NCT01458951|450378364|FG001|Overall Study|Insufficient Clinical Response|0|||
125206153|NCT01458951|450378365|FG002|Overall Study|Insufficient Clinical Response|11|||
125206154|NCT02963558|450378368|FG000|Overall Study|Withdrawn by investigator|1|||
125206155|NCT02963558|450378369|FG001|Overall Study|Withdrawn by investigator|0|||
125206156|NCT02963558|450378368|FG000|Overall Study|Withdrawal by Subject|0|||
125206157|NCT02963558|450378369|FG001|Overall Study|Withdrawal by Subject|1|||
125206158|NCT03309696|450378370|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
125206159|NCT03309696|450378371|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
125648976|NCT01674010|451997451|FG001|Open Treatment Phase 1|Physician Decision|0|||
125648977|NCT01674010|451997452|FG002|Open Treatment Phase 1|Physician Decision|0|||
125648978|NCT01674010|451997450|FG000|Open Treatment Phase 1|Protocol Violation|7|||
125648979|NCT01674010|451997451|FG001|Open Treatment Phase 1|Protocol Violation|0|||
125206160|NCT03309696|450378372|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
125206161|NCT03309696|450378373|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
125206162|NCT01573767|450378374|FG000|Overall Study|Adverse Event|0|||
125206163|NCT01573767|450378375|FG001|Overall Study|Adverse Event|1|||
125206164|NCT01573767|450378376|FG002|Overall Study|Adverse Event|0|||
125206165|NCT01573767|450378377|FG003|Overall Study|Adverse Event|1|||
125206166|NCT01573767|450378374|FG000|Overall Study|Lack of Efficacy|18|||
125206167|NCT01573767|450378375|FG001|Overall Study|Lack of Efficacy|15|||
125206168|NCT01573767|450378376|FG002|Overall Study|Lack of Efficacy|12|||
125206169|NCT01573767|450378377|FG003|Overall Study|Lack of Efficacy|17|||
125424879|NCT00430248|451178699|FG000|Overall Study|Reason Not Specified|8|||
125648980|NCT01674010|451997452|FG002|Open Treatment Phase 1|Protocol Violation|0|||
125206170|NCT01573767|450378374|FG000|Overall Study|Protocol Violation|3|||
125206171|NCT01573767|450378375|FG001|Overall Study|Protocol Violation|1|||
125206172|NCT01573767|450378376|FG002|Overall Study|Protocol Violation|1|||
125206173|NCT01573767|450378377|FG003|Overall Study|Protocol Violation|3|||
125206174|NCT01573767|450378374|FG000|Overall Study|Lost to Follow-up|0|||
125206175|NCT01573767|450378375|FG001|Overall Study|Lost to Follow-up|1|||
125206176|NCT01573767|450378376|FG002|Overall Study|Lost to Follow-up|1|||
125206177|NCT01573767|450378377|FG003|Overall Study|Lost to Follow-up|1|||
125206178|NCT01573767|450378374|FG000|Overall Study|Physician Decision|1|||
125206179|NCT01573767|450378375|FG001|Overall Study|Physician Decision|2|||
125206180|NCT01573767|450378376|FG002|Overall Study|Physician Decision|0|||
125206181|NCT01573767|450378377|FG003|Overall Study|Physician Decision|2|||
125206182|NCT01573767|450378374|FG000|Overall Study|Withdrawal by Subject|0|||
125206183|NCT01573767|450378375|FG001|Overall Study|Withdrawal by Subject|1|||
125206184|NCT01573767|450378376|FG002|Overall Study|Withdrawal by Subject|0|||
125206185|NCT01573767|450378377|FG003|Overall Study|Withdrawal by Subject|0|||
125206186|NCT02368210|450378378|FG000|Overall Study|Withdrawal by Subject|1|||
125206187|NCT02368210|450378379|FG001|Overall Study|Withdrawal by Subject|0|||
125206188|NCT02368210|450378378|FG000|Overall Study|Adverse Event|0|||
125206189|NCT02368210|450378379|FG001|Overall Study|Adverse Event|1|||
125206190|NCT00078949|450378380|FG000|Overall Study|No treated|4|||
125206191|NCT00078949|450378381|FG001|Overall Study|No treated|5|||
125206192|NCT00078949|450378382|FG002|Overall Study|No treated|3|||
125206193|NCT00078949|450378383|FG003|Overall Study|No treated|3|||
125206194|NCT01143064|450378384|FG000|Overall Study|Death|109|||
125206195|NCT01143064|450378385|FG001|Overall Study|Death|91|||
125206196|NCT01143064|450378384|FG000|Overall Study|Adverse Event|0|||
125206197|NCT01143064|450378385|FG001|Overall Study|Adverse Event|1|||
125206198|NCT01143064|450378384|FG000|Overall Study|Withdrawal by Subject|7|||
125206199|NCT01143064|450378385|FG001|Overall Study|Withdrawal by Subject|5|||
125206200|NCT01143064|450378384|FG000|Overall Study|Lost to Follow-up|17|||
125206201|NCT01143064|450378385|FG001|Overall Study|Lost to Follow-up|14|||
125206202|NCT01143064|450378384|FG000|Overall Study|Physician Decision|0|||
125206203|NCT01143064|450378385|FG001|Overall Study|Physician Decision|4|||
125206204|NCT01199822|450378391|FG000|Overall Study|Investigator discontinued therapy|0|||
125206205|NCT01199822|450378392|FG001|Overall Study|Investigator discontinued therapy|1|||
125206206|NCT01199822|450378393|FG002|Overall Study|Investigator discontinued therapy|0|||
125206207|NCT03747302|450378394|FG000|Overall Study|Withdrawal by Subject|1|||
125206208|NCT03747302|450378395|FG001|Overall Study|Withdrawal by Subject|2|||
125206209|NCT03769675|450378396|FG000|Overall Study|Lost to Follow-up|1|||
125206210|NCT01432275|450378399|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
125206211|NCT01432275|450378400|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
125206212|NCT01432275|450378399|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
125206213|NCT01432275|450378400|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
125206214|NCT01432275|450378399|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
125206215|NCT01432275|450378400|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
125206216|NCT01432275|450378399|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
125206217|NCT01432275|450378400|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
125206218|NCT01432275|450378399|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
125206219|NCT01432275|450378400|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
125206220|NCT01432275|450378399|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
125206221|NCT01432275|450378400|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
125206222|NCT01432275|450378399|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
125206223|NCT01432275|450378400|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
125206224|NCT01432275|450378399|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
125206225|NCT01432275|450378400|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
125206226|NCT01432275|450378399|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
125206227|NCT01432275|450378400|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
125206228|NCT02565706|450378401|FG000|Overall Study|Withdrawal by Subject|5|||
125206229|NCT02565706|450378402|FG001|Overall Study|Withdrawal by Subject|7|||
125206230|NCT02565706|450378403|FG002|Overall Study|Withdrawal by Subject|7|||
125206231|NCT02565706|450378404|FG003|Overall Study|Withdrawal by Subject|11|||
125206232|NCT02565706|450378401|FG000|Overall Study|Lost to Follow-up|72|||
125206233|NCT02565706|450378402|FG001|Overall Study|Lost to Follow-up|75|||
125206234|NCT02565706|450378403|FG002|Overall Study|Lost to Follow-up|82|||
125206235|NCT02565706|450378404|FG003|Overall Study|Lost to Follow-up|74|||
125206236|NCT01935700|450378405|FG000|Overall Study|Withdrawal by Subject|1|||
125206237|NCT01935700|450378406|FG001|Overall Study|Withdrawal by Subject|0|||
125206238|NCT01935700|450378405|FG000|Overall Study|Physician Decision|4|||
125206239|NCT01935700|450378406|FG001|Overall Study|Physician Decision|0|||
125206240|NCT03802565|450378412|FG000|Overall Study|Adverse Event|0|||
125206241|NCT03802565|450378413|FG001|Overall Study|Adverse Event|1|||
125206242|NCT03802565|450378414|FG002|Overall Study|Adverse Event|2|||
125206243|NCT03802565|450378415|FG003|Overall Study|Adverse Event|1|||
125206244|NCT03802565|450378416|FG004|Overall Study|Adverse Event|1|||
125206245|NCT03802565|450378412|FG000|Overall Study|Withdrawal by Subject|2|||
125206246|NCT03802565|450378413|FG001|Overall Study|Withdrawal by Subject|2|||
125206247|NCT03802565|450378414|FG002|Overall Study|Withdrawal by Subject|2|||
125206248|NCT03802565|450378415|FG003|Overall Study|Withdrawal by Subject|0|||
125206249|NCT03802565|450378416|FG004|Overall Study|Withdrawal by Subject|1|||
125206250|NCT03802565|450378412|FG000|Overall Study|Protocol Violation|2|||
125206251|NCT03802565|450378413|FG001|Overall Study|Protocol Violation|1|||
125206252|NCT03802565|450378414|FG002|Overall Study|Protocol Violation|4|||
125206253|NCT03802565|450378415|FG003|Overall Study|Protocol Violation|5|||
125206254|NCT03802565|450378416|FG004|Overall Study|Protocol Violation|1|||
125206255|NCT03802565|450378412|FG000|Overall Study|Lost to Follow-up|0|||
125206256|NCT03802565|450378413|FG001|Overall Study|Lost to Follow-up|0|||
125206257|NCT03802565|450378414|FG002|Overall Study|Lost to Follow-up|1|||
125206258|NCT03802565|450378415|FG003|Overall Study|Lost to Follow-up|0|||
125206259|NCT03802565|450378416|FG004|Overall Study|Lost to Follow-up|0|||
125206260|NCT03802565|450378412|FG000|Overall Study|Subjects Related to Each Other|1|||
125206261|NCT03802565|450378413|FG001|Overall Study|Subjects Related to Each Other|0|||
125206262|NCT03802565|450378414|FG002|Overall Study|Subjects Related to Each Other|0|||
125206263|NCT03802565|450378415|FG003|Overall Study|Subjects Related to Each Other|2|||
125206264|NCT03802565|450378416|FG004|Overall Study|Subjects Related to Each Other|1|||
125206265|NCT03802565|450378412|FG000|Overall Study|Elevated Enzymes|0|||
125206266|NCT03802565|450378413|FG001|Overall Study|Elevated Enzymes|0|||
125206267|NCT03802565|450378414|FG002|Overall Study|Elevated Enzymes|0|||
125206268|NCT03802565|450378415|FG003|Overall Study|Elevated Enzymes|0|||
125206269|NCT03802565|450378416|FG004|Overall Study|Elevated Enzymes|2|||
125206270|NCT02124759|450378417|FG000|Overall Study|Withdrawal by Subject|3|||
125206271|NCT02124759|450378418|FG001|Overall Study|Withdrawal by Subject|1|||
125206272|NCT02124759|450378419|FG002|Overall Study|Withdrawal by Subject|1|||
125206273|NCT02124759|450378417|FG000|Overall Study|Screen Fail|2|||
125206274|NCT02124759|450378418|FG001|Overall Study|Screen Fail|2|||
125206275|NCT02124759|450378419|FG002|Overall Study|Screen Fail|3|||
125206276|NCT01068626|450378420|FG000|Overall Study|Adverse Event|3|||
125206277|NCT01068626|450378421|FG001|Overall Study|Adverse Event|0|||
125206278|NCT01068626|450378420|FG000|Overall Study|Withdrawal by Subject|0|||
125206279|NCT01068626|450378421|FG001|Overall Study|Withdrawal by Subject|2|||
125206280|NCT04340843|450378422|FG000|Overall Study|Adverse Event|0|||
125206281|NCT04340843|450378423|FG001|Overall Study|Adverse Event|2|||
125206282|NCT04340843|450378422|FG000|Overall Study|Withdrawal by Subject|0|||
125206283|NCT04340843|450378423|FG001|Overall Study|Withdrawal by Subject|2|||
125206284|NCT04249622|450378424|FG000|Overall Study|Withdrawal by Subject|1|||
125206285|NCT04249622|450378425|FG001|Overall Study|Withdrawal by Subject|1|||
125206286|NCT04249622|450378424|FG000|Overall Study|Alternative therapy|1|||
125206287|NCT04249622|450378425|FG001|Overall Study|Alternative therapy|0|||
125206288|NCT04249622|450378424|FG000|Overall Study|Discontinuation of pertuzumab|1|||
125206289|NCT04249622|450378425|FG001|Overall Study|Discontinuation of pertuzumab|0|||
125206290|NCT03619902|450378428|FG000|Overall Study|Termination of Study by Investigator|1|||
125206291|NCT03619902|450378428|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
125206292|NCT04506905|450378429|FG000|Overall Study|Lost to Follow-up|1|||
125206293|NCT04506905|450378430|FG001|Overall Study|Lost to Follow-up|0|||
125206294|NCT04506905|450378431|FG002|Overall Study|Lost to Follow-up|0|||
125206295|NCT04506905|450378432|FG003|Overall Study|Lost to Follow-up|1|||
125206296|NCT04506905|450378433|FG004|Overall Study|Lost to Follow-up|0|||
125206297|NCT04506905|450378434|FG005|Overall Study|Lost to Follow-up|0|||
125206298|NCT04506905|450378435|FG006|Overall Study|Lost to Follow-up|0|||
125206299|NCT04506905|450378436|FG007|Overall Study|Lost to Follow-up|0|||
125206300|NCT04506905|450378437|FG008|Overall Study|Lost to Follow-up|0|||
125206301|NCT04506905|450378429|FG000|Overall Study|Withdrawal by Subject|0|||
125206302|NCT04506905|450378430|FG001|Overall Study|Withdrawal by Subject|0|||
125206303|NCT04506905|450378431|FG002|Overall Study|Withdrawal by Subject|0|||
125206304|NCT04506905|450378432|FG003|Overall Study|Withdrawal by Subject|2|||
125206305|NCT04506905|450378433|FG004|Overall Study|Withdrawal by Subject|0|||
125206306|NCT04506905|450378434|FG005|Overall Study|Withdrawal by Subject|0|||
125206307|NCT04506905|450378435|FG006|Overall Study|Withdrawal by Subject|0|||
125206308|NCT04506905|450378436|FG007|Overall Study|Withdrawal by Subject|0|||
125206309|NCT04506905|450378437|FG008|Overall Study|Withdrawal by Subject|0|||
125206310|NCT05072106|450379719|FG000|Overall Study|Progressive disease|3|||
125206311|NCT05072106|450379720|FG001|Overall Study|Progressive disease|3|||
125206312|NCT05072106|450379719|FG000|Overall Study|Compassionate use|3|||
125206313|NCT05072106|450379720|FG001|Overall Study|Compassionate use|1|||
125206314|NCT05072106|450379719|FG000|Overall Study|Withdrawal by Subject|1|||
125206315|NCT05072106|450379720|FG001|Overall Study|Withdrawal by Subject|0|||
125206316|NCT03839459|450379721|FG000|Overall Study|Withdrawal by Subject|2|||
125206317|NCT03839459|450379721|FG000|Overall Study|progression of disease|3|||
125206318|NCT01371877|450379725|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
125206319|NCT01371877|450379726|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
125206320|NCT00869557|450379727|FG000|Randomized Phase|Lost to Follow-up|2|||
125206321|NCT00869557|450379728|FG001|Randomized Phase|Lost to Follow-up|1|||
125206322|NCT00869557|450379727|FG000|Randomized Phase|Investigator's Discretion|1|||
125206323|NCT00869557|450379728|FG001|Randomized Phase|Investigator's Discretion|0|||
125206324|NCT00869557|450379727|FG000|Randomized Phase|Withdrew Consent|0|||
125206325|NCT00869557|450379728|FG001|Randomized Phase|Withdrew Consent|1|||
125206326|NCT00869557|450379727|FG000|Extension Phase|Adverse Event|2|||
125206327|NCT00869557|450379728|FG001|Extension Phase|Adverse Event|2|||
125206328|NCT00869557|450379727|FG000|Extension Phase|Lack of Efficacy|1|||
125206329|NCT00869557|450379728|FG001|Extension Phase|Lack of Efficacy|0|||
125206330|NCT00869557|450379727|FG000|Extension Phase|Lost to Follow-up|3|||
125206331|NCT00869557|450379728|FG001|Extension Phase|Lost to Follow-up|1|||
125206332|NCT00869557|450379727|FG000|Extension Phase|Investigator's Discretion|2|||
125206333|NCT00869557|450379728|FG001|Extension Phase|Investigator's Discretion|0|||
125206334|NCT00869557|450379727|FG000|Extension Phase|Withdrew Consent|2|||
125206335|NCT00869557|450379728|FG001|Extension Phase|Withdrew Consent|0|||
125206336|NCT05940077|450379729|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
125206337|NCT02304380|450379730|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
125206338|NCT02304380|450379731|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
125206339|NCT02304380|450379732|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
125206340|NCT02304380|450379733|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
125206341|NCT02304380|450379734|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
125206342|NCT02304380|450379735|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
125206343|NCT04027075|450379736|FG000|Overall Study|Lost to Follow-up|41|||
125206344|NCT04027075|450379737|FG001|Overall Study|Lost to Follow-up|22|||
125206345|NCT02772276|450379741|FG000|Overall Study|Lost to Follow-up|0|||
125206346|NCT02772276|450379742|FG001|Overall Study|Lost to Follow-up|0|||
125206347|NCT02772276|450379743|FG002|Overall Study|Lost to Follow-up|0|||
125206348|NCT02772276|450379744|FG003|Overall Study|Lost to Follow-up|0|||
125206349|NCT02772276|450379745|FG004|Overall Study|Lost to Follow-up|0|||
125206350|NCT02772276|450379746|FG005|Overall Study|Lost to Follow-up|0|||
125206351|NCT02772276|450379747|FG006|Overall Study|Lost to Follow-up|1|||
125206352|NCT02772276|450379748|FG007|Overall Study|Lost to Follow-up|0|||
125206353|NCT02772276|450379749|FG008|Overall Study|Lost to Follow-up|0|||
125206354|NCT02772276|450379750|FG009|Overall Study|Lost to Follow-up|0|||
125206355|NCT02772276|450379751|FG010|Overall Study|Lost to Follow-up|0|||
125206356|NCT02772276|450379752|FG011|Overall Study|Lost to Follow-up|0|||
125206357|NCT02772276|450379753|FG012|Overall Study|Lost to Follow-up|0|||
125206358|NCT02772276|450379741|FG000|Overall Study|Withdrew consent|0|||
125206359|NCT02772276|450379742|FG001|Overall Study|Withdrew consent|0|||
125206360|NCT02772276|450379743|FG002|Overall Study|Withdrew consent|0|||
125206361|NCT02772276|450379744|FG003|Overall Study|Withdrew consent|0|||
125206362|NCT02772276|450379745|FG004|Overall Study|Withdrew consent|0|||
125206363|NCT02772276|450379746|FG005|Overall Study|Withdrew consent|0|||
125206364|NCT02772276|450379747|FG006|Overall Study|Withdrew consent|0|||
125206365|NCT02772276|450379748|FG007|Overall Study|Withdrew consent|1|||
125206366|NCT02772276|450379749|FG008|Overall Study|Withdrew consent|0|||
125206367|NCT02772276|450379750|FG009|Overall Study|Withdrew consent|0|||
125206368|NCT02772276|450379751|FG010|Overall Study|Withdrew consent|0|||
125206369|NCT02772276|450379752|FG011|Overall Study|Withdrew consent|0|||
125206370|NCT02772276|450379753|FG012|Overall Study|Withdrew consent|0|||
125206371|NCT00455520|450379754|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
125206372|NCT00455520|450379755|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
125206373|NCT00455520|450379754|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
125206374|NCT00455520|450379755|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
125206375|NCT00455520|450379754|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
125206376|NCT00455520|450379755|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
125206377|NCT00455520|450379754|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
125206378|NCT00455520|450379755|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
125206379|NCT00455520|450379754|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
125206380|NCT00455520|450379755|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
125206381|NCT00455520|450379754|FG000|Open Label Tapentadol Extended Release|All other|33|||
125206382|NCT00455520|450379755|FG001|Open Label Tapentadol Extended Release|All other|0|||
125206383|NCT00455520|450379754|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
125206384|NCT00455520|450379755|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
125206385|NCT00455520|450379754|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
125206386|NCT00455520|450379755|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
125206387|NCT00455520|450379754|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
125206388|NCT00455520|450379755|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
125206389|NCT00455520|450379754|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
125206390|NCT00455520|450379755|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
125206391|NCT00455520|450379754|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
125206392|NCT00455520|450379755|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
125206393|NCT00455520|450379754|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
125206394|NCT00455520|450379755|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
125206395|NCT02248974|450379757|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
125206396|NCT02248974|450379758|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
125206397|NCT02248974|450379757|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
125206398|NCT02248974|450379758|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
125206399|NCT02248974|450379757|FG000|1-Day Follow-Up|Enrolled in another study|1|||
125206400|NCT02248974|450379758|FG001|1-Day Follow-Up|Enrolled in another study|0|||
125206401|NCT02248974|450379757|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
125206402|NCT02248974|450379758|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
125206403|NCT02248974|450379757|FG000|1-Week Follow-Up|Enrolled in another study|1|||
125206404|NCT02248974|450379758|FG001|1-Week Follow-Up|Enrolled in another study|1|||
125206405|NCT02248974|450379757|FG000|1-Week Follow-Up|Transferred to another facility|1|||
125206406|NCT02248974|450379758|FG001|1-Week Follow-Up|Transferred to another facility|0|||
125206407|NCT02248974|450379757|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
125206408|NCT02248974|450379758|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
125206409|NCT02248974|450379757|FG000|1-Week Follow-Up|Death|1|||
125206410|NCT02248974|450379758|FG001|1-Week Follow-Up|Death|1|||
125206411|NCT02248974|450379757|FG000|1-Week Follow-Up|Excluded because of age|0|||
125206412|NCT02248974|450379758|FG001|1-Week Follow-Up|Excluded because of age|1|||
125206413|NCT02248974|450379757|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
125206414|NCT02248974|450379758|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
125206415|NCT02248974|450379757|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
125206416|NCT02248974|450379758|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
125206417|NCT02248974|450379757|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
125206418|NCT02248974|450379758|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
125206419|NCT02248974|450379757|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
125206420|NCT02248974|450379758|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
125206421|NCT02248974|450379757|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
125206422|NCT02248974|450379758|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
125206423|NCT03448939|450379759|FG000|Overall Study|Adverse Event|5|||
125206424|NCT03448939|450379760|FG001|Overall Study|Adverse Event|1|||
125206425|NCT03448939|450379759|FG000|Overall Study|Lost to Follow-up|6|||
125206426|NCT03448939|450379760|FG001|Overall Study|Lost to Follow-up|6|||
125206427|NCT03448939|450379759|FG000|Overall Study|Pregnancy|1|||
125206428|NCT03448939|450379760|FG001|Overall Study|Pregnancy|1|||
125206429|NCT03448939|450379759|FG000|Overall Study|Withdrawal by Subject|9|||
125206430|NCT03448939|450379760|FG001|Overall Study|Withdrawal by Subject|3|||
125206431|NCT01472965|450379761|FG000|Overall Study|Withdrawal by Subject|1|||
125206432|NCT01472965|450379762|FG001|Overall Study|Withdrawal by Subject|0|||
125206433|NCT00628095|450379763|FG000|Overall Study|Adverse Event|5|||
125206434|NCT00628095|450379764|FG001|Overall Study|Adverse Event|3|||
125206435|NCT00628095|450379763|FG000|Overall Study|Lack of Efficacy|0|||
125206436|NCT00628095|450379764|FG001|Overall Study|Lack of Efficacy|3|||
125206437|NCT00628095|450379763|FG000|Overall Study|Withdrawal by Subject|2|||
125206438|NCT00628095|450379764|FG001|Overall Study|Withdrawal by Subject|0|||
125206439|NCT00628095|450379763|FG000|Overall Study|Other|0|||
125206440|NCT00628095|450379764|FG001|Overall Study|Other|1|||
125206441|NCT03235115|450379768|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
125206442|NCT03235115|450379769|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
125206443|NCT03235115|450379770|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
125206444|NCT03235115|450379771|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
125206445|NCT03235115|450379772|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
125206446|NCT03235115|450379773|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
125206447|NCT00006305|450379776|FG000|Overall Study|Withdrawal by Subject|17|||
125206448|NCT00006305|450379777|FG001|Overall Study|Withdrawal by Subject|10|||
125206449|NCT00006305|450379778|FG002|Overall Study|Withdrawal by Subject|15|||
125206450|NCT00006305|450379779|FG003|Overall Study|Withdrawal by Subject|14|||
125206451|NCT00662558|450379780|FG000|Overall Study|Adverse Event|21|||
125206452|NCT00662558|450379781|FG001|Overall Study|Adverse Event|59|||
125206453|NCT00662558|450379780|FG000|Overall Study|Lack of Efficacy|4|||
125206454|NCT00662558|450379781|FG001|Overall Study|Lack of Efficacy|7|||
125206455|NCT00662558|450379780|FG000|Overall Study|Lost to Follow-up|13|||
125206456|NCT00662558|450379781|FG001|Overall Study|Lost to Follow-up|10|||
125206457|NCT00662558|450379780|FG000|Overall Study|Other|9|||
125206458|NCT00662558|450379781|FG001|Overall Study|Other|14|||
125206459|NCT00662558|450379780|FG000|Overall Study|Withdrawal by Subject|7|||
125206460|NCT00662558|450379781|FG001|Overall Study|Withdrawal by Subject|12|||
125206461|NCT00662558|450379780|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
125206462|NCT00662558|450379781|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
125206463|NCT00329641|450379782|FG000|Overall Study|Did not start treatment|1|||
125206464|NCT00329641|450379782|FG000|Overall Study|Not eligible|1|||
125206465|NCT00329641|450379782|FG000|Overall Study|Adverse Event|3|||
125206466|NCT00329641|450379782|FG000|Overall Study|Other reason, not protocol specified|1|||
125206467|NCT00783224|450379783|FG000|Overall Study|Adverse Event|0|||
125206468|NCT00783224|450379784|FG001|Overall Study|Adverse Event|0|||
125206469|NCT00783224|450379785|FG002|Overall Study|Adverse Event|1|||
125206470|NCT00783224|450379786|FG003|Overall Study|Adverse Event|0|||
125206471|NCT00783224|450379783|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
125206472|NCT00783224|450379784|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
125206473|NCT00783224|450379785|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
125206474|NCT00783224|450379786|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
125206475|NCT00783224|450379783|FG000|Overall Study|Inappropriate as a study subject|0|||
125206476|NCT00783224|450379784|FG001|Overall Study|Inappropriate as a study subject|0|||
125206477|NCT00783224|450379785|FG002|Overall Study|Inappropriate as a study subject|0|||
125206478|NCT00783224|450379786|FG003|Overall Study|Inappropriate as a study subject|1|||
125206479|NCT01711619|450379787|FG000|Overall Study|Early study termination|10|||
125206480|NCT01711619|450379788|FG001|Overall Study|Early study termination|14|||
125206481|NCT01711619|450379787|FG000|Overall Study|Withdrawal by Subject|3|||
125206482|NCT01711619|450379788|FG001|Overall Study|Withdrawal by Subject|7|||
125206483|NCT01711619|450379787|FG000|Overall Study|Protocol Violation|2|||
125206484|NCT01711619|450379788|FG001|Overall Study|Protocol Violation|3|||
125206485|NCT01711619|450379787|FG000|Overall Study|Adverse Event|2|||
125206486|NCT01711619|450379788|FG001|Overall Study|Adverse Event|0|||
125206487|NCT01711619|450379787|FG000|Overall Study|Lost to Follow-up|1|||
125206488|NCT01711619|450379788|FG001|Overall Study|Lost to Follow-up|0|||
125206489|NCT00401960|450379795|FG000|Overall Study|Lost to Follow-up|3|||
125206490|NCT00401960|450379796|FG001|Overall Study|Lost to Follow-up|0|||
125206491|NCT00401960|450379795|FG000|Overall Study|Death|2|||
125206492|NCT00401960|450379796|FG001|Overall Study|Death|0|||
125206493|NCT02649426|450379797|FG000|Overall Study|Follow-up on going|1|||
125206494|NCT02649426|450379798|FG001|Overall Study|Follow-up on going|26|||
125206495|NCT02649426|450379799|FG002|Overall Study|Follow-up on going|28|||
125206496|NCT02649426|450379800|FG003|Overall Study|Follow-up on going|31|||
125206497|NCT02584959|450379801|FG000|Period 1|Withdrawn from study|3|||
125206498|NCT02584959|450379802|FG001|Period 1|Withdrawn from study|4|||
125206499|NCT02584959|450379803|FG002|Period 1|Withdrawn from study|0|||
125206500|NCT02584959|450379801|FG000|Period 2|Withdrawn from study|6|||
125206501|NCT02584959|450379802|FG001|Period 2|Withdrawn from study|1|||
125206502|NCT02584959|450379803|FG002|Period 2|Withdrawn from study|2|||
125206503|NCT03008278|450379806|FG000|Overall Study|Progressive Disease|0|||
125206504|NCT03008278|450379807|FG001|Overall Study|Progressive Disease|0|||
125206505|NCT03008278|450379808|FG002|Overall Study|Progressive Disease|32|||
125206506|NCT03008278|450379806|FG000|Overall Study|Adverse Event|0|||
125206507|NCT03008278|450379807|FG001|Overall Study|Adverse Event|0|||
125206508|NCT03008278|450379808|FG002|Overall Study|Adverse Event|4|||
125206509|NCT03008278|450379806|FG000|Overall Study|Withdrawal by Subject|0|||
125206510|NCT03008278|450379807|FG001|Overall Study|Withdrawal by Subject|0|||
125206511|NCT03008278|450379808|FG002|Overall Study|Withdrawal by Subject|3|||
125206512|NCT03008278|450379806|FG000|Overall Study|Physician Decision|0|||
125206513|NCT03008278|450379807|FG001|Overall Study|Physician Decision|2|||
125206514|NCT03008278|450379808|FG002|Overall Study|Physician Decision|0|||
125206515|NCT00195494|450379809|FG000|Year 1|Adverse Event|0|||
125206516|NCT00195494|450379810|FG001|Year 1|Adverse Event|0|||
125206517|NCT00195494|450379811|FG002|Year 1|Adverse Event|0|||
125206518|NCT00195494|450379812|FG003|Year 1|Adverse Event|0|||
125206519|NCT00195494|450379813|FG004|Year 1|Adverse Event|34|||
125206520|NCT00195494|450379814|FG005|Year 1|Adverse Event|27|||
125206521|NCT00195494|450379809|FG000|Year 1|System Toxicity|0|||
125206522|NCT00195494|450379810|FG001|Year 1|System Toxicity|0|||
125206523|NCT00195494|450379811|FG002|Year 1|System Toxicity|0|||
125206524|NCT00195494|450379812|FG003|Year 1|System Toxicity|0|||
125206525|NCT00195494|450379813|FG004|Year 1|System Toxicity|0|||
125206526|NCT00195494|450379814|FG005|Year 1|System Toxicity|1|||
125206527|NCT00195494|450379809|FG000|Year 1|Lack of Efficacy|0|||
125206528|NCT00195494|450379810|FG001|Year 1|Lack of Efficacy|0|||
125206529|NCT00195494|450379811|FG002|Year 1|Lack of Efficacy|0|||
125206530|NCT00195494|450379812|FG003|Year 1|Lack of Efficacy|0|||
125206531|NCT00195494|450379813|FG004|Year 1|Lack of Efficacy|24|||
125206532|NCT00195494|450379814|FG005|Year 1|Lack of Efficacy|9|||
125206533|NCT00195494|450379809|FG000|Year 1|Compliance|0|||
125206534|NCT00195494|450379810|FG001|Year 1|Compliance|0|||
125206535|NCT00195494|450379811|FG002|Year 1|Compliance|0|||
125206536|NCT00195494|450379812|FG003|Year 1|Compliance|0|||
125206537|NCT00195494|450379813|FG004|Year 1|Compliance|5|||
125206538|NCT00195494|450379814|FG005|Year 1|Compliance|1|||
125206539|NCT00195494|450379809|FG000|Year 1|Lost to Follow-up|0|||
125206540|NCT00195494|450379810|FG001|Year 1|Lost to Follow-up|0|||
125206541|NCT00195494|450379811|FG002|Year 1|Lost to Follow-up|0|||
125206542|NCT00195494|450379812|FG003|Year 1|Lost to Follow-up|0|||
125206543|NCT00195494|450379813|FG004|Year 1|Lost to Follow-up|1|||
125206544|NCT00195494|450379814|FG005|Year 1|Lost to Follow-up|0|||
125206545|NCT00195494|450379809|FG000|Year 1|Missed >4 consecutive doses|0|||
125206546|NCT00195494|450379810|FG001|Year 1|Missed >4 consecutive doses|0|||
125206547|NCT00195494|450379811|FG002|Year 1|Missed >4 consecutive doses|0|||
125206548|NCT00195494|450379812|FG003|Year 1|Missed >4 consecutive doses|0|||
125206549|NCT00195494|450379813|FG004|Year 1|Missed >4 consecutive doses|3|||
125206550|NCT00195494|450379814|FG005|Year 1|Missed >4 consecutive doses|2|||
125206551|NCT00195494|450379809|FG000|Year 1|Protocol deviation|0|||
125206552|NCT00195494|450379810|FG001|Year 1|Protocol deviation|0|||
125206553|NCT00195494|450379811|FG002|Year 1|Protocol deviation|0|||
125206554|NCT00195494|450379812|FG003|Year 1|Protocol deviation|0|||
125206555|NCT00195494|450379813|FG004|Year 1|Protocol deviation|2|||
125206556|NCT00195494|450379814|FG005|Year 1|Protocol deviation|3|||
125206557|NCT00195494|450379809|FG000|Year 1|Physician Decision|0|||
125206558|NCT00195494|450379810|FG001|Year 1|Physician Decision|0|||
125206559|NCT00195494|450379811|FG002|Year 1|Physician Decision|0|||
125206560|NCT00195494|450379812|FG003|Year 1|Physician Decision|0|||
125206561|NCT00195494|450379813|FG004|Year 1|Physician Decision|1|||
125206562|NCT00195494|450379814|FG005|Year 1|Physician Decision|0|||
125206563|NCT00195494|450379809|FG000|Year 1|Withdrawal by Subject|0|||
125206564|NCT00195494|450379810|FG001|Year 1|Withdrawal by Subject|0|||
125206565|NCT00195494|450379811|FG002|Year 1|Withdrawal by Subject|0|||
125206566|NCT00195494|450379812|FG003|Year 1|Withdrawal by Subject|0|||
125206567|NCT00195494|450379813|FG004|Year 1|Withdrawal by Subject|8|||
125206568|NCT00195494|450379814|FG005|Year 1|Withdrawal by Subject|9|||
125206569|NCT00195494|450379809|FG000|Year 1|Protocol Violation|0|||
125206570|NCT00195494|450379810|FG001|Year 1|Protocol Violation|0|||
125206571|NCT00195494|450379811|FG002|Year 1|Protocol Violation|0|||
125206572|NCT00195494|450379812|FG003|Year 1|Protocol Violation|0|||
125206573|NCT00195494|450379813|FG004|Year 1|Protocol Violation|1|||
125206574|NCT00195494|450379814|FG005|Year 1|Protocol Violation|1|||
125206575|NCT00195494|450379809|FG000|Year 2|Adverse Event|3|||
125206576|NCT00195494|450379810|FG001|Year 2|Adverse Event|7|||
125206577|NCT00195494|450379811|FG002|Year 2|Adverse Event|5|||
125206578|NCT00195494|450379812|FG003|Year 2|Adverse Event|9|||
125206579|NCT00195494|450379813|FG004|Year 2|Adverse Event|0|||
125206580|NCT00195494|450379814|FG005|Year 2|Adverse Event|0|||
125206581|NCT00195494|450379809|FG000|Year 2|Lack of Efficacy|0|||
125206582|NCT00195494|450379810|FG001|Year 2|Lack of Efficacy|1|||
125206583|NCT00195494|450379811|FG002|Year 2|Lack of Efficacy|7|||
125206584|NCT00195494|450379812|FG003|Year 2|Lack of Efficacy|7|||
125206585|NCT00195494|450379813|FG004|Year 2|Lack of Efficacy|0|||
125206586|NCT00195494|450379814|FG005|Year 2|Lack of Efficacy|0|||
125206587|NCT00195494|450379809|FG000|Year 2|Compliance|1|||
125206588|NCT00195494|450379810|FG001|Year 2|Compliance|0|||
125206589|NCT00195494|450379811|FG002|Year 2|Compliance|0|||
125206590|NCT00195494|450379812|FG003|Year 2|Compliance|2|||
125206591|NCT00195494|450379813|FG004|Year 2|Compliance|0|||
125206592|NCT00195494|450379814|FG005|Year 2|Compliance|0|||
125206593|NCT00195494|450379809|FG000|Year 2|Lost to Follow-up|0|||
125206594|NCT00195494|450379810|FG001|Year 2|Lost to Follow-up|0|||
125206595|NCT00195494|450379811|FG002|Year 2|Lost to Follow-up|1|||
125206596|NCT00195494|450379812|FG003|Year 2|Lost to Follow-up|1|||
125206597|NCT00195494|450379813|FG004|Year 2|Lost to Follow-up|0|||
125206598|NCT00195494|450379814|FG005|Year 2|Lost to Follow-up|0|||
125206599|NCT00195494|450379809|FG000|Year 2|Missed >4 consecutive doses|1|||
125206600|NCT00195494|450379810|FG001|Year 2|Missed >4 consecutive doses|1|||
125206601|NCT00195494|450379811|FG002|Year 2|Missed >4 consecutive doses|1|||
125206602|NCT00195494|450379812|FG003|Year 2|Missed >4 consecutive doses|0|||
125206603|NCT00195494|450379813|FG004|Year 2|Missed >4 consecutive doses|0|||
125206604|NCT00195494|450379814|FG005|Year 2|Missed >4 consecutive doses|0|||
125206605|NCT00195494|450379809|FG000|Year 2|Protocol deviation|0|||
125206606|NCT00195494|450379810|FG001|Year 2|Protocol deviation|1|||
125206607|NCT00195494|450379811|FG002|Year 2|Protocol deviation|0|||
125206608|NCT00195494|450379812|FG003|Year 2|Protocol deviation|0|||
125206609|NCT00195494|450379813|FG004|Year 2|Protocol deviation|0|||
125206610|NCT00195494|450379814|FG005|Year 2|Protocol deviation|0|||
125206611|NCT00195494|450379809|FG000|Year 2|Physician Decision|1|||
125206612|NCT00195494|450379810|FG001|Year 2|Physician Decision|1|||
125206613|NCT00195494|450379811|FG002|Year 2|Physician Decision|0|||
125206614|NCT00195494|450379812|FG003|Year 2|Physician Decision|0|||
125206615|NCT00195494|450379813|FG004|Year 2|Physician Decision|0|||
125206616|NCT00195494|450379814|FG005|Year 2|Physician Decision|0|||
125206617|NCT00195494|450379809|FG000|Year 2|Withdrawal by Subject|1|||
125648981|NCT01674010|451997450|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
125648982|NCT01674010|451997451|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
125206618|NCT00195494|450379810|FG001|Year 2|Withdrawal by Subject|5|||
125206619|NCT00195494|450379811|FG002|Year 2|Withdrawal by Subject|4|||
125206620|NCT00195494|450379812|FG003|Year 2|Withdrawal by Subject|3|||
125206621|NCT00195494|450379813|FG004|Year 2|Withdrawal by Subject|0|||
125206622|NCT00195494|450379814|FG005|Year 2|Withdrawal by Subject|0|||
125206623|NCT00195494|450379809|FG000|Year 2|System toxicity|0|||
125206624|NCT00195494|450379810|FG001|Year 2|System toxicity|0|||
125206625|NCT00195494|450379811|FG002|Year 2|System toxicity|0|||
125206626|NCT00195494|450379812|FG003|Year 2|System toxicity|1|||
125206627|NCT00195494|450379813|FG004|Year 2|System toxicity|0|||
125206628|NCT00195494|450379814|FG005|Year 2|System toxicity|0|||
125206629|NCT00513357|450379815|FG000|Overall Study|did not receive allocated placebo|2|||
125206630|NCT00513357|450379816|FG001|Overall Study|did not receive allocated placebo|3|||
125206631|NCT00513357|450379815|FG000|Overall Study|Adverse Event|4|||
125206632|NCT00513357|450379816|FG001|Overall Study|Adverse Event|2|||
125206633|NCT00513357|450379815|FG000|Overall Study|Death|2|||
125206634|NCT00513357|450379816|FG001|Overall Study|Death|0|||
125206635|NCT00513357|450379815|FG000|Overall Study|Withdrawal by Subject|5|||
125206636|NCT00513357|450379816|FG001|Overall Study|Withdrawal by Subject|4|||
125206637|NCT00513357|450379815|FG000|Overall Study|Disease Progression|2|||
125206638|NCT00513357|450379816|FG001|Overall Study|Disease Progression|1|||
125206639|NCT01217385|450379821|FG000|Overall Study|Withdrawal by Subject|3|||
125206640|NCT01217385|450379821|FG000|Overall Study|DOSI not performed/not eval|12|||
125206641|NCT01217385|450379821|FG000|Overall Study|Central Path not Available|1|||
125206642|NCT01217385|450379821|FG000|Overall Study|Normal Breast TOI not available|10|||
125206643|NCT00090987|450379822|FG000|Overall Study|Adverse Event|5|||
125206644|NCT00090987|450379822|FG000|Overall Study|Lack of Efficacy|7|||
125206645|NCT00090987|450379822|FG000|Overall Study|Withdrawal by Subject|3|||
125206646|NCT00090987|450379822|FG000|Overall Study|alternative therapy|1|||
125206647|NCT00090987|450379822|FG000|Overall Study|Non-compliance|4|||
125206648|NCT00090987|450379822|FG000|Overall Study|Incarcerated|1|||
125206649|NCT00835679|450379824|FG000|Overall Study|Withdrawal by Subject|1|||
125206650|NCT00835679|450379825|FG001|Overall Study|Withdrawal by Subject|0|||
125206651|NCT00835679|450379826|FG002|Overall Study|Withdrawal by Subject|0|||
125206652|NCT00835679|450379827|FG003|Overall Study|Withdrawal by Subject|0|||
125206653|NCT04769739|450379829|FG000|Overall Study|Colorectal cancer obstruction|2|||
125206654|NCT04769739|450379830|FG001|Overall Study|Colorectal cancer obstruction|0|||
125206655|NCT04769739|450379831|FG002|Overall Study|Colorectal cancer obstruction|0|||
125206656|NCT04769739|450379832|FG003|Overall Study|Colorectal cancer obstruction|0|||
125206657|NCT04769739|450379829|FG000|Overall Study|Failed cecal intubation|1|||
125206658|NCT04769739|450379830|FG001|Overall Study|Failed cecal intubation|0|||
125206659|NCT04769739|450379831|FG002|Overall Study|Failed cecal intubation|0|||
125206660|NCT04769739|450379832|FG003|Overall Study|Failed cecal intubation|1|||
125206661|NCT04769739|450379829|FG000|Overall Study|Poor bowel preparation|0|||
125206662|NCT04769739|450379830|FG001|Overall Study|Poor bowel preparation|0|||
125206663|NCT04769739|450379831|FG002|Overall Study|Poor bowel preparation|0|||
125206664|NCT04769739|450379832|FG003|Overall Study|Poor bowel preparation|1|||
125206665|NCT03689543|450379834|FG000|Overall Study|Adverse Event|0|||
125206666|NCT03689543|450379835|FG001|Overall Study|Adverse Event|0|||
125206667|NCT03689543|450379836|FG002|Overall Study|Adverse Event|1|||
125206668|NCT01634659|450379854|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
125206669|NCT01634659|450379855|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
125206670|NCT01634659|450379854|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
125206671|NCT01634659|450379855|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
125206672|NCT02431806|450379856|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
125206673|NCT02431806|450379857|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
125206674|NCT02431806|450379858|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
125206675|NCT02431806|450379859|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
125206676|NCT02431806|450379856|FG000|Double-blind Treatment Period|Adverse Event|4|||
125206677|NCT02431806|450379857|FG001|Double-blind Treatment Period|Adverse Event|7|||
125206678|NCT02431806|450379858|FG002|Double-blind Treatment Period|Adverse Event|11|||
125206679|NCT02431806|450379859|FG003|Double-blind Treatment Period|Adverse Event|7|||
125206680|NCT02431806|450379856|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
125206681|NCT02431806|450379857|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
125206682|NCT02431806|450379858|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
125206683|NCT02431806|450379859|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
125206684|NCT02431806|450379856|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
125206685|NCT02431806|450379857|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
125206686|NCT02431806|450379858|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
125206687|NCT02431806|450379859|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
125206688|NCT02431806|450379856|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
125206689|NCT02431806|450379857|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
125206690|NCT02431806|450379858|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
125206691|NCT02431806|450379859|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
125206692|NCT02431806|450379856|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
125206693|NCT02431806|450379857|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
125206694|NCT02431806|450379858|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
125206695|NCT02431806|450379859|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
125206696|NCT02431806|450379856|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
125206697|NCT02431806|450379857|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
125206698|NCT02431806|450379858|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
125206699|NCT02431806|450379859|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
125206700|NCT03627416|450379860|FG000|Overall Study|Adverse Event|0|||
125206701|NCT03627416|450379861|FG001|Overall Study|Adverse Event|1|||
125206702|NCT02968433|450379862|FG000|Overall Study|Withdrawal by Subject|1|||
125206703|NCT02079636|450379863|FG000|Overall Study|Death|2|||
125206704|NCT02079636|450379864|FG001|Overall Study|Death|1|||
125206705|NCT02079636|450379865|FG002|Overall Study|Death|0|||
125206706|NCT02079636|450379866|FG003|Overall Study|Death|5|||
125206707|NCT02079636|450379867|FG004|Overall Study|Death|1|||
125206708|NCT02079636|450379868|FG005|Overall Study|Death|2|||
125206709|NCT02079636|450379869|FG006|Overall Study|Death|1|||
125206710|NCT02079636|450379870|FG007|Overall Study|Death|0|||
125206711|NCT02079636|450379871|FG008|Overall Study|Death|0|||
125206712|NCT02079636|450379872|FG009|Overall Study|Death|0|||
125206713|NCT02079636|450379873|FG010|Overall Study|Death|0|||
125206714|NCT02079636|450379874|FG011|Overall Study|Death|1|||
125206715|NCT02079636|450379875|FG012|Overall Study|Death|1|||
125206716|NCT02079636|450379876|FG013|Overall Study|Death|0|||
125206717|NCT02079636|450379877|FG014|Overall Study|Death|2|||
125206718|NCT02079636|450379863|FG000|Overall Study|Adverse Event|1|||
125206719|NCT02079636|450379864|FG001|Overall Study|Adverse Event|1|||
125206720|NCT02079636|450379865|FG002|Overall Study|Adverse Event|0|||
125206721|NCT02079636|450379866|FG003|Overall Study|Adverse Event|1|||
125206722|NCT02079636|450379867|FG004|Overall Study|Adverse Event|1|||
125206723|NCT02079636|450379868|FG005|Overall Study|Adverse Event|2|||
125206724|NCT02079636|450379869|FG006|Overall Study|Adverse Event|0|||
125206725|NCT02079636|450379870|FG007|Overall Study|Adverse Event|0|||
125206726|NCT02079636|450379871|FG008|Overall Study|Adverse Event|0|||
125206727|NCT02079636|450379872|FG009|Overall Study|Adverse Event|0|||
125206728|NCT02079636|450379873|FG010|Overall Study|Adverse Event|0|||
125206729|NCT02079636|450379874|FG011|Overall Study|Adverse Event|0|||
125206730|NCT02079636|450379875|FG012|Overall Study|Adverse Event|0|||
125206731|NCT02079636|450379876|FG013|Overall Study|Adverse Event|0|||
125206732|NCT02079636|450379877|FG014|Overall Study|Adverse Event|0|||
125206733|NCT02079636|450379863|FG000|Overall Study|Progressive disease|0|||
125206734|NCT02079636|450379864|FG001|Overall Study|Progressive disease|0|||
125206735|NCT02079636|450379865|FG002|Overall Study|Progressive disease|0|||
125206736|NCT02079636|450379866|FG003|Overall Study|Progressive disease|2|||
125206737|NCT02079636|450379867|FG004|Overall Study|Progressive disease|0|||
125206738|NCT02079636|450379868|FG005|Overall Study|Progressive disease|0|||
125206739|NCT02079636|450379869|FG006|Overall Study|Progressive disease|0|||
125206740|NCT02079636|450379870|FG007|Overall Study|Progressive disease|0|||
125206741|NCT02079636|450379871|FG008|Overall Study|Progressive disease|0|||
125206742|NCT02079636|450379872|FG009|Overall Study|Progressive disease|0|||
125206743|NCT02079636|450379873|FG010|Overall Study|Progressive disease|0|||
125206744|NCT02079636|450379874|FG011|Overall Study|Progressive disease|0|||
125206745|NCT02079636|450379875|FG012|Overall Study|Progressive disease|1|||
125206746|NCT02079636|450379876|FG013|Overall Study|Progressive disease|0|||
125206747|NCT02079636|450379877|FG014|Overall Study|Progressive disease|0|||
125206748|NCT02079636|450379863|FG000|Overall Study|Withdrawal by Subject|0|||
125206749|NCT02079636|450379864|FG001|Overall Study|Withdrawal by Subject|0|||
125206750|NCT02079636|450379865|FG002|Overall Study|Withdrawal by Subject|0|||
125206751|NCT02079636|450379866|FG003|Overall Study|Withdrawal by Subject|4|||
125206752|NCT02079636|450379867|FG004|Overall Study|Withdrawal by Subject|0|||
125206753|NCT02079636|450379868|FG005|Overall Study|Withdrawal by Subject|1|||
125206754|NCT02079636|450379869|FG006|Overall Study|Withdrawal by Subject|0|||
125206755|NCT02079636|450379870|FG007|Overall Study|Withdrawal by Subject|0|||
125206756|NCT02079636|450379871|FG008|Overall Study|Withdrawal by Subject|0|||
125206757|NCT02079636|450379872|FG009|Overall Study|Withdrawal by Subject|2|||
125206758|NCT02079636|450379873|FG010|Overall Study|Withdrawal by Subject|1|||
125206759|NCT02079636|450379874|FG011|Overall Study|Withdrawal by Subject|1|||
125206760|NCT02079636|450379875|FG012|Overall Study|Withdrawal by Subject|1|||
125206761|NCT02079636|450379876|FG013|Overall Study|Withdrawal by Subject|0|||
125206762|NCT02079636|450379877|FG014|Overall Study|Withdrawal by Subject|2|||
125206763|NCT02079636|450379863|FG000|Overall Study|Physician Decision|0|||
125206764|NCT02079636|450379864|FG001|Overall Study|Physician Decision|0|||
125206765|NCT02079636|450379865|FG002|Overall Study|Physician Decision|0|||
125206766|NCT02079636|450379866|FG003|Overall Study|Physician Decision|0|||
125206767|NCT02079636|450379867|FG004|Overall Study|Physician Decision|0|||
125206768|NCT02079636|450379868|FG005|Overall Study|Physician Decision|1|||
125206769|NCT02079636|450379869|FG006|Overall Study|Physician Decision|0|||
125206770|NCT02079636|450379870|FG007|Overall Study|Physician Decision|0|||
125206771|NCT02079636|450379871|FG008|Overall Study|Physician Decision|0|||
125206772|NCT02079636|450379872|FG009|Overall Study|Physician Decision|1|||
125206773|NCT02079636|450379873|FG010|Overall Study|Physician Decision|1|||
125206774|NCT02079636|450379874|FG011|Overall Study|Physician Decision|0|||
125206775|NCT02079636|450379875|FG012|Overall Study|Physician Decision|0|||
125206776|NCT02079636|450379876|FG013|Overall Study|Physician Decision|0|||
125206777|NCT02079636|450379877|FG014|Overall Study|Physician Decision|1|||
125206778|NCT02079636|450379863|FG000|Overall Study|Lost to Follow-up|0|||
125206779|NCT02079636|450379864|FG001|Overall Study|Lost to Follow-up|0|||
125206780|NCT02079636|450379865|FG002|Overall Study|Lost to Follow-up|0|||
125206781|NCT02079636|450379866|FG003|Overall Study|Lost to Follow-up|0|||
125206782|NCT02079636|450379867|FG004|Overall Study|Lost to Follow-up|0|||
125206783|NCT02079636|450379868|FG005|Overall Study|Lost to Follow-up|0|||
125206784|NCT02079636|450379869|FG006|Overall Study|Lost to Follow-up|0|||
125206785|NCT02079636|450379870|FG007|Overall Study|Lost to Follow-up|1|||
125206786|NCT02079636|450379871|FG008|Overall Study|Lost to Follow-up|0|||
125206787|NCT02079636|450379872|FG009|Overall Study|Lost to Follow-up|0|||
125206788|NCT02079636|450379873|FG010|Overall Study|Lost to Follow-up|0|||
125206789|NCT02079636|450379874|FG011|Overall Study|Lost to Follow-up|0|||
125206790|NCT02079636|450379875|FG012|Overall Study|Lost to Follow-up|0|||
125206791|NCT02079636|450379876|FG013|Overall Study|Lost to Follow-up|0|||
125206792|NCT02079636|450379877|FG014|Overall Study|Lost to Follow-up|0|||
125206793|NCT00875433|450379878|FG000|Overall Study|Progressive disease|41|||
125206794|NCT00875433|450379878|FG000|Overall Study|Other Adverse Event|14|||
125206795|NCT00875433|450379878|FG000|Overall Study|Withdrawal by Subject|2|||
125206796|NCT00875433|450379878|FG000|Overall Study|Other|3|||
125206797|NCT00622336|450379879|FG000|Treatment Phase|Progression of Disease|181|||
125206798|NCT00622336|450379879|FG000|Treatment Phase|Adverse Event|46|||
125206799|NCT00622336|450379879|FG000|Treatment Phase|Other|40|||
125206800|NCT00622336|450379879|FG000|Treatment Phase|Death|14|||
125206801|NCT00622336|450379879|FG000|Treatment Phase|Lack of therapeutic effect|13|||
125206802|NCT00622336|450379879|FG000|Treatment Phase|Withdrawal by Subject|13|||
125206803|NCT00622336|450379879|FG000|Treatment Phase|Lost to Follow-up|2|||
125206804|NCT00622336|450379879|FG000|Extension Phase|Adverse Event|2|||
125206805|NCT00622336|450379879|FG000|Extension Phase|Progressive Disease|6|||
125206806|NCT00622336|450379879|FG000|Extension Phase|Lack of therapeutic effect|2|||
125206807|NCT00622336|450379879|FG000|Extension Phase|Withdrawal by Subject|1|||
125206808|NCT00622336|450379879|FG000|Extension Phase|Lost to Follow-up|1|||
125206809|NCT00622336|450379879|FG000|Extension Phase|Other|9|||
125206810|NCT04148287|450379881|FG000|Overall Study|Death|2|||
125206811|NCT03912428|450379882|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
125206812|NCT03912428|450379883|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
125206813|NCT03912428|450379884|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
125206814|NCT03912428|450379885|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
125206815|NCT03912428|450379882|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
125206816|NCT03912428|450379883|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
125206817|NCT03912428|450379884|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
125206818|NCT03912428|450379885|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
125206819|NCT03912428|450379882|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
125206820|NCT03912428|450379883|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
125206821|NCT03912428|450379884|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
125206822|NCT03912428|450379885|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
125206823|NCT01777139|450381472|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
125206824|NCT01777139|450381473|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
125206825|NCT01777139|450381472|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
125206826|NCT01777139|450381473|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
125206827|NCT01777139|450381472|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
125206828|NCT01777139|450381473|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
125206829|NCT01777139|450381472|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
125206830|NCT01777139|450381473|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
125206831|NCT01777139|450381472|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
125206832|NCT01777139|450381473|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
125206833|NCT01777139|450381472|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
125206834|NCT01777139|450381473|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
125206835|NCT01777139|450381472|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
125206836|NCT01777139|450381473|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
125206837|NCT01777139|450381472|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
125206838|NCT01777139|450381473|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
125206839|NCT05625477|450381474|FG000|Overall Study|Lost to Follow-up|2|||
125206840|NCT05625477|450381475|FG001|Overall Study|Lost to Follow-up|2|||
125206841|NCT05625477|450381476|FG002|Overall Study|Lost to Follow-up|1|||
125206842|NCT05625477|450381477|FG003|Overall Study|Lost to Follow-up|1|||
125206843|NCT05625477|450381478|FG004|Overall Study|Lost to Follow-up|0|||
125206844|NCT05625477|450381474|FG000|Overall Study|Covid quarantine|1|||
125206845|NCT05625477|450381475|FG001|Overall Study|Covid quarantine|0|||
125206846|NCT05625477|450381476|FG002|Overall Study|Covid quarantine|0|||
125206847|NCT05625477|450381477|FG003|Overall Study|Covid quarantine|0|||
125648983|NCT01674010|451997452|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
125648984|NCT01674010|451997450|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
125206848|NCT05625477|450381478|FG004|Overall Study|Covid quarantine|0|||
125206849|NCT02502266|450381479|FG000|Overall Study|Adverse Event|0|||
125206850|NCT02502266|450381480|FG001|Overall Study|Adverse Event|0|||
125206851|NCT02502266|450381481|FG002|Overall Study|Adverse Event|0|||
125206852|NCT02502266|450381482|FG003|Overall Study|Adverse Event|0|||
125206853|NCT02502266|450381483|FG004|Overall Study|Adverse Event|1|||
125206854|NCT02502266|450381484|FG005|Overall Study|Adverse Event|1|||
125206855|NCT02502266|450381485|FG006|Overall Study|Adverse Event|1|||
125206856|NCT02502266|450381479|FG000|Overall Study|Withdrawal by Subject|30|||
125206857|NCT02502266|450381480|FG001|Overall Study|Withdrawal by Subject|15|||
125206858|NCT02502266|450381481|FG002|Overall Study|Withdrawal by Subject|16|||
125206859|NCT02502266|450381482|FG003|Overall Study|Withdrawal by Subject|0|||
125206860|NCT02502266|450381483|FG004|Overall Study|Withdrawal by Subject|0|||
125206861|NCT02502266|450381484|FG005|Overall Study|Withdrawal by Subject|0|||
125206862|NCT02502266|450381485|FG006|Overall Study|Withdrawal by Subject|0|||
125206863|NCT02502266|450381479|FG000|Overall Study|Still on Treatment|0|||
125206864|NCT02502266|450381480|FG001|Overall Study|Still on Treatment|0|||
125206865|NCT02502266|450381481|FG002|Overall Study|Still on Treatment|1|||
125206866|NCT02502266|450381482|FG003|Overall Study|Still on Treatment|0|||
125206867|NCT02502266|450381483|FG004|Overall Study|Still on Treatment|0|||
125206868|NCT02502266|450381484|FG005|Overall Study|Still on Treatment|0|||
125206869|NCT02502266|450381485|FG006|Overall Study|Still on Treatment|0|||
125206870|NCT02502266|450381479|FG000|Overall Study|Other Reasons|19|||
125206871|NCT02502266|450381480|FG001|Overall Study|Other Reasons|6|||
125206872|NCT02502266|450381481|FG002|Overall Study|Other Reasons|14|||
125206873|NCT02502266|450381482|FG003|Overall Study|Other Reasons|0|||
125206874|NCT02502266|450381483|FG004|Overall Study|Other Reasons|1|||
125206875|NCT02502266|450381484|FG005|Overall Study|Other Reasons|1|||
125206876|NCT02502266|450381485|FG006|Overall Study|Other Reasons|0|||
125206877|NCT02502266|450381479|FG000|Overall Study|Arm 4 Discontinued|0|||
125206878|NCT02502266|450381480|FG001|Overall Study|Arm 4 Discontinued|0|||
125206879|NCT02502266|450381481|FG002|Overall Study|Arm 4 Discontinued|0|||
125206880|NCT02502266|450381482|FG003|Overall Study|Arm 4 Discontinued|52|||
125206881|NCT02502266|450381483|FG004|Overall Study|Arm 4 Discontinued|0|||
125206882|NCT02502266|450381484|FG005|Overall Study|Arm 4 Discontinued|0|||
125206883|NCT02502266|450381485|FG006|Overall Study|Arm 4 Discontinued|0|||
125206884|NCT02502266|450381479|FG000|Overall Study|Never treated|0|||
125206885|NCT02502266|450381480|FG001|Overall Study|Never treated|0|||
125206886|NCT02502266|450381481|FG002|Overall Study|Never treated|0|||
125206887|NCT02502266|450381482|FG003|Overall Study|Never treated|0|||
125206888|NCT02502266|450381483|FG004|Overall Study|Never treated|0|||
125206889|NCT02502266|450381484|FG005|Overall Study|Never treated|1|||
125206890|NCT02502266|450381485|FG006|Overall Study|Never treated|0|||
125206891|NCT02921750|450381486|FG000|Overall Study|Adverse Event|1|||
125206892|NCT02921750|450381487|FG001|Overall Study|Adverse Event|2|||
125206893|NCT02921750|450381486|FG000|Overall Study|Withdrawal by Subject|1|||
125206894|NCT02921750|450381487|FG001|Overall Study|Withdrawal by Subject|1|||
125206895|NCT02921750|450381486|FG000|Overall Study|Lost to Follow-up|3|||
125206896|NCT02921750|450381487|FG001|Overall Study|Lost to Follow-up|3|||
125206897|NCT02921750|450381486|FG000|Overall Study|Wound healed|3|||
125206898|NCT02921750|450381487|FG001|Overall Study|Wound healed|3|||
125206899|NCT02921750|450381486|FG000|Overall Study|Serious Adverse Event|1|||
125206900|NCT02921750|450381487|FG001|Overall Study|Serious Adverse Event|2|||
125206901|NCT03605849|450381488|FG000|Overall Study|Adverse Event|20|||
125206902|NCT03605849|450381489|FG001|Overall Study|Adverse Event|21|||
125206903|NCT03605849|450381490|FG002|Overall Study|Adverse Event|29|||
125206904|NCT03605849|450381491|FG003|Overall Study|Adverse Event|11|||
125206905|NCT03605849|450381488|FG000|Overall Study|Lack of Efficacy|4|||
125206906|NCT03605849|450381489|FG001|Overall Study|Lack of Efficacy|7|||
125206907|NCT03605849|450381490|FG002|Overall Study|Lack of Efficacy|9|||
125206908|NCT03605849|450381491|FG003|Overall Study|Lack of Efficacy|2|||
125206909|NCT03605849|450381488|FG000|Overall Study|Lost to Follow-up|8|||
125206910|NCT03605849|450381489|FG001|Overall Study|Lost to Follow-up|8|||
125206911|NCT03605849|450381490|FG002|Overall Study|Lost to Follow-up|14|||
125206912|NCT03605849|450381491|FG003|Overall Study|Lost to Follow-up|11|||
125206913|NCT03605849|450381488|FG000|Overall Study|Non-compliance With IMP|6|||
125206914|NCT03605849|450381489|FG001|Overall Study|Non-compliance With IMP|5|||
125206915|NCT03605849|450381490|FG002|Overall Study|Non-compliance With IMP|2|||
125648985|NCT01674010|451997451|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
125648986|NCT01674010|451997452|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
125648987|NCT01674010|451997450|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
125648988|NCT01674010|451997451|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
125648989|NCT01674010|451997452|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
125648990|NCT01674010|451997450|FG000|Randomization Phase 2|Adverse Event|0|||
125206916|NCT03605849|450381491|FG003|Overall Study|Non-compliance With IMP|1|||
125206917|NCT03605849|450381488|FG000|Overall Study|Protocol Deviation|1|||
125206918|NCT03605849|450381489|FG001|Overall Study|Protocol Deviation|2|||
125206919|NCT03605849|450381490|FG002|Overall Study|Protocol Deviation|1|||
125206920|NCT03605849|450381491|FG003|Overall Study|Protocol Deviation|3|||
125206921|NCT03605849|450381488|FG000|Overall Study|Withdrawal by Subject|33|||
125206922|NCT03605849|450381489|FG001|Overall Study|Withdrawal by Subject|28|||
125206923|NCT03605849|450381490|FG002|Overall Study|Withdrawal by Subject|30|||
125206924|NCT03605849|450381491|FG003|Overall Study|Withdrawal by Subject|28|||
125206925|NCT03605849|450381488|FG000|Overall Study|Site Terminated by Sponsor|0|||
125206926|NCT03605849|450381489|FG001|Overall Study|Site Terminated by Sponsor|0|||
125206927|NCT03605849|450381490|FG002|Overall Study|Site Terminated by Sponsor|0|||
125648991|NCT01674010|451997451|FG001|Randomization Phase 2|Adverse Event|1|||
125206928|NCT03605849|450381491|FG003|Overall Study|Site Terminated by Sponsor|1|||
125206929|NCT03605849|450381488|FG000|Overall Study|Physician Decision|2|||
125206930|NCT03605849|450381489|FG001|Overall Study|Physician Decision|1|||
125206931|NCT03605849|450381490|FG002|Overall Study|Physician Decision|2|||
125206932|NCT03605849|450381491|FG003|Overall Study|Physician Decision|1|||
125206933|NCT03605849|450381488|FG000|Overall Study|Enrolled, but not Treated|2|||
125206934|NCT03605849|450381489|FG001|Overall Study|Enrolled, but not Treated|2|||
125206935|NCT03605849|450381490|FG002|Overall Study|Enrolled, but not Treated|3|||
125206936|NCT03605849|450381491|FG003|Overall Study|Enrolled, but not Treated|2|||
125206937|NCT03605849|450381488|FG000|Overall Study|Other (COVID-19 Related)|0|||
125206938|NCT03605849|450381489|FG001|Overall Study|Other (COVID-19 Related)|1|||
125206939|NCT03605849|450381490|FG002|Overall Study|Other (COVID-19 Related)|1|||
125206940|NCT03605849|450381491|FG003|Overall Study|Other (COVID-19 Related)|0|||
125206941|NCT03605849|450381488|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
125206942|NCT03605849|450381489|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
125206943|NCT03605849|450381490|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
125206944|NCT03605849|450381491|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
125206945|NCT00328094|450381494|FG000|Overall Study|Physician Decision|3|||
125206946|NCT00328094|450381495|FG001|Overall Study|Physician Decision|3|||
125206947|NCT00590538|450381496|FG000|Overall Study|Study terminated before completed|2|||
125206948|NCT02309723|450381497|FG000|Overall Study|Withdrawal by Subject|24|||
125206949|NCT02309723|450381498|FG001|Overall Study|Withdrawal by Subject|23|||
125206950|NCT02309723|450381499|FG002|Overall Study|Withdrawal by Subject|24|||
125206951|NCT01125813|450381500|FG000|Overall Study|Death|1|||
125206952|NCT01125813|450381500|FG000|Overall Study|Withdrawal by Subject|1|||
125206953|NCT01125813|450381500|FG000|Overall Study|Screen Failures|4|||
125206954|NCT00985426|450381501|FG000|Overall Study|Adverse Event|0|||
125206955|NCT00985426|450381502|FG001|Overall Study|Adverse Event|1|||
125206956|NCT00985426|450381501|FG000|Overall Study|Subject Non-Compliance|3|||
125206957|NCT00985426|450381502|FG001|Overall Study|Subject Non-Compliance|3|||
125206958|NCT00985426|450381501|FG000|Overall Study|Withdrawal by Subject|12|||
125206959|NCT00985426|450381502|FG001|Overall Study|Withdrawal by Subject|16|||
125206960|NCT00985426|450381501|FG000|Overall Study|Lost to Follow-up|8|||
125206961|NCT00985426|450381502|FG001|Overall Study|Lost to Follow-up|10|||
125206962|NCT00985426|450381501|FG000|Overall Study|Death|7|||
125206963|NCT00985426|450381502|FG001|Overall Study|Death|3|||
125206964|NCT00985426|450381501|FG000|Overall Study|Protocol Violation|2|||
125206965|NCT00985426|450381502|FG001|Overall Study|Protocol Violation|0|||
125206966|NCT00985426|450381501|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
125206967|NCT00985426|450381502|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
125206968|NCT02327013|450381503|FG000|Overall Study|Adverse Event|4|||
125206969|NCT02327013|450381504|FG001|Overall Study|Adverse Event|4|||
125206970|NCT02327013|450381505|FG002|Overall Study|Adverse Event|3|||
125206971|NCT02327013|450381506|FG003|Overall Study|Adverse Event|0|||
125206972|NCT02327013|450381507|FG004|Overall Study|Adverse Event|1|||
125206973|NCT02327013|450381503|FG000|Overall Study|Lack of Efficacy|2|||
125206974|NCT02327013|450381504|FG001|Overall Study|Lack of Efficacy|0|||
125206975|NCT02327013|450381505|FG002|Overall Study|Lack of Efficacy|5|||
125206976|NCT02327013|450381506|FG003|Overall Study|Lack of Efficacy|0|||
125206977|NCT02327013|450381507|FG004|Overall Study|Lack of Efficacy|1|||
125206978|NCT02327013|450381503|FG000|Overall Study|Non-compliance with IMP|1|||
125206979|NCT02327013|450381504|FG001|Overall Study|Non-compliance with IMP|2|||
125206980|NCT02327013|450381505|FG002|Overall Study|Non-compliance with IMP|7|||
125206981|NCT02327013|450381506|FG003|Overall Study|Non-compliance with IMP|0|||
125206982|NCT02327013|450381507|FG004|Overall Study|Non-compliance with IMP|0|||
125206983|NCT02327013|450381503|FG000|Overall Study|Withdrawal of Consent|1|||
125206984|NCT02327013|450381504|FG001|Overall Study|Withdrawal of Consent|0|||
125206985|NCT02327013|450381505|FG002|Overall Study|Withdrawal of Consent|3|||
125206986|NCT02327013|450381506|FG003|Overall Study|Withdrawal of Consent|0|||
125206987|NCT02327013|450381507|FG004|Overall Study|Withdrawal of Consent|0|||
125206988|NCT02327013|450381503|FG000|Overall Study|Lost to Follow-up|2|||
125206989|NCT02327013|450381504|FG001|Overall Study|Lost to Follow-up|4|||
125206990|NCT02327013|450381505|FG002|Overall Study|Lost to Follow-up|5|||
125206991|NCT02327013|450381506|FG003|Overall Study|Lost to Follow-up|0|||
125206992|NCT02327013|450381507|FG004|Overall Study|Lost to Follow-up|0|||
125206993|NCT02327013|450381503|FG000|Overall Study|Administrative or other reason(s)|1|||
125206994|NCT02327013|450381504|FG001|Overall Study|Administrative or other reason(s)|5|||
125206995|NCT02327013|450381505|FG002|Overall Study|Administrative or other reason(s)|11|||
125206996|NCT02327013|450381506|FG003|Overall Study|Administrative or other reason(s)|1|||
125206997|NCT02327013|450381507|FG004|Overall Study|Administrative or other reason(s)|1|||
125206998|NCT02327013|450381503|FG000|Overall Study|Protocol Violation|0|||
125206999|NCT02327013|450381504|FG001|Overall Study|Protocol Violation|0|||
125207000|NCT02327013|450381505|FG002|Overall Study|Protocol Violation|3|||
125207001|NCT02327013|450381506|FG003|Overall Study|Protocol Violation|0|||
125207002|NCT02327013|450381507|FG004|Overall Study|Protocol Violation|1|||
125207003|NCT02327013|450381503|FG000|Overall Study|Withdrawal before treatment|2|||
125207004|NCT02327013|450381504|FG001|Overall Study|Withdrawal before treatment|1|||
125207005|NCT02327013|450381505|FG002|Overall Study|Withdrawal before treatment|5|||
125207006|NCT02327013|450381506|FG003|Overall Study|Withdrawal before treatment|0|||
125207007|NCT02327013|450381507|FG004|Overall Study|Withdrawal before treatment|0|||
125207008|NCT01565668|450381508|FG000|Overall Study|Death|2|||
125207009|NCT01565668|450381509|FG001|Overall Study|Death|1|||
125207010|NCT01565668|450381508|FG000|Overall Study|Lack of Efficacy|4|||
125207011|NCT01565668|450381509|FG001|Overall Study|Lack of Efficacy|2|||
125207012|NCT01565668|450381508|FG000|Overall Study|Participant went on Hospice Care|1|||
125207013|NCT01565668|450381509|FG001|Overall Study|Participant went on Hospice Care|0|||
125207014|NCT01565668|450381508|FG000|Overall Study|Adverse Event|6|||
125207015|NCT01565668|450381509|FG001|Overall Study|Adverse Event|1|||
125207016|NCT01565668|450381508|FG000|Overall Study|Randomized, but never received drug|0|||
125207017|NCT01565668|450381509|FG001|Overall Study|Randomized, but never received drug|2|||
125207018|NCT01565668|450381508|FG000|Overall Study|Progressive disease|13|||
125207019|NCT01565668|450381509|FG001|Overall Study|Progressive disease|14|||
125207020|NCT01565668|450381508|FG000|Overall Study|Withdrawal by Subject|1|||
125207021|NCT01565668|450381509|FG001|Overall Study|Withdrawal by Subject|3|||
125207022|NCT01565668|450381508|FG000|Overall Study|HSCT Transplant|11|||
125207023|NCT01565668|450381509|FG001|Overall Study|HSCT Transplant|15|||
125207024|NCT04258254|450381510|FG000|Overall Study|Withdrawal by Subject|0|||
125207025|NCT04258254|450381511|FG001|Overall Study|Withdrawal by Subject|1|||
125207026|NCT04258254|450381512|FG002|Overall Study|Withdrawal by Subject|0|||
125207027|NCT02255552|450381513|FG000|Overall Study|Participants enrolled into another study|0|||
125207028|NCT02255552|450381514|FG001|Overall Study|Participants enrolled into another study|11|||
125207029|NCT02255552|450381513|FG000|Overall Study|Withdrawal by Subject|1|||
125207030|NCT02255552|450381514|FG001|Overall Study|Withdrawal by Subject|4|||
125207031|NCT04829331|450381515|FG000|Overall Study|Lost to Follow-up|1|||
125207032|NCT04829331|450381516|FG001|Overall Study|Lost to Follow-up|0|||
125207033|NCT03570554|450381518|FG000|Overall Study|Non-compliance with study drug|0|||
125207034|NCT03570554|450381519|FG001|Overall Study|Non-compliance with study drug|0|||
125207035|NCT03570554|450381520|FG002|Overall Study|Non-compliance with study drug|1|||
125207036|NCT03570554|450381521|FG003|Overall Study|Non-compliance with study drug|0|||
125207037|NCT03570554|450381518|FG000|Overall Study|Adverse Event|0|||
125207038|NCT03570554|450381519|FG001|Overall Study|Adverse Event|0|||
125207039|NCT03570554|450381520|FG002|Overall Study|Adverse Event|0|||
125207040|NCT03570554|450381521|FG003|Overall Study|Adverse Event|1|||
125207041|NCT02223819|450381536|FG000|Overall Study|Lost to Follow-up|2|||
125207042|NCT02956057|450381538|FG000|Overall Study|Discontinued intervention|14|||
125207043|NCT02956057|450381539|FG001|Overall Study|Discontinued intervention|10|||
125207044|NCT02956057|450381540|FG002|Overall Study|Discontinued intervention|7|||
125207045|NCT02956057|450381541|FG003|Overall Study|Discontinued intervention|14|||
125207046|NCT02956057|450381542|FG004|Overall Study|Discontinued intervention|4|||
125207047|NCT02956057|450381543|FG005|Overall Study|Discontinued intervention|17|||
125207048|NCT02956057|450381538|FG000|Overall Study|Lost to Follow-up|0|||
125207049|NCT02956057|450381539|FG001|Overall Study|Lost to Follow-up|2|||
125207050|NCT02956057|450381540|FG002|Overall Study|Lost to Follow-up|1|||
125207051|NCT02956057|450381541|FG003|Overall Study|Lost to Follow-up|1|||
125207052|NCT02956057|450381542|FG004|Overall Study|Lost to Follow-up|1|||
125207053|NCT02956057|450381543|FG005|Overall Study|Lost to Follow-up|0|||
125207054|NCT03435224|450381546|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
125207055|NCT01420679|450381549|FG000|Overall Study|Disease Progression|3|||
125207056|NCT01420679|450381550|FG001|Overall Study|Disease Progression|2|||
125207057|NCT01420679|450381549|FG000|Overall Study|Adverse Event|4|||
125207058|NCT01420679|450381550|FG001|Overall Study|Adverse Event|0|||
125207059|NCT01420679|450381549|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
125207060|NCT01420679|450381550|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
125207061|NCT01420679|450381549|FG000|Overall Study|Patient Decision|1|||
125207062|NCT01420679|450381550|FG001|Overall Study|Patient Decision|0|||
125207063|NCT01420679|450381549|FG000|Overall Study|Investigator Decision|1|||
125207064|NCT01420679|450381550|FG001|Overall Study|Investigator Decision|2|||
125207065|NCT01420679|450381549|FG000|Overall Study|Sponsor Decision|3|||
125207066|NCT01420679|450381550|FG001|Overall Study|Sponsor Decision|3|||
125207067|NCT01420679|450381549|FG000|Overall Study|Other|1|||
125207068|NCT01420679|450381550|FG001|Overall Study|Other|0|||
125207069|NCT00367484|450381551|FG000|Overall Study|Adverse Event|7|||
125207070|NCT00367484|450381551|FG000|Overall Study|Withdrew informed consent|5|||
125207071|NCT00367484|450381551|FG000|Overall Study|Travel to USA|1|||
125207072|NCT00367484|450381551|FG000|Overall Study|Lost to Follow-up|1|||
125207073|NCT00367484|450381551|FG000|Overall Study|Protocol Violation|1|||
125207074|NCT00367484|450381551|FG000|Overall Study|The choice of the patient|1|||
125207075|NCT00367484|450381551|FG000|Overall Study|Lack of Efficacy|1|||
125207076|NCT02604550|450381554|FG000|Overall Study|Lost to Follow-up|7|||
125207077|NCT02604550|450381555|FG001|Overall Study|Lost to Follow-up|6|||
125207078|NCT02604550|450381554|FG000|Overall Study|Withdrawal by Subject|0|||
125207079|NCT02604550|450381555|FG001|Overall Study|Withdrawal by Subject|1|||
125207080|NCT02604550|450381554|FG000|Overall Study|Incomplete data using paper journal|18|||
125207081|NCT02604550|450381555|FG001|Overall Study|Incomplete data using paper journal|19|||
125207082|NCT04472026|450381556|FG000|Overall Study|Lost to Follow-up|5|||
125207083|NCT01404208|450381557|FG000|Overall Study|Discontinued|3|||
125207084|NCT01404208|450381558|FG001|Overall Study|Discontinued|0|||
125207085|NCT04007107|450381561|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
125207086|NCT04007107|450381562|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
125207087|NCT04007107|450381563|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
125207088|NCT04007107|450381564|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
125207089|NCT04068688|450381565|FG000|Overall Study|Lost to Follow-up|1|||
125207090|NCT04068688|450381566|FG001|Overall Study|Lost to Follow-up|1|||
125207091|NCT04068688|450381567|FG002|Overall Study|Lost to Follow-up|0|||
125207092|NCT04068688|450381568|FG003|Overall Study|Lost to Follow-up|0|||
125207093|NCT04068688|450381569|FG004|Overall Study|Lost to Follow-up|5|||
125207094|NCT04068688|450381570|FG005|Overall Study|Lost to Follow-up|5|||
125207095|NCT04068688|450381571|FG006|Overall Study|Lost to Follow-up|0|||
125207096|NCT04068688|450381572|FG007|Overall Study|Lost to Follow-up|0|||
125207097|NCT04068688|450381573|FG008|Overall Study|Lost to Follow-up|1|||
125207098|NCT04068688|450381574|FG009|Overall Study|Lost to Follow-up|0|||
125207099|NCT04068688|450381565|FG000|Overall Study|Withdrawal by Subject|1|||
125207100|NCT04068688|450381566|FG001|Overall Study|Withdrawal by Subject|1|||
125207101|NCT04068688|450381567|FG002|Overall Study|Withdrawal by Subject|0|||
125207102|NCT04068688|450381568|FG003|Overall Study|Withdrawal by Subject|0|||
125207103|NCT04068688|450381569|FG004|Overall Study|Withdrawal by Subject|0|||
125207104|NCT04068688|450381570|FG005|Overall Study|Withdrawal by Subject|0|||
125207105|NCT04068688|450381571|FG006|Overall Study|Withdrawal by Subject|0|||
125207106|NCT04068688|450381572|FG007|Overall Study|Withdrawal by Subject|0|||
125207107|NCT04068688|450381573|FG008|Overall Study|Withdrawal by Subject|0|||
125207108|NCT04068688|450381574|FG009|Overall Study|Withdrawal by Subject|0|||
125207109|NCT04068688|450381565|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
125207110|NCT04068688|450381566|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
125207111|NCT04068688|450381567|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207112|NCT04068688|450381568|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207113|NCT04068688|450381569|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207114|NCT04068688|450381570|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125648992|NCT01674010|451997452|FG002|Randomization Phase 2|Adverse Event|1|||
125207115|NCT04068688|450381571|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207116|NCT04068688|450381572|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207117|NCT04068688|450381573|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207118|NCT04068688|450381574|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
125207119|NCT04679051|450381575|FG000|Overall Study|felt tired after restricted time in bed|3|||
125207120|NCT04679051|450381576|FG001|Overall Study|felt tired after restricted time in bed|0|||
125207121|NCT04679051|450381575|FG000|Overall Study|discomfort with blood pressure cuff|2|||
125207122|NCT04679051|450381576|FG001|Overall Study|discomfort with blood pressure cuff|0|||
125207123|NCT04679051|450381575|FG000|Overall Study|scheduling conflict|1|||
125207124|NCT04679051|450381576|FG001|Overall Study|scheduling conflict|1|||
125207125|NCT04679051|450381575|FG000|Overall Study|Protocol Violation|0|||
125207126|NCT04679051|450381576|FG001|Overall Study|Protocol Violation|4|||
125207127|NCT02332239|450381577|FG000|Overall Study|Lost to Follow-up|4|||
125207128|NCT02332239|450381578|FG001|Overall Study|Lost to Follow-up|6|||
125207129|NCT00115037|450381579|FG000|Phase1|Lost to Follow-up|16|||
125207130|NCT00115037|450381580|FG001|Phase1|Lost to Follow-up|23|||
125207131|NCT00115037|450381581|FG002|Phase1|Lost to Follow-up|0|||
125207132|NCT00115037|450381582|FG003|Phase1|Lost to Follow-up|0|||
125207133|NCT00115037|450381583|FG004|Phase1|Lost to Follow-up|0|||
125207134|NCT00115037|450381584|FG005|Phase1|Lost to Follow-up|0|||
125207135|NCT00115037|450381579|FG000|Phase1|Withdrawal by Subject|9|||
125207136|NCT00115037|450381580|FG001|Phase1|Withdrawal by Subject|4|||
125207137|NCT00115037|450381581|FG002|Phase1|Withdrawal by Subject|0|||
125207138|NCT00115037|450381582|FG003|Phase1|Withdrawal by Subject|0|||
125207139|NCT00115037|450381583|FG004|Phase1|Withdrawal by Subject|0|||
125207140|NCT00115037|450381584|FG005|Phase1|Withdrawal by Subject|0|||
125207141|NCT00115037|450381579|FG000|Phase2|Death|0|||
125207142|NCT00115037|450381580|FG001|Phase2|Death|0|||
125207143|NCT00115037|450381581|FG002|Phase2|Death|1|||
125207144|NCT00115037|450381582|FG003|Phase2|Death|0|||
125207145|NCT00115037|450381583|FG004|Phase2|Death|0|||
125207146|NCT00115037|450381584|FG005|Phase2|Death|1|||
125207147|NCT00115037|450381579|FG000|Phase2|Withdrawal by Subject|0|||
125207148|NCT00115037|450381580|FG001|Phase2|Withdrawal by Subject|0|||
125207149|NCT00115037|450381581|FG002|Phase2|Withdrawal by Subject|2|||
125207150|NCT00115037|450381582|FG003|Phase2|Withdrawal by Subject|1|||
125207151|NCT00115037|450381583|FG004|Phase2|Withdrawal by Subject|2|||
125207152|NCT00115037|450381584|FG005|Phase2|Withdrawal by Subject|1|||
125207153|NCT00115037|450381579|FG000|Phase2|Lost to Follow-up|0|||
125207154|NCT00115037|450381580|FG001|Phase2|Lost to Follow-up|0|||
125207155|NCT00115037|450381581|FG002|Phase2|Lost to Follow-up|12|||
125207156|NCT00115037|450381582|FG003|Phase2|Lost to Follow-up|14|||
125207157|NCT00115037|450381583|FG004|Phase2|Lost to Follow-up|4|||
125207158|NCT00115037|450381584|FG005|Phase2|Lost to Follow-up|10|||
125207159|NCT00396877|450381585|FG000|Overall Study|Lost to Follow-up|2|||
125207160|NCT00396877|450381586|FG001|Overall Study|Lost to Follow-up|1|||
125207161|NCT00396877|450381585|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
125207162|NCT00396877|450381586|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
125207163|NCT03422159|450381589|FG000|Overall Study|Exclusion due to terminal disease|2|||
125207164|NCT03422159|450381590|FG001|Overall Study|Exclusion due to terminal disease|1|||
125207165|NCT02631070|450381591|FG000|Overall Study|Withdrawal by Subject|35|||
125207166|NCT02631070|450381592|FG001|Overall Study|Withdrawal by Subject|13|||
125207167|NCT02631070|450381591|FG000|Overall Study|Death|45|||
125207168|NCT02631070|450381592|FG001|Overall Study|Death|24|||
125207169|NCT02631070|450381591|FG000|Overall Study|Lost to Follow-up|5|||
125207170|NCT02631070|450381592|FG001|Overall Study|Lost to Follow-up|1|||
125207171|NCT02631070|450381591|FG000|Overall Study|Transition to rollover protocol|52|||
125207172|NCT02631070|450381592|FG001|Overall Study|Transition to rollover protocol|21|||
125207173|NCT02631070|450381591|FG000|Overall Study|Other reasons|12|||
125207174|NCT02631070|450381592|FG001|Overall Study|Other reasons|5|||
125207175|NCT03769194|450381599|FG000|Overall Study|Withdrawal by Subject|0|||
125207176|NCT03769194|450381600|FG001|Overall Study|Withdrawal by Subject|7|||
125207177|NCT03769194|450381601|FG002|Overall Study|Withdrawal by Subject|4|||
125207178|NCT03769194|450381602|FG003|Overall Study|Withdrawal by Subject|1|||
125207179|NCT03769194|450381599|FG000|Overall Study|moved from study area|0|||
125207180|NCT03769194|450381600|FG001|Overall Study|moved from study area|2|||
125207181|NCT03769194|450381601|FG002|Overall Study|moved from study area|1|||
125207182|NCT03769194|450381602|FG003|Overall Study|moved from study area|1|||
125207183|NCT03769194|450381599|FG000|Overall Study|Lost to Follow-up|3|||
125207184|NCT03769194|450381600|FG001|Overall Study|Lost to Follow-up|6|||
125207185|NCT03769194|450381601|FG002|Overall Study|Lost to Follow-up|3|||
125207186|NCT03769194|450381602|FG003|Overall Study|Lost to Follow-up|6|||
125207187|NCT03769194|450381599|FG000|Overall Study|other|1|||
125207188|NCT03769194|450381600|FG001|Overall Study|other|3|||
125207189|NCT03769194|450381601|FG002|Overall Study|other|0|||
125207190|NCT03769194|450381602|FG003|Overall Study|other|1|||
125207191|NCT00087126|450381603|FG000|Overall Study|Ineligible - second primary|1|||
125207192|NCT00087126|450381603|FG000|Overall Study|Never treated|1|||
125207193|NCT00934856|450381610|FG000|Feasibility Part|Progressive disease|4|||
125207194|NCT00934856|450381611|FG001|Feasibility Part|Progressive disease|4|||
125207195|NCT00934856|450381612|FG002|Feasibility Part|Progressive disease|2|||
125207196|NCT00934856|450381613|FG003|Feasibility Part|Progressive disease|3|||
125207197|NCT00934856|450381614|FG004|Feasibility Part|Progressive disease|0|||
125207198|NCT00934856|450381615|FG005|Feasibility Part|Progressive disease|0|||
125207199|NCT00934856|450381610|FG000|Feasibility Part|Physician Decision|0|||
125207200|NCT00934856|450381611|FG001|Feasibility Part|Physician Decision|0|||
125207201|NCT00934856|450381612|FG002|Feasibility Part|Physician Decision|1|||
125207202|NCT00934856|450381613|FG003|Feasibility Part|Physician Decision|0|||
125207203|NCT00934856|450381614|FG004|Feasibility Part|Physician Decision|0|||
125207204|NCT00934856|450381615|FG005|Feasibility Part|Physician Decision|0|||
125207205|NCT00934856|450381610|FG000|Feasibility Part|Adverse Event|1|||
125207206|NCT00934856|450381611|FG001|Feasibility Part|Adverse Event|1|||
125207207|NCT00934856|450381612|FG002|Feasibility Part|Adverse Event|0|||
125207208|NCT00934856|450381613|FG003|Feasibility Part|Adverse Event|1|||
125207209|NCT00934856|450381614|FG004|Feasibility Part|Adverse Event|0|||
125207210|NCT00934856|450381615|FG005|Feasibility Part|Adverse Event|2|||
125207211|NCT00934856|450381610|FG000|Feasibility Part|Withdrawal by Subject|0|||
125207212|NCT00934856|450381611|FG001|Feasibility Part|Withdrawal by Subject|0|||
125207213|NCT00934856|450381612|FG002|Feasibility Part|Withdrawal by Subject|0|||
125207214|NCT00934856|450381613|FG003|Feasibility Part|Withdrawal by Subject|1|||
125207215|NCT00934856|450381614|FG004|Feasibility Part|Withdrawal by Subject|0|||
125207216|NCT00934856|450381615|FG005|Feasibility Part|Withdrawal by Subject|1|||
125207217|NCT00934856|450381610|FG000|Extension Part|Adverse Event|0|||
125207218|NCT00934856|450381611|FG001|Extension Part|Adverse Event|0|||
125207219|NCT00934856|450381612|FG002|Extension Part|Adverse Event|0|||
125207220|NCT00934856|450381613|FG003|Extension Part|Adverse Event|1|||
125207221|NCT00934856|450381614|FG004|Extension Part|Adverse Event|4|||
125207222|NCT00934856|450381615|FG005|Extension Part|Adverse Event|4|||
125207223|NCT00934856|450381610|FG000|Extension Part|Progressive disease|0|||
125207224|NCT00934856|450381611|FG001|Extension Part|Progressive disease|0|||
125207225|NCT00934856|450381612|FG002|Extension Part|Progressive disease|0|||
125207226|NCT00934856|450381613|FG003|Extension Part|Progressive disease|1|||
125207227|NCT00934856|450381614|FG004|Extension Part|Progressive disease|0|||
125207228|NCT00934856|450381615|FG005|Extension Part|Progressive disease|0|||
125207229|NCT00934856|450381610|FG000|Extension Part|Non-compliance with drug|0|||
125207230|NCT00934856|450381611|FG001|Extension Part|Non-compliance with drug|0|||
125648993|NCT01674010|451997450|FG000|Randomization Phase 2|Lost to Follow-up|0|||
125207231|NCT00934856|450381612|FG002|Extension Part|Non-compliance with drug|0|||
125207232|NCT00934856|450381613|FG003|Extension Part|Non-compliance with drug|0|||
125207233|NCT00934856|450381614|FG004|Extension Part|Non-compliance with drug|0|||
125207234|NCT00934856|450381615|FG005|Extension Part|Non-compliance with drug|1|||
125207235|NCT01273155|450381616|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
125207236|NCT01273155|450381617|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
125207237|NCT01273155|450381618|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
125207238|NCT01273155|450381619|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
125207239|NCT01273155|450381620|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
125207240|NCT01273155|450381621|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
125207241|NCT01273155|450381622|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
125207242|NCT01273155|450381616|FG000|Overall Study|Change in liver function/no longer eval.|0|||
125207243|NCT01273155|450381617|FG001|Overall Study|Change in liver function/no longer eval.|1|||
125207244|NCT01273155|450381618|FG002|Overall Study|Change in liver function/no longer eval.|0|||
125207245|NCT01273155|450381619|FG003|Overall Study|Change in liver function/no longer eval.|0|||
125207246|NCT01273155|450381620|FG004|Overall Study|Change in liver function/no longer eval.|1|||
125207247|NCT01273155|450381621|FG005|Overall Study|Change in liver function/no longer eval.|0|||
125207248|NCT01273155|450381622|FG006|Overall Study|Change in liver function/no longer eval.|0|||
125207249|NCT01273155|450381616|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
125207250|NCT01273155|450381617|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
125207251|NCT01273155|450381618|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
125207252|NCT01273155|450381619|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
125207253|NCT01273155|450381620|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
125207254|NCT01273155|450381621|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
125207255|NCT01273155|450381622|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
125207256|NCT01273155|450381616|FG000|Overall Study|Died during Cycle 1|0|||
125207257|NCT01273155|450381617|FG001|Overall Study|Died during Cycle 1|0|||
125207258|NCT01273155|450381618|FG002|Overall Study|Died during Cycle 1|1|||
125207259|NCT01273155|450381619|FG003|Overall Study|Died during Cycle 1|1|||
125207260|NCT01273155|450381620|FG004|Overall Study|Died during Cycle 1|0|||
125207261|NCT01273155|450381621|FG005|Overall Study|Died during Cycle 1|2|||
125207262|NCT01273155|450381622|FG006|Overall Study|Died during Cycle 1|2|||
125207263|NCT01273155|450381616|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
125207264|NCT01273155|450381617|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
125207265|NCT01273155|450381618|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
125207266|NCT01273155|450381619|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
125207267|NCT01273155|450381620|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
125207268|NCT01273155|450381621|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
125207269|NCT01273155|450381622|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
125207270|NCT01256385|450381623|FG000|Overall Study|Physician Decision|1|||
125207271|NCT01256385|450381624|FG001|Overall Study|Physician Decision|1|||
125207272|NCT01256385|450381623|FG000|Overall Study|Withdrawal by Subject|2|||
125207273|NCT01256385|450381624|FG001|Overall Study|Withdrawal by Subject|2|||
125207274|NCT00725101|450381625|FG000|Overall Study|Death|3|||
125207275|NCT00725101|450381625|FG000|Overall Study|Lost to Follow-up|353|||
125207276|NCT00725101|450381625|FG000|Overall Study|Protocol Violation|1|||
125207277|NCT00725101|450381625|FG000|Overall Study|Withdrawal by Subject|127|||
125207278|NCT00725101|450381625|FG000|Overall Study|not specified/no reason given|11|||
125207279|NCT03164265|450381626|FG000|Overall Study|Physician Decision|3|||
125207280|NCT03233204|450381627|FG000|Overall Study|Adverse Event|1|||
125207281|NCT03233204|450381627|FG000|Overall Study|Death|1|||
125207282|NCT03233204|450381627|FG000|Overall Study|Withdrawal by Subject|1|||
125207283|NCT03233204|450381627|FG000|Overall Study|Progressive Disease|3|||
125207284|NCT03467763|450381628|FG000|Overall Study|Lost to Follow-up|1|||
125207285|NCT03467763|450381628|FG000|Overall Study|Protocol Violation|2|||
125207286|NCT02889835|450381629|FG000|Overall Study|Lost to Follow-up|13|||
125207287|NCT02889835|450381630|FG001|Overall Study|Lost to Follow-up|13|||
125207288|NCT02889835|450381631|FG002|Overall Study|Lost to Follow-up|13|||
125207289|NCT02889835|450381629|FG000|Overall Study|Withdrawal by Subject|2|||
125207290|NCT02889835|450381630|FG001|Overall Study|Withdrawal by Subject|2|||
125207291|NCT02889835|450381631|FG002|Overall Study|Withdrawal by Subject|2|||
125207292|NCT02889835|450381629|FG000|Overall Study|Protocol Violation|1|||
125207293|NCT02889835|450381630|FG001|Overall Study|Protocol Violation|1|||
125207294|NCT02889835|450381631|FG002|Overall Study|Protocol Violation|1|||
125207295|NCT02889835|450381629|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
125207296|NCT02889835|450381630|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
125207297|NCT02889835|450381631|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
125207298|NCT02889835|450381629|FG000|Overall Study|Death|1|||
125207299|NCT02889835|450381630|FG001|Overall Study|Death|1|||
125207300|NCT02889835|450381631|FG002|Overall Study|Death|1|||
125207301|NCT04918355|450381632|FG000|Overall Study|no qualifying health encounter|497|||
125207302|NCT04918355|450381633|FG001|Overall Study|no qualifying health encounter|192|||
125207303|NCT04918355|450381634|FG002|Overall Study|no qualifying health encounter|438|||
125207304|NCT04918355|450381635|FG003|Overall Study|no qualifying health encounter|424|||
125207305|NCT00577005|450383324|FG000|Overall Study|Lost to Follow-up|3|||
125207306|NCT00577005|450383325|FG001|Overall Study|Lost to Follow-up|2|||
125207307|NCT00577005|450383324|FG000|Overall Study|Withdrawal by Subject|2|||
125207308|NCT00577005|450383325|FG001|Overall Study|Withdrawal by Subject|1|||
125207309|NCT03738800|450383329|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
125207310|NCT03738800|450383330|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
125207311|NCT03738800|450383331|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125207312|NCT03738800|450383329|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
125207313|NCT03738800|450383330|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
125207314|NCT03738800|450383331|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
125207315|NCT03738800|450383329|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
125207316|NCT03738800|450383330|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
125207317|NCT03738800|450383331|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
125207318|NCT01777295|450383332|FG000|Overall Study|Withdrawal by Subject|2|||
125207319|NCT01777295|450383333|FG001|Overall Study|Withdrawal by Subject|2|||
125207320|NCT01777295|450383332|FG000|Overall Study|Pregnancy|0|||
125207321|NCT01777295|450383333|FG001|Overall Study|Pregnancy|1|||
125207322|NCT01777295|450383332|FG000|Overall Study|Personal problem|1|||
125207323|NCT01777295|450383333|FG001|Overall Study|Personal problem|0|||
125207324|NCT01777295|450383332|FG000|Overall Study|Investigator call for AEs check|1|||
125207325|NCT01777295|450383333|FG001|Overall Study|Investigator call for AEs check|0|||
125207326|NCT02554318|450383334|FG000|Overall Study|Withdrawal by Subject|10|||
125207327|NCT02554318|450383335|FG001|Overall Study|Withdrawal by Subject|8|||
125207328|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
125207329|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
125207330|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
125207331|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
125207332|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|Death|1|||
125207333|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|Death|1|||
125207334|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
125207335|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
125207336|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
125207337|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
125207338|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
125207339|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
125207340|NCT00033657|450383336|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
125207341|NCT00033657|450383337|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
125207342|NCT00033657|450383336|FG000|Surgical Resection|not complete resection|0|||
125207343|NCT00033657|450383337|FG001|Surgical Resection|not complete resection|3|||
125207344|NCT00033657|450383336|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
125207345|NCT00033657|450383337|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
125207346|NCT00033657|450383336|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
125207347|NCT00033657|450383337|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
125207348|NCT00033657|450383336|FG000|Adjuvant Chemotherapy|Death|2|||
125207349|NCT00033657|450383337|FG001|Adjuvant Chemotherapy|Death|1|||
125207350|NCT00033657|450383336|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
125207351|NCT00033657|450383337|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
125207352|NCT00033657|450383336|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
125207353|NCT00033657|450383337|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
125207354|NCT00033657|450383336|FG000|Adjuvant Chemotherapy|Other|0|||
125207355|NCT00033657|450383337|FG001|Adjuvant Chemotherapy|Other|2|||
125207356|NCT02945254|450383338|FG000|Overall Study|Lost to Follow-up|1|||
125207357|NCT02945254|450383339|FG001|Overall Study|Lost to Follow-up|0|||
125207358|NCT02945254|450383338|FG000|Overall Study|Withdrawal by Subject|1|||
125207359|NCT02945254|450383339|FG001|Overall Study|Withdrawal by Subject|0|||
125207360|NCT03436199|450383344|FG000|Overall Study|Adverse Event|15|||
125207361|NCT03436199|450383345|FG001|Overall Study|Adverse Event|40|||
125207362|NCT03436199|450383346|FG002|Overall Study|Adverse Event|7|||
125207363|NCT03436199|450383344|FG000|Overall Study|Withdrawal by Subject|4|||
125207364|NCT03436199|450383345|FG001|Overall Study|Withdrawal by Subject|10|||
125207365|NCT03436199|450383346|FG002|Overall Study|Withdrawal by Subject|3|||
125207366|NCT03436199|450383344|FG000|Overall Study|Lost to Follow-up|1|||
125207367|NCT03436199|450383345|FG001|Overall Study|Lost to Follow-up|0|||
125207368|NCT03436199|450383346|FG002|Overall Study|Lost to Follow-up|2|||
125648994|NCT01674010|451997451|FG001|Randomization Phase 2|Lost to Follow-up|1|||
125648995|NCT01674010|451997452|FG002|Randomization Phase 2|Lost to Follow-up|2|||
125207369|NCT03436199|450383344|FG000|Overall Study|Protocol Violation|1|||
125207370|NCT03436199|450383345|FG001|Overall Study|Protocol Violation|1|||
125207371|NCT03436199|450383346|FG002|Overall Study|Protocol Violation|0|||
125207372|NCT03436199|450383344|FG000|Overall Study|Physician Decision|0|||
125207373|NCT03436199|450383345|FG001|Overall Study|Physician Decision|1|||
125207374|NCT03436199|450383346|FG002|Overall Study|Physician Decision|0|||
125207375|NCT03436199|450383344|FG000|Overall Study|Could not return to clinic|1|||
125207376|NCT03436199|450383345|FG001|Overall Study|Could not return to clinic|0|||
125207377|NCT03436199|450383346|FG002|Overall Study|Could not return to clinic|0|||
125207378|NCT03436199|450383344|FG000|Overall Study|Withdrawn per physician|0|||
125207379|NCT03436199|450383345|FG001|Overall Study|Withdrawn per physician|1|||
125207380|NCT03436199|450383346|FG002|Overall Study|Withdrawn per physician|0|||
125207381|NCT00085098|450383347|FG000|Overall Study|Withdrawal by Subject|0|||
125207382|NCT00085098|450383348|FG001|Overall Study|Withdrawal by Subject|1|||
125207383|NCT00085098|450383347|FG000|Overall Study|Ineligible|1|||
125207384|NCT00085098|450383348|FG001|Overall Study|Ineligible|1|||
125207385|NCT03515629|450383349|FG000|Overall Study|Death|0|||
125207386|NCT03515629|450383350|FG001|Overall Study|Death|1|||
125207387|NCT03515629|450383351|FG002|Overall Study|Death|1|||
125207388|NCT03515629|450383349|FG000|Overall Study|Progressive disease|0|||
125207389|NCT03515629|450383350|FG001|Overall Study|Progressive disease|1|||
125207390|NCT03515629|450383351|FG002|Overall Study|Progressive disease|0|||
125207391|NCT01886781|450383352|FG000|Overall Study|Protocol Violation|5|||
125207392|NCT01886781|450383353|FG001|Overall Study|Protocol Violation|0|||
125207393|NCT01886781|450383352|FG000|Overall Study|Adverse Event|1|||
125207394|NCT01886781|450383353|FG001|Overall Study|Adverse Event|0|||
125207395|NCT01886781|450383352|FG000|Overall Study|Lost to Follow-up|5|||
125207396|NCT01886781|450383353|FG001|Overall Study|Lost to Follow-up|0|||
125207397|NCT01886781|450383352|FG000|Overall Study|Withdrawal by Subject|2|||
125207398|NCT01886781|450383353|FG001|Overall Study|Withdrawal by Subject|1|||
125207399|NCT01886781|450383352|FG000|Overall Study|Worsening of symptoms|1|||
125207400|NCT01886781|450383353|FG001|Overall Study|Worsening of symptoms|1|||
125207401|NCT01522235|450383354|FG000|Overall Study|Physician Decision|1|||
125207402|NCT01522235|450383355|FG001|Overall Study|Physician Decision|1|||
125207403|NCT00980018|450383356|FG000|Overall Study|Adverse Event|8|||
125207404|NCT00980018|450383356|FG000|Overall Study|Patient withdrew consent|3|||
125207405|NCT00980018|450383356|FG000|Overall Study|Lost to Follow-up|1|||
125207406|NCT01832818|450383360|FG000|Overall Study|Lost to Follow-up|6|||
125207407|NCT01672294|450383361|FG000|Overall Study|Withdrawal by Subject|4|||
125207408|NCT01672294|450383362|FG001|Overall Study|Withdrawal by Subject|4|||
125207409|NCT01672294|450383363|FG002|Overall Study|Withdrawal by Subject|4|||
125207410|NCT01672294|450383364|FG003|Overall Study|Withdrawal by Subject|4|||
125207411|NCT01672294|450383361|FG000|Overall Study|Excluded by study|1|||
125207412|NCT01672294|450383362|FG001|Overall Study|Excluded by study|1|||
125207413|NCT01672294|450383363|FG002|Overall Study|Excluded by study|0|||
125207414|NCT01672294|450383364|FG003|Overall Study|Excluded by study|0|||
125207415|NCT01672294|450383361|FG000|Overall Study|Lost to Follow-up|1|||
125207416|NCT01672294|450383362|FG001|Overall Study|Lost to Follow-up|16|||
125207417|NCT01672294|450383363|FG002|Overall Study|Lost to Follow-up|7|||
125207418|NCT01672294|450383364|FG003|Overall Study|Lost to Follow-up|9|||
125207419|NCT01438814|450383370|FG000|Overall Study|Adverse Event|3|||
125207420|NCT01438814|450383371|FG001|Overall Study|Adverse Event|3|||
125207421|NCT01438814|450383370|FG000|Overall Study|Protocol Violation|1|||
125207422|NCT01438814|450383371|FG001|Overall Study|Protocol Violation|2|||
125207423|NCT01438814|450383370|FG000|Overall Study|Lost to Follow-up|4|||
125207424|NCT01438814|450383371|FG001|Overall Study|Lost to Follow-up|3|||
125207425|NCT01438814|450383370|FG000|Overall Study|Withdrawal by Subject|4|||
125207426|NCT01438814|450383371|FG001|Overall Study|Withdrawal by Subject|2|||
125207427|NCT01438814|450383370|FG000|Overall Study|Other|2|||
125207428|NCT01438814|450383371|FG001|Overall Study|Other|4|||
125207429|NCT01870297|450383376|FG000|Overall Study|Adverse Event|0|||
125207430|NCT01870297|450383377|FG001|Overall Study|Adverse Event|0|||
125207431|NCT01870297|450383378|FG002|Overall Study|Adverse Event|0|||
125207432|NCT01870297|450383379|FG003|Overall Study|Adverse Event|0|||
125207433|NCT01870297|450383380|FG004|Overall Study|Adverse Event|2|||
125207434|NCT01870297|450383381|FG005|Overall Study|Adverse Event|0|||
125207435|NCT01870297|450383382|FG006|Overall Study|Adverse Event|0|||
125207436|NCT01870297|450383376|FG000|Overall Study|Lost to Follow-up|0|||
125207437|NCT01870297|450383377|FG001|Overall Study|Lost to Follow-up|1|||
125207438|NCT01870297|450383378|FG002|Overall Study|Lost to Follow-up|1|||
125207439|NCT01870297|450383379|FG003|Overall Study|Lost to Follow-up|0|||
125207440|NCT01870297|450383380|FG004|Overall Study|Lost to Follow-up|0|||
125207441|NCT01870297|450383381|FG005|Overall Study|Lost to Follow-up|0|||
125207442|NCT01870297|450383382|FG006|Overall Study|Lost to Follow-up|0|||
125207443|NCT01870297|450383376|FG000|Overall Study|Withdrawal by Subject|0|||
125207444|NCT01870297|450383377|FG001|Overall Study|Withdrawal by Subject|0|||
125207445|NCT01870297|450383378|FG002|Overall Study|Withdrawal by Subject|0|||
125207446|NCT01870297|450383379|FG003|Overall Study|Withdrawal by Subject|0|||
125207447|NCT01870297|450383380|FG004|Overall Study|Withdrawal by Subject|1|||
125207448|NCT01870297|450383381|FG005|Overall Study|Withdrawal by Subject|1|||
125207449|NCT01870297|450383382|FG006|Overall Study|Withdrawal by Subject|1|||
125207450|NCT01870297|450383376|FG000|Overall Study|Sponsor Decision|0|||
125207451|NCT01870297|450383377|FG001|Overall Study|Sponsor Decision|6|||
125207452|NCT01870297|450383378|FG002|Overall Study|Sponsor Decision|0|||
125207453|NCT01870297|450383379|FG003|Overall Study|Sponsor Decision|0|||
125207454|NCT01870297|450383380|FG004|Overall Study|Sponsor Decision|0|||
125207455|NCT01870297|450383381|FG005|Overall Study|Sponsor Decision|0|||
125207456|NCT01870297|450383382|FG006|Overall Study|Sponsor Decision|1|||
125207457|NCT00337779|450383383|FG000|Overall Study|Withdrawal by Subject|10|||
125207458|NCT00337779|450383384|FG001|Overall Study|Withdrawal by Subject|12|||
125207459|NCT00337779|450383383|FG000|Overall Study|Sponsor decision|1|||
125207460|NCT00337779|450383384|FG001|Overall Study|Sponsor decision|1|||
125207461|NCT00337779|450383383|FG000|Overall Study|Physician Decision|3|||
125207462|NCT00337779|450383384|FG001|Overall Study|Physician Decision|6|||
125207463|NCT00337779|450383383|FG000|Overall Study|Protocol Violation|1|||
125207464|NCT00337779|450383384|FG001|Overall Study|Protocol Violation|1|||
125207465|NCT00337779|450383383|FG000|Overall Study|Lost to Follow-up|6|||
125207466|NCT00337779|450383384|FG001|Overall Study|Lost to Follow-up|5|||
125207467|NCT00337779|450383383|FG000|Overall Study|Adverse Event|28|||
125207468|NCT00337779|450383384|FG001|Overall Study|Adverse Event|51|||
125207469|NCT00337779|450383383|FG000|Overall Study|Pregnancy|3|||
125207470|NCT00337779|450383384|FG001|Overall Study|Pregnancy|2|||
125207471|NCT00337779|450383383|FG000|Overall Study|Death|0|||
125207472|NCT00337779|450383384|FG001|Overall Study|Death|1|||
125207473|NCT01162122|450383385|FG000|Overall Study|Withdrawal by Subject|52|||
125207474|NCT01162122|450383386|FG001|Overall Study|Withdrawal by Subject|43|||
125207475|NCT01162122|450383385|FG000|Overall Study|Lost to Follow-up|73|||
125207476|NCT01162122|450383386|FG001|Overall Study|Lost to Follow-up|91|||
125207477|NCT01162122|450383385|FG000|Overall Study|Adverse Event|3|||
125207478|NCT01162122|450383386|FG001|Overall Study|Adverse Event|2|||
125207479|NCT01162122|450383385|FG000|Overall Study|Death|51|||
125207480|NCT01162122|450383386|FG001|Overall Study|Death|46|||
125207481|NCT01162122|450383385|FG000|Overall Study|Protocol Violation|2|||
125207482|NCT01162122|450383386|FG001|Overall Study|Protocol Violation|2|||
125207483|NCT01162122|450383385|FG000|Overall Study|Inappropriate enrollment|5|||
125207484|NCT01162122|450383386|FG001|Overall Study|Inappropriate enrollment|4|||
125207485|NCT01162122|450383385|FG000|Overall Study|Administrative reason|1|||
125207486|NCT01162122|450383386|FG001|Overall Study|Administrative reason|1|||
125207487|NCT01162122|450383385|FG000|Overall Study|Unable to classify|3|||
125207488|NCT01162122|450383386|FG001|Overall Study|Unable to classify|7|||
125207489|NCT01162122|450383385|FG000|Overall Study|Missing primary reason|1|||
125207490|NCT01162122|450383386|FG001|Overall Study|Missing primary reason|0|||
125207491|NCT02020512|450383387|FG000|Overall Study|Adverse Event|1|||
125207492|NCT02020512|450383387|FG000|Overall Study|Lost to Follow-up|3|||
125207493|NCT02020512|450383387|FG000|Overall Study|Protocol Violation|4|||
125207494|NCT00422422|450383391|FG000|Overall Study|Lack of Efficacy|1|||
125207495|NCT00422422|450383391|FG000|Overall Study|Protocol Violation|1|||
125207496|NCT00422422|450383391|FG000|Overall Study|Withdrawal by Subject|2|||
125207497|NCT00422422|450383391|FG000|Overall Study|SAE, non-fatal|1|||
125207498|NCT00422422|450383391|FG000|Overall Study|AE, non-serious non-fatal|5|||
125207499|NCT03313310|450383392|FG000|Phase 2|Lost to Follow-up|4|||
125207500|NCT03313310|450383393|FG001|Phase 2|Lost to Follow-up|0|||
125207501|NCT03313310|450383392|FG000|Phase 3|Lost to Follow-up|0|||
125207502|NCT03313310|450383393|FG001|Phase 3|Lost to Follow-up|1|||
125207503|NCT00926536|450383394|FG000|Overall Study|Physician Decision|1|||
125207504|NCT00926536|450383395|FG001|Overall Study|Physician Decision|2|||
125207505|NCT00990665|450383396|FG000|Overall Study|Unsuccessful Implant|8|||
125207506|NCT00990665|450383396|FG000|Overall Study|Death|29|||
125207507|NCT00990665|450383396|FG000|Overall Study|Heart Transplant|1|||
125207508|NCT00990665|450383396|FG000|Overall Study|Withdrawal by Subject|6|||
125207509|NCT00990665|450383396|FG000|Overall Study|Lost to Follow-up|1|||
125207510|NCT00990665|450383396|FG000|Overall Study|System Explant|3|||
125207511|NCT01080391|450383399|FG000|Overall Study|Randomized but not treated|7|||
125207512|NCT01080391|450383400|FG001|Overall Study|Randomized but not treated|4|||
125207513|NCT01904903|450383401|FG000|Overall Study|Withdrawal by Subject|1|||
125207514|NCT00672841|450383402|FG000|Overall Study|Comfort care|1|||
125207515|NCT00672841|450383403|FG001|Overall Study|Comfort care|4|||
125207516|NCT00672841|450383402|FG000|Overall Study|icteric specimens|0|||
125207517|NCT00672841|450383403|FG001|Overall Study|icteric specimens|3|||
125207518|NCT00672841|450383402|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
125207519|NCT00672841|450383403|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
125207520|NCT00672841|450383402|FG000|Overall Study|Adverse Event|0|||
125207521|NCT00672841|450383403|FG001|Overall Study|Adverse Event|3|||
125207522|NCT00672841|450383402|FG000|Overall Study|Pregnancy|0|||
125207523|NCT00672841|450383403|FG001|Overall Study|Pregnancy|1|||
125207524|NCT03578146|450383404|FG000|Overall Study|Did Not Receive Treatment|1|||
125207525|NCT03578146|450383405|FG001|Overall Study|Did Not Receive Treatment|0|||
125207526|NCT03578146|450383406|FG002|Overall Study|Did Not Receive Treatment|0|||
125207527|NCT03578146|450383407|FG003|Overall Study|Did Not Receive Treatment|0|||
125207528|NCT03578146|450383408|FG004|Overall Study|Did Not Receive Treatment|0|||
125207529|NCT03578146|450383409|FG005|Overall Study|Did Not Receive Treatment|2|||
125207530|NCT03578146|450383404|FG000|Overall Study|Lost to Follow-up|0|||
125207531|NCT03578146|450383405|FG001|Overall Study|Lost to Follow-up|1|||
125207532|NCT03578146|450383406|FG002|Overall Study|Lost to Follow-up|1|||
125207533|NCT03578146|450383407|FG003|Overall Study|Lost to Follow-up|0|||
125207534|NCT03578146|450383408|FG004|Overall Study|Lost to Follow-up|0|||
125207535|NCT03578146|450383409|FG005|Overall Study|Lost to Follow-up|1|||
125207536|NCT01717391|450383410|FG000|Overall Study|Withdrawal by Subject|5|||
125207537|NCT01717391|450383410|FG000|Overall Study|Physician Decision|1|||
125207538|NCT01717391|450383410|FG000|Overall Study|FLT technical failure|3|||
125207539|NCT03677934|450383411|FG000|Overall Study|Adverse Event|1|||
125207540|NCT03677934|450383412|FG001|Overall Study|Adverse Event|1|||
125207541|NCT03677934|450383411|FG000|Overall Study|Death|8|||
125207542|NCT03677934|450383412|FG001|Overall Study|Death|4|||
125207543|NCT03677934|450383411|FG000|Overall Study|Lost to Follow-up|3|||
125207544|NCT03677934|450383412|FG001|Overall Study|Lost to Follow-up|0|||
125207545|NCT03677934|450383411|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125207546|NCT03677934|450383412|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125207547|NCT03677934|450383411|FG000|Overall Study|Physician Decision|0|||
125207548|NCT03677934|450383412|FG001|Overall Study|Physician Decision|1|||
125207549|NCT03677934|450383411|FG000|Overall Study|Withdrawal by Subject|1|||
125207550|NCT03677934|450383412|FG001|Overall Study|Withdrawal by Subject|7|||
125207551|NCT01260584|450383413|FG000|Period 1|Protocol Violation|0|||
125207552|NCT01260584|450383414|FG001|Period 1|Protocol Violation|0|||
125207553|NCT01260584|450383415|FG002|Period 1|Protocol Violation|1|||
125207554|NCT01260584|450383416|FG003|Period 1|Protocol Violation|1|||
125207555|NCT01260584|450383413|FG000|Period 1|Adverse Event|0|||
125207556|NCT01260584|450383414|FG001|Period 1|Adverse Event|0|||
125207557|NCT01260584|450383415|FG002|Period 1|Adverse Event|1|||
125207558|NCT01260584|450383416|FG003|Period 1|Adverse Event|0|||
125207559|NCT01260584|450383413|FG000|Period 2|Protocol Violation|0|||
125207560|NCT01260584|450383414|FG001|Period 2|Protocol Violation|2|||
125207561|NCT01260584|450383415|FG002|Period 2|Protocol Violation|3|||
125207562|NCT01260584|450383416|FG003|Period 2|Protocol Violation|1|||
125207563|NCT01260584|450383413|FG000|Period 2|Adverse Event|1|||
125207564|NCT01260584|450383414|FG001|Period 2|Adverse Event|0|||
125207565|NCT01260584|450383415|FG002|Period 2|Adverse Event|2|||
125207566|NCT01260584|450383416|FG003|Period 2|Adverse Event|0|||
125648996|NCT01674010|451997450|FG000|Randomization Phase 2|Mood episode recurrence|0|||
125648997|NCT01674010|451997451|FG001|Randomization Phase 2|Mood episode recurrence|8|||
125648998|NCT01674010|451997452|FG002|Randomization Phase 2|Mood episode recurrence|2|||
125648999|NCT01674010|451997450|FG000|Randomization Phase 2|Physician Decision|0|||
125649000|NCT01674010|451997451|FG001|Randomization Phase 2|Physician Decision|0|||
125649001|NCT01674010|451997452|FG002|Randomization Phase 2|Physician Decision|2|||
125207567|NCT01260584|450383413|FG000|Period 2|Withdrawal by Subject|0|||
125207568|NCT01260584|450383414|FG001|Period 2|Withdrawal by Subject|1|||
125207569|NCT01260584|450383415|FG002|Period 2|Withdrawal by Subject|0|||
125207570|NCT01260584|450383416|FG003|Period 2|Withdrawal by Subject|0|||
125207571|NCT00932451|450383419|FG000|Overall Study|Withdrawal by Subject|69|||
125207572|NCT00932451|450383419|FG000|Overall Study|Lost to Follow-up|22|||
125207573|NCT00932451|450383419|FG000|Overall Study|Death|726|||
125207574|NCT00932451|450383419|FG000|Overall Study|Other reasons|5|||
125207575|NCT03434249|450383422|FG000|Overall Study|Adverse Event|1|||
125207576|NCT03434249|450383423|FG001|Overall Study|Adverse Event|0|||
125207577|NCT03434249|450383422|FG000|Overall Study|Lost to Follow-up|0|||
125207578|NCT03434249|450383423|FG001|Overall Study|Lost to Follow-up|1|||
125207579|NCT03434249|450383422|FG000|Overall Study|Non-compliance of family|2|||
125207580|NCT03434249|450383423|FG001|Overall Study|Non-compliance of family|1|||
125207581|NCT03434249|450383422|FG000|Overall Study|Difficulties in completing daily diary|2|||
125207582|NCT03434249|450383423|FG001|Overall Study|Difficulties in completing daily diary|1|||
125207583|NCT00561470|450383424|FG000|Overall Study|Adverse Event|74|||
125207584|NCT00561470|450383425|FG001|Overall Study|Adverse Event|163|||
125207585|NCT00561470|450383424|FG000|Overall Study|Disease progression|437|||
125207586|NCT00561470|450383425|FG001|Overall Study|Disease progression|305|||
125207587|NCT00561470|450383424|FG000|Overall Study|poor compliance to protocol|4|||
125207588|NCT00561470|450383425|FG001|Overall Study|poor compliance to protocol|4|||
125207589|NCT00561470|450383424|FG000|Overall Study|Lost to Follow-up|2|||
125207590|NCT00561470|450383425|FG001|Overall Study|Lost to Follow-up|0|||
125207591|NCT00561470|450383424|FG000|Overall Study|Physician Decision|21|||
125207592|NCT00561470|450383425|FG001|Overall Study|Physician Decision|20|||
125207593|NCT00561470|450383424|FG000|Overall Study|Consent Withdrawn|2|||
125207594|NCT00561470|450383425|FG001|Overall Study|Consent Withdrawn|6|||
125207595|NCT00561470|450383424|FG000|Overall Study|Subject request|43|||
125207596|NCT00561470|450383425|FG001|Overall Study|Subject request|77|||
125207597|NCT00561470|450383424|FG000|Overall Study|Metastatic surgery|10|||
125207598|NCT00561470|450383425|FG001|Overall Study|Metastatic surgery|12|||
125207599|NCT00561470|450383424|FG000|Overall Study|Unauthorized procedure|3|||
125207600|NCT00561470|450383425|FG001|Overall Study|Unauthorized procedure|1|||
125207601|NCT00561470|450383424|FG000|Overall Study|Randomized but not treated|5|||
125207602|NCT00561470|450383425|FG001|Overall Study|Randomized but not treated|5|||
125649002|NCT01674010|451997450|FG000|Randomization Phase 2|Pregnancy|0|||
125649003|NCT01674010|451997451|FG001|Randomization Phase 2|Pregnancy|1|||
125649004|NCT01674010|451997452|FG002|Randomization Phase 2|Pregnancy|1|||
125649005|NCT01674010|451997450|FG000|Randomization Phase 2|Protocol Violation|0|||
125649006|NCT01674010|451997451|FG001|Randomization Phase 2|Protocol Violation|1|||
125207603|NCT00561470|450383424|FG000|Overall Study|Missed visit window|1|||
125207604|NCT00561470|450383425|FG001|Overall Study|Missed visit window|4|||
125207605|NCT00561470|450383424|FG000|Overall Study|Planning surgery|1|||
125207606|NCT00561470|450383425|FG001|Overall Study|Planning surgery|1|||
125207607|NCT00561470|450383424|FG000|Overall Study|Ongoing Treatment|11|||
125207608|NCT00561470|450383425|FG001|Overall Study|Ongoing Treatment|14|||
125207609|NCT00637806|450383426|FG000|Double-blind Phase|Study Discontinued|2|||
125207610|NCT00637806|450383427|FG001|Double-blind Phase|Study Discontinued|0|||
125207611|NCT00637806|450383428|FG002|Double-blind Phase|Study Discontinued|1|||
125207612|NCT00637806|450383429|FG003|Double-blind Phase|Study Discontinued|0|||
125207613|NCT00637806|450383426|FG000|Extension Phase|Study Discontinued|0|||
125207614|NCT00637806|450383427|FG001|Extension Phase|Study Discontinued|0|||
125207615|NCT00637806|450383428|FG002|Extension Phase|Study Discontinued|0|||
125207616|NCT00637806|450383429|FG003|Extension Phase|Study Discontinued|1|||
125207617|NCT02918552|450383430|FG000|Overall Study|Failed Pharmacokinetics|1|||
125207618|NCT02918552|450383431|FG001|Overall Study|Failed Pharmacokinetics|0|||
125207619|NCT02918552|450383430|FG000|Overall Study|Withdrawal by Subject|0|||
125207620|NCT02918552|450383431|FG001|Overall Study|Withdrawal by Subject|1|||
125207621|NCT02918552|450383430|FG000|Overall Study|Lost to Follow-up|0|||
125207622|NCT02918552|450383431|FG001|Overall Study|Lost to Follow-up|1|||
125207623|NCT01731470|450383432|FG000|Overall Study|Withdrawal by Subject|1|||
125207624|NCT01731470|450383432|FG000|Overall Study|Did not meet study criteria|1|||
125207625|NCT04395274|450383433|FG000|Overall Study|Lost to Follow-up|20|||
125207626|NCT04395274|450383434|FG001|Overall Study|Lost to Follow-up|11|||
125207627|NCT04395274|450383433|FG000|Overall Study|Withdrawal by Subject|13|||
125207628|NCT04395274|450383434|FG001|Overall Study|Withdrawal by Subject|10|||
125207629|NCT04395274|450383433|FG000|Overall Study|Moved Abroad|0|||
125207630|NCT04395274|450383434|FG001|Overall Study|Moved Abroad|1|||
125207631|NCT03325894|450383435|FG000|Overall Study|Adverse Event|2|||
125207632|NCT03325894|450383436|FG001|Overall Study|Adverse Event|3|||
125207633|NCT03325894|450383435|FG000|Overall Study|Protocol Violation|1|||
125207634|NCT03325894|450383436|FG001|Overall Study|Protocol Violation|2|||
125207635|NCT03325894|450383435|FG000|Overall Study|Withdrawal by Subject|10|||
125207636|NCT03325894|450383436|FG001|Overall Study|Withdrawal by Subject|6|||
125207637|NCT03325894|450383435|FG000|Overall Study|Lost to Follow-up|4|||
125207638|NCT03325894|450383436|FG001|Overall Study|Lost to Follow-up|9|||
125207639|NCT03325894|450383435|FG000|Overall Study|Lack of Efficacy|8|||
125207640|NCT03325894|450383436|FG001|Overall Study|Lack of Efficacy|14|||
125207641|NCT03325894|450383435|FG000|Overall Study|Study Terminated by Sponsor|38|||
125207642|NCT03325894|450383436|FG001|Overall Study|Study Terminated by Sponsor|43|||
125207643|NCT03325894|450383435|FG000|Overall Study|Other (Not received Treatment)|1|||
125207644|NCT03325894|450383436|FG001|Overall Study|Other (Not received Treatment)|0|||
125207645|NCT01592292|450383439|FG000|Overall Study|Follow-up loss|3|||
125207646|NCT01592292|450383440|FG001|Overall Study|Follow-up loss|3|||
125207647|NCT01592292|450383441|FG002|Overall Study|Follow-up loss|1|||
125207648|NCT01592292|450383442|FG003|Overall Study|Follow-up loss|0|||
125207649|NCT01592292|450383439|FG000|Overall Study|Withdrew consent|2|||
125207650|NCT01592292|450383440|FG001|Overall Study|Withdrew consent|1|||
125207651|NCT01592292|450383441|FG002|Overall Study|Withdrew consent|0|||
125207652|NCT01592292|450383442|FG003|Overall Study|Withdrew consent|0|||
125207653|NCT01592292|450383439|FG000|Overall Study|Other|1|||
125207654|NCT01592292|450383440|FG001|Overall Study|Other|1|||
125207655|NCT01592292|450383441|FG002|Overall Study|Other|2|||
125207656|NCT01592292|450383442|FG003|Overall Study|Other|1|||
125207657|NCT00335959|450383443|FG000|Overall Study|Adverse Event|2|||
125207658|NCT00335959|450383443|FG000|Overall Study|Ineligible|1|||
125207659|NCT02450552|450383444|FG000|Overall Study|Withdrawal by Subject|4|||
125207660|NCT02450552|450383445|FG001|Overall Study|Withdrawal by Subject|0|||
125207661|NCT02450552|450383446|FG002|Overall Study|Withdrawal by Subject|4|||
125207662|NCT02450552|450383444|FG000|Overall Study|Physician Decision|1|||
125207663|NCT02450552|450383445|FG001|Overall Study|Physician Decision|0|||
125207664|NCT02450552|450383446|FG002|Overall Study|Physician Decision|1|||
125207665|NCT01876979|450383448|FG000|Overall Study|Physician Decision|2|||
125207666|NCT01876979|450383449|FG001|Overall Study|Physician Decision|3|||
125207667|NCT00948506|450383450|FG000|Overall Study|Withdrawal by Subject|3|||
125207668|NCT00948506|450383451|FG001|Overall Study|Withdrawal by Subject|1|||
125207669|NCT00824382|450383455|FG000|Overall Study|Adverse Event|4|||
125207670|NCT00824382|450383456|FG001|Overall Study|Adverse Event|1|||
125207671|NCT00824382|450383457|FG002|Overall Study|Adverse Event|1|||
125207672|NCT00824382|450383458|FG003|Overall Study|Adverse Event|4|||
125207673|NCT00824382|450383455|FG000|Overall Study|Protocol Violation|1|||
125207674|NCT00824382|450383456|FG001|Overall Study|Protocol Violation|0|||
125207675|NCT00824382|450383457|FG002|Overall Study|Protocol Violation|0|||
125207676|NCT00824382|450383458|FG003|Overall Study|Protocol Violation|1|||
125207677|NCT00824382|450383455|FG000|Overall Study|Investigator's decision|0|||
125207678|NCT00824382|450383456|FG001|Overall Study|Investigator's decision|1|||
125207679|NCT00824382|450383457|FG002|Overall Study|Investigator's decision|2|||
125207680|NCT00824382|450383458|FG003|Overall Study|Investigator's decision|0|||
125207681|NCT00721279|450383459|FG000|Overall Study|Lack of Efficacy|6|||
125207682|NCT00721279|450383460|FG001|Overall Study|Lack of Efficacy|3|||
125207683|NCT00721279|450383459|FG000|Overall Study|Tolerability insufficient|5|||
125207684|NCT00721279|450383460|FG001|Overall Study|Tolerability insufficient|2|||
125207685|NCT00721279|450383459|FG000|Overall Study|Withdrawal by Subject|13|||
125207686|NCT00721279|450383460|FG001|Overall Study|Withdrawal by Subject|3|||
125207687|NCT00721279|450383459|FG000|Overall Study|Other|12|||
125207688|NCT00721279|450383460|FG001|Overall Study|Other|16|||
125207689|NCT02680834|450383461|FG000|Overall Study|Physician Decision|5|||
125207690|NCT02680834|450383462|FG001|Overall Study|Physician Decision|2|||
125207691|NCT02680834|450383461|FG000|Overall Study|Withdrawal by Subject|6|||
125207692|NCT02680834|450383462|FG001|Overall Study|Withdrawal by Subject|0|||
125207693|NCT02680834|450383461|FG000|Overall Study|Lost to Follow-up|0|||
125207694|NCT02680834|450383462|FG001|Overall Study|Lost to Follow-up|1|||
125207695|NCT01732471|450383463|FG000|Overall Study|Withdrawal by Subject|1|||
125207696|NCT00232596|450383464|FG000|6-Week Titration Phase|Adverse Event|6|||
125207697|NCT00232596|450383465|FG001|6-Week Titration Phase|Adverse Event|19|||
125207698|NCT00232596|450383464|FG000|6-Week Titration Phase|Failed to Return|2|||
125207699|NCT00232596|450383465|FG001|6-Week Titration Phase|Failed to Return|1|||
125207700|NCT00232596|450383464|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
125207701|NCT00232596|450383465|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
125207702|NCT00232596|450383464|FG000|6-Week Titration Phase|Protocol Violation|1|||
125207703|NCT00232596|450383465|FG001|6-Week Titration Phase|Protocol Violation|3|||
125207704|NCT00232596|450383464|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
125207705|NCT00232596|450383465|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
125207706|NCT00232596|450383464|FG000|6-Week Titration Phase|Other|3|||
125207707|NCT00232596|450383465|FG001|6-Week Titration Phase|Other|3|||
125207708|NCT00232596|450383464|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
125207709|NCT00232596|450383465|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
125207710|NCT00232596|450383464|FG000|12-Week Maintenance Phase|Adverse Event|7|||
125207711|NCT00232596|450383465|FG001|12-Week Maintenance Phase|Adverse Event|22|||
125207712|NCT00232596|450383464|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
125207713|NCT00232596|450383465|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
125207714|NCT00232596|450383464|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
125207715|NCT00232596|450383465|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
125207716|NCT00232596|450383464|FG000|12-Week Maintenance Phase|Other|1|||
125207717|NCT00232596|450383465|FG001|12-Week Maintenance Phase|Other|3|||
125207718|NCT01253174|450383466|FG000|Period 1|Randomized but not treated|0|||
125207719|NCT01253174|450383467|FG001|Period 1|Randomized but not treated|1|||
125207720|NCT01253174|450383468|FG002|Period 1|Randomized but not treated|1|||
125207721|NCT01253174|450383469|FG003|Period 1|Randomized but not treated|0|||
125207722|NCT01253174|450383470|FG004|Period 1|Randomized but not treated|1|||
125207723|NCT01253174|450383471|FG005|Period 1|Randomized but not treated|0|||
125207724|NCT01253174|450383466|FG000|Period 2|Adverse Event|0|||
125207725|NCT01253174|450383467|FG001|Period 2|Adverse Event|0|||
125207726|NCT01253174|450383468|FG002|Period 2|Adverse Event|1|||
125207727|NCT01253174|450383469|FG003|Period 2|Adverse Event|0|||
125207728|NCT01253174|450383470|FG004|Period 2|Adverse Event|0|||
125207729|NCT01253174|450383471|FG005|Period 2|Adverse Event|0|||
125207730|NCT01253174|450383466|FG000|Period 3|Withdrawal by Subject|0|||
125207731|NCT01253174|450383467|FG001|Period 3|Withdrawal by Subject|1|||
125207732|NCT01253174|450383468|FG002|Period 3|Withdrawal by Subject|0|||
125207733|NCT01253174|450383469|FG003|Period 3|Withdrawal by Subject|0|||
125207734|NCT01253174|450383470|FG004|Period 3|Withdrawal by Subject|1|||
125207735|NCT01253174|450383471|FG005|Period 3|Withdrawal by Subject|0|||
125207736|NCT01253174|450383466|FG000|Period 3|Pregnancy|0|||
125207737|NCT01253174|450383467|FG001|Period 3|Pregnancy|0|||
125207738|NCT01253174|450383468|FG002|Period 3|Pregnancy|1|||
125207739|NCT01253174|450383469|FG003|Period 3|Pregnancy|0|||
125207740|NCT01253174|450383470|FG004|Period 3|Pregnancy|0|||
125207741|NCT01253174|450383471|FG005|Period 3|Pregnancy|0|||
125207742|NCT04438499|450383472|FG000|Overall Study|Lack of Efficacy|3|||
125207743|NCT00224406|450385339|FG000|Overall Study|Re-transplant|0|||
125207744|NCT00224406|450385340|FG001|Overall Study|Re-transplant|2|||
125207745|NCT00224406|450385339|FG000|Overall Study|Death|0|||
125207746|NCT00224406|450385340|FG001|Overall Study|Death|1|||
125207747|NCT00224406|450385339|FG000|Overall Study|Transplant cancelled|0|||
125207748|NCT00224406|450385340|FG001|Overall Study|Transplant cancelled|4|||
125207749|NCT00224406|450385339|FG000|Overall Study|Drug not delivered|2|||
125207750|NCT00224406|450385340|FG001|Overall Study|Drug not delivered|0|||
125207751|NCT00224406|450385339|FG000|Overall Study|Other|4|||
125207752|NCT00224406|450385340|FG001|Overall Study|Other|0|||
125207753|NCT00224406|450385339|FG000|Overall Study|Transplant cancelled|3|||
125207754|NCT00224406|450385340|FG001|Overall Study|Transplant cancelled|0|||
125207755|NCT01556997|450385341|FG000|Overall Study|Adverse Event|10|||
125207756|NCT01556997|450385342|FG001|Overall Study|Adverse Event|12|||
125207757|NCT01556997|450385343|FG002|Overall Study|Adverse Event|12|||
125207758|NCT01556997|450385341|FG000|Overall Study|Lost to Follow-up|6|||
125207759|NCT01556997|450385342|FG001|Overall Study|Lost to Follow-up|6|||
125207760|NCT01556997|450385343|FG002|Overall Study|Lost to Follow-up|4|||
125207761|NCT01556997|450385341|FG000|Overall Study|Physician Decision|1|||
125207762|NCT01556997|450385342|FG001|Overall Study|Physician Decision|1|||
125207763|NCT01556997|450385343|FG002|Overall Study|Physician Decision|1|||
125207764|NCT01556997|450385341|FG000|Overall Study|Withdrawal by Subject|7|||
125207765|NCT01556997|450385342|FG001|Overall Study|Withdrawal by Subject|6|||
125207766|NCT01556997|450385343|FG002|Overall Study|Withdrawal by Subject|8|||
125207767|NCT01556997|450385341|FG000|Overall Study|Other|2|||
125207768|NCT01556997|450385342|FG001|Overall Study|Other|3|||
125207769|NCT01556997|450385343|FG002|Overall Study|Other|7|||
125207770|NCT01172808|450385344|FG000|Overall Study|Adverse Event|8|||
125207771|NCT01172808|450385345|FG001|Overall Study|Adverse Event|4|||
125207772|NCT01172808|450385346|FG002|Overall Study|Adverse Event|8|||
125207773|NCT01172808|450385347|FG003|Overall Study|Adverse Event|3|||
125207774|NCT01172808|450385344|FG000|Overall Study|Lack of Efficacy|1|||
125207775|NCT01172808|450385345|FG001|Overall Study|Lack of Efficacy|0|||
125207776|NCT01172808|450385346|FG002|Overall Study|Lack of Efficacy|0|||
125207777|NCT01172808|450385347|FG003|Overall Study|Lack of Efficacy|0|||
125207778|NCT01172808|450385344|FG000|Overall Study|Protocol Violation|2|||
125207779|NCT01172808|450385345|FG001|Overall Study|Protocol Violation|2|||
125207780|NCT01172808|450385346|FG002|Overall Study|Protocol Violation|2|||
125207781|NCT01172808|450385347|FG003|Overall Study|Protocol Violation|0|||
125207782|NCT01172808|450385344|FG000|Overall Study|Lost to Follow-up|0|||
125207783|NCT01172808|450385345|FG001|Overall Study|Lost to Follow-up|1|||
125207784|NCT01172808|450385346|FG002|Overall Study|Lost to Follow-up|1|||
125207785|NCT01172808|450385347|FG003|Overall Study|Lost to Follow-up|3|||
125207786|NCT01172808|450385344|FG000|Overall Study|Withdrawal by Subject|4|||
125207787|NCT01172808|450385345|FG001|Overall Study|Withdrawal by Subject|1|||
125207788|NCT01172808|450385346|FG002|Overall Study|Withdrawal by Subject|3|||
125207789|NCT01172808|450385347|FG003|Overall Study|Withdrawal by Subject|2|||
125207790|NCT01172808|450385344|FG000|Overall Study|Other|6|||
125207791|NCT01172808|450385345|FG001|Overall Study|Other|5|||
125207792|NCT01172808|450385346|FG002|Overall Study|Other|9|||
125207793|NCT01172808|450385347|FG003|Overall Study|Other|7|||
125207794|NCT01092637|450385355|FG000|Overall Study|Death|47|||
125207795|NCT01092637|450385356|FG001|Overall Study|Death|49|||
125207796|NCT02278367|450385357|FG000|Overall Study|Physician Decision|5|||
125207797|NCT02278367|450385358|FG001|Overall Study|Physician Decision|0|||
125207798|NCT02278367|450385357|FG000|Overall Study|Withdrawal by Subject|5|||
125207799|NCT02278367|450385358|FG001|Overall Study|Withdrawal by Subject|0|||
125207800|NCT05932225|450385360|FG000|Overall Study|Lost to Follow-up|0|||
125207801|NCT05932225|450385361|FG001|Overall Study|Lost to Follow-up|1|||
125207802|NCT05932225|450385362|FG002|Overall Study|Lost to Follow-up|0|||
125207803|NCT05932225|450385360|FG000|Overall Study|Withdrawal by Subject|1|||
125207804|NCT05932225|450385361|FG001|Overall Study|Withdrawal by Subject|0|||
125207805|NCT05932225|450385362|FG002|Overall Study|Withdrawal by Subject|0|||
125207806|NCT05932225|450385360|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
125207807|NCT05932225|450385361|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
125207808|NCT05932225|450385362|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
125207809|NCT02638129|450385363|FG000|Overall Study|Study terminated|28|||
125207810|NCT02638129|450385364|FG001|Overall Study|Study terminated|30|||
125207811|NCT02949908|450385367|FG000|Overall Study|Study termination|2|||
125207812|NCT02607280|450385372|FG000|Overall Study|Adverse Event|4|||
125207813|NCT02607280|450385373|FG001|Overall Study|Adverse Event|0|||
125207814|NCT02607280|450385372|FG000|Overall Study|Decrease in CrCl <15|0|||
125207815|NCT02607280|450385373|FG001|Overall Study|Decrease in CrCl <15|1|||
125207816|NCT01004432|450385374|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
125207817|NCT01004432|450385375|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
125207818|NCT01004432|450385376|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
125207819|NCT01004432|450385377|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
125207820|NCT01004432|450385378|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
125207821|NCT01004432|450385374|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
125207822|NCT01004432|450385375|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
125207823|NCT01004432|450385376|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
125207824|NCT01004432|450385377|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
125207825|NCT01004432|450385378|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
125207826|NCT01004432|450385374|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
125207827|NCT01004432|450385375|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
125207828|NCT01004432|450385376|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
125207829|NCT01004432|450385377|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
125207830|NCT01004432|450385378|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
125207831|NCT01004432|450385374|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
125207832|NCT01004432|450385375|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
125207833|NCT01004432|450385376|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
125207834|NCT01004432|450385377|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
125207835|NCT01004432|450385378|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
125207836|NCT01004432|450385374|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
125207837|NCT01004432|450385375|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
125207838|NCT01004432|450385376|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
125207839|NCT01004432|450385377|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
125207840|NCT01004432|450385378|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
125207841|NCT01004432|450385374|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
125207842|NCT01004432|450385375|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
125207843|NCT01004432|450385376|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
125207844|NCT01004432|450385377|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
125207845|NCT01004432|450385378|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
125207846|NCT01004432|450385374|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
125207847|NCT01004432|450385375|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
125207848|NCT01004432|450385376|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
125207849|NCT01004432|450385377|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
125207850|NCT01004432|450385378|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
125207851|NCT01004432|450385374|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
125207852|NCT01004432|450385375|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
125207853|NCT01004432|450385376|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
125207854|NCT01004432|450385377|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
125207855|NCT01004432|450385378|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
125207856|NCT01004432|450385374|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
125207857|NCT01004432|450385375|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
125207858|NCT01004432|450385376|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
125207859|NCT01004432|450385377|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
125207860|NCT01004432|450385378|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
125207861|NCT01004432|450385374|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
125207862|NCT01004432|450385375|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
125207863|NCT01004432|450385376|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
125207864|NCT01004432|450385377|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
125207865|NCT01004432|450385378|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
125207866|NCT01004432|450385374|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
125207867|NCT01004432|450385375|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
125207868|NCT01004432|450385376|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
125207869|NCT01004432|450385377|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
125207870|NCT01004432|450385378|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
125207871|NCT01004432|450385374|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
125207872|NCT01004432|450385375|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
125207873|NCT01004432|450385376|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
125207874|NCT01004432|450385377|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
125207875|NCT01004432|450385378|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
125207876|NCT01004432|450385374|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
125207877|NCT01004432|450385375|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
125207878|NCT01004432|450385376|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
125207879|NCT01004432|450385377|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
125207880|NCT01004432|450385378|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
125207881|NCT01004432|450385374|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
125207882|NCT01004432|450385375|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
125207883|NCT01004432|450385376|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
125207884|NCT01004432|450385377|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
125207885|NCT01004432|450385378|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
125207886|NCT01004432|450385374|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
125207887|NCT01004432|450385375|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
125207888|NCT01004432|450385376|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
125207889|NCT01004432|450385377|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
125207890|NCT01004432|450385378|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
125207891|NCT02667626|450385379|FG000|Overall Study|Withdrawal by Subject|0|||
125207892|NCT02667626|450385380|FG001|Overall Study|Withdrawal by Subject|1|||
125207893|NCT02696434|450385382|FG000|Overall Study|Adverse Event|3|||
125207894|NCT02696434|450385383|FG001|Overall Study|Adverse Event|1|||
125207895|NCT02696434|450385382|FG000|Overall Study|Lost to Follow-up|5|||
125207896|NCT02696434|450385383|FG001|Overall Study|Lost to Follow-up|4|||
125207897|NCT02696434|450385382|FG000|Overall Study|Withdrawal by Subject|14|||
125207898|NCT02696434|450385383|FG001|Overall Study|Withdrawal by Subject|12|||
125207899|NCT02696434|450385382|FG000|Overall Study|Physician Decision|0|||
125207900|NCT02696434|450385383|FG001|Overall Study|Physician Decision|1|||
125207901|NCT02539134|450385384|FG000|Overall Study|Lost to Follow-up|1|||
125207902|NCT02539134|450385385|FG001|Overall Study|Lost to Follow-up|0|||
125207903|NCT02539134|450385386|FG002|Overall Study|Lost to Follow-up|0|||
125649007|NCT01674010|451997452|FG002|Randomization Phase 2|Protocol Violation|1|||
125207904|NCT02539134|450385387|FG003|Overall Study|Lost to Follow-up|0|||
125207905|NCT02539134|450385388|FG004|Overall Study|Lost to Follow-up|0|||
125649008|NCT01674010|451997450|FG000|Randomization Phase 2|Sponsor Decision|0|||
125207906|NCT02539134|450385389|FG005|Overall Study|Lost to Follow-up|0|||
125207907|NCT01149421|450385390|FG000|Overall Study|Adverse Event|22|||
125207908|NCT01149421|450385391|FG001|Overall Study|Adverse Event|6|||
125207909|NCT01149421|450385392|FG002|Overall Study|Adverse Event|11|||
125207910|NCT01149421|450385390|FG000|Overall Study|Withdrawal by Subject|20|||
125207911|NCT01149421|450385391|FG001|Overall Study|Withdrawal by Subject|12|||
125207912|NCT01149421|450385392|FG002|Overall Study|Withdrawal by Subject|13|||
125207913|NCT01149421|450385390|FG000|Overall Study|Sponsor Decision|0|||
125207914|NCT01149421|450385391|FG001|Overall Study|Sponsor Decision|1|||
125207915|NCT01149421|450385392|FG002|Overall Study|Sponsor Decision|1|||
125207916|NCT01149421|450385390|FG000|Overall Study|Lost to Follow-up|2|||
125207917|NCT01149421|450385391|FG001|Overall Study|Lost to Follow-up|4|||
125207918|NCT01149421|450385392|FG002|Overall Study|Lost to Follow-up|5|||
125207919|NCT01149421|450385390|FG000|Overall Study|Physician Decision|5|||
125207920|NCT01149421|450385391|FG001|Overall Study|Physician Decision|3|||
125207921|NCT01149421|450385392|FG002|Overall Study|Physician Decision|6|||
125207922|NCT01149421|450385390|FG000|Overall Study|Entry Criteria Not Met|1|||
125207923|NCT01149421|450385391|FG001|Overall Study|Entry Criteria Not Met|1|||
125207924|NCT01149421|450385392|FG002|Overall Study|Entry Criteria Not Met|2|||
125207925|NCT01149421|450385390|FG000|Overall Study|Protocol Violation|2|||
125207926|NCT01149421|450385391|FG001|Overall Study|Protocol Violation|2|||
125207927|NCT01149421|450385392|FG002|Overall Study|Protocol Violation|6|||
125207928|NCT00616603|450385393|FG000|Overall Study|Physician Decision|2|||
125207929|NCT00616603|450385394|FG001|Overall Study|Physician Decision|0|||
125207930|NCT00616603|450385395|FG002|Overall Study|Physician Decision|2|||
125207931|NCT00766467|450385397|FG000|Overall Study|Withdrawal by Subject|7|||
125207932|NCT00766467|450385398|FG001|Overall Study|Withdrawal by Subject|2|||
125207933|NCT00766467|450385397|FG000|Overall Study|Adverse Event|1|||
125207934|NCT00766467|450385398|FG001|Overall Study|Adverse Event|1|||
125207935|NCT00766467|450385397|FG000|Overall Study|Protocol Violation|2|||
125207936|NCT00766467|450385398|FG001|Overall Study|Protocol Violation|4|||
125207937|NCT00766467|450385397|FG000|Overall Study|Tumor Progression on Study|0|||
125207938|NCT00766467|450385398|FG001|Overall Study|Tumor Progression on Study|1|||
125207939|NCT00766467|450385397|FG000|Overall Study|Physician Decision|1|||
125207940|NCT00766467|450385398|FG001|Overall Study|Physician Decision|0|||
125207941|NCT00943670|450385408|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
125207942|NCT00943670|450385408|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
125207943|NCT00943670|450385408|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
125207944|NCT00943670|450385408|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
125207945|NCT00943670|450385408|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
125207946|NCT00943670|450385408|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
125207947|NCT00943670|450385408|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
125207948|NCT00943670|450385408|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
125207949|NCT00943670|450385408|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
125207950|NCT00943670|450385408|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
125207951|NCT03956615|450385409|FG000|Overall Study|No multiple myeloma confirmed|2|||
125207952|NCT03956615|450385409|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
125207953|NCT03956615|450385409|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
125207954|NCT03956615|450385409|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
125207955|NCT01069419|450385410|FG000|Overall Study|Adverse Event|233|||
125207956|NCT01069419|450385410|FG000|Overall Study|Lack of Efficacy|332|||
125207957|NCT01069419|450385410|FG000|Overall Study|Lost to Follow-up|49|||
125207958|NCT01069419|450385410|FG000|Overall Study|Remission of disease|11|||
125207959|NCT01069419|450385410|FG000|Overall Study|Withdrawal by Subject|34|||
125207960|NCT01069419|450385410|FG000|Overall Study|Other Reason|43|||
125207961|NCT01069419|450385410|FG000|Overall Study|Missing termination information|13|||
125207962|NCT00908076|450385411|FG000|Overall Study|Lack of Efficacy|1|||
125207963|NCT00908076|450385412|FG001|Overall Study|Lack of Efficacy|1|||
125207964|NCT02382796|450385413|FG000|Overall Study|Global deterioration of health status|1|||
125207965|NCT02382796|450385413|FG000|Overall Study|Objective progression or relapse|3|||
125207966|NCT02382796|450385413|FG000|Overall Study|Commercial dacomitinib became available|3|||
125207967|NCT00334802|450385420|FG000|Overall Study|Progressive Disease|2|||
125207968|NCT00334802|450385421|FG001|Overall Study|Progressive Disease|24|||
125207969|NCT00334802|450385420|FG000|Overall Study|Toxicity|1|||
125207970|NCT00334802|450385421|FG001|Overall Study|Toxicity|5|||
125207971|NCT00334802|450385420|FG000|Overall Study|Lack of Efficacy|1|||
125207972|NCT00334802|450385421|FG001|Overall Study|Lack of Efficacy|3|||
125207973|NCT00334802|450385420|FG000|Overall Study|Patient Condition Aggrevated|1|||
125207974|NCT00334802|450385421|FG001|Overall Study|Patient Condition Aggrevated|0|||
125207975|NCT00334802|450385420|FG000|Overall Study|Physician Decision|1|||
125207976|NCT00334802|450385421|FG001|Overall Study|Physician Decision|0|||
125207977|NCT00334802|450385420|FG000|Overall Study|Withdrawal by Subject|0|||
125207978|NCT00334802|450385421|FG001|Overall Study|Withdrawal by Subject|4|||
125207979|NCT00334802|450385420|FG000|Overall Study|Adverse Event|0|||
125207980|NCT00334802|450385421|FG001|Overall Study|Adverse Event|3|||
125649009|NCT01674010|451997451|FG001|Randomization Phase 2|Sponsor Decision|42|||
125649010|NCT01674010|451997452|FG002|Randomization Phase 2|Sponsor Decision|45|||
125649011|NCT01674010|451997450|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
125649012|NCT01674010|451997451|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
125649013|NCT01674010|451997452|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
125649014|NCT03159455|451997453|FG000|Overall Study|Adverse Event|0|||
125649015|NCT03159455|451997454|FG001|Overall Study|Adverse Event|0|||
125649016|NCT03159455|451997455|FG002|Overall Study|Adverse Event|0|||
125649017|NCT03159455|451997456|FG003|Overall Study|Adverse Event|0|||
125649018|NCT03159455|451997457|FG004|Overall Study|Adverse Event|0|||
125207981|NCT00334802|450385420|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
125649019|NCT03159455|451997458|FG005|Overall Study|Adverse Event|1|||
125649020|NCT01801475|451997466|FG000|Overall Study|Withdrawal by Subject|0|||
125649021|NCT01801475|451997467|FG001|Overall Study|Withdrawal by Subject|0|||
125649022|NCT01801475|451997468|FG002|Overall Study|Withdrawal by Subject|0|||
125649023|NCT01801475|451997469|FG003|Overall Study|Withdrawal by Subject|0|||
125649024|NCT01801475|451997470|FG004|Overall Study|Withdrawal by Subject|1|||
125649025|NCT00421928|451997473|FG000|Overall Study|Adverse Event|61|||
125649026|NCT00421928|451997474|FG001|Overall Study|Adverse Event|140|||
125649027|NCT00421928|451997475|FG002|Overall Study|Adverse Event|22|||
125649028|NCT00421928|451997473|FG000|Overall Study|Lost to Follow-up|5|||
125649029|NCT00421928|451997474|FG001|Overall Study|Lost to Follow-up|0|||
125649030|NCT00421928|451997475|FG002|Overall Study|Lost to Follow-up|3|||
125649031|NCT00421928|451997473|FG000|Overall Study|Withdrawal by Subject|50|||
125649032|NCT00421928|451997474|FG001|Overall Study|Withdrawal by Subject|48|||
125649033|NCT00421928|451997475|FG002|Overall Study|Withdrawal by Subject|43|||
125649034|NCT00421928|451997473|FG000|Overall Study|Lack of Efficacy|15|||
125649035|NCT00421928|451997474|FG001|Overall Study|Lack of Efficacy|7|||
125649036|NCT00421928|451997475|FG002|Overall Study|Lack of Efficacy|35|||
125649037|NCT00421928|451997473|FG000|Overall Study|Study drug non-compliant|6|||
125649038|NCT00421928|451997474|FG001|Overall Study|Study drug non-compliant|7|||
125649039|NCT00421928|451997475|FG002|Overall Study|Study drug non-compliant|4|||
125649040|NCT00421928|451997473|FG000|Overall Study|All other|26|||
125649041|NCT00421928|451997474|FG001|Overall Study|All other|21|||
125649042|NCT00421928|451997475|FG002|Overall Study|All other|27|||
125649043|NCT00421928|451997473|FG000|Overall Study|Death|0|||
125649044|NCT00421928|451997474|FG001|Overall Study|Death|1|||
125649045|NCT00421928|451997475|FG002|Overall Study|Death|0|||
125649046|NCT02713490|451997484|FG000|Overall Study|Withdrawal by Subject|2|||
125649047|NCT02713490|451997485|FG001|Overall Study|Withdrawal by Subject|1|||
125649048|NCT02713490|451997484|FG000|Overall Study|Did not receive study drug|1|||
125649049|NCT02713490|451997485|FG001|Overall Study|Did not receive study drug|0|||
125649050|NCT02713490|451997484|FG000|Overall Study|Met exclusion criteria|0|||
125649051|NCT02713490|451997485|FG001|Overall Study|Met exclusion criteria|1|||
125649052|NCT00346775|451997486|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
125649053|NCT00346775|451997487|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
125649054|NCT00346775|451997486|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
125649055|NCT00346775|451997487|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
125649056|NCT00346775|451997486|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
125649057|NCT00346775|451997487|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
125649058|NCT03799198|451997488|FG000|Overall Study|Lost to Follow-up|4|||
125649059|NCT03799198|451997489|FG001|Overall Study|Lost to Follow-up|8|||
125649060|NCT03799198|451997488|FG000|Overall Study|Death|0|||
125649061|NCT03799198|451997489|FG001|Overall Study|Death|1|||
125649062|NCT00960869|451997490|FG000|Overall Study|Adverse Event|17|||
125649063|NCT00960869|451997491|FG001|Overall Study|Adverse Event|26|||
125207982|NCT00334802|450385421|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
125207983|NCT03887117|450385422|FG000|Overall Study|Discontinued prematurely|0|||
125207984|NCT03887117|450385423|FG001|Overall Study|Discontinued prematurely|1|||
125207985|NCT03887117|450385424|FG002|Overall Study|Discontinued prematurely|1|||
125207986|NCT03887117|450385425|FG003|Overall Study|Discontinued prematurely|2|||
125207987|NCT01739764|450385426|FG000|Overall Study|Adverse Event|0|||
125207988|NCT01739764|450385427|FG001|Overall Study|Adverse Event|3|||
125207989|NCT01739764|450385428|FG002|Overall Study|Adverse Event|4|||
125207990|NCT01739764|450385426|FG000|Overall Study|Death|4|||
125207991|NCT01739764|450385427|FG001|Overall Study|Death|6|||
125207992|NCT01739764|450385428|FG002|Overall Study|Death|38|||
125649064|NCT00960869|451997490|FG000|Overall Study|Withdrawal by Subject|16|||
125649065|NCT00960869|451997491|FG001|Overall Study|Withdrawal by Subject|14|||
125649066|NCT00960869|451997490|FG000|Overall Study|Lost to Follow-up|1|||
125649067|NCT00960869|451997491|FG001|Overall Study|Lost to Follow-up|4|||
125649068|NCT00960869|451997490|FG000|Overall Study|Misc|19|||
125207993|NCT01739764|450385426|FG000|Overall Study|Lost to Follow-up|0|||
125207994|NCT01739764|450385427|FG001|Overall Study|Lost to Follow-up|0|||
125207995|NCT01739764|450385428|FG002|Overall Study|Lost to Follow-up|5|||
125649069|NCT00960869|451997491|FG001|Overall Study|Misc|18|||
125649070|NCT01714726|451997492|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
125207996|NCT01739764|450385426|FG000|Overall Study|Non-Compliance|0|||
125207997|NCT01739764|450385427|FG001|Overall Study|Non-Compliance|0|||
125207998|NCT01739764|450385428|FG002|Overall Study|Non-Compliance|1|||
125207999|NCT01739764|450385426|FG000|Overall Study|Multiple Reasons|3|||
125208000|NCT01739764|450385427|FG001|Overall Study|Multiple Reasons|2|||
125208001|NCT01739764|450385428|FG002|Overall Study|Multiple Reasons|3|||
125208002|NCT01739764|450385426|FG000|Overall Study|Physician Decision|2|||
125208003|NCT01739764|450385427|FG001|Overall Study|Physician Decision|2|||
125208004|NCT01739764|450385428|FG002|Overall Study|Physician Decision|4|||
125208005|NCT01739764|450385426|FG000|Overall Study|Progressive Disease|3|||
125208006|NCT01739764|450385427|FG001|Overall Study|Progressive Disease|5|||
125208007|NCT01739764|450385428|FG002|Overall Study|Progressive Disease|16|||
125208008|NCT01739764|450385426|FG000|Overall Study|Protocol Violation|0|||
125208009|NCT01739764|450385427|FG001|Overall Study|Protocol Violation|0|||
125208010|NCT01739764|450385428|FG002|Overall Study|Protocol Violation|2|||
125208011|NCT01739764|450385426|FG000|Overall Study|Study Terminated by Sponsor|8|||
125208012|NCT01739764|450385427|FG001|Overall Study|Study Terminated by Sponsor|13|||
125208013|NCT01739764|450385428|FG002|Overall Study|Study Terminated by Sponsor|26|||
125208014|NCT01739764|450385426|FG000|Overall Study|Withdrawal by Subject|6|||
125208015|NCT01739764|450385427|FG001|Overall Study|Withdrawal by Subject|5|||
125208016|NCT01739764|450385428|FG002|Overall Study|Withdrawal by Subject|27|||
125208017|NCT01389258|450385429|FG000|Overall Study|Lost to Follow-up|5|||
125208018|NCT01534208|450385430|FG000|Overall Study|Lost to Follow-up|19|||
125208019|NCT01534208|450385431|FG001|Overall Study|Lost to Follow-up|14|||
125208020|NCT01534208|450385430|FG000|Overall Study|Withdrawal by Subject|6|||
125208021|NCT01534208|450385431|FG001|Overall Study|Withdrawal by Subject|20|||
125208022|NCT01534208|450385430|FG000|Overall Study|Adverse Event|15|||
125208023|NCT01534208|450385431|FG001|Overall Study|Adverse Event|8|||
125208024|NCT01534208|450385430|FG000|Overall Study|Physician Decision|2|||
125208025|NCT01534208|450385431|FG001|Overall Study|Physician Decision|0|||
125208026|NCT01534208|450385430|FG000|Overall Study|Lack of Efficacy|0|||
125208027|NCT01534208|450385431|FG001|Overall Study|Lack of Efficacy|3|||
125208028|NCT01534208|450385430|FG000|Overall Study|Protocol Violation|2|||
125208029|NCT01534208|450385431|FG001|Overall Study|Protocol Violation|2|||
125208030|NCT01534208|450385430|FG000|Overall Study|Sponsor decision|4|||
125208031|NCT01534208|450385431|FG001|Overall Study|Sponsor decision|1|||
125208032|NCT01534208|450385430|FG000|Overall Study|Subject relocation|2|||
125208033|NCT01534208|450385431|FG001|Overall Study|Subject relocation|0|||
125208034|NCT01534208|450385430|FG000|Overall Study|Lab assessment|2|||
125208035|NCT01534208|450385431|FG001|Overall Study|Lab assessment|1|||
125208036|NCT01534208|450385430|FG000|Overall Study|Eligibility error|3|||
125208037|NCT01534208|450385431|FG001|Overall Study|Eligibility error|0|||
125208038|NCT01534208|450385430|FG000|Overall Study|PCP decision|1|||
125208039|NCT01534208|450385431|FG001|Overall Study|PCP decision|0|||
125208040|NCT01534208|450385430|FG000|Overall Study|Needed prohibited meds|1|||
125208041|NCT01534208|450385431|FG001|Overall Study|Needed prohibited meds|0|||
125208042|NCT03482167|450385434|FG000|Allocated to Intervention|Physician Decision|1|||
125208043|NCT03482167|450385435|FG001|Allocated to Intervention|Physician Decision|2|||
125208044|NCT03482167|450385434|FG000|Received Intervention|Adverse Event|3|||
125208045|NCT03482167|450385435|FG001|Received Intervention|Adverse Event|1|||
125208046|NCT03482167|450385434|FG000|Received Intervention|Physician Decision|1|||
125208047|NCT03482167|450385435|FG001|Received Intervention|Physician Decision|1|||
125208048|NCT03482167|450385434|FG000|Received Intervention|Withdrawal by Subject|1|||
125208049|NCT03482167|450385435|FG001|Received Intervention|Withdrawal by Subject|0|||
125208050|NCT01001598|450385440|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
125208051|NCT01001598|450385440|FG000|Overall Study|Adverse Event|1|||
125208052|NCT05079230|450385451|FG000|Overall Study|Study Terminated by Sponsor|101|||
125208053|NCT05079230|450385452|FG001|Overall Study|Study Terminated by Sponsor|102|||
125208054|NCT05079230|450385451|FG000|Overall Study|Death|72|||
125208055|NCT05079230|450385452|FG001|Overall Study|Death|66|||
125208056|NCT05079230|450385451|FG000|Overall Study|Withdrew Consent|16|||
125208057|NCT05079230|450385452|FG001|Overall Study|Withdrew Consent|18|||
125208058|NCT05079230|450385451|FG000|Overall Study|Lost to Follow-up|0|||
125208059|NCT05079230|450385452|FG001|Overall Study|Lost to Follow-up|3|||
125208060|NCT02920177|450385453|FG000|Overall Study|Withdrawal by Subject|1|||
125208061|NCT02920177|450385454|FG001|Overall Study|Withdrawal by Subject|1|||
125208062|NCT02920177|450385453|FG000|Overall Study|Physician Decision|1|||
125208063|NCT02920177|450385454|FG001|Overall Study|Physician Decision|0|||
125208064|NCT02920177|450385453|FG000|Overall Study|Lost to Follow-up|0|||
125208065|NCT02920177|450385454|FG001|Overall Study|Lost to Follow-up|1|||
125208066|NCT01362244|450385456|FG000|Overall Study|Adverse Event|3|||
125208067|NCT01362244|450385457|FG001|Overall Study|Adverse Event|5|||
125208068|NCT01362244|450385456|FG000|Overall Study|Lack of Efficacy|5|||
125208069|NCT01362244|450385457|FG001|Overall Study|Lack of Efficacy|11|||
125208070|NCT01362244|450385456|FG000|Overall Study|Lost to Follow-up|0|||
125208071|NCT01362244|450385457|FG001|Overall Study|Lost to Follow-up|2|||
125208072|NCT01362244|450385456|FG000|Overall Study|Protocol Violation|5|||
125208073|NCT01362244|450385457|FG001|Overall Study|Protocol Violation|1|||
125424880|NCT00430248|451178700|FG001|Overall Study|Reason Not Specified|8|||
125208074|NCT01362244|450385456|FG000|Overall Study|Withdrawal by Subject|2|||
125208075|NCT01362244|450385457|FG001|Overall Study|Withdrawal by Subject|1|||
125208076|NCT01362244|450385456|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
125208077|NCT01362244|450385457|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
125208078|NCT01362244|450385456|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
125208079|NCT01362244|450385457|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
125208080|NCT05153148|450385458|FG000|Overall Study|Adverse Event|1|||
125208081|NCT05153148|450385459|FG001|Overall Study|Adverse Event|0|||
125649071|NCT01714726|451997493|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
125649072|NCT01714726|451997494|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
125649073|NCT01714726|451997495|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
125649074|NCT01714726|451997492|FG000|Double-Blinded Induction Period|Adverse Event|0|||
125649075|NCT01714726|451997493|FG001|Double-Blinded Induction Period|Adverse Event|1|||
125649076|NCT01714726|451997494|FG002|Double-Blinded Induction Period|Adverse Event|0|||
125649077|NCT01714726|451997495|FG003|Double-Blinded Induction Period|Adverse Event|0|||
125649078|NCT01714726|451997492|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
125649079|NCT01714726|451997493|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
125649080|NCT01714726|451997494|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
125649081|NCT01714726|451997495|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
125649082|NCT01714726|451997492|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
125649083|NCT01714726|451997493|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
125649084|NCT01714726|451997494|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
125649085|NCT01714726|451997495|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
125649086|NCT01714726|451997492|FG000|Open-Label Period|Other|0|||
125649087|NCT01714726|451997493|FG001|Open-Label Period|Other|0|||
125649088|NCT01714726|451997494|FG002|Open-Label Period|Other|1|||
125649089|NCT01714726|451997495|FG003|Open-Label Period|Other|3|||
125649090|NCT01714726|451997492|FG000|Open-Label Period|Adverse Event|0|||
125649091|NCT01714726|451997493|FG001|Open-Label Period|Adverse Event|0|||
125649092|NCT01714726|451997494|FG002|Open-Label Period|Adverse Event|1|||
125649093|NCT01714726|451997495|FG003|Open-Label Period|Adverse Event|0|||
125649094|NCT01714726|451997492|FG000|Open-Label Period|Withdrawal by Subject|0|||
125649095|NCT01714726|451997493|FG001|Open-Label Period|Withdrawal by Subject|0|||
125649096|NCT01714726|451997494|FG002|Open-Label Period|Withdrawal by Subject|9|||
125649097|NCT01714726|451997495|FG003|Open-Label Period|Withdrawal by Subject|19|||
125649098|NCT01714726|451997492|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
125649099|NCT01714726|451997493|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
125649100|NCT01714726|451997494|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
125649101|NCT01714726|451997495|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
125649102|NCT01714726|451997492|FG000|Open-Label Period|Lost to Follow-up|0|||
125649103|NCT01714726|451997493|FG001|Open-Label Period|Lost to Follow-up|0|||
125649104|NCT01714726|451997494|FG002|Open-Label Period|Lost to Follow-up|3|||
125649105|NCT01714726|451997495|FG003|Open-Label Period|Lost to Follow-up|4|||
125649106|NCT00548340|451997498|FG000|Overall Study|Protocol Violation|2|||
125649107|NCT00548340|451997499|FG001|Overall Study|Protocol Violation|3|||
125649108|NCT00548340|451997500|FG002|Overall Study|Protocol Violation|3|||
125649109|NCT00548340|451997498|FG000|Overall Study|Adverse Event|2|||
125649110|NCT00548340|451997499|FG001|Overall Study|Adverse Event|2|||
125649111|NCT00548340|451997500|FG002|Overall Study|Adverse Event|2|||
125649112|NCT00548340|451997498|FG000|Overall Study|Lost to Follow-up|1|||
125649113|NCT00548340|451997499|FG001|Overall Study|Lost to Follow-up|1|||
125649114|NCT00548340|451997500|FG002|Overall Study|Lost to Follow-up|0|||
125649115|NCT00548340|451997498|FG000|Overall Study|Withdrawal by Subject|2|||
125649116|NCT00548340|451997499|FG001|Overall Study|Withdrawal by Subject|4|||
125649117|NCT00548340|451997500|FG002|Overall Study|Withdrawal by Subject|3|||
125208082|NCT05153148|450385460|FG002|Overall Study|Adverse Event|3|||
125208083|NCT05153148|450385461|FG003|Overall Study|Adverse Event|5|||
125208084|NCT05153148|450385458|FG000|Overall Study|Lost to Follow-up|1|||
125208085|NCT05153148|450385459|FG001|Overall Study|Lost to Follow-up|1|||
125208086|NCT05153148|450385460|FG002|Overall Study|Lost to Follow-up|2|||
125208087|NCT05153148|450385461|FG003|Overall Study|Lost to Follow-up|0|||
125208088|NCT05153148|450385458|FG000|Overall Study|Withdrawal by Subject|6|||
125208089|NCT05153148|450385459|FG001|Overall Study|Withdrawal by Subject|8|||
125208090|NCT05153148|450385460|FG002|Overall Study|Withdrawal by Subject|6|||
125208091|NCT05153148|450385461|FG003|Overall Study|Withdrawal by Subject|8|||
125208092|NCT05153148|450385458|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
125208093|NCT05153148|450385459|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
125208094|NCT05153148|450385460|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
125208095|NCT05153148|450385461|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
125649118|NCT00548340|451997498|FG000|Overall Study|Other|1|||
125649119|NCT00548340|451997499|FG001|Overall Study|Other|1|||
125649120|NCT00548340|451997500|FG002|Overall Study|Other|1|||
125649121|NCT01096017|451997501|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
125649122|NCT01096017|451997502|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
125208096|NCT05153148|450385458|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
125208097|NCT05153148|450385459|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
125208098|NCT05153148|450385460|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
125208099|NCT05153148|450385461|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
125208100|NCT05153148|450385458|FG000|Overall Study|Reason not Specified|1|||
125208101|NCT05153148|450385459|FG001|Overall Study|Reason not Specified|1|||
125208102|NCT05153148|450385460|FG002|Overall Study|Reason not Specified|1|||
125208103|NCT05153148|450385461|FG003|Overall Study|Reason not Specified|1|||
125208104|NCT01712334|450385462|FG000|Treatment Period 1|Randomized in Error|0|||
125208105|NCT01712334|450385463|FG001|Treatment Period 1|Randomized in Error|2|||
125208106|NCT02892513|450385466|FG000|Overall Study|Withdrawal by Subject|0|||
125208107|NCT02892513|450385467|FG001|Overall Study|Withdrawal by Subject|1|||
125208108|NCT03426436|450385468|FG000|Overall Study|Incorrect lead placement|12|||
125208109|NCT03426436|450385468|FG000|Overall Study|Withdrawal by Subject|2|||
125208110|NCT03426436|450385468|FG000|Overall Study|Consent issue|1|||
125208111|NCT03426436|450385468|FG000|Overall Study|ECGs not saved|4|||
125208112|NCT02919267|450385469|FG000|Overall Study|Protocol Violation|0|||
125208113|NCT02919267|450385470|FG001|Overall Study|Protocol Violation|3|||
125208114|NCT02919267|450385471|FG002|Overall Study|Protocol Violation|3|||
125208115|NCT02919267|450385472|FG003|Overall Study|Protocol Violation|4|||
125208116|NCT02407054|450385473|FG000|Overall Study|Adverse Event|1|||
125208117|NCT02407054|450385474|FG001|Overall Study|Adverse Event|4|||
125208118|NCT02407054|450385475|FG002|Overall Study|Adverse Event|1|||
125208119|NCT02407054|450385473|FG000|Overall Study|Non-compliance with Study|0|||
125208120|NCT02407054|450385474|FG001|Overall Study|Non-compliance with Study|2|||
125208121|NCT02407054|450385475|FG002|Overall Study|Non-compliance with Study|1|||
125208122|NCT02407054|450385473|FG000|Overall Study|Physician Decision|1|||
125208123|NCT02407054|450385474|FG001|Overall Study|Physician Decision|3|||
125208124|NCT02407054|450385475|FG002|Overall Study|Physician Decision|3|||
125208125|NCT02407054|450385473|FG000|Overall Study|Withdrawal by Subject|5|||
125208126|NCT02407054|450385474|FG001|Overall Study|Withdrawal by Subject|9|||
125208127|NCT02407054|450385475|FG002|Overall Study|Withdrawal by Subject|2|||
125208128|NCT00131365|450385476|FG000|Overall Study|Withdrawal by Subject|1|||
125208129|NCT00131365|450385476|FG000|Overall Study|Alternative treatment|3|||
125208130|NCT04608344|450385477|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
125208131|NCT04608344|450385478|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
125208132|NCT04608344|450385477|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
125208133|NCT04608344|450385478|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
125208134|NCT02044874|450385479|FG000|Overall Study|Adverse Event|5|||
125208135|NCT02044874|450385480|FG001|Overall Study|Adverse Event|6|||
125208136|NCT02044874|450385481|FG002|Overall Study|Adverse Event|6|||
125208137|NCT02044874|450385479|FG000|Overall Study|Withdrawal by Subject|8|||
125208138|NCT02044874|450385480|FG001|Overall Study|Withdrawal by Subject|16|||
125208139|NCT02044874|450385481|FG002|Overall Study|Withdrawal by Subject|23|||
125208140|NCT02044874|450385479|FG000|Overall Study|Physician Decision|0|||
125208141|NCT02044874|450385480|FG001|Overall Study|Physician Decision|2|||
125208142|NCT02044874|450385481|FG002|Overall Study|Physician Decision|1|||
125208143|NCT02044874|450385479|FG000|Overall Study|Lost to Follow-up|10|||
125208144|NCT02044874|450385480|FG001|Overall Study|Lost to Follow-up|27|||
125208145|NCT02044874|450385481|FG002|Overall Study|Lost to Follow-up|21|||
125208146|NCT02044874|450385479|FG000|Overall Study|Sponsor Decision|0|||
125208147|NCT02044874|450385480|FG001|Overall Study|Sponsor Decision|1|||
125208148|NCT02044874|450385481|FG002|Overall Study|Sponsor Decision|1|||
125208149|NCT02044874|450385479|FG000|Overall Study|Other|7|||
125208150|NCT02044874|450385480|FG001|Overall Study|Other|3|||
125208151|NCT02044874|450385481|FG002|Overall Study|Other|8|||
125208152|NCT00415597|450385482|FG000|Enrollment|Withdrawal by Subject|1|||
125208153|NCT00415597|450385482|FG000|Enrollment|Protocol Violation|1|||
125208154|NCT00415597|450385482|FG000|Treatment|Adverse Event|110|||
125208155|NCT00415597|450385482|FG000|Treatment|Lack of Efficacy|39|||
125208156|NCT00415597|450385482|FG000|Treatment|Protocol Violation|67|||
125208157|NCT00415597|450385482|FG000|Treatment|Physician Decision|3|||
125208158|NCT00415597|450385482|FG000|Treatment|Withdrawal by Subject|51|||
125208159|NCT00415597|450385482|FG000|Treatment|Lost to Follow-up|28|||
125208160|NCT00415597|450385482|FG000|Treatment|Drug Screen|2|||
125208161|NCT00415597|450385482|FG000|Treatment|Administrative|3|||
125208162|NCT00415597|450385482|FG000|Treatment|Sponsor Decision|1|||
125208163|NCT00415597|450385482|FG000|Treatment|Multiple Reasons|1|||
125208164|NCT01447927|450385483|FG000|Overall Study|Adverse Event|4|||
125208165|NCT01447927|450385484|FG001|Overall Study|Adverse Event|3|||
125208166|NCT01447927|450385483|FG000|Overall Study|Withdrawal by Subject|1|||
125208167|NCT01447927|450385484|FG001|Overall Study|Withdrawal by Subject|0|||
125208168|NCT04102865|450385486|FG000|Overall Study|Adverse Event|4|||
125208169|NCT04102865|450385487|FG001|Overall Study|Adverse Event|0|||
125208170|NCT04102865|450385486|FG000|Overall Study|Lost to Follow-up|1|||
125208171|NCT04102865|450385487|FG001|Overall Study|Lost to Follow-up|0|||
125208172|NCT04102865|450385486|FG000|Overall Study|Withdrawal by Subject|2|||
125539886|NCT00859222|451605835|FG003|Overall Study|Adverse Event|24|||
125208173|NCT04102865|450385487|FG001|Overall Study|Withdrawal by Subject|0|||
125208174|NCT01764997|450385488|FG000|Run-in Period|Adverse Event|15|||
125208175|NCT01764997|450385489|FG001|Run-in Period|Adverse Event|0|||
125208176|NCT01764997|450385490|FG002|Run-in Period|Adverse Event|0|||
125208177|NCT01764997|450385491|FG003|Run-in Period|Adverse Event|0|||
125208178|NCT01764997|450385492|FG004|Run-in Period|Adverse Event|0|||
125208179|NCT01764997|450385488|FG000|Run-in Period|Lack of Efficacy|5|||
125208180|NCT01764997|450385489|FG001|Run-in Period|Lack of Efficacy|0|||
125208181|NCT01764997|450385490|FG002|Run-in Period|Lack of Efficacy|0|||
125208182|NCT01764997|450385491|FG003|Run-in Period|Lack of Efficacy|0|||
125208183|NCT01764997|450385492|FG004|Run-in Period|Lack of Efficacy|0|||
125208184|NCT01764997|450385488|FG000|Run-in Period|Poor compliance to protocol|1|||
125208185|NCT01764997|450385489|FG001|Run-in Period|Poor compliance to protocol|0|||
125208186|NCT01764997|450385490|FG002|Run-in Period|Poor compliance to protocol|0|||
125208187|NCT01764997|450385491|FG003|Run-in Period|Poor compliance to protocol|0|||
125208188|NCT01764997|450385492|FG004|Run-in Period|Poor compliance to protocol|0|||
125208189|NCT01764997|450385488|FG000|Run-in Period|Other than specified above|17|||
125208190|NCT01764997|450385489|FG001|Run-in Period|Other than specified above|0|||
125208191|NCT01764997|450385490|FG002|Run-in Period|Other than specified above|0|||
125208192|NCT01764997|450385491|FG003|Run-in Period|Other than specified above|0|||
125208193|NCT01764997|450385492|FG004|Run-in Period|Other than specified above|0|||
125208194|NCT01764997|450385488|FG000|Study Drug Treatment Period|Adverse Event|0|||
125208195|NCT01764997|450385489|FG001|Study Drug Treatment Period|Adverse Event|1|||
125208196|NCT01764997|450385490|FG002|Study Drug Treatment Period|Adverse Event|0|||
125208197|NCT01764997|450385491|FG003|Study Drug Treatment Period|Adverse Event|0|||
125208198|NCT01764997|450385492|FG004|Study Drug Treatment Period|Adverse Event|24|||
125208199|NCT01764997|450385488|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
125208200|NCT01764997|450385489|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
125208201|NCT01764997|450385490|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
125208202|NCT01764997|450385491|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
125208203|NCT01764997|450385492|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
125208204|NCT01764997|450385488|FG000|Study Drug Treatment Period|Other than specified above|0|||
125208205|NCT01764997|450385489|FG001|Study Drug Treatment Period|Other than specified above|0|||
125208206|NCT01764997|450385490|FG002|Study Drug Treatment Period|Other than specified above|0|||
125208207|NCT01764997|450385491|FG003|Study Drug Treatment Period|Other than specified above|0|||
125208208|NCT01764997|450385492|FG004|Study Drug Treatment Period|Other than specified above|10|||
125208209|NCT01210352|450385501|FG000|Overall Study|Adverse Event|0|||
125208210|NCT01210352|450385502|FG001|Overall Study|Adverse Event|0|||
125208211|NCT01210352|450385503|FG002|Overall Study|Adverse Event|0|||
125208212|NCT01210352|450385504|FG003|Overall Study|Adverse Event|0|||
125208213|NCT01210352|450385505|FG004|Overall Study|Adverse Event|0|||
125208214|NCT01210352|450385506|FG005|Overall Study|Adverse Event|0|||
125208215|NCT01210352|450385507|FG006|Overall Study|Adverse Event|0|||
125208216|NCT01210352|450385508|FG007|Overall Study|Adverse Event|2|||
125208217|NCT01210352|450385509|FG008|Overall Study|Adverse Event|1|||
125208218|NCT01210352|450385501|FG000|Overall Study|Lack of Efficacy|0|||
125208219|NCT01210352|450385502|FG001|Overall Study|Lack of Efficacy|0|||
125208220|NCT01210352|450385503|FG002|Overall Study|Lack of Efficacy|0|||
125208221|NCT01210352|450385504|FG003|Overall Study|Lack of Efficacy|0|||
125208222|NCT01210352|450385505|FG004|Overall Study|Lack of Efficacy|0|||
125208223|NCT01210352|450385506|FG005|Overall Study|Lack of Efficacy|0|||
125208224|NCT01210352|450385507|FG006|Overall Study|Lack of Efficacy|1|||
125208225|NCT01210352|450385508|FG007|Overall Study|Lack of Efficacy|0|||
125208226|NCT01210352|450385509|FG008|Overall Study|Lack of Efficacy|0|||
125208227|NCT01210352|450385501|FG000|Overall Study|Physician Decision|0|||
125208228|NCT01210352|450385502|FG001|Overall Study|Physician Decision|0|||
125208229|NCT01210352|450385503|FG002|Overall Study|Physician Decision|0|||
125208230|NCT01210352|450385504|FG003|Overall Study|Physician Decision|0|||
125208231|NCT01210352|450385505|FG004|Overall Study|Physician Decision|0|||
125208232|NCT01210352|450385506|FG005|Overall Study|Physician Decision|0|||
125208233|NCT01210352|450385507|FG006|Overall Study|Physician Decision|0|||
125208234|NCT01210352|450385508|FG007|Overall Study|Physician Decision|1|||
125208235|NCT01210352|450385509|FG008|Overall Study|Physician Decision|2|||
125208236|NCT01210352|450385501|FG000|Overall Study|Withdrawal by Subject|0|||
125208237|NCT01210352|450385502|FG001|Overall Study|Withdrawal by Subject|0|||
125208238|NCT01210352|450385503|FG002|Overall Study|Withdrawal by Subject|1|||
125208239|NCT01210352|450385504|FG003|Overall Study|Withdrawal by Subject|0|||
125208240|NCT01210352|450385505|FG004|Overall Study|Withdrawal by Subject|0|||
125208241|NCT01210352|450385506|FG005|Overall Study|Withdrawal by Subject|0|||
125208242|NCT01210352|450385507|FG006|Overall Study|Withdrawal by Subject|1|||
125208243|NCT01210352|450385508|FG007|Overall Study|Withdrawal by Subject|0|||
125539887|NCT00859222|451605836|FG004|Overall Study|Adverse Event|15|||
125539888|NCT00859222|451605832|FG000|Overall Study|DLT|1|||
125208244|NCT01210352|450385509|FG008|Overall Study|Withdrawal by Subject|1|||
125208245|NCT01210352|450385501|FG000|Overall Study|Patient Discharged Early|0|||
125208246|NCT01210352|450385502|FG001|Overall Study|Patient Discharged Early|0|||
125208247|NCT01210352|450385503|FG002|Overall Study|Patient Discharged Early|1|||
125208248|NCT01210352|450385504|FG003|Overall Study|Patient Discharged Early|0|||
125208249|NCT01210352|450385505|FG004|Overall Study|Patient Discharged Early|0|||
125208250|NCT01210352|450385506|FG005|Overall Study|Patient Discharged Early|0|||
125208251|NCT01210352|450385507|FG006|Overall Study|Patient Discharged Early|0|||
125208252|NCT01210352|450385508|FG007|Overall Study|Patient Discharged Early|0|||
125208253|NCT01210352|450385509|FG008|Overall Study|Patient Discharged Early|0|||
125208254|NCT01298141|450385510|FG000|Overall Study|Adverse Event|3|||
125208255|NCT01298141|450385510|FG000|Overall Study|Refusal of Required Study Procedures|1|||
125208256|NCT01298141|450385510|FG000|Overall Study|Withdrawal by Subject|6|||
125208257|NCT01298141|450385510|FG000|Overall Study|Termination of Study by the Investigator|5|||
125208258|NCT01298141|450385510|FG000|Overall Study|Other|5|||
125208259|NCT01298141|450385510|FG000|Overall Study|Lost to Follow-up|1|||
125208260|NCT01298141|450385510|FG000|Overall Study|Death|6|||
125208261|NCT01298141|450385510|FG000|Overall Study|Not treated|4|||
125208262|NCT02093390|450385514|FG000|Overall Study|Withdrawal by Subject|0|||
125208263|NCT02093390|450385515|FG001|Overall Study|Withdrawal by Subject|1|||
125208264|NCT01854879|450385516|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
125208265|NCT01854879|450385516|FG000|Overall Study|screen fail|3|||
125208266|NCT01854879|450385516|FG000|Overall Study|incomplete data set|1|||
125208267|NCT04683939|450385520|FG000|Overall Study|Study termination by the sponsor|0|||
125208268|NCT04683939|450385521|FG001|Overall Study|Study termination by the sponsor|1|||
125208269|NCT04683939|450385522|FG002|Overall Study|Study termination by the sponsor|2|||
125208270|NCT04683939|450385523|FG003|Overall Study|Study termination by the sponsor|2|||
125208271|NCT04683939|450385520|FG000|Overall Study|Death|1|||
125208272|NCT04683939|450385521|FG001|Overall Study|Death|1|||
125208273|NCT04683939|450385522|FG002|Overall Study|Death|2|||
125208274|NCT04683939|450385523|FG003|Overall Study|Death|1|||
125208275|NCT04683939|450385520|FG000|Overall Study|Withdrawal by Subject|1|||
125208276|NCT04683939|450385521|FG001|Overall Study|Withdrawal by Subject|0|||
125208277|NCT04683939|450385522|FG002|Overall Study|Withdrawal by Subject|0|||
125208278|NCT04683939|450385523|FG003|Overall Study|Withdrawal by Subject|0|||
125208279|NCT04683939|450385520|FG000|Overall Study|Physician Decision|1|||
125208280|NCT04683939|450385521|FG001|Overall Study|Physician Decision|0|||
125208281|NCT04683939|450385522|FG002|Overall Study|Physician Decision|0|||
125208282|NCT04683939|450385523|FG003|Overall Study|Physician Decision|0|||
125208283|NCT04683939|450385520|FG000|Overall Study|Lost to Follow-up|0|||
125208284|NCT04683939|450385521|FG001|Overall Study|Lost to Follow-up|1|||
125208285|NCT04683939|450385522|FG002|Overall Study|Lost to Follow-up|0|||
125208286|NCT04683939|450385523|FG003|Overall Study|Lost to Follow-up|0|||
125208287|NCT02000882|450387192|FG000|Overall Study|Adverse Event|3|||
125208288|NCT02000882|450387192|FG000|Overall Study|Physician Decision|2|||
125208289|NCT02000882|450387192|FG000|Overall Study|Withdrawal by Subject|1|||
125208290|NCT00549601|450387193|FG000|Randomized|Protocol Violation|0|||
125208291|NCT00549601|450387194|FG001|Randomized|Protocol Violation|0|||
125208292|NCT00549601|450387195|FG002|Randomized|Protocol Violation|1|||
125208293|NCT00549601|450387193|FG000|Randomized|Withdrawal by Subject|0|||
125208294|NCT00549601|450387194|FG001|Randomized|Withdrawal by Subject|1|||
125208295|NCT00549601|450387195|FG002|Randomized|Withdrawal by Subject|1|||
125208296|NCT00549601|450387193|FG000|Received Study Drug|Adverse Event|2|||
125208297|NCT00549601|450387194|FG001|Received Study Drug|Adverse Event|5|||
125208298|NCT00549601|450387195|FG002|Received Study Drug|Adverse Event|1|||
125208299|NCT00549601|450387193|FG000|Received Study Drug|Death|0|||
125208300|NCT00549601|450387194|FG001|Received Study Drug|Death|1|||
125208301|NCT00549601|450387195|FG002|Received Study Drug|Death|0|||
125208302|NCT00549601|450387193|FG000|Received Study Drug|Lost to Follow-up|0|||
125208303|NCT00549601|450387194|FG001|Received Study Drug|Lost to Follow-up|1|||
125208304|NCT00549601|450387195|FG002|Received Study Drug|Lost to Follow-up|1|||
125208305|NCT00549601|450387193|FG000|Received Study Drug|Protocol Violation|3|||
125208306|NCT00549601|450387194|FG001|Received Study Drug|Protocol Violation|4|||
125208307|NCT00549601|450387195|FG002|Received Study Drug|Protocol Violation|1|||
125208308|NCT00549601|450387193|FG000|Received Study Drug|Withdrawal by Subject|2|||
125208309|NCT00549601|450387194|FG001|Received Study Drug|Withdrawal by Subject|0|||
125208310|NCT00549601|450387195|FG002|Received Study Drug|Withdrawal by Subject|1|||
125208311|NCT00908596|450387199|FG000|Overall Study|Other reasons|46|||
125208312|NCT00908596|450387200|FG001|Overall Study|Other reasons|6|||
125208313|NCT00908596|450387201|FG002|Overall Study|Other reasons|2|||
125208314|NCT00908596|450387202|FG003|Overall Study|Other reasons|0|||
125208315|NCT00908596|450387199|FG000|Overall Study|Lost to Follow-up|0|||
125208316|NCT00908596|450387200|FG001|Overall Study|Lost to Follow-up|1|||
125208317|NCT00908596|450387201|FG002|Overall Study|Lost to Follow-up|12|||
125208318|NCT00908596|450387202|FG003|Overall Study|Lost to Follow-up|4|||
125208319|NCT00908596|450387199|FG000|Overall Study|Death|0|||
125208320|NCT00908596|450387200|FG001|Overall Study|Death|5|||
125208321|NCT00908596|450387201|FG002|Overall Study|Death|57|||
125208322|NCT00908596|450387202|FG003|Overall Study|Death|32|||
125208323|NCT00908596|450387199|FG000|Overall Study|Protocol Violation|1|||
125208324|NCT00908596|450387200|FG001|Overall Study|Protocol Violation|0|||
125208325|NCT00908596|450387201|FG002|Overall Study|Protocol Violation|0|||
125208326|NCT00908596|450387202|FG003|Overall Study|Protocol Violation|0|||
125208327|NCT00908596|450387199|FG000|Overall Study|Withdrawal by Subject|0|||
125208328|NCT00908596|450387200|FG001|Overall Study|Withdrawal by Subject|1|||
125649123|NCT02600559|451997506|FG000|Overall Study|Withdrawal by Subject|3|||
125649124|NCT02600559|451997506|FG000|Overall Study|Lost to Follow-up|20|||
125649125|NCT00501969|451997507|FG000|Overall Study|Major Protocol Violation|4|||
125649126|NCT00501969|451997507|FG000|Overall Study|Lack of Efficacy|29|||
125649127|NCT00501969|451997507|FG000|Overall Study|Adverse Event|76|||
125649128|NCT00501969|451997507|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
125649129|NCT00501969|451997507|FG000|Overall Study|Subject withdrew consent|51|||
125649130|NCT00501969|451997507|FG000|Overall Study|Lost to Follow-up|4|||
125649131|NCT00501969|451997507|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
125649132|NCT00501969|451997507|FG000|Overall Study|Other: Sponsors Request|10|||
125649133|NCT00501969|451997507|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
125649134|NCT00501969|451997507|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
125649135|NCT00501969|451997507|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
125649136|NCT00501969|451997507|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
125649137|NCT00501969|451997507|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
125649138|NCT00501969|451997507|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
125649139|NCT00501969|451997507|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
125649140|NCT00501969|451997507|FG000|Overall Study|Other: As Required by Local EC|2|||
125649141|NCT00501969|451997507|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
125649142|NCT00501969|451997507|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
125649143|NCT00665366|451997508|FG000|Overall Study|Lack of Efficacy|11|||
125649144|NCT00665366|451997509|FG001|Overall Study|Lack of Efficacy|10|||
125649145|NCT00665366|451997508|FG000|Overall Study|Adverse Event|25|||
125649146|NCT00665366|451997509|FG001|Overall Study|Adverse Event|23|||
125649147|NCT00665366|451997508|FG000|Overall Study|Withdrawal by Subject|11|||
125649148|NCT00665366|451997509|FG001|Overall Study|Withdrawal by Subject|14|||
125649149|NCT00665366|451997508|FG000|Overall Study|Lost to Follow-up|3|||
125649150|NCT00665366|451997509|FG001|Overall Study|Lost to Follow-up|5|||
125649151|NCT00665366|451997508|FG000|Overall Study|Poor compliance/noncompliance|3|||
125649152|NCT00665366|451997509|FG001|Overall Study|Poor compliance/noncompliance|5|||
125649153|NCT00665366|451997508|FG000|Overall Study|Pregnancy|1|||
125649154|NCT00665366|451997509|FG001|Overall Study|Pregnancy|0|||
125649155|NCT00665366|451997508|FG000|Overall Study|No longer meets study criteria|0|||
125649156|NCT00665366|451997509|FG001|Overall Study|No longer meets study criteria|1|||
125649157|NCT00665366|451997508|FG000|Overall Study|Other reasons|4|||
125649158|NCT00665366|451997509|FG001|Overall Study|Other reasons|1|||
125649159|NCT01545375|451997510|FG000|Overall Study|Adverse Event|2|||
125649160|NCT01545375|451997511|FG001|Overall Study|Adverse Event|1|||
125649161|NCT01545375|451997510|FG000|Overall Study|Lost to Follow-up|34|||
125649162|NCT01545375|451997511|FG001|Overall Study|Lost to Follow-up|31|||
125649163|NCT01545375|451997510|FG000|Overall Study|Protocol Violation|3|||
125649164|NCT01545375|451997511|FG001|Overall Study|Protocol Violation|3|||
125539889|NCT00859222|451605833|FG001|Overall Study|DLT|0|||
125539890|NCT00859222|451605834|FG002|Overall Study|DLT|0|||
125539891|NCT00859222|451605835|FG003|Overall Study|DLT|0|||
125539892|NCT00859222|451605836|FG004|Overall Study|DLT|0|||
125539893|NCT00400725|451605847|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
125539894|NCT00400725|451605848|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
125539895|NCT00400725|451605849|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
125539896|NCT00400725|451605847|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
125539897|NCT00400725|451605848|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
125539898|NCT00400725|451605849|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
125539899|NCT00400725|451605847|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
125539900|NCT00400725|451605848|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
125539901|NCT00400725|451605849|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
125539902|NCT00400725|451605847|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
125539903|NCT00400725|451605848|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
125539904|NCT00400725|451605849|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
125539905|NCT00400725|451605847|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
125539906|NCT00400725|451605848|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
125539907|NCT00400725|451605849|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
125539908|NCT00400725|451605847|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
125539909|NCT00400725|451605848|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
125539910|NCT00400725|451605849|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
125539911|NCT00400725|451605847|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
125649165|NCT01545375|451997510|FG000|Overall Study|Withdrawal by Subject|58|||
125649166|NCT01545375|451997511|FG001|Overall Study|Withdrawal by Subject|55|||
125649167|NCT01846039|451997512|FG000|Overall Study|Protocol Violation|1|||
125649168|NCT01846039|451997512|FG000|Overall Study|Subject Withdrew Consent|1|||
125649169|NCT04854421|451997515|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
125649170|NCT04854421|451997516|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
125649171|NCT01980056|451997517|FG000|Overall Study|Death|1|||
125649172|NCT01980056|451997518|FG001|Overall Study|Death|1|||
125649173|NCT01980056|451997519|FG002|Overall Study|Death|0|||
125649174|NCT00408408|451997520|FG000|Overall Study|No follow up data|2|||
125649175|NCT00408408|451997521|FG001|Overall Study|No follow up data|3|||
125649176|NCT00408408|451997522|FG002|Overall Study|No follow up data|0|||
125649177|NCT00408408|451997523|FG003|Overall Study|No follow up data|7|||
125649178|NCT00408408|451997524|FG004|Overall Study|No follow up data|5|||
125649179|NCT00408408|451997525|FG005|Overall Study|No follow up data|3|||
125649180|NCT00399542|451997530|FG000|Overall Study|Adverse Event|18|||
125649181|NCT00399542|451997531|FG001|Overall Study|Adverse Event|15|||
125649182|NCT00399542|451997530|FG000|Overall Study|Protocol Violation|13|||
125649183|NCT00399542|451997531|FG001|Overall Study|Protocol Violation|3|||
125649184|NCT00399542|451997530|FG000|Overall Study|Withdrawal by Subject|28|||
125649185|NCT00399542|451997531|FG001|Overall Study|Withdrawal by Subject|10|||
125649186|NCT00399542|451997530|FG000|Overall Study|Lack of Efficacy|18|||
125649187|NCT00399542|451997531|FG001|Overall Study|Lack of Efficacy|8|||
125649188|NCT00399542|451997530|FG000|Overall Study|Lost to Follow-up|6|||
125649189|NCT00399542|451997531|FG001|Overall Study|Lost to Follow-up|6|||
125649190|NCT00399542|451997530|FG000|Overall Study|Other|1|||
125649191|NCT00399542|451997531|FG001|Overall Study|Other|0|||
125649192|NCT00399542|451997530|FG000|Overall Study|Physician Decision|0|||
125649193|NCT00399542|451997531|FG001|Overall Study|Physician Decision|1|||
125649194|NCT03172026|451997532|FG000|Overall Study|Withdrawal by Subject|1|||
125649195|NCT03172026|451997533|FG001|Overall Study|Withdrawal by Subject|0|||
125649196|NCT03172026|451997532|FG000|Overall Study|COVID restrictions|1|||
125649197|NCT03172026|451997533|FG001|Overall Study|COVID restrictions|0|||
125649198|NCT00265109|451997534|FG000|Overall Study|Withdrawal by Subject|5|||
125649199|NCT00265109|451997534|FG000|Overall Study|Adverse Event|1|||
125649200|NCT02463097|451997535|FG000|Overall Study|Withdrawal by Subject|1|||
125649201|NCT01757821|451997536|FG000|Overall Study|Adverse Event|1|||
125649202|NCT00334893|451997537|FG000|Overall Study|Not Treated|1|||
125649203|NCT00334893|451997538|FG001|Overall Study|Not Treated|0|||
125649204|NCT01552408|451997542|FG000|Overall Study|Lost to Follow-up|2|||
125649205|NCT01552408|451997543|FG001|Overall Study|Lost to Follow-up|0|||
125649206|NCT01552408|451997542|FG000|Overall Study|Relocation|0|||
125649207|NCT01552408|451997543|FG001|Overall Study|Relocation|1|||
125649208|NCT01552408|451997542|FG000|Overall Study|Withdrawal by Subject|2|||
125649209|NCT01552408|451997543|FG001|Overall Study|Withdrawal by Subject|1|||
125649210|NCT03457701|451997550|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
125649211|NCT03457701|451997551|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
125649212|NCT03457701|451997550|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
125649213|NCT03457701|451997551|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
125649214|NCT01288911|451997552|FG000|Double-blind Period|Death|11|||
125649215|NCT01288911|451997553|FG001|Double-blind Period|Death|7|||
125649216|NCT01288911|451997552|FG000|Double-blind Period|Lost to Follow-up|0|||
125649217|NCT01288911|451997553|FG001|Double-blind Period|Lost to Follow-up|2|||
125649218|NCT01288911|451997552|FG000|Double-blind Period|Progressive Disease|75|||
125649219|NCT01288911|451997553|FG001|Double-blind Period|Progressive Disease|103|||
125649220|NCT01288911|451997552|FG000|Double-blind Period|Protocol Violation|1|||
125649221|NCT01288911|451997553|FG001|Double-blind Period|Protocol Violation|0|||
125649222|NCT01288911|451997552|FG000|Double-blind Period|Withdrawal by Subject|25|||
125649223|NCT01288911|451997553|FG001|Double-blind Period|Withdrawal by Subject|26|||
125649224|NCT01288911|451997552|FG000|Double-blind Period|Miscellaneous Reason|29|||
125649225|NCT01288911|451997553|FG001|Double-blind Period|Miscellaneous Reason|42|||
125649226|NCT01288911|451997552|FG000|Double-blind Period|Randomized but never received study drug|1|||
125649227|NCT01288911|451997553|FG001|Double-blind Period|Randomized but never received study drug|2|||
125649228|NCT01288911|451997552|FG000|Open-label Period (All Enzalutamide)|Death|0|||
125649229|NCT01288911|451997553|FG001|Open-label Period (All Enzalutamide)|Death|1|||
125649230|NCT01288911|451997552|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
125649231|NCT01288911|451997553|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
125649232|NCT01288911|451997552|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
125649233|NCT01288911|451997553|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
125649234|NCT01288911|451997552|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
125649235|NCT01288911|451997553|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
125649236|NCT01288911|451997552|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
125649237|NCT01288911|451997553|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
125649238|NCT01288911|451997552|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
125649239|NCT01288911|451997553|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
125649240|NCT02451137|451997560|FG000|Overall Study|Randomized but not treated|19|||
125649241|NCT02451137|451997561|FG001|Overall Study|Randomized but not treated|27|||
125649242|NCT02451137|451997560|FG000|Overall Study|Adverse Event|43|||
125649243|NCT02451137|451997561|FG001|Overall Study|Adverse Event|42|||
125649244|NCT02451137|451997560|FG000|Overall Study|Lack of Efficacy|4|||
125649245|NCT02451137|451997561|FG001|Overall Study|Lack of Efficacy|9|||
125649246|NCT02451137|451997560|FG000|Overall Study|Participant decision:discontinue insulin|41|||
125649247|NCT02451137|451997561|FG001|Overall Study|Participant decision:discontinue insulin|43|||
125649248|NCT02451137|451997560|FG000|Overall Study|Hypoglycemia|2|||
125649249|NCT02451137|451997561|FG001|Overall Study|Hypoglycemia|1|||
125649250|NCT02451137|451997560|FG000|Overall Study|Investigator's decision|23|||
125649251|NCT02451137|451997561|FG001|Overall Study|Investigator's decision|19|||
125649252|NCT02451137|451997560|FG000|Overall Study|Lost to Follow-up|53|||
125649253|NCT02451137|451997561|FG001|Overall Study|Lost to Follow-up|61|||
125649254|NCT02451137|451997560|FG000|Overall Study|Physician Decision|6|||
125649255|NCT02451137|451997561|FG001|Overall Study|Physician Decision|5|||
125649256|NCT02451137|451997560|FG000|Overall Study|Sponsor decision|13|||
125649257|NCT02451137|451997561|FG001|Overall Study|Sponsor decision|25|||
125649258|NCT02451137|451997560|FG000|Overall Study|Withdrawal by Subject|40|||
125649259|NCT02451137|451997561|FG001|Overall Study|Withdrawal by Subject|63|||
125649260|NCT02451137|451997560|FG000|Overall Study|Other than specified above|2|||
125649261|NCT02451137|451997561|FG001|Overall Study|Other than specified above|3|||
125649262|NCT01977573|451997564|FG000|Overall Study|Adverse Event|7|||
125649263|NCT01977573|451997565|FG001|Overall Study|Adverse Event|0|||
125649264|NCT01977573|451997566|FG002|Overall Study|Adverse Event|2|||
125649265|NCT01977573|451997567|FG003|Overall Study|Adverse Event|1|||
125649266|NCT01977573|451997564|FG000|Overall Study|Lost to Follow-up|1|||
125649267|NCT01977573|451997565|FG001|Overall Study|Lost to Follow-up|0|||
125649268|NCT01977573|451997566|FG002|Overall Study|Lost to Follow-up|0|||
125649269|NCT01977573|451997567|FG003|Overall Study|Lost to Follow-up|1|||
125649270|NCT01977573|451997564|FG000|Overall Study|Physician Decision|1|||
125649271|NCT01977573|451997565|FG001|Overall Study|Physician Decision|0|||
125649272|NCT01977573|451997566|FG002|Overall Study|Physician Decision|0|||
125649273|NCT01977573|451997567|FG003|Overall Study|Physician Decision|0|||
125649274|NCT01977573|451997564|FG000|Overall Study|Protocol Violation|3|||
125649275|NCT01977573|451997565|FG001|Overall Study|Protocol Violation|1|||
125649276|NCT01977573|451997566|FG002|Overall Study|Protocol Violation|0|||
125649277|NCT01977573|451997567|FG003|Overall Study|Protocol Violation|0|||
125649278|NCT01977573|451997564|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
125649279|NCT01977573|451997565|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
125649280|NCT01977573|451997566|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
125649281|NCT01977573|451997567|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
125649282|NCT01977573|451997564|FG000|Overall Study|Withdrawal by Subject|6|||
125649283|NCT01977573|451997565|FG001|Overall Study|Withdrawal by Subject|1|||
125649284|NCT01977573|451997566|FG002|Overall Study|Withdrawal by Subject|1|||
125649285|NCT01977573|451997567|FG003|Overall Study|Withdrawal by Subject|1|||
125649286|NCT02993731|451997568|FG000|Overall Study|Study Termination|101|||
125649287|NCT02993731|451997569|FG001|Overall Study|Study Termination|105|||
125649288|NCT01189201|451999672|FG000|Overall Study|Adverse Event|1|||
125649289|NCT01266967|451999673|FG000|Overall Study|Death|69|||
125649290|NCT01266967|451999674|FG001|Overall Study|Death|61|||
125649291|NCT01266967|451999673|FG000|Overall Study|Study Closed/Terminated|15|||
125649292|NCT01266967|451999674|FG001|Overall Study|Study Closed/Terminated|17|||
125649293|NCT01266967|451999673|FG000|Overall Study|Lost to Follow-up|2|||
125649294|NCT01266967|451999674|FG001|Overall Study|Lost to Follow-up|1|||
125649295|NCT01266967|451999673|FG000|Overall Study|Physician Decision|0|||
125208329|NCT00908596|450387201|FG002|Overall Study|Withdrawal by Subject|3|||
125208330|NCT00908596|450387202|FG003|Overall Study|Withdrawal by Subject|1|||
125208331|NCT02437188|450387205|FG000|Overall Study|Randomized but did not receive surgery|4|||
125208332|NCT02437188|450387206|FG001|Overall Study|Randomized but did not receive surgery|8|||
125208333|NCT02437188|450387205|FG000|Overall Study|Adverse Event|0|||
125208334|NCT02437188|450387206|FG001|Overall Study|Adverse Event|1|||
125208335|NCT02661061|450387209|FG000|Overall Study|Lack of Efficacy|1|||
125208336|NCT02661061|450387210|FG001|Overall Study|Lack of Efficacy|1|||
125208337|NCT02661061|450387209|FG000|Overall Study|Withdrawal by Subject|1|||
125208338|NCT02661061|450387210|FG001|Overall Study|Withdrawal by Subject|1|||
125208339|NCT03246061|450387211|FG000|Overall Study|Still in follow-up|15|||
125208340|NCT03246061|450387212|FG001|Overall Study|Still in follow-up|21|||
125208341|NCT01937715|450387217|FG000|Overall Study|Death|0|||
125208342|NCT01937715|450387218|FG001|Overall Study|Death|0|||
125208343|NCT01937715|450387219|FG002|Overall Study|Death|0|||
125208344|NCT01937715|450387220|FG003|Overall Study|Death|1|||
125208345|NCT01937715|450387221|FG004|Overall Study|Death|0|||
125208346|NCT01937715|450387217|FG000|Overall Study|Withdrawal by Subject|0|||
125208347|NCT01937715|450387218|FG001|Overall Study|Withdrawal by Subject|1|||
125208348|NCT01937715|450387219|FG002|Overall Study|Withdrawal by Subject|0|||
125649296|NCT01266967|451999674|FG001|Overall Study|Physician Decision|1|||
125649297|NCT01266967|451999673|FG000|Overall Study|Withdrawal by Subject|3|||
125649298|NCT01266967|451999674|FG001|Overall Study|Withdrawal by Subject|3|||
125649299|NCT04398030|451999675|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
125649300|NCT04398030|451999676|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
125208349|NCT01937715|450387220|FG003|Overall Study|Withdrawal by Subject|0|||
125208350|NCT01937715|450387221|FG004|Overall Study|Withdrawal by Subject|2|||
125208351|NCT01937715|450387217|FG000|Overall Study|Other|0|||
125649301|NCT04398030|451999675|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
125649302|NCT04398030|451999676|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
125649303|NCT02946515|451999679|FG000|Overall Study|Lost to Follow-up|2|||
125649304|NCT02946515|451999680|FG001|Overall Study|Lost to Follow-up|1|||
125649305|NCT02501642|451999681|FG000|Overall Study|Lost to Follow-up|7|||
125649306|NCT02501642|451999682|FG001|Overall Study|Lost to Follow-up|11|||
125649307|NCT01153971|451999693|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
125649308|NCT01153971|451999693|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
125649309|NCT01153971|451999693|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
125649310|NCT01153971|451999693|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
125649311|NCT01153971|451999693|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
125649312|NCT01153971|451999693|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
125649313|NCT01153971|451999693|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
125649314|NCT03410693|451999694|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
125649315|NCT03410693|451999695|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
125649316|NCT03410693|451999694|FG000|Overall Study|Disc trt: Lost to follow up|0|||
125649317|NCT03410693|451999695|FG001|Overall Study|Disc trt: Lost to follow up|1|||
125649318|NCT03410693|451999694|FG000|Overall Study|Disc trt: radiological progression|58|||
125649319|NCT03410693|451999695|FG001|Overall Study|Disc trt: radiological progression|50|||
125649320|NCT03410693|451999694|FG000|Overall Study|Disc trt: Other|1|||
125649321|NCT03410693|451999695|FG001|Overall Study|Disc trt: Other|0|||
125649322|NCT03410693|451999694|FG000|Overall Study|Study drug never administered|1|||
125649323|NCT03410693|451999695|FG001|Overall Study|Study drug never administered|6|||
125649324|NCT03410693|451999694|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
125649325|NCT03410693|451999695|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
125649326|NCT03410693|451999694|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
125649327|NCT03410693|451999695|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
125649328|NCT03410693|451999694|FG000|Overall Study|Disc trt: Physician decision|0|||
125649329|NCT03410693|451999695|FG001|Overall Study|Disc trt: Physician decision|5|||
125649330|NCT03410693|451999694|FG000|Overall Study|Disc trt: clinical progression|1|||
125649331|NCT03410693|451999695|FG001|Overall Study|Disc trt: clinical progression|5|||
125649332|NCT03410693|451999694|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
125649333|NCT03410693|451999695|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
125649334|NCT00953576|451999696|FG000|Overall Study|Adverse Event|0|||
125649335|NCT00953576|451999697|FG001|Overall Study|Adverse Event|1|||
125649336|NCT00953576|451999696|FG000|Overall Study|Ineligible after Consent|2|||
125649337|NCT00953576|451999697|FG001|Overall Study|Ineligible after Consent|0|||
125649338|NCT03628781|451999704|FG000|Overall Study|Lost to Follow-up|16|||
125208352|NCT01937715|450387218|FG001|Overall Study|Other|0|||
125208353|NCT01937715|450387219|FG002|Overall Study|Other|0|||
125208354|NCT01937715|450387220|FG003|Overall Study|Other|3|||
125208355|NCT01937715|450387221|FG004|Overall Study|Other|0|||
125208356|NCT05459558|450387222|FG000|Overall Study|Adverse Event|1|||
125208357|NCT05459558|450387223|FG001|Overall Study|Adverse Event|0|||
125208358|NCT05459558|450387224|FG002|Overall Study|Adverse Event|0|||
125208359|NCT05459558|450387222|FG000|Overall Study|Scheduling issue|0|||
125208360|NCT05459558|450387223|FG001|Overall Study|Scheduling issue|1|||
125208361|NCT05459558|450387224|FG002|Overall Study|Scheduling issue|3|||
125208362|NCT05459558|450387222|FG000|Overall Study|Withdrawal by Subject|0|||
125208363|NCT05459558|450387223|FG001|Overall Study|Withdrawal by Subject|0|||
125208364|NCT05459558|450387224|FG002|Overall Study|Withdrawal by Subject|2|||
125208365|NCT03292458|450387227|FG000|Period 1|Adverse Event|2|||
125208366|NCT03292458|450387228|FG001|Period 1|Adverse Event|0|||
125208367|NCT00593606|450387229|FG000|Overall Study|Adverse Event|13|||
125208368|NCT00593606|450387229|FG000|Overall Study|Withdrawal by Subject|1|||
125208369|NCT00593606|450387229|FG000|Overall Study|Protocol Violation|3|||
125208370|NCT00593606|450387229|FG000|Overall Study|Lost to Follow-up|2|||
125208371|NCT00593606|450387229|FG000|Overall Study|Run-In Failure|5|||
125208372|NCT00593606|450387229|FG000|Overall Study|Screen Failure|3|||
125208373|NCT04643964|450387230|FG000|Overall Study|Lost to Follow-up|55|||
125208374|NCT04643964|450387231|FG001|Overall Study|Lost to Follow-up|59|||
125649339|NCT03628781|451999705|FG001|Overall Study|Lost to Follow-up|8|||
125649340|NCT03628781|451999704|FG000|Overall Study|Withdrawal by Subject|16|||
125649341|NCT03628781|451999705|FG001|Overall Study|Withdrawal by Subject|1|||
125649342|NCT00656669|451999706|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
125649343|NCT00656669|451999706|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
125649344|NCT00656669|451999706|FG000|AC (Cycles 6-9)|Adverse Event|1|||
125649345|NCT00656669|451999706|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
125649346|NCT03778021|451999707|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
125208375|NCT04643964|450387232|FG002|Overall Study|Lost to Follow-up|54|||
125208376|NCT04643964|450387233|FG003|Overall Study|Lost to Follow-up|129|||
125208377|NCT04643964|450387234|FG004|Overall Study|Lost to Follow-up|48|||
125208378|NCT04643964|450387230|FG000|Overall Study|Failed attention check|1|||
125208379|NCT04643964|450387231|FG001|Overall Study|Failed attention check|8|||
125208380|NCT04643964|450387232|FG002|Overall Study|Failed attention check|2|||
125649347|NCT03778021|451999708|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
125649348|NCT00679042|451999711|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
125649349|NCT00679042|451999711|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
125649350|NCT00679042|451999711|FG000|5-Year Follow Up|Death|1|||
125649351|NCT00679042|451999711|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
125649352|NCT00679042|451999711|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
125649353|NCT02687815|451999712|FG000|Overall Study|Lost to Follow-up|2|||
125649354|NCT02687815|451999713|FG001|Overall Study|Lost to Follow-up|4|||
125649355|NCT02687815|451999712|FG000|Overall Study|Withdrawal by Subject|2|||
125649356|NCT02687815|451999713|FG001|Overall Study|Withdrawal by Subject|4|||
125649357|NCT03472586|451999721|FG000|Overall Study|Physician Decision|6|||
125649358|NCT03472586|451999721|FG000|Overall Study|Death|6|||
125649359|NCT03472586|451999721|FG000|Overall Study|Adverse Event|1|||
125649360|NCT02528331|451999722|FG000|Overall Study|Withdrawal by Subject|2|||
125649361|NCT06045026|451999725|FG000|Overall Study|Lost to Follow-up|60|||
125649362|NCT06045026|451999725|FG000|Overall Study|Adverse Event|12|||
125649363|NCT06045026|451999725|FG000|Overall Study|Withdrawal by Subject|3|||
125649364|NCT06045026|451999725|FG000|Overall Study|Enrollment closed|1|||
125649365|NCT00920582|451999726|FG000|Overall Study|Lost to Follow-up|5|||
125649366|NCT00920582|451999727|FG001|Overall Study|Lost to Follow-up|1|||
125649367|NCT00920582|451999728|FG002|Overall Study|Lost to Follow-up|2|||
125649368|NCT00920582|451999729|FG003|Overall Study|Lost to Follow-up|0|||
125649369|NCT00920582|451999726|FG000|Overall Study|Withdrawal by Subject|5|||
125649370|NCT00920582|451999727|FG001|Overall Study|Withdrawal by Subject|4|||
125649371|NCT00920582|451999728|FG002|Overall Study|Withdrawal by Subject|6|||
125649372|NCT00920582|451999729|FG003|Overall Study|Withdrawal by Subject|3|||
125649373|NCT00920582|451999726|FG000|Overall Study|Protocol Violation|1|||
125649374|NCT00920582|451999727|FG001|Overall Study|Protocol Violation|0|||
125649375|NCT00920582|451999728|FG002|Overall Study|Protocol Violation|0|||
125649376|NCT00920582|451999729|FG003|Overall Study|Protocol Violation|0|||
125649377|NCT00920582|451999726|FG000|Overall Study|Other|2|||
125649378|NCT00920582|451999727|FG001|Overall Study|Other|1|||
125649379|NCT00920582|451999728|FG002|Overall Study|Other|3|||
125649380|NCT00920582|451999729|FG003|Overall Study|Other|2|||
125649381|NCT00383292|451999735|FG000|Overall Study|Adverse Event|4|||
125649382|NCT00383292|451999736|FG001|Overall Study|Adverse Event|1|||
125649383|NCT00383292|451999737|FG002|Overall Study|Adverse Event|2|||
125649384|NCT00383292|451999735|FG000|Overall Study|Death|3|||
125649385|NCT00383292|451999736|FG001|Overall Study|Death|3|||
125649386|NCT00383292|451999737|FG002|Overall Study|Death|3|||
125649387|NCT00383292|451999735|FG000|Overall Study|Physician Decision|4|||
125649388|NCT00383292|451999736|FG001|Overall Study|Physician Decision|0|||
125649389|NCT00383292|451999737|FG002|Overall Study|Physician Decision|1|||
125649390|NCT00383292|451999735|FG000|Overall Study|Withdrawal by Subject|3|||
125649391|NCT00383292|451999736|FG001|Overall Study|Withdrawal by Subject|2|||
125649392|NCT00383292|451999737|FG002|Overall Study|Withdrawal by Subject|2|||
125649393|NCT00383292|451999735|FG000|Overall Study|Other|1|||
125649394|NCT00383292|451999736|FG001|Overall Study|Other|0|||
125649395|NCT00383292|451999737|FG002|Overall Study|Other|0|||
125649396|NCT03329404|451999738|FG000|Overall Study|The study was suspended.|1|||
125649397|NCT03329404|451999739|FG001|Overall Study|The study was suspended.|4|||
125649398|NCT01016912|451999740|FG000|End of Treatment Period|Lack of Efficacy|0|||
125649399|NCT01016912|451999741|FG001|End of Treatment Period|Lack of Efficacy|1|||
125649400|NCT01016912|451999742|FG002|End of Treatment Period|Lack of Efficacy|0|||
125649401|NCT01016912|451999743|FG003|End of Treatment Period|Lack of Efficacy|4|||
125649402|NCT01016912|451999744|FG004|End of Treatment Period|Lack of Efficacy|4|||
125649403|NCT01016912|451999740|FG000|End of Treatment Period|Adverse Event|0|||
125649404|NCT01016912|451999741|FG001|End of Treatment Period|Adverse Event|1|||
125649405|NCT01016912|451999742|FG002|End of Treatment Period|Adverse Event|1|||
125649406|NCT01016912|451999743|FG003|End of Treatment Period|Adverse Event|0|||
125649407|NCT01016912|451999744|FG004|End of Treatment Period|Adverse Event|0|||
125649408|NCT01016912|451999740|FG000|End of Treatment Period|Completed double-blind period only|0|||
125649409|NCT01016912|451999741|FG001|End of Treatment Period|Completed double-blind period only|1|||
125649410|NCT01016912|451999742|FG002|End of Treatment Period|Completed double-blind period only|0|||
125649411|NCT01016912|451999743|FG003|End of Treatment Period|Completed double-blind period only|0|||
125649412|NCT01016912|451999744|FG004|End of Treatment Period|Completed double-blind period only|0|||
125649413|NCT01016912|451999740|FG000|Follow-up Period|Other reason|0|||
125649414|NCT01016912|451999741|FG001|Follow-up Period|Other reason|0|||
125649415|NCT01016912|451999742|FG002|Follow-up Period|Other reason|1|||
125649416|NCT01016912|451999743|FG003|Follow-up Period|Other reason|1|||
125649417|NCT01016912|451999744|FG004|Follow-up Period|Other reason|0|||
125649418|NCT02221882|451999745|FG000|Overall Study|Withdrawal by Subject|0|||
125649419|NCT02221882|451999746|FG001|Overall Study|Withdrawal by Subject|0|||
125649420|NCT02221882|451999747|FG002|Overall Study|Withdrawal by Subject|4|||
125649421|NCT02221882|451999748|FG003|Overall Study|Withdrawal by Subject|2|||
125649422|NCT02221882|451999749|FG004|Overall Study|Withdrawal by Subject|2|||
125649423|NCT02221882|451999750|FG005|Overall Study|Withdrawal by Subject|2|||
125649424|NCT02221882|451999745|FG000|Overall Study|Death|0|||
125649425|NCT02221882|451999746|FG001|Overall Study|Death|1|||
125649426|NCT02221882|451999747|FG002|Overall Study|Death|0|||
125649427|NCT02221882|451999748|FG003|Overall Study|Death|0|||
125649428|NCT02221882|451999749|FG004|Overall Study|Death|0|||
125649429|NCT02221882|451999750|FG005|Overall Study|Death|0|||
125649430|NCT00796367|451999751|FG000|Overall Study|Adverse Event|6|||
125649431|NCT00796367|451999752|FG001|Overall Study|Adverse Event|4|||
125649432|NCT00796367|451999753|FG002|Overall Study|Adverse Event|7|||
125649433|NCT00796367|451999751|FG000|Overall Study|Lost to Follow-up|5|||
125649434|NCT00796367|451999752|FG001|Overall Study|Lost to Follow-up|4|||
125649435|NCT00796367|451999753|FG002|Overall Study|Lost to Follow-up|21|||
125649436|NCT00796367|451999751|FG000|Overall Study|Withdrawal by Subject|9|||
125649437|NCT00796367|451999752|FG001|Overall Study|Withdrawal by Subject|11|||
125649438|NCT00796367|451999753|FG002|Overall Study|Withdrawal by Subject|12|||
125649439|NCT00796367|451999751|FG000|Overall Study|Lack of Efficacy|2|||
125649440|NCT00796367|451999752|FG001|Overall Study|Lack of Efficacy|1|||
125649441|NCT00796367|451999753|FG002|Overall Study|Lack of Efficacy|0|||
125649442|NCT00796367|451999751|FG000|Overall Study|non compliance|3|||
125649443|NCT00796367|451999752|FG001|Overall Study|non compliance|1|||
125649444|NCT00796367|451999753|FG002|Overall Study|non compliance|1|||
125649445|NCT00796367|451999751|FG000|Overall Study|Pregnancy|1|||
125649446|NCT00796367|451999752|FG001|Overall Study|Pregnancy|0|||
125649447|NCT00796367|451999753|FG002|Overall Study|Pregnancy|1|||
125649448|NCT00796367|451999751|FG000|Overall Study|Requirement for restricted medication|2|||
125649449|NCT00796367|451999752|FG001|Overall Study|Requirement for restricted medication|0|||
125649450|NCT00796367|451999753|FG002|Overall Study|Requirement for restricted medication|2|||
125649451|NCT00796367|451999751|FG000|Overall Study|other|2|||
125649452|NCT00796367|451999752|FG001|Overall Study|other|4|||
125649453|NCT00796367|451999753|FG002|Overall Study|other|3|||
125649454|NCT05664672|451999754|FG000|Overall Study|Adverse Event|0|||
125649455|NCT05664672|451999755|FG001|Overall Study|Adverse Event|0|||
125649456|NCT05664672|451999756|FG002|Overall Study|Adverse Event|0|||
125649457|NCT05664672|451999757|FG003|Overall Study|Adverse Event|0|||
125649458|NCT05664672|451999758|FG004|Overall Study|Adverse Event|0|||
125649459|NCT05664672|451999759|FG005|Overall Study|Adverse Event|1|||
125649460|NCT05664672|451999754|FG000|Overall Study|Withdrawal by Subject|0|||
125649461|NCT05664672|451999755|FG001|Overall Study|Withdrawal by Subject|1|||
125649462|NCT05664672|451999756|FG002|Overall Study|Withdrawal by Subject|3|||
125649463|NCT05664672|451999757|FG003|Overall Study|Withdrawal by Subject|0|||
125649464|NCT05664672|451999758|FG004|Overall Study|Withdrawal by Subject|5|||
125649465|NCT05664672|451999759|FG005|Overall Study|Withdrawal by Subject|6|||
125649466|NCT05664672|451999754|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
125649467|NCT05664672|451999755|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
125649468|NCT05664672|451999756|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
125649469|NCT05664672|451999757|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
125649470|NCT05664672|451999758|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
125649471|NCT05664672|451999759|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
125649472|NCT05664672|451999754|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
125649473|NCT05664672|451999755|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
125649474|NCT05664672|451999756|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
125649475|NCT05664672|451999757|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
125649476|NCT05664672|451999758|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
125649477|NCT05664672|451999759|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
125649478|NCT04236986|451999768|FG000|Overall Study|Withdrawal by Subject|3|||
125649479|NCT04236986|451999769|FG001|Overall Study|Withdrawal by Subject|1|||
125649480|NCT04034225|451999770|FG000|Overall Study|Death|3|||
125649481|NCT04034225|451999770|FG000|Overall Study|Withdrawal by Subject|2|||
125649482|NCT04034225|451999770|FG000|Overall Study|Study termination by Sponsor|18|||
125649483|NCT04034225|451999770|FG000|Overall Study|Physician Decision|1|||
125649484|NCT04034225|451999770|FG000|Overall Study|Lack of Efficacy|1|||
125649485|NCT01326481|451999776|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
125649486|NCT00307736|451999777|FG000|Overall Study|Adverse Event|0|||
125649487|NCT00307736|451999778|FG001|Overall Study|Adverse Event|0|||
125649488|NCT00307736|451999779|FG002|Overall Study|Adverse Event|1|||
125649489|NCT00307736|451999780|FG003|Overall Study|Adverse Event|3|||
125649490|NCT00307736|451999777|FG000|Overall Study|Withdrawal by Subject|0|||
125208381|NCT04643964|450387233|FG003|Overall Study|Failed attention check|14|||
125208382|NCT04643964|450387234|FG004|Overall Study|Failed attention check|11|||
125208383|NCT01472939|450387235|FG000|Overall Study|Adverse Event|3|||
125649491|NCT00307736|451999778|FG001|Overall Study|Withdrawal by Subject|0|||
125649492|NCT00307736|451999779|FG002|Overall Study|Withdrawal by Subject|2|||
125208384|NCT01472939|450387236|FG001|Overall Study|Adverse Event|7|||
125649493|NCT00307736|451999780|FG003|Overall Study|Withdrawal by Subject|0|||
125649494|NCT02260791|451999783|FG000|Overall Study|Lost to Follow-up|4|||
125649495|NCT02260791|451999784|FG001|Overall Study|Lost to Follow-up|4|||
125649496|NCT02260791|451999783|FG000|Overall Study|Lack of Efficacy|2|||
125649497|NCT02260791|451999784|FG001|Overall Study|Lack of Efficacy|1|||
125649498|NCT02260791|451999783|FG000|Overall Study|Adverse Event|13|||
125649499|NCT02260791|451999784|FG001|Overall Study|Adverse Event|9|||
125649500|NCT02260791|451999783|FG000|Overall Study|Death|1|||
125649501|NCT02260791|451999784|FG001|Overall Study|Death|0|||
125649502|NCT02260791|451999783|FG000|Overall Study|Withdrawal by Subject|11|||
125649503|NCT02260791|451999784|FG001|Overall Study|Withdrawal by Subject|16|||
125649504|NCT02260791|451999783|FG000|Overall Study|Screen failure|0|||
125649505|NCT02260791|451999784|FG001|Overall Study|Screen failure|1|||
125649506|NCT02260791|451999783|FG000|Overall Study|Protocol deviation|2|||
125649507|NCT02260791|451999784|FG001|Overall Study|Protocol deviation|3|||
125649508|NCT00606931|451999785|FG000|Overall Study|Withdrawal by Subject|3|||
125649509|NCT02924129|451999799|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
125649510|NCT02924129|451999800|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
125649511|NCT02924129|451999799|FG000|Overall Study|Withdrawal by Subject|2|||
125649512|NCT02924129|451999800|FG001|Overall Study|Withdrawal by Subject|2|||
125649513|NCT02924129|451999799|FG000|Overall Study|Physician Decision|1|||
125649514|NCT02924129|451999800|FG001|Overall Study|Physician Decision|0|||
125649515|NCT02924129|451999799|FG000|Overall Study|Missed Visit|0|||
125649516|NCT02924129|451999800|FG001|Overall Study|Missed Visit|1|||
125649517|NCT01348828|451999802|FG000|Overall Study|Death|20|||
125649518|NCT01348828|451999802|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
125649519|NCT01348828|451999802|FG000|Overall Study|Conversion|2|||
125649520|NCT01348828|451999802|FG000|Overall Study|missed visit|1|||
125649521|NCT00302731|451999803|FG000|Overall Study|Lost to Follow-up|1|||
125649522|NCT00302731|451999804|FG001|Overall Study|Lost to Follow-up|2|||
125649523|NCT00302731|451999805|FG002|Overall Study|Lost to Follow-up|0|||
125649524|NCT00302731|451999806|FG003|Overall Study|Lost to Follow-up|0|||
125649525|NCT00302731|451999803|FG000|Overall Study|Adverse Event|0|||
125649526|NCT00302731|451999804|FG001|Overall Study|Adverse Event|2|||
125649527|NCT00302731|451999805|FG002|Overall Study|Adverse Event|2|||
125649528|NCT00302731|451999806|FG003|Overall Study|Adverse Event|0|||
125649529|NCT00302731|451999803|FG000|Overall Study|Withdrawal by Subject|1|||
125649530|NCT00302731|451999804|FG001|Overall Study|Withdrawal by Subject|1|||
125649531|NCT00302731|451999805|FG002|Overall Study|Withdrawal by Subject|0|||
125649532|NCT00302731|451999806|FG003|Overall Study|Withdrawal by Subject|0|||
125649533|NCT00302731|451999803|FG000|Overall Study|Protocol Violation|1|||
125649534|NCT00302731|451999804|FG001|Overall Study|Protocol Violation|0|||
125649535|NCT00302731|451999805|FG002|Overall Study|Protocol Violation|0|||
125649536|NCT00302731|451999806|FG003|Overall Study|Protocol Violation|0|||
125649537|NCT00302731|451999803|FG000|Overall Study|cancer unrelated to study discovered|1|||
125649538|NCT00302731|451999804|FG001|Overall Study|cancer unrelated to study discovered|0|||
125649539|NCT00302731|451999805|FG002|Overall Study|cancer unrelated to study discovered|1|||
125649540|NCT00302731|451999806|FG003|Overall Study|cancer unrelated to study discovered|0|||
125649541|NCT01000311|451999807|FG000|Overall Study|Adverse Event|2|||
125649542|NCT01000311|451999808|FG001|Overall Study|Adverse Event|5|||
125649543|NCT01000311|451999807|FG000|Overall Study|Withdrawal by Subject|16|||
125649544|NCT01000311|451999808|FG001|Overall Study|Withdrawal by Subject|24|||
125649545|NCT01000311|451999807|FG000|Overall Study|Lost to Follow-up|15|||
125649546|NCT01000311|451999808|FG001|Overall Study|Lost to Follow-up|24|||
125649547|NCT01000311|451999807|FG000|Overall Study|Protocol Violation|1|||
125649548|NCT01000311|451999808|FG001|Overall Study|Protocol Violation|2|||
125649549|NCT01000311|451999807|FG000|Overall Study|Inappropriate enrollment|2|||
125649550|NCT01000311|451999808|FG001|Overall Study|Inappropriate enrollment|0|||
125649551|NCT01000311|451999807|FG000|Overall Study|Administrative reason|9|||
125649552|NCT01000311|451999808|FG001|Overall Study|Administrative reason|15|||
125649553|NCT01610752|451999811|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
125208385|NCT01472939|450387237|FG002|Overall Study|Adverse Event|7|||
125208386|NCT01472939|450387238|FG003|Overall Study|Adverse Event|14|||
125649554|NCT01610752|451999812|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
125649555|NCT01610752|451999813|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
125208387|NCT01472939|450387235|FG000|Overall Study|Lack of Efficacy|1|||
125649556|NCT02815670|451999814|FG000|Overall Study|Prematurely discontinued of the trial|1|||
125649557|NCT02354599|451999818|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125208388|NCT01472939|450387236|FG001|Overall Study|Lack of Efficacy|0|||
125208389|NCT01472939|450387237|FG002|Overall Study|Lack of Efficacy|0|||
125208390|NCT01472939|450387238|FG003|Overall Study|Lack of Efficacy|1|||
125649558|NCT02354599|451999819|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
125649559|NCT02354599|451999820|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
125649560|NCT02354599|451999821|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
125649561|NCT02354599|451999822|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
125208391|NCT01472939|450387235|FG000|Overall Study|Lost to Follow-up|3|||
125649562|NCT02354599|451999823|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
125649563|NCT02354599|451999818|FG000|Overall Study|Withdrawal by Subject|1|||
125208392|NCT01472939|450387236|FG001|Overall Study|Lost to Follow-up|0|||
125649564|NCT02354599|451999819|FG001|Overall Study|Withdrawal by Subject|1|||
125649565|NCT02354599|451999820|FG002|Overall Study|Withdrawal by Subject|0|||
125208393|NCT01472939|450387237|FG002|Overall Study|Lost to Follow-up|2|||
125208394|NCT01472939|450387238|FG003|Overall Study|Lost to Follow-up|0|||
125208395|NCT01472939|450387235|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
125208396|NCT01472939|450387236|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
125208397|NCT01472939|450387237|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
125208398|NCT01472939|450387238|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
125208399|NCT01472939|450387235|FG000|Overall Study|Prohibited Medication|0|||
125208400|NCT01472939|450387236|FG001|Overall Study|Prohibited Medication|1|||
125208401|NCT01472939|450387237|FG002|Overall Study|Prohibited Medication|0|||
125208402|NCT01472939|450387238|FG003|Overall Study|Prohibited Medication|0|||
125208403|NCT01472939|450387235|FG000|Overall Study|Withdrawal By PI|1|||
125208404|NCT01472939|450387236|FG001|Overall Study|Withdrawal By PI|0|||
125208405|NCT01472939|450387237|FG002|Overall Study|Withdrawal By PI|0|||
125208406|NCT01472939|450387238|FG003|Overall Study|Withdrawal By PI|0|||
125208407|NCT01472939|450387235|FG000|Overall Study|Protocol Violation|3|||
125208408|NCT01472939|450387236|FG001|Overall Study|Protocol Violation|3|||
125208409|NCT01472939|450387237|FG002|Overall Study|Protocol Violation|0|||
125208410|NCT01472939|450387238|FG003|Overall Study|Protocol Violation|1|||
125208411|NCT01472939|450387235|FG000|Overall Study|Withdrawal by Subject|9|||
125208412|NCT01472939|450387236|FG001|Overall Study|Withdrawal by Subject|3|||
125208413|NCT01472939|450387237|FG002|Overall Study|Withdrawal by Subject|1|||
125208414|NCT01472939|450387238|FG003|Overall Study|Withdrawal by Subject|4|||
125208415|NCT00114738|450387239|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
125208416|NCT00114738|450387240|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
125208417|NCT00114738|450387241|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
125208418|NCT00114738|450387239|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
125208419|NCT00114738|450387240|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
125208420|NCT00114738|450387241|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
125208421|NCT00114738|450387239|FG000|Screening for Randomization|Neuropathy|17|||
125208422|NCT00114738|450387240|FG001|Screening for Randomization|Neuropathy|0|||
125208423|NCT00114738|450387241|FG002|Screening for Randomization|Neuropathy|0|||
125208424|NCT00114738|450387239|FG000|Screening for Randomization|Progressive disease|2|||
125208425|NCT00114738|450387240|FG001|Screening for Randomization|Progressive disease|0|||
125208426|NCT00114738|450387241|FG002|Screening for Randomization|Progressive disease|0|||
125208427|NCT00114738|450387239|FG000|Screening for Randomization|CNS Hemorrhage|1|||
125208428|NCT00114738|450387240|FG001|Screening for Randomization|CNS Hemorrhage|0|||
125208429|NCT00114738|450387241|FG002|Screening for Randomization|CNS Hemorrhage|0|||
125208430|NCT00114738|450387239|FG000|Screening for Randomization|Other|1|||
125208431|NCT00114738|450387240|FG001|Screening for Randomization|Other|0|||
125208432|NCT00114738|450387241|FG002|Screening for Randomization|Other|0|||
125208433|NCT00308750|450387242|FG000|Overall Study|Adverse Event|9|||
125208434|NCT00308750|450387243|FG001|Overall Study|Adverse Event|9|||
125208435|NCT00308750|450387244|FG002|Overall Study|Adverse Event|13|||
125208436|NCT00308750|450387242|FG000|Overall Study|Withdrawal by Subject|6|||
125539912|NCT00400725|451605848|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
125539913|NCT00400725|451605849|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
125208437|NCT00308750|450387243|FG001|Overall Study|Withdrawal by Subject|2|||
125208438|NCT00308750|450387244|FG002|Overall Study|Withdrawal by Subject|3|||
125208439|NCT00308750|450387242|FG000|Overall Study|Physician Decision|3|||
125208440|NCT00308750|450387243|FG001|Overall Study|Physician Decision|4|||
125208441|NCT00308750|450387244|FG002|Overall Study|Physician Decision|3|||
125208442|NCT00308750|450387242|FG000|Overall Study|Sponsor Decision|1|||
125208443|NCT00308750|450387243|FG001|Overall Study|Sponsor Decision|0|||
125208444|NCT00308750|450387244|FG002|Overall Study|Sponsor Decision|0|||
125208445|NCT00308750|450387242|FG000|Overall Study|Disease Progression|47|||
125208446|NCT00308750|450387243|FG001|Overall Study|Disease Progression|24|||
125208447|NCT00308750|450387244|FG002|Overall Study|Disease Progression|28|||
125208448|NCT00308750|450387242|FG000|Overall Study|Unrelated Complication|3|||
125208449|NCT00308750|450387243|FG001|Overall Study|Unrelated Complication|0|||
125208450|NCT00308750|450387244|FG002|Overall Study|Unrelated Complication|1|||
125208451|NCT00308750|450387242|FG000|Overall Study|Death|1|||
125208452|NCT00308750|450387243|FG001|Overall Study|Death|0|||
125208453|NCT00308750|450387244|FG002|Overall Study|Death|1|||
125208454|NCT00308750|450387242|FG000|Overall Study|Protocol Violation|1|||
125208455|NCT00308750|450387243|FG001|Overall Study|Protocol Violation|0|||
125208456|NCT00308750|450387244|FG002|Overall Study|Protocol Violation|0|||
125208457|NCT00308750|450387242|FG000|Overall Study|New Primary Disease Identified|1|||
125208458|NCT00308750|450387243|FG001|Overall Study|New Primary Disease Identified|1|||
125208459|NCT00308750|450387244|FG002|Overall Study|New Primary Disease Identified|0|||
125208460|NCT01358578|450387245|FG000|Induction Period|Adverse Event|2|||
125208461|NCT01358578|450387246|FG001|Induction Period|Adverse Event|4|||
125208462|NCT01358578|450387247|FG002|Induction Period|Adverse Event|2|||
125208463|NCT01358578|450387248|FG003|Induction Period|Adverse Event|6|||
125208464|NCT01358578|450387249|FG004|Induction Period|Adverse Event|0|||
125208465|NCT01358578|450387250|FG005|Induction Period|Adverse Event|0|||
125208466|NCT01358578|450387245|FG000|Induction Period|Lack of Efficacy|0|||
125208467|NCT01358578|450387246|FG001|Induction Period|Lack of Efficacy|0|||
125208468|NCT01358578|450387247|FG002|Induction Period|Lack of Efficacy|9|||
125208469|NCT01358578|450387248|FG003|Induction Period|Lack of Efficacy|1|||
125208470|NCT01358578|450387249|FG004|Induction Period|Lack of Efficacy|0|||
125208471|NCT01358578|450387250|FG005|Induction Period|Lack of Efficacy|0|||
125208472|NCT01358578|450387245|FG000|Induction Period|Lost to Follow-up|0|||
125208473|NCT01358578|450387246|FG001|Induction Period|Lost to Follow-up|0|||
125208474|NCT01358578|450387247|FG002|Induction Period|Lost to Follow-up|1|||
125208475|NCT01358578|450387248|FG003|Induction Period|Lost to Follow-up|4|||
125208476|NCT01358578|450387249|FG004|Induction Period|Lost to Follow-up|0|||
125208477|NCT01358578|450387250|FG005|Induction Period|Lost to Follow-up|0|||
125208478|NCT01358578|450387245|FG000|Induction Period|Physician Decision|2|||
125208479|NCT01358578|450387246|FG001|Induction Period|Physician Decision|1|||
125208480|NCT01358578|450387247|FG002|Induction Period|Physician Decision|2|||
125208481|NCT01358578|450387248|FG003|Induction Period|Physician Decision|0|||
125208482|NCT01358578|450387249|FG004|Induction Period|Physician Decision|0|||
125208483|NCT01358578|450387250|FG005|Induction Period|Physician Decision|0|||
125208484|NCT01358578|450387245|FG000|Induction Period|Protocol Deviation|3|||
125208485|NCT01358578|450387246|FG001|Induction Period|Protocol Deviation|5|||
125208486|NCT01358578|450387247|FG002|Induction Period|Protocol Deviation|0|||
125208487|NCT01358578|450387248|FG003|Induction Period|Protocol Deviation|3|||
125208488|NCT01358578|450387249|FG004|Induction Period|Protocol Deviation|0|||
125208489|NCT01358578|450387250|FG005|Induction Period|Protocol Deviation|0|||
125208490|NCT01358578|450387245|FG000|Induction Period|technical problems|0|||
125208491|NCT01358578|450387246|FG001|Induction Period|technical problems|0|||
125208492|NCT01358578|450387247|FG002|Induction Period|technical problems|1|||
125208493|NCT01358578|450387248|FG003|Induction Period|technical problems|1|||
125208494|NCT01358578|450387249|FG004|Induction Period|technical problems|0|||
125208495|NCT01358578|450387250|FG005|Induction Period|technical problems|0|||
125208496|NCT01358578|450387245|FG000|Induction Period|Withdrawal by Subject|5|||
125208497|NCT01358578|450387246|FG001|Induction Period|Withdrawal by Subject|5|||
125208498|NCT01358578|450387247|FG002|Induction Period|Withdrawal by Subject|10|||
125208499|NCT01358578|450387248|FG003|Induction Period|Withdrawal by Subject|6|||
125208500|NCT01358578|450387249|FG004|Induction Period|Withdrawal by Subject|0|||
125208501|NCT01358578|450387250|FG005|Induction Period|Withdrawal by Subject|0|||
125208502|NCT01358578|450387245|FG000|Maintenance Period|Adverse Event|2|||
125208503|NCT01358578|450387246|FG001|Maintenance Period|Adverse Event|7|||
125208504|NCT01358578|450387247|FG002|Maintenance Period|Adverse Event|0|||
125208505|NCT01358578|450387248|FG003|Maintenance Period|Adverse Event|6|||
125208506|NCT01358578|450387249|FG004|Maintenance Period|Adverse Event|4|||
125208507|NCT01358578|450387250|FG005|Maintenance Period|Adverse Event|3|||
125208508|NCT01358578|450387245|FG000|Maintenance Period|Lack of Efficacy|10|||
125208509|NCT01358578|450387246|FG001|Maintenance Period|Lack of Efficacy|2|||
125208510|NCT01358578|450387247|FG002|Maintenance Period|Lack of Efficacy|0|||
125208511|NCT01358578|450387248|FG003|Maintenance Period|Lack of Efficacy|11|||
125208512|NCT01358578|450387249|FG004|Maintenance Period|Lack of Efficacy|3|||
125208513|NCT01358578|450387250|FG005|Maintenance Period|Lack of Efficacy|0|||
125208514|NCT01358578|450387245|FG000|Maintenance Period|Lost to Follow-up|4|||
125208515|NCT01358578|450387246|FG001|Maintenance Period|Lost to Follow-up|0|||
125208516|NCT01358578|450387247|FG002|Maintenance Period|Lost to Follow-up|0|||
125208517|NCT01358578|450387248|FG003|Maintenance Period|Lost to Follow-up|5|||
125208518|NCT01358578|450387249|FG004|Maintenance Period|Lost to Follow-up|1|||
125208519|NCT01358578|450387250|FG005|Maintenance Period|Lost to Follow-up|1|||
125208520|NCT01358578|450387245|FG000|Maintenance Period|Non-compliance with study treatment|3|||
125208521|NCT01358578|450387246|FG001|Maintenance Period|Non-compliance with study treatment|1|||
125208522|NCT01358578|450387247|FG002|Maintenance Period|Non-compliance with study treatment|0|||
125208523|NCT01358578|450387248|FG003|Maintenance Period|Non-compliance with study treatment|2|||
125208524|NCT01358578|450387249|FG004|Maintenance Period|Non-compliance with study treatment|1|||
125208525|NCT01358578|450387250|FG005|Maintenance Period|Non-compliance with study treatment|2|||
125208526|NCT01358578|450387245|FG000|Maintenance Period|Physician Decision|0|||
125208527|NCT01358578|450387246|FG001|Maintenance Period|Physician Decision|1|||
125208528|NCT01358578|450387247|FG002|Maintenance Period|Physician Decision|0|||
125208529|NCT01358578|450387248|FG003|Maintenance Period|Physician Decision|1|||
125208530|NCT01358578|450387249|FG004|Maintenance Period|Physician Decision|0|||
125208531|NCT01358578|450387250|FG005|Maintenance Period|Physician Decision|0|||
125208532|NCT01358578|450387245|FG000|Maintenance Period|Pregnancy|1|||
125208533|NCT01358578|450387246|FG001|Maintenance Period|Pregnancy|0|||
125208534|NCT01358578|450387247|FG002|Maintenance Period|Pregnancy|0|||
125208535|NCT01358578|450387248|FG003|Maintenance Period|Pregnancy|0|||
125208536|NCT01358578|450387249|FG004|Maintenance Period|Pregnancy|0|||
125208537|NCT01358578|450387250|FG005|Maintenance Period|Pregnancy|0|||
125208538|NCT01358578|450387245|FG000|Maintenance Period|Protocol deviation|7|||
125208539|NCT01358578|450387246|FG001|Maintenance Period|Protocol deviation|4|||
125208540|NCT01358578|450387247|FG002|Maintenance Period|Protocol deviation|0|||
125649566|NCT02354599|451999821|FG003|Overall Study|Withdrawal by Subject|0|||
125649567|NCT02354599|451999822|FG004|Overall Study|Withdrawal by Subject|0|||
125649568|NCT02354599|451999823|FG005|Overall Study|Withdrawal by Subject|0|||
125649569|NCT01087944|451999839|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
125649570|NCT01087944|451999840|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
125649571|NCT01087944|451999839|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
125208541|NCT01358578|450387248|FG003|Maintenance Period|Protocol deviation|2|||
125208542|NCT01358578|450387249|FG004|Maintenance Period|Protocol deviation|2|||
125208543|NCT01358578|450387250|FG005|Maintenance Period|Protocol deviation|2|||
125208544|NCT01358578|450387245|FG000|Maintenance Period|Withdrawal by Subject|12|||
125208545|NCT01358578|450387246|FG001|Maintenance Period|Withdrawal by Subject|7|||
125208546|NCT01358578|450387247|FG002|Maintenance Period|Withdrawal by Subject|2|||
125208547|NCT01358578|450387248|FG003|Maintenance Period|Withdrawal by Subject|15|||
125208548|NCT01358578|450387249|FG004|Maintenance Period|Withdrawal by Subject|6|||
125208549|NCT01358578|450387250|FG005|Maintenance Period|Withdrawal by Subject|3|||
125208550|NCT01358578|450387245|FG000|Follow-up Period|Adverse Event|1|||
125208551|NCT01358578|450387246|FG001|Follow-up Period|Adverse Event|1|||
125208552|NCT01358578|450387247|FG002|Follow-up Period|Adverse Event|0|||
125208553|NCT01358578|450387248|FG003|Follow-up Period|Adverse Event|0|||
125208554|NCT01358578|450387249|FG004|Follow-up Period|Adverse Event|0|||
125208555|NCT01358578|450387250|FG005|Follow-up Period|Adverse Event|0|||
125208556|NCT01358578|450387245|FG000|Follow-up Period|Lack of Efficacy|3|||
125208557|NCT01358578|450387246|FG001|Follow-up Period|Lack of Efficacy|0|||
125208558|NCT01358578|450387247|FG002|Follow-up Period|Lack of Efficacy|4|||
125208559|NCT01358578|450387248|FG003|Follow-up Period|Lack of Efficacy|1|||
125208560|NCT01358578|450387249|FG004|Follow-up Period|Lack of Efficacy|0|||
125208561|NCT01358578|450387250|FG005|Follow-up Period|Lack of Efficacy|0|||
125208562|NCT01358578|450387245|FG000|Follow-up Period|Lost to Follow-up|0|||
125208563|NCT01358578|450387246|FG001|Follow-up Period|Lost to Follow-up|1|||
125208564|NCT01358578|450387247|FG002|Follow-up Period|Lost to Follow-up|0|||
125208565|NCT01358578|450387248|FG003|Follow-up Period|Lost to Follow-up|4|||
125208566|NCT01358578|450387249|FG004|Follow-up Period|Lost to Follow-up|0|||
125208567|NCT01358578|450387250|FG005|Follow-up Period|Lost to Follow-up|0|||
125208568|NCT01358578|450387245|FG000|Follow-up Period|non- compliance with study treatment|1|||
125208569|NCT01358578|450387246|FG001|Follow-up Period|non- compliance with study treatment|0|||
125208570|NCT01358578|450387247|FG002|Follow-up Period|non- compliance with study treatment|0|||
125208571|NCT01358578|450387248|FG003|Follow-up Period|non- compliance with study treatment|0|||
125208572|NCT01358578|450387249|FG004|Follow-up Period|non- compliance with study treatment|0|||
125208573|NCT01358578|450387250|FG005|Follow-up Period|non- compliance with study treatment|0|||
125208574|NCT01358578|450387245|FG000|Follow-up Period|Pregnancy|1|||
125208575|NCT01358578|450387246|FG001|Follow-up Period|Pregnancy|0|||
125208576|NCT01358578|450387247|FG002|Follow-up Period|Pregnancy|0|||
125208577|NCT01358578|450387248|FG003|Follow-up Period|Pregnancy|0|||
125208578|NCT01358578|450387249|FG004|Follow-up Period|Pregnancy|0|||
125208579|NCT01358578|450387250|FG005|Follow-up Period|Pregnancy|0|||
125208580|NCT01358578|450387245|FG000|Follow-up Period|Withdrawal by Subject|3|||
125208581|NCT01358578|450387246|FG001|Follow-up Period|Withdrawal by Subject|3|||
125208582|NCT01358578|450387247|FG002|Follow-up Period|Withdrawal by Subject|1|||
125208583|NCT01358578|450387248|FG003|Follow-up Period|Withdrawal by Subject|12|||
125208584|NCT01358578|450387249|FG004|Follow-up Period|Withdrawal by Subject|0|||
125208585|NCT01358578|450387250|FG005|Follow-up Period|Withdrawal by Subject|0|||
125208586|NCT01358578|450387245|FG000|Follow-up Period|Physician Decision|1|||
125208587|NCT01358578|450387246|FG001|Follow-up Period|Physician Decision|1|||
125208588|NCT01358578|450387247|FG002|Follow-up Period|Physician Decision|0|||
125208589|NCT01358578|450387248|FG003|Follow-up Period|Physician Decision|2|||
125208590|NCT01358578|450387249|FG004|Follow-up Period|Physician Decision|0|||
125208591|NCT01358578|450387250|FG005|Follow-up Period|Physician Decision|0|||
125208592|NCT00388297|450387251|FG000|Overall Study|Lost to Follow-up|16|||
125208593|NCT00388297|450387252|FG001|Overall Study|Lost to Follow-up|12|||
125208594|NCT00388297|450387253|FG002|Overall Study|Lost to Follow-up|11|||
125208595|NCT00388297|450387254|FG003|Overall Study|Lost to Follow-up|8|||
125208596|NCT01492101|450387256|FG000|Overall Study|Death|323|||
125208597|NCT01492101|450387257|FG001|Overall Study|Death|322|||
125208598|NCT01492101|450387256|FG000|Overall Study|Withdrawal by Subject|14|||
125208599|NCT01492101|450387257|FG001|Overall Study|Withdrawal by Subject|18|||
125208600|NCT01492101|450387256|FG000|Overall Study|Lost to Follow-up|0|||
125208601|NCT01492101|450387257|FG001|Overall Study|Lost to Follow-up|2|||
125208602|NCT01675154|450387258|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
125649572|NCT01087944|451999840|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
125208603|NCT01675154|450387259|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
125208604|NCT01675154|450387260|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
125208605|NCT01675154|450387261|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
125208606|NCT02971800|450387264|FG000|Overall Study|Protocol Violation|1|||
125208607|NCT02971800|450387264|FG000|Overall Study|Withdrawal by Subject|1|||
125208608|NCT02971800|450387264|FG000|Overall Study|Exclusion criteria prior intervention|1|||
125649573|NCT01159665|451999841|FG000|Overall Study|Withdrawal by Subject|0|||
125208609|NCT02971800|450387264|FG000|Overall Study|Number evaluable participant already reached|4|||
125208610|NCT05323994|450387265|FG000|Overall Study|Protocol Violation|1|||
125208611|NCT00460265|450387266|FG000|Overall Study|Lost to Follow-up|14|||
125208612|NCT00460265|450387267|FG001|Overall Study|Lost to Follow-up|15|||
125208613|NCT00460265|450387266|FG000|Overall Study|Physician Decision|1|||
125208614|NCT00460265|450387267|FG001|Overall Study|Physician Decision|2|||
125208615|NCT00460265|450387266|FG000|Overall Study|Withdrawal by Subject|10|||
125208616|NCT00460265|450387267|FG001|Overall Study|Withdrawal by Subject|25|||
125208617|NCT00460265|450387266|FG000|Overall Study|Ongoing|60|||
125208618|NCT00460265|450387267|FG001|Overall Study|Ongoing|47|||
125208619|NCT02719353|450387269|FG000|First Intervention|Physician Decision|0|||
125208620|NCT02719353|450387270|FG001|First Intervention|Physician Decision|1|||
125208621|NCT01917344|450387274|FG000|Overall Study|Withdrawal by Subject|1|||
125208622|NCT04526574|450387279|FG000|Overall Study|Protocol Violation|3|||
125208623|NCT04526574|450387280|FG001|Overall Study|Protocol Violation|1|||
125208624|NCT04526574|450387279|FG000|Overall Study|Withdrawal by Subject|12|||
125208625|NCT04526574|450387280|FG001|Overall Study|Withdrawal by Subject|9|||
125208626|NCT04526574|450387279|FG000|Overall Study|Other|1|||
125208627|NCT04526574|450387280|FG001|Overall Study|Other|2|||
125208628|NCT04526574|450387279|FG000|Overall Study|Adverse Event|1|||
125208629|NCT04526574|450387280|FG001|Overall Study|Adverse Event|1|||
125208630|NCT04526574|450387279|FG000|Overall Study|Death|2|||
125208631|NCT04526574|450387280|FG001|Overall Study|Death|3|||
125208632|NCT04526574|450387279|FG000|Overall Study|Lost to Follow-up|9|||
125208633|NCT04526574|450387280|FG001|Overall Study|Lost to Follow-up|9|||
125208634|NCT04526574|450387279|FG000|Overall Study|No longer meets eligibility criteria|8|||
125208635|NCT04526574|450387280|FG001|Overall Study|No longer meets eligibility criteria|8|||
125208636|NCT00045734|450387288|FG000|Overall Study|Protocol Violation|1|||
125208637|NCT01524783|450387293|FG000|Blinded Period|Adverse Event|64|||
125208638|NCT01524783|450387294|FG001|Blinded Period|Adverse Event|7|||
125208639|NCT01524783|450387295|FG002|Blinded Period|Adverse Event|0|||
125208640|NCT01524783|450387293|FG000|Blinded Period|Disease Progression|89|||
125208641|NCT01524783|450387294|FG001|Blinded Period|Disease Progression|75|||
125208642|NCT01524783|450387295|FG002|Blinded Period|Disease Progression|0|||
125208643|NCT01524783|450387293|FG000|Blinded Period|Withdrawal by Subject|19|||
125208644|NCT01524783|450387294|FG001|Blinded Period|Withdrawal by Subject|6|||
125208645|NCT01524783|450387295|FG002|Blinded Period|Withdrawal by Subject|0|||
125208646|NCT01524783|450387293|FG000|Blinded Period|Protocol deviation|2|||
125649574|NCT01159665|451999842|FG001|Overall Study|Withdrawal by Subject|1|||
125649575|NCT01159665|451999843|FG002|Overall Study|Withdrawal by Subject|0|||
125649576|NCT01159665|451999844|FG003|Overall Study|Withdrawal by Subject|0|||
125208647|NCT01524783|450387294|FG001|Blinded Period|Protocol deviation|1|||
125208648|NCT01524783|450387295|FG002|Blinded Period|Protocol deviation|0|||
125649577|NCT01159665|451999845|FG004|Overall Study|Withdrawal by Subject|0|||
125649578|NCT01159665|451999846|FG005|Overall Study|Withdrawal by Subject|0|||
125208649|NCT01524783|450387293|FG000|Blinded Period|Death|5|||
125208650|NCT01524783|450387294|FG001|Blinded Period|Death|2|||
125208651|NCT01524783|450387295|FG002|Blinded Period|Death|0|||
125208652|NCT01524783|450387293|FG000|Open-label Period|Disease progression|13|||
125208653|NCT01524783|450387294|FG001|Open-label Period|Disease progression|0|||
125208654|NCT01524783|450387295|FG002|Open-label Period|Disease progression|2|||
125208655|NCT01524783|450387293|FG000|Open-label Period|Administrative problems|5|||
125208656|NCT01524783|450387294|FG001|Open-label Period|Administrative problems|0|||
125208657|NCT01524783|450387295|FG002|Open-label Period|Administrative problems|2|||
125208658|NCT01524783|450387293|FG000|Open-label Period|Adverse Event|5|||
125208659|NCT01524783|450387294|FG001|Open-label Period|Adverse Event|0|||
125649579|NCT01377194|451999848|FG000|Overall Study|Adverse Event|3|||
125649580|NCT01377194|451999849|FG001|Overall Study|Adverse Event|12|||
125649581|NCT01377194|451999850|FG002|Overall Study|Adverse Event|19|||
125649582|NCT01377194|451999848|FG000|Overall Study|Lack of Efficacy|3|||
125649583|NCT01377194|451999849|FG001|Overall Study|Lack of Efficacy|3|||
125649584|NCT01377194|451999850|FG002|Overall Study|Lack of Efficacy|3|||
125208660|NCT01524783|450387295|FG002|Open-label Period|Adverse Event|1|||
125208661|NCT01524783|450387293|FG000|Open-label Period|Withdrawal by Subject|2|||
125208662|NCT01524783|450387294|FG001|Open-label Period|Withdrawal by Subject|0|||
125208663|NCT01524783|450387295|FG002|Open-label Period|Withdrawal by Subject|1|||
125208664|NCT01524783|450387293|FG000|Open-label Period|Protocol deviation|1|||
125208665|NCT01524783|450387294|FG001|Open-label Period|Protocol deviation|0|||
125424881|NCT00430248|451178701|FG002|Overall Study|Reason Not Specified|11|||
125649585|NCT01377194|451999848|FG000|Overall Study|Protocol Violation|4|||
125649586|NCT01377194|451999849|FG001|Overall Study|Protocol Violation|10|||
125208666|NCT01524783|450387295|FG002|Open-label Period|Protocol deviation|0|||
125208667|NCT02054910|450387297|FG000|Overall Study|Lost to Follow-up|4|||
125208668|NCT02054910|450387298|FG001|Overall Study|Lost to Follow-up|1|||
125208669|NCT01096589|450387304|FG000|Overall Study|Adverse Event|2|||
125208670|NCT01096589|450387305|FG001|Overall Study|Adverse Event|1|||
125208671|NCT01096589|450387306|FG002|Overall Study|Adverse Event|2|||
125208672|NCT01096589|450387307|FG003|Overall Study|Adverse Event|1|||
125208673|NCT01096589|450387304|FG000|Overall Study|Withdrawal by Subject|2|||
125208674|NCT01096589|450387305|FG001|Overall Study|Withdrawal by Subject|1|||
125208675|NCT01096589|450387306|FG002|Overall Study|Withdrawal by Subject|1|||
125208676|NCT01096589|450387307|FG003|Overall Study|Withdrawal by Subject|1|||
125208677|NCT01096589|450387304|FG000|Overall Study|Compliance with protocol|0|||
125208678|NCT01096589|450387305|FG001|Overall Study|Compliance with protocol|0|||
125208679|NCT01096589|450387306|FG002|Overall Study|Compliance with protocol|1|||
125208680|NCT01096589|450387307|FG003|Overall Study|Compliance with protocol|0|||
125208681|NCT01096589|450387304|FG000|Overall Study|found treatment exhausting|0|||
125208682|NCT01096589|450387305|FG001|Overall Study|found treatment exhausting|0|||
125208683|NCT01096589|450387306|FG002|Overall Study|found treatment exhausting|0|||
125208684|NCT01096589|450387307|FG003|Overall Study|found treatment exhausting|1|||
125208685|NCT03673345|450387308|FG000|Overall Study|Lost to Follow-up|1|||
125208686|NCT03673345|450387309|FG001|Overall Study|Lost to Follow-up|0|||
125208687|NCT03673345|450387310|FG002|Overall Study|Lost to Follow-up|3|||
125208688|NCT03673345|450387311|FG003|Overall Study|Lost to Follow-up|3|||
125208689|NCT03673345|450387312|FG004|Overall Study|Lost to Follow-up|2|||
125208690|NCT03673345|450387313|FG005|Overall Study|Lost to Follow-up|1|||
125208691|NCT03673345|450387314|FG006|Overall Study|Lost to Follow-up|0|||
125208692|NCT03673345|450387315|FG007|Overall Study|Lost to Follow-up|0|||
125208693|NCT03673345|450387308|FG000|Overall Study|Withdrawal by Subject|1|||
125208694|NCT03673345|450387309|FG001|Overall Study|Withdrawal by Subject|0|||
125208695|NCT03673345|450387310|FG002|Overall Study|Withdrawal by Subject|4|||
125208696|NCT03673345|450387311|FG003|Overall Study|Withdrawal by Subject|2|||
125208697|NCT03673345|450387312|FG004|Overall Study|Withdrawal by Subject|0|||
125208698|NCT03673345|450387313|FG005|Overall Study|Withdrawal by Subject|0|||
125208699|NCT03673345|450387314|FG006|Overall Study|Withdrawal by Subject|0|||
125208700|NCT03673345|450387315|FG007|Overall Study|Withdrawal by Subject|0|||
125208701|NCT03673345|450387308|FG000|Overall Study|Physician Decision|0|||
125208702|NCT03673345|450387309|FG001|Overall Study|Physician Decision|0|||
125539914|NCT00400725|451605847|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
125539915|NCT00400725|451605848|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
125539916|NCT00400725|451605849|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
125539917|NCT00400725|451605847|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
125539918|NCT00400725|451605848|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
125539919|NCT00400725|451605849|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
125539920|NCT00888927|451605857|FG000|Overall Study|Adverse Event|0|||
125539921|NCT00888927|451605858|FG001|Overall Study|Adverse Event|0|||
125539922|NCT00888927|451605859|FG002|Overall Study|Adverse Event|0|||
125539923|NCT00888927|451605860|FG003|Overall Study|Adverse Event|1|||
125539924|NCT00888927|451605857|FG000|Overall Study|Withdrawal of consent|0|||
125539925|NCT00888927|451605858|FG001|Overall Study|Withdrawal of consent|0|||
125539926|NCT00888927|451605859|FG002|Overall Study|Withdrawal of consent|0|||
125539927|NCT00888927|451605860|FG003|Overall Study|Withdrawal of consent|1|||
125539928|NCT01080716|451605861|FG000|Part 1|Physician Decision|1|||
125539929|NCT01080716|451605862|FG001|Part 1|Physician Decision|0|||
125539930|NCT01080716|451605863|FG002|Part 1|Physician Decision|0|||
125539931|NCT01080716|451605864|FG003|Part 1|Physician Decision|0|||
125539932|NCT01056718|451605865|FG000|Overall Study|Withdrawal by Subject|2|||
125539933|NCT01056718|451605865|FG000|Overall Study|Ischemia on baseline stress test|1|||
125539934|NCT05086276|451605866|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
125539935|NCT05086276|451605867|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
125539936|NCT00287690|451605868|FG000|Overall Study|Protocol Violation|20|||
125539937|NCT00287690|451605869|FG001|Overall Study|Protocol Violation|26|||
125539938|NCT03592745|451605870|FG000|Overall Study|Adverse Event|0|||
125539939|NCT03592745|451605871|FG001|Overall Study|Adverse Event|2|||
125539940|NCT03592745|451605870|FG000|Overall Study|Lost to Follow-up|2|||
125539941|NCT03592745|451605871|FG001|Overall Study|Lost to Follow-up|0|||
125539942|NCT03592745|451605870|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
125539943|NCT03592745|451605871|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
125539944|NCT05017103|451605872|FG000|Overall Study|Death|2|||
125539945|NCT03117998|451605875|FG000|Overall Study|Adverse Event|1|||
125539946|NCT03117998|451605876|FG001|Overall Study|Adverse Event|0|||
125539947|NCT03117998|451605877|FG002|Overall Study|Adverse Event|0|||
125539948|NCT03117998|451605878|FG003|Overall Study|Adverse Event|0|||
125539949|NCT03117998|451605879|FG004|Overall Study|Adverse Event|0|||
125539950|NCT03117998|451605880|FG005|Overall Study|Adverse Event|0|||
125539951|NCT03117998|451605875|FG000|Overall Study|Withdrawal by Subject|0|||
125539952|NCT03117998|451605876|FG001|Overall Study|Withdrawal by Subject|0|||
125539953|NCT03117998|451605877|FG002|Overall Study|Withdrawal by Subject|2|||
125539954|NCT03117998|451605878|FG003|Overall Study|Withdrawal by Subject|3|||
125539955|NCT03117998|451605879|FG004|Overall Study|Withdrawal by Subject|3|||
125208703|NCT03673345|450387310|FG002|Overall Study|Physician Decision|2|||
125208704|NCT03673345|450387311|FG003|Overall Study|Physician Decision|0|||
125208705|NCT03673345|450387312|FG004|Overall Study|Physician Decision|0|||
125208706|NCT03673345|450387313|FG005|Overall Study|Physician Decision|0|||
125208707|NCT03673345|450387314|FG006|Overall Study|Physician Decision|0|||
125208708|NCT03673345|450387315|FG007|Overall Study|Physician Decision|0|||
125208709|NCT02267135|450387316|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
125208710|NCT02267135|450387317|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
125208711|NCT02267135|450387316|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
125208712|NCT02267135|450387317|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
125208713|NCT02267135|450387316|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
125208714|NCT02267135|450387317|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
125208715|NCT02267135|450387316|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
125208716|NCT02267135|450387317|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
125208717|NCT02267135|450387316|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
125208718|NCT02267135|450387317|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
125208719|NCT00900731|450387318|FG000|Overall Study|Adverse Event|31|||
125208720|NCT00900731|450387319|FG001|Overall Study|Adverse Event|27|||
125208721|NCT00900731|450387318|FG000|Overall Study|Withdrawal by Subject|8|||
125208722|NCT00900731|450387319|FG001|Overall Study|Withdrawal by Subject|7|||
125208723|NCT00900731|450387318|FG000|Overall Study|Protocol Deviation|8|||
125208724|NCT00900731|450387319|FG001|Overall Study|Protocol Deviation|11|||
125208725|NCT00900731|450387318|FG000|Overall Study|Administrative Problems|5|||
125208726|NCT00900731|450387319|FG001|Overall Study|Administrative Problems|4|||
125208727|NCT00900731|450387318|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
125208728|NCT00900731|450387319|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
125208729|NCT00900731|450387318|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
125208730|NCT00900731|450387319|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
125208731|NCT00900731|450387318|FG000|Overall Study|Lost to Follow-up|2|||
125208732|NCT00900731|450387319|FG001|Overall Study|Lost to Follow-up|3|||
125208733|NCT00900731|450387318|FG000|Overall Study|Lack of Efficacy|1|||
125208734|NCT00900731|450387319|FG001|Overall Study|Lack of Efficacy|3|||
125208735|NCT00900731|450387318|FG000|Overall Study|Death|0|||
125208736|NCT00900731|450387319|FG001|Overall Study|Death|2|||
125208737|NCT03806231|450387320|FG000|Overall Study|Physician Decision|1|||
125208738|NCT03806231|450387321|FG001|Overall Study|Physician Decision|0|||
125208739|NCT03806231|450387320|FG000|Overall Study|Withdrawal by Subject|1|||
125208740|NCT03806231|450387321|FG001|Overall Study|Withdrawal by Subject|0|||
125208741|NCT00932698|450387322|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
125208742|NCT00932698|450387323|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
125208743|NCT00932698|450387324|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
125208744|NCT00932698|450387325|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
125208745|NCT00932698|450387326|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
125208746|NCT00932698|450387327|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
125208747|NCT00932698|450387328|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
125208748|NCT00932698|450387329|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
125208749|NCT00932698|450387330|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
125208750|NCT00932698|450387331|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
125208751|NCT00932698|450387332|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
125208752|NCT00932698|450387322|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208753|NCT00932698|450387323|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
125208754|NCT00932698|450387324|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208755|NCT00932698|450387325|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
125208756|NCT00932698|450387326|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208757|NCT00932698|450387327|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
125208758|NCT00932698|450387328|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
125208759|NCT00932698|450387329|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208760|NCT00932698|450387330|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208761|NCT00932698|450387331|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208762|NCT00932698|450387332|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
125208763|NCT00932698|450387322|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
125208764|NCT00932698|450387323|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
125208765|NCT00932698|450387324|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
125208766|NCT00932698|450387325|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
125208767|NCT00932698|450387326|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
125208768|NCT00932698|450387327|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
125208769|NCT00932698|450387328|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
125208770|NCT00932698|450387329|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
125208771|NCT00932698|450387330|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
125208772|NCT00932698|450387331|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
125208773|NCT00932698|450387332|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
125208774|NCT00932698|450387322|FG000|Part 1 (Dose Escalation)|Other|0|||
125208775|NCT00932698|450387323|FG001|Part 1 (Dose Escalation)|Other|0|||
125208776|NCT00932698|450387324|FG002|Part 1 (Dose Escalation)|Other|1|||
125208777|NCT00932698|450387325|FG003|Part 1 (Dose Escalation)|Other|0|||
125208778|NCT00932698|450387326|FG004|Part 1 (Dose Escalation)|Other|0|||
125208779|NCT00932698|450387327|FG005|Part 1 (Dose Escalation)|Other|0|||
125208780|NCT00932698|450387328|FG006|Part 1 (Dose Escalation)|Other|1|||
125208781|NCT00932698|450387329|FG007|Part 1 (Dose Escalation)|Other|0|||
125208782|NCT00932698|450387330|FG008|Part 1 (Dose Escalation)|Other|0|||
125208783|NCT00932698|450387331|FG009|Part 1 (Dose Escalation)|Other|0|||
125208784|NCT00932698|450387332|FG010|Part 1 (Dose Escalation)|Other|0|||
125208785|NCT00932698|450387322|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208786|NCT00932698|450387323|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208787|NCT00932698|450387324|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208788|NCT00932698|450387325|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208789|NCT00932698|450387326|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208790|NCT00932698|450387327|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208791|NCT00932698|450387328|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
125208792|NCT00932698|450387329|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
125208793|NCT00932698|450387330|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
125208794|NCT00932698|450387331|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
125208795|NCT00932698|450387332|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
125208796|NCT00932698|450387322|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208797|NCT00932698|450387323|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208798|NCT00932698|450387324|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208799|NCT00932698|450387325|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208800|NCT00932698|450387326|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208801|NCT00932698|450387327|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208802|NCT00932698|450387328|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208803|NCT00932698|450387329|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
125208804|NCT00932698|450387330|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
125208805|NCT00932698|450387331|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
125208806|NCT00932698|450387332|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
125208807|NCT00932698|450387322|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
125208808|NCT00932698|450387323|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
125208809|NCT00932698|450387324|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
125208810|NCT00932698|450387325|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
125208811|NCT00932698|450387326|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
125208812|NCT00932698|450387327|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
125208813|NCT00932698|450387328|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
125208814|NCT00932698|450387329|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
125208815|NCT00932698|450387330|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
125208816|NCT00932698|450387331|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
125208817|NCT00932698|450387332|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
125208818|NCT00655681|450387333|FG000|Overall Study|Lost to Follow-up|1|||
125208819|NCT00655681|450387334|FG001|Overall Study|Lost to Follow-up|1|||
125208820|NCT02429310|450387335|FG000|Overall Study|Lost to Follow-up|1|||
125208821|NCT02429310|450387336|FG001|Overall Study|Lost to Follow-up|2|||
125208822|NCT02429310|450387335|FG000|Overall Study|Protocol Violation|1|||
125208823|NCT02429310|450387336|FG001|Overall Study|Protocol Violation|1|||
125208824|NCT00394433|450387337|FG000|Overall Study|Adverse Event|2|||
125208825|NCT00394433|450387337|FG000|Overall Study|Alternative Therapy|1|||
125208826|NCT01554176|450387338|FG000|Treatment Phase|Protocol Violation|1|||
125208827|NCT01554176|450387339|FG001|Treatment Phase|Protocol Violation|2|||
125208828|NCT01554176|450387340|FG002|Treatment Phase|Protocol Violation|0|||
125208829|NCT01554176|450387341|FG003|Treatment Phase|Protocol Violation|0|||
125208830|NCT01554176|450387342|FG004|Treatment Phase|Protocol Violation|0|||
125208831|NCT01554176|450387338|FG000|Treatment Phase|Physician Decision|1|||
125208832|NCT01554176|450387339|FG001|Treatment Phase|Physician Decision|1|||
125208833|NCT01554176|450387340|FG002|Treatment Phase|Physician Decision|0|||
125208834|NCT01554176|450387341|FG003|Treatment Phase|Physician Decision|0|||
125208835|NCT01554176|450387342|FG004|Treatment Phase|Physician Decision|0|||
125208836|NCT01554176|450387338|FG000|Treatment Phase|Lack of Efficacy|0|||
125208837|NCT01554176|450387339|FG001|Treatment Phase|Lack of Efficacy|1|||
125208838|NCT01554176|450387340|FG002|Treatment Phase|Lack of Efficacy|0|||
125208839|NCT01554176|450387341|FG003|Treatment Phase|Lack of Efficacy|0|||
125208840|NCT01554176|450387342|FG004|Treatment Phase|Lack of Efficacy|0|||
125208841|NCT01554176|450387338|FG000|Treatment Phase|Adverse event, non-fatal|1|||
125208842|NCT01554176|450387339|FG001|Treatment Phase|Adverse event, non-fatal|1|||
125208843|NCT01554176|450387340|FG002|Treatment Phase|Adverse event, non-fatal|0|||
125208844|NCT01554176|450387341|FG003|Treatment Phase|Adverse event, non-fatal|0|||
125208845|NCT01554176|450387342|FG004|Treatment Phase|Adverse event, non-fatal|0|||
125208846|NCT01554176|450387338|FG000|Treatment Phase|Non-compliance with study drug|1|||
125208847|NCT01554176|450387339|FG001|Treatment Phase|Non-compliance with study drug|0|||
125208848|NCT01554176|450387340|FG002|Treatment Phase|Non-compliance with study drug|0|||
125208849|NCT01554176|450387341|FG003|Treatment Phase|Non-compliance with study drug|0|||
125208850|NCT01554176|450387342|FG004|Treatment Phase|Non-compliance with study drug|0|||
125208851|NCT01554176|450387338|FG000|Treatment Phase|Withdrawal by Subject|1|||
125208852|NCT01554176|450387339|FG001|Treatment Phase|Withdrawal by Subject|0|||
125208853|NCT01554176|450387340|FG002|Treatment Phase|Withdrawal by Subject|0|||
125208854|NCT01554176|450387341|FG003|Treatment Phase|Withdrawal by Subject|0|||
125208855|NCT01554176|450387342|FG004|Treatment Phase|Withdrawal by Subject|0|||
125208856|NCT01554176|450387338|FG000|Treatment Phase|Lost to Follow-up|3|||
125649587|NCT01377194|451999850|FG002|Overall Study|Protocol Violation|6|||
125208857|NCT01554176|450387339|FG001|Treatment Phase|Lost to Follow-up|0|||
125208858|NCT01554176|450387340|FG002|Treatment Phase|Lost to Follow-up|0|||
125208859|NCT01554176|450387341|FG003|Treatment Phase|Lost to Follow-up|0|||
125208860|NCT01554176|450387342|FG004|Treatment Phase|Lost to Follow-up|0|||
125208861|NCT01554176|450387338|FG000|Run-out Phase|Protocol Violation|0|||
125208862|NCT01554176|450387339|FG001|Run-out Phase|Protocol Violation|0|||
125208863|NCT01554176|450387340|FG002|Run-out Phase|Protocol Violation|0|||
125208864|NCT01554176|450387341|FG003|Run-out Phase|Protocol Violation|1|||
125208865|NCT01554176|450387342|FG004|Run-out Phase|Protocol Violation|0|||
125208866|NCT01085136|450387343|FG000|Part A|Other Adverse event|223|||
125208867|NCT01085136|450387344|FG001|Part A|Other Adverse event|0|||
125208868|NCT01085136|450387345|FG002|Part A|Other Adverse event|0|||
125208869|NCT01085136|450387343|FG000|Part A|Protocol Violation|3|||
125208870|NCT01085136|450387344|FG001|Part A|Protocol Violation|0|||
125208871|NCT01085136|450387345|FG002|Part A|Protocol Violation|0|||
125208872|NCT01085136|450387343|FG000|Part A|Lost to Follow-up|3|||
125208873|NCT01085136|450387344|FG001|Part A|Lost to Follow-up|0|||
125208874|NCT01085136|450387345|FG002|Part A|Lost to Follow-up|0|||
125208875|NCT01085136|450387343|FG000|Part A|Refusal to continue trial medication|64|||
125208876|NCT01085136|450387344|FG001|Part A|Refusal to continue trial medication|0|||
125208877|NCT01085136|450387345|FG002|Part A|Refusal to continue trial medication|0|||
125208878|NCT01085136|450387343|FG000|Part A|Other reason not defined above|30|||
125208879|NCT01085136|450387344|FG001|Part A|Other reason not defined above|0|||
125208880|NCT01085136|450387345|FG002|Part A|Other reason not defined above|0|||
125208881|NCT01085136|450387343|FG000|Part B|Other AE|0|||
125208882|NCT01085136|450387344|FG001|Part B|Other AE|29|||
125208883|NCT01085136|450387345|FG002|Part B|Other AE|8|||
125208884|NCT01085136|450387343|FG000|Part B|Refusal to continue trial medication|0|||
125208885|NCT01085136|450387344|FG001|Part B|Refusal to continue trial medication|12|||
125208886|NCT01085136|450387345|FG002|Part B|Refusal to continue trial medication|7|||
125208887|NCT01085136|450387343|FG000|Part B|Not treated|0|||
125208888|NCT01085136|450387344|FG001|Part B|Not treated|4|||
125208889|NCT01085136|450387345|FG002|Part B|Not treated|8|||
125208890|NCT01085136|450387343|FG000|Part B|Other reason not defined above|0|||
125208891|NCT01085136|450387344|FG001|Part B|Other reason not defined above|6|||
125208892|NCT01085136|450387345|FG002|Part B|Other reason not defined above|3|||
125208893|NCT02678000|450387347|FG000|PART 2|Adverse Event|0|||
125208894|NCT02678000|450387348|FG001|PART 2|Adverse Event|0|||
125208895|NCT02678000|450387349|FG002|PART 2|Adverse Event|2|||
125208896|NCT02678000|450387350|FG003|PART 2|Adverse Event|1|||
125208897|NCT02678000|450387351|FG004|PART 2|Adverse Event|0|||
125208898|NCT02678000|450387347|FG000|PART 2|Withdrawal by Subject|0|||
125208899|NCT02678000|450387348|FG001|PART 2|Withdrawal by Subject|0|||
125208900|NCT02678000|450387349|FG002|PART 2|Withdrawal by Subject|1|||
125208901|NCT02678000|450387350|FG003|PART 2|Withdrawal by Subject|0|||
125208902|NCT02678000|450387351|FG004|PART 2|Withdrawal by Subject|0|||
125208903|NCT01764659|450387354|FG000|Overall Study|Death|1|||
125208904|NCT01764659|450387354|FG000|Overall Study|Physician Decision|1|||
125208905|NCT00628927|450387355|FG000|Overall Study|Problems performing blood draw|6|||
125208906|NCT00628927|450387356|FG001|Overall Study|Problems performing blood draw|0|||
125208907|NCT00628927|450387355|FG000|Overall Study|Lost to Follow-up|1|||
125208908|NCT00628927|450387356|FG001|Overall Study|Lost to Follow-up|0|||
125208909|NCT00628927|450387355|FG000|Overall Study|Equipment failure|1|||
125208910|NCT00628927|450387356|FG001|Overall Study|Equipment failure|0|||
125208911|NCT02440854|450387357|FG000|Overall Study|Relocation of patient|1|||
125208912|NCT02440854|450387357|FG000|Overall Study|Death|6|||
125208913|NCT02440854|450387357|FG000|Overall Study|Lost to Follow-up|10|||
125208914|NCT02440854|450387357|FG000|Overall Study|Afatinib discontinuation|46|||
125649588|NCT01377194|451999848|FG000|Overall Study|Withdrawal by Subject|8|||
125649589|NCT01377194|451999849|FG001|Overall Study|Withdrawal by Subject|10|||
125649590|NCT01377194|451999850|FG002|Overall Study|Withdrawal by Subject|7|||
125208915|NCT02440854|450387357|FG000|Overall Study|stopped study at earlier timepoint|14|||
125649591|NCT01377194|451999848|FG000|Overall Study|Lost to Follow-up|14|||
125649592|NCT01377194|451999849|FG001|Overall Study|Lost to Follow-up|8|||
125208916|NCT02440854|450387357|FG000|Overall Study|Study medication not received|1|||
125208917|NCT02440854|450387357|FG000|Overall Study|Violation of inclusion criteria|2|||
125208918|NCT00316914|450389295|FG000|Overall Study|Withdrawal by Subject|5|||
125208919|NCT00316914|450389296|FG001|Overall Study|Withdrawal by Subject|3|||
125208920|NCT00316914|450389295|FG000|Overall Study|Adverse Event|8|||
125649593|NCT01377194|451999850|FG002|Overall Study|Lost to Follow-up|11|||
125208921|NCT00316914|450389296|FG001|Overall Study|Adverse Event|7|||
125208922|NCT00316914|450389295|FG000|Overall Study|Other Problems|6|||
125208923|NCT00316914|450389296|FG001|Overall Study|Other Problems|11|||
125208924|NCT00316914|450389295|FG000|Overall Study|Missing end of treatment documentation|14|||
125208925|NCT00316914|450389296|FG001|Overall Study|Missing end of treatment documentation|15|||
125208926|NCT04105010|450389297|FG000|Overall Study|Death|3|||
125208927|NCT04105010|450389298|FG001|Overall Study|Death|1|||
125208928|NCT04105010|450389299|FG002|Overall Study|Death|1|||
125208929|NCT04105010|450389300|FG003|Overall Study|Death|54|||
125208930|NCT04105010|450389297|FG000|Overall Study|Lost to Follow-up|0|||
125208931|NCT04105010|450389298|FG001|Overall Study|Lost to Follow-up|0|||
125208932|NCT04105010|450389299|FG002|Overall Study|Lost to Follow-up|0|||
125208933|NCT04105010|450389300|FG003|Overall Study|Lost to Follow-up|4|||
125208934|NCT04105010|450389297|FG000|Overall Study|Withdrawal by Subject|8|||
125208935|NCT04105010|450389298|FG001|Overall Study|Withdrawal by Subject|1|||
125208936|NCT04105010|450389299|FG002|Overall Study|Withdrawal by Subject|1|||
125208937|NCT04105010|450389300|FG003|Overall Study|Withdrawal by Subject|4|||
125208938|NCT04105010|450389297|FG000|Overall Study|Other reason|4|||
125208939|NCT04105010|450389298|FG001|Overall Study|Other reason|7|||
125208940|NCT04105010|450389299|FG002|Overall Study|Other reason|0|||
125208941|NCT04105010|450389300|FG003|Overall Study|Other reason|19|||
125208942|NCT01179737|450389303|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
125208943|NCT01179737|450389304|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
125208944|NCT01179737|450389305|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
125208945|NCT01179737|450389306|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
125208946|NCT01179737|450389303|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
125208947|NCT01179737|450389304|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
125208948|NCT01179737|450389305|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
125208949|NCT01179737|450389306|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
125208950|NCT01179737|450389303|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
125208951|NCT01179737|450389304|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
125208952|NCT01179737|450389305|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
125208953|NCT01179737|450389306|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
125208954|NCT01179737|450389303|FG000|Cohort 1 & Cohort 2|Death|0|||
125208955|NCT01179737|450389304|FG001|Cohort 1 & Cohort 2|Death|0|||
125208956|NCT01179737|450389305|FG002|Cohort 1 & Cohort 2|Death|1|||
125208957|NCT01179737|450389306|FG003|Cohort 1 & Cohort 2|Death|0|||
125208958|NCT01179737|450389303|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
125208959|NCT01179737|450389304|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
125208960|NCT01179737|450389305|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
125208961|NCT01179737|450389306|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
125208962|NCT01179737|450389303|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
125208963|NCT01179737|450389304|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
125208964|NCT01179737|450389305|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
125208965|NCT01179737|450389306|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
125208966|NCT01179737|450389303|FG000|Extension|The study was terminated|3|||
125208967|NCT01179737|450389304|FG001|Extension|The study was terminated|0|||
125208968|NCT01179737|450389305|FG002|Extension|The study was terminated|0|||
125208969|NCT01179737|450389306|FG003|Extension|The study was terminated|0|||
125208970|NCT00717275|450389307|FG000|Overall Study|Premature study termination.|3|||
125208971|NCT00424021|450389311|FG000|NCT00046319 Study Period|Adverse Event|1|||
125208972|NCT00424021|450389312|FG001|NCT00046319 Study Period|Adverse Event|0|||
125208973|NCT00424021|450389313|FG002|NCT00046319 Study Period|Adverse Event|1|||
125208974|NCT00424021|450389314|FG003|NCT00046319 Study Period|Adverse Event|1|||
125208975|NCT00424021|450389311|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
125208976|NCT00424021|450389312|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
125208977|NCT00424021|450389313|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
125208978|NCT00424021|450389314|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
125208979|NCT00424021|450389311|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
125208980|NCT00424021|450389312|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
125208981|NCT00424021|450389313|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
125208982|NCT00424021|450389314|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
125208983|NCT00424021|450389311|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
125208984|NCT00424021|450389312|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
125208985|NCT00424021|450389313|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
125208986|NCT00424021|450389314|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
125208987|NCT00424021|450389311|FG000|AMB-220-E Study Period|Adverse Event|1|||
125208988|NCT00424021|450389312|FG001|AMB-220-E Study Period|Adverse Event|1|||
125208989|NCT00424021|450389313|FG002|AMB-220-E Study Period|Adverse Event|3|||
125208990|NCT00424021|450389314|FG003|AMB-220-E Study Period|Adverse Event|7|||
125208991|NCT00424021|450389311|FG000|AMB-220-E Study Period|Death|0|||
125208992|NCT00424021|450389312|FG001|AMB-220-E Study Period|Death|0|||
125208993|NCT00424021|450389313|FG002|AMB-220-E Study Period|Death|1|||
125208994|NCT00424021|450389314|FG003|AMB-220-E Study Period|Death|1|||
125208995|NCT00424021|450389311|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
125208996|NCT00424021|450389312|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
125208997|NCT00424021|450389313|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
125208998|NCT00424021|450389314|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
125208999|NCT00424021|450389311|FG000|AMB-220-E Study Period|Physician Decision|0|||
125209000|NCT00424021|450389312|FG001|AMB-220-E Study Period|Physician Decision|0|||
125209001|NCT00424021|450389313|FG002|AMB-220-E Study Period|Physician Decision|0|||
125209002|NCT00424021|450389314|FG003|AMB-220-E Study Period|Physician Decision|1|||
125209003|NCT03000530|450389315|FG000|Overall Study|Adverse Event|0|||
125209004|NCT03000530|450389316|FG001|Overall Study|Adverse Event|0|||
125209005|NCT03000530|450389317|FG002|Overall Study|Adverse Event|2|||
125209006|NCT03000530|450389315|FG000|Overall Study|Lost to Follow-up|0|||
125209007|NCT03000530|450389316|FG001|Overall Study|Lost to Follow-up|3|||
125209008|NCT03000530|450389317|FG002|Overall Study|Lost to Follow-up|1|||
125209009|NCT03000530|450389315|FG000|Overall Study|Withdrawal by Subject|0|||
125209010|NCT03000530|450389316|FG001|Overall Study|Withdrawal by Subject|2|||
125209011|NCT03000530|450389317|FG002|Overall Study|Withdrawal by Subject|1|||
125209012|NCT03597022|450389321|FG000|Overall Study|Premature termination of the study|7|||
125209013|NCT03597022|450389322|FG001|Overall Study|Premature termination of the study|7|||
125209014|NCT03597022|450389323|FG002|Overall Study|Premature termination of the study|8|||
125209015|NCT03597022|450389321|FG000|Overall Study|Serious adverse event|1|||
125209016|NCT03597022|450389322|FG001|Overall Study|Serious adverse event|1|||
125209017|NCT03597022|450389323|FG002|Overall Study|Serious adverse event|0|||
125209018|NCT00312572|450389324|FG000|Overall Study|Adverse Event|10|||
125209019|NCT00312572|450389325|FG001|Overall Study|Adverse Event|16|||
125209020|NCT00312572|450389324|FG000|Overall Study|Lost to Follow-up|1|||
125209021|NCT00312572|450389325|FG001|Overall Study|Lost to Follow-up|1|||
125209022|NCT00312572|450389324|FG000|Overall Study|Administrative|4|||
125209023|NCT00312572|450389325|FG001|Overall Study|Administrative|2|||
125209024|NCT00312572|450389324|FG000|Overall Study|Lack of Efficacy|1|||
125209025|NCT00312572|450389325|FG001|Overall Study|Lack of Efficacy|2|||
125209026|NCT02614131|450389328|FG000|Overall Study|Withdrawal by Subject|1|||
125209027|NCT02614131|450389329|FG001|Overall Study|Withdrawal by Subject|0|||
125649594|NCT01230489|451999851|FG000|Overall Study|Death|2|||
125209028|NCT02614131|450389330|FG002|Overall Study|Withdrawal by Subject|0|||
125209029|NCT02614131|450389331|FG003|Overall Study|Withdrawal by Subject|0|||
125209030|NCT02614131|450389332|FG004|Overall Study|Withdrawal by Subject|0|||
125209031|NCT02614131|450389333|FG005|Overall Study|Withdrawal by Subject|0|||
125209032|NCT02614131|450389334|FG006|Overall Study|Withdrawal by Subject|0|||
125209033|NCT02614131|450389328|FG000|Overall Study|Adverse Event|0|||
125209034|NCT02614131|450389329|FG001|Overall Study|Adverse Event|0|||
125209035|NCT02614131|450389330|FG002|Overall Study|Adverse Event|0|||
125209036|NCT02614131|450389331|FG003|Overall Study|Adverse Event|0|||
125209037|NCT02614131|450389332|FG004|Overall Study|Adverse Event|0|||
125209038|NCT02614131|450389333|FG005|Overall Study|Adverse Event|0|||
125209039|NCT02614131|450389334|FG006|Overall Study|Adverse Event|1|||
125209040|NCT01285492|450389339|FG000|Overall Study|Adverse Event|11|||
125209041|NCT01285492|450389340|FG001|Overall Study|Adverse Event|0|||
125209042|NCT01285492|450389339|FG000|Overall Study|Protocol Violation|3|||
125209043|NCT01285492|450389340|FG001|Overall Study|Protocol Violation|0|||
125209044|NCT01285492|450389339|FG000|Overall Study|Withdrawal by Subject|2|||
125209045|NCT01285492|450389340|FG001|Overall Study|Withdrawal by Subject|1|||
125209046|NCT01285492|450389339|FG000|Overall Study|Death|1|||
125209047|NCT01285492|450389340|FG001|Overall Study|Death|0|||
125209048|NCT01797094|450389341|FG000|Overall Study|Adverse Event|1|||
125209049|NCT01797094|450389342|FG001|Overall Study|Adverse Event|1|||
125209050|NCT01797094|450389341|FG000|Overall Study|Personal Reasons|4|||
125209051|NCT01797094|450389342|FG001|Overall Study|Personal Reasons|0|||
125209052|NCT01797094|450389341|FG000|Overall Study|Protocol Violation|0|||
125209053|NCT01797094|450389342|FG001|Overall Study|Protocol Violation|1|||
125209054|NCT01797094|450389341|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125209055|NCT01797094|450389342|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125209056|NCT03217968|450389345|FG000|Overall Study|Withdrawal by Subject|4|||
125209057|NCT03217968|450389345|FG000|Overall Study|Lost to Follow-up|1|||
125209058|NCT03217968|450389345|FG000|Overall Study|Protocol Violation|6|||
125209059|NCT00306787|450389349|FG000|Overall Study|Discontinued without taking study drug|208|||
125209060|NCT00306787|450389350|FG001|Overall Study|Discontinued without taking study drug|215|||
125209061|NCT00306787|450389349|FG000|Overall Study|Adverse Event|1|||
125209062|NCT00306787|450389350|FG001|Overall Study|Adverse Event|1|||
125209063|NCT00306787|450389349|FG000|Overall Study|Lack of Efficacy|1|||
125209064|NCT00306787|450389350|FG001|Overall Study|Lack of Efficacy|0|||
125209065|NCT00306787|450389349|FG000|Overall Study|Protocol Violation|8|||
125209066|NCT00306787|450389350|FG001|Overall Study|Protocol Violation|10|||
125209067|NCT00306787|450389349|FG000|Overall Study|Withdrawal by Subject|2|||
125209068|NCT00306787|450389350|FG001|Overall Study|Withdrawal by Subject|9|||
125209069|NCT00306787|450389349|FG000|Overall Study|Lost to Follow-up|9|||
125209070|NCT00306787|450389350|FG001|Overall Study|Lost to Follow-up|6|||
125209071|NCT00306787|450389349|FG000|Overall Study|Administrative problems|4|||
125209072|NCT00306787|450389350|FG001|Overall Study|Administrative problems|0|||
125209073|NCT00306787|450389349|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125209074|NCT00306787|450389350|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125209075|NCT01887678|450389353|FG000|Overall Study|Adverse Event|4|||
125209076|NCT01887678|450389354|FG001|Overall Study|Adverse Event|6|||
125209077|NCT01887678|450389353|FG000|Overall Study|Exceeded rescue medication dosage|4|||
125209078|NCT01887678|450389354|FG001|Overall Study|Exceeded rescue medication dosage|5|||
125209079|NCT01887678|450389353|FG000|Overall Study|Withdrawal of consent|3|||
125209080|NCT01887678|450389354|FG001|Overall Study|Withdrawal of consent|4|||
125209081|NCT01887678|450389353|FG000|Overall Study|Lost to Follow-up|4|||
125209082|NCT01887678|450389354|FG001|Overall Study|Lost to Follow-up|2|||
125209083|NCT01887678|450389353|FG000|Overall Study|Deterioration of clinical condition|0|||
125209084|NCT01887678|450389354|FG001|Overall Study|Deterioration of clinical condition|4|||
125209085|NCT01887678|450389353|FG000|Overall Study|Lack of Efficacy|1|||
125209086|NCT01887678|450389354|FG001|Overall Study|Lack of Efficacy|2|||
125209087|NCT01887678|450389353|FG000|Overall Study|Non-compliance|0|||
125209088|NCT01887678|450389354|FG001|Overall Study|Non-compliance|3|||
125209089|NCT01887678|450389353|FG000|Overall Study|Specified|1|||
125209090|NCT01887678|450389354|FG001|Overall Study|Specified|2|||
125209091|NCT03013985|450389355|FG000|Overall Study|Protocol Violation|2|||
125209092|NCT03013985|450389356|FG001|Overall Study|Protocol Violation|2|||
125209093|NCT03013985|450389355|FG000|Overall Study|Withdrawal by Subject|14|||
125209094|NCT03013985|450389356|FG001|Overall Study|Withdrawal by Subject|17|||
125209095|NCT00791492|450389359|FG000|Overall Study|Withdrawal by Subject|1|||
125209096|NCT00791492|450389360|FG001|Overall Study|Withdrawal by Subject|2|||
125209097|NCT00791492|450389359|FG000|Overall Study|Liver transplantation|5|||
125209098|NCT00791492|450389360|FG001|Overall Study|Liver transplantation|1|||
125209099|NCT00634049|450389377|FG000|Overall Study|Never received study drug|1|||
125209100|NCT00634049|450389377|FG000|Overall Study|Died prior to receiving study drug|1|||
125209101|NCT00634049|450389377|FG000|Overall Study|Screening failure|1|||
125209102|NCT00314132|450389378|FG000|Overall Study|Lost to Follow-up|3|||
125209103|NCT00314132|450389379|FG001|Overall Study|Lost to Follow-up|13|||
125209104|NCT00314132|450389378|FG000|Overall Study|Withdrawal by Subject|3|||
125209105|NCT00314132|450389379|FG001|Overall Study|Withdrawal by Subject|5|||
125209106|NCT00314132|450389378|FG000|Overall Study|Adverse Event|1|||
125209107|NCT00314132|450389379|FG001|Overall Study|Adverse Event|0|||
125209108|NCT00314132|450389378|FG000|Overall Study|Physician Decision|1|||
125209109|NCT00314132|450389379|FG001|Overall Study|Physician Decision|0|||
125209110|NCT01380691|450389382|FG000|Washout (7 Days)|Protocol Violation|0|||
125209111|NCT01380691|450389383|FG001|Washout (7 Days)|Protocol Violation|0|||
125209112|NCT01380691|450389384|FG002|Washout (7 Days)|Protocol Violation|0|||
125209113|NCT01380691|450389385|FG003|Washout (7 Days)|Protocol Violation|1|||
125209114|NCT01380691|450389382|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
125209115|NCT01380691|450389383|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
125209116|NCT01380691|450389384|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
125209117|NCT01380691|450389385|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
125209118|NCT01987232|450389388|FG000|Overall Study|Ongoing in Study|0|||
125209119|NCT01987232|450389389|FG001|Overall Study|Ongoing in Study|0|||
125209120|NCT01987232|450389390|FG002|Overall Study|Ongoing in Study|0|||
125209121|NCT01987232|450389391|FG003|Overall Study|Ongoing in Study|1|||
125209122|NCT01987232|450389392|FG004|Overall Study|Ongoing in Study|0|||
125209123|NCT00586508|450389393|FG000|Overall Study|Progressive disease|52|||
125209124|NCT00586508|450389394|FG001|Overall Study|Progressive disease|8|||
125209125|NCT00586508|450389393|FG000|Overall Study|Death|0|||
125209126|NCT00586508|450389394|FG001|Overall Study|Death|1|||
125209127|NCT00586508|450389393|FG000|Overall Study|Adverse Event|12|||
125209128|NCT00586508|450389394|FG001|Overall Study|Adverse Event|4|||
125209129|NCT00586508|450389393|FG000|Overall Study|Withdrawal by Subject|4|||
125209130|NCT00586508|450389394|FG001|Overall Study|Withdrawal by Subject|0|||
125209131|NCT03564795|450389395|FG000|Overall Study|Withdrawal by Subject|3|||
125209132|NCT03564795|450389395|FG000|Overall Study|Lost to Follow-up|6|||
125209133|NCT03564795|450389395|FG000|Overall Study|Physician Decision|2|||
125209134|NCT02906033|450389400|FG000|Baseline|Protocol Violation|37|||
125209135|NCT02906033|450389401|FG001|Baseline|Protocol Violation|33|||
125209136|NCT02906033|450389400|FG000|Follow-up|Lost to Follow-up|46|||
125209137|NCT02906033|450389401|FG001|Follow-up|Lost to Follow-up|62|||
125209138|NCT01333956|450389406|FG000|Overall Study|Lost to Follow-up|1|||
125209139|NCT01333956|450389407|FG001|Overall Study|Lost to Follow-up|2|||
125209140|NCT01333956|450389408|FG002|Overall Study|Lost to Follow-up|0|||
125209141|NCT01333956|450389409|FG003|Overall Study|Lost to Follow-up|1|||
125209142|NCT01333956|450389406|FG000|Overall Study|Unable to complete study procedure|1|||
125209143|NCT01333956|450389407|FG001|Overall Study|Unable to complete study procedure|0|||
125209144|NCT01333956|450389408|FG002|Overall Study|Unable to complete study procedure|0|||
125209145|NCT01333956|450389409|FG003|Overall Study|Unable to complete study procedure|1|||
125209146|NCT01333956|450389406|FG000|Overall Study|Withdrawal by Subject|0|||
125539956|NCT03117998|451605880|FG005|Overall Study|Withdrawal by Subject|0|||
125209147|NCT01333956|450389407|FG001|Overall Study|Withdrawal by Subject|2|||
125209148|NCT01333956|450389408|FG002|Overall Study|Withdrawal by Subject|1|||
125209149|NCT01333956|450389409|FG003|Overall Study|Withdrawal by Subject|0|||
125209150|NCT00432276|450389412|FG000|Overall Study|Hyperglycemic Rescue|44|||
125209151|NCT00432276|450389413|FG001|Overall Study|Hyperglycemic Rescue|87|||
125209152|NCT00432276|450389412|FG000|Overall Study|Adverse Event|13|||
125209153|NCT00432276|450389413|FG001|Overall Study|Adverse Event|16|||
125209154|NCT00432276|450389412|FG000|Overall Study|Protocol Violation|25|||
125209155|NCT00432276|450389413|FG001|Overall Study|Protocol Violation|20|||
125209156|NCT00432276|450389412|FG000|Overall Study|Lost to Follow-up|6|||
125209157|NCT00432276|450389413|FG001|Overall Study|Lost to Follow-up|2|||
125209158|NCT00432276|450389412|FG000|Overall Study|Withdrawal by Subject|25|||
125649595|NCT01230489|451999851|FG000|Overall Study|Adverse Event|2|||
125649596|NCT01230489|451999851|FG000|Overall Study|Treatment modality changed|1|||
125649597|NCT01791543|451999852|FG000|Overall Study|Lost to Follow-up|1|||
125649598|NCT01791543|451999852|FG000|Overall Study|Adverse Event|1|||
125649599|NCT01846442|452000974|FG000|Overall Study|Adverse Event|2|||
125649600|NCT01846442|452000975|FG001|Overall Study|Adverse Event|4|||
125649601|NCT01846442|452000976|FG002|Overall Study|Adverse Event|2|||
125649602|NCT01846442|452000977|FG003|Overall Study|Adverse Event|1|||
125649603|NCT01846442|452000974|FG000|Overall Study|Lost to Follow-up|0|||
125649604|NCT01846442|452000975|FG001|Overall Study|Lost to Follow-up|0|||
125649605|NCT01846442|452000976|FG002|Overall Study|Lost to Follow-up|1|||
125649606|NCT01846442|452000977|FG003|Overall Study|Lost to Follow-up|0|||
125649607|NCT01846442|452000974|FG000|Overall Study|Withdrawal by Subject|3|||
125649608|NCT01846442|452000975|FG001|Overall Study|Withdrawal by Subject|2|||
125649609|NCT01846442|452000976|FG002|Overall Study|Withdrawal by Subject|0|||
125649610|NCT01846442|452000977|FG003|Overall Study|Withdrawal by Subject|1|||
125649611|NCT01846442|452000974|FG000|Overall Study|Left the city/Lost medication|1|||
125649612|NCT01846442|452000975|FG001|Overall Study|Left the city/Lost medication|0|||
125649613|NCT01846442|452000976|FG002|Overall Study|Left the city/Lost medication|1|||
125649614|NCT01846442|452000977|FG003|Overall Study|Left the city/Lost medication|1|||
125649615|NCT01224171|452000983|FG000|Overall Study|Adverse Event|8|||
125649616|NCT01224171|452000984|FG001|Overall Study|Adverse Event|4|||
125649617|NCT01224171|452000983|FG000|Overall Study|Protocol Violation|0|||
125649618|NCT01224171|452000984|FG001|Overall Study|Protocol Violation|1|||
125649619|NCT01224171|452000983|FG000|Overall Study|Lack of Efficacy|5|||
125649620|NCT01224171|452000984|FG001|Overall Study|Lack of Efficacy|1|||
125649621|NCT01224171|452000983|FG000|Overall Study|Withdrawal of Consent|2|||
125649622|NCT01224171|452000984|FG001|Overall Study|Withdrawal of Consent|4|||
125649623|NCT01224171|452000983|FG000|Overall Study|Lost to Follow-up|0|||
125649624|NCT01224171|452000984|FG001|Overall Study|Lost to Follow-up|3|||
125649625|NCT03737812|452000985|FG000|Overall Study|Withdrawal by Subject|1|||
125649626|NCT03737812|452000986|FG001|Overall Study|Withdrawal by Subject|2|||
125649627|NCT03737812|452000987|FG002|Overall Study|Withdrawal by Subject|1|||
125649628|NCT03737812|452000985|FG000|Overall Study|Sponsor Discontinued the Study|4|||
125649629|NCT03737812|452000986|FG001|Overall Study|Sponsor Discontinued the Study|3|||
125649630|NCT03737812|452000987|FG002|Overall Study|Sponsor Discontinued the Study|2|||
125649631|NCT03737812|452000985|FG000|Overall Study|Adverse Event|0|||
125649632|NCT03737812|452000986|FG001|Overall Study|Adverse Event|1|||
125649633|NCT03737812|452000987|FG002|Overall Study|Adverse Event|0|||
125649634|NCT03737812|452000985|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
125649635|NCT03737812|452000986|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
125649636|NCT03737812|452000987|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
125649637|NCT02624713|452000988|FG000|Overall Study|Lost to Follow-up|14|||
125649638|NCT02624713|452000989|FG001|Overall Study|Lost to Follow-up|0|||
125649639|NCT00285857|452000993|FG000|Overall Study|Withdrawal by Subject|2|||
125649640|NCT00285857|452000993|FG000|Overall Study|Inadequate initial breast cytology|1|||
125649641|NCT00285857|452000993|FG000|Overall Study|Adverse Event|1|||
125209159|NCT00432276|450389413|FG001|Overall Study|Withdrawal by Subject|20|||
125209160|NCT00432276|450389412|FG000|Overall Study|Physician Decision|6|||
125209161|NCT00432276|450389413|FG001|Overall Study|Physician Decision|8|||
125209162|NCT00432276|450389412|FG000|Overall Study|Other|2|||
125209163|NCT00432276|450389413|FG001|Overall Study|Other|3|||
125209164|NCT05249127|450389414|FG000|Overall Study|Protocol Violation|13|||
125209165|NCT05249127|450389414|FG000|Overall Study|Physician Decision|4|||
125209166|NCT05249127|450389414|FG000|Overall Study|Withdrawal by Subject|2|||
125209167|NCT05249127|450389414|FG000|Overall Study|Participant Non-compliance|1|||
125209168|NCT02073565|450389415|FG000|Cohort A|Withdrawal by Subject|1|||
125209169|NCT02073565|450389416|FG001|Cohort A|Withdrawal by Subject|0|||
125209170|NCT02073565|450389415|FG000|Cohort B|Withdrawal by Subject|1|||
125209171|NCT02073565|450389416|FG001|Cohort B|Withdrawal by Subject|2|||
125209172|NCT02073565|450389415|FG000|Cohort C|Withdrawal by Subject|0|||
125209173|NCT02073565|450389416|FG001|Cohort C|Withdrawal by Subject|2|||
125209174|NCT02073565|450389415|FG000|Cohort C|Lost to Follow-up|0|||
125209175|NCT02073565|450389416|FG001|Cohort C|Lost to Follow-up|2|||
125209176|NCT03646305|450389417|FG000|Overall Study|Lost to Follow-up|4|||
125209177|NCT03646305|450389418|FG001|Overall Study|Lost to Follow-up|2|||
125209178|NCT03646305|450389419|FG002|Overall Study|Lost to Follow-up|2|||
125209179|NCT03646305|450389420|FG003|Overall Study|Lost to Follow-up|1|||
125209180|NCT03646305|450389417|FG000|Overall Study|Withdrawal by Subject|1|||
125209181|NCT03646305|450389418|FG001|Overall Study|Withdrawal by Subject|0|||
125209182|NCT03646305|450389419|FG002|Overall Study|Withdrawal by Subject|0|||
125649642|NCT01161173|452000999|FG000|Overall Study|Protocol Violation|13|||
125649643|NCT01161173|452000999|FG000|Overall Study|Lost to Follow-up|7|||
125209183|NCT03646305|450389420|FG003|Overall Study|Withdrawal by Subject|1|||
125209184|NCT04015518|450389421|FG000|Overall Study|Adverse Event|6|||
125209185|NCT04015518|450389422|FG001|Overall Study|Adverse Event|1|||
125209186|NCT04015518|450389423|FG002|Overall Study|Adverse Event|1|||
125649644|NCT01161173|452000999|FG000|Overall Study|Progressive Disease|82|||
125209187|NCT04015518|450389424|FG003|Overall Study|Adverse Event|3|||
125209188|NCT04015518|450389425|FG004|Overall Study|Adverse Event|3|||
125209189|NCT04015518|450389421|FG000|Overall Study|Lack of Efficacy|1|||
125209190|NCT04015518|450389422|FG001|Overall Study|Lack of Efficacy|0|||
125209191|NCT04015518|450389423|FG002|Overall Study|Lack of Efficacy|1|||
125209192|NCT04015518|450389424|FG003|Overall Study|Lack of Efficacy|0|||
125209193|NCT04015518|450389425|FG004|Overall Study|Lack of Efficacy|4|||
125209194|NCT04015518|450389421|FG000|Overall Study|Lost to Follow-up|0|||
125209195|NCT04015518|450389422|FG001|Overall Study|Lost to Follow-up|0|||
125209196|NCT04015518|450389423|FG002|Overall Study|Lost to Follow-up|0|||
125209197|NCT04015518|450389424|FG003|Overall Study|Lost to Follow-up|0|||
125209198|NCT04015518|450389425|FG004|Overall Study|Lost to Follow-up|1|||
125209199|NCT04015518|450389421|FG000|Overall Study|Withdrawal by Subject|0|||
125209200|NCT04015518|450389422|FG001|Overall Study|Withdrawal by Subject|1|||
125209201|NCT04015518|450389423|FG002|Overall Study|Withdrawal by Subject|0|||
125209202|NCT04015518|450389424|FG003|Overall Study|Withdrawal by Subject|1|||
125209203|NCT04015518|450389425|FG004|Overall Study|Withdrawal by Subject|1|||
125209204|NCT04015518|450389421|FG000|Overall Study|Patient did not come for consecutive visits|0|||
125209205|NCT04015518|450389422|FG001|Overall Study|Patient did not come for consecutive visits|1|||
125209206|NCT04015518|450389423|FG002|Overall Study|Patient did not come for consecutive visits|0|||
125209207|NCT04015518|450389424|FG003|Overall Study|Patient did not come for consecutive visits|0|||
125209208|NCT04015518|450389425|FG004|Overall Study|Patient did not come for consecutive visits|0|||
125209209|NCT04015518|450389421|FG000|Overall Study|not willing to travel due to Covid-19|0|||
125209210|NCT04015518|450389422|FG001|Overall Study|not willing to travel due to Covid-19|0|||
125209211|NCT04015518|450389423|FG002|Overall Study|not willing to travel due to Covid-19|1|||
125209212|NCT04015518|450389424|FG003|Overall Study|not willing to travel due to Covid-19|0|||
125209213|NCT04015518|450389425|FG004|Overall Study|not willing to travel due to Covid-19|0|||
125209214|NCT04015518|450389421|FG000|Overall Study|Patient wants to discontinue treatment|0|||
125209215|NCT04015518|450389422|FG001|Overall Study|Patient wants to discontinue treatment|0|||
125209216|NCT04015518|450389423|FG002|Overall Study|Patient wants to discontinue treatment|0|||
125209217|NCT04015518|450389424|FG003|Overall Study|Patient wants to discontinue treatment|1|||
125209218|NCT04015518|450389425|FG004|Overall Study|Patient wants to discontinue treatment|0|||
125209219|NCT04015518|450389421|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
125209220|NCT04015518|450389422|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
125209221|NCT04015518|450389423|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
125209222|NCT04015518|450389424|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
125539957|NCT03117998|451605875|FG000|Overall Study|Physician Decision|0|||
125539958|NCT03117998|451605876|FG001|Overall Study|Physician Decision|1|||
125539959|NCT03117998|451605877|FG002|Overall Study|Physician Decision|1|||
125539960|NCT03117998|451605878|FG003|Overall Study|Physician Decision|0|||
125539961|NCT03117998|451605879|FG004|Overall Study|Physician Decision|0|||
125539962|NCT03117998|451605880|FG005|Overall Study|Physician Decision|0|||
125539963|NCT03117998|451605875|FG000|Overall Study|Lost to Follow-up|0|||
125539964|NCT03117998|451605876|FG001|Overall Study|Lost to Follow-up|0|||
125539965|NCT03117998|451605877|FG002|Overall Study|Lost to Follow-up|0|||
125539966|NCT03117998|451605878|FG003|Overall Study|Lost to Follow-up|1|||
125539967|NCT03117998|451605879|FG004|Overall Study|Lost to Follow-up|4|||
125539968|NCT03117998|451605880|FG005|Overall Study|Lost to Follow-up|0|||
125539969|NCT03117998|451605875|FG000|Overall Study|Subject noncompliance|0|||
125539970|NCT03117998|451605876|FG001|Overall Study|Subject noncompliance|0|||
125539971|NCT03117998|451605877|FG002|Overall Study|Subject noncompliance|1|||
125539972|NCT03117998|451605878|FG003|Overall Study|Subject noncompliance|0|||
125539973|NCT03117998|451605879|FG004|Overall Study|Subject noncompliance|0|||
125539974|NCT03117998|451605880|FG005|Overall Study|Subject noncompliance|2|||
125539975|NCT03117998|451605875|FG000|Overall Study|Protocol Violation|0|||
125539976|NCT03117998|451605876|FG001|Overall Study|Protocol Violation|0|||
125539977|NCT03117998|451605877|FG002|Overall Study|Protocol Violation|0|||
125539978|NCT03117998|451605878|FG003|Overall Study|Protocol Violation|0|||
125539979|NCT03117998|451605879|FG004|Overall Study|Protocol Violation|0|||
125539980|NCT03117998|451605880|FG005|Overall Study|Protocol Violation|1|||
125539981|NCT00350103|451605884|FG000|Overall Study|Adverse Event|12|||
125539982|NCT00350103|451605885|FG001|Overall Study|Adverse Event|29|||
125539983|NCT00350103|451605886|FG002|Overall Study|Adverse Event|17|||
125539984|NCT00350103|451605884|FG000|Overall Study|Lack of Efficacy|5|||
125539985|NCT00350103|451605885|FG001|Overall Study|Lack of Efficacy|1|||
125539986|NCT00350103|451605886|FG002|Overall Study|Lack of Efficacy|3|||
125539987|NCT00350103|451605884|FG000|Overall Study|Withdrawal by Subject|6|||
125539988|NCT00350103|451605885|FG001|Overall Study|Withdrawal by Subject|6|||
125539989|NCT00350103|451605886|FG002|Overall Study|Withdrawal by Subject|8|||
125539990|NCT00350103|451605884|FG000|Overall Study|Protocol Violation|0|||
125539991|NCT00350103|451605885|FG001|Overall Study|Protocol Violation|0|||
125209223|NCT04015518|450389425|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
125209224|NCT04015518|450389421|FG000|Overall Study|Pregnancy|0|||
125209225|NCT04015518|450389422|FG001|Overall Study|Pregnancy|0|||
125539992|NCT00350103|451605886|FG002|Overall Study|Protocol Violation|1|||
125209226|NCT04015518|450389423|FG002|Overall Study|Pregnancy|0|||
125209227|NCT04015518|450389424|FG003|Overall Study|Pregnancy|0|||
125209228|NCT04015518|450389425|FG004|Overall Study|Pregnancy|1|||
125209229|NCT04015518|450389421|FG000|Overall Study|Personal reasons|1|||
125209230|NCT04015518|450389422|FG001|Overall Study|Personal reasons|0|||
125209231|NCT04015518|450389423|FG002|Overall Study|Personal reasons|0|||
125209232|NCT04015518|450389424|FG003|Overall Study|Personal reasons|0|||
125209233|NCT04015518|450389425|FG004|Overall Study|Personal reasons|1|||
125209234|NCT04015518|450389421|FG000|Overall Study|Withdrew consent|1|||
125209235|NCT04015518|450389422|FG001|Overall Study|Withdrew consent|0|||
125209236|NCT04015518|450389423|FG002|Overall Study|Withdrew consent|0|||
125209237|NCT04015518|450389424|FG003|Overall Study|Withdrew consent|0|||
125209238|NCT04015518|450389425|FG004|Overall Study|Withdrew consent|0|||
125209239|NCT04015518|450389421|FG000|Overall Study|Prostate carcinoma|1|||
125209240|NCT04015518|450389422|FG001|Overall Study|Prostate carcinoma|0|||
125209241|NCT04015518|450389423|FG002|Overall Study|Prostate carcinoma|0|||
125209242|NCT04015518|450389424|FG003|Overall Study|Prostate carcinoma|0|||
125209243|NCT04015518|450389425|FG004|Overall Study|Prostate carcinoma|0|||
125209244|NCT04015518|450389421|FG000|Overall Study|Could not keep appointments due to work|1|||
125209245|NCT04015518|450389422|FG001|Overall Study|Could not keep appointments due to work|0|||
125209246|NCT04015518|450389423|FG002|Overall Study|Could not keep appointments due to work|0|||
125209247|NCT04015518|450389424|FG003|Overall Study|Could not keep appointments due to work|0|||
125209248|NCT04015518|450389425|FG004|Overall Study|Could not keep appointments due to work|0|||
125209249|NCT00386425|450389426|FG000|Overall Study|Physician Decision|3|||
125209250|NCT00386425|450389427|FG001|Overall Study|Physician Decision|0|||
125209251|NCT00386425|450389428|FG002|Overall Study|Physician Decision|0|||
125209252|NCT00386425|450389426|FG000|Overall Study|Withdrawal by Subject|0|||
125209253|NCT00386425|450389427|FG001|Overall Study|Withdrawal by Subject|1|||
125209254|NCT00386425|450389428|FG002|Overall Study|Withdrawal by Subject|0|||
125209255|NCT01324570|450389436|FG000|Overall Study|Adverse Event|4|||
125209256|NCT01324570|450389437|FG001|Overall Study|Adverse Event|7|||
125209257|NCT01324570|450389436|FG000|Overall Study|Withdrawal by Subject|0|||
125209258|NCT01324570|450389437|FG001|Overall Study|Withdrawal by Subject|3|||
125209259|NCT01324570|450389436|FG000|Overall Study|Lack of Efficacy|0|||
125209260|NCT01324570|450389437|FG001|Overall Study|Lack of Efficacy|1|||
125209261|NCT01324570|450389436|FG000|Overall Study|Confirmed or suspected diversion|0|||
125209262|NCT01324570|450389437|FG001|Overall Study|Confirmed or suspected diversion|1|||
125209263|NCT01324570|450389436|FG000|Overall Study|Administrative|0|||
125209264|NCT01324570|450389437|FG001|Overall Study|Administrative|2|||
125209265|NCT02360475|450389438|FG000|Overall Study|Lost to Follow-up|4|||
125209266|NCT02360475|450389439|FG001|Overall Study|Lost to Follow-up|12|||
125209267|NCT02360475|450389440|FG002|Overall Study|Lost to Follow-up|6|||
125209268|NCT02360475|450389441|FG003|Overall Study|Lost to Follow-up|4|||
125209269|NCT02360475|450389438|FG000|Overall Study|Withdrawal by Subject|0|||
125209270|NCT02360475|450389439|FG001|Overall Study|Withdrawal by Subject|1|||
125209271|NCT02360475|450389440|FG002|Overall Study|Withdrawal by Subject|2|||
125209272|NCT02360475|450389441|FG003|Overall Study|Withdrawal by Subject|0|||
125209273|NCT02360475|450389438|FG000|Overall Study|Migrated/moved from study area|0|||
125209274|NCT02360475|450389439|FG001|Overall Study|Migrated/moved from study area|0|||
125209275|NCT02360475|450389440|FG002|Overall Study|Migrated/moved from study area|0|||
125209276|NCT02360475|450389441|FG003|Overall Study|Migrated/moved from study area|1|||
125209277|NCT00207727|450389442|FG000|Overall Study|Withdrawal by Subject|0|||
125209278|NCT00207727|450389443|FG001|Overall Study|Withdrawal by Subject|0|||
125209279|NCT00207727|450389444|FG002|Overall Study|Withdrawal by Subject|0|||
125209280|NCT00207727|450389445|FG003|Overall Study|Withdrawal by Subject|0|||
125209281|NCT00207727|450389446|FG004|Overall Study|Withdrawal by Subject|1|||
125209282|NCT00207727|450389442|FG000|Overall Study|Lost to Follow-up|0|||
125209283|NCT00207727|450389443|FG001|Overall Study|Lost to Follow-up|1|||
125209284|NCT00207727|450389444|FG002|Overall Study|Lost to Follow-up|0|||
125209285|NCT00207727|450389445|FG003|Overall Study|Lost to Follow-up|0|||
125209286|NCT00207727|450389446|FG004|Overall Study|Lost to Follow-up|0|||
125209287|NCT00207727|450389442|FG000|Overall Study|Other|38|||
125209288|NCT00207727|450389443|FG001|Overall Study|Other|41|||
125209289|NCT00207727|450389444|FG002|Overall Study|Other|41|||
125649645|NCT01161173|452000999|FG000|Overall Study|Withdrawal of Consent|5|||
125209290|NCT00207727|450389445|FG003|Overall Study|Other|37|||
125209291|NCT00207727|450389446|FG004|Overall Study|Other|33|||
125209292|NCT00539032|450389451|FG000|Overall Study|Withdrawal by Subject|2|||
125209293|NCT00539032|450389452|FG001|Overall Study|Withdrawal by Subject|1|||
125209294|NCT00435019|450389453|FG000|Overall Study|Adverse Event|1|||
125209295|NCT00435019|450389454|FG001|Overall Study|Adverse Event|0|||
125209296|NCT00435019|450389453|FG000|Overall Study|Lack of Efficacy|1|||
125209297|NCT00435019|450389454|FG001|Overall Study|Lack of Efficacy|2|||
125209298|NCT00435019|450389453|FG000|Overall Study|Protocol Violation|3|||
125209299|NCT00435019|450389454|FG001|Overall Study|Protocol Violation|1|||
125209300|NCT00435019|450389453|FG000|Overall Study|Personal reasons for withdrawal|8|||
125209301|NCT00435019|450389454|FG001|Overall Study|Personal reasons for withdrawal|7|||
125209302|NCT02669082|450389458|FG000|Overall Study|Adverse Event|1|||
125209303|NCT04852276|450389459|FG000|Overall Study|Death|2|||
125209304|NCT04852276|450389460|FG001|Overall Study|Death|0|||
125209305|NCT04852276|450389459|FG000|Overall Study|Lost to Follow-up|15|||
125209306|NCT04852276|450389460|FG001|Overall Study|Lost to Follow-up|9|||
125209307|NCT04852276|450389459|FG000|Overall Study|Withdrawal by Subject|26|||
125209308|NCT04852276|450389460|FG001|Overall Study|Withdrawal by Subject|6|||
125209309|NCT01709864|450391213|FG000|Overall Study|Physician Decision|0|||
125209310|NCT01709864|450391214|FG001|Overall Study|Physician Decision|1|||
125209311|NCT01709864|450391213|FG000|Overall Study|subject/guardian decision|5|||
125209312|NCT01709864|450391214|FG001|Overall Study|subject/guardian decision|6|||
125209313|NCT01709864|450391213|FG000|Overall Study|Lost to Follow-up|1|||
125209314|NCT01709864|450391214|FG001|Overall Study|Lost to Follow-up|0|||
125209315|NCT01709864|450391213|FG000|Overall Study|non-compliance with study treatment|1|||
125209316|NCT01709864|450391214|FG001|Overall Study|non-compliance with study treatment|1|||
125209317|NCT01709864|450391213|FG000|Overall Study|Adverse Event|0|||
125209318|NCT01709864|450391214|FG001|Overall Study|Adverse Event|2|||
125209319|NCT01709864|450391213|FG000|Overall Study|Death|0|||
125649646|NCT01161173|452000999|FG000|Overall Study|Unacceptable Toxicity|21|||
125209320|NCT01709864|450391214|FG001|Overall Study|Death|1|||
125209321|NCT00427999|450391215|FG000|Overall Study|Adverse Event|6|||
125209322|NCT00427999|450391215|FG000|Overall Study|Abnormal laboratory values|1|||
125209323|NCT00427999|450391215|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
125209324|NCT00427999|450391215|FG000|Overall Study|Protocol Violation|2|||
125209325|NCT00427999|450391215|FG000|Overall Study|Withdrawal by Subject|9|||
125209326|NCT00427999|450391215|FG000|Overall Study|Death|1|||
125209327|NCT02380859|450391216|FG000|Overall Study|Withdrawal by Subject|2|||
125209328|NCT02380859|450391217|FG001|Overall Study|Withdrawal by Subject|0|||
125209329|NCT02284568|450391218|FG000|Overall Study|Adverse Event|2|||
125209330|NCT02284568|450391219|FG001|Overall Study|Adverse Event|9|||
125209331|NCT02284568|450391220|FG002|Overall Study|Adverse Event|4|||
125209332|NCT02284568|450391218|FG000|Overall Study|Withdrawal by Subject|22|||
125209333|NCT02284568|450391219|FG001|Overall Study|Withdrawal by Subject|21|||
125209334|NCT02284568|450391220|FG002|Overall Study|Withdrawal by Subject|1|||
125209335|NCT02284568|450391218|FG000|Overall Study|Noncompliance with study drug admin|1|||
125209336|NCT02284568|450391219|FG001|Overall Study|Noncompliance with study drug admin|2|||
125209337|NCT02284568|450391220|FG002|Overall Study|Noncompliance with study drug admin|0|||
125209338|NCT02284568|450391218|FG000|Overall Study|Noncompliance|1|||
125209339|NCT02284568|450391219|FG001|Overall Study|Noncompliance|0|||
125209340|NCT02284568|450391220|FG002|Overall Study|Noncompliance|0|||
125209341|NCT02284568|450391218|FG000|Overall Study|Protocol Violation|0|||
125209342|NCT02284568|450391219|FG001|Overall Study|Protocol Violation|1|||
125209343|NCT02284568|450391220|FG002|Overall Study|Protocol Violation|0|||
125209344|NCT02284568|450391218|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
125209345|NCT02284568|450391219|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
125209346|NCT02284568|450391220|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
125209347|NCT02284568|450391218|FG000|Overall Study|Lost to Follow-up|0|||
125209348|NCT02284568|450391219|FG001|Overall Study|Lost to Follow-up|3|||
125209349|NCT02284568|450391220|FG002|Overall Study|Lost to Follow-up|0|||
125209350|NCT02284568|450391218|FG000|Overall Study|Lack of Efficacy|4|||
125649647|NCT01161173|452000999|FG000|Overall Study|Death|194|||
125649648|NCT01161173|452000999|FG000|Overall Study|End of Study|2|||
125649649|NCT01161173|452000999|FG000|Overall Study|Reasons Not Specified|23|||
125649650|NCT00792467|452001002|FG000|Overall Study|progression of disease|17|||
125649651|NCT00792467|452001002|FG000|Overall Study|Adverse Event|1|||
125649652|NCT00792467|452001002|FG000|Overall Study|patient request|1|||
125649653|NCT00792467|452001002|FG000|Overall Study|Lost to Follow-up|1|||
125649654|NCT00792467|452001002|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
125649655|NCT00792467|452001002|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
125649656|NCT03911401|452001003|FG000|Overall Study|Adverse Event|1|||
125649657|NCT03911401|452001004|FG001|Overall Study|Adverse Event|2|||
125649658|NCT03911401|452001005|FG002|Overall Study|Adverse Event|5|||
125649659|NCT03911401|452001003|FG000|Overall Study|Lack of Efficacy|1|||
125649660|NCT03911401|452001004|FG001|Overall Study|Lack of Efficacy|1|||
125649661|NCT03911401|452001005|FG002|Overall Study|Lack of Efficacy|8|||
125649662|NCT03911401|452001003|FG000|Overall Study|Physician Decision|0|||
125209351|NCT02284568|450391219|FG001|Overall Study|Lack of Efficacy|7|||
125209352|NCT02284568|450391220|FG002|Overall Study|Lack of Efficacy|0|||
125209353|NCT02284568|450391218|FG000|Overall Study|Other|1|||
125209354|NCT02284568|450391219|FG001|Overall Study|Other|2|||
125209355|NCT02284568|450391220|FG002|Overall Study|Other|0|||
125209356|NCT02284568|450391218|FG000|Overall Study|Withdrew before taking study drug|0|||
125209357|NCT02284568|450391219|FG001|Overall Study|Withdrew before taking study drug|1|||
125209358|NCT02284568|450391220|FG002|Overall Study|Withdrew before taking study drug|0|||
125209359|NCT00412217|450391221|FG000|Overall Study|Insufficient Data Available|8|||
125209360|NCT00412217|450391222|FG001|Overall Study|Insufficient Data Available|3|||
125209361|NCT00412217|450391221|FG000|Overall Study|Death|5|||
125209362|NCT00412217|450391222|FG001|Overall Study|Death|4|||
125209363|NCT00412217|450391221|FG000|Overall Study|Disease Progression|2|||
125209364|NCT00412217|450391222|FG001|Overall Study|Disease Progression|3|||
125209365|NCT00412217|450391221|FG000|Overall Study|Investigator Decision|1|||
125209366|NCT00412217|450391222|FG001|Overall Study|Investigator Decision|0|||
125209367|NCT00412217|450391221|FG000|Overall Study|Withdrawal by Subject|2|||
125209368|NCT00412217|450391222|FG001|Overall Study|Withdrawal by Subject|0|||
125209369|NCT00412217|450391221|FG000|Overall Study|Lost to Follow-up|1|||
125209370|NCT00412217|450391222|FG001|Overall Study|Lost to Follow-up|4|||
125209371|NCT00412217|450391221|FG000|Overall Study|Study Terminated by Sponsor|26|||
125209372|NCT00412217|450391222|FG001|Overall Study|Study Terminated by Sponsor|33|||
125209373|NCT00412217|450391221|FG000|Overall Study|Other|1|||
125209374|NCT00412217|450391222|FG001|Overall Study|Other|1|||
125209375|NCT03114657|450391223|FG000|Overall Study|Adverse Event|9|||
125209376|NCT03114657|450391224|FG001|Overall Study|Adverse Event|6|||
125209377|NCT03114657|450391223|FG000|Overall Study|Death|4|||
125209378|NCT03114657|450391224|FG001|Overall Study|Death|0|||
125209379|NCT03114657|450391223|FG000|Overall Study|Multiple Reasons|1|||
125209380|NCT03114657|450391224|FG001|Overall Study|Multiple Reasons|2|||
125209381|NCT03114657|450391223|FG000|Overall Study|Physician Decision|2|||
125209382|NCT03114657|450391224|FG001|Overall Study|Physician Decision|2|||
125209383|NCT03114657|450391223|FG000|Overall Study|Study Terminated By Sponsor|355|||
125209384|NCT03114657|450391224|FG001|Overall Study|Study Terminated By Sponsor|374|||
125209385|NCT03114657|450391223|FG000|Overall Study|Symptomatic Deterioration|0|||
125209386|NCT03114657|450391224|FG001|Overall Study|Symptomatic Deterioration|1|||
125209387|NCT03114657|450391223|FG000|Overall Study|Withdrawal by Subject|28|||
125209388|NCT03114657|450391224|FG001|Overall Study|Withdrawal by Subject|22|||
125209389|NCT01546038|450391225|FG000|Overall Study|Death|15|||
125209390|NCT01546038|450391226|FG001|Overall Study|Death|6|||
125649663|NCT03911401|452001004|FG001|Overall Study|Physician Decision|0|||
125649664|NCT03911401|452001005|FG002|Overall Study|Physician Decision|1|||
125649665|NCT03911401|452001003|FG000|Overall Study|Withdrawal by Subject|1|||
125649666|NCT03911401|452001004|FG001|Overall Study|Withdrawal by Subject|2|||
125649667|NCT03911401|452001005|FG002|Overall Study|Withdrawal by Subject|0|||
125649668|NCT03911401|452001003|FG000|Overall Study|Withdrawal by parent/guardian|4|||
125649669|NCT03911401|452001004|FG001|Overall Study|Withdrawal by parent/guardian|4|||
125649670|NCT03911401|452001005|FG002|Overall Study|Withdrawal by parent/guardian|11|||
125649671|NCT00462501|452001006|FG000|Overall Study|Not treated|3|||
125649672|NCT00462501|452001006|FG000|Overall Study|Adverse Event|2|||
125209391|NCT01546038|450391227|FG002|Overall Study|Death|4|||
125209392|NCT01546038|450391228|FG003|Overall Study|Death|2|||
125209393|NCT01546038|450391229|FG004|Overall Study|Death|9|||
125209394|NCT01546038|450391230|FG005|Overall Study|Death|3|||
125209395|NCT01546038|450391231|FG006|Overall Study|Death|46|||
125209396|NCT01546038|450391232|FG007|Overall Study|Death|76|||
125209397|NCT01546038|450391233|FG008|Overall Study|Death|39|||
125209398|NCT01546038|450391225|FG000|Overall Study|Lost to Follow-up|0|||
125209399|NCT01546038|450391226|FG001|Overall Study|Lost to Follow-up|0|||
125209400|NCT01546038|450391227|FG002|Overall Study|Lost to Follow-up|0|||
125209401|NCT01546038|450391228|FG003|Overall Study|Lost to Follow-up|0|||
125209402|NCT01546038|450391229|FG004|Overall Study|Lost to Follow-up|1|||
125209403|NCT01546038|450391230|FG005|Overall Study|Lost to Follow-up|0|||
125209404|NCT01546038|450391231|FG006|Overall Study|Lost to Follow-up|2|||
125209405|NCT01546038|450391232|FG007|Overall Study|Lost to Follow-up|1|||
125209406|NCT01546038|450391233|FG008|Overall Study|Lost to Follow-up|0|||
125209407|NCT01546038|450391225|FG000|Overall Study|Withdrawal by Subject|1|||
125209408|NCT01546038|450391226|FG001|Overall Study|Withdrawal by Subject|0|||
125209409|NCT01546038|450391227|FG002|Overall Study|Withdrawal by Subject|0|||
125209410|NCT01546038|450391228|FG003|Overall Study|Withdrawal by Subject|1|||
125209411|NCT01546038|450391229|FG004|Overall Study|Withdrawal by Subject|0|||
125209412|NCT01546038|450391230|FG005|Overall Study|Withdrawal by Subject|1|||
125209413|NCT01546038|450391231|FG006|Overall Study|Withdrawal by Subject|3|||
125209414|NCT01546038|450391232|FG007|Overall Study|Withdrawal by Subject|3|||
125649673|NCT00933543|452001009|FG000|Overall Study|Adverse Event|2|||
125649674|NCT00933543|452001010|FG001|Overall Study|Adverse Event|1|||
125649675|NCT00933543|452001009|FG000|Overall Study|Lost to Follow-up|0|||
125209415|NCT01546038|450391233|FG008|Overall Study|Withdrawal by Subject|1|||
125209416|NCT01546038|450391225|FG000|Overall Study|: Randomized, not treated|0|||
125209417|NCT01546038|450391226|FG001|Overall Study|: Randomized, not treated|0|||
125209418|NCT01546038|450391227|FG002|Overall Study|: Randomized, not treated|0|||
125209419|NCT01546038|450391228|FG003|Overall Study|: Randomized, not treated|0|||
125209420|NCT01546038|450391229|FG004|Overall Study|: Randomized, not treated|0|||
125209421|NCT01546038|450391230|FG005|Overall Study|: Randomized, not treated|0|||
125209422|NCT01546038|450391231|FG006|Overall Study|: Randomized, not treated|2|||
125209423|NCT01546038|450391232|FG007|Overall Study|: Randomized, not treated|4|||
125209424|NCT01546038|450391233|FG008|Overall Study|: Randomized, not treated|3|||
125209425|NCT03329248|450391234|FG000|Overall Study|Progressive Disease|6|||
125424882|NCT00002558|451178704|FG000|Overall Study|Withdrawal by Subject|0|||
125209426|NCT00987402|450391235|FG000|Overall Study|Insufficient data entry|86|||
125209427|NCT00987402|450391236|FG001|Overall Study|Insufficient data entry|98|||
125649676|NCT00933543|452001010|FG001|Overall Study|Lost to Follow-up|1|||
125649677|NCT00933543|452001009|FG000|Overall Study|Withdrawal by Subject|0|||
125649678|NCT00933543|452001010|FG001|Overall Study|Withdrawal by Subject|1|||
125649679|NCT00933543|452001009|FG000|Overall Study|Lack of Efficacy|0|||
125649680|NCT00933543|452001010|FG001|Overall Study|Lack of Efficacy|3|||
125649681|NCT00933543|452001009|FG000|Overall Study|Other|1|||
125649682|NCT00933543|452001010|FG001|Overall Study|Other|1|||
125649683|NCT04837807|452001011|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
125649684|NCT04837807|452001012|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
125649685|NCT00612456|452001017|FG000|Overall Study|Adverse Event|1|||
125649686|NCT00612456|452001018|FG001|Overall Study|Adverse Event|0|||
125649687|NCT00612456|452001019|FG002|Overall Study|Adverse Event|0|||
125649688|NCT00612456|452001017|FG000|Overall Study|Lack of Efficacy|1|||
125649689|NCT00612456|452001018|FG001|Overall Study|Lack of Efficacy|1|||
125649690|NCT00612456|452001019|FG002|Overall Study|Lack of Efficacy|0|||
125649691|NCT00612456|452001017|FG000|Overall Study|Withdrawal by Subject|0|||
125649692|NCT00612456|452001018|FG001|Overall Study|Withdrawal by Subject|1|||
125649693|NCT00612456|452001019|FG002|Overall Study|Withdrawal by Subject|0|||
125649694|NCT01258803|452001020|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
125649695|NCT01258803|452001021|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
125649696|NCT01258803|452001022|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
125649697|NCT01258803|452001023|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
125649698|NCT01258803|452001024|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
125209428|NCT01254721|450391237|FG000|Overall Study|Lost to Follow-up|0|||
125209429|NCT01254721|450391238|FG001|Overall Study|Lost to Follow-up|4|||
125209430|NCT01254721|450391237|FG000|Overall Study|Lack of Efficacy|4|||
125209431|NCT01254721|450391238|FG001|Overall Study|Lack of Efficacy|2|||
125209432|NCT01254721|450391237|FG000|Overall Study|Death|0|||
125209433|NCT01254721|450391238|FG001|Overall Study|Death|1|||
125209434|NCT01254721|450391237|FG000|Overall Study|technical problum|1|||
125209435|NCT01254721|450391238|FG001|Overall Study|technical problum|0|||
125209436|NCT01254721|450391237|FG000|Overall Study|Adverse Event|2|||
125209437|NCT01254721|450391238|FG001|Overall Study|Adverse Event|3|||
125209438|NCT01254721|450391237|FG000|Overall Study|Withdrawal by Subject|8|||
125209439|NCT01254721|450391238|FG001|Overall Study|Withdrawal by Subject|11|||
125209440|NCT01254721|450391237|FG000|Overall Study|Wrongly randomization|0|||
125209441|NCT01254721|450391238|FG001|Overall Study|Wrongly randomization|1|||
125209442|NCT01362517|450391243|FG000|Overall Study|Protocol Violation|1|||
125209443|NCT01362517|450391243|FG000|Overall Study|Lost to Follow-up|1|||
125209444|NCT03209518|450391244|FG000|Overall Study|Case Report Forms Uncollected|1|||
125209445|NCT03209518|450391244|FG000|Overall Study|Protocol Deviation|1|||
125209446|NCT00236899|450391245|FG000|Overall Study|Adverse Event (Study Related)|1|||
125209447|NCT00236899|450391246|FG001|Overall Study|Adverse Event (Study Related)|1|||
125209448|NCT00236899|450391247|FG002|Overall Study|Adverse Event (Study Related)|2|||
125209449|NCT00236899|450391248|FG003|Overall Study|Adverse Event (Study Related)|1|||
125209450|NCT00236899|450391245|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
125209451|NCT00236899|450391246|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
125209452|NCT00236899|450391247|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
125209453|NCT00236899|450391248|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
125209454|NCT00236899|450391245|FG000|Overall Study|Death (Study Disease)|1|||
125209455|NCT00236899|450391246|FG001|Overall Study|Death (Study Disease)|4|||
125209456|NCT00236899|450391247|FG002|Overall Study|Death (Study Disease)|0|||
125209457|NCT00236899|450391248|FG003|Overall Study|Death (Study Disease)|0|||
125209458|NCT00236899|450391245|FG000|Overall Study|Death (Not Study Related)|2|||
125209459|NCT00236899|450391246|FG001|Overall Study|Death (Not Study Related)|0|||
125209460|NCT00236899|450391247|FG002|Overall Study|Death (Not Study Related)|0|||
125209461|NCT00236899|450391248|FG003|Overall Study|Death (Not Study Related)|0|||
125209462|NCT00236899|450391245|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
125209463|NCT00236899|450391246|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
125209464|NCT00236899|450391247|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
125209465|NCT00236899|450391248|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
125209466|NCT00236899|450391245|FG000|Overall Study|Lost to Follow-up|0|||
125209467|NCT00236899|450391246|FG001|Overall Study|Lost to Follow-up|1|||
125209468|NCT00236899|450391247|FG002|Overall Study|Lost to Follow-up|0|||
125209469|NCT00236899|450391248|FG003|Overall Study|Lost to Follow-up|0|||
125209470|NCT00236899|450391245|FG000|Overall Study|Entry Criteria Exclusion|0|||
125209471|NCT00236899|450391246|FG001|Overall Study|Entry Criteria Exclusion|1|||
125209472|NCT00236899|450391247|FG002|Overall Study|Entry Criteria Exclusion|1|||
125209473|NCT00236899|450391248|FG003|Overall Study|Entry Criteria Exclusion|0|||
125209474|NCT00236899|450391245|FG000|Overall Study|Protocol Violation|1|||
125209475|NCT00236899|450391246|FG001|Overall Study|Protocol Violation|0|||
125209476|NCT00236899|450391247|FG002|Overall Study|Protocol Violation|0|||
125209477|NCT00236899|450391248|FG003|Overall Study|Protocol Violation|0|||
125209478|NCT00236899|450391245|FG000|Overall Study|Withdrawal by Subject|6|||
125209479|NCT00236899|450391246|FG001|Overall Study|Withdrawal by Subject|4|||
125649699|NCT01258803|452001025|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
125649700|NCT01258803|452001020|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
125649701|NCT01258803|452001021|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
125649702|NCT01258803|452001022|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
125649703|NCT01258803|452001023|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
125649704|NCT01258803|452001024|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
125649705|NCT01258803|452001025|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
125649706|NCT01258803|452001020|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
125649707|NCT01258803|452001021|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
125649708|NCT01258803|452001022|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
125649709|NCT01258803|452001023|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
125649710|NCT01258803|452001024|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
125649711|NCT01258803|452001025|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
125649712|NCT04652245|452001027|FG000|Wash-Out Period|Adverse Event|0|||
125649713|NCT04652245|452001028|FG001|Wash-Out Period|Adverse Event|2|||
125649714|NCT04652245|452001027|FG000|Wash-Out Period|Withdrawal by Subject|0|||
125649715|NCT04652245|452001028|FG001|Wash-Out Period|Withdrawal by Subject|2|||
125649716|NCT04419558|452001031|FG000|DB Period (48 Weeks)|Adverse Event|6|||
125649717|NCT04419558|452001032|FG001|DB Period (48 Weeks)|Adverse Event|6|||
125649718|NCT04419558|452001031|FG000|DB Period (48 Weeks)|Death|14|||
125649719|NCT04419558|452001032|FG001|DB Period (48 Weeks)|Death|11|||
125649720|NCT04419558|452001031|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
125649721|NCT04419558|452001032|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
125649722|NCT04419558|452001031|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
125649723|NCT04419558|452001032|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
125649724|NCT04419558|452001031|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
125649725|NCT04419558|452001032|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
125649726|NCT04419558|452001031|FG000|DB Period (48 Weeks)|Disease Progression|1|||
125649727|NCT04419558|452001032|FG001|DB Period (48 Weeks)|Disease Progression|0|||
125649728|NCT04419558|452001031|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
125649729|NCT04419558|452001032|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
125649730|NCT04419558|452001031|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
125649731|NCT04419558|452001032|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
125649732|NCT04419558|452001031|FG000|DB Period (48 Weeks)|Participant Decision|4|||
125649733|NCT04419558|452001032|FG001|DB Period (48 Weeks)|Participant Decision|3|||
125649734|NCT04419558|452001031|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
125649735|NCT04419558|452001032|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
125649736|NCT04419558|452001031|FG000|OLE Period (48 Weeks)|Death|4|||
125649737|NCT04419558|452001032|FG001|OLE Period (48 Weeks)|Death|6|||
125649738|NCT04419558|452001031|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
125649739|NCT04419558|452001032|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
125649740|NCT04419558|452001031|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
125649741|NCT04419558|452001032|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
125649742|NCT00903357|452001033|FG000|First Intervention|Withdrawal by Subject|5|||
125649743|NCT00903357|452001034|FG001|First Intervention|Withdrawal by Subject|3|||
125649744|NCT00903357|452001033|FG000|First Intervention|Flu|0|||
125649745|NCT00903357|452001034|FG001|First Intervention|Flu|1|||
125649746|NCT00903357|452001033|FG000|Wash Out Period of 2 Weeks|Flu|0|||
125649747|NCT00903357|452001034|FG001|Wash Out Period of 2 Weeks|Flu|1|||
125649748|NCT00903357|452001033|FG000|Second Intervention|Lost to Follow-up|1|||
125649749|NCT00903357|452001034|FG001|Second Intervention|Lost to Follow-up|0|||
125649750|NCT05146999|452001035|FG000|Overall Study|Withdrew consent|6|||
125649751|NCT05146999|452001036|FG001|Overall Study|Withdrew consent|1|||
125649752|NCT05146999|452001035|FG000|Overall Study|Lost to Follow-up|3|||
125649753|NCT05146999|452001036|FG001|Overall Study|Lost to Follow-up|2|||
125649754|NCT05146999|452001035|FG000|Overall Study|Other|1|||
125649755|NCT05146999|452001036|FG001|Overall Study|Other|3|||
125649756|NCT04668157|452001037|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
125649757|NCT04668157|452001038|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
125649758|NCT04668157|452001037|FG000|Treatment Period (52 Weeks)|Other|0|||
125649759|NCT04668157|452001038|FG001|Treatment Period (52 Weeks)|Other|2|||
125649760|NCT04246996|452001043|FG000|Overall Study|Physician Decision|1|||
125649761|NCT04246996|452001044|FG001|Overall Study|Physician Decision|1|||
125649762|NCT04246996|452001043|FG000|Overall Study|Did not meet eligibility criteria|1|||
125649763|NCT04246996|452001044|FG001|Overall Study|Did not meet eligibility criteria|4|||
125649764|NCT02442284|452001045|FG000|Overall Study|Adverse Event|1|||
125649765|NCT02442284|452001045|FG000|Overall Study|Withdrew Consent|2|||
125649766|NCT02442284|452001045|FG000|Overall Study|Lost to Follow-up|3|||
125649767|NCT02442284|452001045|FG000|Overall Study|Other|1|||
125649768|NCT01365182|452001046|FG000|Overall Study|Withdrawal by Subject|10|||
125649769|NCT01365182|452001047|FG001|Overall Study|Withdrawal by Subject|13|||
125649770|NCT01365182|452001048|FG002|Overall Study|Withdrawal by Subject|12|||
125649771|NCT02309372|452001051|FG000|Overall Study|Lost to Follow-up|3|||
125649772|NCT02309372|452001052|FG001|Overall Study|Lost to Follow-up|2|||
125649773|NCT02129192|452001053|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
125649774|NCT02129192|452001054|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
125649775|NCT01231620|452001055|FG000|Overall Study|Physician Decision|3|||
125209480|NCT00236899|450391247|FG002|Overall Study|Withdrawal by Subject|5|||
125209481|NCT00236899|450391248|FG003|Overall Study|Withdrawal by Subject|2|||
125209482|NCT00236899|450391245|FG000|Overall Study|Physician Decision|7|||
125209483|NCT00236899|450391246|FG001|Overall Study|Physician Decision|8|||
125209484|NCT00236899|450391247|FG002|Overall Study|Physician Decision|7|||
125209485|NCT00236899|450391248|FG003|Overall Study|Physician Decision|6|||
125209486|NCT00236899|450391245|FG000|Overall Study|Satisfactory Response|2|||
125209487|NCT00236899|450391246|FG001|Overall Study|Satisfactory Response|0|||
125209488|NCT00236899|450391247|FG002|Overall Study|Satisfactory Response|0|||
125209489|NCT00236899|450391248|FG003|Overall Study|Satisfactory Response|1|||
125209490|NCT00236899|450391245|FG000|Overall Study|Lack of Efficacy|18|||
125209491|NCT00236899|450391246|FG001|Overall Study|Lack of Efficacy|18|||
125209492|NCT00236899|450391247|FG002|Overall Study|Lack of Efficacy|25|||
125209493|NCT00236899|450391248|FG003|Overall Study|Lack of Efficacy|23|||
125209494|NCT03379792|450391250|FG000|Overall Study|Physician Decision|0|||
125209495|NCT03379792|450391251|FG001|Overall Study|Physician Decision|0|||
125209496|NCT03379792|450391252|FG002|Overall Study|Physician Decision|0|||
125209497|NCT03379792|450391253|FG003|Overall Study|Physician Decision|1|||
125209498|NCT03379792|450391254|FG004|Overall Study|Physician Decision|0|||
125209499|NCT03379792|450391255|FG005|Overall Study|Physician Decision|0|||
125209500|NCT03379792|450391250|FG000|Overall Study|Withdrawal by Subject|0|||
125209501|NCT03379792|450391251|FG001|Overall Study|Withdrawal by Subject|0|||
125209502|NCT03379792|450391252|FG002|Overall Study|Withdrawal by Subject|0|||
125209503|NCT03379792|450391253|FG003|Overall Study|Withdrawal by Subject|0|||
125209504|NCT03379792|450391254|FG004|Overall Study|Withdrawal by Subject|1|||
125209505|NCT03379792|450391255|FG005|Overall Study|Withdrawal by Subject|1|||
125209506|NCT01121536|450391256|FG000|Overall Study|Adverse Event|63|||
125209507|NCT01121536|450391256|FG000|Overall Study|Lack of Efficacy|35|||
125209508|NCT01121536|450391256|FG000|Overall Study|Withdrawal by Subject|65|||
125209509|NCT01121536|450391256|FG000|Overall Study|Protocol Violation|20|||
125209510|NCT01121536|450391256|FG000|Overall Study|Noncompliance with study medication|12|||
125209511|NCT01121536|450391256|FG000|Overall Study|Noncompliance with study procedures|9|||
125209512|NCT01121536|450391256|FG000|Overall Study|Lost to Follow-up|39|||
125209513|NCT01121536|450391256|FG000|Overall Study|Other|118|||
125209514|NCT02854605|450391257|FG000|Overall Study|Adverse Event|1|||
125209515|NCT02854605|450391258|FG001|Overall Study|Adverse Event|5|||
125209516|NCT02854605|450391259|FG002|Overall Study|Adverse Event|2|||
125209517|NCT02854605|450391257|FG000|Overall Study|Lost to Follow-up|0|||
125209518|NCT02854605|450391258|FG001|Overall Study|Lost to Follow-up|2|||
125209519|NCT02854605|450391259|FG002|Overall Study|Lost to Follow-up|0|||
125209520|NCT02854605|450391257|FG000|Overall Study|Withdrew Consent|1|||
125209521|NCT02854605|450391258|FG001|Overall Study|Withdrew Consent|0|||
125209522|NCT02854605|450391259|FG002|Overall Study|Withdrew Consent|1|||
125209523|NCT02854605|450391257|FG000|Overall Study|Investigator's Discretion|1|||
125209524|NCT02854605|450391258|FG001|Overall Study|Investigator's Discretion|0|||
125539993|NCT00350103|451605884|FG000|Overall Study|Unsatisfactory Compliance|2|||
125539994|NCT00350103|451605885|FG001|Overall Study|Unsatisfactory Compliance|2|||
125539995|NCT00350103|451605886|FG002|Overall Study|Unsatisfactory Compliance|1|||
125539996|NCT00350103|451605884|FG000|Overall Study|Investigator´s decision|1|||
125539997|NCT00350103|451605885|FG001|Overall Study|Investigator´s decision|1|||
125539998|NCT00350103|451605886|FG002|Overall Study|Investigator´s decision|0|||
125539999|NCT00350103|451605884|FG000|Overall Study|Exclusion criteria met|0|||
125540000|NCT00350103|451605885|FG001|Overall Study|Exclusion criteria met|0|||
125540001|NCT00350103|451605886|FG002|Overall Study|Exclusion criteria met|1|||
125540002|NCT00350103|451605884|FG000|Overall Study|Patient relocated|0|||
125540003|NCT00350103|451605885|FG001|Overall Study|Patient relocated|0|||
125540004|NCT00350103|451605886|FG002|Overall Study|Patient relocated|1|||
125540005|NCT00350103|451605884|FG000|Overall Study|Need for prohibited medication|1|||
125540006|NCT00350103|451605885|FG001|Overall Study|Need for prohibited medication|0|||
125540007|NCT00350103|451605886|FG002|Overall Study|Need for prohibited medication|0|||
125540008|NCT00350103|451605884|FG000|Overall Study|Personal reasons|0|||
125540009|NCT00350103|451605885|FG001|Overall Study|Personal reasons|0|||
125540010|NCT00350103|451605886|FG002|Overall Study|Personal reasons|1|||
125540011|NCT00350103|451605884|FG000|Overall Study|Patient stopped feeling pain|1|||
125540012|NCT00350103|451605885|FG001|Overall Study|Patient stopped feeling pain|0|||
125540013|NCT00350103|451605886|FG002|Overall Study|Patient stopped feeling pain|0|||
125540014|NCT00350103|451605884|FG000|Overall Study|PR greater than 250ms|0|||
125209525|NCT02854605|450391259|FG002|Overall Study|Investigator's Discretion|0|||
125209526|NCT02854605|450391257|FG000|Overall Study|Protocol Violation|0|||
125209527|NCT02854605|450391258|FG001|Overall Study|Protocol Violation|0|||
125209528|NCT02854605|450391259|FG002|Overall Study|Protocol Violation|1|||
125209529|NCT00568334|450391264|FG000|Overall Study|Withdrawal by Subject|0|||
125209530|NCT00568334|450391265|FG001|Overall Study|Withdrawal by Subject|1|||
125209531|NCT00568334|450391264|FG000|Overall Study|Lost to Follow-up|1|||
125209532|NCT00568334|450391265|FG001|Overall Study|Lost to Follow-up|0|||
125209533|NCT01897571|450391266|FG000|Overall Study|Lost to Follow-up|3|||
125209534|NCT01897571|450391267|FG001|Overall Study|Lost to Follow-up|0|||
125209535|NCT01897571|450391268|FG002|Overall Study|Lost to Follow-up|0|||
125209536|NCT01897571|450391269|FG003|Overall Study|Lost to Follow-up|0|||
125649776|NCT01231620|452001056|FG001|Overall Study|Physician Decision|5|||
125649777|NCT01231620|452001057|FG002|Overall Study|Physician Decision|10|||
125649778|NCT01231620|452001055|FG000|Overall Study|Death|12|||
125649779|NCT01231620|452001056|FG001|Overall Study|Death|14|||
125209537|NCT01897571|450391270|FG004|Overall Study|Lost to Follow-up|2|||
125209538|NCT01897571|450391271|FG005|Overall Study|Lost to Follow-up|0|||
125209539|NCT01897571|450391272|FG006|Overall Study|Lost to Follow-up|0|||
125209540|NCT01897571|450391273|FG007|Overall Study|Lost to Follow-up|0|||
125209541|NCT01897571|450391274|FG008|Overall Study|Lost to Follow-up|1|||
125209542|NCT01897571|450391275|FG009|Overall Study|Lost to Follow-up|2|||
125209543|NCT01897571|450391276|FG010|Overall Study|Lost to Follow-up|4|||
125209544|NCT01897571|450391266|FG000|Overall Study|Withdrawal by Subject|0|||
125209545|NCT01897571|450391267|FG001|Overall Study|Withdrawal by Subject|0|||
125209546|NCT01897571|450391268|FG002|Overall Study|Withdrawal by Subject|0|||
125209547|NCT01897571|450391269|FG003|Overall Study|Withdrawal by Subject|0|||
125209548|NCT01897571|450391270|FG004|Overall Study|Withdrawal by Subject|0|||
125209549|NCT01897571|450391271|FG005|Overall Study|Withdrawal by Subject|0|||
125209550|NCT01897571|450391272|FG006|Overall Study|Withdrawal by Subject|0|||
125209551|NCT01897571|450391273|FG007|Overall Study|Withdrawal by Subject|1|||
125209552|NCT01897571|450391274|FG008|Overall Study|Withdrawal by Subject|4|||
125209553|NCT01897571|450391275|FG009|Overall Study|Withdrawal by Subject|3|||
125209554|NCT01897571|450391276|FG010|Overall Study|Withdrawal by Subject|1|||
125209555|NCT01897571|450391266|FG000|Overall Study|Other|1|||
125209556|NCT01897571|450391267|FG001|Overall Study|Other|0|||
125209557|NCT01897571|450391268|FG002|Overall Study|Other|0|||
125209558|NCT01897571|450391269|FG003|Overall Study|Other|3|||
125209559|NCT01897571|450391270|FG004|Overall Study|Other|3|||
125209560|NCT01897571|450391271|FG005|Overall Study|Other|4|||
125209561|NCT01897571|450391272|FG006|Overall Study|Other|7|||
125209562|NCT01897571|450391273|FG007|Overall Study|Other|0|||
125209563|NCT01897571|450391274|FG008|Overall Study|Other|0|||
125209564|NCT01897571|450391275|FG009|Overall Study|Other|0|||
125209565|NCT01897571|450391276|FG010|Overall Study|Other|0|||
125209566|NCT01897571|450391266|FG000|Overall Study|Enrolled in rollover study|0|||
125209567|NCT01897571|450391267|FG001|Overall Study|Enrolled in rollover study|0|||
125209568|NCT01897571|450391268|FG002|Overall Study|Enrolled in rollover study|0|||
125209569|NCT01897571|450391269|FG003|Overall Study|Enrolled in rollover study|0|||
125209570|NCT01897571|450391270|FG004|Overall Study|Enrolled in rollover study|0|||
125209571|NCT01897571|450391271|FG005|Overall Study|Enrolled in rollover study|0|||
125209572|NCT01897571|450391272|FG006|Overall Study|Enrolled in rollover study|0|||
125209573|NCT01897571|450391273|FG007|Overall Study|Enrolled in rollover study|9|||
125209574|NCT01897571|450391274|FG008|Overall Study|Enrolled in rollover study|7|||
125209575|NCT01897571|450391275|FG009|Overall Study|Enrolled in rollover study|9|||
125209576|NCT01897571|450391276|FG010|Overall Study|Enrolled in rollover study|1|||
125209577|NCT01897571|450391266|FG000|Overall Study|Death|2|||
125209578|NCT01897571|450391267|FG001|Overall Study|Death|2|||
125209579|NCT01897571|450391268|FG002|Overall Study|Death|3|||
125209580|NCT01897571|450391269|FG003|Overall Study|Death|6|||
125209581|NCT01897571|450391270|FG004|Overall Study|Death|7|||
125209582|NCT01897571|450391271|FG005|Overall Study|Death|9|||
125209583|NCT01897571|450391272|FG006|Overall Study|Death|5|||
125649780|NCT01231620|452001057|FG002|Overall Study|Death|11|||
125649781|NCT01231620|452001055|FG000|Overall Study|Adverse Event|2|||
125649782|NCT01231620|452001056|FG001|Overall Study|Adverse Event|2|||
125649783|NCT01231620|452001057|FG002|Overall Study|Adverse Event|1|||
125649784|NCT01231620|452001055|FG000|Overall Study|Withdrawal by Subject|6|||
125649785|NCT01231620|452001056|FG001|Overall Study|Withdrawal by Subject|6|||
125649786|NCT01231620|452001057|FG002|Overall Study|Withdrawal by Subject|8|||
125649787|NCT01231620|452001055|FG000|Overall Study|Lost to Follow-up|3|||
125649788|NCT01231620|452001056|FG001|Overall Study|Lost to Follow-up|4|||
125649789|NCT01231620|452001057|FG002|Overall Study|Lost to Follow-up|9|||
125649790|NCT02400281|452001059|FG000|Overall Study|Adverse Event|0|||
125649791|NCT02400281|452001060|FG001|Overall Study|Adverse Event|0|||
125649792|NCT02400281|452001061|FG002|Overall Study|Adverse Event|1|||
125649793|NCT02400281|452001062|FG003|Overall Study|Adverse Event|0|||
125649794|NCT02400281|452001063|FG004|Overall Study|Adverse Event|1|||
125649795|NCT02400281|452001064|FG005|Overall Study|Adverse Event|0|||
125209584|NCT01897571|450391273|FG007|Overall Study|Death|22|||
125209585|NCT01897571|450391274|FG008|Overall Study|Death|23|||
125209586|NCT01897571|450391275|FG009|Overall Study|Death|129|||
125209587|NCT01897571|450391276|FG010|Overall Study|Death|59|||
125209588|NCT05268016|450391279|FG000|Overall Study|Unacceptable toxicity or AE|2|||
125209589|NCT05268016|450391280|FG001|Overall Study|Unacceptable toxicity or AE|2|||
125209590|NCT05268016|450391281|FG002|Overall Study|Unacceptable toxicity or AE|4|||
125209591|NCT05268016|450391282|FG003|Overall Study|Unacceptable toxicity or AE|3|||
125209592|NCT05268016|450391283|FG004|Overall Study|Unacceptable toxicity or AE|1|||
125209593|NCT05268016|450391279|FG000|Overall Study|Withdrawal by Subject|1|||
125649796|NCT02400281|452001059|FG000|Overall Study|Physician Decision|0|||
125649797|NCT02400281|452001060|FG001|Overall Study|Physician Decision|0|||
125649798|NCT02400281|452001061|FG002|Overall Study|Physician Decision|1|||
125649799|NCT02400281|452001062|FG003|Overall Study|Physician Decision|0|||
125649800|NCT02400281|452001063|FG004|Overall Study|Physician Decision|0|||
125649801|NCT02400281|452001064|FG005|Overall Study|Physician Decision|0|||
125649802|NCT00412360|452001065|FG000|Overall Study|Lost to Follow-up|0|||
125649803|NCT00412360|452001066|FG001|Overall Study|Lost to Follow-up|1|||
125649804|NCT00412360|452001065|FG000|Overall Study|Not Transplanted|1|||
125649805|NCT00412360|452001066|FG001|Overall Study|Not Transplanted|2|||
125649806|NCT02576652|452001068|FG000|Overall Study|Withdrawal by Subject|2|||
125649807|NCT00553319|452001079|FG000|Overall Study|Lost to Follow-up|10|||
125649808|NCT00553319|452001080|FG001|Overall Study|Lost to Follow-up|9|||
125649809|NCT00553319|452001081|FG002|Overall Study|Lost to Follow-up|5|||
125649810|NCT00553319|452001079|FG000|Overall Study|wanted treatment elsewhere|2|||
125649811|NCT00553319|452001080|FG001|Overall Study|wanted treatment elsewhere|1|||
125649812|NCT00553319|452001081|FG002|Overall Study|wanted treatment elsewhere|1|||
125649813|NCT00553319|452001079|FG000|Overall Study|non-compliance|0|||
125649814|NCT00553319|452001080|FG001|Overall Study|non-compliance|0|||
125649815|NCT00553319|452001081|FG002|Overall Study|non-compliance|2|||
125649816|NCT00553319|452001079|FG000|Overall Study|incarceration|1|||
125649817|NCT00553319|452001080|FG001|Overall Study|incarceration|0|||
125649818|NCT00553319|452001081|FG002|Overall Study|incarceration|0|||
125649819|NCT00553319|452001079|FG000|Overall Study|moved|1|||
125649820|NCT00553319|452001080|FG001|Overall Study|moved|0|||
125649821|NCT00553319|452001081|FG002|Overall Study|moved|1|||
125649822|NCT01078974|452001082|FG000|Overall Study|Adverse Event|3|||
125649823|NCT00495794|452001087|FG000|Overall Study|Pharmacist did not activate patient|522|||
125649824|NCT00495794|452001088|FG001|Overall Study|Pharmacist did not activate patient|0|||
125649825|NCT03039699|452001089|FG000|Overall Study|Incorrect inclusion|5|||
125649826|NCT03039699|452001090|FG001|Overall Study|Incorrect inclusion|4|||
125649827|NCT03039699|452001089|FG000|Overall Study|Lack of data to assess study endpoint|5|||
125649828|NCT03039699|452001090|FG001|Overall Study|Lack of data to assess study endpoint|3|||
125649829|NCT03039699|452001089|FG000|Overall Study|Bacterial infection|12|||
125649830|NCT03039699|452001090|FG001|Overall Study|Bacterial infection|28|||
125649831|NCT02911285|452001091|FG000|Overall Study|Lost to Follow-up|8|||
125649832|NCT02911285|452001092|FG001|Overall Study|Lost to Follow-up|5|||
125649833|NCT02911285|452001091|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
125649834|NCT02911285|452001092|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
125649835|NCT02985541|452002671|FG000|Overall Study|Withdrawal by Subject|33|||
125649836|NCT02985541|452002671|FG000|Overall Study|Lost to Follow-up|26|||
125649837|NCT02985541|452002671|FG000|Overall Study|Adverse Event|27|||
125649838|NCT02985541|452002671|FG000|Overall Study|Physician Decision|2|||
125649839|NCT02985541|452002671|FG000|Overall Study|Pregnancy|2|||
125649840|NCT02985541|452002671|FG000|Overall Study|Wish for pregnancy|44|||
125649841|NCT02985541|452002671|FG000|Overall Study|Other reason|5|||
125649842|NCT02985541|452002671|FG000|Overall Study|Not valid for analysis|2|||
125649843|NCT00761761|452002677|FG000|Overall Study|Lost to Follow-up|3|||
125209594|NCT05268016|450391280|FG001|Overall Study|Withdrawal by Subject|3|||
125209595|NCT05268016|450391281|FG002|Overall Study|Withdrawal by Subject|2|||
125209596|NCT05268016|450391282|FG003|Overall Study|Withdrawal by Subject|2|||
125209597|NCT05268016|450391283|FG004|Overall Study|Withdrawal by Subject|1|||
125209598|NCT05268016|450391279|FG000|Overall Study|Lost to Follow-up|4|||
125209599|NCT05268016|450391280|FG001|Overall Study|Lost to Follow-up|7|||
125209600|NCT05268016|450391281|FG002|Overall Study|Lost to Follow-up|1|||
125209601|NCT05268016|450391282|FG003|Overall Study|Lost to Follow-up|3|||
125209602|NCT05268016|450391283|FG004|Overall Study|Lost to Follow-up|5|||
125209603|NCT05268016|450391279|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
125209604|NCT05268016|450391280|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
125209605|NCT05268016|450391281|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
125209606|NCT05268016|450391282|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
125209607|NCT05268016|450391283|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
125209608|NCT05268016|450391279|FG000|Overall Study|Lack of Efficacy|0|||
125209609|NCT05268016|450391280|FG001|Overall Study|Lack of Efficacy|0|||
125209610|NCT05268016|450391281|FG002|Overall Study|Lack of Efficacy|0|||
125209611|NCT05268016|450391282|FG003|Overall Study|Lack of Efficacy|0|||
125209612|NCT05268016|450391283|FG004|Overall Study|Lack of Efficacy|4|||
125209613|NCT05268016|450391279|FG000|Overall Study|Physician Decision|0|||
125209614|NCT05268016|450391280|FG001|Overall Study|Physician Decision|0|||
125209615|NCT05268016|450391281|FG002|Overall Study|Physician Decision|0|||
125209616|NCT05268016|450391282|FG003|Overall Study|Physician Decision|1|||
125209617|NCT05268016|450391283|FG004|Overall Study|Physician Decision|0|||
125209618|NCT05268016|450391279|FG000|Overall Study|Other|1|||
125209619|NCT05268016|450391280|FG001|Overall Study|Other|0|||
125209620|NCT05268016|450391281|FG002|Overall Study|Other|1|||
125649844|NCT00761761|452002678|FG001|Overall Study|Lost to Follow-up|1|||
125649845|NCT00761761|452002677|FG000|Overall Study|Withdrawal by Subject|3|||
125649846|NCT00761761|452002678|FG001|Overall Study|Withdrawal by Subject|0|||
125209621|NCT05268016|450391282|FG003|Overall Study|Other|2|||
125649847|NCT01982942|452002680|FG000|Overall Study|Adverse Event|10|||
125209622|NCT05268016|450391283|FG004|Overall Study|Other|0|||
125209623|NCT02273908|450391284|FG000|Overall Study|Adverse Event|16|||
125209624|NCT02273908|450391285|FG001|Overall Study|Adverse Event|0|||
125209625|NCT02273908|450391284|FG000|Overall Study|Lost to Follow-up|10|||
125209626|NCT02273908|450391285|FG001|Overall Study|Lost to Follow-up|1|||
125209627|NCT02273908|450391284|FG000|Overall Study|Did not meet entrance criteria|3|||
125209628|NCT02273908|450391285|FG001|Overall Study|Did not meet entrance criteria|2|||
125209629|NCT02273908|450391284|FG000|Overall Study|Withdrawal by Subject|4|||
125209630|NCT02273908|450391285|FG001|Overall Study|Withdrawal by Subject|2|||
125209631|NCT04908475|450391286|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
125209632|NCT04908475|450391287|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125209633|NCT04908475|450391288|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125209634|NCT04908475|450391289|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125209635|NCT04908475|450391290|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125209636|NCT04908475|450391291|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125209637|NCT04908475|450391286|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
125209638|NCT04908475|450391287|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
125209639|NCT04908475|450391288|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
125209640|NCT04908475|450391289|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
125209641|NCT04908475|450391290|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
125209642|NCT04908475|450391291|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
125209643|NCT04908475|450391286|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
125209644|NCT04908475|450391287|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
125209645|NCT04908475|450391288|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
125209646|NCT04908475|450391289|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
125209647|NCT04908475|450391290|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
125209648|NCT04908475|450391291|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
125209649|NCT04908475|450391286|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125209650|NCT04908475|450391287|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
125209651|NCT04908475|450391288|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
125209652|NCT04908475|450391289|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
125209653|NCT04908475|450391290|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125209654|NCT04908475|450391291|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125209655|NCT04908475|450391286|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
125209656|NCT04908475|450391287|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
125209657|NCT04908475|450391288|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
125209658|NCT04908475|450391289|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
125209659|NCT04908475|450391290|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
125209660|NCT04908475|450391291|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
125209661|NCT04908475|450391286|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
125209662|NCT04908475|450391287|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
125209663|NCT04908475|450391288|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
125209664|NCT04908475|450391289|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
125209665|NCT04908475|450391290|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
125209666|NCT04908475|450391291|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
125209667|NCT00404924|450391292|FG000|Overall Study|Adverse Event|75|||
125209668|NCT00404924|450391293|FG001|Overall Study|Adverse Event|16|||
125209669|NCT00404924|450391292|FG000|Overall Study|Condition under investigation worsened|475|||
125209670|NCT00404924|450391293|FG001|Overall Study|Condition under investigation worsened|264|||
125209671|NCT00404924|450391292|FG000|Overall Study|Lost to Follow-up|1|||
125209672|NCT00404924|450391293|FG001|Overall Study|Lost to Follow-up|1|||
125209673|NCT00404924|450391292|FG000|Overall Study|Withdrawal by Subject|26|||
125209674|NCT00404924|450391293|FG001|Overall Study|Withdrawal by Subject|13|||
125209675|NCT00404924|450391292|FG000|Overall Study|Other|25|||
125209676|NCT00404924|450391293|FG001|Overall Study|Other|11|||
125209677|NCT00404924|450391292|FG000|Overall Study|Randomised but not received treatment|1|||
125209678|NCT00404924|450391293|FG001|Overall Study|Randomised but not received treatment|1|||
125209679|NCT03913104|450391296|FG000|Overall Study|Lost to Follow-up|20|||
125209680|NCT03913104|450391296|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
125209681|NCT03913104|450391296|FG000|Overall Study|Withdrawal by Subject|2|||
125209682|NCT00089635|450391297|FG000|Overall Study|Adverse Event|2|||
125209683|NCT00089635|450391297|FG000|Overall Study|Death|17|||
125209684|NCT00089635|450391297|FG000|Overall Study|Disease Progression|12|||
125209685|NCT00089635|450391297|FG000|Overall Study|Lost to Follow-up|3|||
125209686|NCT00089635|450391297|FG000|Overall Study|Withdrawal by Subject|6|||
125209687|NCT00089635|450391297|FG000|Overall Study|Ineligibility determined|1|||
125209688|NCT00089635|450391297|FG000|Overall Study|Other|2|||
125209689|NCT00821015|450391299|FG000|Overall Study|Lost to Follow-up|12|||
125209690|NCT01593254|450391305|FG000|Overall Study|Disease progression|2|||
125209691|NCT01593254|450391306|FG001|Overall Study|Disease progression|7|||
125209692|NCT01593254|450391305|FG000|Overall Study|Study drug toxicity|6|||
125209693|NCT01593254|450391306|FG001|Overall Study|Study drug toxicity|20|||
125209694|NCT01593254|450391305|FG000|Overall Study|Death|3|||
125209695|NCT01593254|450391306|FG001|Overall Study|Death|3|||
125209696|NCT01593254|450391305|FG000|Overall Study|AE unrelated to study drug|0|||
125209697|NCT01593254|450391306|FG001|Overall Study|AE unrelated to study drug|1|||
125209698|NCT01593254|450391305|FG000|Overall Study|participant request to discontinue study treatment|1|||
125209699|NCT01593254|450391306|FG001|Overall Study|participant request to discontinue study treatment|3|||
125209700|NCT01593254|450391305|FG000|Overall Study|participant withdrew consent|0|||
125209701|NCT01593254|450391306|FG001|Overall Study|participant withdrew consent|9|||
125649848|NCT01982942|452002681|FG001|Overall Study|Adverse Event|5|||
125649849|NCT01982942|452002680|FG000|Overall Study|Lost to Follow-up|4|||
125649850|NCT01982942|452002681|FG001|Overall Study|Lost to Follow-up|3|||
125649851|NCT01982942|452002680|FG000|Overall Study|Multiple sclerosis progression|3|||
125649852|NCT01982942|452002681|FG001|Overall Study|Multiple sclerosis progression|2|||
125649853|NCT01982942|452002680|FG000|Overall Study|Wanted to try therapy not permitted|1|||
125649854|NCT01982942|452002681|FG001|Overall Study|Wanted to try therapy not permitted|0|||
125649855|NCT01982942|452002680|FG000|Overall Study|Subject declined future visits|0|||
125649856|NCT01982942|452002681|FG001|Overall Study|Subject declined future visits|1|||
125649857|NCT01982942|452002680|FG000|Overall Study|Left geographical area|2|||
125649858|NCT01982942|452002681|FG001|Overall Study|Left geographical area|0|||
125649859|NCT01982942|452002680|FG000|Overall Study|Too many pills|1|||
125649860|NCT01982942|452002681|FG001|Overall Study|Too many pills|0|||
125649861|NCT01982942|452002680|FG000|Overall Study|MS Relapse|0|||
125649862|NCT01982942|452002681|FG001|Overall Study|MS Relapse|1|||
125649863|NCT01982942|452002680|FG000|Overall Study|Chose to join a stem cell trial|0|||
125649864|NCT01982942|452002681|FG001|Overall Study|Chose to join a stem cell trial|1|||
125649865|NCT01982942|452002680|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
125649866|NCT01982942|452002681|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
125649867|NCT04511533|452002682|FG000|Treatment|Other|2|||
125649868|NCT04511533|452002682|FG000|Treatment|Withdrawal by Subject|11|||
125649869|NCT04511533|452002682|FG000|Treatment|Death|5|||
125649870|NCT04511533|452002682|FG000|Treatment|Physician Decision|1|||
125649871|NCT04511533|452002682|FG000|Treatment|Progressive Disease|61|||
125649872|NCT04511533|452002682|FG000|Follow-Up|Other|7|||
125649873|NCT04511533|452002682|FG000|Follow-Up|Withdrawal by Subject|5|||
125649874|NCT04511533|452002682|FG000|Follow-Up|Lost to Follow-up|2|||
125649875|NCT04511533|452002682|FG000|Follow-Up|Death|4|||
125649876|NCT02918968|452002685|FG000|1st Line AAT|Progressive disease|9|||
125649877|NCT02918968|452002686|FG001|1st Line AAT|Progressive disease|4|||
125649878|NCT02918968|452002685|FG000|1st Line AAT|Adverse Event|12|||
125649879|NCT02918968|452002686|FG001|1st Line AAT|Adverse Event|3|||
125649880|NCT02918968|452002685|FG000|1st Line AAT|Physician Decision|4|||
125649881|NCT02918968|452002686|FG001|1st Line AAT|Physician Decision|2|||
125649882|NCT02918968|452002685|FG000|1st Line AAT|Withdrawal by Subject|2|||
125649883|NCT02918968|452002686|FG001|1st Line AAT|Withdrawal by Subject|1|||
125649884|NCT02918968|452002685|FG000|1st Line AAT|Lost to Follow-up|0|||
125649885|NCT02918968|452002686|FG001|1st Line AAT|Lost to Follow-up|1|||
125649886|NCT02918968|452002685|FG000|1st Line AAT|Death|1|||
125649887|NCT02918968|452002686|FG001|1st Line AAT|Death|0|||
125649888|NCT02918968|452002685|FG000|1st Line AAT|Miscellaneous|1|||
125649889|NCT02918968|452002686|FG001|1st Line AAT|Miscellaneous|0|||
125649890|NCT02918968|452002685|FG000|2nd Line AAT|Progressive disease|21|||
125649891|NCT02918968|452002686|FG001|2nd Line AAT|Progressive disease|3|||
125649892|NCT02918968|452002685|FG000|2nd Line AAT|Adverse Event|2|||
125649893|NCT02918968|452002686|FG001|2nd Line AAT|Adverse Event|5|||
125649894|NCT02918968|452002685|FG000|2nd Line AAT|Physician Decision|0|||
125649895|NCT02918968|452002686|FG001|2nd Line AAT|Physician Decision|1|||
125649896|NCT02918968|452002685|FG000|2nd Line AAT|Withdrawal by Subject|2|||
125649897|NCT02918968|452002686|FG001|2nd Line AAT|Withdrawal by Subject|2|||
125649898|NCT02918968|452002685|FG000|2nd Line AAT|Death|0|||
125649899|NCT02918968|452002686|FG001|2nd Line AAT|Death|1|||
125649900|NCT00727246|452002687|FG000|Overall Study|could not complete MRI|0|||
125209702|NCT01593254|450391305|FG000|Overall Study|lost to follow up|1|||
125209703|NCT01593254|450391306|FG001|Overall Study|lost to follow up|6|||
125649901|NCT00727246|452002688|FG001|Overall Study|could not complete MRI|1|||
125649902|NCT00727246|452002689|FG002|Overall Study|could not complete MRI|0|||
125649903|NCT00727246|452002690|FG003|Overall Study|could not complete MRI|1|||
125649904|NCT00727246|452002687|FG000|Overall Study|incidental finding|0|||
125649905|NCT00727246|452002688|FG001|Overall Study|incidental finding|0|||
125649906|NCT00727246|452002689|FG002|Overall Study|incidental finding|0|||
125649907|NCT00727246|452002690|FG003|Overall Study|incidental finding|1|||
125649908|NCT00727246|452002687|FG000|Overall Study|withdrawn|0|||
125649909|NCT00727246|452002688|FG001|Overall Study|withdrawn|0|||
125209704|NCT01593254|450391305|FG000|Overall Study|maximum clinical benefit|1|||
125209705|NCT01593254|450391306|FG001|Overall Study|maximum clinical benefit|2|||
125649910|NCT00727246|452002689|FG002|Overall Study|withdrawn|1|||
125649911|NCT00727246|452002690|FG003|Overall Study|withdrawn|0|||
125649912|NCT02696382|452002695|FG000|Overall Study|Death|7|||
125649913|NCT02696382|452002696|FG001|Overall Study|Death|2|||
125649914|NCT02696382|452002695|FG000|Overall Study|Withdrawal by Subject|5|||
125209706|NCT01593254|450391305|FG000|Overall Study|Poor/non compliance|1|||
125209707|NCT01593254|450391306|FG001|Overall Study|Poor/non compliance|1|||
125209708|NCT01593254|450391305|FG000|Overall Study|Pregnancy|0|||
125209709|NCT01593254|450391306|FG001|Overall Study|Pregnancy|3|||
125209710|NCT01593254|450391305|FG000|Overall Study|participant no longer meets study criteria|1|||
125209711|NCT01593254|450391306|FG001|Overall Study|participant no longer meets study criteria|1|||
125209712|NCT01593254|450391305|FG000|Overall Study|Admin reason by sponsor|7|||
125209713|NCT01593254|450391306|FG001|Overall Study|Admin reason by sponsor|3|||
125209714|NCT01593254|450391305|FG000|Overall Study|Imatinib treatment failure|2|||
125209715|NCT01593254|450391306|FG001|Overall Study|Imatinib treatment failure|0|||
125209716|NCT01593254|450391305|FG000|Overall Study|Other Reasons|61|||
125209717|NCT01593254|450391306|FG001|Overall Study|Other Reasons|115|||
125209718|NCT00076999|450391313|FG000|Overall Study|Adverse Event|2|||
125209719|NCT00076999|450391314|FG001|Overall Study|Adverse Event|8|||
125209720|NCT00076999|450391315|FG002|Overall Study|Adverse Event|6|||
125209721|NCT00076999|450391316|FG003|Overall Study|Adverse Event|0|||
125209722|NCT00076999|450391317|FG004|Overall Study|Adverse Event|2|||
125209723|NCT00076999|450391313|FG000|Overall Study|Protocol Violation|0|||
125209724|NCT00076999|450391314|FG001|Overall Study|Protocol Violation|3|||
125209725|NCT00076999|450391315|FG002|Overall Study|Protocol Violation|4|||
125209726|NCT00076999|450391316|FG003|Overall Study|Protocol Violation|0|||
125209727|NCT00076999|450391317|FG004|Overall Study|Protocol Violation|9|||
125209728|NCT00076999|450391313|FG000|Overall Study|Lost to Follow-up|2|||
125209729|NCT00076999|450391314|FG001|Overall Study|Lost to Follow-up|1|||
125209730|NCT00076999|450391315|FG002|Overall Study|Lost to Follow-up|0|||
125209731|NCT00076999|450391316|FG003|Overall Study|Lost to Follow-up|0|||
125209732|NCT00076999|450391317|FG004|Overall Study|Lost to Follow-up|0|||
125209733|NCT00076999|450391313|FG000|Overall Study|Withdrawal by Subject|0|||
125209734|NCT00076999|450391314|FG001|Overall Study|Withdrawal by Subject|4|||
125209735|NCT00076999|450391315|FG002|Overall Study|Withdrawal by Subject|3|||
125209736|NCT00076999|450391316|FG003|Overall Study|Withdrawal by Subject|0|||
125209737|NCT00076999|450391317|FG004|Overall Study|Withdrawal by Subject|1|||
125209738|NCT00076999|450391313|FG000|Overall Study|Other reason (not specified)|8|||
125209739|NCT00076999|450391314|FG001|Overall Study|Other reason (not specified)|8|||
125209740|NCT00076999|450391315|FG002|Overall Study|Other reason (not specified)|4|||
125209741|NCT00076999|450391316|FG003|Overall Study|Other reason (not specified)|1|||
125209742|NCT00076999|450391317|FG004|Overall Study|Other reason (not specified)|13|||
125209743|NCT01857102|450391319|FG000|Period 1|No longer meets Eligibility Criteria|0|||
125209744|NCT01857102|450391320|FG001|Period 1|No longer meets Eligibility Criteria|2|||
125209745|NCT01857102|450391319|FG000|Period 1|Lost to Follow-up|0|||
125209746|NCT01857102|450391320|FG001|Period 1|Lost to Follow-up|3|||
125209747|NCT01857102|450391319|FG000|Period 1|Unsatisfactory Lens Fit|1|||
125209748|NCT01857102|450391320|FG001|Period 1|Unsatisfactory Lens Fit|0|||
125209749|NCT01857102|450391319|FG000|Period 1|Unsatisfactory Visual Response|1|||
125209750|NCT01857102|450391320|FG001|Period 1|Unsatisfactory Visual Response|0|||
125209751|NCT01857102|450391319|FG000|Period 1|Physician Decision|1|||
125209752|NCT01857102|450391320|FG001|Period 1|Physician Decision|0|||
125311752|NCT03566082|450768817|FG000|Overall Study|Failures (revision required)|2|||
125649915|NCT02696382|452002696|FG001|Overall Study|Withdrawal by Subject|12|||
125649916|NCT02696382|452002695|FG000|Overall Study|Lost to Follow-up|4|||
125649917|NCT02696382|452002696|FG001|Overall Study|Lost to Follow-up|7|||
125649918|NCT00483574|452002698|FG000|Overall Study|Adverse Event|6|||
125649919|NCT00483574|452002699|FG001|Overall Study|Adverse Event|0|||
125649920|NCT00483574|452002698|FG000|Overall Study|Protocol Violation|28|||
125649921|NCT00483574|452002699|FG001|Overall Study|Protocol Violation|9|||
125649922|NCT00483574|452002698|FG000|Overall Study|Lost to Follow-up|16|||
125649923|NCT00483574|452002699|FG001|Overall Study|Lost to Follow-up|4|||
125649924|NCT00483574|452002698|FG000|Overall Study|Withdrawal by Subject|52|||
125649925|NCT00483574|452002699|FG001|Overall Study|Withdrawal by Subject|0|||
125649926|NCT00998166|452002700|FG000|Overall Study|Early Study Termination|8|||
125649927|NCT04988035|452002713|FG000|Overall Study|Death|19|||
125649928|NCT04988035|452002714|FG001|Overall Study|Death|13|||
125649929|NCT04988035|452002713|FG000|Overall Study|Lost to Follow-up|12|||
125649930|NCT04988035|452002714|FG001|Overall Study|Lost to Follow-up|6|||
125649931|NCT04988035|452002713|FG000|Overall Study|Protocol Violation|0|||
125649932|NCT04988035|452002714|FG001|Overall Study|Protocol Violation|1|||
125649933|NCT04988035|452002713|FG000|Overall Study|Withdrawal by Subject|2|||
125649934|NCT04988035|452002714|FG001|Overall Study|Withdrawal by Subject|4|||
125649935|NCT04988035|452002713|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
125649936|NCT04988035|452002714|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
125649937|NCT03602976|452002715|FG000|Overall Study|Withdrawal by Subject|1|||
125649938|NCT04626947|452002716|FG000|Overall Study|Study terminated|14|||
125209753|NCT01857102|450391319|FG000|Period 2|Lens Discomfort|1|||
125209754|NCT01857102|450391320|FG001|Period 2|Lens Discomfort|0|||
125209755|NCT01857102|450391319|FG000|Period 2|Unsatisfactory Lens Fit|1|||
125209756|NCT01857102|450391320|FG001|Period 2|Unsatisfactory Lens Fit|0|||
125209757|NCT02603562|450391325|FG000|Overall Study|Lost to Follow-up|1|||
125209758|NCT02117713|450391346|FG000|Week 48|Adverse Event|4|||
125209759|NCT02117713|450391346|FG000|Week 48|Withdrawal by caregiver|2|||
125209760|NCT02117713|450391346|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
125209761|NCT02117713|450391346|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
125209762|NCT02117713|450391346|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
125209763|NCT02117713|450391346|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
125209764|NCT00574795|450391347|FG000|Infant Series|Withdrawal by Subject|2|||
125209765|NCT00574795|450391347|FG000|Infant Series|Protocol Violation|2|||
125209766|NCT00574795|450391347|FG000|Infant Series|Adverse Event|1|||
125209767|NCT00574795|450391347|FG000|After Infant Series|Withdrawal by Subject|1|||
125209768|NCT00574795|450391347|FG000|After Infant Series|Adverse Event|2|||
125209769|NCT00574795|450391347|FG000|Toddler Dose|Withdrawal by Subject|1|||
125209770|NCT00467961|450391351|FG000|Overall Study|Technical Failures|5|||
125209771|NCT00467961|450391351|FG000|Overall Study|Disease Progression|2|||
125209772|NCT03417024|450391352|FG000|Overall Study|Study Termination prior to follow-up|11|||
125209773|NCT03417024|450391352|FG000|Overall Study|Physician Decision|2|||
125209774|NCT03168919|450391353|FG000|Overall Study|Withdrawal by Subject|2|||
125209775|NCT02195427|450391354|FG000|Overall Study|Did not consent to study extension|13|||
125649939|NCT01428882|452002717|FG000|Overall Study|Lack of Efficacy|2|||
125649940|NCT01428882|452002718|FG001|Overall Study|Lack of Efficacy|7|||
125649941|NCT01428882|452002717|FG000|Overall Study|Protocol Violation|4|||
125649942|NCT01428882|452002718|FG001|Overall Study|Protocol Violation|3|||
125649943|NCT00429026|452002721|FG000|Overall Study|Inevaluable for response.|40|||
125649944|NCT03831282|452002722|FG000|Overall Study|Could not place sensor|1|||
125649945|NCT03556202|452002727|FG000|Extension Treatment Period|Adverse Event|18|||
125649946|NCT03556202|452002728|FG001|Extension Treatment Period|Adverse Event|14|||
125649947|NCT03556202|452002729|FG002|Extension Treatment Period|Adverse Event|9|||
125649948|NCT03556202|452002727|FG000|Extension Treatment Period|Death|2|||
125649949|NCT03556202|452002728|FG001|Extension Treatment Period|Death|6|||
125649950|NCT03556202|452002729|FG002|Extension Treatment Period|Death|0|||
125649951|NCT03556202|452002727|FG000|Extension Treatment Period|Lack of Efficacy|5|||
125649952|NCT03556202|452002728|FG001|Extension Treatment Period|Lack of Efficacy|12|||
125649953|NCT03556202|452002729|FG002|Extension Treatment Period|Lack of Efficacy|18|||
125649954|NCT03556202|452002727|FG000|Extension Treatment Period|Lost to Follow-up|9|||
125649955|NCT03556202|452002728|FG001|Extension Treatment Period|Lost to Follow-up|20|||
125649956|NCT03556202|452002729|FG002|Extension Treatment Period|Lost to Follow-up|2|||
125649957|NCT03556202|452002727|FG000|Extension Treatment Period|Pregnancy|2|||
125649958|NCT03556202|452002728|FG001|Extension Treatment Period|Pregnancy|4|||
125649959|NCT03556202|452002729|FG002|Extension Treatment Period|Pregnancy|3|||
125649960|NCT03556202|452002727|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
125649961|NCT03556202|452002728|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
125649962|NCT03556202|452002729|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
125649963|NCT03556202|452002727|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
125649964|NCT03556202|452002728|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
125649965|NCT03556202|452002729|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
125649966|NCT03556202|452002727|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
125649967|NCT03556202|452002728|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
125649968|NCT03556202|452002729|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
125649969|NCT03556202|452002727|FG000|Extension Treatment Period|Physician Decision|0|||
125649970|NCT03556202|452002728|FG001|Extension Treatment Period|Physician Decision|8|||
125649971|NCT03556202|452002729|FG002|Extension Treatment Period|Physician Decision|2|||
125649972|NCT03556202|452002727|FG000|Extension Treatment Period|Protocol Violation|0|||
125649973|NCT03556202|452002728|FG001|Extension Treatment Period|Protocol Violation|1|||
125649974|NCT03556202|452002729|FG002|Extension Treatment Period|Protocol Violation|1|||
125649975|NCT03556202|452002727|FG000|Extension Treatment Period|Sponsor Decision|0|||
125649976|NCT03556202|452002728|FG001|Extension Treatment Period|Sponsor Decision|1|||
125649977|NCT03556202|452002729|FG002|Extension Treatment Period|Sponsor Decision|0|||
125649978|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
125649979|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
125649980|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
125649981|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|Death|1|||
125649982|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|Death|0|||
125649983|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|Death|0|||
125649984|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
125649985|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
125649986|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
125649987|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
125649988|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
125649989|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
125209776|NCT02195427|450391355|FG001|Overall Study|Did not consent to study extension|9|||
125209777|NCT02195427|450391354|FG000|Overall Study|Withdrawal by Subject|4|||
125209778|NCT02195427|450391355|FG001|Overall Study|Withdrawal by Subject|2|||
125209779|NCT02195427|450391354|FG000|Overall Study|Lost to Follow-up|0|||
125209780|NCT02195427|450391355|FG001|Overall Study|Lost to Follow-up|1|||
125209781|NCT02195427|450391354|FG000|Overall Study|Protocol Violation|7|||
125209782|NCT02195427|450391355|FG001|Overall Study|Protocol Violation|14|||
125209783|NCT02195427|450391354|FG000|Overall Study|Conditional re-treatment at W52|2|||
125209784|NCT02195427|450391355|FG001|Overall Study|Conditional re-treatment at W52|1|||
125209785|NCT03403621|450391359|FG000|Overall Study|Withdrawal by Subject|2|||
125209786|NCT03403621|450391360|FG001|Overall Study|Withdrawal by Subject|2|||
125209787|NCT00422292|450391365|FG000|Overall Study|Serious adverse events|1|||
125209788|NCT00422292|450391366|FG001|Overall Study|Serious adverse events|4|||
125209789|NCT00422292|450391367|FG002|Overall Study|Serious adverse events|0|||
125209790|NCT00422292|450391368|FG003|Overall Study|Serious adverse events|0|||
125209791|NCT00422292|450391365|FG000|Overall Study|Adverse Event|1|||
125209792|NCT00422292|450391366|FG001|Overall Study|Adverse Event|0|||
125209793|NCT00422292|450391367|FG002|Overall Study|Adverse Event|1|||
125209794|NCT00422292|450391368|FG003|Overall Study|Adverse Event|0|||
125209795|NCT00422292|450391365|FG000|Overall Study|Protocol Violation|4|||
125209796|NCT00422292|450391366|FG001|Overall Study|Protocol Violation|25|||
125209797|NCT00422292|450391367|FG002|Overall Study|Protocol Violation|8|||
125209798|NCT00422292|450391368|FG003|Overall Study|Protocol Violation|5|||
125209799|NCT00422292|450391365|FG000|Overall Study|Lost to Follow-up|6|||
125209800|NCT00422292|450391366|FG001|Overall Study|Lost to Follow-up|12|||
125209801|NCT00422292|450391367|FG002|Overall Study|Lost to Follow-up|6|||
125209802|NCT00422292|450391368|FG003|Overall Study|Lost to Follow-up|6|||
125209803|NCT00422292|450391365|FG000|Overall Study|Withdrawal by Subject|6|||
125209804|NCT00422292|450391366|FG001|Overall Study|Withdrawal by Subject|25|||
125209805|NCT00422292|450391367|FG002|Overall Study|Withdrawal by Subject|7|||
125209806|NCT00422292|450391368|FG003|Overall Study|Withdrawal by Subject|13|||
125209807|NCT04607980|450391369|FG000|Overall Study|Adverse Event|3|||
125209808|NCT04607980|450391370|FG001|Overall Study|Adverse Event|4|||
125209809|NCT04607980|450391369|FG000|Overall Study|Death|0|||
125209810|NCT04607980|450391370|FG001|Overall Study|Death|1|||
125209811|NCT04607980|450391369|FG000|Overall Study|Withdrawal by Subject|2|||
125209812|NCT04607980|450391370|FG001|Overall Study|Withdrawal by Subject|5|||
125209813|NCT04607980|450391369|FG000|Overall Study|Lost to Follow-up|4|||
125209814|NCT04607980|450391370|FG001|Overall Study|Lost to Follow-up|8|||
125209815|NCT04607980|450391369|FG000|Overall Study|Protocol Violation|0|||
125209816|NCT04607980|450391370|FG001|Overall Study|Protocol Violation|3|||
125209817|NCT04607980|450391369|FG000|Overall Study|Other|3|||
125209818|NCT04607980|450391370|FG001|Overall Study|Other|0|||
125209819|NCT02824562|450393670|FG000|Overall Study|Lost to Follow-up|3|||
125209820|NCT02824562|450393671|FG001|Overall Study|Lost to Follow-up|4|||
125209821|NCT02824562|450393670|FG000|Overall Study|Death|0|||
125209822|NCT02824562|450393671|FG001|Overall Study|Death|1|||
125209823|NCT02168777|450393672|FG000|Overall Study|Withdrawal by Subject|1|||
125209824|NCT02168777|450393673|FG001|Overall Study|Withdrawal by Subject|0|||
125209825|NCT02168777|450393674|FG002|Overall Study|Withdrawal by Subject|2|||
125209826|NCT02168777|450393672|FG000|Overall Study|Adverse Event|1|||
125209827|NCT02168777|450393673|FG001|Overall Study|Adverse Event|0|||
125209828|NCT02168777|450393674|FG002|Overall Study|Adverse Event|1|||
125209829|NCT02168777|450393672|FG000|Overall Study|Disease recurrence|0|||
125209830|NCT02168777|450393673|FG001|Overall Study|Disease recurrence|0|||
125209831|NCT02168777|450393674|FG002|Overall Study|Disease recurrence|1|||
125209832|NCT02168777|450393672|FG000|Overall Study|Radiological disease progression|0|||
125209833|NCT02168777|450393673|FG001|Overall Study|Radiological disease progression|5|||
125209834|NCT02168777|450393674|FG002|Overall Study|Radiological disease progression|5|||
125209835|NCT02168777|450393672|FG000|Overall Study|Clinical disease progression|0|||
125209836|NCT02168777|450393673|FG001|Overall Study|Clinical disease progression|1|||
125209837|NCT02168777|450393674|FG002|Overall Study|Clinical disease progression|2|||
125311753|NCT03566082|450768817|FG000|Overall Study|Lost to Follow-up|8|||
125311754|NCT00983385|450768820|FG000|Observation Period|Not eligible to be dosed|20|||
125311755|NCT00983385|450768820|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
125311756|NCT01279681|450768822|FG000|Overall Study|Disease Progression|9|||
125311757|NCT01279681|450768823|FG001|Overall Study|Disease Progression|6|||
125311758|NCT01279681|450768822|FG000|Overall Study|Withdrawal by Subject|3|||
125311759|NCT01279681|450768823|FG001|Overall Study|Withdrawal by Subject|4|||
125311760|NCT01279681|450768822|FG000|Overall Study|Adverse Event|2|||
125311761|NCT01279681|450768823|FG001|Overall Study|Adverse Event|3|||
125311762|NCT01279681|450768822|FG000|Overall Study|Death|0|||
125311763|NCT01279681|450768823|FG001|Overall Study|Death|1|||
125540015|NCT00350103|451605885|FG001|Overall Study|PR greater than 250ms|0|||
125540016|NCT00350103|451605886|FG002|Overall Study|PR greater than 250ms|1|||
125209838|NCT02168777|450393672|FG000|Overall Study|Other reason|0|||
125209839|NCT02168777|450393673|FG001|Overall Study|Other reason|1|||
125209840|NCT02168777|450393674|FG002|Overall Study|Other reason|0|||
125209841|NCT05243563|450393675|FG000|Overall Study|Withdrawal by Subject|1|||
125209842|NCT05243563|450393676|FG001|Overall Study|Withdrawal by Subject|0|||
125209843|NCT05243563|450393675|FG000|Overall Study|Physician Decision|1|||
125209844|NCT05243563|450393676|FG001|Overall Study|Physician Decision|0|||
125209845|NCT03774394|450393682|FG000|Overall Study|Withdrawal by Subject|2|||
125209846|NCT03774394|450393683|FG001|Overall Study|Withdrawal by Subject|0|||
125540017|NCT00350103|451605884|FG000|Overall Study|Wrong calculation of QT interval|0|||
125540018|NCT00350103|451605885|FG001|Overall Study|Wrong calculation of QT interval|0|||
125540019|NCT00350103|451605886|FG002|Overall Study|Wrong calculation of QT interval|1|||
125540020|NCT00350103|451605884|FG000|Overall Study|Sponsor mistake|1|||
125540021|NCT00350103|451605885|FG001|Overall Study|Sponsor mistake|0|||
125540022|NCT00350103|451605886|FG002|Overall Study|Sponsor mistake|0|||
125540023|NCT00350103|451605884|FG000|Overall Study|Randomization mistake|0|||
125540024|NCT00350103|451605885|FG001|Overall Study|Randomization mistake|1|||
125540025|NCT00350103|451605886|FG002|Overall Study|Randomization mistake|1|||
125540026|NCT00350103|451605884|FG000|Overall Study|Sponsor´s decision|0|||
125540027|NCT00350103|451605885|FG001|Overall Study|Sponsor´s decision|1|||
125540028|NCT00350103|451605886|FG002|Overall Study|Sponsor´s decision|0|||
125540029|NCT00350103|451605884|FG000|Overall Study|Lost, Reason unknown|1|||
125540030|NCT00350103|451605885|FG001|Overall Study|Lost, Reason unknown|1|||
125540031|NCT00350103|451605886|FG002|Overall Study|Lost, Reason unknown|0|||
125540032|NCT00320528|451605887|FG000|Study Period II|Adverse Event|3|||
125540033|NCT00320528|451605888|FG001|Study Period II|Adverse Event|4|||
125540034|NCT00320528|451605889|FG002|Study Period II|Adverse Event|8|||
125540035|NCT00320528|451605887|FG000|Study Period II|Parent/Caregiver Decision|8|||
125540036|NCT00320528|451605888|FG001|Study Period II|Parent/Caregiver Decision|3|||
125540037|NCT00320528|451605889|FG002|Study Period II|Parent/Caregiver Decision|11|||
125540038|NCT00320528|451605887|FG000|Study Period II|Withdrawal by Subject|0|||
125540039|NCT00320528|451605888|FG001|Study Period II|Withdrawal by Subject|1|||
125540040|NCT00320528|451605889|FG002|Study Period II|Withdrawal by Subject|1|||
125540041|NCT00320528|451605887|FG000|Study Period II|Entry Criteria Exclusion|0|||
125540042|NCT00320528|451605888|FG001|Study Period II|Entry Criteria Exclusion|2|||
125540043|NCT00320528|451605889|FG002|Study Period II|Entry Criteria Exclusion|2|||
125540044|NCT00320528|451605887|FG000|Study Period III|Adverse Event|1|||
125540045|NCT00320528|451605888|FG001|Study Period III|Adverse Event|0|||
125540046|NCT00320528|451605889|FG002|Study Period III|Adverse Event|0|||
125540047|NCT00320528|451605887|FG000|Study Period III|Lost to Follow-up|1|||
125540048|NCT00320528|451605888|FG001|Study Period III|Lost to Follow-up|0|||
125540049|NCT00320528|451605889|FG002|Study Period III|Lost to Follow-up|0|||
125540050|NCT00320528|451605887|FG000|Study Period III|Withdrawal by Subject|1|||
125540051|NCT00320528|451605888|FG001|Study Period III|Withdrawal by Subject|1|||
125540052|NCT00320528|451605889|FG002|Study Period III|Withdrawal by Subject|2|||
125540053|NCT00320528|451605887|FG000|Study Period III|Lack of Efficacy|2|||
125540054|NCT00320528|451605888|FG001|Study Period III|Lack of Efficacy|0|||
125540055|NCT00320528|451605889|FG002|Study Period III|Lack of Efficacy|0|||
125540056|NCT00320528|451605887|FG000|Study Period III|Parent/Caregiver Decision|14|||
125540057|NCT00320528|451605888|FG001|Study Period III|Parent/Caregiver Decision|3|||
125540058|NCT00320528|451605889|FG002|Study Period III|Parent/Caregiver Decision|11|||
125540059|NCT00320528|451605887|FG000|Study Period III|Protocol Violation|0|||
125540060|NCT00320528|451605888|FG001|Study Period III|Protocol Violation|1|||
125540061|NCT00320528|451605889|FG002|Study Period III|Protocol Violation|0|||
125540062|NCT00320528|451605887|FG000|Study Period III|Physician Decision|0|||
125540063|NCT00320528|451605888|FG001|Study Period III|Physician Decision|1|||
125540064|NCT00320528|451605889|FG002|Study Period III|Physician Decision|2|||
125540065|NCT00320528|451605887|FG000|Study Period III|Sponsor Decision|0|||
125540066|NCT00320528|451605888|FG001|Study Period III|Sponsor Decision|0|||
125540067|NCT00320528|451605889|FG002|Study Period III|Sponsor Decision|1|||
125540068|NCT00320528|451605887|FG000|Study Period III|Atomoxetine Commercially Available|68|||
125540069|NCT00320528|451605888|FG001|Study Period III|Atomoxetine Commercially Available|25|||
125540070|NCT00320528|451605889|FG002|Study Period III|Atomoxetine Commercially Available|90|||
125540071|NCT04828837|451605890|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
125540072|NCT04828837|451605891|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
125540073|NCT04828837|451605890|FG000|Overall Study|Lost to Follow-up|2|||
125540074|NCT04828837|451605891|FG001|Overall Study|Lost to Follow-up|6|||
125540075|NCT04828837|451605890|FG000|Overall Study|Lack of Efficacy|1|||
125540076|NCT04828837|451605891|FG001|Overall Study|Lack of Efficacy|0|||
125540077|NCT04828837|451605890|FG000|Overall Study|Admitted due to pneumothorax.|1|||
125540078|NCT04828837|451605891|FG001|Overall Study|Admitted due to pneumothorax.|0|||
125540079|NCT04828837|451605890|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
125540080|NCT04828837|451605891|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
125540081|NCT00545753|451605892|FG000|Overall Study|Withdrawal by Subject|0|||
125540082|NCT00545753|451605893|FG001|Overall Study|Withdrawal by Subject|1|||
125540083|NCT00545753|451605894|FG002|Overall Study|Withdrawal by Subject|10|||
125540084|NCT00545753|451605892|FG000|Overall Study|Lost to Follow-up|13|||
125540085|NCT00545753|451605893|FG001|Overall Study|Lost to Follow-up|3|||
125540086|NCT00545753|451605894|FG002|Overall Study|Lost to Follow-up|12|||
125540087|NCT00545753|451605892|FG000|Overall Study|Protocol Violation|3|||
125540088|NCT00545753|451605893|FG001|Overall Study|Protocol Violation|1|||
125540089|NCT00545753|451605894|FG002|Overall Study|Protocol Violation|4|||
125649990|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
125649991|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
125649992|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
125649993|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
125649994|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
125649995|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
125649996|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
125649997|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
125649998|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
125649999|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
125650000|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
125650001|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
125650002|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
125650003|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
125650004|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
125650005|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
125650006|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
125650007|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
125650008|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
125650009|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
125650010|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
125650011|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
125650012|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
125650013|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
125650014|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
125650015|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
125650016|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
125650017|NCT03556202|452002727|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
125650018|NCT03556202|452002728|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
125650019|NCT03556202|452002729|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
125650020|NCT01539512|452002730|FG000|Overall Study|Adverse Event|9|||
125650021|NCT01539512|452002731|FG001|Overall Study|Adverse Event|7|||
125650022|NCT01539512|452002730|FG000|Overall Study|Physician Decision|1|||
125650023|NCT01539512|452002731|FG001|Overall Study|Physician Decision|1|||
125650024|NCT01539512|452002730|FG000|Overall Study|Withdrawal by Subject|12|||
125650025|NCT01539512|452002731|FG001|Overall Study|Withdrawal by Subject|5|||
125650026|NCT01539512|452002730|FG000|Overall Study|Richter's Transformation|1|||
125650027|NCT01539512|452002731|FG001|Overall Study|Richter's Transformation|0|||
125650028|NCT04479358|452002738|FG000|Overall Study|Withdrawal by Subject|0|||
125650029|NCT04479358|452002739|FG001|Overall Study|Withdrawal by Subject|0|||
125650030|NCT04479358|452002740|FG002|Overall Study|Withdrawal by Subject|1|||
125650031|NCT04479358|452002741|FG003|Overall Study|Withdrawal by Subject|0|||
125650032|NCT04479358|452002742|FG004|Overall Study|Withdrawal by Subject|0|||
125650033|NCT04479358|452002743|FG005|Overall Study|Withdrawal by Subject|1|||
125650034|NCT00764465|452002744|FG000|Overall Study|Adverse Event|2|||
125650035|NCT00764465|452002745|FG001|Overall Study|Adverse Event|0|||
125650036|NCT00764465|452002746|FG002|Overall Study|Adverse Event|0|||
125650037|NCT00764465|452002747|FG003|Overall Study|Adverse Event|1|||
125650038|NCT00764465|452002748|FG004|Overall Study|Adverse Event|1|||
125650039|NCT00764465|452002749|FG005|Overall Study|Adverse Event|1|||
125650040|NCT00764465|452002744|FG000|Overall Study|Withdrawal by Subject|0|||
125650041|NCT00764465|452002745|FG001|Overall Study|Withdrawal by Subject|1|||
125650042|NCT00764465|452002746|FG002|Overall Study|Withdrawal by Subject|1|||
125650043|NCT00764465|452002747|FG003|Overall Study|Withdrawal by Subject|0|||
125650044|NCT00764465|452002748|FG004|Overall Study|Withdrawal by Subject|0|||
125650045|NCT00764465|452002749|FG005|Overall Study|Withdrawal by Subject|0|||
125650046|NCT01333501|452002750|FG000|Overall Study|Adverse Event|3|||
125650047|NCT01333501|452002751|FG001|Overall Study|Adverse Event|1|||
125650048|NCT01333501|452002750|FG000|Overall Study|Abnormal laboratory value|2|||
125650049|NCT01333501|452002751|FG001|Overall Study|Abnormal laboratory value|1|||
125650050|NCT01333501|452002750|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125650051|NCT01333501|452002751|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
125650052|NCT01333501|452002750|FG000|Overall Study|Withdrawn consent|3|||
125209847|NCT02697916|450393684|FG000|Overall Study|Death|357|||
125209848|NCT02697916|450393685|FG001|Overall Study|Death|315|||
125650053|NCT01333501|452002751|FG001|Overall Study|Withdrawn consent|12|||
125650054|NCT00674440|452002752|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
125650055|NCT00674440|452002752|FG000|Overall Study|did not have surgery, so unevaluable|7|||
125209849|NCT02697916|450393684|FG000|Overall Study|Withdrawal by Subject|221|||
125424883|NCT00002558|451178705|FG001|Overall Study|Withdrawal by Subject|1|||
125209850|NCT02697916|450393685|FG001|Overall Study|Withdrawal by Subject|393|||
125209851|NCT03334422|450393686|FG000|Overall Study|Adverse Event|1|||
125209852|NCT03334422|450393687|FG001|Overall Study|Adverse Event|3|||
125209853|NCT03334422|450393688|FG002|Overall Study|Adverse Event|2|||
125209854|NCT03334422|450393689|FG003|Overall Study|Adverse Event|2|||
125209855|NCT03334422|450393686|FG000|Overall Study|Lack of Efficacy|10|||
125209856|NCT03334422|450393687|FG001|Overall Study|Lack of Efficacy|2|||
125209857|NCT03334422|450393688|FG002|Overall Study|Lack of Efficacy|7|||
125209858|NCT03334422|450393689|FG003|Overall Study|Lack of Efficacy|3|||
125209859|NCT03334422|450393686|FG000|Overall Study|Withdrawal by Subject|8|||
125209860|NCT03334422|450393687|FG001|Overall Study|Withdrawal by Subject|3|||
125209861|NCT03334422|450393688|FG002|Overall Study|Withdrawal by Subject|1|||
125209862|NCT03334422|450393689|FG003|Overall Study|Withdrawal by Subject|0|||
125209863|NCT03334422|450393686|FG000|Overall Study|Lost to Follow-up|0|||
125209864|NCT03334422|450393687|FG001|Overall Study|Lost to Follow-up|0|||
125650056|NCT00674440|452002752|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
125650057|NCT00914940|452002753|FG000|D0 to D100 Post-transplant|Death|2|||
125650058|NCT00914940|452002753|FG000|D101 to 2 Years Post-transplant|Death|8|||
125209865|NCT03334422|450393688|FG002|Overall Study|Lost to Follow-up|0|||
125209866|NCT03334422|450393689|FG003|Overall Study|Lost to Follow-up|1|||
125209867|NCT03334422|450393686|FG000|Overall Study|Inability to obtain laboratory samples|0|||
125209868|NCT03334422|450393687|FG001|Overall Study|Inability to obtain laboratory samples|1|||
125209869|NCT03334422|450393688|FG002|Overall Study|Inability to obtain laboratory samples|0|||
125209870|NCT03334422|450393689|FG003|Overall Study|Inability to obtain laboratory samples|0|||
125209871|NCT03334422|450393686|FG000|Overall Study|Pregnancy|0|||
125209872|NCT03334422|450393687|FG001|Overall Study|Pregnancy|1|||
125209873|NCT03334422|450393688|FG002|Overall Study|Pregnancy|0|||
125209874|NCT03334422|450393689|FG003|Overall Study|Pregnancy|0|||
125209875|NCT01313221|450393692|FG000|Overall Study|Protocol Violation|0|||
125209876|NCT01313221|450393693|FG001|Overall Study|Protocol Violation|1|||
125209877|NCT01313221|450393694|FG002|Overall Study|Protocol Violation|1|||
125209878|NCT01313221|450393692|FG000|Overall Study|Non-compliance|3|||
125209879|NCT01313221|450393693|FG001|Overall Study|Non-compliance|0|||
125209880|NCT01313221|450393694|FG002|Overall Study|Non-compliance|2|||
125209881|NCT01313221|450393692|FG000|Overall Study|Withdrawal by Subject|2|||
125209882|NCT01313221|450393693|FG001|Overall Study|Withdrawal by Subject|3|||
125209883|NCT01313221|450393694|FG002|Overall Study|Withdrawal by Subject|5|||
125209884|NCT01313221|450393692|FG000|Overall Study|Requirement for alternative therapy|0|||
125209885|NCT01313221|450393693|FG001|Overall Study|Requirement for alternative therapy|1|||
125209886|NCT01313221|450393694|FG002|Overall Study|Requirement for alternative therapy|1|||
125209887|NCT01313221|450393692|FG000|Overall Study|Lost to Follow-up|6|||
125209888|NCT01313221|450393693|FG001|Overall Study|Lost to Follow-up|3|||
125209889|NCT01313221|450393694|FG002|Overall Study|Lost to Follow-up|1|||
125209890|NCT01313221|450393692|FG000|Overall Study|Other|1|||
125209891|NCT01313221|450393693|FG001|Overall Study|Other|0|||
125209892|NCT01313221|450393694|FG002|Overall Study|Other|0|||
125209893|NCT01313221|450393692|FG000|Overall Study|Adverse Event|0|||
125209894|NCT01313221|450393693|FG001|Overall Study|Adverse Event|0|||
125209895|NCT01313221|450393694|FG002|Overall Study|Adverse Event|7|||
125209896|NCT01313221|450393692|FG000|Overall Study|Disease progression|0|||
125209897|NCT01313221|450393693|FG001|Overall Study|Disease progression|0|||
125209898|NCT01313221|450393694|FG002|Overall Study|Disease progression|2|||
125650059|NCT00914940|452002753|FG000|2 Years to 5 Years Post-transplant|Death|3|||
125650060|NCT04095039|452002755|FG000|Overall Study|Withdrawal by Subject|2|||
125650061|NCT04095039|452002756|FG001|Overall Study|Withdrawal by Subject|16|||
125650062|NCT04095039|452002755|FG000|Overall Study|Transplanted|21|||
125650063|NCT04095039|452002756|FG001|Overall Study|Transplanted|24|||
125650064|NCT04095039|452002755|FG000|Overall Study|Transferred to Non-study Facility|47|||
125650065|NCT04095039|452002756|FG001|Overall Study|Transferred to Non-study Facility|44|||
125650066|NCT04095039|452002755|FG000|Overall Study|Withdrawal from internvention target|0|||
125650067|NCT04095039|452002756|FG001|Overall Study|Withdrawal from internvention target|2|||
125650068|NCT04095039|452002755|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
125650069|NCT04095039|452002756|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
125650070|NCT04095039|452002755|FG000|Overall Study|Cacliphylaxis|0|||
125209899|NCT01313221|450393692|FG000|Overall Study|Physician Decision|0|||
125650071|NCT04095039|452002756|FG001|Overall Study|Cacliphylaxis|1|||
125650072|NCT04095039|452002755|FG000|Overall Study|Pregnancy|1|||
125650073|NCT04095039|452002756|FG001|Overall Study|Pregnancy|0|||
125209900|NCT01313221|450393693|FG001|Overall Study|Physician Decision|0|||
125209901|NCT01313221|450393694|FG002|Overall Study|Physician Decision|2|||
125209902|NCT01313221|450393692|FG000|Overall Study|Pregnancy|0|||
125209903|NCT01313221|450393693|FG001|Overall Study|Pregnancy|0|||
125209904|NCT01313221|450393694|FG002|Overall Study|Pregnancy|2|||
125209905|NCT00994214|450393695|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
125209906|NCT00994214|450393696|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
125209907|NCT00994214|450393697|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
125209908|NCT00994214|450393698|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
125209909|NCT00994214|450393695|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
125209910|NCT00994214|450393696|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
125209911|NCT00994214|450393697|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
125209912|NCT00994214|450393698|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
125209913|NCT00994214|450393695|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
125209914|NCT00994214|450393696|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
125209915|NCT00994214|450393697|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
125209916|NCT00994214|450393698|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
125209917|NCT00994214|450393695|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
125209918|NCT00994214|450393696|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
125209919|NCT00994214|450393697|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
125209920|NCT00994214|450393698|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
125209921|NCT00994214|450393695|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
125209922|NCT00994214|450393696|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
125209923|NCT00994214|450393697|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
125209924|NCT00994214|450393698|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
125209925|NCT00994214|450393695|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
125209926|NCT00994214|450393696|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
125209927|NCT00994214|450393697|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
125209928|NCT00994214|450393698|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
125209929|NCT01698268|450393702|FG000|Overall Study|Physician Decision|2|||
125209930|NCT01698268|450393703|FG001|Overall Study|Physician Decision|1|||
125209931|NCT02864316|450393704|FG000|Overall Study|Progressive Disease|2|||
125209932|NCT02864316|450393705|FG001|Overall Study|Progressive Disease|1|||
125209933|NCT02864316|450393704|FG000|Overall Study|Adverse Event|0|||
125209934|NCT02864316|450393705|FG001|Overall Study|Adverse Event|1|||
125209935|NCT00298363|450393706|FG000|Overall Study|Lost to Follow-up|0|||
125209936|NCT00298363|450393707|FG001|Overall Study|Lost to Follow-up|0|||
125209937|NCT00298363|450393708|FG002|Overall Study|Lost to Follow-up|1|||
125209938|NCT00298363|450393706|FG000|Overall Study|Physician Decision|4|||
125209939|NCT00298363|450393707|FG001|Overall Study|Physician Decision|1|||
125209940|NCT00298363|450393708|FG002|Overall Study|Physician Decision|0|||
125209941|NCT00298363|450393706|FG000|Overall Study|Protocol Violation|1|||
125209942|NCT00298363|450393707|FG001|Overall Study|Protocol Violation|1|||
125209943|NCT00298363|450393708|FG002|Overall Study|Protocol Violation|0|||
125209944|NCT00298363|450393706|FG000|Overall Study|Withdrawal by Subject|5|||
125209945|NCT00298363|450393707|FG001|Overall Study|Withdrawal by Subject|1|||
125209946|NCT00298363|450393708|FG002|Overall Study|Withdrawal by Subject|3|||
125209947|NCT00298363|450393706|FG000|Overall Study|Adverse Event|5|||
125209948|NCT00298363|450393707|FG001|Overall Study|Adverse Event|2|||
125209949|NCT00298363|450393708|FG002|Overall Study|Adverse Event|2|||
125209950|NCT00298363|450393706|FG000|Overall Study|Lack of Efficacy|2|||
125209951|NCT00298363|450393707|FG001|Overall Study|Lack of Efficacy|3|||
125209952|NCT00298363|450393708|FG002|Overall Study|Lack of Efficacy|0|||
125209953|NCT04710368|450393709|FG000|Overall Study|Withdrawal by Subject|9|||
125209954|NCT04710368|450393709|FG000|Overall Study|Lost to Follow-up|4|||
125209955|NCT04710368|450393709|FG000|Overall Study|Death|2|||
125209956|NCT04710368|450393709|FG000|Overall Study|Patient preference|11|||
125209957|NCT04710368|450393709|FG000|Overall Study|Treatment discontinuation|1|||
125209958|NCT00135356|450393710|FG000|Overall Study|Adverse Event|6|||
125209959|NCT00135356|450393711|FG001|Overall Study|Adverse Event|2|||
125209960|NCT00135356|450393710|FG000|Overall Study|Lack of Efficacy|2|||
125209961|NCT00135356|450393711|FG001|Overall Study|Lack of Efficacy|0|||
125209962|NCT00135356|450393710|FG000|Overall Study|Lost to Follow-up|3|||
125209963|NCT00135356|450393711|FG001|Overall Study|Lost to Follow-up|1|||
125209964|NCT00135356|450393710|FG000|Overall Study|Surgery for abdominal fat|1|||
125209965|NCT00135356|450393711|FG001|Overall Study|Surgery for abdominal fat|0|||
125209966|NCT00135356|450393710|FG000|Overall Study|Change in antiviral regimen|0|||
125209967|NCT00135356|450393711|FG001|Overall Study|Change in antiviral regimen|1|||
125209968|NCT00135356|450393710|FG000|Overall Study|Poor/noncompliance|1|||
125209969|NCT00135356|450393711|FG001|Overall Study|Poor/noncompliance|1|||
125209970|NCT00135356|450393710|FG000|Overall Study|No longer meets study criteria|2|||
125209971|NCT00135356|450393711|FG001|Overall Study|No longer meets study criteria|0|||
125209972|NCT00135356|450393710|FG000|Overall Study|Withdrawal by Subject|2|||
125209973|NCT00135356|450393711|FG001|Overall Study|Withdrawal by Subject|4|||
125209974|NCT00153816|450393712|FG000|Overall Study|Death|6|||
125209975|NCT00153816|450393713|FG001|Overall Study|Death|5|||
125209976|NCT00153816|450393714|FG002|Overall Study|Death|4|||
125209977|NCT00153816|450393715|FG003|Overall Study|Death|6|||
125209978|NCT00153816|450393716|FG004|Overall Study|Death|0|||
125209979|NCT00153816|450393717|FG005|Overall Study|Death|2|||
125209980|NCT00153816|450393712|FG000|Overall Study|Lost to Follow-up|7|||
125209981|NCT00153816|450393713|FG001|Overall Study|Lost to Follow-up|8|||
125209982|NCT00153816|450393714|FG002|Overall Study|Lost to Follow-up|5|||
125650074|NCT02370173|452002757|FG000|Overall Study|Protocol Violation|1|||
125650075|NCT02370173|452002758|FG001|Overall Study|Protocol Violation|1|||
125650076|NCT02370173|452002757|FG000|Overall Study|Withdrawal by Subject|2|||
125650077|NCT02370173|452002758|FG001|Overall Study|Withdrawal by Subject|2|||
125650078|NCT03205605|452002759|FG000|Overall Study|Withdrawal by Subject|1|||
125650079|NCT00945815|452002762|FG000|Overall Study|Death|3|||
125650080|NCT00945815|452002762|FG000|Overall Study|Not protocol specified|1|||
125650081|NCT00945815|452002762|FG000|Overall Study|Ineligible|3|||
125650082|NCT00945815|452002762|FG000|Overall Study|Did not begin protocol therapy|1|||
125650083|NCT01990339|452002765|FG000|Overall Study|Data Not Available|49|||
125650084|NCT01990339|452002765|FG000|Overall Study|Voluntary Withdrawal|1402|||
125650085|NCT01990339|452002765|FG000|Overall Study|Lost to Follow-up|861|||
125650086|NCT01038609|452002766|FG000|Overall Study|Adverse Event|0|||
125650087|NCT01038609|452002767|FG001|Overall Study|Adverse Event|0|||
125650088|NCT01038609|452002768|FG002|Overall Study|Adverse Event|1|||
125650089|NCT01038609|452002769|FG003|Overall Study|Adverse Event|0|||
125650090|NCT01038609|452002770|FG004|Overall Study|Adverse Event|0|||
125650091|NCT01038609|452002766|FG000|Overall Study|Dosing Error|0|||
125650092|NCT01038609|452002767|FG001|Overall Study|Dosing Error|0|||
125650093|NCT01038609|452002768|FG002|Overall Study|Dosing Error|0|||
125424884|NCT02065336|451178706|FG000|Extension Phase|Study Terminated by Sponsor|0|||
125424885|NCT02065336|451178707|FG001|Extension Phase|Study Terminated by Sponsor|0|||
125424886|NCT02065336|451178708|FG002|Extension Phase|Study Terminated by Sponsor|0|||
125424887|NCT02065336|451178709|FG003|Extension Phase|Study Terminated by Sponsor|0|||
125424888|NCT02065336|451178710|FG004|Extension Phase|Study Terminated by Sponsor|0|||
125424889|NCT02065336|451178711|FG005|Extension Phase|Study Terminated by Sponsor|0|||
125424890|NCT02065336|451178712|FG006|Extension Phase|Study Terminated by Sponsor|0|||
125424891|NCT02065336|451178713|FG007|Extension Phase|Study Terminated by Sponsor|0|||
125424892|NCT02065336|451178714|FG008|Extension Phase|Study Terminated by Sponsor|2|||
125424893|NCT02065336|451178715|FG009|Extension Phase|Study Terminated by Sponsor|8|||
125209983|NCT00153816|450393715|FG003|Overall Study|Lost to Follow-up|8|||
125209984|NCT00153816|450393716|FG004|Overall Study|Lost to Follow-up|7|||
125209985|NCT00153816|450393717|FG005|Overall Study|Lost to Follow-up|9|||
125209986|NCT00153816|450393712|FG000|Overall Study|Withdrawal by Subject|9|||
125209987|NCT00153816|450393713|FG001|Overall Study|Withdrawal by Subject|9|||
125209988|NCT00153816|450393714|FG002|Overall Study|Withdrawal by Subject|9|||
125209989|NCT00153816|450393715|FG003|Overall Study|Withdrawal by Subject|4|||
125209990|NCT00153816|450393716|FG004|Overall Study|Withdrawal by Subject|1|||
125424894|NCT01754467|451178716|FG000|Overall Study|Lost to Follow-up|1|||
125424895|NCT01970462|451178717|FG000|Overall Study|Lost to Follow-up|0|||
125424896|NCT01970462|451178718|FG001|Overall Study|Lost to Follow-up|2|||
125424897|NCT01274182|451178720|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
125424898|NCT01274182|451178721|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125424899|NCT01274182|451178722|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
125424900|NCT01274182|451178720|FG000|Overall Study|Adverse Event|4|||
125424901|NCT01274182|451178721|FG001|Overall Study|Adverse Event|5|||
125424902|NCT01274182|451178722|FG002|Overall Study|Adverse Event|3|||
125424903|NCT01274182|451178720|FG000|Overall Study|Withdrawal by Subject|5|||
125424904|NCT01274182|451178721|FG001|Overall Study|Withdrawal by Subject|5|||
125424905|NCT01274182|451178722|FG002|Overall Study|Withdrawal by Subject|3|||
125424906|NCT01274182|451178720|FG000|Overall Study|Lost to Follow-up|2|||
125424907|NCT01274182|451178721|FG001|Overall Study|Lost to Follow-up|3|||
125424908|NCT01274182|451178722|FG002|Overall Study|Lost to Follow-up|1|||
125424909|NCT01274182|451178720|FG000|Overall Study|Protocol Violation|3|||
125424910|NCT01274182|451178721|FG001|Overall Study|Protocol Violation|2|||
125424911|NCT01274182|451178722|FG002|Overall Study|Protocol Violation|0|||
125424912|NCT01274182|451178720|FG000|Overall Study|Death|1|||
125424913|NCT01274182|451178721|FG001|Overall Study|Death|0|||
125424914|NCT01274182|451178722|FG002|Overall Study|Death|1|||
125424915|NCT02355002|451178723|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
125424916|NCT02355002|451178724|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
125424917|NCT02355002|451178723|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
125424918|NCT02355002|451178724|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
125424919|NCT02355002|451178723|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
125209991|NCT00153816|450393717|FG005|Overall Study|Withdrawal by Subject|5|||
125424920|NCT02355002|451178724|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
125424921|NCT02355002|451178723|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
125424922|NCT02355002|451178724|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
125209992|NCT00153816|450393712|FG000|Overall Study|Follow-up exam not done|8|||
125424923|NCT02355002|451178723|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
125209993|NCT00153816|450393713|FG001|Overall Study|Follow-up exam not done|7|||
125209994|NCT00153816|450393714|FG002|Overall Study|Follow-up exam not done|11|||
125650094|NCT01038609|452002769|FG003|Overall Study|Dosing Error|1|||
125650095|NCT01038609|452002770|FG004|Overall Study|Dosing Error|1|||
125424924|NCT02355002|451178724|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
125424925|NCT02355002|451178723|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
125424926|NCT02355002|451178724|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
125209995|NCT00153816|450393715|FG003|Overall Study|Follow-up exam not done|10|||
125209996|NCT00153816|450393716|FG004|Overall Study|Follow-up exam not done|8|||
125209997|NCT00153816|450393717|FG005|Overall Study|Follow-up exam not done|9|||
125209998|NCT00153816|450393712|FG000|Overall Study|Follow-up exam done, histology missing|2|||
125209999|NCT00153816|450393713|FG001|Overall Study|Follow-up exam done, histology missing|3|||
125210000|NCT00153816|450393714|FG002|Overall Study|Follow-up exam done, histology missing|3|||
125210001|NCT00153816|450393715|FG003|Overall Study|Follow-up exam done, histology missing|3|||
125210002|NCT00153816|450393716|FG004|Overall Study|Follow-up exam done, histology missing|1|||
125210003|NCT00153816|450393717|FG005|Overall Study|Follow-up exam done, histology missing|2|||
125210004|NCT01887288|450393722|FG000|Overall Study|The study was terminated and the PI has|16|||
125210005|NCT00253370|450393725|FG000|Overall Study|Adverse Event|18|||
125424927|NCT02355002|451178723|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
125424928|NCT02355002|451178724|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
125210006|NCT00253370|450393725|FG000|Overall Study|Disease progression|13|||
125210007|NCT00253370|450393725|FG000|Overall Study|Death|2|||
125210008|NCT00253370|450393725|FG000|Overall Study|Withdrawal by Subject|6|||
125210009|NCT00253370|450393725|FG000|Overall Study|Non-protocol therapy|1|||
125210010|NCT00253370|450393725|FG000|Overall Study|Physician Decision|1|||
125210011|NCT00253370|450393725|FG000|Overall Study|Protocol Violation|1|||
125210012|NCT00253370|450393725|FG000|Overall Study|Abdominal pain due to disease|1|||
125210013|NCT05916131|450393726|FG000|Overall Study|Lost to Follow-up|0|||
125210014|NCT05916131|450393727|FG001|Overall Study|Lost to Follow-up|0|||
125210015|NCT05916131|450393728|FG002|Overall Study|Lost to Follow-up|1|||
125210016|NCT05916131|450393729|FG003|Overall Study|Lost to Follow-up|0|||
125210017|NCT01211483|450393739|FG000|Phase 1b|Death|6|||
125210018|NCT01211483|450393740|FG001|Phase 1b|Death|0|||
125210019|NCT01211483|450393741|FG002|Phase 1b|Death|0|||
125210020|NCT01211483|450393742|FG003|Phase 1b|Death|0|||
125210021|NCT01211483|450393739|FG000|Phase 1b|Withdrawal by Subject|1|||
125210022|NCT01211483|450393740|FG001|Phase 1b|Withdrawal by Subject|0|||
125210023|NCT01211483|450393741|FG002|Phase 1b|Withdrawal by Subject|0|||
125210024|NCT01211483|450393742|FG003|Phase 1b|Withdrawal by Subject|0|||
125210025|NCT01211483|450393739|FG000|Phase 2|Lost to Follow-up|0|||
125210026|NCT01211483|450393740|FG001|Phase 2|Lost to Follow-up|1|||
125210027|NCT01211483|450393741|FG002|Phase 2|Lost to Follow-up|1|||
125210028|NCT01211483|450393742|FG003|Phase 2|Lost to Follow-up|2|||
125210029|NCT01211483|450393739|FG000|Phase 2|Death|0|||
125210030|NCT01211483|450393740|FG001|Phase 2|Death|64|||
125210031|NCT01211483|450393741|FG002|Phase 2|Death|53|||
125210032|NCT01211483|450393742|FG003|Phase 2|Death|53|||
125210033|NCT01211483|450393739|FG000|Phase 2|Withdrawal by Subject|0|||
125210034|NCT01211483|450393740|FG001|Phase 2|Withdrawal by Subject|1|||
125210035|NCT01211483|450393741|FG002|Phase 2|Withdrawal by Subject|10|||
125210036|NCT01211483|450393742|FG003|Phase 2|Withdrawal by Subject|5|||
125210037|NCT01211483|450393739|FG000|Phase 2|Study terminated by Sponsor|0|||
125210038|NCT01211483|450393740|FG001|Phase 2|Study terminated by Sponsor|6|||
125210039|NCT01211483|450393741|FG002|Phase 2|Study terminated by Sponsor|8|||
125210040|NCT01211483|450393742|FG003|Phase 2|Study terminated by Sponsor|11|||
125210041|NCT01398410|450393744|FG000|Overall Study|Adverse Event|12|||
125210042|NCT01398410|450393745|FG001|Overall Study|Adverse Event|16|||
125210043|NCT01398410|450393744|FG000|Overall Study|Participants Choice|8|||
125210044|NCT01398410|450393745|FG001|Overall Study|Participants Choice|11|||
125210045|NCT01398410|450393744|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
125210046|NCT01398410|450393745|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
125210047|NCT01398410|450393744|FG000|Overall Study|Other|36|||
125210048|NCT01398410|450393745|FG001|Overall Study|Other|29|||
125210049|NCT04245202|450393746|FG000|Overall Study|Lack of Efficacy|10|||
125210050|NCT04245202|450393747|FG001|Overall Study|Lack of Efficacy|1|||
125210051|NCT02470403|450393748|FG000|Overall Study|Adverse Event|1|||
125210052|NCT02470403|450393749|FG001|Overall Study|Adverse Event|0|||
125210053|NCT02470403|450393750|FG002|Overall Study|Adverse Event|0|||
125210054|NCT02470403|450393751|FG003|Overall Study|Adverse Event|0|||
125210055|NCT02470403|450393752|FG004|Overall Study|Adverse Event|0|||
125210056|NCT02470403|450393748|FG000|Overall Study|Lost to Follow-up|0|||
125540090|NCT01394978|451605895|FG000|Overall Study|Withdrawal by Subject|2|||
125540091|NCT01394978|451605896|FG001|Overall Study|Withdrawal by Subject|4|||
125540092|NCT01394978|451605895|FG000|Overall Study|Lost to Follow-up|13|||
125540093|NCT01394978|451605896|FG001|Overall Study|Lost to Follow-up|20|||
125540094|NCT01394978|451605895|FG000|Overall Study|Death|6|||
125540095|NCT01394978|451605896|FG001|Overall Study|Death|7|||
125540096|NCT01081132|451605897|FG000|Overall Study|Lack of Efficacy|25|||
125540097|NCT01081132|451605898|FG001|Overall Study|Lack of Efficacy|9|||
125540098|NCT01081132|451605897|FG000|Overall Study|Withdrawal by Subject|13|||
125540099|NCT01081132|451605898|FG001|Overall Study|Withdrawal by Subject|16|||
125540100|NCT01081132|451605897|FG000|Overall Study|Lost to Follow-up|4|||
125424929|NCT00689221|451178725|FG000|Overall Study|Ongoing at cut-off date|39|||
125210057|NCT02470403|450393749|FG001|Overall Study|Lost to Follow-up|1|||
125210058|NCT02470403|450393750|FG002|Overall Study|Lost to Follow-up|0|||
125210059|NCT02470403|450393751|FG003|Overall Study|Lost to Follow-up|0|||
125210060|NCT02470403|450393752|FG004|Overall Study|Lost to Follow-up|0|||
125210061|NCT02470403|450393748|FG000|Overall Study|Subject/guardian decision|1|||
125210062|NCT02470403|450393749|FG001|Overall Study|Subject/guardian decision|0|||
125210063|NCT02470403|450393750|FG002|Overall Study|Subject/guardian decision|0|||
125210064|NCT02470403|450393751|FG003|Overall Study|Subject/guardian decision|4|||
125210065|NCT02470403|450393752|FG004|Overall Study|Subject/guardian decision|0|||
125210066|NCT00904839|450393759|FG000|Overall Study|Adverse Event|0|||
125210067|NCT00904839|450393760|FG001|Overall Study|Adverse Event|5|||
125210068|NCT00904839|450393761|FG002|Overall Study|Adverse Event|4|||
125210069|NCT00904839|450393759|FG000|Overall Study|Protocol Violation|0|||
125210070|NCT00904839|450393760|FG001|Overall Study|Protocol Violation|1|||
125210071|NCT00904839|450393761|FG002|Overall Study|Protocol Violation|1|||
125210072|NCT00904839|450393759|FG000|Overall Study|Lost to Follow-up|0|||
125210073|NCT00904839|450393760|FG001|Overall Study|Lost to Follow-up|1|||
125210074|NCT00904839|450393761|FG002|Overall Study|Lost to Follow-up|2|||
125210075|NCT00904839|450393759|FG000|Overall Study|Withdrawal by Subject|0|||
125210076|NCT00904839|450393760|FG001|Overall Study|Withdrawal by Subject|2|||
125210077|NCT00904839|450393761|FG002|Overall Study|Withdrawal by Subject|0|||
125210078|NCT00904839|450393759|FG000|Overall Study|Not treated|1|||
125210079|NCT00904839|450393760|FG001|Overall Study|Not treated|0|||
125210080|NCT00904839|450393761|FG002|Overall Study|Not treated|1|||
125210081|NCT00904839|450393759|FG000|Overall Study|Other than above|0|||
125210082|NCT00904839|450393760|FG001|Overall Study|Other than above|9|||
125210083|NCT00904839|450393761|FG002|Overall Study|Other than above|7|||
125210084|NCT01430624|450393762|FG000|Overall Study|Lost to Follow-up|23|||
125210085|NCT01430624|450393763|FG001|Overall Study|Lost to Follow-up|29|||
125210086|NCT01430624|450393764|FG002|Overall Study|Lost to Follow-up|27|||
125210087|NCT01430624|450393762|FG000|Overall Study|technical or eligibility|5|||
125210088|NCT01430624|450393763|FG001|Overall Study|technical or eligibility|5|||
125210089|NCT01430624|450393764|FG002|Overall Study|technical or eligibility|2|||
125210090|NCT01167634|450393769|FG000|Overall Study|Lost to Follow-up|1|||
125210091|NCT01167634|450393770|FG001|Overall Study|Lost to Follow-up|3|||
125210092|NCT01167634|450393771|FG002|Overall Study|Lost to Follow-up|3|||
125210093|NCT01167634|450393772|FG003|Overall Study|Lost to Follow-up|4|||
125210094|NCT01167634|450393769|FG000|Overall Study|Withdrawal by Subject|1|||
125210095|NCT01167634|450393770|FG001|Overall Study|Withdrawal by Subject|1|||
125210096|NCT01167634|450393771|FG002|Overall Study|Withdrawal by Subject|0|||
125210097|NCT01167634|450393772|FG003|Overall Study|Withdrawal by Subject|0|||
125210098|NCT00553358|450393773|FG000|Overall Study|Randomized but did not receive treatment|3|||
125424930|NCT00689221|451178726|FG001|Overall Study|Ongoing at cut-off date|36|||
125424931|NCT01749982|451178727|FG000|Overall Study|Physician Decision|0|||
125424932|NCT01749982|451178728|FG001|Overall Study|Physician Decision|0|||
125424933|NCT01749982|451178729|FG002|Overall Study|Physician Decision|0|||
125424934|NCT01749982|451178730|FG003|Overall Study|Physician Decision|1|||
125424935|NCT01749982|451178727|FG000|Overall Study|Lost to Follow-up|0|||
125424936|NCT01749982|451178728|FG001|Overall Study|Lost to Follow-up|0|||
125424937|NCT01749982|451178729|FG002|Overall Study|Lost to Follow-up|0|||
125424938|NCT01749982|451178730|FG003|Overall Study|Lost to Follow-up|1|||
125424939|NCT01749982|451178727|FG000|Overall Study|Withdrawal by Subject|0|||
125424940|NCT01749982|451178728|FG001|Overall Study|Withdrawal by Subject|0|||
125424941|NCT01749982|451178729|FG002|Overall Study|Withdrawal by Subject|0|||
125424942|NCT01749982|451178730|FG003|Overall Study|Withdrawal by Subject|1|||
125424943|NCT01596582|451178732|FG000|Overall Study|Deemed ineligible after study visit|3|||
125424944|NCT01596582|451178733|FG001|Overall Study|Deemed ineligible after study visit|6|||
125424945|NCT01596582|451178732|FG000|Overall Study|Missing all outcome data|1|||
125424946|NCT01596582|451178733|FG001|Overall Study|Missing all outcome data|1|||
125424947|NCT04435665|451178734|FG000|Overall Study|Lost to Follow-up|0|||
125424948|NCT04435665|451178735|FG001|Overall Study|Lost to Follow-up|0|||
125424949|NCT04435665|451178736|FG002|Overall Study|Lost to Follow-up|0|||
125424950|NCT04435665|451178737|FG003|Overall Study|Lost to Follow-up|1|||
125424951|NCT03923933|451178741|FG000|Overall Study|Lost to Follow-up|1|||
125424952|NCT03923933|451178742|FG001|Overall Study|Lost to Follow-up|0|||
125424953|NCT03923933|451178741|FG000|Overall Study|Withdrawal by Subject|0|||
125424954|NCT03923933|451178742|FG001|Overall Study|Withdrawal by Subject|1|||
125210099|NCT00553358|450393774|FG001|Overall Study|Randomized but did not receive treatment|3|||
125210100|NCT00553358|450393775|FG002|Overall Study|Randomized but did not receive treatment|1|||
125210101|NCT00553358|450393773|FG000|Overall Study|Lost to Follow-up|22|||
125210102|NCT00553358|450393774|FG001|Overall Study|Lost to Follow-up|26|||
125210103|NCT00553358|450393775|FG002|Overall Study|Lost to Follow-up|18|||
125210104|NCT00553358|450393773|FG000|Overall Study|Withdrew completely|23|||
125210105|NCT00553358|450393774|FG001|Overall Study|Withdrew completely|33|||
125424955|NCT02454101|451178743|FG000|Overall Study|Adverse Event|2|||
125424956|NCT02454101|451178744|FG001|Overall Study|Adverse Event|3|||
125424957|NCT02454101|451178743|FG000|Overall Study|Lost to Follow-up|3|||
125210106|NCT00553358|450393775|FG002|Overall Study|Withdrew completely|34|||
125210107|NCT00553358|450393773|FG000|Overall Study|Died during clinical follow-up|25|||
125210108|NCT00553358|450393774|FG001|Overall Study|Died during clinical follow-up|29|||
125210109|NCT00553358|450393775|FG002|Overall Study|Died during clinical follow-up|32|||
125210110|NCT00553358|450393773|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
125210111|NCT00553358|450393774|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
125210112|NCT00553358|450393775|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
125210113|NCT00553358|450393773|FG000|Overall Study|Died after clinical follow-up ended|1|||
125210114|NCT00553358|450393774|FG001|Overall Study|Died after clinical follow-up ended|2|||
125210115|NCT00553358|450393775|FG002|Overall Study|Died after clinical follow-up ended|0|||
125210116|NCT00553358|450393773|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
125210117|NCT00553358|450393774|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
125210118|NCT00553358|450393775|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
125210119|NCT01074255|450393780|FG000|Overall Study|Did not receive EMEND|2|||
125210120|NCT02943785|450393781|FG000|Overall Study|Adverse Event|112|||
125210121|NCT02943785|450393782|FG001|Overall Study|Adverse Event|97|||
125210122|NCT02943785|450393781|FG000|Overall Study|Withdrawal by Subject|63|||
125210123|NCT02943785|450393782|FG001|Overall Study|Withdrawal by Subject|126|||
125210124|NCT02943785|450393781|FG000|Overall Study|Physician Decision|23|||
125210125|NCT02943785|450393782|FG001|Overall Study|Physician Decision|47|||
125210126|NCT02943785|450393781|FG000|Overall Study|Death|46|||
125210127|NCT02943785|450393782|FG001|Overall Study|Death|46|||
125210128|NCT02943785|450393781|FG000|Overall Study|Lost to Follow-up|1|||
125210129|NCT02943785|450393782|FG001|Overall Study|Lost to Follow-up|0|||
125210130|NCT02943785|450393781|FG000|Overall Study|Other|16|||
125210131|NCT02943785|450393782|FG001|Overall Study|Other|19|||
125210132|NCT02943785|450393781|FG000|Overall Study|Did not receive any study medication|21|||
125210133|NCT02943785|450393782|FG001|Overall Study|Did not receive any study medication|28|||
125210134|NCT01281956|450393785|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
125210135|NCT01281956|450393786|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
125210136|NCT03170609|450393787|FG000|Overall Study|Death|0|||
125210137|NCT03170609|450393788|FG001|Overall Study|Death|0|||
125210138|NCT03170609|450393789|FG002|Overall Study|Death|1|||
125210139|NCT03170609|450393790|FG003|Overall Study|Death|0|||
125210140|NCT03170609|450393791|FG004|Overall Study|Death|0|||
125210141|NCT03170609|450393792|FG005|Overall Study|Death|0|||
125210142|NCT03170609|450393793|FG006|Overall Study|Death|0|||
125210143|NCT03170609|450393787|FG000|Overall Study|Withdrawal by Subject|1|||
125210144|NCT03170609|450393788|FG001|Overall Study|Withdrawal by Subject|2|||
125210145|NCT03170609|450393789|FG002|Overall Study|Withdrawal by Subject|0|||
125210146|NCT03170609|450393790|FG003|Overall Study|Withdrawal by Subject|0|||
125210147|NCT03170609|450393791|FG004|Overall Study|Withdrawal by Subject|0|||
125210148|NCT03170609|450393792|FG005|Overall Study|Withdrawal by Subject|0|||
125210149|NCT03170609|450393793|FG006|Overall Study|Withdrawal by Subject|1|||
125210150|NCT03170609|450393787|FG000|Overall Study|Lost to Follow-up|1|||
125210151|NCT03170609|450393788|FG001|Overall Study|Lost to Follow-up|0|||
125210152|NCT03170609|450393789|FG002|Overall Study|Lost to Follow-up|5|||
125210153|NCT03170609|450393790|FG003|Overall Study|Lost to Follow-up|2|||
125210154|NCT03170609|450393791|FG004|Overall Study|Lost to Follow-up|1|||
125210155|NCT03170609|450393792|FG005|Overall Study|Lost to Follow-up|1|||
125210156|NCT03170609|450393793|FG006|Overall Study|Lost to Follow-up|0|||
125210157|NCT03170609|450393787|FG000|Overall Study|Other|1|||
125210158|NCT03170609|450393788|FG001|Overall Study|Other|0|||
125210159|NCT03170609|450393789|FG002|Overall Study|Other|0|||
125210160|NCT03170609|450393790|FG003|Overall Study|Other|0|||
125210161|NCT03170609|450393791|FG004|Overall Study|Other|0|||
125210162|NCT03170609|450393792|FG005|Overall Study|Other|1|||
125210163|NCT03170609|450393793|FG006|Overall Study|Other|0|||
125210164|NCT01490697|450393795|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
125210165|NCT01490697|450393796|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
125210166|NCT00090584|450393797|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
125210167|NCT00090584|450393798|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
125210168|NCT00090584|450393797|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
125210169|NCT00090584|450393798|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
125210170|NCT00270231|450393799|FG000|First Intervention|Lost to Follow-up|1|||
125210171|NCT00270231|450393800|FG001|First Intervention|Lost to Follow-up|1|||
125210172|NCT00270231|450393799|FG000|Washout Period|Lost to Follow-up|1|||
125210173|NCT00270231|450393800|FG001|Washout Period|Lost to Follow-up|0|||
125210174|NCT00270231|450393799|FG000|Second Intervention|Lost to Follow-up|0|||
125210175|NCT00270231|450393800|FG001|Second Intervention|Lost to Follow-up|1|||
125210176|NCT01969084|450393801|FG000|Overall Study|Adverse Event|0|||
125210177|NCT01969084|450393802|FG001|Overall Study|Adverse Event|1|||
125210178|NCT04776018|450393805|FG000|Overall Study|Death|0|||
125210179|NCT04776018|450393806|FG001|Overall Study|Death|1|||
125210180|NCT04776018|450393807|FG002|Overall Study|Death|4|||
125210181|NCT04776018|450393808|FG003|Overall Study|Death|1|||
125210182|NCT04776018|450393809|FG004|Overall Study|Death|4|||
125210183|NCT04776018|450393810|FG005|Overall Study|Death|0|||
125210184|NCT04776018|450393811|FG006|Overall Study|Death|0|||
125210185|NCT04776018|450393805|FG000|Overall Study|Study terminated by sponsor|2|||
125210186|NCT04776018|450393806|FG001|Overall Study|Study terminated by sponsor|1|||
125210187|NCT04776018|450393807|FG002|Overall Study|Study terminated by sponsor|4|||
125210188|NCT04776018|450393808|FG003|Overall Study|Study terminated by sponsor|0|||
125210189|NCT04776018|450393809|FG004|Overall Study|Study terminated by sponsor|3|||
125210190|NCT04776018|450393810|FG005|Overall Study|Study terminated by sponsor|0|||
125210191|NCT04776018|450393811|FG006|Overall Study|Study terminated by sponsor|0|||
125210192|NCT04776018|450393805|FG000|Overall Study|Withdrawal by Subject|1|||
125210193|NCT04776018|450393806|FG001|Overall Study|Withdrawal by Subject|0|||
125210194|NCT04776018|450393807|FG002|Overall Study|Withdrawal by Subject|0|||
125210195|NCT04776018|450393808|FG003|Overall Study|Withdrawal by Subject|2|||
125210196|NCT04776018|450393809|FG004|Overall Study|Withdrawal by Subject|1|||
125210197|NCT04776018|450393810|FG005|Overall Study|Withdrawal by Subject|0|||
125210198|NCT04776018|450393811|FG006|Overall Study|Withdrawal by Subject|0|||
125210199|NCT04776018|450393805|FG000|Overall Study|Other|0|||
125210200|NCT04776018|450393806|FG001|Overall Study|Other|1|||
125210201|NCT04776018|450393807|FG002|Overall Study|Other|1|||
125210202|NCT04776018|450393808|FG003|Overall Study|Other|0|||
125210203|NCT04776018|450393809|FG004|Overall Study|Other|0|||
125210204|NCT04776018|450393810|FG005|Overall Study|Other|0|||
125210205|NCT04776018|450393811|FG006|Overall Study|Other|0|||
125210206|NCT04776018|450393805|FG000|Overall Study|Lost to Follow-up|0|||
125210207|NCT04776018|450393806|FG001|Overall Study|Lost to Follow-up|0|||
125210208|NCT04776018|450393807|FG002|Overall Study|Lost to Follow-up|1|||
125210209|NCT04776018|450393808|FG003|Overall Study|Lost to Follow-up|0|||
125210210|NCT04776018|450393809|FG004|Overall Study|Lost to Follow-up|0|||
125210211|NCT04776018|450393810|FG005|Overall Study|Lost to Follow-up|0|||
125210212|NCT04776018|450393811|FG006|Overall Study|Lost to Follow-up|0|||
125210213|NCT02908074|450393813|FG000|Overall Study|sponsor/ICON decision|0|||
125210214|NCT02908074|450393814|FG001|Overall Study|sponsor/ICON decision|0|||
125210215|NCT02908074|450393815|FG002|Overall Study|sponsor/ICON decision|1|||
125210216|NCT02908074|450393816|FG003|Overall Study|sponsor/ICON decision|0|||
125210217|NCT02908074|450393817|FG004|Overall Study|sponsor/ICON decision|0|||
125210218|NCT02908074|450393818|FG005|Overall Study|sponsor/ICON decision|0|||
125210219|NCT02908074|450393813|FG000|Overall Study|Protocol Violation|0|||
125210220|NCT02908074|450393814|FG001|Overall Study|Protocol Violation|1|||
125210221|NCT02908074|450393815|FG002|Overall Study|Protocol Violation|0|||
125210222|NCT02908074|450393816|FG003|Overall Study|Protocol Violation|0|||
125210223|NCT02908074|450393817|FG004|Overall Study|Protocol Violation|0|||
125210224|NCT02908074|450393818|FG005|Overall Study|Protocol Violation|0|||
125210225|NCT02908074|450393813|FG000|Overall Study|Adverse Event|5|||
125210226|NCT02908074|450393814|FG001|Overall Study|Adverse Event|2|||
125210227|NCT02908074|450393815|FG002|Overall Study|Adverse Event|0|||
125210228|NCT02908074|450393816|FG003|Overall Study|Adverse Event|0|||
125210229|NCT02908074|450393817|FG004|Overall Study|Adverse Event|1|||
125210230|NCT02908074|450393818|FG005|Overall Study|Adverse Event|0|||
125210231|NCT02908074|450393813|FG000|Overall Study|AESI|1|||
125210232|NCT02908074|450393814|FG001|Overall Study|AESI|0|||
125210233|NCT02908074|450393815|FG002|Overall Study|AESI|1|||
125210234|NCT02908074|450393816|FG003|Overall Study|AESI|0|||
125210235|NCT02908074|450393817|FG004|Overall Study|AESI|1|||
125210236|NCT02908074|450393818|FG005|Overall Study|AESI|0|||
125210237|NCT02908074|450393813|FG000|Overall Study|Discontinuation criteria per protocol|0|||
125210238|NCT02908074|450393814|FG001|Overall Study|Discontinuation criteria per protocol|0|||
125210239|NCT02908074|450393815|FG002|Overall Study|Discontinuation criteria per protocol|1|||
125210240|NCT02908074|450393816|FG003|Overall Study|Discontinuation criteria per protocol|0|||
125210241|NCT02908074|450393817|FG004|Overall Study|Discontinuation criteria per protocol|0|||
125210242|NCT02908074|450393818|FG005|Overall Study|Discontinuation criteria per protocol|1|||
125210243|NCT02908074|450393813|FG000|Overall Study|Withdrawal by Subject|3|||
125210244|NCT02908074|450393814|FG001|Overall Study|Withdrawal by Subject|2|||
125210245|NCT02908074|450393815|FG002|Overall Study|Withdrawal by Subject|2|||
125210246|NCT02908074|450393816|FG003|Overall Study|Withdrawal by Subject|2|||
125210247|NCT02908074|450393817|FG004|Overall Study|Withdrawal by Subject|2|||
125210248|NCT02908074|450393818|FG005|Overall Study|Withdrawal by Subject|2|||
125210249|NCT02908074|450393813|FG000|Overall Study|Lost to Follow-up|0|||
125210250|NCT02908074|450393814|FG001|Overall Study|Lost to Follow-up|1|||
125210251|NCT02908074|450393815|FG002|Overall Study|Lost to Follow-up|1|||
125210252|NCT02908074|450393816|FG003|Overall Study|Lost to Follow-up|1|||
125210253|NCT02908074|450393817|FG004|Overall Study|Lost to Follow-up|0|||
125210254|NCT02908074|450393818|FG005|Overall Study|Lost to Follow-up|1|||
125210255|NCT02655419|450393823|FG000|Overall Study|Enrolled but not treated|1|||
125210256|NCT02655419|450393824|FG001|Overall Study|Enrolled but not treated|5|||
125210257|NCT02655419|450393823|FG000|Overall Study|Withdrawal by Subject|4|||
125210258|NCT02655419|450393824|FG001|Overall Study|Withdrawal by Subject|1|||
125210259|NCT02655419|450393823|FG000|Overall Study|Other|0|||
125210260|NCT02655419|450393824|FG001|Overall Study|Other|1|||
125424958|NCT02454101|451178744|FG001|Overall Study|Lost to Follow-up|4|||
125210261|NCT03053427|450393825|FG000|Overall Study|Adverse Event|4|||
125210262|NCT03053427|450393826|FG001|Overall Study|Adverse Event|4|||
125210263|NCT03053427|450393825|FG000|Overall Study|Lack of Efficacy|1|||
125210264|NCT03053427|450393826|FG001|Overall Study|Lack of Efficacy|3|||
125210265|NCT03053427|450393825|FG000|Overall Study|Lost to Follow-up|2|||
125210266|NCT03053427|450393826|FG001|Overall Study|Lost to Follow-up|2|||
125210267|NCT03053427|450393825|FG000|Overall Study|Worsening of the target disease|0|||
125210268|NCT03053427|450393826|FG001|Overall Study|Worsening of the target disease|1|||
125210269|NCT03053427|450393825|FG000|Overall Study|Protocol Deviation|3|||
125210270|NCT03053427|450393826|FG001|Overall Study|Protocol Deviation|3|||
125210271|NCT03053427|450393825|FG000|Overall Study|Withdrawal by Subject|3|||
125210272|NCT03053427|450393826|FG001|Overall Study|Withdrawal by Subject|2|||
125210273|NCT03053427|450393825|FG000|Overall Study|Miscellaneous|0|||
125210274|NCT03053427|450393826|FG001|Overall Study|Miscellaneous|1|||
125210275|NCT02172040|450393827|FG000|Overall Study|Adverse Event|0|||
125210276|NCT02172040|450393828|FG001|Overall Study|Adverse Event|2|||
125210277|NCT02172040|450393829|FG002|Overall Study|Adverse Event|0|||
125210278|NCT02172040|450393830|FG003|Overall Study|Adverse Event|0|||
125210279|NCT02172040|450393827|FG000|Overall Study|Protocol Violation|0|||
125210280|NCT02172040|450393828|FG001|Overall Study|Protocol Violation|1|||
125210281|NCT02172040|450393829|FG002|Overall Study|Protocol Violation|0|||
125210282|NCT02172040|450393830|FG003|Overall Study|Protocol Violation|0|||
125210283|NCT02172040|450393827|FG000|Overall Study|Withdrawal by Subject|0|||
125210284|NCT02172040|450393828|FG001|Overall Study|Withdrawal by Subject|0|||
125210285|NCT02172040|450393829|FG002|Overall Study|Withdrawal by Subject|1|||
125210286|NCT02172040|450393830|FG003|Overall Study|Withdrawal by Subject|0|||
125210287|NCT02172040|450393827|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
125210288|NCT02172040|450393828|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
125210289|NCT02172040|450393829|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
125210290|NCT02172040|450393830|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
125210291|NCT02172040|450393827|FG000|Overall Study|Family emergency abroad|0|||
125210292|NCT02172040|450393828|FG001|Overall Study|Family emergency abroad|0|||
125210293|NCT02172040|450393829|FG002|Overall Study|Family emergency abroad|0|||
125210294|NCT02172040|450393830|FG003|Overall Study|Family emergency abroad|1|||
125210295|NCT02607306|450393833|FG000|Overall Study|Adverse Event|8|||
125210296|NCT02607306|450393834|FG001|Overall Study|Adverse Event|6|||
125210297|NCT02607306|450393835|FG002|Overall Study|Adverse Event|6|||
125210298|NCT02607306|450393833|FG000|Overall Study|Unclassified|1|||
125210299|NCT02607306|450393834|FG001|Overall Study|Unclassified|4|||
125210300|NCT02607306|450393835|FG002|Overall Study|Unclassified|0|||
125540101|NCT01081132|451605898|FG001|Overall Study|Lost to Follow-up|11|||
125540102|NCT01081132|451605897|FG000|Overall Study|Adverse Event|3|||
125540103|NCT01081132|451605898|FG001|Overall Study|Adverse Event|9|||
125540104|NCT01081132|451605897|FG000|Overall Study|Non Compliance|4|||
125540105|NCT01081132|451605898|FG001|Overall Study|Non Compliance|2|||
125540106|NCT01081132|451605897|FG000|Overall Study|Lack Of Compliance|0|||
125540107|NCT01081132|451605898|FG001|Overall Study|Lack Of Compliance|1|||
125540108|NCT01081132|451605897|FG000|Overall Study|Missed Visits|1|||
125540109|NCT01081132|451605898|FG001|Overall Study|Missed Visits|1|||
125540110|NCT01081132|451605897|FG000|Overall Study|Stopped Taking Meds|2|||
125540111|NCT01081132|451605898|FG001|Overall Study|Stopped Taking Meds|0|||
125540112|NCT01081132|451605897|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
125540113|NCT01081132|451605898|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
125540114|NCT01081132|451605897|FG000|Overall Study|Declined Taper Phase|0|||
125540115|NCT01081132|451605898|FG001|Overall Study|Declined Taper Phase|1|||
125540116|NCT01081132|451605897|FG000|Overall Study|Protocol Violation|3|||
125540117|NCT01081132|451605898|FG001|Overall Study|Protocol Violation|1|||
125540118|NCT02101385|451605901|FG000|Study Treatment|Disease Progression|9|||
125540119|NCT02101385|451605902|FG001|Study Treatment|Disease Progression|3|||
125540120|NCT02101385|451605901|FG000|Study Treatment|Alternative therapy|0|||
125540121|NCT02101385|451605902|FG001|Study Treatment|Alternative therapy|1|||
125540122|NCT02101385|451605901|FG000|Study Treatment|No treatment, per protocol criteria|0|||
125540123|NCT02101385|451605902|FG001|Study Treatment|No treatment, per protocol criteria|4|||
125540124|NCT02101385|451605901|FG000|Study Treatment|Patient Non compliance|0|||
125540125|NCT02101385|451605902|FG001|Study Treatment|Patient Non compliance|2|||
125540126|NCT02101385|451605901|FG000|Study Treatment|Withdrawal by Subject|5|||
125540127|NCT02101385|451605902|FG001|Study Treatment|Withdrawal by Subject|2|||
125540128|NCT02101385|451605901|FG000|Study Treatment|screen failure|1|||
125540129|NCT02101385|451605902|FG001|Study Treatment|screen failure|0|||
125540130|NCT02101385|451605901|FG000|Study Treatment|AE/Side Effects/Complications|8|||
125540131|NCT02101385|451605902|FG001|Study Treatment|AE/Side Effects/Complications|0|||
125540132|NCT02101385|451605901|FG000|Study Treatment|Lost to Follow-up|1|||
125540133|NCT02101385|451605902|FG001|Study Treatment|Lost to Follow-up|0|||
125540134|NCT02101385|451605901|FG000|Study Treatment|Disease Progression before treatment|1|||
125540135|NCT02101385|451605902|FG001|Study Treatment|Disease Progression before treatment|0|||
125540136|NCT02101385|451605901|FG000|Study Treatment|Death|1|||
125210301|NCT02607306|450393833|FG000|Overall Study|Withdrawal by Subject|8|||
125210302|NCT02607306|450393834|FG001|Overall Study|Withdrawal by Subject|10|||
125210303|NCT02607306|450393835|FG002|Overall Study|Withdrawal by Subject|2|||
125210304|NCT02607306|450393833|FG000|Overall Study|Lack of Efficacy|0|||
125210305|NCT02607306|450393834|FG001|Overall Study|Lack of Efficacy|1|||
125210306|NCT02607306|450393835|FG002|Overall Study|Lack of Efficacy|1|||
125210307|NCT02607306|450393833|FG000|Overall Study|Protocol Violation|4|||
125210308|NCT02607306|450393834|FG001|Overall Study|Protocol Violation|2|||
125210309|NCT02607306|450393835|FG002|Overall Study|Protocol Violation|1|||
125210310|NCT03759366|450393836|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
125210311|NCT03759366|450393836|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
125210312|NCT03759366|450393836|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
125210313|NCT03759366|450393836|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
125210314|NCT03759366|450393836|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
125210315|NCT03759366|450393836|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
125210316|NCT03759366|450393836|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
125210317|NCT00597012|450393837|FG000|Overall Study|Death|1|||
125210318|NCT00597012|450393838|FG001|Overall Study|Death|1|||
125210319|NCT00597012|450393837|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
125210320|NCT00597012|450393838|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
125210321|NCT00597012|450393837|FG000|Overall Study|Withdrawal by Subject|7|||
125210322|NCT00597012|450393838|FG001|Overall Study|Withdrawal by Subject|4|||
125210323|NCT00597012|450393837|FG000|Overall Study|Ineligible|2|||
125210324|NCT00597012|450393838|FG001|Overall Study|Ineligible|0|||
125210325|NCT00597012|450393837|FG000|Overall Study|Lost to Follow-up|0|||
125210326|NCT00597012|450393838|FG001|Overall Study|Lost to Follow-up|2|||
125210327|NCT04226495|450393839|FG000|Overall Study|Withdrawal by Subject|3|||
125210328|NCT04226495|450393840|FG001|Overall Study|Withdrawal by Subject|3|||
125210329|NCT04226495|450393839|FG000|Overall Study|PI discretion|3|||
125210330|NCT04226495|450393840|FG001|Overall Study|PI discretion|4|||
125210331|NCT00583102|450393841|FG000|Overall Study|Adverse Event|3|||
125210332|NCT00505661|450393844|FG000|Overall Study|Not Eligible|4|||
125210333|NCT03611582|450393845|FG000|Overall Study|Adverse Event|26|||
125210334|NCT03611582|450393846|FG001|Overall Study|Adverse Event|6|||
125210335|NCT03611582|450393845|FG000|Overall Study|Protocol Violation|0|||
125210336|NCT03611582|450393846|FG001|Overall Study|Protocol Violation|1|||
125210337|NCT03611582|450393845|FG000|Overall Study|Pregnancy|1|||
125210338|NCT03611582|450393846|FG001|Overall Study|Pregnancy|2|||
125210339|NCT03611582|450393845|FG000|Overall Study|Lack of Efficacy|0|||
125210340|NCT03611582|450393846|FG001|Overall Study|Lack of Efficacy|1|||
125210341|NCT03611582|450393845|FG000|Overall Study|At the discretion of the investigator|1|||
125210342|NCT03611582|450393846|FG001|Overall Study|At the discretion of the investigator|0|||
125210343|NCT03611582|450393845|FG000|Overall Study|Safety concern as judged by the investigator|1|||
125210344|NCT03611582|450393846|FG001|Overall Study|Safety concern as judged by the investigator|2|||
125210345|NCT03611582|450393845|FG000|Overall Study|Withdrawal by Subject|4|||
125210346|NCT03611582|450393846|FG001|Overall Study|Withdrawal by Subject|3|||
125210347|NCT03611582|450393845|FG000|Overall Study|Lost to Follow-up|18|||
125210348|NCT03611582|450393846|FG001|Overall Study|Lost to Follow-up|7|||
125210349|NCT03611582|450393845|FG000|Overall Study|other|17|||
125210350|NCT03611582|450393846|FG001|Overall Study|other|16|||
125210351|NCT04459598|450393847|FG000|Overall Study|Adverse Event|1|||
125210352|NCT04459598|450393848|FG001|Overall Study|Adverse Event|1|||
125210353|NCT01078298|450393849|FG000|Overall Study|Lost to Follow-up|12|||
125210354|NCT01078298|450393850|FG001|Overall Study|Lost to Follow-up|13|||
125210355|NCT01078298|450393849|FG000|Overall Study|Withdrawal by Subject|31|||
125210356|NCT01078298|450393850|FG001|Overall Study|Withdrawal by Subject|33|||
125210357|NCT01078298|450393849|FG000|Overall Study|Protocol Violation|6|||
125210358|NCT01078298|450393850|FG001|Overall Study|Protocol Violation|6|||
125210359|NCT01078298|450393849|FG000|Overall Study|Adverse Event|6|||
125210360|NCT01078298|450393850|FG001|Overall Study|Adverse Event|5|||
125210361|NCT01078298|450393849|FG000|Overall Study|Death|2|||
125210362|NCT01078298|450393850|FG001|Overall Study|Death|0|||
125210363|NCT01078298|450393849|FG000|Overall Study|Did not meet entrance criteria|0|||
125210364|NCT01078298|450393850|FG001|Overall Study|Did not meet entrance criteria|1|||
125210365|NCT01078298|450393849|FG000|Overall Study|Other|24|||
125210366|NCT01078298|450393850|FG001|Overall Study|Other|32|||
125210367|NCT00463840|450393851|FG000|Overall Study|Disease progression|7|||
125210368|NCT00463840|450393851|FG000|Overall Study|Withdrawal by Subject|2|||
125210369|NCT00463840|450393851|FG000|Overall Study|Adverse Event|3|||
125311764|NCT01279681|450768822|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
125311765|NCT01279681|450768823|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
125311766|NCT01279681|450768822|FG000|Overall Study|Physician Decision|1|||
125311767|NCT01279681|450768823|FG001|Overall Study|Physician Decision|0|||
125311768|NCT01279681|450768822|FG000|Overall Study|Other Reason|0|||
125311769|NCT01279681|450768823|FG001|Overall Study|Other Reason|2|||
125311770|NCT01467505|450770575|FG000|Overall Study|Adverse Event|1|||
125311771|NCT01467505|450770576|FG001|Overall Study|Adverse Event|0|||
125311772|NCT01467505|450770575|FG000|Overall Study|Withdrawal by Subject|4|||
125311773|NCT01467505|450770576|FG001|Overall Study|Withdrawal by Subject|0|||
125311774|NCT01467505|450770575|FG000|Overall Study|Study Terminated by Sponsor|28|||
125311775|NCT01467505|450770576|FG001|Overall Study|Study Terminated by Sponsor|3|||
125311776|NCT02807623|450770577|FG000|Overall Study|Lost to Follow-up|23|||
125311777|NCT02807623|450770578|FG001|Overall Study|Lost to Follow-up|18|||
125311778|NCT02807623|450770579|FG002|Overall Study|Lost to Follow-up|22|||
125311779|NCT02807623|450770577|FG000|Overall Study|Drug intolerance|0|||
125311780|NCT02807623|450770578|FG001|Overall Study|Drug intolerance|1|||
125311781|NCT02807623|450770579|FG002|Overall Study|Drug intolerance|0|||
125311782|NCT02807623|450770577|FG000|Overall Study|incomplete blood draw|0|||
125311783|NCT02807623|450770578|FG001|Overall Study|incomplete blood draw|2|||
125311784|NCT02807623|450770579|FG002|Overall Study|incomplete blood draw|1|||
125311785|NCT02098746|450770580|FG000|Overall Study|Changes of Investigator|2|||
125311786|NCT02098746|450770580|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125311787|NCT02098746|450770580|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
125311788|NCT02098746|450770580|FG000|Overall Study|Data Not Available After Treatment|1|||
125311789|NCT00217425|450770581|FG000|Overall Study|Never started treatment|2|||
125311790|NCT00217425|450770581|FG000|Overall Study|Patient ineligible|5|||
125311791|NCT00217425|450770581|FG000|Overall Study|Lack of Efficacy|13|||
125311792|NCT00217425|450770581|FG000|Overall Study|Adverse Event|8|||
125311793|NCT00217425|450770581|FG000|Overall Study|Withdrawal by Subject|4|||
125311794|NCT00217425|450770581|FG000|Overall Study|Other complicating disease|1|||
125311795|NCT00217425|450770581|FG000|Overall Study|Other|4|||
125311796|NCT00086047|450770584|FG000|Overall Study|Lost to Follow-up|7|||
125424959|NCT00419263|451178745|FG000|Overall Study|Lost to Follow-up|2|||
125424960|NCT00419263|451178746|FG001|Overall Study|Lost to Follow-up|1|||
125424961|NCT00419263|451178747|FG002|Overall Study|Lost to Follow-up|1|||
125424962|NCT00419263|451178745|FG000|Overall Study|Randomized in Error, Not Treated|1|||
125424963|NCT00419263|451178746|FG001|Overall Study|Randomized in Error, Not Treated|1|||
125311797|NCT00086047|450770585|FG001|Overall Study|Lost to Follow-up|6|||
125424964|NCT00419263|451178747|FG002|Overall Study|Randomized in Error, Not Treated|0|||
125424965|NCT00419263|451178745|FG000|Overall Study|Adverse Event|0|||
125424966|NCT00419263|451178746|FG001|Overall Study|Adverse Event|0|||
125424967|NCT00419263|451178747|FG002|Overall Study|Adverse Event|1|||
125424968|NCT00419263|451178745|FG000|Overall Study|Withdrawal by Subject|0|||
125424969|NCT00419263|451178746|FG001|Overall Study|Withdrawal by Subject|0|||
125424970|NCT00419263|451178747|FG002|Overall Study|Withdrawal by Subject|1|||
125424971|NCT03311373|451178748|FG000|Overall Study|Adverse Event|1|||
125424972|NCT03311373|451178748|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
125424973|NCT03311373|451178748|FG000|Overall Study|Lost to Follow-up|1|||
125424974|NCT03311373|451178748|FG000|Overall Study|Physician Decision|1|||
125424975|NCT03311373|451178748|FG000|Overall Study|Withdrawal by Subject|3|||
125424976|NCT01563536|451178750|FG000|Overall Study|Withdrawal by Subject|0|||
125424977|NCT01563536|451178751|FG001|Overall Study|Withdrawal by Subject|2|||
125424978|NCT01563536|451178750|FG000|Overall Study|Lost to Follow-up|1|||
125424979|NCT01563536|451178751|FG001|Overall Study|Lost to Follow-up|0|||
125424980|NCT00538590|451178762|FG000|Overall Study|Death|1|||
125424981|NCT00538590|451178763|FG001|Overall Study|Death|0|||
125424982|NCT01256567|451178764|FG000|Overall Study|Withdrawal by Subject|1|||
125424983|NCT00671931|451178772|FG000|Overall Study|Physician Decision|1|||
125424984|NCT00671931|451178773|FG001|Overall Study|Physician Decision|0|||
125424985|NCT00671931|451178774|FG002|Overall Study|Physician Decision|0|||
125424986|NCT00671931|451178775|FG003|Overall Study|Physician Decision|2|||
125424987|NCT00671931|451178776|FG004|Overall Study|Physician Decision|1|||
125424988|NCT02925676|451178777|FG000|Overall Study|Withdrawal by Subject|1|||
125424989|NCT03260868|451178778|FG000|Overall Study|Poor Compliance to Protocol|0|||
125424990|NCT03260868|451178779|FG001|Overall Study|Poor Compliance to Protocol|2|||
125424991|NCT03260868|451178778|FG000|Overall Study|Study Terminated By Sponsor|2|||
125424992|NCT03260868|451178779|FG001|Overall Study|Study Terminated By Sponsor|1|||
125424993|NCT03260868|451178778|FG000|Overall Study|Other than specified above|1|||
125424994|NCT03260868|451178779|FG001|Overall Study|Other than specified above|0|||
125424995|NCT00541450|451178780|FG000|Phase A|Adverse Event|3|||
125424996|NCT00541450|451178781|FG001|Phase A|Adverse Event|0|||
125424997|NCT00541450|451178780|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
125424998|NCT00541450|451178781|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
125311798|NCT00086047|450770584|FG000|Overall Study|Physician Decision|0|||
125311799|NCT00086047|450770585|FG001|Overall Study|Physician Decision|1|||
125424999|NCT00541450|451178780|FG000|Phase A|Hyperglycemia|0|||
125425000|NCT00541450|451178781|FG001|Phase A|Hyperglycemia|1|||
125425001|NCT00541450|451178780|FG000|Phase A|Lost to Follow-up|6|||
125311800|NCT02471014|450770586|FG000|Overall Study|Lost to Follow-up|2|||
125311801|NCT02471014|450770587|FG001|Overall Study|Lost to Follow-up|2|||
125311802|NCT04640311|450770588|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
125311803|NCT04640311|450770589|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311804|NCT04640311|450770590|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125425002|NCT00541450|451178781|FG001|Phase A|Lost to Follow-up|4|||
125425003|NCT00541450|451178780|FG000|Phase A|Physician Decision|2|||
125425004|NCT00541450|451178781|FG001|Phase A|Physician Decision|0|||
125425005|NCT00541450|451178780|FG000|Phase A|Protocol Violation|2|||
125425006|NCT00541450|451178781|FG001|Phase A|Protocol Violation|3|||
125425007|NCT00541450|451178780|FG000|Phase A|Withdrawal by Subject|7|||
125425008|NCT00541450|451178781|FG001|Phase A|Withdrawal by Subject|7|||
125311805|NCT04640311|450770591|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125540137|NCT02101385|451605902|FG001|Study Treatment|Death|0|||
125540138|NCT02101385|451605901|FG000|Follow up|Lost to Follow-up|4|||
125540139|NCT02101385|451605902|FG001|Follow up|Lost to Follow-up|9|||
125540140|NCT02101385|451605901|FG000|Follow up|Refused to follow up|5|||
125540141|NCT02101385|451605902|FG001|Follow up|Refused to follow up|4|||
125540142|NCT02101385|451605901|FG000|Follow up|Death|21|||
125540143|NCT02101385|451605902|FG001|Follow up|Death|39|||
125540144|NCT02101385|451605901|FG000|Follow up|study completed|33|||
125540145|NCT02101385|451605902|FG001|Follow up|study completed|52|||
125540146|NCT02101385|451605901|FG000|Follow up|screen failure|2|||
125540147|NCT02101385|451605902|FG001|Follow up|screen failure|0|||
125540148|NCT02101385|451605901|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
125540149|NCT02101385|451605902|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
125540150|NCT02101385|451605901|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
125540151|NCT02101385|451605902|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
125540152|NCT02101385|451605901|FG000|Follow up|Withdrawal by Subject|2|||
125540153|NCT02101385|451605902|FG001|Follow up|Withdrawal by Subject|2|||
125540154|NCT02101385|451605901|FG000|Follow up|PI requested closure of site|0|||
125540155|NCT02101385|451605902|FG001|Follow up|PI requested closure of site|5|||
125540156|NCT02432196|451605903|FG000|Overall Study|Exit - did not receive study device|1|||
125540157|NCT02432196|451605903|FG000|Overall Study|Death|2|||
125540158|NCT02432196|451605903|FG000|Overall Study|Reoperation|3|||
125540159|NCT05038163|451605904|FG000|Stage 1|Did not complete survey|374|||
125540160|NCT05038163|451605905|FG001|Stage 1|Did not complete survey|0|||
125540161|NCT05038163|451605906|FG002|Stage 1|Did not complete survey|0|||
125540162|NCT05038163|451605907|FG003|Stage 1|Did not complete survey|0|||
125540163|NCT05038163|451605908|FG004|Stage 1|Did not complete survey|0|||
125540164|NCT05038163|451605909|FG005|Stage 1|Did not complete survey|0|||
125540165|NCT05038163|451605904|FG000|Stage 2|Did not complete Stage 2 survey|0|||
125540166|NCT05038163|451605905|FG001|Stage 2|Did not complete Stage 2 survey|29|||
125540167|NCT05038163|451605906|FG002|Stage 2|Did not complete Stage 2 survey|30|||
125540168|NCT05038163|451605907|FG003|Stage 2|Did not complete Stage 2 survey|24|||
125540169|NCT05038163|451605908|FG004|Stage 2|Did not complete Stage 2 survey|21|||
125540170|NCT05038163|451605909|FG005|Stage 2|Did not complete Stage 2 survey|100|||
125540171|NCT01905150|451605910|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
125540172|NCT01905150|451605911|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
125540173|NCT01147536|451605912|FG000|Overall Study|Administrative study close|2|||
125540174|NCT01147536|451605912|FG000|Overall Study|Death|1|||
125540175|NCT03762200|451605915|FG000|Overall Study|Death|2|||
125540176|NCT02631577|451605916|FG000|Overall Study|Death|1|||
125540177|NCT02631577|451605917|FG001|Overall Study|Death|7|||
125540178|NCT02631577|451605916|FG000|Overall Study|Withdrawal by Subject|0|||
125540179|NCT02631577|451605917|FG001|Overall Study|Withdrawal by Subject|3|||
125540180|NCT05618912|451605924|FG000|Overall Study|Lost to Follow-up|14|||
125540181|NCT05618912|451605925|FG001|Overall Study|Lost to Follow-up|19|||
125540182|NCT05110690|451605926|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
125540183|NCT05110690|451605926|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
125540184|NCT05110690|451605926|FG000|Completion of Intervention|Lost to Follow-up|1|||
125540185|NCT05110690|451605926|FG000|Completion of Intervention|Death|1|||
125540186|NCT05110690|451605926|FG000|Completion of Intervention|Withdrawal by Subject|2|||
125540187|NCT03973931|451605927|FG000|Overall Study|Lost to Follow-up|47|||
125540188|NCT03973931|451605928|FG001|Overall Study|Lost to Follow-up|63|||
125540189|NCT03973931|451605929|FG002|Overall Study|Lost to Follow-up|51|||
125540190|NCT03973931|451605930|FG003|Overall Study|Lost to Follow-up|54|||
125540191|NCT03973931|451605927|FG000|Overall Study|opted out|6|||
125540192|NCT03973931|451605928|FG001|Overall Study|opted out|5|||
125540193|NCT03973931|451605929|FG002|Overall Study|opted out|5|||
125540194|NCT03973931|451605930|FG003|Overall Study|opted out|1|||
125540195|NCT01302067|451607542|FG000|Overall Study|Death|0|||
125540196|NCT01302067|451607543|FG001|Overall Study|Death|0|||
125540197|NCT01302067|451607544|FG002|Overall Study|Death|1|||
125540198|NCT01302067|451607542|FG000|Overall Study|Physician Decision|9|||
125540199|NCT01302067|451607543|FG001|Overall Study|Physician Decision|5|||
125540200|NCT01302067|451607544|FG002|Overall Study|Physician Decision|14|||
125540201|NCT01302067|451607542|FG000|Overall Study|Lack of Efficacy|8|||
125540202|NCT01302067|451607543|FG001|Overall Study|Lack of Efficacy|4|||
125540203|NCT01302067|451607544|FG002|Overall Study|Lack of Efficacy|2|||
125540204|NCT01302067|451607542|FG000|Overall Study|Lost to Follow-up|9|||
125425009|NCT00541450|451178780|FG000|Phase B|Adverse Event|6|||
125425010|NCT00541450|451178781|FG001|Phase B|Adverse Event|6|||
125311806|NCT04640311|450770592|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311807|NCT04640311|450770593|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311808|NCT04640311|450770594|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311809|NCT04640311|450770595|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311810|NCT04640311|450770596|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311811|NCT04640311|450770597|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311812|NCT04640311|450770598|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311813|NCT04640311|450770599|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311814|NCT04640311|450770600|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311815|NCT04640311|450770588|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311816|NCT04640311|450770589|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
125311817|NCT04640311|450770590|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311818|NCT04640311|450770591|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311819|NCT04640311|450770592|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311820|NCT04640311|450770593|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311821|NCT04640311|450770594|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311822|NCT04640311|450770595|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311823|NCT04640311|450770596|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311824|NCT04640311|450770597|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311825|NCT04640311|450770598|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311826|NCT04640311|450770599|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311827|NCT04640311|450770600|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
125311828|NCT04640311|450770588|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125425011|NCT00541450|451178780|FG000|Phase B|Hyperglycemia|10|||
125540205|NCT01302067|451607543|FG001|Overall Study|Lost to Follow-up|4|||
125540206|NCT01302067|451607544|FG002|Overall Study|Lost to Follow-up|15|||
125540207|NCT01302067|451607542|FG000|Overall Study|Withdrawal by Subject|13|||
125540208|NCT01302067|451607543|FG001|Overall Study|Withdrawal by Subject|6|||
125540209|NCT01302067|451607544|FG002|Overall Study|Withdrawal by Subject|10|||
125540210|NCT01302067|451607542|FG000|Overall Study|Other|1|||
125540211|NCT01302067|451607543|FG001|Overall Study|Other|1|||
125540212|NCT01302067|451607544|FG002|Overall Study|Other|3|||
125540213|NCT01302067|451607542|FG000|Overall Study|Protocol Violation|11|||
125540214|NCT01302067|451607543|FG001|Overall Study|Protocol Violation|0|||
125540215|NCT01302067|451607544|FG002|Overall Study|Protocol Violation|8|||
125540216|NCT01302067|451607542|FG000|Overall Study|Adverse Event|27|||
125540217|NCT01302067|451607543|FG001|Overall Study|Adverse Event|14|||
125540218|NCT01302067|451607544|FG002|Overall Study|Adverse Event|45|||
125540219|NCT02738203|451607546|FG000|Overall Study|Failed IUD Insertion|2|||
125540220|NCT02738203|451607547|FG001|Overall Study|Failed IUD Insertion|2|||
125540221|NCT02738203|451607546|FG000|Overall Study|Protocol Violation|0|||
125540222|NCT02738203|451607547|FG001|Overall Study|Protocol Violation|1|||
125540223|NCT03241927|451607548|FG000|Overall Study|study terminated|1|||
125540224|NCT03241927|451607549|FG001|Overall Study|study terminated|0|||
125540225|NCT00423943|451607550|FG000|Overall Study|Withdrawal by Subject|3|||
125540226|NCT00423943|451607551|FG001|Overall Study|Withdrawal by Subject|1|||
125540227|NCT02383056|451607552|FG000|Overall Study|Adverse Event|1|||
125540228|NCT02383056|451607553|FG001|Overall Study|Adverse Event|0|||
125540229|NCT02383056|451607552|FG000|Overall Study|Lost to Follow-up|0|||
125540230|NCT02383056|451607553|FG001|Overall Study|Lost to Follow-up|2|||
125540231|NCT03245151|451607554|FG000|Overall Study|Withdrawal by Subject|2|||
125540232|NCT03245151|451607555|FG001|Overall Study|Withdrawal by Subject|0|||
125540233|NCT03245151|451607556|FG002|Overall Study|Withdrawal by Subject|0|||
125540234|NCT03245151|451607557|FG003|Overall Study|Withdrawal by Subject|2|||
125540235|NCT03245151|451607558|FG004|Overall Study|Withdrawal by Subject|1|||
125540236|NCT03245151|451607554|FG000|Overall Study|Death|3|||
125540237|NCT03245151|451607555|FG001|Overall Study|Death|14|||
125540238|NCT03245151|451607556|FG002|Overall Study|Death|9|||
125540239|NCT03245151|451607557|FG003|Overall Study|Death|16|||
125540240|NCT03245151|451607558|FG004|Overall Study|Death|7|||
125540241|NCT03245151|451607554|FG000|Overall Study|Sponsor's decision|0|||
125540242|NCT03245151|451607555|FG001|Overall Study|Sponsor's decision|1|||
125540243|NCT03245151|451607556|FG002|Overall Study|Sponsor's decision|0|||
125540244|NCT03245151|451607557|FG003|Overall Study|Sponsor's decision|0|||
125540245|NCT03245151|451607558|FG004|Overall Study|Sponsor's decision|0|||
125540246|NCT00766363|451607567|FG000|Overall Study|Withdrawal by Subject|1|||
125540247|NCT00766363|451607568|FG001|Overall Study|Withdrawal by Subject|0|||
125540248|NCT00766363|451607569|FG002|Overall Study|Withdrawal by Subject|0|||
125540249|NCT00766363|451607570|FG003|Overall Study|Withdrawal by Subject|0|||
125540250|NCT00766363|451607567|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
125540251|NCT00766363|451607568|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
125540252|NCT00766363|451607569|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
125425012|NCT00541450|451178781|FG001|Phase B|Hyperglycemia|9|||
125425013|NCT00541450|451178780|FG000|Phase B|Lost to Follow-up|6|||
125425014|NCT00541450|451178781|FG001|Phase B|Lost to Follow-up|4|||
125425015|NCT00541450|451178780|FG000|Phase B|Physician Decision|4|||
125425016|NCT00541450|451178781|FG001|Phase B|Physician Decision|2|||
125425017|NCT00541450|451178780|FG000|Phase B|Pregnancy|0|||
125425018|NCT00541450|451178781|FG001|Phase B|Pregnancy|1|||
125425019|NCT00541450|451178780|FG000|Phase B|Protocol Violation|3|||
125425020|NCT00541450|451178781|FG001|Phase B|Protocol Violation|3|||
125425021|NCT00541450|451178780|FG000|Phase B|Withdrawal by Subject|8|||
125425022|NCT00541450|451178781|FG001|Phase B|Withdrawal by Subject|6|||
125425023|NCT01298999|451178782|FG000|Overall Study|Physician Decision|0|||
125425024|NCT01298999|451178783|FG001|Overall Study|Physician Decision|1|||
125425025|NCT01298999|451178782|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
125425026|NCT01298999|451178783|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
125425027|NCT02151266|451178784|FG000|Overall Study|Lost to Follow-up|1|||
125425028|NCT02151266|451178785|FG001|Overall Study|Lost to Follow-up|4|||
125425029|NCT02151266|451178786|FG002|Overall Study|Lost to Follow-up|1|||
125425030|NCT02151266|451178784|FG000|Overall Study|Did NOT receive intervention|3|||
125425031|NCT02151266|451178785|FG001|Overall Study|Did NOT receive intervention|6|||
125425032|NCT02151266|451178786|FG002|Overall Study|Did NOT receive intervention|2|||
125425033|NCT02151266|451178784|FG000|Overall Study|Not able to exercise|4|||
125425034|NCT02151266|451178785|FG001|Overall Study|Not able to exercise|5|||
125425035|NCT02151266|451178786|FG002|Overall Study|Not able to exercise|4|||
125425036|NCT01169675|451178787|FG000|Overall Study|Progressive disease|13|||
125425037|NCT01169675|451178788|FG001|Overall Study|Progressive disease|2|||
125425038|NCT01169675|451178789|FG002|Overall Study|Progressive disease|5|||
125425039|NCT01169675|451178790|FG003|Overall Study|Progressive disease|15|||
125425040|NCT01169675|451178791|FG004|Overall Study|Progressive disease|1|||
125425041|NCT01169675|451178787|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125425042|NCT01169675|451178788|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125425043|NCT01169675|451178789|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125425044|NCT01169675|451178790|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125425045|NCT01169675|451178791|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
125425046|NCT01169675|451178787|FG000|Overall Study|Adverse Event|5|||
125425047|NCT01169675|451178788|FG001|Overall Study|Adverse Event|1|||
125425048|NCT01169675|451178789|FG002|Overall Study|Adverse Event|2|||
125425049|NCT01169675|451178790|FG003|Overall Study|Adverse Event|0|||
125425050|NCT01169675|451178791|FG004|Overall Study|Adverse Event|0|||
125425051|NCT01169675|451178787|FG000|Overall Study|Withdrawal by Subject|1|||
125425052|NCT01169675|451178788|FG001|Overall Study|Withdrawal by Subject|0|||
125425053|NCT01169675|451178789|FG002|Overall Study|Withdrawal by Subject|0|||
125425054|NCT01169675|451178790|FG003|Overall Study|Withdrawal by Subject|1|||
125425055|NCT01169675|451178791|FG004|Overall Study|Withdrawal by Subject|2|||
125425056|NCT01169675|451178787|FG000|Overall Study|Other Reason Not Defined Above|0|||
125425057|NCT01169675|451178788|FG001|Overall Study|Other Reason Not Defined Above|0|||
125425058|NCT01169675|451178789|FG002|Overall Study|Other Reason Not Defined Above|0|||
125425059|NCT01169675|451178790|FG003|Overall Study|Other Reason Not Defined Above|1|||
125425060|NCT01169675|451178791|FG004|Overall Study|Other Reason Not Defined Above|1|||
125425061|NCT00803452|451178792|FG000|Overall Study|Adverse Event|0|||
125425062|NCT00803452|451178793|FG001|Overall Study|Adverse Event|2|||
125425063|NCT00803452|451178792|FG000|Overall Study|Lost to Follow-up|0|||
125425064|NCT00803452|451178793|FG001|Overall Study|Lost to Follow-up|3|||
125425065|NCT02816138|451178797|FG000|Overall Study|Adverse Event|1|||
125425066|NCT04839965|451178798|FG000|Overall Study|Death|6|||
125425067|NCT04839965|451178799|FG001|Overall Study|Death|6|||
125311829|NCT04640311|450770589|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
125311830|NCT04640311|450770590|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311831|NCT04640311|450770591|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311832|NCT04640311|450770592|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311833|NCT04640311|450770593|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311834|NCT04640311|450770594|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311835|NCT04640311|450770595|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125425068|NCT04839965|451178798|FG000|Overall Study|Lost to Follow-up|1|||
125425069|NCT04839965|451178799|FG001|Overall Study|Lost to Follow-up|0|||
125425070|NCT02365519|451178800|FG000|Randomized and Treated|Adverse Event|0|||
125425071|NCT02365519|451178801|FG001|Randomized and Treated|Adverse Event|1|||
125425072|NCT02365519|451178802|FG002|Randomized and Treated|Adverse Event|0|||
125425073|NCT02365519|451178800|FG000|Randomized and Treated|Withdrawal by Subject|0|||
125425074|NCT02365519|451178801|FG001|Randomized and Treated|Withdrawal by Subject|1|||
125425075|NCT02365519|451178802|FG002|Randomized and Treated|Withdrawal by Subject|1|||
125425076|NCT02291679|451178803|FG000|Overall Study|Adverse Event|2|||
125425077|NCT02291679|451178804|FG001|Overall Study|Adverse Event|12|||
125425078|NCT02291679|451178805|FG002|Overall Study|Adverse Event|19|||
125425079|NCT02291679|451178803|FG000|Overall Study|Protocol Violation|5|||
125425080|NCT02291679|451178804|FG001|Overall Study|Protocol Violation|1|||
125425081|NCT02291679|451178805|FG002|Overall Study|Protocol Violation|7|||
125425082|NCT02291679|451178803|FG000|Overall Study|Withdrew Consent|18|||
125425083|NCT02291679|451178804|FG001|Overall Study|Withdrew Consent|10|||
125425084|NCT02291679|451178805|FG002|Overall Study|Withdrew Consent|15|||
125425085|NCT02291679|451178803|FG000|Overall Study|Lost to Follow-up|12|||
125425086|NCT02291679|451178804|FG001|Overall Study|Lost to Follow-up|10|||
125425087|NCT02291679|451178805|FG002|Overall Study|Lost to Follow-up|9|||
125425088|NCT02291679|451178803|FG000|Overall Study|Insufficient Therapeutic Response|5|||
125425089|NCT02291679|451178804|FG001|Overall Study|Insufficient Therapeutic Response|5|||
125650096|NCT01038609|452002766|FG000|Overall Study|Death in the Family|1|||
125650097|NCT01038609|452002767|FG001|Overall Study|Death in the Family|0|||
125650098|NCT01038609|452002768|FG002|Overall Study|Death in the Family|0|||
125650099|NCT01038609|452002769|FG003|Overall Study|Death in the Family|0|||
125425090|NCT02291679|451178805|FG002|Overall Study|Insufficient Therapeutic Response|7|||
125425091|NCT02291679|451178803|FG000|Overall Study|Other|2|||
125425092|NCT02291679|451178804|FG001|Overall Study|Other|4|||
125425093|NCT02291679|451178805|FG002|Overall Study|Other|2|||
125425094|NCT00981084|451178806|FG000|Post Intervention (Data Analysis)|poor effort|1|||
125425095|NCT00981084|451178807|FG001|Post Intervention (Data Analysis)|poor effort|1|||
125425096|NCT00981084|451178806|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
125425097|NCT00981084|451178807|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
125425098|NCT02048072|451178808|FG000|Overall Study|Adverse Event|3|||
125425099|NCT02048072|451178808|FG000|Overall Study|Lost to Follow-up|1|||
125425100|NCT00725296|451178810|FG000|Overall Study|Adverse Event|11|||
125425101|NCT00725296|451178810|FG000|Overall Study|Lack of Efficacy|7|||
125425102|NCT00725296|451178810|FG000|Overall Study|Withdrawal by Subject|3|||
125425103|NCT00725296|451178810|FG000|Overall Study|Non-Compliance|2|||
125425104|NCT00725296|451178810|FG000|Overall Study|Lost to Follow-up|1|||
125425105|NCT00725296|451178810|FG000|Overall Study|Other|38|||
125425106|NCT03657277|451178811|FG000|Overall Study|Physician Decision|2|||
125425107|NCT03657277|451178811|FG000|Overall Study|Lost to Follow-up|1|||
125425108|NCT03657277|451178811|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
125425109|NCT03360942|451178813|FG000|Overall Study|Device explanted|2|||
125425110|NCT03360942|451178813|FG000|Overall Study|Study closure|1|||
125425111|NCT03360942|451178813|FG000|Overall Study|Withdrawal by Subject|2|||
125425112|NCT00657618|451178818|FG000|Overall Study|Adverse Event|32|||
125425113|NCT00657618|451178818|FG000|Overall Study|Withdrawal by Subject|8|||
125425114|NCT00657618|451178818|FG000|Overall Study|negative for leishmaniasis|2|||
125425115|NCT00657618|451178818|FG000|Overall Study|didn't start due to schedule conflicts|1|||
125425116|NCT00289887|451180353|FG000|Overall Study|Adverse Event|3|||
125425117|NCT00289887|451180354|FG001|Overall Study|Adverse Event|3|||
125311836|NCT04640311|450770596|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311837|NCT04640311|450770597|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311838|NCT04640311|450770598|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311839|NCT04640311|450770599|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311840|NCT04640311|450770600|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311841|NCT04640311|450770588|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
125311842|NCT04640311|450770589|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
125311843|NCT04640311|450770590|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
125311844|NCT04640311|450770591|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311845|NCT04640311|450770592|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311846|NCT04640311|450770593|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311847|NCT04640311|450770594|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311848|NCT04640311|450770595|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311849|NCT04640311|450770596|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125425118|NCT00289887|451180353|FG000|Overall Study|Lack of Efficacy|3|||
125425119|NCT00289887|451180354|FG001|Overall Study|Lack of Efficacy|11|||
125425120|NCT00289887|451180353|FG000|Overall Study|Lost to Follow-up|3|||
125425121|NCT00289887|451180354|FG001|Overall Study|Lost to Follow-up|3|||
125425122|NCT00289887|451180353|FG000|Overall Study|Protocol Violation|3|||
125425123|NCT00289887|451180354|FG001|Overall Study|Protocol Violation|1|||
125425124|NCT00289887|451180353|FG000|Overall Study|Withdrawal by Subject|3|||
125425125|NCT00289887|451180354|FG001|Overall Study|Withdrawal by Subject|8|||
125425126|NCT00289887|451180353|FG000|Overall Study|Other|7|||
125425127|NCT00289887|451180354|FG001|Overall Study|Other|3|||
125311850|NCT04640311|450770597|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311851|NCT04640311|450770598|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311852|NCT04640311|450770599|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311853|NCT04640311|450770600|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
125311854|NCT04640311|450770588|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311855|NCT04640311|450770589|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311856|NCT04640311|450770590|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
125311857|NCT04640311|450770591|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311858|NCT04640311|450770592|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311859|NCT04640311|450770593|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311860|NCT04640311|450770594|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311861|NCT04640311|450770595|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311862|NCT04640311|450770596|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311863|NCT04640311|450770597|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311864|NCT04640311|450770598|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311865|NCT04640311|450770599|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311866|NCT04640311|450770600|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
125311867|NCT04640311|450770588|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311868|NCT04640311|450770589|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311869|NCT04640311|450770590|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311870|NCT04640311|450770591|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
125311871|NCT04640311|450770592|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311872|NCT04640311|450770593|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311873|NCT04640311|450770594|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
125311874|NCT04640311|450770595|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311875|NCT04640311|450770596|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311876|NCT04640311|450770597|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311877|NCT04640311|450770598|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311878|NCT04640311|450770599|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311879|NCT04640311|450770600|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
125311880|NCT04640311|450770588|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311881|NCT04640311|450770589|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311882|NCT04640311|450770590|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311883|NCT04640311|450770591|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311884|NCT04640311|450770592|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311885|NCT04640311|450770593|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
125311886|NCT04640311|450770594|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311887|NCT04640311|450770595|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311888|NCT04640311|450770596|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
125311889|NCT04640311|450770597|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311890|NCT04640311|450770598|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311891|NCT04640311|450770599|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311892|NCT04640311|450770600|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
125311893|NCT04640311|450770588|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311894|NCT04640311|450770589|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311895|NCT04640311|450770590|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311896|NCT04640311|450770591|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311897|NCT04640311|450770592|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311898|NCT04640311|450770593|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311899|NCT04640311|450770594|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
125311900|NCT04640311|450770595|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311901|NCT04640311|450770596|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311902|NCT04640311|450770597|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311903|NCT04640311|450770598|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
125311904|NCT04640311|450770599|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311905|NCT04640311|450770600|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
125311906|NCT04640311|450770588|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311907|NCT04640311|450770589|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311908|NCT04640311|450770590|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311909|NCT04640311|450770591|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311910|NCT04640311|450770592|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311911|NCT04640311|450770593|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125650100|NCT01038609|452002770|FG004|Overall Study|Death in the Family|0|||
125650101|NCT01038609|452002766|FG000|Overall Study|Refusal of Blood Draws|0|||
125650102|NCT01038609|452002767|FG001|Overall Study|Refusal of Blood Draws|1|||
125650103|NCT01038609|452002768|FG002|Overall Study|Refusal of Blood Draws|0|||
125311912|NCT04640311|450770594|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311913|NCT04640311|450770595|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311914|NCT04640311|450770596|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311915|NCT04640311|450770597|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125650104|NCT01038609|452002769|FG003|Overall Study|Refusal of Blood Draws|0|||
125650105|NCT01038609|452002770|FG004|Overall Study|Refusal of Blood Draws|0|||
125650106|NCT01728194|452002771|FG000|Overall Study|Lost to Follow-up|4|||
125650107|NCT01728194|452002772|FG001|Overall Study|Lost to Follow-up|3|||
125650108|NCT01728194|452002771|FG000|Overall Study|Physician Decision|4|||
125650109|NCT01728194|452002772|FG001|Overall Study|Physician Decision|0|||
125650110|NCT01728194|452002771|FG000|Overall Study|Withdrawal by Subject|7|||
125650111|NCT01728194|452002772|FG001|Overall Study|Withdrawal by Subject|3|||
125650112|NCT01728194|452002771|FG000|Overall Study|Perceived Medication Side Effects|4|||
125650113|NCT01728194|452002772|FG001|Overall Study|Perceived Medication Side Effects|0|||
125650114|NCT01728194|452002771|FG000|Overall Study|Family Member Request|1|||
125650115|NCT01728194|452002772|FG001|Overall Study|Family Member Request|0|||
125650116|NCT01590810|452002775|FG000|Overall Study|Physician Decision|0|||
125650117|NCT01590810|452002776|FG001|Overall Study|Physician Decision|1|||
125650118|NCT01590810|452002777|FG002|Overall Study|Physician Decision|1|||
125650119|NCT01590810|452002778|FG003|Overall Study|Physician Decision|0|||
125650120|NCT01590810|452002779|FG004|Overall Study|Physician Decision|0|||
125650121|NCT04604015|452002780|FG000|Overall Study|Incomplete Data Collection|33|||
125311916|NCT04640311|450770598|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311917|NCT04640311|450770599|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
125311918|NCT04640311|450770600|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
125311919|NCT00592904|450770601|FG000|Overall Study|Adverse Event|15|||
125311920|NCT00592904|450770602|FG001|Overall Study|Adverse Event|25|||
125311921|NCT00592904|450770603|FG002|Overall Study|Adverse Event|13|||
125311922|NCT00592904|450770604|FG003|Overall Study|Adverse Event|5|||
125311923|NCT00592904|450770601|FG000|Overall Study|Protocol Violation|1|||
125311924|NCT00592904|450770602|FG001|Overall Study|Protocol Violation|1|||
125311925|NCT00592904|450770603|FG002|Overall Study|Protocol Violation|0|||
125650122|NCT03655951|452002782|FG000|Overall Study|Lost to Follow-up|39|||
125650123|NCT03655951|452002783|FG001|Overall Study|Lost to Follow-up|20|||
125650124|NCT03655951|452002782|FG000|Overall Study|Withdrawal by Subject|0|||
125650125|NCT03655951|452002783|FG001|Overall Study|Withdrawal by Subject|1|||
125650126|NCT03575975|452002785|FG000|Overall Study|Lost to Follow-up|1|||
125650127|NCT03575975|452002786|FG001|Overall Study|Lost to Follow-up|0|||
125650128|NCT03575975|452002787|FG002|Overall Study|Lost to Follow-up|0|||
125425128|NCT01266850|451180355|FG000|Overall Study|Lost to Follow-up|19|||
125425129|NCT01266850|451180356|FG001|Overall Study|Lost to Follow-up|19|||
125425130|NCT01266850|451180357|FG002|Overall Study|Lost to Follow-up|13|||
125425131|NCT01266850|451180358|FG003|Overall Study|Lost to Follow-up|13|||
125425132|NCT01266850|451180359|FG004|Overall Study|Lost to Follow-up|12|||
125425133|NCT01266850|451180355|FG000|Overall Study|Withdrawal by Subject|8|||
125425134|NCT01266850|451180356|FG001|Overall Study|Withdrawal by Subject|9|||
125425135|NCT01266850|451180357|FG002|Overall Study|Withdrawal by Subject|6|||
125425136|NCT01266850|451180358|FG003|Overall Study|Withdrawal by Subject|9|||
125425137|NCT01266850|451180359|FG004|Overall Study|Withdrawal by Subject|12|||
125425138|NCT01266850|451180355|FG000|Overall Study|Physician Decision|3|||
125425139|NCT01266850|451180356|FG001|Overall Study|Physician Decision|6|||
125425140|NCT01266850|451180357|FG002|Overall Study|Physician Decision|4|||
125425141|NCT01266850|451180358|FG003|Overall Study|Physician Decision|4|||
125425142|NCT01266850|451180359|FG004|Overall Study|Physician Decision|3|||
125425143|NCT01266850|451180355|FG000|Overall Study|Protocol Violation|0|||
125425144|NCT01266850|451180356|FG001|Overall Study|Protocol Violation|1|||
125311926|NCT00592904|450770604|FG003|Overall Study|Protocol Violation|1|||
125311927|NCT00592904|450770601|FG000|Overall Study|Withdrawal by Subject|4|||
125311928|NCT00592904|450770602|FG001|Overall Study|Withdrawal by Subject|16|||
125311929|NCT00592904|450770603|FG002|Overall Study|Withdrawal by Subject|1|||
125311930|NCT00592904|450770604|FG003|Overall Study|Withdrawal by Subject|2|||
125311931|NCT00592904|450770601|FG000|Overall Study|Lack of Efficacy|2|||
125311932|NCT00592904|450770602|FG001|Overall Study|Lack of Efficacy|7|||
125425145|NCT01266850|451180357|FG002|Overall Study|Protocol Violation|0|||
125425146|NCT01266850|451180358|FG003|Overall Study|Protocol Violation|1|||
125425147|NCT01266850|451180359|FG004|Overall Study|Protocol Violation|2|||
125425148|NCT01266850|451180355|FG000|Overall Study|Adverse Event|0|||
125425149|NCT01266850|451180356|FG001|Overall Study|Adverse Event|0|||
125425150|NCT01266850|451180357|FG002|Overall Study|Adverse Event|0|||
125425151|NCT01266850|451180358|FG003|Overall Study|Adverse Event|0|||
125425152|NCT01266850|451180359|FG004|Overall Study|Adverse Event|1|||
125311933|NCT00592904|450770603|FG002|Overall Study|Lack of Efficacy|2|||
125425153|NCT01266850|451180355|FG000|Overall Study|Site Closure|0|||
125311934|NCT00592904|450770604|FG003|Overall Study|Lack of Efficacy|3|||
125311935|NCT00592904|450770601|FG000|Overall Study|Physician Decision|0|||
125311936|NCT00592904|450770602|FG001|Overall Study|Physician Decision|3|||
125311937|NCT00592904|450770603|FG002|Overall Study|Physician Decision|1|||
125311938|NCT00592904|450770604|FG003|Overall Study|Physician Decision|0|||
125311939|NCT00592904|450770601|FG000|Overall Study|Other|3|||
125311940|NCT00592904|450770602|FG001|Overall Study|Other|3|||
125311941|NCT00592904|450770603|FG002|Overall Study|Other|0|||
125311942|NCT00592904|450770604|FG003|Overall Study|Other|0|||
125311943|NCT03191630|450770607|FG000|Overall Study|Lost to Follow-up|7|||
125311944|NCT03191630|450770608|FG001|Overall Study|Lost to Follow-up|7|||
125311945|NCT01367834|450770613|FG000|Overall Study|Withdrawal by Subject|2|||
125311946|NCT01367834|450770614|FG001|Overall Study|Withdrawal by Subject|2|||
125311947|NCT01367834|450770613|FG000|Overall Study|Study was ended.|0|||
125311948|NCT01367834|450770614|FG001|Overall Study|Study was ended.|1|||
125311949|NCT01020786|450770619|FG000|Induction Period|Entry Criteria Not Met|2|||
125311950|NCT01020786|450770619|FG000|Induction Period|Adverse Event|10|||
125311951|NCT01020786|450770619|FG000|Induction Period|Progressive Disease|31|||
125311952|NCT01020786|450770619|FG000|Induction Period|Investigator Decision|3|||
125311953|NCT01020786|450770619|FG000|Induction Period|Withdrawal by Subject|3|||
125311954|NCT01020786|450770619|FG000|Maintenance Period|Adverse Event|8|||
125311955|NCT01020786|450770619|FG000|Maintenance Period|Progressive Disease|43|||
125311956|NCT01020786|450770619|FG000|Maintenance Period|Withdrawal by Subject|8|||
125311957|NCT01020786|450770619|FG000|Maintenance Period|Sponsor Decision|1|||
125311958|NCT01818596|450770628|FG000|Overall Study|Enrolled but Not Treated|4|||
125311959|NCT01818596|450770629|FG001|Overall Study|Enrolled but Not Treated|0|||
125311960|NCT01818596|450770628|FG000|Overall Study|Adverse Event|7|||
125311961|NCT01818596|450770629|FG001|Overall Study|Adverse Event|0|||
125311962|NCT01818596|450770628|FG000|Overall Study|Death|3|||
125311963|NCT01818596|450770629|FG001|Overall Study|Death|0|||
125311964|NCT01818596|450770628|FG000|Overall Study|Investigator's Discretion|4|||
125311965|NCT01818596|450770629|FG001|Overall Study|Investigator's Discretion|0|||
125311966|NCT01818596|450770628|FG000|Overall Study|Protocol Violation|1|||
125311967|NCT01818596|450770629|FG001|Overall Study|Protocol Violation|0|||
125311968|NCT01818596|450770628|FG000|Overall Study|Withdrew Consent|5|||
125311969|NCT01818596|450770629|FG001|Overall Study|Withdrew Consent|0|||
125311970|NCT01818596|450770628|FG000|Overall Study|Lost to Follow-up|7|||
125311971|NCT01818596|450770629|FG001|Overall Study|Lost to Follow-up|0|||
125311972|NCT03801174|450770630|FG000|Overall Study|Withdrawal by Subject|14|||
125311973|NCT03801174|450770631|FG001|Overall Study|Withdrawal by Subject|15|||
125311974|NCT03801174|450770630|FG000|Overall Study|Death|1|||
125311975|NCT03801174|450770631|FG001|Overall Study|Death|0|||
125311976|NCT03801174|450770630|FG000|Overall Study|Pregnancy|2|||
125311977|NCT03801174|450770631|FG001|Overall Study|Pregnancy|2|||
125311978|NCT03801174|450770630|FG000|Overall Study|Lost to Follow-up|19|||
125311979|NCT03801174|450770631|FG001|Overall Study|Lost to Follow-up|10|||
125311980|NCT03801174|450770630|FG000|Overall Study|Other|4|||
125311981|NCT03801174|450770631|FG001|Overall Study|Other|3|||
125311982|NCT03801174|450770630|FG000|Overall Study|Lack of Efficacy|4|||
125311983|NCT03801174|450770631|FG001|Overall Study|Lack of Efficacy|0|||
125311984|NCT03801174|450770630|FG000|Overall Study|Unwilling to complete activities|5|||
125311985|NCT03801174|450770631|FG001|Overall Study|Unwilling to complete activities|6|||
125311986|NCT03801174|450770630|FG000|Overall Study|Moved out of area|3|||
125311987|NCT03801174|450770631|FG001|Overall Study|Moved out of area|0|||
125311988|NCT02915263|450770644|FG000|Overall Study|Covid|3|||
125311989|NCT02915263|450770645|FG001|Overall Study|Covid|2|||
125311990|NCT01879683|450770646|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
125311991|NCT01618669|450770647|FG000|Overall Study|Lost to Follow-up|1|||
125311992|NCT01618669|450770648|FG001|Overall Study|Lost to Follow-up|1|||
125311993|NCT01618669|450770647|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
125311994|NCT01618669|450770648|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
125311995|NCT01618669|450770647|FG000|Overall Study|Adverse Event|16|||
125311996|NCT01618669|450770648|FG001|Overall Study|Adverse Event|7|||
125311997|NCT01618669|450770647|FG000|Overall Study|Protocol Violation|5|||
125311998|NCT01618669|450770648|FG001|Overall Study|Protocol Violation|3|||
125311999|NCT01618669|450770647|FG000|Overall Study|Withdrawal by Subject|9|||
125312000|NCT01618669|450770648|FG001|Overall Study|Withdrawal by Subject|9|||
125312001|NCT01618669|450770647|FG000|Overall Study|Miscellaneous Reason|0|||
125312002|NCT01618669|450770648|FG001|Overall Study|Miscellaneous Reason|1|||
125312003|NCT01702558|450770651|FG000|Overall Study|Withdrawal by Subject|0|||
125312004|NCT01702558|450770652|FG001|Overall Study|Withdrawal by Subject|0|||
125425154|NCT01266850|451180356|FG001|Overall Study|Site Closure|1|||
125312005|NCT01702558|450770653|FG002|Overall Study|Withdrawal by Subject|0|||
125312006|NCT01702558|450770654|FG003|Overall Study|Withdrawal by Subject|12|||
125312007|NCT01702558|450770655|FG004|Overall Study|Withdrawal by Subject|4|||
125312008|NCT01702558|450770651|FG000|Overall Study|Lost to Follow-up|0|||
125312009|NCT01702558|450770652|FG001|Overall Study|Lost to Follow-up|0|||
125312010|NCT01702558|450770653|FG002|Overall Study|Lost to Follow-up|0|||
125312011|NCT01702558|450770654|FG003|Overall Study|Lost to Follow-up|3|||
125425155|NCT01266850|451180357|FG002|Overall Study|Site Closure|1|||
125425156|NCT01266850|451180358|FG003|Overall Study|Site Closure|1|||
125425157|NCT01266850|451180359|FG004|Overall Study|Site Closure|0|||
125425158|NCT00437645|451180361|FG000|Overall Study|Adverse Event|15|||
125425159|NCT00437645|451180362|FG001|Overall Study|Adverse Event|84|||
125425160|NCT00437645|451180361|FG000|Overall Study|Withdrawal by Subject|10|||
125425161|NCT00437645|451180362|FG001|Overall Study|Withdrawal by Subject|22|||
125425162|NCT00437645|451180361|FG000|Overall Study|Protocol Violation|3|||
125425163|NCT00437645|451180362|FG001|Overall Study|Protocol Violation|3|||
125425164|NCT00437645|451180361|FG000|Overall Study|Lost to Follow-up|2|||
125425165|NCT00437645|451180362|FG001|Overall Study|Lost to Follow-up|3|||
125425166|NCT00437645|451180361|FG000|Overall Study|Administrative problems|2|||
125425167|NCT00437645|451180362|FG001|Overall Study|Administrative problems|1|||
125425168|NCT00437645|451180361|FG000|Overall Study|Lack of Efficacy|2|||
125425169|NCT00437645|451180362|FG001|Overall Study|Lack of Efficacy|1|||
125425170|NCT00437645|451180361|FG000|Overall Study|Condition no longer requires study drug|1|||
125425171|NCT00437645|451180362|FG001|Overall Study|Condition no longer requires study drug|1|||
125425172|NCT03382782|451180363|FG000|Cohort 1|Withdrawal by Subject|11|||
125425173|NCT03382782|451180364|FG001|Cohort 1|Withdrawal by Subject|5|||
125425174|NCT03382782|451180365|FG002|Cohort 1|Withdrawal by Subject|0|||
125425175|NCT03382782|451180363|FG000|Cohort 2|Withdrawal by Subject|1|||
125425176|NCT03382782|451180364|FG001|Cohort 2|Withdrawal by Subject|1|||
125425177|NCT03382782|451180365|FG002|Cohort 2|Withdrawal by Subject|0|||
125425178|NCT03382782|451180363|FG000|Cohort 3|Withdrawal by Subject|1|||
125425179|NCT03382782|451180364|FG001|Cohort 3|Withdrawal by Subject|2|||
125425180|NCT03382782|451180365|FG002|Cohort 3|Withdrawal by Subject|0|||
125425181|NCT00337272|451180368|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
125425182|NCT00337272|451180369|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
125425183|NCT00337272|451180368|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
125425184|NCT00337272|451180369|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
125425185|NCT00337272|451180368|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
125425186|NCT00337272|451180369|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
125425187|NCT00337272|451180368|FG000|Treatment Period|Non-compliance|1|||
125425188|NCT00337272|451180369|FG001|Treatment Period|Non-compliance|1|||
125425189|NCT00337272|451180368|FG000|Treatment Period|Withdrawal by Subject|0|||
125425190|NCT00337272|451180369|FG001|Treatment Period|Withdrawal by Subject|1|||
125425191|NCT00337272|451180368|FG000|Withdrawal Period|Non-compliance|0|||
125425192|NCT00337272|451180369|FG001|Withdrawal Period|Non-compliance|1|||
125425193|NCT02565914|451180374|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
125425194|NCT02565914|451180374|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
125425195|NCT02565914|451180374|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
125425196|NCT02565914|451180374|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
125425197|NCT02565914|451180374|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
125425198|NCT02565914|451180374|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
125425199|NCT02565914|451180374|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
125650129|NCT00129220|452002789|FG000|Study Period II|Adverse Event|9|||
125650130|NCT00129220|452002790|FG001|Study Period II|Adverse Event|5|||
125650131|NCT00129220|452002791|FG002|Study Period II|Adverse Event|7|||
125650132|NCT00129220|452002789|FG000|Study Period II|Lack of Efficacy|15|||
125425200|NCT02565914|451180374|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
125425201|NCT02565914|451180374|FG000|Part A (Up to 96 Weeks)|Other|18|||
125425202|NCT02565914|451180374|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
125540253|NCT00766363|451607570|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
125540254|NCT01153321|451607571|FG000|Overall Study|Development of study withdrawal criteria|0|||
125540255|NCT01153321|451607572|FG001|Overall Study|Development of study withdrawal criteria|1|||
125540256|NCT01153321|451607571|FG000|Overall Study|Withdrawal by Subject|0|||
125540257|NCT01153321|451607572|FG001|Overall Study|Withdrawal by Subject|1|||
125540258|NCT01153321|451607571|FG000|Overall Study|Adverse Event|1|||
125540259|NCT01153321|451607572|FG001|Overall Study|Adverse Event|1|||
125540260|NCT00911937|451607573|FG000|Overall Study|Death|1|||
125540261|NCT00911937|451607574|FG001|Overall Study|Death|0|||
125540262|NCT00911937|451607573|FG000|Overall Study|Lost to Follow-up|8|||
125540263|NCT00911937|451607574|FG001|Overall Study|Lost to Follow-up|5|||
125540264|NCT00911937|451607573|FG000|Overall Study|Withdrawal by Subject|10|||
125540265|NCT00911937|451607574|FG001|Overall Study|Withdrawal by Subject|7|||
125540266|NCT00911937|451607573|FG000|Overall Study|Withdrawn due to pregnancy|1|||
125540267|NCT00911937|451607574|FG001|Overall Study|Withdrawn due to pregnancy|0|||
125540268|NCT00911937|451607573|FG000|Overall Study|Adverse Event|11|||
125425203|NCT02565914|451180374|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
125425204|NCT02565914|451180374|FG000|Part B (Up to 96 Weeks)|Other|1|||
125425205|NCT02565914|451180374|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
125425206|NCT02565914|451180374|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
125425207|NCT02565914|451180374|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
125425208|NCT02565914|451180374|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
125540269|NCT00911937|451607574|FG001|Overall Study|Adverse Event|25|||
125425209|NCT02565914|451180374|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
125425210|NCT02565914|451180374|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
125425211|NCT02565914|451180374|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
125650133|NCT00129220|452002790|FG001|Study Period II|Lack of Efficacy|1|||
125650134|NCT00129220|452002791|FG002|Study Period II|Lack of Efficacy|28|||
125650135|NCT00129220|452002789|FG000|Study Period II|Entry Criteria Not Met|2|||
125650136|NCT00129220|452002790|FG001|Study Period II|Entry Criteria Not Met|0|||
125650137|NCT00129220|452002791|FG002|Study Period II|Entry Criteria Not Met|2|||
125650138|NCT00129220|452002789|FG000|Study Period II|Protocol Violation|4|||
125650139|NCT00129220|452002790|FG001|Study Period II|Protocol Violation|2|||
125650140|NCT00129220|452002791|FG002|Study Period II|Protocol Violation|1|||
125650141|NCT00129220|452002789|FG000|Study Period II|Physician Decision|0|||
125650142|NCT00129220|452002790|FG001|Study Period II|Physician Decision|1|||
125650143|NCT00129220|452002791|FG002|Study Period II|Physician Decision|0|||
125650144|NCT00129220|452002789|FG000|Study Period II|Withdrawal by Subject|1|||
125425212|NCT02565914|451180374|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
125425213|NCT02565914|451180374|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
125425214|NCT02565914|451180374|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
125425215|NCT02565914|451180374|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
125650145|NCT00129220|452002790|FG001|Study Period II|Withdrawal by Subject|3|||
125650146|NCT00129220|452002791|FG002|Study Period II|Withdrawal by Subject|4|||
125650147|NCT00129220|452002789|FG000|Study Period II|Reason Not Specified|2|||
125650148|NCT00129220|452002790|FG001|Study Period II|Reason Not Specified|0|||
125650149|NCT00129220|452002791|FG002|Study Period II|Reason Not Specified|5|||
125650150|NCT00129220|452002789|FG000|Study Period III|Adverse Event|1|||
125650151|NCT00129220|452002790|FG001|Study Period III|Adverse Event|0|||
125650152|NCT00129220|452002791|FG002|Study Period III|Adverse Event|3|||
125650153|NCT00129220|452002789|FG000|Study Period III|Protocol Violation|1|||
125650154|NCT00129220|452002790|FG001|Study Period III|Protocol Violation|1|||
125650155|NCT00129220|452002791|FG002|Study Period III|Protocol Violation|2|||
125650156|NCT00129220|452002789|FG000|Study Period III|Withdrawal by Subject|1|||
125650157|NCT00129220|452002790|FG001|Study Period III|Withdrawal by Subject|0|||
125650158|NCT00129220|452002791|FG002|Study Period III|Withdrawal by Subject|3|||
125650159|NCT00129220|452002789|FG000|Study Period III|Sponsor Decision|1|||
125650160|NCT00129220|452002790|FG001|Study Period III|Sponsor Decision|0|||
125650161|NCT00129220|452002791|FG002|Study Period III|Sponsor Decision|0|||
125650162|NCT00129220|452002789|FG000|Study Period III|Reason Not Specified|9|||
125650163|NCT00129220|452002790|FG001|Study Period III|Reason Not Specified|0|||
125650164|NCT00129220|452002791|FG002|Study Period III|Reason Not Specified|2|||
125650165|NCT01883362|452002792|FG000|Treatment|Adverse Event|1|||
125650166|NCT01883362|452002793|FG001|Treatment|Adverse Event|8|||
125650167|NCT01883362|452002792|FG000|Treatment|Withdrawal by Subject|6|||
125650168|NCT01883362|452002793|FG001|Treatment|Withdrawal by Subject|2|||
125650169|NCT01883362|452002792|FG000|Treatment|Administrative problems|4|||
125650170|NCT01883362|452002793|FG001|Treatment|Administrative problems|1|||
125650171|NCT01883362|452002792|FG000|Treatment|Relapse|4|||
125650172|NCT01883362|452002793|FG001|Treatment|Relapse|2|||
125650173|NCT01883362|452002792|FG000|Treatment|Randomized, not treated|1|||
125650174|NCT01883362|452002793|FG001|Treatment|Randomized, not treated|1|||
125650175|NCT01883362|452002792|FG000|Post Treatment Follow-up|Protocol Violation|0|||
125650176|NCT01883362|452002793|FG001|Post Treatment Follow-up|Protocol Violation|1|||
125650177|NCT01883362|452002792|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
125650178|NCT01883362|452002793|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
125650179|NCT01883362|452002792|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
125312012|NCT01702558|450770655|FG004|Overall Study|Lost to Follow-up|0|||
125312013|NCT01702558|450770651|FG000|Overall Study|Death|4|||
125650180|NCT01883362|452002793|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
125650181|NCT01883362|452002792|FG000|Post Treatment Follow-up|Administrative problems|2|||
125650182|NCT01883362|452002793|FG001|Post Treatment Follow-up|Administrative problems|0|||
125650183|NCT01883362|452002792|FG000|Post Treatment Follow-up|Death|8|||
125650184|NCT01883362|452002793|FG001|Post Treatment Follow-up|Death|4|||
125650185|NCT01883362|452002792|FG000|Post Treatment Follow-up|Relapse|1|||
125650186|NCT01883362|452002793|FG001|Post Treatment Follow-up|Relapse|2|||
125650187|NCT01349816|452002794|FG000|Overall Study|Withdrawal by Subject|4|||
125650188|NCT01349816|452002794|FG000|Overall Study|Physician Decision|1|||
125650189|NCT01349816|452002794|FG000|Overall Study|Adverse Event|14|||
125312014|NCT01702558|450770652|FG001|Overall Study|Death|3|||
125650190|NCT01349816|452002794|FG000|Overall Study|Lost to Follow-up|2|||
125650191|NCT01349816|452002794|FG000|Overall Study|Protocol Violation|1|||
125650192|NCT01349816|452002794|FG000|Overall Study|Protocol-specified criteria|8|||
125650193|NCT02569996|452002797|FG000|Overall Study|Adverse Event|6|||
125312015|NCT01702558|450770653|FG002|Overall Study|Death|3|||
125650194|NCT02569996|452002797|FG000|Overall Study|Physician Decision|3|||
125650195|NCT02569996|452002797|FG000|Overall Study|Progression of the disease|18|||
125650196|NCT02569996|452002797|FG000|Overall Study|New anti-lymphoma treatment|1|||
125650197|NCT02569996|452002797|FG000|Overall Study|Non-compliance|9|||
125312016|NCT01702558|450770654|FG003|Overall Study|Death|16|||
125650198|NCT02569996|452002797|FG000|Overall Study|Withdrawal by Subject|5|||
125650199|NCT02569996|452002797|FG000|Overall Study|Lost to Follow-up|5|||
125650200|NCT02569996|452002797|FG000|Overall Study|Complete remission|7|||
125650201|NCT02569996|452002797|FG000|Overall Study|Unknown reason|1|||
125650202|NCT01383317|452002798|FG000|Overall Study|Lost to Follow-up|2|||
125650203|NCT01383317|452002799|FG001|Overall Study|Lost to Follow-up|1|||
125650204|NCT01383317|452002798|FG000|Overall Study|Death|1|||
125650205|NCT01383317|452002799|FG001|Overall Study|Death|0|||
125650206|NCT01383317|452002798|FG000|Overall Study|Adverse Event|0|||
125650207|NCT01383317|452002799|FG001|Overall Study|Adverse Event|1|||
125650208|NCT01397409|452002802|FG000|Stage 2|Adverse Event|0|||
125650209|NCT01397409|452002803|FG001|Stage 2|Adverse Event|0|||
125650210|NCT01397409|452002804|FG002|Stage 2|Adverse Event|0|||
125650211|NCT01397409|452002805|FG003|Stage 2|Adverse Event|0|||
125650212|NCT01397409|452002806|FG004|Stage 2|Adverse Event|6|||
125650213|NCT01397409|452002807|FG005|Stage 2|Adverse Event|3|||
125650214|NCT01397409|452002808|FG006|Stage 2|Adverse Event|0|||
125650215|NCT01397409|452002809|FG007|Stage 2|Adverse Event|0|||
125650216|NCT01397409|452002810|FG008|Stage 2|Adverse Event|0|||
125425216|NCT02565914|451180374|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
125425217|NCT02316769|451180386|FG000|Overall Study|Physician Decision|1|||
125425218|NCT02316769|451180387|FG001|Overall Study|Physician Decision|0|||
125425219|NCT02316769|451180386|FG000|Overall Study|Withdrawal by Subject|1|||
125425220|NCT02316769|451180387|FG001|Overall Study|Withdrawal by Subject|0|||
125425221|NCT00677235|451180388|FG000|Overall Study|Withdrawal by Subject|1|||
125425222|NCT00677235|451180389|FG001|Overall Study|Withdrawal by Subject|1|||
125425223|NCT00677235|451180388|FG000|Overall Study|Lost to Follow-up|2|||
125425224|NCT00677235|451180389|FG001|Overall Study|Lost to Follow-up|1|||
125425225|NCT00677235|451180388|FG000|Overall Study|Death|37|||
125425226|NCT00677235|451180389|FG001|Overall Study|Death|36|||
125650217|NCT01397409|452002811|FG009|Stage 2|Adverse Event|0|||
125650218|NCT01397409|452002802|FG000|Stage 2|Personal Reasons|0|||
125650219|NCT01397409|452002803|FG001|Stage 2|Personal Reasons|0|||
125650220|NCT01397409|452002804|FG002|Stage 2|Personal Reasons|0|||
125650221|NCT01397409|452002805|FG003|Stage 2|Personal Reasons|0|||
125650222|NCT01397409|452002806|FG004|Stage 2|Personal Reasons|1|||
125650223|NCT01397409|452002807|FG005|Stage 2|Personal Reasons|0|||
125650224|NCT01397409|452002808|FG006|Stage 2|Personal Reasons|0|||
125650225|NCT01397409|452002809|FG007|Stage 2|Personal Reasons|0|||
125650226|NCT01397409|452002810|FG008|Stage 2|Personal Reasons|0|||
125650227|NCT01397409|452002811|FG009|Stage 2|Personal Reasons|0|||
125650228|NCT01397409|452002802|FG000|Stage 2|Other Miscellaneous Reasons|0|||
125650229|NCT01397409|452002803|FG001|Stage 2|Other Miscellaneous Reasons|0|||
125650230|NCT01397409|452002804|FG002|Stage 2|Other Miscellaneous Reasons|0|||
125650231|NCT01397409|452002805|FG003|Stage 2|Other Miscellaneous Reasons|0|||
125650232|NCT01397409|452002806|FG004|Stage 2|Other Miscellaneous Reasons|1|||
125650233|NCT01397409|452002807|FG005|Stage 2|Other Miscellaneous Reasons|1|||
125650234|NCT01397409|452002808|FG006|Stage 2|Other Miscellaneous Reasons|0|||
125650235|NCT01397409|452002809|FG007|Stage 2|Other Miscellaneous Reasons|0|||
125650236|NCT01397409|452002810|FG008|Stage 2|Other Miscellaneous Reasons|0|||
125650237|NCT01397409|452002811|FG009|Stage 2|Other Miscellaneous Reasons|0|||
125650238|NCT01397409|452002802|FG000|Stage 3|Adverse Event|0|||
125650239|NCT01397409|452002803|FG001|Stage 3|Adverse Event|0|||
125650240|NCT01397409|452002804|FG002|Stage 3|Adverse Event|0|||
125650241|NCT01397409|452002805|FG003|Stage 3|Adverse Event|0|||
125650242|NCT01397409|452002806|FG004|Stage 3|Adverse Event|0|||
125650243|NCT01397409|452002807|FG005|Stage 3|Adverse Event|0|||
125650244|NCT01397409|452002808|FG006|Stage 3|Adverse Event|0|||
125650245|NCT01397409|452002809|FG007|Stage 3|Adverse Event|1|||
125650246|NCT01397409|452002810|FG008|Stage 3|Adverse Event|0|||
125650247|NCT01397409|452002811|FG009|Stage 3|Adverse Event|0|||
125650248|NCT01397409|452002802|FG000|Stage 3|Other Miscellaneous Reasons|0|||
125650249|NCT01397409|452002803|FG001|Stage 3|Other Miscellaneous Reasons|0|||
125650250|NCT01397409|452002804|FG002|Stage 3|Other Miscellaneous Reasons|0|||
125650251|NCT01397409|452002805|FG003|Stage 3|Other Miscellaneous Reasons|0|||
125650252|NCT01397409|452002806|FG004|Stage 3|Other Miscellaneous Reasons|0|||
125425227|NCT00677235|451180388|FG000|Overall Study|Adverse Experience|1|||
125425228|NCT00677235|451180389|FG001|Overall Study|Adverse Experience|0|||
125425229|NCT01040260|451180390|FG000|Overall Study|Withdrawal by Subject|12|||
125425230|NCT01040260|451180391|FG001|Overall Study|Withdrawal by Subject|6|||
125425231|NCT01040260|451180390|FG000|Overall Study|Lost to Follow-up|3|||
125425232|NCT01040260|451180391|FG001|Overall Study|Lost to Follow-up|5|||
125425233|NCT04570436|451180392|FG000|Overall Study|Adverse Event|0|||
125650253|NCT01397409|452002807|FG005|Stage 3|Other Miscellaneous Reasons|0|||
125425234|NCT04570436|451180393|FG001|Overall Study|Adverse Event|0|||
125650254|NCT01397409|452002808|FG006|Stage 3|Other Miscellaneous Reasons|0|||
125650255|NCT01397409|452002809|FG007|Stage 3|Other Miscellaneous Reasons|1|||
125650256|NCT01397409|452002810|FG008|Stage 3|Other Miscellaneous Reasons|0|||
125650257|NCT01397409|452002811|FG009|Stage 3|Other Miscellaneous Reasons|0|||
125650258|NCT01207427|452002812|FG000|Double-blind Treatment Period|Adverse Event|0|||
125650259|NCT01207427|452002813|FG001|Double-blind Treatment Period|Adverse Event|1|||
125425235|NCT04570436|451180394|FG002|Overall Study|Adverse Event|1|||
125425236|NCT04570436|451180395|FG003|Overall Study|Adverse Event|0|||
125425237|NCT04570436|451180396|FG004|Overall Study|Adverse Event|0|||
125425238|NCT04570436|451180397|FG005|Overall Study|Adverse Event|0|||
125425239|NCT04570436|451180398|FG006|Overall Study|Adverse Event|0|||
125425240|NCT04570436|451180399|FG007|Overall Study|Adverse Event|0|||
125425241|NCT04570436|451180400|FG008|Overall Study|Adverse Event|0|||
125425242|NCT04570436|451180401|FG009|Overall Study|Adverse Event|0|||
125425243|NCT04570436|451180392|FG000|Overall Study|Physician Decision|1|||
125425244|NCT04570436|451180393|FG001|Overall Study|Physician Decision|0|||
125425245|NCT04570436|451180394|FG002|Overall Study|Physician Decision|0|||
125425246|NCT04570436|451180395|FG003|Overall Study|Physician Decision|0|||
125425247|NCT04570436|451180396|FG004|Overall Study|Physician Decision|0|||
125425248|NCT04570436|451180397|FG005|Overall Study|Physician Decision|0|||
125425249|NCT04570436|451180398|FG006|Overall Study|Physician Decision|0|||
125425250|NCT04570436|451180399|FG007|Overall Study|Physician Decision|0|||
125425251|NCT04570436|451180400|FG008|Overall Study|Physician Decision|0|||
125425252|NCT04570436|451180401|FG009|Overall Study|Physician Decision|0|||
125425253|NCT00929162|451180403|FG000|Overall Study|Adverse Event|8|||
125425254|NCT00929162|451180404|FG001|Overall Study|Adverse Event|5|||
125312017|NCT01702558|450770655|FG004|Overall Study|Death|20|||
125312018|NCT01702558|450770651|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
125312019|NCT01702558|450770652|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
125312020|NCT01702558|450770653|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
125312021|NCT01702558|450770654|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
125312022|NCT01702558|450770655|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
125312023|NCT01702558|450770651|FG000|Overall Study|Study Terminated by Sponsor|0|||
125312024|NCT01702558|450770652|FG001|Overall Study|Study Terminated by Sponsor|1|||
125312025|NCT01702558|450770653|FG002|Overall Study|Study Terminated by Sponsor|0|||
125312026|NCT01702558|450770654|FG003|Overall Study|Study Terminated by Sponsor|0|||
125312027|NCT01702558|450770655|FG004|Overall Study|Study Terminated by Sponsor|1|||
125312028|NCT01702558|450770651|FG000|Overall Study|Other|0|||
125312029|NCT01702558|450770652|FG001|Overall Study|Other|0|||
125312030|NCT01702558|450770653|FG002|Overall Study|Other|0|||
125312031|NCT01702558|450770654|FG003|Overall Study|Other|16|||
125312032|NCT01702558|450770655|FG004|Overall Study|Other|17|||
125312033|NCT03259087|450770658|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
125312034|NCT03259087|450770659|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
125312035|NCT03259087|450770660|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
125312036|NCT03259087|450770661|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
125312037|NCT03259087|450770662|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
125312038|NCT03259087|450770658|FG000|Period 2 of Part 2|Adverse Event|0|||
125312039|NCT03259087|450770659|FG001|Period 2 of Part 2|Adverse Event|0|||
125312040|NCT03259087|450770660|FG002|Period 2 of Part 2|Adverse Event|0|||
125312041|NCT03259087|450770661|FG003|Period 2 of Part 2|Adverse Event|0|||
125312042|NCT03259087|450770662|FG004|Period 2 of Part 2|Adverse Event|1|||
125312043|NCT04950465|450770663|FG000|Overall Study|Lost to Follow-up|1|||
125312044|NCT04950465|450770664|FG001|Overall Study|Lost to Follow-up|0|||
125312045|NCT04950465|450770665|FG002|Overall Study|Lost to Follow-up|0|||
125312046|NCT01788566|450770666|FG000|Overall Study|Death|4|||
125312047|NCT01788566|450770666|FG000|Overall Study|Adverse Event|1|||
125312048|NCT01788566|450770666|FG000|Overall Study|Clinical Progressive Disease|3|||
125312049|NCT01620086|450770669|FG000|Overall Study|Withdrawal by Subject|3|||
125312050|NCT01620086|450770670|FG001|Overall Study|Withdrawal by Subject|3|||
125312051|NCT01620086|450770671|FG002|Overall Study|Withdrawal by Subject|0|||
125425255|NCT00929162|451180403|FG000|Overall Study|Withdrawal by Subject|3|||
125425256|NCT00929162|451180404|FG001|Overall Study|Withdrawal by Subject|1|||
125425257|NCT00929162|451180403|FG000|Overall Study|Protocol Violation|32|||
125425258|NCT00929162|451180404|FG001|Overall Study|Protocol Violation|30|||
125425259|NCT00929162|451180403|FG000|Overall Study|Other termination reason|5|||
125425260|NCT00929162|451180404|FG001|Overall Study|Other termination reason|6|||
125425261|NCT03205371|451180407|FG000|Overall Study|Withdrawal by Subject|4|||
125425262|NCT03205371|451180408|FG001|Overall Study|Withdrawal by Subject|1|||
125312052|NCT01620086|450770669|FG000|Overall Study|failed study criteria|1|||
125312053|NCT01620086|450770670|FG001|Overall Study|failed study criteria|4|||
125312054|NCT01620086|450770671|FG002|Overall Study|failed study criteria|0|||
125312055|NCT01620086|450770669|FG000|Overall Study|Physician Decision|1|||
125312056|NCT01620086|450770670|FG001|Overall Study|Physician Decision|0|||
125312057|NCT01620086|450770671|FG002|Overall Study|Physician Decision|0|||
125312058|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Progressive disease|50|||
125312059|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Progressive disease|110|||
125425263|NCT03205371|451180409|FG002|Overall Study|Withdrawal by Subject|0|||
125425264|NCT03205371|451180410|FG003|Overall Study|Withdrawal by Subject|0|||
125425265|NCT03205371|451180411|FG004|Overall Study|Withdrawal by Subject|0|||
125425266|NCT03205371|451180412|FG005|Overall Study|Withdrawal by Subject|0|||
125425267|NCT03205371|451180413|FG006|Overall Study|Withdrawal by Subject|4|||
125425268|NCT03205371|451180414|FG007|Overall Study|Withdrawal by Subject|0|||
125425269|NCT03205371|451180415|FG008|Overall Study|Withdrawal by Subject|2|||
125425270|NCT03205371|451180416|FG009|Overall Study|Withdrawal by Subject|0|||
125312060|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Progressive disease|0|||
125312061|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Progressive disease|0|||
125312062|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
125312063|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
125312064|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125312065|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125312066|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Adverse Event|7|||
125312067|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Adverse Event|7|||
125312068|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Adverse Event|0|||
125312069|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Adverse Event|0|||
125312070|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Other|1|||
125312071|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Other|3|||
125312072|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Other|0|||
125312073|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Other|0|||
125312074|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Physician Decision|6|||
125312075|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Physician Decision|3|||
125312076|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Physician Decision|0|||
125312077|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Physician Decision|0|||
125312078|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Death|1|||
125312079|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Death|1|||
125312080|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Death|0|||
125312081|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Death|0|||
125312082|NCT01695135|450770672|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
125312083|NCT01695135|450770673|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
125312084|NCT01695135|450770674|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
125312085|NCT01695135|450770675|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
125312086|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
125312087|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
125312088|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
125312089|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
125312090|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
125312091|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
125312092|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
125312093|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
125312094|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
125425271|NCT03205371|451180417|FG010|Overall Study|Withdrawal by Subject|0|||
125425272|NCT03205371|451180418|FG011|Overall Study|Withdrawal by Subject|1|||
125425273|NCT03205371|451180407|FG000|Overall Study|Lost to Follow-up|0|||
125425274|NCT03205371|451180408|FG001|Overall Study|Lost to Follow-up|0|||
125425275|NCT03205371|451180409|FG002|Overall Study|Lost to Follow-up|0|||
125425276|NCT03205371|451180410|FG003|Overall Study|Lost to Follow-up|0|||
125425277|NCT03205371|451180411|FG004|Overall Study|Lost to Follow-up|0|||
125425278|NCT03205371|451180412|FG005|Overall Study|Lost to Follow-up|0|||
125425279|NCT03205371|451180413|FG006|Overall Study|Lost to Follow-up|5|||
125425280|NCT03205371|451180414|FG007|Overall Study|Lost to Follow-up|2|||
125425281|NCT03205371|451180415|FG008|Overall Study|Lost to Follow-up|3|||
125425282|NCT03205371|451180416|FG009|Overall Study|Lost to Follow-up|0|||
125425283|NCT03205371|451180417|FG010|Overall Study|Lost to Follow-up|0|||
125425284|NCT03205371|451180418|FG011|Overall Study|Lost to Follow-up|0|||
125425285|NCT03205371|451180407|FG000|Overall Study|Protocol Violation|0|||
125425286|NCT03205371|451180408|FG001|Overall Study|Protocol Violation|0|||
125425287|NCT03205371|451180409|FG002|Overall Study|Protocol Violation|0|||
125425288|NCT03205371|451180410|FG003|Overall Study|Protocol Violation|0|||
125425289|NCT03205371|451180411|FG004|Overall Study|Protocol Violation|0|||
125425290|NCT03205371|451180412|FG005|Overall Study|Protocol Violation|0|||
125425291|NCT03205371|451180413|FG006|Overall Study|Protocol Violation|1|||
125650260|NCT01207427|452002814|FG002|Double-blind Treatment Period|Adverse Event|0|||
125650261|NCT01207427|452002812|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
125312095|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
125425292|NCT03205371|451180414|FG007|Overall Study|Protocol Violation|0|||
125425293|NCT03205371|451180415|FG008|Overall Study|Protocol Violation|0|||
125425294|NCT03205371|451180416|FG009|Overall Study|Protocol Violation|0|||
125425295|NCT03205371|451180417|FG010|Overall Study|Protocol Violation|0|||
125650262|NCT01207427|452002813|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
125650263|NCT01207427|452002814|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
125650264|NCT01207427|452002812|FG000|Double-blind Treatment Period|Protocol Violation|2|||
125650265|NCT01207427|452002813|FG001|Double-blind Treatment Period|Protocol Violation|1|||
125650266|NCT01207427|452002814|FG002|Double-blind Treatment Period|Protocol Violation|1|||
125650267|NCT01207427|452002812|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
125650268|NCT01207427|452002813|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
125650269|NCT01207427|452002814|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125650270|NCT01790633|452002815|FG000|Overall Study|Protocol Violation|1|||
125425296|NCT03205371|451180418|FG011|Overall Study|Protocol Violation|0|||
125425297|NCT03205371|451180407|FG000|Overall Study|Adverse Event|0|||
125425298|NCT03205371|451180408|FG001|Overall Study|Adverse Event|0|||
125425299|NCT03205371|451180409|FG002|Overall Study|Adverse Event|0|||
125425300|NCT03205371|451180410|FG003|Overall Study|Adverse Event|0|||
125425301|NCT03205371|451180411|FG004|Overall Study|Adverse Event|0|||
125425302|NCT03205371|451180412|FG005|Overall Study|Adverse Event|0|||
125425303|NCT03205371|451180413|FG006|Overall Study|Adverse Event|0|||
125425304|NCT03205371|451180414|FG007|Overall Study|Adverse Event|1|||
125425305|NCT03205371|451180415|FG008|Overall Study|Adverse Event|0|||
125425306|NCT03205371|451180416|FG009|Overall Study|Adverse Event|0|||
125425307|NCT03205371|451180417|FG010|Overall Study|Adverse Event|0|||
125425308|NCT03205371|451180418|FG011|Overall Study|Adverse Event|0|||
125425309|NCT02835339|451180420|FG000|Overall Study|Did not receive allocated intervention|13|||
125425310|NCT02835339|451180421|FG001|Overall Study|Did not receive allocated intervention|16|||
125425311|NCT01077544|451180422|FG000|Overall Study|New Cancer Therapy|3|||
125425312|NCT01077544|451180423|FG001|Overall Study|New Cancer Therapy|3|||
125425313|NCT01077544|451180422|FG000|Overall Study|Adverse Event|0|||
125425314|NCT01077544|451180423|FG001|Overall Study|Adverse Event|1|||
125425315|NCT01077544|451180422|FG000|Overall Study|Disease Progression|0|||
125425316|NCT01077544|451180423|FG001|Overall Study|Disease Progression|1|||
125425317|NCT03923959|451180424|FG000|Overall Study|Death|16|||
125425318|NCT03923959|451180425|FG001|Overall Study|Death|12|||
125425319|NCT03923959|451180424|FG000|Overall Study|Lost to Follow-up|56|||
125425320|NCT03923959|451180425|FG001|Overall Study|Lost to Follow-up|56|||
125425321|NCT03923959|451180424|FG000|Overall Study|Withdrawal by Subject|1|||
125425322|NCT03923959|451180425|FG001|Overall Study|Withdrawal by Subject|1|||
125425323|NCT03923959|451180424|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
125425324|NCT03923959|451180425|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
125425325|NCT04918147|451180426|FG000|Overall Study|Disease flare as defined in protocol|0|||
125425326|NCT04918147|451180427|FG001|Overall Study|Disease flare as defined in protocol|2|||
125425327|NCT01375114|451180429|FG000|Overall Study|Lost to Follow-up|1|||
125425328|NCT01375114|451180430|FG001|Overall Study|Lost to Follow-up|0|||
125650271|NCT01790633|452002816|FG001|Overall Study|Protocol Violation|2|||
125650272|NCT01790633|452002815|FG000|Overall Study|Did not have serology performed|47|||
125650273|NCT01790633|452002816|FG001|Overall Study|Did not have serology performed|0|||
125650274|NCT01790633|452002815|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
125650275|NCT01790633|452002816|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
125650276|NCT02930889|452004515|FG000|Overall Study|Lost to Follow-up|2|||
125650277|NCT02930889|452004515|FG000|Overall Study|Withdrawal by Subject|6|||
125650278|NCT02930889|452004515|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
125650279|NCT00198107|452004519|FG000|Double-Blind Period|Adverse Event|1|||
125650280|NCT00198107|452004520|FG001|Double-Blind Period|Adverse Event|1|||
125650281|NCT00198107|452004521|FG002|Double-Blind Period|Adverse Event|0|||
125650282|NCT00198107|452004519|FG000|Double-Blind Period|Lack of Efficacy|2|||
125650283|NCT00198107|452004520|FG001|Double-Blind Period|Lack of Efficacy|0|||
125650284|NCT00198107|452004521|FG002|Double-Blind Period|Lack of Efficacy|0|||
125650285|NCT00198107|452004519|FG000|Double-Blind Period|Lost to Follow-up|2|||
125650286|NCT00198107|452004520|FG001|Double-Blind Period|Lost to Follow-up|1|||
125650287|NCT00198107|452004521|FG002|Double-Blind Period|Lost to Follow-up|0|||
125650288|NCT00198107|452004519|FG000|Double-Blind Period|Physician Decision|1|||
125650289|NCT00198107|452004520|FG001|Double-Blind Period|Physician Decision|0|||
125650290|NCT00198107|452004521|FG002|Double-Blind Period|Physician Decision|0|||
125650291|NCT00198107|452004519|FG000|Double-Blind Period|Withdrawal by Subject|0|||
125650292|NCT00198107|452004520|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125650293|NCT00198107|452004521|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125650294|NCT00198107|452004519|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
125425329|NCT01375114|451180431|FG002|Overall Study|Lost to Follow-up|1|||
125425330|NCT01375114|451180429|FG000|Overall Study|Disease Progression|3|||
125425331|NCT01375114|451180430|FG001|Overall Study|Disease Progression|2|||
125425332|NCT01375114|451180431|FG002|Overall Study|Disease Progression|2|||
125425333|NCT01375114|451180429|FG000|Overall Study|Patient Changed Mind|0|||
125650295|NCT00198107|452004520|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
125425334|NCT01375114|451180430|FG001|Overall Study|Patient Changed Mind|0|||
125425335|NCT01375114|451180431|FG002|Overall Study|Patient Changed Mind|2|||
125425336|NCT01375114|451180429|FG000|Overall Study|Pruritus|0|||
125425337|NCT01375114|451180430|FG001|Overall Study|Pruritus|0|||
125425338|NCT01375114|451180431|FG002|Overall Study|Pruritus|1|||
125425339|NCT01375114|451180429|FG000|Overall Study|Restlessness|0|||
125425340|NCT01375114|451180430|FG001|Overall Study|Restlessness|0|||
125425341|NCT01375114|451180431|FG002|Overall Study|Restlessness|1|||
125425342|NCT01375114|451180429|FG000|Overall Study|Diarrhea|0|||
125425343|NCT01375114|451180430|FG001|Overall Study|Diarrhea|0|||
125425344|NCT01375114|451180431|FG002|Overall Study|Diarrhea|1|||
125425345|NCT01375114|451180429|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
125312096|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
125312097|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
125312098|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Other|0|||
125540270|NCT00911937|451607573|FG000|Overall Study|Lack of Efficacy|11|||
125540271|NCT00911937|451607574|FG001|Overall Study|Lack of Efficacy|6|||
125540272|NCT00911937|451607573|FG000|Overall Study|Did not meet inclusion criteria|9|||
125540273|NCT00911937|451607574|FG001|Overall Study|Did not meet inclusion criteria|11|||
125540274|NCT00911937|451607573|FG000|Overall Study|Protocol Violation|14|||
125540275|NCT00911937|451607574|FG001|Overall Study|Protocol Violation|23|||
125540276|NCT00911937|451607573|FG000|Overall Study|Randomized but not treated|13|||
125540277|NCT00911937|451607574|FG001|Overall Study|Randomized but not treated|13|||
125540278|NCT00911937|451607573|FG000|Overall Study|Other|9|||
125540279|NCT00911937|451607574|FG001|Overall Study|Other|5|||
125540280|NCT01498679|451607579|FG000|Overall Study|Adverse Event|1|||
125540281|NCT01498679|451607580|FG001|Overall Study|Adverse Event|4|||
125540282|NCT01498679|451607579|FG000|Overall Study|Lack of Efficacy|72|||
125540283|NCT01498679|451607580|FG001|Overall Study|Lack of Efficacy|12|||
125540284|NCT01498679|451607579|FG000|Overall Study|Protocol Violation|4|||
125540285|NCT01498679|451607580|FG001|Overall Study|Protocol Violation|0|||
125540286|NCT01498679|451607579|FG000|Overall Study|Physician Decision|0|||
125540287|NCT01498679|451607580|FG001|Overall Study|Physician Decision|2|||
125540288|NCT01498679|451607579|FG000|Overall Study|Withdrawal by Subject|12|||
125540289|NCT01498679|451607580|FG001|Overall Study|Withdrawal by Subject|4|||
125540290|NCT03212989|451607582|FG000|Overall Study|Physician Decision|8|||
125540291|NCT00252577|451607585|FG000|Overall Study|Lost to Follow-up|20|||
125540292|NCT01801735|451607588|FG000|Overall Study|Adverse Event|79|||
125540293|NCT01801735|451607588|FG000|Overall Study|Lack of Efficacy|28|||
125540294|NCT01801735|451607588|FG000|Overall Study|Withdrawal by Subject|27|||
125540295|NCT01801735|451607588|FG000|Overall Study|Protocol Violation|25|||
125540296|NCT01801735|451607588|FG000|Overall Study|Lost to Follow-up|15|||
125540297|NCT01801735|451607588|FG000|Overall Study|Non-compliance with Trial Drug|13|||
125540298|NCT01801735|451607588|FG000|Overall Study|Physician Decision|3|||
125540299|NCT01801735|451607588|FG000|Overall Study|Death|1|||
125540300|NCT01801735|451607588|FG000|Overall Study|Other, including site closure|19|||
125540301|NCT00560066|451607589|FG000|Overall Study|Death|2|||
125540302|NCT00560066|451607590|FG001|Overall Study|Death|1|||
125540303|NCT00560066|451607589|FG000|Overall Study|Withdrawal by Subject|0|||
125540304|NCT00560066|451607590|FG001|Overall Study|Withdrawal by Subject|3|||
125540305|NCT00560066|451607589|FG000|Overall Study|Lost to Follow-up|4|||
125540306|NCT00560066|451607590|FG001|Overall Study|Lost to Follow-up|10|||
125540307|NCT00560066|451607589|FG000|Overall Study|Protocol Violation|0|||
125540308|NCT00560066|451607590|FG001|Overall Study|Protocol Violation|1|||
125540309|NCT00560066|451607589|FG000|Overall Study|Administrative reason|0|||
125540310|NCT00560066|451607590|FG001|Overall Study|Administrative reason|5|||
125540311|NCT00560066|451607589|FG000|Overall Study|Missing primary reason|0|||
125540312|NCT00560066|451607590|FG001|Overall Study|Missing primary reason|2|||
125540313|NCT00620282|451607591|FG000|Overall Study|Adverse Event|0|||
125540314|NCT00620282|451607592|FG001|Overall Study|Adverse Event|1|||
125540315|NCT00620282|451607593|FG002|Overall Study|Adverse Event|0|||
125540316|NCT00620282|451607591|FG000|Overall Study|Arterial line unable to be placed|0|||
125540317|NCT00620282|451607592|FG001|Overall Study|Arterial line unable to be placed|0|||
125540318|NCT00620282|451607593|FG002|Overall Study|Arterial line unable to be placed|1|||
125540319|NCT00620282|451607591|FG000|Overall Study|Withdrawal by Subject|0|||
125540320|NCT00620282|451607592|FG001|Overall Study|Withdrawal by Subject|1|||
125540321|NCT00620282|451607593|FG002|Overall Study|Withdrawal by Subject|0|||
125540322|NCT01258595|451607594|FG000|Overall Study|Lost to Follow-up|1|||
125540323|NCT01258595|451607595|FG001|Overall Study|Lost to Follow-up|0|||
125540324|NCT01258595|451607594|FG000|Overall Study|Withdrawal by Subject|0|||
125540325|NCT01258595|451607595|FG001|Overall Study|Withdrawal by Subject|1|||
125540326|NCT04738292|451607596|FG000|Overall Study|Death|1|||
125540327|NCT01820585|451607597|FG000|Overall Study|Adverse Event|9|||
125540328|NCT01820585|451607598|FG001|Overall Study|Adverse Event|13|||
125312099|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Other|0|||
125540329|NCT01820585|451607599|FG002|Overall Study|Adverse Event|23|||
125540330|NCT01820585|451607600|FG003|Overall Study|Adverse Event|34|||
125540331|NCT01820585|451607597|FG000|Overall Study|Lack of Efficacy|9|||
125540332|NCT01820585|451607598|FG001|Overall Study|Lack of Efficacy|7|||
125540333|NCT01820585|451607599|FG002|Overall Study|Lack of Efficacy|5|||
125540334|NCT01820585|451607600|FG003|Overall Study|Lack of Efficacy|1|||
125540335|NCT01820585|451607597|FG000|Overall Study|Withdrawal by Subject|3|||
125540336|NCT01820585|451607598|FG001|Overall Study|Withdrawal by Subject|7|||
125540337|NCT01820585|451607599|FG002|Overall Study|Withdrawal by Subject|3|||
125540338|NCT01820585|451607600|FG003|Overall Study|Withdrawal by Subject|8|||
125540339|NCT01820585|451607597|FG000|Overall Study|Lost to Follow-up|3|||
125540340|NCT01820585|451607598|FG001|Overall Study|Lost to Follow-up|3|||
125540341|NCT01820585|451607599|FG002|Overall Study|Lost to Follow-up|0|||
125540342|NCT01820585|451607600|FG003|Overall Study|Lost to Follow-up|3|||
125540343|NCT01820585|451607597|FG000|Overall Study|Protocol Violation|3|||
125425346|NCT01375114|451180430|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
125425347|NCT01375114|451180431|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
125425348|NCT01375114|451180429|FG000|Overall Study|Nausea|0|||
125425349|NCT01375114|451180430|FG001|Overall Study|Nausea|1|||
125425350|NCT01375114|451180431|FG002|Overall Study|Nausea|0|||
125425351|NCT01375114|451180429|FG000|Overall Study|Increased AST/ALT|0|||
125425352|NCT01375114|451180430|FG001|Overall Study|Increased AST/ALT|1|||
125650296|NCT00198107|452004521|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
125650297|NCT03996694|452004530|FG000|First Washout (7 Days)|positive urine drug screen|0|||
125425353|NCT01375114|451180431|FG002|Overall Study|Increased AST/ALT|0|||
125425354|NCT01375114|451180429|FG000|Overall Study|Vaginal Hemorrhage|0|||
125425355|NCT01375114|451180430|FG001|Overall Study|Vaginal Hemorrhage|1|||
125425356|NCT01375114|451180431|FG002|Overall Study|Vaginal Hemorrhage|0|||
125312100|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Other|4|||
125312101|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Other|7|||
125312102|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
125312103|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
125312104|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
125312105|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
125312106|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Death|0|||
125312107|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Death|0|||
125312108|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Death|2|||
125312109|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Death|7|||
125312110|NCT01695135|450770672|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
125312111|NCT01695135|450770673|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
125312112|NCT01695135|450770674|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
125312113|NCT01695135|450770675|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
125312114|NCT02562716|450770676|FG000|Overall Study|Adverse Event|7|||
125312115|NCT02562716|450770677|FG001|Overall Study|Adverse Event|14|||
125312116|NCT02562716|450770676|FG000|Overall Study|Withdrawal unrelated to AE|7|||
125312117|NCT02562716|450770677|FG001|Overall Study|Withdrawal unrelated to AE|1|||
125312118|NCT02562716|450770676|FG000|Overall Study|Progression|8|||
125312119|NCT02562716|450770677|FG001|Overall Study|Progression|10|||
125312120|NCT02562716|450770676|FG000|Overall Study|Death|2|||
125312121|NCT02562716|450770677|FG001|Overall Study|Death|1|||
125312122|NCT02562716|450770676|FG000|Overall Study|Not protocol specified|4|||
125312123|NCT02562716|450770677|FG001|Overall Study|Not protocol specified|2|||
125312124|NCT00684996|450770678|FG000|Overall Study|Adverse Event|1|||
125312125|NCT00684996|450770678|FG000|Overall Study|Refusal unrelated to adverse event|1|||
125312126|NCT00684996|450770678|FG000|Overall Study|Progression/relapse|2|||
125312127|NCT00684996|450770678|FG000|Overall Study|Other reasons not protocol specified|1|||
125312128|NCT01076959|450770681|FG000|Overall Study|Adverse Event|767|||
125312129|NCT01076959|450770681|FG000|Overall Study|Lack of Efficacy|849|||
125312130|NCT01076959|450770681|FG000|Overall Study|Non-compliance|274|||
125312131|NCT01076959|450770681|FG000|Overall Study|Lost to Follow-up|241|||
125312132|NCT01076959|450770681|FG000|Overall Study|Other|119|||
125312133|NCT01078441|450770682|FG000|Overall Study|Withdrawal by Subject|1|||
125425357|NCT01375114|451180429|FG000|Overall Study|Family problem|0|||
125425358|NCT01375114|451180430|FG001|Overall Study|Family problem|1|||
125425359|NCT01375114|451180431|FG002|Overall Study|Family problem|0|||
125425360|NCT01375114|451180429|FG000|Overall Study|Protocol Violation|2|||
125425361|NCT01375114|451180430|FG001|Overall Study|Protocol Violation|0|||
125425362|NCT01375114|451180431|FG002|Overall Study|Protocol Violation|0|||
125425363|NCT03338829|451180432|FG000|Overall Study|Lost to Follow-up|4|||
125425364|NCT03338829|451180433|FG001|Overall Study|Lost to Follow-up|2|||
125425365|NCT03338829|451180434|FG002|Overall Study|Lost to Follow-up|4|||
125425366|NCT03338829|451180432|FG000|Overall Study|Pregnancy loss|1|||
125425367|NCT03338829|451180433|FG001|Overall Study|Pregnancy loss|1|||
125425368|NCT03338829|451180434|FG002|Overall Study|Pregnancy loss|0|||
125425369|NCT03338829|451180432|FG000|Overall Study|Protocol Violation|0|||
125650298|NCT03996694|452004531|FG001|First Washout (7 Days)|positive urine drug screen|0|||
125650299|NCT03996694|452004532|FG002|First Washout (7 Days)|positive urine drug screen|1|||
125650300|NCT03996694|452004533|FG003|First Washout (7 Days)|positive urine drug screen|0|||
125650301|NCT03996694|452004534|FG004|First Washout (7 Days)|positive urine drug screen|0|||
125650302|NCT03996694|452004535|FG005|First Washout (7 Days)|positive urine drug screen|0|||
125650303|NCT03996694|452004530|FG000|First Washout (7 Days)|Adverse Event|0|||
125650304|NCT03996694|452004531|FG001|First Washout (7 Days)|Adverse Event|1|||
125312134|NCT01425801|450770683|FG000|Period 1|Withdrawal by Subject|0|||
125312135|NCT01425801|450770684|FG001|Period 1|Withdrawal by Subject|0|||
125312136|NCT01425801|450770685|FG002|Period 1|Withdrawal by Subject|0|||
125650305|NCT03996694|452004532|FG002|First Washout (7 Days)|Adverse Event|0|||
125312137|NCT01425801|450770686|FG003|Period 1|Withdrawal by Subject|0|||
125425370|NCT03338829|451180433|FG001|Overall Study|Protocol Violation|1|||
125425371|NCT03338829|451180434|FG002|Overall Study|Protocol Violation|0|||
125425372|NCT03575325|451180438|FG000|Overall Study|Death|1|||
125650306|NCT03996694|452004533|FG003|First Washout (7 Days)|Adverse Event|0|||
125650307|NCT03996694|452004534|FG004|First Washout (7 Days)|Adverse Event|0|||
125650308|NCT03996694|452004535|FG005|First Washout (7 Days)|Adverse Event|0|||
125650309|NCT03996694|452004530|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
125650310|NCT03996694|452004531|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
125650311|NCT03996694|452004532|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
125650312|NCT03996694|452004533|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
125650313|NCT03996694|452004534|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
125425373|NCT02355743|451180449|FG000|Overall Study|Withdrawal by Subject|1|||
125425374|NCT02355743|451180449|FG000|Overall Study|Lost to Follow-up|1|||
125425375|NCT04212091|451180450|FG000|Overall Study|Lost to Follow-up|0|||
125425376|NCT04212091|451180451|FG001|Overall Study|Lost to Follow-up|0|||
125425377|NCT04212091|451180452|FG002|Overall Study|Lost to Follow-up|0|||
125425378|NCT04212091|451180453|FG003|Overall Study|Lost to Follow-up|0|||
125425379|NCT04212091|451180454|FG004|Overall Study|Lost to Follow-up|1|||
125425380|NCT04212091|451180455|FG005|Overall Study|Lost to Follow-up|1|||
125425381|NCT04212091|451180450|FG000|Overall Study|Participant unable to adhere to visit|0|||
125425382|NCT04212091|451180451|FG001|Overall Study|Participant unable to adhere to visit|0|||
125425383|NCT04212091|451180452|FG002|Overall Study|Participant unable to adhere to visit|0|||
125425384|NCT04212091|451180453|FG003|Overall Study|Participant unable to adhere to visit|0|||
125425385|NCT04212091|451180454|FG004|Overall Study|Participant unable to adhere to visit|1|||
125425386|NCT04212091|451180455|FG005|Overall Study|Participant unable to adhere to visit|0|||
125425387|NCT02612311|451180456|FG000|Overall Study|Adverse Event|16|||
125425388|NCT02612311|451180457|FG001|Overall Study|Adverse Event|12|||
125425389|NCT02612311|451180458|FG002|Overall Study|Adverse Event|7|||
125425390|NCT02612311|451180459|FG003|Overall Study|Adverse Event|13|||
125425391|NCT02612311|451180456|FG000|Overall Study|Death|29|||
125425392|NCT02612311|451180457|FG001|Overall Study|Death|10|||
125425393|NCT02612311|451180458|FG002|Overall Study|Death|11|||
125425394|NCT02612311|451180459|FG003|Overall Study|Death|11|||
125425395|NCT02612311|451180456|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
125425396|NCT02612311|451180457|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
125425397|NCT02612311|451180458|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
125425398|NCT02612311|451180459|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
125425399|NCT02612311|451180456|FG000|Overall Study|Investigator's Decision|11|||
125425400|NCT02612311|451180457|FG001|Overall Study|Investigator's Decision|15|||
125425401|NCT02612311|451180458|FG002|Overall Study|Investigator's Decision|6|||
125425402|NCT02612311|451180459|FG003|Overall Study|Investigator's Decision|6|||
125425403|NCT02612311|451180456|FG000|Overall Study|Lack of Efficacy|0|||
125425404|NCT02612311|451180457|FG001|Overall Study|Lack of Efficacy|0|||
125425405|NCT02612311|451180458|FG002|Overall Study|Lack of Efficacy|1|||
125425406|NCT02612311|451180459|FG003|Overall Study|Lack of Efficacy|1|||
125425407|NCT02612311|451180456|FG000|Overall Study|Lost to Follow-up|2|||
125425408|NCT02612311|451180457|FG001|Overall Study|Lost to Follow-up|2|||
125425409|NCT02612311|451180458|FG002|Overall Study|Lost to Follow-up|1|||
125425410|NCT02612311|451180459|FG003|Overall Study|Lost to Follow-up|2|||
125425411|NCT02612311|451180456|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
125425412|NCT02612311|451180457|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
125425413|NCT02612311|451180458|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
125425414|NCT02612311|451180459|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
125425415|NCT02612311|451180456|FG000|Overall Study|Site Terminated by Sponsor|29|||
125425416|NCT02612311|451180457|FG001|Overall Study|Site Terminated by Sponsor|12|||
125425417|NCT02612311|451180458|FG002|Overall Study|Site Terminated by Sponsor|13|||
125425418|NCT02612311|451180459|FG003|Overall Study|Site Terminated by Sponsor|5|||
125425419|NCT02612311|451180456|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
125425420|NCT02612311|451180457|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
125425421|NCT02612311|451180458|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
125425422|NCT02612311|451180459|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
125425423|NCT02612311|451180456|FG000|Overall Study|Reason Not Specified|3|||
125425424|NCT02612311|451180457|FG001|Overall Study|Reason Not Specified|7|||
125425425|NCT02612311|451180458|FG002|Overall Study|Reason Not Specified|4|||
125425426|NCT02612311|451180459|FG003|Overall Study|Reason Not Specified|5|||
125425427|NCT02612311|451180456|FG000|Overall Study|Unknown/Missing|10|||
125425428|NCT02612311|451180457|FG001|Overall Study|Unknown/Missing|13|||
125425429|NCT02612311|451180458|FG002|Overall Study|Unknown/Missing|4|||
125425430|NCT02612311|451180459|FG003|Overall Study|Unknown/Missing|0|||
125425431|NCT02612311|451180456|FG000|Overall Study|Non-Compliance with Study|1|||
125425432|NCT02612311|451180457|FG001|Overall Study|Non-Compliance with Study|0|||
125425433|NCT02612311|451180458|FG002|Overall Study|Non-Compliance with Study|0|||
125312138|NCT01425801|450770687|FG004|Period 1|Withdrawal by Subject|1|||
125425434|NCT02612311|451180459|FG003|Overall Study|Non-Compliance with Study|0|||
125425435|NCT00715429|451180460|FG000|Overall Study|Did not complete the study diary|0|||
125425436|NCT00715429|451180461|FG001|Overall Study|Did not complete the study diary|1|||
125312139|NCT01425801|450770688|FG005|Period 1|Withdrawal by Subject|0|||
125312140|NCT01425801|450770683|FG000|Period 2|Withdrawal by Subject|0|||
125312141|NCT01425801|450770684|FG001|Period 2|Withdrawal by Subject|0|||
125312142|NCT01425801|450770685|FG002|Period 2|Withdrawal by Subject|0|||
125312143|NCT01425801|450770686|FG003|Period 2|Withdrawal by Subject|0|||
125312144|NCT01425801|450770687|FG004|Period 2|Withdrawal by Subject|1|||
125312145|NCT01425801|450770688|FG005|Period 2|Withdrawal by Subject|0|||
125312146|NCT01425801|450770683|FG000|Period 3|Stability criteria not fullfilled|0|||
125312147|NCT01425801|450770684|FG001|Period 3|Stability criteria not fullfilled|0|||
125425437|NCT04085328|451180462|FG000|Overall Study|Witihdrew Consent|16|||
125312148|NCT01425801|450770685|FG002|Period 3|Stability criteria not fullfilled|1|||
125312149|NCT01425801|450770686|FG003|Period 3|Stability criteria not fullfilled|0|||
125312150|NCT01425801|450770687|FG004|Period 3|Stability criteria not fullfilled|0|||
125312151|NCT01425801|450770688|FG005|Period 3|Stability criteria not fullfilled|0|||
125312152|NCT01425801|450770683|FG000|Period 4|Not able to maintain visit schedule|0|||
125312153|NCT01425801|450770684|FG001|Period 4|Not able to maintain visit schedule|0|||
125312154|NCT01425801|450770685|FG002|Period 4|Not able to maintain visit schedule|1|||
125312155|NCT01425801|450770686|FG003|Period 4|Not able to maintain visit schedule|0|||
125312156|NCT01425801|450770687|FG004|Period 4|Not able to maintain visit schedule|0|||
125312157|NCT01425801|450770688|FG005|Period 4|Not able to maintain visit schedule|0|||
125312158|NCT02868554|450770689|FG000|Overall Study|Lost to Follow-up|3|||
125312159|NCT02868554|450770690|FG001|Overall Study|Lost to Follow-up|0|||
125312160|NCT02868554|450770691|FG002|Overall Study|Lost to Follow-up|1|||
125312161|NCT02175017|450770692|FG000|Overall Study|Did not receive the investigational product|1|||
125312162|NCT02175017|450770693|FG001|Overall Study|Did not receive the investigational product|2|||
125425438|NCT04085328|451180463|FG001|Overall Study|Witihdrew Consent|16|||
125425439|NCT04085328|451180462|FG000|Overall Study|Adverse Event|8|||
125425440|NCT04085328|451180463|FG001|Overall Study|Adverse Event|7|||
125425441|NCT04085328|451180462|FG000|Overall Study|Lost to Follow-up|7|||
125425442|NCT04085328|451180463|FG001|Overall Study|Lost to Follow-up|2|||
125425443|NCT04085328|451180462|FG000|Overall Study|Physician Decision|0|||
125425444|NCT04085328|451180463|FG001|Overall Study|Physician Decision|1|||
125425445|NCT04085328|451180462|FG000|Overall Study|Pregnancy|0|||
125425446|NCT04085328|451180463|FG001|Overall Study|Pregnancy|1|||
125425447|NCT04085328|451180462|FG000|Overall Study|Reasons Related to COVID-19|5|||
125425448|NCT04085328|451180463|FG001|Overall Study|Reasons Related to COVID-19|8|||
125425449|NCT04085328|451180462|FG000|Overall Study|Did not meet inclusion criteria|1|||
125425450|NCT04085328|451180463|FG001|Overall Study|Did not meet inclusion criteria|1|||
125425451|NCT04085328|451180462|FG000|Overall Study|Early termination|1|||
125425452|NCT04085328|451180463|FG001|Overall Study|Early termination|0|||
125425453|NCT00514735|451180464|FG000|Overall Study|Withdrawal by Subject|13|||
125425454|NCT00514735|451180465|FG001|Overall Study|Withdrawal by Subject|5|||
125425455|NCT00514735|451180464|FG000|Overall Study|Death|1|||
125425456|NCT00514735|451180465|FG001|Overall Study|Death|0|||
125425457|NCT00514735|451180464|FG000|Overall Study|Lost to Follow-up|0|||
125425458|NCT00514735|451180465|FG001|Overall Study|Lost to Follow-up|1|||
125650314|NCT03996694|452004535|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
125650315|NCT03996694|452004530|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
125425459|NCT04393441|451180466|FG000|Overall Study|Adverse Event|0|||
125425460|NCT04393441|451180467|FG001|Overall Study|Adverse Event|3|||
125425461|NCT04393441|451180466|FG000|Overall Study|Withdrawal by Subject|5|||
125425462|NCT04393441|451180467|FG001|Overall Study|Withdrawal by Subject|7|||
125425463|NCT04393441|451180466|FG000|Overall Study|Lost to Follow-up|0|||
125425464|NCT04393441|451180467|FG001|Overall Study|Lost to Follow-up|2|||
125425465|NCT04393441|451180466|FG000|Overall Study|Protocol Deviation|2|||
125425466|NCT04393441|451180467|FG001|Overall Study|Protocol Deviation|1|||
125425467|NCT04393441|451180466|FG000|Overall Study|Reason not Specified|1|||
125425468|NCT04393441|451180467|FG001|Overall Study|Reason not Specified|1|||
125425469|NCT01812655|451180468|FG000|Overall Study|Protocol Violation|1|||
125425470|NCT01812655|451180469|FG001|Overall Study|Protocol Violation|1|||
125425471|NCT01812655|451180470|FG002|Overall Study|Protocol Violation|0|||
125425472|NCT00344461|451180488|FG000|Overall Study|Adverse Event|6|||
125425473|NCT00344461|451180488|FG000|Overall Study|Death|1|||
125425474|NCT00344461|451180488|FG000|Overall Study|Lack of Efficacy|2|||
125425475|NCT00344461|451180488|FG000|Overall Study|Lost to Follow-up|2|||
125425476|NCT00344461|451180488|FG000|Overall Study|Physician Decision|2|||
125425477|NCT00344461|451180488|FG000|Overall Study|Protocol Violation|6|||
125312163|NCT02175017|450770692|FG000|Overall Study|Withdrawal by Subject|6|||
125312164|NCT02175017|450770693|FG001|Overall Study|Withdrawal by Subject|3|||
125425478|NCT00344461|451180488|FG000|Overall Study|Withdrawal by Subject|2|||
125425479|NCT00636610|451180491|FG000|Overall Study|Adverse Event|4|||
125425480|NCT00636610|451180492|FG001|Overall Study|Adverse Event|4|||
125425481|NCT00636610|451180491|FG000|Overall Study|Death|6|||
125425482|NCT00636610|451180492|FG001|Overall Study|Death|3|||
125425483|NCT00636610|451180491|FG000|Overall Study|Physician decision to withdraw patient|15|||
125425484|NCT00636610|451180492|FG001|Overall Study|Physician decision to withdraw patient|9|||
125425485|NCT00636610|451180491|FG000|Overall Study|Subject decision to withdraw|15|||
125425486|NCT00636610|451180492|FG001|Overall Study|Subject decision to withdraw|11|||
125425487|NCT00636610|451180491|FG000|Overall Study|Disease progression - radiographic|41|||
125425488|NCT00636610|451180492|FG001|Overall Study|Disease progression - radiographic|51|||
125425489|NCT00636610|451180491|FG000|Overall Study|Disease progression - clinical|8|||
125425490|NCT00636610|451180492|FG001|Overall Study|Disease progression - clinical|3|||
125650316|NCT03996694|452004531|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
125650317|NCT03996694|452004532|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
125650318|NCT03996694|452004533|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
125650319|NCT03996694|452004534|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
125650320|NCT03996694|452004535|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
125650321|NCT00451191|452004540|FG000|Overall Study|withdrawal or received alternate tx|15|||
125650322|NCT00451191|452004541|FG001|Overall Study|withdrawal or received alternate tx|11|||
125650323|NCT01269346|452004543|FG000|Treatment Phase|Disease progression|3|||
125650324|NCT01269346|452004543|FG000|Treatment Phase|Adverse Event|3|||
125650325|NCT01269346|452004543|FG000|Treatment Phase|Withdrawal by Subject|1|||
125650326|NCT01269346|452004543|FG000|Treatment Phase|Other|2|||
125650327|NCT01269346|452004543|FG000|Extension Phase|Adverse Event|6|||
125650328|NCT01269346|452004543|FG000|Extension Phase|Withdrawal by Subject|4|||
125650329|NCT01269346|452004543|FG000|Extension Phase|Disease progression|22|||
125650330|NCT01269346|452004543|FG000|Extension Phase|Physician decision or participant choice|9|||
125650331|NCT01269346|452004543|FG000|Extension Phase|Clinical progression|1|||
125650332|NCT01269346|452004543|FG000|Extension Phase|Started a prohibited con med|1|||
125650333|NCT00247416|452004544|FG000|Overall Study|3 patients were found to be ineligible|1|||
125650334|NCT00247416|452004545|FG001|Overall Study|3 patients were found to be ineligible|2|||
125650335|NCT00798161|452004546|FG000|Overall Study|Adverse Event|3|||
125650336|NCT00798161|452004547|FG001|Overall Study|Adverse Event|4|||
125650337|NCT00798161|452004548|FG002|Overall Study|Adverse Event|6|||
125650338|NCT00798161|452004549|FG003|Overall Study|Adverse Event|6|||
125650339|NCT00798161|452004550|FG004|Overall Study|Adverse Event|5|||
125650340|NCT00798161|452004551|FG005|Overall Study|Adverse Event|2|||
125650341|NCT00798161|452004552|FG006|Overall Study|Adverse Event|4|||
125650342|NCT00798161|452004546|FG000|Overall Study|Protocol Violation|2|||
125650343|NCT00798161|452004547|FG001|Overall Study|Protocol Violation|1|||
125650344|NCT00798161|452004548|FG002|Overall Study|Protocol Violation|3|||
125650345|NCT00798161|452004549|FG003|Overall Study|Protocol Violation|3|||
125312165|NCT02175017|450770692|FG000|Overall Study|Met an exclusion criteria|0|||
125312166|NCT02175017|450770693|FG001|Overall Study|Met an exclusion criteria|1|||
125650346|NCT00798161|452004550|FG004|Overall Study|Protocol Violation|3|||
125650347|NCT00798161|452004551|FG005|Overall Study|Protocol Violation|2|||
125650348|NCT00798161|452004552|FG006|Overall Study|Protocol Violation|0|||
125650349|NCT00798161|452004546|FG000|Overall Study|Lost to Follow-up|1|||
125650350|NCT00798161|452004547|FG001|Overall Study|Lost to Follow-up|3|||
125650351|NCT00798161|452004548|FG002|Overall Study|Lost to Follow-up|4|||
125650352|NCT00798161|452004549|FG003|Overall Study|Lost to Follow-up|3|||
125650353|NCT00798161|452004550|FG004|Overall Study|Lost to Follow-up|4|||
125650354|NCT00798161|452004551|FG005|Overall Study|Lost to Follow-up|0|||
125650355|NCT00798161|452004552|FG006|Overall Study|Lost to Follow-up|0|||
125650356|NCT00798161|452004546|FG000|Overall Study|Withdrawal by Subject|5|||
125650357|NCT00798161|452004547|FG001|Overall Study|Withdrawal by Subject|4|||
125650358|NCT00798161|452004548|FG002|Overall Study|Withdrawal by Subject|5|||
125650359|NCT00798161|452004549|FG003|Overall Study|Withdrawal by Subject|4|||
125650360|NCT00798161|452004550|FG004|Overall Study|Withdrawal by Subject|2|||
125650361|NCT00798161|452004551|FG005|Overall Study|Withdrawal by Subject|3|||
125650362|NCT00798161|452004552|FG006|Overall Study|Withdrawal by Subject|1|||
125312167|NCT02175017|450770692|FG000|Overall Study|Adverse Event|3|||
125312168|NCT02175017|450770693|FG001|Overall Study|Adverse Event|10|||
125312169|NCT02175017|450770692|FG000|Overall Study|Disease progression|20|||
125312170|NCT02175017|450770693|FG001|Overall Study|Disease progression|27|||
125312171|NCT02175017|450770692|FG000|Overall Study|Other than above reasons|3|||
125312172|NCT02175017|450770693|FG001|Overall Study|Other than above reasons|0|||
125312173|NCT04915729|450770694|FG000|Overall Study|Lost to Follow-up|20|||
125312174|NCT04915729|450770695|FG001|Overall Study|Lost to Follow-up|10|||
125312175|NCT04915729|450770694|FG000|Overall Study|Withdrawal by Subject|12|||
125650363|NCT00798161|452004546|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
125650364|NCT00798161|452004547|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
125650365|NCT00798161|452004548|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
125650366|NCT00798161|452004549|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
125650367|NCT00798161|452004550|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
125650368|NCT00798161|452004551|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
125650369|NCT00798161|452004552|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
125650370|NCT02706327|452004553|FG000|Overall Study|Lost to Follow-up|1|||
125650371|NCT02706327|452004554|FG001|Overall Study|Lost to Follow-up|1|||
125650372|NCT02706327|452004555|FG002|Overall Study|Lost to Follow-up|2|||
125650373|NCT02213666|452004558|FG000|Overall Study|Withdrawal by Subject|1|||
125650374|NCT01319422|452004559|FG000|Overall Study|Withdrawal by Subject|1|||
125312176|NCT04915729|450770695|FG001|Overall Study|Withdrawal by Subject|5|||
125312177|NCT04915729|450770694|FG000|Overall Study|Death|34|||
125312178|NCT04915729|450770695|FG001|Overall Study|Death|44|||
125312179|NCT04915729|450770694|FG000|Overall Study|not treated|3|||
125312180|NCT04915729|450770695|FG001|Overall Study|not treated|6|||
125312181|NCT04915729|450770694|FG000|Overall Study|Investigator removed subject|1|||
125312182|NCT04915729|450770695|FG001|Overall Study|Investigator removed subject|2|||
125312183|NCT04915729|450770694|FG000|Overall Study|questionnaire result not evaluated|1|||
125312184|NCT04915729|450770695|FG001|Overall Study|questionnaire result not evaluated|0|||
125312185|NCT04915729|450770694|FG000|Overall Study|refuse of hospital visit|1|||
125312186|NCT04915729|450770695|FG001|Overall Study|refuse of hospital visit|3|||
125312187|NCT04915729|450770694|FG000|Overall Study|Subject withdrew|1|||
125312188|NCT04915729|450770695|FG001|Overall Study|Subject withdrew|0|||
125312189|NCT02294058|450770703|FG000|Overall Study|Adverse Event|16|||
125312190|NCT02294058|450770704|FG001|Overall Study|Adverse Event|7|||
125312191|NCT02294058|450770705|FG002|Overall Study|Adverse Event|13|||
125312192|NCT02294058|450770703|FG000|Overall Study|Lack of Efficacy|3|||
125312193|NCT02294058|450770704|FG001|Overall Study|Lack of Efficacy|3|||
125312194|NCT02294058|450770705|FG002|Overall Study|Lack of Efficacy|0|||
125312195|NCT02294058|450770703|FG000|Overall Study|Lost to Follow-up|1|||
125312196|NCT02294058|450770704|FG001|Overall Study|Lost to Follow-up|0|||
125312197|NCT02294058|450770705|FG002|Overall Study|Lost to Follow-up|2|||
125312198|NCT02294058|450770703|FG000|Overall Study|Withdrawal by Subject|10|||
125312199|NCT02294058|450770704|FG001|Overall Study|Withdrawal by Subject|14|||
125312200|NCT02294058|450770705|FG002|Overall Study|Withdrawal by Subject|13|||
125312201|NCT02294058|450770703|FG000|Overall Study|Physician Decision|2|||
125312202|NCT02294058|450770704|FG001|Overall Study|Physician Decision|1|||
125312203|NCT02294058|450770705|FG002|Overall Study|Physician Decision|0|||
125312204|NCT02294058|450770703|FG000|Overall Study|Miscellaneous|4|||
125312205|NCT02294058|450770704|FG001|Overall Study|Miscellaneous|1|||
125312206|NCT02294058|450770705|FG002|Overall Study|Miscellaneous|1|||
125312207|NCT03575403|450770707|FG000|Overall Study|Adverse Event|1|||
125312208|NCT03575403|450770708|FG001|Overall Study|Adverse Event|0|||
125312209|NCT03575403|450770709|FG002|Overall Study|Adverse Event|0|||
125312210|NCT03575403|450770707|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
125312211|NCT03575403|450770708|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
125312212|NCT03575403|450770709|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
125312213|NCT02330055|450770710|FG000|Overall Study|technical issues|2|||
125312214|NCT02330055|450770711|FG001|Overall Study|technical issues|0|||
125312215|NCT02330055|450770710|FG000|Overall Study|participant forgot to wear device|5|||
125312216|NCT02330055|450770711|FG001|Overall Study|participant forgot to wear device|5|||
125312217|NCT02330055|450770710|FG000|Overall Study|data for less than 60 minutes|3|||
125540344|NCT01820585|451607598|FG001|Overall Study|Protocol Violation|1|||
125540345|NCT01820585|451607599|FG002|Overall Study|Protocol Violation|1|||
125540346|NCT01820585|451607600|FG003|Overall Study|Protocol Violation|1|||
125540347|NCT01820585|451607597|FG000|Overall Study|Subject non-compliance|0|||
125540348|NCT01820585|451607598|FG001|Overall Study|Subject non-compliance|0|||
125540349|NCT01820585|451607599|FG002|Overall Study|Subject non-compliance|1|||
125540350|NCT01820585|451607600|FG003|Overall Study|Subject non-compliance|2|||
125540351|NCT01820585|451607597|FG000|Overall Study|at sponsor request|0|||
125540352|NCT01820585|451607598|FG001|Overall Study|at sponsor request|0|||
125540353|NCT01820585|451607599|FG002|Overall Study|at sponsor request|1|||
125540354|NCT01820585|451607600|FG003|Overall Study|at sponsor request|0|||
125540355|NCT01820585|451607597|FG000|Overall Study|Pregnancy|0|||
125540356|NCT01820585|451607598|FG001|Overall Study|Pregnancy|1|||
125540357|NCT01820585|451607599|FG002|Overall Study|Pregnancy|0|||
125540358|NCT01820585|451607600|FG003|Overall Study|Pregnancy|0|||
125540359|NCT01712659|451607601|FG000|Dose Escalation|Physician Decision|0|||
125540360|NCT01712659|451607602|FG001|Dose Escalation|Physician Decision|1|||
125540361|NCT01712659|451607603|FG002|Dose Escalation|Physician Decision|0|||
125540362|NCT01712659|451607604|FG003|Dose Escalation|Physician Decision|0|||
125540363|NCT01712659|451607605|FG004|Dose Escalation|Physician Decision|0|||
125540364|NCT01712659|451607601|FG000|Dose Escalation|Unable to take study drug|0|||
125540365|NCT01712659|451607602|FG001|Dose Escalation|Unable to take study drug|1|||
125540366|NCT01712659|451607603|FG002|Dose Escalation|Unable to take study drug|0|||
125540367|NCT01712659|451607604|FG003|Dose Escalation|Unable to take study drug|0|||
125540368|NCT01712659|451607605|FG004|Dose Escalation|Unable to take study drug|0|||
125540369|NCT01712659|451607601|FG000|Dose Expansion|Early disease progression|1|||
125540370|NCT01712659|451607602|FG001|Dose Expansion|Early disease progression|0|||
125540371|NCT01712659|451607603|FG002|Dose Expansion|Early disease progression|0|||
125540372|NCT01712659|451607604|FG003|Dose Expansion|Early disease progression|0|||
125540373|NCT01712659|451607605|FG004|Dose Expansion|Early disease progression|0|||
125540374|NCT01712659|451607601|FG000|Dose Expansion|Physician Decision|1|||
125540375|NCT01712659|451607602|FG001|Dose Expansion|Physician Decision|0|||
125540376|NCT01712659|451607603|FG002|Dose Expansion|Physician Decision|0|||
125540377|NCT01712659|451607604|FG003|Dose Expansion|Physician Decision|0|||
125312218|NCT02330055|450770711|FG001|Overall Study|data for less than 60 minutes|3|||
125312219|NCT02330055|450770710|FG000|Overall Study|participant did not sleep|0|||
125312220|NCT02330055|450770711|FG001|Overall Study|participant did not sleep|1|||
125312221|NCT03359174|450770714|FG000|Overall Study|Adverse Event|1|||
125312222|NCT01332994|450770718|FG000|Overall Study|Adverse Event|34|||
125312223|NCT01332994|450770718|FG000|Overall Study|Death|1|||
125312224|NCT01332994|450770718|FG000|Overall Study|Lack of Efficacy|1|||
125312225|NCT01332994|450770718|FG000|Overall Study|Lost to Follow-up|4|||
125312226|NCT01332994|450770718|FG000|Overall Study|Protocol Violation|6|||
125312227|NCT01332994|450770718|FG000|Overall Study|Withdrawal by Subject|15|||
125312228|NCT01332994|450770718|FG000|Overall Study|Administrative Problem|2|||
125312229|NCT01332994|450770718|FG000|Overall Study|Other|8|||
125312230|NCT02800863|450770719|FG000|Overall Study|Adverse Event|14|||
125312231|NCT02800863|450770719|FG000|Overall Study|Another Device Implanted|1|||
125312232|NCT02800863|450770719|FG000|Overall Study|Device Explanted|1|||
125312233|NCT02800863|450770719|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
125312234|NCT02800863|450770719|FG000|Overall Study|Health Issues|1|||
125312235|NCT02800863|450770719|FG000|Overall Study|Insurance Denial|8|||
125312236|NCT02800863|450770719|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
125312237|NCT02800863|450770719|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
125312238|NCT02800863|450770719|FG000|Overall Study|Screen Failure|1|||
125650375|NCT01319422|452004560|FG001|Overall Study|Withdrawal by Subject|0|||
125650376|NCT03417245|452004562|FG000|Overall Study|Adverse Event|1|||
125650377|NCT03417245|452004563|FG001|Overall Study|Adverse Event|0|||
125650378|NCT03417245|452004562|FG000|Overall Study|Protocol Violation|1|||
125650379|NCT03417245|452004563|FG001|Overall Study|Protocol Violation|0|||
125650380|NCT03417245|452004562|FG000|Overall Study|Withdrawal by Subject|1|||
125650381|NCT03417245|452004563|FG001|Overall Study|Withdrawal by Subject|1|||
125650382|NCT02708524|452004571|FG000|Overall Study|Adverse Event|0|||
125650383|NCT02708524|452004572|FG001|Overall Study|Adverse Event|1|||
125650384|NCT02708524|452004573|FG002|Overall Study|Adverse Event|0|||
125650385|NCT02708524|452004574|FG003|Overall Study|Adverse Event|0|||
125650386|NCT02708524|452004571|FG000|Overall Study|Lens Discomfort|1|||
125650387|NCT02708524|452004572|FG001|Overall Study|Lens Discomfort|0|||
125650388|NCT02708524|452004573|FG002|Overall Study|Lens Discomfort|1|||
125650389|NCT02708524|452004574|FG003|Overall Study|Lens Discomfort|0|||
125650390|NCT02708524|452004571|FG000|Overall Study|Lost to Follow-up|1|||
125650391|NCT02708524|452004572|FG001|Overall Study|Lost to Follow-up|1|||
125650392|NCT02708524|452004573|FG002|Overall Study|Lost to Follow-up|1|||
125650393|NCT02708524|452004574|FG003|Overall Study|Lost to Follow-up|0|||
125650394|NCT02708524|452004571|FG000|Overall Study|Protocol Violation|0|||
125650395|NCT02708524|452004572|FG001|Overall Study|Protocol Violation|1|||
125650396|NCT02708524|452004573|FG002|Overall Study|Protocol Violation|0|||
125650397|NCT02708524|452004574|FG003|Overall Study|Protocol Violation|0|||
125650398|NCT02708524|452004571|FG000|Overall Study|Withdrawal by Subject|1|||
125650399|NCT02708524|452004572|FG001|Overall Study|Withdrawal by Subject|1|||
125650400|NCT02708524|452004573|FG002|Overall Study|Withdrawal by Subject|0|||
125650401|NCT02708524|452004574|FG003|Overall Study|Withdrawal by Subject|0|||
125650402|NCT02708524|452004571|FG000|Overall Study|Dispensed incorrect study lens|0|||
125650403|NCT02708524|452004572|FG001|Overall Study|Dispensed incorrect study lens|1|||
125650404|NCT02708524|452004573|FG002|Overall Study|Dispensed incorrect study lens|1|||
125650405|NCT02708524|452004574|FG003|Overall Study|Dispensed incorrect study lens|0|||
125650406|NCT02708524|452004571|FG000|Overall Study|Did not wear lens at final visit|0|||
125650407|NCT02708524|452004572|FG001|Overall Study|Did not wear lens at final visit|1|||
125650408|NCT02708524|452004573|FG002|Overall Study|Did not wear lens at final visit|0|||
125650409|NCT02708524|452004574|FG003|Overall Study|Did not wear lens at final visit|0|||
125650410|NCT02708524|452004571|FG000|Overall Study|Subject lost study lens|1|||
125650411|NCT02708524|452004572|FG001|Overall Study|Subject lost study lens|0|||
125650412|NCT02708524|452004573|FG002|Overall Study|Subject lost study lens|0|||
125650413|NCT02708524|452004574|FG003|Overall Study|Subject lost study lens|0|||
125650414|NCT03781167|452004580|FG000|Overall Study|Adverse Event|23|||
125650415|NCT03781167|452004581|FG001|Overall Study|Adverse Event|25|||
125650416|NCT03781167|452004580|FG000|Overall Study|Withdrew consent|16|||
125650417|NCT03781167|452004581|FG001|Overall Study|Withdrew consent|12|||
125650418|NCT03781167|452004580|FG000|Overall Study|Lost to Follow-up|0|||
125312239|NCT02800863|450770719|FG000|Overall Study|Sponsor Request|6|||
125312240|NCT02800863|450770719|FG000|Overall Study|Death|3|||
125312241|NCT02800863|450770719|FG000|Overall Study|Subject Implant at Another Facility|1|||
125312242|NCT02800863|450770719|FG000|Overall Study|Lost to Follow-up|26|||
125312243|NCT02800863|450770719|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
125650419|NCT03781167|452004581|FG001|Overall Study|Lost to Follow-up|1|||
125650420|NCT03781167|452004580|FG000|Overall Study|Lack of Efficacy|4|||
125650421|NCT03781167|452004581|FG001|Overall Study|Lack of Efficacy|5|||
125650422|NCT03781167|452004580|FG000|Overall Study|Difficulty with drug delivery system|2|||
125650423|NCT03781167|452004581|FG001|Overall Study|Difficulty with drug delivery system|3|||
125650424|NCT03781167|452004580|FG000|Overall Study|Other, not specified|2|||
125650425|NCT03781167|452004581|FG001|Overall Study|Other, not specified|2|||
125312244|NCT02800863|450770719|FG000|Overall Study|Subject and/or Family Request|64|||
125312245|NCT02800863|450770719|FG000|Overall Study|Trial Failure|81|||
125312246|NCT02800863|450770719|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
125312247|NCT00279916|450770720|FG000|Overall Study|Withdrawal by Subject|4|||
125312248|NCT00279916|450770721|FG001|Overall Study|Withdrawal by Subject|3|||
125312249|NCT00279916|450770720|FG000|Overall Study|Lost to Follow-up|3|||
125312250|NCT00279916|450770721|FG001|Overall Study|Lost to Follow-up|2|||
125312251|NCT01807598|450770722|FG000|Overall Study|Withdrawal by Subject|4|||
125312252|NCT01807598|450770722|FG000|Overall Study|Adverse Event|1|||
125312253|NCT01807598|450770722|FG000|Overall Study|Other Physician Decision|1|||
125312254|NCT02717494|450770723|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
125312255|NCT02717494|450770724|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
125312256|NCT02717494|450770725|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
125312257|NCT02717494|450770723|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
125312258|NCT02717494|450770724|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
125312259|NCT02717494|450770725|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
125312260|NCT02717494|450770723|FG000|First Intervention (Step 1)|Death|0|||
125312261|NCT02717494|450770724|FG001|First Intervention (Step 1)|Death|0|||
125312262|NCT02717494|450770725|FG002|First Intervention (Step 1)|Death|1|||
125312263|NCT02717494|450770723|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
125312264|NCT02717494|450770724|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
125312265|NCT02717494|450770725|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
125312266|NCT00731679|450770726|FG000|Overall Study|Adverse Event|7|||
125312267|NCT00731679|450770727|FG001|Overall Study|Adverse Event|8|||
125312268|NCT00731679|450770726|FG000|Overall Study|Withdrawal by Subject|8|||
125312269|NCT00731679|450770727|FG001|Overall Study|Withdrawal by Subject|8|||
125312270|NCT00731679|450770726|FG000|Overall Study|Lost to Follow-up|7|||
125312271|NCT00731679|450770727|FG001|Overall Study|Lost to Follow-up|8|||
125312272|NCT00731679|450770726|FG000|Overall Study|Noncompliance|0|||
125312273|NCT00731679|450770727|FG001|Overall Study|Noncompliance|1|||
125312274|NCT00731679|450770726|FG000|Overall Study|Pregnancy|0|||
125312275|NCT00731679|450770727|FG001|Overall Study|Pregnancy|1|||
125312276|NCT02488005|450770730|FG000|Overall Study|Lost to Follow-up|2|||
125312277|NCT02326597|450770733|FG000|Overall Study|Lost to Follow-up|42|||
125312278|NCT02326597|450770734|FG001|Overall Study|Lost to Follow-up|32|||
125312279|NCT04089761|450770737|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
125312280|NCT04089761|450770737|FG000|"Run In Phase"|Lost to Follow-up|1|||
125312281|NCT04089761|450770737|FG000|"Treatment Phase"|No evaluable data|5|||
125312282|NCT04089761|450770737|FG000|"Treatment Phase"|Lost to Follow-up|1|||
125312283|NCT04739436|450770739|FG000|Overall Study|Lost to Follow-up|21|||
125312284|NCT04739436|450770740|FG001|Overall Study|Lost to Follow-up|23|||
125312285|NCT04739436|450770739|FG000|Overall Study|Withdrawal by Subject|4|||
125312286|NCT04739436|450770740|FG001|Overall Study|Withdrawal by Subject|6|||
125312287|NCT04739436|450770739|FG000|Overall Study|not randomized properly|1|||
125312288|NCT04739436|450770740|FG001|Overall Study|not randomized properly|0|||
125312289|NCT00428948|450770742|FG000|Overall Study|Lost to Follow-up|15|||
125312290|NCT00428948|450770743|FG001|Overall Study|Lost to Follow-up|8|||
125312291|NCT00428948|450770742|FG000|Overall Study|Adverse Event|148|||
125312292|NCT00428948|450770743|FG001|Overall Study|Adverse Event|24|||
125312293|NCT00428948|450770742|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
125312294|NCT00428948|450770743|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
125312295|NCT00428948|450770742|FG000|Overall Study|Investigator Withdrew Subject|3|||
125312296|NCT00428948|450770743|FG001|Overall Study|Investigator Withdrew Subject|4|||
125312297|NCT00428948|450770742|FG000|Overall Study|Subject Withdrew Consent|50|||
125312298|NCT00428948|450770743|FG001|Overall Study|Subject Withdrew Consent|30|||
125312299|NCT00428948|450770742|FG000|Overall Study|Protocol Deviation|1|||
125312300|NCT00428948|450770743|FG001|Overall Study|Protocol Deviation|1|||
125312301|NCT03449758|450772288|FG000|Overall Study|Major protocol deviation|1|||
125312302|NCT03449758|450772288|FG000|Overall Study|Treatment inefficacy|5|||
125312303|NCT03449758|450772288|FG000|Overall Study|Adverse Event|9|||
125312304|NCT03449758|450772288|FG000|Overall Study|Consent withdrawal|1|||
125312305|NCT03449758|450772288|FG000|Overall Study|Other unspecified reason|3|||
125312306|NCT00922623|450772292|FG000|Overall Study|Other|4|||
125312307|NCT00922623|450772292|FG000|Overall Study|Lost to Follow-up|1|||
125312308|NCT01402817|450772293|FG000|Overall Study|Withdrawal by Subject|3|||
125312309|NCT01402817|450772293|FG000|Overall Study|Study Suspended by FDA|8|||
125312310|NCT03310723|450772295|FG000|Overall Study|Withdrawal by Subject|0|||
125312311|NCT03310723|450772296|FG001|Overall Study|Withdrawal by Subject|1|||
125312312|NCT03310723|450772295|FG000|Overall Study|Protocol Violation|0|||
125312313|NCT03310723|450772296|FG001|Overall Study|Protocol Violation|2|||
125312314|NCT01410890|450772297|FG000|Overall Study|Withdrawal by Subject|0|||
125312315|NCT01410890|450772298|FG001|Overall Study|Withdrawal by Subject|1|||
125312316|NCT01121146|450772299|FG000|Overall Study|Death|17|||
125312317|NCT01121146|450772300|FG001|Overall Study|Death|15|||
125312318|NCT01121146|450772299|FG000|Overall Study|Adverse Event|2|||
125312319|NCT01121146|450772300|FG001|Overall Study|Adverse Event|11|||
125312320|NCT01121146|450772299|FG000|Overall Study|Lost to Follow-up|7|||
125312321|NCT01121146|450772300|FG001|Overall Study|Lost to Follow-up|16|||
125312322|NCT00997035|450772303|FG000|3-week Followup Visit|Lost to Follow-up|9|||
125312323|NCT00997035|450772304|FG001|3-week Followup Visit|Lost to Follow-up|6|||
125312324|NCT00997035|450772303|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
125312325|NCT00997035|450772304|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
125312326|NCT01380769|450772305|FG000|Overall Study|Withdrawal by Subject|7|||
125312327|NCT01380769|450772306|FG001|Overall Study|Withdrawal by Subject|11|||
125312328|NCT01380769|450772305|FG000|Overall Study|Physician Decision|1|||
125312329|NCT01380769|450772306|FG001|Overall Study|Physician Decision|1|||
125312330|NCT01380769|450772305|FG000|Overall Study|Adverse Event|1|||
125312331|NCT01380769|450772306|FG001|Overall Study|Adverse Event|1|||
125312332|NCT01380769|450772305|FG000|Overall Study|Protocol Violation|0|||
125312333|NCT01380769|450772306|FG001|Overall Study|Protocol Violation|1|||
125312334|NCT02640547|450772307|FG000|Overall Study|Failure to Return|1|||
125312335|NCT02640547|450772307|FG000|Overall Study|Withdrawal by Subject|1|||
125312336|NCT02640547|450772307|FG000|Overall Study|Death|6|||
125312337|NCT02640547|450772307|FG000|Overall Study|Miscellaneous|3|||
125312338|NCT02753946|450772321|FG000|Overall Study|Adverse Event|7|||
125312339|NCT02753946|450772322|FG001|Overall Study|Adverse Event|6|||
125312340|NCT02753946|450772321|FG000|Overall Study|Withdrawal by Subject|6|||
125312341|NCT02753946|450772322|FG001|Overall Study|Withdrawal by Subject|1|||
125312342|NCT02753946|450772321|FG000|Overall Study|Lack of Efficacy|1|||
125312343|NCT02753946|450772322|FG001|Overall Study|Lack of Efficacy|0|||
125312344|NCT02753946|450772321|FG000|Overall Study|Physician Decision|0|||
125312345|NCT02753946|450772322|FG001|Overall Study|Physician Decision|2|||
125312346|NCT02519439|450772323|FG000|Overall Study|Study Termination|19|||
125312347|NCT02519439|450772323|FG000|Overall Study|Withdrawal by Subject|1|||
125312348|NCT02519439|450772323|FG000|Overall Study|Adverse Event|1|||
125312349|NCT01539759|450772328|FG000|Overall Study|Lost to Follow-up|6|||
125312350|NCT01539759|450772329|FG001|Overall Study|Lost to Follow-up|8|||
125312351|NCT03901144|450772330|FG000|Overall Study|Lost to Follow-up|1|||
125312352|NCT03901144|450772331|FG001|Overall Study|Lost to Follow-up|1|||
125312353|NCT03901144|450772332|FG002|Overall Study|Lost to Follow-up|1|||
125312354|NCT03901144|450772333|FG003|Overall Study|Lost to Follow-up|1|||
125312355|NCT02491983|450772334|FG000|Overall Study|Physician Decision|1|||
125312356|NCT02491983|450772335|FG001|Overall Study|Physician Decision|0|||
125312357|NCT02491983|450772334|FG000|Overall Study|Not meet selection criteria|1|||
125312358|NCT02491983|450772335|FG001|Overall Study|Not meet selection criteria|0|||
125312359|NCT02491983|450772334|FG000|Overall Study|Withdrawal by Subject|0|||
125312360|NCT02491983|450772335|FG001|Overall Study|Withdrawal by Subject|1|||
125312361|NCT02714569|450772336|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
125312362|NCT02714569|450772337|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
125312363|NCT02714569|450772338|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
125312364|NCT02714569|450772339|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
125312365|NCT02714569|450772340|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
125312366|NCT02714569|450772341|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
125312367|NCT02714569|450772342|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
125312368|NCT02714569|450772343|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
125312369|NCT02714569|450772344|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
125312370|NCT02714569|450772345|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
125312371|NCT02714569|450772346|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
125312372|NCT02714569|450772336|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312373|NCT02714569|450772337|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312374|NCT02714569|450772338|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312375|NCT02714569|450772339|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
125312376|NCT02714569|450772340|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312377|NCT02714569|450772341|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312378|NCT02714569|450772342|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312379|NCT02714569|450772343|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312380|NCT02714569|450772344|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312381|NCT02714569|450772345|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312382|NCT02714569|450772346|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
125312383|NCT02714569|450772336|FG000|Part A Third Intervention|Adverse Event|0|||
125312384|NCT02714569|450772337|FG001|Part A Third Intervention|Adverse Event|0|||
125312385|NCT02714569|450772338|FG002|Part A Third Intervention|Adverse Event|1|||
125312386|NCT02714569|450772339|FG003|Part A Third Intervention|Adverse Event|0|||
125312387|NCT02714569|450772340|FG004|Part A Third Intervention|Adverse Event|0|||
125312388|NCT02714569|450772341|FG005|Part A Third Intervention|Adverse Event|0|||
125312389|NCT02714569|450772342|FG006|Part A Third Intervention|Adverse Event|0|||
125312390|NCT02714569|450772343|FG007|Part A Third Intervention|Adverse Event|0|||
125312391|NCT02714569|450772344|FG008|Part A Third Intervention|Adverse Event|0|||
125312392|NCT02714569|450772345|FG009|Part A Third Intervention|Adverse Event|0|||
125312393|NCT02714569|450772346|FG010|Part A Third Intervention|Adverse Event|0|||
125312394|NCT02714569|450772336|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
125312395|NCT02714569|450772337|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312396|NCT02714569|450772338|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312397|NCT02714569|450772339|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312398|NCT02714569|450772340|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312399|NCT02714569|450772341|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
125312400|NCT02714569|450772342|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312401|NCT02714569|450772343|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312402|NCT02714569|450772344|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312403|NCT02714569|450772345|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312404|NCT02714569|450772346|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
125312405|NCT02714569|450772336|FG000|Part B (Overall)|Lost to Follow-up|0|||
125312406|NCT02714569|450772337|FG001|Part B (Overall)|Lost to Follow-up|0|||
125312407|NCT02714569|450772338|FG002|Part B (Overall)|Lost to Follow-up|0|||
125312408|NCT02714569|450772339|FG003|Part B (Overall)|Lost to Follow-up|0|||
125312409|NCT02714569|450772340|FG004|Part B (Overall)|Lost to Follow-up|0|||
125312410|NCT02714569|450772341|FG005|Part B (Overall)|Lost to Follow-up|0|||
125312411|NCT02714569|450772342|FG006|Part B (Overall)|Lost to Follow-up|1|||
125312412|NCT02714569|450772343|FG007|Part B (Overall)|Lost to Follow-up|0|||
125312413|NCT02714569|450772344|FG008|Part B (Overall)|Lost to Follow-up|0|||
125312414|NCT02714569|450772345|FG009|Part B (Overall)|Lost to Follow-up|0|||
125312415|NCT02714569|450772346|FG010|Part B (Overall)|Lost to Follow-up|0|||
125312416|NCT02714569|450772336|FG000|Part B (Overall)|Withdrawal by Subject|0|||
125312417|NCT02714569|450772337|FG001|Part B (Overall)|Withdrawal by Subject|0|||
125312418|NCT02714569|450772338|FG002|Part B (Overall)|Withdrawal by Subject|0|||
125312419|NCT02714569|450772339|FG003|Part B (Overall)|Withdrawal by Subject|0|||
125312420|NCT02714569|450772340|FG004|Part B (Overall)|Withdrawal by Subject|0|||
125312421|NCT02714569|450772341|FG005|Part B (Overall)|Withdrawal by Subject|0|||
125312422|NCT02714569|450772342|FG006|Part B (Overall)|Withdrawal by Subject|0|||
125312423|NCT02714569|450772343|FG007|Part B (Overall)|Withdrawal by Subject|1|||
125312424|NCT02714569|450772344|FG008|Part B (Overall)|Withdrawal by Subject|0|||
125312425|NCT02714569|450772345|FG009|Part B (Overall)|Withdrawal by Subject|1|||
125650426|NCT01590628|452004589|FG000|Overall Study|Death|2|||
125650427|NCT01590628|452004590|FG001|Overall Study|Death|0|||
125650428|NCT00475657|452004591|FG000|Overall Study|Death|1|||
125650429|NCT00475657|452004591|FG000|Overall Study|Sponsor's Decision|3|||
125650430|NCT02992743|452004592|FG000|Overall Study|Withdrawal by Subject|1|||
125650431|NCT02992743|452004593|FG001|Overall Study|Withdrawal by Subject|1|||
125650432|NCT02992743|452004592|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
125312426|NCT02714569|450772346|FG010|Part B (Overall)|Withdrawal by Subject|0|||
125312427|NCT02714569|450772336|FG000|Part B (Overall)|Adverse Event|0|||
125312428|NCT02714569|450772337|FG001|Part B (Overall)|Adverse Event|0|||
125312429|NCT02714569|450772338|FG002|Part B (Overall)|Adverse Event|0|||
125312430|NCT02714569|450772339|FG003|Part B (Overall)|Adverse Event|0|||
125312431|NCT02714569|450772340|FG004|Part B (Overall)|Adverse Event|0|||
125312432|NCT02714569|450772341|FG005|Part B (Overall)|Adverse Event|0|||
125312433|NCT02714569|450772342|FG006|Part B (Overall)|Adverse Event|0|||
125312434|NCT02714569|450772343|FG007|Part B (Overall)|Adverse Event|0|||
125312435|NCT02714569|450772344|FG008|Part B (Overall)|Adverse Event|0|||
125312436|NCT02714569|450772345|FG009|Part B (Overall)|Adverse Event|1|||
125312437|NCT02714569|450772346|FG010|Part B (Overall)|Adverse Event|0|||
125312438|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
125312439|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
125312440|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
125312441|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
125312442|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
125650433|NCT02992743|452004593|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
125650434|NCT02992743|452004592|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
125650435|NCT02992743|452004593|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
125650436|NCT02992743|452004592|FG000|Overall Study|No measurable disease|1|||
125312443|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
125312444|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Death|7|||
125312445|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Death|5|||
125312446|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Death|6|||
125312447|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
125312448|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
125312449|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
125312450|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
125312451|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
125312452|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
125650437|NCT02992743|452004593|FG001|Overall Study|No measurable disease|0|||
125650438|NCT02992743|452004592|FG000|Overall Study|Lost to Follow-up|0|||
125650439|NCT02992743|452004593|FG001|Overall Study|Lost to Follow-up|1|||
125650440|NCT00761735|452004594|FG000|Overall Study|Lost to Follow-up|6|||
125650441|NCT00761735|452004594|FG000|Overall Study|Withdrawal by Subject|6|||
125650442|NCT00761735|452004594|FG000|Overall Study|Non-compliance with protocol|1|||
125650443|NCT00761735|452004594|FG000|Overall Study|Administrative|1|||
125650444|NCT03290131|452004595|FG000|Overall Study|Adverse Event|22|||
125650445|NCT03290131|452004596|FG001|Overall Study|Adverse Event|57|||
125650446|NCT03290131|452004597|FG002|Overall Study|Adverse Event|11|||
125650447|NCT03290131|452004595|FG000|Overall Study|Withdrawal by Subject|18|||
125650448|NCT03290131|452004596|FG001|Overall Study|Withdrawal by Subject|13|||
125650449|NCT03290131|452004597|FG002|Overall Study|Withdrawal by Subject|8|||
125650450|NCT03290131|452004595|FG000|Overall Study|MS Relapse|2|||
125650451|NCT03290131|452004596|FG001|Overall Study|MS Relapse|1|||
125650452|NCT03290131|452004597|FG002|Overall Study|MS Relapse|0|||
125650453|NCT03290131|452004595|FG000|Overall Study|Unknown reason|0|||
125650454|NCT03290131|452004596|FG001|Overall Study|Unknown reason|1|||
125650455|NCT03290131|452004597|FG002|Overall Study|Unknown reason|0|||
125650456|NCT00381680|452004598|FG000|Overall Study|Adverse Event|9|||
125650457|NCT00381680|452004599|FG001|Overall Study|Adverse Event|3|||
125650458|NCT00381680|452004598|FG000|Overall Study|Death|10|||
125650459|NCT00381680|452004599|FG001|Overall Study|Death|7|||
125650460|NCT00381680|452004598|FG000|Overall Study|Lost to Follow-up|3|||
125650461|NCT00381680|452004599|FG001|Overall Study|Lost to Follow-up|2|||
125650462|NCT00381680|452004598|FG000|Overall Study|Physician Decision|25|||
125650463|NCT00381680|452004599|FG001|Overall Study|Physician Decision|6|||
125650464|NCT00381680|452004598|FG000|Overall Study|Withdrawal by Subject|3|||
125650465|NCT00381680|452004599|FG001|Overall Study|Withdrawal by Subject|1|||
125650466|NCT00381680|452004598|FG000|Overall Study|Entry onto another COG Trial|1|||
125650467|NCT00381680|452004599|FG001|Overall Study|Entry onto another COG Trial|2|||
125650468|NCT00381680|452004598|FG000|Overall Study|Alternative Therapy|11|||
125650469|NCT00381680|452004599|FG001|Overall Study|Alternative Therapy|5|||
125650470|NCT00381680|452004598|FG000|Overall Study|Secondary Malignancy|3|||
125650471|NCT00381680|452004599|FG001|Overall Study|Secondary Malignancy|0|||
125650472|NCT00381680|452004598|FG000|Overall Study|Delay initiation|1|||
125650473|NCT00381680|452004599|FG001|Overall Study|Delay initiation|0|||
125650474|NCT00381680|452004598|FG000|Overall Study|Stem Cell Transplant|26|||
125650475|NCT00381680|452004599|FG001|Overall Study|Stem Cell Transplant|10|||
125650476|NCT00381680|452004598|FG000|Overall Study|Relapse|18|||
125650477|NCT00381680|452004599|FG001|Overall Study|Relapse|9|||
125650478|NCT00381680|452004598|FG000|Overall Study|Induction Failure|4|||
125650479|NCT00381680|452004599|FG001|Overall Study|Induction Failure|1|||
125650480|NCT00381680|452004598|FG000|Overall Study|Progression|1|||
125650481|NCT00381680|452004599|FG001|Overall Study|Progression|1|||
125650482|NCT00381680|452004598|FG000|Overall Study|Other not otherwise specified|7|||
125650483|NCT00381680|452004599|FG001|Overall Study|Other not otherwise specified|2|||
125650484|NCT00381680|452004598|FG000|Overall Study|Ineligible|3|||
125650485|NCT00381680|452004599|FG001|Overall Study|Ineligible|1|||
125650486|NCT03099096|452004604|FG000|Overall Study|Adverse Event|1|||
125650487|NCT03099096|452004604|FG000|Overall Study|Physician Decision|1|||
125650488|NCT04629534|452004611|FG000|Overall Study|Physician Decision|1|||
125650489|NCT04629534|452004612|FG001|Overall Study|Physician Decision|0|||
125650490|NCT04629534|452004611|FG000|Overall Study|Protocol Violation|0|||
125650491|NCT04629534|452004612|FG001|Overall Study|Protocol Violation|2|||
125650492|NCT02190604|452004613|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650493|NCT02190604|452004614|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650494|NCT02190604|452004615|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650495|NCT02190604|452004616|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125312453|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Other|1|||
125650496|NCT02190604|452004617|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650497|NCT02190604|452004618|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650498|NCT02190604|452004619|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650499|NCT02190604|452004620|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650500|NCT02190604|452004621|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650501|NCT02190604|452004622|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650502|NCT02190604|452004623|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650503|NCT02190604|452004624|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650504|NCT02190604|452004625|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650505|NCT02190604|452004626|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650506|NCT02190604|452004627|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
125650507|NCT02190604|452004628|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650508|NCT02190604|452004629|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650509|NCT02190604|452004630|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650510|NCT02190604|452004631|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
125650511|NCT02190604|452004613|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650512|NCT02190604|452004614|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650513|NCT02190604|452004615|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650514|NCT02190604|452004616|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125312454|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Other|0|||
125312455|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Other|0|||
125312456|NCT00104650|450772350|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
125312457|NCT00104650|450772351|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
125312458|NCT00104650|450772352|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
125312459|NCT00104650|450772350|FG000|Follow-up Period|Physician Decision|1|||
125312460|NCT00104650|450772351|FG001|Follow-up Period|Physician Decision|1|||
125312461|NCT00104650|450772352|FG002|Follow-up Period|Physician Decision|0|||
125312462|NCT00104650|450772350|FG000|Follow-up Period|Adverse Event|1|||
125312463|NCT00104650|450772351|FG001|Follow-up Period|Adverse Event|0|||
125312464|NCT00104650|450772352|FG002|Follow-up Period|Adverse Event|1|||
125312465|NCT00104650|450772350|FG000|Follow-up Period|Withdrawal by Subject|0|||
125312466|NCT00104650|450772351|FG001|Follow-up Period|Withdrawal by Subject|3|||
125312467|NCT00104650|450772352|FG002|Follow-up Period|Withdrawal by Subject|3|||
125312468|NCT00104650|450772350|FG000|Follow-up Period|Death|6|||
125312469|NCT00104650|450772351|FG001|Follow-up Period|Death|6|||
125312470|NCT00104650|450772352|FG002|Follow-up Period|Death|4|||
125312471|NCT00104650|450772350|FG000|Follow-up Period|Disease progression|3|||
125312472|NCT00104650|450772351|FG001|Follow-up Period|Disease progression|1|||
125312473|NCT00104650|450772352|FG002|Follow-up Period|Disease progression|0|||
125312474|NCT00104650|450772350|FG000|Follow-up Period|Lost to Follow-up|0|||
125312475|NCT00104650|450772351|FG001|Follow-up Period|Lost to Follow-up|1|||
125312476|NCT00104650|450772352|FG002|Follow-up Period|Lost to Follow-up|2|||
125312477|NCT00104650|450772350|FG000|Follow-up Period|Other|0|||
125312478|NCT00104650|450772351|FG001|Follow-up Period|Other|1|||
125312479|NCT00104650|450772352|FG002|Follow-up Period|Other|0|||
125312480|NCT02728089|450772354|FG000|Overall Study|Physician Decision|2|||
125312481|NCT02728089|450772354|FG000|Overall Study|Withdrawal by Subject|1|||
125312482|NCT03384940|450772360|FG000|Overall Study|Progressive disease|36|||
125312483|NCT03384940|450772361|FG001|Overall Study|Progressive disease|11|||
125312484|NCT03384940|450772362|FG002|Overall Study|Progressive disease|13|||
125312485|NCT03384940|450772360|FG000|Overall Study|Clinical progression|4|||
125312486|NCT03384940|450772361|FG001|Overall Study|Clinical progression|0|||
125312487|NCT03384940|450772362|FG002|Overall Study|Clinical progression|3|||
125312488|NCT03384940|450772360|FG000|Overall Study|Adverse Event|7|||
125312489|NCT03384940|450772361|FG001|Overall Study|Adverse Event|1|||
125312490|NCT03384940|450772362|FG002|Overall Study|Adverse Event|1|||
125312491|NCT03384940|450772360|FG000|Overall Study|Withdrawal by Subject|3|||
125312492|NCT03384940|450772361|FG001|Overall Study|Withdrawal by Subject|1|||
125312493|NCT03384940|450772362|FG002|Overall Study|Withdrawal by Subject|0|||
125312494|NCT03384940|450772360|FG000|Overall Study|Physician Decision|1|||
125312495|NCT03384940|450772361|FG001|Overall Study|Physician Decision|1|||
125312496|NCT03384940|450772362|FG002|Overall Study|Physician Decision|0|||
125312497|NCT03384940|450772360|FG000|Overall Study|Death|2|||
125312498|NCT03384940|450772361|FG001|Overall Study|Death|1|||
125312499|NCT03384940|450772362|FG002|Overall Study|Death|0|||
125312500|NCT03384940|450772360|FG000|Overall Study|Other|0|||
125312501|NCT03384940|450772361|FG001|Overall Study|Other|0|||
125312502|NCT03384940|450772362|FG002|Overall Study|Other|1|||
125312503|NCT03089580|450772368|FG000|Overall Study|Lost to Follow-up|2|||
125312504|NCT03087513|450772369|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
125312505|NCT00770601|450772370|FG000|Overall Study|Withdrawal by Subject|1|||
125312506|NCT04417361|450772372|FG000|Overall Study|Withdrawal by Subject|1|||
125312507|NCT04417361|450772373|FG001|Overall Study|Withdrawal by Subject|0|||
125312508|NCT04417361|450772372|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
125312509|NCT04417361|450772373|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
125312510|NCT04965688|450772379|FG000|Overall Study|Withdrawal by Subject|2|||
125312511|NCT05864586|450772380|FG000|Overall Study|Ineligible|4|||
125312512|NCT05864586|450772381|FG001|Overall Study|Ineligible|12|||
125312513|NCT05864586|450772380|FG000|Overall Study|Pregnancy|0|||
125312514|NCT05864586|450772381|FG001|Overall Study|Pregnancy|1|||
125312515|NCT05864586|450772380|FG000|Overall Study|Withdrawal by Subject|0|||
125312516|NCT05864586|450772381|FG001|Overall Study|Withdrawal by Subject|1|||
125312517|NCT00801216|450772382|FG000|Overall Study|Screening Failure|2|||
125312518|NCT00319254|450772386|FG000|Overall Study|Withdrawal by Subject|4|||
125312519|NCT00319254|450772386|FG000|Overall Study|Death|46|||
125312520|NCT00319254|450772386|FG000|Overall Study|Lost to Follow-up|2|||
125312521|NCT00319254|450772386|FG000|Overall Study|Enrolled, Not Treated|2|||
125312522|NCT01505374|450772387|FG000|Overall Study|Lost to Follow-up|1|||
125312523|NCT01505374|450772388|FG001|Overall Study|Lost to Follow-up|0|||
125312524|NCT02452424|450772391|FG000|Overall Study|Death|2|||
125312525|NCT02452424|450772392|FG001|Overall Study|Death|2|||
125312526|NCT02452424|450772393|FG002|Overall Study|Death|2|||
125312527|NCT02452424|450772394|FG003|Overall Study|Death|6|||
125312528|NCT02452424|450772395|FG004|Overall Study|Death|2|||
125312529|NCT02452424|450772396|FG005|Overall Study|Death|0|||
125312530|NCT02452424|450772397|FG006|Overall Study|Death|5|||
125312531|NCT02452424|450772398|FG007|Overall Study|Death|1|||
125312532|NCT02452424|450772399|FG008|Overall Study|Death|3|||
125312533|NCT02452424|450772400|FG009|Overall Study|Death|1|||
125312534|NCT02452424|450772401|FG010|Overall Study|Death|0|||
125312535|NCT02452424|450772391|FG000|Overall Study|Lost to Follow-up|0|||
125312536|NCT02452424|450772392|FG001|Overall Study|Lost to Follow-up|1|||
125312537|NCT02452424|450772393|FG002|Overall Study|Lost to Follow-up|1|||
125312538|NCT02452424|450772394|FG003|Overall Study|Lost to Follow-up|0|||
125312539|NCT02452424|450772395|FG004|Overall Study|Lost to Follow-up|0|||
125312540|NCT02452424|450772396|FG005|Overall Study|Lost to Follow-up|0|||
125312541|NCT02452424|450772397|FG006|Overall Study|Lost to Follow-up|0|||
125312542|NCT02452424|450772398|FG007|Overall Study|Lost to Follow-up|0|||
125312543|NCT02452424|450772399|FG008|Overall Study|Lost to Follow-up|0|||
125312544|NCT02452424|450772400|FG009|Overall Study|Lost to Follow-up|0|||
125312545|NCT02452424|450772401|FG010|Overall Study|Lost to Follow-up|0|||
125312546|NCT02452424|450772391|FG000|Overall Study|Withdrawal by Subject|0|||
125312547|NCT02452424|450772392|FG001|Overall Study|Withdrawal by Subject|0|||
125312548|NCT02452424|450772393|FG002|Overall Study|Withdrawal by Subject|3|||
125312549|NCT02452424|450772394|FG003|Overall Study|Withdrawal by Subject|2|||
125312550|NCT02452424|450772395|FG004|Overall Study|Withdrawal by Subject|0|||
125312551|NCT02452424|450772396|FG005|Overall Study|Withdrawal by Subject|0|||
125312552|NCT02452424|450772397|FG006|Overall Study|Withdrawal by Subject|1|||
125312553|NCT02452424|450772398|FG007|Overall Study|Withdrawal by Subject|0|||
125312554|NCT02452424|450772399|FG008|Overall Study|Withdrawal by Subject|1|||
125312555|NCT02452424|450772400|FG009|Overall Study|Withdrawal by Subject|1|||
125312556|NCT02452424|450772401|FG010|Overall Study|Withdrawal by Subject|0|||
125312557|NCT02452424|450772391|FG000|Overall Study|Other|0|||
125312558|NCT02452424|450772392|FG001|Overall Study|Other|0|||
125312559|NCT02452424|450772393|FG002|Overall Study|Other|1|||
125312560|NCT02452424|450772394|FG003|Overall Study|Other|0|||
125312561|NCT02452424|450772395|FG004|Overall Study|Other|0|||
125312562|NCT02452424|450772396|FG005|Overall Study|Other|1|||
125312563|NCT02452424|450772397|FG006|Overall Study|Other|4|||
125312564|NCT02452424|450772398|FG007|Overall Study|Other|3|||
125312565|NCT02452424|450772399|FG008|Overall Study|Other|0|||
125312566|NCT02452424|450772400|FG009|Overall Study|Other|0|||
125312567|NCT02452424|450772401|FG010|Overall Study|Other|1|||
125312568|NCT02452424|450772391|FG000|Overall Study|Progressive disease (per RECIST)|0|||
125312569|NCT02452424|450772392|FG001|Overall Study|Progressive disease (per RECIST)|0|||
125312570|NCT02452424|450772393|FG002|Overall Study|Progressive disease (per RECIST)|0|||
125312571|NCT02452424|450772394|FG003|Overall Study|Progressive disease (per RECIST)|0|||
125312572|NCT02452424|450772395|FG004|Overall Study|Progressive disease (per RECIST)|0|||
125312573|NCT02452424|450772396|FG005|Overall Study|Progressive disease (per RECIST)|0|||
125312574|NCT02452424|450772397|FG006|Overall Study|Progressive disease (per RECIST)|0|||
125312575|NCT02452424|450772398|FG007|Overall Study|Progressive disease (per RECIST)|0|||
125312576|NCT02452424|450772399|FG008|Overall Study|Progressive disease (per RECIST)|2|||
125312577|NCT02452424|450772400|FG009|Overall Study|Progressive disease (per RECIST)|0|||
125312578|NCT02452424|450772401|FG010|Overall Study|Progressive disease (per RECIST)|0|||
125312579|NCT02452424|450772391|FG000|Overall Study|Adverse Event|0|||
125312580|NCT02452424|450772392|FG001|Overall Study|Adverse Event|0|||
125312581|NCT02452424|450772393|FG002|Overall Study|Adverse Event|0|||
125312582|NCT02452424|450772394|FG003|Overall Study|Adverse Event|0|||
125312583|NCT02452424|450772395|FG004|Overall Study|Adverse Event|0|||
125312584|NCT02452424|450772396|FG005|Overall Study|Adverse Event|0|||
125312585|NCT02452424|450772397|FG006|Overall Study|Adverse Event|0|||
125312586|NCT02452424|450772398|FG007|Overall Study|Adverse Event|0|||
125312587|NCT02452424|450772399|FG008|Overall Study|Adverse Event|0|||
125312588|NCT02452424|450772400|FG009|Overall Study|Adverse Event|0|||
125312589|NCT02452424|450772401|FG010|Overall Study|Adverse Event|1|||
125312590|NCT01463306|450772402|FG000|Overall Study|Adverse Event|6|||
125312591|NCT01463306|450772403|FG001|Overall Study|Adverse Event|9|||
125312592|NCT01463306|450772404|FG002|Overall Study|Adverse Event|3|||
125312593|NCT01463306|450772402|FG000|Overall Study|Death|3|||
125312594|NCT01463306|450772403|FG001|Overall Study|Death|3|||
125312595|NCT01463306|450772404|FG002|Overall Study|Death|0|||
125312596|NCT01463306|450772402|FG000|Overall Study|Lack of Efficacy|22|||
125312597|NCT01463306|450772403|FG001|Overall Study|Lack of Efficacy|16|||
125312598|NCT01463306|450772404|FG002|Overall Study|Lack of Efficacy|1|||
125312599|NCT01463306|450772402|FG000|Overall Study|Lost to Follow-up|5|||
125312600|NCT01463306|450772403|FG001|Overall Study|Lost to Follow-up|2|||
125312601|NCT01463306|450772404|FG002|Overall Study|Lost to Follow-up|0|||
125312602|NCT01463306|450772402|FG000|Overall Study|Protocol Violation|4|||
125312603|NCT01463306|450772403|FG001|Overall Study|Protocol Violation|0|||
125312604|NCT01463306|450772404|FG002|Overall Study|Protocol Violation|0|||
125312605|NCT01463306|450772402|FG000|Overall Study|Withdrawal by Subject|19|||
125312606|NCT01463306|450772403|FG001|Overall Study|Withdrawal by Subject|9|||
125312607|NCT01463306|450772404|FG002|Overall Study|Withdrawal by Subject|1|||
125312608|NCT01463306|450772402|FG000|Overall Study|Other|26|||
125312609|NCT01463306|450772403|FG001|Overall Study|Other|13|||
125312610|NCT01463306|450772404|FG002|Overall Study|Other|0|||
125312611|NCT01463306|450772402|FG000|Overall Study|Approval expiry at site|1|||
125312612|NCT01463306|450772403|FG001|Overall Study|Approval expiry at site|0|||
125312613|NCT01463306|450772404|FG002|Overall Study|Approval expiry at site|0|||
125312614|NCT02679287|450772405|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
125312615|NCT02679287|450772406|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
125650515|NCT02190604|452004617|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125312616|NCT02679287|450772405|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
125312617|NCT02679287|450772406|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
125312618|NCT02679287|450772405|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
125312619|NCT02679287|450772406|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
125312620|NCT02679287|450772405|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
125312621|NCT02679287|450772406|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
125312622|NCT02679287|450772405|FG000|Period 2|Work/Scheduling Conflict|1|||
125312623|NCT02679287|450772406|FG001|Period 2|Work/Scheduling Conflict|0|||
125312624|NCT02679287|450772405|FG000|Period 2|Disliked Mobile System|2|||
125650516|NCT02190604|452004618|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650517|NCT02190604|452004619|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650518|NCT02190604|452004620|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650519|NCT02190604|452004621|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650520|NCT02190604|452004622|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650521|NCT02190604|452004623|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650522|NCT02190604|452004624|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650523|NCT02190604|452004625|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650524|NCT02190604|452004626|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
125650525|NCT02190604|452004627|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650526|NCT02190604|452004628|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650527|NCT02190604|452004629|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650528|NCT02190604|452004630|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650529|NCT02190604|452004631|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
125650530|NCT02797951|452004632|FG000|Overall Study|Adverse Event|4|||
125650531|NCT02797951|452004632|FG000|Overall Study|Death|1|||
125650532|NCT02797951|452004632|FG000|Overall Study|Lack of Efficacy|19|||
125650533|NCT02797951|452004632|FG000|Overall Study|Lost to Follow-up|4|||
125650534|NCT02797951|452004632|FG000|Overall Study|Physician Decision|6|||
125650535|NCT02797951|452004632|FG000|Overall Study|Withdrawal by Subject|15|||
125650536|NCT02369874|452004636|FG000|Overall Study|Lost to Follow-up|2|||
125650537|NCT02369874|452004637|FG001|Overall Study|Lost to Follow-up|2|||
125650538|NCT02369874|452004638|FG002|Overall Study|Lost to Follow-up|2|||
125650539|NCT02369874|452004636|FG000|Overall Study|Withdrawal by Subject|7|||
125650540|NCT02369874|452004637|FG001|Overall Study|Withdrawal by Subject|9|||
125650541|NCT02369874|452004638|FG002|Overall Study|Withdrawal by Subject|27|||
125650542|NCT02369874|452004636|FG000|Overall Study|Miscellaneous|1|||
125650543|NCT02369874|452004637|FG001|Overall Study|Miscellaneous|1|||
125650544|NCT02369874|452004638|FG002|Overall Study|Miscellaneous|0|||
125650545|NCT02369874|452004636|FG000|Overall Study|On Treatment/Off Study|34|||
125650546|NCT02369874|452004637|FG001|Overall Study|On Treatment/Off Study|45|||
125650547|NCT02369874|452004638|FG002|Overall Study|On Treatment/Off Study|32|||
125650548|NCT01012765|452004639|FG000|Treatment Period 1|Adverse Event|1|||
125650549|NCT01012765|452004640|FG001|Treatment Period 1|Adverse Event|0|||
125650550|NCT01012765|452004641|FG002|Treatment Period 1|Adverse Event|1|||
125650551|NCT01012765|452004642|FG003|Treatment Period 1|Adverse Event|0|||
125210370|NCT00866333|450393852|FG000|Overall Study|Withdrawal of consent|0|||
125210371|NCT00866333|450393853|FG001|Overall Study|Withdrawal of consent|1|||
125210372|NCT00866333|450393854|FG002|Overall Study|Withdrawal of consent|2|||
125210373|NCT00866333|450393852|FG000|Overall Study|Reason not Specified|3|||
125210374|NCT00866333|450393853|FG001|Overall Study|Reason not Specified|1|||
125210375|NCT00866333|450393854|FG002|Overall Study|Reason not Specified|1|||
125210376|NCT00866333|450393852|FG000|Overall Study|Study Terminated by Sponsor|2|||
125210377|NCT00866333|450393853|FG001|Overall Study|Study Terminated by Sponsor|5|||
125210378|NCT00866333|450393854|FG002|Overall Study|Study Terminated by Sponsor|9|||
125650552|NCT01012765|452004643|FG004|Treatment Period 1|Adverse Event|0|||
125650553|NCT01012765|452004644|FG005|Treatment Period 1|Adverse Event|0|||
125650554|NCT01012765|452004639|FG000|Treatment Period 1|Withdrawal by Subject|2|||
125650555|NCT01012765|452004640|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125650556|NCT01012765|452004641|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125650557|NCT01012765|452004642|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125650558|NCT01012765|452004643|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125650559|NCT01012765|452004644|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125650560|NCT01012765|452004639|FG000|Treatment Period 1|Administrative problems|0|||
125650561|NCT01012765|452004640|FG001|Treatment Period 1|Administrative problems|0|||
125650562|NCT01012765|452004641|FG002|Treatment Period 1|Administrative problems|1|||
125650563|NCT01012765|452004642|FG003|Treatment Period 1|Administrative problems|1|||
125650564|NCT01012765|452004643|FG004|Treatment Period 1|Administrative problems|1|||
125210379|NCT01653327|450393855|FG000|Overall Study|Withdrawal by Subject|1|||
125312625|NCT02679287|450772406|FG001|Period 2|Disliked Mobile System|0|||
125312626|NCT02679287|450772405|FG000|Period 3|Work/Scheduling Conflict|0|||
125312627|NCT02679287|450772406|FG001|Period 3|Work/Scheduling Conflict|1|||
125312628|NCT00992459|450772415|FG000|Overall Study|Withdrawal by Subject|0|||
125312629|NCT00992459|450772416|FG001|Overall Study|Withdrawal by Subject|1|||
125312630|NCT00992459|450772415|FG000|Overall Study|Adverse Event|1|||
125312631|NCT00992459|450772416|FG001|Overall Study|Adverse Event|0|||
125312632|NCT00543387|450772417|FG000|Panel 1 + Panel 2|Adverse Event|0|||
125312633|NCT00543387|450772418|FG001|Panel 1 + Panel 2|Adverse Event|1|||
125312634|NCT00543387|450772419|FG002|Panel 1 + Panel 2|Adverse Event|0|||
125312635|NCT00543387|450772420|FG003|Panel 1 + Panel 2|Adverse Event|0|||
125312636|NCT00543387|450772421|FG004|Panel 1 + Panel 2|Adverse Event|0|||
125312637|NCT00543387|450772422|FG005|Panel 1 + Panel 2|Adverse Event|0|||
125312638|NCT00543387|450772423|FG006|Panel 1 + Panel 2|Adverse Event|0|||
125312639|NCT00543387|450772424|FG007|Panel 1 + Panel 2|Adverse Event|1|||
125312640|NCT00543387|450772425|FG008|Panel 1 + Panel 2|Adverse Event|1|||
125312641|NCT00543387|450772426|FG009|Panel 1 + Panel 2|Adverse Event|0|||
125312642|NCT00543387|450772427|FG010|Panel 1 + Panel 2|Adverse Event|0|||
125312643|NCT00543387|450772417|FG000|Panel 1 + Panel 2|Physician Decision|0|||
125312644|NCT00543387|450772418|FG001|Panel 1 + Panel 2|Physician Decision|0|||
125312645|NCT00543387|450772419|FG002|Panel 1 + Panel 2|Physician Decision|1|||
125312646|NCT00543387|450772420|FG003|Panel 1 + Panel 2|Physician Decision|0|||
125312647|NCT00543387|450772421|FG004|Panel 1 + Panel 2|Physician Decision|0|||
125312648|NCT00543387|450772422|FG005|Panel 1 + Panel 2|Physician Decision|0|||
125312649|NCT00543387|450772423|FG006|Panel 1 + Panel 2|Physician Decision|0|||
125312650|NCT00543387|450772424|FG007|Panel 1 + Panel 2|Physician Decision|1|||
125312651|NCT00543387|450772425|FG008|Panel 1 + Panel 2|Physician Decision|0|||
125312652|NCT00543387|450772426|FG009|Panel 1 + Panel 2|Physician Decision|0|||
125312653|NCT00543387|450772427|FG010|Panel 1 + Panel 2|Physician Decision|0|||
125312654|NCT00543387|450772417|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
125312655|NCT00543387|450772418|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
125312656|NCT00543387|450772419|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
125312657|NCT00543387|450772420|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
125312658|NCT00543387|450772421|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
125312659|NCT00543387|450772422|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
125312660|NCT00543387|450772423|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
125312661|NCT00543387|450772424|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
125312662|NCT00543387|450772425|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
125312663|NCT00543387|450772426|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
125312664|NCT00543387|450772427|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
125312665|NCT00543387|450772417|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312666|NCT00543387|450772418|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312667|NCT00543387|450772419|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312668|NCT00543387|450772420|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312669|NCT00543387|450772421|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312670|NCT00543387|450772422|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312671|NCT00543387|450772423|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
125312672|NCT00543387|450772424|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312673|NCT00543387|450772425|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312674|NCT00543387|450772426|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312675|NCT00543387|450772427|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
125312676|NCT00543387|450772417|FG000|Crossover Participants|Progressive Disease|0|||
125312677|NCT00543387|450772418|FG001|Crossover Participants|Progressive Disease|0|||
125312678|NCT00543387|450772419|FG002|Crossover Participants|Progressive Disease|0|||
125312679|NCT00543387|450772420|FG003|Crossover Participants|Progressive Disease|0|||
125312680|NCT00543387|450772421|FG004|Crossover Participants|Progressive Disease|0|||
125312681|NCT00543387|450772422|FG005|Crossover Participants|Progressive Disease|0|||
125312682|NCT00543387|450772423|FG006|Crossover Participants|Progressive Disease|0|||
125312683|NCT00543387|450772424|FG007|Crossover Participants|Progressive Disease|0|||
125312684|NCT00543387|450772425|FG008|Crossover Participants|Progressive Disease|0|||
125312685|NCT00543387|450772426|FG009|Crossover Participants|Progressive Disease|1|||
125312686|NCT00543387|450772427|FG010|Crossover Participants|Progressive Disease|2|||
125312687|NCT00543387|450772417|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
125312688|NCT00543387|450772418|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
125312689|NCT00543387|450772419|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
125540378|NCT01712659|451607605|FG004|Dose Expansion|Physician Decision|0|||
125540379|NCT00548262|451607606|FG000|Overall Study|Death|21|||
125540380|NCT00548262|451607606|FG000|Overall Study|Adverse Event|2|||
125540381|NCT00548262|451607606|FG000|Overall Study|Lack of Efficacy|4|||
125540382|NCT00548262|451607606|FG000|Overall Study|Lost to Follow-up|1|||
125540383|NCT00548262|451607606|FG000|Overall Study|Other|3|||
125540384|NCT00548262|451607606|FG000|Overall Study|Withdrawal by Subject|1|||
125540385|NCT02442336|451607610|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
125540386|NCT02442336|451607610|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
125650565|NCT01012765|452004644|FG005|Treatment Period 1|Administrative problems|0|||
125650566|NCT01012765|452004639|FG000|Treatment Period 1|Protocol Violation|0|||
125650567|NCT01012765|452004640|FG001|Treatment Period 1|Protocol Violation|0|||
125650568|NCT01012765|452004641|FG002|Treatment Period 1|Protocol Violation|0|||
125650569|NCT01012765|452004642|FG003|Treatment Period 1|Protocol Violation|2|||
125650570|NCT01012765|452004643|FG004|Treatment Period 1|Protocol Violation|1|||
125650571|NCT01012765|452004644|FG005|Treatment Period 1|Protocol Violation|0|||
125650572|NCT01012765|452004639|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
125650573|NCT01012765|452004640|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
125650574|NCT01012765|452004641|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
125650575|NCT01012765|452004642|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
125650576|NCT01012765|452004643|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
125650577|NCT01012765|452004644|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
125650578|NCT01012765|452004639|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125650579|NCT01012765|452004640|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125650580|NCT01012765|452004641|FG002|Treatment Period 2|Withdrawal by Subject|1|||
125650581|NCT01012765|452004642|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125650582|NCT01012765|452004643|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125650583|NCT01012765|452004644|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125650584|NCT01012765|452004639|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
125650585|NCT01012765|452004640|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
125650586|NCT01012765|452004641|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
125650587|NCT01012765|452004642|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
125650588|NCT01012765|452004643|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
125650589|NCT01012765|452004644|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
125650590|NCT01012765|452004639|FG000|Treatment Period 2|Adverse Event|0|||
125650591|NCT01012765|452004640|FG001|Treatment Period 2|Adverse Event|1|||
125650592|NCT01012765|452004641|FG002|Treatment Period 2|Adverse Event|1|||
125650593|NCT01012765|452004642|FG003|Treatment Period 2|Adverse Event|0|||
125650594|NCT01012765|452004643|FG004|Treatment Period 2|Adverse Event|0|||
125650595|NCT01012765|452004644|FG005|Treatment Period 2|Adverse Event|0|||
125650596|NCT01012765|452004639|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
125650597|NCT01012765|452004640|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
125650598|NCT01012765|452004641|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
125650599|NCT01012765|452004642|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
125650600|NCT01012765|452004643|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
125650601|NCT01012765|452004644|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
125650602|NCT01326312|452004645|FG000|Overall Study|Adverse Event|11|||
125312690|NCT00543387|450772420|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
125312691|NCT00543387|450772421|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
125312692|NCT00543387|450772422|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
125312693|NCT00543387|450772423|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
125312694|NCT00543387|450772424|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
125312695|NCT00543387|450772425|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
125312696|NCT00543387|450772426|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
125312697|NCT00543387|450772427|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
125312698|NCT00940498|450772428|FG000|Overall Study|Death|2|||
125312699|NCT00940498|450772429|FG001|Overall Study|Death|0|||
125312700|NCT00940498|450772430|FG002|Overall Study|Death|0|||
125312701|NCT00940498|450772431|FG003|Overall Study|Death|1|||
125312702|NCT00940498|450772432|FG004|Overall Study|Death|5|||
125312703|NCT00940498|450772433|FG005|Overall Study|Death|0|||
125312704|NCT00940498|450772434|FG006|Overall Study|Death|1|||
125312705|NCT00940498|450772435|FG007|Overall Study|Death|0|||
125312706|NCT00940498|450772428|FG000|Overall Study|Lost to Follow-up|1|||
125312707|NCT00940498|450772429|FG001|Overall Study|Lost to Follow-up|1|||
125312708|NCT00940498|450772430|FG002|Overall Study|Lost to Follow-up|2|||
125312709|NCT00940498|450772431|FG003|Overall Study|Lost to Follow-up|0|||
125312710|NCT00940498|450772432|FG004|Overall Study|Lost to Follow-up|1|||
125312711|NCT00940498|450772433|FG005|Overall Study|Lost to Follow-up|0|||
125312712|NCT00940498|450772434|FG006|Overall Study|Lost to Follow-up|0|||
125312713|NCT00940498|450772435|FG007|Overall Study|Lost to Follow-up|1|||
125312714|NCT00940498|450772428|FG000|Overall Study|Disease Progression|0|||
125312715|NCT00940498|450772429|FG001|Overall Study|Disease Progression|0|||
125312716|NCT00940498|450772430|FG002|Overall Study|Disease Progression|1|||
125312717|NCT00940498|450772431|FG003|Overall Study|Disease Progression|1|||
125312718|NCT00940498|450772432|FG004|Overall Study|Disease Progression|0|||
125650603|NCT01326312|452004646|FG001|Overall Study|Adverse Event|11|||
125650604|NCT01326312|452004647|FG002|Overall Study|Adverse Event|1|||
125650605|NCT01326312|452004645|FG000|Overall Study|Withdrawal by Subject|1|||
125650606|NCT01326312|452004646|FG001|Overall Study|Withdrawal by Subject|2|||
125312719|NCT00940498|450772433|FG005|Overall Study|Disease Progression|1|||
125312720|NCT00940498|450772434|FG006|Overall Study|Disease Progression|0|||
125312721|NCT00940498|450772435|FG007|Overall Study|Disease Progression|0|||
125312722|NCT00940498|450772428|FG000|Overall Study|Physician Decision|0|||
125312723|NCT00940498|450772429|FG001|Overall Study|Physician Decision|0|||
125312724|NCT00940498|450772430|FG002|Overall Study|Physician Decision|0|||
125312725|NCT00940498|450772431|FG003|Overall Study|Physician Decision|0|||
125312726|NCT00940498|450772432|FG004|Overall Study|Physician Decision|2|||
125312727|NCT00940498|450772433|FG005|Overall Study|Physician Decision|0|||
125312728|NCT00940498|450772434|FG006|Overall Study|Physician Decision|0|||
125312729|NCT00940498|450772435|FG007|Overall Study|Physician Decision|0|||
125312730|NCT00940498|450772428|FG000|Overall Study|Not treated due to disease related pain|0|||
125312731|NCT00940498|450772429|FG001|Overall Study|Not treated due to disease related pain|0|||
125312732|NCT00940498|450772430|FG002|Overall Study|Not treated due to disease related pain|0|||
125312733|NCT00940498|450772431|FG003|Overall Study|Not treated due to disease related pain|0|||
125312734|NCT00940498|450772432|FG004|Overall Study|Not treated due to disease related pain|1|||
125312735|NCT00940498|450772433|FG005|Overall Study|Not treated due to disease related pain|0|||
125312736|NCT00940498|450772434|FG006|Overall Study|Not treated due to disease related pain|0|||
125312737|NCT00940498|450772435|FG007|Overall Study|Not treated due to disease related pain|0|||
125312738|NCT01943591|450772436|FG000|Overall Study|Lost to Follow-up|3|||
125312739|NCT01943591|450772437|FG001|Overall Study|Lost to Follow-up|4|||
125312740|NCT01943591|450772436|FG000|Overall Study|Death|2|||
125312741|NCT01943591|450772437|FG001|Overall Study|Death|7|||
125312742|NCT00227721|450773714|FG000|Overall Study|On study, but never treated.|1|||
125312743|NCT01389882|450773723|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
125312744|NCT01389882|450773724|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
125312745|NCT01389882|450773723|FG000|Overall Study|Withdrawal by Subject|0|||
125312746|NCT01389882|450773724|FG001|Overall Study|Withdrawal by Subject|1|||
125312747|NCT00859547|450773736|FG000|Overall Study|Lost to Follow-up|1|||
125312748|NCT00859547|450773736|FG000|Overall Study|Parent withdrew consent|1|||
125312749|NCT01276639|450773747|FG000|Week 0 to 16|Death|1|||
125312750|NCT01276639|450773748|FG001|Week 0 to 16|Death|0|||
125312751|NCT01276639|450773749|FG002|Week 0 to 16|Death|0|||
125312752|NCT01276639|450773750|FG003|Week 0 to 16|Death|0|||
125312753|NCT01276639|450773751|FG004|Week 0 to 16|Death|0|||
125312754|NCT01276639|450773747|FG000|Week 0 to 16|Adverse Event|11|||
125312755|NCT01276639|450773748|FG001|Week 0 to 16|Adverse Event|8|||
125312756|NCT01276639|450773749|FG002|Week 0 to 16|Adverse Event|11|||
125312757|NCT01276639|450773750|FG003|Week 0 to 16|Adverse Event|0|||
125312758|NCT01276639|450773751|FG004|Week 0 to 16|Adverse Event|0|||
125312759|NCT01276639|450773747|FG000|Week 0 to 16|Lack of Efficacy|20|||
125312760|NCT01276639|450773748|FG001|Week 0 to 16|Lack of Efficacy|15|||
125312761|NCT01276639|450773749|FG002|Week 0 to 16|Lack of Efficacy|25|||
125312762|NCT01276639|450773750|FG003|Week 0 to 16|Lack of Efficacy|0|||
125312763|NCT01276639|450773751|FG004|Week 0 to 16|Lack of Efficacy|0|||
125312764|NCT01276639|450773747|FG000|Week 0 to 16|Lost to Follow-up|3|||
125312765|NCT01276639|450773748|FG001|Week 0 to 16|Lost to Follow-up|5|||
125312766|NCT01276639|450773749|FG002|Week 0 to 16|Lost to Follow-up|3|||
125312767|NCT01276639|450773750|FG003|Week 0 to 16|Lost to Follow-up|0|||
125312768|NCT01276639|450773751|FG004|Week 0 to 16|Lost to Follow-up|0|||
125312769|NCT01276639|450773747|FG000|Week 0 to 16|Withdrawal by Subject|8|||
125312770|NCT01276639|450773748|FG001|Week 0 to 16|Withdrawal by Subject|5|||
125312771|NCT01276639|450773749|FG002|Week 0 to 16|Withdrawal by Subject|4|||
125312772|NCT01276639|450773750|FG003|Week 0 to 16|Withdrawal by Subject|0|||
125312773|NCT01276639|450773751|FG004|Week 0 to 16|Withdrawal by Subject|0|||
125312774|NCT01276639|450773747|FG000|Week 0 to 16|Other|7|||
125312775|NCT01276639|450773748|FG001|Week 0 to 16|Other|7|||
125312776|NCT01276639|450773749|FG002|Week 0 to 16|Other|2|||
125312777|NCT01276639|450773750|FG003|Week 0 to 16|Other|0|||
125312778|NCT01276639|450773751|FG004|Week 0 to 16|Other|0|||
125312779|NCT01276639|450773747|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
125312780|NCT01276639|450773748|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
125312781|NCT01276639|450773749|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
125312782|NCT01276639|450773750|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
125312783|NCT01276639|450773751|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
125312784|NCT01276639|450773747|FG000|Week 16 to 52|Death|1|||
125312785|NCT01276639|450773748|FG001|Week 16 to 52|Death|0|||
125312786|NCT01276639|450773749|FG002|Week 16 to 52|Death|0|||
125312787|NCT01276639|450773750|FG003|Week 16 to 52|Death|0|||
125312788|NCT01276639|450773751|FG004|Week 16 to 52|Death|0|||
125312789|NCT01276639|450773747|FG000|Week 16 to 52|Adverse Event|10|||
125312790|NCT01276639|450773748|FG001|Week 16 to 52|Adverse Event|13|||
125312791|NCT01276639|450773749|FG002|Week 16 to 52|Adverse Event|0|||
125312792|NCT01276639|450773750|FG003|Week 16 to 52|Adverse Event|1|||
125312793|NCT01276639|450773751|FG004|Week 16 to 52|Adverse Event|3|||
125312794|NCT01276639|450773747|FG000|Week 16 to 52|Lack of Efficacy|99|||
125312795|NCT01276639|450773748|FG001|Week 16 to 52|Lack of Efficacy|71|||
125312796|NCT01276639|450773749|FG002|Week 16 to 52|Lack of Efficacy|0|||
125312797|NCT01276639|450773750|FG003|Week 16 to 52|Lack of Efficacy|14|||
125312798|NCT01276639|450773751|FG004|Week 16 to 52|Lack of Efficacy|13|||
125312799|NCT01276639|450773747|FG000|Week 16 to 52|Lost to Follow-up|3|||
125312800|NCT01276639|450773748|FG001|Week 16 to 52|Lost to Follow-up|1|||
125312801|NCT01276639|450773749|FG002|Week 16 to 52|Lost to Follow-up|0|||
125312802|NCT01276639|450773750|FG003|Week 16 to 52|Lost to Follow-up|0|||
125312803|NCT01276639|450773751|FG004|Week 16 to 52|Lost to Follow-up|1|||
125312804|NCT01276639|450773747|FG000|Week 16 to 52|Withdrawal by Subject|4|||
125312805|NCT01276639|450773748|FG001|Week 16 to 52|Withdrawal by Subject|4|||
125312806|NCT01276639|450773749|FG002|Week 16 to 52|Withdrawal by Subject|0|||
125312807|NCT01276639|450773750|FG003|Week 16 to 52|Withdrawal by Subject|0|||
125312808|NCT01276639|450773751|FG004|Week 16 to 52|Withdrawal by Subject|1|||
125312809|NCT01276639|450773747|FG000|Week 16 to 52|Other|10|||
125312810|NCT01276639|450773748|FG001|Week 16 to 52|Other|12|||
125312811|NCT01276639|450773749|FG002|Week 16 to 52|Other|0|||
125312812|NCT01276639|450773750|FG003|Week 16 to 52|Other|1|||
125312813|NCT01276639|450773751|FG004|Week 16 to 52|Other|3|||
125312814|NCT00330759|450773757|FG000|Overall Study|Death|316|||
125312815|NCT00330759|450773758|FG001|Overall Study|Death|310|||
125312816|NCT00330759|450773757|FG000|Overall Study|Disease progression|104|||
125312817|NCT00330759|450773758|FG001|Overall Study|Disease progression|126|||
125312818|NCT00330759|450773757|FG000|Overall Study|Withdrawal by Subject|143|||
125312819|NCT00330759|450773758|FG001|Overall Study|Withdrawal by Subject|124|||
125312820|NCT00330759|450773757|FG000|Overall Study|Adverse Event|48|||
125312821|NCT00330759|450773758|FG001|Overall Study|Adverse Event|36|||
125312822|NCT00330759|450773757|FG000|Overall Study|Participant request|31|||
125312823|NCT00330759|450773758|FG001|Overall Study|Participant request|22|||
125312824|NCT00330759|450773757|FG000|Overall Study|Lost to Follow-up|16|||
125312825|NCT00330759|450773758|FG001|Overall Study|Lost to Follow-up|22|||
125312826|NCT00330759|450773757|FG000|Overall Study|Noncompliance|15|||
125312827|NCT00330759|450773758|FG001|Overall Study|Noncompliance|17|||
125312828|NCT00330759|450773757|FG000|Overall Study|Physician Decision|1|||
125312829|NCT00330759|450773758|FG001|Overall Study|Physician Decision|2|||
125312830|NCT00330759|450773757|FG000|Overall Study|Protocol deviation|0|||
125312831|NCT00330759|450773758|FG001|Overall Study|Protocol deviation|2|||
125312832|NCT00330759|450773757|FG000|Overall Study|Ineligibility determined|2|||
125312833|NCT00330759|450773758|FG001|Overall Study|Ineligibility determined|1|||
125312834|NCT00330759|450773757|FG000|Overall Study|Other|36|||
125312835|NCT00330759|450773758|FG001|Overall Study|Other|44|||
125312836|NCT03654690|450773763|FG000|Overall Study|Withdrawal by Subject|1|||
125312837|NCT03654690|450773764|FG001|Overall Study|Withdrawal by Subject|0|||
125312838|NCT03654690|450773765|FG002|Overall Study|Withdrawal by Subject|0|||
125312839|NCT00742183|450773768|FG000|Overall Study|Adverse Event|2|||
125312840|NCT00742183|450773769|FG001|Overall Study|Adverse Event|2|||
125312841|NCT00742183|450773768|FG000|Overall Study|Death|1|||
125312842|NCT00742183|450773769|FG001|Overall Study|Death|0|||
125312843|NCT00742183|450773768|FG000|Overall Study|Physician Decision|0|||
125312844|NCT00742183|450773769|FG001|Overall Study|Physician Decision|2|||
125312845|NCT00742183|450773768|FG000|Overall Study|Lost to Follow-up|4|||
125312846|NCT00742183|450773769|FG001|Overall Study|Lost to Follow-up|4|||
125312847|NCT00742183|450773768|FG000|Overall Study|Required skin-graft|1|||
125312848|NCT00742183|450773769|FG001|Overall Study|Required skin-graft|1|||
125312849|NCT00742183|450773768|FG000|Overall Study|Withdrawal by Subject|1|||
125312850|NCT00742183|450773769|FG001|Overall Study|Withdrawal by Subject|0|||
125312851|NCT00742183|450773768|FG000|Overall Study|Lack of Efficacy|0|||
125312852|NCT00742183|450773769|FG001|Overall Study|Lack of Efficacy|3|||
125312853|NCT00786799|450773772|FG000|Overall Study|Lost to Follow-up|1|||
125312854|NCT00786799|450773773|FG001|Overall Study|Lost to Follow-up|1|||
125312855|NCT02544503|450773774|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
125312856|NCT02544503|450773775|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
125312857|NCT02544503|450773774|FG000|Overall Study|Lost to Follow-up|9|||
125312858|NCT02544503|450773775|FG001|Overall Study|Lost to Follow-up|0|||
125312859|NCT02544503|450773774|FG000|Overall Study|Withdrawal by Subject|1|||
125312860|NCT02544503|450773775|FG001|Overall Study|Withdrawal by Subject|0|||
125312861|NCT01080807|450773779|FG000|Overall Study|Adverse Event|9|||
125312862|NCT01080807|450773780|FG001|Overall Study|Adverse Event|1|||
125312863|NCT01080807|450773779|FG000|Overall Study|Lack of Efficacy|0|||
125312864|NCT01080807|450773780|FG001|Overall Study|Lack of Efficacy|1|||
125312865|NCT01080807|450773779|FG000|Overall Study|Withdrawal by Subject|7|||
125312866|NCT01080807|450773780|FG001|Overall Study|Withdrawal by Subject|2|||
125312867|NCT01080807|450773779|FG000|Overall Study|Protocol Violation|7|||
125312868|NCT01080807|450773780|FG001|Overall Study|Protocol Violation|6|||
125312869|NCT01080807|450773779|FG000|Overall Study|Lost to Follow-up|6|||
125312870|NCT01080807|450773780|FG001|Overall Study|Lost to Follow-up|4|||
125312871|NCT01080807|450773779|FG000|Overall Study|Noncompliance with drug administration|1|||
125312872|NCT01080807|450773780|FG001|Overall Study|Noncompliance with drug administration|1|||
125312873|NCT01080807|450773779|FG000|Overall Study|Noncompliance to study procedures|1|||
125650607|NCT01326312|452004647|FG002|Overall Study|Withdrawal by Subject|1|||
125312874|NCT01080807|450773780|FG001|Overall Study|Noncompliance to study procedures|1|||
125312875|NCT01080807|450773779|FG000|Overall Study|Began working day shift|0|||
125312876|NCT01080807|450773780|FG001|Overall Study|Began working day shift|2|||
125312877|NCT01080807|450773779|FG000|Overall Study|Laid off or terminated from job|1|||
125312878|NCT01080807|450773780|FG001|Overall Study|Laid off or terminated from job|2|||
125312879|NCT01080807|450773779|FG000|Overall Study|Stopped working consistent night shifts|0|||
125312880|NCT01080807|450773780|FG001|Overall Study|Stopped working consistent night shifts|1|||
125312881|NCT01080807|450773779|FG000|Overall Study|Work schedule changing|1|||
125312882|NCT01080807|450773780|FG001|Overall Study|Work schedule changing|1|||
125312883|NCT01080807|450773779|FG000|Overall Study|Work schedule and travel|0|||
125312884|NCT01080807|450773780|FG001|Overall Study|Work schedule and travel|1|||
125312885|NCT01080807|450773779|FG000|Overall Study|Switched to first shift|1|||
125312886|NCT01080807|450773780|FG001|Overall Study|Switched to first shift|0|||
125312887|NCT01080807|450773779|FG000|Overall Study|Moved away without notifying center|1|||
125312888|NCT01080807|450773780|FG001|Overall Study|Moved away without notifying center|0|||
125312889|NCT03922581|450773786|FG000|Overall Study|Lost to Follow-up|20|||
125312890|NCT03922581|450773787|FG001|Overall Study|Lost to Follow-up|9|||
125312891|NCT03922581|450773786|FG000|Overall Study|Physician Decision|1|||
125312892|NCT03922581|450773787|FG001|Overall Study|Physician Decision|1|||
125312893|NCT03922581|450773786|FG000|Overall Study|Withdrawal by Subject|1|||
125312894|NCT03922581|450773787|FG001|Overall Study|Withdrawal by Subject|0|||
125312895|NCT04685798|450773790|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
125312896|NCT02223715|450773791|FG000|Overall Study|Death|31|||
125312897|NCT02223715|450773791|FG000|Overall Study|Lost to Follow-up|73|||
125312898|NCT03956550|450773792|FG000|Overall Study|Sponsor decision|65|||
125312899|NCT03956550|450773793|FG001|Overall Study|Sponsor decision|66|||
125312900|NCT03956550|450773794|FG002|Overall Study|Sponsor decision|64|||
125312901|NCT03956550|450773792|FG000|Overall Study|Adverse Event|0|||
125312902|NCT03956550|450773793|FG001|Overall Study|Adverse Event|1|||
125312903|NCT03956550|450773794|FG002|Overall Study|Adverse Event|0|||
125312904|NCT03956550|450773792|FG000|Overall Study|Withdrawal by Subject|5|||
125312905|NCT03956550|450773793|FG001|Overall Study|Withdrawal by Subject|5|||
125312906|NCT03956550|450773794|FG002|Overall Study|Withdrawal by Subject|6|||
125312907|NCT01745367|450773797|FG000|Overall Study|Death|1|||
125312908|NCT01745367|450773798|FG001|Overall Study|Death|0|||
125312909|NCT01745367|450773797|FG000|Overall Study|Withdrawal by Subject|1|||
125312910|NCT01745367|450773798|FG001|Overall Study|Withdrawal by Subject|2|||
125312911|NCT01745367|450773797|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
125312912|NCT01745367|450773798|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
125312913|NCT01745367|450773797|FG000|Overall Study|Other Reasons Unspecified|0|||
125312914|NCT01745367|450773798|FG001|Overall Study|Other Reasons Unspecified|2|||
125312915|NCT00824473|450773802|FG000|Overall Study|Adverse Event|4|||
125312916|NCT00824473|450773803|FG001|Overall Study|Adverse Event|5|||
125312917|NCT00824473|450773802|FG000|Overall Study|Lack of Efficacy|2|||
125312918|NCT00824473|450773803|FG001|Overall Study|Lack of Efficacy|2|||
125312919|NCT00824473|450773802|FG000|Overall Study|Protocol Violation|2|||
125312920|NCT00824473|450773803|FG001|Overall Study|Protocol Violation|0|||
125312921|NCT00824473|450773802|FG000|Overall Study|Non-Compliance|4|||
125312922|NCT00824473|450773803|FG001|Overall Study|Non-Compliance|2|||
125312923|NCT00824473|450773802|FG000|Overall Study|Withdrawal by Subject|2|||
125312924|NCT00824473|450773803|FG001|Overall Study|Withdrawal by Subject|3|||
125312925|NCT00824473|450773802|FG000|Overall Study|Other|1|||
125312926|NCT00824473|450773803|FG001|Overall Study|Other|1|||
125312927|NCT01359904|450773804|FG000|Overall Study|Withdrawal by Subject|1|||
125312928|NCT01359904|450773805|FG001|Overall Study|Withdrawal by Subject|0|||
125312929|NCT02525588|450773807|FG000|Overall Study|Death|3|||
125312930|NCT02525588|450773808|FG001|Overall Study|Death|1|||
125312931|NCT02525588|450773807|FG000|Overall Study|Lost to Follow-up|2|||
125312932|NCT02525588|450773808|FG001|Overall Study|Lost to Follow-up|0|||
125312933|NCT02525588|450773807|FG000|Overall Study|Withdrawal by Subject|1|||
125312934|NCT02525588|450773808|FG001|Overall Study|Withdrawal by Subject|1|||
125312935|NCT02525588|450773807|FG000|Overall Study|Adverse Event|0|||
125312936|NCT02525588|450773808|FG001|Overall Study|Adverse Event|1|||
125312937|NCT03018691|450773811|FG000|Overall Study|Adverse Event|1|||
125312938|NCT03018691|450773812|FG001|Overall Study|Adverse Event|1|||
125312939|NCT03018691|450773813|FG002|Overall Study|Adverse Event|4|||
125312940|NCT03018691|450773811|FG000|Overall Study|Lack of Efficacy|0|||
125312941|NCT03018691|450773812|FG001|Overall Study|Lack of Efficacy|0|||
125312942|NCT03018691|450773813|FG002|Overall Study|Lack of Efficacy|1|||
125312943|NCT03018691|450773811|FG000|Overall Study|Withdrawal by Subject|0|||
125312944|NCT03018691|450773812|FG001|Overall Study|Withdrawal by Subject|0|||
125312945|NCT03018691|450773813|FG002|Overall Study|Withdrawal by Subject|1|||
125312946|NCT03018691|450773811|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125312947|NCT03018691|450773812|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125312948|NCT03018691|450773813|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125312949|NCT03369418|450773815|FG000|Overall Study|Withdrawal by Subject|3|||
125312950|NCT03369418|450773816|FG001|Overall Study|Withdrawal by Subject|3|||
125312951|NCT00796666|450773818|FG000|Overall Study|Death|2|||
125312952|NCT00796666|450773819|FG001|Overall Study|Death|4|||
125312953|NCT00796666|450773818|FG000|Overall Study|Withdrawal by Subject|2|||
125312954|NCT00796666|450773819|FG001|Overall Study|Withdrawal by Subject|0|||
125312955|NCT00796666|450773818|FG000|Overall Study|Adverse Event|7|||
125312956|NCT00796666|450773819|FG001|Overall Study|Adverse Event|5|||
125312957|NCT00796666|450773818|FG000|Overall Study|Protocol Violation|1|||
125312958|NCT00796666|450773819|FG001|Overall Study|Protocol Violation|0|||
125312959|NCT00796666|450773818|FG000|Overall Study|Other|1|||
125312960|NCT00796666|450773819|FG001|Overall Study|Other|0|||
125312961|NCT00796666|450773818|FG000|Overall Study|Terminated by sponsor|53|||
125312962|NCT00796666|450773819|FG001|Overall Study|Terminated by sponsor|55|||
125312963|NCT00796666|450773818|FG000|Overall Study|Randomized and not treated|1|||
125312964|NCT00796666|450773819|FG001|Overall Study|Randomized and not treated|0|||
125312965|NCT00057863|450773821|FG000|Overall Study|Death|1|||
125312966|NCT00057863|450773821|FG000|Overall Study|Withdrawal by Subject|2|||
125312967|NCT01521507|450773822|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
125312968|NCT01521507|450773823|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
125312969|NCT01521507|450773822|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
125312970|NCT01521507|450773823|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
125312971|NCT01521507|450773822|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
125312972|NCT01521507|450773823|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
125312973|NCT01521507|450773822|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
125312974|NCT01521507|450773823|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
125312975|NCT01521507|450773822|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
125312976|NCT01521507|450773823|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
125312977|NCT01521507|450773822|FG000|Stage 2: Observational Design|Physician Decision|1|||
125312978|NCT01521507|450773823|FG001|Stage 2: Observational Design|Physician Decision|0|||
125312979|NCT01479868|450773824|FG000|Overall Study|Adverse Event|1|||
125312980|NCT01479868|450773824|FG000|Overall Study|Lost to Follow-up|4|||
125312981|NCT01479868|450773824|FG000|Overall Study|Protocol Violation|1|||
125312982|NCT01479868|450773824|FG000|Overall Study|Withdrawal by Subject|1|||
125312983|NCT01479868|450773824|FG000|Overall Study|Sponsor's Decision|1|||
125312984|NCT01479868|450773824|FG000|Overall Study|Initiation of new HCV Therapy|1|||
125312985|NCT01292187|450773825|FG000|Overall Study|Adverse Event|10|||
125312986|NCT01292187|450773826|FG001|Overall Study|Adverse Event|5|||
125312987|NCT01292187|450773825|FG000|Overall Study|Withdrawal by Subject|6|||
125312988|NCT01292187|450773826|FG001|Overall Study|Withdrawal by Subject|5|||
125312989|NCT01292187|450773825|FG000|Overall Study|All other reasons|1|||
125312990|NCT01292187|450773826|FG001|Overall Study|All other reasons|3|||
125312991|NCT00113841|450773828|FG000|Overall Study|Disease progression|0|||
125312992|NCT00113841|450773829|FG001|Overall Study|Disease progression|2|||
125312993|NCT00113841|450773828|FG000|Overall Study|Non-compliant|1|||
125312994|NCT00113841|450773829|FG001|Overall Study|Non-compliant|0|||
125312995|NCT02721875|450773831|FG000|Overall Study|Progressive disease/relapse|1|||
125312996|NCT02721875|450773832|FG001|Overall Study|Progressive disease/relapse|0|||
125312997|NCT00430716|450773833|FG000|Double Blind Phase|Death|1|||
125312998|NCT00430716|450773834|FG001|Double Blind Phase|Death|0|||
125312999|NCT00430716|450773835|FG002|Double Blind Phase|Death|0|||
125313000|NCT00430716|450773833|FG000|Double Blind Phase|No longer willing to participate|2|||
125313001|NCT00430716|450773834|FG001|Double Blind Phase|No longer willing to participate|1|||
125313002|NCT00430716|450773835|FG002|Double Blind Phase|No longer willing to participate|1|||
125313003|NCT00430716|450773833|FG000|Double Blind Phase|Other|0|||
125313004|NCT00430716|450773834|FG001|Double Blind Phase|Other|2|||
125313005|NCT00430716|450773835|FG002|Double Blind Phase|Other|0|||
125313006|NCT00430716|450773833|FG000|Double Blind Phase|Study terminated by sponsor|1|||
125313007|NCT00430716|450773834|FG001|Double Blind Phase|Study terminated by sponsor|1|||
125313008|NCT00430716|450773835|FG002|Double Blind Phase|Study terminated by sponsor|2|||
125313009|NCT00430716|450773833|FG000|Double Blind Phase|Adverse Event|1|||
125313010|NCT00430716|450773834|FG001|Double Blind Phase|Adverse Event|1|||
125313011|NCT00430716|450773835|FG002|Double Blind Phase|Adverse Event|3|||
125313012|NCT00430716|450773833|FG000|Double Blind Phase|Not treated|1|||
125313013|NCT00430716|450773834|FG001|Double Blind Phase|Not treated|0|||
125313014|NCT00430716|450773835|FG002|Double Blind Phase|Not treated|0|||
125313015|NCT00430716|450773833|FG000|Open Label Phase|Lost to Follow-up|1|||
125313016|NCT00430716|450773834|FG001|Open Label Phase|Lost to Follow-up|0|||
125313017|NCT00430716|450773835|FG002|Open Label Phase|Lost to Follow-up|1|||
125313018|NCT00430716|450773833|FG000|Open Label Phase|No longer willing to participate|0|||
125313019|NCT00430716|450773834|FG001|Open Label Phase|No longer willing to participate|1|||
125313020|NCT00430716|450773835|FG002|Open Label Phase|No longer willing to participate|1|||
125313021|NCT00430716|450773833|FG000|Open Label Phase|Other|3|||
125313022|NCT00430716|450773834|FG001|Open Label Phase|Other|1|||
125313023|NCT00430716|450773835|FG002|Open Label Phase|Other|1|||
125313024|NCT00430716|450773833|FG000|Open Label Phase|Protocol Violation|1|||
125313025|NCT00430716|450773834|FG001|Open Label Phase|Protocol Violation|0|||
125313026|NCT00430716|450773835|FG002|Open Label Phase|Protocol Violation|0|||
125313027|NCT00430716|450773833|FG000|Open Label Phase|Study terminated by sponsor|4|||
125313028|NCT00430716|450773834|FG001|Open Label Phase|Study terminated by sponsor|5|||
125313029|NCT00430716|450773835|FG002|Open Label Phase|Study terminated by sponsor|4|||
125313030|NCT01433172|450773836|FG000|Overall Study|Withdrawal by Subject|0|||
125313031|NCT01433172|450773837|FG001|Overall Study|Withdrawal by Subject|1|||
125313032|NCT01433172|450773838|FG002|Overall Study|Withdrawal by Subject|0|||
125313033|NCT01433172|450773836|FG000|Overall Study|Disease Progression|0|||
125313034|NCT01433172|450773837|FG001|Overall Study|Disease Progression|0|||
125313035|NCT01433172|450773838|FG002|Overall Study|Disease Progression|1|||
125313036|NCT01433172|450773836|FG000|Overall Study|Death|0|||
125313037|NCT01433172|450773837|FG001|Overall Study|Death|2|||
125313038|NCT01433172|450773838|FG002|Overall Study|Death|0|||
125313039|NCT00773513|450773839|FG000|Overall Study|Renal Transplant|254|||
125313040|NCT00773513|450773840|FG001|Overall Study|Renal Transplant|263|||
125313041|NCT00773513|450773839|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
125313042|NCT00773513|450773840|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
125313043|NCT00773513|450773839|FG000|Overall Study|Withdrew Consent|68|||
125313044|NCT00773513|450773840|FG001|Overall Study|Withdrew Consent|69|||
125313045|NCT00773513|450773839|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
125313046|NCT00773513|450773840|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
125313047|NCT00773513|450773839|FG000|Overall Study|Failure to Return|22|||
125313048|NCT00773513|450773840|FG001|Overall Study|Failure to Return|8|||
125313049|NCT00773513|450773839|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125313050|NCT00773513|450773840|FG001|Overall Study|Insufficient Therapeutic Response|18|||
125313051|NCT00773513|450773839|FG000|Overall Study|Reason Not Specified|159|||
125313052|NCT00773513|450773840|FG001|Overall Study|Reason Not Specified|126|||
125313053|NCT00773513|450773839|FG000|Overall Study|Death|531|||
125313054|NCT00773513|450773840|FG001|Overall Study|Death|545|||
125313055|NCT03116685|450773845|FG000|Overall Study|Physician Decision|0|||
125313056|NCT03116685|450773846|FG001|Overall Study|Physician Decision|1|||
125313057|NCT01045694|450773847|FG000|Overall Study|Withdrawal by Subject|2|||
125313058|NCT02719171|450775101|FG000|Overall Study|Adverse Event|1|||
125313059|NCT02719171|450775102|FG001|Overall Study|Adverse Event|2|||
125313060|NCT02719171|450775103|FG002|Overall Study|Adverse Event|0|||
125313061|NCT02719171|450775104|FG003|Overall Study|Adverse Event|0|||
125313062|NCT02719171|450775105|FG004|Overall Study|Adverse Event|2|||
125313063|NCT02719171|450775101|FG000|Overall Study|Lost to Follow-up|0|||
125313064|NCT02719171|450775102|FG001|Overall Study|Lost to Follow-up|0|||
125313065|NCT02719171|450775103|FG002|Overall Study|Lost to Follow-up|1|||
125313066|NCT02719171|450775104|FG003|Overall Study|Lost to Follow-up|0|||
125313067|NCT02719171|450775105|FG004|Overall Study|Lost to Follow-up|0|||
125313068|NCT02719171|450775101|FG000|Overall Study|Subject Withdrawal|0|||
125313069|NCT02719171|450775102|FG001|Overall Study|Subject Withdrawal|2|||
125313070|NCT02719171|450775103|FG002|Overall Study|Subject Withdrawal|2|||
125313071|NCT02719171|450775104|FG003|Overall Study|Subject Withdrawal|1|||
125313072|NCT02719171|450775105|FG004|Overall Study|Subject Withdrawal|0|||
125313073|NCT02719171|450775101|FG000|Overall Study|Other|0|||
125313074|NCT02719171|450775102|FG001|Overall Study|Other|0|||
125313075|NCT02719171|450775103|FG002|Overall Study|Other|0|||
125313076|NCT02719171|450775104|FG003|Overall Study|Other|1|||
125313077|NCT02719171|450775105|FG004|Overall Study|Other|0|||
125313078|NCT02796677|450775106|FG000|Overall Study|Adverse Event|11|||
125313079|NCT02796677|450775107|FG001|Overall Study|Adverse Event|22|||
125313080|NCT02796677|450775108|FG002|Overall Study|Adverse Event|14|||
125313081|NCT02796677|450775109|FG003|Overall Study|Adverse Event|14|||
125313082|NCT02796677|450775106|FG000|Overall Study|Protocol Violation|7|||
125313083|NCT02796677|450775107|FG001|Overall Study|Protocol Violation|5|||
125313084|NCT02796677|450775108|FG002|Overall Study|Protocol Violation|4|||
125313085|NCT02796677|450775109|FG003|Overall Study|Protocol Violation|8|||
125313086|NCT02796677|450775106|FG000|Overall Study|Lost to Follow-up|1|||
125313087|NCT02796677|450775107|FG001|Overall Study|Lost to Follow-up|5|||
125313088|NCT02796677|450775108|FG002|Overall Study|Lost to Follow-up|2|||
125313089|NCT02796677|450775109|FG003|Overall Study|Lost to Follow-up|2|||
125313090|NCT02796677|450775106|FG000|Overall Study|Lack of Efficacy|7|||
125313091|NCT02796677|450775107|FG001|Overall Study|Lack of Efficacy|9|||
125313092|NCT02796677|450775108|FG002|Overall Study|Lack of Efficacy|14|||
125313093|NCT02796677|450775109|FG003|Overall Study|Lack of Efficacy|20|||
125313094|NCT02796677|450775106|FG000|Overall Study|Withdrawal by Subject|4|||
125313095|NCT02796677|450775107|FG001|Overall Study|Withdrawal by Subject|14|||
125313096|NCT02796677|450775108|FG002|Overall Study|Withdrawal by Subject|6|||
125313097|NCT02796677|450775109|FG003|Overall Study|Withdrawal by Subject|7|||
125313098|NCT02796677|450775106|FG000|Overall Study|Progressive disease|6|||
125313099|NCT02796677|450775107|FG001|Overall Study|Progressive disease|15|||
125313100|NCT02796677|450775108|FG002|Overall Study|Progressive disease|13|||
125313101|NCT02796677|450775109|FG003|Overall Study|Progressive disease|18|||
125313102|NCT02796677|450775106|FG000|Overall Study|Reason not mentioned|2|||
125313103|NCT02796677|450775107|FG001|Overall Study|Reason not mentioned|3|||
125313104|NCT02796677|450775108|FG002|Overall Study|Reason not mentioned|0|||
125313105|NCT02796677|450775109|FG003|Overall Study|Reason not mentioned|5|||
125313106|NCT00961181|450775110|FG000|Overall Study|Death|2|||
125313107|NCT00961181|450775110|FG000|Overall Study|Withdrawal by Subject|2|||
125313108|NCT00961181|450775110|FG000|Overall Study|Lost to Follow-up|1|||
125313109|NCT03811340|450775111|FG000|Overall Study|subjects did not complete the survey.|90|||
125313110|NCT01045967|450775112|FG000|Second Intervention|Protocol Violation|0|||
125313111|NCT01045967|450775113|FG001|Second Intervention|Protocol Violation|1|||
125313112|NCT01485094|450775123|FG000|Overall Study|Adverse Event|1|||
125313113|NCT01485094|450775124|FG001|Overall Study|Adverse Event|1|||
125313114|NCT01485094|450775125|FG002|Overall Study|Adverse Event|1|||
125313115|NCT01485094|450775123|FG000|Overall Study|Lost to Follow-up|1|||
125313116|NCT01485094|450775124|FG001|Overall Study|Lost to Follow-up|0|||
125313117|NCT01485094|450775125|FG002|Overall Study|Lost to Follow-up|0|||
125313118|NCT01485094|450775123|FG000|Overall Study|Withdrawal by Subject|1|||
125313119|NCT01485094|450775124|FG001|Overall Study|Withdrawal by Subject|1|||
125313120|NCT01485094|450775125|FG002|Overall Study|Withdrawal by Subject|0|||
125313121|NCT02576639|450775126|FG000|Overall Study|Withdrawal by Subject|1|||
125313122|NCT02576639|450775127|FG001|Overall Study|Withdrawal by Subject|2|||
125313123|NCT02576639|450775128|FG002|Overall Study|Withdrawal by Subject|1|||
125313124|NCT02576639|450775129|FG003|Overall Study|Withdrawal by Subject|0|||
125313125|NCT02576639|450775130|FG004|Overall Study|Withdrawal by Subject|1|||
125313126|NCT02576639|450775126|FG000|Overall Study|Adverse Event|1|||
125313127|NCT02576639|450775127|FG001|Overall Study|Adverse Event|0|||
125313128|NCT02576639|450775128|FG002|Overall Study|Adverse Event|1|||
125313129|NCT02576639|450775129|FG003|Overall Study|Adverse Event|1|||
125313130|NCT02576639|450775130|FG004|Overall Study|Adverse Event|2|||
125313131|NCT02576639|450775126|FG000|Overall Study|Physician Decision|0|||
125313132|NCT02576639|450775127|FG001|Overall Study|Physician Decision|0|||
125313133|NCT02576639|450775128|FG002|Overall Study|Physician Decision|0|||
125313134|NCT02576639|450775129|FG003|Overall Study|Physician Decision|0|||
125313135|NCT02576639|450775130|FG004|Overall Study|Physician Decision|1|||
125313136|NCT02079038|450775131|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
125313137|NCT02079038|450775132|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
125313138|NCT02079038|450775131|FG000|Modified Intent to Treat Population|Death|1|||
125313139|NCT02079038|450775132|FG001|Modified Intent to Treat Population|Death|0|||
125313140|NCT02079038|450775131|FG000|Completed 6 Months|Lost to Follow-up|2|||
125313141|NCT02079038|450775132|FG001|Completed 6 Months|Lost to Follow-up|1|||
125313142|NCT02478463|450775133|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
125313143|NCT02478463|450775133|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
125313144|NCT02478463|450775133|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
125313145|NCT01358825|450775136|FG000|Overall Study|Blood sample not drawn|0|||
125313146|NCT01358825|450775137|FG001|Overall Study|Blood sample not drawn|1|||
125313147|NCT01508169|450775141|FG000|Overall Study|Adverse Event|1|||
125313148|NCT01508169|450775142|FG001|Overall Study|Adverse Event|0|||
125313149|NCT01508169|450775141|FG000|Overall Study|Withdrawal by Subject|1|||
125313150|NCT01508169|450775142|FG001|Overall Study|Withdrawal by Subject|0|||
125313151|NCT01508169|450775141|FG000|Overall Study|Lost to Follow-up|1|||
125313152|NCT01508169|450775142|FG001|Overall Study|Lost to Follow-up|2|||
125313153|NCT03600740|450775143|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
125313154|NCT01814527|450775144|FG000|Overall Study|RTP greater than 30 days|6|||
125313155|NCT01814527|450775145|FG001|Overall Study|RTP greater than 30 days|1|||
125313156|NCT04524858|450775146|FG000|Overall Study|Adverse Event|1|||
125313157|NCT03571204|450775147|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
125313158|NCT03571204|450775148|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
125313159|NCT03571204|450775149|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
125313160|NCT03571204|450775147|FG000|Overall Study|Physician Decision|0|||
125313161|NCT03571204|450775148|FG001|Overall Study|Physician Decision|1|||
125313162|NCT03571204|450775149|FG002|Overall Study|Physician Decision|0|||
125313163|NCT02396212|450775150|FG000|Overall Study|Adverse Event|1|||
125313164|NCT02396212|450775150|FG000|Overall Study|Lack of Efficacy|2|||
125313165|NCT01363700|450775151|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
125313166|NCT01363700|450775152|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
125313167|NCT01363700|450775153|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
125313168|NCT01363700|450775154|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
125313169|NCT01363700|450775155|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
125313170|NCT05202418|450775163|FG000|Overall Study|Withdrawal by Subject|2|||
125313171|NCT05202418|450775164|FG001|Overall Study|Withdrawal by Subject|1|||
125313172|NCT05202418|450775163|FG000|Overall Study|Lost to Follow-up|1|||
125313173|NCT05202418|450775164|FG001|Overall Study|Lost to Follow-up|1|||
125313174|NCT01329978|450775168|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
125313175|NCT01329978|450775169|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
125313176|NCT01329978|450775170|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
125313177|NCT01329978|450775171|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
125313178|NCT01329978|450775172|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
125313179|NCT01329978|450775168|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
125313180|NCT01329978|450775169|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
125313181|NCT01329978|450775170|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
125313182|NCT01329978|450775171|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
125313183|NCT01329978|450775172|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
125313184|NCT01329978|450775168|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
125313185|NCT01329978|450775169|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
125650608|NCT01326312|452004645|FG000|Overall Study|Protocol Violation|0|||
125650609|NCT01326312|452004646|FG001|Overall Study|Protocol Violation|1|||
125650610|NCT01326312|452004647|FG002|Overall Study|Protocol Violation|0|||
125650611|NCT01326312|452004645|FG000|Overall Study|Lack of Efficacy|13|||
125650612|NCT01326312|452004646|FG001|Overall Study|Lack of Efficacy|7|||
125650613|NCT01326312|452004647|FG002|Overall Study|Lack of Efficacy|1|||
125650614|NCT01326312|452004645|FG000|Overall Study|Death|1|||
125313186|NCT01329978|450775170|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
125313187|NCT01329978|450775171|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
125313188|NCT01329978|450775172|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
125313189|NCT01329978|450775168|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
125313190|NCT01329978|450775169|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
125313191|NCT01329978|450775170|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
125313192|NCT01329978|450775171|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
125313193|NCT01329978|450775172|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
125313194|NCT01329978|450775168|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
125313195|NCT01329978|450775169|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
125313196|NCT01329978|450775170|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
125313197|NCT01329978|450775171|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
125313198|NCT01329978|450775172|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
125313199|NCT01329978|450775168|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
125313200|NCT01329978|450775169|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
125313201|NCT01329978|450775170|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
125313202|NCT01329978|450775171|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
125313203|NCT01329978|450775172|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
125313204|NCT01329978|450775168|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
125313205|NCT01329978|450775169|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
125313206|NCT01329978|450775170|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
125313207|NCT01329978|450775171|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
125313208|NCT01329978|450775172|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
125313209|NCT04170543|450775182|FG000|Overall Study|Death|1|||
125313210|NCT04170543|450775183|FG001|Overall Study|Death|1|||
125313211|NCT04170543|450775184|FG002|Overall Study|Death|1|||
125313212|NCT04170543|450775185|FG003|Overall Study|Death|1|||
125313213|NCT04170543|450775186|FG004|Overall Study|Death|1|||
125313214|NCT04170543|450775182|FG000|Overall Study|Lost to Follow-up|3|||
125313215|NCT04170543|450775183|FG001|Overall Study|Lost to Follow-up|3|||
125313216|NCT04170543|450775184|FG002|Overall Study|Lost to Follow-up|0|||
125313217|NCT04170543|450775185|FG003|Overall Study|Lost to Follow-up|3|||
125313218|NCT04170543|450775186|FG004|Overall Study|Lost to Follow-up|1|||
125313219|NCT04170543|450775182|FG000|Overall Study|Withdrawal by Subject|13|||
125313220|NCT04170543|450775183|FG001|Overall Study|Withdrawal by Subject|6|||
125313221|NCT04170543|450775184|FG002|Overall Study|Withdrawal by Subject|5|||
125313222|NCT04170543|450775185|FG003|Overall Study|Withdrawal by Subject|4|||
125313223|NCT04170543|450775186|FG004|Overall Study|Withdrawal by Subject|9|||
125313224|NCT04170543|450775182|FG000|Overall Study|Not able to transition to phase 2b|8|||
125313225|NCT04170543|450775183|FG001|Overall Study|Not able to transition to phase 2b|0|||
125313226|NCT04170543|450775184|FG002|Overall Study|Not able to transition to phase 2b|10|||
125313227|NCT04170543|450775185|FG003|Overall Study|Not able to transition to phase 2b|0|||
125313228|NCT04170543|450775186|FG004|Overall Study|Not able to transition to phase 2b|6|||
125313229|NCT04170543|450775182|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
125313230|NCT04170543|450775183|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
125313231|NCT04170543|450775184|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
125313232|NCT04170543|450775185|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
125313233|NCT04170543|450775186|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
125313234|NCT04170543|450775182|FG000|Overall Study|Not Treated|0|||
125313235|NCT04170543|450775183|FG001|Overall Study|Not Treated|0|||
125313236|NCT04170543|450775184|FG002|Overall Study|Not Treated|0|||
125313237|NCT04170543|450775185|FG003|Overall Study|Not Treated|0|||
125313238|NCT04170543|450775186|FG004|Overall Study|Not Treated|2|||
125313239|NCT04170543|450775182|FG000|Overall Study|(CRF)|16|||
125313240|NCT04170543|450775183|FG001|Overall Study|(CRF)|15|||
125313241|NCT04170543|450775184|FG002|Overall Study|(CRF)|12|||
125313242|NCT04170543|450775185|FG003|Overall Study|(CRF)|17|||
125313243|NCT04170543|450775186|FG004|Overall Study|(CRF)|17|||
125313244|NCT04170543|450775182|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
125313245|NCT04170543|450775183|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
125313246|NCT04170543|450775184|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
125313247|NCT04170543|450775185|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
125313248|NCT04170543|450775186|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
125313249|NCT04303559|450775187|FG000|Overall Study|Study closed due to poor enrollment.|1|||
125313250|NCT04037891|450775190|FG000|Open-label Period|Withdrawal by Subject|1|||
125650615|NCT01326312|452004646|FG001|Overall Study|Death|0|||
125650616|NCT01326312|452004647|FG002|Overall Study|Death|1|||
125313251|NCT04037891|450775191|FG001|Open-label Period|Withdrawal by Subject|0|||
125313252|NCT04037891|450775192|FG002|Open-label Period|Withdrawal by Subject|0|||
125313253|NCT04037891|450775190|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
125313254|NCT04037891|450775191|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
125313255|NCT04037891|450775192|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
125650617|NCT01326312|452004645|FG000|Overall Study|progressive disease|0|||
125650618|NCT01326312|452004646|FG001|Overall Study|progressive disease|1|||
125650619|NCT01326312|452004647|FG002|Overall Study|progressive disease|1|||
125650620|NCT01326312|452004645|FG000|Overall Study|Study terminated by Sponsor|8|||
125650621|NCT01326312|452004646|FG001|Overall Study|Study terminated by Sponsor|32|||
125650622|NCT01326312|452004647|FG002|Overall Study|Study terminated by Sponsor|46|||
125650623|NCT01326312|452004645|FG000|Overall Study|Treatment arm terminated|19|||
125650624|NCT01326312|452004646|FG001|Overall Study|Treatment arm terminated|0|||
125650625|NCT01326312|452004647|FG002|Overall Study|Treatment arm terminated|0|||
125650626|NCT01326312|452004645|FG000|Overall Study|QTc > 500|0|||
125650627|NCT01326312|452004646|FG001|Overall Study|QTc > 500|1|||
125650628|NCT01326312|452004647|FG002|Overall Study|QTc > 500|0|||
125650629|NCT02219477|452004648|FG000|Overall Study|Adverse Event|0|||
125650630|NCT02219477|452004649|FG001|Overall Study|Adverse Event|1|||
125650631|NCT02219477|452004650|FG002|Overall Study|Adverse Event|1|||
125650632|NCT02219477|452004648|FG000|Overall Study|Withdrawal by Subject|0|||
125650633|NCT02219477|452004649|FG001|Overall Study|Withdrawal by Subject|1|||
125650634|NCT02219477|452004650|FG002|Overall Study|Withdrawal by Subject|0|||
125650635|NCT00499694|452004655|FG000|Overall Study|Patient never received treatment.|1|||
125650636|NCT00234533|452004656|FG000|Overall Study|Withdrawal by Subject|6|||
125650637|NCT00234533|452004656|FG000|Overall Study|Adverse Event|2|||
125650638|NCT00234533|452004656|FG000|Overall Study|Enrolled but not treated|3|||
125650639|NCT04338685|452004657|FG000|Overall Study|Death|3|||
125650640|NCT04338685|452004658|FG001|Overall Study|Death|4|||
125650641|NCT04338685|452004659|FG002|Overall Study|Death|2|||
125650642|NCT04338685|452004660|FG003|Overall Study|Death|4|||
125650643|NCT04338685|452004661|FG004|Overall Study|Death|4|||
125650644|NCT04338685|452004662|FG005|Overall Study|Death|8|||
125650645|NCT04338685|452004663|FG006|Overall Study|Death|1|||
125650646|NCT04338685|452004664|FG007|Overall Study|Death|0|||
125650647|NCT04338685|452004665|FG008|Overall Study|Death|0|||
125650648|NCT04338685|452004657|FG000|Overall Study|Study terminated by Sponsor|0|||
125650649|NCT04338685|452004658|FG001|Overall Study|Study terminated by Sponsor|0|||
125650650|NCT04338685|452004659|FG002|Overall Study|Study terminated by Sponsor|1|||
125650651|NCT04338685|452004660|FG003|Overall Study|Study terminated by Sponsor|4|||
125650652|NCT04338685|452004661|FG004|Overall Study|Study terminated by Sponsor|0|||
125650653|NCT04338685|452004662|FG005|Overall Study|Study terminated by Sponsor|5|||
125650654|NCT04338685|452004663|FG006|Overall Study|Study terminated by Sponsor|2|||
125650655|NCT04338685|452004664|FG007|Overall Study|Study terminated by Sponsor|4|||
125650656|NCT04338685|452004665|FG008|Overall Study|Study terminated by Sponsor|1|||
125650657|NCT04338685|452004657|FG000|Overall Study|Withdrawal by Subject|1|||
125650658|NCT04338685|452004658|FG001|Overall Study|Withdrawal by Subject|2|||
125650659|NCT04338685|452004659|FG002|Overall Study|Withdrawal by Subject|0|||
125650660|NCT04338685|452004660|FG003|Overall Study|Withdrawal by Subject|2|||
125650661|NCT04338685|452004661|FG004|Overall Study|Withdrawal by Subject|0|||
125650662|NCT04338685|452004662|FG005|Overall Study|Withdrawal by Subject|5|||
125650663|NCT04338685|452004663|FG006|Overall Study|Withdrawal by Subject|1|||
125650664|NCT04338685|452004664|FG007|Overall Study|Withdrawal by Subject|1|||
125650665|NCT04338685|452004665|FG008|Overall Study|Withdrawal by Subject|0|||
125650666|NCT01484691|452004667|FG000|Overall Study|Withdrawal by Subject|1|||
125650667|NCT01484691|452004668|FG001|Overall Study|Withdrawal by Subject|1|||
125650668|NCT01484691|452004669|FG002|Overall Study|Withdrawal by Subject|1|||
125313256|NCT03446313|450775193|FG000|Overall Study|Lost to Follow-up|1|||
125313257|NCT03446313|450775194|FG001|Overall Study|Lost to Follow-up|2|||
125313258|NCT03446313|450775193|FG000|Overall Study|Failed primary screening|3|||
125650669|NCT01484691|452004667|FG000|Overall Study|Physician Decision|0|||
125650670|NCT01484691|452004668|FG001|Overall Study|Physician Decision|2|||
125650671|NCT01484691|452004669|FG002|Overall Study|Physician Decision|1|||
125650672|NCT01314261|452004674|FG000|Overall Study|Adverse Event|1|||
125650673|NCT01314261|452004675|FG001|Overall Study|Adverse Event|0|||
125650674|NCT01314261|452004676|FG002|Overall Study|Adverse Event|0|||
125650675|NCT01314261|452004677|FG003|Overall Study|Adverse Event|0|||
125650676|NCT01314261|452004674|FG000|Overall Study|Withdrawal by Subject|0|||
125650677|NCT01314261|452004675|FG001|Overall Study|Withdrawal by Subject|3|||
125650678|NCT01314261|452004676|FG002|Overall Study|Withdrawal by Subject|1|||
125650679|NCT01314261|452004677|FG003|Overall Study|Withdrawal by Subject|0|||
125313259|NCT03446313|450775194|FG001|Overall Study|Failed primary screening|0|||
125313260|NCT03446313|450775193|FG000|Overall Study|Diagnosed with terminal cancer|1|||
125313261|NCT03446313|450775194|FG001|Overall Study|Diagnosed with terminal cancer|0|||
125650680|NCT01314261|452004674|FG000|Overall Study|Lost to Follow-up|1|||
125650681|NCT01314261|452004675|FG001|Overall Study|Lost to Follow-up|0|||
125313262|NCT03446313|450775193|FG000|Overall Study|Excluded from analysis|1|||
125650682|NCT01314261|452004676|FG002|Overall Study|Lost to Follow-up|2|||
125313263|NCT03446313|450775194|FG001|Overall Study|Excluded from analysis|1|||
125313264|NCT05274958|450775195|FG000|Overall Study|Only completed 1 set of PROMs|22|||
125313265|NCT05274958|450775196|FG001|Overall Study|Only completed 1 set of PROMs|35|||
125313266|NCT05481359|450775197|FG000|Overall Study|Lost to Follow-up|3|||
125313267|NCT05481359|450775197|FG000|Overall Study|Withdrawal by Subject|1|||
125313268|NCT04491136|450775202|FG000|Overall Study|Patient withdraw informed consent|9|||
125313269|NCT04491136|450775202|FG000|Overall Study|Adverse Event|2|||
125313270|NCT04491136|450775202|FG000|Overall Study|Death|3|||
125313271|NCT04491136|450775202|FG000|Overall Study|Lost to Follow-up|3|||
125313272|NCT04491136|450775202|FG000|Overall Study|Physician Decision|45|||
125313273|NCT04491136|450775202|FG000|Overall Study|sponsor terminated the study early|16|||
125313274|NCT04491136|450775202|FG000|Overall Study|Patient/guardian's decision|1|||
125313275|NCT01611194|450775203|FG000|Overall Study|Lost to Follow-up|0|||
125313276|NCT01611194|450775204|FG001|Overall Study|Lost to Follow-up|1|||
125313277|NCT01611194|450775203|FG000|Overall Study|Withdrawal by Subject|0|||
125313278|NCT01611194|450775204|FG001|Overall Study|Withdrawal by Subject|1|||
125313279|NCT01611194|450775203|FG000|Overall Study|drug use|0|||
125313280|NCT01611194|450775204|FG001|Overall Study|drug use|1|||
125313281|NCT00452790|450775207|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
125313282|NCT00452790|450775208|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
125313283|NCT00452790|450775207|FG000|Infant Series|Parent/legal guardian request|8|||
125313284|NCT00452790|450775208|FG001|Infant Series|Parent/legal guardian request|6|||
125313285|NCT00452790|450775207|FG000|Infant Series|Failed to return|4|||
125313286|NCT00452790|450775208|FG001|Infant Series|Failed to return|1|||
125313287|NCT00452790|450775207|FG000|Infant Series|Protocol Violation|1|||
125313288|NCT00452790|450775208|FG001|Infant Series|Protocol Violation|3|||
125313289|NCT00452790|450775207|FG000|Infant Series|Lost to Follow-up|2|||
125313290|NCT00452790|450775208|FG001|Infant Series|Lost to Follow-up|2|||
125313291|NCT00452790|450775207|FG000|Infant Series|Adverse Event|1|||
125313292|NCT00452790|450775208|FG001|Infant Series|Adverse Event|2|||
125313293|NCT00452790|450775207|FG000|Infant Series|Other reasons|1|||
125313294|NCT00452790|450775208|FG001|Infant Series|Other reasons|2|||
125313295|NCT00452790|450775207|FG000|Infant Series|Investigator request|0|||
125313296|NCT00452790|450775208|FG001|Infant Series|Investigator request|1|||
125313297|NCT00452790|450775207|FG000|Infant Series|Death|0|||
125313298|NCT00452790|450775208|FG001|Infant Series|Death|1|||
125313299|NCT00452790|450775207|FG000|After Infant Series|Investigator request|10|||
125313300|NCT00452790|450775208|FG001|After Infant Series|Investigator request|10|||
125313301|NCT00452790|450775207|FG000|After Infant Series|Adverse Event|4|||
125313302|NCT00452790|450775208|FG001|After Infant Series|Adverse Event|1|||
125313303|NCT00452790|450775207|FG000|After Infant Series|Parent/legal guardian request|1|||
125313304|NCT00452790|450775208|FG001|After Infant Series|Parent/legal guardian request|3|||
125313305|NCT00452790|450775207|FG000|After Infant Series|Lost to Follow-up|4|||
125313306|NCT00452790|450775208|FG001|After Infant Series|Lost to Follow-up|0|||
125313307|NCT00452790|450775207|FG000|After Infant Series|Failed to return|1|||
125313308|NCT00452790|450775208|FG001|After Infant Series|Failed to return|0|||
125313309|NCT00452790|450775207|FG000|After Infant Series|Other reasons|1|||
125313310|NCT00452790|450775208|FG001|After Infant Series|Other reasons|0|||
125313311|NCT00452790|450775207|FG000|Toddler Dose|Failed to return|0|||
125313312|NCT00452790|450775208|FG001|Toddler Dose|Failed to return|1|||
125313313|NCT00452790|450775207|FG000|Toddler Dose|Parent/legal guardian request|0|||
125313314|NCT00452790|450775208|FG001|Toddler Dose|Parent/legal guardian request|1|||
125313315|NCT00348673|450775210|FG000|Stage 1|Randomized but not Treated|0|||
125313316|NCT00348673|450775211|FG001|Stage 1|Randomized but not Treated|0|||
125313317|NCT00348673|450775212|FG002|Stage 1|Randomized but not Treated|1|||
125313318|NCT00348673|450775213|FG003|Stage 1|Randomized but not Treated|0|||
125313319|NCT00348673|450775214|FG004|Stage 1|Randomized but not Treated|0|||
125313320|NCT00348673|450775215|FG005|Stage 1|Randomized but not Treated|0|||
125313321|NCT00348673|450775216|FG006|Stage 1|Randomized but not Treated|0|||
125313322|NCT00348673|450775217|FG007|Stage 1|Randomized but not Treated|0|||
125313323|NCT00348673|450775218|FG008|Stage 1|Randomized but not Treated|0|||
125313324|NCT01712204|450775219|FG000|Overall Study|Adverse Event|3|||
125313325|NCT01712204|450775220|FG001|Overall Study|Adverse Event|1|||
125313326|NCT01712204|450775219|FG000|Overall Study|Withdrawal by Subject|3|||
125313327|NCT01712204|450775220|FG001|Overall Study|Withdrawal by Subject|3|||
125313328|NCT01712204|450775219|FG000|Overall Study|Lost to Follow-up|1|||
125313329|NCT01712204|450775220|FG001|Overall Study|Lost to Follow-up|0|||
125313330|NCT01712204|450775219|FG000|Overall Study|Protocol Violation|1|||
125313331|NCT01712204|450775220|FG001|Overall Study|Protocol Violation|1|||
125313332|NCT01150097|450775228|FG000|Months 24 to 36 Post-transplantation|Death|2|||
125313333|NCT01150097|450775229|FG001|Months 24 to 36 Post-transplantation|Death|0|||
125313334|NCT01150097|450775230|FG002|Months 24 to 36 Post-transplantation|Death|0|||
125313335|NCT01150097|450775228|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
125313336|NCT01150097|450775229|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
125313337|NCT01150097|450775230|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
125313338|NCT01150097|450775228|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
125313339|NCT01150097|450775229|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
125313340|NCT01150097|450775230|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
125313341|NCT01150097|450775228|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
125313342|NCT01150097|450775229|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
125313343|NCT01150097|450775230|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
125313344|NCT01150097|450775228|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
125313345|NCT01150097|450775229|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
125313346|NCT01150097|450775230|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
125313347|NCT01150097|450775228|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
125313348|NCT01150097|450775229|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
125313349|NCT01150097|450775230|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
125313350|NCT01150097|450775228|FG000|Months 24 to 48 Post-transplantation|Death|2|||
125313351|NCT01150097|450775229|FG001|Months 24 to 48 Post-transplantation|Death|0|||
125313352|NCT01150097|450775230|FG002|Months 24 to 48 Post-transplantation|Death|0|||
125313353|NCT01114828|450775233|FG000|Overall Study|Adverse Event|1|||
125313354|NCT01114828|450775234|FG001|Overall Study|Adverse Event|1|||
125313355|NCT01114828|450775233|FG000|Overall Study|Lack of Efficacy|0|||
125313356|NCT01114828|450775234|FG001|Overall Study|Lack of Efficacy|2|||
125313357|NCT01114828|450775233|FG000|Overall Study|Protocol Violation|2|||
125313358|NCT01114828|450775234|FG001|Overall Study|Protocol Violation|0|||
125313359|NCT01114828|450775233|FG000|Overall Study|Withdrawal by Subject|0|||
125313360|NCT01114828|450775234|FG001|Overall Study|Withdrawal by Subject|1|||
125313361|NCT00549445|450775235|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
125313362|NCT00549445|450775236|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
125313363|NCT03790111|450777273|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
125313364|NCT03798717|450777278|FG000|Overall Study|Failed Screening|0|||
125313365|NCT03798717|450777279|FG001|Overall Study|Failed Screening|0|||
125313366|NCT03798717|450777280|FG002|Overall Study|Failed Screening|0|||
125313367|NCT03798717|450777281|FG003|Overall Study|Failed Screening|0|||
125313368|NCT03798717|450777282|FG004|Overall Study|Failed Screening|0|||
125313369|NCT03798717|450777283|FG005|Overall Study|Failed Screening|1|||
125313370|NCT03798717|450777278|FG000|Overall Study|Physician Decision|1|||
125313371|NCT03798717|450777279|FG001|Overall Study|Physician Decision|0|||
125313372|NCT03798717|450777280|FG002|Overall Study|Physician Decision|1|||
125313373|NCT03798717|450777281|FG003|Overall Study|Physician Decision|0|||
125313374|NCT03798717|450777282|FG004|Overall Study|Physician Decision|0|||
125313375|NCT03798717|450777283|FG005|Overall Study|Physician Decision|0|||
125313376|NCT03798717|450777278|FG000|Overall Study|Withdrawal by Subject|0|||
125313377|NCT03798717|450777279|FG001|Overall Study|Withdrawal by Subject|0|||
125313378|NCT03798717|450777280|FG002|Overall Study|Withdrawal by Subject|0|||
125313379|NCT03798717|450777281|FG003|Overall Study|Withdrawal by Subject|1|||
125313380|NCT03798717|450777282|FG004|Overall Study|Withdrawal by Subject|0|||
125313381|NCT03798717|450777283|FG005|Overall Study|Withdrawal by Subject|0|||
125313382|NCT03798717|450777278|FG000|Overall Study|Lost to Follow-up|1|||
125313383|NCT03798717|450777279|FG001|Overall Study|Lost to Follow-up|0|||
125313384|NCT03798717|450777280|FG002|Overall Study|Lost to Follow-up|0|||
125313385|NCT03798717|450777281|FG003|Overall Study|Lost to Follow-up|1|||
125313386|NCT03798717|450777282|FG004|Overall Study|Lost to Follow-up|0|||
125313387|NCT03798717|450777283|FG005|Overall Study|Lost to Follow-up|0|||
125313388|NCT03798717|450777278|FG000|Overall Study|Adverse Event|0|||
125313389|NCT03798717|450777279|FG001|Overall Study|Adverse Event|1|||
125313390|NCT03798717|450777280|FG002|Overall Study|Adverse Event|0|||
125313391|NCT03798717|450777281|FG003|Overall Study|Adverse Event|0|||
125313392|NCT03798717|450777282|FG004|Overall Study|Adverse Event|0|||
125313393|NCT03798717|450777283|FG005|Overall Study|Adverse Event|0|||
125313394|NCT03798717|450777278|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
125313395|NCT03798717|450777279|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
125313396|NCT03798717|450777280|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
125313397|NCT03798717|450777281|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
125313398|NCT03798717|450777282|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
125313399|NCT03798717|450777283|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
125313400|NCT01777308|450777287|FG000|Overall Study|Withdrawal by Subject|5|||
125313401|NCT01777308|450777288|FG001|Overall Study|Withdrawal by Subject|1|||
125313402|NCT01777308|450777287|FG000|Overall Study|Migrated/moved from study area|1|||
125313403|NCT01777308|450777288|FG001|Overall Study|Migrated/moved from study area|0|||
125313404|NCT01777308|450777287|FG000|Overall Study|Lost to Follow-up|7|||
125313405|NCT01777308|450777288|FG001|Overall Study|Lost to Follow-up|2|||
125313406|NCT01777308|450777287|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
125313407|NCT01777308|450777288|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
125313408|NCT03212326|450777290|FG000|Overall Study|Physician Decision|4|||
125313409|NCT00985673|450777302|FG000|Overall Study|Lost to Follow-up|6|||
125313410|NCT00985673|450777303|FG001|Overall Study|Lost to Follow-up|7|||
125313411|NCT00985673|450777304|FG002|Overall Study|Lost to Follow-up|6|||
125313412|NCT00985673|450777305|FG003|Overall Study|Lost to Follow-up|10|||
125650683|NCT01314261|452004677|FG003|Overall Study|Lost to Follow-up|2|||
125650684|NCT01314261|452004674|FG000|Overall Study|Virologic Failure|0|||
125650685|NCT01314261|452004675|FG001|Overall Study|Virologic Failure|1|||
125650686|NCT01314261|452004676|FG002|Overall Study|Virologic Failure|0|||
125650687|NCT01314261|452004677|FG003|Overall Study|Virologic Failure|1|||
125650688|NCT04524507|452004678|FG000|Overall Study|Lost to Follow-up|2|||
125650689|NCT04524507|452004679|FG001|Overall Study|Lost to Follow-up|4|||
125650690|NCT04524507|452004678|FG000|Overall Study|Withdrawal by Subject|2|||
125313413|NCT00985673|450777306|FG004|Overall Study|Lost to Follow-up|5|||
125313414|NCT00985673|450777307|FG005|Overall Study|Lost to Follow-up|3|||
125313415|NCT00985673|450777302|FG000|Overall Study|Withdrawal by Subject|0|||
125313416|NCT00985673|450777303|FG001|Overall Study|Withdrawal by Subject|4|||
125313417|NCT00985673|450777304|FG002|Overall Study|Withdrawal by Subject|5|||
125313418|NCT00985673|450777305|FG003|Overall Study|Withdrawal by Subject|2|||
125313419|NCT00985673|450777306|FG004|Overall Study|Withdrawal by Subject|2|||
125313420|NCT00985673|450777307|FG005|Overall Study|Withdrawal by Subject|3|||
125313421|NCT00985673|450777302|FG000|Overall Study|Other|1|||
125313422|NCT00985673|450777303|FG001|Overall Study|Other|0|||
125313423|NCT00985673|450777304|FG002|Overall Study|Other|1|||
125313424|NCT00985673|450777305|FG003|Overall Study|Other|0|||
125313425|NCT00985673|450777306|FG004|Overall Study|Other|1|||
125313426|NCT00985673|450777307|FG005|Overall Study|Other|0|||
125313427|NCT00984256|450777310|FG000|Overall Study|Withdrawal by Subject|0|||
125313428|NCT00984256|450777311|FG001|Overall Study|Withdrawal by Subject|1|||
125313429|NCT03057496|450777312|FG000|Overall Study|Withdrawal by Subject|8|||
125313430|NCT03057496|450777312|FG000|Overall Study|Lost to Follow-up|5|||
125313431|NCT03057496|450777312|FG000|Overall Study|Did not use device during home trial|3|||
125313432|NCT03057496|450777312|FG000|Overall Study|Device failure|2|||
125313433|NCT00280917|450777313|FG000|Overall Study|Adverse Event|1|||
125313434|NCT00280917|450777314|FG001|Overall Study|Adverse Event|1|||
125313435|NCT00280917|450777315|FG002|Overall Study|Adverse Event|4|||
125313436|NCT00280917|450777316|FG003|Overall Study|Adverse Event|1|||
125313437|NCT00280917|450777313|FG000|Overall Study|Change Therapy|1|||
125313438|NCT00280917|450777314|FG001|Overall Study|Change Therapy|2|||
125313439|NCT00280917|450777315|FG002|Overall Study|Change Therapy|0|||
125313440|NCT00280917|450777316|FG003|Overall Study|Change Therapy|0|||
125313441|NCT00280917|450777313|FG000|Overall Study|Withdrawal by Subject|0|||
125313442|NCT00280917|450777314|FG001|Overall Study|Withdrawal by Subject|2|||
125313443|NCT00280917|450777315|FG002|Overall Study|Withdrawal by Subject|0|||
125313444|NCT00280917|450777316|FG003|Overall Study|Withdrawal by Subject|1|||
125313445|NCT00280917|450777313|FG000|Overall Study|Noncompliance|0|||
125313446|NCT00280917|450777314|FG001|Overall Study|Noncompliance|1|||
125313447|NCT00280917|450777315|FG002|Overall Study|Noncompliance|2|||
125313448|NCT00280917|450777316|FG003|Overall Study|Noncompliance|0|||
125313449|NCT01307319|450777317|FG000|Overall Study|Adverse Event|2|||
125313450|NCT01307319|450777318|FG001|Overall Study|Adverse Event|2|||
125313451|NCT01307319|450777319|FG002|Overall Study|Adverse Event|1|||
125313452|NCT01307319|450777317|FG000|Overall Study|Lost to Follow-up|1|||
125313453|NCT01307319|450777318|FG001|Overall Study|Lost to Follow-up|0|||
125313454|NCT01307319|450777319|FG002|Overall Study|Lost to Follow-up|1|||
125313455|NCT01307319|450777317|FG000|Overall Study|Protocol Violation|1|||
125313456|NCT01307319|450777318|FG001|Overall Study|Protocol Violation|1|||
125313457|NCT01307319|450777319|FG002|Overall Study|Protocol Violation|0|||
125313458|NCT01307319|450777317|FG000|Overall Study|Withdrawal by Subject|0|||
125313459|NCT01307319|450777318|FG001|Overall Study|Withdrawal by Subject|1|||
125313460|NCT01307319|450777319|FG002|Overall Study|Withdrawal by Subject|2|||
125313461|NCT01307319|450777317|FG000|Overall Study|Other|0|||
125313462|NCT01307319|450777318|FG001|Overall Study|Other|4|||
125313463|NCT01307319|450777319|FG002|Overall Study|Other|3|||
125650691|NCT04524507|452004679|FG001|Overall Study|Withdrawal by Subject|9|||
125650692|NCT04524507|452004678|FG000|Overall Study|Death|2|||
125650693|NCT04524507|452004679|FG001|Overall Study|Death|10|||
125313464|NCT01731912|450777322|FG000|Overall Study|noncompliance|2|||
125313465|NCT02222558|450777323|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
125650694|NCT02711306|452004680|FG000|Overall Study|Withdrawal by Subject|2|||
125313466|NCT02222558|450777324|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
125313467|NCT02222558|450777325|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
125313468|NCT02222558|450777326|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
125313469|NCT02222558|450777327|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
125313470|NCT02222558|450777328|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
125313471|NCT02222558|450777323|FG000|Period 3|Withdrawal by Subject|0|||
125313472|NCT02222558|450777324|FG001|Period 3|Withdrawal by Subject|0|||
125313473|NCT02222558|450777325|FG002|Period 3|Withdrawal by Subject|0|||
125313474|NCT02222558|450777326|FG003|Period 3|Withdrawal by Subject|0|||
125313475|NCT02222558|450777327|FG004|Period 3|Withdrawal by Subject|0|||
125313476|NCT02222558|450777328|FG005|Period 3|Withdrawal by Subject|1|||
125313477|NCT03400852|450777329|FG000|Blinded Treatment Period|Physician Decision|0|||
125313478|NCT03400852|450777330|FG001|Blinded Treatment Period|Physician Decision|1|||
125650695|NCT02711306|452004681|FG001|Overall Study|Withdrawal by Subject|2|||
125313479|NCT03400852|450777331|FG002|Blinded Treatment Period|Physician Decision|0|||
125313480|NCT03400852|450777329|FG000|Blinded Treatment Period|Adverse Event|1|||
125313481|NCT03400852|450777330|FG001|Blinded Treatment Period|Adverse Event|1|||
125313482|NCT03400852|450777331|FG002|Blinded Treatment Period|Adverse Event|0|||
125313483|NCT03400852|450777329|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
125313484|NCT03400852|450777330|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
125313485|NCT03400852|450777331|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
125313486|NCT03400852|450777329|FG000|Open Label Period|Physician Decision|0|||
125313487|NCT03400852|450777330|FG001|Open Label Period|Physician Decision|0|||
125313488|NCT03400852|450777331|FG002|Open Label Period|Physician Decision|1|||
125313489|NCT03400852|450777329|FG000|Open Label Period|Study terminated by sponsor|0|||
125313490|NCT03400852|450777330|FG001|Open Label Period|Study terminated by sponsor|0|||
125313491|NCT03400852|450777331|FG002|Open Label Period|Study terminated by sponsor|21|||
125313492|NCT00936702|450777332|FG000|Overall Study|Disease progression|34|||
125313493|NCT00936702|450777332|FG000|Overall Study|Adverse Event|8|||
125313494|NCT00936702|450777332|FG000|Overall Study|Withdrawal by Subject|2|||
125313495|NCT00936702|450777332|FG000|Overall Study|Alternative Treatment|1|||
125313496|NCT00936702|450777332|FG000|Overall Study|Other|1|||
125313497|NCT02532465|450777333|FG000|Overall Study|Protocol Violation|1|||
125313498|NCT02532465|450777334|FG001|Overall Study|Protocol Violation|0|||
125313499|NCT02532465|450777333|FG000|Overall Study|Lack of Efficacy|0|||
125313500|NCT02532465|450777334|FG001|Overall Study|Lack of Efficacy|1|||
125313501|NCT00622505|450777335|FG000|Overall Study|Adverse Event|9|||
125313502|NCT00622505|450777336|FG001|Overall Study|Adverse Event|7|||
125313503|NCT00622505|450777335|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
125313504|NCT00622505|450777336|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
125313505|NCT00622505|450777335|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
125313506|NCT00622505|450777336|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
125313507|NCT00622505|450777335|FG000|Overall Study|Withdrawal by Subject|12|||
125313508|NCT00622505|450777336|FG001|Overall Study|Withdrawal by Subject|5|||
125313509|NCT00622505|450777335|FG000|Overall Study|Administrative Problems|2|||
125313510|NCT00622505|450777336|FG001|Overall Study|Administrative Problems|4|||
125313511|NCT00622505|450777335|FG000|Overall Study|Death|2|||
125313512|NCT00622505|450777336|FG001|Overall Study|Death|2|||
125313513|NCT00965081|450777339|FG000|Overall Study|Adverse Event|14|||
125313514|NCT00965081|450777340|FG001|Overall Study|Adverse Event|9|||
125313515|NCT00965081|450777339|FG000|Overall Study|Lack of Efficacy|2|||
125313516|NCT00965081|450777340|FG001|Overall Study|Lack of Efficacy|5|||
125313517|NCT00965081|450777339|FG000|Overall Study|Lost to Follow-up|4|||
125313518|NCT00965081|450777340|FG001|Overall Study|Lost to Follow-up|5|||
125313519|NCT00965081|450777339|FG000|Overall Study|Physician Decision|2|||
125313520|NCT00965081|450777340|FG001|Overall Study|Physician Decision|0|||
125313521|NCT00965081|450777339|FG000|Overall Study|Protocol Violation|2|||
125313522|NCT00965081|450777340|FG001|Overall Study|Protocol Violation|5|||
125313523|NCT00965081|450777339|FG000|Overall Study|Sponsor Decision|1|||
125313524|NCT00965081|450777340|FG001|Overall Study|Sponsor Decision|0|||
125313525|NCT00965081|450777339|FG000|Overall Study|Withdrawal by Subject|4|||
125313526|NCT00965081|450777340|FG001|Overall Study|Withdrawal by Subject|7|||
125313527|NCT00965081|450777339|FG000|Overall Study|Switched to Rescue Arm|5|||
125313528|NCT00965081|450777340|FG001|Overall Study|Switched to Rescue Arm|12|||
125313529|NCT02159066|450777345|FG000|Part I|Adverse Event|7|||
125313530|NCT02159066|450777346|FG001|Part I|Adverse Event|5|||
125313531|NCT02159066|450777347|FG002|Part I|Adverse Event|0|||
125313532|NCT02159066|450777348|FG003|Part I|Adverse Event|0|||
125313533|NCT02159066|450777349|FG004|Part I|Adverse Event|0|||
125313534|NCT02159066|450777350|FG005|Part I|Adverse Event|0|||
125313535|NCT02159066|450777345|FG000|Part I|Death|11|||
125313536|NCT02159066|450777346|FG001|Part I|Death|9|||
125313537|NCT02159066|450777347|FG002|Part I|Death|0|||
125313538|NCT02159066|450777348|FG003|Part I|Death|0|||
125313539|NCT02159066|450777349|FG004|Part I|Death|0|||
125313540|NCT02159066|450777350|FG005|Part I|Death|0|||
125313541|NCT02159066|450777345|FG000|Part I|Progressive Disease|37|||
125313542|NCT02159066|450777346|FG001|Part I|Progressive Disease|46|||
125313543|NCT02159066|450777347|FG002|Part I|Progressive Disease|0|||
125313544|NCT02159066|450777348|FG003|Part I|Progressive Disease|0|||
125313545|NCT02159066|450777349|FG004|Part I|Progressive Disease|0|||
125313546|NCT02159066|450777350|FG005|Part I|Progressive Disease|0|||
125313547|NCT02159066|450777345|FG000|Part I|New Therapy for Study Indication|5|||
125313548|NCT02159066|450777346|FG001|Part I|New Therapy for Study Indication|4|||
125313549|NCT02159066|450777347|FG002|Part I|New Therapy for Study Indication|0|||
125313550|NCT02159066|450777348|FG003|Part I|New Therapy for Study Indication|0|||
125313551|NCT02159066|450777349|FG004|Part I|New Therapy for Study Indication|0|||
125313552|NCT02159066|450777350|FG005|Part I|New Therapy for Study Indication|0|||
125313553|NCT02159066|450777345|FG000|Part I|Termination of participants from the study|3|||
125313554|NCT02159066|450777346|FG001|Part I|Termination of participants from the study|3|||
125313555|NCT02159066|450777347|FG002|Part I|Termination of participants from the study|0|||
125313556|NCT02159066|450777348|FG003|Part I|Termination of participants from the study|0|||
125650696|NCT02811640|452004682|FG000|Overall Study|Technology malfunction|2|||
125650697|NCT02441517|452004683|FG000|Overall Study|Lost to Follow-up|1|||
125650698|NCT02441517|452004683|FG000|Overall Study|Withdrawal by Subject|2|||
125650699|NCT02441517|452004683|FG000|Overall Study|Study Terminated by Sponsor|1|||
125650700|NCT01393444|452004684|FG000|Overall Study|Withdrawal by Subject|1|||
125313557|NCT02159066|450777349|FG004|Part I|Termination of participants from the study|0|||
125313558|NCT02159066|450777350|FG005|Part I|Termination of participants from the study|0|||
125650701|NCT01393444|452004684|FG000|Overall Study|Determined ineligible during screening.|2|||
125650702|NCT03575806|452006119|FG000|Overall Study|Withdrawal by Subject|0|||
125650703|NCT03575806|452006120|FG001|Overall Study|Withdrawal by Subject|2|||
125650704|NCT03575806|452006119|FG000|Overall Study|Protocol Violation|0|||
125650705|NCT03575806|452006120|FG001|Overall Study|Protocol Violation|2|||
125650706|NCT01458535|452006121|FG000|Overall Study|Other|0|||
125650707|NCT01458535|452006122|FG001|Overall Study|Other|0|||
125650708|NCT01458535|452006123|FG002|Overall Study|Other|0|||
125650709|NCT01458535|452006124|FG003|Overall Study|Other|0|||
125650710|NCT01458535|452006125|FG004|Overall Study|Other|1|||
125650711|NCT01458535|452006126|FG005|Overall Study|Other|1|||
125650712|NCT01458535|452006121|FG000|Overall Study|Withdrawal by Subject|0|||
125650713|NCT01458535|452006122|FG001|Overall Study|Withdrawal by Subject|0|||
125650714|NCT01458535|452006123|FG002|Overall Study|Withdrawal by Subject|2|||
125650715|NCT01458535|452006124|FG003|Overall Study|Withdrawal by Subject|0|||
125650716|NCT01458535|452006125|FG004|Overall Study|Withdrawal by Subject|1|||
125650717|NCT01458535|452006126|FG005|Overall Study|Withdrawal by Subject|1|||
125650718|NCT01458535|452006121|FG000|Overall Study|Lost to Follow-up|0|||
125650719|NCT01458535|452006122|FG001|Overall Study|Lost to Follow-up|2|||
125650720|NCT01458535|452006123|FG002|Overall Study|Lost to Follow-up|0|||
125650721|NCT01458535|452006124|FG003|Overall Study|Lost to Follow-up|3|||
125650722|NCT01458535|452006125|FG004|Overall Study|Lost to Follow-up|2|||
125650723|NCT01458535|452006126|FG005|Overall Study|Lost to Follow-up|2|||
125650724|NCT01458535|452006121|FG000|Overall Study|Adverse Event|0|||
125650725|NCT01458535|452006122|FG001|Overall Study|Adverse Event|0|||
125650726|NCT01458535|452006123|FG002|Overall Study|Adverse Event|0|||
125650727|NCT01458535|452006124|FG003|Overall Study|Adverse Event|1|||
125650728|NCT01458535|452006125|FG004|Overall Study|Adverse Event|0|||
125650729|NCT01458535|452006126|FG005|Overall Study|Adverse Event|0|||
125650730|NCT01238861|452006127|FG000|Overall Study|Lost to Follow-up|4|||
125650731|NCT01238861|452006128|FG001|Overall Study|Lost to Follow-up|2|||
125650732|NCT01238861|452006129|FG002|Overall Study|Lost to Follow-up|3|||
125650733|NCT01238861|452006130|FG003|Overall Study|Lost to Follow-up|1|||
125650734|NCT01238861|452006131|FG004|Overall Study|Lost to Follow-up|1|||
125650735|NCT01238861|452006132|FG005|Overall Study|Lost to Follow-up|2|||
125650736|NCT01238861|452006127|FG000|Overall Study|Unplanned surgery|1|||
125650737|NCT01238861|452006128|FG001|Overall Study|Unplanned surgery|0|||
125650738|NCT01238861|452006129|FG002|Overall Study|Unplanned surgery|0|||
125650739|NCT01238861|452006130|FG003|Overall Study|Unplanned surgery|0|||
125650740|NCT01238861|452006131|FG004|Overall Study|Unplanned surgery|0|||
125650741|NCT01238861|452006132|FG005|Overall Study|Unplanned surgery|0|||
125650742|NCT01238861|452006127|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
125650743|NCT01238861|452006128|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
125650744|NCT01238861|452006129|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
125650745|NCT01238861|452006130|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
125650746|NCT01238861|452006131|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
125650747|NCT01238861|452006132|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
125650748|NCT01238861|452006127|FG000|Overall Study|Incorrect enrollment/randomization|0|||
125650749|NCT01238861|452006128|FG001|Overall Study|Incorrect enrollment/randomization|0|||
125650750|NCT01238861|452006129|FG002|Overall Study|Incorrect enrollment/randomization|1|||
125650751|NCT01238861|452006130|FG003|Overall Study|Incorrect enrollment/randomization|0|||
125650752|NCT01238861|452006131|FG004|Overall Study|Incorrect enrollment/randomization|1|||
125650753|NCT01238861|452006132|FG005|Overall Study|Incorrect enrollment/randomization|0|||
125650754|NCT01238861|452006127|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
125650755|NCT01238861|452006128|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
125650756|NCT01238861|452006129|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
125313559|NCT02159066|450777345|FG000|Part I|Physician Decision|2|||
125650757|NCT01238861|452006130|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
125650758|NCT01238861|452006131|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
125650759|NCT01238861|452006132|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
125650760|NCT01238861|452006127|FG000|Overall Study|Subject moved out of state/area|0|||
125650761|NCT01238861|452006128|FG001|Overall Study|Subject moved out of state/area|0|||
125650762|NCT01238861|452006129|FG002|Overall Study|Subject moved out of state/area|1|||
125650763|NCT01238861|452006130|FG003|Overall Study|Subject moved out of state/area|1|||
125650764|NCT01238861|452006131|FG004|Overall Study|Subject moved out of state/area|0|||
125650765|NCT01238861|452006132|FG005|Overall Study|Subject moved out of state/area|0|||
125313560|NCT02159066|450777346|FG001|Part I|Physician Decision|9|||
125650766|NCT01238861|452006127|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
125650767|NCT01238861|452006128|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
125650768|NCT01238861|452006129|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
125650769|NCT01238861|452006130|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
125650770|NCT01238861|452006131|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
125650771|NCT01238861|452006132|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
125650772|NCT01238861|452006127|FG000|Overall Study|Personal problems|0|||
125650773|NCT01238861|452006128|FG001|Overall Study|Personal problems|0|||
125650774|NCT01238861|452006129|FG002|Overall Study|Personal problems|0|||
125650775|NCT01238861|452006130|FG003|Overall Study|Personal problems|1|||
125650776|NCT01238861|452006131|FG004|Overall Study|Personal problems|0|||
125650777|NCT01238861|452006132|FG005|Overall Study|Personal problems|0|||
125650778|NCT01238861|452006127|FG000|Overall Study|Unable to continue visits|0|||
125650779|NCT01238861|452006128|FG001|Overall Study|Unable to continue visits|0|||
125650780|NCT01238861|452006129|FG002|Overall Study|Unable to continue visits|0|||
125650781|NCT01238861|452006130|FG003|Overall Study|Unable to continue visits|1|||
125650782|NCT01238861|452006131|FG004|Overall Study|Unable to continue visits|0|||
125650783|NCT01238861|452006132|FG005|Overall Study|Unable to continue visits|1|||
125650784|NCT01238861|452006127|FG000|Overall Study|Serious adverse event|0|||
125650785|NCT01238861|452006128|FG001|Overall Study|Serious adverse event|0|||
125650786|NCT01238861|452006129|FG002|Overall Study|Serious adverse event|0|||
125650787|NCT01238861|452006130|FG003|Overall Study|Serious adverse event|0|||
125650788|NCT01238861|452006131|FG004|Overall Study|Serious adverse event|0|||
125650789|NCT01238861|452006132|FG005|Overall Study|Serious adverse event|1|||
125650790|NCT01238861|452006127|FG000|Overall Study|Lack of compliance|0|||
125650791|NCT01238861|452006128|FG001|Overall Study|Lack of compliance|0|||
125650792|NCT01238861|452006129|FG002|Overall Study|Lack of compliance|0|||
125650793|NCT01238861|452006130|FG003|Overall Study|Lack of compliance|0|||
125650794|NCT01238861|452006131|FG004|Overall Study|Lack of compliance|0|||
125650795|NCT01238861|452006132|FG005|Overall Study|Lack of compliance|1|||
125650796|NCT01238861|452006127|FG000|Overall Study|Adverse Event|0|||
125650797|NCT01238861|452006128|FG001|Overall Study|Adverse Event|1|||
125650798|NCT01238861|452006129|FG002|Overall Study|Adverse Event|0|||
125650799|NCT01238861|452006130|FG003|Overall Study|Adverse Event|0|||
125650800|NCT01238861|452006131|FG004|Overall Study|Adverse Event|0|||
125650801|NCT01238861|452006132|FG005|Overall Study|Adverse Event|0|||
125650802|NCT01238861|452006127|FG000|Overall Study|Withdrawal by Subject|6|||
125650803|NCT01238861|452006128|FG001|Overall Study|Withdrawal by Subject|5|||
125650804|NCT01238861|452006129|FG002|Overall Study|Withdrawal by Subject|4|||
125650805|NCT01238861|452006130|FG003|Overall Study|Withdrawal by Subject|8|||
125650806|NCT01238861|452006131|FG004|Overall Study|Withdrawal by Subject|10|||
125650807|NCT01238861|452006132|FG005|Overall Study|Withdrawal by Subject|9|||
125650808|NCT01855607|452006133|FG000|Overall Study|Withdrawal by Subject|1|||
125650809|NCT01855607|452006133|FG000|Overall Study|Study was terminated|11|||
125650810|NCT04001790|452006138|FG000|Overall Study|Withdrawal by Subject|1|||
125650811|NCT04001790|452006139|FG001|Overall Study|Withdrawal by Subject|2|||
125650812|NCT04963231|452006144|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
125650813|NCT04963231|452006145|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
125313561|NCT02159066|450777347|FG002|Part I|Physician Decision|0|||
125313562|NCT02159066|450777348|FG003|Part I|Physician Decision|0|||
125313563|NCT02159066|450777349|FG004|Part I|Physician Decision|0|||
125313564|NCT02159066|450777350|FG005|Part I|Physician Decision|0|||
125313565|NCT02159066|450777345|FG000|Part I|Participant/Guardian Decision|9|||
125313566|NCT02159066|450777346|FG001|Part I|Participant/Guardian Decision|3|||
125313567|NCT02159066|450777347|FG002|Part I|Participant/Guardian Decision|0|||
125313568|NCT02159066|450777348|FG003|Part I|Participant/Guardian Decision|0|||
125313569|NCT02159066|450777349|FG004|Part I|Participant/Guardian Decision|0|||
125313570|NCT02159066|450777350|FG005|Part I|Participant/Guardian Decision|0|||
125313571|NCT02159066|450777345|FG000|Part I|Missing Data|1|||
125313572|NCT02159066|450777346|FG001|Part I|Missing Data|0|||
125313573|NCT02159066|450777347|FG002|Part I|Missing Data|0|||
125313574|NCT02159066|450777348|FG003|Part I|Missing Data|0|||
125313575|NCT02159066|450777349|FG004|Part I|Missing Data|0|||
125650814|NCT04963231|452006146|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
125650815|NCT04963231|452006144|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
125650816|NCT04963231|452006145|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
125650817|NCT04963231|452006146|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
125650818|NCT04963231|452006144|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
125650819|NCT04963231|452006145|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
125313576|NCT02159066|450777350|FG005|Part I|Missing Data|0|||
125313577|NCT02159066|450777345|FG000|Part II|Adverse Event|0|||
125313578|NCT02159066|450777346|FG001|Part II|Adverse Event|0|||
125650820|NCT04963231|452006146|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
125650821|NCT04963231|452006144|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
125313579|NCT02159066|450777347|FG002|Part II|Adverse Event|1|||
125313580|NCT02159066|450777348|FG003|Part II|Adverse Event|0|||
125313581|NCT02159066|450777349|FG004|Part II|Adverse Event|1|||
125313582|NCT02159066|450777350|FG005|Part II|Adverse Event|1|||
125650822|NCT04963231|452006145|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
125650823|NCT04963231|452006146|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
125650824|NCT04963231|452006144|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
125650825|NCT04963231|452006145|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
125650826|NCT04963231|452006146|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
125650827|NCT04963231|452006144|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
125650828|NCT04963231|452006145|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
125650829|NCT04963231|452006146|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
125650830|NCT04963231|452006144|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
125650831|NCT04963231|452006145|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
125650832|NCT04963231|452006146|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
125650833|NCT04576702|452006147|FG000|Overall Study|Death|1|||
125650834|NCT04576702|452006148|FG001|Overall Study|Death|0|||
125650835|NCT04576702|452006149|FG002|Overall Study|Death|0|||
125650836|NCT04576702|452006150|FG003|Overall Study|Death|0|||
125650837|NCT04576702|452006147|FG000|Overall Study|Withdrawal by Subject|0|||
125650838|NCT04576702|452006148|FG001|Overall Study|Withdrawal by Subject|2|||
125650839|NCT04576702|452006149|FG002|Overall Study|Withdrawal by Subject|1|||
125650840|NCT04576702|452006150|FG003|Overall Study|Withdrawal by Subject|0|||
125650841|NCT04576702|452006147|FG000|Overall Study|Lost to Follow-up|3|||
125650842|NCT04576702|452006148|FG001|Overall Study|Lost to Follow-up|3|||
125313583|NCT02159066|450777345|FG000|Part II|Death|0|||
125313584|NCT02159066|450777346|FG001|Part II|Death|0|||
125313585|NCT02159066|450777347|FG002|Part II|Death|1|||
125313586|NCT02159066|450777348|FG003|Part II|Death|0|||
125313587|NCT02159066|450777349|FG004|Part II|Death|2|||
125313588|NCT02159066|450777350|FG005|Part II|Death|1|||
125313589|NCT02159066|450777345|FG000|Part II|Progressive Disease|0|||
125313590|NCT02159066|450777346|FG001|Part II|Progressive Disease|0|||
125313591|NCT02159066|450777347|FG002|Part II|Progressive Disease|35|||
125313592|NCT02159066|450777348|FG003|Part II|Progressive Disease|1|||
125313593|NCT02159066|450777349|FG004|Part II|Progressive Disease|7|||
125313594|NCT02159066|450777350|FG005|Part II|Progressive Disease|4|||
125313595|NCT02159066|450777345|FG000|Part II|New Therapy for Study Indication|0|||
125313596|NCT02159066|450777346|FG001|Part II|New Therapy for Study Indication|0|||
125650843|NCT04576702|452006149|FG002|Overall Study|Lost to Follow-up|3|||
125650844|NCT04576702|452006150|FG003|Overall Study|Lost to Follow-up|4|||
125650845|NCT06104423|452006153|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
125650846|NCT06104423|452006154|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
125650847|NCT06104423|452006155|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
125650848|NCT06104423|452006153|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
125313597|NCT02159066|450777347|FG002|Part II|New Therapy for Study Indication|0|||
125313598|NCT02159066|450777348|FG003|Part II|New Therapy for Study Indication|0|||
125313599|NCT02159066|450777349|FG004|Part II|New Therapy for Study Indication|1|||
125313600|NCT02159066|450777350|FG005|Part II|New Therapy for Study Indication|0|||
125650849|NCT06104423|452006154|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
125210380|NCT01738191|450393856|FG000|Overall Study|Withdrawal by Subject|4|||
125210381|NCT01738191|450393857|FG001|Overall Study|Withdrawal by Subject|1|||
125210382|NCT02243046|450393858|FG000|Overall Study|Lost to Follow-up|1|||
125210383|NCT02243046|450393859|FG001|Overall Study|Lost to Follow-up|1|||
125210384|NCT02243046|450393860|FG002|Overall Study|Lost to Follow-up|4|||
125210385|NCT03338569|450393861|FG000|Overall Study|Physician Decision|8|||
125210386|NCT03338569|450393862|FG001|Overall Study|Physician Decision|3|||
125210387|NCT03338569|450393861|FG000|Overall Study|Withdrawal by Subject|0|||
125210388|NCT03338569|450393862|FG001|Overall Study|Withdrawal by Subject|1|||
125210389|NCT03338569|450393861|FG000|Overall Study|Lost to Follow-up|0|||
125210390|NCT03338569|450393862|FG001|Overall Study|Lost to Follow-up|1|||
125210391|NCT02109445|450393865|FG000|Overall Study|Symptomatic deterioration|2|||
125210392|NCT02109445|450393865|FG000|Overall Study|Adverse Event|1|||
125210393|NCT00441363|450395568|FG000|Overall Study|Adverse Event|4|||
125210394|NCT00441363|450395569|FG001|Overall Study|Adverse Event|2|||
125210395|NCT00441363|450395568|FG000|Overall Study|Withdrawal by Subject|3|||
125210396|NCT00441363|450395569|FG001|Overall Study|Withdrawal by Subject|4|||
125313601|NCT02159066|450777345|FG000|Part II|Physician Decision|0|||
125313602|NCT02159066|450777346|FG001|Part II|Physician Decision|0|||
125313603|NCT02159066|450777347|FG002|Part II|Physician Decision|1|||
125210397|NCT00441363|450395568|FG000|Overall Study|Physician Decision|6|||
125210398|NCT00441363|450395569|FG001|Overall Study|Physician Decision|7|||
125210399|NCT00441363|450395568|FG000|Overall Study|Lost to Follow-up|2|||
125210400|NCT00441363|450395569|FG001|Overall Study|Lost to Follow-up|2|||
125313604|NCT02159066|450777348|FG003|Part II|Physician Decision|0|||
125313605|NCT02159066|450777349|FG004|Part II|Physician Decision|0|||
125313606|NCT02159066|450777350|FG005|Part II|Physician Decision|0|||
125313607|NCT02159066|450777345|FG000|Part II|Participant/Guardian Decision|0|||
125313608|NCT02159066|450777346|FG001|Part II|Participant/Guardian Decision|0|||
125313609|NCT02159066|450777347|FG002|Part II|Participant/Guardian Decision|0|||
125313610|NCT02159066|450777348|FG003|Part II|Participant/Guardian Decision|0|||
125313611|NCT02159066|450777349|FG004|Part II|Participant/Guardian Decision|2|||
125313612|NCT02159066|450777350|FG005|Part II|Participant/Guardian Decision|0|||
125313613|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
125313614|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
125313615|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
125313616|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313617|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313618|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313619|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313620|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313621|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313622|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313623|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313624|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313625|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
125313626|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313627|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
125313628|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313629|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
125313630|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313631|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313632|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
125313633|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
125313634|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
125313635|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
125313636|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313637|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
125313638|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313639|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313640|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
125313641|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
125313642|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
125313643|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
125313644|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
125313645|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
125313646|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
125313647|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
125313648|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
125313649|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
125313650|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
125313651|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
125313652|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
125313653|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
125313654|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
125313655|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
125313656|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
125313657|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
125313658|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
125313659|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313660|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313661|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
125313662|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313663|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313664|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313665|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313666|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313667|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313668|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
125313669|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313670|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313671|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313672|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
125313673|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313674|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313675|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313676|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313677|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
125650850|NCT06104423|452006155|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
125650851|NCT00229931|452006158|FG000|Overall Study|Death|1|||
125650852|NCT00229931|452006159|FG001|Overall Study|Death|0|||
125650853|NCT00229931|452006158|FG000|Overall Study|Lost to Follow-up|3|||
125650854|NCT00229931|452006159|FG001|Overall Study|Lost to Follow-up|2|||
125650855|NCT00465101|452006160|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
125650856|NCT00465101|452006160|FG000|Overall Study|Change in health precluded follow up|4|||
125650857|NCT00465101|452006160|FG000|Overall Study|Did not meet study criteria|4|||
125650858|NCT00465101|452006160|FG000|Overall Study|Lost to Follow-up|5|||
125650859|NCT00465101|452006160|FG000|Overall Study|Other|6|||
125650860|NCT00465101|452006160|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
125650861|NCT00465101|452006160|FG000|Overall Study|Patient postponed procedure|1|||
125650862|NCT00465101|452006160|FG000|Overall Study|Site closed due to IRB expiration|1|||
125650863|NCT00465101|452006160|FG000|Overall Study|Unable to obtain IRB approval|1|||
125650864|NCT00465101|452006160|FG000|Overall Study|Death|3|||
125650865|NCT00465101|452006160|FG000|Overall Study|Withdrawal by Subject|25|||
125650866|NCT00465101|452006160|FG000|Overall Study|Physician Decision|1|||
125650867|NCT00465101|452006160|FG000|Overall Study|Withdrew consent prior to procedure|3|||
125650868|NCT00361504|452006161|FG000|Overall Study|Withdrawal by Subject|94|||
125650869|NCT00361504|452006162|FG001|Overall Study|Withdrawal by Subject|31|||
125650870|NCT00361504|452006161|FG000|Overall Study|Lost to Follow-up|40|||
125650871|NCT00361504|452006162|FG001|Overall Study|Lost to Follow-up|7|||
125650872|NCT00361504|452006161|FG000|Overall Study|Adverse Event|203|||
125650873|NCT00361504|452006162|FG001|Overall Study|Adverse Event|82|||
125650874|NCT00361504|452006161|FG000|Overall Study|Lack of Efficacy|72|||
125650875|NCT00361504|452006162|FG001|Overall Study|Lack of Efficacy|7|||
125650876|NCT00361504|452006161|FG000|Overall Study|Resolution of Pain|2|||
125650877|NCT00361504|452006162|FG001|Overall Study|Resolution of Pain|0|||
125313678|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
125313679|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313680|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
125313681|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313682|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
125313683|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313684|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
125313685|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313686|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
125313687|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
125313688|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313689|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313690|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313691|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
125313692|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313693|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313694|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313695|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313696|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313697|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313698|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
125313699|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313700|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313701|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313702|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
125313703|NCT01147666|450777351|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313704|NCT01147666|450777352|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313705|NCT01147666|450777353|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313706|NCT01147666|450777354|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313707|NCT01147666|450777355|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313708|NCT01147666|450777356|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313709|NCT01147666|450777357|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313710|NCT01147666|450777358|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313711|NCT01147666|450777359|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313712|NCT01147666|450777360|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313713|NCT01147666|450777361|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125650878|NCT00361504|452006161|FG000|Overall Study|Study medication non compliant|42|||
125313714|NCT01147666|450777362|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
125650879|NCT00361504|452006162|FG001|Overall Study|Study medication non compliant|15|||
125650880|NCT00361504|452006161|FG000|Overall Study|All other|28|||
125650881|NCT00361504|452006162|FG001|Overall Study|All other|3|||
125650882|NCT01374516|452006165|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
125650883|NCT01374516|452006166|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
125650884|NCT01374516|452006165|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
125650885|NCT01374516|452006166|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
125650886|NCT01374516|452006165|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
125650887|NCT01374516|452006166|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
125650888|NCT01374516|452006165|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
125650889|NCT01374516|452006166|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
125650890|NCT01374516|452006165|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
125650891|NCT01374516|452006166|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
125650892|NCT01374516|452006165|FG000|Surveillance Expansion Period|Protocol Violation|386|||
125650893|NCT01374516|452006166|FG001|Surveillance Expansion Period|Protocol Violation|217|||
125650894|NCT01374516|452006165|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
125650895|NCT01374516|452006166|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
125650896|NCT01374516|452006165|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
125650897|NCT01374516|452006166|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
125650898|NCT01374516|452006165|FG000|Surveillance Expansion Period|Serious adverse event|20|||
125650899|NCT01374516|452006166|FG001|Surveillance Expansion Period|Serious adverse event|5|||
125650900|NCT03219372|452006167|FG000|Overall Study|Withdrawal by Subject|1|||
125650901|NCT03219372|452006168|FG001|Overall Study|Withdrawal by Subject|0|||
125650902|NCT00450814|452006169|FG000|Overall Study|Failed to complete the initial therapy|0|||
125650903|NCT00450814|452006170|FG001|Overall Study|Failed to complete the initial therapy|0|||
125650904|NCT00450814|452006171|FG002|Overall Study|Failed to complete the initial therapy|0|||
125313715|NCT01147666|450777363|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
125313716|NCT01147666|450777364|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
125313717|NCT01147666|450777365|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
125313718|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
125313719|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
125313720|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
125313721|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
125313722|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
125313723|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
125313724|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
125313725|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
125313726|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
125313727|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
125313728|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
125313729|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
125313730|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
125313731|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
125313732|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
125313733|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313734|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313735|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313736|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313737|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
125313738|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
125313739|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
125313740|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
125313741|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313742|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
125313743|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313744|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313745|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
125313746|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
125313747|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
125650905|NCT00450814|452006172|FG003|Overall Study|Failed to complete the initial therapy|1|||
125650906|NCT00450814|452006173|FG004|Overall Study|Failed to complete the initial therapy|1|||
125313748|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313749|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313750|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313751|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
125313752|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125650907|NCT00450814|452006174|FG005|Overall Study|Failed to complete the initial therapy|1|||
125313753|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125650908|NCT00450814|452006175|FG006|Overall Study|Failed to complete the initial therapy|0|||
125650909|NCT00450814|452006176|FG007|Overall Study|Failed to complete the initial therapy|0|||
125313754|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125650910|NCT00450814|452006177|FG008|Overall Study|Failed to complete the initial therapy|0|||
125650911|NCT00450814|452006178|FG009|Overall Study|Failed to complete the initial therapy|0|||
125650912|NCT00450814|452006179|FG010|Overall Study|Failed to complete the initial therapy|0|||
125650913|NCT00450814|452006169|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
125650914|NCT00450814|452006170|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
125650915|NCT00450814|452006171|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
125650916|NCT00450814|452006172|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
125650917|NCT00450814|452006173|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
125650918|NCT00450814|452006174|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
125650919|NCT00450814|452006175|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
125650920|NCT00450814|452006176|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
125650921|NCT00450814|452006177|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
125650922|NCT00450814|452006178|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
125650923|NCT00450814|452006179|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
125650924|NCT00401726|452006180|FG000|Overall Study|Adverse Event|34|||
125650925|NCT00401726|452006181|FG001|Overall Study|Adverse Event|45|||
125650926|NCT00401726|452006180|FG000|Overall Study|Death|0|||
125650927|NCT00401726|452006181|FG001|Overall Study|Death|3|||
125650928|NCT00401726|452006180|FG000|Overall Study|Sponsor Request|0|||
125650929|NCT00401726|452006181|FG001|Overall Study|Sponsor Request|1|||
125650930|NCT00401726|452006180|FG000|Overall Study|Physician Decision|3|||
125650931|NCT00401726|452006181|FG001|Overall Study|Physician Decision|6|||
125650932|NCT00401726|452006180|FG000|Overall Study|Lost to Follow-up|23|||
125650933|NCT00401726|452006181|FG001|Overall Study|Lost to Follow-up|20|||
125650934|NCT00401726|452006180|FG000|Overall Study|Protocol Violation|6|||
125650935|NCT00401726|452006181|FG001|Overall Study|Protocol Violation|3|||
125650936|NCT00401726|452006180|FG000|Overall Study|Withdrawal by Subject|18|||
125650937|NCT00401726|452006181|FG001|Overall Study|Withdrawal by Subject|24|||
125650938|NCT00401726|452006180|FG000|Overall Study|Lack of Efficacy|4|||
125650939|NCT00401726|452006181|FG001|Overall Study|Lack of Efficacy|6|||
125650940|NCT00401726|452006180|FG000|Overall Study|Protocol Deviation|9|||
125650941|NCT00401726|452006181|FG001|Overall Study|Protocol Deviation|4|||
125650942|NCT02067728|452006182|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
125650943|NCT02067728|452006183|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
125650944|NCT02067728|452006182|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
125650945|NCT02067728|452006183|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
125650946|NCT02067728|452006182|FG000|6 Month Measurements|Unable to attend|114|||
125650947|NCT02067728|452006183|FG001|6 Month Measurements|Unable to attend|97|||
125650948|NCT03732534|452006187|FG000|Overall Study|Study terminated by Sponsor|6|||
125650949|NCT00814502|452006188|FG000|Overall Study|Adverse Event|1|||
125650950|NCT00814502|452006189|FG001|Overall Study|Adverse Event|0|||
125650951|NCT00814502|452006188|FG000|Overall Study|Withdrawal by Subject|0|||
125650952|NCT00814502|452006189|FG001|Overall Study|Withdrawal by Subject|2|||
125650953|NCT03735849|452006194|FG000|Overall Study|Lost to Follow-up|1|||
125650954|NCT03735849|452006195|FG001|Overall Study|Lost to Follow-up|0|||
125650955|NCT03735849|452006196|FG002|Overall Study|Lost to Follow-up|0|||
125650956|NCT03735849|452006194|FG000|Overall Study|Participant unable to adhere to visit|1|||
125650957|NCT03735849|452006195|FG001|Overall Study|Participant unable to adhere to visit|0|||
125650958|NCT03735849|452006196|FG002|Overall Study|Participant unable to adhere to visit|0|||
125650959|NCT03735849|452006194|FG000|Overall Study|Not Randomized|0|||
125650960|NCT03735849|452006195|FG001|Overall Study|Not Randomized|0|||
125650961|NCT03735849|452006196|FG002|Overall Study|Not Randomized|4|||
125650962|NCT01050998|452006198|FG000|Overall Study|Adverse Event|1|||
125650963|NCT01050998|452006199|FG001|Overall Study|Adverse Event|0|||
125650964|NCT01050998|452006200|FG002|Overall Study|Adverse Event|1|||
125650965|NCT01050998|452006201|FG003|Overall Study|Adverse Event|0|||
125650966|NCT01050998|452006202|FG004|Overall Study|Adverse Event|2|||
125650967|NCT01050998|452006198|FG000|Overall Study|Withdrawal by Subject|0|||
125650968|NCT01050998|452006199|FG001|Overall Study|Withdrawal by Subject|0|||
125650969|NCT01050998|452006200|FG002|Overall Study|Withdrawal by Subject|0|||
125650970|NCT01050998|452006201|FG003|Overall Study|Withdrawal by Subject|1|||
125650971|NCT01050998|452006202|FG004|Overall Study|Withdrawal by Subject|3|||
125650972|NCT01050998|452006198|FG000|Overall Study|Other|3|||
125650973|NCT01050998|452006199|FG001|Overall Study|Other|2|||
125650974|NCT01050998|452006200|FG002|Overall Study|Other|1|||
125650975|NCT01050998|452006201|FG003|Overall Study|Other|1|||
125650976|NCT01050998|452006202|FG004|Overall Study|Other|5|||
125650977|NCT01050998|452006198|FG000|Overall Study|Data integrity issues|0|||
125650978|NCT01050998|452006199|FG001|Overall Study|Data integrity issues|0|||
125650979|NCT01050998|452006200|FG002|Overall Study|Data integrity issues|1|||
125650980|NCT01050998|452006201|FG003|Overall Study|Data integrity issues|1|||
125650981|NCT01050998|452006202|FG004|Overall Study|Data integrity issues|4|||
125650982|NCT02304484|452006210|FG000|Overall Study|Death|9|||
125650983|NCT02304484|452006210|FG000|Overall Study|Withdrawal by Subject|14|||
125650984|NCT02304484|452006210|FG000|Overall Study|Lost to Follow-up|2|||
125650985|NCT02967055|452006211|FG000|Overall Study|Excluded|40|||
125650986|NCT02967055|452006211|FG000|Overall Study|Screen fail|3|||
125650987|NCT02967055|452006211|FG000|Overall Study|Lost to Follow-up|2|||
125650988|NCT02967055|452006211|FG000|Overall Study|Stopped due to side effects|3|||
125650989|NCT02967055|452006211|FG000|Overall Study|Stopped due to drug cost|1|||
125650990|NCT00145795|452006212|FG000|Overall Study|Adverse Event|1|||
125650991|NCT00145795|452006213|FG001|Overall Study|Adverse Event|0|||
125650992|NCT00570492|452006214|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
125650993|NCT00570492|452006215|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
125650994|NCT00570492|452006216|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
125650995|NCT00570492|452006214|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
125650996|NCT00570492|452006215|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
125650997|NCT00570492|452006216|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
125650998|NCT00570492|452006214|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
125650999|NCT00570492|452006215|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
125651000|NCT00570492|452006216|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
125651001|NCT00570492|452006214|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
125651002|NCT00570492|452006215|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
125651003|NCT00570492|452006216|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
125651004|NCT00570492|452006214|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
125651005|NCT00570492|452006215|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
125651006|NCT00570492|452006216|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
125651007|NCT00570492|452006214|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
125651008|NCT00570492|452006215|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
125651009|NCT00570492|452006216|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
125651010|NCT00570492|452006214|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
125651011|NCT00570492|452006215|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
125651012|NCT00570492|452006216|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
125651013|NCT00570492|452006214|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125651014|NCT00570492|452006215|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
125651015|NCT00570492|452006216|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
125651016|NCT00570492|452006214|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
125651017|NCT00570492|452006215|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
125651018|NCT00570492|452006216|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
125651019|NCT00570492|452006214|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
125651020|NCT00570492|452006215|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
125651021|NCT00570492|452006216|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
125651022|NCT00570492|452006214|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
125651023|NCT00570492|452006215|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
125651024|NCT00570492|452006216|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
125651025|NCT00570492|452006214|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
125651026|NCT00570492|452006215|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
125651027|NCT00570492|452006216|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
125651028|NCT00570492|452006214|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
125651029|NCT00570492|452006215|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
125651030|NCT00570492|452006216|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
125651031|NCT00570492|452006214|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
125651032|NCT00570492|452006215|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
125651033|NCT00570492|452006216|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
125651034|NCT00976989|452006217|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
125651035|NCT00976989|452006218|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
125651036|NCT00976989|452006219|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
125651037|NCT00976989|452006217|FG000|Overall Study|Death|5|||
125313755|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313756|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313757|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313758|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313759|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313760|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313761|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313762|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
125313763|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313764|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125651038|NCT00976989|452006218|FG001|Overall Study|Death|7|||
125651039|NCT00976989|452006219|FG002|Overall Study|Death|10|||
125651040|NCT00976989|452006217|FG000|Overall Study|Refused Treatment|4|||
125313765|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313766|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313767|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
125313768|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
125313769|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313770|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
125313771|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313772|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
125313773|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313774|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313775|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313776|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
125313777|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
125313778|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313779|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313780|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313781|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
125313782|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313783|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313784|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313785|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313786|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313787|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313788|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
125313789|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313790|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313791|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313792|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
125313793|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313794|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313795|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313796|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313797|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313798|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313799|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313800|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313801|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313802|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313803|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313804|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313805|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
125313806|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313807|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
125313808|NCT01147666|450777351|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313809|NCT01147666|450777352|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313810|NCT01147666|450777353|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313811|NCT01147666|450777354|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313812|NCT01147666|450777355|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313813|NCT01147666|450777356|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313814|NCT01147666|450777357|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313815|NCT01147666|450777358|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313816|NCT01147666|450777359|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313817|NCT01147666|450777360|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313818|NCT01147666|450777361|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313819|NCT01147666|450777362|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313820|NCT01147666|450777363|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
125313821|NCT01147666|450777364|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
125313822|NCT01147666|450777365|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
125313823|NCT00474955|450777366|FG000|Overall Study|Adverse Event|2|||
125313824|NCT00474955|450777366|FG000|Overall Study|Drug unavailability|1|||
125313825|NCT00474955|450777366|FG000|Overall Study|Personal reasons|5|||
125313826|NCT01135134|450777367|FG000|Overall Study|Adverse Event|1|||
125313827|NCT01135134|450777368|FG001|Overall Study|Adverse Event|1|||
125313828|NCT01135134|450777367|FG000|Overall Study|Did not meet protocol eligibility|1|||
125313829|NCT01135134|450777368|FG001|Overall Study|Did not meet protocol eligibility|0|||
125313830|NCT00256724|450777373|FG000|Overall Study|Physician Decision|2|||
125313831|NCT00256724|450777374|FG001|Overall Study|Physician Decision|5|||
125651041|NCT00976989|452006218|FG001|Overall Study|Refused Treatment|3|||
125651042|NCT00976989|452006219|FG002|Overall Study|Refused Treatment|5|||
125651043|NCT00976989|452006217|FG000|Overall Study|Failure to Return|2|||
125651044|NCT00976989|452006218|FG001|Overall Study|Failure to Return|1|||
125651045|NCT00976989|452006219|FG002|Overall Study|Failure to Return|0|||
125651046|NCT00976989|452006217|FG000|Overall Study|Recurrence of Disease|0|||
125651047|NCT00976989|452006218|FG001|Overall Study|Recurrence of Disease|1|||
125651048|NCT00976989|452006219|FG002|Overall Study|Recurrence of Disease|0|||
125651049|NCT00976989|452006217|FG000|Overall Study|Other|1|||
125651050|NCT00976989|452006218|FG001|Overall Study|Other|0|||
125651051|NCT00976989|452006219|FG002|Overall Study|Other|1|||
125651052|NCT03958045|452006220|FG000|Overall Study|Withdrawal by Subject|1|||
125651053|NCT02283411|452006221|FG000|Overall Study|Withdrawal by Subject|3|||
125651054|NCT02283411|452006221|FG000|Overall Study|Screen Failed|28|||
125651055|NCT04409262|452006223|FG000|Overall Study|Adverse Event|0|||
125651056|NCT04409262|452006224|FG001|Overall Study|Adverse Event|2|||
125651057|NCT04409262|452006223|FG000|Overall Study|Death|55|||
125651058|NCT04409262|452006224|FG001|Overall Study|Death|97|||
125651059|NCT04409262|452006223|FG000|Overall Study|Lost to Follow-up|12|||
125651060|NCT04409262|452006224|FG001|Overall Study|Lost to Follow-up|23|||
125651061|NCT04409262|452006223|FG000|Overall Study|Lack of Staff|0|||
125651062|NCT04409262|452006224|FG001|Overall Study|Lack of Staff|1|||
125651063|NCT04409262|452006223|FG000|Overall Study|Protocol Violation|3|||
125651064|NCT04409262|452006224|FG001|Overall Study|Protocol Violation|1|||
125651065|NCT04409262|452006223|FG000|Overall Study|Withdrawal by Subject|5|||
125651066|NCT04409262|452006224|FG001|Overall Study|Withdrawal by Subject|10|||
125651067|NCT02500732|452006225|FG000|Overall Study|Physician Decision|0|||
125651068|NCT02500732|452006226|FG001|Overall Study|Physician Decision|1|||
125651069|NCT03328325|452006227|FG000|Overall Study|Lost to Follow-up|4|||
125651070|NCT03328325|452006227|FG000|Overall Study|Physician Decision|1|||
125651071|NCT03328325|452006227|FG000|Overall Study|Withdrawal by Subject|3|||
125651072|NCT03328325|452006227|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
125651073|NCT03759340|452006229|FG000|Overall Study|Adverse Event|2|||
125651074|NCT03759340|452006229|FG000|Overall Study|Lost to Follow-up|1|||
125651075|NCT03759340|452006229|FG000|Overall Study|Withdrawal by Subject|15|||
125651076|NCT03759340|452006229|FG000|Overall Study|Study Terminated by Sponsor|38|||
125651077|NCT00736840|452006230|FG000|Overall Study|Lost to Follow-up|13|||
125651078|NCT03289676|452006233|FG000|Overall Study|Withdrawal by Subject|2|||
125651079|NCT03289676|452006234|FG001|Overall Study|Withdrawal by Subject|0|||
125651080|NCT03289676|452006233|FG000|Overall Study|Protocol Violation|2|||
125651081|NCT03289676|452006234|FG001|Overall Study|Protocol Violation|0|||
125651082|NCT03289676|452006233|FG000|Overall Study|Lost to Follow-up|0|||
125651083|NCT03289676|452006234|FG001|Overall Study|Lost to Follow-up|1|||
125651084|NCT00422227|452006235|FG000|Overall Study|Adverse Event|3|||
125651085|NCT00422227|452006236|FG001|Overall Study|Adverse Event|8|||
125651086|NCT00422227|452006235|FG000|Overall Study|Lost to Follow-up|1|||
125651087|NCT00422227|452006236|FG001|Overall Study|Lost to Follow-up|3|||
125651088|NCT00422227|452006235|FG000|Overall Study|Withdrawal by Subject|0|||
125651089|NCT00422227|452006236|FG001|Overall Study|Withdrawal by Subject|4|||
125651090|NCT01396434|452006237|FG000|Overall Study|Lost to Follow-up|1|||
125651091|NCT01396434|452006238|FG001|Overall Study|Lost to Follow-up|0|||
125651092|NCT01396434|452006239|FG002|Overall Study|Lost to Follow-up|0|||
125651093|NCT01396434|452006237|FG000|Overall Study|Other|10|||
125313832|NCT00256724|450777373|FG000|Overall Study|Protocol Violation|3|||
125313833|NCT00256724|450777374|FG001|Overall Study|Protocol Violation|3|||
125313834|NCT01569841|450777383|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
125313835|NCT01569841|450777384|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
125313836|NCT01859923|450777385|FG000|Overall Study|Adverse Event|0|||
125313837|NCT01859923|450777386|FG001|Overall Study|Adverse Event|0|||
125313838|NCT01859923|450777387|FG002|Overall Study|Adverse Event|1|||
125313839|NCT01859923|450777388|FG003|Overall Study|Adverse Event|1|||
125313840|NCT00764361|450777394|FG000|Overall Study|Withdrawal by Subject|2|||
125313841|NCT00764361|450777395|FG001|Overall Study|Withdrawal by Subject|3|||
125313842|NCT00764361|450777394|FG000|Overall Study|Adverse Event|0|||
125313843|NCT00764361|450777395|FG001|Overall Study|Adverse Event|1|||
125313844|NCT02090426|450777396|FG000|Overall Study|Lost to Follow-up|12|||
125313845|NCT02090426|450777397|FG001|Overall Study|Lost to Follow-up|6|||
125651094|NCT01396434|452006238|FG001|Overall Study|Other|0|||
125651095|NCT01396434|452006239|FG002|Overall Study|Other|0|||
125651096|NCT00157157|452006240|FG000|Overall Study|Withdrawal by Subject|6|||
125651097|NCT00157157|452006240|FG000|Overall Study|Physician Decision|1|||
125651098|NCT00157157|452006240|FG000|Overall Study|Lost to Follow-up|1|||
125651099|NCT00157157|452006240|FG000|Overall Study|Enrolled in another study|1|||
125651100|NCT00157157|452006240|FG000|Overall Study|Met exclusion criteria|1|||
125651101|NCT00157157|452006240|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
125651102|NCT01018680|452007853|FG000|Overall Study|Adverse Event|23|||
125651103|NCT01018680|452007854|FG001|Overall Study|Adverse Event|40|||
125651104|NCT01018680|452007853|FG000|Overall Study|Withdrawal by Subject|10|||
125651105|NCT01018680|452007854|FG001|Overall Study|Withdrawal by Subject|10|||
125651106|NCT01018680|452007853|FG000|Overall Study|Protocol Violation|5|||
125651107|NCT01018680|452007854|FG001|Overall Study|Protocol Violation|8|||
125651108|NCT01018680|452007853|FG000|Overall Study|Sponsor Decision|6|||
125651109|NCT01018680|452007854|FG001|Overall Study|Sponsor Decision|7|||
125651110|NCT01018680|452007853|FG000|Overall Study|Lack of Efficacy|8|||
125651111|NCT01018680|452007854|FG001|Overall Study|Lack of Efficacy|2|||
125651112|NCT01018680|452007853|FG000|Overall Study|Lost to Follow-up|5|||
125651113|NCT01018680|452007854|FG001|Overall Study|Lost to Follow-up|3|||
125651114|NCT01018680|452007853|FG000|Overall Study|Entry Criteria Not Met|1|||
125651115|NCT01018680|452007854|FG001|Overall Study|Entry Criteria Not Met|4|||
125651116|NCT01018680|452007853|FG000|Overall Study|Physician Decision|3|||
125651117|NCT01018680|452007854|FG001|Overall Study|Physician Decision|1|||
125651118|NCT02383966|452007858|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
125651119|NCT02383966|452007859|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
125651120|NCT02383966|452007858|FG000|Overall Study|Randomized, but not treated|1|||
125651121|NCT02383966|452007859|FG001|Overall Study|Randomized, but not treated|3|||
125651122|NCT02163759|452007860|FG000|Overall Study|Withdrawal by Subject|1|||
125651123|NCT02163759|452007861|FG001|Overall Study|Withdrawal by Subject|5|||
125651124|NCT02163759|452007862|FG002|Overall Study|Withdrawal by Subject|1|||
125651125|NCT02163759|452007860|FG000|Overall Study|Adverse Event|0|||
125651126|NCT02163759|452007861|FG001|Overall Study|Adverse Event|0|||
125651127|NCT02163759|452007862|FG002|Overall Study|Adverse Event|1|||
125651128|NCT02163759|452007860|FG000|Overall Study|Death|0|||
125651129|NCT02163759|452007861|FG001|Overall Study|Death|0|||
125651130|NCT02163759|452007862|FG002|Overall Study|Death|1|||
125651131|NCT00219349|452007874|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
125651132|NCT00219349|452007874|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
125651133|NCT00219349|452007874|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
125651134|NCT00219349|452007874|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
125651135|NCT02777554|452007876|FG000|Overall Study|Adverse Event|4|||
125651136|NCT02777554|452007877|FG001|Overall Study|Adverse Event|4|||
125651137|NCT02777554|452007878|FG002|Overall Study|Adverse Event|0|||
125651138|NCT02777554|452007879|FG003|Overall Study|Adverse Event|1|||
125651139|NCT02777554|452007880|FG004|Overall Study|Adverse Event|0|||
125651140|NCT02777554|452007881|FG005|Overall Study|Adverse Event|0|||
125651141|NCT02777554|452007876|FG000|Overall Study|Withdrawal by Subject|3|||
125651142|NCT02777554|452007877|FG001|Overall Study|Withdrawal by Subject|1|||
125651143|NCT02777554|452007878|FG002|Overall Study|Withdrawal by Subject|1|||
125651144|NCT02777554|452007879|FG003|Overall Study|Withdrawal by Subject|0|||
125651145|NCT02777554|452007880|FG004|Overall Study|Withdrawal by Subject|0|||
125651146|NCT02777554|452007881|FG005|Overall Study|Withdrawal by Subject|0|||
125651147|NCT02777554|452007876|FG000|Overall Study|Discharged early due to hurricane|22|||
125651148|NCT02777554|452007877|FG001|Overall Study|Discharged early due to hurricane|20|||
125651149|NCT02777554|452007878|FG002|Overall Study|Discharged early due to hurricane|0|||
125651150|NCT02777554|452007879|FG003|Overall Study|Discharged early due to hurricane|0|||
125651151|NCT02777554|452007880|FG004|Overall Study|Discharged early due to hurricane|0|||
125651152|NCT02777554|452007881|FG005|Overall Study|Discharged early due to hurricane|0|||
125651153|NCT02777554|452007876|FG000|Overall Study|Other - Miscellaneous|1|||
125651154|NCT02777554|452007877|FG001|Overall Study|Other - Miscellaneous|0|||
125651155|NCT02777554|452007878|FG002|Overall Study|Other - Miscellaneous|0|||
125651156|NCT02777554|452007879|FG003|Overall Study|Other - Miscellaneous|0|||
125651157|NCT02777554|452007880|FG004|Overall Study|Other - Miscellaneous|0|||
125651158|NCT02777554|452007881|FG005|Overall Study|Other - Miscellaneous|0|||
125651159|NCT00270205|452007882|FG000|Overall Study|Lost to Follow-up|1|||
125651160|NCT00270205|452007883|FG001|Overall Study|Lost to Follow-up|0|||
125651161|NCT00270205|452007884|FG002|Overall Study|Lost to Follow-up|0|||
125651162|NCT00270205|452007885|FG003|Overall Study|Lost to Follow-up|1|||
125651163|NCT00066573|452007886|FG000|Overall Study|Did not received protocol treatment|28|||
125651164|NCT00066573|452007887|FG001|Overall Study|Did not received protocol treatment|28|||
125651165|NCT00869362|452007888|FG000|Overall Study|Death|0|||
125651166|NCT00869362|452007889|FG001|Overall Study|Death|2|||
125651167|NCT00869362|452007888|FG000|Overall Study|Lost to Follow-up|1|||
125651168|NCT00869362|452007889|FG001|Overall Study|Lost to Follow-up|3|||
125651169|NCT01945034|452007890|FG000|Overall Study|Medication Error|0|||
125651170|NCT01945034|452007891|FG001|Overall Study|Medication Error|1|||
125210401|NCT00441363|450395568|FG000|Overall Study|Other|2|||
125210402|NCT00441363|450395569|FG001|Overall Study|Other|0|||
125210403|NCT02474355|450395572|FG000|Overall Study|Other|43|||
125210404|NCT02474355|450395572|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
125210405|NCT02474355|450395572|FG000|Overall Study|Lost to Follow-up|98|||
125210406|NCT02474355|450395572|FG000|Overall Study|Withdrawal by Subject|124|||
125210407|NCT02474355|450395572|FG000|Overall Study|Death|1361|||
125210408|NCT01066793|450395573|FG000|Overall Study|Death|4|||
125210409|NCT01066793|450395574|FG001|Overall Study|Death|1|||
125210410|NCT01066793|450395575|FG002|Overall Study|Death|1|||
125210411|NCT01066793|450395576|FG003|Overall Study|Death|0|||
125210412|NCT01066793|450395577|FG004|Overall Study|Death|0|||
125210413|NCT01066793|450395578|FG005|Overall Study|Death|0|||
125313846|NCT01141712|450777401|FG000|Overall Study|Disease progression|3|||
125313847|NCT01308736|450777402|FG000|Overall Study|Did not attend a single session|6|||
125313848|NCT01308736|450777403|FG001|Overall Study|Did not attend a single session|5|||
125313849|NCT03634085|450777404|FG000|Overall Study|Adverse Event|1|||
125313850|NCT03634085|450777405|FG001|Overall Study|Adverse Event|0|||
125313851|NCT03634085|450777404|FG000|Overall Study|Withdrawal by Subject|0|||
125313852|NCT03634085|450777405|FG001|Overall Study|Withdrawal by Subject|2|||
125313853|NCT00296816|450777410|FG000|Overall Study|Disease Progression|37|||
125313854|NCT00296816|450777410|FG000|Overall Study|Adverse Event|18|||
125313855|NCT00296816|450777410|FG000|Overall Study|Investigator/Participant request|5|||
125313856|NCT00296816|450777410|FG000|Overall Study|Non-compliance|1|||
125313857|NCT00296816|450777410|FG000|Overall Study|Missing for end of treatment|4|||
125313858|NCT00296816|450777410|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
125313859|NCT00296816|450777410|FG000|Overall Study|Poor performance status|1|||
125313860|NCT00296816|450777410|FG000|Overall Study|Relocation to Florida|1|||
125313861|NCT00296816|450777410|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
125313862|NCT00296816|450777410|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
125313863|NCT00296816|450777410|FG000|Overall Study|Neuropathy/patient preference|1|||
125313864|NCT00296816|450777410|FG000|Overall Study|Proteinuria|1|||
125313865|NCT00296816|450777410|FG000|Overall Study|ineligibility due to radiation treatment|1|||
125313866|NCT00985465|450777416|FG000|Overall Study|Withdrawal by Subject|1|||
125313867|NCT00985465|450777417|FG001|Overall Study|Withdrawal by Subject|2|||
125313868|NCT00985465|450777416|FG000|Overall Study|Considered to be part of the other group|0|||
125313869|NCT00985465|450777417|FG001|Overall Study|Considered to be part of the other group|1|||
125313870|NCT04701333|450777418|FG000|Overall Study|Lost to Follow-up|3|||
125313871|NCT04701333|450777419|FG001|Overall Study|Lost to Follow-up|7|||
125313872|NCT04701333|450777418|FG000|Overall Study|Withdrawal by Subject|0|||
125313873|NCT04701333|450777419|FG001|Overall Study|Withdrawal by Subject|1|||
125313874|NCT01012258|450777420|FG000|Overall Study|Death|14|||
125651171|NCT01945034|452007892|FG002|Overall Study|Medication Error|0|||
125651172|NCT01945034|452007890|FG000|Overall Study|Withdrawal by Subject|0|||
125651173|NCT01945034|452007891|FG001|Overall Study|Withdrawal by Subject|3|||
125313875|NCT01012258|450777420|FG000|Overall Study|Lost to Follow-up|1|||
125313876|NCT01012258|450777420|FG000|Overall Study|Adverse Event|1|||
125313877|NCT01012258|450777420|FG000|Overall Study|Progressive Disease (PD)|18|||
125313878|NCT01012258|450777420|FG000|Overall Study|Symptomatic Deterioration|1|||
125313879|NCT01012258|450777420|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
125651174|NCT01945034|452007892|FG002|Overall Study|Withdrawal by Subject|1|||
125651175|NCT01945034|452007890|FG000|Overall Study|Other|0|||
125651176|NCT01945034|452007891|FG001|Overall Study|Other|1|||
125651177|NCT01945034|452007892|FG002|Overall Study|Other|3|||
125651178|NCT01945034|452007890|FG000|Overall Study|Lost to Follow-up|0|||
125651179|NCT01945034|452007891|FG001|Overall Study|Lost to Follow-up|0|||
125651180|NCT01945034|452007892|FG002|Overall Study|Lost to Follow-up|2|||
125651181|NCT01945034|452007890|FG000|Overall Study|Protocol Violation|1|||
125651182|NCT01945034|452007891|FG001|Overall Study|Protocol Violation|0|||
125651183|NCT01945034|452007892|FG002|Overall Study|Protocol Violation|1|||
125651184|NCT03053102|452007893|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
125651185|NCT03053102|452007893|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
125651186|NCT03323034|452007895|FG000|Overall Study|Lack of Efficacy|5|||
125651187|NCT03323034|452007896|FG001|Overall Study|Lack of Efficacy|5|||
125651188|NCT03323034|452007897|FG002|Overall Study|Lack of Efficacy|6|||
125651189|NCT03323034|452007898|FG003|Overall Study|Lack of Efficacy|5|||
125651190|NCT03323034|452007899|FG004|Overall Study|Lack of Efficacy|5|||
125651191|NCT03323034|452007895|FG000|Overall Study|Physician Decision|0|||
125651192|NCT03323034|452007896|FG001|Overall Study|Physician Decision|0|||
125651193|NCT03323034|452007897|FG002|Overall Study|Physician Decision|0|||
125651194|NCT03323034|452007898|FG003|Overall Study|Physician Decision|0|||
125651195|NCT03323034|452007899|FG004|Overall Study|Physician Decision|1|||
125313880|NCT01012258|450777420|FG000|Overall Study|Another Tumor Discovered|1|||
125313881|NCT01012258|450777420|FG000|Overall Study|Ongoing|29|||
125313882|NCT00580723|450777430|FG000|Overall Study|Did not want to participate in extension|3|||
125313883|NCT00580723|450777430|FG000|Overall Study|Lost to Follow-up|5|||
125313884|NCT00148759|450777431|FG000|Overall Study|Withdrawal by Subject|1|||
125313885|NCT00148759|450777432|FG001|Overall Study|Withdrawal by Subject|1|||
125313886|NCT00148759|450777431|FG000|Overall Study|Lost to Follow-up|1|||
125313887|NCT00148759|450777432|FG001|Overall Study|Lost to Follow-up|0|||
125651196|NCT03323034|452007895|FG000|Overall Study|Withdrawal by Subject|1|||
125651197|NCT03323034|452007896|FG001|Overall Study|Withdrawal by Subject|1|||
125651198|NCT03323034|452007897|FG002|Overall Study|Withdrawal by Subject|0|||
125651199|NCT03323034|452007898|FG003|Overall Study|Withdrawal by Subject|1|||
125651200|NCT03323034|452007899|FG004|Overall Study|Withdrawal by Subject|0|||
125651201|NCT02660489|452007900|FG000|Overall Study|Lost to Follow-up|1|||
125651202|NCT02660489|452007901|FG001|Overall Study|Lost to Follow-up|1|||
125651203|NCT02660489|452007900|FG000|Overall Study|Adverse Event|1|||
125651204|NCT02660489|452007901|FG001|Overall Study|Adverse Event|3|||
125651205|NCT02660489|452007900|FG000|Overall Study|no rhinovirus infection|4|||
125651206|NCT02660489|452007901|FG001|Overall Study|no rhinovirus infection|4|||
125651207|NCT04887922|452007902|FG000|1st Randomization|Decided not to have surgery|0|||
125651208|NCT04887922|452007903|FG001|1st Randomization|Decided not to have surgery|1|||
125651209|NCT04887922|452007904|FG002|1st Randomization|Decided not to have surgery|0|||
125651210|NCT04887922|452007905|FG003|1st Randomization|Decided not to have surgery|0|||
125651211|NCT04887922|452007906|FG004|1st Randomization|Decided not to have surgery|0|||
125651212|NCT00718809|452007907|FG000|Overall Study|Disease progression|9|||
125651213|NCT00718809|452007908|FG001|Overall Study|Disease progression|7|||
125651214|NCT00718809|452007907|FG000|Overall Study|Adverse Event|1|||
125651215|NCT00718809|452007908|FG001|Overall Study|Adverse Event|1|||
125651216|NCT00718809|452007907|FG000|Overall Study|Withdrawal by Subject|0|||
125651217|NCT00718809|452007908|FG001|Overall Study|Withdrawal by Subject|1|||
125651218|NCT00718809|452007907|FG000|Overall Study|Lost to Follow-up|1|||
125651219|NCT00718809|452007908|FG001|Overall Study|Lost to Follow-up|0|||
125651220|NCT00718809|452007907|FG000|Overall Study|Noncompliance|1|||
125651221|NCT00718809|452007908|FG001|Overall Study|Noncompliance|0|||
125651222|NCT00463385|452007909|FG000|Overall Study|Other|4|||
125651223|NCT00463385|452007910|FG001|Overall Study|Other|3|||
125651224|NCT00463385|452007911|FG002|Overall Study|Other|6|||
125651225|NCT00463385|452007912|FG003|Overall Study|Other|4|||
125651226|NCT00463385|452007909|FG000|Overall Study|Adverse Event|5|||
125651227|NCT00463385|452007910|FG001|Overall Study|Adverse Event|8|||
125651228|NCT00463385|452007911|FG002|Overall Study|Adverse Event|4|||
125651229|NCT00463385|452007912|FG003|Overall Study|Adverse Event|2|||
125651230|NCT00463385|452007909|FG000|Overall Study|Lack of Efficacy|6|||
125651231|NCT00463385|452007910|FG001|Overall Study|Lack of Efficacy|6|||
125651232|NCT00463385|452007911|FG002|Overall Study|Lack of Efficacy|7|||
125651233|NCT00463385|452007912|FG003|Overall Study|Lack of Efficacy|9|||
125651234|NCT00463385|452007909|FG000|Overall Study|Withdrawal by Subject|3|||
125651235|NCT00463385|452007910|FG001|Overall Study|Withdrawal by Subject|3|||
125651236|NCT00463385|452007911|FG002|Overall Study|Withdrawal by Subject|3|||
125651237|NCT00463385|452007912|FG003|Overall Study|Withdrawal by Subject|4|||
125651238|NCT00463385|452007909|FG000|Overall Study|Lost to Follow-up|0|||
125651239|NCT00463385|452007910|FG001|Overall Study|Lost to Follow-up|0|||
125651240|NCT00463385|452007911|FG002|Overall Study|Lost to Follow-up|0|||
125651241|NCT00463385|452007912|FG003|Overall Study|Lost to Follow-up|1|||
125651242|NCT00463385|452007909|FG000|Overall Study|Death|2|||
125651243|NCT00463385|452007910|FG001|Overall Study|Death|1|||
125651244|NCT00463385|452007911|FG002|Overall Study|Death|2|||
125651245|NCT00463385|452007912|FG003|Overall Study|Death|0|||
125651246|NCT00463385|452007909|FG000|Overall Study|Missing|2|||
125651247|NCT00463385|452007910|FG001|Overall Study|Missing|0|||
125651248|NCT00463385|452007911|FG002|Overall Study|Missing|0|||
125651249|NCT00463385|452007912|FG003|Overall Study|Missing|2|||
125651250|NCT00463385|452007909|FG000|Overall Study|1 participant received commercial drug|0|||
125651251|NCT00463385|452007910|FG001|Overall Study|1 participant received commercial drug|1|||
125651252|NCT00463385|452007911|FG002|Overall Study|1 participant received commercial drug|0|||
125651253|NCT00463385|452007912|FG003|Overall Study|1 participant received commercial drug|0|||
125651254|NCT00536991|452007915|FG000|Overall Study|Withdrawal by Subject|10|||
125651255|NCT00536991|452007915|FG000|Overall Study|Physician Decision|1|||
125651256|NCT00536991|452007915|FG000|Overall Study|patient ineligible|2|||
125651257|NCT01600755|452007916|FG000|Overall Study|Withdrawal by Subject|6|||
125651258|NCT00447265|452007921|FG000|Overall Study|Physician Decision|1|||
125651259|NCT00447265|452007922|FG001|Overall Study|Physician Decision|0|||
125651260|NCT02204449|452007923|FG000|Overall Study|Lost to Follow-up|7|||
125651261|NCT02204449|452007924|FG001|Overall Study|Lost to Follow-up|9|||
125651262|NCT02204449|452007923|FG000|Overall Study|Death|0|||
125651263|NCT02204449|452007924|FG001|Overall Study|Death|1|||
125651264|NCT02204449|452007923|FG000|Overall Study|Withdrawal by Subject|0|||
125651265|NCT02204449|452007924|FG001|Overall Study|Withdrawal by Subject|1|||
125651266|NCT00503035|452007925|FG000|Overall Study|Lost to Follow-up|2|||
125313888|NCT01454596|450777433|FG000|Overall Study|Death|0|||
125313889|NCT01454596|450777434|FG001|Overall Study|Death|0|||
125651267|NCT00503035|452007925|FG000|Overall Study|Physician Decision|3|||
125313890|NCT01454596|450777435|FG002|Overall Study|Death|0|||
125651268|NCT00503035|452007925|FG000|Overall Study|Ineligible|15|||
125651269|NCT03868410|452007926|FG000|Overall Study|Physician Decision|0|||
125651270|NCT03868410|452007927|FG001|Overall Study|Physician Decision|1|||
125313891|NCT01454596|450777436|FG003|Overall Study|Death|0|||
125313892|NCT01454596|450777437|FG004|Overall Study|Death|0|||
125313893|NCT01454596|450777438|FG005|Overall Study|Death|0|||
125651271|NCT01059175|452007928|FG000|Overall Study|Death|17|||
125651272|NCT01059175|452007929|FG001|Overall Study|Death|17|||
125651273|NCT01059175|452007928|FG000|Overall Study|Adverse Event|4|||
125651274|NCT01059175|452007929|FG001|Overall Study|Adverse Event|2|||
125651275|NCT01059175|452007928|FG000|Overall Study|Lost to Follow-up|0|||
125651276|NCT01059175|452007929|FG001|Overall Study|Lost to Follow-up|1|||
125651277|NCT00643006|452007931|FG000|Overall Study|Lost to Follow-up|5|||
125651278|NCT00643006|452007932|FG001|Overall Study|Lost to Follow-up|4|||
125651279|NCT03471507|452007933|FG000|Overall Study|Lost to Follow-up|1|||
125651280|NCT03471507|452007934|FG001|Overall Study|Lost to Follow-up|3|||
125651281|NCT03471507|452007933|FG000|Overall Study|Physician Decision|0|||
125651282|NCT03471507|452007934|FG001|Overall Study|Physician Decision|1|||
125651283|NCT03471507|452007933|FG000|Overall Study|Withdrawal by Subject|2|||
125651284|NCT03471507|452007934|FG001|Overall Study|Withdrawal by Subject|1|||
125651285|NCT01151085|452007935|FG000|Overall Study|Lost to Follow-up|31|||
125651286|NCT01151085|452007935|FG000|Overall Study|Protocol Violation|25|||
125651287|NCT01308476|452007937|FG000|Overall Study|Lost to Follow-up|2|||
125651288|NCT01308476|452007938|FG001|Overall Study|Lost to Follow-up|2|||
125651289|NCT01308476|452007937|FG000|Overall Study|Other|1|||
125651290|NCT01308476|452007938|FG001|Overall Study|Other|0|||
125651291|NCT00750061|452007941|FG000|Overall Study|Adverse Event|2|||
125651292|NCT00750061|452007942|FG001|Overall Study|Adverse Event|0|||
125651293|NCT00750061|452007941|FG000|Overall Study|Withdrawal by Subject|0|||
125651294|NCT00750061|452007942|FG001|Overall Study|Withdrawal by Subject|1|||
125651295|NCT00750061|452007941|FG000|Overall Study|Physician Decision|0|||
125651296|NCT00750061|452007942|FG001|Overall Study|Physician Decision|1|||
125651297|NCT00812968|452007943|FG000|Overall Study|Relapse after erythroid response|6|||
125651298|NCT00812968|452007943|FG000|Overall Study|Disease progression|1|||
125651299|NCT00812968|452007943|FG000|Overall Study|No further treatment required|1|||
125651300|NCT00812968|452007943|FG000|Overall Study|Study closed due to marketing approval|3|||
125651301|NCT03246152|452007945|FG000|Overall Study|Lost to Follow-up|2|||
125651302|NCT03246152|452007945|FG000|Overall Study|Protocol Violation|1|||
125651303|NCT01243762|452007950|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
125651304|NCT01243762|452007951|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
125651305|NCT01243762|452007952|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
125651306|NCT01243762|452007953|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
125651307|NCT01243762|452007954|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
125651308|NCT01243762|452007955|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
125651309|NCT01243762|452007956|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
125651310|NCT01243762|452007950|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
125651311|NCT01243762|452007951|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
125651312|NCT01243762|452007952|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
125651313|NCT01243762|452007953|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
125651314|NCT01243762|452007954|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
125651315|NCT01243762|452007955|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
125651316|NCT01243762|452007956|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
125651317|NCT01243762|452007950|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
125651318|NCT01243762|452007951|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
125651319|NCT01243762|452007952|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
125651320|NCT01243762|452007953|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
125651321|NCT01243762|452007954|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
125651322|NCT01243762|452007955|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
125651323|NCT01243762|452007956|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
125651324|NCT01243762|452007950|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
125651325|NCT01243762|452007951|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
125651326|NCT01243762|452007952|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
125651327|NCT01243762|452007953|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
125651328|NCT01243762|452007954|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
125651329|NCT01243762|452007955|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
125651330|NCT01243762|452007956|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
125651331|NCT01243762|452007950|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
125651332|NCT01243762|452007951|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
125651333|NCT01243762|452007952|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
125651334|NCT01243762|452007953|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
125651335|NCT01243762|452007954|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
125651336|NCT01243762|452007955|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
125651337|NCT01243762|452007956|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
125651338|NCT01243762|452007950|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
125651339|NCT01243762|452007951|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
125651340|NCT01243762|452007952|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
125651341|NCT01243762|452007953|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
125651342|NCT01243762|452007954|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
125651343|NCT01243762|452007955|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
125210414|NCT01066793|450395573|FG000|Overall Study|Lack of Efficacy|2|||
125210415|NCT01066793|450395574|FG001|Overall Study|Lack of Efficacy|1|||
125210416|NCT01066793|450395575|FG002|Overall Study|Lack of Efficacy|0|||
125210417|NCT01066793|450395576|FG003|Overall Study|Lack of Efficacy|0|||
125210418|NCT01066793|450395577|FG004|Overall Study|Lack of Efficacy|0|||
125210419|NCT01066793|450395578|FG005|Overall Study|Lack of Efficacy|0|||
125210420|NCT01066793|450395573|FG000|Overall Study|Lost to Follow-up|180|||
125210421|NCT01066793|450395574|FG001|Overall Study|Lost to Follow-up|39|||
125210422|NCT01066793|450395575|FG002|Overall Study|Lost to Follow-up|82|||
125651344|NCT01243762|452007956|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
125651345|NCT01243762|452007950|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
125651346|NCT01243762|452007951|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
125651347|NCT01243762|452007952|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
125651348|NCT01243762|452007953|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
125651349|NCT01243762|452007954|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
125651350|NCT01243762|452007955|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
125651351|NCT01243762|452007956|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
125651352|NCT01243762|452007950|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
125651353|NCT01243762|452007951|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
125651354|NCT01243762|452007952|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
125651355|NCT01243762|452007953|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
125651356|NCT01243762|452007954|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
125651357|NCT01243762|452007955|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
125651358|NCT01243762|452007956|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
125651359|NCT02059265|452007957|FG000|Overall Study|Ineligible|4|||
125651360|NCT04753606|452007962|FG000|Overall Study|Adverse Event|1|||
125651361|NCT04753606|452007963|FG001|Overall Study|Adverse Event|0|||
125651362|NCT04753606|452007964|FG002|Overall Study|Adverse Event|0|||
125651363|NCT04145531|452007970|FG000|Part A|Adverse Event|2|||
125651364|NCT04145531|452007971|FG001|Part A|Adverse Event|12|||
125651365|NCT04145531|452007972|FG002|Part A|Adverse Event|6|||
125210423|NCT01066793|450395576|FG003|Overall Study|Lost to Follow-up|16|||
125210424|NCT01066793|450395577|FG004|Overall Study|Lost to Follow-up|0|||
125210425|NCT01066793|450395578|FG005|Overall Study|Lost to Follow-up|1|||
125210426|NCT01066793|450395573|FG000|Overall Study|Physician Decision|3|||
125210427|NCT01066793|450395574|FG001|Overall Study|Physician Decision|0|||
125210428|NCT01066793|450395575|FG002|Overall Study|Physician Decision|0|||
125210429|NCT01066793|450395576|FG003|Overall Study|Physician Decision|0|||
125210430|NCT01066793|450395577|FG004|Overall Study|Physician Decision|0|||
125210431|NCT01066793|450395578|FG005|Overall Study|Physician Decision|0|||
125210432|NCT01066793|450395573|FG000|Overall Study|Protocol Violation|3|||
125210433|NCT01066793|450395574|FG001|Overall Study|Protocol Violation|2|||
125210434|NCT01066793|450395575|FG002|Overall Study|Protocol Violation|2|||
125210435|NCT01066793|450395576|FG003|Overall Study|Protocol Violation|0|||
125210436|NCT01066793|450395577|FG004|Overall Study|Protocol Violation|0|||
125210437|NCT01066793|450395578|FG005|Overall Study|Protocol Violation|0|||
125210438|NCT01066793|450395573|FG000|Overall Study|Withdrawal by Subject|7|||
125210439|NCT01066793|450395574|FG001|Overall Study|Withdrawal by Subject|4|||
125210440|NCT01066793|450395575|FG002|Overall Study|Withdrawal by Subject|1|||
125210441|NCT01066793|450395576|FG003|Overall Study|Withdrawal by Subject|0|||
125210442|NCT01066793|450395577|FG004|Overall Study|Withdrawal by Subject|0|||
125210443|NCT01066793|450395578|FG005|Overall Study|Withdrawal by Subject|0|||
125210444|NCT01066793|450395573|FG000|Overall Study|Early Termination|3|||
125210445|NCT01066793|450395574|FG001|Overall Study|Early Termination|0|||
125210446|NCT01066793|450395575|FG002|Overall Study|Early Termination|0|||
125210447|NCT01066793|450395576|FG003|Overall Study|Early Termination|0|||
125210448|NCT01066793|450395577|FG004|Overall Study|Early Termination|0|||
125210449|NCT01066793|450395578|FG005|Overall Study|Early Termination|0|||
125210450|NCT01066793|450395573|FG000|Overall Study|Lab test not done|7|||
125210451|NCT01066793|450395574|FG001|Overall Study|Lab test not done|0|||
125210452|NCT01066793|450395575|FG002|Overall Study|Lab test not done|0|||
125210453|NCT01066793|450395576|FG003|Overall Study|Lab test not done|1|||
125210454|NCT01066793|450395577|FG004|Overall Study|Lab test not done|0|||
125210455|NCT01066793|450395578|FG005|Overall Study|Lab test not done|0|||
125210456|NCT01066793|450395573|FG000|Overall Study|Miscellaneous|4|||
125210457|NCT01066793|450395574|FG001|Overall Study|Miscellaneous|5|||
125210458|NCT01066793|450395575|FG002|Overall Study|Miscellaneous|6|||
125210459|NCT01066793|450395576|FG003|Overall Study|Miscellaneous|0|||
125210460|NCT01066793|450395577|FG004|Overall Study|Miscellaneous|0|||
125210461|NCT01066793|450395578|FG005|Overall Study|Miscellaneous|0|||
125210462|NCT01066793|450395573|FG000|Overall Study|Non-responders|104|||
125210463|NCT01066793|450395574|FG001|Overall Study|Non-responders|5|||
125210464|NCT01066793|450395575|FG002|Overall Study|Non-responders|11|||
125210465|NCT01066793|450395576|FG003|Overall Study|Non-responders|25|||
125210466|NCT01066793|450395577|FG004|Overall Study|Non-responders|0|||
125210467|NCT01066793|450395578|FG005|Overall Study|Non-responders|0|||
125210468|NCT01066793|450395573|FG000|Overall Study|Other|15|||
125210469|NCT01066793|450395574|FG001|Overall Study|Other|5|||
125210470|NCT01066793|450395575|FG002|Overall Study|Other|6|||
125210471|NCT01066793|450395576|FG003|Overall Study|Other|2|||
125210472|NCT01066793|450395577|FG004|Overall Study|Other|0|||
125210473|NCT01066793|450395578|FG005|Overall Study|Other|0|||
125210474|NCT01066793|450395573|FG000|Overall Study|Relapse|20|||
125210475|NCT01066793|450395574|FG001|Overall Study|Relapse|8|||
125210476|NCT01066793|450395575|FG002|Overall Study|Relapse|2|||
125210477|NCT01066793|450395576|FG003|Overall Study|Relapse|3|||
125210478|NCT01066793|450395577|FG004|Overall Study|Relapse|0|||
125651366|NCT04145531|452007973|FG003|Part A|Adverse Event|0|||
125651367|NCT04145531|452007970|FG000|Part A|Death|1|||
125651368|NCT04145531|452007971|FG001|Part A|Death|2|||
125651369|NCT04145531|452007972|FG002|Part A|Death|0|||
125651370|NCT04145531|452007973|FG003|Part A|Death|0|||
125651371|NCT04145531|452007970|FG000|Part A|Physician Decision|2|||
125651372|NCT04145531|452007971|FG001|Part A|Physician Decision|5|||
125651373|NCT04145531|452007972|FG002|Part A|Physician Decision|2|||
125651374|NCT04145531|452007973|FG003|Part A|Physician Decision|0|||
125651375|NCT04145531|452007970|FG000|Part A|Progressive disease|0|||
125651376|NCT04145531|452007971|FG001|Part A|Progressive disease|2|||
125651377|NCT04145531|452007972|FG002|Part A|Progressive disease|1|||
125651378|NCT04145531|452007973|FG003|Part A|Progressive disease|0|||
125651379|NCT04145531|452007970|FG000|Part A|Protocol deviation|0|||
125651380|NCT04145531|452007971|FG001|Part A|Protocol deviation|0|||
125651381|NCT04145531|452007972|FG002|Part A|Protocol deviation|1|||
125651382|NCT04145531|452007973|FG003|Part A|Protocol deviation|0|||
125651383|NCT04145531|452007970|FG000|Part A|Withdrawal by parent or guardian|1|||
125651384|NCT04145531|452007971|FG001|Part A|Withdrawal by parent or guardian|0|||
125651385|NCT04145531|452007972|FG002|Part A|Withdrawal by parent or guardian|0|||
125651386|NCT04145531|452007973|FG003|Part A|Withdrawal by parent or guardian|0|||
125651387|NCT04145531|452007970|FG000|Part A|Withdrawal by participant|0|||
125651388|NCT04145531|452007971|FG001|Part A|Withdrawal by participant|0|||
125651389|NCT04145531|452007972|FG002|Part A|Withdrawal by participant|1|||
125651390|NCT04145531|452007973|FG003|Part A|Withdrawal by participant|0|||
125651391|NCT04145531|452007970|FG000|Part A|Other|0|||
125651392|NCT04145531|452007971|FG001|Part A|Other|0|||
125651393|NCT04145531|452007972|FG002|Part A|Other|1|||
125651394|NCT04145531|452007973|FG003|Part A|Other|0|||
125651395|NCT04145531|452007970|FG000|Part B|Adverse Event|0|||
125651396|NCT04145531|452007971|FG001|Part B|Adverse Event|0|||
125651397|NCT04145531|452007972|FG002|Part B|Adverse Event|0|||
125651398|NCT04145531|452007973|FG003|Part B|Adverse Event|21|||
125651399|NCT04145531|452007970|FG000|Part B|Physician Decision|0|||
125651400|NCT04145531|452007971|FG001|Part B|Physician Decision|0|||
125651401|NCT04145531|452007972|FG002|Part B|Physician Decision|0|||
125651402|NCT04145531|452007973|FG003|Part B|Physician Decision|7|||
125651403|NCT04145531|452007970|FG000|Part B|Progressive disease|0|||
125651404|NCT04145531|452007971|FG001|Part B|Progressive disease|0|||
125651405|NCT04145531|452007972|FG002|Part B|Progressive disease|0|||
125651406|NCT04145531|452007973|FG003|Part B|Progressive disease|1|||
125651407|NCT04145531|452007970|FG000|Part B|Recurrent disease|0|||
125651408|NCT04145531|452007971|FG001|Part B|Recurrent disease|0|||
125651409|NCT04145531|452007972|FG002|Part B|Recurrent disease|0|||
125651410|NCT04145531|452007973|FG003|Part B|Recurrent disease|1|||
125651411|NCT04145531|452007970|FG000|Part B|Withdrawal by parent or guardian|0|||
125651412|NCT04145531|452007971|FG001|Part B|Withdrawal by parent or guardian|0|||
125651413|NCT04145531|452007972|FG002|Part B|Withdrawal by parent or guardian|0|||
125651414|NCT04145531|452007973|FG003|Part B|Withdrawal by parent or guardian|3|||
125651415|NCT04145531|452007970|FG000|Part B|Withdrawal by participant|0|||
125651416|NCT04145531|452007971|FG001|Part B|Withdrawal by participant|0|||
125651417|NCT04145531|452007972|FG002|Part B|Withdrawal by participant|0|||
125651418|NCT04145531|452007973|FG003|Part B|Withdrawal by participant|1|||
125651419|NCT04145531|452007970|FG000|Part B|Other|0|||
125651420|NCT04145531|452007971|FG001|Part B|Other|0|||
125651421|NCT04145531|452007972|FG002|Part B|Other|0|||
125651422|NCT04145531|452007973|FG003|Part B|Other|1|||
125651423|NCT02985996|452007974|FG000|Overall Study|Withdrawal by Subject|0|||
125651424|NCT02985996|452007975|FG001|Overall Study|Withdrawal by Subject|0|||
125651425|NCT02985996|452007976|FG002|Overall Study|Withdrawal by Subject|1|||
125651426|NCT02985996|452007977|FG003|Overall Study|Withdrawal by Subject|0|||
125651427|NCT02985996|452007978|FG004|Overall Study|Withdrawal by Subject|0|||
125651428|NCT02985996|452007974|FG000|Overall Study|Protocol Violation|0|||
125651429|NCT02985996|452007975|FG001|Overall Study|Protocol Violation|1|||
125425491|NCT00636610|451180491|FG000|Overall Study|Reason for discontinuation not available|3|||
125651430|NCT02985996|452007976|FG002|Overall Study|Protocol Violation|0|||
125651431|NCT02985996|452007977|FG003|Overall Study|Protocol Violation|0|||
125651432|NCT02985996|452007978|FG004|Overall Study|Protocol Violation|0|||
125651433|NCT00442572|452007979|FG000|Overall Study|Relapse|8|||
125651434|NCT00442572|452007980|FG001|Overall Study|Relapse|1|||
125651435|NCT00442572|452007979|FG000|Overall Study|Lost to Follow-up|0|||
125651436|NCT00442572|452007980|FG001|Overall Study|Lost to Follow-up|1|||
125651437|NCT00442572|452007979|FG000|Overall Study|Withdrawal by Subject|0|||
125651438|NCT00442572|452007980|FG001|Overall Study|Withdrawal by Subject|1|||
125651439|NCT04246593|452007984|FG000|Overall Study|Withdrawal by Subject|14|||
125651440|NCT04246593|452007985|FG001|Overall Study|Withdrawal by Subject|13|||
125651441|NCT04246593|452007984|FG000|Overall Study|Lost to Follow-up|124|||
125651442|NCT04246593|452007985|FG001|Overall Study|Lost to Follow-up|71|||
125651443|NCT04246593|452007984|FG000|Overall Study|Moved out of area/became ineligible|3|||
125651444|NCT04246593|452007985|FG001|Overall Study|Moved out of area/became ineligible|1|||
125651445|NCT04246593|452007984|FG000|Overall Study|Reason unknown|4|||
125651446|NCT04246593|452007985|FG001|Overall Study|Reason unknown|2|||
125651447|NCT02058849|452007988|FG000|Overall Study|Hospitalization|1|||
125651448|NCT02058849|452007989|FG001|Overall Study|Hospitalization|1|||
125651449|NCT02058849|452007988|FG000|Overall Study|Death|1|||
125651450|NCT02058849|452007989|FG001|Overall Study|Death|0|||
125651451|NCT02058849|452007988|FG000|Overall Study|Lost to Follow-up|1|||
125651452|NCT02058849|452007989|FG001|Overall Study|Lost to Follow-up|0|||
125651453|NCT02058849|452007988|FG000|Overall Study|Withdrawal by Subject|4|||
125651454|NCT02058849|452007989|FG001|Overall Study|Withdrawal by Subject|0|||
125651455|NCT02260804|452007996|FG000|Induction Study Period|Protocol Violation|2|||
125651456|NCT02260804|452007997|FG001|Induction Study Period|Protocol Violation|0|||
125651457|NCT02260804|452007996|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
125651458|NCT02260804|452007997|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
125651459|NCT02260804|452007996|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
125651460|NCT02260804|452007997|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
125651461|NCT02260804|452007996|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
125651462|NCT02260804|452007997|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
125651463|NCT02260804|452007996|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
125651464|NCT02260804|452007997|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
125651465|NCT02260804|452007996|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
125651466|NCT02260804|452007997|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
125651467|NCT02260804|452007996|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
125651468|NCT02260804|452007997|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
125651469|NCT02260804|452007996|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
125651470|NCT02260804|452007997|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
125651471|NCT02260804|452007996|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
125651472|NCT02260804|452007997|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
125651473|NCT02260804|452007996|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
125651474|NCT02260804|452007997|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
125651475|NCT02260804|452007996|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
125651476|NCT02260804|452007997|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
125651477|NCT02207413|452007998|FG000|Overall Study|Withdrawal by Subject|1|||
125651478|NCT02207413|452007999|FG001|Overall Study|Withdrawal by Subject|0|||
125651479|NCT02207413|452008000|FG002|Overall Study|Withdrawal by Subject|0|||
125651480|NCT02207413|452008001|FG003|Overall Study|Withdrawal by Subject|0|||
125651481|NCT02207413|452008002|FG004|Overall Study|Withdrawal by Subject|3|||
125651482|NCT02207413|452008003|FG005|Overall Study|Withdrawal by Subject|7|||
125651483|NCT02207413|452007998|FG000|Overall Study|Lost to Follow-up|0|||
125651484|NCT02207413|452007999|FG001|Overall Study|Lost to Follow-up|0|||
125651485|NCT02207413|452008000|FG002|Overall Study|Lost to Follow-up|0|||
125651486|NCT02207413|452008001|FG003|Overall Study|Lost to Follow-up|1|||
125651487|NCT02207413|452008002|FG004|Overall Study|Lost to Follow-up|1|||
125651488|NCT02207413|452008003|FG005|Overall Study|Lost to Follow-up|5|||
125651489|NCT02207413|452007998|FG000|Overall Study|Adverse Event|0|||
125651490|NCT02207413|452007999|FG001|Overall Study|Adverse Event|0|||
125651491|NCT02207413|452008000|FG002|Overall Study|Adverse Event|0|||
125651492|NCT02207413|452008001|FG003|Overall Study|Adverse Event|0|||
125651493|NCT02207413|452008002|FG004|Overall Study|Adverse Event|2|||
125651494|NCT02207413|452008003|FG005|Overall Study|Adverse Event|1|||
125651495|NCT02207413|452007998|FG000|Overall Study|Migrated/moved from study area|0|||
125651496|NCT02207413|452007999|FG001|Overall Study|Migrated/moved from study area|0|||
125651497|NCT02207413|452008000|FG002|Overall Study|Migrated/moved from study area|0|||
125651498|NCT02207413|452008001|FG003|Overall Study|Migrated/moved from study area|0|||
125651499|NCT02207413|452008002|FG004|Overall Study|Migrated/moved from study area|1|||
125651500|NCT02207413|452008003|FG005|Overall Study|Migrated/moved from study area|0|||
125651501|NCT01241591|452009720|FG000|Overall Study|Lack of Efficacy|5|||
125651502|NCT01241591|452009721|FG001|Overall Study|Lack of Efficacy|2|||
125651503|NCT01241591|452009722|FG002|Overall Study|Lack of Efficacy|2|||
125651504|NCT01241591|452009723|FG003|Overall Study|Lack of Efficacy|3|||
125651505|NCT01241591|452009720|FG000|Overall Study|Protocol Violation|5|||
125651506|NCT01241591|452009721|FG001|Overall Study|Protocol Violation|2|||
125651507|NCT01241591|452009722|FG002|Overall Study|Protocol Violation|3|||
125651508|NCT01241591|452009723|FG003|Overall Study|Protocol Violation|0|||
125651509|NCT01241591|452009720|FG000|Overall Study|Lost to Follow-up|1|||
125210479|NCT01066793|450395578|FG005|Overall Study|Relapse|0|||
125210480|NCT01066793|450395573|FG000|Overall Study|Result Not Available|1|||
125651510|NCT01241591|452009721|FG001|Overall Study|Lost to Follow-up|2|||
125651511|NCT01241591|452009722|FG002|Overall Study|Lost to Follow-up|2|||
125651512|NCT01241591|452009723|FG003|Overall Study|Lost to Follow-up|2|||
125651513|NCT01241591|452009720|FG000|Overall Study|Screen Failure|3|||
125651514|NCT01241591|452009721|FG001|Overall Study|Screen Failure|2|||
125651515|NCT01241591|452009722|FG002|Overall Study|Screen Failure|1|||
125651516|NCT01241591|452009723|FG003|Overall Study|Screen Failure|0|||
125651517|NCT01241591|452009720|FG000|Overall Study|Withdrawal by Subject|6|||
125651518|NCT01241591|452009721|FG001|Overall Study|Withdrawal by Subject|4|||
125651519|NCT01241591|452009722|FG002|Overall Study|Withdrawal by Subject|2|||
125651520|NCT01241591|452009723|FG003|Overall Study|Withdrawal by Subject|2|||
125651521|NCT01241591|452009720|FG000|Overall Study|Other|0|||
125651522|NCT01241591|452009721|FG001|Overall Study|Other|1|||
125651523|NCT01241591|452009722|FG002|Overall Study|Other|0|||
125651524|NCT01241591|452009723|FG003|Overall Study|Other|1|||
125651525|NCT01241591|452009720|FG000|Overall Study|Adverse Event|3|||
125651526|NCT01241591|452009721|FG001|Overall Study|Adverse Event|11|||
125651527|NCT01241591|452009722|FG002|Overall Study|Adverse Event|12|||
125651528|NCT01241591|452009723|FG003|Overall Study|Adverse Event|4|||
125651529|NCT02147132|452009724|FG000|Overall Study|Lost to Follow-up|1|||
125651530|NCT02147132|452009725|FG001|Overall Study|Lost to Follow-up|0|||
125651531|NCT02147132|452009726|FG002|Overall Study|Lost to Follow-up|0|||
125651532|NCT02147132|452009727|FG003|Overall Study|Lost to Follow-up|0|||
125651533|NCT01798056|452009728|FG000|Overall Study|Serious Adverse Event|13|||
125651534|NCT01798056|452009729|FG001|Overall Study|Serious Adverse Event|12|||
125651535|NCT01798056|452009728|FG000|Overall Study|Withdrawal by Subject|12|||
125651536|NCT01798056|452009729|FG001|Overall Study|Withdrawal by Subject|9|||
125651537|NCT01798056|452009728|FG000|Overall Study|Migrated/moved from study area|1|||
125651538|NCT01798056|452009729|FG001|Overall Study|Migrated/moved from study area|1|||
125651539|NCT01798056|452009728|FG000|Overall Study|Lost to Follow-up|1|||
125651540|NCT01798056|452009729|FG001|Overall Study|Lost to Follow-up|1|||
125651541|NCT01798056|452009728|FG000|Overall Study|Other|0|||
125651542|NCT01798056|452009729|FG001|Overall Study|Other|2|||
125651543|NCT02842736|452009732|FG000|Overall Study|Lost to Follow-up|13|||
125651544|NCT02842736|452009732|FG000|Overall Study|Intervention for menstrual bleeding|17|||
125651545|NCT02842736|452009732|FG000|Overall Study|Withdrawal by Subject|4|||
125651546|NCT02842736|452009732|FG000|Overall Study|Pregnancy|3|||
125651547|NCT02842736|452009732|FG000|Overall Study|Hysterectomy for fibroids|2|||
125651548|NCT02842736|452009732|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
125651549|NCT02842736|452009732|FG000|Overall Study|IUD: Mirena|1|||
125651550|NCT02646566|452009733|FG000|Overall Study|Lost to Follow-up|5|||
125651551|NCT02646566|452009734|FG001|Overall Study|Lost to Follow-up|4|||
125651552|NCT02646566|452009735|FG002|Overall Study|Lost to Follow-up|5|||
125651553|NCT02646566|452009733|FG000|Overall Study|Treatment failure|1|||
125651554|NCT02646566|452009734|FG001|Overall Study|Treatment failure|0|||
125651555|NCT02646566|452009735|FG002|Overall Study|Treatment failure|0|||
125651556|NCT02815540|452009738|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
125651557|NCT02222246|452009739|FG000|Overall Study|No Emergency Department Visits|27|||
125651558|NCT02222246|452009740|FG001|Overall Study|No Emergency Department Visits|26|||
125651559|NCT02222246|452009739|FG000|Overall Study|Physician Decision|0|||
125651560|NCT02222246|452009740|FG001|Overall Study|Physician Decision|1|||
125651561|NCT02064231|452009741|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
125651562|NCT02064231|452009742|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
125651563|NCT02064231|452009743|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
125651564|NCT02064231|452009744|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
125651565|NCT02064231|452009741|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
125651566|NCT02064231|452009742|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
125651567|NCT02064231|452009743|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
125313894|NCT01454596|450777439|FG006|Overall Study|Death|0|||
125313895|NCT01454596|450777440|FG007|Overall Study|Death|0|||
125313896|NCT01454596|450777441|FG008|Overall Study|Death|0|||
125313897|NCT01454596|450777442|FG009|Overall Study|Death|1|||
125313898|NCT01454596|450777443|FG010|Overall Study|Death|1|||
125651568|NCT02064231|452009744|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
125651569|NCT02064231|452009741|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
125651570|NCT02064231|452009742|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
125651571|NCT02064231|452009743|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
125651572|NCT02064231|452009744|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
125651573|NCT02064231|452009741|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
125210481|NCT01066793|450395574|FG001|Overall Study|Result Not Available|0|||
125210482|NCT01066793|450395575|FG002|Overall Study|Result Not Available|0|||
125210483|NCT01066793|450395576|FG003|Overall Study|Result Not Available|0|||
125210484|NCT01066793|450395577|FG004|Overall Study|Result Not Available|0|||
125210485|NCT01066793|450395578|FG005|Overall Study|Result Not Available|0|||
125210486|NCT01066793|450395573|FG000|Overall Study|Treatment Interrupted|1|||
125210487|NCT01066793|450395574|FG001|Overall Study|Treatment Interrupted|1|||
125210488|NCT01066793|450395575|FG002|Overall Study|Treatment Interrupted|0|||
125210489|NCT01066793|450395576|FG003|Overall Study|Treatment Interrupted|0|||
125313899|NCT01454596|450777444|FG011|Overall Study|Death|0|||
125651574|NCT02064231|452009742|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
125651575|NCT02064231|452009743|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
125651576|NCT02064231|452009744|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
125651577|NCT04621227|452009745|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
125210490|NCT01066793|450395577|FG004|Overall Study|Treatment Interrupted|0|||
125651578|NCT04621227|452009745|FG000|Period 3 (29 Days)|Adverse Event|1|||
125651579|NCT04621227|452009745|FG000|Period 8 (2 Days)|Adverse Event|1|||
125651580|NCT01548573|452009746|FG000|Overall Study|Death|3|||
125651581|NCT01548573|452009746|FG000|Overall Study|Withdrawal by Subject|2|||
125651582|NCT01366846|452009749|FG000|Overall Study|Withdrawal by Subject|2|||
125651583|NCT01366846|452009750|FG001|Overall Study|Withdrawal by Subject|0|||
125651584|NCT01366846|452009751|FG002|Overall Study|Withdrawal by Subject|0|||
125651585|NCT01366846|452009752|FG003|Overall Study|Withdrawal by Subject|0|||
125651586|NCT01366846|452009749|FG000|Overall Study|Communication Difficulties|1|||
125651587|NCT01366846|452009750|FG001|Overall Study|Communication Difficulties|4|||
125651588|NCT01366846|452009751|FG002|Overall Study|Communication Difficulties|0|||
125651589|NCT01366846|452009752|FG003|Overall Study|Communication Difficulties|1|||
125651590|NCT01366846|452009749|FG000|Overall Study|Scheduling Conflicts|0|||
125651591|NCT01366846|452009750|FG001|Overall Study|Scheduling Conflicts|0|||
125651592|NCT01366846|452009751|FG002|Overall Study|Scheduling Conflicts|1|||
125651593|NCT01366846|452009752|FG003|Overall Study|Scheduling Conflicts|0|||
125651594|NCT00558831|452009753|FG000|Overall Study|Lost to Follow-up|1|||
125651595|NCT01342445|452009754|FG000|Overall Study|Experienced side effects|0|||
125651596|NCT01342445|452009755|FG001|Overall Study|Experienced side effects|2|||
125651597|NCT05299359|452009756|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
125651598|NCT05299359|452009757|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
125651599|NCT05299359|452009756|FG000|Main Part: Day 1 up to Day 366|Other|2|||
125651600|NCT05299359|452009757|FG001|Main Part: Day 1 up to Day 366|Other|0|||
125651601|NCT05299359|452009756|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
125651602|NCT05299359|452009757|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
125651603|NCT05299359|452009756|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
125651604|NCT05299359|452009757|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
125651605|NCT05299359|452009756|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
125651606|NCT05299359|452009757|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
125651607|NCT05299359|452009756|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
125651608|NCT05299359|452009757|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
125651609|NCT05299359|452009756|FG000|Extension Part: Day 1 to Day 366|Other|0|||
125651610|NCT05299359|452009757|FG001|Extension Part: Day 1 to Day 366|Other|1|||
125651611|NCT02392078|452009758|FG000|Overall Study|Did not have procedure|32|||
125651612|NCT02392078|452009759|FG001|Overall Study|Did not have procedure|43|||
125651613|NCT02392078|452009760|FG002|Overall Study|Did not have procedure|20|||
125651614|NCT02392078|452009761|FG003|Overall Study|Did not have procedure|1|||
125651615|NCT02652793|452009764|FG000|Overall Study|Adverse Event|1|||
125651616|NCT02652793|452009764|FG000|Overall Study|Lost to Follow-up|2|||
125651617|NCT02652793|452009764|FG000|Overall Study|Withdrawal by Subject|1|||
125651618|NCT02957149|452009765|FG000|Overall Study|Withdrawal by Subject|5|||
125651619|NCT04579666|452009766|FG000|RTP (Up to Week 52)|Adverse Event|4|||
125651620|NCT04579666|452009767|FG001|RTP (Up to Week 52)|Adverse Event|3|||
125651621|NCT04579666|452009768|FG002|RTP (Up to Week 52)|Adverse Event|0|||
125651622|NCT04579666|452009769|FG003|RTP (Up to Week 52)|Adverse Event|0|||
125651623|NCT04579666|452009766|FG000|RTP (Up to Week 52)|Death|24|||
125651624|NCT04579666|452009767|FG001|RTP (Up to Week 52)|Death|9|||
125651625|NCT04579666|452009768|FG002|RTP (Up to Week 52)|Death|0|||
125651626|NCT04579666|452009769|FG003|RTP (Up to Week 52)|Death|0|||
125651627|NCT04579666|452009766|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
125651628|NCT04579666|452009767|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
125651629|NCT04579666|452009768|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
125651630|NCT04579666|452009769|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
125651631|NCT04579666|452009766|FG000|RTP (Up to Week 52)|Physician Decision|4|||
125210491|NCT01066793|450395578|FG005|Overall Study|Treatment Interrupted|0|||
125210492|NCT01066793|450395573|FG000|Overall Study|Treatment Never Started|18|||
125210493|NCT01066793|450395574|FG001|Overall Study|Treatment Never Started|5|||
125210494|NCT01066793|450395575|FG002|Overall Study|Treatment Never Started|4|||
125651632|NCT04579666|452009767|FG001|RTP (Up to Week 52)|Physician Decision|1|||
125651633|NCT04579666|452009768|FG002|RTP (Up to Week 52)|Physician Decision|0|||
125210495|NCT01066793|450395576|FG003|Overall Study|Treatment Never Started|1|||
125651634|NCT04579666|452009769|FG003|RTP (Up to Week 52)|Physician Decision|0|||
125651635|NCT04579666|452009766|FG000|RTP (Up to Week 52)|Progressive disease|1|||
125651636|NCT04579666|452009767|FG001|RTP (Up to Week 52)|Progressive disease|0|||
125210496|NCT01066793|450395577|FG004|Overall Study|Treatment Never Started|0|||
125210497|NCT01066793|450395578|FG005|Overall Study|Treatment Never Started|0|||
125210498|NCT01066793|450395573|FG000|Overall Study|Treatment Stopped|2|||
125651637|NCT04579666|452009768|FG002|RTP (Up to Week 52)|Progressive disease|0|||
125651638|NCT04579666|452009769|FG003|RTP (Up to Week 52)|Progressive disease|0|||
125651639|NCT04579666|452009766|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
125651640|NCT04579666|452009767|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
125651641|NCT04579666|452009768|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
125651642|NCT04579666|452009769|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
125651643|NCT04579666|452009766|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
125651644|NCT04579666|452009767|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
125651645|NCT04579666|452009768|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
125651646|NCT04579666|452009769|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
125651647|NCT04579666|452009766|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
125651648|NCT04579666|452009767|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
125651649|NCT04579666|452009768|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
125651650|NCT04579666|452009769|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
125651651|NCT04579666|452009766|FG000|RTP (Up to Week 52)|Other|2|||
125651652|NCT04579666|452009767|FG001|RTP (Up to Week 52)|Other|0|||
125651653|NCT04579666|452009768|FG002|RTP (Up to Week 52)|Other|0|||
125651654|NCT04579666|452009769|FG003|RTP (Up to Week 52)|Other|0|||
125651655|NCT04579666|452009766|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
125651656|NCT04579666|452009767|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
125651657|NCT04579666|452009768|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
125651658|NCT04579666|452009769|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
125651659|NCT04579666|452009766|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
125651660|NCT04579666|452009767|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
125651661|NCT04579666|452009768|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
125651662|NCT04579666|452009769|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
125651663|NCT04579666|452009766|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
125651664|NCT04579666|452009767|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
125651665|NCT04579666|452009768|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
125651666|NCT04579666|452009769|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
125651667|NCT04579666|452009766|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
125651668|NCT04579666|452009767|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
125651669|NCT04579666|452009768|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
125651670|NCT04579666|452009769|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
125651671|NCT04579666|452009766|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
125651672|NCT04579666|452009767|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
125651673|NCT04579666|452009768|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
125651674|NCT04579666|452009769|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
125651675|NCT05450198|452009770|FG000|Overall Study|Withdrawal by Subject|1|||
125651676|NCT05450198|452009771|FG001|Overall Study|Withdrawal by Subject|1|||
125651677|NCT05450198|452009772|FG002|Overall Study|Withdrawal by Subject|2|||
125651678|NCT05450198|452009773|FG003|Overall Study|Withdrawal by Subject|0|||
125651679|NCT05450198|452009770|FG000|Overall Study|Lost to Follow-up|1|||
125651680|NCT05450198|452009771|FG001|Overall Study|Lost to Follow-up|0|||
125651681|NCT05450198|452009772|FG002|Overall Study|Lost to Follow-up|2|||
125651682|NCT05450198|452009773|FG003|Overall Study|Lost to Follow-up|1|||
125651683|NCT04359758|452009777|FG000|Overall Study|Protocol Violation|3|||
125651684|NCT04359758|452009778|FG001|Overall Study|Protocol Violation|2|||
125651685|NCT01748162|452009779|FG000|Overall Study|no additional croup episodes to evaluate|2|||
125651686|NCT01748162|452009780|FG001|Overall Study|no additional croup episodes to evaluate|2|||
125651687|NCT01748162|452009779|FG000|Overall Study|participant consented but did not begin|0|||
125651688|NCT01748162|452009780|FG001|Overall Study|participant consented but did not begin|1|||
125651689|NCT01748162|452009779|FG000|Overall Study|reasons not available|3|||
125651690|NCT01748162|452009780|FG001|Overall Study|reasons not available|2|||
125651691|NCT00505765|452009781|FG000|Overall Study|Withdrawal by Subject|1|||
125651692|NCT00505765|452009782|FG001|Overall Study|Withdrawal by Subject|0|||
125651693|NCT00505765|452009783|FG002|Overall Study|Withdrawal by Subject|0|||
125651694|NCT00505765|452009781|FG000|Overall Study|Adverse Event|1|||
125651695|NCT00505765|452009782|FG001|Overall Study|Adverse Event|2|||
125651696|NCT00505765|452009783|FG002|Overall Study|Adverse Event|0|||
125651697|NCT00505765|452009781|FG000|Overall Study|Noncompliance|0|||
125651698|NCT00505765|452009782|FG001|Overall Study|Noncompliance|1|||
125651699|NCT00505765|452009783|FG002|Overall Study|Noncompliance|3|||
125651700|NCT03841331|452009784|FG000|Overall Study|Withdrawal by Subject|4|||
125651701|NCT03841331|452009785|FG001|Overall Study|Withdrawal by Subject|9|||
125651702|NCT03841331|452009784|FG000|Overall Study|Lost to Follow-up|5|||
125651703|NCT03841331|452009785|FG001|Overall Study|Lost to Follow-up|1|||
125651704|NCT02743117|452009786|FG000|Overall Study|Lost to Follow-up|0|||
125313900|NCT00857285|450777445|FG000|Overall Study|Adverse Event|4|||
125651705|NCT02743117|452009787|FG001|Overall Study|Lost to Follow-up|1|||
125651706|NCT02743117|452009786|FG000|Overall Study|Other|1|||
125651707|NCT02743117|452009787|FG001|Overall Study|Other|0|||
125651708|NCT01207219|452009788|FG000|Overall Study|changed diagnosis during study period|5|||
125651709|NCT01207219|452009789|FG001|Overall Study|changed diagnosis during study period|3|||
125651710|NCT01207219|452009790|FG002|Overall Study|changed diagnosis during study period|1|||
125651711|NCT01207219|452009788|FG000|Overall Study|Lost to Follow-up|6|||
125651712|NCT01207219|452009789|FG001|Overall Study|Lost to Follow-up|8|||
125651713|NCT01207219|452009790|FG002|Overall Study|Lost to Follow-up|6|||
125651714|NCT03532048|452009792|FG000|Overall Study|Lost to Follow-up|12|||
125651715|NCT03532048|452009793|FG001|Overall Study|Lost to Follow-up|17|||
125651716|NCT03532048|452009792|FG000|Overall Study|Withdrawal by Subject|7|||
125651717|NCT03532048|452009793|FG001|Overall Study|Withdrawal by Subject|0|||
125651718|NCT01901393|452009796|FG000|Overall Study|Adverse Event|1|||
125651719|NCT01901393|452009797|FG001|Overall Study|Adverse Event|0|||
125651720|NCT04585906|452009798|FG000|Overall Study|Lost to Follow-up|8|||
125651721|NCT04585906|452009799|FG001|Overall Study|Lost to Follow-up|5|||
125651722|NCT00634933|452009804|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
125651723|NCT00634933|452009805|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
125651724|NCT00634933|452009806|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
125651725|NCT00634933|452009807|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
125651726|NCT00634933|452009808|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
125651727|NCT00634933|452009804|FG000|Part A: Baseline to Week 24|Death|1|||
125651728|NCT00634933|452009805|FG001|Part A: Baseline to Week 24|Death|0|||
125651729|NCT00634933|452009806|FG002|Part A: Baseline to Week 24|Death|0|||
125651730|NCT00634933|452009807|FG003|Part A: Baseline to Week 24|Death|0|||
125651731|NCT00634933|452009808|FG004|Part A: Baseline to Week 24|Death|0|||
125651732|NCT00634933|452009804|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
125651733|NCT00634933|452009805|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
125651734|NCT00634933|452009806|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
125651735|NCT00634933|452009807|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
125651736|NCT00634933|452009808|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
125651737|NCT00634933|452009804|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
125651738|NCT00634933|452009805|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
125651739|NCT00634933|452009806|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
125651740|NCT00634933|452009807|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
125651741|NCT00634933|452009808|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
125651742|NCT00634933|452009804|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
125651743|NCT00634933|452009805|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
125651744|NCT00634933|452009806|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
125651745|NCT00634933|452009807|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
125651746|NCT00634933|452009808|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
125651747|NCT00634933|452009804|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
125651748|NCT00634933|452009805|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
125651749|NCT00634933|452009806|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
125651750|NCT00634933|452009807|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
125651751|NCT00634933|452009808|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
125651752|NCT00634933|452009804|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
125651753|NCT00634933|452009805|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
125651754|NCT00634933|452009806|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
125651755|NCT00634933|452009807|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
125651756|NCT00634933|452009808|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
125651757|NCT00634933|452009804|FG000|Part A: Baseline to Week 24|Other|1|||
125651758|NCT00634933|452009805|FG001|Part A: Baseline to Week 24|Other|8|||
125651759|NCT00634933|452009806|FG002|Part A: Baseline to Week 24|Other|5|||
125651760|NCT00634933|452009807|FG003|Part A: Baseline to Week 24|Other|0|||
125651761|NCT00634933|452009808|FG004|Part A: Baseline to Week 24|Other|0|||
125651762|NCT00634933|452009804|FG000|Between Part A and Part B|Physician Decision|0|||
125651763|NCT00634933|452009805|FG001|Between Part A and Part B|Physician Decision|1|||
125651764|NCT00634933|452009806|FG002|Between Part A and Part B|Physician Decision|0|||
125651765|NCT00634933|452009807|FG003|Between Part A and Part B|Physician Decision|0|||
125651766|NCT00634933|452009808|FG004|Between Part A and Part B|Physician Decision|0|||
125651767|NCT00634933|452009804|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
125651768|NCT00634933|452009805|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
125651769|NCT00634933|452009806|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
125651770|NCT00634933|452009807|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
125651771|NCT00634933|452009808|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
125651772|NCT00634933|452009804|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
125651773|NCT00634933|452009805|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
125651774|NCT00634933|452009806|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
125651775|NCT00634933|452009807|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
125651776|NCT00634933|452009808|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
125651777|NCT00634933|452009804|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
125651778|NCT00634933|452009805|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
125651779|NCT00634933|452009806|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
125651780|NCT00634933|452009807|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
125210499|NCT01066793|450395574|FG001|Overall Study|Treatment Stopped|1|||
125210500|NCT01066793|450395575|FG002|Overall Study|Treatment Stopped|0|||
125651781|NCT00634933|452009808|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
125651782|NCT00634933|452009804|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
125651783|NCT00634933|452009805|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
125651784|NCT00634933|452009806|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
125651785|NCT00634933|452009807|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
125651786|NCT00634933|452009808|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
125651787|NCT00634933|452009804|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
125651788|NCT00634933|452009805|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
125651789|NCT00634933|452009806|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
125651790|NCT00634933|452009807|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
125651791|NCT00634933|452009808|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
125651792|NCT00634933|452009804|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
125651793|NCT00634933|452009805|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
125651794|NCT00634933|452009806|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
125651795|NCT00634933|452009807|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
125651796|NCT00634933|452009808|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
125651797|NCT00634933|452009804|FG000|Part B: Week 24 to Week 52|Other|0|||
125651798|NCT00634933|452009805|FG001|Part B: Week 24 to Week 52|Other|0|||
125651799|NCT00634933|452009806|FG002|Part B: Week 24 to Week 52|Other|5|||
125651800|NCT00634933|452009807|FG003|Part B: Week 24 to Week 52|Other|0|||
125651801|NCT00634933|452009808|FG004|Part B: Week 24 to Week 52|Other|1|||
125651802|NCT01049360|452009809|FG000|Period 1|Adverse Event|0|||
125651803|NCT01049360|452009810|FG001|Period 1|Adverse Event|1|||
125651804|NCT01049360|452009811|FG002|Period 1|Adverse Event|0|||
125651805|NCT01049360|452009812|FG003|Period 1|Adverse Event|1|||
125651806|NCT01049360|452009813|FG004|Period 1|Adverse Event|0|||
125651807|NCT01049360|452009814|FG005|Period 1|Adverse Event|0|||
125651808|NCT01049360|452009815|FG006|Period 1|Adverse Event|0|||
125651809|NCT01049360|452009816|FG007|Period 1|Adverse Event|1|||
125651810|NCT01049360|452009817|FG008|Period 1|Adverse Event|0|||
125651811|NCT01049360|452009818|FG009|Period 1|Adverse Event|0|||
125651812|NCT01049360|452009819|FG010|Period 1|Adverse Event|0|||
125651813|NCT01049360|452009820|FG011|Period 1|Adverse Event|0|||
125651814|NCT01049360|452009821|FG012|Period 1|Adverse Event|1|||
125651815|NCT01049360|452009822|FG013|Period 1|Adverse Event|1|||
125651816|NCT01049360|452009823|FG014|Period 1|Adverse Event|0|||
125651817|NCT01049360|452009824|FG015|Period 1|Adverse Event|0|||
125651818|NCT01049360|452009825|FG016|Period 1|Adverse Event|1|||
125651819|NCT01049360|452009826|FG017|Period 1|Adverse Event|0|||
125651820|NCT01049360|452009827|FG018|Period 1|Adverse Event|1|||
125651821|NCT01049360|452009828|FG019|Period 1|Adverse Event|0|||
125651822|NCT01049360|452009809|FG000|Period 1|Did not meet inc/exc criteria|0|||
125651823|NCT01049360|452009810|FG001|Period 1|Did not meet inc/exc criteria|0|||
125651824|NCT01049360|452009811|FG002|Period 1|Did not meet inc/exc criteria|0|||
125651825|NCT01049360|452009812|FG003|Period 1|Did not meet inc/exc criteria|0|||
125651826|NCT01049360|452009813|FG004|Period 1|Did not meet inc/exc criteria|0|||
125651827|NCT01049360|452009814|FG005|Period 1|Did not meet inc/exc criteria|0|||
125651828|NCT01049360|452009815|FG006|Period 1|Did not meet inc/exc criteria|0|||
125651829|NCT01049360|452009816|FG007|Period 1|Did not meet inc/exc criteria|1|||
125651830|NCT01049360|452009817|FG008|Period 1|Did not meet inc/exc criteria|1|||
125651831|NCT01049360|452009818|FG009|Period 1|Did not meet inc/exc criteria|0|||
125651832|NCT01049360|452009819|FG010|Period 1|Did not meet inc/exc criteria|0|||
125651833|NCT01049360|452009820|FG011|Period 1|Did not meet inc/exc criteria|0|||
125651834|NCT01049360|452009821|FG012|Period 1|Did not meet inc/exc criteria|0|||
125651835|NCT01049360|452009822|FG013|Period 1|Did not meet inc/exc criteria|0|||
125651836|NCT01049360|452009823|FG014|Period 1|Did not meet inc/exc criteria|0|||
125651837|NCT01049360|452009824|FG015|Period 1|Did not meet inc/exc criteria|0|||
125651838|NCT01049360|452009825|FG016|Period 1|Did not meet inc/exc criteria|0|||
125651839|NCT01049360|452009826|FG017|Period 1|Did not meet inc/exc criteria|0|||
125651840|NCT01049360|452009827|FG018|Period 1|Did not meet inc/exc criteria|0|||
125651841|NCT01049360|452009828|FG019|Period 1|Did not meet inc/exc criteria|0|||
125651842|NCT01049360|452009809|FG000|Period 1|Withdrawal by Subject|0|||
125651843|NCT01049360|452009810|FG001|Period 1|Withdrawal by Subject|0|||
125651844|NCT01049360|452009811|FG002|Period 1|Withdrawal by Subject|0|||
125651845|NCT01049360|452009812|FG003|Period 1|Withdrawal by Subject|0|||
125651846|NCT01049360|452009813|FG004|Period 1|Withdrawal by Subject|0|||
125651847|NCT01049360|452009814|FG005|Period 1|Withdrawal by Subject|0|||
125651848|NCT01049360|452009815|FG006|Period 1|Withdrawal by Subject|0|||
125651849|NCT01049360|452009816|FG007|Period 1|Withdrawal by Subject|0|||
125540387|NCT02442336|451607610|FG000|Overall Study|Lost to Follow-up|11|||
125540388|NCT00844532|451607612|FG000|Overall Study|Death|16|||
125651850|NCT01049360|452009817|FG008|Period 1|Withdrawal by Subject|1|||
125651851|NCT01049360|452009818|FG009|Period 1|Withdrawal by Subject|0|||
125651852|NCT01049360|452009819|FG010|Period 1|Withdrawal by Subject|1|||
125651853|NCT01049360|452009820|FG011|Period 1|Withdrawal by Subject|0|||
125651854|NCT01049360|452009821|FG012|Period 1|Withdrawal by Subject|1|||
125540389|NCT00844532|451607612|FG000|Overall Study|Withdrawal by Subject|16|||
125540390|NCT00844532|451607612|FG000|Overall Study|Lost to Follow-up|7|||
125540391|NCT03189745|451607613|FG000|Overall Study|Conflict in work schedule of participant|1|||
125540392|NCT03189745|451607614|FG001|Overall Study|Conflict in work schedule of participant|1|||
125540393|NCT00895154|451607615|FG000|Overall Study|Lost to Follow-up|1|||
125540394|NCT00895154|451607616|FG001|Overall Study|Lost to Follow-up|1|||
125540395|NCT00895154|451607615|FG000|Overall Study|Withdrawal by Subject|0|||
125540396|NCT00895154|451607616|FG001|Overall Study|Withdrawal by Subject|1|||
125540397|NCT01993927|451607617|FG000|Overall Study|Case Report Forms Uncollected|18|||
125540398|NCT01993927|451607617|FG000|Overall Study|Protocol Violation|11|||
125540399|NCT00777088|451607618|FG000|Overall Study|PED Treatment not attempted|1|||
125651855|NCT01049360|452009822|FG013|Period 1|Withdrawal by Subject|0|||
125651856|NCT01049360|452009823|FG014|Period 1|Withdrawal by Subject|0|||
125651857|NCT01049360|452009824|FG015|Period 1|Withdrawal by Subject|0|||
125651858|NCT01049360|452009825|FG016|Period 1|Withdrawal by Subject|0|||
125651859|NCT01049360|452009826|FG017|Period 1|Withdrawal by Subject|0|||
125651860|NCT01049360|452009827|FG018|Period 1|Withdrawal by Subject|0|||
125651861|NCT01049360|452009828|FG019|Period 1|Withdrawal by Subject|0|||
125651862|NCT01049360|452009809|FG000|Period 2|Protocol Violation|0|||
125651863|NCT01049360|452009810|FG001|Period 2|Protocol Violation|0|||
125651864|NCT01049360|452009811|FG002|Period 2|Protocol Violation|0|||
125651865|NCT01049360|452009812|FG003|Period 2|Protocol Violation|1|||
125651866|NCT01049360|452009813|FG004|Period 2|Protocol Violation|0|||
125651867|NCT01049360|452009814|FG005|Period 2|Protocol Violation|0|||
125651868|NCT01049360|452009815|FG006|Period 2|Protocol Violation|0|||
125651869|NCT01049360|452009816|FG007|Period 2|Protocol Violation|0|||
125651870|NCT01049360|452009817|FG008|Period 2|Protocol Violation|0|||
125651871|NCT01049360|452009818|FG009|Period 2|Protocol Violation|0|||
125651872|NCT01049360|452009819|FG010|Period 2|Protocol Violation|0|||
125651873|NCT01049360|452009820|FG011|Period 2|Protocol Violation|0|||
125651874|NCT01049360|452009821|FG012|Period 2|Protocol Violation|0|||
125651875|NCT01049360|452009822|FG013|Period 2|Protocol Violation|0|||
125651876|NCT01049360|452009823|FG014|Period 2|Protocol Violation|1|||
125651877|NCT01049360|452009824|FG015|Period 2|Protocol Violation|1|||
125651878|NCT01049360|452009825|FG016|Period 2|Protocol Violation|0|||
125651879|NCT01049360|452009826|FG017|Period 2|Protocol Violation|0|||
125651880|NCT01049360|452009827|FG018|Period 2|Protocol Violation|0|||
125651881|NCT01049360|452009828|FG019|Period 2|Protocol Violation|0|||
125651882|NCT01049360|452009809|FG000|Period 2|Adverse Event|0|||
125651883|NCT01049360|452009810|FG001|Period 2|Adverse Event|1|||
125651884|NCT01049360|452009811|FG002|Period 2|Adverse Event|0|||
125651885|NCT01049360|452009812|FG003|Period 2|Adverse Event|0|||
125651886|NCT01049360|452009813|FG004|Period 2|Adverse Event|0|||
125651887|NCT01049360|452009814|FG005|Period 2|Adverse Event|0|||
125651888|NCT01049360|452009815|FG006|Period 2|Adverse Event|0|||
125651889|NCT01049360|452009816|FG007|Period 2|Adverse Event|0|||
125651890|NCT01049360|452009817|FG008|Period 2|Adverse Event|1|||
125651891|NCT01049360|452009818|FG009|Period 2|Adverse Event|0|||
125651892|NCT01049360|452009819|FG010|Period 2|Adverse Event|0|||
125651893|NCT01049360|452009820|FG011|Period 2|Adverse Event|0|||
125651894|NCT01049360|452009821|FG012|Period 2|Adverse Event|0|||
125651895|NCT01049360|452009822|FG013|Period 2|Adverse Event|0|||
125651896|NCT01049360|452009823|FG014|Period 2|Adverse Event|0|||
125651897|NCT01049360|452009824|FG015|Period 2|Adverse Event|0|||
125651898|NCT01049360|452009825|FG016|Period 2|Adverse Event|0|||
125651899|NCT01049360|452009826|FG017|Period 2|Adverse Event|0|||
125651900|NCT01049360|452009827|FG018|Period 2|Adverse Event|0|||
125651901|NCT01049360|452009828|FG019|Period 2|Adverse Event|1|||
125651902|NCT01049360|452009809|FG000|Period 2|Withdrawal by Subject|0|||
125651903|NCT01049360|452009810|FG001|Period 2|Withdrawal by Subject|0|||
125651904|NCT01049360|452009811|FG002|Period 2|Withdrawal by Subject|0|||
125651905|NCT01049360|452009812|FG003|Period 2|Withdrawal by Subject|1|||
125651906|NCT01049360|452009813|FG004|Period 2|Withdrawal by Subject|0|||
125651907|NCT01049360|452009814|FG005|Period 2|Withdrawal by Subject|0|||
125651908|NCT01049360|452009815|FG006|Period 2|Withdrawal by Subject|0|||
125651909|NCT01049360|452009816|FG007|Period 2|Withdrawal by Subject|0|||
125651910|NCT01049360|452009817|FG008|Period 2|Withdrawal by Subject|0|||
125651911|NCT01049360|452009818|FG009|Period 2|Withdrawal by Subject|0|||
125651912|NCT01049360|452009819|FG010|Period 2|Withdrawal by Subject|0|||
125651913|NCT01049360|452009820|FG011|Period 2|Withdrawal by Subject|0|||
125651914|NCT01049360|452009821|FG012|Period 2|Withdrawal by Subject|0|||
125651915|NCT01049360|452009822|FG013|Period 2|Withdrawal by Subject|0|||
125651916|NCT01049360|452009823|FG014|Period 2|Withdrawal by Subject|1|||
125651917|NCT01049360|452009824|FG015|Period 2|Withdrawal by Subject|0|||
125210501|NCT01066793|450395576|FG003|Overall Study|Treatment Stopped|1|||
125651918|NCT01049360|452009825|FG016|Period 2|Withdrawal by Subject|0|||
125651919|NCT01049360|452009826|FG017|Period 2|Withdrawal by Subject|0|||
125651920|NCT01049360|452009827|FG018|Period 2|Withdrawal by Subject|0|||
125651921|NCT01049360|452009828|FG019|Period 2|Withdrawal by Subject|1|||
125651922|NCT01049360|452009809|FG000|Period 2|Lack of Efficacy|0|||
125651923|NCT01049360|452009810|FG001|Period 2|Lack of Efficacy|0|||
125651924|NCT01049360|452009811|FG002|Period 2|Lack of Efficacy|0|||
125651925|NCT01049360|452009812|FG003|Period 2|Lack of Efficacy|0|||
125651926|NCT01049360|452009813|FG004|Period 2|Lack of Efficacy|0|||
125651927|NCT01049360|452009814|FG005|Period 2|Lack of Efficacy|1|||
125651928|NCT01049360|452009815|FG006|Period 2|Lack of Efficacy|0|||
125651929|NCT01049360|452009816|FG007|Period 2|Lack of Efficacy|0|||
125651930|NCT01049360|452009817|FG008|Period 2|Lack of Efficacy|0|||
125651931|NCT01049360|452009818|FG009|Period 2|Lack of Efficacy|0|||
125651932|NCT01049360|452009819|FG010|Period 2|Lack of Efficacy|0|||
125651933|NCT01049360|452009820|FG011|Period 2|Lack of Efficacy|0|||
125651934|NCT01049360|452009821|FG012|Period 2|Lack of Efficacy|0|||
125651935|NCT01049360|452009822|FG013|Period 2|Lack of Efficacy|0|||
125651936|NCT01049360|452009823|FG014|Period 2|Lack of Efficacy|0|||
125651937|NCT01049360|452009824|FG015|Period 2|Lack of Efficacy|0|||
125651938|NCT01049360|452009825|FG016|Period 2|Lack of Efficacy|0|||
125651939|NCT01049360|452009826|FG017|Period 2|Lack of Efficacy|0|||
125651940|NCT01049360|452009827|FG018|Period 2|Lack of Efficacy|0|||
125651941|NCT01049360|452009828|FG019|Period 2|Lack of Efficacy|0|||
125651942|NCT01049360|452009809|FG000|Period 4|Protocol Violation|0|||
125651943|NCT01049360|452009810|FG001|Period 4|Protocol Violation|0|||
125651944|NCT01049360|452009811|FG002|Period 4|Protocol Violation|0|||
125651945|NCT01049360|452009812|FG003|Period 4|Protocol Violation|0|||
125651946|NCT01049360|452009813|FG004|Period 4|Protocol Violation|0|||
125651947|NCT01049360|452009814|FG005|Period 4|Protocol Violation|0|||
125651948|NCT01049360|452009815|FG006|Period 4|Protocol Violation|0|||
125651949|NCT01049360|452009816|FG007|Period 4|Protocol Violation|0|||
125651950|NCT01049360|452009817|FG008|Period 4|Protocol Violation|0|||
125651951|NCT01049360|452009818|FG009|Period 4|Protocol Violation|0|||
125651952|NCT01049360|452009819|FG010|Period 4|Protocol Violation|0|||
125651953|NCT01049360|452009820|FG011|Period 4|Protocol Violation|0|||
125651954|NCT01049360|452009821|FG012|Period 4|Protocol Violation|0|||
125651955|NCT01049360|452009822|FG013|Period 4|Protocol Violation|0|||
125651956|NCT01049360|452009823|FG014|Period 4|Protocol Violation|0|||
125651957|NCT01049360|452009824|FG015|Period 4|Protocol Violation|0|||
125651958|NCT01049360|452009825|FG016|Period 4|Protocol Violation|0|||
125651959|NCT01049360|452009826|FG017|Period 4|Protocol Violation|1|||
125651960|NCT01049360|452009827|FG018|Period 4|Protocol Violation|0|||
125651961|NCT01049360|452009828|FG019|Period 4|Protocol Violation|0|||
125651962|NCT01049360|452009809|FG000|Period 4|Withdrawal by Subject|0|||
125651963|NCT01049360|452009810|FG001|Period 4|Withdrawal by Subject|0|||
125651964|NCT01049360|452009811|FG002|Period 4|Withdrawal by Subject|0|||
125651965|NCT01049360|452009812|FG003|Period 4|Withdrawal by Subject|1|||
125651966|NCT01049360|452009813|FG004|Period 4|Withdrawal by Subject|0|||
125651967|NCT01049360|452009814|FG005|Period 4|Withdrawal by Subject|0|||
125651968|NCT01049360|452009815|FG006|Period 4|Withdrawal by Subject|0|||
125651969|NCT01049360|452009816|FG007|Period 4|Withdrawal by Subject|0|||
125651970|NCT01049360|452009817|FG008|Period 4|Withdrawal by Subject|0|||
125651971|NCT01049360|452009818|FG009|Period 4|Withdrawal by Subject|0|||
125651972|NCT01049360|452009819|FG010|Period 4|Withdrawal by Subject|0|||
125651973|NCT01049360|452009820|FG011|Period 4|Withdrawal by Subject|0|||
125651974|NCT01049360|452009821|FG012|Period 4|Withdrawal by Subject|0|||
125651975|NCT01049360|452009822|FG013|Period 4|Withdrawal by Subject|0|||
125651976|NCT01049360|452009823|FG014|Period 4|Withdrawal by Subject|0|||
125651977|NCT01049360|452009824|FG015|Period 4|Withdrawal by Subject|0|||
125651978|NCT01049360|452009825|FG016|Period 4|Withdrawal by Subject|0|||
125651979|NCT01049360|452009826|FG017|Period 4|Withdrawal by Subject|0|||
125651980|NCT01049360|452009827|FG018|Period 4|Withdrawal by Subject|0|||
125651981|NCT01049360|452009828|FG019|Period 4|Withdrawal by Subject|0|||
125651982|NCT01694849|452009829|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
125651983|NCT01694849|452009830|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
125651984|NCT01694849|452009831|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
125651985|NCT01694849|452009829|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
125651986|NCT01694849|452009830|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
125651987|NCT01694849|452009831|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
125651988|NCT01694849|452009829|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
125651989|NCT01694849|452009830|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
125651990|NCT01694849|452009831|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
125651991|NCT01694849|452009829|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
125651992|NCT01694849|452009830|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
125651993|NCT01694849|452009831|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
125651994|NCT01694849|452009829|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
125651995|NCT01694849|452009830|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
125651996|NCT01694849|452009831|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
125651997|NCT01694849|452009829|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
125651998|NCT01694849|452009830|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
125651999|NCT01694849|452009831|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
125652000|NCT01694849|452009829|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
125313901|NCT00857285|450777446|FG001|Overall Study|Adverse Event|2|||
125313902|NCT00857285|450777445|FG000|Overall Study|Lack of Efficacy|0|||
125313903|NCT00857285|450777446|FG001|Overall Study|Lack of Efficacy|2|||
125652001|NCT01694849|452009830|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
125652002|NCT01694849|452009831|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
125652003|NCT01694849|452009829|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
125652004|NCT01694849|452009830|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
125652005|NCT01694849|452009831|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
125652006|NCT00596466|452009834|FG000|Overall Study|Lack of Efficacy|5|||
125652007|NCT00596466|452009834|FG000|Overall Study|Adverse Event|4|||
125652008|NCT00596466|452009834|FG000|Overall Study|Withdrawal by Subject|2|||
125652009|NCT00596466|452009834|FG000|Overall Study|Protocol Violation|2|||
125652010|NCT00596466|452009834|FG000|Overall Study|Unpecified|2|||
125652011|NCT00596466|452009834|FG000|Overall Study|Enrolled, not treated|2|||
125652012|NCT00908375|452009835|FG000|Overall Study|Withdrawal by Subject|2|||
125652013|NCT00908375|452009836|FG001|Overall Study|Withdrawal by Subject|4|||
125652014|NCT00908375|452009835|FG000|Overall Study|Lost to Follow-up|8|||
125652015|NCT00908375|452009836|FG001|Overall Study|Lost to Follow-up|6|||
125313904|NCT00857285|450777445|FG000|Overall Study|Protocol Violation|3|||
125313905|NCT00857285|450777446|FG001|Overall Study|Protocol Violation|1|||
125313906|NCT00857285|450777445|FG000|Overall Study|Withdrawal by Subject|4|||
125313907|NCT00857285|450777446|FG001|Overall Study|Withdrawal by Subject|0|||
125313908|NCT00857285|450777445|FG000|Overall Study|Randomization criteria not met|1|||
125313909|NCT00857285|450777446|FG001|Overall Study|Randomization criteria not met|1|||
125313910|NCT01987102|450777450|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
125313911|NCT01987102|450777451|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
125313912|NCT01987102|450777450|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
125313913|NCT01987102|450777451|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
125313914|NCT01987102|450777450|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
125313915|NCT01987102|450777451|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
125313916|NCT01987102|450777450|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
125313917|NCT01987102|450777451|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
125313918|NCT01987102|450777450|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
125313919|NCT01987102|450777451|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
125313920|NCT01987102|450777450|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
125313921|NCT01987102|450777451|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
125313922|NCT01236521|450777452|FG000|Overall Study|Withdrawal by Subject|12|||
125313923|NCT01236521|450777453|FG001|Overall Study|Withdrawal by Subject|17|||
125652016|NCT00752206|452009837|FG000|Overall Study|Disease progression|8|||
125652017|NCT00752206|452009838|FG001|Overall Study|Disease progression|11|||
125652018|NCT00752206|452009837|FG000|Overall Study|Pregnancy|1|||
125652019|NCT00752206|452009838|FG001|Overall Study|Pregnancy|0|||
125652020|NCT00678652|452009839|FG000|Overall Study|Protocol Violation|2|||
125652021|NCT00678652|452009840|FG001|Overall Study|Protocol Violation|0|||
125652022|NCT00678652|452009841|FG002|Overall Study|Protocol Violation|0|||
125652023|NCT00678652|452009842|FG003|Overall Study|Protocol Violation|0|||
125652024|NCT00678652|452009839|FG000|Overall Study|Pregnancy|0|||
125652025|NCT00678652|452009840|FG001|Overall Study|Pregnancy|0|||
125652026|NCT00678652|452009841|FG002|Overall Study|Pregnancy|1|||
125652027|NCT00678652|452009842|FG003|Overall Study|Pregnancy|0|||
125652028|NCT00678652|452009839|FG000|Overall Study|Relocation|1|||
125652029|NCT00678652|452009840|FG001|Overall Study|Relocation|0|||
125652030|NCT00678652|452009841|FG002|Overall Study|Relocation|0|||
125652031|NCT00678652|452009842|FG003|Overall Study|Relocation|0|||
125652032|NCT05770401|452009845|FG000|Overall Study|Lost to Follow-up|5|||
125652033|NCT05770401|452009846|FG001|Overall Study|Lost to Follow-up|4|||
125652034|NCT00402298|452009847|FG000|Overall Study|Withdrawal by Subject|1|||
125652035|NCT00402298|452009848|FG001|Overall Study|Withdrawal by Subject|0|||
125652036|NCT00480077|452009849|FG000|Overall Study|Death|19|||
125652037|NCT00480077|452009850|FG001|Overall Study|Death|15|||
125652038|NCT00480077|452009849|FG000|Overall Study|early exit|12|||
125652039|NCT00480077|452009850|FG001|Overall Study|early exit|11|||
125652040|NCT04784455|452009851|FG000|Overall Study|Death|4|||
125652041|NCT04298229|452009856|FG000|Overall Study|Physician Decision|1|||
125652042|NCT04298229|452009857|FG001|Overall Study|Physician Decision|1|||
125652043|NCT04298229|452009856|FG000|Overall Study|Withdrawal by Subject|1|||
125652044|NCT04298229|452009857|FG001|Overall Study|Withdrawal by Subject|1|||
125652045|NCT04298229|452009856|FG000|Overall Study|Did not receive IV loop diuretics|2|||
125652046|NCT04298229|452009857|FG001|Overall Study|Did not receive IV loop diuretics|0|||
125652047|NCT00262119|452009859|FG000|Overall Study|Lost to Follow-up|38|||
125652048|NCT00262119|452009860|FG001|Overall Study|Lost to Follow-up|51|||
125652049|NCT00262119|452009861|FG002|Overall Study|Lost to Follow-up|42|||
125652050|NCT00262119|452009859|FG000|Overall Study|Death|20|||
125652051|NCT00262119|452009860|FG001|Overall Study|Death|19|||
125652052|NCT00262119|452009861|FG002|Overall Study|Death|16|||
125652053|NCT01683565|452009862|FG000|Overall Study|Lost to Follow-up|2|||
125652054|NCT01683565|452009863|FG001|Overall Study|Lost to Follow-up|0|||
125313924|NCT01236521|450777452|FG000|Overall Study|Death|2|||
125313925|NCT01236521|450777453|FG001|Overall Study|Death|1|||
125652055|NCT01683565|452009862|FG000|Overall Study|Discontinued Intervention|1|||
125652056|NCT01683565|452009863|FG001|Overall Study|Discontinued Intervention|1|||
125652057|NCT00859313|452009864|FG000|Overall Study|Lack of Efficacy|2|||
125652058|NCT00859313|452009864|FG000|Overall Study|Adverse Event|1|||
125652059|NCT00859313|452009864|FG000|Overall Study|staff error|1|||
125652060|NCT00071006|452009865|FG000|Overall Study|Lack of Efficacy|7|||
125652061|NCT00071006|452009865|FG000|Overall Study|Adverse Event|1|||
125652062|NCT00071006|452009865|FG000|Overall Study|Withdrawal by Subject|1|||
125652063|NCT00071006|452009865|FG000|Overall Study|Other|3|||
125652064|NCT05261126|452009866|FG000|Overall Study|Death|0|||
125652065|NCT05261126|452009867|FG001|Overall Study|Death|0|||
125652066|NCT05261126|452009868|FG002|Overall Study|Death|1|||
125652067|NCT05261126|452009869|FG003|Overall Study|Death|0|||
125652068|NCT05261126|452009870|FG004|Overall Study|Death|0|||
125652069|NCT05261126|452009866|FG000|Overall Study|Lost to Follow-up|0|||
125652070|NCT05261126|452009867|FG001|Overall Study|Lost to Follow-up|0|||
125652071|NCT05261126|452009868|FG002|Overall Study|Lost to Follow-up|0|||
125652072|NCT05261126|452009869|FG003|Overall Study|Lost to Follow-up|0|||
125652073|NCT05261126|452009870|FG004|Overall Study|Lost to Follow-up|1|||
125652074|NCT05261126|452009866|FG000|Overall Study|Physician Decision|1|||
125652075|NCT05261126|452009867|FG001|Overall Study|Physician Decision|0|||
125652076|NCT05261126|452009868|FG002|Overall Study|Physician Decision|0|||
125652077|NCT05261126|452009869|FG003|Overall Study|Physician Decision|0|||
125652078|NCT05261126|452009870|FG004|Overall Study|Physician Decision|0|||
125652079|NCT05261126|452009866|FG000|Overall Study|Screen Failure|0|||
125652080|NCT05261126|452009867|FG001|Overall Study|Screen Failure|0|||
125652081|NCT05261126|452009868|FG002|Overall Study|Screen Failure|0|||
125652082|NCT05261126|452009869|FG003|Overall Study|Screen Failure|0|||
125652083|NCT05261126|452009870|FG004|Overall Study|Screen Failure|1|||
125652084|NCT05261126|452009866|FG000|Overall Study|Withdrawal by Subject|1|||
125652085|NCT05261126|452009867|FG001|Overall Study|Withdrawal by Subject|0|||
125652086|NCT05261126|452009868|FG002|Overall Study|Withdrawal by Subject|1|||
125652087|NCT05261126|452009869|FG003|Overall Study|Withdrawal by Subject|1|||
125652088|NCT05261126|452009870|FG004|Overall Study|Withdrawal by Subject|0|||
125652089|NCT05261126|452009866|FG000|Overall Study|Not Recorded|0|||
125652090|NCT05261126|452009867|FG001|Overall Study|Not Recorded|0|||
125652091|NCT05261126|452009868|FG002|Overall Study|Not Recorded|0|||
125652092|NCT05261126|452009869|FG003|Overall Study|Not Recorded|1|||
125652093|NCT05261126|452009870|FG004|Overall Study|Not Recorded|0|||
125652094|NCT03901274|452009871|FG000|Overall Study|Lost to Follow-up|120|||
125652095|NCT03901274|452009872|FG001|Overall Study|Lost to Follow-up|124|||
125652096|NCT03901274|452009871|FG000|Overall Study|Withdrawal by Subject|0|||
125652097|NCT03901274|452009872|FG001|Overall Study|Withdrawal by Subject|6|||
125652098|NCT05570604|452009873|FG000|Overall Study|Lost to Follow-up|1|||
125652099|NCT05570604|452009874|FG001|Overall Study|Lost to Follow-up|5|||
125652100|NCT05570604|452009873|FG000|Overall Study|Illness|2|||
125652101|NCT05570604|452009874|FG001|Overall Study|Illness|2|||
125652102|NCT00145119|452009877|FG000|Overall Study|Death|45|||
125652103|NCT04527380|452009878|FG000|Overall Study|Lack of Efficacy|0|||
125652104|NCT04527380|452009879|FG001|Overall Study|Lack of Efficacy|1|||
125652105|NCT04527380|452009878|FG000|Overall Study|Withdrawal by Subject|1|||
125652106|NCT04527380|452009879|FG001|Overall Study|Withdrawal by Subject|0|||
125652107|NCT05437211|452009886|FG000|Overall Study|Patient's decision|1|||
125652108|NCT05437211|452009887|FG001|Overall Study|Patient's decision|1|||
125652109|NCT00931515|452009897|FG000|Overall Study|Lost to Follow-up|2|||
125652110|NCT00931515|452009898|FG001|Overall Study|Lost to Follow-up|5|||
125652111|NCT00686894|452009899|FG000|Overall Study|Relapse|2|||
125652112|NCT00686894|452009899|FG000|Overall Study|Protocol Violation|4|||
125652113|NCT01013207|452011792|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
125652114|NCT04196023|452011799|FG000|Overall Study|Withdrawal by Subject|0|||
125652115|NCT04196023|452011800|FG001|Overall Study|Withdrawal by Subject|1|||
125652116|NCT04196023|452011799|FG000|Overall Study|Adverse Event|3|||
125652117|NCT04196023|452011800|FG001|Overall Study|Adverse Event|1|||
125652118|NCT04196023|452011799|FG000|Overall Study|Lost to Follow-up|0|||
125652119|NCT04196023|452011800|FG001|Overall Study|Lost to Follow-up|1|||
125652120|NCT03358407|452011801|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125652121|NCT03358407|452011802|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125652122|NCT03358407|452011803|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
125652123|NCT03358407|452011804|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125652124|NCT03358407|452011805|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125652125|NCT03358407|452011806|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125652126|NCT03358407|452011807|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125652127|NCT03358407|452011808|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125652128|NCT03358407|452011809|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125652129|NCT03358407|452011810|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
125652130|NCT03358407|452011801|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652131|NCT03358407|452011802|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652132|NCT03358407|452011803|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652133|NCT03358407|452011804|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652134|NCT03358407|452011805|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
125425492|NCT00636610|451180492|FG001|Overall Study|Reason for discontinuation not available|2|||
125652135|NCT03358407|452011806|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652136|NCT03358407|452011807|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652137|NCT03358407|452011808|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652138|NCT03358407|452011809|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652139|NCT03358407|452011810|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652140|NCT03358407|452011801|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125652141|NCT03358407|452011802|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125313926|NCT01236521|450777452|FG000|Overall Study|Lost to Follow-up|9|||
125313927|NCT01236521|450777453|FG001|Overall Study|Lost to Follow-up|7|||
125313928|NCT02252146|450779319|FG000|Overall Study|Lack of Efficacy|4|||
125313929|NCT02252146|450779319|FG000|Overall Study|Entered hospice care|1|||
125313930|NCT02252146|450779319|FG000|Overall Study|Inability to travel to study site|1|||
125652142|NCT03358407|452011803|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125652143|NCT03358407|452011804|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125652144|NCT03358407|452011805|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125652145|NCT03358407|452011806|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
125652146|NCT03358407|452011807|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125652147|NCT03358407|452011808|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
125652148|NCT03358407|452011809|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125652149|NCT03358407|452011810|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
125652150|NCT03358407|452011801|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125652151|NCT03358407|452011802|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125652152|NCT03358407|452011803|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125652153|NCT03358407|452011804|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125652154|NCT03358407|452011805|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125652155|NCT03358407|452011806|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
125652156|NCT03358407|452011807|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125652157|NCT03358407|452011808|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
125652158|NCT03358407|452011809|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125652159|NCT03358407|452011810|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
125652160|NCT03358407|452011801|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652161|NCT03358407|452011802|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652162|NCT03358407|452011803|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652163|NCT03358407|452011804|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652164|NCT03358407|452011805|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652165|NCT03358407|452011806|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
125652166|NCT03358407|452011807|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
125652167|NCT03358407|452011808|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652168|NCT03358407|452011809|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652169|NCT03358407|452011810|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
125652170|NCT03358407|452011801|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125652171|NCT03358407|452011802|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125652172|NCT03358407|452011803|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125652173|NCT03358407|452011804|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125652174|NCT03358407|452011805|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125652175|NCT03358407|452011806|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
125652176|NCT03358407|452011807|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
125652177|NCT03358407|452011808|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
125652178|NCT03358407|452011809|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125652179|NCT03358407|452011810|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
125652180|NCT03605758|452011811|FG000|Overall Study|Lost to Follow-up|2|||
125652181|NCT03605758|452011812|FG001|Overall Study|Lost to Follow-up|1|||
125652182|NCT03605758|452011811|FG000|Overall Study|Illness|0|||
125652183|NCT03605758|452011812|FG001|Overall Study|Illness|1|||
125652184|NCT03605758|452011811|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
125652185|NCT03605758|452011812|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
125652186|NCT00489411|452011813|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
125652187|NCT00489411|452011814|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
125652188|NCT00489411|452011813|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
125652189|NCT00489411|452011814|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
125652190|NCT00489411|452011813|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
125652191|NCT00489411|452011814|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
125652192|NCT00489411|452011813|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
125652193|NCT00489411|452011814|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
125652194|NCT00489411|452011813|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
125652195|NCT00489411|452011814|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
125652196|NCT01283009|452011815|FG000|Overall Study|Death|83|||
125652197|NCT01283009|452011816|FG001|Overall Study|Death|78|||
125652198|NCT01283009|452011815|FG000|Overall Study|Study ended early|23|||
125313931|NCT00531284|450779320|FG000|Overall Study|Progressive Disease|1|||
125313932|NCT00531284|450779321|FG001|Overall Study|Progressive Disease|3|||
125652199|NCT01283009|452011816|FG001|Overall Study|Study ended early|26|||
125652200|NCT01283009|452011815|FG000|Overall Study|Withdrawal by Subject|10|||
125652201|NCT01283009|452011816|FG001|Overall Study|Withdrawal by Subject|8|||
125652202|NCT01283009|452011815|FG000|Overall Study|Physician Decision|1|||
125652203|NCT01283009|452011816|FG001|Overall Study|Physician Decision|1|||
125652204|NCT01283009|452011815|FG000|Overall Study|Lost to Follow-up|1|||
125652205|NCT01283009|452011816|FG001|Overall Study|Lost to Follow-up|0|||
125652206|NCT01283009|452011815|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
125652207|NCT01283009|452011816|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
125652208|NCT04640168|452011820|FG000|Overall Study|Withdrawal by Subject|8|||
125652209|NCT04640168|452011821|FG001|Overall Study|Withdrawal by Subject|7|||
125652210|NCT04640168|452011820|FG000|Overall Study|Lost to Follow-up|1|||
125652211|NCT04640168|452011821|FG001|Overall Study|Lost to Follow-up|0|||
125652212|NCT04640168|452011820|FG000|Overall Study|Enrolled but not treated|12|||
125652213|NCT04640168|452011821|FG001|Overall Study|Enrolled but not treated|12|||
125652214|NCT04366258|452011825|FG000|Baseline Assessments|Screen Failure|21|||
125652215|NCT04366258|452011825|FG000|Baseline Assessments|Early Termination|3|||
125652216|NCT00308555|452011826|FG000|Overall Study|Withdrawal by Subject|1|||
125652217|NCT00308555|452011827|FG001|Overall Study|Withdrawal by Subject|0|||
125652218|NCT00308555|452011826|FG000|Overall Study|Physician Decision|2|||
125652219|NCT00308555|452011827|FG001|Overall Study|Physician Decision|0|||
125652220|NCT00276458|452011828|FG000|Overall Study|Adverse Event|0|||
125652221|NCT00276458|452011829|FG001|Overall Study|Adverse Event|2|||
125652222|NCT00276458|452011828|FG000|Overall Study|Lost to Follow-up|2|||
125652223|NCT00276458|452011829|FG001|Overall Study|Lost to Follow-up|2|||
125652224|NCT00276458|452011828|FG000|Overall Study|Protocol Violation|4|||
125652225|NCT00276458|452011829|FG001|Overall Study|Protocol Violation|3|||
125652226|NCT02940392|452011832|FG000|Overall Study|Lost to Follow-up|3|||
125652227|NCT02940392|452011832|FG000|Overall Study|Retreatment|3|||
125652228|NCT02940392|452011832|FG000|Overall Study|Death|2|||
125652229|NCT00910000|452011836|FG000|Overall Study|Adverse Event|0|||
125652230|NCT00910000|452011837|FG001|Overall Study|Adverse Event|3|||
125652231|NCT00910000|452011838|FG002|Overall Study|Adverse Event|2|||
125652232|NCT00910000|452011839|FG003|Overall Study|Adverse Event|2|||
125652233|NCT00910000|452011840|FG004|Overall Study|Adverse Event|0|||
125652234|NCT00910000|452011841|FG005|Overall Study|Adverse Event|1|||
125652235|NCT00910000|452011836|FG000|Overall Study|Withdrawal by Subject|0|||
125652236|NCT00910000|452011837|FG001|Overall Study|Withdrawal by Subject|0|||
125652237|NCT00910000|452011838|FG002|Overall Study|Withdrawal by Subject|1|||
125652238|NCT00910000|452011839|FG003|Overall Study|Withdrawal by Subject|0|||
125652239|NCT00910000|452011840|FG004|Overall Study|Withdrawal by Subject|1|||
125652240|NCT00910000|452011841|FG005|Overall Study|Withdrawal by Subject|0|||
125652241|NCT03125382|452011842|FG000|Randomization|screening failure|1|||
125652242|NCT03125382|452011843|FG001|Randomization|screening failure|4|||
125652243|NCT03125382|452011844|FG002|Randomization|screening failure|2|||
125652244|NCT03125382|452011845|FG003|Randomization|screening failure|0|||
125652245|NCT03125382|452011842|FG000|Follow-up|Death|1|||
125652246|NCT03125382|452011843|FG001|Follow-up|Death|2|||
125652247|NCT03125382|452011844|FG002|Follow-up|Death|1|||
125652248|NCT03125382|452011845|FG003|Follow-up|Death|2|||
125652249|NCT03125382|452011842|FG000|Follow-up|Lost to Follow-up|1|||
125652250|NCT03125382|452011843|FG001|Follow-up|Lost to Follow-up|4|||
125652251|NCT03125382|452011844|FG002|Follow-up|Lost to Follow-up|3|||
125652252|NCT03125382|452011845|FG003|Follow-up|Lost to Follow-up|1|||
125652253|NCT02686749|452011846|FG000|Overall Study|terminated for poor enrollment|2|||
125652254|NCT02686749|452011847|FG001|Overall Study|terminated for poor enrollment|2|||
125652255|NCT05147311|452011850|FG000|Overall Study|Did not complete survey|2|||
125652256|NCT05147311|452011851|FG001|Overall Study|Did not complete survey|1|||
125652257|NCT05147311|452011850|FG000|Overall Study|Patient too sick|1|||
125652258|NCT05147311|452011851|FG001|Overall Study|Patient too sick|2|||
125652259|NCT05147311|452011850|FG000|Overall Study|Death|0|||
125652260|NCT05147311|452011851|FG001|Overall Study|Death|1|||
125652261|NCT05147311|452011850|FG000|Overall Study|Declined survey|1|||
125652262|NCT05147311|452011851|FG001|Overall Study|Declined survey|0|||
125652263|NCT04505592|452011853|FG000|Overall Study|Death|2|||
125652264|NCT04505592|452011854|FG001|Overall Study|Death|1|||
125652265|NCT01015118|452011859|FG000|Overall Study|Protocol Violation|5|||
125652266|NCT01015118|452011860|FG001|Overall Study|Protocol Violation|6|||
125652267|NCT01015118|452011859|FG000|Overall Study|Withdrawal by Subject|103|||
125652268|NCT01015118|452011860|FG001|Overall Study|Withdrawal by Subject|27|||
125652269|NCT01015118|452011859|FG000|Overall Study|Other Adverse Event (AE)|141|||
125652270|NCT01015118|452011860|FG001|Overall Study|Other Adverse Event (AE)|33|||
125652271|NCT01015118|452011859|FG000|Overall Study|Worsening or AE of underlying disease|5|||
125652272|NCT01015118|452011860|FG001|Overall Study|Worsening or AE of underlying disease|4|||
125652273|NCT01015118|452011859|FG000|Overall Study|Progressive disease|364|||
125652274|NCT01015118|452011860|FG001|Overall Study|Progressive disease|229|||
125210502|NCT01066793|450395577|FG004|Overall Study|Treatment Stopped|0|||
125652275|NCT01015118|452011859|FG000|Overall Study|Not treated|9|||
125652276|NCT01015118|452011860|FG001|Overall Study|Not treated|5|||
125652277|NCT01015118|452011859|FG000|Overall Study|Other than stated above|42|||
125313933|NCT00531284|450779322|FG002|Overall Study|Progressive Disease|5|||
125313934|NCT00531284|450779323|FG003|Overall Study|Progressive Disease|42|||
125313935|NCT00531284|450779324|FG004|Overall Study|Progressive Disease|4|||
125313936|NCT00531284|450779325|FG005|Overall Study|Progressive Disease|4|||
125313937|NCT00531284|450779326|FG006|Overall Study|Progressive Disease|3|||
125313938|NCT00531284|450779327|FG007|Overall Study|Progressive Disease|8|||
125313939|NCT00531284|450779328|FG008|Overall Study|Progressive Disease|6|||
125313940|NCT00531284|450779329|FG009|Overall Study|Progressive Disease|3|||
125313941|NCT00531284|450779330|FG010|Overall Study|Progressive Disease|3|||
125313942|NCT00531284|450779331|FG011|Overall Study|Progressive Disease|14|||
125313943|NCT00531284|450779332|FG012|Overall Study|Progressive Disease|2|||
125313944|NCT00531284|450779333|FG013|Overall Study|Progressive Disease|1|||
125313945|NCT00531284|450779334|FG014|Overall Study|Progressive Disease|2|||
125313946|NCT00531284|450779335|FG015|Overall Study|Progressive Disease|11|||
125313947|NCT00531284|450779336|FG016|Overall Study|Progressive Disease|5|||
125313948|NCT00531284|450779320|FG000|Overall Study|Adverse Event|0|||
125313949|NCT00531284|450779321|FG001|Overall Study|Adverse Event|1|||
125313950|NCT00531284|450779322|FG002|Overall Study|Adverse Event|1|||
125313951|NCT00531284|450779323|FG003|Overall Study|Adverse Event|7|||
125313952|NCT00531284|450779324|FG004|Overall Study|Adverse Event|0|||
125313953|NCT00531284|450779325|FG005|Overall Study|Adverse Event|2|||
125313954|NCT00531284|450779326|FG006|Overall Study|Adverse Event|3|||
125313955|NCT00531284|450779327|FG007|Overall Study|Adverse Event|2|||
125313956|NCT00531284|450779328|FG008|Overall Study|Adverse Event|3|||
125313957|NCT00531284|450779329|FG009|Overall Study|Adverse Event|0|||
125313958|NCT00531284|450779330|FG010|Overall Study|Adverse Event|0|||
125313959|NCT00531284|450779331|FG011|Overall Study|Adverse Event|5|||
125313960|NCT00531284|450779332|FG012|Overall Study|Adverse Event|0|||
125313961|NCT00531284|450779333|FG013|Overall Study|Adverse Event|1|||
125313962|NCT00531284|450779334|FG014|Overall Study|Adverse Event|1|||
125313963|NCT00531284|450779335|FG015|Overall Study|Adverse Event|0|||
125313964|NCT00531284|450779336|FG016|Overall Study|Adverse Event|2|||
125313965|NCT00531284|450779320|FG000|Overall Study|Withdrawal by Subject|1|||
125313966|NCT00531284|450779321|FG001|Overall Study|Withdrawal by Subject|0|||
125313967|NCT00531284|450779322|FG002|Overall Study|Withdrawal by Subject|0|||
125313968|NCT00531284|450779323|FG003|Overall Study|Withdrawal by Subject|4|||
125313969|NCT00531284|450779324|FG004|Overall Study|Withdrawal by Subject|0|||
125313970|NCT00531284|450779325|FG005|Overall Study|Withdrawal by Subject|0|||
125313971|NCT00531284|450779326|FG006|Overall Study|Withdrawal by Subject|0|||
125313972|NCT00531284|450779327|FG007|Overall Study|Withdrawal by Subject|0|||
125313973|NCT00531284|450779328|FG008|Overall Study|Withdrawal by Subject|0|||
125313974|NCT00531284|450779329|FG009|Overall Study|Withdrawal by Subject|0|||
125313975|NCT00531284|450779330|FG010|Overall Study|Withdrawal by Subject|0|||
125313976|NCT00531284|450779331|FG011|Overall Study|Withdrawal by Subject|3|||
125313977|NCT00531284|450779332|FG012|Overall Study|Withdrawal by Subject|0|||
125313978|NCT00531284|450779333|FG013|Overall Study|Withdrawal by Subject|1|||
125313979|NCT00531284|450779334|FG014|Overall Study|Withdrawal by Subject|0|||
125313980|NCT00531284|450779335|FG015|Overall Study|Withdrawal by Subject|1|||
125313981|NCT00531284|450779336|FG016|Overall Study|Withdrawal by Subject|1|||
125313982|NCT00531284|450779320|FG000|Overall Study|Other|1|||
125313983|NCT00531284|450779321|FG001|Overall Study|Other|0|||
125313984|NCT00531284|450779322|FG002|Overall Study|Other|0|||
125313985|NCT00531284|450779323|FG003|Overall Study|Other|10|||
125313986|NCT00531284|450779324|FG004|Overall Study|Other|2|||
125313987|NCT00531284|450779325|FG005|Overall Study|Other|1|||
125313988|NCT00531284|450779326|FG006|Overall Study|Other|0|||
125313989|NCT00531284|450779327|FG007|Overall Study|Other|0|||
125313990|NCT00531284|450779328|FG008|Overall Study|Other|2|||
125313991|NCT00531284|450779329|FG009|Overall Study|Other|1|||
125313992|NCT00531284|450779330|FG010|Overall Study|Other|0|||
125652278|NCT01015118|452011860|FG001|Overall Study|Other than stated above|23|||
125313993|NCT00531284|450779331|FG011|Overall Study|Other|2|||
125313994|NCT00531284|450779332|FG012|Overall Study|Other|0|||
125313995|NCT00531284|450779333|FG013|Overall Study|Other|0|||
125313996|NCT00531284|450779334|FG014|Overall Study|Other|1|||
125652279|NCT03522506|452011861|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125652280|NCT03522506|452011862|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125313997|NCT00531284|450779335|FG015|Overall Study|Other|0|||
125313998|NCT00531284|450779336|FG016|Overall Study|Other|0|||
125313999|NCT02219464|450779338|FG000|Overall Study|Withdrawal by Subject|1|||
125314000|NCT02219464|450779339|FG001|Overall Study|Withdrawal by Subject|0|||
125314001|NCT02219464|450779338|FG000|Overall Study|case cancelled|1|||
125314002|NCT02219464|450779339|FG001|Overall Study|case cancelled|0|||
125314003|NCT02219464|450779338|FG000|Overall Study|catheter malfunction|1|||
125314004|NCT02219464|450779339|FG001|Overall Study|catheter malfunction|0|||
125314005|NCT02544321|450779351|FG000|Overall Study|Withdrawal by Subject|1|||
125314006|NCT02544321|450779352|FG001|Overall Study|Withdrawal by Subject|2|||
125314007|NCT02544321|450779351|FG000|Overall Study|Adverse Event|1|||
125314008|NCT02544321|450779352|FG001|Overall Study|Adverse Event|1|||
125314009|NCT02544321|450779351|FG000|Overall Study|Protocol Violation|0|||
125652281|NCT03522506|452011863|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125652282|NCT03522506|452011864|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
125652283|NCT03522506|452011861|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125652284|NCT03522506|452011862|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125652285|NCT03522506|452011863|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125652286|NCT03522506|452011864|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
125652287|NCT03480243|452011865|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
125652288|NCT03480243|452011865|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
125652289|NCT02388906|452011867|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
125652290|NCT02388906|452011868|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
125652291|NCT02388906|452011867|FG000|Treatment Period|Disease progression|121|||
125652292|NCT02388906|452011868|FG001|Treatment Period|Disease progression|100|||
125652293|NCT02388906|452011867|FG000|Treatment Period|Study drug toxicity|41|||
125652294|NCT02388906|452011868|FG001|Treatment Period|Study drug toxicity|208|||
125652295|NCT02388906|452011867|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
125652296|NCT02388906|452011868|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
125652297|NCT02388906|452011867|FG000|Treatment Period|Participant request to stop treatment|5|||
125652298|NCT02388906|452011868|FG001|Treatment Period|Participant request to stop treatment|9|||
125652299|NCT02388906|452011867|FG000|Treatment Period|Participant withdrew consent|2|||
125652300|NCT02388906|452011868|FG001|Treatment Period|Participant withdrew consent|3|||
125652301|NCT02388906|452011867|FG000|Treatment Period|Poor/non-compliance|0|||
125652302|NCT02388906|452011868|FG001|Treatment Period|Poor/non-compliance|1|||
125652303|NCT02388906|452011867|FG000|Treatment Period|Participant no longer meets study criteria|0|||
125652304|NCT02388906|452011868|FG001|Treatment Period|Participant no longer meets study criteria|1|||
125652305|NCT02388906|452011867|FG000|Treatment Period|Other reasons|3|||
125652306|NCT02388906|452011868|FG001|Treatment Period|Other reasons|3|||
125652307|NCT04365387|452011877|FG000|Overall Study|Adverse Event|4|||
125652308|NCT04365387|452011878|FG001|Overall Study|Adverse Event|2|||
125652309|NCT04365387|452011877|FG000|Overall Study|Participants request|14|||
125314010|NCT02544321|450779352|FG001|Overall Study|Protocol Violation|1|||
125314011|NCT01584232|450779353|FG000|Overall Study|Adverse Event|3|||
125314012|NCT01584232|450779354|FG001|Overall Study|Adverse Event|1|||
125652310|NCT04365387|452011878|FG001|Overall Study|Participants request|14|||
125652311|NCT04365387|452011877|FG000|Overall Study|Lost to Follow-up|8|||
125652312|NCT04365387|452011878|FG001|Overall Study|Lost to Follow-up|5|||
125652313|NCT04365387|452011877|FG000|Overall Study|Protocol deviation|3|||
125652314|NCT04365387|452011878|FG001|Overall Study|Protocol deviation|4|||
125652315|NCT04365387|452011877|FG000|Overall Study|Participant compliance with visit schedule|1|||
125652316|NCT04365387|452011878|FG001|Overall Study|Participant compliance with visit schedule|0|||
125652317|NCT04365387|452011877|FG000|Overall Study|Participant incarcerated|1|||
125652318|NCT04365387|452011878|FG001|Overall Study|Participant incarcerated|0|||
125652319|NCT04365387|452011877|FG000|Overall Study|Participant moved out of town (relocated)|0|||
125652320|NCT04365387|452011878|FG001|Overall Study|Participant moved out of town (relocated)|1|||
125652321|NCT04365387|452011877|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
125652322|NCT04365387|452011878|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
125652323|NCT04365387|452011877|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
125652324|NCT04365387|452011878|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
125652325|NCT04410991|452011879|FG000|Overall Study|Poor compliance to protocol|5|||
125652326|NCT04410991|452011880|FG001|Overall Study|Poor compliance to protocol|4|||
125652327|NCT04410991|452011879|FG000|Overall Study|Withdrawal by Subject|59|||
125652328|NCT04410991|452011880|FG001|Overall Study|Withdrawal by Subject|55|||
125652329|NCT04410991|452011879|FG000|Overall Study|Other|10|||
125652330|NCT04410991|452011880|FG001|Overall Study|Other|4|||
125652331|NCT03282123|452011881|FG000|Overall Study|Withdrawal by Subject|5|||
125652332|NCT00938366|452011882|FG000|Overall Study|Withdrawal by Subject|1|||
125652333|NCT00938366|452011883|FG001|Overall Study|Withdrawal by Subject|0|||
125652334|NCT01463631|452011890|FG000|Overall Study|Withdrawal by Subject|0|||
125652335|NCT01463631|452011891|FG001|Overall Study|Withdrawal by Subject|0|||
125652336|NCT01463631|452011892|FG002|Overall Study|Withdrawal by Subject|0|||
125652337|NCT01463631|452011893|FG003|Overall Study|Withdrawal by Subject|1|||
125652338|NCT01463631|452011890|FG000|Overall Study|Death|0|||
125314013|NCT01584232|450779353|FG000|Overall Study|Withdrawal by Subject|2|||
125652339|NCT01463631|452011891|FG001|Overall Study|Death|0|||
125652340|NCT01463631|452011892|FG002|Overall Study|Death|1|||
125652341|NCT01463631|452011893|FG003|Overall Study|Death|0|||
125652342|NCT01463631|452011890|FG000|Overall Study|Progressive Disease|0|||
125652343|NCT01463631|452011891|FG001|Overall Study|Progressive Disease|0|||
125652344|NCT01463631|452011892|FG002|Overall Study|Progressive Disease|0|||
125652345|NCT01463631|452011893|FG003|Overall Study|Progressive Disease|5|||
125652346|NCT05966129|452011896|FG000|Overall Study|Death|1|||
125314014|NCT01584232|450779354|FG001|Overall Study|Withdrawal by Subject|1|||
125314015|NCT01584232|450779353|FG000|Overall Study|Physician Decision|2|||
125652347|NCT05966129|452011897|FG001|Overall Study|Death|2|||
125314016|NCT01584232|450779354|FG001|Overall Study|Physician Decision|1|||
125652348|NCT05966129|452011896|FG000|Overall Study|Lost to Follow-up|63|||
125652349|NCT05966129|452011897|FG001|Overall Study|Lost to Follow-up|66|||
125652350|NCT05966129|452011896|FG000|Overall Study|Protocol Violation|1|||
125652351|NCT05966129|452011897|FG001|Overall Study|Protocol Violation|0|||
125652352|NCT05966129|452011896|FG000|Overall Study|Withdrawal by Subject|26|||
125652353|NCT05966129|452011897|FG001|Overall Study|Withdrawal by Subject|25|||
125652354|NCT05966129|452011896|FG000|Overall Study|Surgery not completed|63|||
125652355|NCT05966129|452011897|FG001|Overall Study|Surgery not completed|69|||
125652356|NCT05966129|452011896|FG000|Overall Study|Surgery logistics issue|2|||
125652357|NCT05966129|452011897|FG001|Overall Study|Surgery logistics issue|1|||
125652358|NCT01298323|452011898|FG000|Overall Study|Adverse Event|2|||
125652359|NCT01298323|452011899|FG001|Overall Study|Adverse Event|4|||
125652360|NCT01298323|452011898|FG000|Overall Study|Death|11|||
125652361|NCT01298323|452011899|FG001|Overall Study|Death|16|||
125652362|NCT01298323|452011898|FG000|Overall Study|Lost to Follow-up|1|||
125652363|NCT01298323|452011899|FG001|Overall Study|Lost to Follow-up|0|||
125652364|NCT01298323|452011898|FG000|Overall Study|Withdrawal by Subject|6|||
125652365|NCT01298323|452011899|FG001|Overall Study|Withdrawal by Subject|3|||
125652366|NCT01298323|452011898|FG000|Overall Study|Protocol Violation|1|||
125652367|NCT01298323|452011899|FG001|Overall Study|Protocol Violation|0|||
125652368|NCT01298323|452011898|FG000|Overall Study|Other|10|||
125652369|NCT01298323|452011899|FG001|Overall Study|Other|9|||
125652370|NCT01298323|452011898|FG000|Overall Study|Ongoing|55|||
125652371|NCT01298323|452011899|FG001|Overall Study|Ongoing|55|||
125652372|NCT01298323|452011898|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125652373|NCT01298323|452011899|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125652374|NCT04089566|452011900|FG000|Overall Study|Death|0|||
125652375|NCT04089566|452011901|FG001|Overall Study|Death|6|||
125652376|NCT04089566|452011902|FG002|Overall Study|Death|10|||
125652377|NCT04089566|452011903|FG003|Overall Study|Death|0|||
125652378|NCT04089566|452011904|FG004|Overall Study|Death|0|||
125652379|NCT04089566|452011905|FG005|Overall Study|Death|0|||
125652380|NCT04089566|452011900|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
125652381|NCT04089566|452011901|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
125652382|NCT04089566|452011902|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
125652383|NCT04089566|452011903|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
125652384|NCT04089566|452011904|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
125652385|NCT04089566|452011905|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
125652386|NCT04089566|452011900|FG000|Overall Study|Reason not Specified|0|||
125652387|NCT04089566|452011901|FG001|Overall Study|Reason not Specified|4|||
125652388|NCT04089566|452011902|FG002|Overall Study|Reason not Specified|4|||
125652389|NCT04089566|452011903|FG003|Overall Study|Reason not Specified|1|||
125652390|NCT04089566|452011904|FG004|Overall Study|Reason not Specified|0|||
125652391|NCT04089566|452011905|FG005|Overall Study|Reason not Specified|0|||
125652392|NCT02396849|452011906|FG000|Overall Study|Lost to Follow-up|1|||
125652393|NCT02396849|452011907|FG001|Overall Study|Lost to Follow-up|1|||
125652394|NCT02396849|452011906|FG000|Overall Study|Did not tolerate intervention|1|||
125652395|NCT02396849|452011907|FG001|Overall Study|Did not tolerate intervention|1|||
125652396|NCT04794491|452011916|FG000|Overall Study|Adverse Event|1|||
125652397|NCT04794491|452011916|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
125652398|NCT04794491|452011916|FG000|Overall Study|Noncompliance With Study Intervention|1|||
125652399|NCT04794491|452011916|FG000|Overall Study|Withdrawal by Subject|2|||
125652400|NCT02950831|452011917|FG000|Overall Study|Lost to Follow-up|1|||
125652401|NCT02950831|452011917|FG000|Overall Study|Withdrawal by Subject|3|||
125652402|NCT02950831|452011917|FG000|Overall Study|stimulation trail failure|5|||
125652403|NCT01965600|452011918|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
125652404|NCT01965600|452011919|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
125652405|NCT01965600|452011920|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
125652406|NCT01965600|452011921|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
125652407|NCT01965600|452011918|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
125652408|NCT01965600|452011919|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
125652409|NCT01965600|452011920|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
125652410|NCT01965600|452011921|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
125652411|NCT01965600|452011918|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
125652412|NCT01965600|452011919|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
125652413|NCT01965600|452011920|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
125652414|NCT01965600|452011921|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
125652415|NCT01965600|452011918|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
125652416|NCT01965600|452011919|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
125652417|NCT01965600|452011920|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
125210503|NCT01066793|450395578|FG005|Overall Study|Treatment Stopped|0|||
125210504|NCT01911793|450395579|FG000|Overall Study|Physician Decision|1|||
125652418|NCT01965600|452011921|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
125652419|NCT01965600|452011918|FG000|Second Intervention|Study terminated by Sponsor|0|||
125652420|NCT01965600|452011919|FG001|Second Intervention|Study terminated by Sponsor|0|||
125652421|NCT01965600|452011920|FG002|Second Intervention|Study terminated by Sponsor|2|||
125652422|NCT01965600|452011921|FG003|Second Intervention|Study terminated by Sponsor|2|||
125652423|NCT01875731|452011927|FG000|Overall Study|Fail to obtain lab sample|1|||
125652424|NCT01875731|452011928|FG001|Overall Study|Fail to obtain lab sample|0|||
125652425|NCT03418727|452011931|FG000|Overall Study|Adverse Event|1|||
125652426|NCT03418727|452011932|FG001|Overall Study|Adverse Event|2|||
125652427|NCT03418727|452011933|FG002|Overall Study|Adverse Event|0|||
125652428|NCT03418727|452011931|FG000|Overall Study|Withdrawal by Subject|0|||
125652429|NCT03418727|452011932|FG001|Overall Study|Withdrawal by Subject|0|||
125652430|NCT03418727|452011933|FG002|Overall Study|Withdrawal by Subject|2|||
125652431|NCT03145207|452011938|FG000|Overall Study|volunteer started taking allergy shots|1|||
125652432|NCT03145207|452011938|FG000|Overall Study|baseline blood pressure high|1|||
125652433|NCT04678557|452011941|FG000|Overall Study|Withdrawal by Subject|1|||
125652434|NCT04678557|452011942|FG001|Overall Study|Withdrawal by Subject|0|||
125652435|NCT04678557|452011941|FG000|Overall Study|Lack of Efficacy|0|||
125652436|NCT04678557|452011942|FG001|Overall Study|Lack of Efficacy|13|||
125652437|NCT04678557|452011941|FG000|Overall Study|Safety Evaluation|0|||
125652438|NCT04678557|452011942|FG001|Overall Study|Safety Evaluation|1|||
125652439|NCT00223990|452011943|FG000|Overall Study|Moved from area|2|||
125652440|NCT00223990|452011944|FG001|Overall Study|Moved from area|1|||
125652441|NCT00223990|452011943|FG000|Overall Study|Withdrawal by Subject|4|||
125652442|NCT00223990|452011944|FG001|Overall Study|Withdrawal by Subject|8|||
125652443|NCT00223990|452011943|FG000|Overall Study|Lost to Follow-up|1|||
125652444|NCT00223990|452011944|FG001|Overall Study|Lost to Follow-up|0|||
125652445|NCT02513732|452013493|FG000|Overall Study|Lost to Follow-up|11|||
125652446|NCT02513732|452013493|FG000|Overall Study|Death|9|||
125652447|NCT02513732|452013493|FG000|Overall Study|Changing hospital|2|||
125652448|NCT01740297|452013495|FG000|Overall Study|Withdrawal by Subject|4|||
125652449|NCT01740297|452013496|FG001|Overall Study|Withdrawal by Subject|16|||
125652450|NCT01740297|452013497|FG002|Overall Study|Withdrawal by Subject|17|||
125652451|NCT01740297|452013495|FG000|Overall Study|Death|8|||
125652452|NCT01740297|452013496|FG001|Overall Study|Death|46|||
125652453|NCT01740297|452013497|FG002|Overall Study|Death|40|||
125652454|NCT01740297|452013495|FG000|Overall Study|Lost to Follow-up|1|||
125652455|NCT01740297|452013496|FG001|Overall Study|Lost to Follow-up|2|||
125652456|NCT01740297|452013497|FG002|Overall Study|Lost to Follow-up|4|||
125652457|NCT00761462|452013501|FG000|Treatment|Subjects never received study medication|23|||
125652458|NCT00761462|452013502|FG001|Treatment|Subjects never received study medication|12|||
125652459|NCT00761462|452013501|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
125652460|NCT00761462|452013502|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
125652461|NCT00761462|452013501|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
125652462|NCT00761462|452013502|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
125652463|NCT00761462|452013501|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
125652464|NCT00761462|452013502|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
125652465|NCT01479777|452013503|FG000|Overall Study|Physician Decision|2|||
125652466|NCT01541644|452013510|FG000|Overall Study|Withdrawal by Subject|3|||
125652467|NCT02389621|452013513|FG000|Treatment Period|Withdrawal by Subject|1|||
125652468|NCT02389621|452013514|FG001|Treatment Period|Withdrawal by Subject|1|||
125652469|NCT02389621|452013513|FG000|Posttreatment Period|Adverse Event|3|||
125652470|NCT02389621|452013514|FG001|Posttreatment Period|Adverse Event|1|||
125652471|NCT02389621|452013513|FG000|Posttreatment Period|Withdrawal by Subject|3|||
125652472|NCT02389621|452013514|FG001|Posttreatment Period|Withdrawal by Subject|2|||
125652473|NCT02389621|452013513|FG000|Posttreatment Period|Lost to Follow-up|1|||
125652474|NCT02389621|452013514|FG001|Posttreatment Period|Lost to Follow-up|1|||
125652475|NCT02389621|452013513|FG000|Posttreatment Period|Other - Miscellaneous|2|||
125652476|NCT02389621|452013514|FG001|Posttreatment Period|Other - Miscellaneous|0|||
125652477|NCT00953017|452013533|FG000|Overall Study|DId not show up for colonoscopy|4|||
125652478|NCT00953017|452013534|FG001|Overall Study|DId not show up for colonoscopy|4|||
125652479|NCT00953017|452013535|FG002|Overall Study|DId not show up for colonoscopy|5|||
125652480|NCT00953017|452013536|FG003|Overall Study|DId not show up for colonoscopy|4|||
125652481|NCT00953017|452013533|FG000|Overall Study|Incomplete data|1|||
125652482|NCT00953017|452013534|FG001|Overall Study|Incomplete data|1|||
125652483|NCT00953017|452013535|FG002|Overall Study|Incomplete data|0|||
125652484|NCT00953017|452013536|FG003|Overall Study|Incomplete data|0|||
125652485|NCT00953017|452013533|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
125652486|NCT00953017|452013534|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
125652487|NCT00953017|452013535|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
125652488|NCT00953017|452013536|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
125652489|NCT00953017|452013533|FG000|Overall Study|Brown stool prior to procedure|0|||
125652490|NCT00953017|452013534|FG001|Overall Study|Brown stool prior to procedure|0|||
125652491|NCT00953017|452013535|FG002|Overall Study|Brown stool prior to procedure|1|||
125652492|NCT00953017|452013536|FG003|Overall Study|Brown stool prior to procedure|0|||
125652493|NCT01473602|452013538|FG000|Overall Study|Adverse Event|1|||
125652494|NCT01473602|452013539|FG001|Overall Study|Adverse Event|2|||
125652495|NCT01473602|452013538|FG000|Overall Study|Death|0|||
125652496|NCT01473602|452013539|FG001|Overall Study|Death|1|||
125652497|NCT01473602|452013538|FG000|Overall Study|Lost to Follow-up|1|||
125652498|NCT01473602|452013539|FG001|Overall Study|Lost to Follow-up|1|||
125652499|NCT01473602|452013538|FG000|Overall Study|Withdrawal by Subject|5|||
125652500|NCT01473602|452013539|FG001|Overall Study|Withdrawal by Subject|4|||
125652501|NCT01473602|452013538|FG000|Overall Study|Physician Decision|1|||
125652502|NCT01473602|452013539|FG001|Overall Study|Physician Decision|0|||
125652503|NCT00449761|452013541|FG000|Overall Study|Disease progression|12|||
125652504|NCT00449761|452013541|FG000|Overall Study|Death|5|||
125652505|NCT00449761|452013541|FG000|Overall Study|New cancer therapy|1|||
125652506|NCT00344968|452013544|FG000|Overall Study|Adverse Event|5|||
125652507|NCT00344968|452013545|FG001|Overall Study|Adverse Event|4|||
125652508|NCT00344968|452013546|FG002|Overall Study|Adverse Event|15|||
125652509|NCT00344968|452013544|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125652510|NCT00344968|452013545|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125652511|NCT00344968|452013546|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
125652512|NCT00344968|452013544|FG000|Overall Study|Protocol Violation|2|||
125652513|NCT00344968|452013545|FG001|Overall Study|Protocol Violation|2|||
125652514|NCT00344968|452013546|FG002|Overall Study|Protocol Violation|5|||
125652515|NCT00344968|452013544|FG000|Overall Study|Withdrawal by Subject|14|||
125652516|NCT00344968|452013545|FG001|Overall Study|Withdrawal by Subject|31|||
125652517|NCT00344968|452013546|FG002|Overall Study|Withdrawal by Subject|27|||
125652518|NCT00344968|452013544|FG000|Overall Study|Lost to Follow-up|24|||
125652519|NCT00344968|452013545|FG001|Overall Study|Lost to Follow-up|37|||
125652520|NCT00344968|452013546|FG002|Overall Study|Lost to Follow-up|37|||
125652521|NCT00344968|452013544|FG000|Overall Study|Death|11|||
125652522|NCT00344968|452013545|FG001|Overall Study|Death|27|||
125652523|NCT00344968|452013546|FG002|Overall Study|Death|31|||
125652524|NCT00344968|452013544|FG000|Overall Study|Other|0|||
125652525|NCT00344968|452013545|FG001|Overall Study|Other|1|||
125652526|NCT00344968|452013546|FG002|Overall Study|Other|0|||
125652527|NCT03735680|452013547|FG000|Overall Study|Withdrawal by Subject|0|||
125652528|NCT03735680|452013548|FG001|Overall Study|Withdrawal by Subject|1|||
125652529|NCT03735680|452013549|FG002|Overall Study|Withdrawal by Subject|0|||
125652530|NCT03735680|452013550|FG003|Overall Study|Withdrawal by Subject|0|||
125652531|NCT03735680|452013551|FG004|Overall Study|Withdrawal by Subject|0|||
125652532|NCT03735680|452013552|FG005|Overall Study|Withdrawal by Subject|1|||
125652533|NCT03735680|452013547|FG000|Overall Study|Patient unable or unwilling to continue|0|||
125652534|NCT03735680|452013548|FG001|Overall Study|Patient unable or unwilling to continue|0|||
125652535|NCT03735680|452013549|FG002|Overall Study|Patient unable or unwilling to continue|1|||
125652536|NCT03735680|452013550|FG003|Overall Study|Patient unable or unwilling to continue|0|||
125652537|NCT03735680|452013551|FG004|Overall Study|Patient unable or unwilling to continue|0|||
125652538|NCT03735680|452013552|FG005|Overall Study|Patient unable or unwilling to continue|0|||
125652539|NCT01422876|452013554|FG000|Week 24|Lost to Follow-up|1|||
125652540|NCT01422876|452013555|FG001|Week 24|Lost to Follow-up|1|||
125652541|NCT01422876|452013556|FG002|Week 24|Lost to Follow-up|2|||
125652542|NCT01422876|452013557|FG003|Week 24|Lost to Follow-up|4|||
125652543|NCT01422876|452013558|FG004|Week 24|Lost to Follow-up|2|||
125652544|NCT01422876|452013559|FG005|Week 24|Lost to Follow-up|0|||
125652545|NCT01422876|452013560|FG006|Week 24|Lost to Follow-up|1|||
125652546|NCT01422876|452013561|FG007|Week 24|Lost to Follow-up|3|||
125652547|NCT01422876|452013562|FG008|Week 24|Lost to Follow-up|3|||
125652548|NCT01422876|452013563|FG009|Week 24|Lost to Follow-up|4|||
125652549|NCT01422876|452013554|FG000|Week 24|Consent withdrawn|5|||
125652550|NCT01422876|452013555|FG001|Week 24|Consent withdrawn|1|||
125652551|NCT01422876|452013556|FG002|Week 24|Consent withdrawn|3|||
125652552|NCT01422876|452013557|FG003|Week 24|Consent withdrawn|4|||
125652553|NCT01422876|452013558|FG004|Week 24|Consent withdrawn|5|||
125652554|NCT01422876|452013559|FG005|Week 24|Consent withdrawn|6|||
125652555|NCT01422876|452013560|FG006|Week 24|Consent withdrawn|5|||
125652556|NCT01422876|452013561|FG007|Week 24|Consent withdrawn|4|||
125652557|NCT01422876|452013562|FG008|Week 24|Consent withdrawn|3|||
125652558|NCT01422876|452013563|FG009|Week 24|Consent withdrawn|6|||
125652559|NCT01422876|452013554|FG000|Week 24|Death|0|||
125425493|NCT00686881|451180498|FG000|Overall Study|Withdrawal by Subject|11|||
125652560|NCT01422876|452013555|FG001|Week 24|Death|1|||
125652561|NCT01422876|452013556|FG002|Week 24|Death|0|||
125652562|NCT01422876|452013557|FG003|Week 24|Death|0|||
125652563|NCT01422876|452013558|FG004|Week 24|Death|0|||
125652564|NCT01422876|452013559|FG005|Week 24|Death|0|||
125652565|NCT01422876|452013560|FG006|Week 24|Death|0|||
125652566|NCT01422876|452013561|FG007|Week 24|Death|0|||
125652567|NCT01422876|452013562|FG008|Week 24|Death|0|||
125652568|NCT01422876|452013563|FG009|Week 24|Death|0|||
125652569|NCT01422876|452013554|FG000|Week 52|Lost to Follow-up|3|||
125652570|NCT01422876|452013555|FG001|Week 52|Lost to Follow-up|5|||
125652571|NCT01422876|452013556|FG002|Week 52|Lost to Follow-up|7|||
125652572|NCT01422876|452013557|FG003|Week 52|Lost to Follow-up|5|||
125652573|NCT01422876|452013558|FG004|Week 52|Lost to Follow-up|8|||
125652574|NCT01422876|452013559|FG005|Week 52|Lost to Follow-up|5|||
125314017|NCT01584232|450779353|FG000|Overall Study|Lost to Follow-up|1|||
125314018|NCT01584232|450779354|FG001|Overall Study|Lost to Follow-up|0|||
125314019|NCT03347123|450779355|FG000|Overall Study|Death|1|||
125652575|NCT01422876|452013560|FG006|Week 52|Lost to Follow-up|5|||
125652576|NCT01422876|452013561|FG007|Week 52|Lost to Follow-up|8|||
125652577|NCT01422876|452013562|FG008|Week 52|Lost to Follow-up|7|||
125652578|NCT01422876|452013563|FG009|Week 52|Lost to Follow-up|8|||
125652579|NCT01422876|452013554|FG000|Week 52|Consent withdrawn|9|||
125652580|NCT01422876|452013555|FG001|Week 52|Consent withdrawn|4|||
125652581|NCT01422876|452013556|FG002|Week 52|Consent withdrawn|6|||
125652582|NCT01422876|452013557|FG003|Week 52|Consent withdrawn|12|||
125652583|NCT01422876|452013558|FG004|Week 52|Consent withdrawn|7|||
125652584|NCT01422876|452013559|FG005|Week 52|Consent withdrawn|12|||
125652585|NCT01422876|452013560|FG006|Week 52|Consent withdrawn|10|||
125652586|NCT01422876|452013561|FG007|Week 52|Consent withdrawn|12|||
125652587|NCT01422876|452013562|FG008|Week 52|Consent withdrawn|13|||
125652588|NCT01422876|452013563|FG009|Week 52|Consent withdrawn|9|||
125652589|NCT01422876|452013554|FG000|Week 52|Death|0|||
125652590|NCT01422876|452013555|FG001|Week 52|Death|1|||
125652591|NCT01422876|452013556|FG002|Week 52|Death|0|||
125652592|NCT01422876|452013557|FG003|Week 52|Death|1|||
125652593|NCT01422876|452013558|FG004|Week 52|Death|0|||
125652594|NCT01422876|452013559|FG005|Week 52|Death|0|||
125652595|NCT01422876|452013560|FG006|Week 52|Death|1|||
125652596|NCT01422876|452013561|FG007|Week 52|Death|3|||
125652597|NCT01422876|452013562|FG008|Week 52|Death|1|||
125652598|NCT01422876|452013563|FG009|Week 52|Death|0|||
125652599|NCT00054639|452013573|FG000|Overall Study|Lack of Efficacy|1|||
125652600|NCT00054639|452013573|FG000|Overall Study|Physician Decision|1|||
125652601|NCT05028816|452013585|FG000|Overall Study|Lost to Follow-up|5|||
125652602|NCT05028816|452013586|FG001|Overall Study|Lost to Follow-up|3|||
125652603|NCT05028816|452013585|FG000|Overall Study|Withdrawal by Subject|4|||
125652604|NCT05028816|452013586|FG001|Overall Study|Withdrawal by Subject|1|||
125652605|NCT05028816|452013585|FG000|Overall Study|Physician Decision|1|||
125652606|NCT05028816|452013586|FG001|Overall Study|Physician Decision|0|||
125652607|NCT05064436|452013587|FG000|Overall Study|Other Reasons|1|||
125652608|NCT05064436|452013588|FG001|Overall Study|Other Reasons|0|||
125652609|NCT01711736|452013590|FG000|Overall Study|Lost to Follow-up|4|||
125652610|NCT01711736|452013591|FG001|Overall Study|Lost to Follow-up|1|||
125652611|NCT01711736|452013590|FG000|Overall Study|Withdrawal by Subject|6|||
125652612|NCT01711736|452013591|FG001|Overall Study|Withdrawal by Subject|6|||
125652613|NCT01711736|452013590|FG000|Overall Study|Migrated/moved from study area|2|||
125652614|NCT01711736|452013591|FG001|Overall Study|Migrated/moved from study area|1|||
125652615|NCT02506101|452013592|FG000|Overall Study|Transportation issues|1|||
125652616|NCT02506101|452013593|FG001|Overall Study|Transportation issues|0|||
125652617|NCT02506101|452013592|FG000|Overall Study|No enrollment and staff unavailability|1|||
125652618|NCT02506101|452013593|FG001|Overall Study|No enrollment and staff unavailability|0|||
125652619|NCT00003526|452013594|FG000|Overall Study|Not evaluable|6|||
125652620|NCT00779857|452013595|FG000|Overall Study|Death|1|||
125652621|NCT00779857|452013595|FG000|Overall Study|Withdrawal by Subject|3|||
125652622|NCT00779857|452013595|FG000|Overall Study|Missed Visit|2|||
125652623|NCT00620776|452013600|FG000|Overall Study|Did not receive treatment|3|||
125652624|NCT00620776|452013601|FG001|Overall Study|Did not receive treatment|5|||
125652625|NCT00620776|452013600|FG000|Overall Study|Adverse Event|2|||
125652626|NCT00620776|452013601|FG001|Overall Study|Adverse Event|3|||
125652627|NCT00620776|452013600|FG000|Overall Study|Lack of Efficacy|2|||
125652628|NCT00620776|452013601|FG001|Overall Study|Lack of Efficacy|1|||
125652629|NCT00620776|452013600|FG000|Overall Study|Lost to Follow-up|2|||
125652630|NCT00620776|452013601|FG001|Overall Study|Lost to Follow-up|5|||
125652631|NCT00620776|452013600|FG000|Overall Study|Withdrawal by Subject|3|||
125652632|NCT00620776|452013601|FG001|Overall Study|Withdrawal by Subject|2|||
125652633|NCT01725217|452013602|FG000|Overall Study|Withdrawal by Subject|1|||
125652634|NCT01725217|452013603|FG001|Overall Study|Withdrawal by Subject|0|||
125652635|NCT01725217|452013604|FG002|Overall Study|Withdrawal by Subject|0|||
125652636|NCT03992456|452013605|FG000|Overall Study|Withdrawal by Subject|1|||
125652637|NCT03992456|452013606|FG001|Overall Study|Withdrawal by Subject|0|||
125652638|NCT03992456|452013605|FG000|Overall Study|Disease progression|4|||
125652639|NCT03992456|452013606|FG001|Overall Study|Disease progression|5|||
125314020|NCT03347123|450779356|FG001|Overall Study|Death|2|||
125652640|NCT03992456|452013605|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
125652641|NCT03992456|452013606|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
125652642|NCT01977625|452013607|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
125652643|NCT01977625|452013608|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
125652644|NCT01977625|452013607|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125652645|NCT01977625|452013608|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
125652646|NCT04113746|452013609|FG000|Overall Study|Lost to Follow-up|4|||
125652647|NCT04113746|452013610|FG001|Overall Study|Lost to Follow-up|4|||
125652648|NCT02594384|452013611|FG000|Overall Study|Disease Progression|3|||
125652649|NCT02594384|452013612|FG001|Overall Study|Disease Progression|7|||
125652650|NCT02594384|452013613|FG002|Overall Study|Disease Progression|0|||
125652651|NCT02594384|452013614|FG003|Overall Study|Disease Progression|2|||
125652652|NCT02594384|452013615|FG004|Overall Study|Disease Progression|2|||
125652653|NCT02594384|452013616|FG005|Overall Study|Disease Progression|12|||
125652654|NCT02594384|452013617|FG006|Overall Study|Disease Progression|5|||
125652655|NCT02594384|452013618|FG007|Overall Study|Disease Progression|5|||
125652656|NCT02594384|452013611|FG000|Overall Study|Adverse Event|0|||
125652657|NCT02594384|452013612|FG001|Overall Study|Adverse Event|1|||
125652658|NCT02594384|452013613|FG002|Overall Study|Adverse Event|4|||
125652659|NCT02594384|452013614|FG003|Overall Study|Adverse Event|1|||
125652660|NCT02594384|452013615|FG004|Overall Study|Adverse Event|0|||
125652661|NCT02594384|452013616|FG005|Overall Study|Adverse Event|6|||
125652662|NCT02594384|452013617|FG006|Overall Study|Adverse Event|1|||
125652663|NCT02594384|452013618|FG007|Overall Study|Adverse Event|1|||
125652664|NCT02594384|452013611|FG000|Overall Study|Withdrawal by Subject|0|||
125652665|NCT02594384|452013612|FG001|Overall Study|Withdrawal by Subject|0|||
125652666|NCT02594384|452013613|FG002|Overall Study|Withdrawal by Subject|0|||
125652667|NCT02594384|452013614|FG003|Overall Study|Withdrawal by Subject|1|||
125652668|NCT02594384|452013615|FG004|Overall Study|Withdrawal by Subject|0|||
125652669|NCT02594384|452013616|FG005|Overall Study|Withdrawal by Subject|0|||
125652670|NCT02594384|452013617|FG006|Overall Study|Withdrawal by Subject|0|||
125652671|NCT02594384|452013618|FG007|Overall Study|Withdrawal by Subject|1|||
125652672|NCT02594384|452013611|FG000|Overall Study|Physician Decision|0|||
125652673|NCT02594384|452013612|FG001|Overall Study|Physician Decision|0|||
125652674|NCT02594384|452013613|FG002|Overall Study|Physician Decision|0|||
125652675|NCT02594384|452013614|FG003|Overall Study|Physician Decision|0|||
125652676|NCT02594384|452013615|FG004|Overall Study|Physician Decision|0|||
125652677|NCT02594384|452013616|FG005|Overall Study|Physician Decision|1|||
125652678|NCT02594384|452013617|FG006|Overall Study|Physician Decision|2|||
125652679|NCT02594384|452013618|FG007|Overall Study|Physician Decision|0|||
125652680|NCT02594384|452013611|FG000|Overall Study|Progressive Leukocytosis|0|||
125652681|NCT02594384|452013612|FG001|Overall Study|Progressive Leukocytosis|0|||
125652682|NCT02594384|452013613|FG002|Overall Study|Progressive Leukocytosis|1|||
125652683|NCT02594384|452013614|FG003|Overall Study|Progressive Leukocytosis|0|||
125652684|NCT02594384|452013615|FG004|Overall Study|Progressive Leukocytosis|0|||
125652685|NCT02594384|452013616|FG005|Overall Study|Progressive Leukocytosis|0|||
125652686|NCT02594384|452013617|FG006|Overall Study|Progressive Leukocytosis|0|||
125652687|NCT02594384|452013618|FG007|Overall Study|Progressive Leukocytosis|0|||
125652688|NCT02594384|452013611|FG000|Overall Study|Lack of Efficacy|0|||
125652689|NCT02594384|452013612|FG001|Overall Study|Lack of Efficacy|0|||
125652690|NCT02594384|452013613|FG002|Overall Study|Lack of Efficacy|0|||
125652691|NCT02594384|452013614|FG003|Overall Study|Lack of Efficacy|0|||
125652692|NCT02594384|452013615|FG004|Overall Study|Lack of Efficacy|1|||
125652693|NCT02594384|452013616|FG005|Overall Study|Lack of Efficacy|0|||
125652694|NCT02594384|452013617|FG006|Overall Study|Lack of Efficacy|0|||
125652695|NCT02594384|452013618|FG007|Overall Study|Lack of Efficacy|0|||
125652696|NCT02594384|452013611|FG000|Overall Study|Substantial noncompliance|0|||
125652697|NCT02594384|452013612|FG001|Overall Study|Substantial noncompliance|0|||
125652698|NCT02594384|452013613|FG002|Overall Study|Substantial noncompliance|0|||
125652699|NCT02594384|452013614|FG003|Overall Study|Substantial noncompliance|0|||
125652700|NCT02594384|452013615|FG004|Overall Study|Substantial noncompliance|0|||
125652701|NCT02594384|452013616|FG005|Overall Study|Substantial noncompliance|0|||
125652702|NCT02594384|452013617|FG006|Overall Study|Substantial noncompliance|1|||
125652703|NCT02594384|452013618|FG007|Overall Study|Substantial noncompliance|0|||
125652704|NCT03919669|452013621|FG000|Overall Study|Withdrawal by Subject|1|||
125652705|NCT03919669|452013622|FG001|Overall Study|Withdrawal by Subject|0|||
125314021|NCT03347123|450779357|FG002|Overall Study|Death|0|||
125314022|NCT03347123|450779358|FG003|Overall Study|Death|0|||
125652706|NCT03919669|452013623|FG002|Overall Study|Withdrawal by Subject|0|||
125652707|NCT04964960|452013624|FG000|Overall Study|Withdrawal by Subject|1|||
125652708|NCT00483119|452013625|FG000|Overall Study|Adverse Event|0|||
125652709|NCT00483119|452013626|FG001|Overall Study|Adverse Event|1|||
125652710|NCT00483119|452013625|FG000|Overall Study|Physician Decision|1|||
125652711|NCT00483119|452013626|FG001|Overall Study|Physician Decision|0|||
125652712|NCT04668066|452013627|FG000|Part 1: Treatment Phase|Adverse Event|0|||
125652713|NCT04668066|452013628|FG001|Part 1: Treatment Phase|Adverse Event|0|||
125652714|NCT04668066|452013629|FG002|Part 1: Treatment Phase|Adverse Event|0|||
125652715|NCT04668066|452013630|FG003|Part 1: Treatment Phase|Adverse Event|0|||
125652716|NCT04668066|452013631|FG004|Part 1: Treatment Phase|Adverse Event|0|||
125652717|NCT04668066|452013632|FG005|Part 1: Treatment Phase|Adverse Event|0|||
125652718|NCT04668066|452013633|FG006|Part 1: Treatment Phase|Adverse Event|0|||
125314023|NCT03347123|450779359|FG004|Overall Study|Death|0|||
125314024|NCT03347123|450779360|FG005|Overall Study|Death|0|||
125652719|NCT04668066|452013634|FG007|Part 1: Treatment Phase|Adverse Event|0|||
125652720|NCT04668066|452013635|FG008|Part 1: Treatment Phase|Adverse Event|0|||
125652721|NCT04668066|452013636|FG009|Part 1: Treatment Phase|Adverse Event|0|||
125652722|NCT04668066|452013637|FG010|Part 1: Treatment Phase|Adverse Event|0|||
125652723|NCT04668066|452013638|FG011|Part 1: Treatment Phase|Adverse Event|1|||
125652724|NCT04668066|452013639|FG012|Part 1: Treatment Phase|Adverse Event|1|||
125652725|NCT04668066|452013640|FG013|Part 1: Treatment Phase|Adverse Event|0|||
125652726|NCT04668066|452013641|FG014|Part 1: Treatment Phase|Adverse Event|0|||
125652727|NCT04668066|452013642|FG015|Part 1: Treatment Phase|Adverse Event|0|||
125652728|NCT04668066|452013643|FG016|Part 1: Treatment Phase|Adverse Event|0|||
125652729|NCT04668066|452013644|FG017|Part 1: Treatment Phase|Adverse Event|0|||
125652730|NCT04668066|452013645|FG018|Part 1: Treatment Phase|Adverse Event|0|||
125652731|NCT04668066|452013627|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652732|NCT04668066|452013628|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652733|NCT04668066|452013629|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
125652734|NCT04668066|452013630|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652735|NCT04668066|452013631|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652736|NCT04668066|452013632|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652737|NCT04668066|452013633|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652738|NCT04668066|452013634|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652739|NCT04668066|452013635|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652740|NCT04668066|452013636|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652741|NCT04668066|452013637|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652742|NCT04668066|452013638|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652743|NCT04668066|452013639|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652744|NCT04668066|452013640|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652745|NCT04668066|452013641|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652746|NCT04668066|452013642|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652747|NCT04668066|452013643|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652748|NCT04668066|452013644|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652749|NCT04668066|452013645|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
125652750|NCT04668066|452013627|FG000|Part 1: Treatment Phase|Other|0|||
125652751|NCT04668066|452013628|FG001|Part 1: Treatment Phase|Other|0|||
125652752|NCT04668066|452013629|FG002|Part 1: Treatment Phase|Other|0|||
125652753|NCT04668066|452013630|FG003|Part 1: Treatment Phase|Other|0|||
125652754|NCT04668066|452013631|FG004|Part 1: Treatment Phase|Other|0|||
125652755|NCT04668066|452013632|FG005|Part 1: Treatment Phase|Other|0|||
125652756|NCT04668066|452013633|FG006|Part 1: Treatment Phase|Other|0|||
125652757|NCT04668066|452013634|FG007|Part 1: Treatment Phase|Other|0|||
125652758|NCT04668066|452013635|FG008|Part 1: Treatment Phase|Other|0|||
125652759|NCT04668066|452013636|FG009|Part 1: Treatment Phase|Other|0|||
125652760|NCT04668066|452013637|FG010|Part 1: Treatment Phase|Other|0|||
125652761|NCT04668066|452013638|FG011|Part 1: Treatment Phase|Other|1|||
125652762|NCT04668066|452013639|FG012|Part 1: Treatment Phase|Other|0|||
125652763|NCT04668066|452013640|FG013|Part 1: Treatment Phase|Other|0|||
125652764|NCT04668066|452013641|FG014|Part 1: Treatment Phase|Other|0|||
125652765|NCT04668066|452013642|FG015|Part 1: Treatment Phase|Other|0|||
125652766|NCT04668066|452013643|FG016|Part 1: Treatment Phase|Other|0|||
125652767|NCT04668066|452013644|FG017|Part 1: Treatment Phase|Other|0|||
125652768|NCT04668066|452013645|FG018|Part 1: Treatment Phase|Other|0|||
125652769|NCT04668066|452013627|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652770|NCT04668066|452013628|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652771|NCT04668066|452013629|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652772|NCT04668066|452013630|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652773|NCT04668066|452013631|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652774|NCT04668066|452013632|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652775|NCT04668066|452013633|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652776|NCT04668066|452013634|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652777|NCT04668066|452013635|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652778|NCT04668066|452013636|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652779|NCT04668066|452013637|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652780|NCT04668066|452013638|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652781|NCT04668066|452013639|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
125314025|NCT03347123|450779361|FG006|Overall Study|Death|0|||
125314026|NCT03347123|450779355|FG000|Overall Study|Withdrawal by Subject|1|||
125314027|NCT03347123|450779356|FG001|Overall Study|Withdrawal by Subject|0|||
125314028|NCT03347123|450779357|FG002|Overall Study|Withdrawal by Subject|0|||
125314029|NCT03347123|450779358|FG003|Overall Study|Withdrawal by Subject|0|||
125314030|NCT03347123|450779359|FG004|Overall Study|Withdrawal by Subject|0|||
125314031|NCT03347123|450779360|FG005|Overall Study|Withdrawal by Subject|0|||
125314032|NCT03347123|450779361|FG006|Overall Study|Withdrawal by Subject|0|||
125314033|NCT03347123|450779355|FG000|Overall Study|Reason not Specified|3|||
125652782|NCT04668066|452013640|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652783|NCT04668066|452013641|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652784|NCT04668066|452013642|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
125652785|NCT04668066|452013643|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652786|NCT04668066|452013644|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652787|NCT04668066|452013645|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
125652788|NCT04668066|452013627|FG000|Part 1: Follow-Up|Adverse Event|0|||
125652789|NCT04668066|452013628|FG001|Part 1: Follow-Up|Adverse Event|0|||
125652790|NCT04668066|452013629|FG002|Part 1: Follow-Up|Adverse Event|0|||
125652791|NCT04668066|452013630|FG003|Part 1: Follow-Up|Adverse Event|0|||
125652792|NCT04668066|452013631|FG004|Part 1: Follow-Up|Adverse Event|0|||
125652793|NCT04668066|452013632|FG005|Part 1: Follow-Up|Adverse Event|0|||
125652794|NCT04668066|452013633|FG006|Part 1: Follow-Up|Adverse Event|0|||
125652795|NCT04668066|452013634|FG007|Part 1: Follow-Up|Adverse Event|0|||
125652796|NCT04668066|452013635|FG008|Part 1: Follow-Up|Adverse Event|0|||
125652797|NCT04668066|452013636|FG009|Part 1: Follow-Up|Adverse Event|0|||
125652798|NCT04668066|452013637|FG010|Part 1: Follow-Up|Adverse Event|0|||
125652799|NCT04668066|452013638|FG011|Part 1: Follow-Up|Adverse Event|1|||
125652800|NCT04668066|452013639|FG012|Part 1: Follow-Up|Adverse Event|0|||
125652801|NCT04668066|452013640|FG013|Part 1: Follow-Up|Adverse Event|0|||
125652802|NCT04668066|452013641|FG014|Part 1: Follow-Up|Adverse Event|0|||
125652803|NCT04668066|452013642|FG015|Part 1: Follow-Up|Adverse Event|0|||
125652804|NCT04668066|452013643|FG016|Part 1: Follow-Up|Adverse Event|0|||
125652805|NCT04668066|452013644|FG017|Part 1: Follow-Up|Adverse Event|0|||
125652806|NCT04668066|452013645|FG018|Part 1: Follow-Up|Adverse Event|0|||
125652807|NCT04668066|452013627|FG000|Part 1: Follow-Up|Other|0|||
125652808|NCT04668066|452013628|FG001|Part 1: Follow-Up|Other|0|||
125652809|NCT04668066|452013629|FG002|Part 1: Follow-Up|Other|0|||
125652810|NCT04668066|452013630|FG003|Part 1: Follow-Up|Other|0|||
125652811|NCT04668066|452013631|FG004|Part 1: Follow-Up|Other|0|||
125652812|NCT04668066|452013632|FG005|Part 1: Follow-Up|Other|0|||
125652813|NCT04668066|452013633|FG006|Part 1: Follow-Up|Other|0|||
125652814|NCT04668066|452013634|FG007|Part 1: Follow-Up|Other|0|||
125652815|NCT04668066|452013635|FG008|Part 1: Follow-Up|Other|0|||
125652816|NCT04668066|452013636|FG009|Part 1: Follow-Up|Other|0|||
125652817|NCT04668066|452013637|FG010|Part 1: Follow-Up|Other|0|||
125652818|NCT04668066|452013638|FG011|Part 1: Follow-Up|Other|1|||
125652819|NCT04668066|452013639|FG012|Part 1: Follow-Up|Other|1|||
125652820|NCT04668066|452013640|FG013|Part 1: Follow-Up|Other|0|||
125652821|NCT04668066|452013641|FG014|Part 1: Follow-Up|Other|0|||
125652822|NCT04668066|452013642|FG015|Part 1: Follow-Up|Other|0|||
125652823|NCT04668066|452013643|FG016|Part 1: Follow-Up|Other|0|||
125652824|NCT04668066|452013644|FG017|Part 1: Follow-Up|Other|0|||
125652825|NCT04668066|452013645|FG018|Part 1: Follow-Up|Other|0|||
125652826|NCT04668066|452013627|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652827|NCT04668066|452013628|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652828|NCT04668066|452013629|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652829|NCT04668066|452013630|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652830|NCT04668066|452013631|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652831|NCT04668066|452013632|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652832|NCT04668066|452013633|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652833|NCT04668066|452013634|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652834|NCT04668066|452013635|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652835|NCT04668066|452013636|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652836|NCT04668066|452013637|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652837|NCT04668066|452013638|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652838|NCT04668066|452013639|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
125652839|NCT04668066|452013640|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652840|NCT04668066|452013641|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652841|NCT04668066|452013642|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
125652842|NCT04668066|452013643|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652843|NCT04668066|452013644|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652844|NCT04668066|452013645|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
125652845|NCT04668066|452013627|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652846|NCT04668066|452013628|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652847|NCT04668066|452013629|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652848|NCT04668066|452013630|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652849|NCT04668066|452013631|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652850|NCT04668066|452013632|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652851|NCT04668066|452013633|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652852|NCT04668066|452013634|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652853|NCT04668066|452013635|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652854|NCT04668066|452013636|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125314034|NCT03347123|450779356|FG001|Overall Study|Reason not Specified|4|||
125652855|NCT04668066|452013637|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652856|NCT04668066|452013638|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652857|NCT04668066|452013639|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652858|NCT04668066|452013640|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652859|NCT04668066|452013641|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652860|NCT04668066|452013642|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652861|NCT04668066|452013643|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652862|NCT04668066|452013644|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
125652863|NCT04668066|452013645|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
125652864|NCT04668066|452013627|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652865|NCT04668066|452013628|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652866|NCT04668066|452013629|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652867|NCT04668066|452013630|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652868|NCT04668066|452013631|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652869|NCT04668066|452013632|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652870|NCT04668066|452013633|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652871|NCT04668066|452013634|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652872|NCT04668066|452013635|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652873|NCT04668066|452013636|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652874|NCT04668066|452013637|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652875|NCT04668066|452013638|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652876|NCT04668066|452013639|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652877|NCT04668066|452013640|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652878|NCT04668066|452013641|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652879|NCT04668066|452013642|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652880|NCT04668066|452013643|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652881|NCT04668066|452013644|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
125652882|NCT04668066|452013645|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
125652883|NCT04668066|452013627|FG000|Part 2: Treatment Phase|Other|0|||
125652884|NCT04668066|452013628|FG001|Part 2: Treatment Phase|Other|0|||
125652885|NCT04668066|452013629|FG002|Part 2: Treatment Phase|Other|0|||
125652886|NCT04668066|452013630|FG003|Part 2: Treatment Phase|Other|0|||
125652887|NCT04668066|452013631|FG004|Part 2: Treatment Phase|Other|0|||
125652888|NCT04668066|452013632|FG005|Part 2: Treatment Phase|Other|0|||
125652889|NCT04668066|452013633|FG006|Part 2: Treatment Phase|Other|0|||
125652890|NCT04668066|452013634|FG007|Part 2: Treatment Phase|Other|0|||
125652891|NCT04668066|452013635|FG008|Part 2: Treatment Phase|Other|0|||
125652892|NCT04668066|452013636|FG009|Part 2: Treatment Phase|Other|0|||
125652893|NCT04668066|452013637|FG010|Part 2: Treatment Phase|Other|0|||
125652894|NCT04668066|452013638|FG011|Part 2: Treatment Phase|Other|0|||
125652895|NCT04668066|452013639|FG012|Part 2: Treatment Phase|Other|0|||
125652896|NCT04668066|452013640|FG013|Part 2: Treatment Phase|Other|0|||
125652897|NCT04668066|452013641|FG014|Part 2: Treatment Phase|Other|0|||
125652898|NCT04668066|452013642|FG015|Part 2: Treatment Phase|Other|0|||
125652899|NCT04668066|452013643|FG016|Part 2: Treatment Phase|Other|0|||
125652900|NCT04668066|452013644|FG017|Part 2: Treatment Phase|Other|0|||
125652901|NCT04668066|452013645|FG018|Part 2: Treatment Phase|Other|1|||
125652902|NCT04668066|452013627|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652903|NCT04668066|452013628|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652904|NCT04668066|452013629|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652905|NCT04668066|452013630|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652906|NCT04668066|452013631|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652907|NCT04668066|452013632|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652908|NCT04668066|452013633|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652909|NCT04668066|452013634|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652910|NCT04668066|452013635|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652911|NCT04668066|452013636|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652912|NCT04668066|452013637|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652913|NCT04668066|452013638|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652914|NCT04668066|452013639|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652915|NCT04668066|452013640|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652916|NCT04668066|452013641|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652917|NCT04668066|452013642|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652918|NCT04668066|452013643|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652919|NCT04668066|452013644|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
125652920|NCT04668066|452013645|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
125652921|NCT01195662|452013650|FG000|Double Blind Treatment Period|Adverse Event|4|||
125652922|NCT01195662|452013651|FG001|Double Blind Treatment Period|Adverse Event|1|||
125652923|NCT01195662|452013652|FG002|Double Blind Treatment Period|Adverse Event|2|||
125652924|NCT01195662|452013650|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
125652925|NCT01195662|452013651|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
125652926|NCT01195662|452013652|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
125652927|NCT01195662|452013650|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
125652928|NCT01195662|452013651|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
125652929|NCT01195662|452013652|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
125652930|NCT01195662|452013650|FG000|Double Blind Treatment Period|Administrative reason|2|||
125652931|NCT01195662|452013651|FG001|Double Blind Treatment Period|Administrative reason|1|||
125652932|NCT01195662|452013652|FG002|Double Blind Treatment Period|Administrative reason|1|||
125652933|NCT01195662|452013650|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
125652934|NCT01195662|452013651|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
125652935|NCT01195662|452013652|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
125652936|NCT01195662|452013650|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
125652937|NCT01195662|452013651|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
125652938|NCT01195662|452013652|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
125652939|NCT01195662|452013650|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
125210505|NCT01911793|450395580|FG001|Overall Study|Physician Decision|5|||
125652940|NCT01195662|452013651|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
125652941|NCT01195662|452013652|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
125652942|NCT01195662|452013650|FG000|Double Blind Treatment Period|Non-specified|3|||
125652943|NCT01195662|452013651|FG001|Double Blind Treatment Period|Non-specified|0|||
125652944|NCT01195662|452013652|FG002|Double Blind Treatment Period|Non-specified|0|||
125652945|NCT01195662|452013650|FG000|Double Blind Treatment Period|Missing disposition information|0|||
125652946|NCT01195662|452013651|FG001|Double Blind Treatment Period|Missing disposition information|1|||
125652947|NCT01195662|452013652|FG002|Double Blind Treatment Period|Missing disposition information|1|||
125652948|NCT01195662|452013650|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
125652949|NCT01195662|452013651|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
125652950|NCT01195662|452013652|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
125652951|NCT01195662|452013650|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
125652952|NCT01195662|452013651|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
125652953|NCT01195662|452013652|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
125652954|NCT01215968|452013653|FG000|Overall Study|Adverse Event|0|||
125652955|NCT01215968|452013654|FG001|Overall Study|Adverse Event|2|||
125652956|NCT01215968|452013653|FG000|Overall Study|Protocol Violation|2|||
125652957|NCT01215968|452013654|FG001|Overall Study|Protocol Violation|4|||
125652958|NCT01215968|452013653|FG000|Overall Study|Not received study drug|0|||
125652959|NCT01215968|452013654|FG001|Overall Study|Not received study drug|1|||
125652960|NCT05643573|452013658|FG000|Overall Study|Adverse Event|117|||
125652961|NCT05643573|452013659|FG001|Overall Study|Adverse Event|90|||
125652962|NCT05643573|452013658|FG000|Overall Study|Death|53|||
125652963|NCT05643573|452013659|FG001|Overall Study|Death|57|||
125652964|NCT05643573|452013658|FG000|Overall Study|Lost to Follow-up|6|||
125652965|NCT05643573|452013659|FG001|Overall Study|Lost to Follow-up|3|||
125652966|NCT05643573|452013658|FG000|Overall Study|Other|18|||
125652967|NCT05643573|452013659|FG001|Overall Study|Other|15|||
125652968|NCT05643573|452013658|FG000|Overall Study|Outcome event|64|||
125314035|NCT03347123|450779357|FG002|Overall Study|Reason not Specified|0|||
125652969|NCT05643573|452013659|FG001|Overall Study|Outcome event|36|||
125652970|NCT05643573|452013658|FG000|Overall Study|Physician Decision|33|||
125652971|NCT05643573|452013659|FG001|Overall Study|Physician Decision|19|||
125652972|NCT05643573|452013658|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
125652973|NCT05643573|452013659|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
125652974|NCT05643573|452013658|FG000|Overall Study|Site terminated by sponsor|10|||
125652975|NCT05643573|452013659|FG001|Overall Study|Site terminated by sponsor|10|||
125652976|NCT05643573|452013658|FG000|Overall Study|Study terminated by sponsor|1|||
125652977|NCT05643573|452013659|FG001|Overall Study|Study terminated by sponsor|0|||
125652978|NCT05643573|452013658|FG000|Overall Study|Withdrawal by Subject|178|||
125652979|NCT05643573|452013659|FG001|Overall Study|Withdrawal by Subject|130|||
125652980|NCT04768881|452013662|FG000|Overall Study|Completed Study Follow-up|0|||
125652981|NCT04768881|452013663|FG001|Overall Study|Completed Study Follow-up|2|||
125652982|NCT04768881|452013662|FG000|Overall Study|Death|3|||
125652983|NCT04768881|452013663|FG001|Overall Study|Death|2|||
125652984|NCT04768881|452013662|FG000|Overall Study|Study Terminated by Sponsor|2|||
125652985|NCT04768881|452013663|FG001|Overall Study|Study Terminated by Sponsor|2|||
125652986|NCT04768881|452013662|FG000|Overall Study|Withdrawal by Subject|2|||
125652987|NCT04768881|452013663|FG001|Overall Study|Withdrawal by Subject|0|||
125652988|NCT04768881|452013662|FG000|Overall Study|Other|2|||
125652989|NCT04768881|452013663|FG001|Overall Study|Other|0|||
125652990|NCT01083121|452013665|FG000|Overall Study|Use of Humira outside the approved label|81|||
125652991|NCT01958619|452013670|FG000|Overall Study|Protocol Violation|2|||
125652992|NCT01958619|452013671|FG001|Overall Study|Protocol Violation|0|||
125652993|NCT01958619|452013672|FG002|Overall Study|Protocol Violation|1|||
125652994|NCT01958619|452013673|FG003|Overall Study|Protocol Violation|0|||
125652995|NCT00985114|452013675|FG000|Overall Study|Adverse Event|1|||
125652996|NCT00985114|452013676|FG001|Overall Study|Adverse Event|0|||
125652997|NCT00985114|452013675|FG000|Overall Study|Withdrawal by Subject|0|||
125314036|NCT03347123|450779358|FG003|Overall Study|Reason not Specified|0|||
125652998|NCT00985114|452013676|FG001|Overall Study|Withdrawal by Subject|2|||
125652999|NCT01119118|452013677|FG000|Overall Study|Adverse Event|1|||
125653000|NCT01593761|452013680|FG000|Overall Study|Lost to Follow-up|1|||
125653001|NCT01593761|452013680|FG000|Overall Study|culture negative for MRSA at baseline|5|||
125653002|NCT01593761|452013680|FG000|Overall Study|positive for hepatitis C virus|1|||
125653003|NCT01593761|452013680|FG000|Overall Study|secondary cellulitis|1|||
125653004|NCT01302366|452015207|FG000|Overall Study|patient choice or noncompliance|5|||
125653005|NCT00509223|452015210|FG000|Overall Study|Lost to Follow-up|1|||
125653006|NCT00509223|452015211|FG001|Overall Study|Lost to Follow-up|1|||
125653007|NCT00509223|452015210|FG000|Overall Study|Adverse Event|1|||
125653008|NCT00509223|452015211|FG001|Overall Study|Adverse Event|1|||
125653009|NCT00509223|452015210|FG000|Overall Study|Withdrawal by Subject|25|||
125653010|NCT00509223|452015211|FG001|Overall Study|Withdrawal by Subject|6|||
125653011|NCT00509223|452015210|FG000|Overall Study|Including: subject change of address|5|||
125653012|NCT00509223|452015211|FG001|Overall Study|Including: subject change of address|2|||
125653013|NCT00509223|452015210|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
125653014|NCT00509223|452015211|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
125314037|NCT03347123|450779359|FG004|Overall Study|Reason not Specified|0|||
125653015|NCT00934661|452015212|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
125653016|NCT00934661|452015213|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
125653017|NCT00467051|452015214|FG000|Overall Study|Adverse Event|2|||
125653018|NCT00437294|452015215|FG000|Overall Study|Adverse Event|5|||
125653019|NCT00437294|452015216|FG001|Overall Study|Adverse Event|4|||
125653020|NCT00437294|452015215|FG000|Overall Study|Death|5|||
125653021|NCT00437294|452015216|FG001|Overall Study|Death|2|||
125653022|NCT00437294|452015215|FG000|Overall Study|Physician Decision|0|||
125653023|NCT00437294|452015216|FG001|Overall Study|Physician Decision|3|||
125653024|NCT00437294|452015215|FG000|Overall Study|Withdrawal by Subject|5|||
125653025|NCT00437294|452015216|FG001|Overall Study|Withdrawal by Subject|0|||
125653026|NCT00437294|452015215|FG000|Overall Study|Progressive Disease|19|||
125653027|NCT00437294|452015216|FG001|Overall Study|Progressive Disease|23|||
125653028|NCT00437294|452015215|FG000|Overall Study|Sponsor Decision|8|||
125653029|NCT00437294|452015216|FG001|Overall Study|Sponsor Decision|9|||
125653030|NCT00437294|452015215|FG000|Overall Study|Protocol Violation|0|||
125653031|NCT00437294|452015216|FG001|Overall Study|Protocol Violation|1|||
125653032|NCT00437294|452015215|FG000|Overall Study|Entry criteria not met|1|||
125653033|NCT00437294|452015216|FG001|Overall Study|Entry criteria not met|1|||
125653034|NCT05279807|452015220|FG000|Overall Study|Withdrawal by Subject|1|||
125653035|NCT05279807|452015221|FG001|Overall Study|Withdrawal by Subject|0|||
125653036|NCT05279807|452015220|FG000|Overall Study|Adverse Event|0|||
125653037|NCT05279807|452015221|FG001|Overall Study|Adverse Event|1|||
125653038|NCT05279807|452015220|FG000|Overall Study|Laboratory Abnormal Results|1|||
125653039|NCT05279807|452015221|FG001|Overall Study|Laboratory Abnormal Results|0|||
125653040|NCT03113760|452015224|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
125653041|NCT03113760|452015225|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
125653042|NCT03113760|452015226|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
125653043|NCT03113760|452015227|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
125653044|NCT03113760|452015224|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
125653045|NCT03113760|452015225|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
125653046|NCT03113760|452015226|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
125653047|NCT03113760|452015227|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
125653048|NCT03113760|452015224|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
125653049|NCT03113760|452015225|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
125653050|NCT03113760|452015226|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
125653051|NCT03113760|452015227|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
125653052|NCT01012609|452015228|FG000|Overall Study|Withdrawal by Subject|1|||
125653053|NCT01012609|452015229|FG001|Overall Study|Withdrawal by Subject|1|||
125653054|NCT01453296|452015230|FG000|Treatment Period 1|Adverse Event|0|||
125653055|NCT01453296|452015231|FG001|Treatment Period 1|Adverse Event|1|||
125653056|NCT01453296|452015230|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
125653057|NCT01453296|452015231|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
125653058|NCT01453296|452015230|FG000|Treatment Period 2|Adverse Event|1|||
125653059|NCT01453296|452015231|FG001|Treatment Period 2|Adverse Event|0|||
125653060|NCT01453296|452015230|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125653061|NCT01453296|452015231|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125653062|NCT03557775|452015232|FG000|Overall Study|Withdrawal by Subject|1|||
125653063|NCT03557775|452015233|FG001|Overall Study|Withdrawal by Subject|2|||
125653064|NCT03557775|452015234|FG002|Overall Study|Withdrawal by Subject|4|||
125653065|NCT03557775|452015232|FG000|Overall Study|Physician Decision|0|||
125653066|NCT03557775|452015233|FG001|Overall Study|Physician Decision|1|||
125653067|NCT03557775|452015234|FG002|Overall Study|Physician Decision|0|||
125653068|NCT03205046|452015242|FG000|Overall Study|Death|10|||
125653069|NCT03205046|452015243|FG001|Overall Study|Death|6|||
125653070|NCT03205046|452015242|FG000|Overall Study|Withdrawal by Subject|1|||
125653071|NCT03205046|452015243|FG001|Overall Study|Withdrawal by Subject|2|||
125653072|NCT03205046|452015242|FG000|Overall Study|Lost to Follow-up|0|||
125653073|NCT03205046|452015243|FG001|Overall Study|Lost to Follow-up|1|||
125653074|NCT03205046|452015242|FG000|Overall Study|Study terminated by sponsor|2|||
125653075|NCT03205046|452015243|FG001|Overall Study|Study terminated by sponsor|1|||
125653076|NCT01023815|452015244|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
125653077|NCT01023815|452015245|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
125653078|NCT01023815|452015246|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
125314038|NCT03347123|450779360|FG005|Overall Study|Reason not Specified|0|||
125314039|NCT03347123|450779361|FG006|Overall Study|Reason not Specified|0|||
125314040|NCT01132807|450779362|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
125314041|NCT01132807|450779363|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
125653079|NCT01023815|452015247|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
125653080|NCT01023815|452015244|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
125653081|NCT01023815|452015245|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
125314042|NCT01132807|450779364|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
125314043|NCT01132807|450779362|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
125653082|NCT01023815|452015246|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
125653083|NCT01023815|452015247|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
125653084|NCT01023815|452015244|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
125653085|NCT01023815|452015245|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
125653086|NCT01023815|452015246|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
125653087|NCT01023815|452015247|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
125653088|NCT01023815|452015244|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
125653089|NCT01023815|452015245|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
125653090|NCT01023815|452015246|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
125653091|NCT01023815|452015247|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
125653092|NCT01023815|452015244|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
125653093|NCT01023815|452015245|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
125653094|NCT01023815|452015246|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
125653095|NCT01023815|452015247|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
125653096|NCT03253809|452015250|FG000|Overall Study|Unable to obtain study related data|14|||
125653097|NCT02319642|452015251|FG000|Overall Study|Adverse Event|2|||
125653098|NCT02319642|452015252|FG001|Overall Study|Adverse Event|4|||
125653099|NCT02319642|452015251|FG000|Overall Study|Lack of Efficacy|1|||
125653100|NCT02319642|452015252|FG001|Overall Study|Lack of Efficacy|1|||
125653101|NCT02319642|452015251|FG000|Overall Study|Withdrawal by Subject|1|||
125653102|NCT02319642|452015252|FG001|Overall Study|Withdrawal by Subject|1|||
125653103|NCT05048875|452015258|FG000|Overall Study|Withdrawal by Subject|1|||
125653104|NCT05048875|452015259|FG001|Overall Study|Withdrawal by Subject|0|||
125653105|NCT05048875|452015260|FG002|Overall Study|Withdrawal by Subject|0|||
125653106|NCT05048875|452015261|FG003|Overall Study|Withdrawal by Subject|0|||
125653107|NCT05048875|452015262|FG004|Overall Study|Withdrawal by Subject|0|||
125653108|NCT05048875|452015263|FG005|Overall Study|Withdrawal by Subject|0|||
125653109|NCT05048875|452015264|FG006|Overall Study|Withdrawal by Subject|0|||
125653110|NCT05048875|452015265|FG007|Overall Study|Withdrawal by Subject|0|||
125653111|NCT05048875|452015258|FG000|Overall Study|Adverse Event|0|||
125653112|NCT05048875|452015259|FG001|Overall Study|Adverse Event|0|||
125653113|NCT05048875|452015260|FG002|Overall Study|Adverse Event|0|||
125653114|NCT05048875|452015261|FG003|Overall Study|Adverse Event|1|||
125653115|NCT05048875|452015262|FG004|Overall Study|Adverse Event|0|||
125653116|NCT05048875|452015263|FG005|Overall Study|Adverse Event|0|||
125653117|NCT05048875|452015264|FG006|Overall Study|Adverse Event|0|||
125653118|NCT05048875|452015265|FG007|Overall Study|Adverse Event|0|||
125653119|NCT02255422|452015270|FG000|Overall Study|Withdrawal by Subject|0|||
125653120|NCT02255422|452015271|FG001|Overall Study|Withdrawal by Subject|0|||
125653121|NCT02255422|452015272|FG002|Overall Study|Withdrawal by Subject|0|||
125653122|NCT02255422|452015273|FG003|Overall Study|Withdrawal by Subject|0|||
125653123|NCT02255422|452015274|FG004|Overall Study|Withdrawal by Subject|0|||
125653124|NCT02255422|452015275|FG005|Overall Study|Withdrawal by Subject|0|||
125653125|NCT02255422|452015276|FG006|Overall Study|Withdrawal by Subject|2|||
125653126|NCT02255422|452015270|FG000|Overall Study|Lost to Follow-up|0|||
125653127|NCT02255422|452015271|FG001|Overall Study|Lost to Follow-up|0|||
125653128|NCT02255422|452015272|FG002|Overall Study|Lost to Follow-up|1|||
125653129|NCT02255422|452015273|FG003|Overall Study|Lost to Follow-up|0|||
125653130|NCT02255422|452015274|FG004|Overall Study|Lost to Follow-up|0|||
125653131|NCT02255422|452015275|FG005|Overall Study|Lost to Follow-up|0|||
125653132|NCT02255422|452015276|FG006|Overall Study|Lost to Follow-up|0|||
125653133|NCT04411641|452015277|FG000|DB Period|Other|7|||
125653134|NCT04411641|452015278|FG001|DB Period|Other|27|||
125653135|NCT04411641|452015279|FG002|DB Period|Other|0|||
125653136|NCT04411641|452015280|FG003|DB Period|Other|0|||
125653137|NCT04411641|452015277|FG000|DB Period|Withdrawal by Subject|67|||
125653138|NCT04411641|452015278|FG001|DB Period|Withdrawal by Subject|122|||
125653139|NCT04411641|452015279|FG002|DB Period|Withdrawal by Subject|0|||
125314044|NCT01132807|450779363|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
125653140|NCT04411641|452015280|FG003|DB Period|Withdrawal by Subject|0|||
125653141|NCT04411641|452015277|FG000|DB Period|Progressive disease|76|||
125653142|NCT04411641|452015278|FG001|DB Period|Progressive disease|116|||
125653143|NCT04411641|452015279|FG002|DB Period|Progressive disease|0|||
125653144|NCT04411641|452015280|FG003|DB Period|Progressive disease|0|||
125653145|NCT04411641|452015277|FG000|DB Period|Poor compliance to protocol|1|||
125653146|NCT04411641|452015278|FG001|DB Period|Poor compliance to protocol|5|||
125653147|NCT04411641|452015279|FG002|DB Period|Poor compliance to protocol|0|||
125314045|NCT01132807|450779364|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
125653148|NCT04411641|452015280|FG003|DB Period|Poor compliance to protocol|0|||
125653149|NCT04411641|452015277|FG000|DB Period|Lack of Efficacy|19|||
125653150|NCT04411641|452015278|FG001|DB Period|Lack of Efficacy|19|||
125653151|NCT04411641|452015279|FG002|DB Period|Lack of Efficacy|0|||
125653152|NCT04411641|452015280|FG003|DB Period|Lack of Efficacy|0|||
125653153|NCT04411641|452015277|FG000|DB Period|Adverse Event|13|||
125653154|NCT04411641|452015278|FG001|DB Period|Adverse Event|29|||
125653155|NCT04411641|452015279|FG002|DB Period|Adverse Event|0|||
125653156|NCT04411641|452015280|FG003|DB Period|Adverse Event|0|||
125653157|NCT04411641|452015277|FG000|DB Period|Randomized and not treated|2|||
125653158|NCT04411641|452015278|FG001|DB Period|Randomized and not treated|2|||
125653159|NCT04411641|452015279|FG002|DB Period|Randomized and not treated|0|||
125653160|NCT04411641|452015280|FG003|DB Period|Randomized and not treated|0|||
125653161|NCT04411641|452015277|FG000|OL|Withdrawal by Subject|0|||
125653162|NCT04411641|452015278|FG001|OL|Withdrawal by Subject|0|||
125653163|NCT04411641|452015279|FG002|OL|Withdrawal by Subject|6|||
125653164|NCT04411641|452015280|FG003|OL|Withdrawal by Subject|17|||
125653165|NCT04411641|452015277|FG000|OL|Progressive disease|0|||
125653166|NCT04411641|452015278|FG001|OL|Progressive disease|0|||
125653167|NCT04411641|452015279|FG002|OL|Progressive disease|1|||
125653168|NCT04411641|452015280|FG003|OL|Progressive disease|2|||
125653169|NCT04411641|452015277|FG000|OL|Poor compliance to protocol|0|||
125653170|NCT04411641|452015278|FG001|OL|Poor compliance to protocol|0|||
125653171|NCT04411641|452015279|FG002|OL|Poor compliance to protocol|1|||
125653172|NCT04411641|452015280|FG003|OL|Poor compliance to protocol|0|||
125653173|NCT04411641|452015277|FG000|OL|Adverse Event|0|||
125653174|NCT04411641|452015278|FG001|OL|Adverse Event|0|||
125653175|NCT04411641|452015279|FG002|OL|Adverse Event|1|||
125653176|NCT04411641|452015280|FG003|OL|Adverse Event|0|||
125653177|NCT04411641|452015277|FG000|OL|Other|0|||
125653178|NCT04411641|452015278|FG001|OL|Other|0|||
125653179|NCT04411641|452015279|FG002|OL|Other|0|||
125653180|NCT04411641|452015280|FG003|OL|Other|6|||
125653181|NCT01250418|452015288|FG000|Overall Study|monitor data failure|1|||
125653182|NCT01250418|452015289|FG001|Overall Study|monitor data failure|1|||
125653183|NCT01761565|452015290|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
125653184|NCT05182840|452015292|FG000|Run-in Period|Not treated|0|||
125653185|NCT05182840|452015293|FG001|Run-in Period|Not treated|1|||
125653186|NCT05182840|452015294|FG002|Run-in Period|Not treated|0|||
125653187|NCT05182840|452015295|FG003|Run-in Period|Not treated|0|||
125653188|NCT05182840|452015296|FG004|Run-in Period|Not treated|0|||
125653189|NCT05182840|452015297|FG005|Run-in Period|Not treated|0|||
125653190|NCT05182840|452015298|FG006|Run-in Period|Not treated|0|||
125653191|NCT05182840|452015299|FG007|Run-in Period|Not treated|0|||
125653192|NCT05182840|452015300|FG008|Run-in Period|Not treated|0|||
125653193|NCT05182840|452015301|FG009|Run-in Period|Not treated|0|||
125653194|NCT05182840|452015292|FG000|Run-in Period|Other reason but not sponsor termination|14|||
125653195|NCT05182840|452015293|FG001|Run-in Period|Other reason but not sponsor termination|18|||
125653196|NCT05182840|452015294|FG002|Run-in Period|Other reason but not sponsor termination|0|||
125653197|NCT05182840|452015295|FG003|Run-in Period|Other reason but not sponsor termination|0|||
125653198|NCT05182840|452015296|FG004|Run-in Period|Other reason but not sponsor termination|0|||
125653199|NCT05182840|452015297|FG005|Run-in Period|Other reason but not sponsor termination|0|||
125653200|NCT05182840|452015298|FG006|Run-in Period|Other reason but not sponsor termination|0|||
125653201|NCT05182840|452015299|FG007|Run-in Period|Other reason but not sponsor termination|0|||
125653202|NCT05182840|452015300|FG008|Run-in Period|Other reason but not sponsor termination|0|||
125653203|NCT05182840|452015301|FG009|Run-in Period|Other reason but not sponsor termination|0|||
125653204|NCT05182840|452015292|FG000|Run-in Period|No reason available|2|||
125653205|NCT05182840|452015293|FG001|Run-in Period|No reason available|2|||
125653206|NCT05182840|452015294|FG002|Run-in Period|No reason available|0|||
125653207|NCT05182840|452015295|FG003|Run-in Period|No reason available|0|||
125653208|NCT05182840|452015296|FG004|Run-in Period|No reason available|0|||
125653209|NCT05182840|452015297|FG005|Run-in Period|No reason available|0|||
125653210|NCT05182840|452015298|FG006|Run-in Period|No reason available|0|||
125653211|NCT05182840|452015299|FG007|Run-in Period|No reason available|0|||
125653212|NCT05182840|452015300|FG008|Run-in Period|No reason available|0|||
125653213|NCT05182840|452015301|FG009|Run-in Period|No reason available|0|||
125653214|NCT05182840|452015292|FG000|Run-in Period|Burden of study procedures|2|||
125653215|NCT05182840|452015293|FG001|Run-in Period|Burden of study procedures|2|||
125653216|NCT05182840|452015294|FG002|Run-in Period|Burden of study procedures|0|||
125653217|NCT05182840|452015295|FG003|Run-in Period|Burden of study procedures|0|||
125653218|NCT05182840|452015296|FG004|Run-in Period|Burden of study procedures|0|||
125653219|NCT05182840|452015297|FG005|Run-in Period|Burden of study procedures|0|||
125653220|NCT05182840|452015298|FG006|Run-in Period|Burden of study procedures|0|||
125314046|NCT02043938|450779368|FG000|Overall Study|Withdrawal by Subject|7|||
125653221|NCT05182840|452015299|FG007|Run-in Period|Burden of study procedures|0|||
125653222|NCT05182840|452015300|FG008|Run-in Period|Burden of study procedures|0|||
125653223|NCT05182840|452015301|FG009|Run-in Period|Burden of study procedures|0|||
125653224|NCT05182840|452015292|FG000|Run-in Period|Change of residence|1|||
125653225|NCT05182840|452015293|FG001|Run-in Period|Change of residence|0|||
125653226|NCT05182840|452015294|FG002|Run-in Period|Change of residence|0|||
125653227|NCT05182840|452015295|FG003|Run-in Period|Change of residence|0|||
125653228|NCT05182840|452015296|FG004|Run-in Period|Change of residence|0|||
125653229|NCT05182840|452015297|FG005|Run-in Period|Change of residence|0|||
125653230|NCT05182840|452015298|FG006|Run-in Period|Change of residence|0|||
125653231|NCT05182840|452015299|FG007|Run-in Period|Change of residence|0|||
125653232|NCT05182840|452015300|FG008|Run-in Period|Change of residence|0|||
125653233|NCT05182840|452015301|FG009|Run-in Period|Change of residence|0|||
125653234|NCT05182840|452015292|FG000|Run-in Period|Adverse Event|5|||
125653235|NCT05182840|452015293|FG001|Run-in Period|Adverse Event|5|||
125653236|NCT05182840|452015294|FG002|Run-in Period|Adverse Event|0|||
125653237|NCT05182840|452015295|FG003|Run-in Period|Adverse Event|0|||
125653238|NCT05182840|452015296|FG004|Run-in Period|Adverse Event|0|||
125653239|NCT05182840|452015297|FG005|Run-in Period|Adverse Event|0|||
125653240|NCT05182840|452015298|FG006|Run-in Period|Adverse Event|0|||
125653241|NCT05182840|452015299|FG007|Run-in Period|Adverse Event|0|||
125653242|NCT05182840|452015300|FG008|Run-in Period|Adverse Event|0|||
125653243|NCT05182840|452015301|FG009|Run-in Period|Adverse Event|0|||
125653244|NCT05182840|452015292|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
125653245|NCT05182840|452015293|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
125653246|NCT05182840|452015294|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125653247|NCT05182840|452015295|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125653248|NCT05182840|452015296|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125653249|NCT05182840|452015297|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125653250|NCT05182840|452015298|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125653251|NCT05182840|452015299|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125653252|NCT05182840|452015300|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125653253|NCT05182840|452015301|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
125653254|NCT05182840|452015292|FG000|Treatment Period|Reason missing|0|||
125653255|NCT05182840|452015293|FG001|Treatment Period|Reason missing|0|||
125653256|NCT05182840|452015294|FG002|Treatment Period|Reason missing|1|||
125653257|NCT05182840|452015295|FG003|Treatment Period|Reason missing|0|||
125653258|NCT05182840|452015296|FG004|Treatment Period|Reason missing|0|||
125653259|NCT05182840|452015297|FG005|Treatment Period|Reason missing|0|||
125653260|NCT05182840|452015298|FG006|Treatment Period|Reason missing|0|||
125653261|NCT05182840|452015299|FG007|Treatment Period|Reason missing|0|||
125653262|NCT05182840|452015300|FG008|Treatment Period|Reason missing|0|||
125653263|NCT05182840|452015301|FG009|Treatment Period|Reason missing|0|||
125653264|NCT05182840|452015292|FG000|Treatment Period|Other but not sponsor termination|0|||
125653265|NCT05182840|452015293|FG001|Treatment Period|Other but not sponsor termination|0|||
125653266|NCT05182840|452015294|FG002|Treatment Period|Other but not sponsor termination|8|||
125653267|NCT05182840|452015295|FG003|Treatment Period|Other but not sponsor termination|6|||
125653268|NCT05182840|452015296|FG004|Treatment Period|Other but not sponsor termination|6|||
125653269|NCT05182840|452015297|FG005|Treatment Period|Other but not sponsor termination|7|||
125653270|NCT05182840|452015298|FG006|Treatment Period|Other but not sponsor termination|5|||
125653271|NCT05182840|452015299|FG007|Treatment Period|Other but not sponsor termination|8|||
125653272|NCT05182840|452015300|FG008|Treatment Period|Other but not sponsor termination|7|||
125653273|NCT05182840|452015301|FG009|Treatment Period|Other but not sponsor termination|2|||
125653274|NCT05182840|452015292|FG000|Treatment Period|Protocol deviation|0|||
125653275|NCT05182840|452015293|FG001|Treatment Period|Protocol deviation|0|||
125653276|NCT05182840|452015294|FG002|Treatment Period|Protocol deviation|0|||
125653277|NCT05182840|452015295|FG003|Treatment Period|Protocol deviation|0|||
125653278|NCT05182840|452015296|FG004|Treatment Period|Protocol deviation|0|||
125653279|NCT05182840|452015297|FG005|Treatment Period|Protocol deviation|0|||
125653280|NCT05182840|452015298|FG006|Treatment Period|Protocol deviation|0|||
125653281|NCT05182840|452015299|FG007|Treatment Period|Protocol deviation|0|||
125653282|NCT05182840|452015300|FG008|Treatment Period|Protocol deviation|1|||
125653283|NCT05182840|452015301|FG009|Treatment Period|Protocol deviation|0|||
125653284|NCT05182840|452015292|FG000|Treatment Period|No reason available|0|||
125653285|NCT05182840|452015293|FG001|Treatment Period|No reason available|0|||
125653286|NCT05182840|452015294|FG002|Treatment Period|No reason available|0|||
125653287|NCT05182840|452015295|FG003|Treatment Period|No reason available|1|||
125653288|NCT05182840|452015296|FG004|Treatment Period|No reason available|0|||
125653289|NCT05182840|452015297|FG005|Treatment Period|No reason available|2|||
125653290|NCT05182840|452015298|FG006|Treatment Period|No reason available|0|||
125653291|NCT05182840|452015299|FG007|Treatment Period|No reason available|1|||
125653292|NCT05182840|452015300|FG008|Treatment Period|No reason available|0|||
125653293|NCT05182840|452015301|FG009|Treatment Period|No reason available|0|||
125653294|NCT05182840|452015292|FG000|Treatment Period|Burden of study procedures|0|||
125653295|NCT05182840|452015293|FG001|Treatment Period|Burden of study procedures|0|||
125653296|NCT05182840|452015294|FG002|Treatment Period|Burden of study procedures|0|||
125653297|NCT05182840|452015295|FG003|Treatment Period|Burden of study procedures|0|||
125653298|NCT05182840|452015296|FG004|Treatment Period|Burden of study procedures|1|||
125653299|NCT05182840|452015297|FG005|Treatment Period|Burden of study procedures|0|||
125653300|NCT05182840|452015298|FG006|Treatment Period|Burden of study procedures|0|||
125653301|NCT05182840|452015299|FG007|Treatment Period|Burden of study procedures|0|||
125653302|NCT05182840|452015300|FG008|Treatment Period|Burden of study procedures|0|||
125653303|NCT05182840|452015301|FG009|Treatment Period|Burden of study procedures|0|||
125653304|NCT05182840|452015292|FG000|Treatment Period|Change of residence|0|||
125653305|NCT05182840|452015293|FG001|Treatment Period|Change of residence|0|||
125653306|NCT05182840|452015294|FG002|Treatment Period|Change of residence|0|||
125653307|NCT05182840|452015295|FG003|Treatment Period|Change of residence|0|||
125653308|NCT05182840|452015296|FG004|Treatment Period|Change of residence|0|||
125653309|NCT05182840|452015297|FG005|Treatment Period|Change of residence|1|||
125653310|NCT05182840|452015298|FG006|Treatment Period|Change of residence|0|||
125653311|NCT05182840|452015299|FG007|Treatment Period|Change of residence|0|||
125653312|NCT05182840|452015300|FG008|Treatment Period|Change of residence|0|||
125653313|NCT05182840|452015301|FG009|Treatment Period|Change of residence|0|||
125653314|NCT05182840|452015292|FG000|Treatment Period|Adverse Event|0|||
125653315|NCT05182840|452015293|FG001|Treatment Period|Adverse Event|0|||
125653316|NCT05182840|452015294|FG002|Treatment Period|Adverse Event|4|||
125653317|NCT05182840|452015295|FG003|Treatment Period|Adverse Event|16|||
125653318|NCT05182840|452015296|FG004|Treatment Period|Adverse Event|12|||
125653319|NCT05182840|452015297|FG005|Treatment Period|Adverse Event|6|||
125653320|NCT05182840|452015298|FG006|Treatment Period|Adverse Event|4|||
125653321|NCT05182840|452015299|FG007|Treatment Period|Adverse Event|8|||
125653322|NCT05182840|452015300|FG008|Treatment Period|Adverse Event|16|||
125653323|NCT05182840|452015301|FG009|Treatment Period|Adverse Event|5|||
125653324|NCT05182840|452015292|FG000|Treatment Period|Not treated with study drug|0|||
125653325|NCT05182840|452015293|FG001|Treatment Period|Not treated with study drug|0|||
125653326|NCT05182840|452015294|FG002|Treatment Period|Not treated with study drug|0|||
125653327|NCT05182840|452015295|FG003|Treatment Period|Not treated with study drug|1|||
125653328|NCT05182840|452015296|FG004|Treatment Period|Not treated with study drug|0|||
125653329|NCT05182840|452015297|FG005|Treatment Period|Not treated with study drug|0|||
125653330|NCT05182840|452015298|FG006|Treatment Period|Not treated with study drug|1|||
125653331|NCT05182840|452015299|FG007|Treatment Period|Not treated with study drug|1|||
125653332|NCT05182840|452015300|FG008|Treatment Period|Not treated with study drug|0|||
125653333|NCT05182840|452015301|FG009|Treatment Period|Not treated with study drug|0|||
125653334|NCT02161380|452015302|FG000|Overall Study|Lost to Follow-up|0|||
125653335|NCT02161380|452015303|FG001|Overall Study|Lost to Follow-up|1|||
125653336|NCT02161380|452015304|FG002|Overall Study|Lost to Follow-up|0|||
125653337|NCT02161380|452015305|FG003|Overall Study|Lost to Follow-up|0|||
125653338|NCT02268214|452015312|FG000|Overall Study|Subject no longer meets study criteria|0|||
125653339|NCT02268214|452015313|FG001|Overall Study|Subject no longer meets study criteria|2|||
125653340|NCT02268214|452015314|FG002|Overall Study|Subject no longer meets study criteria|0|||
125653341|NCT02268214|452015312|FG000|Overall Study|Pregnancy|2|||
125653342|NCT02268214|452015313|FG001|Overall Study|Pregnancy|2|||
125653343|NCT02268214|452015314|FG002|Overall Study|Pregnancy|1|||
125653344|NCT02268214|452015312|FG000|Overall Study|Lost to Follow-up|3|||
125653345|NCT02268214|452015313|FG001|Overall Study|Lost to Follow-up|3|||
125653346|NCT02268214|452015314|FG002|Overall Study|Lost to Follow-up|4|||
125653347|NCT02268214|452015312|FG000|Overall Study|Lack of Efficacy|1|||
125653348|NCT02268214|452015313|FG001|Overall Study|Lack of Efficacy|0|||
125653349|NCT02268214|452015314|FG002|Overall Study|Lack of Efficacy|2|||
125653350|NCT02268214|452015312|FG000|Overall Study|Adverse Event|11|||
125653351|NCT02268214|452015313|FG001|Overall Study|Adverse Event|14|||
125653352|NCT02268214|452015314|FG002|Overall Study|Adverse Event|9|||
125653353|NCT02268214|452015312|FG000|Overall Study|Withdrawal by Subject|4|||
125653354|NCT02268214|452015313|FG001|Overall Study|Withdrawal by Subject|5|||
125653355|NCT02268214|452015314|FG002|Overall Study|Withdrawal by Subject|10|||
125653356|NCT02268214|452015312|FG000|Overall Study|Subject request to discontinue treatment|10|||
125653357|NCT02268214|452015313|FG001|Overall Study|Subject request to discontinue treatment|8|||
125653358|NCT02268214|452015314|FG002|Overall Study|Subject request to discontinue treatment|6|||
125653359|NCT02268214|452015312|FG000|Overall Study|Poor/non-compliance|2|||
125653360|NCT02268214|452015313|FG001|Overall Study|Poor/non-compliance|1|||
125653361|NCT02268214|452015314|FG002|Overall Study|Poor/non-compliance|2|||
125653362|NCT02268214|452015312|FG000|Overall Study|Other reasons|7|||
125653363|NCT02268214|452015313|FG001|Overall Study|Other reasons|3|||
125314047|NCT02043938|450779368|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
125653364|NCT02268214|452015314|FG002|Overall Study|Other reasons|3|||
125653365|NCT02268214|452015312|FG000|Overall Study|Not entering long-term period|2|||
125653366|NCT02268214|452015313|FG001|Overall Study|Not entering long-term period|3|||
125653367|NCT02268214|452015314|FG002|Overall Study|Not entering long-term period|5|||
125653368|NCT04342390|452015315|FG000|Overall Study|Lost to Follow-up|3|||
125653369|NCT04342390|452015316|FG001|Overall Study|Lost to Follow-up|0|||
125653370|NCT00948896|452015326|FG000|Randomization to 24 Months of Age|Death|1|||
125653371|NCT00948896|452015327|FG001|Randomization to 24 Months of Age|Death|0|||
125653372|NCT00948896|452015328|FG002|Randomization to 24 Months of Age|Death|0|||
125653373|NCT00948896|452015329|FG003|Randomization to 24 Months of Age|Death|0|||
125653374|NCT00948896|452015330|FG004|Randomization to 24 Months of Age|Death|2|||
125653375|NCT00948896|452015331|FG005|Randomization to 24 Months of Age|Death|1|||
125653376|NCT00948896|452015332|FG006|Randomization to 24 Months of Age|Death|2|||
125653377|NCT00948896|452015333|FG007|Randomization to 24 Months of Age|Death|1|||
125653378|NCT00948896|452015326|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
125653379|NCT00948896|452015327|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
125653380|NCT00948896|452015328|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
125653381|NCT00948896|452015329|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
125653382|NCT00948896|452015330|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
125653383|NCT00948896|452015331|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
125653384|NCT00948896|452015332|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
125653385|NCT00948896|452015333|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
125653386|NCT00948896|452015326|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
125653387|NCT00948896|452015327|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
125653388|NCT00948896|452015328|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
125653389|NCT00948896|452015329|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
125653390|NCT00948896|452015330|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
125653391|NCT00948896|452015331|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
125653392|NCT00948896|452015332|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
125653393|NCT00948896|452015333|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
125653394|NCT00948896|452015326|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
125653395|NCT00948896|452015327|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
125653396|NCT00948896|452015328|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
125653397|NCT00948896|452015329|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
125653398|NCT00948896|452015330|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
125653399|NCT00948896|452015331|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
125653400|NCT00948896|452015332|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
125653401|NCT00948896|452015333|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
125653402|NCT00948896|452015326|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
125653403|NCT00948896|452015327|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
125653404|NCT00948896|452015328|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
125653405|NCT00948896|452015329|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
125653406|NCT00948896|452015330|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
125653407|NCT00948896|452015331|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
125653408|NCT00948896|452015332|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
125653409|NCT00948896|452015333|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
125653410|NCT00948896|452015326|FG000|24 Months of Age to 36 Months of Age|Death|0|||
125653411|NCT00948896|452015327|FG001|24 Months of Age to 36 Months of Age|Death|2|||
125653412|NCT00948896|452015328|FG002|24 Months of Age to 36 Months of Age|Death|2|||
125653413|NCT00948896|452015329|FG003|24 Months of Age to 36 Months of Age|Death|0|||
125653414|NCT00948896|452015330|FG004|24 Months of Age to 36 Months of Age|Death|0|||
125653415|NCT00948896|452015331|FG005|24 Months of Age to 36 Months of Age|Death|1|||
125653416|NCT00948896|452015332|FG006|24 Months of Age to 36 Months of Age|Death|0|||
125653417|NCT00948896|452015333|FG007|24 Months of Age to 36 Months of Age|Death|0|||
125653418|NCT00948896|452015326|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
125653419|NCT00948896|452015327|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
125653420|NCT00948896|452015328|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
125653421|NCT00948896|452015329|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
125653422|NCT00948896|452015330|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
125653423|NCT00948896|452015331|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
125653424|NCT00948896|452015332|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
125653425|NCT00948896|452015333|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
125653426|NCT00948896|452015326|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
125653427|NCT00948896|452015327|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
125653428|NCT00948896|452015328|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
125653429|NCT00948896|452015329|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
125653430|NCT00948896|452015330|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
125653431|NCT00948896|452015331|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
125653432|NCT00948896|452015332|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
125653433|NCT00948896|452015333|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
125653434|NCT00948896|452015326|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
125653435|NCT00948896|452015327|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
125653436|NCT00948896|452015328|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
125653437|NCT00948896|452015329|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
125653438|NCT00948896|452015330|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
125653439|NCT00948896|452015331|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
125653440|NCT00948896|452015332|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
125653441|NCT00948896|452015333|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
125314048|NCT02043938|450779368|FG000|Overall Study|No show by subject|1|||
125653442|NCT00948896|452015326|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125653443|NCT00948896|452015327|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125653444|NCT00948896|452015328|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125653445|NCT00948896|452015329|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
125653446|NCT00948896|452015330|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125653447|NCT00948896|452015331|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125653448|NCT00948896|452015332|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125653449|NCT00948896|452015333|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
125653450|NCT03795233|452015334|FG000|Overall Study|Withdrawal by Subject|2|||
125653451|NCT03795233|452015335|FG001|Overall Study|Withdrawal by Subject|1|||
125653452|NCT03795233|452015334|FG000|Overall Study|Lost to Follow-up|1|||
125653453|NCT03795233|452015335|FG001|Overall Study|Lost to Follow-up|0|||
125653454|NCT03795233|452015334|FG000|Overall Study|Death|1|||
125653455|NCT03795233|452015335|FG001|Overall Study|Death|0|||
125653456|NCT05403502|452015336|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
125653457|NCT05403502|452015336|FG000|Humalog Lead-In Period|Physician Decision|2|||
125653458|NCT05403502|452015336|FG000|Humalog Lead-In Period|Protocol Violation|1|||
125653459|NCT05403502|452015336|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
125653460|NCT05403502|452015336|FG000|Lyumjev Treatment Period|Physician Decision|2|||
125653461|NCT01054443|452015337|FG000|Overall Study|Withdrawal by Subject|0|||
125653462|NCT01054443|452015338|FG001|Overall Study|Withdrawal by Subject|0|||
125653463|NCT01054443|452015339|FG002|Overall Study|Withdrawal by Subject|0|||
125653464|NCT01054443|452015340|FG003|Overall Study|Withdrawal by Subject|1|||
125653465|NCT01003691|452015344|FG000|Overall Study|Adverse Event|0|||
125653466|NCT01003691|452015345|FG001|Overall Study|Adverse Event|0|||
125653467|NCT01003691|452015346|FG002|Overall Study|Adverse Event|0|||
125653468|NCT01003691|452015347|FG003|Overall Study|Adverse Event|1|||
125653469|NCT00167414|452015348|FG000|Overall Study|Death|10|||
125653470|NCT01869959|452015349|FG000|Randomization Period|Physician Decision|0|||
125653471|NCT01869959|452015350|FG001|Randomization Period|Physician Decision|0|||
125653472|NCT01869959|452015351|FG002|Randomization Period|Physician Decision|0|||
125653473|NCT01869959|452015352|FG003|Randomization Period|Physician Decision|0|||
125653474|NCT01869959|452015353|FG004|Randomization Period|Physician Decision|1|||
125653475|NCT01869959|452015349|FG000|Treatment Period|Adverse Event|1|||
125653476|NCT01869959|452015350|FG001|Treatment Period|Adverse Event|0|||
125653477|NCT01869959|452015351|FG002|Treatment Period|Adverse Event|3|||
125653478|NCT01869959|452015352|FG003|Treatment Period|Adverse Event|1|||
125653479|NCT01869959|452015353|FG004|Treatment Period|Adverse Event|0|||
125653480|NCT01869959|452015349|FG000|Treatment Period|Sponsor decision|0|||
125653481|NCT01869959|452015350|FG001|Treatment Period|Sponsor decision|1|||
125653482|NCT01869959|452015351|FG002|Treatment Period|Sponsor decision|0|||
125653483|NCT01869959|452015352|FG003|Treatment Period|Sponsor decision|1|||
125653484|NCT01869959|452015353|FG004|Treatment Period|Sponsor decision|0|||
125653485|NCT01869959|452015349|FG000|Treatment Period|Withdrawal by Subject|0|||
125653486|NCT01869959|452015350|FG001|Treatment Period|Withdrawal by Subject|1|||
125653487|NCT01869959|452015351|FG002|Treatment Period|Withdrawal by Subject|0|||
125653488|NCT01869959|452015352|FG003|Treatment Period|Withdrawal by Subject|0|||
125653489|NCT01869959|452015353|FG004|Treatment Period|Withdrawal by Subject|0|||
125653490|NCT02576951|452015357|FG000|Overall Study|Lost to Follow-up|0|||
125653491|NCT02576951|452015358|FG001|Overall Study|Lost to Follow-up|0|||
125653492|NCT02576951|452015359|FG002|Overall Study|Lost to Follow-up|2|||
125653493|NCT02576951|452015360|FG003|Overall Study|Lost to Follow-up|2|||
125653494|NCT02576951|452015357|FG000|Overall Study|Withdrawal by Subject|1|||
125653495|NCT02576951|452015358|FG001|Overall Study|Withdrawal by Subject|0|||
125653496|NCT02576951|452015359|FG002|Overall Study|Withdrawal by Subject|0|||
125653497|NCT02576951|452015360|FG003|Overall Study|Withdrawal by Subject|2|||
125653498|NCT02576951|452015357|FG000|Overall Study|Protocol Violation|0|||
125653499|NCT02576951|452015358|FG001|Overall Study|Protocol Violation|0|||
125653500|NCT02576951|452015359|FG002|Overall Study|Protocol Violation|0|||
125653501|NCT02576951|452015360|FG003|Overall Study|Protocol Violation|1|||
125314049|NCT02043938|450779368|FG000|Overall Study|Investigator decision|1|||
125314050|NCT00248495|450779369|FG000|Overall Study|Withdrawal by Subject|1|||
125314051|NCT03812380|450779370|FG000|Overall Study|Protocol Violation|3|||
125314052|NCT03812380|450779371|FG001|Overall Study|Protocol Violation|3|||
125653502|NCT00822237|452017796|FG000|Dose 1 Vaccination|Not vaccinated|3|||
125653503|NCT00822237|452017797|FG001|Dose 1 Vaccination|Not vaccinated|0|||
125653504|NCT00822237|452017796|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
125653505|NCT00822237|452017797|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
125314053|NCT03812380|450779370|FG000|Overall Study|Withdrawal by Subject|5|||
125653506|NCT00822237|452017796|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
125653507|NCT00822237|452017797|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
125653508|NCT00822237|452017796|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
125653509|NCT00822237|452017797|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
125653510|NCT00822237|452017796|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
125653511|NCT00822237|452017797|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
125653512|NCT00968539|452017802|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
125653513|NCT00968539|452017803|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
125653514|NCT00457249|452017804|FG000|Overall Study|Lost to Follow-up|3|||
125653515|NCT00457249|452017805|FG001|Overall Study|Lost to Follow-up|0|||
125653516|NCT00457249|452017804|FG000|Overall Study|Protocol Violation|4|||
125653517|NCT00457249|452017805|FG001|Overall Study|Protocol Violation|1|||
125653518|NCT00457249|452017804|FG000|Overall Study|Withdrawal by Subject|3|||
125653519|NCT00457249|452017805|FG001|Overall Study|Withdrawal by Subject|1|||
125653520|NCT00457249|452017804|FG000|Overall Study|Serious Adverse Events|2|||
125653521|NCT00457249|452017805|FG001|Overall Study|Serious Adverse Events|0|||
125653522|NCT00326118|452017806|FG000|Active Phase|Withdrawal by Subject|4|||
125653523|NCT00326118|452017807|FG001|Active Phase|Withdrawal by Subject|1|||
125653524|NCT02916056|452017808|FG000|Overall Study|Adverse Event|6|||
125653525|NCT02916056|452017808|FG000|Overall Study|Lost to Follow-up|1|||
125653526|NCT02916056|452017808|FG000|Overall Study|Other|12|||
125653527|NCT02916056|452017808|FG000|Overall Study|Protocol Violation|1|||
125653528|NCT02916056|452017808|FG000|Overall Study|Withdrawal by Subject|8|||
125653529|NCT02916056|452017808|FG000|Overall Study|Study Terminated by Sponsor|269|||
125653530|NCT00290511|452017809|FG000|Overall Study|Adverse Event|1|||
125653531|NCT00290511|452017809|FG000|Overall Study|Death|1|||
125653532|NCT00290511|452017809|FG000|Overall Study|Physician Decision|1|||
125653533|NCT00290511|452017809|FG000|Overall Study|Withdrawal by Subject|1|||
125653534|NCT00122954|452017810|FG000|Overall Study|Withdrawal by Subject|2|||
125653535|NCT00122954|452017811|FG001|Overall Study|Withdrawal by Subject|2|||
125653536|NCT00122954|452017810|FG000|Overall Study|Protocol Violation|0|||
125653537|NCT00122954|452017811|FG001|Overall Study|Protocol Violation|1|||
125653538|NCT00526162|452017817|FG000|Overall Study|Device not implanted|3|||
125653539|NCT05993299|452017818|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
125653540|NCT05993299|452017818|FG000|Overall Study|Ongoing|4|||
125653541|NCT03110107|452017819|FG000|Treatment Period|Disease Progression|3|||
125653542|NCT03110107|452017820|FG001|Treatment Period|Disease Progression|9|||
125653543|NCT03110107|452017821|FG002|Treatment Period|Disease Progression|8|||
125653544|NCT03110107|452017822|FG003|Treatment Period|Disease Progression|11|||
125653545|NCT03110107|452017823|FG004|Treatment Period|Disease Progression|8|||
125653546|NCT03110107|452017824|FG005|Treatment Period|Disease Progression|4|||
125653547|NCT03110107|452017825|FG006|Treatment Period|Disease Progression|6|||
125653548|NCT03110107|452017826|FG007|Treatment Period|Disease Progression|7|||
125653549|NCT03110107|452017827|FG008|Treatment Period|Disease Progression|2|||
125653550|NCT03110107|452017828|FG009|Treatment Period|Disease Progression|10|||
125653551|NCT03110107|452017829|FG010|Treatment Period|Disease Progression|5|||
125653552|NCT03110107|452017830|FG011|Treatment Period|Disease Progression|2|||
125653553|NCT03110107|452017831|FG012|Treatment Period|Disease Progression|0|||
125653554|NCT03110107|452017832|FG013|Treatment Period|Disease Progression|5|||
125653555|NCT03110107|452017833|FG014|Treatment Period|Disease Progression|14|||
125653556|NCT03110107|452017834|FG015|Treatment Period|Disease Progression|14|||
125653557|NCT03110107|452017835|FG016|Treatment Period|Disease Progression|4|||
125653558|NCT03110107|452017836|FG017|Treatment Period|Disease Progression|3|||
125653559|NCT03110107|452017837|FG018|Treatment Period|Disease Progression|16|||
125653560|NCT03110107|452017838|FG019|Treatment Period|Disease Progression|14|||
125653561|NCT03110107|452017839|FG020|Treatment Period|Disease Progression|12|||
125653562|NCT03110107|452017840|FG021|Treatment Period|Disease Progression|16|||
125653563|NCT03110107|452017841|FG022|Treatment Period|Disease Progression|18|||
125653564|NCT03110107|452017842|FG023|Treatment Period|Disease Progression|13|||
125653565|NCT03110107|452017843|FG024|Treatment Period|Disease Progression|16|||
125653566|NCT03110107|452017844|FG025|Treatment Period|Disease Progression|31|||
125653567|NCT03110107|452017819|FG000|Treatment Period|Study drug toxicity|1|||
125653568|NCT03110107|452017820|FG001|Treatment Period|Study drug toxicity|0|||
125653569|NCT03110107|452017821|FG002|Treatment Period|Study drug toxicity|1|||
125653570|NCT03110107|452017822|FG003|Treatment Period|Study drug toxicity|2|||
125653571|NCT03110107|452017823|FG004|Treatment Period|Study drug toxicity|0|||
125653572|NCT03110107|452017824|FG005|Treatment Period|Study drug toxicity|3|||
125653573|NCT03110107|452017825|FG006|Treatment Period|Study drug toxicity|1|||
125653574|NCT03110107|452017826|FG007|Treatment Period|Study drug toxicity|1|||
125653575|NCT03110107|452017827|FG008|Treatment Period|Study drug toxicity|3|||
125653576|NCT03110107|452017828|FG009|Treatment Period|Study drug toxicity|2|||
125653577|NCT03110107|452017829|FG010|Treatment Period|Study drug toxicity|0|||
125653578|NCT03110107|452017830|FG011|Treatment Period|Study drug toxicity|2|||
125653579|NCT03110107|452017831|FG012|Treatment Period|Study drug toxicity|0|||
125653580|NCT03110107|452017832|FG013|Treatment Period|Study drug toxicity|0|||
125653581|NCT03110107|452017833|FG014|Treatment Period|Study drug toxicity|2|||
125653582|NCT03110107|452017834|FG015|Treatment Period|Study drug toxicity|3|||
125653583|NCT03110107|452017835|FG016|Treatment Period|Study drug toxicity|3|||
125653584|NCT03110107|452017836|FG017|Treatment Period|Study drug toxicity|3|||
125653585|NCT03110107|452017837|FG018|Treatment Period|Study drug toxicity|1|||
125653586|NCT03110107|452017838|FG019|Treatment Period|Study drug toxicity|2|||
125653587|NCT03110107|452017839|FG020|Treatment Period|Study drug toxicity|2|||
125653588|NCT03110107|452017840|FG021|Treatment Period|Study drug toxicity|0|||
125314054|NCT03812380|450779371|FG001|Overall Study|Withdrawal by Subject|4|||
125314055|NCT03812380|450779370|FG000|Overall Study|Early termination of study|14|||
125314056|NCT03812380|450779371|FG001|Overall Study|Early termination of study|14|||
125314057|NCT01285401|450779372|FG000|Overall Study|Prematurely withdrawn from the study|17|||
125314058|NCT01285401|450779373|FG001|Overall Study|Prematurely withdrawn from the study|29|||
125540400|NCT02729831|451607620|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
125540401|NCT02729831|451607621|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
125540402|NCT02729831|451607622|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
125540403|NCT02729831|451607623|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
125540404|NCT02729831|451607620|FG000|1 Week Post-visit|Lost to Follow-up|43|||
125540405|NCT02729831|451607621|FG001|1 Week Post-visit|Lost to Follow-up|40|||
125540406|NCT02729831|451607622|FG002|1 Week Post-visit|Lost to Follow-up|38|||
125540407|NCT02729831|451607623|FG003|1 Week Post-visit|Lost to Follow-up|36|||
125540408|NCT02729831|451607620|FG000|6 Month Follow-up|Lost to Follow-up|54|||
125540409|NCT02729831|451607621|FG001|6 Month Follow-up|Lost to Follow-up|51|||
125540410|NCT02729831|451607622|FG002|6 Month Follow-up|Lost to Follow-up|48|||
125540411|NCT02729831|451607623|FG003|6 Month Follow-up|Lost to Follow-up|42|||
125540412|NCT02729831|451607620|FG000|6 Month Follow-up|Death|1|||
125540413|NCT02729831|451607621|FG001|6 Month Follow-up|Death|3|||
125540414|NCT02729831|451607622|FG002|6 Month Follow-up|Death|0|||
125540415|NCT02729831|451607623|FG003|6 Month Follow-up|Death|1|||
125540416|NCT01747551|451607624|FG000|Overall Study|Progressive Disease|24|||
125540417|NCT01747551|451607625|FG001|Overall Study|Progressive Disease|17|||
125540418|NCT01747551|451607624|FG000|Overall Study|Death|3|||
125540419|NCT01747551|451607625|FG001|Overall Study|Death|1|||
125540420|NCT01747551|451607624|FG000|Overall Study|Adverse Event|7|||
125540421|NCT01747551|451607625|FG001|Overall Study|Adverse Event|1|||
125540422|NCT01747551|451607624|FG000|Overall Study|Prolonged Treatment Delay|2|||
125540423|NCT01747551|451607625|FG001|Overall Study|Prolonged Treatment Delay|0|||
125540424|NCT01747551|451607624|FG000|Overall Study|Withdrawal by Subject|3|||
125540425|NCT01747551|451607625|FG001|Overall Study|Withdrawal by Subject|1|||
125540426|NCT01747551|451607624|FG000|Overall Study|Physician Decision|2|||
125540427|NCT01747551|451607625|FG001|Overall Study|Physician Decision|1|||
125540428|NCT01747551|451607624|FG000|Overall Study|Other|2|||
125540429|NCT01747551|451607625|FG001|Overall Study|Other|0|||
125540430|NCT01142115|451607626|FG000|First Intervention|Lack of Efficacy|1|||
125540431|NCT01142115|451607627|FG001|First Intervention|Lack of Efficacy|1|||
125540432|NCT01142115|451607626|FG000|First Intervention|Adverse Event|1|||
125540433|NCT01142115|451607627|FG001|First Intervention|Adverse Event|0|||
125540434|NCT03208036|451607628|FG000|Baseline Assessment|Withdrawal by Subject|1|||
125540435|NCT03208036|451607629|FG001|Baseline Assessment|Withdrawal by Subject|1|||
125540436|NCT03208036|451607628|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
125540437|NCT03208036|451607629|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
125540438|NCT03208036|451607628|FG000|Intervention|Withdrawal by Subject|3|||
125540439|NCT03208036|451607629|FG001|Intervention|Withdrawal by Subject|2|||
125540440|NCT03208036|451607628|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
125540441|NCT03208036|451607629|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
125540442|NCT02091206|451607630|FG000|Treatment Period|Adverse Event|0|||
125540443|NCT02091206|451607631|FG001|Treatment Period|Adverse Event|1|||
125540444|NCT02091206|451607632|FG002|Treatment Period|Adverse Event|0|||
125540445|NCT02091206|451607633|FG003|Treatment Period|Adverse Event|0|||
125540446|NCT02091206|451607630|FG000|Treatment Period|Met withdrawal criteria|0|||
125540447|NCT02091206|451607631|FG001|Treatment Period|Met withdrawal criteria|0|||
125540448|NCT02091206|451607632|FG002|Treatment Period|Met withdrawal criteria|1|||
125540449|NCT02091206|451607633|FG003|Treatment Period|Met withdrawal criteria|0|||
125540450|NCT02091206|451607630|FG000|Taper Period|Participant refused study drug|1|||
125540451|NCT02091206|451607631|FG001|Taper Period|Participant refused study drug|0|||
125540452|NCT02091206|451607632|FG002|Taper Period|Participant refused study drug|0|||
125540453|NCT02091206|451607633|FG003|Taper Period|Participant refused study drug|1|||
125540454|NCT02091206|451607630|FG000|Taper Period|Lost to Follow-up|0|||
125540455|NCT02091206|451607631|FG001|Taper Period|Lost to Follow-up|0|||
125540456|NCT02091206|451607632|FG002|Taper Period|Lost to Follow-up|0|||
125540457|NCT02091206|451607633|FG003|Taper Period|Lost to Follow-up|1|||
125540458|NCT00700778|451607634|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
125540459|NCT03381339|451607635|FG000|Overall Study|Protocol Violation|4|||
125540460|NCT03381339|451607636|FG001|Overall Study|Protocol Violation|3|||
125540461|NCT03381339|451607635|FG000|Overall Study|Lost to Follow-up|0|||
125653589|NCT03110107|452017841|FG022|Treatment Period|Study drug toxicity|2|||
125314059|NCT02366312|450779383|FG000|Overall Study|Lost to Follow-up|0|||
125314060|NCT02366312|450779384|FG001|Overall Study|Lost to Follow-up|1|||
125540462|NCT03381339|451607636|FG001|Overall Study|Lost to Follow-up|1|||
125540463|NCT04927247|451607639|FG000|Overall Study|Other|2|||
125540464|NCT04927247|451607640|FG001|Overall Study|Other|1|||
125653590|NCT03110107|452017842|FG023|Treatment Period|Study drug toxicity|6|||
125653591|NCT03110107|452017843|FG024|Treatment Period|Study drug toxicity|7|||
125653592|NCT03110107|452017844|FG025|Treatment Period|Study drug toxicity|6|||
125653593|NCT03110107|452017819|FG000|Treatment Period|Death|0|||
125653594|NCT03110107|452017820|FG001|Treatment Period|Death|0|||
125653595|NCT03110107|452017821|FG002|Treatment Period|Death|0|||
125653596|NCT03110107|452017822|FG003|Treatment Period|Death|0|||
125653597|NCT03110107|452017823|FG004|Treatment Period|Death|0|||
125653598|NCT03110107|452017824|FG005|Treatment Period|Death|0|||
125653599|NCT03110107|452017825|FG006|Treatment Period|Death|0|||
125653600|NCT03110107|452017826|FG007|Treatment Period|Death|0|||
125653601|NCT03110107|452017827|FG008|Treatment Period|Death|0|||
125653602|NCT03110107|452017828|FG009|Treatment Period|Death|0|||
125653603|NCT03110107|452017829|FG010|Treatment Period|Death|0|||
125653604|NCT03110107|452017830|FG011|Treatment Period|Death|0|||
125653605|NCT03110107|452017831|FG012|Treatment Period|Death|1|||
125653606|NCT03110107|452017832|FG013|Treatment Period|Death|0|||
125653607|NCT03110107|452017833|FG014|Treatment Period|Death|0|||
125653608|NCT03110107|452017834|FG015|Treatment Period|Death|0|||
125653609|NCT03110107|452017835|FG016|Treatment Period|Death|0|||
125653610|NCT03110107|452017836|FG017|Treatment Period|Death|0|||
125653611|NCT03110107|452017837|FG018|Treatment Period|Death|0|||
125653612|NCT03110107|452017838|FG019|Treatment Period|Death|0|||
125653613|NCT03110107|452017839|FG020|Treatment Period|Death|0|||
125653614|NCT03110107|452017840|FG021|Treatment Period|Death|0|||
125653615|NCT03110107|452017841|FG022|Treatment Period|Death|0|||
125653616|NCT03110107|452017842|FG023|Treatment Period|Death|0|||
125653617|NCT03110107|452017843|FG024|Treatment Period|Death|0|||
125653618|NCT03110107|452017844|FG025|Treatment Period|Death|0|||
125653619|NCT03110107|452017819|FG000|Treatment Period|Adverse Event|0|||
125653620|NCT03110107|452017820|FG001|Treatment Period|Adverse Event|0|||
125653621|NCT03110107|452017821|FG002|Treatment Period|Adverse Event|1|||
125653622|NCT03110107|452017822|FG003|Treatment Period|Adverse Event|0|||
125653623|NCT03110107|452017823|FG004|Treatment Period|Adverse Event|0|||
125653624|NCT03110107|452017824|FG005|Treatment Period|Adverse Event|2|||
125653625|NCT03110107|452017825|FG006|Treatment Period|Adverse Event|0|||
125653626|NCT03110107|452017826|FG007|Treatment Period|Adverse Event|2|||
125653627|NCT03110107|452017827|FG008|Treatment Period|Adverse Event|0|||
125653628|NCT03110107|452017828|FG009|Treatment Period|Adverse Event|1|||
125653629|NCT03110107|452017829|FG010|Treatment Period|Adverse Event|0|||
125653630|NCT03110107|452017830|FG011|Treatment Period|Adverse Event|0|||
125653631|NCT03110107|452017831|FG012|Treatment Period|Adverse Event|0|||
125653632|NCT03110107|452017832|FG013|Treatment Period|Adverse Event|0|||
125653633|NCT03110107|452017833|FG014|Treatment Period|Adverse Event|0|||
125653634|NCT03110107|452017834|FG015|Treatment Period|Adverse Event|2|||
125653635|NCT03110107|452017835|FG016|Treatment Period|Adverse Event|0|||
125653636|NCT03110107|452017836|FG017|Treatment Period|Adverse Event|1|||
125653637|NCT03110107|452017837|FG018|Treatment Period|Adverse Event|2|||
125653638|NCT03110107|452017838|FG019|Treatment Period|Adverse Event|1|||
125653639|NCT03110107|452017839|FG020|Treatment Period|Adverse Event|4|||
125653640|NCT03110107|452017840|FG021|Treatment Period|Adverse Event|2|||
125653641|NCT03110107|452017841|FG022|Treatment Period|Adverse Event|2|||
125653642|NCT03110107|452017842|FG023|Treatment Period|Adverse Event|2|||
125653643|NCT03110107|452017843|FG024|Treatment Period|Adverse Event|2|||
125653644|NCT03110107|452017844|FG025|Treatment Period|Adverse Event|4|||
125653645|NCT03110107|452017819|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
125653646|NCT03110107|452017820|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
125653647|NCT03110107|452017821|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
125653648|NCT03110107|452017822|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
125653649|NCT03110107|452017823|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
125653650|NCT03110107|452017824|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
125314061|NCT00354679|450779389|FG000|Overall Study|Patient Not Treated|1|||
125314062|NCT03719131|450779391|FG000|Overall Study|Death|1|||
125314063|NCT03719131|450779392|FG001|Overall Study|Death|2|||
125314064|NCT01544920|450779393|FG000|Overall Study|Adverse Event|0|||
125314065|NCT01544920|450779394|FG001|Overall Study|Adverse Event|3|||
125314066|NCT01544920|450779393|FG000|Overall Study|Death|0|||
125314067|NCT01544920|450779394|FG001|Overall Study|Death|1|||
125314068|NCT01544920|450779393|FG000|Overall Study|Lost to Follow-up|11|||
125314069|NCT01544920|450779394|FG001|Overall Study|Lost to Follow-up|12|||
125314070|NCT01544920|450779393|FG000|Overall Study|Protocol Violation|0|||
125314071|NCT01544920|450779394|FG001|Overall Study|Protocol Violation|2|||
125314072|NCT01544920|450779393|FG000|Overall Study|Physician Decision|4|||
125314073|NCT01544920|450779394|FG001|Overall Study|Physician Decision|1|||
125314074|NCT01544920|450779393|FG000|Overall Study|Withdrawal by Subject|4|||
125314075|NCT01544920|450779394|FG001|Overall Study|Withdrawal by Subject|4|||
125314076|NCT00466440|450779395|FG000|Overall Study|Adverse Event|0|||
125314077|NCT00466440|450779396|FG001|Overall Study|Adverse Event|3|||
125314078|NCT00466440|450779397|FG002|Overall Study|Adverse Event|1|||
125314079|NCT00466440|450779395|FG000|Overall Study|Death|1|||
125314080|NCT00466440|450779396|FG001|Overall Study|Death|1|||
125653651|NCT03110107|452017825|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
125653652|NCT03110107|452017826|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
125653653|NCT03110107|452017827|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
125653654|NCT03110107|452017828|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
125653655|NCT03110107|452017829|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
125653656|NCT03110107|452017830|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
125653657|NCT03110107|452017831|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
125653658|NCT03110107|452017832|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
125653659|NCT03110107|452017833|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
125653660|NCT03110107|452017834|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
125653661|NCT03110107|452017835|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
125653662|NCT03110107|452017836|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
125653663|NCT03110107|452017837|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
125653664|NCT03110107|452017838|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
125653665|NCT03110107|452017839|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
125653666|NCT03110107|452017840|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
125653667|NCT03110107|452017841|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
125653668|NCT03110107|452017842|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
125653669|NCT03110107|452017843|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
125653670|NCT03110107|452017844|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
125653671|NCT03110107|452017819|FG000|Treatment Period|Participant withdrew consent|0|||
125653672|NCT03110107|452017820|FG001|Treatment Period|Participant withdrew consent|0|||
125653673|NCT03110107|452017821|FG002|Treatment Period|Participant withdrew consent|1|||
125653674|NCT03110107|452017822|FG003|Treatment Period|Participant withdrew consent|0|||
125653675|NCT03110107|452017823|FG004|Treatment Period|Participant withdrew consent|4|||
125653676|NCT03110107|452017824|FG005|Treatment Period|Participant withdrew consent|3|||
125653677|NCT03110107|452017825|FG006|Treatment Period|Participant withdrew consent|0|||
125653678|NCT03110107|452017826|FG007|Treatment Period|Participant withdrew consent|0|||
125653679|NCT03110107|452017827|FG008|Treatment Period|Participant withdrew consent|0|||
125653680|NCT03110107|452017828|FG009|Treatment Period|Participant withdrew consent|1|||
125653681|NCT03110107|452017829|FG010|Treatment Period|Participant withdrew consent|0|||
125653682|NCT03110107|452017830|FG011|Treatment Period|Participant withdrew consent|0|||
125653683|NCT03110107|452017831|FG012|Treatment Period|Participant withdrew consent|0|||
125653684|NCT03110107|452017832|FG013|Treatment Period|Participant withdrew consent|0|||
125653685|NCT03110107|452017833|FG014|Treatment Period|Participant withdrew consent|0|||
125653686|NCT03110107|452017834|FG015|Treatment Period|Participant withdrew consent|0|||
125653687|NCT03110107|452017835|FG016|Treatment Period|Participant withdrew consent|0|||
125653688|NCT03110107|452017836|FG017|Treatment Period|Participant withdrew consent|0|||
125653689|NCT03110107|452017837|FG018|Treatment Period|Participant withdrew consent|0|||
125653690|NCT03110107|452017838|FG019|Treatment Period|Participant withdrew consent|1|||
125653691|NCT03110107|452017839|FG020|Treatment Period|Participant withdrew consent|0|||
125653692|NCT03110107|452017840|FG021|Treatment Period|Participant withdrew consent|2|||
125653693|NCT03110107|452017841|FG022|Treatment Period|Participant withdrew consent|0|||
125653694|NCT03110107|452017842|FG023|Treatment Period|Participant withdrew consent|0|||
125653695|NCT03110107|452017843|FG024|Treatment Period|Participant withdrew consent|0|||
125653696|NCT03110107|452017844|FG025|Treatment Period|Participant withdrew consent|2|||
125653697|NCT03110107|452017819|FG000|Treatment Period|Participants no longer meets study criteria|0|||
125653698|NCT03110107|452017820|FG001|Treatment Period|Participants no longer meets study criteria|0|||
125653699|NCT03110107|452017821|FG002|Treatment Period|Participants no longer meets study criteria|0|||
125653700|NCT03110107|452017822|FG003|Treatment Period|Participants no longer meets study criteria|0|||
125653701|NCT03110107|452017823|FG004|Treatment Period|Participants no longer meets study criteria|0|||
125653702|NCT03110107|452017824|FG005|Treatment Period|Participants no longer meets study criteria|0|||
125653703|NCT03110107|452017825|FG006|Treatment Period|Participants no longer meets study criteria|0|||
125653704|NCT03110107|452017826|FG007|Treatment Period|Participants no longer meets study criteria|0|||
125653705|NCT03110107|452017827|FG008|Treatment Period|Participants no longer meets study criteria|0|||
125653706|NCT03110107|452017828|FG009|Treatment Period|Participants no longer meets study criteria|0|||
125653707|NCT03110107|452017829|FG010|Treatment Period|Participants no longer meets study criteria|0|||
125653708|NCT03110107|452017830|FG011|Treatment Period|Participants no longer meets study criteria|0|||
125314081|NCT00466440|450779397|FG002|Overall Study|Death|0|||
125314082|NCT00466440|450779395|FG000|Overall Study|Progressive disease|13|||
125314083|NCT00466440|450779396|FG001|Overall Study|Progressive disease|5|||
125314084|NCT00466440|450779397|FG002|Overall Study|Progressive disease|4|||
125314085|NCT00466440|450779395|FG000|Overall Study|Lost to Follow-up|0|||
125314086|NCT00466440|450779396|FG001|Overall Study|Lost to Follow-up|1|||
125314087|NCT00466440|450779397|FG002|Overall Study|Lost to Follow-up|0|||
125314088|NCT00466440|450779395|FG000|Overall Study|Physician Decision|0|||
125653709|NCT03110107|452017831|FG012|Treatment Period|Participants no longer meets study criteria|0|||
125653710|NCT03110107|452017832|FG013|Treatment Period|Participants no longer meets study criteria|0|||
125653711|NCT03110107|452017833|FG014|Treatment Period|Participants no longer meets study criteria|0|||
125653712|NCT03110107|452017834|FG015|Treatment Period|Participants no longer meets study criteria|0|||
125653713|NCT03110107|452017835|FG016|Treatment Period|Participants no longer meets study criteria|0|||
125653714|NCT03110107|452017836|FG017|Treatment Period|Participants no longer meets study criteria|0|||
125653715|NCT03110107|452017837|FG018|Treatment Period|Participants no longer meets study criteria|0|||
125653716|NCT03110107|452017838|FG019|Treatment Period|Participants no longer meets study criteria|0|||
125653717|NCT03110107|452017839|FG020|Treatment Period|Participants no longer meets study criteria|0|||
125653718|NCT03110107|452017840|FG021|Treatment Period|Participants no longer meets study criteria|0|||
125653719|NCT03110107|452017841|FG022|Treatment Period|Participants no longer meets study criteria|0|||
125653720|NCT03110107|452017842|FG023|Treatment Period|Participants no longer meets study criteria|1|||
125653721|NCT03110107|452017843|FG024|Treatment Period|Participants no longer meets study criteria|0|||
125653722|NCT03110107|452017844|FG025|Treatment Period|Participants no longer meets study criteria|0|||
125653723|NCT03110107|452017819|FG000|Treatment Period|Other Reasons|0|||
125653724|NCT03110107|452017820|FG001|Treatment Period|Other Reasons|0|||
125653725|NCT03110107|452017821|FG002|Treatment Period|Other Reasons|1|||
125653726|NCT03110107|452017822|FG003|Treatment Period|Other Reasons|1|||
125653727|NCT03110107|452017823|FG004|Treatment Period|Other Reasons|0|||
125653728|NCT03110107|452017824|FG005|Treatment Period|Other Reasons|1|||
125653729|NCT03110107|452017825|FG006|Treatment Period|Other Reasons|0|||
125653730|NCT03110107|452017826|FG007|Treatment Period|Other Reasons|0|||
125653731|NCT03110107|452017827|FG008|Treatment Period|Other Reasons|0|||
125653732|NCT03110107|452017828|FG009|Treatment Period|Other Reasons|0|||
125653733|NCT03110107|452017829|FG010|Treatment Period|Other Reasons|0|||
125653734|NCT03110107|452017830|FG011|Treatment Period|Other Reasons|0|||
125653735|NCT03110107|452017831|FG012|Treatment Period|Other Reasons|0|||
125653736|NCT03110107|452017832|FG013|Treatment Period|Other Reasons|0|||
125653737|NCT03110107|452017833|FG014|Treatment Period|Other Reasons|0|||
125314089|NCT00466440|450779396|FG001|Overall Study|Physician Decision|1|||
125314090|NCT00466440|450779397|FG002|Overall Study|Physician Decision|2|||
125314091|NCT00466440|450779395|FG000|Overall Study|Protocol entry criteria not met|0|||
125314092|NCT00466440|450779396|FG001|Overall Study|Protocol entry criteria not met|0|||
125314093|NCT00466440|450779397|FG002|Overall Study|Protocol entry criteria not met|4|||
125314094|NCT00466440|450779395|FG000|Overall Study|Withdrawal by Subject|0|||
125314095|NCT00466440|450779396|FG001|Overall Study|Withdrawal by Subject|1|||
125314096|NCT00466440|450779397|FG002|Overall Study|Withdrawal by Subject|0|||
125314097|NCT00466440|450779395|FG000|Overall Study|Sponsor decision|0|||
125314098|NCT00466440|450779396|FG001|Overall Study|Sponsor decision|0|||
125314099|NCT00466440|450779397|FG002|Overall Study|Sponsor decision|1|||
125314100|NCT03294590|450779400|FG000|Overall Study|Lost to Follow-up|105|||
125314101|NCT03294590|450779401|FG001|Overall Study|Lost to Follow-up|107|||
125314102|NCT00255190|450779404|FG000|Overall Study|Adverse Event|17|||
125314103|NCT00255190|450779405|FG001|Overall Study|Adverse Event|36|||
125314104|NCT00255190|450779404|FG000|Overall Study|Protocol Violation|2|||
125314105|NCT00255190|450779405|FG001|Overall Study|Protocol Violation|2|||
125314106|NCT00255190|450779404|FG000|Overall Study|Lost to Follow-up|10|||
125314107|NCT00255190|450779405|FG001|Overall Study|Lost to Follow-up|27|||
125314108|NCT00255190|450779404|FG000|Overall Study|Withdrew Consent|17|||
125314109|NCT00255190|450779405|FG001|Overall Study|Withdrew Consent|48|||
125314110|NCT00255190|450779404|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
125314111|NCT00255190|450779405|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
125314112|NCT00255190|450779404|FG000|Overall Study|Erosive esophagitis not healed|0|||
125314113|NCT00255190|450779405|FG001|Overall Study|Erosive esophagitis not healed|20|||
125314114|NCT00255190|450779404|FG000|Overall Study|Various|4|||
125314115|NCT00255190|450779405|FG001|Overall Study|Various|23|||
125314116|NCT03367858|450779410|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
125314117|NCT03367858|450779411|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
125314118|NCT03367858|450779410|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
125314119|NCT03367858|450779411|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
125314120|NCT03367858|450779410|FG000|3 Month Follow Up|Lost to Follow-up|8|||
125314121|NCT03367858|450779411|FG001|3 Month Follow Up|Lost to Follow-up|3|||
125314122|NCT03367858|450779410|FG000|3 Month Follow Up|Moved out of study area|2|||
125314123|NCT03367858|450779411|FG001|3 Month Follow Up|Moved out of study area|6|||
125314124|NCT03367858|450779410|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
125314125|NCT03367858|450779411|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
125314126|NCT03367858|450779410|FG000|3 Month Follow Up|MRI contraindication|2|||
125314127|NCT03367858|450779411|FG001|3 Month Follow Up|MRI contraindication|1|||
125314128|NCT03367858|450779410|FG000|3 Month Follow Up|Incarcerated|0|||
125314129|NCT03367858|450779411|FG001|3 Month Follow Up|Incarcerated|1|||
125314130|NCT03367858|450779410|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
125653738|NCT03110107|452017834|FG015|Treatment Period|Other Reasons|0|||
125653739|NCT03110107|452017835|FG016|Treatment Period|Other Reasons|0|||
125653740|NCT03110107|452017836|FG017|Treatment Period|Other Reasons|0|||
125653741|NCT03110107|452017837|FG018|Treatment Period|Other Reasons|0|||
125653742|NCT03110107|452017838|FG019|Treatment Period|Other Reasons|0|||
125653743|NCT03110107|452017839|FG020|Treatment Period|Other Reasons|0|||
125653744|NCT03110107|452017840|FG021|Treatment Period|Other Reasons|0|||
125653745|NCT03110107|452017841|FG022|Treatment Period|Other Reasons|0|||
125653746|NCT03110107|452017842|FG023|Treatment Period|Other Reasons|0|||
125653747|NCT03110107|452017843|FG024|Treatment Period|Other Reasons|1|||
125653748|NCT03110107|452017844|FG025|Treatment Period|Other Reasons|0|||
125653749|NCT03985982|452017845|FG000|Double-Blind Phase|Lost to Follow-up|4|||
125653750|NCT03985982|452017846|FG001|Double-Blind Phase|Lost to Follow-up|3|||
125653751|NCT03985982|452017847|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125653752|NCT03985982|452017845|FG000|Double-Blind Phase|Physician Decision|1|||
125653753|NCT03985982|452017846|FG001|Double-Blind Phase|Physician Decision|0|||
125653754|NCT03985982|452017847|FG002|Double-Blind Phase|Physician Decision|0|||
125653755|NCT03985982|452017845|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
125653756|NCT03985982|452017846|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
125653757|NCT03985982|452017847|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125653758|NCT03985982|452017845|FG000|Double-Blind Phase|COVID-19|1|||
125653759|NCT03985982|452017846|FG001|Double-Blind Phase|COVID-19|0|||
125653760|NCT03985982|452017847|FG002|Double-Blind Phase|COVID-19|0|||
125653761|NCT03985982|452017845|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
125653762|NCT03985982|452017846|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
125653763|NCT03985982|452017847|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
125653764|NCT03985982|452017845|FG000|Open-Label Phase|Lost to Follow-up|0|||
125653765|NCT03985982|452017846|FG001|Open-Label Phase|Lost to Follow-up|0|||
125653766|NCT03985982|452017847|FG002|Open-Label Phase|Lost to Follow-up|13|||
125314131|NCT03367858|450779411|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
125314132|NCT03367858|450779410|FG000|6 Month Follow Up|Lost to Follow-up|5|||
125314133|NCT03367858|450779411|FG001|6 Month Follow Up|Lost to Follow-up|2|||
125314134|NCT03367858|450779410|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
125314135|NCT03367858|450779411|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
125653767|NCT03985982|452017845|FG000|Open-Label Phase|Physician Decision|0|||
125653768|NCT03985982|452017846|FG001|Open-Label Phase|Physician Decision|0|||
125653769|NCT03985982|452017847|FG002|Open-Label Phase|Physician Decision|2|||
125653770|NCT03985982|452017845|FG000|Open-Label Phase|Withdrawal by Subject|0|||
125653771|NCT03985982|452017846|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125653772|NCT03985982|452017847|FG002|Open-Label Phase|Withdrawal by Subject|11|||
125653773|NCT03526549|452017849|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
125653774|NCT03526549|452017850|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
125653775|NCT03526549|452017849|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
125653776|NCT03526549|452017850|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
125653777|NCT03526549|452017849|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
125653778|NCT03526549|452017850|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
125653779|NCT03526549|452017849|FG000|Open-label Phase|Adverse Event|4|||
125653780|NCT03526549|452017850|FG001|Open-label Phase|Adverse Event|0|||
125653781|NCT03526549|452017849|FG000|Open-label Phase|Withdrawal by Subject|54|||
125653782|NCT03526549|452017850|FG001|Open-label Phase|Withdrawal by Subject|0|||
125314136|NCT03367858|450779410|FG000|12 Month Follow Up|Lost to Follow-up|3|||
125314137|NCT03367858|450779411|FG001|12 Month Follow Up|Lost to Follow-up|3|||
125314138|NCT03367858|450779410|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
125314139|NCT03367858|450779411|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
125314140|NCT01217463|450779414|FG000|Overall Study|Adverse Event|8|||
125314141|NCT01217463|450779415|FG001|Overall Study|Adverse Event|5|||
125314142|NCT01217463|450779414|FG000|Overall Study|Physician Decision|0|||
125314143|NCT01217463|450779415|FG001|Overall Study|Physician Decision|1|||
125314144|NCT01217463|450779414|FG000|Overall Study|Withdrawal by Subject|3|||
125314145|NCT01217463|450779415|FG001|Overall Study|Withdrawal by Subject|0|||
125314146|NCT01217463|450779414|FG000|Overall Study|Surgery on the Target Limb|0|||
125314147|NCT01217463|450779415|FG001|Overall Study|Surgery on the Target Limb|1|||
125314148|NCT01217463|450779414|FG000|Overall Study|Patient Non-compliant|1|||
125314149|NCT01217463|450779415|FG001|Overall Study|Patient Non-compliant|0|||
125314150|NCT01217463|450779414|FG000|Overall Study|Other|1|||
125653783|NCT03526549|452017849|FG000|Open-label Phase|Lost to Follow-up|35|||
125653784|NCT03526549|452017850|FG001|Open-label Phase|Lost to Follow-up|0|||
125653785|NCT03526549|452017849|FG000|Open-label Phase|Other than Specified|5|||
125314151|NCT01217463|450779415|FG001|Overall Study|Other|1|||
125314152|NCT01623115|450779416|FG000|Overall Study|Randomized but not treated|0|||
125653786|NCT03526549|452017850|FG001|Open-label Phase|Other than Specified|0|||
125653787|NCT05981365|452017855|FG000|Period 1|Adverse Event|1|||
125314153|NCT01623115|450779417|FG001|Overall Study|Randomized but not treated|1|||
125314154|NCT01623115|450779416|FG000|Overall Study|Physician Decision|1|||
125314155|NCT01623115|450779417|FG001|Overall Study|Physician Decision|0|||
125314156|NCT01623115|450779416|FG000|Overall Study|Participants moved|1|||
125314157|NCT01623115|450779417|FG001|Overall Study|Participants moved|5|||
125314158|NCT01623115|450779416|FG000|Overall Study|Adverse Event|10|||
125314159|NCT01623115|450779417|FG001|Overall Study|Adverse Event|13|||
125314160|NCT01623115|450779416|FG000|Overall Study|Poor compliance to protocol|4|||
125314161|NCT01623115|450779417|FG001|Overall Study|Poor compliance to protocol|10|||
125314162|NCT01623115|450779416|FG000|Overall Study|Consent withdrawn by participant|2|||
125314163|NCT01623115|450779417|FG001|Overall Study|Consent withdrawn by participant|6|||
125314164|NCT01623115|450779416|FG000|Overall Study|Related to study drug administration|0|||
125314165|NCT01623115|450779417|FG001|Overall Study|Related to study drug administration|2|||
125314166|NCT01623115|450779416|FG000|Overall Study|Last visit outside protocol visit window|14|||
125314167|NCT01623115|450779417|FG001|Overall Study|Last visit outside protocol visit window|26|||
125314168|NCT01623115|450779416|FG000|Overall Study|Site closure|1|||
125314169|NCT01623115|450779417|FG001|Overall Study|Site closure|7|||
125314170|NCT01623115|450779416|FG000|Overall Study|Death|0|||
125314171|NCT01623115|450779417|FG001|Overall Study|Death|4|||
125314172|NCT01623115|450779416|FG000|Overall Study|Other than specified above|0|||
125314173|NCT01623115|450779417|FG001|Overall Study|Other than specified above|3|||
125314174|NCT03827655|450779418|FG000|Overall Study|Death|0|||
125314175|NCT03827655|450779419|FG001|Overall Study|Death|0|||
125314176|NCT03827655|450779420|FG002|Overall Study|Death|0|||
125314177|NCT03827655|450779421|FG003|Overall Study|Death|0|||
125314178|NCT03827655|450779422|FG004|Overall Study|Death|1|||
125314179|NCT03827655|450779418|FG000|Overall Study|Protocol Deviation|1|||
125314180|NCT03827655|450779419|FG001|Overall Study|Protocol Deviation|0|||
125314181|NCT03827655|450779420|FG002|Overall Study|Protocol Deviation|1|||
125314182|NCT03827655|450779421|FG003|Overall Study|Protocol Deviation|1|||
125314183|NCT03827655|450779422|FG004|Overall Study|Protocol Deviation|0|||
125314184|NCT03827655|450779418|FG000|Overall Study|Withdrawal by Subject|3|||
125314185|NCT03827655|450779419|FG001|Overall Study|Withdrawal by Subject|2|||
125314186|NCT03827655|450779420|FG002|Overall Study|Withdrawal by Subject|2|||
125314187|NCT03827655|450779421|FG003|Overall Study|Withdrawal by Subject|0|||
125314188|NCT03827655|450779422|FG004|Overall Study|Withdrawal by Subject|1|||
125314189|NCT03827655|450779418|FG000|Overall Study|Reason not Specified|3|||
125314190|NCT03827655|450779419|FG001|Overall Study|Reason not Specified|1|||
125314191|NCT03827655|450779420|FG002|Overall Study|Reason not Specified|1|||
125314192|NCT03827655|450779421|FG003|Overall Study|Reason not Specified|1|||
125314193|NCT03827655|450779422|FG004|Overall Study|Reason not Specified|1|||
125314194|NCT01721161|450779424|FG000|Overall Study|Adverse Event|2|||
125314195|NCT01721161|450779425|FG001|Overall Study|Adverse Event|3|||
125314196|NCT01721161|450779424|FG000|Overall Study|Lost to Follow-up|1|||
125314197|NCT01721161|450779425|FG001|Overall Study|Lost to Follow-up|2|||
125314198|NCT01721161|450779424|FG000|Overall Study|Withdrawal by Subject|1|||
125314199|NCT01721161|450779425|FG001|Overall Study|Withdrawal by Subject|1|||
125314200|NCT01721161|450779424|FG000|Overall Study|Other|0|||
125314201|NCT01721161|450779425|FG001|Overall Study|Other|1|||
125314202|NCT02888106|450779429|FG000|Overall Study|Withdrawal by Subject|1|||
125314203|NCT02888106|450779430|FG001|Overall Study|Withdrawal by Subject|2|||
125314204|NCT02888106|450779431|FG002|Overall Study|Withdrawal by Subject|0|||
125314205|NCT02888106|450779432|FG003|Overall Study|Withdrawal by Subject|1|||
125314206|NCT02888106|450779433|FG004|Overall Study|Withdrawal by Subject|0|||
125314207|NCT02888106|450779434|FG005|Overall Study|Withdrawal by Subject|0|||
125314208|NCT02888106|450779429|FG000|Overall Study|Lost to Follow-up|1|||
125314209|NCT02888106|450779430|FG001|Overall Study|Lost to Follow-up|0|||
125314210|NCT02888106|450779431|FG002|Overall Study|Lost to Follow-up|0|||
125314211|NCT02888106|450779432|FG003|Overall Study|Lost to Follow-up|1|||
125314212|NCT02888106|450779433|FG004|Overall Study|Lost to Follow-up|0|||
125314213|NCT02888106|450779434|FG005|Overall Study|Lost to Follow-up|1|||
125314214|NCT02888106|450779429|FG000|Overall Study|Adverse Event|2|||
125314215|NCT02888106|450779430|FG001|Overall Study|Adverse Event|0|||
125653788|NCT05981365|452017856|FG001|Period 1|Adverse Event|0|||
125653789|NCT04780776|452017857|FG000|Titration Week 1-5|Lost to Follow-up|2|||
125653790|NCT04780776|452017858|FG001|Titration Week 1-5|Lost to Follow-up|8|||
125653791|NCT04780776|452017857|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
125314216|NCT02888106|450779431|FG002|Overall Study|Adverse Event|0|||
125314217|NCT02888106|450779432|FG003|Overall Study|Adverse Event|0|||
125314218|NCT02888106|450779433|FG004|Overall Study|Adverse Event|0|||
125653792|NCT04780776|452017858|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
125653793|NCT04780776|452017857|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
125653794|NCT04780776|452017858|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
125314219|NCT02888106|450779434|FG005|Overall Study|Adverse Event|0|||
125314220|NCT02888106|450779429|FG000|Overall Study|Withdrawal of consent|0|||
125314221|NCT02888106|450779430|FG001|Overall Study|Withdrawal of consent|0|||
125314222|NCT02888106|450779431|FG002|Overall Study|Withdrawal of consent|0|||
125314223|NCT02888106|450779432|FG003|Overall Study|Withdrawal of consent|0|||
125314224|NCT02888106|450779433|FG004|Overall Study|Withdrawal of consent|1|||
125314225|NCT02888106|450779434|FG005|Overall Study|Withdrawal of consent|0|||
125314226|NCT02888106|450779429|FG000|Overall Study|Pregnancy|1|||
125314227|NCT02888106|450779430|FG001|Overall Study|Pregnancy|0|||
125653795|NCT03927989|452017859|FG000|Overall Study|Withdrawal by Subject|0|||
125653796|NCT03927989|452017860|FG001|Overall Study|Withdrawal by Subject|1|||
125653797|NCT03772574|452017861|FG000|Overall Study|Protocol Violation|2|||
125653798|NCT03772574|452017862|FG001|Overall Study|Protocol Violation|0|||
125653799|NCT03772574|452017863|FG002|Overall Study|Protocol Violation|0|||
125653800|NCT03772574|452017861|FG000|Overall Study|Discomfort|0|||
125653801|NCT03772574|452017862|FG001|Overall Study|Discomfort|5|||
125653802|NCT03772574|452017863|FG002|Overall Study|Discomfort|4|||
125653803|NCT03193996|452017867|FG000|Overall Study|Withdrawal by Subject|4|||
125653804|NCT03193996|452017867|FG000|Overall Study|Lost to Follow-up|4|||
125653805|NCT03193996|452017867|FG000|Overall Study|Physician Decision|2|||
125653806|NCT03193996|452017867|FG000|Overall Study|Pregnancy|1|||
125653807|NCT03193996|452017867|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
125653808|NCT03193996|452017867|FG000|Overall Study|Complicating disease|1|||
125653809|NCT00348348|452017871|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
125653810|NCT00348348|452017872|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
125653811|NCT00348348|452017871|FG000|Overall Study|Lack of Efficacy|1|||
125653812|NCT00348348|452017872|FG001|Overall Study|Lack of Efficacy|1|||
125653813|NCT00348348|452017871|FG000|Overall Study|Lost to Follow-up|8|||
125653814|NCT00348348|452017872|FG001|Overall Study|Lost to Follow-up|10|||
125653815|NCT00348348|452017871|FG000|Overall Study|Withdrawal by Subject|4|||
125653816|NCT00348348|452017872|FG001|Overall Study|Withdrawal by Subject|1|||
125653817|NCT00348348|452017871|FG000|Overall Study|Other|7|||
125653818|NCT00348348|452017872|FG001|Overall Study|Other|4|||
125653819|NCT00348348|452017871|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
125653820|NCT00348348|452017872|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
125653821|NCT00348348|452017871|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
125653822|NCT00348348|452017872|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
125653823|NCT00348348|452017871|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
125653824|NCT00348348|452017872|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
125653825|NCT00348348|452017871|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
125653826|NCT00348348|452017872|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
125653827|NCT00348348|452017871|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
125653828|NCT00348348|452017872|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
125653829|NCT00348348|452017871|FG000|Overall Study|Adverse event probably related to study|1|||
125653830|NCT00348348|452017872|FG001|Overall Study|Adverse event probably related to study|0|||
125653831|NCT01471197|452017873|FG000|Overall Study|Disease Progression|4|||
125653832|NCT01471197|452017874|FG001|Overall Study|Disease Progression|2|||
125653833|NCT01471197|452017873|FG000|Overall Study|Death|1|||
125653834|NCT01471197|452017874|FG001|Overall Study|Death|0|||
125653835|NCT01471197|452017873|FG000|Overall Study|Study Drug Toxicity|1|||
125653836|NCT01471197|452017874|FG001|Overall Study|Study Drug Toxicity|0|||
125653837|NCT00924313|452017875|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
125653838|NCT00491322|452017878|FG000|Overall Study|Protocol Violation|1|||
125653839|NCT00491322|452017879|FG001|Overall Study|Protocol Violation|0|||
125653840|NCT00491322|452017878|FG000|Overall Study|Pregnancy|0|||
125653841|NCT00491322|452017879|FG001|Overall Study|Pregnancy|1|||
125653842|NCT02331680|452017881|FG000|Overall Study|Adverse Event|3|||
125653843|NCT02331680|452017882|FG001|Overall Study|Adverse Event|0|||
125653844|NCT02331680|452017883|FG002|Overall Study|Adverse Event|2|||
125653845|NCT02331680|452017881|FG000|Overall Study|Physician Decision|1|||
125653846|NCT02331680|452017882|FG001|Overall Study|Physician Decision|1|||
125653847|NCT02331680|452017883|FG002|Overall Study|Physician Decision|2|||
125653848|NCT02331680|452017881|FG000|Overall Study|Withdrawal by Subject|0|||
125653849|NCT02331680|452017882|FG001|Overall Study|Withdrawal by Subject|1|||
125653850|NCT02331680|452017883|FG002|Overall Study|Withdrawal by Subject|2|||
125653851|NCT02331680|452017881|FG000|Overall Study|Met withdrawal criteria|2|||
125653852|NCT02331680|452017882|FG001|Overall Study|Met withdrawal criteria|2|||
125653853|NCT02331680|452017883|FG002|Overall Study|Met withdrawal criteria|5|||
125653854|NCT02331680|452017881|FG000|Overall Study|Non-compliance with study drug|0|||
125653855|NCT02331680|452017882|FG001|Overall Study|Non-compliance with study drug|0|||
125653856|NCT02331680|452017883|FG002|Overall Study|Non-compliance with study drug|1|||
125314228|NCT02888106|450779431|FG002|Overall Study|Pregnancy|0|||
125314229|NCT02888106|450779432|FG003|Overall Study|Pregnancy|0|||
125653857|NCT02331680|452017881|FG000|Overall Study|Protocol Violation|0|||
125653858|NCT02331680|452017882|FG001|Overall Study|Protocol Violation|0|||
125653859|NCT02331680|452017883|FG002|Overall Study|Protocol Violation|3|||
125314230|NCT02888106|450779433|FG004|Overall Study|Pregnancy|0|||
125540465|NCT04927247|451607639|FG000|Overall Study|Physician Decision|0|||
125653860|NCT03426995|452017884|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653861|NCT03426995|452017885|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653862|NCT03426995|452017886|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
125653863|NCT03426995|452017887|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125314231|NCT02888106|450779434|FG005|Overall Study|Pregnancy|0|||
125314232|NCT01894607|450779435|FG000|Overall Study|Ineligible|1|||
125314233|NCT03259555|450779450|FG000|Overall Study|Adverse Event|6|||
125314234|NCT03259555|450779451|FG001|Overall Study|Adverse Event|4|||
125314235|NCT03259555|450779450|FG000|Overall Study|Lack of Efficacy|6|||
125314236|NCT03259555|450779451|FG001|Overall Study|Lack of Efficacy|4|||
125314237|NCT03259555|450779450|FG000|Overall Study|Lost to Follow-up|0|||
125314238|NCT03259555|450779451|FG001|Overall Study|Lost to Follow-up|2|||
125314239|NCT03259555|450779450|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125314240|NCT03259555|450779451|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125314241|NCT03259555|450779450|FG000|Overall Study|Progressive Disease|0|||
125314242|NCT03259555|450779451|FG001|Overall Study|Progressive Disease|2|||
125314243|NCT03259555|450779450|FG000|Overall Study|Withdrawal by Subject|19|||
125314244|NCT03259555|450779451|FG001|Overall Study|Withdrawal by Subject|16|||
125314245|NCT03259555|450779450|FG000|Overall Study|Physician Decision|1|||
125314246|NCT03259555|450779451|FG001|Overall Study|Physician Decision|2|||
125314247|NCT03259555|450779450|FG000|Overall Study|Other|1|||
125314248|NCT03259555|450779451|FG001|Overall Study|Other|0|||
125314249|NCT04393493|450779452|FG000|First 4 Days of Intervention|Early improvement|5|||
125314250|NCT04393493|450779453|FG001|First 4 Days of Intervention|Early improvement|7|||
125314251|NCT01125800|450779454|FG000|Phase I|Protocol Violation|0|||
125653864|NCT03426995|452017888|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653865|NCT03426995|452017889|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653866|NCT03426995|452017890|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653867|NCT03426995|452017891|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653868|NCT03426995|452017892|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653869|NCT03426995|452017893|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653870|NCT03426995|452017894|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125314252|NCT01125800|450779455|FG001|Phase I|Protocol Violation|3|||
125314253|NCT01125800|450779456|FG002|Phase I|Protocol Violation|1|||
125653871|NCT03426995|452017895|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125314254|NCT01125800|450779457|FG003|Phase I|Protocol Violation|1|||
125314255|NCT01125800|450779458|FG004|Phase I|Protocol Violation|0|||
125314256|NCT01125800|450779454|FG000|Phase I|Adverse Event|2|||
125314257|NCT01125800|450779455|FG001|Phase I|Adverse Event|2|||
125314258|NCT01125800|450779456|FG002|Phase I|Adverse Event|1|||
125314259|NCT01125800|450779457|FG003|Phase I|Adverse Event|7|||
125314260|NCT01125800|450779458|FG004|Phase I|Adverse Event|0|||
125314261|NCT01125800|450779454|FG000|Phase I|Administrative problems|1|||
125314262|NCT01125800|450779455|FG001|Phase I|Administrative problems|0|||
125314263|NCT01125800|450779456|FG002|Phase I|Administrative problems|0|||
125314264|NCT01125800|450779457|FG003|Phase I|Administrative problems|0|||
125314265|NCT01125800|450779458|FG004|Phase I|Administrative problems|0|||
125314266|NCT01125800|450779454|FG000|Phase I|Withdrawal by Subject|0|||
125314267|NCT01125800|450779455|FG001|Phase I|Withdrawal by Subject|0|||
125653872|NCT03426995|452017896|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653873|NCT03426995|452017897|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653874|NCT03426995|452017898|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653875|NCT03426995|452017899|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653876|NCT03426995|452017900|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653877|NCT03426995|452017901|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653878|NCT03426995|452017902|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
125653879|NCT03426995|452017884|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653880|NCT03426995|452017885|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653881|NCT03426995|452017886|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653882|NCT03426995|452017887|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653883|NCT03426995|452017888|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653884|NCT03426995|452017889|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
125653885|NCT03426995|452017890|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653886|NCT03426995|452017891|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653887|NCT03426995|452017892|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653888|NCT03426995|452017893|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125314268|NCT01125800|450779456|FG002|Phase I|Withdrawal by Subject|1|||
125314269|NCT01125800|450779457|FG003|Phase I|Withdrawal by Subject|0|||
125314270|NCT01125800|450779458|FG004|Phase I|Withdrawal by Subject|0|||
125314271|NCT01125800|450779454|FG000|Phase I|Disease progression|5|||
125314272|NCT01125800|450779455|FG001|Phase I|Disease progression|4|||
125314273|NCT01125800|450779456|FG002|Phase I|Disease progression|1|||
125314274|NCT01125800|450779457|FG003|Phase I|Disease progression|3|||
125314275|NCT01125800|450779458|FG004|Phase I|Disease progression|0|||
125314276|NCT01125800|450779454|FG000|Phase II|Protocol Violation|0|||
125314277|NCT01125800|450779455|FG001|Phase II|Protocol Violation|0|||
125314278|NCT01125800|450779456|FG002|Phase II|Protocol Violation|0|||
125314279|NCT01125800|450779457|FG003|Phase II|Protocol Violation|0|||
125653889|NCT03426995|452017894|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653890|NCT03426995|452017895|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653891|NCT03426995|452017896|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653892|NCT03426995|452017897|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653893|NCT03426995|452017898|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653894|NCT03426995|452017899|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653895|NCT03426995|452017900|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653896|NCT03426995|452017901|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653897|NCT03426995|452017902|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
125653898|NCT03426995|452017884|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653899|NCT03426995|452017885|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653900|NCT03426995|452017886|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653901|NCT03426995|452017887|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653902|NCT03426995|452017888|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
125653903|NCT03426995|452017889|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
125653904|NCT03426995|452017890|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653905|NCT03426995|452017891|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653906|NCT03426995|452017892|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653907|NCT03426995|452017893|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653908|NCT03426995|452017894|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653909|NCT03426995|452017895|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653910|NCT03426995|452017896|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653911|NCT03426995|452017897|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653912|NCT03426995|452017898|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653913|NCT03426995|452017899|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653914|NCT03426995|452017900|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653915|NCT03426995|452017901|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653916|NCT03426995|452017902|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
125653917|NCT03426995|452017884|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653918|NCT03426995|452017885|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653919|NCT03426995|452017886|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653920|NCT03426995|452017887|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653921|NCT03426995|452017888|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653922|NCT03426995|452017889|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653923|NCT03426995|452017890|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653924|NCT03426995|452017891|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653925|NCT03426995|452017892|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653926|NCT03426995|452017893|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653927|NCT03426995|452017894|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
125653928|NCT03426995|452017895|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653929|NCT03426995|452017896|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653930|NCT03426995|452017897|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653931|NCT03426995|452017898|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653932|NCT03426995|452017899|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653933|NCT03426995|452017900|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653934|NCT03426995|452017901|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653935|NCT03426995|452017902|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
125653936|NCT03426995|452017884|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653937|NCT03426995|452017885|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653938|NCT03426995|452017886|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653939|NCT03426995|452017887|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653940|NCT03426995|452017888|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653941|NCT03426995|452017889|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653942|NCT03426995|452017890|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653943|NCT03426995|452017891|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
125653944|NCT03426995|452017892|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653945|NCT03426995|452017893|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125210506|NCT01533688|450395581|FG000|Overall Study|Withdrawal by Subject|5|||
125210507|NCT01533688|450395582|FG001|Overall Study|Withdrawal by Subject|4|||
125210508|NCT01533688|450395583|FG002|Overall Study|Withdrawal by Subject|3|||
125210509|NCT01533688|450395581|FG000|Overall Study|Medically unstable|1|||
125210510|NCT01533688|450395582|FG001|Overall Study|Medically unstable|3|||
125210511|NCT01533688|450395583|FG002|Overall Study|Medically unstable|3|||
125210512|NCT01533688|450395581|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
125210513|NCT01533688|450395582|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
125210514|NCT01533688|450395583|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
125210515|NCT04591015|450395584|FG000|Overall Study|Death|6|||
125653946|NCT03426995|452017894|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125210516|NCT04591015|450395585|FG001|Overall Study|Death|4|||
125653947|NCT03426995|452017895|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653948|NCT03426995|452017896|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653949|NCT03426995|452017897|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653950|NCT03426995|452017898|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653951|NCT03426995|452017899|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653952|NCT03426995|452017900|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653953|NCT03426995|452017901|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653954|NCT03426995|452017902|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
125653955|NCT03426995|452017884|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653956|NCT03426995|452017885|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653957|NCT03426995|452017886|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653958|NCT03426995|452017887|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653959|NCT03426995|452017888|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653960|NCT03426995|452017889|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653961|NCT03426995|452017890|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653962|NCT03426995|452017891|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653963|NCT03426995|452017892|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653964|NCT03426995|452017893|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653965|NCT03426995|452017894|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653966|NCT03426995|452017895|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653967|NCT03426995|452017896|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653968|NCT03426995|452017897|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653969|NCT03426995|452017898|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
125653970|NCT03426995|452017899|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
125653971|NCT03426995|452017900|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125314280|NCT01125800|450779458|FG004|Phase II|Protocol Violation|1|||
125314281|NCT01125800|450779454|FG000|Phase II|Adverse Event|0|||
125314282|NCT01125800|450779455|FG001|Phase II|Adverse Event|0|||
125314283|NCT01125800|450779456|FG002|Phase II|Adverse Event|0|||
125314284|NCT01125800|450779457|FG003|Phase II|Adverse Event|0|||
125653972|NCT03426995|452017901|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653973|NCT03426995|452017902|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
125653974|NCT03426995|452017884|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653975|NCT03426995|452017885|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653976|NCT03426995|452017886|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653977|NCT03426995|452017887|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653978|NCT03426995|452017888|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653979|NCT03426995|452017889|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653980|NCT03426995|452017890|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653981|NCT03426995|452017891|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653982|NCT03426995|452017892|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653983|NCT03426995|452017893|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653984|NCT03426995|452017894|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125314285|NCT01125800|450779458|FG004|Phase II|Adverse Event|2|||
125314286|NCT01125800|450779454|FG000|Phase II|Disease progression|0|||
125314287|NCT01125800|450779455|FG001|Phase II|Disease progression|0|||
125314288|NCT01125800|450779456|FG002|Phase II|Disease progression|0|||
125314289|NCT01125800|450779457|FG003|Phase II|Disease progression|1|||
125314290|NCT01125800|450779458|FG004|Phase II|Disease progression|8|||
125314291|NCT04332107|450779463|FG000|Day 3|Lost to Follow-up|23|||
125314292|NCT04332107|450779464|FG001|Day 3|Lost to Follow-up|14|||
125314293|NCT04332107|450779463|FG000|Day 3|Missing outcome data|3|||
125314294|NCT04332107|450779464|FG001|Day 3|Missing outcome data|6|||
125314295|NCT04332107|450779463|FG000|Day 14|Lost to Follow-up|13|||
125314296|NCT04332107|450779464|FG001|Day 14|Lost to Follow-up|4|||
125314297|NCT04332107|450779463|FG000|Day 14|Missing outcome data|4|||
125314298|NCT04332107|450779464|FG001|Day 14|Missing outcome data|4|||
125314299|NCT04332107|450779463|FG000|Day 21|Lost to Follow-up|10|||
125314300|NCT04332107|450779464|FG001|Day 21|Lost to Follow-up|2|||
125653985|NCT03426995|452017895|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653986|NCT03426995|452017896|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653987|NCT03426995|452017897|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653988|NCT03426995|452017898|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
125653989|NCT03426995|452017899|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
125314301|NCT01670721|450779469|FG000|Overall Study|Participant's decision|15|||
125314302|NCT01670721|450779469|FG000|Overall Study|Other than specified above|38|||
125314303|NCT04970654|450779472|FG000|Overall Study|Withdrawal by parents/guardian|1|||
125314304|NCT04970654|450779473|FG001|Overall Study|Withdrawal by parents/guardian|2|||
125314305|NCT04970654|450779472|FG000|Overall Study|Unclassified|2|||
125314306|NCT04970654|450779473|FG001|Overall Study|Unclassified|1|||
125653990|NCT03426995|452017900|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653991|NCT03426995|452017901|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653992|NCT03426995|452017902|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
125653993|NCT05939388|452017903|FG000|Overall Study|Lost to Follow-up|1|||
125653994|NCT00602667|452017904|FG000|Overall Study|Still on Therapy|0|||
125653995|NCT00602667|452017905|FG001|Overall Study|Still on Therapy|2|||
125314307|NCT04970654|450779472|FG000|Overall Study|Lost to Follow-up|1|||
125314308|NCT04970654|450779473|FG001|Overall Study|Lost to Follow-up|0|||
125314309|NCT05579977|450779481|FG000|Treatment Phase|Other|0|||
125314310|NCT05579977|450779482|FG001|Treatment Phase|Other|0|||
125314311|NCT05579977|450779483|FG002|Treatment Phase|Other|0|||
125314312|NCT05579977|450779484|FG003|Treatment Phase|Other|2|||
125314313|NCT05579977|450779485|FG004|Treatment Phase|Other|1|||
125314314|NCT05579977|450779486|FG005|Treatment Phase|Other|2|||
125314315|NCT05579977|450779487|FG006|Treatment Phase|Other|1|||
125314316|NCT05579977|450779488|FG007|Treatment Phase|Other|2|||
125314317|NCT05579977|450779489|FG008|Treatment Phase|Other|2|||
125314318|NCT05579977|450779490|FG009|Treatment Phase|Other|1|||
125314319|NCT05579977|450779491|FG010|Treatment Phase|Other|0|||
125314320|NCT05579977|450779492|FG011|Treatment Phase|Other|0|||
125314321|NCT05579977|450779493|FG012|Treatment Phase|Other|3|||
125314322|NCT05579977|450779481|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
125314323|NCT05579977|450779482|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
125314324|NCT05579977|450779483|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
125314325|NCT05579977|450779484|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
125314326|NCT05579977|450779485|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
125314327|NCT05579977|450779486|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
125314328|NCT05579977|450779487|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
125314329|NCT05579977|450779488|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
125314330|NCT05579977|450779489|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
125314331|NCT05579977|450779490|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
125314332|NCT05579977|450779491|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
125314333|NCT05579977|450779492|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
125314334|NCT05579977|450779493|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
125314335|NCT05579977|450779481|FG000|Treatment Phase|Withdrawal by Subject|2|||
125314336|NCT05579977|450779482|FG001|Treatment Phase|Withdrawal by Subject|0|||
125314337|NCT05579977|450779483|FG002|Treatment Phase|Withdrawal by Subject|0|||
125314338|NCT05579977|450779484|FG003|Treatment Phase|Withdrawal by Subject|1|||
125314339|NCT05579977|450779485|FG004|Treatment Phase|Withdrawal by Subject|2|||
125314340|NCT05579977|450779486|FG005|Treatment Phase|Withdrawal by Subject|0|||
125314341|NCT05579977|450779487|FG006|Treatment Phase|Withdrawal by Subject|1|||
125314342|NCT05579977|450779488|FG007|Treatment Phase|Withdrawal by Subject|8|||
125314343|NCT05579977|450779489|FG008|Treatment Phase|Withdrawal by Subject|3|||
125314344|NCT05579977|450779490|FG009|Treatment Phase|Withdrawal by Subject|3|||
125314345|NCT05579977|450779491|FG010|Treatment Phase|Withdrawal by Subject|5|||
125314346|NCT05579977|450779492|FG011|Treatment Phase|Withdrawal by Subject|1|||
125314347|NCT05579977|450779493|FG012|Treatment Phase|Withdrawal by Subject|3|||
125314348|NCT05579977|450779481|FG000|Treatment Phase|Study terminated by sponsor|70|||
125314349|NCT05579977|450779482|FG001|Treatment Phase|Study terminated by sponsor|70|||
125314350|NCT05579977|450779483|FG002|Treatment Phase|Study terminated by sponsor|61|||
125314351|NCT05579977|450779484|FG003|Treatment Phase|Study terminated by sponsor|59|||
125314352|NCT05579977|450779485|FG004|Treatment Phase|Study terminated by sponsor|63|||
125314353|NCT05579977|450779486|FG005|Treatment Phase|Study terminated by sponsor|53|||
125314354|NCT05579977|450779487|FG006|Treatment Phase|Study terminated by sponsor|66|||
125314355|NCT05579977|450779488|FG007|Treatment Phase|Study terminated by sponsor|48|||
125314356|NCT05579977|450779489|FG008|Treatment Phase|Study terminated by sponsor|47|||
125314357|NCT05579977|450779490|FG009|Treatment Phase|Study terminated by sponsor|37|||
125314358|NCT05579977|450779491|FG010|Treatment Phase|Study terminated by sponsor|44|||
125314359|NCT05579977|450779492|FG011|Treatment Phase|Study terminated by sponsor|36|||
125314360|NCT05579977|450779493|FG012|Treatment Phase|Study terminated by sponsor|32|||
125653996|NCT00602667|452017906|FG002|Overall Study|Still on Therapy|2|||
125653997|NCT00602667|452017904|FG000|Overall Study|Death|0|||
125314361|NCT05579977|450779481|FG000|Treatment Phase|Pregnancy|0|||
125653998|NCT00602667|452017905|FG001|Overall Study|Death|1|||
125314362|NCT05579977|450779482|FG001|Treatment Phase|Pregnancy|0|||
125653999|NCT00602667|452017906|FG002|Overall Study|Death|1|||
125654000|NCT00602667|452017904|FG000|Overall Study|Family request|3|||
125654001|NCT00602667|452017905|FG001|Overall Study|Family request|25|||
125314363|NCT05579977|450779483|FG002|Treatment Phase|Pregnancy|0|||
125314364|NCT05579977|450779484|FG003|Treatment Phase|Pregnancy|0|||
125314365|NCT05579977|450779485|FG004|Treatment Phase|Pregnancy|0|||
125314366|NCT05579977|450779486|FG005|Treatment Phase|Pregnancy|0|||
125314367|NCT05579977|450779487|FG006|Treatment Phase|Pregnancy|0|||
125654002|NCT00602667|452017906|FG002|Overall Study|Family request|6|||
125654003|NCT00602667|452017904|FG000|Overall Study|Excessive toxicity|1|||
125314368|NCT05579977|450779488|FG007|Treatment Phase|Pregnancy|0|||
125314369|NCT05579977|450779489|FG008|Treatment Phase|Pregnancy|0|||
125314370|NCT05579977|450779490|FG009|Treatment Phase|Pregnancy|1|||
125314371|NCT05579977|450779491|FG010|Treatment Phase|Pregnancy|0|||
125314372|NCT05579977|450779492|FG011|Treatment Phase|Pregnancy|0|||
125314373|NCT05579977|450779493|FG012|Treatment Phase|Pregnancy|0|||
125314374|NCT05579977|450779481|FG000|Treatment Phase|Physician Decision|0|||
125314375|NCT05579977|450779482|FG001|Treatment Phase|Physician Decision|0|||
125314376|NCT05579977|450779483|FG002|Treatment Phase|Physician Decision|0|||
125314377|NCT05579977|450779484|FG003|Treatment Phase|Physician Decision|0|||
125314378|NCT05579977|450779485|FG004|Treatment Phase|Physician Decision|0|||
125314379|NCT05579977|450779486|FG005|Treatment Phase|Physician Decision|0|||
125314380|NCT05579977|450779487|FG006|Treatment Phase|Physician Decision|0|||
125314381|NCT05579977|450779488|FG007|Treatment Phase|Physician Decision|0|||
125314382|NCT05579977|450779489|FG008|Treatment Phase|Physician Decision|0|||
125314383|NCT05579977|450779490|FG009|Treatment Phase|Physician Decision|0|||
125314384|NCT05579977|450779491|FG010|Treatment Phase|Physician Decision|0|||
125314385|NCT05579977|450779492|FG011|Treatment Phase|Physician Decision|1|||
125314386|NCT05579977|450779493|FG012|Treatment Phase|Physician Decision|0|||
125314387|NCT05579977|450779481|FG000|Treatment Phase|Lost to Follow-up|0|||
125314388|NCT05579977|450779482|FG001|Treatment Phase|Lost to Follow-up|0|||
125314389|NCT05579977|450779483|FG002|Treatment Phase|Lost to Follow-up|0|||
125314390|NCT05579977|450779484|FG003|Treatment Phase|Lost to Follow-up|1|||
125314391|NCT05579977|450779485|FG004|Treatment Phase|Lost to Follow-up|1|||
125314392|NCT05579977|450779486|FG005|Treatment Phase|Lost to Follow-up|1|||
125314393|NCT05579977|450779487|FG006|Treatment Phase|Lost to Follow-up|0|||
125314394|NCT05579977|450779488|FG007|Treatment Phase|Lost to Follow-up|1|||
125314395|NCT05579977|450779489|FG008|Treatment Phase|Lost to Follow-up|2|||
125314396|NCT05579977|450779490|FG009|Treatment Phase|Lost to Follow-up|2|||
125314397|NCT05579977|450779491|FG010|Treatment Phase|Lost to Follow-up|1|||
125314398|NCT05579977|450779492|FG011|Treatment Phase|Lost to Follow-up|4|||
125314399|NCT05579977|450779493|FG012|Treatment Phase|Lost to Follow-up|3|||
125314400|NCT05579977|450779481|FG000|Treatment Phase|Death|1|||
125314401|NCT05579977|450779482|FG001|Treatment Phase|Death|0|||
125314402|NCT05579977|450779483|FG002|Treatment Phase|Death|0|||
125314403|NCT05579977|450779484|FG003|Treatment Phase|Death|0|||
125314404|NCT05579977|450779485|FG004|Treatment Phase|Death|0|||
125314405|NCT05579977|450779486|FG005|Treatment Phase|Death|0|||
125314406|NCT05579977|450779487|FG006|Treatment Phase|Death|0|||
125314407|NCT05579977|450779488|FG007|Treatment Phase|Death|0|||
125314408|NCT05579977|450779489|FG008|Treatment Phase|Death|0|||
125314409|NCT05579977|450779490|FG009|Treatment Phase|Death|0|||
125314410|NCT05579977|450779491|FG010|Treatment Phase|Death|0|||
125314411|NCT05579977|450779492|FG011|Treatment Phase|Death|0|||
125314412|NCT05579977|450779493|FG012|Treatment Phase|Death|0|||
125314413|NCT05579977|450779481|FG000|Treatment Phase|Adverse Event|0|||
125314414|NCT05579977|450779482|FG001|Treatment Phase|Adverse Event|3|||
125314415|NCT05579977|450779483|FG002|Treatment Phase|Adverse Event|11|||
125314416|NCT05579977|450779484|FG003|Treatment Phase|Adverse Event|10|||
125314417|NCT05579977|450779485|FG004|Treatment Phase|Adverse Event|5|||
125314418|NCT05579977|450779486|FG005|Treatment Phase|Adverse Event|17|||
125314419|NCT05579977|450779487|FG006|Treatment Phase|Adverse Event|5|||
125314420|NCT05579977|450779488|FG007|Treatment Phase|Adverse Event|5|||
125314421|NCT05579977|450779489|FG008|Treatment Phase|Adverse Event|12|||
125314422|NCT05579977|450779490|FG009|Treatment Phase|Adverse Event|20|||
125314423|NCT05579977|450779491|FG010|Treatment Phase|Adverse Event|15|||
125314424|NCT05579977|450779492|FG011|Treatment Phase|Adverse Event|24|||
125314425|NCT05579977|450779493|FG012|Treatment Phase|Adverse Event|23|||
125314426|NCT05579977|450779481|FG000|Treatment Phase|Randomized not treated|0|||
125314427|NCT05579977|450779482|FG001|Treatment Phase|Randomized not treated|0|||
125314428|NCT05579977|450779483|FG002|Treatment Phase|Randomized not treated|0|||
125314429|NCT05579977|450779484|FG003|Treatment Phase|Randomized not treated|0|||
125314430|NCT05579977|450779485|FG004|Treatment Phase|Randomized not treated|1|||
125314431|NCT05579977|450779486|FG005|Treatment Phase|Randomized not treated|0|||
125314432|NCT05579977|450779487|FG006|Treatment Phase|Randomized not treated|0|||
125314433|NCT05579977|450779488|FG007|Treatment Phase|Randomized not treated|0|||
125314434|NCT05579977|450779489|FG008|Treatment Phase|Randomized not treated|0|||
125314435|NCT05579977|450779490|FG009|Treatment Phase|Randomized not treated|0|||
125314436|NCT05579977|450779491|FG010|Treatment Phase|Randomized not treated|0|||
125314437|NCT05579977|450779492|FG011|Treatment Phase|Randomized not treated|0|||
125314438|NCT05579977|450779493|FG012|Treatment Phase|Randomized not treated|0|||
125314439|NCT05579977|450779481|FG000|Follow up|Death|1|||
125314440|NCT05579977|450779482|FG001|Follow up|Death|0|||
125314441|NCT05579977|450779483|FG002|Follow up|Death|0|||
125314442|NCT05579977|450779484|FG003|Follow up|Death|0|||
125314443|NCT05579977|450779485|FG004|Follow up|Death|0|||
125314444|NCT05579977|450779486|FG005|Follow up|Death|0|||
125314445|NCT05579977|450779487|FG006|Follow up|Death|0|||
125314446|NCT05579977|450779488|FG007|Follow up|Death|0|||
125314447|NCT05579977|450779489|FG008|Follow up|Death|0|||
125314448|NCT05579977|450779490|FG009|Follow up|Death|0|||
125314449|NCT05579977|450779491|FG010|Follow up|Death|0|||
125314450|NCT05579977|450779492|FG011|Follow up|Death|0|||
125654004|NCT00602667|452017905|FG001|Overall Study|Excessive toxicity|1|||
125654005|NCT00602667|452017906|FG002|Overall Study|Excessive toxicity|0|||
125654006|NCT00602667|452017904|FG000|Overall Study|Second malignancy|0|||
125654007|NCT00602667|452017905|FG001|Overall Study|Second malignancy|1|||
125654008|NCT00602667|452017906|FG002|Overall Study|Second malignancy|0|||
125654009|NCT00602667|452017904|FG000|Overall Study|Physician Decision|2|||
125654010|NCT00602667|452017905|FG001|Overall Study|Physician Decision|3|||
125654011|NCT00602667|452017906|FG002|Overall Study|Physician Decision|8|||
125654012|NCT00602667|452017904|FG000|Overall Study|Progressive disease|13|||
125654013|NCT00602667|452017905|FG001|Overall Study|Progressive disease|48|||
125654014|NCT00602667|452017906|FG002|Overall Study|Progressive disease|45|||
125654015|NCT00602667|452017904|FG000|Overall Study|Progressive disease prior to therapy|0|||
125654016|NCT00602667|452017905|FG001|Overall Study|Progressive disease prior to therapy|0|||
125654017|NCT00602667|452017906|FG002|Overall Study|Progressive disease prior to therapy|1|||
125654018|NCT04410978|452017912|FG000|Overall Study|Poor compliance to protocol|2|||
125654019|NCT04410978|452017913|FG001|Overall Study|Poor compliance to protocol|4|||
125654020|NCT04410978|452017912|FG000|Overall Study|Withdrawal by Subject|64|||
125654021|NCT04410978|452017913|FG001|Overall Study|Withdrawal by Subject|66|||
125654022|NCT04410978|452017912|FG000|Overall Study|Other|6|||
125654023|NCT04410978|452017913|FG001|Overall Study|Other|7|||
125654024|NCT04410978|452017912|FG000|Overall Study|Missing study status|1|||
125654025|NCT04410978|452017913|FG001|Overall Study|Missing study status|0|||
125654026|NCT05153629|452017915|FG000|Overall Study|Withdrawal by Subject|0|||
125654027|NCT05153629|452017916|FG001|Overall Study|Withdrawal by Subject|2|||
125654028|NCT00885677|452017921|FG000|Overall Study|Death|40|||
125654029|NCT00885677|452017922|FG001|Overall Study|Death|34|||
125654030|NCT00885677|452017921|FG000|Overall Study|Lost to Follow-up|15|||
125654031|NCT00885677|452017922|FG001|Overall Study|Lost to Follow-up|13|||
125654032|NCT00885677|452017921|FG000|Overall Study|Protocol Violation|54|||
125654033|NCT00885677|452017922|FG001|Overall Study|Protocol Violation|54|||
125654034|NCT00885677|452017921|FG000|Overall Study|premature study closure|41|||
125654035|NCT00885677|452017922|FG001|Overall Study|premature study closure|44|||
125654036|NCT00885677|452017921|FG000|Overall Study|device/lead revision or replacement|7|||
125654037|NCT00885677|452017922|FG001|Overall Study|device/lead revision or replacement|6|||
125654038|NCT00885677|452017921|FG000|Overall Study|Heart transplantation|1|||
125654039|NCT00885677|452017922|FG001|Overall Study|Heart transplantation|0|||
125654040|NCT00885677|452017921|FG000|Overall Study|Inclusion/exclusion not met|25|||
125654041|NCT00885677|452017922|FG001|Overall Study|Inclusion/exclusion not met|27|||
125654042|NCT00972309|452017923|FG000|Overall Study|Switched to alternative treatment|0|||
125654043|NCT00972309|452017924|FG001|Overall Study|Switched to alternative treatment|2|||
125654044|NCT00972309|452017923|FG000|Overall Study|Refused further treatment|0|||
125654045|NCT00972309|452017924|FG001|Overall Study|Refused further treatment|1|||
125654046|NCT00972309|452017923|FG000|Overall Study|Late determination of ineligibility|0|||
125654047|NCT00972309|452017924|FG001|Overall Study|Late determination of ineligibility|1|||
125654048|NCT00972309|452017923|FG000|Overall Study|Second malignancy|1|||
125654049|NCT00972309|452017924|FG001|Overall Study|Second malignancy|1|||
125654050|NCT00972309|452017923|FG000|Overall Study|Visa issues|0|||
125654051|NCT00972309|452017924|FG001|Overall Study|Visa issues|1|||
125654052|NCT00972309|452017923|FG000|Overall Study|Secondary cancer (SCC)|0|||
125654053|NCT00972309|452017924|FG001|Overall Study|Secondary cancer (SCC)|1|||
125654054|NCT00972309|452017923|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
125654055|NCT00972309|452017924|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
125654056|NCT00972309|452017923|FG000|Overall Study|Lost to Follow-up|1|||
125210517|NCT04591015|450395584|FG000|Overall Study|Withdrawal by Subject|6|||
125210518|NCT04591015|450395585|FG001|Overall Study|Withdrawal by Subject|3|||
125210519|NCT04591015|450395584|FG000|Overall Study|Lost to Follow-up|16|||
125210520|NCT04591015|450395585|FG001|Overall Study|Lost to Follow-up|11|||
125210521|NCT02509078|450395586|FG000|Overall Study|Protocol Violation|1|||
125210522|NCT02509078|450395587|FG001|Overall Study|Protocol Violation|1|||
125210523|NCT02686814|450395588|FG000|Overall Study|Physician Decision|14|||
125210524|NCT02686814|450395588|FG000|Overall Study|Withdrawal by Subject|4|||
125210525|NCT02686814|450395588|FG000|Overall Study|Death|1|||
125210526|NCT00290693|450395589|FG000|Overall Study|Withdrawal by Subject|2|||
125210527|NCT02907619|450395590|FG000|Overall Study|Study terminated by sponsor|18|||
125210528|NCT02907619|450395591|FG001|Overall Study|Study terminated by sponsor|18|||
125210529|NCT02907619|450395592|FG002|Overall Study|Study terminated by sponsor|19|||
125210530|NCT02907619|450395590|FG000|Overall Study|Death|0|||
125210531|NCT02907619|450395591|FG001|Overall Study|Death|0|||
125210532|NCT02907619|450395592|FG002|Overall Study|Death|1|||
125210533|NCT02907619|450395590|FG000|Overall Study|Withdrawal by Subject|1|||
125210534|NCT02907619|450395591|FG001|Overall Study|Withdrawal by Subject|1|||
125210535|NCT02907619|450395592|FG002|Overall Study|Withdrawal by Subject|0|||
125654057|NCT00972309|452017924|FG001|Overall Study|Lost to Follow-up|1|||
125654058|NCT00972309|452017923|FG000|Overall Study|Disease progression on study|10|||
125654059|NCT00972309|452017924|FG001|Overall Study|Disease progression on study|4|||
125654060|NCT01233284|452017928|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
125210536|NCT02907619|450395590|FG000|Overall Study|Other|0|||
125314451|NCT05579977|450779493|FG012|Follow up|Death|0|||
125314452|NCT05579977|450779481|FG000|Follow up|Lost to Follow-up|0|||
125314453|NCT05579977|450779482|FG001|Follow up|Lost to Follow-up|0|||
125314454|NCT05579977|450779483|FG002|Follow up|Lost to Follow-up|0|||
125314455|NCT05579977|450779484|FG003|Follow up|Lost to Follow-up|1|||
125314456|NCT05579977|450779485|FG004|Follow up|Lost to Follow-up|1|||
125314457|NCT05579977|450779486|FG005|Follow up|Lost to Follow-up|2|||
125314458|NCT05579977|450779487|FG006|Follow up|Lost to Follow-up|1|||
125314459|NCT05579977|450779488|FG007|Follow up|Lost to Follow-up|1|||
125314460|NCT05579977|450779489|FG008|Follow up|Lost to Follow-up|3|||
125314461|NCT05579977|450779490|FG009|Follow up|Lost to Follow-up|2|||
125314462|NCT05579977|450779491|FG010|Follow up|Lost to Follow-up|2|||
125314463|NCT05579977|450779492|FG011|Follow up|Lost to Follow-up|4|||
125314464|NCT05579977|450779493|FG012|Follow up|Lost to Follow-up|4|||
125314465|NCT05579977|450779481|FG000|Follow up|Withdrawal by Subject|2|||
125314466|NCT05579977|450779482|FG001|Follow up|Withdrawal by Subject|0|||
125314467|NCT05579977|450779483|FG002|Follow up|Withdrawal by Subject|0|||
125314468|NCT05579977|450779484|FG003|Follow up|Withdrawal by Subject|0|||
125314469|NCT05579977|450779485|FG004|Follow up|Withdrawal by Subject|1|||
125314470|NCT05579977|450779486|FG005|Follow up|Withdrawal by Subject|0|||
125314471|NCT05579977|450779487|FG006|Follow up|Withdrawal by Subject|1|||
125314472|NCT05579977|450779488|FG007|Follow up|Withdrawal by Subject|4|||
125314473|NCT05579977|450779489|FG008|Follow up|Withdrawal by Subject|2|||
125314474|NCT05579977|450779490|FG009|Follow up|Withdrawal by Subject|3|||
125314475|NCT05579977|450779491|FG010|Follow up|Withdrawal by Subject|3|||
125314476|NCT05579977|450779492|FG011|Follow up|Withdrawal by Subject|1|||
125314477|NCT05579977|450779493|FG012|Follow up|Withdrawal by Subject|3|||
125314478|NCT00350844|450779494|FG000|Overall Study|Lost to Follow-up|1|||
125314479|NCT01420926|450779495|FG000|Overall Study|Adverse Event|6|||
125314480|NCT01420926|450779496|FG001|Overall Study|Adverse Event|4|||
125314481|NCT01420926|450779495|FG000|Overall Study|Death|18|||
125314482|NCT01420926|450779496|FG001|Overall Study|Death|17|||
125314483|NCT01420926|450779495|FG000|Overall Study|Withdrawal by Subject|11|||
125314484|NCT01420926|450779496|FG001|Overall Study|Withdrawal by Subject|17|||
125314485|NCT01420926|450779495|FG000|Overall Study|Non-protocol treatment|17|||
125314486|NCT01420926|450779496|FG001|Overall Study|Non-protocol treatment|20|||
125314487|NCT01420926|450779495|FG000|Overall Study|Physician Decision|8|||
125314488|NCT01420926|450779496|FG001|Overall Study|Physician Decision|5|||
125314489|NCT02775916|450779499|FG000|Overall Study|Adverse Event|1|||
125314490|NCT02775916|450779500|FG001|Overall Study|Adverse Event|0|||
125314491|NCT02775916|450779499|FG000|Overall Study|Subject/Guardian Decision|2|||
125314492|NCT02775916|450779500|FG001|Overall Study|Subject/Guardian Decision|0|||
125314493|NCT02614729|450781637|FG000|Overall Study|Withdrawal by Subject|1|||
125314494|NCT02614729|450781638|FG001|Overall Study|Withdrawal by Subject|0|||
125314495|NCT01232868|450781639|FG000|Overall Study|Lost to Follow-up|2|||
125314496|NCT01232868|450781640|FG001|Overall Study|Lost to Follow-up|4|||
125314497|NCT02539797|450781641|FG000|Overall Study|Lost to Follow-up|0|||
125314498|NCT02539797|450781642|FG001|Overall Study|Lost to Follow-up|1|||
125314499|NCT02539797|450781643|FG002|Overall Study|Lost to Follow-up|0|||
125314500|NCT04002960|450781645|FG000|Overall Study|Withdrawn prior to Completion|2|||
125314501|NCT00865345|450781648|FG000|Overall Study|Withdrawal by Subject|2|||
125314502|NCT00383786|450781649|FG000|Overall Study|Protocol Violation|2|||
125314503|NCT00383786|450781650|FG001|Overall Study|Protocol Violation|6|||
125314504|NCT00383786|450781649|FG000|Overall Study|Withdrawal by Subject|2|||
125314505|NCT00383786|450781650|FG001|Overall Study|Withdrawal by Subject|5|||
125314506|NCT00383786|450781649|FG000|Overall Study|Physician Decision|0|||
125314507|NCT00383786|450781650|FG001|Overall Study|Physician Decision|1|||
125314508|NCT01517750|450781653|FG000|Overall Study|Lost to Follow-up|1|||
125314509|NCT01517750|450781654|FG001|Overall Study|Lost to Follow-up|2|||
125314510|NCT01517750|450781655|FG002|Overall Study|Lost to Follow-up|4|||
125314511|NCT01517750|450781656|FG003|Overall Study|Lost to Follow-up|1|||
125314512|NCT02723773|450781657|FG000|Overall Study|Adverse Event|934|||
125314513|NCT02723773|450781658|FG001|Overall Study|Adverse Event|3|||
125314514|NCT02723773|450781659|FG002|Overall Study|Adverse Event|1|||
125314515|NCT02723773|450781660|FG003|Overall Study|Adverse Event|9|||
125314516|NCT02723773|450781657|FG000|Overall Study|Protocol Violation|1|||
125314517|NCT02723773|450781658|FG001|Overall Study|Protocol Violation|0|||
125314518|NCT02723773|450781659|FG002|Overall Study|Protocol Violation|0|||
125314519|NCT02723773|450781660|FG003|Overall Study|Protocol Violation|0|||
125314520|NCT02723773|450781657|FG000|Overall Study|Withdrawal by Subject|360|||
125314521|NCT02723773|450781658|FG001|Overall Study|Withdrawal by Subject|5|||
125314522|NCT02723773|450781659|FG002|Overall Study|Withdrawal by Subject|6|||
125314523|NCT02723773|450781660|FG003|Overall Study|Withdrawal by Subject|10|||
125314524|NCT02723773|450781657|FG000|Overall Study|Migrated/moved from study area|37|||
125314525|NCT02723773|450781658|FG001|Overall Study|Migrated/moved from study area|0|||
125314526|NCT02723773|450781659|FG002|Overall Study|Migrated/moved from study area|0|||
125314527|NCT02723773|450781660|FG003|Overall Study|Migrated/moved from study area|1|||
125314528|NCT02723773|450781657|FG000|Overall Study|Lost to Follow-up|198|||
125314529|NCT02723773|450781658|FG001|Overall Study|Lost to Follow-up|0|||
125314530|NCT02723773|450781659|FG002|Overall Study|Lost to Follow-up|0|||
125654061|NCT01233284|452017929|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
125654062|NCT01233284|452017930|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
125654063|NCT01233284|452017931|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
125654064|NCT01233284|452017932|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
125654065|NCT01233284|452017928|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
125654066|NCT01233284|452017929|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
125654067|NCT01233284|452017930|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
125654068|NCT01233284|452017931|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
125654069|NCT01233284|452017932|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
125654070|NCT01233284|452017928|FG000|Period 1 (4 Weeks)|Other|0|||
125654071|NCT01233284|452017929|FG001|Period 1 (4 Weeks)|Other|0|||
125654072|NCT01233284|452017930|FG002|Period 1 (4 Weeks)|Other|1|||
125654073|NCT01233284|452017931|FG003|Period 1 (4 Weeks)|Other|0|||
125654074|NCT01233284|452017932|FG004|Period 1 (4 Weeks)|Other|0|||
125654075|NCT01233284|452017928|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125654076|NCT01233284|452017929|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125654077|NCT01233284|452017930|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
125654078|NCT01233284|452017931|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125654079|NCT01233284|452017932|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125654080|NCT01233284|452017928|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125654081|NCT01233284|452017929|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125654082|NCT01233284|452017930|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
125654083|NCT01233284|452017931|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125654084|NCT01233284|452017932|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125654085|NCT01233284|452017928|FG000|Period 3 (4 Weeks)|Other|0|||
125654086|NCT01233284|452017929|FG001|Period 3 (4 Weeks)|Other|0|||
125654087|NCT01233284|452017930|FG002|Period 3 (4 Weeks)|Other|0|||
125654088|NCT01233284|452017931|FG003|Period 3 (4 Weeks)|Other|1|||
125654089|NCT01233284|452017932|FG004|Period 3 (4 Weeks)|Other|0|||
125654090|NCT01233284|452017928|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
125654091|NCT01233284|452017929|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
125654092|NCT01233284|452017930|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
125654093|NCT01233284|452017931|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
125654094|NCT01233284|452017932|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
125654095|NCT01233284|452017928|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
125654096|NCT01233284|452017929|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
125654097|NCT01233284|452017930|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
125654098|NCT01233284|452017931|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
125654099|NCT01233284|452017932|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
125654100|NCT00828009|452017935|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
125654101|NCT00828009|452017935|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
125654102|NCT00828009|452017935|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
125654103|NCT00828009|452017935|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
125654104|NCT00828009|452017935|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
125654105|NCT00828009|452017935|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
125654106|NCT00828009|452017935|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
125654107|NCT00828009|452017935|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
125654108|NCT00828009|452017935|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
125654109|NCT00828009|452017935|FG000|Step 2 - Maintenance Therapy|Death|1|||
125654110|NCT00828009|452017935|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
125654111|NCT00828009|452017935|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
125654112|NCT00828009|452017935|FG000|Step 2 - Maintenance Therapy|Other|1|||
125654113|NCT00157820|452017943|FG000|Randomized|Physician Decision|4|||
125654114|NCT00157820|452017944|FG001|Randomized|Physician Decision|2|||
125654115|NCT00157820|452017945|FG002|Randomized|Physician Decision|3|||
125654116|NCT00157820|452017943|FG000|Randomized|Withdrawal by Subject|1|||
125654117|NCT00157820|452017944|FG001|Randomized|Withdrawal by Subject|2|||
125314531|NCT02723773|450781660|FG003|Overall Study|Lost to Follow-up|0|||
125314532|NCT02723773|450781657|FG000|Overall Study|Other|189|||
125314533|NCT02723773|450781658|FG001|Overall Study|Other|1|||
125314534|NCT02723773|450781659|FG002|Overall Study|Other|2|||
125314535|NCT02723773|450781660|FG003|Overall Study|Other|2|||
125314536|NCT03629886|450781661|FG000|Overall Study|Migrated / moved from the study area|0|||
125654118|NCT00157820|452017945|FG002|Randomized|Withdrawal by Subject|3|||
125654119|NCT00157820|452017943|FG000|Randomized|Protocol Violation|2|||
125654120|NCT00157820|452017944|FG001|Randomized|Protocol Violation|1|||
125654121|NCT00157820|452017945|FG002|Randomized|Protocol Violation|2|||
125654122|NCT00157820|452017943|FG000|1st 8 Month|Death|7|||
125654123|NCT00157820|452017944|FG001|1st 8 Month|Death|8|||
125654124|NCT00157820|452017945|FG002|1st 8 Month|Death|3|||
125654125|NCT00157820|452017943|FG000|1st 8 Month|Lost to Follow-up|1|||
125654126|NCT00157820|452017944|FG001|1st 8 Month|Lost to Follow-up|2|||
125314537|NCT03629886|450781662|FG001|Overall Study|Migrated / moved from the study area|55|||
125654127|NCT00157820|452017945|FG002|1st 8 Month|Lost to Follow-up|1|||
125314538|NCT03629886|450781661|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
125654128|NCT00157820|452017943|FG000|1st 8 Month|Premature cross-over|0|||
125654129|NCT00157820|452017944|FG001|1st 8 Month|Premature cross-over|2|||
125654130|NCT00157820|452017945|FG002|1st 8 Month|Premature cross-over|2|||
125654131|NCT00157820|452017943|FG000|2nd 8 Months|Death|3|||
125654132|NCT00157820|452017944|FG001|2nd 8 Months|Death|1|||
125654133|NCT00157820|452017945|FG002|2nd 8 Months|Death|3|||
125654134|NCT00157820|452017943|FG000|2nd 8 Months|Lost to Follow-up|1|||
125654135|NCT00157820|452017944|FG001|2nd 8 Months|Lost to Follow-up|5|||
125654136|NCT00157820|452017945|FG002|2nd 8 Months|Lost to Follow-up|2|||
125654137|NCT00157820|452017943|FG000|2nd 8 Months|Premature cross-over|1|||
125654138|NCT00157820|452017944|FG001|2nd 8 Months|Premature cross-over|7|||
125654139|NCT00157820|452017945|FG002|2nd 8 Months|Premature cross-over|9|||
125654140|NCT01721369|452017946|FG000|Overall Study|Not initial etiological diagnosis|12|||
125654141|NCT00563706|452019674|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
125654142|NCT00563706|452019675|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
125654143|NCT00563706|452019676|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
125654144|NCT00563706|452019677|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
125654145|NCT00563706|452019678|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
125654146|NCT00563706|452019679|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
125654147|NCT00563706|452019680|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
125654148|NCT00563706|452019681|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
125654149|NCT00563706|452019682|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
125654150|NCT00563706|452019674|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
125654151|NCT00563706|452019675|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
125654152|NCT00563706|452019676|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
125654153|NCT00563706|452019677|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
125654154|NCT00563706|452019678|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
125654155|NCT00563706|452019679|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
125654156|NCT00563706|452019680|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
125654157|NCT00563706|452019681|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
125654158|NCT00563706|452019682|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
125654159|NCT00563706|452019674|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
125654160|NCT00563706|452019675|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
125654161|NCT00563706|452019676|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
125654162|NCT00563706|452019677|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
125654163|NCT00563706|452019678|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
125654164|NCT00563706|452019679|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
125654165|NCT00563706|452019680|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
125654166|NCT00563706|452019681|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
125654167|NCT00563706|452019682|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
125654168|NCT00563706|452019674|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
125654169|NCT00563706|452019675|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125654170|NCT00563706|452019676|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125654171|NCT00563706|452019677|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125654172|NCT00563706|452019678|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125654173|NCT00563706|452019679|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125654174|NCT00563706|452019680|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125654175|NCT00563706|452019681|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
125654176|NCT00563706|452019682|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
125654177|NCT00563706|452019674|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125654178|NCT00563706|452019675|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125654179|NCT00563706|452019676|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125654180|NCT00563706|452019677|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125654181|NCT00563706|452019678|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125654182|NCT00563706|452019679|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125654183|NCT00563706|452019680|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
125654184|NCT00563706|452019681|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
125654185|NCT00563706|452019682|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
125654186|NCT00299546|452019683|FG000|Overall Study|Death|3|||
125654187|NCT00299546|452019684|FG001|Overall Study|Death|2|||
125654188|NCT00299546|452019685|FG002|Overall Study|Death|0|||
125654189|NCT00299546|452019683|FG000|Overall Study|Lost to Follow-up|2|||
125654190|NCT00299546|452019684|FG001|Overall Study|Lost to Follow-up|2|||
125654191|NCT00299546|452019685|FG002|Overall Study|Lost to Follow-up|5|||
125654192|NCT00299546|452019683|FG000|Overall Study|Adverse Event|37|||
125314539|NCT03629886|450781662|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
125314540|NCT03629886|450781661|FG000|Overall Study|Study vaccine not administrated|0|||
125654193|NCT00299546|452019684|FG001|Overall Study|Adverse Event|22|||
125654194|NCT00299546|452019685|FG002|Overall Study|Adverse Event|27|||
125654195|NCT00299546|452019683|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
125654196|NCT00299546|452019684|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
125654197|NCT00299546|452019685|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
125654198|NCT00299546|452019683|FG000|Overall Study|Other|24|||
125654199|NCT00299546|452019684|FG001|Overall Study|Other|26|||
125654200|NCT00299546|452019685|FG002|Overall Study|Other|19|||
125654201|NCT00299546|452019683|FG000|Overall Study|Not treated|0|||
125654202|NCT00299546|452019684|FG001|Overall Study|Not treated|1|||
125654203|NCT00299546|452019685|FG002|Overall Study|Not treated|1|||
125654204|NCT03099265|452019686|FG000|Overall Study|Adverse Event|1|||
125654205|NCT02526017|452019687|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125654206|NCT02526017|452019688|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125654207|NCT02526017|452019689|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125314541|NCT03629886|450781662|FG001|Overall Study|Study vaccine not administrated|3|||
125314542|NCT03629886|450781661|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
125314543|NCT03629886|450781662|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
125314544|NCT03629886|450781661|FG000|Overall Study|Refused vaccination step of the study|0|||
125314545|NCT03629886|450781662|FG001|Overall Study|Refused vaccination step of the study|44|||
125314546|NCT00404651|450781663|FG000|Overall Study|Serious Adverse Event|0|||
125314547|NCT00404651|450781664|FG001|Overall Study|Serious Adverse Event|0|||
125314548|NCT00404651|450781665|FG002|Overall Study|Serious Adverse Event|2|||
125314549|NCT00404651|450781666|FG003|Overall Study|Serious Adverse Event|0|||
125314550|NCT00404651|450781663|FG000|Overall Study|Protocol Violation|10|||
125314551|NCT00404651|450781664|FG001|Overall Study|Protocol Violation|5|||
125314552|NCT00404651|450781665|FG002|Overall Study|Protocol Violation|14|||
125314553|NCT00404651|450781666|FG003|Overall Study|Protocol Violation|5|||
125314554|NCT00404651|450781663|FG000|Overall Study|Lost to Follow-up|15|||
125314555|NCT00404651|450781664|FG001|Overall Study|Lost to Follow-up|11|||
125314556|NCT00404651|450781665|FG002|Overall Study|Lost to Follow-up|13|||
125314557|NCT00404651|450781666|FG003|Overall Study|Lost to Follow-up|10|||
125314558|NCT00404651|450781663|FG000|Overall Study|Withdrawal by Subject|14|||
125314559|NCT00404651|450781664|FG001|Overall Study|Withdrawal by Subject|12|||
125314560|NCT00404651|450781665|FG002|Overall Study|Withdrawal by Subject|16|||
125314561|NCT00404651|450781666|FG003|Overall Study|Withdrawal by Subject|6|||
125314562|NCT00346216|450781668|FG000|Overall Study|Other|181|||
125314563|NCT00346216|450781669|FG001|Overall Study|Other|231|||
125314564|NCT00346216|450781670|FG002|Overall Study|Other|205|||
125314565|NCT00346216|450781668|FG000|Overall Study|No longer willing to participate|600|||
125314566|NCT00346216|450781669|FG001|Overall Study|No longer willing to participate|606|||
125314567|NCT00346216|450781670|FG002|Overall Study|No longer willing to participate|585|||
125314568|NCT00346216|450781668|FG000|Overall Study|Withdrawal by Subject|661|||
125314569|NCT00346216|450781669|FG001|Overall Study|Withdrawal by Subject|692|||
125314570|NCT00346216|450781670|FG002|Overall Study|Withdrawal by Subject|651|||
125314571|NCT00346216|450781668|FG000|Overall Study|Lost to Follow-up|611|||
125314572|NCT00346216|450781669|FG001|Overall Study|Lost to Follow-up|588|||
125314573|NCT00346216|450781670|FG002|Overall Study|Lost to Follow-up|542|||
125314574|NCT00346216|450781668|FG000|Overall Study|Physician Decision|80|||
125314575|NCT00346216|450781669|FG001|Overall Study|Physician Decision|76|||
125314576|NCT00346216|450781670|FG002|Overall Study|Physician Decision|59|||
125314577|NCT00346216|450781668|FG000|Overall Study|Does not meet entrance criteria|13|||
125314578|NCT00346216|450781669|FG001|Overall Study|Does not meet entrance criteria|10|||
125314579|NCT00346216|450781670|FG002|Overall Study|Does not meet entrance criteria|8|||
125314580|NCT00346216|450781668|FG000|Overall Study|Death|189|||
125314581|NCT00346216|450781669|FG001|Overall Study|Death|192|||
125314582|NCT00346216|450781670|FG002|Overall Study|Death|228|||
125314583|NCT00346216|450781668|FG000|Overall Study|Study terminated by sponsor|11|||
125314584|NCT00346216|450781669|FG001|Overall Study|Study terminated by sponsor|4|||
125314585|NCT00346216|450781670|FG002|Overall Study|Study terminated by sponsor|8|||
125314586|NCT00346216|450781668|FG000|Overall Study|Missing Subject Summary Status|62|||
125314587|NCT00346216|450781669|FG001|Overall Study|Missing Subject Summary Status|61|||
125314588|NCT00346216|450781670|FG002|Overall Study|Missing Subject Summary Status|62|||
125314589|NCT01220167|450781676|FG000|Period 3|Urine positive for substance abuse|0|||
125314590|NCT01220167|450781677|FG001|Period 3|Urine positive for substance abuse|1|||
125654208|NCT02526017|452019690|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125654209|NCT02526017|452019691|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
125654210|NCT02526017|452019692|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125654211|NCT02526017|452019693|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125314591|NCT01220167|450781678|FG002|Period 3|Urine positive for substance abuse|0|||
125314592|NCT00619515|450781682|FG000|Overall Study|Study Termination by IRB|73|||
125314593|NCT02420093|450781686|FG000|Overall Study|Withdrawal by Subject|1|||
125314594|NCT02420093|450781687|FG001|Overall Study|Withdrawal by Subject|1|||
125314595|NCT04862065|450781688|FG000|Screening|Protocol Violation|54|||
125654212|NCT02526017|452019694|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125654213|NCT02526017|452019695|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
125314596|NCT04862065|450781689|FG001|Screening|Protocol Violation|0|||
125314597|NCT04862065|450781690|FG002|Screening|Protocol Violation|0|||
125654214|NCT02674568|452019699|FG000|Overall Study|Withdrawal by Subject|5|||
125314598|NCT04862065|450781688|FG000|Screening|Insufficient Sample|1|||
125314599|NCT04862065|450781689|FG001|Screening|Insufficient Sample|0|||
125314600|NCT04862065|450781690|FG002|Screening|Insufficient Sample|0|||
125314601|NCT04862065|450781688|FG000|Follow-Up|Lost to Follow-up|3|||
125314602|NCT04862065|450781689|FG001|Follow-Up|Lost to Follow-up|0|||
125314603|NCT04862065|450781690|FG002|Follow-Up|Lost to Follow-up|0|||
125314604|NCT03244917|450781694|FG000|Overall Study|Lost to Follow-up|2|||
125314605|NCT03244917|450781695|FG001|Overall Study|Lost to Follow-up|2|||
125314606|NCT03001557|450781696|FG000|Core Phase|Randomized but not treated|0|||
125314607|NCT03001557|450781697|FG001|Core Phase|Randomized but not treated|0|||
125314608|NCT03001557|450781698|FG002|Core Phase|Randomized but not treated|1|||
125314609|NCT03001557|450781699|FG003|Core Phase|Randomized but not treated|0|||
125314610|NCT03001557|450781700|FG004|Core Phase|Randomized but not treated|0|||
125654215|NCT02674568|452019699|FG000|Overall Study|Death|303|||
125654216|NCT02674568|452019699|FG000|Overall Study|Physician Decision|2|||
125654217|NCT02674568|452019699|FG000|Overall Study|Lost to Follow-up|9|||
125654218|NCT02674568|452019699|FG000|Overall Study|Other, Not Specified|20|||
125654219|NCT00396318|452019700|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
125654220|NCT00938392|452019701|FG000|Overall Study|Adverse Event|0|||
125654221|NCT00938392|452019702|FG001|Overall Study|Adverse Event|1|||
125654222|NCT00938392|452019701|FG000|Overall Study|Withdrawal by Subject|0|||
125654223|NCT00938392|452019702|FG001|Overall Study|Withdrawal by Subject|1|||
125654224|NCT00938392|452019701|FG000|Overall Study|Lost to Follow-up|2|||
125654225|NCT00938392|452019702|FG001|Overall Study|Lost to Follow-up|2|||
125654226|NCT00124709|452019703|FG000|Overall Study|Randomized but did not take medication|3|||
125654227|NCT00124709|452019704|FG001|Overall Study|Randomized but did not take medication|1|||
125654228|NCT00124709|452019703|FG000|Overall Study|Adverse Event|3|||
125654229|NCT00124709|452019704|FG001|Overall Study|Adverse Event|0|||
125654230|NCT00124709|452019703|FG000|Overall Study|Lack of Efficacy|5|||
125654231|NCT00124709|452019704|FG001|Overall Study|Lack of Efficacy|10|||
125654232|NCT00124709|452019703|FG000|Overall Study|Protocol Violation|3|||
125654233|NCT00124709|452019704|FG001|Overall Study|Protocol Violation|5|||
125654234|NCT00124709|452019703|FG000|Overall Study|Withdrawal by Subject|127|||
125654235|NCT00124709|452019704|FG001|Overall Study|Withdrawal by Subject|136|||
125654236|NCT00124709|452019703|FG000|Overall Study|Lost to Follow-up|114|||
125654237|NCT00124709|452019704|FG001|Overall Study|Lost to Follow-up|120|||
125654238|NCT01728376|452019705|FG000|Overall Study|Adverse Event|1|||
125654239|NCT01728376|452019706|FG001|Overall Study|Adverse Event|1|||
125654240|NCT01728376|452019707|FG002|Overall Study|Adverse Event|1|||
125654241|NCT01728376|452019708|FG003|Overall Study|Adverse Event|1|||
125654242|NCT01728376|452019709|FG004|Overall Study|Adverse Event|1|||
125654243|NCT01728376|452019710|FG005|Overall Study|Adverse Event|0|||
125654244|NCT01728376|452019705|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
125654245|NCT01728376|452019706|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
125654246|NCT01728376|452019707|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
125654247|NCT01728376|452019708|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
125654248|NCT01728376|452019709|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
125654249|NCT01728376|452019710|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
125654250|NCT01728376|452019705|FG000|Overall Study|No relevant bacteria|2|||
125654251|NCT01728376|452019706|FG001|Overall Study|No relevant bacteria|0|||
125654252|NCT01728376|452019707|FG002|Overall Study|No relevant bacteria|0|||
125654253|NCT01728376|452019708|FG003|Overall Study|No relevant bacteria|0|||
125654254|NCT01728376|452019709|FG004|Overall Study|No relevant bacteria|1|||
125654255|NCT01728376|452019710|FG005|Overall Study|No relevant bacteria|1|||
125654256|NCT01728376|452019705|FG000|Overall Study|Did not receive treatment|0|||
125654257|NCT01728376|452019706|FG001|Overall Study|Did not receive treatment|1|||
125654258|NCT01728376|452019707|FG002|Overall Study|Did not receive treatment|0|||
125654259|NCT01728376|452019708|FG003|Overall Study|Did not receive treatment|0|||
125654260|NCT01728376|452019709|FG004|Overall Study|Did not receive treatment|0|||
125654261|NCT01728376|452019710|FG005|Overall Study|Did not receive treatment|0|||
125654262|NCT01728376|452019705|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
125654263|NCT01728376|452019706|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
125654264|NCT01728376|452019707|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
125654265|NCT01728376|452019708|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
125654266|NCT01728376|452019709|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
125314611|NCT03001557|450781701|FG005|Core Phase|Randomized but not treated|0|||
125654267|NCT01728376|452019710|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
125654268|NCT04341727|452019723|FG000|Overall Study|Withdrawal by Subject|0|||
125654269|NCT04341727|452019724|FG001|Overall Study|Withdrawal by Subject|0|||
125654270|NCT04341727|452019725|FG002|Overall Study|Withdrawal by Subject|1|||
125654271|NCT04341727|452019726|FG003|Overall Study|Withdrawal by Subject|0|||
125654272|NCT04341727|452019723|FG000|Overall Study|Lost to Follow-up|0|||
125654273|NCT04341727|452019724|FG001|Overall Study|Lost to Follow-up|0|||
125654274|NCT04341727|452019725|FG002|Overall Study|Lost to Follow-up|0|||
125314612|NCT03001557|450781702|FG006|Core Phase|Randomized but not treated|0|||
125654275|NCT04341727|452019726|FG003|Overall Study|Lost to Follow-up|1|||
125654276|NCT05604521|452019727|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
125654277|NCT05604521|452019728|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
125654278|NCT05604521|452019727|FG000|Overall Study|Adverse Event|1|||
125654279|NCT05604521|452019728|FG001|Overall Study|Adverse Event|0|||
125654280|NCT01491737|452019729|FG000|Overall Study|Withdrawal by Subject|20|||
125654281|NCT01491737|452019730|FG001|Overall Study|Withdrawal by Subject|17|||
125654282|NCT01491737|452019729|FG000|Overall Study|Lost to Follow-up|2|||
125654283|NCT01491737|452019730|FG001|Overall Study|Lost to Follow-up|10|||
125654284|NCT01491737|452019729|FG000|Overall Study|Death|63|||
125654285|NCT01491737|452019730|FG001|Overall Study|Death|57|||
125654286|NCT01491737|452019729|FG000|Overall Study|Study Termination by Sponsor|36|||
125654287|NCT01491737|452019730|FG001|Overall Study|Study Termination by Sponsor|36|||
125654288|NCT01491737|452019729|FG000|Overall Study|Reason Not Specified|8|||
125654289|NCT01491737|452019730|FG001|Overall Study|Reason Not Specified|9|||
125654290|NCT04311411|452019731|FG000|Overall Study|Adverse Event|2|||
125654291|NCT04311411|452019732|FG001|Overall Study|Adverse Event|3|||
125654292|NCT04311411|452019733|FG002|Overall Study|Adverse Event|2|||
125654293|NCT04311411|452019731|FG000|Overall Study|Withdrawal by Subject|3|||
125654294|NCT04311411|452019732|FG001|Overall Study|Withdrawal by Subject|3|||
125654295|NCT04311411|452019733|FG002|Overall Study|Withdrawal by Subject|0|||
125654296|NCT01976663|452019734|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
125654297|NCT01976663|452019734|FG000|Overall Study|Personal Reasons|6|||
125654298|NCT01976663|452019734|FG000|Overall Study|Withdrawal by Subject|4|||
125654299|NCT01976663|452019734|FG000|Overall Study|Screen Failure|3|||
125654300|NCT01976663|452019734|FG000|Overall Study|Adverse Event|2|||
125654301|NCT01976663|452019734|FG000|Overall Study|Lost to Follow-up|3|||
125654302|NCT01817764|452019735|FG000|Overall Study|Adverse Event|7|||
125654303|NCT01817764|452019736|FG001|Overall Study|Adverse Event|10|||
125654304|NCT01817764|452019735|FG000|Overall Study|Lack of Efficacy|9|||
125654305|NCT01817764|452019736|FG001|Overall Study|Lack of Efficacy|7|||
125654306|NCT01817764|452019735|FG000|Overall Study|Protocol Violation|7|||
125654307|NCT01817764|452019736|FG001|Overall Study|Protocol Violation|5|||
125654308|NCT01817764|452019735|FG000|Overall Study|Lost to Follow-up|1|||
125654309|NCT01817764|452019736|FG001|Overall Study|Lost to Follow-up|4|||
125654310|NCT01817764|452019735|FG000|Overall Study|Withdrawal by Subject|10|||
125654311|NCT01817764|452019736|FG001|Overall Study|Withdrawal by Subject|12|||
125654312|NCT04888377|452019737|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
125654313|NCT04888377|452019738|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
125654314|NCT04888377|452019737|FG000|Overall Study|Physician Decision|6|||
125654315|NCT04888377|452019738|FG001|Overall Study|Physician Decision|6|||
125654316|NCT04888377|452019737|FG000|Overall Study|Withdrawal by Subject|7|||
125654317|NCT04888377|452019738|FG001|Overall Study|Withdrawal by Subject|3|||
125654318|NCT05644756|452019739|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
125654319|NCT05644756|452019739|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
125654320|NCT00478933|452019744|FG000|Overall Study|Protocol Violation|22|||
125654321|NCT00478933|452019744|FG000|Overall Study|Informed consent not verified|3|||
125654322|NCT00478933|452019744|FG000|Overall Study|Inadequate data available|53|||
125654323|NCT03586427|452019747|FG000|Overall Study|Lost to Follow-up|0|||
125654324|NCT03586427|452019748|FG001|Overall Study|Lost to Follow-up|3|||
125654325|NCT03586427|452019749|FG002|Overall Study|Lost to Follow-up|1|||
125654326|NCT03586427|452019750|FG003|Overall Study|Lost to Follow-up|3|||
125654327|NCT03586427|452019751|FG004|Overall Study|Lost to Follow-up|3|||
125654328|NCT03586427|452019747|FG000|Overall Study|Withdrawal by Subject|0|||
125654329|NCT03586427|452019748|FG001|Overall Study|Withdrawal by Subject|1|||
125654330|NCT03586427|452019749|FG002|Overall Study|Withdrawal by Subject|2|||
125654331|NCT03586427|452019750|FG003|Overall Study|Withdrawal by Subject|1|||
125654332|NCT03586427|452019751|FG004|Overall Study|Withdrawal by Subject|1|||
125654333|NCT03586427|452019747|FG000|Overall Study|Adverse Event|0|||
125654334|NCT03586427|452019748|FG001|Overall Study|Adverse Event|0|||
125654335|NCT03586427|452019749|FG002|Overall Study|Adverse Event|1|||
125314613|NCT03001557|450781703|FG007|Core Phase|Randomized but not treated|0|||
125654336|NCT03586427|452019750|FG003|Overall Study|Adverse Event|0|||
125314614|NCT03001557|450781696|FG000|Extension Phase|Adverse Event|0|||
125314615|NCT03001557|450781697|FG001|Extension Phase|Adverse Event|0|||
125654337|NCT03586427|452019751|FG004|Overall Study|Adverse Event|0|||
125314616|NCT03001557|450781698|FG002|Extension Phase|Adverse Event|0|||
125314617|NCT03001557|450781699|FG003|Extension Phase|Adverse Event|0|||
125654338|NCT03586427|452019747|FG000|Overall Study|Protocol Violation|0|||
125654339|NCT03586427|452019748|FG001|Overall Study|Protocol Violation|0|||
125654340|NCT03586427|452019749|FG002|Overall Study|Protocol Violation|1|||
125654341|NCT03586427|452019750|FG003|Overall Study|Protocol Violation|0|||
125654342|NCT03586427|452019751|FG004|Overall Study|Protocol Violation|1|||
125654343|NCT03586427|452019747|FG000|Overall Study|Noncompliance with study drug|0|||
125654344|NCT03586427|452019748|FG001|Overall Study|Noncompliance with study drug|0|||
125314618|NCT03001557|450781700|FG004|Extension Phase|Adverse Event|0|||
125654345|NCT03586427|452019749|FG002|Overall Study|Noncompliance with study drug|1|||
125654346|NCT03586427|452019750|FG003|Overall Study|Noncompliance with study drug|0|||
125654347|NCT03586427|452019751|FG004|Overall Study|Noncompliance with study drug|0|||
125654348|NCT00494234|452019752|FG000|Overall Study|Withdrawal by Subject|1|||
125654349|NCT00494234|452019753|FG001|Overall Study|Withdrawal by Subject|0|||
125654350|NCT00494234|452019752|FG000|Overall Study|Disease progression|11|||
125654351|NCT00494234|452019753|FG001|Overall Study|Disease progression|8|||
125654352|NCT00494234|452019752|FG000|Overall Study|Death|2|||
125654353|NCT00494234|452019753|FG001|Overall Study|Death|1|||
125654354|NCT00423137|452019754|FG000|Overall Study|Lost to Follow-up|0|||
125654355|NCT00423137|452019755|FG001|Overall Study|Lost to Follow-up|0|||
125654356|NCT00423137|452019756|FG002|Overall Study|Lost to Follow-up|1|||
125654357|NCT00423137|452019757|FG003|Overall Study|Lost to Follow-up|0|||
125654358|NCT00423137|452019754|FG000|Overall Study|Protocol Violation|0|||
125654359|NCT00423137|452019755|FG001|Overall Study|Protocol Violation|0|||
125654360|NCT00423137|452019756|FG002|Overall Study|Protocol Violation|0|||
125654361|NCT00423137|452019757|FG003|Overall Study|Protocol Violation|1|||
125654362|NCT00423137|452019754|FG000|Overall Study|Adverse Event Study disease worse|1|||
125654363|NCT00423137|452019755|FG001|Overall Study|Adverse Event Study disease worse|0|||
125654364|NCT00423137|452019756|FG002|Overall Study|Adverse Event Study disease worse|3|||
125654365|NCT00423137|452019757|FG003|Overall Study|Adverse Event Study disease worse|1|||
125654366|NCT00423137|452019754|FG000|Overall Study|Adverse Event Other|0|||
125654367|NCT00423137|452019755|FG001|Overall Study|Adverse Event Other|0|||
125654368|NCT00423137|452019756|FG002|Overall Study|Adverse Event Other|2|||
125654369|NCT00423137|452019757|FG003|Overall Study|Adverse Event Other|0|||
125654370|NCT00593385|452019762|FG000|Overall Study|Death|14|||
125654371|NCT00593385|452019762|FG000|Overall Study|Lost to Follow-up|17|||
125654372|NCT00593385|452019762|FG000|Overall Study|Withdrawal by Subject|9|||
125654373|NCT01298362|452019770|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
125654374|NCT01298362|452019771|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
125654375|NCT00762073|452019774|FG000|Overall Study|Lack of Efficacy|1|||
125654376|NCT00762073|452019775|FG001|Overall Study|Lack of Efficacy|1|||
125654377|NCT00762073|452019776|FG002|Overall Study|Lack of Efficacy|0|||
125654378|NCT00762073|452019777|FG003|Overall Study|Lack of Efficacy|0|||
125654379|NCT00762073|452019774|FG000|Overall Study|Adverse Event|1|||
125654380|NCT00762073|452019775|FG001|Overall Study|Adverse Event|0|||
125654381|NCT00762073|452019776|FG002|Overall Study|Adverse Event|1|||
125654382|NCT00762073|452019777|FG003|Overall Study|Adverse Event|1|||
125654383|NCT00762073|452019774|FG000|Overall Study|Significant Subject Noncompliance|0|||
125654384|NCT00762073|452019775|FG001|Overall Study|Significant Subject Noncompliance|1|||
125654385|NCT00762073|452019776|FG002|Overall Study|Significant Subject Noncompliance|0|||
125654386|NCT00762073|452019777|FG003|Overall Study|Significant Subject Noncompliance|1|||
125654387|NCT00762073|452019774|FG000|Overall Study|Withdrawal by Subject|1|||
125654388|NCT00762073|452019775|FG001|Overall Study|Withdrawal by Subject|2|||
125654389|NCT00762073|452019776|FG002|Overall Study|Withdrawal by Subject|1|||
125654390|NCT00762073|452019777|FG003|Overall Study|Withdrawal by Subject|1|||
125654391|NCT00762073|452019774|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
125654392|NCT00762073|452019775|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
125654393|NCT00762073|452019776|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
125654394|NCT00762073|452019777|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
125654395|NCT00326625|452019779|FG000|Overall Study|Adverse Event|20|||
125654396|NCT00326625|452019780|FG001|Overall Study|Adverse Event|9|||
125654397|NCT00326625|452019779|FG000|Overall Study|Withdrawal by Subject|15|||
125654398|NCT00326625|452019780|FG001|Overall Study|Withdrawal by Subject|12|||
125654399|NCT00326625|452019779|FG000|Overall Study|Death|18|||
125654400|NCT00326625|452019780|FG001|Overall Study|Death|16|||
125654401|NCT00326625|452019779|FG000|Overall Study|Lost to Follow-up|1|||
125654402|NCT00326625|452019780|FG001|Overall Study|Lost to Follow-up|0|||
125654403|NCT00326625|452019779|FG000|Overall Study|prescheduled medical intervention|0|||
125654404|NCT00326625|452019780|FG001|Overall Study|prescheduled medical intervention|1|||
125654405|NCT01265875|452019781|FG000|Overall Study|Uncooperative/unreliable|1|||
125654406|NCT05275673|452019782|FG000|Overall Study|Study Termination by Sponsor|2|||
125654407|NCT05275673|452019783|FG001|Overall Study|Study Termination by Sponsor|3|||
125654408|NCT05275673|452019782|FG000|Overall Study|Death|1|||
125654409|NCT05275673|452019783|FG001|Overall Study|Death|0|||
125654410|NCT05275673|452019782|FG000|Overall Study|Withdrawal by Subject|1|||
125654411|NCT05275673|452019783|FG001|Overall Study|Withdrawal by Subject|0|||
125654412|NCT04456998|452019784|FG000|Overall Study|Adverse Event|0|||
125654413|NCT04456998|452019785|FG001|Overall Study|Adverse Event|4|||
125654414|NCT04456998|452019784|FG000|Overall Study|Protocol Deviation|0|||
125654415|NCT04456998|452019785|FG001|Overall Study|Protocol Deviation|1|||
125654416|NCT04456998|452019784|FG000|Overall Study|Withdrawal by Subject|0|||
125654417|NCT04456998|452019785|FG001|Overall Study|Withdrawal by Subject|1|||
125654418|NCT00400985|452019786|FG000|Overall Study|Withdrawal by Subject|5|||
125654419|NCT00400985|452019786|FG000|Overall Study|system modification|8|||
125654420|NCT00400985|452019786|FG000|Overall Study|Death|30|||
125654421|NCT00400985|452019786|FG000|Overall Study|Lost to Follow-up|9|||
125654422|NCT03792633|452019791|FG000|Overall Study|Alternative Treatment|17|||
125654423|NCT03792633|452019792|FG001|Overall Study|Alternative Treatment|19|||
125654424|NCT03792633|452019791|FG000|Overall Study|Death|2|||
125654425|NCT03792633|452019792|FG001|Overall Study|Death|0|||
125654426|NCT03792633|452019791|FG000|Overall Study|Disease progression|8|||
125654427|NCT03792633|452019792|FG001|Overall Study|Disease progression|9|||
125654428|NCT03792633|452019791|FG000|Overall Study|Lost to Follow-up|1|||
125654429|NCT03792633|452019792|FG001|Overall Study|Lost to Follow-up|1|||
125654430|NCT03792633|452019791|FG000|Overall Study|Screen fail|1|||
125654431|NCT03792633|452019792|FG001|Overall Study|Screen fail|0|||
125654432|NCT03792633|452019791|FG000|Overall Study|Second malignancy|0|||
125654433|NCT03792633|452019792|FG001|Overall Study|Second malignancy|1|||
125654434|NCT03179462|452019795|FG000|Overall Study|screening failure|1|||
125654435|NCT03179462|452019796|FG001|Overall Study|screening failure|2|||
125314619|NCT03001557|450781701|FG005|Extension Phase|Adverse Event|2|||
125314620|NCT03001557|450781702|FG006|Extension Phase|Adverse Event|0|||
125314621|NCT03001557|450781703|FG007|Extension Phase|Adverse Event|0|||
125314622|NCT03001557|450781696|FG000|Extension Phase|Withdrawal by Subject|0|||
125314623|NCT03001557|450781697|FG001|Extension Phase|Withdrawal by Subject|0|||
125314624|NCT03001557|450781698|FG002|Extension Phase|Withdrawal by Subject|0|||
125314625|NCT03001557|450781699|FG003|Extension Phase|Withdrawal by Subject|0|||
125314626|NCT03001557|450781700|FG004|Extension Phase|Withdrawal by Subject|0|||
125314627|NCT03001557|450781701|FG005|Extension Phase|Withdrawal by Subject|1|||
125314628|NCT03001557|450781702|FG006|Extension Phase|Withdrawal by Subject|5|||
125314629|NCT03001557|450781703|FG007|Extension Phase|Withdrawal by Subject|2|||
125314630|NCT03001557|450781696|FG000|Extension Phase|Lost to Follow-up|0|||
125314631|NCT03001557|450781697|FG001|Extension Phase|Lost to Follow-up|0|||
125314632|NCT03001557|450781698|FG002|Extension Phase|Lost to Follow-up|0|||
125314633|NCT03001557|450781699|FG003|Extension Phase|Lost to Follow-up|0|||
125314634|NCT03001557|450781700|FG004|Extension Phase|Lost to Follow-up|0|||
125314635|NCT03001557|450781701|FG005|Extension Phase|Lost to Follow-up|0|||
125314636|NCT03001557|450781702|FG006|Extension Phase|Lost to Follow-up|2|||
125314637|NCT03001557|450781703|FG007|Extension Phase|Lost to Follow-up|1|||
125314638|NCT03001557|450781696|FG000|Extension Phase|Administrative Reason|0|||
125314639|NCT03001557|450781697|FG001|Extension Phase|Administrative Reason|0|||
125314640|NCT03001557|450781698|FG002|Extension Phase|Administrative Reason|0|||
125314641|NCT03001557|450781699|FG003|Extension Phase|Administrative Reason|0|||
125314642|NCT03001557|450781700|FG004|Extension Phase|Administrative Reason|0|||
125314643|NCT03001557|450781701|FG005|Extension Phase|Administrative Reason|1|||
125314644|NCT03001557|450781702|FG006|Extension Phase|Administrative Reason|3|||
125314645|NCT03001557|450781703|FG007|Extension Phase|Administrative Reason|3|||
125314646|NCT03001557|450781696|FG000|Extension Phase|Loss of caregiver|0|||
125314647|NCT03001557|450781697|FG001|Extension Phase|Loss of caregiver|0|||
125314648|NCT03001557|450781698|FG002|Extension Phase|Loss of caregiver|0|||
125314649|NCT03001557|450781699|FG003|Extension Phase|Loss of caregiver|0|||
125314650|NCT03001557|450781700|FG004|Extension Phase|Loss of caregiver|0|||
125314651|NCT03001557|450781701|FG005|Extension Phase|Loss of caregiver|0|||
125314652|NCT03001557|450781702|FG006|Extension Phase|Loss of caregiver|1|||
125314653|NCT03001557|450781703|FG007|Extension Phase|Loss of caregiver|0|||
125314654|NCT03001557|450781696|FG000|Extension Phase|Others|0|||
125314655|NCT03001557|450781697|FG001|Extension Phase|Others|0|||
125314656|NCT03001557|450781698|FG002|Extension Phase|Others|0|||
125314657|NCT03001557|450781699|FG003|Extension Phase|Others|0|||
125314658|NCT03001557|450781700|FG004|Extension Phase|Others|0|||
125314659|NCT03001557|450781701|FG005|Extension Phase|Others|1|||
125314660|NCT03001557|450781702|FG006|Extension Phase|Others|3|||
125314661|NCT03001557|450781703|FG007|Extension Phase|Others|0|||
125314662|NCT01272232|450781704|FG000|Weeks 0-56|Adverse Event|39|||
125314663|NCT01272232|450781705|FG001|Weeks 0-56|Adverse Event|18|||
125314664|NCT01272232|450781706|FG002|Weeks 0-56|Adverse Event|7|||
125314665|NCT01272232|450781704|FG000|Weeks 0-56|Lack of Efficacy|0|||
125314666|NCT01272232|450781705|FG001|Weeks 0-56|Lack of Efficacy|0|||
125314667|NCT01272232|450781706|FG002|Weeks 0-56|Lack of Efficacy|3|||
125314668|NCT01272232|450781704|FG000|Weeks 0-56|Protocol Violation|12|||
125314669|NCT01272232|450781705|FG001|Weeks 0-56|Protocol Violation|8|||
125314670|NCT01272232|450781706|FG002|Weeks 0-56|Protocol Violation|13|||
125654436|NCT03179462|452019797|FG002|Overall Study|screening failure|0|||
125314671|NCT01272232|450781704|FG000|Weeks 0-56|Withdrawal criteria|32|||
125314672|NCT01272232|450781705|FG001|Weeks 0-56|Withdrawal criteria|14|||
125314673|NCT01272232|450781706|FG002|Weeks 0-56|Withdrawal criteria|37|||
125314674|NCT01272232|450781704|FG000|Weeks 0-56|Unclassified|16|||
125314675|NCT01272232|450781705|FG001|Weeks 0-56|Unclassified|7|||
125654437|NCT03743571|452019800|FG000|Overall Study|Withdrawal by Subject|1|||
125314676|NCT01272232|450781706|FG002|Weeks 0-56|Unclassified|12|||
125314677|NCT01272232|450781704|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
125314678|NCT01272232|450781705|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
125314679|NCT01272232|450781706|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
125654438|NCT03743571|452019801|FG001|Overall Study|Withdrawal by Subject|1|||
125654439|NCT03743571|452019800|FG000|Overall Study|Lost to Follow-up|1|||
125654440|NCT03743571|452019801|FG001|Overall Study|Lost to Follow-up|2|||
125654441|NCT04115488|452019802|FG000|Overall Study|Adverse Event|8|||
125654442|NCT04115488|452019803|FG001|Overall Study|Adverse Event|4|||
125654443|NCT04115488|452019802|FG000|Overall Study|Withdrawal by Subject|3|||
125654444|NCT04115488|452019803|FG001|Overall Study|Withdrawal by Subject|6|||
125654445|NCT04115488|452019802|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
125654446|NCT04115488|452019803|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
125654447|NCT04115488|452019802|FG000|Overall Study|Patient 's location change|1|||
125654448|NCT04115488|452019803|FG001|Overall Study|Patient 's location change|0|||
125654449|NCT04115488|452019802|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
125654450|NCT04115488|452019803|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
125654451|NCT01058707|452019816|FG000|Overall Study|Disease Progression|15|||
125654452|NCT01058707|452019817|FG001|Overall Study|Disease Progression|20|||
125654453|NCT01058707|452019818|FG002|Overall Study|Disease Progression|20|||
125654454|NCT01058707|452019819|FG003|Overall Study|Disease Progression|15|||
125654455|NCT01058707|452019820|FG004|Overall Study|Disease Progression|23|||
125654456|NCT01058707|452019821|FG005|Overall Study|Disease Progression|10|||
125654457|NCT01058707|452019822|FG006|Overall Study|Disease Progression|12|||
125654458|NCT01058707|452019816|FG000|Overall Study|Adverse Event|11|||
125654459|NCT01058707|452019817|FG001|Overall Study|Adverse Event|4|||
125654460|NCT01058707|452019818|FG002|Overall Study|Adverse Event|7|||
125654461|NCT01058707|452019819|FG003|Overall Study|Adverse Event|6|||
125654462|NCT01058707|452019820|FG004|Overall Study|Adverse Event|7|||
125654463|NCT01058707|452019821|FG005|Overall Study|Adverse Event|3|||
125654464|NCT01058707|452019822|FG006|Overall Study|Adverse Event|1|||
125654465|NCT01058707|452019816|FG000|Overall Study|Subject Decision|5|||
125654466|NCT01058707|452019817|FG001|Overall Study|Subject Decision|3|||
125654467|NCT01058707|452019818|FG002|Overall Study|Subject Decision|3|||
125654468|NCT01058707|452019819|FG003|Overall Study|Subject Decision|1|||
125654469|NCT01058707|452019820|FG004|Overall Study|Subject Decision|2|||
125654470|NCT01058707|452019821|FG005|Overall Study|Subject Decision|3|||
125654471|NCT01058707|452019822|FG006|Overall Study|Subject Decision|6|||
125654472|NCT01058707|452019816|FG000|Overall Study|Lost to Follow-up|0|||
125654473|NCT01058707|452019817|FG001|Overall Study|Lost to Follow-up|0|||
125654474|NCT01058707|452019818|FG002|Overall Study|Lost to Follow-up|1|||
125654475|NCT01058707|452019819|FG003|Overall Study|Lost to Follow-up|0|||
125654476|NCT01058707|452019820|FG004|Overall Study|Lost to Follow-up|0|||
125654477|NCT01058707|452019821|FG005|Overall Study|Lost to Follow-up|0|||
125654478|NCT01058707|452019822|FG006|Overall Study|Lost to Follow-up|0|||
125654479|NCT01058707|452019816|FG000|Overall Study|Reason Not Specified|0|||
125654480|NCT01058707|452019817|FG001|Overall Study|Reason Not Specified|3|||
125654481|NCT01058707|452019818|FG002|Overall Study|Reason Not Specified|2|||
125654482|NCT01058707|452019819|FG003|Overall Study|Reason Not Specified|0|||
125654483|NCT01058707|452019820|FG004|Overall Study|Reason Not Specified|7|||
125654484|NCT01058707|452019821|FG005|Overall Study|Reason Not Specified|1|||
125654485|NCT01058707|452019822|FG006|Overall Study|Reason Not Specified|7|||
125654486|NCT01821391|452019823|FG000|Overall Study|Adverse Event|1|||
125654487|NCT01821391|452019824|FG001|Overall Study|Adverse Event|0|||
125654488|NCT04880850|452019826|FG000|Overall Study|Death|2|||
125654489|NCT04880850|452019827|FG001|Overall Study|Death|1|||
125654490|NCT04880850|452019826|FG000|Overall Study|Lost to Follow-up|3|||
125654491|NCT04880850|452019827|FG001|Overall Study|Lost to Follow-up|6|||
125654492|NCT04880850|452019826|FG000|Overall Study|Physician Decision|2|||
125654493|NCT04880850|452019827|FG001|Overall Study|Physician Decision|1|||
125654494|NCT04880850|452019826|FG000|Overall Study|Withdrawal by Subject|9|||
125654495|NCT04880850|452019827|FG001|Overall Study|Withdrawal by Subject|10|||
125654496|NCT03417102|452019828|FG000|Overall Study|Adverse Event|0|||
125654497|NCT03417102|452019829|FG001|Overall Study|Adverse Event|1|||
125654498|NCT03417102|452019828|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
125654499|NCT03417102|452019829|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
125654500|NCT03417102|452019828|FG000|Overall Study|Other|0|||
125654501|NCT03417102|452019829|FG001|Overall Study|Other|1|||
125654502|NCT00526227|452019831|FG000|Overall Study|Device not implanted|1|||
125654503|NCT00526227|452019831|FG000|Overall Study|Death|1|||
125654504|NCT03222856|452019834|FG000|Overall Study|Adverse Event|6|||
125654505|NCT03222856|452019834|FG000|Overall Study|Death|1|||
125654506|NCT03280628|452021302|FG000|Overall Study|Lost to Follow-up|8|||
125654507|NCT03280628|452021303|FG001|Overall Study|Lost to Follow-up|6|||
125654508|NCT03280628|452021304|FG002|Overall Study|Lost to Follow-up|11|||
125210537|NCT02907619|450395591|FG001|Overall Study|Other|1|||
125654509|NCT01361308|452021307|FG000|Overall Study|Withdrawal by Subject|9|||
125654510|NCT01361308|452021308|FG001|Overall Study|Withdrawal by Subject|13|||
125654511|NCT01361308|452021307|FG000|Overall Study|Physician Decision|3|||
125654512|NCT01361308|452021308|FG001|Overall Study|Physician Decision|3|||
125654513|NCT01361308|452021307|FG000|Overall Study|Lack of Efficacy|2|||
125654514|NCT01361308|452021308|FG001|Overall Study|Lack of Efficacy|0|||
125654515|NCT01361308|452021307|FG000|Overall Study|Protocol Violation|1|||
125654516|NCT01361308|452021308|FG001|Overall Study|Protocol Violation|0|||
125654517|NCT01361308|452021307|FG000|Overall Study|Lost to Follow-up|5|||
125654518|NCT01361308|452021308|FG001|Overall Study|Lost to Follow-up|4|||
125654519|NCT01361308|452021307|FG000|Overall Study|Adverse Event|8|||
125654520|NCT01361308|452021308|FG001|Overall Study|Adverse Event|4|||
125654521|NCT01361308|452021307|FG000|Overall Study|Eligibility Criteria Not Met|2|||
125654522|NCT01361308|452021308|FG001|Overall Study|Eligibility Criteria Not Met|3|||
125654523|NCT01361308|452021307|FG000|Overall Study|Failed C-SSRS|5|||
125654524|NCT01361308|452021308|FG001|Overall Study|Failed C-SSRS|2|||
125654525|NCT01361308|452021307|FG000|Overall Study|Other|0|||
125654526|NCT01361308|452021308|FG001|Overall Study|Other|1|||
125654527|NCT03839693|452021313|FG000|Overall Study|Lost to Follow-up|0|||
125654528|NCT03839693|452021314|FG001|Overall Study|Lost to Follow-up|2|||
125654529|NCT03839693|452021315|FG002|Overall Study|Lost to Follow-up|2|||
125654530|NCT03839693|452021313|FG000|Overall Study|Withdrawal by Subject|1|||
125654531|NCT03839693|452021314|FG001|Overall Study|Withdrawal by Subject|0|||
125654532|NCT03839693|452021315|FG002|Overall Study|Withdrawal by Subject|2|||
125654533|NCT03839693|452021313|FG000|Overall Study|subject moved out of the area|1|||
125654534|NCT03839693|452021314|FG001|Overall Study|subject moved out of the area|0|||
125654535|NCT03839693|452021315|FG002|Overall Study|subject moved out of the area|0|||
125654536|NCT00700115|452021324|FG000|Overall Study|Withdrawal by Subject|1|||
125654537|NCT00700115|452021325|FG001|Overall Study|Withdrawal by Subject|0|||
125654538|NCT00700115|452021324|FG000|Overall Study|Lost to Follow-up|0|||
125654539|NCT00700115|452021325|FG001|Overall Study|Lost to Follow-up|1|||
125654540|NCT02503215|452021326|FG000|Overall Study|Unable to wear compression stockings|1|||
125654541|NCT02503215|452021326|FG000|Overall Study|Unable to use positive airway pressure|2|||
125654542|NCT02983305|452021331|FG000|Overall Study|incomplete data|2|||
125654543|NCT02983305|452021332|FG001|Overall Study|incomplete data|0|||
125654544|NCT00706901|452021333|FG000|Overall Study|Lost to Follow-up|2|||
125654545|NCT00706901|452021334|FG001|Overall Study|Lost to Follow-up|3|||
125654546|NCT00706901|452021335|FG002|Overall Study|Lost to Follow-up|2|||
125654547|NCT00706901|452021333|FG000|Overall Study|Withdrawal by Subject|4|||
125654548|NCT00706901|452021334|FG001|Overall Study|Withdrawal by Subject|2|||
125654549|NCT00706901|452021335|FG002|Overall Study|Withdrawal by Subject|5|||
125654550|NCT00706901|452021333|FG000|Overall Study|In Jail|1|||
125654551|NCT00706901|452021334|FG001|Overall Study|In Jail|0|||
125654552|NCT00706901|452021335|FG002|Overall Study|In Jail|1|||
125654553|NCT00706901|452021333|FG000|Overall Study|Death|1|||
125654554|NCT00706901|452021334|FG001|Overall Study|Death|0|||
125654555|NCT00706901|452021335|FG002|Overall Study|Death|0|||
125654556|NCT03433482|452021336|FG000|Overall Study|Lost to Follow-up|1|||
125654557|NCT03433482|452021337|FG001|Overall Study|Lost to Follow-up|0|||
125654558|NCT03433482|452021338|FG002|Overall Study|Lost to Follow-up|1|||
125654559|NCT03433482|452021339|FG003|Overall Study|Lost to Follow-up|1|||
125654560|NCT03433482|452021336|FG000|Overall Study|Withdrawal by Subject|0|||
125654561|NCT03433482|452021337|FG001|Overall Study|Withdrawal by Subject|0|||
125654562|NCT03433482|452021338|FG002|Overall Study|Withdrawal by Subject|1|||
125654563|NCT03433482|452021339|FG003|Overall Study|Withdrawal by Subject|0|||
125654564|NCT03433482|452021336|FG000|Overall Study|Unknown reason|0|||
125654565|NCT03433482|452021337|FG001|Overall Study|Unknown reason|0|||
125654566|NCT03433482|452021338|FG002|Overall Study|Unknown reason|2|||
125654567|NCT03433482|452021339|FG003|Overall Study|Unknown reason|0|||
125654568|NCT01646268|452021340|FG000|Overall Study|Adverse Event|6|||
125654569|NCT01646268|452021341|FG001|Overall Study|Adverse Event|7|||
125654570|NCT01646268|452021340|FG000|Overall Study|Lack of Efficacy|1|||
125654571|NCT01646268|452021341|FG001|Overall Study|Lack of Efficacy|3|||
125654572|NCT01646268|452021340|FG000|Overall Study|Protocol Violation|0|||
125654573|NCT01646268|452021341|FG001|Overall Study|Protocol Violation|1|||
125654574|NCT01646268|452021340|FG000|Overall Study|Withdrawal by Subject|2|||
125654575|NCT01646268|452021341|FG001|Overall Study|Withdrawal by Subject|5|||
125654576|NCT01646268|452021340|FG000|Overall Study|Other|2|||
125654577|NCT01646268|452021341|FG001|Overall Study|Other|0|||
125654578|NCT01519635|452021346|FG000|Overall Study|Withdrawal by Subject|0|||
125654579|NCT01519635|452021347|FG001|Overall Study|Withdrawal by Subject|1|||
125654580|NCT01519635|452021346|FG000|Overall Study|No possibility to put a catheter|1|||
125654581|NCT01519635|452021347|FG001|Overall Study|No possibility to put a catheter|2|||
125654582|NCT01300741|452021348|FG000|Overall Study|Lens deposits|1|||
125654583|NCT01300741|452021348|FG000|Overall Study|Lost to Follow-up|1|||
125654584|NCT01300741|452021348|FG000|Overall Study|Discomfort|1|||
125654585|NCT02325414|452021349|FG000|Overall Study|Withdrawal by Subject|3|||
125654586|NCT02325414|452021350|FG001|Overall Study|Withdrawal by Subject|1|||
125654587|NCT02325414|452021349|FG000|Overall Study|Lost to Follow-up|5|||
125654588|NCT02325414|452021350|FG001|Overall Study|Lost to Follow-up|5|||
125425494|NCT00686881|451180499|FG001|Overall Study|Withdrawal by Subject|18|||
125425495|NCT00686881|451180498|FG000|Overall Study|Lost to Follow-up|0|||
125654589|NCT01339273|452021352|FG000|Overall Study|Lost to Follow-up|8|||
125654590|NCT01339273|452021353|FG001|Overall Study|Lost to Follow-up|8|||
125654591|NCT00560573|452021354|FG000|Overall Study|Death|4|||
125654592|NCT00560573|452021355|FG001|Overall Study|Death|1|||
125654593|NCT00560573|452021356|FG002|Overall Study|Death|4|||
125654594|NCT00560573|452021357|FG003|Overall Study|Death|5|||
125654595|NCT00560573|452021358|FG004|Overall Study|Death|1|||
125654596|NCT00560573|452021359|FG005|Overall Study|Death|10|||
125314680|NCT01272232|450781704|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
125314681|NCT01272232|450781705|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
125314682|NCT01272232|450781706|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
125314683|NCT01272232|450781704|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
125314684|NCT01272232|450781705|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
125314685|NCT01272232|450781706|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
125314686|NCT01272232|450781704|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
125314687|NCT01272232|450781705|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
125314688|NCT01272232|450781706|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
125314689|NCT01272232|450781704|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
125314690|NCT01272232|450781705|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
125314691|NCT01272232|450781706|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
125314692|NCT01960140|450781710|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
125314693|NCT00628030|450781711|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
125314694|NCT00628030|450781712|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
125314695|NCT00628030|450781711|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
125314696|NCT00628030|450781712|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
125314697|NCT00628030|450781711|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
125314698|NCT00628030|450781712|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
125314699|NCT01156480|450781714|FG000|Overall Study|change in diagnosis|0|||
125314700|NCT01156480|450781715|FG001|Overall Study|change in diagnosis|1|||
125314701|NCT01176058|450781716|FG000|Overall Study|Adverse Event|1|||
125314702|NCT01176058|450781717|FG001|Overall Study|Adverse Event|0|||
125314703|NCT01176058|450781716|FG000|Overall Study|Insufficient clinical response|2|||
125314704|NCT01176058|450781717|FG001|Overall Study|Insufficient clinical response|2|||
125314705|NCT01176058|450781716|FG000|Overall Study|Insufficient mycological response|0|||
125314706|NCT01176058|450781717|FG001|Overall Study|Insufficient mycological response|1|||
125314707|NCT01176058|450781716|FG000|Overall Study|Withdrawal by Subject|1|||
125314708|NCT01176058|450781717|FG001|Overall Study|Withdrawal by Subject|0|||
125314709|NCT04276233|450781718|FG000|Overall Study|Adverse Event|1|||
125314710|NCT04276233|450781718|FG000|Overall Study|Lost to Follow-up|3|||
125314711|NCT04276233|450781718|FG000|Overall Study|Physician Decision|4|||
125314712|NCT04276233|450781718|FG000|Overall Study|Withdrawal by Subject|2|||
125314713|NCT01946139|450781719|FG000|Overall Study|Withdrawal by Subject|8|||
125314714|NCT01946139|450781719|FG000|Overall Study|ineligible|8|||
125314715|NCT01946139|450781719|FG000|Overall Study|Specimens not available|4|||
125314716|NCT02525471|450781726|FG000|Overall Study|Screen Failure|6|||
125314717|NCT02525471|450781726|FG000|Overall Study|Withdrawal by Subject|4|||
125314718|NCT02525471|450781726|FG000|Overall Study|Death|1|||
125314719|NCT00890825|450781727|FG000|Overall Study|Withdrawal by Subject|1|||
125314720|NCT00890825|450781728|FG001|Overall Study|Withdrawal by Subject|0|||
125314721|NCT00890825|450781727|FG000|Overall Study|Alive at data cut off (DCO)|13|||
125314722|NCT00890825|450781728|FG001|Overall Study|Alive at data cut off (DCO)|14|||
125314723|NCT02336607|450781729|FG000|Overall Study|Physician Decision|1|||
125314724|NCT02336607|450781730|FG001|Overall Study|Physician Decision|4|||
125314725|NCT02336607|450781731|FG002|Overall Study|Physician Decision|3|||
125314726|NCT02336607|450781732|FG003|Overall Study|Physician Decision|15|||
125314727|NCT02336607|450781729|FG000|Overall Study|Lack of Efficacy|1|||
125314728|NCT02336607|450781730|FG001|Overall Study|Lack of Efficacy|0|||
125314729|NCT02336607|450781731|FG002|Overall Study|Lack of Efficacy|0|||
125314730|NCT02336607|450781732|FG003|Overall Study|Lack of Efficacy|2|||
125314731|NCT02336607|450781729|FG000|Overall Study|Lost to Follow-up|2|||
125314732|NCT02336607|450781730|FG001|Overall Study|Lost to Follow-up|1|||
125314733|NCT02336607|450781731|FG002|Overall Study|Lost to Follow-up|0|||
125314734|NCT02336607|450781732|FG003|Overall Study|Lost to Follow-up|21|||
125314735|NCT02336607|450781729|FG000|Overall Study|Protocol Violation|0|||
125314736|NCT02336607|450781730|FG001|Overall Study|Protocol Violation|1|||
125314737|NCT02336607|450781731|FG002|Overall Study|Protocol Violation|1|||
125314738|NCT02336607|450781732|FG003|Overall Study|Protocol Violation|3|||
125314739|NCT02336607|450781729|FG000|Overall Study|Adverse Event|0|||
125314740|NCT02336607|450781730|FG001|Overall Study|Adverse Event|2|||
125314741|NCT02336607|450781731|FG002|Overall Study|Adverse Event|2|||
125654597|NCT00560573|452021354|FG000|Overall Study|Lost to Follow-up|0|||
125654598|NCT00560573|452021355|FG001|Overall Study|Lost to Follow-up|0|||
125314742|NCT02336607|450781732|FG003|Overall Study|Adverse Event|26|||
125314743|NCT02336607|450781729|FG000|Overall Study|Withdrawal by Subject|0|||
125314744|NCT02336607|450781730|FG001|Overall Study|Withdrawal by Subject|2|||
125314745|NCT02336607|450781731|FG002|Overall Study|Withdrawal by Subject|0|||
125314746|NCT02336607|450781732|FG003|Overall Study|Withdrawal by Subject|20|||
125314747|NCT01216202|450781735|FG000|Overall Study|Withdrawal by Subject|8|||
125314748|NCT01216202|450781736|FG001|Overall Study|Withdrawal by Subject|0|||
125314749|NCT01216202|450781735|FG000|Overall Study|Death|0|||
125314750|NCT01216202|450781736|FG001|Overall Study|Death|2|||
125314751|NCT01216202|450781735|FG000|Overall Study|Lost to Follow-up|14|||
125654599|NCT00560573|452021356|FG002|Overall Study|Lost to Follow-up|0|||
125654600|NCT00560573|452021357|FG003|Overall Study|Lost to Follow-up|1|||
125654601|NCT00560573|452021358|FG004|Overall Study|Lost to Follow-up|1|||
125654602|NCT00560573|452021359|FG005|Overall Study|Lost to Follow-up|0|||
125654603|NCT00560573|452021354|FG000|Overall Study|Withdrawal by Subject|0|||
125654604|NCT00560573|452021355|FG001|Overall Study|Withdrawal by Subject|0|||
125654605|NCT00560573|452021356|FG002|Overall Study|Withdrawal by Subject|0|||
125654606|NCT00560573|452021357|FG003|Overall Study|Withdrawal by Subject|1|||
125654607|NCT00560573|452021358|FG004|Overall Study|Withdrawal by Subject|1|||
125654608|NCT00560573|452021359|FG005|Overall Study|Withdrawal by Subject|0|||
125654609|NCT00560573|452021354|FG000|Overall Study|Other|2|||
125654610|NCT00560573|452021355|FG001|Overall Study|Other|2|||
125654611|NCT00560573|452021356|FG002|Overall Study|Other|2|||
125654612|NCT00560573|452021357|FG003|Overall Study|Other|3|||
125654613|NCT00560573|452021358|FG004|Overall Study|Other|3|||
125654614|NCT00560573|452021359|FG005|Overall Study|Other|3|||
125654615|NCT00560573|452021354|FG000|Overall Study|Enrolled, not treated|0|||
125654616|NCT00560573|452021355|FG001|Overall Study|Enrolled, not treated|0|||
125654617|NCT00560573|452021356|FG002|Overall Study|Enrolled, not treated|0|||
125654618|NCT00560573|452021357|FG003|Overall Study|Enrolled, not treated|0|||
125654619|NCT00560573|452021358|FG004|Overall Study|Enrolled, not treated|1|||
125654620|NCT00560573|452021359|FG005|Overall Study|Enrolled, not treated|0|||
125654621|NCT00726882|452021360|FG000|Overall Study|Withdrawal by Subject|5|||
125314752|NCT01216202|450781736|FG001|Overall Study|Lost to Follow-up|0|||
125654622|NCT00726882|452021360|FG000|Overall Study|Lost to Follow-up|7|||
125654623|NCT00726882|452021360|FG000|Overall Study|Other|10|||
125654624|NCT00347776|452021361|FG000|1.5 Month Follow-up|Death|2|||
125654625|NCT00347776|452021362|FG001|1.5 Month Follow-up|Death|0|||
125654626|NCT00347776|452021363|FG002|1.5 Month Follow-up|Death|0|||
125654627|NCT00347776|452021361|FG000|1.5 Month Follow-up|reached the endpoint|12|||
125654628|NCT00347776|452021362|FG001|1.5 Month Follow-up|reached the endpoint|8|||
125654629|NCT00347776|452021363|FG002|1.5 Month Follow-up|reached the endpoint|12|||
125654630|NCT00347776|452021361|FG000|6 Month Follow-up|Death|2|||
125654631|NCT00347776|452021362|FG001|6 Month Follow-up|Death|1|||
125654632|NCT00347776|452021363|FG002|6 Month Follow-up|Death|3|||
125654633|NCT00347776|452021361|FG000|6 Month Follow-up|reached endpont|20|||
125654634|NCT00347776|452021362|FG001|6 Month Follow-up|reached endpont|12|||
125654635|NCT00347776|452021363|FG002|6 Month Follow-up|reached endpont|15|||
125654636|NCT00347776|452021361|FG000|12 Month Follow-up|Lost to Follow-up|7|||
125654637|NCT00347776|452021362|FG001|12 Month Follow-up|Lost to Follow-up|6|||
125654638|NCT00347776|452021363|FG002|12 Month Follow-up|Lost to Follow-up|6|||
125314753|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314754|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314755|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314756|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
125314757|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314758|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314759|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314760|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314761|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314762|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
125314763|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
125314764|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
125314765|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
125314766|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
125314767|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
125314768|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
125314769|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
125314770|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
125314771|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
125314772|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
125314773|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
125314774|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
125654639|NCT00347776|452021361|FG000|12 Month Follow-up|Death|3|||
125654640|NCT00347776|452021362|FG001|12 Month Follow-up|Death|4|||
125654641|NCT00347776|452021363|FG002|12 Month Follow-up|Death|4|||
125654642|NCT00347776|452021361|FG000|12 Month Follow-up|Reached endpoint|13|||
125654643|NCT00347776|452021362|FG001|12 Month Follow-up|Reached endpoint|6|||
125654644|NCT00347776|452021363|FG002|12 Month Follow-up|Reached endpoint|9|||
125654645|NCT00594568|452021364|FG000|Initial Treatment|Adverse Event|51|||
125654646|NCT00594568|452021365|FG001|Initial Treatment|Adverse Event|121|||
125654647|NCT00594568|452021366|FG002|Initial Treatment|Adverse Event|144|||
125654648|NCT00594568|452021364|FG000|Initial Treatment|Death|6|||
125654649|NCT00594568|452021365|FG001|Initial Treatment|Death|11|||
125654650|NCT00594568|452021366|FG002|Initial Treatment|Death|15|||
125654651|NCT00594568|452021364|FG000|Initial Treatment|Lost to Follow-up|4|||
125654652|NCT00594568|452021365|FG001|Initial Treatment|Lost to Follow-up|1|||
125654653|NCT00594568|452021366|FG002|Initial Treatment|Lost to Follow-up|4|||
125654654|NCT00594568|452021364|FG000|Initial Treatment|Physician Decision|3|||
125654655|NCT00594568|452021365|FG001|Initial Treatment|Physician Decision|2|||
125654656|NCT00594568|452021366|FG002|Initial Treatment|Physician Decision|4|||
125654657|NCT00594568|452021364|FG000|Initial Treatment|Protocol Violation|2|||
125654658|NCT00594568|452021365|FG001|Initial Treatment|Protocol Violation|2|||
125654659|NCT00594568|452021366|FG002|Initial Treatment|Protocol Violation|5|||
125654660|NCT00594568|452021364|FG000|Initial Treatment|Withdrawal by Subject|25|||
125654661|NCT00594568|452021365|FG001|Initial Treatment|Withdrawal by Subject|31|||
125654662|NCT00594568|452021366|FG002|Initial Treatment|Withdrawal by Subject|46|||
125654663|NCT00594568|452021364|FG000|Initial Treatment|Sponsor decision|193|||
125654664|NCT00594568|452021365|FG001|Initial Treatment|Sponsor decision|142|||
125654665|NCT00594568|452021366|FG002|Initial Treatment|Sponsor decision|147|||
125654666|NCT00594568|452021364|FG000|Initial Treatment|Caregiver decision|21|||
125654667|NCT00594568|452021365|FG001|Initial Treatment|Caregiver decision|36|||
125654668|NCT00594568|452021366|FG002|Initial Treatment|Caregiver decision|36|||
125654669|NCT00594568|452021364|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
125654670|NCT00594568|452021365|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
125654671|NCT00594568|452021366|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
125654672|NCT00594568|452021364|FG000|Initial Treatment|Entry criteria exclusion|0|||
125654673|NCT00594568|452021365|FG001|Initial Treatment|Entry criteria exclusion|1|||
125654674|NCT00594568|452021366|FG002|Initial Treatment|Entry criteria exclusion|1|||
125654675|NCT00594568|452021364|FG000|Delayed Start|Death|0|||
125654676|NCT00594568|452021365|FG001|Delayed Start|Death|0|||
125654677|NCT00594568|452021366|FG002|Delayed Start|Death|1|||
125654678|NCT00594568|452021364|FG000|Delayed Start|Adverse Event|12|||
125654679|NCT00594568|452021365|FG001|Delayed Start|Adverse Event|2|||
125654680|NCT00594568|452021366|FG002|Delayed Start|Adverse Event|2|||
125654681|NCT00594568|452021364|FG000|Delayed Start|Withdrawal by Subject|4|||
125654682|NCT00594568|452021365|FG001|Delayed Start|Withdrawal by Subject|3|||
125654683|NCT00594568|452021366|FG002|Delayed Start|Withdrawal by Subject|0|||
125654684|NCT00594568|452021364|FG000|Delayed Start|Physician Decision|0|||
125654685|NCT00594568|452021365|FG001|Delayed Start|Physician Decision|0|||
125654686|NCT00594568|452021366|FG002|Delayed Start|Physician Decision|1|||
125654687|NCT00594568|452021364|FG000|Delayed Start|Lost to Follow-up|0|||
125654688|NCT00594568|452021365|FG001|Delayed Start|Lost to Follow-up|0|||
125654689|NCT00594568|452021366|FG002|Delayed Start|Lost to Follow-up|1|||
125654690|NCT00594568|452021364|FG000|Delayed Start|Caregiver Decision|5|||
125654691|NCT00594568|452021365|FG001|Delayed Start|Caregiver Decision|6|||
125654692|NCT00594568|452021366|FG002|Delayed Start|Caregiver Decision|2|||
125654693|NCT00594568|452021364|FG000|Delayed Start|Sponsor Decision|77|||
125654694|NCT00594568|452021365|FG001|Delayed Start|Sponsor Decision|66|||
125654695|NCT00594568|452021366|FG002|Delayed Start|Sponsor Decision|59|||
125654696|NCT00594568|452021364|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
125654697|NCT00594568|452021365|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
125654698|NCT00594568|452021366|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
125654699|NCT00594568|452021364|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
125654700|NCT00594568|452021365|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
125654701|NCT00594568|452021366|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
125654702|NCT00594568|452021364|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
125654703|NCT00594568|452021365|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
125654704|NCT00594568|452021366|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
125654705|NCT00594568|452021364|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
125654706|NCT00594568|452021365|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
125654707|NCT00594568|452021366|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
125654708|NCT00594568|452021364|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
125654709|NCT00594568|452021365|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
125654710|NCT00594568|452021366|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
125654711|NCT00594568|452021364|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
125654712|NCT00594568|452021365|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
125654713|NCT00594568|452021366|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
125654714|NCT04478994|452021367|FG000|Overall Study|Withdrawal by Subject|1|||
125654715|NCT04478994|452021368|FG001|Overall Study|Withdrawal by Subject|1|||
125654716|NCT01100073|452021369|FG000|Overall Study|Lack of Efficacy|4|||
125654717|NCT01100073|452021369|FG000|Overall Study|Insufficient Tolerability|21|||
125654718|NCT01100073|452021369|FG000|Overall Study|Withdrawal by Subject|13|||
125654719|NCT01100073|452021369|FG000|Overall Study|Lost to Follow-up|39|||
125654720|NCT01100073|452021369|FG000|Overall Study|Lack of effect + patient's wish|2|||
125654721|NCT01100073|452021369|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
125654722|NCT01100073|452021369|FG000|Overall Study|Other|8|||
125654723|NCT01100073|452021369|FG000|Overall Study|Missing|5|||
125654724|NCT00518531|452021370|FG000|Treatment Period 1|Adverse Event|5|||
125654725|NCT00518531|452021371|FG001|Treatment Period 1|Adverse Event|0|||
125654726|NCT00518531|452021370|FG000|Treatment Period 1|Lost to Follow-up|5|||
125654727|NCT00518531|452021371|FG001|Treatment Period 1|Lost to Follow-up|3|||
125654728|NCT00518531|452021370|FG000|Treatment Period 1|Physician Decision|1|||
125654729|NCT00518531|452021371|FG001|Treatment Period 1|Physician Decision|0|||
125654730|NCT00518531|452021370|FG000|Treatment Period 1|Protocol Violation|2|||
125654731|NCT00518531|452021371|FG001|Treatment Period 1|Protocol Violation|0|||
125654732|NCT00518531|452021370|FG000|Treatment Period 1|Withdrawal by Subject|4|||
125654733|NCT00518531|452021371|FG001|Treatment Period 1|Withdrawal by Subject|6|||
125654734|NCT00518531|452021370|FG000|Treatment Period 1|Early crossover|1|||
125654735|NCT00518531|452021371|FG001|Treatment Period 1|Early crossover|3|||
125654736|NCT00518531|452021370|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125654737|NCT00518531|452021371|FG001|Treatment Period 2|Withdrawal by Subject|8|||
125654738|NCT00518531|452021370|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
125654739|NCT00518531|452021371|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
125654740|NCT00518531|452021370|FG000|Treatment Period 2|Adverse Event|1|||
125654741|NCT00518531|452021371|FG001|Treatment Period 2|Adverse Event|7|||
125654742|NCT00518531|452021370|FG000|Treatment Period 2|Protocol-specified criteria|0|||
125654743|NCT00518531|452021371|FG001|Treatment Period 2|Protocol-specified criteria|1|||
125654744|NCT00518531|452021370|FG000|Treatment Period 2|Non-compliance|1|||
125654745|NCT00518531|452021371|FG001|Treatment Period 2|Non-compliance|2|||
125654746|NCT01656850|452021372|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
125654747|NCT01656850|452021373|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
125654748|NCT00602927|452021376|FG000|Period 1: 13 Days|Protocol Violation|2|||
125654749|NCT00602927|452021377|FG001|Period 1: 13 Days|Protocol Violation|4|||
125654750|NCT00602927|452021376|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
125314775|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
125654751|NCT00602927|452021377|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
125654752|NCT00602927|452021376|FG000|Period 1: 13 Days|Time|1|||
125654753|NCT00602927|452021377|FG001|Period 1: 13 Days|Time|0|||
125654754|NCT00602927|452021376|FG000|Period 1: 13 Days|Claustrophobia|0|||
125654755|NCT00602927|452021377|FG001|Period 1: 13 Days|Claustrophobia|1|||
125654756|NCT00602927|452021376|FG000|Period 2: 14 Days|Protocol Violation|0|||
125654757|NCT00602927|452021377|FG001|Period 2: 14 Days|Protocol Violation|2|||
125654758|NCT00602927|452021376|FG000|Period 3: 13 Days|Protocol Violation|0|||
125654759|NCT00602927|452021377|FG001|Period 3: 13 Days|Protocol Violation|1|||
125654760|NCT00602927|452021376|FG000|Period 3: 13 Days|MRI data quality|2|||
125654761|NCT00602927|452021377|FG001|Period 3: 13 Days|MRI data quality|2|||
125654762|NCT01741259|452021383|FG000|Overall Study|Protocol Violation|6|||
125654763|NCT01741259|452021384|FG001|Overall Study|Protocol Violation|4|||
125654764|NCT01741259|452021383|FG000|Overall Study|Withdrawal by Subject|0|||
125654765|NCT01741259|452021384|FG001|Overall Study|Withdrawal by Subject|2|||
125654766|NCT03722849|452021394|FG000|Overall Study|Withdrawal by Subject|1|||
125654767|NCT03722849|452021395|FG001|Overall Study|Withdrawal by Subject|1|||
125654768|NCT04633434|452021398|FG000|Overall Study|Lost to Follow-up|32|||
125654769|NCT04633434|452021399|FG001|Overall Study|Lost to Follow-up|32|||
125654770|NCT04409509|452021414|FG000|Overall Study|Failure to meet randomization requirement|1|||
125654771|NCT04409509|452021415|FG001|Overall Study|Failure to meet randomization requirement|0|||
125654772|NCT04409509|452021414|FG000|Overall Study|Adverse Event|0|||
125654773|NCT04409509|452021415|FG001|Overall Study|Adverse Event|1|||
125654774|NCT04409509|452021414|FG000|Overall Study|Death|11|||
125654775|NCT04409509|452021415|FG001|Overall Study|Death|10|||
125314776|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
125314777|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
125314778|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
125314779|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
125314780|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
125314781|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
125314782|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
125314783|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
125314784|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
125314785|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
125314786|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
125314787|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
125314788|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
125314789|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
125314790|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
125314791|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
125540466|NCT04927247|451607640|FG001|Overall Study|Physician Decision|1|||
125654776|NCT04409509|452021414|FG000|Overall Study|Non-compliance with study drug|0|||
125654777|NCT04409509|452021415|FG001|Overall Study|Non-compliance with study drug|1|||
125654778|NCT04409509|452021414|FG000|Overall Study|Lost to Follow-up|0|||
125314792|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
125654779|NCT04409509|452021415|FG001|Overall Study|Lost to Follow-up|3|||
125654780|NCT04409509|452021414|FG000|Overall Study|Withdrawal by Subject|0|||
125654781|NCT04409509|452021415|FG001|Overall Study|Withdrawal by Subject|3|||
125654782|NCT04409509|452021414|FG000|Overall Study|Randomized by mistake|0|||
125654783|NCT04409509|452021415|FG001|Overall Study|Randomized by mistake|1|||
125654784|NCT04409509|452021414|FG000|Overall Study|Other|1|||
125654785|NCT04409509|452021415|FG001|Overall Study|Other|1|||
125654786|NCT04882085|452021421|FG000|Overall Study|Death|6|||
125654787|NCT04882085|452021422|FG001|Overall Study|Death|9|||
125654788|NCT04882085|452021421|FG000|Overall Study|Withdrawal by Subject|0|||
125654789|NCT04882085|452021422|FG001|Overall Study|Withdrawal by Subject|3|||
125654790|NCT04882085|452021421|FG000|Overall Study|Randomized not treated|1|||
125654791|NCT04882085|452021422|FG001|Overall Study|Randomized not treated|0|||
125654792|NCT00965562|452021426|FG000|Overall Study|Lost to Follow-up|1|||
125654793|NCT00965562|452021427|FG001|Overall Study|Lost to Follow-up|2|||
125654794|NCT00965562|452021428|FG002|Overall Study|Lost to Follow-up|3|||
125654795|NCT00965562|452021426|FG000|Overall Study|Withdrawal by Subject|2|||
125654796|NCT00965562|452021427|FG001|Overall Study|Withdrawal by Subject|2|||
125654797|NCT00965562|452021428|FG002|Overall Study|Withdrawal by Subject|0|||
125654798|NCT00816166|452021429|FG000|Overall Study|Lost to Follow-up|6|||
125654799|NCT00816166|452021430|FG001|Overall Study|Lost to Follow-up|10|||
125654800|NCT00816166|452021429|FG000|Overall Study|Death|4|||
125654801|NCT00816166|452021430|FG001|Overall Study|Death|2|||
125654802|NCT02756182|452021431|FG000|Overall Study|StudyTechnical Difficulties|4|||
125654803|NCT01608321|452021441|FG000|Overall Study|Withdrawal by Subject|1|||
125654804|NCT01608321|452021442|FG001|Overall Study|Withdrawal by Subject|0|||
125654805|NCT02062385|452021443|FG000|Overall Study|Adverse Event|19|||
125654806|NCT02062385|452021444|FG001|Overall Study|Adverse Event|13|||
125654807|NCT02062385|452021445|FG002|Overall Study|Adverse Event|1|||
125654808|NCT02062385|452021446|FG003|Overall Study|Adverse Event|0|||
125654809|NCT02062385|452021443|FG000|Overall Study|Protocol Violation|1|||
125654810|NCT02062385|452021444|FG001|Overall Study|Protocol Violation|0|||
125654811|NCT02062385|452021445|FG002|Overall Study|Protocol Violation|0|||
125654812|NCT02062385|452021446|FG003|Overall Study|Protocol Violation|0|||
125654813|NCT02062385|452021443|FG000|Overall Study|Incomplete EPI by database lock|2|||
125654814|NCT02062385|452021444|FG001|Overall Study|Incomplete EPI by database lock|0|||
125654815|NCT02062385|452021445|FG002|Overall Study|Incomplete EPI by database lock|0|||
125654816|NCT02062385|452021446|FG003|Overall Study|Incomplete EPI by database lock|0|||
125654817|NCT02062385|452021443|FG000|Overall Study|Moved|10|||
125654818|NCT02062385|452021444|FG001|Overall Study|Moved|11|||
125654819|NCT02062385|452021445|FG002|Overall Study|Moved|1|||
125654820|NCT02062385|452021446|FG003|Overall Study|Moved|0|||
125654821|NCT02062385|452021443|FG000|Overall Study|Withdrawn by parent/guardian|46|||
125654822|NCT02062385|452021444|FG001|Overall Study|Withdrawn by parent/guardian|41|||
125654823|NCT02062385|452021445|FG002|Overall Study|Withdrawn by parent/guardian|9|||
125654824|NCT02062385|452021446|FG003|Overall Study|Withdrawn by parent/guardian|8|||
125654825|NCT02062385|452021443|FG000|Overall Study|Death|0|||
125654826|NCT02062385|452021444|FG001|Overall Study|Death|0|||
125654827|NCT02062385|452021445|FG002|Overall Study|Death|0|||
125654828|NCT02062385|452021446|FG003|Overall Study|Death|1|||
125654829|NCT02062385|452021443|FG000|Overall Study|Lost to Follow-up|0|||
125654830|NCT02062385|452021444|FG001|Overall Study|Lost to Follow-up|0|||
125654831|NCT02062385|452021445|FG002|Overall Study|Lost to Follow-up|1|||
125654832|NCT02062385|452021446|FG003|Overall Study|Lost to Follow-up|0|||
125654833|NCT01319994|452022944|FG000|Overall Study|Protocol Violation|7|||
125654834|NCT01319994|452022945|FG001|Overall Study|Protocol Violation|6|||
125654835|NCT01340794|452022946|FG000|Overall Study|Withdrawal by Subject|0|||
125654836|NCT01340794|452022947|FG001|Overall Study|Withdrawal by Subject|1|||
125654837|NCT01118949|452022950|FG000|Overall Study|Adverse Event|5|||
125654838|NCT01118949|452022950|FG000|Overall Study|Withdrawal by Subject|4|||
125654839|NCT00685763|452022955|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
125654840|NCT00685763|452022955|FG000|Overall Study|Protocol Violation|1|||
125314793|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
125314794|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
125654841|NCT00698009|452022956|FG000|Overall Study|Withdrawal by Subject|1|||
125314795|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
125654842|NCT00057330|452022962|FG000|Overall Study|Adverse Event|9|||
125314796|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
125654843|NCT00057330|452022963|FG001|Overall Study|Adverse Event|12|||
125654844|NCT00057330|452022962|FG000|Overall Study|Death|1|||
125654845|NCT00057330|452022963|FG001|Overall Study|Death|0|||
125654846|NCT00057330|452022962|FG000|Overall Study|Protocol Violation|1|||
125425496|NCT00686881|451180499|FG001|Overall Study|Lost to Follow-up|1|||
125654847|NCT00057330|452022963|FG001|Overall Study|Protocol Violation|1|||
125654848|NCT00057330|452022962|FG000|Overall Study|Withdrawal by Subject|115|||
125654849|NCT00057330|452022963|FG001|Overall Study|Withdrawal by Subject|84|||
125654850|NCT00057330|452022962|FG000|Overall Study|Lost to Follow-up|745|||
125654851|NCT00057330|452022963|FG001|Overall Study|Lost to Follow-up|617|||
125654852|NCT00057330|452022962|FG000|Overall Study|Physician Decision|1|||
125654853|NCT00057330|452022963|FG001|Overall Study|Physician Decision|0|||
125654854|NCT00057330|452022962|FG000|Overall Study|Other|260|||
125654855|NCT00057330|452022963|FG001|Overall Study|Other|206|||
125654856|NCT00471237|452022964|FG000|Overall Study|Adverse Event|6|||
125654857|NCT00471237|452022965|FG001|Overall Study|Adverse Event|5|||
125654858|NCT00471237|452022966|FG002|Overall Study|Adverse Event|4|||
125654859|NCT00471237|452022967|FG003|Overall Study|Adverse Event|8|||
125654860|NCT00471237|452022968|FG004|Overall Study|Adverse Event|7|||
125654861|NCT00471237|452022969|FG005|Overall Study|Adverse Event|5|||
125654862|NCT00471237|452022970|FG006|Overall Study|Adverse Event|0|||
125654863|NCT00471237|452022964|FG000|Overall Study|Lost to Follow-up|1|||
125654864|NCT00471237|452022965|FG001|Overall Study|Lost to Follow-up|1|||
125654865|NCT00471237|452022966|FG002|Overall Study|Lost to Follow-up|0|||
125654866|NCT00471237|452022967|FG003|Overall Study|Lost to Follow-up|2|||
125654867|NCT00471237|452022968|FG004|Overall Study|Lost to Follow-up|3|||
125654868|NCT00471237|452022969|FG005|Overall Study|Lost to Follow-up|0|||
125654869|NCT00471237|452022970|FG006|Overall Study|Lost to Follow-up|0|||
125654870|NCT00471237|452022964|FG000|Overall Study|Protocol Violation|3|||
125654871|NCT00471237|452022965|FG001|Overall Study|Protocol Violation|6|||
125654872|NCT00471237|452022966|FG002|Overall Study|Protocol Violation|3|||
125654873|NCT00471237|452022967|FG003|Overall Study|Protocol Violation|2|||
125654874|NCT00471237|452022968|FG004|Overall Study|Protocol Violation|2|||
125654875|NCT00471237|452022969|FG005|Overall Study|Protocol Violation|4|||
125654876|NCT00471237|452022970|FG006|Overall Study|Protocol Violation|1|||
125654877|NCT00471237|452022964|FG000|Overall Study|Withdrawal by Subject|8|||
125654878|NCT00471237|452022965|FG001|Overall Study|Withdrawal by Subject|6|||
125654879|NCT00471237|452022966|FG002|Overall Study|Withdrawal by Subject|5|||
125654880|NCT00471237|452022967|FG003|Overall Study|Withdrawal by Subject|8|||
125654881|NCT00471237|452022968|FG004|Overall Study|Withdrawal by Subject|7|||
125654882|NCT00471237|452022969|FG005|Overall Study|Withdrawal by Subject|4|||
125654883|NCT00471237|452022970|FG006|Overall Study|Withdrawal by Subject|2|||
125654884|NCT00471237|452022964|FG000|Overall Study|Sponsor terminated study|20|||
125654885|NCT00471237|452022965|FG001|Overall Study|Sponsor terminated study|23|||
125654886|NCT00471237|452022966|FG002|Overall Study|Sponsor terminated study|19|||
125654887|NCT00471237|452022967|FG003|Overall Study|Sponsor terminated study|22|||
125654888|NCT00471237|452022968|FG004|Overall Study|Sponsor terminated study|18|||
125654889|NCT00471237|452022969|FG005|Overall Study|Sponsor terminated study|24|||
125654890|NCT00471237|452022970|FG006|Overall Study|Sponsor terminated study|0|||
125654891|NCT00471237|452022964|FG000|Overall Study|Non-compliance|0|||
125654892|NCT00471237|452022965|FG001|Overall Study|Non-compliance|1|||
125654893|NCT00471237|452022966|FG002|Overall Study|Non-compliance|0|||
125654894|NCT00471237|452022967|FG003|Overall Study|Non-compliance|1|||
125654895|NCT00471237|452022968|FG004|Overall Study|Non-compliance|0|||
125654896|NCT00471237|452022969|FG005|Overall Study|Non-compliance|0|||
125654897|NCT00471237|452022970|FG006|Overall Study|Non-compliance|0|||
125654898|NCT00471237|452022964|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
125654899|NCT00471237|452022965|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
125654900|NCT00471237|452022966|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
125654901|NCT00471237|452022967|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
125654902|NCT00471237|452022968|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
125654903|NCT00471237|452022969|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
125654904|NCT00471237|452022970|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
125654905|NCT00471237|452022964|FG000|Overall Study|Early stopping due to non-efficacy|1|||
125654906|NCT00471237|452022965|FG001|Overall Study|Early stopping due to non-efficacy|0|||
125654907|NCT00471237|452022966|FG002|Overall Study|Early stopping due to non-efficacy|0|||
125654908|NCT00471237|452022967|FG003|Overall Study|Early stopping due to non-efficacy|0|||
125654909|NCT00471237|452022968|FG004|Overall Study|Early stopping due to non-efficacy|1|||
125654910|NCT00471237|452022969|FG005|Overall Study|Early stopping due to non-efficacy|0|||
125654911|NCT00471237|452022970|FG006|Overall Study|Early stopping due to non-efficacy|0|||
125314797|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
125314798|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
125314799|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
125314800|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
125540467|NCT04927247|451607639|FG000|Overall Study|Adverse Event|1|||
125654912|NCT00471237|452022964|FG000|Overall Study|Participant planned to travel to abraod|1|||
125654913|NCT00471237|452022965|FG001|Overall Study|Participant planned to travel to abraod|0|||
125654914|NCT00471237|452022966|FG002|Overall Study|Participant planned to travel to abraod|0|||
125654915|NCT00471237|452022967|FG003|Overall Study|Participant planned to travel to abraod|0|||
125654916|NCT00471237|452022968|FG004|Overall Study|Participant planned to travel to abraod|0|||
125654917|NCT00471237|452022969|FG005|Overall Study|Participant planned to travel to abraod|1|||
125654918|NCT00471237|452022970|FG006|Overall Study|Participant planned to travel to abraod|0|||
125654919|NCT00471237|452022964|FG000|Overall Study|High parathyroid hormone|0|||
125654920|NCT00471237|452022965|FG001|Overall Study|High parathyroid hormone|0|||
125654921|NCT00471237|452022966|FG002|Overall Study|High parathyroid hormone|1|||
125654922|NCT00471237|452022967|FG003|Overall Study|High parathyroid hormone|0|||
125654923|NCT00471237|452022968|FG004|Overall Study|High parathyroid hormone|0|||
125654924|NCT00471237|452022969|FG005|Overall Study|High parathyroid hormone|0|||
125654925|NCT00471237|452022970|FG006|Overall Study|High parathyroid hormone|0|||
125654926|NCT00471237|452022964|FG000|Overall Study|Participant lost medication|0|||
125654927|NCT00471237|452022965|FG001|Overall Study|Participant lost medication|0|||
125654928|NCT00471237|452022966|FG002|Overall Study|Participant lost medication|0|||
125654929|NCT00471237|452022967|FG003|Overall Study|Participant lost medication|0|||
125654930|NCT00471237|452022968|FG004|Overall Study|Participant lost medication|1|||
125654931|NCT00471237|452022969|FG005|Overall Study|Participant lost medication|0|||
125654932|NCT00471237|452022970|FG006|Overall Study|Participant lost medication|0|||
125654933|NCT00471237|452022964|FG000|Overall Study|Administration of prohibited medicine|0|||
125654934|NCT00471237|452022965|FG001|Overall Study|Administration of prohibited medicine|0|||
125654935|NCT00471237|452022966|FG002|Overall Study|Administration of prohibited medicine|0|||
125654936|NCT00471237|452022967|FG003|Overall Study|Administration of prohibited medicine|0|||
125654937|NCT00471237|452022968|FG004|Overall Study|Administration of prohibited medicine|1|||
125654938|NCT00471237|452022969|FG005|Overall Study|Administration of prohibited medicine|0|||
125654939|NCT00471237|452022970|FG006|Overall Study|Administration of prohibited medicine|0|||
125654940|NCT00471237|452022964|FG000|Overall Study|Participant shifted residence|0|||
125654941|NCT00471237|452022965|FG001|Overall Study|Participant shifted residence|0|||
125654942|NCT00471237|452022966|FG002|Overall Study|Participant shifted residence|0|||
125654943|NCT00471237|452022967|FG003|Overall Study|Participant shifted residence|0|||
125654944|NCT00471237|452022968|FG004|Overall Study|Participant shifted residence|1|||
125654945|NCT00471237|452022969|FG005|Overall Study|Participant shifted residence|0|||
125654946|NCT00471237|452022970|FG006|Overall Study|Participant shifted residence|0|||
125654947|NCT00471237|452022964|FG000|Overall Study|Participant's decision|0|||
125654948|NCT00471237|452022965|FG001|Overall Study|Participant's decision|0|||
125654949|NCT00471237|452022966|FG002|Overall Study|Participant's decision|0|||
125654950|NCT00471237|452022967|FG003|Overall Study|Participant's decision|0|||
125654951|NCT00471237|452022968|FG004|Overall Study|Participant's decision|0|||
125654952|NCT00471237|452022969|FG005|Overall Study|Participant's decision|1|||
125654953|NCT00471237|452022970|FG006|Overall Study|Participant's decision|0|||
125654954|NCT01605370|452022975|FG000|Overall Study|Adverse Event|1|||
125654955|NCT01605370|452022976|FG001|Overall Study|Adverse Event|0|||
125654956|NCT00627094|452022977|FG000|Overall Study|Adverse Event|8|||
125654957|NCT00627094|452022978|FG001|Overall Study|Adverse Event|7|||
125654958|NCT00627094|452022977|FG000|Overall Study|Lost to Follow-up|1|||
125654959|NCT00627094|452022978|FG001|Overall Study|Lost to Follow-up|0|||
125654960|NCT00627094|452022977|FG000|Overall Study|Withdrawal by Subject|1|||
125654961|NCT00627094|452022978|FG001|Overall Study|Withdrawal by Subject|1|||
125654962|NCT00627094|452022977|FG000|Overall Study|ulcer healed|1|||
125654963|NCT00627094|452022978|FG001|Overall Study|ulcer healed|7|||
125654964|NCT00627094|452022977|FG000|Overall Study|Other reason|1|||
125654965|NCT00627094|452022978|FG001|Overall Study|Other reason|0|||
125654966|NCT01353586|452022981|FG000|Overall Study|Procedure terminated prior to ablation|3|||
125654967|NCT01353586|452022982|FG001|Overall Study|Procedure terminated prior to ablation|0|||
125654968|NCT01353586|452022981|FG000|Overall Study|Never had insertion of study catheter|4|||
125654969|NCT01353586|452022982|FG001|Overall Study|Never had insertion of study catheter|1|||
125654970|NCT01353586|452022981|FG000|Overall Study|Neurological exam not done|0|||
125654971|NCT01353586|452022982|FG001|Overall Study|Neurological exam not done|1|||
125654972|NCT00585468|452022983|FG000|First Intervention|Withdrawal by Subject|1|||
125654973|NCT00585468|452022984|FG001|First Intervention|Withdrawal by Subject|1|||
125654974|NCT00943826|452022994|FG000|Concurrent Phase|Adverse Event|50|||
125654975|NCT00943826|452022995|FG001|Concurrent Phase|Adverse Event|27|||
125654976|NCT00943826|452022994|FG000|Concurrent Phase|Withdrew consent|3|||
125654977|NCT00943826|452022995|FG001|Concurrent Phase|Withdrew consent|7|||
125654978|NCT00943826|452022994|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
125654979|NCT00943826|452022995|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
125654980|NCT00943826|452022994|FG000|Concurrent Phase|Administrative reasons|2|||
125654981|NCT00943826|452022995|FG001|Concurrent Phase|Administrative reasons|1|||
125654982|NCT00943826|452022994|FG000|Concurrent Phase|Protocol Violation|1|||
125654983|NCT00943826|452022995|FG001|Concurrent Phase|Protocol Violation|0|||
125654984|NCT00943826|452022994|FG000|Maintenance Phase|Adverse Event|31|||
125654985|NCT00943826|452022995|FG001|Maintenance Phase|Adverse Event|30|||
125654986|NCT00943826|452022994|FG000|Maintenance Phase|Withdrew consent|2|||
125654987|NCT00943826|452022995|FG001|Maintenance Phase|Withdrew consent|4|||
125654988|NCT00943826|452022994|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
125654989|NCT00943826|452022995|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
125654990|NCT00943826|452022994|FG000|Maintenance Phase|Administrative reasons|4|||
125654991|NCT00943826|452022995|FG001|Maintenance Phase|Administrative reasons|1|||
125654992|NCT00943826|452022994|FG000|Maintenance Phase|Failure to return|0|||
125654993|NCT00943826|452022995|FG001|Maintenance Phase|Failure to return|1|||
125654994|NCT00943826|452022994|FG000|Monotherapy Phase|Adverse Event|42|||
125654995|NCT00943826|452022995|FG001|Monotherapy Phase|Adverse Event|5|||
125654996|NCT00943826|452022994|FG000|Monotherapy Phase|Administrative reasons|11|||
125210538|NCT02907619|450395592|FG002|Overall Study|Other|0|||
125654997|NCT00943826|452022995|FG001|Monotherapy Phase|Administrative reasons|5|||
125654998|NCT00943826|452022994|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
125654999|NCT00943826|452022995|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
125655000|NCT00943826|452022994|FG000|Monotherapy Phase|Withdrew Consent|2|||
125655001|NCT00943826|452022995|FG001|Monotherapy Phase|Withdrew Consent|3|||
125655002|NCT00943826|452022994|FG000|Monotherapy Phase|Failure to return|2|||
125655003|NCT00943826|452022995|FG001|Monotherapy Phase|Failure to return|1|||
125655004|NCT00943826|452022994|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
125655005|NCT00943826|452022995|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
125655006|NCT00943826|452022994|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
125655007|NCT00943826|452022995|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
125655008|NCT00943826|452022994|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
125655009|NCT00943826|452022995|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
125655010|NCT00943826|452022994|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
125655011|NCT00943826|452022995|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
125655012|NCT00807040|452023000|FG000|Overall Study|Death|24|||
125655013|NCT00807040|452023001|FG001|Overall Study|Death|29|||
125655014|NCT00807040|452023000|FG000|Overall Study|Withdrawal by Subject|8|||
125655015|NCT00807040|452023001|FG001|Overall Study|Withdrawal by Subject|6|||
125655016|NCT00807040|452023000|FG000|Overall Study|Lost to Follow-up|4|||
125655017|NCT00807040|452023001|FG001|Overall Study|Lost to Follow-up|6|||
125655018|NCT00625846|452023002|FG000|Overall Study|Withdrawal by Subject|2|||
125655019|NCT00625846|452023003|FG001|Overall Study|Withdrawal by Subject|0|||
125655020|NCT00625846|452023004|FG002|Overall Study|Withdrawal by Subject|1|||
125655021|NCT00625846|452023005|FG003|Overall Study|Withdrawal by Subject|2|||
125655022|NCT00455923|452023008|FG000|Overall Study|Pregnancy|0|||
125655023|NCT00455923|452023009|FG001|Overall Study|Pregnancy|2|||
125655024|NCT00455923|452023008|FG000|Overall Study|Other|3|||
125655025|NCT00455923|452023009|FG001|Overall Study|Other|1|||
125655026|NCT01870921|452023012|FG000|Overall Study|Subject decision|80|||
125655027|NCT01870921|452023012|FG000|Overall Study|Severe non-compliance to protocol|7|||
125655028|NCT01870921|452023012|FG000|Overall Study|Subject Lost to Follow up|2|||
125655029|NCT01870921|452023012|FG000|Overall Study|Other|1|||
125655030|NCT02279888|452023013|FG000|Overall Study|Death|326|||
125655031|NCT02279888|452023013|FG000|Overall Study|Withdrawal by Subject|38|||
125655032|NCT02279888|452023013|FG000|Overall Study|Lost to Follow-up|21|||
125655033|NCT02279888|452023013|FG000|Overall Study|Physician Decision|62|||
125655034|NCT02279888|452023013|FG000|Overall Study|Subject Non-compliance|43|||
125655035|NCT02279888|452023013|FG000|Overall Study|Not implanted|14|||
125655036|NCT02279888|452023013|FG000|Overall Study|Visit not performed|26|||
125655037|NCT02335411|452023014|FG000|Overall Study|Death|223|||
125655038|NCT02335411|452023015|FG001|Overall Study|Death|22|||
125655039|NCT02335411|452023016|FG002|Overall Study|Death|26|||
125655040|NCT02335411|452023014|FG000|Overall Study|Physician Decision|3|||
125655041|NCT02335411|452023015|FG001|Overall Study|Physician Decision|0|||
125655042|NCT02335411|452023016|FG002|Overall Study|Physician Decision|0|||
125655043|NCT02335411|452023014|FG000|Overall Study|Protocol Violation|1|||
125655044|NCT02335411|452023015|FG001|Overall Study|Protocol Violation|0|||
125655045|NCT02335411|452023016|FG002|Overall Study|Protocol Violation|0|||
125655046|NCT02335411|452023014|FG000|Overall Study|Withdrawal by Subject|11|||
125655047|NCT02335411|452023015|FG001|Overall Study|Withdrawal by Subject|0|||
125655048|NCT02335411|452023016|FG002|Overall Study|Withdrawal by Subject|3|||
125655049|NCT02335411|452023014|FG000|Overall Study|Sponsor Decision|12|||
125655050|NCT02335411|452023015|FG001|Overall Study|Sponsor Decision|3|||
125655051|NCT02335411|452023016|FG002|Overall Study|Sponsor Decision|2|||
125655052|NCT02335411|452023014|FG000|Overall Study|Adverse Event|9|||
125655053|NCT02335411|452023015|FG001|Overall Study|Adverse Event|0|||
125655054|NCT02335411|452023016|FG002|Overall Study|Adverse Event|0|||
125655055|NCT01891669|452023017|FG000|Overall Study|Death|0|||
125655056|NCT01891669|452023018|FG001|Overall Study|Death|0|||
125655057|NCT01891669|452023019|FG002|Overall Study|Death|0|||
125655058|NCT01891669|452023020|FG003|Overall Study|Death|0|||
125655059|NCT01891669|452023021|FG004|Overall Study|Death|0|||
125655060|NCT01891669|452023022|FG005|Overall Study|Death|0|||
125655061|NCT01891669|452023023|FG006|Overall Study|Death|0|||
125655062|NCT01891669|452023024|FG007|Overall Study|Death|1|||
125655063|NCT01891669|452023025|FG008|Overall Study|Death|0|||
125655064|NCT01891669|452023026|FG009|Overall Study|Death|1|||
125655065|NCT01891669|452023017|FG000|Overall Study|Withdrawal by Subject|1|||
125655066|NCT01891669|452023018|FG001|Overall Study|Withdrawal by Subject|1|||
125655067|NCT01891669|452023019|FG002|Overall Study|Withdrawal by Subject|0|||
125655068|NCT01891669|452023020|FG003|Overall Study|Withdrawal by Subject|0|||
125655069|NCT01891669|452023021|FG004|Overall Study|Withdrawal by Subject|0|||
125655070|NCT01891669|452023022|FG005|Overall Study|Withdrawal by Subject|0|||
125655071|NCT01891669|452023023|FG006|Overall Study|Withdrawal by Subject|1|||
125655072|NCT01891669|452023024|FG007|Overall Study|Withdrawal by Subject|2|||
125655073|NCT01891669|452023025|FG008|Overall Study|Withdrawal by Subject|1|||
125540468|NCT04927247|451607640|FG001|Overall Study|Adverse Event|0|||
125314801|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
125655074|NCT01891669|452023026|FG009|Overall Study|Withdrawal by Subject|1|||
125655075|NCT01891669|452023017|FG000|Overall Study|Other|1|||
125655076|NCT01891669|452023018|FG001|Overall Study|Other|0|||
125655077|NCT01891669|452023019|FG002|Overall Study|Other|0|||
125655078|NCT01891669|452023020|FG003|Overall Study|Other|0|||
125655079|NCT01891669|452023021|FG004|Overall Study|Other|0|||
125655080|NCT01891669|452023022|FG005|Overall Study|Other|0|||
125655081|NCT01891669|452023023|FG006|Overall Study|Other|0|||
125655082|NCT01891669|452023024|FG007|Overall Study|Other|1|||
125655083|NCT01891669|452023025|FG008|Overall Study|Other|0|||
125655084|NCT01891669|452023026|FG009|Overall Study|Other|0|||
125655085|NCT03075826|452023028|FG000|Overall Study|Withdrawal by Subject|1|||
125655086|NCT03075826|452023028|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
125655087|NCT00650806|452023029|FG000|Overall Study|Adverse Event|0|||
125655088|NCT00650806|452023030|FG001|Overall Study|Adverse Event|5|||
125655089|NCT00650806|452023031|FG002|Overall Study|Adverse Event|3|||
125655090|NCT00650806|452023032|FG003|Overall Study|Adverse Event|4|||
125655091|NCT00650806|452023029|FG000|Overall Study|Lost to Follow-up|7|||
125655092|NCT00650806|452023030|FG001|Overall Study|Lost to Follow-up|6|||
125655093|NCT00650806|452023031|FG002|Overall Study|Lost to Follow-up|11|||
125655094|NCT00650806|452023032|FG003|Overall Study|Lost to Follow-up|10|||
125655095|NCT00650806|452023029|FG000|Overall Study|Protocol Violation|0|||
125655096|NCT00650806|452023030|FG001|Overall Study|Protocol Violation|0|||
125655097|NCT00650806|452023031|FG002|Overall Study|Protocol Violation|0|||
125655098|NCT00650806|452023032|FG003|Overall Study|Protocol Violation|1|||
125655099|NCT00650806|452023029|FG000|Overall Study|Pregnancy|0|||
125655100|NCT00650806|452023030|FG001|Overall Study|Pregnancy|0|||
125655101|NCT00650806|452023031|FG002|Overall Study|Pregnancy|0|||
125655102|NCT00650806|452023032|FG003|Overall Study|Pregnancy|1|||
125655103|NCT00650806|452023029|FG000|Overall Study|Withdrawal by Subject|7|||
125655104|NCT00650806|452023030|FG001|Overall Study|Withdrawal by Subject|5|||
125655105|NCT00650806|452023031|FG002|Overall Study|Withdrawal by Subject|8|||
125655106|NCT00650806|452023032|FG003|Overall Study|Withdrawal by Subject|6|||
125655107|NCT00650806|452023029|FG000|Overall Study|Noncompliance with study drug regimen|1|||
125655108|NCT00650806|452023030|FG001|Overall Study|Noncompliance with study drug regimen|1|||
125655109|NCT00650806|452023031|FG002|Overall Study|Noncompliance with study drug regimen|0|||
125655110|NCT00650806|452023032|FG003|Overall Study|Noncompliance with study drug regimen|0|||
125655111|NCT00650806|452023029|FG000|Overall Study|Study terminated by sponsor|2|||
125655112|NCT00650806|452023030|FG001|Overall Study|Study terminated by sponsor|3|||
125655113|NCT00650806|452023031|FG002|Overall Study|Study terminated by sponsor|5|||
125655114|NCT00650806|452023032|FG003|Overall Study|Study terminated by sponsor|4|||
125655115|NCT00650806|452023029|FG000|Overall Study|Other|1|||
125655116|NCT00650806|452023030|FG001|Overall Study|Other|1|||
125655117|NCT00650806|452023031|FG002|Overall Study|Other|2|||
125655118|NCT00650806|452023032|FG003|Overall Study|Other|0|||
125655119|NCT03707145|452023033|FG000|Overall Study|Lost to Follow-up|0|||
125655120|NCT03707145|452023034|FG001|Overall Study|Lost to Follow-up|1|||
125655121|NCT03707145|452023035|FG002|Overall Study|Lost to Follow-up|1|||
125655122|NCT03707145|452023036|FG003|Overall Study|Lost to Follow-up|0|||
125655123|NCT04636437|452023037|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
125655124|NCT04636437|452023038|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
125655125|NCT04636437|452023039|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
125655126|NCT04636437|452023037|FG000|Overall Study|Started weight loss drug/program|2|||
125655127|NCT04636437|452023038|FG001|Overall Study|Started weight loss drug/program|1|||
125655128|NCT04636437|452023039|FG002|Overall Study|Started weight loss drug/program|1|||
125655129|NCT04636437|452023037|FG000|Overall Study|Lost to Follow-up|3|||
125655130|NCT04636437|452023038|FG001|Overall Study|Lost to Follow-up|1|||
125655131|NCT04636437|452023039|FG002|Overall Study|Lost to Follow-up|4|||
125655132|NCT04636437|452023037|FG000|Overall Study|Participant or physician decision|3|||
125314802|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
125314803|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
125314804|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
125655133|NCT04636437|452023038|FG001|Overall Study|Participant or physician decision|1|||
125655134|NCT04636437|452023039|FG002|Overall Study|Participant or physician decision|1|||
125655135|NCT00352664|452023041|FG000|Overall Study|Withdrawal by Subject|7|||
125655136|NCT00352664|452023042|FG001|Overall Study|Withdrawal by Subject|0|||
125655137|NCT03075215|452023045|FG000|12-Month Primary Endpoint|Death|152|||
125655138|NCT03075215|452023045|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
125655139|NCT03075215|452023045|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
125655140|NCT03075215|452023045|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
125655141|NCT02146365|452023046|FG000|Overall Study|Lost to Follow-up|2|||
125655142|NCT02146365|452023047|FG001|Overall Study|Lost to Follow-up|1|||
125655143|NCT02146365|452023048|FG002|Overall Study|Lost to Follow-up|3|||
125655144|NCT02146365|452023049|FG003|Overall Study|Lost to Follow-up|3|||
125655145|NCT02146365|452023050|FG004|Overall Study|Lost to Follow-up|1|||
125655146|NCT02146365|452023051|FG005|Overall Study|Lost to Follow-up|1|||
125655147|NCT02146365|452023052|FG006|Overall Study|Lost to Follow-up|0|||
125655148|NCT02146365|452023053|FG007|Overall Study|Lost to Follow-up|1|||
125655149|NCT02146365|452023046|FG000|Overall Study|Withdrawal by Subject|1|||
125655150|NCT02146365|452023047|FG001|Overall Study|Withdrawal by Subject|2|||
125655151|NCT02146365|452023048|FG002|Overall Study|Withdrawal by Subject|1|||
125655152|NCT02146365|452023049|FG003|Overall Study|Withdrawal by Subject|5|||
125314805|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
125314806|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
125314807|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
125314808|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
125314809|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
125314810|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
125655153|NCT02146365|452023050|FG004|Overall Study|Withdrawal by Subject|1|||
125655154|NCT02146365|452023051|FG005|Overall Study|Withdrawal by Subject|0|||
125655155|NCT02146365|452023052|FG006|Overall Study|Withdrawal by Subject|0|||
125655156|NCT02146365|452023053|FG007|Overall Study|Withdrawal by Subject|0|||
125655157|NCT02146365|452023046|FG000|Overall Study|Unable to Comply with Protocol|0|||
125655158|NCT02146365|452023047|FG001|Overall Study|Unable to Comply with Protocol|1|||
125655159|NCT02146365|452023048|FG002|Overall Study|Unable to Comply with Protocol|1|||
125655160|NCT02146365|452023049|FG003|Overall Study|Unable to Comply with Protocol|0|||
125655161|NCT02146365|452023050|FG004|Overall Study|Unable to Comply with Protocol|0|||
125655162|NCT02146365|452023051|FG005|Overall Study|Unable to Comply with Protocol|0|||
125655163|NCT02146365|452023052|FG006|Overall Study|Unable to Comply with Protocol|0|||
125655164|NCT02146365|452023053|FG007|Overall Study|Unable to Comply with Protocol|0|||
125655165|NCT02146365|452023046|FG000|Overall Study|Other|1|||
125655166|NCT02146365|452023047|FG001|Overall Study|Other|0|||
125655167|NCT02146365|452023048|FG002|Overall Study|Other|2|||
125655168|NCT02146365|452023049|FG003|Overall Study|Other|1|||
125655169|NCT02146365|452023050|FG004|Overall Study|Other|0|||
125655170|NCT02146365|452023051|FG005|Overall Study|Other|0|||
125655171|NCT02146365|452023052|FG006|Overall Study|Other|0|||
125655172|NCT02146365|452023053|FG007|Overall Study|Other|0|||
125655173|NCT01843660|452023054|FG000|Overall Study|Other|30|||
125655174|NCT01977482|452023055|FG000|Overall Study|Adverse Event|0|||
125655175|NCT01977482|452023056|FG001|Overall Study|Adverse Event|1|||
125655176|NCT01977482|452023057|FG002|Overall Study|Adverse Event|1|||
125655177|NCT01977482|452023058|FG003|Overall Study|Adverse Event|0|||
125655178|NCT01977482|452023059|FG004|Overall Study|Adverse Event|2|||
125314811|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
125314812|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
125314813|NCT02365649|450781747|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314814|NCT02365649|450781748|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314815|NCT02365649|450781749|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
125314816|NCT02365649|450781750|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314817|NCT02365649|450781751|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314818|NCT02365649|450781752|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314819|NCT02365649|450781753|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314820|NCT02365649|450781754|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314821|NCT02365649|450781755|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314822|NCT02365649|450781756|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
125314823|NCT02365649|450781747|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314824|NCT02365649|450781748|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314825|NCT02365649|450781749|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314826|NCT02365649|450781750|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314827|NCT02365649|450781751|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314828|NCT02365649|450781752|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125540469|NCT00591851|451607641|FG000|Overall Study|Withdrawal by Subject|3|||
125540470|NCT00591851|451607641|FG000|Overall Study|Adverse Event|2|||
125540471|NCT00591851|451607641|FG000|Overall Study|Progressive Disease|1|||
125655179|NCT01977482|452023060|FG005|Overall Study|Adverse Event|0|||
125655180|NCT01977482|452023055|FG000|Overall Study|Lost to Follow-up|1|||
125655181|NCT01977482|452023056|FG001|Overall Study|Lost to Follow-up|0|||
125655182|NCT01977482|452023057|FG002|Overall Study|Lost to Follow-up|0|||
125655183|NCT01977482|452023058|FG003|Overall Study|Lost to Follow-up|0|||
125655184|NCT01977482|452023059|FG004|Overall Study|Lost to Follow-up|0|||
125655185|NCT01977482|452023060|FG005|Overall Study|Lost to Follow-up|0|||
125655186|NCT01977482|452023055|FG000|Overall Study|Physician Decision|0|||
125655187|NCT01977482|452023056|FG001|Overall Study|Physician Decision|1|||
125655188|NCT01977482|452023057|FG002|Overall Study|Physician Decision|0|||
125655189|NCT01977482|452023058|FG003|Overall Study|Physician Decision|0|||
125655190|NCT01977482|452023059|FG004|Overall Study|Physician Decision|0|||
125655191|NCT01977482|452023060|FG005|Overall Study|Physician Decision|0|||
125655192|NCT01977482|452023055|FG000|Overall Study|Protocol Violation|0|||
125314829|NCT02365649|450781753|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
125314830|NCT02365649|450781754|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314831|NCT02365649|450781755|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125314832|NCT02365649|450781756|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
125655193|NCT01977482|452023056|FG001|Overall Study|Protocol Violation|0|||
125655194|NCT01977482|452023057|FG002|Overall Study|Protocol Violation|1|||
125655195|NCT01977482|452023058|FG003|Overall Study|Protocol Violation|0|||
125655196|NCT01977482|452023059|FG004|Overall Study|Protocol Violation|0|||
125655197|NCT01977482|452023060|FG005|Overall Study|Protocol Violation|0|||
125655198|NCT01977482|452023055|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
125655199|NCT01977482|452023056|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
125655200|NCT01977482|452023057|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
125655201|NCT01977482|452023058|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
125655202|NCT01977482|452023059|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
125655203|NCT01977482|452023060|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
125655204|NCT01977482|452023055|FG000|Overall Study|Withdrawal by Subject|2|||
125655205|NCT01977482|452023056|FG001|Overall Study|Withdrawal by Subject|4|||
125655206|NCT01977482|452023057|FG002|Overall Study|Withdrawal by Subject|1|||
125655207|NCT01977482|452023058|FG003|Overall Study|Withdrawal by Subject|3|||
125655208|NCT01977482|452023059|FG004|Overall Study|Withdrawal by Subject|1|||
125655209|NCT01977482|452023060|FG005|Overall Study|Withdrawal by Subject|5|||
125655210|NCT00209560|452023061|FG000|Overall Study|Lack of Efficacy|1|||
125655211|NCT00209560|452023062|FG001|Overall Study|Lack of Efficacy|0|||
125655212|NCT00795886|452023063|FG000|Overall Study|Death|10|||
125655213|NCT05554471|452023073|FG000|Overall Study|Physician Decision|2|||
125655214|NCT05554471|452023074|FG001|Overall Study|Physician Decision|1|||
125655215|NCT05554471|452023073|FG000|Overall Study|Lost to Follow-up|2|||
125655216|NCT05554471|452023074|FG001|Overall Study|Lost to Follow-up|1|||
125655217|NCT05554471|452023073|FG000|Overall Study|Death|0|||
125655218|NCT05554471|452023074|FG001|Overall Study|Death|1|||
125655219|NCT03188991|452023075|FG000|Overall Study|Withdrawal by Subject|0|||
125655220|NCT03188991|452023076|FG001|Overall Study|Withdrawal by Subject|0|||
125655221|NCT03188991|452023077|FG002|Overall Study|Withdrawal by Subject|0|||
125655222|NCT03188991|452023078|FG003|Overall Study|Withdrawal by Subject|1|||
125655223|NCT04502862|452023081|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
125655224|NCT04502862|452023082|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
125655225|NCT04502862|452023081|FG000|Overall Study|Withdrawal by Subject|1|||
125655226|NCT04502862|452023082|FG001|Overall Study|Withdrawal by Subject|0|||
125655227|NCT04502862|452023081|FG000|Overall Study|Adverse Event|1|||
125655228|NCT04502862|452023082|FG001|Overall Study|Adverse Event|1|||
125655229|NCT02856282|452024434|FG000|Overall Study|Withdrawal by Subject|1|||
125655230|NCT02074982|452024435|FG000|Overall Study|Adverse Event|15|||
125655231|NCT02074982|452024436|FG001|Overall Study|Adverse Event|7|||
125655232|NCT02074982|452024435|FG000|Overall Study|Lack of Efficacy|6|||
125655233|NCT02074982|452024436|FG001|Overall Study|Lack of Efficacy|1|||
125314833|NCT02365649|450781747|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314834|NCT02365649|450781748|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314835|NCT02365649|450781749|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314836|NCT02365649|450781750|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314837|NCT02365649|450781751|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314838|NCT02365649|450781752|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314839|NCT02365649|450781753|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
125314840|NCT02365649|450781754|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
125314841|NCT02365649|450781755|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
125314842|NCT02365649|450781756|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
125314843|NCT02365649|450781747|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
125314844|NCT02365649|450781748|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
125314845|NCT02365649|450781749|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
125314846|NCT02365649|450781750|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
125314847|NCT02365649|450781751|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
125314848|NCT02365649|450781752|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
125655234|NCT02074982|452024435|FG000|Overall Study|Lost to Follow-up|9|||
125655235|NCT02074982|452024436|FG001|Overall Study|Lost to Follow-up|10|||
125655236|NCT02074982|452024435|FG000|Overall Study|Non-compliance with study treatment|0|||
125655237|NCT02074982|452024436|FG001|Overall Study|Non-compliance with study treatment|2|||
125655238|NCT02074982|452024435|FG000|Overall Study|Physician Decision|1|||
125655239|NCT02074982|452024436|FG001|Overall Study|Physician Decision|1|||
125655240|NCT02074982|452024435|FG000|Overall Study|Pregnancy|1|||
125655241|NCT02074982|452024436|FG001|Overall Study|Pregnancy|2|||
125655242|NCT02074982|452024435|FG000|Overall Study|Protocol deviation|4|||
125655243|NCT02074982|452024436|FG001|Overall Study|Protocol deviation|3|||
125655244|NCT02074982|452024435|FG000|Overall Study|Technical problems|0|||
125655245|NCT02074982|452024436|FG001|Overall Study|Technical problems|2|||
125314849|NCT02365649|450781753|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
125314850|NCT02365649|450781754|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
125314851|NCT02365649|450781755|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
125314852|NCT02365649|450781756|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
125314853|NCT02365649|450781747|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314854|NCT02365649|450781748|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314855|NCT02365649|450781749|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314856|NCT02365649|450781750|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314857|NCT02365649|450781751|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314858|NCT02365649|450781752|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314859|NCT02365649|450781753|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
125314860|NCT02365649|450781754|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
125314861|NCT02365649|450781755|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
125314862|NCT02365649|450781756|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
125314863|NCT02365649|450781747|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314864|NCT02365649|450781748|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314865|NCT02365649|450781749|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314866|NCT02365649|450781750|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314867|NCT02365649|450781751|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314868|NCT02365649|450781752|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314869|NCT02365649|450781753|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
125314870|NCT02365649|450781754|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125314871|NCT02365649|450781755|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
125314872|NCT02365649|450781756|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
125655246|NCT02074982|452024435|FG000|Overall Study|Subject/guardian decision|15|||
125655247|NCT02074982|452024436|FG001|Overall Study|Subject/guardian decision|24|||
125655248|NCT02074982|452024435|FG000|Overall Study|Death|0|||
125655249|NCT02074982|452024436|FG001|Overall Study|Death|2|||
125655250|NCT02094573|452024441|FG000|Overall Study|Adverse Event|4|||
125655251|NCT02094573|452024442|FG001|Overall Study|Adverse Event|14|||
125655252|NCT02094573|452024441|FG000|Overall Study|Clinical Progressive Disease|9|||
125655253|NCT02094573|452024442|FG001|Overall Study|Clinical Progressive Disease|13|||
125655254|NCT02094573|452024441|FG000|Overall Study|Death|11|||
125655255|NCT02094573|452024442|FG001|Overall Study|Death|3|||
125655256|NCT02094573|452024441|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
125655257|NCT02094573|452024442|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
125655258|NCT02094573|452024441|FG000|Overall Study|Non-compliance with Study Drug|1|||
125655259|NCT02094573|452024442|FG001|Overall Study|Non-compliance with Study Drug|1|||
125655260|NCT02094573|452024441|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
125655261|NCT02094573|452024442|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
125655262|NCT02094573|452024441|FG000|Overall Study|Physician Decision|4|||
125655263|NCT02094573|452024442|FG001|Overall Study|Physician Decision|4|||
125655264|NCT02094573|452024441|FG000|Overall Study|Site Terminated by Sponsor|10|||
125655265|NCT02094573|452024442|FG001|Overall Study|Site Terminated by Sponsor|17|||
125655266|NCT02094573|452024441|FG000|Overall Study|Withdrawal by Subject|6|||
125655267|NCT02094573|452024442|FG001|Overall Study|Withdrawal by Subject|8|||
125655268|NCT02094573|452024441|FG000|Overall Study|Randomized but not Treated|3|||
125655269|NCT02094573|452024442|FG001|Overall Study|Randomized but not Treated|0|||
125655270|NCT01160770|452024443|FG000|Overall Study|Adverse Event|10|||
125655271|NCT01160770|452024443|FG000|Overall Study|Protocol Violation|2|||
125655272|NCT01160770|452024443|FG000|Overall Study|Subject/parent/caregiver request|33|||
125655273|NCT01160770|452024443|FG000|Overall Study|Physician Decision|1|||
125655274|NCT01160770|452024443|FG000|Overall Study|Lost to Follow-up|7|||
125655275|NCT01160770|452024443|FG000|Overall Study|Study termination or sponsor request|1|||
125655276|NCT01160770|452024443|FG000|Overall Study|Death|9|||
125655277|NCT01160770|452024443|FG000|Overall Study|Lack of Efficacy|15|||
125655278|NCT01160770|452024443|FG000|Overall Study|Other Reasons|1|||
125655279|NCT00848965|452024448|FG000|Overall Study|Adverse Event|1|||
125655280|NCT00848965|452024448|FG000|Overall Study|Withdrawal by Subject|1|||
125655281|NCT01976104|452024449|FG000|Overall Study|Adverse Event|0|||
125655282|NCT01976104|452024450|FG001|Overall Study|Adverse Event|0|||
125655283|NCT01976104|452024451|FG002|Overall Study|Adverse Event|1|||
125655284|NCT01976104|452024452|FG003|Overall Study|Adverse Event|0|||
125655285|NCT01976104|452024449|FG000|Overall Study|Lost to Follow-up|3|||
125655286|NCT01976104|452024450|FG001|Overall Study|Lost to Follow-up|0|||
125655287|NCT01976104|452024451|FG002|Overall Study|Lost to Follow-up|1|||
125655288|NCT01976104|452024452|FG003|Overall Study|Lost to Follow-up|1|||
125655289|NCT01976104|452024449|FG000|Overall Study|Subject Choice|0|||
125655290|NCT01976104|452024450|FG001|Overall Study|Subject Choice|1|||
125655291|NCT01976104|452024451|FG002|Overall Study|Subject Choice|0|||
125655292|NCT01976104|452024452|FG003|Overall Study|Subject Choice|1|||
125655293|NCT01976104|452024449|FG000|Overall Study|Withdrawal by Subject|3|||
125655294|NCT01976104|452024450|FG001|Overall Study|Withdrawal by Subject|0|||
125655295|NCT01976104|452024451|FG002|Overall Study|Withdrawal by Subject|0|||
125655296|NCT01976104|452024452|FG003|Overall Study|Withdrawal by Subject|1|||
125655297|NCT01976104|452024449|FG000|Overall Study|Other|0|||
125655298|NCT01976104|452024450|FG001|Overall Study|Other|1|||
125655299|NCT01976104|452024451|FG002|Overall Study|Other|0|||
125655300|NCT01976104|452024452|FG003|Overall Study|Other|0|||
125655301|NCT01317199|452024453|FG000|Dose-escalation Phase 1|Physician Decision|5|||
125655302|NCT01317199|452024454|FG001|Dose-escalation Phase 1|Physician Decision|0|||
125655303|NCT01317199|452024455|FG002|Dose-escalation Phase 1|Physician Decision|0|||
125655304|NCT01317199|452024456|FG003|Dose-escalation Phase 1|Physician Decision|0|||
125655305|NCT01317199|452024453|FG000|Dose-escalation Phase 1|Disease progression|1|||
125655306|NCT01317199|452024454|FG001|Dose-escalation Phase 1|Disease progression|0|||
125655307|NCT01317199|452024455|FG002|Dose-escalation Phase 1|Disease progression|0|||
125655308|NCT01317199|452024456|FG003|Dose-escalation Phase 1|Disease progression|0|||
125655309|NCT01317199|452024453|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
125655310|NCT01317199|452024454|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
125655311|NCT01317199|452024455|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
125655312|NCT01317199|452024456|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
125655313|NCT01317199|452024453|FG000|Randomized Phase 2|Disease progression|0|||
125655314|NCT01317199|452024454|FG001|Randomized Phase 2|Disease progression|3|||
125655315|NCT01317199|452024455|FG002|Randomized Phase 2|Disease progression|7|||
125655316|NCT01317199|452024456|FG003|Randomized Phase 2|Disease progression|5|||
125655317|NCT01317199|452024453|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
125655318|NCT01317199|452024454|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
125655319|NCT01317199|452024455|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
125655320|NCT01317199|452024456|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
125655321|NCT01317199|452024453|FG000|Randomized Phase 2|Adverse Event|0|||
125655322|NCT01317199|452024454|FG001|Randomized Phase 2|Adverse Event|0|||
125655323|NCT01317199|452024455|FG002|Randomized Phase 2|Adverse Event|0|||
125655324|NCT01317199|452024456|FG003|Randomized Phase 2|Adverse Event|1|||
125655325|NCT01317199|452024453|FG000|Randomized Phase 2|Comorbidities|0|||
125655326|NCT01317199|452024454|FG001|Randomized Phase 2|Comorbidities|2|||
125655327|NCT01317199|452024455|FG002|Randomized Phase 2|Comorbidities|2|||
125655328|NCT01317199|452024456|FG003|Randomized Phase 2|Comorbidities|2|||
125655329|NCT01317199|452024453|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
125655330|NCT01317199|452024454|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
125655331|NCT01317199|452024455|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
125655332|NCT01317199|452024456|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
125655333|NCT01317199|452024453|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
125655334|NCT01317199|452024454|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
125655335|NCT01317199|452024455|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
125655336|NCT01317199|452024456|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
125655337|NCT01317199|452024453|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
125655338|NCT01317199|452024454|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
125655339|NCT01317199|452024455|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
125655340|NCT01317199|452024456|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
125655341|NCT01317199|452024453|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
125655342|NCT01317199|452024454|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
125655343|NCT01317199|452024455|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
125655344|NCT01317199|452024456|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
125655345|NCT01353209|452024457|FG000|Overall Study|Adverse Event|1|||
125655346|NCT01353209|452024458|FG001|Overall Study|Adverse Event|1|||
125655347|NCT01301625|452024471|FG000|Overall Study|Death|5|||
125655348|NCT01301625|452024471|FG000|Overall Study|Not Due|21|||
125655349|NCT01301625|452024471|FG000|Overall Study|Expected|8|||
125655350|NCT01301625|452024471|FG000|Overall Study|Lost to Follow-up|1|||
125655351|NCT03237325|452024474|FG000|Overall Study|Lost to Follow-up|3|||
125655352|NCT03237325|452024475|FG001|Overall Study|Lost to Follow-up|5|||
125655353|NCT03237325|452024474|FG000|Overall Study|Physician Decision|2|||
125655354|NCT03237325|452024475|FG001|Overall Study|Physician Decision|4|||
125655355|NCT03237325|452024474|FG000|Overall Study|Withdrawal by Subject|9|||
125655356|NCT03237325|452024475|FG001|Overall Study|Withdrawal by Subject|12|||
125655357|NCT03237325|452024474|FG000|Overall Study|Noncompliance with Study Procedures|1|||
125655358|NCT03237325|452024475|FG001|Overall Study|Noncompliance with Study Procedures|1|||
125655359|NCT03237325|452024474|FG000|Overall Study|Termination by Sponsor|0|||
125655360|NCT03237325|452024475|FG001|Overall Study|Termination by Sponsor|1|||
125655361|NCT03237325|452024474|FG000|Overall Study|Reason other than described|0|||
125655362|NCT03237325|452024475|FG001|Overall Study|Reason other than described|2|||
125655363|NCT02684370|452024476|FG000|Part A|Adverse Event|2|||
125655364|NCT02684370|452024477|FG001|Part A|Adverse Event|0|||
125655365|NCT02684370|452024478|FG002|Part A|Adverse Event|1|||
125655366|NCT02684370|452024479|FG003|Part A|Adverse Event|0|||
125655367|NCT02684370|452024480|FG004|Part A|Adverse Event|0|||
125655368|NCT02684370|452024481|FG005|Part A|Adverse Event|0|||
125655369|NCT02684370|452024476|FG000|Part A|Lost to Follow-up|1|||
125655370|NCT02684370|452024477|FG001|Part A|Lost to Follow-up|1|||
125655371|NCT02684370|452024478|FG002|Part A|Lost to Follow-up|0|||
125655372|NCT02684370|452024479|FG003|Part A|Lost to Follow-up|0|||
125655373|NCT02684370|452024480|FG004|Part A|Lost to Follow-up|0|||
125655374|NCT02684370|452024481|FG005|Part A|Lost to Follow-up|0|||
125655375|NCT02684370|452024476|FG000|Part A|Subject Withdrawal|1|||
125655376|NCT02684370|452024477|FG001|Part A|Subject Withdrawal|0|||
125655377|NCT02684370|452024478|FG002|Part A|Subject Withdrawal|3|||
125655378|NCT02684370|452024479|FG003|Part A|Subject Withdrawal|0|||
125655379|NCT02684370|452024480|FG004|Part A|Subject Withdrawal|0|||
125655380|NCT02684370|452024481|FG005|Part A|Subject Withdrawal|0|||
125655381|NCT02684370|452024476|FG000|Part A|Other|0|||
125655382|NCT02684370|452024477|FG001|Part A|Other|0|||
125655383|NCT02684370|452024478|FG002|Part A|Other|1|||
125655384|NCT02684370|452024479|FG003|Part A|Other|0|||
125655385|NCT02684370|452024480|FG004|Part A|Other|0|||
125655386|NCT02684370|452024481|FG005|Part A|Other|0|||
125655387|NCT02684370|452024476|FG000|Part B|Adverse Event|0|||
125655388|NCT02684370|452024477|FG001|Part B|Adverse Event|0|||
125655389|NCT02684370|452024478|FG002|Part B|Adverse Event|0|||
125655390|NCT02684370|452024479|FG003|Part B|Adverse Event|0|||
125655391|NCT02684370|452024480|FG004|Part B|Adverse Event|2|||
125655392|NCT02684370|452024481|FG005|Part B|Adverse Event|1|||
125655393|NCT02684370|452024476|FG000|Part B|Lost to Follow-up|0|||
125655394|NCT02684370|452024477|FG001|Part B|Lost to Follow-up|0|||
125655395|NCT02684370|452024478|FG002|Part B|Lost to Follow-up|0|||
125655396|NCT02684370|452024479|FG003|Part B|Lost to Follow-up|1|||
125655397|NCT02684370|452024480|FG004|Part B|Lost to Follow-up|2|||
125655398|NCT02684370|452024481|FG005|Part B|Lost to Follow-up|5|||
125655399|NCT02684370|452024476|FG000|Part B|Subject Withdrawal|0|||
125655400|NCT02684370|452024477|FG001|Part B|Subject Withdrawal|0|||
125655401|NCT02684370|452024478|FG002|Part B|Subject Withdrawal|0|||
125655402|NCT02684370|452024479|FG003|Part B|Subject Withdrawal|1|||
125655403|NCT02684370|452024480|FG004|Part B|Subject Withdrawal|1|||
125655404|NCT02684370|452024481|FG005|Part B|Subject Withdrawal|2|||
125655405|NCT04221373|452024482|FG000|Overall Study|Physician Decision|4|||
125655406|NCT04221373|452024483|FG001|Overall Study|Physician Decision|0|||
125655407|NCT00183170|452024489|FG000|First Intervention|Did not complete study|1|||
125655408|NCT00183170|452024490|FG001|First Intervention|Did not complete study|0|||
125655409|NCT00183170|452024489|FG000|First Intervention|Did not meet targeted BrAC|1|||
125655410|NCT00183170|452024490|FG001|First Intervention|Did not meet targeted BrAC|0|||
125655411|NCT00183170|452024489|FG000|Washout 1 Week|Did not complete study|6|||
125655412|NCT00183170|452024490|FG001|Washout 1 Week|Did not complete study|8|||
125655413|NCT00183170|452024489|FG000|Second Intervention|Did not complete study|1|||
125655414|NCT00183170|452024490|FG001|Second Intervention|Did not complete study|0|||
125655415|NCT00183170|452024489|FG000|Second Intervention|Did not meet targeted BrAC|0|||
125655416|NCT00183170|452024490|FG001|Second Intervention|Did not meet targeted BrAC|2|||
125655417|NCT00924820|452024491|FG000|Overall Study|Death|2|||
125655418|NCT00924820|452024491|FG000|Overall Study|Ineligible, Screen Failure|5|||
125655419|NCT04983589|452024492|FG000|Overall Study|Withdrawal by Subject|0|||
125655420|NCT04983589|452024493|FG001|Overall Study|Withdrawal by Subject|3|||
125655421|NCT04983589|452024492|FG000|Overall Study|COVID-19 Infection|1|||
125655422|NCT04983589|452024493|FG001|Overall Study|COVID-19 Infection|0|||
125655423|NCT04983589|452024492|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
125655424|NCT04983589|452024493|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
125655425|NCT00761969|452024494|FG000|Overall Study|Death|112|||
125655426|NCT00761969|452024495|FG001|Overall Study|Death|47|||
125655427|NCT00761969|452024494|FG000|Overall Study|Lost to Follow-up|88|||
125655428|NCT00761969|452024495|FG001|Overall Study|Lost to Follow-up|93|||
125655429|NCT00978120|452024496|FG000|Overall Study|Death|0|||
125655430|NCT00978120|452024497|FG001|Overall Study|Death|0|||
125655431|NCT00978120|452024498|FG002|Overall Study|Death|0|||
125655432|NCT00978120|452024499|FG003|Overall Study|Death|1|||
125540472|NCT00760474|451607642|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
125540473|NCT00760474|451607643|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
125540474|NCT00760474|451607642|FG000|Placebo Washout Period|Other|0|||
125540475|NCT00760474|451607643|FG001|Placebo Washout Period|Other|1|||
125540476|NCT00760474|451607642|FG000|Period 2 (P2)|Lost to Follow-up|1|||
125540477|NCT00760474|451607643|FG001|Period 2 (P2)|Lost to Follow-up|0|||
125540478|NCT00760474|451607642|FG000|Period 2 (P2)|Adverse Event|0|||
125540479|NCT00760474|451607643|FG001|Period 2 (P2)|Adverse Event|1|||
125655433|NCT00978120|452024496|FG000|Overall Study|Lost to Follow-up|0|||
125655434|NCT00978120|452024497|FG001|Overall Study|Lost to Follow-up|0|||
125655435|NCT00978120|452024498|FG002|Overall Study|Lost to Follow-up|3|||
125655436|NCT00978120|452024499|FG003|Overall Study|Lost to Follow-up|0|||
125655437|NCT00978120|452024496|FG000|Overall Study|Withdrawal by Subject|2|||
125655438|NCT00978120|452024497|FG001|Overall Study|Withdrawal by Subject|0|||
125655439|NCT00978120|452024498|FG002|Overall Study|Withdrawal by Subject|0|||
125655440|NCT00978120|452024499|FG003|Overall Study|Withdrawal by Subject|0|||
125655441|NCT00978120|452024496|FG000|Overall Study|Moved out of state|0|||
125655442|NCT00978120|452024497|FG001|Overall Study|Moved out of state|0|||
125655443|NCT00978120|452024498|FG002|Overall Study|Moved out of state|0|||
125655444|NCT00978120|452024499|FG003|Overall Study|Moved out of state|1|||
125655445|NCT01068418|452024502|FG000|Overall Study|Physician Decision|12|||
125655446|NCT03155269|452024509|FG000|Overall Study|Withdrawal by Subject|4|||
125655447|NCT03155269|452024510|FG001|Overall Study|Withdrawal by Subject|5|||
125655448|NCT03155269|452024509|FG000|Overall Study|Lost to Follow-up|1|||
125655449|NCT03155269|452024510|FG001|Overall Study|Lost to Follow-up|2|||
125655450|NCT02181673|452024511|FG000|Up to Week 24|Adverse Event|2|||
125655451|NCT02181673|452024512|FG001|Up to Week 24|Adverse Event|0|||
125655452|NCT02181673|452024513|FG002|Up to Week 24|Adverse Event|3|||
125655453|NCT02181673|452024511|FG000|Up to Week 24|Death|1|||
125655454|NCT02181673|452024512|FG001|Up to Week 24|Death|0|||
125655455|NCT02181673|452024513|FG002|Up to Week 24|Death|0|||
125655456|NCT02181673|452024511|FG000|Up to Week 24|Lack of Efficacy|1|||
125655457|NCT02181673|452024512|FG001|Up to Week 24|Lack of Efficacy|0|||
125655458|NCT02181673|452024513|FG002|Up to Week 24|Lack of Efficacy|0|||
125655459|NCT02181673|452024511|FG000|Up to Week 24|Lost to Follow-up|1|||
125655460|NCT02181673|452024512|FG001|Up to Week 24|Lost to Follow-up|0|||
125655461|NCT02181673|452024513|FG002|Up to Week 24|Lost to Follow-up|0|||
125655462|NCT02181673|452024511|FG000|Up to Week 24|Physician Decision|0|||
125655463|NCT02181673|452024512|FG001|Up to Week 24|Physician Decision|0|||
125655464|NCT02181673|452024513|FG002|Up to Week 24|Physician Decision|3|||
125655465|NCT02181673|452024511|FG000|Up to Week 24|Withdrawal by Subject|10|||
125655466|NCT02181673|452024512|FG001|Up to Week 24|Withdrawal by Subject|0|||
125655467|NCT02181673|452024513|FG002|Up to Week 24|Withdrawal by Subject|1|||
125655468|NCT02181673|452024511|FG000|Up to Week 24|Other|2|||
125655469|NCT02181673|452024512|FG001|Up to Week 24|Other|0|||
125314873|NCT01188772|450781763|FG000|Overall Study|Randomized but Not Treated|0|||
125314874|NCT01188772|450781764|FG001|Overall Study|Randomized but Not Treated|1|||
125314875|NCT01188772|450781765|FG002|Overall Study|Randomized but Not Treated|0|||
125314876|NCT01188772|450781766|FG003|Overall Study|Randomized but Not Treated|0|||
125314877|NCT01188772|450781763|FG000|Overall Study|Adverse Event|0|||
125314878|NCT01188772|450781764|FG001|Overall Study|Adverse Event|1|||
125314879|NCT01188772|450781765|FG002|Overall Study|Adverse Event|2|||
125314880|NCT01188772|450781766|FG003|Overall Study|Adverse Event|0|||
125314881|NCT01188772|450781763|FG000|Overall Study|Lost to Follow-up|4|||
125314882|NCT01188772|450781764|FG001|Overall Study|Lost to Follow-up|1|||
125314883|NCT01188772|450781765|FG002|Overall Study|Lost to Follow-up|1|||
125314884|NCT01188772|450781766|FG003|Overall Study|Lost to Follow-up|1|||
125314885|NCT01188772|450781763|FG000|Overall Study|Non-responder|0|||
125314886|NCT01188772|450781764|FG001|Overall Study|Non-responder|0|||
125314887|NCT01188772|450781765|FG002|Overall Study|Non-responder|3|||
125314888|NCT01188772|450781766|FG003|Overall Study|Non-responder|0|||
125314889|NCT01188772|450781763|FG000|Overall Study|Physician Decision|0|||
125314890|NCT01188772|450781764|FG001|Overall Study|Physician Decision|0|||
125314891|NCT01188772|450781765|FG002|Overall Study|Physician Decision|1|||
125314892|NCT01188772|450781766|FG003|Overall Study|Physician Decision|0|||
125314893|NCT01188772|450781763|FG000|Overall Study|Terminated by Sponsor|0|||
125314894|NCT01188772|450781764|FG001|Overall Study|Terminated by Sponsor|0|||
125314895|NCT01188772|450781765|FG002|Overall Study|Terminated by Sponsor|1|||
125314896|NCT01188772|450781766|FG003|Overall Study|Terminated by Sponsor|0|||
125314897|NCT01188772|450781763|FG000|Overall Study|Treatment Failure|0|||
125314898|NCT01188772|450781764|FG001|Overall Study|Treatment Failure|0|||
125314899|NCT01188772|450781765|FG002|Overall Study|Treatment Failure|1|||
125314900|NCT01188772|450781766|FG003|Overall Study|Treatment Failure|0|||
125314901|NCT01188772|450781763|FG000|Overall Study|Virologic Failure|1|||
125314902|NCT01188772|450781764|FG001|Overall Study|Virologic Failure|0|||
125314903|NCT01188772|450781765|FG002|Overall Study|Virologic Failure|0|||
125314904|NCT01188772|450781766|FG003|Overall Study|Virologic Failure|0|||
125314905|NCT01188772|450781763|FG000|Overall Study|Withdrawal by Subject|0|||
125314906|NCT01188772|450781764|FG001|Overall Study|Withdrawal by Subject|0|||
125314907|NCT01188772|450781765|FG002|Overall Study|Withdrawal by Subject|2|||
125314908|NCT01188772|450781766|FG003|Overall Study|Withdrawal by Subject|0|||
125314909|NCT03370718|450781773|FG000|Overall Study|Withdrawal by Subject|1|||
125314910|NCT03863509|450781776|FG000|Overall Study|COVID-19 shutdown period|0|||
125314911|NCT03863509|450781777|FG001|Overall Study|COVID-19 shutdown period|4|||
125655470|NCT02181673|452024513|FG002|Up to Week 24|Other|3|||
125655471|NCT02181673|452024511|FG000|Up to Week 24|Randomized not Treated|0|||
125314912|NCT03863509|450781778|FG002|Overall Study|COVID-19 shutdown period|0|||
125314913|NCT03863509|450781776|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
125314914|NCT03863509|450781777|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
125314915|NCT03863509|450781778|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
125314916|NCT03863509|450781776|FG000|Overall Study|Lost to Follow-up|8|||
125314917|NCT03863509|450781777|FG001|Overall Study|Lost to Follow-up|0|||
125314918|NCT03863509|450781778|FG002|Overall Study|Lost to Follow-up|2|||
125655472|NCT02181673|452024512|FG001|Up to Week 24|Randomized not Treated|0|||
125655473|NCT02181673|452024513|FG002|Up to Week 24|Randomized not Treated|1|||
125655474|NCT02181673|452024511|FG000|Week 24-Week 60|Adverse Event|0|||
125655475|NCT02181673|452024512|FG001|Week 24-Week 60|Adverse Event|4|||
125314919|NCT03863509|450781776|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
125655476|NCT02181673|452024513|FG002|Week 24-Week 60|Adverse Event|10|||
125655477|NCT02181673|452024511|FG000|Week 24-Week 60|Other|0|||
125655478|NCT02181673|452024512|FG001|Week 24-Week 60|Other|2|||
125655479|NCT02181673|452024513|FG002|Week 24-Week 60|Other|1|||
125655480|NCT02181673|452024511|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
125655481|NCT02181673|452024512|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
125655482|NCT02181673|452024513|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
125655483|NCT02181673|452024511|FG000|Week 24-Week 60|Pregnancy|0|||
125655484|NCT02181673|452024512|FG001|Week 24-Week 60|Pregnancy|0|||
125655485|NCT02181673|452024513|FG002|Week 24-Week 60|Pregnancy|1|||
125655486|NCT02181673|452024511|FG000|Week 24-Week 60|Lack of Efficacy|0|||
125655487|NCT02181673|452024512|FG001|Week 24-Week 60|Lack of Efficacy|0|||
125655488|NCT02181673|452024513|FG002|Week 24-Week 60|Lack of Efficacy|1|||
125655489|NCT02181673|452024511|FG000|Week 24-Week 60|Lost to Follow-up|0|||
125655490|NCT02181673|452024512|FG001|Week 24-Week 60|Lost to Follow-up|0|||
125655491|NCT02181673|452024513|FG002|Week 24-Week 60|Lost to Follow-up|1|||
125655492|NCT02181673|452024511|FG000|Week 24-Week 60|Physician Decision|0|||
125655493|NCT02181673|452024512|FG001|Week 24-Week 60|Physician Decision|0|||
125655494|NCT02181673|452024513|FG002|Week 24-Week 60|Physician Decision|1|||
125655495|NCT00138658|452024514|FG000|Overall Study|Adverse Event|23|||
125655496|NCT00138658|452024514|FG000|Overall Study|Death|1|||
125655497|NCT00138658|452024514|FG000|Overall Study|Disease Progression|21|||
125655498|NCT00138658|452024514|FG000|Overall Study|Physician Decision|11|||
125655499|NCT00138658|452024514|FG000|Overall Study|Withdrawal by Subject|5|||
125655500|NCT03733301|452024517|FG000|Overall Study|Screen Fail|1|||
125655501|NCT03733301|452024518|FG001|Overall Study|Screen Fail|0|||
125655502|NCT03733301|452024519|FG002|Overall Study|Screen Fail|0|||
125655503|NCT03733301|452024517|FG000|Overall Study|Non-compliance|1|||
125655504|NCT03733301|452024518|FG001|Overall Study|Non-compliance|0|||
125655505|NCT03733301|452024519|FG002|Overall Study|Non-compliance|0|||
125655506|NCT03733301|452024517|FG000|Overall Study|Lack of Efficacy|2|||
125655507|NCT03733301|452024518|FG001|Overall Study|Lack of Efficacy|3|||
125655508|NCT03733301|452024519|FG002|Overall Study|Lack of Efficacy|0|||
125655509|NCT03733301|452024517|FG000|Overall Study|Adverse Event|0|||
125655510|NCT03733301|452024518|FG001|Overall Study|Adverse Event|1|||
125655511|NCT03733301|452024519|FG002|Overall Study|Adverse Event|3|||
125655512|NCT03733301|452024517|FG000|Overall Study|Withdrawal by Subject|3|||
125655513|NCT03733301|452024518|FG001|Overall Study|Withdrawal by Subject|5|||
125655514|NCT03733301|452024519|FG002|Overall Study|Withdrawal by Subject|1|||
125655515|NCT04637815|452024520|FG000|Overall Study|Death|1|||
125655516|NCT04637815|452024521|FG001|Overall Study|Death|0|||
125655517|NCT04637815|452024520|FG000|Overall Study|Lost to Follow-up|5|||
125655518|NCT04637815|452024521|FG001|Overall Study|Lost to Follow-up|2|||
125655519|NCT00320801|452024522|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
125655520|NCT00320801|452024523|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
125655521|NCT00320801|452024524|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
125655522|NCT00320801|452024525|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
125655523|NCT00320801|452024522|FG000|Open-label Run-in Period|Adverse Event|33|||
125655524|NCT00320801|452024523|FG001|Open-label Run-in Period|Adverse Event|0|||
125655525|NCT00320801|452024524|FG002|Open-label Run-in Period|Adverse Event|0|||
125655526|NCT00320801|452024525|FG003|Open-label Run-in Period|Adverse Event|0|||
125314920|NCT03863509|450781777|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
125314921|NCT03863509|450781778|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
125314922|NCT03863509|450781776|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
125314923|NCT03863509|450781777|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
125314924|NCT03863509|450781778|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
125314925|NCT01572480|450781781|FG000|Participants Enrolled|Withdrawal by Subject|1|||
125314926|NCT01572480|450781781|FG000|Drug Administration|Discontinued drug/Off Study|1|||
125314927|NCT01572480|450781781|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
125314928|NCT01572480|450781781|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
125314929|NCT06172348|450781782|FG000|Treatment Period 2|Adverse Event|0|||
125314930|NCT06172348|450781783|FG001|Treatment Period 2|Adverse Event|0|||
125314931|NCT06172348|450781784|FG002|Treatment Period 2|Adverse Event|1|||
125655527|NCT00320801|452024522|FG000|Open-label Run-in Period|Administrative|10|||
125655528|NCT00320801|452024523|FG001|Open-label Run-in Period|Administrative|0|||
125655529|NCT00320801|452024524|FG002|Open-label Run-in Period|Administrative|0|||
125655530|NCT00320801|452024525|FG003|Open-label Run-in Period|Administrative|0|||
125655531|NCT00320801|452024522|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
125655532|NCT00320801|452024523|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
125655533|NCT00320801|452024524|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
125655534|NCT00320801|452024525|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
125655535|NCT00320801|452024522|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
125655536|NCT00320801|452024523|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
125655537|NCT00320801|452024524|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
125655538|NCT00320801|452024525|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
125655539|NCT00320801|452024522|FG000|Open-label Run-in Period|Did not qualify|1|||
125655540|NCT00320801|452024523|FG001|Open-label Run-in Period|Did not qualify|0|||
125655541|NCT00320801|452024524|FG002|Open-label Run-in Period|Did not qualify|0|||
125655542|NCT00320801|452024525|FG003|Open-label Run-in Period|Did not qualify|0|||
125655543|NCT00320801|452024522|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125655544|NCT00320801|452024523|FG001|Double-blind Phase|Withdrawal by Subject|0|||
125655545|NCT00320801|452024524|FG002|Double-blind Phase|Withdrawal by Subject|1|||
125655546|NCT00320801|452024525|FG003|Double-blind Phase|Withdrawal by Subject|0|||
125655547|NCT00320801|452024522|FG000|Double-blind Phase|Adverse Event|0|||
125655548|NCT00320801|452024523|FG001|Double-blind Phase|Adverse Event|2|||
125655549|NCT00320801|452024524|FG002|Double-blind Phase|Adverse Event|8|||
125655550|NCT00320801|452024525|FG003|Double-blind Phase|Adverse Event|0|||
125655551|NCT00320801|452024522|FG000|Double-blind Phase|Administrative|0|||
125655552|NCT00320801|452024523|FG001|Double-blind Phase|Administrative|0|||
125655553|NCT00320801|452024524|FG002|Double-blind Phase|Administrative|4|||
125655554|NCT00320801|452024525|FG003|Double-blind Phase|Administrative|0|||
125655555|NCT00320801|452024522|FG000|Double-blind Phase|Lack of Efficacy|0|||
125655556|NCT00320801|452024523|FG001|Double-blind Phase|Lack of Efficacy|9|||
125655557|NCT00320801|452024524|FG002|Double-blind Phase|Lack of Efficacy|1|||
125655558|NCT00320801|452024525|FG003|Double-blind Phase|Lack of Efficacy|0|||
125655559|NCT00320801|452024522|FG000|Extension Phase|Withdrawal by Subject|0|||
125655560|NCT00320801|452024523|FG001|Extension Phase|Withdrawal by Subject|0|||
125655561|NCT00320801|452024524|FG002|Extension Phase|Withdrawal by Subject|0|||
125655562|NCT00320801|452024525|FG003|Extension Phase|Withdrawal by Subject|6|||
125655563|NCT00320801|452024522|FG000|Extension Phase|Adverse Event|0|||
125655564|NCT00320801|452024523|FG001|Extension Phase|Adverse Event|0|||
125655565|NCT00320801|452024524|FG002|Extension Phase|Adverse Event|0|||
125655566|NCT00320801|452024525|FG003|Extension Phase|Adverse Event|8|||
125655567|NCT00320801|452024522|FG000|Extension Phase|Administrative|0|||
125655568|NCT00320801|452024523|FG001|Extension Phase|Administrative|0|||
125655569|NCT00320801|452024524|FG002|Extension Phase|Administrative|0|||
125655570|NCT00320801|452024525|FG003|Extension Phase|Administrative|29|||
125655571|NCT00320801|452024522|FG000|Extension Phase|Lack of Efficacy|0|||
125655572|NCT00320801|452024523|FG001|Extension Phase|Lack of Efficacy|0|||
125655573|NCT00320801|452024524|FG002|Extension Phase|Lack of Efficacy|0|||
125655574|NCT00320801|452024525|FG003|Extension Phase|Lack of Efficacy|2|||
125655575|NCT00320801|452024522|FG000|Extension Phase|Lost to Follow-up|0|||
125655576|NCT00320801|452024523|FG001|Extension Phase|Lost to Follow-up|0|||
125655577|NCT00320801|452024524|FG002|Extension Phase|Lost to Follow-up|0|||
125655578|NCT00320801|452024525|FG003|Extension Phase|Lost to Follow-up|3|||
125655579|NCT00337727|452024526|FG000|Overall Study|Adverse Event|5|||
125655580|NCT00337727|452024527|FG001|Overall Study|Adverse Event|3|||
125655581|NCT00337727|452024526|FG000|Overall Study|Lost to Follow-up|5|||
125655582|NCT00337727|452024527|FG001|Overall Study|Lost to Follow-up|4|||
125655583|NCT00337727|452024526|FG000|Overall Study|Physician Decision|1|||
125655584|NCT00337727|452024527|FG001|Overall Study|Physician Decision|0|||
125655585|NCT00337727|452024526|FG000|Overall Study|Protocol Violation|4|||
125655586|NCT00337727|452024527|FG001|Overall Study|Protocol Violation|0|||
125314932|NCT06172348|450781785|FG003|Treatment Period 2|Adverse Event|0|||
125314933|NCT06172348|450781786|FG004|Treatment Period 2|Adverse Event|0|||
125314934|NCT06172348|450781787|FG005|Treatment Period 2|Adverse Event|0|||
125314935|NCT00191334|450781788|FG000|Overall Study|Adverse Event|4|||
125314936|NCT00191334|450781788|FG000|Overall Study|Disease Progression or Relapse|8|||
125314937|NCT00191334|450781788|FG000|Overall Study|Physician Decision|1|||
125314938|NCT00191334|450781788|FG000|Overall Study|Withdrawal by Subject|4|||
125314939|NCT00866814|450781789|FG000|Overall Study|Lost to Follow-up|12|||
125314940|NCT00866814|450781789|FG000|Overall Study|Adverse Event|2|||
125314941|NCT00866814|450781789|FG000|Overall Study|Physician Decision|1|||
125314942|NCT00866814|450781789|FG000|Overall Study|Death|1|||
125314943|NCT00866814|450781789|FG000|Overall Study|No longer wished to participate|1|||
125314944|NCT00866814|450781789|FG000|Overall Study|Unable to meet follow-up requirements|2|||
125314945|NCT00866814|450781789|FG000|Overall Study|Moved to area without study site|1|||
125314946|NCT01063153|450781790|FG000|Overall Study|Found Ineligible During Screening|2|||
125314947|NCT01063153|450781791|FG001|Overall Study|Found Ineligible During Screening|0|||
125655587|NCT00337727|452024526|FG000|Overall Study|Withdrawal by Subject|3|||
125655588|NCT00337727|452024527|FG001|Overall Study|Withdrawal by Subject|5|||
125655589|NCT00577031|452024528|FG000|Overall Study|Adverse Event|52|||
125314948|NCT01063153|450781790|FG000|Overall Study|Lost to Follow-up|0|||
125314949|NCT01063153|450781791|FG001|Overall Study|Lost to Follow-up|7|||
125655590|NCT00577031|452024528|FG000|Overall Study|Progression of disease|93|||
125655591|NCT00577031|452024528|FG000|Overall Study|Protocol Violation|5|||
125655592|NCT00577031|452024528|FG000|Overall Study|Participant withdrew consent|13|||
125655593|NCT00577031|452024528|FG000|Overall Study|Participant non-compliance|5|||
125655594|NCT00577031|452024528|FG000|Overall Study|Need for surgery|17|||
125314950|NCT01063153|450781790|FG000|Overall Study|Withdrawal by Subject|0|||
125314951|NCT01063153|450781791|FG001|Overall Study|Withdrawal by Subject|1|||
125655595|NCT00577031|452024528|FG000|Overall Study|Medical decision|14|||
125655596|NCT00577031|452024528|FG000|Overall Study|Death|6|||
125655597|NCT06067191|452024530|FG000|Overall Study|Withdrawal by Subject|0|||
125655598|NCT06067191|452024531|FG001|Overall Study|Withdrawal by Subject|1|||
125655599|NCT04764669|452024532|FG000|Overall Study|Adverse Event|1|||
125655600|NCT04764669|452024533|FG001|Overall Study|Adverse Event|0|||
125655601|NCT04764669|452024534|FG002|Overall Study|Adverse Event|1|||
125655602|NCT04764669|452024535|FG003|Overall Study|Adverse Event|0|||
125655603|NCT04764669|452024532|FG000|Overall Study|Subject Choice|0|||
125655604|NCT04764669|452024533|FG001|Overall Study|Subject Choice|0|||
125655605|NCT04764669|452024534|FG002|Overall Study|Subject Choice|1|||
125655606|NCT04764669|452024535|FG003|Overall Study|Subject Choice|0|||
125655607|NCT04764669|452024532|FG000|Overall Study|Withdrawal by Subject|2|||
125655608|NCT04764669|452024533|FG001|Overall Study|Withdrawal by Subject|0|||
125655609|NCT04764669|452024534|FG002|Overall Study|Withdrawal by Subject|0|||
125655610|NCT04764669|452024535|FG003|Overall Study|Withdrawal by Subject|0|||
125655611|NCT00890409|452024538|FG000|Overall Study|Lost to Follow-up|20|||
125655612|NCT00890409|452024539|FG001|Overall Study|Lost to Follow-up|21|||
125655613|NCT01067339|452024540|FG000|Overall Study|Withdrawal by Subject|6|||
125655614|NCT01067339|452024541|FG001|Overall Study|Withdrawal by Subject|5|||
125655615|NCT00769132|452024545|FG000|Period 1|Adverse Event|1|||
125655616|NCT00769132|452024546|FG001|Period 1|Adverse Event|0|||
125655617|NCT00769132|452024547|FG002|Period 1|Adverse Event|0|||
125655618|NCT00769132|452024548|FG003|Period 1|Adverse Event|1|||
125655619|NCT00769132|452024545|FG000|Period 2|Withdrawal by Subject|0|||
125655620|NCT00769132|452024546|FG001|Period 2|Withdrawal by Subject|0|||
125655621|NCT00769132|452024547|FG002|Period 2|Withdrawal by Subject|0|||
125655622|NCT00769132|452024548|FG003|Period 2|Withdrawal by Subject|1|||
125314952|NCT01063153|450781790|FG000|Overall Study|Physician Decision|0|||
125314953|NCT01063153|450781791|FG001|Overall Study|Physician Decision|4|||
125314954|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
125314955|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
125314956|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
125314957|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
125314958|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
125314959|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
125314960|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
125314961|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
125314962|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
125314963|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
125314964|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
125314965|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
125314966|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
125314967|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
125314968|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
125314969|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
125314970|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
125314971|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
125314972|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
125314973|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
125314974|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
125314975|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
125314976|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
125314977|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
125314978|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
125314979|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
125314980|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
125314981|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
125655623|NCT00769132|452024545|FG000|Period 3|Withdrawal by Subject|1|||
125655624|NCT00769132|452024546|FG001|Period 3|Withdrawal by Subject|0|||
125655625|NCT00769132|452024547|FG002|Period 3|Withdrawal by Subject|0|||
125655626|NCT00769132|452024548|FG003|Period 3|Withdrawal by Subject|0|||
125314982|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
125655627|NCT00769132|452024545|FG000|Period 4|Withdrawal by Subject|0|||
125655628|NCT00769132|452024546|FG001|Period 4|Withdrawal by Subject|1|||
125655629|NCT00769132|452024547|FG002|Period 4|Withdrawal by Subject|0|||
125655630|NCT00769132|452024548|FG003|Period 4|Withdrawal by Subject|0|||
125655631|NCT02230332|452024549|FG000|Overall Study|Adverse Event|2|||
125655632|NCT02230332|452024550|FG001|Overall Study|Adverse Event|1|||
125655633|NCT02230332|452024549|FG000|Overall Study|Lost to Follow-up|1|||
125655634|NCT02230332|452024550|FG001|Overall Study|Lost to Follow-up|0|||
125655635|NCT02230332|452024549|FG000|Overall Study|Protocol Violation|1|||
125655636|NCT02230332|452024550|FG001|Overall Study|Protocol Violation|0|||
125655637|NCT00877799|452024552|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
125655638|NCT00877799|452024553|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
125655639|NCT00877799|452024554|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
125655640|NCT00877799|452024555|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
125655641|NCT00877799|452024556|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
125655642|NCT00877799|452024552|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
125655643|NCT00877799|452024553|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
125655644|NCT00877799|452024554|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
125655645|NCT00877799|452024555|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
125655646|NCT00877799|452024556|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
125655647|NCT00877799|452024552|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
125655648|NCT00877799|452024553|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
125655649|NCT00877799|452024554|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
125655650|NCT00877799|452024555|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
125655651|NCT00877799|452024556|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
125655652|NCT00877799|452024552|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
125655653|NCT00877799|452024553|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
125655654|NCT00877799|452024554|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
125655655|NCT00877799|452024555|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
125655656|NCT00877799|452024556|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
125655657|NCT00877799|452024552|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
125655658|NCT00877799|452024553|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
125655659|NCT00877799|452024554|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
125655660|NCT00877799|452024555|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
125655661|NCT00877799|452024556|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
125655662|NCT04054011|452024557|FG000|Overall Study|COVID|3|||
125655663|NCT00669110|452024561|FG000|Overall Study|Adverse Event|4|||
125655664|NCT00669110|452024562|FG001|Overall Study|Adverse Event|3|||
125655665|NCT00669110|452024561|FG000|Overall Study|Caregiver request|3|||
125655666|NCT00669110|452024562|FG001|Overall Study|Caregiver request|2|||
125655667|NCT00669110|452024561|FG000|Overall Study|Physician Decision|0|||
125655668|NCT00669110|452024562|FG001|Overall Study|Physician Decision|1|||
125655669|NCT00669110|452024561|FG000|Overall Study|Lost to Follow-up|1|||
125655670|NCT00669110|452024562|FG001|Overall Study|Lost to Follow-up|0|||
125655671|NCT00669110|452024561|FG000|Overall Study|Protocol Violation|0|||
125655672|NCT00669110|452024562|FG001|Overall Study|Protocol Violation|5|||
125655673|NCT00669110|452024561|FG000|Overall Study|Withdrawal by Subject|0|||
125655674|NCT00669110|452024562|FG001|Overall Study|Withdrawal by Subject|2|||
125655675|NCT00127192|452024563|FG000|Overall Study|Adverse Event|0|||
125655676|NCT00127192|452024564|FG001|Overall Study|Adverse Event|1|||
125655677|NCT00127192|452024565|FG002|Overall Study|Adverse Event|1|||
125655678|NCT00127192|452024566|FG003|Overall Study|Adverse Event|1|||
125655679|NCT00127192|452024567|FG004|Overall Study|Adverse Event|0|||
125655680|NCT00127192|452024563|FG000|Overall Study|Lack of Efficacy|2|||
125655681|NCT00127192|452024564|FG001|Overall Study|Lack of Efficacy|0|||
125655682|NCT00127192|452024565|FG002|Overall Study|Lack of Efficacy|0|||
125655683|NCT00127192|452024566|FG003|Overall Study|Lack of Efficacy|0|||
125655684|NCT00127192|452024567|FG004|Overall Study|Lack of Efficacy|2|||
125655685|NCT00127192|452024563|FG000|Overall Study|Withdrawal by Subject|0|||
125655686|NCT00127192|452024564|FG001|Overall Study|Withdrawal by Subject|0|||
125655687|NCT00127192|452024565|FG002|Overall Study|Withdrawal by Subject|1|||
125655688|NCT00127192|452024566|FG003|Overall Study|Withdrawal by Subject|0|||
125655689|NCT00127192|452024567|FG004|Overall Study|Withdrawal by Subject|3|||
125655690|NCT00127192|452024563|FG000|Overall Study|Adverse event in pre-treatment period|1|||
125655691|NCT00127192|452024564|FG001|Overall Study|Adverse event in pre-treatment period|0|||
125655692|NCT00127192|452024565|FG002|Overall Study|Adverse event in pre-treatment period|0|||
125655693|NCT00127192|452024566|FG003|Overall Study|Adverse event in pre-treatment period|0|||
125655694|NCT00127192|452024567|FG004|Overall Study|Adverse event in pre-treatment period|0|||
125655695|NCT00227591|452024570|FG000|Overall Study|Withdrawal by Subject|1|||
125655696|NCT00077766|452024571|FG000|Overall Study|Adverse Event|1|||
125655697|NCT00077766|452024572|FG001|Overall Study|Adverse Event|1|||
125655698|NCT00077766|452024571|FG000|Overall Study|Withdrawal by Subject|4|||
125655699|NCT00077766|452024572|FG001|Overall Study|Withdrawal by Subject|3|||
125655700|NCT00077766|452024571|FG000|Overall Study|Death|12|||
125655701|NCT00077766|452024572|FG001|Overall Study|Death|10|||
125655702|NCT00077766|452024571|FG000|Overall Study|Lost to Follow-up|2|||
125655703|NCT00077766|452024572|FG001|Overall Study|Lost to Follow-up|0|||
125655704|NCT00077766|452024571|FG000|Overall Study|Protocol Violation|1|||
125655705|NCT00077766|452024572|FG001|Overall Study|Protocol Violation|0|||
125655706|NCT00077766|452024571|FG000|Overall Study|Kidney Transplantation|9|||
125655707|NCT00077766|452024572|FG001|Overall Study|Kidney Transplantation|5|||
125655708|NCT00077766|452024571|FG000|Overall Study|Transplantation|5|||
125655709|NCT00077766|452024572|FG001|Overall Study|Transplantation|1|||
125655710|NCT00077766|452024571|FG000|Overall Study|Investigators Discretion|1|||
125655711|NCT00077766|452024572|FG001|Overall Study|Investigators Discretion|0|||
125655712|NCT00077766|452024571|FG000|Overall Study|Participant's decision|1|||
125655713|NCT00077766|452024572|FG001|Overall Study|Participant's decision|0|||
125655714|NCT00077766|452024571|FG000|Overall Study|Dialysis Discontinued|1|||
125655715|NCT00077766|452024572|FG001|Overall Study|Dialysis Discontinued|0|||
125655716|NCT00077766|452024571|FG000|Overall Study|Dialysis|0|||
125655717|NCT00077766|452024572|FG001|Overall Study|Dialysis|1|||
125655718|NCT00077766|452024571|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
125655719|NCT00077766|452024572|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
125655720|NCT00077766|452024571|FG000|Overall Study|Started Nocturnal Dialysis|0|||
125655721|NCT00077766|452024572|FG001|Overall Study|Started Nocturnal Dialysis|1|||
125655722|NCT00077766|452024571|FG000|Overall Study|Stop Dialysis|0|||
125655723|NCT00077766|452024572|FG001|Overall Study|Stop Dialysis|1|||
125655724|NCT00077766|452024571|FG000|Overall Study|Participants Vacation|2|||
125655725|NCT00077766|452024572|FG001|Overall Study|Participants Vacation|1|||
125655726|NCT01886105|452024573|FG000|Overall Study|Lack of Efficacy|3|||
125655727|NCT03843775|452024576|FG000|Overall Study|Adverse Event|1|||
125655728|NCT03843775|452024577|FG001|Overall Study|Adverse Event|1|||
125655729|NCT03843775|452024576|FG000|Overall Study|Lack of Efficacy|2|||
125655730|NCT03843775|452024577|FG001|Overall Study|Lack of Efficacy|6|||
125655731|NCT03843775|452024576|FG000|Overall Study|Withdrawal by Subject|0|||
125655732|NCT03843775|452024577|FG001|Overall Study|Withdrawal by Subject|1|||
125655733|NCT04150107|452024580|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
125655734|NCT04150107|452024581|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
125655735|NCT04150107|452024580|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
125655736|NCT04150107|452024581|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
125655737|NCT04455620|452024582|FG000|Overall Study|Withdrawal by Subject|0|||
125655738|NCT04455620|452024583|FG001|Overall Study|Withdrawal by Subject|0|||
125655739|NCT04455620|452024584|FG002|Overall Study|Withdrawal by Subject|2|||
125655740|NCT04455620|452024585|FG003|Overall Study|Withdrawal by Subject|0|||
125655741|NCT04455620|452024586|FG004|Overall Study|Withdrawal by Subject|1|||
125655742|NCT04455620|452024582|FG000|Overall Study|Lost to Follow-up|0|||
125655743|NCT04455620|452024583|FG001|Overall Study|Lost to Follow-up|0|||
125655744|NCT04455620|452024584|FG002|Overall Study|Lost to Follow-up|1|||
125655745|NCT04455620|452024585|FG003|Overall Study|Lost to Follow-up|1|||
125655746|NCT04455620|452024586|FG004|Overall Study|Lost to Follow-up|0|||
125655747|NCT04455620|452024582|FG000|Overall Study|Death|1|||
125655748|NCT04455620|452024583|FG001|Overall Study|Death|6|||
125655749|NCT04455620|452024584|FG002|Overall Study|Death|20|||
125655750|NCT04455620|452024585|FG003|Overall Study|Death|1|||
125655751|NCT04455620|452024586|FG004|Overall Study|Death|7|||
125655752|NCT04455620|452024582|FG000|Overall Study|Study Termination|0|||
125655753|NCT04455620|452024583|FG001|Overall Study|Study Termination|2|||
125655754|NCT04455620|452024584|FG002|Overall Study|Study Termination|1|||
125655755|NCT04455620|452024585|FG003|Overall Study|Study Termination|0|||
125655756|NCT04455620|452024586|FG004|Overall Study|Study Termination|6|||
125655757|NCT02851069|452024588|FG000|Overall Study|Failure to Return|3|||
125655758|NCT02851069|452024588|FG000|Overall Study|Other|3|||
125314983|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
125314984|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
125314985|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
125314986|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
125655759|NCT03539952|452024594|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
125655760|NCT03539952|452024595|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
125655761|NCT03539952|452024594|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
125655762|NCT03539952|452024595|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
125655763|NCT03539952|452024594|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
125655764|NCT03539952|452024595|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
125655765|NCT03539952|452024594|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
125655766|NCT03539952|452024595|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
125655767|NCT03539952|452024594|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
125655768|NCT03539952|452024595|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
125655769|NCT03539952|452024594|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
125655770|NCT03539952|452024595|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
125655771|NCT03539952|452024594|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
125655772|NCT03539952|452024595|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
125655773|NCT02087865|452025853|FG000|Overall Study|Withdrawal by Subject|6|||
125655774|NCT02087865|452025854|FG001|Overall Study|Withdrawal by Subject|0|||
125655775|NCT02087865|452025855|FG002|Overall Study|Withdrawal by Subject|1|||
125655776|NCT02087865|452025853|FG000|Overall Study|Lost to Follow-up|0|||
125655777|NCT02087865|452025854|FG001|Overall Study|Lost to Follow-up|0|||
125655778|NCT02087865|452025855|FG002|Overall Study|Lost to Follow-up|1|||
125314987|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
125314988|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
125314989|NCT02831764|450784128|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
125314990|NCT02831764|450784129|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
125314991|NCT02831764|450784130|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
125314992|NCT02831764|450784131|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
125314993|NCT02831764|450784132|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
125314994|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
125314995|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
125314996|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
125314997|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
125314998|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
125314999|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125315000|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125315001|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
125315002|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125315003|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125315004|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125315005|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125315006|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
125315007|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
125315008|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125315009|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
125315010|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
125315011|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
125315012|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
125315013|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
125315014|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
125315015|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
125315016|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
125315017|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
125315018|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
125315019|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
125315020|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
125315021|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
125315022|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
125315023|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
125315024|NCT02831764|450784128|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
125315025|NCT02831764|450784129|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
125315026|NCT02831764|450784130|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
125315027|NCT02831764|450784131|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
125315028|NCT02831764|450784132|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
125315029|NCT02831764|450784128|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125315030|NCT02831764|450784129|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125315031|NCT02831764|450784130|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125315032|NCT02831764|450784131|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125655779|NCT02087865|452025853|FG000|Overall Study|Drug Non-compliance|0|||
125655780|NCT02087865|452025854|FG001|Overall Study|Drug Non-compliance|2|||
125655781|NCT02087865|452025855|FG002|Overall Study|Drug Non-compliance|0|||
125655782|NCT02087865|452025853|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
125655783|NCT02087865|452025854|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
125655784|NCT02087865|452025855|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
125655785|NCT01392469|452025858|FG000|Overall Study|Adverse Event|2|||
125655786|NCT01392469|452025858|FG000|Overall Study|Withdrawal by Subject|1|||
125655787|NCT01392469|452025858|FG000|Overall Study|Protocol Violation|1|||
125655788|NCT03255226|452025859|FG000|Overall Study|Adverse Event|2|||
125655789|NCT03255226|452025859|FG000|Overall Study|Physician Decision|3|||
125655790|NCT03255226|452025859|FG000|Overall Study|Withdrawal by Subject|1|||
125655791|NCT03255226|452025859|FG000|Overall Study|Serum or blood sodium increased|4|||
125655792|NCT03255226|452025859|FG000|Overall Study|Serum or blood potassium increased|4|||
125655793|NCT01035229|452025860|FG000|Overall Study|Adverse Event|61|||
125655794|NCT01035229|452025861|FG001|Overall Study|Adverse Event|14|||
125655795|NCT01035229|452025860|FG000|Overall Study|Withdrawal by Subject|20|||
125655796|NCT01035229|452025861|FG001|Overall Study|Withdrawal by Subject|7|||
125315033|NCT02831764|450784132|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
125315034|NCT02831764|450784128|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125315035|NCT02831764|450784129|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125315036|NCT02831764|450784130|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125315037|NCT02831764|450784131|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125315038|NCT02831764|450784132|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
125315039|NCT02831764|450784128|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125315040|NCT02831764|450784129|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125315041|NCT02831764|450784130|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125315042|NCT02831764|450784131|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125315043|NCT02831764|450784132|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
125315044|NCT02831764|450784128|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125315045|NCT02831764|450784129|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125315046|NCT02831764|450784130|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125315047|NCT02831764|450784131|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125315048|NCT02831764|450784132|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
125315049|NCT04564846|450784133|FG000|Overall Study|Withdrawal by Subject|2|||
125315050|NCT04564846|450784134|FG001|Overall Study|Withdrawal by Subject|1|||
125315051|NCT04564846|450784133|FG000|Overall Study|Physician Decision|0|||
125315052|NCT04564846|450784134|FG001|Overall Study|Physician Decision|1|||
125315053|NCT04564846|450784133|FG000|Overall Study|Lost to Follow-up|0|||
125315054|NCT04564846|450784134|FG001|Overall Study|Lost to Follow-up|1|||
125315055|NCT04564846|450784133|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
125315056|NCT04564846|450784134|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
125315057|NCT04564846|450784133|FG000|Overall Study|Subject non-compliance|1|||
125315058|NCT04564846|450784134|FG001|Overall Study|Subject non-compliance|0|||
125315059|NCT02735239|450784135|FG000|Overall Study|Adverse Event|0|||
125315060|NCT02735239|450784136|FG001|Overall Study|Adverse Event|0|||
125315061|NCT02735239|450784137|FG002|Overall Study|Adverse Event|4|||
125315062|NCT02735239|450784138|FG003|Overall Study|Adverse Event|0|||
125315063|NCT02735239|450784139|FG004|Overall Study|Adverse Event|0|||
125315064|NCT02735239|450784140|FG005|Overall Study|Adverse Event|0|||
125315065|NCT02735239|450784135|FG000|Overall Study|Death|1|||
125315066|NCT02735239|450784136|FG001|Overall Study|Death|1|||
125315067|NCT02735239|450784137|FG002|Overall Study|Death|0|||
125315068|NCT02735239|450784138|FG003|Overall Study|Death|0|||
125315069|NCT02735239|450784139|FG004|Overall Study|Death|0|||
125315070|NCT02735239|450784140|FG005|Overall Study|Death|0|||
125315071|NCT02735239|450784135|FG000|Overall Study|Physician Decision|0|||
125315072|NCT02735239|450784136|FG001|Overall Study|Physician Decision|0|||
125315073|NCT02735239|450784137|FG002|Overall Study|Physician Decision|1|||
125315074|NCT02735239|450784138|FG003|Overall Study|Physician Decision|0|||
125315075|NCT02735239|450784139|FG004|Overall Study|Physician Decision|0|||
125315076|NCT02735239|450784140|FG005|Overall Study|Physician Decision|0|||
125315077|NCT02735239|450784135|FG000|Overall Study|Progressive disease|3|||
125315078|NCT02735239|450784136|FG001|Overall Study|Progressive disease|1|||
125315079|NCT02735239|450784137|FG002|Overall Study|Progressive disease|3|||
125315080|NCT02735239|450784138|FG003|Overall Study|Progressive disease|0|||
125315081|NCT02735239|450784139|FG004|Overall Study|Progressive disease|0|||
125315082|NCT02735239|450784140|FG005|Overall Study|Progressive disease|2|||
125315083|NCT02735239|450784135|FG000|Overall Study|Withdrawal by Subject|0|||
125315084|NCT02735239|450784136|FG001|Overall Study|Withdrawal by Subject|1|||
125315085|NCT02735239|450784137|FG002|Overall Study|Withdrawal by Subject|0|||
125315086|NCT02735239|450784138|FG003|Overall Study|Withdrawal by Subject|0|||
125315087|NCT02735239|450784139|FG004|Overall Study|Withdrawal by Subject|0|||
125315088|NCT02735239|450784140|FG005|Overall Study|Withdrawal by Subject|0|||
125315089|NCT02038153|450784143|FG000|Overall Study|Withdrawal by Subject|1|||
125315090|NCT03016312|450784144|FG000|Overall Study|discontinued before the treatment started|0|||
125315091|NCT03016312|450784145|FG001|Overall Study|discontinued before the treatment started|1|||
125315092|NCT03016312|450784144|FG000|Overall Study|Withdrawal by Subject|37|||
125315093|NCT03016312|450784145|FG001|Overall Study|Withdrawal by Subject|44|||
125315094|NCT03016312|450784144|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
125315095|NCT03016312|450784145|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
125655797|NCT01035229|452025860|FG000|Overall Study|Lost to Follow-up|1|||
125315096|NCT03016312|450784144|FG000|Overall Study|Physician Decision|1|||
125315097|NCT03016312|450784145|FG001|Overall Study|Physician Decision|3|||
125315098|NCT03016312|450784144|FG000|Overall Study|Lost to Follow-up|12|||
125315099|NCT03016312|450784145|FG001|Overall Study|Lost to Follow-up|12|||
125315100|NCT03016312|450784144|FG000|Overall Study|Death|210|||
125315101|NCT03016312|450784145|FG001|Overall Study|Death|184|||
125315102|NCT03016312|450784144|FG000|Overall Study|loss to contact|1|||
125315103|NCT03016312|450784145|FG001|Overall Study|loss to contact|0|||
125425497|NCT00686881|451180498|FG000|Overall Study|Treatment-related adverse event|10|||
125655798|NCT01035229|452025861|FG001|Overall Study|Lost to Follow-up|0|||
125655799|NCT01035229|452025860|FG000|Overall Study|Administrative problems|1|||
125655800|NCT01035229|452025861|FG001|Overall Study|Administrative problems|1|||
125655801|NCT01035229|452025860|FG000|Overall Study|Death|13|||
125655802|NCT01035229|452025861|FG001|Overall Study|Death|5|||
125655803|NCT01035229|452025860|FG000|Overall Study|New cancer therapy|2|||
125655804|NCT01035229|452025861|FG001|Overall Study|New cancer therapy|0|||
125655805|NCT01035229|452025860|FG000|Overall Study|Protocol Violation|0|||
125655806|NCT01035229|452025861|FG001|Overall Study|Protocol Violation|2|||
125655807|NCT01035229|452025860|FG000|Overall Study|Sponsor's decision to end study|3|||
125655808|NCT01035229|452025861|FG001|Overall Study|Sponsor's decision to end study|3|||
125655809|NCT01035229|452025860|FG000|Overall Study|Disease Progression|261|||
125315104|NCT03016312|450784144|FG000|Overall Study|started a new cancer therapy|1|||
125315105|NCT03016312|450784145|FG001|Overall Study|started a new cancer therapy|0|||
125315106|NCT01050634|450784146|FG000|Overall Study|Enrolled, but Not Treated|56|||
125315107|NCT01050634|450784146|FG000|Overall Study|Death|2|||
125315108|NCT01050634|450784146|FG000|Overall Study|Adverse Event|42|||
125315109|NCT01050634|450784146|FG000|Overall Study|Lost to Follow-up|2|||
125655810|NCT01035229|452025861|FG001|Overall Study|Disease Progression|152|||
125655811|NCT00564486|452025864|FG000|Overall Study|Adverse Event|0|||
125655812|NCT00564486|452025865|FG001|Overall Study|Adverse Event|1|||
125655813|NCT00564486|452025866|FG002|Overall Study|Adverse Event|0|||
125655814|NCT00564486|452025867|FG003|Overall Study|Adverse Event|0|||
125655815|NCT00564486|452025864|FG000|Overall Study|Withdrawal by Subject|4|||
125655816|NCT00564486|452025865|FG001|Overall Study|Withdrawal by Subject|0|||
125655817|NCT00564486|452025866|FG002|Overall Study|Withdrawal by Subject|0|||
125655818|NCT00564486|452025867|FG003|Overall Study|Withdrawal by Subject|5|||
125655819|NCT00564486|452025864|FG000|Overall Study|Subject refused to have blood drawn|0|||
125315110|NCT01050634|450784146|FG000|Overall Study|Other|21|||
125315111|NCT01050634|450784146|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
125315112|NCT00496015|450784147|FG000|Overall Study|Other|1|||
125315113|NCT00496015|450784148|FG001|Overall Study|Other|0|||
125315114|NCT00496015|450784149|FG002|Overall Study|Other|0|||
125315115|NCT00496015|450784150|FG003|Overall Study|Other|1|||
125315116|NCT00496015|450784151|FG004|Overall Study|Other|0|||
125315117|NCT00527735|450784152|FG000|Overall Study|Disease progression|47|||
125315118|NCT00527735|450784153|FG001|Overall Study|Disease progression|61|||
125315119|NCT00527735|450784154|FG002|Overall Study|Disease progression|53|||
125315120|NCT00527735|450784152|FG000|Overall Study|Death|23|||
125315121|NCT00527735|450784153|FG001|Overall Study|Death|13|||
125315122|NCT00527735|450784154|FG002|Overall Study|Death|15|||
125315123|NCT00527735|450784152|FG000|Overall Study|Completed treatment in treatment phase|14|||
125315124|NCT00527735|450784153|FG001|Overall Study|Completed treatment in treatment phase|13|||
125315125|NCT00527735|450784154|FG002|Overall Study|Completed treatment in treatment phase|18|||
125315126|NCT00527735|450784152|FG000|Overall Study|Adverse Event|10|||
125315127|NCT00527735|450784153|FG001|Overall Study|Adverse Event|6|||
125315128|NCT00527735|450784154|FG002|Overall Study|Adverse Event|7|||
125315129|NCT00527735|450784152|FG000|Overall Study|Not identified|5|||
125315130|NCT00527735|450784153|FG001|Overall Study|Not identified|5|||
125315131|NCT00527735|450784154|FG002|Overall Study|Not identified|5|||
125315132|NCT00527735|450784152|FG000|Overall Study|Withdrawal by Subject|5|||
125315133|NCT00527735|450784153|FG001|Overall Study|Withdrawal by Subject|4|||
125315134|NCT00527735|450784154|FG002|Overall Study|Withdrawal by Subject|3|||
125315135|NCT00527735|450784152|FG000|Overall Study|No longer met study criteria|2|||
125315136|NCT00527735|450784153|FG001|Overall Study|No longer met study criteria|2|||
125315137|NCT00527735|450784154|FG002|Overall Study|No longer met study criteria|1|||
125655820|NCT00564486|452025865|FG001|Overall Study|Subject refused to have blood drawn|0|||
125655821|NCT00564486|452025866|FG002|Overall Study|Subject refused to have blood drawn|1|||
125655822|NCT00564486|452025867|FG003|Overall Study|Subject refused to have blood drawn|0|||
125655823|NCT00564486|452025864|FG000|Overall Study|Lost to Follow-up|3|||
125655824|NCT00564486|452025865|FG001|Overall Study|Lost to Follow-up|0|||
125655825|NCT00564486|452025866|FG002|Overall Study|Lost to Follow-up|2|||
125655826|NCT00564486|452025867|FG003|Overall Study|Lost to Follow-up|2|||
125655827|NCT03862807|452025872|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
125655828|NCT04362761|452025873|FG000|Part A (48 Weeks)|Adverse Event|2|||
125315138|NCT00527735|450784152|FG000|Overall Study|Lost to Follow-up|0|||
125315139|NCT00527735|450784153|FG001|Overall Study|Lost to Follow-up|0|||
125315140|NCT00527735|450784154|FG002|Overall Study|Lost to Follow-up|3|||
125315141|NCT00527735|450784152|FG000|Overall Study|Poor compliance or noncompliance|0|||
125315142|NCT00527735|450784153|FG001|Overall Study|Poor compliance or noncompliance|1|||
125315143|NCT00527735|450784154|FG002|Overall Study|Poor compliance or noncompliance|1|||
125315144|NCT00527735|450784152|FG000|Overall Study|Completed treatment during maintenance|2|||
125655829|NCT04362761|452025873|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
125655830|NCT04362761|452025873|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
125655831|NCT04362761|452025873|FG000|Part A (48 Weeks)|Other|5|||
125655832|NCT04362761|452025873|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
125655833|NCT04362761|452025873|FG000|Part B (86 Weeks)|Other|4|||
125315145|NCT00527735|450784153|FG001|Overall Study|Completed treatment during maintenance|2|||
125315146|NCT00527735|450784154|FG002|Overall Study|Completed treatment during maintenance|1|||
125315147|NCT01535807|450784155|FG000|Overall Study|Withdrawal by Subject|1|||
125315148|NCT01535807|450784156|FG001|Overall Study|Withdrawal by Subject|1|||
125315149|NCT01535807|450784155|FG000|Overall Study|Data collection error|1|||
125315150|NCT01535807|450784156|FG001|Overall Study|Data collection error|1|||
125315151|NCT02730728|450784159|FG000|Overall Study|Withdrawal by Subject|0|||
125315152|NCT02730728|450784160|FG001|Overall Study|Withdrawal by Subject|1|||
125315153|NCT02730728|450784161|FG002|Overall Study|Withdrawal by Subject|0|||
125315154|NCT02730728|450784159|FG000|Overall Study|Lack of Efficacy|0|||
125315155|NCT02730728|450784160|FG001|Overall Study|Lack of Efficacy|1|||
125315156|NCT02730728|450784161|FG002|Overall Study|Lack of Efficacy|1|||
125315157|NCT01855412|450784162|FG000|Overall Study|Death|77|||
125315158|NCT01855412|450784163|FG001|Overall Study|Death|123|||
125315159|NCT01855412|450784164|FG002|Overall Study|Death|30|||
125315160|NCT01855412|450784162|FG000|Overall Study|Lost to Follow-up|28|||
125315161|NCT01855412|450784163|FG001|Overall Study|Lost to Follow-up|46|||
125315162|NCT01855412|450784164|FG002|Overall Study|Lost to Follow-up|15|||
125315163|NCT01855412|450784162|FG000|Overall Study|Withdrawal by Subject|77|||
125315164|NCT01855412|450784163|FG001|Overall Study|Withdrawal by Subject|123|||
125315165|NCT01855412|450784164|FG002|Overall Study|Withdrawal by Subject|24|||
125315166|NCT01855412|450784162|FG000|Overall Study|Physician Decision|25|||
125315167|NCT01855412|450784163|FG001|Overall Study|Physician Decision|31|||
125315168|NCT01855412|450784164|FG002|Overall Study|Physician Decision|3|||
125315169|NCT01855412|450784162|FG000|Overall Study|Site Closure|4|||
125315170|NCT01855412|450784163|FG001|Overall Study|Site Closure|18|||
125315171|NCT01855412|450784164|FG002|Overall Study|Site Closure|1|||
125315172|NCT01855412|450784162|FG000|Overall Study|Reason not Specified|1|||
125315173|NCT01855412|450784163|FG001|Overall Study|Reason not Specified|2|||
125315174|NCT01855412|450784164|FG002|Overall Study|Reason not Specified|3|||
125315175|NCT01702844|450784179|FG000|Overall Study|Adverse Event|9|||
125315176|NCT01702844|450784179|FG000|Overall Study|Death|1|||
125315177|NCT01702844|450784179|FG000|Overall Study|Withdrawal by Subject|3|||
125315178|NCT01702844|450784179|FG000|Overall Study|Physician Decision|6|||
125315179|NCT02123134|450784180|FG000|Overall Study|Withdrawal of consent|3|||
125315180|NCT02123134|450784181|FG001|Overall Study|Withdrawal of consent|2|||
125315181|NCT02123134|450784180|FG000|Overall Study|Administrative decision|0|||
125315182|NCT02123134|450784181|FG001|Overall Study|Administrative decision|1|||
125315183|NCT03431441|450784182|FG000|Overall Study|Withdrawal by Subject|2|||
125315184|NCT03431441|450784182|FG000|Overall Study|Adverse Event|2|||
125315185|NCT03431441|450784182|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
125315186|NCT00764699|450784196|FG000|Overall Study|PI left and study terminated|3|||
125315187|NCT03985761|450784198|FG000|Overall Study|Withdrawal by Subject|2|||
125315188|NCT03985761|450784199|FG001|Overall Study|Withdrawal by Subject|3|||
125315189|NCT02322281|450784202|FG000|Overall Study|Progressive Disease|42|||
125315190|NCT02322281|450784203|FG001|Overall Study|Progressive Disease|14|||
125315191|NCT02322281|450784204|FG002|Overall Study|Progressive Disease|49|||
125315192|NCT02322281|450784202|FG000|Overall Study|Adverse Event|3|||
125315193|NCT02322281|450784203|FG001|Overall Study|Adverse Event|4|||
125315194|NCT02322281|450784204|FG002|Overall Study|Adverse Event|6|||
125315195|NCT02322281|450784202|FG000|Overall Study|Death|3|||
125315196|NCT02322281|450784203|FG001|Overall Study|Death|3|||
125315197|NCT02322281|450784204|FG002|Overall Study|Death|3|||
125315198|NCT02322281|450784202|FG000|Overall Study|Withdrawal by Subject|1|||
125315199|NCT02322281|450784203|FG001|Overall Study|Withdrawal by Subject|1|||
125315200|NCT02322281|450784204|FG002|Overall Study|Withdrawal by Subject|6|||
125315201|NCT02322281|450784202|FG000|Overall Study|Physician Decision|2|||
125315202|NCT02322281|450784203|FG001|Overall Study|Physician Decision|0|||
125315203|NCT02322281|450784204|FG002|Overall Study|Physician Decision|5|||
125315204|NCT02322281|450784202|FG000|Overall Study|Study Terminated by Sponsor|2|||
125315205|NCT02322281|450784203|FG001|Overall Study|Study Terminated by Sponsor|0|||
125315206|NCT02322281|450784204|FG002|Overall Study|Study Terminated by Sponsor|0|||
125315207|NCT02322281|450784202|FG000|Overall Study|Missing|0|||
125315208|NCT02322281|450784203|FG001|Overall Study|Missing|0|||
125315209|NCT02322281|450784204|FG002|Overall Study|Missing|1|||
125315210|NCT02322281|450784202|FG000|Overall Study|Miscellaneous|0|||
125315211|NCT02322281|450784203|FG001|Overall Study|Miscellaneous|0|||
125315212|NCT02322281|450784204|FG002|Overall Study|Miscellaneous|4|||
125315213|NCT05789745|450784208|FG000|Overall Study|Withdrawal by Subject|0|||
125315214|NCT05789745|450784209|FG001|Overall Study|Withdrawal by Subject|0|||
125315215|NCT05789745|450784210|FG002|Overall Study|Withdrawal by Subject|0|||
125315216|NCT05789745|450784211|FG003|Overall Study|Withdrawal by Subject|0|||
125315217|NCT05789745|450784212|FG004|Overall Study|Withdrawal by Subject|1|||
125315218|NCT05470387|450784216|FG000|Overall Study|Protocol Violation|0|||
125315219|NCT05470387|450784217|FG001|Overall Study|Protocol Violation|3|||
125315220|NCT03275740|450784218|FG000|Overall Study|Adverse Event|0|||
125315221|NCT03275740|450784219|FG001|Overall Study|Adverse Event|0|||
125315222|NCT03275740|450784220|FG002|Overall Study|Adverse Event|0|||
125315223|NCT03275740|450784221|FG003|Overall Study|Adverse Event|0|||
125315224|NCT03275740|450784222|FG004|Overall Study|Adverse Event|1|||
125315225|NCT03275740|450784223|FG005|Overall Study|Adverse Event|0|||
125315226|NCT03275740|450784224|FG006|Overall Study|Adverse Event|0|||
125315227|NCT03275740|450784225|FG007|Overall Study|Adverse Event|0|||
125315228|NCT03275740|450784226|FG008|Overall Study|Adverse Event|0|||
125315229|NCT03275740|450784227|FG009|Overall Study|Adverse Event|0|||
125315230|NCT03275740|450784228|FG010|Overall Study|Adverse Event|0|||
125315231|NCT03275740|450784229|FG011|Overall Study|Adverse Event|0|||
125655834|NCT00684645|452025874|FG000|Overall Study|Death|2|||
125655835|NCT00684645|452025874|FG000|Overall Study|Progressive disease|67|||
125655836|NCT00684645|452025874|FG000|Overall Study|Adverse Event|27|||
125655837|NCT00684645|452025874|FG000|Overall Study|Lost to Follow-up|3|||
125655838|NCT00684645|452025874|FG000|Overall Study|Other|15|||
125315232|NCT03275740|450784218|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315233|NCT03275740|450784219|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315234|NCT03275740|450784220|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315235|NCT03275740|450784221|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315236|NCT03275740|450784222|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315237|NCT03275740|450784223|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
125315238|NCT03275740|450784224|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315239|NCT03275740|450784225|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315240|NCT03275740|450784226|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315241|NCT03275740|450784227|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315242|NCT03275740|450784228|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315243|NCT03275740|450784229|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
125315244|NCT03275740|450784218|FG000|Overall Study|Withdrawal by Subject|0|||
125315245|NCT03275740|450784219|FG001|Overall Study|Withdrawal by Subject|0|||
125315246|NCT03275740|450784220|FG002|Overall Study|Withdrawal by Subject|0|||
125315247|NCT03275740|450784221|FG003|Overall Study|Withdrawal by Subject|0|||
125315248|NCT03275740|450784222|FG004|Overall Study|Withdrawal by Subject|0|||
125315249|NCT03275740|450784223|FG005|Overall Study|Withdrawal by Subject|0|||
125315250|NCT03275740|450784224|FG006|Overall Study|Withdrawal by Subject|0|||
125315251|NCT03275740|450784225|FG007|Overall Study|Withdrawal by Subject|0|||
125315252|NCT03275740|450784226|FG008|Overall Study|Withdrawal by Subject|1|||
125315253|NCT03275740|450784227|FG009|Overall Study|Withdrawal by Subject|1|||
125315254|NCT03275740|450784228|FG010|Overall Study|Withdrawal by Subject|0|||
125315255|NCT03275740|450784229|FG011|Overall Study|Withdrawal by Subject|0|||
125315256|NCT00687401|450784231|FG000|Overall Study|Protocol Violation|7|||
125315257|NCT00687401|450784231|FG000|Overall Study|Adverse Event|6|||
125315258|NCT00687401|450784231|FG000|Overall Study|Lack of Efficacy|6|||
125315259|NCT00687401|450784231|FG000|Overall Study|Withdrawal by Subject|4|||
125315260|NCT00687401|450784231|FG000|Overall Study|Did not return for visit|3|||
125655839|NCT00798707|452025888|FG000|Overall Study|Adverse Event|6|||
125315261|NCT00687401|450784231|FG000|Overall Study|For reasons different from those above|4|||
125315262|NCT02920892|450784232|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
125315263|NCT02920892|450784233|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
125315264|NCT02920892|450784234|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
125315265|NCT02920892|450784232|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
125315266|NCT02920892|450784233|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
125315267|NCT02920892|450784234|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
125315268|NCT02920892|450784232|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
125655840|NCT00798707|452025889|FG001|Overall Study|Adverse Event|8|||
125655841|NCT00798707|452025890|FG002|Overall Study|Adverse Event|8|||
125655842|NCT00798707|452025888|FG000|Overall Study|Failed to return|2|||
125655843|NCT00798707|452025889|FG001|Overall Study|Failed to return|2|||
125655844|NCT00798707|452025890|FG002|Overall Study|Failed to return|0|||
125655845|NCT00798707|452025888|FG000|Overall Study|Investigator|0|||
125655846|NCT00798707|452025889|FG001|Overall Study|Investigator|1|||
125655847|NCT00798707|452025890|FG002|Overall Study|Investigator|2|||
125655848|NCT00798707|452025888|FG000|Overall Study|Lack of Efficacy|2|||
125655849|NCT00798707|452025889|FG001|Overall Study|Lack of Efficacy|2|||
125655850|NCT00798707|452025890|FG002|Overall Study|Lack of Efficacy|1|||
125655851|NCT00798707|452025888|FG000|Overall Study|Lost to Follow-up|5|||
125655852|NCT00798707|452025889|FG001|Overall Study|Lost to Follow-up|6|||
125655853|NCT00798707|452025890|FG002|Overall Study|Lost to Follow-up|6|||
125655854|NCT00798707|452025888|FG000|Overall Study|Other|0|||
125315269|NCT02920892|450784233|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
125655855|NCT00798707|452025889|FG001|Overall Study|Other|1|||
125655856|NCT00798707|452025890|FG002|Overall Study|Other|0|||
125655857|NCT00798707|452025888|FG000|Overall Study|Protocol Violation|4|||
125655858|NCT00798707|452025889|FG001|Overall Study|Protocol Violation|0|||
125655859|NCT00798707|452025890|FG002|Overall Study|Protocol Violation|2|||
125655860|NCT00798707|452025888|FG000|Overall Study|Withdrawal by Subject|3|||
125655861|NCT00798707|452025889|FG001|Overall Study|Withdrawal by Subject|8|||
125655862|NCT00798707|452025890|FG002|Overall Study|Withdrawal by Subject|2|||
125315270|NCT02920892|450784234|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
125315271|NCT02920892|450784232|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
125315272|NCT02920892|450784233|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
125315273|NCT02920892|450784234|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
125315274|NCT02920892|450784232|FG000|Placebo-Controlled Period|Physician Decision|0|||
125315275|NCT02920892|450784233|FG001|Placebo-Controlled Period|Physician Decision|0|||
125315276|NCT02920892|450784234|FG002|Placebo-Controlled Period|Physician Decision|1|||
125315277|NCT02920892|450784232|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
125315278|NCT02920892|450784233|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
125315279|NCT02920892|450784234|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
125315280|NCT02920892|450784232|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125315281|NCT02920892|450784233|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
125315282|NCT02920892|450784234|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
125315283|NCT02920892|450784232|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
125315284|NCT02920892|450784233|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
125315285|NCT02920892|450784234|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
125315286|NCT04486235|450784235|FG000|Overall Study|Pregnancy|1|||
125315287|NCT04486235|450784236|FG001|Overall Study|Pregnancy|0|||
125315288|NCT04486235|450784235|FG000|Overall Study|Lost to Follow-up|1|||
125315289|NCT04486235|450784236|FG001|Overall Study|Lost to Follow-up|0|||
125315290|NCT03935126|450784237|FG000|Overall Study|Study termination by sponsor|3|||
125315291|NCT02520726|450784238|FG000|Overall Study|Lost to Follow-up|3|||
125315292|NCT02520726|450784239|FG001|Overall Study|Lost to Follow-up|2|||
125315293|NCT03649217|450784240|FG000|Overall Study|subject had severe ataxia not initially found|1|||
125315294|NCT03649217|450784240|FG000|Overall Study|subject had cognitive issues not initially found|1|||
125315295|NCT01092728|450784241|FG000|Overall Study|Withdrawal by Subject|2|||
125315296|NCT01092728|450784242|FG001|Overall Study|Withdrawal by Subject|0|||
125315297|NCT01092728|450784241|FG000|Overall Study|Adverse Event|0|||
125315298|NCT01092728|450784242|FG001|Overall Study|Adverse Event|1|||
125315299|NCT01092728|450784241|FG000|Overall Study|Disease Progression|1|||
125315300|NCT01092728|450784242|FG001|Overall Study|Disease Progression|13|||
125315301|NCT01092728|450784241|FG000|Overall Study|Prohibited Concomitant Medications|1|||
125315302|NCT01092728|450784242|FG001|Overall Study|Prohibited Concomitant Medications|0|||
125315303|NCT02552966|450784243|FG000|Overall Study|Lost to Follow-up|2|||
125315304|NCT02552966|450784243|FG000|Overall Study|Withdrawal by Subject|3|||
125315305|NCT00721396|450784244|FG000|Overall Study|Adverse Event|4|||
125315306|NCT00721396|450784245|FG001|Overall Study|Adverse Event|7|||
125315307|NCT00721396|450784246|FG002|Overall Study|Adverse Event|2|||
125315308|NCT00721396|450784247|FG003|Overall Study|Adverse Event|0|||
125315309|NCT00721396|450784244|FG000|Overall Study|Withdrawal by Subject|12|||
125315310|NCT00721396|450784245|FG001|Overall Study|Withdrawal by Subject|15|||
125315311|NCT00721396|450784246|FG002|Overall Study|Withdrawal by Subject|3|||
125315312|NCT00721396|450784247|FG003|Overall Study|Withdrawal by Subject|7|||
125315313|NCT00721396|450784244|FG000|Overall Study|Lost to Follow-up|7|||
125315314|NCT00721396|450784245|FG001|Overall Study|Lost to Follow-up|9|||
125315315|NCT00721396|450784246|FG002|Overall Study|Lost to Follow-up|3|||
125315316|NCT00721396|450784247|FG003|Overall Study|Lost to Follow-up|3|||
125315317|NCT00721396|450784244|FG000|Overall Study|Protocol Violation|4|||
125315318|NCT00721396|450784245|FG001|Overall Study|Protocol Violation|3|||
125315319|NCT00721396|450784246|FG002|Overall Study|Protocol Violation|1|||
125315320|NCT00721396|450784247|FG003|Overall Study|Protocol Violation|0|||
125315321|NCT00721396|450784244|FG000|Overall Study|Inappropriate enrollment|0|||
125315322|NCT00721396|450784245|FG001|Overall Study|Inappropriate enrollment|2|||
125315323|NCT00721396|450784246|FG002|Overall Study|Inappropriate enrollment|0|||
125315324|NCT00721396|450784247|FG003|Overall Study|Inappropriate enrollment|0|||
125315325|NCT00721396|450784244|FG000|Overall Study|Administrative reason|3|||
125315326|NCT00721396|450784245|FG001|Overall Study|Administrative reason|0|||
125315327|NCT00721396|450784246|FG002|Overall Study|Administrative reason|1|||
125315328|NCT00721396|450784247|FG003|Overall Study|Administrative reason|0|||
125315329|NCT01091675|450784249|FG000|Overall Study|Adverse Event|7|||
125315330|NCT01091675|450784249|FG000|Overall Study|Lack of Efficacy|27|||
125315331|NCT00614380|450784250|FG000|Overall Study|Adverse Event|14|||
125315332|NCT00614380|450784251|FG001|Overall Study|Adverse Event|4|||
125315333|NCT00614380|450784252|FG002|Overall Study|Adverse Event|0|||
125315334|NCT00614380|450784253|FG003|Overall Study|Adverse Event|0|||
125315335|NCT00614380|450784250|FG000|Overall Study|Lost to Follow-up|6|||
125315336|NCT00614380|450784251|FG001|Overall Study|Lost to Follow-up|1|||
125315337|NCT00614380|450784252|FG002|Overall Study|Lost to Follow-up|0|||
125315338|NCT00614380|450784253|FG003|Overall Study|Lost to Follow-up|0|||
125315339|NCT00614380|450784250|FG000|Overall Study|Non compliant with the protocol|12|||
125315340|NCT00614380|450784251|FG001|Overall Study|Non compliant with the protocol|2|||
125315341|NCT00614380|450784252|FG002|Overall Study|Non compliant with the protocol|1|||
125315342|NCT00614380|450784253|FG003|Overall Study|Non compliant with the protocol|2|||
125315343|NCT00614380|450784250|FG000|Overall Study|Consent withdrawn|3|||
125315344|NCT00614380|450784251|FG001|Overall Study|Consent withdrawn|1|||
125315345|NCT00614380|450784252|FG002|Overall Study|Consent withdrawn|0|||
125315346|NCT00614380|450784253|FG003|Overall Study|Consent withdrawn|0|||
125315347|NCT02021565|450784267|FG000|Baseline Through Intervention|Death|0|||
125315348|NCT02021565|450784268|FG001|Baseline Through Intervention|Death|1|||
125315349|NCT02021565|450784267|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
125315350|NCT02021565|450784268|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
125315351|NCT02021565|450784267|FG000|Baseline Through Intervention|Protocol Violation|0|||
125315352|NCT02021565|450784268|FG001|Baseline Through Intervention|Protocol Violation|7|||
125315353|NCT02021565|450784267|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
125315354|NCT02021565|450784268|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
125315355|NCT02021565|450784267|FG000|3-month Follow-up|Death|3|||
125315356|NCT02021565|450784268|FG001|3-month Follow-up|Death|0|||
125315357|NCT02021565|450784267|FG000|3-month Follow-up|Withdrawal by Subject|4|||
125315358|NCT02021565|450784268|FG001|3-month Follow-up|Withdrawal by Subject|0|||
125315359|NCT02021565|450784267|FG000|3-month Follow-up|Protocol Violation|3|||
125315360|NCT02021565|450784268|FG001|3-month Follow-up|Protocol Violation|2|||
125315361|NCT03318549|450784269|FG000|Overall Study|Withdrawal by Subject|5|||
125315362|NCT03318549|450784270|FG001|Overall Study|Withdrawal by Subject|19|||
125315363|NCT03318549|450784271|FG002|Overall Study|Withdrawal by Subject|2|||
125315364|NCT03318549|450784272|FG003|Overall Study|Withdrawal by Subject|0|||
125315365|NCT03318549|450784273|FG004|Overall Study|Withdrawal by Subject|0|||
125315366|NCT03318549|450784274|FG005|Overall Study|Withdrawal by Subject|0|||
125315367|NCT03318549|450784275|FG006|Overall Study|Withdrawal by Subject|0|||
125315368|NCT03318549|450784269|FG000|Overall Study|Physician Decision|0|||
125315369|NCT03318549|450784270|FG001|Overall Study|Physician Decision|4|||
125315370|NCT03318549|450784271|FG002|Overall Study|Physician Decision|1|||
125315371|NCT03318549|450784272|FG003|Overall Study|Physician Decision|0|||
125315372|NCT03318549|450784273|FG004|Overall Study|Physician Decision|0|||
125315373|NCT03318549|450784274|FG005|Overall Study|Physician Decision|0|||
125315374|NCT03318549|450784275|FG006|Overall Study|Physician Decision|0|||
125315375|NCT03318549|450784269|FG000|Overall Study|Lost to Follow-up|0|||
125315376|NCT03318549|450784270|FG001|Overall Study|Lost to Follow-up|3|||
125315377|NCT03318549|450784271|FG002|Overall Study|Lost to Follow-up|3|||
125315378|NCT03318549|450784272|FG003|Overall Study|Lost to Follow-up|0|||
125315379|NCT03318549|450784273|FG004|Overall Study|Lost to Follow-up|0|||
125315380|NCT03318549|450784274|FG005|Overall Study|Lost to Follow-up|0|||
125315381|NCT03318549|450784275|FG006|Overall Study|Lost to Follow-up|0|||
125315382|NCT00510835|450784278|FG000|Overall Study|Withdrawal by Subject|6|||
125315383|NCT00510835|450784279|FG001|Overall Study|Withdrawal by Subject|2|||
125315384|NCT00510835|450784280|FG002|Overall Study|Withdrawal by Subject|2|||
125315385|NCT00607087|450784284|FG000|Overall Study|Withdrawal by Subject|9|||
125315386|NCT00607087|450784285|FG001|Overall Study|Withdrawal by Subject|4|||
125315387|NCT00607087|450784286|FG002|Overall Study|Withdrawal by Subject|4|||
125315388|NCT00607087|450784284|FG000|Overall Study|Adverse Event|3|||
125315389|NCT00607087|450784285|FG001|Overall Study|Adverse Event|2|||
125315390|NCT00607087|450784286|FG002|Overall Study|Adverse Event|3|||
125315391|NCT00607087|450784284|FG000|Overall Study|Other reason|1|||
125315392|NCT00607087|450784285|FG001|Overall Study|Other reason|5|||
125315393|NCT00607087|450784286|FG002|Overall Study|Other reason|2|||
125315394|NCT00607087|450784284|FG000|Overall Study|Poor compliance to protocol|1|||
125315395|NCT00607087|450784285|FG001|Overall Study|Poor compliance to protocol|0|||
125315396|NCT00607087|450784286|FG002|Overall Study|Poor compliance to protocol|1|||
125315397|NCT00607087|450784284|FG000|Overall Study|Lost to Follow-up|1|||
125315398|NCT00607087|450784285|FG001|Overall Study|Lost to Follow-up|0|||
125315399|NCT00607087|450784286|FG002|Overall Study|Lost to Follow-up|0|||
125315400|NCT00607087|450784284|FG000|Period 1|Withdrawal by Subject|7|||
125315401|NCT00607087|450784285|FG001|Period 1|Withdrawal by Subject|2|||
125315402|NCT00607087|450784286|FG002|Period 1|Withdrawal by Subject|3|||
125315403|NCT00607087|450784284|FG000|Period 1|Adverse Event|3|||
125315404|NCT00607087|450784285|FG001|Period 1|Adverse Event|0|||
125315405|NCT00607087|450784286|FG002|Period 1|Adverse Event|0|||
125315406|NCT00607087|450784284|FG000|Period 1|Poor compliance to protocol|1|||
125315407|NCT00607087|450784285|FG001|Period 1|Poor compliance to protocol|0|||
125315408|NCT00607087|450784286|FG002|Period 1|Poor compliance to protocol|0|||
125315409|NCT00607087|450784284|FG000|Period 1|Lost to Follow-up|1|||
125315410|NCT00607087|450784285|FG001|Period 1|Lost to Follow-up|0|||
125315411|NCT00607087|450784286|FG002|Period 1|Lost to Follow-up|0|||
125315412|NCT00607087|450784284|FG000|Period 1|Other reason|0|||
125315413|NCT00607087|450784285|FG001|Period 1|Other reason|4|||
125315414|NCT00607087|450784286|FG002|Period 1|Other reason|2|||
125315415|NCT00607087|450784284|FG000|Period 2|Withdrawal by Subject|0|||
125315416|NCT00607087|450784285|FG001|Period 2|Withdrawal by Subject|1|||
125315417|NCT00607087|450784286|FG002|Period 2|Withdrawal by Subject|1|||
125315418|NCT00607087|450784284|FG000|Period 2|Other reason|1|||
125315419|NCT00607087|450784285|FG001|Period 2|Other reason|1|||
125315420|NCT00607087|450784286|FG002|Period 2|Other reason|0|||
125315421|NCT00607087|450784284|FG000|Period 2|Adverse Event|0|||
125315422|NCT00607087|450784285|FG001|Period 2|Adverse Event|1|||
125315423|NCT00607087|450784286|FG002|Period 2|Adverse Event|3|||
125315424|NCT00607087|450784284|FG000|Period 2|Poor compliance to protocol|0|||
125315425|NCT00607087|450784285|FG001|Period 2|Poor compliance to protocol|0|||
125315426|NCT00607087|450784286|FG002|Period 2|Poor compliance to protocol|1|||
125315427|NCT00607087|450784284|FG000|Period 3|Withdrawal by Subject|2|||
125315428|NCT00607087|450784285|FG001|Period 3|Withdrawal by Subject|1|||
125315429|NCT00607087|450784286|FG002|Period 3|Withdrawal by Subject|0|||
125315430|NCT00607087|450784284|FG000|Period 3|Adverse Event|0|||
125315431|NCT00607087|450784285|FG001|Period 3|Adverse Event|1|||
125315432|NCT00607087|450784286|FG002|Period 3|Adverse Event|0|||
125315433|NCT00650767|450784288|FG000|Overall Study|Adverse Event|0|||
125315434|NCT00650767|450784289|FG001|Overall Study|Adverse Event|3|||
125315435|NCT00650767|450784290|FG002|Overall Study|Adverse Event|10|||
125315436|NCT00650767|450784291|FG003|Overall Study|Adverse Event|8|||
125315437|NCT00650767|450784288|FG000|Overall Study|Death|1|||
125315438|NCT00650767|450784289|FG001|Overall Study|Death|0|||
125315439|NCT00650767|450784290|FG002|Overall Study|Death|0|||
125315440|NCT00650767|450784291|FG003|Overall Study|Death|0|||
125315441|NCT00650767|450784288|FG000|Overall Study|Withdrawal by Subject|2|||
125315442|NCT00650767|450784289|FG001|Overall Study|Withdrawal by Subject|4|||
125315443|NCT00650767|450784290|FG002|Overall Study|Withdrawal by Subject|3|||
125315444|NCT00650767|450784291|FG003|Overall Study|Withdrawal by Subject|3|||
125315445|NCT00650767|450784288|FG000|Overall Study|Lost to Follow-up|1|||
125655863|NCT00798707|452025888|FG000|Overall Study|Randomized not treated|4|||
125655864|NCT00798707|452025889|FG001|Overall Study|Randomized not treated|5|||
125655865|NCT00798707|452025890|FG002|Overall Study|Randomized not treated|1|||
125655866|NCT02525627|452025891|FG000|Overall Study|Revision|1|||
125655867|NCT02525627|452025892|FG001|Overall Study|Revision|1|||
125655868|NCT02525627|452025891|FG000|Overall Study|Withdrawal by Subject|1|||
125655869|NCT02525627|452025892|FG001|Overall Study|Withdrawal by Subject|2|||
125655870|NCT02525627|452025891|FG000|Overall Study|Death|1|||
125655871|NCT02525627|452025892|FG001|Overall Study|Death|0|||
125655872|NCT02525627|452025891|FG000|Overall Study|Site terminated|11|||
125655873|NCT02525627|452025892|FG001|Overall Study|Site terminated|10|||
125655874|NCT03746080|452025893|FG000|Overall Study|In follow up|2|||
125655875|NCT03746080|452025893|FG000|Overall Study|Death|15|||
125655876|NCT01473589|452025894|FG000|Overall Study|Adverse Event|1|||
125655877|NCT01473589|452025895|FG001|Overall Study|Adverse Event|1|||
125655878|NCT01473589|452025894|FG000|Overall Study|Death|2|||
125655879|NCT01473589|452025895|FG001|Overall Study|Death|0|||
125655880|NCT01473589|452025894|FG000|Overall Study|Lost to Follow-up|2|||
125655881|NCT01473589|452025895|FG001|Overall Study|Lost to Follow-up|2|||
125655882|NCT01473589|452025894|FG000|Overall Study|Protocol Violation|1|||
125655883|NCT01473589|452025895|FG001|Overall Study|Protocol Violation|0|||
125655884|NCT01473589|452025894|FG000|Overall Study|Withdrawal by Subject|5|||
125655885|NCT01473589|452025895|FG001|Overall Study|Withdrawal by Subject|11|||
125655886|NCT01473589|452025894|FG000|Overall Study|Physician Decision|0|||
125655887|NCT01473589|452025895|FG001|Overall Study|Physician Decision|1|||
125655888|NCT01473589|452025894|FG000|Overall Study|Entry criteria not met|0|||
125655889|NCT01473589|452025895|FG001|Overall Study|Entry criteria not met|1|||
125655890|NCT03256526|452025896|FG000|Overall Study|Adverse Event|1|||
125655891|NCT03256526|452025897|FG001|Overall Study|Adverse Event|0|||
125655892|NCT03256526|452025898|FG002|Overall Study|Adverse Event|1|||
125655893|NCT03256526|452025896|FG000|Overall Study|Lost to Follow-up|1|||
125655894|NCT03256526|452025897|FG001|Overall Study|Lost to Follow-up|0|||
125655895|NCT03256526|452025898|FG002|Overall Study|Lost to Follow-up|2|||
125655896|NCT03606109|452025899|FG000|Overall Study|Lost to Follow-up|2|||
125655897|NCT03606109|452025900|FG001|Overall Study|Lost to Follow-up|1|||
125655898|NCT03669640|452025901|FG000|Overall Study|Study Terminated by Sponsor|0|||
125655899|NCT03669640|452025902|FG001|Overall Study|Study Terminated by Sponsor|0|||
125655900|NCT03669640|452025903|FG002|Overall Study|Study Terminated by Sponsor|0|||
125655901|NCT03669640|452025904|FG003|Overall Study|Study Terminated by Sponsor|0|||
125655902|NCT03669640|452025905|FG004|Overall Study|Study Terminated by Sponsor|1|||
125655903|NCT03669640|452025906|FG005|Overall Study|Study Terminated by Sponsor|0|||
125315446|NCT00650767|450784289|FG001|Overall Study|Lost to Follow-up|1|||
125315447|NCT00650767|450784290|FG002|Overall Study|Lost to Follow-up|1|||
125315448|NCT00650767|450784291|FG003|Overall Study|Lost to Follow-up|0|||
125315449|NCT00650767|450784288|FG000|Overall Study|Other|1|||
125315450|NCT00650767|450784289|FG001|Overall Study|Other|1|||
125655904|NCT03669640|452025901|FG000|Overall Study|Lost to Follow-up|0|||
125655905|NCT03669640|452025902|FG001|Overall Study|Lost to Follow-up|0|||
125655906|NCT03669640|452025903|FG002|Overall Study|Lost to Follow-up|2|||
125655907|NCT03669640|452025904|FG003|Overall Study|Lost to Follow-up|0|||
125315451|NCT00650767|450784290|FG002|Overall Study|Other|0|||
125315452|NCT00650767|450784291|FG003|Overall Study|Other|0|||
125315453|NCT01774799|450784292|FG000|Overall Study|Lost to Follow-up|1|||
125655908|NCT03669640|452025905|FG004|Overall Study|Lost to Follow-up|0|||
125655909|NCT03669640|452025906|FG005|Overall Study|Lost to Follow-up|0|||
125655910|NCT03669640|452025901|FG000|Overall Study|Death|0|||
125655911|NCT03669640|452025902|FG001|Overall Study|Death|0|||
125655912|NCT03669640|452025903|FG002|Overall Study|Death|1|||
125655913|NCT03669640|452025904|FG003|Overall Study|Death|0|||
125655914|NCT03669640|452025905|FG004|Overall Study|Death|0|||
125655915|NCT03669640|452025906|FG005|Overall Study|Death|0|||
125655916|NCT03669640|452025901|FG000|Overall Study|Withdrawal by Subject|1|||
125655917|NCT03669640|452025902|FG001|Overall Study|Withdrawal by Subject|2|||
125655918|NCT03669640|452025903|FG002|Overall Study|Withdrawal by Subject|1|||
125315454|NCT01774799|450784293|FG001|Overall Study|Lost to Follow-up|1|||
125655919|NCT03669640|452025904|FG003|Overall Study|Withdrawal by Subject|0|||
125655920|NCT03669640|452025905|FG004|Overall Study|Withdrawal by Subject|1|||
125655921|NCT03669640|452025906|FG005|Overall Study|Withdrawal by Subject|3|||
125655922|NCT03669640|452025901|FG000|Overall Study|Protocol Violation|1|||
125655923|NCT03669640|452025902|FG001|Overall Study|Protocol Violation|0|||
125655924|NCT03669640|452025903|FG002|Overall Study|Protocol Violation|0|||
125655925|NCT03669640|452025904|FG003|Overall Study|Protocol Violation|0|||
125655926|NCT03669640|452025905|FG004|Overall Study|Protocol Violation|0|||
125655927|NCT03669640|452025906|FG005|Overall Study|Protocol Violation|0|||
125655928|NCT03669640|452025901|FG000|Overall Study|Physician Decision|0|||
125655929|NCT03669640|452025902|FG001|Overall Study|Physician Decision|2|||
125655930|NCT03669640|452025903|FG002|Overall Study|Physician Decision|0|||
125655931|NCT03669640|452025904|FG003|Overall Study|Physician Decision|0|||
125655932|NCT03669640|452025905|FG004|Overall Study|Physician Decision|0|||
125655933|NCT03669640|452025906|FG005|Overall Study|Physician Decision|0|||
125655934|NCT03669640|452025901|FG000|Overall Study|Disease Relapse|1|||
125655935|NCT03669640|452025902|FG001|Overall Study|Disease Relapse|0|||
125655936|NCT03669640|452025903|FG002|Overall Study|Disease Relapse|0|||
125655937|NCT03669640|452025904|FG003|Overall Study|Disease Relapse|0|||
125655938|NCT03669640|452025905|FG004|Overall Study|Disease Relapse|0|||
125655939|NCT03669640|452025906|FG005|Overall Study|Disease Relapse|0|||
125655940|NCT03669640|452025901|FG000|Overall Study|Adverse Event|2|||
125655941|NCT03669640|452025902|FG001|Overall Study|Adverse Event|1|||
125655942|NCT03669640|452025903|FG002|Overall Study|Adverse Event|0|||
125655943|NCT03669640|452025904|FG003|Overall Study|Adverse Event|0|||
125655944|NCT03669640|452025905|FG004|Overall Study|Adverse Event|1|||
125655945|NCT03669640|452025906|FG005|Overall Study|Adverse Event|0|||
125655946|NCT05553600|452025907|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
125655947|NCT05553600|452025908|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
125655948|NCT05553600|452025909|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
125655949|NCT05553600|452025910|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
125655950|NCT05553600|452025907|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
125655951|NCT05553600|452025908|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
125655952|NCT05553600|452025909|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
125655953|NCT05553600|452025910|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
125655954|NCT05553600|452025907|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
125655955|NCT05553600|452025908|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
125315455|NCT01774799|450784294|FG002|Overall Study|Lost to Follow-up|0|||
125315456|NCT01774799|450784295|FG003|Overall Study|Lost to Follow-up|0|||
125315457|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
125315458|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
125315459|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
125315460|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
125315461|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
125315462|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
125315463|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
125315464|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
125315465|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
125315466|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
125315467|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
125315468|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
125315469|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
125315470|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
125315471|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
125655956|NCT05553600|452025909|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
125315472|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
125655957|NCT05553600|452025910|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
125655958|NCT05553600|452025907|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
125315473|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
125315474|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
125655959|NCT05553600|452025908|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
125655960|NCT05553600|452025909|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
125655961|NCT05553600|452025910|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
125655962|NCT05553600|452025907|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
125655963|NCT05553600|452025908|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
125655964|NCT05553600|452025909|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
125315475|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
125315476|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
125315477|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
125315478|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
125315479|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
125315480|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
125315481|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
125315482|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
125315483|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
125315484|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
125315485|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
125315486|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
125315487|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
125315488|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
125315489|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
125315490|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
125315491|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
125315492|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
125315493|NCT02586623|450784296|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
125315494|NCT02586623|450784297|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
125315495|NCT02586623|450784298|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
125315496|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
125315497|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
125315498|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
125315499|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
125315500|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
125315501|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
125315502|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
125315503|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
125315504|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
125315505|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
125315506|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
125315507|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
125315508|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
125315509|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
125315510|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
125315511|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
125315512|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
125315513|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
125315514|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
125315515|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
125315516|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
125315517|NCT02586623|450784296|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
125315518|NCT02586623|450784297|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
125315519|NCT02586623|450784298|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
125315520|NCT02910466|450784299|FG000|Overall Study|Adverse Event|1|||
125315521|NCT02910466|450784299|FG000|Overall Study|Withdrawal by Subject|3|||
125315522|NCT02910466|450784299|FG000|Overall Study|Lost to Follow-up|5|||
125315523|NCT02910466|450784299|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
125315524|NCT02910466|450784299|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
125315525|NCT01808196|450784306|FG000|Overall Study|Lost to Follow-up|1|||
125315526|NCT00479713|450784307|FG000|Overall Study|Adverse Event|8|||
125315527|NCT00479713|450784308|FG001|Overall Study|Adverse Event|6|||
125315528|NCT00479713|450784307|FG000|Overall Study|Death|1|||
125315529|NCT00479713|450784308|FG001|Overall Study|Death|0|||
125315530|NCT00479713|450784307|FG000|Overall Study|Lost to Follow-up|0|||
125315531|NCT00479713|450784308|FG001|Overall Study|Lost to Follow-up|1|||
125315532|NCT00479713|450784307|FG000|Overall Study|Protocol Violation|0|||
125315533|NCT00479713|450784308|FG001|Overall Study|Protocol Violation|1|||
125315534|NCT00479713|450784307|FG000|Overall Study|Withdrawal by Subject|4|||
125315535|NCT00479713|450784308|FG001|Overall Study|Withdrawal by Subject|1|||
125315536|NCT00141102|450784309|FG000|Overall Study|Adverse Event|233|||
125315537|NCT00141102|450784310|FG001|Overall Study|Adverse Event|305|||
125315538|NCT00141102|450784309|FG000|Overall Study|Laboratory Abnormality|9|||
125315539|NCT00141102|450784310|FG001|Overall Study|Laboratory Abnormality|33|||
125315540|NCT00141102|450784309|FG000|Overall Study|Lack of Efficacy|21|||
125315541|NCT00141102|450784310|FG001|Overall Study|Lack of Efficacy|26|||
125315542|NCT00141102|450784309|FG000|Overall Study|Lost to Follow-up|29|||
125315543|NCT00141102|450784310|FG001|Overall Study|Lost to Follow-up|32|||
125315544|NCT00141102|450784309|FG000|Overall Study|Other|87|||
125315545|NCT00141102|450784310|FG001|Overall Study|Other|76|||
125315546|NCT00141102|450784309|FG000|Overall Study|Withdrawal by Subject|112|||
125315547|NCT00141102|450784310|FG001|Overall Study|Withdrawal by Subject|142|||
125315548|NCT00141102|450784309|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
125315549|NCT00141102|450784310|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
125315550|NCT00141102|450784309|FG000|Overall Study|Death|2|||
125315551|NCT00141102|450784310|FG001|Overall Study|Death|2|||
125315552|NCT01871519|450784315|FG000|Overall Study|Death|26|||
125315553|NCT01871519|450784315|FG000|Overall Study|Lost to Follow-up|15|||
125315554|NCT01871519|450784315|FG000|Overall Study|Withdrawal by Subject|49|||
125315555|NCT00794950|450784316|FG000|BCG Induction|Withdrawal by Subject|2|||
125315556|NCT00794950|450784316|FG000|BCG Induction|ineligible|3|||
125315557|NCT00794950|450784316|FG000|BCG Induction|noncompliant w. BCG|1|||
125315558|NCT00794950|450784316|FG000|BCG Induction|Adverse Event|1|||
125315559|NCT00794950|450784316|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
125315560|NCT00794950|450784316|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
125315561|NCT00794950|450784316|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
125315562|NCT00794950|450784316|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
125315563|NCT02485704|450784317|FG000|Overall Study|Lost to Follow-up|4|||
125315564|NCT02485704|450784318|FG001|Overall Study|Lost to Follow-up|5|||
125315565|NCT02485704|450784317|FG000|Overall Study|Withdrawal by Subject|0|||
125315566|NCT02485704|450784318|FG001|Overall Study|Withdrawal by Subject|3|||
125315567|NCT02485704|450784317|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
125315568|NCT02485704|450784318|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
125315569|NCT04481243|450786042|FG000|Overall Study|Withdrawal by Subject|4|||
125315570|NCT02173769|450786044|FG000|Overall Study|Protocol Violation|4|||
125315571|NCT04388111|450786045|FG000|Overall Study|Lost to Follow-up|5|||
125315572|NCT04388111|450786046|FG001|Overall Study|Lost to Follow-up|3|||
125315573|NCT04388111|450786045|FG000|Overall Study|Adverse Event|1|||
125315574|NCT04388111|450786046|FG001|Overall Study|Adverse Event|1|||
125315575|NCT04388111|450786045|FG000|Overall Study|Protocol Violation|2|||
125315576|NCT04388111|450786046|FG001|Overall Study|Protocol Violation|4|||
125315577|NCT04388111|450786045|FG000|Overall Study|Withdrawal by Subject|1|||
125315578|NCT04388111|450786046|FG001|Overall Study|Withdrawal by Subject|0|||
125315579|NCT00928486|450786047|FG000|Overall Study|Adverse Event|2|||
125315580|NCT00928486|450786047|FG000|Overall Study|Disease Progression|7|||
125655965|NCT05553600|452025910|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
125655966|NCT05553600|452025907|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
125315581|NCT00928486|450786047|FG000|Overall Study|Withdrawal by Subject|1|||
125315582|NCT01342913|450786048|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
125315583|NCT01342913|450786049|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125315584|NCT01342913|450786050|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125315585|NCT01342913|450786048|FG000|2-week Run-in Period|Physician Decision|6|||
125315586|NCT01342913|450786049|FG001|2-week Run-in Period|Physician Decision|0|||
125315587|NCT01342913|450786050|FG002|2-week Run-in Period|Physician Decision|0|||
125315588|NCT01342913|450786048|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
125315589|NCT01342913|450786049|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
125315590|NCT01342913|450786050|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
125315591|NCT01342913|450786048|FG000|2-week Run-in Period|Adverse Event|2|||
125315592|NCT01342913|450786049|FG001|2-week Run-in Period|Adverse Event|0|||
125315593|NCT01342913|450786050|FG002|2-week Run-in Period|Adverse Event|0|||
125315594|NCT01342913|450786048|FG000|2-week Run-in Period|Protocol Violation|5|||
125315595|NCT01342913|450786049|FG001|2-week Run-in Period|Protocol Violation|0|||
125315596|NCT01342913|450786050|FG002|2-week Run-in Period|Protocol Violation|0|||
125315597|NCT01342913|450786048|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
125315598|NCT01342913|450786049|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
125315599|NCT01342913|450786050|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
125315600|NCT01342913|450786048|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125315601|NCT01342913|450786049|FG001|Double-Blind Treatment Period|Adverse Event|3|||
125315602|NCT01342913|450786050|FG002|Double-Blind Treatment Period|Adverse Event|6|||
125315603|NCT01342913|450786048|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
125315604|NCT01342913|450786049|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
125315605|NCT01342913|450786050|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
125315606|NCT01342913|450786048|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
125315607|NCT01342913|450786049|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
125315608|NCT01342913|450786050|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
125315609|NCT01342913|450786048|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125315610|NCT01342913|450786049|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
125315611|NCT01342913|450786050|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
125655967|NCT05553600|452025908|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
125315612|NCT01342913|450786048|FG000|Double-Blind Treatment Period|Physician Decision|0|||
125315613|NCT01342913|450786049|FG001|Double-Blind Treatment Period|Physician Decision|2|||
125315614|NCT01342913|450786050|FG002|Double-Blind Treatment Period|Physician Decision|0|||
125315615|NCT01342913|450786048|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125315616|NCT01342913|450786049|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
125315617|NCT01342913|450786050|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
125315618|NCT00387881|450786055|FG000|Overall Study|Lost to Follow-up|23|||
125315619|NCT00387881|450786056|FG001|Overall Study|Lost to Follow-up|23|||
125315620|NCT00387881|450786055|FG000|Overall Study|Protocol Violation|2|||
125315621|NCT00387881|450786056|FG001|Overall Study|Protocol Violation|12|||
125315622|NCT00387881|450786055|FG000|Overall Study|Withdrawal by Subject|15|||
125315623|NCT00387881|450786056|FG001|Overall Study|Withdrawal by Subject|18|||
125315624|NCT00387881|450786055|FG000|Overall Study|Sponsor terminated Study|0|||
125315625|NCT00387881|450786056|FG001|Overall Study|Sponsor terminated Study|1|||
125315626|NCT00387881|450786055|FG000|Overall Study|Not eligible|6|||
125315627|NCT00387881|450786056|FG001|Overall Study|Not eligible|7|||
125315628|NCT00387881|450786055|FG000|Overall Study|No opportunity to treat headache|32|||
125315629|NCT00387881|450786056|FG001|Overall Study|No opportunity to treat headache|34|||
125315630|NCT00387881|450786055|FG000|Overall Study|Not otherwise specified|11|||
125315631|NCT00387881|450786056|FG001|Overall Study|Not otherwise specified|7|||
125315632|NCT00453154|450786057|FG000|Double BIind Maintenance|Adverse Event|0|||
125315633|NCT00453154|450786058|FG001|Double BIind Maintenance|Adverse Event|0|||
125315634|NCT00453154|450786059|FG002|Double BIind Maintenance|Adverse Event|3|||
125315635|NCT00453154|450786060|FG003|Double BIind Maintenance|Adverse Event|12|||
125315636|NCT00453154|450786057|FG000|Double BIind Maintenance|Death|0|||
125315637|NCT00453154|450786058|FG001|Double BIind Maintenance|Death|0|||
125315638|NCT00453154|450786059|FG002|Double BIind Maintenance|Death|2|||
125315639|NCT00453154|450786060|FG003|Double BIind Maintenance|Death|1|||
125315640|NCT00453154|450786057|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
125315641|NCT00453154|450786058|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
125315642|NCT00453154|450786059|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
125315643|NCT00453154|450786060|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
125315644|NCT00453154|450786057|FG000|Double BIind Maintenance|Progression|0|||
125315645|NCT00453154|450786058|FG001|Double BIind Maintenance|Progression|0|||
125315646|NCT00453154|450786059|FG002|Double BIind Maintenance|Progression|29|||
125315647|NCT00453154|450786060|FG003|Double BIind Maintenance|Progression|26|||
125315648|NCT00453154|450786057|FG000|Double BIind Maintenance|Medical Issues|0|||
125315649|NCT00453154|450786058|FG001|Double BIind Maintenance|Medical Issues|0|||
125315650|NCT00453154|450786059|FG002|Double BIind Maintenance|Medical Issues|3|||
125315651|NCT00453154|450786060|FG003|Double BIind Maintenance|Medical Issues|1|||
125315652|NCT00453154|450786057|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
125315653|NCT00453154|450786058|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
125315654|NCT00453154|450786059|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
125315655|NCT00453154|450786060|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
125315656|NCT01790594|450786061|FG000|Overall Study|Death|1|||
125315657|NCT01790594|450786062|FG001|Overall Study|Death|0|||
125315658|NCT01790594|450786063|FG002|Overall Study|Death|0|||
125315659|NCT01790594|450786061|FG000|Overall Study|Physician Decision|2|||
125315660|NCT01790594|450786062|FG001|Overall Study|Physician Decision|1|||
125315661|NCT01790594|450786063|FG002|Overall Study|Physician Decision|0|||
125315662|NCT01790594|450786061|FG000|Overall Study|Withdrawal by Subject|2|||
125315663|NCT01790594|450786062|FG001|Overall Study|Withdrawal by Subject|0|||
125315664|NCT01790594|450786063|FG002|Overall Study|Withdrawal by Subject|0|||
125315665|NCT01790594|450786061|FG000|Overall Study|Transplant was not done|0|||
125315666|NCT01790594|450786062|FG001|Overall Study|Transplant was not done|0|||
125315667|NCT01790594|450786063|FG002|Overall Study|Transplant was not done|3|||
125315668|NCT01790594|450786061|FG000|Overall Study|Terminated prior to week 76|0|||
125315669|NCT01790594|450786062|FG001|Overall Study|Terminated prior to week 76|2|||
125315670|NCT01790594|450786063|FG002|Overall Study|Terminated prior to week 76|0|||
125315671|NCT03291067|450786065|FG000|Overall Study|Adverse Event|0|||
125315672|NCT03291067|450786066|FG001|Overall Study|Adverse Event|2|||
125315673|NCT03291067|450786067|FG002|Overall Study|Adverse Event|17|||
125315674|NCT03291067|450786068|FG003|Overall Study|Adverse Event|3|||
125315675|NCT03291067|450786065|FG000|Overall Study|Lost to Follow-up|2|||
125315676|NCT03291067|450786066|FG001|Overall Study|Lost to Follow-up|1|||
125315677|NCT03291067|450786067|FG002|Overall Study|Lost to Follow-up|0|||
125315678|NCT03291067|450786068|FG003|Overall Study|Lost to Follow-up|1|||
125315679|NCT03291067|450786065|FG000|Overall Study|Physician Decision|0|||
125315680|NCT03291067|450786066|FG001|Overall Study|Physician Decision|0|||
125315681|NCT03291067|450786067|FG002|Overall Study|Physician Decision|1|||
125315682|NCT03291067|450786068|FG003|Overall Study|Physician Decision|0|||
125315683|NCT03291067|450786065|FG000|Overall Study|Protocol Violation|5|||
125315684|NCT03291067|450786066|FG001|Overall Study|Protocol Violation|3|||
125315685|NCT03291067|450786067|FG002|Overall Study|Protocol Violation|4|||
125315686|NCT03291067|450786068|FG003|Overall Study|Protocol Violation|2|||
125315687|NCT03291067|450786065|FG000|Overall Study|Withdrawal by Subject|3|||
125315688|NCT03291067|450786066|FG001|Overall Study|Withdrawal by Subject|4|||
125315689|NCT03291067|450786067|FG002|Overall Study|Withdrawal by Subject|7|||
125315690|NCT03291067|450786068|FG003|Overall Study|Withdrawal by Subject|5|||
125315691|NCT03291067|450786065|FG000|Overall Study|Other|0|||
125315692|NCT03291067|450786066|FG001|Overall Study|Other|4|||
125315693|NCT03291067|450786067|FG002|Overall Study|Other|4|||
125315694|NCT03291067|450786068|FG003|Overall Study|Other|6|||
125315695|NCT02152631|450786069|FG000|Overall Study|Adverse Event|32|||
125315696|NCT02152631|450786070|FG001|Overall Study|Adverse Event|4|||
125315697|NCT02152631|450786069|FG000|Overall Study|Withdrawal by Subject|13|||
125315698|NCT02152631|450786070|FG001|Overall Study|Withdrawal by Subject|16|||
125315699|NCT02152631|450786069|FG000|Overall Study|Noncompliance with study drug|1|||
125315700|NCT02152631|450786070|FG001|Overall Study|Noncompliance with study drug|0|||
125315701|NCT02152631|450786069|FG000|Overall Study|Physician Decision|1|||
125315702|NCT02152631|450786070|FG001|Overall Study|Physician Decision|2|||
125315703|NCT02152631|450786069|FG000|Overall Study|Lost to Follow-up|0|||
125315704|NCT02152631|450786070|FG001|Overall Study|Lost to Follow-up|1|||
125315705|NCT02152631|450786069|FG000|Overall Study|On Treatment|19|||
125315706|NCT02152631|450786070|FG001|Overall Study|On Treatment|3|||
125315707|NCT05473026|450786071|FG000|Overall Study|Lost to Follow-up|5|||
125315708|NCT05473026|450786072|FG001|Overall Study|Lost to Follow-up|2|||
125315709|NCT03683173|450786083|FG000|Completed Follow-up|Unavailable|235|||
125655968|NCT05553600|452025909|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
125655969|NCT05553600|452025910|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
125655970|NCT05553600|452025907|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
125655971|NCT05553600|452025908|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
125655972|NCT05553600|452025909|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
125655973|NCT05553600|452025910|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
125655974|NCT05553600|452025907|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
125655975|NCT05553600|452025908|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
125655976|NCT05553600|452025909|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
125655977|NCT05553600|452025910|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
125655978|NCT05553600|452025907|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
125655979|NCT05553600|452025908|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
125655980|NCT05553600|452025909|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
125655981|NCT05553600|452025910|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
125655982|NCT05553600|452025907|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
125655983|NCT05553600|452025908|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
125655984|NCT05553600|452025909|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
125655985|NCT05553600|452025910|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
125655986|NCT05553600|452025907|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
125655987|NCT05553600|452025908|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
125315710|NCT03683173|450786084|FG001|Completed Follow-up|Unavailable|217|||
125315711|NCT03683173|450786083|FG000|Completed Follow-up|Refused|69|||
125315712|NCT03683173|450786084|FG001|Completed Follow-up|Refused|59|||
125315713|NCT03683173|450786083|FG000|Completed Follow-up|Disconnected phone|65|||
125315714|NCT03683173|450786084|FG001|Completed Follow-up|Disconnected phone|95|||
125315715|NCT03683173|450786083|FG000|Completed Follow-up|Health issue/deceased|10|||
125315716|NCT03683173|450786084|FG001|Completed Follow-up|Health issue/deceased|4|||
125315717|NCT03683173|450786083|FG000|Completed Follow-up|Moved away|8|||
125315718|NCT03683173|450786084|FG001|Completed Follow-up|Moved away|1|||
125315719|NCT02210000|450786085|FG000|Overall Study|Study Terminated|11|||
125315720|NCT02210000|450786086|FG001|Overall Study|Study Terminated|12|||
125315721|NCT02210000|450786085|FG000|Overall Study|Withdrawal by Subject|7|||
125315722|NCT02210000|450786086|FG001|Overall Study|Withdrawal by Subject|1|||
125315723|NCT02210000|450786085|FG000|Overall Study|Adverse Event|1|||
125315724|NCT02210000|450786086|FG001|Overall Study|Adverse Event|5|||
125315725|NCT02210000|450786085|FG000|Overall Study|Lost to Follow-up|0|||
125315726|NCT02210000|450786086|FG001|Overall Study|Lost to Follow-up|2|||
125315727|NCT02210000|450786085|FG000|Overall Study|Physician Decision|0|||
125315728|NCT02210000|450786086|FG001|Overall Study|Physician Decision|1|||
125315729|NCT01329263|450786089|FG000|Overall Study|Lost to Follow-up|4|||
125315730|NCT01329263|450786090|FG001|Overall Study|Lost to Follow-up|21|||
125315731|NCT01329263|450786089|FG000|Overall Study|Withdrawal by Subject|1|||
125655988|NCT05553600|452025909|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
125315732|NCT01329263|450786090|FG001|Overall Study|Withdrawal by Subject|2|||
125315733|NCT00308139|450786092|FG000|Overall Study|Adverse Event|20|||
125315734|NCT00308139|450786093|FG001|Overall Study|Adverse Event|14|||
125315735|NCT00308139|450786092|FG000|Overall Study|Lost to Follow-up|13|||
125315736|NCT00308139|450786093|FG001|Overall Study|Lost to Follow-up|8|||
125315737|NCT00308139|450786092|FG000|Overall Study|Protocol Violation|3|||
125315738|NCT00308139|450786093|FG001|Overall Study|Protocol Violation|2|||
125315739|NCT00308139|450786092|FG000|Overall Study|Withdrawal of Consent|40|||
125315740|NCT00308139|450786093|FG001|Overall Study|Withdrawal of Consent|42|||
125315741|NCT00308139|450786092|FG000|Overall Study|Investigator Decision|11|||
125315742|NCT00308139|450786093|FG001|Overall Study|Investigator Decision|10|||
125655989|NCT05553600|452025910|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
125655990|NCT05553600|452025907|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
125655991|NCT05553600|452025908|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
125655992|NCT05553600|452025909|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
125655993|NCT05553600|452025910|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
125655994|NCT02116309|452025915|FG000|Overall Study|Lost to Follow-up|0|||
125655995|NCT02116309|452025916|FG001|Overall Study|Lost to Follow-up|1|||
125655996|NCT03710824|452025917|FG000|Overall Study|Withdrawal by Subject|1|||
125655997|NCT03710824|452025917|FG000|Overall Study|Lost to Follow-up|3|||
125655998|NCT03710824|452025917|FG000|Overall Study|Adverse Event|25|||
125655999|NCT03710824|452025917|FG000|Overall Study|Treatment discontinuation|2|||
125656000|NCT02329834|452025918|FG000|Overall Study|Physician Decision|1|||
125656001|NCT02329834|452025919|FG001|Overall Study|Physician Decision|0|||
125656002|NCT00578448|452025920|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
125656003|NCT00578448|452025920|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
125656004|NCT00578448|452025920|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
125656005|NCT00578448|452025920|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
125656006|NCT05102162|452025925|FG000|Overall Study|Withdrawal by Subject|3|||
125656007|NCT05102162|452025926|FG001|Overall Study|Withdrawal by Subject|0|||
125656008|NCT05102162|452025925|FG000|Overall Study|Baseline cultures negative|4|||
125656009|NCT05102162|452025926|FG001|Overall Study|Baseline cultures negative|2|||
125656010|NCT05102162|452025925|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
125656011|NCT05102162|452025926|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
125656012|NCT05102162|452025925|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
125656013|NCT05102162|452025926|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
125656014|NCT01165424|452025927|FG000|Overall Study|Clinical adverse experiences|1|||
125656015|NCT01165424|452025927|FG000|Overall Study|Laboratory adverse experiences|1|||
125656016|NCT01165424|452025927|FG000|Overall Study|Did not meet entry criteria|1|||
125656017|NCT01165424|452025927|FG000|Overall Study|Participant moved (relocated)|1|||
125656018|NCT00557830|452025928|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
125656019|NCT00557830|452025929|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
125656020|NCT00557830|452025930|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
125656021|NCT00557830|452025928|FG000|Screening Treatment Phase|Adverse Event|2|||
125656022|NCT00557830|452025929|FG001|Screening Treatment Phase|Adverse Event|0|||
125656023|NCT00557830|452025930|FG002|Screening Treatment Phase|Adverse Event|0|||
125656024|NCT00557830|452025928|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
125656025|NCT00557830|452025929|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
125656026|NCT00557830|452025930|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
125656027|NCT00538473|452025932|FG000|Overall Study|Adverse Event|1|||
125656028|NCT00538473|452025933|FG001|Overall Study|Adverse Event|0|||
125656029|NCT01833897|452025934|FG000|Overall Study|Lack of Efficacy|1|||
125656030|NCT02184988|452025942|FG000|Overall Study|Pregnancy|2|||
125656031|NCT02184988|452025942|FG000|Overall Study|Adverse Event|2|||
125656032|NCT02184988|452025942|FG000|Overall Study|moving away/travelling/unable to complet|6|||
125656033|NCT02184988|452025942|FG000|Overall Study|work scheduling issues|4|||
125656034|NCT02184988|452025942|FG000|Overall Study|various other reasons|9|||
125656035|NCT02184988|452025942|FG000|Overall Study|Lost to Follow-up|32|||
125656036|NCT00690573|452025951|FG000|Overall Study|Lack of Efficacy|8|||
125656037|NCT00690573|452025951|FG000|Overall Study|Withdrawal by Subject|1|||
125656038|NCT01283282|452025952|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
125656039|NCT01283282|452025953|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
125656040|NCT01283282|452025952|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
125656041|NCT01283282|452025953|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
125656042|NCT01283282|452025952|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
125656043|NCT01283282|452025953|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
125656044|NCT00777920|452025954|FG000|Overall Study|Adverse Event|39|||
125656045|NCT00777920|452025954|FG000|Overall Study|Withdrawal of Consent|4|||
125656046|NCT00777920|452025954|FG000|Overall Study|Lost to Follow-up|1|||
125656047|NCT00777920|452025954|FG000|Overall Study|Investigator's discretion|1|||
125315743|NCT00308139|450786092|FG000|Overall Study|Loss of Glucose Control|5|||
125315744|NCT00308139|450786093|FG001|Overall Study|Loss of Glucose Control|7|||
125315745|NCT00308139|450786092|FG000|Overall Study|Administrative|1|||
125315746|NCT00308139|450786093|FG001|Overall Study|Administrative|4|||
125315747|NCT00308139|450786092|FG000|Overall Study|Other|1|||
125656048|NCT00777920|452025954|FG000|Overall Study|Clinical status did not improve|1|||
125656049|NCT00777920|452025954|FG000|Overall Study|Other, not specified|4|||
125656050|NCT00483717|452025955|FG000|Overall Study|Protocol Violation|5|||
125656051|NCT00483717|452025956|FG001|Overall Study|Protocol Violation|7|||
125656052|NCT00483717|452025955|FG000|Overall Study|Time of dosing missing|1|||
125315748|NCT00308139|450786093|FG001|Overall Study|Other|0|||
125315749|NCT00833040|450786096|FG000|Overall Study|Adverse Event|0|||
125315750|NCT00833040|450786097|FG001|Overall Study|Adverse Event|0|||
125315751|NCT00833040|450786098|FG002|Overall Study|Adverse Event|0|||
125315752|NCT00833040|450786099|FG003|Overall Study|Adverse Event|0|||
125315753|NCT00833040|450786100|FG004|Overall Study|Adverse Event|0|||
125315754|NCT00833040|450786101|FG005|Overall Study|Adverse Event|1|||
125315755|NCT02313766|450786102|FG000|Overall Study|surgery cancelled|1|||
125656053|NCT00483717|452025956|FG001|Overall Study|Time of dosing missing|1|||
125656054|NCT00483717|452025955|FG000|Overall Study|No treatment for migraine|16|||
125656055|NCT00483717|452025956|FG001|Overall Study|No treatment for migraine|13|||
125656056|NCT00483717|452025955|FG000|Overall Study|Lost to Follow-up|1|||
125656057|NCT00483717|452025956|FG001|Overall Study|Lost to Follow-up|0|||
125656058|NCT00483717|452025955|FG000|Overall Study|Withdrawal by Subject|1|||
125656059|NCT00483717|452025956|FG001|Overall Study|Withdrawal by Subject|0|||
125656060|NCT03878108|452025957|FG000|Overall Study|Adverse Event|1|||
125656061|NCT03878108|452025958|FG001|Overall Study|Adverse Event|0|||
125656062|NCT01682681|452025959|FG000|Overall Study|Lack of Efficacy|62|||
125656063|NCT01682681|452025959|FG000|Overall Study|Withdrawal by Subject|1|||
125656064|NCT01682681|452025959|FG000|Overall Study|Moved to other hospital|10|||
125656065|NCT01682681|452025959|FG000|Overall Study|Lost to Follow-up|174|||
125656066|NCT01682681|452025959|FG000|Overall Study|Adverse Event|46|||
125656067|NCT01682681|452025959|FG000|Overall Study|tapering of topiramate|5|||
125656068|NCT01682681|452025959|FG000|Overall Study|Other|21|||
125656069|NCT01682681|452025959|FG000|Overall Study|Low compliance|13|||
125656070|NCT00975000|452025960|FG000|Overall Study|Other|1|||
125656071|NCT00975000|452025961|FG001|Overall Study|Other|0|||
125656072|NCT00975000|452025960|FG000|Overall Study|Adverse Event|1|||
125656073|NCT00975000|452025961|FG001|Overall Study|Adverse Event|1|||
125656074|NCT00975000|452025960|FG000|Overall Study|Withdrawal by Subject|2|||
125656075|NCT00975000|452025961|FG001|Overall Study|Withdrawal by Subject|2|||
125656076|NCT00975000|452025960|FG000|Overall Study|Lost to Follow-up|0|||
125656077|NCT00975000|452025961|FG001|Overall Study|Lost to Follow-up|1|||
125656078|NCT00975000|452025960|FG000|Overall Study|Protocol-specified Criteria|1|||
125656079|NCT00975000|452025961|FG001|Overall Study|Protocol-specified Criteria|0|||
125656080|NCT00975000|452025960|FG000|Overall Study|Non-compliance|0|||
125656081|NCT00975000|452025961|FG001|Overall Study|Non-compliance|1|||
125656082|NCT01525407|452025962|FG000|Overall Study|Change in recipient treatment plan|2|||
125656083|NCT01525407|452025963|FG001|Overall Study|Change in recipient treatment plan|2|||
125656084|NCT01525407|452025962|FG000|Overall Study|Withdrawal by Subject|0|||
125656085|NCT01525407|452025963|FG001|Overall Study|Withdrawal by Subject|1|||
125656086|NCT01525407|452025962|FG000|Overall Study|Transplant was delayed|0|||
125656087|NCT01525407|452025963|FG001|Overall Study|Transplant was delayed|1|||
125656088|NCT01525407|452025962|FG000|Overall Study|Delay in Transplant|1|||
125656089|NCT01525407|452025963|FG001|Overall Study|Delay in Transplant|0|||
125656090|NCT01819467|452027402|FG000|Overall Study|Physician Decision|20|||
125656091|NCT01819467|452027403|FG001|Overall Study|Physician Decision|9|||
125656092|NCT02875340|452027405|FG000|Overall Study|Death|2|||
125315756|NCT02313766|450786103|FG001|Overall Study|surgery cancelled|0|||
125315757|NCT02313766|450786104|FG002|Overall Study|surgery cancelled|0|||
125656093|NCT02875340|452027405|FG000|Overall Study|Withdrawal by Subject|2|||
125656094|NCT02875340|452027405|FG000|Overall Study|Physician Decision|3|||
125656095|NCT02875340|452027405|FG000|Overall Study|Adverse Event|1|||
125656096|NCT01607398|452027408|FG000|Overall Study|Adverse Event|0|||
125656097|NCT01607398|452027409|FG001|Overall Study|Adverse Event|2|||
125656098|NCT01607398|452027408|FG000|Overall Study|Severe COPD|2|||
125656099|NCT01607398|452027409|FG001|Overall Study|Severe COPD|0|||
125656100|NCT03457727|452027410|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
125315758|NCT02313766|450786102|FG000|Overall Study|Lost to Follow-up|0|||
125315759|NCT02313766|450786103|FG001|Overall Study|Lost to Follow-up|2|||
125315760|NCT02313766|450786104|FG002|Overall Study|Lost to Follow-up|0|||
125315761|NCT02313766|450786102|FG000|Overall Study|Adverse Event|0|||
125315762|NCT02313766|450786103|FG001|Overall Study|Adverse Event|1|||
125315763|NCT02313766|450786104|FG002|Overall Study|Adverse Event|0|||
125656101|NCT03457727|452027411|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
125315764|NCT02193776|450786106|FG000|Overall Study|Consent withdrawn|1|||
125315765|NCT02193776|450786107|FG001|Overall Study|Consent withdrawn|0|||
125315766|NCT02193776|450786108|FG002|Overall Study|Consent withdrawn|0|||
125315767|NCT02193776|450786109|FG003|Overall Study|Consent withdrawn|0|||
125540480|NCT04664400|451607644|FG000|Overall Study|Withdrawal by Subject|2|||
125656102|NCT03457727|452027412|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
125656103|NCT03457727|452027413|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
125656104|NCT00929201|452027414|FG000|Period 1|Withdrawal by Subject|0|||
125656105|NCT00929201|452027415|FG001|Period 1|Withdrawal by Subject|1|||
125656106|NCT01299272|452027418|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
125656107|NCT01299272|452027419|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
125656108|NCT01299272|452027420|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
125656109|NCT01299272|452027421|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
125656110|NCT01299272|452027418|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
125315768|NCT02193776|450786106|FG000|Overall Study|Failure to comply with protocol|0|||
125315769|NCT02193776|450786107|FG001|Overall Study|Failure to comply with protocol|1|||
125540481|NCT00515853|451607645|FG000|Overall Study|Lost to Follow-up|9|||
125315770|NCT02193776|450786108|FG002|Overall Study|Failure to comply with protocol|0|||
125315771|NCT02193776|450786109|FG003|Overall Study|Failure to comply with protocol|0|||
125315772|NCT02193776|450786106|FG000|Overall Study|Investigator/Sponsor decision|1|||
125315773|NCT02193776|450786107|FG001|Overall Study|Investigator/Sponsor decision|1|||
125315774|NCT02193776|450786108|FG002|Overall Study|Investigator/Sponsor decision|0|||
125315775|NCT02193776|450786109|FG003|Overall Study|Investigator/Sponsor decision|0|||
125315776|NCT02193776|450786106|FG000|Overall Study|Death|1|||
125315777|NCT02193776|450786107|FG001|Overall Study|Death|0|||
125315778|NCT02193776|450786108|FG002|Overall Study|Death|0|||
125315779|NCT02193776|450786109|FG003|Overall Study|Death|0|||
125315780|NCT02193776|450786106|FG000|Overall Study|Adverse event/Specific toxicity|5|||
125315781|NCT02193776|450786107|FG001|Overall Study|Adverse event/Specific toxicity|5|||
125315782|NCT02193776|450786108|FG002|Overall Study|Adverse event/Specific toxicity|2|||
125315783|NCT02193776|450786109|FG003|Overall Study|Adverse event/Specific toxicity|2|||
125315784|NCT01458639|450786110|FG000|Overall Study|Physician Decision|4|||
125315785|NCT01458639|450786110|FG000|Overall Study|Equipment issue|1|||
125315786|NCT01458639|450786110|FG000|Overall Study|Inability to obtain subject blood sample|1|||
125315787|NCT01884077|450786111|FG000|Overall Study|screen fail|0|||
125315788|NCT01884077|450786112|FG001|Overall Study|screen fail|2|||
125315789|NCT01884077|450786111|FG000|Overall Study|canceled surgery|2|||
125315790|NCT01884077|450786112|FG001|Overall Study|canceled surgery|0|||
125315791|NCT01884077|450786111|FG000|Overall Study|Lost to Follow-up|0|||
125315792|NCT01884077|450786112|FG001|Overall Study|Lost to Follow-up|4|||
125656111|NCT01299272|452027419|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
125656112|NCT01299272|452027420|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
125656113|NCT01299272|452027421|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
125656114|NCT01299272|452027418|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
125656115|NCT01299272|452027419|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
125656116|NCT01299272|452027420|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
125656117|NCT01299272|452027421|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
125656118|NCT01299272|452027418|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
125656119|NCT01299272|452027419|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
125656120|NCT01299272|452027420|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
125656121|NCT01299272|452027421|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
125656122|NCT01299272|452027418|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
125656123|NCT01299272|452027419|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
125656124|NCT01299272|452027420|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
125656125|NCT01299272|452027421|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
125656126|NCT01299272|452027418|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
125656127|NCT01299272|452027419|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
125656128|NCT01299272|452027420|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
125656129|NCT01299272|452027421|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
125656130|NCT01299272|452027418|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
125656131|NCT01299272|452027419|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
125656132|NCT01299272|452027420|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
125656133|NCT01299272|452027421|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
125656134|NCT01299272|452027418|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
125656135|NCT01299272|452027419|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
125656136|NCT01299272|452027420|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
125656137|NCT01299272|452027421|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
125656138|NCT01299272|452027418|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
125656139|NCT01299272|452027419|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
125656140|NCT01299272|452027420|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
125656141|NCT01299272|452027421|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
125656142|NCT01299272|452027418|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
125656143|NCT01299272|452027419|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
125656144|NCT01299272|452027420|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
125656145|NCT01299272|452027421|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
125656146|NCT01299272|452027418|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
125656147|NCT01299272|452027419|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
125656148|NCT01299272|452027420|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
125656149|NCT01299272|452027421|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
125656150|NCT01299272|452027418|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
125656151|NCT01299272|452027419|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
125315793|NCT01884077|450786111|FG000|Overall Study|study closed|6|||
125315794|NCT01884077|450786112|FG001|Overall Study|study closed|4|||
125656152|NCT01299272|452027420|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
125315795|NCT01755234|450786113|FG000|Overall Study|Lost to Follow-up|11|||
125315796|NCT01755234|450786114|FG001|Overall Study|Lost to Follow-up|6|||
125540482|NCT00515853|451607646|FG001|Overall Study|Lost to Follow-up|13|||
125315797|NCT01755234|450786113|FG000|Overall Study|Change in surgical case|2|||
125315798|NCT01755234|450786114|FG001|Overall Study|Change in surgical case|1|||
125315799|NCT01755234|450786113|FG000|Overall Study|case cancelled|1|||
125315800|NCT01755234|450786114|FG001|Overall Study|case cancelled|0|||
125315801|NCT01755234|450786113|FG000|Overall Study|Withdrawal by Subject|0|||
125315802|NCT01755234|450786114|FG001|Overall Study|Withdrawal by Subject|1|||
125315803|NCT01755234|450786113|FG000|Overall Study|unblinded|1|||
125315804|NCT01755234|450786114|FG001|Overall Study|unblinded|0|||
125315805|NCT00981149|450786115|FG000|Overall Study|Lost to Follow-up|1|||
125315806|NCT00981149|450786116|FG001|Overall Study|Lost to Follow-up|2|||
125315807|NCT00981149|450786115|FG000|Overall Study|Withdrawal by Subject|1|||
125315808|NCT00981149|450786116|FG001|Overall Study|Withdrawal by Subject|1|||
125315809|NCT02648204|450786117|FG000|Overall Study|Withdrawal by Subject|12|||
125315810|NCT02648204|450786118|FG001|Overall Study|Withdrawal by Subject|8|||
125315811|NCT02648204|450786119|FG002|Overall Study|Withdrawal by Subject|2|||
125315812|NCT02648204|450786120|FG003|Overall Study|Withdrawal by Subject|6|||
125315813|NCT02648204|450786117|FG000|Overall Study|Lost to Follow-up|5|||
125315814|NCT02648204|450786118|FG001|Overall Study|Lost to Follow-up|8|||
125315815|NCT02648204|450786119|FG002|Overall Study|Lost to Follow-up|4|||
125315816|NCT02648204|450786120|FG003|Overall Study|Lost to Follow-up|6|||
125315817|NCT02648204|450786117|FG000|Overall Study|Missing follow-up information|4|||
125315818|NCT02648204|450786118|FG001|Overall Study|Missing follow-up information|4|||
125656153|NCT01299272|452027421|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
125656154|NCT01299272|452027418|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
125656155|NCT01299272|452027419|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
125656156|NCT01299272|452027420|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
125656157|NCT01299272|452027421|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
125656158|NCT01299272|452027418|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
125656159|NCT01299272|452027419|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
125656160|NCT01299272|452027420|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
125656161|NCT01299272|452027421|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
125656162|NCT01299272|452027418|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
125656163|NCT01299272|452027419|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
125656164|NCT01299272|452027420|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
125656165|NCT01299272|452027421|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
125656166|NCT01299272|452027418|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
125656167|NCT01299272|452027419|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
125656168|NCT01299272|452027420|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
125656169|NCT01299272|452027421|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
125656170|NCT01299272|452027418|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
125656171|NCT01299272|452027419|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
125656172|NCT01299272|452027420|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
125656173|NCT01299272|452027421|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
125656174|NCT01299272|452027418|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
125656175|NCT01299272|452027419|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
125656176|NCT01299272|452027420|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
125656177|NCT01299272|452027421|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
125656178|NCT01299272|452027418|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
125656179|NCT01299272|452027419|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
125656180|NCT01299272|452027420|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
125656181|NCT01299272|452027421|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
125656182|NCT01299272|452027418|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
125656183|NCT01299272|452027419|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
125656184|NCT01299272|452027420|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
125656185|NCT01299272|452027421|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
125656186|NCT01299272|452027418|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
125656187|NCT01299272|452027419|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
125656188|NCT01299272|452027420|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
125656189|NCT01299272|452027421|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
125656190|NCT01299272|452027418|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
125656191|NCT01299272|452027419|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
125656192|NCT01299272|452027420|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
125656193|NCT01299272|452027421|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
125315819|NCT02648204|450786119|FG002|Overall Study|Missing follow-up information|4|||
125315820|NCT02648204|450786120|FG003|Overall Study|Missing follow-up information|2|||
125315821|NCT02648204|450786117|FG000|Overall Study|Death|1|||
125315822|NCT02648204|450786118|FG001|Overall Study|Death|1|||
125315823|NCT02648204|450786119|FG002|Overall Study|Death|2|||
125425498|NCT00686881|451180499|FG001|Overall Study|Treatment-related adverse event|9|||
125656194|NCT01299272|452027418|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
125656195|NCT01299272|452027419|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
125656196|NCT01299272|452027420|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
125656197|NCT01299272|452027421|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
125656198|NCT01299272|452027418|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
125656199|NCT01299272|452027419|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
125656200|NCT01299272|452027420|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
125656201|NCT01299272|452027421|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
125656202|NCT01299272|452027418|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
125656203|NCT01299272|452027419|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
125656204|NCT01299272|452027420|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
125656205|NCT01299272|452027421|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
125656206|NCT00464308|452027422|FG000|Overall Study|Adverse Event|22|||
125656207|NCT00464308|452027423|FG001|Overall Study|Adverse Event|27|||
125656208|NCT00464308|452027424|FG002|Overall Study|Adverse Event|16|||
125656209|NCT00464308|452027422|FG000|Overall Study|Lost to Follow-up|29|||
125656210|NCT00464308|452027423|FG001|Overall Study|Lost to Follow-up|19|||
125656211|NCT00464308|452027424|FG002|Overall Study|Lost to Follow-up|20|||
125656212|NCT00464308|452027422|FG000|Overall Study|Patient discontinued and other reasons|17|||
125656213|NCT00464308|452027423|FG001|Overall Study|Patient discontinued and other reasons|17|||
125656214|NCT00464308|452027424|FG002|Overall Study|Patient discontinued and other reasons|23|||
125656215|NCT00464308|452027422|FG000|Overall Study|Physician Decision|1|||
125656216|NCT00464308|452027423|FG001|Overall Study|Physician Decision|0|||
125656217|NCT00464308|452027424|FG002|Overall Study|Physician Decision|0|||
125656218|NCT01513759|452027425|FG000|Overall Study|Protocol Violation|4|||
125656219|NCT01513759|452027425|FG000|Overall Study|Death during catheter placement|1|||
125656220|NCT00630994|452027426|FG000|Overall Study|Adverse Event|1|||
125656221|NCT00630994|452027426|FG000|Overall Study|Disease Progression|1|||
125656222|NCT00630994|452027426|FG000|Overall Study|Lack of Efficacy|1|||
125656223|NCT00630994|452027426|FG000|Overall Study|Other|1|||
125656224|NCT03533608|452027427|FG000|Overall Study|Withdrawal by Subject|3|||
125656225|NCT03533608|452027427|FG000|Overall Study|Physician Decision|2|||
125656226|NCT03286426|452027428|FG000|Overall Study|Physician Decision|3|||
125656227|NCT03514121|452027429|FG000|Overall Study|Withdrawal by Subject|0|||
125656228|NCT03514121|452027430|FG001|Overall Study|Withdrawal by Subject|0|||
125656229|NCT03514121|452027431|FG002|Overall Study|Withdrawal by Subject|0|||
125656230|NCT03514121|452027432|FG003|Overall Study|Withdrawal by Subject|0|||
125656231|NCT03514121|452027433|FG004|Overall Study|Withdrawal by Subject|1|||
125656232|NCT03514121|452027434|FG005|Overall Study|Withdrawal by Subject|2|||
125656233|NCT03514121|452027435|FG006|Overall Study|Withdrawal by Subject|1|||
125656234|NCT03514121|452027436|FG007|Overall Study|Withdrawal by Subject|1|||
125656235|NCT03514121|452027437|FG008|Overall Study|Withdrawal by Subject|7|||
125656236|NCT03514121|452027438|FG009|Overall Study|Withdrawal by Subject|2|||
125656237|NCT03514121|452027429|FG000|Overall Study|Death|0|||
125656238|NCT03514121|452027430|FG001|Overall Study|Death|0|||
125656239|NCT03514121|452027431|FG002|Overall Study|Death|0|||
125656240|NCT03514121|452027432|FG003|Overall Study|Death|0|||
125656241|NCT03514121|452027433|FG004|Overall Study|Death|0|||
125656242|NCT03514121|452027434|FG005|Overall Study|Death|3|||
125656243|NCT03514121|452027435|FG006|Overall Study|Death|2|||
125656244|NCT03514121|452027436|FG007|Overall Study|Death|1|||
125656245|NCT03514121|452027437|FG008|Overall Study|Death|26|||
125656246|NCT03514121|452027438|FG009|Overall Study|Death|3|||
125656247|NCT03514121|452027429|FG000|Overall Study|Lost to Follow-up|0|||
125656248|NCT03514121|452027430|FG001|Overall Study|Lost to Follow-up|0|||
125656249|NCT03514121|452027431|FG002|Overall Study|Lost to Follow-up|1|||
125656250|NCT03514121|452027432|FG003|Overall Study|Lost to Follow-up|0|||
125315824|NCT02648204|450786120|FG003|Overall Study|Death|2|||
125315825|NCT02648204|450786117|FG000|Overall Study|Adverse Event|0|||
125315826|NCT02648204|450786118|FG001|Overall Study|Adverse Event|0|||
125315827|NCT02648204|450786119|FG002|Overall Study|Adverse Event|1|||
125315828|NCT02648204|450786120|FG003|Overall Study|Adverse Event|0|||
125315829|NCT02634333|450786121|FG000|Overall Study|Completed out of Window|3|||
125315830|NCT02634333|450786122|FG001|Overall Study|Completed out of Window|2|||
125315831|NCT02634333|450786121|FG000|Overall Study|Missed Visit|5|||
125656251|NCT03514121|452027433|FG004|Overall Study|Lost to Follow-up|0|||
125656252|NCT03514121|452027434|FG005|Overall Study|Lost to Follow-up|0|||
125656253|NCT03514121|452027435|FG006|Overall Study|Lost to Follow-up|0|||
125656254|NCT03514121|452027436|FG007|Overall Study|Lost to Follow-up|0|||
125656255|NCT03514121|452027437|FG008|Overall Study|Lost to Follow-up|1|||
125656256|NCT03514121|452027438|FG009|Overall Study|Lost to Follow-up|0|||
125656257|NCT03514121|452027429|FG000|Overall Study|Adverse Event|0|||
125656258|NCT03514121|452027430|FG001|Overall Study|Adverse Event|0|||
125656259|NCT03514121|452027431|FG002|Overall Study|Adverse Event|0|||
125315832|NCT02634333|450786122|FG001|Overall Study|Missed Visit|2|||
125315833|NCT02634333|450786121|FG000|Overall Study|Lost to Follow-up|12|||
125656260|NCT03514121|452027432|FG003|Overall Study|Adverse Event|0|||
125656261|NCT03514121|452027433|FG004|Overall Study|Adverse Event|0|||
125656262|NCT03514121|452027434|FG005|Overall Study|Adverse Event|0|||
125656263|NCT03514121|452027435|FG006|Overall Study|Adverse Event|1|||
125656264|NCT03514121|452027436|FG007|Overall Study|Adverse Event|0|||
125656265|NCT03514121|452027437|FG008|Overall Study|Adverse Event|0|||
125656266|NCT03514121|452027438|FG009|Overall Study|Adverse Event|0|||
125656267|NCT03514121|452027429|FG000|Overall Study|Other|0|||
125656268|NCT03514121|452027430|FG001|Overall Study|Other|1|||
125656269|NCT03514121|452027431|FG002|Overall Study|Other|1|||
125656270|NCT03514121|452027432|FG003|Overall Study|Other|0|||
125656271|NCT03514121|452027433|FG004|Overall Study|Other|1|||
125656272|NCT03514121|452027434|FG005|Overall Study|Other|2|||
125656273|NCT03514121|452027435|FG006|Overall Study|Other|3|||
125656274|NCT03514121|452027436|FG007|Overall Study|Other|2|||
125656275|NCT03514121|452027437|FG008|Overall Study|Other|7|||
125656276|NCT03514121|452027438|FG009|Overall Study|Other|3|||
125656277|NCT03514121|452027429|FG000|Overall Study|Study termination by Sponsor|0|||
125656278|NCT03514121|452027430|FG001|Overall Study|Study termination by Sponsor|0|||
125656279|NCT03514121|452027431|FG002|Overall Study|Study termination by Sponsor|0|||
125656280|NCT03514121|452027432|FG003|Overall Study|Study termination by Sponsor|0|||
125656281|NCT03514121|452027433|FG004|Overall Study|Study termination by Sponsor|0|||
125656282|NCT03514121|452027434|FG005|Overall Study|Study termination by Sponsor|0|||
125656283|NCT03514121|452027435|FG006|Overall Study|Study termination by Sponsor|0|||
125656284|NCT03514121|452027436|FG007|Overall Study|Study termination by Sponsor|0|||
125656285|NCT03514121|452027437|FG008|Overall Study|Study termination by Sponsor|11|||
125656286|NCT03514121|452027438|FG009|Overall Study|Study termination by Sponsor|3|||
125656287|NCT03514121|452027429|FG000|Overall Study|Investigator decision|0|||
125656288|NCT03514121|452027430|FG001|Overall Study|Investigator decision|0|||
125656289|NCT03514121|452027431|FG002|Overall Study|Investigator decision|0|||
125656290|NCT03514121|452027432|FG003|Overall Study|Investigator decision|0|||
125656291|NCT03514121|452027433|FG004|Overall Study|Investigator decision|0|||
125656292|NCT03514121|452027434|FG005|Overall Study|Investigator decision|0|||
125656293|NCT03514121|452027435|FG006|Overall Study|Investigator decision|0|||
125656294|NCT03514121|452027436|FG007|Overall Study|Investigator decision|0|||
125656295|NCT03514121|452027437|FG008|Overall Study|Investigator decision|1|||
125656296|NCT03514121|452027438|FG009|Overall Study|Investigator decision|0|||
125656297|NCT03286400|452027442|FG000|Overall Study|Death|10|||
125656298|NCT03286400|452027442|FG000|Overall Study|Lost to Follow-up|10|||
125656299|NCT03286400|452027442|FG000|Overall Study|Physician Decision|1|||
125656300|NCT03286400|452027442|FG000|Overall Study|Scheduling difficulty|4|||
125656301|NCT00826176|452027445|FG000|Overall Study|Lost to Follow-up|1|||
125656302|NCT00826176|452027446|FG001|Overall Study|Lost to Follow-up|0|||
125315834|NCT02634333|450786122|FG001|Overall Study|Lost to Follow-up|7|||
125315835|NCT02634333|450786121|FG000|Overall Study|Withdrawal by Subject|9|||
125315836|NCT02634333|450786122|FG001|Overall Study|Withdrawal by Subject|13|||
125315837|NCT02634333|450786121|FG000|Overall Study|Death|11|||
125315838|NCT02634333|450786122|FG001|Overall Study|Death|8|||
125315839|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
125315840|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
125315841|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Death|1|||
125315842|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Death|2|||
125315843|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
125315844|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
125315845|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
125315846|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
125315847|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
125315848|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
125315849|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
125315850|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
125315851|NCT01794000|450786123|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
125315852|NCT01794000|450786124|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
125315853|NCT01794000|450786123|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
125315854|NCT01794000|450786124|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
125656303|NCT00826176|452027445|FG000|Overall Study|Subject Withdrew Consent|3|||
125656304|NCT00826176|452027446|FG001|Overall Study|Subject Withdrew Consent|0|||
125540483|NCT00515853|451607645|FG000|Overall Study|Withdrawal by Subject|6|||
125656305|NCT00826176|452027445|FG000|Overall Study|Administrative|9|||
125656306|NCT00826176|452027446|FG001|Overall Study|Administrative|0|||
125315855|NCT02748863|450786125|FG000|Treatment Period 1|Adverse Event|0|||
125540484|NCT00515853|451607646|FG001|Overall Study|Withdrawal by Subject|4|||
125656307|NCT00297882|452027451|FG000|Day 14|Lack of Efficacy|12|||
125656308|NCT00297882|452027452|FG001|Day 14|Lack of Efficacy|49|||
125656309|NCT00297882|452027451|FG000|Day 28|Lost to Follow-up|13|||
125315856|NCT02748863|450786126|FG001|Treatment Period 1|Adverse Event|1|||
125315857|NCT02748863|450786127|FG002|Treatment Period 1|Adverse Event|0|||
125315858|NCT02748863|450786128|FG003|Treatment Period 1|Adverse Event|0|||
125315859|NCT02748863|450786129|FG004|Treatment Period 1|Adverse Event|0|||
125315860|NCT02748863|450786125|FG000|Treatment Period 1|Lack of Efficacy|0|||
125315861|NCT02748863|450786126|FG001|Treatment Period 1|Lack of Efficacy|0|||
125315862|NCT02748863|450786127|FG002|Treatment Period 1|Lack of Efficacy|1|||
125315863|NCT02748863|450786128|FG003|Treatment Period 1|Lack of Efficacy|0|||
125315864|NCT02748863|450786129|FG004|Treatment Period 1|Lack of Efficacy|0|||
125315865|NCT02748863|450786125|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125315866|NCT02748863|450786126|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125315867|NCT02748863|450786127|FG002|Treatment Period 1|Withdrawal by Subject|1|||
125315868|NCT02748863|450786128|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125315869|NCT02748863|450786129|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125315870|NCT02748863|450786125|FG000|Treatment Period 2|Lost to Follow-up|2|||
125315871|NCT02748863|450786126|FG001|Treatment Period 2|Lost to Follow-up|0|||
125315872|NCT02748863|450786127|FG002|Treatment Period 2|Lost to Follow-up|0|||
125315873|NCT02748863|450786128|FG003|Treatment Period 2|Lost to Follow-up|0|||
125315874|NCT02748863|450786129|FG004|Treatment Period 2|Lost to Follow-up|0|||
125315875|NCT02748863|450786125|FG000|Treatment Period 2|Adverse Event|3|||
125315876|NCT02748863|450786126|FG001|Treatment Period 2|Adverse Event|2|||
125315877|NCT02748863|450786127|FG002|Treatment Period 2|Adverse Event|0|||
125315878|NCT02748863|450786128|FG003|Treatment Period 2|Adverse Event|2|||
125315879|NCT02748863|450786129|FG004|Treatment Period 2|Adverse Event|0|||
125315880|NCT02748863|450786125|FG000|Treatment Period 2|Lack of Efficacy|0|||
125315881|NCT02748863|450786126|FG001|Treatment Period 2|Lack of Efficacy|1|||
125315882|NCT02748863|450786127|FG002|Treatment Period 2|Lack of Efficacy|0|||
125315883|NCT02748863|450786128|FG003|Treatment Period 2|Lack of Efficacy|0|||
125315884|NCT02748863|450786129|FG004|Treatment Period 2|Lack of Efficacy|0|||
125315885|NCT02748863|450786125|FG000|Treatment Period 2|Pregnancy|0|||
125315886|NCT02748863|450786126|FG001|Treatment Period 2|Pregnancy|0|||
125315887|NCT02748863|450786127|FG002|Treatment Period 2|Pregnancy|0|||
125315888|NCT02748863|450786128|FG003|Treatment Period 2|Pregnancy|0|||
125315889|NCT02748863|450786129|FG004|Treatment Period 2|Pregnancy|1|||
125315890|NCT04537793|450786130|FG000|Part B (24 Weeks)|Adverse Event|0|||
125315891|NCT04537793|450786131|FG001|Part B (24 Weeks)|Adverse Event|1|||
125315892|NCT01255423|450786132|FG000|Overall Study|Abnormal Laboratory value|3|||
125315893|NCT01255423|450786133|FG001|Overall Study|Abnormal Laboratory value|2|||
125315894|NCT01255423|450786132|FG000|Overall Study|Use of prohibited medications|0|||
125315895|NCT01255423|450786133|FG001|Overall Study|Use of prohibited medications|1|||
125315896|NCT00657046|450786135|FG000|Overall Study|Adverse Event|1|||
125315897|NCT00657046|450786136|FG001|Overall Study|Adverse Event|1|||
125315898|NCT00657046|450786137|FG002|Overall Study|Adverse Event|0|||
125315899|NCT00657046|450786135|FG000|Overall Study|Protocol Violation|2|||
125315900|NCT00657046|450786136|FG001|Overall Study|Protocol Violation|2|||
125315901|NCT00657046|450786137|FG002|Overall Study|Protocol Violation|0|||
125315902|NCT00657046|450786135|FG000|Overall Study|Withdrawal by Subject|1|||
125315903|NCT00657046|450786136|FG001|Overall Study|Withdrawal by Subject|0|||
125315904|NCT00657046|450786137|FG002|Overall Study|Withdrawal by Subject|0|||
125315905|NCT00657046|450786135|FG000|Overall Study|Death|0|||
125315906|NCT00657046|450786136|FG001|Overall Study|Death|0|||
125315907|NCT00657046|450786137|FG002|Overall Study|Death|1|||
125315908|NCT00657046|450786135|FG000|Overall Study|Surgery|0|||
125315909|NCT00657046|450786136|FG001|Overall Study|Surgery|0|||
125315910|NCT00657046|450786137|FG002|Overall Study|Surgery|1|||
125315911|NCT01858363|450786138|FG000|Overall Study|Death|35|||
125315912|NCT01858363|450786139|FG001|Overall Study|Death|9|||
125315913|NCT01858363|450786138|FG000|Overall Study|Withdrawal by Subject|28|||
125315914|NCT01858363|450786139|FG001|Overall Study|Withdrawal by Subject|14|||
125315915|NCT01858363|450786138|FG000|Overall Study|Lost to Follow-up|13|||
125315916|NCT01858363|450786139|FG001|Overall Study|Lost to Follow-up|3|||
125315917|NCT03480152|450786149|FG000|Phase I|Signed consent. Died before treatment.|1|||
125315918|NCT03480152|450786150|FG001|Phase I|Signed consent. Died before treatment.|0|||
125315919|NCT03480152|450786151|FG002|Phase I|Signed consent. Died before treatment.|0|||
125315920|NCT00101686|450786152|FG000|Overall Study|Progressive Disease|37|||
125315921|NCT00101686|450786153|FG001|Overall Study|Progressive Disease|28|||
125315922|NCT00101686|450786154|FG002|Overall Study|Progressive Disease|37|||
125315923|NCT00101686|450786155|FG003|Overall Study|Progressive Disease|38|||
125315924|NCT00101686|450786156|FG004|Overall Study|Progressive Disease|28|||
125315925|NCT00101686|450786157|FG005|Overall Study|Progressive Disease|25|||
125315926|NCT00101686|450786158|FG006|Overall Study|Progressive Disease|5|||
125315927|NCT00101686|450786159|FG007|Overall Study|Progressive Disease|7|||
125315928|NCT00101686|450786160|FG008|Overall Study|Progressive Disease|10|||
125315929|NCT00101686|450786161|FG009|Overall Study|Progressive Disease|8|||
125315930|NCT00101686|450786152|FG000|Overall Study|initiation other anti-cancer treatment|4|||
125315931|NCT00101686|450786153|FG001|Overall Study|initiation other anti-cancer treatment|3|||
125315932|NCT00101686|450786154|FG002|Overall Study|initiation other anti-cancer treatment|4|||
125315933|NCT00101686|450786155|FG003|Overall Study|initiation other anti-cancer treatment|3|||
125315934|NCT00101686|450786156|FG004|Overall Study|initiation other anti-cancer treatment|1|||
125315935|NCT00101686|450786157|FG005|Overall Study|initiation other anti-cancer treatment|1|||
125315936|NCT00101686|450786158|FG006|Overall Study|initiation other anti-cancer treatment|2|||
125315937|NCT00101686|450786159|FG007|Overall Study|initiation other anti-cancer treatment|2|||
125315938|NCT00101686|450786160|FG008|Overall Study|initiation other anti-cancer treatment|3|||
125315939|NCT00101686|450786161|FG009|Overall Study|initiation other anti-cancer treatment|3|||
125315940|NCT00101686|450786152|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
125315941|NCT00101686|450786153|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
125315942|NCT00101686|450786154|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
125315943|NCT00101686|450786155|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
125315944|NCT00101686|450786156|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
125315945|NCT00101686|450786157|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
125315946|NCT00101686|450786158|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
125315947|NCT00101686|450786159|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
125315948|NCT00101686|450786160|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
125315949|NCT00101686|450786161|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
125315950|NCT00101686|450786152|FG000|Overall Study|unacceptable toxicity|3|||
125315951|NCT00101686|450786153|FG001|Overall Study|unacceptable toxicity|9|||
125315952|NCT00101686|450786154|FG002|Overall Study|unacceptable toxicity|10|||
125315953|NCT00101686|450786155|FG003|Overall Study|unacceptable toxicity|6|||
125315954|NCT00101686|450786156|FG004|Overall Study|unacceptable toxicity|16|||
125315955|NCT00101686|450786157|FG005|Overall Study|unacceptable toxicity|10|||
125315956|NCT00101686|450786158|FG006|Overall Study|unacceptable toxicity|4|||
125315957|NCT00101686|450786159|FG007|Overall Study|unacceptable toxicity|2|||
125315958|NCT00101686|450786160|FG008|Overall Study|unacceptable toxicity|1|||
125315959|NCT00101686|450786161|FG009|Overall Study|unacceptable toxicity|4|||
125315960|NCT00101686|450786152|FG000|Overall Study|Randomized but did not receive treament|1|||
125315961|NCT00101686|450786153|FG001|Overall Study|Randomized but did not receive treament|6|||
125315962|NCT00101686|450786154|FG002|Overall Study|Randomized but did not receive treament|2|||
125315963|NCT00101686|450786155|FG003|Overall Study|Randomized but did not receive treament|2|||
125315964|NCT00101686|450786156|FG004|Overall Study|Randomized but did not receive treament|2|||
125315965|NCT00101686|450786157|FG005|Overall Study|Randomized but did not receive treament|2|||
125315966|NCT00101686|450786158|FG006|Overall Study|Randomized but did not receive treament|0|||
125315967|NCT00101686|450786159|FG007|Overall Study|Randomized but did not receive treament|1|||
125656310|NCT00297882|452027452|FG001|Day 28|Lost to Follow-up|23|||
125656311|NCT00297882|452027451|FG000|Day 28|Lack of Efficacy|3|||
125656312|NCT00297882|452027452|FG001|Day 28|Lack of Efficacy|0|||
125656313|NCT04484805|452027453|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
125656314|NCT04484805|452027454|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
125315968|NCT00101686|450786160|FG008|Overall Study|Randomized but did not receive treament|0|||
125315969|NCT00101686|450786161|FG009|Overall Study|Randomized but did not receive treament|1|||
125315970|NCT00101686|450786152|FG000|Overall Study|intercurrent non-cancer related illness|0|||
125315971|NCT00101686|450786153|FG001|Overall Study|intercurrent non-cancer related illness|0|||
125315972|NCT00101686|450786154|FG002|Overall Study|intercurrent non-cancer related illness|2|||
125315973|NCT00101686|450786155|FG003|Overall Study|intercurrent non-cancer related illness|0|||
125315974|NCT00101686|450786156|FG004|Overall Study|intercurrent non-cancer related illness|1|||
125315975|NCT00101686|450786157|FG005|Overall Study|intercurrent non-cancer related illness|3|||
125315976|NCT00101686|450786158|FG006|Overall Study|intercurrent non-cancer related illness|1|||
125315977|NCT00101686|450786159|FG007|Overall Study|intercurrent non-cancer related illness|0|||
125315978|NCT00101686|450786160|FG008|Overall Study|intercurrent non-cancer related illness|1|||
125315979|NCT00101686|450786161|FG009|Overall Study|intercurrent non-cancer related illness|1|||
125315980|NCT00101686|450786152|FG000|Overall Study|Physician Decision|10|||
125315981|NCT00101686|450786153|FG001|Overall Study|Physician Decision|13|||
125315982|NCT00101686|450786154|FG002|Overall Study|Physician Decision|6|||
125315983|NCT00101686|450786155|FG003|Overall Study|Physician Decision|7|||
125315984|NCT00101686|450786156|FG004|Overall Study|Physician Decision|8|||
125315985|NCT00101686|450786157|FG005|Overall Study|Physician Decision|9|||
125315986|NCT00101686|450786158|FG006|Overall Study|Physician Decision|5|||
125315987|NCT00101686|450786159|FG007|Overall Study|Physician Decision|5|||
125315988|NCT00101686|450786160|FG008|Overall Study|Physician Decision|1|||
125315989|NCT00101686|450786161|FG009|Overall Study|Physician Decision|1|||
125315990|NCT00101686|450786152|FG000|Overall Study|Other|1|||
125315991|NCT00101686|450786153|FG001|Overall Study|Other|4|||
125315992|NCT00101686|450786154|FG002|Overall Study|Other|1|||
125315993|NCT00101686|450786155|FG003|Overall Study|Other|6|||
125315994|NCT00101686|450786156|FG004|Overall Study|Other|2|||
125315995|NCT00101686|450786157|FG005|Overall Study|Other|12|||
125315996|NCT00101686|450786158|FG006|Overall Study|Other|1|||
125315997|NCT00101686|450786159|FG007|Overall Study|Other|5|||
125315998|NCT00101686|450786160|FG008|Overall Study|Other|3|||
125540485|NCT01011153|451607651|FG000|Overall Study|Less than 78 cases completed|8|||
125315999|NCT00101686|450786161|FG009|Overall Study|Other|3|||
125540486|NCT01011153|451607652|FG001|Overall Study|Less than 78 cases completed|11|||
125656315|NCT04484805|452027453|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
125656316|NCT04484805|452027454|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
125656317|NCT04242264|452027455|FG000|Overall Study|Lost to Follow-up|2|||
125656318|NCT04242264|452027456|FG001|Overall Study|Lost to Follow-up|2|||
125656319|NCT04242264|452027457|FG002|Overall Study|Lost to Follow-up|1|||
125656320|NCT04242264|452027458|FG003|Overall Study|Lost to Follow-up|1|||
125656321|NCT04242264|452027455|FG000|Overall Study|Withdrawal by Subject|1|||
125656322|NCT04242264|452027456|FG001|Overall Study|Withdrawal by Subject|0|||
125656323|NCT04242264|452027457|FG002|Overall Study|Withdrawal by Subject|0|||
125656324|NCT04242264|452027458|FG003|Overall Study|Withdrawal by Subject|0|||
125656325|NCT04139642|452027460|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
125656326|NCT04139642|452027461|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
125656327|NCT00433771|452027463|FG000|Overall Study|screen fail|14|||
125656328|NCT00433771|452027463|FG000|Overall Study|Treated and later found to be ineligible|2|||
125656329|NCT00433771|452027463|FG000|Overall Study|Death|2|||
125656330|NCT00433771|452027463|FG000|Overall Study|Failure to deploy stent|1|||
125656331|NCT00539006|452027467|FG000|Pre-treatment|Other|0|||
125656332|NCT00539006|452027468|FG001|Pre-treatment|Other|1|||
125656333|NCT00539006|452027469|FG002|Pre-treatment|Other|0|||
125656334|NCT00539006|452027470|FG003|Pre-treatment|Other|0|||
125656335|NCT00539006|452027467|FG000|Treatment Period 1|Lost to Follow-up|0|||
125656336|NCT00539006|452027468|FG001|Treatment Period 1|Lost to Follow-up|0|||
125656337|NCT00539006|452027469|FG002|Treatment Period 1|Lost to Follow-up|1|||
125656338|NCT00539006|452027470|FG003|Treatment Period 1|Lost to Follow-up|0|||
125656339|NCT00539006|452027467|FG000|Treatment Period 1|Protocol Violation|0|||
125656340|NCT00539006|452027468|FG001|Treatment Period 1|Protocol Violation|0|||
125656341|NCT00539006|452027469|FG002|Treatment Period 1|Protocol Violation|1|||
125656342|NCT00539006|452027470|FG003|Treatment Period 1|Protocol Violation|0|||
125656343|NCT00539006|452027467|FG000|Treatment Period 1|Lack of Efficacy|0|||
125656344|NCT00539006|452027468|FG001|Treatment Period 1|Lack of Efficacy|0|||
125656345|NCT00539006|452027469|FG002|Treatment Period 1|Lack of Efficacy|0|||
125656346|NCT00539006|452027470|FG003|Treatment Period 1|Lack of Efficacy|1|||
125656347|NCT00539006|452027467|FG000|Washout|Adverse Event|2|||
125656348|NCT00539006|452027468|FG001|Washout|Adverse Event|1|||
125656349|NCT00539006|452027469|FG002|Washout|Adverse Event|0|||
125656350|NCT00539006|452027470|FG003|Washout|Adverse Event|0|||
125656351|NCT00539006|452027467|FG000|Washout|Protocol Violation|1|||
125656352|NCT00539006|452027468|FG001|Washout|Protocol Violation|1|||
125656353|NCT00539006|452027469|FG002|Washout|Protocol Violation|0|||
125656354|NCT00539006|452027470|FG003|Washout|Protocol Violation|0|||
125656355|NCT00539006|452027467|FG000|Washout|Withdrawal by Subject|0|||
125656356|NCT00539006|452027468|FG001|Washout|Withdrawal by Subject|2|||
125656357|NCT00539006|452027469|FG002|Washout|Withdrawal by Subject|0|||
125656358|NCT00539006|452027470|FG003|Washout|Withdrawal by Subject|0|||
125656359|NCT00539006|452027467|FG000|Washout|Failed to meet continuation criteria|16|||
125656360|NCT00539006|452027468|FG001|Washout|Failed to meet continuation criteria|5|||
125656361|NCT00539006|452027469|FG002|Washout|Failed to meet continuation criteria|14|||
125656362|NCT00539006|452027470|FG003|Washout|Failed to meet continuation criteria|6|||
125656363|NCT00539006|452027467|FG000|Washout|Other|1|||
125656364|NCT00539006|452027468|FG001|Washout|Other|1|||
125656365|NCT00539006|452027469|FG002|Washout|Other|2|||
125656366|NCT00539006|452027470|FG003|Washout|Other|3|||
125656367|NCT00539006|452027467|FG000|Treatment Period 2|Protocol Violation|1|||
125656368|NCT00539006|452027468|FG001|Treatment Period 2|Protocol Violation|0|||
125656369|NCT00539006|452027469|FG002|Treatment Period 2|Protocol Violation|0|||
125656370|NCT00539006|452027470|FG003|Treatment Period 2|Protocol Violation|0|||
125656371|NCT00539006|452027467|FG000|Treatment Period 2|Other|0|||
125656372|NCT00539006|452027468|FG001|Treatment Period 2|Other|1|||
125656373|NCT00539006|452027469|FG002|Treatment Period 2|Other|0|||
125656374|NCT00539006|452027470|FG003|Treatment Period 2|Other|0|||
125656375|NCT02353572|452027471|FG000|Overall Study|Withdrawal by Subject|1|||
125656376|NCT02353572|452027471|FG000|Overall Study|Study terminated|2|||
125656377|NCT01036594|452027479|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
125656378|NCT01036594|452027480|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
125656379|NCT01036594|452027479|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
125316000|NCT00101686|450786152|FG000|Overall Study|Withdrawal by Subject|9|||
125316001|NCT00101686|450786153|FG001|Overall Study|Withdrawal by Subject|8|||
125316002|NCT00101686|450786154|FG002|Overall Study|Withdrawal by Subject|6|||
125316003|NCT00101686|450786155|FG003|Overall Study|Withdrawal by Subject|8|||
125656380|NCT01036594|452027480|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
125656381|NCT01036594|452027479|FG000|Week 12 Evaluation|Adverse Event|5|||
125656382|NCT01036594|452027480|FG001|Week 12 Evaluation|Adverse Event|0|||
125656383|NCT01036594|452027479|FG000|Week 12 Evaluation|Physician Decision|1|||
125656384|NCT01036594|452027480|FG001|Week 12 Evaluation|Physician Decision|0|||
125656385|NCT01036594|452027479|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
125656386|NCT01036594|452027480|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
125316004|NCT00101686|450786156|FG004|Overall Study|Withdrawal by Subject|8|||
125316005|NCT00101686|450786157|FG005|Overall Study|Withdrawal by Subject|7|||
125316006|NCT00101686|450786158|FG006|Overall Study|Withdrawal by Subject|7|||
125316007|NCT00101686|450786159|FG007|Overall Study|Withdrawal by Subject|7|||
125316008|NCT00101686|450786160|FG008|Overall Study|Withdrawal by Subject|8|||
125656387|NCT01036594|452027479|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
125656388|NCT01036594|452027480|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
125656389|NCT01036594|452027479|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
125656390|NCT01036594|452027480|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
125656391|NCT01036594|452027479|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
125656392|NCT01036594|452027480|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
125656393|NCT01036594|452027479|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
125656394|NCT01036594|452027480|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
125656395|NCT01244516|452027483|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
125656396|NCT01244516|452027484|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
125656397|NCT01244516|452027485|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
125656398|NCT01244516|452027483|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
125656399|NCT01244516|452027484|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
125656400|NCT01244516|452027485|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
125656401|NCT01244516|452027483|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
125656402|NCT01244516|452027484|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
125656403|NCT01244516|452027485|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
125656404|NCT01244516|452027483|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
125656405|NCT01244516|452027484|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
125656406|NCT01244516|452027485|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
125656407|NCT01244516|452027483|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
125656408|NCT01244516|452027484|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
125656409|NCT01244516|452027485|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
125656410|NCT01244516|452027483|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
125656411|NCT01244516|452027484|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
125656412|NCT01244516|452027485|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
125656413|NCT01244516|452027483|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
125656414|NCT01244516|452027484|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
125656415|NCT01244516|452027485|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
125656416|NCT00244881|452027492|FG000|Overall Study|Withdrawal by Subject|3|||
125656417|NCT03664024|452027493|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
125656418|NCT03664024|452027493|FG000|Overall Study|Lost to Follow-up|2|||
125656419|NCT03664024|452027493|FG000|Overall Study|Withdrawal by Subject|2|||
125656420|NCT03664024|452027493|FG000|Overall Study|Death|80|||
125656421|NCT03159611|452027494|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
125656422|NCT03159611|452027495|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
125656423|NCT03159611|452027494|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
125656424|NCT03159611|452027495|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
125656425|NCT03159611|452027494|FG000|Overall Study|Protocol Violation|7|||
125656426|NCT03159611|452027495|FG001|Overall Study|Protocol Violation|4|||
125656427|NCT03159611|452027494|FG000|Overall Study|Adverse Event|1|||
125656428|NCT03159611|452027495|FG001|Overall Study|Adverse Event|0|||
125656429|NCT03159611|452027494|FG000|Overall Study|Withdrawal by Subject|1|||
125656430|NCT03159611|452027495|FG001|Overall Study|Withdrawal by Subject|1|||
125656431|NCT03159611|452027494|FG000|Overall Study|Non-compliance with protocol requirement|3|||
125656432|NCT03159611|452027495|FG001|Overall Study|Non-compliance with protocol requirement|2|||
125656433|NCT03159611|452027494|FG000|Overall Study|Inability to perform procedures|1|||
125656434|NCT03159611|452027495|FG001|Overall Study|Inability to perform procedures|0|||
125656435|NCT02057549|452027497|FG000|Overall Study|Lost to Follow-up|1|||
125656436|NCT02057549|452027498|FG001|Overall Study|Lost to Follow-up|0|||
125656437|NCT02057549|452027497|FG000|Overall Study|Physician Decision|1|||
125656438|NCT02057549|452027498|FG001|Overall Study|Physician Decision|0|||
125656439|NCT02057549|452027497|FG000|Overall Study|Withdrawal by Subject|1|||
125656440|NCT02057549|452027498|FG001|Overall Study|Withdrawal by Subject|0|||
125656441|NCT01418365|452027499|FG000|First Intervention|Withdrawal by Subject|0|||
125656442|NCT01418365|452027500|FG001|First Intervention|Withdrawal by Subject|1|||
125656443|NCT01418365|452027499|FG000|First Intervention|Non-compliance|1|||
125316009|NCT00101686|450786161|FG009|Overall Study|Withdrawal by Subject|9|||
125316010|NCT00867165|450786162|FG000|Overall Study|Adverse Event|3|||
125656444|NCT01418365|452027500|FG001|First Intervention|Non-compliance|0|||
125656445|NCT01418365|452027499|FG000|Second Intervention|Withdrawal by Subject|0|||
125656446|NCT01418365|452027500|FG001|Second Intervention|Withdrawal by Subject|1|||
125656447|NCT03319368|452027501|FG000|Overall Study|Discharge swabs not collected from resident|57|||
125656448|NCT03319368|452027502|FG001|Overall Study|Discharge swabs not collected from resident|46|||
125656449|NCT03000075|452027503|FG000|Part A|Adverse Event|4|||
125656450|NCT03000075|452027504|FG001|Part A|Adverse Event|0|||
125656451|NCT03000075|452027505|FG002|Part A|Adverse Event|0|||
125656452|NCT03000075|452027506|FG003|Part A|Adverse Event|0|||
125656453|NCT03000075|452027507|FG004|Part A|Adverse Event|0|||
125656454|NCT03000075|452027508|FG005|Part A|Adverse Event|0|||
125656455|NCT03000075|452027509|FG006|Part A|Adverse Event|0|||
125656456|NCT03000075|452027503|FG000|Part B|Not dosed due to AE|0|||
125656457|NCT03000075|452027504|FG001|Part B|Not dosed due to AE|0|||
125656458|NCT03000075|452027505|FG002|Part B|Not dosed due to AE|0|||
125656459|NCT03000075|452027506|FG003|Part B|Not dosed due to AE|0|||
125656460|NCT03000075|452027507|FG004|Part B|Not dosed due to AE|0|||
125656461|NCT03000075|452027508|FG005|Part B|Not dosed due to AE|2|||
125656462|NCT03000075|452027509|FG006|Part B|Not dosed due to AE|1|||
125656463|NCT03000075|452027503|FG000|Part B|Adverse Event|0|||
125656464|NCT03000075|452027504|FG001|Part B|Adverse Event|0|||
125656465|NCT03000075|452027505|FG002|Part B|Adverse Event|0|||
125656466|NCT03000075|452027506|FG003|Part B|Adverse Event|0|||
125656467|NCT03000075|452027507|FG004|Part B|Adverse Event|1|||
125656468|NCT03000075|452027508|FG005|Part B|Adverse Event|0|||
125316011|NCT00867165|450786163|FG001|Overall Study|Adverse Event|0|||
125316012|NCT00867165|450786162|FG000|Overall Study|Withdrawal by Subject|1|||
125316013|NCT00867165|450786163|FG001|Overall Study|Withdrawal by Subject|0|||
125316014|NCT02738008|450786164|FG000|Overall Study|Study Terminated by Sponsor|1|||
125316015|NCT02738008|450786165|FG001|Overall Study|Study Terminated by Sponsor|5|||
125316016|NCT02738008|450786166|FG002|Overall Study|Study Terminated by Sponsor|3|||
125316017|NCT02738008|450786164|FG000|Overall Study|Adverse Event|0|||
125316018|NCT02738008|450786165|FG001|Overall Study|Adverse Event|1|||
125316019|NCT02738008|450786166|FG002|Overall Study|Adverse Event|2|||
125316020|NCT03550378|450786169|FG000|Overall Study|Death|0|||
125316021|NCT03550378|450786170|FG001|Overall Study|Death|1|||
125316022|NCT00468299|450786171|FG000|Overall Study|Withdrawal by Subject|0|||
125316023|NCT00468299|450786172|FG001|Overall Study|Withdrawal by Subject|1|||
125316024|NCT03546621|450786173|FG000|Overall Study|Withdrawal by Subject|0|||
125316025|NCT03546621|450786174|FG001|Overall Study|Withdrawal by Subject|1|||
125316026|NCT03546621|450786175|FG002|Overall Study|Withdrawal by Subject|2|||
125316027|NCT03546621|450786176|FG003|Overall Study|Withdrawal by Subject|1|||
125316028|NCT03546621|450786173|FG000|Overall Study|Lost to Follow-up|0|||
125316029|NCT03546621|450786174|FG001|Overall Study|Lost to Follow-up|1|||
125316030|NCT03546621|450786175|FG002|Overall Study|Lost to Follow-up|0|||
125316031|NCT03546621|450786176|FG003|Overall Study|Lost to Follow-up|0|||
125316032|NCT03546621|450786173|FG000|Overall Study|Adverse Event|0|||
125316033|NCT03546621|450786174|FG001|Overall Study|Adverse Event|1|||
125316034|NCT03546621|450786175|FG002|Overall Study|Adverse Event|0|||
125316035|NCT03546621|450786176|FG003|Overall Study|Adverse Event|1|||
125316036|NCT03546621|450786173|FG000|Overall Study|Progressive disease|0|||
125316037|NCT03546621|450786174|FG001|Overall Study|Progressive disease|0|||
125316038|NCT03546621|450786175|FG002|Overall Study|Progressive disease|0|||
125316039|NCT03546621|450786176|FG003|Overall Study|Progressive disease|1|||
125316040|NCT00377520|450786181|FG000|Overall Study|Ineligible (Prior radiation)|1|||
125316041|NCT00462306|450786188|FG000|Overall Study|insufficient data|0|||
125316042|NCT00462306|450786189|FG001|Overall Study|insufficient data|13|||
125316043|NCT00154297|450786191|FG000|Overall Study|Death|5|||
125316044|NCT00154297|450786192|FG001|Overall Study|Death|2|||
125316045|NCT00154297|450786191|FG000|Overall Study|Withdrawal by Subject|0|||
125316046|NCT00154297|450786192|FG001|Overall Study|Withdrawal by Subject|5|||
125316047|NCT00154297|450786191|FG000|Overall Study|Lost to Follow-up|3|||
125316048|NCT00154297|450786192|FG001|Overall Study|Lost to Follow-up|0|||
125316049|NCT05051579|450786194|FG000|Overall Study|Withdrawal by Subject|3|||
125316050|NCT05051579|450786195|FG001|Overall Study|Withdrawal by Subject|5|||
125316051|NCT05051579|450786196|FG002|Overall Study|Withdrawal by Subject|2|||
125656469|NCT03000075|452027509|FG006|Part B|Adverse Event|0|||
125656470|NCT00440193|452027510|FG000|Treatment Period|Adverse Event|74|||
125656471|NCT00440193|452027511|FG001|Treatment Period|Adverse Event|67|||
125656472|NCT00440193|452027510|FG000|Treatment Period|Death|19|||
125656473|NCT00440193|452027511|FG001|Treatment Period|Death|22|||
125316052|NCT05051579|450786197|FG003|Overall Study|Withdrawal by Subject|1|||
125316053|NCT05051579|450786198|FG004|Overall Study|Withdrawal by Subject|4|||
125316054|NCT05051579|450786199|FG005|Overall Study|Withdrawal by Subject|0|||
125316055|NCT05051579|450786200|FG006|Overall Study|Withdrawal by Subject|4|||
125656474|NCT00440193|452027510|FG000|Treatment Period|Lack of Efficacy|0|||
125656475|NCT00440193|452027511|FG001|Treatment Period|Lack of Efficacy|1|||
125656476|NCT00440193|452027510|FG000|Treatment Period|Lost to Follow-up|12|||
125656477|NCT00440193|452027511|FG001|Treatment Period|Lost to Follow-up|18|||
125656478|NCT00440193|452027510|FG000|Treatment Period|Physician Decision|3|||
125656479|NCT00440193|452027511|FG001|Treatment Period|Physician Decision|6|||
125656480|NCT00440193|452027510|FG000|Treatment Period|Protocol Violation|16|||
125316056|NCT05051579|450786194|FG000|Overall Study|Lost to Follow-up|1|||
125316057|NCT05051579|450786195|FG001|Overall Study|Lost to Follow-up|0|||
125316058|NCT05051579|450786196|FG002|Overall Study|Lost to Follow-up|0|||
125316059|NCT05051579|450786197|FG003|Overall Study|Lost to Follow-up|0|||
125316060|NCT05051579|450786198|FG004|Overall Study|Lost to Follow-up|1|||
125656481|NCT00440193|452027511|FG001|Treatment Period|Protocol Violation|19|||
125656482|NCT00440193|452027510|FG000|Treatment Period|Withdrawal by Subject|36|||
125656483|NCT00440193|452027511|FG001|Treatment Period|Withdrawal by Subject|77|||
125656484|NCT00440193|452027510|FG000|Treatment Period|Clinical endpoint reached|28|||
125656485|NCT00440193|452027511|FG001|Treatment Period|Clinical endpoint reached|25|||
125656486|NCT00440193|452027510|FG000|Treatment Period|Study terminated by sponsor|102|||
125656487|NCT00440193|452027511|FG001|Treatment Period|Study terminated by sponsor|94|||
125656488|NCT00440193|452027510|FG000|Treatment Period|Protocol driven decision point|2|||
125656489|NCT00440193|452027511|FG001|Treatment Period|Protocol driven decision point|2|||
125656490|NCT00440193|452027510|FG000|Treatment Period|Switch to commercial drug|0|||
125656491|NCT00440193|452027511|FG001|Treatment Period|Switch to commercial drug|2|||
125656492|NCT00440193|452027510|FG000|Treatment Period|Technical problems|1|||
125656493|NCT00440193|452027511|FG001|Treatment Period|Technical problems|1|||
125656494|NCT00440193|452027510|FG000|Treatment Period|Participant convenience|5|||
125656495|NCT00440193|452027511|FG001|Treatment Period|Participant convenience|2|||
125656496|NCT00440193|452027510|FG000|Treatment Period|Participant did not receive treatment|7|||
125656497|NCT00440193|452027511|FG001|Treatment Period|Participant did not receive treatment|13|||
125316061|NCT05051579|450786199|FG005|Overall Study|Lost to Follow-up|0|||
125316062|NCT05051579|450786200|FG006|Overall Study|Lost to Follow-up|1|||
125316063|NCT05051579|450786194|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
125316064|NCT05051579|450786195|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
125316065|NCT05051579|450786196|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
125316066|NCT05051579|450786197|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
125316067|NCT05051579|450786198|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
125316068|NCT05051579|450786199|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
125316069|NCT05051579|450786200|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
125316070|NCT05051579|450786194|FG000|Overall Study|Adverse Event|2|||
125316071|NCT05051579|450786195|FG001|Overall Study|Adverse Event|1|||
125316072|NCT05051579|450786196|FG002|Overall Study|Adverse Event|0|||
125316073|NCT05051579|450786197|FG003|Overall Study|Adverse Event|4|||
125316074|NCT05051579|450786198|FG004|Overall Study|Adverse Event|1|||
125316075|NCT05051579|450786199|FG005|Overall Study|Adverse Event|2|||
125316076|NCT05051579|450786200|FG006|Overall Study|Adverse Event|0|||
125316077|NCT05051579|450786194|FG000|Overall Study|Inadvertent Enrollment|0|||
125316078|NCT05051579|450786195|FG001|Overall Study|Inadvertent Enrollment|0|||
125316079|NCT05051579|450786196|FG002|Overall Study|Inadvertent Enrollment|0|||
125316080|NCT05051579|450786197|FG003|Overall Study|Inadvertent Enrollment|0|||
125316081|NCT05051579|450786198|FG004|Overall Study|Inadvertent Enrollment|0|||
125316082|NCT05051579|450786199|FG005|Overall Study|Inadvertent Enrollment|0|||
125316083|NCT05051579|450786200|FG006|Overall Study|Inadvertent Enrollment|1|||
125316084|NCT05051579|450786194|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
125316085|NCT05051579|450786195|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
125316086|NCT05051579|450786196|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
125316087|NCT05051579|450786197|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
125316088|NCT05051579|450786198|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
125316089|NCT05051579|450786199|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
125316090|NCT05051579|450786200|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
125316091|NCT05051579|450786194|FG000|Overall Study|Sponsor Decision|0|||
125316092|NCT05051579|450786195|FG001|Overall Study|Sponsor Decision|0|||
125316093|NCT05051579|450786196|FG002|Overall Study|Sponsor Decision|0|||
125316094|NCT05051579|450786197|FG003|Overall Study|Sponsor Decision|0|||
125316095|NCT05051579|450786198|FG004|Overall Study|Sponsor Decision|1|||
125316096|NCT05051579|450786199|FG005|Overall Study|Sponsor Decision|0|||
125316097|NCT05051579|450786200|FG006|Overall Study|Sponsor Decision|0|||
125316098|NCT05051579|450786194|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
125316099|NCT05051579|450786195|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
125316100|NCT05051579|450786196|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
125316101|NCT05051579|450786197|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
125316102|NCT05051579|450786198|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
125316103|NCT05051579|450786199|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
125316104|NCT05051579|450786200|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
125316105|NCT00990106|450786201|FG000|Overall Study|"too busy to continue"|1|||
125316106|NCT00990106|450786202|FG001|Overall Study|"too busy to continue"|2|||
125656498|NCT00440193|452027510|FG000|Treatment Period|Site closed by investigator|0|||
125656499|NCT00440193|452027511|FG001|Treatment Period|Site closed by investigator|2|||
125656500|NCT00440193|452027510|FG000|Observational Period|Adverse Event|2|||
125656501|NCT00440193|452027511|FG001|Observational Period|Adverse Event|2|||
125656502|NCT00440193|452027510|FG000|Observational Period|Death|15|||
125316107|NCT00990106|450786201|FG000|Overall Study|Lost to Follow-up|1|||
125316108|NCT00990106|450786202|FG001|Overall Study|Lost to Follow-up|3|||
125316109|NCT00990106|450786201|FG000|Overall Study|Withdrawal by Subject|2|||
125316110|NCT00990106|450786202|FG001|Overall Study|Withdrawal by Subject|1|||
125316111|NCT00990106|450786201|FG000|Overall Study|opted for open label prazosin|1|||
125316112|NCT00990106|450786202|FG001|Overall Study|opted for open label prazosin|1|||
125316113|NCT00990106|450786201|FG000|Overall Study|relocation/deployment|4|||
125656503|NCT00440193|452027511|FG001|Observational Period|Death|20|||
125656504|NCT00440193|452027510|FG000|Observational Period|Lost to Follow-up|12|||
125656505|NCT00440193|452027511|FG001|Observational Period|Lost to Follow-up|8|||
125656506|NCT00440193|452027510|FG000|Observational Period|Protocol Violation|1|||
125656507|NCT00440193|452027511|FG001|Observational Period|Protocol Violation|0|||
125656508|NCT00440193|452027510|FG000|Observational Period|Withdrawal by Subject|11|||
125656509|NCT00440193|452027511|FG001|Observational Period|Withdrawal by Subject|8|||
125656510|NCT00440193|452027510|FG000|Observational Period|Physician Decision|1|||
125656511|NCT00440193|452027511|FG001|Observational Period|Physician Decision|0|||
125656512|NCT00440193|452027510|FG000|Observational Period|Clinical endpoint reached|1|||
125656513|NCT00440193|452027511|FG001|Observational Period|Clinical endpoint reached|0|||
125656514|NCT00440193|452027510|FG000|Observational Period|Participant convenience|2|||
125656515|NCT00440193|452027511|FG001|Observational Period|Participant convenience|0|||
125656516|NCT00530621|452027517|FG000|Overall Study|Adverse Event|11|||
125656517|NCT00530621|452027518|FG001|Overall Study|Adverse Event|8|||
125656518|NCT00530621|452027517|FG000|Overall Study|Physician Decision|2|||
125656519|NCT00530621|452027518|FG001|Overall Study|Physician Decision|4|||
125656520|NCT00530621|452027517|FG000|Overall Study|Progressive Disease (PD)|47|||
125656521|NCT00530621|452027518|FG001|Overall Study|Progressive Disease (PD)|40|||
125656522|NCT00530621|452027517|FG000|Overall Study|Sponsor Decision|12|||
125656523|NCT00530621|452027518|FG001|Overall Study|Sponsor Decision|15|||
125656524|NCT00530621|452027517|FG000|Overall Study|Subject Decision|4|||
125656525|NCT00530621|452027518|FG001|Overall Study|Subject Decision|7|||
125656526|NCT00530621|452027517|FG000|Overall Study|Death|3|||
125656527|NCT00530621|452027518|FG001|Overall Study|Death|6|||
125656528|NCT00530621|452027517|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
125656529|NCT00530621|452027518|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
125656530|NCT00518011|452027519|FG000|Overall Study|Death|1|||
125656531|NCT00518011|452027520|FG001|Overall Study|Death|1|||
125656532|NCT00518011|452027519|FG000|Overall Study|Adverse Event|2|||
125656533|NCT00518011|452027520|FG001|Overall Study|Adverse Event|3|||
125656534|NCT00518011|452027519|FG000|Overall Study|Disease Progression|2|||
125656535|NCT00518011|452027520|FG001|Overall Study|Disease Progression|2|||
125656536|NCT00518011|452027519|FG000|Overall Study|Other Reasons|3|||
125656537|NCT00518011|452027520|FG001|Overall Study|Other Reasons|2|||
125656538|NCT00518011|452027519|FG000|Overall Study|Withdrawal by Subject|1|||
125656539|NCT00518011|452027520|FG001|Overall Study|Withdrawal by Subject|0|||
125656540|NCT03409328|452027521|FG000|Overall Study|Lost to Follow-up|6|||
125656541|NCT03409328|452027522|FG001|Overall Study|Lost to Follow-up|3|||
125656542|NCT03930615|452027523|FG000|Overall Study|Death|9|||
125656543|NCT03930615|452027524|FG001|Overall Study|Death|3|||
125656544|NCT03930615|452027523|FG000|Overall Study|Lost to Follow-up|1|||
125656545|NCT03930615|452027524|FG001|Overall Study|Lost to Follow-up|2|||
125656546|NCT03930615|452027523|FG000|Overall Study|Physician Decision|3|||
125656547|NCT03930615|452027524|FG001|Overall Study|Physician Decision|4|||
125656548|NCT03930615|452027523|FG000|Overall Study|Withdrawal by Subject|13|||
125656549|NCT03930615|452027524|FG001|Overall Study|Withdrawal by Subject|2|||
125656550|NCT03930615|452027523|FG000|Overall Study|Not treated|1|||
125656551|NCT03930615|452027524|FG001|Overall Study|Not treated|1|||
125656552|NCT04797637|452027532|FG000|Overall Study|Lost to Follow-up|23|||
125656553|NCT04797637|452027533|FG001|Overall Study|Lost to Follow-up|32|||
125656554|NCT04797637|452027532|FG000|Overall Study|Withdrawal by Subject|0|||
125656555|NCT04797637|452027533|FG001|Overall Study|Withdrawal by Subject|1|||
125316114|NCT00990106|450786202|FG001|Overall Study|relocation/deployment|1|||
125316115|NCT00990106|450786201|FG000|Overall Study|started exclusionary medication|0|||
125316116|NCT00990106|450786202|FG001|Overall Study|started exclusionary medication|1|||
125316117|NCT00990106|450786201|FG000|Overall Study|planned major surgery|0|||
125316118|NCT00990106|450786202|FG001|Overall Study|planned major surgery|1|||
125316119|NCT00990106|450786201|FG000|Overall Study|scheduling conflicts|0|||
125656558|NCT02061293|452027536|FG000|Overall Study|Elevated Blood Pressure|1|||
125656559|NCT02061293|452027537|FG001|Overall Study|Elevated Blood Pressure|1|||
125656560|NCT03505606|452028882|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
125316120|NCT00990106|450786202|FG001|Overall Study|scheduling conflicts|2|||
125656561|NCT03505606|452028883|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
125656562|NCT03505606|452028884|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
125656563|NCT03505606|452028882|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
125316121|NCT00410956|450786203|FG000|Overall Study|Adverse Event|1|||
125316122|NCT00410956|450786203|FG000|Overall Study|Death|2|||
125316123|NCT00410956|450786203|FG000|Overall Study|Lack of Efficacy|10|||
125316124|NCT00410956|450786203|FG000|Overall Study|Physician Decision|6|||
125316125|NCT01650194|450786204|FG000|Overall Study|Progressive Disease (PD)|35|||
125316126|NCT01650194|450786204|FG000|Overall Study|Withdrawal by Subject|2|||
125316127|NCT01650194|450786204|FG000|Overall Study|Miscellaneous|10|||
125316128|NCT00880698|450786207|FG000|Overall Study|Death|0|||
125316129|NCT00880698|450786208|FG001|Overall Study|Death|0|||
125316130|NCT00880698|450786209|FG002|Overall Study|Death|1|||
125316131|NCT00880698|450786210|FG003|Overall Study|Death|2|||
125316132|NCT00880698|450786207|FG000|Overall Study|Lost to Follow-up|1|||
125316133|NCT00880698|450786208|FG001|Overall Study|Lost to Follow-up|3|||
125316134|NCT00880698|450786209|FG002|Overall Study|Lost to Follow-up|0|||
125316135|NCT00880698|450786210|FG003|Overall Study|Lost to Follow-up|1|||
125316136|NCT04158583|450786213|FG000|Overall Study|Withdrawal by Subject|1|||
125316137|NCT04158583|450786214|FG001|Overall Study|Withdrawal by Subject|1|||
125316138|NCT04158583|450786215|FG002|Overall Study|Withdrawal by Subject|0|||
125316139|NCT04158583|450786216|FG003|Overall Study|Withdrawal by Subject|0|||
125316140|NCT04158583|450786217|FG004|Overall Study|Withdrawal by Subject|1|||
125316141|NCT04158583|450786218|FG005|Overall Study|Withdrawal by Subject|0|||
125316142|NCT04158583|450786219|FG006|Overall Study|Withdrawal by Subject|0|||
125316143|NCT04158583|450786220|FG007|Overall Study|Withdrawal by Subject|0|||
125316144|NCT04158583|450786221|FG008|Overall Study|Withdrawal by Subject|2|||
125316145|NCT04158583|450786222|FG009|Overall Study|Withdrawal by Subject|0|||
125316146|NCT04158583|450786213|FG000|Overall Study|Study Terminated by Sponsor|0|||
125316147|NCT04158583|450786214|FG001|Overall Study|Study Terminated by Sponsor|0|||
125316148|NCT04158583|450786215|FG002|Overall Study|Study Terminated by Sponsor|0|||
125316149|NCT04158583|450786216|FG003|Overall Study|Study Terminated by Sponsor|1|||
125316150|NCT04158583|450786217|FG004|Overall Study|Study Terminated by Sponsor|0|||
125316151|NCT04158583|450786218|FG005|Overall Study|Study Terminated by Sponsor|0|||
125316152|NCT04158583|450786219|FG006|Overall Study|Study Terminated by Sponsor|0|||
125316153|NCT04158583|450786220|FG007|Overall Study|Study Terminated by Sponsor|0|||
125316154|NCT04158583|450786221|FG008|Overall Study|Study Terminated by Sponsor|0|||
125316155|NCT04158583|450786222|FG009|Overall Study|Study Terminated by Sponsor|0|||
125316156|NCT04158583|450786213|FG000|Overall Study|Progressive Disease|1|||
125316157|NCT04158583|450786214|FG001|Overall Study|Progressive Disease|0|||
125316158|NCT04158583|450786215|FG002|Overall Study|Progressive Disease|3|||
125316159|NCT04158583|450786216|FG003|Overall Study|Progressive Disease|5|||
125316160|NCT04158583|450786217|FG004|Overall Study|Progressive Disease|0|||
125316161|NCT04158583|450786218|FG005|Overall Study|Progressive Disease|1|||
125316162|NCT04158583|450786219|FG006|Overall Study|Progressive Disease|6|||
125316163|NCT04158583|450786220|FG007|Overall Study|Progressive Disease|2|||
125316164|NCT04158583|450786221|FG008|Overall Study|Progressive Disease|1|||
125316165|NCT04158583|450786222|FG009|Overall Study|Progressive Disease|2|||
125316166|NCT04158583|450786213|FG000|Overall Study|Lost to Follow-up|0|||
125316167|NCT04158583|450786214|FG001|Overall Study|Lost to Follow-up|0|||
125316168|NCT04158583|450786215|FG002|Overall Study|Lost to Follow-up|1|||
125316169|NCT04158583|450786216|FG003|Overall Study|Lost to Follow-up|1|||
125316170|NCT04158583|450786217|FG004|Overall Study|Lost to Follow-up|1|||
125316171|NCT04158583|450786218|FG005|Overall Study|Lost to Follow-up|0|||
125316172|NCT04158583|450786219|FG006|Overall Study|Lost to Follow-up|0|||
125316173|NCT04158583|450786220|FG007|Overall Study|Lost to Follow-up|0|||
125316174|NCT04158583|450786221|FG008|Overall Study|Lost to Follow-up|0|||
125316175|NCT04158583|450786222|FG009|Overall Study|Lost to Follow-up|0|||
125316176|NCT04158583|450786213|FG000|Overall Study|Due To Patient Status|0|||
125316177|NCT04158583|450786214|FG001|Overall Study|Due To Patient Status|0|||
125316178|NCT04158583|450786215|FG002|Overall Study|Due To Patient Status|0|||
125316179|NCT04158583|450786216|FG003|Overall Study|Due To Patient Status|0|||
125656564|NCT03505606|452028883|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
125656565|NCT03505606|452028884|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
125656566|NCT03505606|452028882|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
125656567|NCT03505606|452028883|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
125656568|NCT03505606|452028884|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
125316180|NCT04158583|450786217|FG004|Overall Study|Due To Patient Status|0|||
125316181|NCT04158583|450786218|FG005|Overall Study|Due To Patient Status|0|||
125316182|NCT04158583|450786219|FG006|Overall Study|Due To Patient Status|0|||
125316183|NCT04158583|450786220|FG007|Overall Study|Due To Patient Status|0|||
125316184|NCT04158583|450786221|FG008|Overall Study|Due To Patient Status|1|||
125316185|NCT04158583|450786222|FG009|Overall Study|Due To Patient Status|0|||
125316186|NCT04158583|450786213|FG000|Overall Study|Death|3|||
125316187|NCT04158583|450786214|FG001|Overall Study|Death|4|||
125316188|NCT04158583|450786215|FG002|Overall Study|Death|2|||
125316189|NCT04158583|450786216|FG003|Overall Study|Death|2|||
125316190|NCT04158583|450786217|FG004|Overall Study|Death|4|||
125316191|NCT04158583|450786218|FG005|Overall Study|Death|3|||
125316192|NCT04158583|450786219|FG006|Overall Study|Death|5|||
125316193|NCT04158583|450786220|FG007|Overall Study|Death|2|||
125656569|NCT03505606|452028882|FG000|Overall Study|Poor compliance with refractive correction|0|||
125656570|NCT03505606|452028883|FG001|Overall Study|Poor compliance with refractive correction|0|||
125656571|NCT03505606|452028884|FG002|Overall Study|Poor compliance with refractive correction|1|||
125656572|NCT03505606|452028882|FG000|Overall Study|Insufficient anisometropia|0|||
125656573|NCT03505606|452028883|FG001|Overall Study|Insufficient anisometropia|0|||
125656574|NCT03505606|452028884|FG002|Overall Study|Insufficient anisometropia|2|||
125656575|NCT03505606|452028882|FG000|Overall Study|Ectopia Lentis|0|||
125656576|NCT03505606|452028883|FG001|Overall Study|Ectopia Lentis|0|||
125656577|NCT03505606|452028884|FG002|Overall Study|Ectopia Lentis|1|||
125656578|NCT03505606|452028882|FG000|Overall Study|alternation of amblyopic eye|0|||
125656579|NCT03505606|452028883|FG001|Overall Study|alternation of amblyopic eye|1|||
125656580|NCT03505606|452028884|FG002|Overall Study|alternation of amblyopic eye|0|||
125656581|NCT00648739|452028896|FG000|Overall Study|Adverse Event|1|||
125656582|NCT00648739|452028897|FG001|Overall Study|Adverse Event|0|||
125656583|NCT00648739|452028898|FG002|Overall Study|Adverse Event|1|||
125656584|NCT00648739|452028899|FG003|Overall Study|Adverse Event|2|||
125656585|NCT00648739|452028900|FG004|Overall Study|Adverse Event|1|||
125656586|NCT00648739|452028901|FG005|Overall Study|Adverse Event|0|||
125656587|NCT00648739|452028902|FG006|Overall Study|Adverse Event|0|||
125656588|NCT00648739|452028896|FG000|Overall Study|Withdrawal by Subject|1|||
125656589|NCT00648739|452028897|FG001|Overall Study|Withdrawal by Subject|0|||
125656590|NCT00648739|452028898|FG002|Overall Study|Withdrawal by Subject|1|||
125656591|NCT00648739|452028899|FG003|Overall Study|Withdrawal by Subject|0|||
125656592|NCT00648739|452028900|FG004|Overall Study|Withdrawal by Subject|0|||
125656593|NCT00648739|452028901|FG005|Overall Study|Withdrawal by Subject|2|||
125656594|NCT00648739|452028902|FG006|Overall Study|Withdrawal by Subject|0|||
125656595|NCT00648739|452028896|FG000|Overall Study|Lack of Efficacy|0|||
125656596|NCT00648739|452028897|FG001|Overall Study|Lack of Efficacy|0|||
125656597|NCT00648739|452028898|FG002|Overall Study|Lack of Efficacy|0|||
125656598|NCT00648739|452028899|FG003|Overall Study|Lack of Efficacy|0|||
125656599|NCT00648739|452028900|FG004|Overall Study|Lack of Efficacy|1|||
125656600|NCT00648739|452028901|FG005|Overall Study|Lack of Efficacy|2|||
125656601|NCT00648739|452028902|FG006|Overall Study|Lack of Efficacy|0|||
125656602|NCT00648739|452028896|FG000|Overall Study|Investigator Considered it Advisable|0|||
125656603|NCT00648739|452028897|FG001|Overall Study|Investigator Considered it Advisable|0|||
125656604|NCT00648739|452028898|FG002|Overall Study|Investigator Considered it Advisable|0|||
125656605|NCT00648739|452028899|FG003|Overall Study|Investigator Considered it Advisable|0|||
125656606|NCT00648739|452028900|FG004|Overall Study|Investigator Considered it Advisable|0|||
125656607|NCT00648739|452028901|FG005|Overall Study|Investigator Considered it Advisable|1|||
125656608|NCT00648739|452028902|FG006|Overall Study|Investigator Considered it Advisable|1|||
125656609|NCT00648739|452028896|FG000|Overall Study|Death|0|||
125656610|NCT00648739|452028897|FG001|Overall Study|Death|1|||
125656611|NCT00648739|452028898|FG002|Overall Study|Death|0|||
125656612|NCT00648739|452028899|FG003|Overall Study|Death|0|||
125656613|NCT00648739|452028900|FG004|Overall Study|Death|0|||
125656614|NCT00648739|452028901|FG005|Overall Study|Death|0|||
125656615|NCT00648739|452028902|FG006|Overall Study|Death|0|||
125656616|NCT00648739|452028896|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
125656617|NCT00648739|452028897|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
125656618|NCT00648739|452028898|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
125656619|NCT00648739|452028899|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
125656620|NCT00648739|452028900|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
125656621|NCT00648739|452028901|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
125656622|NCT00648739|452028902|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
125656623|NCT00648739|452028896|FG000|Overall Study|Follow-up Visits Not Completed|0|||
125656624|NCT00648739|452028897|FG001|Overall Study|Follow-up Visits Not Completed|1|||
125656625|NCT00648739|452028898|FG002|Overall Study|Follow-up Visits Not Completed|0|||
125656626|NCT00648739|452028899|FG003|Overall Study|Follow-up Visits Not Completed|0|||
125656627|NCT00648739|452028900|FG004|Overall Study|Follow-up Visits Not Completed|0|||
125656628|NCT00648739|452028901|FG005|Overall Study|Follow-up Visits Not Completed|0|||
125656629|NCT00648739|452028902|FG006|Overall Study|Follow-up Visits Not Completed|0|||
125656630|NCT00242567|452028907|FG000|Overall Study|Adverse Event|70|||
125656631|NCT00242567|452028908|FG001|Overall Study|Adverse Event|43|||
125656632|NCT00242567|452028907|FG000|Overall Study|Disease Progression|17|||
125656633|NCT00242567|452028908|FG001|Overall Study|Disease Progression|22|||
125656634|NCT00242567|452028907|FG000|Overall Study|Symptomatic deterioration|9|||
125656635|NCT00242567|452028908|FG001|Overall Study|Symptomatic deterioration|3|||
125656636|NCT00242567|452028907|FG000|Overall Study|Lack of Efficacy|2|||
125656637|NCT00242567|452028908|FG001|Overall Study|Lack of Efficacy|2|||
125656638|NCT00242567|452028907|FG000|Overall Study|Lost to Follow-up|9|||
125656639|NCT00242567|452028908|FG001|Overall Study|Lost to Follow-up|19|||
125656640|NCT00242567|452028907|FG000|Overall Study|Withdrawal by Subject|33|||
125656641|NCT00242567|452028908|FG001|Overall Study|Withdrawal by Subject|28|||
125656642|NCT00242567|452028907|FG000|Overall Study|Protocol Violation|12|||
125656643|NCT00242567|452028908|FG001|Overall Study|Protocol Violation|12|||
125316194|NCT04158583|450786221|FG008|Overall Study|Death|0|||
125316195|NCT04158583|450786222|FG009|Overall Study|Death|1|||
125316196|NCT04158583|450786213|FG000|Overall Study|Clinical Progression Disease|0|||
125656644|NCT00242567|452028907|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
125656645|NCT00242567|452028908|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
125656646|NCT00242567|452028907|FG000|Overall Study|Other|14|||
125656647|NCT00242567|452028908|FG001|Overall Study|Other|9|||
125656648|NCT04930536|452028911|FG000|Overall Study|Adverse Event|1|||
125656649|NCT04930536|452028912|FG001|Overall Study|Adverse Event|0|||
125656650|NCT04930536|452028911|FG000|Overall Study|Disease Progression|2|||
125656651|NCT04930536|452028912|FG001|Overall Study|Disease Progression|0|||
125656652|NCT04930536|452028911|FG000|Overall Study|Patient Decision|4|||
125656653|NCT04930536|452028912|FG001|Overall Study|Patient Decision|2|||
125656654|NCT04930536|452028911|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
125656655|NCT04930536|452028912|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
125656656|NCT01432600|452028913|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
125656657|NCT01432600|452028914|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
125656658|NCT01432600|452028915|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
125656659|NCT03079869|452028924|FG000|Overall Study|Adverse Event|6|||
125656660|NCT03079869|452028925|FG001|Overall Study|Adverse Event|8|||
125656661|NCT03079869|452028924|FG000|Overall Study|Withdrawal by Subject|4|||
125656662|NCT03079869|452028925|FG001|Overall Study|Withdrawal by Subject|1|||
125656663|NCT03079869|452028924|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
125656664|NCT03079869|452028925|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
125656665|NCT02411110|452028926|FG000|Treatment Period 1|Adverse Event|4|||
125656666|NCT02411110|452028927|FG001|Treatment Period 1|Adverse Event|2|||
125656667|NCT02411110|452028926|FG000|Treatment Period 1|Lost to Follow-up|1|||
125656668|NCT02411110|452028927|FG001|Treatment Period 1|Lost to Follow-up|0|||
125656669|NCT02411110|452028926|FG000|Treatment Period 1|Personal Reasons|2|||
125656670|NCT02411110|452028927|FG001|Treatment Period 1|Personal Reasons|5|||
125656671|NCT02411110|452028926|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
125656672|NCT02411110|452028927|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
125656673|NCT02411110|452028926|FG000|Treatment Period 2|Adverse Event|1|||
125656674|NCT02411110|452028927|FG001|Treatment Period 2|Adverse Event|0|||
125656675|NCT02411110|452028926|FG000|Treatment Period 2|Lost to Follow-up|0|||
125656676|NCT02411110|452028927|FG001|Treatment Period 2|Lost to Follow-up|2|||
125656677|NCT02411110|452028926|FG000|Treatment Period 2|Personal Reasons|0|||
125656678|NCT02411110|452028927|FG001|Treatment Period 2|Personal Reasons|2|||
125656679|NCT03292731|452028928|FG000|Overall Study|Protocol Violation|4|||
125656680|NCT03292731|452028929|FG001|Overall Study|Protocol Violation|11|||
125656681|NCT03292731|452028930|FG002|Overall Study|Protocol Violation|1|||
125656682|NCT03901352|452028934|FG000|Double-blind Phase|Adverse Event|6|||
125656683|NCT03901352|452028935|FG001|Double-blind Phase|Adverse Event|4|||
125656684|NCT03901352|452028934|FG000|Double-blind Phase|Death|1|||
125656685|NCT03901352|452028935|FG001|Double-blind Phase|Death|0|||
125656686|NCT03901352|452028934|FG000|Double-blind Phase|Lack of Efficacy|0|||
125656687|NCT03901352|452028935|FG001|Double-blind Phase|Lack of Efficacy|1|||
125656688|NCT03901352|452028934|FG000|Double-blind Phase|Protocol Violation|0|||
125656689|NCT03901352|452028935|FG001|Double-blind Phase|Protocol Violation|1|||
125656690|NCT03901352|452028934|FG000|Double-blind Phase|Withdrawal by Subject|10|||
125656691|NCT03901352|452028935|FG001|Double-blind Phase|Withdrawal by Subject|8|||
125656692|NCT03901352|452028934|FG000|Open-label Extension Phase|Adverse Event|24|||
125656693|NCT03901352|452028935|FG001|Open-label Extension Phase|Adverse Event|0|||
125656694|NCT03901352|452028934|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
125656695|NCT03901352|452028935|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
125656696|NCT03901352|452028934|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
125656697|NCT03901352|452028935|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
125656698|NCT03901352|452028934|FG000|Open-label Extension Phase|Other|1|||
125656699|NCT03901352|452028935|FG001|Open-label Extension Phase|Other|0|||
125656700|NCT02871921|452028940|FG000|Overall Study|Withdrawal by Subject|34|||
125656701|NCT02871921|452028941|FG001|Overall Study|Withdrawal by Subject|27|||
125656702|NCT02871921|452028942|FG002|Overall Study|Withdrawal by Subject|27|||
125656703|NCT02871921|452028943|FG003|Overall Study|Withdrawal by Subject|30|||
125656704|NCT00824993|452028953|FG000|Overall Study|Withdrawal by Subject|1|||
125316197|NCT04158583|450786214|FG001|Overall Study|Clinical Progression Disease|0|||
125316198|NCT04158583|450786215|FG002|Overall Study|Clinical Progression Disease|0|||
125656705|NCT00824993|452028954|FG001|Overall Study|Withdrawal by Subject|1|||
125656706|NCT00824993|452028953|FG000|Overall Study|Malignancy Relapse|9|||
125656707|NCT00824993|452028954|FG001|Overall Study|Malignancy Relapse|10|||
125656708|NCT00824993|452028953|FG000|Overall Study|Rapid Bone Loss|0|||
125656709|NCT00824993|452028954|FG001|Overall Study|Rapid Bone Loss|1|||
125656710|NCT00824993|452028953|FG000|Overall Study|Non-Compliant|2|||
125656711|NCT00824993|452028954|FG001|Overall Study|Non-Compliant|1|||
125656712|NCT00824993|452028953|FG000|Overall Study|Insurance Issue|2|||
125656713|NCT00824993|452028954|FG001|Overall Study|Insurance Issue|1|||
125656714|NCT00824993|452028953|FG000|Overall Study|Death|0|||
125656715|NCT00824993|452028954|FG001|Overall Study|Death|3|||
125656716|NCT02596009|452028955|FG000|Overall Study|Administrative problems|0|||
125656717|NCT02596009|452028956|FG001|Overall Study|Administrative problems|1|||
125656718|NCT02596009|452028957|FG002|Overall Study|Administrative problems|0|||
125656719|NCT02596009|452028958|FG003|Overall Study|Administrative problems|0|||
125656720|NCT02596009|452028959|FG004|Overall Study|Administrative problems|0|||
125656721|NCT02596009|452028960|FG005|Overall Study|Administrative problems|0|||
125656722|NCT02998645|452028961|FG000|Treatment Period 1|Adverse Event|6|||
125656723|NCT02998645|452028961|FG000|Treatment Period 1|Death|5|||
125656724|NCT02998645|452028961|FG000|Treatment Period 1|Technical Problems|4|||
125656725|NCT02998645|452028961|FG000|Treatment Period 1|Lack of Efficacy|2|||
125656726|NCT02998645|452028961|FG000|Treatment Period 1|Progressive disease|1|||
125656727|NCT02998645|452028961|FG000|Treatment Period 1|Subject/guardian decision|1|||
125656728|NCT02998645|452028961|FG000|Treatment Period 2|Lack of Efficacy|5|||
125656729|NCT02998645|452028961|FG000|Treatment Period 2|Adverse Event|2|||
125656730|NCT02998645|452028961|FG000|Treatment Period 2|Progressive disease|2|||
125656731|NCT02998645|452028961|FG000|Treatment Period 2|Physician Decision|1|||
125316199|NCT04158583|450786216|FG003|Overall Study|Clinical Progression Disease|1|||
125316200|NCT04158583|450786217|FG004|Overall Study|Clinical Progression Disease|0|||
125316201|NCT04158583|450786218|FG005|Overall Study|Clinical Progression Disease|0|||
125316202|NCT04158583|450786219|FG006|Overall Study|Clinical Progression Disease|0|||
125316203|NCT04158583|450786220|FG007|Overall Study|Clinical Progression Disease|0|||
125316204|NCT04158583|450786221|FG008|Overall Study|Clinical Progression Disease|0|||
125316205|NCT04158583|450786222|FG009|Overall Study|Clinical Progression Disease|0|||
125316206|NCT04158583|450786213|FG000|Overall Study|Clinical Progression|0|||
125656732|NCT04611152|452028965|FG000|Overall Study|Adverse Event|9|||
125656733|NCT04611152|452028966|FG001|Overall Study|Adverse Event|8|||
125656734|NCT04611152|452028965|FG000|Overall Study|Non-compliance with study schedule|1|||
125656735|NCT04611152|452028966|FG001|Overall Study|Non-compliance with study schedule|3|||
125316207|NCT04158583|450786214|FG001|Overall Study|Clinical Progression|0|||
125316208|NCT04158583|450786215|FG002|Overall Study|Clinical Progression|0|||
125316209|NCT04158583|450786216|FG003|Overall Study|Clinical Progression|0|||
125316210|NCT04158583|450786217|FG004|Overall Study|Clinical Progression|1|||
125316211|NCT04158583|450786218|FG005|Overall Study|Clinical Progression|0|||
125316212|NCT04158583|450786219|FG006|Overall Study|Clinical Progression|2|||
125316213|NCT04158583|450786220|FG007|Overall Study|Clinical Progression|0|||
125316214|NCT04158583|450786221|FG008|Overall Study|Clinical Progression|0|||
125316215|NCT04158583|450786222|FG009|Overall Study|Clinical Progression|0|||
125316216|NCT04158583|450786213|FG000|Overall Study|Clinical Deterioration|0|||
125316217|NCT04158583|450786214|FG001|Overall Study|Clinical Deterioration|0|||
125316218|NCT04158583|450786215|FG002|Overall Study|Clinical Deterioration|0|||
125316219|NCT04158583|450786216|FG003|Overall Study|Clinical Deterioration|1|||
125316220|NCT04158583|450786217|FG004|Overall Study|Clinical Deterioration|0|||
125316221|NCT04158583|450786218|FG005|Overall Study|Clinical Deterioration|0|||
125316222|NCT04158583|450786219|FG006|Overall Study|Clinical Deterioration|0|||
125316223|NCT04158583|450786220|FG007|Overall Study|Clinical Deterioration|0|||
125316224|NCT04158583|450786221|FG008|Overall Study|Clinical Deterioration|0|||
125316225|NCT04158583|450786222|FG009|Overall Study|Clinical Deterioration|1|||
125316226|NCT00320515|450786223|FG000|Overall Study|Death|33|||
125316227|NCT00320515|450786223|FG000|Overall Study|Lost to Follow-up|6|||
125316228|NCT00320515|450786223|FG000|Overall Study|Physician Decision|2|||
125316229|NCT00320515|450786223|FG000|Overall Study|Withdrawal by Subject|8|||
125316230|NCT01777776|450786224|FG000|Overall Study|Adverse Event|2|||
125316231|NCT01777776|450786225|FG001|Overall Study|Adverse Event|4|||
125316232|NCT01777776|450786226|FG002|Overall Study|Adverse Event|0|||
125316233|NCT01777776|450786227|FG003|Overall Study|Adverse Event|0|||
125316234|NCT01777776|450786224|FG000|Overall Study|Disease Progression|4|||
125316235|NCT01777776|450786225|FG001|Overall Study|Disease Progression|8|||
125316236|NCT01777776|450786226|FG002|Overall Study|Disease Progression|6|||
125316237|NCT01777776|450786227|FG003|Overall Study|Disease Progression|3|||
125316238|NCT01777776|450786224|FG000|Overall Study|Withdrawal by Subject|0|||
125316239|NCT01777776|450786225|FG001|Overall Study|Withdrawal by Subject|0|||
125656736|NCT04611152|452028965|FG000|Overall Study|Withdrawal by Subject|5|||
125656737|NCT04611152|452028966|FG001|Overall Study|Withdrawal by Subject|6|||
125656738|NCT04611152|452028965|FG000|Overall Study|Lost to Follow-up|11|||
125656739|NCT04611152|452028966|FG001|Overall Study|Lost to Follow-up|2|||
125656740|NCT03644927|452028967|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
125656741|NCT03644927|452028968|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
125656742|NCT00956813|452028969|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
125656743|NCT00956813|452028970|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
125316240|NCT01777776|450786226|FG002|Overall Study|Withdrawal by Subject|0|||
125316241|NCT01777776|450786227|FG003|Overall Study|Withdrawal by Subject|1|||
125316242|NCT00851786|450786228|FG000|Overall Study|Withdrawal by Subject|0|||
125316243|NCT00851786|450786229|FG001|Overall Study|Withdrawal by Subject|1|||
125316244|NCT00851786|450786228|FG000|Overall Study|Protocol Violation|0|||
125656744|NCT00956813|452028969|FG000|Flaxseed and Placebo|Ineligible|3|||
125656745|NCT00956813|452028970|FG001|Flaxseed and Placebo|Ineligible|1|||
125656746|NCT01275170|452028975|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
125656747|NCT01275170|452028976|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
125656748|NCT01275170|452028977|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
125656749|NCT01275170|452028978|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
125656750|NCT01275170|452028979|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
125656751|NCT01275170|452028980|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
125656752|NCT01275170|452028981|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
125656753|NCT01275170|452028982|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
125656754|NCT02864953|452028983|FG000|Overall Study|Adverse Event|22|||
125656755|NCT02864953|452028984|FG001|Overall Study|Adverse Event|19|||
125656756|NCT02864953|452028983|FG000|Overall Study|Withdrawal by Subject|1|||
125656757|NCT02864953|452028984|FG001|Overall Study|Withdrawal by Subject|0|||
125656758|NCT02864953|452028983|FG000|Overall Study|Physician Decision|4|||
125656759|NCT02864953|452028984|FG001|Overall Study|Physician Decision|2|||
125656760|NCT02864953|452028983|FG000|Overall Study|Death|3|||
125656761|NCT02864953|452028984|FG001|Overall Study|Death|13|||
125656762|NCT02864953|452028983|FG000|Overall Study|Reason not specified|14|||
125656763|NCT02864953|452028984|FG001|Overall Study|Reason not specified|12|||
125656764|NCT02864953|452028983|FG000|Overall Study|Withdrew Prior to Dosing|9|||
125656765|NCT02864953|452028984|FG001|Overall Study|Withdrew Prior to Dosing|8|||
125656766|NCT01023022|452028987|FG000|Overall Study|Death|5|||
125656767|NCT01023022|452028987|FG000|Overall Study|Lost to Follow-up|7|||
125656768|NCT01023022|452028987|FG000|Overall Study|due to technical issues|2|||
125656769|NCT03917654|452028988|FG000|Year 1|Withdrawal by Subject|1|||
125656770|NCT03917654|452028989|FG001|Year 1|Withdrawal by Subject|0|||
125656771|NCT03917654|452028990|FG002|Year 1|Withdrawal by Subject|0|||
125656772|NCT03917654|452028991|FG003|Year 1|Withdrawal by Subject|0|||
125656773|NCT03917654|452028992|FG004|Year 1|Withdrawal by Subject|0|||
125656774|NCT03917654|452028993|FG005|Year 1|Withdrawal by Subject|1|||
125656775|NCT03917654|452028994|FG006|Year 1|Withdrawal by Subject|6|||
125656776|NCT03917654|452028995|FG007|Year 1|Withdrawal by Subject|2|||
125656777|NCT03917654|452028996|FG008|Year 1|Withdrawal by Subject|5|||
125656778|NCT03917654|452028997|FG009|Year 1|Withdrawal by Subject|3|||
125656779|NCT03917654|452028998|FG010|Year 1|Withdrawal by Subject|1|||
125656780|NCT03917654|452028999|FG011|Year 1|Withdrawal by Subject|0|||
125656781|NCT03917654|452028988|FG000|Year 1|Travel|0|||
125656782|NCT03917654|452028989|FG001|Year 1|Travel|1|||
125656783|NCT03917654|452028990|FG002|Year 1|Travel|1|||
125656784|NCT03917654|452028991|FG003|Year 1|Travel|0|||
125656785|NCT03917654|452028992|FG004|Year 1|Travel|4|||
125656786|NCT03917654|452028993|FG005|Year 1|Travel|4|||
125656787|NCT03917654|452028994|FG006|Year 1|Travel|10|||
125656788|NCT03917654|452028995|FG007|Year 1|Travel|8|||
125656789|NCT03917654|452028996|FG008|Year 1|Travel|2|||
125656790|NCT03917654|452028997|FG009|Year 1|Travel|5|||
125656791|NCT03917654|452028998|FG010|Year 1|Travel|3|||
125656792|NCT03917654|452028999|FG011|Year 1|Travel|3|||
125656793|NCT03917654|452028988|FG000|Year 1|Subject moved away from site|0|||
125656794|NCT03917654|452028989|FG001|Year 1|Subject moved away from site|1|||
125656795|NCT03917654|452028990|FG002|Year 1|Subject moved away from site|0|||
125656796|NCT03917654|452028991|FG003|Year 1|Subject moved away from site|0|||
125656797|NCT03917654|452028992|FG004|Year 1|Subject moved away from site|0|||
125656798|NCT03917654|452028993|FG005|Year 1|Subject moved away from site|0|||
125656799|NCT03917654|452028994|FG006|Year 1|Subject moved away from site|1|||
125656800|NCT03917654|452028995|FG007|Year 1|Subject moved away from site|2|||
125656801|NCT03917654|452028996|FG008|Year 1|Subject moved away from site|1|||
125656802|NCT03917654|452028997|FG009|Year 1|Subject moved away from site|0|||
125656803|NCT03917654|452028998|FG010|Year 1|Subject moved away from site|0|||
125656804|NCT03917654|452028999|FG011|Year 1|Subject moved away from site|3|||
125656805|NCT03917654|452028988|FG000|Year 1|Spouse/Family member request|0|||
125656806|NCT03917654|452028989|FG001|Year 1|Spouse/Family member request|0|||
125656807|NCT03917654|452028990|FG002|Year 1|Spouse/Family member request|1|||
125656808|NCT03917654|452028991|FG003|Year 1|Spouse/Family member request|0|||
125656809|NCT03917654|452028992|FG004|Year 1|Spouse/Family member request|1|||
125656810|NCT03917654|452028993|FG005|Year 1|Spouse/Family member request|0|||
125656811|NCT03917654|452028994|FG006|Year 1|Spouse/Family member request|0|||
125656812|NCT03917654|452028995|FG007|Year 1|Spouse/Family member request|2|||
125656813|NCT03917654|452028996|FG008|Year 1|Spouse/Family member request|0|||
125656814|NCT03917654|452028997|FG009|Year 1|Spouse/Family member request|0|||
125656815|NCT03917654|452028998|FG010|Year 1|Spouse/Family member request|0|||
125656816|NCT03917654|452028999|FG011|Year 1|Spouse/Family member request|1|||
125316245|NCT00851786|450786229|FG001|Overall Study|Protocol Violation|1|||
125656817|NCT03917654|452028988|FG000|Year 1|Death|0|||
125656818|NCT03917654|452028989|FG001|Year 1|Death|0|||
125656819|NCT03917654|452028990|FG002|Year 1|Death|0|||
125656820|NCT03917654|452028991|FG003|Year 1|Death|0|||
125656821|NCT03917654|452028992|FG004|Year 1|Death|0|||
125656822|NCT03917654|452028993|FG005|Year 1|Death|0|||
125316246|NCT00851786|450786228|FG000|Overall Study|Lost to Follow-up|1|||
125316247|NCT00851786|450786229|FG001|Overall Study|Lost to Follow-up|0|||
125316248|NCT00851786|450786228|FG000|Overall Study|Incarceration|1|||
125316249|NCT00851786|450786229|FG001|Overall Study|Incarceration|0|||
125316250|NCT00851786|450786228|FG000|Overall Study|Site Closure|1|||
125316251|NCT00851786|450786229|FG001|Overall Study|Site Closure|0|||
125316252|NCT00851786|450786228|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
125316253|NCT00851786|450786229|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
125316254|NCT03737123|450788374|FG000|Study Treatment|Adverse Event|2|||
125316255|NCT03737123|450788375|FG001|Study Treatment|Adverse Event|0|||
125316256|NCT03737123|450788374|FG000|Study Treatment|Disease Progression|2|||
125316257|NCT03737123|450788375|FG001|Study Treatment|Disease Progression|0|||
125316258|NCT03737123|450788374|FG000|Study Treatment|Withdrawal by Subject|2|||
125316259|NCT03737123|450788375|FG001|Study Treatment|Withdrawal by Subject|0|||
125316260|NCT03737123|450788374|FG000|Follow up|Death|1|||
125316261|NCT03737123|450788375|FG001|Follow up|Death|0|||
125316262|NCT03737123|450788374|FG000|Follow up|Withdrawal by Subject|1|||
125316263|NCT03737123|450788375|FG001|Follow up|Withdrawal by Subject|0|||
125316264|NCT03737123|450788374|FG000|Follow up|Termination of study|4|||
125316265|NCT03737123|450788375|FG001|Follow up|Termination of study|0|||
125316266|NCT04233801|450788387|FG000|Overall Study|Other than listed|0|||
125316267|NCT04233801|450788388|FG001|Overall Study|Other than listed|0|||
125316268|NCT04233801|450788389|FG002|Overall Study|Other than listed|1|||
125316269|NCT04233801|450788387|FG000|Overall Study|Withdrawal by Subject|0|||
125316270|NCT04233801|450788388|FG001|Overall Study|Withdrawal by Subject|2|||
125316271|NCT04233801|450788389|FG002|Overall Study|Withdrawal by Subject|3|||
125316272|NCT01169103|450788391|FG000|Overall Study|Lost to Follow-up|3|||
125316273|NCT01169103|450788392|FG001|Overall Study|Lost to Follow-up|3|||
125316274|NCT01169103|450788391|FG000|Overall Study|Withdrawal by Subject|3|||
125316275|NCT01169103|450788392|FG001|Overall Study|Withdrawal by Subject|1|||
125316276|NCT02792231|450788397|FG000|Overall Study|Patient/guardian decision|32|||
125316277|NCT02792231|450788398|FG001|Overall Study|Patient/guardian decision|42|||
125316278|NCT02792231|450788397|FG000|Overall Study|Adverse Event|15|||
125316279|NCT02792231|450788398|FG001|Overall Study|Adverse Event|11|||
125316280|NCT02792231|450788397|FG000|Overall Study|Physician Decision|14|||
125316281|NCT02792231|450788398|FG001|Overall Study|Physician Decision|12|||
125316282|NCT02792231|450788397|FG000|Overall Study|Lack of Efficacy|7|||
125316283|NCT02792231|450788398|FG001|Overall Study|Lack of Efficacy|9|||
125316284|NCT02792231|450788397|FG000|Overall Study|Lost to Follow-up|9|||
125316285|NCT02792231|450788398|FG001|Overall Study|Lost to Follow-up|5|||
125316286|NCT02792231|450788397|FG000|Overall Study|Pregnancy|1|||
125316287|NCT02792231|450788398|FG001|Overall Study|Pregnancy|3|||
125316288|NCT02792231|450788397|FG000|Overall Study|Non-compliance with study treatment|2|||
125316289|NCT02792231|450788398|FG001|Overall Study|Non-compliance with study treatment|1|||
125316290|NCT02792231|450788397|FG000|Overall Study|Protocol deviation|2|||
125316291|NCT02792231|450788398|FG001|Overall Study|Protocol deviation|0|||
125316292|NCT02792231|450788397|FG000|Overall Study|Technical problems|0|||
125316293|NCT02792231|450788398|FG001|Overall Study|Technical problems|1|||
125316294|NCT05196828|450788399|FG000|Overall Study|Withdrawal by Subject|2|||
125316295|NCT05196828|450788400|FG001|Overall Study|Withdrawal by Subject|0|||
125316296|NCT05196828|450788399|FG000|Overall Study|Lost to Follow-up|0|||
125316297|NCT05196828|450788400|FG001|Overall Study|Lost to Follow-up|4|||
125316298|NCT05196828|450788399|FG000|Overall Study|Adverse Event|1|||
125316299|NCT05196828|450788400|FG001|Overall Study|Adverse Event|0|||
125656823|NCT03917654|452028994|FG006|Year 1|Death|0|||
125656824|NCT03917654|452028995|FG007|Year 1|Death|0|||
125656825|NCT03917654|452028996|FG008|Year 1|Death|1|||
125656826|NCT03917654|452028997|FG009|Year 1|Death|1|||
125656827|NCT03917654|452028998|FG010|Year 1|Death|0|||
125656828|NCT03917654|452028999|FG011|Year 1|Death|0|||
125656829|NCT03917654|452028988|FG000|Year 1|Lost to Follow-up|0|||
125656830|NCT03917654|452028989|FG001|Year 1|Lost to Follow-up|0|||
125656831|NCT03917654|452028990|FG002|Year 1|Lost to Follow-up|0|||
125656832|NCT03917654|452028991|FG003|Year 1|Lost to Follow-up|0|||
125656833|NCT03917654|452028992|FG004|Year 1|Lost to Follow-up|0|||
125656834|NCT03917654|452028993|FG005|Year 1|Lost to Follow-up|0|||
125656835|NCT03917654|452028994|FG006|Year 1|Lost to Follow-up|2|||
125656836|NCT03917654|452028995|FG007|Year 1|Lost to Follow-up|0|||
125656837|NCT03917654|452028996|FG008|Year 1|Lost to Follow-up|0|||
125316300|NCT02469623|450788401|FG000|Overall Study|Not consented for long-term follow-up|4|||
125316301|NCT02469623|450788401|FG000|Overall Study|Lost to Follow-up|4|||
125316302|NCT02469623|450788401|FG000|Overall Study|Withdrawal by Subject|2|||
125316303|NCT02469623|450788401|FG000|Overall Study|Death|3|||
125316304|NCT04073186|450788402|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
125316305|NCT04073186|450788402|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
125316306|NCT04073186|450788402|FG000|First Wearing Cycle|Protocol Violation|1|||
125316307|NCT04073186|450788402|FG000|First Wearing Cycle|Lens Discomfort|2|||
125656838|NCT03917654|452028997|FG009|Year 1|Lost to Follow-up|0|||
125656839|NCT03917654|452028998|FG010|Year 1|Lost to Follow-up|0|||
125656840|NCT03917654|452028999|FG011|Year 1|Lost to Follow-up|0|||
125656841|NCT03917654|452028988|FG000|Year 1|Missed visits|0|||
125656842|NCT03917654|452028989|FG001|Year 1|Missed visits|0|||
125656843|NCT03917654|452028990|FG002|Year 1|Missed visits|0|||
125656844|NCT03917654|452028991|FG003|Year 1|Missed visits|0|||
125656845|NCT03917654|452028992|FG004|Year 1|Missed visits|0|||
125656846|NCT03917654|452028993|FG005|Year 1|Missed visits|0|||
125656847|NCT03917654|452028994|FG006|Year 1|Missed visits|0|||
125656848|NCT03917654|452028995|FG007|Year 1|Missed visits|0|||
125656849|NCT03917654|452028996|FG008|Year 1|Missed visits|0|||
125656850|NCT03917654|452028997|FG009|Year 1|Missed visits|0|||
125656851|NCT03917654|452028998|FG010|Year 1|Missed visits|1|||
125656852|NCT03917654|452028999|FG011|Year 1|Missed visits|1|||
125656853|NCT03917654|452028988|FG000|Year 1|Pregnancy|0|||
125656854|NCT03917654|452028989|FG001|Year 1|Pregnancy|0|||
125656855|NCT03917654|452028990|FG002|Year 1|Pregnancy|0|||
125656856|NCT03917654|452028991|FG003|Year 1|Pregnancy|0|||
125656857|NCT03917654|452028992|FG004|Year 1|Pregnancy|0|||
125656858|NCT03917654|452028993|FG005|Year 1|Pregnancy|0|||
125656859|NCT03917654|452028994|FG006|Year 1|Pregnancy|0|||
125656860|NCT03917654|452028995|FG007|Year 1|Pregnancy|1|||
125656861|NCT03917654|452028996|FG008|Year 1|Pregnancy|0|||
125656862|NCT03917654|452028997|FG009|Year 1|Pregnancy|1|||
125656863|NCT03917654|452028998|FG010|Year 1|Pregnancy|0|||
125656864|NCT03917654|452028999|FG011|Year 1|Pregnancy|0|||
125656865|NCT03917654|452028988|FG000|Year 2|Travel|1|||
125656866|NCT03917654|452028989|FG001|Year 2|Travel|0|||
125656867|NCT03917654|452028990|FG002|Year 2|Travel|0|||
125656868|NCT03917654|452028991|FG003|Year 2|Travel|0|||
125656869|NCT03917654|452028992|FG004|Year 2|Travel|1|||
125656870|NCT03917654|452028993|FG005|Year 2|Travel|1|||
125656871|NCT03917654|452028994|FG006|Year 2|Travel|2|||
125656872|NCT03917654|452028995|FG007|Year 2|Travel|1|||
125656873|NCT03917654|452028996|FG008|Year 2|Travel|0|||
125656874|NCT03917654|452028997|FG009|Year 2|Travel|1|||
125656875|NCT03917654|452028998|FG010|Year 2|Travel|0|||
125656876|NCT03917654|452028999|FG011|Year 2|Travel|1|||
125656877|NCT03917654|452028988|FG000|Year 2|Married|1|||
125656878|NCT03917654|452028989|FG001|Year 2|Married|0|||
125656879|NCT03917654|452028990|FG002|Year 2|Married|0|||
125656880|NCT03917654|452028991|FG003|Year 2|Married|0|||
125656881|NCT03917654|452028992|FG004|Year 2|Married|0|||
125656882|NCT03917654|452028993|FG005|Year 2|Married|0|||
125656883|NCT03917654|452028994|FG006|Year 2|Married|1|||
125656884|NCT03917654|452028995|FG007|Year 2|Married|1|||
125656885|NCT03917654|452028996|FG008|Year 2|Married|0|||
125656886|NCT03917654|452028997|FG009|Year 2|Married|0|||
125656887|NCT03917654|452028998|FG010|Year 2|Married|0|||
125656888|NCT03917654|452028999|FG011|Year 2|Married|0|||
125656889|NCT03917654|452028988|FG000|Year 2|Subject moved away from site|1|||
125656890|NCT03917654|452028989|FG001|Year 2|Subject moved away from site|0|||
125656891|NCT03917654|452028990|FG002|Year 2|Subject moved away from site|0|||
125656892|NCT03917654|452028991|FG003|Year 2|Subject moved away from site|0|||
125656893|NCT03917654|452028992|FG004|Year 2|Subject moved away from site|1|||
125656894|NCT03917654|452028993|FG005|Year 2|Subject moved away from site|0|||
125656895|NCT03917654|452028994|FG006|Year 2|Subject moved away from site|2|||
125656896|NCT03917654|452028995|FG007|Year 2|Subject moved away from site|3|||
125656897|NCT03917654|452028996|FG008|Year 2|Subject moved away from site|0|||
125656898|NCT03917654|452028997|FG009|Year 2|Subject moved away from site|2|||
125656899|NCT03917654|452028998|FG010|Year 2|Subject moved away from site|0|||
125656900|NCT03917654|452028999|FG011|Year 2|Subject moved away from site|1|||
125656901|NCT03917654|452028988|FG000|Year 2|Year 2 Screening failure|0|||
125656902|NCT03917654|452028989|FG001|Year 2|Year 2 Screening failure|1|||
125656903|NCT03917654|452028990|FG002|Year 2|Year 2 Screening failure|0|||
125656904|NCT03917654|452028991|FG003|Year 2|Year 2 Screening failure|0|||
125656905|NCT03917654|452028992|FG004|Year 2|Year 2 Screening failure|2|||
125656906|NCT03917654|452028993|FG005|Year 2|Year 2 Screening failure|0|||
125656907|NCT03917654|452028994|FG006|Year 2|Year 2 Screening failure|4|||
125656908|NCT03917654|452028995|FG007|Year 2|Year 2 Screening failure|3|||
125656909|NCT03917654|452028996|FG008|Year 2|Year 2 Screening failure|10|||
125656910|NCT03917654|452028997|FG009|Year 2|Year 2 Screening failure|2|||
125656911|NCT03917654|452028998|FG010|Year 2|Year 2 Screening failure|1|||
125656912|NCT03917654|452028999|FG011|Year 2|Year 2 Screening failure|1|||
125656913|NCT03917654|452028988|FG000|Year 2|Death|0|||
125656914|NCT03917654|452028989|FG001|Year 2|Death|0|||
125656915|NCT03917654|452028990|FG002|Year 2|Death|0|||
125656916|NCT03917654|452028991|FG003|Year 2|Death|0|||
125656917|NCT03917654|452028992|FG004|Year 2|Death|0|||
125656918|NCT03917654|452028993|FG005|Year 2|Death|1|||
125656919|NCT03917654|452028994|FG006|Year 2|Death|0|||
125656920|NCT03917654|452028995|FG007|Year 2|Death|0|||
125656921|NCT03917654|452028996|FG008|Year 2|Death|1|||
125656922|NCT03917654|452028997|FG009|Year 2|Death|1|||
125656923|NCT03917654|452028998|FG010|Year 2|Death|0|||
125656924|NCT03917654|452028999|FG011|Year 2|Death|0|||
125656925|NCT03917654|452028988|FG000|Year 2|Withdrawal by Subject|0|||
125656926|NCT03917654|452028989|FG001|Year 2|Withdrawal by Subject|0|||
125656927|NCT03917654|452028990|FG002|Year 2|Withdrawal by Subject|0|||
125656928|NCT03917654|452028991|FG003|Year 2|Withdrawal by Subject|0|||
125656929|NCT03917654|452028992|FG004|Year 2|Withdrawal by Subject|0|||
125656930|NCT03917654|452028993|FG005|Year 2|Withdrawal by Subject|0|||
125656931|NCT03917654|452028994|FG006|Year 2|Withdrawal by Subject|3|||
125656932|NCT03917654|452028995|FG007|Year 2|Withdrawal by Subject|0|||
125656933|NCT03917654|452028996|FG008|Year 2|Withdrawal by Subject|2|||
125656934|NCT03917654|452028997|FG009|Year 2|Withdrawal by Subject|5|||
125656935|NCT03917654|452028998|FG010|Year 2|Withdrawal by Subject|0|||
125656936|NCT03917654|452028999|FG011|Year 2|Withdrawal by Subject|0|||
125656937|NCT03917654|452028988|FG000|Year 2|Spouse/family member request|0|||
125656938|NCT03917654|452028989|FG001|Year 2|Spouse/family member request|0|||
125656939|NCT03917654|452028990|FG002|Year 2|Spouse/family member request|0|||
125656940|NCT03917654|452028991|FG003|Year 2|Spouse/family member request|0|||
125656941|NCT03917654|452028992|FG004|Year 2|Spouse/family member request|0|||
125656942|NCT03917654|452028993|FG005|Year 2|Spouse/family member request|0|||
125656943|NCT03917654|452028994|FG006|Year 2|Spouse/family member request|1|||
125656944|NCT03917654|452028995|FG007|Year 2|Spouse/family member request|0|||
125656945|NCT03917654|452028996|FG008|Year 2|Spouse/family member request|0|||
125656946|NCT03917654|452028997|FG009|Year 2|Spouse/family member request|0|||
125656947|NCT03917654|452028998|FG010|Year 2|Spouse/family member request|0|||
125656948|NCT03917654|452028999|FG011|Year 2|Spouse/family member request|0|||
125656949|NCT03917654|452028988|FG000|Year 2|Lost to Follow-up|0|||
125656950|NCT03917654|452028989|FG001|Year 2|Lost to Follow-up|0|||
125656951|NCT03917654|452028990|FG002|Year 2|Lost to Follow-up|0|||
125656952|NCT03917654|452028991|FG003|Year 2|Lost to Follow-up|0|||
125656953|NCT03917654|452028992|FG004|Year 2|Lost to Follow-up|0|||
125656954|NCT03917654|452028993|FG005|Year 2|Lost to Follow-up|0|||
125656955|NCT03917654|452028994|FG006|Year 2|Lost to Follow-up|1|||
125656956|NCT03917654|452028995|FG007|Year 2|Lost to Follow-up|0|||
125656957|NCT03917654|452028996|FG008|Year 2|Lost to Follow-up|1|||
125656958|NCT03917654|452028997|FG009|Year 2|Lost to Follow-up|0|||
125656959|NCT03917654|452028998|FG010|Year 2|Lost to Follow-up|0|||
125656960|NCT03917654|452028999|FG011|Year 2|Lost to Follow-up|1|||
125656961|NCT03917654|452028988|FG000|Year 2|Adverse Event|0|||
125656962|NCT03917654|452028989|FG001|Year 2|Adverse Event|0|||
125656963|NCT03917654|452028990|FG002|Year 2|Adverse Event|0|||
125656964|NCT03917654|452028991|FG003|Year 2|Adverse Event|0|||
125656965|NCT03917654|452028992|FG004|Year 2|Adverse Event|0|||
125656966|NCT03917654|452028993|FG005|Year 2|Adverse Event|0|||
125656967|NCT03917654|452028994|FG006|Year 2|Adverse Event|0|||
125656968|NCT03917654|452028995|FG007|Year 2|Adverse Event|0|||
125656969|NCT03917654|452028996|FG008|Year 2|Adverse Event|0|||
125656970|NCT03917654|452028997|FG009|Year 2|Adverse Event|1|||
125656971|NCT03917654|452028998|FG010|Year 2|Adverse Event|0|||
125656972|NCT03917654|452028999|FG011|Year 2|Adverse Event|0|||
125656973|NCT00905437|452029001|FG000|Overall Study|Adverse Event|3|||
125656974|NCT00905437|452029002|FG001|Overall Study|Adverse Event|2|||
125656975|NCT00905437|452029001|FG000|Overall Study|Lost to Follow-up|0|||
125656976|NCT00905437|452029002|FG001|Overall Study|Lost to Follow-up|1|||
125656977|NCT00905437|452029001|FG000|Overall Study|Withdrawal by Subject|0|||
125656978|NCT00905437|452029002|FG001|Overall Study|Withdrawal by Subject|1|||
125656979|NCT00905437|452029001|FG000|Overall Study|Other|5|||
125656980|NCT00905437|452029002|FG001|Overall Study|Other|6|||
125656981|NCT03128931|452029005|FG000|Overall Study|Physician Decision|1|||
125656982|NCT03128931|452029005|FG000|Overall Study|Equipment Issues|3|||
125656983|NCT01329562|452029006|FG000|Overall Study|Protocol Violation|5|||
125656984|NCT01329562|452029007|FG001|Overall Study|Protocol Violation|3|||
125656985|NCT01329562|452029006|FG000|Overall Study|Lost to Follow-up|1|||
125656986|NCT01329562|452029007|FG001|Overall Study|Lost to Follow-up|1|||
125656987|NCT01329562|452029006|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
125656988|NCT01329562|452029007|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
125656989|NCT01329562|452029006|FG000|Overall Study|Physician Decision|0|||
125656990|NCT01329562|452029007|FG001|Overall Study|Physician Decision|1|||
125656991|NCT03252015|452029008|FG000|Overall Study|Withdrawal by Subject|0|||
125656992|NCT03252015|452029009|FG001|Overall Study|Withdrawal by Subject|1|||
125656993|NCT03252015|452029010|FG002|Overall Study|Withdrawal by Subject|1|||
125656994|NCT03252015|452029011|FG003|Overall Study|Withdrawal by Subject|0|||
125656995|NCT03252015|452029008|FG000|Overall Study|Adverse Event|1|||
125656996|NCT03252015|452029009|FG001|Overall Study|Adverse Event|0|||
125656997|NCT03252015|452029010|FG002|Overall Study|Adverse Event|0|||
125656998|NCT03252015|452029011|FG003|Overall Study|Adverse Event|1|||
125656999|NCT00061568|452029014|FG000|Overall Study|Lost to Follow-up|12|||
125657000|NCT00061568|452029015|FG001|Overall Study|Lost to Follow-up|0|||
125657001|NCT00061568|452029014|FG000|Overall Study|Death|6|||
125657002|NCT00061568|452029015|FG001|Overall Study|Death|0|||
125657003|NCT00061568|452029014|FG000|Overall Study|Withdrawal by Subject|1|||
125657004|NCT00061568|452029015|FG001|Overall Study|Withdrawal by Subject|0|||
125657005|NCT01071278|452029019|FG000|Overall Study|Premature Discontinuation|254|||
125657006|NCT01071278|452029019|FG000|Overall Study|Completion Status Unknown|459|||
125657007|NCT00903409|452029020|FG000|Overall Study|Adverse Event|11|||
125657008|NCT00903409|452029021|FG001|Overall Study|Adverse Event|9|||
125657009|NCT00903409|452029020|FG000|Overall Study|Non-compliance with Protocol|1|||
125657010|NCT00903409|452029021|FG001|Overall Study|Non-compliance with Protocol|1|||
125657011|NCT00903409|452029020|FG000|Overall Study|Laboratory Abnormality|2|||
125316308|NCT04073186|450788402|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
125316309|NCT04073186|450788402|FG000|Second Wearing Cycle|Adverse Event|1|||
125316310|NCT01096316|450788403|FG000|Overall Study|Lost to Follow-up|15|||
125316311|NCT01096316|450788404|FG001|Overall Study|Lost to Follow-up|9|||
125316312|NCT02763644|450788405|FG000|Overall Study|Patient/guardian decision|1|||
125316313|NCT02763644|450788406|FG001|Overall Study|Patient/guardian decision|0|||
125316314|NCT02763644|450788405|FG000|Overall Study|Death|1|||
125316315|NCT02763644|450788406|FG001|Overall Study|Death|1|||
125316316|NCT02763644|450788405|FG000|Overall Study|Adverse Event|1|||
125657012|NCT00903409|452029021|FG001|Overall Study|Laboratory Abnormality|0|||
125657013|NCT00903409|452029020|FG000|Overall Study|Withdrawal by Subject|8|||
125657014|NCT00903409|452029021|FG001|Overall Study|Withdrawal by Subject|8|||
125657015|NCT00903409|452029020|FG000|Overall Study|Other|2|||
125657016|NCT00903409|452029021|FG001|Overall Study|Other|3|||
125657017|NCT00903409|452029020|FG000|Overall Study|Lost to Follow-up|2|||
125657018|NCT00903409|452029021|FG001|Overall Study|Lost to Follow-up|6|||
125657019|NCT00797316|452029022|FG000|Overall Study|Administrative problems|1|||
125657020|NCT00797316|452029023|FG001|Overall Study|Administrative problems|0|||
125657021|NCT00797316|452029022|FG000|Overall Study|Adverse Event|5|||
125657022|NCT00797316|452029023|FG001|Overall Study|Adverse Event|3|||
125657023|NCT00797316|452029022|FG000|Overall Study|Lost to Follow-up|4|||
125657024|NCT00797316|452029023|FG001|Overall Study|Lost to Follow-up|8|||
125657025|NCT00797316|452029022|FG000|Overall Study|Protocol Deviation|1|||
125657026|NCT00797316|452029023|FG001|Overall Study|Protocol Deviation|2|||
125657027|NCT00797316|452029022|FG000|Overall Study|Patient withdrew consent|12|||
125657028|NCT00797316|452029023|FG001|Overall Study|Patient withdrew consent|6|||
125657029|NCT00797316|452029022|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125657030|NCT00797316|452029023|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
125657031|NCT03239340|452029026|FG000|Overall Study|Other|26|||
125657032|NCT03239340|452029026|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
125657033|NCT03239340|452029026|FG000|Overall Study|Death|40|||
125657034|NCT03239340|452029026|FG000|Overall Study|Lost to Follow-up|2|||
125657035|NCT03239340|452029026|FG000|Overall Study|Physician Decision|16|||
125657036|NCT03239340|452029026|FG000|Overall Study|Withdrawal by Subject|27|||
125657037|NCT04066894|452029030|FG000|Overall Study|Lack of Efficacy|1|||
125657038|NCT04066894|452029030|FG000|Overall Study|Screen Failure|1|||
125657039|NCT03494816|452029031|FG000|Overall Study|Protocol Violation|2|||
125657040|NCT03494816|452029031|FG000|Overall Study|Physician Decision|2|||
125657041|NCT03494816|452029031|FG000|Overall Study|Did not start trial treatment|1|||
125657042|NCT03494816|452029031|FG000|Overall Study|Adverse Event|1|||
125657043|NCT00314262|452029032|FG000|Overall Study|Adverse Event|2|||
125657044|NCT00314262|452029032|FG000|Overall Study|Withdrawal by Subject|2|||
125657045|NCT00314262|452029032|FG000|Overall Study|Physician Decision|1|||
125657046|NCT01126359|452029033|FG000|First Intervention (20-minutes)|Physician Decision|0|||
125657047|NCT01126359|452029034|FG001|First Intervention (20-minutes)|Physician Decision|1|||
125657048|NCT00902486|452029035|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
125657049|NCT00902486|452029036|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
125657050|NCT00902486|452029037|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
125657051|NCT00902486|452029038|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
125657052|NCT00902486|452029039|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
125657053|NCT00902486|452029040|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
125657054|NCT00902486|452029035|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
125657055|NCT00902486|452029036|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
125657056|NCT00902486|452029037|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
125657057|NCT00902486|452029038|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
125657058|NCT00902486|452029039|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
125657059|NCT00902486|452029040|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
125657060|NCT00902486|452029035|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
125657061|NCT00902486|452029036|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
125657062|NCT00902486|452029037|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
125657063|NCT00902486|452029038|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
125657064|NCT00902486|452029039|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
125657065|NCT00902486|452029040|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
125657066|NCT00902486|452029035|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
125316317|NCT02763644|450788406|FG001|Overall Study|Adverse Event|1|||
125657067|NCT00902486|452029036|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
125657068|NCT00902486|452029037|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
125657069|NCT00902486|452029038|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
125657070|NCT00902486|452029039|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
125657071|NCT00902486|452029040|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
125657072|NCT00902486|452029035|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
125316318|NCT02836652|450788407|FG000|Overall Study|Death|3|||
125657073|NCT00902486|452029036|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
125316319|NCT02836652|450788408|FG001|Overall Study|Death|3|||
125316320|NCT02836652|450788407|FG000|Overall Study|Transplant/Explant|3|||
125657074|NCT00902486|452029037|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
125657075|NCT00902486|452029038|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
125657076|NCT00902486|452029039|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
125657077|NCT00902486|452029040|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
125657078|NCT00902486|452029035|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
125657079|NCT00902486|452029036|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
125657080|NCT00902486|452029037|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
125657081|NCT00902486|452029038|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
125657082|NCT00902486|452029039|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
125657083|NCT00902486|452029040|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
125657084|NCT00902486|452029035|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
125657085|NCT00902486|452029036|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
125657086|NCT00902486|452029037|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
125657087|NCT00902486|452029038|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
125657088|NCT00902486|452029039|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
125657089|NCT00902486|452029040|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
125657090|NCT00902486|452029035|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
125657091|NCT00902486|452029036|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
125657092|NCT00902486|452029037|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
125657093|NCT00902486|452029038|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
125657094|NCT00902486|452029039|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
125657095|NCT00902486|452029040|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
125657096|NCT00902486|452029035|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
125657097|NCT00902486|452029036|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
125657098|NCT00902486|452029037|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
125657099|NCT00902486|452029038|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
125657100|NCT00902486|452029039|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
125657101|NCT00902486|452029040|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
125657102|NCT00902486|452029035|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
125657103|NCT00902486|452029036|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
125657104|NCT00902486|452029037|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
125657105|NCT00902486|452029038|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
125657106|NCT00902486|452029039|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
125657107|NCT00902486|452029040|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
125657108|NCT00902486|452029035|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
125316321|NCT02836652|450788408|FG001|Overall Study|Transplant/Explant|4|||
125316322|NCT02836652|450788407|FG000|Overall Study|Withdrawn|9|||
125316323|NCT02836652|450788408|FG001|Overall Study|Withdrawn|9|||
125316324|NCT02836652|450788407|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
125316325|NCT02836652|450788408|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
125316326|NCT00473434|450788409|FG000|Overall Study|Physician Decision|3|||
125316327|NCT00473434|450788409|FG000|Overall Study|Withdrawal by Subject|9|||
125316328|NCT00473434|450788409|FG000|Overall Study|Compliance|3|||
125316329|NCT00473434|450788409|FG000|Overall Study|Lack of Efficacy|3|||
125316330|NCT00473434|450788409|FG000|Overall Study|Adverse Event|3|||
125316331|NCT00473434|450788409|FG000|Overall Study|Patient was selling medication to others|1|||
125316332|NCT00473434|450788409|FG000|Overall Study|Safety evaluation|1|||
125316333|NCT00473434|450788409|FG000|Overall Study|Reason not specified|6|||
125316334|NCT00473434|450788409|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
125316335|NCT00473434|450788409|FG000|Overall Study|Switching to trial medication|1|||
125316336|NCT00473434|450788409|FG000|Overall Study|No longer required|1|||
125316337|NCT02349633|450788410|FG000|Overall Study|Death|0|||
125316338|NCT02349633|450788411|FG001|Overall Study|Death|1|||
125316339|NCT02349633|450788412|FG002|Overall Study|Death|0|||
125316340|NCT02349633|450788413|FG003|Overall Study|Death|0|||
125316341|NCT02349633|450788414|FG004|Overall Study|Death|0|||
125316342|NCT02349633|450788415|FG005|Overall Study|Death|1|||
125316343|NCT02349633|450788416|FG006|Overall Study|Death|1|||
125316344|NCT02349633|450788417|FG007|Overall Study|Death|1|||
125316345|NCT02349633|450788418|FG008|Overall Study|Death|0|||
125316346|NCT02349633|450788419|FG009|Overall Study|Death|1|||
125316347|NCT02349633|450788420|FG010|Overall Study|Death|0|||
125316348|NCT02349633|450788421|FG011|Overall Study|Death|0|||
125316349|NCT02349633|450788422|FG012|Overall Study|Death|0|||
125316350|NCT02349633|450788423|FG013|Overall Study|Death|0|||
125316351|NCT02349633|450788410|FG000|Overall Study|Withdrawal by Subject|0|||
125316352|NCT02349633|450788411|FG001|Overall Study|Withdrawal by Subject|0|||
125316353|NCT02349633|450788412|FG002|Overall Study|Withdrawal by Subject|0|||
125316354|NCT02349633|450788413|FG003|Overall Study|Withdrawal by Subject|1|||
125316355|NCT02349633|450788414|FG004|Overall Study|Withdrawal by Subject|0|||
125316356|NCT02349633|450788415|FG005|Overall Study|Withdrawal by Subject|0|||
125316357|NCT02349633|450788416|FG006|Overall Study|Withdrawal by Subject|0|||
125316358|NCT02349633|450788417|FG007|Overall Study|Withdrawal by Subject|2|||
125316359|NCT02349633|450788418|FG008|Overall Study|Withdrawal by Subject|2|||
125316360|NCT02349633|450788419|FG009|Overall Study|Withdrawal by Subject|1|||
125316361|NCT02349633|450788420|FG010|Overall Study|Withdrawal by Subject|0|||
125316362|NCT02349633|450788421|FG011|Overall Study|Withdrawal by Subject|0|||
125316363|NCT02349633|450788422|FG012|Overall Study|Withdrawal by Subject|0|||
125316364|NCT02349633|450788423|FG013|Overall Study|Withdrawal by Subject|0|||
125316365|NCT02349633|450788410|FG000|Overall Study|Withdrawal of informed consent|0|||
125316366|NCT02349633|450788411|FG001|Overall Study|Withdrawal of informed consent|0|||
125316367|NCT02349633|450788412|FG002|Overall Study|Withdrawal of informed consent|0|||
125316368|NCT02349633|450788413|FG003|Overall Study|Withdrawal of informed consent|1|||
125316369|NCT02349633|450788414|FG004|Overall Study|Withdrawal of informed consent|1|||
125316370|NCT02349633|450788415|FG005|Overall Study|Withdrawal of informed consent|0|||
125316371|NCT02349633|450788416|FG006|Overall Study|Withdrawal of informed consent|0|||
125316372|NCT02349633|450788417|FG007|Overall Study|Withdrawal of informed consent|3|||
125316373|NCT02349633|450788418|FG008|Overall Study|Withdrawal of informed consent|0|||
125316374|NCT02349633|450788419|FG009|Overall Study|Withdrawal of informed consent|0|||
125316375|NCT02349633|450788420|FG010|Overall Study|Withdrawal of informed consent|0|||
125316376|NCT02349633|450788421|FG011|Overall Study|Withdrawal of informed consent|0|||
125316377|NCT02349633|450788422|FG012|Overall Study|Withdrawal of informed consent|0|||
125316378|NCT02349633|450788423|FG013|Overall Study|Withdrawal of informed consent|0|||
125316379|NCT02349633|450788410|FG000|Overall Study|Transition to compassionate use|0|||
125316380|NCT02349633|450788411|FG001|Overall Study|Transition to compassionate use|0|||
125316381|NCT02349633|450788412|FG002|Overall Study|Transition to compassionate use|0|||
125316382|NCT02349633|450788413|FG003|Overall Study|Transition to compassionate use|0|||
125316383|NCT02349633|450788414|FG004|Overall Study|Transition to compassionate use|1|||
125316384|NCT02349633|450788415|FG005|Overall Study|Transition to compassionate use|0|||
125316385|NCT02349633|450788416|FG006|Overall Study|Transition to compassionate use|0|||
125316386|NCT02349633|450788417|FG007|Overall Study|Transition to compassionate use|3|||
125316387|NCT02349633|450788418|FG008|Overall Study|Transition to compassionate use|0|||
125316388|NCT02349633|450788419|FG009|Overall Study|Transition to compassionate use|1|||
125316389|NCT02349633|450788420|FG010|Overall Study|Transition to compassionate use|0|||
125316390|NCT02349633|450788421|FG011|Overall Study|Transition to compassionate use|0|||
125316391|NCT02349633|450788422|FG012|Overall Study|Transition to compassionate use|0|||
125316392|NCT02349633|450788423|FG013|Overall Study|Transition to compassionate use|0|||
125316393|NCT02349633|450788410|FG000|Overall Study|Early termination of survival follow-up|0|||
125316394|NCT02349633|450788411|FG001|Overall Study|Early termination of survival follow-up|0|||
125316395|NCT02349633|450788412|FG002|Overall Study|Early termination of survival follow-up|0|||
125316396|NCT02349633|450788413|FG003|Overall Study|Early termination of survival follow-up|0|||
125316397|NCT02349633|450788414|FG004|Overall Study|Early termination of survival follow-up|0|||
125316398|NCT02349633|450788415|FG005|Overall Study|Early termination of survival follow-up|0|||
125316399|NCT02349633|450788416|FG006|Overall Study|Early termination of survival follow-up|0|||
125657109|NCT00902486|452029036|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
125657110|NCT00902486|452029037|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
125657111|NCT00902486|452029038|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
125657112|NCT00902486|452029039|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
125657113|NCT00902486|452029040|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
125657114|NCT02332655|452029041|FG000|Overall Study|Lack of Efficacy|1|||
125657115|NCT01808508|452031080|FG000|Overall Study|Lost to Follow-up|1|||
125657116|NCT01808508|452031081|FG001|Overall Study|Lost to Follow-up|0|||
125657117|NCT01808508|452031082|FG002|Overall Study|Lost to Follow-up|0|||
125657118|NCT01017731|452031083|FG000|Overall Study|Lost to Follow-up|2|||
125657119|NCT01017731|452031083|FG000|Overall Study|Withdrawal by Subject|3|||
125657120|NCT01017731|452031083|FG000|Overall Study|Physician Decision|2|||
125657121|NCT01017731|452031083|FG000|Overall Study|Adverse Event|1|||
125657122|NCT05378269|452031084|FG000|Overall Study|Protocol Violation|1|||
125657123|NCT05378269|452031085|FG001|Overall Study|Protocol Violation|0|||
125657124|NCT05378269|452031086|FG002|Overall Study|Protocol Violation|2|||
125316400|NCT02349633|450788417|FG007|Overall Study|Early termination of survival follow-up|4|||
125316401|NCT02349633|450788418|FG008|Overall Study|Early termination of survival follow-up|0|||
125316402|NCT02349633|450788419|FG009|Overall Study|Early termination of survival follow-up|0|||
125316403|NCT02349633|450788420|FG010|Overall Study|Early termination of survival follow-up|0|||
125316404|NCT02349633|450788421|FG011|Overall Study|Early termination of survival follow-up|0|||
125316405|NCT02349633|450788422|FG012|Overall Study|Early termination of survival follow-up|0|||
125657125|NCT05378269|452031087|FG003|Overall Study|Protocol Violation|0|||
125657126|NCT05378269|452031088|FG004|Overall Study|Protocol Violation|0|||
125657127|NCT00359073|452031089|FG000|Overall Study|Withdrawal by Subject|1|||
125657128|NCT00359073|452031090|FG001|Overall Study|Withdrawal by Subject|1|||
125316406|NCT02349633|450788423|FG013|Overall Study|Early termination of survival follow-up|0|||
125316407|NCT02349633|450788410|FG000|Overall Study|Termination by sponsor|0|||
125316408|NCT02349633|450788411|FG001|Overall Study|Termination by sponsor|0|||
125316409|NCT02349633|450788412|FG002|Overall Study|Termination by sponsor|0|||
125316410|NCT02349633|450788413|FG003|Overall Study|Termination by sponsor|0|||
125316411|NCT02349633|450788414|FG004|Overall Study|Termination by sponsor|0|||
125316412|NCT02349633|450788415|FG005|Overall Study|Termination by sponsor|0|||
125316413|NCT02349633|450788416|FG006|Overall Study|Termination by sponsor|0|||
125316414|NCT02349633|450788417|FG007|Overall Study|Termination by sponsor|1|||
125316415|NCT02349633|450788418|FG008|Overall Study|Termination by sponsor|0|||
125316416|NCT02349633|450788419|FG009|Overall Study|Termination by sponsor|2|||
125316417|NCT02349633|450788420|FG010|Overall Study|Termination by sponsor|0|||
125316418|NCT02349633|450788421|FG011|Overall Study|Termination by sponsor|0|||
125316419|NCT02349633|450788422|FG012|Overall Study|Termination by sponsor|0|||
125316420|NCT02349633|450788423|FG013|Overall Study|Termination by sponsor|0|||
125316421|NCT02349633|450788410|FG000|Overall Study|Other|0|||
125316422|NCT02349633|450788411|FG001|Overall Study|Other|0|||
125316423|NCT02349633|450788412|FG002|Overall Study|Other|0|||
125316424|NCT02349633|450788413|FG003|Overall Study|Other|0|||
125316425|NCT02349633|450788414|FG004|Overall Study|Other|0|||
125316426|NCT02349633|450788415|FG005|Overall Study|Other|0|||
125316427|NCT02349633|450788416|FG006|Overall Study|Other|0|||
125316428|NCT02349633|450788417|FG007|Overall Study|Other|2|||
125316429|NCT02349633|450788418|FG008|Overall Study|Other|0|||
125316430|NCT02349633|450788419|FG009|Overall Study|Other|0|||
125316431|NCT02349633|450788420|FG010|Overall Study|Other|0|||
125316432|NCT02349633|450788421|FG011|Overall Study|Other|0|||
125316433|NCT02349633|450788422|FG012|Overall Study|Other|0|||
125657129|NCT00359073|452031089|FG000|Overall Study|Eligibility criteria no longer met|3|||
125657130|NCT00359073|452031090|FG001|Overall Study|Eligibility criteria no longer met|0|||
125657131|NCT00359073|452031089|FG000|Overall Study|developed RV16 antibody|0|||
125657132|NCT00359073|452031090|FG001|Overall Study|developed RV16 antibody|1|||
125657133|NCT03387423|452031093|FG000|Overall Study|Lost to Follow-up|16|||
125657134|NCT03387423|452031094|FG001|Overall Study|Lost to Follow-up|12|||
125657135|NCT03387423|452031095|FG002|Overall Study|Lost to Follow-up|1|||
125657136|NCT03387423|452031096|FG003|Overall Study|Lost to Follow-up|0|||
125657137|NCT03387423|452031093|FG000|Overall Study|Other|0|||
125657138|NCT03387423|452031094|FG001|Overall Study|Other|3|||
125657139|NCT03387423|452031095|FG002|Overall Study|Other|0|||
125657140|NCT03387423|452031096|FG003|Overall Study|Other|0|||
125657141|NCT03387423|452031093|FG000|Overall Study|Administrative Reason|166|||
125657142|NCT03387423|452031094|FG001|Overall Study|Administrative Reason|89|||
125657143|NCT03387423|452031095|FG002|Overall Study|Administrative Reason|17|||
125657144|NCT03387423|452031096|FG003|Overall Study|Administrative Reason|19|||
125657145|NCT03387423|452031093|FG000|Overall Study|Revocation Consent|76|||
125657146|NCT03387423|452031094|FG001|Overall Study|Revocation Consent|32|||
125657147|NCT03387423|452031095|FG002|Overall Study|Revocation Consent|3|||
125657148|NCT03387423|452031096|FG003|Overall Study|Revocation Consent|5|||
125657149|NCT01371006|452031097|FG000|Overall Study|Adverse Event|1|||
125657150|NCT01371006|452031098|FG001|Overall Study|Adverse Event|0|||
125657151|NCT01721200|452031099|FG000|Overall Study|Lost to Follow-up|3|||
125657152|NCT01721200|452031100|FG001|Overall Study|Lost to Follow-up|5|||
125657153|NCT03926728|452031101|FG000|Overall Study|Withdrawal by Subject|0|||
125657154|NCT03926728|452031102|FG001|Overall Study|Withdrawal by Subject|1|||
125657155|NCT03926728|452031103|FG002|Overall Study|Withdrawal by Subject|1|||
125657156|NCT03926728|452031104|FG003|Overall Study|Withdrawal by Subject|0|||
125657157|NCT03926728|452031105|FG004|Overall Study|Withdrawal by Subject|0|||
125657158|NCT03926728|452031106|FG005|Overall Study|Withdrawal by Subject|1|||
125657159|NCT03926728|452031107|FG006|Overall Study|Withdrawal by Subject|1|||
125657160|NCT03926728|452031108|FG007|Overall Study|Withdrawal by Subject|0|||
125657161|NCT03926728|452031109|FG008|Overall Study|Withdrawal by Subject|0|||
125657162|NCT03926728|452031110|FG009|Overall Study|Withdrawal by Subject|1|||
125657163|NCT03926728|452031111|FG010|Overall Study|Withdrawal by Subject|0|||
125316434|NCT02349633|450788423|FG013|Overall Study|Other|0|||
125316435|NCT01008943|450788425|FG000|Overall Study|Withdrawal by Subject|1|||
125316436|NCT01453140|450788428|FG000|Overall Study|Adverse Event|3|||
125316437|NCT02611479|450788429|FG000|Baseline Enrollment|Exited study|13|||
125316438|NCT02611479|450788429|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
125316439|NCT02611479|450788429|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
125316440|NCT02611479|450788429|FG000|Data Cleaning|No baseline function or pain metrics|2|||
125657164|NCT03926728|452031112|FG011|Overall Study|Withdrawal by Subject|0|||
125657165|NCT02729545|452031115|FG000|Overall Study|Pregnancy|1|||
125657166|NCT02729545|452031116|FG001|Overall Study|Pregnancy|1|||
125657167|NCT02729545|452031115|FG000|Overall Study|Lost to Follow-up|0|||
125657168|NCT02729545|452031116|FG001|Overall Study|Lost to Follow-up|1|||
125657169|NCT02729545|452031115|FG000|Overall Study|Withdrawal by Subject|2|||
125657170|NCT02729545|452031116|FG001|Overall Study|Withdrawal by Subject|3|||
125657171|NCT01956123|452031119|FG000|COS Cycle 2|Protocol Violation|8|||
125657172|NCT01956123|452031120|FG001|COS Cycle 2|Protocol Violation|3|||
125316441|NCT00743249|450788430|FG000|Overall Study|Adverse Event|0|||
125316442|NCT00743249|450788431|FG001|Overall Study|Adverse Event|4|||
125316443|NCT00743249|450788430|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
125316444|NCT00743249|450788431|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
125316445|NCT00743249|450788430|FG000|Overall Study|Unsuccessful insertion of stent|2|||
125316446|NCT00743249|450788431|FG001|Overall Study|Unsuccessful insertion of stent|1|||
125657173|NCT01956123|452031121|FG002|COS Cycle 2|Protocol Violation|0|||
125657174|NCT01956123|452031122|FG003|COS Cycle 2|Protocol Violation|0|||
125657175|NCT01956123|452031119|FG000|COS Cycle 2|Adverse Event|3|||
125657176|NCT01956123|452031120|FG001|COS Cycle 2|Adverse Event|4|||
125657177|NCT01956123|452031121|FG002|COS Cycle 2|Adverse Event|0|||
125657178|NCT01956123|452031122|FG003|COS Cycle 2|Adverse Event|0|||
125657179|NCT01956123|452031119|FG000|COS Cycle 2|Personal Reasons|2|||
125657180|NCT01956123|452031120|FG001|COS Cycle 2|Personal Reasons|0|||
125657181|NCT01956123|452031121|FG002|COS Cycle 2|Personal Reasons|0|||
125657182|NCT01956123|452031122|FG003|COS Cycle 2|Personal Reasons|0|||
125657183|NCT01956123|452031119|FG000|COS Cycle 2|Withdrawal by Subject|1|||
125657184|NCT01956123|452031120|FG001|COS Cycle 2|Withdrawal by Subject|0|||
125657185|NCT01956123|452031121|FG002|COS Cycle 2|Withdrawal by Subject|0|||
125657186|NCT01956123|452031122|FG003|COS Cycle 2|Withdrawal by Subject|0|||
125657187|NCT01956123|452031119|FG000|COS Cycle 3|Protocol Violation|0|||
125657188|NCT01956123|452031120|FG001|COS Cycle 3|Protocol Violation|0|||
125657189|NCT01956123|452031121|FG002|COS Cycle 3|Protocol Violation|2|||
125657190|NCT01956123|452031122|FG003|COS Cycle 3|Protocol Violation|1|||
125657191|NCT01956123|452031119|FG000|COS Cycle 3|Adverse Event|0|||
125657192|NCT01956123|452031120|FG001|COS Cycle 3|Adverse Event|0|||
125657193|NCT01956123|452031121|FG002|COS Cycle 3|Adverse Event|3|||
125657194|NCT01956123|452031122|FG003|COS Cycle 3|Adverse Event|0|||
125657195|NCT01956123|452031119|FG000|COS Cycle 3|Personal Reasons|0|||
125657196|NCT01956123|452031120|FG001|COS Cycle 3|Personal Reasons|0|||
125657197|NCT01956123|452031121|FG002|COS Cycle 3|Personal Reasons|1|||
125316447|NCT00423657|450788435|FG000|Overall Study|Withdrew consent|10|||
125316448|NCT00423657|450788436|FG001|Overall Study|Withdrew consent|8|||
125316449|NCT00423657|450788435|FG000|Overall Study|Non-compliance|0|||
125316450|NCT00423657|450788436|FG001|Overall Study|Non-compliance|1|||
125316451|NCT00423657|450788435|FG000|Overall Study|Other|15|||
125316452|NCT00423657|450788436|FG001|Overall Study|Other|16|||
125316453|NCT00423657|450788435|FG000|Overall Study|Request of sponsor/investigator|1|||
125316454|NCT00423657|450788436|FG001|Overall Study|Request of sponsor/investigator|0|||
125316455|NCT02653326|450788440|FG000|Overall Study|Lost to Follow-up|10|||
125316456|NCT02653326|450788441|FG001|Overall Study|Lost to Follow-up|7|||
125316457|NCT02422498|450788442|FG000|Overall Study|Inevaluable|4|||
125316458|NCT03206216|450788443|FG000|Overall Study|Withdrawal by Subject|0|||
125316459|NCT03206216|450788444|FG001|Overall Study|Withdrawal by Subject|1|||
125316460|NCT01054456|450788447|FG000|Overall Study|Other|1|||
125316461|NCT04621448|450788448|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
125316462|NCT04621448|450788449|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
125316463|NCT04621448|450788450|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
125316464|NCT04621448|450788451|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
125316465|NCT04621448|450788448|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
125316466|NCT04621448|450788449|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
125316467|NCT04621448|450788450|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
125316468|NCT04621448|450788451|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
125316469|NCT04621448|450788448|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
125316470|NCT04621448|450788449|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
125316471|NCT04621448|450788450|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
125316472|NCT04621448|450788451|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
125316473|NCT04621448|450788448|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
125316474|NCT04621448|450788449|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
125316475|NCT04621448|450788450|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
125316476|NCT04621448|450788451|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
125316477|NCT04590014|450788454|FG000|Overall Study|Withdrawal by Subject|1|||
125657198|NCT01956123|452031122|FG003|COS Cycle 3|Personal Reasons|0|||
125316478|NCT04590014|450788455|FG001|Overall Study|Withdrawal by Subject|0|||
125316479|NCT01506271|450788456|FG000|Overall Study|Progressive disease|0|||
125316480|NCT01506271|450788457|FG001|Overall Study|Progressive disease|1|||
125316481|NCT01506271|450788458|FG002|Overall Study|Progressive disease|0|||
125316482|NCT01506271|450788456|FG000|Overall Study|Protocol Violation|3|||
125316483|NCT01506271|450788457|FG001|Overall Study|Protocol Violation|1|||
125316484|NCT01506271|450788458|FG002|Overall Study|Protocol Violation|0|||
125316485|NCT01506271|450788456|FG000|Overall Study|Death|0|||
125657199|NCT01956123|452031119|FG000|COS Cycle 3|Withdrawal by Subject|0|||
125657200|NCT01956123|452031120|FG001|COS Cycle 3|Withdrawal by Subject|0|||
125657201|NCT01956123|452031121|FG002|COS Cycle 3|Withdrawal by Subject|0|||
125657202|NCT01956123|452031122|FG003|COS Cycle 3|Withdrawal by Subject|1|||
125657203|NCT00398632|452031123|FG000|Overall Study|Withdrawal by Subject|1|||
125657204|NCT00398632|452031123|FG000|Overall Study|Lack of Efficacy|1|||
125657205|NCT02118896|452031124|FG000|Overall Study|Death|4|||
125657206|NCT02118896|452031125|FG001|Overall Study|Death|0|||
125657207|NCT02118896|452031126|FG002|Overall Study|Death|4|||
125316486|NCT01506271|450788457|FG001|Overall Study|Death|1|||
125316487|NCT01506271|450788458|FG002|Overall Study|Death|0|||
125316488|NCT01506271|450788456|FG000|Overall Study|Adverse Event|0|||
125316489|NCT01506271|450788457|FG001|Overall Study|Adverse Event|2|||
125316490|NCT01506271|450788458|FG002|Overall Study|Adverse Event|0|||
125316491|NCT01506271|450788456|FG000|Overall Study|Insufficient supply of study drug|1|||
125316492|NCT01506271|450788457|FG001|Overall Study|Insufficient supply of study drug|0|||
125316493|NCT01506271|450788458|FG002|Overall Study|Insufficient supply of study drug|0|||
125316494|NCT01506271|450788456|FG000|Overall Study|Withdrawal by Subject|0|||
125316495|NCT01506271|450788457|FG001|Overall Study|Withdrawal by Subject|1|||
125316496|NCT01506271|450788458|FG002|Overall Study|Withdrawal by Subject|1|||
125316497|NCT01506271|450788456|FG000|Overall Study|Lost to Follow-up|0|||
125316498|NCT01506271|450788457|FG001|Overall Study|Lost to Follow-up|1|||
125316499|NCT01506271|450788458|FG002|Overall Study|Lost to Follow-up|2|||
125316500|NCT03040141|450788459|FG000|Overall Study|Death|1|||
125316501|NCT03040141|450788460|FG001|Overall Study|Death|2|||
125316502|NCT03040141|450788461|FG002|Overall Study|Death|3|||
125316503|NCT03040141|450788459|FG000|Overall Study|Withdrawal by Subject|3|||
125316504|NCT03040141|450788460|FG001|Overall Study|Withdrawal by Subject|1|||
125316505|NCT03040141|450788461|FG002|Overall Study|Withdrawal by Subject|1|||
125316506|NCT03040141|450788459|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
125316507|NCT03040141|450788460|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
125316508|NCT03040141|450788461|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
125316509|NCT03040141|450788459|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
125316510|NCT03040141|450788460|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
125316511|NCT03040141|450788461|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
125316512|NCT01391663|450788462|FG000|Overall Study|Withdrawal by Subject|0|||
125316513|NCT01391663|450788463|FG001|Overall Study|Withdrawal by Subject|0|||
125316514|NCT01391663|450788464|FG002|Overall Study|Withdrawal by Subject|1|||
125316515|NCT01391663|450788465|FG003|Overall Study|Withdrawal by Subject|0|||
125316516|NCT03515824|450788466|FG000|Overall Study|Death|3|||
125316517|NCT03515824|450788467|FG001|Overall Study|Death|2|||
125316518|NCT03515824|450788468|FG002|Overall Study|Death|6|||
125316519|NCT03515824|450788469|FG003|Overall Study|Death|0|||
125316520|NCT03515824|450788466|FG000|Overall Study|Lost to Follow-up|0|||
125316521|NCT03515824|450788467|FG001|Overall Study|Lost to Follow-up|1|||
125316522|NCT03515824|450788468|FG002|Overall Study|Lost to Follow-up|1|||
125316523|NCT03515824|450788469|FG003|Overall Study|Lost to Follow-up|0|||
125316524|NCT03515824|450788466|FG000|Overall Study|Study terminated by sponsor|0|||
125316525|NCT03515824|450788467|FG001|Overall Study|Study terminated by sponsor|1|||
125316526|NCT03515824|450788468|FG002|Overall Study|Study terminated by sponsor|6|||
125316527|NCT03515824|450788469|FG003|Overall Study|Study terminated by sponsor|0|||
125316528|NCT03515824|450788466|FG000|Overall Study|Status not recorded|0|||
125316529|NCT03515824|450788467|FG001|Overall Study|Status not recorded|0|||
125316530|NCT03515824|450788468|FG002|Overall Study|Status not recorded|2|||
125316531|NCT03515824|450788469|FG003|Overall Study|Status not recorded|0|||
125316532|NCT00920855|450788470|FG000|Overall Study|Adverse Event|1|||
125316533|NCT00920855|450788471|FG001|Overall Study|Adverse Event|1|||
125316534|NCT00920855|450788472|FG002|Overall Study|Adverse Event|4|||
125316535|NCT00920855|450788470|FG000|Overall Study|Withdrawal by Subject|2|||
125316536|NCT00920855|450788471|FG001|Overall Study|Withdrawal by Subject|1|||
125316537|NCT00920855|450788472|FG002|Overall Study|Withdrawal by Subject|6|||
125316538|NCT00920855|450788470|FG000|Overall Study|Disease progression|2|||
125316539|NCT00920855|450788471|FG001|Overall Study|Disease progression|1|||
125316540|NCT00920855|450788472|FG002|Overall Study|Disease progression|10|||
125316541|NCT00920855|450788470|FG000|Overall Study|Noncompliance to study medication|0|||
125316542|NCT00920855|450788471|FG001|Overall Study|Noncompliance to study medication|0|||
125316543|NCT00920855|450788472|FG002|Overall Study|Noncompliance to study medication|1|||
125316544|NCT00920855|450788470|FG000|Overall Study|Response plateau; started maintenance|0|||
125316545|NCT00920855|450788471|FG001|Overall Study|Response plateau; started maintenance|0|||
125657208|NCT02118896|452031127|FG003|Overall Study|Death|6|||
125657209|NCT02118896|452031128|FG004|Overall Study|Death|3|||
125657210|NCT02118896|452031129|FG005|Overall Study|Death|1|||
125657211|NCT02118896|452031130|FG006|Overall Study|Death|0|||
125657212|NCT02118896|452031131|FG007|Overall Study|Death|0|||
125657213|NCT02118896|452031132|FG008|Overall Study|Death|0|||
125657214|NCT02118896|452031133|FG009|Overall Study|Death|0|||
125657215|NCT02118896|452031124|FG000|Overall Study|Adverse Event|5|||
125657216|NCT02118896|452031125|FG001|Overall Study|Adverse Event|4|||
125657217|NCT02118896|452031126|FG002|Overall Study|Adverse Event|4|||
125657218|NCT02118896|452031127|FG003|Overall Study|Adverse Event|5|||
125657219|NCT02118896|452031128|FG004|Overall Study|Adverse Event|5|||
125657220|NCT02118896|452031129|FG005|Overall Study|Adverse Event|9|||
125657221|NCT02118896|452031130|FG006|Overall Study|Adverse Event|1|||
125657222|NCT02118896|452031131|FG007|Overall Study|Adverse Event|1|||
125657223|NCT02118896|452031132|FG008|Overall Study|Adverse Event|4|||
125316546|NCT00920855|450788472|FG002|Overall Study|Response plateau; started maintenance|1|||
125316547|NCT01384734|450788473|FG000|Overall Study|Adverse Event|0|||
125316548|NCT01384734|450788474|FG001|Overall Study|Adverse Event|3|||
125316549|NCT01384734|450788475|FG002|Overall Study|Adverse Event|0|||
125657224|NCT02118896|452031133|FG009|Overall Study|Adverse Event|0|||
125657225|NCT02118896|452031124|FG000|Overall Study|Consent withdrawn|2|||
125657226|NCT02118896|452031125|FG001|Overall Study|Consent withdrawn|0|||
125657227|NCT02118896|452031126|FG002|Overall Study|Consent withdrawn|3|||
125657228|NCT02118896|452031127|FG003|Overall Study|Consent withdrawn|4|||
125657229|NCT02118896|452031128|FG004|Overall Study|Consent withdrawn|1|||
125657230|NCT02118896|452031129|FG005|Overall Study|Consent withdrawn|4|||
125657231|NCT02118896|452031130|FG006|Overall Study|Consent withdrawn|0|||
125657232|NCT02118896|452031131|FG007|Overall Study|Consent withdrawn|0|||
125657233|NCT02118896|452031132|FG008|Overall Study|Consent withdrawn|0|||
125657234|NCT02118896|452031133|FG009|Overall Study|Consent withdrawn|0|||
125316550|NCT01384734|450788476|FG003|Overall Study|Adverse Event|2|||
125316551|NCT01384734|450788477|FG004|Overall Study|Adverse Event|7|||
125316552|NCT01384734|450788473|FG000|Overall Study|Death|1|||
125316553|NCT01384734|450788474|FG001|Overall Study|Death|0|||
125316554|NCT01384734|450788475|FG002|Overall Study|Death|1|||
125316555|NCT01384734|450788476|FG003|Overall Study|Death|0|||
125316556|NCT01384734|450788477|FG004|Overall Study|Death|0|||
125316557|NCT01384734|450788473|FG000|Overall Study|Continuation criteria not met|0|||
125316558|NCT01384734|450788474|FG001|Overall Study|Continuation criteria not met|0|||
125316559|NCT01384734|450788475|FG002|Overall Study|Continuation criteria not met|1|||
125316560|NCT01384734|450788476|FG003|Overall Study|Continuation criteria not met|1|||
125316561|NCT01384734|450788477|FG004|Overall Study|Continuation criteria not met|0|||
125316562|NCT01384734|450788473|FG000|Overall Study|Lack of Efficacy|3|||
125316563|NCT01384734|450788474|FG001|Overall Study|Lack of Efficacy|7|||
125316564|NCT01384734|450788475|FG002|Overall Study|Lack of Efficacy|4|||
125316565|NCT01384734|450788476|FG003|Overall Study|Lack of Efficacy|4|||
125316566|NCT01384734|450788477|FG004|Overall Study|Lack of Efficacy|2|||
125316567|NCT01384734|450788473|FG000|Overall Study|Lost to Follow-up|5|||
125316568|NCT01384734|450788474|FG001|Overall Study|Lost to Follow-up|3|||
125657235|NCT02118896|452031124|FG000|Overall Study|Non-compliance|2|||
125657236|NCT02118896|452031125|FG001|Overall Study|Non-compliance|1|||
125657237|NCT02118896|452031126|FG002|Overall Study|Non-compliance|1|||
125657238|NCT02118896|452031127|FG003|Overall Study|Non-compliance|5|||
125657239|NCT02118896|452031128|FG004|Overall Study|Non-compliance|0|||
125657240|NCT02118896|452031129|FG005|Overall Study|Non-compliance|1|||
125657241|NCT02118896|452031130|FG006|Overall Study|Non-compliance|0|||
125657242|NCT02118896|452031131|FG007|Overall Study|Non-compliance|1|||
125657243|NCT02118896|452031132|FG008|Overall Study|Non-compliance|0|||
125657244|NCT02118896|452031133|FG009|Overall Study|Non-compliance|0|||
125657245|NCT02118896|452031124|FG000|Overall Study|Pregnancy|1|||
125657246|NCT02118896|452031125|FG001|Overall Study|Pregnancy|1|||
125657247|NCT02118896|452031126|FG002|Overall Study|Pregnancy|0|||
125657248|NCT02118896|452031127|FG003|Overall Study|Pregnancy|0|||
125657249|NCT02118896|452031128|FG004|Overall Study|Pregnancy|1|||
125657250|NCT02118896|452031129|FG005|Overall Study|Pregnancy|3|||
125657251|NCT02118896|452031130|FG006|Overall Study|Pregnancy|1|||
125657252|NCT02118896|452031131|FG007|Overall Study|Pregnancy|0|||
125657253|NCT02118896|452031132|FG008|Overall Study|Pregnancy|0|||
125657254|NCT02118896|452031133|FG009|Overall Study|Pregnancy|0|||
125657255|NCT02118896|452031124|FG000|Overall Study|Lost to Follow-up|1|||
125657256|NCT02118896|452031125|FG001|Overall Study|Lost to Follow-up|2|||
125657257|NCT02118896|452031126|FG002|Overall Study|Lost to Follow-up|1|||
125657258|NCT02118896|452031127|FG003|Overall Study|Lost to Follow-up|0|||
125657259|NCT02118896|452031128|FG004|Overall Study|Lost to Follow-up|2|||
125657260|NCT02118896|452031129|FG005|Overall Study|Lost to Follow-up|1|||
125657261|NCT02118896|452031130|FG006|Overall Study|Lost to Follow-up|0|||
125657262|NCT02118896|452031131|FG007|Overall Study|Lost to Follow-up|0|||
125657263|NCT02118896|452031132|FG008|Overall Study|Lost to Follow-up|0|||
125657264|NCT02118896|452031133|FG009|Overall Study|Lost to Follow-up|0|||
125657265|NCT02118896|452031124|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
125657266|NCT02118896|452031125|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
125657267|NCT02118896|452031126|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
125657268|NCT02118896|452031127|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
125316569|NCT01384734|450788475|FG002|Overall Study|Lost to Follow-up|3|||
125316570|NCT01384734|450788476|FG003|Overall Study|Lost to Follow-up|8|||
125316571|NCT01384734|450788477|FG004|Overall Study|Lost to Follow-up|5|||
125657269|NCT02118896|452031128|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
125657270|NCT02118896|452031129|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
125657271|NCT02118896|452031130|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
125657272|NCT02118896|452031131|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
125657273|NCT02118896|452031132|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
125657274|NCT02118896|452031133|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
125316572|NCT01384734|450788473|FG000|Overall Study|Non-compliance with study drug|1|||
125316573|NCT01384734|450788474|FG001|Overall Study|Non-compliance with study drug|2|||
125316574|NCT01384734|450788475|FG002|Overall Study|Non-compliance with study drug|6|||
125316575|NCT01384734|450788476|FG003|Overall Study|Non-compliance with study drug|0|||
125316576|NCT01384734|450788477|FG004|Overall Study|Non-compliance with study drug|2|||
125316577|NCT01384734|450788473|FG000|Overall Study|Pregnancy|0|||
125316578|NCT01384734|450788474|FG001|Overall Study|Pregnancy|1|||
125316579|NCT01384734|450788475|FG002|Overall Study|Pregnancy|0|||
125316580|NCT01384734|450788476|FG003|Overall Study|Pregnancy|0|||
125316581|NCT01384734|450788477|FG004|Overall Study|Pregnancy|1|||
125316582|NCT01384734|450788473|FG000|Overall Study|Sponsor terminated|0|||
125316583|NCT01384734|450788474|FG001|Overall Study|Sponsor terminated|0|||
125316584|NCT01384734|450788475|FG002|Overall Study|Sponsor terminated|0|||
125316585|NCT01384734|450788476|FG003|Overall Study|Sponsor terminated|0|||
125316586|NCT01384734|450788477|FG004|Overall Study|Sponsor terminated|1|||
125316587|NCT01384734|450788473|FG000|Overall Study|Withdrawal by Subject|5|||
125316588|NCT01384734|450788474|FG001|Overall Study|Withdrawal by Subject|5|||
125316589|NCT01384734|450788475|FG002|Overall Study|Withdrawal by Subject|6|||
125316590|NCT01384734|450788476|FG003|Overall Study|Withdrawal by Subject|7|||
125316591|NCT01384734|450788477|FG004|Overall Study|Withdrawal by Subject|9|||
125316592|NCT01384734|450788473|FG000|Overall Study|Investigator relocating|0|||
125316593|NCT01384734|450788474|FG001|Overall Study|Investigator relocating|2|||
125316594|NCT01384734|450788475|FG002|Overall Study|Investigator relocating|0|||
125316595|NCT01384734|450788476|FG003|Overall Study|Investigator relocating|3|||
125316596|NCT01384734|450788477|FG004|Overall Study|Investigator relocating|1|||
125316597|NCT01384734|450788473|FG000|Overall Study|Unable to come back for visit|1|||
125316598|NCT01384734|450788474|FG001|Overall Study|Unable to come back for visit|0|||
125316599|NCT01384734|450788475|FG002|Overall Study|Unable to come back for visit|1|||
125316600|NCT01384734|450788476|FG003|Overall Study|Unable to come back for visit|1|||
125316601|NCT01384734|450788477|FG004|Overall Study|Unable to come back for visit|0|||
125316602|NCT01384734|450788473|FG000|Overall Study|Prison|0|||
125316603|NCT01384734|450788474|FG001|Overall Study|Prison|0|||
125316604|NCT01384734|450788475|FG002|Overall Study|Prison|1|||
125316605|NCT01384734|450788476|FG003|Overall Study|Prison|0|||
125316606|NCT01384734|450788477|FG004|Overall Study|Prison|0|||
125316607|NCT01384734|450788473|FG000|Overall Study|As per Exclusion criteria|0|||
125316608|NCT01384734|450788474|FG001|Overall Study|As per Exclusion criteria|1|||
125316609|NCT01384734|450788475|FG002|Overall Study|As per Exclusion criteria|0|||
125316610|NCT01384734|450788476|FG003|Overall Study|As per Exclusion criteria|0|||
125657275|NCT02118896|452031124|FG000|Overall Study|Prohibited medication|0|||
125657276|NCT02118896|452031125|FG001|Overall Study|Prohibited medication|0|||
125657277|NCT02118896|452031126|FG002|Overall Study|Prohibited medication|0|||
125657278|NCT02118896|452031127|FG003|Overall Study|Prohibited medication|0|||
125657279|NCT02118896|452031128|FG004|Overall Study|Prohibited medication|1|||
125657280|NCT02118896|452031129|FG005|Overall Study|Prohibited medication|3|||
125657281|NCT02118896|452031130|FG006|Overall Study|Prohibited medication|0|||
125657282|NCT02118896|452031131|FG007|Overall Study|Prohibited medication|0|||
125657283|NCT02118896|452031132|FG008|Overall Study|Prohibited medication|0|||
125657284|NCT02118896|452031133|FG009|Overall Study|Prohibited medication|0|||
125657285|NCT02118896|452031124|FG000|Overall Study|Miscellaneous|1|||
125657286|NCT02118896|452031125|FG001|Overall Study|Miscellaneous|2|||
125657287|NCT02118896|452031126|FG002|Overall Study|Miscellaneous|0|||
125657288|NCT02118896|452031127|FG003|Overall Study|Miscellaneous|2|||
125657289|NCT02118896|452031128|FG004|Overall Study|Miscellaneous|0|||
125657290|NCT02118896|452031129|FG005|Overall Study|Miscellaneous|4|||
125657291|NCT02118896|452031130|FG006|Overall Study|Miscellaneous|0|||
125657292|NCT02118896|452031131|FG007|Overall Study|Miscellaneous|0|||
125657293|NCT02118896|452031132|FG008|Overall Study|Miscellaneous|0|||
125657294|NCT02118896|452031133|FG009|Overall Study|Miscellaneous|0|||
125657295|NCT02050373|452031137|FG000|Overall Study|Adverse Event|4|||
125657296|NCT02050373|452031138|FG001|Overall Study|Adverse Event|7|||
125657297|NCT02050373|452031137|FG000|Overall Study|Death|3|||
125316611|NCT01384734|450788477|FG004|Overall Study|As per Exclusion criteria|0|||
125657298|NCT02050373|452031138|FG001|Overall Study|Death|3|||
125657299|NCT00572910|452031141|FG000|Overall Study|Adverse Event|1|||
125657300|NCT00572910|452031142|FG001|Overall Study|Adverse Event|2|||
125657301|NCT00572910|452031143|FG002|Overall Study|Adverse Event|0|||
125657302|NCT00572910|452031144|FG003|Overall Study|Adverse Event|2|||
125657303|NCT00572910|452031145|FG004|Overall Study|Adverse Event|0|||
125316612|NCT01384734|450788473|FG000|Overall Study|Missed End of treatment visit|0|||
125316613|NCT01384734|450788474|FG001|Overall Study|Missed End of treatment visit|0|||
125316614|NCT01384734|450788475|FG002|Overall Study|Missed End of treatment visit|0|||
125316615|NCT01384734|450788476|FG003|Overall Study|Missed End of treatment visit|1|||
125316616|NCT01384734|450788477|FG004|Overall Study|Missed End of treatment visit|0|||
125316617|NCT01384734|450788473|FG000|Overall Study|Adhesion problem|0|||
125316618|NCT01384734|450788474|FG001|Overall Study|Adhesion problem|0|||
125316619|NCT01384734|450788475|FG002|Overall Study|Adhesion problem|0|||
125316620|NCT01384734|450788476|FG003|Overall Study|Adhesion problem|1|||
125657304|NCT00572910|452031146|FG005|Overall Study|Adverse Event|0|||
125657305|NCT00572910|452031147|FG006|Overall Study|Adverse Event|4|||
125657306|NCT00572910|452031148|FG007|Overall Study|Adverse Event|2|||
125657307|NCT00572910|452031149|FG008|Overall Study|Adverse Event|1|||
125657308|NCT00572910|452031150|FG009|Overall Study|Adverse Event|3|||
125657309|NCT00572910|452031151|FG010|Overall Study|Adverse Event|2|||
125657310|NCT00572910|452031141|FG000|Overall Study|Lost to Follow-up|0|||
125657311|NCT00572910|452031142|FG001|Overall Study|Lost to Follow-up|1|||
125657312|NCT00572910|452031143|FG002|Overall Study|Lost to Follow-up|1|||
125316621|NCT01384734|450788477|FG004|Overall Study|Adhesion problem|0|||
125316622|NCT01384734|450788473|FG000|Overall Study|Early termination|0|||
125316623|NCT01384734|450788474|FG001|Overall Study|Early termination|0|||
125316624|NCT01384734|450788475|FG002|Overall Study|Early termination|0|||
125316625|NCT01384734|450788476|FG003|Overall Study|Early termination|0|||
125316626|NCT01384734|450788477|FG004|Overall Study|Early termination|1|||
125316627|NCT01384734|450788473|FG000|Overall Study|Physician Decision|1|||
125316628|NCT01384734|450788474|FG001|Overall Study|Physician Decision|0|||
125316629|NCT01384734|450788475|FG002|Overall Study|Physician Decision|0|||
125316630|NCT01384734|450788476|FG003|Overall Study|Physician Decision|0|||
125316631|NCT01384734|450788477|FG004|Overall Study|Physician Decision|0|||
125316632|NCT01290523|450788478|FG000|Overall Study|Death|3|||
125316633|NCT00539994|450788479|FG000|Overall Study|Lost to Follow-up|2|||
125316634|NCT00539994|450788480|FG001|Overall Study|Lost to Follow-up|1|||
125316635|NCT00539994|450788481|FG002|Overall Study|Lost to Follow-up|0|||
125316636|NCT00539994|450788479|FG000|Overall Study|Withdrawal by Subject|1|||
125316637|NCT00539994|450788480|FG001|Overall Study|Withdrawal by Subject|0|||
125316638|NCT00539994|450788481|FG002|Overall Study|Withdrawal by Subject|1|||
125316639|NCT00539994|450788479|FG000|Overall Study|Physician Decision|0|||
125316640|NCT00539994|450788480|FG001|Overall Study|Physician Decision|0|||
125316641|NCT00539994|450788481|FG002|Overall Study|Physician Decision|1|||
125316642|NCT03071263|450788482|FG000|Overall Study|Adverse Event|1|||
125316643|NCT03071263|450788483|FG001|Overall Study|Adverse Event|3|||
125316644|NCT03071263|450788482|FG000|Overall Study|Withdrawal by Subject|1|||
125316645|NCT03071263|450788483|FG001|Overall Study|Withdrawal by Subject|3|||
125316646|NCT03071263|450788482|FG000|Overall Study|Physician Decision|1|||
125316647|NCT03071263|450788483|FG001|Overall Study|Physician Decision|0|||
125316648|NCT03071263|450788482|FG000|Overall Study|Participant moved to another city|0|||
125316649|NCT03071263|450788483|FG001|Overall Study|Participant moved to another city|1|||
125316650|NCT03084796|450788484|FG000|Overall Study|Adverse Event|4|||
125316651|NCT03084796|450788485|FG001|Overall Study|Adverse Event|5|||
125316652|NCT03084796|450788486|FG002|Overall Study|Adverse Event|6|||
125316653|NCT03084796|450788487|FG003|Overall Study|Adverse Event|2|||
125316654|NCT03084796|450788488|FG004|Overall Study|Adverse Event|3|||
125316655|NCT03084796|450788489|FG005|Overall Study|Adverse Event|5|||
125316656|NCT03084796|450788484|FG000|Overall Study|Withdrawal by Subject|3|||
125316657|NCT03084796|450788485|FG001|Overall Study|Withdrawal by Subject|5|||
125316658|NCT03084796|450788486|FG002|Overall Study|Withdrawal by Subject|2|||
125316659|NCT03084796|450788487|FG003|Overall Study|Withdrawal by Subject|1|||
125316660|NCT03084796|450788488|FG004|Overall Study|Withdrawal by Subject|3|||
125316661|NCT03084796|450788489|FG005|Overall Study|Withdrawal by Subject|0|||
125316662|NCT03084796|450788484|FG000|Overall Study|Protocol Violation|0|||
125316663|NCT03084796|450788485|FG001|Overall Study|Protocol Violation|0|||
125316664|NCT03084796|450788486|FG002|Overall Study|Protocol Violation|1|||
125316665|NCT03084796|450788487|FG003|Overall Study|Protocol Violation|0|||
125316666|NCT03084796|450788488|FG004|Overall Study|Protocol Violation|1|||
125316667|NCT03084796|450788489|FG005|Overall Study|Protocol Violation|1|||
125316668|NCT03084796|450788484|FG000|Overall Study|Lack of Efficacy|0|||
125316669|NCT03084796|450788485|FG001|Overall Study|Lack of Efficacy|0|||
125316670|NCT03084796|450788486|FG002|Overall Study|Lack of Efficacy|1|||
125316671|NCT03084796|450788487|FG003|Overall Study|Lack of Efficacy|0|||
125316672|NCT03084796|450788488|FG004|Overall Study|Lack of Efficacy|1|||
125316673|NCT03084796|450788489|FG005|Overall Study|Lack of Efficacy|0|||
125316674|NCT03084796|450788484|FG000|Overall Study|Lost to Follow-up|0|||
125657313|NCT00572910|452031144|FG003|Overall Study|Lost to Follow-up|2|||
125657314|NCT00572910|452031145|FG004|Overall Study|Lost to Follow-up|1|||
125657315|NCT00572910|452031146|FG005|Overall Study|Lost to Follow-up|0|||
125316675|NCT03084796|450788485|FG001|Overall Study|Lost to Follow-up|0|||
125316676|NCT03084796|450788486|FG002|Overall Study|Lost to Follow-up|1|||
125657316|NCT00572910|452031147|FG006|Overall Study|Lost to Follow-up|0|||
125316677|NCT03084796|450788487|FG003|Overall Study|Lost to Follow-up|1|||
125316678|NCT03084796|450788488|FG004|Overall Study|Lost to Follow-up|3|||
125316679|NCT03084796|450788489|FG005|Overall Study|Lost to Follow-up|1|||
125316680|NCT03084796|450788484|FG000|Overall Study|Randomization error|0|||
125316681|NCT03084796|450788485|FG001|Overall Study|Randomization error|0|||
125316682|NCT03084796|450788486|FG002|Overall Study|Randomization error|1|||
125316683|NCT03084796|450788487|FG003|Overall Study|Randomization error|0|||
125316684|NCT03084796|450788488|FG004|Overall Study|Randomization error|0|||
125316685|NCT03084796|450788489|FG005|Overall Study|Randomization error|0|||
125316686|NCT05470985|450788490|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
125657317|NCT00572910|452031148|FG007|Overall Study|Lost to Follow-up|0|||
125657318|NCT00572910|452031149|FG008|Overall Study|Lost to Follow-up|0|||
125657319|NCT00572910|452031150|FG009|Overall Study|Lost to Follow-up|1|||
125657320|NCT00572910|452031151|FG010|Overall Study|Lost to Follow-up|0|||
125657321|NCT00572910|452031141|FG000|Overall Study|Withdrawal by Subject|3|||
125657322|NCT00572910|452031142|FG001|Overall Study|Withdrawal by Subject|0|||
125657323|NCT00572910|452031143|FG002|Overall Study|Withdrawal by Subject|1|||
125657324|NCT00572910|452031144|FG003|Overall Study|Withdrawal by Subject|0|||
125657325|NCT00572910|452031145|FG004|Overall Study|Withdrawal by Subject|1|||
125657326|NCT00572910|452031146|FG005|Overall Study|Withdrawal by Subject|3|||
125657327|NCT00572910|452031147|FG006|Overall Study|Withdrawal by Subject|0|||
125657328|NCT00572910|452031148|FG007|Overall Study|Withdrawal by Subject|2|||
125657329|NCT00572910|452031149|FG008|Overall Study|Withdrawal by Subject|2|||
125657330|NCT00572910|452031150|FG009|Overall Study|Withdrawal by Subject|2|||
125657331|NCT00572910|452031151|FG010|Overall Study|Withdrawal by Subject|1|||
125657332|NCT00592007|452031156|FG000|Overall Study|Withdrawal by Subject|1|||
125657333|NCT00592007|452031156|FG000|Overall Study|patient ineligible (out of lab range)|1|||
125657334|NCT01569074|452031160|FG000|Overall Study|Study stopped|6|||
125657335|NCT01569074|452031161|FG001|Overall Study|Study stopped|6|||
125657336|NCT01569074|452031162|FG002|Overall Study|Study stopped|8|||
125657337|NCT01569074|452031163|FG003|Overall Study|Study stopped|7|||
125657338|NCT01569074|452031164|FG004|Overall Study|Study stopped|7|||
125657339|NCT01569074|452031160|FG000|Overall Study|Study-specific discontinuation criteria|0|||
125657340|NCT01569074|452031161|FG001|Overall Study|Study-specific discontinuation criteria|1|||
125657341|NCT01569074|452031162|FG002|Overall Study|Study-specific discontinuation criteria|0|||
125657342|NCT01569074|452031163|FG003|Overall Study|Study-specific discontinuation criteria|0|||
125657343|NCT01569074|452031164|FG004|Overall Study|Study-specific discontinuation criteria|0|||
125657344|NCT01569074|452031160|FG000|Overall Study|Severe non-compliance to protocol|0|||
125657345|NCT01569074|452031161|FG001|Overall Study|Severe non-compliance to protocol|0|||
125657346|NCT01569074|452031162|FG002|Overall Study|Severe non-compliance to protocol|1|||
125657347|NCT01569074|452031163|FG003|Overall Study|Severe non-compliance to protocol|0|||
125316687|NCT05470985|450788491|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
125316688|NCT05470985|450788490|FG000|Double Blind Treatment Period|Physician Decision|0|||
125316689|NCT05470985|450788491|FG001|Double Blind Treatment Period|Physician Decision|1|||
125316690|NCT05470985|450788490|FG000|Long Term Extension|Adverse Event|0|||
125316691|NCT05470985|450788491|FG001|Long Term Extension|Adverse Event|1|||
125316692|NCT05470985|450788490|FG000|Long Term Extension|Study terminated by sponsor|2|||
125316693|NCT05470985|450788491|FG001|Long Term Extension|Study terminated by sponsor|0|||
125316694|NCT01917747|450788492|FG000|Overall Study|Withdrawal by Subject|1|||
125316695|NCT01917747|450788493|FG001|Overall Study|Withdrawal by Subject|2|||
125316696|NCT01917747|450788492|FG000|Overall Study|Lost to Follow-up|18|||
125316697|NCT01917747|450788493|FG001|Overall Study|Lost to Follow-up|9|||
125316698|NCT02741245|450788494|FG000|Overall Study|Adverse Event|0|||
125316699|NCT02741245|450788495|FG001|Overall Study|Adverse Event|0|||
125316700|NCT02741245|450788496|FG002|Overall Study|Adverse Event|0|||
125316701|NCT02741245|450788497|FG003|Overall Study|Adverse Event|2|||
125316702|NCT02741245|450788498|FG004|Overall Study|Adverse Event|2|||
125316703|NCT02741245|450788494|FG000|Overall Study|Protocol Violation|0|||
125316704|NCT02741245|450788495|FG001|Overall Study|Protocol Violation|1|||
125316705|NCT02741245|450788496|FG002|Overall Study|Protocol Violation|0|||
125316706|NCT02741245|450788497|FG003|Overall Study|Protocol Violation|1|||
125316707|NCT02741245|450788498|FG004|Overall Study|Protocol Violation|0|||
125316708|NCT02741245|450788494|FG000|Overall Study|Withdrawal by Subject|0|||
125316709|NCT02741245|450788495|FG001|Overall Study|Withdrawal by Subject|0|||
125316710|NCT02741245|450788496|FG002|Overall Study|Withdrawal by Subject|0|||
125316711|NCT02741245|450788497|FG003|Overall Study|Withdrawal by Subject|1|||
125316712|NCT02741245|450788498|FG004|Overall Study|Withdrawal by Subject|0|||
125316713|NCT00152503|450788501|FG000|Overall Study|Adverse Event|4|||
125316714|NCT02922725|450788502|FG000|Overall Study|Withdrawal by Subject|1|||
125316715|NCT02922725|450788503|FG001|Overall Study|Withdrawal by Subject|0|||
125316716|NCT02922725|450788504|FG002|Overall Study|Withdrawal by Subject|0|||
125316717|NCT01300234|450788505|FG000|Overall Study|Adverse Event|1|||
125316718|NCT01300234|450788506|FG001|Overall Study|Adverse Event|1|||
125316719|NCT01300234|450788505|FG000|Overall Study|Protocol Violation|2|||
125657348|NCT01569074|452031164|FG004|Overall Study|Severe non-compliance to protocol|0|||
125657349|NCT01569074|452031160|FG000|Overall Study|eg change in circumstances|0|||
125657350|NCT01569074|452031161|FG001|Overall Study|eg change in circumstances|2|||
125657351|NCT01569074|452031162|FG002|Overall Study|eg change in circumstances|0|||
125657352|NCT01569074|452031163|FG003|Overall Study|eg change in circumstances|1|||
125657353|NCT01569074|452031164|FG004|Overall Study|eg change in circumstances|1|||
125657354|NCT01569074|452031160|FG000|Overall Study|Adverse Event|1|||
125657355|NCT01569074|452031161|FG001|Overall Study|Adverse Event|0|||
125316720|NCT01300234|450788506|FG001|Overall Study|Protocol Violation|3|||
125316721|NCT01300234|450788505|FG000|Overall Study|Withdrawal by Subject|5|||
125316722|NCT01300234|450788506|FG001|Overall Study|Withdrawal by Subject|9|||
125316723|NCT01300234|450788505|FG000|Overall Study|Lost to Follow-up|14|||
125316724|NCT01300234|450788506|FG001|Overall Study|Lost to Follow-up|12|||
125316725|NCT01300234|450788505|FG000|Overall Study|Pregnancy|2|||
125316726|NCT01300234|450788506|FG001|Overall Study|Pregnancy|1|||
125657356|NCT01569074|452031162|FG002|Overall Study|Adverse Event|3|||
125657357|NCT01569074|452031163|FG003|Overall Study|Adverse Event|0|||
125657358|NCT01569074|452031164|FG004|Overall Study|Adverse Event|0|||
125657359|NCT01803464|452031165|FG000|Overall Study|Incomplete data|0|||
125657360|NCT01803464|452031166|FG001|Overall Study|Incomplete data|0|||
125657361|NCT01803464|452031167|FG002|Overall Study|Incomplete data|4|||
125657362|NCT01803464|452031168|FG003|Overall Study|Incomplete data|0|||
125657363|NCT01803464|452031165|FG000|Overall Study|Withdrawal by Subject|1|||
125657364|NCT01803464|452031166|FG001|Overall Study|Withdrawal by Subject|0|||
125657365|NCT01803464|452031167|FG002|Overall Study|Withdrawal by Subject|0|||
125657366|NCT01803464|452031168|FG003|Overall Study|Withdrawal by Subject|0|||
125657367|NCT02860039|452031174|FG000|Overall Study|Death|4|||
125657368|NCT02860039|452031175|FG001|Overall Study|Death|0|||
125657369|NCT02860039|452031174|FG000|Overall Study|Lost to Follow-up|2|||
125657370|NCT02860039|452031175|FG001|Overall Study|Lost to Follow-up|2|||
125657371|NCT02860039|452031174|FG000|Overall Study|Protocol Violation|3|||
125657372|NCT02860039|452031175|FG001|Overall Study|Protocol Violation|1|||
125657373|NCT02860039|452031174|FG000|Overall Study|Withdrawal by Subject|1|||
125657374|NCT02860039|452031175|FG001|Overall Study|Withdrawal by Subject|0|||
125657375|NCT02860039|452031174|FG000|Overall Study|Not otherwise eligible|1|||
125657376|NCT02860039|452031175|FG001|Overall Study|Not otherwise eligible|1|||
125657377|NCT01360021|452031176|FG000|Overall Study|Eligibility criteria + other|2|||
125657378|NCT01360021|452031177|FG001|Overall Study|Eligibility criteria + other|1|||
125657379|NCT01360021|452031178|FG002|Overall Study|Eligibility criteria + other|1|||
125657380|NCT01360021|452031176|FG000|Overall Study|Protocol Violation|0|||
125657381|NCT01360021|452031177|FG001|Overall Study|Protocol Violation|0|||
125657382|NCT01360021|452031178|FG002|Overall Study|Protocol Violation|1|||
125657383|NCT01360021|452031176|FG000|Overall Study|Withdrawal by Subject|4|||
125657384|NCT01360021|452031177|FG001|Overall Study|Withdrawal by Subject|0|||
125657385|NCT01360021|452031178|FG002|Overall Study|Withdrawal by Subject|2|||
125657386|NCT01360021|452031176|FG000|Overall Study|Adverse Event|2|||
125657387|NCT01360021|452031177|FG001|Overall Study|Adverse Event|3|||
125657388|NCT01360021|452031178|FG002|Overall Study|Adverse Event|3|||
125657389|NCT01257737|452031180|FG000|Overall Study|Lost to Follow-up|1|||
125657390|NCT01257737|452031181|FG001|Overall Study|Lost to Follow-up|2|||
125657391|NCT01257737|452031180|FG000|Overall Study|Liver transplant|1|||
125657392|NCT01257737|452031181|FG001|Overall Study|Liver transplant|0|||
125657393|NCT01257737|452031180|FG000|Overall Study|Relocation out of the country|0|||
125657394|NCT01257737|452031181|FG001|Overall Study|Relocation out of the country|1|||
125657395|NCT01257737|452031180|FG000|Overall Study|Withdrew from study|0|||
125657396|NCT01257737|452031181|FG001|Overall Study|Withdrew from study|1|||
125657397|NCT03170271|452031185|FG000|Overall Study|Adverse Event|7|||
125657398|NCT03170271|452031186|FG001|Overall Study|Adverse Event|2|||
125657399|NCT03170271|452031185|FG000|Overall Study|Lost to Follow-up|0|||
125657400|NCT03170271|452031186|FG001|Overall Study|Lost to Follow-up|1|||
125657401|NCT03170271|452031185|FG000|Overall Study|Physician Decision|1|||
125657402|NCT03170271|452031186|FG001|Overall Study|Physician Decision|0|||
125657403|NCT03170271|452031185|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
125657404|NCT03170271|452031186|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
125657405|NCT03170271|452031185|FG000|Overall Study|Withdrawal by Subject|17|||
125657406|NCT03170271|452031186|FG001|Overall Study|Withdrawal by Subject|5|||
125657407|NCT03170271|452031185|FG000|Overall Study|Other|2|||
125657408|NCT03170271|452031186|FG001|Overall Study|Other|2|||
125657409|NCT03170271|452031185|FG000|Overall Study|Randomized in error|4|||
125657410|NCT03170271|452031186|FG001|Overall Study|Randomized in error|0|||
125657411|NCT05168657|452031189|FG000|Overall Study|Adverse Event|0|||
125657412|NCT05168657|452031190|FG001|Overall Study|Adverse Event|0|||
125657413|NCT05168657|452031191|FG002|Overall Study|Adverse Event|1|||
125657414|NCT05168657|452031192|FG003|Overall Study|Adverse Event|0|||
125657415|NCT05168657|452031193|FG004|Overall Study|Adverse Event|0|||
125657416|NCT05168657|452031194|FG005|Overall Study|Adverse Event|0|||
125657417|NCT05168657|452031195|FG006|Overall Study|Adverse Event|0|||
125657418|NCT05168657|452031196|FG007|Overall Study|Adverse Event|0|||
125657419|NCT04935931|452031197|FG000|Overall Study|Withdrawal by Subject|1|||
125657420|NCT00424632|452031200|FG000|Overall Study|Death|0|||
125657421|NCT00424632|452031201|FG001|Overall Study|Death|0|||
125657422|NCT00424632|452031202|FG002|Overall Study|Death|0|||
125657423|NCT00424632|452031203|FG003|Overall Study|Death|0|||
125657424|NCT00424632|452031204|FG004|Overall Study|Death|0|||
125657425|NCT00424632|452031205|FG005|Overall Study|Death|2|||
125657426|NCT00424632|452031206|FG006|Overall Study|Death|0|||
125657427|NCT00424632|452031207|FG007|Overall Study|Death|0|||
125657428|NCT00424632|452031208|FG008|Overall Study|Death|0|||
125657429|NCT00424632|452031209|FG009|Overall Study|Death|0|||
125657430|NCT00424632|452031200|FG000|Overall Study|Adverse Event|0|||
125657431|NCT00424632|452031201|FG001|Overall Study|Adverse Event|0|||
125657432|NCT00424632|452031202|FG002|Overall Study|Adverse Event|0|||
125657433|NCT00424632|452031203|FG003|Overall Study|Adverse Event|0|||
125657434|NCT00424632|452031204|FG004|Overall Study|Adverse Event|0|||
125657435|NCT00424632|452031205|FG005|Overall Study|Adverse Event|0|||
125316727|NCT01300234|450788505|FG000|Overall Study|Participant reached stopping critera|2|||
125316728|NCT01300234|450788506|FG001|Overall Study|Participant reached stopping critera|0|||
125316729|NCT01300234|450788505|FG000|Overall Study|Participant stopped medication|1|||
125316730|NCT01300234|450788506|FG001|Overall Study|Participant stopped medication|1|||
125316731|NCT01300234|450788505|FG000|Overall Study|Participant refused return to hospital|1|||
125316732|NCT01300234|450788506|FG001|Overall Study|Participant refused return to hospital|0|||
125316733|NCT03253679|450788507|FG000|Overall Study|Screen Failure|1|||
125316734|NCT04816214|450788508|FG000|Overall Study|Progressive Disease|4|||
125316735|NCT04816214|450788509|FG001|Overall Study|Progressive Disease|0|||
125316736|NCT04816214|450788510|FG002|Overall Study|Progressive Disease|0|||
125316737|NCT04816214|450788508|FG000|Overall Study|Death|1|||
125316738|NCT04816214|450788509|FG001|Overall Study|Death|0|||
125316739|NCT04816214|450788510|FG002|Overall Study|Death|0|||
125316740|NCT04816214|450788508|FG000|Overall Study|Study Terminated by Sponsor|1|||
125316741|NCT04816214|450788509|FG001|Overall Study|Study Terminated by Sponsor|0|||
125316742|NCT04816214|450788510|FG002|Overall Study|Study Terminated by Sponsor|0|||
125316743|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
125316744|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
125316745|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
125316746|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
125316747|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
125316748|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
125316749|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
125316750|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
125316751|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
125316752|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
125316753|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
125316754|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
125316755|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
125316756|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
125316757|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
125316758|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
125316759|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
125316760|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
125316761|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
125316762|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
125316763|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
125316764|NCT00550407|450788511|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
125316765|NCT00550407|450788512|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
125316766|NCT00550407|450788513|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
125316767|NCT00550407|450788511|FG000|26-Week Randomized Phase|Adverse Event|0|||
125316768|NCT00550407|450788512|FG001|26-Week Randomized Phase|Adverse Event|5|||
125316769|NCT00550407|450788513|FG002|26-Week Randomized Phase|Adverse Event|2|||
125316770|NCT00550407|450788511|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
125316771|NCT00550407|450788512|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
125316772|NCT00550407|450788513|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
125316773|NCT00550407|450788511|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
125316774|NCT00550407|450788512|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
125316775|NCT00550407|450788513|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
125316776|NCT00550407|450788511|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
125316777|NCT00550407|450788512|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
125316778|NCT00550407|450788513|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
125316779|NCT00584415|450788514|FG000|Overall Study|Adverse Event|7|||
125316780|NCT00717249|450788517|FG000|Overall Study|Lens Discomfort|4|||
125316781|NCT00717249|450788518|FG001|Overall Study|Lens Discomfort|1|||
125316782|NCT00717249|450788517|FG000|Overall Study|Unsatisfactory visual Response|0|||
125316783|NCT00717249|450788518|FG001|Overall Study|Unsatisfactory visual Response|2|||
125316784|NCT00717249|450788517|FG000|Overall Study|Adverse Event|4|||
125316785|NCT00717249|450788518|FG001|Overall Study|Adverse Event|2|||
125316786|NCT00717249|450788517|FG000|Overall Study|Lost to Follow-up|2|||
125316787|NCT00717249|450788518|FG001|Overall Study|Lost to Follow-up|0|||
125316788|NCT00717249|450788517|FG000|Overall Study|Withdrawal by Subject|1|||
125316789|NCT00717249|450788518|FG001|Overall Study|Withdrawal by Subject|2|||
125316790|NCT00717249|450788517|FG000|Overall Study|Pregnancy|6|||
125316791|NCT00717249|450788518|FG001|Overall Study|Pregnancy|3|||
125316792|NCT00717249|450788517|FG000|Overall Study|Protocol Violation|0|||
125316793|NCT00717249|450788518|FG001|Overall Study|Protocol Violation|2|||
125316794|NCT00717249|450788517|FG000|Overall Study|Subject became Ineligible|1|||
125316795|NCT00717249|450788518|FG001|Overall Study|Subject became Ineligible|1|||
125316796|NCT00717249|450788517|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
125316797|NCT00717249|450788518|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
125316798|NCT00717249|450788517|FG000|Overall Study|Gastric Surgery|0|||
125657436|NCT00424632|452031206|FG006|Overall Study|Adverse Event|0|||
125657437|NCT00424632|452031207|FG007|Overall Study|Adverse Event|0|||
125657438|NCT00424632|452031208|FG008|Overall Study|Adverse Event|3|||
125316799|NCT00717249|450788518|FG001|Overall Study|Gastric Surgery|1|||
125316800|NCT00717249|450788517|FG000|Overall Study|Diagnosed with Diabetes|1|||
125657439|NCT00424632|452031209|FG009|Overall Study|Adverse Event|2|||
125657440|NCT00424632|452031200|FG000|Overall Study|Global deterioration of health status|0|||
125657441|NCT00424632|452031201|FG001|Overall Study|Global deterioration of health status|0|||
125657442|NCT00424632|452031202|FG002|Overall Study|Global deterioration of health status|0|||
125657443|NCT00424632|452031203|FG003|Overall Study|Global deterioration of health status|1|||
125657444|NCT00424632|452031204|FG004|Overall Study|Global deterioration of health status|1|||
125657445|NCT00424632|452031205|FG005|Overall Study|Global deterioration of health status|0|||
125657446|NCT00424632|452031206|FG006|Overall Study|Global deterioration of health status|0|||
125657447|NCT00424632|452031207|FG007|Overall Study|Global deterioration of health status|0|||
125657448|NCT00424632|452031208|FG008|Overall Study|Global deterioration of health status|0|||
125657449|NCT00424632|452031209|FG009|Overall Study|Global deterioration of health status|0|||
125657450|NCT00424632|452031200|FG000|Overall Study|Objective progression or relapse|1|||
125657451|NCT00424632|452031201|FG001|Overall Study|Objective progression or relapse|1|||
125657452|NCT00424632|452031202|FG002|Overall Study|Objective progression or relapse|1|||
125657453|NCT00424632|452031203|FG003|Overall Study|Objective progression or relapse|2|||
125657454|NCT00424632|452031204|FG004|Overall Study|Objective progression or relapse|2|||
125657455|NCT00424632|452031205|FG005|Overall Study|Objective progression or relapse|13|||
125657456|NCT00424632|452031206|FG006|Overall Study|Objective progression or relapse|7|||
125657457|NCT00424632|452031207|FG007|Overall Study|Objective progression or relapse|3|||
125657458|NCT00424632|452031208|FG008|Overall Study|Objective progression or relapse|12|||
125657459|NCT00424632|452031209|FG009|Overall Study|Objective progression or relapse|4|||
125657460|NCT00424632|452031200|FG000|Overall Study|Other|0|||
125657461|NCT00424632|452031201|FG001|Overall Study|Other|0|||
125657462|NCT00424632|452031202|FG002|Overall Study|Other|0|||
125657463|NCT00424632|452031203|FG003|Overall Study|Other|1|||
125657464|NCT00424632|452031204|FG004|Overall Study|Other|0|||
125657465|NCT00424632|452031205|FG005|Overall Study|Other|0|||
125657466|NCT00424632|452031206|FG006|Overall Study|Other|0|||
125657467|NCT00424632|452031207|FG007|Overall Study|Other|0|||
125657468|NCT00424632|452031208|FG008|Overall Study|Other|1|||
125657469|NCT00424632|452031209|FG009|Overall Study|Other|0|||
125657470|NCT01984229|452031210|FG000|Safety Follow-up Period|Adverse Event|1|||
125657471|NCT01984229|452031211|FG001|Safety Follow-up Period|Adverse Event|1|||
125657472|NCT01984229|452031210|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
125657473|NCT01984229|452031211|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
125657474|NCT02325739|452031212|FG000|Phase I Part|Adverse Event|1|||
125657475|NCT02325739|452031213|FG001|Phase I Part|Adverse Event|0|||
125657476|NCT02325739|452031214|FG002|Phase I Part|Adverse Event|1|||
125657477|NCT02325739|452031215|FG003|Phase I Part|Adverse Event|2|||
125657478|NCT02325739|452031216|FG004|Phase I Part|Adverse Event|3|||
125657479|NCT02325739|452031217|FG005|Phase I Part|Adverse Event|1|||
125657480|NCT02325739|452031218|FG006|Phase I Part|Adverse Event|0|||
125657481|NCT02325739|452031219|FG007|Phase I Part|Adverse Event|2|||
125657482|NCT02325739|452031220|FG008|Phase I Part|Adverse Event|0|||
125657483|NCT02325739|452031221|FG009|Phase I Part|Adverse Event|0|||
125657484|NCT02325739|452031222|FG010|Phase I Part|Adverse Event|0|||
125657485|NCT02325739|452031212|FG000|Phase I Part|Progressive disease|9|||
125657486|NCT02325739|452031213|FG001|Phase I Part|Progressive disease|6|||
125657487|NCT02325739|452031214|FG002|Phase I Part|Progressive disease|3|||
125657488|NCT02325739|452031215|FG003|Phase I Part|Progressive disease|23|||
125657489|NCT02325739|452031216|FG004|Phase I Part|Progressive disease|14|||
125657490|NCT02325739|452031217|FG005|Phase I Part|Progressive disease|6|||
125657491|NCT02325739|452031218|FG006|Phase I Part|Progressive disease|6|||
125657492|NCT02325739|452031219|FG007|Phase I Part|Progressive disease|3|||
125316801|NCT00717249|450788518|FG001|Overall Study|Diagnosed with Diabetes|0|||
125657493|NCT02325739|452031220|FG008|Phase I Part|Progressive disease|0|||
125657494|NCT02325739|452031221|FG009|Phase I Part|Progressive disease|0|||
125316802|NCT00717249|450788517|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
125316803|NCT00717249|450788518|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
125657495|NCT02325739|452031222|FG010|Phase I Part|Progressive disease|0|||
125657496|NCT02325739|452031212|FG000|Phase I Part|Subject/guardian decision|1|||
125657497|NCT02325739|452031213|FG001|Phase I Part|Subject/guardian decision|0|||
125657498|NCT02325739|452031214|FG002|Phase I Part|Subject/guardian decision|1|||
125657499|NCT02325739|452031215|FG003|Phase I Part|Subject/guardian decision|1|||
125657500|NCT02325739|452031216|FG004|Phase I Part|Subject/guardian decision|0|||
125657501|NCT02325739|452031217|FG005|Phase I Part|Subject/guardian decision|0|||
125657502|NCT02325739|452031218|FG006|Phase I Part|Subject/guardian decision|0|||
125657503|NCT02325739|452031219|FG007|Phase I Part|Subject/guardian decision|1|||
125316804|NCT00717249|450788517|FG000|Overall Study|Subject relocated|1|||
125657504|NCT02325739|452031220|FG008|Phase I Part|Subject/guardian decision|0|||
125316805|NCT00717249|450788518|FG001|Overall Study|Subject relocated|0|||
125316806|NCT00717249|450788517|FG000|Overall Study|Headaches|1|||
125316807|NCT00717249|450788518|FG001|Overall Study|Headaches|0|||
125316808|NCT00360412|450788519|FG000|Overall Study|Adverse Event|37|||
125316809|NCT00360412|450788520|FG001|Overall Study|Adverse Event|65|||
125316810|NCT00360412|450788519|FG000|Overall Study|Protocol Violation|2|||
125316811|NCT00360412|450788520|FG001|Overall Study|Protocol Violation|5|||
125316812|NCT00360412|450788519|FG000|Overall Study|Patient withdrew consent|27|||
125316813|NCT00360412|450788520|FG001|Overall Study|Patient withdrew consent|52|||
125657505|NCT02325739|452031221|FG009|Phase I Part|Subject/guardian decision|0|||
125657506|NCT02325739|452031222|FG010|Phase I Part|Subject/guardian decision|0|||
125657507|NCT02325739|452031212|FG000|Phase I Part|Death|0|||
125657508|NCT02325739|452031213|FG001|Phase I Part|Death|0|||
125657509|NCT02325739|452031214|FG002|Phase I Part|Death|0|||
125657510|NCT02325739|452031215|FG003|Phase I Part|Death|0|||
125657511|NCT02325739|452031216|FG004|Phase I Part|Death|2|||
125657512|NCT02325739|452031217|FG005|Phase I Part|Death|0|||
125657513|NCT02325739|452031218|FG006|Phase I Part|Death|0|||
125657514|NCT02325739|452031219|FG007|Phase I Part|Death|0|||
125657515|NCT02325739|452031220|FG008|Phase I Part|Death|0|||
125657516|NCT02325739|452031221|FG009|Phase I Part|Death|0|||
125657517|NCT02325739|452031222|FG010|Phase I Part|Death|0|||
125657518|NCT02325739|452031212|FG000|Phase II Part|Adverse Event|0|||
125657519|NCT02325739|452031213|FG001|Phase II Part|Adverse Event|0|||
125657520|NCT02325739|452031214|FG002|Phase II Part|Adverse Event|0|||
125657521|NCT02325739|452031215|FG003|Phase II Part|Adverse Event|0|||
125657522|NCT02325739|452031216|FG004|Phase II Part|Adverse Event|0|||
125657523|NCT02325739|452031217|FG005|Phase II Part|Adverse Event|0|||
125657524|NCT02325739|452031218|FG006|Phase II Part|Adverse Event|0|||
125657525|NCT02325739|452031219|FG007|Phase II Part|Adverse Event|0|||
125657526|NCT02325739|452031220|FG008|Phase II Part|Adverse Event|4|||
125657527|NCT02325739|452031221|FG009|Phase II Part|Adverse Event|5|||
125657528|NCT02325739|452031222|FG010|Phase II Part|Adverse Event|1|||
125657529|NCT02325739|452031212|FG000|Phase II Part|Physician Decision|0|||
125657530|NCT02325739|452031213|FG001|Phase II Part|Physician Decision|0|||
125657531|NCT02325739|452031214|FG002|Phase II Part|Physician Decision|0|||
125657532|NCT02325739|452031215|FG003|Phase II Part|Physician Decision|0|||
125657533|NCT02325739|452031216|FG004|Phase II Part|Physician Decision|0|||
125657534|NCT02325739|452031217|FG005|Phase II Part|Physician Decision|0|||
125657535|NCT02325739|452031218|FG006|Phase II Part|Physician Decision|0|||
125657536|NCT02325739|452031219|FG007|Phase II Part|Physician Decision|0|||
125657537|NCT02325739|452031220|FG008|Phase II Part|Physician Decision|0|||
125657538|NCT02325739|452031221|FG009|Phase II Part|Physician Decision|1|||
125657539|NCT02325739|452031222|FG010|Phase II Part|Physician Decision|0|||
125657540|NCT02325739|452031212|FG000|Phase II Part|Progressive disease|0|||
125657541|NCT02325739|452031213|FG001|Phase II Part|Progressive disease|0|||
125657542|NCT02325739|452031214|FG002|Phase II Part|Progressive disease|0|||
125657543|NCT02325739|452031215|FG003|Phase II Part|Progressive disease|0|||
125657544|NCT02325739|452031216|FG004|Phase II Part|Progressive disease|0|||
125657545|NCT02325739|452031217|FG005|Phase II Part|Progressive disease|0|||
125657546|NCT02325739|452031218|FG006|Phase II Part|Progressive disease|0|||
125657547|NCT02325739|452031219|FG007|Phase II Part|Progressive disease|0|||
125657548|NCT02325739|452031220|FG008|Phase II Part|Progressive disease|22|||
125657549|NCT02325739|452031221|FG009|Phase II Part|Progressive disease|29|||
125657550|NCT02325739|452031222|FG010|Phase II Part|Progressive disease|18|||
125657551|NCT02325739|452031212|FG000|Phase II Part|Subject/guardian decision|0|||
125657552|NCT02325739|452031213|FG001|Phase II Part|Subject/guardian decision|0|||
125657553|NCT02325739|452031214|FG002|Phase II Part|Subject/guardian decision|0|||
125657554|NCT02325739|452031215|FG003|Phase II Part|Subject/guardian decision|0|||
125657555|NCT02325739|452031216|FG004|Phase II Part|Subject/guardian decision|0|||
125316814|NCT00360412|450788519|FG000|Overall Study|Lack of therapeutic efficacy|46|||
125316815|NCT00360412|450788520|FG001|Overall Study|Lack of therapeutic efficacy|61|||
125657556|NCT02325739|452031217|FG005|Phase II Part|Subject/guardian decision|0|||
125657557|NCT02325739|452031218|FG006|Phase II Part|Subject/guardian decision|0|||
125657558|NCT02325739|452031219|FG007|Phase II Part|Subject/guardian decision|0|||
125316816|NCT00360412|450788519|FG000|Overall Study|Physician Decision|2|||
125316817|NCT00360412|450788520|FG001|Overall Study|Physician Decision|4|||
125657559|NCT02325739|452031220|FG008|Phase II Part|Subject/guardian decision|4|||
125657560|NCT02325739|452031221|FG009|Phase II Part|Subject/guardian decision|1|||
125657561|NCT02325739|452031222|FG010|Phase II Part|Subject/guardian decision|1|||
125657562|NCT03728257|452031224|FG000|Overall Study|Death|3|||
125657563|NCT03728257|452031225|FG001|Overall Study|Death|0|||
125657564|NCT00621309|452031227|FG000|Overall Study|Withdrawal by Subject|2|||
125657565|NCT00621309|452031228|FG001|Overall Study|Withdrawal by Subject|0|||
125657566|NCT00621309|452031229|FG002|Overall Study|Withdrawal by Subject|1|||
125657567|NCT00621309|452031230|FG003|Overall Study|Withdrawal by Subject|1|||
125657568|NCT00621309|452031231|FG004|Overall Study|Withdrawal by Subject|1|||
125657569|NCT00621309|452031232|FG005|Overall Study|Withdrawal by Subject|1|||
125657570|NCT01306968|452031235|FG000|Overall Study|Lost to Follow-up|1|||
125316818|NCT00360412|450788519|FG000|Overall Study|Other|5|||
125316819|NCT00360412|450788520|FG001|Overall Study|Other|6|||
125316820|NCT00360412|450788519|FG000|Overall Study|Study termination by Sponsor|214|||
125316821|NCT00360412|450788520|FG001|Overall Study|Study termination by Sponsor|469|||
125316822|NCT00871871|450788521|FG000|Part I|Adverse Event|0|||
125316823|NCT00871871|450788522|FG001|Part I|Adverse Event|2|||
125316824|NCT00871871|450788523|FG002|Part I|Adverse Event|0|||
125316825|NCT00871871|450788524|FG003|Part I|Adverse Event|0|||
125316826|NCT00871871|450788521|FG000|Part I|Withdrawal by Subject|3|||
125316827|NCT00871871|450788522|FG001|Part I|Withdrawal by Subject|0|||
125316828|NCT00871871|450788523|FG002|Part I|Withdrawal by Subject|0|||
125316829|NCT00871871|450788524|FG003|Part I|Withdrawal by Subject|0|||
125316830|NCT00871871|450788521|FG000|Part I|Laboratory abnormality|0|||
125316831|NCT00871871|450788522|FG001|Part I|Laboratory abnormality|1|||
125316832|NCT00871871|450788523|FG002|Part I|Laboratory abnormality|0|||
125316833|NCT00871871|450788524|FG003|Part I|Laboratory abnormality|0|||
125657571|NCT01306968|452031236|FG001|Overall Study|Lost to Follow-up|1|||
125657572|NCT01306968|452031237|FG002|Overall Study|Lost to Follow-up|0|||
125657573|NCT01306968|452031238|FG003|Overall Study|Lost to Follow-up|0|||
125657574|NCT01306968|452031235|FG000|Overall Study|Physician Decision|0|||
125657575|NCT01306968|452031236|FG001|Overall Study|Physician Decision|1|||
125657576|NCT01306968|452031237|FG002|Overall Study|Physician Decision|0|||
125657577|NCT01306968|452031238|FG003|Overall Study|Physician Decision|0|||
125657578|NCT01306968|452031235|FG000|Overall Study|Relocated and left active duty|0|||
125657579|NCT01306968|452031236|FG001|Overall Study|Relocated and left active duty|1|||
125657580|NCT01306968|452031237|FG002|Overall Study|Relocated and left active duty|1|||
125657581|NCT01306968|452031238|FG003|Overall Study|Relocated and left active duty|1|||
125657582|NCT01306968|452031235|FG000|Overall Study|Withdrew - time commitment|0|||
125657583|NCT01306968|452031236|FG001|Overall Study|Withdrew - time commitment|0|||
125657584|NCT01306968|452031237|FG002|Overall Study|Withdrew - time commitment|0|||
125657585|NCT01306968|452031238|FG003|Overall Study|Withdrew - time commitment|2|||
125657586|NCT01306968|452031235|FG000|Overall Study|Withdrew over privacy concerns|0|||
125657587|NCT01306968|452031236|FG001|Overall Study|Withdrew over privacy concerns|0|||
125657588|NCT01306968|452031237|FG002|Overall Study|Withdrew over privacy concerns|0|||
125657589|NCT01306968|452031238|FG003|Overall Study|Withdrew over privacy concerns|1|||
125657590|NCT04993339|452031239|FG000|Overall Study|Lost to Follow-up|0|||
125657591|NCT04993339|452031240|FG001|Overall Study|Lost to Follow-up|1|||
125657592|NCT04993339|452031239|FG000|Overall Study|no MRI scan|3|||
125657593|NCT04993339|452031240|FG001|Overall Study|no MRI scan|1|||
125657594|NCT03868059|452031242|FG000|Overall Study|Adverse Event|3|||
125657595|NCT03868059|452031242|FG000|Overall Study|Lost to Follow-up|3|||
125657596|NCT03868059|452031242|FG000|Overall Study|Withdrawal by Subject|6|||
125657597|NCT02949219|452031243|FG000|Overall Study|Withdrawal by Subject|1|||
125657598|NCT02044094|452031260|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
125657599|NCT02044094|452031260|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
125657600|NCT02044094|452031260|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
125657601|NCT02044094|452031260|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
125657602|NCT02044094|452031260|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
125657603|NCT02044094|452031260|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
125657604|NCT02044094|452031260|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
125657605|NCT02044094|452031260|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
125657606|NCT03353415|452031263|FG000|Masked CGM Wear|Lost to Follow-up|2|||
125657607|NCT03353415|452031263|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
125657608|NCT02392377|452031264|FG000|Overall Study|Withdrawal by Subject|0|||
125657609|NCT02392377|452031265|FG001|Overall Study|Withdrawal by Subject|1|||
125657610|NCT01298661|452031268|FG000|Overall Study|Withdrawal by Subject|2|||
125657611|NCT01298661|452031269|FG001|Overall Study|Withdrawal by Subject|0|||
125657612|NCT01298661|452031270|FG002|Overall Study|Withdrawal by Subject|2|||
125657613|NCT03515837|452034224|FG000|Overall Study|Death|219|||
125657614|NCT03515837|452034225|FG001|Overall Study|Death|227|||
125657615|NCT03515837|452034224|FG000|Overall Study|Lost to Follow-up|0|||
125657616|NCT03515837|452034225|FG001|Overall Study|Lost to Follow-up|1|||
125657617|NCT03515837|452034224|FG000|Overall Study|Withdrawal by Subject|0|||
125316834|NCT00871871|450788521|FG000|Part II|Lack of Efficacy|0|||
125316835|NCT00871871|450788522|FG001|Part II|Lack of Efficacy|0|||
125316836|NCT00871871|450788523|FG002|Part II|Lack of Efficacy|1|||
125316837|NCT00871871|450788524|FG003|Part II|Lack of Efficacy|0|||
125657618|NCT03515837|452034225|FG001|Overall Study|Withdrawal by Subject|4|||
125657619|NCT03515837|452034224|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
125657620|NCT03515837|452034225|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
125316838|NCT00871871|450788521|FG000|Part II|Withdrawal by Subject|0|||
125316839|NCT00871871|450788522|FG001|Part II|Withdrawal by Subject|0|||
125316840|NCT00871871|450788523|FG002|Part II|Withdrawal by Subject|2|||
125657621|NCT01964898|452034226|FG000|Overall Study|ineligible post-randomization|1|||
125316841|NCT00871871|450788524|FG003|Part II|Withdrawal by Subject|1|||
125316842|NCT00871871|450788521|FG000|Part II|Adverse Event|0|||
125316843|NCT00871871|450788522|FG001|Part II|Adverse Event|0|||
125316844|NCT00871871|450788523|FG002|Part II|Adverse Event|1|||
125316845|NCT00871871|450788524|FG003|Part II|Adverse Event|2|||
125316846|NCT00871871|450788521|FG000|Part II|Protocol Violation|0|||
125316847|NCT00871871|450788522|FG001|Part II|Protocol Violation|0|||
125316848|NCT00871871|450788523|FG002|Part II|Protocol Violation|0|||
125316849|NCT00871871|450788524|FG003|Part II|Protocol Violation|1|||
125657622|NCT01964898|452034227|FG001|Overall Study|ineligible post-randomization|1|||
125657623|NCT01964898|452034226|FG000|Overall Study|did not receive the allocated interventi|2|||
125657624|NCT01964898|452034227|FG001|Overall Study|did not receive the allocated interventi|1|||
125657625|NCT01964898|452034226|FG000|Overall Study|Lost to Follow-up|3|||
125657626|NCT01964898|452034227|FG001|Overall Study|Lost to Follow-up|5|||
125657627|NCT01964898|452034226|FG000|Overall Study|Withdrawal by Subject|1|||
125657628|NCT01964898|452034227|FG001|Overall Study|Withdrawal by Subject|0|||
125316850|NCT03064490|450788530|FG000|Overall Study|Physician Decision|5|||
125657629|NCT02325401|452034228|FG000|Overall Study|Withdrawal by Subject|0|||
125657630|NCT02325401|452034229|FG001|Overall Study|Withdrawal by Subject|1|||
125657631|NCT02325401|452034230|FG002|Overall Study|Withdrawal by Subject|1|||
125657632|NCT03526679|452034231|FG000|Overall Study|still under treatment|2|||
125657633|NCT02545868|452034232|FG000|Overall Study|Lack of Efficacy|1|||
125657634|NCT02545868|452034233|FG001|Overall Study|Lack of Efficacy|1|||
125657635|NCT02545868|452034234|FG002|Overall Study|Lack of Efficacy|0|||
125657636|NCT02545868|452034232|FG000|Overall Study|Lost to Follow-up|1|||
125657637|NCT02545868|452034233|FG001|Overall Study|Lost to Follow-up|5|||
125657638|NCT02545868|452034234|FG002|Overall Study|Lost to Follow-up|1|||
125657639|NCT02545868|452034232|FG000|Overall Study|Non-compliance|1|||
125657640|NCT02545868|452034233|FG001|Overall Study|Non-compliance|1|||
125316851|NCT01928927|450788531|FG000|Overall Study|Lost to Follow-up|1|||
125657641|NCT02545868|452034234|FG002|Overall Study|Non-compliance|1|||
125657642|NCT02545868|452034232|FG000|Overall Study|Treatment change|21|||
125657643|NCT02545868|452034233|FG001|Overall Study|Treatment change|19|||
125657644|NCT02545868|452034234|FG002|Overall Study|Treatment change|22|||
125657645|NCT02545868|452034232|FG000|Overall Study|Physician Decision|1|||
125657646|NCT02545868|452034233|FG001|Overall Study|Physician Decision|1|||
125657647|NCT02545868|452034234|FG002|Overall Study|Physician Decision|1|||
125657648|NCT02545868|452034232|FG000|Overall Study|Withdrawal by Subject|6|||
125657649|NCT02545868|452034233|FG001|Overall Study|Withdrawal by Subject|7|||
125657650|NCT02545868|452034234|FG002|Overall Study|Withdrawal by Subject|9|||
125657651|NCT04465916|452034239|FG000|Overall Study|Withdrawal by Subject|0|||
125657652|NCT04465916|452034240|FG001|Overall Study|Withdrawal by Subject|1|||
125657653|NCT00468312|452034242|FG000|Overall Study|Adverse Event|2|||
125657654|NCT00468312|452034243|FG001|Overall Study|Adverse Event|1|||
125657655|NCT00468312|452034242|FG000|Overall Study|Lack of Efficacy|0|||
125657656|NCT00468312|452034243|FG001|Overall Study|Lack of Efficacy|1|||
125657657|NCT00468312|452034242|FG000|Overall Study|Withdrawal by Subject|0|||
125657658|NCT00468312|452034243|FG001|Overall Study|Withdrawal by Subject|1|||
125657659|NCT00468312|452034242|FG000|Overall Study|Protocol Violation|2|||
125657660|NCT00468312|452034243|FG001|Overall Study|Protocol Violation|1|||
125657661|NCT00468312|452034242|FG000|Overall Study|Did not meet protocol eligibility|0|||
125657662|NCT00468312|452034243|FG001|Overall Study|Did not meet protocol eligibility|1|||
125657663|NCT01052038|452034244|FG000|Overall Study|Lost to Follow-up|2|||
125657664|NCT01052038|452034245|FG001|Overall Study|Lost to Follow-up|3|||
125657665|NCT01052038|452034246|FG002|Overall Study|Lost to Follow-up|1|||
125657666|NCT01052038|452034244|FG000|Overall Study|Protocol Violation|2|||
125657667|NCT01052038|452034245|FG001|Overall Study|Protocol Violation|3|||
125316852|NCT01928927|450788532|FG001|Overall Study|Lost to Follow-up|0|||
125316853|NCT01928927|450788531|FG000|Overall Study|Withdrawal by Subject|1|||
125316854|NCT01928927|450788532|FG001|Overall Study|Withdrawal by Subject|1|||
125316855|NCT02421172|450790416|FG000|Period 1|Adverse Event|1|||
125316856|NCT02421172|450790417|FG001|Period 1|Adverse Event|0|||
125316857|NCT02421172|450790418|FG002|Period 1|Adverse Event|0|||
125316858|NCT02421172|450790419|FG003|Period 1|Adverse Event|0|||
125316859|NCT02421172|450790420|FG004|Period 1|Adverse Event|0|||
125316860|NCT02421172|450790416|FG000|Period 1|Lost to Follow-up|3|||
125316861|NCT02421172|450790417|FG001|Period 1|Lost to Follow-up|1|||
125316862|NCT02421172|450790418|FG002|Period 1|Lost to Follow-up|0|||
125657668|NCT01052038|452034246|FG002|Overall Study|Protocol Violation|3|||
125657669|NCT03976076|452034247|FG000|Overall Study|Withdrawal by Subject|2|||
125657670|NCT01325701|452034248|FG000|Overall Study|Adverse Event|12|||
125657671|NCT01325701|452034249|FG001|Overall Study|Adverse Event|0|||
125657672|NCT01325701|452034248|FG000|Overall Study|Protocol Violation|1|||
125657673|NCT01325701|452034249|FG001|Overall Study|Protocol Violation|0|||
125657674|NCT01325701|452034248|FG000|Overall Study|Physician Decision|2|||
125657675|NCT01325701|452034249|FG001|Overall Study|Physician Decision|2|||
125657676|NCT01325701|452034248|FG000|Overall Study|Withdrawal by Subject|2|||
125316863|NCT02421172|450790419|FG003|Period 1|Lost to Follow-up|0|||
125316864|NCT02421172|450790420|FG004|Period 1|Lost to Follow-up|0|||
125316865|NCT02421172|450790416|FG000|Period 1|Patient/guardian decision|0|||
125316866|NCT02421172|450790417|FG001|Period 1|Patient/guardian decision|1|||
125657677|NCT01325701|452034249|FG001|Overall Study|Withdrawal by Subject|1|||
125316867|NCT02421172|450790418|FG002|Period 1|Patient/guardian decision|0|||
125657678|NCT01325701|452034248|FG000|Overall Study|Rollerover Extension Study|4|||
125657679|NCT01325701|452034249|FG001|Overall Study|Rollerover Extension Study|0|||
125657680|NCT01643928|452034256|FG000|Overall Study|Lost to Follow-up|1|||
125657681|NCT01643928|452034257|FG001|Overall Study|Lost to Follow-up|0|||
125657682|NCT01643928|452034258|FG002|Overall Study|Lost to Follow-up|2|||
125657683|NCT01643928|452034259|FG003|Overall Study|Lost to Follow-up|0|||
125657684|NCT01643928|452034260|FG004|Overall Study|Lost to Follow-up|0|||
125657685|NCT01643928|452034256|FG000|Overall Study|Withdrawal by Subject|2|||
125657686|NCT01643928|452034257|FG001|Overall Study|Withdrawal by Subject|0|||
125657687|NCT01643928|452034258|FG002|Overall Study|Withdrawal by Subject|0|||
125657688|NCT01643928|452034259|FG003|Overall Study|Withdrawal by Subject|1|||
125657689|NCT01643928|452034260|FG004|Overall Study|Withdrawal by Subject|0|||
125657690|NCT01643928|452034256|FG000|Overall Study|Pregnancy|0|||
125657691|NCT01643928|452034257|FG001|Overall Study|Pregnancy|0|||
125657692|NCT01643928|452034258|FG002|Overall Study|Pregnancy|0|||
125657693|NCT01643928|452034259|FG003|Overall Study|Pregnancy|1|||
125657694|NCT01643928|452034260|FG004|Overall Study|Pregnancy|0|||
125657695|NCT01643928|452034256|FG000|Overall Study|Other|5|||
125657696|NCT01643928|452034257|FG001|Overall Study|Other|1|||
125657697|NCT01643928|452034258|FG002|Overall Study|Other|1|||
125657698|NCT01643928|452034259|FG003|Overall Study|Other|0|||
125657699|NCT01643928|452034260|FG004|Overall Study|Other|0|||
125657700|NCT01643928|452034256|FG000|Overall Study|Adverse Event|2|||
125657701|NCT01643928|452034257|FG001|Overall Study|Adverse Event|1|||
125657702|NCT01643928|452034258|FG002|Overall Study|Adverse Event|0|||
125657703|NCT01643928|452034259|FG003|Overall Study|Adverse Event|1|||
125657704|NCT01643928|452034260|FG004|Overall Study|Adverse Event|2|||
125657705|NCT03692078|452034261|FG000|Overall Study|Adverse Event|0|||
125657706|NCT03692078|452034262|FG001|Overall Study|Adverse Event|0|||
125657707|NCT03692078|452034263|FG002|Overall Study|Adverse Event|0|||
125657708|NCT03692078|452034264|FG003|Overall Study|Adverse Event|0|||
125657709|NCT03692078|452034265|FG004|Overall Study|Adverse Event|0|||
125657710|NCT03692078|452034266|FG005|Overall Study|Adverse Event|1|||
125657711|NCT03692078|452034267|FG006|Overall Study|Adverse Event|0|||
125657712|NCT03692078|452034261|FG000|Overall Study|Enrollment Closed|5|||
125657713|NCT03692078|452034262|FG001|Overall Study|Enrollment Closed|0|||
125657714|NCT03692078|452034263|FG002|Overall Study|Enrollment Closed|0|||
125657715|NCT03692078|452034264|FG003|Overall Study|Enrollment Closed|0|||
125657716|NCT03692078|452034265|FG004|Overall Study|Enrollment Closed|0|||
125316868|NCT02421172|450790419|FG003|Period 1|Patient/guardian decision|0|||
125316869|NCT02421172|450790420|FG004|Period 1|Patient/guardian decision|0|||
125316870|NCT02421172|450790416|FG000|Period 2|Adverse Event|0|||
125316871|NCT02421172|450790417|FG001|Period 2|Adverse Event|0|||
125657717|NCT03692078|452034266|FG005|Overall Study|Enrollment Closed|0|||
125657718|NCT03692078|452034267|FG006|Overall Study|Enrollment Closed|0|||
125657719|NCT03692078|452034261|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
125657720|NCT03692078|452034262|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
125657721|NCT03692078|452034263|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
125657722|NCT03692078|452034264|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
125657723|NCT03692078|452034265|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
125657724|NCT03692078|452034266|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
125657725|NCT03692078|452034267|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
125316872|NCT02421172|450790418|FG002|Period 2|Adverse Event|4|||
125316873|NCT02421172|450790419|FG003|Period 2|Adverse Event|0|||
125316874|NCT02421172|450790420|FG004|Period 2|Adverse Event|0|||
125316875|NCT02421172|450790416|FG000|Period 2|Lost to Follow-up|0|||
125316876|NCT02421172|450790417|FG001|Period 2|Lost to Follow-up|0|||
125316877|NCT02421172|450790418|FG002|Period 2|Lost to Follow-up|0|||
125316878|NCT02421172|450790419|FG003|Period 2|Lost to Follow-up|1|||
125316879|NCT02421172|450790420|FG004|Period 2|Lost to Follow-up|0|||
125316880|NCT02421172|450790416|FG000|Period 2|Patient/guardian decision|0|||
125657726|NCT03692078|452034261|FG000|Overall Study|Withdrawal by Subject|0|||
125657727|NCT03692078|452034262|FG001|Overall Study|Withdrawal by Subject|2|||
125657728|NCT03692078|452034263|FG002|Overall Study|Withdrawal by Subject|0|||
125657729|NCT03692078|452034264|FG003|Overall Study|Withdrawal by Subject|1|||
125657730|NCT03692078|452034265|FG004|Overall Study|Withdrawal by Subject|5|||
125657731|NCT03692078|452034266|FG005|Overall Study|Withdrawal by Subject|3|||
125316881|NCT02421172|450790417|FG001|Period 2|Patient/guardian decision|0|||
125316882|NCT02421172|450790418|FG002|Period 2|Patient/guardian decision|3|||
125316883|NCT02421172|450790419|FG003|Period 2|Patient/guardian decision|2|||
125657732|NCT03692078|452034267|FG006|Overall Study|Withdrawal by Subject|3|||
125657733|NCT01005680|452034268|FG000|Overall Study|Lost to Follow-up|4|||
125657734|NCT01005680|452034269|FG001|Overall Study|Lost to Follow-up|6|||
125657735|NCT01005680|452034268|FG000|Overall Study|Withdrawal by Subject|1|||
125657736|NCT01005680|452034269|FG001|Overall Study|Withdrawal by Subject|4|||
125657737|NCT01005680|452034268|FG000|Overall Study|Physician Decision|1|||
125657738|NCT01005680|452034269|FG001|Overall Study|Physician Decision|1|||
125657739|NCT03576131|452034270|FG000|Overall Study|Investigator decision|0|||
125657740|NCT03576131|452034271|FG001|Overall Study|Investigator decision|0|||
125657741|NCT03576131|452034272|FG002|Overall Study|Investigator decision|0|||
125657742|NCT03576131|452034273|FG003|Overall Study|Investigator decision|1|||
125657743|NCT03576131|452034274|FG004|Overall Study|Investigator decision|0|||
125657744|NCT03576131|452034275|FG005|Overall Study|Investigator decision|1|||
125657745|NCT03576131|452034276|FG006|Overall Study|Investigator decision|0|||
125657746|NCT03576131|452034277|FG007|Overall Study|Investigator decision|0|||
125657747|NCT03576131|452034270|FG000|Overall Study|Withdrawal by Subject|1|||
125657748|NCT03576131|452034271|FG001|Overall Study|Withdrawal by Subject|1|||
125657749|NCT03576131|452034272|FG002|Overall Study|Withdrawal by Subject|0|||
125657750|NCT03576131|452034273|FG003|Overall Study|Withdrawal by Subject|1|||
125657751|NCT03576131|452034274|FG004|Overall Study|Withdrawal by Subject|2|||
125657752|NCT03576131|452034275|FG005|Overall Study|Withdrawal by Subject|3|||
125657753|NCT03576131|452034276|FG006|Overall Study|Withdrawal by Subject|1|||
125657754|NCT03576131|452034277|FG007|Overall Study|Withdrawal by Subject|0|||
125657755|NCT03576131|452034270|FG000|Overall Study|Death|3|||
125657756|NCT03576131|452034271|FG001|Overall Study|Death|3|||
125657757|NCT03576131|452034272|FG002|Overall Study|Death|1|||
125657758|NCT03576131|452034273|FG003|Overall Study|Death|5|||
125657759|NCT03576131|452034274|FG004|Overall Study|Death|4|||
125657760|NCT03576131|452034275|FG005|Overall Study|Death|1|||
125657761|NCT03576131|452034276|FG006|Overall Study|Death|0|||
125657762|NCT03576131|452034277|FG007|Overall Study|Death|1|||
125316884|NCT02421172|450790420|FG004|Period 2|Patient/guardian decision|1|||
125316885|NCT00683878|450790424|FG000|Overall Study|Lack of Efficacy|3|||
125316886|NCT00683878|450790425|FG001|Overall Study|Lack of Efficacy|0|||
125316887|NCT00683878|450790426|FG002|Overall Study|Lack of Efficacy|1|||
125316888|NCT00683878|450790424|FG000|Overall Study|Adverse Event|4|||
125316889|NCT00683878|450790425|FG001|Overall Study|Adverse Event|3|||
125657763|NCT03576131|452034270|FG000|Overall Study|New anti-cancer treatment|5|||
125657764|NCT03576131|452034271|FG001|Overall Study|New anti-cancer treatment|1|||
125316890|NCT00683878|450790426|FG002|Overall Study|Adverse Event|3|||
125316891|NCT00683878|450790424|FG000|Overall Study|Withdrawal by Subject|9|||
125316892|NCT00683878|450790425|FG001|Overall Study|Withdrawal by Subject|8|||
125316893|NCT00683878|450790426|FG002|Overall Study|Withdrawal by Subject|6|||
125316894|NCT00683878|450790424|FG000|Overall Study|Death|0|||
125316895|NCT00683878|450790425|FG001|Overall Study|Death|1|||
125316896|NCT00683878|450790426|FG002|Overall Study|Death|0|||
125316897|NCT00683878|450790424|FG000|Overall Study|Lost to Follow-up|4|||
125316898|NCT00683878|450790425|FG001|Overall Study|Lost to Follow-up|2|||
125316899|NCT00683878|450790426|FG002|Overall Study|Lost to Follow-up|4|||
125316900|NCT00683878|450790424|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
125316901|NCT00683878|450790425|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
125316902|NCT00683878|450790426|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
125316903|NCT02869633|450790430|FG000|Overall Study|Death|2|||
125316904|NCT02869633|450790431|FG001|Overall Study|Death|1|||
125316905|NCT02869633|450790430|FG000|Overall Study|Patient refused follow-up|1|||
125316906|NCT02869633|450790431|FG001|Overall Study|Patient refused follow-up|0|||
125316907|NCT02869633|450790430|FG000|Overall Study|Provider discretion|1|||
125316908|NCT02869633|450790431|FG001|Overall Study|Provider discretion|0|||
125316909|NCT02869633|450790430|FG000|Overall Study|Investigator decision|1|||
125316910|NCT02869633|450790431|FG001|Overall Study|Investigator decision|0|||
125316911|NCT02869633|450790430|FG000|Overall Study|Lost to Follow-up|0|||
125316912|NCT02869633|450790431|FG001|Overall Study|Lost to Follow-up|1|||
125316913|NCT02869633|450790430|FG000|Overall Study|Not eligible|6|||
125316914|NCT02869633|450790431|FG001|Overall Study|Not eligible|1|||
125316915|NCT02869633|450790430|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
125316916|NCT02869633|450790431|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
125316917|NCT02869633|450790430|FG000|Overall Study|Withdrawal by Subject|0|||
125316918|NCT02869633|450790431|FG001|Overall Study|Withdrawal by Subject|1|||
125316919|NCT04024891|450790432|FG000|Overall Study|Pregnancy|0|||
125316920|NCT04024891|450790433|FG001|Overall Study|Pregnancy|1|||
125657765|NCT03576131|452034272|FG002|Overall Study|New anti-cancer treatment|2|||
125657766|NCT03576131|452034273|FG003|Overall Study|New anti-cancer treatment|3|||
125657767|NCT03576131|452034274|FG004|Overall Study|New anti-cancer treatment|0|||
125657768|NCT03576131|452034275|FG005|Overall Study|New anti-cancer treatment|0|||
125657769|NCT03576131|452034276|FG006|Overall Study|New anti-cancer treatment|0|||
125316921|NCT01421017|450790434|FG000|Overall Study|Withdrawal by Subject|2|||
125316922|NCT01421017|450790435|FG001|Overall Study|Withdrawal by Subject|0|||
125316923|NCT01421017|450790436|FG002|Overall Study|Withdrawal by Subject|0|||
125316924|NCT01421017|450790434|FG000|Overall Study|POD|0|||
125316925|NCT01421017|450790435|FG001|Overall Study|POD|6|||
125316926|NCT01421017|450790436|FG002|Overall Study|POD|3|||
125316927|NCT03489863|450790437|FG000|Overall Study|Withdrawal by Subject|0|||
125316928|NCT03489863|450790438|FG001|Overall Study|Withdrawal by Subject|1|||
125316929|NCT00962208|450790440|FG000|Overall Study|Could not achieve good vision|9|||
125657770|NCT03576131|452034277|FG007|Overall Study|New anti-cancer treatment|0|||
125657771|NCT03576131|452034270|FG000|Overall Study|Unspecified reason|0|||
125316930|NCT00962208|450790441|FG001|Overall Study|Could not achieve good vision|0|||
125316931|NCT00962208|450790440|FG000|Overall Study|Contraindicated to continue study|5|||
125316932|NCT00962208|450790441|FG001|Overall Study|Contraindicated to continue study|1|||
125316933|NCT00962208|450790440|FG000|Overall Study|Lost to Follow-up|0|||
125316934|NCT00962208|450790441|FG001|Overall Study|Lost to Follow-up|9|||
125316935|NCT00791388|450790442|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
125316936|NCT00791388|450790443|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
125316937|NCT00791388|450790444|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
125316938|NCT00791388|450790445|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
125316939|NCT00791388|450790446|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
125316940|NCT00791388|450790442|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
125316941|NCT00791388|450790443|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
125316942|NCT00791388|450790444|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
125316943|NCT00791388|450790445|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
125657772|NCT03576131|452034271|FG001|Overall Study|Unspecified reason|0|||
125657773|NCT03576131|452034272|FG002|Overall Study|Unspecified reason|1|||
125657774|NCT03576131|452034273|FG003|Overall Study|Unspecified reason|1|||
125657775|NCT03576131|452034274|FG004|Overall Study|Unspecified reason|1|||
125657776|NCT03576131|452034275|FG005|Overall Study|Unspecified reason|1|||
125316944|NCT00791388|450790446|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
125316945|NCT00791388|450790442|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
125316946|NCT00791388|450790443|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
125316947|NCT00791388|450790444|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
125316948|NCT00791388|450790445|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
125657777|NCT03576131|452034276|FG006|Overall Study|Unspecified reason|0|||
125657778|NCT03576131|452034277|FG007|Overall Study|Unspecified reason|0|||
125657779|NCT03576131|452034270|FG000|Overall Study|Subject non-compliance|0|||
125657780|NCT03576131|452034271|FG001|Overall Study|Subject non-compliance|0|||
125657781|NCT03576131|452034272|FG002|Overall Study|Subject non-compliance|0|||
125657782|NCT03576131|452034273|FG003|Overall Study|Subject non-compliance|0|||
125657783|NCT03576131|452034274|FG004|Overall Study|Subject non-compliance|0|||
125657784|NCT03576131|452034275|FG005|Overall Study|Subject non-compliance|1|||
125657785|NCT03576131|452034276|FG006|Overall Study|Subject non-compliance|0|||
125657786|NCT03576131|452034277|FG007|Overall Study|Subject non-compliance|0|||
125657787|NCT03069365|452034294|FG000|Overall Study|Adverse Event|1|||
125657788|NCT01965431|452034295|FG000|Overall Study|Adverse Event|0|||
125657789|NCT01965431|452034296|FG001|Overall Study|Adverse Event|1|||
125657790|NCT01965431|452034297|FG002|Overall Study|Adverse Event|0|||
125657791|NCT01965431|452034298|FG003|Overall Study|Adverse Event|0|||
125657792|NCT01965431|452034299|FG004|Overall Study|Adverse Event|0|||
125657793|NCT01965431|452034300|FG005|Overall Study|Adverse Event|0|||
125657794|NCT01965431|452034295|FG000|Overall Study|Other than stated above|6|||
125657795|NCT01965431|452034296|FG001|Overall Study|Other than stated above|5|||
125657796|NCT01965431|452034297|FG002|Overall Study|Other than stated above|6|||
125657797|NCT01965431|452034298|FG003|Overall Study|Other than stated above|6|||
125657798|NCT01965431|452034299|FG004|Overall Study|Other than stated above|6|||
125657799|NCT01965431|452034300|FG005|Overall Study|Other than stated above|6|||
125657800|NCT04635631|452034301|FG000|Overall Study|Adverse Event|1|||
125657801|NCT04635631|452034301|FG000|Overall Study|Progressive disease|13|||
125657802|NCT04635631|452034301|FG000|Overall Study|Withdrawal by Subject|1|||
125657803|NCT03901339|452034302|FG000|Overall Study|Death|220|||
125657804|NCT03901339|452034303|FG001|Overall Study|Death|192|||
125657805|NCT03901339|452034302|FG000|Overall Study|Informed consent withdrawn|13|||
125657806|NCT03901339|452034303|FG001|Overall Study|Informed consent withdrawn|40|||
125657807|NCT03901339|452034302|FG000|Overall Study|Sponsor request|30|||
125657808|NCT03901339|452034303|FG001|Overall Study|Sponsor request|23|||
125657809|NCT03901339|452034302|FG000|Overall Study|Reason not specified|5|||
125657810|NCT03901339|452034303|FG001|Overall Study|Reason not specified|7|||
125657811|NCT03901339|452034302|FG000|Overall Study|Lost to Follow-up|4|||
125657812|NCT03901339|452034303|FG001|Overall Study|Lost to Follow-up|7|||
125657813|NCT03901339|452034302|FG000|Overall Study|Covid19|0|||
125657814|NCT03901339|452034303|FG001|Overall Study|Covid19|2|||
125657815|NCT02886494|452034305|FG000|Overall Study|Adverse Event|1|||
125657816|NCT02886494|452034306|FG001|Overall Study|Adverse Event|0|||
125657817|NCT02886494|452034305|FG000|Overall Study|Withdrawal by Subject|12|||
125657818|NCT02886494|452034306|FG001|Overall Study|Withdrawal by Subject|3|||
125657819|NCT02886494|452034305|FG000|Overall Study|Protocol Violation|4|||
125657820|NCT02886494|452034306|FG001|Overall Study|Protocol Violation|1|||
125657821|NCT00457418|452034307|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
125657822|NCT00457418|452034307|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
125316949|NCT00791388|450790446|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
125316950|NCT02995980|450790447|FG000|Overall Study|Lost to Follow-up|14|||
125657823|NCT00457418|452034307|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
125657824|NCT00457418|452034307|FG000|Post PK Maintenance|Adverse Event|10|||
125316951|NCT00657540|450790449|FG000|Overall Study|Lost to Follow-up|1|||
125316952|NCT00657540|450790450|FG001|Overall Study|Lost to Follow-up|4|||
125316953|NCT03010527|450790452|FG000|Overall Study|Death|0|||
125316954|NCT03010527|450790453|FG001|Overall Study|Death|0|||
125316955|NCT03010527|450790454|FG002|Overall Study|Death|1|||
125316956|NCT03010527|450790452|FG000|Overall Study|Adverse Event|0|||
125316957|NCT03010527|450790453|FG001|Overall Study|Adverse Event|4|||
125316958|NCT03010527|450790454|FG002|Overall Study|Adverse Event|2|||
125316959|NCT03010527|450790452|FG000|Overall Study|Protocol Violation|0|||
125657825|NCT00457418|452034307|FG000|Post PK Maintenance|Progression of Disease|6|||
125657826|NCT00457418|452034307|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
125657827|NCT00457418|452034307|FG000|Post PK Maintenance|Lost to Follow-up|1|||
125657828|NCT01785472|452034308|FG000|Overall Study|Adverse Event|5|||
125657829|NCT01785472|452034309|FG001|Overall Study|Adverse Event|4|||
125657830|NCT01785472|452034310|FG002|Overall Study|Adverse Event|6|||
125657831|NCT01785472|452034308|FG000|Overall Study|Lack of Efficacy|2|||
125657832|NCT01785472|452034309|FG001|Overall Study|Lack of Efficacy|0|||
125657833|NCT01785472|452034310|FG002|Overall Study|Lack of Efficacy|1|||
125657834|NCT01785472|452034308|FG000|Overall Study|Lost to Follow-up|1|||
125657835|NCT01785472|452034309|FG001|Overall Study|Lost to Follow-up|2|||
125657836|NCT01785472|452034310|FG002|Overall Study|Lost to Follow-up|0|||
125657837|NCT01785472|452034308|FG000|Overall Study|Physician Decision|1|||
125657838|NCT01785472|452034309|FG001|Overall Study|Physician Decision|1|||
125657839|NCT01785472|452034310|FG002|Overall Study|Physician Decision|1|||
125657840|NCT01785472|452034308|FG000|Overall Study|Protocol deviation|0|||
125657841|NCT01785472|452034309|FG001|Overall Study|Protocol deviation|2|||
125657842|NCT01785472|452034310|FG002|Overall Study|Protocol deviation|2|||
125657843|NCT01785472|452034308|FG000|Overall Study|Subject/guardian decision|15|||
125657844|NCT01785472|452034309|FG001|Overall Study|Subject/guardian decision|10|||
125657845|NCT01785472|452034310|FG002|Overall Study|Subject/guardian decision|11|||
125657846|NCT01785472|452034308|FG000|Overall Study|Technical problems|0|||
125657847|NCT01785472|452034309|FG001|Overall Study|Technical problems|0|||
125657848|NCT01785472|452034310|FG002|Overall Study|Technical problems|1|||
125657849|NCT00595127|452034311|FG000|Overall Study|Death|6|||
125657850|NCT00595127|452034311|FG000|Overall Study|Relapsed|3|||
125657851|NCT00595127|452034311|FG000|Overall Study|joined another trial|1|||
125657852|NCT02086968|452034313|FG000|Overall Study|Adverse Event|1|||
125657853|NCT02086968|452034314|FG001|Overall Study|Adverse Event|5|||
125657854|NCT02086968|452034313|FG000|Overall Study|Lost to Follow-up|2|||
125657855|NCT02086968|452034314|FG001|Overall Study|Lost to Follow-up|3|||
125657856|NCT02086968|452034313|FG000|Overall Study|Study drug received outside protocol|0|||
125657857|NCT02086968|452034314|FG001|Overall Study|Study drug received outside protocol|1|||
125657858|NCT02086968|452034313|FG000|Overall Study|Physician Decision|4|||
125316960|NCT03010527|450790453|FG001|Overall Study|Protocol Violation|1|||
125316961|NCT03010527|450790454|FG002|Overall Study|Protocol Violation|0|||
125316962|NCT03010527|450790452|FG000|Overall Study|Lost to Follow-up|0|||
125316963|NCT03010527|450790453|FG001|Overall Study|Lost to Follow-up|2|||
125657859|NCT02086968|452034314|FG001|Overall Study|Physician Decision|0|||
125657860|NCT02086968|452034313|FG000|Overall Study|Withdrawal by Subject|1|||
125657861|NCT02086968|452034314|FG001|Overall Study|Withdrawal by Subject|4|||
125657862|NCT03099161|452034315|FG000|Overall Study|Adverse Event|0|||
125657863|NCT03099161|452034316|FG001|Overall Study|Adverse Event|0|||
125657864|NCT03099161|452034317|FG002|Overall Study|Adverse Event|2|||
125657865|NCT03099161|452034315|FG000|Overall Study|Physician Decision|2|||
125657866|NCT03099161|452034316|FG001|Overall Study|Physician Decision|0|||
125657867|NCT03099161|452034317|FG002|Overall Study|Physician Decision|0|||
125657868|NCT03099161|452034315|FG000|Overall Study|Progressive Disease|1|||
125657869|NCT03099161|452034316|FG001|Overall Study|Progressive Disease|4|||
125657870|NCT03099161|452034317|FG002|Overall Study|Progressive Disease|1|||
125657871|NCT02723786|452034318|FG000|Overall Study|Lost to Follow-up|1|||
125657872|NCT03123120|452034319|FG000|Overall Study|Lost to Follow-up|0|||
125657873|NCT03123120|452034320|FG001|Overall Study|Lost to Follow-up|1|||
125657874|NCT03123120|452034319|FG000|Overall Study|Withdrawal by Subject|0|||
125657875|NCT03123120|452034320|FG001|Overall Study|Withdrawal by Subject|1|||
125316964|NCT03010527|450790454|FG002|Overall Study|Lost to Follow-up|1|||
125316965|NCT03010527|450790452|FG000|Overall Study|Withdrawal by Subject|0|||
125316966|NCT03010527|450790453|FG001|Overall Study|Withdrawal by Subject|3|||
125657876|NCT00203892|452034321|FG000|Overall Study|Physician Decision|1|||
125657877|NCT00203892|452034322|FG001|Overall Study|Physician Decision|2|||
125657878|NCT00203892|452034323|FG002|Overall Study|Physician Decision|0|||
125657879|NCT00203892|452034321|FG000|Overall Study|Death|1|||
125657880|NCT00203892|452034322|FG001|Overall Study|Death|0|||
125657881|NCT00203892|452034323|FG002|Overall Study|Death|0|||
125657882|NCT00806416|452034324|FG000|Period 1 - Part I|Adverse Event|0|||
125657883|NCT00806416|452034325|FG001|Period 1 - Part I|Adverse Event|1|||
125657884|NCT00806416|452034326|FG002|Period 1 - Part I|Adverse Event|0|||
125316967|NCT03010527|450790454|FG002|Overall Study|Withdrawal by Subject|4|||
125316968|NCT03010527|450790452|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
125657885|NCT00806416|452034327|FG003|Period 1 - Part I|Adverse Event|0|||
125657886|NCT00806416|452034324|FG000|Period 1 - Part I|Lost to Follow-up|0|||
125657887|NCT00806416|452034325|FG001|Period 1 - Part I|Lost to Follow-up|2|||
125316969|NCT03010527|450790453|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
125657888|NCT00806416|452034326|FG002|Period 1 - Part I|Lost to Follow-up|0|||
125657889|NCT00806416|452034327|FG003|Period 1 - Part I|Lost to Follow-up|0|||
125657890|NCT00806416|452034324|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
125657891|NCT00806416|452034325|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
125657892|NCT00806416|452034326|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
125657893|NCT00806416|452034327|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
125657894|NCT00806416|452034324|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
125657895|NCT00806416|452034325|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
125657896|NCT00806416|452034326|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
125657897|NCT00806416|452034327|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
125657898|NCT03345485|452034339|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
125657899|NCT03345485|452034340|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
125657900|NCT03345485|452034341|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
125657901|NCT03345485|452034342|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
125657902|NCT03345485|452034343|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
125657903|NCT03345485|452034344|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
125657904|NCT03345485|452034345|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
125657905|NCT03345485|452034346|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
125657906|NCT03345485|452034347|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
125657907|NCT03345485|452034348|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
125657908|NCT03345485|452034349|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
125657909|NCT03345485|452034350|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
125657910|NCT03345485|452034351|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
125657911|NCT03359473|452034352|FG000|Overall Study|Adverse Event|0|||
125657912|NCT03359473|452034353|FG001|Overall Study|Adverse Event|2|||
125657913|NCT03359473|452034354|FG002|Overall Study|Adverse Event|5|||
125657914|NCT03359473|452034355|FG003|Overall Study|Adverse Event|3|||
125657915|NCT03359473|452034352|FG000|Overall Study|Lost to Follow-up|0|||
125657916|NCT03359473|452034353|FG001|Overall Study|Lost to Follow-up|1|||
125657917|NCT03359473|452034354|FG002|Overall Study|Lost to Follow-up|0|||
125657918|NCT03359473|452034355|FG003|Overall Study|Lost to Follow-up|0|||
125657919|NCT03359473|452034352|FG000|Overall Study|Physician Decision|0|||
125657920|NCT03359473|452034353|FG001|Overall Study|Physician Decision|1|||
125657921|NCT03359473|452034354|FG002|Overall Study|Physician Decision|0|||
125657922|NCT03359473|452034355|FG003|Overall Study|Physician Decision|1|||
125657923|NCT03359473|452034352|FG000|Overall Study|Withdrawal by Subject|1|||
125657924|NCT03359473|452034353|FG001|Overall Study|Withdrawal by Subject|2|||
125657925|NCT03359473|452034354|FG002|Overall Study|Withdrawal by Subject|1|||
125657926|NCT03359473|452034355|FG003|Overall Study|Withdrawal by Subject|0|||
125657927|NCT03359473|452034352|FG000|Overall Study|Protocol-defined stopping criteria|1|||
125657928|NCT03359473|452034353|FG001|Overall Study|Protocol-defined stopping criteria|0|||
125657929|NCT03359473|452034354|FG002|Overall Study|Protocol-defined stopping criteria|0|||
125657930|NCT03359473|452034355|FG003|Overall Study|Protocol-defined stopping criteria|1|||
125657931|NCT05302414|452034356|FG000|Pretest to Posttest|Lost to Follow-up|12|||
125657932|NCT05302414|452034357|FG001|Pretest to Posttest|Lost to Follow-up|8|||
125657933|NCT05302414|452034358|FG002|Pretest to Posttest|Lost to Follow-up|8|||
125657934|NCT05302414|452034356|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
125657935|NCT05302414|452034357|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
125657936|NCT05302414|452034358|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
125657937|NCT01610284|452034359|FG000|Randomization Phase|Adverse Event|1|||
125657938|NCT01610284|452034360|FG001|Randomization Phase|Adverse Event|0|||
125657939|NCT01610284|452034359|FG000|Randomization Phase|Physician Decision|1|||
125657940|NCT01610284|452034360|FG001|Randomization Phase|Physician Decision|1|||
125657941|NCT01610284|452034359|FG000|Randomization Phase|Death|0|||
125657942|NCT01610284|452034360|FG001|Randomization Phase|Death|1|||
125657943|NCT01610284|452034359|FG000|Treatment Phase|Adverse Event|80|||
125657944|NCT01610284|452034360|FG001|Treatment Phase|Adverse Event|12|||
125657945|NCT01610284|452034359|FG000|Treatment Phase|Lost to Follow-up|1|||
125657946|NCT01610284|452034360|FG001|Treatment Phase|Lost to Follow-up|0|||
125657947|NCT01610284|452034359|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
125657948|NCT01610284|452034360|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
125657949|NCT01610284|452034359|FG000|Treatment Phase|Physician Decision|27|||
125657950|NCT01610284|452034360|FG001|Treatment Phase|Physician Decision|24|||
125657951|NCT01610284|452034359|FG000|Treatment Phase|Progressive Disease|377|||
125657952|NCT01610284|452034360|FG001|Treatment Phase|Progressive Disease|486|||
125316970|NCT03010527|450790454|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
125657953|NCT01610284|452034359|FG000|Treatment Phase|Protocol Deviation|2|||
125657954|NCT01610284|452034360|FG001|Treatment Phase|Protocol Deviation|3|||
125657955|NCT01610284|452034359|FG000|Treatment Phase|Study terminated by Sponsor|18|||
125657956|NCT01610284|452034360|FG001|Treatment Phase|Study terminated by Sponsor|15|||
125657957|NCT01610284|452034359|FG000|Treatment Phase|Subject/Guardian Decision|55|||
125657958|NCT01610284|452034360|FG001|Treatment Phase|Subject/Guardian Decision|23|||
125316971|NCT03010527|450790452|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
125657959|NCT01610284|452034359|FG000|Treatment Phase|Death|6|||
125316972|NCT03010527|450790453|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
125316973|NCT03010527|450790454|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
125316974|NCT03010527|450790452|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
125316975|NCT03010527|450790453|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
125316976|NCT03010527|450790454|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
125316977|NCT02656017|450790455|FG000|Overall Study|Study burden|3|||
125316978|NCT02656017|450790456|FG001|Overall Study|Study burden|3|||
125316979|NCT02656017|450790455|FG000|Overall Study|Adverse Event|2|||
125657960|NCT01610284|452034360|FG001|Treatment Phase|Death|5|||
125657961|NCT01610284|452034359|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
125657962|NCT01610284|452034360|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125657963|NCT01610284|452034359|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
125657964|NCT01610284|452034360|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
125657965|NCT01610284|452034359|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
125657966|NCT01610284|452034360|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
125657967|NCT01610284|452034359|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
125657968|NCT01610284|452034360|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
125316980|NCT02656017|450790456|FG001|Overall Study|Adverse Event|1|||
125316981|NCT02656017|450790455|FG000|Overall Study|Unable/unwilling to take study medication|2|||
125316982|NCT02656017|450790456|FG001|Overall Study|Unable/unwilling to take study medication|1|||
125316983|NCT02656017|450790455|FG000|Overall Study|Began Tolvaptan|1|||
125316984|NCT02656017|450790456|FG001|Overall Study|Began Tolvaptan|1|||
125316985|NCT02656017|450790455|FG000|Overall Study|Withdrawal by Subject|1|||
125316986|NCT02656017|450790456|FG001|Overall Study|Withdrawal by Subject|0|||
125316987|NCT04245111|450790457|FG000|Overall Study|Lost to Follow-up|5|||
125316988|NCT04245111|450790458|FG001|Overall Study|Lost to Follow-up|1|||
125316989|NCT04245111|450790459|FG002|Overall Study|Lost to Follow-up|1|||
125316990|NCT03309878|450790460|FG000|Overall Study|Adverse Event|1|||
125657969|NCT01610284|452034359|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
125657970|NCT01610284|452034360|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
125657971|NCT01610284|452034359|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
125657972|NCT01610284|452034360|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
125657973|NCT01102972|452034363|FG000|Overall Study|Adverse Event|8|||
125657974|NCT01102972|452034364|FG001|Overall Study|Adverse Event|2|||
125657975|NCT01102972|452034363|FG000|Overall Study|Lack of Efficacy|2|||
125657976|NCT01102972|452034364|FG001|Overall Study|Lack of Efficacy|1|||
125657977|NCT01102972|452034363|FG000|Overall Study|Protocol Violation|1|||
125657978|NCT01102972|452034364|FG001|Overall Study|Protocol Violation|0|||
125657979|NCT01102972|452034363|FG000|Overall Study|Lost to Follow-up|10|||
125657980|NCT01102972|452034364|FG001|Overall Study|Lost to Follow-up|5|||
125657981|NCT01102972|452034363|FG000|Overall Study|Investigator Discretion|2|||
125657982|NCT01102972|452034364|FG001|Overall Study|Investigator Discretion|0|||
125657983|NCT01102972|452034363|FG000|Overall Study|Withdrawal by Subject|6|||
125657984|NCT01102972|452034364|FG001|Overall Study|Withdrawal by Subject|6|||
125657985|NCT01856257|452034365|FG000|Overall Study|Death|2|||
125657986|NCT01856257|452034366|FG001|Overall Study|Death|0|||
125657987|NCT01856257|452034367|FG002|Overall Study|Death|0|||
125657988|NCT01856257|452034368|FG003|Overall Study|Death|0|||
125657989|NCT01856257|452034365|FG000|Overall Study|Physician Decision|0|||
125657990|NCT01856257|452034366|FG001|Overall Study|Physician Decision|0|||
125657991|NCT01856257|452034367|FG002|Overall Study|Physician Decision|0|||
125657992|NCT01856257|452034368|FG003|Overall Study|Physician Decision|1|||
125657993|NCT01856257|452034365|FG000|Overall Study|Withdrawal by Subject|1|||
125657994|NCT01856257|452034366|FG001|Overall Study|Withdrawal by Subject|1|||
125657995|NCT01856257|452034367|FG002|Overall Study|Withdrawal by Subject|0|||
125657996|NCT01856257|452034368|FG003|Overall Study|Withdrawal by Subject|0|||
125657997|NCT01856257|452034365|FG000|Overall Study|Donor complication|0|||
125657998|NCT01856257|452034366|FG001|Overall Study|Donor complication|0|||
125657999|NCT01856257|452034367|FG002|Overall Study|Donor complication|0|||
125658000|NCT01856257|452034368|FG003|Overall Study|Donor complication|1|||
125658001|NCT01125358|452034372|FG000|Overall Study|Adverse Event|3|||
125658002|NCT01125358|452034373|FG001|Overall Study|Adverse Event|0|||
125658003|NCT01125358|452034374|FG002|Overall Study|Adverse Event|0|||
125316991|NCT03309878|450790461|FG001|Overall Study|Adverse Event|0|||
125658004|NCT01125358|452034375|FG003|Overall Study|Adverse Event|2|||
125658005|NCT01125358|452034372|FG000|Overall Study|Perceived Lack of Efficacy|6|||
125658006|NCT01125358|452034373|FG001|Overall Study|Perceived Lack of Efficacy|3|||
125658007|NCT01125358|452034374|FG002|Overall Study|Perceived Lack of Efficacy|7|||
125658008|NCT01125358|452034375|FG003|Overall Study|Perceived Lack of Efficacy|4|||
125658009|NCT01125358|452034372|FG000|Overall Study|Protocol Violation|1|||
125658010|NCT01125358|452034373|FG001|Overall Study|Protocol Violation|0|||
125316992|NCT03309878|450790462|FG002|Overall Study|Adverse Event|0|||
125316993|NCT03309878|450790463|FG003|Overall Study|Adverse Event|0|||
125316994|NCT03309878|450790460|FG000|Overall Study|Did not maintain eligibility|2|||
125316995|NCT03309878|450790461|FG001|Overall Study|Did not maintain eligibility|1|||
125658011|NCT01125358|452034374|FG002|Overall Study|Protocol Violation|0|||
125658012|NCT01125358|452034375|FG003|Overall Study|Protocol Violation|0|||
125658013|NCT01125358|452034372|FG000|Overall Study|Sponsor Decision|0|||
125658014|NCT01125358|452034373|FG001|Overall Study|Sponsor Decision|0|||
125658015|NCT01125358|452034374|FG002|Overall Study|Sponsor Decision|1|||
125658016|NCT01125358|452034375|FG003|Overall Study|Sponsor Decision|1|||
125658017|NCT01125358|452034372|FG000|Overall Study|Withdrawal by Subject|2|||
125658018|NCT01125358|452034373|FG001|Overall Study|Withdrawal by Subject|1|||
125658019|NCT01125358|452034374|FG002|Overall Study|Withdrawal by Subject|1|||
125658020|NCT01125358|452034375|FG003|Overall Study|Withdrawal by Subject|1|||
125658021|NCT01157065|452034376|FG000|Overall Study|Death|0|||
125658022|NCT01157065|452034377|FG001|Overall Study|Death|1|||
125658023|NCT01060007|452034378|FG000|Overall Study|Withdrawal by Subject|1|||
125658024|NCT01060007|452034378|FG000|Overall Study|Inevaluable for response at surgery|3|||
125658025|NCT00742859|452034381|FG000|Overall Study|Adverse Event|5|||
125658026|NCT00742859|452034382|FG001|Overall Study|Adverse Event|6|||
125658027|NCT00742859|452034383|FG002|Overall Study|Adverse Event|3|||
125658028|NCT00742859|452034384|FG003|Overall Study|Adverse Event|1|||
125658029|NCT00742859|452034381|FG000|Overall Study|Death|1|||
125658030|NCT00742859|452034382|FG001|Overall Study|Death|0|||
125658031|NCT00742859|452034383|FG002|Overall Study|Death|0|||
125658032|NCT00742859|452034384|FG003|Overall Study|Death|1|||
125658033|NCT00742859|452034381|FG000|Overall Study|Physician Decision|1|||
125658034|NCT00742859|452034382|FG001|Overall Study|Physician Decision|2|||
125658035|NCT00742859|452034383|FG002|Overall Study|Physician Decision|0|||
125658036|NCT00742859|452034384|FG003|Overall Study|Physician Decision|0|||
125658037|NCT00742859|452034381|FG000|Overall Study|Withdrawal by Subject|4|||
125658038|NCT00742859|452034382|FG001|Overall Study|Withdrawal by Subject|2|||
125658039|NCT00742859|452034383|FG002|Overall Study|Withdrawal by Subject|4|||
125658040|NCT00742859|452034384|FG003|Overall Study|Withdrawal by Subject|1|||
125658041|NCT00742859|452034381|FG000|Overall Study|Endpoint|0|||
125658042|NCT00742859|452034382|FG001|Overall Study|Endpoint|1|||
125658043|NCT00742859|452034383|FG002|Overall Study|Endpoint|1|||
125658044|NCT00742859|452034384|FG003|Overall Study|Endpoint|2|||
125658045|NCT00742859|452034381|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
125658046|NCT00742859|452034382|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
125658047|NCT00742859|452034383|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
125658048|NCT00742859|452034384|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
125658049|NCT00742859|452034381|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
125658050|NCT00742859|452034382|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
125658051|NCT00742859|452034383|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
125658052|NCT00742859|452034384|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
125658053|NCT00742859|452034381|FG000|Overall Study|Sponsor request patient out of town|0|||
125658054|NCT00742859|452034382|FG001|Overall Study|Sponsor request patient out of town|0|||
125658055|NCT00742859|452034383|FG002|Overall Study|Sponsor request patient out of town|1|||
125658056|NCT00742859|452034384|FG003|Overall Study|Sponsor request patient out of town|1|||
125658057|NCT00742859|452034381|FG000|Overall Study|Site error|0|||
125658058|NCT00742859|452034382|FG001|Overall Study|Site error|0|||
125316996|NCT03309878|450790462|FG002|Overall Study|Did not maintain eligibility|0|||
125316997|NCT03309878|450790463|FG003|Overall Study|Did not maintain eligibility|0|||
125316998|NCT03309878|450790460|FG000|Overall Study|Withdrawal by Subject|0|||
125316999|NCT03309878|450790461|FG001|Overall Study|Withdrawal by Subject|1|||
125317000|NCT03309878|450790462|FG002|Overall Study|Withdrawal by Subject|0|||
125317001|NCT03309878|450790463|FG003|Overall Study|Withdrawal by Subject|0|||
125317002|NCT03192176|450790465|FG000|Overall Study|Adverse Event|1|||
125317003|NCT03192176|450790466|FG001|Overall Study|Adverse Event|0|||
125317004|NCT03192176|450790467|FG002|Overall Study|Adverse Event|4|||
125317005|NCT03192176|450790468|FG003|Overall Study|Adverse Event|5|||
125317006|NCT03192176|450790469|FG004|Overall Study|Adverse Event|3|||
125317007|NCT03192176|450790470|FG005|Overall Study|Adverse Event|2|||
125317008|NCT03192176|450790471|FG006|Overall Study|Adverse Event|3|||
125658059|NCT00742859|452034383|FG002|Overall Study|Site error|1|||
125658060|NCT00742859|452034384|FG003|Overall Study|Site error|1|||
125658061|NCT00962013|452034389|FG000|Overall Study|Did not have surgery|1|||
125658062|NCT00962013|452034389|FG000|Overall Study|Death|8|||
125317009|NCT03192176|450790472|FG007|Overall Study|Adverse Event|3|||
125317010|NCT03192176|450790465|FG000|Overall Study|Lost to Follow-up|0|||
125317011|NCT03192176|450790466|FG001|Overall Study|Lost to Follow-up|0|||
125317012|NCT03192176|450790467|FG002|Overall Study|Lost to Follow-up|1|||
125317013|NCT03192176|450790468|FG003|Overall Study|Lost to Follow-up|2|||
125317014|NCT03192176|450790469|FG004|Overall Study|Lost to Follow-up|3|||
125658063|NCT00962013|452034389|FG000|Overall Study|Lost to Follow-up|12|||
125658064|NCT00962013|452034389|FG000|Overall Study|Unable/Unwilling to return|6|||
125658065|NCT00962013|452034389|FG000|Overall Study|Withdrawal by Subject|8|||
125658066|NCT00962013|452034389|FG000|Overall Study|Removal of study device|3|||
125658067|NCT00962013|452034389|FG000|Overall Study|Site Termination|24|||
125658068|NCT00962013|452034389|FG000|Overall Study|No 5 year evaluation|6|||
125658069|NCT04527549|452034390|FG000|Overall Study|Withdrawal by Subject|1|||
125658070|NCT04527549|452034391|FG001|Overall Study|Withdrawal by Subject|1|||
125658071|NCT00445458|452034404|FG000|Overall Study|Disease Progression|3|||
125658072|NCT00445458|452034405|FG001|Overall Study|Disease Progression|4|||
125658073|NCT00445458|452034406|FG002|Overall Study|Disease Progression|54|||
125658074|NCT00445458|452034407|FG003|Overall Study|Disease Progression|27|||
125658075|NCT00445458|452034404|FG000|Overall Study|Withdrawal by Subject|0|||
125658076|NCT00445458|452034405|FG001|Overall Study|Withdrawal by Subject|0|||
125658077|NCT00445458|452034406|FG002|Overall Study|Withdrawal by Subject|7|||
125658078|NCT00445458|452034407|FG003|Overall Study|Withdrawal by Subject|0|||
125658079|NCT00445458|452034404|FG000|Overall Study|Adverse Event|0|||
125658080|NCT00445458|452034405|FG001|Overall Study|Adverse Event|0|||
125658081|NCT00445458|452034406|FG002|Overall Study|Adverse Event|3|||
125658082|NCT00445458|452034407|FG003|Overall Study|Adverse Event|0|||
125658083|NCT00445458|452034404|FG000|Overall Study|Death|0|||
125658084|NCT00445458|452034405|FG001|Overall Study|Death|1|||
125658085|NCT00445458|452034406|FG002|Overall Study|Death|2|||
125658086|NCT00445458|452034407|FG003|Overall Study|Death|0|||
125658087|NCT00445458|452034404|FG000|Overall Study|Physician Decision|0|||
125658088|NCT00445458|452034405|FG001|Overall Study|Physician Decision|0|||
125658089|NCT00445458|452034406|FG002|Overall Study|Physician Decision|1|||
125658090|NCT00445458|452034407|FG003|Overall Study|Physician Decision|1|||
125658091|NCT00445458|452034404|FG000|Overall Study|Surgery|0|||
125658092|NCT00445458|452034405|FG001|Overall Study|Surgery|0|||
125658093|NCT00445458|452034406|FG002|Overall Study|Surgery|1|||
125658094|NCT00445458|452034407|FG003|Overall Study|Surgery|0|||
125658095|NCT00728988|452034412|FG000|Overall Study|Not Treated|2|||
125658096|NCT00728988|452034413|FG001|Overall Study|Not Treated|2|||
125658097|NCT00728988|452034412|FG000|Overall Study|Death|1|||
125658098|NCT00728988|452034413|FG001|Overall Study|Death|1|||
125658099|NCT00728988|452034412|FG000|Overall Study|Adverse Event|3|||
125658100|NCT00728988|452034413|FG001|Overall Study|Adverse Event|2|||
125658101|NCT00728988|452034412|FG000|Overall Study|Other|85|||
125658102|NCT00728988|452034413|FG001|Overall Study|Other|77|||
125658103|NCT00728988|452034412|FG000|Overall Study|Withdrawal by Subject|2|||
125658104|NCT00728988|452034413|FG001|Overall Study|Withdrawal by Subject|6|||
125658105|NCT03186794|452034417|FG000|Overall Study|Physician Decision|2|||
125317015|NCT03192176|450790470|FG005|Overall Study|Lost to Follow-up|1|||
125317016|NCT03192176|450790471|FG006|Overall Study|Lost to Follow-up|1|||
125658106|NCT03186794|452034417|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
125658107|NCT00111007|452034419|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
125658108|NCT00111007|452034420|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
125317017|NCT03192176|450790472|FG007|Overall Study|Lost to Follow-up|1|||
125317018|NCT03192176|450790465|FG000|Overall Study|Physician Decision|1|||
125317019|NCT03192176|450790466|FG001|Overall Study|Physician Decision|0|||
125317020|NCT03192176|450790467|FG002|Overall Study|Physician Decision|0|||
125317021|NCT03192176|450790468|FG003|Overall Study|Physician Decision|0|||
125317022|NCT03192176|450790469|FG004|Overall Study|Physician Decision|0|||
125317023|NCT03192176|450790470|FG005|Overall Study|Physician Decision|2|||
125317024|NCT03192176|450790471|FG006|Overall Study|Physician Decision|1|||
125317025|NCT03192176|450790472|FG007|Overall Study|Physician Decision|0|||
125317026|NCT03192176|450790465|FG000|Overall Study|Protocol Deviation|1|||
125317027|NCT03192176|450790466|FG001|Overall Study|Protocol Deviation|1|||
125317028|NCT03192176|450790467|FG002|Overall Study|Protocol Deviation|0|||
125317029|NCT03192176|450790468|FG003|Overall Study|Protocol Deviation|0|||
125317030|NCT03192176|450790469|FG004|Overall Study|Protocol Deviation|2|||
125317031|NCT03192176|450790470|FG005|Overall Study|Protocol Deviation|0|||
125317032|NCT03192176|450790471|FG006|Overall Study|Protocol Deviation|0|||
125317033|NCT03192176|450790472|FG007|Overall Study|Protocol Deviation|0|||
125317034|NCT03192176|450790465|FG000|Overall Study|Withdrawal by Subject|3|||
125317035|NCT03192176|450790466|FG001|Overall Study|Withdrawal by Subject|4|||
125317036|NCT03192176|450790467|FG002|Overall Study|Withdrawal by Subject|0|||
125317037|NCT03192176|450790468|FG003|Overall Study|Withdrawal by Subject|4|||
125317038|NCT03192176|450790469|FG004|Overall Study|Withdrawal by Subject|3|||
125317039|NCT03192176|450790470|FG005|Overall Study|Withdrawal by Subject|4|||
125317040|NCT03192176|450790471|FG006|Overall Study|Withdrawal by Subject|4|||
125317041|NCT03192176|450790472|FG007|Overall Study|Withdrawal by Subject|2|||
125317042|NCT03192176|450790465|FG000|Overall Study|Miscellaneous|1|||
125658109|NCT00111007|452034419|FG000|Double-blind (DB) Treatment|Death|5|||
125658110|NCT00111007|452034420|FG001|Double-blind (DB) Treatment|Death|2|||
125658111|NCT00111007|452034419|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
125658112|NCT00111007|452034420|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
125658113|NCT00111007|452034419|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
125658114|NCT00111007|452034420|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
125317043|NCT03192176|450790466|FG001|Overall Study|Miscellaneous|0|||
125317044|NCT03192176|450790467|FG002|Overall Study|Miscellaneous|1|||
125317045|NCT03192176|450790468|FG003|Overall Study|Miscellaneous|1|||
125317046|NCT03192176|450790469|FG004|Overall Study|Miscellaneous|1|||
125317047|NCT03192176|450790470|FG005|Overall Study|Miscellaneous|2|||
125658115|NCT00111007|452034419|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
125658116|NCT00111007|452034420|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
125317048|NCT03192176|450790471|FG006|Overall Study|Miscellaneous|0|||
125317049|NCT03192176|450790472|FG007|Overall Study|Miscellaneous|1|||
125317050|NCT00667628|450790473|FG000|Overall Study|Lost to Follow-up|1|||
125317051|NCT00667628|450790474|FG001|Overall Study|Lost to Follow-up|0|||
125317052|NCT00667628|450790473|FG000|Overall Study|Death|6|||
125317053|NCT00667628|450790474|FG001|Overall Study|Death|6|||
125317054|NCT00667628|450790473|FG000|Overall Study|Investigator Considers in Best Interest|1|||
125317055|NCT00667628|450790474|FG001|Overall Study|Investigator Considers in Best Interest|0|||
125317056|NCT00667628|450790473|FG000|Overall Study|Sponsor Terminated Study|17|||
125317057|NCT00667628|450790474|FG001|Overall Study|Sponsor Terminated Study|21|||
125317058|NCT04244253|450790475|FG000|Overall Study|Adverse Event|2|||
125317059|NCT04244253|450790476|FG001|Overall Study|Adverse Event|2|||
125658117|NCT00111007|452034419|FG000|Double-blind (DB) Treatment|Relapse|1|||
125658118|NCT00111007|452034420|FG001|Double-blind (DB) Treatment|Relapse|0|||
125658119|NCT00111007|452034419|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
125317060|NCT04244253|450790477|FG002|Overall Study|Adverse Event|4|||
125317061|NCT04244253|450790475|FG000|Overall Study|Protocol Violation|1|||
125317062|NCT04244253|450790476|FG001|Overall Study|Protocol Violation|2|||
125317063|NCT04244253|450790477|FG002|Overall Study|Protocol Violation|1|||
125317064|NCT04244253|450790475|FG000|Overall Study|Withdrawal by Subject|0|||
125317065|NCT04244253|450790476|FG001|Overall Study|Withdrawal by Subject|1|||
125317066|NCT04244253|450790477|FG002|Overall Study|Withdrawal by Subject|6|||
125317067|NCT04244253|450790475|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125317068|NCT04244253|450790476|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125317069|NCT04244253|450790477|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125317070|NCT04663321|450790478|FG000|Overall Study|Study terminated by Sponsor|2|||
125317071|NCT04663321|450790479|FG001|Overall Study|Study terminated by Sponsor|1|||
125317072|NCT04663321|450790480|FG002|Overall Study|Study terminated by Sponsor|2|||
125317073|NCT04663321|450790478|FG000|Overall Study|Withdrawal by Subject|10|||
125317074|NCT04663321|450790479|FG001|Overall Study|Withdrawal by Subject|3|||
125317075|NCT04663321|450790480|FG002|Overall Study|Withdrawal by Subject|2|||
125317076|NCT04663321|450790478|FG000|Overall Study|Not provided|0|||
125317077|NCT04663321|450790479|FG001|Overall Study|Not provided|0|||
125317078|NCT04663321|450790480|FG002|Overall Study|Not provided|1|||
125317079|NCT03532542|450790483|FG000|Overall Study|Death|1|||
125317080|NCT03532542|450790484|FG001|Overall Study|Death|0|||
125317081|NCT03532542|450790483|FG000|Overall Study|Study Terminated by Sponsor|41|||
125317082|NCT03532542|450790484|FG001|Overall Study|Study Terminated by Sponsor|65|||
125317083|NCT03532542|450790483|FG000|Overall Study|Withdrawal by Subject|6|||
125317084|NCT03532542|450790484|FG001|Overall Study|Withdrawal by Subject|5|||
125317085|NCT01962441|450790485|FG000|Randomized Period|Randomized but Never Treated|4|||
125317086|NCT01962441|450790486|FG001|Randomized Period|Randomized but Never Treated|2|||
125317087|NCT01962441|450790487|FG002|Randomized Period|Randomized but Never Treated|3|||
125317088|NCT01962441|450790485|FG000|Randomized Period|Lost to Follow-up|2|||
125317089|NCT01962441|450790486|FG001|Randomized Period|Lost to Follow-up|4|||
125317090|NCT01962441|450790487|FG002|Randomized Period|Lost to Follow-up|4|||
125317091|NCT01962441|450790485|FG000|Randomized Period|Withdrew Consent|3|||
125317092|NCT01962441|450790486|FG001|Randomized Period|Withdrew Consent|3|||
125317093|NCT01962441|450790487|FG002|Randomized Period|Withdrew Consent|2|||
125317094|NCT01962441|450790485|FG000|Randomized Period|Adverse Event|1|||
125317095|NCT01962441|450790486|FG001|Randomized Period|Adverse Event|1|||
125317096|NCT01962441|450790487|FG002|Randomized Period|Adverse Event|0|||
125317097|NCT01962441|450790485|FG000|Randomized Period|Death|0|||
125317098|NCT01962441|450790486|FG001|Randomized Period|Death|0|||
125317099|NCT01962441|450790487|FG002|Randomized Period|Death|2|||
125317100|NCT01962441|450790485|FG000|Randomized Period|Protocol Violation|0|||
125658120|NCT00111007|452034420|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
125658121|NCT00111007|452034419|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
125317101|NCT01962441|450790486|FG001|Randomized Period|Protocol Violation|1|||
125317102|NCT01962441|450790487|FG002|Randomized Period|Protocol Violation|0|||
125317103|NCT01962441|450790485|FG000|Retreatment Substudy|Lack of Efficacy|1|||
125317104|NCT01962441|450790486|FG001|Retreatment Substudy|Lack of Efficacy|0|||
125317105|NCT01962441|450790487|FG002|Retreatment Substudy|Lack of Efficacy|0|||
125658122|NCT00111007|452034420|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
125658123|NCT00111007|452034419|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
125317106|NCT01962441|450790485|FG000|Retreatment Substudy|Lost to Follow-up|1|||
125317107|NCT01962441|450790486|FG001|Retreatment Substudy|Lost to Follow-up|0|||
125317108|NCT01962441|450790487|FG002|Retreatment Substudy|Lost to Follow-up|0|||
125317109|NCT02055898|450790488|FG000|First Intervention (5 Days)|Physician Decision|2|||
125317110|NCT02055898|450790489|FG001|First Intervention (5 Days)|Physician Decision|0|||
125317111|NCT02055898|450790488|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
125317112|NCT02055898|450790489|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
125317113|NCT02314052|450790493|FG000|Cycle One|Adverse Event|0|||
125317114|NCT02314052|450790494|FG001|Cycle One|Adverse Event|0|||
125317115|NCT02314052|450790495|FG002|Cycle One|Adverse Event|0|||
125317116|NCT02314052|450790496|FG003|Cycle One|Adverse Event|1|||
125317117|NCT02314052|450790497|FG004|Cycle One|Adverse Event|0|||
125317118|NCT02314052|450790498|FG005|Cycle One|Adverse Event|0|||
125317119|NCT00117637|450790499|FG000|First Intervention (Period 1)|Adverse Event|11|||
125317120|NCT00117637|450790500|FG001|First Intervention (Period 1)|Adverse Event|16|||
125317121|NCT00117637|450790499|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
125317122|NCT00117637|450790500|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
125317123|NCT00117637|450790499|FG000|First Intervention (Period 1)|Protocol Violation|1|||
125317124|NCT00117637|450790500|FG001|First Intervention (Period 1)|Protocol Violation|0|||
125317125|NCT00117637|450790499|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
125317126|NCT00117637|450790500|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
125317127|NCT00117637|450790499|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
125317128|NCT00117637|450790500|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
125317129|NCT00117637|450790499|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
125317130|NCT00117637|450790500|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
125317131|NCT00117637|450790499|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
125317132|NCT00117637|450790500|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
125317133|NCT00117637|450790499|FG000|First Intervention (Period 1)|reason not reported|0|||
125317134|NCT00117637|450790500|FG001|First Intervention (Period 1)|reason not reported|1|||
125317135|NCT00117637|450790499|FG000|Second Intervention (Period 2)|Adverse Event|0|||
125317136|NCT00117637|450790500|FG001|Second Intervention (Period 2)|Adverse Event|9|||
125317137|NCT00117637|450790499|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
125317138|NCT00117637|450790500|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
125317139|NCT00117637|450790499|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
125317140|NCT00117637|450790500|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
125658124|NCT00111007|452034420|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
125658125|NCT00111007|452034419|FG000|Active Follow-up|Adverse Event|1|||
125658126|NCT00111007|452034420|FG001|Active Follow-up|Adverse Event|0|||
125658127|NCT00111007|452034419|FG000|Active Follow-up|Death|2|||
125658128|NCT00111007|452034420|FG001|Active Follow-up|Death|0|||
125658129|NCT00111007|452034419|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
125658130|NCT00111007|452034420|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
125658131|NCT00111007|452034419|FG000|Long Term Follow-up|Death|34|||
125658132|NCT00111007|452034420|FG001|Long Term Follow-up|Death|39|||
125658133|NCT00111007|452034419|FG000|Long Term Follow-up|Lost to Follow-up|1|||
125658134|NCT00111007|452034420|FG001|Long Term Follow-up|Lost to Follow-up|1|||
125658135|NCT00111007|452034419|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
125658136|NCT00111007|452034420|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
125658137|NCT00111007|452034419|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
125658138|NCT00111007|452034420|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
125658139|NCT00111007|452034419|FG000|Long Term Follow-up|Missing|10|||
125658140|NCT00111007|452034420|FG001|Long Term Follow-up|Missing|3|||
125658141|NCT02380248|452034421|FG000|Overall Study|Lost to Follow-up|11|||
125658142|NCT02380248|452034421|FG000|Overall Study|Withdrawal by Subject|3|||
125658143|NCT00605839|452034422|FG000|Overall Study|Protocol Violation|1|||
125658144|NCT00605839|452034423|FG001|Overall Study|Protocol Violation|0|||
125658145|NCT00605839|452034424|FG002|Overall Study|Protocol Violation|0|||
125658146|NCT01381068|452034425|FG000|Overall Study|Death|1|||
125658147|NCT01381068|452034426|FG001|Overall Study|Death|0|||
125658148|NCT00752895|452034433|FG000|Overall Study|Withdrawal by Subject|8|||
125658149|NCT00752895|452034434|FG001|Overall Study|Withdrawal by Subject|3|||
125658150|NCT00083226|452034435|FG000|Overall Study|Lack of Efficacy|19|||
125658151|NCT00083226|452034435|FG000|Overall Study|Adverse Event|9|||
125658152|NCT00083226|452034435|FG000|Overall Study|Death|4|||
125658153|NCT00083226|452034435|FG000|Overall Study|Withdrawal by Subject|4|||
125658154|NCT00083226|452034435|FG000|Overall Study|Other|2|||
125658155|NCT00083226|452034435|FG000|Overall Study|ineligible or not receiving treatment|4|||
125658156|NCT00909857|452034436|FG000|Overall Study|Withdrawal by Subject|6|||
125658157|NCT00909857|452034437|FG001|Overall Study|Withdrawal by Subject|10|||
125658158|NCT00909857|452034436|FG000|Overall Study|Adverse Event|5|||
125658159|NCT00909857|452034437|FG001|Overall Study|Adverse Event|5|||
125658160|NCT00909857|452034436|FG000|Overall Study|Lost to Follow-up|2|||
125658161|NCT00909857|452034437|FG001|Overall Study|Lost to Follow-up|5|||
125658162|NCT00909857|452034436|FG000|Overall Study|Protocol Violation|2|||
125658163|NCT00909857|452034437|FG001|Overall Study|Protocol Violation|1|||
125658164|NCT00909857|452034436|FG000|Overall Study|Pregnancy|1|||
125658165|NCT00909857|452034437|FG001|Overall Study|Pregnancy|0|||
125658166|NCT00909857|452034436|FG000|Overall Study|Other|1|||
125658167|NCT00909857|452034437|FG001|Overall Study|Other|0|||
125658168|NCT00909857|452034436|FG000|Overall Study|Did not receive study medication|19|||
125317141|NCT00117637|450790499|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
125317142|NCT00117637|450790500|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
125317143|NCT00117637|450790499|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
125317144|NCT00117637|450790500|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
125658169|NCT00909857|452034437|FG001|Overall Study|Did not receive study medication|24|||
125658170|NCT00604175|452034438|FG000|Entry Through Week 28|Death|2|||
125658171|NCT00604175|452034439|FG001|Entry Through Week 28|Death|0|||
125658172|NCT00604175|452034440|FG002|Entry Through Week 28|Death|0|||
125658173|NCT00604175|452034438|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
125658174|NCT00604175|452034439|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
125658175|NCT00604175|452034440|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
125658176|NCT00604175|452034438|FG000|Entry Through Week 28|Lost to Follow-up|4|||
125658177|NCT00604175|452034439|FG001|Entry Through Week 28|Lost to Follow-up|3|||
125658178|NCT00604175|452034440|FG002|Entry Through Week 28|Lost to Follow-up|0|||
125658179|NCT00604175|452034438|FG000|Entry Through Week 28|Ineligible|1|||
125658180|NCT00604175|452034439|FG001|Entry Through Week 28|Ineligible|0|||
125658181|NCT00604175|452034440|FG002|Entry Through Week 28|Ineligible|0|||
125658182|NCT00604175|452034438|FG000|Entry Through Week 28|Did not start intervention|2|||
125658183|NCT00604175|452034439|FG001|Entry Through Week 28|Did not start intervention|0|||
125658184|NCT00604175|452034440|FG002|Entry Through Week 28|Did not start intervention|1|||
125658185|NCT00604175|452034438|FG000|Week 29 Through Week 72|Death|0|||
125658186|NCT00604175|452034439|FG001|Week 29 Through Week 72|Death|0|||
125658187|NCT00604175|452034440|FG002|Week 29 Through Week 72|Death|1|||
125658188|NCT00604175|452034438|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
125658189|NCT00604175|452034439|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
125658190|NCT00604175|452034440|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
125658191|NCT00604175|452034438|FG000|Week 29 Through Week 72|Site closure|0|||
125658192|NCT00604175|452034439|FG001|Week 29 Through Week 72|Site closure|1|||
125658193|NCT00604175|452034440|FG002|Week 29 Through Week 72|Site closure|0|||
125658194|NCT00604175|452034438|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
125658195|NCT00604175|452034439|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
125658196|NCT00604175|452034440|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
125658197|NCT03205163|452034441|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
125658198|NCT03205163|452034442|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
125658199|NCT03443973|452035632|FG000|Double-blind Treatment Period|Adverse Event|5|||
125658200|NCT03443973|452035633|FG001|Double-blind Treatment Period|Adverse Event|19|||
125658201|NCT03443973|452035634|FG002|Double-blind Treatment Period|Adverse Event|0|||
125658202|NCT03443973|452035635|FG003|Double-blind Treatment Period|Adverse Event|0|||
125658203|NCT03443973|452035632|FG000|Double-blind Treatment Period|Death|5|||
125658204|NCT03443973|452035633|FG001|Double-blind Treatment Period|Death|7|||
125658205|NCT03443973|452035634|FG002|Double-blind Treatment Period|Death|0|||
125658206|NCT03443973|452035635|FG003|Double-blind Treatment Period|Death|0|||
125658207|NCT03443973|452035632|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
125658208|NCT03443973|452035633|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
125658209|NCT03443973|452035634|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
125658210|NCT03443973|452035635|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
125658211|NCT03443973|452035632|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
125658212|NCT03443973|452035633|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
125658213|NCT03443973|452035634|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
125658214|NCT03443973|452035635|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
125658215|NCT03443973|452035632|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
125658216|NCT03443973|452035633|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
125317145|NCT00117637|450790499|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
125317146|NCT00117637|450790500|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
125317147|NCT00117637|450790499|FG000|Second Intervention (Period 2)|reason not reported|1|||
125317148|NCT00117637|450790500|FG001|Second Intervention (Period 2)|reason not reported|0|||
125317149|NCT01620060|450790501|FG000|Overall Study|Adverse Event|9|||
125317150|NCT01620060|450790501|FG000|Overall Study|Protocol Violation|1|||
125317151|NCT01620060|450790501|FG000|Overall Study|Withdrawal by Subject|1|||
125317152|NCT01620060|450790501|FG000|Overall Study|Did not comply with Study Produre|1|||
125317153|NCT01620060|450790501|FG000|Overall Study|Family emergency|1|||
125317154|NCT01620060|450790501|FG000|Overall Study|Per Sponsor Decision|2|||
125317155|NCT01582061|450790502|FG000|Overall Study|Lack of Efficacy|3|||
125317156|NCT01582061|450790503|FG001|Overall Study|Lack of Efficacy|23|||
125317157|NCT01582061|450790502|FG000|Overall Study|Adverse Event|12|||
125658217|NCT03443973|452035634|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
125658218|NCT03443973|452035635|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
125658219|NCT03443973|452035632|FG000|Double-blind Treatment Period|Physician Decision|5|||
125658220|NCT03443973|452035633|FG001|Double-blind Treatment Period|Physician Decision|6|||
125658221|NCT03443973|452035634|FG002|Double-blind Treatment Period|Physician Decision|0|||
125658222|NCT03443973|452035635|FG003|Double-blind Treatment Period|Physician Decision|0|||
125658223|NCT03443973|452035632|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
125317158|NCT01582061|450790503|FG001|Overall Study|Adverse Event|8|||
125317159|NCT01582061|450790502|FG000|Overall Study|Withdrawal by Subject|10|||
125317160|NCT01582061|450790503|FG001|Overall Study|Withdrawal by Subject|4|||
125317161|NCT01582061|450790502|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125658224|NCT03443973|452035633|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
125658225|NCT03443973|452035634|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
125658226|NCT03443973|452035635|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
125658227|NCT03443973|452035632|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
125658228|NCT03443973|452035633|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
125658229|NCT03443973|452035634|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125658230|NCT03443973|452035635|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
125658231|NCT03443973|452035632|FG000|Open-label Extension Period|Reason Not Specified|0|||
125658232|NCT03443973|452035633|FG001|Open-label Extension Period|Reason Not Specified|0|||
125658233|NCT03443973|452035634|FG002|Open-label Extension Period|Reason Not Specified|3|||
125658234|NCT03443973|452035635|FG003|Open-label Extension Period|Reason Not Specified|0|||
125658235|NCT03443973|452035632|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
125658236|NCT03443973|452035633|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
125658237|NCT03443973|452035634|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
125658238|NCT03443973|452035635|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
125658239|NCT02209454|452035639|FG000|Second Period|Adverse Event|1|||
125658240|NCT02209454|452035640|FG001|Second Period|Adverse Event|0|||
125658241|NCT00366678|452035645|FG000|Infant Series|Withdrawal by Subject|8|||
125658242|NCT00366678|452035646|FG001|Infant Series|Withdrawal by Subject|6|||
125658243|NCT00366678|452035647|FG002|Infant Series|Withdrawal by Subject|0|||
125658244|NCT00366678|452035645|FG000|Infant Series|Protocol Violation|4|||
125658245|NCT00366678|452035646|FG001|Infant Series|Protocol Violation|3|||
125658246|NCT00366678|452035647|FG002|Infant Series|Protocol Violation|0|||
125658247|NCT00366678|452035645|FG000|Infant Series|Failed to return|1|||
125658248|NCT00366678|452035646|FG001|Infant Series|Failed to return|1|||
125658249|NCT00366678|452035647|FG002|Infant Series|Failed to return|0|||
125658250|NCT00366678|452035645|FG000|Infant Series|Adverse Event|1|||
125658251|NCT00366678|452035646|FG001|Infant Series|Adverse Event|0|||
125658252|NCT00366678|452035647|FG002|Infant Series|Adverse Event|0|||
125658253|NCT00366678|452035645|FG000|After Infant|Withdrawal by Subject|8|||
125658254|NCT00366678|452035646|FG001|After Infant|Withdrawal by Subject|4|||
125658255|NCT00366678|452035647|FG002|After Infant|Withdrawal by Subject|0|||
125658256|NCT00366678|452035645|FG000|After Infant|Lost to Follow-up|2|||
125658257|NCT00366678|452035646|FG001|After Infant|Lost to Follow-up|1|||
125658258|NCT00366678|452035647|FG002|After Infant|Lost to Follow-up|0|||
125658259|NCT00366678|452035645|FG000|After Infant|Failed to return|5|||
125658260|NCT00366678|452035646|FG001|After Infant|Failed to return|5|||
125658261|NCT00366678|452035647|FG002|After Infant|Failed to return|0|||
125658262|NCT00366678|452035645|FG000|After Infant|Adverse Event|1|||
125317162|NCT01582061|450790503|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125317163|NCT01582061|450790502|FG000|Overall Study|Death|0|||
125317164|NCT01582061|450790503|FG001|Overall Study|Death|1|||
125317165|NCT01582061|450790502|FG000|Overall Study|condition no longer requires study drug|1|||
125317166|NCT01582061|450790503|FG001|Overall Study|condition no longer requires study drug|0|||
125317167|NCT01582061|450790502|FG000|Overall Study|Lost to Follow-up|1|||
125658263|NCT00366678|452035646|FG001|After Infant|Adverse Event|0|||
125658264|NCT00366678|452035647|FG002|After Infant|Adverse Event|0|||
125658265|NCT00366678|452035645|FG000|After Infant|Protocol Violation|1|||
125658266|NCT00366678|452035646|FG001|After Infant|Protocol Violation|0|||
125658267|NCT00366678|452035647|FG002|After Infant|Protocol Violation|0|||
125658268|NCT00366678|452035645|FG000|Toddler Dose|Protocol Violation|2|||
125658269|NCT00366678|452035646|FG001|Toddler Dose|Protocol Violation|1|||
125658270|NCT00366678|452035647|FG002|Toddler Dose|Protocol Violation|0|||
125658271|NCT00366678|452035645|FG000|Toddler Dose|Failed to return|1|||
125658272|NCT00366678|452035646|FG001|Toddler Dose|Failed to return|0|||
125658273|NCT00366678|452035647|FG002|Toddler Dose|Failed to return|0|||
125658274|NCT00366678|452035645|FG000|Toddler Dose|Withdrawal by Subject|1|||
125658275|NCT00366678|452035646|FG001|Toddler Dose|Withdrawal by Subject|0|||
125658276|NCT00366678|452035647|FG002|Toddler Dose|Withdrawal by Subject|0|||
125658277|NCT00366678|452035645|FG000|Toddler Dose|protocol deviation|1|||
125658278|NCT00366678|452035646|FG001|Toddler Dose|protocol deviation|0|||
125658279|NCT00366678|452035647|FG002|Toddler Dose|protocol deviation|0|||
125658280|NCT04292171|452035648|FG000|Overall Study|Pharmacy error|2|||
125658281|NCT04292171|452035649|FG001|Overall Study|Pharmacy error|0|||
125658282|NCT04292171|452035648|FG000|Overall Study|Delivered prior to procedure|0|||
125658283|NCT04292171|452035649|FG001|Overall Study|Delivered prior to procedure|1|||
125658284|NCT01777191|452035650|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
125658285|NCT01777191|452035651|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
125658286|NCT01777191|452035650|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
125658287|NCT01777191|452035651|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
125658288|NCT01777191|452035650|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
125658289|NCT01777191|452035651|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
125658290|NCT01777191|452035650|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
125317168|NCT01582061|450790503|FG001|Overall Study|Lost to Follow-up|0|||
125317169|NCT00231777|450790504|FG000|Overall Study|Lost to Follow-up|3|||
125658291|NCT01777191|452035651|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
125658292|NCT01777191|452035650|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
125658293|NCT01777191|452035651|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
125317170|NCT00231777|450790505|FG001|Overall Study|Lost to Follow-up|0|||
125317171|NCT00231777|450790504|FG000|Overall Study|Other|3|||
125317172|NCT00231777|450790505|FG001|Overall Study|Other|2|||
125317173|NCT04551989|450790508|FG000|Overall Study|Adverse Event|4|||
125317174|NCT04551989|450790508|FG000|Overall Study|Protocol Violation|3|||
125317175|NCT04551989|450790508|FG000|Overall Study|Lost to Follow-up|1|||
125317176|NCT04551989|450790508|FG000|Overall Study|Physician Decision|3|||
125317177|NCT04698343|450790509|FG000|Overall Study|Withdrawal by Subject|6|||
125317178|NCT04698343|450790509|FG000|Overall Study|Physician Decision|2|||
125317179|NCT04698343|450790509|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
125317180|NCT04698343|450790509|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
125317181|NCT04698343|450790509|FG000|Overall Study|Personal reasons|3|||
125317182|NCT04698343|450790509|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
125317183|NCT02756338|450790510|FG000|Overall Study|Withdrawn by Investigator|1|||
125317184|NCT02756338|450790510|FG000|Overall Study|Device Replaced with Pacemaker|4|||
125317185|NCT00088530|450790513|FG000|Overall Study|Progressive/Relapsed Disease|28|||
125317186|NCT00088530|450790514|FG001|Overall Study|Progressive/Relapsed Disease|39|||
125317187|NCT00088530|450790513|FG000|Overall Study|Adverse Event|15|||
125317188|NCT00088530|450790514|FG001|Overall Study|Adverse Event|9|||
125317189|NCT00088530|450790513|FG000|Overall Study|Withdrawal by Subject|2|||
125317190|NCT00088530|450790514|FG001|Overall Study|Withdrawal by Subject|5|||
125317191|NCT00088530|450790513|FG000|Overall Study|Lost to Follow-up|2|||
125317192|NCT00088530|450790514|FG001|Overall Study|Lost to Follow-up|0|||
125317193|NCT00088530|450790513|FG000|Overall Study|Physician Decision|2|||
125317194|NCT00088530|450790514|FG001|Overall Study|Physician Decision|0|||
125317195|NCT00088530|450790513|FG000|Overall Study|Sponsor decision|0|||
125317196|NCT00088530|450790514|FG001|Overall Study|Sponsor decision|1|||
125317197|NCT00088530|450790513|FG000|Overall Study|Patient never treated|1|||
125317198|NCT00088530|450790514|FG001|Overall Study|Patient never treated|0|||
125317199|NCT00300755|450790517|FG000|Overall Study|Adverse Event|1|||
125317200|NCT00300755|450790518|FG001|Overall Study|Adverse Event|2|||
125317201|NCT00300755|450790519|FG002|Overall Study|Adverse Event|1|||
125317202|NCT00300755|450790517|FG000|Overall Study|Withdrawal by Subject|0|||
125317203|NCT00300755|450790518|FG001|Overall Study|Withdrawal by Subject|2|||
125317204|NCT00300755|450790519|FG002|Overall Study|Withdrawal by Subject|0|||
125317205|NCT00300755|450790517|FG000|Overall Study|Protocol Violation|0|||
125317206|NCT00300755|450790518|FG001|Overall Study|Protocol Violation|0|||
125317207|NCT00300755|450790519|FG002|Overall Study|Protocol Violation|1|||
125317208|NCT02694744|450790523|FG000|Overall Study|Adverse Event|2|||
125317209|NCT02694744|450790524|FG001|Overall Study|Adverse Event|1|||
125317210|NCT02694744|450790523|FG000|Overall Study|Withdrawal by Subject|2|||
125317211|NCT02694744|450790524|FG001|Overall Study|Withdrawal by Subject|1|||
125317212|NCT02694744|450790523|FG000|Overall Study|Physician Decision|1|||
125317213|NCT02694744|450790524|FG001|Overall Study|Physician Decision|2|||
125317214|NCT02694744|450790523|FG000|Overall Study|Lost to Follow-up|1|||
125317215|NCT02694744|450790524|FG001|Overall Study|Lost to Follow-up|0|||
125317216|NCT02694744|450790523|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
125317217|NCT02694744|450790524|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
125317218|NCT00686777|450790525|FG000|Overall Study|Adverse Event|2|||
125317219|NCT00686777|450790525|FG000|Overall Study|Pregnancy|1|||
125317220|NCT00686777|450790525|FG000|Overall Study|Withdrawal by Subject|2|||
125317221|NCT00686777|450790525|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
125317222|NCT00686777|450790525|FG000|Overall Study|No Visit|1|||
125658294|NCT01777191|452035650|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
125658295|NCT01777191|452035651|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
125658296|NCT01777191|452035650|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
125658297|NCT01777191|452035651|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
125658298|NCT01777191|452035650|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
125658299|NCT01777191|452035651|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
125658300|NCT01777191|452035650|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
125658301|NCT01777191|452035651|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
125317223|NCT01945021|450790526|FG000|Overall Study|Adverse Event|1|||
125317224|NCT01945021|450790526|FG000|Overall Study|Withdrawal of consent|12|||
125317225|NCT01945021|450790526|FG000|Overall Study|Lost to Follow-up|5|||
125317226|NCT01945021|450790526|FG000|Overall Study|Death|65|||
125317227|NCT03582215|450790527|FG000|Overall Study|Adverse Event|1|||
125317228|NCT03582215|450790528|FG001|Overall Study|Adverse Event|0|||
125317229|NCT03582215|450790529|FG002|Overall Study|Adverse Event|0|||
125317230|NCT03582215|450790530|FG003|Overall Study|Adverse Event|0|||
125317231|NCT03582215|450790531|FG004|Overall Study|Adverse Event|0|||
125317232|NCT03582215|450790532|FG005|Overall Study|Adverse Event|0|||
125317233|NCT03582215|450790533|FG006|Overall Study|Adverse Event|2|||
125658302|NCT01777191|452035650|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
125658303|NCT01777191|452035651|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
125658304|NCT01777191|452035650|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
125658305|NCT01777191|452035651|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
125658306|NCT00388674|452035659|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
125658307|NCT00388674|452035660|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
125658308|NCT00388674|452035659|FG000|Initial Treatment|Adverse Event|22|||
125658309|NCT00388674|452035660|FG001|Initial Treatment|Adverse Event|87|||
125658310|NCT00388674|452035659|FG000|Initial Treatment|Death|215|||
125658311|NCT00388674|452035660|FG001|Initial Treatment|Death|216|||
125658312|NCT00388674|452035659|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
125658313|NCT00388674|452035660|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
125658314|NCT00388674|452035659|FG000|Initial Treatment|HCC|12|||
125658315|NCT00388674|452035660|FG001|Initial Treatment|HCC|20|||
125658316|NCT00388674|452035659|FG000|Initial Treatment|Lost to Follow-up|526|||
125658317|NCT00388674|452035660|FG001|Initial Treatment|Lost to Follow-up|624|||
125658318|NCT00388674|452035659|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
125658319|NCT00388674|452035660|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
125658320|NCT00388674|452035659|FG000|Initial Treatment|Never Treated with Study Medication|1|||
125658321|NCT00388674|452035660|FG001|Initial Treatment|Never Treated with Study Medication|7|||
125658322|NCT00388674|452035659|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
125658323|NCT00388674|452035660|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
125658324|NCT00388674|452035659|FG000|Initial Treatment|Not Defined|125|||
125658325|NCT00388674|452035660|FG001|Initial Treatment|Not Defined|172|||
125658326|NCT00388674|452035659|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
125658327|NCT00388674|452035660|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
125658328|NCT00388674|452035659|FG000|Initial Treatment|Pregnancy|26|||
125658329|NCT00388674|452035660|FG001|Initial Treatment|Pregnancy|16|||
125658330|NCT00388674|452035659|FG000|Initial Treatment|Study Drug Toxicity|5|||
125658331|NCT00388674|452035660|FG001|Initial Treatment|Study Drug Toxicity|92|||
125658332|NCT00388674|452035659|FG000|Initial Treatment|Participant Request|501|||
125658333|NCT00388674|452035660|FG001|Initial Treatment|Participant Request|673|||
125658334|NCT00388674|452035659|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
125658335|NCT00388674|452035660|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
125317234|NCT03582215|450790534|FG007|Overall Study|Adverse Event|2|||
125317235|NCT02163902|450790535|FG000|Overall Study|Subject's Request|3|||
125658336|NCT00388674|452035659|FG000|Initial Treatment|Not Reported|10|||
125658337|NCT00388674|452035660|FG001|Initial Treatment|Not Reported|12|||
125658338|NCT00388674|452035659|FG000|End of Study|Administrative Reason By Sponsor|299|||
125658339|NCT00388674|452035660|FG001|End of Study|Administrative Reason By Sponsor|253|||
125658340|NCT00388674|452035659|FG000|End of Study|Death|239|||
125658341|NCT00388674|452035660|FG001|End of Study|Death|262|||
125658342|NCT00388674|452035659|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
125658343|NCT00388674|452035660|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
125658344|NCT00388674|452035659|FG000|End of Study|HCC|8|||
125658345|NCT00388674|452035660|FG001|End of Study|HCC|7|||
125658346|NCT00388674|452035659|FG000|End of Study|Lost to Follow-up|587|||
125658347|NCT00388674|452035660|FG001|End of Study|Lost to Follow-up|715|||
125658348|NCT00388674|452035659|FG000|End of Study|Malignancy (Non-HCC)|1|||
125658349|NCT00388674|452035660|FG001|End of Study|Malignancy (Non-HCC)|1|||
125658350|NCT00388674|452035659|FG000|End of Study|Non-Study Related Comorbidities|3|||
125658351|NCT00388674|452035660|FG001|End of Study|Non-Study Related Comorbidities|4|||
125658352|NCT00388674|452035659|FG000|End of Study|Not Defined|135|||
125658353|NCT00388674|452035660|FG001|End of Study|Not Defined|214|||
125658354|NCT00388674|452035659|FG000|End of Study|Participant Withdrew Consent|437|||
125658355|NCT00388674|452035660|FG001|End of Study|Participant Withdrew Consent|673|||
125658356|NCT00388674|452035659|FG000|End of Study|No Off-Treatment Status Data|22|||
125658357|NCT00388674|452035660|FG001|End of Study|No Off-Treatment Status Data|30|||
125658358|NCT00388674|452035659|FG000|End of Study|Not Reported|0|||
125658359|NCT00388674|452035660|FG001|End of Study|Not Reported|1|||
125658360|NCT00759174|452035661|FG000|Overall Study|Other|0|||
125658361|NCT00759174|452035662|FG001|Overall Study|Other|2|||
125658362|NCT01890109|452035663|FG000|Overall Study|Withdrawal by Subject|0|||
125658363|NCT01890109|452035664|FG001|Overall Study|Withdrawal by Subject|3|||
125658364|NCT01890109|452035663|FG000|Overall Study|Lost to Follow-up|1|||
125658365|NCT01890109|452035664|FG001|Overall Study|Lost to Follow-up|2|||
125658366|NCT00568776|452035667|FG000|Overall Study|Adverse Event|8|||
125658367|NCT00568776|452035668|FG001|Overall Study|Adverse Event|8|||
125658368|NCT00568776|452035669|FG002|Overall Study|Adverse Event|10|||
125658369|NCT00568776|452035670|FG003|Overall Study|Adverse Event|8|||
125658370|NCT00568776|452035667|FG000|Overall Study|Death|0|||
125658371|NCT00568776|452035668|FG001|Overall Study|Death|1|||
125317236|NCT02163902|450790536|FG001|Overall Study|Subject's Request|4|||
125658372|NCT00568776|452035669|FG002|Overall Study|Death|4|||
125658373|NCT00568776|452035670|FG003|Overall Study|Death|3|||
125317237|NCT02163902|450790535|FG000|Overall Study|Lost to Follow-up|6|||
125317238|NCT02163902|450790536|FG001|Overall Study|Lost to Follow-up|7|||
125658374|NCT00568776|452035667|FG000|Overall Study|Physician Decision|0|||
125658375|NCT00568776|452035668|FG001|Overall Study|Physician Decision|2|||
125658376|NCT00568776|452035669|FG002|Overall Study|Physician Decision|0|||
125658377|NCT00568776|452035670|FG003|Overall Study|Physician Decision|0|||
125658378|NCT00568776|452035667|FG000|Overall Study|Lack of Efficacy|2|||
125658379|NCT00568776|452035668|FG001|Overall Study|Lack of Efficacy|2|||
125658380|NCT00568776|452035669|FG002|Overall Study|Lack of Efficacy|2|||
125658381|NCT00568776|452035670|FG003|Overall Study|Lack of Efficacy|4|||
125658382|NCT00568776|452035667|FG000|Overall Study|Lost to Follow-up|1|||
125658383|NCT00568776|452035668|FG001|Overall Study|Lost to Follow-up|1|||
125658384|NCT00568776|452035669|FG002|Overall Study|Lost to Follow-up|1|||
125658385|NCT00568776|452035670|FG003|Overall Study|Lost to Follow-up|1|||
125658386|NCT00568776|452035667|FG000|Overall Study|Protocol Violation|1|||
125658387|NCT00568776|452035668|FG001|Overall Study|Protocol Violation|0|||
125658388|NCT00568776|452035669|FG002|Overall Study|Protocol Violation|1|||
125658389|NCT00568776|452035670|FG003|Overall Study|Protocol Violation|1|||
125658390|NCT00568776|452035667|FG000|Overall Study|Withdrawal by Subject|13|||
125658391|NCT00568776|452035668|FG001|Overall Study|Withdrawal by Subject|15|||
125658392|NCT00568776|452035669|FG002|Overall Study|Withdrawal by Subject|13|||
125658393|NCT00568776|452035670|FG003|Overall Study|Withdrawal by Subject|7|||
125658394|NCT00568776|452035667|FG000|Overall Study|Loss of Caregiver|0|||
125658395|NCT00568776|452035668|FG001|Overall Study|Loss of Caregiver|2|||
125658396|NCT00568776|452035669|FG002|Overall Study|Loss of Caregiver|1|||
125658397|NCT00568776|452035670|FG003|Overall Study|Loss of Caregiver|2|||
125658398|NCT00568776|452035667|FG000|Overall Study|Sponsor Decision|2|||
125658399|NCT00568776|452035668|FG001|Overall Study|Sponsor Decision|2|||
125658400|NCT00568776|452035669|FG002|Overall Study|Sponsor Decision|41|||
125658401|NCT00568776|452035670|FG003|Overall Study|Sponsor Decision|42|||
125658402|NCT00568776|452035667|FG000|Overall Study|Miscellaeneous|3|||
125658403|NCT00568776|452035668|FG001|Overall Study|Miscellaeneous|3|||
125658404|NCT00568776|452035669|FG002|Overall Study|Miscellaeneous|1|||
125658405|NCT00568776|452035670|FG003|Overall Study|Miscellaeneous|4|||
125658406|NCT00996632|452035671|FG000|Overall Study|Physician Decision|0|||
125658407|NCT00996632|452035672|FG001|Overall Study|Physician Decision|0|||
125658408|NCT02861534|452035675|FG000|Overall Study|Death|541|||
125658409|NCT02861534|452035676|FG001|Overall Study|Death|552|||
125658410|NCT02861534|452035675|FG000|Overall Study|Lost to Follow-up|14|||
125658411|NCT02861534|452035676|FG001|Overall Study|Lost to Follow-up|14|||
125658412|NCT02861534|452035675|FG000|Overall Study|Site Terminated by Sponsor|4|||
125317239|NCT02163902|450790535|FG000|Overall Study|Administrative Decision|2|||
125317240|NCT02163902|450790536|FG001|Overall Study|Administrative Decision|2|||
125317241|NCT03119259|450790537|FG000|Overall Study|Withdrawn as no longer eligible|1|||
125317242|NCT03119259|450790538|FG001|Overall Study|Withdrawn as no longer eligible|0|||
125317243|NCT03119259|450790537|FG000|Overall Study|Withdrawal by Subject|4|||
125317244|NCT03119259|450790538|FG001|Overall Study|Withdrawal by Subject|2|||
125317245|NCT03119259|450790537|FG000|Overall Study|Lost to Follow-up|0|||
125317246|NCT03119259|450790538|FG001|Overall Study|Lost to Follow-up|1|||
125317247|NCT02903160|450790541|FG000|Overall Study|Adverse Event|2|||
125317248|NCT02903160|450790541|FG000|Overall Study|Death|1|||
125317249|NCT02903160|450790541|FG000|Overall Study|Lost to Follow-up|2|||
125658413|NCT02861534|452035676|FG001|Overall Study|Site Terminated by Sponsor|3|||
125658414|NCT02861534|452035675|FG000|Overall Study|Withdrawal by Subject|15|||
125658415|NCT02861534|452035676|FG001|Overall Study|Withdrawal by Subject|18|||
125658416|NCT02780115|452035677|FG000|Overall Study|Withdrawal by Subject|0|||
125658417|NCT02780115|452035678|FG001|Overall Study|Withdrawal by Subject|1|||
125658418|NCT02780115|452035679|FG002|Overall Study|Withdrawal by Subject|1|||
125658419|NCT02780115|452035680|FG003|Overall Study|Withdrawal by Subject|0|||
125658420|NCT02780115|452035681|FG004|Overall Study|Withdrawal by Subject|0|||
125658421|NCT02780115|452035677|FG000|Overall Study|Adverse Event|0|||
125658422|NCT02780115|452035678|FG001|Overall Study|Adverse Event|0|||
125658423|NCT02780115|452035679|FG002|Overall Study|Adverse Event|0|||
125658424|NCT02780115|452035680|FG003|Overall Study|Adverse Event|1|||
125658425|NCT02780115|452035681|FG004|Overall Study|Adverse Event|1|||
125317250|NCT02903160|450790541|FG000|Overall Study|Withdrawal by Subject|1|||
125658426|NCT01179191|452035682|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
125658427|NCT01179191|452035682|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
125658428|NCT01179191|452035682|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
125658429|NCT01179191|452035682|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
125317251|NCT02903160|450790541|FG000|Overall Study|Medical Insurance Barriers|1|||
125317252|NCT01664910|450790544|FG000|Overall Study|Adverse Event|0|||
125317253|NCT01664910|450790545|FG001|Overall Study|Adverse Event|0|||
125317254|NCT01664910|450790546|FG002|Overall Study|Adverse Event|1|||
125658430|NCT01179191|452035682|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
125658431|NCT01179191|452035682|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
125658432|NCT01179191|452035682|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
125658433|NCT01179191|452035682|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
125658434|NCT01179191|452035682|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
125658435|NCT01179191|452035682|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
125658436|NCT01179191|452035682|FG000|Maintenance Phase (8 Weeks)|Other|66|||
125658437|NCT00916617|452035683|FG000|Overall Study|Adverse Event|3|||
125658438|NCT00916617|452035684|FG001|Overall Study|Adverse Event|2|||
125658439|NCT00916617|452035685|FG002|Overall Study|Adverse Event|6|||
125658440|NCT00916617|452035686|FG003|Overall Study|Adverse Event|3|||
125658441|NCT00916617|452035683|FG000|Overall Study|Withdrawal by Subject|3|||
125658442|NCT00916617|452035684|FG001|Overall Study|Withdrawal by Subject|2|||
125658443|NCT00916617|452035685|FG002|Overall Study|Withdrawal by Subject|0|||
125658444|NCT00916617|452035686|FG003|Overall Study|Withdrawal by Subject|1|||
125658445|NCT00916617|452035683|FG000|Overall Study|Caregiver Request|3|||
125658446|NCT00916617|452035684|FG001|Overall Study|Caregiver Request|2|||
125658447|NCT00916617|452035685|FG002|Overall Study|Caregiver Request|1|||
125658448|NCT00916617|452035686|FG003|Overall Study|Caregiver Request|0|||
125658449|NCT00916617|452035683|FG000|Overall Study|Physician Decision|1|||
125658450|NCT00916617|452035684|FG001|Overall Study|Physician Decision|1|||
125658451|NCT00916617|452035685|FG002|Overall Study|Physician Decision|0|||
125658452|NCT00916617|452035686|FG003|Overall Study|Physician Decision|0|||
125658453|NCT00916617|452035683|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
125658454|NCT00916617|452035684|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
125658455|NCT00916617|452035685|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
125658456|NCT00916617|452035686|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
125658457|NCT00916617|452035683|FG000|Overall Study|Lost to Follow-up|2|||
125658458|NCT00916617|452035684|FG001|Overall Study|Lost to Follow-up|1|||
125658459|NCT00916617|452035685|FG002|Overall Study|Lost to Follow-up|0|||
125658460|NCT00916617|452035686|FG003|Overall Study|Lost to Follow-up|0|||
125658461|NCT00916617|452035683|FG000|Overall Study|Lack of Efficacy|1|||
125658462|NCT00916617|452035684|FG001|Overall Study|Lack of Efficacy|0|||
125658463|NCT00916617|452035685|FG002|Overall Study|Lack of Efficacy|0|||
125658464|NCT00916617|452035686|FG003|Overall Study|Lack of Efficacy|0|||
125658465|NCT00916617|452035683|FG000|Overall Study|Other|2|||
125658466|NCT00916617|452035684|FG001|Overall Study|Other|0|||
125658467|NCT00916617|452035685|FG002|Overall Study|Other|0|||
125658468|NCT00916617|452035686|FG003|Overall Study|Other|2|||
125658469|NCT01988337|452035689|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
125658470|NCT00556166|452035697|FG000|Overall Study|Withdrawal by Subject|1|||
125658471|NCT01612780|452035698|FG000|Overall Study|Treatment not completed|1|||
125658472|NCT01612780|452035698|FG000|Overall Study|Withdrawal by Subject|5|||
125658473|NCT03466060|452035699|FG000|Period 1|Test Lens Damage|0|||
125658474|NCT03466060|452035700|FG001|Period 1|Test Lens Damage|2|||
125658475|NCT03466060|452035701|FG002|Period 1|Test Lens Damage|0|||
125658476|NCT03466060|452035702|FG003|Period 1|Test Lens Damage|0|||
125658477|NCT03466060|452035703|FG004|Period 1|Test Lens Damage|0|||
125658478|NCT03466060|452035704|FG005|Period 1|Test Lens Damage|0|||
125658479|NCT03466060|452035699|FG000|Period 1|Withdrawal by Subject|0|||
125658480|NCT03466060|452035700|FG001|Period 1|Withdrawal by Subject|0|||
125658481|NCT03466060|452035701|FG002|Period 1|Withdrawal by Subject|2|||
125658482|NCT03466060|452035702|FG003|Period 1|Withdrawal by Subject|0|||
125658483|NCT03466060|452035703|FG004|Period 1|Withdrawal by Subject|0|||
125658484|NCT03466060|452035704|FG005|Period 1|Withdrawal by Subject|0|||
125658485|NCT03466060|452035699|FG000|Period 1|Lost to Follow-up|0|||
125658486|NCT03466060|452035700|FG001|Period 1|Lost to Follow-up|0|||
125658487|NCT03466060|452035701|FG002|Period 1|Lost to Follow-up|0|||
125658488|NCT03466060|452035702|FG003|Period 1|Lost to Follow-up|1|||
125658489|NCT03466060|452035703|FG004|Period 1|Lost to Follow-up|0|||
125658490|NCT03466060|452035704|FG005|Period 1|Lost to Follow-up|0|||
125658491|NCT03466060|452035699|FG000|Period 1|Grade 2 Conjunctivitis|0|||
125658492|NCT03466060|452035700|FG001|Period 1|Grade 2 Conjunctivitis|0|||
125658493|NCT03466060|452035701|FG002|Period 1|Grade 2 Conjunctivitis|1|||
125658494|NCT03466060|452035702|FG003|Period 1|Grade 2 Conjunctivitis|0|||
125658495|NCT03466060|452035703|FG004|Period 1|Grade 2 Conjunctivitis|0|||
125658496|NCT03466060|452035704|FG005|Period 1|Grade 2 Conjunctivitis|0|||
125658497|NCT03466060|452035699|FG000|Period 2|Lens Handling Difficulties|0|||
125658498|NCT03466060|452035700|FG001|Period 2|Lens Handling Difficulties|0|||
125658499|NCT03466060|452035701|FG002|Period 2|Lens Handling Difficulties|1|||
125658500|NCT03466060|452035702|FG003|Period 2|Lens Handling Difficulties|0|||
125658501|NCT03466060|452035703|FG004|Period 2|Lens Handling Difficulties|0|||
125658502|NCT03466060|452035704|FG005|Period 2|Lens Handling Difficulties|0|||
125658503|NCT02985515|452035707|FG000|Olfaction Testing|Lost to Follow-up|0|||
125658504|NCT02985515|452035708|FG001|Olfaction Testing|Lost to Follow-up|5|||
125658505|NCT02985515|452035707|FG000|Olfaction Testing|Protocol Violation|0|||
125658506|NCT02985515|452035708|FG001|Olfaction Testing|Protocol Violation|3|||
125658507|NCT03972709|452035714|FG000|Overall Study|Withdrawal by Subject|18|||
125658508|NCT03972709|452035715|FG001|Overall Study|Withdrawal by Subject|7|||
125658509|NCT03972709|452035716|FG002|Overall Study|Withdrawal by Subject|14|||
125658510|NCT03972709|452035714|FG000|Overall Study|Study Terminated by Sponsor|48|||
125658511|NCT03972709|452035715|FG001|Overall Study|Study Terminated by Sponsor|25|||
125658512|NCT03972709|452035716|FG002|Overall Study|Study Terminated by Sponsor|50|||
125658513|NCT03972709|452035714|FG000|Overall Study|Physician Decision|1|||
125658514|NCT03972709|452035715|FG001|Overall Study|Physician Decision|0|||
125317255|NCT00730158|450790550|FG000|Overall Study|Withdrawal by Subject|1|||
125317256|NCT00730158|450790551|FG001|Overall Study|Withdrawal by Subject|1|||
125317257|NCT04678115|450790552|FG000|Overall Study|Lost to Follow-up|1|||
125317258|NCT04678115|450790553|FG001|Overall Study|Lost to Follow-up|0|||
125317259|NCT01168349|450790554|FG000|Overall Study|Death|157|||
125317260|NCT01168349|450790554|FG000|Overall Study|Lost to Follow-up|34|||
125317261|NCT01168349|450790554|FG000|Overall Study|Withdrawal by Subject|9|||
125317262|NCT01168349|450790554|FG000|Overall Study|Kidney transplantation|3|||
125317263|NCT01168349|450790554|FG000|Overall Study|Other|22|||
125317264|NCT01168349|450790554|FG000|Overall Study|Protocol Violation|76|||
125317265|NCT04059549|450790555|FG000|Overall Study|Withdrawal by Subject|2|||
125317266|NCT04059549|450790556|FG001|Overall Study|Withdrawal by Subject|0|||
125317267|NCT00988884|450790558|FG000|Overall Study|Adverse Event|0|||
125317268|NCT00988884|450790559|FG001|Overall Study|Adverse Event|1|||
125317269|NCT00988884|450790558|FG000|Overall Study|Lost to Follow-up|20|||
125317270|NCT00988884|450790559|FG001|Overall Study|Lost to Follow-up|16|||
125317271|NCT00988884|450790558|FG000|Overall Study|Protocol Violation|0|||
125317272|NCT00988884|450790559|FG001|Overall Study|Protocol Violation|1|||
125317273|NCT00988884|450790558|FG000|Overall Study|Withdrawal by Subject|15|||
125317274|NCT00988884|450790559|FG001|Overall Study|Withdrawal by Subject|18|||
125317275|NCT01632020|450790560|FG000|Overall Study|Withdrawal by Subject|1|||
125317276|NCT01632020|450790561|FG001|Overall Study|Withdrawal by Subject|0|||
125658515|NCT03972709|452035716|FG002|Overall Study|Physician Decision|0|||
125658516|NCT03972709|452035714|FG000|Overall Study|COVID-19|0|||
125658517|NCT03972709|452035715|FG001|Overall Study|COVID-19|1|||
125658518|NCT03972709|452035716|FG002|Overall Study|COVID-19|1|||
125658519|NCT03972709|452035714|FG000|Overall Study|Lost to Follow-up|6|||
125658520|NCT03972709|452035715|FG001|Overall Study|Lost to Follow-up|1|||
125658521|NCT03972709|452035716|FG002|Overall Study|Lost to Follow-up|2|||
125658522|NCT03972709|452035714|FG000|Overall Study|Death|5|||
125658523|NCT03972709|452035715|FG001|Overall Study|Death|1|||
125658524|NCT03972709|452035716|FG002|Overall Study|Death|4|||
125658525|NCT03972709|452035714|FG000|Overall Study|Adverse Event|3|||
125658526|NCT03972709|452035715|FG001|Overall Study|Adverse Event|1|||
125658527|NCT03972709|452035716|FG002|Overall Study|Adverse Event|4|||
125658528|NCT03972709|452035714|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
125658529|NCT03972709|452035715|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
125658530|NCT03972709|452035716|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
125658531|NCT03972709|452035714|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
125658532|NCT03972709|452035715|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
125658533|NCT03972709|452035716|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
125658534|NCT03972709|452035714|FG000|Overall Study|Subject Unable to be Contacted|0|||
125658535|NCT03972709|452035715|FG001|Overall Study|Subject Unable to be Contacted|1|||
125658536|NCT03972709|452035716|FG002|Overall Study|Subject Unable to be Contacted|0|||
125658537|NCT03972709|452035714|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
125658538|NCT03972709|452035715|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
125658539|NCT03972709|452035716|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
125658540|NCT03972709|452035714|FG000|Overall Study|Subject Moved|0|||
125658541|NCT03972709|452035715|FG001|Overall Study|Subject Moved|1|||
125658542|NCT03972709|452035716|FG002|Overall Study|Subject Moved|0|||
125540487|NCT01011153|451607653|FG002|Overall Study|Less than 78 cases completed|9|||
125540488|NCT03014479|451607654|FG000|Overall Study|Adverse Event|0|||
125540489|NCT03014479|451607655|FG001|Overall Study|Adverse Event|1|||
125540490|NCT03014479|451607654|FG000|Overall Study|Voluntary Withdrawal|0|||
125540491|NCT03014479|451607655|FG001|Overall Study|Voluntary Withdrawal|2|||
125540492|NCT03014479|451607654|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
125540493|NCT03014479|451607655|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
125658543|NCT03972709|452035714|FG000|Overall Study|Missed Study Visits|1|||
125658544|NCT03972709|452035715|FG001|Overall Study|Missed Study Visits|0|||
125658545|NCT03972709|452035716|FG002|Overall Study|Missed Study Visits|0|||
125658546|NCT01339000|452035719|FG000|Overall Study|study closed due to lack of drug supply|1|||
125658547|NCT01339000|452035720|FG001|Overall Study|study closed due to lack of drug supply|0|||
125658548|NCT00938015|452035722|FG000|Overall Study|Death|2|||
125658549|NCT00938015|452035722|FG000|Overall Study|Lost to Follow-up|32|||
125658550|NCT00938015|452035722|FG000|Overall Study|Adverse Event|32|||
125317277|NCT01632020|450790560|FG000|Overall Study|Adverse Event|1|||
125540494|NCT02217501|451607664|FG000|Overall Study|Death|3|||
125540495|NCT02217501|451607665|FG001|Overall Study|Death|4|||
125658551|NCT00938015|452035722|FG000|Overall Study|Non-responder|52|||
125317278|NCT01632020|450790561|FG001|Overall Study|Adverse Event|0|||
125317279|NCT01362348|450790563|FG000|Overall Study|Protocol-defined stopping criteria|9|||
125317280|NCT01362348|450790563|FG000|Overall Study|Study closed/terminated|5|||
125317281|NCT00647296|450790566|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
125317282|NCT00647296|450790567|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
125317283|NCT00647296|450790568|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
125317284|NCT00647296|450790569|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
125658552|NCT00938015|452035722|FG000|Overall Study|Reason not related to Etanercept|29|||
125658553|NCT02341482|452035723|FG000|Overall Study|Adverse Event|1|||
125317285|NCT00647296|450790566|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
125317286|NCT00647296|450790567|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
125317287|NCT00647296|450790568|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
125658554|NCT00834366|452035726|FG000|Treatment Period 1|Adverse Event|1|||
125658555|NCT00834366|452035727|FG001|Treatment Period 1|Adverse Event|1|||
125658556|NCT00090259|452035728|FG000|Overall Study|Lost to Follow-up|30|||
125658557|NCT00090259|452035729|FG001|Overall Study|Lost to Follow-up|26|||
125317288|NCT00647296|450790569|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
125317289|NCT00647296|450790566|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
125317290|NCT00647296|450790567|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
125317291|NCT00647296|450790568|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
125317292|NCT00647296|450790569|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
125317293|NCT00647296|450790566|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
125317294|NCT00647296|450790567|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
125658558|NCT00090259|452035728|FG000|Overall Study|Withdrawal by Subject|21|||
125658559|NCT00090259|452035729|FG001|Overall Study|Withdrawal by Subject|15|||
125658560|NCT00090259|452035728|FG000|Overall Study|Investigator site closed|11|||
125658561|NCT00090259|452035729|FG001|Overall Study|Investigator site closed|7|||
125658562|NCT00960687|452035732|FG000|Washout Period of 7 Days|Adverse Event|3|||
125658563|NCT00960687|452035733|FG001|Washout Period of 7 Days|Adverse Event|2|||
125658564|NCT00960687|452035732|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
125658565|NCT00960687|452035733|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125317295|NCT00647296|450790568|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
125317296|NCT00647296|450790569|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
125317297|NCT00647296|450790566|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
125317298|NCT00647296|450790567|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
125317299|NCT00647296|450790568|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
125317300|NCT00647296|450790569|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
125658566|NCT00285012|452035734|FG000|Assigned to Study Treatment (Tx)|Other|2|||
125658567|NCT00285012|452035735|FG001|Assigned to Study Treatment (Tx)|Other|3|||
125658568|NCT00285012|452035734|FG000|Received Study Tx|Death|2|||
125658569|NCT00285012|452035735|FG001|Received Study Tx|Death|1|||
125658570|NCT00285012|452035734|FG000|Received Study Tx|Adverse Event|5|||
125658571|NCT00285012|452035735|FG001|Received Study Tx|Adverse Event|11|||
125658572|NCT00285012|452035734|FG000|Received Study Tx|Lack of Efficacy|0|||
125658573|NCT00285012|452035735|FG001|Received Study Tx|Lack of Efficacy|3|||
125658574|NCT00285012|452035734|FG000|Received Study Tx|Lost to Follow-up|29|||
125658575|NCT00285012|452035735|FG001|Received Study Tx|Lost to Follow-up|31|||
125658576|NCT00285012|452035734|FG000|Received Study Tx|Withdrawal by Subject|31|||
125658577|NCT00285012|452035735|FG001|Received Study Tx|Withdrawal by Subject|43|||
125658578|NCT00285012|452035734|FG000|Received Study Tx|Other|5|||
125658579|NCT00285012|452035735|FG001|Received Study Tx|Other|5|||
125658580|NCT02873195|452035736|FG000|Overall Study|Ineligible|5|||
125658581|NCT02873195|452035737|FG001|Overall Study|Ineligible|0|||
125658582|NCT05004181|452035738|FG000|Overall Study|Withdrawal of consent|0|||
125658583|NCT05004181|452035739|FG001|Overall Study|Withdrawal of consent|0|||
125658584|NCT05004181|452035740|FG002|Overall Study|Withdrawal of consent|1|||
125658585|NCT05004181|452035741|FG003|Overall Study|Withdrawal of consent|3|||
125658586|NCT05004181|452035742|FG004|Overall Study|Withdrawal of consent|3|||
125658587|NCT05004181|452035743|FG005|Overall Study|Withdrawal of consent|0|||
125658588|NCT05004181|452035744|FG006|Overall Study|Withdrawal of consent|30|||
125658589|NCT05004181|452035745|FG007|Overall Study|Withdrawal of consent|9|||
125658590|NCT05004181|452035746|FG008|Overall Study|Withdrawal of consent|3|||
125658591|NCT05004181|452035747|FG009|Overall Study|Withdrawal of consent|2|||
125658592|NCT05004181|452035748|FG010|Overall Study|Withdrawal of consent|5|||
125658593|NCT05004181|452035749|FG011|Overall Study|Withdrawal of consent|1|||
125658594|NCT05004181|452035738|FG000|Overall Study|Lost to Follow-up|2|||
125658595|NCT05004181|452035739|FG001|Overall Study|Lost to Follow-up|4|||
125317301|NCT00647296|450790566|FG000|Part 2: 4-week Placebo Washout|Death|3|||
125317302|NCT00647296|450790567|FG001|Part 2: 4-week Placebo Washout|Death|0|||
125658596|NCT05004181|452035740|FG002|Overall Study|Lost to Follow-up|2|||
125658597|NCT05004181|452035741|FG003|Overall Study|Lost to Follow-up|3|||
125658598|NCT05004181|452035742|FG004|Overall Study|Lost to Follow-up|5|||
125658599|NCT05004181|452035743|FG005|Overall Study|Lost to Follow-up|2|||
125658600|NCT05004181|452035744|FG006|Overall Study|Lost to Follow-up|15|||
125317303|NCT00647296|450790568|FG002|Part 2: 4-week Placebo Washout|Death|0|||
125317304|NCT00647296|450790569|FG003|Part 2: 4-week Placebo Washout|Death|0|||
125658601|NCT05004181|452035745|FG007|Overall Study|Lost to Follow-up|12|||
125658602|NCT05004181|452035746|FG008|Overall Study|Lost to Follow-up|38|||
125317305|NCT00647296|450790566|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
125658603|NCT05004181|452035747|FG009|Overall Study|Lost to Follow-up|6|||
125658604|NCT05004181|452035748|FG010|Overall Study|Lost to Follow-up|6|||
125658605|NCT05004181|452035749|FG011|Overall Study|Lost to Follow-up|0|||
125658606|NCT05004181|452035738|FG000|Overall Study|Death|0|||
125658607|NCT05004181|452035739|FG001|Overall Study|Death|0|||
125658608|NCT05004181|452035740|FG002|Overall Study|Death|0|||
125658609|NCT05004181|452035741|FG003|Overall Study|Death|0|||
125658610|NCT05004181|452035742|FG004|Overall Study|Death|0|||
125658611|NCT05004181|452035743|FG005|Overall Study|Death|0|||
125658612|NCT05004181|452035744|FG006|Overall Study|Death|1|||
125658613|NCT05004181|452035745|FG007|Overall Study|Death|0|||
125658614|NCT05004181|452035746|FG008|Overall Study|Death|2|||
125658615|NCT05004181|452035747|FG009|Overall Study|Death|0|||
125658616|NCT05004181|452035748|FG010|Overall Study|Death|0|||
125658617|NCT05004181|452035749|FG011|Overall Study|Death|0|||
125658618|NCT05004181|452035738|FG000|Overall Study|Physician Decision|0|||
125658619|NCT05004181|452035739|FG001|Overall Study|Physician Decision|0|||
125658620|NCT05004181|452035740|FG002|Overall Study|Physician Decision|0|||
125658621|NCT05004181|452035741|FG003|Overall Study|Physician Decision|0|||
125658622|NCT05004181|452035742|FG004|Overall Study|Physician Decision|0|||
125658623|NCT05004181|452035743|FG005|Overall Study|Physician Decision|0|||
125658624|NCT05004181|452035744|FG006|Overall Study|Physician Decision|2|||
125658625|NCT05004181|452035745|FG007|Overall Study|Physician Decision|0|||
125658626|NCT05004181|452035746|FG008|Overall Study|Physician Decision|7|||
125658627|NCT05004181|452035747|FG009|Overall Study|Physician Decision|0|||
125658628|NCT05004181|452035748|FG010|Overall Study|Physician Decision|0|||
125658629|NCT05004181|452035749|FG011|Overall Study|Physician Decision|0|||
125658630|NCT05004181|452035738|FG000|Overall Study|Withdrawal by Subject|2|||
125658631|NCT05004181|452035739|FG001|Overall Study|Withdrawal by Subject|3|||
125658632|NCT05004181|452035740|FG002|Overall Study|Withdrawal by Subject|2|||
125658633|NCT05004181|452035741|FG003|Overall Study|Withdrawal by Subject|2|||
125658634|NCT05004181|452035742|FG004|Overall Study|Withdrawal by Subject|4|||
125658635|NCT05004181|452035743|FG005|Overall Study|Withdrawal by Subject|2|||
125658636|NCT05004181|452035744|FG006|Overall Study|Withdrawal by Subject|4|||
125658637|NCT05004181|452035745|FG007|Overall Study|Withdrawal by Subject|22|||
125658638|NCT05004181|452035746|FG008|Overall Study|Withdrawal by Subject|8|||
125658639|NCT05004181|452035747|FG009|Overall Study|Withdrawal by Subject|1|||
125658640|NCT05004181|452035748|FG010|Overall Study|Withdrawal by Subject|3|||
125658641|NCT05004181|452035749|FG011|Overall Study|Withdrawal by Subject|2|||
125658642|NCT05004181|452035738|FG000|Overall Study|Protocol Violation|2|||
125658643|NCT05004181|452035739|FG001|Overall Study|Protocol Violation|3|||
125658644|NCT05004181|452035740|FG002|Overall Study|Protocol Violation|0|||
125658645|NCT05004181|452035741|FG003|Overall Study|Protocol Violation|0|||
125658646|NCT05004181|452035742|FG004|Overall Study|Protocol Violation|1|||
125658647|NCT05004181|452035743|FG005|Overall Study|Protocol Violation|0|||
125658648|NCT05004181|452035744|FG006|Overall Study|Protocol Violation|16|||
125658649|NCT05004181|452035745|FG007|Overall Study|Protocol Violation|18|||
125658650|NCT05004181|452035746|FG008|Overall Study|Protocol Violation|2|||
125658651|NCT05004181|452035747|FG009|Overall Study|Protocol Violation|2|||
125658652|NCT05004181|452035748|FG010|Overall Study|Protocol Violation|2|||
125658653|NCT05004181|452035749|FG011|Overall Study|Protocol Violation|1|||
125658654|NCT05004181|452035738|FG000|Overall Study|Not further specified|1|||
125658655|NCT05004181|452035739|FG001|Overall Study|Not further specified|0|||
125658656|NCT05004181|452035740|FG002|Overall Study|Not further specified|0|||
125658657|NCT05004181|452035741|FG003|Overall Study|Not further specified|0|||
125658658|NCT05004181|452035742|FG004|Overall Study|Not further specified|0|||
125658659|NCT05004181|452035743|FG005|Overall Study|Not further specified|0|||
125658660|NCT05004181|452035744|FG006|Overall Study|Not further specified|1|||
125658661|NCT05004181|452035745|FG007|Overall Study|Not further specified|0|||
125658662|NCT05004181|452035746|FG008|Overall Study|Not further specified|2|||
125658663|NCT05004181|452035747|FG009|Overall Study|Not further specified|1|||
125658664|NCT05004181|452035748|FG010|Overall Study|Not further specified|0|||
125658665|NCT05004181|452035749|FG011|Overall Study|Not further specified|1|||
125658666|NCT04278872|452035750|FG000|Overall Study|Adverse Event|1|||
125658667|NCT04278872|452035751|FG001|Overall Study|Adverse Event|0|||
125658668|NCT04278872|452035750|FG000|Overall Study|Protocol Violation|0|||
125658669|NCT04278872|452035751|FG001|Overall Study|Protocol Violation|1|||
125658670|NCT04278872|452035750|FG000|Overall Study|Study Termination|2|||
125658671|NCT04278872|452035751|FG001|Overall Study|Study Termination|0|||
125658672|NCT00633217|452035752|FG000|Overall Study|Adverse Event|5|||
125658673|NCT00633217|452035753|FG001|Overall Study|Adverse Event|9|||
125658674|NCT00633217|452035752|FG000|Overall Study|Lack of Efficacy|0|||
125658675|NCT00633217|452035753|FG001|Overall Study|Lack of Efficacy|2|||
125658676|NCT00633217|452035752|FG000|Overall Study|Protocol Violation|3|||
125658677|NCT00633217|452035753|FG001|Overall Study|Protocol Violation|7|||
125658678|NCT00633217|452035752|FG000|Overall Study|Lost to Follow-up|2|||
125658679|NCT00633217|452035753|FG001|Overall Study|Lost to Follow-up|2|||
125658680|NCT00633217|452035752|FG000|Overall Study|Investigator Discretion|2|||
125658681|NCT00633217|452035753|FG001|Overall Study|Investigator Discretion|0|||
125658682|NCT00633217|452035752|FG000|Overall Study|Withdrew Consent|3|||
125658683|NCT00633217|452035753|FG001|Overall Study|Withdrew Consent|3|||
125658684|NCT00096031|452035754|FG000|Overall Study|Adverse Event|3|||
125658685|NCT00096031|452035754|FG000|Overall Study|Lack of Efficacy|42|||
125658686|NCT00096031|452035754|FG000|Overall Study|Death|4|||
125658687|NCT00096031|452035754|FG000|Overall Study|Withdrawal by Subject|1|||
125658688|NCT00096031|452035754|FG000|Overall Study|Ineligible|8|||
125658689|NCT00096031|452035754|FG000|Overall Study|Not protocol specified|5|||
125658690|NCT05257109|452035755|FG000|Overall Study|Withdrawal by Subject|1|||
125658691|NCT05257109|452035756|FG001|Overall Study|Withdrawal by Subject|0|||
125658692|NCT05257109|452035757|FG002|Overall Study|Withdrawal by Subject|0|||
125658693|NCT05257109|452035758|FG003|Overall Study|Withdrawal by Subject|0|||
125658694|NCT03993288|452037462|FG000|Overall Study|Lost to Follow-up|2|||
125658695|NCT03993288|452037463|FG001|Overall Study|Lost to Follow-up|1|||
125658696|NCT03993288|452037462|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
125658697|NCT03993288|452037463|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
125658698|NCT03993288|452037462|FG000|Overall Study|wrong randomization|0|||
125658699|NCT03993288|452037463|FG001|Overall Study|wrong randomization|1|||
125658700|NCT03993288|452037462|FG000|Overall Study|improper enrollment|0|||
125658701|NCT03993288|452037463|FG001|Overall Study|improper enrollment|1|||
125658702|NCT03993288|452037462|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
125658703|NCT03993288|452037463|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
125658704|NCT03993288|452037462|FG000|Overall Study|developed SAE|2|||
125658705|NCT03993288|452037463|FG001|Overall Study|developed SAE|0|||
125658706|NCT03993288|452037462|FG000|Overall Study|consent withdrawal|1|||
125658707|NCT03993288|452037463|FG001|Overall Study|consent withdrawal|0|||
125658708|NCT03993288|452037462|FG000|Overall Study|did not follow the treatment schedule|1|||
125658709|NCT03993288|452037463|FG001|Overall Study|did not follow the treatment schedule|0|||
125658710|NCT03993288|452037462|FG000|Overall Study|did not follow the treatment regimen|1|||
125658711|NCT03993288|452037463|FG001|Overall Study|did not follow the treatment regimen|0|||
125658712|NCT03993288|452037462|FG000|Overall Study|Adverse Event|1|||
125658713|NCT03993288|452037463|FG001|Overall Study|Adverse Event|0|||
125658714|NCT03993288|452037462|FG000|Overall Study|Withdrawal by Subject|1|||
125658715|NCT03993288|452037463|FG001|Overall Study|Withdrawal by Subject|1|||
125658716|NCT00915473|452037464|FG000|Screening|Withdrawal by Subject|1|||
125658717|NCT00915473|452037465|FG001|Screening|Withdrawal by Subject|0|||
125658718|NCT00915473|452037464|FG000|4-week Follow Up|Lost to Follow-up|1|||
125658719|NCT00915473|452037465|FG001|4-week Follow Up|Lost to Follow-up|5|||
125658720|NCT01389024|452037466|FG000|Overall Study|Withdrawal by Subject|0|||
125658721|NCT01389024|452037467|FG001|Overall Study|Withdrawal by Subject|1|||
125658722|NCT01389024|452037466|FG000|Overall Study|Lost to Follow-up|1|||
125658723|NCT01389024|452037467|FG001|Overall Study|Lost to Follow-up|0|||
125658724|NCT00819091|452037468|FG000|Overall Study|Adverse Event|3|||
125658725|NCT00819091|452037469|FG001|Overall Study|Adverse Event|5|||
125658726|NCT00819091|452037468|FG000|Overall Study|Protocol Violation|0|||
125658727|NCT00819091|452037469|FG001|Overall Study|Protocol Violation|1|||
125658728|NCT00819091|452037468|FG000|Overall Study|Lost to Follow-up|2|||
125658729|NCT00819091|452037469|FG001|Overall Study|Lost to Follow-up|0|||
125317306|NCT00647296|450790567|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
125317307|NCT00647296|450790568|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
125317308|NCT00647296|450790569|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
125317309|NCT00647296|450790566|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
125317310|NCT00647296|450790567|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
125317311|NCT00647296|450790568|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
125317312|NCT00647296|450790569|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
125317313|NCT00647296|450790566|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
125317314|NCT00647296|450790567|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
125317315|NCT00647296|450790568|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
125317316|NCT00647296|450790569|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
125317317|NCT00647296|450790566|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
125317318|NCT00647296|450790567|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
125317319|NCT00647296|450790568|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
125658730|NCT00819091|452037468|FG000|Overall Study|Withdrawal by Subject|1|||
125658731|NCT00819091|452037469|FG001|Overall Study|Withdrawal by Subject|2|||
125658732|NCT00819091|452037468|FG000|Overall Study|Other|1|||
125658733|NCT00819091|452037469|FG001|Overall Study|Other|2|||
125658734|NCT01461369|452037472|FG000|Overall Study|Lack of Efficacy|2|||
125658735|NCT01461369|452037473|FG001|Overall Study|Lack of Efficacy|0|||
125658736|NCT01461369|452037474|FG002|Overall Study|Lack of Efficacy|6|||
125658737|NCT01461369|452037472|FG000|Overall Study|Lost to Follow-up|0|||
125317320|NCT00647296|450790569|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
125658738|NCT01461369|452037473|FG001|Overall Study|Lost to Follow-up|0|||
125658739|NCT01461369|452037474|FG002|Overall Study|Lost to Follow-up|3|||
125658740|NCT01461369|452037472|FG000|Overall Study|Adverse Event|9|||
125658741|NCT01461369|452037473|FG001|Overall Study|Adverse Event|12|||
125658742|NCT01461369|452037474|FG002|Overall Study|Adverse Event|4|||
125317321|NCT00647296|450790566|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
125317322|NCT00647296|450790567|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
125317323|NCT00647296|450790568|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
125317324|NCT00647296|450790569|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
125317325|NCT01787461|450790570|FG000|Overall Study|Adverse Event|4|||
125317326|NCT01787461|450790571|FG001|Overall Study|Adverse Event|3|||
125317327|NCT01787461|450790570|FG000|Overall Study|Lost to Follow-up|3|||
125317328|NCT01787461|450790571|FG001|Overall Study|Lost to Follow-up|2|||
125317329|NCT01787461|450790570|FG000|Overall Study|No longer met eligibility criteria|1|||
125317330|NCT01787461|450790571|FG001|Overall Study|No longer met eligibility criteria|0|||
125317331|NCT01787461|450790570|FG000|Overall Study|Withdrawal by Subject|3|||
125317332|NCT01787461|450790571|FG001|Overall Study|Withdrawal by Subject|4|||
125317333|NCT01787461|450790570|FG000|Overall Study|Protocol Violation|3|||
125317334|NCT01787461|450790571|FG001|Overall Study|Protocol Violation|0|||
125317335|NCT01519323|450792296|FG000|Overall Study|Death|3|||
125317336|NCT01519323|450792297|FG001|Overall Study|Death|2|||
125317337|NCT01519323|450792296|FG000|Overall Study|Study terminated by sponsor|0|||
125317338|NCT01519323|450792297|FG001|Overall Study|Study terminated by sponsor|1|||
125317339|NCT00383552|450792300|FG000|Overall Study|Adverse Event|7|||
125317340|NCT00383552|450792301|FG001|Overall Study|Adverse Event|6|||
125317341|NCT00383552|450792302|FG002|Overall Study|Adverse Event|9|||
125317342|NCT00383552|450792303|FG003|Overall Study|Adverse Event|6|||
125317343|NCT00383552|450792300|FG000|Overall Study|Lack of Efficacy|4|||
125317344|NCT00383552|450792301|FG001|Overall Study|Lack of Efficacy|13|||
125317345|NCT00383552|450792302|FG002|Overall Study|Lack of Efficacy|29|||
125317346|NCT00383552|450792303|FG003|Overall Study|Lack of Efficacy|42|||
125317347|NCT00383552|450792300|FG000|Overall Study|Lost to Follow-up|0|||
125317348|NCT00383552|450792301|FG001|Overall Study|Lost to Follow-up|1|||
125317349|NCT00383552|450792302|FG002|Overall Study|Lost to Follow-up|5|||
125317350|NCT00383552|450792303|FG003|Overall Study|Lost to Follow-up|1|||
125317351|NCT00383552|450792300|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
125317352|NCT00383552|450792301|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
125317353|NCT00383552|450792302|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
125317354|NCT00383552|450792303|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
125317355|NCT00383552|450792300|FG000|Overall Study|Did not wish to continue (related)|1|||
125317356|NCT00383552|450792301|FG001|Overall Study|Did not wish to continue (related)|0|||
125317357|NCT00383552|450792302|FG002|Overall Study|Did not wish to continue (related)|2|||
125317358|NCT00383552|450792303|FG003|Overall Study|Did not wish to continue (related)|3|||
125317359|NCT00383552|450792300|FG000|Overall Study|Noncompliance with the protocol|11|||
125317360|NCT00383552|450792301|FG001|Overall Study|Noncompliance with the protocol|6|||
125317361|NCT00383552|450792302|FG002|Overall Study|Noncompliance with the protocol|8|||
125317362|NCT00383552|450792303|FG003|Overall Study|Noncompliance with the protocol|10|||
125317363|NCT00383552|450792300|FG000|Overall Study|Did not meet protocol eligibility|8|||
125317364|NCT00383552|450792301|FG001|Overall Study|Did not meet protocol eligibility|6|||
125317365|NCT00383552|450792302|FG002|Overall Study|Did not meet protocol eligibility|2|||
125317366|NCT00383552|450792303|FG003|Overall Study|Did not meet protocol eligibility|3|||
125317367|NCT00383552|450792300|FG000|Overall Study|Administrative|1|||
125317368|NCT00383552|450792301|FG001|Overall Study|Administrative|0|||
125317369|NCT00383552|450792302|FG002|Overall Study|Administrative|1|||
125317370|NCT00383552|450792303|FG003|Overall Study|Administrative|1|||
125317371|NCT03096834|450792304|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
125317372|NCT03096834|450792305|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
125317373|NCT03096834|450792306|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
125317374|NCT03096834|450792307|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
125317375|NCT03096834|450792304|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
125317376|NCT03096834|450792305|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
125317377|NCT03096834|450792306|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
125317378|NCT03096834|450792307|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
125317379|NCT03096834|450792304|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
125317380|NCT03096834|450792305|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
125658743|NCT01461369|452037472|FG000|Overall Study|Protocol Violation|1|||
125658744|NCT01461369|452037473|FG001|Overall Study|Protocol Violation|2|||
125658745|NCT01461369|452037474|FG002|Overall Study|Protocol Violation|2|||
125658746|NCT01461369|452037472|FG000|Overall Study|Withdrawal by Subject|1|||
125317381|NCT03096834|450792306|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
125317382|NCT03096834|450792307|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
125317383|NCT03096834|450792304|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
125317384|NCT03096834|450792305|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
125317385|NCT03096834|450792306|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
125317386|NCT03096834|450792307|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
125317387|NCT03096834|450792304|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
125317388|NCT03096834|450792305|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
125658747|NCT01461369|452037473|FG001|Overall Study|Withdrawal by Subject|3|||
125317389|NCT03096834|450792306|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
125317390|NCT03096834|450792307|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
125317391|NCT03096834|450792304|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
125317392|NCT03096834|450792305|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
125317393|NCT03096834|450792306|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
125317394|NCT03096834|450792307|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
125317395|NCT03096834|450792304|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
125317396|NCT03096834|450792305|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
125317397|NCT03096834|450792306|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
125317398|NCT03096834|450792307|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
125317399|NCT03096834|450792304|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
125317400|NCT03096834|450792305|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
125658748|NCT01461369|452037474|FG002|Overall Study|Withdrawal by Subject|2|||
125658749|NCT00734617|452037481|FG000|Overall Study|Adverse Event|4|||
125658750|NCT00734617|452037482|FG001|Overall Study|Adverse Event|7|||
125658751|NCT00734617|452037481|FG000|Overall Study|Withdrawal by Subject|103|||
125658752|NCT00734617|452037482|FG001|Overall Study|Withdrawal by Subject|95|||
125658753|NCT02367729|452037483|FG000|Overall Study|Organic disorder diagnosed|2|||
125317401|NCT03096834|450792306|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
125317402|NCT03096834|450792307|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
125317403|NCT03096834|450792304|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
125317404|NCT03096834|450792305|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
125317405|NCT03096834|450792306|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
125317406|NCT03096834|450792307|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
125317407|NCT03096834|450792304|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
125317408|NCT03096834|450792305|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
125658754|NCT02367729|452037484|FG001|Overall Study|Organic disorder diagnosed|1|||
125658755|NCT02367729|452037483|FG000|Overall Study|Adverse Event|1|||
125658756|NCT02367729|452037484|FG001|Overall Study|Adverse Event|2|||
125658757|NCT02367729|452037483|FG000|Overall Study|Withdrawal by Subject|0|||
125658758|NCT02367729|452037484|FG001|Overall Study|Withdrawal by Subject|5|||
125658759|NCT02742818|452037494|FG000|Overall Study|Adverse Event|0|||
125658760|NCT02742818|452037495|FG001|Overall Study|Adverse Event|1|||
125658761|NCT02742818|452037494|FG000|Overall Study|Protocol Violation|0|||
125658762|NCT02742818|452037495|FG001|Overall Study|Protocol Violation|1|||
125658763|NCT01260194|452037497|FG000|Overall Study|Withdrawal of Consent|1|||
125658764|NCT04854707|452037498|FG000|Overall Study|Lack of Efficacy|78|||
125658765|NCT04854707|452037499|FG001|Overall Study|Lack of Efficacy|59|||
125658766|NCT04854707|452037500|FG002|Overall Study|Lack of Efficacy|30|||
125658767|NCT05674721|452037510|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
125658768|NCT05674721|452037511|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
125658769|NCT05674721|452037510|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
125658770|NCT05674721|452037511|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
125658771|NCT05013749|452037520|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
125658772|NCT05013749|452037521|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
125658773|NCT05013749|452037520|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
125658774|NCT05013749|452037521|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
125658775|NCT02017535|452037524|FG000|Overall Study|Withdrawal by Subject|1|||
125658776|NCT02017535|452037525|FG001|Overall Study|Withdrawal by Subject|0|||
125658777|NCT02017535|452037526|FG002|Overall Study|Withdrawal by Subject|0|||
125658778|NCT02017535|452037527|FG003|Overall Study|Withdrawal by Subject|0|||
125658779|NCT01393626|452037528|FG000|Overall Study|Adverse Event|2|||
125658780|NCT01393626|452037529|FG001|Overall Study|Adverse Event|1|||
125658781|NCT01393626|452037530|FG002|Overall Study|Adverse Event|5|||
125658782|NCT01393626|452037531|FG003|Overall Study|Adverse Event|0|||
125658783|NCT01393626|452037528|FG000|Overall Study|Did not meet entrance criteria|1|||
125658784|NCT01393626|452037529|FG001|Overall Study|Did not meet entrance criteria|0|||
125658785|NCT01393626|452037530|FG002|Overall Study|Did not meet entrance criteria|0|||
125658786|NCT01393626|452037531|FG003|Overall Study|Did not meet entrance criteria|0|||
125658787|NCT01393626|452037528|FG000|Overall Study|Lack of Efficacy|6|||
125658788|NCT01393626|452037529|FG001|Overall Study|Lack of Efficacy|6|||
125658789|NCT01393626|452037530|FG002|Overall Study|Lack of Efficacy|4|||
125658790|NCT01393626|452037531|FG003|Overall Study|Lack of Efficacy|1|||
125658791|NCT01393626|452037528|FG000|Overall Study|Lost to Follow-up|1|||
125658792|NCT01393626|452037529|FG001|Overall Study|Lost to Follow-up|1|||
125658793|NCT01393626|452037530|FG002|Overall Study|Lost to Follow-up|1|||
125658794|NCT01393626|452037531|FG003|Overall Study|Lost to Follow-up|0|||
125317409|NCT03096834|450792306|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
125317410|NCT03096834|450792307|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
125317411|NCT03096834|450792304|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
125658795|NCT01393626|452037528|FG000|Overall Study|Withdrawal by Subject|6|||
125658796|NCT01393626|452037529|FG001|Overall Study|Withdrawal by Subject|4|||
125317412|NCT03096834|450792305|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
125317413|NCT03096834|450792306|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
125317414|NCT03096834|450792307|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
125317415|NCT03096834|450792304|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
125317416|NCT03096834|450792305|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
125317417|NCT03096834|450792306|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
125317418|NCT03096834|450792307|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
125317419|NCT00966654|450792308|FG000|Overall Study|Study was terminated,PI left institution|12|||
125317420|NCT04416204|450792311|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
125317421|NCT04416204|450792312|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
125317422|NCT04416204|450792313|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
125317423|NCT04416204|450792314|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
125317424|NCT03858049|450792315|FG000|Overall Study|Adverse Event|16|||
125317425|NCT03858049|450792316|FG001|Overall Study|Adverse Event|9|||
125317426|NCT03858049|450792315|FG000|Overall Study|Other|1|||
125317427|NCT03858049|450792316|FG001|Overall Study|Other|1|||
125317428|NCT04456504|450792317|FG000|Overall Study|Lost to Follow-up|2|||
125658797|NCT01393626|452037530|FG002|Overall Study|Withdrawal by Subject|0|||
125658798|NCT01393626|452037531|FG003|Overall Study|Withdrawal by Subject|0|||
125658799|NCT01393626|452037528|FG000|Overall Study|Other|1|||
125658800|NCT01393626|452037529|FG001|Overall Study|Other|0|||
125658801|NCT01393626|452037530|FG002|Overall Study|Other|0|||
125317429|NCT04617782|450792318|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
125317430|NCT04617782|450792318|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
125317431|NCT04617782|450792318|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
125317432|NCT04617782|450792318|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
125317433|NCT04617782|450792318|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
125317434|NCT04617782|450792318|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
125317435|NCT01405768|450792319|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
125317436|NCT01405768|450792320|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
125317437|NCT01690052|450792323|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
125317438|NCT01690052|450792324|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
125317439|NCT01474317|450792334|FG000|Overall Study|Adverse Event|1|||
125317440|NCT01474317|450792334|FG000|Overall Study|Subject ineligible for study|1|||
125317441|NCT01381016|450792337|FG000|Overall Study|Lost to Follow-up|1|||
125317442|NCT01381016|450792338|FG001|Overall Study|Lost to Follow-up|1|||
125317443|NCT01381016|450792337|FG000|Overall Study|Screen Failure|2|||
125317444|NCT01381016|450792338|FG001|Overall Study|Screen Failure|2|||
125317445|NCT01381016|450792337|FG000|Overall Study|Withdrawal by Subject|0|||
125317446|NCT01381016|450792338|FG001|Overall Study|Withdrawal by Subject|1|||
125317447|NCT01381016|450792337|FG000|Overall Study|Physician Decision|0|||
125317448|NCT01381016|450792338|FG001|Overall Study|Physician Decision|2|||
125317449|NCT01693029|450792339|FG000|Overall Study|Withdrawal by Subject|15|||
125317450|NCT01693029|450792340|FG001|Overall Study|Withdrawal by Subject|22|||
125317451|NCT01693029|450792339|FG000|Overall Study|Kidney transplantation|7|||
125317452|NCT01693029|450792340|FG001|Overall Study|Kidney transplantation|7|||
125317453|NCT01693029|450792339|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
125317454|NCT01693029|450792340|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
125317455|NCT01693029|450792339|FG000|Overall Study|Protocol Violation|6|||
125317456|NCT01693029|450792340|FG001|Overall Study|Protocol Violation|7|||
125317457|NCT01693029|450792339|FG000|Overall Study|Change in dialysis modality|2|||
125317458|NCT01693029|450792340|FG001|Overall Study|Change in dialysis modality|1|||
125317459|NCT01693029|450792339|FG000|Overall Study|Physician Decision|0|||
125317460|NCT01693029|450792340|FG001|Overall Study|Physician Decision|2|||
125317461|NCT01693029|450792339|FG000|Overall Study|Lost to Follow-up|0|||
125317462|NCT01693029|450792340|FG001|Overall Study|Lost to Follow-up|1|||
125317463|NCT01693029|450792339|FG000|Overall Study|Adverse Event|1|||
125317464|NCT01693029|450792340|FG001|Overall Study|Adverse Event|6|||
125317465|NCT01693029|450792339|FG000|Overall Study|Death|5|||
125317466|NCT01693029|450792340|FG001|Overall Study|Death|8|||
125317467|NCT01693029|450792339|FG000|Overall Study|Non-compliance|2|||
125317468|NCT01693029|450792340|FG001|Overall Study|Non-compliance|1|||
125317469|NCT02647281|450792341|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317470|NCT02647281|450792342|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317471|NCT02647281|450792343|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317472|NCT02647281|450792344|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317473|NCT02647281|450792345|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317474|NCT02647281|450792346|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317475|NCT02647281|450792347|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317476|NCT02647281|450792348|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
125317477|NCT02647281|450792349|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
125317478|NCT05801991|450792350|FG000|Overall Study|Lost to Follow-up|1|||
125658802|NCT01393626|452037531|FG003|Overall Study|Other|0|||
125658803|NCT01393626|452037528|FG000|Overall Study|Protocol Violation|1|||
125658804|NCT01393626|452037529|FG001|Overall Study|Protocol Violation|0|||
125317479|NCT05801991|450792351|FG001|Overall Study|Lost to Follow-up|0|||
125317480|NCT01451723|450792353|FG000|Overall Study|study halted|6|||
125317481|NCT01451723|450792354|FG001|Overall Study|study halted|5|||
125317482|NCT01631435|450792355|FG000|Overall Study|Adverse Event|2|||
125317483|NCT01631435|450792355|FG000|Overall Study|Withdrawal by Subject|2|||
125317484|NCT01631435|450792355|FG000|Overall Study|incomplete study procedure|5|||
125317485|NCT01005251|450792364|FG000|Overall Study|Withdrawal by Subject|2|||
125317486|NCT01005251|450792365|FG001|Overall Study|Withdrawal by Subject|5|||
125317487|NCT01005251|450792366|FG002|Overall Study|Withdrawal by Subject|3|||
125317488|NCT01005251|450792367|FG003|Overall Study|Withdrawal by Subject|4|||
125317489|NCT01005251|450792368|FG004|Overall Study|Withdrawal by Subject|9|||
125317490|NCT01005251|450792364|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
125317491|NCT01005251|450792365|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125317492|NCT01005251|450792366|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
125317493|NCT01005251|450792367|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
125317494|NCT01005251|450792368|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
125317495|NCT01005251|450792364|FG000|Overall Study|Adverse Event|2|||
125317496|NCT01005251|450792365|FG001|Overall Study|Adverse Event|6|||
125317497|NCT01005251|450792366|FG002|Overall Study|Adverse Event|8|||
125317498|NCT01005251|450792367|FG003|Overall Study|Adverse Event|5|||
125317499|NCT01005251|450792368|FG004|Overall Study|Adverse Event|4|||
125317500|NCT01005251|450792364|FG000|Overall Study|Protocol Violation|1|||
125317501|NCT01005251|450792365|FG001|Overall Study|Protocol Violation|0|||
125317502|NCT01005251|450792366|FG002|Overall Study|Protocol Violation|0|||
125317503|NCT01005251|450792367|FG003|Overall Study|Protocol Violation|0|||
125317504|NCT01005251|450792368|FG004|Overall Study|Protocol Violation|2|||
125317505|NCT01005251|450792364|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
125317506|NCT01005251|450792365|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
125317507|NCT01005251|450792366|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
125317508|NCT01005251|450792367|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
125317509|NCT01005251|450792368|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
125317510|NCT01005251|450792364|FG000|Overall Study|Lost to Follow-up|1|||
125317511|NCT01005251|450792365|FG001|Overall Study|Lost to Follow-up|4|||
125317512|NCT01005251|450792366|FG002|Overall Study|Lost to Follow-up|2|||
125317513|NCT01005251|450792367|FG003|Overall Study|Lost to Follow-up|0|||
125317514|NCT01005251|450792368|FG004|Overall Study|Lost to Follow-up|0|||
125317515|NCT01005251|450792364|FG000|Overall Study|Physician Decision|0|||
125317516|NCT01005251|450792365|FG001|Overall Study|Physician Decision|0|||
125317517|NCT01005251|450792366|FG002|Overall Study|Physician Decision|0|||
125317518|NCT01005251|450792367|FG003|Overall Study|Physician Decision|0|||
125317519|NCT01005251|450792368|FG004|Overall Study|Physician Decision|2|||
125317520|NCT01005251|450792364|FG000|Overall Study|Patient moved|1|||
125317521|NCT01005251|450792365|FG001|Overall Study|Patient moved|0|||
125317522|NCT01005251|450792366|FG002|Overall Study|Patient moved|0|||
125540496|NCT02019667|451607666|FG000|First Intervention (6 Months)|Adverse Event|0|||
125540497|NCT02019667|451607667|FG001|First Intervention (6 Months)|Adverse Event|1|||
125540498|NCT02019667|451607666|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
125540499|NCT02019667|451607667|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
125540500|NCT02019667|451607666|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
125540501|NCT02019667|451607667|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
125317523|NCT01005251|450792367|FG003|Overall Study|Patient moved|0|||
125317524|NCT01005251|450792368|FG004|Overall Study|Patient moved|0|||
125317525|NCT01005251|450792364|FG000|Overall Study|Wrong drug dispensed|0|||
125317526|NCT01005251|450792365|FG001|Overall Study|Wrong drug dispensed|1|||
125317527|NCT01005251|450792366|FG002|Overall Study|Wrong drug dispensed|0|||
125317528|NCT01005251|450792367|FG003|Overall Study|Wrong drug dispensed|0|||
125317529|NCT01005251|450792368|FG004|Overall Study|Wrong drug dispensed|0|||
125317530|NCT01005251|450792364|FG000|Overall Study|Randomized in error|0|||
125317531|NCT01005251|450792365|FG001|Overall Study|Randomized in error|0|||
125317532|NCT01005251|450792366|FG002|Overall Study|Randomized in error|1|||
125317533|NCT01005251|450792367|FG003|Overall Study|Randomized in error|1|||
125317534|NCT01005251|450792368|FG004|Overall Study|Randomized in error|0|||
125317535|NCT01005251|450792364|FG000|Overall Study|Lack of Efficacy|0|||
125317536|NCT01005251|450792365|FG001|Overall Study|Lack of Efficacy|0|||
125317537|NCT01005251|450792366|FG002|Overall Study|Lack of Efficacy|1|||
125317538|NCT01005251|450792367|FG003|Overall Study|Lack of Efficacy|1|||
125317539|NCT01005251|450792368|FG004|Overall Study|Lack of Efficacy|0|||
125317540|NCT00443040|450792369|FG000|Overall Study|Withdrawal by Subject|1|||
125317541|NCT00443040|450792370|FG001|Overall Study|Withdrawal by Subject|0|||
125317542|NCT00443040|450792371|FG002|Overall Study|Withdrawal by Subject|0|||
125317543|NCT00443040|450792369|FG000|Overall Study|Converted to an open laparotomy|3|||
125317544|NCT00443040|450792370|FG001|Overall Study|Converted to an open laparotomy|0|||
125317545|NCT00443040|450792371|FG002|Overall Study|Converted to an open laparotomy|1|||
125317546|NCT00435409|450792375|FG000|Overall Study|Protocol Violation|1|||
125540502|NCT03981861|451607671|FG000|Overall Study|Withdrawal by Subject|3|||
125540503|NCT00432666|451609357|FG000|Main Period|Adverse Event|1|||
125540504|NCT00432666|451609358|FG001|Main Period|Adverse Event|1|||
125317547|NCT00435409|450792376|FG001|Overall Study|Protocol Violation|2|||
125317548|NCT00435409|450792377|FG002|Overall Study|Protocol Violation|0|||
125317549|NCT00435409|450792375|FG000|Overall Study|Lost to Follow-up|1|||
125317550|NCT00435409|450792376|FG001|Overall Study|Lost to Follow-up|2|||
125317551|NCT00435409|450792377|FG002|Overall Study|Lost to Follow-up|0|||
125317552|NCT00435409|450792375|FG000|Overall Study|Death|8|||
125317553|NCT00435409|450792376|FG001|Overall Study|Death|6|||
125317554|NCT00435409|450792377|FG002|Overall Study|Death|6|||
125317555|NCT00435409|450792375|FG000|Overall Study|Objective progression or relapse|158|||
125317556|NCT00435409|450792376|FG001|Overall Study|Objective progression or relapse|93|||
125317557|NCT00435409|450792377|FG002|Overall Study|Objective progression or relapse|58|||
125317558|NCT00435409|450792375|FG000|Overall Study|Global deterioration of health status|0|||
125317559|NCT00435409|450792376|FG001|Overall Study|Global deterioration of health status|0|||
125317560|NCT00435409|450792377|FG002|Overall Study|Global deterioration of health status|4|||
125317561|NCT00435409|450792375|FG000|Overall Study|Withdrawal by Subject|8|||
125317562|NCT00435409|450792376|FG001|Overall Study|Withdrawal by Subject|7|||
125317563|NCT00435409|450792377|FG002|Overall Study|Withdrawal by Subject|1|||
125317564|NCT00435409|450792375|FG000|Overall Study|Other|45|||
125317565|NCT00435409|450792376|FG001|Overall Study|Other|30|||
125317566|NCT00435409|450792377|FG002|Overall Study|Other|1|||
125317567|NCT00435409|450792375|FG000|Overall Study|Adverse Event|0|||
125317568|NCT00435409|450792376|FG001|Overall Study|Adverse Event|0|||
125317569|NCT00435409|450792377|FG002|Overall Study|Adverse Event|8|||
125317570|NCT00435409|450792375|FG000|Overall Study|Sponsor decision|0|||
125317571|NCT00435409|450792376|FG001|Overall Study|Sponsor decision|3|||
125317572|NCT00435409|450792377|FG002|Overall Study|Sponsor decision|0|||
125317573|NCT03661723|450792379|FG000|Overall Study|Disease Progression|4|||
125317574|NCT03661723|450792380|FG001|Overall Study|Disease Progression|24|||
125317575|NCT03661723|450792381|FG002|Overall Study|Disease Progression|4|||
125317576|NCT03661723|450792382|FG003|Overall Study|Disease Progression|19|||
125317577|NCT03661723|450792379|FG000|Overall Study|Withdrawal by Subject|1|||
125317578|NCT03661723|450792380|FG001|Overall Study|Withdrawal by Subject|0|||
125317579|NCT03661723|450792381|FG002|Overall Study|Withdrawal by Subject|2|||
125317580|NCT03661723|450792382|FG003|Overall Study|Withdrawal by Subject|4|||
125317581|NCT03661723|450792379|FG000|Overall Study|Physician Decision|1|||
125317582|NCT03661723|450792380|FG001|Overall Study|Physician Decision|0|||
125317583|NCT03661723|450792381|FG002|Overall Study|Physician Decision|0|||
125317584|NCT03661723|450792382|FG003|Overall Study|Physician Decision|0|||
125317585|NCT03661723|450792379|FG000|Overall Study|Clinical Deterioration|0|||
125317586|NCT03661723|450792380|FG001|Overall Study|Clinical Deterioration|0|||
125317587|NCT03661723|450792381|FG002|Overall Study|Clinical Deterioration|0|||
125317588|NCT03661723|450792382|FG003|Overall Study|Clinical Deterioration|1|||
125317589|NCT00883779|450792385|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
125317590|NCT00883779|450792386|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
125317591|NCT00883779|450792385|FG000|Primary Study Treatment Phase|Disease progression|75|||
125317592|NCT00883779|450792386|FG001|Primary Study Treatment Phase|Disease progression|59|||
125317593|NCT00883779|450792385|FG000|Primary Study Treatment Phase|Adverse Event|16|||
125317594|NCT00883779|450792386|FG001|Primary Study Treatment Phase|Adverse Event|16|||
125317595|NCT00883779|450792385|FG000|Primary Study Treatment Phase|Death|2|||
125317596|NCT00883779|450792386|FG001|Primary Study Treatment Phase|Death|3|||
125317597|NCT00883779|450792385|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
125317598|NCT00883779|450792386|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
125317599|NCT00883779|450792385|FG000|Primary Study Treatment Phase|Other|3|||
125317600|NCT00883779|450792386|FG001|Primary Study Treatment Phase|Other|0|||
125317601|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Adverse Event|2|||
125317602|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Adverse Event|3|||
125317603|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Death|1|||
125317604|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Death|3|||
125317605|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
125317606|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
125317607|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
125317608|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
125317609|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Disease progression|103|||
125658805|NCT01393626|452037530|FG002|Overall Study|Protocol Violation|2|||
125317610|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Disease progression|122|||
125317611|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Other|3|||
125317612|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Other|0|||
125317613|NCT00883779|450792385|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
125317614|NCT00883779|450792386|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
125317615|NCT00883779|450792385|FG000|Off-study Phase|Death|185|||
125317616|NCT00883779|450792386|FG001|Off-study Phase|Death|174|||
125317617|NCT00883779|450792385|FG000|Off-study Phase|Refused treatment|1|||
125317618|NCT00883779|450792386|FG001|Off-study Phase|Refused treatment|1|||
125317619|NCT00883779|450792385|FG000|Off-study Phase|Failure to return|5|||
125317620|NCT00883779|450792386|FG001|Off-study Phase|Failure to return|6|||
125317621|NCT00883779|450792385|FG000|Off-study Phase|Other|18|||
125317622|NCT00883779|450792386|FG001|Off-study Phase|Other|21|||
125317623|NCT00499681|450792387|FG000|Overall Study|toxicity|0|||
125317624|NCT00499681|450792388|FG001|Overall Study|toxicity|1|||
125317625|NCT00499681|450792387|FG000|Overall Study|disease progression|0|||
125317626|NCT00499681|450792388|FG001|Overall Study|disease progression|1|||
125317627|NCT02174731|450792389|FG000|Overall Study|Participant decision|67|||
125317628|NCT02174731|450792390|FG001|Overall Study|Participant decision|64|||
125317629|NCT02174731|450792389|FG000|Overall Study|Incorrect enrolment before randomization|0|||
125317630|NCT02174731|450792390|FG001|Overall Study|Incorrect enrolment before randomization|1|||
125317631|NCT02174731|450792389|FG000|Overall Study|Missing|2|||
125317632|NCT02174731|450792390|FG001|Overall Study|Missing|0|||
125317633|NCT00079040|450792391|FG000|Overall Study|Withdrew before treatment|1|||
125317634|NCT00079040|450792391|FG000|Overall Study|Ineligible|1|||
125317635|NCT00739401|450792394|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
125317636|NCT00739401|450792394|FG000|Overall Study|Death|3|||
125317637|NCT00739401|450792394|FG000|Overall Study|Withdrawal by Subject|4|||
125317638|NCT04575155|450792395|FG000|2 Month|Withdrawal by Subject|1|||
125317639|NCT04575155|450792396|FG001|2 Month|Withdrawal by Subject|1|||
125317640|NCT04575155|450792395|FG000|2 Month|Lost to Follow-up|5|||
125317641|NCT04575155|450792396|FG001|2 Month|Lost to Follow-up|3|||
125317642|NCT04575155|450792395|FG000|2 Month|Ineligible|1|||
125317643|NCT04575155|450792396|FG001|2 Month|Ineligible|0|||
125317644|NCT00467740|450792399|FG000|Overall Study|Adverse Event|0|||
125317645|NCT00467740|450792400|FG001|Overall Study|Adverse Event|0|||
125317646|NCT00467740|450792401|FG002|Overall Study|Adverse Event|1|||
125317647|NCT00467740|450792402|FG003|Overall Study|Adverse Event|0|||
125317648|NCT00467740|450792403|FG004|Overall Study|Adverse Event|0|||
125317649|NCT00467740|450792399|FG000|Overall Study|Protocol Violation|0|||
125317650|NCT00467740|450792400|FG001|Overall Study|Protocol Violation|0|||
125317651|NCT00467740|450792401|FG002|Overall Study|Protocol Violation|1|||
125317652|NCT00467740|450792402|FG003|Overall Study|Protocol Violation|0|||
125317653|NCT00467740|450792403|FG004|Overall Study|Protocol Violation|0|||
125317654|NCT00467740|450792399|FG000|Overall Study|Lost to Follow-up|0|||
125317655|NCT00467740|450792400|FG001|Overall Study|Lost to Follow-up|1|||
125317656|NCT00467740|450792401|FG002|Overall Study|Lost to Follow-up|0|||
125317657|NCT00467740|450792402|FG003|Overall Study|Lost to Follow-up|0|||
125317658|NCT00467740|450792403|FG004|Overall Study|Lost to Follow-up|0|||
125317659|NCT00467740|450792399|FG000|Overall Study|Withdrawal by Subject|1|||
125317660|NCT00467740|450792400|FG001|Overall Study|Withdrawal by Subject|1|||
125317661|NCT00467740|450792401|FG002|Overall Study|Withdrawal by Subject|0|||
125317662|NCT00467740|450792402|FG003|Overall Study|Withdrawal by Subject|1|||
125317663|NCT00467740|450792403|FG004|Overall Study|Withdrawal by Subject|0|||
125317664|NCT00467740|450792399|FG000|Overall Study|Lack of Efficacy|0|||
125317665|NCT00467740|450792400|FG001|Overall Study|Lack of Efficacy|1|||
125317666|NCT00467740|450792401|FG002|Overall Study|Lack of Efficacy|0|||
125317667|NCT00467740|450792402|FG003|Overall Study|Lack of Efficacy|0|||
125317668|NCT00467740|450792403|FG004|Overall Study|Lack of Efficacy|0|||
125317669|NCT03535974|450792404|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
125317670|NCT03535974|450792405|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
125317671|NCT03535974|450792406|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
125317672|NCT03535974|450792404|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
125317673|NCT03535974|450792405|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
125317674|NCT03535974|450792406|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
125317675|NCT02678351|450792407|FG000|Overall Study|Withdrawal by Subject|1|||
125317676|NCT01919229|450792408|FG000|Overall Study|Subject/guardian decision|0|||
125317677|NCT01919229|450792409|FG001|Overall Study|Subject/guardian decision|0|||
125317678|NCT01919229|450792410|FG002|Overall Study|Subject/guardian decision|1|||
125317679|NCT04999839|450792419|FG000|Overall Study|Adverse Event|1|||
125317680|NCT04999839|450792420|FG001|Overall Study|Adverse Event|1|||
125317681|NCT04999839|450792421|FG002|Overall Study|Adverse Event|1|||
125317682|NCT04999839|450792422|FG003|Overall Study|Adverse Event|1|||
125317683|NCT04999839|450792423|FG004|Overall Study|Adverse Event|1|||
125317684|NCT04999839|450792419|FG000|Overall Study|Lost to Follow-up|2|||
125317685|NCT04999839|450792420|FG001|Overall Study|Lost to Follow-up|0|||
125317686|NCT04999839|450792421|FG002|Overall Study|Lost to Follow-up|2|||
125317687|NCT04999839|450792422|FG003|Overall Study|Lost to Follow-up|4|||
125317688|NCT04999839|450792423|FG004|Overall Study|Lost to Follow-up|1|||
125317689|NCT04999839|450792419|FG000|Overall Study|Withdrawal by Subject|6|||
125317690|NCT04999839|450792420|FG001|Overall Study|Withdrawal by Subject|5|||
125658806|NCT01393626|452037531|FG003|Overall Study|Protocol Violation|0|||
125317691|NCT04999839|450792421|FG002|Overall Study|Withdrawal by Subject|3|||
125317692|NCT04999839|450792422|FG003|Overall Study|Withdrawal by Subject|2|||
125658807|NCT03506425|452037532|FG000|Overall Study|Adverse Event|1|||
125317693|NCT04999839|450792423|FG004|Overall Study|Withdrawal by Subject|2|||
125317694|NCT04999839|450792419|FG000|Overall Study|Lack of Efficacy|0|||
125317695|NCT04999839|450792420|FG001|Overall Study|Lack of Efficacy|1|||
125317696|NCT04999839|450792421|FG002|Overall Study|Lack of Efficacy|0|||
125317697|NCT04999839|450792422|FG003|Overall Study|Lack of Efficacy|0|||
125317698|NCT04999839|450792423|FG004|Overall Study|Lack of Efficacy|0|||
125317699|NCT04999839|450792419|FG000|Overall Study|Physician Decision|0|||
125317700|NCT04999839|450792420|FG001|Overall Study|Physician Decision|0|||
125317701|NCT04999839|450792421|FG002|Overall Study|Physician Decision|0|||
125317702|NCT04999839|450792422|FG003|Overall Study|Physician Decision|0|||
125317703|NCT04999839|450792423|FG004|Overall Study|Physician Decision|1|||
125317704|NCT04999839|450792419|FG000|Overall Study|Sponsor request|0|||
125317705|NCT04999839|450792420|FG001|Overall Study|Sponsor request|1|||
125317706|NCT04999839|450792421|FG002|Overall Study|Sponsor request|0|||
125317707|NCT04999839|450792422|FG003|Overall Study|Sponsor request|0|||
125317708|NCT04999839|450792423|FG004|Overall Study|Sponsor request|0|||
125317709|NCT04999839|450792419|FG000|Overall Study|Other|0|||
125317710|NCT04999839|450792420|FG001|Overall Study|Other|0|||
125317711|NCT04999839|450792421|FG002|Overall Study|Other|1|||
125317712|NCT04999839|450792422|FG003|Overall Study|Other|0|||
125317713|NCT04999839|450792423|FG004|Overall Study|Other|0|||
125317714|NCT00399516|450792424|FG000|Overall Study|Lost to Follow-up|2|||
125317715|NCT00982735|450792425|FG000|Overall Study|Lost to Follow-up|6|||
125317716|NCT00982735|450792425|FG000|Overall Study|Patient ineligible for trial|224|||
125317717|NCT00539981|450792435|FG000|Overall Study|Adverse events (AE)|3|||
125317718|NCT00539981|450792436|FG001|Overall Study|Adverse events (AE)|3|||
125317719|NCT00539981|450792435|FG000|Overall Study|Lost to Follow-up|260|||
125317720|NCT00539981|450792436|FG001|Overall Study|Lost to Follow-up|251|||
125317721|NCT00539981|450792435|FG000|Overall Study|Withdrew consent|22|||
125317722|NCT00539981|450792436|FG001|Overall Study|Withdrew consent|14|||
125317723|NCT00539981|450792435|FG000|Overall Study|Death|1|||
125317724|NCT00539981|450792436|FG001|Overall Study|Death|1|||
125317725|NCT00539981|450792435|FG000|Overall Study|Other reason-unspecified|9|||
125317726|NCT00539981|450792436|FG001|Overall Study|Other reason-unspecified|13|||
125317727|NCT02675907|450792437|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
125317728|NCT02675907|450792438|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
125317729|NCT02675907|450792437|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
125317730|NCT02675907|450792438|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
125317731|NCT02675907|450792437|FG000|Study Overall|Lack of Efficacy|1|||
125317732|NCT02675907|450792438|FG001|Study Overall|Lack of Efficacy|0|||
125317733|NCT02675907|450792437|FG000|Study Overall|Withdrawal by Subject|2|||
125317734|NCT02675907|450792438|FG001|Study Overall|Withdrawal by Subject|2|||
125317735|NCT02675907|450792437|FG000|Study Overall|Lost to Follow-up|0|||
125317736|NCT02675907|450792438|FG001|Study Overall|Lost to Follow-up|2|||
125317737|NCT01611792|450792439|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
125317738|NCT01611792|450792440|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
125317739|NCT01611792|450792439|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
125317740|NCT01611792|450792440|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
125317741|NCT02898454|450792443|FG000|Overall Study|Adverse Event|4|||
125317742|NCT02898454|450792444|FG001|Overall Study|Adverse Event|1|||
125317743|NCT02898454|450792445|FG002|Overall Study|Adverse Event|2|||
125317744|NCT02898454|450792443|FG000|Overall Study|Protocol Violation|1|||
125317745|NCT02898454|450792444|FG001|Overall Study|Protocol Violation|0|||
125317746|NCT02898454|450792445|FG002|Overall Study|Protocol Violation|1|||
125317747|NCT02898454|450792443|FG000|Overall Study|Lack of Efficacy|4|||
125317748|NCT02898454|450792444|FG001|Overall Study|Lack of Efficacy|1|||
125317749|NCT02898454|450792445|FG002|Overall Study|Lack of Efficacy|0|||
125317750|NCT02898454|450792443|FG000|Overall Study|Withdrawal by Subject|6|||
125317751|NCT02898454|450792444|FG001|Overall Study|Withdrawal by Subject|3|||
125317752|NCT02898454|450792445|FG002|Overall Study|Withdrawal by Subject|3|||
125317753|NCT02898454|450792443|FG000|Overall Study|Lost to Follow-up|1|||
125317754|NCT02898454|450792444|FG001|Overall Study|Lost to Follow-up|0|||
125317755|NCT02898454|450792445|FG002|Overall Study|Lost to Follow-up|0|||
125317756|NCT02898454|450792443|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
125317757|NCT02898454|450792444|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
125317758|NCT02898454|450792445|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
125658808|NCT03506425|452037533|FG001|Overall Study|Adverse Event|3|||
125658809|NCT03506425|452037534|FG002|Overall Study|Adverse Event|0|||
125317759|NCT01601535|450792446|FG000|Phase 1|Adverse Event|1|||
125317760|NCT01601535|450792447|FG001|Phase 1|Adverse Event|0|||
125317761|NCT01601535|450792448|FG002|Phase 1|Adverse Event|2|||
125317762|NCT01601535|450792449|FG003|Phase 1|Adverse Event|1|||
125317763|NCT01601535|450792450|FG004|Phase 1|Adverse Event|0|||
125317764|NCT01601535|450792451|FG005|Phase 1|Adverse Event|0|||
125317765|NCT01601535|450792446|FG000|Phase 1|Withdrawal by Subject|2|||
125317766|NCT01601535|450792447|FG001|Phase 1|Withdrawal by Subject|1|||
125317767|NCT01601535|450792448|FG002|Phase 1|Withdrawal by Subject|1|||
125540505|NCT00432666|451609357|FG000|Main Period|Consent Withdrawn|1|||
125658810|NCT03506425|452037532|FG000|Overall Study|Death|1|||
125658811|NCT03506425|452037533|FG001|Overall Study|Death|0|||
125317768|NCT01601535|450792449|FG003|Phase 1|Withdrawal by Subject|2|||
125317769|NCT01601535|450792450|FG004|Phase 1|Withdrawal by Subject|0|||
125317770|NCT01601535|450792451|FG005|Phase 1|Withdrawal by Subject|0|||
125317771|NCT01601535|450792446|FG000|Phase 1|Progressive Disease|2|||
125317772|NCT01601535|450792447|FG001|Phase 1|Progressive Disease|3|||
125317773|NCT01601535|450792448|FG002|Phase 1|Progressive Disease|2|||
125317774|NCT01601535|450792449|FG003|Phase 1|Progressive Disease|1|||
125317775|NCT01601535|450792450|FG004|Phase 1|Progressive Disease|0|||
125317776|NCT01601535|450792451|FG005|Phase 1|Progressive Disease|0|||
125317777|NCT01601535|450792446|FG000|Phase 1|Started Another Treatment|1|||
125317778|NCT01601535|450792447|FG001|Phase 1|Started Another Treatment|2|||
125317779|NCT01601535|450792448|FG002|Phase 1|Started Another Treatment|0|||
125317780|NCT01601535|450792449|FG003|Phase 1|Started Another Treatment|0|||
125317781|NCT01601535|450792450|FG004|Phase 1|Started Another Treatment|0|||
125317782|NCT01601535|450792451|FG005|Phase 1|Started Another Treatment|0|||
125317783|NCT01601535|450792446|FG000|Phase 2|Adverse Event|0|||
125317784|NCT01601535|450792447|FG001|Phase 2|Adverse Event|0|||
125317785|NCT01601535|450792448|FG002|Phase 2|Adverse Event|0|||
125317786|NCT01601535|450792449|FG003|Phase 2|Adverse Event|0|||
125317787|NCT01601535|450792450|FG004|Phase 2|Adverse Event|5|||
125317788|NCT01601535|450792451|FG005|Phase 2|Adverse Event|1|||
125317789|NCT01601535|450792446|FG000|Phase 2|Withdrawal by Subject|0|||
125317790|NCT01601535|450792447|FG001|Phase 2|Withdrawal by Subject|0|||
125317791|NCT01601535|450792448|FG002|Phase 2|Withdrawal by Subject|0|||
125317792|NCT01601535|450792449|FG003|Phase 2|Withdrawal by Subject|0|||
125317793|NCT01601535|450792450|FG004|Phase 2|Withdrawal by Subject|8|||
125317794|NCT01601535|450792451|FG005|Phase 2|Withdrawal by Subject|2|||
125317795|NCT01601535|450792446|FG000|Phase 2|Progressive Disease|0|||
125317796|NCT01601535|450792447|FG001|Phase 2|Progressive Disease|0|||
125317797|NCT01601535|450792448|FG002|Phase 2|Progressive Disease|0|||
125317798|NCT01601535|450792449|FG003|Phase 2|Progressive Disease|0|||
125317799|NCT01601535|450792450|FG004|Phase 2|Progressive Disease|5|||
125317800|NCT01601535|450792451|FG005|Phase 2|Progressive Disease|7|||
125317801|NCT01601535|450792446|FG000|Phase 2|Started Another Treatment|0|||
125317802|NCT01601535|450792447|FG001|Phase 2|Started Another Treatment|0|||
125317803|NCT01601535|450792448|FG002|Phase 2|Started Another Treatment|0|||
125317804|NCT01601535|450792449|FG003|Phase 2|Started Another Treatment|0|||
125317805|NCT01601535|450792450|FG004|Phase 2|Started Another Treatment|1|||
125317806|NCT01601535|450792451|FG005|Phase 2|Started Another Treatment|2|||
125317807|NCT03649074|450792452|FG000|Overall Study|Lost to Follow-up|2|||
125317808|NCT03649074|450792453|FG001|Overall Study|Lost to Follow-up|1|||
125317809|NCT03649074|450792452|FG000|Overall Study|Adverse Event|1|||
125317810|NCT03649074|450792453|FG001|Overall Study|Adverse Event|0|||
125317811|NCT03649074|450792452|FG000|Overall Study|Physician Decision|1|||
125317812|NCT03649074|450792453|FG001|Overall Study|Physician Decision|0|||
125317813|NCT03649074|450792452|FG000|Overall Study|Withdrawal by Subject|0|||
125317814|NCT03649074|450792453|FG001|Overall Study|Withdrawal by Subject|2|||
125317815|NCT03649074|450792452|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
125317816|NCT03649074|450792453|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
125317817|NCT03649074|450792452|FG000|Overall Study|Other|1|||
125317818|NCT03649074|450792453|FG001|Overall Study|Other|0|||
125317819|NCT00795704|450792454|FG000|Overall Study|Withdrawal by Subject|3|||
125317820|NCT00795704|450792455|FG001|Overall Study|Withdrawal by Subject|2|||
125317821|NCT00795704|450792454|FG000|Overall Study|Adverse Event|1|||
125317822|NCT00795704|450792455|FG001|Overall Study|Adverse Event|1|||
125317823|NCT03980730|450792456|FG000|Overall Study|Study Terminated by Sponsor|0|||
125317824|NCT03980730|450792457|FG001|Overall Study|Study Terminated by Sponsor|3|||
125317825|NCT03980730|450792456|FG000|Overall Study|Adverse Event|2|||
125317826|NCT03980730|450792457|FG001|Overall Study|Adverse Event|0|||
125317827|NCT03980730|450792456|FG000|Overall Study|Sponsor Request|0|||
125317828|NCT03980730|450792457|FG001|Overall Study|Sponsor Request|1|||
125317829|NCT00556894|450792458|FG000|Overall Study|Adverse Event|2|||
125317830|NCT00556894|450792459|FG001|Overall Study|Adverse Event|3|||
125317831|NCT00556894|450792460|FG002|Overall Study|Adverse Event|3|||
125317832|NCT00556894|450792458|FG000|Overall Study|Death|1|||
125317833|NCT00556894|450792459|FG001|Overall Study|Death|0|||
125317834|NCT00556894|450792460|FG002|Overall Study|Death|0|||
125317835|NCT00556894|450792458|FG000|Overall Study|regulatory decision in Bulgaria|10|||
125317836|NCT00556894|450792459|FG001|Overall Study|regulatory decision in Bulgaria|14|||
125317837|NCT00556894|450792460|FG002|Overall Study|regulatory decision in Bulgaria|13|||
125317838|NCT00556894|450792458|FG000|Overall Study|Change in therapy|2|||
125658812|NCT03506425|452037534|FG002|Overall Study|Death|0|||
125658813|NCT03506425|452037532|FG000|Overall Study|Withdrawal by Subject|0|||
125317839|NCT00556894|450792459|FG001|Overall Study|Change in therapy|1|||
125317840|NCT00556894|450792460|FG002|Overall Study|Change in therapy|2|||
125317841|NCT00556894|450792458|FG000|Overall Study|Withdrawal by Subject|1|||
125317842|NCT00556894|450792459|FG001|Overall Study|Withdrawal by Subject|1|||
125317843|NCT00556894|450792460|FG002|Overall Study|Withdrawal by Subject|1|||
125317844|NCT00880620|450792461|FG000|Overall Study|Adverse Event|4|||
125317845|NCT00880620|450792462|FG001|Overall Study|Adverse Event|5|||
125317846|NCT00880620|450792463|FG002|Overall Study|Adverse Event|15|||
125317847|NCT00880620|450792464|FG003|Overall Study|Adverse Event|15|||
125317848|NCT00880620|450792461|FG000|Overall Study|Death|0|||
125317849|NCT00880620|450792462|FG001|Overall Study|Death|0|||
125317850|NCT00880620|450792463|FG002|Overall Study|Death|1|||
125317851|NCT00880620|450792464|FG003|Overall Study|Death|0|||
125317852|NCT00880620|450792461|FG000|Overall Study|Lack of Efficacy|12|||
125317853|NCT00880620|450792462|FG001|Overall Study|Lack of Efficacy|4|||
125317854|NCT00880620|450792463|FG002|Overall Study|Lack of Efficacy|0|||
125317855|NCT00880620|450792464|FG003|Overall Study|Lack of Efficacy|1|||
125317856|NCT00880620|450792461|FG000|Overall Study|Lost to Follow-up|0|||
125317857|NCT00880620|450792462|FG001|Overall Study|Lost to Follow-up|1|||
125317858|NCT00880620|450792463|FG002|Overall Study|Lost to Follow-up|1|||
125317859|NCT00880620|450792464|FG003|Overall Study|Lost to Follow-up|0|||
125317860|NCT00880620|450792461|FG000|Overall Study|Protocol Violation|0|||
125317861|NCT00880620|450792462|FG001|Overall Study|Protocol Violation|1|||
125317862|NCT00880620|450792463|FG002|Overall Study|Protocol Violation|0|||
125317863|NCT00880620|450792464|FG003|Overall Study|Protocol Violation|2|||
125317864|NCT00880620|450792461|FG000|Overall Study|Withdrawal by Subject|4|||
125317865|NCT00880620|450792462|FG001|Overall Study|Withdrawal by Subject|3|||
125317866|NCT00880620|450792463|FG002|Overall Study|Withdrawal by Subject|1|||
125317867|NCT00880620|450792464|FG003|Overall Study|Withdrawal by Subject|3|||
125317868|NCT00880620|450792461|FG000|Overall Study|Noncompliance|0|||
125317869|NCT00880620|450792462|FG001|Overall Study|Noncompliance|0|||
125317870|NCT00880620|450792463|FG002|Overall Study|Noncompliance|1|||
125317871|NCT00880620|450792464|FG003|Overall Study|Noncompliance|1|||
125317872|NCT00880620|450792461|FG000|Overall Study|Other|1|||
125317873|NCT00880620|450792462|FG001|Overall Study|Other|1|||
125317874|NCT00880620|450792463|FG002|Overall Study|Other|2|||
125317875|NCT00880620|450792464|FG003|Overall Study|Other|2|||
125317876|NCT03883581|450792466|FG000|Overall Study|Withdrawal by Subject|4|||
125317877|NCT04612725|450792467|FG000|Overall Study|Adverse Event|1|||
125317878|NCT04612725|450792468|FG001|Overall Study|Adverse Event|3|||
125317879|NCT04612725|450792469|FG002|Overall Study|Adverse Event|1|||
125317880|NCT04612725|450792470|FG003|Overall Study|Adverse Event|0|||
125317881|NCT04612725|450792471|FG004|Overall Study|Adverse Event|1|||
125317882|NCT04612725|450792467|FG000|Overall Study|Lost to Follow-up|0|||
125317883|NCT04612725|450792468|FG001|Overall Study|Lost to Follow-up|1|||
125317884|NCT04612725|450792469|FG002|Overall Study|Lost to Follow-up|0|||
125317885|NCT04612725|450792470|FG003|Overall Study|Lost to Follow-up|0|||
125317886|NCT04612725|450792471|FG004|Overall Study|Lost to Follow-up|0|||
125317887|NCT04612725|450792467|FG000|Overall Study|Physician Decision|2|||
125317888|NCT04612725|450792468|FG001|Overall Study|Physician Decision|0|||
125317889|NCT04612725|450792469|FG002|Overall Study|Physician Decision|0|||
125317890|NCT04612725|450792470|FG003|Overall Study|Physician Decision|0|||
125317891|NCT04612725|450792471|FG004|Overall Study|Physician Decision|0|||
125317892|NCT04612725|450792467|FG000|Overall Study|Study terminated by sponsor|3|||
125317893|NCT04612725|450792468|FG001|Overall Study|Study terminated by sponsor|1|||
125317894|NCT04612725|450792469|FG002|Overall Study|Study terminated by sponsor|2|||
125317895|NCT04612725|450792470|FG003|Overall Study|Study terminated by sponsor|4|||
125317896|NCT04612725|450792471|FG004|Overall Study|Study terminated by sponsor|5|||
125317897|NCT04612725|450792467|FG000|Overall Study|Withdrawal by Subject|8|||
125317898|NCT04612725|450792468|FG001|Overall Study|Withdrawal by Subject|3|||
125317899|NCT04612725|450792469|FG002|Overall Study|Withdrawal by Subject|5|||
125317900|NCT04612725|450792470|FG003|Overall Study|Withdrawal by Subject|1|||
125317901|NCT04612725|450792471|FG004|Overall Study|Withdrawal by Subject|9|||
125317902|NCT04612725|450792467|FG000|Overall Study|Other|0|||
125317903|NCT04612725|450792468|FG001|Overall Study|Other|0|||
125317904|NCT04612725|450792469|FG002|Overall Study|Other|0|||
125317905|NCT04612725|450792470|FG003|Overall Study|Other|0|||
125317906|NCT04612725|450792471|FG004|Overall Study|Other|1|||
125317907|NCT02354235|450792472|FG000|Overall Study|Adverse Event|2|||
125317908|NCT02354235|450792473|FG001|Overall Study|Adverse Event|2|||
125317909|NCT02354235|450792472|FG000|Overall Study|Physician Decision|0|||
125317910|NCT02354235|450792473|FG001|Overall Study|Physician Decision|1|||
125317911|NCT02354235|450792472|FG000|Overall Study|Withdrawal by Subject|1|||
125317912|NCT02354235|450792473|FG001|Overall Study|Withdrawal by Subject|3|||
125317913|NCT02354235|450792472|FG000|Overall Study|Conflict with the stopping criteria|0|||
125317914|NCT02354235|450792473|FG001|Overall Study|Conflict with the stopping criteria|1|||
125317915|NCT04750642|450792476|FG000|Overall Study|Adverse Event|1|||
125317916|NCT04750642|450792477|FG001|Overall Study|Adverse Event|0|||
125317917|NCT04750642|450792476|FG000|Overall Study|Withdrawal by Subject|0|||
125317918|NCT04750642|450792477|FG001|Overall Study|Withdrawal by Subject|1|||
125317919|NCT04750642|450792476|FG000|Overall Study|Protocol Violation|0|||
125317920|NCT04750642|450792477|FG001|Overall Study|Protocol Violation|1|||
125317921|NCT02926638|450792478|FG000|Overall Study|Progression|2|||
125317922|NCT02926638|450792479|FG001|Overall Study|Progression|5|||
125317923|NCT02926638|450792478|FG000|Overall Study|Ineligible|1|||
125317924|NCT02926638|450792479|FG001|Overall Study|Ineligible|0|||
125317925|NCT02926638|450792478|FG000|Overall Study|Not protocol specified|1|||
125317926|NCT02926638|450792479|FG001|Overall Study|Not protocol specified|0|||
125317927|NCT00644423|450793888|FG000|Overall Study|Lost to Follow-up|1|||
125317928|NCT00644423|450793889|FG001|Overall Study|Lost to Follow-up|1|||
125317929|NCT02426580|450793890|FG000|Overall Study|Death|2|||
125317930|NCT02426580|450793891|FG001|Overall Study|Death|2|||
125658814|NCT03506425|452037533|FG001|Overall Study|Withdrawal by Subject|0|||
125658815|NCT03506425|452037534|FG002|Overall Study|Withdrawal by Subject|1|||
125658816|NCT02643394|452037537|FG000|Overall Study|Protocol Violation|4|||
125658817|NCT02643394|452037538|FG001|Overall Study|Protocol Violation|5|||
125658818|NCT04088734|452037539|FG000|Overall Study|Other, Not Specified|5|||
125658819|NCT00096200|452037540|FG000|Overall Study|Adverse Event|0|||
125658820|NCT00096200|452037541|FG001|Overall Study|Adverse Event|4|||
125317931|NCT02426580|450793890|FG000|Overall Study|Lost to Follow-up|0|||
125317932|NCT02426580|450793891|FG001|Overall Study|Lost to Follow-up|9|||
125317933|NCT02426580|450793890|FG000|Overall Study|transfer to hemodialysis|5|||
125317934|NCT02426580|450793891|FG001|Overall Study|transfer to hemodialysis|5|||
125317935|NCT02426580|450793890|FG000|Overall Study|Kidney transplant|3|||
125317936|NCT02426580|450793891|FG001|Overall Study|Kidney transplant|0|||
125317937|NCT02426580|450793890|FG000|Overall Study|Allergic to egg white|1|||
125317938|NCT02426580|450793891|FG001|Overall Study|Allergic to egg white|0|||
125317939|NCT00445549|450793892|FG000|Overall Study|progressive disease|12|||
125317940|NCT00768989|450793895|FG000|Prior to Week 24|Withdrawal by Subject|1|||
125317941|NCT00768989|450793896|FG001|Prior to Week 24|Withdrawal by Subject|0|||
125317942|NCT00768989|450793895|FG000|Prior to Week 24|Adverse Event|3|||
125317943|NCT00768989|450793896|FG001|Prior to Week 24|Adverse Event|0|||
125317944|NCT00768989|450793895|FG000|Prior to Week 24|Lost to Follow-up|0|||
125317945|NCT00768989|450793896|FG001|Prior to Week 24|Lost to Follow-up|1|||
125317946|NCT00768989|450793895|FG000|Prior to Week 24|Protocol Violation|0|||
125317947|NCT00768989|450793896|FG001|Prior to Week 24|Protocol Violation|2|||
125317948|NCT00768989|450793895|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
125317949|NCT00768989|450793896|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
125317950|NCT00768989|450793895|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
125317951|NCT00768989|450793896|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
125317952|NCT00768989|450793895|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
125317953|NCT00768989|450793896|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
125317954|NCT00768989|450793895|FG000|On or After Week 36|Lack of Efficacy|1|||
125317955|NCT00768989|450793896|FG001|On or After Week 36|Lack of Efficacy|0|||
125317956|NCT00768989|450793895|FG000|On or After Week 36|Adverse Event|0|||
125317957|NCT00768989|450793896|FG001|On or After Week 36|Adverse Event|1|||
125317958|NCT00768989|450793895|FG000|On or After Week 36|Lost to Follow-up|1|||
125317959|NCT00768989|450793896|FG001|On or After Week 36|Lost to Follow-up|0|||
125317960|NCT00768989|450793895|FG000|On or After Week 36|Poor Compliance|1|||
125317961|NCT00768989|450793896|FG001|On or After Week 36|Poor Compliance|0|||
125317962|NCT00768989|450793895|FG000|On or After Week 36|Protocol Violation|1|||
125317963|NCT00768989|450793896|FG001|On or After Week 36|Protocol Violation|0|||
125317964|NCT00768989|450793895|FG000|On or After Week 36|Did not attend termination visit|2|||
125317965|NCT00768989|450793896|FG001|On or After Week 36|Did not attend termination visit|0|||
125317966|NCT00768989|450793895|FG000|On or After Week 36|Sponsor Termination|45|||
125317967|NCT00768989|450793896|FG001|On or After Week 36|Sponsor Termination|26|||
125317968|NCT00718510|450793905|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
125317969|NCT00718510|450793906|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125317970|NCT00718510|450793905|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
125317971|NCT00718510|450793906|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
125317972|NCT00844376|450793912|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
125317973|NCT00844376|450793913|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
125317974|NCT01011673|450793914|FG000|Randomized|Secondary headache|2|||
125317975|NCT01011673|450793915|FG001|Randomized|Secondary headache|1|||
125317976|NCT01011673|450793914|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
125317977|NCT01011673|450793915|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
125317978|NCT00549640|450793916|FG000|Overall Study|Withdrawal by Subject|6|||
125317979|NCT00549640|450793917|FG001|Overall Study|Withdrawal by Subject|12|||
125317980|NCT00549640|450793916|FG000|Overall Study|Adverse Event|5|||
125317981|NCT00549640|450793917|FG001|Overall Study|Adverse Event|0|||
125317982|NCT00549640|450793916|FG000|Overall Study|Lost to Follow-up|7|||
125317983|NCT00549640|450793917|FG001|Overall Study|Lost to Follow-up|4|||
125317984|NCT00660192|450793918|FG000|Overall Study|Lost to Follow-up|2|||
125317985|NCT00660192|450793919|FG001|Overall Study|Lost to Follow-up|3|||
125317986|NCT02734693|450793920|FG000|Overall Study|Adverse Event|1|||
125317987|NCT02734693|450793921|FG001|Overall Study|Adverse Event|3|||
125317988|NCT02734693|450793922|FG002|Overall Study|Adverse Event|3|||
125317989|NCT02734693|450793920|FG000|Overall Study|Lack of Efficacy|1|||
125317990|NCT02734693|450793921|FG001|Overall Study|Lack of Efficacy|0|||
125317991|NCT02734693|450793922|FG002|Overall Study|Lack of Efficacy|0|||
125317992|NCT02734693|450793920|FG000|Overall Study|Lost to Follow-up|2|||
125317993|NCT02734693|450793921|FG001|Overall Study|Lost to Follow-up|0|||
125317994|NCT02734693|450793922|FG002|Overall Study|Lost to Follow-up|0|||
125317995|NCT02734693|450793920|FG000|Overall Study|Protocol Violation|1|||
125658821|NCT00096200|452037542|FG002|Overall Study|Adverse Event|0|||
125317996|NCT02734693|450793921|FG001|Overall Study|Protocol Violation|0|||
125317997|NCT02734693|450793922|FG002|Overall Study|Protocol Violation|0|||
125317998|NCT02734693|450793920|FG000|Overall Study|Withdrawal by Subject|1|||
125317999|NCT02734693|450793921|FG001|Overall Study|Withdrawal by Subject|0|||
125318000|NCT02734693|450793922|FG002|Overall Study|Withdrawal by Subject|0|||
125318001|NCT03740048|450793924|FG000|Overall Study|Withdrawal by Subject|1|||
125318002|NCT03740048|450793925|FG001|Overall Study|Withdrawal by Subject|1|||
125318003|NCT03740048|450793924|FG000|Overall Study|Death|1|||
125318004|NCT03740048|450793925|FG001|Overall Study|Death|6|||
125318005|NCT03740048|450793924|FG000|Overall Study|Switched to thrice-weekly HD|2|||
125318006|NCT03740048|450793925|FG001|Overall Study|Switched to thrice-weekly HD|0|||
125318007|NCT03740048|450793924|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
125318008|NCT03740048|450793925|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
125318009|NCT03740048|450793924|FG000|Overall Study|Lost to Follow-up|0|||
125318010|NCT03740048|450793925|FG001|Overall Study|Lost to Follow-up|1|||
125318011|NCT03740048|450793924|FG000|Overall Study|Non-compliance with HD|0|||
125318012|NCT03740048|450793925|FG001|Overall Study|Non-compliance with HD|1|||
125318013|NCT01476722|450793926|FG000|Overall Study|Adverse Event|1|||
125318014|NCT03261336|450793927|FG000|Overall Study|Adverse Event|1|||
125318015|NCT01069484|450793929|FG000|Overall Study|Death-in-near-family|1|||
125318016|NCT01069484|450793930|FG001|Overall Study|Death-in-near-family|0|||
125318017|NCT01069484|450793929|FG000|Overall Study|No specific reason|8|||
125318018|NCT01069484|450793930|FG001|Overall Study|No specific reason|2|||
125318019|NCT01069484|450793929|FG000|Overall Study|Illness mother or child|3|||
125318020|NCT01069484|450793930|FG001|Overall Study|Illness mother or child|1|||
125318021|NCT00292942|450793932|FG000|Overall Study|Withdrawal by Subject|0|||
125318022|NCT00292942|450793933|FG001|Overall Study|Withdrawal by Subject|0|||
125318023|NCT00292942|450793934|FG002|Overall Study|Withdrawal by Subject|1|||
125318024|NCT00292942|450793935|FG003|Overall Study|Withdrawal by Subject|0|||
125318025|NCT00292942|450793932|FG000|Overall Study|Adverse Event|0|||
125318026|NCT00292942|450793933|FG001|Overall Study|Adverse Event|0|||
125318027|NCT00292942|450793934|FG002|Overall Study|Adverse Event|0|||
125318028|NCT00292942|450793935|FG003|Overall Study|Adverse Event|1|||
125318029|NCT00644358|450793936|FG000|Overall Study|Adverse Event|124|||
125318030|NCT00644358|450793936|FG000|Overall Study|Lost to Follow-up|105|||
125318031|NCT00644358|450793936|FG000|Overall Study|Consent Withdrawal|64|||
125318032|NCT00644358|450793936|FG000|Overall Study|Lack of Effectiveness|39|||
125318033|NCT00644358|450793936|FG000|Overall Study|Protocol Violation|5|||
125318034|NCT00644358|450793936|FG000|Overall Study|Noncompliance|14|||
125318035|NCT00644358|450793936|FG000|Overall Study|Other Unspecified|11|||
125318036|NCT00651924|450793943|FG000|Overall Study|Withdrawal by PI|0|||
125318037|NCT00651924|450793944|FG001|Overall Study|Withdrawal by PI|2|||
125318038|NCT00651924|450793943|FG000|Overall Study|Withdrawal by Subject|0|||
125318039|NCT00651924|450793944|FG001|Overall Study|Withdrawal by Subject|5|||
125318040|NCT00758771|450793945|FG000|Overall Study|Withdrawal by Subject|1|||
125318041|NCT00758771|450793946|FG001|Overall Study|Withdrawal by Subject|1|||
125318042|NCT00758771|450793945|FG000|Overall Study|Did not meet eligibility criteria|2|||
125318043|NCT00758771|450793946|FG001|Overall Study|Did not meet eligibility criteria|4|||
125318044|NCT00960063|450793947|FG000|Overall Study|Adverse Event|1|||
125318045|NCT00960063|450793948|FG001|Overall Study|Adverse Event|0|||
125318046|NCT00960063|450793949|FG002|Overall Study|Adverse Event|0|||
125318047|NCT00960063|450793947|FG000|Overall Study|Progression of Disease|0|||
125318048|NCT00960063|450793948|FG001|Overall Study|Progression of Disease|0|||
125318049|NCT00960063|450793949|FG002|Overall Study|Progression of Disease|3|||
125318050|NCT00771914|450793950|FG000|Overall Study|Physician Decision|0|||
125318051|NCT00771914|450793951|FG001|Overall Study|Physician Decision|0|||
125318052|NCT00771914|450793952|FG002|Overall Study|Physician Decision|0|||
125318053|NCT00771914|450793953|FG003|Overall Study|Physician Decision|1|||
125318054|NCT00771914|450793950|FG000|Overall Study|Lost to Follow-up|0|||
125318055|NCT00771914|450793951|FG001|Overall Study|Lost to Follow-up|0|||
125318056|NCT00771914|450793952|FG002|Overall Study|Lost to Follow-up|0|||
125318057|NCT00771914|450793953|FG003|Overall Study|Lost to Follow-up|1|||
125318058|NCT02978417|450793957|FG000|Overall Study|Lost to Follow-up|2|||
125318059|NCT02978417|450793958|FG001|Overall Study|Lost to Follow-up|2|||
125318060|NCT05083351|450793963|FG000|Overall Study|Adverse Event|3|||
125318061|NCT05083351|450793963|FG000|Overall Study|Did not meet data inclusion criteria|8|||
125318062|NCT05083351|450793963|FG000|Overall Study|Did not meet eligibility criteria|19|||
125318063|NCT05083351|450793963|FG000|Overall Study|Study Staff Decision|19|||
125318064|NCT01759420|450793969|FG000|Overall Study|Screen failure|5|||
125318065|NCT01759420|450793969|FG000|Overall Study|Inaccurate EKG machine readings|1|||
125318066|NCT01129622|450793972|FG000|Overall Study|Withdrawal by Subject|2|||
125318067|NCT00960375|450793975|FG000|Overall Study|Lost to Follow-up|20|||
125318068|NCT00960375|450793976|FG001|Overall Study|Lost to Follow-up|22|||
125318069|NCT00591006|450793977|FG000|Overall Study|Withdrawal by Subject|0|||
125658822|NCT00096200|452037540|FG000|Overall Study|Withdrawal by Subject|1|||
125318070|NCT00591006|450793978|FG001|Overall Study|Withdrawal by Subject|0|||
125318071|NCT00591006|450793979|FG002|Overall Study|Withdrawal by Subject|0|||
125318072|NCT00591006|450793980|FG003|Overall Study|Withdrawal by Subject|0|||
125318073|NCT00591006|450793981|FG004|Overall Study|Withdrawal by Subject|0|||
125318074|NCT00591006|450793982|FG005|Overall Study|Withdrawal by Subject|0|||
125318075|NCT00591006|450793983|FG006|Overall Study|Withdrawal by Subject|0|||
125318076|NCT00591006|450793984|FG007|Overall Study|Withdrawal by Subject|0|||
125318077|NCT00591006|450793985|FG008|Overall Study|Withdrawal by Subject|0|||
125318078|NCT00591006|450793986|FG009|Overall Study|Withdrawal by Subject|0|||
125318079|NCT00591006|450793987|FG010|Overall Study|Withdrawal by Subject|0|||
125318080|NCT00591006|450793988|FG011|Overall Study|Withdrawal by Subject|0|||
125318081|NCT00591006|450793989|FG012|Overall Study|Withdrawal by Subject|0|||
125318082|NCT00591006|450793990|FG013|Overall Study|Withdrawal by Subject|0|||
125318083|NCT00591006|450793991|FG014|Overall Study|Withdrawal by Subject|0|||
125318084|NCT00591006|450793992|FG015|Overall Study|Withdrawal by Subject|1|||
125318085|NCT00591006|450793993|FG016|Overall Study|Withdrawal by Subject|0|||
125318086|NCT00591006|450793994|FG017|Overall Study|Withdrawal by Subject|0|||
125318087|NCT00591006|450793995|FG018|Overall Study|Withdrawal by Subject|0|||
125318088|NCT00591006|450793996|FG019|Overall Study|Withdrawal by Subject|0|||
125318089|NCT00591006|450793997|FG020|Overall Study|Withdrawal by Subject|0|||
125318090|NCT00591006|450793998|FG021|Overall Study|Withdrawal by Subject|0|||
125318091|NCT00591006|450793999|FG022|Overall Study|Withdrawal by Subject|0|||
125318092|NCT00591006|450794000|FG023|Overall Study|Withdrawal by Subject|1|||
125318093|NCT00591006|450793977|FG000|Overall Study|Adverse Event|0|||
125318094|NCT00591006|450793978|FG001|Overall Study|Adverse Event|0|||
125318095|NCT00591006|450793979|FG002|Overall Study|Adverse Event|0|||
125318096|NCT00591006|450793980|FG003|Overall Study|Adverse Event|0|||
125318097|NCT00591006|450793981|FG004|Overall Study|Adverse Event|0|||
125318098|NCT00591006|450793982|FG005|Overall Study|Adverse Event|0|||
125318099|NCT00591006|450793983|FG006|Overall Study|Adverse Event|0|||
125318100|NCT00591006|450793984|FG007|Overall Study|Adverse Event|0|||
125318101|NCT00591006|450793985|FG008|Overall Study|Adverse Event|0|||
125318102|NCT00591006|450793986|FG009|Overall Study|Adverse Event|0|||
125318103|NCT00591006|450793987|FG010|Overall Study|Adverse Event|0|||
125318104|NCT00591006|450793988|FG011|Overall Study|Adverse Event|0|||
125318105|NCT00591006|450793989|FG012|Overall Study|Adverse Event|0|||
125318106|NCT00591006|450793990|FG013|Overall Study|Adverse Event|0|||
125318107|NCT00591006|450793991|FG014|Overall Study|Adverse Event|0|||
125318108|NCT00591006|450793992|FG015|Overall Study|Adverse Event|0|||
125318109|NCT00591006|450793993|FG016|Overall Study|Adverse Event|0|||
125318110|NCT00591006|450793994|FG017|Overall Study|Adverse Event|0|||
125318111|NCT00591006|450793995|FG018|Overall Study|Adverse Event|0|||
125318112|NCT00591006|450793996|FG019|Overall Study|Adverse Event|0|||
125318113|NCT00591006|450793997|FG020|Overall Study|Adverse Event|0|||
125318114|NCT00591006|450793998|FG021|Overall Study|Adverse Event|0|||
125318115|NCT00591006|450793999|FG022|Overall Study|Adverse Event|1|||
125318116|NCT00591006|450794000|FG023|Overall Study|Adverse Event|0|||
125318117|NCT00689390|450794001|FG000|Overall Study|Adverse Event|19|||
125318118|NCT00689390|450794002|FG001|Overall Study|Adverse Event|0|||
125318119|NCT00689390|450794001|FG000|Overall Study|Lost to Follow-up|179|||
125318120|NCT00689390|450794002|FG001|Overall Study|Lost to Follow-up|7|||
125318121|NCT00689390|450794001|FG000|Overall Study|Withdrawal by Subject|117|||
125318122|NCT00689390|450794002|FG001|Overall Study|Withdrawal by Subject|3|||
125318123|NCT00689390|450794001|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
125318124|NCT00689390|450794002|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
125318125|NCT00689390|450794001|FG000|Overall Study|Non-Compliance With Protocol|21|||
125658823|NCT00096200|452037541|FG001|Overall Study|Withdrawal by Subject|2|||
125658824|NCT00096200|452037542|FG002|Overall Study|Withdrawal by Subject|0|||
125658825|NCT00096200|452037540|FG000|Overall Study|Ineligible pathology|0|||
125658826|NCT00096200|452037541|FG001|Overall Study|Ineligible pathology|1|||
125658827|NCT00096200|452037542|FG002|Overall Study|Ineligible pathology|0|||
125658828|NCT03083639|452037549|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
125658829|NCT03083639|452037550|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
125658830|NCT03083639|452037549|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
125658831|NCT03083639|452037550|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
125658832|NCT02125734|452037551|FG000|Period 2|Adverse Event|0|||
125658833|NCT02125734|452037552|FG001|Period 2|Adverse Event|1|||
125658834|NCT01591499|452037553|FG000|Baseline Visit|Withdrawal by Subject|0|||
125658835|NCT01591499|452037554|FG001|Baseline Visit|Withdrawal by Subject|2|||
125658836|NCT01591499|452037555|FG002|Baseline Visit|Withdrawal by Subject|0|||
125658837|NCT01591499|452037556|FG003|Baseline Visit|Withdrawal by Subject|2|||
125658838|NCT01591499|452037553|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
125658839|NCT01591499|452037554|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
125658840|NCT01591499|452037555|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
125658841|NCT01591499|452037556|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
125658842|NCT01591499|452037553|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
125658843|NCT01591499|452037554|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
125658844|NCT01591499|452037555|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
125318126|NCT00689390|450794002|FG001|Overall Study|Non-Compliance With Protocol|0|||
125540506|NCT00432666|451609358|FG001|Main Period|Consent Withdrawn|0|||
125658845|NCT01591499|452037556|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
125658846|NCT02704130|452037557|FG000|Overall Study|Physician Decision|5|||
125658847|NCT02704130|452037558|FG001|Overall Study|Physician Decision|3|||
125658848|NCT02666768|452037559|FG000|Overall Study|Withdrawal by Subject|4|||
125658849|NCT03940742|452037562|FG000|Overall Study|Lost to Follow-up|0|||
125658850|NCT03940742|452037563|FG001|Overall Study|Lost to Follow-up|0|||
125658851|NCT03940742|452037564|FG002|Overall Study|Lost to Follow-up|0|||
125658852|NCT03940742|452037565|FG003|Overall Study|Lost to Follow-up|1|||
125658853|NCT02032823|452037566|FG000|Overall Study|Death|75|||
125658854|NCT02032823|452037567|FG001|Overall Study|Death|109|||
125658855|NCT02032823|452037566|FG000|Overall Study|Lost to Follow-up|18|||
125658856|NCT02032823|452037567|FG001|Overall Study|Lost to Follow-up|17|||
125658857|NCT02032823|452037566|FG000|Overall Study|Withdrawal by Subject|70|||
125658858|NCT02032823|452037567|FG001|Overall Study|Withdrawal by Subject|53|||
125658859|NCT02032823|452037566|FG000|Overall Study|Ongoing study at data cut-off|755|||
125658860|NCT02032823|452037567|FG001|Overall Study|Ongoing study at data cut-off|731|||
125658861|NCT02032823|452037566|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
125658862|NCT02032823|452037567|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
125658863|NCT03889197|452037568|FG000|Overall Study|Withdrawal by Subject|1|||
125658864|NCT03889197|452037569|FG001|Overall Study|Withdrawal by Subject|0|||
125658865|NCT03889197|452037568|FG000|Overall Study|Physician Decision|0|||
125658866|NCT03889197|452037569|FG001|Overall Study|Physician Decision|1|||
125658867|NCT03889197|452037568|FG000|Overall Study|met exclusion criteria|0|||
125658868|NCT03889197|452037569|FG001|Overall Study|met exclusion criteria|1|||
125658869|NCT03889197|452037568|FG000|Overall Study|Protocol Violation|1|||
125658870|NCT03889197|452037569|FG001|Overall Study|Protocol Violation|0|||
125658871|NCT05246111|452037570|FG000|Period 01|NOT ELIGIBLE IC5|1|||
125658872|NCT05246111|452037571|FG001|Period 01|NOT ELIGIBLE IC5|0|||
125658873|NCT03078192|452037573|FG000|Overall Study|Withdrawal by Subject|2|||
125658874|NCT03078192|452037574|FG001|Overall Study|Withdrawal by Subject|1|||
125658875|NCT03078192|452037573|FG000|Overall Study|screen failure|0|||
125658876|NCT03078192|452037574|FG001|Overall Study|screen failure|3|||
125658877|NCT02508649|452037577|FG000|Overall Study|Withdrawal by Subject|4|||
125658878|NCT02508649|452037578|FG001|Overall Study|Withdrawal by Subject|6|||
125658879|NCT02508649|452037579|FG002|Overall Study|Withdrawal by Subject|5|||
125658880|NCT02508649|452037580|FG003|Overall Study|Withdrawal by Subject|6|||
125658881|NCT02508649|452037577|FG000|Overall Study|Investigator withdrew the subject|1|||
125658882|NCT02508649|452037578|FG001|Overall Study|Investigator withdrew the subject|2|||
125658883|NCT02508649|452037579|FG002|Overall Study|Investigator withdrew the subject|1|||
125658884|NCT02508649|452037580|FG003|Overall Study|Investigator withdrew the subject|0|||
125658885|NCT02508649|452037577|FG000|Overall Study|Post randomization screening failure|12|||
125658886|NCT02508649|452037578|FG001|Overall Study|Post randomization screening failure|4|||
125658887|NCT02508649|452037579|FG002|Overall Study|Post randomization screening failure|9|||
125658888|NCT02508649|452037580|FG003|Overall Study|Post randomization screening failure|3|||
125658889|NCT02508649|452037577|FG000|Overall Study|Lost to Follow-up|1|||
125658890|NCT02508649|452037578|FG001|Overall Study|Lost to Follow-up|1|||
125658891|NCT02508649|452037579|FG002|Overall Study|Lost to Follow-up|0|||
125658892|NCT02508649|452037580|FG003|Overall Study|Lost to Follow-up|1|||
125658893|NCT03594175|452037588|FG000|Overall Study|Not treated|8|||
125658894|NCT03594175|452037589|FG001|Overall Study|Not treated|1|||
125658895|NCT03594175|452037590|FG002|Overall Study|Not treated|5|||
125658896|NCT03594175|452037588|FG000|Overall Study|Adverse Event|3|||
125658897|NCT03594175|452037589|FG001|Overall Study|Adverse Event|0|||
125658898|NCT03594175|452037590|FG002|Overall Study|Adverse Event|0|||
125658899|NCT03594175|452037588|FG000|Overall Study|Withdrawal by Subject|3|||
125658900|NCT03594175|452037589|FG001|Overall Study|Withdrawal by Subject|0|||
125658901|NCT03594175|452037590|FG002|Overall Study|Withdrawal by Subject|0|||
125658902|NCT03594175|452037588|FG000|Overall Study|Protocol Violation|2|||
125658903|NCT03594175|452037589|FG001|Overall Study|Protocol Violation|2|||
125658904|NCT03594175|452037590|FG002|Overall Study|Protocol Violation|2|||
125658905|NCT01915498|452037591|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125658906|NCT01915498|452037592|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125658907|NCT01915498|452037593|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125658908|NCT01915498|452037594|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
125658909|NCT01915498|452037595|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
125658910|NCT01915498|452037596|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125658911|NCT01915498|452037597|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125658912|NCT01915498|452037598|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125658913|NCT01915498|452037599|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125658914|NCT01915498|452037600|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
125658915|NCT01915498|452037601|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125658916|NCT01915498|452037602|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125658917|NCT01915498|452037603|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
125658918|NCT01915498|452037604|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
125658919|NCT01915498|452037605|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
125658920|NCT01915498|452037606|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
125658921|NCT01915498|452037607|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
125658922|NCT01915498|452037608|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
125658923|NCT01915498|452037609|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
125658924|NCT01915498|452037591|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125658925|NCT01915498|452037592|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125658926|NCT01915498|452037593|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125658927|NCT01915498|452037594|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125658928|NCT01915498|452037595|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125658929|NCT01915498|452037596|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
125658930|NCT01915498|452037597|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125658931|NCT01915498|452037598|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125658932|NCT01915498|452037599|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125658933|NCT01915498|452037600|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
125658934|NCT01915498|452037601|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125658935|NCT01915498|452037602|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125658936|NCT01915498|452037603|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125658937|NCT01915498|452037604|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
125658938|NCT01915498|452037605|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
125658939|NCT01915498|452037606|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
125658940|NCT01915498|452037607|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
125658941|NCT01915498|452037608|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
125658942|NCT01915498|452037609|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
125658943|NCT01915498|452037591|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
125658944|NCT01915498|452037592|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658945|NCT01915498|452037593|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658946|NCT01915498|452037594|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658947|NCT01915498|452037595|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658948|NCT01915498|452037596|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
125658949|NCT01915498|452037597|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658950|NCT01915498|452037598|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658951|NCT01915498|452037599|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658952|NCT01915498|452037600|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658953|NCT01915498|452037601|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658954|NCT01915498|452037602|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658955|NCT01915498|452037603|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658956|NCT01915498|452037604|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658957|NCT01915498|452037605|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
125658958|NCT01915498|452037606|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658959|NCT01915498|452037607|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658960|NCT01915498|452037608|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
125658961|NCT01915498|452037609|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
125658962|NCT01915498|452037591|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658963|NCT01915498|452037592|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658964|NCT01915498|452037593|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658965|NCT01915498|452037594|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658966|NCT01915498|452037595|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658967|NCT01915498|452037596|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658968|NCT01915498|452037597|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658969|NCT01915498|452037598|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658970|NCT01915498|452037599|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658971|NCT01915498|452037600|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658972|NCT01915498|452037601|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
125658973|NCT01915498|452037602|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658974|NCT01915498|452037603|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658975|NCT01915498|452037604|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
125658976|NCT01915498|452037605|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658977|NCT01915498|452037606|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125540507|NCT00432666|451609357|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
125658978|NCT01915498|452037607|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
125658979|NCT01915498|452037608|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
125658980|NCT01915498|452037609|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
125658981|NCT01915498|452037591|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
125658982|NCT01915498|452037592|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
125658983|NCT01915498|452037593|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125658984|NCT01915498|452037594|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
125658985|NCT01915498|452037595|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125658986|NCT01915498|452037596|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125658987|NCT01915498|452037597|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
125658988|NCT01915498|452037598|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125658989|NCT01915498|452037599|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125658990|NCT01915498|452037600|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125658991|NCT01915498|452037601|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
125658992|NCT01915498|452037602|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125658993|NCT01915498|452037603|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
125658994|NCT01915498|452037604|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
125658995|NCT01915498|452037605|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
125658996|NCT01915498|452037606|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
125658997|NCT01915498|452037607|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
125658998|NCT01915498|452037608|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
125658999|NCT01915498|452037609|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
125659000|NCT01915498|452037591|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125659001|NCT01915498|452037592|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125659002|NCT01915498|452037593|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
125659003|NCT01915498|452037594|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125659004|NCT01915498|452037595|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125659005|NCT01915498|452037596|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125659006|NCT01915498|452037597|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125659007|NCT01915498|452037598|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125318127|NCT00689390|450794001|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
125318128|NCT00689390|450794002|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
125659008|NCT01915498|452037599|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125659009|NCT01915498|452037600|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125659010|NCT01915498|452037601|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125659011|NCT01915498|452037602|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125659012|NCT01915498|452037603|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125659013|NCT01915498|452037604|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125659014|NCT01915498|452037605|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125659015|NCT01915498|452037606|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
125659016|NCT01915498|452037607|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
125659017|NCT01915498|452037608|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
125659018|NCT01915498|452037609|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
125659019|NCT01915498|452037591|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659020|NCT01915498|452037592|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659021|NCT01915498|452037593|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659022|NCT01915498|452037594|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659023|NCT01915498|452037595|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
125659024|NCT01915498|452037596|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659025|NCT01915498|452037597|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659026|NCT01915498|452037598|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659027|NCT01915498|452037599|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659028|NCT01915498|452037600|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
125659029|NCT01915498|452037601|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659030|NCT01915498|452037602|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659031|NCT01915498|452037603|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659032|NCT01915498|452037604|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659033|NCT01915498|452037605|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659034|NCT01915498|452037606|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659035|NCT01915498|452037607|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659036|NCT01915498|452037608|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659037|NCT01915498|452037609|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
125659038|NCT01915498|452037591|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
125659039|NCT01915498|452037592|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
125659040|NCT01915498|452037593|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
125659041|NCT01915498|452037594|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
125659042|NCT01915498|452037595|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
125659043|NCT01915498|452037596|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
125659044|NCT01915498|452037597|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
125659045|NCT01915498|452037598|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
125659046|NCT01915498|452037599|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
125659047|NCT01915498|452037600|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
125659048|NCT01915498|452037601|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
125659049|NCT01915498|452037602|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
125659050|NCT01915498|452037603|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
125659051|NCT01915498|452037604|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
125659052|NCT01915498|452037605|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
125659053|NCT01915498|452037606|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
125659054|NCT01915498|452037607|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
125659055|NCT01915498|452037608|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
125659056|NCT01915498|452037609|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
125659057|NCT01915498|452037591|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659058|NCT01915498|452037592|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659059|NCT01915498|452037593|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659060|NCT01915498|452037594|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659061|NCT01915498|452037595|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659062|NCT01915498|452037596|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659063|NCT01915498|452037597|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659064|NCT01915498|452037598|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659065|NCT01915498|452037599|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659066|NCT01915498|452037600|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659067|NCT01915498|452037601|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
125659068|NCT01915498|452037602|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659069|NCT01915498|452037603|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659070|NCT01915498|452037604|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659071|NCT01915498|452037605|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659072|NCT01915498|452037606|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659073|NCT01915498|452037607|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659074|NCT01915498|452037608|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659075|NCT01915498|452037609|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
125659076|NCT01915498|452037591|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
125659077|NCT01915498|452037592|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
125659078|NCT01915498|452037593|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125659079|NCT01915498|452037594|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125659080|NCT01915498|452037595|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
125659081|NCT01915498|452037596|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
125659082|NCT01915498|452037597|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125659083|NCT01915498|452037598|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
125659084|NCT01915498|452037599|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125659085|NCT01915498|452037600|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
125659086|NCT01915498|452037601|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125659087|NCT01915498|452037602|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125659088|NCT01915498|452037603|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
125659089|NCT01915498|452037604|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
125659090|NCT01915498|452037605|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
125659091|NCT01915498|452037606|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
125659092|NCT01915498|452037607|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
125659093|NCT01915498|452037608|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
125659094|NCT01915498|452037609|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
125659095|NCT01915498|452037591|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
125659096|NCT01915498|452037592|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
125659097|NCT01915498|452037593|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
125659098|NCT01915498|452037594|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
125659099|NCT01915498|452037595|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
125659100|NCT01915498|452037596|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
125659101|NCT01915498|452037597|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
125659102|NCT01915498|452037598|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
125659103|NCT01915498|452037599|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
125659104|NCT01915498|452037600|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
125318129|NCT00689390|450794001|FG000|Overall Study|Administrative|37|||
125659105|NCT01915498|452037601|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
125659106|NCT01915498|452037602|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
125659107|NCT01915498|452037603|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
125659108|NCT01915498|452037604|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
125659109|NCT01915498|452037605|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
125659110|NCT01915498|452037606|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
125659111|NCT01915498|452037607|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
125659112|NCT01915498|452037608|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
125659113|NCT01915498|452037609|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
125659114|NCT01915498|452037591|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659115|NCT01915498|452037592|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659116|NCT01915498|452037593|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659117|NCT01915498|452037594|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659118|NCT01915498|452037595|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659119|NCT01915498|452037596|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659120|NCT01915498|452037597|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659121|NCT01915498|452037598|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659122|NCT01915498|452037599|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659123|NCT01915498|452037600|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659124|NCT01915498|452037601|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659125|NCT01915498|452037602|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659126|NCT01915498|452037603|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659127|NCT01915498|452037604|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659128|NCT01915498|452037605|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659129|NCT01915498|452037606|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659130|NCT01915498|452037607|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659131|NCT01915498|452037608|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
125659132|NCT01915498|452037609|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
125659133|NCT01915498|452037591|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659134|NCT01915498|452037592|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659135|NCT01915498|452037593|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659136|NCT01915498|452037594|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659137|NCT01915498|452037595|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659138|NCT01915498|452037596|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659139|NCT01915498|452037597|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659140|NCT01915498|452037598|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659141|NCT01915498|452037599|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659142|NCT01915498|452037600|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659143|NCT01915498|452037601|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659144|NCT01915498|452037602|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659145|NCT01915498|452037603|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659146|NCT01915498|452037604|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659147|NCT01915498|452037605|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659148|NCT01915498|452037606|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659149|NCT01915498|452037607|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659150|NCT01915498|452037608|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
125659151|NCT01915498|452037609|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
125659152|NCT01915498|452037591|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659153|NCT01915498|452037592|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659154|NCT01915498|452037593|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659155|NCT01915498|452037594|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659156|NCT01915498|452037595|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659157|NCT01915498|452037596|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659158|NCT01915498|452037597|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659159|NCT01915498|452037598|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659160|NCT01915498|452037599|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659161|NCT01915498|452037600|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659162|NCT01915498|452037601|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659163|NCT01915498|452037602|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659164|NCT01915498|452037603|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659165|NCT01915498|452037604|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659166|NCT01915498|452037605|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659167|NCT01915498|452037606|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659168|NCT01915498|452037607|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659169|NCT01915498|452037608|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
125659170|NCT01915498|452037609|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
125659171|NCT01907516|452037610|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
125659172|NCT01907516|452037611|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
125659173|NCT01907516|452037610|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
125659174|NCT01907516|452037611|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
125659175|NCT01907516|452037610|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
125659176|NCT01907516|452037611|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
125659177|NCT01907516|452037610|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
125659178|NCT01907516|452037611|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
125659179|NCT00891527|452039148|FG000|Overall Study|Withdrawal by Subject|2|||
125659180|NCT02953262|452039151|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
125659181|NCT02953262|452039152|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
125659182|NCT02953262|452039153|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
125659183|NCT02953262|452039154|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
125659184|NCT00740480|452039155|FG000|Overall Study|Adverse Event|1|||
125659185|NCT00740480|452039155|FG000|Overall Study|Physician Decision|1|||
125659186|NCT03349437|452039160|FG000|Screening|Screen Fail|4|||
125659187|NCT03349437|452039161|FG001|Screening|Screen Fail|0|||
125659188|NCT03349437|452039162|FG002|Screening|Screen Fail|0|||
125659189|NCT03349437|452039160|FG000|Screening|Withdrawn|1|||
125659190|NCT03349437|452039161|FG001|Screening|Withdrawn|0|||
125659191|NCT03349437|452039162|FG002|Screening|Withdrawn|0|||
125659192|NCT02406742|452039163|FG000|Overall Study|Progression of Disease|5|||
125659193|NCT02406742|452039164|FG001|Overall Study|Progression of Disease|1|||
125659194|NCT02406742|452039165|FG002|Overall Study|Progression of Disease|6|||
125659195|NCT02406742|452039163|FG000|Overall Study|Adverse Event|3|||
125659196|NCT02406742|452039164|FG001|Overall Study|Adverse Event|0|||
125659197|NCT02406742|452039165|FG002|Overall Study|Adverse Event|2|||
125659198|NCT02406742|452039163|FG000|Overall Study|Death|1|||
125659199|NCT02406742|452039164|FG001|Overall Study|Death|0|||
125659200|NCT02406742|452039165|FG002|Overall Study|Death|0|||
125659201|NCT02406742|452039163|FG000|Overall Study|Lack of Efficacy|0|||
125659202|NCT02406742|452039164|FG001|Overall Study|Lack of Efficacy|0|||
125659203|NCT02406742|452039165|FG002|Overall Study|Lack of Efficacy|1|||
125659204|NCT02406742|452039163|FG000|Overall Study|Withdrawal by Participant|1|||
125659205|NCT02406742|452039164|FG001|Overall Study|Withdrawal by Participant|2|||
125659206|NCT02406742|452039165|FG002|Overall Study|Withdrawal by Participant|0|||
125659207|NCT02406742|452039163|FG000|Overall Study|Physician Decision|1|||
125659208|NCT02406742|452039164|FG001|Overall Study|Physician Decision|2|||
125659209|NCT02406742|452039165|FG002|Overall Study|Physician Decision|1|||
125659210|NCT02406742|452039163|FG000|Overall Study|Transition to other treatment|2|||
125659211|NCT02406742|452039164|FG001|Overall Study|Transition to other treatment|0|||
125659212|NCT02406742|452039165|FG002|Overall Study|Transition to other treatment|1|||
125659213|NCT02406742|452039163|FG000|Overall Study|Other Reasons|1|||
125659214|NCT02406742|452039164|FG001|Overall Study|Other Reasons|11|||
125659215|NCT02406742|452039165|FG002|Overall Study|Other Reasons|5|||
125659216|NCT01563029|452039168|FG000|Overall Study|Adverse Event|1|||
125659217|NCT01563029|452039169|FG001|Overall Study|Adverse Event|0|||
125659218|NCT01563029|452039170|FG002|Overall Study|Adverse Event|1|||
125659219|NCT01563029|452039171|FG003|Overall Study|Adverse Event|2|||
125659220|NCT01563029|452039172|FG004|Overall Study|Adverse Event|1|||
125659221|NCT01563029|452039168|FG000|Overall Study|Lack of Efficacy|42|||
125659222|NCT01563029|452039169|FG001|Overall Study|Lack of Efficacy|16|||
125659223|NCT01563029|452039170|FG002|Overall Study|Lack of Efficacy|23|||
125659224|NCT01563029|452039171|FG003|Overall Study|Lack of Efficacy|21|||
125659225|NCT01563029|452039172|FG004|Overall Study|Lack of Efficacy|19|||
125659226|NCT01563029|452039168|FG000|Overall Study|Protocol Violation|1|||
125659227|NCT01563029|452039169|FG001|Overall Study|Protocol Violation|2|||
125659228|NCT01563029|452039170|FG002|Overall Study|Protocol Violation|3|||
125659229|NCT01563029|452039171|FG003|Overall Study|Protocol Violation|1|||
125659230|NCT01563029|452039172|FG004|Overall Study|Protocol Violation|3|||
125659231|NCT01563029|452039168|FG000|Overall Study|Protocol defined stopping criteria|1|||
125659232|NCT01563029|452039169|FG001|Overall Study|Protocol defined stopping criteria|0|||
125659233|NCT01563029|452039170|FG002|Overall Study|Protocol defined stopping criteria|0|||
125659234|NCT01563029|452039171|FG003|Overall Study|Protocol defined stopping criteria|0|||
125659235|NCT01563029|452039172|FG004|Overall Study|Protocol defined stopping criteria|0|||
125659236|NCT01563029|452039168|FG000|Overall Study|Lost to Follow-up|1|||
125659237|NCT01563029|452039169|FG001|Overall Study|Lost to Follow-up|0|||
125659238|NCT01563029|452039170|FG002|Overall Study|Lost to Follow-up|1|||
125659239|NCT01563029|452039171|FG003|Overall Study|Lost to Follow-up|1|||
125659240|NCT01563029|452039172|FG004|Overall Study|Lost to Follow-up|1|||
125659241|NCT01563029|452039168|FG000|Overall Study|Physician Decision|3|||
125659242|NCT01563029|452039169|FG001|Overall Study|Physician Decision|5|||
125659243|NCT01563029|452039170|FG002|Overall Study|Physician Decision|2|||
125659244|NCT01563029|452039171|FG003|Overall Study|Physician Decision|4|||
125659245|NCT01563029|452039172|FG004|Overall Study|Physician Decision|2|||
125659246|NCT01563029|452039168|FG000|Overall Study|Withdrawal by Subject|4|||
125659247|NCT01563029|452039169|FG001|Overall Study|Withdrawal by Subject|1|||
125659248|NCT01563029|452039170|FG002|Overall Study|Withdrawal by Subject|3|||
125659249|NCT01563029|452039171|FG003|Overall Study|Withdrawal by Subject|4|||
125659250|NCT01563029|452039172|FG004|Overall Study|Withdrawal by Subject|3|||
125659251|NCT01569594|452039173|FG000|Overall Study|Physician Decision|4|||
125659252|NCT01569594|452039173|FG000|Overall Study|Death|13|||
125659253|NCT01569594|452039173|FG000|Overall Study|Lost to Follow-up|22|||
125659254|NCT01569594|452039173|FG000|Overall Study|Adverse Event|2|||
125659255|NCT01569594|452039173|FG000|Overall Study|Withdrawal by Subject|13|||
125659256|NCT01569594|452039173|FG000|Overall Study|Other|4|||
125659257|NCT01569594|452039173|FG000|Overall Study|No ECM used|9|||
125659258|NCT01826201|452039178|FG000|Overall Study|Non compliance with protocol|4|||
125659259|NCT01615822|452039179|FG000|Period 1|Withdrawal by Subject|0|||
125659260|NCT01615822|452039180|FG001|Period 1|Withdrawal by Subject|1|||
125659261|NCT01615822|452039181|FG002|Period 1|Withdrawal by Subject|0|||
125659262|NCT01615822|452039179|FG000|Period 1|Adverse Event|1|||
125659263|NCT01615822|452039180|FG001|Period 1|Adverse Event|1|||
125659264|NCT01615822|452039181|FG002|Period 1|Adverse Event|0|||
125659265|NCT01615822|452039179|FG000|Period 2|Lost to Follow-up|0|||
125659266|NCT01615822|452039180|FG001|Period 2|Lost to Follow-up|1|||
125659267|NCT01615822|452039181|FG002|Period 2|Lost to Follow-up|2|||
125659268|NCT00537056|452039184|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
125659269|NCT02628418|452039189|FG000|Overall Study|Lost to Follow-up|1|||
125659270|NCT02628418|452039190|FG001|Overall Study|Lost to Follow-up|2|||
125659271|NCT01071083|452039191|FG000|Overall Study|Adverse Event|1|||
125659272|NCT01071083|452039192|FG001|Overall Study|Adverse Event|0|||
125659273|NCT01071083|452039193|FG002|Overall Study|Adverse Event|1|||
125659274|NCT01071083|452039194|FG003|Overall Study|Adverse Event|0|||
125659275|NCT01071083|452039195|FG004|Overall Study|Adverse Event|1|||
125659276|NCT01071083|452039191|FG000|Overall Study|Withdrawal by Subject|3|||
125659277|NCT01071083|452039192|FG001|Overall Study|Withdrawal by Subject|0|||
125659278|NCT01071083|452039193|FG002|Overall Study|Withdrawal by Subject|2|||
125659279|NCT01071083|452039194|FG003|Overall Study|Withdrawal by Subject|0|||
125659280|NCT01071083|452039195|FG004|Overall Study|Withdrawal by Subject|3|||
125659281|NCT01071083|452039191|FG000|Overall Study|Physician Decision|1|||
125659282|NCT01071083|452039192|FG001|Overall Study|Physician Decision|0|||
125659283|NCT01071083|452039193|FG002|Overall Study|Physician Decision|0|||
125659284|NCT01071083|452039194|FG003|Overall Study|Physician Decision|1|||
125659285|NCT01071083|452039195|FG004|Overall Study|Physician Decision|1|||
125659286|NCT01071083|452039191|FG000|Overall Study|Early Rescue|1|||
125659287|NCT01071083|452039192|FG001|Overall Study|Early Rescue|0|||
125659288|NCT01071083|452039193|FG002|Overall Study|Early Rescue|0|||
125659289|NCT01071083|452039194|FG003|Overall Study|Early Rescue|0|||
125659290|NCT01071083|452039195|FG004|Overall Study|Early Rescue|1|||
125659291|NCT01071083|452039191|FG000|Overall Study|Subject Moved|0|||
125659292|NCT01071083|452039192|FG001|Overall Study|Subject Moved|1|||
125659293|NCT01071083|452039193|FG002|Overall Study|Subject Moved|0|||
125659294|NCT01071083|452039194|FG003|Overall Study|Subject Moved|0|||
125659295|NCT01071083|452039195|FG004|Overall Study|Subject Moved|0|||
125659296|NCT01071083|452039191|FG000|Overall Study|Images Not Usable (Motion)|0|||
125659297|NCT01071083|452039192|FG001|Overall Study|Images Not Usable (Motion)|1|||
125659298|NCT01071083|452039193|FG002|Overall Study|Images Not Usable (Motion)|0|||
125659299|NCT01071083|452039194|FG003|Overall Study|Images Not Usable (Motion)|0|||
125659300|NCT01071083|452039195|FG004|Overall Study|Images Not Usable (Motion)|0|||
125659301|NCT01071083|452039191|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
125659302|NCT01071083|452039192|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
125659303|NCT01071083|452039193|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
125659304|NCT01071083|452039194|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
125659305|NCT01071083|452039195|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
125659306|NCT01071083|452039191|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
125659307|NCT01071083|452039192|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
125659308|NCT01071083|452039193|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
125659309|NCT01071083|452039194|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
125659310|NCT01071083|452039195|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
125659311|NCT01071083|452039191|FG000|Overall Study|Subject Refused to Continue|1|||
125659312|NCT01071083|452039192|FG001|Overall Study|Subject Refused to Continue|0|||
125659313|NCT01071083|452039193|FG002|Overall Study|Subject Refused to Continue|0|||
125659314|NCT01071083|452039194|FG003|Overall Study|Subject Refused to Continue|0|||
125659315|NCT01071083|452039195|FG004|Overall Study|Subject Refused to Continue|0|||
125659316|NCT04732728|452039196|FG000|Overall Study|Death|12|||
125659317|NCT04732728|452039196|FG000|Overall Study|Withdrawn|136|||
125659318|NCT02072174|452039197|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
125659319|NCT02072174|452039198|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
125659320|NCT02072174|452039197|FG000|Overall Study|Protocol Violation|16|||
125659321|NCT02072174|452039198|FG001|Overall Study|Protocol Violation|23|||
125659322|NCT02072174|452039197|FG000|Overall Study|Physician Decision|0|||
125659323|NCT02072174|452039198|FG001|Overall Study|Physician Decision|1|||
125659324|NCT02072174|452039197|FG000|Overall Study|Non-compliance with protocol requirement|2|||
125659325|NCT02072174|452039198|FG001|Overall Study|Non-compliance with protocol requirement|0|||
125659326|NCT03891875|452039199|FG000|Overall Study|Withdrawal by Subject|20|||
125659327|NCT03891875|452039200|FG001|Overall Study|Withdrawal by Subject|3|||
125659328|NCT03891875|452039199|FG000|Overall Study|Adverse Event|10|||
125659329|NCT03891875|452039200|FG001|Overall Study|Adverse Event|4|||
125659330|NCT03891875|452039199|FG000|Overall Study|Physician Decision|1|||
125659331|NCT03891875|452039200|FG001|Overall Study|Physician Decision|1|||
125659332|NCT03891875|452039199|FG000|Overall Study|Protocol Violation|1|||
125659333|NCT03891875|452039200|FG001|Overall Study|Protocol Violation|0|||
125659334|NCT03891875|452039199|FG000|Overall Study|Lost to Follow-up|1|||
125659335|NCT03891875|452039200|FG001|Overall Study|Lost to Follow-up|0|||
125659336|NCT03891875|452039199|FG000|Overall Study|COVID-19 infection|1|||
125659337|NCT03891875|452039200|FG001|Overall Study|COVID-19 infection|0|||
125659338|NCT02426125|452039205|FG000|Overall Study|Lost to Follow-up|14|||
125659339|NCT02426125|452039206|FG001|Overall Study|Lost to Follow-up|12|||
125659340|NCT02426125|452039205|FG000|Overall Study|Withdrawal by Subject|13|||
125318130|NCT00689390|450794002|FG001|Overall Study|Administrative|0|||
125318131|NCT02343263|450794003|FG000|Overall Study|Physician Decision|5|||
125659341|NCT02426125|452039206|FG001|Overall Study|Withdrawal by Subject|14|||
125659342|NCT02426125|452039205|FG000|Overall Study|Death|185|||
125659343|NCT02426125|452039206|FG001|Overall Study|Death|200|||
125659344|NCT02426125|452039205|FG000|Overall Study|Randomized, But Never Treated|5|||
125659345|NCT02426125|452039206|FG001|Overall Study|Randomized, But Never Treated|2|||
125659346|NCT02858076|452039207|FG000|Overall Study|Death|6|||
125659347|NCT02858076|452039208|FG001|Overall Study|Death|3|||
125659348|NCT02858076|452039207|FG000|Overall Study|Withdrawal by Subject|1|||
125659349|NCT02858076|452039208|FG001|Overall Study|Withdrawal by Subject|5|||
125318132|NCT02343263|450794004|FG001|Overall Study|Physician Decision|3|||
125318133|NCT02343263|450794005|FG002|Overall Study|Physician Decision|1|||
125318134|NCT00525512|450794023|FG000|Double-Blind Phase|Adverse Event|48|||
125318135|NCT00525512|450794024|FG001|Double-Blind Phase|Adverse Event|28|||
125318136|NCT00525512|450794025|FG002|Double-Blind Phase|Adverse Event|0|||
125318137|NCT00525512|450794026|FG003|Double-Blind Phase|Adverse Event|0|||
125318138|NCT00525512|450794023|FG000|Double-Blind Phase|Protocol Violation|3|||
125318139|NCT00525512|450794024|FG001|Double-Blind Phase|Protocol Violation|1|||
125318140|NCT00525512|450794025|FG002|Double-Blind Phase|Protocol Violation|0|||
125318141|NCT00525512|450794026|FG003|Double-Blind Phase|Protocol Violation|0|||
125318142|NCT00525512|450794023|FG000|Double-Blind Phase|Lost to Follow-up|3|||
125318143|NCT00525512|450794024|FG001|Double-Blind Phase|Lost to Follow-up|7|||
125318144|NCT00525512|450794025|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125318145|NCT00525512|450794026|FG003|Double-Blind Phase|Lost to Follow-up|0|||
125318146|NCT00525512|450794023|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
125318147|NCT00525512|450794024|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
125318148|NCT00525512|450794025|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125318149|NCT00525512|450794026|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
125318150|NCT00525512|450794023|FG000|Double-Blind Phase|Lack of Efficacy|13|||
125318151|NCT00525512|450794024|FG001|Double-Blind Phase|Lack of Efficacy|5|||
125318152|NCT00525512|450794025|FG002|Double-Blind Phase|Lack of Efficacy|0|||
125318153|NCT00525512|450794026|FG003|Double-Blind Phase|Lack of Efficacy|0|||
125318154|NCT00525512|450794023|FG000|Double-Blind Phase|Other reason (not specified)|12|||
125318155|NCT00525512|450794024|FG001|Double-Blind Phase|Other reason (not specified)|13|||
125318156|NCT00525512|450794025|FG002|Double-Blind Phase|Other reason (not specified)|0|||
125318157|NCT00525512|450794026|FG003|Double-Blind Phase|Other reason (not specified)|0|||
125318158|NCT00525512|450794023|FG000|Open-Label Phase|Adverse Event|0|||
125318159|NCT00525512|450794024|FG001|Open-Label Phase|Adverse Event|0|||
125318160|NCT00525512|450794025|FG002|Open-Label Phase|Adverse Event|1|||
125318161|NCT00525512|450794026|FG003|Open-Label Phase|Adverse Event|0|||
125318162|NCT00525512|450794023|FG000|Open-Label Phase|Lost to Follow-up|0|||
125318163|NCT00525512|450794024|FG001|Open-Label Phase|Lost to Follow-up|0|||
125318164|NCT00525512|450794025|FG002|Open-Label Phase|Lost to Follow-up|1|||
125318165|NCT00525512|450794026|FG003|Open-Label Phase|Lost to Follow-up|0|||
125318166|NCT00525512|450794023|FG000|Open-Label Phase|Other reason (not specified)|0|||
125318167|NCT00525512|450794024|FG001|Open-Label Phase|Other reason (not specified)|0|||
125318168|NCT00525512|450794025|FG002|Open-Label Phase|Other reason (not specified)|4|||
125318169|NCT00525512|450794026|FG003|Open-Label Phase|Other reason (not specified)|5|||
125318170|NCT03289208|450794027|FG000|Overall Study|Adverse Event|1|||
125318171|NCT03289208|450794028|FG001|Overall Study|Adverse Event|0|||
125659350|NCT02858076|452039207|FG000|Overall Study|Lost to Follow-up|2|||
125659351|NCT02858076|452039208|FG001|Overall Study|Lost to Follow-up|7|||
125659352|NCT02858076|452039207|FG000|Overall Study|Completed Out of Window|1|||
125659353|NCT02858076|452039208|FG001|Overall Study|Completed Out of Window|3|||
125659354|NCT00664066|452039211|FG000|Overall Study|Study terminated|3|||
125659355|NCT01495793|452039213|FG000|Overall Study|Lost to Follow-up|1|||
125659356|NCT01495793|452039213|FG000|Overall Study|Violation of inclusion criteria|1|||
125659357|NCT03014570|452039216|FG000|Overall Study|COVID-19 Restrictions|38|||
125659358|NCT03014570|452039217|FG001|Overall Study|COVID-19 Restrictions|24|||
125318172|NCT03289208|450794029|FG002|Overall Study|Adverse Event|0|||
125318173|NCT03353675|450794033|FG000|Overall Study|Adverse Event|4|||
125318174|NCT02025179|450794036|FG000|Overall Study|Lost to Follow-up|0|||
125318175|NCT02025179|450794037|FG001|Overall Study|Lost to Follow-up|0|||
125318176|NCT02025179|450794038|FG002|Overall Study|Lost to Follow-up|1|||
125318177|NCT02362724|450794039|FG000|Overall Study|Withdrawal by Subject|3|||
125318178|NCT02362724|450794040|FG001|Overall Study|Withdrawal by Subject|1|||
125659359|NCT03014570|452039216|FG000|Overall Study|Death|70|||
125659360|NCT03014570|452039217|FG001|Overall Study|Death|79|||
125659361|NCT03014570|452039216|FG000|Overall Study|Transfer from facility|11|||
125659362|NCT03014570|452039217|FG001|Overall Study|Transfer from facility|14|||
125659363|NCT03014570|452039216|FG000|Overall Study|Hospitalized|5|||
125318179|NCT02362724|450794039|FG000|Overall Study|Adverse Event|3|||
125318180|NCT02362724|450794040|FG001|Overall Study|Adverse Event|0|||
125318181|NCT00402168|450794041|FG000|Randomized|Lost to Follow-up|1|||
125318182|NCT00402168|450794042|FG001|Randomized|Lost to Follow-up|0|||
125318183|NCT00402168|450794041|FG000|Randomized|Withdrawal by Subject|0|||
125318184|NCT00402168|450794042|FG001|Randomized|Withdrawal by Subject|1|||
125318185|NCT00402168|450794041|FG000|Treatment (up to 12 Months)|Death|0|||
125318186|NCT00402168|450794042|FG001|Treatment (up to 12 Months)|Death|1|||
125659364|NCT03014570|452039217|FG001|Overall Study|Hospitalized|3|||
125659365|NCT03014570|452039216|FG000|Overall Study|Transfer within facility|1|||
125659366|NCT03014570|452039217|FG001|Overall Study|Transfer within facility|0|||
125659367|NCT03014570|452039216|FG000|Overall Study|Site refusal|0|||
125318187|NCT00402168|450794041|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
125318188|NCT00402168|450794042|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
125318189|NCT00402168|450794041|FG000|Treatment (up to 12 Months)|non-specified|0|||
125318190|NCT00402168|450794042|FG001|Treatment (up to 12 Months)|non-specified|1|||
125659368|NCT03014570|452039217|FG001|Overall Study|Site refusal|11|||
125659369|NCT03701516|452039223|FG000|Period 1|Lost to Follow-up|0|||
125659370|NCT03701516|452039224|FG001|Period 1|Lost to Follow-up|1|||
125659371|NCT03701516|452039223|FG000|Period 1|Adverse Event|0|||
125659372|NCT03701516|452039224|FG001|Period 1|Adverse Event|2|||
125318191|NCT00402168|450794041|FG000|Long Term (LT)|Adverse Event|1|||
125318192|NCT00402168|450794042|FG001|Long Term (LT)|Adverse Event|5|||
125318193|NCT00402168|450794041|FG000|Long Term (LT)|Withdrawal by Subject|4|||
125659373|NCT03701516|452039223|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
125659374|NCT03701516|452039224|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
125659375|NCT03701516|452039223|FG000|Period 1|Non Compliance to Protocol|2|||
125659376|NCT03701516|452039224|FG001|Period 1|Non Compliance to Protocol|1|||
125659377|NCT03701516|452039223|FG000|Period 1|Withdrawal by Subject|0|||
125659378|NCT03701516|452039224|FG001|Period 1|Withdrawal by Subject|1|||
125659379|NCT03701516|452039223|FG000|Period 2|failed to meet all eligibility creiteria|1|||
125659380|NCT03701516|452039224|FG001|Period 2|failed to meet all eligibility creiteria|0|||
125659381|NCT03701516|452039223|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
125659382|NCT03701516|452039224|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
125659383|NCT00478673|452039225|FG000|30-Days Post-Procedure|Death|2|||
125659384|NCT00478673|452039225|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
125659385|NCT00478673|452039225|FG000|30-Days Post-Procedure|Missed Visit|7|||
125659386|NCT00478673|452039225|FG000|12-Months Post-Procedure|Death|23|||
125659387|NCT00478673|452039225|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
125659388|NCT00478673|452039225|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
125659389|NCT00478673|452039225|FG000|12-Months Post-Procedure|Missed Visit|25|||
125659390|NCT00478673|452039225|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
125659391|NCT00981019|452039226|FG000|Overall Study|Did not respond|65|||
125659392|NCT00981019|452039226|FG000|Overall Study|Did not match target population|94|||
125659393|NCT00981019|452039226|FG000|Overall Study|Inadvertent exclusion|239|||
125659394|NCT00981019|452039226|FG000|Overall Study|Hit the survey after closure|79|||
125659395|NCT00358670|452039227|FG000|Overall Study|Adverse Event|26|||
125659396|NCT00358670|452039228|FG001|Overall Study|Adverse Event|29|||
125659397|NCT00358670|452039227|FG000|Overall Study|Lack of Efficacy|20|||
125659398|NCT00358670|452039228|FG001|Overall Study|Lack of Efficacy|23|||
125318194|NCT00402168|450794042|FG001|Long Term (LT)|Withdrawal by Subject|7|||
125318195|NCT00402168|450794041|FG000|Long Term (LT)|Pregnancy|0|||
125318196|NCT00402168|450794042|FG001|Long Term (LT)|Pregnancy|1|||
125659399|NCT00358670|452039227|FG000|Overall Study|Protocol Violation|6|||
125659400|NCT00358670|452039228|FG001|Overall Study|Protocol Violation|9|||
125659401|NCT00358670|452039227|FG000|Overall Study|Lost to Follow-up|4|||
125659402|NCT00358670|452039228|FG001|Overall Study|Lost to Follow-up|5|||
125659403|NCT00358670|452039227|FG000|Overall Study|Withdrawal by Subject|13|||
125318197|NCT00402168|450794041|FG000|Long Term (LT)|Lost to Follow-up|1|||
125659404|NCT00358670|452039228|FG001|Overall Study|Withdrawal by Subject|24|||
125659405|NCT00358670|452039227|FG000|Overall Study|Protocol Defined Clinical Event|0|||
125659406|NCT00358670|452039228|FG001|Overall Study|Protocol Defined Clinical Event|1|||
125659407|NCT00358670|452039227|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
125659408|NCT00358670|452039228|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
125659409|NCT00358670|452039227|FG000|Overall Study|Administrative|153|||
125659410|NCT00358670|452039228|FG001|Overall Study|Administrative|125|||
125659411|NCT05083559|452039229|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
125659412|NCT05083559|452039230|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
125659413|NCT05083559|452039229|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
125659414|NCT05083559|452039230|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
125659415|NCT05083559|452039229|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
125659416|NCT05083559|452039230|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
125659417|NCT03428217|452039232|FG000|Overall Study|Death|89|||
125659418|NCT03428217|452039233|FG001|Overall Study|Death|93|||
125659419|NCT03428217|452039232|FG000|Overall Study|Withdrawal by Subject|8|||
125659420|NCT03428217|452039233|FG001|Overall Study|Withdrawal by Subject|7|||
125659421|NCT03428217|452039232|FG000|Overall Study|Lost to Follow-up|1|||
125659422|NCT03428217|452039233|FG001|Overall Study|Lost to Follow-up|3|||
125659423|NCT03428217|452039232|FG000|Overall Study|Study terminated by sponsor|124|||
125659424|NCT03428217|452039233|FG001|Overall Study|Study terminated by sponsor|118|||
125659425|NCT03428217|452039232|FG000|Overall Study|Other, Not Specified|1|||
125659426|NCT03428217|452039233|FG001|Overall Study|Other, Not Specified|0|||
125659427|NCT05899218|452039234|FG000|Overall Study|Lost to Follow-up|2|||
125659428|NCT05899218|452039235|FG001|Overall Study|Lost to Follow-up|2|||
125659429|NCT05899218|452039234|FG000|Overall Study|deemed ineligible out of country|1|||
125659430|NCT05899218|452039235|FG001|Overall Study|deemed ineligible out of country|0|||
125659431|NCT03151226|452039236|FG000|Overall Study|Withdrawal by Subject|2|||
125659432|NCT03151226|452039236|FG000|Overall Study|not wear device correctly|1|||
125659433|NCT02304302|452039239|FG000|Overall Study|Adverse Event|2|||
125659434|NCT02304302|452039240|FG001|Overall Study|Adverse Event|3|||
125659435|NCT02304302|452039239|FG000|Overall Study|Lost to Follow-up|1|||
125659436|NCT02304302|452039240|FG001|Overall Study|Lost to Follow-up|4|||
125659437|NCT02304302|452039239|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
125659438|NCT02304302|452039240|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
125659439|NCT00391118|452039241|FG000|Overall Study|Adverse Event|3|||
125659440|NCT00391118|452039242|FG001|Overall Study|Adverse Event|10|||
125659441|NCT00391118|452039243|FG002|Overall Study|Adverse Event|7|||
125659442|NCT00391118|452039241|FG000|Overall Study|Lost to Follow-up|0|||
125659443|NCT00391118|452039242|FG001|Overall Study|Lost to Follow-up|2|||
125659444|NCT00391118|452039243|FG002|Overall Study|Lost to Follow-up|3|||
125659445|NCT00391118|452039241|FG000|Overall Study|Withdrawal by Subject|0|||
125659446|NCT00391118|452039242|FG001|Overall Study|Withdrawal by Subject|9|||
125659447|NCT00391118|452039243|FG002|Overall Study|Withdrawal by Subject|1|||
125659448|NCT00391118|452039241|FG000|Overall Study|Death|0|||
125659449|NCT00391118|452039242|FG001|Overall Study|Death|1|||
125659450|NCT00391118|452039243|FG002|Overall Study|Death|0|||
125659451|NCT00391118|452039241|FG000|Overall Study|Physician Decision|0|||
125659452|NCT00391118|452039242|FG001|Overall Study|Physician Decision|3|||
125659453|NCT00391118|452039243|FG002|Overall Study|Physician Decision|0|||
125659454|NCT00391118|452039241|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
125659455|NCT00391118|452039242|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
125659456|NCT00391118|452039243|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
125659457|NCT00391118|452039241|FG000|Overall Study|Progressive Disease|7|||
125659458|NCT00391118|452039242|FG001|Overall Study|Progressive Disease|26|||
125659459|NCT00391118|452039243|FG002|Overall Study|Progressive Disease|43|||
125659460|NCT00391118|452039241|FG000|Overall Study|Sponsor Decision|0|||
125659461|NCT00391118|452039242|FG001|Overall Study|Sponsor Decision|1|||
125659462|NCT00391118|452039243|FG002|Overall Study|Sponsor Decision|3|||
125659463|NCT00391118|452039241|FG000|Overall Study|Protocol Violation|1|||
125659464|NCT00391118|452039242|FG001|Overall Study|Protocol Violation|0|||
125659465|NCT00391118|452039243|FG002|Overall Study|Protocol Violation|0|||
125659466|NCT05473247|452039244|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
125659467|NCT01345058|452039245|FG000|Overall Study|Withdrawal by Subject|1|||
125659468|NCT01345058|452039246|FG001|Overall Study|Withdrawal by Subject|0|||
125659469|NCT01345058|452039245|FG000|Overall Study|Participant Reported Increase in Events|1|||
125659470|NCT01345058|452039246|FG001|Overall Study|Participant Reported Increase in Events|0|||
125659471|NCT01345058|452039245|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
125659472|NCT01345058|452039246|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
125659473|NCT01345058|452039245|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
125659474|NCT01345058|452039246|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
125659475|NCT01345058|452039245|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
125659476|NCT01345058|452039246|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
125659477|NCT01892020|452039252|FG000|Period 1|Adverse Event|1|||
125659478|NCT01892020|452039253|FG001|Period 1|Adverse Event|1|||
125659479|NCT01892020|452039252|FG000|Period 1|Protocol Violation|2|||
125659480|NCT01892020|452039253|FG001|Period 1|Protocol Violation|4|||
125659481|NCT01892020|452039252|FG000|Period 1|Unclassified|0|||
125659482|NCT01892020|452039253|FG001|Period 1|Unclassified|1|||
125659483|NCT01892020|452039252|FG000|Period 2|Protocol Violation|1|||
125659484|NCT01892020|452039253|FG001|Period 2|Protocol Violation|0|||
125659485|NCT00402779|452039254|FG000|Overall Study|Screen Failure|77|||
125659486|NCT00402779|452039255|FG001|Overall Study|Screen Failure|76|||
125659487|NCT03107715|452039257|FG000|Overall Study|did not deliver at the home hospital|4|||
125659488|NCT03107715|452039258|FG001|Overall Study|did not deliver at the home hospital|6|||
125659489|NCT03107715|452039257|FG000|Overall Study|infant stillborn|0|||
125659490|NCT03107715|452039258|FG001|Overall Study|infant stillborn|1|||
125659491|NCT02149199|452039259|FG000|Overall Study|Study specific withdrawal criteria|4|||
125659492|NCT02149199|452039260|FG001|Overall Study|Study specific withdrawal criteria|21|||
125659493|NCT02149199|452039261|FG002|Overall Study|Study specific withdrawal criteria|6|||
125659494|NCT02149199|452039259|FG000|Overall Study|Other|20|||
125659495|NCT02149199|452039260|FG001|Overall Study|Other|25|||
125659496|NCT02149199|452039261|FG002|Overall Study|Other|20|||
125659497|NCT02149199|452039259|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
125659498|NCT02149199|452039260|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
125659499|NCT02149199|452039261|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
125659500|NCT02149199|452039259|FG000|Overall Study|Withdrawal by Subject|75|||
125659501|NCT02149199|452039260|FG001|Overall Study|Withdrawal by Subject|93|||
125659502|NCT02149199|452039261|FG002|Overall Study|Withdrawal by Subject|77|||
125659503|NCT02149199|452039259|FG000|Overall Study|Protocol Violation|16|||
125540508|NCT00432666|451609358|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
125540509|NCT00432666|451609357|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
125540510|NCT00432666|451609358|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
125540511|NCT00432666|451609357|FG000|Open-Label Extension Period|Adverse Event|5|||
125540512|NCT00432666|451609358|FG001|Open-Label Extension Period|Adverse Event|0|||
125540513|NCT00432666|451609357|FG000|Open-Label Extension Period|Consent withdrawn|10|||
125540514|NCT00432666|451609358|FG001|Open-Label Extension Period|Consent withdrawn|0|||
125540515|NCT00432666|451609357|FG000|Open-Label Extension Period|Physician Decision|3|||
125540516|NCT00432666|451609358|FG001|Open-Label Extension Period|Physician Decision|0|||
125540517|NCT00978627|451609359|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
125540518|NCT00978627|451609360|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
125540519|NCT00978627|451609359|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
125540520|NCT00978627|451609360|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
125540521|NCT00978627|451609359|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
125540522|NCT00978627|451609360|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
125540523|NCT00978627|451609359|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
125540524|NCT00978627|451609360|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
125540525|NCT00978627|451609359|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
125540526|NCT00978627|451609360|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
125540527|NCT00978627|451609359|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
125540528|NCT00978627|451609360|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
125540529|NCT00978627|451609359|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
125540530|NCT00978627|451609360|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
125540531|NCT00978627|451609359|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
125540532|NCT00978627|451609360|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
125540533|NCT00978627|451609359|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
125540534|NCT00978627|451609360|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
125540535|NCT02516332|451609363|FG000|Overall Study|Withdrawal by Subject|2|||
125540536|NCT02516332|451609364|FG001|Overall Study|Withdrawal by Subject|1|||
125540537|NCT02516332|451609365|FG002|Overall Study|Withdrawal by Subject|2|||
125540538|NCT03037931|451609366|FG000|Overall Study|Death|354|||
125540539|NCT03037931|451609367|FG001|Overall Study|Death|367|||
125540540|NCT03037931|451609366|FG000|Overall Study|Lost to Follow-up|7|||
125540541|NCT03037931|451609367|FG001|Overall Study|Lost to Follow-up|4|||
125540542|NCT03037931|451609366|FG000|Overall Study|Withdrawal by Subject|48|||
125540543|NCT03037931|451609367|FG001|Overall Study|Withdrawal by Subject|41|||
125540544|NCT00605215|451609368|FG000|Overall Study|Death|0|||
125540545|NCT00605215|451609369|FG001|Overall Study|Death|0|||
125540546|NCT00605215|451609370|FG002|Overall Study|Death|1|||
125540547|NCT00605215|451609368|FG000|Overall Study|Adverse Event|19|||
125540548|NCT00605215|451609369|FG001|Overall Study|Adverse Event|21|||
125540549|NCT00605215|451609370|FG002|Overall Study|Adverse Event|26|||
125540550|NCT00605215|451609368|FG000|Overall Study|Refusal to sign the re-consent form|8|||
125659504|NCT02149199|452039260|FG001|Overall Study|Protocol Violation|13|||
125659505|NCT02149199|452039261|FG002|Overall Study|Protocol Violation|15|||
125659506|NCT02149199|452039259|FG000|Overall Study|Lost to Follow-up|3|||
125659507|NCT02149199|452039260|FG001|Overall Study|Lost to Follow-up|12|||
125659508|NCT02149199|452039261|FG002|Overall Study|Lost to Follow-up|11|||
125540551|NCT00605215|451609369|FG001|Overall Study|Refusal to sign the re-consent form|3|||
125540552|NCT00605215|451609370|FG002|Overall Study|Refusal to sign the re-consent form|3|||
125540553|NCT00605215|451609368|FG000|Overall Study|Withdrawal by Subject|39|||
125540554|NCT00605215|451609369|FG001|Overall Study|Withdrawal by Subject|37|||
125659509|NCT02149199|452039259|FG000|Overall Study|Death|0|||
125659510|NCT02149199|452039260|FG001|Overall Study|Death|0|||
125659511|NCT02149199|452039261|FG002|Overall Study|Death|1|||
125659512|NCT02149199|452039259|FG000|Overall Study|Adverse Event|6|||
125659513|NCT02149199|452039260|FG001|Overall Study|Adverse Event|15|||
125659514|NCT02149199|452039261|FG002|Overall Study|Adverse Event|9|||
125659515|NCT03252756|452039262|FG000|Overall Study|Protocol Violation|2|||
125659516|NCT03252756|452039263|FG001|Overall Study|Protocol Violation|4|||
125659517|NCT03252756|452039262|FG000|Overall Study|COVID-19 Pandemic|1|||
125659518|NCT03252756|452039263|FG001|Overall Study|COVID-19 Pandemic|1|||
125659519|NCT03252756|452039262|FG000|Overall Study|Study Drug Expiration|0|||
125659520|NCT03252756|452039263|FG001|Overall Study|Study Drug Expiration|1|||
125659521|NCT01500434|452039266|FG000|Overall Study|Death|1|||
125659522|NCT01500434|452039266|FG000|Overall Study|Withdrawal by Subject|1|||
125659523|NCT01500434|452039266|FG000|Overall Study|Missed 12-month follow-up|5|||
125659524|NCT04881448|452039270|FG000|Overall Study|Study cancelled by sponsor|220|||
125659525|NCT04881448|452039270|FG000|Overall Study|Withdrawal by Subject|2|||
125659526|NCT04881448|452039270|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
125659527|NCT02662556|452039271|FG000|Overall Study|Adverse Event|4|||
125540555|NCT00605215|451609370|FG002|Overall Study|Withdrawal by Subject|27|||
125540556|NCT00605215|451609368|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
125540557|NCT00605215|451609369|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
125540558|NCT00605215|451609370|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
125540559|NCT00605215|451609368|FG000|Overall Study|Protocol Violation|3|||
125540560|NCT00605215|451609369|FG001|Overall Study|Protocol Violation|4|||
125540561|NCT00605215|451609370|FG002|Overall Study|Protocol Violation|1|||
125540562|NCT00605215|451609368|FG000|Overall Study|Pregnancy|8|||
125540563|NCT00605215|451609369|FG001|Overall Study|Pregnancy|5|||
125540564|NCT00605215|451609370|FG002|Overall Study|Pregnancy|4|||
125540565|NCT00605215|451609368|FG000|Overall Study|Lost to Follow-up|8|||
125540566|NCT00605215|451609369|FG001|Overall Study|Lost to Follow-up|5|||
125540567|NCT00605215|451609370|FG002|Overall Study|Lost to Follow-up|2|||
125540568|NCT00605215|451609368|FG000|Overall Study|Other than specified|0|||
125540569|NCT00605215|451609369|FG001|Overall Study|Other than specified|2|||
125540570|NCT00605215|451609370|FG002|Overall Study|Other than specified|1|||
125540571|NCT02914275|451609371|FG000|Overall Study|Lost to Follow-up|84|||
125540572|NCT02914275|451609372|FG001|Overall Study|Lost to Follow-up|29|||
125540573|NCT02914275|451609371|FG000|Overall Study|Withdrawal by Subject|26|||
125540574|NCT02914275|451609372|FG001|Overall Study|Withdrawal by Subject|10|||
125540575|NCT02914275|451609371|FG000|Overall Study|Protocol Violation|1|||
125540576|NCT02914275|451609372|FG001|Overall Study|Protocol Violation|1|||
125540577|NCT02914275|451609371|FG000|Overall Study|Physician Decision|3|||
125540578|NCT02914275|451609372|FG001|Overall Study|Physician Decision|1|||
125540579|NCT02914275|451609371|FG000|Overall Study|Other|4|||
125540580|NCT02914275|451609372|FG001|Overall Study|Other|1|||
125540581|NCT02914275|451609371|FG000|Overall Study|Excluded due to invalid informed consent|3|||
125540582|NCT02914275|451609372|FG001|Overall Study|Excluded due to invalid informed consent|0|||
125540583|NCT02704754|451609377|FG000|Overall Study|Lost to Follow-up|1|||
125540584|NCT02704754|451609378|FG001|Overall Study|Lost to Follow-up|1|||
125540585|NCT02704754|451609377|FG000|Overall Study|Lack of Efficacy|1|||
125540586|NCT02704754|451609378|FG001|Overall Study|Lack of Efficacy|0|||
125540587|NCT02704754|451609377|FG000|Overall Study|Withdrawal by Subject|1|||
125540588|NCT02704754|451609378|FG001|Overall Study|Withdrawal by Subject|0|||
125540589|NCT03809429|451609382|FG000|Overall Study|Withdrawal by Subject|7|||
125540590|NCT03809429|451609383|FG001|Overall Study|Withdrawal by Subject|3|||
125540591|NCT03809429|451609382|FG000|Overall Study|Adverse Event|6|||
125540592|NCT03809429|451609383|FG001|Overall Study|Adverse Event|9|||
125540593|NCT03809429|451609382|FG000|Overall Study|COVID-19|3|||
125540594|NCT03809429|451609383|FG001|Overall Study|COVID-19|1|||
125540595|NCT03809429|451609382|FG000|Overall Study|Participant was discontinued by investigator|12|||
125540596|NCT03809429|451609383|FG001|Overall Study|Participant was discontinued by investigator|7|||
125540597|NCT04214600|451609385|FG000|Overall Study|Lost to Follow-up|9|||
125540598|NCT04214600|451609386|FG001|Overall Study|Lost to Follow-up|14|||
125540599|NCT03507777|451609387|FG000|Overall Study|Lost to Follow-up|5|||
125540600|NCT03507777|451609388|FG001|Overall Study|Lost to Follow-up|7|||
125659528|NCT02662556|452039271|FG000|Overall Study|Lack of Efficacy|4|||
125659529|NCT00005879|452039276|FG000|Overall Study|Withdrawal by Subject|8|||
125659530|NCT00005879|452039277|FG001|Overall Study|Withdrawal by Subject|10|||
125659531|NCT05022121|452039279|FG000|Overall Study|Lack of Efficacy|1|||
125659532|NCT05022121|452039280|FG001|Overall Study|Lack of Efficacy|0|||
125540601|NCT03507777|451609387|FG000|Overall Study|Withdrawal by Subject|6|||
125540602|NCT03507777|451609388|FG001|Overall Study|Withdrawal by Subject|11|||
125540603|NCT03507777|451609387|FG000|Overall Study|Death|30|||
125540604|NCT03507777|451609388|FG001|Overall Study|Death|44|||
125540605|NCT03507777|451609387|FG000|Overall Study|Other Reasons|3|||
125540606|NCT03507777|451609388|FG001|Overall Study|Other Reasons|8|||
125540607|NCT02366468|451609389|FG000|Overall Study|Adverse Event|2|||
125540608|NCT02366468|451609390|FG001|Overall Study|Adverse Event|0|||
125659533|NCT05022121|452039279|FG000|Overall Study|Lost to Follow-up|0|||
125659534|NCT05022121|452039280|FG001|Overall Study|Lost to Follow-up|2|||
125659535|NCT02395536|452039287|FG000|Overall Study|Lost to Follow-up|4|||
125659536|NCT02395536|452039288|FG001|Overall Study|Lost to Follow-up|4|||
125659537|NCT02395536|452039287|FG000|Overall Study|Death|2|||
125659538|NCT02395536|452039288|FG001|Overall Study|Death|0|||
125659539|NCT02395536|452039287|FG000|Overall Study|Physician Decision|4|||
125659540|NCT02395536|452039288|FG001|Overall Study|Physician Decision|6|||
125659541|NCT02395536|452039287|FG000|Overall Study|Withdrawal by Subject|9|||
125659542|NCT02395536|452039288|FG001|Overall Study|Withdrawal by Subject|17|||
125659543|NCT02395536|452039287|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
125659544|NCT02395536|452039288|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
125659545|NCT02395536|452039287|FG000|Overall Study|Insurance issue|0|||
125659546|NCT02395536|452039288|FG001|Overall Study|Insurance issue|1|||
125659547|NCT00131937|452039289|FG000|Overall Study|Adverse Event|3|||
125659548|NCT00131937|452039289|FG000|Overall Study|Withdrawal by Subject|2|||
125659549|NCT00131937|452039289|FG000|Overall Study|Physician Decision|1|||
125659550|NCT00131937|452039289|FG000|Overall Study|Disease Progression|7|||
125659551|NCT00131937|452039289|FG000|Overall Study|Alternative therapy|1|||
125659552|NCT01186744|452041522|FG000|Overall Study|Lack of Efficacy|156|||
125659553|NCT01186744|452041523|FG001|Overall Study|Lack of Efficacy|99|||
125659554|NCT01186744|452041524|FG002|Overall Study|Lack of Efficacy|0|||
125659555|NCT01186744|452041525|FG003|Overall Study|Lack of Efficacy|2|||
125659556|NCT01186744|452041526|FG004|Overall Study|Lack of Efficacy|2|||
125659557|NCT01186744|452041527|FG005|Overall Study|Lack of Efficacy|5|||
125659558|NCT01186744|452041522|FG000|Overall Study|Protocol Violation|1|||
125659559|NCT01186744|452041523|FG001|Overall Study|Protocol Violation|2|||
125659560|NCT01186744|452041524|FG002|Overall Study|Protocol Violation|0|||
125659561|NCT01186744|452041525|FG003|Overall Study|Protocol Violation|1|||
125659562|NCT01186744|452041526|FG004|Overall Study|Protocol Violation|1|||
125659563|NCT01186744|452041527|FG005|Overall Study|Protocol Violation|2|||
125659564|NCT01186744|452041522|FG000|Overall Study|Lost to Follow-up|15|||
125659565|NCT01186744|452041523|FG001|Overall Study|Lost to Follow-up|16|||
125659566|NCT01186744|452041524|FG002|Overall Study|Lost to Follow-up|2|||
125659567|NCT01186744|452041525|FG003|Overall Study|Lost to Follow-up|1|||
125659568|NCT01186744|452041526|FG004|Overall Study|Lost to Follow-up|1|||
125659569|NCT01186744|452041527|FG005|Overall Study|Lost to Follow-up|4|||
125659570|NCT01186744|452041522|FG000|Overall Study|Screen failure|1|||
125659571|NCT01186744|452041523|FG001|Overall Study|Screen failure|1|||
125659572|NCT01186744|452041524|FG002|Overall Study|Screen failure|0|||
125659573|NCT01186744|452041525|FG003|Overall Study|Screen failure|1|||
125659574|NCT01186744|452041526|FG004|Overall Study|Screen failure|0|||
125659575|NCT01186744|452041527|FG005|Overall Study|Screen failure|0|||
125659576|NCT01186744|452041522|FG000|Overall Study|Withdrawal by Subject|14|||
125659577|NCT01186744|452041523|FG001|Overall Study|Withdrawal by Subject|10|||
125659578|NCT01186744|452041524|FG002|Overall Study|Withdrawal by Subject|2|||
125659579|NCT01186744|452041525|FG003|Overall Study|Withdrawal by Subject|5|||
125659580|NCT01186744|452041526|FG004|Overall Study|Withdrawal by Subject|0|||
125659581|NCT01186744|452041527|FG005|Overall Study|Withdrawal by Subject|6|||
125659582|NCT01186744|452041522|FG000|Overall Study|Study terminated by Sponsor|1|||
125659583|NCT01186744|452041523|FG001|Overall Study|Study terminated by Sponsor|0|||
125659584|NCT01186744|452041524|FG002|Overall Study|Study terminated by Sponsor|0|||
125659585|NCT01186744|452041525|FG003|Overall Study|Study terminated by Sponsor|0|||
125659586|NCT01186744|452041526|FG004|Overall Study|Study terminated by Sponsor|0|||
125659587|NCT01186744|452041527|FG005|Overall Study|Study terminated by Sponsor|0|||
125659588|NCT01186744|452041522|FG000|Overall Study|Other|9|||
125659589|NCT01186744|452041523|FG001|Overall Study|Other|10|||
125659590|NCT01186744|452041524|FG002|Overall Study|Other|1|||
125659591|NCT01186744|452041525|FG003|Overall Study|Other|2|||
125659592|NCT01186744|452041526|FG004|Overall Study|Other|1|||
125659593|NCT01186744|452041527|FG005|Overall Study|Other|5|||
125659594|NCT01186744|452041522|FG000|Overall Study|Adverse Event|10|||
125659595|NCT01186744|452041523|FG001|Overall Study|Adverse Event|14|||
125659596|NCT01186744|452041524|FG002|Overall Study|Adverse Event|1|||
125659597|NCT01186744|452041525|FG003|Overall Study|Adverse Event|0|||
125659598|NCT01186744|452041526|FG004|Overall Study|Adverse Event|1|||
125659599|NCT01186744|452041527|FG005|Overall Study|Adverse Event|4|||
125659600|NCT01186744|452041522|FG000|Overall Study|Death|1|||
125659601|NCT01186744|452041523|FG001|Overall Study|Death|0|||
125659602|NCT01186744|452041524|FG002|Overall Study|Death|0|||
125659603|NCT01186744|452041525|FG003|Overall Study|Death|0|||
125659604|NCT01186744|452041526|FG004|Overall Study|Death|0|||
125659605|NCT01186744|452041527|FG005|Overall Study|Death|0|||
125659606|NCT01020773|452041530|FG000|Overall Study|Withdrawal by Subject|4|||
125659607|NCT01020773|452041531|FG001|Overall Study|Withdrawal by Subject|3|||
125659608|NCT02675426|452041532|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
125540609|NCT02366468|451609389|FG000|Overall Study|Withdrawal by Subject|1|||
125659609|NCT02675426|452041533|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
125659610|NCT02675426|452041534|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
125659611|NCT02675426|452041535|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
125659612|NCT02675426|452041532|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
125659613|NCT02675426|452041533|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
125659614|NCT02675426|452041534|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
125659615|NCT02675426|452041535|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
125659616|NCT02675426|452041532|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
125659617|NCT02675426|452041533|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
125659618|NCT02675426|452041534|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
125659619|NCT02675426|452041535|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
125659620|NCT02675426|452041532|FG000|Period 1: Week 1 to Week 12|Other|2|||
125659621|NCT02675426|452041533|FG001|Period 1: Week 1 to Week 12|Other|1|||
125659622|NCT02675426|452041534|FG002|Period 1: Week 1 to Week 12|Other|0|||
125659623|NCT02675426|452041535|FG003|Period 1: Week 1 to Week 12|Other|2|||
125659624|NCT02675426|452041532|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
125659625|NCT02675426|452041533|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
125659626|NCT02675426|452041534|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
125659627|NCT02675426|452041535|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
125659628|NCT02675426|452041532|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
125659629|NCT02675426|452041533|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
125659630|NCT02675426|452041534|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
125659631|NCT02675426|452041535|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
125659632|NCT02675426|452041532|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
125659633|NCT02675426|452041533|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
125659634|NCT02675426|452041534|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
125659635|NCT02675426|452041535|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
125659636|NCT02675426|452041532|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
125659637|NCT02675426|452041533|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
125659638|NCT02675426|452041534|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
125659639|NCT02675426|452041535|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
125659640|NCT02675426|452041532|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
125659641|NCT02675426|452041533|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
125659642|NCT02675426|452041534|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
125659643|NCT02675426|452041535|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
125659644|NCT02675426|452041532|FG000|Period 2: Week 12 to Week 260|Other|8|||
125659645|NCT02675426|452041533|FG001|Period 2: Week 12 to Week 260|Other|12|||
125659646|NCT02675426|452041534|FG002|Period 2: Week 12 to Week 260|Other|23|||
125659647|NCT02675426|452041535|FG003|Period 2: Week 12 to Week 260|Other|15|||
125659648|NCT00953927|452041536|FG000|Overall Study|Lost to Follow-up|61|||
125659649|NCT00953927|452041537|FG001|Overall Study|Lost to Follow-up|65|||
125659650|NCT00953927|452041536|FG000|Overall Study|Withdrawal by Subject|36|||
125659651|NCT00953927|452041537|FG001|Overall Study|Withdrawal by Subject|25|||
125659652|NCT00953927|452041536|FG000|Overall Study|Death|7|||
125659653|NCT00953927|452041537|FG001|Overall Study|Death|4|||
125659654|NCT00953927|452041536|FG000|Overall Study|Other study discontinuation|1|||
125659655|NCT00953927|452041537|FG001|Overall Study|Other study discontinuation|1|||
125659656|NCT01652573|452041538|FG000|Overall Study|Adverse Event|0|||
125659657|NCT01652573|452041539|FG001|Overall Study|Adverse Event|1|||
125659658|NCT00934622|452041540|FG000|Overall Study|Lost to Follow-up|7|||
125659659|NCT00934622|452041540|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
125659660|NCT01856686|452041545|FG000|Overall Study|Lost to Follow-up|5|||
125659661|NCT01856686|452041546|FG001|Overall Study|Lost to Follow-up|11|||
125659662|NCT03284424|452041547|FG000|Overall Study|Death|70|||
125659663|NCT03284424|452041548|FG001|Overall Study|Death|24|||
125659664|NCT03284424|452041547|FG000|Overall Study|Lost to Follow-up|3|||
125659665|NCT03284424|452041548|FG001|Overall Study|Lost to Follow-up|1|||
125659666|NCT03284424|452041547|FG000|Overall Study|Physician Decision|1|||
125659667|NCT03284424|452041548|FG001|Overall Study|Physician Decision|2|||
125659668|NCT03284424|452041547|FG000|Overall Study|Withdrawal by Subject|4|||
125659669|NCT03284424|452041548|FG001|Overall Study|Withdrawal by Subject|5|||
125659670|NCT03284424|452041547|FG000|Overall Study|Sponsor's decision|27|||
125659671|NCT03284424|452041548|FG001|Overall Study|Sponsor's decision|22|||
125659672|NCT00602979|452041551|FG000|Overall Study|Lost to Follow-up|3|||
125659673|NCT00602979|452041552|FG001|Overall Study|Lost to Follow-up|2|||
125659674|NCT00602979|452041553|FG002|Overall Study|Lost to Follow-up|3|||
125659675|NCT00602979|452041554|FG003|Overall Study|Lost to Follow-up|2|||
125659676|NCT00602979|452041555|FG004|Overall Study|Lost to Follow-up|3|||
125659677|NCT00602979|452041551|FG000|Overall Study|Failed Intubation|0|||
125659678|NCT00602979|452041552|FG001|Overall Study|Failed Intubation|1|||
125659679|NCT00602979|452041553|FG002|Overall Study|Failed Intubation|0|||
125659680|NCT00602979|452041554|FG003|Overall Study|Failed Intubation|1|||
125659681|NCT00602979|452041555|FG004|Overall Study|Failed Intubation|0|||
125659682|NCT02962739|452041556|FG000|Overall Study|Withdrawal by Subject|0|||
125659683|NCT02962739|452041557|FG001|Overall Study|Withdrawal by Subject|1|||
125659684|NCT02962739|452041558|FG002|Overall Study|Withdrawal by Subject|0|||
125659685|NCT02962739|452041559|FG003|Overall Study|Withdrawal by Subject|0|||
125659686|NCT02962739|452041560|FG004|Overall Study|Withdrawal by Subject|0|||
125659687|NCT02962739|452041561|FG005|Overall Study|Withdrawal by Subject|0|||
125659688|NCT02962739|452041556|FG000|Overall Study|Protocol Violation|0|||
125659689|NCT02962739|452041557|FG001|Overall Study|Protocol Violation|0|||
125659690|NCT02962739|452041558|FG002|Overall Study|Protocol Violation|1|||
125659691|NCT02962739|452041559|FG003|Overall Study|Protocol Violation|0|||
125659692|NCT02962739|452041560|FG004|Overall Study|Protocol Violation|1|||
125659693|NCT02962739|452041561|FG005|Overall Study|Protocol Violation|0|||
125659694|NCT01268683|452041565|FG000|Overall Study|Lost to Follow-up|1|||
125659695|NCT01268683|452041565|FG000|Overall Study|Death|1|||
125659696|NCT02216214|452041566|FG000|Overall Study|Randomized Never Received Study Drug|1|||
125659697|NCT02216214|452041567|FG001|Overall Study|Randomized Never Received Study Drug|0|||
125659698|NCT02216214|452041566|FG000|Overall Study|Adverse Event|10|||
125659699|NCT02216214|452041567|FG001|Overall Study|Adverse Event|8|||
125659700|NCT02216214|452041566|FG000|Overall Study|Lack of Efficacy|2|||
125659701|NCT02216214|452041567|FG001|Overall Study|Lack of Efficacy|2|||
125659702|NCT02216214|452041566|FG000|Overall Study|Lost to Follow-up|3|||
125659703|NCT02216214|452041567|FG001|Overall Study|Lost to Follow-up|2|||
125659704|NCT02216214|452041566|FG000|Overall Study|Protocol Violation|4|||
125659705|NCT02216214|452041567|FG001|Overall Study|Protocol Violation|2|||
125659706|NCT02216214|452041566|FG000|Overall Study|Withdrawal by Subject|22|||
125659707|NCT02216214|452041567|FG001|Overall Study|Withdrawal by Subject|20|||
125659708|NCT02216214|452041566|FG000|Overall Study|Study Terminated By Sponsor|0|||
125659709|NCT02216214|452041567|FG001|Overall Study|Study Terminated By Sponsor|1|||
125659710|NCT02216214|452041566|FG000|Overall Study|Miscellaneous|1|||
125659711|NCT02216214|452041567|FG001|Overall Study|Miscellaneous|1|||
125659712|NCT00713830|452041568|FG000|Overall Study|Adverse Event|23|||
125659713|NCT00713830|452041569|FG001|Overall Study|Adverse Event|71|||
125659714|NCT00713830|452041568|FG000|Overall Study|Lack of Efficacy|24|||
125659715|NCT00713830|452041569|FG001|Overall Study|Lack of Efficacy|16|||
125659716|NCT00713830|452041568|FG000|Overall Study|Lost to Follow-up|2|||
125659717|NCT00713830|452041569|FG001|Overall Study|Lost to Follow-up|9|||
125659718|NCT00713830|452041568|FG000|Overall Study|Withdrawal by Subject|13|||
125659719|NCT00713830|452041569|FG001|Overall Study|Withdrawal by Subject|23|||
125659720|NCT00713830|452041568|FG000|Overall Study|Poor Compliance to Protocol|7|||
125659721|NCT00713830|452041569|FG001|Overall Study|Poor Compliance to Protocol|14|||
125659722|NCT00713830|452041568|FG000|Overall Study|Familial and Personal Reasons|9|||
125659723|NCT00713830|452041569|FG001|Overall Study|Familial and Personal Reasons|34|||
125659724|NCT00713830|452041568|FG000|Overall Study|Sponsor Decision|4|||
125659725|NCT00713830|452041569|FG001|Overall Study|Sponsor Decision|10|||
125659726|NCT03981614|452041570|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
125659727|NCT03981614|452041571|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
125659728|NCT03981614|452041572|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
125659729|NCT00499252|452041573|FG000|Overall Study|Adverse Event|3|||
125659730|NCT00499252|452041573|FG000|Overall Study|Refused further treatment|2|||
125659731|NCT00499252|452041573|FG000|Overall Study|Ineligible|4|||
125659732|NCT00499252|452041573|FG000|Overall Study|<no further label>|3|||
125659733|NCT00566631|452041574|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
125659734|NCT00566631|452041574|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
125659735|NCT00566631|452041574|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
125659736|NCT00566631|452041574|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
125659737|NCT00566631|452041574|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
125659738|NCT00566631|452041574|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
125659739|NCT00566631|452041574|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
125659740|NCT00566631|452041574|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
125659741|NCT00566631|452041574|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
125659742|NCT00566631|452041574|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
125659743|NCT00566631|452041574|FG000|Part 2: Extension Phase|Adverse Event|11|||
125659744|NCT00566631|452041574|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
125659745|NCT00566631|452041574|FG000|Part 2: Extension Phase|Death|1|||
125659746|NCT00566631|452041574|FG000|Part 2: Extension Phase|Other|5|||
125659747|NCT03387735|452041575|FG000|Overall Study|Lost to Follow-up|4|||
125659748|NCT03387735|452041576|FG001|Overall Study|Lost to Follow-up|8|||
125659749|NCT03387735|452041575|FG000|Overall Study|Death|4|||
125659750|NCT03387735|452041576|FG001|Overall Study|Death|8|||
125659751|NCT03020966|452041578|FG000|Overall Study|Withdrawal by Subject|2|||
125659752|NCT03020966|452041579|FG001|Overall Study|Withdrawal by Subject|0|||
125659753|NCT03747939|452041583|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
125659754|NCT03747939|452041584|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
125659755|NCT03747939|452041585|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
125659756|NCT03747939|452041586|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
125659757|NCT03747939|452041583|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
125659758|NCT03747939|452041584|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
125659759|NCT03747939|452041585|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
125659760|NCT03747939|452041586|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
125659761|NCT03747939|452041583|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
125659762|NCT03747939|452041584|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
125659763|NCT03747939|452041585|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
125659764|NCT03747939|452041586|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
125659765|NCT03747939|452041583|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
125659766|NCT03747939|452041584|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
125659767|NCT03747939|452041585|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
125659768|NCT03747939|452041586|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
125659769|NCT03747939|452041583|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
125659770|NCT03747939|452041584|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
125659771|NCT03747939|452041585|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
125659772|NCT03747939|452041586|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
125659773|NCT03747939|452041583|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
125659774|NCT03747939|452041584|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
125659775|NCT03747939|452041585|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
125659776|NCT03747939|452041586|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
125659777|NCT03747939|452041583|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
125659778|NCT03747939|452041584|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
125659779|NCT03747939|452041585|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
125659780|NCT03747939|452041586|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
125659781|NCT03747939|452041583|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
125659782|NCT03747939|452041584|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
125659783|NCT03747939|452041585|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
125659784|NCT03747939|452041586|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
125659785|NCT03747939|452041583|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
125659786|NCT03747939|452041584|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
125659787|NCT03747939|452041585|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
125659788|NCT03747939|452041586|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
125659789|NCT03747939|452041583|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
125659790|NCT03747939|452041584|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
125659791|NCT03747939|452041585|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
125659792|NCT03747939|452041586|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
125659793|NCT03747939|452041583|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
125659794|NCT03747939|452041584|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
125659795|NCT03747939|452041585|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
125659796|NCT03747939|452041586|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
125659797|NCT03747939|452041583|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
125659798|NCT03747939|452041584|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
125659799|NCT03747939|452041585|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
125659800|NCT03747939|452041586|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
125659801|NCT03747939|452041583|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
125659802|NCT03747939|452041584|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
125659803|NCT03747939|452041585|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
125659804|NCT03747939|452041586|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
125659805|NCT03747939|452041583|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
125659806|NCT03747939|452041584|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
125659807|NCT03747939|452041585|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
125659808|NCT03747939|452041586|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
125659809|NCT01215955|452041587|FG000|Overall Study|Adverse Event|1|||
125659810|NCT01215955|452041588|FG001|Overall Study|Adverse Event|4|||
125659811|NCT01215955|452041589|FG002|Overall Study|Adverse Event|2|||
125659812|NCT01215955|452041590|FG003|Overall Study|Adverse Event|3|||
125659813|NCT01215955|452041587|FG000|Overall Study|Death|2|||
125659814|NCT01215955|452041588|FG001|Overall Study|Death|0|||
125659815|NCT01215955|452041589|FG002|Overall Study|Death|1|||
125659816|NCT01215955|452041590|FG003|Overall Study|Death|3|||
125659817|NCT01215955|452041587|FG000|Overall Study|Entry Criteria Not Met|1|||
125659818|NCT01215955|452041588|FG001|Overall Study|Entry Criteria Not Met|3|||
125659819|NCT01215955|452041589|FG002|Overall Study|Entry Criteria Not Met|4|||
125659820|NCT01215955|452041590|FG003|Overall Study|Entry Criteria Not Met|7|||
125659821|NCT01215955|452041587|FG000|Overall Study|Lack of Efficacy|1|||
125659822|NCT01215955|452041588|FG001|Overall Study|Lack of Efficacy|2|||
125659823|NCT01215955|452041589|FG002|Overall Study|Lack of Efficacy|1|||
125659824|NCT01215955|452041590|FG003|Overall Study|Lack of Efficacy|0|||
125659825|NCT01215955|452041587|FG000|Overall Study|Lost to Follow-up|4|||
125659826|NCT01215955|452041588|FG001|Overall Study|Lost to Follow-up|4|||
125540610|NCT02366468|451609390|FG001|Overall Study|Withdrawal by Subject|5|||
125659827|NCT01215955|452041589|FG002|Overall Study|Lost to Follow-up|8|||
125659828|NCT01215955|452041590|FG003|Overall Study|Lost to Follow-up|9|||
125659829|NCT01215955|452041587|FG000|Overall Study|Physician Decision|4|||
125659830|NCT01215955|452041588|FG001|Overall Study|Physician Decision|10|||
125659831|NCT01215955|452041589|FG002|Overall Study|Physician Decision|8|||
125659832|NCT01215955|452041590|FG003|Overall Study|Physician Decision|11|||
125659833|NCT01215955|452041587|FG000|Overall Study|Protocol Violation|17|||
125659834|NCT01215955|452041588|FG001|Overall Study|Protocol Violation|13|||
125659835|NCT01215955|452041589|FG002|Overall Study|Protocol Violation|8|||
125659836|NCT01215955|452041590|FG003|Overall Study|Protocol Violation|8|||
125659837|NCT01215955|452041587|FG000|Overall Study|Sponsor Decision|1|||
125659838|NCT01215955|452041588|FG001|Overall Study|Sponsor Decision|2|||
125659839|NCT01215955|452041589|FG002|Overall Study|Sponsor Decision|0|||
125659840|NCT01215955|452041590|FG003|Overall Study|Sponsor Decision|1|||
125659841|NCT01215955|452041587|FG000|Overall Study|Withdrawal by Subject|14|||
125659842|NCT01215955|452041588|FG001|Overall Study|Withdrawal by Subject|15|||
125659843|NCT01215955|452041589|FG002|Overall Study|Withdrawal by Subject|13|||
125659844|NCT01215955|452041590|FG003|Overall Study|Withdrawal by Subject|9|||
125659845|NCT01215955|452041587|FG000|Overall Study|Quality Issues|0|||
125659846|NCT01215955|452041588|FG001|Overall Study|Quality Issues|0|||
125659847|NCT01215955|452041589|FG002|Overall Study|Quality Issues|3|||
125659848|NCT01215955|452041590|FG003|Overall Study|Quality Issues|2|||
125659849|NCT02494583|452041593|FG000|Overall Study|Death|224|||
125659850|NCT02494583|452041594|FG001|Overall Study|Death|214|||
125659851|NCT02494583|452041595|FG002|Overall Study|Death|225|||
125659852|NCT02494583|452041593|FG000|Overall Study|Lost to Follow-up|1|||
125659853|NCT02494583|452041594|FG001|Overall Study|Lost to Follow-up|0|||
125659854|NCT02494583|452041595|FG002|Overall Study|Lost to Follow-up|0|||
125659855|NCT02494583|452041593|FG000|Overall Study|Protocol Violation|1|||
125659856|NCT02494583|452041594|FG001|Overall Study|Protocol Violation|2|||
125659857|NCT02494583|452041595|FG002|Overall Study|Protocol Violation|0|||
125659858|NCT02494583|452041593|FG000|Overall Study|Screen Failure|0|||
125659859|NCT02494583|452041594|FG001|Overall Study|Screen Failure|1|||
125659860|NCT02494583|452041595|FG002|Overall Study|Screen Failure|0|||
125659861|NCT02494583|452041593|FG000|Overall Study|Transferred to Extension Study|15|||
125659862|NCT02494583|452041594|FG001|Overall Study|Transferred to Extension Study|15|||
125659863|NCT02494583|452041595|FG002|Overall Study|Transferred to Extension Study|6|||
125659864|NCT02494583|452041593|FG000|Overall Study|Did Not Continue on Extension Study|8|||
125659865|NCT02494583|452041594|FG001|Overall Study|Did Not Continue on Extension Study|10|||
125659866|NCT02494583|452041595|FG002|Overall Study|Did Not Continue on Extension Study|4|||
125659867|NCT02494583|452041593|FG000|Overall Study|Withdrawal by Subject|7|||
125659868|NCT02494583|452041594|FG001|Overall Study|Withdrawal by Subject|15|||
125659869|NCT02494583|452041595|FG002|Overall Study|Withdrawal by Subject|15|||
125659870|NCT01787188|452041596|FG000|Overall Study|Adverse Event|2|||
125659871|NCT01787188|452041597|FG001|Overall Study|Adverse Event|4|||
125659872|NCT01787188|452041598|FG002|Overall Study|Adverse Event|6|||
125659873|NCT01787188|452041596|FG000|Overall Study|Lack of Efficacy|7|||
125659874|NCT01787188|452041597|FG001|Overall Study|Lack of Efficacy|3|||
125659875|NCT01787188|452041598|FG002|Overall Study|Lack of Efficacy|5|||
125659876|NCT01787188|452041596|FG000|Overall Study|Non-compliance with Study Drug|0|||
125659877|NCT01787188|452041597|FG001|Overall Study|Non-compliance with Study Drug|1|||
125659878|NCT01787188|452041598|FG002|Overall Study|Non-compliance with Study Drug|0|||
125659879|NCT01787188|452041596|FG000|Overall Study|Withdrawal by Subject|4|||
125659880|NCT01787188|452041597|FG001|Overall Study|Withdrawal by Subject|3|||
125659881|NCT01787188|452041598|FG002|Overall Study|Withdrawal by Subject|2|||
125659882|NCT01787188|452041596|FG000|Overall Study|Protocol Violation|3|||
125659883|NCT01787188|452041597|FG001|Overall Study|Protocol Violation|2|||
125659884|NCT01787188|452041598|FG002|Overall Study|Protocol Violation|3|||
125659885|NCT01787188|452041596|FG000|Overall Study|Lost to Follow-up|1|||
125659886|NCT01787188|452041597|FG001|Overall Study|Lost to Follow-up|2|||
125659887|NCT01787188|452041598|FG002|Overall Study|Lost to Follow-up|2|||
125659888|NCT01787188|452041596|FG000|Overall Study|Other, including patient moved|0|||
125659889|NCT01787188|452041597|FG001|Overall Study|Other, including patient moved|3|||
125659890|NCT01787188|452041598|FG002|Overall Study|Other, including patient moved|0|||
125659891|NCT02756078|452041601|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
125659892|NCT02756078|452041602|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
125659893|NCT02756078|452041601|FG000|Period 1|Lost to Follow-up|0|||
125659894|NCT02756078|452041602|FG001|Period 1|Lost to Follow-up|2|||
125659895|NCT02756078|452041601|FG000|Period 1|Protocol Violation|0|||
125659896|NCT02756078|452041602|FG001|Period 1|Protocol Violation|1|||
125659897|NCT02756078|452041601|FG000|Period 1|Adverse Event|1|||
125659898|NCT02756078|452041602|FG001|Period 1|Adverse Event|10|||
125659899|NCT02756078|452041601|FG000|Period 1|Withdrawal by Subject|6|||
125659900|NCT02756078|452041602|FG001|Period 1|Withdrawal by Subject|6|||
125659901|NCT02756078|452041601|FG000|Period 1|Lens Discomfort|2|||
125659902|NCT02756078|452041602|FG001|Period 1|Lens Discomfort|2|||
125659903|NCT02756078|452041601|FG000|Period 2|Adverse Event|3|||
125659904|NCT02756078|452041602|FG001|Period 2|Adverse Event|5|||
125659905|NCT02756078|452041601|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
125659906|NCT02756078|452041602|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
125659907|NCT02756078|452041601|FG000|Period 2|Withdrawal by Subject|3|||
125659908|NCT02756078|452041602|FG001|Period 2|Withdrawal by Subject|1|||
125659909|NCT05349188|452041603|FG000|Overall Study|Withdrawal by Subject|1|||
125659910|NCT05349188|452041604|FG001|Overall Study|Withdrawal by Subject|0|||
125659911|NCT00943384|452041605|FG000|Overall Study|Dispositioned prior to treatment|23|||
125659912|NCT00943384|452041605|FG000|Overall Study|Treated off protocol-protocol violation|5|||
125659913|NCT00943384|452041605|FG000|Overall Study|Lost to Follow-up|16|||
125659914|NCT00943384|452041605|FG000|Overall Study|Withdrawal by Subject|5|||
125659915|NCT00835068|452041608|FG000|Overall Study|Death|1|||
125659916|NCT00835068|452041609|FG001|Overall Study|Death|0|||
125659917|NCT00835068|452041608|FG000|Overall Study|Adverse Event|0|||
125659918|NCT00835068|452041609|FG001|Overall Study|Adverse Event|1|||
125659919|NCT00835068|452041608|FG000|Overall Study|Other|8|||
125659920|NCT00835068|452041609|FG001|Overall Study|Other|0|||
125659921|NCT00835068|452041608|FG000|Overall Study|Withdrawal by Subject|1|||
125659922|NCT00835068|452041609|FG001|Overall Study|Withdrawal by Subject|0|||
125659923|NCT02575807|452041610|FG000|Overall Study|Death|8|||
125659924|NCT02575807|452041611|FG001|Overall Study|Death|3|||
125659925|NCT02575807|452041612|FG002|Overall Study|Death|7|||
125659926|NCT02575807|452041613|FG003|Overall Study|Death|0|||
125659927|NCT02575807|452041614|FG004|Overall Study|Death|1|||
125659928|NCT02575807|452041610|FG000|Overall Study|Study terminated by Sponsor|0|||
125659929|NCT02575807|452041611|FG001|Overall Study|Study terminated by Sponsor|1|||
125659930|NCT02575807|452041612|FG002|Overall Study|Study terminated by Sponsor|7|||
125659931|NCT02575807|452041613|FG003|Overall Study|Study terminated by Sponsor|0|||
125659932|NCT02575807|452041614|FG004|Overall Study|Study terminated by Sponsor|1|||
125659933|NCT02575807|452041610|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
125659934|NCT02575807|452041611|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
125659935|NCT02575807|452041612|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
125659936|NCT02575807|452041613|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
125659937|NCT02575807|452041614|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
125659938|NCT02575807|452041610|FG000|Overall Study|Terminated due to physician decision|0|||
125659939|NCT02575807|452041611|FG001|Overall Study|Terminated due to physician decision|0|||
125659940|NCT02575807|452041612|FG002|Overall Study|Terminated due to physician decision|1|||
125659941|NCT02575807|452041613|FG003|Overall Study|Terminated due to physician decision|0|||
125659942|NCT02575807|452041614|FG004|Overall Study|Terminated due to physician decision|0|||
125659943|NCT02575807|452041610|FG000|Overall Study|Subject ineligible - medical implant|0|||
125659944|NCT02575807|452041611|FG001|Overall Study|Subject ineligible - medical implant|0|||
125659945|NCT02575807|452041612|FG002|Overall Study|Subject ineligible - medical implant|0|||
125659946|NCT02575807|452041613|FG003|Overall Study|Subject ineligible - medical implant|1|||
125659947|NCT02575807|452041614|FG004|Overall Study|Subject ineligible - medical implant|0|||
125659948|NCT02575807|452041610|FG000|Overall Study|Withdrawal by Subject|0|||
125659949|NCT02575807|452041611|FG001|Overall Study|Withdrawal by Subject|0|||
125659950|NCT02575807|452041612|FG002|Overall Study|Withdrawal by Subject|1|||
125659951|NCT02575807|452041613|FG003|Overall Study|Withdrawal by Subject|1|||
125659952|NCT02575807|452041614|FG004|Overall Study|Withdrawal by Subject|2|||
125659953|NCT02180659|452041615|FG000|Overall Study|Adverse Event|1|||
125659954|NCT02180659|452041616|FG001|Overall Study|Adverse Event|0|||
125659955|NCT02180659|452041615|FG000|Overall Study|Lost to Follow-up|4|||
125659956|NCT02180659|452041616|FG001|Overall Study|Lost to Follow-up|2|||
125659957|NCT02180659|452041615|FG000|Overall Study|Subject incarcerated during conduct|1|||
125659958|NCT02180659|452041616|FG001|Overall Study|Subject incarcerated during conduct|0|||
125659959|NCT02180659|452041615|FG000|Overall Study|Withdrawal by Subject|0|||
125659960|NCT02180659|452041616|FG001|Overall Study|Withdrawal by Subject|2|||
125659961|NCT02180659|452041615|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
125659962|NCT02180659|452041616|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
125659963|NCT00481871|452041619|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
125659964|NCT00481871|452041620|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
125659965|NCT00481871|452041621|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
125659966|NCT00481871|452041622|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
125659967|NCT00481871|452041623|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
125659968|NCT03151707|452041624|FG000|Overall Study|Lost to Follow-up|6|||
125659969|NCT03332212|452041625|FG000|Overall Study|Not treated|0|||
125659970|NCT03332212|452041626|FG001|Overall Study|Not treated|1|||
125659971|NCT03332212|452041627|FG002|Overall Study|Not treated|0|||
125659972|NCT03332212|452041628|FG003|Overall Study|Not treated|0|||
125659973|NCT03332212|452041625|FG000|Overall Study|Adverse Event|0|||
125659974|NCT03332212|452041626|FG001|Overall Study|Adverse Event|0|||
125659975|NCT03332212|452041627|FG002|Overall Study|Adverse Event|0|||
125659976|NCT03332212|452041628|FG003|Overall Study|Adverse Event|1|||
125659977|NCT03332212|452041625|FG000|Overall Study|worsening of disease under study|1|||
125659978|NCT03332212|452041626|FG001|Overall Study|worsening of disease under study|1|||
125659979|NCT03332212|452041627|FG002|Overall Study|worsening of disease under study|0|||
125659980|NCT03332212|452041628|FG003|Overall Study|worsening of disease under study|0|||
125659981|NCT02058368|452041633|FG000|Overall Study|Adverse Event|15|||
125659982|NCT02058368|452041634|FG001|Overall Study|Adverse Event|20|||
125659983|NCT02058368|452041633|FG000|Overall Study|Lack of Efficacy|0|||
125659984|NCT02058368|452041634|FG001|Overall Study|Lack of Efficacy|1|||
125659985|NCT02058368|452041633|FG000|Overall Study|Protocol Violation|0|||
125659986|NCT02058368|452041634|FG001|Overall Study|Protocol Violation|4|||
125659987|NCT02058368|452041633|FG000|Overall Study|Lost to Follow-up|2|||
125659988|NCT02058368|452041634|FG001|Overall Study|Lost to Follow-up|0|||
125659989|NCT02058368|452041633|FG000|Overall Study|Physician Decision|2|||
125659990|NCT02058368|452041634|FG001|Overall Study|Physician Decision|3|||
125659991|NCT02058368|452041633|FG000|Overall Study|Withdrawal by Subject|22|||
125659992|NCT02058368|452041634|FG001|Overall Study|Withdrawal by Subject|26|||
125659993|NCT01652872|452041637|FG000|Overall Study|Death|36|||
125659994|NCT01652872|452041638|FG001|Overall Study|Death|39|||
125659995|NCT01652872|452041637|FG000|Overall Study|Lost to Follow-up|28|||
125659996|NCT01652872|452041638|FG001|Overall Study|Lost to Follow-up|23|||
125659997|NCT01652872|452041637|FG000|Overall Study|Decision by sponsor|5|||
125659998|NCT01652872|452041638|FG001|Overall Study|Decision by sponsor|7|||
125659999|NCT01652872|452041637|FG000|Overall Study|Withdrawal by Subject|76|||
125660000|NCT01652872|452041638|FG001|Overall Study|Withdrawal by Subject|84|||
125660001|NCT04529096|452041641|FG000|Overall Study|Adverse Event|6|||
125660002|NCT04529096|452041642|FG001|Overall Study|Adverse Event|1|||
125660003|NCT04529096|452041641|FG000|Overall Study|Lack of Efficacy|1|||
125660004|NCT04529096|452041642|FG001|Overall Study|Lack of Efficacy|0|||
125660005|NCT04529096|452041641|FG000|Overall Study|Lost to Follow-up|1|||
125660006|NCT04529096|452041642|FG001|Overall Study|Lost to Follow-up|1|||
125660007|NCT04529096|452041641|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125660008|NCT04529096|452041642|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125660009|NCT04529096|452041641|FG000|Overall Study|Physician Decision|1|||
125660010|NCT04529096|452041642|FG001|Overall Study|Physician Decision|3|||
125660011|NCT04529096|452041641|FG000|Overall Study|Withdrawal by Subject|5|||
125660012|NCT04529096|452041642|FG001|Overall Study|Withdrawal by Subject|0|||
125660013|NCT01216319|452041643|FG000|Overall Study|Lost to Follow-up|2|||
125660014|NCT01216319|452041643|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
125660015|NCT00390572|452041647|FG000|Overall Study|Lost to Follow-up|8|||
125660016|NCT00390572|452041648|FG001|Overall Study|Lost to Follow-up|4|||
125660017|NCT00390572|452041647|FG000|Overall Study|health condition|0|||
125660018|NCT00390572|452041648|FG001|Overall Study|health condition|1|||
125660019|NCT02392559|452041649|FG000|Overall Study|Withdrawal by Subject|0|||
125660020|NCT02392559|452041650|FG001|Overall Study|Withdrawal by Subject|1|||
125660021|NCT01966107|452041651|FG000|Overall Study|excluded from FAS|21|||
125660022|NCT01966107|452041652|FG001|Overall Study|excluded from FAS|20|||
125660023|NCT01966107|452041651|FG000|Overall Study|discontinued treatment|345|||
125660024|NCT01966107|452041652|FG001|Overall Study|discontinued treatment|372|||
125660025|NCT01966107|452041651|FG000|Overall Study|due to study closure|164|||
125540611|NCT02366468|451609389|FG000|Overall Study|Lost to Follow-up|2|||
125540612|NCT02366468|451609390|FG001|Overall Study|Lost to Follow-up|0|||
125540613|NCT02366468|451609389|FG000|Overall Study|Death|1|||
125540614|NCT02366468|451609390|FG001|Overall Study|Death|2|||
125540615|NCT02366468|451609389|FG000|Overall Study|Other|0|||
125540616|NCT02366468|451609390|FG001|Overall Study|Other|2|||
125540617|NCT01552603|451609391|FG000|Overall Study|Physician Decision|1|||
125540618|NCT04797650|451609396|FG000|Overall Study|Reason Not Specified|5|||
125540619|NCT04797650|451609397|FG001|Overall Study|Reason Not Specified|12|||
125540620|NCT04797650|451609398|FG002|Overall Study|Reason Not Specified|5|||
125540621|NCT04797650|451609396|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
125540622|NCT04797650|451609397|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
125540623|NCT04797650|451609398|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
125540624|NCT04797650|451609396|FG000|Overall Study|Lack of Efficacy|1|||
125540625|NCT04797650|451609397|FG001|Overall Study|Lack of Efficacy|0|||
125540626|NCT04797650|451609398|FG002|Overall Study|Lack of Efficacy|1|||
125540627|NCT04797650|451609396|FG000|Overall Study|Non-compliance with Study Drug|0|||
125540628|NCT04797650|451609397|FG001|Overall Study|Non-compliance with Study Drug|0|||
125540629|NCT04797650|451609398|FG002|Overall Study|Non-compliance with Study Drug|2|||
125540630|NCT04797650|451609396|FG000|Overall Study|Lost to Follow-up|4|||
125540631|NCT04797650|451609397|FG001|Overall Study|Lost to Follow-up|6|||
125540632|NCT04797650|451609398|FG002|Overall Study|Lost to Follow-up|1|||
125540633|NCT00446043|451609399|FG000|Overall Study|Adverse Event|9|||
125540634|NCT00446043|451609399|FG000|Overall Study|Withdrawal by Subject|70|||
125540635|NCT00446043|451609399|FG000|Overall Study|Protocol Violation|2|||
125540636|NCT00446043|451609399|FG000|Overall Study|Lost to Follow-up|42|||
125540637|NCT00446043|451609399|FG000|Overall Study|Pregnancy|2|||
125540638|NCT00657020|451609400|FG000|PERIOD 1|Adverse Event|0|||
125540639|NCT00657020|451609401|FG001|PERIOD 1|Adverse Event|1|||
125660026|NCT01966107|452041652|FG001|Overall Study|due to study closure|186|||
125660027|NCT01966107|452041651|FG000|Overall Study|withdrew from the study|272|||
125660028|NCT01966107|452041652|FG001|Overall Study|withdrew from the study|303|||
125660029|NCT00532779|452041653|FG000|Overall Study|Adverse Event|122|||
125660030|NCT00532779|452041654|FG001|Overall Study|Adverse Event|112|||
125660031|NCT00532779|452041655|FG002|Overall Study|Adverse Event|56|||
125660032|NCT00532779|452041653|FG000|Overall Study|Lost to Follow-up|76|||
125660033|NCT00532779|452041654|FG001|Overall Study|Lost to Follow-up|65|||
125660034|NCT00532779|452041655|FG002|Overall Study|Lost to Follow-up|66|||
125660035|NCT00532779|452041653|FG000|Overall Study|Withdrawal by Subject|63|||
125660036|NCT00532779|452041654|FG001|Overall Study|Withdrawal by Subject|60|||
125660037|NCT00532779|452041655|FG002|Overall Study|Withdrawal by Subject|90|||
125660038|NCT00532779|452041653|FG000|Overall Study|Lack of Efficacy|12|||
125660039|NCT00532779|452041654|FG001|Overall Study|Lack of Efficacy|12|||
125660040|NCT00532779|452041655|FG002|Overall Study|Lack of Efficacy|40|||
125660041|NCT00532779|452041653|FG000|Overall Study|Protocol Violation|5|||
125660042|NCT00532779|452041654|FG001|Overall Study|Protocol Violation|9|||
125660043|NCT00532779|452041655|FG002|Overall Study|Protocol Violation|7|||
125660044|NCT00532779|452041653|FG000|Overall Study|Pregnancy|2|||
125660045|NCT00532779|452041654|FG001|Overall Study|Pregnancy|5|||
125660046|NCT00532779|452041655|FG002|Overall Study|Pregnancy|3|||
125660047|NCT00532779|452041653|FG000|Overall Study|Death|0|||
125660048|NCT00532779|452041654|FG001|Overall Study|Death|1|||
125660049|NCT00532779|452041655|FG002|Overall Study|Death|0|||
125660050|NCT00532779|452041653|FG000|Overall Study|Drug noncompliance, moved, other|14|||
125660051|NCT00532779|452041654|FG001|Overall Study|Drug noncompliance, moved, other|23|||
125660052|NCT00532779|452041655|FG002|Overall Study|Drug noncompliance, moved, other|29|||
125660053|NCT00689273|452041656|FG000|Overall Study|Adverse Event|3|||
125660054|NCT00689273|452041657|FG001|Overall Study|Adverse Event|1|||
125660055|NCT00689273|452041656|FG000|Overall Study|Lack of Efficacy|3|||
125660056|NCT00689273|452041657|FG001|Overall Study|Lack of Efficacy|0|||
125660057|NCT00689273|452041656|FG000|Overall Study|Lost to Follow-up|0|||
125660058|NCT00689273|452041657|FG001|Overall Study|Lost to Follow-up|2|||
125660059|NCT00689273|452041656|FG000|Overall Study|Other|6|||
125660060|NCT00689273|452041657|FG001|Overall Study|Other|2|||
125660061|NCT00689273|452041656|FG000|Overall Study|Randomized but not Treated|1|||
125660062|NCT00689273|452041657|FG001|Overall Study|Randomized but not Treated|0|||
125660063|NCT01556165|452041658|FG000|Overall Study|Adverse Event|5|||
125660064|NCT01556165|452041659|FG001|Overall Study|Adverse Event|3|||
125660065|NCT01556165|452041658|FG000|Overall Study|Protocol Violation|0|||
125660066|NCT01556165|452041659|FG001|Overall Study|Protocol Violation|3|||
125660067|NCT01556165|452041658|FG000|Overall Study|Withdrawal of Consent|7|||
125660068|NCT01556165|452041659|FG001|Overall Study|Withdrawal of Consent|1|||
125660069|NCT01238172|452041660|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
125660070|NCT01238172|452041661|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
125660071|NCT01238172|452041660|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
125660072|NCT01238172|452041661|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
125660073|NCT02531698|452041662|FG000|Overall Study|Adverse Event|2|||
125660074|NCT02531698|452041663|FG001|Overall Study|Adverse Event|1|||
125660075|NCT02531698|452041662|FG000|Overall Study|Withdrawal by Subject|6|||
125660076|NCT02531698|452041663|FG001|Overall Study|Withdrawal by Subject|1|||
125660077|NCT02531698|452041662|FG000|Overall Study|Protocol Violation|2|||
125660078|NCT02531698|452041663|FG001|Overall Study|Protocol Violation|0|||
125660079|NCT02531698|452041662|FG000|Overall Study|Lost to Follow-up|1|||
125660080|NCT02531698|452041663|FG001|Overall Study|Lost to Follow-up|0|||
125660081|NCT00701558|452041664|FG000|Overall Study|Death|7|||
125660082|NCT00701558|452041664|FG000|Overall Study|Lost to Follow-up|8|||
125660083|NCT01640964|452041665|FG000|Overall Study|Lost to Follow-up|0|||
125660084|NCT01640964|452041666|FG001|Overall Study|Lost to Follow-up|0|||
125660085|NCT01640964|452041667|FG002|Overall Study|Lost to Follow-up|1|||
125660086|NCT01640964|452041665|FG000|Overall Study|Protocol Deviation|1|||
125660087|NCT01640964|452041666|FG001|Overall Study|Protocol Deviation|1|||
125660088|NCT01640964|452041667|FG002|Overall Study|Protocol Deviation|2|||
125660089|NCT02787746|452041668|FG000|Overall Study|Adverse Event|42|||
125660090|NCT02787746|452041668|FG000|Overall Study|Withdrawal by Subject|65|||
125660091|NCT02787746|452041668|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
125660092|NCT04822701|452041671|FG000|Overall Study|Not treated|2|||
125660093|NCT04822701|452041672|FG001|Overall Study|Not treated|0|||
125660094|NCT04822701|452041671|FG000|Overall Study|Lost to Follow-up|1|||
125660095|NCT04822701|452041672|FG001|Overall Study|Lost to Follow-up|0|||
125660096|NCT04822701|452041671|FG000|Overall Study|Withdrawal by Subject|1|||
125660097|NCT04822701|452041672|FG001|Overall Study|Withdrawal by Subject|0|||
125660098|NCT02038959|452043462|FG000|Overall Study|Withdrawal by Subject|6|||
125660099|NCT02038959|452043463|FG001|Overall Study|Withdrawal by Subject|8|||
125660100|NCT01788163|452043471|FG000|Overall Study|Other|53|||
125660101|NCT01788163|452043472|FG001|Overall Study|Other|0|||
125660102|NCT01788163|452043473|FG002|Overall Study|Other|0|||
125660103|NCT01788163|452043474|FG003|Overall Study|Other|0|||
125660104|NCT01788163|452043475|FG004|Overall Study|Other|0|||
125660105|NCT01788163|452043476|FG005|Overall Study|Other|7|||
125660106|NCT01788163|452043477|FG006|Overall Study|Other|1|||
125660107|NCT01788163|452043478|FG007|Overall Study|Other|48|||
125660108|NCT01788163|452043479|FG008|Overall Study|Other|15|||
125660109|NCT01788163|452043471|FG000|Overall Study|Withdrawal by Subject|2|||
125660110|NCT01788163|452043472|FG001|Overall Study|Withdrawal by Subject|0|||
125660111|NCT01788163|452043473|FG002|Overall Study|Withdrawal by Subject|0|||
125660112|NCT01788163|452043474|FG003|Overall Study|Withdrawal by Subject|0|||
125660113|NCT01788163|452043475|FG004|Overall Study|Withdrawal by Subject|0|||
125660114|NCT01788163|452043476|FG005|Overall Study|Withdrawal by Subject|0|||
125660115|NCT01788163|452043477|FG006|Overall Study|Withdrawal by Subject|0|||
125660116|NCT01788163|452043478|FG007|Overall Study|Withdrawal by Subject|0|||
125660117|NCT01788163|452043479|FG008|Overall Study|Withdrawal by Subject|1|||
125660118|NCT00545441|452043480|FG000|Overall Study|Fistula draining at 6 months|2|||
125660119|NCT00545441|452043481|FG001|Overall Study|Fistula draining at 6 months|4|||
125660120|NCT00545441|452043480|FG000|Overall Study|Lost to Follow-up|9|||
125660121|NCT00545441|452043481|FG001|Overall Study|Lost to Follow-up|5|||
125660122|NCT00545441|452043480|FG000|Overall Study|Technical failure|0|||
125660123|NCT00545441|452043481|FG001|Overall Study|Technical failure|1|||
125660124|NCT00545441|452043480|FG000|Overall Study|Withdrawal by Subject|1|||
125660125|NCT00545441|452043481|FG001|Overall Study|Withdrawal by Subject|1|||
125660126|NCT00545441|452043480|FG000|Overall Study|Persistence or recurrence of fistula|5|||
125660127|NCT00545441|452043481|FG001|Overall Study|Persistence or recurrence of fistula|2|||
125660128|NCT00545441|452043480|FG000|Overall Study|Patients were not treated|1|||
125660129|NCT00545441|452043481|FG001|Overall Study|Patients were not treated|3|||
125660130|NCT00265239|452043482|FG000|Overall Study|Adverse Event|2|||
125660131|NCT00265239|452043483|FG001|Overall Study|Adverse Event|1|||
125660132|NCT02803138|452043488|FG000|Overall Study|Failure to return|38|||
125660133|NCT02803138|452043488|FG000|Overall Study|Insufficient virological response|2|||
125660134|NCT02803138|452043488|FG000|Overall Study|Withdrawn consent|1|||
125660135|NCT02803138|452043488|FG000|Overall Study|Death|1|||
125660136|NCT02803138|452043488|FG000|Overall Study|Other, not specified|28|||
125660137|NCT00424515|452043489|FG000|Overall Study|Progressive Disease|10|||
125660138|NCT00424515|452043490|FG001|Overall Study|Progressive Disease|11|||
125660139|NCT00424515|452043489|FG000|Overall Study|Adverse Event|0|||
125660140|NCT00424515|452043490|FG001|Overall Study|Adverse Event|1|||
125660141|NCT00424515|452043489|FG000|Overall Study|Intercurrent Illness|0|||
125660142|NCT00424515|452043490|FG001|Overall Study|Intercurrent Illness|1|||
125660143|NCT00424515|452043489|FG000|Overall Study|Withdrawal by Subject|1|||
125660144|NCT00424515|452043490|FG001|Overall Study|Withdrawal by Subject|0|||
125660145|NCT00267020|452043491|FG000|Overall Study|Adverse Event|22|||
125660146|NCT00267020|452043492|FG001|Overall Study|Adverse Event|5|||
125660147|NCT00267020|452043491|FG000|Overall Study|Death|2|||
125660148|NCT00267020|452043492|FG001|Overall Study|Death|1|||
125660149|NCT00267020|452043491|FG000|Overall Study|Withdrawal by Subject|17|||
125660150|NCT00267020|452043492|FG001|Overall Study|Withdrawal by Subject|7|||
125660151|NCT00267020|452043491|FG000|Overall Study|Physician Decision|3|||
125660152|NCT00267020|452043492|FG001|Overall Study|Physician Decision|2|||
125660153|NCT00267020|452043491|FG000|Overall Study|Disease Progression|39|||
125660154|NCT00267020|452043492|FG001|Overall Study|Disease Progression|25|||
125660155|NCT00267020|452043491|FG000|Overall Study|Unrelated Complication|1|||
125660156|NCT00267020|452043492|FG001|Overall Study|Unrelated Complication|1|||
125660157|NCT00267020|452043491|FG000|Overall Study|Sponsor Request|1|||
125660158|NCT00267020|452043492|FG001|Overall Study|Sponsor Request|0|||
125660159|NCT00267020|452043491|FG000|Overall Study|Other|1|||
125660160|NCT00267020|452043492|FG001|Overall Study|Other|2|||
125660161|NCT04071366|452043493|FG000|Part 1: Open-label (29 Days)|Death|4|||
125660162|NCT04071366|452043494|FG001|Part 1: Open-label (29 Days)|Death|2|||
125660163|NCT04071366|452043495|FG002|Part 1: Open-label (29 Days)|Death|8|||
125660164|NCT04071366|452043496|FG003|Part 1: Open-label (29 Days)|Death|0|||
125660165|NCT04071366|452043497|FG004|Part 1: Open-label (29 Days)|Death|0|||
125660166|NCT04071366|452043493|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
125660167|NCT04071366|452043494|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
125660168|NCT04071366|452043495|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
125660169|NCT04071366|452043496|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
125660170|NCT04071366|452043497|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
125660171|NCT04071366|452043493|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
125660172|NCT04071366|452043494|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
125660173|NCT04071366|452043495|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
125660174|NCT04071366|452043496|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
125660175|NCT04071366|452043497|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
125660176|NCT04071366|452043493|FG000|Part 2: Randomized (29 Days)|Death|0|||
125660177|NCT04071366|452043494|FG001|Part 2: Randomized (29 Days)|Death|0|||
125660178|NCT04071366|452043495|FG002|Part 2: Randomized (29 Days)|Death|0|||
125660179|NCT04071366|452043496|FG003|Part 2: Randomized (29 Days)|Death|2|||
125660180|NCT04071366|452043497|FG004|Part 2: Randomized (29 Days)|Death|2|||
125660181|NCT04071366|452043493|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
125660182|NCT04071366|452043494|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
125660183|NCT04071366|452043495|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
125660184|NCT04071366|452043496|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
125660185|NCT04071366|452043497|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
125660186|NCT04071366|452043493|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
125660187|NCT04071366|452043494|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
125660188|NCT04071366|452043495|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
125660189|NCT04071366|452043496|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
125660190|NCT04071366|452043497|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
125660191|NCT04071366|452043493|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
125660192|NCT04071366|452043494|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
125660193|NCT04071366|452043495|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
125660194|NCT04071366|452043496|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
125660195|NCT04071366|452043497|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
125660196|NCT04071366|452043493|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
125660197|NCT04071366|452043494|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
125660198|NCT04071366|452043495|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
125660199|NCT04071366|452043496|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
125660200|NCT04071366|452043497|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
125660201|NCT04071366|452043493|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
125660202|NCT04071366|452043494|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
125660203|NCT04071366|452043495|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
125660204|NCT04071366|452043496|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
125660205|NCT04071366|452043497|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
125660206|NCT04071366|452043493|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
125660207|NCT04071366|452043494|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
125660208|NCT04071366|452043495|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
125660209|NCT04071366|452043496|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
125660210|NCT04071366|452043497|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
125660211|NCT00021229|452043498|FG000|Overall Study|Adverse Event|10|||
125660212|NCT00021229|452043499|FG001|Overall Study|Adverse Event|5|||
125660213|NCT00021229|452043500|FG002|Overall Study|Adverse Event|2|||
125660214|NCT00021229|452043498|FG000|Overall Study|Death|0|||
125660215|NCT00021229|452043499|FG001|Overall Study|Death|1|||
125660216|NCT00021229|452043500|FG002|Overall Study|Death|0|||
125660217|NCT00021229|452043498|FG000|Overall Study|Withdrawal by Subject|7|||
125660218|NCT00021229|452043499|FG001|Overall Study|Withdrawal by Subject|7|||
125660219|NCT00021229|452043500|FG002|Overall Study|Withdrawal by Subject|1|||
125660220|NCT00021229|452043498|FG000|Overall Study|Progressive Disease|15|||
125660221|NCT00021229|452043499|FG001|Overall Study|Progressive Disease|19|||
125660222|NCT00021229|452043500|FG002|Overall Study|Progressive Disease|12|||
125660223|NCT00021229|452043498|FG000|Overall Study|Protocol Violation|1|||
125660224|NCT00021229|452043499|FG001|Overall Study|Protocol Violation|1|||
125660225|NCT00021229|452043500|FG002|Overall Study|Protocol Violation|0|||
125660226|NCT00021229|452043498|FG000|Overall Study|Physician Decision|0|||
125660227|NCT00021229|452043499|FG001|Overall Study|Physician Decision|0|||
125660228|NCT00021229|452043500|FG002|Overall Study|Physician Decision|1|||
125660229|NCT00021229|452043498|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
125660230|NCT00021229|452043499|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
125660231|NCT00021229|452043500|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
125660232|NCT02156466|452043501|FG000|Overall Study|Adverse Event|0|||
125660233|NCT02156466|452043502|FG001|Overall Study|Adverse Event|0|||
125660234|NCT02156466|452043503|FG002|Overall Study|Adverse Event|1|||
125660235|NCT02156466|452043504|FG003|Overall Study|Adverse Event|1|||
125660236|NCT02156466|452043505|FG004|Overall Study|Adverse Event|0|||
125660237|NCT02156466|452043501|FG000|Overall Study|Quantiferon Positivity|0|||
125660238|NCT02156466|452043502|FG001|Overall Study|Quantiferon Positivity|0|||
125660239|NCT02156466|452043503|FG002|Overall Study|Quantiferon Positivity|0|||
125660240|NCT02156466|452043504|FG003|Overall Study|Quantiferon Positivity|1|||
125660241|NCT02156466|452043505|FG004|Overall Study|Quantiferon Positivity|0|||
125660242|NCT02237118|452043506|FG000|Overall Study|Protocol Violation|0|||
125660243|NCT02237118|452043507|FG001|Overall Study|Protocol Violation|1|||
125660244|NCT02237118|452043506|FG000|Overall Study|consent withdrawn|1|||
125660245|NCT02237118|452043507|FG001|Overall Study|consent withdrawn|0|||
125660246|NCT00399490|452043508|FG000|Overall Study|Adverse Event|19|||
125660247|NCT00399490|452043508|FG000|Overall Study|Lack of Efficacy|31|||
125660248|NCT00399490|452043508|FG000|Overall Study|Lost to Follow-up|5|||
125660249|NCT00399490|452043508|FG000|Overall Study|Withdrawal by Subject|18|||
125660250|NCT00399490|452043508|FG000|Overall Study|Other|25|||
125660251|NCT02499406|452043509|FG000|Overall Study|missed 3 treatment sessions|4|||
125660252|NCT00902265|452043510|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
125660253|NCT00902265|452043510|FG000|Overall Study|Adverse Event|2|||
125660254|NCT00902265|452043510|FG000|Overall Study|Lack of Efficacy|2|||
125660255|NCT00902265|452043510|FG000|Overall Study|Protocol Violation|1|||
125660256|NCT04701658|452043511|FG000|Overall Study|Lost to Follow-up|6|||
125660257|NCT02866695|452043514|FG000|Overall Study|Adverse Event|1|||
125660258|NCT02866695|452043514|FG000|Overall Study|Lost to Follow-up|1|||
125660259|NCT03224234|452043515|FG000|Main Study|Lost to Follow-up|5|||
125660260|NCT03224234|452043516|FG001|Main Study|Lost to Follow-up|5|||
125660261|NCT05016765|452043517|FG000|Overall Study|Lost to Follow-up|4|||
125660262|NCT01346501|452043521|FG000|Overall Study|Initiated Other Biological Agents|3|||
125660263|NCT01346501|452043522|FG001|Overall Study|Initiated Other Biological Agents|1|||
125660264|NCT01346501|452043521|FG000|Overall Study|Other|8|||
125660265|NCT01346501|452043522|FG001|Overall Study|Other|12|||
125660266|NCT02564952|452043523|FG000|Overall Study|Adverse Event|6|||
125660267|NCT02564952|452043523|FG000|Overall Study|Lost to Follow-up|1|||
125660268|NCT02564952|452043523|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
125660269|NCT02564952|452043523|FG000|Overall Study|Withdrawal by Subject|1|||
125660270|NCT02564952|452043523|FG000|Overall Study|Low Efficacy|1|||
125660271|NCT02564952|452043523|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
125660272|NCT00756652|452043524|FG000|Original Phase|Withdrawal by Subject|864|||
125660273|NCT00756652|452043525|FG001|Original Phase|Withdrawal by Subject|23|||
125660274|NCT00756652|452043524|FG000|Original Phase|Lost to Follow-up|601|||
125660275|NCT00756652|452043525|FG001|Original Phase|Lost to Follow-up|0|||
125660276|NCT00756652|452043524|FG000|Original Phase|Other Discontinuation|797|||
125660277|NCT00756652|452043525|FG001|Original Phase|Other Discontinuation|5|||
125660278|NCT00756652|452043524|FG000|Original Phase|Participant Noncompliance|18622|||
125660279|NCT00756652|452043525|FG001|Original Phase|Participant Noncompliance|424|||
125660280|NCT00756652|452043524|FG000|Original Phase|Unknown Discontinuation Reason|2|||
125660281|NCT00756652|452043525|FG001|Original Phase|Unknown Discontinuation Reason|0|||
125660282|NCT00756652|452043524|FG000|Original Phase|Participants without data|3259|||
125660283|NCT00756652|452043525|FG001|Original Phase|Participants without data|466|||
125660284|NCT00756652|452043524|FG000|Original Phase|Death|168|||
125660285|NCT00756652|452043525|FG001|Original Phase|Death|1|||
125660286|NCT00756652|452043524|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
125660287|NCT00756652|452043525|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
125660288|NCT00756652|452043524|FG000|Re-Op Phase|Withdrawal by Subject|62|||
125660289|NCT00756652|452043525|FG001|Re-Op Phase|Withdrawal by Subject|0|||
125660290|NCT00756652|452043524|FG000|Re-Op Phase|Death|6|||
125660291|NCT00756652|452043525|FG001|Re-Op Phase|Death|0|||
125660292|NCT00756652|452043524|FG000|Re-Op Phase|Lost to Follow-up|340|||
125660293|NCT00756652|452043525|FG001|Re-Op Phase|Lost to Follow-up|0|||
125660294|NCT00756652|452043524|FG000|Re-Op Phase|Site Closed|2454|||
125660295|NCT00756652|452043525|FG001|Re-Op Phase|Site Closed|0|||
125660296|NCT00756652|452043524|FG000|Re-Op Phase|Withdrawn after explant|14|||
125660297|NCT00756652|452043525|FG001|Re-Op Phase|Withdrawn after explant|0|||
125660298|NCT01850108|452043526|FG000|Overall Study|Lost to Follow-up|4|||
125660299|NCT01850108|452043526|FG000|Overall Study|Not eligible|1|||
125660300|NCT01850108|452043526|FG000|Overall Study|Failed engraftment|2|||
125660301|NCT01850108|452043526|FG000|Overall Study|Physician Decision|1|||
125660302|NCT00038467|452043527|FG000|Overall Study|Adverse Event|170|||
125660303|NCT00038467|452043528|FG001|Overall Study|Adverse Event|145|||
125660304|NCT00038467|452043527|FG000|Overall Study|Withdrawal by Subject|150|||
125660305|NCT00038467|452043528|FG001|Overall Study|Withdrawal by Subject|107|||
125660306|NCT00038467|452043527|FG000|Overall Study|Protocol Violation|19|||
125660307|NCT00038467|452043528|FG001|Overall Study|Protocol Violation|22|||
125660308|NCT00038467|452043527|FG000|Overall Study|Death|22|||
125660309|NCT00038467|452043528|FG001|Overall Study|Death|16|||
125660310|NCT00038467|452043527|FG000|Overall Study|Lost to Follow-up|15|||
125660311|NCT00038467|452043528|FG001|Overall Study|Lost to Follow-up|10|||
125660312|NCT00038467|452043527|FG000|Overall Study|Recurrence|109|||
125660313|NCT00038467|452043528|FG001|Overall Study|Recurrence|179|||
125660314|NCT00038467|452043527|FG000|Overall Study|Randomized, but not treated|31|||
125660315|NCT00038467|452043528|FG001|Overall Study|Randomized, but not treated|35|||
125660316|NCT00038467|452043527|FG000|Overall Study|Other|26|||
125660317|NCT00038467|452043528|FG001|Overall Study|Other|28|||
125660318|NCT01988493|452043529|FG000|Overall Study|Randomized but not treated|0|||
125660319|NCT01988493|452043530|FG001|Overall Study|Randomized but not treated|0|||
125660320|NCT01988493|452043531|FG002|Overall Study|Randomized but not treated|0|||
125660321|NCT01988493|452043532|FG003|Overall Study|Randomized but not treated|0|||
125660322|NCT01988493|452043533|FG004|Overall Study|Randomized but not treated|1|||
125660323|NCT01523301|452043534|FG000|Overall Study|Adverse Event|25|||
125660324|NCT01523301|452043535|FG001|Overall Study|Adverse Event|16|||
125660325|NCT01523301|452043534|FG000|Overall Study|Lack of Efficacy|0|||
125660326|NCT01523301|452043535|FG001|Overall Study|Lack of Efficacy|2|||
125660327|NCT01523301|452043534|FG000|Overall Study|Protocol Violation|3|||
125660328|NCT01523301|452043535|FG001|Overall Study|Protocol Violation|4|||
125660329|NCT01523301|452043534|FG000|Overall Study|Lost to Follow-up|1|||
125660330|NCT01523301|452043535|FG001|Overall Study|Lost to Follow-up|0|||
125660331|NCT01523301|452043534|FG000|Overall Study|Withdrawal by Subject|6|||
125660332|NCT01523301|452043535|FG001|Overall Study|Withdrawal by Subject|8|||
125660333|NCT01523301|452043534|FG000|Overall Study|Other Reason|0|||
125660334|NCT01523301|452043535|FG001|Overall Study|Other Reason|2|||
125660335|NCT01447628|452043538|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
125660336|NCT01447628|452043539|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
125660337|NCT01447628|452043540|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
125660338|NCT01447628|452043541|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
125660339|NCT00185731|452043542|FG000|Overall Study|Withdrawal by Subject|1|||
125660340|NCT00185731|452043542|FG000|Overall Study|Not Eligible|1|||
125660341|NCT03087773|452043543|FG000|Overall Study|Withdrawal by Subject|8|||
125660342|NCT03087773|452043544|FG001|Overall Study|Withdrawal by Subject|4|||
125660343|NCT03087773|452043543|FG000|Overall Study|Lost to Follow-up|12|||
125660344|NCT03087773|452043544|FG001|Overall Study|Lost to Follow-up|8|||
125660345|NCT01308762|452043549|FG000|Overall Study|Protocol Violation|0|||
125660346|NCT01308762|452043550|FG001|Overall Study|Protocol Violation|1|||
125660347|NCT01308762|452043551|FG002|Overall Study|Protocol Violation|0|||
125660348|NCT02617446|452043552|FG000|Overall Study|Withdrawal by Subject|0|||
125660349|NCT02617446|452043553|FG001|Overall Study|Withdrawal by Subject|2|||
125660350|NCT02617446|452043554|FG002|Overall Study|Withdrawal by Subject|0|||
125660351|NCT02617446|452043552|FG000|Overall Study|Adverse Event|1|||
125660352|NCT02617446|452043553|FG001|Overall Study|Adverse Event|0|||
125660353|NCT02617446|452043554|FG002|Overall Study|Adverse Event|5|||
125660354|NCT02617446|452043552|FG000|Overall Study|Lost to Follow-up|3|||
125660355|NCT02617446|452043553|FG001|Overall Study|Lost to Follow-up|0|||
125660356|NCT02617446|452043554|FG002|Overall Study|Lost to Follow-up|0|||
125660357|NCT02617446|452043552|FG000|Overall Study|Death|0|||
125660358|NCT02617446|452043553|FG001|Overall Study|Death|0|||
125660359|NCT02617446|452043554|FG002|Overall Study|Death|2|||
125660360|NCT00530088|452043555|FG000|Overall Study|Disease Progression|4|||
125660361|NCT00530088|452043555|FG000|Overall Study|Physician Decision|4|||
125660362|NCT00530088|452043555|FG000|Overall Study|Other Not Specified|2|||
125660363|NCT00902278|452043556|FG000|Overall Study|Physician Decision|1|||
125660364|NCT00902278|452043557|FG001|Overall Study|Physician Decision|0|||
125660365|NCT00902278|452043558|FG002|Overall Study|Physician Decision|2|||
125660366|NCT00902278|452043559|FG003|Overall Study|Physician Decision|0|||
125660367|NCT00902278|452043560|FG004|Overall Study|Physician Decision|1|||
125660368|NCT00902278|452043556|FG000|Overall Study|Lost to Follow-up|3|||
125660369|NCT00902278|452043557|FG001|Overall Study|Lost to Follow-up|2|||
125660370|NCT00902278|452043558|FG002|Overall Study|Lost to Follow-up|3|||
125660371|NCT00902278|452043559|FG003|Overall Study|Lost to Follow-up|0|||
125660372|NCT00902278|452043560|FG004|Overall Study|Lost to Follow-up|1|||
125660373|NCT02362646|452043561|FG000|Overall Study|Death|15|||
125660374|NCT02362646|452043562|FG001|Overall Study|Death|8|||
125660375|NCT02362646|452043561|FG000|Overall Study|Withdrawal by Subject|2|||
125660376|NCT02362646|452043562|FG001|Overall Study|Withdrawal by Subject|2|||
125660377|NCT02362646|452043561|FG000|Overall Study|received transplant|21|||
125660378|NCT02362646|452043562|FG001|Overall Study|received transplant|14|||
125660379|NCT00865306|452043563|FG000|Controlled Trial|Lost to Follow-up|1|||
125660380|NCT00865306|452043564|FG001|Controlled Trial|Lost to Follow-up|1|||
125660381|NCT00865306|452043563|FG000|Controlled Trial|Difficulty commuting|2|||
125660382|NCT00865306|452043564|FG001|Controlled Trial|Difficulty commuting|0|||
125660383|NCT00865306|452043563|FG000|Controlled Trial|Improved btw baseline and first session|1|||
125660384|NCT00865306|452043564|FG001|Controlled Trial|Improved btw baseline and first session|0|||
125660385|NCT00865306|452043563|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
125660386|NCT00865306|452043564|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
125660387|NCT00865306|452043563|FG000|Controlled Trial|Withdrawal by Subject|0|||
125660388|NCT00865306|452043564|FG001|Controlled Trial|Withdrawal by Subject|1|||
125660389|NCT02181842|452043566|FG000|Overall Study|Case Report Forms Uncollected|2|||
125660390|NCT00929864|452043567|FG000|Overall Study|Death|1|||
125660391|NCT00929864|452043568|FG001|Overall Study|Death|1|||
125660392|NCT00929864|452043567|FG000|Overall Study|Adverse Event|11|||
125660393|NCT00929864|452043568|FG001|Overall Study|Adverse Event|30|||
125660394|NCT00929864|452043567|FG000|Overall Study|Lack of Efficacy|19|||
125660395|NCT00929864|452043568|FG001|Overall Study|Lack of Efficacy|16|||
125660396|NCT00929864|452043567|FG000|Overall Study|Lost to Follow-up|7|||
125660397|NCT00929864|452043568|FG001|Overall Study|Lost to Follow-up|12|||
125660398|NCT00929864|452043567|FG000|Overall Study|Withdrawal by Subject|20|||
125660399|NCT00929864|452043568|FG001|Overall Study|Withdrawal by Subject|9|||
125660400|NCT00929864|452043567|FG000|Overall Study|No longer met criteria|2|||
125660401|NCT00929864|452043568|FG001|Overall Study|No longer met criteria|1|||
125660402|NCT00929864|452043567|FG000|Overall Study|Poor or non-compliance|3|||
125660403|NCT00929864|452043568|FG001|Overall Study|Poor or non-compliance|3|||
125660404|NCT00929864|452043567|FG000|Overall Study|Pregnancy|0|||
125660405|NCT00929864|452043568|FG001|Overall Study|Pregnancy|3|||
125660406|NCT00929864|452043567|FG000|Overall Study|Administrative reason by Sponsor|1|||
125660407|NCT00929864|452043568|FG001|Overall Study|Administrative reason by Sponsor|1|||
125660408|NCT00929864|452043567|FG000|Overall Study|Non-specified|2|||
125660409|NCT00929864|452043568|FG001|Overall Study|Non-specified|7|||
125660410|NCT03454672|452043580|FG000|Overall Study|Adverse Event|1|||
125660411|NCT03454672|452043581|FG001|Overall Study|Adverse Event|1|||
125660412|NCT03454672|452043580|FG000|Overall Study|Lost to Follow-up|1|||
125660413|NCT03454672|452043581|FG001|Overall Study|Lost to Follow-up|3|||
125660414|NCT03454672|452043580|FG000|Overall Study|painful|1|||
125660415|NCT03454672|452043581|FG001|Overall Study|painful|2|||
125660416|NCT03454672|452043580|FG000|Overall Study|Non-compliance|2|||
125660417|NCT03454672|452043581|FG001|Overall Study|Non-compliance|4|||
125660418|NCT03454672|452043580|FG000|Overall Study|personal reasons|3|||
125660419|NCT03454672|452043581|FG001|Overall Study|personal reasons|2|||
125660420|NCT03454672|452043580|FG000|Overall Study|Withdrawal by Subject|1|||
125660421|NCT03454672|452043581|FG001|Overall Study|Withdrawal by Subject|0|||
125660422|NCT03985293|452043583|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
125660423|NCT03985293|452043584|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
125660424|NCT03985293|452043585|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
125540640|NCT04772898|451609402|FG000|Overall Study|Withdrawal by Subject|0|||
125540641|NCT04772898|451609403|FG001|Overall Study|Withdrawal by Subject|1|||
125540642|NCT01144052|451609404|FG000|Overall Study|Withdrawal by Subject|1|||
125540643|NCT01144052|451609405|FG001|Overall Study|Withdrawal by Subject|1|||
125540644|NCT02947087|451609406|FG000|Overall Study|Withdrawal by Subject|3|||
125540645|NCT02947087|451609407|FG001|Overall Study|Withdrawal by Subject|2|||
125540646|NCT01879722|451609411|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125540647|NCT01879722|451609412|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
125540648|NCT01879722|451609413|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
125540649|NCT01879722|451609414|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
125540650|NCT01879722|451609415|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
125540651|NCT01879722|451609416|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
125540652|NCT01879722|451609417|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
125540653|NCT01879722|451609418|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
125540654|NCT01879722|451609419|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
125540655|NCT01879722|451609420|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
125540656|NCT01879722|451609411|FG000|Overall Study|Voluntary Withdrawal|0|||
125540657|NCT01879722|451609412|FG001|Overall Study|Voluntary Withdrawal|0|||
125540658|NCT01879722|451609413|FG002|Overall Study|Voluntary Withdrawal|0|||
125540659|NCT01879722|451609414|FG003|Overall Study|Voluntary Withdrawal|0|||
125540660|NCT01879722|451609415|FG004|Overall Study|Voluntary Withdrawal|0|||
125540661|NCT01879722|451609416|FG005|Overall Study|Voluntary Withdrawal|0|||
125540662|NCT01879722|451609417|FG006|Overall Study|Voluntary Withdrawal|0|||
125540663|NCT01879722|451609418|FG007|Overall Study|Voluntary Withdrawal|0|||
125540664|NCT01879722|451609419|FG008|Overall Study|Voluntary Withdrawal|1|||
125540665|NCT01879722|451609420|FG009|Overall Study|Voluntary Withdrawal|0|||
125540666|NCT01327495|451609423|FG000|Overall Study|Adverse Event|2|||
125540667|NCT01327495|451609424|FG001|Overall Study|Adverse Event|1|||
125540668|NCT01327495|451609425|FG002|Overall Study|Adverse Event|1|||
125540669|NCT01327495|451609426|FG003|Overall Study|Adverse Event|0|||
125540670|NCT01327495|451609427|FG004|Overall Study|Adverse Event|0|||
125540671|NCT01327495|451609428|FG005|Overall Study|Adverse Event|2|||
125540672|NCT01327495|451609423|FG000|Overall Study|Withdrawal by Subject|0|||
125540673|NCT01327495|451609424|FG001|Overall Study|Withdrawal by Subject|1|||
125540674|NCT01327495|451609425|FG002|Overall Study|Withdrawal by Subject|1|||
125540675|NCT01327495|451609426|FG003|Overall Study|Withdrawal by Subject|0|||
125540676|NCT01327495|451609427|FG004|Overall Study|Withdrawal by Subject|1|||
125540677|NCT01327495|451609428|FG005|Overall Study|Withdrawal by Subject|0|||
125540678|NCT01327495|451609423|FG000|Overall Study|Physician Decision|0|||
125540679|NCT01327495|451609424|FG001|Overall Study|Physician Decision|0|||
125540680|NCT01327495|451609425|FG002|Overall Study|Physician Decision|0|||
125540681|NCT01327495|451609426|FG003|Overall Study|Physician Decision|0|||
125540682|NCT01327495|451609427|FG004|Overall Study|Physician Decision|2|||
125540683|NCT01327495|451609428|FG005|Overall Study|Physician Decision|0|||
125540684|NCT00006011|451609430|FG000|Overall Study|Disease progression|13|||
125540685|NCT00006011|451609431|FG001|Overall Study|Disease progression|6|||
125540686|NCT00006011|451609432|FG002|Overall Study|Disease progression|26|||
125540687|NCT00006011|451609430|FG000|Overall Study|Refused further treatment|15|||
125540688|NCT00006011|451609431|FG001|Overall Study|Refused further treatment|13|||
125540689|NCT00006011|451609432|FG002|Overall Study|Refused further treatment|26|||
125540690|NCT00006011|451609430|FG000|Overall Study|Adverse Event|15|||
125540691|NCT00006011|451609431|FG001|Overall Study|Adverse Event|39|||
125540692|NCT00006011|451609432|FG002|Overall Study|Adverse Event|5|||
125540693|NCT00006011|451609430|FG000|Overall Study|Death|0|||
125540694|NCT00006011|451609431|FG001|Overall Study|Death|1|||
125540695|NCT00006011|451609432|FG002|Overall Study|Death|2|||
125540696|NCT00006011|451609430|FG000|Overall Study|Other|4|||
125540697|NCT00006011|451609431|FG001|Overall Study|Other|2|||
125540698|NCT00006011|451609432|FG002|Overall Study|Other|5|||
125540699|NCT00006011|451609430|FG000|Overall Study|Ineligible|18|||
125660425|NCT03985293|452043586|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
125540700|NCT00006011|451609431|FG001|Overall Study|Ineligible|16|||
125540701|NCT00006011|451609432|FG002|Overall Study|Ineligible|9|||
125540702|NCT00774930|451609436|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
125540703|NCT00774930|451609437|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
125540704|NCT00774930|451609436|FG000|DB Phase|Adverse Event|1|||
125540705|NCT00774930|451609437|FG001|DB Phase|Adverse Event|2|||
125660426|NCT03985293|452043587|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
125660427|NCT03985293|452043588|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
125660428|NCT03985293|452043583|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
125660429|NCT03985293|452043584|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
125660430|NCT03985293|452043585|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
125660431|NCT03985293|452043586|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
125660432|NCT03985293|452043587|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
125660433|NCT03985293|452043588|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
125660434|NCT03985293|452043583|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
125660435|NCT03985293|452043584|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
125660436|NCT03985293|452043585|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
125660437|NCT03985293|452043586|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
125660438|NCT03985293|452043587|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
125660439|NCT03985293|452043588|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
125660440|NCT03985293|452043583|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
125660441|NCT03985293|452043584|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
125660442|NCT03985293|452043585|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
125660443|NCT03985293|452043586|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
125660444|NCT03985293|452043587|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
125660445|NCT03985293|452043588|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
125660446|NCT03985293|452043583|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
125660447|NCT03985293|452043584|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
125660448|NCT03985293|452043585|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
125660449|NCT03985293|452043586|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
125660450|NCT03985293|452043587|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
125660451|NCT03985293|452043588|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
125660452|NCT03985293|452043583|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
125660453|NCT03985293|452043584|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
125660454|NCT03985293|452043585|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
125660455|NCT03985293|452043586|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
125660456|NCT03985293|452043587|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
125660457|NCT03985293|452043588|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
125660458|NCT03985293|452043583|FG000|FOLLOW-UP|Lost to Follow-up|0|||
125660459|NCT03985293|452043584|FG001|FOLLOW-UP|Lost to Follow-up|0|||
125660460|NCT03985293|452043585|FG002|FOLLOW-UP|Lost to Follow-up|1|||
125660461|NCT03985293|452043586|FG003|FOLLOW-UP|Lost to Follow-up|0|||
125660462|NCT03985293|452043587|FG004|FOLLOW-UP|Lost to Follow-up|0|||
125660463|NCT03985293|452043588|FG005|FOLLOW-UP|Lost to Follow-up|0|||
125660464|NCT03302299|452045103|FG000|Overall Study|Protocol Violation|1|||
125660465|NCT04318535|452045104|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
125660466|NCT04318535|452045105|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
125660467|NCT04318535|452045106|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
125660468|NCT00858234|452045107|FG000|Overall Study|Adverse Event|6|||
125660469|NCT00858234|452045107|FG000|Overall Study|Progressive disease|2|||
125660470|NCT00858234|452045107|FG000|Overall Study|Status unknown|1|||
125660471|NCT01678924|452045109|FG000|Overall Study|Adverse Event|1|||
125660472|NCT01678924|452045110|FG001|Overall Study|Adverse Event|1|||
125660473|NCT01678924|452045111|FG002|Overall Study|Adverse Event|0|||
125660474|NCT01678924|452045112|FG003|Overall Study|Adverse Event|1|||
125660475|NCT01678924|452045109|FG000|Overall Study|Lack of Efficacy|7|||
125660476|NCT01678924|452045110|FG001|Overall Study|Lack of Efficacy|2|||
125660477|NCT01678924|452045111|FG002|Overall Study|Lack of Efficacy|0|||
125660478|NCT01678924|452045112|FG003|Overall Study|Lack of Efficacy|5|||
125660479|NCT01678924|452045109|FG000|Overall Study|Lost to Follow-up|0|||
125660480|NCT01678924|452045110|FG001|Overall Study|Lost to Follow-up|4|||
125660481|NCT01678924|452045111|FG002|Overall Study|Lost to Follow-up|0|||
125660482|NCT01678924|452045112|FG003|Overall Study|Lost to Follow-up|2|||
125660483|NCT01678924|452045109|FG000|Overall Study|Personal Reasons|2|||
125660484|NCT01678924|452045110|FG001|Overall Study|Personal Reasons|2|||
125660485|NCT01678924|452045111|FG002|Overall Study|Personal Reasons|2|||
125660486|NCT01678924|452045112|FG003|Overall Study|Personal Reasons|7|||
125660487|NCT01678924|452045109|FG000|Overall Study|Withdrawal by Subject|0|||
125660488|NCT01678924|452045110|FG001|Overall Study|Withdrawal by Subject|3|||
125660489|NCT01678924|452045111|FG002|Overall Study|Withdrawal by Subject|0|||
125660490|NCT01678924|452045112|FG003|Overall Study|Withdrawal by Subject|2|||
125660491|NCT01678924|452045109|FG000|Overall Study|Unable to attend scheduled visits|0|||
125660492|NCT01678924|452045110|FG001|Overall Study|Unable to attend scheduled visits|0|||
125660493|NCT01678924|452045111|FG002|Overall Study|Unable to attend scheduled visits|0|||
125660494|NCT01678924|452045112|FG003|Overall Study|Unable to attend scheduled visits|1|||
125660495|NCT00640614|452045115|FG000|Overall Study|Lost to Follow-up|1|||
125660496|NCT00640614|452045116|FG001|Overall Study|Lost to Follow-up|0|||
125660497|NCT00529802|452045117|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
125660498|NCT00529802|452045117|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
125660499|NCT00529802|452045117|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
125660500|NCT00529802|452045117|FG000|Evaluable for Primary Endpoint|Death|1|||
125660501|NCT00529802|452045117|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
125660502|NCT00529802|452045117|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
125660503|NCT00529802|452045117|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
125660504|NCT02428231|452045123|FG000|Overall Study|Other|10|||
125660505|NCT02428231|452045124|FG001|Overall Study|Other|16|||
125660506|NCT02428231|452045123|FG000|Overall Study|Required Symptomatic Therapy|0|||
125660507|NCT02428231|452045124|FG001|Overall Study|Required Symptomatic Therapy|1|||
125660508|NCT02428231|452045123|FG000|Overall Study|Adverse Event|3|||
125660509|NCT02428231|452045124|FG001|Overall Study|Adverse Event|0|||
125660510|NCT01784419|452045127|FG000|Overall Study|Adverse Event|3|||
125660511|NCT02253654|452045128|FG000|Overall Study|Withdrawal by Subject|12|||
125660512|NCT02253654|452045129|FG001|Overall Study|Withdrawal by Subject|4|||
125660513|NCT02253654|452045128|FG000|Overall Study|Decision by Sponsor|1|||
125660514|NCT02253654|452045129|FG001|Overall Study|Decision by Sponsor|1|||
125660515|NCT02253654|452045128|FG000|Overall Study|Lost to Follow-up|2|||
125660516|NCT02253654|452045129|FG001|Overall Study|Lost to Follow-up|5|||
125660517|NCT02253654|452045128|FG000|Overall Study|Death|4|||
125660518|NCT02253654|452045129|FG001|Overall Study|Death|7|||
125660519|NCT02253654|452045128|FG000|Overall Study|Did Not Receive Study Treatment|4|||
125660520|NCT02253654|452045129|FG001|Overall Study|Did Not Receive Study Treatment|1|||
125660521|NCT03456726|452045132|FG000|Overall Study|Disease Progression|6|||
125660522|NCT03456726|452045133|FG001|Overall Study|Disease Progression|1|||
125660523|NCT03456726|452045132|FG000|Overall Study|Adverse Event|4|||
125660524|NCT03456726|452045133|FG001|Overall Study|Adverse Event|2|||
125660525|NCT03456726|452045132|FG000|Overall Study|Withdrawal by Subject|1|||
125660526|NCT03456726|452045133|FG001|Overall Study|Withdrawal by Subject|0|||
125660527|NCT03456726|452045132|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
125660528|NCT03456726|452045133|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
125660529|NCT04470622|452045134|FG000|Overall Study|Withdrawal by Subject|0|||
125660530|NCT04470622|452045135|FG001|Overall Study|Withdrawal by Subject|1|||
125660531|NCT04470622|452045134|FG000|Overall Study|Screen Failure|0|||
125660532|NCT04470622|452045135|FG001|Overall Study|Screen Failure|1|||
125660533|NCT04470622|452045134|FG000|Overall Study|Death|0|||
125660534|NCT04470622|452045135|FG001|Overall Study|Death|1|||
125660535|NCT02576054|452045136|FG000|Overall Study|Withdrawal by Subject|1|||
125660536|NCT01190098|452045137|FG000|Overall Study|Adverse Event|2|||
125660537|NCT01190098|452045138|FG001|Overall Study|Adverse Event|0|||
125660538|NCT01190098|452045137|FG000|Overall Study|Patient coomorbidity|0|||
125660539|NCT01190098|452045138|FG001|Overall Study|Patient coomorbidity|1|||
125660540|NCT01190098|452045137|FG000|Overall Study|Lack of transportation|1|||
125660541|NCT01190098|452045138|FG001|Overall Study|Lack of transportation|0|||
125660542|NCT01190098|452045137|FG000|Overall Study|Other|0|||
125660543|NCT01190098|452045138|FG001|Overall Study|Other|1|||
125660544|NCT02957682|452045139|FG000|Overall Study|Adverse Event|64|||
125660545|NCT02957682|452045140|FG001|Overall Study|Adverse Event|67|||
125660546|NCT02957682|452045139|FG000|Overall Study|Poor Compliance to Protocol|30|||
125660547|NCT02957682|452045140|FG001|Overall Study|Poor Compliance to Protocol|26|||
125660548|NCT02957682|452045139|FG000|Overall Study|Physician Decision|4|||
125660549|NCT02957682|452045140|FG001|Overall Study|Physician Decision|4|||
125660550|NCT02957682|452045139|FG000|Overall Study|Study Terminated by Sponsor|4|||
125660551|NCT02957682|452045140|FG001|Overall Study|Study Terminated by Sponsor|3|||
125660552|NCT02957682|452045139|FG000|Overall Study|Subject Moved|10|||
125660553|NCT02957682|452045140|FG001|Overall Study|Subject Moved|16|||
125660554|NCT02957682|452045139|FG000|Overall Study|Withdrawal by Subject|64|||
125660555|NCT02957682|452045140|FG001|Overall Study|Withdrawal by Subject|33|||
125660556|NCT02957682|452045139|FG000|Overall Study|Related to IMP Administration|3|||
125660557|NCT02957682|452045140|FG001|Overall Study|Related to IMP Administration|6|||
125660558|NCT02957682|452045139|FG000|Overall Study|Non-disclosed|16|||
125660559|NCT02957682|452045140|FG001|Overall Study|Non-disclosed|12|||
125660560|NCT02957682|452045139|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
125660561|NCT02957682|452045140|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
125660562|NCT04651218|452045141|FG000|Overall Study|Withdrawal by Subject|0|||
125660563|NCT04651218|452045142|FG001|Overall Study|Withdrawal by Subject|2|||
125660564|NCT00765999|452045143|FG000|Overall Study|Adverse Event|203|||
125660565|NCT00765999|452045143|FG000|Overall Study|Insufficient Therapeutic Response|100|||
125660566|NCT00765999|452045143|FG000|Overall Study|Protocol Violation|95|||
125660567|NCT00765999|452045143|FG000|Overall Study|Consent Withdrawn|202|||
125660568|NCT00765999|452045143|FG000|Overall Study|Lost to Follow-up|131|||
125660569|NCT00765999|452045143|FG000|Overall Study|Study Terminated by Sponsor|2|||
125660570|NCT00765999|452045143|FG000|Overall Study|Other Miscellaneous Reasons|51|||
125660571|NCT00414011|452045144|FG000|Overall Study|Physician Decision|3|||
125660572|NCT00414011|452045144|FG000|Overall Study|Withdrawal by Subject|2|||
125660573|NCT02476851|452045145|FG000|Overall Study|Protocol Violation|1|||
125660574|NCT02476851|452045146|FG001|Overall Study|Protocol Violation|1|||
125660575|NCT01399125|452045147|FG000|Overall Study|Adverse Event|32|||
125660576|NCT01399125|452045148|FG001|Overall Study|Adverse Event|30|||
125660577|NCT01399125|452045147|FG000|Overall Study|Abnormal Lab values|0|||
125660578|NCT01399125|452045148|FG001|Overall Study|Abnormal Lab values|1|||
125660579|NCT01399125|452045147|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125660580|NCT01399125|452045148|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
125660581|NCT01399125|452045147|FG000|Overall Study|Withdrawal by Subject|5|||
125660582|NCT01399125|452045148|FG001|Overall Study|Withdrawal by Subject|8|||
125660583|NCT01399125|452045147|FG000|Overall Study|Lost to Follow-up|2|||
125660584|NCT01399125|452045148|FG001|Overall Study|Lost to Follow-up|3|||
125660585|NCT01399125|452045147|FG000|Overall Study|Administrative Problems|7|||
125660586|NCT01399125|452045148|FG001|Overall Study|Administrative Problems|11|||
125660587|NCT01399125|452045147|FG000|Overall Study|Death|0|||
125660588|NCT01399125|452045148|FG001|Overall Study|Death|1|||
125660589|NCT01399125|452045147|FG000|Overall Study|Protocol Deviation|5|||
125660590|NCT01399125|452045148|FG001|Overall Study|Protocol Deviation|2|||
125660591|NCT00647426|452045151|FG000|Overall Study|Withdrawal by Subject|2|||
125660592|NCT03343054|452045157|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
125660593|NCT03343054|452045158|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
125660594|NCT03343054|452045159|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
125660595|NCT03343054|452045157|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
125660596|NCT03343054|452045158|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
125660597|NCT03343054|452045159|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
125660598|NCT03343054|452045157|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
125660599|NCT03343054|452045158|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
125660600|NCT03343054|452045159|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
125660601|NCT03343054|452045157|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
125660602|NCT03343054|452045158|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
125660603|NCT03343054|452045159|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
125660604|NCT03578276|452045160|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
125660605|NCT03578276|452045161|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
125660606|NCT02626182|452045162|FG000|Overall Study|Adverse Event|2|||
125660607|NCT02626182|452045163|FG001|Overall Study|Adverse Event|0|||
125660608|NCT00883740|452045164|FG000|First Intervention|Lost to Follow-up|1|||
125660609|NCT00883740|452045165|FG001|First Intervention|Lost to Follow-up|0|||
125660610|NCT00883740|452045164|FG000|First Intervention|No longer willing to participate|2|||
125660611|NCT00883740|452045165|FG001|First Intervention|No longer willing to participate|0|||
125660612|NCT00883740|452045164|FG000|First Intervention|Protocol Violation|3|||
125660613|NCT00883740|452045165|FG001|First Intervention|Protocol Violation|6|||
125660614|NCT00883740|452045164|FG000|First Intervention|Adverse Event|1|||
125660615|NCT00883740|452045165|FG001|First Intervention|Adverse Event|2|||
125660616|NCT00883740|452045164|FG000|Second Intervention|Protocol Violation|1|||
125660617|NCT00883740|452045165|FG001|Second Intervention|Protocol Violation|0|||
125660618|NCT00883740|452045164|FG000|Second Intervention|No longer willing to participate|0|||
125660619|NCT00883740|452045165|FG001|Second Intervention|No longer willing to participate|1|||
125660620|NCT00981409|452045166|FG000|Overall Study|Adverse Event|4|||
125660621|NCT00981409|452045167|FG001|Overall Study|Adverse Event|0|||
125660622|NCT00981409|452045166|FG000|Overall Study|Protocol Violation|0|||
125660623|NCT00981409|452045167|FG001|Overall Study|Protocol Violation|1|||
125660624|NCT00981409|452045166|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
125660625|NCT00981409|452045167|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
125660626|NCT03869684|452045176|FG000|Overall Study|Adverse Event|0|||
125660627|NCT03869684|452045177|FG001|Overall Study|Adverse Event|3|||
125660628|NCT03869684|452045178|FG002|Overall Study|Adverse Event|1|||
125660629|NCT03869684|452045176|FG000|Overall Study|Withdrawal by Subject|1|||
125660630|NCT03869684|452045177|FG001|Overall Study|Withdrawal by Subject|0|||
125660631|NCT03869684|452045178|FG002|Overall Study|Withdrawal by Subject|0|||
125660632|NCT03869684|452045176|FG000|Overall Study|Lost to Follow-up|1|||
125660633|NCT03869684|452045177|FG001|Overall Study|Lost to Follow-up|0|||
125660634|NCT03869684|452045178|FG002|Overall Study|Lost to Follow-up|0|||
125660635|NCT03869684|452045176|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
125660636|NCT03869684|452045177|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
125660637|NCT03869684|452045178|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
125660638|NCT00078312|452045179|FG000|Overall Study|Adverse Event|43|||
125660639|NCT00078312|452045179|FG000|Overall Study|Lack of Efficacy|15|||
125660640|NCT00078312|452045179|FG000|Overall Study|Lost to Follow-up|41|||
125660641|NCT00078312|452045179|FG000|Overall Study|Physician Decision|9|||
125660642|NCT00078312|452045179|FG000|Overall Study|Protocol Violation|3|||
125660643|NCT00078312|452045179|FG000|Overall Study|Withdrawal by Subject|33|||
125660644|NCT00078312|452045179|FG000|Overall Study|Miscellaneous|33|||
125660645|NCT04840901|452045180|FG000|Overall Study|Lost to Follow-up|3|||
125660646|NCT04840901|452045181|FG001|Overall Study|Lost to Follow-up|1|||
125660647|NCT04840901|452045180|FG000|Overall Study|Moved|1|||
125660648|NCT04840901|452045181|FG001|Overall Study|Moved|0|||
125660649|NCT04840901|452045180|FG000|Overall Study|Unable to comply with study schedule|0|||
125660650|NCT04840901|452045181|FG001|Overall Study|Unable to comply with study schedule|1|||
125660651|NCT04840901|452045180|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
125660652|NCT04840901|452045181|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
125660653|NCT05354206|452045182|FG000|Overall Study|Withdrawal by Subject|1|||
125660654|NCT05354206|452045183|FG001|Overall Study|Withdrawal by Subject|0|||
125660655|NCT04285983|452045184|FG000|Overall Study|Protocol Violation|6|||
125660656|NCT04936334|452045185|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
125660657|NCT00422058|452045186|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
125660658|NCT00422058|452045187|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
125660659|NCT00422058|452045188|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
125660660|NCT00422058|452045189|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
125660661|NCT00422058|452045190|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
125660662|NCT00422058|452045191|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
125660663|NCT00422058|452045186|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
125660664|NCT00422058|452045187|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
125660665|NCT00422058|452045188|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
125660666|NCT00422058|452045189|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
125660667|NCT00422058|452045190|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
125660668|NCT00422058|452045191|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
125660669|NCT00422058|452045186|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
125660670|NCT00422058|452045187|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
125660671|NCT00422058|452045188|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
125660672|NCT00422058|452045189|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
125660673|NCT00422058|452045190|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
125660674|NCT00422058|452045191|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
125660675|NCT00422058|452045186|FG000|Double-Blind, Week 0-20|Other|11|||
125660676|NCT00422058|452045187|FG001|Double-Blind, Week 0-20|Other|3|||
125660677|NCT00422058|452045188|FG002|Double-Blind, Week 0-20|Other|8|||
125660678|NCT00422058|452045189|FG003|Double-Blind, Week 0-20|Other|8|||
125660679|NCT00422058|452045190|FG004|Double-Blind, Week 0-20|Other|4|||
125660680|NCT00422058|452045191|FG005|Double-Blind, Week 0-20|Other|10|||
125660681|NCT00422058|452045186|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
125660682|NCT00422058|452045187|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
125660683|NCT00422058|452045188|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
125660684|NCT00422058|452045189|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
125660685|NCT00422058|452045190|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
125660686|NCT00422058|452045191|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
125660687|NCT00422058|452045186|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
125660688|NCT00422058|452045187|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
125660689|NCT00422058|452045188|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
125660690|NCT00422058|452045189|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
125660691|NCT00422058|452045190|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
125660692|NCT00422058|452045191|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
125660693|NCT00422058|452045186|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
125660694|NCT00422058|452045187|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
125660695|NCT00422058|452045188|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
125660696|NCT00422058|452045189|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
125660697|NCT00422058|452045190|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
125660698|NCT00422058|452045191|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
125660699|NCT00422058|452045186|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
125660700|NCT00422058|452045187|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
125660701|NCT00422058|452045188|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
125660702|NCT00422058|452045189|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
125660703|NCT00422058|452045190|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
125660704|NCT00422058|452045191|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
125660705|NCT00422058|452045186|FG000|Open-Label Extension, Week 20-104|Other|13|||
125660706|NCT00422058|452045187|FG001|Open-Label Extension, Week 20-104|Other|14|||
125660707|NCT00422058|452045188|FG002|Open-Label Extension, Week 20-104|Other|6|||
125660708|NCT00422058|452045189|FG003|Open-Label Extension, Week 20-104|Other|13|||
125660709|NCT00422058|452045190|FG004|Open-Label Extension, Week 20-104|Other|16|||
125660710|NCT00422058|452045191|FG005|Open-Label Extension, Week 20-104|Other|18|||
125660711|NCT00627458|452045194|FG000|Overall Study|Migrated from study area|1|||
125660712|NCT00627458|452045195|FG001|Overall Study|Migrated from study area|0|||
125660713|NCT00627458|452045196|FG002|Overall Study|Migrated from study area|1|||
125660714|NCT00627458|452045194|FG000|Overall Study|Withdrawal by Subject|2|||
125660715|NCT00627458|452045195|FG001|Overall Study|Withdrawal by Subject|6|||
125660716|NCT00627458|452045196|FG002|Overall Study|Withdrawal by Subject|5|||
125660717|NCT00627458|452045194|FG000|Overall Study|Lost to Follow-up|1|||
125660718|NCT00627458|452045195|FG001|Overall Study|Lost to Follow-up|1|||
125660719|NCT00627458|452045196|FG002|Overall Study|Lost to Follow-up|0|||
125660720|NCT02587325|452045200|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
125660721|NCT02587325|452045201|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
125660722|NCT02587325|452045202|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
125660723|NCT02587325|452045203|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
125660724|NCT02587325|452045204|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
125660725|NCT02587325|452045200|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
125660726|NCT02587325|452045201|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
125660727|NCT02587325|452045202|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
125660728|NCT02587325|452045203|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
125660729|NCT02587325|452045204|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
125660730|NCT02587325|452045200|FG000|32-Week Optional Extension Part|Adverse Event|0|||
125660731|NCT02587325|452045201|FG001|32-Week Optional Extension Part|Adverse Event|0|||
125660732|NCT02587325|452045202|FG002|32-Week Optional Extension Part|Adverse Event|1|||
125660733|NCT02587325|452045203|FG003|32-Week Optional Extension Part|Adverse Event|0|||
125660734|NCT02587325|452045204|FG004|32-Week Optional Extension Part|Adverse Event|0|||
125660735|NCT02587325|452045200|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
125660736|NCT02587325|452045201|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
125660737|NCT02587325|452045202|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
125660738|NCT02587325|452045203|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
125660739|NCT02587325|452045204|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
125660740|NCT01831596|452045205|FG000|Overall Study|Other|8|||
125660741|NCT02602080|452045206|FG000|Overall Study|Protocol Violation|6|||
125660742|NCT02602080|452045207|FG001|Overall Study|Protocol Violation|1|||
125660743|NCT02602080|452045208|FG002|Overall Study|Protocol Violation|3|||
125660744|NCT04355767|452045211|FG000|Overall Study|Withdrawal by Subject|2|||
125660745|NCT04355767|452045212|FG001|Overall Study|Withdrawal by Subject|2|||
125660746|NCT04355767|452045211|FG000|Overall Study|Death|5|||
125660747|NCT04355767|452045212|FG001|Overall Study|Death|1|||
125660748|NCT01999322|452045213|FG000|Overall Study|Adverse Event|1|||
125660749|NCT01999322|452045214|FG001|Overall Study|Adverse Event|0|||
125660750|NCT02200614|452045215|FG000|Double Blind Treatment|Adverse Event|86|||
125660751|NCT02200614|452045216|FG001|Double Blind Treatment|Adverse Event|48|||
125660752|NCT02200614|452045215|FG000|Double Blind Treatment|Confirmed metastasis|120|||
125660753|NCT02200614|452045216|FG001|Double Blind Treatment|Confirmed metastasis|140|||
125660754|NCT02200614|452045215|FG000|Double Blind Treatment|Judgment of the investigator|59|||
125660755|NCT02200614|452045216|FG001|Double Blind Treatment|Judgment of the investigator|99|||
125660756|NCT02200614|452045215|FG000|Double Blind Treatment|Metastasis by local reading|1|||
125660757|NCT02200614|452045216|FG001|Double Blind Treatment|Metastasis by local reading|3|||
125660758|NCT02200614|452045215|FG000|Double Blind Treatment|Other reason|6|||
125660759|NCT02200614|452045216|FG001|Double Blind Treatment|Other reason|2|||
125660760|NCT02200614|452045215|FG000|Double Blind Treatment|Personal reason|77|||
125660761|NCT02200614|452045216|FG001|Double Blind Treatment|Personal reason|85|||
125660762|NCT02200614|452045215|FG000|Double Blind Treatment|Protocol deviation|14|||
125660763|NCT02200614|452045216|FG001|Double Blind Treatment|Protocol deviation|7|||
125660764|NCT02200614|452045215|FG000|Double Blind Treatment|Not treated|1|||
125660765|NCT02200614|452045216|FG001|Double Blind Treatment|Not treated|0|||
125660766|NCT02200614|452045215|FG000|Open Label|Adverse Event|41|||
125660767|NCT02200614|452045216|FG001|Open Label|Adverse Event|11|||
125660768|NCT02200614|452045215|FG000|Open Label|Confirmed metastasis|1|||
125660769|NCT02200614|452045216|FG001|Open Label|Confirmed metastasis|0|||
125660770|NCT02200614|452045215|FG000|Open Label|Judgment of the investigator|29|||
125660771|NCT02200614|452045216|FG001|Open Label|Judgment of the investigator|2|||
125660772|NCT02200614|452045215|FG000|Open Label|Metastasis by local reading|138|||
125660773|NCT02200614|452045216|FG001|Open Label|Metastasis by local reading|27|||
125660774|NCT02200614|452045215|FG000|Open Label|Other reason|22|||
125660775|NCT02200614|452045216|FG001|Open Label|Other reason|4|||
125660776|NCT02200614|452045215|FG000|Open Label|Personal reason|60|||
125660777|NCT02200614|452045216|FG001|Open Label|Personal reason|8|||
125660778|NCT02200614|452045215|FG000|Open Label|Protocol deviation|3|||
125660779|NCT02200614|452045216|FG001|Open Label|Protocol deviation|2|||
125660780|NCT02200614|452045215|FG000|Open Label|Missing|2|||
125660781|NCT02200614|452045216|FG001|Open Label|Missing|2|||
125660782|NCT01898884|452045217|FG000|Multiple Dose Period|Adverse Event|0|||
125660783|NCT01898884|452045218|FG001|Multiple Dose Period|Adverse Event|0|||
125660784|NCT01898884|452045219|FG002|Multiple Dose Period|Adverse Event|0|||
125660785|NCT01898884|452045220|FG003|Multiple Dose Period|Adverse Event|0|||
125660786|NCT01898884|452045221|FG004|Multiple Dose Period|Adverse Event|0|||
125660787|NCT01898884|452045222|FG005|Multiple Dose Period|Adverse Event|0|||
125660788|NCT01898884|452045223|FG006|Multiple Dose Period|Adverse Event|1|||
125660789|NCT01898884|452045224|FG007|Multiple Dose Period|Adverse Event|0|||
125660790|NCT01898884|452045225|FG008|Multiple Dose Period|Adverse Event|0|||
125660791|NCT01898884|452045217|FG000|Multiple Dose Period|Randomized Not Treated|0|||
125660792|NCT01898884|452045218|FG001|Multiple Dose Period|Randomized Not Treated|0|||
125660793|NCT01898884|452045219|FG002|Multiple Dose Period|Randomized Not Treated|0|||
125660794|NCT01898884|452045220|FG003|Multiple Dose Period|Randomized Not Treated|0|||
125660795|NCT01898884|452045221|FG004|Multiple Dose Period|Randomized Not Treated|0|||
125660796|NCT01898884|452045222|FG005|Multiple Dose Period|Randomized Not Treated|0|||
125660797|NCT01898884|452045223|FG006|Multiple Dose Period|Randomized Not Treated|0|||
125660798|NCT01898884|452045224|FG007|Multiple Dose Period|Randomized Not Treated|0|||
125660799|NCT01898884|452045225|FG008|Multiple Dose Period|Randomized Not Treated|1|||
125660800|NCT01336608|452046829|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
125660801|NCT01336608|452046830|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125660802|NCT01336608|452046831|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125660803|NCT01336608|452046832|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125660804|NCT01336608|452046829|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
125660805|NCT01336608|452046830|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125660806|NCT01336608|452046831|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125660807|NCT01336608|452046832|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125660808|NCT01336608|452046829|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
125660809|NCT01336608|452046830|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
125660810|NCT01336608|452046831|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
125660811|NCT01336608|452046832|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
125660812|NCT01336608|452046829|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
125660813|NCT01336608|452046830|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
125660814|NCT01336608|452046831|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
125660815|NCT01336608|452046832|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
125660816|NCT01336608|452046829|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
125660817|NCT01336608|452046830|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125660818|NCT01336608|452046831|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125660819|NCT01336608|452046832|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125660820|NCT01336608|452046829|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
125660821|NCT01336608|452046830|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
125660822|NCT01336608|452046831|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
125660823|NCT01336608|452046832|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
125660824|NCT01336608|452046829|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125660825|NCT01336608|452046830|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
125660826|NCT01336608|452046831|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125660827|NCT01336608|452046832|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125660828|NCT01336608|452046829|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
125660829|NCT01336608|452046830|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
125660830|NCT01336608|452046831|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
125660831|NCT01336608|452046832|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
125660832|NCT01336608|452046829|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
125660833|NCT01336608|452046830|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
125660834|NCT01336608|452046831|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
125660835|NCT01336608|452046832|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
125660836|NCT01336608|452046829|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
125660837|NCT01336608|452046830|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
125660838|NCT01336608|452046831|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
125660839|NCT01336608|452046832|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
125660840|NCT01336608|452046829|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125660841|NCT01336608|452046830|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
125660842|NCT01336608|452046831|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125660843|NCT01336608|452046832|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125660844|NCT01336608|452046829|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
125660845|NCT01336608|452046830|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
125660846|NCT01336608|452046831|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
125660847|NCT01336608|452046832|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
125660848|NCT01336608|452046829|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125660849|NCT01336608|452046830|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
125660850|NCT01336608|452046831|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
125660851|NCT01336608|452046832|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
125660852|NCT00080288|452046833|FG000|Overall Study|Adverse Event|7|||
125660853|NCT00080288|452046834|FG001|Overall Study|Adverse Event|4|||
125660854|NCT00080288|452046833|FG000|Overall Study|Lost to Follow-up|3|||
125660855|NCT00080288|452046834|FG001|Overall Study|Lost to Follow-up|5|||
125660856|NCT00080288|452046833|FG000|Overall Study|Physician Decision|6|||
125660857|NCT00080288|452046834|FG001|Overall Study|Physician Decision|2|||
125660858|NCT00080288|452046833|FG000|Overall Study|Withdrawal by Subject|3|||
125660859|NCT00080288|452046834|FG001|Overall Study|Withdrawal by Subject|16|||
125660860|NCT00080288|452046833|FG000|Overall Study|Miscellaneous|11|||
125660861|NCT00080288|452046834|FG001|Overall Study|Miscellaneous|11|||
125660862|NCT03044431|452046835|FG000|Overall Study|Lost to Follow-up|59|||
125660863|NCT02328547|452046836|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
125660864|NCT02328547|452046837|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
125660865|NCT02328547|452046836|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
125660866|NCT02328547|452046837|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
125660867|NCT00344305|452046841|FG000|Overall Study|Lost to Follow-up|2|||
125660868|NCT00344305|452046842|FG001|Overall Study|Lost to Follow-up|0|||
125660869|NCT00344305|452046841|FG000|Overall Study|Participant was not contacted in window|0|||
125660870|NCT00344305|452046842|FG001|Overall Study|Participant was not contacted in window|1|||
125660871|NCT01726335|452046849|FG000|Overall Study|Lost to Follow-up|2|||
125660872|NCT01726335|452046849|FG000|Overall Study|Withdrawal by Subject|15|||
125660873|NCT01726335|452046849|FG000|Overall Study|Adverse Event|4|||
125660874|NCT01726335|452046849|FG000|Overall Study|Lost to Follow-up|2|||
125660875|NCT01726335|452046849|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
125660876|NCT01796860|452046854|FG000|Overall Study|Withdrawal by Subject|3|||
125660877|NCT02703454|452046863|FG000|Overall Study|Not treated|1|||
125660878|NCT02703454|452046864|FG001|Overall Study|Not treated|3|||
125660879|NCT02703454|452046863|FG000|Overall Study|Withdrawal by Subject|4|||
125660880|NCT02703454|452046864|FG001|Overall Study|Withdrawal by Subject|3|||
125660881|NCT02703454|452046863|FG000|Overall Study|Lost to Follow-up|1|||
125660882|NCT02703454|452046864|FG001|Overall Study|Lost to Follow-up|2|||
125660883|NCT02703454|452046863|FG000|Overall Study|Study discontinuation|5|||
125660884|NCT02703454|452046864|FG001|Overall Study|Study discontinuation|8|||
125660885|NCT00791154|452046865|FG000|Overall Study|Noncompliance|0|||
125660886|NCT00791154|452046866|FG001|Overall Study|Noncompliance|1|||
125660887|NCT00791154|452046867|FG002|Overall Study|Noncompliance|0|||
125660888|NCT00791154|452046868|FG003|Overall Study|Noncompliance|0|||
125660889|NCT00791154|452046869|FG004|Overall Study|Noncompliance|1|||
125660890|NCT00791154|452046870|FG005|Overall Study|Noncompliance|1|||
125660891|NCT00791154|452046871|FG006|Overall Study|Noncompliance|1|||
125660892|NCT00791154|452046865|FG000|Overall Study|Adverse Event|0|||
125660893|NCT00791154|452046866|FG001|Overall Study|Adverse Event|0|||
125660894|NCT00791154|452046867|FG002|Overall Study|Adverse Event|0|||
125660895|NCT00791154|452046868|FG003|Overall Study|Adverse Event|0|||
125660896|NCT00791154|452046869|FG004|Overall Study|Adverse Event|2|||
125660897|NCT00791154|452046870|FG005|Overall Study|Adverse Event|0|||
125660898|NCT00791154|452046871|FG006|Overall Study|Adverse Event|1|||
125660899|NCT00791154|452046865|FG000|Overall Study|Full Consent withdrawn|1|||
125660900|NCT00791154|452046866|FG001|Overall Study|Full Consent withdrawn|3|||
125660901|NCT00791154|452046867|FG002|Overall Study|Full Consent withdrawn|0|||
125660902|NCT00791154|452046868|FG003|Overall Study|Full Consent withdrawn|0|||
125660903|NCT00791154|452046869|FG004|Overall Study|Full Consent withdrawn|1|||
125660904|NCT00791154|452046870|FG005|Overall Study|Full Consent withdrawn|3|||
125660905|NCT00791154|452046871|FG006|Overall Study|Full Consent withdrawn|1|||
125660906|NCT00791154|452046865|FG000|Overall Study|Lost to Follow-up|0|||
125660907|NCT00791154|452046866|FG001|Overall Study|Lost to Follow-up|0|||
125660908|NCT00791154|452046867|FG002|Overall Study|Lost to Follow-up|0|||
125660909|NCT00791154|452046868|FG003|Overall Study|Lost to Follow-up|1|||
125660910|NCT00791154|452046869|FG004|Overall Study|Lost to Follow-up|2|||
125660911|NCT00791154|452046870|FG005|Overall Study|Lost to Follow-up|0|||
125660912|NCT00791154|452046871|FG006|Overall Study|Lost to Follow-up|4|||
125660913|NCT00791154|452046865|FG000|Overall Study|Death|5|||
125660914|NCT00791154|452046866|FG001|Overall Study|Death|4|||
125660915|NCT00791154|452046867|FG002|Overall Study|Death|4|||
125660916|NCT00791154|452046868|FG003|Overall Study|Death|7|||
125660917|NCT00791154|452046869|FG004|Overall Study|Death|54|||
125660918|NCT00791154|452046870|FG005|Overall Study|Death|54|||
125660919|NCT00791154|452046871|FG006|Overall Study|Death|52|||
125660920|NCT00791154|452046865|FG000|Overall Study|Other event|0|||
125660921|NCT00791154|452046866|FG001|Overall Study|Other event|0|||
125660922|NCT00791154|452046867|FG002|Overall Study|Other event|2|||
125660923|NCT00791154|452046868|FG003|Overall Study|Other event|0|||
125660924|NCT00791154|452046869|FG004|Overall Study|Other event|2|||
125660925|NCT00791154|452046870|FG005|Overall Study|Other event|4|||
125660926|NCT00791154|452046871|FG006|Overall Study|Other event|2|||
125660927|NCT02284373|452046872|FG000|Overall Study|Withdrawal by Subject|0|||
125660928|NCT02284373|452046873|FG001|Overall Study|Withdrawal by Subject|1|||
125660929|NCT02284373|452046874|FG002|Overall Study|Withdrawal by Subject|0|||
125660930|NCT02284373|452046872|FG000|Overall Study|Other|0|||
125660931|NCT02284373|452046873|FG001|Overall Study|Other|1|||
125660932|NCT02284373|452046874|FG002|Overall Study|Other|0|||
125660933|NCT02284373|452046872|FG000|Overall Study|Lost to Follow-up|0|||
125660934|NCT02284373|452046873|FG001|Overall Study|Lost to Follow-up|1|||
125660935|NCT02284373|452046874|FG002|Overall Study|Lost to Follow-up|0|||
125660936|NCT01508325|452046878|FG000|Overall Study|Withdrawal by Subject|8|||
125660937|NCT01508325|452046879|FG001|Overall Study|Withdrawal by Subject|9|||
125660938|NCT01508325|452046878|FG000|Overall Study|Protocol Violation|0|||
125660939|NCT01508325|452046879|FG001|Overall Study|Protocol Violation|3|||
125660940|NCT01508325|452046878|FG000|Overall Study|Physician Decision|2|||
125660941|NCT01508325|452046879|FG001|Overall Study|Physician Decision|1|||
125660942|NCT01508325|452046878|FG000|Overall Study|Adverse Event|1|||
125660943|NCT01508325|452046879|FG001|Overall Study|Adverse Event|0|||
125660944|NCT01508325|452046878|FG000|Overall Study|Lost to Follow-up|5|||
125660945|NCT01508325|452046879|FG001|Overall Study|Lost to Follow-up|6|||
125660946|NCT01508325|452046878|FG000|Overall Study|Other|2|||
125660947|NCT01508325|452046879|FG001|Overall Study|Other|2|||
125660948|NCT03543046|452046880|FG000|Overall Study|Adverse Event|1|||
125660949|NCT03543046|452046881|FG001|Overall Study|Adverse Event|1|||
125660950|NCT03543046|452046880|FG000|Overall Study|Physician Decision|1|||
125660951|NCT03543046|452046881|FG001|Overall Study|Physician Decision|1|||
125660952|NCT03543046|452046880|FG000|Overall Study|Protocol Violation|1|||
125660953|NCT03543046|452046881|FG001|Overall Study|Protocol Violation|0|||
125660954|NCT01227954|452046882|FG000|Overall Study|Protocol Violation|6|||
125660955|NCT01227954|452046882|FG000|Overall Study|No protocol treatment|7|||
125660956|NCT02748616|452046884|FG000|Overall Study|Lost to Follow-up|1|||
125660957|NCT02748616|452046884|FG000|Overall Study|Withdrawal by Subject|2|||
125660958|NCT02748616|452046884|FG000|Overall Study|Physician Decision|2|||
125660959|NCT02748616|452046884|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
125660960|NCT01296152|452046885|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
125660961|NCT01414062|452046890|FG000|Overall Study|Lost to Follow-up|3|||
125660962|NCT01414062|452046891|FG001|Overall Study|Lost to Follow-up|2|||
125660963|NCT01414062|452046890|FG000|Overall Study|Left Country|1|||
125660964|NCT01414062|452046891|FG001|Overall Study|Left Country|1|||
125660965|NCT01414062|452046890|FG000|Overall Study|Family Disapproval|1|||
125660966|NCT01414062|452046891|FG001|Overall Study|Family Disapproval|0|||
125660967|NCT01414062|452046890|FG000|Overall Study|Withdrawal by Subject|0|||
125660968|NCT01414062|452046891|FG001|Overall Study|Withdrawal by Subject|1|||
125660969|NCT04057118|452046894|FG000|Overall Study|Adverse Event|1|||
125660970|NCT04057118|452046895|FG001|Overall Study|Adverse Event|0|||
125660971|NCT04057118|452046896|FG002|Overall Study|Adverse Event|1|||
125660972|NCT04057118|452046897|FG003|Overall Study|Adverse Event|1|||
125660973|NCT04057118|452046894|FG000|Overall Study|Physician Decision|0|||
125660974|NCT04057118|452046895|FG001|Overall Study|Physician Decision|0|||
125660975|NCT04057118|452046896|FG002|Overall Study|Physician Decision|1|||
125660976|NCT04057118|452046897|FG003|Overall Study|Physician Decision|1|||
125660977|NCT04057118|452046894|FG000|Overall Study|Withdrawal by Subject|2|||
125660978|NCT04057118|452046895|FG001|Overall Study|Withdrawal by Subject|2|||
125660979|NCT04057118|452046896|FG002|Overall Study|Withdrawal by Subject|0|||
125660980|NCT04057118|452046897|FG003|Overall Study|Withdrawal by Subject|2|||
125660981|NCT04057118|452046894|FG000|Overall Study|Not Specific|0|||
125660982|NCT04057118|452046895|FG001|Overall Study|Not Specific|0|||
125660983|NCT04057118|452046896|FG002|Overall Study|Not Specific|1|||
125660984|NCT04057118|452046897|FG003|Overall Study|Not Specific|1|||
125660985|NCT02787785|452046900|FG000|Overall Study|Death|3|||
125660986|NCT02787785|452046901|FG001|Overall Study|Death|4|||
125660987|NCT02787785|452046900|FG000|Overall Study|Lost to Follow-up|1|||
125660988|NCT02787785|452046901|FG001|Overall Study|Lost to Follow-up|1|||
125660989|NCT02787785|452046900|FG000|Overall Study|Withdrawal by Subject|0|||
125660990|NCT02787785|452046901|FG001|Overall Study|Withdrawal by Subject|5|||
125660991|NCT00110084|452046905|FG000|Overall Study|Adverse Event|9|||
125660992|NCT00110084|452046905|FG000|Overall Study|Death|1|||
125660993|NCT00110084|452046905|FG000|Overall Study|Patient Refusal|10|||
125660994|NCT00110084|452046905|FG000|Overall Study|Alternate Therapy|5|||
125660995|NCT00110084|452046905|FG000|Overall Study|Intercurrent Illness|1|||
125660996|NCT00110084|452046905|FG000|Overall Study|Other|2|||
125660997|NCT00103259|452046906|FG000|Overall Study|Death|3|||
125660998|NCT00103259|452046907|FG001|Overall Study|Death|2|||
125660999|NCT00103259|452046906|FG000|Overall Study|Withdrawal by Subject|2|||
125661000|NCT00103259|452046907|FG001|Overall Study|Withdrawal by Subject|3|||
125661001|NCT00103259|452046906|FG000|Overall Study|alternative therapy|1|||
125661002|NCT00103259|452046907|FG001|Overall Study|alternative therapy|0|||
125661003|NCT00103259|452046906|FG000|Overall Study|other (reasons were not specified)|2|||
125661004|NCT00103259|452046907|FG001|Overall Study|other (reasons were not specified)|1|||
125661005|NCT00103259|452046906|FG000|Overall Study|ineligible/no protocol therapy|4|||
125661006|NCT00103259|452046907|FG001|Overall Study|ineligible/no protocol therapy|6|||
125661007|NCT04101721|452046910|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
125661008|NCT04101721|452046911|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
125661009|NCT04101721|452046910|FG000|Overall Study|Death|0|||
125661010|NCT04101721|452046911|FG001|Overall Study|Death|1|||
125661011|NCT04101721|452046910|FG000|Overall Study|Lost to Follow-up|0|||
125661012|NCT04101721|452046911|FG001|Overall Study|Lost to Follow-up|3|||
125661013|NCT02610842|452046912|FG000|Overall Study|Lost to Follow-up|5|||
125661014|NCT04736576|452046913|FG000|Overall Study|Progressive disease|3|||
125661015|NCT04736576|452046914|FG001|Overall Study|Progressive disease|1|||
125661016|NCT04736576|452046913|FG000|Overall Study|Death|1|||
125661017|NCT04736576|452046914|FG001|Overall Study|Death|0|||
125661018|NCT04330482|452046919|FG000|Overall Study|Lost to Follow-up|2|||
125661019|NCT04330482|452046920|FG001|Overall Study|Lost to Follow-up|1|||
125661020|NCT04330482|452046919|FG000|Overall Study|Withdrawal by Subject|0|||
125661021|NCT04330482|452046920|FG001|Overall Study|Withdrawal by Subject|3|||
125661022|NCT05144477|452046922|FG000|Overall Study|Withdrawal by Subject|1|||
125661023|NCT05144477|452046923|FG001|Overall Study|Withdrawal by Subject|1|||
125661024|NCT03273712|452046924|FG000|Overall Study|Death|5|||
125661025|NCT03273712|452046924|FG000|Overall Study|Adverse Event|1|||
125661026|NCT03273712|452046924|FG000|Overall Study|Disease Progression|1|||
125661027|NCT02268045|452046927|FG000|Overall Study|Death|4|||
125661028|NCT02268045|452046928|FG001|Overall Study|Death|4|||
125661029|NCT02268045|452046927|FG000|Overall Study|Disease Progression|2|||
125661030|NCT02268045|452046928|FG001|Overall Study|Disease Progression|1|||
125661031|NCT02268045|452046927|FG000|Overall Study|Adverse Event|7|||
125661032|NCT02268045|452046928|FG001|Overall Study|Adverse Event|7|||
125661033|NCT02268045|452046927|FG000|Overall Study|Withdrawal by Subject|2|||
125661034|NCT02268045|452046928|FG001|Overall Study|Withdrawal by Subject|6|||
125661035|NCT02268045|452046927|FG000|Overall Study|Physician Decision|0|||
125661036|NCT02268045|452046928|FG001|Overall Study|Physician Decision|1|||
125661037|NCT02268045|452046927|FG000|Overall Study|Protocol Violation|1|||
125661038|NCT02268045|452046928|FG001|Overall Study|Protocol Violation|1|||
125661039|NCT01154673|452046929|FG000|Overall Study|Lost to Follow-up|1|||
125661040|NCT01154673|452046930|FG001|Overall Study|Lost to Follow-up|0|||
125661041|NCT01154673|452046929|FG000|Overall Study|moved out of province|1|||
125661042|NCT01154673|452046930|FG001|Overall Study|moved out of province|0|||
125661043|NCT00646282|452046931|FG000|Overall Study|Protocol terminated|4|||
125661044|NCT00646282|452046932|FG001|Overall Study|Protocol terminated|4|||
125661045|NCT01289990|452046933|FG000|Overall Study|Death|0|||
125318198|NCT00402168|450794042|FG001|Long Term (LT)|Lost to Follow-up|0|||
125318199|NCT00402168|450794041|FG000|Long Term (LT)|Death|4|||
125318200|NCT00402168|450794042|FG001|Long Term (LT)|Death|0|||
125318201|NCT00402168|450794041|FG000|Long Term (LT)|Lack of Efficacy|0|||
125661046|NCT01289990|452046934|FG001|Overall Study|Death|0|||
125661047|NCT01289990|452046935|FG002|Overall Study|Death|0|||
125661048|NCT01289990|452046936|FG003|Overall Study|Death|1|||
125661049|NCT01289990|452046937|FG004|Overall Study|Death|2|||
125661050|NCT01289990|452046938|FG005|Overall Study|Death|1|||
125661051|NCT01289990|452046939|FG006|Overall Study|Death|0|||
125661052|NCT01289990|452046940|FG007|Overall Study|Death|0|||
125661053|NCT01289990|452046941|FG008|Overall Study|Death|0|||
125661054|NCT01289990|452046942|FG009|Overall Study|Death|0|||
125661055|NCT01289990|452046943|FG010|Overall Study|Death|0|||
125661056|NCT01289990|452046944|FG011|Overall Study|Death|1|||
125661057|NCT01289990|452046945|FG012|Overall Study|Death|0|||
125661058|NCT01289990|452046933|FG000|Overall Study|Lost to Follow-up|3|||
125661059|NCT01289990|452046934|FG001|Overall Study|Lost to Follow-up|2|||
125661060|NCT01289990|452046935|FG002|Overall Study|Lost to Follow-up|5|||
125661061|NCT01289990|452046936|FG003|Overall Study|Lost to Follow-up|5|||
125661062|NCT01289990|452046937|FG004|Overall Study|Lost to Follow-up|3|||
125661063|NCT01289990|452046938|FG005|Overall Study|Lost to Follow-up|4|||
125661064|NCT01289990|452046939|FG006|Overall Study|Lost to Follow-up|2|||
125661065|NCT01289990|452046940|FG007|Overall Study|Lost to Follow-up|2|||
125661066|NCT01289990|452046941|FG008|Overall Study|Lost to Follow-up|1|||
125661067|NCT01289990|452046942|FG009|Overall Study|Lost to Follow-up|4|||
125661068|NCT01289990|452046943|FG010|Overall Study|Lost to Follow-up|2|||
125661069|NCT01289990|452046944|FG011|Overall Study|Lost to Follow-up|1|||
125661070|NCT01289990|452046945|FG012|Overall Study|Lost to Follow-up|2|||
125661071|NCT01289990|452046933|FG000|Overall Study|Withdrawal by Subject|15|||
125661072|NCT01289990|452046934|FG001|Overall Study|Withdrawal by Subject|14|||
125661073|NCT01289990|452046935|FG002|Overall Study|Withdrawal by Subject|12|||
125661074|NCT01289990|452046936|FG003|Overall Study|Withdrawal by Subject|13|||
125661075|NCT01289990|452046937|FG004|Overall Study|Withdrawal by Subject|8|||
125661076|NCT01289990|452046938|FG005|Overall Study|Withdrawal by Subject|7|||
125661077|NCT01289990|452046939|FG006|Overall Study|Withdrawal by Subject|13|||
125661078|NCT01289990|452046940|FG007|Overall Study|Withdrawal by Subject|9|||
125661079|NCT01289990|452046941|FG008|Overall Study|Withdrawal by Subject|12|||
125661080|NCT01289990|452046942|FG009|Overall Study|Withdrawal by Subject|13|||
125661081|NCT01289990|452046943|FG010|Overall Study|Withdrawal by Subject|11|||
125661082|NCT01289990|452046944|FG011|Overall Study|Withdrawal by Subject|13|||
125661083|NCT01289990|452046945|FG012|Overall Study|Withdrawal by Subject|16|||
125661084|NCT01289990|452046933|FG000|Overall Study|discontinued in preceding trial|18|||
125661085|NCT01289990|452046934|FG001|Overall Study|discontinued in preceding trial|20|||
125661086|NCT01289990|452046935|FG002|Overall Study|discontinued in preceding trial|41|||
125661087|NCT01289990|452046936|FG003|Overall Study|discontinued in preceding trial|17|||
125661088|NCT01289990|452046937|FG004|Overall Study|discontinued in preceding trial|11|||
125318202|NCT00402168|450794042|FG001|Long Term (LT)|Lack of Efficacy|2|||
125318203|NCT00402168|450794041|FG000|Long Term (LT)|non-specified|1|||
125318204|NCT00402168|450794042|FG001|Long Term (LT)|non-specified|2|||
125661089|NCT01289990|452046938|FG005|Overall Study|discontinued in preceding trial|12|||
125661090|NCT01289990|452046939|FG006|Overall Study|discontinued in preceding trial|18|||
125661091|NCT01289990|452046940|FG007|Overall Study|discontinued in preceding trial|8|||
125661092|NCT01289990|452046941|FG008|Overall Study|discontinued in preceding trial|17|||
125661093|NCT01289990|452046942|FG009|Overall Study|discontinued in preceding trial|21|||
125661094|NCT01289990|452046943|FG010|Overall Study|discontinued in preceding trial|17|||
125661095|NCT01289990|452046944|FG011|Overall Study|discontinued in preceding trial|17|||
125661096|NCT01289990|452046945|FG012|Overall Study|discontinued in preceding trial|24|||
125661097|NCT01289990|452046933|FG000|Overall Study|did not continue in extension|41|||
125661098|NCT01289990|452046934|FG001|Overall Study|did not continue in extension|45|||
125661099|NCT01289990|452046935|FG002|Overall Study|did not continue in extension|51|||
125661100|NCT01289990|452046936|FG003|Overall Study|did not continue in extension|51|||
125661101|NCT01289990|452046937|FG004|Overall Study|did not continue in extension|48|||
125661102|NCT01289990|452046938|FG005|Overall Study|did not continue in extension|50|||
125661103|NCT01289990|452046939|FG006|Overall Study|did not continue in extension|54|||
125661104|NCT01289990|452046940|FG007|Overall Study|did not continue in extension|36|||
125661105|NCT01289990|452046941|FG008|Overall Study|did not continue in extension|44|||
125661106|NCT01289990|452046942|FG009|Overall Study|did not continue in extension|48|||
125661107|NCT01289990|452046943|FG010|Overall Study|did not continue in extension|45|||
125661108|NCT01289990|452046944|FG011|Overall Study|did not continue in extension|34|||
125661109|NCT01289990|452046945|FG012|Overall Study|did not continue in extension|56|||
125661110|NCT01289990|452046933|FG000|Overall Study|Not treated|0|||
125661111|NCT01289990|452046934|FG001|Overall Study|Not treated|0|||
125661112|NCT01289990|452046935|FG002|Overall Study|Not treated|0|||
125661113|NCT01289990|452046936|FG003|Overall Study|Not treated|0|||
125661114|NCT01289990|452046937|FG004|Overall Study|Not treated|0|||
125661115|NCT01289990|452046938|FG005|Overall Study|Not treated|0|||
125661116|NCT01289990|452046939|FG006|Overall Study|Not treated|1|||
125661117|NCT01289990|452046940|FG007|Overall Study|Not treated|0|||
125661118|NCT01289990|452046941|FG008|Overall Study|Not treated|1|||
125661119|NCT01289990|452046942|FG009|Overall Study|Not treated|0|||
125661120|NCT01289990|452046943|FG010|Overall Study|Not treated|1|||
125661121|NCT01289990|452046944|FG011|Overall Study|Not treated|2|||
125661122|NCT01289990|452046945|FG012|Overall Study|Not treated|0|||
125661123|NCT00683904|452046946|FG000|Dose Level 1|Disease progression|2|||
125661124|NCT00683904|452046947|FG001|Dose Level 1|Disease progression|0|||
125661125|NCT00683904|452046946|FG000|Dose Level 1|Adverse Event|1|||
125661126|NCT00683904|452046947|FG001|Dose Level 1|Adverse Event|0|||
125661127|NCT00683904|452046946|FG000|Dose Level 2|Adverse Event|0|||
125661128|NCT00683904|452046947|FG001|Dose Level 2|Adverse Event|2|||
125661129|NCT01488071|452046948|FG000|Overall Study|Adverse Event|15|||
125661130|NCT01488071|452046949|FG001|Overall Study|Adverse Event|23|||
125661131|NCT01488071|452046948|FG000|Overall Study|Lack of Efficacy|11|||
125318205|NCT00402168|450794041|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
125318206|NCT00402168|450794042|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
125318207|NCT00402168|450794041|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
125318208|NCT00402168|450794042|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
125318209|NCT00395746|450794048|FG000|Overall Study|Adverse Event|5|||
125318210|NCT00395746|450794049|FG001|Overall Study|Adverse Event|2|||
125318211|NCT00395746|450794050|FG002|Overall Study|Adverse Event|2|||
125318212|NCT00395746|450794048|FG000|Overall Study|Protocol Violation|0|||
125318213|NCT00395746|450794049|FG001|Overall Study|Protocol Violation|1|||
125318214|NCT00395746|450794050|FG002|Overall Study|Protocol Violation|0|||
125318215|NCT00395746|450794048|FG000|Overall Study|Lack of Efficacy|2|||
125661132|NCT01488071|452046949|FG001|Overall Study|Lack of Efficacy|17|||
125661133|NCT01488071|452046948|FG000|Overall Study|Non-compliance with study drug|2|||
125661134|NCT01488071|452046949|FG001|Overall Study|Non-compliance with study drug|0|||
125661135|NCT01488071|452046948|FG000|Overall Study|Protocol Violation|5|||
125661136|NCT01488071|452046949|FG001|Overall Study|Protocol Violation|7|||
125661137|NCT01488071|452046948|FG000|Overall Study|Withdrawal of Consent|14|||
125661138|NCT01488071|452046949|FG001|Overall Study|Withdrawal of Consent|12|||
125661139|NCT01488071|452046948|FG000|Overall Study|Lost to Follow-up|1|||
125661140|NCT01488071|452046949|FG001|Overall Study|Lost to Follow-up|0|||
125661141|NCT01488071|452046948|FG000|Overall Study|Administrative or Other Reason(s)|5|||
125661142|NCT01488071|452046949|FG001|Overall Study|Administrative or Other Reason(s)|4|||
125661143|NCT04449354|452046950|FG000|Overall Study|Withdrawal by Subject|1|||
125661144|NCT05789420|452046951|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
125661145|NCT05789420|452046951|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
125661146|NCT02720094|452046952|FG000|Overall Study|Scheduled exit visit/end of study|2|||
125661147|NCT02720094|452046953|FG001|Overall Study|Scheduled exit visit/end of study|1|||
125661148|NCT02720094|452046952|FG000|Overall Study|Death|4|||
125318216|NCT00395746|450794049|FG001|Overall Study|Lack of Efficacy|0|||
125661149|NCT02720094|452046953|FG001|Overall Study|Death|7|||
125661150|NCT02720094|452046952|FG000|Overall Study|Withdrawal by Subject|55|||
125661151|NCT02720094|452046953|FG001|Overall Study|Withdrawal by Subject|56|||
125661152|NCT02720094|452046952|FG000|Overall Study|Lost to Follow-up|2|||
125661153|NCT02720094|452046953|FG001|Overall Study|Lost to Follow-up|7|||
125661154|NCT02720094|452046952|FG000|Overall Study|Physician Decision|1|||
125661155|NCT02720094|452046953|FG001|Overall Study|Physician Decision|3|||
125661156|NCT02720094|452046952|FG000|Overall Study|Inappropriate enrollment|1|||
125661157|NCT02720094|452046953|FG001|Overall Study|Inappropriate enrollment|3|||
125661158|NCT02720094|452046952|FG000|Overall Study|Ongoing|2210|||
125661159|NCT02720094|452046953|FG001|Overall Study|Ongoing|2203|||
125661160|NCT02720094|452046952|FG000|Overall Study|Relocation|1|||
125661161|NCT02720094|452046953|FG001|Overall Study|Relocation|1|||
125661162|NCT01220128|452046954|FG000|Overall Study|Progressive disease|0|||
125661163|NCT01220128|452046955|FG001|Overall Study|Progressive disease|0|||
125661164|NCT01220128|452046956|FG002|Overall Study|Progressive disease|2|||
125661165|NCT01220128|452046957|FG003|Overall Study|Progressive disease|0|||
125661166|NCT01220128|452046958|FG004|Overall Study|Progressive disease|0|||
125661167|NCT01220128|452046959|FG005|Overall Study|Progressive disease|0|||
125661168|NCT01220128|452046960|FG006|Overall Study|Progressive disease|0|||
125661169|NCT01220128|452046954|FG000|Overall Study|Sponsor study termination|0|||
125661170|NCT01220128|452046955|FG001|Overall Study|Sponsor study termination|1|||
125661171|NCT01220128|452046956|FG002|Overall Study|Sponsor study termination|0|||
125661172|NCT01220128|452046957|FG003|Overall Study|Sponsor study termination|0|||
125661173|NCT01220128|452046958|FG004|Overall Study|Sponsor study termination|0|||
125661174|NCT01220128|452046959|FG005|Overall Study|Sponsor study termination|0|||
125661175|NCT01220128|452046960|FG006|Overall Study|Sponsor study termination|1|||
125661176|NCT01220128|452046954|FG000|Overall Study|Adverse event, serious fatal|2|||
125661177|NCT01220128|452046955|FG001|Overall Study|Adverse event, serious fatal|0|||
125661178|NCT01220128|452046956|FG002|Overall Study|Adverse event, serious fatal|0|||
125661179|NCT01220128|452046957|FG003|Overall Study|Adverse event, serious fatal|0|||
125661180|NCT01220128|452046958|FG004|Overall Study|Adverse event, serious fatal|0|||
125661181|NCT01220128|452046959|FG005|Overall Study|Adverse event, serious fatal|0|||
125661182|NCT01220128|452046960|FG006|Overall Study|Adverse event, serious fatal|1|||
125661183|NCT01220128|452046954|FG000|Overall Study|Adverse event, non-fatal|1|||
125318217|NCT00395746|450794050|FG002|Overall Study|Lack of Efficacy|17|||
125318218|NCT00395746|450794048|FG000|Overall Study|Hypoglycaemia|2|||
125661184|NCT01220128|452046955|FG001|Overall Study|Adverse event, non-fatal|0|||
125661185|NCT01220128|452046956|FG002|Overall Study|Adverse event, non-fatal|0|||
125661186|NCT01220128|452046957|FG003|Overall Study|Adverse event, non-fatal|0|||
125661187|NCT01220128|452046958|FG004|Overall Study|Adverse event, non-fatal|0|||
125661188|NCT01220128|452046959|FG005|Overall Study|Adverse event, non-fatal|0|||
125661189|NCT01220128|452046960|FG006|Overall Study|Adverse event, non-fatal|3|||
125661190|NCT01220128|452046954|FG000|Overall Study|Other|0|||
125661191|NCT01220128|452046955|FG001|Overall Study|Other|0|||
125661192|NCT01220128|452046956|FG002|Overall Study|Other|1|||
125661193|NCT01220128|452046957|FG003|Overall Study|Other|0|||
125661194|NCT01220128|452046958|FG004|Overall Study|Other|0|||
125661195|NCT01220128|452046959|FG005|Overall Study|Other|0|||
125661196|NCT01220128|452046960|FG006|Overall Study|Other|0|||
125661197|NCT01220128|452046954|FG000|Overall Study|Consent withdrawn by subject|1|||
125661198|NCT01220128|452046955|FG001|Overall Study|Consent withdrawn by subject|0|||
125661199|NCT01220128|452046956|FG002|Overall Study|Consent withdrawn by subject|0|||
125661200|NCT01220128|452046957|FG003|Overall Study|Consent withdrawn by subject|0|||
125661201|NCT01220128|452046958|FG004|Overall Study|Consent withdrawn by subject|0|||
125661202|NCT01220128|452046959|FG005|Overall Study|Consent withdrawn by subject|0|||
125661203|NCT01220128|452046960|FG006|Overall Study|Consent withdrawn by subject|0|||
125661204|NCT02913261|452046961|FG000|Overall Study|Technical problems|0|||
125661205|NCT02913261|452046962|FG001|Overall Study|Technical problems|1|||
125661206|NCT02913261|452046961|FG000|Overall Study|Lack of Efficacy|32|||
125661207|NCT02913261|452046962|FG001|Overall Study|Lack of Efficacy|69|||
125661208|NCT02913261|452046961|FG000|Overall Study|Adverse Event|27|||
125661209|NCT02913261|452046962|FG001|Overall Study|Adverse Event|5|||
125661210|NCT02913261|452046961|FG000|Overall Study|Death|25|||
125661211|NCT02913261|452046962|FG001|Overall Study|Death|22|||
125661212|NCT02913261|452046961|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
125661213|NCT02913261|452046962|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
125661214|NCT02913261|452046961|FG000|Overall Study|Disease relapse|8|||
125661215|NCT02913261|452046962|FG001|Overall Study|Disease relapse|13|||
125661216|NCT02913261|452046961|FG000|Overall Study|Physician Decision|8|||
125661217|NCT02913261|452046962|FG001|Overall Study|Physician Decision|9|||
125661218|NCT02913261|452046961|FG000|Overall Study|Subject/guardian decision|4|||
125661219|NCT02913261|452046962|FG001|Overall Study|Subject/guardian decision|6|||
125661220|NCT02913261|452046961|FG000|Overall Study|Graft loss|2|||
125661221|NCT02913261|452046962|FG001|Overall Study|Graft loss|0|||
125661222|NCT02340078|452046963|FG000|Overall Study|Protocol Violation|1|||
125661223|NCT00567996|452046967|FG000|Overall Study|Adverse Event|18|||
125661224|NCT00567996|452046968|FG001|Overall Study|Adverse Event|16|||
125661225|NCT00567996|452046969|FG002|Overall Study|Adverse Event|13|||
125661226|NCT00567996|452046967|FG000|Overall Study|Protocol Deviation|9|||
125661227|NCT00567996|452046968|FG001|Overall Study|Protocol Deviation|11|||
125661228|NCT00567996|452046969|FG002|Overall Study|Protocol Deviation|13|||
125661229|NCT00567996|452046967|FG000|Overall Study|Withdrawal by Subject|8|||
125661230|NCT00567996|452046968|FG001|Overall Study|Withdrawal by Subject|12|||
125318219|NCT00395746|450794049|FG001|Overall Study|Hypoglycaemia|1|||
125661231|NCT00567996|452046969|FG002|Overall Study|Withdrawal by Subject|22|||
125661232|NCT00567996|452046967|FG000|Overall Study|Abnormal Lab value(s)|2|||
125661233|NCT00567996|452046968|FG001|Overall Study|Abnormal Lab value(s)|1|||
125661234|NCT00567996|452046969|FG002|Overall Study|Abnormal Lab value(s)|2|||
125661235|NCT00567996|452046967|FG000|Overall Study|Abnormal test procedure result(s)|2|||
125661236|NCT00567996|452046968|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125661237|NCT00567996|452046969|FG002|Overall Study|Abnormal test procedure result(s)|1|||
125661238|NCT00567996|452046967|FG000|Overall Study|Lost to Follow-up|2|||
125661239|NCT00567996|452046968|FG001|Overall Study|Lost to Follow-up|5|||
125661240|NCT00567996|452046969|FG002|Overall Study|Lost to Follow-up|2|||
125661241|NCT00567996|452046967|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125661242|NCT00567996|452046968|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125661243|NCT00567996|452046969|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
125661244|NCT00567996|452046967|FG000|Overall Study|Administrative problems|1|||
125661245|NCT00567996|452046968|FG001|Overall Study|Administrative problems|1|||
125661246|NCT00567996|452046969|FG002|Overall Study|Administrative problems|0|||
125661247|NCT00567996|452046967|FG000|Overall Study|Death|1|||
125661248|NCT00567996|452046968|FG001|Overall Study|Death|0|||
125661249|NCT00567996|452046969|FG002|Overall Study|Death|2|||
125661250|NCT00567996|452046967|FG000|Overall Study|Patient's inability to use the device|0|||
125661251|NCT00567996|452046968|FG001|Overall Study|Patient's inability to use the device|1|||
125661252|NCT00567996|452046969|FG002|Overall Study|Patient's inability to use the device|0|||
125661253|NCT02524665|452046972|FG000|Overall Study|Lost to Follow-up|1|||
125661254|NCT00883129|452046975|FG000|Overall Study|Adverse Event|7|||
125661255|NCT00883129|452046976|FG001|Overall Study|Adverse Event|15|||
125661256|NCT00883129|452046975|FG000|Overall Study|Withdrawal by Subject|8|||
125661257|NCT00883129|452046976|FG001|Overall Study|Withdrawal by Subject|9|||
125661258|NCT00883129|452046975|FG000|Overall Study|Non-compliance|3|||
125661259|NCT00883129|452046976|FG001|Overall Study|Non-compliance|6|||
125661260|NCT00883129|452046975|FG000|Overall Study|Lost to Follow-up|1|||
125661261|NCT00883129|452046976|FG001|Overall Study|Lost to Follow-up|2|||
125661262|NCT00883129|452046975|FG000|Overall Study|Death|1|||
125661263|NCT00883129|452046976|FG001|Overall Study|Death|2|||
125661264|NCT00883129|452046975|FG000|Overall Study|Defined Treatment Failure|0|||
125661265|NCT00883129|452046976|FG001|Overall Study|Defined Treatment Failure|2|||
125661266|NCT03273257|452046978|FG000|Overall Study|Death|0|||
125661267|NCT03273257|452046979|FG001|Overall Study|Death|1|||
125661268|NCT03273257|452046978|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
125661269|NCT03273257|452046979|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
125661270|NCT03273257|452046978|FG000|Overall Study|Study terminated|3|||
125661271|NCT03273257|452046979|FG001|Overall Study|Study terminated|2|||
125661272|NCT00391092|452049081|FG000|Overall Study|Death|78|||
125661273|NCT00391092|452049082|FG001|Overall Study|Death|81|||
125661274|NCT00391092|452049081|FG000|Overall Study|Lost to Follow-up|13|||
125661275|NCT00391092|452049082|FG001|Overall Study|Lost to Follow-up|18|||
125661276|NCT00391092|452049081|FG000|Overall Study|Alive on treatment|29|||
125661277|NCT00391092|452049082|FG001|Overall Study|Alive on treatment|33|||
125661278|NCT00391092|452049081|FG000|Overall Study|Alive in follow-up|88|||
125661279|NCT00391092|452049082|FG001|Overall Study|Alive in follow-up|84|||
125661280|NCT01901146|452049083|FG000|Neoadjuvant Phase|Death|1|||
125661281|NCT01901146|452049084|FG001|Neoadjuvant Phase|Death|2|||
125661282|NCT01901146|452049085|FG002|Neoadjuvant Phase|Death|0|||
125661283|NCT01901146|452049086|FG003|Neoadjuvant Phase|Death|0|||
125661284|NCT01901146|452049087|FG004|Neoadjuvant Phase|Death|0|||
125661285|NCT01901146|452049083|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
125661286|NCT01901146|452049084|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
125661287|NCT01901146|452049085|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
125661288|NCT01901146|452049086|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
125661289|NCT01901146|452049087|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
125661290|NCT01901146|452049083|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
125661291|NCT01901146|452049084|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
125661292|NCT01901146|452049085|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
125661293|NCT01901146|452049086|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
125661294|NCT01901146|452049087|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
125661295|NCT01901146|452049083|FG000|Neoadjuvant Phase|Physician Decision|1|||
125661296|NCT01901146|452049084|FG001|Neoadjuvant Phase|Physician Decision|2|||
125661297|NCT01901146|452049085|FG002|Neoadjuvant Phase|Physician Decision|0|||
125661298|NCT01901146|452049086|FG003|Neoadjuvant Phase|Physician Decision|0|||
125661299|NCT01901146|452049087|FG004|Neoadjuvant Phase|Physician Decision|0|||
125661300|NCT01901146|452049083|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
125661301|NCT01901146|452049084|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
125661302|NCT01901146|452049085|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
125661303|NCT01901146|452049086|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
125661304|NCT01901146|452049087|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
125661305|NCT01901146|452049083|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
125661306|NCT01901146|452049084|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
125661307|NCT01901146|452049085|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
125661308|NCT01901146|452049086|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
125661309|NCT01901146|452049087|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
125661310|NCT01901146|452049083|FG000|Adjuvant Phase|Other|0|||
125661311|NCT01901146|452049084|FG001|Adjuvant Phase|Other|0|||
125661312|NCT01901146|452049085|FG002|Adjuvant Phase|Other|1|||
125661313|NCT01901146|452049086|FG003|Adjuvant Phase|Other|0|||
125661314|NCT01901146|452049087|FG004|Adjuvant Phase|Other|0|||
125661315|NCT01901146|452049083|FG000|Adjuvant Phase|Death|0|||
125661316|NCT01901146|452049084|FG001|Adjuvant Phase|Death|0|||
125661317|NCT01901146|452049085|FG002|Adjuvant Phase|Death|0|||
125661318|NCT01901146|452049086|FG003|Adjuvant Phase|Death|0|||
125661319|NCT01901146|452049087|FG004|Adjuvant Phase|Death|3|||
125661320|NCT01901146|452049083|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
125661321|NCT01901146|452049084|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
125661322|NCT01901146|452049085|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
125661323|NCT01901146|452049086|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
125661324|NCT01901146|452049087|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
125661325|NCT01901146|452049083|FG000|Adjuvant Phase|Physician Decision|0|||
125661326|NCT01901146|452049084|FG001|Adjuvant Phase|Physician Decision|0|||
125661327|NCT01901146|452049085|FG002|Adjuvant Phase|Physician Decision|9|||
125661328|NCT01901146|452049086|FG003|Adjuvant Phase|Physician Decision|2|||
125661329|NCT01901146|452049087|FG004|Adjuvant Phase|Physician Decision|4|||
125661330|NCT01901146|452049083|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
125661331|NCT01901146|452049084|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
125661332|NCT01901146|452049085|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
125661333|NCT01901146|452049086|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
125318220|NCT00395746|450794050|FG002|Overall Study|Hypoglycaemia|0|||
125318221|NCT00395746|450794048|FG000|Overall Study|Subject decision|0|||
125318222|NCT00395746|450794049|FG001|Overall Study|Subject decision|0|||
125318223|NCT00395746|450794050|FG002|Overall Study|Subject decision|1|||
125318224|NCT00395746|450794048|FG000|Overall Study|Withdrawal of consent|0|||
125318225|NCT00395746|450794049|FG001|Overall Study|Withdrawal of consent|0|||
125318226|NCT00395746|450794050|FG002|Overall Study|Withdrawal of consent|1|||
125318227|NCT00395746|450794048|FG000|Overall Study|Difficultulty in use of device|0|||
125318228|NCT00395746|450794049|FG001|Overall Study|Difficultulty in use of device|0|||
125318229|NCT00395746|450794050|FG002|Overall Study|Difficultulty in use of device|1|||
125318230|NCT00395746|450794048|FG000|Overall Study|Unable to visit site on schedule|1|||
125661334|NCT01901146|452049087|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
125661335|NCT00297492|452049088|FG000|Set Quit Date|Lost to Follow-up|7|||
125661336|NCT00297492|452049089|FG001|Set Quit Date|Lost to Follow-up|13|||
125661337|NCT00297492|452049090|FG002|Set Quit Date|Lost to Follow-up|5|||
125661338|NCT00297492|452049088|FG000|6 Month Follow-up|Lost to Follow-up|63|||
125661339|NCT00297492|452049089|FG001|6 Month Follow-up|Lost to Follow-up|49|||
125661340|NCT00297492|452049090|FG002|6 Month Follow-up|Lost to Follow-up|27|||
125661341|NCT02414854|452049091|FG000|Overall Study|Adverse Event|9|||
125661342|NCT02414854|452049092|FG001|Overall Study|Adverse Event|7|||
125661343|NCT02414854|452049093|FG002|Overall Study|Adverse Event|1|||
125661344|NCT02414854|452049094|FG003|Overall Study|Adverse Event|12|||
125661345|NCT02414854|452049091|FG000|Overall Study|Poor compliance to protocol|1|||
125661346|NCT02414854|452049092|FG001|Overall Study|Poor compliance to protocol|1|||
125661347|NCT02414854|452049093|FG002|Overall Study|Poor compliance to protocol|2|||
125661348|NCT02414854|452049094|FG003|Overall Study|Poor compliance to protocol|2|||
125661349|NCT02414854|452049091|FG000|Overall Study|Other than specified above|12|||
125661350|NCT02414854|452049092|FG001|Overall Study|Other than specified above|37|||
125661351|NCT02414854|452049093|FG002|Overall Study|Other than specified above|17|||
125318231|NCT00395746|450794049|FG001|Overall Study|Unable to visit site on schedule|0|||
125318232|NCT00395746|450794050|FG002|Overall Study|Unable to visit site on schedule|0|||
125318233|NCT03137992|450794055|FG000|Washout Period 1|Adverse Event|1|||
125661352|NCT02414854|452049094|FG003|Overall Study|Other than specified above|37|||
125661353|NCT00606801|452049095|FG000|Intervention|Protocol Violation|3|||
125661354|NCT00606801|452049096|FG001|Intervention|Protocol Violation|3|||
125661355|NCT00303316|452049099|FG000|Overall Study|Protocol Violation|1|||
125661356|NCT00303316|452049100|FG001|Overall Study|Protocol Violation|0|||
125661357|NCT00303316|452049099|FG000|Overall Study|Lost to Follow-up|0|||
125661358|NCT00303316|452049100|FG001|Overall Study|Lost to Follow-up|1|||
125318234|NCT03137992|450794056|FG001|Washout Period 1|Adverse Event|1|||
125318235|NCT03137992|450794057|FG002|Washout Period 1|Adverse Event|0|||
125318236|NCT03137992|450794058|FG003|Washout Period 1|Adverse Event|0|||
125318237|NCT03137992|450794059|FG004|Washout Period 1|Adverse Event|0|||
125661359|NCT00303316|452049099|FG000|Overall Study|Withdrawal by Subject|1|||
125661360|NCT00303316|452049100|FG001|Overall Study|Withdrawal by Subject|2|||
125661361|NCT02016755|452049103|FG000|Overall Study|Major amputation of index limb|2|||
125661362|NCT02016755|452049103|FG000|Overall Study|Adverse Event|2|||
125661363|NCT02016755|452049103|FG000|Overall Study|Physician Decision|1|||
125661364|NCT02016755|452049103|FG000|Overall Study|Death|2|||
125661365|NCT01396161|452049108|FG000|Overall Study|Withdrawal by Subject|0|||
125661366|NCT01396161|452049109|FG001|Overall Study|Withdrawal by Subject|0|||
125661367|NCT01396161|452049110|FG002|Overall Study|Withdrawal by Subject|0|||
125318238|NCT03137992|450794060|FG005|Washout Period 1|Adverse Event|1|||
125318239|NCT03137992|450794055|FG000|Washout Period 1|Withdrawal by Subject|0|||
125318240|NCT03137992|450794056|FG001|Washout Period 1|Withdrawal by Subject|1|||
125318241|NCT03137992|450794057|FG002|Washout Period 1|Withdrawal by Subject|1|||
125318242|NCT03137992|450794058|FG003|Washout Period 1|Withdrawal by Subject|0|||
125318243|NCT03137992|450794059|FG004|Washout Period 1|Withdrawal by Subject|0|||
125318244|NCT03137992|450794060|FG005|Washout Period 1|Withdrawal by Subject|0|||
125318245|NCT03137992|450794055|FG000|Washout Period 1|Principal Investigator Discretion|0|||
125318246|NCT03137992|450794056|FG001|Washout Period 1|Principal Investigator Discretion|1|||
125661368|NCT01396161|452049111|FG003|Overall Study|Withdrawal by Subject|0|||
125661369|NCT01396161|452049112|FG004|Overall Study|Withdrawal by Subject|1|||
125661370|NCT01396161|452049113|FG005|Overall Study|Withdrawal by Subject|0|||
125661371|NCT01396161|452049114|FG006|Overall Study|Withdrawal by Subject|0|||
125661372|NCT01396161|452049108|FG000|Overall Study|Other|0|||
125661373|NCT01396161|452049109|FG001|Overall Study|Other|0|||
125661374|NCT01396161|452049110|FG002|Overall Study|Other|0|||
125661375|NCT01396161|452049111|FG003|Overall Study|Other|0|||
125661376|NCT01396161|452049112|FG004|Overall Study|Other|0|||
125661377|NCT01396161|452049113|FG005|Overall Study|Other|0|||
125661378|NCT01396161|452049114|FG006|Overall Study|Other|1|||
125661379|NCT00552617|452049115|FG000|Overall Study|Not Treated|0|||
125661380|NCT00552617|452049116|FG001|Overall Study|Not Treated|0|||
125661381|NCT00552617|452049117|FG002|Overall Study|Not Treated|1|||
125661382|NCT00552617|452049118|FG003|Overall Study|Not Treated|0|||
125661383|NCT00552617|452049119|FG004|Overall Study|Not Treated|0|||
125661384|NCT00552617|452049120|FG005|Overall Study|Not Treated|0|||
125661385|NCT00552617|452049121|FG006|Overall Study|Not Treated|0|||
125661386|NCT00552617|452049122|FG007|Overall Study|Not Treated|0|||
125661387|NCT00552617|452049123|FG008|Overall Study|Not Treated|0|||
125661388|NCT00552617|452049124|FG009|Overall Study|Not Treated|1|||
125661389|NCT00552617|452049115|FG000|Overall Study|Lost to Follow-up|0|||
125661390|NCT00552617|452049116|FG001|Overall Study|Lost to Follow-up|0|||
125661391|NCT00552617|452049117|FG002|Overall Study|Lost to Follow-up|0|||
125661392|NCT00552617|452049118|FG003|Overall Study|Lost to Follow-up|1|||
125661393|NCT00552617|452049119|FG004|Overall Study|Lost to Follow-up|0|||
125661394|NCT00552617|452049120|FG005|Overall Study|Lost to Follow-up|2|||
125661395|NCT00552617|452049121|FG006|Overall Study|Lost to Follow-up|0|||
125661396|NCT00552617|452049122|FG007|Overall Study|Lost to Follow-up|0|||
125661397|NCT00552617|452049123|FG008|Overall Study|Lost to Follow-up|2|||
125661398|NCT00552617|452049124|FG009|Overall Study|Lost to Follow-up|0|||
125661399|NCT00337129|452049127|FG000|Overall Study|Adverse Event|4|||
125661400|NCT00337129|452049127|FG000|Overall Study|Withdrawal by Subject|1|||
125661401|NCT00337129|452049127|FG000|Overall Study|Lack of Efficacy|32|||
125661402|NCT00337129|452049127|FG000|Overall Study|Death|2|||
125661403|NCT00337129|452049127|FG000|Overall Study|not protocol specified|1|||
125661404|NCT00306852|452049131|FG000|Overall Study|Death|14|||
125661405|NCT00306852|452049132|FG001|Overall Study|Death|14|||
125661406|NCT00306852|452049131|FG000|Overall Study|Lost to Follow-up|15|||
125661407|NCT00306852|452049132|FG001|Overall Study|Lost to Follow-up|24|||
125661408|NCT01467570|452049133|FG000|Overall Study|Lost to Follow-up|8|||
125661409|NCT01467570|452049134|FG001|Overall Study|Lost to Follow-up|9|||
125661410|NCT02766088|452049137|FG000|Overall Study|Sponsor study termination|498|||
125661411|NCT02766088|452049137|FG000|Overall Study|Migrated/moved from the study area|1|||
125661412|NCT02766088|452049137|FG000|Overall Study|Lost to Follow-up|5|||
125661413|NCT02766088|452049137|FG000|Overall Study|Other|1|||
125661414|NCT02766088|452049137|FG000|Overall Study|Death|1|||
125661415|NCT01222715|452049138|FG000|Overall Study|Adverse Event|0|||
125661416|NCT01222715|452049139|FG001|Overall Study|Adverse Event|4|||
125661417|NCT01222715|452049138|FG000|Overall Study|Death|0|||
125661418|NCT01222715|452049139|FG001|Overall Study|Death|1|||
125661419|NCT01222715|452049138|FG000|Overall Study|Lack of Efficacy|22|||
125661420|NCT01222715|452049139|FG001|Overall Study|Lack of Efficacy|14|||
125661421|NCT01222715|452049138|FG000|Overall Study|Physician Decision|12|||
125661422|NCT01222715|452049139|FG001|Overall Study|Physician Decision|2|||
125661423|NCT01222715|452049138|FG000|Overall Study|Refusal of further protocol therapy|0|||
125661424|NCT01222715|452049139|FG001|Overall Study|Refusal of further protocol therapy|4|||
125661425|NCT01222715|452049138|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
125318247|NCT03137992|450794057|FG002|Washout Period 1|Principal Investigator Discretion|0|||
125318248|NCT03137992|450794058|FG003|Washout Period 1|Principal Investigator Discretion|0|||
125661426|NCT01222715|452049139|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
125661427|NCT01222715|452049138|FG000|Overall Study|Ineligible|0|||
125661428|NCT01222715|452049139|FG001|Overall Study|Ineligible|1|||
125661429|NCT01222715|452049138|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
125661430|NCT01222715|452049139|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
125661431|NCT03555890|452049146|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125661432|NCT03555890|452049147|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125661433|NCT03555890|452049148|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125661434|NCT03555890|452049149|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
125661435|NCT03372369|452049150|FG000|Qualification Period|Withdrawal by Subject|16|||
125661436|NCT03372369|452049151|FG001|Qualification Period|Withdrawal by Subject|13|||
125661437|NCT03372369|452049150|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
125661438|NCT03372369|452049151|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
125661439|NCT03372369|452049150|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
125661440|NCT03372369|452049151|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
125661441|NCT02239601|452049152|FG000|Overall Study|Withdrawal by Subject|3|||
125661442|NCT02239601|452049153|FG001|Overall Study|Withdrawal by Subject|4|||
125661443|NCT02239601|452049152|FG000|Overall Study|Protocol Violation|4|||
125661444|NCT02239601|452049153|FG001|Overall Study|Protocol Violation|2|||
125661445|NCT04682639|452049154|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
125661446|NCT04682639|452049155|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
125661447|NCT04682639|452049156|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
125661448|NCT04682639|452049157|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
125661449|NCT04682639|452049158|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
125661450|NCT04682639|452049154|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
125661451|NCT04682639|452049155|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
125661452|NCT04682639|452049156|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
125661453|NCT04682639|452049157|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125661454|NCT04682639|452049158|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125661455|NCT04682639|452049154|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
125661456|NCT04682639|452049155|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125661457|NCT04682639|452049156|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125661458|NCT04682639|452049157|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125661459|NCT04682639|452049158|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125661460|NCT04682639|452049154|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
125661461|NCT04682639|452049155|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
125661462|NCT04682639|452049156|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
125661463|NCT04682639|452049157|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
125661464|NCT04682639|452049158|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
125661465|NCT04682639|452049154|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
125661466|NCT04682639|452049155|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
125661467|NCT04682639|452049156|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
125661468|NCT04682639|452049157|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
125661469|NCT04682639|452049158|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
125661470|NCT04682639|452049154|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
125661471|NCT04682639|452049155|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
125661472|NCT04682639|452049156|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
125661473|NCT04682639|452049157|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
125661474|NCT04682639|452049158|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
125661475|NCT04682639|452049154|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
125661476|NCT04682639|452049155|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
125661477|NCT04682639|452049156|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
125661478|NCT04682639|452049157|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
125661479|NCT04682639|452049158|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
125661480|NCT04682639|452049154|FG000|OLE Period (28 Weeks)|Other|1|||
125661481|NCT04682639|452049155|FG001|OLE Period (28 Weeks)|Other|2|||
125661482|NCT04682639|452049156|FG002|OLE Period (28 Weeks)|Other|0|||
125661483|NCT04682639|452049157|FG003|OLE Period (28 Weeks)|Other|0|||
125661484|NCT04682639|452049158|FG004|OLE Period (28 Weeks)|Other|1|||
125661485|NCT04682639|452049154|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
125661486|NCT04682639|452049155|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
125661487|NCT04682639|452049156|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
125661488|NCT04682639|452049157|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
125661489|NCT04682639|452049158|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
125661490|NCT04682639|452049154|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
125661491|NCT04682639|452049155|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
125661492|NCT04682639|452049156|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125661493|NCT04682639|452049157|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125661494|NCT04682639|452049158|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125661495|NCT04682639|452049154|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
125661496|NCT04682639|452049155|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
125661497|NCT04682639|452049156|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125661498|NCT04682639|452049157|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125661499|NCT04682639|452049158|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125661500|NCT04682639|452049154|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
125661501|NCT04682639|452049155|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
125661502|NCT04682639|452049156|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
125661503|NCT04682639|452049157|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
125661504|NCT04682639|452049158|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
125661505|NCT01392170|452049161|FG000|Overall Study|Withdrawal by Subject|1|||
125661506|NCT01392170|452049161|FG000|Overall Study|Ineligible|1|||
125661507|NCT00589693|452049178|FG000|Overall Study|randomized in error|12|||
125661508|NCT00589693|452049179|FG001|Overall Study|randomized in error|6|||
125661509|NCT00589693|452049178|FG000|Overall Study|Adverse Event|4|||
125661510|NCT00589693|452049179|FG001|Overall Study|Adverse Event|4|||
125661511|NCT00589693|452049178|FG000|Overall Study|Death|26|||
125661512|NCT00589693|452049179|FG001|Overall Study|Death|16|||
125661513|NCT00589693|452049178|FG000|Overall Study|Lack of Efficacy|0|||
125661514|NCT00589693|452049179|FG001|Overall Study|Lack of Efficacy|1|||
125661515|NCT00589693|452049178|FG000|Overall Study|Lost to Follow-up|1|||
125661516|NCT00589693|452049179|FG001|Overall Study|Lost to Follow-up|0|||
125661517|NCT00589693|452049178|FG000|Overall Study|Physician Decision|0|||
125661518|NCT00589693|452049179|FG001|Overall Study|Physician Decision|1|||
125661519|NCT00589693|452049178|FG000|Overall Study|Protocol Violation|1|||
125661520|NCT00589693|452049179|FG001|Overall Study|Protocol Violation|1|||
125661521|NCT01682512|452049180|FG000|Overall Study|Adverse Event|6|||
125661522|NCT01682512|452049181|FG001|Overall Study|Adverse Event|5|||
125661523|NCT01682512|452049182|FG002|Overall Study|Adverse Event|2|||
125661524|NCT01682512|452049180|FG000|Overall Study|Withdrawal by Subject|2|||
125661525|NCT01682512|452049181|FG001|Overall Study|Withdrawal by Subject|6|||
125661526|NCT01682512|452049182|FG002|Overall Study|Withdrawal by Subject|3|||
125661527|NCT01682512|452049180|FG000|Overall Study|Physician Decision|0|||
125661528|NCT01682512|452049181|FG001|Overall Study|Physician Decision|2|||
125661529|NCT01682512|452049182|FG002|Overall Study|Physician Decision|0|||
125661530|NCT01682512|452049180|FG000|Overall Study|Study terminated by sponsor|46|||
125661531|NCT01682512|452049181|FG001|Overall Study|Study terminated by sponsor|43|||
125661532|NCT01682512|452049182|FG002|Overall Study|Study terminated by sponsor|0|||
125661533|NCT01682512|452049180|FG000|Overall Study|Lost to Follow-up|3|||
125661534|NCT01682512|452049181|FG001|Overall Study|Lost to Follow-up|0|||
125661535|NCT01682512|452049182|FG002|Overall Study|Lost to Follow-up|2|||
125661536|NCT01682512|452049180|FG000|Overall Study|Protocol Violation|2|||
125661537|NCT01682512|452049181|FG001|Overall Study|Protocol Violation|3|||
125661538|NCT01682512|452049182|FG002|Overall Study|Protocol Violation|2|||
125661539|NCT01682512|452049180|FG000|Overall Study|Primary lack of efficacy|10|||
125661540|NCT01682512|452049181|FG001|Overall Study|Primary lack of efficacy|7|||
125661541|NCT01682512|452049182|FG002|Overall Study|Primary lack of efficacy|7|||
125661542|NCT01682512|452049180|FG000|Overall Study|Secondary lack of efficacy|1|||
125661543|NCT01682512|452049181|FG001|Overall Study|Secondary lack of efficacy|1|||
125661544|NCT01682512|452049182|FG002|Overall Study|Secondary lack of efficacy|0|||
125661545|NCT01682512|452049180|FG000|Overall Study|Other than stated above|2|||
125661546|NCT01682512|452049181|FG001|Overall Study|Other than stated above|4|||
125661547|NCT01682512|452049182|FG002|Overall Study|Other than stated above|2|||
125661548|NCT00054275|452049183|FG000|Overall Study|Withdrawal by Subject|4|||
125661549|NCT00054275|452049183|FG000|Overall Study|Adverse Event|5|||
125661550|NCT00054275|452049183|FG000|Overall Study|Progressive disease in cycle 1|1|||
125661551|NCT00054275|452049183|FG000|Overall Study|Physician Decision|1|||
125661552|NCT02030834|452049191|FG000|Overall Study|Death|4|||
125661553|NCT02030834|452049192|FG001|Overall Study|Death|0|||
125661554|NCT02030834|452049193|FG002|Overall Study|Death|0|||
125661555|NCT02030834|452049191|FG000|Overall Study|Manufacturing failure|2|||
125661556|NCT02030834|452049192|FG001|Overall Study|Manufacturing failure|0|||
125318249|NCT03137992|450794059|FG004|Washout Period 1|Principal Investigator Discretion|0|||
125318250|NCT03137992|450794060|FG005|Washout Period 1|Principal Investigator Discretion|0|||
125318251|NCT03137992|450794055|FG000|Washout Period 1|COPD Exacerbation|1|||
125661557|NCT02030834|452049193|FG002|Overall Study|Manufacturing failure|1|||
125661558|NCT02030834|452049191|FG000|Overall Study|Disease progression|2|||
125661559|NCT02030834|452049192|FG001|Overall Study|Disease progression|0|||
125661560|NCT02030834|452049193|FG002|Overall Study|Disease progression|2|||
125661561|NCT02030834|452049191|FG000|Overall Study|Lost to Follow-up|1|||
125661562|NCT02030834|452049192|FG001|Overall Study|Lost to Follow-up|0|||
125661563|NCT02030834|452049193|FG002|Overall Study|Lost to Follow-up|0|||
125661564|NCT02030834|452049191|FG000|Overall Study|Withdrawal by Subject|1|||
125661565|NCT02030834|452049192|FG001|Overall Study|Withdrawal by Subject|0|||
125661566|NCT02030834|452049193|FG002|Overall Study|Withdrawal by Subject|0|||
125661567|NCT02030834|452049191|FG000|Overall Study|Lack of funding|1|||
125661568|NCT02030834|452049192|FG001|Overall Study|Lack of funding|0|||
125661569|NCT02030834|452049193|FG002|Overall Study|Lack of funding|0|||
125661570|NCT04333199|452049198|FG000|Evaluated Patients|Lost to Follow-up|0|||
125661571|NCT04333199|452049199|FG001|Evaluated Patients|Lost to Follow-up|1|||
125661572|NCT04333199|452049200|FG002|Evaluated Patients|Lost to Follow-up|2|||
125661573|NCT01155284|452049209|FG000|Overall Study|Withdrawal by Subject|4|||
125318252|NCT03137992|450794056|FG001|Washout Period 1|COPD Exacerbation|1|||
125661574|NCT01155284|452049210|FG001|Overall Study|Withdrawal by Subject|3|||
125661575|NCT01155284|452049209|FG000|Overall Study|Lost to Follow-up|1|||
125661576|NCT01155284|452049210|FG001|Overall Study|Lost to Follow-up|2|||
125661577|NCT01155284|452049209|FG000|Overall Study|Physician Decision|1|||
125661578|NCT01155284|452049210|FG001|Overall Study|Physician Decision|0|||
125661579|NCT01155284|452049209|FG000|Overall Study|Adverse Event|1|||
125661580|NCT01155284|452049210|FG001|Overall Study|Adverse Event|0|||
125661581|NCT01766310|452049211|FG000|Overall Study|Lost to Follow-up|1|||
125661582|NCT01766310|452049212|FG001|Overall Study|Lost to Follow-up|3|||
125661583|NCT01556490|452049221|FG000|Randomized Patients Summary|Protocol Violation|22|||
125661584|NCT01556490|452049222|FG001|Randomized Patients Summary|Protocol Violation|23|||
125661585|NCT01556490|452049221|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
125661586|NCT01556490|452049222|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
125661587|NCT04529499|452049228|FG000|Overall Study|Withdrawal by Subject|9|||
125661588|NCT04529499|452049229|FG001|Overall Study|Withdrawal by Subject|11|||
125661589|NCT04529499|452049228|FG000|Overall Study|Physician Decision|1|||
125661590|NCT04529499|452049229|FG001|Overall Study|Physician Decision|2|||
125661591|NCT04529499|452049228|FG000|Overall Study|Adverse Event|4|||
125661592|NCT04529499|452049229|FG001|Overall Study|Adverse Event|4|||
125661593|NCT04529499|452049228|FG000|Overall Study|Death|14|||
125661594|NCT04529499|452049229|FG001|Overall Study|Death|11|||
125661595|NCT04529499|452049228|FG000|Overall Study|Lost to Follow-up|1|||
125661596|NCT04529499|452049229|FG001|Overall Study|Lost to Follow-up|1|||
125661597|NCT04529499|452049228|FG000|Overall Study|Others|7|||
125661598|NCT04529499|452049229|FG001|Overall Study|Others|11|||
125661599|NCT00758706|452049230|FG000|Overall Study|Adverse Event|4|||
125661600|NCT00758706|452049231|FG001|Overall Study|Adverse Event|4|||
125661601|NCT01039584|452049232|FG000|Overall Study|Withdrawal by Subject|4|||
125661602|NCT01039584|452049233|FG001|Overall Study|Withdrawal by Subject|2|||
125661603|NCT01039584|452049234|FG002|Overall Study|Withdrawal by Subject|1|||
125661604|NCT01039584|452049232|FG000|Overall Study|Protocol Violation|10|||
125661605|NCT01039584|452049233|FG001|Overall Study|Protocol Violation|4|||
125661606|NCT01039584|452049234|FG002|Overall Study|Protocol Violation|6|||
125661607|NCT01039584|452049232|FG000|Overall Study|Lost to Follow-up|5|||
125661608|NCT01039584|452049233|FG001|Overall Study|Lost to Follow-up|3|||
125661609|NCT01039584|452049234|FG002|Overall Study|Lost to Follow-up|4|||
125661610|NCT01039584|452049232|FG000|Overall Study|Negative Baseline culture for Candida|59|||
125661611|NCT01039584|452049233|FG001|Overall Study|Negative Baseline culture for Candida|59|||
125661612|NCT01039584|452049234|FG002|Overall Study|Negative Baseline culture for Candida|24|||
125661613|NCT01039584|452049232|FG000|Overall Study|Lack of Efficacy|7|||
125661614|NCT01039584|452049233|FG001|Overall Study|Lack of Efficacy|6|||
125661615|NCT01039584|452049234|FG002|Overall Study|Lack of Efficacy|10|||
125661616|NCT01039584|452049232|FG000|Overall Study|other|1|||
125661617|NCT01039584|452049233|FG001|Overall Study|other|3|||
125661618|NCT01039584|452049234|FG002|Overall Study|other|1|||
125661619|NCT01039584|452049232|FG000|Overall Study|Pap smear with significant pathology|10|||
125661620|NCT01039584|452049233|FG001|Overall Study|Pap smear with significant pathology|10|||
125661621|NCT01039584|452049234|FG002|Overall Study|Pap smear with significant pathology|3|||
125661622|NCT01039584|452049232|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
125661623|NCT01039584|452049233|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
125661624|NCT01039584|452049234|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
125661625|NCT01494649|452049235|FG000|Overall Study|Lost to Follow-up|0|||
125661626|NCT01494649|452049236|FG001|Overall Study|Lost to Follow-up|1|||
125661627|NCT03467971|452049237|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125661628|NCT03467971|452049238|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125661629|NCT01174368|452049241|FG000|Overall Study|Withdrawal by Subject|1|||
125661630|NCT00000135|452049264|FG000|Overall Study|Death|27|||
125661631|NCT00000135|452049265|FG001|Overall Study|Death|14|||
125661632|NCT01311505|452049266|FG000|First Intervention Period|Protocol Violation|0|||
125661633|NCT01311505|452049267|FG001|First Intervention Period|Protocol Violation|1|||
125661634|NCT03022799|452049268|FG000|Overall Study|Adverse Event|0|||
125661635|NCT03022799|452049269|FG001|Overall Study|Adverse Event|0|||
125661636|NCT03022799|452049270|FG002|Overall Study|Adverse Event|0|||
125661637|NCT03022799|452049271|FG003|Overall Study|Adverse Event|0|||
125661638|NCT03022799|452049272|FG004|Overall Study|Adverse Event|0|||
125661639|NCT03022799|452049273|FG005|Overall Study|Adverse Event|0|||
125661640|NCT03022799|452049274|FG006|Overall Study|Adverse Event|0|||
125661641|NCT03022799|452049275|FG007|Overall Study|Adverse Event|0|||
125661642|NCT03022799|452049276|FG008|Overall Study|Adverse Event|0|||
125661643|NCT03022799|452049277|FG009|Overall Study|Adverse Event|1|||
125661644|NCT03022799|452049278|FG010|Overall Study|Adverse Event|1|||
125661645|NCT03022799|452049279|FG011|Overall Study|Adverse Event|0|||
125661646|NCT03022799|452049280|FG012|Overall Study|Adverse Event|0|||
125661647|NCT00759759|452049281|FG000|Overall Study|didn't return for period 2|1|||
125661648|NCT00759759|452049282|FG001|Overall Study|didn't return for period 2|0|||
125661649|NCT00759759|452049281|FG000|Overall Study|Didn't receive drug in period 2|1|||
125661650|NCT00759759|452049282|FG001|Overall Study|Didn't receive drug in period 2|0|||
125661651|NCT00759759|452049281|FG000|Overall Study|Withdrawal by Subject|2|||
125661652|NCT00759759|452049282|FG001|Overall Study|Withdrawal by Subject|1|||
125661653|NCT01211613|452050624|FG000|Overall Study|Lost to Follow-up|2|||
125661654|NCT01211613|452050625|FG001|Overall Study|Lost to Follow-up|2|||
125661655|NCT01211613|452050626|FG002|Overall Study|Lost to Follow-up|2|||
125661656|NCT01211613|452050624|FG000|Overall Study|Withdrawal by Subject|1|||
125661657|NCT01211613|452050625|FG001|Overall Study|Withdrawal by Subject|0|||
125661658|NCT01211613|452050626|FG002|Overall Study|Withdrawal by Subject|0|||
125661659|NCT03853213|452050627|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
125661660|NCT03853213|452050628|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
125661661|NCT03853213|452050627|FG000|Overall Study|Other (e.g., too busy)|0|||
125661662|NCT03853213|452050628|FG001|Overall Study|Other (e.g., too busy)|2|||
125661663|NCT01458132|452050629|FG000|Overall Study|Other|15|||
125661664|NCT01458132|452050630|FG001|Overall Study|Other|3|||
125318253|NCT03137992|450794057|FG002|Washout Period 1|COPD Exacerbation|1|||
125318254|NCT03137992|450794058|FG003|Washout Period 1|COPD Exacerbation|0|||
125318255|NCT03137992|450794059|FG004|Washout Period 1|COPD Exacerbation|1|||
125318256|NCT03137992|450794060|FG005|Washout Period 1|COPD Exacerbation|1|||
125318257|NCT03137992|450794055|FG000|Washout Period 1|Subject Noncompliance|1|||
125318258|NCT03137992|450794056|FG001|Washout Period 1|Subject Noncompliance|0|||
125318259|NCT03137992|450794057|FG002|Washout Period 1|Subject Noncompliance|0|||
125318260|NCT03137992|450794058|FG003|Washout Period 1|Subject Noncompliance|0|||
125318261|NCT03137992|450794059|FG004|Washout Period 1|Subject Noncompliance|1|||
125318262|NCT03137992|450794060|FG005|Washout Period 1|Subject Noncompliance|0|||
125318263|NCT03137992|450794055|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
125318264|NCT03137992|450794056|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
125318265|NCT03137992|450794057|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
125318266|NCT03137992|450794058|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
125318267|NCT03137992|450794059|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
125318268|NCT03137992|450794060|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
125318269|NCT03137992|450794055|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
125318270|NCT03137992|450794056|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
125661665|NCT00833976|452050631|FG000|Overall Study|Withdrawal by Subject|5|||
125661666|NCT00833976|452050631|FG000|Overall Study|Lost to Follow-up|4|||
125661667|NCT00833976|452050631|FG000|Overall Study|Did not meet eligibility criteria|41|||
125661668|NCT00833976|452050631|FG000|Overall Study|Physician Decision|1|||
125661669|NCT03911960|452050632|FG000|Overall Study|Lost to Follow-up|5|||
125661670|NCT03911960|452050633|FG001|Overall Study|Lost to Follow-up|3|||
125661671|NCT02239692|452050634|FG000|Overall Study|Incomplete colonoscopy|1|||
125661672|NCT02239692|452050635|FG001|Overall Study|Incomplete colonoscopy|2|||
125661673|NCT02239692|452050634|FG000|Overall Study|Adverse Event|0|||
125661674|NCT02239692|452050635|FG001|Overall Study|Adverse Event|1|||
125661675|NCT02239692|452050634|FG000|Overall Study|Physician Decision|0|||
125661676|NCT02239692|452050635|FG001|Overall Study|Physician Decision|1|||
125661677|NCT02239692|452050634|FG000|Overall Study|Lost to Follow-up|1|||
125661678|NCT02239692|452050635|FG001|Overall Study|Lost to Follow-up|4|||
125661679|NCT02239692|452050634|FG000|Overall Study|Withdrawal by Subject|3|||
125661680|NCT02239692|452050635|FG001|Overall Study|Withdrawal by Subject|5|||
125661681|NCT02239692|452050634|FG000|Overall Study|Other reason|1|||
125661682|NCT02239692|452050635|FG001|Overall Study|Other reason|0|||
125661683|NCT01614925|452050637|FG000|Overall Study|Withdrawal by Subject|1|||
125661684|NCT01614925|452050638|FG001|Overall Study|Withdrawal by Subject|0|||
125661685|NCT01614925|452050637|FG000|Overall Study|Protocol Violation|3|||
125661686|NCT01614925|452050638|FG001|Overall Study|Protocol Violation|2|||
125661687|NCT02437890|452050643|FG000|Overall Study|Non-compliance to study drug|0|||
125661688|NCT02437890|452050644|FG001|Overall Study|Non-compliance to study drug|1|||
125661689|NCT02437890|452050645|FG002|Overall Study|Non-compliance to study drug|0|||
125661690|NCT02437890|452050646|FG003|Overall Study|Non-compliance to study drug|0|||
125661691|NCT02437890|452050647|FG004|Overall Study|Non-compliance to study drug|1|||
125661692|NCT02437890|452050643|FG000|Overall Study|Sponsor's decision|1|||
125661693|NCT02437890|452050644|FG001|Overall Study|Sponsor's decision|1|||
125661694|NCT02437890|452050645|FG002|Overall Study|Sponsor's decision|4|||
125661695|NCT02437890|452050646|FG003|Overall Study|Sponsor's decision|0|||
125661696|NCT02437890|452050647|FG004|Overall Study|Sponsor's decision|2|||
125661697|NCT02437890|452050643|FG000|Overall Study|Physician Decision|0|||
125661698|NCT02437890|452050644|FG001|Overall Study|Physician Decision|0|||
125661699|NCT02437890|452050645|FG002|Overall Study|Physician Decision|0|||
125661700|NCT02437890|452050646|FG003|Overall Study|Physician Decision|1|||
125661701|NCT02437890|452050647|FG004|Overall Study|Physician Decision|0|||
125661702|NCT02437890|452050643|FG000|Overall Study|Unable to attend visit(s)|1|||
125661703|NCT02437890|452050644|FG001|Overall Study|Unable to attend visit(s)|0|||
125661704|NCT02437890|452050645|FG002|Overall Study|Unable to attend visit(s)|0|||
125661705|NCT02437890|452050646|FG003|Overall Study|Unable to attend visit(s)|0|||
125661706|NCT02437890|452050647|FG004|Overall Study|Unable to attend visit(s)|0|||
125661707|NCT02437890|452050643|FG000|Overall Study|Lack of Efficacy|1|||
125661708|NCT02437890|452050644|FG001|Overall Study|Lack of Efficacy|3|||
125661709|NCT02437890|452050645|FG002|Overall Study|Lack of Efficacy|0|||
125661710|NCT02437890|452050646|FG003|Overall Study|Lack of Efficacy|3|||
125661711|NCT02437890|452050647|FG004|Overall Study|Lack of Efficacy|1|||
125661712|NCT02437890|452050643|FG000|Overall Study|Adverse Event|4|||
125661713|NCT02437890|452050644|FG001|Overall Study|Adverse Event|9|||
125661714|NCT02437890|452050645|FG002|Overall Study|Adverse Event|5|||
125661715|NCT02437890|452050646|FG003|Overall Study|Adverse Event|11|||
125661716|NCT02437890|452050647|FG004|Overall Study|Adverse Event|7|||
125661717|NCT02437890|452050643|FG000|Overall Study|Withdrawal by Subject|1|||
125661718|NCT02437890|452050644|FG001|Overall Study|Withdrawal by Subject|2|||
125661719|NCT02437890|452050645|FG002|Overall Study|Withdrawal by Subject|6|||
125661720|NCT02437890|452050646|FG003|Overall Study|Withdrawal by Subject|5|||
125661721|NCT02437890|452050647|FG004|Overall Study|Withdrawal by Subject|5|||
125661722|NCT02437890|452050643|FG000|Overall Study|Death|0|||
125661723|NCT02437890|452050644|FG001|Overall Study|Death|0|||
125661724|NCT02437890|452050645|FG002|Overall Study|Death|0|||
125661725|NCT02437890|452050646|FG003|Overall Study|Death|2|||
125661726|NCT02437890|452050647|FG004|Overall Study|Death|0|||
125661727|NCT04723173|452050648|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
125661728|NCT02996448|452050649|FG000|Overall Study|Study terminated due to adverse effects|3|||
125661729|NCT01422720|452050650|FG000|Overall Study|Adverse Event|16|||
125661730|NCT01422720|452050650|FG000|Overall Study|Lack of Efficacy|1|||
125661731|NCT01422720|452050650|FG000|Overall Study|Withdrawal by Subject|4|||
125661732|NCT01422720|452050650|FG000|Overall Study|Ineligibility|1|||
125661733|NCT02082262|452050651|FG000|Overall Study|Withdrawal by Subject|3|||
125661734|NCT02082262|452050651|FG000|Overall Study|Adverse Event|48|||
125661735|NCT01586624|452050652|FG000|Overall Study|Adverse Event|3|||
125661736|NCT01586624|452050653|FG001|Overall Study|Adverse Event|0|||
125661737|NCT01586624|452050654|FG002|Overall Study|Adverse Event|2|||
125661738|NCT01586624|452050655|FG003|Overall Study|Adverse Event|1|||
125661739|NCT01586624|452050656|FG004|Overall Study|Adverse Event|3|||
125661740|NCT01586624|452050657|FG005|Overall Study|Adverse Event|3|||
125661741|NCT01586624|452050658|FG006|Overall Study|Adverse Event|2|||
125661742|NCT01586624|452050659|FG007|Overall Study|Adverse Event|3|||
125661743|NCT01586624|452050652|FG000|Overall Study|Physician Decision|0|||
125661744|NCT01586624|452050653|FG001|Overall Study|Physician Decision|1|||
125661745|NCT01586624|452050654|FG002|Overall Study|Physician Decision|1|||
125661746|NCT01586624|452050655|FG003|Overall Study|Physician Decision|0|||
125661747|NCT01586624|452050656|FG004|Overall Study|Physician Decision|2|||
125661748|NCT01586624|452050657|FG005|Overall Study|Physician Decision|0|||
125661749|NCT01586624|452050658|FG006|Overall Study|Physician Decision|1|||
125661750|NCT01586624|452050659|FG007|Overall Study|Physician Decision|1|||
125661751|NCT01586624|452050652|FG000|Overall Study|Withdrawal by Subject|0|||
125661752|NCT01586624|452050653|FG001|Overall Study|Withdrawal by Subject|0|||
125661753|NCT01586624|452050654|FG002|Overall Study|Withdrawal by Subject|0|||
125661754|NCT01586624|452050655|FG003|Overall Study|Withdrawal by Subject|1|||
125661755|NCT01586624|452050656|FG004|Overall Study|Withdrawal by Subject|0|||
125661756|NCT01586624|452050657|FG005|Overall Study|Withdrawal by Subject|0|||
125661757|NCT01586624|452050658|FG006|Overall Study|Withdrawal by Subject|0|||
125661758|NCT01586624|452050659|FG007|Overall Study|Withdrawal by Subject|0|||
125661759|NCT01586624|452050652|FG000|Overall Study|Evidence of disease progression|1|||
125661760|NCT01586624|452050653|FG001|Overall Study|Evidence of disease progression|3|||
125661761|NCT01586624|452050654|FG002|Overall Study|Evidence of disease progression|2|||
125661762|NCT01586624|452050655|FG003|Overall Study|Evidence of disease progression|5|||
125661763|NCT01586624|452050656|FG004|Overall Study|Evidence of disease progression|3|||
125661764|NCT01586624|452050657|FG005|Overall Study|Evidence of disease progression|5|||
125661765|NCT01586624|452050658|FG006|Overall Study|Evidence of disease progression|4|||
125661766|NCT01586624|452050659|FG007|Overall Study|Evidence of disease progression|6|||
125661767|NCT01586624|452050652|FG000|Overall Study|Screen failure (no treatment received)|0|||
125661768|NCT01586624|452050653|FG001|Overall Study|Screen failure (no treatment received)|0|||
125661769|NCT01586624|452050654|FG002|Overall Study|Screen failure (no treatment received)|0|||
125661770|NCT01586624|452050655|FG003|Overall Study|Screen failure (no treatment received)|0|||
125661771|NCT01586624|452050656|FG004|Overall Study|Screen failure (no treatment received)|0|||
125661772|NCT01586624|452050657|FG005|Overall Study|Screen failure (no treatment received)|0|||
125661773|NCT01586624|452050658|FG006|Overall Study|Screen failure (no treatment received)|1|||
125661774|NCT01586624|452050659|FG007|Overall Study|Screen failure (no treatment received)|0|||
125661775|NCT01074307|452050661|FG000|Overall Study|No primary endpoint evaluation|14|||
125318271|NCT03137992|450794057|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
125661776|NCT01074307|452050662|FG001|Overall Study|No primary endpoint evaluation|6|||
125661777|NCT01074307|452050661|FG000|Overall Study|Exclusion criterion|0|||
125661778|NCT01074307|452050662|FG001|Overall Study|Exclusion criterion|1|||
125661779|NCT01074307|452050661|FG000|Overall Study|Protocol Violation|8|||
125661780|NCT01074307|452050662|FG001|Overall Study|Protocol Violation|5|||
125661781|NCT02162511|452050667|FG000|Overall Study|Lack of Efficacy|0|||
125661782|NCT02162511|452050668|FG001|Overall Study|Lack of Efficacy|0|||
125661783|NCT02162511|452050669|FG002|Overall Study|Lack of Efficacy|2|||
125661784|NCT01160198|452050670|FG000|Overall Study|Withdrawal by Subject|2|||
125661785|NCT01160198|452050671|FG001|Overall Study|Withdrawal by Subject|1|||
125661786|NCT01160198|452050672|FG002|Overall Study|Withdrawal by Subject|0|||
125318272|NCT03137992|450794058|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
125318273|NCT03137992|450794059|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
125318274|NCT03137992|450794060|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
125318275|NCT03137992|450794055|FG000|Period 2 (Visit 3)|Adverse Event|0|||
125318276|NCT03137992|450794056|FG001|Period 2 (Visit 3)|Adverse Event|1|||
125318277|NCT03137992|450794057|FG002|Period 2 (Visit 3)|Adverse Event|0|||
125661787|NCT01160198|452050670|FG000|Overall Study|Adverse Event|0|||
125661788|NCT01160198|452050671|FG001|Overall Study|Adverse Event|1|||
125661789|NCT01160198|452050672|FG002|Overall Study|Adverse Event|0|||
125661790|NCT01160198|452050670|FG000|Overall Study|Lost to Follow-up|0|||
125661791|NCT01160198|452050671|FG001|Overall Study|Lost to Follow-up|1|||
125661792|NCT01160198|452050672|FG002|Overall Study|Lost to Follow-up|0|||
125661793|NCT01160198|452050670|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
125661794|NCT01160198|452050671|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
125661795|NCT01160198|452050672|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
125318278|NCT03137992|450794058|FG003|Period 2 (Visit 3)|Adverse Event|0|||
125318279|NCT03137992|450794059|FG004|Period 2 (Visit 3)|Adverse Event|0|||
125318280|NCT03137992|450794060|FG005|Period 2 (Visit 3)|Adverse Event|0|||
125318281|NCT03137992|450794055|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
125661796|NCT01286207|452050674|FG000|Overall Study|Adverse Event|27|||
125661797|NCT01286207|452050675|FG001|Overall Study|Adverse Event|41|||
125661798|NCT01286207|452050676|FG002|Overall Study|Adverse Event|8|||
125661799|NCT01286207|452050674|FG000|Overall Study|Lost to Follow-up|49|||
125661800|NCT01286207|452050675|FG001|Overall Study|Lost to Follow-up|43|||
125661801|NCT01286207|452050676|FG002|Overall Study|Lost to Follow-up|20|||
125661802|NCT01286207|452050674|FG000|Overall Study|Withdrawal by Subject|93|||
125661803|NCT01286207|452050675|FG001|Overall Study|Withdrawal by Subject|79|||
125661804|NCT01286207|452050676|FG002|Overall Study|Withdrawal by Subject|41|||
125661805|NCT01286207|452050674|FG000|Overall Study|Lack of Response|92|||
125661806|NCT01286207|452050675|FG001|Overall Study|Lack of Response|38|||
125661807|NCT01286207|452050676|FG002|Overall Study|Lack of Response|8|||
125661808|NCT01286207|452050674|FG000|Overall Study|Other|37|||
125661809|NCT01286207|452050675|FG001|Overall Study|Other|47|||
125661810|NCT01286207|452050676|FG002|Overall Study|Other|13|||
125661811|NCT01383954|452050677|FG000|Overall Study|Lack of Efficacy|2|||
125661812|NCT01383954|452050677|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
125661813|NCT01383954|452050677|FG000|Overall Study|Adverse Event|1|||
125661814|NCT01383954|452050677|FG000|Overall Study|Reason Not Specified|9|||
125661815|NCT00450177|452050678|FG000|Overall Study|Adverse Event|7|||
125661816|NCT00450177|452050679|FG001|Overall Study|Adverse Event|4|||
125661817|NCT00450177|452050678|FG000|Overall Study|Withdrawal by Subject|1|||
125661818|NCT00450177|452050679|FG001|Overall Study|Withdrawal by Subject|6|||
125661819|NCT00450177|452050678|FG000|Overall Study|Withdrawal by Primary Team|1|||
125318282|NCT03137992|450794056|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
125318283|NCT03137992|450794057|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
125318284|NCT03137992|450794058|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
125661820|NCT00450177|452050679|FG001|Overall Study|Withdrawal by Primary Team|1|||
125661821|NCT00763269|452050681|FG000|Overall Study|Lost to Follow-up|12|||
125661822|NCT00763269|452050682|FG001|Overall Study|Lost to Follow-up|13|||
125661823|NCT03174925|452050685|FG000|Overall Study|Elastographic images not retrievable|2|||
125661824|NCT03174925|452050685|FG000|Overall Study|Elastography image not interpretable|1|||
125661825|NCT04247594|452050688|FG000|Overall Study|Withdrawal by Subject|4|||
125661826|NCT02609178|452050691|FG000|First Crown|Withdrawal by Subject|0|||
125661827|NCT02609178|452050692|FG001|First Crown|Withdrawal by Subject|0|||
125661828|NCT02609178|452050693|FG002|First Crown|Withdrawal by Subject|1|||
125661829|NCT02609178|452050694|FG003|First Crown|Withdrawal by Subject|1|||
125661830|NCT02609178|452050695|FG004|First Crown|Withdrawal by Subject|0|||
125661831|NCT02609178|452050696|FG005|First Crown|Withdrawal by Subject|0|||
125661832|NCT01128153|452050697|FG000|Overall Study|Adverse Event|1|||
125661833|NCT01128153|452050698|FG001|Overall Study|Adverse Event|3|||
125661834|NCT01128153|452050697|FG000|Overall Study|Condition under investigation worsened|8|||
125318285|NCT03137992|450794059|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
125318286|NCT03137992|450794060|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
125318287|NCT03137992|450794055|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
125318288|NCT03137992|450794056|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
125318289|NCT03137992|450794057|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
125318290|NCT03137992|450794058|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
125318291|NCT03137992|450794059|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
125318292|NCT03137992|450794060|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
125318293|NCT03137992|450794055|FG000|Washout Period 2|COPD Exacerbation|1|||
125318294|NCT03137992|450794056|FG001|Washout Period 2|COPD Exacerbation|1|||
125661835|NCT01128153|452050698|FG001|Overall Study|Condition under investigation worsened|7|||
125661836|NCT01128153|452050697|FG000|Overall Study|Withdrawal by Subject|2|||
125661837|NCT01128153|452050698|FG001|Overall Study|Withdrawal by Subject|3|||
125661838|NCT01128153|452050697|FG000|Overall Study|Incorrect enrolment to study|2|||
125661839|NCT01128153|452050698|FG001|Overall Study|Incorrect enrolment to study|1|||
125318295|NCT03137992|450794057|FG002|Washout Period 2|COPD Exacerbation|0|||
125318296|NCT03137992|450794058|FG003|Washout Period 2|COPD Exacerbation|0|||
125318297|NCT03137992|450794059|FG004|Washout Period 2|COPD Exacerbation|1|||
125318298|NCT03137992|450794060|FG005|Washout Period 2|COPD Exacerbation|0|||
125661840|NCT01128153|452050697|FG000|Overall Study|Protocol Violation|2|||
125661841|NCT01128153|452050698|FG001|Overall Study|Protocol Violation|0|||
125661842|NCT01128153|452050697|FG000|Overall Study|Developed discontinuation criteria|1|||
125661843|NCT01128153|452050698|FG001|Overall Study|Developed discontinuation criteria|1|||
125661844|NCT03451331|452050699|FG000|Overall Study|Withdrawal by Subject|1|||
125661845|NCT03451331|452050700|FG001|Overall Study|Withdrawal by Subject|0|||
125661846|NCT03451331|452050699|FG000|Overall Study|Unable to start treatment.|1|||
125661847|NCT03451331|452050700|FG001|Overall Study|Unable to start treatment.|1|||
125661848|NCT00572156|452050701|FG000|Overall Study|Adverse Event|3|||
125661849|NCT00572156|452050702|FG001|Overall Study|Adverse Event|1|||
125661850|NCT00572156|452050703|FG002|Overall Study|Adverse Event|5|||
125661851|NCT00572156|452050704|FG003|Overall Study|Adverse Event|1|||
125661852|NCT00572156|452050701|FG000|Overall Study|Lost to Follow-up|1|||
125661853|NCT00572156|452050702|FG001|Overall Study|Lost to Follow-up|1|||
125661854|NCT00572156|452050703|FG002|Overall Study|Lost to Follow-up|1|||
125661855|NCT00572156|452050704|FG003|Overall Study|Lost to Follow-up|0|||
125661856|NCT00572156|452050701|FG000|Overall Study|Protocol Violation|1|||
125661857|NCT00572156|452050702|FG001|Overall Study|Protocol Violation|2|||
125661858|NCT00572156|452050703|FG002|Overall Study|Protocol Violation|0|||
125661859|NCT00572156|452050704|FG003|Overall Study|Protocol Violation|2|||
125661860|NCT00572156|452050701|FG000|Overall Study|Patient/Parent Decision|1|||
125661861|NCT00572156|452050702|FG001|Overall Study|Patient/Parent Decision|6|||
125661862|NCT00572156|452050703|FG002|Overall Study|Patient/Parent Decision|4|||
125661863|NCT00572156|452050704|FG003|Overall Study|Patient/Parent Decision|3|||
125661864|NCT00572156|452050701|FG000|Overall Study|Sponsor Decision|20|||
125661865|NCT00572156|452050702|FG001|Overall Study|Sponsor Decision|16|||
125661866|NCT00572156|452050703|FG002|Overall Study|Sponsor Decision|17|||
125661867|NCT00572156|452050704|FG003|Overall Study|Sponsor Decision|19|||
125661868|NCT02261974|452050705|FG000|Overall Study|Withdrawal by Subject|3|||
125661869|NCT02261974|452050706|FG001|Overall Study|Withdrawal by Subject|2|||
125661870|NCT02261974|452050705|FG000|Overall Study|Pregnancy|0|||
125661871|NCT02261974|452050706|FG001|Overall Study|Pregnancy|1|||
125661872|NCT02261974|452050705|FG000|Overall Study|Missed treatment cut-off date|6|||
125661873|NCT02261974|452050706|FG001|Overall Study|Missed treatment cut-off date|3|||
125661874|NCT02261974|452050705|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
125661875|NCT02261974|452050706|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
125661876|NCT02261974|452050705|FG000|Overall Study|Lost to Follow-up|2|||
125661877|NCT02261974|452050706|FG001|Overall Study|Lost to Follow-up|0|||
125661878|NCT02261974|452050705|FG000|Overall Study|Adverse Event|1|||
125661879|NCT02261974|452050706|FG001|Overall Study|Adverse Event|0|||
125661880|NCT01347879|452050707|FG000|Overall Study|Adverse Event|0|||
125661881|NCT01347879|452050708|FG001|Overall Study|Adverse Event|12|||
125661882|NCT01347879|452050707|FG000|Overall Study|Lost to Follow-up|2|||
125661883|NCT01347879|452050708|FG001|Overall Study|Lost to Follow-up|0|||
125661884|NCT01347879|452050707|FG000|Overall Study|Withdrawal by Subject|3|||
125661885|NCT01347879|452050708|FG001|Overall Study|Withdrawal by Subject|2|||
125661886|NCT01347879|452050707|FG000|Overall Study|Other|2|||
125661887|NCT01347879|452050708|FG001|Overall Study|Other|3|||
125661888|NCT01238822|452050711|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
125661889|NCT00996918|452050712|FG000|Overall Study|Lack of Efficacy|1|||
125661890|NCT00996918|452050713|FG001|Overall Study|Lack of Efficacy|1|||
125318299|NCT03137992|450794055|FG000|Washout Period 2|Subject Non-compliance|0|||
125318300|NCT03137992|450794056|FG001|Washout Period 2|Subject Non-compliance|1|||
125318301|NCT03137992|450794057|FG002|Washout Period 2|Subject Non-compliance|0|||
125318302|NCT03137992|450794058|FG003|Washout Period 2|Subject Non-compliance|0|||
125318303|NCT03137992|450794059|FG004|Washout Period 2|Subject Non-compliance|0|||
125318304|NCT03137992|450794060|FG005|Washout Period 2|Subject Non-compliance|0|||
125318305|NCT03137992|450794055|FG000|Washout Period 2|Adverse Event|0|||
125318306|NCT03137992|450794056|FG001|Washout Period 2|Adverse Event|0|||
125661891|NCT00996918|452050714|FG002|Overall Study|Lack of Efficacy|2|||
125661892|NCT00996918|452050715|FG003|Overall Study|Lack of Efficacy|2|||
125661893|NCT00996918|452050716|FG004|Overall Study|Lack of Efficacy|0|||
125318307|NCT03137992|450794057|FG002|Washout Period 2|Adverse Event|0|||
125318308|NCT03137992|450794058|FG003|Washout Period 2|Adverse Event|1|||
125318309|NCT03137992|450794059|FG004|Washout Period 2|Adverse Event|1|||
125318310|NCT03137992|450794060|FG005|Washout Period 2|Adverse Event|0|||
125661894|NCT00996918|452050712|FG000|Overall Study|Adverse Event|2|||
125661895|NCT00996918|452050713|FG001|Overall Study|Adverse Event|5|||
125661896|NCT00996918|452050714|FG002|Overall Study|Adverse Event|2|||
125661897|NCT00996918|452050715|FG003|Overall Study|Adverse Event|6|||
125661898|NCT00996918|452050716|FG004|Overall Study|Adverse Event|0|||
125661899|NCT00996918|452050712|FG000|Overall Study|Withdrawal by Subject|1|||
125661900|NCT00996918|452050713|FG001|Overall Study|Withdrawal by Subject|4|||
125661901|NCT00996918|452050714|FG002|Overall Study|Withdrawal by Subject|3|||
125661902|NCT00996918|452050715|FG003|Overall Study|Withdrawal by Subject|3|||
125661903|NCT00996918|452050716|FG004|Overall Study|Withdrawal by Subject|2|||
125661904|NCT00996918|452050712|FG000|Overall Study|Physician Decision|1|||
125661905|NCT00996918|452050713|FG001|Overall Study|Physician Decision|0|||
125661906|NCT00996918|452050714|FG002|Overall Study|Physician Decision|0|||
125661907|NCT00996918|452050715|FG003|Overall Study|Physician Decision|0|||
125661908|NCT00996918|452050716|FG004|Overall Study|Physician Decision|0|||
125661909|NCT00996918|452050712|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
125661910|NCT00996918|452050713|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
125661911|NCT00996918|452050714|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
125661912|NCT00996918|452050715|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
125661913|NCT00996918|452050716|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
125661914|NCT00996918|452050712|FG000|Overall Study|Loss of Caregiver|0|||
125661915|NCT00996918|452050713|FG001|Overall Study|Loss of Caregiver|1|||
125661916|NCT00996918|452050714|FG002|Overall Study|Loss of Caregiver|0|||
125661917|NCT00996918|452050715|FG003|Overall Study|Loss of Caregiver|0|||
125661918|NCT00996918|452050716|FG004|Overall Study|Loss of Caregiver|0|||
125661919|NCT00996918|452050712|FG000|Overall Study|Other|3|||
125661920|NCT00996918|452050713|FG001|Overall Study|Other|1|||
125661921|NCT00996918|452050714|FG002|Overall Study|Other|0|||
125661922|NCT00996918|452050715|FG003|Overall Study|Other|0|||
125661923|NCT00996918|452050716|FG004|Overall Study|Other|0|||
125661924|NCT04440007|452050721|FG000|Overall Study|Adverse Event|0|||
125661925|NCT04440007|452050722|FG001|Overall Study|Adverse Event|1|||
125661926|NCT04440007|452050721|FG000|Overall Study|Lost to Follow-up|1|||
125661927|NCT04440007|452050722|FG001|Overall Study|Lost to Follow-up|3|||
125661928|NCT04440007|452050721|FG000|Overall Study|Death|7|||
125661929|NCT04440007|452050722|FG001|Overall Study|Death|2|||
125661930|NCT04440007|452050721|FG000|Overall Study|Physician Decision|1|||
125661931|NCT04440007|452050722|FG001|Overall Study|Physician Decision|1|||
125661932|NCT04440007|452050721|FG000|Overall Study|Withdrawal by Subject|2|||
125661933|NCT04440007|452050722|FG001|Overall Study|Withdrawal by Subject|1|||
125661934|NCT04440007|452050721|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
125661935|NCT04440007|452050722|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
125661936|NCT04440007|452050721|FG000|Overall Study|Discontinued prior to dosing|0|||
125661937|NCT04440007|452050722|FG001|Overall Study|Discontinued prior to dosing|2|||
125661938|NCT01466673|452050723|FG000|Overall Study|Non-compliance with study treatment|2|||
125661939|NCT01466673|452050724|FG001|Overall Study|Non-compliance with study treatment|0|||
125661940|NCT01466673|452050723|FG000|Overall Study|Lost to Follow-up|3|||
125661941|NCT01466673|452050724|FG001|Overall Study|Lost to Follow-up|5|||
125661942|NCT01466673|452050723|FG000|Overall Study|Adverse Event|2|||
125661943|NCT01466673|452050724|FG001|Overall Study|Adverse Event|1|||
125661944|NCT00854607|452050725|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
125661945|NCT03959137|452050728|FG000|Overall Study|Protocol Violation|6|||
125661946|NCT00190684|452050729|FG000|Overall Study|Adverse Event|86|||
125661947|NCT00190684|452050729|FG000|Overall Study|Satisfactory response|80|||
125661948|NCT00190684|452050729|FG000|Overall Study|Lack of efficacy|204|||
125661949|NCT00190684|452050729|FG000|Overall Study|Lost to Follow-up|232|||
125661950|NCT00190684|452050729|FG000|Overall Study|Patient moved|60|||
125661951|NCT00190684|452050729|FG000|Overall Study|Patient Decision|432|||
125661952|NCT00190684|452050729|FG000|Overall Study|Clinical relapse|67|||
125661953|NCT00190684|452050729|FG000|Overall Study|Sponsor's decision|17|||
125661954|NCT00190684|452050729|FG000|Overall Study|Physician Decision|84|||
125661955|NCT00190684|452050729|FG000|Overall Study|Protocol Violation|123|||
125661956|NCT00190684|452050729|FG000|Overall Study|Study Period III Completed|103|||
125661957|NCT00190684|452050729|FG000|Overall Study|Study Period V Completed|1|||
125661958|NCT00829439|452050735|FG000|Overall Study|Adverse Event|0|||
125661959|NCT00829439|452050736|FG001|Overall Study|Adverse Event|0|||
125661960|NCT00829439|452050737|FG002|Overall Study|Adverse Event|1|||
125661961|NCT00829439|452050738|FG003|Overall Study|Adverse Event|0|||
125661962|NCT00123487|452050739|FG000|Randomized|Death prior to starting treatment|0|||
125661963|NCT00123487|452050740|FG001|Randomized|Death prior to starting treatment|1|||
125661964|NCT00123487|452050739|FG000|Randomized|SAE prior to starting treatment|1|||
125661965|NCT00123487|452050740|FG001|Randomized|SAE prior to starting treatment|0|||
125661966|NCT00123487|452050739|FG000|Treated With Study Drug|Adverse Event|23|||
125661967|NCT00123487|452050740|FG001|Treated With Study Drug|Adverse Event|22|||
125661968|NCT00123487|452050739|FG000|Treated With Study Drug|Disease Progression|141|||
125661969|NCT00123487|452050740|FG001|Treated With Study Drug|Disease Progression|122|||
125661970|NCT00123487|452050739|FG000|Treated With Study Drug|Physician Decision|8|||
125661971|NCT00123487|452050740|FG001|Treated With Study Drug|Physician Decision|9|||
125661972|NCT00123487|452050739|FG000|Treated With Study Drug|Other|59|||
125661973|NCT00123487|452050740|FG001|Treated With Study Drug|Other|58|||
125661974|NCT00123487|452050739|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
125661975|NCT00123487|452050740|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
125661976|NCT00123487|452050739|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
125661977|NCT00123487|452050740|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
125661978|NCT00123487|452050739|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
125661979|NCT00123487|452050740|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
125661980|NCT00995488|452050741|FG000|Overall Study|Withdrawal by Subject|1|||
125661981|NCT03672396|452050744|FG000|Overall Study|Withdrawal by Subject|4|||
125661982|NCT03672396|452050744|FG000|Overall Study|Physician Decision|1|||
125661983|NCT03672396|452050744|FG000|Overall Study|Adverse Event|1|||
125661984|NCT04639310|452050749|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
125661985|NCT04639310|452050750|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
125661986|NCT01408576|452052376|FG000|Overall Study|Lack of Efficacy|17|||
125661987|NCT01408576|452052377|FG001|Overall Study|Lack of Efficacy|30|||
125661988|NCT01408576|452052378|FG002|Overall Study|Lack of Efficacy|48|||
125661989|NCT01408576|452052376|FG000|Overall Study|Protocol Violation|1|||
125661990|NCT01408576|452052377|FG001|Overall Study|Protocol Violation|2|||
125661991|NCT01408576|452052378|FG002|Overall Study|Protocol Violation|2|||
125661992|NCT01408576|452052376|FG000|Overall Study|Lost to Follow-up|10|||
125661993|NCT01408576|452052377|FG001|Overall Study|Lost to Follow-up|9|||
125661994|NCT01408576|452052378|FG002|Overall Study|Lost to Follow-up|17|||
125661995|NCT01408576|452052376|FG000|Overall Study|Withdrawal by Subject|34|||
125661996|NCT01408576|452052377|FG001|Overall Study|Withdrawal by Subject|60|||
125318311|NCT03137992|450794055|FG000|Washout Period 2|Withdrawal by Subject|1|||
125318312|NCT03137992|450794056|FG001|Washout Period 2|Withdrawal by Subject|0|||
125318313|NCT03137992|450794057|FG002|Washout Period 2|Withdrawal by Subject|0|||
125318314|NCT03137992|450794058|FG003|Washout Period 2|Withdrawal by Subject|0|||
125318315|NCT03137992|450794059|FG004|Washout Period 2|Withdrawal by Subject|1|||
125318316|NCT03137992|450794060|FG005|Washout Period 2|Withdrawal by Subject|0|||
125661997|NCT01408576|452052378|FG002|Overall Study|Withdrawal by Subject|66|||
125661998|NCT01408576|452052376|FG000|Overall Study|Sponsor terminated study|89|||
125661999|NCT01408576|452052377|FG001|Overall Study|Sponsor terminated study|333|||
125662000|NCT01408576|452052378|FG002|Overall Study|Sponsor terminated study|330|||
125318317|NCT03137992|450794055|FG000|Washout Period 2|Sponsor Decision|0|||
125318318|NCT03137992|450794056|FG001|Washout Period 2|Sponsor Decision|0|||
125318319|NCT03137992|450794057|FG002|Washout Period 2|Sponsor Decision|0|||
125662001|NCT01408576|452052376|FG000|Overall Study|AE, serious fatal|4|||
125662002|NCT01408576|452052377|FG001|Overall Study|AE, serious fatal|4|||
125662003|NCT01408576|452052378|FG002|Overall Study|AE, serious fatal|1|||
125318320|NCT03137992|450794058|FG003|Washout Period 2|Sponsor Decision|0|||
125318321|NCT03137992|450794059|FG004|Washout Period 2|Sponsor Decision|0|||
125318322|NCT03137992|450794060|FG005|Washout Period 2|Sponsor Decision|1|||
125318323|NCT03137992|450794055|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
125318324|NCT03137992|450794056|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
125318325|NCT03137992|450794057|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
125318326|NCT03137992|450794058|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
125318327|NCT03137992|450794059|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
125662004|NCT01408576|452052376|FG000|Overall Study|SAE, non-fatal|11|||
125662005|NCT01408576|452052377|FG001|Overall Study|SAE, non-fatal|23|||
125662006|NCT01408576|452052378|FG002|Overall Study|SAE, non-fatal|14|||
125662007|NCT01408576|452052376|FG000|Overall Study|AE, non-serious non-fatal|12|||
125662008|NCT01408576|452052377|FG001|Overall Study|AE, non-serious non-fatal|19|||
125662009|NCT01408576|452052378|FG002|Overall Study|AE, non-serious non-fatal|11|||
125662010|NCT01408576|452052376|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
125662011|NCT01408576|452052377|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125662012|NCT01408576|452052378|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125662013|NCT01408576|452052376|FG000|Overall Study|AE, unknown type|0|||
125662014|NCT01408576|452052377|FG001|Overall Study|AE, unknown type|1|||
125662015|NCT01408576|452052378|FG002|Overall Study|AE, unknown type|0|||
125662016|NCT01408576|452052376|FG000|Overall Study|Other|10|||
125662017|NCT01408576|452052377|FG001|Overall Study|Other|16|||
125662018|NCT01408576|452052378|FG002|Overall Study|Other|18|||
125662019|NCT00802529|452052379|FG000|Overall Study|Lost to Follow-up|0|||
125662020|NCT00802529|452052380|FG001|Overall Study|Lost to Follow-up|1|||
125662021|NCT00563524|452052388|FG000|Overall Study|Adverse Event|0|||
125662022|NCT00563524|452052389|FG001|Overall Study|Adverse Event|1|||
125662023|NCT00563524|452052390|FG002|Overall Study|Adverse Event|0|||
125662024|NCT00563524|452052391|FG003|Overall Study|Adverse Event|0|||
125662025|NCT00563524|452052392|FG004|Overall Study|Adverse Event|2|||
125662026|NCT00563524|452052393|FG005|Overall Study|Adverse Event|0|||
125662027|NCT00563524|452052388|FG000|Overall Study|Lost to Follow-up|1|||
125662028|NCT00563524|452052389|FG001|Overall Study|Lost to Follow-up|0|||
125662029|NCT00563524|452052390|FG002|Overall Study|Lost to Follow-up|0|||
125662030|NCT00563524|452052391|FG003|Overall Study|Lost to Follow-up|0|||
125318328|NCT03137992|450794060|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
125662031|NCT00563524|452052392|FG004|Overall Study|Lost to Follow-up|0|||
125662032|NCT00563524|452052393|FG005|Overall Study|Lost to Follow-up|0|||
125662033|NCT00563524|452052388|FG000|Overall Study|Protocol Violation|0|||
125662034|NCT00563524|452052389|FG001|Overall Study|Protocol Violation|1|||
125662035|NCT00563524|452052390|FG002|Overall Study|Protocol Violation|0|||
125318329|NCT03137992|450794055|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
125318330|NCT03137992|450794056|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
125318331|NCT03137992|450794057|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
125318332|NCT03137992|450794058|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
125318333|NCT03137992|450794059|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
125318334|NCT03137992|450794060|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
125662036|NCT00563524|452052391|FG003|Overall Study|Protocol Violation|0|||
125662037|NCT00563524|452052392|FG004|Overall Study|Protocol Violation|0|||
125318335|NCT03137992|450794055|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
125318336|NCT03137992|450794056|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
125318337|NCT03137992|450794057|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
125662038|NCT00563524|452052393|FG005|Overall Study|Protocol Violation|0|||
125662039|NCT00563524|452052388|FG000|Overall Study|Withdrawal by Subject|1|||
125662040|NCT00563524|452052389|FG001|Overall Study|Withdrawal by Subject|1|||
125662041|NCT00563524|452052390|FG002|Overall Study|Withdrawal by Subject|3|||
125662042|NCT00563524|452052391|FG003|Overall Study|Withdrawal by Subject|0|||
125662043|NCT00563524|452052392|FG004|Overall Study|Withdrawal by Subject|0|||
125662044|NCT00563524|452052393|FG005|Overall Study|Withdrawal by Subject|1|||
125662045|NCT00817778|452052397|FG000|Overall Study|Adverse Event|1|||
125662046|NCT00817778|452052398|FG001|Overall Study|Adverse Event|0|||
125662047|NCT00817778|452052397|FG000|Overall Study|Withdrawal by Subject|1|||
125662048|NCT00817778|452052398|FG001|Overall Study|Withdrawal by Subject|1|||
125662049|NCT00817778|452052397|FG000|Overall Study|Protocol Violation|0|||
125662050|NCT00817778|452052398|FG001|Overall Study|Protocol Violation|1|||
125662051|NCT00817778|452052397|FG000|Overall Study|Study-specific discontinuation criteria|0|||
125662052|NCT00817778|452052398|FG001|Overall Study|Study-specific discontinuation criteria|1|||
125662053|NCT00817778|452052397|FG000|Overall Study|Poor venous access|1|||
125662054|NCT00817778|452052398|FG001|Overall Study|Poor venous access|0|||
125662055|NCT02360397|452052400|FG000|Overall Study|Incomplete screening|3|||
125662056|NCT02360397|452052400|FG000|Overall Study|Adverse Event|1|||
125662057|NCT01537549|452052401|FG000|Overall Study|Lost to Follow-up|1|||
125662058|NCT01537549|452052401|FG000|Overall Study|Withdrawal by Subject|2|||
125662059|NCT02923115|452052409|FG000|Overall Study|Lost to Follow-up|0|||
125662060|NCT02923115|452052410|FG001|Overall Study|Lost to Follow-up|0|||
125662061|NCT02923115|452052411|FG002|Overall Study|Lost to Follow-up|0|||
125662062|NCT02923115|452052412|FG003|Overall Study|Lost to Follow-up|1|||
125662063|NCT02923115|452052413|FG004|Overall Study|Lost to Follow-up|0|||
125662064|NCT02923115|452052414|FG005|Overall Study|Lost to Follow-up|0|||
125662065|NCT02923115|452052409|FG000|Overall Study|Withdrawal by Subject|0|||
125662066|NCT02923115|452052410|FG001|Overall Study|Withdrawal by Subject|1|||
125662067|NCT02923115|452052411|FG002|Overall Study|Withdrawal by Subject|0|||
125662068|NCT02923115|452052412|FG003|Overall Study|Withdrawal by Subject|0|||
125662069|NCT02923115|452052413|FG004|Overall Study|Withdrawal by Subject|0|||
125662070|NCT02923115|452052414|FG005|Overall Study|Withdrawal by Subject|0|||
125662071|NCT02923115|452052409|FG000|Overall Study|Randomized, but not dosed|0|||
125662072|NCT02923115|452052410|FG001|Overall Study|Randomized, but not dosed|0|||
125662073|NCT02923115|452052411|FG002|Overall Study|Randomized, but not dosed|3|||
125662074|NCT02923115|452052412|FG003|Overall Study|Randomized, but not dosed|1|||
125662075|NCT02923115|452052413|FG004|Overall Study|Randomized, but not dosed|5|||
125662076|NCT02923115|452052414|FG005|Overall Study|Randomized, but not dosed|0|||
125662077|NCT04056299|452052415|FG000|Overall Study|Sponsor discontinued study|3|||
125662078|NCT04056299|452052416|FG001|Overall Study|Sponsor discontinued study|3|||
125662079|NCT00068406|452052418|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
125662080|NCT00068406|452052418|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
125662081|NCT03231709|452052419|FG000|Treatment Period 1|Reason not Specified|0|||
125662082|NCT03231709|452052420|FG001|Treatment Period 1|Reason not Specified|1|||
125662083|NCT03231709|452052419|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
125662084|NCT03231709|452052420|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
125662085|NCT01875991|452052421|FG000|Overall Study|Withdrawal by Subject|6|||
125662086|NCT01875991|452052422|FG001|Overall Study|Withdrawal by Subject|6|||
125662087|NCT01875991|452052421|FG000|Overall Study|Sponsor Decision|1|||
125662088|NCT01875991|452052422|FG001|Overall Study|Sponsor Decision|0|||
125662089|NCT02419469|452052423|FG000|Overall Study|Withdrawal by Subject|1|||
125662090|NCT02454972|452052424|FG000|Overall Study|Progressive disease|17|||
125662091|NCT02454972|452052425|FG001|Overall Study|Progressive disease|16|||
125662092|NCT02454972|452052426|FG002|Overall Study|Progressive disease|59|||
125662093|NCT02454972|452052427|FG003|Overall Study|Progressive disease|23|||
125662094|NCT02454972|452052428|FG004|Overall Study|Progressive disease|16|||
125662095|NCT02454972|452052429|FG005|Overall Study|Progressive disease|12|||
125662096|NCT02454972|452052430|FG006|Overall Study|Progressive disease|19|||
125662097|NCT02454972|452052431|FG007|Overall Study|Progressive disease|27|||
125662098|NCT02454972|452052432|FG008|Overall Study|Progressive disease|0|||
125662099|NCT02454972|452052424|FG000|Overall Study|Death|0|||
125662100|NCT02454972|452052425|FG001|Overall Study|Death|0|||
125662101|NCT02454972|452052426|FG002|Overall Study|Death|5|||
125662102|NCT02454972|452052427|FG003|Overall Study|Death|1|||
125662103|NCT02454972|452052428|FG004|Overall Study|Death|0|||
125662104|NCT02454972|452052429|FG005|Overall Study|Death|0|||
125662105|NCT02454972|452052430|FG006|Overall Study|Death|0|||
125662106|NCT02454972|452052431|FG007|Overall Study|Death|0|||
125662107|NCT02454972|452052432|FG008|Overall Study|Death|95|||
125662108|NCT02454972|452052424|FG000|Overall Study|Physician Decision|0|||
125662109|NCT02454972|452052425|FG001|Overall Study|Physician Decision|1|||
125662110|NCT02454972|452052426|FG002|Overall Study|Physician Decision|2|||
125662111|NCT02454972|452052427|FG003|Overall Study|Physician Decision|1|||
125662112|NCT02454972|452052428|FG004|Overall Study|Physician Decision|2|||
125662113|NCT02454972|452052429|FG005|Overall Study|Physician Decision|0|||
125662114|NCT02454972|452052430|FG006|Overall Study|Physician Decision|0|||
125662115|NCT02454972|452052431|FG007|Overall Study|Physician Decision|1|||
125662116|NCT02454972|452052432|FG008|Overall Study|Physician Decision|0|||
125318338|NCT03137992|450794058|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
125662117|NCT02454972|452052424|FG000|Overall Study|Non treatment-related adverse event|2|||
125662118|NCT02454972|452052425|FG001|Overall Study|Non treatment-related adverse event|0|||
125318339|NCT03137992|450794059|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
125662119|NCT02454972|452052426|FG002|Overall Study|Non treatment-related adverse event|1|||
125662120|NCT02454972|452052427|FG003|Overall Study|Non treatment-related adverse event|0|||
125662121|NCT02454972|452052428|FG004|Overall Study|Non treatment-related adverse event|0|||
125662122|NCT02454972|452052429|FG005|Overall Study|Non treatment-related adverse event|1|||
125662123|NCT02454972|452052430|FG006|Overall Study|Non treatment-related adverse event|0|||
125662124|NCT02454972|452052431|FG007|Overall Study|Non treatment-related adverse event|1|||
125662125|NCT02454972|452052432|FG008|Overall Study|Non treatment-related adverse event|0|||
125662126|NCT02454972|452052424|FG000|Overall Study|Treatment-related adverse events|0|||
125662127|NCT02454972|452052425|FG001|Overall Study|Treatment-related adverse events|1|||
125662128|NCT02454972|452052426|FG002|Overall Study|Treatment-related adverse events|1|||
125662129|NCT02454972|452052427|FG003|Overall Study|Treatment-related adverse events|0|||
125662130|NCT02454972|452052428|FG004|Overall Study|Treatment-related adverse events|2|||
125318340|NCT03137992|450794060|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
125318341|NCT03137992|450794055|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125662131|NCT02454972|452052429|FG005|Overall Study|Treatment-related adverse events|0|||
125662132|NCT02454972|452052430|FG006|Overall Study|Treatment-related adverse events|0|||
125662133|NCT02454972|452052431|FG007|Overall Study|Treatment-related adverse events|2|||
125662134|NCT02454972|452052432|FG008|Overall Study|Treatment-related adverse events|0|||
125662135|NCT02454972|452052424|FG000|Overall Study|Patient moves to compassionate use|0|||
125662136|NCT02454972|452052425|FG001|Overall Study|Patient moves to compassionate use|0|||
125662137|NCT02454972|452052426|FG002|Overall Study|Patient moves to compassionate use|0|||
125662138|NCT02454972|452052427|FG003|Overall Study|Patient moves to compassionate use|0|||
125662139|NCT02454972|452052428|FG004|Overall Study|Patient moves to compassionate use|0|||
125318342|NCT03137992|450794056|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125318343|NCT03137992|450794057|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125318344|NCT03137992|450794058|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
125318345|NCT03137992|450794059|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125318346|NCT03137992|450794060|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
125318347|NCT03137992|450794055|FG000|Part 2 (Open-label Extension)|Per study team|1|||
125318348|NCT03137992|450794056|FG001|Part 2 (Open-label Extension)|Per study team|0|||
125318349|NCT03137992|450794057|FG002|Part 2 (Open-label Extension)|Per study team|0|||
125318350|NCT03137992|450794058|FG003|Part 2 (Open-label Extension)|Per study team|0|||
125318351|NCT03137992|450794059|FG004|Part 2 (Open-label Extension)|Per study team|0|||
125318352|NCT03137992|450794060|FG005|Part 2 (Open-label Extension)|Per study team|0|||
125318353|NCT03137992|450794055|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
125662140|NCT02454972|452052429|FG005|Overall Study|Patient moves to compassionate use|0|||
125662141|NCT02454972|452052430|FG006|Overall Study|Patient moves to compassionate use|2|||
125662142|NCT02454972|452052431|FG007|Overall Study|Patient moves to compassionate use|0|||
125662143|NCT02454972|452052432|FG008|Overall Study|Patient moves to compassionate use|0|||
125662144|NCT02454972|452052424|FG000|Overall Study|Withdrawal by Subject|0|||
125662145|NCT02454972|452052425|FG001|Overall Study|Withdrawal by Subject|1|||
125662146|NCT02454972|452052426|FG002|Overall Study|Withdrawal by Subject|5|||
125662147|NCT02454972|452052427|FG003|Overall Study|Withdrawal by Subject|2|||
125318354|NCT03137992|450794056|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
125662148|NCT02454972|452052428|FG004|Overall Study|Withdrawal by Subject|3|||
125318355|NCT03137992|450794057|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
125540706|NCT00774930|451609436|FG000|DB Phase|Subject Decision|1|||
125662149|NCT02454972|452052429|FG005|Overall Study|Withdrawal by Subject|2|||
125662150|NCT02454972|452052430|FG006|Overall Study|Withdrawal by Subject|0|||
125662151|NCT02454972|452052431|FG007|Overall Study|Withdrawal by Subject|1|||
125662152|NCT02454972|452052432|FG008|Overall Study|Withdrawal by Subject|2|||
125662153|NCT02454972|452052424|FG000|Overall Study|Multiple delay/holds on treatment|0|||
125662154|NCT02454972|452052425|FG001|Overall Study|Multiple delay/holds on treatment|0|||
125662155|NCT02454972|452052426|FG002|Overall Study|Multiple delay/holds on treatment|0|||
125662156|NCT02454972|452052427|FG003|Overall Study|Multiple delay/holds on treatment|1|||
125662157|NCT02454972|452052428|FG004|Overall Study|Multiple delay/holds on treatment|0|||
125318356|NCT03137992|450794058|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
125318357|NCT03137992|450794059|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
125318358|NCT03137992|450794060|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
125318359|NCT02370420|450794061|FG000|Overall Study|Physician Decision|3|||
125318360|NCT02370420|450794062|FG001|Overall Study|Physician Decision|3|||
125318361|NCT02370420|450794061|FG000|Overall Study|Lost to Follow-up|11|||
125318362|NCT02370420|450794062|FG001|Overall Study|Lost to Follow-up|9|||
125318363|NCT03077542|450794063|FG000|Overall Study|Death|4|||
125318364|NCT03077542|450794064|FG001|Overall Study|Death|0|||
125318365|NCT03077542|450794063|FG000|Overall Study|Physician Decision|6|||
125318366|NCT03077542|450794064|FG001|Overall Study|Physician Decision|1|||
125318367|NCT03077542|450794063|FG000|Overall Study|Withdrawal by Subject|0|||
125318368|NCT03077542|450794064|FG001|Overall Study|Withdrawal by Subject|1|||
125318369|NCT01300728|450794065|FG000|Overall Study|Withdrawal by Subject|1|||
125318370|NCT01300728|450794066|FG001|Overall Study|Withdrawal by Subject|1|||
125318371|NCT01300728|450794065|FG000|Overall Study|Physician Decision|1|||
125318372|NCT01300728|450794066|FG001|Overall Study|Physician Decision|0|||
125318373|NCT00301808|450794069|FG000|Overall Study|Adverse Event|5|||
125318374|NCT00301808|450794069|FG000|Overall Study|Death|3|||
125662158|NCT02454972|452052429|FG005|Overall Study|Multiple delay/holds on treatment|0|||
125662159|NCT02454972|452052430|FG006|Overall Study|Multiple delay/holds on treatment|0|||
125318375|NCT00301808|450794069|FG000|Overall Study|Lack of Efficacy|4|||
125318376|NCT05893862|450794073|FG000|Overall Study|Physician Decision|0|||
125318377|NCT05893862|450794074|FG001|Overall Study|Physician Decision|1|||
125318378|NCT05893862|450794075|FG002|Overall Study|Physician Decision|0|||
125318379|NCT05893862|450794076|FG003|Overall Study|Physician Decision|0|||
125318380|NCT05893862|450794077|FG004|Overall Study|Physician Decision|1|||
125318381|NCT05893862|450794078|FG005|Overall Study|Physician Decision|0|||
125318382|NCT05893862|450794073|FG000|Overall Study|Withdrawal by Subject|1|||
125318383|NCT05893862|450794074|FG001|Overall Study|Withdrawal by Subject|7|||
125318384|NCT05893862|450794075|FG002|Overall Study|Withdrawal by Subject|1|||
125318385|NCT05893862|450794076|FG003|Overall Study|Withdrawal by Subject|3|||
125318386|NCT05893862|450794077|FG004|Overall Study|Withdrawal by Subject|3|||
125318387|NCT05893862|450794078|FG005|Overall Study|Withdrawal by Subject|2|||
125318388|NCT05893862|450794073|FG000|Overall Study|Adverse Event|1|||
125318389|NCT05893862|450794074|FG001|Overall Study|Adverse Event|4|||
125318390|NCT05893862|450794075|FG002|Overall Study|Adverse Event|2|||
125318391|NCT05893862|450794076|FG003|Overall Study|Adverse Event|2|||
125318392|NCT05893862|450794077|FG004|Overall Study|Adverse Event|1|||
125318393|NCT05893862|450794078|FG005|Overall Study|Adverse Event|0|||
125318394|NCT02429830|450794079|FG000|Overall Study|Lost to Follow-up|1|||
125318395|NCT02429830|450794079|FG000|Overall Study|Device Explant|2|||
125318396|NCT01908426|450796243|FG000|Overall Study|Adverse Event|98|||
125318397|NCT01908426|450796244|FG001|Overall Study|Adverse Event|11|||
125318398|NCT01908426|450796243|FG000|Overall Study|Clinical Deterioration|72|||
125318399|NCT01908426|450796244|FG001|Overall Study|Clinical Deterioration|38|||
125318400|NCT01908426|450796243|FG000|Overall Study|Lack of Efficacy|3|||
125318401|NCT01908426|450796244|FG001|Overall Study|Lack of Efficacy|0|||
125318402|NCT01908426|450796243|FG000|Overall Study|Lost to Follow-up|0|||
125318403|NCT01908426|450796244|FG001|Overall Study|Lost to Follow-up|1|||
125318404|NCT01908426|450796243|FG000|Overall Study|Physician Decision|3|||
125318405|NCT01908426|450796244|FG001|Overall Study|Physician Decision|3|||
125662160|NCT02454972|452052431|FG007|Overall Study|Multiple delay/holds on treatment|0|||
125662161|NCT02454972|452052432|FG008|Overall Study|Multiple delay/holds on treatment|0|||
125662162|NCT02454972|452052424|FG000|Overall Study|Never treated|0|||
125662163|NCT02454972|452052425|FG001|Overall Study|Never treated|0|||
125662164|NCT02454972|452052426|FG002|Overall Study|Never treated|3|||
125318406|NCT01908426|450796243|FG000|Overall Study|Withdrawal by Subject|11|||
125318407|NCT01908426|450796244|FG001|Overall Study|Withdrawal by Subject|6|||
125318408|NCT01908426|450796243|FG000|Overall Study|Progressive Disease|206|||
125318409|NCT01908426|450796244|FG001|Overall Study|Progressive Disease|152|||
125318410|NCT01908426|450796243|FG000|Overall Study|Protocol Violation|1|||
125318411|NCT01908426|450796244|FG001|Overall Study|Protocol Violation|0|||
125318412|NCT01908426|450796243|FG000|Overall Study|No Study Treatment Given|3|||
125318413|NCT01908426|450796244|FG001|Overall Study|No Study Treatment Given|0|||
125318414|NCT03346434|450796245|FG000|Overall Study|Randomized in Error|0|||
125318415|NCT03346434|450796246|FG001|Overall Study|Randomized in Error|0|||
125318416|NCT03346434|450796247|FG002|Overall Study|Randomized in Error|0|||
125318417|NCT03346434|450796248|FG003|Overall Study|Randomized in Error|0|||
125318418|NCT03346434|450796249|FG004|Overall Study|Randomized in Error|1|||
125318419|NCT03346434|450796250|FG005|Overall Study|Randomized in Error|0|||
125318420|NCT03346434|450796245|FG000|Overall Study|Withdrawal by Subject|0|||
125318421|NCT03346434|450796246|FG001|Overall Study|Withdrawal by Subject|0|||
125318422|NCT03346434|450796247|FG002|Overall Study|Withdrawal by Subject|1|||
125318423|NCT03346434|450796248|FG003|Overall Study|Withdrawal by Subject|0|||
125318424|NCT03346434|450796249|FG004|Overall Study|Withdrawal by Subject|1|||
125540707|NCT00774930|451609437|FG001|DB Phase|Subject Decision|5|||
125662165|NCT02454972|452052427|FG003|Overall Study|Never treated|1|||
125662166|NCT02454972|452052428|FG004|Overall Study|Never treated|1|||
125662167|NCT02454972|452052429|FG005|Overall Study|Never treated|0|||
125662168|NCT02454972|452052430|FG006|Overall Study|Never treated|0|||
125662169|NCT02454972|452052431|FG007|Overall Study|Never treated|0|||
125662170|NCT02454972|452052432|FG008|Overall Study|Never treated|5|||
125662171|NCT02454972|452052424|FG000|Overall Study|Lost to Follow-up|0|||
125662172|NCT02454972|452052425|FG001|Overall Study|Lost to Follow-up|0|||
125662173|NCT02454972|452052426|FG002|Overall Study|Lost to Follow-up|0|||
125662174|NCT02454972|452052427|FG003|Overall Study|Lost to Follow-up|0|||
125662175|NCT02454972|452052428|FG004|Overall Study|Lost to Follow-up|0|||
125662176|NCT02454972|452052429|FG005|Overall Study|Lost to Follow-up|0|||
125318425|NCT03346434|450796250|FG005|Overall Study|Withdrawal by Subject|0|||
125318426|NCT03346434|450796245|FG000|Overall Study|Lost to Follow-up|0|||
125318427|NCT03346434|450796246|FG001|Overall Study|Lost to Follow-up|0|||
125318428|NCT03346434|450796247|FG002|Overall Study|Lost to Follow-up|0|||
125318429|NCT03346434|450796248|FG003|Overall Study|Lost to Follow-up|0|||
125318430|NCT03346434|450796249|FG004|Overall Study|Lost to Follow-up|1|||
125318431|NCT03346434|450796250|FG005|Overall Study|Lost to Follow-up|1|||
125318432|NCT03346434|450796245|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
125318433|NCT03346434|450796246|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
125318434|NCT03346434|450796247|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
125318435|NCT03346434|450796248|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
125318436|NCT03346434|450796249|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
125318437|NCT03346434|450796250|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
125318438|NCT01419236|450796266|FG000|Overall Study|Adverse Event|1|||
125318439|NCT01419236|450796267|FG001|Overall Study|Adverse Event|0|||
125318440|NCT01419236|450796266|FG000|Overall Study|Lack of Efficacy|0|||
125318441|NCT01419236|450796267|FG001|Overall Study|Lack of Efficacy|1|||
125318442|NCT01419236|450796266|FG000|Overall Study|Lost to Follow-up|1|||
125318443|NCT01419236|450796267|FG001|Overall Study|Lost to Follow-up|0|||
125318444|NCT01419236|450796266|FG000|Overall Study|Physician Decision|1|||
125318445|NCT01419236|450796267|FG001|Overall Study|Physician Decision|0|||
125318446|NCT01419236|450796266|FG000|Overall Study|Withdrawal by Subject|1|||
125318447|NCT01419236|450796267|FG001|Overall Study|Withdrawal by Subject|4|||
125318448|NCT01419236|450796266|FG000|Overall Study|Entry Criteria Not Met|1|||
125318449|NCT01419236|450796267|FG001|Overall Study|Entry Criteria Not Met|0|||
125318450|NCT00762359|450796274|FG000|Overall Study|Adverse Event|20|||
125318451|NCT00762359|450796275|FG001|Overall Study|Adverse Event|23|||
125318452|NCT00762359|450796274|FG000|Overall Study|Protocol Violation|21|||
125318453|NCT00762359|450796275|FG001|Overall Study|Protocol Violation|13|||
125318454|NCT00762359|450796274|FG000|Overall Study|Withdrawal by Subject|13|||
125318455|NCT00762359|450796275|FG001|Overall Study|Withdrawal by Subject|10|||
125318456|NCT00762359|450796274|FG000|Overall Study|Lack of Efficacy|0|||
125318457|NCT00762359|450796275|FG001|Overall Study|Lack of Efficacy|4|||
125318458|NCT00762359|450796274|FG000|Overall Study|Institution closed|2|||
125318459|NCT00762359|450796275|FG001|Overall Study|Institution closed|3|||
125318460|NCT00762359|450796274|FG000|Overall Study|Physician Decision|2|||
125318461|NCT00762359|450796275|FG001|Overall Study|Physician Decision|3|||
125318462|NCT00762359|450796274|FG000|Overall Study|Removal|0|||
125318463|NCT00762359|450796275|FG001|Overall Study|Removal|1|||
125318464|NCT00762359|450796274|FG000|Overall Study|Withdrew consent|1|||
125318465|NCT00762359|450796275|FG001|Overall Study|Withdrew consent|0|||
125318466|NCT01453049|450796276|FG000|Overall Study|Protocol Violation|2|||
125318467|NCT01453049|450796277|FG001|Overall Study|Protocol Violation|5|||
125318468|NCT01453049|450796276|FG000|Overall Study|Lost to Follow-up|2|||
125318469|NCT01453049|450796277|FG001|Overall Study|Lost to Follow-up|1|||
125318470|NCT01453049|450796276|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
125318471|NCT01453049|450796277|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
125318472|NCT01453049|450796276|FG000|Overall Study|Withdrawal by Subject|1|||
125318473|NCT01453049|450796277|FG001|Overall Study|Withdrawal by Subject|0|||
125318474|NCT01453049|450796276|FG000|Overall Study|Randomized in Error|1|||
125318475|NCT01453049|450796277|FG001|Overall Study|Randomized in Error|0|||
125318476|NCT00882440|450796278|FG000|Overall Study|Adverse Event|2|||
125318477|NCT00882440|450796279|FG001|Overall Study|Adverse Event|2|||
125318478|NCT00882440|450796280|FG002|Overall Study|Adverse Event|2|||
125318479|NCT00882440|450796281|FG003|Overall Study|Adverse Event|1|||
125662177|NCT02454972|452052430|FG006|Overall Study|Lost to Follow-up|0|||
125318480|NCT00882440|450796282|FG004|Overall Study|Adverse Event|1|||
125318481|NCT00882440|450796283|FG005|Overall Study|Adverse Event|4|||
125318482|NCT00882440|450796284|FG006|Overall Study|Adverse Event|2|||
125318483|NCT00882440|450796278|FG000|Overall Study|Lack of Efficacy|3|||
125318484|NCT00882440|450796279|FG001|Overall Study|Lack of Efficacy|5|||
125318485|NCT00882440|450796280|FG002|Overall Study|Lack of Efficacy|2|||
125662178|NCT02454972|452052431|FG007|Overall Study|Lost to Follow-up|0|||
125318486|NCT00882440|450796281|FG003|Overall Study|Lack of Efficacy|0|||
125318487|NCT00882440|450796282|FG004|Overall Study|Lack of Efficacy|0|||
125662179|NCT02454972|452052432|FG008|Overall Study|Lost to Follow-up|2|||
125318488|NCT00882440|450796283|FG005|Overall Study|Lack of Efficacy|3|||
125318489|NCT00882440|450796284|FG006|Overall Study|Lack of Efficacy|0|||
125318490|NCT00882440|450796278|FG000|Overall Study|Lost to Follow-up|2|||
125318491|NCT00882440|450796279|FG001|Overall Study|Lost to Follow-up|0|||
125318492|NCT00882440|450796280|FG002|Overall Study|Lost to Follow-up|1|||
125318493|NCT00882440|450796281|FG003|Overall Study|Lost to Follow-up|1|||
125318494|NCT00882440|450796282|FG004|Overall Study|Lost to Follow-up|1|||
125318495|NCT00882440|450796283|FG005|Overall Study|Lost to Follow-up|0|||
125318496|NCT00882440|450796284|FG006|Overall Study|Lost to Follow-up|1|||
125318497|NCT00882440|450796278|FG000|Overall Study|Protocol Violation|0|||
125318498|NCT00882440|450796279|FG001|Overall Study|Protocol Violation|0|||
125318499|NCT00882440|450796280|FG002|Overall Study|Protocol Violation|1|||
125318500|NCT00882440|450796281|FG003|Overall Study|Protocol Violation|1|||
125318501|NCT00882440|450796282|FG004|Overall Study|Protocol Violation|1|||
125318502|NCT00882440|450796283|FG005|Overall Study|Protocol Violation|0|||
125318503|NCT00882440|450796284|FG006|Overall Study|Protocol Violation|0|||
125318504|NCT00882440|450796278|FG000|Overall Study|Withdrawal by Subject|2|||
125318505|NCT00882440|450796279|FG001|Overall Study|Withdrawal by Subject|1|||
125318506|NCT00882440|450796280|FG002|Overall Study|Withdrawal by Subject|1|||
125318507|NCT00882440|450796281|FG003|Overall Study|Withdrawal by Subject|0|||
125318508|NCT00882440|450796282|FG004|Overall Study|Withdrawal by Subject|6|||
125318509|NCT00882440|450796283|FG005|Overall Study|Withdrawal by Subject|0|||
125318510|NCT00882440|450796284|FG006|Overall Study|Withdrawal by Subject|1|||
125318511|NCT00882440|450796278|FG000|Overall Study|Patient Uncooperative|2|||
125318512|NCT00882440|450796279|FG001|Overall Study|Patient Uncooperative|0|||
125318513|NCT00882440|450796280|FG002|Overall Study|Patient Uncooperative|0|||
125318514|NCT00882440|450796281|FG003|Overall Study|Patient Uncooperative|0|||
125318515|NCT00882440|450796282|FG004|Overall Study|Patient Uncooperative|1|||
125318516|NCT00882440|450796283|FG005|Overall Study|Patient Uncooperative|0|||
125318517|NCT00882440|450796284|FG006|Overall Study|Patient Uncooperative|0|||
125662180|NCT02454972|452052424|FG000|Overall Study|Study termination|0|||
125662181|NCT02454972|452052425|FG001|Overall Study|Study termination|0|||
125662182|NCT02454972|452052426|FG002|Overall Study|Study termination|0|||
125662183|NCT02454972|452052427|FG003|Overall Study|Study termination|0|||
125662184|NCT02454972|452052428|FG004|Overall Study|Study termination|0|||
125662185|NCT02454972|452052429|FG005|Overall Study|Study termination|0|||
125662186|NCT02454972|452052430|FG006|Overall Study|Study termination|0|||
125662187|NCT02454972|452052431|FG007|Overall Study|Study termination|0|||
125662188|NCT02454972|452052432|FG008|Overall Study|Study termination|6|||
125662189|NCT01377233|452052433|FG000|Open-label|Adverse Event|1|||
125662190|NCT01377233|452052434|FG001|Open-label|Adverse Event|0|||
125662191|NCT01377233|452052435|FG002|Open-label|Adverse Event|0|||
125662192|NCT01377233|452052436|FG003|Open-label|Adverse Event|0|||
125662193|NCT01377233|452052437|FG004|Open-label|Adverse Event|0|||
125662194|NCT01377233|452052433|FG000|Open-label|Withdrawal by Subject|3|||
125662195|NCT01377233|452052434|FG001|Open-label|Withdrawal by Subject|0|||
125662196|NCT01377233|452052435|FG002|Open-label|Withdrawal by Subject|0|||
125662197|NCT01377233|452052436|FG003|Open-label|Withdrawal by Subject|0|||
125662198|NCT01377233|452052437|FG004|Open-label|Withdrawal by Subject|0|||
125662199|NCT01377233|452052433|FG000|Double-blind|Adverse Event|0|||
125662200|NCT01377233|452052434|FG001|Double-blind|Adverse Event|1|||
125662201|NCT01377233|452052435|FG002|Double-blind|Adverse Event|2|||
125662202|NCT01377233|452052436|FG003|Double-blind|Adverse Event|2|||
125662203|NCT01377233|452052437|FG004|Double-blind|Adverse Event|0|||
125662204|NCT01377233|452052433|FG000|Double-blind|Protocol Violation|0|||
125662205|NCT01377233|452052434|FG001|Double-blind|Protocol Violation|0|||
125662206|NCT01377233|452052435|FG002|Double-blind|Protocol Violation|0|||
125662207|NCT01377233|452052436|FG003|Double-blind|Protocol Violation|0|||
125662208|NCT01377233|452052437|FG004|Double-blind|Protocol Violation|1|||
125662209|NCT01377233|452052433|FG000|Double-blind|Withdrawal by Subject|0|||
125662210|NCT01377233|452052434|FG001|Double-blind|Withdrawal by Subject|0|||
125662211|NCT01377233|452052435|FG002|Double-blind|Withdrawal by Subject|0|||
125662212|NCT01377233|452052436|FG003|Double-blind|Withdrawal by Subject|1|||
125662213|NCT01377233|452052437|FG004|Double-blind|Withdrawal by Subject|0|||
125662214|NCT01377233|452052433|FG000|Double-blind|Administrative or other|0|||
125318518|NCT03287791|450796285|FG000|Overall Study|Insufficient Therapeutic Response|0|||
125318519|NCT03287791|450796286|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125318520|NCT03287791|450796287|FG002|Overall Study|Insufficient Therapeutic Response|1|||
125318521|NCT03287791|450796285|FG000|Overall Study|Adverse Event|0|||
125318522|NCT03287791|450796286|FG001|Overall Study|Adverse Event|4|||
125318523|NCT03287791|450796287|FG002|Overall Study|Adverse Event|3|||
125540708|NCT00774930|451609436|FG000|DB Phase|Sponsor Decision|0|||
125662215|NCT01377233|452052434|FG001|Double-blind|Administrative or other|0|||
125662216|NCT01377233|452052435|FG002|Double-blind|Administrative or other|0|||
125662217|NCT01377233|452052436|FG003|Double-blind|Administrative or other|1|||
125662218|NCT01377233|452052437|FG004|Double-blind|Administrative or other|1|||
125662219|NCT01785875|452052438|FG000|Overall Study|Withdrawal by Subject|41|||
125662220|NCT01785875|452052439|FG001|Overall Study|Withdrawal by Subject|34|||
125662221|NCT01785875|452052440|FG002|Overall Study|Withdrawal by Subject|36|||
125318524|NCT03287791|450796285|FG000|Overall Study|Withdrawal by Subject|12|||
125318525|NCT03287791|450796286|FG001|Overall Study|Withdrawal by Subject|12|||
125318526|NCT03287791|450796287|FG002|Overall Study|Withdrawal by Subject|17|||
125318527|NCT03287791|450796285|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
125318528|NCT03287791|450796286|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
125318529|NCT03287791|450796287|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
125318530|NCT03287791|450796285|FG000|Overall Study|Lost to Follow-up|8|||
125318531|NCT03287791|450796286|FG001|Overall Study|Lost to Follow-up|14|||
125318532|NCT03287791|450796287|FG002|Overall Study|Lost to Follow-up|11|||
125318533|NCT03287791|450796285|FG000|Overall Study|Protocol Violation|7|||
125318534|NCT03287791|450796286|FG001|Overall Study|Protocol Violation|2|||
125318535|NCT03287791|450796287|FG002|Overall Study|Protocol Violation|1|||
125318536|NCT03287791|450796285|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
125318537|NCT03287791|450796286|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
125318538|NCT03287791|450796287|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
125318539|NCT03287791|450796285|FG000|Overall Study|Too much time between 2 visits|0|||
125318540|NCT03287791|450796286|FG001|Overall Study|Too much time between 2 visits|1|||
125318541|NCT03287791|450796287|FG002|Overall Study|Too much time between 2 visits|0|||
125318542|NCT03287791|450796285|FG000|Overall Study|Non-compliance|0|||
125318543|NCT03287791|450796286|FG001|Overall Study|Non-compliance|1|||
125318544|NCT03287791|450796287|FG002|Overall Study|Non-compliance|0|||
125318545|NCT03287791|450796285|FG000|Overall Study|Did not meet inclusion criteria|1|||
125318546|NCT03287791|450796286|FG001|Overall Study|Did not meet inclusion criteria|0|||
125318547|NCT03287791|450796287|FG002|Overall Study|Did not meet inclusion criteria|0|||
125318548|NCT05482308|450796292|FG000|Overall Study|Withdrawal by Subject|1|||
125318549|NCT05482308|450796293|FG001|Overall Study|Withdrawal by Subject|0|||
125318550|NCT05482308|450796292|FG000|Overall Study|No longer meets eligibility criteria|0|||
125318551|NCT05482308|450796293|FG001|Overall Study|No longer meets eligibility criteria|1|||
125425499|NCT00686881|451180498|FG000|Overall Study|Met discontinuation criteria|5|||
125425500|NCT00686881|451180499|FG001|Overall Study|Met discontinuation criteria|0|||
125425501|NCT00686881|451180498|FG000|Overall Study|Onset of malignant tumor|11|||
125425502|NCT00686881|451180499|FG001|Overall Study|Onset of malignant tumor|11|||
125425503|NCT00686881|451180498|FG000|Overall Study|Lack of Efficacy|4|||
125425504|NCT00686881|451180499|FG001|Overall Study|Lack of Efficacy|3|||
125425505|NCT00686881|451180498|FG000|Overall Study|Physician Decision|1|||
125425506|NCT00686881|451180499|FG001|Overall Study|Physician Decision|0|||
125425507|NCT00686881|451180498|FG000|Overall Study|Circumstances of site|1|||
125425508|NCT00686881|451180499|FG001|Overall Study|Circumstances of site|1|||
125425509|NCT00686881|451180498|FG000|Overall Study|Did not meet protocol eligibility|1|||
125425510|NCT00686881|451180499|FG001|Overall Study|Did not meet protocol eligibility|0|||
125425511|NCT00686881|451180498|FG000|Overall Study|Irregular visits|1|||
125425512|NCT00686881|451180499|FG001|Overall Study|Irregular visits|0|||
125425513|NCT00686881|451180498|FG000|Overall Study|Study discontinuation|35|||
125425514|NCT00686881|451180499|FG001|Overall Study|Study discontinuation|32|||
125425515|NCT00686881|451180498|FG000|Overall Study|Never received study drug|2|||
125425516|NCT00686881|451180499|FG001|Overall Study|Never received study drug|6|||
125425517|NCT02355028|451180503|FG000|Overall Study|Adverse Event|2|||
125425518|NCT02355028|451180504|FG001|Overall Study|Adverse Event|0|||
125425519|NCT02355028|451180503|FG000|Overall Study|Withdrawal by Subject|1|||
125425520|NCT02355028|451180504|FG001|Overall Study|Withdrawal by Subject|1|||
125425521|NCT02355028|451180503|FG000|Overall Study|Deemed ineligible after randomization|8|||
125425522|NCT02355028|451180504|FG001|Overall Study|Deemed ineligible after randomization|4|||
125425523|NCT01971723|451180505|FG000|Overall Study|Withdrawal by Subject|1|||
125425524|NCT01971723|451180506|FG001|Overall Study|Withdrawal by Subject|1|||
125425525|NCT01971723|451180505|FG000|Overall Study|Protocol Violation|1|||
125425526|NCT01971723|451180506|FG001|Overall Study|Protocol Violation|2|||
125425527|NCT05899686|451180507|FG000|Overall Study|Protocol Violation|1|||
125425528|NCT01592370|451180517|FG000|Overall Study|Disease Progression|62|||
125425529|NCT01592370|451180518|FG001|Overall Study|Disease Progression|16|||
125425530|NCT01592370|451180519|FG002|Overall Study|Disease Progression|52|||
125425531|NCT01592370|451180520|FG003|Overall Study|Disease Progression|3|||
125425532|NCT01592370|451180521|FG004|Overall Study|Disease Progression|3|||
125425533|NCT01592370|451180522|FG005|Overall Study|Disease Progression|31|||
125425534|NCT01592370|451180523|FG006|Overall Study|Disease Progression|14|||
125425535|NCT01592370|451180517|FG000|Overall Study|Study Drug Toxicity|14|||
125425536|NCT01592370|451180518|FG001|Overall Study|Study Drug Toxicity|3|||
125425537|NCT01592370|451180519|FG002|Overall Study|Study Drug Toxicity|0|||
125425538|NCT01592370|451180520|FG003|Overall Study|Study Drug Toxicity|0|||
125425539|NCT01592370|451180521|FG004|Overall Study|Study Drug Toxicity|0|||
125425540|NCT01592370|451180522|FG005|Overall Study|Study Drug Toxicity|0|||
125425541|NCT01592370|451180523|FG006|Overall Study|Study Drug Toxicity|1|||
125425542|NCT01592370|451180517|FG000|Overall Study|AE unrelated to study drug|4|||
125425543|NCT01592370|451180518|FG001|Overall Study|AE unrelated to study drug|3|||
125425544|NCT01592370|451180519|FG002|Overall Study|AE unrelated to study drug|0|||
125425545|NCT01592370|451180520|FG003|Overall Study|AE unrelated to study drug|0|||
125425546|NCT01592370|451180521|FG004|Overall Study|AE unrelated to study drug|0|||
125662222|NCT01785875|452052438|FG000|Overall Study|Lost to Follow-up|19|||
125662223|NCT01785875|452052439|FG001|Overall Study|Lost to Follow-up|22|||
125662224|NCT01785875|452052440|FG002|Overall Study|Lost to Follow-up|6|||
125662225|NCT01785875|452052438|FG000|Overall Study|Death|27|||
125662226|NCT01785875|452052439|FG001|Overall Study|Death|16|||
125662227|NCT01785875|452052440|FG002|Overall Study|Death|7|||
125662228|NCT01785875|452052438|FG000|Overall Study|Sponsor Decision|0|||
125662229|NCT01785875|452052439|FG001|Overall Study|Sponsor Decision|2|||
125662230|NCT01785875|452052440|FG002|Overall Study|Sponsor Decision|0|||
125662231|NCT01785875|452052438|FG000|Overall Study|Protocol Specified Criteria|207|||
125662232|NCT01785875|452052439|FG001|Overall Study|Protocol Specified Criteria|214|||
125662233|NCT01785875|452052440|FG002|Overall Study|Protocol Specified Criteria|55|||
125662234|NCT01785875|452052438|FG000|Overall Study|Missing|0|||
125662235|NCT01785875|452052439|FG001|Overall Study|Missing|1|||
125662236|NCT01785875|452052440|FG002|Overall Study|Missing|3|||
125662237|NCT04991311|452052443|FG000|Overall Study|Adverse Event|1|||
125662238|NCT00755937|452052444|FG000|Recruitment|Unknown if infliximab received|164|||
125662239|NCT00755937|452052444|FG000|Observational Follow-up|Lost to Follow-up|148|||
125662240|NCT01440595|452052447|FG000|Overall Study|Lost to Follow-up|0|||
125662241|NCT01440595|452052448|FG001|Overall Study|Lost to Follow-up|1|||
125662242|NCT01440595|452052449|FG002|Overall Study|Lost to Follow-up|0|||
125662243|NCT01440595|452052447|FG000|Overall Study|Study terminated by sponsor.|1|||
125662244|NCT01440595|452052448|FG001|Overall Study|Study terminated by sponsor.|2|||
125662245|NCT01440595|452052449|FG002|Overall Study|Study terminated by sponsor.|1|||
125662246|NCT01223196|452052450|FG000|Overall Study|Lost to Follow-up|2|||
125662247|NCT01223196|452052451|FG001|Overall Study|Lost to Follow-up|0|||
125662248|NCT01223196|452052450|FG000|Overall Study|Physician Decision|1|||
125662249|NCT01223196|452052451|FG001|Overall Study|Physician Decision|0|||
125662250|NCT01223196|452052450|FG000|Overall Study|Withdrawal by Subject|1|||
125662251|NCT01223196|452052451|FG001|Overall Study|Withdrawal by Subject|0|||
125662252|NCT05180630|452052457|FG000|First Intervention|Physician Decision|0|||
125662253|NCT05180630|452052458|FG001|First Intervention|Physician Decision|0|||
125662254|NCT05180630|452052459|FG002|First Intervention|Physician Decision|3|||
125425547|NCT01592370|451180522|FG005|Overall Study|AE unrelated to study drug|0|||
125425548|NCT01592370|451180523|FG006|Overall Study|AE unrelated to study drug|1|||
125662255|NCT02725671|452052465|FG000|Overall Study|Lost to Follow-up|1|||
125662256|NCT00965263|452052466|FG000|Overall Study|Physician Decision|2|||
125662257|NCT00965263|452052467|FG001|Overall Study|Physician Decision|0|||
125662258|NCT00965263|452052466|FG000|Overall Study|Family emergency|0|||
125662259|NCT00965263|452052467|FG001|Overall Study|Family emergency|1|||
125662260|NCT00965263|452052466|FG000|Overall Study|Protocol Violation|0|||
125662261|NCT00965263|452052467|FG001|Overall Study|Protocol Violation|2|||
125662262|NCT00963599|452052468|FG000|Overall Study|Adverse Event|2|||
125662263|NCT00963599|452052469|FG001|Overall Study|Adverse Event|0|||
125662264|NCT00963599|452052470|FG002|Overall Study|Adverse Event|1|||
125662265|NCT00963599|452052471|FG003|Overall Study|Adverse Event|2|||
125662266|NCT00963599|452052468|FG000|Overall Study|Lack of Efficacy|0|||
125662267|NCT00963599|452052469|FG001|Overall Study|Lack of Efficacy|2|||
125662268|NCT00963599|452052470|FG002|Overall Study|Lack of Efficacy|1|||
125662269|NCT00963599|452052471|FG003|Overall Study|Lack of Efficacy|4|||
125662270|NCT00963599|452052468|FG000|Overall Study|Lost to Follow-up|0|||
125662271|NCT00963599|452052469|FG001|Overall Study|Lost to Follow-up|1|||
125662272|NCT00963599|452052470|FG002|Overall Study|Lost to Follow-up|1|||
125662273|NCT00963599|452052471|FG003|Overall Study|Lost to Follow-up|1|||
125662274|NCT00963599|452052468|FG000|Overall Study|Protocol Violation|2|||
125662275|NCT00963599|452052469|FG001|Overall Study|Protocol Violation|2|||
125540709|NCT00774930|451609437|FG001|DB Phase|Sponsor Decision|1|||
125540710|NCT00774930|451609436|FG000|DB Phase|Disease Progression|1|||
125540711|NCT00774930|451609437|FG001|DB Phase|Disease Progression|1|||
125540712|NCT00774930|451609436|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
125540713|NCT00774930|451609437|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
125540714|NCT00774930|451609436|FG000|IOL Phase|Adverse Event|1|||
125662276|NCT00963599|452052470|FG002|Overall Study|Protocol Violation|3|||
125662277|NCT00963599|452052471|FG003|Overall Study|Protocol Violation|4|||
125662278|NCT00963599|452052468|FG000|Overall Study|Withdrawal by Subject|2|||
125662279|NCT00963599|452052469|FG001|Overall Study|Withdrawal by Subject|1|||
125662280|NCT00963599|452052470|FG002|Overall Study|Withdrawal by Subject|3|||
125662281|NCT00963599|452052471|FG003|Overall Study|Withdrawal by Subject|3|||
125662282|NCT03496207|452052474|FG000|Base Study|Adverse Event|0|||
125662283|NCT03496207|452052475|FG001|Base Study|Adverse Event|0|||
125662284|NCT03496207|452052476|FG002|Base Study|Adverse Event|1|||
125662285|NCT03496207|452052477|FG003|Base Study|Adverse Event|1|||
125425549|NCT01592370|451180517|FG000|Overall Study|Request to discontinue study treatment|5|||
125662286|NCT03496207|452052478|FG004|Base Study|Adverse Event|4|||
125662287|NCT03496207|452052474|FG000|Base Study|Death|0|||
125662288|NCT03496207|452052475|FG001|Base Study|Death|0|||
125662289|NCT03496207|452052476|FG002|Base Study|Death|0|||
125662290|NCT03496207|452052477|FG003|Base Study|Death|0|||
125662291|NCT03496207|452052478|FG004|Base Study|Death|1|||
125662292|NCT03496207|452052474|FG000|Base Study|Withdrawal by Subject|0|||
125662293|NCT03496207|452052475|FG001|Base Study|Withdrawal by Subject|0|||
125540715|NCT00774930|451609437|FG001|IOL Phase|Adverse Event|1|||
125540716|NCT00774930|451609436|FG000|IOL Phase|Subject Decision|4|||
125540717|NCT00774930|451609437|FG001|IOL Phase|Subject Decision|3|||
125540718|NCT00774930|451609436|FG000|IOL Phase|Physician Decision|3|||
125540719|NCT00774930|451609437|FG001|IOL Phase|Physician Decision|2|||
125540720|NCT00774930|451609436|FG000|IOL Phase|Sponsor Decision|1|||
125540721|NCT00774930|451609437|FG001|IOL Phase|Sponsor Decision|0|||
125540722|NCT00774930|451609436|FG000|IOL Phase|Disease Progression|2|||
125540723|NCT00774930|451609437|FG001|IOL Phase|Disease Progression|1|||
125540724|NCT00774930|451609436|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
125540725|NCT00774930|451609437|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
125540726|NCT00774930|451609436|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
125540727|NCT00774930|451609437|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
125540728|NCT00774930|451609436|FG000|IOL Phase|Other|1|||
125425550|NCT01592370|451180518|FG001|Overall Study|Request to discontinue study treatment|0|||
125425551|NCT01592370|451180519|FG002|Overall Study|Request to discontinue study treatment|2|||
125425552|NCT01592370|451180520|FG003|Overall Study|Request to discontinue study treatment|0|||
125425553|NCT01592370|451180521|FG004|Overall Study|Request to discontinue study treatment|1|||
125425554|NCT01592370|451180522|FG005|Overall Study|Request to discontinue study treatment|2|||
125425555|NCT01592370|451180523|FG006|Overall Study|Request to discontinue study treatment|0|||
125425556|NCT01592370|451180517|FG000|Overall Study|Withdrew consent|1|||
125425557|NCT01592370|451180518|FG001|Overall Study|Withdrew consent|2|||
125425558|NCT01592370|451180519|FG002|Overall Study|Withdrew consent|1|||
125425559|NCT01592370|451180520|FG003|Overall Study|Withdrew consent|1|||
125425560|NCT01592370|451180521|FG004|Overall Study|Withdrew consent|0|||
125425561|NCT01592370|451180522|FG005|Overall Study|Withdrew consent|0|||
125425562|NCT01592370|451180523|FG006|Overall Study|Withdrew consent|0|||
125425563|NCT01592370|451180517|FG000|Overall Study|Maximum clinical benefit|11|||
125425564|NCT01592370|451180518|FG001|Overall Study|Maximum clinical benefit|1|||
125425565|NCT01592370|451180519|FG002|Overall Study|Maximum clinical benefit|7|||
125425566|NCT01592370|451180520|FG003|Overall Study|Maximum clinical benefit|1|||
125425567|NCT01592370|451180521|FG004|Overall Study|Maximum clinical benefit|0|||
125425568|NCT01592370|451180522|FG005|Overall Study|Maximum clinical benefit|0|||
125425569|NCT01592370|451180523|FG006|Overall Study|Maximum clinical benefit|0|||
125425570|NCT01592370|451180517|FG000|Overall Study|No longer meets study criteria|1|||
125425571|NCT01592370|451180518|FG001|Overall Study|No longer meets study criteria|0|||
125425572|NCT01592370|451180519|FG002|Overall Study|No longer meets study criteria|0|||
125425573|NCT01592370|451180520|FG003|Overall Study|No longer meets study criteria|0|||
125425574|NCT01592370|451180521|FG004|Overall Study|No longer meets study criteria|0|||
125425575|NCT01592370|451180522|FG005|Overall Study|No longer meets study criteria|0|||
125425576|NCT01592370|451180523|FG006|Overall Study|No longer meets study criteria|0|||
125540729|NCT00774930|451609437|FG001|IOL Phase|Other|0|||
125540730|NCT00774930|451609436|FG000|IOL Phase|Brain radiation|0|||
125540731|NCT00774930|451609437|FG001|IOL Phase|Brain radiation|1|||
125318636|NCT02250326|450796309|FG000|Treatment|Death|1|||
125318637|NCT02250326|450796310|FG001|Treatment|Death|13|||
125318638|NCT02250326|450796311|FG002|Treatment|Death|2|||
125318639|NCT02250326|450796309|FG000|Treatment|Adverse Event|8|||
125318640|NCT02250326|450796310|FG001|Treatment|Adverse Event|8|||
125318641|NCT02250326|450796311|FG002|Treatment|Adverse Event|9|||
125318642|NCT02250326|450796309|FG000|Treatment|Progressive Disease|42|||
125318643|NCT02250326|450796310|FG001|Treatment|Progressive Disease|40|||
125318644|NCT02250326|450796311|FG002|Treatment|Progressive Disease|47|||
125318645|NCT02250326|450796309|FG000|Treatment|Symptomatic Deterioration|9|||
125318646|NCT02250326|450796310|FG001|Treatment|Symptomatic Deterioration|4|||
125318647|NCT02250326|450796311|FG002|Treatment|Symptomatic Deterioration|10|||
125318648|NCT02250326|450796309|FG000|Treatment|Withdrawal by Subject|11|||
125318649|NCT02250326|450796310|FG001|Treatment|Withdrawal by Subject|6|||
125318650|NCT02250326|450796311|FG002|Treatment|Withdrawal by Subject|4|||
125318651|NCT02250326|450796309|FG000|Treatment|Other reasons|8|||
125318652|NCT02250326|450796310|FG001|Treatment|Other reasons|7|||
125318653|NCT02250326|450796311|FG002|Treatment|Other reasons|7|||
125318654|NCT02250326|450796309|FG000|Extension Period|Progressive Disease|0|||
125318655|NCT02250326|450796310|FG001|Extension Period|Progressive Disease|2|||
125318656|NCT02250326|450796311|FG002|Extension Period|Progressive Disease|0|||
125318657|NCT02250326|450796309|FG000|Extension Period|Withdrawal by Subject|0|||
125318658|NCT02250326|450796310|FG001|Extension Period|Withdrawal by Subject|1|||
125318659|NCT02250326|450796311|FG002|Extension Period|Withdrawal by Subject|0|||
125318660|NCT02250326|450796309|FG000|Extension Period|Withdrawal by investigator|0|||
125318661|NCT02250326|450796310|FG001|Extension Period|Withdrawal by investigator|1|||
125318662|NCT02250326|450796311|FG002|Extension Period|Withdrawal by investigator|0|||
125318663|NCT00416624|450796312|FG000|Overall Study|Withdrawal by Subject|1|||
125318664|NCT00416624|450796313|FG001|Overall Study|Withdrawal by Subject|6|||
125318665|NCT00416624|450796314|FG002|Overall Study|Withdrawal by Subject|4|||
125318666|NCT00416624|450796315|FG003|Overall Study|Withdrawal by Subject|9|||
125318667|NCT00416624|450796312|FG000|Overall Study|Death|4|||
125318668|NCT00416624|450796313|FG001|Overall Study|Death|7|||
125318669|NCT00416624|450796314|FG002|Overall Study|Death|7|||
125318670|NCT00416624|450796315|FG003|Overall Study|Death|1|||
125318671|NCT00416624|450796312|FG000|Overall Study|Adverse Event|8|||
125318672|NCT00416624|450796313|FG001|Overall Study|Adverse Event|3|||
125318673|NCT00416624|450796314|FG002|Overall Study|Adverse Event|2|||
125318674|NCT00416624|450796315|FG003|Overall Study|Adverse Event|2|||
125318675|NCT00416624|450796312|FG000|Overall Study|Other|8|||
125318676|NCT00416624|450796313|FG001|Overall Study|Other|11|||
125318677|NCT00416624|450796314|FG002|Overall Study|Other|5|||
125318678|NCT00416624|450796315|FG003|Overall Study|Other|5|||
125318679|NCT00416624|450796312|FG000|Overall Study|Cancel|1|||
125318680|NCT00416624|450796313|FG001|Overall Study|Cancel|0|||
125318681|NCT00416624|450796314|FG002|Overall Study|Cancel|0|||
125318682|NCT00416624|450796315|FG003|Overall Study|Cancel|0|||
125318683|NCT03924622|450796316|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
125318684|NCT03924622|450796317|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
125318685|NCT03924622|450796318|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
125318686|NCT03924622|450796319|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
125318687|NCT03924622|450796320|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
125318688|NCT03924622|450796321|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
125318689|NCT00141453|450796324|FG000|Overall Study|Protocol Violation|6|||
125318690|NCT00141453|450796325|FG001|Overall Study|Protocol Violation|5|||
125318691|NCT00866177|450796330|FG000|Overall Study|Withdrawal by Subject|1|||
125318692|NCT00866177|450796330|FG000|Overall Study|Not Treated|151|||
125318693|NCT03585660|450796331|FG000|Overall Study|operator error|1|||
125318694|NCT03585660|450796331|FG000|Overall Study|technical error|2|||
125318695|NCT03585660|450796331|FG000|Overall Study|hip prosthesis|2|||
125318696|NCT03585660|450796331|FG000|Overall Study|did not undergo biopsy|8|||
125318697|NCT03585660|450796331|FG000|Overall Study|scanner problem|2|||
125318698|NCT05635461|450796336|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125318699|NCT05635461|450796337|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125318700|NCT05635461|450796338|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125318701|NCT05635461|450796339|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125318702|NCT05635461|450796340|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
125318703|NCT05635461|450796341|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
125318704|NCT05635461|450796336|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125318705|NCT05635461|450796337|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
125318706|NCT05635461|450796338|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125318707|NCT05635461|450796339|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125318708|NCT05635461|450796340|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125318709|NCT05635461|450796341|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
125318710|NCT05635461|450796336|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125318711|NCT05635461|450796337|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125318712|NCT05635461|450796338|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125318713|NCT05635461|450796339|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
125318714|NCT05635461|450796340|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125318715|NCT05635461|450796341|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
125318716|NCT03760029|450796344|FG000|Overall Study|Death|1|||
125318717|NCT03760029|450796345|FG001|Overall Study|Death|0|||
125318718|NCT03760029|450796346|FG002|Overall Study|Death|0|||
125318719|NCT03760029|450796344|FG000|Overall Study|Lost to Follow-up|0|||
125318720|NCT03760029|450796345|FG001|Overall Study|Lost to Follow-up|2|||
125318721|NCT03760029|450796346|FG002|Overall Study|Lost to Follow-up|1|||
125318722|NCT03760029|450796344|FG000|Overall Study|Withdrawal by Subject|1|||
125318723|NCT03760029|450796345|FG001|Overall Study|Withdrawal by Subject|4|||
125318724|NCT03760029|450796346|FG002|Overall Study|Withdrawal by Subject|1|||
125318725|NCT03760029|450796344|FG000|Overall Study|Withdrawal by parent/guardian|4|||
125662294|NCT03496207|452052476|FG002|Base Study|Withdrawal by Subject|1|||
125662295|NCT03496207|452052477|FG003|Base Study|Withdrawal by Subject|0|||
125318726|NCT03760029|450796345|FG001|Overall Study|Withdrawal by parent/guardian|4|||
125318727|NCT03760029|450796346|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125318728|NCT03760029|450796344|FG000|Overall Study|Other|2|||
125318729|NCT03760029|450796345|FG001|Overall Study|Other|1|||
125318730|NCT03760029|450796346|FG002|Overall Study|Other|0|||
125318731|NCT04890652|450796350|FG000|Overall Study|Withdrawal by Subject|2|||
125318732|NCT00524485|450796351|FG000|Overall Study|Withdrawal by Subject|5|||
125318733|NCT00667888|450796356|FG000|Overall Study|Death|1|||
125318734|NCT00667888|450796357|FG001|Overall Study|Death|1|||
125318735|NCT00667888|450796356|FG000|Overall Study|Withdrawal by Subject|6|||
125318736|NCT00667888|450796357|FG001|Overall Study|Withdrawal by Subject|3|||
125318737|NCT00667888|450796356|FG000|Overall Study|Proceed with other treatment|3|||
125662296|NCT03496207|452052478|FG004|Base Study|Withdrawal by Subject|1|||
125662297|NCT03496207|452052474|FG000|Extension Period|Adverse Event|0|||
125662298|NCT03496207|452052475|FG001|Extension Period|Adverse Event|0|||
125662299|NCT03496207|452052476|FG002|Extension Period|Adverse Event|0|||
125662300|NCT03496207|452052477|FG003|Extension Period|Adverse Event|1|||
125662301|NCT03496207|452052478|FG004|Extension Period|Adverse Event|1|||
125318738|NCT00667888|450796357|FG001|Overall Study|Proceed with other treatment|3|||
125318739|NCT00667888|450796356|FG000|Overall Study|Ineligible after SIM|0|||
125318740|NCT00667888|450796357|FG001|Overall Study|Ineligible after SIM|2|||
125318741|NCT02140047|450796358|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125318742|NCT02140047|450796359|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125318743|NCT02140047|450796360|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125318744|NCT00659061|450796361|FG000|Overall Study|Migration due to political unrest|21|||
125318745|NCT00659061|450796362|FG001|Overall Study|Migration due to political unrest|15|||
125318746|NCT01277744|450796363|FG000|Overall Study|Physician Decision|2|||
125318747|NCT00325897|450796364|FG000|Overall Study|Lost to Follow-up|12|||
125318748|NCT00325897|450796365|FG001|Overall Study|Lost to Follow-up|13|||
125318749|NCT03915717|450796366|FG000|Overall Study|EchoMark Not Implanted|6|||
125318750|NCT03748823|450796368|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
125318751|NCT03748823|450796369|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
125318752|NCT03748823|450796368|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
125318753|NCT03748823|450796369|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
125318754|NCT03748823|450796368|FG000|Extension Period|Withdrawal by Subject|9|||
125318755|NCT03748823|450796369|FG001|Extension Period|Withdrawal by Subject|12|||
125318756|NCT03748823|450796368|FG000|Extension Period|Death|2|||
125318757|NCT03748823|450796369|FG001|Extension Period|Death|2|||
125318758|NCT03748823|450796368|FG000|Extension Period|Other than Specified|0|||
125318759|NCT03748823|450796369|FG001|Extension Period|Other than Specified|1|||
125318760|NCT03748823|450796368|FG000|Extension Period|Protocol Violation|1|||
125318761|NCT03748823|450796369|FG001|Extension Period|Protocol Violation|0|||
125318762|NCT03748823|450796368|FG000|Extension Period|Lost to Follow-up|0|||
125318763|NCT03748823|450796369|FG001|Extension Period|Lost to Follow-up|1|||
125318764|NCT03748823|450796368|FG000|Extension Period|Lack of Efficacy|0|||
125318765|NCT03748823|450796369|FG001|Extension Period|Lack of Efficacy|1|||
125318766|NCT03748823|450796368|FG000|Extension Period|Physician Decision|1|||
125318767|NCT03748823|450796369|FG001|Extension Period|Physician Decision|2|||
125318768|NCT00626275|450796370|FG000|Part A - Treatment Period 1|Adverse Event|1|||
125318769|NCT00626275|450796371|FG001|Part A - Treatment Period 1|Adverse Event|0|||
125318770|NCT00626275|450796372|FG002|Part A - Treatment Period 1|Adverse Event|0|||
125318771|NCT00626275|450796373|FG003|Part A - Treatment Period 1|Adverse Event|0|||
125318772|NCT00626275|450796374|FG004|Part A - Treatment Period 1|Adverse Event|0|||
125318773|NCT00626275|450796375|FG005|Part A - Treatment Period 1|Adverse Event|0|||
125318774|NCT00626275|450796376|FG006|Part A - Treatment Period 1|Adverse Event|0|||
125318775|NCT00626275|450796377|FG007|Part A - Treatment Period 1|Adverse Event|0|||
125318776|NCT00626275|450796370|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318777|NCT00626275|450796371|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318778|NCT00626275|450796372|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
125318779|NCT00626275|450796373|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318780|NCT00626275|450796374|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318781|NCT00626275|450796375|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318782|NCT00626275|450796376|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318783|NCT00626275|450796377|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
125318784|NCT00626275|450796370|FG000|Part B|Lost to Follow-up|0|||
125318785|NCT00626275|450796371|FG001|Part B|Lost to Follow-up|0|||
125318786|NCT00626275|450796372|FG002|Part B|Lost to Follow-up|0|||
125318787|NCT00626275|450796373|FG003|Part B|Lost to Follow-up|0|||
125318788|NCT00626275|450796374|FG004|Part B|Lost to Follow-up|0|||
125318789|NCT00626275|450796375|FG005|Part B|Lost to Follow-up|0|||
125318790|NCT00626275|450796376|FG006|Part B|Lost to Follow-up|1|||
125318791|NCT00626275|450796377|FG007|Part B|Lost to Follow-up|0|||
125318792|NCT00626275|450796370|FG000|Part B|Withdrawal by Subject|0|||
125318793|NCT00626275|450796371|FG001|Part B|Withdrawal by Subject|0|||
125318794|NCT00626275|450796372|FG002|Part B|Withdrawal by Subject|0|||
125318795|NCT00626275|450796373|FG003|Part B|Withdrawal by Subject|0|||
125318796|NCT00626275|450796374|FG004|Part B|Withdrawal by Subject|0|||
125318797|NCT00626275|450796375|FG005|Part B|Withdrawal by Subject|0|||
125318798|NCT00626275|450796376|FG006|Part B|Withdrawal by Subject|0|||
125318799|NCT00626275|450796377|FG007|Part B|Withdrawal by Subject|1|||
125318800|NCT01046565|450796378|FG000|Overall Study|Adverse Event|2|||
125318801|NCT01046565|450796378|FG000|Overall Study|Withdrawal by Subject|7|||
125318802|NCT01650558|450796379|FG000|Overall Study|Migration out of study area|61|||
125318803|NCT01650558|450796380|FG001|Overall Study|Migration out of study area|71|||
125318804|NCT01650558|450796381|FG002|Overall Study|Migration out of study area|56|||
125318805|NCT01650558|450796379|FG000|Overall Study|Lost to Follow-up|10|||
125318806|NCT01650558|450796380|FG001|Overall Study|Lost to Follow-up|13|||
125318807|NCT01650558|450796381|FG002|Overall Study|Lost to Follow-up|6|||
125318808|NCT01650558|450796379|FG000|Overall Study|Death|10|||
125318809|NCT01650558|450796380|FG001|Overall Study|Death|6|||
125318810|NCT01650558|450796381|FG002|Overall Study|Death|8|||
125318811|NCT01650558|450796379|FG000|Overall Study|Withdrawal by Subject|1|||
125318812|NCT01650558|450796380|FG001|Overall Study|Withdrawal by Subject|1|||
125318813|NCT01650558|450796381|FG002|Overall Study|Withdrawal by Subject|3|||
125318814|NCT01650558|450796379|FG000|Overall Study|Non-compliant participant|1|||
125662302|NCT03496207|452052474|FG000|Extension Period|Death|1|||
125662303|NCT03496207|452052475|FG001|Extension Period|Death|0|||
125662304|NCT03496207|452052476|FG002|Extension Period|Death|0|||
125662305|NCT03496207|452052477|FG003|Extension Period|Death|1|||
125318815|NCT01650558|450796380|FG001|Overall Study|Non-compliant participant|0|||
125318816|NCT01650558|450796381|FG002|Overall Study|Non-compliant participant|2|||
125662306|NCT03496207|452052478|FG004|Extension Period|Death|2|||
125662307|NCT03496207|452052474|FG000|Extension Period|Withdrawal by Subject|1|||
125662308|NCT03496207|452052475|FG001|Extension Period|Withdrawal by Subject|0|||
125662309|NCT03496207|452052476|FG002|Extension Period|Withdrawal by Subject|0|||
125662310|NCT03496207|452052477|FG003|Extension Period|Withdrawal by Subject|1|||
125662311|NCT03496207|452052478|FG004|Extension Period|Withdrawal by Subject|1|||
125662312|NCT03496207|452052474|FG000|Extension Period|Elevated hemoglobin levels|0|||
125662313|NCT03496207|452052475|FG001|Extension Period|Elevated hemoglobin levels|0|||
125662314|NCT03496207|452052476|FG002|Extension Period|Elevated hemoglobin levels|0|||
125662315|NCT03496207|452052477|FG003|Extension Period|Elevated hemoglobin levels|0|||
125662316|NCT03496207|452052478|FG004|Extension Period|Elevated hemoglobin levels|1|||
125662317|NCT02164539|452052479|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
125662318|NCT02164539|452052480|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
125662319|NCT02164539|452052481|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
125662320|NCT02164539|452052482|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
125662321|NCT02164539|452052483|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
125662322|NCT02164539|452052484|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
125662323|NCT02164539|452052485|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
125662324|NCT02164539|452052479|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
125662325|NCT02164539|452052480|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
125662326|NCT02164539|452052481|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
125318817|NCT01650558|450796379|FG000|Overall Study|Physician Decision|0|||
125662327|NCT02164539|452052482|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
125662328|NCT02164539|452052483|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
125662329|NCT02164539|452052484|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
125662330|NCT02164539|452052485|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
125662331|NCT02164539|452052479|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
125318818|NCT01650558|450796380|FG001|Overall Study|Physician Decision|1|||
125318819|NCT01650558|450796381|FG002|Overall Study|Physician Decision|0|||
125318820|NCT00528957|450796384|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
125318821|NCT00528957|450796385|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
125318822|NCT00528957|450796384|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
125318823|NCT00528957|450796385|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
125318824|NCT00528957|450796384|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
125318825|NCT00528957|450796385|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
125318826|NCT00528957|450796384|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
125318827|NCT00528957|450796385|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
125318828|NCT00528957|450796384|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
125318829|NCT00528957|450796385|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
125318830|NCT00528957|450796384|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
125318831|NCT00528957|450796385|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
125318832|NCT00528957|450796384|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
125318833|NCT00528957|450796385|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
125318834|NCT00528957|450796384|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
125318835|NCT00528957|450796385|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
125318836|NCT00528957|450796384|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
125318837|NCT00528957|450796385|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
125318838|NCT00528957|450796384|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
125318839|NCT00528957|450796385|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
125318840|NCT00528957|450796384|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
125318841|NCT00528957|450796385|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
125318842|NCT00528957|450796384|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
125318843|NCT00528957|450796385|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
125318844|NCT00528957|450796384|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
125662332|NCT02164539|452052480|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
125662333|NCT02164539|452052481|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
125662334|NCT02164539|452052482|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
125662335|NCT02164539|452052483|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
125662336|NCT02164539|452052484|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
125662337|NCT02164539|452052485|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
125662338|NCT02164539|452052479|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
125662339|NCT02164539|452052480|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
125318845|NCT00528957|450796385|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
125318846|NCT00528957|450796384|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
125318847|NCT00528957|450796385|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
125318848|NCT00528957|450796384|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
125318849|NCT00528957|450796385|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
125318850|NCT00528957|450796384|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
125318851|NCT00528957|450796385|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
125318852|NCT03624881|450796386|FG000|Overall Study|Screen Failure|14|||
125318853|NCT03624881|450796387|FG001|Overall Study|Screen Failure|0|||
125318854|NCT03624881|450796386|FG000|Overall Study|No Catheter Inserted|6|||
125318855|NCT03624881|450796387|FG001|Overall Study|No Catheter Inserted|1|||
125318856|NCT03624881|450796386|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
125318857|NCT03624881|450796387|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
125318858|NCT03624881|450796386|FG000|Overall Study|Death|2|||
125318859|NCT03624881|450796387|FG001|Overall Study|Death|0|||
125318860|NCT03624881|450796386|FG000|Overall Study|Lost to Follow-up|10|||
125318861|NCT03624881|450796387|FG001|Overall Study|Lost to Follow-up|4|||
125318862|NCT03624881|450796386|FG000|Overall Study|Withdrawal by Subject|12|||
125318863|NCT03624881|450796387|FG001|Overall Study|Withdrawal by Subject|1|||
125318864|NCT04258423|450796390|FG000|Overall Study|Study Closure|2|||
125318865|NCT04258423|450796391|FG001|Overall Study|Study Closure|2|||
125318866|NCT03284710|450797801|FG000|Overall Study|Withdrawal by Subject|1|||
125318867|NCT03284710|450797802|FG001|Overall Study|Withdrawal by Subject|0|||
125318868|NCT03284710|450797803|FG002|Overall Study|Withdrawal by Subject|1|||
125318869|NCT03284710|450797804|FG003|Overall Study|Withdrawal by Subject|6|||
125318870|NCT03284710|450797801|FG000|Overall Study|Lost to Follow-up|3|||
125318871|NCT03284710|450797802|FG001|Overall Study|Lost to Follow-up|3|||
125318872|NCT03284710|450797803|FG002|Overall Study|Lost to Follow-up|1|||
125318873|NCT03284710|450797804|FG003|Overall Study|Lost to Follow-up|0|||
125318874|NCT03284710|450797801|FG000|Overall Study|Physician Decision|1|||
125318875|NCT03284710|450797802|FG001|Overall Study|Physician Decision|0|||
125318876|NCT03284710|450797803|FG002|Overall Study|Physician Decision|0|||
125318877|NCT03284710|450797804|FG003|Overall Study|Physician Decision|0|||
125318878|NCT03284710|450797801|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
125318879|NCT03284710|450797802|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
125318880|NCT03284710|450797803|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
125318881|NCT03284710|450797804|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
125318882|NCT03284710|450797801|FG000|Overall Study|HIV Infection|0|||
125318883|NCT03284710|450797802|FG001|Overall Study|HIV Infection|2|||
125318884|NCT03284710|450797803|FG002|Overall Study|HIV Infection|2|||
125318885|NCT03284710|450797804|FG003|Overall Study|HIV Infection|1|||
125318886|NCT02412306|450797807|FG000|Overall Study|Lost to Follow-up|0|||
125318887|NCT02412306|450797808|FG001|Overall Study|Lost to Follow-up|1|||
125318888|NCT02412306|450797809|FG002|Overall Study|Lost to Follow-up|0|||
125318889|NCT02412306|450797810|FG003|Overall Study|Lost to Follow-up|0|||
125318890|NCT02412306|450797811|FG004|Overall Study|Lost to Follow-up|0|||
125318891|NCT02412306|450797807|FG000|Overall Study|Withdrawal by Subject|0|||
125318892|NCT02412306|450797808|FG001|Overall Study|Withdrawal by Subject|0|||
125318893|NCT02412306|450797809|FG002|Overall Study|Withdrawal by Subject|1|||
125318894|NCT02412306|450797810|FG003|Overall Study|Withdrawal by Subject|0|||
125318895|NCT02412306|450797811|FG004|Overall Study|Withdrawal by Subject|0|||
125318896|NCT02412306|450797807|FG000|Overall Study|Death|5|||
125318897|NCT02412306|450797808|FG001|Overall Study|Death|7|||
125318898|NCT02412306|450797809|FG002|Overall Study|Death|15|||
125318899|NCT02412306|450797810|FG003|Overall Study|Death|0|||
125318900|NCT02412306|450797811|FG004|Overall Study|Death|2|||
125318901|NCT01706458|450797815|FG000|Overall Study|Physician Decision|3|||
125318902|NCT01706458|450797816|FG001|Overall Study|Physician Decision|4|||
125318903|NCT04349891|450797822|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
125318904|NCT04349891|450797823|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
125318905|NCT04349891|450797822|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
125318906|NCT04349891|450797823|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
125318907|NCT04349891|450797822|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
125318908|NCT04349891|450797823|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
125318909|NCT04349891|450797822|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
125318910|NCT04349891|450797823|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
125318911|NCT02927301|450797826|FG000|Overall Study|Death|39|||
125318912|NCT02927301|450797826|FG000|Overall Study|Lost to Follow-up|8|||
125318913|NCT02927301|450797826|FG000|Overall Study|Physician Decision|2|||
125318914|NCT02927301|450797826|FG000|Overall Study|Withdrawal by Subject|12|||
125318915|NCT02927301|450797826|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
125318916|NCT04247347|450797831|FG000|Overall Study|Withdrawal by Subject|2|||
125318917|NCT04247347|450797832|FG001|Overall Study|Withdrawal by Subject|3|||
125318918|NCT04247347|450797833|FG002|Overall Study|Withdrawal by Subject|3|||
125318919|NCT04247347|450797831|FG000|Overall Study|Lost to Follow-up|1|||
125318920|NCT04247347|450797832|FG001|Overall Study|Lost to Follow-up|1|||
125318921|NCT04247347|450797833|FG002|Overall Study|Lost to Follow-up|1|||
125318922|NCT03562195|450797834|FG000|Overall Study|Adverse Event|0|||
125318923|NCT03562195|450797835|FG001|Overall Study|Adverse Event|6|||
125318924|NCT03562195|450797834|FG000|Overall Study|Lack of Efficacy|0|||
125318925|NCT03562195|450797835|FG001|Overall Study|Lack of Efficacy|5|||
125318926|NCT03562195|450797834|FG000|Overall Study|Protocol Violation|0|||
125318927|NCT03562195|450797835|FG001|Overall Study|Protocol Violation|1|||
125318928|NCT03562195|450797834|FG000|Overall Study|Lost to Follow-up|0|||
125318929|NCT03562195|450797835|FG001|Overall Study|Lost to Follow-up|1|||
125318930|NCT03562195|450797834|FG000|Overall Study|Physician Decision|1|||
125318931|NCT03562195|450797835|FG001|Overall Study|Physician Decision|0|||
125318932|NCT03562195|450797834|FG000|Overall Study|Withdrawal by Subject|3|||
125318933|NCT03562195|450797835|FG001|Overall Study|Withdrawal by Subject|0|||
125318934|NCT02529852|450797836|FG000|Overall Study|Withdrawal by Subject|2|||
125318935|NCT02269124|450797842|FG000|Overall Study|Lost to Follow-up|1|||
125318936|NCT02269124|450797843|FG001|Overall Study|Lost to Follow-up|0|||
125318937|NCT02269124|450797842|FG000|Overall Study|Withdrawal by Subject|0|||
125318938|NCT02269124|450797843|FG001|Overall Study|Withdrawal by Subject|2|||
125318939|NCT00614575|450797845|FG000|Overall Study|Adverse Event|106|||
125318940|NCT00614575|450797845|FG000|Overall Study|Lost to Follow-up|55|||
125318941|NCT00614575|450797845|FG000|Overall Study|Lack of Efficacy|14|||
125318942|NCT00614575|450797845|FG000|Overall Study|Withdrawal by Subject|6|||
125318943|NCT00614575|450797845|FG000|Overall Study|Death|3|||
125318944|NCT00614575|450797845|FG000|Overall Study|Physician Decision|2|||
125318945|NCT00614575|450797845|FG000|Overall Study|No data were collected.|18|||
125318946|NCT00614575|450797845|FG000|Overall Study|Irregularly enrolled patients|23|||
125318947|NCT00614575|450797845|FG000|Overall Study|No treatment|1|||
125318948|NCT03452540|450797846|FG000|Overall Study|Adverse Event|1|||
125318949|NCT03452540|450797846|FG000|Overall Study|Withdrawal by Subject|1|||
125318950|NCT03452540|450797846|FG000|Overall Study|Other SAE and AE|2|||
125318951|NCT04664153|450797849|FG000|Overall Study|Lack of Efficacy|0|||
125318952|NCT04664153|450797850|FG001|Overall Study|Lack of Efficacy|0|||
125318953|NCT04664153|450797851|FG002|Overall Study|Lack of Efficacy|1|||
125318954|NCT04664153|450797852|FG003|Overall Study|Lack of Efficacy|0|||
125318955|NCT04664153|450797849|FG000|Overall Study|Physician Decision|0|||
125318956|NCT04664153|450797850|FG001|Overall Study|Physician Decision|0|||
125318957|NCT04664153|450797851|FG002|Overall Study|Physician Decision|1|||
125318958|NCT04664153|450797852|FG003|Overall Study|Physician Decision|0|||
125318959|NCT04664153|450797849|FG000|Overall Study|Withdrawal by Subject|3|||
125318960|NCT04664153|450797850|FG001|Overall Study|Withdrawal by Subject|2|||
125318961|NCT04664153|450797851|FG002|Overall Study|Withdrawal by Subject|1|||
125318962|NCT04664153|450797852|FG003|Overall Study|Withdrawal by Subject|2|||
125318963|NCT04664153|450797849|FG000|Overall Study|Other|0|||
125318964|NCT04664153|450797850|FG001|Overall Study|Other|1|||
125318965|NCT04664153|450797851|FG002|Overall Study|Other|0|||
125318966|NCT04664153|450797852|FG003|Overall Study|Other|0|||
125318967|NCT04664153|450797849|FG000|Overall Study|Adverse Event|4|||
125318968|NCT04664153|450797850|FG001|Overall Study|Adverse Event|0|||
125318969|NCT04664153|450797851|FG002|Overall Study|Adverse Event|1|||
125318970|NCT04664153|450797852|FG003|Overall Study|Adverse Event|0|||
125318971|NCT01045460|450797853|FG000|Overall Study|Physician Decision|3|||
125318972|NCT01045460|450797854|FG001|Overall Study|Physician Decision|2|||
125318973|NCT01045460|450797853|FG000|Overall Study|Lost to Follow-up|0|||
125318974|NCT01045460|450797854|FG001|Overall Study|Lost to Follow-up|1|||
125318975|NCT01045460|450797853|FG000|Overall Study|Lack of Efficacy|3|||
125318976|NCT01045460|450797854|FG001|Overall Study|Lack of Efficacy|0|||
125318977|NCT00097500|450797855|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
125318978|NCT00097500|450797856|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
125318979|NCT00097500|450797855|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
125318980|NCT00097500|450797856|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
125318981|NCT00097500|450797855|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
125318982|NCT00097500|450797856|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
125318983|NCT00097500|450797855|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
125318984|NCT00097500|450797856|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
125318985|NCT00097500|450797855|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
125318986|NCT00097500|450797856|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
125318987|NCT00097500|450797855|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
125318988|NCT00097500|450797856|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
125540732|NCT00774930|451609436|FG000|LTOLE Phase|Adverse Event|7|||
125540733|NCT00774930|451609437|FG001|LTOLE Phase|Adverse Event|3|||
125318989|NCT00097500|450797855|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
125318990|NCT00097500|450797856|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
125318991|NCT01600885|450797860|FG000|First Period|Adverse Event|1|||
125318992|NCT01600885|450797861|FG001|First Period|Adverse Event|1|||
125318993|NCT01600885|450797860|FG000|First Period|moved out of area|1|||
125318994|NCT01600885|450797861|FG001|First Period|moved out of area|0|||
125318995|NCT00436332|450797862|FG000|Overall Study|Adverse Event|9|||
125318996|NCT00436332|450797862|FG000|Overall Study|Withdrawal by Subject|2|||
125318997|NCT00436332|450797862|FG000|Overall Study|Progression|59|||
125318998|NCT00436332|450797862|FG000|Overall Study|Death|2|||
125318999|NCT00436332|450797862|FG000|Overall Study|Not Protocol Specified|6|||
125319000|NCT00436332|450797862|FG000|Overall Study|Ineligible|2|||
125319001|NCT00436332|450797862|FG000|Overall Study|Never Received Treatment|3|||
125319002|NCT00472108|450797863|FG000|Overall Study|Lost to Follow-up|0|||
125319003|NCT00472108|450797864|FG001|Overall Study|Lost to Follow-up|1|||
125319004|NCT00642356|450797871|FG000|Overall Study|Adverse Event|1|||
125319005|NCT00642356|450797872|FG001|Overall Study|Adverse Event|0|||
125319006|NCT00642356|450797871|FG000|Overall Study|Protocol Violation|0|||
125319007|NCT00642356|450797872|FG001|Overall Study|Protocol Violation|3|||
125319008|NCT00642356|450797871|FG000|Overall Study|Lack of Efficacy|1|||
125319009|NCT00642356|450797872|FG001|Overall Study|Lack of Efficacy|0|||
125319010|NCT01009060|450797873|FG000|Overall Study|Adverse Event|1|||
125319011|NCT01009060|450797874|FG001|Overall Study|Adverse Event|2|||
125319012|NCT01009060|450797873|FG000|Overall Study|Protocol Violation|0|||
125319013|NCT01009060|450797874|FG001|Overall Study|Protocol Violation|1|||
125319014|NCT01009060|450797873|FG000|Overall Study|Lost to Follow-up|1|||
125319015|NCT01009060|450797874|FG001|Overall Study|Lost to Follow-up|0|||
125319016|NCT01009060|450797873|FG000|Overall Study|Physician Decision|1|||
125319017|NCT01009060|450797874|FG001|Overall Study|Physician Decision|1|||
125319018|NCT01009060|450797873|FG000|Overall Study|Withdrawal by Subject|1|||
125319019|NCT01009060|450797874|FG001|Overall Study|Withdrawal by Subject|1|||
125319020|NCT00005906|450797875|FG000|Overall Study|Lack of Efficacy|3|||
125319021|NCT00286442|450797880|FG000|Overall Study|Hyperglycemic Rescue|19|||
125319022|NCT00286442|450797881|FG001|Overall Study|Hyperglycemic Rescue|17|||
125319023|NCT00286442|450797882|FG002|Overall Study|Hyperglycemic Rescue|25|||
125319024|NCT00286442|450797880|FG000|Overall Study|Adverse Event|7|||
125319025|NCT00286442|450797881|FG001|Overall Study|Adverse Event|6|||
125319026|NCT00286442|450797882|FG002|Overall Study|Adverse Event|1|||
125319027|NCT00286442|450797880|FG000|Overall Study|Protocol Violation|2|||
125319028|NCT00286442|450797881|FG001|Overall Study|Protocol Violation|4|||
125319029|NCT00286442|450797882|FG002|Overall Study|Protocol Violation|2|||
125319030|NCT00286442|450797880|FG000|Overall Study|Lost to Follow-up|5|||
125319031|NCT00286442|450797881|FG001|Overall Study|Lost to Follow-up|2|||
125319032|NCT00286442|450797882|FG002|Overall Study|Lost to Follow-up|1|||
125319033|NCT00286442|450797880|FG000|Overall Study|Physician Decision|1|||
125319034|NCT00286442|450797881|FG001|Overall Study|Physician Decision|1|||
125319035|NCT00286442|450797882|FG002|Overall Study|Physician Decision|1|||
125319036|NCT00286442|450797880|FG000|Overall Study|Administrative Error|1|||
125319037|NCT00286442|450797881|FG001|Overall Study|Administrative Error|1|||
125319038|NCT00286442|450797882|FG002|Overall Study|Administrative Error|0|||
125319039|NCT00286442|450797880|FG000|Overall Study|Withdrawal by Subject|2|||
125319040|NCT00286442|450797881|FG001|Overall Study|Withdrawal by Subject|14|||
125319041|NCT00286442|450797882|FG002|Overall Study|Withdrawal by Subject|2|||
125319042|NCT02542865|450797885|FG000|Overall Study|Identified as screen failure|1|||
125319043|NCT02542865|450797886|FG001|Overall Study|Identified as screen failure|0|||
125319044|NCT02542865|450797885|FG000|Overall Study|Withdrawal by Subject|16|||
125319045|NCT02542865|450797886|FG001|Overall Study|Withdrawal by Subject|0|||
125319046|NCT01339689|450797889|FG000|Overall Study|Adverse Event|1|||
125319047|NCT01339689|450797890|FG001|Overall Study|Adverse Event|2|||
125319048|NCT01339689|450797889|FG000|Overall Study|Lost to Follow-up|9|||
125319049|NCT01339689|450797890|FG001|Overall Study|Lost to Follow-up|3|||
125319050|NCT01339689|450797889|FG000|Overall Study|Withdrawal by Subject|3|||
125319051|NCT01339689|450797890|FG001|Overall Study|Withdrawal by Subject|0|||
125319052|NCT01339689|450797889|FG000|Overall Study|Noncompliance|1|||
125319053|NCT01339689|450797890|FG001|Overall Study|Noncompliance|0|||
125319054|NCT01339689|450797889|FG000|Overall Study|Relocated out of area|0|||
125319055|NCT01339689|450797890|FG001|Overall Study|Relocated out of area|1|||
125319056|NCT01339689|450797889|FG000|Overall Study|Other|2|||
125319057|NCT01339689|450797890|FG001|Overall Study|Other|2|||
125319058|NCT01339689|450797889|FG000|Overall Study|multiple reasons|1|||
125319059|NCT01339689|450797890|FG001|Overall Study|multiple reasons|1|||
125319060|NCT04571944|450797891|FG000|Overall Study|Death|1|||
125319061|NCT04571944|450797892|FG001|Overall Study|Death|0|||
125319062|NCT04571944|450797891|FG000|Overall Study|Withdrawal by Subject|3|||
125319063|NCT04571944|450797892|FG001|Overall Study|Withdrawal by Subject|0|||
125319064|NCT04571944|450797891|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
125319065|NCT04571944|450797892|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
125319066|NCT04913610|450797895|FG000|Randomized Participants|Did Not Receive Treatment|0|||
125319067|NCT04913610|450797896|FG001|Randomized Participants|Did Not Receive Treatment|0|||
125319068|NCT04913610|450797897|FG002|Randomized Participants|Did Not Receive Treatment|1|||
125319069|NCT04913610|450797898|FG003|Randomized Participants|Did Not Receive Treatment|1|||
125319070|NCT04913610|450797899|FG004|Randomized Participants|Did Not Receive Treatment|0|||
125319071|NCT04913610|450797895|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
125319072|NCT04913610|450797896|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
125319073|NCT04913610|450797897|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
125319074|NCT04913610|450797898|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
125319075|NCT04913610|450797899|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
125319076|NCT02358473|450797904|FG000|Overall Study|Disease Progession|6|||
125319077|NCT02358473|450797904|FG000|Overall Study|Adverse Event|3|||
125319078|NCT02358473|450797904|FG000|Overall Study|Withdrawal by Subject|2|||
125319079|NCT02358473|450797904|FG000|Overall Study|Physician Decision|2|||
125319080|NCT02051764|450797905|FG000|Overall Study|Study terminated by sponsor|0|||
125319081|NCT02051764|450797906|FG001|Overall Study|Study terminated by sponsor|7|||
125319082|NCT03557970|450797907|FG000|Overall Study|Study closure|1|||
125319083|NCT03557970|450797908|FG001|Overall Study|Study closure|0|||
125319084|NCT03557970|450797907|FG000|Overall Study|Physician Decision|0|||
125319085|NCT03557970|450797908|FG001|Overall Study|Physician Decision|1|||
125319086|NCT03557970|450797907|FG000|Overall Study|Death|0|||
125319087|NCT03557970|450797908|FG001|Overall Study|Death|1|||
125319088|NCT03155724|450797909|FG000|Overall Study|Death|3|||
125319089|NCT03155724|450797909|FG000|Overall Study|Physician Decision|1|||
125319090|NCT03155724|450797909|FG000|Overall Study|Study closure|7|||
125319091|NCT00321789|450797913|FG000|Overall Study|Lost to Follow-up|4|||
125319092|NCT00321789|450797914|FG001|Overall Study|Lost to Follow-up|7|||
125319093|NCT00321789|450797913|FG000|Overall Study|Withdrawal by Subject|6|||
125319094|NCT00321789|450797914|FG001|Overall Study|Withdrawal by Subject|6|||
125319095|NCT00321789|450797913|FG000|Overall Study|Protocol Violation|5|||
125319096|NCT00321789|450797914|FG001|Overall Study|Protocol Violation|3|||
125319097|NCT03309020|450797916|FG000|Overall Study|Death|1|||
125319098|NCT03309020|450797917|FG001|Overall Study|Death|0|||
125319099|NCT03309020|450797916|FG000|Overall Study|Did not undergo surgery|2|||
125319100|NCT03309020|450797917|FG001|Overall Study|Did not undergo surgery|1|||
125319101|NCT02919761|450797920|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
125319102|NCT02919761|450797921|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
125319103|NCT02919761|450797922|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
125319104|NCT02919761|450797920|FG000|Part 1: Open Label|Adverse Event|1|||
125319105|NCT02919761|450797921|FG001|Part 1: Open Label|Adverse Event|0|||
125319106|NCT02919761|450797922|FG002|Part 1: Open Label|Adverse Event|0|||
125319107|NCT02919761|450797920|FG000|Part 1: Open Label|Lost to Follow-up|1|||
125319108|NCT02919761|450797921|FG001|Part 1: Open Label|Lost to Follow-up|0|||
125319109|NCT02919761|450797922|FG002|Part 1: Open Label|Lost to Follow-up|0|||
125319110|NCT02919761|450797920|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
125319111|NCT02919761|450797921|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
125319112|NCT02919761|450797922|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
125319113|NCT02919761|450797920|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
125319114|NCT02919761|450797921|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
125319115|NCT02919761|450797922|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
125319116|NCT02919761|450797920|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
125319117|NCT02919761|450797921|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
125319118|NCT02919761|450797922|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
125319119|NCT02919761|450797920|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
125319120|NCT02919761|450797921|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
125319121|NCT02919761|450797922|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
125319122|NCT02919761|450797920|FG000|Part 1: Open Label|Termination by Sponsor|1|||
125319123|NCT02919761|450797921|FG001|Part 1: Open Label|Termination by Sponsor|0|||
125319124|NCT02919761|450797922|FG002|Part 1: Open Label|Termination by Sponsor|0|||
125319125|NCT02919761|450797920|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
125319126|NCT02919761|450797921|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
125319127|NCT02919761|450797922|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
125319128|NCT02919761|450797920|FG000|Part 2: Double-blind|Adverse Event|0|||
125319129|NCT02919761|450797921|FG001|Part 2: Double-blind|Adverse Event|1|||
125319130|NCT02919761|450797922|FG002|Part 2: Double-blind|Adverse Event|0|||
125319131|NCT02919761|450797920|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
125319132|NCT02919761|450797921|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
125319133|NCT02919761|450797922|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
125319134|NCT02919761|450797920|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
125319135|NCT02919761|450797921|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
125319136|NCT02919761|450797922|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
125319137|NCT02919761|450797920|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
125319138|NCT02919761|450797921|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
125319139|NCT02919761|450797922|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
125319140|NCT02919761|450797920|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
125319141|NCT02919761|450797921|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
125319142|NCT02919761|450797922|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
125319143|NCT02919761|450797920|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
125319144|NCT02919761|450797921|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
125662340|NCT02164539|452052481|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
125662341|NCT02164539|452052482|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
125662342|NCT02164539|452052483|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
125662343|NCT02164539|452052484|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
125662344|NCT02164539|452052485|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
125662345|NCT02164539|452052479|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
125662346|NCT02164539|452052480|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
125662347|NCT02164539|452052481|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
125662348|NCT02164539|452052482|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
125662349|NCT02164539|452052483|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
125662350|NCT02164539|452052484|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
125662351|NCT02164539|452052485|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
125662352|NCT02164539|452052479|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
125662353|NCT02164539|452052480|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
125662354|NCT02164539|452052481|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
125662355|NCT02164539|452052482|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
125662356|NCT02164539|452052483|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
125662357|NCT02164539|452052484|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
125662358|NCT02164539|452052485|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
125662359|NCT01255722|452052486|FG000|Overall Study|Adverse Event|0|||
125662360|NCT01255722|452052487|FG001|Overall Study|Adverse Event|1|||
125662361|NCT01255722|452052488|FG002|Overall Study|Adverse Event|1|||
125319145|NCT02919761|450797922|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
125319146|NCT02919761|450797920|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
125319147|NCT02919761|450797921|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
125319148|NCT02919761|450797922|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
125319149|NCT03409796|450800098|FG000|Overall Study|Adverse Event|2|||
125319150|NCT03409796|450800099|FG001|Overall Study|Adverse Event|0|||
125319151|NCT03409796|450800098|FG000|Overall Study|Other|0|||
125319152|NCT03409796|450800099|FG001|Overall Study|Other|1|||
125319153|NCT00740220|450800100|FG000|Overall Study|screen failures (non-COPD patients)|9|||
125319154|NCT01602224|450800101|FG000|Overall Study|Adverse Event|0|||
125319155|NCT01602224|450800102|FG001|Overall Study|Adverse Event|1|||
125319156|NCT01602224|450800103|FG002|Overall Study|Adverse Event|0|||
125319157|NCT01602224|450800101|FG000|Overall Study|Investigator Decison|1|||
125319158|NCT01602224|450800102|FG001|Overall Study|Investigator Decison|0|||
125319159|NCT01602224|450800103|FG002|Overall Study|Investigator Decison|0|||
125319160|NCT01602224|450800101|FG000|Overall Study|Lost to Follow-up|0|||
125319161|NCT01602224|450800102|FG001|Overall Study|Lost to Follow-up|0|||
125319162|NCT01602224|450800103|FG002|Overall Study|Lost to Follow-up|1|||
125319163|NCT01602224|450800101|FG000|Overall Study|Protocol Violation|0|||
125319164|NCT01602224|450800102|FG001|Overall Study|Protocol Violation|1|||
125319165|NCT01602224|450800103|FG002|Overall Study|Protocol Violation|0|||
125319166|NCT01602224|450800101|FG000|Overall Study|Sponsor Decision|2|||
125319167|NCT01602224|450800102|FG001|Overall Study|Sponsor Decision|3|||
125319168|NCT01602224|450800103|FG002|Overall Study|Sponsor Decision|2|||
125319169|NCT01602224|450800101|FG000|Overall Study|Withdrawal by Subject|5|||
125319170|NCT01602224|450800102|FG001|Overall Study|Withdrawal by Subject|3|||
125319171|NCT01602224|450800103|FG002|Overall Study|Withdrawal by Subject|3|||
125319172|NCT01352117|450800104|FG000|Overall Study|Death|15|||
125319173|NCT01352117|450800105|FG001|Overall Study|Death|16|||
125319174|NCT01352117|450800104|FG000|Overall Study|Withdrawal by Subject|1|||
125319175|NCT01352117|450800105|FG001|Overall Study|Withdrawal by Subject|0|||
125319176|NCT01352117|450800104|FG000|Overall Study|Lost to Follow-up|2|||
125319177|NCT01352117|450800105|FG001|Overall Study|Lost to Follow-up|7|||
125319178|NCT01352117|450800104|FG000|Overall Study|Non-adherent to study requirements|1|||
125319179|NCT01352117|450800105|FG001|Overall Study|Non-adherent to study requirements|1|||
125319180|NCT01352117|450800104|FG000|Overall Study|Did not initiate study treatment|1|||
125319181|NCT01352117|450800105|FG001|Overall Study|Did not initiate study treatment|0|||
125319182|NCT01352117|450800104|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
125319183|NCT01352117|450800105|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
125319184|NCT00633477|450800106|FG000|Overall Study|Death|1|||
125319185|NCT00633477|450800107|FG001|Overall Study|Death|0|||
125319186|NCT00633477|450800106|FG000|Overall Study|Randomized but not treated|1|||
125319187|NCT00633477|450800107|FG001|Overall Study|Randomized but not treated|0|||
125662362|NCT01255722|452052486|FG000|Overall Study|asymptomatic patient|1|||
125662363|NCT01255722|452052487|FG001|Overall Study|asymptomatic patient|0|||
125662364|NCT01255722|452052488|FG002|Overall Study|asymptomatic patient|0|||
125319188|NCT00770653|450800111|FG000|Overall Study|Adverse Event|13|||
125319189|NCT00770653|450800112|FG001|Overall Study|Adverse Event|5|||
125319190|NCT00770653|450800111|FG000|Overall Study|Protocol Violation|8|||
125319191|NCT00770653|450800112|FG001|Overall Study|Protocol Violation|6|||
125319192|NCT00770653|450800111|FG000|Overall Study|Withdrawal by Subject|4|||
125319193|NCT00770653|450800112|FG001|Overall Study|Withdrawal by Subject|7|||
125319194|NCT00770653|450800111|FG000|Overall Study|Lack of Compliance|1|||
125319195|NCT00770653|450800112|FG001|Overall Study|Lack of Compliance|4|||
125319196|NCT00770653|450800111|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
125319197|NCT00770653|450800112|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
125319198|NCT00770653|450800111|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
125319199|NCT00770653|450800112|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
125319200|NCT00770653|450800111|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
125319201|NCT00770653|450800112|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
125319202|NCT00770653|450800111|FG000|Overall Study|Lost to Follow-up|1|||
125319203|NCT00770653|450800112|FG001|Overall Study|Lost to Follow-up|2|||
125319204|NCT00770653|450800111|FG000|Overall Study|Physician Decision|1|||
125319205|NCT00770653|450800112|FG001|Overall Study|Physician Decision|0|||
125319206|NCT04906499|450800117|FG000|Overall Study|Lack of time|1|||
125319207|NCT03525444|450800123|FG000|Overall Study|Adverse Event|0|||
125319208|NCT03525444|450800124|FG001|Overall Study|Adverse Event|1|||
125319209|NCT03525444|450800123|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
125319210|NCT03525444|450800124|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
125319211|NCT03525444|450800123|FG000|Overall Study|Other|0|||
125319212|NCT03525444|450800124|FG001|Overall Study|Other|1|||
125319213|NCT00262860|450800125|FG000|Overall Study|Adverse Event|2|||
125319214|NCT02741128|450800126|FG000|Overall Study|Protocol Violation|4|||
125319215|NCT02741128|450800127|FG001|Overall Study|Protocol Violation|1|||
125319216|NCT02741128|450800126|FG000|Overall Study|Withdrawal by Subject|2|||
125319217|NCT02741128|450800127|FG001|Overall Study|Withdrawal by Subject|0|||
125319218|NCT02741128|450800126|FG000|Overall Study|Lost to Follow-up|1|||
125319219|NCT02741128|450800127|FG001|Overall Study|Lost to Follow-up|0|||
125319220|NCT01419769|450800128|FG000|Overall Study|Did not receive the AXIOS stent|3|||
125319221|NCT01419769|450800128|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
125319222|NCT00878501|450800129|FG000|Overall Study|Adverse Event|11|||
125319223|NCT00878501|450800130|FG001|Overall Study|Adverse Event|3|||
125319224|NCT00878501|450800131|FG002|Overall Study|Adverse Event|3|||
125319225|NCT00878501|450800129|FG000|Overall Study|Lack of Efficacy|2|||
125319226|NCT00878501|450800130|FG001|Overall Study|Lack of Efficacy|1|||
125319227|NCT00878501|450800131|FG002|Overall Study|Lack of Efficacy|0|||
125319228|NCT00878501|450800129|FG000|Overall Study|Withdrawal by Subject|2|||
125319229|NCT00878501|450800130|FG001|Overall Study|Withdrawal by Subject|1|||
125319230|NCT00878501|450800131|FG002|Overall Study|Withdrawal by Subject|2|||
125319231|NCT00878501|450800129|FG000|Overall Study|Protocol Violation|0|||
125319232|NCT00878501|450800130|FG001|Overall Study|Protocol Violation|0|||
125319233|NCT00878501|450800131|FG002|Overall Study|Protocol Violation|1|||
125319234|NCT00878501|450800129|FG000|Overall Study|Incorrect enrolment|1|||
125319235|NCT00878501|450800130|FG001|Overall Study|Incorrect enrolment|2|||
125319236|NCT00878501|450800131|FG002|Overall Study|Incorrect enrolment|0|||
125319237|NCT00878501|450800129|FG000|Overall Study|Intake of prohibited concom. medication|0|||
125319238|NCT00878501|450800130|FG001|Overall Study|Intake of prohibited concom. medication|0|||
125319239|NCT00878501|450800131|FG002|Overall Study|Intake of prohibited concom. medication|1|||
125319240|NCT00878501|450800129|FG000|Overall Study|Mis-randomisation of patient|1|||
125319241|NCT00878501|450800130|FG001|Overall Study|Mis-randomisation of patient|0|||
125319242|NCT00878501|450800131|FG002|Overall Study|Mis-randomisation of patient|0|||
125319243|NCT00878501|450800129|FG000|Overall Study|Administrative|0|||
125319244|NCT00878501|450800130|FG001|Overall Study|Administrative|0|||
125319245|NCT00878501|450800131|FG002|Overall Study|Administrative|1|||
125319246|NCT00812708|450800132|FG000|Overall Study|Device could not be implanted|2|||
125319247|NCT00812708|450800132|FG000|Overall Study|Lack of medical insurance|1|||
125319248|NCT00812708|450800132|FG000|Overall Study|Switched to another study|1|||
125319249|NCT00812708|450800132|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
125319250|NCT00812708|450800132|FG000|Overall Study|Signed consent but later withdrew|3|||
125319251|NCT01959503|450800133|FG000|Overall Study|Death|2|||
125319252|NCT01959503|450800134|FG001|Overall Study|Death|1|||
125319253|NCT01959503|450800133|FG000|Overall Study|Randomized but not treated|1|||
125319254|NCT01959503|450800134|FG001|Overall Study|Randomized but not treated|1|||
125319255|NCT01600326|450800135|FG000|Overall Study|Lost to Follow-up|1|||
125319256|NCT01600326|450800136|FG001|Overall Study|Lost to Follow-up|1|||
125662365|NCT01255722|452052486|FG000|Overall Study|beta-blocker contraindicated|2|||
125662366|NCT01255722|452052487|FG001|Overall Study|beta-blocker contraindicated|0|||
125662367|NCT01255722|452052488|FG002|Overall Study|beta-blocker contraindicated|0|||
125319257|NCT01131507|450800138|FG000|Overall Study|Adverse Event|1|||
125319258|NCT01131507|450800138|FG000|Overall Study|Lost to Follow-up|1|||
125319259|NCT01131507|450800138|FG000|Overall Study|Withdrawal by Subject|1|||
125319260|NCT01393158|450800139|FG000|Overall Study|Adverse Event|1|||
125319261|NCT01393158|450800140|FG001|Overall Study|Adverse Event|0|||
125319262|NCT03224130|450800141|FG000|Overall Study|consent issue|0|||
125319263|NCT03224130|450800142|FG001|Overall Study|consent issue|1|||
125319264|NCT03095651|450800145|FG000|Overall Study|Lost to Follow-up|1|||
125319265|NCT03095651|450800146|FG001|Overall Study|Lost to Follow-up|1|||
125319266|NCT03095651|450800147|FG002|Overall Study|Lost to Follow-up|0|||
125319267|NCT03095651|450800148|FG003|Overall Study|Lost to Follow-up|1|||
125319268|NCT03095651|450800149|FG004|Overall Study|Lost to Follow-up|0|||
125319269|NCT03095651|450800150|FG005|Overall Study|Lost to Follow-up|0|||
125319270|NCT03095651|450800151|FG006|Overall Study|Lost to Follow-up|0|||
125319271|NCT03095651|450800152|FG007|Overall Study|Lost to Follow-up|0|||
125319272|NCT03095651|450800145|FG000|Overall Study|Withdrawal by Subject|0|||
125319273|NCT03095651|450800146|FG001|Overall Study|Withdrawal by Subject|0|||
125319274|NCT03095651|450800147|FG002|Overall Study|Withdrawal by Subject|0|||
125319275|NCT03095651|450800148|FG003|Overall Study|Withdrawal by Subject|0|||
125319276|NCT03095651|450800149|FG004|Overall Study|Withdrawal by Subject|0|||
125319277|NCT03095651|450800150|FG005|Overall Study|Withdrawal by Subject|1|||
125319278|NCT03095651|450800151|FG006|Overall Study|Withdrawal by Subject|0|||
125319279|NCT03095651|450800152|FG007|Overall Study|Withdrawal by Subject|0|||
125319280|NCT02587520|450800158|FG000|Overall Study|Protocol Violation|2|||
125319281|NCT02587520|450800159|FG001|Overall Study|Protocol Violation|0|||
125319282|NCT02587520|450800160|FG002|Overall Study|Protocol Violation|0|||
125319283|NCT02587520|450800161|FG003|Overall Study|Protocol Violation|2|||
125319284|NCT02587520|450800162|FG004|Overall Study|Protocol Violation|0|||
125319285|NCT02587520|450800163|FG005|Overall Study|Protocol Violation|1|||
125319286|NCT02587520|450800164|FG006|Overall Study|Protocol Violation|1|||
125319287|NCT02587520|450800165|FG007|Overall Study|Protocol Violation|1|||
125319288|NCT02587520|450800166|FG008|Overall Study|Protocol Violation|3|||
125319289|NCT02587520|450800167|FG009|Overall Study|Protocol Violation|3|||
125319290|NCT02587520|450800168|FG010|Overall Study|Protocol Violation|1|||
125319291|NCT02587520|450800169|FG011|Overall Study|Protocol Violation|2|||
125319292|NCT02587520|450800170|FG012|Overall Study|Protocol Violation|0|||
125319293|NCT02587520|450800171|FG013|Overall Study|Protocol Violation|0|||
125319294|NCT02587520|450800172|FG014|Overall Study|Protocol Violation|0|||
125319295|NCT02587520|450800173|FG015|Overall Study|Protocol Violation|0|||
125319296|NCT02587520|450800174|FG016|Overall Study|Protocol Violation|0|||
125319297|NCT02587520|450800175|FG017|Overall Study|Protocol Violation|0|||
125319298|NCT02587520|450800158|FG000|Overall Study|Adverse Event|0|||
125319299|NCT02587520|450800159|FG001|Overall Study|Adverse Event|0|||
125319300|NCT02587520|450800160|FG002|Overall Study|Adverse Event|0|||
125319301|NCT02587520|450800161|FG003|Overall Study|Adverse Event|0|||
125319302|NCT02587520|450800162|FG004|Overall Study|Adverse Event|0|||
125319303|NCT02587520|450800163|FG005|Overall Study|Adverse Event|0|||
125319304|NCT02587520|450800164|FG006|Overall Study|Adverse Event|0|||
125319305|NCT02587520|450800165|FG007|Overall Study|Adverse Event|0|||
125319306|NCT02587520|450800166|FG008|Overall Study|Adverse Event|0|||
125319307|NCT02587520|450800167|FG009|Overall Study|Adverse Event|0|||
125319308|NCT02587520|450800168|FG010|Overall Study|Adverse Event|0|||
125319309|NCT02587520|450800169|FG011|Overall Study|Adverse Event|1|||
125319310|NCT02587520|450800170|FG012|Overall Study|Adverse Event|0|||
125319311|NCT02587520|450800171|FG013|Overall Study|Adverse Event|0|||
125319312|NCT02587520|450800172|FG014|Overall Study|Adverse Event|0|||
125319313|NCT02587520|450800173|FG015|Overall Study|Adverse Event|0|||
125319314|NCT02587520|450800174|FG016|Overall Study|Adverse Event|0|||
125319315|NCT02587520|450800175|FG017|Overall Study|Adverse Event|0|||
125319316|NCT02587520|450800158|FG000|Overall Study|Withdrawal by Subject|0|||
125319317|NCT02587520|450800159|FG001|Overall Study|Withdrawal by Subject|0|||
125319318|NCT02587520|450800160|FG002|Overall Study|Withdrawal by Subject|1|||
125319319|NCT02587520|450800161|FG003|Overall Study|Withdrawal by Subject|1|||
125319320|NCT02587520|450800162|FG004|Overall Study|Withdrawal by Subject|0|||
125319321|NCT02587520|450800163|FG005|Overall Study|Withdrawal by Subject|1|||
125319322|NCT02587520|450800164|FG006|Overall Study|Withdrawal by Subject|1|||
125319323|NCT02587520|450800165|FG007|Overall Study|Withdrawal by Subject|0|||
125319324|NCT02587520|450800166|FG008|Overall Study|Withdrawal by Subject|0|||
125319325|NCT02587520|450800167|FG009|Overall Study|Withdrawal by Subject|0|||
125319326|NCT02587520|450800168|FG010|Overall Study|Withdrawal by Subject|0|||
125319327|NCT02587520|450800169|FG011|Overall Study|Withdrawal by Subject|0|||
125662368|NCT03835975|452052491|FG000|Overall Study|Lost to Follow-up|1|||
125662369|NCT03835975|452052492|FG001|Overall Study|Lost to Follow-up|1|||
125662370|NCT03835975|452052493|FG002|Overall Study|Lost to Follow-up|0|||
125662371|NCT03835975|452052494|FG003|Overall Study|Lost to Follow-up|0|||
125662372|NCT03835975|452052495|FG004|Overall Study|Lost to Follow-up|0|||
125662373|NCT03835975|452052491|FG000|Overall Study|No longer met eligibility criteria|0|||
125662374|NCT03835975|452052492|FG001|Overall Study|No longer met eligibility criteria|1|||
125662375|NCT03835975|452052493|FG002|Overall Study|No longer met eligibility criteria|0|||
125662376|NCT03835975|452052494|FG003|Overall Study|No longer met eligibility criteria|0|||
125319328|NCT02587520|450800170|FG012|Overall Study|Withdrawal by Subject|0|||
125319329|NCT02587520|450800171|FG013|Overall Study|Withdrawal by Subject|1|||
125319330|NCT02587520|450800172|FG014|Overall Study|Withdrawal by Subject|0|||
125319331|NCT02587520|450800173|FG015|Overall Study|Withdrawal by Subject|0|||
125319332|NCT02587520|450800174|FG016|Overall Study|Withdrawal by Subject|0|||
125319333|NCT02587520|450800175|FG017|Overall Study|Withdrawal by Subject|0|||
125319334|NCT02587520|450800158|FG000|Overall Study|Lost to Follow-up|0|||
125319335|NCT02587520|450800159|FG001|Overall Study|Lost to Follow-up|2|||
125319336|NCT02587520|450800160|FG002|Overall Study|Lost to Follow-up|0|||
125319337|NCT02587520|450800161|FG003|Overall Study|Lost to Follow-up|2|||
125662377|NCT03835975|452052495|FG004|Overall Study|No longer met eligibility criteria|0|||
125662378|NCT03835975|452052491|FG000|Overall Study|Protocol Violation|1|||
125662379|NCT03835975|452052492|FG001|Overall Study|Protocol Violation|1|||
125662380|NCT03835975|452052493|FG002|Overall Study|Protocol Violation|2|||
125662381|NCT03835975|452052494|FG003|Overall Study|Protocol Violation|0|||
125662382|NCT03835975|452052495|FG004|Overall Study|Protocol Violation|0|||
125662383|NCT03835975|452052491|FG000|Overall Study|Withdrawal by Subject|1|||
125662384|NCT03835975|452052492|FG001|Overall Study|Withdrawal by Subject|0|||
125662385|NCT03835975|452052493|FG002|Overall Study|Withdrawal by Subject|1|||
125662386|NCT03835975|452052494|FG003|Overall Study|Withdrawal by Subject|1|||
125662387|NCT03835975|452052495|FG004|Overall Study|Withdrawal by Subject|0|||
125210539|NCT02636699|450395599|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
125210540|NCT02636699|450395600|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
125210541|NCT02636699|450395601|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
125210542|NCT02636699|450395599|FG000|Screening Period|Withdrawal by Subject|0|||
125210543|NCT02636699|450395600|FG001|Screening Period|Withdrawal by Subject|0|||
125210544|NCT02636699|450395601|FG002|Screening Period|Withdrawal by Subject|23|||
125210545|NCT02636699|450395599|FG000|Screening Period|Adverse Event|0|||
125210546|NCT02636699|450395600|FG001|Screening Period|Adverse Event|0|||
125210547|NCT02636699|450395601|FG002|Screening Period|Adverse Event|1|||
125210548|NCT02636699|450395599|FG000|Screening Period|Other not specified|0|||
125210549|NCT02636699|450395600|FG001|Screening Period|Other not specified|0|||
125210550|NCT02636699|450395601|FG002|Screening Period|Other not specified|3|||
125210551|NCT02636699|450395599|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
125210552|NCT02636699|450395600|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
125210553|NCT02636699|450395601|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
125210554|NCT02636699|450395599|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
125210555|NCT02636699|450395600|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
125210556|NCT02636699|450395601|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
125210557|NCT02636699|450395599|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
125210558|NCT02636699|450395600|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
125210559|NCT02636699|450395601|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
125210560|NCT02636699|450395599|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
125210561|NCT02636699|450395600|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
125210562|NCT02636699|450395601|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
125210563|NCT02636699|450395599|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
125210564|NCT02636699|450395600|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
125210565|NCT02636699|450395601|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
125210566|NCT02636699|450395599|FG000|Treatment and Follow-up Periods|Other|3|||
125210567|NCT02636699|450395600|FG001|Treatment and Follow-up Periods|Other|1|||
125210568|NCT02636699|450395601|FG002|Treatment and Follow-up Periods|Other|0|||
125210569|NCT01636947|450395606|FG000|Overall Study|Not Treated|2|||
125210570|NCT01636947|450395607|FG001|Overall Study|Not Treated|2|||
125210571|NCT01636947|450395606|FG000|Overall Study|Lost to Follow-up|4|||
125210572|NCT01636947|450395607|FG001|Overall Study|Lost to Follow-up|0|||
125210573|NCT01636947|450395606|FG000|Overall Study|Protocol Violation|1|||
125210574|NCT01636947|450395607|FG001|Overall Study|Protocol Violation|1|||
125210575|NCT01636947|450395606|FG000|Overall Study|Withdrawal by Subject|3|||
125210576|NCT01636947|450395607|FG001|Overall Study|Withdrawal by Subject|3|||
125210577|NCT01636947|450395606|FG000|Overall Study|Adverse Event|1|||
125210578|NCT01636947|450395607|FG001|Overall Study|Adverse Event|1|||
125210579|NCT01636947|450395606|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
125210580|NCT01636947|450395607|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
125210581|NCT00369161|450395608|FG000|Overall Study|Adverse Event|15|||
125210582|NCT00369161|450395609|FG001|Overall Study|Adverse Event|13|||
125210583|NCT00369161|450395608|FG000|Overall Study|Abnormal laboratory value|0|||
125210584|NCT00369161|450395609|FG001|Overall Study|Abnormal laboratory value|1|||
125210585|NCT00369161|450395608|FG000|Overall Study|Lack of Efficacy|3|||
125210586|NCT00369161|450395609|FG001|Overall Study|Lack of Efficacy|1|||
125210587|NCT00369161|450395608|FG000|Overall Study|Protocol Violation|0|||
125210588|NCT00369161|450395609|FG001|Overall Study|Protocol Violation|2|||
125210589|NCT00369161|450395608|FG000|Overall Study|Withdrawal by Subject|2|||
125210590|NCT00369161|450395609|FG001|Overall Study|Withdrawal by Subject|3|||
125210591|NCT00369161|450395608|FG000|Overall Study|Death|1|||
125210592|NCT00369161|450395609|FG001|Overall Study|Death|2|||
125210593|NCT00369161|450395608|FG000|Overall Study|Graft loss|4|||
125210594|NCT00369161|450395609|FG001|Overall Study|Graft loss|0|||
125210595|NCT00369161|450395608|FG000|Overall Study|Administrative Problem|2|||
125210596|NCT00369161|450395609|FG001|Overall Study|Administrative Problem|2|||
125210597|NCT02147067|450395610|FG000|Overall Study|Withdrawal by Subject|2|||
125210598|NCT02147067|450395611|FG001|Overall Study|Withdrawal by Subject|2|||
125210599|NCT02603107|450395612|FG000|Randomized Phase|Withdrew consent|8|||
125210600|NCT02603107|450395613|FG001|Randomized Phase|Withdrew consent|15|||
125210601|NCT02603107|450395612|FG000|Randomized Phase|Lost to Follow-up|1|||
125210602|NCT02603107|450395613|FG001|Randomized Phase|Lost to Follow-up|3|||
125210603|NCT02603107|450395612|FG000|Randomized Phase|Adverse Event|2|||
125319338|NCT02587520|450800162|FG004|Overall Study|Lost to Follow-up|0|||
125319339|NCT02587520|450800163|FG005|Overall Study|Lost to Follow-up|1|||
125319340|NCT02587520|450800164|FG006|Overall Study|Lost to Follow-up|1|||
125319341|NCT02587520|450800165|FG007|Overall Study|Lost to Follow-up|1|||
125319342|NCT02587520|450800166|FG008|Overall Study|Lost to Follow-up|0|||
125319343|NCT02587520|450800167|FG009|Overall Study|Lost to Follow-up|2|||
125319344|NCT02587520|450800168|FG010|Overall Study|Lost to Follow-up|2|||
125319345|NCT02587520|450800169|FG011|Overall Study|Lost to Follow-up|1|||
125319346|NCT02587520|450800170|FG012|Overall Study|Lost to Follow-up|0|||
125319347|NCT02587520|450800171|FG013|Overall Study|Lost to Follow-up|0|||
125319348|NCT02587520|450800172|FG014|Overall Study|Lost to Follow-up|0|||
125319349|NCT02587520|450800173|FG015|Overall Study|Lost to Follow-up|0|||
125319350|NCT02587520|450800174|FG016|Overall Study|Lost to Follow-up|0|||
125319351|NCT02587520|450800175|FG017|Overall Study|Lost to Follow-up|0|||
125319352|NCT01751061|450800176|FG000|Overall Study|Death|1|||
125319353|NCT01751061|450800177|FG001|Overall Study|Death|0|||
125319354|NCT01751061|450800176|FG000|Overall Study|patient death|5|||
125319355|NCT01751061|450800177|FG001|Overall Study|patient death|0|||
125319356|NCT01751061|450800176|FG000|Overall Study|Lost to Follow-up|40|||
125319357|NCT01751061|450800177|FG001|Overall Study|Lost to Follow-up|25|||
125319358|NCT01751061|450800176|FG000|Overall Study|patient regained decisional capacity|4|||
125319359|NCT01751061|450800177|FG001|Overall Study|patient regained decisional capacity|8|||
125319360|NCT01751061|450800176|FG000|Overall Study|Withdrawal by Subject|4|||
125319361|NCT01751061|450800177|FG001|Overall Study|Withdrawal by Subject|1|||
125319362|NCT01751061|450800176|FG000|Overall Study|Physician Decision|2|||
125319363|NCT01751061|450800177|FG001|Overall Study|Physician Decision|0|||
125319364|NCT01194830|450800179|FG000|Overall Study|Adverse Event|3|||
125319365|NCT01194830|450800180|FG001|Overall Study|Adverse Event|2|||
125319366|NCT01194830|450800179|FG000|Overall Study|Protocol Violation|5|||
125319367|NCT01194830|450800180|FG001|Overall Study|Protocol Violation|4|||
125319368|NCT01194830|450800179|FG000|Overall Study|Lost to Follow-up|9|||
125319369|NCT01194830|450800180|FG001|Overall Study|Lost to Follow-up|7|||
125319370|NCT01194830|450800179|FG000|Overall Study|Withdrawal by Subject|2|||
125319371|NCT01194830|450800180|FG001|Overall Study|Withdrawal by Subject|1|||
125319372|NCT01194830|450800179|FG000|Overall Study|Lack of Efficacy|1|||
125319373|NCT01194830|450800180|FG001|Overall Study|Lack of Efficacy|1|||
125319374|NCT01194830|450800179|FG000|Overall Study|Non-compliance issues|4|||
125319375|NCT01194830|450800180|FG001|Overall Study|Non-compliance issues|4|||
125319376|NCT01194830|450800179|FG000|Overall Study|Other Reason|12|||
125319377|NCT01194830|450800180|FG001|Overall Study|Other Reason|8|||
125319378|NCT01815918|450800183|FG000|Overall Study|Patient samples not analyzable|3|||
125319379|NCT01815918|450800184|FG001|Overall Study|Patient samples not analyzable|4|||
125319380|NCT01815918|450800183|FG000|Overall Study|Lack of Efficacy|15|||
125319381|NCT01815918|450800184|FG001|Overall Study|Lack of Efficacy|15|||
125319382|NCT02814916|450800187|FG000|Overall Study|Withdrawal of consent|0|||
125319383|NCT02814916|450800188|FG001|Overall Study|Withdrawal of consent|2|||
125319384|NCT02814916|450800189|FG002|Overall Study|Withdrawal of consent|0|||
125319385|NCT02814916|450800187|FG000|Overall Study|Lost to Follow-up|0|||
125319386|NCT02814916|450800188|FG001|Overall Study|Lost to Follow-up|1|||
125319387|NCT02814916|450800189|FG002|Overall Study|Lost to Follow-up|0|||
125319388|NCT02814916|450800187|FG000|Overall Study|Other, not specified|0|||
125319389|NCT02814916|450800188|FG001|Overall Study|Other, not specified|1|||
125319390|NCT02814916|450800189|FG002|Overall Study|Other, not specified|0|||
125319391|NCT04739982|450800200|FG000|Overall Study|Lost to Follow-up|176|||
125319392|NCT04739982|450800201|FG001|Overall Study|Lost to Follow-up|65|||
125319393|NCT04739982|450800200|FG000|Overall Study|Withdrawal by Subject|19|||
125319394|NCT04739982|450800201|FG001|Overall Study|Withdrawal by Subject|0|||
125319395|NCT04739982|450800200|FG000|Overall Study|Protocol Violation|0|||
125319396|NCT04739982|450800201|FG001|Overall Study|Protocol Violation|5|||
125319397|NCT00702702|450800202|FG000|Overall Study|Study prematurely terminated|56|||
125319398|NCT02240485|450800203|FG000|3 Months Post-admission|Lost to Follow-up|1|||
125319399|NCT02240485|450800204|FG001|3 Months Post-admission|Lost to Follow-up|5|||
125319400|NCT02240485|450800203|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
125319401|NCT02240485|450800204|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
125319402|NCT02240485|450800203|FG000|9 Months Post-admission|Lost to Follow-up|3|||
125319403|NCT02240485|450800204|FG001|9 Months Post-admission|Lost to Follow-up|1|||
125319404|NCT02240485|450800203|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
125319405|NCT02240485|450800204|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
125319406|NCT02240485|450800203|FG000|18 Months Post-admission|Lost to Follow-up|1|||
125319407|NCT02240485|450800204|FG001|18 Months Post-admission|Lost to Follow-up|1|||
125319408|NCT02240485|450800203|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
125319409|NCT02240485|450800204|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
125319410|NCT00953667|450800205|FG000|Overall Study|Lost to Follow-up|11|||
125319411|NCT00953667|450800205|FG000|Overall Study|Physician Decision|35|||
125319412|NCT00953667|450800205|FG000|Overall Study|Withdrawal by Subject|63|||
125319413|NCT00953667|450800205|FG000|Overall Study|Adverse Event|10|||
125319414|NCT00953667|450800205|FG000|Overall Study|poor venous access,unable to draw blood|4|||
125319415|NCT04819945|450800206|FG000|Overall Study|Lost to Follow-up|1|||
125319416|NCT00475670|450800207|FG000|Overall Study|Death|0|||
125319417|NCT00475670|450800208|FG001|Overall Study|Death|1|||
125319418|NCT00475670|450800207|FG000|Overall Study|Lack of Efficacy|3|||
125319419|NCT00475670|450800208|FG001|Overall Study|Lack of Efficacy|34|||
125319420|NCT00475670|450800207|FG000|Overall Study|Refused treatment|0|||
125319421|NCT00475670|450800208|FG001|Overall Study|Refused treatment|2|||
125319422|NCT00475670|450800207|FG000|Overall Study|Failure to Return|0|||
125319423|NCT00475670|450800208|FG001|Overall Study|Failure to Return|1|||
125319424|NCT00475670|450800207|FG000|Overall Study|Other|0|||
125319425|NCT00475670|450800208|FG001|Overall Study|Other|3|||
125319426|NCT04949191|450800209|FG000|Overall Study|Non-compliance with Study Drug|1|||
125319427|NCT04949191|450800210|FG001|Overall Study|Non-compliance with Study Drug|0|||
125319428|NCT04949191|450800211|FG002|Overall Study|Non-compliance with Study Drug|0|||
125319429|NCT04949191|450800212|FG003|Overall Study|Non-compliance with Study Drug|0|||
125319430|NCT04949191|450800209|FG000|Overall Study|Progressive Disease|0|||
125319431|NCT04949191|450800210|FG001|Overall Study|Progressive Disease|1|||
125319432|NCT04949191|450800211|FG002|Overall Study|Progressive Disease|0|||
125319433|NCT04949191|450800212|FG003|Overall Study|Progressive Disease|0|||
125319434|NCT04949191|450800209|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
125319435|NCT04949191|450800210|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
125319436|NCT04949191|450800211|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
125319437|NCT04949191|450800212|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
125319438|NCT04949191|450800209|FG000|Overall Study|Sponsor Terminated Study|0|||
125319439|NCT04949191|450800210|FG001|Overall Study|Sponsor Terminated Study|0|||
125319440|NCT04949191|450800211|FG002|Overall Study|Sponsor Terminated Study|1|||
125319441|NCT04949191|450800212|FG003|Overall Study|Sponsor Terminated Study|1|||
125319442|NCT02913482|450800213|FG000|Overall Study|Death|0|||
125319443|NCT02913482|450800214|FG001|Overall Study|Death|2|||
125319444|NCT02913482|450800215|FG002|Overall Study|Death|2|||
125319445|NCT02913482|450800213|FG000|Overall Study|Progressive Disease|1|||
125319446|NCT02913482|450800214|FG001|Overall Study|Progressive Disease|1|||
125319447|NCT02913482|450800215|FG002|Overall Study|Progressive Disease|1|||
125319448|NCT02913482|450800213|FG000|Overall Study|Reason not specified|0|||
125319449|NCT02913482|450800214|FG001|Overall Study|Reason not specified|0|||
125319450|NCT02913482|450800215|FG002|Overall Study|Reason not specified|1|||
125319451|NCT02913482|450800213|FG000|Overall Study|Withdrawal by Subject|0|||
125319452|NCT02913482|450800214|FG001|Overall Study|Withdrawal by Subject|1|||
125319453|NCT02913482|450800215|FG002|Overall Study|Withdrawal by Subject|1|||
125319454|NCT00918385|450800218|FG000|Monotherapy|Adverse Event|1|||
125319455|NCT00918385|450800219|FG001|Monotherapy|Adverse Event|6|||
125319456|NCT00918385|450800218|FG000|Monotherapy|Complicating illness|1|||
125319457|NCT00918385|450800219|FG001|Monotherapy|Complicating illness|0|||
125319458|NCT00918385|450800218|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
125319459|NCT00918385|450800219|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
125319460|NCT00918385|450800218|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
125319461|NCT00918385|450800219|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
125319462|NCT00918385|450800218|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
125319463|NCT00918385|450800219|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
125319464|NCT00918385|450800218|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
125319465|NCT00918385|450800219|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
125319466|NCT00317473|450800221|FG000|Overall Study|Withdrawal by Subject|2|||
125319467|NCT00317473|450800222|FG001|Overall Study|Withdrawal by Subject|1|||
125319468|NCT00317473|450800223|FG002|Overall Study|Withdrawal by Subject|2|||
125319469|NCT00317473|450800224|FG003|Overall Study|Withdrawal by Subject|1|||
125319470|NCT00317473|450800225|FG004|Overall Study|Withdrawal by Subject|3|||
125319471|NCT00317473|450800226|FG005|Overall Study|Withdrawal by Subject|1|||
125319472|NCT00317473|450800221|FG000|Overall Study|Relocation|1|||
125319473|NCT00317473|450800222|FG001|Overall Study|Relocation|0|||
125319474|NCT00317473|450800223|FG002|Overall Study|Relocation|1|||
125319475|NCT00317473|450800224|FG003|Overall Study|Relocation|1|||
125319476|NCT00317473|450800225|FG004|Overall Study|Relocation|5|||
125319477|NCT00317473|450800226|FG005|Overall Study|Relocation|2|||
125319478|NCT00317473|450800221|FG000|Overall Study|Death|1|||
125319479|NCT00317473|450800222|FG001|Overall Study|Death|0|||
125319480|NCT00317473|450800223|FG002|Overall Study|Death|0|||
125319481|NCT00317473|450800224|FG003|Overall Study|Death|0|||
125319482|NCT00317473|450800225|FG004|Overall Study|Death|0|||
125319483|NCT00317473|450800226|FG005|Overall Study|Death|0|||
125319484|NCT00317473|450800221|FG000|Overall Study|Other|0|||
125319485|NCT00317473|450800222|FG001|Overall Study|Other|2|||
125319486|NCT00317473|450800223|FG002|Overall Study|Other|0|||
125319487|NCT00317473|450800224|FG003|Overall Study|Other|0|||
125540734|NCT00774930|451609436|FG000|LTOLE Phase|Subject decision|0|||
125319488|NCT00317473|450800225|FG004|Overall Study|Other|0|||
125319489|NCT00317473|450800226|FG005|Overall Study|Other|0|||
125319490|NCT03416868|450800230|FG000|Overall Study|Withdrawal by Subject|2|||
125319491|NCT03416868|450800230|FG000|Overall Study|Lost to Follow-up|1|||
125210604|NCT02603107|450395613|FG001|Randomized Phase|Adverse Event|0|||
125210605|NCT02603107|450395612|FG000|Randomized Phase|Death|1|||
125210606|NCT02603107|450395613|FG001|Randomized Phase|Death|1|||
125210607|NCT02603107|450395612|FG000|Randomized Phase|Non-compliance with study drug|1|||
125210608|NCT02603107|450395613|FG001|Randomized Phase|Non-compliance with study drug|1|||
125210609|NCT02603107|450395612|FG000|Randomized Phase|Investigator's discretion|0|||
125210610|NCT02603107|450395613|FG001|Randomized Phase|Investigator's discretion|1|||
125210611|NCT02603107|450395612|FG000|Randomized Phase|Lack of Efficacy|1|||
125210612|NCT02603107|450395613|FG001|Randomized Phase|Lack of Efficacy|0|||
125319492|NCT01323582|450800231|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
125319493|NCT01323582|450800232|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
125319494|NCT01323582|450800231|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
125662388|NCT00061945|452052496|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
125662389|NCT00061945|452052497|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
125662390|NCT00061945|452052496|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
125662391|NCT00061945|452052497|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
125662392|NCT00061945|452052496|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
125662393|NCT00061945|452052497|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
125662394|NCT00061945|452052496|FG000|Course IV: Alemtuzumab|Early exits|6|||
125662395|NCT00061945|452052497|FG001|Course IV: Alemtuzumab|Early exits|15|||
125662396|NCT00975884|452052499|FG000|Overall Study|Adverse Event|1|||
125662397|NCT00975884|452052500|FG001|Overall Study|Adverse Event|0|||
125662398|NCT00975884|452052499|FG000|Overall Study|Lost to Follow-up|5|||
125662399|NCT00975884|452052500|FG001|Overall Study|Lost to Follow-up|3|||
125662400|NCT00975884|452052499|FG000|Overall Study|Withdrawal by Subject|9|||
125662401|NCT00975884|452052500|FG001|Overall Study|Withdrawal by Subject|9|||
125662402|NCT00975884|452052499|FG000|Overall Study|Other|1|||
125662403|NCT00975884|452052500|FG001|Overall Study|Other|3|||
125662404|NCT01656967|452052501|FG000|Overall Study|faulty monitor|1|||
125662405|NCT01656967|452052502|FG001|Overall Study|faulty monitor|0|||
125662406|NCT01656967|452052501|FG000|Overall Study|unsuccessful ETT insertion|3|||
125662407|NCT01656967|452052502|FG001|Overall Study|unsuccessful ETT insertion|2|||
125662408|NCT05166512|452052503|FG000|Randomized|Lost to Follow-up|2|||
125319495|NCT01323582|450800232|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
125319496|NCT01323582|450800231|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
125319497|NCT01323582|450800232|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
125319498|NCT00083889|450800233|FG000|Overall Study|Adverse Event|76|||
125319499|NCT00083889|450800234|FG001|Overall Study|Adverse Event|86|||
125319500|NCT00083889|450800233|FG000|Overall Study|Protocol Violation|2|||
125319501|NCT00083889|450800234|FG001|Overall Study|Protocol Violation|2|||
125319502|NCT00083889|450800233|FG000|Overall Study|Withdrawal by Subject|22|||
125319503|NCT00083889|450800234|FG001|Overall Study|Withdrawal by Subject|24|||
125319504|NCT00083889|450800233|FG000|Overall Study|Lack of Efficacy|240|||
125319505|NCT00083889|450800234|FG001|Overall Study|Lack of Efficacy|219|||
125319506|NCT00083889|450800233|FG000|Overall Study|Decision of sponsor|32|||
125319507|NCT00083889|450800234|FG001|Overall Study|Decision of sponsor|4|||
125319508|NCT00083889|450800233|FG000|Overall Study|Randomized: did not take study drug|0|||
125319509|NCT00083889|450800234|FG001|Overall Study|Randomized: did not take study drug|15|||
125319510|NCT00083889|450800233|FG000|Overall Study|Completed on marketed sunitinub|3|||
125319511|NCT00083889|450800234|FG001|Overall Study|Completed on marketed sunitinub|0|||
125319512|NCT00083889|450800233|FG000|Overall Study|Crossover to SU011248|0|||
125319513|NCT00083889|450800234|FG001|Overall Study|Crossover to SU011248|25|||
125319514|NCT00388349|450800235|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
125319515|NCT00388349|450800236|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
125319516|NCT00112736|450800237|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
125319517|NCT00112736|450800238|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
125319518|NCT05435339|450800239|FG000|Overall Study|Death|1|||
125319519|NCT05435339|450800240|FG001|Overall Study|Death|0|||
125319520|NCT05435339|450800241|FG002|Overall Study|Death|3|||
125319521|NCT05435339|450800242|FG003|Overall Study|Death|1|||
125319522|NCT05435339|450800243|FG004|Overall Study|Death|3|||
125319523|NCT05435339|450800244|FG005|Overall Study|Death|2|||
125319524|NCT05435339|450800245|FG006|Overall Study|Death|4|||
125319525|NCT05435339|450800246|FG007|Overall Study|Death|6|||
125319526|NCT05435339|450800239|FG000|Overall Study|Sponsor Decision|0|||
125662409|NCT05166512|452052504|FG001|Randomized|Lost to Follow-up|0|||
125662410|NCT05166512|452052503|FG000|Randomized|Withdrawal by Subject|1|||
125662411|NCT05166512|452052504|FG001|Randomized|Withdrawal by Subject|0|||
125662412|NCT05166512|452052503|FG000|Baseline Data Collection|Lost to Follow-up|0|||
125662413|NCT05166512|452052504|FG001|Baseline Data Collection|Lost to Follow-up|3|||
125662414|NCT05166512|452052503|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
125210613|NCT02603107|450395612|FG000|Randomized Phase|Protocol Violation|1|||
125210614|NCT02603107|450395613|FG001|Randomized Phase|Protocol Violation|0|||
125210615|NCT02603107|450395612|FG000|Optional Extension Phase|Lost to Follow-up|3|||
125319527|NCT05435339|450800240|FG001|Overall Study|Sponsor Decision|1|||
125319528|NCT05435339|450800241|FG002|Overall Study|Sponsor Decision|0|||
125319529|NCT05435339|450800242|FG003|Overall Study|Sponsor Decision|0|||
125319530|NCT05435339|450800243|FG004|Overall Study|Sponsor Decision|2|||
125319531|NCT05435339|450800244|FG005|Overall Study|Sponsor Decision|1|||
125319532|NCT05435339|450800245|FG006|Overall Study|Sponsor Decision|2|||
125319533|NCT05435339|450800246|FG007|Overall Study|Sponsor Decision|2|||
125319534|NCT05435339|450800239|FG000|Overall Study|Withdrawal by Subject|0|||
125319535|NCT05435339|450800240|FG001|Overall Study|Withdrawal by Subject|0|||
125319536|NCT05435339|450800241|FG002|Overall Study|Withdrawal by Subject|0|||
125319537|NCT05435339|450800242|FG003|Overall Study|Withdrawal by Subject|0|||
125319538|NCT05435339|450800243|FG004|Overall Study|Withdrawal by Subject|1|||
125319539|NCT05435339|450800244|FG005|Overall Study|Withdrawal by Subject|0|||
125319540|NCT05435339|450800245|FG006|Overall Study|Withdrawal by Subject|1|||
125319541|NCT05435339|450800246|FG007|Overall Study|Withdrawal by Subject|1|||
125319542|NCT00537394|450800249|FG000|First Year of Follow-up|Death|7|||
125319543|NCT00537394|450800250|FG001|First Year of Follow-up|Death|0|||
125319544|NCT00537394|450800251|FG002|First Year of Follow-up|Death|0|||
125319545|NCT00537394|450800249|FG000|First Year of Follow-up|Severe debilitation|1|||
125319546|NCT00537394|450800250|FG001|First Year of Follow-up|Severe debilitation|0|||
125319547|NCT00537394|450800251|FG002|First Year of Follow-up|Severe debilitation|1|||
125319548|NCT00537394|450800249|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
125319549|NCT00537394|450800250|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
125319550|NCT00537394|450800251|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
125319551|NCT00537394|450800249|FG000|First Year of Follow-up|Lost to Follow-up|1|||
125319552|NCT00537394|450800250|FG001|First Year of Follow-up|Lost to Follow-up|5|||
125319553|NCT00537394|450800251|FG002|First Year of Follow-up|Lost to Follow-up|1|||
125319554|NCT00537394|450800249|FG000|2nd Year of Follow-up|Death|4|||
125319555|NCT00537394|450800250|FG001|2nd Year of Follow-up|Death|1|||
125319556|NCT00537394|450800251|FG002|2nd Year of Follow-up|Death|2|||
125319557|NCT00537394|450800249|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
125319558|NCT00537394|450800250|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
125319559|NCT00537394|450800251|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
125319560|NCT00537394|450800249|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
125319561|NCT00537394|450800250|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
125319562|NCT00537394|450800251|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
125319563|NCT00537394|450800249|FG000|2nd Year of Follow-up|Clinic site closure|1|||
125319564|NCT00537394|450800250|FG001|2nd Year of Follow-up|Clinic site closure|0|||
125319565|NCT00537394|450800251|FG002|2nd Year of Follow-up|Clinic site closure|0|||
125319566|NCT03473236|450800255|FG000|Overall Study|Withdrawal by Subject|0|||
125319567|NCT03473236|450800256|FG001|Overall Study|Withdrawal by Subject|0|||
125319568|NCT03473236|450800257|FG002|Overall Study|Withdrawal by Subject|0|||
125319569|NCT03473236|450800258|FG003|Overall Study|Withdrawal by Subject|0|||
125319570|NCT03473236|450800259|FG004|Overall Study|Withdrawal by Subject|0|||
125319571|NCT03473236|450800260|FG005|Overall Study|Withdrawal by Subject|1|||
125319572|NCT03473236|450800261|FG006|Overall Study|Withdrawal by Subject|0|||
125319573|NCT03473236|450800262|FG007|Overall Study|Withdrawal by Subject|0|||
125319574|NCT03473236|450800263|FG008|Overall Study|Withdrawal by Subject|1|||
125319575|NCT03473236|450800264|FG009|Overall Study|Withdrawal by Subject|0|||
125319576|NCT00685165|450800265|FG000|Washout Period of 14 Days|Adverse Event|1|||
125319577|NCT00685165|450800266|FG001|Washout Period of 14 Days|Adverse Event|0|||
125319578|NCT05135871|450800267|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
125319579|NCT05135871|450800268|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
125319580|NCT05135871|450800269|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
125319581|NCT05135871|450800270|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
125319582|NCT04886154|450800276|FG000|Overall Study|Adverse Event|0|||
125319583|NCT04886154|450800277|FG001|Overall Study|Adverse Event|0|||
125319584|NCT04886154|450800278|FG002|Overall Study|Adverse Event|0|||
125319585|NCT04886154|450800279|FG003|Overall Study|Adverse Event|0|||
125319586|NCT04886154|450800280|FG004|Overall Study|Adverse Event|1|||
125319587|NCT04886154|450800281|FG005|Overall Study|Adverse Event|0|||
125319588|NCT04886154|450800282|FG006|Overall Study|Adverse Event|0|||
125319589|NCT04886154|450800283|FG007|Overall Study|Adverse Event|1|||
125319590|NCT04886154|450800284|FG008|Overall Study|Adverse Event|1|||
125319591|NCT04886154|450800285|FG009|Overall Study|Adverse Event|0|||
125319592|NCT04886154|450800286|FG010|Overall Study|Adverse Event|0|||
125319593|NCT04886154|450800287|FG011|Overall Study|Adverse Event|1|||
125319594|NCT04886154|450800288|FG012|Overall Study|Adverse Event|0|||
125319595|NCT04886154|450800289|FG013|Overall Study|Adverse Event|0|||
125319596|NCT04886154|450800290|FG014|Overall Study|Adverse Event|3|||
125319597|NCT04886154|450800276|FG000|Overall Study|Lost to Follow-up|1|||
125319598|NCT04886154|450800277|FG001|Overall Study|Lost to Follow-up|0|||
125319599|NCT04886154|450800278|FG002|Overall Study|Lost to Follow-up|2|||
125319600|NCT04886154|450800279|FG003|Overall Study|Lost to Follow-up|0|||
125319601|NCT04886154|450800280|FG004|Overall Study|Lost to Follow-up|17|||
125319602|NCT04886154|450800281|FG005|Overall Study|Lost to Follow-up|7|||
125319603|NCT04886154|450800282|FG006|Overall Study|Lost to Follow-up|8|||
125319604|NCT04886154|450800283|FG007|Overall Study|Lost to Follow-up|7|||
125319605|NCT04886154|450800284|FG008|Overall Study|Lost to Follow-up|8|||
125319606|NCT04886154|450800285|FG009|Overall Study|Lost to Follow-up|0|||
125319607|NCT04886154|450800286|FG010|Overall Study|Lost to Follow-up|2|||
125319608|NCT04886154|450800287|FG011|Overall Study|Lost to Follow-up|0|||
125319609|NCT04886154|450800288|FG012|Overall Study|Lost to Follow-up|0|||
125319610|NCT04886154|450800289|FG013|Overall Study|Lost to Follow-up|0|||
125319611|NCT04886154|450800290|FG014|Overall Study|Lost to Follow-up|0|||
125319612|NCT04886154|450800276|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319613|NCT04886154|450800277|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319614|NCT04886154|450800278|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319615|NCT04886154|450800279|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319616|NCT04886154|450800280|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319617|NCT04886154|450800281|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319618|NCT04886154|450800282|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
125319619|NCT04886154|450800283|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319620|NCT04886154|450800284|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319621|NCT04886154|450800285|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319622|NCT04886154|450800286|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319623|NCT04886154|450800287|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319624|NCT04886154|450800288|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319625|NCT04886154|450800289|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319626|NCT04886154|450800290|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
125319627|NCT04886154|450800276|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319628|NCT04886154|450800277|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319629|NCT04886154|450800278|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319630|NCT04886154|450800279|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319631|NCT04886154|450800280|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125319632|NCT04886154|450800281|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319633|NCT04886154|450800282|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
125319634|NCT04886154|450800283|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125319635|NCT04886154|450800284|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319636|NCT04886154|450800285|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319637|NCT04886154|450800286|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319638|NCT04886154|450800287|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319639|NCT04886154|450800288|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319640|NCT04886154|450800289|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125319641|NCT04886154|450800290|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125319642|NCT04886154|450800276|FG000|Overall Study|Other, Not Specified|0|||
125319643|NCT04886154|450800277|FG001|Overall Study|Other, Not Specified|0|||
125319644|NCT04886154|450800278|FG002|Overall Study|Other, Not Specified|0|||
125319645|NCT04886154|450800279|FG003|Overall Study|Other, Not Specified|0|||
125319646|NCT04886154|450800280|FG004|Overall Study|Other, Not Specified|11|||
125319647|NCT04886154|450800281|FG005|Overall Study|Other, Not Specified|8|||
125319648|NCT04886154|450800282|FG006|Overall Study|Other, Not Specified|9|||
125319649|NCT04886154|450800283|FG007|Overall Study|Other, Not Specified|10|||
125319650|NCT04886154|450800284|FG008|Overall Study|Other, Not Specified|6|||
125319651|NCT04886154|450800285|FG009|Overall Study|Other, Not Specified|1|||
125319652|NCT04886154|450800286|FG010|Overall Study|Other, Not Specified|1|||
125319653|NCT04886154|450800287|FG011|Overall Study|Other, Not Specified|2|||
125319654|NCT04886154|450800288|FG012|Overall Study|Other, Not Specified|1|||
125319655|NCT04886154|450800289|FG013|Overall Study|Other, Not Specified|2|||
125319656|NCT04886154|450800290|FG014|Overall Study|Other, Not Specified|3|||
125319657|NCT01400698|450800292|FG000|Overall Study|Lost to Follow-up|2|||
125319658|NCT01400698|450800293|FG001|Overall Study|Lost to Follow-up|5|||
125319659|NCT01400698|450800294|FG002|Overall Study|Lost to Follow-up|2|||
125319660|NCT01400698|450800295|FG003|Overall Study|Lost to Follow-up|1|||
125319661|NCT01400698|450800296|FG004|Overall Study|Lost to Follow-up|4|||
125319662|NCT01400698|450800297|FG005|Overall Study|Lost to Follow-up|3|||
125319663|NCT01400698|450800292|FG000|Overall Study|Withdrawal by Subject|8|||
125319664|NCT01400698|450800293|FG001|Overall Study|Withdrawal by Subject|2|||
125319665|NCT01400698|450800294|FG002|Overall Study|Withdrawal by Subject|0|||
125319666|NCT01400698|450800295|FG003|Overall Study|Withdrawal by Subject|4|||
125319667|NCT01400698|450800296|FG004|Overall Study|Withdrawal by Subject|1|||
125319668|NCT01400698|450800297|FG005|Overall Study|Withdrawal by Subject|3|||
125319669|NCT01400698|450800292|FG000|Overall Study|Protocol Violation|0|||
125662415|NCT05166512|452052504|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
125319670|NCT01400698|450800293|FG001|Overall Study|Protocol Violation|1|||
125319671|NCT01400698|450800294|FG002|Overall Study|Protocol Violation|0|||
125319672|NCT01400698|450800295|FG003|Overall Study|Protocol Violation|0|||
125662416|NCT05166512|452052503|FG000|Baseline Data Collection|Protocol Violation|2|||
125319673|NCT01400698|450800296|FG004|Overall Study|Protocol Violation|1|||
125319674|NCT01400698|450800297|FG005|Overall Study|Protocol Violation|0|||
125319675|NCT01400698|450800292|FG000|Overall Study|Non-compliance|0|||
125319676|NCT01400698|450800293|FG001|Overall Study|Non-compliance|1|||
125319677|NCT01400698|450800294|FG002|Overall Study|Non-compliance|0|||
125319678|NCT01400698|450800295|FG003|Overall Study|Non-compliance|1|||
125319679|NCT01400698|450800296|FG004|Overall Study|Non-compliance|0|||
125319680|NCT01400698|450800297|FG005|Overall Study|Non-compliance|0|||
125319681|NCT01400698|450800292|FG000|Overall Study|Adverse Event|1|||
125319682|NCT01400698|450800293|FG001|Overall Study|Adverse Event|0|||
125319683|NCT01400698|450800294|FG002|Overall Study|Adverse Event|0|||
125319684|NCT01400698|450800295|FG003|Overall Study|Adverse Event|0|||
125319685|NCT01400698|450800296|FG004|Overall Study|Adverse Event|0|||
125319686|NCT01400698|450800297|FG005|Overall Study|Adverse Event|0|||
125319687|NCT01400698|450800292|FG000|Overall Study|Other|4|||
125319688|NCT01400698|450800293|FG001|Overall Study|Other|2|||
125319689|NCT01400698|450800294|FG002|Overall Study|Other|0|||
125319690|NCT01400698|450800295|FG003|Overall Study|Other|2|||
125319691|NCT01400698|450800296|FG004|Overall Study|Other|1|||
125319692|NCT01400698|450800297|FG005|Overall Study|Other|0|||
125319693|NCT00948064|450801990|FG000|Phase I|No treatment received|1|||
125319694|NCT00948064|450801991|FG001|Phase I|No treatment received|0|||
125319695|NCT00948064|450801992|FG002|Phase I|No treatment received|0|||
125319696|NCT00948064|450801990|FG000|Phase II|Physician Decision|0|||
125319697|NCT00948064|450801991|FG001|Phase II|Physician Decision|0|||
125319698|NCT00948064|450801992|FG002|Phase II|Physician Decision|1|||
125319699|NCT00948064|450801990|FG000|Phase II|Withdrawal by Subject|0|||
125319700|NCT00948064|450801991|FG001|Phase II|Withdrawal by Subject|1|||
125319701|NCT00948064|450801992|FG002|Phase II|Withdrawal by Subject|0|||
125319702|NCT00179621|450801994|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
125319703|NCT00179621|450801995|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
125319704|NCT00179621|450801996|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
125319705|NCT00179621|450801997|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
125319706|NCT00179621|450801994|FG000|Double-Blind Period|Adverse Event|2|||
125319707|NCT00179621|450801995|FG001|Double-Blind Period|Adverse Event|7|||
125319708|NCT00179621|450801996|FG002|Double-Blind Period|Adverse Event|4|||
125319709|NCT00179621|450801997|FG003|Double-Blind Period|Adverse Event|0|||
125319710|NCT00179621|450801994|FG000|Double-Blind Period|Withdrawal by Subject|2|||
125319711|NCT00179621|450801995|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125319712|NCT00179621|450801996|FG002|Double-Blind Period|Withdrawal by Subject|3|||
125319713|NCT00179621|450801997|FG003|Double-Blind Period|Withdrawal by Subject|0|||
125319714|NCT00179621|450801994|FG000|Double-Blind Period|Death|0|||
125319715|NCT00179621|450801995|FG001|Double-Blind Period|Death|1|||
125319716|NCT00179621|450801996|FG002|Double-Blind Period|Death|2|||
125319717|NCT00179621|450801997|FG003|Double-Blind Period|Death|0|||
125319718|NCT00179621|450801994|FG000|Double-Blind Period|Protocol Violation|1|||
125319719|NCT00179621|450801995|FG001|Double-Blind Period|Protocol Violation|0|||
125319720|NCT00179621|450801996|FG002|Double-Blind Period|Protocol Violation|0|||
125319721|NCT00179621|450801997|FG003|Double-Blind Period|Protocol Violation|0|||
125319722|NCT00179621|450801994|FG000|Double-Blind Period|Other|0|||
125319723|NCT00179621|450801995|FG001|Double-Blind Period|Other|2|||
125319724|NCT00179621|450801996|FG002|Double-Blind Period|Other|2|||
125319725|NCT00179621|450801997|FG003|Double-Blind Period|Other|0|||
125319726|NCT00179621|450801994|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
125319727|NCT00179621|450801995|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
125319728|NCT00179621|450801996|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
125319729|NCT00179621|450801997|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
125319730|NCT00179621|450801994|FG000|Open-Label Period|Adverse Event|0|||
125319731|NCT00179621|450801995|FG001|Open-Label Period|Adverse Event|6|||
125319732|NCT00179621|450801996|FG002|Open-Label Period|Adverse Event|5|||
125319733|NCT00179621|450801997|FG003|Open-Label Period|Adverse Event|6|||
125319734|NCT00179621|450801994|FG000|Open-Label Period|Withdrawal by Subject|0|||
125319735|NCT00179621|450801995|FG001|Open-Label Period|Withdrawal by Subject|2|||
125319736|NCT00179621|450801996|FG002|Open-Label Period|Withdrawal by Subject|2|||
125319737|NCT00179621|450801997|FG003|Open-Label Period|Withdrawal by Subject|2|||
125319738|NCT00179621|450801994|FG000|Open-Label Period|Death|0|||
125319739|NCT00179621|450801995|FG001|Open-Label Period|Death|0|||
125319740|NCT00179621|450801996|FG002|Open-Label Period|Death|1|||
125319741|NCT00179621|450801997|FG003|Open-Label Period|Death|2|||
125319742|NCT00179621|450801994|FG000|Open-Label Period|Other|0|||
125319743|NCT00179621|450801995|FG001|Open-Label Period|Other|1|||
125319744|NCT00179621|450801996|FG002|Open-Label Period|Other|1|||
125319745|NCT00179621|450801997|FG003|Open-Label Period|Other|2|||
125319746|NCT02973100|450801999|FG000|Overall Study|Adverse Event|1|||
125319747|NCT02973100|450802000|FG001|Overall Study|Adverse Event|2|||
125319748|NCT02973100|450802001|FG002|Overall Study|Adverse Event|1|||
125319749|NCT02973100|450802002|FG003|Overall Study|Adverse Event|2|||
125319750|NCT02973100|450801999|FG000|Overall Study|Lost to Follow-up|3|||
125319751|NCT02973100|450802000|FG001|Overall Study|Lost to Follow-up|1|||
125319752|NCT02973100|450802001|FG002|Overall Study|Lost to Follow-up|1|||
125319753|NCT02973100|450802002|FG003|Overall Study|Lost to Follow-up|0|||
125319754|NCT02973100|450801999|FG000|Overall Study|Withdrawal by Subject|3|||
125319755|NCT02973100|450802000|FG001|Overall Study|Withdrawal by Subject|5|||
125319756|NCT02973100|450802001|FG002|Overall Study|Withdrawal by Subject|1|||
125319757|NCT02973100|450802002|FG003|Overall Study|Withdrawal by Subject|4|||
125319758|NCT02973100|450801999|FG000|Overall Study|Notification of change in address|0|||
125319759|NCT02973100|450802000|FG001|Overall Study|Notification of change in address|0|||
125319760|NCT02973100|450802001|FG002|Overall Study|Notification of change in address|0|||
125319761|NCT02973100|450802002|FG003|Overall Study|Notification of change in address|1|||
125319762|NCT02973100|450801999|FG000|Overall Study|Failed to attend Safety followup period|0|||
125319763|NCT02973100|450802000|FG001|Overall Study|Failed to attend Safety followup period|0|||
125319764|NCT02973100|450802001|FG002|Overall Study|Failed to attend Safety followup period|1|||
125319765|NCT02973100|450802002|FG003|Overall Study|Failed to attend Safety followup period|0|||
125319766|NCT04516746|450802013|FG000|Overall Study|Randomized but not Treated|51|||
125319767|NCT04516746|450802014|FG001|Overall Study|Randomized but not Treated|19|||
125319768|NCT04516746|450802013|FG000|Overall Study|Adverse Event|0|||
125319769|NCT04516746|450802014|FG001|Overall Study|Adverse Event|1|||
125319770|NCT04516746|450802013|FG000|Overall Study|Death|62|||
125319771|NCT04516746|450802014|FG001|Overall Study|Death|32|||
125319772|NCT04516746|450802013|FG000|Overall Study|Lost to Follow-up|3431|||
125319773|NCT04516746|450802014|FG001|Overall Study|Lost to Follow-up|1831|||
125319774|NCT04516746|450802013|FG000|Overall Study|Withdrawal by Subject|1946|||
125319775|NCT04516746|450802014|FG001|Overall Study|Withdrawal by Subject|1696|||
125319776|NCT04516746|450802013|FG000|Overall Study|Physician Decision|10|||
125319777|NCT04516746|450802014|FG001|Overall Study|Physician Decision|8|||
125319778|NCT04516746|450802013|FG000|Overall Study|Other|35|||
125319779|NCT04516746|450802014|FG001|Overall Study|Other|16|||
125319780|NCT03115359|450802017|FG000|Overall Study|Withdrawal by Subject|29|||
125319781|NCT03115359|450802018|FG001|Overall Study|Withdrawal by Subject|39|||
125319782|NCT03115359|450802017|FG000|Overall Study|Scheduling conflict|25|||
125319783|NCT03115359|450802018|FG001|Overall Study|Scheduling conflict|23|||
125319784|NCT03115359|450802017|FG000|Overall Study|Personal reasons including health|12|||
125319785|NCT03115359|450802018|FG001|Overall Study|Personal reasons including health|9|||
125319786|NCT03115359|450802017|FG000|Overall Study|Transportation barriers|3|||
125319787|NCT03115359|450802018|FG001|Overall Study|Transportation barriers|0|||
125319788|NCT03115359|450802017|FG000|Overall Study|No longer interested|5|||
125319789|NCT03115359|450802018|FG001|Overall Study|No longer interested|4|||
125319790|NCT03115359|450802017|FG000|Overall Study|No reason provided|45|||
125319791|NCT03115359|450802018|FG001|Overall Study|No reason provided|47|||
125319792|NCT05543265|450802024|FG000|Overall Study|Lost to Follow-up|3|||
125319793|NCT05543265|450802025|FG001|Overall Study|Lost to Follow-up|3|||
125319794|NCT05543265|450802024|FG000|Overall Study|Withdrawal by Subject|0|||
125319795|NCT05543265|450802025|FG001|Overall Study|Withdrawal by Subject|1|||
125319796|NCT05316597|450802026|FG000|First Session|Withdrawal by Subject|0|||
125319797|NCT05316597|450802027|FG001|First Session|Withdrawal by Subject|1|||
125319798|NCT05316597|450802026|FG000|Washout Period|Lost to Follow-up|1|||
125319799|NCT05316597|450802027|FG001|Washout Period|Lost to Follow-up|2|||
125319800|NCT05316597|450802026|FG000|Washout Period|Physician Decision|1|||
125319801|NCT05316597|450802027|FG001|Washout Period|Physician Decision|1|||
125319802|NCT05316597|450802026|FG000|Washout Period|Excluded before second session|1|||
125319803|NCT05316597|450802027|FG001|Washout Period|Excluded before second session|1|||
125319804|NCT05316597|450802026|FG000|Washout Period|Withdrawal by Subject|0|||
125319805|NCT05316597|450802027|FG001|Washout Period|Withdrawal by Subject|4|||
125319806|NCT05526716|450802028|FG000|Overall Study|Death|1|||
125319807|NCT05526716|450802029|FG001|Overall Study|Death|2|||
125319808|NCT05526716|450802028|FG000|Overall Study|Lost to Follow-up|17|||
125319809|NCT05526716|450802029|FG001|Overall Study|Lost to Follow-up|15|||
125319810|NCT05526716|450802028|FG000|Overall Study|Physician Decision|0|||
125319811|NCT05526716|450802029|FG001|Overall Study|Physician Decision|1|||
125319812|NCT05526716|450802028|FG000|Overall Study|Randomized by mistake without study treatment|0|||
125319813|NCT05526716|450802029|FG001|Overall Study|Randomized by mistake without study treatment|1|||
125319814|NCT05526716|450802028|FG000|Overall Study|Withdrawal by Subject|12|||
125319815|NCT05526716|450802029|FG001|Overall Study|Withdrawal by Subject|12|||
125319816|NCT05526716|450802028|FG000|Overall Study|Not reported|0|||
125319817|NCT05526716|450802029|FG001|Overall Study|Not reported|2|||
125319818|NCT04750824|450802030|FG000|Overall Study|Toxicity/intolerability|3|||
125319819|NCT04750824|450802031|FG001|Overall Study|Toxicity/intolerability|1|||
125319820|NCT04750824|450802030|FG000|Overall Study|Death|1|||
125319821|NCT04750824|450802031|FG001|Overall Study|Death|3|||
125319822|NCT04750824|450802030|FG000|Overall Study|Scheduled duration of therapy complete|1|||
125319823|NCT04750824|450802031|FG001|Overall Study|Scheduled duration of therapy complete|9|||
125319824|NCT04750824|450802030|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
125662417|NCT05166512|452052504|FG001|Baseline Data Collection|Protocol Violation|0|||
125319825|NCT04750824|450802031|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
125319826|NCT03547518|450802039|FG000|Overall Study|Lost to Follow-up|2|||
125319827|NCT03547518|450802040|FG001|Overall Study|Lost to Follow-up|0|||
125319828|NCT02384551|450802042|FG000|Overall Study|Lost to Follow-up|13|||
125319829|NCT02384551|450802043|FG001|Overall Study|Lost to Follow-up|14|||
125319830|NCT02384551|450802044|FG002|Overall Study|Lost to Follow-up|14|||
125319831|NCT02384551|450802045|FG003|Overall Study|Lost to Follow-up|14|||
125319832|NCT04742556|450802046|FG000|Overall Study|Withdrawal by Subject|0|||
125319833|NCT04742556|450802047|FG001|Overall Study|Withdrawal by Subject|1|||
125319834|NCT04742556|450802048|FG002|Overall Study|Withdrawal by Subject|0|||
125319835|NCT04742556|450802046|FG000|Overall Study|Adverse Event|0|||
125319836|NCT04742556|450802047|FG001|Overall Study|Adverse Event|0|||
125319837|NCT04742556|450802048|FG002|Overall Study|Adverse Event|2|||
125319838|NCT04742556|450802046|FG000|Overall Study|Clinical disease progression|0|||
125319839|NCT04742556|450802047|FG001|Overall Study|Clinical disease progression|1|||
125319840|NCT04742556|450802048|FG002|Overall Study|Clinical disease progression|2|||
125319841|NCT04742556|450802046|FG000|Overall Study|Objective disease progression|3|||
125319842|NCT04742556|450802047|FG001|Overall Study|Objective disease progression|2|||
125319843|NCT04742556|450802048|FG002|Overall Study|Objective disease progression|4|||
125319844|NCT03035032|450802049|FG000|Overall Study|Adverse Event|2|||
125319845|NCT03035032|450802049|FG000|Overall Study|Death|9|||
125319846|NCT03035032|450802049|FG000|Overall Study|Lost to Follow-up|1|||
125319847|NCT03035032|450802049|FG000|Overall Study|Progressive Disease|22|||
125319848|NCT03035032|450802049|FG000|Overall Study|Protocol Violation|2|||
125319849|NCT03035032|450802049|FG000|Overall Study|Withdrawal by Subject|2|||
125319850|NCT03035032|450802049|FG000|Overall Study|Physician Decision|5|||
125319851|NCT02201524|450802050|FG000|Overall Study|Adverse Event|0|||
125319852|NCT02201524|450802051|FG001|Overall Study|Adverse Event|2|||
125319853|NCT02201524|450802052|FG002|Overall Study|Adverse Event|1|||
125319854|NCT02201524|450802053|FG003|Overall Study|Adverse Event|0|||
125319855|NCT02201524|450802050|FG000|Overall Study|Insufficient clinical response|1|||
125319856|NCT02201524|450802051|FG001|Overall Study|Insufficient clinical response|0|||
125319857|NCT02201524|450802052|FG002|Overall Study|Insufficient clinical response|0|||
125319858|NCT02201524|450802053|FG003|Overall Study|Insufficient clinical response|0|||
125319859|NCT02201524|450802050|FG000|Overall Study|Lost to Follow-up|0|||
125319860|NCT02201524|450802051|FG001|Overall Study|Lost to Follow-up|0|||
125319861|NCT02201524|450802052|FG002|Overall Study|Lost to Follow-up|2|||
125319862|NCT02201524|450802053|FG003|Overall Study|Lost to Follow-up|0|||
125319863|NCT02201524|450802050|FG000|Overall Study|No longer meets eligibility criteria|0|||
125319864|NCT02201524|450802051|FG001|Overall Study|No longer meets eligibility criteria|0|||
125319865|NCT02201524|450802052|FG002|Overall Study|No longer meets eligibility criteria|0|||
125319866|NCT02201524|450802053|FG003|Overall Study|No longer meets eligibility criteria|2|||
125319867|NCT02201524|450802050|FG000|Overall Study|Protocol Violation|0|||
125319868|NCT02201524|450802051|FG001|Overall Study|Protocol Violation|0|||
125319869|NCT02201524|450802052|FG002|Overall Study|Protocol Violation|0|||
125319870|NCT02201524|450802053|FG003|Overall Study|Protocol Violation|1|||
125319871|NCT02201524|450802050|FG000|Overall Study|Withdrawal by Subject|0|||
125319872|NCT02201524|450802051|FG001|Overall Study|Withdrawal by Subject|0|||
125319873|NCT02201524|450802052|FG002|Overall Study|Withdrawal by Subject|1|||
125319874|NCT02201524|450802053|FG003|Overall Study|Withdrawal by Subject|1|||
125319875|NCT02201524|450802050|FG000|Overall Study|Other|1|||
125319876|NCT02201524|450802051|FG001|Overall Study|Other|1|||
125319877|NCT02201524|450802052|FG002|Overall Study|Other|0|||
125319878|NCT02201524|450802053|FG003|Overall Study|Other|0|||
125319879|NCT02914639|450802055|FG000|Overall Study|Withdrawal by Subject|0|||
125319880|NCT02914639|450802056|FG001|Overall Study|Withdrawal by Subject|2|||
125319881|NCT01018030|450802058|FG000|Overall Study|Adverse Event|10|||
125319882|NCT01018030|450802059|FG001|Overall Study|Adverse Event|5|||
125319883|NCT01018030|450802060|FG002|Overall Study|Adverse Event|5|||
125319884|NCT01018030|450802058|FG000|Overall Study|Withdrawal by Subject|2|||
125319885|NCT01018030|450802059|FG001|Overall Study|Withdrawal by Subject|2|||
125319886|NCT01018030|450802060|FG002|Overall Study|Withdrawal by Subject|4|||
125319887|NCT01018030|450802058|FG000|Overall Study|Lost to Follow-up|2|||
125319888|NCT01018030|450802059|FG001|Overall Study|Lost to Follow-up|0|||
125319889|NCT01018030|450802060|FG002|Overall Study|Lost to Follow-up|3|||
125319890|NCT01018030|450802058|FG000|Overall Study|Protocol Violation|2|||
125319891|NCT01018030|450802059|FG001|Overall Study|Protocol Violation|1|||
125319892|NCT01018030|450802060|FG002|Overall Study|Protocol Violation|0|||
125319893|NCT01018030|450802058|FG000|Overall Study|Physician Decision|1|||
125319894|NCT01018030|450802059|FG001|Overall Study|Physician Decision|0|||
125319895|NCT01018030|450802060|FG002|Overall Study|Physician Decision|1|||
125319896|NCT01018030|450802058|FG000|Overall Study|Lack of Efficacy|1|||
125319897|NCT01018030|450802059|FG001|Overall Study|Lack of Efficacy|0|||
125319898|NCT01018030|450802060|FG002|Overall Study|Lack of Efficacy|0|||
125319899|NCT01018030|450802058|FG000|Overall Study|Did Not Receive Study Drug|1|||
125319900|NCT01018030|450802059|FG001|Overall Study|Did Not Receive Study Drug|3|||
125319901|NCT01018030|450802060|FG002|Overall Study|Did Not Receive Study Drug|0|||
125319902|NCT03617172|450802063|FG000|Overall Study|Lost to Follow-up|1|||
125319903|NCT03617172|450802064|FG001|Overall Study|Lost to Follow-up|0|||
125319904|NCT01089504|450802065|FG000|Overall Study|Lost to Follow-up|1|||
125319905|NCT01089504|450802066|FG001|Overall Study|Lost to Follow-up|1|||
125319906|NCT01089504|450802065|FG000|Overall Study|Withdrawal by Subject|2|||
125319907|NCT01089504|450802066|FG001|Overall Study|Withdrawal by Subject|0|||
125319908|NCT01924845|450802067|FG000|Overall Study|Adverse Event|3|||
125319909|NCT01924845|450802067|FG000|Overall Study|Withdrawal by Subject|2|||
125319910|NCT01924845|450802067|FG000|Overall Study|Protocol Violation|1|||
125319911|NCT00062439|450802068|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
125319912|NCT00062439|450802068|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
125319913|NCT00062439|450802068|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
125319914|NCT00062439|450802068|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
125319915|NCT00062439|450802068|FG000|Post Chemoradiation Assessment|Death|1|||
125319916|NCT00062439|450802068|FG000|Post Chemoradiation Assessment|Disease progression|2|||
125319917|NCT00062439|450802068|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
125319918|NCT00062439|450802068|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
125319919|NCT00062439|450802068|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
125319920|NCT00062439|450802068|FG000|Surgery|Physician Decision|4|||
125319921|NCT00062439|450802068|FG000|Surgery|Death|1|||
125319922|NCT00062439|450802068|FG000|Surgery|Adverse Event|2|||
125319923|NCT00062439|450802068|FG000|Consolidation Chemotherapy|Adverse Event|2|||
125319924|NCT00001832|450802072|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
125319925|NCT00001832|450802073|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
125319926|NCT00001832|450802074|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
125319927|NCT00001832|450802075|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
125319928|NCT00001832|450802076|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
125319929|NCT00001832|450802077|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
125319930|NCT00001832|450802078|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
125319931|NCT00001832|450802079|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
125319932|NCT00001832|450802080|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
125319933|NCT00001832|450802081|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
125319934|NCT00001832|450802082|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
125319935|NCT00001832|450802083|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
125319936|NCT00001832|450802084|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
125319937|NCT00001832|450802085|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
125319938|NCT00001832|450802086|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
125319939|NCT00001832|450802072|FG000|Treatment Period|Death during treatment|0|||
125319940|NCT00001832|450802073|FG001|Treatment Period|Death during treatment|0|||
125319941|NCT00001832|450802074|FG002|Treatment Period|Death during treatment|0|||
125319942|NCT00001832|450802075|FG003|Treatment Period|Death during treatment|0|||
125319943|NCT00001832|450802076|FG004|Treatment Period|Death during treatment|0|||
125319944|NCT00001832|450802077|FG005|Treatment Period|Death during treatment|1|||
125319945|NCT00001832|450802078|FG006|Treatment Period|Death during treatment|0|||
125319946|NCT00001832|450802079|FG007|Treatment Period|Death during treatment|0|||
125319947|NCT00001832|450802080|FG008|Treatment Period|Death during treatment|0|||
125319948|NCT00001832|450802081|FG009|Treatment Period|Death during treatment|0|||
125319949|NCT00001832|450802082|FG010|Treatment Period|Death during treatment|0|||
125319950|NCT00001832|450802083|FG011|Treatment Period|Death during treatment|0|||
125319951|NCT00001832|450802084|FG012|Treatment Period|Death during treatment|0|||
125319952|NCT00001832|450802085|FG013|Treatment Period|Death during treatment|0|||
125319953|NCT00001832|450802086|FG014|Treatment Period|Death during treatment|0|||
125319954|NCT00001832|450802072|FG000|Treatment Period|Not treated|0|||
125319955|NCT00001832|450802073|FG001|Treatment Period|Not treated|0|||
125319956|NCT00001832|450802074|FG002|Treatment Period|Not treated|0|||
125319957|NCT00001832|450802075|FG003|Treatment Period|Not treated|0|||
125319958|NCT00001832|450802076|FG004|Treatment Period|Not treated|0|||
125319959|NCT00001832|450802077|FG005|Treatment Period|Not treated|0|||
125319960|NCT00001832|450802078|FG006|Treatment Period|Not treated|0|||
125319961|NCT00001832|450802079|FG007|Treatment Period|Not treated|1|||
125319962|NCT00001832|450802080|FG008|Treatment Period|Not treated|0|||
125319963|NCT00001832|450802081|FG009|Treatment Period|Not treated|0|||
125319964|NCT00001832|450802082|FG010|Treatment Period|Not treated|0|||
125319965|NCT00001832|450802083|FG011|Treatment Period|Not treated|0|||
125319966|NCT00001832|450802084|FG012|Treatment Period|Not treated|0|||
125319967|NCT00001832|450802085|FG013|Treatment Period|Not treated|0|||
125319968|NCT00001832|450802086|FG014|Treatment Period|Not treated|0|||
125319969|NCT01546857|450802088|FG000|Overall Study|Withdrawal by Subject|2|||
125319970|NCT01546857|450802089|FG001|Overall Study|Withdrawal by Subject|3|||
125319971|NCT01469221|450802090|FG000|Double Blind Phase|Protocol Violation|1|||
125319972|NCT01469221|450802091|FG001|Double Blind Phase|Protocol Violation|0|||
125319973|NCT01469221|450802092|FG002|Double Blind Phase|Protocol Violation|0|||
125319974|NCT01469221|450802090|FG000|Double Blind Phase|Physician Decision|1|||
125319975|NCT01469221|450802091|FG001|Double Blind Phase|Physician Decision|1|||
125319976|NCT01469221|450802092|FG002|Double Blind Phase|Physician Decision|0|||
125319977|NCT01469221|450802090|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
125540735|NCT00774930|451609437|FG001|LTOLE Phase|Subject decision|5|||
125319978|NCT01469221|450802091|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
125319979|NCT01469221|450802092|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
125319980|NCT02004236|450802100|FG000|Overall Study|Lack of Efficacy|0|||
125319981|NCT02004236|450802101|FG001|Overall Study|Lack of Efficacy|0|||
125319982|NCT02004236|450802102|FG002|Overall Study|Lack of Efficacy|16|||
125319983|NCT00918281|450802105|FG000|Overall Study|Physician Decision|29|||
125319984|NCT00168844|450802106|FG000|Overall Study|Adverse Event|31|||
125319985|NCT00168844|450802107|FG001|Overall Study|Adverse Event|32|||
125319986|NCT00168844|450802108|FG002|Overall Study|Adverse Event|48|||
125319987|NCT00168844|450802106|FG000|Overall Study|Lost to Follow-up|4|||
125319988|NCT00168844|450802107|FG001|Overall Study|Lost to Follow-up|5|||
125319989|NCT00168844|450802108|FG002|Overall Study|Lost to Follow-up|11|||
125319990|NCT00168844|450802106|FG000|Overall Study|Withdrawal by Subject|12|||
125319991|NCT00168844|450802107|FG001|Overall Study|Withdrawal by Subject|9|||
125319992|NCT00168844|450802108|FG002|Overall Study|Withdrawal by Subject|19|||
125319993|NCT00168844|450802106|FG000|Overall Study|Protocol Violation|2|||
125319994|NCT00168844|450802107|FG001|Overall Study|Protocol Violation|2|||
125319995|NCT00168844|450802108|FG002|Overall Study|Protocol Violation|4|||
125319996|NCT00168844|450802106|FG000|Overall Study|Other|6|||
125319997|NCT00168844|450802107|FG001|Overall Study|Other|7|||
125319998|NCT00168844|450802108|FG002|Overall Study|Other|9|||
125319999|NCT00849940|450802117|FG000|Overall Study|Physician Decision|4|||
125320000|NCT00601835|450802118|FG000|Overall Study|Withdrawal by Subject|9|||
125320001|NCT00601835|450802119|FG001|Overall Study|Withdrawal by Subject|6|||
125320002|NCT00601835|450802118|FG000|Overall Study|Physician Decision|1|||
125320003|NCT00601835|450802119|FG001|Overall Study|Physician Decision|0|||
125320004|NCT00601835|450802118|FG000|Overall Study|Lost to Follow-up|37|||
125320005|NCT00601835|450802119|FG001|Overall Study|Lost to Follow-up|5|||
125320006|NCT00601835|450802118|FG000|Overall Study|Adverse Event|1|||
125320007|NCT00601835|450802119|FG001|Overall Study|Adverse Event|1|||
125320008|NCT00601835|450802118|FG000|Overall Study|Relocate|12|||
125320009|NCT00601835|450802119|FG001|Overall Study|Relocate|2|||
125320010|NCT01927497|450802120|FG000|Overall Study|Death|0|||
125320011|NCT01927497|450802121|FG001|Overall Study|Death|1|||
125320012|NCT01927497|450802120|FG000|Overall Study|Protocol Violation|2|||
125320013|NCT01927497|450802121|FG001|Overall Study|Protocol Violation|0|||
125320014|NCT03914417|450802122|FG000|Overall Study|Withdrawal by Subject|2|||
125320015|NCT03361137|450802123|FG000|Overall Study|Reason not specified|1|||
125320016|NCT03361137|450802124|FG001|Overall Study|Reason not specified|0|||
125320017|NCT03361137|450802125|FG002|Overall Study|Reason not specified|0|||
125320018|NCT03361137|450802126|FG003|Overall Study|Reason not specified|0|||
125320019|NCT03361137|450802127|FG004|Overall Study|Reason not specified|0|||
125320020|NCT03009058|450802128|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
125320021|NCT01486966|450802131|FG000|Overall Study|Adverse Event|0|||
125320022|NCT01486966|450802132|FG001|Overall Study|Adverse Event|1|||
125320023|NCT01486966|450802131|FG000|Overall Study|Withdrawal by Subject|0|||
125320024|NCT01486966|450802132|FG001|Overall Study|Withdrawal by Subject|1|||
125320025|NCT00506350|450802133|FG000|Overall Study|Serious Adverse Event|1|||
125320026|NCT00506350|450802134|FG001|Overall Study|Serious Adverse Event|0|||
125320027|NCT00506350|450802135|FG002|Overall Study|Serious Adverse Event|0|||
125320028|NCT00506350|450802136|FG003|Overall Study|Serious Adverse Event|0|||
125320029|NCT00506350|450802137|FG004|Overall Study|Serious Adverse Event|0|||
125320030|NCT00506350|450802138|FG005|Overall Study|Serious Adverse Event|0|||
125320031|NCT00506350|450802139|FG006|Overall Study|Serious Adverse Event|0|||
125320032|NCT00506350|450802140|FG007|Overall Study|Serious Adverse Event|0|||
125320033|NCT00506350|450802141|FG008|Overall Study|Serious Adverse Event|0|||
125320034|NCT00506350|450802133|FG000|Overall Study|Adverse Event|0|||
125320035|NCT00506350|450802134|FG001|Overall Study|Adverse Event|0|||
125320036|NCT00506350|450802135|FG002|Overall Study|Adverse Event|0|||
125320037|NCT00506350|450802136|FG003|Overall Study|Adverse Event|0|||
125320038|NCT00506350|450802137|FG004|Overall Study|Adverse Event|0|||
125320039|NCT00506350|450802138|FG005|Overall Study|Adverse Event|0|||
125320040|NCT00506350|450802139|FG006|Overall Study|Adverse Event|0|||
125320041|NCT00506350|450802140|FG007|Overall Study|Adverse Event|1|||
125320042|NCT00506350|450802141|FG008|Overall Study|Adverse Event|1|||
125320043|NCT00506350|450802133|FG000|Overall Study|Protocol Violation|0|||
125320044|NCT00506350|450802134|FG001|Overall Study|Protocol Violation|0|||
125320045|NCT00506350|450802135|FG002|Overall Study|Protocol Violation|1|||
125320046|NCT00506350|450802136|FG003|Overall Study|Protocol Violation|0|||
125320047|NCT00506350|450802137|FG004|Overall Study|Protocol Violation|0|||
125320048|NCT00506350|450802138|FG005|Overall Study|Protocol Violation|0|||
125320049|NCT00506350|450802139|FG006|Overall Study|Protocol Violation|1|||
125320050|NCT00506350|450802140|FG007|Overall Study|Protocol Violation|0|||
125320051|NCT00506350|450802141|FG008|Overall Study|Protocol Violation|0|||
125320052|NCT00506350|450802133|FG000|Overall Study|Withdrawal by Subject|0|||
125320053|NCT00506350|450802134|FG001|Overall Study|Withdrawal by Subject|1|||
125320054|NCT00506350|450802135|FG002|Overall Study|Withdrawal by Subject|1|||
125320055|NCT00506350|450802136|FG003|Overall Study|Withdrawal by Subject|1|||
125320056|NCT00506350|450802137|FG004|Overall Study|Withdrawal by Subject|4|||
125320057|NCT00506350|450802138|FG005|Overall Study|Withdrawal by Subject|1|||
125320058|NCT00506350|450802139|FG006|Overall Study|Withdrawal by Subject|1|||
125320059|NCT00506350|450802140|FG007|Overall Study|Withdrawal by Subject|2|||
125320060|NCT00506350|450802141|FG008|Overall Study|Withdrawal by Subject|0|||
125320061|NCT00506350|450802133|FG000|Overall Study|Lost to Follow-up|1|||
125320062|NCT00506350|450802134|FG001|Overall Study|Lost to Follow-up|1|||
125320063|NCT00506350|450802135|FG002|Overall Study|Lost to Follow-up|1|||
125320064|NCT00506350|450802136|FG003|Overall Study|Lost to Follow-up|1|||
125320065|NCT00506350|450802137|FG004|Overall Study|Lost to Follow-up|2|||
125320066|NCT00506350|450802138|FG005|Overall Study|Lost to Follow-up|1|||
125320067|NCT00506350|450802139|FG006|Overall Study|Lost to Follow-up|0|||
125320068|NCT00506350|450802140|FG007|Overall Study|Lost to Follow-up|0|||
125320069|NCT00506350|450802141|FG008|Overall Study|Lost to Follow-up|2|||
125320070|NCT00506350|450802133|FG000|Overall Study|Medical Reason|0|||
125320071|NCT00506350|450802134|FG001|Overall Study|Medical Reason|0|||
125320072|NCT00506350|450802135|FG002|Overall Study|Medical Reason|0|||
125320073|NCT00506350|450802136|FG003|Overall Study|Medical Reason|0|||
125320074|NCT00506350|450802137|FG004|Overall Study|Medical Reason|1|||
125320075|NCT00506350|450802138|FG005|Overall Study|Medical Reason|0|||
125320076|NCT00506350|450802139|FG006|Overall Study|Medical Reason|0|||
125320077|NCT00506350|450802140|FG007|Overall Study|Medical Reason|0|||
125320078|NCT00506350|450802141|FG008|Overall Study|Medical Reason|0|||
125320079|NCT00506350|450802133|FG000|Overall Study|Other|1|||
125320080|NCT00506350|450802134|FG001|Overall Study|Other|1|||
125320081|NCT00506350|450802135|FG002|Overall Study|Other|3|||
125320082|NCT00506350|450802136|FG003|Overall Study|Other|0|||
125320083|NCT00506350|450802137|FG004|Overall Study|Other|3|||
125320084|NCT00506350|450802138|FG005|Overall Study|Other|0|||
125320085|NCT00506350|450802139|FG006|Overall Study|Other|0|||
125320086|NCT00506350|450802140|FG007|Overall Study|Other|2|||
125320087|NCT00506350|450802141|FG008|Overall Study|Other|2|||
125320088|NCT01691794|450802142|FG000|Overall Study|Poor/Non-Compliance|1|||
125320089|NCT01691794|450802143|FG001|Overall Study|Poor/Non-Compliance|4|||
125320090|NCT01691794|450802144|FG002|Overall Study|Poor/Non-Compliance|1|||
125320091|NCT01691794|450802142|FG000|Overall Study|Death|0|||
125320092|NCT01691794|450802143|FG001|Overall Study|Death|0|||
125320093|NCT01691794|450802144|FG002|Overall Study|Death|1|||
125320094|NCT01691794|450802142|FG000|Overall Study|Lack of Efficacy|0|||
125320095|NCT01691794|450802143|FG001|Overall Study|Lack of Efficacy|7|||
125320096|NCT01691794|450802144|FG002|Overall Study|Lack of Efficacy|1|||
125320097|NCT01691794|450802142|FG000|Overall Study|Participant request to discontinue|0|||
125320098|NCT01691794|450802143|FG001|Overall Study|Participant request to discontinue|1|||
125320099|NCT01691794|450802144|FG002|Overall Study|Participant request to discontinue|0|||
125320100|NCT01691794|450802142|FG000|Overall Study|Adverse Event|0|||
125320101|NCT01691794|450802143|FG001|Overall Study|Adverse Event|1|||
125320102|NCT01691794|450802144|FG002|Overall Study|Adverse Event|1|||
125320103|NCT01691794|450802142|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
125320104|NCT01691794|450802143|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
125320105|NCT01691794|450802144|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
125320106|NCT01691794|450802142|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
125320107|NCT01691794|450802143|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
125320108|NCT01691794|450802144|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
125320109|NCT04972786|450802145|FG000|First Intervention (1 Day)|Adverse Event|1|||
125320110|NCT04972786|450802146|FG001|First Intervention (1 Day)|Adverse Event|0|||
125320111|NCT00844844|450802147|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
125320112|NCT00844844|450802147|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
125320113|NCT00844844|450802147|FG000|Extension Treatment Period|Adverse Event|2|||
125320114|NCT00844844|450802147|FG000|Post Treatment Period|Withdrawal by Subject|1|||
125320115|NCT05472090|450802150|FG000|Overall Study|Adverse Event|2|||
125320116|NCT05472090|450802151|FG001|Overall Study|Adverse Event|3|||
125320117|NCT05472090|450802150|FG000|Overall Study|Lack of Efficacy|1|||
125320118|NCT05472090|450802151|FG001|Overall Study|Lack of Efficacy|0|||
125320119|NCT05472090|450802150|FG000|Overall Study|Physician Decision|1|||
125320120|NCT05472090|450802151|FG001|Overall Study|Physician Decision|0|||
125320121|NCT05472090|450802150|FG000|Overall Study|Withdrawal by Subject|2|||
125320122|NCT05472090|450802151|FG001|Overall Study|Withdrawal by Subject|0|||
125320123|NCT05472090|450802150|FG000|Overall Study|Lost to Follow-up|0|||
125320124|NCT05472090|450802151|FG001|Overall Study|Lost to Follow-up|3|||
125320125|NCT01350999|450802153|FG000|Overall Study|Adverse Event|4|||
125320126|NCT01350999|450802154|FG001|Overall Study|Adverse Event|9|||
125320127|NCT01350999|450802155|FG002|Overall Study|Adverse Event|10|||
125320128|NCT01350999|450802153|FG000|Overall Study|Voluntary withdrawal|3|||
125320129|NCT01350999|450802154|FG001|Overall Study|Voluntary withdrawal|4|||
125320130|NCT01350999|450802155|FG002|Overall Study|Voluntary withdrawal|6|||
125320131|NCT01350999|450802153|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
125320132|NCT01350999|450802154|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
125320133|NCT01350999|450802155|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
125320134|NCT02891174|450804254|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
125320135|NCT02891174|450804255|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
125320136|NCT02891174|450804254|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
125320137|NCT02891174|450804255|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
125320138|NCT02891174|450804254|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
125320139|NCT02891174|450804255|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
125320140|NCT02891174|450804254|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
125320141|NCT02891174|450804255|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
125320142|NCT02891174|450804254|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
125320143|NCT02891174|450804255|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
125320144|NCT02891174|450804254|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
125320145|NCT02891174|450804255|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
125320146|NCT02891174|450804254|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
125320147|NCT02891174|450804255|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
125320148|NCT04124939|450804256|FG000|Overall Study|Lost to Follow-up|1|||
125320149|NCT04124939|450804257|FG001|Overall Study|Lost to Follow-up|3|||
125320150|NCT04235140|450804258|FG000|Overall Study|Adverse Event|2|||
125320151|NCT04235140|450804258|FG000|Overall Study|Lost to Follow-up|1|||
125320152|NCT04235140|450804258|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
125320153|NCT04235140|450804258|FG000|Overall Study|Commercial drug is available for participants|7|||
125320154|NCT02177695|450804260|FG000|ITT Analysis|Ineligible|5|||
125320155|NCT02177695|450804261|FG001|ITT Analysis|Ineligible|5|||
125320156|NCT02177695|450804260|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
125320157|NCT02177695|450804261|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
125320158|NCT02177695|450804260|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
125320159|NCT02177695|450804261|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
125320160|NCT02177695|450804260|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
125320161|NCT02177695|450804261|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
125320162|NCT00419393|450804262|FG000|Overall Study|Adverse Event|5|||
125320163|NCT00419393|450804262|FG000|Overall Study|Protocol Violation|5|||
125320164|NCT00419393|450804262|FG000|Overall Study|Withdrawal by Subject|7|||
125320165|NCT00419393|450804262|FG000|Overall Study|Other: Sponsor request|3|||
125320166|NCT00419393|450804262|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
125320167|NCT00419393|450804262|FG000|Overall Study|Other: Site closure|1|||
125320168|NCT00419393|450804262|FG000|Overall Study|Other: Other health problems|1|||
125320169|NCT00419393|450804262|FG000|Overall Study|Other: Investigator decision|1|||
125320170|NCT00979901|450804263|FG000|Overall Study|Adverse Event|1|||
125320171|NCT00979901|450804264|FG001|Overall Study|Adverse Event|3|||
125320172|NCT00979901|450804265|FG002|Overall Study|Adverse Event|9|||
125320173|NCT00979901|450804266|FG003|Overall Study|Adverse Event|2|||
125320174|NCT00979901|450804263|FG000|Overall Study|Lack of Efficacy|8|||
125320175|NCT00979901|450804264|FG001|Overall Study|Lack of Efficacy|4|||
125320176|NCT00979901|450804265|FG002|Overall Study|Lack of Efficacy|9|||
125320177|NCT00979901|450804266|FG003|Overall Study|Lack of Efficacy|0|||
125320178|NCT00979901|450804263|FG000|Overall Study|Lost to Follow-up|1|||
125320179|NCT00979901|450804264|FG001|Overall Study|Lost to Follow-up|1|||
125320180|NCT00979901|450804265|FG002|Overall Study|Lost to Follow-up|2|||
125320181|NCT00979901|450804266|FG003|Overall Study|Lost to Follow-up|0|||
125320182|NCT00979901|450804263|FG000|Overall Study|Protocol Violation|2|||
125320183|NCT00979901|450804264|FG001|Overall Study|Protocol Violation|2|||
125320184|NCT00979901|450804265|FG002|Overall Study|Protocol Violation|7|||
125320185|NCT00979901|450804266|FG003|Overall Study|Protocol Violation|1|||
125320186|NCT00979901|450804263|FG000|Overall Study|Withdrawal by Subject|2|||
125320187|NCT00979901|450804264|FG001|Overall Study|Withdrawal by Subject|1|||
125320188|NCT00979901|450804265|FG002|Overall Study|Withdrawal by Subject|1|||
125320189|NCT00979901|450804266|FG003|Overall Study|Withdrawal by Subject|1|||
125320190|NCT00979901|450804263|FG000|Overall Study|Noncompliance|1|||
125320191|NCT00979901|450804264|FG001|Overall Study|Noncompliance|0|||
125320192|NCT00979901|450804265|FG002|Overall Study|Noncompliance|0|||
125320193|NCT00979901|450804266|FG003|Overall Study|Noncompliance|0|||
125320194|NCT00979901|450804263|FG000|Overall Study|out-of-state|1|||
125320195|NCT00979901|450804264|FG001|Overall Study|out-of-state|0|||
125320196|NCT00979901|450804265|FG002|Overall Study|out-of-state|0|||
125320197|NCT00979901|450804266|FG003|Overall Study|out-of-state|0|||
125320198|NCT00979901|450804263|FG000|Overall Study|vacation|1|||
125320199|NCT00979901|450804264|FG001|Overall Study|vacation|0|||
125320200|NCT00979901|450804265|FG002|Overall Study|vacation|0|||
125320201|NCT00979901|450804266|FG003|Overall Study|vacation|0|||
125320202|NCT00979901|450804263|FG000|Overall Study|elevated lab values pre-randomization|1|||
125320203|NCT00979901|450804264|FG001|Overall Study|elevated lab values pre-randomization|0|||
125320204|NCT00979901|450804265|FG002|Overall Study|elevated lab values pre-randomization|0|||
125320205|NCT00979901|450804266|FG003|Overall Study|elevated lab values pre-randomization|0|||
125320206|NCT00979901|450804263|FG000|Overall Study|Discontinued in Error|0|||
125320207|NCT00979901|450804264|FG001|Overall Study|Discontinued in Error|1|||
125320208|NCT00979901|450804265|FG002|Overall Study|Discontinued in Error|0|||
125320209|NCT00979901|450804266|FG003|Overall Study|Discontinued in Error|0|||
125320210|NCT00979901|450804263|FG000|Overall Study|Left Country|0|||
125320211|NCT00979901|450804264|FG001|Overall Study|Left Country|0|||
125320212|NCT00979901|450804265|FG002|Overall Study|Left Country|1|||
125320213|NCT00979901|450804266|FG003|Overall Study|Left Country|0|||
125320214|NCT00979901|450804263|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
125320215|NCT00979901|450804264|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
125320216|NCT00979901|450804265|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
125320217|NCT00979901|450804266|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
125320218|NCT01317472|450804268|FG000|Overall Study|Withdrawal by Subject|1|||
125320219|NCT01317472|450804269|FG001|Overall Study|Withdrawal by Subject|0|||
125320220|NCT01317472|450804268|FG000|Overall Study|Unrelated hospitalization|1|||
125320221|NCT01317472|450804269|FG001|Overall Study|Unrelated hospitalization|0|||
125320222|NCT02182895|450804272|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
125320223|NCT02182895|450804273|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
125320224|NCT00836589|450804280|FG000|Overall Study|Lost to Follow-up|246|||
125320225|NCT00836589|450804280|FG000|Overall Study|Death|429|||
125320226|NCT00836589|450804280|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
125320227|NCT02399215|450804302|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
125320228|NCT02399215|450804302|FG000|Overall Study|Withdrawal by Subject|1|||
125320229|NCT00772538|450804303|FG000|Overall Study|Adverse Event|6|||
125320230|NCT00772538|450804304|FG001|Overall Study|Adverse Event|6|||
125320231|NCT00772538|450804303|FG000|Overall Study|Protocol Violation|3|||
125320232|NCT00772538|450804304|FG001|Overall Study|Protocol Violation|3|||
125320233|NCT00772538|450804303|FG000|Overall Study|Lost to Follow-up|1|||
125320234|NCT00772538|450804304|FG001|Overall Study|Lost to Follow-up|1|||
125320235|NCT00772538|450804303|FG000|Overall Study|Withdrawal by Subject|3|||
125320236|NCT00772538|450804304|FG001|Overall Study|Withdrawal by Subject|8|||
125320237|NCT00772538|450804303|FG000|Overall Study|Lack of Efficacy|0|||
125320238|NCT00772538|450804304|FG001|Overall Study|Lack of Efficacy|1|||
125320239|NCT00772538|450804303|FG000|Overall Study|Other|7|||
125320240|NCT00772538|450804304|FG001|Overall Study|Other|7|||
125320241|NCT00189540|450804305|FG000|Overall Study|Withdrawal by Subject|3|||
125320242|NCT00189540|450804306|FG001|Overall Study|Withdrawal by Subject|0|||
125320243|NCT00189540|450804305|FG000|Overall Study|Death|4|||
125320244|NCT00189540|450804306|FG001|Overall Study|Death|1|||
125320245|NCT00713609|450804307|FG000|Overall Study|Adverse Event|2|||
125320246|NCT00713609|450804308|FG001|Overall Study|Adverse Event|0|||
125320247|NCT00713609|450804309|FG002|Overall Study|Adverse Event|2|||
125320248|NCT00713609|450804310|FG003|Overall Study|Adverse Event|2|||
125320249|NCT00713609|450804311|FG004|Overall Study|Adverse Event|3|||
125320250|NCT00713609|450804312|FG005|Overall Study|Adverse Event|1|||
125320251|NCT00713609|450804307|FG000|Overall Study|Lost to Follow-up|5|||
125320252|NCT00713609|450804308|FG001|Overall Study|Lost to Follow-up|7|||
125320253|NCT00713609|450804309|FG002|Overall Study|Lost to Follow-up|5|||
125320254|NCT00713609|450804310|FG003|Overall Study|Lost to Follow-up|5|||
125320255|NCT00713609|450804311|FG004|Overall Study|Lost to Follow-up|7|||
125320256|NCT00713609|450804312|FG005|Overall Study|Lost to Follow-up|0|||
125320257|NCT00713609|450804307|FG000|Overall Study|Lack of Efficacy|1|||
125320258|NCT00713609|450804308|FG001|Overall Study|Lack of Efficacy|3|||
125320259|NCT00713609|450804309|FG002|Overall Study|Lack of Efficacy|0|||
125320260|NCT00713609|450804310|FG003|Overall Study|Lack of Efficacy|0|||
125320261|NCT00713609|450804311|FG004|Overall Study|Lack of Efficacy|1|||
125320262|NCT00713609|450804312|FG005|Overall Study|Lack of Efficacy|0|||
125320263|NCT00713609|450804307|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
125320264|NCT00713609|450804308|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
125320265|NCT00713609|450804309|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
125320266|NCT00713609|450804310|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
125320267|NCT00713609|450804311|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
125320268|NCT00713609|450804312|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
125320269|NCT00713609|450804307|FG000|Overall Study|Withdrawal by Subject|6|||
125320270|NCT00713609|450804308|FG001|Overall Study|Withdrawal by Subject|1|||
125320271|NCT00713609|450804309|FG002|Overall Study|Withdrawal by Subject|5|||
125662418|NCT05166512|452052503|FG000|4 Month Data Collection|Lost to Follow-up|1|||
125320272|NCT00713609|450804310|FG003|Overall Study|Withdrawal by Subject|1|||
125320273|NCT00713609|450804311|FG004|Overall Study|Withdrawal by Subject|5|||
125320274|NCT00713609|450804312|FG005|Overall Study|Withdrawal by Subject|7|||
125320275|NCT00713609|450804307|FG000|Overall Study|Protocol Violation|6|||
125320276|NCT00713609|450804308|FG001|Overall Study|Protocol Violation|3|||
125320277|NCT00713609|450804309|FG002|Overall Study|Protocol Violation|1|||
125320278|NCT00713609|450804310|FG003|Overall Study|Protocol Violation|1|||
125320279|NCT00713609|450804311|FG004|Overall Study|Protocol Violation|2|||
125320280|NCT00713609|450804312|FG005|Overall Study|Protocol Violation|0|||
125320281|NCT01903356|450804313|FG000|Overall Study|Lost to Follow-up|7|||
125320282|NCT01903356|450804313|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
125320283|NCT01903356|450804313|FG000|Overall Study|Violated the dosage and administration|3|||
125320284|NCT04529083|450804314|FG000|Overall Study|Withdrawal by Subject|3|||
125320285|NCT03305666|450804315|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
125320286|NCT03305666|450804316|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
125320287|NCT04196686|450804318|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
125320288|NCT04196686|450804319|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
125320289|NCT02587221|450804323|FG000|Overall Study|Adverse Event|3|||
125320290|NCT02587221|450804324|FG001|Overall Study|Adverse Event|3|||
125320291|NCT02587221|450804323|FG000|Overall Study|Death|33|||
125320292|NCT02587221|450804324|FG001|Overall Study|Death|34|||
125320293|NCT02587221|450804323|FG000|Overall Study|Withdrawal by Subject|66|||
125320294|NCT02587221|450804324|FG001|Overall Study|Withdrawal by Subject|61|||
125320295|NCT02587221|450804323|FG000|Overall Study|Lost to Follow-up|21|||
125320296|NCT02587221|450804324|FG001|Overall Study|Lost to Follow-up|19|||
125320297|NCT02587221|450804323|FG000|Overall Study|Protocol Violation|6|||
125320298|NCT02587221|450804324|FG001|Overall Study|Protocol Violation|5|||
125320299|NCT02587221|450804323|FG000|Overall Study|Other Reason or Unspecified|2|||
125320300|NCT02587221|450804324|FG001|Overall Study|Other Reason or Unspecified|1|||
125320301|NCT02546609|450804325|FG000|Overall Study|Withdrawal by Subject|0|||
125320302|NCT02546609|450804326|FG001|Overall Study|Withdrawal by Subject|1|||
125320303|NCT02546609|450804327|FG002|Overall Study|Withdrawal by Subject|2|||
125320304|NCT02546609|450804325|FG000|Overall Study|Adverse Event|0|||
125320305|NCT02546609|450804326|FG001|Overall Study|Adverse Event|6|||
125320306|NCT02546609|450804327|FG002|Overall Study|Adverse Event|1|||
125320307|NCT02546609|450804325|FG000|Overall Study|Protocol Violation|0|||
125320308|NCT02546609|450804326|FG001|Overall Study|Protocol Violation|1|||
125320309|NCT02546609|450804327|FG002|Overall Study|Protocol Violation|1|||
125320310|NCT02546609|450804325|FG000|Overall Study|Lost to Follow-up|2|||
125320311|NCT02546609|450804326|FG001|Overall Study|Lost to Follow-up|3|||
125320312|NCT02546609|450804327|FG002|Overall Study|Lost to Follow-up|1|||
125320313|NCT02546609|450804325|FG000|Overall Study|travel or work schedule restriction|0|||
125320314|NCT02546609|450804326|FG001|Overall Study|travel or work schedule restriction|0|||
125320315|NCT02546609|450804327|FG002|Overall Study|travel or work schedule restriction|2|||
125320316|NCT00914849|450804328|FG000|Overall Study|Withdrawal by Subject|1|||
125320317|NCT00914849|450804329|FG001|Overall Study|Withdrawal by Subject|0|||
125320318|NCT00914849|450804328|FG000|Overall Study|Not eligible|0|||
125320319|NCT00914849|450804329|FG001|Overall Study|Not eligible|1|||
125320320|NCT01001221|450804330|FG000|Overall Study|Adverse Event|1|||
125320321|NCT01001221|450804331|FG001|Overall Study|Adverse Event|2|||
125320322|NCT01001221|450804332|FG002|Overall Study|Adverse Event|0|||
125320323|NCT01001221|450804333|FG003|Overall Study|Adverse Event|2|||
125320324|NCT01001221|450804334|FG004|Overall Study|Adverse Event|0|||
125320325|NCT01001221|450804330|FG000|Overall Study|Disease progression|3|||
125320326|NCT01001221|450804331|FG001|Overall Study|Disease progression|2|||
125320327|NCT01001221|450804332|FG002|Overall Study|Disease progression|2|||
125320328|NCT01001221|450804333|FG003|Overall Study|Disease progression|4|||
125320329|NCT01001221|450804334|FG004|Overall Study|Disease progression|0|||
125320330|NCT01001221|450804330|FG000|Overall Study|Other|1|||
125320331|NCT01001221|450804331|FG001|Overall Study|Other|1|||
125320332|NCT01001221|450804332|FG002|Overall Study|Other|0|||
125320333|NCT01001221|450804333|FG003|Overall Study|Other|0|||
125320334|NCT01001221|450804334|FG004|Overall Study|Other|0|||
125320335|NCT01001221|450804330|FG000|Overall Study|Not treated; protocol exclusion|0|||
125320336|NCT01001221|450804331|FG001|Overall Study|Not treated; protocol exclusion|0|||
125320337|NCT01001221|450804332|FG002|Overall Study|Not treated; protocol exclusion|1|||
125320338|NCT01001221|450804333|FG003|Overall Study|Not treated; protocol exclusion|0|||
125320339|NCT01001221|450804334|FG004|Overall Study|Not treated; protocol exclusion|0|||
125320340|NCT05106959|450804335|FG000|Overall Study|Lost to Follow-up|1|||
125320341|NCT01292486|450804336|FG000|Overall Study|Protocol Violation|2|||
125320342|NCT01292486|450804336|FG000|Overall Study|Did not meet screening criteria|2|||
125320343|NCT01292486|450804336|FG000|Overall Study|Adverse Event|1|||
125320344|NCT01292486|450804336|FG000|Overall Study|Physician Decision|1|||
125320345|NCT04602390|450804341|FG000|Overall Study|Withdrawal by Subject|0|||
125320346|NCT04602390|450804342|FG001|Overall Study|Withdrawal by Subject|0|||
125320347|NCT04602390|450804343|FG002|Overall Study|Withdrawal by Subject|0|||
125320348|NCT04602390|450804344|FG003|Overall Study|Withdrawal by Subject|0|||
125320349|NCT04602390|450804345|FG004|Overall Study|Withdrawal by Subject|1|||
125320350|NCT04602390|450804346|FG005|Overall Study|Withdrawal by Subject|0|||
125320351|NCT04602390|450804341|FG000|Overall Study|Adverse Event|0|||
125320352|NCT04602390|450804342|FG001|Overall Study|Adverse Event|0|||
125320353|NCT04602390|450804343|FG002|Overall Study|Adverse Event|0|||
125320354|NCT04602390|450804344|FG003|Overall Study|Adverse Event|0|||
125320355|NCT04602390|450804345|FG004|Overall Study|Adverse Event|0|||
125320356|NCT04602390|450804346|FG005|Overall Study|Adverse Event|1|||
125320357|NCT00265564|450804347|FG000|Overall Study|Lost to Follow-up|5|||
125320358|NCT00265564|450804348|FG001|Overall Study|Lost to Follow-up|7|||
125320359|NCT00265564|450804347|FG000|Overall Study|met exclusion criteria|5|||
125320360|NCT00265564|450804348|FG001|Overall Study|met exclusion criteria|2|||
125320361|NCT01553084|450804349|FG000|Overall Study|Withdrawal by Subject|15|||
125320362|NCT01553084|450804350|FG001|Overall Study|Withdrawal by Subject|13|||
125320363|NCT01553084|450804351|FG002|Overall Study|Withdrawal by Subject|35|||
125320364|NCT03988400|450804352|FG000|Overall Study|Adverse Event|1|||
125320365|NCT03988400|450804353|FG001|Overall Study|Adverse Event|0|||
125320366|NCT03988400|450804352|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
125320367|NCT03988400|450804353|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
125320368|NCT03988400|450804352|FG000|Overall Study|Lost to Follow-up|0|||
125320369|NCT03988400|450804353|FG001|Overall Study|Lost to Follow-up|1|||
125320370|NCT04201431|450804354|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
125320371|NCT04201431|450804355|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
125320372|NCT04201431|450804356|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
125320373|NCT01176032|450804357|FG000|Overall Study|Adverse Event|1|||
125320374|NCT01176032|450804358|FG001|Overall Study|Adverse Event|0|||
125320375|NCT01176032|450804357|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125320376|NCT01176032|450804358|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125320377|NCT01176032|450804357|FG000|Overall Study|Protocol Violation|1|||
125320378|NCT01176032|450804358|FG001|Overall Study|Protocol Violation|0|||
125320379|NCT01176032|450804357|FG000|Overall Study|Informed consent withdrawn|3|||
125320380|NCT01176032|450804358|FG001|Overall Study|Informed consent withdrawn|0|||
125320381|NCT01176032|450804357|FG000|Overall Study|Other|1|||
125320382|NCT01176032|450804358|FG001|Overall Study|Other|0|||
125320383|NCT01791244|450804361|FG000|Overall Study|Adverse Event|5|||
125320384|NCT01791244|450804362|FG001|Overall Study|Adverse Event|7|||
125320385|NCT01791244|450804361|FG000|Overall Study|Insufficient clinical response|10|||
125320386|NCT01791244|450804362|FG001|Overall Study|Insufficient clinical response|10|||
125320387|NCT01791244|450804361|FG000|Overall Study|Laboratory Abnormality|0|||
125320388|NCT01791244|450804362|FG001|Overall Study|Laboratory Abnormality|1|||
125320389|NCT01149096|450804363|FG000|Overall Study|Lost to Follow-up|0|||
125320390|NCT01149096|450804364|FG001|Overall Study|Lost to Follow-up|1|||
125320391|NCT04079296|450804365|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
125320392|NCT04079296|450804366|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
125320393|NCT04079296|450804367|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
125320394|NCT04079296|450804368|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
125320395|NCT04079296|450804369|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
125320396|NCT04079296|450804365|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
125320397|NCT04079296|450804366|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
125320398|NCT04079296|450804367|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
125320399|NCT04079296|450804368|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
125320400|NCT04079296|450804369|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
125320401|NCT04079296|450804365|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
125320402|NCT04079296|450804366|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
125320403|NCT04079296|450804367|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
125320404|NCT04079296|450804368|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
125320405|NCT04079296|450804369|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
125320406|NCT04079296|450804365|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
125320407|NCT04079296|450804366|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
125320408|NCT04079296|450804367|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
125320409|NCT04079296|450804368|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
125662419|NCT05166512|452052504|FG001|4 Month Data Collection|Lost to Follow-up|0|||
125662420|NCT05166512|452052503|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
125662421|NCT05166512|452052504|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
125662422|NCT05166512|452052503|FG000|12 Month Data Collection|Lost to Follow-up|3|||
125320410|NCT04079296|450804369|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
125320411|NCT04079296|450804365|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
125320412|NCT04079296|450804366|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
125320413|NCT04079296|450804367|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
125320414|NCT04079296|450804368|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
125320415|NCT04079296|450804369|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
125320416|NCT04079296|450804365|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
125320417|NCT04079296|450804366|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
125320418|NCT04079296|450804367|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
125320419|NCT04079296|450804368|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
125320420|NCT04079296|450804369|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
125320421|NCT04079296|450804365|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
125320422|NCT04079296|450804366|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
125320423|NCT04079296|450804367|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
125320424|NCT04079296|450804368|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
125320425|NCT04079296|450804369|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
125320426|NCT04079296|450804365|FG000|Dose Expansion Phase (168 Days)|Death|0|||
125320427|NCT04079296|450804366|FG001|Dose Expansion Phase (168 Days)|Death|0|||
125320428|NCT04079296|450804367|FG002|Dose Expansion Phase (168 Days)|Death|0|||
125320429|NCT04079296|450804368|FG003|Dose Expansion Phase (168 Days)|Death|1|||
125320430|NCT04079296|450804369|FG004|Dose Expansion Phase (168 Days)|Death|0|||
125320431|NCT01346358|450804382|FG000|Overall Study|Withdrawal by Subject|1|||
125320432|NCT01346358|450804383|FG001|Overall Study|Withdrawal by Subject|0|||
125320433|NCT01346358|450804384|FG002|Overall Study|Withdrawal by Subject|1|||
125320434|NCT01346358|450804385|FG003|Overall Study|Withdrawal by Subject|1|||
125320435|NCT01346358|450804386|FG004|Overall Study|Withdrawal by Subject|0|||
125320436|NCT01346358|450804387|FG005|Overall Study|Withdrawal by Subject|2|||
125320437|NCT01346358|450804388|FG006|Overall Study|Withdrawal by Subject|1|||
125320438|NCT01346358|450804389|FG007|Overall Study|Withdrawal by Subject|1|||
125320439|NCT01346358|450804390|FG008|Overall Study|Withdrawal by Subject|1|||
125320440|NCT01346358|450804382|FG000|Overall Study|Adverse Event|1|||
125320441|NCT01346358|450804383|FG001|Overall Study|Adverse Event|0|||
125320442|NCT01346358|450804384|FG002|Overall Study|Adverse Event|0|||
125320443|NCT01346358|450804385|FG003|Overall Study|Adverse Event|0|||
125320444|NCT01346358|450804386|FG004|Overall Study|Adverse Event|1|||
125320445|NCT01346358|450804387|FG005|Overall Study|Adverse Event|0|||
125320446|NCT01346358|450804388|FG006|Overall Study|Adverse Event|0|||
125320447|NCT01346358|450804389|FG007|Overall Study|Adverse Event|0|||
125320448|NCT01346358|450804390|FG008|Overall Study|Adverse Event|1|||
125320449|NCT01346358|450804382|FG000|Overall Study|Non-Compliance|0|||
125320450|NCT01346358|450804383|FG001|Overall Study|Non-Compliance|0|||
125320451|NCT01346358|450804384|FG002|Overall Study|Non-Compliance|0|||
125320452|NCT01346358|450804385|FG003|Overall Study|Non-Compliance|0|||
125320453|NCT01346358|450804386|FG004|Overall Study|Non-Compliance|0|||
125320454|NCT01346358|450804387|FG005|Overall Study|Non-Compliance|0|||
125320455|NCT01346358|450804388|FG006|Overall Study|Non-Compliance|0|||
125320456|NCT01346358|450804389|FG007|Overall Study|Non-Compliance|2|||
125320457|NCT01346358|450804390|FG008|Overall Study|Non-Compliance|0|||
125320458|NCT01346358|450804382|FG000|Overall Study|Physician Decision|0|||
125320459|NCT01346358|450804383|FG001|Overall Study|Physician Decision|1|||
125320460|NCT01346358|450804384|FG002|Overall Study|Physician Decision|0|||
125320461|NCT01346358|450804385|FG003|Overall Study|Physician Decision|0|||
125320462|NCT01346358|450804386|FG004|Overall Study|Physician Decision|0|||
125320463|NCT01346358|450804387|FG005|Overall Study|Physician Decision|0|||
125320464|NCT01346358|450804388|FG006|Overall Study|Physician Decision|0|||
125320465|NCT01346358|450804389|FG007|Overall Study|Physician Decision|1|||
125320466|NCT01346358|450804390|FG008|Overall Study|Physician Decision|1|||
125320467|NCT05058365|450804393|FG000|Overall Study|Migration|1|||
125320468|NCT05058365|450804394|FG001|Overall Study|Migration|1|||
125320469|NCT04038359|450804395|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
125320470|NCT04038359|450804396|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
125320471|NCT04038359|450804395|FG000|Overall Study|Death|8|||
125320472|NCT04038359|450804396|FG001|Overall Study|Death|7|||
125320473|NCT04038359|450804395|FG000|Overall Study|Lost to Follow-up|3|||
125320474|NCT04038359|450804396|FG001|Overall Study|Lost to Follow-up|0|||
125320475|NCT04038359|450804395|FG000|Overall Study|Participant Moved|1|||
125320476|NCT04038359|450804396|FG001|Overall Study|Participant Moved|0|||
125320477|NCT04038359|450804395|FG000|Overall Study|Withdrawal by Subject|4|||
125320478|NCT04038359|450804396|FG001|Overall Study|Withdrawal by Subject|3|||
125320479|NCT04038359|450804395|FG000|Overall Study|Physician Decision|3|||
125320480|NCT04038359|450804396|FG001|Overall Study|Physician Decision|2|||
125320481|NCT04038359|450804395|FG000|Overall Study|Adverse Event|0|||
125320482|NCT04038359|450804396|FG001|Overall Study|Adverse Event|2|||
125320483|NCT04038359|450804395|FG000|Overall Study|Progressive Disease|0|||
125320484|NCT04038359|450804396|FG001|Overall Study|Progressive Disease|1|||
125320485|NCT00703014|450804397|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
125320486|NCT00703014|450804398|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
125320487|NCT00703014|450804399|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
125320488|NCT00703014|450804400|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
125320489|NCT00703014|450804397|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
125320490|NCT00703014|450804398|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
125320491|NCT00703014|450804399|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
125320492|NCT00703014|450804400|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
125320493|NCT05121766|450804401|FG000|Overall Study|Covid reinfection|3|||
125320494|NCT05121766|450804402|FG001|Overall Study|Covid reinfection|0|||
125320495|NCT05121766|450804401|FG000|Overall Study|Withdrawal by Subject|3|||
125320496|NCT05121766|450804402|FG001|Overall Study|Withdrawal by Subject|1|||
125320497|NCT05121766|450804401|FG000|Overall Study|Adverse Event|2|||
125320498|NCT05121766|450804402|FG001|Overall Study|Adverse Event|4|||
125320499|NCT05121766|450804401|FG000|Overall Study|Lost to Follow-up|0|||
125320500|NCT05121766|450804402|FG001|Overall Study|Lost to Follow-up|1|||
125320501|NCT01033240|450804406|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
125425577|NCT01592370|451180517|FG000|Overall Study|Other Reasons|6|||
125320502|NCT01033240|450804407|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
125320503|NCT01033240|450804408|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
125320504|NCT01033240|450804406|FG000|Overall Study|Death|2|||
125320505|NCT01033240|450804407|FG001|Overall Study|Death|0|||
125320506|NCT01033240|450804408|FG002|Overall Study|Death|0|||
125320507|NCT01033240|450804406|FG000|Overall Study|Withdrew Consent|2|||
125320508|NCT01033240|450804407|FG001|Overall Study|Withdrew Consent|9|||
125320509|NCT01033240|450804408|FG002|Overall Study|Withdrew Consent|2|||
125320510|NCT01033240|450804406|FG000|Overall Study|Disease Progression|35|||
125320511|NCT01033240|450804407|FG001|Overall Study|Disease Progression|32|||
125320512|NCT01033240|450804408|FG002|Overall Study|Disease Progression|41|||
125320513|NCT01033240|450804406|FG000|Overall Study|Investigator Discretion|0|||
125320514|NCT01033240|450804407|FG001|Overall Study|Investigator Discretion|0|||
125320515|NCT01033240|450804408|FG002|Overall Study|Investigator Discretion|2|||
125320516|NCT01033240|450804406|FG000|Overall Study|Other|0|||
125320517|NCT01033240|450804407|FG001|Overall Study|Other|1|||
125320518|NCT01033240|450804408|FG002|Overall Study|Other|2|||
125320519|NCT05468814|450804409|FG000|Overall Study|Lost to Follow-up|5|||
125320520|NCT05468814|450804410|FG001|Overall Study|Lost to Follow-up|6|||
125320521|NCT04716426|450804412|FG000|Overall Study|Vaccination|1|||
125320522|NCT04716426|450804413|FG001|Overall Study|Vaccination|1|||
125320523|NCT04716426|450804412|FG000|Overall Study|Contamination|1|||
125320524|NCT04716426|450804413|FG001|Overall Study|Contamination|0|||
125320525|NCT00551759|450804414|FG000|Overall Study|Adverse Event|7|||
125320526|NCT00551759|450804414|FG000|Overall Study|Death|5|||
125320527|NCT00551759|450804414|FG000|Overall Study|Ineligible|1|||
125320528|NCT02960217|450804415|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
125320529|NCT02960217|450804416|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
125320530|NCT02960217|450804415|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
125320531|NCT02960217|450804416|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
125320532|NCT02960217|450804415|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
125320533|NCT02960217|450804416|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
125320534|NCT02960217|450804415|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
125320535|NCT02960217|450804416|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
125320536|NCT02960217|450804415|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
125320537|NCT02960217|450804416|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
125320538|NCT02960217|450804415|FG000|Open-Label Extension Phase|Adverse Event|1|||
125320539|NCT02960217|450804416|FG001|Open-Label Extension Phase|Adverse Event|0|||
125320540|NCT02960217|450804415|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
125320541|NCT02960217|450804416|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
125320542|NCT02960217|450804415|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
125320543|NCT02960217|450804416|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
125320544|NCT02960217|450804415|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
125320545|NCT02960217|450804416|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
125320546|NCT00625131|450804419|FG000|Overall Study|Lost to Follow-up|3|||
125320547|NCT00625131|450804420|FG001|Overall Study|Lost to Follow-up|2|||
125320548|NCT00625131|450804421|FG002|Overall Study|Lost to Follow-up|0|||
125320549|NCT00625131|450804419|FG000|Overall Study|Withdrawal by Subject|1|||
125320550|NCT00625131|450804420|FG001|Overall Study|Withdrawal by Subject|0|||
125320551|NCT00625131|450804421|FG002|Overall Study|Withdrawal by Subject|5|||
125320552|NCT00668148|450804437|FG000|Overall Study|Adverse Event|5|||
125320553|NCT00668148|450804437|FG000|Overall Study|Subject Non-compliance|1|||
125320554|NCT00668148|450804437|FG000|Overall Study|Progressive Disease Before Treatment|2|||
125320555|NCT00668148|450804437|FG000|Overall Study|Withdrawal of Consent|2|||
125320556|NCT01766050|450806297|FG000|Overall Study|Adverse Event|1|||
125320557|NCT01766050|450806297|FG000|Overall Study|Lost to Follow-up|1|||
125320558|NCT01766050|450806297|FG000|Overall Study|Withdrawal by Subject|2|||
125320559|NCT00089297|450806300|FG000|Overall Study|Adverse Event|9|||
125320560|NCT00089297|450806300|FG000|Overall Study|Death|1|||
125320561|NCT00089297|450806300|FG000|Overall Study|Withdrawal by Subject|12|||
125320562|NCT00089297|450806300|FG000|Overall Study|Disease progression|2|||
125320563|NCT00089297|450806300|FG000|Overall Study|Ineligible|11|||
125320564|NCT00089297|450806300|FG000|Overall Study|Secondary malignancy|1|||
125320565|NCT00089297|450806300|FG000|Overall Study|IRB approval not ready|1|||
125320566|NCT00089297|450806300|FG000|Overall Study|Non-compliance|1|||
125320567|NCT01910298|450806305|FG000|Overall Study|Adverse Event|1|||
125320568|NCT01910298|450806306|FG001|Overall Study|Adverse Event|0|||
125320569|NCT01910298|450806305|FG000|Overall Study|Withdrawal by Subject|2|||
125320570|NCT01910298|450806306|FG001|Overall Study|Withdrawal by Subject|7|||
125320571|NCT01910298|450806305|FG000|Overall Study|Protocol Deviation|0|||
125320572|NCT01910298|450806306|FG001|Overall Study|Protocol Deviation|5|||
125320573|NCT01910298|450806305|FG000|Overall Study|Lost to Follow-up|1|||
125662423|NCT05166512|452052504|FG001|12 Month Data Collection|Lost to Follow-up|1|||
125320574|NCT01910298|450806306|FG001|Overall Study|Lost to Follow-up|1|||
125320575|NCT01910298|450806305|FG000|Overall Study|Study Terminated by Sponsor|1|||
125320576|NCT01910298|450806306|FG001|Overall Study|Study Terminated by Sponsor|17|||
125320577|NCT01910298|450806305|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125320578|NCT01910298|450806306|FG001|Overall Study|Other Miscellaneous Reasons|2|||
125320579|NCT03037385|450806310|FG000|Overall Study|Adverse Event|0|||
125320580|NCT03037385|450806311|FG001|Overall Study|Adverse Event|0|||
125320581|NCT03037385|450806312|FG002|Overall Study|Adverse Event|1|||
125320582|NCT03037385|450806313|FG003|Overall Study|Adverse Event|0|||
125320583|NCT03037385|450806314|FG004|Overall Study|Adverse Event|0|||
125320584|NCT03037385|450806315|FG005|Overall Study|Adverse Event|0|||
125320585|NCT03037385|450806316|FG006|Overall Study|Adverse Event|0|||
125320586|NCT03037385|450806317|FG007|Overall Study|Adverse Event|0|||
125320587|NCT03037385|450806318|FG008|Overall Study|Adverse Event|0|||
125320588|NCT03037385|450806319|FG009|Overall Study|Adverse Event|6|||
125320589|NCT03037385|450806310|FG000|Overall Study|Death|1|||
125320590|NCT03037385|450806311|FG001|Overall Study|Death|4|||
125320591|NCT03037385|450806312|FG002|Overall Study|Death|2|||
125320592|NCT03037385|450806313|FG003|Overall Study|Death|2|||
125320593|NCT03037385|450806314|FG004|Overall Study|Death|5|||
125320594|NCT03037385|450806315|FG005|Overall Study|Death|2|||
125320595|NCT03037385|450806316|FG006|Overall Study|Death|1|||
125320596|NCT03037385|450806317|FG007|Overall Study|Death|4|||
125320597|NCT03037385|450806318|FG008|Overall Study|Death|3|||
125320598|NCT03037385|450806319|FG009|Overall Study|Death|240|||
125320599|NCT03037385|450806310|FG000|Overall Study|Initiation of Another Therapy|1|||
125320600|NCT03037385|450806311|FG001|Overall Study|Initiation of Another Therapy|0|||
125320601|NCT03037385|450806312|FG002|Overall Study|Initiation of Another Therapy|0|||
125320602|NCT03037385|450806313|FG003|Overall Study|Initiation of Another Therapy|0|||
125320603|NCT03037385|450806314|FG004|Overall Study|Initiation of Another Therapy|0|||
125320604|NCT03037385|450806315|FG005|Overall Study|Initiation of Another Therapy|0|||
125320605|NCT03037385|450806316|FG006|Overall Study|Initiation of Another Therapy|0|||
125320606|NCT03037385|450806317|FG007|Overall Study|Initiation of Another Therapy|1|||
125320607|NCT03037385|450806318|FG008|Overall Study|Initiation of Another Therapy|0|||
125320608|NCT03037385|450806319|FG009|Overall Study|Initiation of Another Therapy|2|||
125320609|NCT03037385|450806310|FG000|Overall Study|Lost to Follow-up|0|||
125320610|NCT03037385|450806311|FG001|Overall Study|Lost to Follow-up|0|||
125320611|NCT03037385|450806312|FG002|Overall Study|Lost to Follow-up|0|||
125320612|NCT03037385|450806313|FG003|Overall Study|Lost to Follow-up|0|||
125320613|NCT03037385|450806314|FG004|Overall Study|Lost to Follow-up|0|||
125320614|NCT03037385|450806315|FG005|Overall Study|Lost to Follow-up|1|||
125320615|NCT03037385|450806316|FG006|Overall Study|Lost to Follow-up|0|||
125320616|NCT03037385|450806317|FG007|Overall Study|Lost to Follow-up|0|||
125320617|NCT03037385|450806318|FG008|Overall Study|Lost to Follow-up|0|||
125320618|NCT03037385|450806319|FG009|Overall Study|Lost to Follow-up|16|||
125320619|NCT03037385|450806310|FG000|Overall Study|Physician Decision|0|||
125320620|NCT03037385|450806311|FG001|Overall Study|Physician Decision|0|||
125320621|NCT03037385|450806312|FG002|Overall Study|Physician Decision|0|||
125320622|NCT03037385|450806313|FG003|Overall Study|Physician Decision|0|||
125320623|NCT03037385|450806314|FG004|Overall Study|Physician Decision|0|||
125320624|NCT03037385|450806315|FG005|Overall Study|Physician Decision|0|||
125320625|NCT03037385|450806316|FG006|Overall Study|Physician Decision|0|||
125320626|NCT03037385|450806317|FG007|Overall Study|Physician Decision|0|||
125320627|NCT03037385|450806318|FG008|Overall Study|Physician Decision|0|||
125320628|NCT03037385|450806319|FG009|Overall Study|Physician Decision|1|||
125320629|NCT03037385|450806310|FG000|Overall Study|Progressive Disease|0|||
125320630|NCT03037385|450806311|FG001|Overall Study|Progressive Disease|1|||
125320631|NCT03037385|450806312|FG002|Overall Study|Progressive Disease|1|||
125320632|NCT03037385|450806313|FG003|Overall Study|Progressive Disease|5|||
125320633|NCT03037385|450806314|FG004|Overall Study|Progressive Disease|2|||
125320634|NCT03037385|450806315|FG005|Overall Study|Progressive Disease|0|||
125320635|NCT03037385|450806316|FG006|Overall Study|Progressive Disease|1|||
125320636|NCT03037385|450806317|FG007|Overall Study|Progressive Disease|0|||
125320637|NCT03037385|450806318|FG008|Overall Study|Progressive Disease|0|||
125320638|NCT03037385|450806319|FG009|Overall Study|Progressive Disease|30|||
125320639|NCT03037385|450806310|FG000|Overall Study|Withdrawal by Subject|0|||
125320640|NCT03037385|450806311|FG001|Overall Study|Withdrawal by Subject|0|||
125320641|NCT03037385|450806312|FG002|Overall Study|Withdrawal by Subject|1|||
125320642|NCT03037385|450806313|FG003|Overall Study|Withdrawal by Subject|2|||
125320643|NCT03037385|450806314|FG004|Overall Study|Withdrawal by Subject|1|||
125320644|NCT03037385|450806315|FG005|Overall Study|Withdrawal by Subject|3|||
125320645|NCT03037385|450806316|FG006|Overall Study|Withdrawal by Subject|0|||
125320646|NCT03037385|450806317|FG007|Overall Study|Withdrawal by Subject|0|||
125320647|NCT03037385|450806318|FG008|Overall Study|Withdrawal by Subject|0|||
125320648|NCT03037385|450806319|FG009|Overall Study|Withdrawal by Subject|52|||
125320649|NCT03037385|450806310|FG000|Overall Study|Reason Not Specified|0|||
125662424|NCT05166512|452052503|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
125320650|NCT03037385|450806311|FG001|Overall Study|Reason Not Specified|1|||
125320651|NCT03037385|450806312|FG002|Overall Study|Reason Not Specified|0|||
125320652|NCT03037385|450806313|FG003|Overall Study|Reason Not Specified|4|||
125320653|NCT03037385|450806314|FG004|Overall Study|Reason Not Specified|3|||
125320654|NCT03037385|450806315|FG005|Overall Study|Reason Not Specified|6|||
125320655|NCT03037385|450806316|FG006|Overall Study|Reason Not Specified|2|||
125320656|NCT03037385|450806317|FG007|Overall Study|Reason Not Specified|0|||
125320657|NCT03037385|450806318|FG008|Overall Study|Reason Not Specified|1|||
125320658|NCT03037385|450806319|FG009|Overall Study|Reason Not Specified|181|||
125320659|NCT01838694|450806324|FG000|Overall Study|Adverse Event|0|||
125320660|NCT01838694|450806325|FG001|Overall Study|Adverse Event|1|||
125320661|NCT00672555|450806326|FG000|Overall Study|Lost to Follow-up|4|||
125320662|NCT00672555|450806326|FG000|Overall Study|Did not want to answer questionnaire|2|||
125320663|NCT03623243|450806327|FG000|Overall Study|Adverse Event|15|||
125320664|NCT03623243|450806327|FG000|Overall Study|Guardian Decision|1|||
125320665|NCT03623243|450806327|FG000|Overall Study|New Therapy for Study Indication|1|||
125320666|NCT03623243|450806327|FG000|Overall Study|Protocol Deviation|3|||
125320667|NCT03623243|450806327|FG000|Overall Study|Physician Decision|4|||
125320668|NCT03623243|450806327|FG000|Overall Study|Patient Decision|15|||
125320669|NCT02153086|450806330|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
125320670|NCT02153086|450806330|FG000|Overall Study|Other|2|||
125320671|NCT00446849|450806331|FG000|Acute Phase|Lack of Efficacy|64|||
125320672|NCT00446849|450806331|FG000|Acute Phase|Protocol Violation|10|||
125320673|NCT00446849|450806331|FG000|Acute Phase|Consent withdrawn|4|||
125320674|NCT00446849|450806331|FG000|Acute Phase|Lost to Follow-up|2|||
125320675|NCT00446849|450806331|FG000|Acute Phase|Physician Decision|1|||
125320676|NCT00446849|450806331|FG000|Acute Phase|noncompliance|1|||
125320677|NCT00446849|450806331|FG000|Maintenance Phase|Lack of Efficacy|40|||
125320678|NCT00446849|450806331|FG000|Maintenance Phase|Protocol Violation|7|||
125320679|NCT00446849|450806331|FG000|Maintenance Phase|Adverse Event|6|||
125320680|NCT00446849|450806331|FG000|Maintenance Phase|Consent withdrawn|5|||
125320681|NCT00446849|450806331|FG000|Maintenance Phase|Lost to Follow-up|3|||
125320682|NCT00446849|450806331|FG000|Maintenance Phase|Pregnancy|1|||
125320683|NCT00446849|450806331|FG000|Maintenance Phase|noncompliance|2|||
125320684|NCT00446849|450806331|FG000|Maintenance Phase|prohibited medication use|2|||
125320685|NCT00446849|450806331|FG000|Maintenance Phase|antibiotic use|1|||
125320686|NCT00446849|450806331|FG000|Maintenance Phase|study closure|1|||
125320687|NCT00446849|450806331|FG000|Maintenance Phase|hydrocodone use|1|||
125320688|NCT00446849|450806331|FG000|Maintenance Phase|concomitant medication use|1|||
125320689|NCT05546476|450806334|FG000|Period 1: Part A|Adverse Event|2|||
125320690|NCT05546476|450806335|FG001|Period 1: Part A|Adverse Event|0|||
125320691|NCT05546476|450806336|FG002|Period 1: Part A|Adverse Event|0|||
125320692|NCT05546476|450806337|FG003|Period 1: Part A|Adverse Event|1|||
125320693|NCT05546476|450806334|FG000|Period 1: Part A|Death|4|||
125320694|NCT05546476|450806335|FG001|Period 1: Part A|Death|4|||
125320695|NCT05546476|450806336|FG002|Period 1: Part A|Death|5|||
125320696|NCT05546476|450806337|FG003|Period 1: Part A|Death|6|||
125320697|NCT05546476|450806334|FG000|Period 1: Part A|Lack of Efficacy|0|||
125320698|NCT05546476|450806335|FG001|Period 1: Part A|Lack of Efficacy|0|||
125320699|NCT05546476|450806336|FG002|Period 1: Part A|Lack of Efficacy|0|||
125320700|NCT05546476|450806337|FG003|Period 1: Part A|Lack of Efficacy|1|||
125320701|NCT05546476|450806334|FG000|Period 1: Part A|Lost to Follow-up|0|||
125320702|NCT05546476|450806335|FG001|Period 1: Part A|Lost to Follow-up|0|||
125320703|NCT05546476|450806336|FG002|Period 1: Part A|Lost to Follow-up|0|||
125320704|NCT05546476|450806337|FG003|Period 1: Part A|Lost to Follow-up|1|||
125320705|NCT05546476|450806334|FG000|Period 1: Part A|Physician Decision|1|||
125320706|NCT05546476|450806335|FG001|Period 1: Part A|Physician Decision|0|||
125320707|NCT05546476|450806336|FG002|Period 1: Part A|Physician Decision|0|||
125320708|NCT05546476|450806337|FG003|Period 1: Part A|Physician Decision|0|||
125320709|NCT05546476|450806334|FG000|Period 1: Part A|Progressive disease|3|||
125320710|NCT05546476|450806335|FG001|Period 1: Part A|Progressive disease|5|||
125320711|NCT05546476|450806336|FG002|Period 1: Part A|Progressive disease|0|||
125320712|NCT05546476|450806337|FG003|Period 1: Part A|Progressive disease|1|||
125320713|NCT05546476|450806334|FG000|Period 1: Part A|Withdrawal by Subject|1|||
125320714|NCT05546476|450806335|FG001|Period 1: Part A|Withdrawal by Subject|1|||
125320715|NCT05546476|450806336|FG002|Period 1: Part A|Withdrawal by Subject|1|||
125320716|NCT05546476|450806337|FG003|Period 1: Part A|Withdrawal by Subject|2|||
125320717|NCT05546476|450806334|FG000|Period 1: Part A|Global deterioration of health status|2|||
125320718|NCT05546476|450806335|FG001|Period 1: Part A|Global deterioration of health status|2|||
125320719|NCT05546476|450806336|FG002|Period 1: Part A|Global deterioration of health status|1|||
125320720|NCT05546476|450806337|FG003|Period 1: Part A|Global deterioration of health status|4|||
125320721|NCT05546476|450806334|FG000|Period 1: Part A|Other: Unspecified|0|||
125320722|NCT05546476|450806335|FG001|Period 1: Part A|Other: Unspecified|2|||
125320723|NCT05546476|450806336|FG002|Period 1: Part A|Other: Unspecified|0|||
125320724|NCT05546476|450806337|FG003|Period 1: Part A|Other: Unspecified|0|||
125320725|NCT05546476|450806334|FG000|Period 2: Part B|Ongoing|26|||
125320726|NCT05546476|450806335|FG001|Period 2: Part B|Ongoing|27|||
125320727|NCT05546476|450806336|FG002|Period 2: Part B|Ongoing|35|||
125320728|NCT05546476|450806337|FG003|Period 2: Part B|Ongoing|29|||
125320729|NCT00807911|450806340|FG000|Overall Study|Withdrawal by Subject|12|||
125320730|NCT00807911|450806341|FG001|Overall Study|Withdrawal by Subject|10|||
125320731|NCT00807911|450806340|FG000|Overall Study|Ineligible|0|||
125320732|NCT00807911|450806341|FG001|Overall Study|Ineligible|4|||
125320733|NCT02953652|450806342|FG000|Overall Study|Adverse Event|18|||
125320734|NCT02953652|450806342|FG000|Overall Study|Withdrawal by Subject|6|||
125320735|NCT02953652|450806342|FG000|Overall Study|Protocol Violation|1|||
125320736|NCT02953652|450806342|FG000|Overall Study|Disease Progression|27|||
125320737|NCT03780452|450806346|FG000|Overall Study|Screening failure|2|||
125320738|NCT03796728|450806352|FG000|Overall Study|Lost to Follow-up|8|||
125320739|NCT03796728|450806352|FG000|Overall Study|Reason not Specified|16|||
125320740|NCT00333775|450806353|FG000|Overall Study|Death|144|||
125320741|NCT00333775|450806354|FG001|Overall Study|Death|149|||
125320742|NCT00333775|450806355|FG002|Overall Study|Death|143|||
125320743|NCT00333775|450806353|FG000|Overall Study|In Follow-up When Study Stopped|87|||
125320744|NCT00333775|450806354|FG001|Overall Study|In Follow-up When Study Stopped|92|||
125320745|NCT00333775|450806355|FG002|Overall Study|In Follow-up When Study Stopped|96|||
125320746|NCT00333775|450806353|FG000|Overall Study|Lost to Follow-up|10|||
125320747|NCT00333775|450806354|FG001|Overall Study|Lost to Follow-up|7|||
125320748|NCT00333775|450806355|FG002|Overall Study|Lost to Follow-up|8|||
125320749|NCT01383928|450806359|FG000|Overall Study|Initiation of ASCT|2|||
125320750|NCT01383928|450806360|FG001|Overall Study|Initiation of ASCT|1|||
125320751|NCT01383928|450806361|FG002|Overall Study|Initiation of ASCT|18|||
125320752|NCT01383928|450806359|FG000|Overall Study|Adverse Event|1|||
125320753|NCT01383928|450806360|FG001|Overall Study|Adverse Event|2|||
125320754|NCT01383928|450806361|FG002|Overall Study|Adverse Event|8|||
125320755|NCT01383928|450806359|FG000|Overall Study|Other|1|||
125320756|NCT01383928|450806360|FG001|Overall Study|Other|3|||
125320757|NCT01383928|450806361|FG002|Overall Study|Other|4|||
125320758|NCT01383928|450806359|FG000|Overall Study|Progressive Disease|1|||
125320759|NCT01383928|450806360|FG001|Overall Study|Progressive Disease|1|||
125320760|NCT01383928|450806361|FG002|Overall Study|Progressive Disease|5|||
125320761|NCT01383928|450806359|FG000|Overall Study|Withdrawal by Subject|0|||
125320762|NCT01383928|450806360|FG001|Overall Study|Withdrawal by Subject|0|||
125320763|NCT01383928|450806361|FG002|Overall Study|Withdrawal by Subject|4|||
125320764|NCT01383928|450806359|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
125320765|NCT01383928|450806360|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
125320766|NCT01383928|450806361|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
125320767|NCT03651765|450806364|FG000|Overall Study|Adverse Event|6|||
125320768|NCT03651765|450806364|FG000|Overall Study|Lack of Efficacy|18|||
125320769|NCT03651765|450806364|FG000|Overall Study|Lost to Follow-up|5|||
125320770|NCT03651765|450806364|FG000|Overall Study|Non-Compliance with Study Drug|4|||
125320771|NCT03651765|450806364|FG000|Overall Study|Physician Decision|6|||
125320772|NCT03651765|450806364|FG000|Overall Study|Pregnancy|1|||
125320773|NCT03651765|450806364|FG000|Overall Study|Discontinued by Sponsor|40|||
125320774|NCT03651765|450806364|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
125320775|NCT03651765|450806364|FG000|Overall Study|Withdrawal by Subject|24|||
125320776|NCT03651765|450806364|FG000|Overall Study|Miscellaneous|6|||
125320777|NCT04842747|450806376|FG000|Overall Study|Withdrawal by Subject|6|||
125320778|NCT04842747|450806377|FG001|Overall Study|Withdrawal by Subject|2|||
125320779|NCT04842747|450806376|FG000|Overall Study|Lost to Follow-up|1|||
125320780|NCT04842747|450806377|FG001|Overall Study|Lost to Follow-up|2|||
125320781|NCT04842747|450806376|FG000|Overall Study|Physician Decision|1|||
125320782|NCT04842747|450806377|FG001|Overall Study|Physician Decision|0|||
125320783|NCT04842747|450806376|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
125320784|NCT04842747|450806377|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
125320785|NCT01743469|450806378|FG000|Active Treatment Phase|Adverse Event|10|||
125320786|NCT01743469|450806379|FG001|Active Treatment Phase|Adverse Event|5|||
125320787|NCT01743469|450806380|FG002|Active Treatment Phase|Adverse Event|8|||
125320788|NCT01743469|450806381|FG003|Active Treatment Phase|Adverse Event|1|||
125662425|NCT05166512|452052504|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
125662426|NCT02139306|452052507|FG000|Overall Study|Withdrawal by Subject|4|||
125662427|NCT02139306|452052508|FG001|Overall Study|Withdrawal by Subject|6|||
125662428|NCT02139306|452052507|FG000|Overall Study|Adverse Event|3|||
125662429|NCT02139306|452052508|FG001|Overall Study|Adverse Event|4|||
125662430|NCT02139306|452052507|FG000|Overall Study|Physician Decision|0|||
125662431|NCT02139306|452052508|FG001|Overall Study|Physician Decision|1|||
125662432|NCT02139306|452052507|FG000|Overall Study|Other Unspecified|2|||
125662433|NCT02139306|452052508|FG001|Overall Study|Other Unspecified|3|||
125320789|NCT01743469|450806378|FG000|Active Treatment Phase|Disease Progression|40|||
125320790|NCT01743469|450806379|FG001|Active Treatment Phase|Disease Progression|47|||
125320791|NCT01743469|450806380|FG002|Active Treatment Phase|Disease Progression|30|||
125320792|NCT01743469|450806381|FG003|Active Treatment Phase|Disease Progression|20|||
125320793|NCT01743469|450806378|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
125320794|NCT01743469|450806379|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
125320795|NCT01743469|450806380|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
125320796|NCT01743469|450806381|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
125320797|NCT01743469|450806378|FG000|Active Treatment Phase|Missing|1|||
125662434|NCT02139306|452052507|FG000|Overall Study|Protocol Violation|4|||
125320798|NCT01743469|450806379|FG001|Active Treatment Phase|Missing|0|||
125320799|NCT01743469|450806380|FG002|Active Treatment Phase|Missing|0|||
125320800|NCT01743469|450806381|FG003|Active Treatment Phase|Missing|0|||
125320801|NCT01743469|450806378|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
125320802|NCT01743469|450806379|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
125320803|NCT01743469|450806380|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
125320804|NCT01743469|450806381|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
125320805|NCT01743469|450806378|FG000|Follow-up Period - Post-Treatment|Death|43|||
125320806|NCT01743469|450806379|FG001|Follow-up Period - Post-Treatment|Death|47|||
125320807|NCT01743469|450806380|FG002|Follow-up Period - Post-Treatment|Death|22|||
125320808|NCT01743469|450806381|FG003|Follow-up Period - Post-Treatment|Death|16|||
125320809|NCT01743469|450806378|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
125320810|NCT01743469|450806379|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
125320811|NCT01743469|450806380|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
125320812|NCT01743469|450806381|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
125320813|NCT01451606|450806382|FG000|Overall Study|Withdrawal by Subject|4|||
125320814|NCT01451606|450806383|FG001|Overall Study|Withdrawal by Subject|3|||
125320815|NCT04011540|450806389|FG000|Overall Study|Lost to Follow-up|9|||
125320816|NCT04011540|450806390|FG001|Overall Study|Lost to Follow-up|6|||
125320817|NCT02138890|450806395|FG000|Overall Study|Adverse Event|1|||
125320818|NCT02138890|450806396|FG001|Overall Study|Adverse Event|0|||
125320819|NCT01446159|450806397|FG000|Overall Study|Withdrawal by Subject|1|||
125320820|NCT01446159|450806398|FG001|Overall Study|Withdrawal by Subject|0|||
125320821|NCT01446159|450806399|FG002|Overall Study|Withdrawal by Subject|14|||
125320822|NCT01446159|450806400|FG003|Overall Study|Withdrawal by Subject|11|||
125320823|NCT01446159|450806397|FG000|Overall Study|Lost to Follow-up|0|||
125320824|NCT01446159|450806398|FG001|Overall Study|Lost to Follow-up|0|||
125320825|NCT01446159|450806399|FG002|Overall Study|Lost to Follow-up|1|||
125320826|NCT01446159|450806400|FG003|Overall Study|Lost to Follow-up|2|||
125320827|NCT01446159|450806397|FG000|Overall Study|Death|2|||
125320828|NCT01446159|450806398|FG001|Overall Study|Death|3|||
125320829|NCT01446159|450806399|FG002|Overall Study|Death|43|||
125320830|NCT01446159|450806400|FG003|Overall Study|Death|36|||
125320831|NCT01446159|450806397|FG000|Overall Study|Other|0|||
125320832|NCT01446159|450806398|FG001|Overall Study|Other|0|||
125320833|NCT01446159|450806399|FG002|Overall Study|Other|13|||
125320834|NCT01446159|450806400|FG003|Overall Study|Other|13|||
125320835|NCT03668873|450806401|FG000|Overall Study|Lost to Follow-up|6|||
125320836|NCT03668873|450806402|FG001|Overall Study|Lost to Follow-up|3|||
125320837|NCT02183675|450806403|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
125320838|NCT02183675|450806404|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
125320839|NCT02183675|450806405|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
125320840|NCT02183675|450806406|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
125320841|NCT02183675|450806407|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
125320842|NCT02183675|450806408|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
125320843|NCT01521117|450806409|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
125320844|NCT01521117|450806410|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
125320845|NCT01521117|450806409|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
125320846|NCT01521117|450806410|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
125320847|NCT01521117|450806409|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
125320848|NCT01521117|450806410|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
125320849|NCT00795535|450806415|FG000|Overall Study|incomplete data and technical problems|20|||
125320850|NCT04576988|450806416|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
125320851|NCT04576988|450806417|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
125320852|NCT04576988|450806416|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
125320853|NCT04576988|450806417|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
125320854|NCT04576988|450806416|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
125320855|NCT04576988|450806417|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
125320856|NCT04576988|450806416|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
125320857|NCT04576988|450806417|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
125320858|NCT04576988|450806416|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
125320859|NCT04576988|450806417|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
125320860|NCT04576988|450806416|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
125320861|NCT04576988|450806417|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
125320862|NCT04576988|450806416|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
125320863|NCT04576988|450806417|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
125320864|NCT04576988|450806416|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
125320865|NCT04576988|450806417|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
125320866|NCT04576988|450806416|FG000|Long Term Double Blind (LTDB)|Death|2|||
125320867|NCT04576988|450806417|FG001|Long Term Double Blind (LTDB)|Death|1|||
125320868|NCT04576988|450806416|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
125320869|NCT04576988|450806417|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
125320870|NCT00617734|450806418|FG000|Overall Study|Withdrew Consent|2|||
125662435|NCT02139306|452052508|FG001|Overall Study|Protocol Violation|0|||
125662436|NCT02956005|452052509|FG000|Overall Study|Not eligible|1|||
125662437|NCT02956005|452052509|FG000|Overall Study|Withdrawal by Subject|3|||
125662438|NCT02956005|452052509|FG000|Overall Study|Physician Decision|12|||
125662439|NCT03909971|452052510|FG000|Overall Study|Other Reasons Not Specified|0|||
125662440|NCT03909971|452052511|FG001|Overall Study|Other Reasons Not Specified|1|||
125662441|NCT03909971|452052510|FG000|Overall Study|Global Deterioration of Health Status|2|||
125662442|NCT03909971|452052511|FG001|Overall Study|Global Deterioration of Health Status|1|||
125662443|NCT03909971|452052510|FG000|Overall Study|Progressive Disease|6|||
125662444|NCT03909971|452052511|FG001|Overall Study|Progressive Disease|14|||
125662445|NCT03909971|452052510|FG000|Overall Study|Death|2|||
125662446|NCT03909971|452052511|FG001|Overall Study|Death|6|||
125662447|NCT01185639|452052512|FG000|Overall Study|Progressed and didn't receive therapy|2|||
125662448|NCT01861717|452052517|FG000|Overall Study|Lost to Follow-up|1|||
125210616|NCT02603107|450395613|FG001|Optional Extension Phase|Lost to Follow-up|3|||
125210617|NCT02603107|450395612|FG000|Optional Extension Phase|Withdrew consent|3|||
125210618|NCT02603107|450395613|FG001|Optional Extension Phase|Withdrew consent|2|||
125210619|NCT02603107|450395612|FG000|Optional Extension Phase|Investigator's discretion|2|||
125210620|NCT02603107|450395613|FG001|Optional Extension Phase|Investigator's discretion|2|||
125210621|NCT02603107|450395612|FG000|Optional Extension Phase|Pregnancy|0|||
125210622|NCT02603107|450395613|FG001|Optional Extension Phase|Pregnancy|3|||
125210623|NCT02603107|450395612|FG000|Optional Extension Phase|Adverse Event|0|||
125210624|NCT02603107|450395613|FG001|Optional Extension Phase|Adverse Event|2|||
125210625|NCT02603107|450395612|FG000|Optional Extension Phase|Not treated in extension phase|0|||
125210626|NCT02603107|450395613|FG001|Optional Extension Phase|Not treated in extension phase|1|||
125210627|NCT02603107|450395612|FG000|Optional Extension Phase|Protocol Violation|1|||
125210628|NCT02603107|450395613|FG001|Optional Extension Phase|Protocol Violation|0|||
125210629|NCT03411902|450395614|FG000|Overall Study|Lost to Follow-up|3|||
125210630|NCT03411902|450395615|FG001|Overall Study|Lost to Follow-up|0|||
125210631|NCT00419159|450395616|FG000|Overall Study|Adverse Event|7|||
125210632|NCT00419159|450395617|FG001|Overall Study|Adverse Event|15|||
125210633|NCT00419159|450395616|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125210634|NCT00419159|450395617|FG001|Overall Study|Abnormal laboratory value(s)|2|||
125210635|NCT00419159|450395616|FG000|Overall Study|Subject's no longer requires study drug|0|||
125210636|NCT00419159|450395617|FG001|Overall Study|Subject's no longer requires study drug|1|||
125210637|NCT00419159|450395616|FG000|Overall Study|Protocol Violation|1|||
125210638|NCT00419159|450395617|FG001|Overall Study|Protocol Violation|0|||
125210639|NCT00419159|450395616|FG000|Overall Study|Withdrawal by Subject|10|||
125210640|NCT00419159|450395617|FG001|Overall Study|Withdrawal by Subject|3|||
125210641|NCT00419159|450395616|FG000|Overall Study|Lost to Follow-up|0|||
125210642|NCT00419159|450395617|FG001|Overall Study|Lost to Follow-up|1|||
125210643|NCT00419159|450395616|FG000|Overall Study|Death|2|||
125210644|NCT00419159|450395617|FG001|Overall Study|Death|2|||
125210645|NCT00419159|450395616|FG000|Overall Study|Disease progression|79|||
125210646|NCT00419159|450395617|FG001|Overall Study|Disease progression|76|||
125210647|NCT01017601|450395618|FG000|Overall Study|Disease Progression|12|||
125210648|NCT01017601|450395619|FG001|Overall Study|Disease Progression|12|||
125210649|NCT01017601|450395618|FG000|Overall Study|Withdrawal by Subject|0|||
125210650|NCT01017601|450395619|FG001|Overall Study|Withdrawal by Subject|1|||
125210651|NCT00187278|450395624|FG000|Overall Study|Protocol Violation|10|||
125210652|NCT00187278|450395625|FG001|Overall Study|Protocol Violation|13|||
125210653|NCT00803205|450395626|FG000|Overall Study|Adverse Event|7|||
125210654|NCT00803205|450395627|FG001|Overall Study|Adverse Event|2|||
125210655|NCT00803205|450395626|FG000|Overall Study|Lost to Follow-up|1|||
125210656|NCT00803205|450395627|FG001|Overall Study|Lost to Follow-up|0|||
125210657|NCT00803205|450395626|FG000|Overall Study|Withdrawal by Subject|9|||
125210658|NCT00803205|450395627|FG001|Overall Study|Withdrawal by Subject|9|||
125210659|NCT00803205|450395626|FG000|Overall Study|Physician Decision|1|||
125210660|NCT00803205|450395627|FG001|Overall Study|Physician Decision|0|||
125210661|NCT00803205|450395626|FG000|Overall Study|Protocol Violation|1|||
125210662|NCT00803205|450395627|FG001|Overall Study|Protocol Violation|1|||
125210663|NCT00803205|450395626|FG000|Overall Study|Medical Monitor Decision|1|||
125210664|NCT00803205|450395627|FG001|Overall Study|Medical Monitor Decision|0|||
125210665|NCT00803205|450395626|FG000|Overall Study|Acquired a Lung Infection|0|||
125210666|NCT00803205|450395627|FG001|Overall Study|Acquired a Lung Infection|1|||
125210667|NCT00803205|450395626|FG000|Overall Study|Sponsor Decision|0|||
125210668|NCT00803205|450395627|FG001|Overall Study|Sponsor Decision|1|||
125210669|NCT02735096|450395628|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
125210670|NCT00379808|450395629|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
125210671|NCT00379808|450395630|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
125210672|NCT02638259|450395634|FG000|Treatment Period 1|Adverse Event|1|||
125210673|NCT02638259|450395635|FG001|Treatment Period 1|Adverse Event|5|||
125210674|NCT02638259|450395634|FG000|Treatment Period 1|Death|0|||
125210675|NCT02638259|450395635|FG001|Treatment Period 1|Death|1|||
125210676|NCT02638259|450395634|FG000|Treatment Period 1|Lack of Efficacy|0|||
125210677|NCT02638259|450395635|FG001|Treatment Period 1|Lack of Efficacy|1|||
125320871|NCT00617734|450806419|FG001|Overall Study|Withdrew Consent|0|||
125320872|NCT00617734|450806418|FG000|Overall Study|Adverse Event|4|||
125320873|NCT00617734|450806419|FG001|Overall Study|Adverse Event|1|||
125320874|NCT00617734|450806418|FG000|Overall Study|Protocol Violation|1|||
125320875|NCT00617734|450806419|FG001|Overall Study|Protocol Violation|0|||
125320876|NCT00617734|450806418|FG000|Overall Study|Found Ineligible After Randomization|1|||
125320877|NCT00617734|450806419|FG001|Overall Study|Found Ineligible After Randomization|4|||
125320878|NCT00617734|450806418|FG000|Overall Study|Lost to Follow-up|0|||
125320879|NCT00617734|450806419|FG001|Overall Study|Lost to Follow-up|1|||
125320880|NCT01844765|450806420|FG000|Overall Study|Adverse Event|6|||
125320881|NCT01844765|450806421|FG001|Overall Study|Adverse Event|8|||
125320882|NCT01844765|450806420|FG000|Overall Study|Withdrawal by Subject|2|||
125320883|NCT01844765|450806421|FG001|Overall Study|Withdrawal by Subject|3|||
125320884|NCT01844765|450806420|FG000|Overall Study|Disease progression|1|||
125320885|NCT01844765|450806421|FG001|Overall Study|Disease progression|0|||
125320886|NCT01844765|450806420|FG000|Overall Study|Administrative problems|3|||
125320887|NCT01844765|450806421|FG001|Overall Study|Administrative problems|4|||
125320888|NCT01844765|450806420|FG000|Overall Study|Protocol deviation|2|||
125320889|NCT01844765|450806421|FG001|Overall Study|Protocol deviation|0|||
125320890|NCT01844765|450806420|FG000|Overall Study|Untreated|1|||
125320891|NCT01844765|450806421|FG001|Overall Study|Untreated|0|||
125320892|NCT00556075|450806427|FG000|Overall Study|Lost to Follow-up|3|||
125320893|NCT00556075|450806428|FG001|Overall Study|Lost to Follow-up|0|||
125320894|NCT00556075|450806429|FG002|Overall Study|Lost to Follow-up|3|||
125320895|NCT00556075|450806427|FG000|Overall Study|Withdrawal by Subject|3|||
125320896|NCT00556075|450806428|FG001|Overall Study|Withdrawal by Subject|3|||
125320897|NCT00556075|450806429|FG002|Overall Study|Withdrawal by Subject|0|||
125320898|NCT00556075|450806427|FG000|Overall Study|Protocol Violation|1|||
125320899|NCT00556075|450806428|FG001|Overall Study|Protocol Violation|1|||
125320900|NCT00556075|450806429|FG002|Overall Study|Protocol Violation|3|||
125320901|NCT00556075|450806427|FG000|Overall Study|Not eligible|1|||
125320902|NCT00556075|450806428|FG001|Overall Study|Not eligible|1|||
125320903|NCT00556075|450806429|FG002|Overall Study|Not eligible|2|||
125320904|NCT00556075|450806427|FG000|Overall Study|Adverse Event|1|||
125320905|NCT00556075|450806428|FG001|Overall Study|Adverse Event|2|||
125320906|NCT00556075|450806429|FG002|Overall Study|Adverse Event|0|||
125320907|NCT00556075|450806427|FG000|Overall Study|Personal issues|4|||
125320908|NCT00556075|450806428|FG001|Overall Study|Personal issues|1|||
125320909|NCT00556075|450806429|FG002|Overall Study|Personal issues|0|||
125320910|NCT00556075|450806427|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
125320911|NCT00556075|450806428|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
125320912|NCT00556075|450806429|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
125320913|NCT02485691|450806430|FG000|Overall Study|Adverse Event|25|||
125320914|NCT02485691|450806431|FG001|Overall Study|Adverse Event|11|||
125320915|NCT02485691|450806430|FG000|Overall Study|Poor compliance to protocol|0|||
125320916|NCT02485691|450806431|FG001|Overall Study|Poor compliance to protocol|1|||
125320917|NCT02485691|450806430|FG000|Overall Study|Disease progression|57|||
125320918|NCT02485691|450806431|FG001|Overall Study|Disease progression|92|||
125320919|NCT02485691|450806430|FG000|Overall Study|Investigator's decision|23|||
125320920|NCT02485691|450806431|FG001|Overall Study|Investigator's decision|5|||
125320921|NCT02485691|450806430|FG000|Overall Study|Participant's request|13|||
125320922|NCT02485691|450806431|FG001|Overall Study|Participant's request|6|||
125320923|NCT02485691|450806430|FG000|Overall Study|Other reason|8|||
125320924|NCT02485691|450806431|FG001|Overall Study|Other reason|9|||
125320925|NCT02485691|450806430|FG000|Overall Study|Randomized and not treated|3|||
125320926|NCT02485691|450806431|FG001|Overall Study|Randomized and not treated|2|||
125320927|NCT00604565|450806432|FG000|Overall Study|Study terminated|0|||
125320928|NCT00604565|450806433|FG001|Overall Study|Study terminated|3|||
125320929|NCT04292535|450806434|FG000|Overall Study|Withdrawal by Subject|0|||
125320930|NCT04292535|450806435|FG001|Overall Study|Withdrawal by Subject|0|||
125320931|NCT04292535|450806436|FG002|Overall Study|Withdrawal by Subject|0|||
125320932|NCT04292535|450806437|FG003|Overall Study|Withdrawal by Subject|0|||
125320933|NCT04292535|450806438|FG004|Overall Study|Withdrawal by Subject|0|||
125320934|NCT04292535|450806439|FG005|Overall Study|Withdrawal by Subject|0|||
125320935|NCT04292535|450806440|FG006|Overall Study|Withdrawal by Subject|0|||
125320936|NCT04292535|450806441|FG007|Overall Study|Withdrawal by Subject|1|||
125320937|NCT04292535|450806442|FG008|Overall Study|Withdrawal by Subject|0|||
125320938|NCT04292535|450806443|FG009|Overall Study|Withdrawal by Subject|0|||
125320939|NCT04292535|450806444|FG010|Overall Study|Withdrawal by Subject|0|||
125320940|NCT04292535|450806445|FG011|Overall Study|Withdrawal by Subject|0|||
125320941|NCT04292535|450806446|FG012|Overall Study|Withdrawal by Subject|0|||
125320942|NCT04292535|450806447|FG013|Overall Study|Withdrawal by Subject|0|||
125320943|NCT04292535|450806434|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320944|NCT04292535|450806435|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320945|NCT04292535|450806436|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320946|NCT04292535|450806437|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320947|NCT04292535|450806438|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320948|NCT04292535|450806439|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320949|NCT04292535|450806440|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320950|NCT04292535|450806441|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
125320951|NCT04292535|450806442|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320952|NCT04292535|450806443|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320953|NCT04292535|450806444|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320954|NCT04292535|450806445|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
125320955|NCT04292535|450806446|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
125320956|NCT04292535|450806447|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
125320957|NCT04292535|450806434|FG000|Overall Study|Report of Dizziness|0|||
125320958|NCT04292535|450806435|FG001|Overall Study|Report of Dizziness|0|||
125320959|NCT04292535|450806436|FG002|Overall Study|Report of Dizziness|0|||
125320960|NCT04292535|450806437|FG003|Overall Study|Report of Dizziness|0|||
125320961|NCT04292535|450806438|FG004|Overall Study|Report of Dizziness|0|||
125320962|NCT04292535|450806439|FG005|Overall Study|Report of Dizziness|0|||
125320963|NCT04292535|450806440|FG006|Overall Study|Report of Dizziness|0|||
125320964|NCT04292535|450806441|FG007|Overall Study|Report of Dizziness|0|||
125320965|NCT04292535|450806442|FG008|Overall Study|Report of Dizziness|0|||
125320966|NCT04292535|450806443|FG009|Overall Study|Report of Dizziness|0|||
125320967|NCT04292535|450806444|FG010|Overall Study|Report of Dizziness|0|||
125320968|NCT04292535|450806445|FG011|Overall Study|Report of Dizziness|0|||
125662449|NCT01861717|452052517|FG000|Overall Study|Withdrawal by Subject|1|||
125320969|NCT04292535|450806446|FG012|Overall Study|Report of Dizziness|0|||
125320970|NCT04292535|450806447|FG013|Overall Study|Report of Dizziness|1|||
125320971|NCT04292535|450806434|FG000|Overall Study|Equipment Failure|0|||
125320972|NCT04292535|450806435|FG001|Overall Study|Equipment Failure|0|||
125320973|NCT04292535|450806436|FG002|Overall Study|Equipment Failure|0|||
125320974|NCT04292535|450806437|FG003|Overall Study|Equipment Failure|0|||
125320975|NCT04292535|450806438|FG004|Overall Study|Equipment Failure|0|||
125320976|NCT04292535|450806439|FG005|Overall Study|Equipment Failure|0|||
125320977|NCT04292535|450806440|FG006|Overall Study|Equipment Failure|0|||
125320978|NCT04292535|450806441|FG007|Overall Study|Equipment Failure|0|||
125320979|NCT04292535|450806442|FG008|Overall Study|Equipment Failure|0|||
125320980|NCT04292535|450806443|FG009|Overall Study|Equipment Failure|0|||
125320981|NCT04292535|450806444|FG010|Overall Study|Equipment Failure|0|||
125320982|NCT04292535|450806445|FG011|Overall Study|Equipment Failure|1|||
125320983|NCT04292535|450806446|FG012|Overall Study|Equipment Failure|0|||
125320984|NCT04292535|450806447|FG013|Overall Study|Equipment Failure|0|||
125320985|NCT03836625|450806448|FG000|Overall Study|Lost to Follow-up|9|||
125320986|NCT03836625|450806449|FG001|Overall Study|Lost to Follow-up|9|||
125320987|NCT03836625|450806448|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
125320988|NCT03836625|450806449|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
125320989|NCT03836625|450806448|FG000|Overall Study|Death|0|||
125320990|NCT03836625|450806449|FG001|Overall Study|Death|1|||
125320991|NCT03836625|450806448|FG000|Overall Study|Refused follow-up|0|||
125320992|NCT03836625|450806449|FG001|Overall Study|Refused follow-up|1|||
125320993|NCT01420861|450806454|FG000|Overall Study|Adverse Event|2|||
125320994|NCT01420861|450806454|FG000|Overall Study|Study terminated by Sponsor|7|||
125320995|NCT01420861|450806454|FG000|Overall Study|Screen failure|7|||
125320996|NCT01420861|450806454|FG000|Overall Study|Randomized not Treated|2|||
125320997|NCT01247324|450806455|FG000|Overall Study|Death|6|||
125320998|NCT01247324|450806456|FG001|Overall Study|Death|10|||
125320999|NCT01247324|450806455|FG000|Overall Study|Physician Decision|2|||
125321000|NCT01247324|450806456|FG001|Overall Study|Physician Decision|3|||
125321001|NCT01247324|450806455|FG000|Overall Study|Non-compliance with study drug|3|||
125321002|NCT01247324|450806456|FG001|Overall Study|Non-compliance with study drug|0|||
125321003|NCT01247324|450806455|FG000|Overall Study|Lack of Efficacy|24|||
125321004|NCT01247324|450806456|FG001|Overall Study|Lack of Efficacy|14|||
125321005|NCT01247324|450806455|FG000|Overall Study|Non-compliance|3|||
125321006|NCT01247324|450806456|FG001|Overall Study|Non-compliance|2|||
125321007|NCT01247324|450806455|FG000|Overall Study|Pregnancy|5|||
125321008|NCT01247324|450806456|FG001|Overall Study|Pregnancy|10|||
125321009|NCT01247324|450806455|FG000|Overall Study|Protocol Violation|1|||
125321010|NCT01247324|450806456|FG001|Overall Study|Protocol Violation|1|||
125321011|NCT01247324|450806455|FG000|Overall Study|Reason not specified|42|||
125321012|NCT01247324|450806456|FG001|Overall Study|Reason not specified|32|||
125321013|NCT01247324|450806455|FG000|Overall Study|Consent withdrawn by participant|41|||
125321014|NCT01247324|450806456|FG001|Overall Study|Consent withdrawn by participant|56|||
125321015|NCT01247324|450806455|FG000|Overall Study|Adverse Event|49|||
125321016|NCT01247324|450806456|FG001|Overall Study|Adverse Event|35|||
125321017|NCT01247324|450806455|FG000|Overall Study|Lost to Follow-up|3|||
125321018|NCT01247324|450806456|FG001|Overall Study|Lost to Follow-up|6|||
125321019|NCT01247324|450806455|FG000|Overall Study|Study Terminated by Sponsor|4|||
125321020|NCT01247324|450806456|FG001|Overall Study|Study Terminated by Sponsor|1|||
125321021|NCT01247324|450806455|FG000|Overall Study|Missing|2|||
125321022|NCT01247324|450806456|FG001|Overall Study|Missing|1|||
125321023|NCT01253291|450806457|FG000|Overall Study|Withdrawal by Subject|1|||
125321024|NCT01253291|450806458|FG001|Overall Study|Withdrawal by Subject|1|||
125321025|NCT01253291|450806459|FG002|Overall Study|Withdrawal by Subject|0|||
125321026|NCT01253291|450806460|FG003|Overall Study|Withdrawal by Subject|0|||
125321027|NCT01253291|450806461|FG004|Overall Study|Withdrawal by Subject|0|||
125321028|NCT01253291|450806457|FG000|Overall Study|Adverse Event|0|||
125321029|NCT01253291|450806458|FG001|Overall Study|Adverse Event|1|||
125321030|NCT01253291|450806459|FG002|Overall Study|Adverse Event|0|||
125321031|NCT01253291|450806460|FG003|Overall Study|Adverse Event|0|||
125321032|NCT01253291|450806461|FG004|Overall Study|Adverse Event|0|||
125321033|NCT01253291|450806457|FG000|Overall Study|Lack of Efficacy|1|||
125321034|NCT01253291|450806458|FG001|Overall Study|Lack of Efficacy|0|||
125321035|NCT01253291|450806459|FG002|Overall Study|Lack of Efficacy|0|||
125321036|NCT01253291|450806460|FG003|Overall Study|Lack of Efficacy|0|||
125321037|NCT01253291|450806461|FG004|Overall Study|Lack of Efficacy|0|||
125321038|NCT01253291|450806457|FG000|Overall Study|Physician Decision|2|||
125321039|NCT01253291|450806458|FG001|Overall Study|Physician Decision|0|||
125321040|NCT01253291|450806459|FG002|Overall Study|Physician Decision|0|||
125321041|NCT01253291|450806460|FG003|Overall Study|Physician Decision|0|||
125321042|NCT01253291|450806461|FG004|Overall Study|Physician Decision|2|||
125321043|NCT01021020|450808033|FG000|Period I|Protocol Violation|1|||
125321044|NCT01021020|450808033|FG000|Period I|Withdrawal by Subject|1|||
125321045|NCT01021020|450808033|FG000|14 Day Washout Period A|Physician Decision|1|||
125321046|NCT03598036|450808036|FG000|Overall Study|Withdrawal by Subject|1|||
125321047|NCT03598036|450808037|FG001|Overall Study|Withdrawal by Subject|0|||
125321048|NCT04607668|450808039|FG000|Overall Study|Death|49|||
125321049|NCT04607668|450808040|FG001|Overall Study|Death|26|||
125321050|NCT04607668|450808039|FG000|Overall Study|Lost to Follow-up|3|||
125321051|NCT04607668|450808040|FG001|Overall Study|Lost to Follow-up|4|||
125321052|NCT04607668|450808039|FG000|Overall Study|Study terminated by Sponsor|92|||
125321053|NCT04607668|450808040|FG001|Overall Study|Study terminated by Sponsor|114|||
125321054|NCT04607668|450808039|FG000|Overall Study|Withdrawal by Subject|12|||
125321055|NCT04607668|450808040|FG001|Overall Study|Withdrawal by Subject|11|||
125321056|NCT04607668|450808039|FG000|Overall Study|Other, unspecified|8|||
125321057|NCT04607668|450808040|FG001|Overall Study|Other, unspecified|7|||
125321058|NCT01488045|450808041|FG000|Overall Study|Withdrawal by Subject|6|||
125321059|NCT01488045|450808042|FG001|Overall Study|Withdrawal by Subject|11|||
125321060|NCT01488045|450808041|FG000|Overall Study|Failure to present for colonoscopy|3|||
125321061|NCT01488045|450808042|FG001|Overall Study|Failure to present for colonoscopy|6|||
125321062|NCT01488045|450808041|FG000|Overall Study|Failure to report exclusion criteria|0|||
125321063|NCT01488045|450808042|FG001|Overall Study|Failure to report exclusion criteria|1|||
125321064|NCT02230410|450808049|FG000|Overall Study|Screen Failure|3|||
125321065|NCT02388269|450808056|FG000|Overall Study|Adverse Event|2|||
125321066|NCT02388269|450808057|FG001|Overall Study|Adverse Event|0|||
125321067|NCT02388269|450808058|FG002|Overall Study|Adverse Event|0|||
125321068|NCT02388269|450808056|FG000|Overall Study|Withdrawal by Subject|1|||
125321069|NCT02388269|450808057|FG001|Overall Study|Withdrawal by Subject|2|||
125321070|NCT02388269|450808058|FG002|Overall Study|Withdrawal by Subject|0|||
125321071|NCT02388269|450808056|FG000|Overall Study|less than 50% stimulations|1|||
125321072|NCT02388269|450808057|FG001|Overall Study|less than 50% stimulations|0|||
125321073|NCT02388269|450808058|FG002|Overall Study|less than 50% stimulations|0|||
125321074|NCT02388269|450808056|FG000|Overall Study|no diary data|3|||
125321075|NCT02388269|450808057|FG001|Overall Study|no diary data|0|||
125321076|NCT02388269|450808058|FG002|Overall Study|no diary data|0|||
125321077|NCT02388269|450808056|FG000|Overall Study|Protocol Violation|2|||
125321078|NCT02388269|450808057|FG001|Overall Study|Protocol Violation|0|||
125321079|NCT02388269|450808058|FG002|Overall Study|Protocol Violation|0|||
125321080|NCT02388269|450808056|FG000|Overall Study|Screen Failure|0|||
125321081|NCT02388269|450808057|FG001|Overall Study|Screen Failure|0|||
125321082|NCT02388269|450808058|FG002|Overall Study|Screen Failure|10|||
125321083|NCT03448406|450808059|FG000|Overall Study|Noncompliance of scheduled visits|1|||
125321084|NCT03448406|450808060|FG001|Overall Study|Noncompliance of scheduled visits|2|||
125321085|NCT03448406|450808059|FG000|Overall Study|Withdrawal by Subject|1|||
125321086|NCT03448406|450808060|FG001|Overall Study|Withdrawal by Subject|2|||
125321087|NCT03448406|450808059|FG000|Overall Study|Protocol Violation|1|||
125321088|NCT03448406|450808060|FG001|Overall Study|Protocol Violation|0|||
125321089|NCT03448406|450808059|FG000|Overall Study|Adverse Event|8|||
125321090|NCT03448406|450808060|FG001|Overall Study|Adverse Event|9|||
125321091|NCT03405792|450808061|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
125321092|NCT03405792|450808062|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
125321093|NCT03405792|450808061|FG000|Overall Study|o Did not receive pembrolizumab|1|||
125662450|NCT03033069|452052518|FG000|Overall Study|Adverse Event|6|||
125662451|NCT03033069|452052519|FG001|Overall Study|Adverse Event|7|||
125321094|NCT03405792|450808062|FG001|Overall Study|o Did not receive pembrolizumab|0|||
125662452|NCT03033069|452052520|FG002|Overall Study|Adverse Event|4|||
125321095|NCT03962491|450808063|FG000|Overall Study|Lost to Follow-up|4|||
125321096|NCT03962491|450808064|FG001|Overall Study|Lost to Follow-up|5|||
125321097|NCT03882021|450808065|FG000|Enrollment|Procedure aborted/cancelled|2|||
125662453|NCT03033069|452052521|FG003|Overall Study|Adverse Event|6|||
125662454|NCT03033069|452052518|FG000|Overall Study|Lack of Efficacy|0|||
125662455|NCT03033069|452052519|FG001|Overall Study|Lack of Efficacy|0|||
125662456|NCT03033069|452052520|FG002|Overall Study|Lack of Efficacy|1|||
125662457|NCT03033069|452052521|FG003|Overall Study|Lack of Efficacy|0|||
125662458|NCT03033069|452052518|FG000|Overall Study|Lost to Follow-up|6|||
125321098|NCT03882021|450808065|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
125321099|NCT03882021|450808065|FG000|Enrollment to 3-Month|Death|1|||
125321100|NCT03882021|450808065|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
125321101|NCT03882021|450808065|FG000|Enrollment to 3-Month|Missed Visit|4|||
125321102|NCT03882021|450808065|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
125321103|NCT03882021|450808065|FG000|6-Month to 12-Month Visit|Death|1|||
125321104|NCT03882021|450808065|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
125321105|NCT03186209|450808066|FG000|Overall Study|Withdrawal by Subject|11|||
125321106|NCT03186209|450808067|FG001|Overall Study|Withdrawal by Subject|22|||
125321107|NCT03186209|450808066|FG000|Overall Study|Pregnancy|1|||
125321108|NCT03186209|450808067|FG001|Overall Study|Pregnancy|0|||
125321109|NCT03186209|450808066|FG000|Overall Study|Adverse Event|4|||
125321110|NCT03186209|450808067|FG001|Overall Study|Adverse Event|0|||
125321111|NCT03186209|450808066|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
125321112|NCT03186209|450808067|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
125321113|NCT03186209|450808066|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
125321114|NCT03186209|450808067|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
125321115|NCT03186209|450808066|FG000|Overall Study|Fail to meet randomization criteria|0|||
125321116|NCT03186209|450808067|FG001|Overall Study|Fail to meet randomization criteria|1|||
125321117|NCT03186209|450808066|FG000|Overall Study|Lost to Follow-up|0|||
125321118|NCT03186209|450808067|FG001|Overall Study|Lost to Follow-up|1|||
125321119|NCT02559622|450808072|FG000|Overall Study|Progressive disease|0|||
125321120|NCT02559622|450808073|FG001|Overall Study|Progressive disease|1|||
125321121|NCT02559622|450808074|FG002|Overall Study|Progressive disease|0|||
125321122|NCT02559622|450808075|FG003|Overall Study|Progressive disease|0|||
125321123|NCT02559622|450808072|FG000|Overall Study|Adverse Event|0|||
125321124|NCT02559622|450808073|FG001|Overall Study|Adverse Event|2|||
125321125|NCT02559622|450808074|FG002|Overall Study|Adverse Event|2|||
125321126|NCT02559622|450808075|FG003|Overall Study|Adverse Event|2|||
125321127|NCT02559622|450808072|FG000|Overall Study|Patient/guardian decision|1|||
125321128|NCT02559622|450808073|FG001|Overall Study|Patient/guardian decision|2|||
125321129|NCT02559622|450808074|FG002|Overall Study|Patient/guardian decision|0|||
125321130|NCT02559622|450808075|FG003|Overall Study|Patient/guardian decision|1|||
125321131|NCT02163538|450808076|FG000|Overall Study|Protocol Violation|1|||
125321132|NCT02163538|450808077|FG001|Overall Study|Protocol Violation|0|||
125321133|NCT02163538|450808076|FG000|Overall Study|Physician Decision|0|||
125321134|NCT02163538|450808077|FG001|Overall Study|Physician Decision|1|||
125321135|NCT01339832|450808080|FG000|Overall Study|Lost to Follow-up|3|||
125321136|NCT01339832|450808080|FG000|Overall Study|Death|11|||
125321137|NCT01126749|450808081|FG000|Phase 1b|Other|0|||
125321138|NCT01126749|450808082|FG001|Phase 1b|Other|1|||
125321139|NCT01126749|450808083|FG002|Phase 1b|Other|0|||
125321140|NCT01126749|450808084|FG003|Phase 1b|Other|0|||
125321141|NCT01126749|450808081|FG000|Phase 1b|Withdrawal by Subject|0|||
125321142|NCT01126749|450808082|FG001|Phase 1b|Withdrawal by Subject|1|||
125321143|NCT01126749|450808083|FG002|Phase 1b|Withdrawal by Subject|0|||
125321144|NCT01126749|450808084|FG003|Phase 1b|Withdrawal by Subject|0|||
125321145|NCT01126749|450808081|FG000|Phase 1b|Death|3|||
125321146|NCT01126749|450808082|FG001|Phase 1b|Death|4|||
125321147|NCT01126749|450808083|FG002|Phase 1b|Death|0|||
125321148|NCT01126749|450808084|FG003|Phase 1b|Death|0|||
125321149|NCT01126749|450808081|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
125321150|NCT01126749|450808082|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
125321151|NCT01126749|450808083|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
125321152|NCT01126749|450808084|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
125321153|NCT01126749|450808081|FG000|Phase 2|Study Termination by Sponsor|0|||
125662459|NCT03033069|452052519|FG001|Overall Study|Lost to Follow-up|5|||
125321154|NCT01126749|450808082|FG001|Phase 2|Study Termination by Sponsor|0|||
125662460|NCT03033069|452052520|FG002|Overall Study|Lost to Follow-up|5|||
125321155|NCT01126749|450808083|FG002|Phase 2|Study Termination by Sponsor|12|||
125321156|NCT01126749|450808084|FG003|Phase 2|Study Termination by Sponsor|6|||
125321157|NCT01126749|450808081|FG000|Phase 2|Other|0|||
125321158|NCT01126749|450808082|FG001|Phase 2|Other|0|||
125321159|NCT01126749|450808083|FG002|Phase 2|Other|4|||
125321160|NCT01126749|450808084|FG003|Phase 2|Other|2|||
125321161|NCT01126749|450808081|FG000|Phase 2|Withdrawal by Subject|0|||
125321162|NCT01126749|450808082|FG001|Phase 2|Withdrawal by Subject|0|||
125321163|NCT01126749|450808083|FG002|Phase 2|Withdrawal by Subject|0|||
125662461|NCT03033069|452052521|FG003|Overall Study|Lost to Follow-up|6|||
125321164|NCT01126749|450808084|FG003|Phase 2|Withdrawal by Subject|2|||
125321165|NCT01126749|450808081|FG000|Phase 2|Lost to Follow-up|0|||
125321166|NCT01126749|450808082|FG001|Phase 2|Lost to Follow-up|0|||
125662462|NCT03033069|452052518|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125662463|NCT03033069|452052519|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125662464|NCT03033069|452052520|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125662465|NCT03033069|452052521|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125662466|NCT03033069|452052518|FG000|Overall Study|Protocol Deviation|0|||
125662467|NCT03033069|452052519|FG001|Overall Study|Protocol Deviation|1|||
125662468|NCT03033069|452052520|FG002|Overall Study|Protocol Deviation|0|||
125662469|NCT03033069|452052521|FG003|Overall Study|Protocol Deviation|0|||
125662470|NCT03033069|452052518|FG000|Overall Study|Withdrawal by Subject|10|||
125662471|NCT03033069|452052519|FG001|Overall Study|Withdrawal by Subject|10|||
125662472|NCT03033069|452052520|FG002|Overall Study|Withdrawal by Subject|11|||
125662473|NCT03033069|452052521|FG003|Overall Study|Withdrawal by Subject|6|||
125662474|NCT03033069|452052518|FG000|Overall Study|Withdrawal By Caregiver|1|||
125662475|NCT03033069|452052519|FG001|Overall Study|Withdrawal By Caregiver|0|||
125662476|NCT03033069|452052520|FG002|Overall Study|Withdrawal By Caregiver|0|||
125662477|NCT03033069|452052521|FG003|Overall Study|Withdrawal By Caregiver|0|||
125662478|NCT03033069|452052518|FG000|Overall Study|Reason not Specified|0|||
125662479|NCT03033069|452052519|FG001|Overall Study|Reason not Specified|1|||
125662480|NCT03033069|452052520|FG002|Overall Study|Reason not Specified|0|||
125662481|NCT03033069|452052521|FG003|Overall Study|Reason not Specified|1|||
125662482|NCT00430638|452052522|FG000|Overall Study|Adverse Event|15|||
125662483|NCT00430638|452052523|FG001|Overall Study|Adverse Event|15|||
125662484|NCT00430638|452052522|FG000|Overall Study|Uncontrolled blood pressure|48|||
125662485|NCT00430638|452052523|FG001|Overall Study|Uncontrolled blood pressure|13|||
125662486|NCT00430638|452052522|FG000|Overall Study|Lost to Follow-up|1|||
125662487|NCT00430638|452052523|FG001|Overall Study|Lost to Follow-up|7|||
125662488|NCT00430638|452052522|FG000|Overall Study|Protocol Violation|6|||
125662489|NCT00430638|452052523|FG001|Overall Study|Protocol Violation|4|||
125662490|NCT00430638|452052522|FG000|Overall Study|Withdrawal by Subject|4|||
125662491|NCT00430638|452052523|FG001|Overall Study|Withdrawal by Subject|6|||
125662492|NCT00430638|452052522|FG000|Overall Study|Non-compliant|2|||
125662493|NCT00430638|452052523|FG001|Overall Study|Non-compliant|1|||
125662494|NCT00430638|452052522|FG000|Overall Study|Other|2|||
125662495|NCT00430638|452052523|FG001|Overall Study|Other|2|||
125662496|NCT05458895|452052525|FG000|Overall Study|Withdrawal by Subject|8|||
125662497|NCT05458895|452052525|FG000|Overall Study|Lost to Follow-up|17|||
125662498|NCT05458895|452052525|FG000|Overall Study|Pregnancy|2|||
125662499|NCT05458895|452052525|FG000|Overall Study|Withdrawal by Study Team|1|||
125662500|NCT01084603|452053990|FG000|Baseline|Withdrawal by Subject|2|||
125662501|NCT01084603|452053990|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
125662502|NCT01084603|452053990|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
125662503|NCT01084603|452053990|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
125662504|NCT01084603|452053990|FG000|Washout Period 4|Adverse Event|1|||
125662505|NCT03862625|452053997|FG000|Overall Study|Lost to Follow-up|0|||
125662506|NCT03862625|452053998|FG001|Overall Study|Lost to Follow-up|1|||
125662507|NCT01791127|452053999|FG000|Overall Study|Death|356|||
125662508|NCT01791127|452053999|FG000|Overall Study|Patient has withdrawn from study|293|||
125662509|NCT01791127|452053999|FG000|Overall Study|Lost to Follow-up|42|||
125662510|NCT01791127|452053999|FG000|Overall Study|All Siello leads are explanted|31|||
125662511|NCT01791127|452053999|FG000|Overall Study|Completion of 30 day safety registry|1|||
125662512|NCT01791127|452053999|FG000|Overall Study|Study terminated for EP Passion|749|||
125662513|NCT00520494|452054000|FG000|Overall Study|Withdrawal by Subject|1|||
125662514|NCT03471182|452054003|FG000|Overall Study|Withdrawal by Subject|1|||
125662515|NCT03471182|452054004|FG001|Overall Study|Withdrawal by Subject|1|||
125662516|NCT03471182|452054005|FG002|Overall Study|Withdrawal by Subject|0|||
125662517|NCT03471182|452054003|FG000|Overall Study|Technical failure|2|||
125662518|NCT03471182|452054004|FG001|Overall Study|Technical failure|0|||
125662519|NCT03471182|452054005|FG002|Overall Study|Technical failure|0|||
125662520|NCT04440163|452054007|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
125662521|NCT04440163|452054008|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
125662522|NCT04440163|452054009|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
125662523|NCT04440163|452054010|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
125662524|NCT04440163|452054011|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
125662525|NCT04440163|452054012|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
125662526|NCT04440163|452054013|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
125662527|NCT04440163|452054014|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
125662528|NCT04440163|452054007|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
125662529|NCT04440163|452054008|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
125662530|NCT04440163|452054009|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
125662531|NCT04440163|452054010|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
125662532|NCT04440163|452054011|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
125662533|NCT04440163|452054012|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
125321167|NCT01126749|450808083|FG002|Phase 2|Lost to Follow-up|0|||
125321168|NCT01126749|450808084|FG003|Phase 2|Lost to Follow-up|1|||
125321169|NCT01126749|450808081|FG000|Phase 2|Death|0|||
125321170|NCT01126749|450808082|FG001|Phase 2|Death|0|||
125321171|NCT01126749|450808083|FG002|Phase 2|Death|22|||
125321172|NCT01126749|450808084|FG003|Phase 2|Death|22|||
125321173|NCT01126749|450808081|FG000|Phase 2|Adverse Event|0|||
125321174|NCT01126749|450808082|FG001|Phase 2|Adverse Event|0|||
125321175|NCT01126749|450808083|FG002|Phase 2|Adverse Event|0|||
125321176|NCT01126749|450808084|FG003|Phase 2|Adverse Event|1|||
125321177|NCT00627393|450808087|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
125321178|NCT00627393|450808088|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
125321179|NCT00627393|450808087|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
125321180|NCT00627393|450808088|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
125321181|NCT00627393|450808087|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
125321182|NCT00627393|450808088|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
125321183|NCT00627393|450808087|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
125321184|NCT00627393|450808088|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
125321185|NCT01056822|450808089|FG000|Overall Study|Adverse Event|0|||
125321186|NCT01056822|450808090|FG001|Overall Study|Adverse Event|1|||
125321187|NCT01056822|450808089|FG000|Overall Study|Protocol Violation|6|||
125321188|NCT01056822|450808090|FG001|Overall Study|Protocol Violation|5|||
125321189|NCT01056822|450808089|FG000|Overall Study|Withdrawal by Subject|1|||
125321190|NCT01056822|450808090|FG001|Overall Study|Withdrawal by Subject|1|||
125321191|NCT01056822|450808089|FG000|Overall Study|Lost to Follow-up|1|||
125321192|NCT01056822|450808090|FG001|Overall Study|Lost to Follow-up|0|||
125321193|NCT05498649|450808091|FG000|Overall Study|Lost to Follow-up|1|||
125321194|NCT02761330|450808096|FG000|Treatment Week 1|Withdrawal by Subject|0|||
125321195|NCT02761330|450808097|FG001|Treatment Week 1|Withdrawal by Subject|0|||
125321196|NCT02761330|450808098|FG002|Treatment Week 1|Withdrawal by Subject|0|||
125321197|NCT02761330|450808099|FG003|Treatment Week 1|Withdrawal by Subject|1|||
125321198|NCT02761330|450808100|FG004|Treatment Week 1|Withdrawal by Subject|0|||
125321199|NCT02761330|450808101|FG005|Treatment Week 1|Withdrawal by Subject|1|||
125321200|NCT03043313|450808104|FG000|Overall Study|Withdrawal by Subject|5|||
125321201|NCT03043313|450808105|FG001|Overall Study|Withdrawal by Subject|1|||
125321202|NCT03043313|450808106|FG002|Overall Study|Withdrawal by Subject|1|||
125321203|NCT03043313|450808104|FG000|Overall Study|Lost to Follow-up|1|||
125321204|NCT03043313|450808105|FG001|Overall Study|Lost to Follow-up|1|||
125321205|NCT03043313|450808106|FG002|Overall Study|Lost to Follow-up|0|||
125321206|NCT03043313|450808104|FG000|Overall Study|Death|28|||
125321207|NCT03043313|450808105|FG001|Overall Study|Death|26|||
125321208|NCT03043313|450808106|FG002|Overall Study|Death|17|||
125321209|NCT03043313|450808104|FG000|Overall Study|Participation terminated by sponsor|11|||
125321210|NCT03043313|450808105|FG001|Overall Study|Participation terminated by sponsor|13|||
125321211|NCT03043313|450808106|FG002|Overall Study|Participation terminated by sponsor|13|||
125321212|NCT00980954|450808107|FG000|Overall Study|Protocol Violation|9|||
125321213|NCT00980954|450808108|FG001|Overall Study|Protocol Violation|15|||
125321214|NCT02657889|450808109|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
125321215|NCT02657889|450808110|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
125321216|NCT02657889|450808111|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
125321217|NCT02657889|450808112|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
125321218|NCT02657889|450808109|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
125321219|NCT02657889|450808110|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
125321220|NCT02657889|450808111|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
125321221|NCT02657889|450808112|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
125321222|NCT02657889|450808109|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
125321223|NCT02657889|450808110|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
125321224|NCT02657889|450808111|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
125321225|NCT02657889|450808112|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
125321226|NCT02657889|450808109|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
125321227|NCT02657889|450808110|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
125321228|NCT02657889|450808111|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
125321229|NCT02657889|450808112|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
125321230|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
125321231|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
125321232|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
125321233|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
125321234|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
125321235|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
125321236|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
125321237|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
125321238|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
125425578|NCT01592370|451180518|FG001|Overall Study|Other Reasons|0|||
125662534|NCT04440163|452054013|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
125662535|NCT04440163|452054014|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
125662536|NCT04440163|452054007|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
125662537|NCT04440163|452054008|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
125662538|NCT04440163|452054009|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
125662539|NCT04440163|452054010|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
125662540|NCT04440163|452054011|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
125662541|NCT04440163|452054012|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
125662542|NCT04440163|452054013|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
125662543|NCT04440163|452054014|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
125662544|NCT04440163|452054007|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
125662545|NCT04440163|452054008|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
125321239|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
125321240|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
125321241|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
125321242|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
125321243|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
125321244|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
125321245|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
125321246|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
125321247|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
125321248|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
125321249|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
125321250|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
125321251|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
125321252|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
125321253|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
125321254|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
125321255|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
125321256|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
125321257|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
125321258|NCT02657889|450808109|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
125321259|NCT02657889|450808110|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
125321260|NCT02657889|450808111|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
125321261|NCT02657889|450808112|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
125321262|NCT00374140|450808113|FG000|Overall Study|Lost to Follow-up|1|||
125321263|NCT00374140|450808113|FG000|Overall Study|Protocol Violation|1|||
125321264|NCT01576341|450808114|FG000|Overall Study|Withdrawal by Subject|24|||
125321265|NCT01576341|450808114|FG000|Overall Study|Adverse Event|10|||
125321266|NCT01576341|450808114|FG000|Overall Study|Death|21|||
125321267|NCT01576341|450808114|FG000|Overall Study|Physician Decision|2|||
125321268|NCT01576341|450808114|FG000|Overall Study|Lost to Follow-up|2|||
125321269|NCT01576341|450808114|FG000|Overall Study|Kidney transplantation|10|||
125321270|NCT01576341|450808114|FG000|Overall Study|Protocol Violation|12|||
125321271|NCT01576341|450808114|FG000|Overall Study|Other|12|||
125321272|NCT00517296|450808118|FG000|Overall Study|Withdrawal by Subject|1|||
125321273|NCT00517296|450808119|FG001|Overall Study|Withdrawal by Subject|0|||
125321274|NCT04366349|450808120|FG000|Overall Study|Withdrawal by Subject|1|||
125321275|NCT04366349|450808121|FG001|Overall Study|Withdrawal by Subject|0|||
125321276|NCT04366349|450808122|FG002|Overall Study|Withdrawal by Subject|0|||
125321277|NCT04366349|450808123|FG003|Overall Study|Withdrawal by Subject|0|||
125321278|NCT04366349|450808124|FG004|Overall Study|Withdrawal by Subject|0|||
125321279|NCT04366349|450808125|FG005|Overall Study|Withdrawal by Subject|0|||
125321280|NCT03413891|450808130|FG000|Overall Study|Lost to Follow-up|2|||
125321281|NCT03413891|450808131|FG001|Overall Study|Lost to Follow-up|1|||
125321282|NCT03413891|450808130|FG000|Overall Study|Protocol Violation|0|||
125321283|NCT03413891|450808131|FG001|Overall Study|Protocol Violation|1|||
125321284|NCT04905134|450808135|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
125321285|NCT04905134|450808135|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
125662546|NCT04440163|452054009|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
125662547|NCT04440163|452054010|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
125662548|NCT04440163|452054011|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
125321286|NCT03642873|450808136|FG000|Third Intervention (1 Day)|Screen failure|0|||
125321287|NCT03642873|450808137|FG001|Third Intervention (1 Day)|Screen failure|0|||
125321288|NCT03642873|450808138|FG002|Third Intervention (1 Day)|Screen failure|0|||
125321289|NCT03642873|450808139|FG003|Third Intervention (1 Day)|Screen failure|0|||
125321290|NCT03642873|450808140|FG004|Third Intervention (1 Day)|Screen failure|1|||
125321291|NCT03642873|450808141|FG005|Third Intervention (1 Day)|Screen failure|0|||
125662549|NCT04440163|452054012|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
125662550|NCT04440163|452054013|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
125662551|NCT04440163|452054014|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
125662552|NCT04440163|452054007|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
125662553|NCT04440163|452054008|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
125662554|NCT04440163|452054009|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
125662555|NCT04440163|452054010|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
125662556|NCT04440163|452054011|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
125662557|NCT04440163|452054012|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
125662558|NCT04440163|452054013|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
125662559|NCT04440163|452054014|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
125662560|NCT04440163|452054007|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
125662561|NCT04440163|452054008|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
125662562|NCT04440163|452054009|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
125662563|NCT04440163|452054010|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
125321292|NCT05556265|450808142|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
125321293|NCT05556265|450808143|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
125321294|NCT05556265|450808144|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
125321295|NCT05556265|450808145|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
125321296|NCT05556265|450808146|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
125321297|NCT05556265|450808142|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
125321298|NCT05556265|450808143|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
125321299|NCT05556265|450808144|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
125321300|NCT05556265|450808145|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
125321301|NCT05556265|450808146|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
125321302|NCT05556265|450808142|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
125321303|NCT05556265|450808143|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
125321304|NCT05556265|450808144|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
125321305|NCT05556265|450808145|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
125321306|NCT05556265|450808146|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
125321307|NCT05556265|450808142|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
125321308|NCT05556265|450808143|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
125321309|NCT05556265|450808144|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
125321310|NCT05556265|450808145|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
125321311|NCT05556265|450808146|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
125321312|NCT05556265|450808142|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
125321313|NCT05556265|450808143|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
125321314|NCT05556265|450808144|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
125321315|NCT05556265|450808145|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
125321316|NCT05556265|450808146|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
125321317|NCT05556265|450808142|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
125321318|NCT05556265|450808143|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
125321319|NCT05556265|450808144|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
125321320|NCT05556265|450808145|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
125321321|NCT05556265|450808146|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
125321322|NCT05556265|450808142|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
125321323|NCT05556265|450808143|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
125321324|NCT05556265|450808144|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
125321325|NCT05556265|450808145|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
125321326|NCT05556265|450808146|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
125321327|NCT05556265|450808142|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
125321328|NCT05556265|450808143|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
125321329|NCT05556265|450808144|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
125321330|NCT05556265|450808145|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
125321331|NCT05556265|450808146|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
125321332|NCT05556265|450808142|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
125321333|NCT05556265|450808143|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
125321334|NCT05556265|450808144|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
125321335|NCT05556265|450808145|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
125321336|NCT05556265|450808146|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
125321337|NCT03221556|450808149|FG000|Allocation|post-randomization exclusion|0|||
125321338|NCT03221556|450808150|FG001|Allocation|post-randomization exclusion|1|||
125321339|NCT03221556|450808149|FG000|Follow-Up|Withdrawal by Subject|0|||
125321340|NCT03221556|450808150|FG001|Follow-Up|Withdrawal by Subject|1|||
125321341|NCT02234843|450808153|FG000|Overall Study|Death|1|||
125321342|NCT02234843|450808154|FG001|Overall Study|Death|0|||
125321343|NCT02234843|450808155|FG002|Overall Study|Death|0|||
125321344|NCT02234843|450808156|FG003|Overall Study|Death|0|||
125321345|NCT02234843|450808157|FG004|Overall Study|Death|0|||
125321346|NCT02234843|450808158|FG005|Overall Study|Death|0|||
125321347|NCT02234843|450808159|FG006|Overall Study|Death|0|||
125321348|NCT02234843|450808160|FG007|Overall Study|Death|0|||
125321349|NCT02234843|450808161|FG008|Overall Study|Death|0|||
125321350|NCT02234843|450808162|FG009|Overall Study|Death|0|||
125321351|NCT02234843|450808153|FG000|Overall Study|Protocol Violation|1|||
125321352|NCT02234843|450808154|FG001|Overall Study|Protocol Violation|0|||
125321353|NCT02234843|450808155|FG002|Overall Study|Protocol Violation|1|||
125321354|NCT02234843|450808156|FG003|Overall Study|Protocol Violation|0|||
125321355|NCT02234843|450808157|FG004|Overall Study|Protocol Violation|0|||
125321356|NCT02234843|450808158|FG005|Overall Study|Protocol Violation|0|||
125321357|NCT02234843|450808159|FG006|Overall Study|Protocol Violation|0|||
125321358|NCT02234843|450808160|FG007|Overall Study|Protocol Violation|0|||
125321359|NCT02234843|450808161|FG008|Overall Study|Protocol Violation|0|||
125321360|NCT02234843|450808162|FG009|Overall Study|Protocol Violation|0|||
125321361|NCT02234843|450808153|FG000|Overall Study|Efficacy outcome reached|2|||
125321362|NCT02234843|450808154|FG001|Overall Study|Efficacy outcome reached|0|||
125321363|NCT02234843|450808155|FG002|Overall Study|Efficacy outcome reached|0|||
125321364|NCT02234843|450808156|FG003|Overall Study|Efficacy outcome reached|0|||
125321365|NCT02234843|450808157|FG004|Overall Study|Efficacy outcome reached|0|||
125321366|NCT02234843|450808158|FG005|Overall Study|Efficacy outcome reached|2|||
125321367|NCT02234843|450808159|FG006|Overall Study|Efficacy outcome reached|0|||
125321368|NCT02234843|450808160|FG007|Overall Study|Efficacy outcome reached|0|||
125321369|NCT02234843|450808161|FG008|Overall Study|Efficacy outcome reached|0|||
125321370|NCT02234843|450808162|FG009|Overall Study|Efficacy outcome reached|0|||
125321371|NCT02234843|450808153|FG000|Overall Study|Patient convenience|2|||
125321372|NCT02234843|450808154|FG001|Overall Study|Patient convenience|0|||
125321373|NCT02234843|450808155|FG002|Overall Study|Patient convenience|0|||
125321374|NCT02234843|450808156|FG003|Overall Study|Patient convenience|0|||
125321375|NCT02234843|450808157|FG004|Overall Study|Patient convenience|0|||
125321376|NCT02234843|450808158|FG005|Overall Study|Patient convenience|1|||
125321377|NCT02234843|450808159|FG006|Overall Study|Patient convenience|0|||
125321378|NCT02234843|450808160|FG007|Overall Study|Patient convenience|0|||
125321379|NCT02234843|450808161|FG008|Overall Study|Patient convenience|0|||
125321380|NCT02234843|450808162|FG009|Overall Study|Patient convenience|0|||
125321381|NCT02234843|450808153|FG000|Overall Study|Withdrawal by Subject|5|||
125321382|NCT02234843|450808154|FG001|Overall Study|Withdrawal by Subject|1|||
125321383|NCT02234843|450808155|FG002|Overall Study|Withdrawal by Subject|1|||
125321384|NCT02234843|450808156|FG003|Overall Study|Withdrawal by Subject|0|||
125321385|NCT02234843|450808157|FG004|Overall Study|Withdrawal by Subject|0|||
125321386|NCT02234843|450808158|FG005|Overall Study|Withdrawal by Subject|7|||
125321387|NCT02234843|450808159|FG006|Overall Study|Withdrawal by Subject|0|||
125321388|NCT02234843|450808160|FG007|Overall Study|Withdrawal by Subject|0|||
125321389|NCT02234843|450808161|FG008|Overall Study|Withdrawal by Subject|0|||
125321390|NCT02234843|450808162|FG009|Overall Study|Withdrawal by Subject|0|||
125321391|NCT02234843|450808153|FG000|Overall Study|Recovery|1|||
125321392|NCT02234843|450808154|FG001|Overall Study|Recovery|0|||
125662564|NCT04440163|452054011|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
125662565|NCT04440163|452054012|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
125662566|NCT04440163|452054013|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
125662567|NCT04440163|452054014|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
125662568|NCT04440163|452054007|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
125662569|NCT04440163|452054008|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
125662570|NCT04440163|452054009|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
125662571|NCT04440163|452054010|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
125321393|NCT02234843|450808155|FG002|Overall Study|Recovery|0|||
125321394|NCT02234843|450808156|FG003|Overall Study|Recovery|0|||
125321395|NCT02234843|450808157|FG004|Overall Study|Recovery|0|||
125321396|NCT02234843|450808158|FG005|Overall Study|Recovery|0|||
125321397|NCT02234843|450808159|FG006|Overall Study|Recovery|0|||
125321398|NCT02234843|450808160|FG007|Overall Study|Recovery|0|||
125321399|NCT02234843|450808161|FG008|Overall Study|Recovery|0|||
125321400|NCT02234843|450808162|FG009|Overall Study|Recovery|0|||
125321401|NCT02234843|450808153|FG000|Overall Study|Other|0|||
125321402|NCT02234843|450808154|FG001|Overall Study|Other|2|||
125321403|NCT02234843|450808155|FG002|Overall Study|Other|0|||
125321404|NCT02234843|450808156|FG003|Overall Study|Other|1|||
125321405|NCT02234843|450808157|FG004|Overall Study|Other|0|||
125321406|NCT02234843|450808158|FG005|Overall Study|Other|1|||
125321407|NCT02234843|450808159|FG006|Overall Study|Other|0|||
125321408|NCT02234843|450808160|FG007|Overall Study|Other|1|||
125321409|NCT02234843|450808161|FG008|Overall Study|Other|0|||
125321410|NCT02234843|450808162|FG009|Overall Study|Other|0|||
125321411|NCT02234843|450808153|FG000|Overall Study|Physician Decision|4|||
125321412|NCT02234843|450808154|FG001|Overall Study|Physician Decision|1|||
125321413|NCT02234843|450808155|FG002|Overall Study|Physician Decision|0|||
125321414|NCT02234843|450808156|FG003|Overall Study|Physician Decision|1|||
125321415|NCT02234843|450808157|FG004|Overall Study|Physician Decision|0|||
125321416|NCT02234843|450808158|FG005|Overall Study|Physician Decision|0|||
125321417|NCT02234843|450808159|FG006|Overall Study|Physician Decision|0|||
125321418|NCT02234843|450808160|FG007|Overall Study|Physician Decision|1|||
125321419|NCT02234843|450808161|FG008|Overall Study|Physician Decision|0|||
125321420|NCT02234843|450808162|FG009|Overall Study|Physician Decision|0|||
125321421|NCT02234843|450808153|FG000|Overall Study|Adverse Event|5|||
125321422|NCT02234843|450808154|FG001|Overall Study|Adverse Event|1|||
125321423|NCT02234843|450808155|FG002|Overall Study|Adverse Event|1|||
125321424|NCT02234843|450808156|FG003|Overall Study|Adverse Event|3|||
125321425|NCT02234843|450808157|FG004|Overall Study|Adverse Event|2|||
125321426|NCT02234843|450808158|FG005|Overall Study|Adverse Event|1|||
125321427|NCT02234843|450808159|FG006|Overall Study|Adverse Event|0|||
125321428|NCT02234843|450808160|FG007|Overall Study|Adverse Event|0|||
125321429|NCT02234843|450808161|FG008|Overall Study|Adverse Event|1|||
125321430|NCT02234843|450808162|FG009|Overall Study|Adverse Event|0|||
125321431|NCT02234843|450808153|FG000|Overall Study|Non-compliance with study drug|1|||
125321432|NCT02234843|450808154|FG001|Overall Study|Non-compliance with study drug|0|||
125321433|NCT02234843|450808155|FG002|Overall Study|Non-compliance with study drug|0|||
125321434|NCT02234843|450808156|FG003|Overall Study|Non-compliance with study drug|0|||
125321435|NCT02234843|450808157|FG004|Overall Study|Non-compliance with study drug|0|||
125321436|NCT02234843|450808158|FG005|Overall Study|Non-compliance with study drug|1|||
125321437|NCT02234843|450808159|FG006|Overall Study|Non-compliance with study drug|1|||
125321438|NCT02234843|450808160|FG007|Overall Study|Non-compliance with study drug|0|||
125321439|NCT02234843|450808161|FG008|Overall Study|Non-compliance with study drug|0|||
125321440|NCT02234843|450808162|FG009|Overall Study|Non-compliance with study drug|0|||
125321441|NCT02234843|450808153|FG000|Overall Study|Lost to Follow-up|0|||
125321442|NCT02234843|450808154|FG001|Overall Study|Lost to Follow-up|1|||
125321443|NCT02234843|450808155|FG002|Overall Study|Lost to Follow-up|0|||
125321444|NCT02234843|450808156|FG003|Overall Study|Lost to Follow-up|0|||
125321445|NCT02234843|450808157|FG004|Overall Study|Lost to Follow-up|0|||
125321446|NCT02234843|450808158|FG005|Overall Study|Lost to Follow-up|0|||
125321447|NCT02234843|450808159|FG006|Overall Study|Lost to Follow-up|1|||
125321448|NCT02234843|450808160|FG007|Overall Study|Lost to Follow-up|0|||
125321449|NCT02234843|450808161|FG008|Overall Study|Lost to Follow-up|0|||
125321450|NCT02234843|450808162|FG009|Overall Study|Lost to Follow-up|0|||
125321451|NCT03905096|450808163|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
125321452|NCT03905096|450808164|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
125321453|NCT02016781|450808165|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
125321454|NCT02016781|450808166|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
125321455|NCT02016781|450808165|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
125321456|NCT02016781|450808166|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
125321457|NCT02016781|450808165|FG000|Final Database Lock|Withdrawal by Subject|2|||
125321458|NCT02016781|450808166|FG001|Final Database Lock|Withdrawal by Subject|1|||
125662572|NCT04440163|452054011|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
125321459|NCT02016781|450808165|FG000|Final Database Lock|Lost to Follow-up|11|||
125321460|NCT02016781|450808166|FG001|Final Database Lock|Lost to Follow-up|4|||
125321461|NCT02016781|450808165|FG000|Final Database Lock|Missing data|0|||
125321462|NCT02016781|450808166|FG001|Final Database Lock|Missing data|3|||
125321463|NCT02336282|450808167|FG000|Overall Study|Unrelated illness|1|||
125321464|NCT02336282|450808167|FG000|Overall Study|Uncomfortable with technology|1|||
125321465|NCT02336282|450808167|FG000|Overall Study|Lost to Follow-up|1|||
125321466|NCT02336282|450808167|FG000|Overall Study|Not enough time to complete sessions|2|||
125321467|NCT03724942|450808169|FG000|Overall Study|Adverse Event|20|||
125321468|NCT03724942|450808170|FG001|Overall Study|Adverse Event|14|||
125321469|NCT03724942|450808169|FG000|Overall Study|Lack of Efficacy|0|||
125321470|NCT03724942|450808170|FG001|Overall Study|Lack of Efficacy|1|||
125321471|NCT03724942|450808169|FG000|Overall Study|Physician Decision|5|||
125321472|NCT03724942|450808170|FG001|Overall Study|Physician Decision|2|||
125321473|NCT03724942|450808169|FG000|Overall Study|Protocol Violation|1|||
125321474|NCT03724942|450808170|FG001|Overall Study|Protocol Violation|0|||
125321475|NCT03724942|450808169|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
125662573|NCT04440163|452054012|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
125321476|NCT03724942|450808170|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
125321477|NCT03724942|450808169|FG000|Overall Study|Withdrawal by Legal Representative|3|||
125321478|NCT03724942|450808170|FG001|Overall Study|Withdrawal by Legal Representative|0|||
125321479|NCT04875975|450808171|FG000|Overall Study|Adverse Event|1|||
125321480|NCT04875975|450808172|FG001|Overall Study|Adverse Event|2|||
125662574|NCT04440163|452054013|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
125321481|NCT04875975|450808171|FG000|Overall Study|Lack of Efficacy|2|||
125662575|NCT04440163|452054014|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
125662576|NCT04440163|452054007|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
125321482|NCT04875975|450808172|FG001|Overall Study|Lack of Efficacy|2|||
125321483|NCT04875975|450808171|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
125321484|NCT04875975|450808172|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
125321485|NCT04875975|450808171|FG000|Overall Study|Relapse With Insults|0|||
125321486|NCT04875975|450808172|FG001|Overall Study|Relapse With Insults|1|||
125321487|NCT04875975|450808171|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
125321488|NCT04875975|450808172|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
125321489|NCT03253393|450808173|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
125321490|NCT03253393|450808174|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
125321491|NCT03253393|450808175|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
125321492|NCT04515771|450809939|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
125321493|NCT04515771|450809940|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
125321494|NCT04515771|450809939|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
125321495|NCT04515771|450809940|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
125321496|NCT04515771|450809939|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
125321497|NCT04515771|450809940|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
125321498|NCT00948246|450809941|FG000|Overall Study|Lost to Follow-up|11|||
125321499|NCT00948246|450809941|FG000|Overall Study|Adverse Event|11|||
125321500|NCT00948246|450809941|FG000|Overall Study|Death|1|||
125321501|NCT00948246|450809941|FG000|Overall Study|Withdrawal by Subject|1|||
125321502|NCT04199351|450809944|FG000|Overall Study|Decision by sponsor|0|||
125321503|NCT04199351|450809945|FG001|Overall Study|Decision by sponsor|0|||
125321504|NCT04199351|450809946|FG002|Overall Study|Decision by sponsor|0|||
125321505|NCT04199351|450809947|FG003|Overall Study|Decision by sponsor|2|||
125321506|NCT04199351|450809948|FG004|Overall Study|Decision by sponsor|0|||
125321507|NCT04199351|450809949|FG005|Overall Study|Decision by sponsor|0|||
125321508|NCT04199351|450809950|FG006|Overall Study|Decision by sponsor|0|||
125321509|NCT04199351|450809951|FG007|Overall Study|Decision by sponsor|0|||
125321510|NCT04199351|450809952|FG008|Overall Study|Decision by sponsor|0|||
125321511|NCT04199351|450809953|FG009|Overall Study|Decision by sponsor|6|||
125321512|NCT04199351|450809944|FG000|Overall Study|Lost to Follow-up|0|||
125321513|NCT04199351|450809945|FG001|Overall Study|Lost to Follow-up|0|||
125321514|NCT04199351|450809946|FG002|Overall Study|Lost to Follow-up|1|||
125321515|NCT04199351|450809947|FG003|Overall Study|Lost to Follow-up|0|||
125321516|NCT04199351|450809948|FG004|Overall Study|Lost to Follow-up|0|||
125321517|NCT04199351|450809949|FG005|Overall Study|Lost to Follow-up|1|||
125321518|NCT04199351|450809950|FG006|Overall Study|Lost to Follow-up|0|||
125662577|NCT04440163|452054008|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
125662578|NCT04440163|452054009|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
125662579|NCT04440163|452054010|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
125662580|NCT04440163|452054011|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
125662581|NCT04440163|452054012|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
125662582|NCT04440163|452054013|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
125662583|NCT04440163|452054014|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
125662584|NCT04440163|452054007|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
125662585|NCT04440163|452054008|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
125662586|NCT04440163|452054009|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
125662587|NCT04440163|452054010|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
125662588|NCT04440163|452054011|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
125662589|NCT04440163|452054012|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
125662590|NCT04440163|452054013|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
125662591|NCT04440163|452054014|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
125662592|NCT04440163|452054007|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
125662593|NCT04440163|452054008|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
125662594|NCT04440163|452054009|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
125662595|NCT04440163|452054010|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
125662596|NCT04440163|452054011|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
125662597|NCT04440163|452054012|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
125662598|NCT04440163|452054013|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
125662599|NCT04440163|452054014|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
125662600|NCT04440163|452054007|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
125662601|NCT04440163|452054008|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
125321519|NCT04199351|450809951|FG007|Overall Study|Lost to Follow-up|0|||
125321520|NCT04199351|450809952|FG008|Overall Study|Lost to Follow-up|0|||
125321521|NCT04199351|450809953|FG009|Overall Study|Lost to Follow-up|0|||
125321522|NCT04199351|450809944|FG000|Overall Study|Withdrawal by Subject|0|||
125321523|NCT04199351|450809945|FG001|Overall Study|Withdrawal by Subject|1|||
125321524|NCT04199351|450809946|FG002|Overall Study|Withdrawal by Subject|0|||
125321525|NCT04199351|450809947|FG003|Overall Study|Withdrawal by Subject|0|||
125321526|NCT04199351|450809948|FG004|Overall Study|Withdrawal by Subject|1|||
125321527|NCT04199351|450809949|FG005|Overall Study|Withdrawal by Subject|4|||
125321528|NCT04199351|450809950|FG006|Overall Study|Withdrawal by Subject|2|||
125321529|NCT04199351|450809951|FG007|Overall Study|Withdrawal by Subject|0|||
125321530|NCT04199351|450809952|FG008|Overall Study|Withdrawal by Subject|3|||
125321531|NCT04199351|450809953|FG009|Overall Study|Withdrawal by Subject|0|||
125662602|NCT04440163|452054009|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
125662603|NCT04440163|452054010|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
125662604|NCT04440163|452054011|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
125662605|NCT04440163|452054012|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
125662606|NCT04440163|452054013|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
125662607|NCT04440163|452054014|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
125662608|NCT04440163|452054007|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125662609|NCT04440163|452054008|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125662610|NCT04440163|452054009|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125662611|NCT04440163|452054010|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
125662612|NCT04440163|452054011|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125662613|NCT04440163|452054012|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125662614|NCT04440163|452054013|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125662615|NCT04440163|452054014|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
125662616|NCT02018042|452054017|FG000|Overall Study|Withdrawal by Subject|1|||
125662617|NCT01954082|452054018|FG000|Overall Study|Study Suspension|42|||
125662618|NCT01954082|452054019|FG001|Overall Study|Study Suspension|36|||
125662619|NCT01954082|452054018|FG000|Overall Study|Adverse Event|10|||
125662620|NCT01954082|452054019|FG001|Overall Study|Adverse Event|4|||
125662621|NCT01954082|452054018|FG000|Overall Study|Intolerance|0|||
125662622|NCT01954082|452054019|FG001|Overall Study|Intolerance|1|||
125662623|NCT01954082|452054018|FG000|Overall Study|Non-compliance|6|||
125662624|NCT01954082|452054019|FG001|Overall Study|Non-compliance|4|||
125662625|NCT01954082|452054018|FG000|Overall Study|Physician Decision|2|||
125662626|NCT01954082|452054019|FG001|Overall Study|Physician Decision|0|||
125662627|NCT01954082|452054018|FG000|Overall Study|Parent Decision|1|||
125662628|NCT01954082|452054019|FG001|Overall Study|Parent Decision|0|||
125662629|NCT01954082|452054018|FG000|Overall Study|Withdrawal by Subject|0|||
125662630|NCT01954082|452054019|FG001|Overall Study|Withdrawal by Subject|1|||
125662631|NCT01954082|452054018|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
125662632|NCT01954082|452054019|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
125662633|NCT01954082|452054018|FG000|Overall Study|Redirection of Care|0|||
125662634|NCT01954082|452054019|FG001|Overall Study|Redirection of Care|2|||
125662635|NCT01954082|452054018|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
125662636|NCT01954082|452054019|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
125662637|NCT01954082|452054018|FG000|Overall Study|Comfort Care|0|||
125662638|NCT01954082|452054019|FG001|Overall Study|Comfort Care|1|||
125662639|NCT01954082|452054018|FG000|Overall Study|Infant Moved|0|||
125662640|NCT01954082|452054019|FG001|Overall Study|Infant Moved|1|||
125662641|NCT01954082|452054018|FG000|Overall Study|Randomized not Treated|4|||
125662642|NCT01954082|452054019|FG001|Overall Study|Randomized not Treated|2|||
125662643|NCT00707174|452054022|FG000|Overall Study|Adverse Event|1|||
125662644|NCT00707174|452054023|FG001|Overall Study|Adverse Event|6|||
125662645|NCT00707174|452054022|FG000|Overall Study|Withdrawal by Subject|4|||
125662646|NCT00707174|452054023|FG001|Overall Study|Withdrawal by Subject|1|||
125662647|NCT01453374|452054024|FG000|Overall Study|Adverse Event|7|||
125662648|NCT01453374|452054024|FG000|Overall Study|Lack of Efficacy|1|||
125662649|NCT01453374|452054024|FG000|Overall Study|Lost to Follow-up|3|||
125662650|NCT01453374|452054024|FG000|Overall Study|Withdrawal by Subject|5|||
125662651|NCT01453374|452054024|FG000|Overall Study|Incarcerated|2|||
125662652|NCT00709735|452054032|FG000|Overall Study|Lost to Follow-up|1|||
125662653|NCT00709735|452054033|FG001|Overall Study|Lost to Follow-up|1|||
125662654|NCT00709735|452054032|FG000|Overall Study|Relapse into Opioid Abuse|0|||
125662655|NCT00709735|452054033|FG001|Overall Study|Relapse into Opioid Abuse|1|||
125662656|NCT00709735|452054032|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
125662657|NCT00709735|452054033|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
125662658|NCT00666718|452054034|FG000|Overall Study|Adverse Event|0|||
125662659|NCT00666718|452054035|FG001|Overall Study|Adverse Event|1|||
125662660|NCT00666718|452054034|FG000|Overall Study|Death|1|||
125662661|NCT00666718|452054035|FG001|Overall Study|Death|0|||
125321532|NCT00474487|450809957|FG000|Overall Study|Withdrawal by Subject|6|||
125662662|NCT00666718|452054034|FG000|Overall Study|Lost to Follow-up|1|||
125662663|NCT00666718|452054035|FG001|Overall Study|Lost to Follow-up|0|||
125662664|NCT00666718|452054034|FG000|Overall Study|Entry Criteria Not Met|2|||
125662665|NCT00666718|452054035|FG001|Overall Study|Entry Criteria Not Met|0|||
125662666|NCT00666718|452054034|FG000|Overall Study|Protocol Violation|1|||
125662667|NCT00666718|452054035|FG001|Overall Study|Protocol Violation|3|||
125662668|NCT00666718|452054034|FG000|Overall Study|Withdrawal by Subject|7|||
125662669|NCT00666718|452054035|FG001|Overall Study|Withdrawal by Subject|12|||
125662670|NCT00666718|452054034|FG000|Overall Study|Physician Decision|0|||
125662671|NCT00666718|452054035|FG001|Overall Study|Physician Decision|2|||
125662672|NCT00810615|452054038|FG000|Overall Study|Withdrawal by Subject|1|||
125662673|NCT00810615|452054039|FG001|Overall Study|Withdrawal by Subject|1|||
125321533|NCT00474487|450809958|FG001|Overall Study|Withdrawal by Subject|0|||
125321534|NCT00474487|450809959|FG002|Overall Study|Withdrawal by Subject|0|||
125321535|NCT00474487|450809960|FG003|Overall Study|Withdrawal by Subject|0|||
125321536|NCT00474487|450809957|FG000|Overall Study|Lost to Follow-up|20|||
125321537|NCT00474487|450809958|FG001|Overall Study|Lost to Follow-up|1|||
125662674|NCT02525562|452054040|FG000|Overall Study|Death|9|||
125662675|NCT02525562|452054041|FG001|Overall Study|Death|0|||
125662676|NCT02525562|452054042|FG002|Overall Study|Death|0|||
125662677|NCT02525562|452054040|FG000|Overall Study|Lost to Follow-up|19|||
125662678|NCT02525562|452054041|FG001|Overall Study|Lost to Follow-up|0|||
125662679|NCT02525562|452054042|FG002|Overall Study|Lost to Follow-up|0|||
125662680|NCT02525562|452054040|FG000|Overall Study|Withdrawal by Subject|37|||
125662681|NCT02525562|452054041|FG001|Overall Study|Withdrawal by Subject|0|||
125662682|NCT02525562|452054042|FG002|Overall Study|Withdrawal by Subject|0|||
125662683|NCT02525562|452054040|FG000|Overall Study|Revision/Removal of Study Device|4|||
125321538|NCT00474487|450809959|FG002|Overall Study|Lost to Follow-up|7|||
125321539|NCT00474487|450809960|FG003|Overall Study|Lost to Follow-up|0|||
125321540|NCT00474487|450809957|FG000|Overall Study|Inappropriate enrollment|4|||
125662684|NCT02525562|452054041|FG001|Overall Study|Revision/Removal of Study Device|0|||
125662685|NCT02525562|452054042|FG002|Overall Study|Revision/Removal of Study Device|0|||
125662686|NCT02525562|452054040|FG000|Overall Study|Study Closed by Sponsor|154|||
125321541|NCT00474487|450809958|FG001|Overall Study|Inappropriate enrollment|0|||
125321542|NCT00474487|450809959|FG002|Overall Study|Inappropriate enrollment|7|||
125321543|NCT00474487|450809960|FG003|Overall Study|Inappropriate enrollment|0|||
125321544|NCT00474487|450809957|FG000|Overall Study|Death|0|||
125321545|NCT00474487|450809958|FG001|Overall Study|Death|1|||
125321546|NCT00474487|450809959|FG002|Overall Study|Death|0|||
125321547|NCT00474487|450809960|FG003|Overall Study|Death|0|||
125321548|NCT02443688|450809963|FG000|Overall Study|Adverse Event|2|||
125321549|NCT02443688|450809964|FG001|Overall Study|Adverse Event|3|||
125321550|NCT02443688|450809965|FG002|Overall Study|Adverse Event|2|||
125321551|NCT02443688|450809963|FG000|Overall Study|Lost to Follow-up|1|||
125321552|NCT02443688|450809964|FG001|Overall Study|Lost to Follow-up|0|||
125321553|NCT02443688|450809965|FG002|Overall Study|Lost to Follow-up|0|||
125321554|NCT02443688|450809963|FG000|Overall Study|Physician Decision|3|||
125321555|NCT02443688|450809964|FG001|Overall Study|Physician Decision|0|||
125321556|NCT02443688|450809965|FG002|Overall Study|Physician Decision|1|||
125321557|NCT02443688|450809963|FG000|Overall Study|Pregnancy|0|||
125321558|NCT02443688|450809964|FG001|Overall Study|Pregnancy|0|||
125321559|NCT02443688|450809965|FG002|Overall Study|Pregnancy|1|||
125321560|NCT02443688|450809963|FG000|Overall Study|Withdrawal by Subject|3|||
125321561|NCT02443688|450809964|FG001|Overall Study|Withdrawal by Subject|3|||
125321562|NCT02443688|450809965|FG002|Overall Study|Withdrawal by Subject|4|||
125321563|NCT02443688|450809963|FG000|Overall Study|Non-compliance with study drug|1|||
125321564|NCT02443688|450809964|FG001|Overall Study|Non-compliance with study drug|2|||
125321565|NCT02443688|450809965|FG002|Overall Study|Non-compliance with study drug|4|||
125321566|NCT02443688|450809963|FG000|Overall Study|Sponsor Request|2|||
125321567|NCT02443688|450809964|FG001|Overall Study|Sponsor Request|1|||
125321568|NCT02443688|450809965|FG002|Overall Study|Sponsor Request|0|||
125321569|NCT03182374|450809966|FG000|Overall Study|Lost to Follow-up|3|||
125321570|NCT03182374|450809967|FG001|Overall Study|Lost to Follow-up|2|||
125321571|NCT03182374|450809966|FG000|Overall Study|Lack of Efficacy|8|||
125321572|NCT03182374|450809967|FG001|Overall Study|Lack of Efficacy|14|||
125321573|NCT03182374|450809966|FG000|Overall Study|Withdrawal by Subject|1|||
125321574|NCT03182374|450809967|FG001|Overall Study|Withdrawal by Subject|1|||
125321575|NCT03182374|450809966|FG000|Overall Study|exit for non-compliance|1|||
125321576|NCT03182374|450809967|FG001|Overall Study|exit for non-compliance|1|||
125662687|NCT02525562|452054041|FG001|Overall Study|Study Closed by Sponsor|0|||
125662688|NCT02525562|452054042|FG002|Overall Study|Study Closed by Sponsor|0|||
125662689|NCT02567266|452054043|FG000|Overall Study|Withdrawal by Subject|10|||
125662690|NCT02567266|452054044|FG001|Overall Study|Withdrawal by Subject|7|||
125662691|NCT02567266|452054045|FG002|Overall Study|Withdrawal by Subject|6|||
125662692|NCT02567266|452054043|FG000|Overall Study|Lost to Follow-up|13|||
125662693|NCT02567266|452054044|FG001|Overall Study|Lost to Follow-up|8|||
125321577|NCT03182374|450809966|FG000|Overall Study|one subject was randomized but not treated|1|||
125321578|NCT03182374|450809967|FG001|Overall Study|one subject was randomized but not treated|0|||
125662694|NCT02567266|452054045|FG002|Overall Study|Lost to Follow-up|10|||
125321579|NCT03182374|450809966|FG000|Overall Study|Other reasons|0|||
125321580|NCT03182374|450809967|FG001|Overall Study|Other reasons|3|||
125321581|NCT03198715|450809975|FG000|Overall Study|Death|0|||
125321582|NCT03198715|450809976|FG001|Overall Study|Death|0|||
125321583|NCT03198715|450809977|FG002|Overall Study|Death|1|||
125321584|NCT03198715|450809978|FG003|Overall Study|Death|0|||
125321585|NCT03198715|450809979|FG004|Overall Study|Death|2|||
125321586|NCT03198715|450809975|FG000|Overall Study|Other|0|||
125321587|NCT03198715|450809976|FG001|Overall Study|Other|1|||
125321588|NCT03198715|450809977|FG002|Overall Study|Other|1|||
125321589|NCT03198715|450809978|FG003|Overall Study|Other|0|||
125321590|NCT03198715|450809979|FG004|Overall Study|Other|0|||
125321591|NCT00616759|450809980|FG000|Overall Study|Physician Decision|2|||
125321592|NCT00616759|450809981|FG001|Overall Study|Physician Decision|0|||
125321593|NCT00616759|450809980|FG000|Overall Study|Withdrawal by Subject|1|||
125321594|NCT00616759|450809981|FG001|Overall Study|Withdrawal by Subject|2|||
125321595|NCT02007096|450809982|FG000|Overall Study|medication not available|2|||
125321596|NCT02007096|450809983|FG001|Overall Study|medication not available|0|||
125321597|NCT02007096|450809982|FG000|Overall Study|did not inject saline|0|||
125321598|NCT02007096|450809983|FG001|Overall Study|did not inject saline|3|||
125321599|NCT02007096|450809982|FG000|Overall Study|did not follow postoperative protocol|8|||
125321600|NCT02007096|450809983|FG001|Overall Study|did not follow postoperative protocol|11|||
125321601|NCT02007096|450809982|FG000|Overall Study|converted to open surgery|1|||
125321602|NCT02007096|450809983|FG001|Overall Study|converted to open surgery|1|||
125321603|NCT02007096|450809982|FG000|Overall Study|no mesh placed|0|||
125321604|NCT02007096|450809983|FG001|Overall Study|no mesh placed|1|||
125321605|NCT02558894|450809988|FG000|Overall Study|Death; any cause, entire study duration|28|||
125321606|NCT02558894|450809989|FG001|Overall Study|Death; any cause, entire study duration|31|||
125321607|NCT02558894|450809988|FG000|Overall Study|Withdrawal by Subject|2|||
125321608|NCT02558894|450809989|FG001|Overall Study|Withdrawal by Subject|1|||
125321609|NCT02558894|450809988|FG000|Overall Study|Closure of Part A|2|||
125321610|NCT02558894|450809989|FG001|Overall Study|Closure of Part A|1|||
125321611|NCT02476617|450809995|FG000|Overall Study|Adverse Event|1|||
125321612|NCT02476617|450809995|FG000|Overall Study|Lost to Follow-up|1|||
125321613|NCT03486912|450809996|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
125321614|NCT03486912|450809997|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
125321615|NCT03486912|450809998|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
125321616|NCT03486912|450809999|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
125321617|NCT03486912|450809996|FG000|Treatment Period|Withdrawal by Subject|3|||
125321618|NCT03486912|450809997|FG001|Treatment Period|Withdrawal by Subject|3|||
125321619|NCT03486912|450809998|FG002|Treatment Period|Withdrawal by Subject|3|||
125321620|NCT03486912|450809999|FG003|Treatment Period|Withdrawal by Subject|2|||
125321621|NCT03486912|450809996|FG000|Treatment Period|Other Reasons|0|||
125321622|NCT03486912|450809997|FG001|Treatment Period|Other Reasons|2|||
125321623|NCT03486912|450809998|FG002|Treatment Period|Other Reasons|1|||
125321624|NCT03486912|450809999|FG003|Treatment Period|Other Reasons|1|||
125321625|NCT03486912|450809996|FG000|Treatment Period|Adverse Event|0|||
125321626|NCT03486912|450809997|FG001|Treatment Period|Adverse Event|1|||
125321627|NCT03486912|450809998|FG002|Treatment Period|Adverse Event|1|||
125321628|NCT03486912|450809999|FG003|Treatment Period|Adverse Event|0|||
125321629|NCT03486912|450809996|FG000|Treatment Period|Lost to Follow-up|1|||
125321630|NCT03486912|450809997|FG001|Treatment Period|Lost to Follow-up|0|||
125321631|NCT03486912|450809998|FG002|Treatment Period|Lost to Follow-up|0|||
125321632|NCT03486912|450809999|FG003|Treatment Period|Lost to Follow-up|2|||
125321633|NCT02491684|450810000|FG000|Treatment Phase|Adverse Event|2|||
125321634|NCT02491684|450810001|FG001|Treatment Phase|Adverse Event|2|||
125321635|NCT02491684|450810000|FG000|Treatment Phase|Incorrect randomisation|1|||
125321636|NCT02491684|450810001|FG001|Treatment Phase|Incorrect randomisation|0|||
125321637|NCT02491684|450810000|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
125321638|NCT02491684|450810001|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
125321639|NCT01263769|450810003|FG000|Overall Study|Non-Compliant with treatment|1|||
125321640|NCT02242942|450810006|FG000|Overall Study|Death|17|||
125321641|NCT02242942|450810007|FG001|Overall Study|Death|20|||
125321642|NCT02242942|450810008|FG002|Overall Study|Death|2|||
125321643|NCT02242942|450810006|FG000|Overall Study|Physician Decision|1|||
125321644|NCT02242942|450810007|FG001|Overall Study|Physician Decision|0|||
125321645|NCT02242942|450810008|FG002|Overall Study|Physician Decision|0|||
125321646|NCT02242942|450810006|FG000|Overall Study|Withdrawal by Subject|8|||
125321647|NCT02242942|450810007|FG001|Overall Study|Withdrawal by Subject|10|||
125321648|NCT02242942|450810008|FG002|Overall Study|Withdrawal by Subject|0|||
125321649|NCT02242942|450810006|FG000|Overall Study|On-going in Study|190|||
125321650|NCT02242942|450810007|FG001|Overall Study|On-going in Study|186|||
125321651|NCT02242942|450810008|FG002|Overall Study|On-going in Study|11|||
125321652|NCT03259230|450810009|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
125321653|NCT03259230|450810010|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
125321654|NCT00561652|450810011|FG000|Overall Study|Withdrawal by Subject|0|||
125321655|NCT00561652|450810012|FG001|Overall Study|Withdrawal by Subject|1|||
125321656|NCT03019406|450810016|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
125321657|NCT03019406|450810017|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
125321658|NCT03019406|450810018|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
125321659|NCT03019406|450810019|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
125321660|NCT00231816|450810022|FG000|Overall Study|Adverse Event|1|||
125321661|NCT00231816|450810023|FG001|Overall Study|Adverse Event|0|||
125321662|NCT00231816|450810022|FG000|Overall Study|Lost to Follow-up|8|||
125321663|NCT00231816|450810023|FG001|Overall Study|Lost to Follow-up|5|||
125321664|NCT00231816|450810022|FG000|Overall Study|Protocol Violation|2|||
125321665|NCT00231816|450810023|FG001|Overall Study|Protocol Violation|3|||
125321666|NCT00231816|450810022|FG000|Overall Study|Withdrawal by Subject|3|||
125321667|NCT00231816|450810023|FG001|Overall Study|Withdrawal by Subject|3|||
125321668|NCT00231816|450810022|FG000|Overall Study|Other|2|||
125321669|NCT00231816|450810023|FG001|Overall Study|Other|1|||
125321670|NCT00468169|450810024|FG000|Overall Study|Withdrawal by Subject|1|||
125321671|NCT00468169|450810025|FG001|Overall Study|Withdrawal by Subject|0|||
125321672|NCT01283139|450810031|FG000|Overall Study|Lost to Follow-up|5|||
125321673|NCT01283139|450810032|FG001|Overall Study|Lost to Follow-up|2|||
125321674|NCT01283139|450810033|FG002|Overall Study|Lost to Follow-up|3|||
125321675|NCT01283139|450810034|FG003|Overall Study|Lost to Follow-up|1|||
125321676|NCT01283139|450810031|FG000|Overall Study|Withdrawal by Subject|8|||
125662695|NCT02643966|452054046|FG000|First Screening Round|ineligible|1|||
125662696|NCT02643966|452054046|FG000|First Screening Round|excluded from analysis|2|||
125662697|NCT02643966|452054046|FG000|First Screening Round|Lost to Follow-up|56|||
125662698|NCT02643966|452054046|FG000|First Screening Round|Withdrawal by Subject|28|||
125662699|NCT02643966|452054046|FG000|First Screening Round|Death|1|||
125662700|NCT02643966|452054046|FG000|Between First and Second Screening|Lost to Follow-up|65|||
125662701|NCT02643966|452054046|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
125662702|NCT02643966|452054046|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
125321677|NCT01283139|450810032|FG001|Overall Study|Withdrawal by Subject|8|||
125321678|NCT01283139|450810033|FG002|Overall Study|Withdrawal by Subject|6|||
125321679|NCT01283139|450810034|FG003|Overall Study|Withdrawal by Subject|8|||
125321680|NCT01283139|450810031|FG000|Overall Study|Death|2|||
125321681|NCT01283139|450810032|FG001|Overall Study|Death|0|||
125321682|NCT01283139|450810033|FG002|Overall Study|Death|2|||
125321683|NCT01283139|450810034|FG003|Overall Study|Death|2|||
125321684|NCT01283139|450810031|FG000|Overall Study|Lack of Efficacy|1|||
125321685|NCT01283139|450810032|FG001|Overall Study|Lack of Efficacy|2|||
125321686|NCT01283139|450810033|FG002|Overall Study|Lack of Efficacy|2|||
125321687|NCT01283139|450810034|FG003|Overall Study|Lack of Efficacy|1|||
125321688|NCT01283139|450810031|FG000|Overall Study|Early termination due to AE/SAE|1|||
125321689|NCT01283139|450810032|FG001|Overall Study|Early termination due to AE/SAE|1|||
125321690|NCT01283139|450810033|FG002|Overall Study|Early termination due to AE/SAE|0|||
125321691|NCT01283139|450810034|FG003|Overall Study|Early termination due to AE/SAE|0|||
125321692|NCT01283139|450810031|FG000|Overall Study|Participant's refusal to continue|0|||
125321693|NCT01283139|450810032|FG001|Overall Study|Participant's refusal to continue|3|||
125321694|NCT01283139|450810033|FG002|Overall Study|Participant's refusal to continue|1|||
125321695|NCT01283139|450810034|FG003|Overall Study|Participant's refusal to continue|1|||
125321696|NCT01283139|450810031|FG000|Overall Study|Pregnancy|0|||
125321697|NCT01283139|450810032|FG001|Overall Study|Pregnancy|1|||
125321698|NCT01283139|450810033|FG002|Overall Study|Pregnancy|1|||
125321699|NCT01283139|450810034|FG003|Overall Study|Pregnancy|0|||
125321700|NCT01283139|450810031|FG000|Overall Study|Missed follow-up visit|0|||
125321701|NCT01283139|450810032|FG001|Overall Study|Missed follow-up visit|1|||
125321702|NCT01283139|450810033|FG002|Overall Study|Missed follow-up visit|2|||
125321703|NCT01283139|450810034|FG003|Overall Study|Missed follow-up visit|2|||
125321704|NCT01283139|450810031|FG000|Overall Study|Participant randomized in error|0|||
125321705|NCT01283139|450810032|FG001|Overall Study|Participant randomized in error|0|||
125321706|NCT01283139|450810033|FG002|Overall Study|Participant randomized in error|1|||
125321707|NCT01283139|450810034|FG003|Overall Study|Participant randomized in error|0|||
125321708|NCT00976274|450810035|FG000|Overall Study|Lost to Follow-up|5|||
125321709|NCT00976274|450810036|FG001|Overall Study|Lost to Follow-up|5|||
125321710|NCT00976274|450810035|FG000|Overall Study|Withdrawal by Subject|1|||
125321711|NCT00976274|450810036|FG001|Overall Study|Withdrawal by Subject|1|||
125321712|NCT00976274|450810035|FG000|Overall Study|Physician Decision|1|||
125321713|NCT00976274|450810036|FG001|Overall Study|Physician Decision|2|||
125662703|NCT02643966|452054046|FG000|Second Screening Round|Withdrawal by Subject|20|||
125662704|NCT02643966|452054046|FG000|Second Screening Round|Lost to Follow-up|57|||
125321714|NCT01075243|450810037|FG000|Overall Study|Lost to Follow-up|5|||
125321715|NCT01075243|450810038|FG001|Overall Study|Lost to Follow-up|2|||
125321716|NCT01075243|450810039|FG002|Overall Study|Lost to Follow-up|0|||
125321717|NCT01075243|450810037|FG000|Overall Study|Withdrawal by Subject|1|||
125321718|NCT01075243|450810038|FG001|Overall Study|Withdrawal by Subject|1|||
125321719|NCT01075243|450810039|FG002|Overall Study|Withdrawal by Subject|0|||
125321720|NCT00784563|450810042|FG000|Years 1 & 2|Withdrawal by Subject|3|||
125321721|NCT00784563|450810043|FG001|Years 1 & 2|Withdrawal by Subject|2|||
125321722|NCT00784563|450810044|FG002|Years 1 & 2|Withdrawal by Subject|0|||
125321723|NCT00784563|450810042|FG000|Years 1 & 2|Adverse Event|0|||
125321724|NCT00784563|450810043|FG001|Years 1 & 2|Adverse Event|3|||
125321725|NCT00784563|450810044|FG002|Years 1 & 2|Adverse Event|0|||
125321726|NCT00784563|450810042|FG000|Year 3|Withdrawal by Subject|0|||
125321727|NCT00784563|450810043|FG001|Year 3|Withdrawal by Subject|0|||
125321728|NCT00784563|450810044|FG002|Year 3|Withdrawal by Subject|2|||
125321729|NCT00784563|450810042|FG000|Year 3|Adverse Event|0|||
125321730|NCT00784563|450810043|FG001|Year 3|Adverse Event|0|||
125321731|NCT00784563|450810044|FG002|Year 3|Adverse Event|1|||
125321732|NCT01614249|450810045|FG000|Overall Study|Lost to Follow-up|11|||
125321733|NCT01614249|450810046|FG001|Overall Study|Lost to Follow-up|23|||
125321734|NCT02954536|450810047|FG000|Overall Study|Adverse Event|2|||
125321735|NCT02954536|450810047|FG000|Overall Study|Death|12|||
125321736|NCT02946580|450810048|FG000|Overall Study|Withdrawal by Subject|1|||
125321737|NCT02946580|450810049|FG001|Overall Study|Withdrawal by Subject|2|||
125321738|NCT02946580|450810048|FG000|Overall Study|Adverse Event|0|||
125321739|NCT02946580|450810049|FG001|Overall Study|Adverse Event|2|||
125321740|NCT02946580|450810048|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
125321741|NCT02946580|450810049|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
125321742|NCT04764162|450810053|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
125321743|NCT04764162|450810054|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
125321744|NCT00791934|450810055|FG000|Overall Study|Withdrawal by Subject|2|||
125662705|NCT02643966|452054046|FG000|Second Screening Round|Physician Decision|2|||
125662706|NCT02643966|452054046|FG000|Second Screening Round|Death|4|||
125662707|NCT02643966|452054046|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
125662708|NCT02643966|452054046|FG000|Between Second and Third Screening|Death|1|||
125662709|NCT02643966|452054046|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
125662710|NCT02643966|452054046|FG000|Third Screening Round|PI excluded|2|||
125662711|NCT02643966|452054046|FG000|Third Screening Round|Lost to Follow-up|241|||
125662712|NCT03611751|452054051|FG000|Pre-treatment|Randomized but not treated|1|||
125662713|NCT03611751|452054052|FG001|Pre-treatment|Randomized but not treated|1|||
125662714|NCT03611751|452054053|FG002|Pre-treatment|Randomized but not treated|0|||
125662715|NCT03611751|452054051|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
125662716|NCT03611751|452054052|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
125662717|NCT03611751|452054053|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
125662718|NCT03611751|452054051|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
125662719|NCT03611751|452054052|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
125662720|NCT03611751|452054053|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
125662721|NCT03611751|452054051|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
125662722|NCT03611751|452054052|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
125662723|NCT03611751|452054053|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
125662724|NCT03611751|452054051|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
125662725|NCT03611751|452054052|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
125662726|NCT03611751|452054053|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
125662727|NCT03611751|452054051|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
125662728|NCT03611751|452054052|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
125662729|NCT03611751|452054053|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
125662730|NCT03611751|452054051|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
125662731|NCT03611751|452054052|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
125662732|NCT03611751|452054053|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
125662733|NCT03611751|452054051|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
125662734|NCT03611751|452054052|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
125662735|NCT03611751|452054053|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
125662736|NCT03611751|452054051|FG000|Treatment Week 0 - Week 16|Death|0|||
125662737|NCT03611751|452054052|FG001|Treatment Week 0 - Week 16|Death|0|||
125662738|NCT03611751|452054053|FG002|Treatment Week 0 - Week 16|Death|1|||
125662739|NCT03611751|452054051|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
125662740|NCT03611751|452054052|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
125662741|NCT03611751|452054053|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
125662742|NCT03611751|452054051|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
125662743|NCT03611751|452054052|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
125662744|NCT03611751|452054053|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
125662745|NCT03611751|452054051|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
125662746|NCT03611751|452054052|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
125662747|NCT03611751|452054053|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
125662748|NCT03611751|452054051|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
125662749|NCT03611751|452054052|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
125662750|NCT03611751|452054053|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
125321745|NCT00791934|450810055|FG000|Overall Study|Did not consent for extended follow-up|13|||
125321746|NCT02018562|450810056|FG000|Overall Study|Withdrawal by Subject|2|||
125662751|NCT03611751|452054051|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
125662752|NCT03611751|452054052|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
125662753|NCT03611751|452054053|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
125662754|NCT03611751|452054051|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
125321747|NCT02018562|450810057|FG001|Overall Study|Withdrawal by Subject|0|||
125321748|NCT02018562|450810056|FG000|Overall Study|Discharged prior to study completion|1|||
125321749|NCT02018562|450810057|FG001|Overall Study|Discharged prior to study completion|0|||
125321750|NCT05194124|450810058|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321751|NCT05194124|450810059|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321752|NCT05194124|450810060|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321753|NCT05194124|450810061|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
125321754|NCT05194124|450810062|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321755|NCT05194124|450810063|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
125321756|NCT05194124|450810064|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321757|NCT05194124|450810065|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321758|NCT05194124|450810066|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321759|NCT05194124|450810067|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
125321760|NCT05194124|450810058|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321761|NCT05194124|450810059|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321762|NCT05194124|450810060|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321763|NCT05194124|450810061|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321764|NCT05194124|450810062|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321765|NCT05194124|450810063|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321766|NCT05194124|450810064|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321767|NCT05194124|450810065|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321768|NCT05194124|450810066|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
125321769|NCT05194124|450810067|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
125321770|NCT04609319|450810068|FG000|Overall Study|Death|64|||
125321771|NCT04609319|450810069|FG001|Overall Study|Death|49|||
125321772|NCT04609319|450810070|FG002|Overall Study|Death|1|||
125321773|NCT04609319|450810068|FG000|Overall Study|Withdrawal of consent|15|||
125321774|NCT04609319|450810069|FG001|Overall Study|Withdrawal of consent|3|||
125321775|NCT04609319|450810070|FG002|Overall Study|Withdrawal of consent|0|||
125321776|NCT04609319|450810068|FG000|Overall Study|Lost to Follow-up|20|||
125321777|NCT04609319|450810069|FG001|Overall Study|Lost to Follow-up|33|||
125321778|NCT04609319|450810070|FG002|Overall Study|Lost to Follow-up|0|||
125321779|NCT04609319|450810068|FG000|Overall Study|Alive until end of follow-up|60|||
125321780|NCT04609319|450810069|FG001|Overall Study|Alive until end of follow-up|53|||
125321781|NCT04609319|450810070|FG002|Overall Study|Alive until end of follow-up|1|||
125321782|NCT03474588|450810081|FG000|Overall Study|Withdrawal by Subject|4|||
125321783|NCT03474588|450810082|FG001|Overall Study|Withdrawal by Subject|3|||
125321784|NCT03474588|450810081|FG000|Overall Study|Death|0|||
125321785|NCT03474588|450810082|FG001|Overall Study|Death|1|||
125321786|NCT03804528|450810084|FG000|Overall Study|Time Commitment|18|||
125321787|NCT03804528|450810084|FG000|Overall Study|Health Reasons|5|||
125321788|NCT01607957|450810085|FG000|Overall Study|Not treated|1|||
125321789|NCT01607957|450810086|FG001|Overall Study|Not treated|1|||
125321790|NCT01607957|450810085|FG000|Overall Study|Death|367|||
125321791|NCT01607957|450810086|FG001|Overall Study|Death|211|||
125321792|NCT01607957|450810085|FG000|Overall Study|Lost to Follow-up|3|||
125321793|NCT01607957|450810086|FG001|Overall Study|Lost to Follow-up|3|||
125321794|NCT01607957|450810085|FG000|Overall Study|Participant refusal|1|||
125321795|NCT01607957|450810086|FG001|Overall Study|Participant refusal|0|||
125321796|NCT03589859|450810095|FG000|Overall Study|Withdrawal by Subject|0|||
125321797|NCT03589859|450810096|FG001|Overall Study|Withdrawal by Subject|6|||
125321798|NCT02331134|450810097|FG000|Overall Study|Withdrawal by Subject|1|||
125321799|NCT04966013|450810098|FG000|Overall Study|Withdrawal by Subject|0|||
125321800|NCT04966013|450810099|FG001|Overall Study|Withdrawal by Subject|2|||
125321801|NCT04966013|450810100|FG002|Overall Study|Withdrawal by Subject|1|||
125321802|NCT04966013|450810098|FG000|Overall Study|Adverse Event|2|||
125321803|NCT04966013|450810099|FG001|Overall Study|Adverse Event|1|||
125321804|NCT04966013|450810100|FG002|Overall Study|Adverse Event|1|||
125321805|NCT03518086|450810104|FG000|Overall Study|Adverse Event|23|||
125321806|NCT03518086|450810105|FG001|Overall Study|Adverse Event|15|||
125321807|NCT03518086|450810106|FG002|Overall Study|Adverse Event|3|||
125321808|NCT03518086|450810107|FG003|Overall Study|Adverse Event|2|||
125321809|NCT03518086|450810104|FG000|Overall Study|Withdrawal by Subject|8|||
125321810|NCT03518086|450810105|FG001|Overall Study|Withdrawal by Subject|5|||
125321811|NCT03518086|450810106|FG002|Overall Study|Withdrawal by Subject|1|||
125321812|NCT03518086|450810107|FG003|Overall Study|Withdrawal by Subject|0|||
125662755|NCT03611751|452054052|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
125662756|NCT03611751|452054053|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
125662757|NCT03611751|452054051|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
125321813|NCT03518086|450810104|FG000|Overall Study|Lack of Efficacy|5|||
125321814|NCT03518086|450810105|FG001|Overall Study|Lack of Efficacy|5|||
125321815|NCT03518086|450810106|FG002|Overall Study|Lack of Efficacy|0|||
125321816|NCT03518086|450810107|FG003|Overall Study|Lack of Efficacy|2|||
125321817|NCT03518086|450810104|FG000|Overall Study|Protocol Violation|1|||
125321818|NCT03518086|450810105|FG001|Overall Study|Protocol Violation|5|||
125321819|NCT03518086|450810106|FG002|Overall Study|Protocol Violation|1|||
125321820|NCT03518086|450810107|FG003|Overall Study|Protocol Violation|3|||
125321821|NCT03518086|450810104|FG000|Overall Study|Lost to Follow-up|0|||
125321822|NCT03518086|450810105|FG001|Overall Study|Lost to Follow-up|3|||
125321823|NCT03518086|450810106|FG002|Overall Study|Lost to Follow-up|0|||
125321824|NCT03518086|450810107|FG003|Overall Study|Lost to Follow-up|0|||
125321825|NCT03518086|450810104|FG000|Overall Study|Insufficient Diary Data|0|||
125321826|NCT03518086|450810105|FG001|Overall Study|Insufficient Diary Data|2|||
125321827|NCT03518086|450810106|FG002|Overall Study|Insufficient Diary Data|0|||
125321828|NCT03518086|450810107|FG003|Overall Study|Insufficient Diary Data|0|||
125321829|NCT03518086|450810104|FG000|Overall Study|Non- compliance to Protocol|0|||
125321830|NCT03518086|450810105|FG001|Overall Study|Non- compliance to Protocol|1|||
125321831|NCT03518086|450810106|FG002|Overall Study|Non- compliance to Protocol|0|||
125321832|NCT03518086|450810107|FG003|Overall Study|Non- compliance to Protocol|0|||
125321833|NCT03518086|450810104|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
125321834|NCT03518086|450810105|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
125321835|NCT03518086|450810106|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
125321836|NCT03518086|450810107|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
125321837|NCT03518086|450810104|FG000|Overall Study|Site Terminated by Sponsor|0|||
125321838|NCT03518086|450810105|FG001|Overall Study|Site Terminated by Sponsor|1|||
125321839|NCT03518086|450810106|FG002|Overall Study|Site Terminated by Sponsor|0|||
125321840|NCT03518086|450810107|FG003|Overall Study|Site Terminated by Sponsor|0|||
125321841|NCT03518086|450810104|FG000|Overall Study|Pregnancy|0|||
125321842|NCT03518086|450810105|FG001|Overall Study|Pregnancy|0|||
125321843|NCT03518086|450810106|FG002|Overall Study|Pregnancy|0|||
125321844|NCT03518086|450810107|FG003|Overall Study|Pregnancy|2|||
125321845|NCT05967260|450810108|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
125321846|NCT05967260|450810109|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
125321847|NCT00626106|450810110|FG000|Overall Study|Withdrawal by Subject|2|||
125321848|NCT00626106|450810111|FG001|Overall Study|Withdrawal by Subject|1|||
125321849|NCT00626106|450810110|FG000|Overall Study|Lost to Follow-up|1|||
125321850|NCT00626106|450810111|FG001|Overall Study|Lost to Follow-up|4|||
125321851|NCT00626106|450810110|FG000|Overall Study|Death|64|||
125321852|NCT00626106|450810111|FG001|Overall Study|Death|19|||
125321853|NCT03007966|450811707|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
125321854|NCT03007966|450811708|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
125321855|NCT01428258|450811709|FG000|Intervention 1|Withdrawal by Subject|2|||
125321856|NCT01428258|450811710|FG001|Intervention 1|Withdrawal by Subject|0|||
125321857|NCT00248625|450811711|FG000|Overall Study|Withdrawal by Subject|0|||
125321858|NCT00248625|450811712|FG001|Overall Study|Withdrawal by Subject|2|||
125321859|NCT03085095|450811713|FG000|Overall Study|Adverse Event|23|||
125321860|NCT03085095|450811714|FG001|Overall Study|Adverse Event|8|||
125321861|NCT03085095|450811713|FG000|Overall Study|Protocol Violation|0|||
125321862|NCT03085095|450811714|FG001|Overall Study|Protocol Violation|1|||
125321863|NCT03085095|450811713|FG000|Overall Study|Lost to Follow-up|2|||
125321864|NCT03085095|450811714|FG001|Overall Study|Lost to Follow-up|1|||
125321865|NCT03085095|450811713|FG000|Overall Study|Withdrawal by Subject|17|||
125321866|NCT03085095|450811714|FG001|Overall Study|Withdrawal by Subject|6|||
125321867|NCT03085095|450811713|FG000|Overall Study|Physician Decision|9|||
125321868|NCT03085095|450811714|FG001|Overall Study|Physician Decision|3|||
125321869|NCT03085095|450811713|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
125321870|NCT03085095|450811714|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
125321871|NCT03085095|450811713|FG000|Overall Study|Did not Receive Study Drug|2|||
125321872|NCT03085095|450811714|FG001|Overall Study|Did not Receive Study Drug|2|||
125321873|NCT03085095|450811713|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
125321874|NCT03085095|450811714|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
125321875|NCT00408317|450811715|FG000|First Intervention Period|Adverse Event|0|||
125321876|NCT00408317|450811716|FG001|First Intervention Period|Adverse Event|1|||
125321877|NCT00408317|450811715|FG000|Second Intervention Period|Adverse Event|2|||
125321878|NCT00408317|450811716|FG001|Second Intervention Period|Adverse Event|0|||
125321879|NCT00408317|450811715|FG000|Second Intervention Period|Protocol Violation|0|||
125321880|NCT00408317|450811716|FG001|Second Intervention Period|Protocol Violation|1|||
125321881|NCT00408317|450811715|FG000|Second Intervention Period|Withdrawal of consent|0|||
125321882|NCT00408317|450811716|FG001|Second Intervention Period|Withdrawal of consent|1|||
125662758|NCT03611751|452054052|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
125321883|NCT00286468|450811717|FG000|Overall Study|Hyperglycemic Rescue|28|||
125321884|NCT00286468|450811718|FG001|Overall Study|Hyperglycemic Rescue|30|||
125321885|NCT00286468|450811719|FG002|Overall Study|Hyperglycemic Rescue|31|||
125321886|NCT00286468|450811717|FG000|Overall Study|Adverse Event|2|||
125321887|NCT00286468|450811718|FG001|Overall Study|Adverse Event|6|||
125321888|NCT00286468|450811719|FG002|Overall Study|Adverse Event|4|||
125321889|NCT00286468|450811717|FG000|Overall Study|Protocol Violation|0|||
125321890|NCT00286468|450811718|FG001|Overall Study|Protocol Violation|3|||
125321891|NCT00286468|450811719|FG002|Overall Study|Protocol Violation|1|||
125321892|NCT00286468|450811717|FG000|Overall Study|Lost to Follow-up|1|||
125321893|NCT00286468|450811718|FG001|Overall Study|Lost to Follow-up|1|||
125321894|NCT00286468|450811719|FG002|Overall Study|Lost to Follow-up|2|||
125321895|NCT00286468|450811717|FG000|Overall Study|Withdrawal by Subject|3|||
125321896|NCT00286468|450811718|FG001|Overall Study|Withdrawal by Subject|8|||
125321897|NCT00286468|450811719|FG002|Overall Study|Withdrawal by Subject|11|||
125321898|NCT00286468|450811717|FG000|Overall Study|Physician Decision|3|||
125321899|NCT00286468|450811718|FG001|Overall Study|Physician Decision|2|||
125321900|NCT00286468|450811719|FG002|Overall Study|Physician Decision|1|||
125321901|NCT02923726|450811720|FG000|Overall Study|Death|196|||
125321902|NCT02923726|450811721|FG001|Overall Study|Death|175|||
125321903|NCT02923726|450811720|FG000|Overall Study|Withdrawal by Subject|337|||
125321904|NCT02923726|450811721|FG001|Overall Study|Withdrawal by Subject|307|||
125321905|NCT00074711|450811723|FG000|Overall Study|Withdrawal by Subject|1|||
125321906|NCT00074711|450811724|FG001|Overall Study|Withdrawal by Subject|1|||
125321907|NCT00074711|450811723|FG000|Overall Study|Lost to Follow-up|10|||
125321908|NCT00074711|450811724|FG001|Overall Study|Lost to Follow-up|8|||
125321909|NCT00074711|450811723|FG000|Overall Study|Participant stopped study drug|4|||
125321910|NCT00074711|450811724|FG001|Overall Study|Participant stopped study drug|6|||
125321911|NCT03466658|450811725|FG000|Overall Study|Withdrawal by Subject|3|||
125321912|NCT05365217|450811726|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125321913|NCT05365217|450811727|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125321914|NCT00129402|450811730|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
125321915|NCT00129402|450811731|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
125321916|NCT00129402|450811732|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
125321917|NCT00129402|450811733|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
125321918|NCT00129402|450811734|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
125321919|NCT00129402|450811735|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
125321920|NCT00129402|450811736|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
125321921|NCT00129402|450811730|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125321922|NCT00129402|450811731|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125321923|NCT00129402|450811732|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125321924|NCT00129402|450811733|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125321925|NCT00129402|450811734|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125321926|NCT00129402|450811735|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
125321927|NCT00129402|450811736|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
125321928|NCT00129402|450811730|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125321929|NCT00129402|450811731|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125321930|NCT00129402|450811732|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125321931|NCT00129402|450811733|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
125321932|NCT00129402|450811734|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125321933|NCT00129402|450811735|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125321934|NCT00129402|450811736|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
125321935|NCT00129402|450811730|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125321936|NCT00129402|450811731|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125321937|NCT00129402|450811732|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
125662759|NCT03611751|452054053|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
125662760|NCT03611751|452054051|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
125662761|NCT03611751|452054052|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
125662762|NCT03611751|452054053|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
125662763|NCT03611751|452054051|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
125662764|NCT03611751|452054052|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
125662765|NCT03611751|452054053|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
125662766|NCT03611751|452054051|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
125662767|NCT03611751|452054052|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
125662768|NCT03611751|452054053|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
125662769|NCT03611751|452054051|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
125662770|NCT03611751|452054052|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
125662771|NCT03611751|452054053|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
125662772|NCT03611751|452054051|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
125662773|NCT03611751|452054052|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
125662774|NCT03611751|452054053|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
125662775|NCT03611751|452054051|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
125662776|NCT03611751|452054052|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
125662777|NCT03611751|452054053|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
125662778|NCT03611751|452054051|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
125662779|NCT03611751|452054052|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
125321938|NCT00129402|450811733|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125321939|NCT00129402|450811734|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
125662780|NCT03611751|452054053|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
125662781|NCT02441179|452054054|FG000|Overall Study|Withdrawal by Subject|1|||
125662782|NCT02441179|452054055|FG001|Overall Study|Withdrawal by Subject|1|||
125321940|NCT00129402|450811735|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125321941|NCT00129402|450811736|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
125321942|NCT00129402|450811730|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125321943|NCT00129402|450811731|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125321944|NCT00129402|450811732|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
125321945|NCT00129402|450811733|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125321946|NCT00129402|450811734|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125321947|NCT00129402|450811735|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125321948|NCT00129402|450811736|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
125321949|NCT00129402|450811730|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125321950|NCT00129402|450811731|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125321951|NCT00129402|450811732|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
125321952|NCT00129402|450811733|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125321953|NCT00129402|450811734|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125321954|NCT00129402|450811735|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
125321955|NCT00129402|450811736|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
125321956|NCT00129402|450811730|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125321957|NCT00129402|450811731|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125321958|NCT00129402|450811732|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
125321959|NCT00129402|450811733|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125321960|NCT00129402|450811734|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125321961|NCT00129402|450811735|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125321962|NCT00129402|450811736|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
125321963|NCT00129402|450811730|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125321964|NCT00129402|450811731|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125321965|NCT00129402|450811732|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
125321966|NCT00129402|450811733|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125321967|NCT00129402|450811734|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125321968|NCT00129402|450811735|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
125321969|NCT00129402|450811736|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
125321970|NCT00129402|450811730|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125321971|NCT00129402|450811731|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125321972|NCT00129402|450811732|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
125321973|NCT00129402|450811733|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125321974|NCT00129402|450811734|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125321975|NCT00129402|450811735|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
125321976|NCT00129402|450811736|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
125321977|NCT00129402|450811730|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125321978|NCT00129402|450811731|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125321979|NCT00129402|450811732|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125321980|NCT00129402|450811733|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125321981|NCT00129402|450811734|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125321982|NCT00129402|450811735|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
125321983|NCT00129402|450811736|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
125321984|NCT00129402|450811730|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125321985|NCT00129402|450811731|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125321986|NCT00129402|450811732|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125321987|NCT00129402|450811733|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125321988|NCT00129402|450811734|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125321989|NCT00129402|450811735|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
125321990|NCT00129402|450811736|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
125321991|NCT00129402|450811730|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125321992|NCT00129402|450811731|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125321993|NCT00129402|450811732|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125321994|NCT00129402|450811733|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125321995|NCT00129402|450811734|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125321996|NCT00129402|450811735|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
125321997|NCT00129402|450811736|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
125321998|NCT00129402|450811730|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125321999|NCT00129402|450811731|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125425579|NCT01592370|451180519|FG002|Overall Study|Other Reasons|10|||
125540736|NCT00774930|451609436|FG000|LTOLE Phase|Physician Decision|4|||
125662783|NCT02702271|452054056|FG000|Overall Study|Death|36|||
125322000|NCT00129402|450811732|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125322001|NCT00129402|450811733|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125322002|NCT00129402|450811734|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125322003|NCT00129402|450811735|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
125322004|NCT00129402|450811736|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
125322005|NCT01527149|450811737|FG000|Overall Study|Death|2|||
125322006|NCT01680341|450811738|FG000|Overall Study|Adverse Event|3|||
125322007|NCT01680341|450811739|FG001|Overall Study|Adverse Event|2|||
125322008|NCT01680341|450811738|FG000|Overall Study|Unclassified|18|||
125322009|NCT01680341|450811739|FG001|Overall Study|Unclassified|15|||
125322010|NCT00481832|450811740|FG000|Enrollment|Physician Decision|8|||
125322011|NCT00481832|450811740|FG000|Enrollment|Unable to collect enough stem cells|2|||
125322012|NCT00481832|450811740|FG000|Inter-transplant Period|Adverse Event|4|||
125322013|NCT00481832|450811740|FG000|Inter-transplant Period|Death|3|||
125322014|NCT00481832|450811740|FG000|Inter-transplant Period|Physician Decision|4|||
125322015|NCT00481832|450811740|FG000|Inter-transplant Period|Disease relapse|11|||
125322016|NCT00481832|450811740|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
125322017|NCT02992288|450811741|FG000|Overall Study|Adverse Event|8|||
125322018|NCT02992288|450811742|FG001|Overall Study|Adverse Event|2|||
125322019|NCT02992288|450811743|FG002|Overall Study|Adverse Event|2|||
125322020|NCT02992288|450811744|FG003|Overall Study|Adverse Event|2|||
125322021|NCT02992288|450811745|FG004|Overall Study|Adverse Event|2|||
125322022|NCT02992288|450811746|FG005|Overall Study|Adverse Event|7|||
125322023|NCT02992288|450811741|FG000|Overall Study|Non-compliance with study drug|0|||
125322024|NCT02992288|450811742|FG001|Overall Study|Non-compliance with study drug|1|||
125322025|NCT02992288|450811743|FG002|Overall Study|Non-compliance with study drug|1|||
125322026|NCT02992288|450811744|FG003|Overall Study|Non-compliance with study drug|0|||
125322027|NCT02992288|450811745|FG004|Overall Study|Non-compliance with study drug|1|||
125322028|NCT02992288|450811746|FG005|Overall Study|Non-compliance with study drug|0|||
125322029|NCT02992288|450811741|FG000|Overall Study|Physician Decision|3|||
125322030|NCT02992288|450811742|FG001|Overall Study|Physician Decision|0|||
125322031|NCT02992288|450811743|FG002|Overall Study|Physician Decision|1|||
125322032|NCT02992288|450811744|FG003|Overall Study|Physician Decision|0|||
125322033|NCT02992288|450811745|FG004|Overall Study|Physician Decision|0|||
125322034|NCT02992288|450811746|FG005|Overall Study|Physician Decision|1|||
125322035|NCT02992288|450811741|FG000|Overall Study|Death|2|||
125322036|NCT02992288|450811742|FG001|Overall Study|Death|0|||
125322037|NCT02992288|450811743|FG002|Overall Study|Death|2|||
125322038|NCT02992288|450811744|FG003|Overall Study|Death|1|||
125322039|NCT02992288|450811745|FG004|Overall Study|Death|2|||
125322040|NCT02992288|450811746|FG005|Overall Study|Death|0|||
125322041|NCT02992288|450811741|FG000|Overall Study|Lost to Follow-up|0|||
125322042|NCT02992288|450811742|FG001|Overall Study|Lost to Follow-up|0|||
125322043|NCT02992288|450811743|FG002|Overall Study|Lost to Follow-up|0|||
125322044|NCT02992288|450811744|FG003|Overall Study|Lost to Follow-up|1|||
125322045|NCT02992288|450811745|FG004|Overall Study|Lost to Follow-up|0|||
125322046|NCT02992288|450811746|FG005|Overall Study|Lost to Follow-up|0|||
125322047|NCT02992288|450811741|FG000|Overall Study|Protocol Violation|0|||
125322048|NCT02992288|450811742|FG001|Overall Study|Protocol Violation|0|||
125322049|NCT02992288|450811743|FG002|Overall Study|Protocol Violation|0|||
125322050|NCT02992288|450811744|FG003|Overall Study|Protocol Violation|0|||
125322051|NCT02992288|450811745|FG004|Overall Study|Protocol Violation|0|||
125322052|NCT02992288|450811746|FG005|Overall Study|Protocol Violation|1|||
125322053|NCT02992288|450811741|FG000|Overall Study|Withdrawal by Subject|4|||
125322054|NCT02992288|450811742|FG001|Overall Study|Withdrawal by Subject|2|||
125322055|NCT02992288|450811743|FG002|Overall Study|Withdrawal by Subject|1|||
125322056|NCT02992288|450811744|FG003|Overall Study|Withdrawal by Subject|5|||
125322057|NCT02992288|450811745|FG004|Overall Study|Withdrawal by Subject|3|||
125322058|NCT02992288|450811746|FG005|Overall Study|Withdrawal by Subject|4|||
125322059|NCT02006472|450811750|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
125322060|NCT02006472|450811751|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
125322061|NCT02006472|450811752|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
125322062|NCT02006472|450811753|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
125322063|NCT02006472|450811754|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
125322064|NCT02006472|450811750|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
125322065|NCT02006472|450811751|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
125322066|NCT02006472|450811752|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
125322067|NCT02006472|450811753|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
125322068|NCT02006472|450811754|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
125322069|NCT02006472|450811750|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
125322070|NCT02006472|450811751|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
125322071|NCT02006472|450811752|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
125322072|NCT02006472|450811753|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
125322073|NCT02006472|450811754|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
125322074|NCT02006472|450811750|FG000|Period 1 (Through Week 26)|Other|1|||
125322075|NCT02006472|450811751|FG001|Period 1 (Through Week 26)|Other|5|||
125322076|NCT02006472|450811752|FG002|Period 1 (Through Week 26)|Other|0|||
125322077|NCT02006472|450811753|FG003|Period 1 (Through Week 26)|Other|2|||
125322078|NCT02006472|450811754|FG004|Period 1 (Through Week 26)|Other|3|||
125322079|NCT02006472|450811750|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
125322080|NCT02006472|450811751|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
125322081|NCT02006472|450811752|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
125322082|NCT02006472|450811753|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
125322083|NCT02006472|450811754|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
125322084|NCT02006472|450811750|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
125322085|NCT02006472|450811751|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
125322086|NCT02006472|450811752|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
125322087|NCT02006472|450811753|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
125322088|NCT02006472|450811754|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
125322089|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
125322090|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
125322091|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
125322092|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
125322093|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
125322094|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
125322095|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
125322096|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
125322097|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
125322098|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
125322099|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
125322100|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
125322101|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
125322102|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
125322103|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
125322104|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Other|0|||
125322105|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Other|1|||
125322106|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Other|0|||
125322107|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Other|1|||
125322108|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Other|0|||
125322109|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Not treated|0|||
125322110|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Not treated|0|||
125322111|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Not treated|2|||
125322112|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Not treated|0|||
125322113|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Not treated|0|||
125322114|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
125322115|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
125322116|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
125322117|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
125322118|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
125322119|NCT02006472|450811750|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
125322120|NCT02006472|450811751|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
125322121|NCT02006472|450811752|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
125322122|NCT02006472|450811753|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
125322123|NCT02006472|450811754|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
125322124|NCT00499486|450811755|FG000|Overall Study|Withdrawal by Subject|16|||
125322125|NCT00656513|450811756|FG000|Overall Study|Protocol Violation|1|||
125322126|NCT00656513|450811757|FG001|Overall Study|Protocol Violation|0|||
125322127|NCT00656513|450811758|FG002|Overall Study|Protocol Violation|2|||
125322128|NCT00656513|450811756|FG000|Overall Study|Withdrawal by Subject|0|||
125322129|NCT00656513|450811757|FG001|Overall Study|Withdrawal by Subject|11|||
125322130|NCT00656513|450811758|FG002|Overall Study|Withdrawal by Subject|4|||
125322131|NCT00656513|450811756|FG000|Overall Study|Death|0|||
125322132|NCT00656513|450811757|FG001|Overall Study|Death|0|||
125322133|NCT00656513|450811758|FG002|Overall Study|Death|1|||
125322134|NCT00656513|450811756|FG000|Overall Study|Missing data|0|||
125322135|NCT00656513|450811757|FG001|Overall Study|Missing data|11|||
125322136|NCT00656513|450811758|FG002|Overall Study|Missing data|9|||
125322137|NCT00656513|450811756|FG000|Overall Study|Incomplete treatment|3|||
125322138|NCT00656513|450811757|FG001|Overall Study|Incomplete treatment|0|||
125322139|NCT00656513|450811758|FG002|Overall Study|Incomplete treatment|0|||
125322140|NCT00656513|450811756|FG000|Overall Study|Treatment completed outside of timeframe|0|||
125322141|NCT00656513|450811757|FG001|Overall Study|Treatment completed outside of timeframe|3|||
125322142|NCT00656513|450811758|FG002|Overall Study|Treatment completed outside of timeframe|1|||
125322143|NCT00656513|450811756|FG000|Overall Study|Missing baseline form|0|||
125322144|NCT00656513|450811757|FG001|Overall Study|Missing baseline form|5|||
125322145|NCT00656513|450811758|FG002|Overall Study|Missing baseline form|5|||
125322146|NCT00087152|450811759|FG000|Overall Study|Ineligible|6|||
125322147|NCT01436149|450811763|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
125322148|NCT01436149|450811764|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
125322149|NCT01436149|450811765|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
125322150|NCT01436149|450811763|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
125322151|NCT01436149|450811764|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
125322152|NCT01436149|450811765|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
125322153|NCT01436149|450811763|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
125322154|NCT01436149|450811764|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125322155|NCT01436149|450811765|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125322156|NCT01436149|450811763|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
125322157|NCT01436149|450811764|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125322158|NCT01436149|450811765|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125322159|NCT01436149|450811763|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
125322160|NCT01436149|450811764|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
125322161|NCT01436149|450811765|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
125322162|NCT01436149|450811763|FG000|Antidepressant Lead-in Phase|Other|119|||
125322163|NCT01436149|450811764|FG001|Antidepressant Lead-in Phase|Other|0|||
125322164|NCT01436149|450811765|FG002|Antidepressant Lead-in Phase|Other|0|||
125322165|NCT01436149|450811763|FG000|Randomized Phase|Adverse Event|9|||
125322166|NCT01436149|450811764|FG001|Randomized Phase|Adverse Event|10|||
125322167|NCT01436149|450811765|FG002|Randomized Phase|Adverse Event|11|||
125322168|NCT01436149|450811763|FG000|Randomized Phase|Protocol Violation|4|||
125322169|NCT01436149|450811764|FG001|Randomized Phase|Protocol Violation|5|||
125322170|NCT01436149|450811765|FG002|Randomized Phase|Protocol Violation|0|||
125322171|NCT01436149|450811763|FG000|Randomized Phase|Withdrawal by Subject|16|||
125322172|NCT01436149|450811764|FG001|Randomized Phase|Withdrawal by Subject|10|||
125322173|NCT01436149|450811765|FG002|Randomized Phase|Withdrawal by Subject|10|||
125322174|NCT01436149|450811763|FG000|Randomized Phase|Lost to Follow-up|34|||
125322175|NCT01436149|450811764|FG001|Randomized Phase|Lost to Follow-up|5|||
125322176|NCT01436149|450811765|FG002|Randomized Phase|Lost to Follow-up|6|||
125322177|NCT01436149|450811763|FG000|Randomized Phase|Lack of Efficacy|0|||
125322178|NCT01436149|450811764|FG001|Randomized Phase|Lack of Efficacy|0|||
125322179|NCT01436149|450811765|FG002|Randomized Phase|Lack of Efficacy|1|||
125322180|NCT01436149|450811763|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
125322181|NCT01436149|450811764|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
125322182|NCT01436149|450811765|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
125322183|NCT01436149|450811763|FG000|Randomized Phase|Other|12|||
125322184|NCT01436149|450811764|FG001|Randomized Phase|Other|5|||
125322185|NCT01436149|450811765|FG002|Randomized Phase|Other|11|||
125322186|NCT01643668|450811769|FG000|Overall Study|Death|1|||
125322187|NCT00322881|450811770|FG000|Overall Study|Death|2|||
125322188|NCT00322881|450811770|FG000|Overall Study|Adverse Event|1|||
125322189|NCT00322881|450811770|FG000|Overall Study|Disease Progression|2|||
125322190|NCT02285855|450811773|FG000|Overall Study|Withdrawal by Subject|2|||
125322191|NCT02285855|450811774|FG001|Overall Study|Withdrawal by Subject|1|||
125322192|NCT03253796|450811775|FG000|Period 1: Run-In|Adverse Event|4|||
125322193|NCT03253796|450811776|FG001|Period 1: Run-In|Adverse Event|0|||
125322194|NCT03253796|450811777|FG002|Period 1: Run-In|Adverse Event|0|||
125322195|NCT03253796|450811778|FG003|Period 1: Run-In|Adverse Event|0|||
125322196|NCT03253796|450811779|FG004|Period 1: Run-In|Adverse Event|0|||
125322197|NCT03253796|450811775|FG000|Period 1: Run-In|Lack of Efficacy|1|||
125322198|NCT03253796|450811776|FG001|Period 1: Run-In|Lack of Efficacy|0|||
125322199|NCT03253796|450811777|FG002|Period 1: Run-In|Lack of Efficacy|0|||
125322200|NCT03253796|450811778|FG003|Period 1: Run-In|Lack of Efficacy|0|||
125322201|NCT03253796|450811779|FG004|Period 1: Run-In|Lack of Efficacy|0|||
125322202|NCT03253796|450811775|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
125322203|NCT03253796|450811776|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
125322204|NCT03253796|450811777|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
125322205|NCT03253796|450811778|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
125322206|NCT03253796|450811779|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
125322207|NCT03253796|450811775|FG000|Period 1: Run-In|Protocol Violation|5|||
125322208|NCT03253796|450811776|FG001|Period 1: Run-In|Protocol Violation|0|||
125322209|NCT03253796|450811777|FG002|Period 1: Run-In|Protocol Violation|0|||
125322210|NCT03253796|450811778|FG003|Period 1: Run-In|Protocol Violation|0|||
125322211|NCT03253796|450811779|FG004|Period 1: Run-In|Protocol Violation|0|||
125322212|NCT03253796|450811775|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
125322213|NCT03253796|450811776|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
125322214|NCT03253796|450811777|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
125322215|NCT03253796|450811778|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
125322216|NCT03253796|450811779|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
125322217|NCT03253796|450811775|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
125322218|NCT03253796|450811776|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
125322219|NCT03253796|450811777|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
125322220|NCT03253796|450811778|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
125322221|NCT03253796|450811779|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
125322222|NCT03253796|450811775|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
125322223|NCT03253796|450811776|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
125322224|NCT03253796|450811777|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
125322225|NCT03253796|450811778|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
125322226|NCT03253796|450811779|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
125322227|NCT03253796|450811775|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
125322228|NCT03253796|450811776|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
125322229|NCT03253796|450811777|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
125322230|NCT03253796|450811778|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
125322231|NCT03253796|450811779|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
125322232|NCT03253796|450811775|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
125322233|NCT03253796|450811776|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
125322234|NCT03253796|450811777|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
125322235|NCT03253796|450811778|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
125322236|NCT03253796|450811779|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
125322237|NCT03253796|450811775|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
125322238|NCT03253796|450811776|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
125322239|NCT03253796|450811777|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
125322240|NCT03253796|450811778|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
125322241|NCT03253796|450811779|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
125322242|NCT03253796|450811775|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
125322243|NCT03253796|450811776|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
125322244|NCT03253796|450811777|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
125322245|NCT03253796|450811778|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
125322246|NCT03253796|450811779|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
125322247|NCT00528112|450811780|FG000|Treatment up to 3 Years|Adverse Event|313|||
125322248|NCT00528112|450811781|FG001|Treatment up to 3 Years|Adverse Event|278|||
125322249|NCT00528112|450811780|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
125322250|NCT00528112|450811781|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
125322251|NCT00528112|450811780|FG000|Treatment up to 3 Years|Protocol Violation|16|||
125322252|NCT00528112|450811781|FG001|Treatment up to 3 Years|Protocol Violation|16|||
125322253|NCT00528112|450811780|FG000|Treatment up to 3 Years|Death|0|||
125322254|NCT00528112|450811781|FG001|Treatment up to 3 Years|Death|1|||
125322255|NCT00528112|450811780|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
125322256|NCT00528112|450811781|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
125322257|NCT00528112|450811780|FG000|Treatment up to 3 Years|Pregnancy|9|||
125322258|NCT00528112|450811781|FG001|Treatment up to 3 Years|Pregnancy|10|||
125322259|NCT00528112|450811780|FG000|Treatment up to 3 Years|Other reasons|186|||
125322260|NCT00528112|450811781|FG001|Treatment up to 3 Years|Other reasons|186|||
125322261|NCT00528112|450811780|FG000|Extension Phase|Withdrawal by Subject|0|||
125322262|NCT00528112|450811781|FG001|Extension Phase|Withdrawal by Subject|3|||
125322263|NCT00528112|450811780|FG000|Extension Phase|Other reasons|0|||
125322264|NCT00528112|450811781|FG001|Extension Phase|Other reasons|100|||
125322265|NCT00528112|450811780|FG000|Extension Phase|Pregnancy|0|||
125322266|NCT00528112|450811781|FG001|Extension Phase|Pregnancy|3|||
125322267|NCT00528112|450811780|FG000|Extension Phase|Lost to Follow-up|0|||
125322268|NCT00528112|450811781|FG001|Extension Phase|Lost to Follow-up|12|||
125322269|NCT00528112|450811780|FG000|Extension Phase|Death|0|||
125322270|NCT00528112|450811781|FG001|Extension Phase|Death|1|||
125322271|NCT00528112|450811780|FG000|Extension Phase|Adverse Event|0|||
125322272|NCT00528112|450811781|FG001|Extension Phase|Adverse Event|36|||
125322273|NCT00528112|450811780|FG000|Extension Phase|Protocol Violation|0|||
125322274|NCT00528112|450811781|FG001|Extension Phase|Protocol Violation|2|||
125322275|NCT02718898|450811782|FG000|Blinded Treatment Period|Adverse Event|5|||
125322276|NCT02718898|450811783|FG001|Blinded Treatment Period|Adverse Event|1|||
125322277|NCT02718898|450811784|FG002|Blinded Treatment Period|Adverse Event|0|||
125322278|NCT02718898|450811785|FG003|Blinded Treatment Period|Adverse Event|0|||
125322279|NCT02718898|450811786|FG004|Blinded Treatment Period|Adverse Event|0|||
125322280|NCT02718898|450811787|FG005|Blinded Treatment Period|Adverse Event|0|||
125322281|NCT02718898|450811788|FG006|Blinded Treatment Period|Adverse Event|0|||
125322282|NCT02718898|450811782|FG000|Blinded Treatment Period|Physician Decision|1|||
125322283|NCT02718898|450811783|FG001|Blinded Treatment Period|Physician Decision|0|||
125322284|NCT02718898|450811784|FG002|Blinded Treatment Period|Physician Decision|0|||
125322285|NCT02718898|450811785|FG003|Blinded Treatment Period|Physician Decision|0|||
125322286|NCT02718898|450811786|FG004|Blinded Treatment Period|Physician Decision|0|||
125322287|NCT02718898|450811787|FG005|Blinded Treatment Period|Physician Decision|0|||
125322288|NCT02718898|450811788|FG006|Blinded Treatment Period|Physician Decision|0|||
125322289|NCT02718898|450811782|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
125322290|NCT02718898|450811783|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
125322291|NCT02718898|450811784|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
125322292|NCT02718898|450811785|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
125322293|NCT02718898|450811786|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
125322294|NCT02718898|450811787|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
125322295|NCT02718898|450811788|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
125322296|NCT02718898|450811782|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
125322297|NCT02718898|450811783|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
125322298|NCT02718898|450811784|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
125322299|NCT02718898|450811785|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
125322300|NCT02718898|450811786|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
125322301|NCT02718898|450811787|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
125322302|NCT02718898|450811788|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
125322303|NCT02718898|450811782|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
125322304|NCT02718898|450811783|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
125322305|NCT02718898|450811784|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
125322306|NCT02718898|450811785|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
125322307|NCT02718898|450811786|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
125322308|NCT02718898|450811787|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
125322309|NCT02718898|450811788|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
125322310|NCT02718898|450811782|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125322311|NCT02718898|450811783|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125322312|NCT02718898|450811784|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125322313|NCT02718898|450811785|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
125322314|NCT02718898|450811786|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125322315|NCT02718898|450811787|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125322316|NCT02718898|450811788|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
125322317|NCT02718898|450811782|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125322318|NCT02718898|450811783|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125322319|NCT02718898|450811784|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
125322320|NCT02718898|450811785|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
125322321|NCT02718898|450811786|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125322322|NCT02718898|450811787|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125322323|NCT02718898|450811788|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125322324|NCT02718898|450811782|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125322325|NCT02718898|450811783|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125322326|NCT02718898|450811784|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
125322327|NCT02718898|450811785|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
125322328|NCT02718898|450811786|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125322329|NCT02718898|450811787|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125322330|NCT02718898|450811788|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
125322331|NCT02718898|450811782|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125322332|NCT02718898|450811783|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125322333|NCT02718898|450811784|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125322334|NCT02718898|450811785|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
125322335|NCT02718898|450811786|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125322336|NCT02718898|450811787|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125322337|NCT02718898|450811788|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
125322338|NCT02718898|450811782|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125322339|NCT02718898|450811783|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125322340|NCT02718898|450811784|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125322341|NCT02718898|450811785|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
125322342|NCT02718898|450811786|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125322343|NCT02718898|450811787|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125322344|NCT02718898|450811788|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
125322345|NCT02718898|450811782|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
125322346|NCT02718898|450811783|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
125322347|NCT02718898|450811784|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
125322348|NCT02718898|450811785|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
125322349|NCT02718898|450811786|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
125322350|NCT02718898|450811787|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
125322351|NCT02718898|450811788|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
125322352|NCT02718898|450811782|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
125322353|NCT02718898|450811783|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
125322354|NCT02718898|450811784|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
125322355|NCT02718898|450811785|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
125322356|NCT02718898|450811786|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
125322357|NCT02718898|450811787|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
125425580|NCT01592370|451180520|FG003|Overall Study|Other Reasons|0|||
125540737|NCT00774930|451609437|FG001|LTOLE Phase|Physician Decision|1|||
125322358|NCT02718898|450811788|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
125322359|NCT02718898|450811782|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125322360|NCT02718898|450811783|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125322361|NCT02718898|450811784|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125322362|NCT02718898|450811785|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125322363|NCT02718898|450811786|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125322364|NCT02718898|450811787|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
125322365|NCT02718898|450811788|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
125322366|NCT00894803|450811789|FG000|Overall Study|Death|20|||
125322367|NCT00894803|450811790|FG001|Overall Study|Death|4|||
125322368|NCT00894803|450811789|FG000|Overall Study|Lost to Follow-up|0|||
125322369|NCT00894803|450811790|FG001|Overall Study|Lost to Follow-up|1|||
125322370|NCT04484961|450811791|FG000|Overall Study|Lost to Follow-up|9|||
125322371|NCT04484961|450811792|FG001|Overall Study|Lost to Follow-up|9|||
125322372|NCT01667900|450811793|FG000|Part B|Death|0|||
125322373|NCT01667900|450811794|FG001|Part B|Death|0|||
125322374|NCT01667900|450811795|FG002|Part B|Death|0|||
125322375|NCT01667900|450811796|FG003|Part B|Death|0|||
125322376|NCT01667900|450811797|FG004|Part B|Death|0|||
125322377|NCT01667900|450811798|FG005|Part B|Death|0|||
125322378|NCT01667900|450811799|FG006|Part B|Death|0|||
125322379|NCT01667900|450811800|FG007|Part B|Death|0|||
125322380|NCT01667900|450811801|FG008|Part B|Death|0|||
125322381|NCT01667900|450811802|FG009|Part B|Death|0|||
125322382|NCT01667900|450811803|FG010|Part B|Death|0|||
125322383|NCT01667900|450811804|FG011|Part B|Death|0|||
125322384|NCT01667900|450811805|FG012|Part B|Death|0|||
125322385|NCT01667900|450811806|FG013|Part B|Death|0|||
125322386|NCT01667900|450811807|FG014|Part B|Death|0|||
125322387|NCT01667900|450811808|FG015|Part B|Death|0|||
125322388|NCT01667900|450811809|FG016|Part B|Death|1|||
125322389|NCT01667900|450811810|FG017|Part B|Death|0|||
125322390|NCT01667900|450811811|FG018|Part B|Death|0|||
125322391|NCT01667900|450811812|FG019|Part B|Death|0|||
125322392|NCT00004563|450811817|FG000|Overall Study|Withdrawal by Subject|20|||
125322393|NCT00004563|450811818|FG001|Overall Study|Withdrawal by Subject|16|||
125322394|NCT00004563|450811817|FG000|Overall Study|Lack of Efficacy|3|||
125322395|NCT00004563|450811818|FG001|Overall Study|Lack of Efficacy|5|||
125322396|NCT00004563|450811817|FG000|Overall Study|Death|2|||
125322397|NCT00004563|450811818|FG001|Overall Study|Death|3|||
125322398|NCT03337308|450811819|FG000|Overall Study|Adverse Event|2|||
125322399|NCT03337308|450811820|FG001|Overall Study|Adverse Event|3|||
125322400|NCT03337308|450811821|FG002|Overall Study|Adverse Event|3|||
125322401|NCT03337308|450811822|FG003|Overall Study|Adverse Event|1|||
125322402|NCT03337308|450811819|FG000|Overall Study|Lost to Follow-up|1|||
125322403|NCT03337308|450811820|FG001|Overall Study|Lost to Follow-up|2|||
125322404|NCT03337308|450811821|FG002|Overall Study|Lost to Follow-up|0|||
125322405|NCT03337308|450811822|FG003|Overall Study|Lost to Follow-up|0|||
125322406|NCT03337308|450811819|FG000|Overall Study|Withdrawal by Subject|2|||
125322407|NCT03337308|450811820|FG001|Overall Study|Withdrawal by Subject|1|||
125322408|NCT03337308|450811821|FG002|Overall Study|Withdrawal by Subject|2|||
125322409|NCT03337308|450811822|FG003|Overall Study|Withdrawal by Subject|1|||
125322410|NCT03337308|450811819|FG000|Overall Study|Protocol Violation|0|||
125322411|NCT03337308|450811820|FG001|Overall Study|Protocol Violation|1|||
125322412|NCT03337308|450811821|FG002|Overall Study|Protocol Violation|0|||
125322413|NCT03337308|450811822|FG003|Overall Study|Protocol Violation|0|||
125322414|NCT00762164|450811825|FG000|Overall Study|Lost to Follow-up|1|||
125322415|NCT00762164|450811826|FG001|Overall Study|Lost to Follow-up|1|||
125322416|NCT00762164|450811825|FG000|Overall Study|Discontinued medication|2|||
125322417|NCT00762164|450811826|FG001|Overall Study|Discontinued medication|0|||
125322418|NCT00762164|450811825|FG000|Overall Study|Withdrawal by Subject|0|||
125322419|NCT00762164|450811826|FG001|Overall Study|Withdrawal by Subject|1|||
125322420|NCT03094416|450811829|FG000|Run-in|Screening failure|8|||
125662784|NCT02702271|452054057|FG001|Overall Study|Death|7|||
125322421|NCT03094416|450811829|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
125322422|NCT03094416|450811829|FG000|Run-in|Withdrawal by Subject|3|||
125322423|NCT03094416|450811829|FG000|Treatment Period|Withdrawal by Subject|2|||
125322424|NCT04528641|450811831|FG000|Overall Study|Withdrawal by Subject|0|||
125322425|NCT04528641|450811832|FG001|Overall Study|Withdrawal by Subject|0|||
125322426|NCT04528641|450811833|FG002|Overall Study|Withdrawal by Subject|0|||
125322427|NCT04528641|450811834|FG003|Overall Study|Withdrawal by Subject|1|||
125322428|NCT04528641|450811835|FG004|Overall Study|Withdrawal by Subject|0|||
125322429|NCT04528641|450811836|FG005|Overall Study|Withdrawal by Subject|1|||
125322430|NCT03341299|450811837|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
125322431|NCT03341299|450811838|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
125322432|NCT03341299|450811839|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
125322433|NCT03341299|450811840|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
125322434|NCT00945009|450811843|FG000|Overall Study|Lack of Efficacy|10|||
125322435|NCT00945009|450811844|FG001|Overall Study|Lack of Efficacy|0|||
125322436|NCT00945009|450811845|FG002|Overall Study|Lack of Efficacy|0|||
125662785|NCT02702271|452054056|FG000|Overall Study|Lost to Follow-up|12|||
125322437|NCT00945009|450811843|FG000|Overall Study|Physician Decision|21|||
125322438|NCT00945009|450811844|FG001|Overall Study|Physician Decision|4|||
125322439|NCT00945009|450811845|FG002|Overall Study|Physician Decision|3|||
125322440|NCT00945009|450811843|FG000|Overall Study|Protocol Violation|6|||
125322441|NCT00945009|450811844|FG001|Overall Study|Protocol Violation|1|||
125322442|NCT00945009|450811845|FG002|Overall Study|Protocol Violation|0|||
125322443|NCT00945009|450811843|FG000|Overall Study|Withdrawal by Subject|1|||
125322444|NCT00945009|450811844|FG001|Overall Study|Withdrawal by Subject|0|||
125322445|NCT00945009|450811845|FG002|Overall Study|Withdrawal by Subject|0|||
125322446|NCT00945009|450811843|FG000|Overall Study|Ineligible|6|||
125322447|NCT00945009|450811844|FG001|Overall Study|Ineligible|1|||
125322448|NCT00945009|450811845|FG002|Overall Study|Ineligible|0|||
125322449|NCT00945009|450811843|FG000|Overall Study|Inevaluable|0|||
125322450|NCT00945009|450811844|FG001|Overall Study|Inevaluable|1|||
125322451|NCT00945009|450811845|FG002|Overall Study|Inevaluable|0|||
125322452|NCT00945009|450811843|FG000|Overall Study|Refusal of further protocol|1|||
125322453|NCT00945009|450811844|FG001|Overall Study|Refusal of further protocol|0|||
125322454|NCT00945009|450811845|FG002|Overall Study|Refusal of further protocol|0|||
125322455|NCT04607005|450811846|FG000|Overall Study|Adverse Event|0|||
125322456|NCT04607005|450811847|FG001|Overall Study|Adverse Event|1|||
125322457|NCT04607005|450811846|FG000|Overall Study|Lack of Efficacy|1|||
125322458|NCT04607005|450811847|FG001|Overall Study|Lack of Efficacy|6|||
125322459|NCT04607005|450811846|FG000|Overall Study|Withdrawal by Subject|4|||
125322460|NCT04607005|450811847|FG001|Overall Study|Withdrawal by Subject|9|||
125322461|NCT04607005|450811846|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
125322462|NCT04607005|450811847|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
125322463|NCT03919773|450811856|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
125322464|NCT03919773|450811857|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
125322465|NCT03919773|450811856|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
125322466|NCT03919773|450811857|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
125322467|NCT04659044|450811860|FG000|Induction|Physician Decision|1|||
125322468|NCT04659044|450811860|FG000|Induction|Adverse Event|2|||
125322469|NCT05417438|450811862|FG000|Overall Study|Withdrawal by Subject|3|||
125322470|NCT02994108|450813732|FG000|Intervention Messages|Withdrawal by Subject|2|||
125322471|NCT02994108|450813733|FG001|Intervention Messages|Withdrawal by Subject|0|||
125322472|NCT02994108|450813732|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
125322473|NCT02994108|450813733|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
125322474|NCT02994108|450813732|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
125322475|NCT02994108|450813733|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
125322476|NCT02994108|450813732|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
125322477|NCT02994108|450813733|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
125322478|NCT00781768|450813734|FG000|Overall Study|Not transplanted.|0|||
125322479|NCT00781768|450813735|FG001|Overall Study|Not transplanted.|2|||
125322480|NCT00079417|450813744|FG000|Overall Study|Physician Decision|2|||
125322481|NCT00079417|450813744|FG000|Overall Study|Ineligible|7|||
125322482|NCT02458313|450813745|FG000|Overall Study|Withdrawal by Subject|6|||
125322483|NCT02458313|450813746|FG001|Overall Study|Withdrawal by Subject|8|||
125322484|NCT02458313|450813745|FG000|Overall Study|Excluded for motion during MRI|1|||
125322485|NCT02458313|450813746|FG001|Overall Study|Excluded for motion during MRI|2|||
125322486|NCT02081677|450813747|FG000|Overall Study|Adverse Event|0|||
125322487|NCT02081677|450813748|FG001|Overall Study|Adverse Event|0|||
125322488|NCT02081677|450813749|FG002|Overall Study|Adverse Event|1|||
125322489|NCT02081677|450813750|FG003|Overall Study|Adverse Event|0|||
125322490|NCT02081677|450813747|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125322491|NCT02081677|450813748|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125322492|NCT02081677|450813749|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
125322493|NCT02081677|450813750|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
125322494|NCT02081677|450813747|FG000|Overall Study|Not comfortable with lens care system|1|||
125322495|NCT02081677|450813748|FG001|Overall Study|Not comfortable with lens care system|0|||
125322496|NCT02081677|450813749|FG002|Overall Study|Not comfortable with lens care system|0|||
125322497|NCT02081677|450813750|FG003|Overall Study|Not comfortable with lens care system|0|||
125322498|NCT02081677|450813747|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
125322499|NCT02081677|450813748|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
125322500|NCT02081677|450813749|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
125322501|NCT02081677|450813750|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
125322502|NCT00904969|450813751|FG000|Overall Study|Lost to Follow-up|4|||
125322503|NCT00904969|450813751|FG000|Overall Study|Withdrawal by Subject|3|||
125322504|NCT00904969|450813751|FG000|Overall Study|Additional Treatments|11|||
125322505|NCT00904969|450813751|FG000|Overall Study|Case Aborted; Subject Exited|1|||
125322506|NCT01097668|450813752|FG000|Overall Study|Withdrawal by Subject|1|||
125322507|NCT01097668|450813753|FG001|Overall Study|Withdrawal by Subject|2|||
125322508|NCT01097668|450813752|FG000|Overall Study|Lost to Follow-up|1|||
125322509|NCT01097668|450813753|FG001|Overall Study|Lost to Follow-up|0|||
125322510|NCT00199381|450813760|FG000|Overall Study|Withdrawal by Subject|38|||
125322511|NCT00199381|450813760|FG000|Overall Study|Adverse Event|73|||
125322512|NCT00199381|450813760|FG000|Overall Study|Protocol Violation|6|||
125322513|NCT00199381|450813760|FG000|Overall Study|Lack of Efficacy|27|||
125322514|NCT00199381|450813760|FG000|Overall Study|Not including due to early termination|37|||
125322515|NCT00199381|450813760|FG000|Overall Study|Study termination by Sponsor|323|||
125322516|NCT00385671|450813762|FG000|Overall Study|Adverse Event|14|||
125322517|NCT00385671|450813763|FG001|Overall Study|Adverse Event|27|||
125322518|NCT00385671|450813764|FG002|Overall Study|Adverse Event|18|||
125322519|NCT00385671|450813762|FG000|Overall Study|Lack of Efficacy|5|||
125322520|NCT00385671|450813763|FG001|Overall Study|Lack of Efficacy|9|||
125322521|NCT00385671|450813764|FG002|Overall Study|Lack of Efficacy|5|||
125322522|NCT00385671|450813762|FG000|Overall Study|Lost to Follow-up|6|||
125322523|NCT00385671|450813763|FG001|Overall Study|Lost to Follow-up|6|||
125322524|NCT00385671|450813764|FG002|Overall Study|Lost to Follow-up|5|||
125322525|NCT00385671|450813762|FG000|Overall Study|Physician Decision|2|||
125322526|NCT00385671|450813763|FG001|Overall Study|Physician Decision|1|||
125322527|NCT00385671|450813764|FG002|Overall Study|Physician Decision|2|||
125322528|NCT00385671|450813762|FG000|Overall Study|Protocol Violation|5|||
125322529|NCT00385671|450813763|FG001|Overall Study|Protocol Violation|2|||
125322530|NCT00385671|450813764|FG002|Overall Study|Protocol Violation|1|||
125322531|NCT00385671|450813762|FG000|Overall Study|Sponsor Decision|2|||
125322532|NCT00385671|450813763|FG001|Overall Study|Sponsor Decision|2|||
125322533|NCT00385671|450813764|FG002|Overall Study|Sponsor Decision|1|||
125322534|NCT00385671|450813762|FG000|Overall Study|Withdrawal by Subject|4|||
125322535|NCT00385671|450813763|FG001|Overall Study|Withdrawal by Subject|4|||
125322536|NCT00385671|450813764|FG002|Overall Study|Withdrawal by Subject|4|||
125322537|NCT04944992|450813765|FG000|Overall Study|Lost to Follow-up|1|||
125322538|NCT04944992|450813766|FG001|Overall Study|Lost to Follow-up|1|||
125322539|NCT04944992|450813765|FG000|Overall Study|Physician Decision|1|||
125322540|NCT04944992|450813766|FG001|Overall Study|Physician Decision|0|||
125322541|NCT04944992|450813765|FG000|Overall Study|Withdrawal by Subject|6|||
125322542|NCT04944992|450813766|FG001|Overall Study|Withdrawal by Subject|1|||
125322543|NCT01295814|450813767|FG000|Overall Study|Lack of Efficacy|0|||
125322544|NCT01295814|450813768|FG001|Overall Study|Lack of Efficacy|2|||
125322545|NCT01295814|450813767|FG000|Overall Study|Withdrawal by Subject|2|||
125322546|NCT01295814|450813768|FG001|Overall Study|Withdrawal by Subject|0|||
125322547|NCT03414983|450813769|FG000|Pre-Treatment|Other reasons|1|||
125322548|NCT03414983|450813770|FG001|Pre-Treatment|Other reasons|0|||
125322549|NCT03414983|450813769|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
125322550|NCT03414983|450813770|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
125322551|NCT03414983|450813769|FG000|Pre-Treatment|Participant withdrew consent|1|||
125322552|NCT03414983|450813770|FG001|Pre-Treatment|Participant withdrew consent|3|||
125322553|NCT03414983|450813769|FG000|Treatment|Participant withdrew consent|4|||
125322554|NCT03414983|450813770|FG001|Treatment|Participant withdrew consent|3|||
125322555|NCT03414983|450813769|FG000|Treatment|Participant request to discontinue study treatment|8|||
125322556|NCT03414983|450813770|FG001|Treatment|Participant request to discontinue study treatment|10|||
125322557|NCT03414983|450813769|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
125322558|NCT03414983|450813770|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
125322559|NCT03414983|450813769|FG000|Treatment|Death|0|||
125322560|NCT03414983|450813770|FG001|Treatment|Death|1|||
125322561|NCT03414983|450813769|FG000|Treatment|Study Drug Toxicity|10|||
125322562|NCT03414983|450813770|FG001|Treatment|Study Drug Toxicity|5|||
125322563|NCT03414983|450813769|FG000|Treatment|Disease Progression|75|||
125322564|NCT03414983|450813770|FG001|Treatment|Disease Progression|29|||
125322565|NCT03414983|450813769|FG000|Treatment|Not reported|1|||
125322566|NCT03414983|450813770|FG001|Treatment|Not reported|0|||
125322567|NCT03414983|450813769|FG000|Treatment|Other reasons|3|||
125322568|NCT03414983|450813770|FG001|Treatment|Other reasons|2|||
125322569|NCT03414983|450813769|FG000|Treatment|Poor/non-compliance|2|||
125322570|NCT03414983|450813770|FG001|Treatment|Poor/non-compliance|0|||
125322571|NCT03414983|450813769|FG000|Treatment|Maximum clinical benefit|5|||
125322572|NCT03414983|450813770|FG001|Treatment|Maximum clinical benefit|9|||
125322573|NCT03414983|450813769|FG000|Treatment|Lost to Follow-up|0|||
125322574|NCT03414983|450813770|FG001|Treatment|Lost to Follow-up|1|||
125322575|NCT03414983|450813769|FG000|Treatment|Administrative reasons by sponsor|1|||
125322576|NCT03414983|450813770|FG001|Treatment|Administrative reasons by sponsor|0|||
125322577|NCT01775501|450813773|FG000|Overall Study|Discontinued prior to treatment|1|||
125662786|NCT02702271|452054057|FG001|Overall Study|Lost to Follow-up|0|||
125322578|NCT03780244|450813781|FG000|Overall Study|Lost to Follow-up|1|||
125322579|NCT03780244|450813782|FG001|Overall Study|Lost to Follow-up|0|||
125322580|NCT00804908|450813785|FG000|Overall Study|Other|115|||
125322581|NCT00804908|450813786|FG001|Overall Study|Other|116|||
125322582|NCT00804908|450813787|FG002|Overall Study|Other|114|||
125322583|NCT01280903|450813788|FG000|Overall Study|Lost to Follow-up|23|||
125322584|NCT01280903|450813789|FG001|Overall Study|Lost to Follow-up|16|||
125322585|NCT03453164|450813790|FG000|Overall Study|Lack of Efficacy|16|||
125322586|NCT03453164|450813790|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
125322587|NCT03822117|450813792|FG000|Overall Study|Death|18|||
125322588|NCT03822117|450813793|FG001|Overall Study|Death|17|||
125322589|NCT03822117|450813794|FG002|Overall Study|Death|12|||
125322590|NCT03822117|450813795|FG003|Overall Study|Death|4|||
125322591|NCT03822117|450813792|FG000|Overall Study|Lost to Follow-up|1|||
125322592|NCT03822117|450813793|FG001|Overall Study|Lost to Follow-up|2|||
125322593|NCT03822117|450813794|FG002|Overall Study|Lost to Follow-up|3|||
125322594|NCT03822117|450813795|FG003|Overall Study|Lost to Follow-up|0|||
125322595|NCT03822117|450813792|FG000|Overall Study|Study Terminated by Sponsor|25|||
125322596|NCT03822117|450813793|FG001|Overall Study|Study Terminated by Sponsor|11|||
125322597|NCT03822117|450813794|FG002|Overall Study|Study Terminated by Sponsor|6|||
125322598|NCT03822117|450813795|FG003|Overall Study|Study Terminated by Sponsor|0|||
125322599|NCT03822117|450813792|FG000|Overall Study|Withdrawal by Subject|4|||
125322600|NCT03822117|450813793|FG001|Overall Study|Withdrawal by Subject|0|||
125322601|NCT03822117|450813794|FG002|Overall Study|Withdrawal by Subject|3|||
125322602|NCT03822117|450813795|FG003|Overall Study|Withdrawal by Subject|0|||
125322603|NCT03822117|450813792|FG000|Overall Study|Disease Progression|1|||
125322604|NCT03822117|450813793|FG001|Overall Study|Disease Progression|2|||
125322605|NCT03822117|450813794|FG002|Overall Study|Disease Progression|1|||
125322606|NCT03822117|450813795|FG003|Overall Study|Disease Progression|0|||
125322607|NCT03822117|450813792|FG000|Overall Study|Never Returned to Hospital|0|||
125322608|NCT03822117|450813793|FG001|Overall Study|Never Returned to Hospital|0|||
125322609|NCT03822117|450813794|FG002|Overall Study|Never Returned to Hospital|1|||
125322610|NCT03822117|450813795|FG003|Overall Study|Never Returned to Hospital|0|||
125322611|NCT01074502|450813796|FG000|Overall Study|Withdrawal by Subject|1|||
125322612|NCT03459079|450813797|FG000|Overall Study|Adverse Event|4|||
125322613|NCT03459079|450813798|FG001|Overall Study|Adverse Event|2|||
125322614|NCT03459079|450813799|FG002|Overall Study|Adverse Event|0|||
125322615|NCT03459079|450813797|FG000|Overall Study|Withdrawal by Subject|2|||
125322616|NCT03459079|450813798|FG001|Overall Study|Withdrawal by Subject|2|||
125322617|NCT03459079|450813799|FG002|Overall Study|Withdrawal by Subject|0|||
125322618|NCT00726063|450813803|FG000|Overall Study|Adverse Event|9|||
125322619|NCT00726063|450813804|FG001|Overall Study|Adverse Event|7|||
125322620|NCT05176314|450813806|FG000|Overall Study|Lost to Follow-up|2|||
125322621|NCT05176314|450813806|FG000|Overall Study|Physician Decision|1|||
125322622|NCT05176314|450813806|FG000|Overall Study|Adverse Event|1|||
125322623|NCT01231984|450813807|FG000|Study Period 1|Withdrawal by Subject|0|||
125322624|NCT01231984|450813808|FG001|Study Period 1|Withdrawal by Subject|0|||
125322625|NCT01231984|450813809|FG002|Study Period 1|Withdrawal by Subject|0|||
125322626|NCT01231984|450813810|FG003|Study Period 1|Withdrawal by Subject|1|||
125322627|NCT01231984|450813807|FG000|Study Period 1|Lost to Follow-up|1|||
125322628|NCT01231984|450813808|FG001|Study Period 1|Lost to Follow-up|1|||
125322629|NCT01231984|450813809|FG002|Study Period 1|Lost to Follow-up|1|||
125322630|NCT01231984|450813810|FG003|Study Period 1|Lost to Follow-up|0|||
125322631|NCT01231984|450813807|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
125322632|NCT01231984|450813808|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
125322633|NCT01231984|450813809|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
125322634|NCT01231984|450813810|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
125322635|NCT01231984|450813807|FG000|Study Period 1|Screen Failure|0|||
125322636|NCT01231984|450813808|FG001|Study Period 1|Screen Failure|0|||
125322637|NCT01231984|450813809|FG002|Study Period 1|Screen Failure|0|||
125322638|NCT01231984|450813810|FG003|Study Period 1|Screen Failure|1|||
125322639|NCT01231984|450813807|FG000|Study Period 1|Non-compliance with study requirements|5|||
125322640|NCT01231984|450813808|FG001|Study Period 1|Non-compliance with study requirements|0|||
125322641|NCT01231984|450813809|FG002|Study Period 1|Non-compliance with study requirements|2|||
125322642|NCT01231984|450813810|FG003|Study Period 1|Non-compliance with study requirements|1|||
125322643|NCT01231984|450813807|FG000|Study Period 1|Protocol Violation|3|||
125322644|NCT01231984|450813808|FG001|Study Period 1|Protocol Violation|4|||
125322645|NCT01231984|450813809|FG002|Study Period 1|Protocol Violation|2|||
125322646|NCT01231984|450813810|FG003|Study Period 1|Protocol Violation|3|||
125322647|NCT01231984|450813807|FG000|Study Period 1|Adverse Event|1|||
125322648|NCT01231984|450813808|FG001|Study Period 1|Adverse Event|0|||
125322649|NCT01231984|450813809|FG002|Study Period 1|Adverse Event|0|||
125322650|NCT01231984|450813810|FG003|Study Period 1|Adverse Event|0|||
125322651|NCT01231984|450813807|FG000|Study Period 1|Other|0|||
125322652|NCT01231984|450813808|FG001|Study Period 1|Other|0|||
125322653|NCT01231984|450813809|FG002|Study Period 1|Other|0|||
125322654|NCT01231984|450813810|FG003|Study Period 1|Other|1|||
125322655|NCT01231984|450813807|FG000|Study Period 2|Withdrawal by Subject|1|||
125322656|NCT01231984|450813808|FG001|Study Period 2|Withdrawal by Subject|1|||
125322657|NCT01231984|450813809|FG002|Study Period 2|Withdrawal by Subject|0|||
125322658|NCT01231984|450813810|FG003|Study Period 2|Withdrawal by Subject|0|||
125322659|NCT01231984|450813807|FG000|Study Period 2|Lost to Follow-up|1|||
125322660|NCT01231984|450813808|FG001|Study Period 2|Lost to Follow-up|0|||
125322661|NCT01231984|450813809|FG002|Study Period 2|Lost to Follow-up|0|||
125322662|NCT01231984|450813810|FG003|Study Period 2|Lost to Follow-up|3|||
125322663|NCT01231984|450813807|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
125322664|NCT01231984|450813808|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
125322665|NCT01231984|450813809|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
125322666|NCT01231984|450813810|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
125322667|NCT02766023|450813813|FG000|Overall Study|Lost to Follow-up|23|||
125322668|NCT02766023|450813814|FG001|Overall Study|Lost to Follow-up|11|||
125322669|NCT02766023|450813813|FG000|Overall Study|Pregnancy|1|||
125322670|NCT02766023|450813814|FG001|Overall Study|Pregnancy|0|||
125322671|NCT02766023|450813813|FG000|Overall Study|Adverse Event|1|||
125322672|NCT02766023|450813814|FG001|Overall Study|Adverse Event|0|||
125322673|NCT02766023|450813813|FG000|Overall Study|Withdrawal by Subject|4|||
125322674|NCT02766023|450813814|FG001|Overall Study|Withdrawal by Subject|5|||
125322675|NCT02766023|450813813|FG000|Overall Study|Physician Decision|1|||
125322676|NCT02766023|450813814|FG001|Overall Study|Physician Decision|0|||
125322677|NCT02766023|450813813|FG000|Overall Study|Not Eligible at Enrollment|0|||
125322678|NCT02766023|450813814|FG001|Overall Study|Not Eligible at Enrollment|1|||
125322679|NCT06271993|450813815|FG000|Overall Study|Not reactive to histamine|5|||
125322680|NCT06271993|450813816|FG001|Overall Study|Not reactive to histamine|5|||
125322681|NCT06271993|450813817|FG002|Overall Study|Not reactive to histamine|5|||
125322682|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
125322683|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
125322684|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
125322685|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
125322686|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
125322687|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
125322688|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
125322689|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
125322690|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
125322691|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
125322692|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
125322693|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
125322694|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
125322695|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
125322696|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
125322697|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
125322698|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
125322699|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
125322700|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
125322701|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
125322702|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
125322703|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
125322704|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125322705|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125322706|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
125662787|NCT02702271|452054056|FG000|Overall Study|Withdrawal by Subject|8|||
125662788|NCT02702271|452054057|FG001|Overall Study|Withdrawal by Subject|1|||
125662789|NCT02702271|452054056|FG000|Overall Study|Physician Decision|2|||
125662790|NCT02702271|452054057|FG001|Overall Study|Physician Decision|0|||
125662791|NCT02702271|452054056|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
125662792|NCT02702271|452054057|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
125662793|NCT03091400|452054058|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
125662794|NCT03091400|452054059|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
125662795|NCT00051636|452054060|FG000|Period 1 - Core|Adverse Event|2|||
125662796|NCT00051636|452054061|FG001|Period 1 - Core|Adverse Event|2|||
125662797|NCT00051636|452054060|FG000|Period 1 - Core|Protocol Violation|1|||
125662798|NCT00051636|452054061|FG001|Period 1 - Core|Protocol Violation|0|||
125662799|NCT00051636|452054060|FG000|Period 1 - Core|Withdrawal by Subject|1|||
125662800|NCT00051636|452054061|FG001|Period 1 - Core|Withdrawal by Subject|2|||
125662801|NCT00051636|452054060|FG000|Period 1 - Core|Lost to Follow-up|0|||
125662802|NCT00051636|452054061|FG001|Period 1 - Core|Lost to Follow-up|2|||
125662803|NCT00051636|452054060|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
125662804|NCT00051636|452054061|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
125662805|NCT00051636|452054060|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
125662806|NCT00051636|452054061|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
125662807|NCT00051636|452054060|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
125662808|NCT00051636|452054061|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
125662809|NCT00051636|452054060|FG000|Period 2- Extended Observation Period|Death|4|||
125662810|NCT00051636|452054061|FG001|Period 2- Extended Observation Period|Death|5|||
125662811|NCT00051636|452054060|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
125662812|NCT00051636|452054061|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
125322707|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
125662813|NCT00479765|452054062|FG000|Overall Study|study terminated|4|||
125662814|NCT03056001|452054065|FG000|Overall Study|Death|24|||
125322708|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
125322709|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
125322710|NCT04026113|450813822|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
125322711|NCT04026113|450813823|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
125322712|NCT04026113|450813824|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
125322713|NCT04026113|450813825|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
125322714|NCT04026113|450813822|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
125322715|NCT04026113|450813823|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
125322716|NCT04026113|450813824|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
125322717|NCT04026113|450813825|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
125322718|NCT04613362|450813827|FG000|3 Month Follow-up|Lost to Follow-up|1|||
125322719|NCT04613362|450813828|FG001|3 Month Follow-up|Lost to Follow-up|2|||
125322720|NCT04613362|450813827|FG000|6 Month Follow-up|Lost to Follow-up|0|||
125322721|NCT04613362|450813828|FG001|6 Month Follow-up|Lost to Follow-up|1|||
125322722|NCT02218372|450813829|FG000|Overall Study|Adverse Event|1|||
125322723|NCT02218372|450813830|FG001|Overall Study|Adverse Event|1|||
125322724|NCT02218372|450813829|FG000|Overall Study|Miscellaneous|2|||
125322725|NCT02218372|450813830|FG001|Overall Study|Miscellaneous|1|||
125322726|NCT02218372|450813829|FG000|Overall Study|Randomized but did not receive treatment|2|||
125322727|NCT02218372|450813830|FG001|Overall Study|Randomized but did not receive treatment|3|||
125322728|NCT02218372|450813829|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125322729|NCT02218372|450813830|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125322730|NCT00671658|450813839|FG000|Overall Study|Physician Decision|5|||
125322731|NCT01921205|450813840|FG000|Overall Study|Adverse Event|12|||
125322732|NCT01921205|450813841|FG001|Overall Study|Adverse Event|7|||
125322733|NCT01921205|450813840|FG000|Overall Study|Lack of Efficacy|1|||
125322734|NCT01921205|450813841|FG001|Overall Study|Lack of Efficacy|0|||
125322735|NCT01921205|450813840|FG000|Overall Study|Protocol Violation|1|||
125322736|NCT01921205|450813841|FG001|Overall Study|Protocol Violation|3|||
125322737|NCT01921205|450813840|FG000|Overall Study|Lost to Follow-up|1|||
125322738|NCT01921205|450813841|FG001|Overall Study|Lost to Follow-up|1|||
125322739|NCT01921205|450813840|FG000|Overall Study|Withdrawal by Subject|6|||
125322740|NCT01921205|450813841|FG001|Overall Study|Withdrawal by Subject|5|||
125322741|NCT01921205|450813840|FG000|Overall Study|Use Of Prohibited Medication|0|||
125322742|NCT01921205|450813841|FG001|Overall Study|Use Of Prohibited Medication|1|||
125322743|NCT01921205|450813840|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
125322744|NCT01921205|450813841|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
125322745|NCT01921205|450813840|FG000|Overall Study|Non Compliance Of The Parent|0|||
125322746|NCT01921205|450813841|FG001|Overall Study|Non Compliance Of The Parent|1|||
125322747|NCT01921205|450813840|FG000|Overall Study|Non Compliance Of Child|0|||
125322748|NCT01921205|450813841|FG001|Overall Study|Non Compliance Of Child|1|||
125322749|NCT00456846|450813843|FG000|Overall Study|Adverse Event|2|||
125322750|NCT00456846|450813844|FG001|Overall Study|Adverse Event|15|||
125322751|NCT00456846|450813843|FG000|Overall Study|Physician Decision|11|||
125322752|NCT00456846|450813844|FG001|Overall Study|Physician Decision|6|||
125322753|NCT00456846|450813843|FG000|Overall Study|Protocol Deviation|2|||
125322754|NCT00456846|450813844|FG001|Overall Study|Protocol Deviation|0|||
125322755|NCT00456846|450813843|FG000|Overall Study|Participant Discretion|1|||
125322756|NCT00456846|450813844|FG001|Overall Study|Participant Discretion|5|||
125322757|NCT00456846|450813843|FG000|Overall Study|Other|0|||
125322758|NCT00456846|450813844|FG001|Overall Study|Other|2|||
125322759|NCT03125395|450813846|FG000|Overall Study|Adverse Event|2|||
125322760|NCT03125395|450813846|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
125322761|NCT03125395|450813846|FG000|Overall Study|Physician Decision|2|||
125322762|NCT03125395|450813846|FG000|Overall Study|Commercial drug is available|5|||
125322763|NCT01668784|450813847|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
125322764|NCT01668784|450813848|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
125322765|NCT01668784|450813847|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
125322766|NCT01668784|450813848|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
125322767|NCT01668784|450813847|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
125322768|NCT01668784|450813848|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
125322769|NCT01668784|450813847|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
125322770|NCT01668784|450813848|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
125322771|NCT01668784|450813847|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
125322772|NCT01668784|450813848|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
125322773|NCT01668784|450813847|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
125322774|NCT01668784|450813848|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
125322775|NCT01668784|450813847|FG000|Treatment Period|Disease Progression|316|||
125322776|NCT01668784|450813848|FG001|Treatment Period|Disease Progression|293|||
125322777|NCT01668784|450813847|FG000|Treatment Period|Study Drug Toxicity|46|||
125322778|NCT01668784|450813848|FG001|Treatment Period|Study Drug Toxicity|53|||
125322779|NCT01668784|450813847|FG000|Treatment Period|Death|1|||
125322780|NCT01668784|450813848|FG001|Treatment Period|Death|1|||
125322781|NCT01668784|450813847|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
125322782|NCT01668784|450813848|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
125322783|NCT01668784|450813847|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
125322784|NCT01668784|450813848|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
125322785|NCT01668784|450813847|FG000|Treatment Period|Withdrawal by Subject|5|||
125322786|NCT01668784|450813848|FG001|Treatment Period|Withdrawal by Subject|3|||
125322787|NCT01668784|450813847|FG000|Treatment Period|Maximal Clinical Benefit|3|||
125322788|NCT01668784|450813848|FG001|Treatment Period|Maximal Clinical Benefit|3|||
125322789|NCT01668784|450813847|FG000|Treatment Period|Other|2|||
125322790|NCT01668784|450813848|FG001|Treatment Period|Other|8|||
125322791|NCT01668784|450813847|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
125322792|NCT01668784|450813848|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
125322793|NCT02783690|450813856|FG000|Overall Study|Withdrawal by Subject|3|||
125322794|NCT02783690|450813857|FG001|Overall Study|Withdrawal by Subject|3|||
125322795|NCT03157830|450813861|FG000|Overall Study|Lost to Follow-up|1|||
125322796|NCT03157830|450813861|FG000|Overall Study|Withdrawal by Subject|1|||
125322797|NCT05138653|450813864|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
125322798|NCT05138653|450813865|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322799|NCT05138653|450813866|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322800|NCT05138653|450813867|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322801|NCT05138653|450813868|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322802|NCT05138653|450813869|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322803|NCT05138653|450813870|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322804|NCT05138653|450813871|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322805|NCT05138653|450813872|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322806|NCT05138653|450813873|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322807|NCT05138653|450813874|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322808|NCT05138653|450813875|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322809|NCT05138653|450813876|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322810|NCT05138653|450813877|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322811|NCT05138653|450813878|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322812|NCT05138653|450813879|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
125322813|NCT05138653|450813864|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322814|NCT05138653|450813865|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
125322815|NCT05138653|450813866|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322816|NCT05138653|450813867|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322817|NCT05138653|450813868|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322818|NCT05138653|450813869|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322819|NCT05138653|450813870|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322820|NCT05138653|450813871|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322821|NCT05138653|450813872|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
125322822|NCT05138653|450813873|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322823|NCT05138653|450813874|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322824|NCT05138653|450813875|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322825|NCT05138653|450813876|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322826|NCT05138653|450813877|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322827|NCT05138653|450813878|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322828|NCT05138653|450813879|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
125322829|NCT05138653|450813864|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322830|NCT05138653|450813865|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
125322831|NCT05138653|450813866|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322832|NCT05138653|450813867|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322833|NCT05138653|450813868|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
125322834|NCT05138653|450813869|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322835|NCT05138653|450813870|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322836|NCT05138653|450813871|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322837|NCT05138653|450813872|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322838|NCT05138653|450813873|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322839|NCT05138653|450813874|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322840|NCT05138653|450813875|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322841|NCT05138653|450813876|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322842|NCT05138653|450813877|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322843|NCT05138653|450813878|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125322844|NCT05138653|450813879|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
125425581|NCT01592370|451180521|FG004|Overall Study|Other Reasons|0|||
125322845|NCT05138653|450813864|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322846|NCT05138653|450813865|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322847|NCT05138653|450813866|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322848|NCT05138653|450813867|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322849|NCT05138653|450813868|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322850|NCT05138653|450813869|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322851|NCT05138653|450813870|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
125322852|NCT05138653|450813871|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322853|NCT05138653|450813872|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322854|NCT05138653|450813873|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322855|NCT05138653|450813874|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322856|NCT05138653|450813875|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322857|NCT05138653|450813876|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322858|NCT05138653|450813877|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322859|NCT05138653|450813878|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322860|NCT05138653|450813879|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
125322861|NCT05138653|450813864|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322862|NCT05138653|450813865|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322863|NCT05138653|450813866|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322864|NCT05138653|450813867|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322865|NCT05138653|450813868|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322866|NCT05138653|450813869|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322867|NCT05138653|450813870|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322868|NCT05138653|450813871|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322869|NCT05138653|450813872|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322870|NCT05138653|450813873|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322871|NCT05138653|450813874|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
125322872|NCT05138653|450813875|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322873|NCT05138653|450813876|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
125322874|NCT05138653|450813877|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322875|NCT05138653|450813878|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
125322876|NCT05138653|450813879|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
125322877|NCT05138653|450813864|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322878|NCT05138653|450813865|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322879|NCT05138653|450813866|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322880|NCT05138653|450813867|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322881|NCT05138653|450813868|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322882|NCT05138653|450813869|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322883|NCT05138653|450813870|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322884|NCT05138653|450813871|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322885|NCT05138653|450813872|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322886|NCT05138653|450813873|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322887|NCT05138653|450813874|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322888|NCT05138653|450813875|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322889|NCT05138653|450813876|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322890|NCT05138653|450813877|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322891|NCT05138653|450813878|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
125322892|NCT05138653|450813879|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
125322893|NCT05138653|450813864|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322894|NCT05138653|450813865|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322895|NCT05138653|450813866|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322896|NCT05138653|450813867|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322897|NCT05138653|450813868|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322898|NCT05138653|450813869|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322899|NCT05138653|450813870|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322900|NCT05138653|450813871|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322901|NCT05138653|450813872|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322902|NCT05138653|450813873|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322903|NCT05138653|450813874|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322904|NCT05138653|450813875|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322905|NCT05138653|450813876|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322906|NCT05138653|450813877|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
125322907|NCT05138653|450813878|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125322908|NCT05138653|450813879|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
125425582|NCT01592370|451180522|FG005|Overall Study|Other Reasons|1|||
125322909|NCT04272242|450813880|FG000|Overall Study|Withdrawal by Subject|3|||
125322910|NCT04272242|450813880|FG000|Overall Study|Lost to Follow-up|1|||
125322911|NCT04272242|450813880|FG000|Overall Study|Adverse Event|1|||
125322912|NCT02702492|450813881|FG000|Overall Study|Disease progression|3|||
125322913|NCT02702492|450813882|FG001|Overall Study|Disease progression|3|||
125322914|NCT02702492|450813883|FG002|Overall Study|Disease progression|2|||
125322915|NCT02702492|450813884|FG003|Overall Study|Disease progression|4|||
125322916|NCT02702492|450813885|FG004|Overall Study|Disease progression|4|||
125322917|NCT02702492|450813886|FG005|Overall Study|Disease progression|1|||
125322918|NCT02702492|450813887|FG006|Overall Study|Disease progression|2|||
125322919|NCT02702492|450813888|FG007|Overall Study|Disease progression|8|||
125322920|NCT02702492|450813889|FG008|Overall Study|Disease progression|5|||
125322921|NCT02702492|450813890|FG009|Overall Study|Disease progression|1|||
125322922|NCT02702492|450813891|FG010|Overall Study|Disease progression|0|||
125322923|NCT02702492|450813892|FG011|Overall Study|Disease progression|3|||
125322924|NCT02702492|450813893|FG012|Overall Study|Disease progression|2|||
125322925|NCT02702492|450813881|FG000|Overall Study|Clinical progression|0|||
125322926|NCT02702492|450813882|FG001|Overall Study|Clinical progression|0|||
125322927|NCT02702492|450813883|FG002|Overall Study|Clinical progression|2|||
125322928|NCT02702492|450813884|FG003|Overall Study|Clinical progression|1|||
125322929|NCT02702492|450813885|FG004|Overall Study|Clinical progression|0|||
125322930|NCT02702492|450813886|FG005|Overall Study|Clinical progression|2|||
125322931|NCT02702492|450813887|FG006|Overall Study|Clinical progression|1|||
125322932|NCT02702492|450813888|FG007|Overall Study|Clinical progression|4|||
125322933|NCT02702492|450813889|FG008|Overall Study|Clinical progression|0|||
125322934|NCT02702492|450813890|FG009|Overall Study|Clinical progression|0|||
125322935|NCT02702492|450813891|FG010|Overall Study|Clinical progression|1|||
125322936|NCT02702492|450813892|FG011|Overall Study|Clinical progression|2|||
125322937|NCT02702492|450813893|FG012|Overall Study|Clinical progression|0|||
125322938|NCT02702492|450813881|FG000|Overall Study|Adverse Event|0|||
125322939|NCT02702492|450813882|FG001|Overall Study|Adverse Event|0|||
125322940|NCT02702492|450813883|FG002|Overall Study|Adverse Event|1|||
125322941|NCT02702492|450813884|FG003|Overall Study|Adverse Event|2|||
125322942|NCT02702492|450813885|FG004|Overall Study|Adverse Event|1|||
125322943|NCT02702492|450813886|FG005|Overall Study|Adverse Event|0|||
125322944|NCT02702492|450813887|FG006|Overall Study|Adverse Event|1|||
125322945|NCT02702492|450813888|FG007|Overall Study|Adverse Event|0|||
125322946|NCT02702492|450813889|FG008|Overall Study|Adverse Event|2|||
125322947|NCT02702492|450813890|FG009|Overall Study|Adverse Event|0|||
125322948|NCT02702492|450813891|FG010|Overall Study|Adverse Event|0|||
125322949|NCT02702492|450813892|FG011|Overall Study|Adverse Event|0|||
125322950|NCT02702492|450813893|FG012|Overall Study|Adverse Event|1|||
125322951|NCT02702492|450813881|FG000|Overall Study|Other|0|||
125322952|NCT02702492|450813882|FG001|Overall Study|Other|0|||
125322953|NCT02702492|450813883|FG002|Overall Study|Other|0|||
125322954|NCT02702492|450813884|FG003|Overall Study|Other|0|||
125322955|NCT02702492|450813885|FG004|Overall Study|Other|0|||
125322956|NCT02702492|450813886|FG005|Overall Study|Other|0|||
125322957|NCT02702492|450813887|FG006|Overall Study|Other|0|||
125322958|NCT02702492|450813888|FG007|Overall Study|Other|0|||
125322959|NCT02702492|450813889|FG008|Overall Study|Other|0|||
125322960|NCT02702492|450813890|FG009|Overall Study|Other|0|||
125322961|NCT02702492|450813891|FG010|Overall Study|Other|0|||
125322962|NCT02702492|450813892|FG011|Overall Study|Other|0|||
125322963|NCT02702492|450813893|FG012|Overall Study|Other|1|||
125322964|NCT01824836|450813894|FG000|Overall Study|Adverse Event|48|||
125322965|NCT01824836|450813894|FG000|Overall Study|Withdrawal by Subject|63|||
125322966|NCT01824836|450813894|FG000|Overall Study|Other complicating disease|116|||
125322967|NCT01824836|450813894|FG000|Overall Study|Disease progression|5|||
125322968|NCT01824836|450813894|FG000|Overall Study|Alternative therapy|2|||
125322969|NCT01824836|450813894|FG000|Overall Study|Depression|1|||
125322970|NCT01824836|450813894|FG000|Overall Study|Non-compliance|3|||
125322971|NCT01824836|450813894|FG000|Overall Study|Patient regained ovarian function|3|||
125322972|NCT01824836|450813894|FG000|Overall Study|Lost to Follow-up|8|||
125322973|NCT01824836|450813894|FG000|Overall Study|Physician Decision|2|||
125322974|NCT01824836|450813894|FG000|Overall Study|Research office was closed|3|||
125322975|NCT01824836|450813894|FG000|Overall Study|Relocation|3|||
125322976|NCT01824836|450813894|FG000|Overall Study|Insurance-related issue|1|||
125322977|NCT01824836|450813894|FG000|Overall Study|Transportation issue|1|||
125322978|NCT01824836|450813894|FG000|Overall Study|Patient transferred care|1|||
125322979|NCT01824836|450813894|FG000|Overall Study|Unknown reasons|4|||
125322980|NCT01824836|450813894|FG000|Overall Study|Never started treatment|16|||
125322981|NCT00751296|450816069|FG000|Overall Study|Adverse Event|2|||
125322982|NCT01972217|450816070|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
125322983|NCT01972217|450816071|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
125322984|NCT01972217|450816072|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
125322985|NCT01972217|450816073|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
125322986|NCT01972217|450816070|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
125425583|NCT01592370|451180523|FG006|Overall Study|Other Reasons|0|||
125322987|NCT01972217|450816071|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
125322988|NCT01972217|450816072|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
125322989|NCT01972217|450816073|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
125322990|NCT01972217|450816070|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
125322991|NCT01972217|450816071|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
125322992|NCT01972217|450816072|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
125322993|NCT01972217|450816073|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
125322994|NCT01972217|450816070|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
125322995|NCT01972217|450816071|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
125322996|NCT01972217|450816072|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
125322997|NCT01972217|450816073|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
125322998|NCT01972217|450816070|FG000|Part B Double-blind, Randomised Period|Death|0|||
125322999|NCT01972217|450816071|FG001|Part B Double-blind, Randomised Period|Death|0|||
125323000|NCT01972217|450816072|FG002|Part B Double-blind, Randomised Period|Death|43|||
125323001|NCT01972217|450816073|FG003|Part B Double-blind, Randomised Period|Death|44|||
125323002|NCT01972217|450816070|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
125323003|NCT01972217|450816071|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
125323004|NCT01972217|450816072|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
125323005|NCT01972217|450816073|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
125323006|NCT01972217|450816070|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
125323007|NCT01972217|450816071|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
125323008|NCT01972217|450816072|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
125323009|NCT01972217|450816073|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
125323010|NCT01972217|450816070|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
125323011|NCT01972217|450816071|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
125323012|NCT01972217|450816072|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
125323013|NCT01972217|450816073|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
125323014|NCT01972217|450816070|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
125323015|NCT01972217|450816071|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
125323016|NCT01972217|450816072|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
125323017|NCT01972217|450816073|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
125323018|NCT04106557|450816075|FG000|Overall Study|Physician Decision|0|||
125323019|NCT04106557|450816076|FG001|Overall Study|Physician Decision|1|||
125323020|NCT04106557|450816077|FG002|Overall Study|Physician Decision|0|||
125323021|NCT04106557|450816075|FG000|Overall Study|Protocol Violation|0|||
125323022|NCT04106557|450816076|FG001|Overall Study|Protocol Violation|1|||
125323023|NCT04106557|450816077|FG002|Overall Study|Protocol Violation|0|||
125323024|NCT03175367|450816078|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
125323025|NCT03175367|450816079|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
125323026|NCT03175367|450816080|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
125323027|NCT03175367|450816081|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
125323028|NCT03175367|450816082|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
125323029|NCT03175367|450816083|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
125323030|NCT03175367|450816084|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
125323031|NCT03175367|450816078|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
125323032|NCT03175367|450816079|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
125323033|NCT03175367|450816080|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
125323034|NCT03175367|450816081|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
125323035|NCT03175367|450816082|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
125323036|NCT03175367|450816083|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
125323037|NCT03175367|450816084|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
125323038|NCT03175367|450816078|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125323039|NCT03175367|450816079|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125323040|NCT03175367|450816080|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
125323041|NCT03175367|450816081|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
125323042|NCT03175367|450816082|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125323043|NCT03175367|450816083|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125323044|NCT03175367|450816084|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125323045|NCT03175367|450816078|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
125323046|NCT03175367|450816079|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
125323047|NCT03175367|450816080|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
125323048|NCT03175367|450816081|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
125323049|NCT03175367|450816082|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
125323050|NCT03175367|450816083|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
125323051|NCT03175367|450816084|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
125323052|NCT03175367|450816078|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125323053|NCT03175367|450816079|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125323054|NCT03175367|450816080|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
125323055|NCT03175367|450816081|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125323056|NCT03175367|450816082|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
125323057|NCT03175367|450816083|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125323058|NCT03175367|450816084|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125323059|NCT03175367|450816078|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125323060|NCT03175367|450816079|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125323061|NCT03175367|450816080|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125323062|NCT03175367|450816081|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125323063|NCT03175367|450816082|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125323064|NCT03175367|450816083|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
125323065|NCT03175367|450816084|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
125323066|NCT03175367|450816078|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125323067|NCT03175367|450816079|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125323068|NCT03175367|450816080|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125323069|NCT03175367|450816081|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125323070|NCT03175367|450816082|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125323071|NCT03175367|450816083|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
125323072|NCT03175367|450816084|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
125323073|NCT02151058|450816085|FG000|Overall Study|Withdrawal by Subject|1|||
125323074|NCT02151058|450816086|FG001|Overall Study|Withdrawal by Subject|1|||
125323075|NCT02151058|450816087|FG002|Overall Study|Withdrawal by Subject|3|||
125323076|NCT02151058|450816085|FG000|Overall Study|Lost to Follow-up|1|||
125323077|NCT02151058|450816086|FG001|Overall Study|Lost to Follow-up|0|||
125323078|NCT02151058|450816087|FG002|Overall Study|Lost to Follow-up|2|||
125323079|NCT00674817|450816089|FG000|Period 1|Withdrawal by Subject|2|||
125323080|NCT00674817|450816089|FG000|Period 1|Protocol Violation|1|||
125323081|NCT00674817|450816089|FG000|Period 3|Adverse Event|1|||
125323082|NCT00674817|450816089|FG000|Period 3|Protocol Violation|1|||
125323083|NCT00674817|450816089|FG000|Period 4|Adverse Event|1|||
125323084|NCT03379818|450816090|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
125323085|NCT03379818|450816091|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
125323086|NCT03379818|450816090|FG000|Overall Study|Withdrawal by Subject|2|||
125323087|NCT03379818|450816091|FG001|Overall Study|Withdrawal by Subject|3|||
125323088|NCT03379818|450816090|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
125323089|NCT03379818|450816091|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
125323090|NCT03199976|450816092|FG000|Overall Study|Lack of Efficacy|3|||
125323091|NCT03199976|450816093|FG001|Overall Study|Lack of Efficacy|6|||
125323092|NCT03199976|450816094|FG002|Overall Study|Lack of Efficacy|13|||
125323093|NCT03199976|450816092|FG000|Overall Study|Withdrawal by Subject|1|||
125323094|NCT03199976|450816093|FG001|Overall Study|Withdrawal by Subject|0|||
125323095|NCT03199976|450816094|FG002|Overall Study|Withdrawal by Subject|0|||
125323096|NCT03199976|450816092|FG000|Overall Study|Lost to Follow-up|0|||
125323097|NCT03199976|450816093|FG001|Overall Study|Lost to Follow-up|1|||
125323098|NCT03199976|450816094|FG002|Overall Study|Lost to Follow-up|1|||
125323099|NCT01780506|450816101|FG000|Double-Blind Phase|Randomized but not Treated|3|||
125323100|NCT01780506|450816102|FG001|Double-Blind Phase|Randomized but not Treated|2|||
125323101|NCT01780506|450816101|FG000|Double-Blind Phase|Adverse Event|4|||
125323102|NCT01780506|450816102|FG001|Double-Blind Phase|Adverse Event|14|||
125323103|NCT01780506|450816101|FG000|Double-Blind Phase|Death|1|||
125323104|NCT01780506|450816102|FG001|Double-Blind Phase|Death|2|||
125323105|NCT01780506|450816101|FG000|Double-Blind Phase|Pregnancy|2|||
125323106|NCT01780506|450816102|FG001|Double-Blind Phase|Pregnancy|1|||
125323107|NCT01780506|450816101|FG000|Double-Blind Phase|Lack of Efficacy|1|||
125323108|NCT01780506|450816102|FG001|Double-Blind Phase|Lack of Efficacy|1|||
125323109|NCT01780506|450816101|FG000|Double-Blind Phase|Investigator's Discretion|5|||
125323110|NCT01780506|450816102|FG001|Double-Blind Phase|Investigator's Discretion|2|||
125323111|NCT01780506|450816101|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
125323112|NCT01780506|450816102|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
125323113|NCT01780506|450816101|FG000|Double-Blind Phase|Protocol Violation|4|||
125323114|NCT01780506|450816102|FG001|Double-Blind Phase|Protocol Violation|3|||
125323115|NCT01780506|450816101|FG000|Double-Blind Phase|Withdrew Consent|23|||
125323116|NCT01780506|450816102|FG001|Double-Blind Phase|Withdrew Consent|24|||
125323117|NCT01780506|450816101|FG000|Double-Blind Phase|Lost to Follow-up|23|||
125323118|NCT01780506|450816102|FG001|Double-Blind Phase|Lost to Follow-up|26|||
125323119|NCT01780506|450816101|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
125323120|NCT01780506|450816102|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
125323121|NCT05236270|450816103|FG000|Overall Study|Lost to Follow-up|3|||
125323122|NCT05236270|450816104|FG001|Overall Study|Lost to Follow-up|2|||
125323123|NCT05236270|450816105|FG002|Overall Study|Lost to Follow-up|0|||
125323124|NCT05236270|450816106|FG003|Overall Study|Lost to Follow-up|0|||
125323125|NCT05236270|450816107|FG004|Overall Study|Lost to Follow-up|2|||
125323126|NCT05236270|450816108|FG005|Overall Study|Lost to Follow-up|0|||
125323127|NCT05236270|450816109|FG006|Overall Study|Lost to Follow-up|1|||
125323128|NCT05236270|450816110|FG007|Overall Study|Lost to Follow-up|3|||
125323129|NCT04030143|450816111|FG000|Overall Study|Adverse Event|5|||
125323130|NCT04030143|450816112|FG001|Overall Study|Adverse Event|10|||
125323131|NCT04030143|450816111|FG000|Overall Study|Lost to Follow-up|3|||
125323132|NCT04030143|450816112|FG001|Overall Study|Lost to Follow-up|7|||
125323133|NCT04030143|450816111|FG000|Overall Study|Protocol Deviation|2|||
125323134|NCT04030143|450816112|FG001|Overall Study|Protocol Deviation|2|||
125323135|NCT04030143|450816111|FG000|Overall Study|Withdrawal by Subject|16|||
125323136|NCT04030143|450816112|FG001|Overall Study|Withdrawal by Subject|18|||
125323137|NCT04030143|450816111|FG000|Overall Study|Physician Decision|1|||
125323138|NCT04030143|450816112|FG001|Overall Study|Physician Decision|1|||
125323139|NCT04030143|450816111|FG000|Overall Study|Due to Covid-19|2|||
125323140|NCT04030143|450816112|FG001|Overall Study|Due to Covid-19|3|||
125323141|NCT04030143|450816111|FG000|Overall Study|Not Due to Covid-19|1|||
125323142|NCT04030143|450816112|FG001|Overall Study|Not Due to Covid-19|1|||
125323143|NCT01499940|450816113|FG000|Overall Study|Study was withdrawn before completion.|9|||
125323144|NCT00412984|450816114|FG000|Overall Study|Death|331|||
125323145|NCT00412984|450816115|FG001|Overall Study|Death|349|||
125323146|NCT00412984|450816114|FG000|Overall Study|Adverse Event|679|||
125323147|NCT00412984|450816115|FG001|Overall Study|Adverse Event|738|||
125323148|NCT00412984|450816114|FG000|Overall Study|Withdrawal by Subject|921|||
125323149|NCT00412984|450816115|FG001|Overall Study|Withdrawal by Subject|989|||
125323150|NCT00412984|450816114|FG000|Overall Study|Lost to Follow-up|51|||
125323151|NCT00412984|450816115|FG001|Overall Study|Lost to Follow-up|39|||
125323152|NCT00412984|450816114|FG000|Overall Study|Poor/Noncompliance|57|||
125323153|NCT00412984|450816115|FG001|Overall Study|Poor/Noncompliance|77|||
125323154|NCT00412984|450816114|FG000|Overall Study|Pregnancy|1|||
125323155|NCT00412984|450816115|FG001|Overall Study|Pregnancy|0|||
125323156|NCT00412984|450816114|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
125323157|NCT00412984|450816115|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
125323158|NCT00412984|450816114|FG000|Overall Study|Administrative Reason by Sponsor|11|||
125323159|NCT00412984|450816115|FG001|Overall Study|Administrative Reason by Sponsor|8|||
125323160|NCT00412984|450816114|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
125323161|NCT00412984|450816115|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
125323162|NCT00412984|450816114|FG000|Overall Study|Other Reason|80|||
125323163|NCT00412984|450816115|FG001|Overall Study|Other Reason|92|||
125323164|NCT00412984|450816114|FG000|Overall Study|Not Reported|11|||
125323165|NCT00412984|450816115|FG001|Overall Study|Not Reported|12|||
125323166|NCT04218240|450816116|FG000|Overall Study|Withdrawal by Subject|6|||
125323167|NCT04218240|450816117|FG001|Overall Study|Withdrawal by Subject|0|||
125323168|NCT04218240|450816116|FG000|Overall Study|Lack of Efficacy|24|||
125323169|NCT04218240|450816117|FG001|Overall Study|Lack of Efficacy|19|||
125323170|NCT04218240|450816116|FG000|Overall Study|Physician Decision|0|||
125323171|NCT04218240|450816117|FG001|Overall Study|Physician Decision|1|||
125323172|NCT04218240|450816116|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
125323173|NCT04218240|450816117|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
125323174|NCT04914364|450816118|FG000|Overall Study|No longer eligible for study|1|||
125323175|NCT04914364|450816118|FG000|Overall Study|Lost to Follow-up|2|||
125323176|NCT04097678|450816119|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
125323177|NCT04097678|450816120|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
125662815|NCT01364298|452054066|FG000|Overall Study|Adverse Event|3|||
125662816|NCT01364298|452054067|FG001|Overall Study|Adverse Event|4|||
125662817|NCT01364298|452054066|FG000|Overall Study|Lack of adherence to treatment|1|||
125662818|NCT01364298|452054067|FG001|Overall Study|Lack of adherence to treatment|3|||
125662819|NCT01364298|452054066|FG000|Overall Study|Lack of Efficacy|1|||
125662820|NCT01364298|452054067|FG001|Overall Study|Lack of Efficacy|0|||
125662821|NCT01364298|452054066|FG000|Overall Study|Lost to Follow-up|5|||
125662822|NCT01364298|452054067|FG001|Overall Study|Lost to Follow-up|10|||
125662823|NCT01364298|452054066|FG000|Overall Study|Withdrawal by Subject|3|||
125662824|NCT01364298|452054067|FG001|Overall Study|Withdrawal by Subject|3|||
125662825|NCT01364298|452054066|FG000|Overall Study|Other|1|||
125662826|NCT01364298|452054067|FG001|Overall Study|Other|3|||
125323178|NCT03694678|450816121|FG000|Overall Study|Withdrawal by Subject|2|||
125323179|NCT03694678|450816122|FG001|Overall Study|Withdrawal by Subject|0|||
125323180|NCT03694678|450816121|FG000|Overall Study|Lost to Follow-up|2|||
125323181|NCT03694678|450816122|FG001|Overall Study|Lost to Follow-up|3|||
125662827|NCT03707522|452054070|FG000|Overall Study|Lost to Follow-up|24|||
125323182|NCT02435212|450816123|FG000|Core Phase|Adverse Event|8|||
125323183|NCT02435212|450816124|FG001|Core Phase|Adverse Event|5|||
125323184|NCT02435212|450816123|FG000|Core Phase|Withdrawal by Subject|3|||
125323185|NCT02435212|450816124|FG001|Core Phase|Withdrawal by Subject|0|||
125323186|NCT02435212|450816123|FG000|Core Phase|Withdrawal by parent/guardian|9|||
125323187|NCT02435212|450816124|FG001|Core Phase|Withdrawal by parent/guardian|4|||
125662828|NCT03707522|452054071|FG001|Overall Study|Lost to Follow-up|27|||
125210678|NCT02638259|450395634|FG000|Treatment Period 1|Protocol Violation|0|||
125323188|NCT02435212|450816123|FG000|Core Phase|Protocol Violation|1|||
125323189|NCT02435212|450816124|FG001|Core Phase|Protocol Violation|2|||
125323190|NCT02435212|450816123|FG000|Core Phase|Physician Decision|3|||
125323191|NCT02435212|450816124|FG001|Core Phase|Physician Decision|0|||
125323192|NCT02435212|450816123|FG000|Core Phase|Lost to Follow-up|0|||
125323193|NCT02435212|450816124|FG001|Core Phase|Lost to Follow-up|1|||
125323194|NCT02435212|450816123|FG000|Core Phase|Lack of Efficacy|0|||
125323195|NCT02435212|450816124|FG001|Core Phase|Lack of Efficacy|1|||
125323196|NCT02435212|450816123|FG000|Core Phase|Recovery|1|||
125323197|NCT02435212|450816124|FG001|Core Phase|Recovery|0|||
125323198|NCT02435212|450816123|FG000|Optional Extension Phase|Adverse Event|3|||
125323199|NCT02435212|450816124|FG001|Optional Extension Phase|Adverse Event|9|||
125323200|NCT02435212|450816123|FG000|Optional Extension Phase|Physician Decision|6|||
125323201|NCT02435212|450816124|FG001|Optional Extension Phase|Physician Decision|8|||
125323202|NCT02435212|450816123|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
125323203|NCT02435212|450816124|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
125323204|NCT02435212|450816123|FG000|Optional Extension Phase|Lack of Efficacy|2|||
125323205|NCT02435212|450816124|FG001|Optional Extension Phase|Lack of Efficacy|3|||
125323206|NCT02435212|450816123|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
125323207|NCT02435212|450816124|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
125323208|NCT02435212|450816123|FG000|Optional Extension Phase|Protocol Violation|0|||
125323209|NCT02435212|450816124|FG001|Optional Extension Phase|Protocol Violation|1|||
125323210|NCT02435212|450816123|FG000|Optional Extension Phase|Recovery|1|||
125323211|NCT02435212|450816124|FG001|Optional Extension Phase|Recovery|1|||
125323212|NCT02435212|450816123|FG000|Optional Extension Phase|Death|1|||
125323213|NCT02435212|450816124|FG001|Optional Extension Phase|Death|0|||
125323214|NCT02435212|450816123|FG000|Optional Extension Phase|Technical problems|2|||
125323215|NCT02435212|450816124|FG001|Optional Extension Phase|Technical problems|0|||
125323216|NCT05966142|450816134|FG000|Overall Study|Death|3|||
125323217|NCT05966142|450816135|FG001|Overall Study|Death|3|||
125323218|NCT05966142|450816134|FG000|Overall Study|Lost to Follow-up|55|||
125323219|NCT05966142|450816135|FG001|Overall Study|Lost to Follow-up|52|||
125323220|NCT05966142|450816134|FG000|Overall Study|Physician Decision|1|||
125323221|NCT05966142|450816135|FG001|Overall Study|Physician Decision|0|||
125323222|NCT05966142|450816134|FG000|Overall Study|Withdrawal by Subject|9|||
125323223|NCT05966142|450816135|FG001|Overall Study|Withdrawal by Subject|8|||
125323224|NCT05966142|450816134|FG000|Overall Study|Duplicate Enrollment|1|||
125323225|NCT05966142|450816135|FG001|Overall Study|Duplicate Enrollment|0|||
125323226|NCT05966142|450816134|FG000|Overall Study|Study Logistical Reason|1|||
125323227|NCT05966142|450816135|FG001|Overall Study|Study Logistical Reason|0|||
125323228|NCT05966142|450816134|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
125323229|NCT05966142|450816135|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
125323230|NCT04852302|450816141|FG000|Overall Study|Withdrawal by Subject|2|||
125323231|NCT04852302|450816141|FG000|Overall Study|Did not complete CALM therapy.|2|||
125323232|NCT03267277|450816142|FG000|Overall Study|Withdrawal by Subject|1|||
125323233|NCT04849364|450816143|FG000|Overall Study|Eligibility criteria not meet|0|||
125323234|NCT04849364|450816144|FG001|Overall Study|Eligibility criteria not meet|1|||
125323235|NCT04849364|450816145|FG002|Overall Study|Eligibility criteria not meet|0|||
125323236|NCT03521570|450816147|FG000|Overall Study|Not eligible|11|||
125323237|NCT04531176|450816150|FG000|Overall Study|Study was stopped early|24|||
125323238|NCT04531176|450816151|FG001|Overall Study|Study was stopped early|26|||
125323239|NCT04531176|450816152|FG002|Overall Study|Study was stopped early|24|||
125323240|NCT01345240|450816165|FG000|Overall Study|Adverse Event|3|||
125323241|NCT01345240|450816166|FG001|Overall Study|Adverse Event|5|||
125323242|NCT01345240|450816167|FG002|Overall Study|Adverse Event|4|||
125323243|NCT01345240|450816168|FG003|Overall Study|Adverse Event|2|||
125323244|NCT01345240|450816169|FG004|Overall Study|Adverse Event|1|||
125323245|NCT01345240|450816165|FG000|Overall Study|Lost to Follow-up|8|||
125323246|NCT01345240|450816166|FG001|Overall Study|Lost to Follow-up|9|||
125323247|NCT01345240|450816167|FG002|Overall Study|Lost to Follow-up|14|||
125323248|NCT01345240|450816168|FG003|Overall Study|Lost to Follow-up|7|||
125323249|NCT01345240|450816169|FG004|Overall Study|Lost to Follow-up|9|||
125323250|NCT04298697|450816170|FG000|Overall Study|Lost to Follow-up|5|||
125323251|NCT04298697|450816171|FG001|Overall Study|Lost to Follow-up|5|||
125323252|NCT04298697|450816172|FG002|Overall Study|Lost to Follow-up|1|||
125323253|NCT04298697|450816173|FG003|Overall Study|Lost to Follow-up|0|||
125323254|NCT04298697|450816170|FG000|Overall Study|Withdrawal by Subject|0|||
125323255|NCT04298697|450816171|FG001|Overall Study|Withdrawal by Subject|3|||
125323256|NCT04298697|450816172|FG002|Overall Study|Withdrawal by Subject|2|||
125323257|NCT04298697|450816173|FG003|Overall Study|Withdrawal by Subject|3|||
125662829|NCT03707522|452054072|FG002|Overall Study|Lost to Follow-up|41|||
125323258|NCT00449696|450816174|FG000|Overall Study|Other Treatment Required|6|||
125323259|NCT00449696|450816175|FG001|Overall Study|Other Treatment Required|1|||
125323260|NCT00449696|450816174|FG000|Overall Study|Withdrawal by Subject|5|||
125323261|NCT00449696|450816175|FG001|Overall Study|Withdrawal by Subject|5|||
125323262|NCT00449696|450816174|FG000|Overall Study|Lost to Follow-up|2|||
125323263|NCT00449696|450816175|FG001|Overall Study|Lost to Follow-up|3|||
125323264|NCT00449696|450816174|FG000|Overall Study|Others|7|||
125323265|NCT00449696|450816175|FG001|Overall Study|Others|0|||
125323266|NCT01903460|450816180|FG000|Overall Study|Adverse Event|0|||
125323267|NCT01903460|450816181|FG001|Overall Study|Adverse Event|0|||
125323268|NCT01903460|450816182|FG002|Overall Study|Adverse Event|0|||
125323269|NCT01903460|450816183|FG003|Overall Study|Adverse Event|1|||
125323270|NCT02246530|450816184|FG000|Overall Study|Lost to Follow-up|4|||
125323271|NCT02246530|450816185|FG001|Overall Study|Lost to Follow-up|0|||
125323272|NCT00888173|450816186|FG000|Overall Study|Wrong Primary|1|||
125323273|NCT00888173|450816186|FG000|Overall Study|Ineligible: required test not done|1|||
125323274|NCT01488890|450816187|FG000|Overall Study|Serious adverse event|2|||
125323275|NCT01488890|450816188|FG001|Overall Study|Serious adverse event|0|||
125323276|NCT01488890|450816189|FG002|Overall Study|Serious adverse event|0|||
125323277|NCT01488890|450816190|FG003|Overall Study|Serious adverse event|0|||
125323278|NCT01488890|450816187|FG000|Overall Study|Protocol Violation|3|||
125323279|NCT01488890|450816188|FG001|Overall Study|Protocol Violation|0|||
125323280|NCT01488890|450816189|FG002|Overall Study|Protocol Violation|4|||
125323281|NCT01488890|450816190|FG003|Overall Study|Protocol Violation|0|||
125323282|NCT01488890|450816187|FG000|Overall Study|Lost to Follow-up|13|||
125323283|NCT01488890|450816188|FG001|Overall Study|Lost to Follow-up|10|||
125323284|NCT01488890|450816189|FG002|Overall Study|Lost to Follow-up|20|||
125323285|NCT01488890|450816190|FG003|Overall Study|Lost to Follow-up|3|||
125323286|NCT01488890|450816187|FG000|Overall Study|Withdrawal by Subject|14|||
125662830|NCT03707522|452054073|FG003|Overall Study|Lost to Follow-up|36|||
125662831|NCT00420849|452054074|FG000|Overall Study|Lack of Efficacy|154|||
125662832|NCT00420849|452054074|FG000|Overall Study|Adverse Event|107|||
125662833|NCT00420849|452054074|FG000|Overall Study|Withdrawal by Subject|28|||
125662834|NCT00420849|452054074|FG000|Overall Study|Death|18|||
125662835|NCT00420849|452054074|FG000|Overall Study|Other|14|||
125662836|NCT00420849|452054074|FG000|Overall Study|Transplant|8|||
125662837|NCT00420849|452054074|FG000|Overall Study|Protocol Violation|1|||
125662838|NCT00420849|452054074|FG000|Overall Study|Lost to Follow-up|1|||
125662839|NCT00659581|452054075|FG000|Overall Study|Adverse Event|1006|||
125662840|NCT00659581|452054075|FG000|Overall Study|Lack of Efficacy|1183|||
125662841|NCT00659581|452054075|FG000|Overall Study|Other|6393|||
125323287|NCT01488890|450816188|FG001|Overall Study|Withdrawal by Subject|10|||
125323288|NCT01488890|450816189|FG002|Overall Study|Withdrawal by Subject|11|||
125323289|NCT01488890|450816190|FG003|Overall Study|Withdrawal by Subject|2|||
125323290|NCT05712460|450816191|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323291|NCT05712460|450816192|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323292|NCT05712460|450816193|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125662842|NCT00944125|452054081|FG000|3 to 6 Months|Withdrawal by Subject|0|||
125323293|NCT05712460|450816194|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323294|NCT05712460|450816195|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323295|NCT05712460|450816196|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323296|NCT05712460|450816197|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323297|NCT05712460|450816198|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
125323298|NCT05712460|450816199|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323299|NCT05712460|450816200|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323300|NCT05712460|450816201|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323301|NCT05712460|450816202|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
125323302|NCT00829426|450816206|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
125323303|NCT00829426|450816207|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
125323304|NCT05135767|450816210|FG000|Baseline|Lost to Follow-up|1|||
125323305|NCT05135767|450816211|FG001|Baseline|Lost to Follow-up|1|||
125323306|NCT05135767|450816210|FG000|Baseline|Withdrawal by Subject|0|||
125323307|NCT05135767|450816211|FG001|Baseline|Withdrawal by Subject|2|||
125662843|NCT00944125|452054082|FG001|3 to 6 Months|Withdrawal by Subject|2|||
125662844|NCT00944125|452054081|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
125323308|NCT05135767|450816210|FG000|Active Study Phase|Lost to Follow-up|2|||
125323309|NCT05135767|450816211|FG001|Active Study Phase|Lost to Follow-up|0|||
125323310|NCT02260934|450816215|FG000|Overall Study|Lost to Follow-up|2|||
125323311|NCT02260934|450816216|FG001|Overall Study|Lost to Follow-up|1|||
125323312|NCT02260934|450816215|FG000|Overall Study|Withdrawal by Subject|0|||
125323313|NCT02260934|450816216|FG001|Overall Study|Withdrawal by Subject|2|||
125323314|NCT02260934|450816215|FG000|Overall Study|Participant Relocated|1|||
125323315|NCT02260934|450816216|FG001|Overall Study|Participant Relocated|0|||
125323316|NCT02260934|450816215|FG000|Overall Study|Site error|0|||
125323317|NCT02260934|450816216|FG001|Overall Study|Site error|1|||
125323318|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
125323319|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
125323320|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
125662845|NCT00944125|452054082|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
125210679|NCT02638259|450395635|FG001|Treatment Period 1|Protocol Violation|3|||
125210680|NCT02638259|450395634|FG000|Treatment Period 1|Withdrawal by Subject|4|||
125323321|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
125323322|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
125323323|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
125323324|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
125323325|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
125323326|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
125323327|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
125662846|NCT00446134|452054083|FG000|Overall Study|Adverse Event|7|||
125323328|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
125323329|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
125323330|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
125323331|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
125323332|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
125323333|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
125323334|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
125323335|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
125323336|NCT03605667|450816217|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
125323337|NCT03605667|450816218|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
125323338|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
125323339|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
125323340|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Other|6|||
125323341|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Other|8|||
125323342|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
125323343|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
125323344|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
125323345|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
125323346|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
125323347|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
125323348|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
125323349|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
125323350|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
125323351|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
125323352|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
125323353|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
125323354|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Death|0|||
125323355|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Death|2|||
125323356|NCT03605667|450816217|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
125323357|NCT03605667|450816218|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
125323358|NCT03597347|450816221|FG000|Overall Study|Withdrawal by Subject|1|||
125323359|NCT03597347|450816222|FG001|Overall Study|Withdrawal by Subject|1|||
125323360|NCT03597347|450816223|FG002|Overall Study|Withdrawal by Subject|0|||
125323361|NCT03597347|450816221|FG000|Overall Study|Withdrawal due to Covid-19|3|||
125323362|NCT03597347|450816222|FG001|Overall Study|Withdrawal due to Covid-19|0|||
125323363|NCT03597347|450816223|FG002|Overall Study|Withdrawal due to Covid-19|0|||
125323364|NCT03597347|450816221|FG000|Overall Study|Sponsor decision to terminate study|3|||
125323365|NCT03597347|450816222|FG001|Overall Study|Sponsor decision to terminate study|2|||
125323366|NCT03597347|450816223|FG002|Overall Study|Sponsor decision to terminate study|4|||
125323367|NCT02532517|450816229|FG000|Overall Study|Did not complete 24-Month visit|4|||
125323368|NCT02532517|450816229|FG000|Overall Study|Failed Angiographic eligibility|1|||
125323369|NCT02532517|450816229|FG000|Overall Study|Lost to Follow-up|4|||
125662847|NCT00446134|452054084|FG001|Overall Study|Adverse Event|17|||
125662848|NCT00446134|452054085|FG002|Overall Study|Adverse Event|13|||
125662849|NCT00446134|452054086|FG003|Overall Study|Adverse Event|18|||
125662850|NCT00446134|452054083|FG000|Overall Study|Lack of Efficacy|19|||
125662851|NCT00446134|452054084|FG001|Overall Study|Lack of Efficacy|19|||
125662852|NCT00446134|452054085|FG002|Overall Study|Lack of Efficacy|24|||
125662853|NCT00446134|452054086|FG003|Overall Study|Lack of Efficacy|19|||
125662854|NCT00446134|452054083|FG000|Overall Study|Protocol Violation|0|||
125662855|NCT00446134|452054084|FG001|Overall Study|Protocol Violation|2|||
125662856|NCT00446134|452054085|FG002|Overall Study|Protocol Violation|1|||
125662857|NCT00446134|452054086|FG003|Overall Study|Protocol Violation|0|||
125323370|NCT02532517|450816229|FG000|Overall Study|Withdrawal by Subject|4|||
125323371|NCT02532517|450816229|FG000|Overall Study|Death|4|||
125323372|NCT03312231|450816230|FG000|Overall Study|Lost to Follow-up|2|||
125323373|NCT03312231|450816231|FG001|Overall Study|Lost to Follow-up|6|||
125662858|NCT00446134|452054083|FG000|Overall Study|Lost to Follow-up|1|||
125662859|NCT00446134|452054084|FG001|Overall Study|Lost to Follow-up|3|||
125323374|NCT03312231|450816232|FG002|Overall Study|Lost to Follow-up|1|||
125323375|NCT03312231|450816233|FG003|Overall Study|Lost to Follow-up|3|||
125323376|NCT03312231|450816234|FG004|Overall Study|Lost to Follow-up|1|||
125662860|NCT00446134|452054085|FG002|Overall Study|Lost to Follow-up|1|||
125662861|NCT00446134|452054086|FG003|Overall Study|Lost to Follow-up|1|||
125662862|NCT00446134|452054083|FG000|Overall Study|Withdrawal by Subject|3|||
125323377|NCT03312231|450816230|FG000|Overall Study|Withdrawal by Subject|0|||
125323378|NCT03312231|450816231|FG001|Overall Study|Withdrawal by Subject|3|||
125323379|NCT03312231|450816232|FG002|Overall Study|Withdrawal by Subject|1|||
125323380|NCT03312231|450816233|FG003|Overall Study|Withdrawal by Subject|0|||
125323381|NCT03312231|450816234|FG004|Overall Study|Withdrawal by Subject|0|||
125323382|NCT03312231|450816230|FG000|Overall Study|Death|0|||
125323383|NCT03312231|450816231|FG001|Overall Study|Death|1|||
125323384|NCT03312231|450816232|FG002|Overall Study|Death|1|||
125323385|NCT03312231|450816233|FG003|Overall Study|Death|0|||
125323386|NCT03312231|450816234|FG004|Overall Study|Death|0|||
125323387|NCT03312231|450816230|FG000|Overall Study|Study Vaccination not Received|1|||
125323388|NCT03312231|450816231|FG001|Overall Study|Study Vaccination not Received|1|||
125323389|NCT03312231|450816232|FG002|Overall Study|Study Vaccination not Received|1|||
125323390|NCT03312231|450816233|FG003|Overall Study|Study Vaccination not Received|0|||
125323391|NCT03312231|450816234|FG004|Overall Study|Study Vaccination not Received|0|||
125323392|NCT05720897|450816235|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
125323393|NCT05720897|450816236|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
125323394|NCT00400179|450816237|FG000|Overall Study|Adverse Event|2|||
125323395|NCT00400179|450816238|FG001|Overall Study|Adverse Event|2|||
125323396|NCT00400179|450816237|FG000|Overall Study|Death|1|||
125323397|NCT00400179|450816238|FG001|Overall Study|Death|2|||
125323398|NCT00400179|450816237|FG000|Overall Study|Withdrew Consent|1|||
125323399|NCT00400179|450816238|FG001|Overall Study|Withdrew Consent|5|||
125323400|NCT00400179|450816237|FG000|Overall Study|Disease progression|1|||
125323401|NCT00400179|450816238|FG001|Overall Study|Disease progression|1|||
125323402|NCT00400179|450816237|FG000|Overall Study|Intercurrent illness|0|||
125323403|NCT00400179|450816238|FG001|Overall Study|Intercurrent illness|1|||
125323404|NCT00400179|450816237|FG000|Overall Study|Investigator judgment|0|||
125323405|NCT00400179|450816238|FG001|Overall Study|Investigator judgment|1|||
125323406|NCT00400179|450816237|FG000|Overall Study|Randomization error/patient ineligible|1|||
125323407|NCT00400179|450816238|FG001|Overall Study|Randomization error/patient ineligible|6|||
125323408|NCT04780061|450816239|FG000|Overall Study|Withdrawal by Subject|5|||
125323409|NCT04780061|450816240|FG001|Overall Study|Withdrawal by Subject|8|||
125323410|NCT04780061|450816239|FG000|Overall Study|Adverse Event|2|||
125323411|NCT04780061|450816240|FG001|Overall Study|Adverse Event|2|||
125323412|NCT04780061|450816239|FG000|Overall Study|Lost to Follow-up|1|||
125323413|NCT04780061|450816240|FG001|Overall Study|Lost to Follow-up|5|||
125323414|NCT04825574|450816241|FG000|Overall Study|Commercial treatment became available|1|||
125323415|NCT04825574|450816241|FG000|Overall Study|Disease progression|1|||
125323416|NCT00303069|450817686|FG000|Overall Study|Lost to Follow-up|1|||
125323417|NCT00303069|450817687|FG001|Overall Study|Lost to Follow-up|0|||
125323418|NCT00303069|450817688|FG002|Overall Study|Lost to Follow-up|0|||
125323419|NCT00303069|450817689|FG003|Overall Study|Lost to Follow-up|2|||
125323420|NCT00303069|450817686|FG000|Overall Study|subject moved|1|||
125323421|NCT00303069|450817687|FG001|Overall Study|subject moved|0|||
125323422|NCT00303069|450817688|FG002|Overall Study|subject moved|0|||
125323423|NCT00303069|450817689|FG003|Overall Study|subject moved|0|||
125323424|NCT00303069|450817686|FG000|Overall Study|Recruitment into Army Reserves|0|||
125323425|NCT00303069|450817687|FG001|Overall Study|Recruitment into Army Reserves|0|||
125323426|NCT00303069|450817688|FG002|Overall Study|Recruitment into Army Reserves|1|||
125323427|NCT00303069|450817689|FG003|Overall Study|Recruitment into Army Reserves|0|||
125323428|NCT00092417|450817690|FG000|Overall Study|Lost to Follow-up|2|||
125323429|NCT00092417|450817691|FG001|Overall Study|Lost to Follow-up|0|||
125323430|NCT00092417|450817690|FG000|Overall Study|Withdrawal by Subject|2|||
125323431|NCT00092417|450817691|FG001|Overall Study|Withdrawal by Subject|1|||
125323432|NCT00092417|450817690|FG000|Overall Study|Other|1|||
125323433|NCT00092417|450817691|FG001|Overall Study|Other|0|||
125323434|NCT02318706|450817695|FG000|Double-blind Phase|Adverse Event|7|||
125323435|NCT02318706|450817696|FG001|Double-blind Phase|Adverse Event|4|||
125323436|NCT02318706|450817697|FG002|Double-blind Phase|Adverse Event|3|||
125323437|NCT02318706|450817698|FG003|Double-blind Phase|Adverse Event|10|||
125323438|NCT02318706|450817699|FG004|Double-blind Phase|Adverse Event|0|||
125323439|NCT02318706|450817695|FG000|Double-blind Phase|Lost to Follow-up|1|||
125323440|NCT02318706|450817696|FG001|Double-blind Phase|Lost to Follow-up|0|||
125323441|NCT02318706|450817697|FG002|Double-blind Phase|Lost to Follow-up|0|||
125323442|NCT02318706|450817698|FG003|Double-blind Phase|Lost to Follow-up|0|||
125323443|NCT02318706|450817699|FG004|Double-blind Phase|Lost to Follow-up|0|||
125323444|NCT02318706|450817695|FG000|Double-blind Phase|Protocol Violation|4|||
125323445|NCT02318706|450817696|FG001|Double-blind Phase|Protocol Violation|2|||
125323446|NCT02318706|450817697|FG002|Double-blind Phase|Protocol Violation|4|||
125323447|NCT02318706|450817698|FG003|Double-blind Phase|Protocol Violation|3|||
125323448|NCT02318706|450817699|FG004|Double-blind Phase|Protocol Violation|0|||
125323449|NCT02318706|450817695|FG000|Double-blind Phase|Withdrawal by Subject|9|||
125323450|NCT02318706|450817696|FG001|Double-blind Phase|Withdrawal by Subject|5|||
125323451|NCT02318706|450817697|FG002|Double-blind Phase|Withdrawal by Subject|7|||
125323452|NCT02318706|450817698|FG003|Double-blind Phase|Withdrawal by Subject|10|||
125323453|NCT02318706|450817699|FG004|Double-blind Phase|Withdrawal by Subject|0|||
125323454|NCT02318706|450817695|FG000|Double-blind Phase|Other|4|||
125323455|NCT02318706|450817696|FG001|Double-blind Phase|Other|1|||
125323456|NCT02318706|450817697|FG002|Double-blind Phase|Other|2|||
125323457|NCT02318706|450817698|FG003|Double-blind Phase|Other|1|||
125323458|NCT02318706|450817699|FG004|Double-blind Phase|Other|0|||
125323459|NCT02318706|450817695|FG000|Double-blind Phase|Death|0|||
125323460|NCT02318706|450817696|FG001|Double-blind Phase|Death|0|||
125323461|NCT02318706|450817697|FG002|Double-blind Phase|Death|2|||
125323462|NCT02318706|450817698|FG003|Double-blind Phase|Death|0|||
125323463|NCT02318706|450817699|FG004|Double-blind Phase|Death|0|||
125323464|NCT02318706|450817695|FG000|Open-label Extension Phase|Adverse Event|0|||
125323465|NCT02318706|450817696|FG001|Open-label Extension Phase|Adverse Event|0|||
125323466|NCT02318706|450817697|FG002|Open-label Extension Phase|Adverse Event|0|||
125323467|NCT02318706|450817698|FG003|Open-label Extension Phase|Adverse Event|0|||
125323468|NCT02318706|450817699|FG004|Open-label Extension Phase|Adverse Event|21|||
125323469|NCT02318706|450817695|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
125323470|NCT02318706|450817696|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
125323471|NCT02318706|450817697|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
125323472|NCT02318706|450817698|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
125323473|NCT02318706|450817699|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
125323474|NCT02318706|450817695|FG000|Open-label Extension Phase|Death|0|||
125323475|NCT02318706|450817696|FG001|Open-label Extension Phase|Death|0|||
125323476|NCT02318706|450817697|FG002|Open-label Extension Phase|Death|0|||
125323477|NCT02318706|450817698|FG003|Open-label Extension Phase|Death|0|||
125323478|NCT02318706|450817699|FG004|Open-label Extension Phase|Death|1|||
125323479|NCT02318706|450817695|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
125323480|NCT02318706|450817696|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
125323481|NCT02318706|450817697|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
125323482|NCT02318706|450817698|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
125323483|NCT02318706|450817699|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
125323484|NCT01456039|450817700|FG000|Phase 1 (First Step)|Disease Progression|1|||
125323485|NCT01456039|450817701|FG001|Phase 1 (First Step)|Disease Progression|1|||
125323486|NCT01456039|450817702|FG002|Phase 1 (First Step)|Disease Progression|0|||
125323487|NCT01456039|450817700|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
125323488|NCT01456039|450817701|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
125323489|NCT01456039|450817702|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
125323490|NCT01456039|450817700|FG000|Phase 1 (First Step)|Adverse Event|0|||
125323491|NCT01456039|450817701|FG001|Phase 1 (First Step)|Adverse Event|3|||
125323492|NCT01456039|450817702|FG002|Phase 1 (First Step)|Adverse Event|0|||
125323493|NCT01456039|450817700|FG000|Phase 1 (First Step)|Other|0|||
125323494|NCT01456039|450817701|FG001|Phase 1 (First Step)|Other|1|||
125323495|NCT01456039|450817702|FG002|Phase 1 (First Step)|Other|0|||
125323496|NCT01456039|450817700|FG000|Phase 2 (Second Step)|Disease Progression|0|||
125323497|NCT01456039|450817701|FG001|Phase 2 (Second Step)|Disease Progression|0|||
125323498|NCT01456039|450817702|FG002|Phase 2 (Second Step)|Disease Progression|17|||
125323499|NCT01456039|450817700|FG000|Phase 2 (Second Step)|Adverse Event|0|||
125323500|NCT01456039|450817701|FG001|Phase 2 (Second Step)|Adverse Event|0|||
125323501|NCT01456039|450817702|FG002|Phase 2 (Second Step)|Adverse Event|10|||
125323502|NCT01456039|450817700|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
125323503|NCT01456039|450817701|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
125323504|NCT01456039|450817702|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
125323505|NCT01456039|450817700|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
125323506|NCT01456039|450817701|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
125323507|NCT01456039|450817702|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
125323508|NCT01456039|450817700|FG000|Phase 2 (Second Step)|Other|0|||
125323509|NCT01456039|450817701|FG001|Phase 2 (Second Step)|Other|0|||
125323510|NCT01456039|450817702|FG002|Phase 2 (Second Step)|Other|1|||
125323511|NCT00335777|450817706|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
125323512|NCT00335777|450817706|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
125323513|NCT00335777|450817706|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
125323514|NCT00335777|450817706|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
125323515|NCT00335777|450817706|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
125323516|NCT00992108|450817709|FG000|Overall Study|Lost to Follow-up|0|||
125323517|NCT00992108|450817710|FG001|Overall Study|Lost to Follow-up|1|||
125323518|NCT04639245|450817715|FG000|Overall Study|Death|1|||
125323519|NCT01702311|450817716|FG000|Overall Study|Withdrawal by Subject|3|||
125323520|NCT01702311|450817717|FG001|Overall Study|Withdrawal by Subject|2|||
125323521|NCT01702311|450817716|FG000|Overall Study|Discharge less than 24 hours|10|||
125323522|NCT01702311|450817717|FG001|Overall Study|Discharge less than 24 hours|7|||
125323523|NCT01702311|450817716|FG000|Overall Study|Physician Decision|3|||
125323524|NCT01702311|450817717|FG001|Overall Study|Physician Decision|4|||
125323525|NCT01209689|450817720|FG000|Overall Study|Insufficient Therapeutic Response|7|||
125323526|NCT01209689|450817721|FG001|Overall Study|Insufficient Therapeutic Response|2|||
125323527|NCT01209689|450817720|FG000|Overall Study|Refused Treatment|8|||
125323528|NCT01209689|450817721|FG001|Overall Study|Refused Treatment|3|||
125323529|NCT01209689|450817720|FG000|Overall Study|Adverse Event|4|||
125323530|NCT01209689|450817721|FG001|Overall Study|Adverse Event|0|||
125323531|NCT01209689|450817720|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
125323532|NCT01209689|450817721|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
125323533|NCT01209689|450817720|FG000|Overall Study|Failure to Return|3|||
125323534|NCT01209689|450817721|FG001|Overall Study|Failure to Return|0|||
125323535|NCT01209689|450817720|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
125323536|NCT01209689|450817721|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
125323537|NCT03337477|450817722|FG000|Overall Study|not categorized into the listed ones|11|||
125323538|NCT03337477|450817723|FG001|Overall Study|not categorized into the listed ones|9|||
125323539|NCT03337477|450817722|FG000|Overall Study|Withdrawal by Subject|0|||
125323540|NCT03337477|450817723|FG001|Overall Study|Withdrawal by Subject|1|||
125323541|NCT03337477|450817722|FG000|Overall Study|Death|0|||
125323542|NCT03337477|450817723|FG001|Overall Study|Death|1|||
125323543|NCT03337477|450817722|FG000|Overall Study|Lost to Follow-up|0|||
125323544|NCT03337477|450817723|FG001|Overall Study|Lost to Follow-up|2|||
125323545|NCT03181932|450817724|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
125323546|NCT03181932|450817725|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
125323547|NCT03181932|450817724|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
125323548|NCT03181932|450817725|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
125323549|NCT03181932|450817724|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
125323550|NCT03181932|450817725|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
125323551|NCT03181932|450817724|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
125323552|NCT03181932|450817725|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
125323553|NCT03181932|450817724|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
125323554|NCT03181932|450817725|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
125323555|NCT03181932|450817724|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
125323556|NCT03181932|450817725|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
125323557|NCT03181932|450817724|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
125323558|NCT03181932|450817725|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
125323559|NCT03181932|450817724|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
125323560|NCT03181932|450817725|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
125323561|NCT03181932|450817724|FG000|Period 2 (Open-label Period)|Reason missing|2|||
125323562|NCT03181932|450817725|FG001|Period 2 (Open-label Period)|Reason missing|0|||
125323563|NCT02220920|450817726|FG000|Overall Study|Adverse Event|1|||
125323564|NCT02220920|450817727|FG001|Overall Study|Adverse Event|0|||
125323565|NCT02220920|450817726|FG000|Overall Study|Lack of Efficacy|0|||
125323566|NCT02220920|450817727|FG001|Overall Study|Lack of Efficacy|1|||
125323567|NCT02220920|450817726|FG000|Overall Study|Withdrawal by Subject|1|||
125323568|NCT02220920|450817727|FG001|Overall Study|Withdrawal by Subject|0|||
125323569|NCT02220920|450817726|FG000|Overall Study|Conflict with the stopping criteria|1|||
125323570|NCT02220920|450817727|FG001|Overall Study|Conflict with the stopping criteria|2|||
125323571|NCT00853307|450817728|FG000|Overall Study|Adverse Event|1|||
125323572|NCT00853307|450817729|FG001|Overall Study|Adverse Event|2|||
125323573|NCT00853307|450817728|FG000|Overall Study|Withdrawal by Subject|1|||
125323574|NCT00853307|450817729|FG001|Overall Study|Withdrawal by Subject|2|||
125323575|NCT00853307|450817728|FG000|Overall Study|Reason Not Specified|0|||
125323576|NCT00853307|450817729|FG001|Overall Study|Reason Not Specified|1|||
125323577|NCT00473564|450817730|FG000|Overall Study|robot surgery aborted in OR|23|||
125323578|NCT01112917|450817731|FG000|Overall Study|Death|2|||
125323579|NCT01112917|450817732|FG001|Overall Study|Death|11|||
125323580|NCT01112917|450817731|FG000|Overall Study|Lost to Follow-up|1|||
125323581|NCT01112917|450817732|FG001|Overall Study|Lost to Follow-up|1|||
125323582|NCT01112917|450817731|FG000|Overall Study|Withdrawal by Subject|1|||
125323583|NCT01112917|450817732|FG001|Overall Study|Withdrawal by Subject|3|||
125323584|NCT01112917|450817731|FG000|Overall Study|Unable to Convert Filter|3|||
125323585|NCT01112917|450817732|FG001|Overall Study|Unable to Convert Filter|0|||
125323586|NCT02177123|450817733|FG000|Overall Study|Lost to Follow-up|6|||
125323587|NCT02177123|450817733|FG000|Overall Study|Withdrawal by Subject|4|||
125323588|NCT02177123|450817733|FG000|Overall Study|Adverse Event|4|||
125323589|NCT02177123|450817733|FG000|Overall Study|Physician Decision|3|||
125323590|NCT02177123|450817733|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
125323591|NCT02177123|450817733|FG000|Overall Study|Excluded for medical reasons|2|||
125323592|NCT02177123|450817733|FG000|Overall Study|Death|1|||
125323593|NCT02177123|450817733|FG000|Overall Study|Other|1|||
125323594|NCT02177123|450817733|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
125323595|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
125323596|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
125323597|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
125323598|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Death|9|||
125323599|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Death|0|||
125323600|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Death|0|||
125323601|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
125323602|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
125323603|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
125323604|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
125323605|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
125323606|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
125323607|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Other|135|||
125323608|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Other|0|||
125323609|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Other|0|||
125323610|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
125323611|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
125323612|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
125323613|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
125323614|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
125323615|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
125323616|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
125323617|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
125323618|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
125323619|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Other|3|||
125323620|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Other|0|||
125323621|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Other|0|||
125323622|NCT02118584|450817737|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
125323623|NCT02118584|450817738|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
125323624|NCT02118584|450817739|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
125323625|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
125323626|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
125323627|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
125323628|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
125323629|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
125323630|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
125323631|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
125323632|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
125323633|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
125323634|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
125323635|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
125323636|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
125323637|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
125323638|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
125323639|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
125323640|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
125323641|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
125323642|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
125323643|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
125323644|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
125323645|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
125323646|NCT02118584|450817737|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
125323647|NCT02118584|450817738|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
125323648|NCT02118584|450817739|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
125323649|NCT03103542|450817742|FG000|Overall Study|Physician Decision|2|||
125323650|NCT03103542|450817742|FG000|Overall Study|Adverse Event|2|||
125323651|NCT03103542|450817742|FG000|Overall Study|Other|2|||
125323652|NCT03103542|450817742|FG000|Overall Study|Withdrawal by Subject|1|||
125323653|NCT03406780|450817743|FG000|Overall Study|Withdrawal by Subject|1|||
125323654|NCT03406780|450817744|FG001|Overall Study|Withdrawal by Subject|1|||
125323655|NCT03406780|450817743|FG000|Overall Study|Other|0|||
125323656|NCT03406780|450817744|FG001|Overall Study|Other|2|||
125323657|NCT00837434|450817745|FG000|Overall Study|Physician Decision|3|||
125323658|NCT00837434|450817746|FG001|Overall Study|Physician Decision|0|||
125323659|NCT00837434|450817745|FG000|Overall Study|Lost to Follow-up|1|||
125323660|NCT00837434|450817746|FG001|Overall Study|Lost to Follow-up|1|||
125323661|NCT00837434|450817745|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
125323662|NCT00837434|450817746|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
125323663|NCT00837434|450817745|FG000|Overall Study|Noncompliant|2|||
125323664|NCT00837434|450817746|FG001|Overall Study|Noncompliant|0|||
125323665|NCT00837434|450817745|FG000|Overall Study|Baseline assessments not done in time|1|||
125323666|NCT00837434|450817746|FG001|Overall Study|Baseline assessments not done in time|0|||
125323667|NCT00837434|450817745|FG000|Overall Study|Unable to obtain study drug|1|||
125323668|NCT00837434|450817746|FG001|Overall Study|Unable to obtain study drug|0|||
125323669|NCT03041038|450817763|FG000|Overall Study|Withdrawal by Subject|4|||
125323670|NCT03041038|450817764|FG001|Overall Study|Withdrawal by Subject|0|||
125323671|NCT03041038|450817763|FG000|Overall Study|Lost to Follow-up|1|||
125323672|NCT03041038|450817764|FG001|Overall Study|Lost to Follow-up|1|||
125323673|NCT03041038|450817763|FG000|Overall Study|Protocol Violation|1|||
125323674|NCT03041038|450817764|FG001|Overall Study|Protocol Violation|1|||
125323675|NCT00360230|450817765|FG000|Overall Study|Withdrawal by Subject|1|||
125323676|NCT00360230|450817766|FG001|Overall Study|Withdrawal by Subject|1|||
125323677|NCT00360230|450817767|FG002|Overall Study|Withdrawal by Subject|0|||
125323678|NCT00360230|450817768|FG003|Overall Study|Withdrawal by Subject|1|||
125323679|NCT00360230|450817769|FG004|Overall Study|Withdrawal by Subject|1|||
125323680|NCT00360230|450817770|FG005|Overall Study|Withdrawal by Subject|1|||
125323681|NCT00360230|450817771|FG006|Overall Study|Withdrawal by Subject|0|||
125323682|NCT00360230|450817765|FG000|Overall Study|Migrated|4|||
125323683|NCT00360230|450817766|FG001|Overall Study|Migrated|1|||
125323684|NCT00360230|450817767|FG002|Overall Study|Migrated|3|||
125323685|NCT00360230|450817768|FG003|Overall Study|Migrated|1|||
125323686|NCT00360230|450817769|FG004|Overall Study|Migrated|4|||
125323687|NCT00360230|450817770|FG005|Overall Study|Migrated|1|||
125323688|NCT00360230|450817771|FG006|Overall Study|Migrated|1|||
125323689|NCT00360230|450817765|FG000|Overall Study|Other|1|||
125323690|NCT00360230|450817766|FG001|Overall Study|Other|0|||
125323691|NCT00360230|450817767|FG002|Overall Study|Other|0|||
125323692|NCT00360230|450817768|FG003|Overall Study|Other|0|||
125323693|NCT00360230|450817769|FG004|Overall Study|Other|0|||
125323694|NCT00360230|450817770|FG005|Overall Study|Other|0|||
125323695|NCT00360230|450817771|FG006|Overall Study|Other|0|||
125323696|NCT00360230|450817765|FG000|Overall Study|Protocol Violation|0|||
125323697|NCT00360230|450817766|FG001|Overall Study|Protocol Violation|0|||
125323698|NCT00360230|450817767|FG002|Overall Study|Protocol Violation|0|||
125323699|NCT00360230|450817768|FG003|Overall Study|Protocol Violation|0|||
125323700|NCT00360230|450817769|FG004|Overall Study|Protocol Violation|0|||
125323701|NCT00360230|450817770|FG005|Overall Study|Protocol Violation|1|||
125323702|NCT00360230|450817771|FG006|Overall Study|Protocol Violation|0|||
125323703|NCT00360230|450817765|FG000|Overall Study|Death|0|||
125323704|NCT00360230|450817766|FG001|Overall Study|Death|1|||
125323705|NCT00360230|450817767|FG002|Overall Study|Death|0|||
125323706|NCT00360230|450817768|FG003|Overall Study|Death|0|||
125323707|NCT00360230|450817769|FG004|Overall Study|Death|0|||
125323708|NCT00360230|450817770|FG005|Overall Study|Death|1|||
125323709|NCT00360230|450817771|FG006|Overall Study|Death|1|||
125323710|NCT00581308|450817772|FG000|Pre Discharge|Lost to Follow-up|1|||
125323711|NCT00581308|450817772|FG000|Pre Discharge|Device Removed|1|||
125323712|NCT00581308|450817772|FG000|Month 1|Lost to Follow-up|3|||
125323713|NCT00581308|450817772|FG000|Month 1|Withdrawal by Subject|2|||
125323714|NCT00581308|450817772|FG000|Month 1|Device Removed|2|||
125323715|NCT00581308|450817772|FG000|Month 1|Uknown|1|||
125323716|NCT00581308|450817772|FG000|Month 6|Lost to Follow-up|1|||
125323717|NCT00581308|450817772|FG000|Month 6|Withdrawal by Subject|2|||
125323718|NCT00581308|450817772|FG000|Month 12|Death|1|||
125323719|NCT00581308|450817772|FG000|Month 12|Lost to Follow-up|14|||
125323720|NCT00581308|450817772|FG000|Month 12|Withdrawal by Subject|3|||
125323721|NCT00581308|450817772|FG000|Month 12|Device Removed|1|||
125323722|NCT00581308|450817772|FG000|Month 12|Other|1|||
125323723|NCT00886379|450817773|FG000|Overall Study|Transferred Schools|0|||
125323724|NCT00886379|450817774|FG001|Overall Study|Transferred Schools|0|||
125323725|NCT00886379|450817775|FG002|Overall Study|Transferred Schools|2|||
125323726|NCT00886379|450817776|FG003|Overall Study|Transferred Schools|1|||
125323727|NCT00886379|450817777|FG004|Overall Study|Transferred Schools|1|||
125323728|NCT00886379|450817773|FG000|Overall Study|Final blood draw not obtained|3|||
125323729|NCT00886379|450817774|FG001|Overall Study|Final blood draw not obtained|3|||
125323730|NCT00886379|450817775|FG002|Overall Study|Final blood draw not obtained|4|||
125323731|NCT00886379|450817776|FG003|Overall Study|Final blood draw not obtained|2|||
125323732|NCT00886379|450817777|FG004|Overall Study|Final blood draw not obtained|2|||
125323733|NCT04558125|450817778|FG000|Overall Study|Death|1|||
125323734|NCT01614886|450817779|FG000|Overall Study|Adverse Event|15|||
125323735|NCT01614886|450817780|FG001|Overall Study|Adverse Event|20|||
125323736|NCT01614886|450817779|FG000|Overall Study|Withdrawal by Subject|4|||
125323737|NCT01614886|450817780|FG001|Overall Study|Withdrawal by Subject|4|||
125323738|NCT01614886|450817779|FG000|Overall Study|Death|1|||
125323739|NCT01614886|450817780|FG001|Overall Study|Death|0|||
125323740|NCT01614886|450817779|FG000|Overall Study|Protocol deviation|0|||
125323741|NCT01614886|450817780|FG001|Overall Study|Protocol deviation|2|||
125323742|NCT01207414|450817782|FG000|Overall Study|Adverse Event|25|||
125323743|NCT01207414|450817783|FG001|Overall Study|Adverse Event|39|||
125323744|NCT01207414|450817782|FG000|Overall Study|Abnormal test procedure results|0|||
125323745|NCT01207414|450817783|FG001|Overall Study|Abnormal test procedure results|1|||
125323746|NCT01207414|450817782|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
125323747|NCT01207414|450817783|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
125323748|NCT01207414|450817782|FG000|Overall Study|Patient withdrew consent|14|||
125323749|NCT01207414|450817783|FG001|Overall Study|Patient withdrew consent|11|||
125323750|NCT01207414|450817782|FG000|Overall Study|Lost to Follow-up|15|||
125323751|NCT01207414|450817783|FG001|Overall Study|Lost to Follow-up|17|||
125323752|NCT01207414|450817782|FG000|Overall Study|Administrative problems|1|||
125323753|NCT01207414|450817783|FG001|Overall Study|Administrative problems|1|||
125323754|NCT01207414|450817782|FG000|Overall Study|Protocol deviation|12|||
125323755|NCT01207414|450817783|FG001|Overall Study|Protocol deviation|9|||
125323756|NCT01207414|450817782|FG000|Overall Study|Randomized in error|1|||
125323757|NCT01207414|450817783|FG001|Overall Study|Randomized in error|0|||
125323758|NCT01527370|450817784|FG000|Overall Study|Withdrawal by Subject|4|||
125323759|NCT01527370|450817784|FG000|Overall Study|Physician Decision|1|||
125323760|NCT01527370|450817784|FG000|Overall Study|Death|1|||
125323761|NCT01748292|450817787|FG000|Overall Study|Adverse Event|2|||
125323762|NCT01748292|450817788|FG001|Overall Study|Adverse Event|4|||
125323763|NCT01748292|450817787|FG000|Overall Study|Lost to Follow-up|0|||
125323764|NCT01748292|450817788|FG001|Overall Study|Lost to Follow-up|3|||
125323765|NCT01748292|450817787|FG000|Overall Study|Death|0|||
125323766|NCT01748292|450817788|FG001|Overall Study|Death|3|||
125323767|NCT01748292|450817787|FG000|Overall Study|Withdrawal by Subject|0|||
125323768|NCT01748292|450817788|FG001|Overall Study|Withdrawal by Subject|2|||
125323769|NCT02224560|450817789|FG000|Overall Study|Protocol Deviation|1|||
125323770|NCT02224560|450817790|FG001|Overall Study|Protocol Deviation|0|||
125323771|NCT02224560|450817791|FG002|Overall Study|Protocol Deviation|0|||
125323772|NCT02224560|450817789|FG000|Overall Study|Withdrawal by Subject|2|||
125323773|NCT02224560|450817790|FG001|Overall Study|Withdrawal by Subject|0|||
125323774|NCT02224560|450817791|FG002|Overall Study|Withdrawal by Subject|1|||
125323775|NCT02224560|450817789|FG000|Overall Study|Met Withdrawal Criteria|1|||
125323776|NCT02224560|450817790|FG001|Overall Study|Met Withdrawal Criteria|0|||
125323777|NCT02224560|450817791|FG002|Overall Study|Met Withdrawal Criteria|0|||
125323778|NCT02224560|450817789|FG000|Overall Study|Adverse Event|4|||
125323779|NCT02224560|450817790|FG001|Overall Study|Adverse Event|1|||
125323780|NCT02224560|450817791|FG002|Overall Study|Adverse Event|1|||
125323781|NCT02224560|450817789|FG000|Overall Study|Withdrawn by Investigator|1|||
125323782|NCT02224560|450817790|FG001|Overall Study|Withdrawn by Investigator|1|||
125323783|NCT02224560|450817791|FG002|Overall Study|Withdrawn by Investigator|0|||
125323784|NCT02340026|450817794|FG000|Treatment Phase|Withdrawal by Subject|2|||
125323785|NCT02340026|450817795|FG001|Treatment Phase|Withdrawal by Subject|2|||
125323786|NCT02340026|450817794|FG000|Follow-up Phase|Lost to Follow-up|1|||
125323787|NCT02340026|450817795|FG001|Follow-up Phase|Lost to Follow-up|0|||
125323788|NCT02738801|450817808|FG000|Overall Study|Adverse Event|1|||
125323789|NCT02738801|450817809|FG001|Overall Study|Adverse Event|1|||
125323790|NCT02738801|450817808|FG000|Overall Study|Withdrawal by Subject|0|||
125323791|NCT02738801|450817809|FG001|Overall Study|Withdrawal by Subject|1|||
125323792|NCT03279081|450817810|FG000|Overall Study|Withdrawal by Subject|12|||
125323793|NCT03279081|450817811|FG001|Overall Study|Withdrawal by Subject|20|||
125323794|NCT03279081|450817810|FG000|Overall Study|Physician Decision|4|||
125323795|NCT03279081|450817811|FG001|Overall Study|Physician Decision|1|||
125323796|NCT03279081|450817810|FG000|Overall Study|Lost to Follow-up|8|||
125323797|NCT03279081|450817811|FG001|Overall Study|Lost to Follow-up|8|||
125323798|NCT03279081|450817810|FG000|Overall Study|Death|0|||
125323799|NCT03279081|450817811|FG001|Overall Study|Death|1|||
125323800|NCT03279081|450817810|FG000|Overall Study|Adverse Event|1|||
125323801|NCT03279081|450817811|FG001|Overall Study|Adverse Event|0|||
125323802|NCT03279081|450817810|FG000|Overall Study|Reason not Specified|14|||
125323803|NCT03279081|450817811|FG001|Overall Study|Reason not Specified|4|||
125323804|NCT01210313|450817820|FG000|Overall Study|Withdrawal by Subject|3|||
125323805|NCT01210313|450817820|FG000|Overall Study|Adverse Event|2|||
125323806|NCT01210313|450817820|FG000|Overall Study|Distant recurrence|4|||
125323807|NCT01210313|450817820|FG000|Overall Study|Non-compliance|7|||
125323808|NCT01710345|450817821|FG000|Overall Study|Adverse Event|0|||
125323809|NCT01710345|450817822|FG001|Overall Study|Adverse Event|2|||
125662863|NCT00446134|452054084|FG001|Overall Study|Withdrawal by Subject|3|||
125662864|NCT00446134|452054085|FG002|Overall Study|Withdrawal by Subject|1|||
125662865|NCT00446134|452054086|FG003|Overall Study|Withdrawal by Subject|3|||
125662866|NCT00446134|452054083|FG000|Overall Study|Physician Decision|0|||
125662867|NCT00446134|452054084|FG001|Overall Study|Physician Decision|0|||
125662868|NCT00446134|452054085|FG002|Overall Study|Physician Decision|0|||
125662869|NCT00446134|452054086|FG003|Overall Study|Physician Decision|2|||
125662870|NCT00446134|452054083|FG000|Overall Study|Adverse Event-Diarrhea|1|||
125662871|NCT00446134|452054084|FG001|Overall Study|Adverse Event-Diarrhea|1|||
125662872|NCT00446134|452054085|FG002|Overall Study|Adverse Event-Diarrhea|2|||
125662873|NCT00446134|452054086|FG003|Overall Study|Adverse Event-Diarrhea|0|||
125323810|NCT01710345|450817823|FG002|Overall Study|Adverse Event|0|||
125662874|NCT00446134|452054083|FG000|Overall Study|Reason Not Completed|3|||
125662875|NCT00446134|452054084|FG001|Overall Study|Reason Not Completed|0|||
125323811|NCT01710345|450817821|FG000|Overall Study|Lack of Efficacy|2|||
125323812|NCT01710345|450817822|FG001|Overall Study|Lack of Efficacy|3|||
125323813|NCT01710345|450817823|FG002|Overall Study|Lack of Efficacy|1|||
125323814|NCT01710345|450817821|FG000|Overall Study|Drug Dosing Error|1|||
125323815|NCT01710345|450817822|FG001|Overall Study|Drug Dosing Error|0|||
125323816|NCT01710345|450817823|FG002|Overall Study|Drug Dosing Error|0|||
125323817|NCT01502293|450817826|FG000|Overall Study|Progressive Disease|20|||
125323818|NCT01502293|450817827|FG001|Overall Study|Progressive Disease|12|||
125323819|NCT01502293|450817828|FG002|Overall Study|Progressive Disease|2|||
125323820|NCT01502293|450817826|FG000|Overall Study|Withdrawal by Subject|3|||
125323821|NCT01502293|450817827|FG001|Overall Study|Withdrawal by Subject|3|||
125323822|NCT01502293|450817828|FG002|Overall Study|Withdrawal by Subject|1|||
125323823|NCT01502293|450817826|FG000|Overall Study|Adverse Event|0|||
125323824|NCT01502293|450817827|FG001|Overall Study|Adverse Event|2|||
125323825|NCT01502293|450817828|FG002|Overall Study|Adverse Event|0|||
125323826|NCT01502293|450817826|FG000|Overall Study|Reason Not Specified|2|||
125323827|NCT01502293|450817827|FG001|Overall Study|Reason Not Specified|0|||
125323828|NCT01502293|450817828|FG002|Overall Study|Reason Not Specified|0|||
125323829|NCT01502293|450817826|FG000|Overall Study|Physician Decision|0|||
125323830|NCT01502293|450817827|FG001|Overall Study|Physician Decision|0|||
125323831|NCT01502293|450817828|FG002|Overall Study|Physician Decision|1|||
125323832|NCT00107653|450817838|FG000|Overall Study|Adverse Event|24|||
125323833|NCT00107653|450817839|FG001|Overall Study|Adverse Event|43|||
125323834|NCT00107653|450817838|FG000|Overall Study|Insufficient Therapeutic Response|25|||
125323835|NCT00107653|450817839|FG001|Overall Study|Insufficient Therapeutic Response|11|||
125323836|NCT00107653|450817838|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
125323837|NCT00107653|450817839|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
125323838|NCT00107653|450817838|FG000|Overall Study|Protocol Violation|1|||
125323839|NCT00107653|450817839|FG001|Overall Study|Protocol Violation|0|||
125323840|NCT00107653|450817838|FG000|Overall Study|Withdrawal by Subject|12|||
125323841|NCT00107653|450817839|FG001|Overall Study|Withdrawal by Subject|13|||
125323842|NCT00107653|450817838|FG000|Overall Study|Lost to Follow-up|13|||
125323843|NCT00107653|450817839|FG001|Overall Study|Lost to Follow-up|5|||
125323844|NCT00107653|450817838|FG000|Overall Study|Administrative Reasons|3|||
125323845|NCT00107653|450817839|FG001|Overall Study|Administrative Reasons|3|||
125323846|NCT01838395|450817840|FG000|Overall Study|Withdrawal by Subject|0|||
125323847|NCT01838395|450817841|FG001|Overall Study|Withdrawal by Subject|0|||
125323848|NCT01838395|450817842|FG002|Overall Study|Withdrawal by Subject|0|||
125323849|NCT01838395|450817843|FG003|Overall Study|Withdrawal by Subject|0|||
125323850|NCT01838395|450817844|FG004|Overall Study|Withdrawal by Subject|1|||
125323851|NCT01838395|450817845|FG005|Overall Study|Withdrawal by Subject|0|||
125323852|NCT01838395|450817840|FG000|Overall Study|Death|0|||
125323853|NCT01838395|450817841|FG001|Overall Study|Death|0|||
125323854|NCT01838395|450817842|FG002|Overall Study|Death|1|||
125323855|NCT01838395|450817843|FG003|Overall Study|Death|0|||
125323856|NCT01838395|450817844|FG004|Overall Study|Death|0|||
125323857|NCT01838395|450817845|FG005|Overall Study|Death|0|||
125323858|NCT01838395|450817840|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125323859|NCT01838395|450817841|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
125323860|NCT01838395|450817842|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125323861|NCT01838395|450817843|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125323862|NCT01838395|450817844|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125323863|NCT01838395|450817845|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
125323864|NCT03694353|450817847|FG000|Overall Study|Withdrawal by Subject|1|||
125323865|NCT03694353|450817847|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
125323866|NCT00651742|450817848|FG000|Overall Study|Objective Disease Progression|22|||
125323867|NCT00651742|450817848|FG000|Overall Study|Toxicity|3|||
125323868|NCT00651742|450817848|FG000|Overall Study|Investigator Judgment|1|||
125323869|NCT00651742|450817848|FG000|Overall Study|Withdrawal of Consent|1|||
125323870|NCT00651742|450817848|FG000|Overall Study|Enrolled but not treated|1|||
125323871|NCT01535040|450817849|FG000|Overall Study|Physician Decision|0|||
125323872|NCT01535040|450817850|FG001|Overall Study|Physician Decision|1|||
125323873|NCT01535040|450817849|FG000|Overall Study|Withdrawal by Subject|13|||
125323874|NCT01535040|450817850|FG001|Overall Study|Withdrawal by Subject|10|||
125323875|NCT01535040|450817849|FG000|Overall Study|Never Started|9|||
125323876|NCT01535040|450817850|FG001|Overall Study|Never Started|4|||
125323877|NCT01535040|450817849|FG000|Overall Study|Toxicity|7|||
125323878|NCT01535040|450817850|FG001|Overall Study|Toxicity|5|||
125323879|NCT01535040|450817849|FG000|Overall Study|Multiple Reasons|1|||
125323880|NCT01535040|450817850|FG001|Overall Study|Multiple Reasons|1|||
125662876|NCT00446134|452054085|FG002|Overall Study|Reason Not Completed|1|||
125662877|NCT00446134|452054086|FG003|Overall Study|Reason Not Completed|2|||
125662878|NCT00743119|452054087|FG000|Overall Study|unreliable|3|||
125662879|NCT00743119|452054087|FG000|Overall Study|Withdrawal by Subject|1|||
125662880|NCT04816877|452054088|FG000|Overall Study|Withdrawal by Subject|1|||
125662881|NCT04816877|452054089|FG001|Overall Study|Withdrawal by Subject|0|||
125662882|NCT00295620|452054091|FG000|Overall Study|Lost to Follow-up|9|||
125323881|NCT05430854|450817851|FG000|Overall Study|Trial terminated by Sponsor|39|||
125323882|NCT05430854|450817852|FG001|Overall Study|Trial terminated by Sponsor|50|||
125323883|NCT05430854|450817853|FG002|Overall Study|Trial terminated by Sponsor|46|||
125323884|NCT05430854|450817851|FG000|Overall Study|Withdrawal by Subject|0|||
125323885|NCT05430854|450817852|FG001|Overall Study|Withdrawal by Subject|3|||
125323886|NCT05430854|450817853|FG002|Overall Study|Withdrawal by Subject|0|||
125323887|NCT04314284|450817854|FG000|Overall Study|Withdrawal by Subject|4|||
125323888|NCT04314284|450817855|FG001|Overall Study|Withdrawal by Subject|7|||
125323889|NCT04314284|450817854|FG000|Overall Study|Consented but did not complete survey|0|||
125323890|NCT04314284|450817855|FG001|Overall Study|Consented but did not complete survey|6|||
125323891|NCT01652235|450817856|FG000|Overall Study|Death|9|||
125323892|NCT01652235|450817856|FG000|Overall Study|Lost to Follow-up|5|||
125323893|NCT01652235|450817856|FG000|Overall Study|Withdrawal by Subject|2|||
125323894|NCT02023086|450817857|FG000|Overall Study|Withdrawal by Subject|2|||
125323895|NCT02023086|450817858|FG001|Overall Study|Withdrawal by Subject|0|||
125323896|NCT02608684|450819405|FG000|Overall Study|Physician Decision|2|||
125323897|NCT02608684|450819405|FG000|Overall Study|Withdrawal by Subject|1|||
125323898|NCT00755183|450819407|FG000|Overall Study|Adverse Event|5|||
125323899|NCT00755183|450819408|FG001|Overall Study|Adverse Event|2|||
125323900|NCT00755183|450819407|FG000|Overall Study|Protocol Violation|0|||
125323901|NCT00755183|450819408|FG001|Overall Study|Protocol Violation|1|||
125323902|NCT00755183|450819407|FG000|Overall Study|Withdrawal by Subject|0|||
125323903|NCT00755183|450819408|FG001|Overall Study|Withdrawal by Subject|2|||
125323904|NCT00755183|450819407|FG000|Overall Study|Administrative|2|||
125323905|NCT00755183|450819408|FG001|Overall Study|Administrative|1|||
125323906|NCT00148317|450819409|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
125323907|NCT00148317|450819409|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
125323908|NCT00148317|450819409|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
125323909|NCT00124943|450819410|FG000|Phase II|Adverse Event|0|||
125323910|NCT00124943|450819411|FG001|Phase II|Adverse Event|2|||
125323911|NCT00124943|450819412|FG002|Phase II|Adverse Event|0|||
125323912|NCT00124943|450819413|FG003|Phase II|Adverse Event|1|||
125323913|NCT00124943|450819410|FG000|Phase II|Protocol Violation|0|||
125323914|NCT00124943|450819411|FG001|Phase II|Protocol Violation|0|||
125323915|NCT00124943|450819412|FG002|Phase II|Protocol Violation|0|||
125323916|NCT00124943|450819413|FG003|Phase II|Protocol Violation|1|||
125323917|NCT00124943|450819410|FG000|Phase II|Lost to Follow-up|0|||
125323918|NCT00124943|450819411|FG001|Phase II|Lost to Follow-up|0|||
125323919|NCT00124943|450819412|FG002|Phase II|Lost to Follow-up|0|||
125323920|NCT00124943|450819413|FG003|Phase II|Lost to Follow-up|1|||
125323921|NCT00124943|450819410|FG000|Phase II|Withdrawal by Subject|0|||
125323922|NCT00124943|450819411|FG001|Phase II|Withdrawal by Subject|0|||
125323923|NCT00124943|450819412|FG002|Phase II|Withdrawal by Subject|0|||
125323924|NCT00124943|450819413|FG003|Phase II|Withdrawal by Subject|2|||
125323925|NCT02939287|450819415|FG000|Overall Study|met exclusion criteria|1|||
125323926|NCT02939287|450819416|FG001|Overall Study|met exclusion criteria|1|||
125323927|NCT02939287|450819417|FG002|Overall Study|met exclusion criteria|1|||
125323928|NCT02939287|450819415|FG000|Overall Study|Did not complete survey|2|||
125323929|NCT02939287|450819416|FG001|Overall Study|Did not complete survey|2|||
125323930|NCT02939287|450819417|FG002|Overall Study|Did not complete survey|0|||
125323931|NCT02939287|450819415|FG000|Overall Study|Withdrawal by Subject|1|||
125323932|NCT02939287|450819416|FG001|Overall Study|Withdrawal by Subject|1|||
125323933|NCT02939287|450819417|FG002|Overall Study|Withdrawal by Subject|0|||
125323934|NCT02903771|450819418|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
125323935|NCT02903771|450819419|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
125323936|NCT02903771|450819420|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
125323937|NCT02903771|450819421|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
125323938|NCT02903771|450819422|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
125323939|NCT02903771|450819423|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
125323940|NCT02903771|450819424|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
125323941|NCT02903771|450819418|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
125323942|NCT02903771|450819419|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
125323943|NCT02903771|450819420|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
125323944|NCT02903771|450819421|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
125323945|NCT02903771|450819422|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
125323946|NCT02903771|450819423|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
125323947|NCT02903771|450819424|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
125323948|NCT02903771|450819418|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125323949|NCT02903771|450819419|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125323950|NCT02903771|450819420|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
125323951|NCT02903771|450819421|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125323952|NCT02903771|450819422|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125323953|NCT02903771|450819423|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
125323954|NCT02903771|450819424|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
125323955|NCT02903771|450819418|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125323956|NCT02903771|450819419|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125323957|NCT02903771|450819420|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125323958|NCT02903771|450819421|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125323959|NCT02903771|450819422|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
125323960|NCT02903771|450819423|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125662883|NCT00295620|452054092|FG001|Overall Study|Lost to Follow-up|5|||
125323961|NCT02903771|450819424|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
125323962|NCT02903771|450819418|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
125323963|NCT02903771|450819419|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
125323964|NCT02903771|450819420|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
125323965|NCT02903771|450819421|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
125323966|NCT02903771|450819422|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
125323967|NCT02903771|450819423|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
125323968|NCT02903771|450819424|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
125323969|NCT02903771|450819418|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125323970|NCT02903771|450819419|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125323971|NCT02903771|450819420|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125323972|NCT02903771|450819421|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125323973|NCT02903771|450819422|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
125323974|NCT02903771|450819423|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125662884|NCT00295620|452054091|FG000|Overall Study|Withdrawal by Subject|37|||
125323975|NCT02903771|450819424|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
125323976|NCT02903771|450819418|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125323977|NCT02903771|450819419|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125323978|NCT02903771|450819420|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125323979|NCT02903771|450819421|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125323980|NCT02903771|450819422|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
125662885|NCT00295620|452054092|FG001|Overall Study|Withdrawal by Subject|50|||
125662886|NCT00295620|452054091|FG000|Overall Study|Death|206|||
125662887|NCT00295620|452054092|FG001|Overall Study|Death|207|||
125662888|NCT00295620|452054091|FG000|Overall Study|Other reasons|10|||
125662889|NCT00295620|452054092|FG001|Overall Study|Other reasons|9|||
125662890|NCT00295620|452054091|FG000|Overall Study|Discontinuation by sponsor|580|||
125662891|NCT00295620|452054092|FG001|Overall Study|Discontinuation by sponsor|593|||
125662892|NCT00295620|452054091|FG000|Overall Study|Protocol Violation|30|||
125662893|NCT00295620|452054092|FG001|Overall Study|Protocol Violation|32|||
125662894|NCT01309828|452054093|FG000|Overall Study|Adverse Event|10|||
125662895|NCT01309828|452054094|FG001|Overall Study|Adverse Event|11|||
125662896|NCT01309828|452054093|FG000|Overall Study|Voluntary Withdrawal|5|||
125662897|NCT01309828|452054094|FG001|Overall Study|Voluntary Withdrawal|4|||
125662898|NCT01309828|452054093|FG000|Overall Study|Major Protocol Deviation|0|||
125662899|NCT01309828|452054094|FG001|Overall Study|Major Protocol Deviation|1|||
125662900|NCT01309828|452054093|FG000|Overall Study|Other|1|||
125662901|NCT01309828|452054094|FG001|Overall Study|Other|0|||
125662902|NCT02556632|452054097|FG000|Overall Study|Lost to Follow-up|1|||
125662903|NCT02556632|452054098|FG001|Overall Study|Lost to Follow-up|0|||
125662904|NCT02556632|452054099|FG002|Overall Study|Lost to Follow-up|0|||
125662905|NCT02556632|452054097|FG000|Overall Study|Disliked Intervention|1|||
125662906|NCT02556632|452054098|FG001|Overall Study|Disliked Intervention|1|||
125662907|NCT02556632|452054099|FG002|Overall Study|Disliked Intervention|1|||
125662908|NCT02556632|452054097|FG000|Overall Study|No Reason|1|||
125662909|NCT02556632|452054098|FG001|Overall Study|No Reason|0|||
125662910|NCT02556632|452054099|FG002|Overall Study|No Reason|1|||
125662911|NCT02556632|452054097|FG000|Overall Study|Personal Issues|0|||
125662912|NCT02556632|452054098|FG001|Overall Study|Personal Issues|1|||
125662913|NCT02556632|452054099|FG002|Overall Study|Personal Issues|1|||
125662914|NCT02556632|452054097|FG000|Overall Study|Changed Mind|0|||
125662915|NCT02556632|452054098|FG001|Overall Study|Changed Mind|1|||
125662916|NCT02556632|452054099|FG002|Overall Study|Changed Mind|0|||
125662917|NCT02556632|452054097|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
125662918|NCT02556632|452054098|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
125662919|NCT02556632|452054099|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
125662920|NCT02556632|452054097|FG000|Overall Study|Unrelated Adverse Event|1|||
125662921|NCT02556632|452054098|FG001|Overall Study|Unrelated Adverse Event|0|||
125662922|NCT02556632|452054099|FG002|Overall Study|Unrelated Adverse Event|3|||
125662923|NCT02556632|452054097|FG000|Overall Study|Related Adverse Event|0|||
125662924|NCT02556632|452054098|FG001|Overall Study|Related Adverse Event|1|||
125662925|NCT02556632|452054099|FG002|Overall Study|Related Adverse Event|0|||
125662926|NCT02556632|452054097|FG000|Overall Study|Possibly Related Adverse Event|0|||
125662927|NCT02556632|452054098|FG001|Overall Study|Possibly Related Adverse Event|0|||
125662928|NCT02556632|452054099|FG002|Overall Study|Possibly Related Adverse Event|1|||
125662929|NCT02556632|452054097|FG000|Overall Study|Did Not Start RT|0|||
125662930|NCT02556632|452054098|FG001|Overall Study|Did Not Start RT|1|||
125662931|NCT02556632|452054099|FG002|Overall Study|Did Not Start RT|0|||
125662932|NCT02556632|452054097|FG000|Overall Study|Ineligible|0|||
125662933|NCT02556632|452054098|FG001|Overall Study|Ineligible|1|||
125662934|NCT02556632|452054099|FG002|Overall Study|Ineligible|0|||
125662935|NCT02556632|452054097|FG000|Overall Study|Disliked Study Procedures|0|||
125662936|NCT02556632|452054098|FG001|Overall Study|Disliked Study Procedures|0|||
125662937|NCT02556632|452054099|FG002|Overall Study|Disliked Study Procedures|1|||
125662938|NCT02556632|452054097|FG000|Overall Study|Treatment or Change Delay|0|||
125662939|NCT02556632|452054098|FG001|Overall Study|Treatment or Change Delay|0|||
125662940|NCT02556632|452054099|FG002|Overall Study|Treatment or Change Delay|1|||
125662941|NCT02574260|452054104|FG000|Overall Study|Disease Progression|1|||
125662942|NCT04523831|452054110|FG000|Overall Study|Lost to Follow-up|15|||
125662943|NCT04523831|452054111|FG001|Overall Study|Lost to Follow-up|17|||
125662944|NCT04523831|452054110|FG000|Overall Study|Death|0|||
125662945|NCT04523831|452054111|FG001|Overall Study|Death|3|||
125662946|NCT04523831|452054110|FG000|Overall Study|Adverse Event|2|||
125662947|NCT04523831|452054111|FG001|Overall Study|Adverse Event|0|||
125662948|NCT02367781|452054116|FG000|Overall Study|Withdrawal by Subject|20|||
125662949|NCT02367781|452054117|FG001|Overall Study|Withdrawal by Subject|13|||
125662950|NCT02367781|452054116|FG000|Overall Study|Protocol Violation|0|||
125662951|NCT02367781|452054117|FG001|Overall Study|Protocol Violation|1|||
125323981|NCT02903771|450819423|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125323982|NCT02903771|450819424|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
125323983|NCT02903771|450819418|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125323984|NCT02903771|450819419|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125323985|NCT02903771|450819420|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125323986|NCT02903771|450819421|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125323987|NCT02903771|450819422|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
125323988|NCT02903771|450819423|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125323989|NCT02903771|450819424|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
125323990|NCT02903771|450819418|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125323991|NCT02903771|450819419|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125323992|NCT02903771|450819420|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125323993|NCT02903771|450819421|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125323994|NCT02903771|450819422|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
125323995|NCT02903771|450819423|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125323996|NCT02903771|450819424|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
125323997|NCT02903771|450819418|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125323998|NCT02903771|450819419|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125323999|NCT02903771|450819420|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125324000|NCT02903771|450819421|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125324001|NCT02903771|450819422|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
125324002|NCT02903771|450819423|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125324003|NCT02903771|450819424|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
125324004|NCT02903771|450819418|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125324005|NCT02903771|450819419|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125324006|NCT02903771|450819420|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125324007|NCT02903771|450819421|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125324008|NCT02903771|450819422|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
125324009|NCT02903771|450819423|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125324010|NCT02903771|450819424|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
125324011|NCT01435382|450819432|FG000|Overall Study|Lost to Follow-up|1|||
125324012|NCT01435382|450819433|FG001|Overall Study|Lost to Follow-up|0|||
125324013|NCT01435382|450819434|FG002|Overall Study|Lost to Follow-up|1|||
125324014|NCT01435382|450819435|FG003|Overall Study|Lost to Follow-up|0|||
125324015|NCT01435382|450819432|FG000|Overall Study|Withdrawal by Subject|0|||
125324016|NCT01435382|450819433|FG001|Overall Study|Withdrawal by Subject|2|||
125324017|NCT01435382|450819434|FG002|Overall Study|Withdrawal by Subject|0|||
125324018|NCT01435382|450819435|FG003|Overall Study|Withdrawal by Subject|1|||
125324019|NCT00910650|450819436|FG000|Overall Study|Death|2|||
125324020|NCT03367793|450819437|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125324021|NCT03367793|450819438|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125324022|NCT03367793|450819439|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
125324023|NCT03367793|450819440|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125324024|NCT03367793|450819441|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125324025|NCT03367793|450819442|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
125324026|NCT02435992|450819443|FG000|Overall Study|non compliance with protocol|2|||
125324027|NCT02435992|450819444|FG001|Overall Study|non compliance with protocol|0|||
125662952|NCT02367781|452054116|FG000|Overall Study|Physician Decision|7|||
125662953|NCT02367781|452054117|FG001|Overall Study|Physician Decision|0|||
125662954|NCT02367781|452054116|FG000|Overall Study|Randomized in Error|5|||
125662955|NCT02367781|452054117|FG001|Overall Study|Randomized in Error|4|||
125662956|NCT02367781|452054116|FG000|Overall Study|Non-Compliance|1|||
125662957|NCT02367781|452054117|FG001|Overall Study|Non-Compliance|0|||
125662958|NCT02367781|452054116|FG000|Overall Study|Lost to Follow-up|1|||
125662959|NCT02367781|452054117|FG001|Overall Study|Lost to Follow-up|2|||
125662960|NCT02367781|452054116|FG000|Overall Study|Death|330|||
125662961|NCT02367781|452054117|FG001|Overall Study|Death|176|||
125662962|NCT02367781|452054116|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
125324028|NCT02435992|450819445|FG002|Overall Study|non compliance with protocol|1|||
125324029|NCT02435992|450819446|FG003|Overall Study|non compliance with protocol|0|||
125324030|NCT02435992|450819447|FG004|Overall Study|non compliance with protocol|0|||
125324031|NCT02435992|450819443|FG000|Overall Study|Adverse Event|11|||
125324032|NCT02435992|450819444|FG001|Overall Study|Adverse Event|6|||
125324033|NCT02435992|450819445|FG002|Overall Study|Adverse Event|12|||
125324034|NCT02435992|450819446|FG003|Overall Study|Adverse Event|0|||
125324035|NCT02435992|450819447|FG004|Overall Study|Adverse Event|0|||
125324036|NCT02435992|450819443|FG000|Overall Study|Lack of Efficacy|4|||
125324037|NCT02435992|450819444|FG001|Overall Study|Lack of Efficacy|10|||
125324038|NCT02435992|450819445|FG002|Overall Study|Lack of Efficacy|9|||
125324039|NCT02435992|450819446|FG003|Overall Study|Lack of Efficacy|0|||
125324040|NCT02435992|450819447|FG004|Overall Study|Lack of Efficacy|0|||
125324041|NCT02435992|450819443|FG000|Overall Study|Withdrawal by Subject|10|||
125324042|NCT02435992|450819444|FG001|Overall Study|Withdrawal by Subject|8|||
125324043|NCT02435992|450819445|FG002|Overall Study|Withdrawal by Subject|20|||
125324044|NCT02435992|450819446|FG003|Overall Study|Withdrawal by Subject|0|||
125324045|NCT02435992|450819447|FG004|Overall Study|Withdrawal by Subject|0|||
125324046|NCT02435992|450819443|FG000|Overall Study|Other Reason|1|||
125324047|NCT02435992|450819444|FG001|Overall Study|Other Reason|0|||
125324048|NCT02435992|450819445|FG002|Overall Study|Other Reason|0|||
125324049|NCT02435992|450819446|FG003|Overall Study|Other Reason|0|||
125324050|NCT02435992|450819447|FG004|Overall Study|Other Reason|0|||
125324051|NCT02435992|450819443|FG000|Overall Study|Physician Decision|0|||
125324052|NCT02435992|450819444|FG001|Overall Study|Physician Decision|0|||
125324053|NCT02435992|450819445|FG002|Overall Study|Physician Decision|1|||
125324054|NCT02435992|450819446|FG003|Overall Study|Physician Decision|0|||
125324055|NCT02435992|450819447|FG004|Overall Study|Physician Decision|0|||
125324056|NCT00260533|450819448|FG000|Overall Study|Other|3|||
125324057|NCT00260533|450819449|FG001|Overall Study|Other|3|||
125324058|NCT01761877|450819450|FG000|Overall Study|Adverse Event|7|||
125324059|NCT01761877|450819451|FG001|Overall Study|Adverse Event|0|||
125324060|NCT01761877|450819450|FG000|Overall Study|Withdrawal by Subject|6|||
125324061|NCT01761877|450819451|FG001|Overall Study|Withdrawal by Subject|4|||
125324062|NCT01761877|450819450|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
125324063|NCT01761877|450819451|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
125324064|NCT01761877|450819450|FG000|Overall Study|Death|0|||
125324065|NCT01761877|450819451|FG001|Overall Study|Death|1|||
125324066|NCT01761877|450819450|FG000|Overall Study|MRI intolerant|1|||
125324067|NCT01761877|450819451|FG001|Overall Study|MRI intolerant|6|||
125324068|NCT01310777|450819453|FG000|Overall Study|Adverse Event|23|||
125324069|NCT01310777|450819454|FG001|Overall Study|Adverse Event|1|||
125324070|NCT01310777|450819455|FG002|Overall Study|Adverse Event|15|||
125324071|NCT01310777|450819453|FG000|Overall Study|Lost to Follow-up|0|||
125324072|NCT01310777|450819454|FG001|Overall Study|Lost to Follow-up|4|||
125324073|NCT01310777|450819455|FG002|Overall Study|Lost to Follow-up|1|||
125324074|NCT01310777|450819453|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
125324075|NCT01310777|450819454|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
125324076|NCT01310777|450819455|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
125324077|NCT01310777|450819453|FG000|Overall Study|Inadequate Control of IOP|5|||
125324078|NCT01310777|450819454|FG001|Overall Study|Inadequate Control of IOP|7|||
125324079|NCT01310777|450819455|FG002|Overall Study|Inadequate Control of IOP|10|||
125324080|NCT01310777|450819453|FG000|Overall Study|Other|4|||
125324081|NCT01310777|450819454|FG001|Overall Study|Other|1|||
125324082|NCT01310777|450819455|FG002|Overall Study|Other|2|||
125324083|NCT03697252|450819456|FG000|Overall Study|Adverse Event|3|||
125324084|NCT03697252|450819457|FG001|Overall Study|Adverse Event|2|||
125324085|NCT03697252|450819456|FG000|Overall Study|Withdrawal by Subject|14|||
125324086|NCT03697252|450819457|FG001|Overall Study|Withdrawal by Subject|14|||
125324087|NCT03697252|450819456|FG000|Overall Study|Lost to Follow-up|0|||
125324088|NCT03697252|450819457|FG001|Overall Study|Lost to Follow-up|1|||
125324089|NCT03697252|450819456|FG000|Overall Study|Physician Decision|1|||
125324090|NCT03697252|450819457|FG001|Overall Study|Physician Decision|1|||
125324091|NCT03697252|450819456|FG000|Overall Study|Other|0|||
125324092|NCT03697252|450819457|FG001|Overall Study|Other|1|||
125324093|NCT02383576|450819458|FG000|Overall Study|Death|53|||
125324094|NCT02383576|450819459|FG001|Overall Study|Death|33|||
125324095|NCT02383576|450819458|FG000|Overall Study|Lost to Follow-up|7|||
125324096|NCT02383576|450819459|FG001|Overall Study|Lost to Follow-up|1|||
125324097|NCT02383576|450819458|FG000|Overall Study|Withdrew Consent|1|||
125324098|NCT02383576|450819459|FG001|Overall Study|Withdrew Consent|6|||
125324099|NCT02383576|450819458|FG000|Overall Study|Investigator's Decision|0|||
125324100|NCT02383576|450819459|FG001|Overall Study|Investigator's Decision|1|||
125324101|NCT02383576|450819458|FG000|Overall Study|Administrative/Other|2|||
125324102|NCT02383576|450819459|FG001|Overall Study|Administrative/Other|4|||
125324103|NCT04711850|450819460|FG000|Overall Study|Graft loss|2|||
125324104|NCT04711850|450819461|FG001|Overall Study|Graft loss|1|||
125324105|NCT04711850|450819460|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
125324106|NCT04711850|450819461|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
125662963|NCT02367781|452054117|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
125662964|NCT02367781|452054116|FG000|Overall Study|Prolonged Hospitalization|1|||
125662965|NCT02367781|452054117|FG001|Overall Study|Prolonged Hospitalization|0|||
125662966|NCT02367781|452054116|FG000|Overall Study|Death Prior First Dose|1|||
125662967|NCT02367781|452054117|FG001|Overall Study|Death Prior First Dose|0|||
125662968|NCT02367781|452054116|FG000|Overall Study|Administrative-Change Facility|1|||
125324107|NCT04711850|450819460|FG000|Overall Study|Study terminated by sponsor|5|||
125324108|NCT04711850|450819461|FG001|Overall Study|Study terminated by sponsor|3|||
125324109|NCT04711850|450819460|FG000|Overall Study|Sponsor decision|0|||
125324110|NCT04711850|450819461|FG001|Overall Study|Sponsor decision|2|||
125324111|NCT00774046|450819462|FG000|Screening|Not eligible|56|||
125324112|NCT00774046|450819462|FG000|Enrollment|Desired other therapy/refused|28|||
125324113|NCT00774046|450819462|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
125324114|NCT01353898|450819474|FG000|Overall Study|Study site terminated|0|||
125324115|NCT01353898|450819475|FG001|Overall Study|Study site terminated|0|||
125324116|NCT01353898|450819476|FG002|Overall Study|Study site terminated|0|||
125324117|NCT01353898|450819477|FG003|Overall Study|Study site terminated|0|||
125324118|NCT01353898|450819478|FG004|Overall Study|Study site terminated|0|||
125324119|NCT01353898|450819479|FG005|Overall Study|Study site terminated|1|||
125662969|NCT02367781|452054117|FG001|Overall Study|Administrative-Change Facility|0|||
125662970|NCT02367781|452054116|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
125662971|NCT02367781|452054117|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
125662972|NCT02367781|452054116|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
125662973|NCT02367781|452054117|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
125324120|NCT03558737|450819480|FG000|Overall Study|Death|1|||
125324121|NCT03558737|450819481|FG001|Overall Study|Death|1|||
125324122|NCT03041181|450819484|FG000|Overall Study|Disease Progression|1|||
125324123|NCT03041181|450819485|FG001|Overall Study|Disease Progression|2|||
125324124|NCT03050801|450819492|FG000|Experiment 1|Lost to Follow-up|0|||
125324125|NCT03050801|450819493|FG001|Experiment 1|Lost to Follow-up|1|||
125324126|NCT03050801|450819494|FG002|Experiment 1|Lost to Follow-up|0|||
125324127|NCT03050801|450819495|FG003|Experiment 1|Lost to Follow-up|0|||
125324128|NCT03050801|450819496|FG004|Experiment 1|Lost to Follow-up|0|||
125324129|NCT03050801|450819497|FG005|Experiment 1|Lost to Follow-up|0|||
125324130|NCT03050801|450819492|FG000|Experiment 1|Physician Decision|0|||
125324131|NCT03050801|450819493|FG001|Experiment 1|Physician Decision|3|||
125324132|NCT03050801|450819494|FG002|Experiment 1|Physician Decision|0|||
125324133|NCT03050801|450819495|FG003|Experiment 1|Physician Decision|0|||
125324134|NCT03050801|450819496|FG004|Experiment 1|Physician Decision|0|||
125324135|NCT03050801|450819497|FG005|Experiment 1|Physician Decision|0|||
125324136|NCT03050801|450819492|FG000|Experiment 1|Change of experimental design|0|||
125324137|NCT03050801|450819493|FG001|Experiment 1|Change of experimental design|3|||
125324138|NCT03050801|450819494|FG002|Experiment 1|Change of experimental design|0|||
125324139|NCT03050801|450819495|FG003|Experiment 1|Change of experimental design|0|||
125324140|NCT03050801|450819496|FG004|Experiment 1|Change of experimental design|0|||
125324141|NCT03050801|450819497|FG005|Experiment 1|Change of experimental design|0|||
125324142|NCT03050801|450819492|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
125324143|NCT03050801|450819493|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
125324144|NCT03050801|450819494|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
125324145|NCT03050801|450819495|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
125324146|NCT03050801|450819496|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
125324147|NCT03050801|450819497|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
125324148|NCT03050801|450819492|FG000|Experiment 2|Lost to Follow-up|0|||
125324149|NCT03050801|450819493|FG001|Experiment 2|Lost to Follow-up|0|||
125324150|NCT03050801|450819494|FG002|Experiment 2|Lost to Follow-up|0|||
125324151|NCT03050801|450819495|FG003|Experiment 2|Lost to Follow-up|1|||
125324152|NCT03050801|450819496|FG004|Experiment 2|Lost to Follow-up|1|||
125324153|NCT03050801|450819497|FG005|Experiment 2|Lost to Follow-up|0|||
125324154|NCT03050801|450819492|FG000|Experiment 2|Physician Decision|0|||
125324155|NCT03050801|450819493|FG001|Experiment 2|Physician Decision|0|||
125324156|NCT03050801|450819494|FG002|Experiment 2|Physician Decision|0|||
125324157|NCT03050801|450819495|FG003|Experiment 2|Physician Decision|0|||
125324158|NCT03050801|450819496|FG004|Experiment 2|Physician Decision|1|||
125324159|NCT03050801|450819497|FG005|Experiment 2|Physician Decision|0|||
125324160|NCT03050801|450819492|FG000|Experiment 2|Pregnancy|0|||
125324161|NCT03050801|450819493|FG001|Experiment 2|Pregnancy|0|||
125324162|NCT03050801|450819494|FG002|Experiment 2|Pregnancy|0|||
125324163|NCT03050801|450819495|FG003|Experiment 2|Pregnancy|0|||
125324164|NCT03050801|450819496|FG004|Experiment 2|Pregnancy|1|||
125324165|NCT03050801|450819497|FG005|Experiment 2|Pregnancy|0|||
125324166|NCT03050801|450819492|FG000|Experiment 2|Withdrawal by Subject|0|||
125324167|NCT03050801|450819493|FG001|Experiment 2|Withdrawal by Subject|0|||
125324168|NCT03050801|450819494|FG002|Experiment 2|Withdrawal by Subject|0|||
125324169|NCT03050801|450819495|FG003|Experiment 2|Withdrawal by Subject|1|||
125324170|NCT03050801|450819496|FG004|Experiment 2|Withdrawal by Subject|0|||
125324171|NCT03050801|450819497|FG005|Experiment 2|Withdrawal by Subject|0|||
125324172|NCT03050801|450819492|FG000|Experiment 2|Poor data quality|0|||
125324173|NCT03050801|450819493|FG001|Experiment 2|Poor data quality|0|||
125324174|NCT03050801|450819494|FG002|Experiment 2|Poor data quality|0|||
125324175|NCT03050801|450819495|FG003|Experiment 2|Poor data quality|4|||
125324176|NCT03050801|450819496|FG004|Experiment 2|Poor data quality|1|||
125324177|NCT03050801|450819497|FG005|Experiment 2|Poor data quality|0|||
125324178|NCT03050801|450819492|FG000|Experiment 2|Discomfort during stimulation|0|||
125324179|NCT03050801|450819493|FG001|Experiment 2|Discomfort during stimulation|0|||
125324180|NCT03050801|450819494|FG002|Experiment 2|Discomfort during stimulation|0|||
125324181|NCT03050801|450819495|FG003|Experiment 2|Discomfort during stimulation|0|||
125324182|NCT03050801|450819496|FG004|Experiment 2|Discomfort during stimulation|0|||
125324183|NCT03050801|450819497|FG005|Experiment 2|Discomfort during stimulation|2|||
125324184|NCT03600909|450819498|FG000|Overall Study|Not treated|0|||
125324185|NCT03600909|450819499|FG001|Overall Study|Not treated|3|||
125324186|NCT03600909|450819500|FG002|Overall Study|Not treated|0|||
125324187|NCT04973449|450819501|FG000|Overall Study|Withdrawal by Subject|3|||
125324188|NCT04973449|450819502|FG001|Overall Study|Withdrawal by Subject|3|||
125324189|NCT04973449|450819503|FG002|Overall Study|Withdrawal by Subject|2|||
125324190|NCT04973449|450819504|FG003|Overall Study|Withdrawal by Subject|5|||
125324191|NCT04973449|450819505|FG004|Overall Study|Withdrawal by Subject|5|||
125324192|NCT04973449|450819506|FG005|Overall Study|Withdrawal by Subject|4|||
125324193|NCT04973449|450819507|FG006|Overall Study|Withdrawal by Subject|7|||
125324194|NCT04973449|450819508|FG007|Overall Study|Withdrawal by Subject|5|||
125324195|NCT04973449|450819501|FG000|Overall Study|Lost to Follow-up|15|||
125324196|NCT04973449|450819502|FG001|Overall Study|Lost to Follow-up|16|||
125662974|NCT02367781|452054116|FG000|Overall Study|Study Terminated by Sponsor|3|||
125662975|NCT02367781|452054117|FG001|Overall Study|Study Terminated by Sponsor|1|||
125662976|NCT02367781|452054116|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
125324197|NCT04973449|450819503|FG002|Overall Study|Lost to Follow-up|16|||
125324198|NCT04973449|450819504|FG003|Overall Study|Lost to Follow-up|13|||
125324199|NCT04973449|450819505|FG004|Overall Study|Lost to Follow-up|5|||
125324200|NCT04973449|450819506|FG005|Overall Study|Lost to Follow-up|6|||
125324201|NCT04973449|450819507|FG006|Overall Study|Lost to Follow-up|10|||
125324202|NCT04973449|450819508|FG007|Overall Study|Lost to Follow-up|6|||
125324203|NCT04973449|450819501|FG000|Overall Study|Death|1|||
125324204|NCT04973449|450819502|FG001|Overall Study|Death|0|||
125324205|NCT04973449|450819503|FG002|Overall Study|Death|0|||
125324206|NCT04973449|450819504|FG003|Overall Study|Death|0|||
125324207|NCT04973449|450819505|FG004|Overall Study|Death|0|||
125324208|NCT04973449|450819506|FG005|Overall Study|Death|1|||
125324209|NCT04973449|450819507|FG006|Overall Study|Death|0|||
125324210|NCT04973449|450819508|FG007|Overall Study|Death|0|||
125324211|NCT04973449|450819501|FG000|Overall Study|Other|1|||
125324212|NCT04973449|450819502|FG001|Overall Study|Other|1|||
125324213|NCT04973449|450819503|FG002|Overall Study|Other|2|||
125324214|NCT04973449|450819504|FG003|Overall Study|Other|1|||
125324215|NCT04973449|450819505|FG004|Overall Study|Other|4|||
125324216|NCT04973449|450819506|FG005|Overall Study|Other|0|||
125324217|NCT04973449|450819507|FG006|Overall Study|Other|2|||
125324218|NCT04973449|450819508|FG007|Overall Study|Other|2|||
125324219|NCT00521079|450819509|FG000|Overall Study|Adverse Event|7|||
125324220|NCT00521079|450819510|FG001|Overall Study|Adverse Event|1|||
125324221|NCT00521079|450819509|FG000|Overall Study|Lost to Follow-up|2|||
125324222|NCT00521079|450819510|FG001|Overall Study|Lost to Follow-up|1|||
125324223|NCT00521079|450819509|FG000|Overall Study|Withdrawal by Subject|5|||
125324224|NCT00521079|450819510|FG001|Overall Study|Withdrawal by Subject|3|||
125324225|NCT02651675|450819511|FG000|Overall Study|Death|0|||
125324226|NCT02651675|450819512|FG001|Overall Study|Death|0|||
125324227|NCT02651675|450819513|FG002|Overall Study|Death|1|||
125324228|NCT03674411|450819514|FG000|Overall Study|Non-treatment|4|||
125324229|NCT01506596|450819515|FG000|Overall Study|ineligible pathology|1|||
125324230|NCT04606134|450819523|FG000|Overall Study|Adverse Event|0|||
125662977|NCT02367781|452054117|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
125662978|NCT02367781|452054116|FG000|Overall Study|Sponsor Decision|2|||
125662979|NCT02367781|452054117|FG001|Overall Study|Sponsor Decision|0|||
125662980|NCT02367781|452054116|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
125662981|NCT02367781|452054117|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
125324231|NCT04606134|450819524|FG001|Overall Study|Adverse Event|1|||
125324232|NCT01099267|450819525|FG000|MDS-003 Study|Adverse Event|37|||
125324233|NCT01099267|450819525|FG000|MDS-003 Study|Lack of Efficacy|52|||
125324234|NCT01099267|450819525|FG000|MDS-003 Study|Withdrawal by Subject|8|||
125324235|NCT01099267|450819525|FG000|MDS-003 Study|Lost to Follow-up|1|||
125324236|NCT01099267|450819525|FG000|MDS-003 Study|Death|11|||
125324237|NCT01099267|450819525|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
125324238|NCT01099267|450819525|FG000|MDS-003 Study|Disease Progression|7|||
125324239|NCT01099267|450819525|FG000|MDS-003 Study|Investigator Decision|2|||
125324240|NCT01099267|450819525|FG000|MDS-003 Study|Non-Compliance|2|||
125324241|NCT01099267|450819525|FG000|MDS-003 Study|Loss of Response|1|||
125324242|NCT01099267|450819525|FG000|MDS-003 Study|Secondary Malign Disease|1|||
125324243|NCT04050553|450819534|FG000|Period 1|Physician Decision|2|||
125324244|NCT04050553|450819535|FG001|Period 1|Physician Decision|2|||
125324245|NCT04050553|450819534|FG000|Period 1|Adverse Event|1|||
125324246|NCT04050553|450819535|FG001|Period 1|Adverse Event|1|||
125324247|NCT04050553|450819534|FG000|Period 1|Withdrawal by Subject|0|||
125324248|NCT04050553|450819535|FG001|Period 1|Withdrawal by Subject|1|||
125324249|NCT04050553|450819534|FG000|Wash-out|Adverse Event|0|||
125324250|NCT04050553|450819535|FG001|Wash-out|Adverse Event|1|||
125324251|NCT04050553|450819534|FG000|Wash-out|Withdrawal by Subject|0|||
125324252|NCT04050553|450819535|FG001|Wash-out|Withdrawal by Subject|1|||
125324253|NCT03472885|450819538|FG000|24-Week Treatment Period|Adverse Event|1|||
125324254|NCT02201953|450819539|FG000|Overall Study|Randomized but Never Treated|1|||
125324255|NCT02201953|450819540|FG001|Overall Study|Randomized but Never Treated|5|||
125324256|NCT02201953|450819539|FG000|Overall Study|Lack of Efficacy|9|||
125324257|NCT02201953|450819540|FG001|Overall Study|Lack of Efficacy|30|||
125324258|NCT02201953|450819539|FG000|Overall Study|Lost to Follow-up|8|||
125324259|NCT02201953|450819540|FG001|Overall Study|Lost to Follow-up|8|||
125324260|NCT02201953|450819539|FG000|Overall Study|Withdrew Consent|2|||
125324261|NCT02201953|450819540|FG001|Overall Study|Withdrew Consent|5|||
125324262|NCT02201953|450819539|FG000|Overall Study|Adverse Event|0|||
125324263|NCT02201953|450819540|FG001|Overall Study|Adverse Event|5|||
125324264|NCT02201953|450819539|FG000|Overall Study|Death|0|||
125324265|NCT02201953|450819540|FG001|Overall Study|Death|3|||
125324266|NCT01615939|450821372|FG000|Overall Study|Lost to Follow-up|5|||
125324267|NCT01615939|450821373|FG001|Overall Study|Lost to Follow-up|0|||
125324268|NCT02892344|450821377|FG000|Overall Study|Protocol deviation|3|||
125324269|NCT02892344|450821378|FG001|Overall Study|Protocol deviation|4|||
125324270|NCT02892344|450821377|FG000|Overall Study|Adverse Event|1|||
125324271|NCT02892344|450821378|FG001|Overall Study|Adverse Event|8|||
125324272|NCT02892344|450821377|FG000|Overall Study|Lost to Follow-up|0|||
125324273|NCT02892344|450821378|FG001|Overall Study|Lost to Follow-up|1|||
125324274|NCT02892344|450821377|FG000|Overall Study|Non-compliance with study treatment|0|||
125324275|NCT02892344|450821378|FG001|Overall Study|Non-compliance with study treatment|1|||
125324276|NCT02892344|450821377|FG000|Overall Study|Physician Decision|0|||
125324277|NCT02892344|450821378|FG001|Overall Study|Physician Decision|2|||
125324278|NCT02892344|450821377|FG000|Overall Study|Subject/guardian decision|0|||
125324279|NCT02892344|450821378|FG001|Overall Study|Subject/guardian decision|4|||
125324280|NCT02892344|450821377|FG000|Overall Study|Technical problems|0|||
125324281|NCT02892344|450821378|FG001|Overall Study|Technical problems|1|||
125324282|NCT01520506|450821379|FG000|Overall Study|Missed Visit|4|||
125324283|NCT01520506|450821379|FG000|Overall Study|Lost to Follow-up|1|||
125324284|NCT01520506|450821379|FG000|Overall Study|Withdrawal by Subject|1|||
125324285|NCT00425269|450821380|FG000|Overall Study|Pregnancy|5|||
125324286|NCT00425269|450821381|FG001|Overall Study|Pregnancy|7|||
125324287|NCT00425269|450821380|FG000|Overall Study|Lost to Follow-up|9|||
125324288|NCT00425269|450821381|FG001|Overall Study|Lost to Follow-up|9|||
125324289|NCT00425269|450821380|FG000|Overall Study|moved or medical reason|5|||
125324290|NCT00425269|450821381|FG001|Overall Study|moved or medical reason|4|||
125324291|NCT01084655|450821386|FG000|Overall Study|Radiographic disease progression|3|||
125324292|NCT01084655|450821387|FG001|Overall Study|Radiographic disease progression|2|||
125324293|NCT01084655|450821388|FG002|Overall Study|Radiographic disease progression|8|||
125324294|NCT01084655|450821386|FG000|Overall Study|Withdrawal by Subject|1|||
125324295|NCT01084655|450821387|FG001|Overall Study|Withdrawal by Subject|0|||
125324296|NCT01084655|450821388|FG002|Overall Study|Withdrawal by Subject|4|||
125324297|NCT01084655|450821386|FG000|Overall Study|Adverse Event|2|||
125324298|NCT01084655|450821387|FG001|Overall Study|Adverse Event|1|||
125324299|NCT01084655|450821388|FG002|Overall Study|Adverse Event|2|||
125324300|NCT01084655|450821386|FG000|Overall Study|Other|0|||
125324301|NCT01084655|450821387|FG001|Overall Study|Other|3|||
125324302|NCT01084655|450821388|FG002|Overall Study|Other|2|||
125324303|NCT01084655|450821386|FG000|Overall Study|Symptomatic deterioration|0|||
125324304|NCT01084655|450821387|FG001|Overall Study|Symptomatic deterioration|0|||
125324305|NCT01084655|450821388|FG002|Overall Study|Symptomatic deterioration|2|||
125324306|NCT01084655|450821386|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
125324307|NCT01084655|450821387|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
125324308|NCT01084655|450821388|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
125324309|NCT00535496|450821389|FG000|Overall Study|Lost to Follow-up|0|||
125324310|NCT00535496|450821390|FG001|Overall Study|Lost to Follow-up|1|||
125324311|NCT00535496|450821391|FG002|Overall Study|Lost to Follow-up|0|||
125324312|NCT00535496|450821392|FG003|Overall Study|Lost to Follow-up|0|||
125324313|NCT00535496|450821389|FG000|Overall Study|Not treated with sugammadex|0|||
125324314|NCT00535496|450821390|FG001|Overall Study|Not treated with sugammadex|1|||
125324315|NCT00535496|450821391|FG002|Overall Study|Not treated with sugammadex|0|||
125324316|NCT00535496|450821392|FG003|Overall Study|Not treated with sugammadex|0|||
125324317|NCT02326155|450821394|FG000|Overall Study|Adverse Event|21|||
125324318|NCT02326155|450821395|FG001|Overall Study|Adverse Event|5|||
125324319|NCT02326155|450821394|FG000|Overall Study|Death|3|||
125324320|NCT02326155|450821395|FG001|Overall Study|Death|0|||
125662982|NCT02623426|452054118|FG000|Overall Study|Lost to Follow-up|0|||
125662983|NCT02623426|452054119|FG001|Overall Study|Lost to Follow-up|0|||
125662984|NCT02623426|452054120|FG002|Overall Study|Lost to Follow-up|1|||
125662985|NCT02623426|452054118|FG000|Overall Study|Withdrawal by Subject|1|||
125662986|NCT02623426|452054119|FG001|Overall Study|Withdrawal by Subject|2|||
125662987|NCT02623426|452054120|FG002|Overall Study|Withdrawal by Subject|2|||
125662988|NCT03185949|452054123|FG000|ITT Analysis|Withdrawal by Subject|4|||
125662989|NCT03185949|452054124|FG001|ITT Analysis|Withdrawal by Subject|3|||
125662990|NCT03185949|452054123|FG000|PP Analysis|Protocol Violation|2|||
125662991|NCT03185949|452054124|FG001|PP Analysis|Protocol Violation|2|||
125662992|NCT03185949|452054123|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
125324321|NCT02326155|450821394|FG000|Overall Study|Lack of Efficacy|49|||
125324322|NCT02326155|450821395|FG001|Overall Study|Lack of Efficacy|5|||
125324323|NCT02326155|450821394|FG000|Overall Study|Lost to Follow-up|14|||
125324324|NCT02326155|450821395|FG001|Overall Study|Lost to Follow-up|3|||
125324325|NCT02326155|450821394|FG000|Overall Study|Protocol Violation|2|||
125324326|NCT02326155|450821395|FG001|Overall Study|Protocol Violation|0|||
125324327|NCT02326155|450821394|FG000|Overall Study|Withdrawal by Subject|34|||
125324328|NCT02326155|450821395|FG001|Overall Study|Withdrawal by Subject|11|||
125324329|NCT02326155|450821394|FG000|Overall Study|Disease progression|37|||
125324330|NCT02326155|450821395|FG001|Overall Study|Disease progression|4|||
125324331|NCT02326155|450821394|FG000|Overall Study|Study close|188|||
125324332|NCT02326155|450821395|FG001|Overall Study|Study close|21|||
125324333|NCT02326155|450821394|FG000|Overall Study|except for study close|46|||
125324334|NCT02326155|450821395|FG001|Overall Study|except for study close|13|||
125324335|NCT05024032|450821396|FG000|Overall Study|Withdrawal by Subject|0|||
125324336|NCT05024032|450821397|FG001|Overall Study|Withdrawal by Subject|3|||
125324337|NCT05024032|450821398|FG002|Overall Study|Withdrawal by Subject|4|||
125324338|NCT05024032|450821396|FG000|Overall Study|Adverse Event|0|||
125324339|NCT05024032|450821397|FG001|Overall Study|Adverse Event|1|||
125324340|NCT05024032|450821398|FG002|Overall Study|Adverse Event|0|||
125324341|NCT05024032|450821396|FG000|Overall Study|Protocol Deviation|1|||
125324342|NCT05024032|450821397|FG001|Overall Study|Protocol Deviation|0|||
125324343|NCT05024032|450821398|FG002|Overall Study|Protocol Deviation|0|||
125324344|NCT03591406|450821401|FG000|Overall Study|Adverse Event|5|||
125324345|NCT03591406|450821402|FG001|Overall Study|Adverse Event|3|||
125324346|NCT03591406|450821401|FG000|Overall Study|Protocol Violation|2|||
125324347|NCT03591406|450821402|FG001|Overall Study|Protocol Violation|1|||
125662993|NCT03185949|452054124|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
125662994|NCT05166421|452054133|FG000|Overall Study|Other|3|||
125662995|NCT05166421|452054134|FG001|Overall Study|Other|1|||
125662996|NCT05166421|452054135|FG002|Overall Study|Other|1|||
125662997|NCT05166421|452054133|FG000|Overall Study|Withdrawal by Subject|5|||
125662998|NCT05166421|452054134|FG001|Overall Study|Withdrawal by Subject|3|||
125662999|NCT05166421|452054135|FG002|Overall Study|Withdrawal by Subject|6|||
125663000|NCT05166421|452054133|FG000|Overall Study|Lost to Follow-up|4|||
125663001|NCT05166421|452054134|FG001|Overall Study|Lost to Follow-up|1|||
125663002|NCT05166421|452054135|FG002|Overall Study|Lost to Follow-up|7|||
125663003|NCT03724968|452056114|FG000|Overall Study|Insurance issues|0|||
125663004|NCT03724968|452056115|FG001|Overall Study|Insurance issues|1|||
125663005|NCT03724968|452056114|FG000|Overall Study|Study closed|0|||
125663006|NCT03724968|452056115|FG001|Overall Study|Study closed|1|||
125663007|NCT01142466|452056116|FG000|Overall Study|Adverse Event|2|||
125663008|NCT01142466|452056117|FG001|Overall Study|Adverse Event|1|||
125663009|NCT01142466|452056116|FG000|Overall Study|Withdrawal by Subject|1|||
125663010|NCT01142466|452056117|FG001|Overall Study|Withdrawal by Subject|1|||
125663011|NCT00681824|452056118|FG000|Overall Study|withdrawn by investigator|0|||
125663012|NCT00681824|452056119|FG001|Overall Study|withdrawn by investigator|0|||
125663013|NCT00681824|452056120|FG002|Overall Study|withdrawn by investigator|1|||
125663014|NCT00681824|452056118|FG000|Overall Study|scheduling conflict|1|||
125663015|NCT00681824|452056119|FG001|Overall Study|scheduling conflict|0|||
125663016|NCT00681824|452056120|FG002|Overall Study|scheduling conflict|0|||
125324348|NCT03591406|450821401|FG000|Overall Study|Withdrawal by Subject|0|||
125324349|NCT03591406|450821402|FG001|Overall Study|Withdrawal by Subject|5|||
125324350|NCT01083771|450821403|FG000|Overall Study|non-compliant|2|||
125663017|NCT00681824|452056118|FG000|Overall Study|Death|0|||
125663018|NCT00681824|452056119|FG001|Overall Study|Death|1|||
125663019|NCT00681824|452056120|FG002|Overall Study|Death|0|||
125663020|NCT03724916|452056121|FG000|Overall Study|Withdrawal by Subject|0|||
125663021|NCT03724916|452056122|FG001|Overall Study|Withdrawal by Subject|1|||
125663022|NCT03724916|452056123|FG002|Overall Study|Withdrawal by Subject|1|||
125663023|NCT03724916|452056124|FG003|Overall Study|Withdrawal by Subject|2|||
125663024|NCT03724916|452056121|FG000|Overall Study|Randomized but not Treated|1|||
125663025|NCT03724916|452056122|FG001|Overall Study|Randomized but not Treated|0|||
125663026|NCT03724916|452056123|FG002|Overall Study|Randomized but not Treated|0|||
125663027|NCT03724916|452056124|FG003|Overall Study|Randomized but not Treated|0|||
125324351|NCT01083771|450821403|FG000|Overall Study|Withdrawal by Subject|3|||
125663028|NCT03591107|452056129|FG000|Overall Study|Same patient in both arms|1|||
125324352|NCT02066181|450821404|FG000|Overall Study|Withdrawal by Subject|1|||
125324353|NCT02066181|450821405|FG001|Overall Study|Withdrawal by Subject|1|||
125324354|NCT00939393|450821408|FG000|Overall Study|Withdrawal by Subject|1|||
125324355|NCT00939393|450821409|FG001|Overall Study|Withdrawal by Subject|0|||
125324356|NCT00939393|450821408|FG000|Overall Study|Lost to Follow-up|3|||
125324357|NCT00939393|450821409|FG001|Overall Study|Lost to Follow-up|0|||
125324358|NCT02851615|450821410|FG000|Overall Study|Cognitive Issue|1|||
125324359|NCT02851615|450821411|FG001|Overall Study|Cognitive Issue|0|||
125324360|NCT02851615|450821410|FG000|Overall Study|Lost to Follow-up|0|||
125324361|NCT02851615|450821411|FG001|Overall Study|Lost to Follow-up|4|||
125324362|NCT00371150|450821420|FG000|Overall Study|Lost to Follow-up|3|||
125324363|NCT00371150|450821421|FG001|Overall Study|Lost to Follow-up|2|||
125324364|NCT03714672|450821422|FG000|Overall Study|Adverse Event|0|||
125324365|NCT03714672|450821423|FG001|Overall Study|Adverse Event|0|||
125324366|NCT03714672|450821424|FG002|Overall Study|Adverse Event|3|||
125324367|NCT03714672|450821425|FG003|Overall Study|Adverse Event|0|||
125324368|NCT03714672|450821422|FG000|Overall Study|Physician Decision|0|||
125324369|NCT03714672|450821423|FG001|Overall Study|Physician Decision|1|||
125324370|NCT03714672|450821424|FG002|Overall Study|Physician Decision|0|||
125324371|NCT03714672|450821425|FG003|Overall Study|Physician Decision|0|||
125324372|NCT03714672|450821422|FG000|Overall Study|Other Reason|1|||
125324373|NCT03714672|450821423|FG001|Overall Study|Other Reason|2|||
125324374|NCT03714672|450821424|FG002|Overall Study|Other Reason|1|||
125324375|NCT03714672|450821425|FG003|Overall Study|Other Reason|1|||
125324376|NCT03714672|450821422|FG000|Overall Study|Lost to Follow-up|1|||
125324377|NCT03714672|450821423|FG001|Overall Study|Lost to Follow-up|1|||
125324378|NCT03714672|450821424|FG002|Overall Study|Lost to Follow-up|0|||
125324379|NCT03714672|450821425|FG003|Overall Study|Lost to Follow-up|0|||
125324380|NCT02345070|450821427|FG000|Overall Study|Adverse Event|12|||
125324381|NCT02345070|450821428|FG001|Overall Study|Adverse Event|8|||
125324382|NCT02345070|450821429|FG002|Overall Study|Adverse Event|16|||
125324383|NCT02345070|450821427|FG000|Overall Study|Poor compliance to protocol|2|||
125324384|NCT02345070|450821428|FG001|Overall Study|Poor compliance to protocol|0|||
125324385|NCT02345070|450821429|FG002|Overall Study|Poor compliance to protocol|0|||
125324386|NCT02345070|450821427|FG000|Overall Study|Other than specified above|6|||
125324387|NCT02345070|450821428|FG001|Overall Study|Other than specified above|3|||
125324388|NCT02345070|450821429|FG002|Overall Study|Other than specified above|7|||
125324389|NCT00321620|450821435|FG000|Overall Study|Death|269|||
125324390|NCT00321620|450821436|FG001|Overall Study|Death|294|||
125324391|NCT00321620|450821435|FG000|Overall Study|Withdrawal by Subject|164|||
125324392|NCT00321620|450821436|FG001|Overall Study|Withdrawal by Subject|147|||
125324393|NCT00321620|450821435|FG000|Overall Study|Disease progression|113|||
125324394|NCT00321620|450821436|FG001|Overall Study|Disease progression|117|||
125324395|NCT00321620|450821435|FG000|Overall Study|Adverse Event|43|||
125324396|NCT00321620|450821436|FG001|Overall Study|Adverse Event|56|||
125324397|NCT00321620|450821435|FG000|Overall Study|Lost to Follow-up|13|||
125324398|NCT00321620|450821436|FG001|Overall Study|Lost to Follow-up|9|||
125324399|NCT00321620|450821435|FG000|Overall Study|Physician Decision|4|||
125324400|NCT00321620|450821436|FG001|Overall Study|Physician Decision|1|||
125324401|NCT00321620|450821435|FG000|Overall Study|Noncompliance|14|||
125324402|NCT00321620|450821436|FG001|Overall Study|Noncompliance|7|||
125324403|NCT00321620|450821435|FG000|Overall Study|Protocol deviation|4|||
125324404|NCT00321620|450821436|FG001|Overall Study|Protocol deviation|3|||
125324405|NCT00321620|450821435|FG000|Overall Study|Ineligibility determined|2|||
125324406|NCT00321620|450821436|FG001|Overall Study|Ineligibility determined|3|||
125324407|NCT00321620|450821435|FG000|Overall Study|Participant request|75|||
125324408|NCT00321620|450821436|FG001|Overall Study|Participant request|52|||
125324409|NCT00321620|450821435|FG000|Overall Study|Other|42|||
125324410|NCT00321620|450821436|FG001|Overall Study|Other|33|||
125324411|NCT03829228|450821437|FG000|Overall Study|Protocol Violation|1|||
125324412|NCT03304626|450821440|FG000|Overall Study|Adverse Event|1|||
125324413|NCT03304626|450821441|FG001|Overall Study|Adverse Event|0|||
125324414|NCT03304626|450821440|FG000|Overall Study|Lack of Efficacy|1|||
125324415|NCT03304626|450821441|FG001|Overall Study|Lack of Efficacy|1|||
125324416|NCT01462370|450821448|FG000|Overall Study|Lack of Qualifying Event|1|||
125324417|NCT01462370|450821449|FG001|Overall Study|Lack of Qualifying Event|1|||
125324418|NCT01462370|450821448|FG000|Overall Study|Physician Decision|0|||
125324419|NCT01462370|450821449|FG001|Overall Study|Physician Decision|1|||
125324420|NCT01462370|450821448|FG000|Overall Study|Withdrawal by Subject|0|||
125324421|NCT01462370|450821449|FG001|Overall Study|Withdrawal by Subject|3|||
125324422|NCT04385277|450821452|FG000|Overall Study|Physician Decision|2|||
125324423|NCT04385277|450821452|FG000|Overall Study|Ineligible|1|||
125324424|NCT04385277|450821452|FG000|Overall Study|Patient/Parent Refusal|2|||
125324425|NCT03566511|450821453|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
125324426|NCT03566511|450821454|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
125324427|NCT00981656|450821463|FG000|Overall Study|Protocol Violation|1|||
125324428|NCT00981656|450821463|FG000|Overall Study|Did not start protocol treatment|2|||
125324429|NCT00687596|450821464|FG000|Overall Study|Adverse Event (AE)|10|||
125324430|NCT00687596|450821465|FG001|Overall Study|Adverse Event (AE)|3|||
125324431|NCT00687596|450821464|FG000|Overall Study|Radiological Disease Progression|6|||
125324432|NCT00687596|450821465|FG001|Overall Study|Radiological Disease Progression|2|||
125324433|NCT00687596|450821464|FG000|Overall Study|Clinical Disease Progression|1|||
125324434|NCT00687596|450821465|FG001|Overall Study|Clinical Disease Progression|3|||
125324435|NCT00687596|450821464|FG000|Overall Study|Investigator Discretion|3|||
125324436|NCT00687596|450821465|FG001|Overall Study|Investigator Discretion|1|||
125324437|NCT00687596|450821464|FG000|Overall Study|Sponsor Terminated Study|6|||
125324438|NCT00687596|450821465|FG001|Overall Study|Sponsor Terminated Study|17|||
125324439|NCT03331315|450821470|FG000|Overall Study|Physician Decision|18|||
125324440|NCT03331315|450821471|FG001|Overall Study|Physician Decision|14|||
125324441|NCT02461758|450821475|FG000|Overall Study|Lost to Follow-up|0|||
125324442|NCT02461758|450821476|FG001|Overall Study|Lost to Follow-up|1|||
125324443|NCT02461758|450821477|FG002|Overall Study|Lost to Follow-up|1|||
125324444|NCT02461758|450821478|FG003|Overall Study|Lost to Follow-up|0|||
125324445|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
125324446|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
125324447|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
125324448|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
125324449|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
125324450|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
125324451|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
125324452|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
125324453|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
125324454|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
125324455|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
125324456|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
125324457|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
125324458|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
125324459|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
125324460|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
125324461|NCT03773978|450821490|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
125324462|NCT03773978|450821491|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
125324463|NCT03773978|450821490|FG000|DBW Period|Adverse Event|2|||
125324464|NCT03773978|450821491|FG001|DBW Period|Adverse Event|2|||
125324465|NCT03773978|450821490|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
125324466|NCT03773978|450821491|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
125324467|NCT03773978|450821490|FG000|DBW Period|Withdrawal by Subject|2|||
125324468|NCT03773978|450821491|FG001|DBW Period|Withdrawal by Subject|1|||
125324469|NCT03773978|450821490|FG000|DBW Period|Due to epidemic or pandemic|5|||
125324470|NCT03773978|450821491|FG001|DBW Period|Due to epidemic or pandemic|6|||
125324471|NCT03773978|450821490|FG000|DBW Period|Study team decision|1|||
125324472|NCT03773978|450821491|FG001|DBW Period|Study team decision|0|||
125324473|NCT01033019|450821492|FG000|Overall Study|Withdrawal by Subject|1|||
125324474|NCT01033019|450821493|FG001|Overall Study|Withdrawal by Subject|0|||
125324475|NCT00888134|450821497|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
125324476|NCT00888134|450821497|FG000|Follow-up|being followed for long-term survival|1|||
125324477|NCT03224819|450821499|FG000|Overall Study|Withdrawal by Subject|0|||
125324478|NCT03224819|450821500|FG001|Overall Study|Withdrawal by Subject|0|||
125324479|NCT03224819|450821501|FG002|Overall Study|Withdrawal by Subject|0|||
125324480|NCT03224819|450821502|FG003|Overall Study|Withdrawal by Subject|0|||
125324481|NCT03224819|450821503|FG004|Overall Study|Withdrawal by Subject|0|||
125324482|NCT03224819|450821504|FG005|Overall Study|Withdrawal by Subject|0|||
125324483|NCT03224819|450821505|FG006|Overall Study|Withdrawal by Subject|0|||
125324484|NCT03224819|450821506|FG007|Overall Study|Withdrawal by Subject|0|||
125324485|NCT03224819|450821507|FG008|Overall Study|Withdrawal by Subject|0|||
125324486|NCT03224819|450821508|FG009|Overall Study|Withdrawal by Subject|0|||
125324487|NCT03224819|450821509|FG010|Overall Study|Withdrawal by Subject|0|||
125324488|NCT03224819|450821510|FG011|Overall Study|Withdrawal by Subject|0|||
125324489|NCT03224819|450821511|FG012|Overall Study|Withdrawal by Subject|1|||
125324490|NCT03224819|450821512|FG013|Overall Study|Withdrawal by Subject|0|||
125324491|NCT03224819|450821499|FG000|Overall Study|Sponsor Decision|0|||
125324492|NCT03224819|450821500|FG001|Overall Study|Sponsor Decision|0|||
125324493|NCT03224819|450821501|FG002|Overall Study|Sponsor Decision|0|||
125324494|NCT03224819|450821502|FG003|Overall Study|Sponsor Decision|1|||
125324495|NCT03224819|450821503|FG004|Overall Study|Sponsor Decision|1|||
125324496|NCT03224819|450821504|FG005|Overall Study|Sponsor Decision|2|||
125324497|NCT03224819|450821505|FG006|Overall Study|Sponsor Decision|1|||
125324498|NCT03224819|450821506|FG007|Overall Study|Sponsor Decision|1|||
125324499|NCT03224819|450821507|FG008|Overall Study|Sponsor Decision|1|||
125324500|NCT03224819|450821508|FG009|Overall Study|Sponsor Decision|2|||
125324501|NCT03224819|450821509|FG010|Overall Study|Sponsor Decision|1|||
125324502|NCT03224819|450821510|FG011|Overall Study|Sponsor Decision|1|||
125324503|NCT03224819|450821511|FG012|Overall Study|Sponsor Decision|1|||
125324504|NCT03224819|450821512|FG013|Overall Study|Sponsor Decision|0|||
125324505|NCT03224819|450821499|FG000|Overall Study|Lost to Follow-up|0|||
125324506|NCT03224819|450821500|FG001|Overall Study|Lost to Follow-up|0|||
125324507|NCT03224819|450821501|FG002|Overall Study|Lost to Follow-up|0|||
125324508|NCT03224819|450821502|FG003|Overall Study|Lost to Follow-up|0|||
125324509|NCT03224819|450821503|FG004|Overall Study|Lost to Follow-up|0|||
125324510|NCT03224819|450821504|FG005|Overall Study|Lost to Follow-up|0|||
125324511|NCT03224819|450821505|FG006|Overall Study|Lost to Follow-up|0|||
125324512|NCT03224819|450821506|FG007|Overall Study|Lost to Follow-up|0|||
125324513|NCT03224819|450821507|FG008|Overall Study|Lost to Follow-up|1|||
125324514|NCT03224819|450821508|FG009|Overall Study|Lost to Follow-up|0|||
125324515|NCT03224819|450821509|FG010|Overall Study|Lost to Follow-up|0|||
125324516|NCT03224819|450821510|FG011|Overall Study|Lost to Follow-up|0|||
125324517|NCT03224819|450821511|FG012|Overall Study|Lost to Follow-up|0|||
125324518|NCT03224819|450821512|FG013|Overall Study|Lost to Follow-up|0|||
125324519|NCT03224819|450821499|FG000|Overall Study|Death|0|||
125324520|NCT03224819|450821500|FG001|Overall Study|Death|1|||
125324521|NCT03224819|450821501|FG002|Overall Study|Death|0|||
125324522|NCT03224819|450821502|FG003|Overall Study|Death|0|||
125324523|NCT03224819|450821503|FG004|Overall Study|Death|0|||
125324524|NCT03224819|450821504|FG005|Overall Study|Death|0|||
125324525|NCT03224819|450821505|FG006|Overall Study|Death|0|||
125324526|NCT03224819|450821506|FG007|Overall Study|Death|1|||
125324527|NCT03224819|450821507|FG008|Overall Study|Death|0|||
125324528|NCT03224819|450821508|FG009|Overall Study|Death|0|||
125324529|NCT03224819|450821509|FG010|Overall Study|Death|0|||
125324530|NCT03224819|450821510|FG011|Overall Study|Death|1|||
125324531|NCT03224819|450821511|FG012|Overall Study|Death|0|||
125324532|NCT03224819|450821512|FG013|Overall Study|Death|0|||
125324533|NCT03104868|450821513|FG000|6 Week Follow up|Lost to Follow-up|5|||
125324534|NCT03104868|450821514|FG001|6 Week Follow up|Lost to Follow-up|8|||
125324535|NCT03104868|450821513|FG000|6 Week Follow up|Death|1|||
125324536|NCT03104868|450821514|FG001|6 Week Follow up|Death|1|||
125324537|NCT03104868|450821513|FG000|6 Week Follow up|Withdrawal by Subject|7|||
125324538|NCT03104868|450821514|FG001|6 Week Follow up|Withdrawal by Subject|6|||
125324539|NCT03104868|450821513|FG000|6 Week Follow up|Completed Later Timepoint|24|||
125324540|NCT03104868|450821514|FG001|6 Week Follow up|Completed Later Timepoint|22|||
125324541|NCT03104868|450821513|FG000|6 Month Follow up|Lost to Follow-up|2|||
125324542|NCT03104868|450821514|FG001|6 Month Follow up|Lost to Follow-up|2|||
125324543|NCT03104868|450821513|FG000|6 Month Follow up|Death|0|||
125324544|NCT03104868|450821514|FG001|6 Month Follow up|Death|1|||
125324545|NCT03104868|450821513|FG000|6 Month Follow up|Completed Later Timepoint|22|||
125324546|NCT03104868|450821514|FG001|6 Month Follow up|Completed Later Timepoint|32|||
125324547|NCT03104868|450821513|FG000|12 Month Follow up|Lost to Follow-up|1|||
125324548|NCT03104868|450821514|FG001|12 Month Follow up|Lost to Follow-up|2|||
125324549|NCT03104868|450821513|FG000|12 Month Follow up|Death|0|||
125324550|NCT03104868|450821514|FG001|12 Month Follow up|Death|1|||
125324551|NCT03104868|450821513|FG000|12 Month Follow up|Withdrawal by Subject|0|||
125324552|NCT03104868|450821514|FG001|12 Month Follow up|Withdrawal by Subject|3|||
125324553|NCT03104868|450821513|FG000|12 Month Follow up|Completed Later Timepoint|32|||
125324554|NCT03104868|450821514|FG001|12 Month Follow up|Completed Later Timepoint|29|||
125324555|NCT03104868|450821513|FG000|18 Month Follow up|Lost to Follow-up|7|||
125324556|NCT03104868|450821514|FG001|18 Month Follow up|Lost to Follow-up|11|||
125324557|NCT03104868|450821513|FG000|18 Month Follow up|Death|2|||
125324558|NCT03104868|450821514|FG001|18 Month Follow up|Death|1|||
125324559|NCT03104868|450821513|FG000|18 Month Follow up|Withdrawal by Subject|1|||
125324560|NCT03104868|450821514|FG001|18 Month Follow up|Withdrawal by Subject|2|||
125324561|NCT03104868|450821513|FG000|18 Month Follow up|Graft Loss|1|||
125324562|NCT03104868|450821514|FG001|18 Month Follow up|Graft Loss|1|||
125324563|NCT03104868|450821513|FG000|18 Month Follow up|Completed Later Timepoint|19|||
125324564|NCT03104868|450821514|FG001|18 Month Follow up|Completed Later Timepoint|20|||
125324565|NCT03104868|450821513|FG000|24 Month Follow up|Lost to Follow-up|15|||
125324566|NCT03104868|450821514|FG001|24 Month Follow up|Lost to Follow-up|16|||
125663029|NCT03591107|452056130|FG001|Overall Study|Same patient in both arms|1|||
125663030|NCT03591107|452056129|FG000|Overall Study|Sought care at other clinics|0|||
125663031|NCT03591107|452056130|FG001|Overall Study|Sought care at other clinics|2|||
125663032|NCT03591107|452056129|FG000|Overall Study|Discharged from clinic|0|||
125324567|NCT03104868|450821513|FG000|24 Month Follow up|Death|3|||
125324568|NCT03104868|450821514|FG001|24 Month Follow up|Death|2|||
125324569|NCT03104868|450821513|FG000|24 Month Follow up|Withdrawal by Subject|1|||
125324570|NCT03104868|450821514|FG001|24 Month Follow up|Withdrawal by Subject|0|||
125663033|NCT03591107|452056130|FG001|Overall Study|Discharged from clinic|1|||
125324571|NCT03104868|450821513|FG000|24 Month Follow up|Graft Loss|2|||
125324572|NCT03104868|450821514|FG001|24 Month Follow up|Graft Loss|0|||
125324573|NCT00005780|450821515|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
125324574|NCT04408989|450821516|FG000|Overall Study|Lost to Follow-up|0|||
125324575|NCT04408989|450821517|FG001|Overall Study|Lost to Follow-up|0|||
125324576|NCT04408989|450821518|FG002|Overall Study|Lost to Follow-up|1|||
125324577|NCT04408989|450821516|FG000|Overall Study|Withdrawal by Subject|0|||
125324578|NCT04408989|450821517|FG001|Overall Study|Withdrawal by Subject|0|||
125324579|NCT04408989|450821518|FG002|Overall Study|Withdrawal by Subject|2|||
125324580|NCT05082857|450821519|FG000|Overall Study|participants relocated and could not continue|2|||
125324581|NCT05082857|450821520|FG001|Overall Study|participants relocated and could not continue|1|||
125324582|NCT05082857|450821519|FG000|Overall Study|Lost to Follow-up|1|||
125324583|NCT05082857|450821520|FG001|Overall Study|Lost to Follow-up|3|||
125324584|NCT04672239|450821521|FG000|Week 2 Survey|Failed survey check items|1|||
125324585|NCT04672239|450821522|FG001|Week 2 Survey|Failed survey check items|2|||
125324586|NCT04672239|450821523|FG002|Week 2 Survey|Failed survey check items|3|||
125324587|NCT04672239|450821521|FG000|Week 2 Survey|Partially completed survey|7|||
125324588|NCT04672239|450821522|FG001|Week 2 Survey|Partially completed survey|1|||
125324589|NCT04672239|450821523|FG002|Week 2 Survey|Partially completed survey|4|||
125324590|NCT04672239|450821521|FG000|Week 2 Survey|Withdrawal by Subject|0|||
125324591|NCT04672239|450821522|FG001|Week 2 Survey|Withdrawal by Subject|1|||
125324592|NCT04672239|450821523|FG002|Week 2 Survey|Withdrawal by Subject|0|||
125324593|NCT04672239|450821521|FG000|Week 2 Survey|Lost to Follow-up|3|||
125324594|NCT04672239|450821522|FG001|Week 2 Survey|Lost to Follow-up|2|||
125663034|NCT03591107|452056129|FG000|Overall Study|Withdrawal by Subject|0|||
125663035|NCT03591107|452056130|FG001|Overall Study|Withdrawal by Subject|1|||
125663036|NCT03836729|452056139|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
125663037|NCT01270841|452056140|FG000|Overall Study|Adverse Event|0|||
125663038|NCT01270841|452056141|FG001|Overall Study|Adverse Event|1|||
125663039|NCT01270841|452056142|FG002|Overall Study|Adverse Event|0|||
125663040|NCT01270841|452056143|FG003|Overall Study|Adverse Event|3|||
125663041|NCT01270841|452056140|FG000|Overall Study|Withdrawal by Subject|3|||
125663042|NCT01270841|452056141|FG001|Overall Study|Withdrawal by Subject|2|||
125663043|NCT01270841|452056142|FG002|Overall Study|Withdrawal by Subject|3|||
125663044|NCT01270841|452056143|FG003|Overall Study|Withdrawal by Subject|3|||
125663045|NCT01270841|452056140|FG000|Overall Study|Lost to Follow-up|3|||
125663046|NCT01270841|452056141|FG001|Overall Study|Lost to Follow-up|1|||
125663047|NCT01270841|452056142|FG002|Overall Study|Lost to Follow-up|4|||
125663048|NCT01270841|452056143|FG003|Overall Study|Lost to Follow-up|2|||
125663049|NCT01270841|452056140|FG000|Overall Study|Physician Decision|0|||
125663050|NCT01270841|452056141|FG001|Overall Study|Physician Decision|1|||
125663051|NCT01270841|452056142|FG002|Overall Study|Physician Decision|0|||
125663052|NCT01270841|452056143|FG003|Overall Study|Physician Decision|0|||
125663053|NCT01270841|452056140|FG000|Overall Study|Did not qualify|6|||
125663054|NCT01270841|452056141|FG001|Overall Study|Did not qualify|3|||
125663055|NCT01270841|452056142|FG002|Overall Study|Did not qualify|4|||
125663056|NCT01270841|452056143|FG003|Overall Study|Did not qualify|5|||
125663057|NCT01270841|452056140|FG000|Overall Study|Protocol Violation|1|||
125663058|NCT01270841|452056141|FG001|Overall Study|Protocol Violation|5|||
125663059|NCT01270841|452056142|FG002|Overall Study|Protocol Violation|0|||
125663060|NCT01270841|452056143|FG003|Overall Study|Protocol Violation|0|||
125663061|NCT01270841|452056140|FG000|Overall Study|Enrolled in error|0|||
125663062|NCT01270841|452056141|FG001|Overall Study|Enrolled in error|1|||
125663063|NCT01270841|452056142|FG002|Overall Study|Enrolled in error|0|||
125663064|NCT01270841|452056143|FG003|Overall Study|Enrolled in error|0|||
125663065|NCT04388527|452056144|FG000|Overall Study|Death|14|||
125663066|NCT04388527|452056144|FG000|Overall Study|Withdrawal by Subject|2|||
125663067|NCT04388527|452056144|FG000|Overall Study|Lost to Follow-up|1|||
125663068|NCT00782275|452056145|FG000|Overall Study|Adverse Event|11|||
125663069|NCT00782275|452056145|FG000|Overall Study|Withdrawal by Subject|1|||
125663070|NCT00782275|452056145|FG000|Overall Study|Progressive Disease|21|||
125663071|NCT00782275|452056145|FG000|Overall Study|Physician Decision|4|||
125663072|NCT00782275|452056145|FG000|Overall Study|Not started treatment|1|||
125663073|NCT00782275|452056145|FG000|Overall Study|Other|3|||
125663074|NCT00787566|452056152|FG000|Overall Study|AE related to chemotherapy|0|||
125663075|NCT00787566|452056153|FG001|Overall Study|AE related to chemotherapy|1|||
125663076|NCT00787566|452056154|FG002|Overall Study|AE related to chemotherapy|0|||
125663077|NCT00417027|452056155|FG000|Overall Study|Protocol Violation|0|||
125663078|NCT00417027|452056156|FG001|Overall Study|Protocol Violation|5|||
125663079|NCT00417027|452056157|FG002|Overall Study|Protocol Violation|5|||
125663080|NCT00544557|452056158|FG000|Overall Study|Adverse Event|140|||
125663081|NCT00544557|452056158|FG000|Overall Study|Lack of Efficacy|196|||
125663082|NCT00544557|452056158|FG000|Overall Study|Other|98|||
125663083|NCT01333475|452056164|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
125663084|NCT01333475|452056165|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
125324595|NCT04672239|450821523|FG002|Week 2 Survey|Lost to Follow-up|5|||
125663085|NCT01333475|452056164|FG000|Overall Study|Toxicity|1|||
125663086|NCT01333475|452056165|FG001|Overall Study|Toxicity|3|||
125324596|NCT04672239|450821521|FG000|Week 6 Survey|Failed survey check items|2|||
125324597|NCT04672239|450821522|FG001|Week 6 Survey|Failed survey check items|2|||
125663087|NCT02981602|452056166|FG000|Overall Study|Adverse Event|0|||
125663088|NCT02981602|452056167|FG001|Overall Study|Adverse Event|0|||
125663089|NCT02981602|452056168|FG002|Overall Study|Adverse Event|0|||
125324598|NCT04672239|450821523|FG002|Week 6 Survey|Failed survey check items|2|||
125663090|NCT02981602|452056169|FG003|Overall Study|Adverse Event|1|||
125663091|NCT02981602|452056170|FG004|Overall Study|Adverse Event|0|||
125663092|NCT01169987|452056171|FG000|Overall Study|Withdrawal by Subject|3|||
125324599|NCT04672239|450821521|FG000|Week 6 Survey|Partially completed survey|3|||
125324600|NCT04672239|450821522|FG001|Week 6 Survey|Partially completed survey|3|||
125324601|NCT04672239|450821523|FG002|Week 6 Survey|Partially completed survey|2|||
125324602|NCT04672239|450821521|FG000|Week 6 Survey|Withdrawal by Subject|1|||
125324603|NCT04672239|450821522|FG001|Week 6 Survey|Withdrawal by Subject|1|||
125324604|NCT04672239|450821523|FG002|Week 6 Survey|Withdrawal by Subject|1|||
125324605|NCT04672239|450821521|FG000|Week 6 Survey|Withdrawn by PI|0|||
125324606|NCT04672239|450821522|FG001|Week 6 Survey|Withdrawn by PI|1|||
125324607|NCT04672239|450821523|FG002|Week 6 Survey|Withdrawn by PI|0|||
125324608|NCT04672239|450821521|FG000|Week 6 Survey|Lost to Follow-up|12|||
125324609|NCT04672239|450821522|FG001|Week 6 Survey|Lost to Follow-up|2|||
125324610|NCT04672239|450821523|FG002|Week 6 Survey|Lost to Follow-up|5|||
125324611|NCT04672239|450821521|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
125324612|NCT04672239|450821522|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
125324613|NCT04672239|450821523|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
125324614|NCT04672239|450821521|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
125324615|NCT04672239|450821522|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
125324616|NCT04672239|450821523|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
125324617|NCT04672239|450821521|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
125324618|NCT04672239|450821522|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
125324619|NCT04672239|450821523|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
125324620|NCT04672239|450821521|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
125324621|NCT04672239|450821522|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
125324622|NCT04672239|450821523|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
125324623|NCT04672239|450821521|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
125324624|NCT04672239|450821522|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
125324625|NCT04672239|450821523|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
125324626|NCT04672239|450821521|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
125324627|NCT04672239|450821522|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
125324628|NCT04672239|450821523|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
125324629|NCT04672239|450821521|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
125324630|NCT04672239|450821522|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
125324631|NCT04672239|450821523|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
125324632|NCT05408429|450821529|FG000|Overall Study|Lost to Follow-up|1|||
125324633|NCT05408429|450821530|FG001|Overall Study|Lost to Follow-up|1|||
125324634|NCT05408429|450821531|FG002|Overall Study|Lost to Follow-up|0|||
125324635|NCT05408429|450821529|FG000|Overall Study|Withdrawal by Subject|5|||
125324636|NCT05408429|450821530|FG001|Overall Study|Withdrawal by Subject|0|||
125324637|NCT05408429|450821531|FG002|Overall Study|Withdrawal by Subject|1|||
125324638|NCT01074970|450821533|FG000|Overall Study|Never Treated|0|||
125324639|NCT01074970|450821534|FG001|Overall Study|Never Treated|0|||
125324640|NCT01074970|450821535|FG002|Overall Study|Never Treated|8|||
125324641|NCT01074970|450821536|FG003|Overall Study|Never Treated|1|||
125324642|NCT01074970|450821533|FG000|Overall Study|Adverse Event|1|||
125324643|NCT01074970|450821534|FG001|Overall Study|Adverse Event|0|||
125324644|NCT01074970|450821535|FG002|Overall Study|Adverse Event|4|||
125324645|NCT01074970|450821536|FG003|Overall Study|Adverse Event|3|||
125324646|NCT01074970|450821533|FG000|Overall Study|Disease progression during treatment|3|||
125324647|NCT01074970|450821534|FG001|Overall Study|Disease progression during treatment|1|||
125324648|NCT01074970|450821535|FG002|Overall Study|Disease progression during treatment|2|||
125324649|NCT01074970|450821536|FG003|Overall Study|Disease progression during treatment|9|||
125324650|NCT01074970|450821533|FG000|Overall Study|Lost to Follow-up|0|||
125324651|NCT01074970|450821534|FG001|Overall Study|Lost to Follow-up|0|||
125324652|NCT01074970|450821535|FG002|Overall Study|Lost to Follow-up|1|||
125324653|NCT01074970|450821536|FG003|Overall Study|Lost to Follow-up|0|||
125324654|NCT01074970|450821533|FG000|Overall Study|Withdrawal by Subject|0|||
125324655|NCT01074970|450821534|FG001|Overall Study|Withdrawal by Subject|0|||
125324656|NCT01074970|450821535|FG002|Overall Study|Withdrawal by Subject|6|||
125324657|NCT01074970|450821536|FG003|Overall Study|Withdrawal by Subject|4|||
125324658|NCT05565742|450821541|FG000|Overall Study|Withdrawal by Subject|0|||
125324659|NCT05565742|450821542|FG001|Overall Study|Withdrawal by Subject|0|||
125324660|NCT05565742|450821543|FG002|Overall Study|Withdrawal by Subject|2|||
125324661|NCT05565742|450821544|FG003|Overall Study|Withdrawal by Subject|2|||
125324662|NCT05565742|450821545|FG004|Overall Study|Withdrawal by Subject|2|||
125324663|NCT05565742|450821541|FG000|Overall Study|Death|1|||
125324664|NCT05565742|450821542|FG001|Overall Study|Death|0|||
125324665|NCT05565742|450821543|FG002|Overall Study|Death|0|||
125324666|NCT05565742|450821544|FG003|Overall Study|Death|0|||
125324667|NCT05565742|450821545|FG004|Overall Study|Death|0|||
125324668|NCT05565742|450821541|FG000|Overall Study|Participant Travelled Abroad|0|||
125324669|NCT05565742|450821542|FG001|Overall Study|Participant Travelled Abroad|0|||
125324670|NCT05565742|450821543|FG002|Overall Study|Participant Travelled Abroad|0|||
125324671|NCT05565742|450821544|FG003|Overall Study|Participant Travelled Abroad|0|||
125324672|NCT05565742|450821545|FG004|Overall Study|Participant Travelled Abroad|1|||
125324673|NCT02855125|450821546|FG000|Overall Study|Withdrawal by Subject|2|||
125324674|NCT02855125|450821547|FG001|Overall Study|Withdrawal by Subject|2|||
125324675|NCT02855125|450821546|FG000|Overall Study|Clinical Disease Progression|5|||
125324676|NCT02855125|450821547|FG001|Overall Study|Clinical Disease Progression|4|||
125324677|NCT02855125|450821546|FG000|Overall Study|Radiologic Disease Progression|36|||
125324678|NCT02855125|450821547|FG001|Overall Study|Radiologic Disease Progression|39|||
125324679|NCT02855125|450821546|FG000|Overall Study|Adverse Event|11|||
125324680|NCT02855125|450821547|FG001|Overall Study|Adverse Event|7|||
125663093|NCT01169987|452056171|FG000|Overall Study|Lost to Follow-up|24|||
125663094|NCT01169987|452056171|FG000|Overall Study|Other|4|||
125324681|NCT02855125|450821546|FG000|Overall Study|Physician Decision|1|||
125324682|NCT02855125|450821547|FG001|Overall Study|Physician Decision|0|||
125324683|NCT02855125|450821546|FG000|Overall Study|On Treatment|9|||
125324684|NCT02855125|450821547|FG001|Overall Study|On Treatment|11|||
125324685|NCT02855125|450821546|FG000|Overall Study|Randomized but not treated|0|||
125324686|NCT02855125|450821547|FG001|Overall Study|Randomized but not treated|1|||
125324687|NCT04467905|450821548|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
125324688|NCT04467905|450821549|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
125324689|NCT04467905|450821550|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
125324690|NCT04467905|450821548|FG000|Overall Study|Conversion to SR|0|||
125324691|NCT04467905|450821549|FG001|Overall Study|Conversion to SR|0|||
125324692|NCT04467905|450821550|FG002|Overall Study|Conversion to SR|3|||
125324693|NCT04467905|450821548|FG000|Overall Study|Technical issue with Holter ECG|0|||
125324694|NCT04467905|450821549|FG001|Overall Study|Technical issue with Holter ECG|0|||
125324695|NCT04467905|450821550|FG002|Overall Study|Technical issue with Holter ECG|3|||
125324696|NCT04467905|450821548|FG000|Overall Study|Hemodynamic instability|0|||
125324697|NCT04467905|450821549|FG001|Overall Study|Hemodynamic instability|0|||
125324698|NCT04467905|450821550|FG002|Overall Study|Hemodynamic instability|1|||
125324699|NCT04467905|450821548|FG000|Overall Study|Site misinterpretation of protocol|0|||
125324700|NCT04467905|450821549|FG001|Overall Study|Site misinterpretation of protocol|0|||
125324701|NCT04467905|450821550|FG002|Overall Study|Site misinterpretation of protocol|1|||
125324702|NCT02419001|450822568|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
125324703|NCT02419001|450822569|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
125324704|NCT00744497|450822570|FG000|Overall Study|Withdrawal by Subject|21|||
125324705|NCT00744497|450822571|FG001|Overall Study|Withdrawal by Subject|18|||
125324706|NCT00744497|450822570|FG000|Overall Study|Death|11|||
125324707|NCT00744497|450822571|FG001|Overall Study|Death|9|||
125324708|NCT00744497|450822570|FG000|Overall Study|Lost to Follow-up|4|||
125324709|NCT00744497|450822571|FG001|Overall Study|Lost to Follow-up|2|||
125324710|NCT00744497|450822570|FG000|Overall Study|Poor compliance/noncompliance|9|||
125324711|NCT00744497|450822571|FG001|Overall Study|Poor compliance/noncompliance|5|||
125324712|NCT00744497|450822570|FG000|Overall Study|No longer meets study criteria|7|||
125324713|NCT00744497|450822571|FG001|Overall Study|No longer meets study criteria|3|||
125324714|NCT00744497|450822570|FG000|Overall Study|Administrative Reason By Sponsor|25|||
125324715|NCT00744497|450822571|FG001|Overall Study|Administrative Reason By Sponsor|8|||
125324716|NCT00744497|450822570|FG000|Overall Study|Disease progression|312|||
125324717|NCT00744497|450822571|FG001|Overall Study|Disease progression|219|||
125324718|NCT00744497|450822570|FG000|Overall Study|Study drug toxicity|68|||
125324719|NCT00744497|450822571|FG001|Overall Study|Study drug toxicity|141|||
125324720|NCT00744497|450822570|FG000|Overall Study|Adverse event unrelated to study drug|78|||
125324721|NCT00744497|450822571|FG001|Overall Study|Adverse event unrelated to study drug|122|||
125324722|NCT00744497|450822570|FG000|Overall Study|Patient requested to stop study drug|65|||
125324723|NCT00744497|450822571|FG001|Overall Study|Patient requested to stop study drug|80|||
125324724|NCT00744497|450822570|FG000|Overall Study|Maximum clinical benefit|141|||
125663095|NCT00386100|452056172|FG000|Overall Study|Did not receive study medication|6|||
125663096|NCT00386100|452056173|FG001|Overall Study|Did not receive study medication|4|||
125663097|NCT00386100|452056172|FG000|Overall Study|Adverse Event|15|||
125663098|NCT00386100|452056173|FG001|Overall Study|Adverse Event|25|||
125663099|NCT00386100|452056172|FG000|Overall Study|Death|0|||
125663100|NCT00386100|452056173|FG001|Overall Study|Death|1|||
125663101|NCT00386100|452056172|FG000|Overall Study|Insufficient therapeutic effect|30|||
125663102|NCT00386100|452056173|FG001|Overall Study|Insufficient therapeutic effect|6|||
125663103|NCT00386100|452056172|FG000|Overall Study|Lost to Follow-up|29|||
125663104|NCT00386100|452056173|FG001|Overall Study|Lost to Follow-up|29|||
125663105|NCT00386100|452056172|FG000|Overall Study|Non-compliance|18|||
125663106|NCT00386100|452056173|FG001|Overall Study|Non-compliance|19|||
125663107|NCT00386100|452056172|FG000|Overall Study|Protocol Violation|5|||
125663108|NCT00386100|452056173|FG001|Overall Study|Protocol Violation|3|||
125663109|NCT00386100|452056172|FG000|Overall Study|Withdrawal by Subject|32|||
125324725|NCT00744497|450822571|FG001|Overall Study|Maximum clinical benefit|142|||
125324726|NCT00744497|450822570|FG000|Overall Study|Not defined|19|||
125324727|NCT00744497|450822571|FG001|Overall Study|Not defined|13|||
125324728|NCT03819114|450822574|FG000|Overall Study|Protocol Violation|0|||
125324729|NCT03819114|450822575|FG001|Overall Study|Protocol Violation|1|||
125324730|NCT03819114|450822576|FG002|Overall Study|Protocol Violation|1|||
125324731|NCT03819114|450822577|FG003|Overall Study|Protocol Violation|0|||
125324732|NCT03819114|450822574|FG000|Overall Study|Lost to Follow-up|0|||
125324733|NCT03819114|450822575|FG001|Overall Study|Lost to Follow-up|0|||
125324734|NCT03819114|450822576|FG002|Overall Study|Lost to Follow-up|1|||
125324735|NCT03819114|450822577|FG003|Overall Study|Lost to Follow-up|0|||
125324736|NCT02379728|450822578|FG000|Overall Study|Lost to Follow-up|1|||
125324737|NCT02379728|450822579|FG001|Overall Study|Lost to Follow-up|0|||
125324738|NCT02379728|450822580|FG002|Overall Study|Lost to Follow-up|3|||
125324739|NCT02379728|450822581|FG003|Overall Study|Lost to Follow-up|0|||
125324740|NCT02379728|450822578|FG000|Overall Study|Withdrawal by Subject|5|||
125324741|NCT02379728|450822579|FG001|Overall Study|Withdrawal by Subject|0|||
125324742|NCT02379728|450822580|FG002|Overall Study|Withdrawal by Subject|5|||
125324743|NCT02379728|450822581|FG003|Overall Study|Withdrawal by Subject|3|||
125324744|NCT02379728|450822578|FG000|Overall Study|Protocol Violation|0|||
125324745|NCT02379728|450822579|FG001|Overall Study|Protocol Violation|0|||
125324746|NCT02379728|450822580|FG002|Overall Study|Protocol Violation|2|||
125324747|NCT02379728|450822581|FG003|Overall Study|Protocol Violation|0|||
125324748|NCT05101122|450822585|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
125324749|NCT05101122|450822585|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
125324750|NCT05101122|450822585|FG000|AD313 80/5|Withdrawal by Subject|1|||
125324751|NCT05101122|450822585|FG000|AD313 80/10|Physician Decision|1|||
125324752|NCT03131219|450822586|FG000|Initial Evaluation Period|Adverse Event|2|||
125324753|NCT03131219|450822587|FG001|Initial Evaluation Period|Adverse Event|0|||
125324754|NCT03131219|450822586|FG000|Initial Evaluation Period|Protocol Violation|1|||
125324755|NCT03131219|450822587|FG001|Initial Evaluation Period|Protocol Violation|0|||
125324756|NCT03131219|450822586|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
125324757|NCT03131219|450822587|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
125324758|NCT03131219|450822586|FG000|Initial Evaluation Period|Physician Decision|1|||
125324759|NCT03131219|450822587|FG001|Initial Evaluation Period|Physician Decision|0|||
125324760|NCT03131219|450822586|FG000|Extension Period|Physician Decision|1|||
125324761|NCT03131219|450822587|FG001|Extension Period|Physician Decision|0|||
125324762|NCT04945733|450822590|FG000|Overall Study|Physician Decision|1|||
125324763|NCT04945733|450822591|FG001|Overall Study|Physician Decision|3|||
125324764|NCT04945733|450822592|FG002|Overall Study|Physician Decision|0|||
125324765|NCT04945733|450822590|FG000|Overall Study|Withdrawal by Subject|3|||
125663110|NCT00386100|452056173|FG001|Overall Study|Withdrawal by Subject|31|||
125663111|NCT00386100|452056172|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
125663112|NCT00386100|452056173|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
125663113|NCT00386100|452056172|FG000|Overall Study|BMD <2.5|1|||
125663114|NCT00386100|452056173|FG001|Overall Study|BMD <2.5|0|||
125663115|NCT00386100|452056172|FG000|Overall Study|Consecutive elevated Hba1C|1|||
125663116|NCT00386100|452056173|FG001|Overall Study|Consecutive elevated Hba1C|0|||
125663117|NCT00386100|452056172|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
125663118|NCT00386100|452056173|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
125663119|NCT00386100|452056172|FG000|Overall Study|Laboratory findings|1|||
125663120|NCT00386100|452056173|FG001|Overall Study|Laboratory findings|0|||
125663121|NCT00386100|452056172|FG000|Overall Study|Participant's concern due to CPK levels|1|||
125663122|NCT00386100|452056173|FG001|Overall Study|Participant's concern due to CPK levels|0|||
125663123|NCT00386100|452056172|FG000|Overall Study|Participant moving out of state|2|||
125663124|NCT00386100|452056173|FG001|Overall Study|Participant moving out of state|0|||
125663125|NCT00386100|452056172|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
125663126|NCT00386100|452056173|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
125663127|NCT00386100|452056172|FG000|Overall Study|Didn't meet entry criteria|1|||
125663128|NCT00386100|452056173|FG001|Overall Study|Didn't meet entry criteria|1|||
125663129|NCT00386100|452056172|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
125663130|NCT00386100|452056173|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
125663131|NCT00386100|452056172|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
125663132|NCT00386100|452056173|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
125663133|NCT00386100|452056172|FG000|Overall Study|Bad metabolic control & patient security|1|||
125663134|NCT00386100|452056173|FG001|Overall Study|Bad metabolic control & patient security|0|||
125663135|NCT00386100|452056172|FG000|Overall Study|Bone loss by DXA bone scan|1|||
125663136|NCT00386100|452056173|FG001|Overall Study|Bone loss by DXA bone scan|0|||
125663137|NCT00386100|452056172|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
125663138|NCT00386100|452056173|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
125663139|NCT00386100|452056172|FG000|Overall Study|7.6% bone loss|1|||
125663140|NCT00386100|452056173|FG001|Overall Study|7.6% bone loss|0|||
125663141|NCT00386100|452056172|FG000|Overall Study|Osteoporosis|0|||
125663142|NCT00386100|452056173|FG001|Overall Study|Osteoporosis|1|||
125324766|NCT04945733|450822591|FG001|Overall Study|Withdrawal by Subject|3|||
125324767|NCT04945733|450822592|FG002|Overall Study|Withdrawal by Subject|0|||
125324768|NCT01709721|450822595|FG000|Open Label Phase|Withdrawal by Subject|0|||
125324769|NCT01709721|450822596|FG001|Open Label Phase|Withdrawal by Subject|0|||
125324770|NCT01709721|450822597|FG002|Open Label Phase|Withdrawal by Subject|5|||
125324771|NCT01709721|450822595|FG000|Open Label Phase|Adverse Event|0|||
125663143|NCT00386100|452056172|FG000|Overall Study|Positive pregnancy test|1|||
125663144|NCT00386100|452056173|FG001|Overall Study|Positive pregnancy test|3|||
125663145|NCT00386100|452056172|FG000|Overall Study|Out of country for 5 months|1|||
125663146|NCT00386100|452056173|FG001|Overall Study|Out of country for 5 months|0|||
125324772|NCT01709721|450822596|FG001|Open Label Phase|Adverse Event|0|||
125324773|NCT01709721|450822597|FG002|Open Label Phase|Adverse Event|8|||
125324774|NCT01709721|450822595|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
125324775|NCT01709721|450822596|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
125324776|NCT01709721|450822597|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
125324777|NCT01709721|450822595|FG000|Open Label Phase|Investigator Decision|0|||
125324778|NCT01709721|450822596|FG001|Open Label Phase|Investigator Decision|0|||
125324779|NCT01709721|450822597|FG002|Open Label Phase|Investigator Decision|1|||
125324780|NCT01709721|450822595|FG000|Open Label Phase|Sponsor Decision|0|||
125324781|NCT01709721|450822596|FG001|Open Label Phase|Sponsor Decision|0|||
125324782|NCT01709721|450822597|FG002|Open Label Phase|Sponsor Decision|2|||
125324783|NCT01709721|450822595|FG000|Open Label Phase|Protocol Violation|0|||
125324784|NCT01709721|450822596|FG001|Open Label Phase|Protocol Violation|0|||
125324785|NCT01709721|450822597|FG002|Open Label Phase|Protocol Violation|1|||
125324786|NCT01709721|450822595|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
125324787|NCT01709721|450822596|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
125324788|NCT01709721|450822597|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
125324789|NCT01709721|450822595|FG000|Open Label Phase|Inadequate Pain Control|0|||
125324790|NCT01709721|450822596|FG001|Open Label Phase|Inadequate Pain Control|0|||
125324791|NCT01709721|450822597|FG002|Open Label Phase|Inadequate Pain Control|37|||
125324792|NCT01709721|450822595|FG000|Open Label Phase|Other, Specify in text field in database|0|||
125324793|NCT01709721|450822596|FG001|Open Label Phase|Other, Specify in text field in database|0|||
125324794|NCT01709721|450822597|FG002|Open Label Phase|Other, Specify in text field in database|14|||
125324795|NCT01709721|450822595|FG000|Randomized Phase|Adverse Event|0|||
125324796|NCT01709721|450822596|FG001|Randomized Phase|Adverse Event|1|||
125324797|NCT01709721|450822597|FG002|Randomized Phase|Adverse Event|0|||
125324798|NCT01709721|450822595|FG000|Randomized Phase|Lost to Follow-up|1|||
125324799|NCT01709721|450822596|FG001|Randomized Phase|Lost to Follow-up|0|||
125324800|NCT01709721|450822597|FG002|Randomized Phase|Lost to Follow-up|0|||
125324801|NCT01709721|450822595|FG000|Randomized Phase|Inadequate Pain Control|1|||
125324802|NCT01709721|450822596|FG001|Randomized Phase|Inadequate Pain Control|2|||
125324803|NCT01709721|450822597|FG002|Randomized Phase|Inadequate Pain Control|0|||
125324804|NCT01709721|450822595|FG000|Randomized Phase|Other, Specify text field in database|1|||
125324805|NCT01709721|450822596|FG001|Randomized Phase|Other, Specify text field in database|3|||
125324806|NCT01709721|450822597|FG002|Randomized Phase|Other, Specify text field in database|0|||
125324807|NCT00763035|450822598|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
125324808|NCT00763035|450822599|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
125324809|NCT00763035|450822598|FG000|First Intervention|Adverse Event|0|||
125324810|NCT00763035|450822599|FG001|First Intervention|Adverse Event|1|||
125324811|NCT00763035|450822598|FG000|Second Intervention|Adverse Event|1|||
125324812|NCT00763035|450822599|FG001|Second Intervention|Adverse Event|0|||
125324813|NCT00763035|450822598|FG000|Second Intervention|Physician Decision|2|||
125324814|NCT00763035|450822599|FG001|Second Intervention|Physician Decision|0|||
125324815|NCT02131259|450822600|FG000|Overall Study|Progressive disease|751|||
125324816|NCT02131259|450822600|FG000|Overall Study|Adverse Event|341|||
125324817|NCT02131259|450822600|FG000|Overall Study|Lost to Follow-up|7|||
125324818|NCT02131259|450822600|FG000|Overall Study|Relocation|32|||
125324819|NCT02131259|450822600|FG000|Overall Study|Other|63|||
125324820|NCT02131259|450822600|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
125324821|NCT02131259|450822600|FG000|Overall Study|Progressive disease/relocation|1|||
125324822|NCT02131259|450822600|FG000|Overall Study|Progressive disease/other|2|||
125324823|NCT02131259|450822600|FG000|Overall Study|AE/lost to follow-up|1|||
125324824|NCT02131259|450822600|FG000|Overall Study|AE/other|1|||
125324825|NCT02131259|450822600|FG000|Overall Study|Progressive disease/AE/other|1|||
125663147|NCT00386100|452056172|FG000|Overall Study|Hb1Ac >8%|0|||
125663148|NCT00386100|452056173|FG001|Overall Study|Hb1Ac >8%|1|||
125663149|NCT00386100|452056172|FG000|Overall Study|Participant randomized in error|1|||
125663150|NCT00386100|452056173|FG001|Overall Study|Participant randomized in error|0|||
125663151|NCT01706770|452056176|FG000|Overall Study|Lost to Follow-up|1|||
125663152|NCT01706770|452056177|FG001|Overall Study|Lost to Follow-up|0|||
125663153|NCT01706770|452056176|FG000|Overall Study|Physician Decision|1|||
125663154|NCT01706770|452056177|FG001|Overall Study|Physician Decision|0|||
125663155|NCT00886782|452056181|FG000|Overall Study|Disease progression|3|||
125663156|NCT00886782|452056182|FG001|Overall Study|Disease progression|3|||
125324826|NCT02131259|450822600|FG000|Overall Study|Missing|3|||
125324827|NCT03219723|450822601|FG000|Overall Study|Case Report Forms Uncollected|6|||
125324828|NCT03219723|450822601|FG000|Overall Study|Protocol Deviation|4|||
125324829|NCT03137381|450822602|FG000|Overall Study|Adverse Event|3|||
125324830|NCT03137381|450822603|FG001|Overall Study|Adverse Event|0|||
125663157|NCT00886782|452056183|FG002|Overall Study|Disease progression|3|||
125324831|NCT03137381|450822604|FG002|Overall Study|Adverse Event|2|||
125324832|NCT03137381|450822605|FG003|Overall Study|Adverse Event|0|||
125324833|NCT03137381|450822602|FG000|Overall Study|Lost to Follow-up|2|||
125324834|NCT03137381|450822603|FG001|Overall Study|Lost to Follow-up|1|||
125324835|NCT03137381|450822604|FG002|Overall Study|Lost to Follow-up|1|||
125324836|NCT03137381|450822605|FG003|Overall Study|Lost to Follow-up|0|||
125324837|NCT03137381|450822602|FG000|Overall Study|Protocol deviation|1|||
125324838|NCT03137381|450822603|FG001|Overall Study|Protocol deviation|1|||
125324839|NCT03137381|450822604|FG002|Overall Study|Protocol deviation|0|||
125324840|NCT03137381|450822605|FG003|Overall Study|Protocol deviation|1|||
125324841|NCT03137381|450822602|FG000|Overall Study|Withdrawal by Investigator|0|||
125324842|NCT03137381|450822603|FG001|Overall Study|Withdrawal by Investigator|1|||
125324843|NCT03137381|450822604|FG002|Overall Study|Withdrawal by Investigator|1|||
125324844|NCT03137381|450822605|FG003|Overall Study|Withdrawal by Investigator|0|||
125324845|NCT03137381|450822602|FG000|Overall Study|Withdrawal by Subject|3|||
125324846|NCT03137381|450822603|FG001|Overall Study|Withdrawal by Subject|4|||
125324847|NCT03137381|450822604|FG002|Overall Study|Withdrawal by Subject|3|||
125324848|NCT03137381|450822605|FG003|Overall Study|Withdrawal by Subject|0|||
125324849|NCT03137381|450822602|FG000|Overall Study|Pregnancy|0|||
125324850|NCT03137381|450822603|FG001|Overall Study|Pregnancy|0|||
125324851|NCT03137381|450822604|FG002|Overall Study|Pregnancy|1|||
125324852|NCT03137381|450822605|FG003|Overall Study|Pregnancy|0|||
125324853|NCT00459316|450822610|FG000|Steps 1 & 2|Other eligibility failure|1|||
125324854|NCT00459316|450822611|FG001|Steps 1 & 2|Other eligibility failure|1|||
125324855|NCT00459316|450822612|FG002|Steps 1 & 2|Other eligibility failure|0|||
125324856|NCT00459316|450822610|FG000|Steps 1 & 2|Death|1|||
125324857|NCT00459316|450822611|FG001|Steps 1 & 2|Death|1|||
125324858|NCT00459316|450822612|FG002|Steps 1 & 2|Death|0|||
125324859|NCT00459316|450822610|FG000|Steps 1 & 2|Not able to get to clinic|7|||
125324860|NCT00459316|450822611|FG001|Steps 1 & 2|Not able to get to clinic|4|||
125324861|NCT00459316|450822612|FG002|Steps 1 & 2|Not able to get to clinic|0|||
125324862|NCT00459316|450822610|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
125324863|NCT00459316|450822611|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
125324864|NCT00459316|450822612|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
125324865|NCT00459316|450822610|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
125324866|NCT00459316|450822611|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
125324867|NCT00459316|450822612|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
125324868|NCT00459316|450822610|FG000|Steps 1 & 2|Lost to Follow-up|5|||
125324869|NCT00459316|450822611|FG001|Steps 1 & 2|Lost to Follow-up|0|||
125324870|NCT00459316|450822612|FG002|Steps 1 & 2|Lost to Follow-up|2|||
125324871|NCT00459316|450822610|FG000|Step 3|Withdrawal by Subject|3|||
125324872|NCT00459316|450822611|FG001|Step 3|Withdrawal by Subject|0|||
125324873|NCT00459316|450822612|FG002|Step 3|Withdrawal by Subject|1|||
125663158|NCT00886782|452056181|FG000|Overall Study|Study drug toxicity|0|||
125663159|NCT00886782|452056182|FG001|Overall Study|Study drug toxicity|0|||
125663160|NCT00886782|452056183|FG002|Overall Study|Study drug toxicity|1|||
125663161|NCT00886782|452056181|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
125663162|NCT00886782|452056182|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
125663163|NCT00886782|452056183|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
125663164|NCT01612702|452056184|FG000|Overall Study|Protocol Violation|11|||
125663165|NCT01612702|452056185|FG001|Overall Study|Protocol Violation|11|||
125663166|NCT03636542|452056186|FG000|Overall Study|Lost to Follow-up|1|||
125663167|NCT03636542|452056187|FG001|Overall Study|Lost to Follow-up|1|||
125663168|NCT03636542|452056186|FG000|Overall Study|Physician Decision|0|||
125663169|NCT03636542|452056187|FG001|Overall Study|Physician Decision|1|||
125663170|NCT03636542|452056186|FG000|Overall Study|Withdrawal by Subject|1|||
125663171|NCT03636542|452056187|FG001|Overall Study|Withdrawal by Subject|0|||
125663172|NCT01542736|452056190|FG000|Overall Study|Death|1|||
125663173|NCT03674827|452056191|FG000|Treatment Phase|Adverse Event|0|||
125663174|NCT03674827|452056192|FG001|Treatment Phase|Adverse Event|0|||
125663175|NCT03674827|452056193|FG002|Treatment Phase|Adverse Event|0|||
125663176|NCT03674827|452056194|FG003|Treatment Phase|Adverse Event|0|||
125663177|NCT03674827|452056195|FG004|Treatment Phase|Adverse Event|0|||
125663178|NCT03674827|452056196|FG005|Treatment Phase|Adverse Event|2|||
125663179|NCT03674827|452056191|FG000|Treatment Phase|Death|2|||
125324874|NCT01980017|450822613|FG000|Overall Study|Lost to Follow-up|30|||
125324875|NCT01980017|450822614|FG001|Overall Study|Lost to Follow-up|21|||
125324876|NCT01980017|450822613|FG000|Overall Study|Death|0|||
125324877|NCT01980017|450822614|FG001|Overall Study|Death|1|||
125324878|NCT03044106|450822615|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
125324879|NCT03044106|450822616|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
125324880|NCT02057250|450822617|FG000|AID Assessment Phase|Adverse Event|3|||
125324881|NCT02057250|450822618|FG001|AID Assessment Phase|Adverse Event|2|||
125324882|NCT02057250|450822619|FG002|AID Assessment Phase|Adverse Event|6|||
125663180|NCT03674827|452056192|FG001|Treatment Phase|Death|0|||
125663181|NCT03674827|452056193|FG002|Treatment Phase|Death|0|||
125663182|NCT03674827|452056194|FG003|Treatment Phase|Death|0|||
125324883|NCT02057250|450822620|FG003|AID Assessment Phase|Adverse Event|1|||
125324884|NCT02057250|450822621|FG004|AID Assessment Phase|Adverse Event|0|||
125663183|NCT03674827|452056195|FG004|Treatment Phase|Death|1|||
125324885|NCT02057250|450822617|FG000|AID Assessment Phase|Other than specified above|1|||
125324886|NCT02057250|450822618|FG001|AID Assessment Phase|Other than specified above|1|||
125324887|NCT02057250|450822619|FG002|AID Assessment Phase|Other than specified above|1|||
125324888|NCT02057250|450822620|FG003|AID Assessment Phase|Other than specified above|1|||
125324889|NCT02057250|450822621|FG004|AID Assessment Phase|Other than specified above|0|||
125324890|NCT02057250|450822617|FG000|Extension Phase|Adverse Event|0|||
125324891|NCT02057250|450822618|FG001|Extension Phase|Adverse Event|0|||
125324892|NCT02057250|450822619|FG002|Extension Phase|Adverse Event|0|||
125324893|NCT02057250|450822620|FG003|Extension Phase|Adverse Event|0|||
125324894|NCT02057250|450822621|FG004|Extension Phase|Adverse Event|15|||
125324895|NCT02057250|450822617|FG000|Extension Phase|Lack of Efficacy|0|||
125324896|NCT02057250|450822618|FG001|Extension Phase|Lack of Efficacy|0|||
125324897|NCT02057250|450822619|FG002|Extension Phase|Lack of Efficacy|0|||
125324898|NCT02057250|450822620|FG003|Extension Phase|Lack of Efficacy|0|||
125324899|NCT02057250|450822621|FG004|Extension Phase|Lack of Efficacy|10|||
125324900|NCT02057250|450822617|FG000|Extension Phase|Entered in this period but not treated|0|||
125324901|NCT02057250|450822618|FG001|Extension Phase|Entered in this period but not treated|0|||
125663184|NCT03674827|452056196|FG005|Treatment Phase|Death|0|||
125663185|NCT03674827|452056191|FG000|Treatment Phase|Progressive Disease|0|||
125663186|NCT03674827|452056192|FG001|Treatment Phase|Progressive Disease|4|||
125663187|NCT03674827|452056193|FG002|Treatment Phase|Progressive Disease|3|||
125663188|NCT03674827|452056194|FG003|Treatment Phase|Progressive Disease|4|||
125663189|NCT03674827|452056195|FG004|Treatment Phase|Progressive Disease|4|||
125663190|NCT03674827|452056196|FG005|Treatment Phase|Progressive Disease|9|||
125663191|NCT03674827|452056191|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
125663192|NCT03674827|452056192|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
125663193|NCT03674827|452056193|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
125663194|NCT03674827|452056194|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
125324902|NCT02057250|450822619|FG002|Extension Phase|Entered in this period but not treated|0|||
125324903|NCT02057250|450822620|FG003|Extension Phase|Entered in this period but not treated|0|||
125324904|NCT02057250|450822621|FG004|Extension Phase|Entered in this period but not treated|4|||
125324905|NCT02057250|450822617|FG000|Extension Phase|Other than specified above|0|||
125324906|NCT02057250|450822618|FG001|Extension Phase|Other than specified above|0|||
125324907|NCT02057250|450822619|FG002|Extension Phase|Other than specified above|0|||
125324908|NCT02057250|450822620|FG003|Extension Phase|Other than specified above|0|||
125324909|NCT02057250|450822621|FG004|Extension Phase|Other than specified above|7|||
125324910|NCT00423579|450822625|FG000|Overall Study|Lost to Follow-up|3|||
125324911|NCT00423579|450822626|FG001|Overall Study|Lost to Follow-up|0|||
125324912|NCT00423579|450822625|FG000|Overall Study|Protocol Violation|1|||
125324913|NCT00423579|450822626|FG001|Overall Study|Protocol Violation|3|||
125324914|NCT00423579|450822625|FG000|Overall Study|Diagnosis of diabetes|0|||
125324915|NCT00423579|450822626|FG001|Overall Study|Diagnosis of diabetes|1|||
125324916|NCT02161016|450822629|FG000|Overall Study|withdrawn by IRB|1|||
125324917|NCT00003475|450822630|FG000|Overall Study|Not evaluable|13|||
125324918|NCT03675126|450822634|FG000|Overall Study|Study Terminated by Sponsor|9|||
125324919|NCT03675126|450822634|FG000|Overall Study|Death|2|||
125324920|NCT03675126|450822634|FG000|Overall Study|Withdrawal by Subject|4|||
125324921|NCT00001959|450822635|FG000|Overall Study|newly diagnosed colon cancer|1|||
125324922|NCT00001959|450822635|FG000|Overall Study|disabling sedation|1|||
125324923|NCT00001959|450822635|FG000|Overall Study|non-compliance|1|||
125324924|NCT04189952|450822640|FG000|Follow-up Period|Death|1|||
125324925|NCT04189952|450822640|FG000|Follow-up Period|Withdrawal by Subject|1|||
125324926|NCT01052493|450822641|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
125324927|NCT01052493|450822642|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
125324928|NCT01052493|450822643|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
125324929|NCT01498068|450822644|FG000|Overall Study|Withdrawal by Subject|1|||
125324930|NCT01498068|450822645|FG001|Overall Study|Withdrawal by Subject|1|||
125324931|NCT01318915|450822648|FG000|Overall Study|Lost to Follow-up|1|||
125324932|NCT00453206|450822650|FG000|Overall Study|Death|1|||
125324933|NCT05523089|450822654|FG000|Overall Study|Withdrawal by Subject|1|||
125324934|NCT05523089|450822655|FG001|Overall Study|Withdrawal by Subject|0|||
125663195|NCT03674827|452056195|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
125663196|NCT03674827|452056196|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
125324935|NCT05523089|450822656|FG002|Overall Study|Withdrawal by Subject|0|||
125663197|NCT03674827|452056191|FG000|Treatment Phase|Withdrawal by Subject|0|||
125663198|NCT03674827|452056192|FG001|Treatment Phase|Withdrawal by Subject|0|||
125324936|NCT05523089|450822654|FG000|Overall Study|Lost to Follow-up|1|||
125324937|NCT05523089|450822655|FG001|Overall Study|Lost to Follow-up|0|||
125324938|NCT05523089|450822656|FG002|Overall Study|Lost to Follow-up|0|||
125324939|NCT02681523|450822657|FG000|Overall Study|Adverse Event|1|||
125324940|NCT02681523|450822657|FG000|Overall Study|Patient Non-compliance|1|||
125324941|NCT01899040|450822658|FG000|Overall Study|Randomized in error|0|||
125324942|NCT01899040|450822659|FG001|Overall Study|Randomized in error|1|||
125324943|NCT01899040|450822660|FG002|Overall Study|Randomized in error|1|||
125324944|NCT01899040|450822658|FG000|Overall Study|Adverse Event|3|||
125324945|NCT01899040|450822659|FG001|Overall Study|Adverse Event|1|||
125324946|NCT01899040|450822660|FG002|Overall Study|Adverse Event|2|||
125324947|NCT01899040|450822658|FG000|Overall Study|Unspecified reasons|4|||
125324948|NCT01899040|450822659|FG001|Overall Study|Unspecified reasons|4|||
125324949|NCT01899040|450822660|FG002|Overall Study|Unspecified reasons|0|||
125324950|NCT01899040|450822658|FG000|Overall Study|Compliance issues|1|||
125324951|NCT01899040|450822659|FG001|Overall Study|Compliance issues|2|||
125324952|NCT01899040|450822660|FG002|Overall Study|Compliance issues|0|||
125324953|NCT02638220|450822666|FG000|Overall Study|Lost to Follow-up|6|||
125324954|NCT02638220|450822666|FG000|Overall Study|Withdrawal by Subject|3|||
125324955|NCT02638220|450822666|FG000|Overall Study|Physician Decision|1|||
125324956|NCT02638220|450822666|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
125324957|NCT03204188|450822667|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
125324958|NCT03204188|450822667|FG000|Immunotherapy Phase (1 Year)|Death|1|||
125324959|NCT03204188|450822667|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
125324960|NCT03204188|450822667|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
125324961|NCT01198795|450824248|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
125324962|NCT01198795|450824248|FG000|Overall Study|Withdrawal by Subject|17|||
125324963|NCT01198795|450824248|FG000|Overall Study|Lost to Follow-up|15|||
125324964|NCT01198795|450824248|FG000|Overall Study|Adverse Event|9|||
125324965|NCT01198795|450824248|FG000|Overall Study|Lack of Efficacy|5|||
125324966|NCT01198795|450824248|FG000|Overall Study|Protocol Violation|2|||
125324967|NCT01198795|450824248|FG000|Overall Study|Other Reason|4|||
125324968|NCT00936715|450824281|FG000|Overall Study|Investigators Discretion|1|||
125324969|NCT00936715|450824281|FG000|Overall Study|Protocol Violation|1|||
125324970|NCT00936715|450824281|FG000|Overall Study|Safety or Tolerability Reasons|4|||
125324971|NCT02492763|450824282|FG000|Overall Study|Withdrawal by Subject|0|||
125324972|NCT02492763|450824283|FG001|Overall Study|Withdrawal by Subject|2|||
125324973|NCT02492763|450824284|FG002|Overall Study|Withdrawal by Subject|1|||
125324974|NCT02492763|450824285|FG003|Overall Study|Withdrawal by Subject|0|||
125324975|NCT02492763|450824282|FG000|Overall Study|Adverse Event|3|||
125324976|NCT02492763|450824283|FG001|Overall Study|Adverse Event|1|||
125324977|NCT02492763|450824284|FG002|Overall Study|Adverse Event|1|||
125324978|NCT02492763|450824285|FG003|Overall Study|Adverse Event|2|||
125324979|NCT02492763|450824282|FG000|Overall Study|Death|0|||
125324980|NCT02492763|450824283|FG001|Overall Study|Death|0|||
125324981|NCT02492763|450824284|FG002|Overall Study|Death|1|||
125324982|NCT02492763|450824285|FG003|Overall Study|Death|0|||
125324983|NCT02492763|450824282|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
125324984|NCT02492763|450824283|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
125324985|NCT02492763|450824284|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
125324986|NCT02492763|450824285|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
125324987|NCT02492763|450824282|FG000|Overall Study|Lost to Follow-up|0|||
125324988|NCT02492763|450824283|FG001|Overall Study|Lost to Follow-up|0|||
125324989|NCT02492763|450824284|FG002|Overall Study|Lost to Follow-up|1|||
125324990|NCT02492763|450824285|FG003|Overall Study|Lost to Follow-up|0|||
125324991|NCT02492763|450824282|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125324992|NCT02492763|450824283|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125324993|NCT02492763|450824284|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125324994|NCT02492763|450824285|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125324995|NCT02492763|450824282|FG000|Overall Study|Screen Failure|0|||
125324996|NCT02492763|450824283|FG001|Overall Study|Screen Failure|0|||
125324997|NCT02492763|450824284|FG002|Overall Study|Screen Failure|0|||
125324998|NCT02492763|450824285|FG003|Overall Study|Screen Failure|1|||
125324999|NCT02492763|450824282|FG000|Overall Study|Study Terminated by Sponsor|13|||
125325000|NCT02492763|450824283|FG001|Overall Study|Study Terminated by Sponsor|10|||
125325001|NCT02492763|450824284|FG002|Overall Study|Study Terminated by Sponsor|6|||
125325002|NCT02492763|450824285|FG003|Overall Study|Study Terminated by Sponsor|10|||
125325003|NCT01337960|450824286|FG000|Overall Study|Lost to Follow-up|1|||
125325004|NCT01337960|450824287|FG001|Overall Study|Lost to Follow-up|0|||
125325005|NCT01337960|450824288|FG002|Overall Study|Lost to Follow-up|0|||
125325006|NCT01337960|450824286|FG000|Overall Study|Withdrawal by Subject|1|||
125325007|NCT01337960|450824287|FG001|Overall Study|Withdrawal by Subject|0|||
125325008|NCT01337960|450824288|FG002|Overall Study|Withdrawal by Subject|0|||
125325009|NCT01772316|450824289|FG000|Overall Study|Serious adverse event|1|||
125325010|NCT01772316|450824289|FG000|Overall Study|Inform consent withdrawn|1|||
125325011|NCT01772316|450824289|FG000|Overall Study|Withdrawn by sponsor decision|5|||
125325012|NCT01747876|450824291|FG000|Overall Study|Adverse Event|1|||
125325013|NCT01747876|450824292|FG001|Overall Study|Adverse Event|0|||
125325014|NCT01747876|450824293|FG002|Overall Study|Adverse Event|2|||
125325015|NCT01747876|450824291|FG000|Overall Study|Withdrawal by Subject|0|||
125325016|NCT01747876|450824292|FG001|Overall Study|Withdrawal by Subject|1|||
125325017|NCT01747876|450824293|FG002|Overall Study|Withdrawal by Subject|1|||
125325018|NCT01747876|450824291|FG000|Overall Study|Disease progression|4|||
125325019|NCT01747876|450824292|FG001|Overall Study|Disease progression|13|||
125325020|NCT01747876|450824293|FG002|Overall Study|Disease progression|8|||
125325021|NCT01747876|450824291|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
125325022|NCT01747876|450824292|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
125325023|NCT01747876|450824293|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
125325024|NCT00914316|450824296|FG000|Phase 1|Physician Decision|4|||
125325025|NCT00914316|450824297|FG001|Phase 1|Physician Decision|0|||
125325026|NCT00914316|450824298|FG002|Phase 1|Physician Decision|1|||
125325027|NCT00914316|450824299|FG003|Phase 1|Physician Decision|2|||
125325028|NCT00914316|450824296|FG000|Phase 1|Withdrawal by Subject|0|||
125325029|NCT00914316|450824297|FG001|Phase 1|Withdrawal by Subject|2|||
125325030|NCT00914316|450824298|FG002|Phase 1|Withdrawal by Subject|4|||
125325031|NCT00914316|450824299|FG003|Phase 1|Withdrawal by Subject|0|||
125325032|NCT00914316|450824296|FG000|Phase 1|Adverse Event|1|||
125325033|NCT00914316|450824297|FG001|Phase 1|Adverse Event|0|||
125325034|NCT00914316|450824298|FG002|Phase 1|Adverse Event|0|||
125325035|NCT00914316|450824299|FG003|Phase 1|Adverse Event|0|||
125325036|NCT00914316|450824296|FG000|Phase 2|Withdrawal by Subject|1|||
125325037|NCT00914316|450824297|FG001|Phase 2|Withdrawal by Subject|0|||
125325038|NCT00914316|450824298|FG002|Phase 2|Withdrawal by Subject|1|||
125325039|NCT00914316|450824299|FG003|Phase 2|Withdrawal by Subject|0|||
125325040|NCT05660577|450824308|FG000|Overall Study|Discontinued|9|||
125325041|NCT03363841|450824311|FG000|Overall Study|Adverse Event|1|||
125325042|NCT03363841|450824311|FG000|Overall Study|Withdrawal by Subject|1|||
125325043|NCT03363841|450824311|FG000|Overall Study|Death|7|||
125325044|NCT03363841|450824311|FG000|Overall Study|Physician Decision|1|||
125325045|NCT01744977|450824312|FG000|Overall Study|Withdrawal by Subject|1|||
125325046|NCT01744977|450824313|FG001|Overall Study|Withdrawal by Subject|2|||
125325047|NCT01744977|450824312|FG000|Overall Study|Death|2|||
125325048|NCT01744977|450824313|FG001|Overall Study|Death|3|||
125210681|NCT02638259|450395635|FG001|Treatment Period 1|Withdrawal by Subject|6|||
125325049|NCT01744977|450824312|FG000|Overall Study|Lost to Follow-up|2|||
125325050|NCT01744977|450824313|FG001|Overall Study|Lost to Follow-up|0|||
125325051|NCT01744977|450824312|FG000|Overall Study|No longer meets inclusion|6|||
125325052|NCT01744977|450824313|FG001|Overall Study|No longer meets inclusion|0|||
125325053|NCT03879772|450824322|FG000|Overall Study|Adverse Event|2|||
125325054|NCT03879772|450824323|FG001|Overall Study|Adverse Event|2|||
125325055|NCT03879772|450824324|FG002|Overall Study|Adverse Event|3|||
125325056|NCT03879772|450824325|FG003|Overall Study|Adverse Event|4|||
125325057|NCT03879772|450824326|FG004|Overall Study|Adverse Event|3|||
125325058|NCT03879772|450824322|FG000|Overall Study|Treatment Failure|1|||
125325059|NCT03879772|450824323|FG001|Overall Study|Treatment Failure|0|||
125325060|NCT03879772|450824324|FG002|Overall Study|Treatment Failure|0|||
125325061|NCT03879772|450824325|FG003|Overall Study|Treatment Failure|2|||
125325062|NCT03879772|450824326|FG004|Overall Study|Treatment Failure|1|||
125325063|NCT03879772|450824322|FG000|Overall Study|Lost to Follow-up|0|||
125325064|NCT03879772|450824323|FG001|Overall Study|Lost to Follow-up|0|||
125325065|NCT03879772|450824324|FG002|Overall Study|Lost to Follow-up|0|||
125325066|NCT03879772|450824325|FG003|Overall Study|Lost to Follow-up|0|||
125325067|NCT03879772|450824326|FG004|Overall Study|Lost to Follow-up|1|||
125325068|NCT03879772|450824322|FG000|Overall Study|Withdrawal by Subject|0|||
125325069|NCT03879772|450824323|FG001|Overall Study|Withdrawal by Subject|1|||
125325070|NCT03879772|450824324|FG002|Overall Study|Withdrawal by Subject|3|||
125325071|NCT03879772|450824325|FG003|Overall Study|Withdrawal by Subject|1|||
125325072|NCT03879772|450824326|FG004|Overall Study|Withdrawal by Subject|1|||
125325073|NCT03879772|450824322|FG000|Overall Study|Protocol Violation|0|||
125325074|NCT03879772|450824323|FG001|Overall Study|Protocol Violation|0|||
125325075|NCT03879772|450824324|FG002|Overall Study|Protocol Violation|3|||
125325076|NCT03879772|450824325|FG003|Overall Study|Protocol Violation|1|||
125325077|NCT03879772|450824326|FG004|Overall Study|Protocol Violation|2|||
125325078|NCT03879772|450824322|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
125325079|NCT03879772|450824323|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
125325080|NCT03879772|450824324|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
125325081|NCT03879772|450824325|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
125325082|NCT03879772|450824326|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
125325083|NCT03818321|450824329|FG000|Overall Study|Withdrawal by Subject|1|||
125325084|NCT03818321|450824330|FG001|Overall Study|Withdrawal by Subject|2|||
125325085|NCT00106704|450824331|FG000|Overall Study|Adverse Event|10|||
125325086|NCT00106704|450824332|FG001|Overall Study|Adverse Event|7|||
125325087|NCT00106704|450824331|FG000|Overall Study|Death|2|||
125325088|NCT00106704|450824332|FG001|Overall Study|Death|1|||
125325089|NCT00106704|450824331|FG000|Overall Study|Lack of Efficacy|67|||
125325090|NCT00106704|450824332|FG001|Overall Study|Lack of Efficacy|69|||
125325091|NCT00106704|450824331|FG000|Overall Study|Lost to Follow-up|7|||
125325092|NCT00106704|450824332|FG001|Overall Study|Lost to Follow-up|3|||
125325093|NCT00106704|450824331|FG000|Overall Study|Pregnancy|1|||
125325094|NCT00106704|450824332|FG001|Overall Study|Pregnancy|0|||
125325095|NCT00106704|450824331|FG000|Overall Study|Protocol Violation|4|||
125325096|NCT00106704|450824332|FG001|Overall Study|Protocol Violation|7|||
125325097|NCT00106704|450824331|FG000|Overall Study|Withdrawal by Subject|14|||
125325098|NCT00106704|450824332|FG001|Overall Study|Withdrawal by Subject|21|||
125325099|NCT00106704|450824331|FG000|Overall Study|Patient moved|1|||
125325100|NCT00106704|450824332|FG001|Overall Study|Patient moved|0|||
125663199|NCT03674827|452056193|FG002|Treatment Phase|Withdrawal by Subject|0|||
125663200|NCT03674827|452056194|FG003|Treatment Phase|Withdrawal by Subject|0|||
125663201|NCT03674827|452056195|FG004|Treatment Phase|Withdrawal by Subject|0|||
125663202|NCT03674827|452056196|FG005|Treatment Phase|Withdrawal by Subject|1|||
125663203|NCT03674827|452056191|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
125663204|NCT03674827|452056192|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
125663205|NCT03674827|452056193|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
125325101|NCT00106704|450824331|FG000|Overall Study|Site terminated|0|||
125325102|NCT00106704|450824332|FG001|Overall Study|Site terminated|1|||
125325103|NCT00106704|450824331|FG000|Overall Study|Planned major surgery|1|||
125325104|NCT00106704|450824332|FG001|Overall Study|Planned major surgery|0|||
125663206|NCT03674827|452056194|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
125663207|NCT03674827|452056195|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
125663208|NCT03674827|452056196|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
125663209|NCT03674827|452056191|FG000|Treatment Phase|Other|0|||
125663210|NCT03674827|452056192|FG001|Treatment Phase|Other|1|||
125663211|NCT03674827|452056193|FG002|Treatment Phase|Other|0|||
125663212|NCT03674827|452056194|FG003|Treatment Phase|Other|0|||
125663213|NCT03674827|452056195|FG004|Treatment Phase|Other|0|||
125663214|NCT03674827|452056196|FG005|Treatment Phase|Other|1|||
125663215|NCT03674827|452056191|FG000|Long-Term Follow-up Phase|Death|2|||
125663216|NCT03674827|452056192|FG001|Long-Term Follow-up Phase|Death|4|||
125663217|NCT03674827|452056193|FG002|Long-Term Follow-up Phase|Death|2|||
125663218|NCT03674827|452056194|FG003|Long-Term Follow-up Phase|Death|3|||
125663219|NCT03674827|452056195|FG004|Long-Term Follow-up Phase|Death|2|||
125663220|NCT03674827|452056196|FG005|Long-Term Follow-up Phase|Death|6|||
125663221|NCT03674827|452056191|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
125663222|NCT03674827|452056192|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
125663223|NCT03674827|452056193|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
125663224|NCT03674827|452056194|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
125663225|NCT03674827|452056195|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
125663226|NCT03674827|452056196|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
125663227|NCT03674827|452056191|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
125663228|NCT03674827|452056192|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
125663229|NCT03674827|452056193|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
125663230|NCT03674827|452056194|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
125663231|NCT03674827|452056195|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
125663232|NCT03674827|452056196|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
125663233|NCT01783483|452056197|FG000|Overall Study|Death|3|||
125663234|NCT01783483|452056198|FG001|Overall Study|Death|3|||
125663235|NCT01783483|452056197|FG000|Overall Study|Lost to Follow-up|14|||
125663236|NCT01783483|452056198|FG001|Overall Study|Lost to Follow-up|10|||
125325105|NCT00106704|450824331|FG000|Overall Study|Patient Received Glycemic Medication|22|||
125325106|NCT00106704|450824332|FG001|Overall Study|Patient Received Glycemic Medication|41|||
125325107|NCT00106704|450824331|FG000|Overall Study|Unable to re-enter US|1|||
125325108|NCT00106704|450824332|FG001|Overall Study|Unable to re-enter US|0|||
125325109|NCT00106704|450824331|FG000|Overall Study|Laboratory test|1|||
125325110|NCT00106704|450824332|FG001|Overall Study|Laboratory test|1|||
125325111|NCT03216226|450824335|FG000|Overall Study|Adverse Event|3|||
125325112|NCT03216226|450824336|FG001|Overall Study|Adverse Event|0|||
125325113|NCT03216226|450824335|FG000|Overall Study|Protocol Violation|1|||
125325114|NCT03216226|450824336|FG001|Overall Study|Protocol Violation|3|||
125325115|NCT03216226|450824335|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
125325116|NCT03216226|450824336|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
125325117|NCT03216226|450824335|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
125325118|NCT03216226|450824336|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
125325119|NCT03216226|450824335|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
125325120|NCT03216226|450824336|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
125325121|NCT00871975|450824339|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
125325122|NCT00871975|450824339|FG000|Overall Study|Catheters could not be inserted|1|||
125325123|NCT00871975|450824339|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
125325124|NCT00871975|450824339|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
125325125|NCT05249582|450824340|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
125663237|NCT01783483|452056197|FG000|Overall Study|Withdrawal by Subject|2|||
125663238|NCT01783483|452056198|FG001|Overall Study|Withdrawal by Subject|1|||
125663239|NCT01783483|452056197|FG000|Overall Study|Physician Decision|1|||
125663240|NCT01783483|452056198|FG001|Overall Study|Physician Decision|1|||
125663241|NCT04130919|452056201|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
125663242|NCT04130919|452056202|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
125663243|NCT04130919|452056203|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
125663244|NCT04130919|452056204|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
125325126|NCT05249582|450824341|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
125325127|NCT05249582|450824340|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
125325128|NCT05249582|450824341|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
125325129|NCT05249582|450824340|FG000|Overall Study|Declined to use virtual reality headset|1|||
125325130|NCT05249582|450824341|FG001|Overall Study|Declined to use virtual reality headset|0|||
125325131|NCT00283296|450824342|FG000|Overall Study|in-home trial not completed|5|||
125325132|NCT02668653|450824343|FG000|Overall Study|Refractory disease|41|||
125325133|NCT02668653|450824344|FG001|Overall Study|Refractory disease|70|||
125325134|NCT02668653|450824343|FG000|Overall Study|Relapse|44|||
125325135|NCT02668653|450824344|FG001|Overall Study|Relapse|65|||
125325136|NCT02668653|450824343|FG000|Overall Study|Adverse Event|58|||
125325137|NCT02668653|450824344|FG001|Overall Study|Adverse Event|23|||
125325138|NCT02668653|450824343|FG000|Overall Study|Subject decision to stop study drug|25|||
125325139|NCT02668653|450824344|FG001|Overall Study|Subject decision to stop study drug|23|||
125325140|NCT02668653|450824343|FG000|Overall Study|Other reasons not specified|16|||
125325141|NCT02668653|450824344|FG001|Overall Study|Other reasons not specified|11|||
125325142|NCT02668653|450824343|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
125325143|NCT02668653|450824344|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
125325144|NCT02668653|450824343|FG000|Overall Study|Investigator decision|10|||
125325145|NCT02668653|450824344|FG001|Overall Study|Investigator decision|7|||
125325146|NCT02668653|450824343|FG000|Overall Study|Failure to meet continuation criteria|5|||
125325147|NCT02668653|450824344|FG001|Overall Study|Failure to meet continuation criteria|12|||
125325148|NCT02668653|450824343|FG000|Overall Study|Lost to Follow-up|1|||
125325149|NCT02668653|450824344|FG001|Overall Study|Lost to Follow-up|0|||
125325150|NCT02668653|450824343|FG000|Overall Study|Pregnancy|0|||
125325151|NCT02668653|450824344|FG001|Overall Study|Pregnancy|1|||
125325152|NCT02668653|450824343|FG000|Overall Study|Death|0|||
125325153|NCT02668653|450824344|FG001|Overall Study|Death|1|||
125325154|NCT02158442|450824347|FG000|Overall Study|Withdrawal by Subject|1|||
125325155|NCT02158442|450824348|FG001|Overall Study|Withdrawal by Subject|0|||
125325156|NCT02158442|450824347|FG000|Overall Study|Perfusion staff not available|1|||
125325157|NCT02158442|450824348|FG001|Overall Study|Perfusion staff not available|0|||
125325158|NCT01294553|450824349|FG000|Overall Study|Duplicated Participants|1|||
125325159|NCT01294553|450824349|FG000|Overall Study|Protocol Violation|268|||
125325160|NCT00926237|450824352|FG000|Overall Study|Withdrawal by Subject|2|||
125325161|NCT00926237|450824353|FG001|Overall Study|Withdrawal by Subject|1|||
125325162|NCT00632229|450824359|FG000|Overall Study|Adverse Event|6|||
125325163|NCT00632229|450824360|FG001|Overall Study|Adverse Event|0|||
125325164|NCT00632229|450824359|FG000|Overall Study|Lost to Follow-up|0|||
125325165|NCT00632229|450824360|FG001|Overall Study|Lost to Follow-up|3|||
125325166|NCT00632229|450824359|FG000|Overall Study|Lack of Efficacy|0|||
125325167|NCT00632229|450824360|FG001|Overall Study|Lack of Efficacy|2|||
125325168|NCT00632229|450824359|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
125325169|NCT00632229|450824360|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
125325170|NCT05386329|450824361|FG000|Overall Study|Lost to Follow-up|3|||
125325171|NCT00577889|450824362|FG000|Overall Study|Withdrawal by Subject|1|||
125325172|NCT00577889|450824363|FG001|Overall Study|Withdrawal by Subject|0|||
125325173|NCT00577889|450824364|FG002|Overall Study|Withdrawal by Subject|0|||
125325174|NCT02667119|450824368|FG000|Overall Study|Lost to Follow-up|3|||
125325175|NCT02667119|450824369|FG001|Overall Study|Lost to Follow-up|0|||
125325176|NCT03783078|450824370|FG000|Overall Study|Death|31|||
125325177|NCT03783078|450824370|FG000|Overall Study|Sponsor Decision|23|||
125325178|NCT03783078|450824370|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125325179|NCT02059278|450824372|FG000|Overall Study|Adverse Event|1|||
125325180|NCT02059278|450824373|FG001|Overall Study|Adverse Event|1|||
125325181|NCT02059278|450824372|FG000|Overall Study|Lost to Follow-up|1|||
125325182|NCT02059278|450824373|FG001|Overall Study|Lost to Follow-up|0|||
125325183|NCT02059278|450824372|FG000|Overall Study|Withdrawal by Subject|0|||
125325184|NCT02059278|450824373|FG001|Overall Study|Withdrawal by Subject|3|||
125325185|NCT02059278|450824372|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
125325186|NCT02059278|450824373|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
125325187|NCT00737672|450824376|FG000|Overall Study|Graft Abandonment|48|||
125325188|NCT00737672|450824377|FG001|Overall Study|Graft Abandonment|56|||
125663245|NCT04130919|452056205|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
125325189|NCT00737672|450824376|FG000|Overall Study|Death|23|||
125663246|NCT04130919|452056206|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
125325190|NCT00737672|450824377|FG001|Overall Study|Death|22|||
125325191|NCT00737672|450824376|FG000|Overall Study|Withdrawal by Subject|1|||
125325192|NCT00737672|450824377|FG001|Overall Study|Withdrawal by Subject|2|||
125325193|NCT00737672|450824376|FG000|Overall Study|Lost to Follow-up|1|||
125325194|NCT00737672|450824377|FG001|Overall Study|Lost to Follow-up|0|||
125325195|NCT00737672|450824376|FG000|Overall Study|Miscellaneous|7|||
125325196|NCT00737672|450824377|FG001|Overall Study|Miscellaneous|1|||
125325197|NCT00737672|450824376|FG000|Overall Study|Physician Decision|0|||
125325198|NCT00737672|450824377|FG001|Overall Study|Physician Decision|2|||
125325199|NCT02694185|450824378|FG000|Overall Study|Withdrawal by Subject|45|||
125325200|NCT02694185|450824379|FG001|Overall Study|Withdrawal by Subject|0|||
125325201|NCT05972993|450824391|FG000|Overall Study|Lost to Follow-up|2|||
125325202|NCT05972993|450824392|FG001|Overall Study|Lost to Follow-up|0|||
125325203|NCT05972993|450824393|FG002|Overall Study|Lost to Follow-up|1|||
125325204|NCT05972993|450824394|FG003|Overall Study|Lost to Follow-up|0|||
125325205|NCT05972993|450824395|FG004|Overall Study|Lost to Follow-up|0|||
125325206|NCT05972993|450824396|FG005|Overall Study|Lost to Follow-up|0|||
125325207|NCT05972993|450824397|FG006|Overall Study|Lost to Follow-up|0|||
125325208|NCT05972993|450824398|FG007|Overall Study|Lost to Follow-up|2|||
125325209|NCT05972993|450824399|FG008|Overall Study|Lost to Follow-up|0|||
125325210|NCT03866577|450824402|FG000|Overall Study|Protocol Violation|0|||
125325211|NCT03866577|450824403|FG001|Overall Study|Protocol Violation|0|||
125325212|NCT03866577|450824404|FG002|Overall Study|Protocol Violation|0|||
125325213|NCT03866577|450824405|FG003|Overall Study|Protocol Violation|0|||
125325214|NCT03866577|450824406|FG004|Overall Study|Protocol Violation|0|||
125325215|NCT03866577|450824407|FG005|Overall Study|Protocol Violation|0|||
125325216|NCT03866577|450824408|FG006|Overall Study|Protocol Violation|0|||
125325217|NCT03866577|450824409|FG007|Overall Study|Protocol Violation|0|||
125325218|NCT03866577|450824410|FG008|Overall Study|Protocol Violation|0|||
125325219|NCT03866577|450824411|FG009|Overall Study|Protocol Violation|0|||
125325220|NCT03866577|450824412|FG010|Overall Study|Protocol Violation|0|||
125325221|NCT03866577|450824413|FG011|Overall Study|Protocol Violation|1|||
125325222|NCT03866577|450824414|FG012|Overall Study|Protocol Violation|0|||
125325223|NCT03866577|450824402|FG000|Overall Study|Withdrawal by Subject|0|||
125325224|NCT03866577|450824403|FG001|Overall Study|Withdrawal by Subject|0|||
125325225|NCT03866577|450824404|FG002|Overall Study|Withdrawal by Subject|0|||
125325226|NCT03866577|450824405|FG003|Overall Study|Withdrawal by Subject|0|||
125325227|NCT03866577|450824406|FG004|Overall Study|Withdrawal by Subject|0|||
125325228|NCT03866577|450824407|FG005|Overall Study|Withdrawal by Subject|0|||
125325229|NCT03866577|450824408|FG006|Overall Study|Withdrawal by Subject|0|||
125325230|NCT03866577|450824409|FG007|Overall Study|Withdrawal by Subject|0|||
125325231|NCT03866577|450824410|FG008|Overall Study|Withdrawal by Subject|1|||
125325232|NCT03866577|450824411|FG009|Overall Study|Withdrawal by Subject|1|||
125325233|NCT03866577|450824412|FG010|Overall Study|Withdrawal by Subject|0|||
125325234|NCT03866577|450824413|FG011|Overall Study|Withdrawal by Subject|0|||
125325235|NCT03866577|450824414|FG012|Overall Study|Withdrawal by Subject|0|||
125325236|NCT03866577|450824402|FG000|Overall Study|Not qualified for IVIg infusion|0|||
125325237|NCT03866577|450824403|FG001|Overall Study|Not qualified for IVIg infusion|0|||
125325238|NCT03866577|450824404|FG002|Overall Study|Not qualified for IVIg infusion|0|||
125325239|NCT03866577|450824405|FG003|Overall Study|Not qualified for IVIg infusion|0|||
125325240|NCT03866577|450824406|FG004|Overall Study|Not qualified for IVIg infusion|0|||
125325241|NCT03866577|450824407|FG005|Overall Study|Not qualified for IVIg infusion|0|||
125325242|NCT03866577|450824408|FG006|Overall Study|Not qualified for IVIg infusion|0|||
125325243|NCT03866577|450824409|FG007|Overall Study|Not qualified for IVIg infusion|0|||
125325244|NCT03866577|450824410|FG008|Overall Study|Not qualified for IVIg infusion|0|||
125325245|NCT03866577|450824411|FG009|Overall Study|Not qualified for IVIg infusion|1|||
125325246|NCT03866577|450824412|FG010|Overall Study|Not qualified for IVIg infusion|0|||
125325247|NCT03866577|450824413|FG011|Overall Study|Not qualified for IVIg infusion|0|||
125325248|NCT03866577|450824414|FG012|Overall Study|Not qualified for IVIg infusion|0|||
125325249|NCT04825678|450824415|FG000|Overall Study|Decision by Sponsor|2|||
125325250|NCT04825678|450824416|FG001|Overall Study|Decision by Sponsor|3|||
125325251|NCT04825678|450824415|FG000|Overall Study|Withdrawal of Consent From Study|7|||
125325252|NCT04825678|450824416|FG001|Overall Study|Withdrawal of Consent From Study|9|||
125325253|NCT04825678|450824415|FG000|Overall Study|Lost to Follow-up|3|||
125325254|NCT04825678|450824416|FG001|Overall Study|Lost to Follow-up|4|||
125325255|NCT04825678|450824415|FG000|Overall Study|Never Received Investigational Product|1|||
125325256|NCT04825678|450824416|FG001|Overall Study|Never Received Investigational Product|1|||
125325257|NCT03818256|450824417|FG000|Overall Study|Withdrawal by Subject|2|||
125325258|NCT03818256|450824418|FG001|Overall Study|Withdrawal by Subject|2|||
125325259|NCT03818256|450824417|FG000|Overall Study|Adverse Event|3|||
125325260|NCT03818256|450824418|FG001|Overall Study|Adverse Event|1|||
125325261|NCT03818256|450824417|FG000|Overall Study|Lost to Follow-up|0|||
125325262|NCT03818256|450824418|FG001|Overall Study|Lost to Follow-up|5|||
125325263|NCT03818256|450824417|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
125325264|NCT03818256|450824418|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
125325265|NCT03818256|450824417|FG000|Overall Study|Not reporting for scheduled visits|1|||
125325266|NCT03818256|450824418|FG001|Overall Study|Not reporting for scheduled visits|0|||
125325267|NCT03818256|450824417|FG000|Overall Study|Non-compliant with investigational product|1|||
125325268|NCT03818256|450824418|FG001|Overall Study|Non-compliant with investigational product|0|||
125325269|NCT00734149|450824420|FG000|Overall Study|Withdrawal by Subject|1|||
125325270|NCT03043794|450824424|FG000|Overall Study|Lost to Follow-up|1|||
125325271|NCT04323124|450824427|FG000|Overall Study|Adverse Event|0|||
125325272|NCT04323124|450824428|FG001|Overall Study|Adverse Event|0|||
125325273|NCT04323124|450824429|FG002|Overall Study|Adverse Event|0|||
125325274|NCT04323124|450824430|FG003|Overall Study|Adverse Event|0|||
125325275|NCT04323124|450824431|FG004|Overall Study|Adverse Event|0|||
125325276|NCT04323124|450824432|FG005|Overall Study|Adverse Event|1|||
125325277|NCT04323124|450824433|FG006|Overall Study|Adverse Event|0|||
125325278|NCT04323124|450824434|FG007|Overall Study|Adverse Event|1|||
125325279|NCT04323124|450824435|FG008|Overall Study|Adverse Event|1|||
125325280|NCT04323124|450824436|FG009|Overall Study|Adverse Event|0|||
125325281|NCT04323124|450824437|FG010|Overall Study|Adverse Event|0|||
125325282|NCT04323124|450824438|FG011|Overall Study|Adverse Event|0|||
125325283|NCT04323124|450824439|FG012|Overall Study|Adverse Event|0|||
125325284|NCT04323124|450824440|FG013|Overall Study|Adverse Event|0|||
125325285|NCT04323124|450824441|FG014|Overall Study|Adverse Event|0|||
125325286|NCT04323124|450824427|FG000|Overall Study|Other|0|||
125325287|NCT04323124|450824428|FG001|Overall Study|Other|0|||
125663247|NCT04130919|452056201|FG000|Blinded Treatment Phase|Adverse Event|0|||
125663248|NCT04130919|452056202|FG001|Blinded Treatment Phase|Adverse Event|0|||
125663249|NCT04130919|452056203|FG002|Blinded Treatment Phase|Adverse Event|1|||
125663250|NCT04130919|452056204|FG003|Blinded Treatment Phase|Adverse Event|0|||
125663251|NCT04130919|452056205|FG004|Blinded Treatment Phase|Adverse Event|0|||
125663252|NCT04130919|452056206|FG005|Blinded Treatment Phase|Adverse Event|0|||
125663253|NCT04130919|452056201|FG000|Blinded Treatment Phase|Disease worsening|0|||
125663254|NCT04130919|452056202|FG001|Blinded Treatment Phase|Disease worsening|0|||
125663255|NCT04130919|452056203|FG002|Blinded Treatment Phase|Disease worsening|1|||
125663256|NCT04130919|452056204|FG003|Blinded Treatment Phase|Disease worsening|0|||
125663257|NCT04130919|452056205|FG004|Blinded Treatment Phase|Disease worsening|0|||
125663258|NCT04130919|452056206|FG005|Blinded Treatment Phase|Disease worsening|0|||
125663259|NCT04130919|452056201|FG000|Blinded Treatment Phase|Investigator's decision|0|||
125663260|NCT04130919|452056202|FG001|Blinded Treatment Phase|Investigator's decision|1|||
125663261|NCT04130919|452056203|FG002|Blinded Treatment Phase|Investigator's decision|0|||
125663262|NCT04130919|452056204|FG003|Blinded Treatment Phase|Investigator's decision|0|||
125663263|NCT04130919|452056205|FG004|Blinded Treatment Phase|Investigator's decision|0|||
125663264|NCT04130919|452056206|FG005|Blinded Treatment Phase|Investigator's decision|0|||
125663265|NCT04130919|452056201|FG000|Blinded Treatment Phase|Withdrew consent|1|||
125663266|NCT04130919|452056202|FG001|Blinded Treatment Phase|Withdrew consent|0|||
125663267|NCT04130919|452056203|FG002|Blinded Treatment Phase|Withdrew consent|0|||
125663268|NCT04130919|452056204|FG003|Blinded Treatment Phase|Withdrew consent|0|||
125663269|NCT04130919|452056205|FG004|Blinded Treatment Phase|Withdrew consent|0|||
125663270|NCT04130919|452056206|FG005|Blinded Treatment Phase|Withdrew consent|0|||
125663271|NCT04130919|452056201|FG000|Open-label Treatment Phase|Withdrew consent|0|||
125663272|NCT04130919|452056202|FG001|Open-label Treatment Phase|Withdrew consent|0|||
125663273|NCT04130919|452056203|FG002|Open-label Treatment Phase|Withdrew consent|0|||
125663274|NCT04130919|452056204|FG003|Open-label Treatment Phase|Withdrew consent|1|||
125663275|NCT04130919|452056205|FG004|Open-label Treatment Phase|Withdrew consent|1|||
125663276|NCT04130919|452056206|FG005|Open-label Treatment Phase|Withdrew consent|1|||
125663277|NCT04130919|452056201|FG000|Open-label Treatment Phase|Disease worsening|0|||
125663278|NCT04130919|452056202|FG001|Open-label Treatment Phase|Disease worsening|0|||
125663279|NCT04130919|452056203|FG002|Open-label Treatment Phase|Disease worsening|0|||
125663280|NCT04130919|452056204|FG003|Open-label Treatment Phase|Disease worsening|1|||
125663281|NCT04130919|452056205|FG004|Open-label Treatment Phase|Disease worsening|0|||
125663282|NCT04130919|452056206|FG005|Open-label Treatment Phase|Disease worsening|1|||
125663283|NCT04130919|452056201|FG000|Open-label Treatment Phase|Investigator's decision|0|||
125663284|NCT04130919|452056202|FG001|Open-label Treatment Phase|Investigator's decision|0|||
125663285|NCT04130919|452056203|FG002|Open-label Treatment Phase|Investigator's decision|0|||
125663286|NCT04130919|452056204|FG003|Open-label Treatment Phase|Investigator's decision|1|||
125663287|NCT04130919|452056205|FG004|Open-label Treatment Phase|Investigator's decision|0|||
125663288|NCT04130919|452056206|FG005|Open-label Treatment Phase|Investigator's decision|0|||
125663289|NCT04130919|452056201|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
125663290|NCT04130919|452056202|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
125663291|NCT04130919|452056203|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
125663292|NCT04130919|452056204|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
125663293|NCT04130919|452056205|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
125663294|NCT04130919|452056206|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
125663295|NCT04130919|452056201|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
125663296|NCT04130919|452056202|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
125663297|NCT04130919|452056203|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
125663298|NCT04130919|452056204|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
125663299|NCT04130919|452056205|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
125663300|NCT04130919|452056206|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
125663301|NCT02624518|452056207|FG000|Overall Study|Physician Decision|1|||
125663302|NCT00370396|452056208|FG000|Overall Study|Withdrawal by Subject|0|||
125325288|NCT04323124|450824429|FG002|Overall Study|Other|0|||
125325289|NCT04323124|450824430|FG003|Overall Study|Other|0|||
125325290|NCT04323124|450824431|FG004|Overall Study|Other|1|||
125325291|NCT04323124|450824432|FG005|Overall Study|Other|0|||
125325292|NCT04323124|450824433|FG006|Overall Study|Other|0|||
125325293|NCT04323124|450824434|FG007|Overall Study|Other|0|||
125325294|NCT04323124|450824435|FG008|Overall Study|Other|1|||
125325295|NCT04323124|450824436|FG009|Overall Study|Other|0|||
125325296|NCT04323124|450824437|FG010|Overall Study|Other|0|||
125325297|NCT04323124|450824438|FG011|Overall Study|Other|0|||
125325298|NCT04323124|450824439|FG012|Overall Study|Other|0|||
125325299|NCT04323124|450824440|FG013|Overall Study|Other|0|||
125325300|NCT04323124|450824441|FG014|Overall Study|Other|0|||
125325301|NCT04323124|450824427|FG000|Overall Study|Coming from a red zone (COVID)|0|||
125325302|NCT04323124|450824428|FG001|Overall Study|Coming from a red zone (COVID)|0|||
125325303|NCT04323124|450824429|FG002|Overall Study|Coming from a red zone (COVID)|0|||
125325304|NCT04323124|450824430|FG003|Overall Study|Coming from a red zone (COVID)|0|||
125325305|NCT04323124|450824431|FG004|Overall Study|Coming from a red zone (COVID)|1|||
125325306|NCT04323124|450824432|FG005|Overall Study|Coming from a red zone (COVID)|1|||
125325307|NCT04323124|450824433|FG006|Overall Study|Coming from a red zone (COVID)|0|||
125325308|NCT04323124|450824434|FG007|Overall Study|Coming from a red zone (COVID)|0|||
125325309|NCT04323124|450824435|FG008|Overall Study|Coming from a red zone (COVID)|0|||
125325310|NCT04323124|450824436|FG009|Overall Study|Coming from a red zone (COVID)|0|||
125325311|NCT04323124|450824437|FG010|Overall Study|Coming from a red zone (COVID)|0|||
125325312|NCT04323124|450824438|FG011|Overall Study|Coming from a red zone (COVID)|0|||
125325313|NCT04323124|450824439|FG012|Overall Study|Coming from a red zone (COVID)|0|||
125325314|NCT04323124|450824440|FG013|Overall Study|Coming from a red zone (COVID)|0|||
125325315|NCT04323124|450824441|FG014|Overall Study|Coming from a red zone (COVID)|0|||
125325316|NCT04323124|450824427|FG000|Overall Study|No longer meets eligibility criteria|0|||
125325317|NCT04323124|450824428|FG001|Overall Study|No longer meets eligibility criteria|0|||
125325318|NCT04323124|450824429|FG002|Overall Study|No longer meets eligibility criteria|0|||
125325319|NCT04323124|450824430|FG003|Overall Study|No longer meets eligibility criteria|0|||
125325320|NCT04323124|450824431|FG004|Overall Study|No longer meets eligibility criteria|0|||
125325321|NCT04323124|450824432|FG005|Overall Study|No longer meets eligibility criteria|0|||
125325322|NCT04323124|450824433|FG006|Overall Study|No longer meets eligibility criteria|0|||
125325323|NCT04323124|450824434|FG007|Overall Study|No longer meets eligibility criteria|1|||
125325324|NCT04323124|450824435|FG008|Overall Study|No longer meets eligibility criteria|0|||
125325325|NCT04323124|450824436|FG009|Overall Study|No longer meets eligibility criteria|0|||
125325326|NCT04323124|450824437|FG010|Overall Study|No longer meets eligibility criteria|0|||
125325327|NCT04323124|450824438|FG011|Overall Study|No longer meets eligibility criteria|0|||
125325328|NCT04323124|450824439|FG012|Overall Study|No longer meets eligibility criteria|0|||
125325329|NCT04323124|450824440|FG013|Overall Study|No longer meets eligibility criteria|1|||
125325330|NCT04323124|450824441|FG014|Overall Study|No longer meets eligibility criteria|1|||
125325331|NCT04323124|450824427|FG000|Overall Study|Study terminated by sponsor|0|||
125325332|NCT04323124|450824428|FG001|Overall Study|Study terminated by sponsor|0|||
125325333|NCT04323124|450824429|FG002|Overall Study|Study terminated by sponsor|0|||
125325334|NCT04323124|450824430|FG003|Overall Study|Study terminated by sponsor|0|||
125325335|NCT04323124|450824431|FG004|Overall Study|Study terminated by sponsor|0|||
125325336|NCT04323124|450824432|FG005|Overall Study|Study terminated by sponsor|0|||
125325337|NCT04323124|450824433|FG006|Overall Study|Study terminated by sponsor|0|||
125325338|NCT04323124|450824434|FG007|Overall Study|Study terminated by sponsor|0|||
125325339|NCT04323124|450824435|FG008|Overall Study|Study terminated by sponsor|0|||
125325340|NCT04323124|450824436|FG009|Overall Study|Study terminated by sponsor|0|||
125325341|NCT04323124|450824437|FG010|Overall Study|Study terminated by sponsor|0|||
125325342|NCT04323124|450824438|FG011|Overall Study|Study terminated by sponsor|2|||
125325343|NCT04323124|450824439|FG012|Overall Study|Study terminated by sponsor|1|||
125325344|NCT04323124|450824440|FG013|Overall Study|Study terminated by sponsor|0|||
125325345|NCT04323124|450824441|FG014|Overall Study|Study terminated by sponsor|0|||
125325346|NCT00489307|450824442|FG000|Overall Study|Death|1|||
125325347|NCT00489307|450824443|FG001|Overall Study|Death|1|||
125325348|NCT00489307|450824442|FG000|Overall Study|Lost to Follow-up|2|||
125325349|NCT00489307|450824443|FG001|Overall Study|Lost to Follow-up|2|||
125325350|NCT00489307|450824442|FG000|Overall Study|Physician Decision|1|||
125325351|NCT00489307|450824443|FG001|Overall Study|Physician Decision|0|||
125325352|NCT00489307|450824442|FG000|Overall Study|Withdrawal by Subject|2|||
125325353|NCT00489307|450824443|FG001|Overall Study|Withdrawal by Subject|4|||
125325354|NCT00489307|450824442|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
125325355|NCT00489307|450824443|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
125325356|NCT00489307|450824442|FG000|Overall Study|Surgery after assignment|1|||
125325357|NCT00489307|450824443|FG001|Overall Study|Surgery after assignment|0|||
125325358|NCT00489307|450824442|FG000|Overall Study|Did not fill up the forms|2|||
125325359|NCT00489307|450824443|FG001|Overall Study|Did not fill up the forms|1|||
125325360|NCT00489307|450824442|FG000|Overall Study|Patient or family refusal|5|||
125325361|NCT00489307|450824443|FG001|Overall Study|Patient or family refusal|9|||
125325362|NCT04586205|450824444|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
125425584|NCT01735201|451182279|FG000|Overall Study|Adverse Event|1|||
125325363|NCT04586205|450824445|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
125325364|NCT01586364|450827070|FG000|Overall Study|Withdrawal by Subject|40|||
125325365|NCT01586364|450827070|FG000|Overall Study|Adverse Event|37|||
125325366|NCT01586364|450827070|FG000|Overall Study|Lost to Follow-up|17|||
125325367|NCT01586364|450827070|FG000|Overall Study|Protocol Violation|16|||
125325368|NCT01586364|450827070|FG000|Overall Study|Lack of Efficacy|1|||
125325369|NCT01586364|450827070|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
125325370|NCT01586364|450827070|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
125325371|NCT01586364|450827070|FG000|Overall Study|Other-Site closure due to PI illness|1|||
125325372|NCT01586364|450827070|FG000|Overall Study|Other-PI discretion, site closing|2|||
125325373|NCT01586364|450827070|FG000|Overall Study|Other-Not specified|1|||
125325374|NCT02121535|450827071|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
125325375|NCT02121535|450827072|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
125325376|NCT02121535|450827071|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
125325377|NCT02121535|450827072|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
125325378|NCT00091949|450827073|FG000|Overall Study|Withdrawal by Subject|117|||
125325379|NCT00091949|450827074|FG001|Overall Study|Withdrawal by Subject|110|||
125325380|NCT00091949|450827073|FG000|Overall Study|Lost to Follow-up|58|||
125325381|NCT00091949|450827074|FG001|Overall Study|Lost to Follow-up|41|||
125325382|NCT01256788|450827075|FG000|Overall Study|Lost to Follow-up|5|||
125325383|NCT01256788|450827076|FG001|Overall Study|Lost to Follow-up|8|||
125325384|NCT01256788|450827077|FG002|Overall Study|Lost to Follow-up|3|||
125325385|NCT02083354|450827078|FG000|Overall Study|Withdrawal by Subject|9|||
125325386|NCT02083354|450827078|FG000|Overall Study|Lost to Follow-up|1|||
125325387|NCT02083354|450827078|FG000|Overall Study|Adverse Event|3|||
125325388|NCT02083354|450827078|FG000|Overall Study|Disease progression|46|||
125325389|NCT02083354|450827078|FG000|Overall Study|Study closed/terminated|5|||
125325390|NCT03312634|450827079|FG000|Overall Study|Adverse Event|11|||
125325391|NCT03312634|450827080|FG001|Overall Study|Adverse Event|0|||
125325392|NCT03312634|450827079|FG000|Overall Study|Sponsor request|2|||
125325393|NCT03312634|450827080|FG001|Overall Study|Sponsor request|0|||
125325394|NCT03312634|450827079|FG000|Overall Study|Withdrawal by Subject|31|||
125325395|NCT03312634|450827080|FG001|Overall Study|Withdrawal by Subject|9|||
125325396|NCT03312634|450827079|FG000|Overall Study|Enrolled in an interventional study|0|||
125325397|NCT03312634|450827080|FG001|Overall Study|Enrolled in an interventional study|52|||
125325398|NCT03312634|450827079|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
125325399|NCT03312634|450827080|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
125325400|NCT03312634|450827079|FG000|Overall Study|Death|0|||
125325401|NCT03312634|450827080|FG001|Overall Study|Death|1|||
125325402|NCT03312634|450827079|FG000|Overall Study|Non-compliance|0|||
125325403|NCT03312634|450827080|FG001|Overall Study|Non-compliance|2|||
125325404|NCT03312634|450827079|FG000|Overall Study|Lost to Follow-up|0|||
125325405|NCT03312634|450827080|FG001|Overall Study|Lost to Follow-up|1|||
125325406|NCT03312634|450827079|FG000|Overall Study|Enrolled into non-interventional study|0|||
125325407|NCT03312634|450827080|FG001|Overall Study|Enrolled into non-interventional study|5|||
125325408|NCT03312634|450827079|FG000|Overall Study|Worsening clinical condition|0|||
125325409|NCT03312634|450827080|FG001|Overall Study|Worsening clinical condition|1|||
125325410|NCT03312634|450827079|FG000|Overall Study|Participant did not want to travel|0|||
125325411|NCT03312634|450827080|FG001|Overall Study|Participant did not want to travel|1|||
125325412|NCT03312634|450827079|FG000|Overall Study|Physician Decision|1|||
125325413|NCT03312634|450827080|FG001|Overall Study|Physician Decision|0|||
125325414|NCT03312634|450827079|FG000|Overall Study|Other|13|||
125325415|NCT03312634|450827080|FG001|Overall Study|Other|0|||
125325416|NCT00906204|450827081|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
125325417|NCT00906204|450827082|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
125325418|NCT00906204|450827081|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
125325419|NCT00906204|450827082|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
125325420|NCT00906204|450827081|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
125325421|NCT00906204|450827082|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
125325422|NCT00906204|450827081|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
125325423|NCT00906204|450827082|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
125325424|NCT00906204|450827081|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
125325425|NCT00906204|450827082|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
125325426|NCT04328077|450827083|FG000|Overall Study|Lost to Follow-up|0|||
125325427|NCT04328077|450827084|FG001|Overall Study|Lost to Follow-up|1|||
125325428|NCT04328077|450827085|FG002|Overall Study|Lost to Follow-up|0|||
125325429|NCT04328077|450827086|FG003|Overall Study|Lost to Follow-up|0|||
125325430|NCT04328077|450827083|FG000|Overall Study|Withdrawal by Subject|0|||
125325431|NCT04328077|450827084|FG001|Overall Study|Withdrawal by Subject|1|||
125325432|NCT04328077|450827085|FG002|Overall Study|Withdrawal by Subject|1|||
125325433|NCT04328077|450827086|FG003|Overall Study|Withdrawal by Subject|3|||
125325434|NCT05291520|450827087|FG000|Overall Study|Lost to Follow-up|0|||
125325435|NCT05291520|450827088|FG001|Overall Study|Lost to Follow-up|0|||
125325436|NCT05291520|450827089|FG002|Overall Study|Lost to Follow-up|1|||
125325437|NCT01347112|450827090|FG000|Overall Study|Withdrawal by Subject|1|||
125325438|NCT01347112|450827091|FG001|Overall Study|Withdrawal by Subject|7|||
125325439|NCT01347112|450827090|FG000|Overall Study|Lost to Follow-up|3|||
125325440|NCT01347112|450827091|FG001|Overall Study|Lost to Follow-up|5|||
125325441|NCT00696072|450827096|FG000|Overall Study|continuing active treatment|10|||
125325442|NCT00696072|450827097|FG001|Overall Study|continuing active treatment|13|||
125325443|NCT00696072|450827096|FG000|Overall Study|Adverse Event|10|||
125325444|NCT00696072|450827097|FG001|Overall Study|Adverse Event|6|||
125325445|NCT00696072|450827096|FG000|Overall Study|Patient Request|3|||
125325446|NCT00696072|450827097|FG001|Overall Study|Patient Request|7|||
125325447|NCT00696072|450827096|FG000|Overall Study|Investigator Request|1|||
125325448|NCT00696072|450827097|FG001|Overall Study|Investigator Request|4|||
125325449|NCT00696072|450827096|FG000|Overall Study|Sponsor Request|0|||
125325450|NCT00696072|450827097|FG001|Overall Study|Sponsor Request|1|||
125325451|NCT00696072|450827096|FG000|Overall Study|Disease Progression|32|||
125325452|NCT00696072|450827097|FG001|Overall Study|Disease Progression|30|||
125325453|NCT00696072|450827096|FG000|Overall Study|Non-specified|1|||
125325454|NCT00696072|450827097|FG001|Overall Study|Non-specified|2|||
125325455|NCT01597596|450827098|FG000|Overall Study|Study terminated by sponsor|1|||
125325456|NCT01597596|450827099|FG001|Overall Study|Study terminated by sponsor|0|||
125325457|NCT01597596|450827098|FG000|Overall Study|Physician Decision|0|||
125325458|NCT01597596|450827099|FG001|Overall Study|Physician Decision|1|||
125325459|NCT00313014|450827120|FG000|Overall Study|Withdrawal by Subject|11|||
125325460|NCT00313014|450827121|FG001|Overall Study|Withdrawal by Subject|7|||
125325461|NCT00313014|450827122|FG002|Overall Study|Withdrawal by Subject|5|||
125325462|NCT00313014|450827120|FG000|Overall Study|Adverse Event|14|||
125325463|NCT00313014|450827121|FG001|Overall Study|Adverse Event|29|||
125325464|NCT00313014|450827122|FG002|Overall Study|Adverse Event|16|||
125325465|NCT00313014|450827120|FG000|Overall Study|Lost to Follow-up|7|||
125325466|NCT00313014|450827121|FG001|Overall Study|Lost to Follow-up|6|||
125325467|NCT00313014|450827122|FG002|Overall Study|Lost to Follow-up|10|||
125325468|NCT00313014|450827120|FG000|Overall Study|Administrative|9|||
125325469|NCT00313014|450827121|FG001|Overall Study|Administrative|6|||
125325470|NCT00313014|450827122|FG002|Overall Study|Administrative|14|||
125325471|NCT00313014|450827120|FG000|Overall Study|Lack of Efficacy|52|||
125325472|NCT00313014|450827121|FG001|Overall Study|Lack of Efficacy|25|||
125325473|NCT00313014|450827122|FG002|Overall Study|Lack of Efficacy|16|||
125325474|NCT01054885|450827123|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
125325475|NCT01054885|450827124|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125325476|NCT01054885|450827125|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125325477|NCT01054885|450827126|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125325478|NCT01054885|450827127|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125325479|NCT01054885|450827128|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125325480|NCT01054885|450827129|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125325481|NCT01054885|450827123|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
125325482|NCT01054885|450827124|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
125325483|NCT01054885|450827125|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
125325484|NCT01054885|450827126|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
125325485|NCT01054885|450827127|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
125325486|NCT01054885|450827128|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
125325487|NCT01054885|450827129|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
125325488|NCT01054885|450827123|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
125325489|NCT01054885|450827124|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125325490|NCT01054885|450827125|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125325491|NCT01054885|450827126|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125325492|NCT01054885|450827127|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125325493|NCT01054885|450827128|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125325494|NCT01054885|450827129|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125325495|NCT01054885|450827123|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
125325496|NCT01054885|450827124|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125325497|NCT01054885|450827125|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125325498|NCT01054885|450827126|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125325499|NCT01054885|450827127|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125325500|NCT01054885|450827128|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125325501|NCT01054885|450827129|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125325502|NCT01054885|450827123|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
125325503|NCT01054885|450827124|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
125325504|NCT01054885|450827125|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
125325505|NCT01054885|450827126|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
125325506|NCT01054885|450827127|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
125210682|NCT02638259|450395634|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
125325507|NCT01054885|450827128|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
125325508|NCT01054885|450827129|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
125325509|NCT01054885|450827123|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
125325510|NCT01054885|450827124|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125325511|NCT01054885|450827125|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125325512|NCT01054885|450827126|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125325513|NCT01054885|450827127|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125325514|NCT01054885|450827128|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125325515|NCT01054885|450827129|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125325516|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
125325517|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
125325518|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
125325519|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
125325520|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
125325521|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
125325522|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
125325523|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125325524|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125325525|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
125325526|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
125325527|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125325528|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
125325529|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125325530|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
125325531|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
125325532|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
125325533|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
125325534|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
125325535|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
125325536|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
125325537|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
125325538|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
125325539|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
125325540|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
125325541|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
125325542|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
125325543|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
125325544|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
125325545|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
125325546|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
125325547|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
125325548|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
125325549|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
125325550|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
125663303|NCT00370396|452056209|FG001|Overall Study|Withdrawal by Subject|0|||
125663304|NCT00370396|452056210|FG002|Overall Study|Withdrawal by Subject|1|||
125663305|NCT00370396|452056208|FG000|Overall Study|Lost to Follow-up|11|||
125663306|NCT00370396|452056209|FG001|Overall Study|Lost to Follow-up|1|||
125663307|NCT00370396|452056210|FG002|Overall Study|Lost to Follow-up|0|||
125663308|NCT01462695|452056211|FG000|Overall Study|Adverse Event|1|||
125663309|NCT01462695|452056212|FG001|Overall Study|Adverse Event|1|||
125663310|NCT01462695|452056211|FG000|Overall Study|Death|2|||
125663311|NCT01462695|452056212|FG001|Overall Study|Death|0|||
125663312|NCT01462695|452056211|FG000|Overall Study|Lack of Efficacy|6|||
125663313|NCT01462695|452056212|FG001|Overall Study|Lack of Efficacy|12|||
125663314|NCT01462695|452056211|FG000|Overall Study|Physician Decision|5|||
125663315|NCT01462695|452056212|FG001|Overall Study|Physician Decision|0|||
125663316|NCT01462695|452056211|FG000|Overall Study|Withdrawal by Subject|2|||
125663317|NCT01462695|452056212|FG001|Overall Study|Withdrawal by Subject|0|||
125663318|NCT01462695|452056211|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
125663319|NCT01462695|452056212|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
125663320|NCT02400905|452056213|FG000|Overall Study|Death|24|||
125663321|NCT02400905|452056213|FG000|Overall Study|Lost to Follow-up|18|||
125663322|NCT02400905|452056213|FG000|Overall Study|Withdrawal by Subject|16|||
125663323|NCT02400905|452056213|FG000|Overall Study|Physician Decision|4|||
125663324|NCT02400905|452056213|FG000|Overall Study|Other|1|||
125325551|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125325552|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125325553|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
125325554|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125325555|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125325556|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
125325557|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
125325558|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125325559|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
125325560|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
125325561|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125325562|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125325563|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
125325564|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
125325565|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
125325566|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
125325567|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
125325568|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
125325569|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
125325570|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
125325571|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
125325572|NCT01054885|450827123|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125325573|NCT01054885|450827124|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
125325574|NCT01054885|450827125|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
125325575|NCT01054885|450827126|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
125325576|NCT01054885|450827127|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
125325577|NCT01054885|450827128|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
125325578|NCT01054885|450827129|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
125325579|NCT01421719|450827132|FG000|Overall Study|Withdrawal by Subject|4|||
125325580|NCT01942837|450827133|FG000|Overall Study|Death|1|||
125325581|NCT01942837|450827133|FG000|Overall Study|Symptomatic or radiographic progression|49|||
125325582|NCT01942837|450827133|FG000|Overall Study|Adverse Event|6|||
125325583|NCT01942837|450827133|FG000|Overall Study|Physician Decision|3|||
125663325|NCT01358708|452056216|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
125663326|NCT01358708|452056217|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125663327|NCT01358708|452056216|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
125663328|NCT01358708|452056217|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
125663329|NCT04363736|452056220|FG000|Overall Study|Withdrawal by Subject|1|||
125663330|NCT04363736|452056221|FG001|Overall Study|Withdrawal by Subject|0|||
125663331|NCT04363736|452056220|FG000|Overall Study|Lost to Follow-up|10|||
125663332|NCT04363736|452056221|FG001|Overall Study|Lost to Follow-up|7|||
125663333|NCT04363736|452056220|FG000|Overall Study|Death|8|||
125663334|NCT04363736|452056221|FG001|Overall Study|Death|6|||
125663335|NCT03125629|452056223|FG000|Overall Study|Withdrawal by Subject|2|||
125663336|NCT03125629|452056223|FG000|Overall Study|Equipment malfunction|1|||
125663337|NCT02176642|452056226|FG000|Overall Study|Withdrawal by Subject|0|||
125663338|NCT02176642|452056227|FG001|Overall Study|Withdrawal by Subject|1|||
125663339|NCT00217971|452056228|FG000|Overall Study|Adverse Event|1|||
125663340|NCT00217971|452056229|FG001|Overall Study|Adverse Event|1|||
125663341|NCT00217971|452056228|FG000|Overall Study|Lost to Follow-up|15|||
125663342|NCT00217971|452056229|FG001|Overall Study|Lost to Follow-up|19|||
125663343|NCT00217971|452056228|FG000|Overall Study|Physician Decision|0|||
125663344|NCT00217971|452056229|FG001|Overall Study|Physician Decision|1|||
125663345|NCT00217971|452056228|FG000|Overall Study|Withdrawal by Subject|7|||
125663346|NCT00217971|452056229|FG001|Overall Study|Withdrawal by Subject|12|||
125663347|NCT00217971|452056228|FG000|Overall Study|non compliant|1|||
125663348|NCT00217971|452056229|FG001|Overall Study|non compliant|0|||
125663349|NCT02989610|452056230|FG000|Overall Study|Withdrawal by Subject|20|||
125663350|NCT02989610|452056230|FG000|Overall Study|Departure of PI from Site|8|||
125663351|NCT02989610|452056230|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
125325584|NCT01942837|450827133|FG000|Overall Study|Withdrawal by Subject|2|||
125325585|NCT01942837|450827133|FG000|Overall Study|Intercurrent Illness|1|||
125663352|NCT02989610|452056230|FG000|Overall Study|Lost to Follow-up|3|||
125663353|NCT02989610|452056230|FG000|Overall Study|Death|3|||
125663354|NCT02989610|452056230|FG000|Overall Study|System Explant|3|||
125663355|NCT02989610|452056230|FG000|Overall Study|Subject Non-Compliance|2|||
125663356|NCT02989610|452056230|FG000|Overall Study|System Revision|2|||
125663357|NCT02989610|452056230|FG000|Overall Study|PI Left, Study Closing|1|||
125663358|NCT02989610|452056230|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
125210683|NCT02638259|450395635|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
125325586|NCT01942837|450827133|FG000|Overall Study|On treatment|3|||
125325587|NCT01942837|450827133|FG000|Overall Study|Never initiate the treatment|2|||
125325588|NCT03250273|450827145|FG000|Overall Study|Disease Progression|2|||
125325589|NCT03250273|450827146|FG001|Overall Study|Disease Progression|11|||
125325590|NCT03250273|450827145|FG000|Overall Study|Death|0|||
125325591|NCT03250273|450827146|FG001|Overall Study|Death|1|||
125325592|NCT04226742|450827147|FG000|Overall Study|Lost to Follow-up|16|||
125325593|NCT04226742|450827148|FG001|Overall Study|Lost to Follow-up|13|||
125325594|NCT04226742|450827147|FG000|Overall Study|Withdrawal by Subject|5|||
125325595|NCT04226742|450827148|FG001|Overall Study|Withdrawal by Subject|3|||
125325596|NCT01759446|450827150|FG000|Overall Study|Protocol Violation|1|||
125325597|NCT01759446|450827151|FG001|Overall Study|Protocol Violation|0|||
125325598|NCT01759446|450827152|FG002|Overall Study|Protocol Violation|1|||
125325599|NCT01759446|450827153|FG003|Overall Study|Protocol Violation|0|||
125325600|NCT01759446|450827154|FG004|Overall Study|Protocol Violation|0|||
125325601|NCT01759446|450827150|FG000|Overall Study|Withdrawal by Subject|0|||
125325602|NCT01759446|450827151|FG001|Overall Study|Withdrawal by Subject|1|||
125325603|NCT01759446|450827152|FG002|Overall Study|Withdrawal by Subject|0|||
125325604|NCT01759446|450827153|FG003|Overall Study|Withdrawal by Subject|1|||
125325605|NCT01759446|450827154|FG004|Overall Study|Withdrawal by Subject|0|||
125325606|NCT04646044|450827156|FG000|Overall Study|Lost to Follow-up|0|||
125325607|NCT04646044|450827157|FG001|Overall Study|Lost to Follow-up|0|||
125325608|NCT04646044|450827158|FG002|Overall Study|Lost to Follow-up|1|||
125663359|NCT02989610|452056230|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
125663360|NCT00808015|452056233|FG000|Overall Study|Death|1|||
125663361|NCT00808015|452056233|FG000|Overall Study|Lack of Efficacy|58|||
125663362|NCT00808015|452056233|FG000|Overall Study|Lost to Follow-up|76|||
125663363|NCT00808015|452056233|FG000|Overall Study|Participants not willing to participate|158|||
125663364|NCT00808015|452056233|FG000|Overall Study|Adverse Event|22|||
125663365|NCT00808015|452056233|FG000|Overall Study|Other|25|||
125663366|NCT00808015|452056233|FG000|Overall Study|Enrolled but not treated|4|||
125663367|NCT04508621|452056237|FG000|Overall Study|Adverse Event|39|||
125663368|NCT04508621|452056238|FG001|Overall Study|Adverse Event|16|||
125663369|NCT04508621|452056237|FG000|Overall Study|Lack of Efficacy|2|||
125663370|NCT04508621|452056238|FG001|Overall Study|Lack of Efficacy|8|||
125663371|NCT04508621|452056237|FG000|Overall Study|Physician Decision|0|||
125663372|NCT04508621|452056238|FG001|Overall Study|Physician Decision|1|||
125663373|NCT04508621|452056237|FG000|Overall Study|Withdrawal by Subject|10|||
125663374|NCT04508621|452056238|FG001|Overall Study|Withdrawal by Subject|14|||
125663375|NCT04508621|452056237|FG000|Overall Study|Lost to Follow-up|12|||
125663376|NCT04508621|452056238|FG001|Overall Study|Lost to Follow-up|9|||
125663377|NCT04508621|452056237|FG000|Overall Study|COVID-19 related crisis|3|||
125663378|NCT04508621|452056238|FG001|Overall Study|COVID-19 related crisis|0|||
125663379|NCT04508621|452056237|FG000|Overall Study|Subject non-compliance|1|||
125663380|NCT04508621|452056238|FG001|Overall Study|Subject non-compliance|0|||
125663381|NCT01066039|452056239|FG000|Overall Study|Adverse Event|6|||
125663382|NCT01066039|452056239|FG000|Overall Study|Withdrawal by Subject|17|||
125663383|NCT01066039|452056239|FG000|Overall Study|Protocol Violation|2|||
125663384|NCT01066039|452056239|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
125663385|NCT01066039|452056239|FG000|Overall Study|Investigator's Request|1|||
125663386|NCT01066039|452056239|FG000|Overall Study|Dropout due to Insulin Administration|1|||
125663387|NCT01066039|452056239|FG000|Overall Study|Additional Antihypertensive Required|4|||
125663388|NCT01066039|452056239|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
125663389|NCT01066039|452056239|FG000|Overall Study|Failure to Control Blood Pressure|1|||
125663390|NCT01066039|452056239|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
125663391|NCT00084617|452056249|FG000|Overall Study|Withdrawal by Subject|7|||
125663392|NCT00084617|452056249|FG000|Overall Study|Lack of Efficacy|1|||
125663393|NCT00084617|452056249|FG000|Overall Study|Protocol Violation|1|||
125663394|NCT01625286|452056250|FG000|Overall Study|Adverse Event|0|||
125663395|NCT01625286|452056251|FG001|Overall Study|Adverse Event|0|||
125663396|NCT01625286|452056252|FG002|Overall Study|Adverse Event|0|||
125663397|NCT01625286|452056253|FG003|Overall Study|Adverse Event|0|||
125663398|NCT01625286|452056254|FG004|Overall Study|Adverse Event|1|||
125663399|NCT01625286|452056255|FG005|Overall Study|Adverse Event|2|||
125663400|NCT01625286|452056256|FG006|Overall Study|Adverse Event|1|||
125663401|NCT01625286|452056250|FG000|Overall Study|Death|0|||
125663402|NCT01625286|452056251|FG001|Overall Study|Death|0|||
125663403|NCT01625286|452056252|FG002|Overall Study|Death|1|||
125325609|NCT04646044|450827159|FG003|Overall Study|Lost to Follow-up|0|||
125325610|NCT04646044|450827156|FG000|Overall Study|Withdrawal by Subject|0|||
125663404|NCT01625286|452056253|FG003|Overall Study|Death|1|||
125663405|NCT01625286|452056254|FG004|Overall Study|Death|0|||
125325611|NCT04646044|450827157|FG001|Overall Study|Withdrawal by Subject|1|||
125663406|NCT01625286|452056255|FG005|Overall Study|Death|11|||
125325612|NCT04646044|450827158|FG002|Overall Study|Withdrawal by Subject|0|||
125663407|NCT01625286|452056256|FG006|Overall Study|Death|16|||
125663408|NCT01625286|452056250|FG000|Overall Study|Withdrawal by Subject|0|||
125663409|NCT01625286|452056251|FG001|Overall Study|Withdrawal by Subject|1|||
125663410|NCT01625286|452056252|FG002|Overall Study|Withdrawal by Subject|0|||
125663411|NCT01625286|452056253|FG003|Overall Study|Withdrawal by Subject|1|||
125663412|NCT01625286|452056254|FG004|Overall Study|Withdrawal by Subject|0|||
125325613|NCT04646044|450827159|FG003|Overall Study|Withdrawal by Subject|0|||
125325614|NCT01391546|450827160|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
125325615|NCT01391546|450827161|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
125325616|NCT02156076|450827163|FG000|Treatment Period|no longer meets study criteria|0|||
125325617|NCT02156076|450827164|FG001|Treatment Period|no longer meets study criteria|0|||
125325618|NCT02156076|450827165|FG002|Treatment Period|no longer meets study criteria|1|||
125325619|NCT02156076|450827166|FG003|Treatment Period|no longer meets study criteria|0|||
125325620|NCT02156076|450827163|FG000|Treatment Period|Poor/non-compliance|0|||
125325621|NCT02156076|450827164|FG001|Treatment Period|Poor/non-compliance|1|||
125325622|NCT02156076|450827165|FG002|Treatment Period|Poor/non-compliance|0|||
125325623|NCT02156076|450827166|FG003|Treatment Period|Poor/non-compliance|0|||
125325624|NCT02156076|450827163|FG000|Treatment Period|Lost to Follow-up|0|||
125663413|NCT01625286|452056255|FG005|Overall Study|Withdrawal by Subject|0|||
125663414|NCT01625286|452056256|FG006|Overall Study|Withdrawal by Subject|1|||
125663415|NCT01625286|452056250|FG000|Overall Study|Any reason not specifically recorded|0|||
125663416|NCT01625286|452056251|FG001|Overall Study|Any reason not specifically recorded|0|||
125663417|NCT01625286|452056252|FG002|Overall Study|Any reason not specifically recorded|0|||
125663418|NCT01625286|452056253|FG003|Overall Study|Any reason not specifically recorded|0|||
125663419|NCT01625286|452056254|FG004|Overall Study|Any reason not specifically recorded|0|||
125663420|NCT01625286|452056255|FG005|Overall Study|Any reason not specifically recorded|1|||
125663421|NCT01625286|452056256|FG006|Overall Study|Any reason not specifically recorded|0|||
125663422|NCT01625286|452056250|FG000|Overall Study|Progressive disease|6|||
125663423|NCT01625286|452056251|FG001|Overall Study|Progressive disease|3|||
125663424|NCT01625286|452056252|FG002|Overall Study|Progressive disease|4|||
125663425|NCT01625286|452056253|FG003|Overall Study|Progressive disease|5|||
125663426|NCT01625286|452056254|FG004|Overall Study|Progressive disease|5|||
125663427|NCT01625286|452056255|FG005|Overall Study|Progressive disease|0|||
125663428|NCT01625286|452056256|FG006|Overall Study|Progressive disease|0|||
125663429|NCT01625286|452056250|FG000|Overall Study|Lost to Follow-up|0|||
125663430|NCT01625286|452056251|FG001|Overall Study|Lost to Follow-up|0|||
125663431|NCT01625286|452056252|FG002|Overall Study|Lost to Follow-up|0|||
125663432|NCT01625286|452056253|FG003|Overall Study|Lost to Follow-up|0|||
125663433|NCT01625286|452056254|FG004|Overall Study|Lost to Follow-up|0|||
125663434|NCT01625286|452056255|FG005|Overall Study|Lost to Follow-up|0|||
125663435|NCT01625286|452056256|FG006|Overall Study|Lost to Follow-up|1|||
125663436|NCT00928135|452056257|FG000|Overall Study|Withdrawal by Subject|1|||
125663437|NCT00928135|452056258|FG001|Overall Study|Withdrawal by Subject|0|||
125663438|NCT03338673|452056261|FG000|Overall Study|Lost to Follow-up|1|||
125663439|NCT03338673|452056262|FG001|Overall Study|Lost to Follow-up|1|||
125663440|NCT00434148|452056265|FG000|Overall Study|Adverse Event|18|||
125663441|NCT00434148|452056266|FG001|Overall Study|Adverse Event|18|||
125663442|NCT00434148|452056265|FG000|Overall Study|Lack of Efficacy|25|||
125663443|NCT00434148|452056266|FG001|Overall Study|Lack of Efficacy|28|||
125663444|NCT00434148|452056265|FG000|Overall Study|Withdrawal by Subject|15|||
125663445|NCT00434148|452056266|FG001|Overall Study|Withdrawal by Subject|15|||
125663446|NCT00434148|452056265|FG000|Overall Study|Protocol Violation|4|||
125663447|NCT00434148|452056266|FG001|Overall Study|Protocol Violation|0|||
125663448|NCT00434148|452056265|FG000|Overall Study|Administrative problems|6|||
125663449|NCT00434148|452056266|FG001|Overall Study|Administrative problems|10|||
125663450|NCT00434148|452056265|FG000|Overall Study|Lost to Follow-up|0|||
125663451|NCT00434148|452056266|FG001|Overall Study|Lost to Follow-up|1|||
125663452|NCT00434148|452056265|FG000|Overall Study|Condition no longer requires study drug|1|||
125663453|NCT00434148|452056266|FG001|Overall Study|Condition no longer requires study drug|0|||
125663454|NCT00434148|452056265|FG000|Overall Study|Abnormal test procedure result|0|||
125663455|NCT00434148|452056266|FG001|Overall Study|Abnormal test procedure result|1|||
125663456|NCT00828516|452056267|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
125663457|NCT00990093|452056268|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
125663458|NCT00990093|452056269|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
125663459|NCT00990093|452056268|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
125663460|NCT00990093|452056269|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
125663461|NCT00990093|452056268|FG000|Test Period 1 (1-14 Days)|Other|1|||
125663462|NCT00990093|452056269|FG001|Test Period 1 (1-14 Days)|Other|0|||
125663463|NCT00990093|452056268|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
125663464|NCT00990093|452056269|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
125663465|NCT00990093|452056268|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
125663466|NCT00990093|452056269|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
125663467|NCT00990093|452056268|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
125663468|NCT00990093|452056269|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
125325625|NCT02156076|450827164|FG001|Treatment Period|Lost to Follow-up|0|||
125663469|NCT00990093|452056268|FG000|Test Period 2 (15-28 Days)|Other|0|||
125663470|NCT00990093|452056269|FG001|Test Period 2 (15-28 Days)|Other|1|||
125663471|NCT04556838|452056272|FG000|Overall Study|Withdrawal by Subject|3|||
125325626|NCT02156076|450827165|FG002|Treatment Period|Lost to Follow-up|0|||
125325627|NCT02156076|450827166|FG003|Treatment Period|Lost to Follow-up|1|||
125325628|NCT02156076|450827163|FG000|Treatment Period|Withdrawal by Subject|0|||
125325629|NCT02156076|450827164|FG001|Treatment Period|Withdrawal by Subject|0|||
125325630|NCT02156076|450827165|FG002|Treatment Period|Withdrawal by Subject|1|||
125325631|NCT02156076|450827166|FG003|Treatment Period|Withdrawal by Subject|0|||
125325632|NCT02156076|450827163|FG000|Treatment Period|Subject request to discontinue treatment|0|||
125325633|NCT02156076|450827164|FG001|Treatment Period|Subject request to discontinue treatment|1|||
125325634|NCT02156076|450827165|FG002|Treatment Period|Subject request to discontinue treatment|0|||
125325635|NCT02156076|450827166|FG003|Treatment Period|Subject request to discontinue treatment|0|||
125325636|NCT02156076|450827163|FG000|Treatment Period|Adverse Event|0|||
125325637|NCT02156076|450827164|FG001|Treatment Period|Adverse Event|0|||
125325638|NCT02156076|450827165|FG002|Treatment Period|Adverse Event|0|||
125325639|NCT02156076|450827166|FG003|Treatment Period|Adverse Event|1|||
125325640|NCT02156076|450827163|FG000|Follow-up Period|Withdrawal by Subject|1|||
125325641|NCT02156076|450827164|FG001|Follow-up Period|Withdrawal by Subject|0|||
125325642|NCT02156076|450827165|FG002|Follow-up Period|Withdrawal by Subject|0|||
125325643|NCT02156076|450827166|FG003|Follow-up Period|Withdrawal by Subject|0|||
125325644|NCT01213472|450827169|FG000|Overall Study|Recurrence/Progressive disease|25|||
125325645|NCT01213472|450827169|FG000|Overall Study|Withdrawal by Subject|1|||
125325646|NCT01213472|450827169|FG000|Overall Study|Physician Decision|1|||
125325647|NCT04225897|450827170|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325648|NCT04225897|450827171|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
125325649|NCT04225897|450827172|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325650|NCT04225897|450827173|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325651|NCT04225897|450827174|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325652|NCT04225897|450827175|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325653|NCT04225897|450827176|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325654|NCT04225897|450827177|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325655|NCT04225897|450827178|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325656|NCT04225897|450827179|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325657|NCT04225897|450827180|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325658|NCT04225897|450827181|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
125325659|NCT04225897|450827170|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325660|NCT04225897|450827171|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325661|NCT04225897|450827172|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
125325662|NCT04225897|450827173|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325663|NCT04225897|450827174|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325664|NCT04225897|450827175|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325665|NCT04225897|450827176|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325666|NCT04225897|450827177|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325667|NCT04225897|450827178|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325668|NCT04225897|450827179|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325669|NCT04225897|450827180|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325670|NCT04225897|450827181|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
125325671|NCT04225897|450827170|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325672|NCT04225897|450827171|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325673|NCT04225897|450827172|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
125325674|NCT04225897|450827173|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325675|NCT04225897|450827174|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325676|NCT04225897|450827175|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325677|NCT04225897|450827176|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325678|NCT04225897|450827177|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325679|NCT04225897|450827178|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325680|NCT04225897|450827179|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325681|NCT04225897|450827180|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325682|NCT04225897|450827181|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
125325683|NCT04225897|450827170|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325684|NCT04225897|450827171|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325685|NCT04225897|450827172|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325686|NCT04225897|450827173|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325687|NCT04225897|450827174|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325688|NCT04225897|450827175|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325689|NCT04225897|450827176|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325690|NCT04225897|450827177|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
125325691|NCT04225897|450827178|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125210684|NCT02638259|450395634|FG000|Treatment Period 2|Adverse Event|5|||
125325692|NCT04225897|450827179|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325693|NCT04225897|450827180|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325694|NCT04225897|450827181|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
125325695|NCT02085460|450827182|FG000|Overall Study|Adverse Event|2|||
125325696|NCT02085460|450827183|FG001|Overall Study|Adverse Event|2|||
125325697|NCT02085460|450827184|FG002|Overall Study|Adverse Event|1|||
125325698|NCT02085460|450827182|FG000|Overall Study|Physician Decision|1|||
125325699|NCT02085460|450827183|FG001|Overall Study|Physician Decision|1|||
125325700|NCT02085460|450827184|FG002|Overall Study|Physician Decision|2|||
125325701|NCT02085460|450827182|FG000|Overall Study|Withdrawal by Subject|11|||
125325702|NCT02085460|450827183|FG001|Overall Study|Withdrawal by Subject|5|||
125325703|NCT02085460|450827184|FG002|Overall Study|Withdrawal by Subject|7|||
125325704|NCT01285323|450827185|FG000|Overall Study|Adverse Event|9|||
125325705|NCT01285323|450827186|FG001|Overall Study|Adverse Event|8|||
125325706|NCT01285323|450827185|FG000|Overall Study|Lack of Efficacy|4|||
125325707|NCT01285323|450827186|FG001|Overall Study|Lack of Efficacy|2|||
125325708|NCT01285323|450827185|FG000|Overall Study|Withdrawal by Subject|15|||
125325709|NCT01285323|450827186|FG001|Overall Study|Withdrawal by Subject|11|||
125325710|NCT01285323|450827185|FG000|Overall Study|Protocol Violation|1|||
125325711|NCT01285323|450827186|FG001|Overall Study|Protocol Violation|2|||
125325712|NCT01285323|450827185|FG000|Overall Study|Non-compliance with study procedures|2|||
125325713|NCT01285323|450827186|FG001|Overall Study|Non-compliance with study procedures|3|||
125325714|NCT01285323|450827185|FG000|Overall Study|Lost to Follow-up|1|||
125325715|NCT01285323|450827186|FG001|Overall Study|Lost to Follow-up|1|||
125325716|NCT01285323|450827185|FG000|Overall Study|Other|1|||
125325717|NCT01285323|450827186|FG001|Overall Study|Other|3|||
125325718|NCT02703597|450827187|FG000|Assignment to Baseline|Lost to Follow-up|17|||
125325719|NCT02703597|450827188|FG001|Assignment to Baseline|Lost to Follow-up|16|||
125325720|NCT02703597|450827187|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
125325721|NCT02703597|450827188|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
125325722|NCT02703597|450827187|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
125325723|NCT02703597|450827188|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
125325724|NCT02703597|450827187|FG000|First Post-test to First Follow-up|Site drop out|0|||
125325725|NCT02703597|450827188|FG001|First Post-test to First Follow-up|Site drop out|58|||
125325726|NCT02703597|450827187|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
125325727|NCT02703597|450827188|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
125325728|NCT02703597|450827187|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
125325729|NCT02703597|450827188|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
125325730|NCT02703597|450827187|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
125325731|NCT02703597|450827188|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
125325732|NCT02606643|450827189|FG000|Overall Study|did not meet inclusion criteria|1|||
125325733|NCT02606643|450827190|FG001|Overall Study|did not meet inclusion criteria|3|||
125325734|NCT02796170|450827192|FG000|Overall Study|Lost to Follow-up|3|||
125325735|NCT02796170|450827193|FG001|Overall Study|Lost to Follow-up|0|||
125325736|NCT04313244|450827197|FG000|Overall Study|Withdrawal of Consent|3|||
125325737|NCT04313244|450827198|FG001|Overall Study|Withdrawal of Consent|3|||
125325738|NCT04313244|450827197|FG000|Overall Study|Met Exclusion Criteria|1|||
125325739|NCT04313244|450827198|FG001|Overall Study|Met Exclusion Criteria|0|||
125325740|NCT04313244|450827197|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
125325741|NCT04313244|450827198|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
125325742|NCT01472289|450827201|FG000|Overall Study|Death|2|||
125325743|NCT00907335|450827202|FG000|Overall Study|Withdrawal by Subject|2|||
125325744|NCT00907335|450827203|FG001|Overall Study|Withdrawal by Subject|0|||
125325745|NCT00907335|450827202|FG000|Overall Study|Adverse Event|4|||
125325746|NCT00907335|450827203|FG001|Overall Study|Adverse Event|1|||
125325747|NCT00907335|450827202|FG000|Overall Study|Lost to Follow-up|2|||
125325748|NCT00907335|450827203|FG001|Overall Study|Lost to Follow-up|0|||
125325749|NCT03873116|450827204|FG000|Part 1|Study drug discontinuation due to rash|0|||
125325750|NCT03873116|450827205|FG001|Part 1|Study drug discontinuation due to rash|0|||
125325751|NCT03873116|450827206|FG002|Part 1|Study drug discontinuation due to rash|0|||
125325752|NCT03873116|450827207|FG003|Part 1|Study drug discontinuation due to rash|0|||
125325753|NCT03873116|450827208|FG004|Part 1|Study drug discontinuation due to rash|0|||
125325754|NCT03873116|450827209|FG005|Part 1|Study drug discontinuation due to rash|1|||
125325755|NCT03873116|450827204|FG000|Part 2|Withdrawal by Subject|0|||
125325756|NCT03873116|450827205|FG001|Part 2|Withdrawal by Subject|0|||
125325757|NCT03873116|450827206|FG002|Part 2|Withdrawal by Subject|1|||
125325758|NCT03873116|450827207|FG003|Part 2|Withdrawal by Subject|0|||
125325759|NCT03873116|450827208|FG004|Part 2|Withdrawal by Subject|0|||
125325760|NCT03873116|450827209|FG005|Part 2|Withdrawal by Subject|0|||
125325761|NCT03873116|450827204|FG000|Part 2|Lab abnormality or AE|0|||
125325762|NCT03873116|450827205|FG001|Part 2|Lab abnormality or AE|0|||
125325763|NCT03873116|450827206|FG002|Part 2|Lab abnormality or AE|0|||
125325764|NCT03873116|450827207|FG003|Part 2|Lab abnormality or AE|0|||
125325765|NCT03873116|450827208|FG004|Part 2|Lab abnormality or AE|1|||
125325766|NCT03873116|450827209|FG005|Part 2|Lab abnormality or AE|0|||
125325767|NCT03873116|450827204|FG000|Part 3|Withdrawal by Subject|0|||
125325768|NCT03873116|450827205|FG001|Part 3|Withdrawal by Subject|0|||
125325769|NCT03873116|450827206|FG002|Part 3|Withdrawal by Subject|0|||
125325770|NCT03873116|450827207|FG003|Part 3|Withdrawal by Subject|0|||
125325771|NCT03873116|450827208|FG004|Part 3|Withdrawal by Subject|1|||
125325772|NCT03873116|450827209|FG005|Part 3|Withdrawal by Subject|0|||
125325773|NCT00912808|450827210|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
125325774|NCT00912808|450827211|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
125325775|NCT00912808|450827210|FG000|Washout|Withdrawal by Subject|0|||
125325776|NCT00912808|450827211|FG001|Washout|Withdrawal by Subject|1|||
125325777|NCT00912808|450827210|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
125325778|NCT00912808|450827211|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
125325779|NCT00912808|450827210|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
125325780|NCT00912808|450827211|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
125325781|NCT00474812|450827223|FG000|Overall Study|Withdrawal by Subject|5|||
125325782|NCT00474812|450827223|FG000|Overall Study|No Initiation of treatment|2|||
125325783|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
125325784|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
125325785|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
125325786|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
125325787|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Adverse Event|2|||
125325788|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Adverse Event|5|||
125325789|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Adverse Event|1|||
125325790|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Adverse Event|2|||
125325791|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Death|13|||
125325792|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Death|17|||
125325793|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Death|1|||
125325794|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Death|0|||
125325795|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
125325796|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
125325797|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
125325798|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
125325799|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Disease Progression|2|||
125325800|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Disease Progression|0|||
125325801|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Disease Progression|0|||
125325802|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Disease Progression|0|||
125325803|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
125325804|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
125325805|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
125325806|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
125325807|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
125325808|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
125325809|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
125325810|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
125325811|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
125325812|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
125325813|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
125325814|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
125325815|NCT03955146|450827231|FG000|DB Period (48 Weeks)|Participant Decision|9|||
125325816|NCT03955146|450827232|FG001|DB Period (48 Weeks)|Participant Decision|12|||
125325817|NCT03955146|450827233|FG002|DB Period (48 Weeks)|Participant Decision|1|||
125325818|NCT03955146|450827234|FG003|DB Period (48 Weeks)|Participant Decision|1|||
125663472|NCT04556838|452056273|FG001|Overall Study|Withdrawal by Subject|1|||
125663473|NCT04556838|452056274|FG002|Overall Study|Withdrawal by Subject|2|||
125663474|NCT04556838|452056272|FG000|Overall Study|Adverse Event|0|||
125663475|NCT04556838|452056273|FG001|Overall Study|Adverse Event|1|||
125663476|NCT04556838|452056274|FG002|Overall Study|Adverse Event|1|||
125663477|NCT04556838|452056272|FG000|Overall Study|Lost to Follow-up|0|||
125663478|NCT04556838|452056273|FG001|Overall Study|Lost to Follow-up|0|||
125663479|NCT04556838|452056274|FG002|Overall Study|Lost to Follow-up|2|||
125663480|NCT04556838|452056272|FG000|Overall Study|Subject travel|0|||
125325819|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
125325820|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
125325821|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
125325822|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
125325823|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
125325824|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
125325825|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
125325826|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
125325827|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
125325828|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
125663481|NCT04556838|452056273|FG001|Overall Study|Subject travel|1|||
125663482|NCT04556838|452056274|FG002|Overall Study|Subject travel|0|||
125325829|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
125325830|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
125325831|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
125325832|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
125663483|NCT04556838|452056272|FG000|Overall Study|Physician Decision|1|||
125663484|NCT04556838|452056273|FG001|Overall Study|Physician Decision|0|||
125663485|NCT04556838|452056274|FG002|Overall Study|Physician Decision|0|||
125663486|NCT00995930|452056275|FG000|Overall Study|Protocol deviation|2|||
125663487|NCT00995930|452056276|FG001|Overall Study|Protocol deviation|5|||
125325833|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
125325834|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
125325835|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
125325836|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
125663488|NCT00995930|452056275|FG000|Overall Study|Death|0|||
125663489|NCT00995930|452056276|FG001|Overall Study|Death|1|||
125663490|NCT00995930|452056275|FG000|Overall Study|Administrative problems|4|||
125325837|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
125325838|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
125325839|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
125325840|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
125325841|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
125325842|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
125325843|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
125325844|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
125325845|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
125325846|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
125325847|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
125325848|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
125325849|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
125325850|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
125325851|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
125325852|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
125325853|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
125325854|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
125325855|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
125325856|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
125325857|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
125325858|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
125325859|NCT03955146|450827231|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
125325860|NCT03955146|450827232|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
125325861|NCT03955146|450827233|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
125325862|NCT03955146|450827234|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
125325863|NCT04363320|450827237|FG000|Overall Study|Lost to Follow-up|43|||
125325864|NCT04363320|450827238|FG001|Overall Study|Lost to Follow-up|42|||
125325865|NCT04363320|450827239|FG002|Overall Study|Lost to Follow-up|24|||
125325866|NCT04363320|450827240|FG003|Overall Study|Lost to Follow-up|29|||
125325867|NCT04363320|450827237|FG000|Overall Study|Death|0|||
125325868|NCT04363320|450827238|FG001|Overall Study|Death|0|||
125325869|NCT04363320|450827239|FG002|Overall Study|Death|1|||
125325870|NCT04363320|450827240|FG003|Overall Study|Death|0|||
125325871|NCT02002598|450827241|FG000|Dose Level 1|Withdrawal by Subject|1|||
125325872|NCT02002598|450827242|FG001|Dose Level 1|Withdrawal by Subject|0|||
125325873|NCT02002598|450827243|FG002|Dose Level 1|Withdrawal by Subject|0|||
125325874|NCT02002598|450827244|FG003|Dose Level 1|Withdrawal by Subject|0|||
125325875|NCT02002598|450827245|FG004|Dose Level 1|Withdrawal by Subject|0|||
125325876|NCT05632211|450827246|FG000|Overall Study|Withdrawal by Subject|2|||
125325877|NCT05632211|450827247|FG001|Overall Study|Withdrawal by Subject|0|||
125325878|NCT05632211|450827248|FG002|Overall Study|Withdrawal by Subject|2|||
125325879|NCT05632211|450827246|FG000|Overall Study|Other reasons|1|||
125325880|NCT05632211|450827247|FG001|Overall Study|Other reasons|1|||
125325881|NCT05632211|450827248|FG002|Overall Study|Other reasons|1|||
125325882|NCT02628873|450827249|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
125325883|NCT02628873|450827250|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
125325884|NCT02628873|450827249|FG000|Second Test (1 Hour)|Physician Decision|1|||
125325885|NCT02628873|450827250|FG001|Second Test (1 Hour)|Physician Decision|0|||
125663491|NCT00995930|452056276|FG001|Overall Study|Administrative problems|2|||
125325886|NCT00541658|450827251|FG000|Overall Study|Adverse Event|28|||
125325887|NCT00541658|450827252|FG001|Overall Study|Adverse Event|37|||
125325888|NCT00541658|450827253|FG002|Overall Study|Adverse Event|25|||
125325889|NCT00541658|450827251|FG000|Overall Study|Physician Decision|0|||
125325890|NCT00541658|450827252|FG001|Overall Study|Physician Decision|0|||
125663492|NCT00995930|452056275|FG000|Overall Study|Lost to Follow-up|1|||
125325891|NCT00541658|450827253|FG002|Overall Study|Physician Decision|4|||
125325892|NCT00541658|450827251|FG000|Overall Study|Lost to Follow-up|3|||
125325893|NCT00541658|450827252|FG001|Overall Study|Lost to Follow-up|3|||
125325894|NCT00541658|450827253|FG002|Overall Study|Lost to Follow-up|6|||
125325895|NCT00541658|450827251|FG000|Overall Study|Protocol Violation|0|||
125325896|NCT00541658|450827252|FG001|Overall Study|Protocol Violation|1|||
125325897|NCT00541658|450827253|FG002|Overall Study|Protocol Violation|1|||
125325898|NCT00541658|450827251|FG000|Overall Study|Withdrawal by Subject|28|||
125325899|NCT00541658|450827252|FG001|Overall Study|Withdrawal by Subject|32|||
125325900|NCT00541658|450827253|FG002|Overall Study|Withdrawal by Subject|32|||
125325901|NCT00541658|450827251|FG000|Overall Study|Took No Study Drug|1|||
125325902|NCT00541658|450827252|FG001|Overall Study|Took No Study Drug|0|||
125325903|NCT00541658|450827253|FG002|Overall Study|Took No Study Drug|0|||
125325904|NCT04123470|450827254|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
125325905|NCT04123470|450827255|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
125325906|NCT04123470|450827254|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
125325907|NCT04123470|450827255|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
125325908|NCT04123470|450827254|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
125325909|NCT04123470|450827255|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
125325910|NCT04123470|450827254|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
125325911|NCT04123470|450827255|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
125325912|NCT02195518|450827256|FG000|Overall Study|Adverse Event|1|||
125325913|NCT02195518|450827256|FG000|Overall Study|Protocol Violation|4|||
125325914|NCT02195518|450827256|FG000|Overall Study|Pregnancy|2|||
125325915|NCT02195518|450827256|FG000|Overall Study|Withdrawal by Subject|1|||
125325916|NCT02195518|450827256|FG000|Overall Study|Lost to Follow-up|1|||
125325917|NCT05530252|450827257|FG000|Overall Study|Lost to Follow-up|1|||
125325918|NCT05530252|450827258|FG001|Overall Study|Lost to Follow-up|1|||
125325919|NCT05530252|450827259|FG002|Overall Study|Lost to Follow-up|1|||
125325920|NCT00911170|450827265|FG000|Treatment Period|Randomized in error|1|||
125325921|NCT00911170|450827266|FG001|Treatment Period|Randomized in error|1|||
125325922|NCT00911170|450827265|FG000|Treatment Period|Ineligibility determined|1|||
125325923|NCT00911170|450827266|FG001|Treatment Period|Ineligibility determined|3|||
125325924|NCT00911170|450827265|FG000|Treatment Period|Protocol deviation|1|||
125325925|NCT00911170|450827266|FG001|Treatment Period|Protocol deviation|2|||
125325926|NCT00911170|450827265|FG000|Treatment Period|Adverse Event|9|||
125325927|NCT00911170|450827266|FG001|Treatment Period|Adverse Event|10|||
125325928|NCT00911170|450827265|FG000|Treatment Period|Withdrawal by Subject|4|||
125325929|NCT00911170|450827266|FG001|Treatment Period|Withdrawal by Subject|4|||
125325930|NCT00911170|450827265|FG000|Treatment Period|Disease progression|0|||
125325931|NCT00911170|450827266|FG001|Treatment Period|Disease progression|2|||
125325932|NCT00911170|450827265|FG000|Treatment Period|Physician Decision|5|||
125325933|NCT00911170|450827266|FG001|Treatment Period|Physician Decision|5|||
125325934|NCT00911170|450827265|FG000|Treatment Period|Lost to Follow-up|0|||
125325935|NCT00911170|450827266|FG001|Treatment Period|Lost to Follow-up|1|||
125325936|NCT00911170|450827265|FG000|Treatment Period|Death|6|||
125325937|NCT00911170|450827266|FG001|Treatment Period|Death|9|||
125325938|NCT00911170|450827265|FG000|Long Term Follow-Up|Continuing in study|274|||
125325939|NCT00911170|450827266|FG001|Long Term Follow-Up|Continuing in study|269|||
125325940|NCT00911170|450827265|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
125325941|NCT00911170|450827266|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
125325942|NCT00911170|450827265|FG000|Long Term Follow-Up|Physician Decision|5|||
125325943|NCT00911170|450827266|FG001|Long Term Follow-Up|Physician Decision|4|||
125325944|NCT00911170|450827265|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
125325945|NCT00911170|450827266|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
125325946|NCT00911170|450827265|FG000|Long Term Follow-Up|Death|116|||
125325947|NCT00911170|450827266|FG001|Long Term Follow-Up|Death|121|||
125325948|NCT02594124|450827267|FG000|Overall Study|Adverse Event|0|||
125325949|NCT02594124|450827268|FG001|Overall Study|Adverse Event|5|||
125325950|NCT02594124|450827269|FG002|Overall Study|Adverse Event|8|||
125325951|NCT02594124|450827270|FG003|Overall Study|Adverse Event|1|||
125325952|NCT02594124|450827271|FG004|Overall Study|Adverse Event|0|||
125325953|NCT02594124|450827272|FG005|Overall Study|Adverse Event|0|||
125663493|NCT00995930|452056276|FG001|Overall Study|Lost to Follow-up|2|||
125663494|NCT00995930|452056275|FG000|Overall Study|Withdrawal by Subject|3|||
125663495|NCT00995930|452056276|FG001|Overall Study|Withdrawal by Subject|4|||
125663496|NCT00995930|452056275|FG000|Overall Study|Adverse Event|11|||
125325954|NCT02594124|450827273|FG006|Overall Study|Adverse Event|2|||
125325955|NCT02594124|450827274|FG007|Overall Study|Adverse Event|2|||
125325956|NCT02594124|450827275|FG008|Overall Study|Adverse Event|0|||
125663497|NCT00995930|452056276|FG001|Overall Study|Adverse Event|14|||
125325957|NCT02594124|450827267|FG000|Overall Study|Withdrawal by Subject|2|||
125325958|NCT02594124|450827268|FG001|Overall Study|Withdrawal by Subject|3|||
125325959|NCT02594124|450827269|FG002|Overall Study|Withdrawal by Subject|5|||
125325960|NCT02594124|450827270|FG003|Overall Study|Withdrawal by Subject|1|||
125325961|NCT02594124|450827271|FG004|Overall Study|Withdrawal by Subject|8|||
125663498|NCT05003167|452056279|FG000|Overall Study|Withdrawal by Subject|1|||
125325962|NCT02594124|450827272|FG005|Overall Study|Withdrawal by Subject|4|||
125325963|NCT02594124|450827273|FG006|Overall Study|Withdrawal by Subject|13|||
125325964|NCT02594124|450827274|FG007|Overall Study|Withdrawal by Subject|19|||
125325965|NCT02594124|450827275|FG008|Overall Study|Withdrawal by Subject|0|||
125325966|NCT02594124|450827267|FG000|Overall Study|Physician Decision|0|||
125325967|NCT02594124|450827268|FG001|Overall Study|Physician Decision|2|||
125325968|NCT02594124|450827269|FG002|Overall Study|Physician Decision|0|||
125325969|NCT02594124|450827270|FG003|Overall Study|Physician Decision|0|||
125325970|NCT02594124|450827271|FG004|Overall Study|Physician Decision|0|||
125325971|NCT02594124|450827272|FG005|Overall Study|Physician Decision|0|||
125325972|NCT02594124|450827273|FG006|Overall Study|Physician Decision|0|||
125325973|NCT02594124|450827274|FG007|Overall Study|Physician Decision|1|||
125325974|NCT02594124|450827275|FG008|Overall Study|Physician Decision|0|||
125325975|NCT02594124|450827267|FG000|Overall Study|Commercial drug|0|||
125325976|NCT02594124|450827268|FG001|Overall Study|Commercial drug|1|||
125325977|NCT02594124|450827269|FG002|Overall Study|Commercial drug|6|||
125325978|NCT02594124|450827270|FG003|Overall Study|Commercial drug|3|||
125325979|NCT02594124|450827271|FG004|Overall Study|Commercial drug|0|||
125325980|NCT02594124|450827272|FG005|Overall Study|Commercial drug|0|||
125325981|NCT02594124|450827273|FG006|Overall Study|Commercial drug|7|||
125325982|NCT02594124|450827274|FG007|Overall Study|Commercial drug|11|||
125325983|NCT02594124|450827275|FG008|Overall Study|Commercial drug|2|||
125325984|NCT02594124|450827267|FG000|Overall Study|Reason Not Specified|1|||
125325985|NCT02594124|450827268|FG001|Overall Study|Reason Not Specified|3|||
125325986|NCT02594124|450827269|FG002|Overall Study|Reason Not Specified|4|||
125325987|NCT02594124|450827270|FG003|Overall Study|Reason Not Specified|0|||
125325988|NCT02594124|450827271|FG004|Overall Study|Reason Not Specified|0|||
125325989|NCT02594124|450827272|FG005|Overall Study|Reason Not Specified|1|||
125325990|NCT02594124|450827273|FG006|Overall Study|Reason Not Specified|1|||
125325991|NCT02594124|450827274|FG007|Overall Study|Reason Not Specified|6|||
125325992|NCT02594124|450827275|FG008|Overall Study|Reason Not Specified|1|||
125325993|NCT02514083|450827280|FG000|Overall Study|Adverse Event|1|||
125325994|NCT02141295|450828915|FG000|Overall Study|Adverse Event|1|||
125325995|NCT02141295|450828916|FG001|Overall Study|Adverse Event|18|||
125325996|NCT02141295|450828917|FG002|Overall Study|Adverse Event|11|||
125325997|NCT02141295|450828915|FG000|Overall Study|Physician Decision|2|||
125325998|NCT02141295|450828916|FG001|Overall Study|Physician Decision|19|||
125325999|NCT02141295|450828917|FG002|Overall Study|Physician Decision|14|||
125326000|NCT02141295|450828915|FG000|Overall Study|Study terminated by sponsor|0|||
125326001|NCT02141295|450828916|FG001|Overall Study|Study terminated by sponsor|6|||
125326002|NCT02141295|450828917|FG002|Overall Study|Study terminated by sponsor|6|||
125326003|NCT02141295|450828915|FG000|Overall Study|Non-compliance|0|||
125326004|NCT02141295|450828916|FG001|Overall Study|Non-compliance|1|||
125326005|NCT02141295|450828917|FG002|Overall Study|Non-compliance|0|||
125326006|NCT02141295|450828915|FG000|Overall Study|Progressive disease|3|||
125326007|NCT02141295|450828916|FG001|Overall Study|Progressive disease|32|||
125326008|NCT02141295|450828917|FG002|Overall Study|Progressive disease|50|||
125326009|NCT02141295|450828915|FG000|Overall Study|Reason not specified|0|||
125326010|NCT02141295|450828916|FG001|Overall Study|Reason not specified|9|||
125326011|NCT02141295|450828917|FG002|Overall Study|Reason not specified|10|||
125326012|NCT02141295|450828915|FG000|Overall Study|Withdrawal by Subject|0|||
125326013|NCT02141295|450828916|FG001|Overall Study|Withdrawal by Subject|9|||
125326014|NCT02141295|450828917|FG002|Overall Study|Withdrawal by Subject|4|||
125326015|NCT01710501|450828918|FG000|Overall Study|Lost to Follow-up|2|||
125326016|NCT01710501|450828919|FG001|Overall Study|Lost to Follow-up|0|||
125326017|NCT01710501|450828920|FG002|Overall Study|Lost to Follow-up|0|||
125326018|NCT02536976|450828921|FG000|Overall Study|Physician Decision|0|||
125326019|NCT02536976|450828922|FG001|Overall Study|Physician Decision|1|||
125326020|NCT01671319|450828925|FG000|Overall Study|Withdrawal by Subject|1|||
125326021|NCT01709084|450828926|FG000|Overall Study|Lost to Follow-up|4|||
125326022|NCT01709084|450828927|FG001|Overall Study|Lost to Follow-up|7|||
125326023|NCT01709084|450828926|FG000|Overall Study|Withdrawal by Subject|2|||
125326024|NCT01709084|450828927|FG001|Overall Study|Withdrawal by Subject|2|||
125326025|NCT01709084|450828926|FG000|Overall Study|Adverse Event|5|||
125326026|NCT01709084|450828927|FG001|Overall Study|Adverse Event|0|||
125326027|NCT01709084|450828926|FG000|Overall Study|Other|5|||
125326028|NCT01709084|450828927|FG001|Overall Study|Other|3|||
125326029|NCT01709084|450828926|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
125326030|NCT01709084|450828927|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
125326031|NCT01709084|450828926|FG000|Overall Study|Not Treated|0|||
125326032|NCT01709084|450828927|FG001|Overall Study|Not Treated|2|||
125326033|NCT02144610|450828928|FG000|Overall Study|Physician Decision|1|||
125326034|NCT02144610|450828929|FG001|Overall Study|Physician Decision|0|||
125326035|NCT02144610|450828928|FG000|Overall Study|Withdrawal by Subject|1|||
125326036|NCT02144610|450828929|FG001|Overall Study|Withdrawal by Subject|5|||
125326037|NCT02144610|450828928|FG000|Overall Study|Death|2|||
125326038|NCT02144610|450828929|FG001|Overall Study|Death|2|||
125326039|NCT02144610|450828928|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
125326040|NCT02144610|450828929|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
125663499|NCT02842086|452056280|FG000|Overall Study|Randomized but Never Treated|6|||
125663500|NCT02842086|452056281|FG001|Overall Study|Randomized but Never Treated|6|||
125663501|NCT02842086|452056280|FG000|Overall Study|Still in Double-Blind Phase|7|||
125663502|NCT02842086|452056281|FG001|Overall Study|Still in Double-Blind Phase|3|||
125326041|NCT02144610|450828928|FG000|Overall Study|Other|0|||
125326042|NCT02144610|450828929|FG001|Overall Study|Other|1|||
125326043|NCT00214201|450828931|FG000|Overall Study|Withdrawal by Subject|2|||
125326044|NCT00214201|450828932|FG001|Overall Study|Withdrawal by Subject|0|||
125326045|NCT00214201|450828931|FG000|Overall Study|Death|0|||
125326046|NCT00214201|450828932|FG001|Overall Study|Death|2|||
125326047|NCT01399372|450828933|FG000|Overall Study|Protocol Violation|3|||
125326048|NCT01399372|450828934|FG001|Overall Study|Protocol Violation|1|||
125326049|NCT01432730|450828935|FG000|Period 1|Adverse Event|2|||
125326050|NCT01432730|450828936|FG001|Period 1|Adverse Event|0|||
125326051|NCT01432730|450828935|FG000|Period 2|Adverse Event|0|||
125326052|NCT01432730|450828936|FG001|Period 2|Adverse Event|4|||
125326053|NCT01712399|450828939|FG000|Overall Study|Lost to Follow-up|1|||
125326054|NCT01712399|450828939|FG000|Overall Study|Withdrawal by Subject|39|||
125326055|NCT01712399|450828939|FG000|Overall Study|Death|1|||
125326056|NCT01712399|450828939|FG000|Overall Study|Adverse Event|11|||
125326057|NCT01712399|450828939|FG000|Overall Study|Study closure|345|||
125326058|NCT01298648|450828940|FG000|Overall Study|Withdrawal by Subject|2|||
125326059|NCT01298648|450828940|FG000|Overall Study|Lost to Follow-up|21|||
125326060|NCT02038933|450828945|FG000|Overall Study|Disease progression|104|||
125326061|NCT02038933|450828945|FG000|Overall Study|Study drug toxicity|6|||
125326062|NCT02038933|450828945|FG000|Overall Study|Adverse event unrelated to study drug|6|||
125326063|NCT02038933|450828945|FG000|Overall Study|Participant request to discontinue treatment|2|||
125326064|NCT02038933|450828945|FG000|Overall Study|Lost to Follow-up|1|||
125326065|NCT02038933|450828945|FG000|Overall Study|Other reasons|2|||
125326066|NCT04154904|450828946|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
125326067|NCT04154904|450828947|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
125326068|NCT04154904|450828948|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
125326069|NCT02085161|450828950|FG000|Overall Study|Not Treated|1|||
125326070|NCT02085161|450828951|FG001|Overall Study|Not Treated|0|||
125326071|NCT02085161|450828952|FG002|Overall Study|Not Treated|0|||
125326072|NCT02085161|450828953|FG003|Overall Study|Not Treated|0|||
125326073|NCT02085161|450828950|FG000|Overall Study|Adverse Event|8|||
125326074|NCT02085161|450828951|FG001|Overall Study|Adverse Event|5|||
125326075|NCT02085161|450828952|FG002|Overall Study|Adverse Event|4|||
125326076|NCT02085161|450828953|FG003|Overall Study|Adverse Event|5|||
125326077|NCT02085161|450828950|FG000|Overall Study|Protocol Violation|0|||
125326078|NCT02085161|450828951|FG001|Overall Study|Protocol Violation|1|||
125326079|NCT02085161|450828952|FG002|Overall Study|Protocol Violation|0|||
125326080|NCT02085161|450828953|FG003|Overall Study|Protocol Violation|1|||
125326081|NCT02085161|450828950|FG000|Overall Study|Withdrawal by Subject|2|||
125326082|NCT02085161|450828951|FG001|Overall Study|Withdrawal by Subject|4|||
125326083|NCT02085161|450828952|FG002|Overall Study|Withdrawal by Subject|0|||
125326084|NCT02085161|450828953|FG003|Overall Study|Withdrawal by Subject|3|||
125326085|NCT02085161|450828950|FG000|Overall Study|Other Reason|1|||
125326086|NCT02085161|450828951|FG001|Overall Study|Other Reason|0|||
125326087|NCT02085161|450828952|FG002|Overall Study|Other Reason|1|||
125326088|NCT02085161|450828953|FG003|Overall Study|Other Reason|1|||
125326089|NCT01936870|450828958|FG000|Overall Study|No Visit After Treatment|176|||
125326090|NCT01936870|450828958|FG000|Overall Study|Protocol Violation|12|||
125326091|NCT01936870|450828958|FG000|Overall Study|No Drug Administration|1|||
125326092|NCT02399163|450828962|FG000|Overall Study|Adverse Event|2|||
125326093|NCT02399163|450828962|FG000|Overall Study|Protocol Deviation|2|||
125326094|NCT02399163|450828962|FG000|Overall Study|Withdrawal by Participant|5|||
125326095|NCT03910244|450828963|FG000|Overall Study|Adverse Event|14|||
125663503|NCT02842086|452056280|FG000|Overall Study|Adverse Event|18|||
125326096|NCT03910244|450828964|FG001|Overall Study|Adverse Event|0|||
125326097|NCT03910244|450828963|FG000|Overall Study|Death|1|||
125326098|NCT03910244|450828964|FG001|Overall Study|Death|0|||
125663504|NCT02842086|452056281|FG001|Overall Study|Adverse Event|20|||
125326099|NCT03910244|450828963|FG000|Overall Study|Lost to Follow-up|0|||
125326100|NCT03910244|450828964|FG001|Overall Study|Lost to Follow-up|2|||
125326101|NCT03910244|450828963|FG000|Overall Study|Joint withdrawal decision|1|||
125326102|NCT03910244|450828964|FG001|Overall Study|Joint withdrawal decision|0|||
125326103|NCT03910244|450828963|FG000|Overall Study|Study Terminated by Sponsor|7|||
125663505|NCT02842086|452056280|FG000|Overall Study|Death|3|||
125210685|NCT02638259|450395635|FG001|Treatment Period 2|Adverse Event|4|||
125326104|NCT03910244|450828964|FG001|Overall Study|Study Terminated by Sponsor|4|||
125326105|NCT03910244|450828963|FG000|Overall Study|Physician Decision|1|||
125326106|NCT03910244|450828964|FG001|Overall Study|Physician Decision|0|||
125326107|NCT03910244|450828963|FG000|Overall Study|Protocol Violation|1|||
125326108|NCT03910244|450828964|FG001|Overall Study|Protocol Violation|0|||
125326109|NCT03910244|450828963|FG000|Overall Study|Withdrawal by Subject|7|||
125326110|NCT03910244|450828964|FG001|Overall Study|Withdrawal by Subject|2|||
125326111|NCT00803569|450828967|FG000|Overall Study|Progressive Disease|3|||
125663506|NCT02842086|452056281|FG001|Overall Study|Death|3|||
125326112|NCT00803569|450828967|FG000|Overall Study|Noncompliance|1|||
125326113|NCT03345784|450828968|FG000|Overall Study|Withdrawal by Subject|2|||
125326114|NCT03345784|450828969|FG001|Overall Study|Withdrawal by Subject|1|||
125326115|NCT04798196|450828970|FG000|Overall Study|Lost to Follow-up|3|||
125326116|NCT04798196|450828971|FG001|Overall Study|Lost to Follow-up|1|||
125326117|NCT04798196|450828972|FG002|Overall Study|Lost to Follow-up|3|||
125326118|NCT00728689|450828978|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
125326119|NCT00728689|450828979|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
125326120|NCT00929695|450828980|FG000|Overall Study|Death|2|||
125326121|NCT00929695|450828981|FG001|Overall Study|Death|1|||
125326122|NCT00929695|450828980|FG000|Overall Study|Withdrawal by Subject|0|||
125326123|NCT00929695|450828981|FG001|Overall Study|Withdrawal by Subject|2|||
125326124|NCT00929695|450828980|FG000|Overall Study|discharge home|4|||
125326125|NCT00929695|450828981|FG001|Overall Study|discharge home|3|||
125326126|NCT00929695|450828980|FG000|Overall Study|incorrect stratification|2|||
125326127|NCT00929695|450828981|FG001|Overall Study|incorrect stratification|0|||
125326128|NCT00887809|450828983|FG000|Overall Study|Patient Not Treated|3|||
125326129|NCT00887809|450828984|FG001|Overall Study|Patient Not Treated|0|||
125326130|NCT00887809|450828983|FG000|Overall Study|Death|1|||
125326131|NCT00887809|450828984|FG001|Overall Study|Death|0|||
125326132|NCT01690143|450828989|FG000|Overall Study|Withdrawal by Subject|1|||
125326133|NCT03777982|450828990|FG000|Overall Study|Physician Decision|0|||
125326134|NCT03777982|450828991|FG001|Overall Study|Physician Decision|1|||
125326135|NCT00870740|450828992|FG000|Overall Study|Adverse Event|2|||
125326136|NCT00870740|450828993|FG001|Overall Study|Adverse Event|1|||
125326137|NCT00870740|450828994|FG002|Overall Study|Adverse Event|3|||
125326138|NCT00870740|450828995|FG003|Overall Study|Adverse Event|2|||
125326139|NCT00870740|450828996|FG004|Overall Study|Adverse Event|1|||
125326140|NCT00870740|450828997|FG005|Overall Study|Adverse Event|6|||
125326141|NCT00870740|450828992|FG000|Overall Study|Consent Withdrawn|6|||
125326142|NCT00870740|450828993|FG001|Overall Study|Consent Withdrawn|3|||
125326143|NCT00870740|450828994|FG002|Overall Study|Consent Withdrawn|4|||
125326144|NCT00870740|450828995|FG003|Overall Study|Consent Withdrawn|6|||
125326145|NCT00870740|450828996|FG004|Overall Study|Consent Withdrawn|6|||
125326146|NCT00870740|450828997|FG005|Overall Study|Consent Withdrawn|5|||
125326147|NCT00870740|450828992|FG000|Overall Study|Investigator Decision|2|||
125326148|NCT00870740|450828993|FG001|Overall Study|Investigator Decision|0|||
125326149|NCT00870740|450828994|FG002|Overall Study|Investigator Decision|1|||
125326150|NCT00870740|450828995|FG003|Overall Study|Investigator Decision|0|||
125326151|NCT00870740|450828996|FG004|Overall Study|Investigator Decision|0|||
125326152|NCT00870740|450828997|FG005|Overall Study|Investigator Decision|0|||
125326153|NCT00870740|450828992|FG000|Overall Study|Subject Non-compliance|0|||
125326154|NCT00870740|450828993|FG001|Overall Study|Subject Non-compliance|0|||
125326155|NCT00870740|450828994|FG002|Overall Study|Subject Non-compliance|0|||
125326156|NCT00870740|450828995|FG003|Overall Study|Subject Non-compliance|0|||
125326157|NCT00870740|450828996|FG004|Overall Study|Subject Non-compliance|0|||
125326158|NCT00870740|450828997|FG005|Overall Study|Subject Non-compliance|1|||
125326159|NCT00870740|450828992|FG000|Overall Study|Death|0|||
125326160|NCT00870740|450828993|FG001|Overall Study|Death|0|||
125326161|NCT00870740|450828994|FG002|Overall Study|Death|0|||
125326162|NCT00870740|450828995|FG003|Overall Study|Death|0|||
125326163|NCT00870740|450828996|FG004|Overall Study|Death|1|||
125326164|NCT00870740|450828997|FG005|Overall Study|Death|0|||
125326165|NCT00870740|450828992|FG000|Overall Study|Other|2|||
125326166|NCT00870740|450828993|FG001|Overall Study|Other|5|||
125326167|NCT00870740|450828994|FG002|Overall Study|Other|2|||
125326168|NCT00870740|450828995|FG003|Overall Study|Other|4|||
125326169|NCT00870740|450828996|FG004|Overall Study|Other|3|||
125326170|NCT00870740|450828997|FG005|Overall Study|Other|5|||
125326171|NCT03755934|450829000|FG000|Overall Study|Adverse Event|4|||
125326172|NCT03755934|450829001|FG001|Overall Study|Adverse Event|1|||
125326173|NCT03755934|450829002|FG002|Overall Study|Adverse Event|1|||
125326174|NCT03755934|450829003|FG003|Overall Study|Adverse Event|3|||
125326175|NCT03755934|450829000|FG000|Overall Study|Physician Decision|2|||
125326176|NCT03755934|450829001|FG001|Overall Study|Physician Decision|0|||
125326177|NCT03755934|450829002|FG002|Overall Study|Physician Decision|0|||
125326178|NCT03755934|450829003|FG003|Overall Study|Physician Decision|1|||
125326179|NCT03755934|450829000|FG000|Overall Study|Withdrawal by Subject|5|||
125326180|NCT03755934|450829001|FG001|Overall Study|Withdrawal by Subject|0|||
125326181|NCT03755934|450829002|FG002|Overall Study|Withdrawal by Subject|0|||
125326182|NCT03755934|450829003|FG003|Overall Study|Withdrawal by Subject|1|||
125326183|NCT03755934|450829000|FG000|Overall Study|Other|3|||
125326184|NCT03755934|450829001|FG001|Overall Study|Other|1|||
125326185|NCT03755934|450829002|FG002|Overall Study|Other|3|||
125326186|NCT03755934|450829003|FG003|Overall Study|Other|1|||
125326187|NCT00307801|450829004|FG000|Overall Study|Adverse Event|12|||
125326188|NCT00307801|450829005|FG001|Overall Study|Adverse Event|4|||
125326189|NCT00307801|450829004|FG000|Overall Study|Withdrawal by Subject|9|||
125326190|NCT00307801|450829005|FG001|Overall Study|Withdrawal by Subject|4|||
125326191|NCT00307801|450829004|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
125326192|NCT00307801|450829005|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
125326193|NCT00307801|450829004|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
125326194|NCT00307801|450829005|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
125326195|NCT00307801|450829004|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
125326196|NCT00307801|450829005|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
125326197|NCT00307801|450829004|FG000|Overall Study|Wrong Randomization|1|||
125326198|NCT00307801|450829005|FG001|Overall Study|Wrong Randomization|0|||
125326199|NCT00307801|450829004|FG000|Overall Study|Lack of Efficacy|0|||
125326200|NCT00307801|450829005|FG001|Overall Study|Lack of Efficacy|2|||
125326201|NCT00307801|450829004|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
125326202|NCT00307801|450829005|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
125326203|NCT00307801|450829004|FG000|Overall Study|Frustration with e-diary|1|||
125326204|NCT00307801|450829005|FG001|Overall Study|Frustration with e-diary|0|||
125326205|NCT00307801|450829004|FG000|Overall Study|Protocol Violation|3|||
125326206|NCT00307801|450829005|FG001|Overall Study|Protocol Violation|2|||
125326207|NCT00307801|450829004|FG000|Overall Study|No reason specified|2|||
125326208|NCT00307801|450829005|FG001|Overall Study|No reason specified|0|||
125326209|NCT00307801|450829004|FG000|Overall Study|Pregnancy|0|||
125326210|NCT00307801|450829005|FG001|Overall Study|Pregnancy|1|||
125326211|NCT00551642|450829011|FG000|Treatment Period|Protocol Deviation|6|||
125326212|NCT00551642|450829012|FG001|Treatment Period|Protocol Deviation|11|||
125326213|NCT00551642|450829011|FG000|Treatment Period|Delivery device failure|1|||
125326214|NCT00551642|450829012|FG001|Treatment Period|Delivery device failure|3|||
125326215|NCT00551642|450829011|FG000|Treatment Period|Physician Decision|0|||
125326216|NCT00551642|450829012|FG001|Treatment Period|Physician Decision|1|||
125326217|NCT00551642|450829011|FG000|Treatment Period|Death|33|||
125326218|NCT00551642|450829012|FG001|Treatment Period|Death|31|||
125326219|NCT00551642|450829011|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
125326220|NCT00551642|450829012|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
125326221|NCT00551642|450829011|FG000|Treatment Period|Adverse Event|15|||
125326222|NCT00551642|450829012|FG001|Treatment Period|Adverse Event|12|||
125326223|NCT00551642|450829011|FG000|Treatment Period|Withdrawal by Subject|2|||
125326224|NCT00551642|450829012|FG001|Treatment Period|Withdrawal by Subject|1|||
125326225|NCT00361296|450829014|FG000|Overall Study|Physician Decision|1|||
125326226|NCT00361296|450829014|FG000|Overall Study|Lack of Efficacy|2|||
125326227|NCT00198822|450829015|FG000|Overall Study|Lost to Follow-up|14|||
125326228|NCT00198822|450829016|FG001|Overall Study|Lost to Follow-up|20|||
125326229|NCT00198822|450829017|FG002|Overall Study|Lost to Follow-up|21|||
125326230|NCT03011099|450829018|FG000|Overall Study|Withdrawal by Subject|0|||
125326231|NCT03011099|450829019|FG001|Overall Study|Withdrawal by Subject|2|||
125326232|NCT02072668|450829023|FG000|Second Intervention|Lost to Follow-up|1|||
125326233|NCT02072668|450829024|FG001|Second Intervention|Lost to Follow-up|0|||
125326234|NCT04482647|450829025|FG000|Overall Study|Time constraints|2|||
125326235|NCT04482647|450829025|FG000|Overall Study|Health issues|1|||
125326236|NCT04482647|450829025|FG000|Overall Study|Death in the family|1|||
125326237|NCT04482647|450829025|FG000|Overall Study|Disliked the intervention|1|||
125326238|NCT04482647|450829025|FG000|Overall Study|No reasons specified|7|||
125425585|NCT01735201|451182280|FG001|Overall Study|Adverse Event|1|||
125425586|NCT01735201|451182281|FG002|Overall Study|Adverse Event|0|||
125425587|NCT01735201|451182282|FG003|Overall Study|Adverse Event|1|||
125425588|NCT01735201|451182283|FG004|Overall Study|Adverse Event|1|||
125425589|NCT01735201|451182284|FG005|Overall Study|Adverse Event|3|||
125425590|NCT01735201|451182285|FG006|Overall Study|Adverse Event|2|||
125425591|NCT01735201|451182286|FG007|Overall Study|Adverse Event|1|||
125425592|NCT01735201|451182279|FG000|Overall Study|Personal Reasons|1|||
125425593|NCT01735201|451182280|FG001|Overall Study|Personal Reasons|0|||
125425594|NCT01735201|451182281|FG002|Overall Study|Personal Reasons|0|||
125425595|NCT01735201|451182282|FG003|Overall Study|Personal Reasons|0|||
125663507|NCT02842086|452056280|FG000|Overall Study|Investigator's Discretion|9|||
125663508|NCT02842086|452056281|FG001|Overall Study|Investigator's Discretion|13|||
125663509|NCT02842086|452056280|FG000|Overall Study|Non-Compliance with Study Drug|9|||
125663510|NCT02842086|452056281|FG001|Overall Study|Non-Compliance with Study Drug|8|||
125663511|NCT02842086|452056280|FG000|Overall Study|Protocol Violation|8|||
125425596|NCT01735201|451182283|FG004|Overall Study|Personal Reasons|0|||
125326251|NCT04163341|450829030|FG000|Overall Study|Withdrawal by Subject|2|||
125326252|NCT04163341|450829031|FG001|Overall Study|Withdrawal by Subject|0|||
125326253|NCT04163341|450829030|FG000|Overall Study|Lost to Follow-up|3|||
125326254|NCT04163341|450829031|FG001|Overall Study|Lost to Follow-up|4|||
125326255|NCT02484391|450829033|FG000|Overall Study|Lack of Efficacy|15|||
125326256|NCT02484391|450829034|FG001|Overall Study|Lack of Efficacy|14|||
125326257|NCT02484391|450829035|FG002|Overall Study|Lack of Efficacy|3|||
125326258|NCT02484391|450829033|FG000|Overall Study|Lost to Follow-up|0|||
125326259|NCT02484391|450829034|FG001|Overall Study|Lost to Follow-up|0|||
125326260|NCT02484391|450829035|FG002|Overall Study|Lost to Follow-up|2|||
125326261|NCT02484391|450829033|FG000|Overall Study|Physician Decision|1|||
125326262|NCT02484391|450829034|FG001|Overall Study|Physician Decision|3|||
125326263|NCT02484391|450829035|FG002|Overall Study|Physician Decision|0|||
125326264|NCT02484391|450829033|FG000|Overall Study|Went to Transplant|5|||
125326265|NCT02484391|450829034|FG001|Overall Study|Went to Transplant|3|||
125326266|NCT02484391|450829035|FG002|Overall Study|Went to Transplant|2|||
125326267|NCT00905164|450829038|FG000|Period 1|Protocol Violation|0|||
125326268|NCT00905164|450829039|FG001|Period 1|Protocol Violation|1|||
125326269|NCT04730804|450829044|FG000|Overall Study|Physician Decision|0|||
125326270|NCT04730804|450829045|FG001|Overall Study|Physician Decision|0|||
125326271|NCT04730804|450829046|FG002|Overall Study|Physician Decision|0|||
125326272|NCT04730804|450829047|FG003|Overall Study|Physician Decision|0|||
125326273|NCT04730804|450829048|FG004|Overall Study|Physician Decision|0|||
125326274|NCT04730804|450829049|FG005|Overall Study|Physician Decision|1|||
125326275|NCT04730804|450829044|FG000|Overall Study|Withdrawal by Subject|0|||
125326276|NCT04730804|450829045|FG001|Overall Study|Withdrawal by Subject|0|||
125326277|NCT04730804|450829046|FG002|Overall Study|Withdrawal by Subject|0|||
125326278|NCT04730804|450829047|FG003|Overall Study|Withdrawal by Subject|0|||
125326279|NCT04730804|450829048|FG004|Overall Study|Withdrawal by Subject|1|||
125326280|NCT04730804|450829049|FG005|Overall Study|Withdrawal by Subject|2|||
125326281|NCT05366738|450831351|FG000|Overall Study|Adverse Event|0|||
125326282|NCT05366738|450831352|FG001|Overall Study|Adverse Event|1|||
125326283|NCT05366738|450831353|FG002|Overall Study|Adverse Event|0|||
125326284|NCT01389596|450831354|FG000|Overall Study|Protocol Violation|3|||
125326285|NCT01389596|450831355|FG001|Overall Study|Protocol Violation|4|||
125326286|NCT01389596|450831356|FG002|Overall Study|Protocol Violation|3|||
125326287|NCT01389596|450831354|FG000|Overall Study|Withdrawal by Subject|1|||
125326288|NCT01389596|450831355|FG001|Overall Study|Withdrawal by Subject|2|||
125326289|NCT01389596|450831356|FG002|Overall Study|Withdrawal by Subject|2|||
125326290|NCT01389596|450831354|FG000|Overall Study|Insufficient Clinical Response|3|||
125326291|NCT01389596|450831355|FG001|Overall Study|Insufficient Clinical Response|4|||
125326292|NCT01389596|450831356|FG002|Overall Study|Insufficient Clinical Response|5|||
125326293|NCT01389596|450831354|FG000|Overall Study|Adverse Event|1|||
125326294|NCT01389596|450831355|FG001|Overall Study|Adverse Event|4|||
125326295|NCT01389596|450831356|FG002|Overall Study|Adverse Event|0|||
125326296|NCT01389596|450831354|FG000|Overall Study|Death|0|||
125326297|NCT01389596|450831355|FG001|Overall Study|Death|1|||
125326298|NCT01389596|450831356|FG002|Overall Study|Death|0|||
125326299|NCT01389596|450831354|FG000|Overall Study|Other Unspecified|2|||
125326300|NCT01389596|450831355|FG001|Overall Study|Other Unspecified|1|||
125326301|NCT01389596|450831356|FG002|Overall Study|Other Unspecified|0|||
125326302|NCT01124006|450831360|FG000|Overall Study|Withdrawal by Subject|2|||
125326303|NCT01124006|450831361|FG001|Overall Study|Withdrawal by Subject|2|||
125326304|NCT01124006|450831362|FG002|Overall Study|Withdrawal by Subject|0|||
125326305|NCT01124006|450831360|FG000|Overall Study|Lost to Follow-up|1|||
125326306|NCT01124006|450831361|FG001|Overall Study|Lost to Follow-up|0|||
125326307|NCT01124006|450831362|FG002|Overall Study|Lost to Follow-up|1|||
125326308|NCT01124006|450831360|FG000|Overall Study|Other|0|||
125326309|NCT01124006|450831361|FG001|Overall Study|Other|0|||
125326310|NCT01124006|450831362|FG002|Overall Study|Other|1|||
125326311|NCT03841604|450831370|FG000|Overall Study|Withdrawal by Subject|3|||
125326312|NCT03841604|450831371|FG001|Overall Study|Withdrawal by Subject|1|||
125326313|NCT03841604|450831370|FG000|Overall Study|Adverse Event|4|||
125326314|NCT03841604|450831371|FG001|Overall Study|Adverse Event|2|||
125326315|NCT03841604|450831370|FG000|Overall Study|Physician Decision|1|||
125326316|NCT03841604|450831371|FG001|Overall Study|Physician Decision|0|||
125326317|NCT03877510|450831374|FG000|Overall Study|Death|6|||
125326318|NCT03877510|450831374|FG000|Overall Study|Lost to Follow-up|2|||
125326319|NCT03877510|450831374|FG000|Overall Study|Non-compliance with study drug|2|||
125326320|NCT03877510|450831374|FG000|Overall Study|Lack of Efficacy|14|||
125326321|NCT03877510|450831374|FG000|Overall Study|Adverse Event|20|||
125326322|NCT03877510|450831374|FG000|Overall Study|Withdrawal by Subject|22|||
125326323|NCT03877510|450831374|FG000|Overall Study|Miscellaneous|1|||
125326324|NCT01417377|450831375|FG000|Overall Study|Lost to Follow-up|12|||
125326325|NCT01417377|450831375|FG000|Overall Study|Enrolled, but not treated|1|||
125326326|NCT02113982|450831376|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
125326327|NCT02113982|450831377|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
125326328|NCT02113982|450831378|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
125326329|NCT02113982|450831379|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
125326330|NCT02113982|450831380|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
125326331|NCT02113982|450831381|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
125326332|NCT02113982|450831382|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
125326333|NCT02113982|450831383|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
125326334|NCT02113982|450831384|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
125326335|NCT02113982|450831385|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
125326336|NCT02113982|450831386|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
125326337|NCT02113982|450831387|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
125326338|NCT02113982|450831388|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
125326339|NCT02113982|450831389|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
125326340|NCT02113982|450831376|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
125326341|NCT02113982|450831377|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
125326342|NCT02113982|450831378|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
125326343|NCT02113982|450831379|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
125663512|NCT02842086|452056281|FG001|Overall Study|Protocol Violation|4|||
125663513|NCT02842086|452056280|FG000|Overall Study|Withdrew Consent|205|||
125663514|NCT02842086|452056281|FG001|Overall Study|Withdrew Consent|194|||
125663515|NCT02842086|452056280|FG000|Overall Study|Lost to Follow-up|274|||
125663516|NCT02842086|452056281|FG001|Overall Study|Lost to Follow-up|236|||
125663517|NCT02842086|452056280|FG000|Overall Study|HIV-1 Infection|5|||
125663518|NCT02842086|452056281|FG001|Overall Study|HIV-1 Infection|6|||
125663519|NCT03751124|452056282|FG000|Overall Study|Adverse Event|4|||
125663520|NCT03751124|452056283|FG001|Overall Study|Adverse Event|3|||
125663521|NCT03751124|452056282|FG000|Overall Study|Protocol Deviation|0|||
125663522|NCT03751124|452056283|FG001|Overall Study|Protocol Deviation|1|||
125663523|NCT03751124|452056282|FG000|Overall Study|Lost to Follow-up|6|||
125663524|NCT03751124|452056283|FG001|Overall Study|Lost to Follow-up|4|||
125663525|NCT03751124|452056282|FG000|Overall Study|Withdrawal by Subject|6|||
125663526|NCT03751124|452056283|FG001|Overall Study|Withdrawal by Subject|8|||
125663527|NCT03751124|452056282|FG000|Overall Study|Lack of Efficacy|1|||
125663528|NCT03751124|452056283|FG001|Overall Study|Lack of Efficacy|1|||
125663529|NCT03751124|452056282|FG000|Overall Study|Pregnancy|0|||
125663530|NCT03751124|452056283|FG001|Overall Study|Pregnancy|1|||
125663531|NCT03751124|452056282|FG000|Overall Study|Other|9|||
125663532|NCT03751124|452056283|FG001|Overall Study|Other|9|||
125663533|NCT03751124|452056282|FG000|Overall Study|Participants who did not receive any study drug|0|||
125663534|NCT03751124|452056283|FG001|Overall Study|Participants who did not receive any study drug|1|||
125663535|NCT00555399|452056286|FG000|Overall Study|Withdrawal by Subject|0|||
125663536|NCT00555399|452056287|FG001|Overall Study|Withdrawal by Subject|0|||
125663537|NCT00555399|452056288|FG002|Overall Study|Withdrawal by Subject|1|||
125663538|NCT00555399|452056289|FG003|Overall Study|Withdrawal by Subject|0|||
125663539|NCT00555399|452056290|FG004|Overall Study|Withdrawal by Subject|0|||
125663540|NCT00555399|452056291|FG005|Overall Study|Withdrawal by Subject|0|||
125663541|NCT00555399|452056292|FG006|Overall Study|Withdrawal by Subject|0|||
125663542|NCT00555399|452056293|FG007|Overall Study|Withdrawal by Subject|0|||
125663543|NCT00555399|452056294|FG008|Overall Study|Withdrawal by Subject|0|||
125663544|NCT00555399|452056295|FG009|Overall Study|Withdrawal by Subject|0|||
125663545|NCT00555399|452056296|FG010|Overall Study|Withdrawal by Subject|0|||
125663546|NCT00555399|452056297|FG011|Overall Study|Withdrawal by Subject|1|||
125663547|NCT00555399|452056286|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
125663548|NCT00555399|452056287|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
125663549|NCT00555399|452056288|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
125663550|NCT00555399|452056289|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
125663551|NCT00555399|452056290|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
125663552|NCT00555399|452056291|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
125663553|NCT00555399|452056292|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
125663554|NCT00555399|452056293|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
125663555|NCT00555399|452056294|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
125663556|NCT00555399|452056295|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
125663557|NCT00555399|452056296|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
125663558|NCT00555399|452056297|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
125663559|NCT01858558|452057791|FG000|Overall Study|Death|1|||
125663560|NCT01858558|452057792|FG001|Overall Study|Death|1|||
125663561|NCT01858558|452057791|FG000|Overall Study|Lost to Follow-up|1|||
125663562|NCT01858558|452057792|FG001|Overall Study|Lost to Follow-up|0|||
125663563|NCT01858558|452057791|FG000|Overall Study|Disease progression|3|||
125663564|NCT01858558|452057792|FG001|Overall Study|Disease progression|1|||
125663565|NCT01858558|452057791|FG000|Overall Study|Product contamination|2|||
125663566|NCT01858558|452057792|FG001|Overall Study|Product contamination|0|||
125663567|NCT01858558|452057791|FG000|Overall Study|Failed expansion of cell product|2|||
125663568|NCT01858558|452057792|FG001|Overall Study|Failed expansion of cell product|0|||
125663569|NCT00343642|452057793|FG000|Overall Study|Lost to Follow-up|0|||
125663570|NCT00343642|452057794|FG001|Overall Study|Lost to Follow-up|1|||
125663571|NCT00343642|452057795|FG002|Overall Study|Lost to Follow-up|0|||
125663572|NCT00343642|452057793|FG000|Overall Study|Pregnancy|1|||
125663573|NCT00343642|452057794|FG001|Overall Study|Pregnancy|0|||
125663574|NCT00343642|452057795|FG002|Overall Study|Pregnancy|2|||
125663575|NCT00343642|452057793|FG000|Overall Study|Withdrawal by Subject|2|||
125663576|NCT00343642|452057794|FG001|Overall Study|Withdrawal by Subject|3|||
125663577|NCT00343642|452057795|FG002|Overall Study|Withdrawal by Subject|4|||
125663578|NCT00343642|452057793|FG000|Overall Study|Adverse Event|0|||
125663579|NCT00343642|452057794|FG001|Overall Study|Adverse Event|0|||
125663580|NCT00343642|452057795|FG002|Overall Study|Adverse Event|1|||
125663581|NCT00343642|452057793|FG000|Overall Study|Flare up|6|||
125663582|NCT00343642|452057794|FG001|Overall Study|Flare up|4|||
125663583|NCT00343642|452057795|FG002|Overall Study|Flare up|0|||
125663584|NCT00569231|452057802|FG000|Overall Study|Study unrelated surgery|1|||
125425597|NCT01735201|451182284|FG005|Overall Study|Personal Reasons|0|||
125326344|NCT02113982|450831380|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
125326345|NCT02113982|450831381|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
125326346|NCT02113982|450831382|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
125326347|NCT02113982|450831383|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
125326348|NCT02113982|450831384|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
125326349|NCT02113982|450831385|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
125326350|NCT02113982|450831386|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
125326351|NCT02113982|450831387|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
125326352|NCT02113982|450831388|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
125326353|NCT02113982|450831389|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
125326354|NCT02113982|450831376|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326355|NCT02113982|450831377|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326356|NCT02113982|450831378|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326357|NCT02113982|450831379|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125663585|NCT00569231|452057802|FG000|Overall Study|Airfare expense|2|||
125663586|NCT00569231|452057802|FG000|Overall Study|Withdrawal by Subject|1|||
125326358|NCT02113982|450831380|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326359|NCT02113982|450831381|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326360|NCT02113982|450831382|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
125326361|NCT02113982|450831383|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326362|NCT02113982|450831384|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326363|NCT02113982|450831385|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326364|NCT02113982|450831386|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125663587|NCT00569231|452057802|FG000|Overall Study|Car accident injury|1|||
125663588|NCT00569231|452057802|FG000|Overall Study|Non-compliance|2|||
125326365|NCT02113982|450831387|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326366|NCT02113982|450831388|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125326367|NCT02113982|450831389|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
125663589|NCT00700310|452057805|FG000|Overall Study|Adverse Event|6|||
125663590|NCT00700310|452057806|FG001|Overall Study|Adverse Event|10|||
125663591|NCT00700310|452057807|FG002|Overall Study|Adverse Event|5|||
125663592|NCT00700310|452057808|FG003|Overall Study|Adverse Event|11|||
125663593|NCT00700310|452057805|FG000|Overall Study|Lost to Follow-up|4|||
125663594|NCT00700310|452057806|FG001|Overall Study|Lost to Follow-up|1|||
125663595|NCT00700310|452057807|FG002|Overall Study|Lost to Follow-up|0|||
125663596|NCT00700310|452057808|FG003|Overall Study|Lost to Follow-up|1|||
125663597|NCT00700310|452057805|FG000|Overall Study|Withdrawal by Subject|8|||
125663598|NCT00700310|452057806|FG001|Overall Study|Withdrawal by Subject|9|||
125663599|NCT00700310|452057807|FG002|Overall Study|Withdrawal by Subject|8|||
125663600|NCT00700310|452057808|FG003|Overall Study|Withdrawal by Subject|8|||
125663601|NCT00700310|452057805|FG000|Overall Study|Lack of Efficacy|0|||
125663602|NCT00700310|452057806|FG001|Overall Study|Lack of Efficacy|3|||
125663603|NCT00700310|452057807|FG002|Overall Study|Lack of Efficacy|0|||
125663604|NCT00700310|452057808|FG003|Overall Study|Lack of Efficacy|1|||
125663605|NCT00700310|452057805|FG000|Overall Study|Administrative/Other|1|||
125663606|NCT00700310|452057806|FG001|Overall Study|Administrative/Other|3|||
125663607|NCT00700310|452057807|FG002|Overall Study|Administrative/Other|1|||
125663608|NCT00700310|452057808|FG003|Overall Study|Administrative/Other|3|||
125663609|NCT00700310|452057805|FG000|Overall Study|Randomized, Not Treated|2|||
125663610|NCT00700310|452057806|FG001|Overall Study|Randomized, Not Treated|0|||
125663611|NCT00700310|452057807|FG002|Overall Study|Randomized, Not Treated|2|||
125663612|NCT00700310|452057808|FG003|Overall Study|Randomized, Not Treated|2|||
125663613|NCT03053622|452057814|FG000|Overall Study|Lost to Follow-up|0|||
125663614|NCT03053622|452057815|FG001|Overall Study|Lost to Follow-up|0|||
125663615|NCT03053622|452057816|FG002|Overall Study|Lost to Follow-up|0|||
125663616|NCT03053622|452057817|FG003|Overall Study|Lost to Follow-up|1|||
125663617|NCT02598622|452057818|FG000|Overall Study|Withdrawal by Subject|3|||
125663618|NCT02598622|452057819|FG001|Overall Study|Withdrawal by Subject|0|||
125663619|NCT02598622|452057818|FG000|Overall Study|Physician Decision|3|||
125663620|NCT02598622|452057819|FG001|Overall Study|Physician Decision|0|||
125663621|NCT04575038|452057820|FG000|Overall Study|Withdrawal by Subject|1|||
125663622|NCT04575038|452057821|FG001|Overall Study|Withdrawal by Subject|1|||
125663623|NCT01902134|452057823|FG000|Overall Study|Adverse Event|3|||
125663624|NCT01902134|452057824|FG001|Overall Study|Adverse Event|1|||
125326368|NCT02113982|450831376|FG000|Stage 1: Dose Escalation|Transplant|0|||
125326369|NCT02113982|450831377|FG001|Stage 1: Dose Escalation|Transplant|1|||
125326370|NCT02113982|450831378|FG002|Stage 1: Dose Escalation|Transplant|0|||
125326371|NCT02113982|450831379|FG003|Stage 1: Dose Escalation|Transplant|0|||
125326372|NCT02113982|450831380|FG004|Stage 1: Dose Escalation|Transplant|0|||
125326373|NCT02113982|450831381|FG005|Stage 1: Dose Escalation|Transplant|1|||
125326374|NCT02113982|450831382|FG006|Stage 1: Dose Escalation|Transplant|0|||
125663625|NCT01902134|452057825|FG002|Overall Study|Adverse Event|2|||
125663626|NCT01902134|452057826|FG003|Overall Study|Adverse Event|1|||
125663627|NCT01902134|452057827|FG004|Overall Study|Adverse Event|1|||
125663628|NCT01902134|452057828|FG005|Overall Study|Adverse Event|3|||
125326375|NCT02113982|450831383|FG007|Stage 1: Dose Escalation|Transplant|0|||
125326376|NCT02113982|450831384|FG008|Stage 1: Dose Escalation|Transplant|0|||
125326377|NCT02113982|450831385|FG009|Stage 1: Dose Escalation|Transplant|0|||
125326378|NCT02113982|450831386|FG010|Stage 1: Dose Escalation|Transplant|0|||
125326379|NCT02113982|450831387|FG011|Stage 1: Dose Escalation|Transplant|0|||
125326380|NCT02113982|450831388|FG012|Stage 1: Dose Escalation|Transplant|0|||
125326381|NCT02113982|450831389|FG013|Stage 1: Dose Escalation|Transplant|0|||
125326382|NCT02113982|450831376|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
125326383|NCT02113982|450831377|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
125326384|NCT02113982|450831378|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
125326385|NCT02113982|450831379|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
125326386|NCT02113982|450831380|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
125326387|NCT02113982|450831381|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
125326388|NCT02113982|450831382|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
125326389|NCT02113982|450831383|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
125326390|NCT02113982|450831384|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
125326391|NCT02113982|450831385|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
125326392|NCT02113982|450831386|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
125326393|NCT02113982|450831387|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
125326394|NCT02113982|450831388|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
125326395|NCT02113982|450831389|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
125326396|NCT02113982|450831376|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
125326397|NCT02113982|450831377|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
125326398|NCT02113982|450831378|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
125326399|NCT02113982|450831379|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
125326400|NCT02113982|450831380|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
125326401|NCT02113982|450831381|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
125326402|NCT02113982|450831382|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
125326403|NCT02113982|450831383|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
125326404|NCT02113982|450831384|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
125326405|NCT02113982|450831385|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
125326406|NCT02113982|450831386|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
125326407|NCT02113982|450831387|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
125326408|NCT02113982|450831388|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
125326409|NCT02113982|450831389|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
125326410|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
125326411|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
125326412|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
125326413|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
125326414|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
125326415|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
125326416|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
125326417|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
125326418|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
125326419|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
125326420|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
125326421|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
125326422|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
125326423|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
125326424|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
125326425|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
125326426|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
125326427|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
125326428|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
125326429|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
125326430|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
125326431|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
125326432|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
125326433|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
125326434|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
125326435|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
125326436|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
125326437|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
125326438|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326439|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326440|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326441|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326442|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326443|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326444|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326445|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
125326446|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326447|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
125326448|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
125326449|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326450|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326451|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
125326452|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326453|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326454|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326455|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326456|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326457|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326458|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326459|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
125326460|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326461|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
125326462|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326463|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326464|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326465|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
125326466|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326467|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326468|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326469|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326470|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326471|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326472|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326473|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
125326474|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326475|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326476|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326477|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326478|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326479|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
125326480|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Transplant|0|||
125326481|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Transplant|0|||
125326482|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Transplant|0|||
125326483|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Transplant|0|||
125326484|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Transplant|0|||
125326485|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Transplant|0|||
125663629|NCT01902134|452057823|FG000|Overall Study|Lack of Efficacy|0|||
125663630|NCT01902134|452057824|FG001|Overall Study|Lack of Efficacy|0|||
125663631|NCT01902134|452057825|FG002|Overall Study|Lack of Efficacy|2|||
125663632|NCT01902134|452057826|FG003|Overall Study|Lack of Efficacy|0|||
125663633|NCT01902134|452057827|FG004|Overall Study|Lack of Efficacy|0|||
125663634|NCT01902134|452057828|FG005|Overall Study|Lack of Efficacy|1|||
125663635|NCT01902134|452057823|FG000|Overall Study|Physician Decision|0|||
125663636|NCT01902134|452057824|FG001|Overall Study|Physician Decision|1|||
125663637|NCT01902134|452057825|FG002|Overall Study|Physician Decision|0|||
125663638|NCT01902134|452057826|FG003|Overall Study|Physician Decision|0|||
125663639|NCT01902134|452057827|FG004|Overall Study|Physician Decision|0|||
125663640|NCT01902134|452057828|FG005|Overall Study|Physician Decision|0|||
125663641|NCT01902134|452057823|FG000|Overall Study|Protocol Violation|0|||
125663642|NCT01902134|452057824|FG001|Overall Study|Protocol Violation|0|||
125663643|NCT01902134|452057825|FG002|Overall Study|Protocol Violation|0|||
125663644|NCT01902134|452057826|FG003|Overall Study|Protocol Violation|0|||
125663645|NCT01902134|452057827|FG004|Overall Study|Protocol Violation|0|||
125663646|NCT01902134|452057828|FG005|Overall Study|Protocol Violation|1|||
125663647|NCT01902134|452057823|FG000|Overall Study|Withdrawal by Subject|4|||
125663648|NCT01902134|452057824|FG001|Overall Study|Withdrawal by Subject|8|||
125663649|NCT01902134|452057825|FG002|Overall Study|Withdrawal by Subject|9|||
125663650|NCT01902134|452057826|FG003|Overall Study|Withdrawal by Subject|1|||
125663651|NCT01902134|452057827|FG004|Overall Study|Withdrawal by Subject|5|||
125663652|NCT01902134|452057828|FG005|Overall Study|Withdrawal by Subject|4|||
125663653|NCT01902134|452057823|FG000|Overall Study|no compliance|1|||
125663654|NCT01902134|452057824|FG001|Overall Study|no compliance|0|||
125663655|NCT01902134|452057825|FG002|Overall Study|no compliance|0|||
125663656|NCT01902134|452057826|FG003|Overall Study|no compliance|0|||
125663657|NCT01902134|452057827|FG004|Overall Study|no compliance|0|||
125326486|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Transplant|0|||
125326487|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Transplant|0|||
125663658|NCT01902134|452057828|FG005|Overall Study|no compliance|0|||
125663659|NCT01902134|452057823|FG000|Overall Study|Other|0|||
125663660|NCT01902134|452057824|FG001|Overall Study|Other|1|||
125663661|NCT01902134|452057825|FG002|Overall Study|Other|2|||
125663662|NCT01902134|452057826|FG003|Overall Study|Other|0|||
125326488|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Transplant|0|||
125326489|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Transplant|4|||
125326490|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Transplant|2|||
125326491|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Transplant|0|||
125326492|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Transplant|0|||
125326493|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Transplant|0|||
125326494|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
125326495|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
125326496|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
125326497|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
125326498|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
125326499|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
125326500|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
125326501|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
125326502|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
125326503|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
125326504|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
125326505|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
125326506|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
125326507|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
125326508|NCT02113982|450831376|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
125326509|NCT02113982|450831377|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
125326510|NCT02113982|450831378|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
125326511|NCT02113982|450831379|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
125326512|NCT02113982|450831380|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
125326513|NCT02113982|450831381|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
125326514|NCT02113982|450831382|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
125326515|NCT02113982|450831383|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
125326516|NCT02113982|450831384|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
125326517|NCT02113982|450831385|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
125326518|NCT02113982|450831386|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
125326519|NCT02113982|450831387|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
125326520|NCT02113982|450831388|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
125326521|NCT02113982|450831389|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
125326522|NCT02113982|450831376|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326523|NCT02113982|450831377|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326524|NCT02113982|450831378|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326525|NCT02113982|450831379|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326526|NCT02113982|450831380|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326527|NCT02113982|450831381|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326528|NCT02113982|450831382|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326529|NCT02113982|450831383|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326530|NCT02113982|450831384|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326531|NCT02113982|450831385|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326532|NCT02113982|450831386|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326533|NCT02113982|450831387|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
125326534|NCT02113982|450831388|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
125663663|NCT01902134|452057827|FG004|Overall Study|Other|1|||
125663664|NCT01902134|452057828|FG005|Overall Study|Other|0|||
125663665|NCT00305110|452057829|FG000|Overall Study|Missing data|29|||
125663666|NCT00678379|452057830|FG000|Overall Study|Injection performed after tonsillectomy|2|||
125663667|NCT00678379|452057831|FG001|Overall Study|Injection performed after tonsillectomy|0|||
125663668|NCT00678379|452057832|FG002|Overall Study|Injection performed after tonsillectomy|1|||
125663669|NCT00678379|452057830|FG000|Overall Study|Incomplete Data|4|||
125663670|NCT00678379|452057831|FG001|Overall Study|Incomplete Data|3|||
125663671|NCT00678379|452057832|FG002|Overall Study|Incomplete Data|3|||
125663672|NCT01835470|452057833|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
125663673|NCT01835470|452057833|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
125663674|NCT04335110|452057851|FG000|Overall Study|Withdrawal by Subject|1|||
125663675|NCT04335110|452057852|FG001|Overall Study|Withdrawal by Subject|1|||
125663676|NCT04335110|452057851|FG000|Overall Study|Death|0|||
125663677|NCT04335110|452057852|FG001|Overall Study|Death|1|||
125663678|NCT00350519|452057853|FG000|Overall Study|Death|0|||
125326535|NCT02113982|450831389|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
125326536|NCT02113982|450831376|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326537|NCT02113982|450831377|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326538|NCT02113982|450831378|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326539|NCT02113982|450831379|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326540|NCT02113982|450831380|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326541|NCT02113982|450831381|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326542|NCT02113982|450831382|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326543|NCT02113982|450831383|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
125425598|NCT01735201|451182285|FG006|Overall Study|Personal Reasons|0|||
125663679|NCT00350519|452057854|FG001|Overall Study|Death|1|||
125326544|NCT02113982|450831384|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326545|NCT02113982|450831385|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326546|NCT02113982|450831386|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326547|NCT02113982|450831387|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
125326548|NCT02113982|450831388|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326549|NCT02113982|450831389|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
125326550|NCT02113982|450831376|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326551|NCT02113982|450831377|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326552|NCT02113982|450831378|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326553|NCT02113982|450831379|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326554|NCT02113982|450831380|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326555|NCT02113982|450831381|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326556|NCT02113982|450831382|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326557|NCT02113982|450831383|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326558|NCT02113982|450831384|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326559|NCT02113982|450831385|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326560|NCT02113982|450831386|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326561|NCT02113982|450831387|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
125326562|NCT02113982|450831388|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326563|NCT02113982|450831389|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
125326564|NCT02113982|450831376|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
125326565|NCT02113982|450831377|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
125326566|NCT02113982|450831378|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
125326567|NCT02113982|450831379|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
125326568|NCT02113982|450831380|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
125326569|NCT02113982|450831381|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
125326570|NCT02113982|450831382|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
125326571|NCT02113982|450831383|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
125326572|NCT02113982|450831384|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
125663680|NCT00350519|452057853|FG000|Overall Study|Physician Decision|0|||
125663681|NCT00350519|452057854|FG001|Overall Study|Physician Decision|1|||
125663682|NCT00350519|452057853|FG000|Overall Study|Protocol Violation|1|||
125663683|NCT00350519|452057854|FG001|Overall Study|Protocol Violation|2|||
125663684|NCT00350519|452057853|FG000|Overall Study|Withdrawal by Subject|3|||
125326573|NCT02113982|450831385|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
125326574|NCT02113982|450831386|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
125326575|NCT02113982|450831387|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
125663685|NCT00350519|452057854|FG001|Overall Study|Withdrawal by Subject|2|||
125663686|NCT02595528|452057855|FG000|Overall Study|Withdrawal by Subject|1|||
125663687|NCT02595528|452057856|FG001|Overall Study|Withdrawal by Subject|2|||
125663688|NCT02595528|452057857|FG002|Overall Study|Withdrawal by Subject|1|||
125663689|NCT02595528|452057858|FG003|Overall Study|Withdrawal by Subject|3|||
125663690|NCT02595528|452057855|FG000|Overall Study|Lost to Follow-up|1|||
125663691|NCT02595528|452057856|FG001|Overall Study|Lost to Follow-up|1|||
125663692|NCT02595528|452057857|FG002|Overall Study|Lost to Follow-up|0|||
125663693|NCT02595528|452057858|FG003|Overall Study|Lost to Follow-up|1|||
125663694|NCT00948025|452057859|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
125663695|NCT00948025|452057860|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
125663696|NCT00948025|452057859|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
125663697|NCT00948025|452057860|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
125663698|NCT00948025|452057859|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
125663699|NCT00948025|452057860|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
125663700|NCT01637961|452057861|FG000|Overall Study|Ineligible: wrong primary|1|||
125663701|NCT01637961|452057861|FG000|Overall Study|Ineligible: inadequate pathology|1|||
125663702|NCT03101293|452057865|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
125663703|NCT03101293|452057866|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
125663704|NCT03333382|452057872|FG000|Overall Study|Lost to Follow-up|1|||
125663705|NCT03333382|452057873|FG001|Overall Study|Lost to Follow-up|0|||
125663706|NCT00550420|452057874|FG000|Overall Study|Adverse Event|28|||
125663707|NCT00550420|452057874|FG000|Overall Study|Lost to Follow-up|8|||
125663708|NCT00550420|452057874|FG000|Overall Study|Protocol Violation|11|||
125663709|NCT00550420|452057874|FG000|Overall Study|Withdrawal by Subject|30|||
125663710|NCT00550420|452057874|FG000|Overall Study|Still in study at termination|206|||
125663711|NCT00550420|452057874|FG000|Overall Study|Missing|2|||
125663712|NCT00550420|452057874|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
125326576|NCT02113982|450831388|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
125326577|NCT02113982|450831389|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
125326578|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326579|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125663713|NCT00550420|452057874|FG000|Overall Study|Investigators opinion|1|||
125326580|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125663714|NCT00550420|452057874|FG000|Overall Study|Lack of curative effect|1|||
125663715|NCT00550420|452057874|FG000|Overall Study|Unethical stop of enrollment|2|||
125663716|NCT00550420|452057874|FG000|Overall Study|Caregiver's decision to withdraw|1|||
125326581|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326582|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326583|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326584|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326585|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326586|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326587|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326588|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326589|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326590|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
125326591|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
125326592|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326593|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326594|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326595|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326596|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326597|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326598|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326599|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326600|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326601|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326602|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326603|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
125326604|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
125326605|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
125326606|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326607|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326608|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326609|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326610|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326611|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326612|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326613|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326614|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326615|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326616|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326617|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
125326618|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
125326619|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
125326620|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326621|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326622|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326623|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326624|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326625|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326626|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326627|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326628|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326629|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326630|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326631|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
125326632|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
125326633|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
125326634|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326635|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326636|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326637|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326638|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326639|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326640|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326641|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326642|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326643|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326644|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326645|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326646|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
125326647|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
125326648|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326649|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326650|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326651|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326652|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326653|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326654|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326655|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326656|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326657|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326658|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326659|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326660|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
125326661|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
125326662|NCT02113982|450831376|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326663|NCT02113982|450831377|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326664|NCT02113982|450831378|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326665|NCT02113982|450831379|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326666|NCT02113982|450831380|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326667|NCT02113982|450831381|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326668|NCT02113982|450831382|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326669|NCT02113982|450831383|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326670|NCT02113982|450831384|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326671|NCT02113982|450831385|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326672|NCT02113982|450831386|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326673|NCT02113982|450831387|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326674|NCT02113982|450831388|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
125326675|NCT02113982|450831389|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
125326676|NCT01774721|450831390|FG000|Overall Study|Death|133|||
125326677|NCT01774721|450831391|FG001|Overall Study|Death|152|||
125326678|NCT01774721|450831390|FG000|Overall Study|Withdrawal by Subject|20|||
125326679|NCT01774721|450831391|FG001|Overall Study|Withdrawal by Subject|14|||
125326680|NCT01774721|450831390|FG000|Overall Study|Lost to Follow-up|6|||
125326681|NCT01774721|450831391|FG001|Overall Study|Lost to Follow-up|7|||
125326682|NCT01774721|450831390|FG000|Overall Study|Did not meet eligibility criteria|0|||
125326683|NCT01774721|450831391|FG001|Overall Study|Did not meet eligibility criteria|3|||
125326684|NCT01774721|450831390|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
125326685|NCT01774721|450831391|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
125326686|NCT01774721|450831390|FG000|Overall Study|Study terminated by sponsor|5|||
125326687|NCT01774721|450831391|FG001|Overall Study|Study terminated by sponsor|0|||
125326688|NCT01774721|450831390|FG000|Overall Study|Disease progression|5|||
125326689|NCT01774721|450831391|FG001|Overall Study|Disease progression|0|||
125326690|NCT03594110|450831392|FG000|Interventional Part|Participant concerned about study treatment|23|||
125326691|NCT03594110|450831393|FG001|Interventional Part|Participant concerned about study treatment|28|||
125326692|NCT03594110|450831392|FG000|Interventional Part|Doctor advice|38|||
125326693|NCT03594110|450831393|FG001|Interventional Part|Doctor advice|40|||
125326694|NCT03594110|450831392|FG000|Interventional Part|Participants' wish|89|||
125326695|NCT03594110|450831393|FG001|Interventional Part|Participants' wish|68|||
125326696|NCT03594110|450831392|FG000|Interventional Part|Adverse event-non-fatal events|119|||
125326697|NCT03594110|450831393|FG001|Interventional Part|Adverse event-non-fatal events|116|||
125326698|NCT03594110|450831392|FG000|Interventional Part|Study drug stopped, reason missing|336|||
125326699|NCT03594110|450831393|FG001|Interventional Part|Study drug stopped, reason missing|294|||
125326700|NCT03594110|450831392|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
125326701|NCT03594110|450831393|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
125326702|NCT03594110|450831392|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
125326703|NCT03594110|450831393|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
125326704|NCT03594110|450831392|FG000|Interventional Part|Contraindicated drug started|32|||
125326705|NCT03594110|450831393|FG001|Interventional Part|Contraindicated drug started|18|||
125326706|NCT03594110|450831392|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
125326707|NCT03594110|450831393|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
125326708|NCT03594110|450831392|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
125326709|NCT03594110|450831393|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
125326710|NCT03594110|450831392|FG000|Non-interventional Part|Withdrawal by Subject|3|||
125326711|NCT03594110|450831393|FG001|Non-interventional Part|Withdrawal by Subject|4|||
125326712|NCT03594110|450831392|FG000|Non-interventional Part|Lost to Follow-up|45|||
125326713|NCT03594110|450831393|FG001|Non-interventional Part|Lost to Follow-up|41|||
125663717|NCT00550420|452057874|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
125326714|NCT02351817|450831394|FG000|Period 1|Adverse Event|1|||
125326715|NCT02351817|450831395|FG001|Period 1|Adverse Event|2|||
125326716|NCT02351817|450831394|FG000|Period 1|Lack of Efficacy|0|||
125326717|NCT02351817|450831395|FG001|Period 1|Lack of Efficacy|1|||
125326718|NCT02351817|450831394|FG000|Period 2|Adverse Event|0|||
125326719|NCT02351817|450831395|FG001|Period 2|Adverse Event|2|||
125326720|NCT02351817|450831394|FG000|Period 2|Protocol Violation|1|||
125326721|NCT02351817|450831395|FG001|Period 2|Protocol Violation|0|||
125326722|NCT02488915|450831398|FG000|Overall Study|Death|21|||
125326723|NCT02488915|450831398|FG000|Overall Study|Lost to Follow-up|4|||
125326724|NCT02488915|450831398|FG000|Overall Study|Withdrawal by Subject|1|||
125326725|NCT00684021|450831401|FG000|Overall Study|MRI Contraindicated|1|||
125326726|NCT00684021|450831402|FG001|Overall Study|MRI Contraindicated|1|||
125326727|NCT00684021|450831403|FG002|Overall Study|MRI Contraindicated|1|||
125326728|NCT00684021|450831404|FG003|Overall Study|MRI Contraindicated|0|||
125326729|NCT00684021|450831401|FG000|Overall Study|MRI not performed|0|||
125326730|NCT00684021|450831402|FG001|Overall Study|MRI not performed|1|||
125326731|NCT00684021|450831403|FG002|Overall Study|MRI not performed|1|||
125326732|NCT00684021|450831404|FG003|Overall Study|MRI not performed|2|||
125326733|NCT00684021|450831401|FG000|Overall Study|Death|1|||
125326734|NCT00684021|450831402|FG001|Overall Study|Death|0|||
125326735|NCT00684021|450831403|FG002|Overall Study|Death|0|||
125326736|NCT00684021|450831404|FG003|Overall Study|Death|0|||
125326737|NCT00927953|450831405|FG000|Overall Study|Death|2|||
125326738|NCT00927953|450831406|FG001|Overall Study|Death|1|||
125326739|NCT02976038|450831407|FG000|Overall Study|Physician Decision|22|||
125326740|NCT02976038|450831407|FG000|Overall Study|Withdrawal by Subject|3|||
125326741|NCT02976038|450831407|FG000|Overall Study|Lost to Follow-up|2|||
125326742|NCT02976038|450831407|FG000|Overall Study|Adverse Event|1|||
125326743|NCT01046396|450831408|FG000|Overall Study|Withdrawal by Subject|5|||
125326744|NCT01208207|450831409|FG000|Part I|Adverse Event|19|||
125326745|NCT01208207|450831410|FG001|Part I|Adverse Event|2|||
125326746|NCT01208207|450831411|FG002|Part I|Adverse Event|6|||
125326747|NCT01208207|450831412|FG003|Part I|Adverse Event|0|||
125326748|NCT01208207|450831413|FG004|Part I|Adverse Event|0|||
125326749|NCT01208207|450831414|FG005|Part I|Adverse Event|0|||
125326750|NCT01208207|450831415|FG006|Part I|Adverse Event|0|||
125326751|NCT01208207|450831409|FG000|Part I|Lack of Efficacy|21|||
125326752|NCT01208207|450831410|FG001|Part I|Lack of Efficacy|3|||
125326753|NCT01208207|450831411|FG002|Part I|Lack of Efficacy|2|||
125326754|NCT01208207|450831412|FG003|Part I|Lack of Efficacy|0|||
125326755|NCT01208207|450831413|FG004|Part I|Lack of Efficacy|0|||
125326756|NCT01208207|450831414|FG005|Part I|Lack of Efficacy|0|||
125326757|NCT01208207|450831415|FG006|Part I|Lack of Efficacy|0|||
125326758|NCT01208207|450831409|FG000|Part I|Lost to Follow-up|6|||
125326759|NCT01208207|450831410|FG001|Part I|Lost to Follow-up|1|||
125326760|NCT01208207|450831411|FG002|Part I|Lost to Follow-up|0|||
125326761|NCT01208207|450831412|FG003|Part I|Lost to Follow-up|0|||
125326762|NCT01208207|450831413|FG004|Part I|Lost to Follow-up|0|||
125326763|NCT01208207|450831414|FG005|Part I|Lost to Follow-up|0|||
125326764|NCT01208207|450831415|FG006|Part I|Lost to Follow-up|0|||
125663718|NCT00550420|452057874|FG000|Overall Study|Exclusion criteria|1|||
125663719|NCT00550420|452057874|FG000|Overall Study|Prohibited medicine|1|||
125663720|NCT02773446|452057879|FG000|First Admission|Withdrawal by Subject|0|||
125663721|NCT02773446|452057880|FG001|First Admission|Withdrawal by Subject|0|||
125663722|NCT02773446|452057881|FG002|First Admission|Withdrawal by Subject|0|||
125663723|NCT02773446|452057882|FG003|First Admission|Withdrawal by Subject|1|||
125663724|NCT02773446|452057883|FG004|First Admission|Withdrawal by Subject|0|||
125663725|NCT02773446|452057884|FG005|First Admission|Withdrawal by Subject|0|||
125663726|NCT02773446|452057879|FG000|First Admission|Lost to Follow-up|1|||
125326765|NCT01208207|450831409|FG000|Part I|Non-Compliance With Study Drug|1|||
125326766|NCT01208207|450831410|FG001|Part I|Non-Compliance With Study Drug|0|||
125326767|NCT01208207|450831411|FG002|Part I|Non-Compliance With Study Drug|1|||
125326768|NCT01208207|450831412|FG003|Part I|Non-Compliance With Study Drug|0|||
125326769|NCT01208207|450831413|FG004|Part I|Non-Compliance With Study Drug|0|||
125326770|NCT01208207|450831414|FG005|Part I|Non-Compliance With Study Drug|0|||
125326771|NCT01208207|450831415|FG006|Part I|Non-Compliance With Study Drug|0|||
125326772|NCT01208207|450831409|FG000|Part I|Physician Decision|0|||
125326773|NCT01208207|450831410|FG001|Part I|Physician Decision|1|||
125326774|NCT01208207|450831411|FG002|Part I|Physician Decision|0|||
125326775|NCT01208207|450831412|FG003|Part I|Physician Decision|0|||
125326776|NCT01208207|450831413|FG004|Part I|Physician Decision|0|||
125326777|NCT01208207|450831414|FG005|Part I|Physician Decision|0|||
125326778|NCT01208207|450831415|FG006|Part I|Physician Decision|0|||
125326779|NCT01208207|450831409|FG000|Part I|Progressive Disease|1|||
125326780|NCT01208207|450831410|FG001|Part I|Progressive Disease|0|||
125326781|NCT01208207|450831411|FG002|Part I|Progressive Disease|0|||
125326782|NCT01208207|450831412|FG003|Part I|Progressive Disease|0|||
125326783|NCT01208207|450831413|FG004|Part I|Progressive Disease|0|||
125326784|NCT01208207|450831414|FG005|Part I|Progressive Disease|0|||
125326785|NCT01208207|450831415|FG006|Part I|Progressive Disease|0|||
125326786|NCT01208207|450831409|FG000|Part I|Protocol Violation|8|||
125326787|NCT01208207|450831410|FG001|Part I|Protocol Violation|0|||
125326788|NCT01208207|450831411|FG002|Part I|Protocol Violation|2|||
125326789|NCT01208207|450831412|FG003|Part I|Protocol Violation|0|||
125326790|NCT01208207|450831413|FG004|Part I|Protocol Violation|0|||
125326791|NCT01208207|450831414|FG005|Part I|Protocol Violation|0|||
125326792|NCT01208207|450831415|FG006|Part I|Protocol Violation|0|||
125326793|NCT01208207|450831409|FG000|Part I|Withdrawal by Subject|14|||
125326794|NCT01208207|450831410|FG001|Part I|Withdrawal by Subject|4|||
125326795|NCT01208207|450831411|FG002|Part I|Withdrawal by Subject|4|||
125326796|NCT01208207|450831412|FG003|Part I|Withdrawal by Subject|0|||
125326797|NCT01208207|450831413|FG004|Part I|Withdrawal by Subject|0|||
125326798|NCT01208207|450831414|FG005|Part I|Withdrawal by Subject|0|||
125326799|NCT01208207|450831415|FG006|Part I|Withdrawal by Subject|0|||
125326800|NCT01208207|450831409|FG000|Part II|Withdrawal by Subject|0|||
125326801|NCT01208207|450831410|FG001|Part II|Withdrawal by Subject|0|||
125326802|NCT01208207|450831411|FG002|Part II|Withdrawal by Subject|0|||
125326803|NCT01208207|450831412|FG003|Part II|Withdrawal by Subject|10|||
125326804|NCT01208207|450831413|FG004|Part II|Withdrawal by Subject|9|||
125326805|NCT01208207|450831414|FG005|Part II|Withdrawal by Subject|3|||
125326806|NCT01208207|450831415|FG006|Part II|Withdrawal by Subject|5|||
125326807|NCT01208207|450831409|FG000|Part II|Adverse Event|0|||
125326808|NCT01208207|450831410|FG001|Part II|Adverse Event|0|||
125326809|NCT01208207|450831411|FG002|Part II|Adverse Event|0|||
125326810|NCT01208207|450831412|FG003|Part II|Adverse Event|5|||
125326811|NCT01208207|450831413|FG004|Part II|Adverse Event|9|||
125326812|NCT01208207|450831414|FG005|Part II|Adverse Event|4|||
125326813|NCT01208207|450831415|FG006|Part II|Adverse Event|2|||
125326814|NCT01208207|450831409|FG000|Part II|Lack of Efficacy|0|||
125326815|NCT01208207|450831410|FG001|Part II|Lack of Efficacy|0|||
125326816|NCT01208207|450831411|FG002|Part II|Lack of Efficacy|0|||
125326817|NCT01208207|450831412|FG003|Part II|Lack of Efficacy|6|||
125326818|NCT01208207|450831413|FG004|Part II|Lack of Efficacy|4|||
125326819|NCT01208207|450831414|FG005|Part II|Lack of Efficacy|3|||
125326820|NCT01208207|450831415|FG006|Part II|Lack of Efficacy|3|||
125326821|NCT01208207|450831409|FG000|Part II|Lost to Follow-up|0|||
125326822|NCT01208207|450831410|FG001|Part II|Lost to Follow-up|0|||
125326823|NCT01208207|450831411|FG002|Part II|Lost to Follow-up|0|||
125326824|NCT01208207|450831412|FG003|Part II|Lost to Follow-up|4|||
125326825|NCT01208207|450831413|FG004|Part II|Lost to Follow-up|0|||
125326826|NCT01208207|450831414|FG005|Part II|Lost to Follow-up|2|||
125326827|NCT01208207|450831415|FG006|Part II|Lost to Follow-up|1|||
125326828|NCT01208207|450831409|FG000|Part II|Non-Compliance With Study Drug|0|||
125326829|NCT01208207|450831410|FG001|Part II|Non-Compliance With Study Drug|0|||
125326830|NCT01208207|450831411|FG002|Part II|Non-Compliance With Study Drug|0|||
125326831|NCT01208207|450831412|FG003|Part II|Non-Compliance With Study Drug|4|||
125326832|NCT01208207|450831413|FG004|Part II|Non-Compliance With Study Drug|1|||
125326833|NCT01208207|450831414|FG005|Part II|Non-Compliance With Study Drug|1|||
125326834|NCT01208207|450831415|FG006|Part II|Non-Compliance With Study Drug|0|||
125326835|NCT01208207|450831409|FG000|Part II|Physician Decision|0|||
125326836|NCT01208207|450831410|FG001|Part II|Physician Decision|0|||
125326837|NCT01208207|450831411|FG002|Part II|Physician Decision|0|||
125326838|NCT01208207|450831412|FG003|Part II|Physician Decision|1|||
125326839|NCT01208207|450831413|FG004|Part II|Physician Decision|0|||
125326840|NCT01208207|450831414|FG005|Part II|Physician Decision|2|||
125326841|NCT01208207|450831415|FG006|Part II|Physician Decision|0|||
125326842|NCT01208207|450831409|FG000|Part II|Protocol Violation|0|||
125326843|NCT01208207|450831410|FG001|Part II|Protocol Violation|0|||
125326844|NCT01208207|450831411|FG002|Part II|Protocol Violation|0|||
125326845|NCT01208207|450831412|FG003|Part II|Protocol Violation|1|||
125326846|NCT01208207|450831413|FG004|Part II|Protocol Violation|0|||
125326847|NCT01208207|450831414|FG005|Part II|Protocol Violation|0|||
125326848|NCT01208207|450831415|FG006|Part II|Protocol Violation|0|||
125326849|NCT01208207|450831409|FG000|Part II|Technical Problems|0|||
125326850|NCT01208207|450831410|FG001|Part II|Technical Problems|0|||
125326851|NCT01208207|450831411|FG002|Part II|Technical Problems|0|||
125326852|NCT01208207|450831412|FG003|Part II|Technical Problems|1|||
125326853|NCT01208207|450831413|FG004|Part II|Technical Problems|0|||
125326854|NCT01208207|450831414|FG005|Part II|Technical Problems|1|||
125326855|NCT01208207|450831415|FG006|Part II|Technical Problems|0|||
125326856|NCT04041414|450831416|FG000|Overall Study|Lost to Follow-up|1|||
125326857|NCT04041414|450831417|FG001|Overall Study|Lost to Follow-up|2|||
125326858|NCT04004988|450831418|FG000|Period 1|Physician Decision|2|||
125326859|NCT04004988|450831419|FG001|Period 1|Physician Decision|0|||
125326860|NCT04004988|450831418|FG000|Period 1|Withdrawal by Subject|0|||
125326861|NCT04004988|450831419|FG001|Period 1|Withdrawal by Subject|1|||
125326862|NCT04004988|450831418|FG000|Period 1|Adverse Event|1|||
125326863|NCT04004988|450831419|FG001|Period 1|Adverse Event|2|||
125326864|NCT00930046|450831420|FG000|Overall Study|Wound catheter malfunctioned|1|||
125326865|NCT00930046|450831421|FG001|Overall Study|Wound catheter malfunctioned|2|||
125326866|NCT01598532|450831422|FG000|Overall Study|Lost to Follow-up|3|||
125326867|NCT01598532|450831422|FG000|Overall Study|Did not meet inclusion criteria|8|||
125326868|NCT04682366|450831423|FG000|Overall Study|Lost to Follow-up|1|||
125326869|NCT04682366|450831424|FG001|Overall Study|Lost to Follow-up|1|||
125326870|NCT00702221|450831425|FG000|Overall Study|Adverse Event|4|||
125326871|NCT00702221|450831426|FG001|Overall Study|Adverse Event|3|||
125326872|NCT01867671|450831430|FG000|Overall Study|Adverse Event|5|||
125326873|NCT01867671|450831431|FG001|Overall Study|Adverse Event|3|||
125326874|NCT01867671|450831430|FG000|Overall Study|Anaphylaxis|0|||
125326875|NCT01867671|450831431|FG001|Overall Study|Anaphylaxis|1|||
125326876|NCT01867671|450831430|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
125326877|NCT01867671|450831431|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
125326878|NCT01867671|450831430|FG000|Overall Study|Lost to Follow-up|0|||
125326879|NCT01867671|450831431|FG001|Overall Study|Lost to Follow-up|1|||
125326880|NCT01867671|450831430|FG000|Overall Study|Non-compliance with Study Drug|1|||
125326881|NCT01867671|450831431|FG001|Overall Study|Non-compliance with Study Drug|2|||
125326882|NCT01867671|450831430|FG000|Overall Study|Withdrawal by Subject|21|||
125326883|NCT01867671|450831431|FG001|Overall Study|Withdrawal by Subject|21|||
125326884|NCT01523366|450831432|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125326885|NCT01523366|450831433|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125326886|NCT01523366|450831432|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
125326887|NCT01523366|450831433|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
125326888|NCT04543279|450831434|FG000|Overall Study|Withdrawal by Subject|1|||
125326889|NCT04543279|450831435|FG001|Overall Study|Withdrawal by Subject|0|||
125326890|NCT04543279|450831434|FG000|Overall Study|Adverse Event|1|||
125326891|NCT04543279|450831435|FG001|Overall Study|Adverse Event|0|||
125326892|NCT04543279|450831434|FG000|Overall Study|Physician Decision|1|||
125326893|NCT04543279|450831435|FG001|Overall Study|Physician Decision|0|||
125326894|NCT01352715|450831436|FG000|Overall Study|Death|3|||
125326895|NCT01352715|450831437|FG001|Overall Study|Death|3|||
125326896|NCT01352715|450831436|FG000|Overall Study|Lost to Follow-up|5|||
125326897|NCT01352715|450831437|FG001|Overall Study|Lost to Follow-up|7|||
125326898|NCT01352715|450831436|FG000|Overall Study|Withdrawal by Subject|4|||
125326899|NCT01352715|450831437|FG001|Overall Study|Withdrawal by Subject|8|||
125326900|NCT01352715|450831436|FG000|Overall Study|site closure|16|||
125326901|NCT01352715|450831437|FG001|Overall Study|site closure|15|||
125326902|NCT01352715|450831436|FG000|Overall Study|no final visit in closeout period|15|||
125326903|NCT01352715|450831437|FG001|Overall Study|no final visit in closeout period|12|||
125326904|NCT01352715|450831436|FG000|Overall Study|major ineligibility|2|||
125326905|NCT01352715|450831437|FG001|Overall Study|major ineligibility|1|||
125326906|NCT04596267|450831438|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
125326907|NCT04596267|450831439|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
125326908|NCT04596267|450831438|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
125326909|NCT04596267|450831439|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
125326910|NCT00071058|450831440|FG000|Overall Study|brain tumor-removed from study|1|||
125326911|NCT02000440|450831441|FG000|Overall Study|Adverse Event|3|||
125326912|NCT02000440|450831441|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
125326913|NCT04109547|450831442|FG000|Overall Study|Withdrawal by Subject|3|||
125326914|NCT04109547|450831443|FG001|Overall Study|Withdrawal by Subject|2|||
125326915|NCT04109547|450831444|FG002|Overall Study|Withdrawal by Subject|6|||
125326916|NCT04109547|450831445|FG003|Overall Study|Withdrawal by Subject|6|||
125326917|NCT04109547|450831442|FG000|Overall Study|Lost to Follow-up|0|||
125326918|NCT04109547|450831443|FG001|Overall Study|Lost to Follow-up|0|||
125326919|NCT04109547|450831444|FG002|Overall Study|Lost to Follow-up|0|||
125326920|NCT04109547|450831445|FG003|Overall Study|Lost to Follow-up|1|||
125326921|NCT04109547|450831442|FG000|Overall Study|Physician Decision|1|||
125326922|NCT04109547|450831443|FG001|Overall Study|Physician Decision|2|||
125326923|NCT04109547|450831444|FG002|Overall Study|Physician Decision|0|||
125326924|NCT04109547|450831445|FG003|Overall Study|Physician Decision|0|||
125326925|NCT01550003|450831446|FG000|Overall Study|Adverse Event|0|||
125326926|NCT01550003|450831447|FG001|Overall Study|Adverse Event|9|||
125326927|NCT01550003|450831448|FG002|Overall Study|Adverse Event|15|||
125326928|NCT01550003|450831446|FG000|Overall Study|Lack of Efficacy|4|||
125326929|NCT01550003|450831447|FG001|Overall Study|Lack of Efficacy|11|||
125326930|NCT01550003|450831448|FG002|Overall Study|Lack of Efficacy|15|||
125326931|NCT01550003|450831446|FG000|Overall Study|Protocol Violation|0|||
125326932|NCT01550003|450831447|FG001|Overall Study|Protocol Violation|3|||
125326933|NCT01550003|450831448|FG002|Overall Study|Protocol Violation|2|||
125326934|NCT01550003|450831446|FG000|Overall Study|Lost to Follow-up|1|||
125326935|NCT01550003|450831447|FG001|Overall Study|Lost to Follow-up|4|||
125326936|NCT01550003|450831448|FG002|Overall Study|Lost to Follow-up|8|||
125326937|NCT01550003|450831446|FG000|Overall Study|Consent withdrawn|2|||
125326938|NCT01550003|450831447|FG001|Overall Study|Consent withdrawn|11|||
125326939|NCT01550003|450831448|FG002|Overall Study|Consent withdrawn|23|||
125326940|NCT01550003|450831446|FG000|Overall Study|Missing|1|||
125326941|NCT01550003|450831447|FG001|Overall Study|Missing|0|||
125326942|NCT01550003|450831448|FG002|Overall Study|Missing|2|||
125326943|NCT01550003|450831446|FG000|Overall Study|Study closure as announced by sponsor|7|||
125326944|NCT01550003|450831447|FG001|Overall Study|Study closure as announced by sponsor|6|||
125326945|NCT01550003|450831448|FG002|Overall Study|Study closure as announced by sponsor|24|||
125326946|NCT01550003|450831446|FG000|Overall Study|Protocol Noncompliance|1|||
125326947|NCT01550003|450831447|FG001|Overall Study|Protocol Noncompliance|0|||
125326948|NCT01550003|450831448|FG002|Overall Study|Protocol Noncompliance|0|||
125326949|NCT01550003|450831446|FG000|Overall Study|Study closure|0|||
125326950|NCT01550003|450831447|FG001|Overall Study|Study closure|1|||
125326951|NCT01550003|450831448|FG002|Overall Study|Study closure|1|||
125326952|NCT01550003|450831446|FG000|Overall Study|Patient reached adulthood|0|||
125326953|NCT01550003|450831447|FG001|Overall Study|Patient reached adulthood|1|||
125326954|NCT01550003|450831448|FG002|Overall Study|Patient reached adulthood|0|||
125326955|NCT01550003|450831446|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
125326956|NCT01550003|450831447|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
125326957|NCT01550003|450831448|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
125326958|NCT01550003|450831446|FG000|Overall Study|Sponsor's order|0|||
125326959|NCT01550003|450831447|FG001|Overall Study|Sponsor's order|3|||
125326960|NCT01550003|450831448|FG002|Overall Study|Sponsor's order|3|||
125326961|NCT01550003|450831446|FG000|Overall Study|Sponsor's decision|1|||
125326962|NCT01550003|450831447|FG001|Overall Study|Sponsor's decision|5|||
125326963|NCT01550003|450831448|FG002|Overall Study|Sponsor's decision|4|||
125326964|NCT01550003|450831446|FG000|Overall Study|Subject mother passed away|0|||
125326965|NCT01550003|450831447|FG001|Overall Study|Subject mother passed away|1|||
125326966|NCT01550003|450831448|FG002|Overall Study|Subject mother passed away|0|||
125326967|NCT01550003|450831446|FG000|Overall Study|Discontinuation|0|||
125326968|NCT01550003|450831447|FG001|Overall Study|Discontinuation|1|||
125326969|NCT01550003|450831448|FG002|Overall Study|Discontinuation|0|||
125326970|NCT01550003|450831446|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
125326971|NCT01550003|450831447|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
125326972|NCT01550003|450831448|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
125326973|NCT01550003|450831446|FG000|Overall Study|Site closure|0|||
125326974|NCT01550003|450831447|FG001|Overall Study|Site closure|2|||
125326975|NCT01550003|450831448|FG002|Overall Study|Site closure|0|||
125326976|NCT01550003|450831446|FG000|Overall Study|Pregnancy|0|||
125326977|NCT01550003|450831447|FG001|Overall Study|Pregnancy|1|||
125326978|NCT01550003|450831448|FG002|Overall Study|Pregnancy|0|||
125326979|NCT01550003|450831446|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
125326980|NCT01550003|450831447|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
125326981|NCT01550003|450831448|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
125326982|NCT01550003|450831446|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
125326983|NCT01550003|450831447|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
125326984|NCT01550003|450831448|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
125326985|NCT01550003|450831446|FG000|Overall Study|Switching to adult rheumatologist|0|||
125326986|NCT01550003|450831447|FG001|Overall Study|Switching to adult rheumatologist|0|||
125326987|NCT01550003|450831448|FG002|Overall Study|Switching to adult rheumatologist|1|||
125326988|NCT01550003|450831446|FG000|Overall Study|Patient transition to adult care|0|||
125326989|NCT01550003|450831447|FG001|Overall Study|Patient transition to adult care|0|||
125326990|NCT01550003|450831448|FG002|Overall Study|Patient transition to adult care|1|||
125326991|NCT01550003|450831446|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
125326992|NCT01550003|450831447|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
125326993|NCT01550003|450831448|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
125326994|NCT01550003|450831446|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
125326995|NCT01550003|450831447|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
125326996|NCT01550003|450831448|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
125326997|NCT01550003|450831446|FG000|Overall Study|Per Sponsor request|1|||
125326998|NCT01550003|450831447|FG001|Overall Study|Per Sponsor request|0|||
125326999|NCT01550003|450831448|FG002|Overall Study|Per Sponsor request|1|||
125327000|NCT01550003|450831446|FG000|Overall Study|Patient not compliance|0|||
125327001|NCT01550003|450831447|FG001|Overall Study|Patient not compliance|0|||
125327002|NCT01550003|450831448|FG002|Overall Study|Patient not compliance|1|||
125327003|NCT01550003|450831446|FG000|Overall Study|Non-compliance|0|||
125327004|NCT01550003|450831447|FG001|Overall Study|Non-compliance|0|||
125327005|NCT01550003|450831448|FG002|Overall Study|Non-compliance|1|||
125327006|NCT01550003|450831446|FG000|Overall Study|Study closed|0|||
125327007|NCT01550003|450831447|FG001|Overall Study|Study closed|1|||
125327008|NCT01550003|450831448|FG002|Overall Study|Study closed|0|||
125327009|NCT01550003|450831446|FG000|Overall Study|Transitioned to adult rheumatology|0|||
125327010|NCT01550003|450831447|FG001|Overall Study|Transitioned to adult rheumatology|0|||
125327011|NCT01550003|450831448|FG002|Overall Study|Transitioned to adult rheumatology|1|||
125327012|NCT01656408|450831449|FG000|Overall Study|Adverse Event|0|||
125327013|NCT01656408|450831450|FG001|Overall Study|Adverse Event|0|||
125327014|NCT01656408|450831451|FG002|Overall Study|Adverse Event|1|||
125327015|NCT01656408|450831452|FG003|Overall Study|Adverse Event|0|||
125327016|NCT01656408|450831453|FG004|Overall Study|Adverse Event|0|||
125327017|NCT01656408|450831454|FG005|Overall Study|Adverse Event|1|||
125327018|NCT01656408|450831455|FG006|Overall Study|Adverse Event|1|||
125327019|NCT01656408|450831456|FG007|Overall Study|Adverse Event|0|||
125327020|NCT01656408|450831457|FG008|Overall Study|Adverse Event|1|||
125327021|NCT01656408|450831458|FG009|Overall Study|Adverse Event|0|||
125327022|NCT01656408|450831449|FG000|Overall Study|Physician Decision|1|||
125327023|NCT01656408|450831450|FG001|Overall Study|Physician Decision|0|||
125327024|NCT01656408|450831451|FG002|Overall Study|Physician Decision|1|||
125327025|NCT01656408|450831452|FG003|Overall Study|Physician Decision|0|||
125327026|NCT01656408|450831453|FG004|Overall Study|Physician Decision|1|||
125327027|NCT01656408|450831454|FG005|Overall Study|Physician Decision|1|||
125327028|NCT01656408|450831455|FG006|Overall Study|Physician Decision|0|||
125327029|NCT01656408|450831456|FG007|Overall Study|Physician Decision|1|||
125327030|NCT01656408|450831457|FG008|Overall Study|Physician Decision|1|||
125327031|NCT01656408|450831458|FG009|Overall Study|Physician Decision|3|||
125327032|NCT03995368|450831459|FG000|Overall Study|Lost to Follow-up|1|||
125327033|NCT03995368|450831460|FG001|Overall Study|Lost to Follow-up|4|||
125327034|NCT03995368|450831461|FG002|Overall Study|Lost to Follow-up|1|||
125327035|NCT03995368|450831459|FG000|Overall Study|Did not meet inclusion criteria|1|||
125327036|NCT03995368|450831460|FG001|Overall Study|Did not meet inclusion criteria|6|||
125327037|NCT03995368|450831461|FG002|Overall Study|Did not meet inclusion criteria|3|||
125327038|NCT03995368|450831459|FG000|Overall Study|Withdrawal by Subject|0|||
125327039|NCT03995368|450831460|FG001|Overall Study|Withdrawal by Subject|1|||
125327040|NCT03995368|450831461|FG002|Overall Study|Withdrawal by Subject|1|||
125327041|NCT03592186|450831462|FG000|Overall Study|Withdrawal by Subject|1|||
125327042|NCT03592186|450831463|FG001|Overall Study|Withdrawal by Subject|0|||
125327043|NCT03592186|450831462|FG000|Overall Study|Lost to Follow-up|16|||
125327044|NCT03592186|450831463|FG001|Overall Study|Lost to Follow-up|11|||
125327045|NCT01409707|450831466|FG000|Overall Study|Withdrawal by Subject|5|||
125327046|NCT01409707|450831467|FG001|Overall Study|Withdrawal by Subject|17|||
125327047|NCT01409707|450831468|FG002|Overall Study|Withdrawal by Subject|16|||
125327048|NCT01658436|450831469|FG000|Overall Study|Adverse Event|6|||
125327049|NCT01658436|450831470|FG001|Overall Study|Adverse Event|5|||
125327050|NCT01658436|450831469|FG000|Overall Study|Physician Decision|1|||
125327051|NCT01658436|450831470|FG001|Overall Study|Physician Decision|0|||
125327052|NCT01658436|450831469|FG000|Overall Study|Progressive disease|12|||
125327053|NCT01658436|450831470|FG001|Overall Study|Progressive disease|4|||
125327054|NCT01658436|450831469|FG000|Overall Study|Study terminated by sponsor|0|||
125327055|NCT01658436|450831470|FG001|Overall Study|Study terminated by sponsor|1|||
125327056|NCT01658436|450831469|FG000|Overall Study|Subject/guardian decision|0|||
125327057|NCT01658436|450831470|FG001|Overall Study|Subject/guardian decision|1|||
125327058|NCT01658436|450831469|FG000|Overall Study|Death|1|||
125327059|NCT01658436|450831470|FG001|Overall Study|Death|0|||
125327060|NCT01217229|450831471|FG000|Overall Study|Adverse Event|1|||
125327061|NCT01217229|450831471|FG000|Overall Study|Disease progression, deterioration|2|||
125327062|NCT01217229|450831471|FG000|Overall Study|Disease progression, Cheson criteria|14|||
125327063|NCT01217229|450831471|FG000|Overall Study|Protocol Violation|1|||
125327064|NCT01217229|450831471|FG000|Overall Study|Disease progression not confirmed|2|||
125327065|NCT03987503|450831472|FG000|Overall Study|Lost to Follow-up|20|||
125327066|NCT03987503|450831472|FG000|Overall Study|Withdrawal by Subject|2|||
125327067|NCT01929317|450831480|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
125327068|NCT01929317|450831481|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
125327069|NCT01929317|450831480|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
125327070|NCT01929317|450831481|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
125327071|NCT01929317|450831480|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
125327072|NCT01929317|450831481|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
125327073|NCT01929317|450831480|FG000|Long-term Phase|Adverse Event|5|||
125327074|NCT01929317|450831481|FG001|Long-term Phase|Adverse Event|1|||
125327075|NCT01929317|450831480|FG000|Long-term Phase|Physician Decision|3|||
125327076|NCT01929317|450831481|FG001|Long-term Phase|Physician Decision|0|||
125327077|NCT01929317|450831480|FG000|Long-term Phase|Withdrawal by Subject|4|||
125327078|NCT01929317|450831481|FG001|Long-term Phase|Withdrawal by Subject|0|||
125327079|NCT01929317|450831480|FG000|Long-term Phase|Protocol Violation|1|||
125327080|NCT01929317|450831481|FG001|Long-term Phase|Protocol Violation|0|||
125327081|NCT01929317|450831480|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
125327082|NCT01929317|450831481|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
125327083|NCT01929317|450831480|FG000|Long-term Phase|Study Closed/Terminated|5|||
125327084|NCT01929317|450831481|FG001|Long-term Phase|Study Closed/Terminated|3|||
125327085|NCT04322526|450831484|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
125327086|NCT04322526|450831485|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
125327087|NCT04322526|450831484|FG000|Washout (1 Week)|Lost to Follow-up|1|||
125327088|NCT04322526|450831485|FG001|Washout (1 Week)|Lost to Follow-up|2|||
125327089|NCT01523756|450831486|FG000|Baseline Period|Adverse Event|0|||
125327090|NCT01523756|450831487|FG001|Baseline Period|Adverse Event|1|||
125663727|NCT02773446|452057880|FG001|First Admission|Lost to Follow-up|0|||
125327091|NCT01523756|450831486|FG000|Test Period 1|Adverse Event|1|||
125327092|NCT01523756|450831487|FG001|Test Period 1|Adverse Event|0|||
125327093|NCT01523756|450831486|FG000|Test Period 2|Withdrawal by Subject|0|||
125327094|NCT01523756|450831487|FG001|Test Period 2|Withdrawal by Subject|1|||
125663728|NCT02773446|452057881|FG002|First Admission|Lost to Follow-up|0|||
125327095|NCT00993967|450831488|FG000|Overall Study|Adverse Event|8|||
125327096|NCT00993967|450831488|FG000|Overall Study|Death|1|||
125327097|NCT00993967|450831488|FG000|Overall Study|Lost to Follow-up|14|||
125327098|NCT00993967|450831488|FG000|Overall Study|Withdrawal by Subject|36|||
125327099|NCT00993967|450831488|FG000|Overall Study|Protocol Violation|2|||
125327100|NCT02760498|450831489|FG000|Overall Study|Adverse Event|3|||
125327101|NCT02760498|450831490|FG001|Overall Study|Adverse Event|3|||
125327102|NCT02760498|450831491|FG002|Overall Study|Adverse Event|1|||
125327103|NCT02760498|450831492|FG003|Overall Study|Adverse Event|1|||
125327104|NCT02760498|450831493|FG004|Overall Study|Adverse Event|0|||
125327105|NCT02760498|450831494|FG005|Overall Study|Adverse Event|6|||
125327106|NCT02760498|450831489|FG000|Overall Study|Death|7|||
125327107|NCT02760498|450831490|FG001|Overall Study|Death|5|||
125327108|NCT02760498|450831491|FG002|Overall Study|Death|5|||
125327109|NCT02760498|450831492|FG003|Overall Study|Death|7|||
125327110|NCT02760498|450831493|FG004|Overall Study|Death|0|||
125327111|NCT02760498|450831494|FG005|Overall Study|Death|23|||
125327112|NCT02760498|450831489|FG000|Overall Study|Lost to Follow-up|0|||
125327113|NCT02760498|450831490|FG001|Overall Study|Lost to Follow-up|0|||
125327114|NCT02760498|450831491|FG002|Overall Study|Lost to Follow-up|0|||
125327115|NCT02760498|450831492|FG003|Overall Study|Lost to Follow-up|0|||
125327116|NCT02760498|450831493|FG004|Overall Study|Lost to Follow-up|0|||
125327117|NCT02760498|450831494|FG005|Overall Study|Lost to Follow-up|3|||
125327118|NCT02760498|450831489|FG000|Overall Study|Non-compliance with study drug|0|||
125327119|NCT02760498|450831490|FG001|Overall Study|Non-compliance with study drug|2|||
125327120|NCT02760498|450831491|FG002|Overall Study|Non-compliance with study drug|0|||
125327121|NCT02760498|450831492|FG003|Overall Study|Non-compliance with study drug|0|||
125327122|NCT02760498|450831493|FG004|Overall Study|Non-compliance with study drug|0|||
125327123|NCT02760498|450831494|FG005|Overall Study|Non-compliance with study drug|0|||
125327124|NCT02760498|450831489|FG000|Overall Study|Participant decision|1|||
125327125|NCT02760498|450831490|FG001|Overall Study|Participant decision|4|||
125327126|NCT02760498|450831491|FG002|Overall Study|Participant decision|2|||
125327127|NCT02760498|450831492|FG003|Overall Study|Participant decision|2|||
125327128|NCT02760498|450831493|FG004|Overall Study|Participant decision|1|||
125327129|NCT02760498|450831494|FG005|Overall Study|Participant decision|6|||
125327130|NCT02760498|450831489|FG000|Overall Study|Sponsor decision|0|||
125327131|NCT02760498|450831490|FG001|Overall Study|Sponsor decision|0|||
125327132|NCT02760498|450831491|FG002|Overall Study|Sponsor decision|0|||
125327133|NCT02760498|450831492|FG003|Overall Study|Sponsor decision|3|||
125327134|NCT02760498|450831493|FG004|Overall Study|Sponsor decision|0|||
125663729|NCT02773446|452057882|FG003|First Admission|Lost to Follow-up|0|||
125663730|NCT02773446|452057883|FG004|First Admission|Lost to Follow-up|0|||
125663731|NCT02773446|452057884|FG005|First Admission|Lost to Follow-up|0|||
125663732|NCT03237611|452057885|FG000|Overall Study|Withdrawal by Subject|1|||
125663733|NCT03237611|452057885|FG000|Overall Study|Ineligible|1|||
125663734|NCT01613131|452057888|FG000|Overall Study|Withdrawal by Subject|3|||
125663735|NCT01613131|452057889|FG001|Overall Study|Withdrawal by Subject|5|||
125663736|NCT01814761|452057890|FG000|Overall Study|Other Reasons|1|||
125663737|NCT01814761|452057891|FG001|Overall Study|Other Reasons|10|||
125663738|NCT01814761|452057890|FG000|Overall Study|Ocular Adverse Event|6|||
125327135|NCT02760498|450831494|FG005|Overall Study|Sponsor decision|0|||
125327136|NCT02760498|450831489|FG000|Overall Study|Physician Decision|3|||
125327137|NCT02760498|450831490|FG001|Overall Study|Physician Decision|4|||
125327138|NCT02760498|450831491|FG002|Overall Study|Physician Decision|1|||
125327139|NCT02760498|450831492|FG003|Overall Study|Physician Decision|4|||
125327140|NCT02760498|450831493|FG004|Overall Study|Physician Decision|0|||
125327141|NCT02760498|450831494|FG005|Overall Study|Physician Decision|2|||
125327142|NCT02760498|450831489|FG000|Overall Study|Disease progression|21|||
125327143|NCT02760498|450831490|FG001|Overall Study|Disease progression|19|||
125327144|NCT02760498|450831491|FG002|Overall Study|Disease progression|20|||
125327145|NCT02760498|450831492|FG003|Overall Study|Disease progression|18|||
125327146|NCT02760498|450831493|FG004|Overall Study|Disease progression|4|||
125327147|NCT02760498|450831494|FG005|Overall Study|Disease progression|55|||
125327148|NCT02760498|450831489|FG000|Overall Study|Withdrawal by Subject|4|||
125327149|NCT02760498|450831490|FG001|Overall Study|Withdrawal by Subject|7|||
125327150|NCT02760498|450831491|FG002|Overall Study|Withdrawal by Subject|5|||
125327151|NCT02760498|450831492|FG003|Overall Study|Withdrawal by Subject|1|||
125327152|NCT02760498|450831493|FG004|Overall Study|Withdrawal by Subject|0|||
125327153|NCT02760498|450831494|FG005|Overall Study|Withdrawal by Subject|6|||
125327154|NCT02760498|450831489|FG000|Overall Study|Other than specified|1|||
125327155|NCT02760498|450831490|FG001|Overall Study|Other than specified|6|||
125327156|NCT02760498|450831491|FG002|Overall Study|Other than specified|0|||
125327157|NCT02760498|450831492|FG003|Overall Study|Other than specified|3|||
125327158|NCT02760498|450831493|FG004|Overall Study|Other than specified|1|||
125327159|NCT02760498|450831494|FG005|Overall Study|Other than specified|0|||
125327160|NCT02760498|450831489|FG000|Overall Study|Not treated|0|||
125327161|NCT02760498|450831490|FG001|Overall Study|Not treated|0|||
125327162|NCT02760498|450831491|FG002|Overall Study|Not treated|0|||
125327163|NCT02760498|450831492|FG003|Overall Study|Not treated|0|||
125327164|NCT02760498|450831493|FG004|Overall Study|Not treated|0|||
125327165|NCT02760498|450831494|FG005|Overall Study|Not treated|2|||
125327166|NCT00935584|450831497|FG000|Overall Study|Withdrawal by Subject|9|||
125327167|NCT00935584|450831498|FG001|Overall Study|Withdrawal by Subject|0|||
125327168|NCT00935584|450831497|FG000|Overall Study|Death|3|||
125327169|NCT00935584|450831498|FG001|Overall Study|Death|0|||
125327170|NCT00935584|450831497|FG000|Overall Study|Lost to Follow-up|8|||
125327171|NCT00935584|450831498|FG001|Overall Study|Lost to Follow-up|0|||
125327172|NCT00935584|450831497|FG000|Overall Study|No show|9|||
125327173|NCT00935584|450831498|FG001|Overall Study|No show|0|||
125327174|NCT00935584|450831497|FG000|Overall Study|Relocated|3|||
125327175|NCT00935584|450831498|FG001|Overall Study|Relocated|0|||
125327176|NCT00935584|450831497|FG000|Overall Study|Patient changed provider|3|||
125327177|NCT00935584|450831498|FG001|Overall Study|Patient changed provider|0|||
125327178|NCT00935584|450831497|FG000|Overall Study|Provider dropped out of study|14|||
125327179|NCT00935584|450831498|FG001|Overall Study|Provider dropped out of study|4|||
125327180|NCT00687193|450831499|FG000|Overall Study|Adverse Event|0|||
125327181|NCT00687193|450831500|FG001|Overall Study|Adverse Event|1|||
125327182|NCT00687193|450831501|FG002|Overall Study|Adverse Event|2|||
125327183|NCT00687193|450831502|FG003|Overall Study|Adverse Event|3|||
125327184|NCT00687193|450831503|FG004|Overall Study|Adverse Event|0|||
125327185|NCT00687193|450831504|FG005|Overall Study|Adverse Event|2|||
125327186|NCT00687193|450831499|FG000|Overall Study|Lack of Efficacy|1|||
125327187|NCT00687193|450831500|FG001|Overall Study|Lack of Efficacy|1|||
125327188|NCT00687193|450831501|FG002|Overall Study|Lack of Efficacy|0|||
125327189|NCT00687193|450831502|FG003|Overall Study|Lack of Efficacy|0|||
125327190|NCT00687193|450831503|FG004|Overall Study|Lack of Efficacy|0|||
125327191|NCT00687193|450831504|FG005|Overall Study|Lack of Efficacy|2|||
125327192|NCT00687193|450831499|FG000|Overall Study|Protocol Violation|1|||
125327193|NCT00687193|450831500|FG001|Overall Study|Protocol Violation|2|||
125327194|NCT00687193|450831501|FG002|Overall Study|Protocol Violation|0|||
125327195|NCT00687193|450831502|FG003|Overall Study|Protocol Violation|1|||
125327196|NCT00687193|450831503|FG004|Overall Study|Protocol Violation|2|||
125327197|NCT00687193|450831504|FG005|Overall Study|Protocol Violation|0|||
125327198|NCT03534804|450831505|FG000|Overall Study|Withdrawal by Subject|1|||
125327199|NCT04986904|450831506|FG000|Overall Study|Lost to Follow-up|11|||
125327200|NCT04986904|450831506|FG000|Overall Study|Withdrawal by Subject|1|||
125327201|NCT00174187|450831507|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
125327202|NCT00174187|450831508|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
125327203|NCT00174187|450831509|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
125327204|NCT00174187|450831507|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
125327205|NCT00174187|450831508|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
125327206|NCT00174187|450831509|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
125327207|NCT00174187|450831507|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
125327208|NCT00174187|450831508|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
125327209|NCT00174187|450831509|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
125327210|NCT00174187|450831507|FG000|Period 1 (up to 3 Years)|Other|0|||
125327211|NCT00174187|450831508|FG001|Period 1 (up to 3 Years)|Other|1|||
125327212|NCT00174187|450831509|FG002|Period 1 (up to 3 Years)|Other|0|||
125327213|NCT00174187|450831507|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
125327214|NCT00174187|450831508|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
125327215|NCT00174187|450831509|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
125327216|NCT00174187|450831507|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
125327217|NCT00174187|450831508|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
125327218|NCT00174187|450831509|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
125327219|NCT00174187|450831507|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
125327220|NCT00174187|450831508|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
125327221|NCT00174187|450831509|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
125327222|NCT00174187|450831507|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
125327223|NCT00174187|450831508|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
125327224|NCT00174187|450831509|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
125327225|NCT00174187|450831507|FG000|Period 2 (After 3 Years)|Other|0|||
125327226|NCT00174187|450831508|FG001|Period 2 (After 3 Years)|Other|0|||
125327227|NCT00174187|450831509|FG002|Period 2 (After 3 Years)|Other|5|||
125327228|NCT03435211|450831510|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
125327229|NCT00759941|450831511|FG000|Overall Study|Use of medication|1|||
125327230|NCT00759941|450831512|FG001|Overall Study|Use of medication|0|||
125327231|NCT00759941|450831511|FG000|Overall Study|Adverse Event|1|||
125327232|NCT00759941|450831512|FG001|Overall Study|Adverse Event|0|||
125327233|NCT00759941|450831511|FG000|Overall Study|Exited in error by site|1|||
125663739|NCT01814761|452057891|FG001|Overall Study|Ocular Adverse Event|15|||
125327234|NCT00759941|450831512|FG001|Overall Study|Exited in error by site|1|||
125327235|NCT03863080|450831513|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
125327236|NCT03863080|450831514|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
125327237|NCT03863080|450831515|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
125327238|NCT03863080|450831516|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
125327239|NCT03863080|450831513|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
125327240|NCT03863080|450831514|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
125327241|NCT03863080|450831515|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
125327242|NCT03863080|450831516|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
125327243|NCT03863080|450831513|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
125327244|NCT03863080|450831514|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
125327245|NCT03863080|450831515|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
125327246|NCT03863080|450831516|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
125327247|NCT01342211|450831517|FG000|Overall Study|Lost to Follow-up|0|||
125327248|NCT01342211|450831518|FG001|Overall Study|Lost to Follow-up|0|||
125327249|NCT01342211|450831519|FG002|Overall Study|Lost to Follow-up|0|||
125327250|NCT01342211|450831520|FG003|Overall Study|Lost to Follow-up|1|||
125327251|NCT01342211|450831521|FG004|Overall Study|Lost to Follow-up|0|||
125327252|NCT01342211|450831517|FG000|Overall Study|Adverse Event|0|||
125327253|NCT01342211|450831518|FG001|Overall Study|Adverse Event|0|||
125327254|NCT01342211|450831519|FG002|Overall Study|Adverse Event|0|||
125327255|NCT01342211|450831520|FG003|Overall Study|Adverse Event|0|||
125327256|NCT01342211|450831521|FG004|Overall Study|Adverse Event|1|||
125327257|NCT01342211|450831517|FG000|Overall Study|Withdrawal by Subject|0|||
125327258|NCT01342211|450831518|FG001|Overall Study|Withdrawal by Subject|0|||
125327259|NCT01342211|450831519|FG002|Overall Study|Withdrawal by Subject|0|||
125327260|NCT01342211|450831520|FG003|Overall Study|Withdrawal by Subject|1|||
125327261|NCT01342211|450831521|FG004|Overall Study|Withdrawal by Subject|0|||
125327262|NCT01342211|450831517|FG000|Overall Study|Randomized, but not Treated|0|||
125327263|NCT01342211|450831518|FG001|Overall Study|Randomized, but not Treated|2|||
125327264|NCT01342211|450831519|FG002|Overall Study|Randomized, but not Treated|0|||
125327265|NCT01342211|450831520|FG003|Overall Study|Randomized, but not Treated|0|||
125327266|NCT01342211|450831521|FG004|Overall Study|Randomized, but not Treated|1|||
125327267|NCT01588522|450831533|FG000|Overall Study|Withdrawal by Subject|1|||
125327268|NCT01588522|450831534|FG001|Overall Study|Withdrawal by Subject|5|||
125327269|NCT01588522|450831535|FG002|Overall Study|Withdrawal by Subject|3|||
125327270|NCT01588522|450831536|FG003|Overall Study|Withdrawal by Subject|1|||
125327271|NCT01588522|450831537|FG004|Overall Study|Withdrawal by Subject|2|||
125327272|NCT01588522|450831538|FG005|Overall Study|Withdrawal by Subject|0|||
125327273|NCT01588522|450831533|FG000|Overall Study|Lack of Efficacy|0|||
125327274|NCT01588522|450831534|FG001|Overall Study|Lack of Efficacy|0|||
125327275|NCT01588522|450831535|FG002|Overall Study|Lack of Efficacy|0|||
125327276|NCT01588522|450831536|FG003|Overall Study|Lack of Efficacy|0|||
125327277|NCT01588522|450831537|FG004|Overall Study|Lack of Efficacy|1|||
125327278|NCT01588522|450831538|FG005|Overall Study|Lack of Efficacy|0|||
125327279|NCT01588522|450831533|FG000|Overall Study|Adverse Event|0|||
125327280|NCT01588522|450831534|FG001|Overall Study|Adverse Event|0|||
125327281|NCT01588522|450831535|FG002|Overall Study|Adverse Event|0|||
125327282|NCT01588522|450831536|FG003|Overall Study|Adverse Event|1|||
125327283|NCT01588522|450831537|FG004|Overall Study|Adverse Event|0|||
125327284|NCT01588522|450831538|FG005|Overall Study|Adverse Event|0|||
125327285|NCT01588522|450831533|FG000|Overall Study|Grade 2 alopecia|1|||
125327286|NCT01588522|450831534|FG001|Overall Study|Grade 2 alopecia|0|||
125327287|NCT01588522|450831535|FG002|Overall Study|Grade 2 alopecia|0|||
125327288|NCT01588522|450831536|FG003|Overall Study|Grade 2 alopecia|0|||
125327289|NCT01588522|450831537|FG004|Overall Study|Grade 2 alopecia|0|||
125327290|NCT01588522|450831538|FG005|Overall Study|Grade 2 alopecia|0|||
125327291|NCT01588522|450831533|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
125327292|NCT01588522|450831534|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
125327293|NCT01588522|450831535|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
125327294|NCT01588522|450831536|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
125327295|NCT01588522|450831537|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
125327296|NCT01588522|450831538|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
125663740|NCT01814761|452057890|FG000|Overall Study|Lost to Follow-up|1|||
125663741|NCT01814761|452057891|FG001|Overall Study|Lost to Follow-up|5|||
125663742|NCT03137082|452057892|FG000|Overall Study|Withdrawal by Subject|1|||
125663743|NCT03137082|452057893|FG001|Overall Study|Withdrawal by Subject|1|||
125663744|NCT03137082|452057892|FG000|Overall Study|Lost to Follow-up|1|||
125327297|NCT01588522|450831533|FG000|Overall Study|Taken off taxane-based regimen|0|||
125327298|NCT01588522|450831534|FG001|Overall Study|Taken off taxane-based regimen|0|||
125327299|NCT01588522|450831535|FG002|Overall Study|Taken off taxane-based regimen|0|||
125327300|NCT01588522|450831536|FG003|Overall Study|Taken off taxane-based regimen|1|||
125327301|NCT01588522|450831537|FG004|Overall Study|Taken off taxane-based regimen|0|||
125327302|NCT01588522|450831538|FG005|Overall Study|Taken off taxane-based regimen|0|||
125327303|NCT01588522|450831533|FG000|Overall Study|Did not initiate chemotherapy|0|||
125327304|NCT01588522|450831534|FG001|Overall Study|Did not initiate chemotherapy|0|||
125327305|NCT01588522|450831535|FG002|Overall Study|Did not initiate chemotherapy|0|||
125327306|NCT01588522|450831536|FG003|Overall Study|Did not initiate chemotherapy|0|||
125327307|NCT01588522|450831537|FG004|Overall Study|Did not initiate chemotherapy|1|||
125327308|NCT01588522|450831538|FG005|Overall Study|Did not initiate chemotherapy|0|||
125663745|NCT03137082|452057893|FG001|Overall Study|Lost to Follow-up|0|||
125663746|NCT01020305|452057896|FG000|Overall Study|Adverse Event|2|||
125663747|NCT01017029|452057900|FG000|Overall Study|Lost to Follow-up|1|||
125663748|NCT01017029|452057901|FG001|Overall Study|Lost to Follow-up|0|||
125663749|NCT01017029|452057900|FG000|Overall Study|Administrative problem|0|||
125663750|NCT01017029|452057901|FG001|Overall Study|Administrative problem|1|||
125663751|NCT01017029|452057900|FG000|Overall Study|Death|3|||
125663752|NCT01017029|452057901|FG001|Overall Study|Death|1|||
125663753|NCT00618774|452057902|FG000|Overall Study|Adverse Event|5|||
125663754|NCT00618774|452057903|FG001|Overall Study|Adverse Event|3|||
125663755|NCT00618774|452057902|FG000|Overall Study|Withdrawal by Subject|1|||
125663756|NCT00618774|452057903|FG001|Overall Study|Withdrawal by Subject|0|||
125663757|NCT02753400|452057905|FG000|Overall Study|Adverse Event|3|||
125663758|NCT02753400|452057906|FG001|Overall Study|Adverse Event|0|||
125663759|NCT02753400|452057905|FG000|Overall Study|Withdrawal by Subject|2|||
125663760|NCT02753400|452057906|FG001|Overall Study|Withdrawal by Subject|1|||
125663761|NCT01415921|452057907|FG000|Overall Study|Adverse Event|0|||
125327309|NCT03205423|450831541|FG000|Overall Study|Personal|1|||
125327310|NCT03205423|450831542|FG001|Overall Study|Personal|1|||
125327311|NCT03205423|450831541|FG000|Overall Study|Physician Decision|0|||
125327312|NCT03205423|450831542|FG001|Overall Study|Physician Decision|2|||
125327313|NCT05786651|450831545|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
125327314|NCT04390763|450831546|FG000|Safety run-in Part|Adverse Event|4|||
125327315|NCT04390763|450831547|FG001|Safety run-in Part|Adverse Event|0|||
125327316|NCT04390763|450831548|FG002|Safety run-in Part|Adverse Event|0|||
125327317|NCT04390763|450831549|FG003|Safety run-in Part|Adverse Event|0|||
125327318|NCT04390763|450831546|FG000|Safety run-in Part|Physician Decision|1|||
125327319|NCT04390763|450831547|FG001|Safety run-in Part|Physician Decision|0|||
125327320|NCT04390763|450831548|FG002|Safety run-in Part|Physician Decision|0|||
125327321|NCT04390763|450831549|FG003|Safety run-in Part|Physician Decision|0|||
125327322|NCT04390763|450831546|FG000|Safety run-in Part|Progressive Disease|6|||
125327323|NCT04390763|450831547|FG001|Safety run-in Part|Progressive Disease|0|||
125327324|NCT04390763|450831548|FG002|Safety run-in Part|Progressive Disease|0|||
125327325|NCT04390763|450831549|FG003|Safety run-in Part|Progressive Disease|0|||
125327326|NCT04390763|450831546|FG000|Randomized Part|Adverse Event|0|||
125327327|NCT04390763|450831547|FG001|Randomized Part|Adverse Event|11|||
125327328|NCT04390763|450831548|FG002|Randomized Part|Adverse Event|5|||
125327329|NCT04390763|450831549|FG003|Randomized Part|Adverse Event|5|||
125327330|NCT04390763|450831546|FG000|Randomized Part|Death|0|||
125327331|NCT04390763|450831547|FG001|Randomized Part|Death|3|||
125327332|NCT04390763|450831548|FG002|Randomized Part|Death|4|||
125327333|NCT04390763|450831549|FG003|Randomized Part|Death|2|||
125327334|NCT04390763|450831546|FG000|Randomized Part|Physician Decision|0|||
125327335|NCT04390763|450831547|FG001|Randomized Part|Physician Decision|2|||
125327336|NCT04390763|450831548|FG002|Randomized Part|Physician Decision|2|||
125327337|NCT04390763|450831549|FG003|Randomized Part|Physician Decision|9|||
125327338|NCT04390763|450831546|FG000|Randomized Part|Progressive Disease|0|||
125327339|NCT04390763|450831547|FG001|Randomized Part|Progressive Disease|24|||
125327340|NCT04390763|450831548|FG002|Randomized Part|Progressive Disease|31|||
125327341|NCT04390763|450831549|FG003|Randomized Part|Progressive Disease|23|||
125327342|NCT04390763|450831546|FG000|Randomized Part|Study terminated by sponsor|0|||
125327343|NCT04390763|450831547|FG001|Randomized Part|Study terminated by sponsor|1|||
125327344|NCT04390763|450831548|FG002|Randomized Part|Study terminated by sponsor|0|||
125327345|NCT04390763|450831549|FG003|Randomized Part|Study terminated by sponsor|0|||
125327346|NCT04390763|450831546|FG000|Randomized Part|Participant Decision|0|||
125327347|NCT04390763|450831547|FG001|Randomized Part|Participant Decision|5|||
125327348|NCT04390763|450831548|FG002|Randomized Part|Participant Decision|7|||
125327349|NCT04390763|450831549|FG003|Randomized Part|Participant Decision|6|||
125327350|NCT04390763|450831546|FG000|Randomized Part|Not treated|0|||
125327351|NCT04390763|450831547|FG001|Randomized Part|Not treated|4|||
125327352|NCT04390763|450831548|FG002|Randomized Part|Not treated|2|||
125327353|NCT04390763|450831549|FG003|Randomized Part|Not treated|7|||
125327354|NCT01803607|450833143|FG000|Overall Study|Adverse Event|5|||
125327355|NCT01803607|450833144|FG001|Overall Study|Adverse Event|3|||
125327356|NCT01803607|450833143|FG000|Overall Study|Lack of Efficacy|0|||
125327357|NCT01803607|450833144|FG001|Overall Study|Lack of Efficacy|1|||
125327358|NCT01803607|450833143|FG000|Overall Study|Protocol Violation|3|||
125663762|NCT01415921|452057908|FG001|Overall Study|Adverse Event|1|||
125663763|NCT01415921|452057907|FG000|Overall Study|Physician Decision|1|||
125327359|NCT01803607|450833144|FG001|Overall Study|Protocol Violation|2|||
125327360|NCT01803607|450833143|FG000|Overall Study|Study terminated by sponsor|54|||
125327361|NCT01803607|450833144|FG001|Overall Study|Study terminated by sponsor|56|||
125327362|NCT01803607|450833143|FG000|Overall Study|Withdrawal by Subject|6|||
125327363|NCT01803607|450833144|FG001|Overall Study|Withdrawal by Subject|5|||
125327364|NCT03077412|450833145|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
125425599|NCT01735201|451182286|FG007|Overall Study|Personal Reasons|0|||
125327365|NCT03077412|450833146|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
125327366|NCT03077412|450833147|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
125327367|NCT03077412|450833145|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
125327368|NCT03077412|450833146|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
125327369|NCT03077412|450833147|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
125327370|NCT03077412|450833145|FG000|Overall Study|Adverse Event|1|||
125327371|NCT03077412|450833146|FG001|Overall Study|Adverse Event|2|||
125327372|NCT03077412|450833147|FG002|Overall Study|Adverse Event|2|||
125327373|NCT03077412|450833145|FG000|Overall Study|Investigator's Discretion|0|||
125327374|NCT03077412|450833146|FG001|Overall Study|Investigator's Discretion|1|||
125327375|NCT03077412|450833147|FG002|Overall Study|Investigator's Discretion|1|||
125327376|NCT03077412|450833145|FG000|Overall Study|Withdrew Consent|0|||
125327377|NCT03077412|450833146|FG001|Overall Study|Withdrew Consent|2|||
125327378|NCT03077412|450833147|FG002|Overall Study|Withdrew Consent|0|||
125327379|NCT02266888|450833151|FG000|Overall Study|Death|2|||
125327380|NCT02266888|450833152|FG001|Overall Study|Death|2|||
125327381|NCT02266888|450833153|FG002|Overall Study|Death|4|||
125327382|NCT02266888|450833154|FG003|Overall Study|Death|2|||
125327383|NCT02266888|450833151|FG000|Overall Study|Physician Decision|0|||
125327384|NCT02266888|450833152|FG001|Overall Study|Physician Decision|1|||
125327385|NCT02266888|450833153|FG002|Overall Study|Physician Decision|2|||
125327386|NCT02266888|450833154|FG003|Overall Study|Physician Decision|2|||
125327387|NCT02266888|450833151|FG000|Overall Study|Study Terminated|5|||
125327388|NCT02266888|450833152|FG001|Overall Study|Study Terminated|1|||
125327389|NCT02266888|450833153|FG002|Overall Study|Study Terminated|0|||
125327390|NCT02266888|450833154|FG003|Overall Study|Study Terminated|0|||
125327391|NCT02266888|450833151|FG000|Overall Study|No Longer Eligible|0|||
125327392|NCT02266888|450833152|FG001|Overall Study|No Longer Eligible|0|||
125327393|NCT02266888|450833153|FG002|Overall Study|No Longer Eligible|0|||
125327394|NCT02266888|450833154|FG003|Overall Study|No Longer Eligible|2|||
125327395|NCT02266888|450833151|FG000|Overall Study|Randomization Closed|0|||
125327396|NCT02266888|450833152|FG001|Overall Study|Randomization Closed|0|||
125327397|NCT02266888|450833153|FG002|Overall Study|Randomization Closed|4|||
125327398|NCT02266888|450833154|FG003|Overall Study|Randomization Closed|0|||
125327399|NCT02266888|450833151|FG000|Overall Study|Personnel unavailable at transplant|0|||
125327400|NCT02266888|450833152|FG001|Overall Study|Personnel unavailable at transplant|0|||
125327401|NCT02266888|450833153|FG002|Overall Study|Personnel unavailable at transplant|0|||
125327402|NCT02266888|450833154|FG003|Overall Study|Personnel unavailable at transplant|1|||
125327403|NCT02266888|450833151|FG000|Overall Study|Transfer of care|0|||
125327404|NCT02266888|450833152|FG001|Overall Study|Transfer of care|0|||
125327405|NCT02266888|450833153|FG002|Overall Study|Transfer of care|1|||
125327406|NCT02266888|450833154|FG003|Overall Study|Transfer of care|0|||
125327407|NCT02351856|450833155|FG000|Overall Study|Adverse Event|2|||
125327408|NCT02351856|450833155|FG000|Overall Study|Physician Decision|5|||
125327409|NCT02351856|450833155|FG000|Overall Study|Study terminated by sponsor|1|||
125327410|NCT01281124|450833158|FG000|Overall Study|Death|1|||
125327411|NCT03038100|450833159|FG000|Overall Study|Death|289|||
125327412|NCT03038100|450833160|FG001|Overall Study|Death|272|||
125327413|NCT03038100|450833159|FG000|Overall Study|Lost to Follow-up|9|||
125327414|NCT03038100|450833160|FG001|Overall Study|Lost to Follow-up|10|||
125327415|NCT03038100|450833159|FG000|Overall Study|Protocol Deviation|1|||
125327416|NCT03038100|450833160|FG001|Overall Study|Protocol Deviation|4|||
125327417|NCT03038100|450833159|FG000|Overall Study|Withdrawal by Subject|45|||
125327418|NCT03038100|450833160|FG001|Overall Study|Withdrawal by Subject|51|||
125327419|NCT03038100|450833159|FG000|Overall Study|Study Terminated By Sponsor|305|||
125327420|NCT03038100|450833160|FG001|Overall Study|Study Terminated By Sponsor|311|||
125327421|NCT03038100|450833159|FG000|Overall Study|Physician Decision|1|||
125327422|NCT03038100|450833160|FG001|Overall Study|Physician Decision|3|||
125327423|NCT00918255|450833161|FG000|Overall Study|Adverse Event|1|||
125327424|NCT00918255|450833162|FG001|Overall Study|Adverse Event|0|||
125663764|NCT01415921|452057908|FG001|Overall Study|Physician Decision|1|||
125663765|NCT01415921|452057907|FG000|Overall Study|Withdrawal by Subject|0|||
125327425|NCT00918255|450833163|FG002|Overall Study|Adverse Event|0|||
125327426|NCT00918255|450833161|FG000|Overall Study|Withdrawal by Subject|1|||
125327427|NCT00918255|450833162|FG001|Overall Study|Withdrawal by Subject|0|||
125327428|NCT00918255|450833163|FG002|Overall Study|Withdrawal by Subject|2|||
125327429|NCT00918255|450833161|FG000|Overall Study|Lack of Efficacy|1|||
125327430|NCT00918255|450833162|FG001|Overall Study|Lack of Efficacy|0|||
125327431|NCT00918255|450833163|FG002|Overall Study|Lack of Efficacy|0|||
125327432|NCT00918255|450833161|FG000|Overall Study|Lost to Follow-up|1|||
125327433|NCT00918255|450833162|FG001|Overall Study|Lost to Follow-up|0|||
125327434|NCT00918255|450833163|FG002|Overall Study|Lost to Follow-up|2|||
125327435|NCT00918255|450833161|FG000|Overall Study|Exceeded allowed number of interventions|0|||
125327436|NCT00918255|450833162|FG001|Overall Study|Exceeded allowed number of interventions|0|||
125327437|NCT00918255|450833163|FG002|Overall Study|Exceeded allowed number of interventions|1|||
125327438|NCT00918255|450833161|FG000|Overall Study|Non-compliance|1|||
125327439|NCT00918255|450833162|FG001|Overall Study|Non-compliance|0|||
125327440|NCT00918255|450833163|FG002|Overall Study|Non-compliance|0|||
125327441|NCT00918255|450833161|FG000|Overall Study|Investigator discretion|1|||
125327442|NCT00918255|450833162|FG001|Overall Study|Investigator discretion|0|||
125327443|NCT00918255|450833163|FG002|Overall Study|Investigator discretion|0|||
125327444|NCT02392624|450833164|FG000|Overall Study|Withdrawal by Subject|15|||
125327445|NCT02392624|450833165|FG001|Overall Study|Withdrawal by Subject|12|||
125327446|NCT02392624|450833166|FG002|Overall Study|Withdrawal by Subject|9|||
125327447|NCT02392624|450833164|FG000|Overall Study|Adverse Event|4|||
125327448|NCT02392624|450833165|FG001|Overall Study|Adverse Event|1|||
125327449|NCT02392624|450833166|FG002|Overall Study|Adverse Event|2|||
125327450|NCT02392624|450833164|FG000|Overall Study|Pregnancy|1|||
125327451|NCT02392624|450833165|FG001|Overall Study|Pregnancy|0|||
125327452|NCT02392624|450833166|FG002|Overall Study|Pregnancy|0|||
125327453|NCT02392624|450833164|FG000|Overall Study|Protocol Violation|0|||
125327454|NCT02392624|450833165|FG001|Overall Study|Protocol Violation|0|||
125327455|NCT02392624|450833166|FG002|Overall Study|Protocol Violation|1|||
125327456|NCT02392624|450833164|FG000|Overall Study|Sponsor/Investigator Decision|2|||
125327457|NCT02392624|450833165|FG001|Overall Study|Sponsor/Investigator Decision|1|||
125327458|NCT02392624|450833166|FG002|Overall Study|Sponsor/Investigator Decision|0|||
125327459|NCT02392624|450833164|FG000|Overall Study|Other|49|||
125327460|NCT02392624|450833165|FG001|Overall Study|Other|1|||
125327461|NCT02392624|450833166|FG002|Overall Study|Other|1|||
125663766|NCT01415921|452057908|FG001|Overall Study|Withdrawal by Subject|1|||
125663767|NCT01415921|452057907|FG000|Overall Study|Other|2|||
125663768|NCT01415921|452057908|FG001|Overall Study|Other|0|||
125663769|NCT01830920|452057913|FG000|Overall Study|Adverse Event|1|||
125663770|NCT01830920|452057914|FG001|Overall Study|Adverse Event|0|||
125663771|NCT01830920|452057915|FG002|Overall Study|Adverse Event|1|||
125663772|NCT01830920|452057916|FG003|Overall Study|Adverse Event|0|||
125663773|NCT01830920|452057917|FG004|Overall Study|Adverse Event|0|||
125663774|NCT01830920|452057913|FG000|Overall Study|Withdrawal by Subject|2|||
125663775|NCT01830920|452057914|FG001|Overall Study|Withdrawal by Subject|2|||
125663776|NCT01830920|452057915|FG002|Overall Study|Withdrawal by Subject|1|||
125663777|NCT01830920|452057916|FG003|Overall Study|Withdrawal by Subject|7|||
125663778|NCT01830920|452057917|FG004|Overall Study|Withdrawal by Subject|1|||
125663779|NCT01830920|452057913|FG000|Overall Study|Death|3|||
125663780|NCT01830920|452057914|FG001|Overall Study|Death|3|||
125663781|NCT01830920|452057915|FG002|Overall Study|Death|5|||
125663782|NCT01830920|452057916|FG003|Overall Study|Death|4|||
125663783|NCT01830920|452057917|FG004|Overall Study|Death|4|||
125663784|NCT01830920|452057913|FG000|Overall Study|Other|15|||
125663785|NCT01830920|452057914|FG001|Overall Study|Other|1|||
125663786|NCT01830920|452057915|FG002|Overall Study|Other|1|||
125663787|NCT01830920|452057916|FG003|Overall Study|Other|5|||
125663788|NCT01830920|452057917|FG004|Overall Study|Other|3|||
125663789|NCT03876873|452057919|FG000|Overall Study|Physician Decision|0|||
125663790|NCT03876873|452057920|FG001|Overall Study|Physician Decision|1|||
125663791|NCT03547531|452057921|FG000|Overall Study|not coming in data collection : sick|2|||
125663792|NCT03547531|452057922|FG001|Overall Study|not coming in data collection : sick|2|||
125663793|NCT03547531|452057921|FG000|Overall Study|having family occasion|0|||
125663794|NCT03547531|452057922|FG001|Overall Study|having family occasion|2|||
125663795|NCT03402126|452057931|FG000|Overall Study|Lost to Follow-up|6|||
125663796|NCT03402126|452057931|FG000|Overall Study|Protocol Violation|10|||
125663797|NCT03402126|452057931|FG000|Overall Study|Sponsor request/Study termination|29|||
125663798|NCT03402126|452057931|FG000|Overall Study|Study product no longer in use|1|||
125663799|NCT03402126|452057931|FG000|Overall Study|Technical problems|1|||
125663800|NCT03402126|452057931|FG000|Overall Study|Withdrawal by Subject|6|||
125663801|NCT03402126|452057931|FG000|Overall Study|Physician Decision|2|||
125663802|NCT03402126|452057931|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
125663803|NCT03402126|452057931|FG000|Overall Study|Death|4|||
125663804|NCT02117479|452057932|FG000|Overall Study|Death|13|||
125663805|NCT02117479|452057933|FG001|Overall Study|Death|8|||
125663806|NCT02117479|452057932|FG000|Overall Study|Adverse Event|8|||
125663807|NCT02117479|452057933|FG001|Overall Study|Adverse Event|16|||
125663808|NCT02117479|452057932|FG000|Overall Study|Subject decision|8|||
125663809|NCT02117479|452057933|FG001|Overall Study|Subject decision|9|||
125663810|NCT02117479|452057932|FG000|Overall Study|Disease progression|104|||
125663811|NCT02117479|452057933|FG001|Overall Study|Disease progression|108|||
125663812|NCT02117479|452057932|FG000|Overall Study|Noncompliance with study treatment|1|||
125663813|NCT02117479|452057933|FG001|Overall Study|Noncompliance with study treatment|0|||
125327462|NCT00706238|450833167|FG000|Overall Study|Disease progression|4|||
125327463|NCT00706238|450833167|FG000|Overall Study|Other|1|||
125327464|NCT01193244|450833170|FG000|Overall Study|Withdrawal by Subject|79|||
125327465|NCT01193244|450833171|FG001|Overall Study|Withdrawal by Subject|97|||
125327466|NCT01193244|450833170|FG000|Overall Study|Other|303|||
125327467|NCT01193244|450833171|FG001|Overall Study|Other|278|||
125327468|NCT01193244|450833170|FG000|Overall Study|Lost to Follow-up|6|||
125327469|NCT01193244|450833171|FG001|Overall Study|Lost to Follow-up|15|||
125663814|NCT02117479|452057932|FG000|Overall Study|Study terminated by the sponsor|4|||
125663815|NCT02117479|452057933|FG001|Overall Study|Study terminated by the sponsor|6|||
125663816|NCT02117479|452057932|FG000|Overall Study|Physician Decision|7|||
125663817|NCT02117479|452057933|FG001|Overall Study|Physician Decision|2|||
125663818|NCT02117479|452057932|FG000|Overall Study|Other unspecified|11|||
125663819|NCT02117479|452057933|FG001|Overall Study|Other unspecified|7|||
125663820|NCT02444182|452057934|FG000|Overall Study|non-compliance|2|||
125663821|NCT02444182|452057935|FG001|Overall Study|non-compliance|1|||
125663822|NCT02444182|452057934|FG000|Overall Study|Lost to Follow-up|0|||
125327470|NCT03763877|450833173|FG000|Overall Study|Withdrawal by Subject|3|||
125327471|NCT03763877|450833174|FG001|Overall Study|Withdrawal by Subject|1|||
125663823|NCT02444182|452057935|FG001|Overall Study|Lost to Follow-up|4|||
125663824|NCT01959230|452057938|FG000|Overall Study|Failure to follow study procedures|0|||
125663825|NCT01959230|452057939|FG001|Overall Study|Failure to follow study procedures|1|||
125663826|NCT01959230|452057938|FG000|Overall Study|Administrative reasons|2|||
125663827|NCT01959230|452057939|FG001|Overall Study|Administrative reasons|0|||
125663828|NCT01959230|452057938|FG000|Overall Study|Withdrawal by Subject|2|||
125663829|NCT01959230|452057939|FG001|Overall Study|Withdrawal by Subject|0|||
125327472|NCT03763877|450833175|FG002|Overall Study|Withdrawal by Subject|3|||
125327473|NCT03763877|450833176|FG003|Overall Study|Withdrawal by Subject|4|||
125327474|NCT03763877|450833173|FG000|Overall Study|Adverse Event|1|||
125327475|NCT03763877|450833174|FG001|Overall Study|Adverse Event|1|||
125327476|NCT03763877|450833175|FG002|Overall Study|Adverse Event|3|||
125327477|NCT03763877|450833176|FG003|Overall Study|Adverse Event|1|||
125327478|NCT03763877|450833173|FG000|Overall Study|Protocol Violation|1|||
125327479|NCT03763877|450833174|FG001|Overall Study|Protocol Violation|1|||
125327480|NCT03763877|450833175|FG002|Overall Study|Protocol Violation|0|||
125327481|NCT03763877|450833176|FG003|Overall Study|Protocol Violation|0|||
125327482|NCT03763877|450833173|FG000|Overall Study|Lost to Follow-up|0|||
125327483|NCT03763877|450833174|FG001|Overall Study|Lost to Follow-up|1|||
125327484|NCT03763877|450833175|FG002|Overall Study|Lost to Follow-up|1|||
125327485|NCT03763877|450833176|FG003|Overall Study|Lost to Follow-up|0|||
125327486|NCT03040336|450833177|FG000|Overall Study|Death|1|||
125327487|NCT03040336|450833178|FG001|Overall Study|Death|0|||
125327488|NCT03040336|450833177|FG000|Overall Study|Withdrawal by Subject|2|||
125327489|NCT03040336|450833178|FG001|Overall Study|Withdrawal by Subject|3|||
125327490|NCT00068692|450833183|FG000|Step 1: Registration|Disese progression/relapse|5|||
125327491|NCT00068692|450833184|FG001|Step 1: Registration|Disese progression/relapse|0|||
125327492|NCT00068692|450833185|FG002|Step 1: Registration|Disese progression/relapse|0|||
125327493|NCT00068692|450833186|FG003|Step 1: Registration|Disese progression/relapse|0|||
125327494|NCT00068692|450833187|FG004|Step 1: Registration|Disese progression/relapse|0|||
125327495|NCT00068692|450833188|FG005|Step 1: Registration|Disese progression/relapse|0|||
125327496|NCT00068692|450833189|FG006|Step 1: Registration|Disese progression/relapse|0|||
125327497|NCT00068692|450833190|FG007|Step 1: Registration|Disese progression/relapse|0|||
125327498|NCT00068692|450833183|FG000|Step 1: Registration|Adverse Event|7|||
125327499|NCT00068692|450833184|FG001|Step 1: Registration|Adverse Event|0|||
125327500|NCT00068692|450833185|FG002|Step 1: Registration|Adverse Event|0|||
125327501|NCT00068692|450833186|FG003|Step 1: Registration|Adverse Event|0|||
125327502|NCT00068692|450833187|FG004|Step 1: Registration|Adverse Event|0|||
125327503|NCT00068692|450833188|FG005|Step 1: Registration|Adverse Event|0|||
125327504|NCT00068692|450833189|FG006|Step 1: Registration|Adverse Event|0|||
125327505|NCT00068692|450833190|FG007|Step 1: Registration|Adverse Event|0|||
125327506|NCT00068692|450833183|FG000|Step 1: Registration|Death|1|||
125327507|NCT00068692|450833184|FG001|Step 1: Registration|Death|0|||
125327508|NCT00068692|450833185|FG002|Step 1: Registration|Death|0|||
125327509|NCT00068692|450833186|FG003|Step 1: Registration|Death|0|||
125327510|NCT00068692|450833187|FG004|Step 1: Registration|Death|0|||
125327511|NCT00068692|450833188|FG005|Step 1: Registration|Death|0|||
125327512|NCT00068692|450833189|FG006|Step 1: Registration|Death|0|||
125327513|NCT00068692|450833190|FG007|Step 1: Registration|Death|0|||
125327514|NCT00068692|450833183|FG000|Step 1: Registration|Withdrawal by Subject|11|||
125327515|NCT00068692|450833184|FG001|Step 1: Registration|Withdrawal by Subject|0|||
125327516|NCT00068692|450833185|FG002|Step 1: Registration|Withdrawal by Subject|0|||
125327517|NCT00068692|450833186|FG003|Step 1: Registration|Withdrawal by Subject|0|||
125327518|NCT00068692|450833187|FG004|Step 1: Registration|Withdrawal by Subject|0|||
125663830|NCT00720304|452057940|FG000|Overall Study|Withdrawal by Subject|14|||
125663831|NCT00720304|452057941|FG001|Overall Study|Withdrawal by Subject|1|||
125663832|NCT00720304|452057940|FG000|Overall Study|Death|1|||
125327519|NCT00068692|450833188|FG005|Step 1: Registration|Withdrawal by Subject|0|||
125327520|NCT00068692|450833189|FG006|Step 1: Registration|Withdrawal by Subject|0|||
125327521|NCT00068692|450833190|FG007|Step 1: Registration|Withdrawal by Subject|0|||
125327522|NCT00068692|450833183|FG000|Step 1: Registration|Alternative therapy|2|||
125327523|NCT00068692|450833184|FG001|Step 1: Registration|Alternative therapy|0|||
125327524|NCT00068692|450833185|FG002|Step 1: Registration|Alternative therapy|0|||
125327525|NCT00068692|450833186|FG003|Step 1: Registration|Alternative therapy|0|||
125327526|NCT00068692|450833187|FG004|Step 1: Registration|Alternative therapy|0|||
125327527|NCT00068692|450833188|FG005|Step 1: Registration|Alternative therapy|0|||
125327528|NCT00068692|450833189|FG006|Step 1: Registration|Alternative therapy|0|||
125327529|NCT00068692|450833190|FG007|Step 1: Registration|Alternative therapy|0|||
125327530|NCT00068692|450833183|FG000|Step 1: Registration|Complicating disease|2|||
125327531|NCT00068692|450833184|FG001|Step 1: Registration|Complicating disease|0|||
125327532|NCT00068692|450833185|FG002|Step 1: Registration|Complicating disease|0|||
125327533|NCT00068692|450833186|FG003|Step 1: Registration|Complicating disease|0|||
125327534|NCT00068692|450833187|FG004|Step 1: Registration|Complicating disease|0|||
125327535|NCT00068692|450833188|FG005|Step 1: Registration|Complicating disease|0|||
125327536|NCT00068692|450833189|FG006|Step 1: Registration|Complicating disease|0|||
125327537|NCT00068692|450833190|FG007|Step 1: Registration|Complicating disease|0|||
125327538|NCT00068692|450833183|FG000|Step 1: Registration|Protocol Violation|1|||
125327539|NCT00068692|450833184|FG001|Step 1: Registration|Protocol Violation|0|||
125327540|NCT00068692|450833185|FG002|Step 1: Registration|Protocol Violation|0|||
125327541|NCT00068692|450833186|FG003|Step 1: Registration|Protocol Violation|0|||
125327542|NCT00068692|450833187|FG004|Step 1: Registration|Protocol Violation|0|||
125327543|NCT00068692|450833188|FG005|Step 1: Registration|Protocol Violation|0|||
125327544|NCT00068692|450833189|FG006|Step 1: Registration|Protocol Violation|0|||
125327545|NCT00068692|450833190|FG007|Step 1: Registration|Protocol Violation|0|||
125327546|NCT00068692|450833183|FG000|Step 1: Registration|Not eligible|6|||
125327547|NCT00068692|450833184|FG001|Step 1: Registration|Not eligible|0|||
125327548|NCT00068692|450833185|FG002|Step 1: Registration|Not eligible|0|||
125327549|NCT00068692|450833186|FG003|Step 1: Registration|Not eligible|0|||
125327550|NCT00068692|450833187|FG004|Step 1: Registration|Not eligible|0|||
125327551|NCT00068692|450833188|FG005|Step 1: Registration|Not eligible|0|||
125327552|NCT00068692|450833189|FG006|Step 1: Registration|Not eligible|0|||
125327553|NCT00068692|450833190|FG007|Step 1: Registration|Not eligible|0|||
125327554|NCT00068692|450833183|FG000|Step 1: Registration|Other|2|||
125327555|NCT00068692|450833184|FG001|Step 1: Registration|Other|0|||
125327556|NCT00068692|450833185|FG002|Step 1: Registration|Other|0|||
125327557|NCT00068692|450833186|FG003|Step 1: Registration|Other|0|||
125327558|NCT00068692|450833187|FG004|Step 1: Registration|Other|0|||
125327559|NCT00068692|450833188|FG005|Step 1: Registration|Other|0|||
125327560|NCT00068692|450833189|FG006|Step 1: Registration|Other|0|||
125327561|NCT00068692|450833190|FG007|Step 1: Registration|Other|0|||
125327562|NCT00068692|450833183|FG000|Step 1: Registration|Not start protocol therapy|3|||
125327563|NCT00068692|450833184|FG001|Step 1: Registration|Not start protocol therapy|0|||
125327564|NCT00068692|450833185|FG002|Step 1: Registration|Not start protocol therapy|0|||
125327565|NCT00068692|450833186|FG003|Step 1: Registration|Not start protocol therapy|0|||
125327566|NCT00068692|450833187|FG004|Step 1: Registration|Not start protocol therapy|0|||
125327567|NCT00068692|450833188|FG005|Step 1: Registration|Not start protocol therapy|0|||
125327568|NCT00068692|450833189|FG006|Step 1: Registration|Not start protocol therapy|0|||
125327569|NCT00068692|450833190|FG007|Step 1: Registration|Not start protocol therapy|0|||
125327570|NCT00068692|450833183|FG000|Step 1: Registration|Registered but not randomized|0|||
125327571|NCT00068692|450833184|FG001|Step 1: Registration|Registered but not randomized|1|||
125327572|NCT00068692|450833185|FG002|Step 1: Registration|Registered but not randomized|0|||
125327573|NCT00068692|450833186|FG003|Step 1: Registration|Registered but not randomized|0|||
125327574|NCT00068692|450833187|FG004|Step 1: Registration|Registered but not randomized|0|||
125327575|NCT00068692|450833188|FG005|Step 1: Registration|Registered but not randomized|0|||
125327576|NCT00068692|450833189|FG006|Step 1: Registration|Registered but not randomized|0|||
125327577|NCT00068692|450833190|FG007|Step 1: Registration|Registered but not randomized|0|||
125327578|NCT00068692|450833183|FG000|Step 2: Randomization|Disesae progression/replase|0|||
125327579|NCT00068692|450833184|FG001|Step 2: Randomization|Disesae progression/replase|0|||
125327580|NCT00068692|450833185|FG002|Step 2: Randomization|Disesae progression/replase|1|||
125327581|NCT00068692|450833186|FG003|Step 2: Randomization|Disesae progression/replase|1|||
125327582|NCT00068692|450833187|FG004|Step 2: Randomization|Disesae progression/replase|0|||
125327583|NCT00068692|450833188|FG005|Step 2: Randomization|Disesae progression/replase|0|||
125327584|NCT00068692|450833189|FG006|Step 2: Randomization|Disesae progression/replase|0|||
125327585|NCT00068692|450833190|FG007|Step 2: Randomization|Disesae progression/replase|0|||
125327586|NCT00068692|450833183|FG000|Step 2: Randomization|Adverse Event|0|||
125327587|NCT00068692|450833184|FG001|Step 2: Randomization|Adverse Event|0|||
125327588|NCT00068692|450833185|FG002|Step 2: Randomization|Adverse Event|4|||
125327589|NCT00068692|450833186|FG003|Step 2: Randomization|Adverse Event|2|||
125327590|NCT00068692|450833187|FG004|Step 2: Randomization|Adverse Event|2|||
125327591|NCT00068692|450833188|FG005|Step 2: Randomization|Adverse Event|3|||
125663833|NCT00720304|452057941|FG001|Overall Study|Death|0|||
125327592|NCT00068692|450833189|FG006|Step 2: Randomization|Adverse Event|4|||
125327593|NCT00068692|450833190|FG007|Step 2: Randomization|Adverse Event|4|||
125327594|NCT00068692|450833183|FG000|Step 2: Randomization|Death|0|||
125327595|NCT00068692|450833184|FG001|Step 2: Randomization|Death|0|||
125327596|NCT00068692|450833185|FG002|Step 2: Randomization|Death|0|||
125327597|NCT00068692|450833186|FG003|Step 2: Randomization|Death|0|||
125327598|NCT00068692|450833187|FG004|Step 2: Randomization|Death|1|||
125327599|NCT00068692|450833188|FG005|Step 2: Randomization|Death|0|||
125327600|NCT00068692|450833189|FG006|Step 2: Randomization|Death|0|||
125327601|NCT00068692|450833190|FG007|Step 2: Randomization|Death|1|||
125327602|NCT00068692|450833183|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
125327603|NCT00068692|450833184|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
125327604|NCT00068692|450833185|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
125327605|NCT00068692|450833186|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
125327606|NCT00068692|450833187|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
125327607|NCT00068692|450833188|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
125327608|NCT00068692|450833189|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
125327609|NCT00068692|450833190|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
125327610|NCT00068692|450833183|FG000|Step 2: Randomization|alternative therapy|0|||
125327611|NCT00068692|450833184|FG001|Step 2: Randomization|alternative therapy|0|||
125327612|NCT00068692|450833185|FG002|Step 2: Randomization|alternative therapy|0|||
125327613|NCT00068692|450833186|FG003|Step 2: Randomization|alternative therapy|1|||
125327614|NCT00068692|450833187|FG004|Step 2: Randomization|alternative therapy|1|||
125327615|NCT00068692|450833188|FG005|Step 2: Randomization|alternative therapy|0|||
125327616|NCT00068692|450833189|FG006|Step 2: Randomization|alternative therapy|0|||
125327617|NCT00068692|450833190|FG007|Step 2: Randomization|alternative therapy|0|||
125327618|NCT00068692|450833183|FG000|Step 2: Randomization|Physician Decision|0|||
125327619|NCT00068692|450833184|FG001|Step 2: Randomization|Physician Decision|0|||
125327620|NCT00068692|450833185|FG002|Step 2: Randomization|Physician Decision|0|||
125327621|NCT00068692|450833186|FG003|Step 2: Randomization|Physician Decision|1|||
125327622|NCT00068692|450833187|FG004|Step 2: Randomization|Physician Decision|1|||
125327623|NCT00068692|450833188|FG005|Step 2: Randomization|Physician Decision|0|||
125327624|NCT00068692|450833189|FG006|Step 2: Randomization|Physician Decision|0|||
125327625|NCT00068692|450833190|FG007|Step 2: Randomization|Physician Decision|0|||
125327626|NCT00068692|450833183|FG000|Step 2: Randomization|Other|0|||
125327627|NCT00068692|450833184|FG001|Step 2: Randomization|Other|0|||
125327628|NCT00068692|450833185|FG002|Step 2: Randomization|Other|0|||
125327629|NCT00068692|450833186|FG003|Step 2: Randomization|Other|1|||
125327630|NCT00068692|450833187|FG004|Step 2: Randomization|Other|0|||
125327631|NCT00068692|450833188|FG005|Step 2: Randomization|Other|1|||
125327632|NCT00068692|450833189|FG006|Step 2: Randomization|Other|0|||
125327633|NCT00068692|450833190|FG007|Step 2: Randomization|Other|0|||
125327634|NCT00068692|450833183|FG000|Step 2: Randomization|never start protocol therapy|0|||
125327635|NCT00068692|450833184|FG001|Step 2: Randomization|never start protocol therapy|0|||
125327636|NCT00068692|450833185|FG002|Step 2: Randomization|never start protocol therapy|1|||
125327637|NCT00068692|450833186|FG003|Step 2: Randomization|never start protocol therapy|0|||
125327638|NCT00068692|450833187|FG004|Step 2: Randomization|never start protocol therapy|1|||
125327639|NCT00068692|450833188|FG005|Step 2: Randomization|never start protocol therapy|0|||
125327640|NCT00068692|450833189|FG006|Step 2: Randomization|never start protocol therapy|0|||
125327641|NCT00068692|450833190|FG007|Step 2: Randomization|never start protocol therapy|0|||
125327642|NCT00248040|450833195|FG000|Overall Study|transplantectomy|2|||
125327643|NCT00248040|450833196|FG001|Overall Study|transplantectomy|1|||
125327644|NCT00248040|450833197|FG002|Overall Study|transplantectomy|3|||
125327645|NCT00248040|450833195|FG000|Overall Study|transplant cancelled post treat start|1|||
125327646|NCT00248040|450833196|FG001|Overall Study|transplant cancelled post treat start|0|||
125327647|NCT00248040|450833197|FG002|Overall Study|transplant cancelled post treat start|0|||
125327648|NCT00248040|450833195|FG000|Overall Study|Death|0|||
125327649|NCT00248040|450833196|FG001|Overall Study|Death|0|||
125327650|NCT00248040|450833197|FG002|Overall Study|Death|1|||
125327651|NCT00628108|450833208|FG000|Overall Study|Adverse Event|0|||
125327652|NCT00628108|450833209|FG001|Overall Study|Adverse Event|3|||
125327653|NCT00628108|450833208|FG000|Overall Study|Withdrawal by Subject|1|||
125327654|NCT00628108|450833209|FG001|Overall Study|Withdrawal by Subject|0|||
125327655|NCT03848832|450833210|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
125327656|NCT03848832|450833211|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
125327657|NCT03848832|450833212|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
125327658|NCT03848832|450833210|FG000|Overall Study|Withdrawal by Subject|0|||
125327659|NCT03848832|450833211|FG001|Overall Study|Withdrawal by Subject|0|||
125327660|NCT03848832|450833212|FG002|Overall Study|Withdrawal by Subject|1|||
125327661|NCT03848832|450833210|FG000|Overall Study|Withdrawal (Covid-19)|0|||
125327662|NCT03848832|450833211|FG001|Overall Study|Withdrawal (Covid-19)|2|||
125327663|NCT03848832|450833212|FG002|Overall Study|Withdrawal (Covid-19)|0|||
125327664|NCT03848832|450833210|FG000|Overall Study|Physician Decision|2|||
125327665|NCT03848832|450833211|FG001|Overall Study|Physician Decision|1|||
125327666|NCT03848832|450833212|FG002|Overall Study|Physician Decision|3|||
125327667|NCT03848832|450833210|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
125327668|NCT03848832|450833211|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
125327669|NCT03848832|450833212|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
125327670|NCT03848832|450833210|FG000|Overall Study|Adverse Event|1|||
125327671|NCT03848832|450833211|FG001|Overall Study|Adverse Event|0|||
125327672|NCT03848832|450833212|FG002|Overall Study|Adverse Event|0|||
125327673|NCT01760733|450833213|FG000|Waiting List|Death|18|||
125327674|NCT01760733|450833213|FG000|Waiting List|Removed from waiting list|41|||
125327675|NCT01760733|450833213|FG000|Waiting List|Not received a transplant yet|13|||
125663834|NCT00720304|452057940|FG000|Overall Study|Physician Decision|5|||
125663835|NCT00720304|452057941|FG001|Overall Study|Physician Decision|2|||
125663836|NCT00720304|452057940|FG000|Overall Study|Adverse Event|3|||
125663837|NCT00720304|452057941|FG001|Overall Study|Adverse Event|1|||
125663838|NCT00720304|452057940|FG000|Overall Study|Disease progression|6|||
125663839|NCT00720304|452057941|FG001|Overall Study|Disease progression|1|||
125663840|NCT00423488|452057942|FG000|Overall Study|No evidence of study drug intake|2|||
125663841|NCT00423488|452057943|FG001|Overall Study|No evidence of study drug intake|1|||
125663842|NCT00423488|452057942|FG000|Overall Study|No post baseline data|3|||
125663843|NCT00423488|452057943|FG001|Overall Study|No post baseline data|0|||
125663844|NCT00527397|452057946|FG000|Overall Study|Adverse Event|3|||
125663845|NCT00527397|452057946|FG000|Overall Study|Lack of Efficacy|1|||
125663846|NCT00527397|452057946|FG000|Overall Study|Protocol Violation|1|||
125663847|NCT00527397|452057946|FG000|Overall Study|Withdrawal by Subject|6|||
125327676|NCT01760733|450833213|FG000|Transplanted|Not reached 10 years post transplant|184|||
125327677|NCT01760733|450833213|FG000|Transplanted|Death|26|||
125327678|NCT01760733|450833213|FG000|Transplanted|Graft loss|7|||
125327679|NCT02404025|450833214|FG000|Overall Study|Adverse Event|1|||
125327680|NCT02404025|450833214|FG000|Overall Study|Lack of Efficacy|3|||
125327681|NCT01524796|450833215|FG000|Overall Study|Adverse Event|13|||
125327682|NCT01524796|450833215|FG000|Overall Study|Lack of Efficacy|3|||
125327683|NCT01524796|450833215|FG000|Overall Study|Lost to Follow-up|1|||
125663848|NCT00527397|452057946|FG000|Overall Study|Study terminated by sponsor|13|||
125663849|NCT01749033|452057947|FG000|Overall Study|Did not receive allocated intervention|3|||
125663850|NCT01749033|452057948|FG001|Overall Study|Did not receive allocated intervention|3|||
125663851|NCT01749033|452057949|FG002|Overall Study|Did not receive allocated intervention|0|||
125663852|NCT01749033|452057947|FG000|Overall Study|Lost to Follow-up|0|||
125663853|NCT01749033|452057948|FG001|Overall Study|Lost to Follow-up|2|||
125663854|NCT01749033|452057949|FG002|Overall Study|Lost to Follow-up|1|||
125663855|NCT00068237|452057950|FG000|Overall Study|Ineligible|3|||
125327684|NCT01524796|450833215|FG000|Overall Study|The price|1|||
125327685|NCT01524796|450833215|FG000|Overall Study|Withdrawal by Subject|4|||
125327686|NCT01524796|450833215|FG000|Overall Study|Move|1|||
125327687|NCT01524796|450833215|FG000|Overall Study|Deterioration of pains|1|||
125327688|NCT01524796|450833215|FG000|Overall Study|Gall stone surgery|1|||
125327689|NCT01524796|450833215|FG000|Overall Study|Nervous about confidentiality|1|||
125327690|NCT01524796|450833215|FG000|Overall Study|Switch to carbamazapine|1|||
125327691|NCT01524796|450833215|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
125327692|NCT03938259|450833219|FG000|Overall Study|unable to establish baseline for ventilation|1|||
125327693|NCT03938259|450833220|FG001|Overall Study|unable to establish baseline for ventilation|1|||
125327694|NCT01002339|450833221|FG000|Overall Study|Withdrawal by Subject|0|||
125327695|NCT01002339|450833222|FG001|Overall Study|Withdrawal by Subject|1|||
125327696|NCT01002339|450833223|FG002|Overall Study|Withdrawal by Subject|0|||
125327697|NCT01002339|450833221|FG000|Overall Study|Incorrect treatment assignment|0|||
125327698|NCT01002339|450833222|FG001|Overall Study|Incorrect treatment assignment|0|||
125327699|NCT01002339|450833223|FG002|Overall Study|Incorrect treatment assignment|1|||
125327700|NCT01002339|450833221|FG000|Overall Study|Protocol Violation|0|||
125327701|NCT01002339|450833222|FG001|Overall Study|Protocol Violation|0|||
125327702|NCT01002339|450833223|FG002|Overall Study|Protocol Violation|2|||
125327703|NCT01002339|450833221|FG000|Overall Study|Lung cancer detected before transplant|0|||
125327704|NCT01002339|450833222|FG001|Overall Study|Lung cancer detected before transplant|0|||
125327705|NCT01002339|450833223|FG002|Overall Study|Lung cancer detected before transplant|1|||
125327706|NCT01002339|450833221|FG000|Overall Study|Randomized. Not transplanted|0|||
125327707|NCT01002339|450833222|FG001|Overall Study|Randomized. Not transplanted|0|||
125327708|NCT01002339|450833223|FG002|Overall Study|Randomized. Not transplanted|1|||
125327709|NCT01907854|450833224|FG000|Overall Study|Protocol Violation|1|||
125327710|NCT01907854|450833225|FG001|Overall Study|Protocol Violation|1|||
125327711|NCT01907854|450833224|FG000|Overall Study|Withdrawal by Subject|9|||
125327712|NCT01907854|450833225|FG001|Overall Study|Withdrawal by Subject|7|||
125327713|NCT01907854|450833224|FG000|Overall Study|Lost to Follow-up|2|||
125327714|NCT01907854|450833225|FG001|Overall Study|Lost to Follow-up|2|||
125327715|NCT01907854|450833224|FG000|Overall Study|Unclassified|4|||
125327716|NCT01907854|450833225|FG001|Overall Study|Unclassified|3|||
125327717|NCT02215252|450833228|FG000|Overall Study|Adverse Event|1|||
125327718|NCT02215252|450833229|FG001|Overall Study|Adverse Event|5|||
125327719|NCT02215252|450833230|FG002|Overall Study|Adverse Event|2|||
125327720|NCT02215252|450833228|FG000|Overall Study|Lost to Follow-up|0|||
125327721|NCT02215252|450833229|FG001|Overall Study|Lost to Follow-up|0|||
125327722|NCT02215252|450833230|FG002|Overall Study|Lost to Follow-up|1|||
125327723|NCT02215252|450833228|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
125425600|NCT01735201|451182279|FG000|Overall Study|Protocol Violation|1|||
125663856|NCT00068237|452057950|FG000|Overall Study|No protocol treatment received|2|||
125663857|NCT00383019|452057951|FG000|Overall Study|Adverse Event|5|||
125663858|NCT00383019|452057952|FG001|Overall Study|Adverse Event|1|||
125663859|NCT00383019|452057951|FG000|Overall Study|Withdrawal by Subject|0|||
125663860|NCT00383019|452057952|FG001|Overall Study|Withdrawal by Subject|1|||
125327724|NCT02215252|450833229|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
125327725|NCT02215252|450833230|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
125327726|NCT02215252|450833228|FG000|Overall Study|Protocol Violation|0|||
125327727|NCT02215252|450833229|FG001|Overall Study|Protocol Violation|1|||
125327728|NCT02215252|450833230|FG002|Overall Study|Protocol Violation|0|||
125327729|NCT02215252|450833228|FG000|Overall Study|Withdrawal by Subject|1|||
125327730|NCT02215252|450833229|FG001|Overall Study|Withdrawal by Subject|0|||
125327731|NCT02215252|450833230|FG002|Overall Study|Withdrawal by Subject|0|||
125327732|NCT02215252|450833228|FG000|Overall Study|Other|0|||
125327733|NCT02215252|450833229|FG001|Overall Study|Other|1|||
125327734|NCT02215252|450833230|FG002|Overall Study|Other|1|||
125327735|NCT03774576|450833231|FG000|Period 2|Adverse Event|1|||
125327736|NCT01716234|450833232|FG000|Overall Study|Protocol Violation|0|||
125327737|NCT01716234|450833233|FG001|Overall Study|Protocol Violation|0|||
125327738|NCT01716234|450833234|FG002|Overall Study|Protocol Violation|0|||
125327739|NCT01716234|450833235|FG003|Overall Study|Protocol Violation|1|||
125327740|NCT01716234|450833236|FG004|Overall Study|Protocol Violation|1|||
125327741|NCT01716234|450833237|FG005|Overall Study|Protocol Violation|1|||
125327742|NCT01716234|450833238|FG006|Overall Study|Protocol Violation|0|||
125327743|NCT01716234|450833232|FG000|Overall Study|Lack of Efficacy|0|||
125327744|NCT01716234|450833233|FG001|Overall Study|Lack of Efficacy|0|||
125327745|NCT01716234|450833234|FG002|Overall Study|Lack of Efficacy|0|||
125327746|NCT01716234|450833235|FG003|Overall Study|Lack of Efficacy|1|||
125327747|NCT01716234|450833236|FG004|Overall Study|Lack of Efficacy|0|||
125327748|NCT01716234|450833237|FG005|Overall Study|Lack of Efficacy|0|||
125327749|NCT01716234|450833238|FG006|Overall Study|Lack of Efficacy|0|||
125327750|NCT01716234|450833232|FG000|Overall Study|Did not meet protocol eligibility|0|||
125327751|NCT01716234|450833233|FG001|Overall Study|Did not meet protocol eligibility|0|||
125327752|NCT01716234|450833234|FG002|Overall Study|Did not meet protocol eligibility|1|||
125327753|NCT01716234|450833235|FG003|Overall Study|Did not meet protocol eligibility|0|||
125327754|NCT01716234|450833236|FG004|Overall Study|Did not meet protocol eligibility|0|||
125327755|NCT01716234|450833237|FG005|Overall Study|Did not meet protocol eligibility|4|||
125327756|NCT01716234|450833238|FG006|Overall Study|Did not meet protocol eligibility|0|||
125327757|NCT01716234|450833232|FG000|Overall Study|Adverse Event|7|||
125327758|NCT01716234|450833233|FG001|Overall Study|Adverse Event|10|||
125327759|NCT01716234|450833234|FG002|Overall Study|Adverse Event|2|||
125327760|NCT01716234|450833235|FG003|Overall Study|Adverse Event|8|||
125327761|NCT01716234|450833236|FG004|Overall Study|Adverse Event|3|||
125327762|NCT01716234|450833237|FG005|Overall Study|Adverse Event|6|||
125327763|NCT01716234|450833238|FG006|Overall Study|Adverse Event|0|||
125327764|NCT01716234|450833232|FG000|Overall Study|Withdrawal by Subject|3|||
125327765|NCT01716234|450833233|FG001|Overall Study|Withdrawal by Subject|0|||
125327766|NCT01716234|450833234|FG002|Overall Study|Withdrawal by Subject|2|||
125327767|NCT01716234|450833235|FG003|Overall Study|Withdrawal by Subject|2|||
125327768|NCT01716234|450833236|FG004|Overall Study|Withdrawal by Subject|1|||
125327769|NCT01716234|450833237|FG005|Overall Study|Withdrawal by Subject|3|||
125327770|NCT01716234|450833238|FG006|Overall Study|Withdrawal by Subject|0|||
125327771|NCT00515619|450833240|FG000|Overall Study|Adverse Event|34|||
125327772|NCT00515619|450833240|FG000|Overall Study|Lack of Efficacy|92|||
125327773|NCT00515619|450833240|FG000|Overall Study|Withdrawal by Subject|66|||
125327774|NCT00515619|450833240|FG000|Overall Study|Protocol Violation|3|||
125327775|NCT00515619|450833240|FG000|Overall Study|Lost to Follow-up|4|||
125327776|NCT00515619|450833240|FG000|Overall Study|Unsatisfactory compliance|6|||
125327777|NCT00515619|450833240|FG000|Overall Study|Other: Site discontinuing trials|2|||
125327778|NCT00515619|450833240|FG000|Overall Study|Other: Subject cannot attend visits|2|||
125327779|NCT00515619|450833240|FG000|Overall Study|Other: Subject required surgery|1|||
125327780|NCT00515619|450833240|FG000|Overall Study|Other: Subject moved to another country|1|||
125327781|NCT00515619|450833240|FG000|Overall Study|Other: Investigator decision|1|||
125327782|NCT00515619|450833240|FG000|Overall Study|Other: Subject became pregnant|1|||
125327783|NCT00515619|450833240|FG000|Overall Study|Other: Request from sponsor|1|||
125327784|NCT00515619|450833240|FG000|Overall Study|Other: Drug available on license|1|||
125327785|NCT00515619|450833240|FG000|Overall Study|Other: Subject interested in other AED|1|||
125327786|NCT03815929|450833241|FG000|Overall Study|Lost to Follow-up|2|||
125327787|NCT03815929|450833242|FG001|Overall Study|Lost to Follow-up|1|||
125327788|NCT03815929|450833243|FG002|Overall Study|Lost to Follow-up|0|||
125327789|NCT03815929|450833241|FG000|Overall Study|Physician Decision|2|||
125327790|NCT03815929|450833242|FG001|Overall Study|Physician Decision|2|||
125327791|NCT03815929|450833243|FG002|Overall Study|Physician Decision|0|||
125327792|NCT03815929|450833241|FG000|Overall Study|Withdrawal by Subject|0|||
125327793|NCT03815929|450833242|FG001|Overall Study|Withdrawal by Subject|0|||
125327794|NCT03815929|450833243|FG002|Overall Study|Withdrawal by Subject|1|||
125327795|NCT01467960|450833244|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
125327796|NCT01467960|450833245|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
125327797|NCT01467960|450833246|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
125327798|NCT01467960|450833247|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
125327799|NCT01467960|450833248|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
125327800|NCT01467960|450833249|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
125327801|NCT00771758|450833250|FG000|Overall Study|Adverse Event|2|||
125327802|NCT00771758|450833251|FG001|Overall Study|Adverse Event|8|||
125327803|NCT00771758|450833252|FG002|Overall Study|Adverse Event|1|||
125327804|NCT00771758|450833250|FG000|Overall Study|Lack of Efficacy|0|||
125327805|NCT00771758|450833251|FG001|Overall Study|Lack of Efficacy|2|||
125327806|NCT00771758|450833252|FG002|Overall Study|Lack of Efficacy|1|||
125327807|NCT00771758|450833250|FG000|Overall Study|Lost to Follow-up|1|||
125327808|NCT00771758|450833251|FG001|Overall Study|Lost to Follow-up|0|||
125327809|NCT00771758|450833252|FG002|Overall Study|Lost to Follow-up|0|||
125327810|NCT00771758|450833250|FG000|Overall Study|Protocol Violation|1|||
125327811|NCT00771758|450833251|FG001|Overall Study|Protocol Violation|0|||
125327812|NCT00771758|450833252|FG002|Overall Study|Protocol Violation|0|||
125327813|NCT00771758|450833250|FG000|Overall Study|Withdrawal by Subject|1|||
125327814|NCT00771758|450833251|FG001|Overall Study|Withdrawal by Subject|0|||
125327815|NCT00771758|450833252|FG002|Overall Study|Withdrawal by Subject|0|||
125327816|NCT00771758|450833250|FG000|Overall Study|Other|3|||
125327817|NCT00771758|450833251|FG001|Overall Study|Other|2|||
125327818|NCT00771758|450833252|FG002|Overall Study|Other|0|||
125327819|NCT03067077|450833253|FG000|Overall Study|Did not receive surgery|4|||
125327820|NCT03067077|450833254|FG001|Overall Study|Did not receive surgery|5|||
125327821|NCT03067077|450833253|FG000|Overall Study|Lost to Follow-up|3|||
125327822|NCT03067077|450833254|FG001|Overall Study|Lost to Follow-up|2|||
125327823|NCT01394016|450833256|FG000|Overall Study|Progressive Disease|2|||
125327824|NCT01394016|450833257|FG001|Overall Study|Progressive Disease|0|||
125327825|NCT01394016|450833258|FG002|Overall Study|Progressive Disease|0|||
125327826|NCT01394016|450833259|FG003|Overall Study|Progressive Disease|0|||
125327827|NCT01394016|450833260|FG004|Overall Study|Progressive Disease|0|||
125327828|NCT01394016|450833261|FG005|Overall Study|Progressive Disease|0|||
125327829|NCT01394016|450833262|FG006|Overall Study|Progressive Disease|0|||
125327830|NCT01394016|450833263|FG007|Overall Study|Progressive Disease|0|||
125327831|NCT01394016|450833264|FG008|Overall Study|Progressive Disease|0|||
125327832|NCT01394016|450833265|FG009|Overall Study|Progressive Disease|0|||
125327833|NCT01394016|450833266|FG010|Overall Study|Progressive Disease|0|||
125327834|NCT01394016|450833267|FG011|Overall Study|Progressive Disease|0|||
125327835|NCT01394016|450833268|FG012|Overall Study|Progressive Disease|0|||
125327836|NCT01394016|450833269|FG013|Overall Study|Progressive Disease|0|||
125327837|NCT01394016|450833270|FG014|Overall Study|Progressive Disease|0|||
125327838|NCT01394016|450833271|FG015|Overall Study|Progressive Disease|0|||
125327839|NCT01394016|450833272|FG016|Overall Study|Progressive Disease|0|||
125327840|NCT01394016|450833273|FG017|Overall Study|Progressive Disease|0|||
125327841|NCT01394016|450833274|FG018|Overall Study|Progressive Disease|0|||
125327842|NCT01394016|450833256|FG000|Overall Study|Withdrawal by Subject|0|||
125327843|NCT01394016|450833257|FG001|Overall Study|Withdrawal by Subject|0|||
125327844|NCT01394016|450833258|FG002|Overall Study|Withdrawal by Subject|0|||
125327845|NCT01394016|450833259|FG003|Overall Study|Withdrawal by Subject|0|||
125327846|NCT01394016|450833260|FG004|Overall Study|Withdrawal by Subject|0|||
125327847|NCT01394016|450833261|FG005|Overall Study|Withdrawal by Subject|0|||
125327848|NCT01394016|450833262|FG006|Overall Study|Withdrawal by Subject|0|||
125327849|NCT01394016|450833263|FG007|Overall Study|Withdrawal by Subject|1|||
125327850|NCT01394016|450833264|FG008|Overall Study|Withdrawal by Subject|1|||
125327851|NCT01394016|450833265|FG009|Overall Study|Withdrawal by Subject|1|||
125327852|NCT01394016|450833266|FG010|Overall Study|Withdrawal by Subject|4|||
125327853|NCT01394016|450833267|FG011|Overall Study|Withdrawal by Subject|0|||
125327854|NCT01394016|450833268|FG012|Overall Study|Withdrawal by Subject|0|||
125327855|NCT01394016|450833269|FG013|Overall Study|Withdrawal by Subject|3|||
125327856|NCT01394016|450833270|FG014|Overall Study|Withdrawal by Subject|1|||
125327857|NCT01394016|450833271|FG015|Overall Study|Withdrawal by Subject|3|||
125327858|NCT01394016|450833272|FG016|Overall Study|Withdrawal by Subject|1|||
125327859|NCT01394016|450833273|FG017|Overall Study|Withdrawal by Subject|1|||
125327860|NCT01394016|450833274|FG018|Overall Study|Withdrawal by Subject|2|||
125327861|NCT01394016|450833256|FG000|Overall Study|Adverse Event|0|||
125327862|NCT01394016|450833257|FG001|Overall Study|Adverse Event|0|||
125327863|NCT01394016|450833258|FG002|Overall Study|Adverse Event|0|||
125327864|NCT01394016|450833259|FG003|Overall Study|Adverse Event|0|||
125327865|NCT01394016|450833260|FG004|Overall Study|Adverse Event|0|||
125327866|NCT01394016|450833261|FG005|Overall Study|Adverse Event|0|||
125327867|NCT01394016|450833262|FG006|Overall Study|Adverse Event|0|||
125327868|NCT01394016|450833263|FG007|Overall Study|Adverse Event|0|||
125327869|NCT01394016|450833264|FG008|Overall Study|Adverse Event|0|||
125327870|NCT01394016|450833265|FG009|Overall Study|Adverse Event|1|||
125327871|NCT01394016|450833266|FG010|Overall Study|Adverse Event|0|||
125327872|NCT01394016|450833267|FG011|Overall Study|Adverse Event|0|||
125327873|NCT01394016|450833268|FG012|Overall Study|Adverse Event|0|||
125327874|NCT01394016|450833269|FG013|Overall Study|Adverse Event|0|||
125327875|NCT01394016|450833270|FG014|Overall Study|Adverse Event|0|||
125327876|NCT01394016|450833271|FG015|Overall Study|Adverse Event|0|||
125327877|NCT01394016|450833272|FG016|Overall Study|Adverse Event|1|||
125327878|NCT01394016|450833273|FG017|Overall Study|Adverse Event|1|||
125663861|NCT03797222|452057953|FG000|Overall Study|Withdrawal by Subject|1|||
125663862|NCT00725725|452057955|FG000|Overall Study|Adverse Event|1|||
125663863|NCT00725725|452057956|FG001|Overall Study|Adverse Event|3|||
125663864|NCT00725725|452057957|FG002|Overall Study|Adverse Event|2|||
125663865|NCT00725725|452057955|FG000|Overall Study|Lost to Follow-up|2|||
125663866|NCT00725725|452057956|FG001|Overall Study|Lost to Follow-up|0|||
125663867|NCT00725725|452057957|FG002|Overall Study|Lost to Follow-up|2|||
125663868|NCT00725725|452057955|FG000|Overall Study|Withdrawal by Subject|1|||
125663869|NCT00725725|452057956|FG001|Overall Study|Withdrawal by Subject|0|||
125663870|NCT00725725|452057957|FG002|Overall Study|Withdrawal by Subject|1|||
125663871|NCT00725725|452057955|FG000|Overall Study|Protocol Violation|0|||
125663872|NCT00725725|452057956|FG001|Overall Study|Protocol Violation|1|||
125663873|NCT00725725|452057957|FG002|Overall Study|Protocol Violation|0|||
125663874|NCT00378482|452057958|FG000|Overall Study|Lost to Follow-up|1|||
125663875|NCT00378482|452057958|FG000|Overall Study|Lack of Efficacy|8|||
125663876|NCT00378482|452057958|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
125663877|NCT00378482|452057958|FG000|Overall Study|Withdrawal by Subject|4|||
125663878|NCT00378482|452057958|FG000|Overall Study|Adverse Event|9|||
125327879|NCT01394016|450833274|FG018|Overall Study|Adverse Event|0|||
125663879|NCT01355523|452059561|FG000|Overall Study|Withdrawal by Subject|1|||
125663880|NCT01355523|452059562|FG001|Overall Study|Withdrawal by Subject|4|||
125663881|NCT01355523|452059561|FG000|Overall Study|Lost to Follow-up|0|||
125663882|NCT01355523|452059562|FG001|Overall Study|Lost to Follow-up|2|||
125663883|NCT01355523|452059561|FG000|Overall Study|Protocol Violation|0|||
125663884|NCT01355523|452059562|FG001|Overall Study|Protocol Violation|2|||
125663885|NCT01355523|452059561|FG000|Overall Study|Adverse Event|0|||
125663886|NCT01355523|452059562|FG001|Overall Study|Adverse Event|2|||
125663887|NCT01011907|452059563|FG000|Overall Study|Withdrawal by Subject|13|||
125663888|NCT01011907|452059564|FG001|Overall Study|Withdrawal by Subject|11|||
125663889|NCT01011907|452059563|FG000|Overall Study|Adverse Event|1|||
125663890|NCT01011907|452059564|FG001|Overall Study|Adverse Event|4|||
125663891|NCT01272193|452059565|FG000|Overall Study|Adverse Event|1|||
125663892|NCT01272193|452059566|FG001|Overall Study|Adverse Event|1|||
125663893|NCT01272193|452059565|FG000|Overall Study|Lack of Efficacy|0|||
125663894|NCT01272193|452059566|FG001|Overall Study|Lack of Efficacy|3|||
125663895|NCT01272193|452059565|FG000|Overall Study|Withdrawal Criteria|1|||
125663896|NCT01272193|452059566|FG001|Overall Study|Withdrawal Criteria|1|||
125663897|NCT01272193|452059565|FG000|Overall Study|Unclassified|8|||
125663898|NCT01272193|452059566|FG001|Overall Study|Unclassified|7|||
125663899|NCT01440647|452059569|FG000|Overall Study|Death|2|||
125663900|NCT01440647|452059570|FG001|Overall Study|Death|3|||
125663901|NCT01406873|452059571|FG000|Overall Study|Withdrawal by Subject|1|||
125663902|NCT01406873|452059572|FG001|Overall Study|Withdrawal by Subject|1|||
125663903|NCT00736099|452059574|FG000|Overall Study|Adverse Event|61|||
125663904|NCT00736099|452059575|FG001|Overall Study|Adverse Event|18|||
125663905|NCT00736099|452059574|FG000|Overall Study|Protocol Violation|10|||
125327880|NCT01394016|450833256|FG000|Overall Study|Sponsor Decision|0|||
125327881|NCT01394016|450833257|FG001|Overall Study|Sponsor Decision|0|||
125327882|NCT01394016|450833258|FG002|Overall Study|Sponsor Decision|0|||
125327883|NCT01394016|450833259|FG003|Overall Study|Sponsor Decision|0|||
125327884|NCT01394016|450833260|FG004|Overall Study|Sponsor Decision|0|||
125327885|NCT01394016|450833261|FG005|Overall Study|Sponsor Decision|0|||
125327886|NCT01394016|450833262|FG006|Overall Study|Sponsor Decision|0|||
125327887|NCT01394016|450833263|FG007|Overall Study|Sponsor Decision|0|||
125327888|NCT01394016|450833264|FG008|Overall Study|Sponsor Decision|0|||
125327889|NCT01394016|450833265|FG009|Overall Study|Sponsor Decision|0|||
125327890|NCT01394016|450833266|FG010|Overall Study|Sponsor Decision|0|||
125327891|NCT01394016|450833267|FG011|Overall Study|Sponsor Decision|0|||
125327892|NCT01394016|450833268|FG012|Overall Study|Sponsor Decision|1|||
125327893|NCT01394016|450833269|FG013|Overall Study|Sponsor Decision|0|||
125327894|NCT01394016|450833270|FG014|Overall Study|Sponsor Decision|0|||
125327895|NCT01394016|450833271|FG015|Overall Study|Sponsor Decision|0|||
125327896|NCT01394016|450833272|FG016|Overall Study|Sponsor Decision|0|||
125327897|NCT01394016|450833273|FG017|Overall Study|Sponsor Decision|0|||
125327898|NCT01394016|450833274|FG018|Overall Study|Sponsor Decision|0|||
125327899|NCT01394016|450833256|FG000|Overall Study|Lost to Follow-up|0|||
125327900|NCT01394016|450833257|FG001|Overall Study|Lost to Follow-up|0|||
125327901|NCT01394016|450833258|FG002|Overall Study|Lost to Follow-up|0|||
125663906|NCT00736099|452059575|FG001|Overall Study|Protocol Violation|4|||
125663907|NCT00736099|452059574|FG000|Overall Study|Lost to Follow-up|12|||
125663908|NCT00736099|452059575|FG001|Overall Study|Lost to Follow-up|5|||
125663909|NCT00736099|452059574|FG000|Overall Study|Withdrawal by Subject|42|||
125663910|NCT00736099|452059575|FG001|Overall Study|Withdrawal by Subject|13|||
125663911|NCT00736099|452059574|FG000|Overall Study|Lack of Efficacy|15|||
125663912|NCT00736099|452059575|FG001|Overall Study|Lack of Efficacy|8|||
125327902|NCT01394016|450833259|FG003|Overall Study|Lost to Follow-up|0|||
125663913|NCT00736099|452059574|FG000|Overall Study|Other reason|43|||
125663914|NCT00736099|452059575|FG001|Overall Study|Other reason|10|||
125663915|NCT02290028|452059576|FG000|Overall Study|Death|217|||
125327903|NCT01394016|450833260|FG004|Overall Study|Lost to Follow-up|0|||
125327904|NCT01394016|450833261|FG005|Overall Study|Lost to Follow-up|0|||
125327905|NCT01394016|450833262|FG006|Overall Study|Lost to Follow-up|0|||
125327906|NCT01394016|450833263|FG007|Overall Study|Lost to Follow-up|0|||
125327907|NCT01394016|450833264|FG008|Overall Study|Lost to Follow-up|0|||
125327908|NCT01394016|450833265|FG009|Overall Study|Lost to Follow-up|0|||
125327909|NCT01394016|450833266|FG010|Overall Study|Lost to Follow-up|0|||
125663916|NCT02290028|452059576|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
125327910|NCT01394016|450833267|FG011|Overall Study|Lost to Follow-up|0|||
125327911|NCT01394016|450833268|FG012|Overall Study|Lost to Follow-up|0|||
125327912|NCT01394016|450833269|FG013|Overall Study|Lost to Follow-up|0|||
125327913|NCT01394016|450833270|FG014|Overall Study|Lost to Follow-up|0|||
125327914|NCT01394016|450833271|FG015|Overall Study|Lost to Follow-up|0|||
125327915|NCT01394016|450833272|FG016|Overall Study|Lost to Follow-up|0|||
125327916|NCT01394016|450833273|FG017|Overall Study|Lost to Follow-up|0|||
125327917|NCT01394016|450833274|FG018|Overall Study|Lost to Follow-up|1|||
125327918|NCT04949490|450833282|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125327919|NCT04949490|450833283|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125327920|NCT04949490|450833284|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125327921|NCT04949490|450833285|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
125327922|NCT04949490|450833286|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125327923|NCT04949490|450833287|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
125327924|NCT04949490|450833282|FG000|Group A and Group B|Withdrawal by Subject|0|||
125327925|NCT04949490|450833283|FG001|Group A and Group B|Withdrawal by Subject|0|||
125327926|NCT04949490|450833284|FG002|Group A and Group B|Withdrawal by Subject|1|||
125327927|NCT04949490|450833285|FG003|Group A and Group B|Withdrawal by Subject|0|||
125327928|NCT04949490|450833286|FG004|Group A and Group B|Withdrawal by Subject|0|||
125327929|NCT04949490|450833287|FG005|Group A and Group B|Withdrawal by Subject|0|||
125327930|NCT04949490|450833282|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125327931|NCT04949490|450833283|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125327932|NCT04949490|450833284|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125327933|NCT04949490|450833285|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125327934|NCT04949490|450833286|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
125327935|NCT04949490|450833287|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
125327936|NCT04949490|450833282|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
125327937|NCT04949490|450833283|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
125327938|NCT04949490|450833284|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
125663917|NCT02290028|452059576|FG000|Overall Study|No longer under care of study physician|76|||
125663918|NCT02290028|452059576|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
125663919|NCT02290028|452059576|FG000|Overall Study|Withdrawal by Subject|52|||
125663920|NCT02290028|452059576|FG000|Overall Study|Study site closure|44|||
125663921|NCT02290028|452059576|FG000|Overall Study|Lost to Follow-up|34|||
125663922|NCT02290028|452059576|FG000|Overall Study|Miscellaneous|10|||
125663923|NCT02290028|452059576|FG000|Overall Study|Transition to EP PASSION|1295|||
125663924|NCT02290028|452059576|FG000|Overall Study|Planned study completion at 12 months|257|||
125663925|NCT03202511|452059577|FG000|Overall Study|Withdrawal by Subject|1|||
125663926|NCT03202511|452059578|FG001|Overall Study|Withdrawal by Subject|0|||
125663927|NCT00096382|452059581|FG000|Overall Study|Not treated|1|||
125663928|NCT00096382|452059582|FG001|Overall Study|Not treated|0|||
125663929|NCT00096382|452059581|FG000|Overall Study|Death during treatment|1|||
125663930|NCT00096382|452059582|FG001|Overall Study|Death during treatment|0|||
125663931|NCT00289731|452059584|FG000|Overall Study|Adverse Event|1|||
125663932|NCT00289731|452059585|FG001|Overall Study|Adverse Event|2|||
125663933|NCT00289731|452059586|FG002|Overall Study|Adverse Event|2|||
125663934|NCT00289731|452059584|FG000|Overall Study|Other|1|||
125663935|NCT00289731|452059585|FG001|Overall Study|Other|0|||
125663936|NCT00289731|452059586|FG002|Overall Study|Other|0|||
125663937|NCT04378010|452059587|FG000|Overall Study|Adverse Event|8|||
125663938|NCT04378010|452059588|FG001|Overall Study|Adverse Event|14|||
125663939|NCT04378010|452059589|FG002|Overall Study|Adverse Event|4|||
125663940|NCT04378010|452059587|FG000|Overall Study|Withdrawal by Subject|0|||
125663941|NCT04378010|452059588|FG001|Overall Study|Withdrawal by Subject|2|||
125663942|NCT04378010|452059589|FG002|Overall Study|Withdrawal by Subject|1|||
125663943|NCT04378010|452059587|FG000|Overall Study|Protocol Violation|2|||
125663944|NCT04378010|452059588|FG001|Overall Study|Protocol Violation|1|||
125663945|NCT04378010|452059589|FG002|Overall Study|Protocol Violation|4|||
125663946|NCT04378010|452059587|FG000|Overall Study|Study terminated by Sponsor|22|||
125663947|NCT04378010|452059588|FG001|Overall Study|Study terminated by Sponsor|16|||
125663948|NCT04378010|452059589|FG002|Overall Study|Study terminated by Sponsor|22|||
125663949|NCT04378010|452059587|FG000|Overall Study|Subject inability to complete study visit|0|||
125663950|NCT04378010|452059588|FG001|Overall Study|Subject inability to complete study visit|0|||
125327939|NCT04949490|450833285|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
125425601|NCT01735201|451182280|FG001|Overall Study|Protocol Violation|0|||
125327940|NCT04949490|450833286|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
125327941|NCT04949490|450833287|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
125327942|NCT02017405|450833288|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125327943|NCT02017405|450833289|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125327944|NCT02017405|450833290|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125327945|NCT02017405|450833291|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125327946|NCT02017405|450833292|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
125327947|NCT02017405|450833293|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
125327948|NCT02017405|450833288|FG000|Open-label Phase|Adverse Event|1|||
125327949|NCT02017405|450833289|FG001|Open-label Phase|Adverse Event|1|||
125327950|NCT02017405|450833290|FG002|Open-label Phase|Adverse Event|0|||
125327951|NCT02017405|450833291|FG003|Open-label Phase|Adverse Event|0|||
125327952|NCT02017405|450833292|FG004|Open-label Phase|Adverse Event|0|||
125327953|NCT02017405|450833293|FG005|Open-label Phase|Adverse Event|0|||
125327954|NCT02864394|450833295|FG000|Overall Study|Death|184|||
125327955|NCT02864394|450833296|FG001|Overall Study|Death|189|||
125327956|NCT02864394|450833295|FG000|Overall Study|Lost to Follow-up|0|||
125327957|NCT02864394|450833296|FG001|Overall Study|Lost to Follow-up|2|||
125327958|NCT02864394|450833295|FG000|Overall Study|Sponsor Decision|26|||
125327959|NCT02864394|450833296|FG001|Overall Study|Sponsor Decision|11|||
125327960|NCT02864394|450833295|FG000|Overall Study|Withdrawal by Subject|3|||
125327961|NCT02864394|450833296|FG001|Overall Study|Withdrawal by Subject|10|||
125327962|NCT00777153|450835409|FG000|Overall Study|Lost to Follow-up|1|||
125327963|NCT00777153|450835410|FG001|Overall Study|Lost to Follow-up|1|||
125327964|NCT00777153|450835411|FG002|Overall Study|Lost to Follow-up|0|||
125327965|NCT00777153|450835409|FG000|Overall Study|Death|85|||
125327966|NCT00777153|450835410|FG001|Overall Study|Death|73|||
125327967|NCT00777153|450835411|FG002|Overall Study|Death|33|||
125327968|NCT00777153|450835409|FG000|Overall Study|Withdrawal by Subject|3|||
125327969|NCT00777153|450835410|FG001|Overall Study|Withdrawal by Subject|4|||
125327970|NCT00777153|450835411|FG002|Overall Study|Withdrawal by Subject|3|||
125327971|NCT00777153|450835409|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
125327972|NCT00777153|450835410|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
125327973|NCT00777153|450835411|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
125327974|NCT00554216|450835413|FG000|Overall Study|Lost to Follow-up|92|||
125327975|NCT00554216|450835414|FG001|Overall Study|Lost to Follow-up|31|||
125327976|NCT00554216|450835415|FG002|Overall Study|Lost to Follow-up|63|||
125327977|NCT00554216|450835413|FG000|Overall Study|Adverse Event|16|||
125327978|NCT00554216|450835414|FG001|Overall Study|Adverse Event|16|||
125327979|NCT00554216|450835415|FG002|Overall Study|Adverse Event|36|||
125327980|NCT00554216|450835413|FG000|Overall Study|Withdrawal by Subject|92|||
125327981|NCT00554216|450835414|FG001|Overall Study|Withdrawal by Subject|31|||
125327982|NCT00554216|450835415|FG002|Overall Study|Withdrawal by Subject|43|||
125327983|NCT00554216|450835413|FG000|Overall Study|Non compliance|10|||
125327984|NCT00554216|450835414|FG001|Overall Study|Non compliance|4|||
125327985|NCT00554216|450835415|FG002|Overall Study|Non compliance|5|||
125327986|NCT00554216|450835413|FG000|Overall Study|Pregnancy|2|||
125327987|NCT00554216|450835414|FG001|Overall Study|Pregnancy|1|||
125327988|NCT00554216|450835415|FG002|Overall Study|Pregnancy|14|||
125327989|NCT00554216|450835413|FG000|Overall Study|Restricted med|3|||
125327990|NCT00554216|450835414|FG001|Overall Study|Restricted med|1|||
125327991|NCT00554216|450835415|FG002|Overall Study|Restricted med|1|||
125327992|NCT00554216|450835413|FG000|Overall Study|Other|12|||
125327993|NCT00554216|450835414|FG001|Overall Study|Other|7|||
125327994|NCT00554216|450835415|FG002|Overall Study|Other|10|||
125327995|NCT00554216|450835413|FG000|Overall Study|Lack of Efficacy|15|||
125327996|NCT00554216|450835414|FG001|Overall Study|Lack of Efficacy|3|||
125327997|NCT00554216|450835415|FG002|Overall Study|Lack of Efficacy|0|||
125327998|NCT02079246|450835416|FG000|OLEX|Withdrawal before treatment|1|||
125327999|NCT02079246|450835417|FG001|OLEX|Withdrawal before treatment|0|||
125328000|NCT02079246|450835416|FG000|OLEX|Death|11|||
125328001|NCT02079246|450835417|FG001|OLEX|Death|0|||
125328002|NCT02079246|450835416|FG000|OLEX|Adverse Event|66|||
125328003|NCT02079246|450835417|FG001|OLEX|Adverse Event|0|||
125328004|NCT02079246|450835416|FG000|OLEX|Withdrawal by Subject|60|||
125328005|NCT02079246|450835417|FG001|OLEX|Withdrawal by Subject|0|||
125328006|NCT02079246|450835416|FG000|OLEX|Lost to Follow-up|6|||
125328007|NCT02079246|450835417|FG001|OLEX|Lost to Follow-up|0|||
125328008|NCT02079246|450835416|FG000|OLEX|Protocol Violation|6|||
125328009|NCT02079246|450835417|FG001|OLEX|Protocol Violation|0|||
125328010|NCT02079246|450835416|FG000|OLEX|Lack of Efficacy|3|||
125328011|NCT02079246|450835417|FG001|OLEX|Lack of Efficacy|0|||
125328012|NCT02079246|450835416|FG000|OLEX|Results of the lead-in studies|58|||
125328013|NCT02079246|450835417|FG001|OLEX|Results of the lead-in studies|0|||
125328014|NCT02079246|450835416|FG000|OLEX|Other: Disallowed medication|8|||
125328015|NCT02079246|450835417|FG001|OLEX|Other: Disallowed medication|0|||
125328016|NCT02079246|450835416|FG000|OLEX|Other: Insufficient compliance|2|||
125328017|NCT02079246|450835417|FG001|OLEX|Other: Insufficient compliance|0|||
125328018|NCT02079246|450835416|FG000|OLEX|Other: Caregiver unavailable|3|||
125328019|NCT02079246|450835417|FG001|OLEX|Other: Caregiver unavailable|0|||
125328020|NCT02079246|450835416|FG000|OLEX|Other: Coordinator decision|1|||
125328021|NCT02079246|450835417|FG001|OLEX|Other: Coordinator decision|0|||
125328022|NCT02079246|450835416|FG000|OLEX|Other: Worsening of condition|1|||
125328023|NCT02079246|450835417|FG001|OLEX|Other: Worsening of condition|0|||
125328024|NCT02079246|450835416|FG000|OLEX|Other: Moved to nursing home|1|||
125328025|NCT02079246|450835417|FG001|OLEX|Other: Moved to nursing home|0|||
125328026|NCT02079246|450835416|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
125328027|NCT02079246|450835417|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
125328028|NCT02079246|450835416|FG000|OLEX-MEM|Adverse Event|0|||
125328029|NCT02079246|450835417|FG001|OLEX-MEM|Adverse Event|6|||
125328030|NCT02079246|450835416|FG000|OLEX-MEM|Withdrawal by Subject|0|||
125328031|NCT02079246|450835417|FG001|OLEX-MEM|Withdrawal by Subject|7|||
125328032|NCT02079246|450835416|FG000|OLEX-MEM|Protocol Violation|0|||
125328033|NCT02079246|450835417|FG001|OLEX-MEM|Protocol Violation|2|||
125328034|NCT02079246|450835416|FG000|OLEX-MEM|Lost to Follow-up|0|||
125328035|NCT02079246|450835417|FG001|OLEX-MEM|Lost to Follow-up|1|||
125328036|NCT02079246|450835416|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
125328037|NCT02079246|450835417|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
125328038|NCT00463567|450835418|FG000|Overall Study|Adverse Event|29|||
125328039|NCT00463567|450835419|FG001|Overall Study|Adverse Event|26|||
125328040|NCT00463567|450835420|FG002|Overall Study|Adverse Event|17|||
125328041|NCT00463567|450835421|FG003|Overall Study|Adverse Event|46|||
125328042|NCT00463567|450835422|FG004|Overall Study|Adverse Event|10|||
125328043|NCT00463567|450835423|FG005|Overall Study|Adverse Event|10|||
125328044|NCT00463567|450835424|FG006|Overall Study|Adverse Event|4|||
125328045|NCT00463567|450835418|FG000|Overall Study|Withdrawal by Subject|29|||
125328046|NCT00463567|450835419|FG001|Overall Study|Withdrawal by Subject|22|||
125328047|NCT00463567|450835420|FG002|Overall Study|Withdrawal by Subject|20|||
125328048|NCT00463567|450835421|FG003|Overall Study|Withdrawal by Subject|37|||
125328049|NCT00463567|450835422|FG004|Overall Study|Withdrawal by Subject|6|||
125328050|NCT00463567|450835423|FG005|Overall Study|Withdrawal by Subject|5|||
125328051|NCT00463567|450835424|FG006|Overall Study|Withdrawal by Subject|1|||
125328052|NCT00463567|450835418|FG000|Overall Study|Protocol Deviation|13|||
125328053|NCT00463567|450835419|FG001|Overall Study|Protocol Deviation|9|||
125328054|NCT00463567|450835420|FG002|Overall Study|Protocol Deviation|14|||
125328055|NCT00463567|450835421|FG003|Overall Study|Protocol Deviation|11|||
125328056|NCT00463567|450835422|FG004|Overall Study|Protocol Deviation|1|||
125328057|NCT00463567|450835423|FG005|Overall Study|Protocol Deviation|1|||
125328058|NCT00463567|450835424|FG006|Overall Study|Protocol Deviation|2|||
125328059|NCT00463567|450835418|FG000|Overall Study|Lost to Follow-up|12|||
125328060|NCT00463567|450835419|FG001|Overall Study|Lost to Follow-up|6|||
125328061|NCT00463567|450835420|FG002|Overall Study|Lost to Follow-up|13|||
125328062|NCT00463567|450835421|FG003|Overall Study|Lost to Follow-up|8|||
125328063|NCT00463567|450835422|FG004|Overall Study|Lost to Follow-up|1|||
125328064|NCT00463567|450835423|FG005|Overall Study|Lost to Follow-up|1|||
125328065|NCT00463567|450835424|FG006|Overall Study|Lost to Follow-up|1|||
125328066|NCT00463567|450835418|FG000|Overall Study|Administrative problems|5|||
125328067|NCT00463567|450835419|FG001|Overall Study|Administrative problems|3|||
125328068|NCT00463567|450835420|FG002|Overall Study|Administrative problems|6|||
125328069|NCT00463567|450835421|FG003|Overall Study|Administrative problems|9|||
125328070|NCT00463567|450835422|FG004|Overall Study|Administrative problems|3|||
125328071|NCT00463567|450835423|FG005|Overall Study|Administrative problems|2|||
125328072|NCT00463567|450835424|FG006|Overall Study|Administrative problems|2|||
125328073|NCT00463567|450835418|FG000|Overall Study|Lack of Efficacy|4|||
125328074|NCT00463567|450835419|FG001|Overall Study|Lack of Efficacy|9|||
125328075|NCT00463567|450835420|FG002|Overall Study|Lack of Efficacy|9|||
125328076|NCT00463567|450835421|FG003|Overall Study|Lack of Efficacy|17|||
125663951|NCT04378010|452059589|FG002|Overall Study|Subject inability to complete study visit|1|||
125663952|NCT04378010|452059587|FG000|Overall Study|Subject never dosed|0|||
125663953|NCT04378010|452059588|FG001|Overall Study|Subject never dosed|1|||
125663954|NCT04378010|452059589|FG002|Overall Study|Subject never dosed|0|||
125663955|NCT02019979|452059590|FG000|Overall Study|study terminated|14|||
125663956|NCT02513459|452059591|FG000|Overall Study|Adverse Event|7|||
125328077|NCT00463567|450835422|FG004|Overall Study|Lack of Efficacy|1|||
125328078|NCT00463567|450835423|FG005|Overall Study|Lack of Efficacy|0|||
125663957|NCT02513459|452059591|FG000|Overall Study|Withdrew consent|5|||
125663958|NCT02513459|452059591|FG000|Overall Study|Loss of efficacy|2|||
125663959|NCT02513459|452059591|FG000|Overall Study|Pregnancy|2|||
125663960|NCT02513459|452059591|FG000|Overall Study|Subject decision|2|||
125328079|NCT00463567|450835424|FG006|Overall Study|Lack of Efficacy|1|||
125328080|NCT00463567|450835418|FG000|Overall Study|Abnormal lab value(s)|1|||
125328081|NCT00463567|450835419|FG001|Overall Study|Abnormal lab value(s)|1|||
125328082|NCT00463567|450835420|FG002|Overall Study|Abnormal lab value(s)|2|||
125328083|NCT00463567|450835421|FG003|Overall Study|Abnormal lab value(s)|1|||
125328084|NCT00463567|450835422|FG004|Overall Study|Abnormal lab value(s)|1|||
125328085|NCT00463567|450835423|FG005|Overall Study|Abnormal lab value(s)|0|||
125328086|NCT00463567|450835424|FG006|Overall Study|Abnormal lab value(s)|0|||
125663961|NCT02513459|452059591|FG000|Overall Study|Lack of response|1|||
125663962|NCT02513459|452059591|FG000|Overall Study|Reproductive plans|1|||
125663963|NCT02513459|452059591|FG000|Overall Study|Surgery planned-- not done|1|||
125328087|NCT00463567|450835418|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125328088|NCT00463567|450835419|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125328089|NCT00463567|450835420|FG002|Overall Study|Abnormal test procedure result(s)|6|||
125328090|NCT00463567|450835421|FG003|Overall Study|Abnormal test procedure result(s)|2|||
125328091|NCT00463567|450835422|FG004|Overall Study|Abnormal test procedure result(s)|0|||
125328092|NCT00463567|450835423|FG005|Overall Study|Abnormal test procedure result(s)|2|||
125328093|NCT00463567|450835424|FG006|Overall Study|Abnormal test procedure result(s)|0|||
125328094|NCT00463567|450835418|FG000|Overall Study|Death|1|||
125328095|NCT00463567|450835419|FG001|Overall Study|Death|0|||
125328096|NCT00463567|450835420|FG002|Overall Study|Death|2|||
125328097|NCT00463567|450835421|FG003|Overall Study|Death|0|||
125328098|NCT00463567|450835422|FG004|Overall Study|Death|0|||
125328099|NCT00463567|450835423|FG005|Overall Study|Death|0|||
125328100|NCT00463567|450835424|FG006|Overall Study|Death|0|||
125328101|NCT02633306|450835425|FG000|Overall Study|Withdrawal by Subject|3|||
125328102|NCT00956007|450835426|FG000|Overall Study|Protocol Violation|27|||
125328103|NCT00956007|450835427|FG001|Overall Study|Protocol Violation|23|||
125328104|NCT01746901|450835428|FG000|Naloxone Challenge Phase|Adverse Event|2|||
125328105|NCT01746901|450835429|FG001|Naloxone Challenge Phase|Adverse Event|0|||
125328106|NCT01746901|450835430|FG002|Naloxone Challenge Phase|Adverse Event|0|||
125328107|NCT01746901|450835431|FG003|Naloxone Challenge Phase|Adverse Event|0|||
125328108|NCT01746901|450835432|FG004|Naloxone Challenge Phase|Adverse Event|0|||
125328109|NCT01746901|450835433|FG005|Naloxone Challenge Phase|Adverse Event|0|||
125328110|NCT01746901|450835434|FG006|Naloxone Challenge Phase|Adverse Event|0|||
125663964|NCT04023994|452059595|FG000|Overall Study|Lost to Follow-up|0|||
125663965|NCT04023994|452059596|FG001|Overall Study|Lost to Follow-up|1|||
125663966|NCT04023994|452059597|FG002|Overall Study|Lost to Follow-up|2|||
125663967|NCT04023994|452059598|FG003|Overall Study|Lost to Follow-up|0|||
125663968|NCT04023994|452059599|FG004|Overall Study|Lost to Follow-up|0|||
125663969|NCT04023994|452059600|FG005|Overall Study|Lost to Follow-up|0|||
125663970|NCT04023994|452059595|FG000|Overall Study|Withdrawal by Subject|0|||
125663971|NCT04023994|452059596|FG001|Overall Study|Withdrawal by Subject|0|||
125663972|NCT04023994|452059597|FG002|Overall Study|Withdrawal by Subject|0|||
125663973|NCT04023994|452059598|FG003|Overall Study|Withdrawal by Subject|1|||
125663974|NCT04023994|452059599|FG004|Overall Study|Withdrawal by Subject|0|||
125663975|NCT04023994|452059600|FG005|Overall Study|Withdrawal by Subject|0|||
125663976|NCT00923195|452059601|FG000|Overall Study|Death|0|||
125663977|NCT00923195|452059602|FG001|Overall Study|Death|1|||
125663978|NCT00467818|452059605|FG000|Overall Study|Adverse Event|1|||
125663979|NCT00467818|452059606|FG001|Overall Study|Adverse Event|0|||
125663980|NCT00467818|452059605|FG000|Overall Study|Lost to Follow-up|2|||
125663981|NCT00467818|452059606|FG001|Overall Study|Lost to Follow-up|2|||
125663982|NCT02143947|452059610|FG000|Overall Study|Lost to Follow-up|4|||
125663983|NCT02143947|452059611|FG001|Overall Study|Lost to Follow-up|2|||
125663984|NCT01244815|452059612|FG000|Overall Study|Not Treated|0|||
125663985|NCT01244815|452059613|FG001|Overall Study|Not Treated|1|||
125663986|NCT01244815|452059614|FG002|Overall Study|Not Treated|0|||
125663987|NCT01244815|452059615|FG003|Overall Study|Not Treated|0|||
125663988|NCT01244815|452059612|FG000|Overall Study|Adverse Event|4|||
125663989|NCT01244815|452059613|FG001|Overall Study|Adverse Event|7|||
125663990|NCT01244815|452059614|FG002|Overall Study|Adverse Event|5|||
125663991|NCT01244815|452059615|FG003|Overall Study|Adverse Event|5|||
125663992|NCT01244815|452059612|FG000|Overall Study|Treatment Failure|0|||
125663993|NCT01244815|452059613|FG001|Overall Study|Treatment Failure|0|||
125663994|NCT01244815|452059614|FG002|Overall Study|Treatment Failure|0|||
125663995|NCT01244815|452059615|FG003|Overall Study|Treatment Failure|1|||
125663996|NCT01244815|452059612|FG000|Overall Study|Lost to Follow-up|3|||
125663997|NCT01244815|452059613|FG001|Overall Study|Lost to Follow-up|2|||
125328111|NCT01746901|450835435|FG007|Naloxone Challenge Phase|Adverse Event|0|||
125328112|NCT01746901|450835436|FG008|Naloxone Challenge Phase|Adverse Event|0|||
125328113|NCT01746901|450835428|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
125328114|NCT01746901|450835429|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328115|NCT01746901|450835430|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328116|NCT01746901|450835431|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125663998|NCT01244815|452059614|FG002|Overall Study|Lost to Follow-up|3|||
125663999|NCT01244815|452059615|FG003|Overall Study|Lost to Follow-up|2|||
125664000|NCT01244815|452059612|FG000|Overall Study|Withdrawal by Subject|0|||
125664001|NCT01244815|452059613|FG001|Overall Study|Withdrawal by Subject|2|||
125664002|NCT01244815|452059614|FG002|Overall Study|Withdrawal by Subject|0|||
125664003|NCT01244815|452059615|FG003|Overall Study|Withdrawal by Subject|3|||
125664004|NCT01244815|452059612|FG000|Overall Study|Protocol Violation|7|||
125664005|NCT01244815|452059613|FG001|Overall Study|Protocol Violation|4|||
125664006|NCT01244815|452059614|FG002|Overall Study|Protocol Violation|3|||
125664007|NCT01244815|452059615|FG003|Overall Study|Protocol Violation|1|||
125664008|NCT01244815|452059612|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
125664009|NCT01244815|452059613|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
125664010|NCT01244815|452059614|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
125664011|NCT01244815|452059615|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
125664012|NCT01313728|452059617|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
125664013|NCT02487979|452059624|FG000|Overall Study|Physician Decision|2|||
125664014|NCT02487979|452059624|FG000|Overall Study|Withdrawal by Subject|2|||
125664015|NCT02487979|452059624|FG000|Overall Study|Progressive Disease|17|||
125328117|NCT01746901|450835432|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328118|NCT01746901|450835433|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328119|NCT01746901|450835434|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328120|NCT01746901|450835435|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328121|NCT01746901|450835436|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
125328122|NCT01746901|450835428|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328123|NCT01746901|450835429|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
125328124|NCT01746901|450835430|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328125|NCT01746901|450835431|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328126|NCT01746901|450835432|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328127|NCT01746901|450835433|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328128|NCT01746901|450835434|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328129|NCT01746901|450835435|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328130|NCT01746901|450835436|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125328131|NCT01746901|450835428|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328132|NCT01746901|450835429|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
125328133|NCT01746901|450835430|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
125328134|NCT01746901|450835431|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328135|NCT01746901|450835432|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328136|NCT01746901|450835433|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328137|NCT01746901|450835434|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328138|NCT01746901|450835435|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328139|NCT01746901|450835436|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
125328140|NCT01746901|450835428|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328141|NCT01746901|450835429|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
125328142|NCT01746901|450835430|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
125328143|NCT01746901|450835431|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328144|NCT01746901|450835432|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328145|NCT01746901|450835433|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328146|NCT01746901|450835434|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328147|NCT01746901|450835435|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328148|NCT01746901|450835436|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
125328149|NCT01746901|450835428|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328150|NCT01746901|450835429|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
125328151|NCT01746901|450835430|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
125328152|NCT01746901|450835431|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328153|NCT01746901|450835432|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328154|NCT01746901|450835433|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328155|NCT01746901|450835434|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328156|NCT01746901|450835435|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328157|NCT01746901|450835436|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125328158|NCT01746901|450835428|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
125328159|NCT01746901|450835429|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
125328160|NCT01746901|450835430|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
125328161|NCT01746901|450835431|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
125328162|NCT01746901|450835432|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
125328163|NCT01746901|450835433|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
125328164|NCT01746901|450835434|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
125328165|NCT01746901|450835435|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
125328166|NCT01746901|450835436|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
125328167|NCT01746901|450835428|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328168|NCT01746901|450835429|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328169|NCT01746901|450835430|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328170|NCT01746901|450835431|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328171|NCT01746901|450835432|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328172|NCT01746901|450835433|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328173|NCT01746901|450835434|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125328174|NCT01746901|450835435|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
125328175|NCT01746901|450835436|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
125664016|NCT00447694|452059625|FG000|Overall Study|Adverse Event|2|||
125664017|NCT00447694|452059625|FG000|Overall Study|Abnormal laboratory value|1|||
125664018|NCT00447694|452059625|FG000|Overall Study|Abnormal test procedure result|1|||
125664019|NCT00447694|452059625|FG000|Overall Study|Withdrawal by Subject|2|||
125664020|NCT01507831|452059629|FG000|Overall Study|Randomized but not treated|0|||
125664021|NCT01507831|452059630|FG001|Overall Study|Randomized but not treated|3|||
125664022|NCT01507831|452059629|FG000|Overall Study|Adverse Event|48|||
125664023|NCT01507831|452059630|FG001|Overall Study|Adverse Event|113|||
125664024|NCT01507831|452059629|FG000|Overall Study|Death|6|||
125664025|NCT01507831|452059630|FG001|Overall Study|Death|2|||
125664026|NCT01507831|452059629|FG000|Overall Study|Poor compliance to protocol|38|||
125664027|NCT01507831|452059630|FG001|Overall Study|Poor compliance to protocol|60|||
125664028|NCT01507831|452059629|FG000|Overall Study|Physician Decision|0|||
125664029|NCT01507831|452059630|FG001|Overall Study|Physician Decision|4|||
125664030|NCT01507831|452059629|FG000|Overall Study|Participant moved|5|||
125664031|NCT01507831|452059630|FG001|Overall Study|Participant moved|19|||
125664032|NCT01507831|452059629|FG000|Overall Study|Consent withdrawn by participant|34|||
125664033|NCT01507831|452059630|FG001|Overall Study|Consent withdrawn by participant|72|||
125664034|NCT01507831|452059629|FG000|Overall Study|Related to study drug administration|5|||
125664035|NCT01507831|452059630|FG001|Overall Study|Related to study drug administration|14|||
125664036|NCT01507831|452059629|FG000|Overall Study|Last visit outside protocol visit window|51|||
125664037|NCT01507831|452059630|FG001|Overall Study|Last visit outside protocol visit window|143|||
125664038|NCT01507831|452059629|FG000|Overall Study|Selection criteria finally not met|0|||
125328176|NCT01746901|450835428|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
125328177|NCT01746901|450835429|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
125328178|NCT01746901|450835430|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
125328179|NCT01746901|450835431|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
125664039|NCT01507831|452059630|FG001|Overall Study|Selection criteria finally not met|1|||
125664040|NCT01507831|452059629|FG000|Overall Study|Site closure|0|||
125664041|NCT01507831|452059630|FG001|Overall Study|Site closure|3|||
125664042|NCT01507831|452059629|FG000|Overall Study|Potential lost to follow-up|3|||
125664043|NCT01507831|452059630|FG001|Overall Study|Potential lost to follow-up|0|||
125664044|NCT01507831|452059629|FG000|Overall Study|Other|3|||
125664045|NCT01507831|452059630|FG001|Overall Study|Other|6|||
125664046|NCT04380701|452059632|FG000|Overall Study|Pregnancy|0|||
125664047|NCT04380701|452059633|FG001|Overall Study|Pregnancy|0|||
125664048|NCT04380701|452059634|FG002|Overall Study|Pregnancy|0|||
125664049|NCT04380701|452059635|FG003|Overall Study|Pregnancy|0|||
125664050|NCT04380701|452059636|FG004|Overall Study|Pregnancy|0|||
125664051|NCT04380701|452059637|FG005|Overall Study|Pregnancy|0|||
125664052|NCT04380701|452059638|FG006|Overall Study|Pregnancy|0|||
125664053|NCT04380701|452059639|FG007|Overall Study|Pregnancy|0|||
125664054|NCT04380701|452059640|FG008|Overall Study|Pregnancy|0|||
125664055|NCT04380701|452059641|FG009|Overall Study|Pregnancy|0|||
125664056|NCT04380701|452059642|FG010|Overall Study|Pregnancy|0|||
125664057|NCT04380701|452059643|FG011|Overall Study|Pregnancy|0|||
125664058|NCT04380701|452059644|FG012|Overall Study|Pregnancy|0|||
125664059|NCT04380701|452059645|FG013|Overall Study|Pregnancy|0|||
125664060|NCT04380701|452059646|FG014|Overall Study|Pregnancy|0|||
125664061|NCT04380701|452059647|FG015|Overall Study|Pregnancy|0|||
125664062|NCT04380701|452059648|FG016|Overall Study|Pregnancy|0|||
125664063|NCT04380701|452059649|FG017|Overall Study|Pregnancy|0|||
125664064|NCT04380701|452059650|FG018|Overall Study|Pregnancy|0|||
125664065|NCT04380701|452059651|FG019|Overall Study|Pregnancy|0|||
125664066|NCT04380701|452059652|FG020|Overall Study|Pregnancy|0|||
125664067|NCT04380701|452059653|FG021|Overall Study|Pregnancy|0|||
125664068|NCT04380701|452059654|FG022|Overall Study|Pregnancy|0|||
125664069|NCT04380701|452059655|FG023|Overall Study|Pregnancy|0|||
125664070|NCT04380701|452059656|FG024|Overall Study|Pregnancy|0|||
125664071|NCT04380701|452059657|FG025|Overall Study|Pregnancy|0|||
125664072|NCT04380701|452059658|FG026|Overall Study|Pregnancy|0|||
125664073|NCT04380701|452059659|FG027|Overall Study|Pregnancy|0|||
125664074|NCT04380701|452059660|FG028|Overall Study|Pregnancy|0|||
125664075|NCT04380701|452059661|FG029|Overall Study|Pregnancy|0|||
125664076|NCT04380701|452059662|FG030|Overall Study|Pregnancy|0|||
125664077|NCT04380701|452059663|FG031|Overall Study|Pregnancy|0|||
125664078|NCT04380701|452059664|FG032|Overall Study|Pregnancy|1|||
125664079|NCT04380701|452059665|FG033|Overall Study|Pregnancy|0|||
125664080|NCT04380701|452059632|FG000|Overall Study|Lost to Follow-up|0|||
125328180|NCT01746901|450835432|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
125664081|NCT04380701|452059633|FG001|Overall Study|Lost to Follow-up|0|||
125664082|NCT04380701|452059634|FG002|Overall Study|Lost to Follow-up|0|||
125664083|NCT04380701|452059635|FG003|Overall Study|Lost to Follow-up|0|||
125664084|NCT04380701|452059636|FG004|Overall Study|Lost to Follow-up|0|||
125664085|NCT04380701|452059637|FG005|Overall Study|Lost to Follow-up|0|||
125664086|NCT04380701|452059638|FG006|Overall Study|Lost to Follow-up|0|||
125664087|NCT04380701|452059639|FG007|Overall Study|Lost to Follow-up|0|||
125664088|NCT04380701|452059640|FG008|Overall Study|Lost to Follow-up|0|||
125664089|NCT04380701|452059641|FG009|Overall Study|Lost to Follow-up|0|||
125664090|NCT04380701|452059642|FG010|Overall Study|Lost to Follow-up|0|||
125664091|NCT04380701|452059643|FG011|Overall Study|Lost to Follow-up|0|||
125664092|NCT04380701|452059644|FG012|Overall Study|Lost to Follow-up|0|||
125328181|NCT01746901|450835433|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
125328182|NCT01746901|450835434|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
125328183|NCT01746901|450835435|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
125328184|NCT01746901|450835436|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
125328185|NCT01746901|450835428|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328186|NCT01746901|450835429|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328187|NCT01746901|450835430|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328188|NCT01746901|450835431|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
125664093|NCT04380701|452059645|FG013|Overall Study|Lost to Follow-up|0|||
125664094|NCT04380701|452059646|FG014|Overall Study|Lost to Follow-up|0|||
125664095|NCT04380701|452059647|FG015|Overall Study|Lost to Follow-up|0|||
125328189|NCT01746901|450835432|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328190|NCT01746901|450835433|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328191|NCT01746901|450835434|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328192|NCT01746901|450835435|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328193|NCT01746901|450835436|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
125328194|NCT01746901|450835428|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328195|NCT01746901|450835429|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328196|NCT01746901|450835430|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328197|NCT01746901|450835431|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328198|NCT01746901|450835432|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328199|NCT01746901|450835433|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
125328200|NCT01746901|450835434|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328201|NCT01746901|450835435|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
125328202|NCT01746901|450835436|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
125328203|NCT01746901|450835428|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125328204|NCT01746901|450835429|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125328205|NCT01746901|450835430|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125664096|NCT04380701|452059648|FG016|Overall Study|Lost to Follow-up|0|||
125664097|NCT04380701|452059649|FG017|Overall Study|Lost to Follow-up|0|||
125664098|NCT04380701|452059650|FG018|Overall Study|Lost to Follow-up|0|||
125664099|NCT04380701|452059651|FG019|Overall Study|Lost to Follow-up|0|||
125664100|NCT04380701|452059652|FG020|Overall Study|Lost to Follow-up|1|||
125664101|NCT04380701|452059653|FG021|Overall Study|Lost to Follow-up|0|||
125664102|NCT04380701|452059654|FG022|Overall Study|Lost to Follow-up|0|||
125664103|NCT04380701|452059655|FG023|Overall Study|Lost to Follow-up|1|||
125664104|NCT04380701|452059656|FG024|Overall Study|Lost to Follow-up|0|||
125664105|NCT04380701|452059657|FG025|Overall Study|Lost to Follow-up|0|||
125664106|NCT04380701|452059658|FG026|Overall Study|Lost to Follow-up|0|||
125664107|NCT04380701|452059659|FG027|Overall Study|Lost to Follow-up|0|||
125664108|NCT04380701|452059660|FG028|Overall Study|Lost to Follow-up|0|||
125664109|NCT04380701|452059661|FG029|Overall Study|Lost to Follow-up|1|||
125664110|NCT04380701|452059662|FG030|Overall Study|Lost to Follow-up|0|||
125664111|NCT04380701|452059663|FG031|Overall Study|Lost to Follow-up|0|||
125664112|NCT04380701|452059664|FG032|Overall Study|Lost to Follow-up|0|||
125664113|NCT04380701|452059665|FG033|Overall Study|Lost to Follow-up|1|||
125664114|NCT04380701|452059632|FG000|Overall Study|Private reason(s)|0|||
125664115|NCT04380701|452059633|FG001|Overall Study|Private reason(s)|0|||
125664116|NCT04380701|452059634|FG002|Overall Study|Private reason(s)|0|||
125664117|NCT04380701|452059635|FG003|Overall Study|Private reason(s)|0|||
125664118|NCT04380701|452059636|FG004|Overall Study|Private reason(s)|0|||
125664119|NCT04380701|452059637|FG005|Overall Study|Private reason(s)|0|||
125664120|NCT04380701|452059638|FG006|Overall Study|Private reason(s)|1|||
125664121|NCT04380701|452059639|FG007|Overall Study|Private reason(s)|0|||
125664122|NCT04380701|452059640|FG008|Overall Study|Private reason(s)|1|||
125664123|NCT04380701|452059641|FG009|Overall Study|Private reason(s)|1|||
125664124|NCT04380701|452059642|FG010|Overall Study|Private reason(s)|0|||
125664125|NCT04380701|452059643|FG011|Overall Study|Private reason(s)|0|||
125664126|NCT04380701|452059644|FG012|Overall Study|Private reason(s)|0|||
125664127|NCT04380701|452059645|FG013|Overall Study|Private reason(s)|0|||
125664128|NCT04380701|452059646|FG014|Overall Study|Private reason(s)|0|||
125664129|NCT04380701|452059647|FG015|Overall Study|Private reason(s)|0|||
125664130|NCT04380701|452059648|FG016|Overall Study|Private reason(s)|0|||
125664131|NCT04380701|452059649|FG017|Overall Study|Private reason(s)|0|||
125328206|NCT01746901|450835431|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125664132|NCT04380701|452059650|FG018|Overall Study|Private reason(s)|0|||
125664133|NCT04380701|452059651|FG019|Overall Study|Private reason(s)|0|||
125664134|NCT04380701|452059652|FG020|Overall Study|Private reason(s)|0|||
125664135|NCT04380701|452059653|FG021|Overall Study|Private reason(s)|0|||
125664136|NCT04380701|452059654|FG022|Overall Study|Private reason(s)|0|||
125664137|NCT04380701|452059655|FG023|Overall Study|Private reason(s)|1|||
125664138|NCT04380701|452059656|FG024|Overall Study|Private reason(s)|0|||
125664139|NCT04380701|452059657|FG025|Overall Study|Private reason(s)|0|||
125664140|NCT04380701|452059658|FG026|Overall Study|Private reason(s)|0|||
125664141|NCT04380701|452059659|FG027|Overall Study|Private reason(s)|0|||
125664142|NCT04380701|452059660|FG028|Overall Study|Private reason(s)|0|||
125664143|NCT04380701|452059661|FG029|Overall Study|Private reason(s)|1|||
125664144|NCT04380701|452059662|FG030|Overall Study|Private reason(s)|0|||
125664145|NCT04380701|452059663|FG031|Overall Study|Private reason(s)|0|||
125664146|NCT04380701|452059664|FG032|Overall Study|Private reason(s)|0|||
125664147|NCT04380701|452059665|FG033|Overall Study|Private reason(s)|0|||
125664148|NCT04380701|452059632|FG000|Overall Study|Withdrawal by Subject|0|||
125664149|NCT04380701|452059633|FG001|Overall Study|Withdrawal by Subject|0|||
125664150|NCT04380701|452059634|FG002|Overall Study|Withdrawal by Subject|0|||
125664151|NCT04380701|452059635|FG003|Overall Study|Withdrawal by Subject|0|||
125664152|NCT04380701|452059636|FG004|Overall Study|Withdrawal by Subject|0|||
125664153|NCT04380701|452059637|FG005|Overall Study|Withdrawal by Subject|0|||
125664154|NCT04380701|452059638|FG006|Overall Study|Withdrawal by Subject|1|||
125664155|NCT04380701|452059639|FG007|Overall Study|Withdrawal by Subject|1|||
125664156|NCT04380701|452059640|FG008|Overall Study|Withdrawal by Subject|0|||
125664157|NCT04380701|452059641|FG009|Overall Study|Withdrawal by Subject|0|||
125664158|NCT04380701|452059642|FG010|Overall Study|Withdrawal by Subject|0|||
125664159|NCT04380701|452059643|FG011|Overall Study|Withdrawal by Subject|1|||
125664160|NCT04380701|452059644|FG012|Overall Study|Withdrawal by Subject|0|||
125664161|NCT04380701|452059645|FG013|Overall Study|Withdrawal by Subject|1|||
125664162|NCT04380701|452059646|FG014|Overall Study|Withdrawal by Subject|0|||
125664163|NCT04380701|452059647|FG015|Overall Study|Withdrawal by Subject|0|||
125664164|NCT04380701|452059648|FG016|Overall Study|Withdrawal by Subject|1|||
125664165|NCT04380701|452059649|FG017|Overall Study|Withdrawal by Subject|0|||
125664166|NCT04380701|452059650|FG018|Overall Study|Withdrawal by Subject|0|||
125664167|NCT04380701|452059651|FG019|Overall Study|Withdrawal by Subject|0|||
125664168|NCT04380701|452059652|FG020|Overall Study|Withdrawal by Subject|0|||
125664169|NCT04380701|452059653|FG021|Overall Study|Withdrawal by Subject|0|||
125664170|NCT04380701|452059654|FG022|Overall Study|Withdrawal by Subject|2|||
125664171|NCT04380701|452059655|FG023|Overall Study|Withdrawal by Subject|2|||
125664172|NCT04380701|452059656|FG024|Overall Study|Withdrawal by Subject|1|||
125664173|NCT04380701|452059657|FG025|Overall Study|Withdrawal by Subject|1|||
125664174|NCT04380701|452059658|FG026|Overall Study|Withdrawal by Subject|0|||
125664175|NCT04380701|452059659|FG027|Overall Study|Withdrawal by Subject|0|||
125664176|NCT04380701|452059660|FG028|Overall Study|Withdrawal by Subject|0|||
125664177|NCT04380701|452059661|FG029|Overall Study|Withdrawal by Subject|0|||
125664178|NCT04380701|452059662|FG030|Overall Study|Withdrawal by Subject|0|||
125664179|NCT04380701|452059663|FG031|Overall Study|Withdrawal by Subject|0|||
125664180|NCT04380701|452059664|FG032|Overall Study|Withdrawal by Subject|0|||
125664181|NCT04380701|452059665|FG033|Overall Study|Withdrawal by Subject|0|||
125664182|NCT04380701|452059632|FG000|Overall Study|Adverse Event|0|||
125664183|NCT04380701|452059633|FG001|Overall Study|Adverse Event|0|||
125664184|NCT04380701|452059634|FG002|Overall Study|Adverse Event|0|||
125664185|NCT04380701|452059635|FG003|Overall Study|Adverse Event|0|||
125664186|NCT04380701|452059636|FG004|Overall Study|Adverse Event|0|||
125664187|NCT04380701|452059637|FG005|Overall Study|Adverse Event|1|||
125664188|NCT04380701|452059638|FG006|Overall Study|Adverse Event|0|||
125664189|NCT04380701|452059639|FG007|Overall Study|Adverse Event|0|||
125664190|NCT04380701|452059640|FG008|Overall Study|Adverse Event|0|||
125664191|NCT04380701|452059641|FG009|Overall Study|Adverse Event|0|||
125664192|NCT04380701|452059642|FG010|Overall Study|Adverse Event|0|||
125664193|NCT04380701|452059643|FG011|Overall Study|Adverse Event|0|||
125664194|NCT04380701|452059644|FG012|Overall Study|Adverse Event|0|||
125664195|NCT04380701|452059645|FG013|Overall Study|Adverse Event|0|||
125664196|NCT04380701|452059646|FG014|Overall Study|Adverse Event|0|||
125664197|NCT04380701|452059647|FG015|Overall Study|Adverse Event|1|||
125328207|NCT01746901|450835432|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125328208|NCT01746901|450835433|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125328209|NCT01746901|450835434|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
125328210|NCT01746901|450835435|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
125328211|NCT01746901|450835436|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
125328212|NCT02968004|450835440|FG000|Main Study Phase|Adverse Event|1|||
125664198|NCT04380701|452059648|FG016|Overall Study|Adverse Event|0|||
125664199|NCT04380701|452059649|FG017|Overall Study|Adverse Event|0|||
125664200|NCT04380701|452059650|FG018|Overall Study|Adverse Event|0|||
125664201|NCT04380701|452059651|FG019|Overall Study|Adverse Event|1|||
125328213|NCT02968004|450835441|FG001|Main Study Phase|Adverse Event|0|||
125664202|NCT04380701|452059652|FG020|Overall Study|Adverse Event|0|||
125664203|NCT04380701|452059653|FG021|Overall Study|Adverse Event|0|||
125664204|NCT04380701|452059654|FG022|Overall Study|Adverse Event|0|||
125664205|NCT04380701|452059655|FG023|Overall Study|Adverse Event|0|||
125664206|NCT04380701|452059656|FG024|Overall Study|Adverse Event|0|||
125664207|NCT04380701|452059657|FG025|Overall Study|Adverse Event|0|||
125664208|NCT04380701|452059658|FG026|Overall Study|Adverse Event|0|||
125664209|NCT04380701|452059659|FG027|Overall Study|Adverse Event|0|||
125664210|NCT04380701|452059660|FG028|Overall Study|Adverse Event|0|||
125664211|NCT04380701|452059661|FG029|Overall Study|Adverse Event|0|||
125328214|NCT02968004|450835440|FG000|Main Study Phase|Withdrawal by Subject|0|||
125328215|NCT02968004|450835441|FG001|Main Study Phase|Withdrawal by Subject|1|||
125328216|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
125328217|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
125328218|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
125328219|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
125328220|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
125328221|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
125328222|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
125328223|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
125328224|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
125328225|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
125328226|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
125328227|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
125328228|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
125328229|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
125328230|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
125328231|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
125328232|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
125328233|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
125328234|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
125328235|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
125328236|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
125328237|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
125328238|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
125328239|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
125328240|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
125328241|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
125328242|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
125328243|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
125328244|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
125328245|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
125328246|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
125328247|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
125328248|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
125328249|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
125328250|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
125328251|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
125328252|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
125328253|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
125328254|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
125328255|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
125328256|NCT02968004|450835440|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
125328257|NCT02968004|450835441|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
125328258|NCT05029362|450835442|FG000|Overall Study|Lost to Follow-up|9|||
125328259|NCT00419952|450835445|FG000|Overall Study|Adverse Event|8|||
125328260|NCT00419952|450835446|FG001|Overall Study|Adverse Event|10|||
125328261|NCT00419952|450835445|FG000|Overall Study|Withdrawal by Subject|44|||
125328262|NCT00419952|450835446|FG001|Overall Study|Withdrawal by Subject|43|||
125328263|NCT00419952|450835445|FG000|Overall Study|Lost to Follow-up|43|||
125328264|NCT00419952|450835446|FG001|Overall Study|Lost to Follow-up|34|||
125328265|NCT00419952|450835445|FG000|Overall Study|Protocol Violation|32|||
125328266|NCT00419952|450835446|FG001|Overall Study|Protocol Violation|24|||
125328267|NCT00419952|450835445|FG000|Overall Study|Pregnancy|4|||
125328268|NCT00419952|450835446|FG001|Overall Study|Pregnancy|2|||
125328269|NCT00419952|450835445|FG000|Overall Study|Physician Decision|1|||
125328270|NCT00419952|450835446|FG001|Overall Study|Physician Decision|3|||
125328271|NCT00419952|450835445|FG000|Overall Study|Incorrectly enrolled|10|||
125328272|NCT00419952|450835446|FG001|Overall Study|Incorrectly enrolled|3|||
125328273|NCT00419952|450835445|FG000|Overall Study|Intake of prohibited medication|2|||
125328274|NCT00419952|450835446|FG001|Overall Study|Intake of prohibited medication|2|||
125328275|NCT00419952|450835445|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
125328276|NCT00419952|450835446|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
125328277|NCT00419952|450835445|FG000|Overall Study|Diary or medication non-compliance|2|||
125328278|NCT00419952|450835446|FG001|Overall Study|Diary or medication non-compliance|4|||
125328279|NCT00419952|450835445|FG000|Overall Study|Abnormal ECG|1|||
125328280|NCT00419952|450835446|FG001|Overall Study|Abnormal ECG|0|||
125328281|NCT03126591|450835447|FG000|Overall Study|Death|6|||
125328282|NCT03126591|450835448|FG001|Overall Study|Death|3|||
125328283|NCT03126591|450835449|FG002|Overall Study|Death|17|||
125664212|NCT04380701|452059662|FG030|Overall Study|Adverse Event|0|||
125664213|NCT04380701|452059663|FG031|Overall Study|Adverse Event|0|||
125664214|NCT04380701|452059664|FG032|Overall Study|Adverse Event|0|||
125664215|NCT04380701|452059665|FG033|Overall Study|Adverse Event|0|||
125328284|NCT03126591|450835447|FG000|Overall Study|Progressive Disease|0|||
125328285|NCT03126591|450835448|FG001|Overall Study|Progressive Disease|1|||
125328286|NCT03126591|450835449|FG002|Overall Study|Progressive Disease|2|||
125328287|NCT03126591|450835447|FG000|Overall Study|Terminated by Sponsor|0|||
125328288|NCT03126591|450835448|FG001|Overall Study|Terminated by Sponsor|1|||
125328289|NCT03126591|450835449|FG002|Overall Study|Terminated by Sponsor|4|||
125328290|NCT03126591|450835447|FG000|Overall Study|Withdrawal by Subject|1|||
125328291|NCT03126591|450835448|FG001|Overall Study|Withdrawal by Subject|1|||
125328292|NCT03126591|450835449|FG002|Overall Study|Withdrawal by Subject|4|||
125328293|NCT02158546|450835450|FG000|Overall Study|Physician Decision|0|||
125328294|NCT02158546|450835451|FG001|Overall Study|Physician Decision|1|||
125328295|NCT02158546|450835452|FG002|Overall Study|Physician Decision|0|||
125328296|NCT02158546|450835453|FG003|Overall Study|Physician Decision|0|||
125328297|NCT02158546|450835450|FG000|Overall Study|Non-compliance|0|||
125328298|NCT02158546|450835451|FG001|Overall Study|Non-compliance|1|||
125328299|NCT02158546|450835452|FG002|Overall Study|Non-compliance|0|||
125328300|NCT02158546|450835453|FG003|Overall Study|Non-compliance|1|||
125328301|NCT02158546|450835450|FG000|Overall Study|Failure to meet eligibility criteria|0|||
125328302|NCT02158546|450835451|FG001|Overall Study|Failure to meet eligibility criteria|1|||
125328303|NCT02158546|450835452|FG002|Overall Study|Failure to meet eligibility criteria|0|||
125328304|NCT02158546|450835453|FG003|Overall Study|Failure to meet eligibility criteria|0|||
125328305|NCT02158546|450835450|FG000|Overall Study|Lack of Efficacy|1|||
125328306|NCT02158546|450835451|FG001|Overall Study|Lack of Efficacy|1|||
125328307|NCT02158546|450835452|FG002|Overall Study|Lack of Efficacy|0|||
125328308|NCT02158546|450835453|FG003|Overall Study|Lack of Efficacy|0|||
125328309|NCT02158546|450835450|FG000|Overall Study|Adverse Event|2|||
125328310|NCT02158546|450835451|FG001|Overall Study|Adverse Event|2|||
125328311|NCT02158546|450835452|FG002|Overall Study|Adverse Event|0|||
125328312|NCT02158546|450835453|FG003|Overall Study|Adverse Event|0|||
125328313|NCT02158546|450835450|FG000|Overall Study|Withdrawal by Subject|6|||
125328314|NCT02158546|450835451|FG001|Overall Study|Withdrawal by Subject|2|||
125328315|NCT02158546|450835452|FG002|Overall Study|Withdrawal by Subject|1|||
125328316|NCT02158546|450835453|FG003|Overall Study|Withdrawal by Subject|0|||
125328317|NCT02158546|450835450|FG000|Overall Study|Lost to Follow-up|5|||
125328318|NCT02158546|450835451|FG001|Overall Study|Lost to Follow-up|4|||
125328319|NCT02158546|450835452|FG002|Overall Study|Lost to Follow-up|0|||
125328320|NCT02158546|450835453|FG003|Overall Study|Lost to Follow-up|1|||
125328321|NCT02158546|450835450|FG000|Overall Study|Site Excluded|5|||
125328322|NCT02158546|450835451|FG001|Overall Study|Site Excluded|5|||
125328323|NCT02158546|450835452|FG002|Overall Study|Site Excluded|3|||
125328324|NCT02158546|450835453|FG003|Overall Study|Site Excluded|4|||
125328325|NCT02900378|450835454|FG000|Randomization (Visit 2)|Adverse Event|14|||
125328326|NCT02900378|450835455|FG001|Randomization (Visit 2)|Adverse Event|11|||
125328327|NCT02900378|450835454|FG000|Randomization (Visit 2)|Death|1|||
125328328|NCT02900378|450835455|FG001|Randomization (Visit 2)|Death|4|||
125328329|NCT02900378|450835454|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
125328330|NCT02900378|450835455|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
125328331|NCT02900378|450835454|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
125328332|NCT02900378|450835455|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
125328333|NCT02900378|450835454|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
125328334|NCT02900378|450835455|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
125328335|NCT02900378|450835454|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
125328336|NCT02900378|450835455|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
125328337|NCT02900378|450835454|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
125328338|NCT02900378|450835455|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
125328339|NCT02531802|450835457|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
125328340|NCT02531802|450835458|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
125328341|NCT02531802|450835459|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
125328342|NCT02531802|450835460|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
125328343|NCT02531802|450835461|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
125328344|NCT02531802|450835462|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
125328345|NCT02531802|450835463|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
125328346|NCT02531802|450835464|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
125328347|NCT02531802|450835465|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
125328348|NCT02531802|450835466|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
125328349|NCT02531802|450835467|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
125328350|NCT02531802|450835468|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
125328351|NCT02531802|450835469|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
125664216|NCT04380701|452059632|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
125328352|NCT02531802|450835470|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
125328353|NCT02531802|450835471|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
125328354|NCT02531802|450835472|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
125328355|NCT02531802|450835473|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
125328356|NCT02531802|450835474|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
125328357|NCT02531802|450835475|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
125328358|NCT02531802|450835476|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
125328359|NCT02531802|450835477|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
125328360|NCT02531802|450835457|FG000|Received Vaccination 2|Physician Decision|0|||
125328361|NCT02531802|450835458|FG001|Received Vaccination 2|Physician Decision|0|||
125328362|NCT02531802|450835459|FG002|Received Vaccination 2|Physician Decision|0|||
125328363|NCT02531802|450835460|FG003|Received Vaccination 2|Physician Decision|0|||
125328364|NCT02531802|450835461|FG004|Received Vaccination 2|Physician Decision|0|||
125328365|NCT02531802|450835462|FG005|Received Vaccination 2|Physician Decision|1|||
125328366|NCT02531802|450835463|FG006|Received Vaccination 2|Physician Decision|0|||
125328367|NCT02531802|450835464|FG007|Received Vaccination 2|Physician Decision|0|||
125328368|NCT02531802|450835465|FG008|Received Vaccination 2|Physician Decision|0|||
125328369|NCT02531802|450835466|FG009|Received Vaccination 2|Physician Decision|2|||
125328370|NCT02531802|450835467|FG010|Received Vaccination 2|Physician Decision|0|||
125328371|NCT02531802|450835468|FG011|Received Vaccination 2|Physician Decision|0|||
125328372|NCT02531802|450835469|FG012|Received Vaccination 2|Physician Decision|0|||
125328373|NCT02531802|450835470|FG013|Received Vaccination 2|Physician Decision|1|||
125328374|NCT02531802|450835471|FG014|Received Vaccination 2|Physician Decision|0|||
125328375|NCT02531802|450835472|FG015|Received Vaccination 2|Physician Decision|0|||
125328376|NCT02531802|450835473|FG016|Received Vaccination 2|Physician Decision|0|||
125328377|NCT02531802|450835474|FG017|Received Vaccination 2|Physician Decision|1|||
125328378|NCT02531802|450835475|FG018|Received Vaccination 2|Physician Decision|0|||
125328379|NCT02531802|450835476|FG019|Received Vaccination 2|Physician Decision|0|||
125328380|NCT02531802|450835477|FG020|Received Vaccination 2|Physician Decision|0|||
125328381|NCT02531802|450835457|FG000|Received Vaccination 2|Adverse Event|0|||
125328382|NCT02531802|450835458|FG001|Received Vaccination 2|Adverse Event|0|||
125328383|NCT02531802|450835459|FG002|Received Vaccination 2|Adverse Event|0|||
125328384|NCT02531802|450835460|FG003|Received Vaccination 2|Adverse Event|0|||
125328385|NCT02531802|450835461|FG004|Received Vaccination 2|Adverse Event|0|||
125328386|NCT02531802|450835462|FG005|Received Vaccination 2|Adverse Event|2|||
125328387|NCT02531802|450835463|FG006|Received Vaccination 2|Adverse Event|0|||
125328388|NCT02531802|450835464|FG007|Received Vaccination 2|Adverse Event|0|||
125328389|NCT02531802|450835465|FG008|Received Vaccination 2|Adverse Event|0|||
125328390|NCT02531802|450835466|FG009|Received Vaccination 2|Adverse Event|0|||
125328391|NCT02531802|450835467|FG010|Received Vaccination 2|Adverse Event|0|||
125328392|NCT02531802|450835468|FG011|Received Vaccination 2|Adverse Event|0|||
125328393|NCT02531802|450835469|FG012|Received Vaccination 2|Adverse Event|0|||
125328394|NCT02531802|450835470|FG013|Received Vaccination 2|Adverse Event|0|||
125328395|NCT02531802|450835471|FG014|Received Vaccination 2|Adverse Event|0|||
125328396|NCT02531802|450835472|FG015|Received Vaccination 2|Adverse Event|0|||
125328397|NCT02531802|450835473|FG016|Received Vaccination 2|Adverse Event|0|||
125328398|NCT02531802|450835474|FG017|Received Vaccination 2|Adverse Event|2|||
125328399|NCT02531802|450835475|FG018|Received Vaccination 2|Adverse Event|1|||
125328400|NCT02531802|450835476|FG019|Received Vaccination 2|Adverse Event|0|||
125328401|NCT02531802|450835477|FG020|Received Vaccination 2|Adverse Event|1|||
125328402|NCT02531802|450835457|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
125328403|NCT02531802|450835458|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
125328404|NCT02531802|450835459|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
125328405|NCT02531802|450835460|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
125328406|NCT02531802|450835461|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
125328407|NCT02531802|450835462|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
125328408|NCT02531802|450835463|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
125328409|NCT02531802|450835464|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
125328410|NCT02531802|450835465|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
125328411|NCT02531802|450835466|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
125664217|NCT04380701|452059633|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
125664218|NCT04380701|452059634|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
125664219|NCT04380701|452059635|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
125664220|NCT04380701|452059636|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
125328412|NCT02531802|450835467|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
125328413|NCT02531802|450835468|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
125328414|NCT02531802|450835469|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
125328415|NCT02531802|450835470|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
125328416|NCT02531802|450835471|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
125328417|NCT02531802|450835472|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
125425602|NCT01735201|451182281|FG002|Overall Study|Protocol Violation|0|||
125664221|NCT04380701|452059637|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
125664222|NCT04380701|452059638|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
125664223|NCT04380701|452059639|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
125664224|NCT04380701|452059640|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
125664225|NCT04380701|452059641|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
125664226|NCT04380701|452059642|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
125664227|NCT04380701|452059643|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
125664228|NCT04380701|452059644|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
125664229|NCT04380701|452059645|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
125664230|NCT04380701|452059646|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
125664231|NCT04380701|452059647|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
125664232|NCT04380701|452059648|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
125664233|NCT04380701|452059649|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
125664234|NCT04380701|452059650|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
125664235|NCT04380701|452059651|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
125664236|NCT04380701|452059652|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
125664237|NCT04380701|452059653|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
125664238|NCT04380701|452059654|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
125664239|NCT04380701|452059655|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
125664240|NCT04380701|452059656|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
125664241|NCT04380701|452059657|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
125664242|NCT04380701|452059658|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
125664243|NCT04380701|452059659|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
125664244|NCT04380701|452059660|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
125664245|NCT04380701|452059661|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
125664246|NCT04380701|452059662|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
125664247|NCT04380701|452059663|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
125664248|NCT04380701|452059664|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
125664249|NCT04380701|452059665|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
125664250|NCT04380701|452059632|FG000|Overall Study|Physician Decision|0|||
125664251|NCT04380701|452059633|FG001|Overall Study|Physician Decision|0|||
125664252|NCT04380701|452059634|FG002|Overall Study|Physician Decision|0|||
125664253|NCT04380701|452059635|FG003|Overall Study|Physician Decision|0|||
125664254|NCT04380701|452059636|FG004|Overall Study|Physician Decision|0|||
125664255|NCT04380701|452059637|FG005|Overall Study|Physician Decision|0|||
125664256|NCT04380701|452059638|FG006|Overall Study|Physician Decision|0|||
125664257|NCT04380701|452059639|FG007|Overall Study|Physician Decision|0|||
125664258|NCT04380701|452059640|FG008|Overall Study|Physician Decision|0|||
125664259|NCT04380701|452059641|FG009|Overall Study|Physician Decision|0|||
125664260|NCT04380701|452059642|FG010|Overall Study|Physician Decision|0|||
125664261|NCT04380701|452059643|FG011|Overall Study|Physician Decision|0|||
125664262|NCT04380701|452059644|FG012|Overall Study|Physician Decision|0|||
125664263|NCT04380701|452059645|FG013|Overall Study|Physician Decision|0|||
125664264|NCT04380701|452059646|FG014|Overall Study|Physician Decision|0|||
125664265|NCT04380701|452059647|FG015|Overall Study|Physician Decision|0|||
125664266|NCT04380701|452059648|FG016|Overall Study|Physician Decision|0|||
125664267|NCT04380701|452059649|FG017|Overall Study|Physician Decision|0|||
125664268|NCT04380701|452059650|FG018|Overall Study|Physician Decision|0|||
125664269|NCT04380701|452059651|FG019|Overall Study|Physician Decision|0|||
125328418|NCT02531802|450835473|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
125328419|NCT02531802|450835474|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
125328420|NCT02531802|450835475|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
125328421|NCT02531802|450835476|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
125328422|NCT02531802|450835477|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
125328423|NCT01249261|450835483|FG000|Overall Study|Withdrawal by Subject|1|||
125328424|NCT01249261|450835484|FG001|Overall Study|Withdrawal by Subject|0|||
125328425|NCT02819804|450835485|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
125328426|NCT00482053|450835489|FG000|Inter-treatment Period|Disease progression|1|||
125328427|NCT00346697|450835492|FG000|Overall Study|Lost to Follow-up|0|||
125328428|NCT00346697|450835493|FG001|Overall Study|Lost to Follow-up|1|||
125328429|NCT01055197|450835495|FG000|Overall Study|Protocol Violation|7|||
125328430|NCT01055197|450835496|FG001|Overall Study|Protocol Violation|2|||
125328431|NCT01055197|450835495|FG000|Overall Study|Withdrawal by Subject|2|||
125328432|NCT01055197|450835496|FG001|Overall Study|Withdrawal by Subject|0|||
125328433|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
125328434|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
125664270|NCT04380701|452059652|FG020|Overall Study|Physician Decision|0|||
125664271|NCT04380701|452059653|FG021|Overall Study|Physician Decision|0|||
125664272|NCT04380701|452059654|FG022|Overall Study|Physician Decision|0|||
125664273|NCT04380701|452059655|FG023|Overall Study|Physician Decision|0|||
125664274|NCT04380701|452059656|FG024|Overall Study|Physician Decision|2|||
125664275|NCT04380701|452059657|FG025|Overall Study|Physician Decision|0|||
125664276|NCT04380701|452059658|FG026|Overall Study|Physician Decision|0|||
125328435|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
125664277|NCT04380701|452059659|FG027|Overall Study|Physician Decision|0|||
125328436|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
125328437|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125328438|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
125328439|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
125328440|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
125328441|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
125328442|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
125328443|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
125328444|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
125328445|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
125328446|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
125328447|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
125328448|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
125328449|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
125328450|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
125328451|NCT03739203|450835497|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
125328452|NCT03739203|450835498|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
125328453|NCT03739203|450835499|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
125328454|NCT03739203|450835497|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
125328455|NCT03739203|450835498|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
125328456|NCT03739203|450835499|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
125328457|NCT03739203|450835497|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
125328458|NCT03739203|450835498|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
125328459|NCT03739203|450835499|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
125328460|NCT03739203|450835497|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
125328461|NCT03739203|450835498|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
125328462|NCT03739203|450835499|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
125328463|NCT03739203|450835497|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
125328464|NCT03739203|450835498|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
125328465|NCT03739203|450835499|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
125328466|NCT03131570|450835500|FG000|Overall Study|Adverse Event|1|||
125328467|NCT03131570|450835501|FG001|Overall Study|Adverse Event|0|||
125328468|NCT01782378|450835502|FG000|First Series|Lost to Follow-up|7|||
125328469|NCT01782378|450835503|FG001|First Series|Lost to Follow-up|8|||
125328470|NCT01782378|450835502|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
125664278|NCT04380701|452059660|FG028|Overall Study|Physician Decision|0|||
125664279|NCT04380701|452059661|FG029|Overall Study|Physician Decision|0|||
125664280|NCT04380701|452059662|FG030|Overall Study|Physician Decision|0|||
125664281|NCT04380701|452059663|FG031|Overall Study|Physician Decision|0|||
125664282|NCT04380701|452059664|FG032|Overall Study|Physician Decision|0|||
125664283|NCT04380701|452059665|FG033|Overall Study|Physician Decision|0|||
125664284|NCT04380701|452059632|FG000|Overall Study|Death|0|||
125664285|NCT04380701|452059633|FG001|Overall Study|Death|0|||
125664286|NCT04380701|452059634|FG002|Overall Study|Death|0|||
125664287|NCT04380701|452059635|FG003|Overall Study|Death|0|||
125664288|NCT04380701|452059636|FG004|Overall Study|Death|0|||
125664289|NCT04380701|452059637|FG005|Overall Study|Death|0|||
125664290|NCT04380701|452059638|FG006|Overall Study|Death|0|||
125664291|NCT04380701|452059639|FG007|Overall Study|Death|0|||
125664292|NCT04380701|452059640|FG008|Overall Study|Death|0|||
125664293|NCT04380701|452059641|FG009|Overall Study|Death|0|||
125664294|NCT04380701|452059642|FG010|Overall Study|Death|0|||
125664295|NCT04380701|452059643|FG011|Overall Study|Death|0|||
125664296|NCT04380701|452059644|FG012|Overall Study|Death|0|||
125664297|NCT04380701|452059645|FG013|Overall Study|Death|0|||
125664298|NCT04380701|452059646|FG014|Overall Study|Death|0|||
125664299|NCT04380701|452059647|FG015|Overall Study|Death|0|||
125664300|NCT04380701|452059648|FG016|Overall Study|Death|0|||
125664301|NCT04380701|452059649|FG017|Overall Study|Death|0|||
125664302|NCT04380701|452059650|FG018|Overall Study|Death|0|||
125664303|NCT04380701|452059651|FG019|Overall Study|Death|0|||
125664304|NCT04380701|452059652|FG020|Overall Study|Death|0|||
125664305|NCT04380701|452059653|FG021|Overall Study|Death|0|||
125664306|NCT04380701|452059654|FG022|Overall Study|Death|0|||
125664307|NCT04380701|452059655|FG023|Overall Study|Death|0|||
125664308|NCT04380701|452059656|FG024|Overall Study|Death|1|||
125664309|NCT04380701|452059657|FG025|Overall Study|Death|0|||
125664310|NCT04380701|452059658|FG026|Overall Study|Death|0|||
125664311|NCT04380701|452059659|FG027|Overall Study|Death|0|||
125664312|NCT04380701|452059660|FG028|Overall Study|Death|0|||
125664313|NCT04380701|452059661|FG029|Overall Study|Death|0|||
125664314|NCT04380701|452059662|FG030|Overall Study|Death|0|||
125664315|NCT04380701|452059663|FG031|Overall Study|Death|0|||
125664316|NCT04380701|452059664|FG032|Overall Study|Death|0|||
125664317|NCT04380701|452059665|FG033|Overall Study|Death|0|||
125664318|NCT04380701|452059632|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125328471|NCT01782378|450835503|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
125328472|NCT01782378|450835502|FG000|Second Series|Lost to Follow-up|8|||
125328473|NCT01782378|450835503|FG001|Second Series|Lost to Follow-up|7|||
125328474|NCT01782378|450835502|FG000|Second Series|Did not choose to complete S2 Optional|18|||
125664319|NCT04380701|452059633|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664320|NCT04380701|452059634|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664321|NCT04380701|452059635|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664322|NCT04380701|452059636|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664323|NCT04380701|452059637|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664324|NCT04380701|452059638|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664325|NCT04380701|452059639|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664326|NCT04380701|452059640|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664327|NCT04380701|452059641|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664328|NCT04380701|452059642|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664329|NCT04380701|452059643|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664330|NCT04380701|452059644|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664331|NCT04380701|452059645|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664332|NCT04380701|452059646|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664333|NCT04380701|452059647|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664334|NCT04380701|452059648|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664335|NCT04380701|452059649|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664336|NCT04380701|452059650|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664337|NCT04380701|452059651|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664338|NCT04380701|452059652|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664339|NCT04380701|452059653|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
125664340|NCT04380701|452059654|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
125664341|NCT04380701|452059655|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
125664342|NCT04380701|452059656|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
125664343|NCT04380701|452059657|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664344|NCT04380701|452059658|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125328475|NCT01782378|450835503|FG001|Second Series|Did not choose to complete S2 Optional|0|||
125328476|NCT00830440|450835504|FG000|Overall Study|Protocol Violation|1|||
125328477|NCT00830440|450835505|FG001|Overall Study|Protocol Violation|0|||
125328478|NCT00830440|450835504|FG000|Overall Study|Withdrawal by Subject|1|||
125328479|NCT00830440|450835505|FG001|Overall Study|Withdrawal by Subject|0|||
125328480|NCT00830440|450835504|FG000|Overall Study|unsuccessful procedure|4|||
125328481|NCT00830440|450835505|FG001|Overall Study|unsuccessful procedure|0|||
125328482|NCT00830440|450835504|FG000|Overall Study|Adverse Event|2|||
125328483|NCT00830440|450835505|FG001|Overall Study|Adverse Event|0|||
125328484|NCT00391586|450835508|FG000|Overall Study|Progressive disease|13|||
125328485|NCT00391586|450835508|FG000|Overall Study|Adverse Event|5|||
125328486|NCT00391586|450835508|FG000|Overall Study|Physician Decision|2|||
125328487|NCT00391586|450835508|FG000|Overall Study|Death|4|||
125328488|NCT00904982|450835509|FG000|Overall Study|Withdrawal by Subject|2|||
125328489|NCT00904982|450835510|FG001|Overall Study|Withdrawal by Subject|0|||
125328490|NCT00904982|450835511|FG002|Overall Study|Withdrawal by Subject|0|||
125328491|NCT00904982|450835512|FG003|Overall Study|Withdrawal by Subject|0|||
125328492|NCT02420821|450835517|FG000|Overall Study|Lost to Follow-up|6|||
125328493|NCT02420821|450835518|FG001|Overall Study|Lost to Follow-up|6|||
125328494|NCT02420821|450835517|FG000|Overall Study|Non-compliance|0|||
125328495|NCT02420821|450835518|FG001|Overall Study|Non-compliance|2|||
125328496|NCT02420821|450835517|FG000|Overall Study|Physician Decision|6|||
125328497|NCT02420821|450835518|FG001|Overall Study|Physician Decision|2|||
125328498|NCT02420821|450835517|FG000|Overall Study|Withdrawal by Subject|32|||
125328499|NCT02420821|450835518|FG001|Overall Study|Withdrawal by Subject|25|||
125328500|NCT02420821|450835517|FG000|Overall Study|Death|270|||
125328501|NCT02420821|450835518|FG001|Overall Study|Death|263|||
125328502|NCT02420821|450835517|FG000|Overall Study|Study Terminated By Sponsor|145|||
125328503|NCT02420821|450835518|FG001|Overall Study|Study Terminated By Sponsor|149|||
125328504|NCT02420821|450835517|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
125328505|NCT02420821|450835518|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
125328506|NCT02420821|450835517|FG000|Overall Study|Adverse Event|0|||
125328507|NCT02420821|450835518|FG001|Overall Study|Adverse Event|1|||
125664345|NCT04380701|452059659|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125328508|NCT02420821|450835517|FG000|Overall Study|Protinuria|0|||
125328509|NCT02420821|450835518|FG001|Overall Study|Protinuria|1|||
125328510|NCT02420821|450835517|FG000|Overall Study|Progressive Disease|1|||
125328511|NCT02420821|450835518|FG001|Overall Study|Progressive Disease|1|||
125328512|NCT02420821|450835517|FG000|Overall Study|Disease Progression|0|||
125328513|NCT02420821|450835518|FG001|Overall Study|Disease Progression|1|||
125328514|NCT02420821|450835517|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
125328515|NCT02420821|450835518|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
125328516|NCT00686712|450835519|FG000|Overall Study|Protocol Violation|8|||
125328517|NCT00686712|450835520|FG001|Overall Study|Protocol Violation|8|||
125328518|NCT00686712|450835521|FG002|Overall Study|Protocol Violation|10|||
125328519|NCT00686712|450835519|FG000|Overall Study|Lost to Follow-up|1|||
125328520|NCT00686712|450835520|FG001|Overall Study|Lost to Follow-up|2|||
125328521|NCT00686712|450835521|FG002|Overall Study|Lost to Follow-up|3|||
125328522|NCT00686712|450835519|FG000|Overall Study|Adverse Event|1|||
125328523|NCT00686712|450835520|FG001|Overall Study|Adverse Event|1|||
125664346|NCT04380701|452059660|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664347|NCT04380701|452059661|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664348|NCT04380701|452059662|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664349|NCT04380701|452059663|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664350|NCT04380701|452059664|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664351|NCT04380701|452059665|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
125664352|NCT00363129|452059666|FG000|Overall Study|Withdrawal by Subject|11|||
125664353|NCT00363129|452059667|FG001|Overall Study|Withdrawal by Subject|18|||
125664354|NCT00363129|452059666|FG000|Overall Study|Adverse Event|8|||
125664355|NCT00363129|452059667|FG001|Overall Study|Adverse Event|3|||
125664356|NCT00363129|452059666|FG000|Overall Study|Alternate Treatment|2|||
125664357|NCT00363129|452059667|FG001|Overall Study|Alternate Treatment|4|||
125664358|NCT00363129|452059666|FG000|Overall Study|Other Medical Problems|2|||
125664359|NCT00363129|452059667|FG001|Overall Study|Other Medical Problems|4|||
125664360|NCT00363129|452059666|FG000|Overall Study|Death|0|||
125664361|NCT00363129|452059667|FG001|Overall Study|Death|1|||
125664362|NCT00363129|452059666|FG000|Overall Study|Other Reasons|6|||
125664363|NCT00363129|452059667|FG001|Overall Study|Other Reasons|3|||
125664364|NCT03296553|452059668|FG000|Overall Study|Withdrawal by Subject|1|||
125328524|NCT00686712|450835521|FG002|Overall Study|Adverse Event|0|||
125328525|NCT03058146|450835522|FG000|Overall Study|Withdrawal by Subject|4|||
125328526|NCT03058146|450835523|FG001|Overall Study|Withdrawal by Subject|1|||
125328527|NCT03058146|450835522|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
125328528|NCT03058146|450835523|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
125328529|NCT01352793|450835526|FG000|Overall Study|Lost to Follow-up|289|||
125328530|NCT01352793|450835527|FG001|Overall Study|Lost to Follow-up|125|||
125328531|NCT01352793|450835526|FG000|Overall Study|Withdrawal by Subject|120|||
125328532|NCT01352793|450835527|FG001|Overall Study|Withdrawal by Subject|55|||
125328533|NCT01352793|450835526|FG000|Overall Study|Protocol Violation|44|||
125328534|NCT01352793|450835527|FG001|Overall Study|Protocol Violation|23|||
125328535|NCT01352793|450835526|FG000|Overall Study|Adverse Event|44|||
125328536|NCT01352793|450835527|FG001|Overall Study|Adverse Event|10|||
125328537|NCT01352793|450835526|FG000|Overall Study|Physician Decision|1|||
125328538|NCT01352793|450835527|FG001|Overall Study|Physician Decision|0|||
125328539|NCT01352793|450835526|FG000|Overall Study|Pregnancy|26|||
125328540|NCT01352793|450835527|FG001|Overall Study|Pregnancy|8|||
125328541|NCT01352793|450835526|FG000|Overall Study|Other|25|||
125328542|NCT01352793|450835527|FG001|Overall Study|Other|7|||
125328543|NCT01352793|450835526|FG000|Overall Study|Medication error|2|||
125328544|NCT01352793|450835527|FG001|Overall Study|Medication error|2|||
125328545|NCT01352793|450835526|FG000|Overall Study|Death|1|||
125328546|NCT01352793|450835527|FG001|Overall Study|Death|0|||
125328547|NCT01352793|450835526|FG000|Overall Study|Randomized but not vaccinated|8|||
125328548|NCT01352793|450835527|FG001|Overall Study|Randomized but not vaccinated|0|||
125328549|NCT01352793|450835526|FG000|Overall Study|No longer meets eligibility criteria|25|||
125328550|NCT01352793|450835527|FG001|Overall Study|No longer meets eligibility criteria|15|||
125328551|NCT02839200|450835530|FG000|Overall Study|Withdrawal by Subject|2|||
125328552|NCT02839200|450835531|FG001|Overall Study|Withdrawal by Subject|0|||
125664365|NCT03296553|452059669|FG001|Overall Study|Withdrawal by Subject|1|||
125664366|NCT03296553|452059668|FG000|Overall Study|Death|1|||
125664367|NCT03296553|452059669|FG001|Overall Study|Death|0|||
125664368|NCT02713243|452059670|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
125664369|NCT02713243|452059671|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
125664370|NCT02713243|452059670|FG000|Overall Study|Administrative problems|0|||
125328553|NCT02839200|450835532|FG002|Overall Study|Withdrawal by Subject|1|||
125328554|NCT02839200|450835533|FG003|Overall Study|Withdrawal by Subject|0|||
125328555|NCT02839200|450835534|FG004|Overall Study|Withdrawal by Subject|0|||
125328556|NCT02839200|450835535|FG005|Overall Study|Withdrawal by Subject|1|||
125664371|NCT02713243|452059671|FG001|Overall Study|Administrative problems|1|||
125664372|NCT02713243|452059670|FG000|Overall Study|Protocol deviation|0|||
125664373|NCT02713243|452059671|FG001|Overall Study|Protocol deviation|1|||
125328557|NCT02839200|450835530|FG000|Overall Study|Lost to Follow-up|2|||
125328558|NCT02839200|450835531|FG001|Overall Study|Lost to Follow-up|0|||
125328559|NCT02839200|450835532|FG002|Overall Study|Lost to Follow-up|0|||
125328560|NCT02839200|450835533|FG003|Overall Study|Lost to Follow-up|0|||
125664374|NCT01619085|452059672|FG000|Overall Study|Adverse Event|231|||
125664375|NCT01619085|452059672|FG000|Overall Study|Protocol Violation|4|||
125664376|NCT01619085|452059672|FG000|Overall Study|Lost to Follow-up|3|||
125664377|NCT01619085|452059672|FG000|Overall Study|Withdrawal by Subject|45|||
125664378|NCT01619085|452059672|FG000|Overall Study|Other than specified|96|||
125664379|NCT01619085|452059672|FG000|Overall Study|Not treated|1|||
125328561|NCT02839200|450835534|FG004|Overall Study|Lost to Follow-up|1|||
125328562|NCT02839200|450835535|FG005|Overall Study|Lost to Follow-up|0|||
125664380|NCT01619085|452059672|FG000|Overall Study|Death|145|||
125664381|NCT03125915|452059677|FG000|1 Month Follow up|Lost to Follow-up|3|||
125664382|NCT03125915|452059678|FG001|1 Month Follow up|Lost to Follow-up|3|||
125664383|NCT03125915|452059679|FG002|1 Month Follow up|Lost to Follow-up|2|||
125664384|NCT03125915|452059680|FG003|1 Month Follow up|Lost to Follow-up|3|||
125328563|NCT02839200|450835530|FG000|Overall Study|Adverse Event|0|||
125328564|NCT02839200|450835531|FG001|Overall Study|Adverse Event|0|||
125328565|NCT02839200|450835532|FG002|Overall Study|Adverse Event|0|||
125328566|NCT02839200|450835533|FG003|Overall Study|Adverse Event|0|||
125328567|NCT02839200|450835534|FG004|Overall Study|Adverse Event|1|||
125328568|NCT02839200|450835535|FG005|Overall Study|Adverse Event|0|||
125328569|NCT02839200|450835530|FG000|Overall Study|Randomized in error|0|||
125328570|NCT02839200|450835531|FG001|Overall Study|Randomized in error|1|||
125328571|NCT02839200|450835532|FG002|Overall Study|Randomized in error|0|||
125328572|NCT02839200|450835533|FG003|Overall Study|Randomized in error|0|||
125328573|NCT02839200|450835534|FG004|Overall Study|Randomized in error|0|||
125328574|NCT02839200|450835535|FG005|Overall Study|Randomized in error|0|||
125328575|NCT01094119|450835538|FG000|Overall Study|Lack of Efficacy|2|||
125328576|NCT01094119|450835539|FG001|Overall Study|Lack of Efficacy|4|||
125328577|NCT02205736|450835542|FG000|Overall Study|Lost to Follow-up|106|||
125328578|NCT03326713|450835543|FG000|Overall Study|Death|2|||
125328579|NCT03326713|450835544|FG001|Overall Study|Death|1|||
125328580|NCT03326713|450835545|FG002|Overall Study|Death|0|||
125328581|NCT03326713|450835543|FG000|Overall Study|Lost to Follow-up|20|||
125328582|NCT03326713|450835544|FG001|Overall Study|Lost to Follow-up|21|||
125328583|NCT03326713|450835545|FG002|Overall Study|Lost to Follow-up|33|||
125328584|NCT03326713|450835543|FG000|Overall Study|Withdrawal by Subject|1|||
125328585|NCT03326713|450835544|FG001|Overall Study|Withdrawal by Subject|2|||
125328586|NCT03326713|450835545|FG002|Overall Study|Withdrawal by Subject|11|||
125328587|NCT03326713|450835543|FG000|Overall Study|Found Ineligible|11|||
125328588|NCT03326713|450835544|FG001|Overall Study|Found Ineligible|11|||
125328589|NCT03326713|450835545|FG002|Overall Study|Found Ineligible|8|||
125328590|NCT06078124|450835551|FG000|Overall Study|Lost to Follow-up|14|||
125328591|NCT06078124|450835552|FG001|Overall Study|Lost to Follow-up|14|||
125328592|NCT01198977|450835553|FG000|Overall Study|Lost to Follow-up|1|||
125328593|NCT01198977|450835554|FG001|Overall Study|Lost to Follow-up|0|||
125328594|NCT01285557|450835555|FG000|Overall Study|Death|173|||
125328595|NCT01285557|450835556|FG001|Overall Study|Death|90|||
125328596|NCT01285557|450835555|FG000|Overall Study|Lost to Follow-up|6|||
125328597|NCT01285557|450835556|FG001|Overall Study|Lost to Follow-up|2|||
125328598|NCT01285557|450835555|FG000|Overall Study|Withdrew Consent|6|||
125328599|NCT01285557|450835556|FG001|Overall Study|Withdrew Consent|1|||
125664385|NCT03125915|452059677|FG000|3 Month Follow-up|Lost to Follow-up|6|||
125664386|NCT03125915|452059678|FG001|3 Month Follow-up|Lost to Follow-up|4|||
125664387|NCT03125915|452059679|FG002|3 Month Follow-up|Lost to Follow-up|4|||
125664388|NCT03125915|452059680|FG003|3 Month Follow-up|Lost to Follow-up|2|||
125664389|NCT03125915|452059677|FG000|6 Month Follow-up|Lost to Follow-up|7|||
125664390|NCT03125915|452059678|FG001|6 Month Follow-up|Lost to Follow-up|3|||
125664391|NCT03125915|452059679|FG002|6 Month Follow-up|Lost to Follow-up|6|||
125664392|NCT03125915|452059680|FG003|6 Month Follow-up|Lost to Follow-up|3|||
125664393|NCT01458119|452059681|FG000|Overall Study|Physician Decision|4|||
125664394|NCT01458119|452059681|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
125664395|NCT01458119|452059681|FG000|Overall Study|Pregnancy|1|||
125664396|NCT01458119|452059681|FG000|Overall Study|Death|2|||
125664397|NCT01458119|452059681|FG000|Overall Study|Adverse Event|1|||
125328600|NCT01285557|450835555|FG000|Overall Study|Sponsor Study Termination|23|||
125328601|NCT01285557|450835556|FG001|Overall Study|Sponsor Study Termination|13|||
125328602|NCT01285557|450835555|FG000|Overall Study|Randomized but not treated|1|||
125328603|NCT01285557|450835556|FG001|Overall Study|Randomized but not treated|1|||
125328604|NCT01285557|450835555|FG000|Overall Study|Study follow-up ongoing|28|||
125328605|NCT01285557|450835556|FG001|Overall Study|Study follow-up ongoing|14|||
125664398|NCT01458119|452059681|FG000|Overall Study|Consent Withdrawn by Participant|8|||
125664399|NCT01458119|452059681|FG000|Overall Study|Non-compliance With Study Drug|3|||
125664400|NCT00435825|452059682|FG000|Overall Study|Abnormality of Laboratory Test|0|||
125328606|NCT01285557|450835555|FG000|Overall Study|Sponsor Decision|2|||
125664401|NCT00435825|452059683|FG001|Overall Study|Abnormality of Laboratory Test|1|||
125328607|NCT01285557|450835556|FG001|Overall Study|Sponsor Decision|1|||
125328608|NCT05615922|450835558|FG000|Overall Study|Lost to Follow-up|1|||
125328609|NCT03173248|450835562|FG000|Overall Study|Death|28|||
125328610|NCT03173248|450835563|FG001|Overall Study|Death|46|||
125328611|NCT03173248|450835562|FG000|Overall Study|Lost to Follow-up|0|||
125328612|NCT03173248|450835563|FG001|Overall Study|Lost to Follow-up|1|||
125328613|NCT03173248|450835562|FG000|Overall Study|Withdrawal by Subject|6|||
125328614|NCT03173248|450835563|FG001|Overall Study|Withdrawal by Subject|4|||
125328615|NCT03173248|450835562|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
125328616|NCT03173248|450835563|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
125328617|NCT01648751|450835566|FG000|Overall Study|Withdrawal by Subject|2|||
125328618|NCT01648751|450835567|FG001|Overall Study|Withdrawal by Subject|3|||
125328619|NCT02991768|450835571|FG000|Overall Study|Physician Decision|4|||
125328620|NCT03467750|450835572|FG000|Overall Study|Surgery canceled|1|||
125328621|NCT03467750|450835573|FG001|Overall Study|Surgery canceled|0|||
125328622|NCT03467750|450835572|FG000|Overall Study|Protocol Violation|1|||
125328623|NCT03467750|450835573|FG001|Overall Study|Protocol Violation|1|||
125328624|NCT03467750|450835572|FG000|Overall Study|Withdrawal by Subject|0|||
125328625|NCT03467750|450835573|FG001|Overall Study|Withdrawal by Subject|1|||
125328626|NCT05673876|450835574|FG000|Overall Study|Death|3|||
125328627|NCT05673876|450835575|FG001|Overall Study|Death|1|||
125328628|NCT05673876|450835574|FG000|Overall Study|Study Terminated by Sponsor|0|||
125328629|NCT05673876|450835575|FG001|Overall Study|Study Terminated by Sponsor|1|||
125328630|NCT05673876|450835574|FG000|Overall Study|Physician Decision|0|||
125328631|NCT05673876|450835575|FG001|Overall Study|Physician Decision|1|||
125328632|NCT04500158|450835578|FG000|Overall Study|Physician Decision|17|||
125328633|NCT04500158|450835579|FG001|Overall Study|Physician Decision|11|||
125328634|NCT02749422|450835582|FG000|Overall Study|Lost to Follow-up|0|||
125328635|NCT02749422|450835583|FG001|Overall Study|Lost to Follow-up|2|||
125328636|NCT02749422|450835582|FG000|Overall Study|Ineligible|0|||
125328637|NCT02749422|450835583|FG001|Overall Study|Ineligible|1|||
125328638|NCT04988477|450835589|FG000|Overall Study|Death|1|||
125328639|NCT04988477|450835590|FG001|Overall Study|Death|0|||
125328640|NCT04988477|450835591|FG002|Overall Study|Death|0|||
125328641|NCT04988477|450835589|FG000|Overall Study|Lost to Follow-up|5|||
125328642|NCT04988477|450835590|FG001|Overall Study|Lost to Follow-up|2|||
125328643|NCT04988477|450835591|FG002|Overall Study|Lost to Follow-up|0|||
125328644|NCT04988477|450835589|FG000|Overall Study|Withdrawal by Subject|2|||
125328645|NCT04988477|450835590|FG001|Overall Study|Withdrawal by Subject|0|||
125328646|NCT04988477|450835591|FG002|Overall Study|Withdrawal by Subject|0|||
125328647|NCT04610281|450837267|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
125328648|NCT04610281|450837268|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
125328649|NCT01458392|450837270|FG000|Overall Study|Death|2|||
125328650|NCT01458392|450837271|FG001|Overall Study|Death|11|||
125328651|NCT01458392|450837272|FG002|Overall Study|Death|22|||
125328652|NCT01458392|450837270|FG000|Overall Study|At the discretion of the sponsor|0|||
125328653|NCT01458392|450837271|FG001|Overall Study|At the discretion of the sponsor|2|||
125328654|NCT01458392|450837272|FG002|Overall Study|At the discretion of the sponsor|7|||
125328655|NCT01458392|450837270|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
125328656|NCT01458392|450837271|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
125328657|NCT01458392|450837272|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
125328658|NCT00753506|450837275|FG000|Overall Study|Withdrawal by Subject|4|||
125328659|NCT00753506|450837276|FG001|Overall Study|Withdrawal by Subject|1|||
125328660|NCT00753506|450837275|FG000|Overall Study|Lost to Follow-up|2|||
125328661|NCT00753506|450837276|FG001|Overall Study|Lost to Follow-up|0|||
125328662|NCT00753506|450837275|FG000|Overall Study|Other reason|1|||
125328663|NCT00753506|450837276|FG001|Overall Study|Other reason|1|||
125328664|NCT03557034|450837285|FG000|Overall Study|Withdrawal by Subject|1|||
125328665|NCT03557034|450837286|FG001|Overall Study|Withdrawal by Subject|0|||
125328666|NCT00790842|450837288|FG000|Dose Level 1|Adverse Event|1|||
125328667|NCT00790842|450837289|FG001|Dose Level 1|Adverse Event|0|||
125328668|NCT00790842|450837290|FG002|Dose Level 1|Adverse Event|0|||
125328669|NCT00790842|450837291|FG003|Dose Level 1|Adverse Event|2|||
125328670|NCT00790842|450837292|FG004|Dose Level 1|Adverse Event|0|||
125328671|NCT00790842|450837293|FG005|Dose Level 1|Adverse Event|0|||
125328672|NCT00790842|450837294|FG006|Dose Level 1|Adverse Event|0|||
125328673|NCT00790842|450837295|FG007|Dose Level 1|Adverse Event|1|||
125328674|NCT00790842|450837296|FG008|Dose Level 1|Adverse Event|0|||
125328675|NCT00790842|450837297|FG009|Dose Level 1|Adverse Event|0|||
125328676|NCT00790842|450837298|FG010|Dose Level 1|Adverse Event|0|||
125328677|NCT00790842|450837288|FG000|Dose Level 1|Physician Decision|1|||
125328678|NCT00790842|450837289|FG001|Dose Level 1|Physician Decision|0|||
125328679|NCT00790842|450837290|FG002|Dose Level 1|Physician Decision|0|||
125328680|NCT00790842|450837291|FG003|Dose Level 1|Physician Decision|0|||
125328681|NCT00790842|450837292|FG004|Dose Level 1|Physician Decision|0|||
125328682|NCT00790842|450837293|FG005|Dose Level 1|Physician Decision|0|||
125328683|NCT00790842|450837294|FG006|Dose Level 1|Physician Decision|0|||
125328684|NCT00790842|450837295|FG007|Dose Level 1|Physician Decision|1|||
125328685|NCT00790842|450837296|FG008|Dose Level 1|Physician Decision|0|||
125328686|NCT00790842|450837297|FG009|Dose Level 1|Physician Decision|0|||
125328687|NCT00790842|450837298|FG010|Dose Level 1|Physician Decision|0|||
125328688|NCT00790842|450837288|FG000|Dose Level 1|Withdrawal by Subject|1|||
125328689|NCT00790842|450837289|FG001|Dose Level 1|Withdrawal by Subject|0|||
125664402|NCT00435825|452059684|FG002|Overall Study|Abnormality of Laboratory Test|0|||
125664403|NCT00435825|452059685|FG003|Overall Study|Abnormality of Laboratory Test|0|||
125664404|NCT00435825|452059682|FG000|Overall Study|Insufficient Therapeutic Response|3|||
125664405|NCT00435825|452059683|FG001|Overall Study|Insufficient Therapeutic Response|1|||
125664406|NCT00435825|452059684|FG002|Overall Study|Insufficient Therapeutic Response|0|||
125328690|NCT00790842|450837290|FG002|Dose Level 1|Withdrawal by Subject|0|||
125328691|NCT00790842|450837291|FG003|Dose Level 1|Withdrawal by Subject|0|||
125328692|NCT00790842|450837292|FG004|Dose Level 1|Withdrawal by Subject|0|||
125328693|NCT00790842|450837293|FG005|Dose Level 1|Withdrawal by Subject|0|||
125328694|NCT00790842|450837294|FG006|Dose Level 1|Withdrawal by Subject|0|||
125328695|NCT00790842|450837295|FG007|Dose Level 1|Withdrawal by Subject|0|||
125328696|NCT00790842|450837296|FG008|Dose Level 1|Withdrawal by Subject|0|||
125328697|NCT00790842|450837297|FG009|Dose Level 1|Withdrawal by Subject|0|||
125328698|NCT00790842|450837298|FG010|Dose Level 1|Withdrawal by Subject|0|||
125328699|NCT00790842|450837288|FG000|Dose Level 2|Death|0|||
125328700|NCT00790842|450837289|FG001|Dose Level 2|Death|1|||
125328701|NCT00790842|450837290|FG002|Dose Level 2|Death|0|||
125328702|NCT00790842|450837291|FG003|Dose Level 2|Death|0|||
125328703|NCT00790842|450837292|FG004|Dose Level 2|Death|1|||
125328704|NCT00790842|450837293|FG005|Dose Level 2|Death|0|||
125328705|NCT00790842|450837294|FG006|Dose Level 2|Death|0|||
125328706|NCT00790842|450837295|FG007|Dose Level 2|Death|0|||
125328707|NCT00790842|450837296|FG008|Dose Level 2|Death|0|||
125328708|NCT00790842|450837297|FG009|Dose Level 2|Death|0|||
125328709|NCT00790842|450837298|FG010|Dose Level 2|Death|0|||
125328710|NCT00790842|450837288|FG000|Dose Level 2|Physician Decision|0|||
125328711|NCT00790842|450837289|FG001|Dose Level 2|Physician Decision|1|||
125328712|NCT00790842|450837290|FG002|Dose Level 2|Physician Decision|0|||
125328713|NCT00790842|450837291|FG003|Dose Level 2|Physician Decision|0|||
125328714|NCT00790842|450837292|FG004|Dose Level 2|Physician Decision|0|||
125328715|NCT00790842|450837293|FG005|Dose Level 2|Physician Decision|0|||
125328716|NCT00790842|450837294|FG006|Dose Level 2|Physician Decision|0|||
125328717|NCT00790842|450837295|FG007|Dose Level 2|Physician Decision|0|||
125328718|NCT00790842|450837296|FG008|Dose Level 2|Physician Decision|0|||
125328719|NCT00790842|450837297|FG009|Dose Level 2|Physician Decision|0|||
125328720|NCT00790842|450837298|FG010|Dose Level 2|Physician Decision|0|||
125328721|NCT00790842|450837288|FG000|Dose Level 2|Withdrawal by Subject|0|||
125328722|NCT00790842|450837289|FG001|Dose Level 2|Withdrawal by Subject|1|||
125328723|NCT00790842|450837290|FG002|Dose Level 2|Withdrawal by Subject|0|||
125328724|NCT00790842|450837291|FG003|Dose Level 2|Withdrawal by Subject|0|||
125328725|NCT00790842|450837292|FG004|Dose Level 2|Withdrawal by Subject|0|||
125328726|NCT00790842|450837293|FG005|Dose Level 2|Withdrawal by Subject|0|||
125328727|NCT00790842|450837294|FG006|Dose Level 2|Withdrawal by Subject|0|||
125328728|NCT00790842|450837295|FG007|Dose Level 2|Withdrawal by Subject|0|||
125328729|NCT00790842|450837296|FG008|Dose Level 2|Withdrawal by Subject|0|||
125328730|NCT00790842|450837297|FG009|Dose Level 2|Withdrawal by Subject|0|||
125328731|NCT00790842|450837298|FG010|Dose Level 2|Withdrawal by Subject|0|||
125328732|NCT00790842|450837288|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328733|NCT00790842|450837289|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328734|NCT00790842|450837290|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328735|NCT00790842|450837291|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328736|NCT00790842|450837292|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328737|NCT00790842|450837293|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328738|NCT00790842|450837294|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328739|NCT00790842|450837295|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328740|NCT00790842|450837296|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
125328741|NCT00790842|450837297|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328742|NCT00790842|450837298|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
125328743|NCT00790842|450837288|FG000|Dose Level 3|Adverse Event|0|||
125328744|NCT00790842|450837289|FG001|Dose Level 3|Adverse Event|0|||
125328745|NCT00790842|450837290|FG002|Dose Level 3|Adverse Event|1|||
125328746|NCT00790842|450837291|FG003|Dose Level 3|Adverse Event|0|||
125328747|NCT00790842|450837292|FG004|Dose Level 3|Adverse Event|0|||
125328748|NCT00790842|450837293|FG005|Dose Level 3|Adverse Event|0|||
125328749|NCT00790842|450837294|FG006|Dose Level 3|Adverse Event|0|||
125328750|NCT00790842|450837295|FG007|Dose Level 3|Adverse Event|0|||
125328751|NCT00790842|450837296|FG008|Dose Level 3|Adverse Event|0|||
125328752|NCT00790842|450837297|FG009|Dose Level 3|Adverse Event|0|||
125328753|NCT00790842|450837298|FG010|Dose Level 3|Adverse Event|0|||
125328754|NCT00790842|450837288|FG000|Dose Level 3|Withdrawal by Subject|0|||
125328755|NCT00790842|450837289|FG001|Dose Level 3|Withdrawal by Subject|0|||
125328756|NCT00790842|450837290|FG002|Dose Level 3|Withdrawal by Subject|3|||
125328757|NCT00790842|450837291|FG003|Dose Level 3|Withdrawal by Subject|0|||
125328758|NCT00790842|450837292|FG004|Dose Level 3|Withdrawal by Subject|0|||
125328759|NCT00790842|450837293|FG005|Dose Level 3|Withdrawal by Subject|0|||
125328760|NCT00790842|450837294|FG006|Dose Level 3|Withdrawal by Subject|0|||
125328761|NCT00790842|450837295|FG007|Dose Level 3|Withdrawal by Subject|0|||
125328762|NCT00790842|450837296|FG008|Dose Level 3|Withdrawal by Subject|0|||
125328763|NCT00790842|450837297|FG009|Dose Level 3|Withdrawal by Subject|2|||
125328764|NCT00790842|450837298|FG010|Dose Level 3|Withdrawal by Subject|0|||
125328765|NCT00790842|450837288|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328766|NCT00790842|450837289|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328767|NCT00790842|450837290|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328768|NCT00790842|450837291|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328769|NCT00790842|450837292|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328770|NCT00790842|450837293|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
125328771|NCT00790842|450837294|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328772|NCT00790842|450837295|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328773|NCT00790842|450837296|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328774|NCT00790842|450837297|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328775|NCT00790842|450837298|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
125328776|NCT00790842|450837288|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328777|NCT00790842|450837289|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328778|NCT00790842|450837290|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
125328779|NCT00790842|450837291|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328780|NCT00790842|450837292|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328781|NCT00790842|450837293|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328782|NCT00790842|450837294|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328783|NCT00790842|450837295|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328784|NCT00790842|450837296|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328785|NCT00790842|450837297|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328786|NCT00790842|450837298|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
125328787|NCT00790842|450837288|FG000|Dose Level 4|Adverse Event|0|||
125328788|NCT00790842|450837289|FG001|Dose Level 4|Adverse Event|0|||
125328789|NCT00790842|450837290|FG002|Dose Level 4|Adverse Event|0|||
125328790|NCT00790842|450837291|FG003|Dose Level 4|Adverse Event|0|||
125328791|NCT00790842|450837292|FG004|Dose Level 4|Adverse Event|0|||
125328792|NCT00790842|450837293|FG005|Dose Level 4|Adverse Event|0|||
125328793|NCT00790842|450837294|FG006|Dose Level 4|Adverse Event|1|||
125328794|NCT00790842|450837295|FG007|Dose Level 4|Adverse Event|0|||
125328795|NCT00790842|450837296|FG008|Dose Level 4|Adverse Event|0|||
125328796|NCT00790842|450837297|FG009|Dose Level 4|Adverse Event|0|||
125328797|NCT00790842|450837298|FG010|Dose Level 4|Adverse Event|0|||
125328798|NCT00790842|450837288|FG000|Dose Level 4|Physician Decision|0|||
125328799|NCT00790842|450837289|FG001|Dose Level 4|Physician Decision|0|||
125328800|NCT00790842|450837290|FG002|Dose Level 4|Physician Decision|0|||
125328801|NCT00790842|450837291|FG003|Dose Level 4|Physician Decision|0|||
125328802|NCT00790842|450837292|FG004|Dose Level 4|Physician Decision|0|||
125328803|NCT00790842|450837293|FG005|Dose Level 4|Physician Decision|0|||
125328804|NCT00790842|450837294|FG006|Dose Level 4|Physician Decision|1|||
125328805|NCT00790842|450837295|FG007|Dose Level 4|Physician Decision|0|||
125328806|NCT00790842|450837296|FG008|Dose Level 4|Physician Decision|0|||
125328807|NCT00790842|450837297|FG009|Dose Level 4|Physician Decision|0|||
125328808|NCT00790842|450837298|FG010|Dose Level 4|Physician Decision|1|||
125328809|NCT00790842|450837288|FG000|Dose Level 4|Withdrawal by Subject|0|||
125328810|NCT00790842|450837289|FG001|Dose Level 4|Withdrawal by Subject|0|||
125328811|NCT00790842|450837290|FG002|Dose Level 4|Withdrawal by Subject|0|||
125328812|NCT00790842|450837291|FG003|Dose Level 4|Withdrawal by Subject|0|||
125328813|NCT00790842|450837292|FG004|Dose Level 4|Withdrawal by Subject|0|||
125328814|NCT00790842|450837293|FG005|Dose Level 4|Withdrawal by Subject|0|||
125328815|NCT00790842|450837294|FG006|Dose Level 4|Withdrawal by Subject|0|||
125328816|NCT00790842|450837295|FG007|Dose Level 4|Withdrawal by Subject|0|||
125328817|NCT00790842|450837296|FG008|Dose Level 4|Withdrawal by Subject|0|||
125328818|NCT00790842|450837297|FG009|Dose Level 4|Withdrawal by Subject|0|||
125328819|NCT00790842|450837298|FG010|Dose Level 4|Withdrawal by Subject|1|||
125328820|NCT00790842|450837288|FG000|Expansion Cohort|Adverse Event|0|||
125328821|NCT00790842|450837289|FG001|Expansion Cohort|Adverse Event|0|||
125328822|NCT00790842|450837290|FG002|Expansion Cohort|Adverse Event|0|||
125328823|NCT00790842|450837291|FG003|Expansion Cohort|Adverse Event|0|||
125328824|NCT00790842|450837292|FG004|Expansion Cohort|Adverse Event|0|||
125328825|NCT00790842|450837293|FG005|Expansion Cohort|Adverse Event|0|||
125328826|NCT00790842|450837294|FG006|Expansion Cohort|Adverse Event|1|||
125328827|NCT00790842|450837295|FG007|Expansion Cohort|Adverse Event|0|||
125328828|NCT00790842|450837296|FG008|Expansion Cohort|Adverse Event|0|||
125328829|NCT00790842|450837297|FG009|Expansion Cohort|Adverse Event|0|||
125328830|NCT00790842|450837298|FG010|Expansion Cohort|Adverse Event|0|||
125328831|NCT00790842|450837288|FG000|Expansion Cohort|Death|0|||
125328832|NCT00790842|450837289|FG001|Expansion Cohort|Death|0|||
125328833|NCT00790842|450837290|FG002|Expansion Cohort|Death|2|||
125328834|NCT00790842|450837291|FG003|Expansion Cohort|Death|0|||
125328835|NCT00790842|450837292|FG004|Expansion Cohort|Death|0|||
125328836|NCT00790842|450837293|FG005|Expansion Cohort|Death|0|||
125328837|NCT00790842|450837294|FG006|Expansion Cohort|Death|0|||
125664407|NCT00435825|452059685|FG003|Overall Study|Insufficient Therapeutic Response|3|||
125664408|NCT00435825|452059682|FG000|Overall Study|Other Protocol Violation|1|||
125664409|NCT00435825|452059683|FG001|Overall Study|Other Protocol Violation|0|||
125664410|NCT00435825|452059684|FG002|Overall Study|Other Protocol Violation|0|||
125664411|NCT00435825|452059685|FG003|Overall Study|Other Protocol Violation|0|||
125664412|NCT00435825|452059682|FG000|Overall Study|Refused treatment|2|||
125664413|NCT00435825|452059683|FG001|Overall Study|Refused treatment|0|||
125664414|NCT00435825|452059684|FG002|Overall Study|Refused treatment|0|||
125664415|NCT00435825|452059685|FG003|Overall Study|Refused treatment|5|||
125664416|NCT00435825|452059682|FG000|Overall Study|Failure to return|5|||
125664417|NCT00435825|452059683|FG001|Overall Study|Failure to return|0|||
125328838|NCT00790842|450837295|FG007|Expansion Cohort|Death|0|||
125328839|NCT00790842|450837296|FG008|Expansion Cohort|Death|0|||
125328840|NCT00790842|450837297|FG009|Expansion Cohort|Death|0|||
125328841|NCT00790842|450837298|FG010|Expansion Cohort|Death|0|||
125328842|NCT00790842|450837288|FG000|Expansion Cohort|Physician Decision|0|||
125328843|NCT00790842|450837289|FG001|Expansion Cohort|Physician Decision|0|||
125328844|NCT00790842|450837290|FG002|Expansion Cohort|Physician Decision|1|||
125328845|NCT00790842|450837291|FG003|Expansion Cohort|Physician Decision|0|||
125328846|NCT00790842|450837292|FG004|Expansion Cohort|Physician Decision|0|||
125328847|NCT00790842|450837293|FG005|Expansion Cohort|Physician Decision|0|||
125328848|NCT00790842|450837294|FG006|Expansion Cohort|Physician Decision|0|||
125328849|NCT00790842|450837295|FG007|Expansion Cohort|Physician Decision|0|||
125328850|NCT00790842|450837296|FG008|Expansion Cohort|Physician Decision|0|||
125328851|NCT00790842|450837297|FG009|Expansion Cohort|Physician Decision|0|||
125328852|NCT00790842|450837298|FG010|Expansion Cohort|Physician Decision|0|||
125328853|NCT00790842|450837288|FG000|Expansion Cohort|Withdrawal by Subject|0|||
125328854|NCT00790842|450837289|FG001|Expansion Cohort|Withdrawal by Subject|0|||
125328855|NCT00790842|450837290|FG002|Expansion Cohort|Withdrawal by Subject|3|||
125328856|NCT00790842|450837291|FG003|Expansion Cohort|Withdrawal by Subject|0|||
125328857|NCT00790842|450837292|FG004|Expansion Cohort|Withdrawal by Subject|0|||
125328858|NCT00790842|450837293|FG005|Expansion Cohort|Withdrawal by Subject|0|||
125328859|NCT00790842|450837294|FG006|Expansion Cohort|Withdrawal by Subject|0|||
125328860|NCT00790842|450837295|FG007|Expansion Cohort|Withdrawal by Subject|0|||
125328861|NCT00790842|450837296|FG008|Expansion Cohort|Withdrawal by Subject|0|||
125328862|NCT00790842|450837297|FG009|Expansion Cohort|Withdrawal by Subject|0|||
125328863|NCT00790842|450837298|FG010|Expansion Cohort|Withdrawal by Subject|0|||
125328864|NCT00790842|450837288|FG000|Expansion Cohort|Study Closure|0|||
125328865|NCT00790842|450837289|FG001|Expansion Cohort|Study Closure|0|||
125328866|NCT00790842|450837290|FG002|Expansion Cohort|Study Closure|1|||
125328867|NCT00790842|450837291|FG003|Expansion Cohort|Study Closure|0|||
125328868|NCT00790842|450837292|FG004|Expansion Cohort|Study Closure|0|||
125328869|NCT00790842|450837293|FG005|Expansion Cohort|Study Closure|0|||
125328870|NCT00790842|450837294|FG006|Expansion Cohort|Study Closure|0|||
125328871|NCT00790842|450837295|FG007|Expansion Cohort|Study Closure|0|||
125328872|NCT00790842|450837296|FG008|Expansion Cohort|Study Closure|0|||
125328873|NCT00790842|450837297|FG009|Expansion Cohort|Study Closure|0|||
125328874|NCT00790842|450837298|FG010|Expansion Cohort|Study Closure|0|||
125328875|NCT03809104|450837299|FG000|Overall Study|Withdrawal by Subject|3|||
125328876|NCT00885170|450837310|FG000|Overall Study|Adverse Event|12|||
125328877|NCT00885170|450837311|FG001|Overall Study|Adverse Event|4|||
125328878|NCT00885170|450837310|FG000|Overall Study|Excessive bone loss|6|||
125328879|NCT00885170|450837311|FG001|Overall Study|Excessive bone loss|3|||
125328880|NCT00885170|450837310|FG000|Overall Study|Lost to Follow-up|2|||
125328881|NCT00885170|450837311|FG001|Overall Study|Lost to Follow-up|1|||
125328882|NCT00885170|450837310|FG000|Overall Study|Physician Decision|2|||
125328883|NCT00885170|450837311|FG001|Overall Study|Physician Decision|1|||
125328884|NCT00885170|450837310|FG000|Overall Study|Protocol Violation|3|||
125328885|NCT00885170|450837311|FG001|Overall Study|Protocol Violation|1|||
125328886|NCT00885170|450837310|FG000|Overall Study|Withdrawal by Subject|13|||
125664418|NCT00435825|452059684|FG002|Overall Study|Failure to return|4|||
125328887|NCT00885170|450837311|FG001|Overall Study|Withdrawal by Subject|13|||
125328888|NCT00561925|450837312|FG000|14 Day Lead-In Period|Adverse Event|38|||
125328889|NCT00561925|450837313|FG001|14 Day Lead-In Period|Adverse Event|0|||
125328890|NCT00561925|450837314|FG002|14 Day Lead-In Period|Adverse Event|0|||
125328891|NCT00561925|450837315|FG003|14 Day Lead-In Period|Adverse Event|0|||
125328892|NCT00561925|450837316|FG004|14 Day Lead-In Period|Adverse Event|0|||
125328893|NCT00561925|450837312|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
125328894|NCT00561925|450837313|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
125328895|NCT00561925|450837314|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
125328896|NCT00561925|450837315|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
125328897|NCT00561925|450837316|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
125328898|NCT00561925|450837312|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
125328899|NCT00561925|450837313|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
125328900|NCT00561925|450837314|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
125328901|NCT00561925|450837315|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
125328902|NCT00561925|450837316|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
125664419|NCT00435825|452059685|FG003|Overall Study|Failure to return|0|||
125664420|NCT00435825|452059682|FG000|Overall Study|Did not receive study drug|1|||
125664421|NCT00435825|452059683|FG001|Overall Study|Did not receive study drug|0|||
125664422|NCT00435825|452059684|FG002|Overall Study|Did not receive study drug|2|||
125664423|NCT00435825|452059685|FG003|Overall Study|Did not receive study drug|0|||
125664424|NCT00435825|452059682|FG000|Overall Study|Did not enter follow-up|0|||
125664425|NCT00435825|452059683|FG001|Overall Study|Did not enter follow-up|4|||
125664426|NCT00435825|452059684|FG002|Overall Study|Did not enter follow-up|1|||
125664427|NCT00435825|452059685|FG003|Overall Study|Did not enter follow-up|3|||
125664428|NCT00435825|452059682|FG000|Overall Study|Did not complete full follow-up period|6|||
125664429|NCT00435825|452059683|FG001|Overall Study|Did not complete full follow-up period|6|||
125664430|NCT00435825|452059684|FG002|Overall Study|Did not complete full follow-up period|4|||
125664431|NCT00435825|452059685|FG003|Overall Study|Did not complete full follow-up period|5|||
125664432|NCT01123980|452059688|FG000|Overall Study|Adverse Event|1|||
125664433|NCT01123980|452059689|FG001|Overall Study|Adverse Event|1|||
125664434|NCT01123980|452059688|FG000|Overall Study|Lack of Efficacy|1|||
125664435|NCT01123980|452059689|FG001|Overall Study|Lack of Efficacy|0|||
125664436|NCT01123980|452059688|FG000|Overall Study|Physician Decision|0|||
125664437|NCT01123980|452059689|FG001|Overall Study|Physician Decision|1|||
125664438|NCT01123980|452059688|FG000|Overall Study|Lost to Follow-up|0|||
125664439|NCT01123980|452059689|FG001|Overall Study|Lost to Follow-up|6|||
125664440|NCT01123980|452059688|FG000|Overall Study|Protocol Violation|6|||
125664441|NCT01123980|452059689|FG001|Overall Study|Protocol Violation|6|||
125664442|NCT01123980|452059688|FG000|Overall Study|Withdrawal by Subject|5|||
125664443|NCT01123980|452059689|FG001|Overall Study|Withdrawal by Subject|3|||
125664444|NCT01123980|452059688|FG000|Overall Study|Unclassified|6|||
125664445|NCT01123980|452059689|FG001|Overall Study|Unclassified|7|||
125664446|NCT01225991|452059690|FG000|Overall Study|Withdrawal by Subject|6|||
125664447|NCT00789828|452059691|FG000|Core Period (48 Weeks)|Administrative problems|0|||
125664448|NCT00789828|452059692|FG001|Core Period (48 Weeks)|Administrative problems|1|||
125664449|NCT00789828|452059691|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
125664450|NCT00789828|452059692|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
125664451|NCT00789828|452059691|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
125664452|NCT00789828|452059692|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
125664453|NCT00789828|452059691|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
125664454|NCT00789828|452059692|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
125664455|NCT00789828|452059691|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
125664456|NCT00789828|452059692|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
125664457|NCT00789828|452059691|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
125664458|NCT00789828|452059692|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
125664459|NCT00789828|452059691|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
125664460|NCT00789828|452059692|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
125664461|NCT00789828|452059691|FG000|Open-label Extension Period (4 Years)|Death|1|||
125664462|NCT00789828|452059692|FG001|Open-label Extension Period (4 Years)|Death|0|||
125664463|NCT00789828|452059691|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
125664464|NCT00789828|452059692|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
125328903|NCT00561925|450837312|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
125328904|NCT00561925|450837313|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
125664465|NCT00789828|452059691|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
125664466|NCT00789828|452059692|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
125664467|NCT02094937|452059693|FG000|8 Weeks in Period 1|Adverse Event|9|||
125664468|NCT02094937|452059694|FG001|8 Weeks in Period 1|Adverse Event|0|||
125664469|NCT02094937|452059695|FG002|8 Weeks in Period 1|Adverse Event|0|||
125328905|NCT00561925|450837314|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
125328906|NCT00561925|450837315|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
125328907|NCT00561925|450837316|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
125328908|NCT00561925|450837312|FG000|14 Day Lead-In Period|Other|5|||
125328909|NCT00561925|450837313|FG001|14 Day Lead-In Period|Other|0|||
125328910|NCT00561925|450837314|FG002|14 Day Lead-In Period|Other|0|||
125328911|NCT00561925|450837315|FG003|14 Day Lead-In Period|Other|0|||
125328912|NCT00561925|450837316|FG004|14 Day Lead-In Period|Other|0|||
125328913|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
125328914|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
125328915|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
125328916|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
125328917|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
125328918|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
125664470|NCT02094937|452059696|FG003|8 Weeks in Period 1|Adverse Event|0|||
125664471|NCT02094937|452059693|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
125664472|NCT02094937|452059694|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
125664473|NCT02094937|452059695|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
125328919|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
125328920|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
125328921|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
125328922|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
125328923|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
125328924|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
125328925|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
125328926|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
125328927|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
125328928|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
125328929|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
125328930|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
125328931|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
125328932|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
125328933|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
125328934|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
125328935|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
125328936|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
125328937|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
125328938|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
125328939|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
125328940|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
125328941|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
125328942|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
125328943|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Death|0|||
125328944|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Death|6|||
125328945|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Death|3|||
125328946|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Death|0|||
125328947|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Death|0|||
125328948|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
125328949|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
125328950|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
125328951|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
125328952|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
125328953|NCT00561925|450837312|FG000|144-week Double-blind, Double-dummy|Other|0|||
125328954|NCT00561925|450837313|FG001|144-week Double-blind, Double-dummy|Other|8|||
125328955|NCT00561925|450837314|FG002|144-week Double-blind, Double-dummy|Other|11|||
125328956|NCT00561925|450837315|FG003|144-week Double-blind, Double-dummy|Other|0|||
125328957|NCT00561925|450837316|FG004|144-week Double-blind, Double-dummy|Other|0|||
125328958|NCT00561925|450837312|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
125328959|NCT00561925|450837313|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
125328960|NCT00561925|450837314|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
125328961|NCT00561925|450837315|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
125328962|NCT00561925|450837316|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
125328963|NCT00724698|450837317|FG000|Overall Study|Adverse Event|9|||
125328964|NCT00724698|450837317|FG000|Overall Study|Failure of Therapy|4|||
125328965|NCT00724698|450837317|FG000|Overall Study|Poor Compliance|16|||
125328966|NCT00724698|450837317|FG000|Overall Study|Lost to Follow-up|36|||
125328967|NCT00724698|450837317|FG000|Overall Study|No Info|25|||
125328968|NCT05021978|450837318|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
125328969|NCT05021978|450837319|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
125328970|NCT05021978|450837320|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
125328971|NCT05021978|450837321|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
125328972|NCT05021978|450837318|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
125328973|NCT05021978|450837319|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
125328974|NCT05021978|450837320|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
125328975|NCT05021978|450837321|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
125328976|NCT02177032|450837324|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
125328977|NCT02177032|450837325|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
125328978|NCT02177032|450837326|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
125328979|NCT02177032|450837327|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
125328980|NCT02177032|450837324|FG000|Overall Study|Lost to Follow-up|0|||
125328981|NCT02177032|450837325|FG001|Overall Study|Lost to Follow-up|2|||
125328982|NCT02177032|450837326|FG002|Overall Study|Lost to Follow-up|0|||
125328983|NCT02177032|450837327|FG003|Overall Study|Lost to Follow-up|0|||
125328984|NCT02177032|450837324|FG000|Overall Study|OTHER|2|||
125328985|NCT02177032|450837325|FG001|Overall Study|OTHER|0|||
125328986|NCT02177032|450837326|FG002|Overall Study|OTHER|1|||
125328987|NCT02177032|450837327|FG003|Overall Study|OTHER|0|||
125328988|NCT02177032|450837324|FG000|Overall Study|Withdrawal by Subject|1|||
125328989|NCT02177032|450837325|FG001|Overall Study|Withdrawal by Subject|0|||
125328990|NCT02177032|450837326|FG002|Overall Study|Withdrawal by Subject|1|||
125664474|NCT02094937|452059696|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
125664475|NCT02094937|452059693|FG000|8 Weeks in Period 1|Protocol Violation|2|||
125664476|NCT02094937|452059694|FG001|8 Weeks in Period 1|Protocol Violation|0|||
125664477|NCT02094937|452059695|FG002|8 Weeks in Period 1|Protocol Violation|0|||
125664478|NCT02094937|452059696|FG003|8 Weeks in Period 1|Protocol Violation|0|||
125664479|NCT02094937|452059693|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
125664480|NCT02094937|452059694|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
125664481|NCT02094937|452059695|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
125664482|NCT02094937|452059696|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
125664483|NCT02094937|452059693|FG000|8 Weeks in Period 1|Physician Decision|1|||
125664484|NCT02094937|452059694|FG001|8 Weeks in Period 1|Physician Decision|0|||
125664485|NCT02094937|452059695|FG002|8 Weeks in Period 1|Physician Decision|0|||
125664486|NCT02094937|452059696|FG003|8 Weeks in Period 1|Physician Decision|0|||
125664487|NCT02094937|452059693|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
125664488|NCT02094937|452059694|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
125664489|NCT02094937|452059695|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
125664490|NCT02094937|452059696|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
125664491|NCT02094937|452059693|FG000|12 Weeks in Period 2|Adverse Event|0|||
125664492|NCT02094937|452059694|FG001|12 Weeks in Period 2|Adverse Event|2|||
125664493|NCT02094937|452059695|FG002|12 Weeks in Period 2|Adverse Event|4|||
125664494|NCT02094937|452059696|FG003|12 Weeks in Period 2|Adverse Event|1|||
125664495|NCT02094937|452059693|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
125664496|NCT02094937|452059694|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
125664497|NCT02094937|452059695|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
125664498|NCT02094937|452059696|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
125664499|NCT02094937|452059693|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
125664500|NCT02094937|452059694|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
125664501|NCT02094937|452059695|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
125664502|NCT02094937|452059696|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
125664503|NCT02094937|452059693|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
125664504|NCT02094937|452059694|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
125664505|NCT02094937|452059695|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
125664506|NCT02094937|452059696|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
125664507|NCT02094937|452059693|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
125664508|NCT02094937|452059694|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
125664509|NCT02094937|452059695|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
125664510|NCT02094937|452059696|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
125664511|NCT01133392|452059697|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
125664512|NCT01133392|452059698|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
125664513|NCT01133392|452059697|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
125664514|NCT01133392|452059698|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
125664515|NCT05788237|452059699|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
125664516|NCT05788237|452059700|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
125664517|NCT05788237|452059701|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
125664518|NCT05788237|452059702|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
125664519|NCT05788237|452059699|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
125664520|NCT05788237|452059700|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
125664521|NCT05788237|452059701|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
125664522|NCT05788237|452059702|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
125664523|NCT05788237|452059699|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
125664524|NCT05788237|452059700|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
125664525|NCT05788237|452059701|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
125664526|NCT05788237|452059702|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
125664527|NCT05788237|452059699|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
125664528|NCT05788237|452059700|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
125664529|NCT05788237|452059701|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
125664530|NCT05788237|452059702|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
125664531|NCT05788237|452059699|FG000|SSA (Approximately 2 Months)|Death|0|||
125664532|NCT05788237|452059700|FG001|SSA (Approximately 2 Months)|Death|1|||
125664533|NCT05788237|452059701|FG002|SSA (Approximately 2 Months)|Death|0|||
125664534|NCT05788237|452059702|FG003|SSA (Approximately 2 Months)|Death|0|||
125664535|NCT05788237|452059699|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
125664536|NCT05788237|452059700|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
125664537|NCT05788237|452059701|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
125664538|NCT05788237|452059702|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
125664539|NCT05788237|452059699|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
125664540|NCT05788237|452059700|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
125664541|NCT05788237|452059701|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
125664542|NCT05788237|452059702|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
125664543|NCT05788237|452059699|FG000|SSB (Approximately 1 Month)|Other|0|||
125328991|NCT02177032|450837327|FG003|Overall Study|Withdrawal by Subject|0|||
125328992|NCT00665652|450837328|FG000|Overall Study|Adverse Event|4|||
125328993|NCT00665652|450837328|FG000|Overall Study|Death|1|||
125328994|NCT00665652|450837328|FG000|Overall Study|No longer met inclusion criteria.|1|||
125328995|NCT02556177|450837332|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
125328996|NCT02556177|450837333|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
125328997|NCT00734539|450837343|FG000|Main Study|Death|33|||
125328998|NCT00734539|450837344|FG001|Main Study|Death|32|||
125328999|NCT00734539|450837343|FG000|Main Study|Physician Decision|2|||
125329000|NCT00734539|450837344|FG001|Main Study|Physician Decision|0|||
125329001|NCT00734539|450837343|FG000|Main Study|Withdrawal by Subject|1|||
125664544|NCT05788237|452059700|FG001|SSB (Approximately 1 Month)|Other|0|||
125664545|NCT05788237|452059701|FG002|SSB (Approximately 1 Month)|Other|0|||
125664546|NCT05788237|452059702|FG003|SSB (Approximately 1 Month)|Other|1|||
125664547|NCT00207714|452060886|FG000|Overall Study|Adverse Event|6|||
125664548|NCT00207714|452060887|FG001|Overall Study|Adverse Event|2|||
125664549|NCT00207714|452060888|FG002|Overall Study|Adverse Event|4|||
125664550|NCT00207714|452060889|FG003|Overall Study|Adverse Event|3|||
125664551|NCT00207714|452060890|FG004|Overall Study|Adverse Event|1|||
125664552|NCT00207714|452060886|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
125664553|NCT00207714|452060887|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125664554|NCT00207714|452060888|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
125664555|NCT00207714|452060889|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
125664556|NCT00207714|452060890|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
125664557|NCT00207714|452060886|FG000|Overall Study|Other|3|||
125664558|NCT00207714|452060887|FG001|Overall Study|Other|2|||
125664559|NCT00207714|452060888|FG002|Overall Study|Other|5|||
125664560|NCT00207714|452060889|FG003|Overall Study|Other|1|||
125664561|NCT00207714|452060890|FG004|Overall Study|Other|0|||
125664562|NCT03627195|452060891|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
125664563|NCT03627195|452060892|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
125664564|NCT03627195|452060893|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
125664565|NCT03627195|452060894|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
125664566|NCT03627195|452060895|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
125664567|NCT03627195|452060896|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
125664568|NCT00833547|452060901|FG000|Overall Study|Withdrawal by Subject|2|||
125664569|NCT00833547|452060902|FG001|Overall Study|Withdrawal by Subject|2|||
125664570|NCT00686790|452060905|FG000|Overall Study|Adverse Event|2|||
125664571|NCT00686790|452060905|FG000|Overall Study|Withdrawal by Subject|1|||
125664572|NCT00686790|452060905|FG000|Overall Study|Death|1|||
125664573|NCT00686790|452060905|FG000|Overall Study|Lost to Follow-up|12|||
125664574|NCT02082912|452060909|FG000|Overall Study|Physician Decision|0|||
125664575|NCT02082912|452060910|FG001|Overall Study|Physician Decision|1|||
125664576|NCT00697112|452060927|FG000|Overall Study|Adverse Event|8|||
125664577|NCT00697112|452060927|FG000|Overall Study|Lost to Follow-up|1|||
125664578|NCT00697112|452060927|FG000|Overall Study|Did not meet inclusion criteria|1|||
125664579|NCT00736333|452060928|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
125664580|NCT00736333|452060928|FG000|Overall Study|Data Missing|2|||
125664581|NCT00736333|452060928|FG000|Overall Study|Tumor Progression|75|||
125664582|NCT00736333|452060928|FG000|Overall Study|Toxicity|6|||
125664583|NCT00736333|452060928|FG000|Overall Study|Withdrawal by Subject|10|||
125664584|NCT00736333|452060928|FG000|Overall Study|Death|7|||
125664585|NCT00736333|452060928|FG000|Overall Study|Other|4|||
125664586|NCT04126733|452060929|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
125664587|NCT04126733|452060929|FG000|Treatment Period|Adverse Event|8|||
125664588|NCT04126733|452060929|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
125664589|NCT04126733|452060929|FG000|Treatment Period|Physician Decision|5|||
125664590|NCT04126733|452060929|FG000|Treatment Period|Death|1|||
125664591|NCT04126733|452060929|FG000|Treatment Period|Other Reasons|2|||
125664592|NCT04126733|452060929|FG000|Active Follow-up Period|Death|13|||
125664593|NCT04126733|452060929|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
125664594|NCT04126733|452060929|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
125664595|NCT04126733|452060929|FG000|Active Follow-up Period|Other Reasons|1|||
125329002|NCT00734539|450837344|FG001|Main Study|Withdrawal by Subject|3|||
125329003|NCT00734539|450837343|FG000|Main Study|Enrolled in error; ineligible|1|||
125329004|NCT00734539|450837344|FG001|Main Study|Enrolled in error; ineligible|0|||
125664596|NCT04126733|452060929|FG000|Long-term Follow-up Period|Death|22|||
125664597|NCT04126733|452060929|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
125664598|NCT04126733|452060929|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
125664599|NCT02629133|452060931|FG000|Overall Study|Lost to Follow-up|3|||
125664600|NCT02629133|452060932|FG001|Overall Study|Lost to Follow-up|1|||
125664601|NCT02629133|452060931|FG000|Overall Study|Withdrawal by Subject|1|||
125664602|NCT02629133|452060932|FG001|Overall Study|Withdrawal by Subject|1|||
125664603|NCT03216954|452060933|FG000|Overall Study|Adverse Event|0|||
125664604|NCT03216954|452060934|FG001|Overall Study|Adverse Event|0|||
125664605|NCT03216954|452060935|FG002|Overall Study|Adverse Event|1|||
125664606|NCT03216954|452060936|FG003|Overall Study|Adverse Event|0|||
125664607|NCT03216954|452060937|FG004|Overall Study|Adverse Event|1|||
125664608|NCT03216954|452060933|FG000|Overall Study|Withdrawal by Subject|2|||
125664609|NCT03216954|452060934|FG001|Overall Study|Withdrawal by Subject|0|||
125664610|NCT03216954|452060935|FG002|Overall Study|Withdrawal by Subject|0|||
125664611|NCT03216954|452060936|FG003|Overall Study|Withdrawal by Subject|0|||
125664612|NCT03216954|452060937|FG004|Overall Study|Withdrawal by Subject|0|||
125664613|NCT03216954|452060933|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
125664614|NCT03216954|452060934|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
125664615|NCT03216954|452060935|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
125664616|NCT03216954|452060936|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
125664617|NCT03216954|452060937|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
125664618|NCT02598193|452060938|FG000|Overall Study|Adverse Event|13|||
125664619|NCT02598193|452060938|FG000|Overall Study|Withdrawal by Subject|1|||
125664620|NCT02598193|452060938|FG000|Overall Study|Listed in active lung transplant list|1|||
125664621|NCT02598193|452060938|FG000|Overall Study|Does not want to take Nintedanib|1|||
125664622|NCT02354976|452060944|FG000|Overall Study|Other - reason not specified|1|||
125664623|NCT02354976|452060945|FG001|Overall Study|Other - reason not specified|0|||
125664624|NCT02354976|452060946|FG002|Overall Study|Other - reason not specified|1|||
125664625|NCT02354976|452060944|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
125664626|NCT02354976|452060945|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
125664627|NCT02354976|452060946|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
125664628|NCT02354976|452060944|FG000|Overall Study|Adverse Event|1|||
125664629|NCT02354976|452060945|FG001|Overall Study|Adverse Event|0|||
125664630|NCT02354976|452060946|FG002|Overall Study|Adverse Event|2|||
125664631|NCT00986154|452060947|FG000|Overall Study|Death|136|||
125664632|NCT00986154|452060948|FG001|Overall Study|Death|127|||
125664633|NCT00986154|452060947|FG000|Overall Study|Lost to Follow-up|7|||
125664634|NCT00986154|452060948|FG001|Overall Study|Lost to Follow-up|4|||
125664635|NCT00986154|452060947|FG000|Overall Study|Withdrawal by Subject|32|||
125664636|NCT00986154|452060948|FG001|Overall Study|Withdrawal by Subject|33|||
125664637|NCT00986154|452060947|FG000|Overall Study|investigator/subject decide not continue|6|||
125664638|NCT00986154|452060948|FG001|Overall Study|investigator/subject decide not continue|3|||
125664639|NCT00986154|452060947|FG000|Overall Study|never received study drug|25|||
125664640|NCT00986154|452060948|FG001|Overall Study|never received study drug|27|||
125664641|NCT03726437|452060949|FG000|Overall Study|Lost to Follow-up|85|||
125664642|NCT03726437|452060950|FG001|Overall Study|Lost to Follow-up|76|||
125664643|NCT00068445|452060951|FG000|Randomization|Cancel|1|||
125664644|NCT00068445|452060952|FG001|Randomization|Cancel|3|||
125664645|NCT00068445|452060951|FG000|Randomization|Ineligible|1|||
125664646|NCT00068445|452060952|FG001|Randomization|Ineligible|1|||
125664647|NCT00068445|452060951|FG000|Treatment|Refused Further Treatment|13|||
125664648|NCT00068445|452060952|FG001|Treatment|Refused Further Treatment|10|||
125664649|NCT00068445|452060951|FG000|Treatment|Adverse Event|7|||
125664650|NCT00068445|452060952|FG001|Treatment|Adverse Event|1|||
125664651|NCT00068445|452060951|FG000|Treatment|Other (Specifics not available)|9|||
125664652|NCT00068445|452060952|FG001|Treatment|Other (Specifics not available)|5|||
125664653|NCT01896700|452060953|FG000|Overall Study|Adverse Event|4|||
125664654|NCT01896700|452060954|FG001|Overall Study|Adverse Event|5|||
125664655|NCT01896700|452060953|FG000|Overall Study|Withdrawal by Subject|0|||
125664656|NCT01896700|452060954|FG001|Overall Study|Withdrawal by Subject|1|||
125664657|NCT03118765|452060956|FG000|Overall Study|Withdrawal by Subject|0|||
125664658|NCT03118765|452060957|FG001|Overall Study|Withdrawal by Subject|0|||
125664659|NCT03118765|452060958|FG002|Overall Study|Withdrawal by Subject|1|||
125664660|NCT03118765|452060959|FG003|Overall Study|Withdrawal by Subject|0|||
125664661|NCT03118765|452060960|FG004|Overall Study|Withdrawal by Subject|0|||
125664662|NCT03118765|452060956|FG000|Overall Study|Adverse Event|1|||
125664663|NCT03118765|452060957|FG001|Overall Study|Adverse Event|1|||
125664664|NCT03118765|452060958|FG002|Overall Study|Adverse Event|1|||
125664665|NCT03118765|452060959|FG003|Overall Study|Adverse Event|1|||
125664666|NCT03118765|452060960|FG004|Overall Study|Adverse Event|1|||
125664667|NCT03118765|452060956|FG000|Overall Study|Non compliance with Study Procedures|0|||
125664668|NCT03118765|452060957|FG001|Overall Study|Non compliance with Study Procedures|0|||
125664669|NCT03118765|452060958|FG002|Overall Study|Non compliance with Study Procedures|0|||
125664670|NCT03118765|452060959|FG003|Overall Study|Non compliance with Study Procedures|1|||
125664671|NCT03118765|452060960|FG004|Overall Study|Non compliance with Study Procedures|0|||
125664672|NCT03118765|452060956|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
125664673|NCT03118765|452060957|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
125664674|NCT03118765|452060958|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
125664675|NCT03118765|452060959|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
125664676|NCT03118765|452060960|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
125664677|NCT03118765|452060956|FG000|Overall Study|COPD Exacerbation|1|||
125664678|NCT03118765|452060957|FG001|Overall Study|COPD Exacerbation|0|||
125664679|NCT03118765|452060958|FG002|Overall Study|COPD Exacerbation|0|||
125664680|NCT03118765|452060959|FG003|Overall Study|COPD Exacerbation|1|||
125664681|NCT03118765|452060960|FG004|Overall Study|COPD Exacerbation|0|||
125664682|NCT03118765|452060956|FG000|Overall Study|Lost to Follow-up|1|||
125664683|NCT03118765|452060957|FG001|Overall Study|Lost to Follow-up|0|||
125664684|NCT03118765|452060958|FG002|Overall Study|Lost to Follow-up|1|||
125664685|NCT03118765|452060959|FG003|Overall Study|Lost to Follow-up|0|||
125664686|NCT03118765|452060960|FG004|Overall Study|Lost to Follow-up|0|||
125664687|NCT03118765|452060956|FG000|Overall Study|Sponsor Decision|1|||
125664688|NCT03118765|452060957|FG001|Overall Study|Sponsor Decision|0|||
125664689|NCT03118765|452060958|FG002|Overall Study|Sponsor Decision|1|||
125664690|NCT03118765|452060959|FG003|Overall Study|Sponsor Decision|0|||
125664691|NCT03118765|452060960|FG004|Overall Study|Sponsor Decision|1|||
125664692|NCT00849524|452060961|FG000|Overall Study|Lack of Efficacy|3|||
125664693|NCT00879970|452060967|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
125664694|NCT00879970|452060968|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
125664695|NCT00879970|452060969|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
125664696|NCT00879970|452060970|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
125664697|NCT00879970|452060971|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
125664698|NCT00879970|452060967|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
125664699|NCT00879970|452060968|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
125664700|NCT00879970|452060969|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
125664701|NCT00879970|452060970|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
125664702|NCT00879970|452060971|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
125664703|NCT00879970|452060967|FG000|Period 1 TZD Randomization|Death|2|||
125664704|NCT00879970|452060968|FG001|Period 1 TZD Randomization|Death|1|||
125664705|NCT00879970|452060969|FG002|Period 1 TZD Randomization|Death|0|||
125664706|NCT00879970|452060970|FG003|Period 1 TZD Randomization|Death|0|||
125664707|NCT00879970|452060971|FG004|Period 1 TZD Randomization|Death|0|||
125664708|NCT00879970|452060967|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
125664709|NCT00879970|452060968|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
125664710|NCT00879970|452060969|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
125664711|NCT00879970|452060970|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
125664712|NCT00879970|452060971|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
125664713|NCT00879970|452060967|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
125664714|NCT00879970|452060968|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
125664715|NCT00879970|452060969|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
125664716|NCT00879970|452060970|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
125664717|NCT00879970|452060971|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
125664718|NCT00879970|452060967|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
125664719|NCT00879970|452060968|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
125664720|NCT00879970|452060969|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
125664721|NCT00879970|452060970|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
125664722|NCT00879970|452060971|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
125664723|NCT00879970|452060967|FG000|Period 2 Vitamin D Randomization|Death|0|||
125664724|NCT00879970|452060968|FG001|Period 2 Vitamin D Randomization|Death|0|||
125664725|NCT00879970|452060969|FG002|Period 2 Vitamin D Randomization|Death|0|||
125664726|NCT00879970|452060970|FG003|Period 2 Vitamin D Randomization|Death|2|||
125664727|NCT00879970|452060971|FG004|Period 2 Vitamin D Randomization|Death|0|||
125664728|NCT01610167|452060972|FG000|Overall Study|Scheduling conflict.|0|||
125664729|NCT01610167|452060973|FG001|Overall Study|Scheduling conflict.|0|||
125664730|NCT01610167|452060974|FG002|Overall Study|Scheduling conflict.|2|||
125664731|NCT01021137|452060976|FG000|Overall Study|Lost to Follow-up|9|||
125664732|NCT01021137|452060977|FG001|Overall Study|Lost to Follow-up|4|||
125664733|NCT01021137|452060978|FG002|Overall Study|Lost to Follow-up|2|||
125664734|NCT01021137|452060979|FG003|Overall Study|Lost to Follow-up|6|||
125664735|NCT01021137|452060976|FG000|Overall Study|Withdrawal by Subject|1|||
125664736|NCT01021137|452060977|FG001|Overall Study|Withdrawal by Subject|0|||
125664737|NCT01021137|452060978|FG002|Overall Study|Withdrawal by Subject|0|||
125664738|NCT01021137|452060979|FG003|Overall Study|Withdrawal by Subject|3|||
125664739|NCT03439293|452060980|FG000|Overall Study|Death|22|||
125664740|NCT03439293|452060980|FG000|Overall Study|Withdrawal by Subject|8|||
125664741|NCT03439293|452060980|FG000|Overall Study|Lost to Follow-up|2|||
125664742|NCT03439293|452060980|FG000|Overall Study|Reason Not Specified|28|||
125664743|NCT03439293|452060980|FG000|Overall Study|Missing|1|||
125664744|NCT02766400|452060984|FG000|Overall Study|Death|1|||
125664745|NCT02766400|452060985|FG001|Overall Study|Death|2|||
125664746|NCT02766400|452060984|FG000|Overall Study|Withdrawal by Subject|1|||
125664747|NCT02766400|452060985|FG001|Overall Study|Withdrawal by Subject|0|||
125664748|NCT03499249|452060990|FG000|Overall Study|Physician Decision|1|||
125664749|NCT01559818|452060997|FG000|Overall Study|Physician Decision|1|||
125664750|NCT01559818|452060997|FG000|Overall Study|Pregnancy|1|||
125664751|NCT01559818|452060997|FG000|Overall Study|Study terminated by Sponsor|4|||
125210686|NCT02638259|450395634|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125664752|NCT01559818|452060997|FG000|Overall Study|Withdrawal by Subject|1|||
125664753|NCT04071626|452060998|FG000|Overall Study|Withdrawal by Subject|1|||
125664754|NCT04071626|452060999|FG001|Overall Study|Withdrawal by Subject|1|||
125664755|NCT04071626|452060998|FG000|Overall Study|Protocol Violation|0|||
125664756|NCT04071626|452060999|FG001|Overall Study|Protocol Violation|1|||
125664757|NCT01374906|452061000|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125664758|NCT01374906|452061001|FG001|Overall Study|Abnormal laboratory value(s)|3|||
125664759|NCT01374906|452061000|FG000|Overall Study|Administrative problems|2|||
125664760|NCT01374906|452061001|FG001|Overall Study|Administrative problems|2|||
125664761|NCT01374906|452061000|FG000|Overall Study|Adverse Event|10|||
125664762|NCT01374906|452061001|FG001|Overall Study|Adverse Event|11|||
125664763|NCT01374906|452061000|FG000|Overall Study|Death|0|||
125664764|NCT01374906|452061001|FG001|Overall Study|Death|2|||
125664765|NCT01374906|452061000|FG000|Overall Study|Protocol Violation|2|||
125664766|NCT01374906|452061001|FG001|Overall Study|Protocol Violation|2|||
125664767|NCT01374906|452061000|FG000|Overall Study|Withdrawal by Subject|15|||
125664768|NCT01374906|452061001|FG001|Overall Study|Withdrawal by Subject|9|||
125664769|NCT01374906|452061000|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
125664770|NCT01374906|452061001|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
125664771|NCT02475980|452061006|FG000|Overall Study|Lost to Follow-up|4|||
125664772|NCT02475980|452061006|FG000|Overall Study|Withdrawal by Subject|1|||
125664773|NCT00665626|452061010|FG000|Overall Study|Lack of Efficacy|8|||
125664774|NCT00665626|452061011|FG001|Overall Study|Lack of Efficacy|5|||
125664775|NCT00665626|452061010|FG000|Overall Study|Lost to Follow-up|0|||
125664776|NCT00665626|452061011|FG001|Overall Study|Lost to Follow-up|2|||
125664777|NCT00665626|452061010|FG000|Overall Study|Withdrawal by Subject|0|||
125664778|NCT00665626|452061011|FG001|Overall Study|Withdrawal by Subject|1|||
125664779|NCT00665626|452061010|FG000|Overall Study|Protocol Violation|0|||
125664780|NCT00665626|452061011|FG001|Overall Study|Protocol Violation|2|||
125664781|NCT00665626|452061010|FG000|Overall Study|Adverse Event|1|||
125664782|NCT00665626|452061011|FG001|Overall Study|Adverse Event|9|||
125664783|NCT00665626|452061010|FG000|Overall Study|Due to exclusion criteria|0|||
125664784|NCT00665626|452061011|FG001|Overall Study|Due to exclusion criteria|1|||
125664785|NCT00665626|452061010|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
125664786|NCT00665626|452061011|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
125664787|NCT00665626|452061010|FG000|Overall Study|Unably to comply with dosing regimen|0|||
125664788|NCT00665626|452061011|FG001|Overall Study|Unably to comply with dosing regimen|1|||
125664789|NCT00665626|452061010|FG000|Overall Study|Death|1|||
125664790|NCT00665626|452061011|FG001|Overall Study|Death|0|||
125664791|NCT04147611|452061012|FG000|Overall Study|Physician Decision|0|||
125664792|NCT04147611|452061013|FG001|Overall Study|Physician Decision|1|||
125664793|NCT01010230|452061014|FG000|Overall Study|Withdrawal by Subject|6|||
125664794|NCT01010230|452061015|FG001|Overall Study|Withdrawal by Subject|5|||
125664795|NCT01010230|452061014|FG000|Overall Study|Lost to Follow-up|4|||
125664796|NCT01010230|452061015|FG001|Overall Study|Lost to Follow-up|2|||
125664797|NCT00530439|452061016|FG000|Overall Study|GDM|9|||
125664798|NCT00530439|452061017|FG001|Overall Study|GDM|3|||
125664799|NCT00530439|452061016|FG000|Overall Study|Withdraw|18|||
125664800|NCT00530439|452061017|FG001|Overall Study|Withdraw|14|||
125664801|NCT00530439|452061016|FG000|Overall Study|Missed abortion|1|||
125664802|NCT00530439|452061017|FG001|Overall Study|Missed abortion|4|||
125664803|NCT00530439|452061016|FG000|Overall Study|Misclassification|2|||
125664804|NCT00530439|452061017|FG001|Overall Study|Misclassification|0|||
125664805|NCT00530439|452061016|FG000|Overall Study|Twin pregnancy|0|||
125664806|NCT00530439|452061017|FG001|Overall Study|Twin pregnancy|2|||
125664807|NCT00530439|452061016|FG000|Overall Study|Severe malformation/abortion|0|||
125664808|NCT00530439|452061017|FG001|Overall Study|Severe malformation/abortion|3|||
125664809|NCT01629693|452061020|FG000|Overall Study|Lost to Follow-up|2|||
125664810|NCT01629693|452061021|FG001|Overall Study|Lost to Follow-up|4|||
125664811|NCT01629693|452061020|FG000|Overall Study|Withdrawal by Subject|2|||
125664812|NCT01629693|452061021|FG001|Overall Study|Withdrawal by Subject|2|||
125664813|NCT01629693|452061020|FG000|Overall Study|Adverse Event|1|||
125664814|NCT01629693|452061021|FG001|Overall Study|Adverse Event|0|||
125664815|NCT01629693|452061020|FG000|Overall Study|Investigator decision|0|||
125664816|NCT01629693|452061021|FG001|Overall Study|Investigator decision|1|||
125664817|NCT01629693|452061020|FG000|Overall Study|Poor comfort of study lenses|0|||
125664818|NCT01629693|452061021|FG001|Overall Study|Poor comfort of study lenses|2|||
125664819|NCT01629693|452061020|FG000|Overall Study|Subject decision unrelated to AE|0|||
125664820|NCT01629693|452061021|FG001|Overall Study|Subject decision unrelated to AE|1|||
125664821|NCT01529749|452061022|FG000|Overall Study|Lost to Follow-up|0|||
125664822|NCT01529749|452061023|FG001|Overall Study|Lost to Follow-up|1|||
125664823|NCT01529749|452061024|FG002|Overall Study|Lost to Follow-up|1|||
125664824|NCT01529749|452061025|FG003|Overall Study|Lost to Follow-up|0|||
125664825|NCT01529749|452061022|FG000|Overall Study|Physician Decision|0|||
125664826|NCT01529749|452061023|FG001|Overall Study|Physician Decision|0|||
125664827|NCT01529749|452061024|FG002|Overall Study|Physician Decision|0|||
125664828|NCT01529749|452061025|FG003|Overall Study|Physician Decision|1|||
125664829|NCT01529749|452061022|FG000|Overall Study|Withdrawal by Subject|0|||
125664830|NCT01529749|452061023|FG001|Overall Study|Withdrawal by Subject|1|||
125329005|NCT02504151|450837347|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
125329006|NCT02504151|450837348|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
125329007|NCT02504151|450837347|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
125329008|NCT02504151|450837348|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
125664831|NCT01529749|452061024|FG002|Overall Study|Withdrawal by Subject|1|||
125664832|NCT01529749|452061025|FG003|Overall Study|Withdrawal by Subject|0|||
125664833|NCT01529749|452061022|FG000|Overall Study|Protocol Violation|0|||
125664834|NCT01529749|452061023|FG001|Overall Study|Protocol Violation|0|||
125664835|NCT01529749|452061024|FG002|Overall Study|Protocol Violation|0|||
125664836|NCT01529749|452061025|FG003|Overall Study|Protocol Violation|1|||
125664837|NCT04385199|452061026|FG000|Overall Study|Withdrawal by Subject|1|||
125664838|NCT04385199|452061027|FG001|Overall Study|Withdrawal by Subject|0|||
125664839|NCT00860574|452062652|FG000|Overall Study|Death|2|||
125664840|NCT00860574|452062652|FG000|Overall Study|Relapse|1|||
125664841|NCT01246986|452062653|FG000|Overall Study|Lost to Follow-up|0|||
125664842|NCT01246986|452062654|FG001|Overall Study|Lost to Follow-up|1|||
125664843|NCT01246986|452062655|FG002|Overall Study|Lost to Follow-up|3|||
125664844|NCT01246986|452062656|FG003|Overall Study|Lost to Follow-up|0|||
125664845|NCT01246986|452062657|FG004|Overall Study|Lost to Follow-up|0|||
125664846|NCT01246986|452062658|FG005|Overall Study|Lost to Follow-up|1|||
125664847|NCT01246986|452062659|FG006|Overall Study|Lost to Follow-up|0|||
125664848|NCT01246986|452062653|FG000|Overall Study|Withdrawal by Subject|3|||
125664849|NCT01246986|452062654|FG001|Overall Study|Withdrawal by Subject|4|||
125664850|NCT01246986|452062655|FG002|Overall Study|Withdrawal by Subject|3|||
125664851|NCT01246986|452062656|FG003|Overall Study|Withdrawal by Subject|0|||
125664852|NCT01246986|452062657|FG004|Overall Study|Withdrawal by Subject|4|||
125664853|NCT01246986|452062658|FG005|Overall Study|Withdrawal by Subject|0|||
125664854|NCT01246986|452062659|FG006|Overall Study|Withdrawal by Subject|0|||
125664855|NCT01335399|452062663|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
125664856|NCT01335399|452062664|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
125664857|NCT01335399|452062663|FG000|Pre-treatment Period|Participant request to discontinue|0|||
125664858|NCT01335399|452062664|FG001|Pre-treatment Period|Participant request to discontinue|1|||
125664859|NCT01335399|452062663|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
125664860|NCT01335399|452062664|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
125664861|NCT01335399|452062663|FG000|Pre-treatment Period|Consent withdrawal|3|||
125664862|NCT01335399|452062664|FG001|Pre-treatment Period|Consent withdrawal|0|||
125664863|NCT01335399|452062663|FG000|Treatment Period|Disease progression|117|||
125664864|NCT01335399|452062664|FG001|Treatment Period|Disease progression|145|||
125664865|NCT01335399|452062663|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
125664866|NCT01335399|452062664|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
125664867|NCT01335399|452062663|FG000|Treatment Period|Study drug toxicity|52|||
125664868|NCT01335399|452062664|FG001|Treatment Period|Study drug toxicity|64|||
125664869|NCT01335399|452062663|FG000|Treatment Period|Participant request to discontinue|30|||
125664870|NCT01335399|452062664|FG001|Treatment Period|Participant request to discontinue|22|||
125664871|NCT01335399|452062663|FG000|Treatment Period|Other reasons|30|||
125664872|NCT01335399|452062664|FG001|Treatment Period|Other reasons|30|||
125664873|NCT01335399|452062663|FG000|Treatment Period|Consent withdrawal|10|||
125664874|NCT01335399|452062664|FG001|Treatment Period|Consent withdrawal|7|||
125664875|NCT01335399|452062663|FG000|Treatment Period|Death|7|||
125664876|NCT01335399|452062664|FG001|Treatment Period|Death|6|||
125664877|NCT01335399|452062663|FG000|Treatment Period|Poor/Non-compliance|3|||
125664878|NCT01335399|452062664|FG001|Treatment Period|Poor/Non-compliance|4|||
125664879|NCT01335399|452062663|FG000|Treatment Period|Lost to Follow-up|2|||
125664880|NCT01335399|452062664|FG001|Treatment Period|Lost to Follow-up|2|||
125664881|NCT01335399|452062663|FG000|Treatment Period|Maximum clinical benefit|1|||
125664882|NCT01335399|452062664|FG001|Treatment Period|Maximum clinical benefit|1|||
125664883|NCT01335399|452062663|FG000|Treatment Period|No longer meet study criteria|1|||
125664884|NCT01335399|452062664|FG001|Treatment Period|No longer meet study criteria|1|||
125664885|NCT01335399|452062663|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
125664886|NCT01335399|452062664|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
125664887|NCT01416142|452062665|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
125664888|NCT01416142|452062666|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
125664889|NCT01416142|452062667|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
125664890|NCT02464059|452062668|FG000|Overall Study|Lost to Follow-up|6|||
125664891|NCT00304954|452062671|FG000|Overall Study|Withdrawal by Subject|0|||
125664892|NCT00304954|452062672|FG001|Overall Study|Withdrawal by Subject|0|||
125664893|NCT00304954|452062673|FG002|Overall Study|Withdrawal by Subject|1|||
125664894|NCT00304954|452062674|FG003|Overall Study|Withdrawal by Subject|0|||
125664895|NCT00304954|452062671|FG000|Overall Study|Adverse Event|1|||
125664896|NCT00304954|452062672|FG001|Overall Study|Adverse Event|0|||
125664897|NCT00304954|452062673|FG002|Overall Study|Adverse Event|0|||
125664898|NCT00304954|452062674|FG003|Overall Study|Adverse Event|0|||
125664899|NCT03990389|452062677|FG000|Overall Study|Lost to Follow-up|3|||
125664900|NCT03990389|452062678|FG001|Overall Study|Lost to Follow-up|0|||
125664901|NCT01326702|452062679|FG000|Overall Study|Other|1|||
125664902|NCT01326702|452062680|FG001|Overall Study|Other|0|||
125664903|NCT01326702|452062681|FG002|Overall Study|Other|0|||
125664904|NCT01326702|452062682|FG003|Overall Study|Other|0|||
125664905|NCT01326702|452062683|FG004|Overall Study|Other|0|||
125664906|NCT01326702|452062684|FG005|Overall Study|Other|1|||
125664907|NCT01326702|452062685|FG006|Overall Study|Other|0|||
125664908|NCT01326702|452062679|FG000|Overall Study|progressive disease|1|||
125664909|NCT01326702|452062680|FG001|Overall Study|progressive disease|1|||
125664910|NCT01326702|452062681|FG002|Overall Study|progressive disease|3|||
125664911|NCT01326702|452062682|FG003|Overall Study|progressive disease|1|||
125664912|NCT01326702|452062683|FG004|Overall Study|progressive disease|3|||
125664913|NCT01326702|452062684|FG005|Overall Study|progressive disease|2|||
125664914|NCT01326702|452062685|FG006|Overall Study|progressive disease|3|||
125664915|NCT01326702|452062679|FG000|Overall Study|Death|0|||
125664916|NCT01326702|452062680|FG001|Overall Study|Death|1|||
125664917|NCT01326702|452062681|FG002|Overall Study|Death|0|||
125664918|NCT01326702|452062682|FG003|Overall Study|Death|0|||
125664919|NCT01326702|452062683|FG004|Overall Study|Death|0|||
125664920|NCT01326702|452062684|FG005|Overall Study|Death|0|||
125664921|NCT01326702|452062685|FG006|Overall Study|Death|0|||
125664922|NCT01326702|452062679|FG000|Overall Study|Adverse Event|0|||
125664923|NCT01326702|452062680|FG001|Overall Study|Adverse Event|0|||
125664924|NCT01326702|452062681|FG002|Overall Study|Adverse Event|1|||
125664925|NCT01326702|452062682|FG003|Overall Study|Adverse Event|1|||
125664926|NCT01326702|452062683|FG004|Overall Study|Adverse Event|0|||
125664927|NCT01326702|452062684|FG005|Overall Study|Adverse Event|3|||
125664928|NCT01326702|452062685|FG006|Overall Study|Adverse Event|1|||
125664929|NCT01326702|452062679|FG000|Overall Study|Withdrawal by Subject|0|||
125664930|NCT01326702|452062680|FG001|Overall Study|Withdrawal by Subject|0|||
125329009|NCT02504151|450837347|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
125664931|NCT01326702|452062681|FG002|Overall Study|Withdrawal by Subject|1|||
125329010|NCT02504151|450837348|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125329011|NCT02504151|450837347|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
125329012|NCT02504151|450837348|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
125329013|NCT00389610|450837351|FG000|Overall Study|Disease Progression|0|||
125329014|NCT00389610|450837352|FG001|Overall Study|Disease Progression|19|||
125329015|NCT00389610|450837351|FG000|Overall Study|Death|0|||
125329016|NCT00389610|450837352|FG001|Overall Study|Death|1|||
125329017|NCT00389610|450837351|FG000|Overall Study|Physician Decision|0|||
125664932|NCT01326702|452062682|FG003|Overall Study|Withdrawal by Subject|0|||
125664933|NCT01326702|452062683|FG004|Overall Study|Withdrawal by Subject|1|||
125664934|NCT01326702|452062684|FG005|Overall Study|Withdrawal by Subject|1|||
125664935|NCT01326702|452062685|FG006|Overall Study|Withdrawal by Subject|3|||
125664936|NCT01326702|452062679|FG000|Overall Study|Not Treated|0|||
125664937|NCT01326702|452062680|FG001|Overall Study|Not Treated|0|||
125664938|NCT01326702|452062681|FG002|Overall Study|Not Treated|0|||
125664939|NCT01326702|452062682|FG003|Overall Study|Not Treated|1|||
125664940|NCT01326702|452062683|FG004|Overall Study|Not Treated|0|||
125664941|NCT01326702|452062684|FG005|Overall Study|Not Treated|1|||
125664942|NCT01326702|452062685|FG006|Overall Study|Not Treated|0|||
125664943|NCT01835132|452062687|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
125664944|NCT00856778|452062688|FG000|Overall Study|Adverse Event|7|||
125664945|NCT00856778|452062688|FG000|Overall Study|Withdrawal by Subject|10|||
125664946|NCT00856778|452062688|FG000|Overall Study|Study deviation|2|||
125664947|NCT00856778|452062688|FG000|Overall Study|Lost to Follow-up|5|||
125664948|NCT03208933|452062689|FG000|Overall Study|Death|3|||
125664949|NCT03208933|452062689|FG000|Overall Study|Withdrawal by Subject|3|||
125664950|NCT03208933|452062689|FG000|Overall Study|Adverse Event|1|||
125664951|NCT03208933|452062689|FG000|Overall Study|Lost to Follow-up|2|||
125664952|NCT03208933|452062689|FG000|Overall Study|Physician Decision|3|||
125664953|NCT03208933|452062689|FG000|Overall Study|Protocol Violation|1|||
125664954|NCT00331773|452062690|FG000|Overall Study|Withdrawal by Subject|6|||
125664955|NCT00331773|452062691|FG001|Overall Study|Withdrawal by Subject|4|||
125664956|NCT00331773|452062690|FG000|Overall Study|Protocol Violation|10|||
125664957|NCT00331773|452062691|FG001|Overall Study|Protocol Violation|3|||
125664958|NCT00379587|452062692|FG000|Overall Study|Lost to Follow-up|2|||
125664959|NCT00525031|452062697|FG000|Overall Study|Disease Progression|1|||
125664960|NCT00525031|452062698|FG001|Overall Study|Disease Progression|1|||
125329018|NCT00389610|450837352|FG001|Overall Study|Physician Decision|1|||
125664961|NCT00830063|452062699|FG000|Overall Study|Adverse Event|7|||
125329019|NCT00389610|450837351|FG000|Overall Study|Withdrawal by Subject|0|||
125329020|NCT00389610|450837352|FG001|Overall Study|Withdrawal by Subject|1|||
125664962|NCT00830063|452062700|FG001|Overall Study|Adverse Event|13|||
125664963|NCT00830063|452062701|FG002|Overall Study|Adverse Event|16|||
125664964|NCT00830063|452062702|FG003|Overall Study|Adverse Event|13|||
125664965|NCT00830063|452062699|FG000|Overall Study|Death|1|||
125664966|NCT00830063|452062700|FG001|Overall Study|Death|0|||
125425603|NCT01735201|451182282|FG003|Overall Study|Protocol Violation|0|||
125664967|NCT00830063|452062701|FG002|Overall Study|Death|0|||
125664968|NCT00830063|452062702|FG003|Overall Study|Death|0|||
125664969|NCT00830063|452062699|FG000|Overall Study|Lost to Follow-up|0|||
125664970|NCT00830063|452062700|FG001|Overall Study|Lost to Follow-up|0|||
125664971|NCT00830063|452062701|FG002|Overall Study|Lost to Follow-up|3|||
125664972|NCT00830063|452062702|FG003|Overall Study|Lost to Follow-up|1|||
125664973|NCT00830063|452062699|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
125664974|NCT00830063|452062700|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
125664975|NCT00830063|452062701|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
125664976|NCT00830063|452062702|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
125664977|NCT00830063|452062699|FG000|Overall Study|Lack of Efficacy|51|||
125664978|NCT00830063|452062700|FG001|Overall Study|Lack of Efficacy|23|||
125664979|NCT00830063|452062701|FG002|Overall Study|Lack of Efficacy|25|||
125664980|NCT00830063|452062702|FG003|Overall Study|Lack of Efficacy|32|||
125664981|NCT00830063|452062699|FG000|Overall Study|Other|5|||
125664982|NCT00830063|452062700|FG001|Overall Study|Other|5|||
125664983|NCT00830063|452062701|FG002|Overall Study|Other|8|||
125664984|NCT00830063|452062702|FG003|Overall Study|Other|6|||
125664985|NCT00830063|452062699|FG000|Overall Study|Withdrawal by Subject|16|||
125664986|NCT00830063|452062700|FG001|Overall Study|Withdrawal by Subject|10|||
125664987|NCT00830063|452062701|FG002|Overall Study|Withdrawal by Subject|16|||
125664988|NCT00830063|452062702|FG003|Overall Study|Withdrawal by Subject|13|||
125664989|NCT00830063|452062699|FG000|Overall Study|Protocol Violation|1|||
125664990|NCT00830063|452062700|FG001|Overall Study|Protocol Violation|0|||
125664991|NCT00830063|452062701|FG002|Overall Study|Protocol Violation|3|||
125664992|NCT00830063|452062702|FG003|Overall Study|Protocol Violation|2|||
125664993|NCT00830063|452062699|FG000|Overall Study|Randomized But Not Treated|0|||
125664994|NCT00830063|452062700|FG001|Overall Study|Randomized But Not Treated|2|||
125664995|NCT00830063|452062701|FG002|Overall Study|Randomized But Not Treated|0|||
125664996|NCT00830063|452062702|FG003|Overall Study|Randomized But Not Treated|2|||
125664997|NCT02140164|452062703|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
125664998|NCT01872689|452062714|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
125664999|NCT01872689|452062715|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
125665000|NCT01872689|452062716|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
125665001|NCT01872689|452062717|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
125665002|NCT01872689|452062714|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
125665003|NCT01872689|452062715|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
125665004|NCT01872689|452062716|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
125665005|NCT01872689|452062717|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
125665006|NCT01872689|452062714|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
125665007|NCT01872689|452062715|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
125665008|NCT01872689|452062716|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
125665009|NCT01872689|452062717|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
125665010|NCT01872689|452062714|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
125665011|NCT01872689|452062715|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
125665012|NCT01872689|452062716|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
125665013|NCT01872689|452062717|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
125665014|NCT01872689|452062714|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
125665015|NCT01872689|452062715|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
125665016|NCT01872689|452062716|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
125665017|NCT01872689|452062717|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
125329021|NCT00538902|450837353|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
125329022|NCT00538902|450837354|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
125329023|NCT00538902|450837355|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
125329024|NCT00538902|450837353|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
125329025|NCT00538902|450837354|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
125329026|NCT00538902|450837355|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
125329027|NCT00538902|450837353|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
125329028|NCT00538902|450837354|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
125329029|NCT00538902|450837355|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
125329030|NCT00538902|450837353|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
125329031|NCT00538902|450837354|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
125329032|NCT00538902|450837355|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
125329033|NCT00538902|450837353|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
125329034|NCT00538902|450837354|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
125329035|NCT00538902|450837355|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
125329036|NCT00538902|450837353|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
125329037|NCT00538902|450837354|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
125425604|NCT01735201|451182283|FG004|Overall Study|Protocol Violation|0|||
125665018|NCT01872689|452062714|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
125665019|NCT01872689|452062715|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
125665020|NCT01872689|452062716|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
125329038|NCT00538902|450837355|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
125329039|NCT00538902|450837353|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
125329040|NCT00538902|450837354|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
125329041|NCT00538902|450837355|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
125329042|NCT00538902|450837353|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
125329043|NCT00538902|450837354|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
125329044|NCT00538902|450837355|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
125329045|NCT02557139|450837359|FG000|Overall Study|Significant liver elevation|1|||
125329046|NCT02557139|450837360|FG001|Overall Study|Significant liver elevation|0|||
125329047|NCT02557139|450837361|FG002|Overall Study|Significant liver elevation|1|||
125329048|NCT02557139|450837359|FG000|Overall Study|Withdrawal by Subject|1|||
125329049|NCT02557139|450837360|FG001|Overall Study|Withdrawal by Subject|0|||
125329050|NCT02557139|450837361|FG002|Overall Study|Withdrawal by Subject|0|||
125329051|NCT02557139|450837359|FG000|Overall Study|Illness of prohibited medication|0|||
125329052|NCT02557139|450837360|FG001|Overall Study|Illness of prohibited medication|0|||
125665021|NCT01872689|452062717|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
125665022|NCT01872689|452062714|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
125665023|NCT01872689|452062715|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
125665024|NCT01872689|452062716|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
125665025|NCT01872689|452062717|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
125665026|NCT01872689|452062714|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
125665027|NCT01872689|452062715|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
125665028|NCT01872689|452062716|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
125665029|NCT01872689|452062717|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
125665030|NCT01872689|452062714|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
125665031|NCT01872689|452062715|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
125665032|NCT01872689|452062716|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
125665033|NCT01872689|452062717|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
125665034|NCT01872689|452062714|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
125665035|NCT01872689|452062715|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
125665036|NCT01872689|452062716|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
125665037|NCT01872689|452062717|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
125665038|NCT01872689|452062714|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
125665039|NCT01872689|452062715|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
125665040|NCT01872689|452062716|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
125665041|NCT01872689|452062717|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
125665042|NCT01872689|452062714|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
125665043|NCT01872689|452062715|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
125665044|NCT01872689|452062716|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
125665045|NCT01872689|452062717|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
125665046|NCT01872689|452062714|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
125665047|NCT01872689|452062715|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
125665048|NCT01872689|452062716|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
125665049|NCT01872689|452062717|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
125665050|NCT01872689|452062714|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
125665051|NCT01872689|452062715|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
125665052|NCT01872689|452062716|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
125665053|NCT01872689|452062717|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
125665054|NCT00881959|452062720|FG000|Overall Study|Lost to Follow-up|2|||
125665055|NCT00881959|452062721|FG001|Overall Study|Lost to Follow-up|4|||
125665056|NCT00686374|452062723|FG000|Overall Study|Lack of Efficacy|10|||
125665057|NCT00686374|452062723|FG000|Overall Study|Adverse Event|8|||
125665058|NCT00686374|452062723|FG000|Overall Study|Withdrew consent|5|||
125665059|NCT00686374|452062723|FG000|Overall Study|Lost to Follow-up|1|||
125329053|NCT02557139|450837361|FG002|Overall Study|Illness of prohibited medication|1|||
125329054|NCT01454102|450837362|FG000|Overall Study|Continuing in the treatment period|0|||
125329055|NCT01454102|450837363|FG001|Overall Study|Continuing in the treatment period|0|||
125329056|NCT01454102|450837364|FG002|Overall Study|Continuing in the treatment period|0|||
125329057|NCT01454102|450837365|FG003|Overall Study|Continuing in the treatment period|0|||
125329058|NCT01454102|450837366|FG004|Overall Study|Continuing in the treatment period|3|||
125329059|NCT01454102|450837367|FG005|Overall Study|Continuing in the treatment period|3|||
125329060|NCT01454102|450837368|FG006|Overall Study|Continuing in the treatment period|2|||
125329061|NCT01454102|450837369|FG007|Overall Study|Continuing in the treatment period|0|||
125329062|NCT01454102|450837370|FG008|Overall Study|Continuing in the treatment period|1|||
125665060|NCT00686374|452062723|FG000|Overall Study|Missing reason|33|||
125665061|NCT00686374|452062723|FG000|Overall Study|Other, not specified|4|||
125665062|NCT01070966|452062724|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
125665063|NCT01070966|452062724|FG000|Participants for Safety Evaluation|Off-label use|9|||
125665064|NCT01070966|452062724|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
125665065|NCT01070966|452062724|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
125665066|NCT01070966|452062724|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
125665067|NCT01070966|452062724|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
125665068|NCT01070966|452062724|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
125665069|NCT01070966|452062724|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
125665070|NCT01725113|452062725|FG000|Overall Study|Kidney Transplant|1|||
125665071|NCT01725113|452062726|FG001|Overall Study|Kidney Transplant|1|||
125665072|NCT01725113|452062725|FG000|Overall Study|Withdrawal by Subject|0|||
125665073|NCT01725113|452062726|FG001|Overall Study|Withdrawal by Subject|1|||
125665074|NCT01808209|452062727|FG000|Overall Study|Lost to Follow-up|0|||
125665075|NCT01808209|452062728|FG001|Overall Study|Lost to Follow-up|1|||
125665076|NCT03066440|452062729|FG000|Overall Study|Physician Decision|1|||
125665077|NCT03066440|452062730|FG001|Overall Study|Physician Decision|1|||
125665078|NCT03066440|452062729|FG000|Overall Study|Protocol Violation|0|||
125665079|NCT03066440|452062730|FG001|Overall Study|Protocol Violation|2|||
125665080|NCT01106352|452062738|FG000|Overall Study|Subjects untreated|0|||
125665081|NCT01106352|452062739|FG001|Overall Study|Subjects untreated|0|||
125665082|NCT01106352|452062740|FG002|Overall Study|Subjects untreated|0|||
125665083|NCT01106352|452062741|FG003|Overall Study|Subjects untreated|3|||
125665084|NCT01106352|452062742|FG004|Overall Study|Subjects untreated|4|||
125665085|NCT01106352|452062738|FG000|Overall Study|Sponsor Decision|1|||
125665086|NCT01106352|452062739|FG001|Overall Study|Sponsor Decision|0|||
125665087|NCT01106352|452062740|FG002|Overall Study|Sponsor Decision|0|||
125665088|NCT01106352|452062741|FG003|Overall Study|Sponsor Decision|0|||
125665089|NCT01106352|452062742|FG004|Overall Study|Sponsor Decision|0|||
125665090|NCT01106352|452062738|FG000|Overall Study|Too ill to come in for the visit|0|||
125665091|NCT01106352|452062739|FG001|Overall Study|Too ill to come in for the visit|0|||
125665092|NCT01106352|452062740|FG002|Overall Study|Too ill to come in for the visit|1|||
125665093|NCT01106352|452062741|FG003|Overall Study|Too ill to come in for the visit|0|||
125665094|NCT01106352|452062742|FG004|Overall Study|Too ill to come in for the visit|0|||
125665095|NCT01106352|452062738|FG000|Overall Study|Lost to Follow-up|0|||
125665096|NCT01106352|452062739|FG001|Overall Study|Lost to Follow-up|0|||
125665097|NCT01106352|452062740|FG002|Overall Study|Lost to Follow-up|0|||
125665098|NCT01106352|452062741|FG003|Overall Study|Lost to Follow-up|0|||
125665099|NCT01106352|452062742|FG004|Overall Study|Lost to Follow-up|1|||
125665100|NCT01106352|452062738|FG000|Overall Study|Death|0|||
125665101|NCT01106352|452062739|FG001|Overall Study|Death|0|||
125665102|NCT01106352|452062740|FG002|Overall Study|Death|1|||
125665103|NCT01106352|452062741|FG003|Overall Study|Death|3|||
125665104|NCT01106352|452062742|FG004|Overall Study|Death|1|||
125665105|NCT01106352|452062738|FG000|Overall Study|Disease progression|0|||
125665106|NCT01106352|452062739|FG001|Overall Study|Disease progression|0|||
125665107|NCT01106352|452062740|FG002|Overall Study|Disease progression|0|||
125665108|NCT01106352|452062741|FG003|Overall Study|Disease progression|1|||
125665109|NCT01106352|452062742|FG004|Overall Study|Disease progression|0|||
125665110|NCT01106352|452062738|FG000|Overall Study|Withdrawal by Subject|0|||
125665111|NCT01106352|452062739|FG001|Overall Study|Withdrawal by Subject|0|||
125665112|NCT01106352|452062740|FG002|Overall Study|Withdrawal by Subject|0|||
125665113|NCT01106352|452062741|FG003|Overall Study|Withdrawal by Subject|3|||
125665114|NCT01106352|452062742|FG004|Overall Study|Withdrawal by Subject|2|||
125665115|NCT01106352|452062738|FG000|Overall Study|Went on hospice|0|||
125665116|NCT01106352|452062739|FG001|Overall Study|Went on hospice|0|||
125665117|NCT01106352|452062740|FG002|Overall Study|Went on hospice|0|||
125665118|NCT01106352|452062741|FG003|Overall Study|Went on hospice|1|||
125665119|NCT01106352|452062742|FG004|Overall Study|Went on hospice|0|||
125665120|NCT01106352|452062738|FG000|Overall Study|Subject entered hospice|0|||
125665121|NCT01106352|452062739|FG001|Overall Study|Subject entered hospice|0|||
125665122|NCT01106352|452062740|FG002|Overall Study|Subject entered hospice|0|||
125665123|NCT01106352|452062741|FG003|Overall Study|Subject entered hospice|1|||
125665124|NCT01106352|452062742|FG004|Overall Study|Subject entered hospice|0|||
125329063|NCT01454102|450837371|FG009|Overall Study|Continuing in the treatment period|0|||
125329064|NCT01454102|450837372|FG010|Overall Study|Continuing in the treatment period|0|||
125329065|NCT01454102|450837373|FG011|Overall Study|Continuing in the treatment period|4|||
125665125|NCT01106352|452062738|FG000|Overall Study|Home hospice since July 2013|0|||
125329066|NCT01454102|450837374|FG012|Overall Study|Continuing in the treatment period|7|||
125665126|NCT01106352|452062739|FG001|Overall Study|Home hospice since July 2013|0|||
125665127|NCT01106352|452062740|FG002|Overall Study|Home hospice since July 2013|0|||
125665128|NCT01106352|452062741|FG003|Overall Study|Home hospice since July 2013|1|||
125665129|NCT01106352|452062742|FG004|Overall Study|Home hospice since July 2013|0|||
125665130|NCT03944707|452062743|FG000|Overall Study|Adverse Event|0|||
125665131|NCT03944707|452062744|FG001|Overall Study|Adverse Event|2|||
125665132|NCT03944707|452062743|FG000|Overall Study|Study terminated by sponsor|12|||
125665133|NCT03944707|452062744|FG001|Overall Study|Study terminated by sponsor|7|||
125665134|NCT03944707|452062743|FG000|Overall Study|Subject decision|0|||
125665135|NCT03944707|452062744|FG001|Overall Study|Subject decision|1|||
125329067|NCT01454102|450837375|FG013|Overall Study|Continuing in the treatment period|4|||
125329068|NCT01454102|450837376|FG014|Overall Study|Continuing in the treatment period|3|||
125329069|NCT01454102|450837377|FG015|Overall Study|Continuing in the treatment period|1|||
125329070|NCT02592798|450837383|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
125329071|NCT02592798|450837384|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
125329072|NCT02592798|450837383|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
125329073|NCT02592798|450837384|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
125329074|NCT02592798|450837383|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
125329075|NCT02592798|450837384|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
125329076|NCT02592798|450837383|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
125329077|NCT02592798|450837384|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
125329078|NCT02592798|450837383|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
125329079|NCT02592798|450837384|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
125329080|NCT02592798|450837383|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
125329081|NCT02592798|450837384|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
125329082|NCT02592798|450837383|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
125329083|NCT02592798|450837384|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
125329084|NCT02592798|450837383|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
125329085|NCT02592798|450837384|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
125329086|NCT02592798|450837383|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
125329087|NCT02592798|450837384|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
125329088|NCT02592798|450837383|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
125329089|NCT02592798|450837384|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
125329090|NCT02592798|450837383|FG000|Transition From DB2 to OLE|Other reasons|1|||
125329091|NCT02592798|450837384|FG001|Transition From DB2 to OLE|Other reasons|0|||
125329092|NCT02592798|450837383|FG000|Open Label Period (OLE)|Other reasons|0|||
125329093|NCT02592798|450837384|FG001|Open Label Period (OLE)|Other reasons|2|||
125329094|NCT02592798|450837383|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
125329095|NCT02592798|450837384|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
125329096|NCT02592798|450837383|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
125329097|NCT02592798|450837384|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
125329098|NCT02592798|450837383|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
125329099|NCT02592798|450837384|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
125329100|NCT02592798|450837383|FG000|Open Label Period (OLE)|Adverse Event|0|||
125329101|NCT02592798|450837384|FG001|Open Label Period (OLE)|Adverse Event|1|||
125329102|NCT00705016|450837385|FG000|Overall Study|Adverse Event|6|||
125329103|NCT00705016|450837386|FG001|Overall Study|Adverse Event|11|||
125329104|NCT00705016|450837387|FG002|Overall Study|Adverse Event|10|||
125329105|NCT00705016|450837385|FG000|Overall Study|Death|5|||
125329106|NCT00705016|450837386|FG001|Overall Study|Death|7|||
125329107|NCT00705016|450837387|FG002|Overall Study|Death|5|||
125329108|NCT00705016|450837385|FG000|Overall Study|Protocol Violation|0|||
125329109|NCT00705016|450837386|FG001|Overall Study|Protocol Violation|1|||
125329110|NCT00705016|450837387|FG002|Overall Study|Protocol Violation|1|||
125329111|NCT00705016|450837385|FG000|Overall Study|Withdrawal by Subject|4|||
125329112|NCT00705016|450837386|FG001|Overall Study|Withdrawal by Subject|3|||
125329113|NCT00705016|450837387|FG002|Overall Study|Withdrawal by Subject|2|||
125329114|NCT00705016|450837385|FG000|Overall Study|Progressive Disease|33|||
125329115|NCT00705016|450837386|FG001|Overall Study|Progressive Disease|29|||
125329116|NCT00705016|450837387|FG002|Overall Study|Progressive Disease|33|||
125329117|NCT00705016|450837385|FG000|Overall Study|Symptomatic Deterioration|3|||
125665136|NCT00751998|452062752|FG000|Overall Study|Lost to Follow-up|7|||
125665137|NCT00751998|452062752|FG000|Overall Study|Death|11|||
125665138|NCT00751998|452062752|FG000|Overall Study|Withdrawal by Subject|2|||
125665139|NCT01965535|452062753|FG000|Overall Study|Lack of Efficacy|2|||
125665140|NCT01965535|452062754|FG001|Overall Study|Lack of Efficacy|1|||
125665141|NCT02983227|452062755|FG000|Overall Study|Adverse Event|21|||
125665142|NCT02983227|452062756|FG001|Overall Study|Adverse Event|3|||
125665143|NCT02983227|452062755|FG000|Overall Study|Death|3|||
125665144|NCT02983227|452062756|FG001|Overall Study|Death|0|||
125665145|NCT02983227|452062755|FG000|Overall Study|Lack of Efficacy|8|||
125665146|NCT02983227|452062756|FG001|Overall Study|Lack of Efficacy|1|||
125329118|NCT00705016|450837386|FG001|Overall Study|Symptomatic Deterioration|1|||
125329119|NCT00705016|450837387|FG002|Overall Study|Symptomatic Deterioration|1|||
125329120|NCT00705016|450837385|FG000|Overall Study|Other|9|||
125329121|NCT00705016|450837386|FG001|Overall Study|Other|6|||
125329122|NCT00705016|450837387|FG002|Overall Study|Other|6|||
125329123|NCT01967940|450837394|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
125329124|NCT01967940|450837395|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
125329125|NCT01967940|450837396|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
125329126|NCT01967940|450837397|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
125665147|NCT02983227|452062755|FG000|Overall Study|Lost to Follow-up|3|||
125665148|NCT02983227|452062756|FG001|Overall Study|Lost to Follow-up|0|||
125329127|NCT01967940|450837394|FG000|Part 2|Adverse Event|0|||
125329128|NCT01967940|450837395|FG001|Part 2|Adverse Event|0|||
125665149|NCT02983227|452062755|FG000|Overall Study|Multiple Reasons|2|||
125665150|NCT02983227|452062756|FG001|Overall Study|Multiple Reasons|1|||
125665151|NCT02983227|452062755|FG000|Overall Study|Physician Decision|3|||
125665152|NCT02983227|452062756|FG001|Overall Study|Physician Decision|1|||
125665153|NCT02983227|452062755|FG000|Overall Study|Withdrawal by Subject|19|||
125665154|NCT02983227|452062756|FG001|Overall Study|Withdrawal by Subject|8|||
125665155|NCT01493531|452062759|FG000|Overall Study|Adverse Event|4|||
125665156|NCT01493531|452062760|FG001|Overall Study|Adverse Event|12|||
125665157|NCT01493531|452062761|FG002|Overall Study|Adverse Event|9|||
125665158|NCT01493531|452062759|FG000|Overall Study|Gout flare|3|||
125665159|NCT01493531|452062760|FG001|Overall Study|Gout flare|0|||
125665160|NCT01493531|452062761|FG002|Overall Study|Gout flare|2|||
125665161|NCT01493531|452062759|FG000|Overall Study|Protocol Violation|8|||
125665162|NCT01493531|452062760|FG001|Overall Study|Protocol Violation|15|||
125665163|NCT01493531|452062761|FG002|Overall Study|Protocol Violation|12|||
125665164|NCT01493531|452062759|FG000|Overall Study|Sponsor terminated study|5|||
125665165|NCT01493531|452062760|FG001|Overall Study|Sponsor terminated study|2|||
125665166|NCT01493531|452062761|FG002|Overall Study|Sponsor terminated study|3|||
125665167|NCT01493531|452062759|FG000|Overall Study|Lost to Follow-up|5|||
125665168|NCT01493531|452062760|FG001|Overall Study|Lost to Follow-up|7|||
125665169|NCT01493531|452062761|FG002|Overall Study|Lost to Follow-up|11|||
125665170|NCT01493531|452062759|FG000|Overall Study|Withdrawal by Subject|16|||
125665171|NCT01493531|452062760|FG001|Overall Study|Withdrawal by Subject|13|||
125665172|NCT01493531|452062761|FG002|Overall Study|Withdrawal by Subject|11|||
125665173|NCT01493531|452062759|FG000|Overall Study|Death|0|||
125665174|NCT01493531|452062760|FG001|Overall Study|Death|1|||
125665175|NCT01493531|452062761|FG002|Overall Study|Death|0|||
125665176|NCT01946282|452062762|FG000|Year 1|Did not return FIT kit|4186|||
125665177|NCT01946282|452062763|FG001|Year 1|Did not return FIT kit|608|||
125665178|NCT01946282|452062764|FG002|Year 1|Did not return FIT kit|654|||
125665179|NCT01946282|452062762|FG000|Year 2|Did not return FIT kit|803|||
125665180|NCT01946282|452062763|FG001|Year 2|Did not return FIT kit|131|||
125665181|NCT01946282|452062764|FG002|Year 2|Did not return FIT kit|115|||
125665182|NCT01946282|452062762|FG000|Year 3|Did not return FIT kit|288|||
125665183|NCT01946282|452062763|FG001|Year 3|Did not return FIT kit|43|||
125665184|NCT01946282|452062764|FG002|Year 3|Did not return FIT kit|30|||
125665185|NCT03031431|452062767|FG000|Overall Study|Infant removed by maternal request|1|||
125665186|NCT01205529|452062768|FG000|Overall Study|Procedure Cancelled|4|||
125665187|NCT01205529|452062768|FG000|Overall Study|Withdrawal by Subject|2|||
125665188|NCT01205529|452062768|FG000|Overall Study|Physician Decision|4|||
125665189|NCT01205529|452062768|FG000|Overall Study|Unstable post op|15|||
125665190|NCT01205529|452062768|FG000|Overall Study|No longer met criteria|30|||
125665191|NCT01027884|452062773|FG000|Overall Study|Adverse Event|2|||
125665192|NCT01027884|452062774|FG001|Overall Study|Adverse Event|1|||
125665193|NCT01027884|452062773|FG000|Overall Study|Protocol Violation|1|||
125665194|NCT01027884|452062774|FG001|Overall Study|Protocol Violation|0|||
125665195|NCT01027884|452062773|FG000|Overall Study|Non-compliance|1|||
125665196|NCT01027884|452062774|FG001|Overall Study|Non-compliance|1|||
125665197|NCT01027884|452062773|FG000|Overall Study|Withdrawal by Subject|0|||
125665198|NCT01027884|452062774|FG001|Overall Study|Withdrawal by Subject|1|||
125665199|NCT01027884|452062773|FG000|Overall Study|Lost to Follow-up|0|||
125665200|NCT01027884|452062774|FG001|Overall Study|Lost to Follow-up|1|||
125665201|NCT01027884|452062773|FG000|Overall Study|Spinal fixation surgery|0|||
125665202|NCT01027884|452062774|FG001|Overall Study|Spinal fixation surgery|3|||
125665203|NCT03670537|452062775|FG000|Overall Study|Protocol Violation|1|||
125665204|NCT02059187|452062776|FG000|Overall Study|Adverse Event|0|||
125665205|NCT02059187|452062777|FG001|Overall Study|Adverse Event|3|||
125665206|NCT02059187|452062776|FG000|Overall Study|Death|1|||
125665207|NCT02059187|452062777|FG001|Overall Study|Death|1|||
125665208|NCT02059187|452062776|FG000|Overall Study|Lost to Follow-up|9|||
125665209|NCT02059187|452062777|FG001|Overall Study|Lost to Follow-up|8|||
125665210|NCT02059187|452062776|FG000|Overall Study|Non-compliance with study drug|1|||
125665211|NCT02059187|452062777|FG001|Overall Study|Non-compliance with study drug|0|||
125665212|NCT02059187|452062776|FG000|Overall Study|Physician Decision|1|||
125665213|NCT02059187|452062777|FG001|Overall Study|Physician Decision|2|||
125665214|NCT02059187|452062776|FG000|Overall Study|Protocol Violation|1|||
125665215|NCT02059187|452062777|FG001|Overall Study|Protocol Violation|0|||
125665216|NCT02059187|452062776|FG000|Overall Study|Withdrawal by Subject|12|||
125665217|NCT02059187|452062777|FG001|Overall Study|Withdrawal by Subject|8|||
125665218|NCT03070431|452062778|FG000|Overall Study|Withdrawal by Subject|2|||
125665219|NCT03070431|452062778|FG000|Overall Study|Lost to Follow-up|2|||
125665220|NCT01889862|452062779|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
125665221|NCT01889862|452062780|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
125665222|NCT01889862|452062781|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
125665223|NCT01889862|452062782|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
125665224|NCT01889862|452062783|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
125665225|NCT01889862|452062779|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
125665226|NCT01889862|452062780|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
125665227|NCT01889862|452062781|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
125665228|NCT01889862|452062782|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
125665229|NCT01889862|452062783|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
125665230|NCT01889862|452062779|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
125665231|NCT01889862|452062780|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
125665232|NCT01889862|452062781|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
125665233|NCT01889862|452062782|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
125665234|NCT01889862|452062783|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
125665235|NCT01889862|452062779|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
125665236|NCT01889862|452062780|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
125665237|NCT01889862|452062781|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
125665238|NCT01889862|452062782|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
125665239|NCT01889862|452062783|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
125665240|NCT01889862|452062779|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
125665241|NCT01889862|452062780|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
125665242|NCT01889862|452062781|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
125665243|NCT01889862|452062782|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
125665244|NCT01889862|452062783|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
125665245|NCT01889862|452062779|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
125665246|NCT01889862|452062780|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
125665247|NCT01889862|452062781|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
125665248|NCT01889862|452062782|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
125665249|NCT01889862|452062783|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
125665250|NCT01889862|452062779|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
125665251|NCT01889862|452062780|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
125665252|NCT01889862|452062781|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
125665253|NCT01889862|452062782|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
125665254|NCT01889862|452062783|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
125665255|NCT01889862|452062779|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
125665256|NCT01889862|452062780|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
125665257|NCT01889862|452062781|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
125665258|NCT01889862|452062782|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
125665259|NCT01889862|452062783|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
125665260|NCT01889862|452062779|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
125665261|NCT01889862|452062780|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
125665262|NCT01889862|452062781|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
125665263|NCT01889862|452062782|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
125665264|NCT01889862|452062783|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
125665265|NCT01889862|452062779|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
125665266|NCT01889862|452062780|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
125665267|NCT01889862|452062781|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
125665268|NCT01889862|452062782|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
125665269|NCT01889862|452062783|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
125665270|NCT00845026|452062784|FG000|Study Period III|Adverse Event|23|||
125665271|NCT00845026|452062785|FG001|Study Period III|Adverse Event|19|||
125665272|NCT00845026|452062784|FG000|Study Period III|Perceived lack of efficacy|27|||
125665273|NCT00845026|452062785|FG001|Study Period III|Perceived lack of efficacy|15|||
125665274|NCT00845026|452062784|FG000|Study Period III|Withdrawal by Subject|19|||
125665275|NCT00845026|452062785|FG001|Study Period III|Withdrawal by Subject|15|||
125329129|NCT01967940|450837396|FG002|Part 2|Adverse Event|0|||
125329130|NCT01967940|450837397|FG003|Part 2|Adverse Event|1|||
125329131|NCT01967940|450837394|FG000|Part 2|Unknown Reason|0|||
125329132|NCT01967940|450837395|FG001|Part 2|Unknown Reason|0|||
125329133|NCT01967940|450837396|FG002|Part 2|Unknown Reason|0|||
125329134|NCT01967940|450837397|FG003|Part 2|Unknown Reason|1|||
125329135|NCT00942604|450837399|FG000|Overall Study|Protocol Violation|1|||
125329136|NCT00942604|450837400|FG001|Overall Study|Protocol Violation|1|||
125329137|NCT00942604|450837399|FG000|Overall Study|Adverse Event|0|||
125329138|NCT00942604|450837400|FG001|Overall Study|Adverse Event|1|||
125329139|NCT00942604|450837399|FG000|Overall Study|Withdrawal by Subject|0|||
125329140|NCT00942604|450837400|FG001|Overall Study|Withdrawal by Subject|1|||
125329141|NCT00942604|450837399|FG000|Overall Study|Patient relocation|1|||
125329142|NCT00942604|450837400|FG001|Overall Study|Patient relocation|1|||
125329143|NCT01188343|450837401|FG000|Overall Study|Not vaccinated|0|||
125329144|NCT01188343|450837402|FG001|Overall Study|Not vaccinated|2|||
125329145|NCT01188343|450837403|FG002|Overall Study|Not vaccinated|1|||
125329146|NCT01188343|450837401|FG000|Overall Study|Withdrawal by Subject|1|||
125329147|NCT01188343|450837402|FG001|Overall Study|Withdrawal by Subject|24|||
125329148|NCT01188343|450837403|FG002|Overall Study|Withdrawal by Subject|0|||
125665276|NCT00845026|452062784|FG000|Study Period III|Entry Criteria not met|8|||
125665277|NCT00845026|452062785|FG001|Study Period III|Entry Criteria not met|11|||
125665278|NCT00845026|452062784|FG000|Study Period III|Lost to Follow-up|4|||
125665279|NCT00845026|452062785|FG001|Study Period III|Lost to Follow-up|5|||
125329149|NCT01143246|450837404|FG000|Overall Study|Adverse Event|24|||
125329150|NCT01143246|450837405|FG001|Overall Study|Adverse Event|28|||
125329151|NCT01143246|450837404|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
125665280|NCT00845026|452062784|FG000|Study Period III|Protocol Violation|8|||
125665281|NCT00845026|452062785|FG001|Study Period III|Protocol Violation|1|||
125665282|NCT00845026|452062784|FG000|Study Period III|Scheduled conflict|3|||
125665283|NCT00845026|452062785|FG001|Study Period III|Scheduled conflict|1|||
125665284|NCT00845026|452062784|FG000|Study Period III|Subject is moving or has moved|2|||
125665285|NCT00845026|452062785|FG001|Study Period III|Subject is moving or has moved|4|||
125665286|NCT00845026|452062784|FG000|Study Period III|Transportation issues|1|||
125665287|NCT00845026|452062785|FG001|Study Period III|Transportation issues|1|||
125665288|NCT00845026|452062784|FG000|Study Period IV|Adverse Event|4|||
125665289|NCT00845026|452062785|FG001|Study Period IV|Adverse Event|0|||
125665290|NCT00845026|452062784|FG000|Study Period IV|Perceived lack of efficacy|2|||
125665291|NCT00845026|452062785|FG001|Study Period IV|Perceived lack of efficacy|1|||
125665292|NCT00845026|452062784|FG000|Study Period IV|Protocol Violation|3|||
125665293|NCT00845026|452062785|FG001|Study Period IV|Protocol Violation|1|||
125665294|NCT00845026|452062784|FG000|Study Period IV|Lost to Follow-up|1|||
125665295|NCT00845026|452062785|FG001|Study Period IV|Lost to Follow-up|0|||
125665296|NCT00845026|452062784|FG000|Study Period IV|Withdrawal by Subject|4|||
125665297|NCT00845026|452062785|FG001|Study Period IV|Withdrawal by Subject|1|||
125665298|NCT00845026|452062784|FG000|Study Period IV|Entry Criteria Not Met|1|||
125665299|NCT00845026|452062785|FG001|Study Period IV|Entry Criteria Not Met|0|||
125665300|NCT00845026|452062784|FG000|Study Period IV|Subject is moving or has moved|0|||
125665301|NCT00845026|452062785|FG001|Study Period IV|Subject is moving or has moved|1|||
125665302|NCT00845026|452062784|FG000|Study Period IV|Scheduling conflict|1|||
125665303|NCT00845026|452062785|FG001|Study Period IV|Scheduling conflict|0|||
125665304|NCT01325532|452062786|FG000|Overall Study|Withdrawal by Subject|2|||
125665305|NCT01325532|452062787|FG001|Overall Study|Withdrawal by Subject|0|||
125665306|NCT03012815|452062788|FG000|Overall Study|Lost to Follow-up|1|||
125665307|NCT03012815|452062789|FG001|Overall Study|Lost to Follow-up|0|||
125665308|NCT03012815|452062788|FG000|Overall Study|Physician Decision|3|||
125665309|NCT03012815|452062789|FG001|Overall Study|Physician Decision|2|||
125665310|NCT03012815|452062788|FG000|Overall Study|Adverse Event|1|||
125665311|NCT03012815|452062789|FG001|Overall Study|Adverse Event|0|||
125665312|NCT01252238|452062790|FG000|Overall Study|Sponsor terminated study|4|||
125665313|NCT01252238|452062791|FG001|Overall Study|Sponsor terminated study|4|||
125665314|NCT01252238|452062792|FG002|Overall Study|Sponsor terminated study|4|||
125665315|NCT06371079|452062797|FG000|Overall Study|Missing data|88|||
125329152|NCT01143246|450837405|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
125329153|NCT01143246|450837404|FG000|Overall Study|Lost to Follow-up|0|||
125329154|NCT01143246|450837405|FG001|Overall Study|Lost to Follow-up|1|||
125329155|NCT01143246|450837404|FG000|Overall Study|Death|16|||
125329156|NCT01143246|450837405|FG001|Overall Study|Death|15|||
125329157|NCT01143246|450837404|FG000|Overall Study|Reason not Specified|3|||
125329158|NCT01143246|450837405|FG001|Overall Study|Reason not Specified|5|||
125329159|NCT01663103|450837406|FG000|Overall Study|Withdrawal by Subject|1|||
125329160|NCT01663103|450837407|FG001|Overall Study|Withdrawal by Subject|2|||
125329161|NCT01663103|450837406|FG000|Overall Study|Adverse Event|1|||
125329162|NCT01663103|450837407|FG001|Overall Study|Adverse Event|0|||
125329163|NCT01663103|450837406|FG000|Overall Study|dog bite|1|||
125329164|NCT01663103|450837407|FG001|Overall Study|dog bite|0|||
125329165|NCT05375760|450837408|FG000|Overall Study|Adverse Event|1|||
125329166|NCT05375760|450837409|FG001|Overall Study|Adverse Event|0|||
125329167|NCT05375760|450837408|FG000|Overall Study|Death|0|||
125329168|NCT05375760|450837409|FG001|Overall Study|Death|1|||
125329169|NCT05375760|450837408|FG000|Overall Study|Lost to Follow-up|6|||
125329170|NCT05375760|450837409|FG001|Overall Study|Lost to Follow-up|6|||
125329171|NCT05375760|450837408|FG000|Overall Study|Withdrawal by Subject|17|||
125329172|NCT05375760|450837409|FG001|Overall Study|Withdrawal by Subject|19|||
125329173|NCT05375760|450837408|FG000|Overall Study|Dosing halted by FDA|96|||
125329174|NCT05375760|450837409|FG001|Overall Study|Dosing halted by FDA|100|||
125329175|NCT05375760|450837408|FG000|Overall Study|Not compliant with study visit|2|||
125329176|NCT05375760|450837409|FG001|Overall Study|Not compliant with study visit|0|||
125329177|NCT05375760|450837408|FG000|Overall Study|Physician Decision|1|||
125329178|NCT05375760|450837409|FG001|Overall Study|Physician Decision|0|||
125665316|NCT06371079|452062798|FG001|Overall Study|Missing data|247|||
125665317|NCT03276962|452062800|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
125665318|NCT03276962|452062801|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
125665319|NCT03276962|452062802|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
125665320|NCT03276962|452062803|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
125665321|NCT03276962|452062804|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
125665322|NCT03276962|452062800|FG000|Overall Study|Protocol Deviation|2|||
125665323|NCT03276962|452062801|FG001|Overall Study|Protocol Deviation|0|||
125665324|NCT03276962|452062802|FG002|Overall Study|Protocol Deviation|1|||
125665325|NCT03276962|452062803|FG003|Overall Study|Protocol Deviation|2|||
125665326|NCT03276962|452062804|FG004|Overall Study|Protocol Deviation|1|||
125329179|NCT05375760|450837408|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
125329180|NCT05375760|450837409|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
125329181|NCT05375760|450837408|FG000|Overall Study|Participant moved|1|||
125665327|NCT03276962|452062800|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
125665328|NCT03276962|452062801|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
125665329|NCT03276962|452062802|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
125665330|NCT03276962|452062803|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
125665331|NCT03276962|452062804|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
125665332|NCT03276962|452062800|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
125665333|NCT03276962|452062801|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
125665334|NCT03276962|452062802|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
125665335|NCT03276962|452062803|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
125665336|NCT03276962|452062804|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
125665337|NCT03276962|452062800|FG000|Overall Study|Lost to Follow-up|10|||
125665338|NCT03276962|452062801|FG001|Overall Study|Lost to Follow-up|10|||
125665339|NCT03276962|452062802|FG002|Overall Study|Lost to Follow-up|4|||
125665340|NCT03276962|452062803|FG003|Overall Study|Lost to Follow-up|6|||
125665341|NCT03276962|452062804|FG004|Overall Study|Lost to Follow-up|10|||
125665342|NCT03276962|452062800|FG000|Overall Study|Other|0|||
125665343|NCT03276962|452062801|FG001|Overall Study|Other|2|||
125665344|NCT03276962|452062802|FG002|Overall Study|Other|0|||
125665345|NCT03276962|452062803|FG003|Overall Study|Other|2|||
125665346|NCT03276962|452062804|FG004|Overall Study|Other|1|||
125665347|NCT00411762|452062805|FG000|Overall Study|Withdrawal by Subject|5|||
125665348|NCT03550794|452062814|FG000|Overall Study|No longer met inclusion criteria|1|||
125665349|NCT03550794|452062815|FG001|Overall Study|No longer met inclusion criteria|2|||
125665350|NCT03550794|452062814|FG000|Overall Study|Goals of care changed|1|||
125665351|NCT03550794|452062815|FG001|Overall Study|Goals of care changed|0|||
125665352|NCT03550794|452062814|FG000|Overall Study|Withdrawal by Subject|2|||
125329182|NCT05375760|450837409|FG001|Overall Study|Participant moved|0|||
125329183|NCT00363480|450837410|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
125329184|NCT00363480|450837410|FG000|Overall Study|Adverse Event|4|||
125329185|NCT00363480|450837410|FG000|Overall Study|Lost to Follow-up|5|||
125329186|NCT00363480|450837410|FG000|Overall Study|Withdrawal by Subject|5|||
125329187|NCT00363480|450837410|FG000|Overall Study|Non-compliance of subject|1|||
125329188|NCT00363480|450837410|FG000|Overall Study|Participant discontinued on its own|1|||
125329189|NCT05567783|450837413|FG000|Overall Study|Death|2|||
125329190|NCT05567783|450837414|FG001|Overall Study|Death|3|||
125329191|NCT05567783|450837415|FG002|Overall Study|Death|0|||
125329192|NCT05567783|450837413|FG000|Overall Study|Lost to Follow-up|25|||
125665353|NCT03550794|452062815|FG001|Overall Study|Withdrawal by Subject|0|||
125665354|NCT03550794|452062814|FG000|Overall Study|Death|0|||
125665355|NCT03550794|452062815|FG001|Overall Study|Death|1|||
125329193|NCT05567783|450837414|FG001|Overall Study|Lost to Follow-up|19|||
125665356|NCT00558519|452062816|FG000|Overall Study|Ph+|20|||
125329194|NCT05567783|450837415|FG002|Overall Study|Lost to Follow-up|17|||
125329195|NCT05567783|450837413|FG000|Overall Study|Physician Decision|10|||
125329196|NCT05567783|450837414|FG001|Overall Study|Physician Decision|7|||
125329197|NCT05567783|450837415|FG002|Overall Study|Physician Decision|9|||
125329198|NCT05567783|450837413|FG000|Overall Study|Study Terminated by Sponsor|924|||
125329199|NCT05567783|450837414|FG001|Overall Study|Study Terminated by Sponsor|937|||
125329200|NCT05567783|450837415|FG002|Overall Study|Study Terminated by Sponsor|941|||
125329201|NCT05567783|450837413|FG000|Overall Study|Withdrawal by Subject|23|||
125329202|NCT05567783|450837414|FG001|Overall Study|Withdrawal by Subject|27|||
125329203|NCT05567783|450837415|FG002|Overall Study|Withdrawal by Subject|24|||
125329204|NCT05567783|450837413|FG000|Overall Study|Incarcerated|1|||
125329205|NCT05567783|450837414|FG001|Overall Study|Incarcerated|0|||
125329206|NCT05567783|450837415|FG002|Overall Study|Incarcerated|0|||
125329207|NCT05567783|450837413|FG000|Overall Study|Participant randomized in error|4|||
125329208|NCT05567783|450837414|FG001|Overall Study|Participant randomized in error|2|||
125329209|NCT05567783|450837415|FG002|Overall Study|Participant randomized in error|2|||
125329210|NCT03113487|450837420|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
125329211|NCT03944577|450837426|FG000|Overall Study|Adverse Event|3|||
125665357|NCT00558519|452062816|FG000|Overall Study|Ineligible|1|||
125665358|NCT00558519|452062816|FG000|Overall Study|Insufficient data|1|||
125665359|NCT00558519|452062816|FG000|Overall Study|Never received treatment|1|||
125329212|NCT00949702|450837436|FG000|Overall Study|Death|40|||
125329213|NCT00949702|450837436|FG000|Overall Study|Disease progression|7|||
125329214|NCT00949702|450837436|FG000|Overall Study|Withdrawal of consent|1|||
125329215|NCT01654302|450837437|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
125329216|NCT01654302|450837438|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
125329217|NCT04119414|450837439|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
125665360|NCT02278952|452062817|FG000|Overall Study|Insufficient Sample|6|||
125665361|NCT00869089|452062820|FG000|Overall Study|Lost to Follow-up|1|||
125665362|NCT00869089|452062820|FG000|Overall Study|Withdrawal by Subject|1|||
125665363|NCT00869089|452062820|FG000|Overall Study|Screen Fail|1|||
125329218|NCT00630838|450837444|FG000|Overall Study|Death|0|||
125329219|NCT00630838|450837445|FG001|Overall Study|Death|1|||
125665364|NCT01963676|452064477|FG000|Overall Study|Withdrawal by Subject|1|||
125665365|NCT01963676|452064478|FG001|Overall Study|Withdrawal by Subject|0|||
125665366|NCT01246973|452064479|FG000|Overall Study|Other|38|||
125665367|NCT01246973|452064480|FG001|Overall Study|Other|25|||
125665368|NCT01246973|452064479|FG000|Overall Study|Adverse Event|16|||
125665369|NCT01246973|452064480|FG001|Overall Study|Adverse Event|9|||
125665370|NCT01246973|452064479|FG000|Overall Study|Withdrawal by Subject|7|||
125665371|NCT01246973|452064480|FG001|Overall Study|Withdrawal by Subject|13|||
125665372|NCT00766506|452064481|FG000|Overall Study|Use rescue medication after 3 hours|3|||
125665373|NCT00766506|452064482|FG001|Overall Study|Use rescue medication after 3 hours|0|||
125665374|NCT00766506|452064481|FG000|Overall Study|Other|2|||
125665375|NCT00766506|452064482|FG001|Overall Study|Other|2|||
125665376|NCT02496221|452064483|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
125665377|NCT02496221|452064484|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
125665378|NCT02496221|452064483|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
125665379|NCT02496221|452064484|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
125665380|NCT02496221|452064483|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
125665381|NCT02496221|452064484|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
125665382|NCT03262233|452064485|FG000|Overall Study|Withdrawal by Subject|12|||
125665383|NCT03262233|452064486|FG001|Overall Study|Withdrawal by Subject|8|||
125665384|NCT03262233|452064487|FG002|Overall Study|Withdrawal by Subject|21|||
125665385|NCT03262233|452064488|FG003|Overall Study|Withdrawal by Subject|13|||
125665386|NCT03262233|452064485|FG000|Overall Study|Declined due to shock|1|||
125665387|NCT03262233|452064486|FG001|Overall Study|Declined due to shock|2|||
125665388|NCT03262233|452064487|FG002|Overall Study|Declined due to shock|2|||
125665389|NCT03262233|452064488|FG003|Overall Study|Declined due to shock|3|||
125665390|NCT03262233|452064485|FG000|Overall Study|Protocol Violation|5|||
125665391|NCT03262233|452064486|FG001|Overall Study|Protocol Violation|10|||
125665392|NCT03262233|452064487|FG002|Overall Study|Protocol Violation|2|||
125665393|NCT03262233|452064488|FG003|Overall Study|Protocol Violation|13|||
125665394|NCT03262233|452064485|FG000|Overall Study|data collection artifact|0|||
125665395|NCT03262233|452064486|FG001|Overall Study|data collection artifact|1|||
125665396|NCT03262233|452064487|FG002|Overall Study|data collection artifact|0|||
125665397|NCT03262233|452064488|FG003|Overall Study|data collection artifact|0|||
125665398|NCT01120600|452064491|FG000|Overall Study|Adverse Event|7|||
125665399|NCT01120600|452064492|FG001|Overall Study|Adverse Event|7|||
125665400|NCT01120600|452064491|FG000|Overall Study|Excessive Bone Loss|0|||
125665401|NCT01120600|452064492|FG001|Overall Study|Excessive Bone Loss|4|||
125665402|NCT01120600|452064491|FG000|Overall Study|Lost to Follow-up|1|||
125665403|NCT01120600|452064492|FG001|Overall Study|Lost to Follow-up|3|||
125665404|NCT01120600|452064491|FG000|Overall Study|Physician Decision|1|||
125665405|NCT01120600|452064492|FG001|Overall Study|Physician Decision|3|||
125665406|NCT01120600|452064491|FG000|Overall Study|Protocol Violation|0|||
125665407|NCT01120600|452064492|FG001|Overall Study|Protocol Violation|4|||
125665408|NCT01120600|452064491|FG000|Overall Study|Withdrawal by Subject|10|||
125665409|NCT01120600|452064492|FG001|Overall Study|Withdrawal by Subject|11|||
125329220|NCT00630838|450837444|FG000|Overall Study|Lost to Follow-up|0|||
125329221|NCT00630838|450837445|FG001|Overall Study|Lost to Follow-up|1|||
125329222|NCT00670748|450837446|FG000|Overall Study|Death during treatment|1|||
125329223|NCT00670748|450837447|FG001|Overall Study|Death during treatment|1|||
125329224|NCT00670748|450837448|FG002|Overall Study|Death during treatment|1|||
125329225|NCT00670748|450837449|FG003|Overall Study|Death during treatment|0|||
125329226|NCT00670748|450837446|FG000|Overall Study|Not off study|2|||
125329227|NCT00670748|450837447|FG001|Overall Study|Not off study|1|||
125329228|NCT00670748|450837448|FG002|Overall Study|Not off study|1|||
125329229|NCT00670748|450837449|FG003|Overall Study|Not off study|1|||
125329230|NCT02807402|450837455|FG000|Overall Study|Failure to Return|1|||
125329231|NCT02807402|450837455|FG000|Overall Study|Death|3|||
125329232|NCT02807402|450837455|FG000|Overall Study|Other|2|||
125329233|NCT04922216|450837459|FG000|Overall Study|Withdrawal by Subject|0|||
125329234|NCT04922216|450837460|FG001|Overall Study|Withdrawal by Subject|1|||
125665410|NCT01165242|452064493|FG000|Overall Study|Unreachable Subjects|1|||
125665411|NCT01165242|452064494|FG001|Overall Study|Unreachable Subjects|0|||
125665412|NCT01165242|452064495|FG002|Overall Study|Unreachable Subjects|0|||
125665413|NCT01165242|452064493|FG000|Overall Study|Incarcerated Subjects|0|||
125665414|NCT01165242|452064494|FG001|Overall Study|Incarcerated Subjects|1|||
125665415|NCT01165242|452064495|FG002|Overall Study|Incarcerated Subjects|0|||
125665416|NCT01165242|452064493|FG000|Overall Study|Visit 2 Declined by Subject|0|||
125665417|NCT01165242|452064494|FG001|Overall Study|Visit 2 Declined by Subject|0|||
125665418|NCT01165242|452064495|FG002|Overall Study|Visit 2 Declined by Subject|1|||
125665419|NCT01165242|452064493|FG000|Overall Study|Withdrawal by Subject|0|||
125665420|NCT01165242|452064494|FG001|Overall Study|Withdrawal by Subject|2|||
125329235|NCT04922216|450837461|FG002|Overall Study|Withdrawal by Subject|0|||
125329236|NCT04922216|450837462|FG003|Overall Study|Withdrawal by Subject|0|||
125665421|NCT01165242|452064495|FG002|Overall Study|Withdrawal by Subject|2|||
125665422|NCT01165242|452064493|FG000|Overall Study|Extended Holiday|0|||
125665423|NCT01165242|452064494|FG001|Overall Study|Extended Holiday|0|||
125665424|NCT01165242|452064495|FG002|Overall Study|Extended Holiday|1|||
125665425|NCT01165242|452064493|FG000|Overall Study|Lost to Follow-up|9|||
125665426|NCT01165242|452064494|FG001|Overall Study|Lost to Follow-up|7|||
125665427|NCT01165242|452064495|FG002|Overall Study|Lost to Follow-up|10|||
125665428|NCT03770000|452064496|FG000|Overall Study|Premature discontinuation due to PD|0|||
125665429|NCT03770000|452064497|FG001|Overall Study|Premature discontinuation due to PD|0|||
125665430|NCT03770000|452064498|FG002|Overall Study|Premature discontinuation due to PD|1|||
125665431|NCT03770000|452064499|FG003|Overall Study|Premature discontinuation due to PD|3|||
125665432|NCT03770000|452064500|FG004|Overall Study|Premature discontinuation due to PD|2|||
125665433|NCT03877237|452064501|FG000|Overall Study|Adverse Event|1|||
125665434|NCT03877237|452064502|FG001|Overall Study|Adverse Event|2|||
125665435|NCT03877237|452064501|FG000|Overall Study|Death|3|||
125665436|NCT03877237|452064502|FG001|Overall Study|Death|2|||
125665437|NCT03877237|452064501|FG000|Overall Study|Physician Decision|1|||
125665438|NCT03877237|452064502|FG001|Overall Study|Physician Decision|0|||
125665439|NCT03877237|452064501|FG000|Overall Study|Withdrawal by Subject|0|||
125665440|NCT03877237|452064502|FG001|Overall Study|Withdrawal by Subject|2|||
125665441|NCT00566098|452064504|FG000|Collection of MILs|Withdrawal by Subject|1|||
125665442|NCT00566098|452064504|FG000|Collection of MILs|Relapsed|1|||
125665443|NCT00566098|452064504|FG000|Generation of MILs Product|Relapsed|1|||
125665444|NCT00566098|452064504|FG000|Administration of ASCT+MILs|Death|10|||
125665445|NCT00566098|452064504|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
125665446|NCT02236754|452064505|FG000|Overall Study|Withdrawal by Subject|1|||
125665447|NCT02236754|452064506|FG001|Overall Study|Withdrawal by Subject|0|||
125665448|NCT00382291|452064507|FG000|Overall Study|Adverse Event|1|||
125665449|NCT00382291|452064508|FG001|Overall Study|Adverse Event|2|||
125665450|NCT00382291|452064509|FG002|Overall Study|Adverse Event|2|||
125665451|NCT00382291|452064507|FG000|Overall Study|Protocol Violation|1|||
125665452|NCT00382291|452064508|FG001|Overall Study|Protocol Violation|0|||
125665453|NCT00382291|452064509|FG002|Overall Study|Protocol Violation|0|||
125665454|NCT00382291|452064507|FG000|Overall Study|Temporary study suspension|2|||
125665455|NCT00382291|452064508|FG001|Overall Study|Temporary study suspension|2|||
125665456|NCT00382291|452064509|FG002|Overall Study|Temporary study suspension|5|||
125665457|NCT00382291|452064507|FG000|Overall Study|Withdrawal by Subject|0|||
125665458|NCT00382291|452064508|FG001|Overall Study|Withdrawal by Subject|2|||
125665459|NCT00382291|452064509|FG002|Overall Study|Withdrawal by Subject|0|||
125665460|NCT00382291|452064507|FG000|Overall Study|Physician Decision|0|||
125665461|NCT00382291|452064508|FG001|Overall Study|Physician Decision|1|||
125665462|NCT00382291|452064509|FG002|Overall Study|Physician Decision|0|||
125665463|NCT00382291|452064507|FG000|Overall Study|Lack of Efficacy|0|||
125665464|NCT00382291|452064508|FG001|Overall Study|Lack of Efficacy|0|||
125665465|NCT00382291|452064509|FG002|Overall Study|Lack of Efficacy|1|||
125665466|NCT00265083|452064514|FG000|Overall Study|Adverse Event|5|||
125665467|NCT00265083|452064515|FG001|Overall Study|Adverse Event|13|||
125665468|NCT00265083|452064516|FG002|Overall Study|Adverse Event|15|||
125665469|NCT00265083|452064514|FG000|Overall Study|Lost to Follow-up|3|||
125665470|NCT00265083|452064515|FG001|Overall Study|Lost to Follow-up|4|||
125665471|NCT00265083|452064516|FG002|Overall Study|Lost to Follow-up|4|||
125665472|NCT00265083|452064514|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
125665473|NCT00265083|452064515|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
125665474|NCT00265083|452064516|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
125665475|NCT00265083|452064514|FG000|Overall Study|Other|1|||
125665476|NCT00265083|452064515|FG001|Overall Study|Other|12|||
125665477|NCT00265083|452064516|FG002|Overall Study|Other|9|||
125665478|NCT04242186|452064517|FG000|Overall Study|Death|5|||
125665479|NCT00534092|452064518|FG000|Overall Study|Lost to Follow-up|1|||
125665480|NCT00534092|452064519|FG001|Overall Study|Lost to Follow-up|0|||
125665481|NCT00534092|452064518|FG000|Overall Study|personal reasons/family concerns|1|||
125665482|NCT00534092|452064519|FG001|Overall Study|personal reasons/family concerns|0|||
125665483|NCT02323295|452064520|FG000|Overall Study|Adverse Event|0|||
125665484|NCT02323295|452064521|FG001|Overall Study|Adverse Event|1|||
125665485|NCT02323295|452064520|FG000|Overall Study|Withdrawal by Subject|0|||
125665486|NCT02323295|452064521|FG001|Overall Study|Withdrawal by Subject|1|||
125665487|NCT02323295|452064520|FG000|Overall Study|Patient did not have surgery as planned.|0|||
125665488|NCT02323295|452064521|FG001|Overall Study|Patient did not have surgery as planned.|1|||
125665489|NCT01155063|452064522|FG000|Overall Study|Adverse Event|1|||
125665490|NCT01155063|452064522|FG000|Overall Study|Withdrawal by Subject|1|||
125665491|NCT01155063|452064522|FG000|Overall Study|Study terminated by sponsor|87|||
125665492|NCT01314703|452064523|FG000|Overall Study|screen failure and closed enrollment|8|||
125665493|NCT02770716|452064530|FG000|Overall Study|Death|101|||
125665494|NCT02770716|452064531|FG001|Overall Study|Death|45|||
125665495|NCT02770716|452064530|FG000|Overall Study|Withdrawal by Subject|4|||
125665496|NCT02770716|452064531|FG001|Overall Study|Withdrawal by Subject|2|||
125665497|NCT02770716|452064530|FG000|Overall Study|Lost to Follow-up|1|||
125665498|NCT02770716|452064531|FG001|Overall Study|Lost to Follow-up|0|||
125665499|NCT02770716|452064530|FG000|Overall Study|Various reasons|6|||
125665500|NCT02770716|452064531|FG001|Overall Study|Various reasons|2|||
125665501|NCT03989115|452064532|FG000|Overall Study|Withdrawal by Subject|2|||
125665502|NCT03989115|452064533|FG001|Overall Study|Withdrawal by Subject|1|||
125329237|NCT04922216|450837463|FG004|Overall Study|Withdrawal by Subject|0|||
125665503|NCT03989115|452064534|FG002|Overall Study|Withdrawal by Subject|3|||
125665504|NCT03989115|452064535|FG003|Overall Study|Withdrawal by Subject|0|||
125665505|NCT03989115|452064536|FG004|Overall Study|Withdrawal by Subject|17|||
125665506|NCT03989115|452064537|FG005|Overall Study|Withdrawal by Subject|1|||
125665507|NCT03989115|452064538|FG006|Overall Study|Withdrawal by Subject|0|||
125665508|NCT03989115|452064539|FG007|Overall Study|Withdrawal by Subject|0|||
125665509|NCT03989115|452064532|FG000|Overall Study|Sponsor decision to terminate the study|1|||
125665510|NCT03989115|452064533|FG001|Overall Study|Sponsor decision to terminate the study|1|||
125665511|NCT03989115|452064534|FG002|Overall Study|Sponsor decision to terminate the study|0|||
125665512|NCT03989115|452064535|FG003|Overall Study|Sponsor decision to terminate the study|1|||
125665513|NCT03989115|452064536|FG004|Overall Study|Sponsor decision to terminate the study|11|||
125665514|NCT03989115|452064537|FG005|Overall Study|Sponsor decision to terminate the study|0|||
125665515|NCT03989115|452064538|FG006|Overall Study|Sponsor decision to terminate the study|2|||
125665516|NCT03989115|452064539|FG007|Overall Study|Sponsor decision to terminate the study|1|||
125665517|NCT03989115|452064532|FG000|Overall Study|Lost to Follow-up|2|||
125665518|NCT03989115|452064533|FG001|Overall Study|Lost to Follow-up|0|||
125665519|NCT03989115|452064534|FG002|Overall Study|Lost to Follow-up|0|||
125665520|NCT03989115|452064535|FG003|Overall Study|Lost to Follow-up|0|||
125329238|NCT04922216|450837464|FG005|Overall Study|Withdrawal by Subject|0|||
125329239|NCT04922216|450837465|FG006|Overall Study|Withdrawal by Subject|0|||
125329240|NCT04922216|450837466|FG007|Overall Study|Withdrawal by Subject|2|||
125665521|NCT03989115|452064536|FG004|Overall Study|Lost to Follow-up|1|||
125665522|NCT03989115|452064537|FG005|Overall Study|Lost to Follow-up|0|||
125665523|NCT03989115|452064538|FG006|Overall Study|Lost to Follow-up|0|||
125665524|NCT03989115|452064539|FG007|Overall Study|Lost to Follow-up|0|||
125665525|NCT03989115|452064532|FG000|Overall Study|Death|2|||
125665526|NCT03989115|452064533|FG001|Overall Study|Death|2|||
125665527|NCT03989115|452064534|FG002|Overall Study|Death|9|||
125665528|NCT03989115|452064535|FG003|Overall Study|Death|6|||
125665529|NCT03989115|452064536|FG004|Overall Study|Death|31|||
125665530|NCT03989115|452064537|FG005|Overall Study|Death|6|||
125665531|NCT03989115|452064538|FG006|Overall Study|Death|2|||
125665532|NCT03989115|452064539|FG007|Overall Study|Death|3|||
125665533|NCT03989115|452064532|FG000|Overall Study|Other|1|||
125665534|NCT03989115|452064533|FG001|Overall Study|Other|2|||
125665535|NCT03989115|452064534|FG002|Overall Study|Other|0|||
125665536|NCT03989115|452064535|FG003|Overall Study|Other|0|||
125665537|NCT03989115|452064536|FG004|Overall Study|Other|5|||
125665538|NCT03989115|452064537|FG005|Overall Study|Other|0|||
125665539|NCT03989115|452064538|FG006|Overall Study|Other|0|||
125665540|NCT03989115|452064539|FG007|Overall Study|Other|0|||
125665541|NCT02499354|452064540|FG000|Overall Study|Withdrawal by Subject|1|||
125665542|NCT02499354|452064541|FG001|Overall Study|Withdrawal by Subject|0|||
125665543|NCT01759381|452064545|FG000|Overall Study|Death|1|||
125665544|NCT01759381|452064546|FG001|Overall Study|Death|0|||
125665545|NCT00447603|452064548|FG000|Screening|Withdrawal by Subject|1|||
125665546|NCT00447603|452064549|FG001|Screening|Withdrawal by Subject|0|||
125665547|NCT00447603|452064550|FG002|Screening|Withdrawal by Subject|0|||
125665548|NCT00447603|452064548|FG000|Screening|Protocol Violation|1|||
125665549|NCT00447603|452064549|FG001|Screening|Protocol Violation|0|||
125665550|NCT00447603|452064550|FG002|Screening|Protocol Violation|0|||
125665551|NCT00447603|452064548|FG000|Screening|Screen Failure|4|||
125665552|NCT00447603|452064549|FG001|Screening|Screen Failure|0|||
125665553|NCT00447603|452064550|FG002|Screening|Screen Failure|0|||
125665554|NCT00447603|452064548|FG000|Screening|Study Terminated by Sponsor|15|||
125665555|NCT00447603|452064549|FG001|Screening|Study Terminated by Sponsor|0|||
125665556|NCT00447603|452064550|FG002|Screening|Study Terminated by Sponsor|0|||
125665557|NCT00447603|452064548|FG000|Filter Period|Adverse Event|0|||
125665558|NCT00447603|452064549|FG001|Filter Period|Adverse Event|0|||
125665559|NCT00447603|452064550|FG002|Filter Period|Adverse Event|1|||
125665560|NCT00447603|452064548|FG000|Filter Period|Screen Failure|0|||
125665561|NCT00447603|452064549|FG001|Filter Period|Screen Failure|3|||
125665562|NCT00447603|452064550|FG002|Filter Period|Screen Failure|4|||
125329241|NCT04922216|450837467|FG008|Overall Study|Withdrawal by Subject|0|||
125425605|NCT01735201|451182284|FG005|Overall Study|Protocol Violation|0|||
125665563|NCT00447603|452064548|FG000|Filter Period|Study terminated by Sponsor|0|||
125665564|NCT00447603|452064549|FG001|Filter Period|Study terminated by Sponsor|1|||
125665565|NCT00447603|452064550|FG002|Filter Period|Study terminated by Sponsor|10|||
125665566|NCT02410837|452064555|FG000|Overall Study|Death|387|||
125665567|NCT02410837|452064555|FG000|Overall Study|Lost to Follow-up|50|||
125665568|NCT02410837|452064555|FG000|Overall Study|Withdrawal by Subject|44|||
125665569|NCT02410837|452064555|FG000|Overall Study|Physician Decision|6|||
125665570|NCT02410837|452064555|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
125665571|NCT00106028|452064563|FG000|Overall Study|Adverse Event|3|||
125665572|NCT00106028|452064564|FG001|Overall Study|Adverse Event|2|||
125665573|NCT00106028|452064563|FG000|Overall Study|Protocol Violation|1|||
125665574|NCT00106028|452064564|FG001|Overall Study|Protocol Violation|1|||
125329242|NCT04922216|450837468|FG009|Overall Study|Withdrawal by Subject|0|||
125329243|NCT04922216|450837469|FG010|Overall Study|Withdrawal by Subject|0|||
125329244|NCT04922216|450837470|FG011|Overall Study|Withdrawal by Subject|0|||
125329245|NCT04922216|450837471|FG012|Overall Study|Withdrawal by Subject|1|||
125329246|NCT04922216|450837472|FG013|Overall Study|Withdrawal by Subject|1|||
125329247|NCT04922216|450837473|FG014|Overall Study|Withdrawal by Subject|1|||
125329248|NCT04922216|450837474|FG015|Overall Study|Withdrawal by Subject|0|||
125329249|NCT04922216|450837475|FG016|Overall Study|Withdrawal by Subject|0|||
125329250|NCT04922216|450837476|FG017|Overall Study|Withdrawal by Subject|1|||
125329251|NCT04922216|450837477|FG018|Overall Study|Withdrawal by Subject|1|||
125329252|NCT04922216|450837478|FG019|Overall Study|Withdrawal by Subject|1|||
125329253|NCT04922216|450837479|FG020|Overall Study|Withdrawal by Subject|1|||
125329254|NCT04922216|450837480|FG021|Overall Study|Withdrawal by Subject|0|||
125329255|NCT04922216|450837481|FG022|Overall Study|Withdrawal by Subject|0|||
125329256|NCT04922216|450837482|FG023|Overall Study|Withdrawal by Subject|2|||
125329257|NCT04922216|450837483|FG024|Overall Study|Withdrawal by Subject|0|||
125329258|NCT04922216|450837484|FG025|Overall Study|Withdrawal by Subject|0|||
125329259|NCT04922216|450837485|FG026|Overall Study|Withdrawal by Subject|1|||
125329260|NCT04922216|450837486|FG027|Overall Study|Withdrawal by Subject|0|||
125329261|NCT04922216|450837487|FG028|Overall Study|Withdrawal by Subject|0|||
125329262|NCT04922216|450837488|FG029|Overall Study|Withdrawal by Subject|0|||
125329263|NCT04922216|450837489|FG030|Overall Study|Withdrawal by Subject|1|||
125329264|NCT04922216|450837490|FG031|Overall Study|Withdrawal by Subject|0|||
125329265|NCT04922216|450837459|FG000|Overall Study|Lost to Follow-up|1|||
125329266|NCT04922216|450837460|FG001|Overall Study|Lost to Follow-up|0|||
125329267|NCT04922216|450837461|FG002|Overall Study|Lost to Follow-up|2|||
125329268|NCT04922216|450837462|FG003|Overall Study|Lost to Follow-up|0|||
125329269|NCT04922216|450837463|FG004|Overall Study|Lost to Follow-up|0|||
125329270|NCT04922216|450837464|FG005|Overall Study|Lost to Follow-up|2|||
125329271|NCT04922216|450837465|FG006|Overall Study|Lost to Follow-up|0|||
125665575|NCT00106028|452064563|FG000|Overall Study|Withdrawal by Subject|2|||
125665576|NCT00106028|452064564|FG001|Overall Study|Withdrawal by Subject|8|||
125665577|NCT00106028|452064563|FG000|Overall Study|Lost to Follow-up|0|||
125665578|NCT00106028|452064564|FG001|Overall Study|Lost to Follow-up|1|||
125665579|NCT01280981|452064565|FG000|Overall Study|Withdrawal by Subject|11|||
125665580|NCT01280981|452064565|FG000|Overall Study|Protocol Violation|2|||
125665581|NCT01280981|452064565|FG000|Overall Study|Lack of Efficacy|13|||
125665582|NCT01280981|452064565|FG000|Overall Study|Lost to Follow-up|3|||
125665583|NCT01280981|452064565|FG000|Overall Study|Adverse Event|6|||
125665584|NCT01280981|452064565|FG000|Overall Study|Irregular or discontinued menses|3|||
125665585|NCT01280981|452064565|FG000|Overall Study|Failed to return|45|||
125665586|NCT01280981|452064565|FG000|Overall Study|Non-compliance with protocol|3|||
125665587|NCT01280981|452064565|FG000|Overall Study|Withdrawal of consent|3|||
125665588|NCT01280981|452064565|FG000|Overall Study|Elective surgery|2|||
125665589|NCT01280981|452064565|FG000|Overall Study|Study site closure|1|||
125665590|NCT01256398|452064567|FG000|Overall Study|Withdrawal by Subject|1|||
125665591|NCT01238211|452064568|FG000|Overall Study|Continues active treatment|31|||
125665592|NCT01238211|452064568|FG000|Overall Study|Adverse Event|7|||
125665593|NCT01238211|452064568|FG000|Overall Study|Death|4|||
125665594|NCT01238211|452064568|FG000|Overall Study|Relapse/Progression|2|||
125665595|NCT01238211|452064568|FG000|Overall Study|Withdrawal by Subject|7|||
125665596|NCT01238211|452064568|FG000|Overall Study|Non-protocol treatment|4|||
125665597|NCT01238211|452064568|FG000|Overall Study|Investigator/Patient Decision|3|||
125665598|NCT04428502|452064569|FG000|Overall Study|Did not meet entrance criteria|14|||
125665599|NCT00449930|452064572|FG000|Overall Study|Adverse Event|9|||
125665600|NCT00449930|452064573|FG001|Overall Study|Adverse Event|19|||
125665601|NCT00449930|452064572|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
125665602|NCT00449930|452064573|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
125665603|NCT00449930|452064572|FG000|Overall Study|Lack of Efficacy|10|||
125665604|NCT00449930|452064573|FG001|Overall Study|Lack of Efficacy|1|||
125665605|NCT00449930|452064572|FG000|Overall Study|Lost to Follow-up|9|||
125665606|NCT00449930|452064573|FG001|Overall Study|Lost to Follow-up|14|||
125665607|NCT00449930|452064572|FG000|Overall Study|Physician Decision|1|||
125329272|NCT04922216|450837466|FG007|Overall Study|Lost to Follow-up|1|||
125329273|NCT04922216|450837467|FG008|Overall Study|Lost to Follow-up|1|||
125329274|NCT04922216|450837468|FG009|Overall Study|Lost to Follow-up|2|||
125329275|NCT04922216|450837469|FG010|Overall Study|Lost to Follow-up|2|||
125329276|NCT04922216|450837470|FG011|Overall Study|Lost to Follow-up|1|||
125329277|NCT04922216|450837471|FG012|Overall Study|Lost to Follow-up|1|||
125329278|NCT04922216|450837472|FG013|Overall Study|Lost to Follow-up|0|||
125329279|NCT04922216|450837473|FG014|Overall Study|Lost to Follow-up|1|||
125665608|NCT00449930|452064573|FG001|Overall Study|Physician Decision|2|||
125665609|NCT00449930|452064572|FG000|Overall Study|Protocol Violation|14|||
125665610|NCT00449930|452064573|FG001|Overall Study|Protocol Violation|15|||
125665611|NCT00449930|452064572|FG000|Overall Study|Withdrawal by Subject|16|||
125665612|NCT00449930|452064573|FG001|Overall Study|Withdrawal by Subject|23|||
125665613|NCT00449930|452064572|FG000|Overall Study|Glycemic discontinuation criteria|1|||
125329280|NCT04922216|450837474|FG015|Overall Study|Lost to Follow-up|0|||
125329281|NCT04922216|450837475|FG016|Overall Study|Lost to Follow-up|0|||
125329282|NCT04922216|450837476|FG017|Overall Study|Lost to Follow-up|2|||
125329283|NCT04922216|450837477|FG018|Overall Study|Lost to Follow-up|1|||
125329284|NCT04922216|450837478|FG019|Overall Study|Lost to Follow-up|0|||
125329285|NCT04922216|450837479|FG020|Overall Study|Lost to Follow-up|1|||
125329286|NCT04922216|450837480|FG021|Overall Study|Lost to Follow-up|0|||
125329287|NCT04922216|450837481|FG022|Overall Study|Lost to Follow-up|2|||
125329288|NCT04922216|450837482|FG023|Overall Study|Lost to Follow-up|1|||
125329289|NCT04922216|450837483|FG024|Overall Study|Lost to Follow-up|0|||
125665614|NCT00449930|452064573|FG001|Overall Study|Glycemic discontinuation criteria|1|||
125665615|NCT01864525|452064574|FG000|Overall Study|Adverse Event|1|||
125665616|NCT01864525|452064575|FG001|Overall Study|Adverse Event|0|||
125665617|NCT03712228|452064576|FG000|Treatment Period 1|Lack of Efficacy|0|||
125665618|NCT03712228|452064577|FG001|Treatment Period 1|Lack of Efficacy|0|||
125665619|NCT03712228|452064578|FG002|Treatment Period 1|Lack of Efficacy|0|||
125329290|NCT04922216|450837484|FG025|Overall Study|Lost to Follow-up|2|||
125329291|NCT04922216|450837485|FG026|Overall Study|Lost to Follow-up|0|||
125329292|NCT04922216|450837486|FG027|Overall Study|Lost to Follow-up|0|||
125329293|NCT04922216|450837487|FG028|Overall Study|Lost to Follow-up|1|||
125329294|NCT04922216|450837488|FG029|Overall Study|Lost to Follow-up|0|||
125329295|NCT04922216|450837489|FG030|Overall Study|Lost to Follow-up|2|||
125329296|NCT04922216|450837490|FG031|Overall Study|Lost to Follow-up|1|||
125329297|NCT04721977|450837491|FG000|Overall Study|Death|15|||
125329298|NCT04721977|450837491|FG000|Overall Study|Ongoing|51|||
125329299|NCT03278249|450837492|FG000|Overall Study|Withdrawal by Subject|2|||
125329300|NCT03278249|450837492|FG000|Overall Study|Lost to Follow-up|1|||
125329301|NCT00775190|450839064|FG000|Overall Study|Lost to Follow-up|2|||
125329302|NCT00775190|450839065|FG001|Overall Study|Lost to Follow-up|3|||
125329303|NCT00775190|450839064|FG000|Overall Study|Withdrawal by Subject|1|||
125329304|NCT00775190|450839065|FG001|Overall Study|Withdrawal by Subject|2|||
125329305|NCT00775190|450839064|FG000|Overall Study|Protocol Violation|1|||
125329306|NCT00775190|450839065|FG001|Overall Study|Protocol Violation|0|||
125329307|NCT00904033|450839070|FG000|Overall Study|Withdrawal by Subject|1|||
125329308|NCT00904033|450839071|FG001|Overall Study|Withdrawal by Subject|1|||
125329309|NCT00904033|450839072|FG002|Overall Study|Withdrawal by Subject|0|||
125329310|NCT00904033|450839073|FG003|Overall Study|Withdrawal by Subject|0|||
125329311|NCT00904033|450839070|FG000|Overall Study|Physician Decision|0|||
125329312|NCT00904033|450839071|FG001|Overall Study|Physician Decision|0|||
125329313|NCT00904033|450839072|FG002|Overall Study|Physician Decision|1|||
125329314|NCT00904033|450839073|FG003|Overall Study|Physician Decision|0|||
125329315|NCT00904033|450839070|FG000|Overall Study|Unable to obtain final blood draw|0|||
125329316|NCT00904033|450839071|FG001|Overall Study|Unable to obtain final blood draw|0|||
125329317|NCT00904033|450839072|FG002|Overall Study|Unable to obtain final blood draw|0|||
125329318|NCT00904033|450839073|FG003|Overall Study|Unable to obtain final blood draw|2|||
125329319|NCT01600716|450839076|FG000|Overall Study|Other Reasons|3|||
125329320|NCT01600716|450839077|FG001|Overall Study|Other Reasons|1|||
125329321|NCT01600716|450839076|FG000|Overall Study|Personal Reasons|0|||
125329322|NCT01600716|450839077|FG001|Overall Study|Personal Reasons|2|||
125329323|NCT01600716|450839076|FG000|Overall Study|Lost to Follow-up|0|||
125329324|NCT01600716|450839077|FG001|Overall Study|Lost to Follow-up|2|||
125329325|NCT01600716|450839076|FG000|Overall Study|Pregnancy|1|||
125329326|NCT01600716|450839077|FG001|Overall Study|Pregnancy|0|||
125329327|NCT01600716|450839076|FG000|Overall Study|Lack of Efficacy|2|||
125329328|NCT01600716|450839077|FG001|Overall Study|Lack of Efficacy|1|||
125329329|NCT01600716|450839076|FG000|Overall Study|Adverse Event|1|||
125329330|NCT01600716|450839077|FG001|Overall Study|Adverse Event|1|||
125329331|NCT03349034|450839080|FG000|Overall Study|catheters dislodged during transport|2|||
125329332|NCT03349034|450839081|FG001|Overall Study|catheters dislodged during transport|0|||
125329333|NCT03349034|450839080|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
125329334|NCT03349034|450839081|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
125329335|NCT03349034|450839080|FG000|Overall Study|soft tissue flap used|1|||
125329336|NCT03349034|450839081|FG001|Overall Study|soft tissue flap used|0|||
125329337|NCT03349034|450839080|FG000|Overall Study|Other|0|||
125329338|NCT03349034|450839081|FG001|Overall Study|Other|1|||
125329339|NCT01177397|450839082|FG000|Overall Study|Protocol Violation|0|||
125329340|NCT01177397|450839083|FG001|Overall Study|Protocol Violation|0|||
125329341|NCT01177397|450839084|FG002|Overall Study|Protocol Violation|0|||
125329342|NCT01177397|450839085|FG003|Overall Study|Protocol Violation|0|||
125665620|NCT03712228|452064579|FG003|Treatment Period 1|Lack of Efficacy|0|||
125329343|NCT01177397|450839086|FG004|Overall Study|Protocol Violation|0|||
125329344|NCT01177397|450839087|FG005|Overall Study|Protocol Violation|1|||
125329345|NCT01177397|450839088|FG006|Overall Study|Protocol Violation|0|||
125329346|NCT01177397|450839089|FG007|Overall Study|Protocol Violation|0|||
125329347|NCT01177397|450839090|FG008|Overall Study|Protocol Violation|0|||
125329348|NCT01177397|450839091|FG009|Overall Study|Protocol Violation|0|||
125329349|NCT01177397|450839092|FG010|Overall Study|Protocol Violation|0|||
125329350|NCT01177397|450839093|FG011|Overall Study|Protocol Violation|0|||
125665621|NCT03712228|452064580|FG004|Treatment Period 1|Lack of Efficacy|0|||
125665622|NCT03712228|452064581|FG005|Treatment Period 1|Lack of Efficacy|1|||
125665623|NCT03712228|452064576|FG000|Treatment Period 2|Pregnancy|0|||
125665624|NCT03712228|452064577|FG001|Treatment Period 2|Pregnancy|0|||
125665625|NCT03712228|452064578|FG002|Treatment Period 2|Pregnancy|0|||
125665626|NCT03712228|452064579|FG003|Treatment Period 2|Pregnancy|1|||
125665627|NCT03712228|452064580|FG004|Treatment Period 2|Pregnancy|0|||
125665628|NCT03712228|452064581|FG005|Treatment Period 2|Pregnancy|0|||
125665629|NCT03712228|452064576|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125665630|NCT03712228|452064577|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125665631|NCT03712228|452064578|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125665632|NCT03712228|452064579|FG003|Treatment Period 2|Withdrawal by Subject|1|||
125665633|NCT03712228|452064580|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125665634|NCT03712228|452064581|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125665635|NCT01964105|452064582|FG000|Overall Study|Lost to Follow-up|2|||
125665636|NCT01964105|452064583|FG001|Overall Study|Lost to Follow-up|13|||
125665637|NCT01964105|452064584|FG002|Overall Study|Lost to Follow-up|0|||
125665638|NCT02295280|452064585|FG000|Overall Study|Adverse Event|0|||
125665639|NCT02295280|452064586|FG001|Overall Study|Adverse Event|1|||
125329351|NCT01177397|450839082|FG000|Overall Study|Lost to Follow-up|0|||
125329352|NCT01177397|450839083|FG001|Overall Study|Lost to Follow-up|0|||
125329353|NCT01177397|450839084|FG002|Overall Study|Lost to Follow-up|0|||
125665640|NCT03001011|452064587|FG000|Overall Study|Adverse Event|9|||
125665641|NCT03001011|452064588|FG001|Overall Study|Adverse Event|3|||
125665642|NCT03001011|452064587|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
125665643|NCT03001011|452064588|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
125665644|NCT03001011|452064587|FG000|Overall Study|Other than specified above|3|||
125665645|NCT03001011|452064588|FG001|Overall Study|Other than specified above|8|||
125665646|NCT02875067|452064589|FG000|Overall Study|Withdrawal by Subject|1|||
125665647|NCT02875067|452064589|FG000|Overall Study|Withdrawal by Termination of Study|5|||
125665648|NCT00065065|452064590|FG000|Overall Study|Adverse Event|3|||
125665649|NCT00065065|452064591|FG001|Overall Study|Adverse Event|2|||
125665650|NCT00065065|452064590|FG000|Overall Study|Withdrawal by Subject|1|||
125665651|NCT00065065|452064591|FG001|Overall Study|Withdrawal by Subject|5|||
125665652|NCT00065065|452064590|FG000|Overall Study|Lack of Efficacy|4|||
125665653|NCT00065065|452064591|FG001|Overall Study|Lack of Efficacy|11|||
125665654|NCT00065065|452064590|FG000|Overall Study|Other|2|||
125665655|NCT00065065|452064591|FG001|Overall Study|Other|2|||
125665656|NCT01050673|452064595|FG000|Overall Study|Physician Decision|4|||
125665657|NCT01050673|452064596|FG001|Overall Study|Physician Decision|5|||
125665658|NCT05288673|452064597|FG000|Overall Study|Consent withdrawn by subject|0|||
125665659|NCT05288673|452064598|FG001|Overall Study|Consent withdrawn by subject|0|||
125665660|NCT05288673|452064599|FG002|Overall Study|Consent withdrawn by subject|1|||
125665661|NCT03056352|452064600|FG000|Overall Study|Lost to Follow-up|1|||
125665662|NCT00124449|452064605|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
125665663|NCT00124449|452064606|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
125665664|NCT00124449|452064605|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
125665665|NCT00124449|452064606|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
125665666|NCT00124449|452064605|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
125665667|NCT00124449|452064606|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
125665668|NCT00124449|452064605|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
125665669|NCT00124449|452064606|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
125665670|NCT00124449|452064605|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
125665671|NCT00124449|452064606|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
125665672|NCT00124449|452064605|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
125665673|NCT00124449|452064606|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
125665674|NCT00124449|452064605|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
125665675|NCT00124449|452064606|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
125665676|NCT00124449|452064605|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
125665677|NCT00124449|452064606|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
125665678|NCT00124449|452064605|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
125665679|NCT00124449|452064606|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
125665680|NCT00124449|452064605|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
125665681|NCT00124449|452064606|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
125665682|NCT00124449|452064605|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
125665683|NCT00124449|452064606|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
125329354|NCT01177397|450839085|FG003|Overall Study|Lost to Follow-up|0|||
125665684|NCT00124449|452064605|FG000|18-Month Untreated Observation Period|Relocated|1|||
125665685|NCT00124449|452064606|FG001|18-Month Untreated Observation Period|Relocated|0|||
125665686|NCT01254045|452064607|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
125665687|NCT01254045|452064608|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
125329355|NCT01177397|450839086|FG004|Overall Study|Lost to Follow-up|1|||
125329356|NCT01177397|450839087|FG005|Overall Study|Lost to Follow-up|0|||
125329357|NCT01177397|450839088|FG006|Overall Study|Lost to Follow-up|0|||
125329358|NCT01177397|450839089|FG007|Overall Study|Lost to Follow-up|2|||
125329359|NCT01177397|450839090|FG008|Overall Study|Lost to Follow-up|0|||
125329360|NCT01177397|450839091|FG009|Overall Study|Lost to Follow-up|0|||
125329361|NCT01177397|450839092|FG010|Overall Study|Lost to Follow-up|0|||
125329362|NCT01177397|450839093|FG011|Overall Study|Lost to Follow-up|0|||
125329363|NCT01177397|450839082|FG000|Overall Study|Death|0|||
125329364|NCT01177397|450839083|FG001|Overall Study|Death|0|||
125540738|NCT00774930|451609436|FG000|LTOLE Phase|Sponsor decision|2|||
125540739|NCT00774930|451609437|FG001|LTOLE Phase|Sponsor decision|1|||
125540740|NCT00774930|451609436|FG000|LTOLE Phase|Disease Progression|2|||
125540741|NCT00774930|451609437|FG001|LTOLE Phase|Disease Progression|5|||
125540742|NCT00774930|451609436|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
125540743|NCT00774930|451609437|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
125540744|NCT00774930|451609436|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
125540745|NCT00774930|451609437|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
125540746|NCT01631227|451609438|FG000|Overall Study|withdrawn consent|27|||
125540747|NCT01631227|451609439|FG001|Overall Study|withdrawn consent|21|||
125540748|NCT01631227|451609438|FG000|Overall Study|Adverse Event|1|||
125540749|NCT01631227|451609439|FG001|Overall Study|Adverse Event|0|||
125540750|NCT01631227|451609438|FG000|Overall Study|administrative|2|||
125540751|NCT01631227|451609439|FG001|Overall Study|administrative|1|||
125540752|NCT03020576|451609440|FG000|Overall Study|Withdrawal by Subject|1|||
125540753|NCT03020576|451609441|FG001|Overall Study|Withdrawal by Subject|2|||
125540754|NCT01177800|451609443|FG000|Overall Study|Adverse Event|9|||
125540755|NCT01177800|451609444|FG001|Overall Study|Adverse Event|3|||
125540756|NCT01177800|451609443|FG000|Overall Study|Protocol Violation|0|||
125540757|NCT01177800|451609444|FG001|Overall Study|Protocol Violation|1|||
125540758|NCT01177800|451609443|FG000|Overall Study|Physician Decision|1|||
125540759|NCT01177800|451609444|FG001|Overall Study|Physician Decision|0|||
125540760|NCT01177800|451609443|FG000|Overall Study|Withdrawal of informed consent|0|||
125540761|NCT01177800|451609444|FG001|Overall Study|Withdrawal of informed consent|1|||
125540762|NCT03527550|451609445|FG000|Overall Study|Lost to Follow-up|4|||
125540763|NCT03527550|451609446|FG001|Overall Study|Lost to Follow-up|2|||
125540764|NCT03527550|451609445|FG000|Overall Study|Withdrawal by Subject|4|||
125540765|NCT03527550|451609446|FG001|Overall Study|Withdrawal by Subject|1|||
125540766|NCT03527550|451609445|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
125540767|NCT03527550|451609446|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
125540768|NCT01097707|451609447|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
125540769|NCT01097707|451609448|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
125540770|NCT01097707|451609449|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
125540771|NCT01097707|451609450|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
125540772|NCT01097707|451609451|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
125540773|NCT01097707|451609447|FG000|Overall Study|Adverse Event|4|||
125540774|NCT01097707|451609448|FG001|Overall Study|Adverse Event|2|||
125540775|NCT01097707|451609449|FG002|Overall Study|Adverse Event|3|||
125540776|NCT01097707|451609450|FG003|Overall Study|Adverse Event|1|||
125540777|NCT01097707|451609451|FG004|Overall Study|Adverse Event|3|||
125540778|NCT01097707|451609447|FG000|Overall Study|Entry Criteria Not Met|2|||
125540779|NCT01097707|451609448|FG001|Overall Study|Entry Criteria Not Met|1|||
125540780|NCT01097707|451609449|FG002|Overall Study|Entry Criteria Not Met|1|||
125540781|NCT01097707|451609450|FG003|Overall Study|Entry Criteria Not Met|0|||
125540782|NCT01097707|451609451|FG004|Overall Study|Entry Criteria Not Met|1|||
125540783|NCT01097707|451609447|FG000|Overall Study|Lack of Efficacy|1|||
125540784|NCT01097707|451609448|FG001|Overall Study|Lack of Efficacy|0|||
125540785|NCT01097707|451609449|FG002|Overall Study|Lack of Efficacy|0|||
125540786|NCT01097707|451609450|FG003|Overall Study|Lack of Efficacy|1|||
125540787|NCT01097707|451609451|FG004|Overall Study|Lack of Efficacy|0|||
125540788|NCT01097707|451609447|FG000|Overall Study|Lost to Follow-up|1|||
125540789|NCT01097707|451609448|FG001|Overall Study|Lost to Follow-up|1|||
125540790|NCT01097707|451609449|FG002|Overall Study|Lost to Follow-up|2|||
125540791|NCT01097707|451609450|FG003|Overall Study|Lost to Follow-up|0|||
125540792|NCT01097707|451609451|FG004|Overall Study|Lost to Follow-up|3|||
125540793|NCT01097707|451609447|FG000|Overall Study|Protocol Violation|2|||
125540794|NCT01097707|451609448|FG001|Overall Study|Protocol Violation|2|||
125540795|NCT01097707|451609449|FG002|Overall Study|Protocol Violation|3|||
125540796|NCT01097707|451609450|FG003|Overall Study|Protocol Violation|2|||
125329365|NCT01177397|450839084|FG002|Overall Study|Death|1|||
125329366|NCT01177397|450839085|FG003|Overall Study|Death|1|||
125329367|NCT01177397|450839086|FG004|Overall Study|Death|0|||
125540797|NCT01097707|451609451|FG004|Overall Study|Protocol Violation|2|||
125540798|NCT01097707|451609447|FG000|Overall Study|Sponsor Decision|31|||
125540799|NCT01097707|451609448|FG001|Overall Study|Sponsor Decision|31|||
125540800|NCT01097707|451609449|FG002|Overall Study|Sponsor Decision|34|||
125540801|NCT01097707|451609450|FG003|Overall Study|Sponsor Decision|35|||
125540802|NCT01097707|451609451|FG004|Overall Study|Sponsor Decision|36|||
125540803|NCT01097707|451609447|FG000|Overall Study|Withdrawal by Subject|3|||
125329368|NCT01177397|450839087|FG005|Overall Study|Death|0|||
125329369|NCT01177397|450839088|FG006|Overall Study|Death|0|||
125329370|NCT01177397|450839089|FG007|Overall Study|Death|5|||
125329371|NCT01177397|450839090|FG008|Overall Study|Death|2|||
125329372|NCT01177397|450839091|FG009|Overall Study|Death|1|||
125329373|NCT01177397|450839092|FG010|Overall Study|Death|0|||
125329374|NCT01177397|450839093|FG011|Overall Study|Death|0|||
125329375|NCT01177397|450839082|FG000|Overall Study|Withdrawal by Subject|0|||
125329376|NCT01177397|450839083|FG001|Overall Study|Withdrawal by Subject|0|||
125329377|NCT01177397|450839084|FG002|Overall Study|Withdrawal by Subject|1|||
125329378|NCT01177397|450839085|FG003|Overall Study|Withdrawal by Subject|1|||
125329379|NCT01177397|450839086|FG004|Overall Study|Withdrawal by Subject|1|||
125329380|NCT01177397|450839087|FG005|Overall Study|Withdrawal by Subject|2|||
125329381|NCT01177397|450839088|FG006|Overall Study|Withdrawal by Subject|0|||
125329382|NCT01177397|450839089|FG007|Overall Study|Withdrawal by Subject|5|||
125329383|NCT01177397|450839090|FG008|Overall Study|Withdrawal by Subject|9|||
125329384|NCT01177397|450839091|FG009|Overall Study|Withdrawal by Subject|1|||
125329385|NCT01177397|450839092|FG010|Overall Study|Withdrawal by Subject|1|||
125329386|NCT01177397|450839093|FG011|Overall Study|Withdrawal by Subject|0|||
125329387|NCT01177397|450839082|FG000|Overall Study|Adverse Event|0|||
125329388|NCT01177397|450839083|FG001|Overall Study|Adverse Event|0|||
125329389|NCT01177397|450839084|FG002|Overall Study|Adverse Event|1|||
125329390|NCT01177397|450839085|FG003|Overall Study|Adverse Event|2|||
125329391|NCT01177397|450839086|FG004|Overall Study|Adverse Event|0|||
125329392|NCT01177397|450839087|FG005|Overall Study|Adverse Event|12|||
125329393|NCT01177397|450839088|FG006|Overall Study|Adverse Event|1|||
125329394|NCT01177397|450839089|FG007|Overall Study|Adverse Event|14|||
125329395|NCT01177397|450839090|FG008|Overall Study|Adverse Event|8|||
125665688|NCT01254045|452064609|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
125665689|NCT01254045|452064610|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
125665690|NCT01254045|452064611|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
125665691|NCT01254045|452064612|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
125665692|NCT02971605|452064613|FG000|Overall Study|Withdrawal by Subject|1|||
125665693|NCT00597207|452064614|FG000|Overall Study|Lost to Follow-up|5|||
125665694|NCT00597207|452064615|FG001|Overall Study|Lost to Follow-up|7|||
125665695|NCT00520351|452064616|FG000|First Intervention|Withdrawal by Subject|1|||
125665696|NCT00520351|452064617|FG001|First Intervention|Withdrawal by Subject|1|||
125665697|NCT01298596|452064622|FG000|Overall Study|Withdrawal by Subject|1|||
125665698|NCT01298596|452064623|FG001|Overall Study|Withdrawal by Subject|1|||
125665699|NCT01298596|452064622|FG000|Overall Study|Death|5|||
125665700|NCT01298596|452064623|FG001|Overall Study|Death|3|||
125665701|NCT01298596|452064622|FG000|Overall Study|Lost to Follow-up|6|||
125665702|NCT01298596|452064623|FG001|Overall Study|Lost to Follow-up|14|||
125665703|NCT01298596|452064622|FG000|Overall Study|Referred for further management|16|||
125665704|NCT01298596|452064623|FG001|Overall Study|Referred for further management|15|||
125665705|NCT04128696|452064626|FG000|Overall Study|Lost to Follow-up|3|||
125665706|NCT04128696|452064627|FG001|Overall Study|Lost to Follow-up|7|||
125665707|NCT04128696|452064626|FG000|Overall Study|Withdrawal by Subject|12|||
125665708|NCT04128696|452064627|FG001|Overall Study|Withdrawal by Subject|11|||
125665709|NCT04128696|452064626|FG000|Overall Study|Study Closed/Terminated|26|||
125665710|NCT04128696|452064627|FG001|Overall Study|Study Closed/Terminated|38|||
125665711|NCT04128696|452064626|FG000|Overall Study|Physician Decision|2|||
125665712|NCT04128696|452064627|FG001|Overall Study|Physician Decision|3|||
125665713|NCT00585039|452064628|FG000|Overall Study|medication spilled|2|||
125665714|NCT00585039|452064629|FG001|Overall Study|medication spilled|0|||
125665715|NCT01585831|452064636|FG000|Overall Study|Physician Decision|0|||
125665716|NCT01585831|452064637|FG001|Overall Study|Physician Decision|1|||
125665717|NCT01585831|452064636|FG000|Overall Study|Withdrawal by Subject|2|||
125665718|NCT01585831|452064637|FG001|Overall Study|Withdrawal by Subject|1|||
125665719|NCT02046369|452064638|FG000|Overall Study|Adverse Event|3|||
125665720|NCT02046369|452064639|FG001|Overall Study|Adverse Event|3|||
125665721|NCT02046369|452064638|FG000|Overall Study|Lack of Efficacy|3|||
125665722|NCT02046369|452064639|FG001|Overall Study|Lack of Efficacy|3|||
125665723|NCT02046369|452064638|FG000|Overall Study|Lost to Follow-up|3|||
125665724|NCT02046369|452064639|FG001|Overall Study|Lost to Follow-up|3|||
125665725|NCT02046369|452064638|FG000|Overall Study|Protocol Violation|1|||
125665726|NCT02046369|452064639|FG001|Overall Study|Protocol Violation|2|||
125329396|NCT01177397|450839091|FG009|Overall Study|Adverse Event|6|||
125329397|NCT01177397|450839092|FG010|Overall Study|Adverse Event|3|||
125665727|NCT02046369|452064638|FG000|Overall Study|Withdrawal by Subject|3|||
125665728|NCT02046369|452064639|FG001|Overall Study|Withdrawal by Subject|6|||
125665729|NCT02046369|452064638|FG000|Overall Study|never received study drug|0|||
125665730|NCT02046369|452064639|FG001|Overall Study|never received study drug|1|||
125329398|NCT01177397|450839093|FG011|Overall Study|Adverse Event|7|||
125329399|NCT01177397|450839082|FG000|Overall Study|Disease progression|1|||
125329400|NCT01177397|450839083|FG001|Overall Study|Disease progression|2|||
125665731|NCT02046369|452064638|FG000|Overall Study|non compliance|1|||
125665732|NCT02046369|452064639|FG001|Overall Study|non compliance|0|||
125665733|NCT02133352|452064643|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
125665734|NCT00579254|452064644|FG000|Overall Study|Lost to Follow-up|39|||
125665735|NCT00579254|452064644|FG000|Overall Study|Discontinued when study terminated|73|||
125665736|NCT02557672|452064645|FG000|Overall Study|Withdrawal by Subject|4|||
125665737|NCT02557672|452064646|FG001|Overall Study|Withdrawal by Subject|2|||
125665738|NCT03705169|452064647|FG000|Overall Study|Lost to Follow-up|0|||
125665739|NCT03705169|452064648|FG001|Overall Study|Lost to Follow-up|0|||
125665740|NCT03705169|452064649|FG002|Overall Study|Lost to Follow-up|0|||
125665741|NCT03705169|452064650|FG003|Overall Study|Lost to Follow-up|2|||
125665742|NCT03705169|452064651|FG004|Overall Study|Lost to Follow-up|0|||
125665743|NCT03705169|452064652|FG005|Overall Study|Lost to Follow-up|2|||
125665744|NCT03705169|452064653|FG006|Overall Study|Lost to Follow-up|1|||
125665745|NCT03705169|452064654|FG007|Overall Study|Lost to Follow-up|0|||
125665746|NCT03705169|452064655|FG008|Overall Study|Lost to Follow-up|0|||
125665747|NCT03705169|452064656|FG009|Overall Study|Lost to Follow-up|1|||
125665748|NCT03705169|452064647|FG000|Overall Study|Adverse Event|0|||
125665749|NCT03705169|452064648|FG001|Overall Study|Adverse Event|0|||
125665750|NCT03705169|452064649|FG002|Overall Study|Adverse Event|0|||
125665751|NCT03705169|452064650|FG003|Overall Study|Adverse Event|1|||
125665752|NCT03705169|452064651|FG004|Overall Study|Adverse Event|0|||
125665753|NCT03705169|452064652|FG005|Overall Study|Adverse Event|0|||
125665754|NCT03705169|452064653|FG006|Overall Study|Adverse Event|0|||
125665755|NCT03705169|452064654|FG007|Overall Study|Adverse Event|0|||
125665756|NCT03705169|452064655|FG008|Overall Study|Adverse Event|0|||
125665757|NCT03705169|452064656|FG009|Overall Study|Adverse Event|0|||
125665758|NCT03705169|452064647|FG000|Overall Study|Site Closure|0|||
125665759|NCT03705169|452064648|FG001|Overall Study|Site Closure|0|||
125665760|NCT03705169|452064649|FG002|Overall Study|Site Closure|0|||
125665761|NCT03705169|452064650|FG003|Overall Study|Site Closure|1|||
125665762|NCT03705169|452064651|FG004|Overall Study|Site Closure|0|||
125665763|NCT03705169|452064652|FG005|Overall Study|Site Closure|0|||
125665764|NCT03705169|452064653|FG006|Overall Study|Site Closure|0|||
125665765|NCT03705169|452064654|FG007|Overall Study|Site Closure|0|||
125665766|NCT03705169|452064655|FG008|Overall Study|Site Closure|0|||
125665767|NCT03705169|452064656|FG009|Overall Study|Site Closure|0|||
125665768|NCT03705169|452064647|FG000|Overall Study|Did not receive study treatment|0|||
125665769|NCT03705169|452064648|FG001|Overall Study|Did not receive study treatment|0|||
125665770|NCT03705169|452064649|FG002|Overall Study|Did not receive study treatment|0|||
125665771|NCT03705169|452064650|FG003|Overall Study|Did not receive study treatment|1|||
125665772|NCT03705169|452064651|FG004|Overall Study|Did not receive study treatment|0|||
125665773|NCT03705169|452064652|FG005|Overall Study|Did not receive study treatment|0|||
125665774|NCT03705169|452064653|FG006|Overall Study|Did not receive study treatment|0|||
125665775|NCT03705169|452064654|FG007|Overall Study|Did not receive study treatment|0|||
125665776|NCT03705169|452064655|FG008|Overall Study|Did not receive study treatment|0|||
125665777|NCT03705169|452064656|FG009|Overall Study|Did not receive study treatment|0|||
125665778|NCT03705169|452064647|FG000|Overall Study|Concerns about study visit compliance|0|||
125665779|NCT03705169|452064648|FG001|Overall Study|Concerns about study visit compliance|0|||
125665780|NCT03705169|452064649|FG002|Overall Study|Concerns about study visit compliance|0|||
125665781|NCT03705169|452064650|FG003|Overall Study|Concerns about study visit compliance|1|||
125329401|NCT01177397|450839084|FG002|Overall Study|Disease progression|5|||
125329402|NCT01177397|450839085|FG003|Overall Study|Disease progression|5|||
125329403|NCT01177397|450839086|FG004|Overall Study|Disease progression|4|||
125329404|NCT01177397|450839087|FG005|Overall Study|Disease progression|10|||
125329405|NCT01177397|450839088|FG006|Overall Study|Disease progression|10|||
125665782|NCT03705169|452064651|FG004|Overall Study|Concerns about study visit compliance|0|||
125665783|NCT03705169|452064652|FG005|Overall Study|Concerns about study visit compliance|0|||
125665784|NCT03705169|452064653|FG006|Overall Study|Concerns about study visit compliance|0|||
125665785|NCT03705169|452064654|FG007|Overall Study|Concerns about study visit compliance|0|||
125665786|NCT03705169|452064655|FG008|Overall Study|Concerns about study visit compliance|0|||
125665787|NCT03705169|452064656|FG009|Overall Study|Concerns about study visit compliance|0|||
125665788|NCT01690520|452066160|FG000|Overall Study|Death|25|||
125665789|NCT01690520|452066161|FG001|Overall Study|Death|21|||
125665790|NCT01690520|452066160|FG000|Overall Study|Lost to Follow-up|2|||
125665791|NCT01690520|452066161|FG001|Overall Study|Lost to Follow-up|3|||
125665792|NCT01690520|452066160|FG000|Overall Study|Withdrawal by Subject|2|||
125665793|NCT01690520|452066161|FG001|Overall Study|Withdrawal by Subject|0|||
125665794|NCT01690520|452066160|FG000|Overall Study|Relapse|0|||
125665795|NCT01690520|452066161|FG001|Overall Study|Relapse|1|||
125665796|NCT01690520|452066160|FG000|Overall Study|Other|0|||
125329406|NCT01177397|450839089|FG007|Overall Study|Disease progression|21|||
125329407|NCT01177397|450839090|FG008|Overall Study|Disease progression|18|||
125665797|NCT01690520|452066161|FG001|Overall Study|Other|1|||
125665798|NCT01690520|452066160|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
125329408|NCT01177397|450839091|FG009|Overall Study|Disease progression|12|||
125665799|NCT01690520|452066161|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
125665800|NCT04006847|452066162|FG000|Overall Study|Product issue|1|||
125665801|NCT01375010|452066163|FG000|Overall Study|Lost to Follow-up|8|||
125665802|NCT01375010|452066164|FG001|Overall Study|Lost to Follow-up|2|||
125665803|NCT01375010|452066163|FG000|Overall Study|Withdrawal by Subject|4|||
125665804|NCT01375010|452066164|FG001|Overall Study|Withdrawal by Subject|2|||
125665805|NCT02614703|452066165|FG000|Overall Study|Withdrawal by Subject|7|||
125665806|NCT02614703|452066166|FG001|Overall Study|Withdrawal by Subject|1|||
125665807|NCT02402933|452066167|FG000|Overall Study|Withdrawal by Subject|4|||
125665808|NCT02402933|452066167|FG000|Overall Study|Discontinued; Site Termination|10|||
125665809|NCT01681771|452066168|FG000|Overall Study|Lost to Follow-up|4|||
125665810|NCT01681771|452066169|FG001|Overall Study|Lost to Follow-up|2|||
125665811|NCT02919475|452066177|FG000|Overall Study|Adverse Event|3|||
125665812|NCT02919475|452066178|FG001|Overall Study|Adverse Event|3|||
125665813|NCT02919475|452066179|FG002|Overall Study|Adverse Event|3|||
125665814|NCT02919475|452066180|FG003|Overall Study|Adverse Event|9|||
125665815|NCT02919475|452066181|FG004|Overall Study|Adverse Event|2|||
125665816|NCT02919475|452066177|FG000|Overall Study|Death|0|||
125665817|NCT02919475|452066178|FG001|Overall Study|Death|1|||
125665818|NCT02919475|452066179|FG002|Overall Study|Death|0|||
125665819|NCT02919475|452066180|FG003|Overall Study|Death|0|||
125665820|NCT02919475|452066181|FG004|Overall Study|Death|0|||
125665821|NCT02919475|452066177|FG000|Overall Study|Lost to Follow-up|0|||
125665822|NCT02919475|452066178|FG001|Overall Study|Lost to Follow-up|0|||
125665823|NCT02919475|452066179|FG002|Overall Study|Lost to Follow-up|0|||
125665824|NCT02919475|452066180|FG003|Overall Study|Lost to Follow-up|1|||
125665825|NCT02919475|452066181|FG004|Overall Study|Lost to Follow-up|0|||
125665826|NCT02919475|452066177|FG000|Overall Study|Withdrawal by Subject|2|||
125665827|NCT02919475|452066178|FG001|Overall Study|Withdrawal by Subject|3|||
125665828|NCT02919475|452066179|FG002|Overall Study|Withdrawal by Subject|1|||
125665829|NCT02919475|452066180|FG003|Overall Study|Withdrawal by Subject|2|||
125665830|NCT02919475|452066181|FG004|Overall Study|Withdrawal by Subject|2|||
125665831|NCT02919475|452066177|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
125665832|NCT02919475|452066178|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
125665833|NCT02919475|452066179|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
125665834|NCT02919475|452066180|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
125665835|NCT02919475|452066181|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125665836|NCT01847313|452066188|FG000|Overall Study|Death|0|||
125665837|NCT01847313|452066189|FG001|Overall Study|Death|1|||
125665838|NCT01847313|452066188|FG000|Overall Study|Withdrawal by Subject|0|||
125665839|NCT01847313|452066189|FG001|Overall Study|Withdrawal by Subject|1|||
125665840|NCT02370784|452066190|FG000|Overall Study|Patient started prohibited medication|0|||
125665841|NCT02370784|452066191|FG001|Overall Study|Patient started prohibited medication|1|||
125665842|NCT00775983|452066192|FG000|Overall Study|Protocol Violation|1|||
125665843|NCT00775983|452066193|FG001|Overall Study|Protocol Violation|2|||
125665844|NCT02962882|452066194|FG000|Overall Study|Adverse Event|2|||
125665845|NCT02962882|452066194|FG000|Overall Study|Withdrawal by Subject|2|||
125665846|NCT02962882|452066194|FG000|Overall Study|Transfer from ICU|32|||
125665847|NCT01312779|452066195|FG000|Overall Study|Withdrawal by Subject|2|||
125665848|NCT01312779|452066195|FG000|Overall Study|Death|3|||
125665849|NCT01312779|452066195|FG000|Overall Study|Not Implanted with Device|27|||
125665850|NCT01663714|452066198|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
125665851|NCT01663714|452066198|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
125665852|NCT01663714|452066198|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
125665853|NCT01663714|452066198|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
125665854|NCT01663714|452066198|FG000|Long-Term Follow-Up|Death|4|||
125665855|NCT01663714|452066198|FG000|Long-Term Follow-Up|Non-compliance|1|||
125665856|NCT00597584|452066199|FG000|Overall Study|Adverse Event|4|||
125329409|NCT01177397|450839092|FG010|Overall Study|Disease progression|10|||
125329410|NCT01177397|450839093|FG011|Overall Study|Disease progression|8|||
125329411|NCT01177397|450839082|FG000|Overall Study|Other reasons|0|||
125329412|NCT01177397|450839083|FG001|Overall Study|Other reasons|0|||
125329413|NCT01177397|450839084|FG002|Overall Study|Other reasons|1|||
125329414|NCT01177397|450839085|FG003|Overall Study|Other reasons|0|||
125329415|NCT01177397|450839086|FG004|Overall Study|Other reasons|1|||
125329416|NCT01177397|450839087|FG005|Overall Study|Other reasons|1|||
125665857|NCT00597584|452066200|FG001|Overall Study|Adverse Event|2|||
125665858|NCT00597584|452066199|FG000|Overall Study|Death|53|||
125665859|NCT00597584|452066200|FG001|Overall Study|Death|30|||
125665860|NCT00597584|452066199|FG000|Overall Study|Lack of Efficacy|1|||
125329417|NCT01177397|450839088|FG006|Overall Study|Other reasons|2|||
125329418|NCT01177397|450839089|FG007|Overall Study|Other reasons|6|||
125329419|NCT01177397|450839090|FG008|Overall Study|Other reasons|10|||
125665861|NCT00597584|452066200|FG001|Overall Study|Lack of Efficacy|0|||
125665862|NCT00597584|452066199|FG000|Overall Study|Lost to Follow-up|2|||
125665863|NCT00597584|452066200|FG001|Overall Study|Lost to Follow-up|4|||
125665864|NCT00597584|452066199|FG000|Overall Study|Physician Decision|3|||
125665865|NCT00597584|452066200|FG001|Overall Study|Physician Decision|0|||
125329420|NCT01177397|450839091|FG009|Overall Study|Other reasons|8|||
125329421|NCT01177397|450839092|FG010|Overall Study|Other reasons|0|||
125665866|NCT00597584|452066199|FG000|Overall Study|Pregnancy|2|||
125665867|NCT00597584|452066200|FG001|Overall Study|Pregnancy|0|||
125665868|NCT00597584|452066199|FG000|Overall Study|Withdrawal by Subject|44|||
125665869|NCT00597584|452066200|FG001|Overall Study|Withdrawal by Subject|12|||
125665870|NCT00597584|452066199|FG000|Overall Study|Discontinued Dialysis|0|||
125665871|NCT00597584|452066200|FG001|Overall Study|Discontinued Dialysis|1|||
125665872|NCT00597584|452066199|FG000|Overall Study|Lost ability to consent|1|||
125665873|NCT00597584|452066200|FG001|Overall Study|Lost ability to consent|1|||
125665874|NCT00597584|452066199|FG000|Overall Study|Never dosed|1|||
125665875|NCT00597584|452066200|FG001|Overall Study|Never dosed|0|||
125665876|NCT00597584|452066199|FG000|Overall Study|Relocation|8|||
125665877|NCT00597584|452066200|FG001|Overall Study|Relocation|6|||
125665878|NCT00597584|452066199|FG000|Overall Study|Renal transplant|9|||
125665879|NCT00597584|452066200|FG001|Overall Study|Renal transplant|7|||
125329422|NCT01177397|450839093|FG011|Overall Study|Other reasons|2|||
125329423|NCT00865566|450839094|FG000|Overall Study|Death|1|||
125329424|NCT00865566|450839095|FG001|Overall Study|Death|11|||
125665880|NCT00660790|452066201|FG000|Baseline to 3 Months|Death|1|||
125665881|NCT00660790|452066201|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
125665882|NCT00660790|452066201|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
125665883|NCT02791659|452066202|FG000|Overall Study|Protocol Violation|0|||
125665884|NCT02791659|452066203|FG001|Overall Study|Protocol Violation|1|||
125665885|NCT03840811|452066204|FG000|Overall Study|Lost to Follow-up|0|||
125665886|NCT03840811|452066205|FG001|Overall Study|Lost to Follow-up|0|||
125665887|NCT03840811|452066206|FG002|Overall Study|Lost to Follow-up|1|||
125665888|NCT01904383|452066207|FG000|Overall Study|CRF not collected|117|||
125665889|NCT01904383|452066207|FG000|Overall Study|Reason not listed|147|||
125665890|NCT01904383|452066207|FG000|Overall Study|Lost to Follow-up|674|||
125665891|NCT01904383|452066207|FG000|Overall Study|Lack of Efficacy|370|||
125329425|NCT00865566|450839094|FG000|Overall Study|Lost to Follow-up|314|||
125329426|NCT00865566|450839095|FG001|Overall Study|Lost to Follow-up|315|||
125329427|NCT00865566|450839094|FG000|Overall Study|Withdrawal by Subject|45|||
125329428|NCT00865566|450839095|FG001|Overall Study|Withdrawal by Subject|65|||
125329429|NCT00865566|450839094|FG000|Overall Study|Physician Decision|0|||
125329430|NCT00865566|450839095|FG001|Overall Study|Physician Decision|1|||
125329431|NCT00865566|450839094|FG000|Overall Study|Participant relocated|78|||
125329432|NCT00865566|450839095|FG001|Overall Study|Participant relocated|107|||
125329433|NCT00865566|450839094|FG000|Overall Study|Participant unable to adhere|27|||
125329434|NCT00865566|450839095|FG001|Overall Study|Participant unable to adhere|42|||
125329435|NCT00865566|450839094|FG000|Overall Study|Other; N=245 due to early study closure|154|||
125329436|NCT00865566|450839095|FG001|Overall Study|Other; N=245 due to early study closure|139|||
125329437|NCT00865566|450839094|FG000|Overall Study|HIV infection|5|||
125329438|NCT00865566|450839095|FG001|Overall Study|HIV infection|7|||
125329439|NCT00719472|450839098|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
125329440|NCT00719472|450839098|FG000|Enrolled in Study|Subject decision to withdraw|8|||
125329441|NCT00719472|450839098|FG000|Enrolled in Study|Various Reasons|17|||
125329442|NCT00719472|450839098|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
125329443|NCT00719472|450839098|FG000|Received Cycle 1 Treatment|Death|5|||
125329444|NCT00719472|450839098|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
125329445|NCT00719472|450839098|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
125329446|NCT00719472|450839098|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
125329447|NCT00719472|450839098|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
125329448|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
125329449|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Death|6|||
125329450|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Disease progression|3|||
125665892|NCT01904383|452066207|FG000|Overall Study|Improvement|141|||
125665893|NCT01904383|452066207|FG000|Overall Study|Adverse Event|271|||
125665894|NCT01904383|452066207|FG000|Overall Study|No patient visit after entry|54|||
125665895|NCT01625845|452066208|FG000|Overall Study|Adverse Event|1|||
125665896|NCT01625845|452066209|FG001|Overall Study|Adverse Event|2|||
125665897|NCT01625845|452066208|FG000|Overall Study|Lost to Follow-up|2|||
125665898|NCT01625845|452066209|FG001|Overall Study|Lost to Follow-up|1|||
125665899|NCT01625845|452066208|FG000|Overall Study|Withdrawal by Subject|2|||
125665900|NCT01625845|452066209|FG001|Overall Study|Withdrawal by Subject|0|||
125329451|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
125329452|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
125329453|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
125329454|NCT00719472|450839098|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
125329455|NCT02395471|450839099|FG000|Overall Study|Lost to Follow-up|2|||
125329456|NCT02395471|450839100|FG001|Overall Study|Lost to Follow-up|0|||
125329457|NCT02395471|450839099|FG000|Overall Study|Withdrawal by Subject|2|||
125665901|NCT01294592|452066210|FG000|Overall Study|Adverse Event|28|||
125665902|NCT01294592|452066211|FG001|Overall Study|Adverse Event|13|||
125665903|NCT01294592|452066210|FG000|Overall Study|Lack of Efficacy|7|||
125665904|NCT01294592|452066211|FG001|Overall Study|Lack of Efficacy|5|||
125665905|NCT01294592|452066210|FG000|Overall Study|Protocol Violation|1|||
125665906|NCT01294592|452066211|FG001|Overall Study|Protocol Violation|7|||
125329458|NCT02395471|450839100|FG001|Overall Study|Withdrawal by Subject|1|||
125329459|NCT02395471|450839099|FG000|Overall Study|Physician Decision|1|||
125329460|NCT02395471|450839100|FG001|Overall Study|Physician Decision|0|||
125329461|NCT02395471|450839099|FG000|Overall Study|Protocol Violation|0|||
125329462|NCT02395471|450839100|FG001|Overall Study|Protocol Violation|1|||
125329463|NCT02395471|450839099|FG000|Overall Study|Failure to swollow sponge twice|1|||
125329464|NCT02395471|450839100|FG001|Overall Study|Failure to swollow sponge twice|0|||
125329465|NCT02395471|450839099|FG000|Overall Study|Patient did not return for procedure|0|||
125329466|NCT02395471|450839100|FG001|Overall Study|Patient did not return for procedure|1|||
125329467|NCT02395471|450839099|FG000|Overall Study|Subject not eligible|1|||
125329468|NCT02395471|450839100|FG001|Overall Study|Subject not eligible|0|||
125329469|NCT01244893|450839101|FG000|Baseline|Protocol Violation|0|||
125329470|NCT01244893|450839102|FG001|Baseline|Protocol Violation|1|||
125329471|NCT01244893|450839101|FG000|1-Week Follow Up|Lost to Follow-up|1|||
125329472|NCT01244893|450839102|FG001|1-Week Follow Up|Lost to Follow-up|0|||
125329473|NCT00357552|450839103|FG000|Screening|Did not meet eligibility criteria|84|||
125329474|NCT00357552|450839103|FG000|Weeks 0 to 24|Death|1|||
125329475|NCT00357552|450839103|FG000|Weeks 24 to 104|Death|3|||
125329476|NCT00357552|450839103|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
125329477|NCT00711191|450839108|FG000|Overall Study|Adverse Event|1|||
125329478|NCT00711191|450839109|FG001|Overall Study|Adverse Event|1|||
125665907|NCT01294592|452066210|FG000|Overall Study|Lost to Follow-up|7|||
125665908|NCT01294592|452066211|FG001|Overall Study|Lost to Follow-up|9|||
125665909|NCT01294592|452066210|FG000|Overall Study|Physician Decision|6|||
125665910|NCT01294592|452066211|FG001|Overall Study|Physician Decision|11|||
125665911|NCT01294592|452066210|FG000|Overall Study|Withdrawal by Subject|28|||
125665912|NCT01294592|452066211|FG001|Overall Study|Withdrawal by Subject|28|||
125665913|NCT02853929|452066212|FG000|Overall Study|Lost to Follow-up|3|||
125665914|NCT02853929|452066213|FG001|Overall Study|Lost to Follow-up|0|||
125665915|NCT02853929|452066212|FG000|Overall Study|Withdrawal by Subject|1|||
125665916|NCT02853929|452066213|FG001|Overall Study|Withdrawal by Subject|0|||
125665917|NCT02853929|452066212|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
125665918|NCT02853929|452066213|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
125665919|NCT02762565|452066214|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
125665920|NCT03549130|452066215|FG000|Overall Study|Adverse Event|0|||
125665921|NCT03549130|452066216|FG001|Overall Study|Adverse Event|1|||
125665922|NCT03549130|452066215|FG000|Overall Study|Lost to Follow-up|0|||
125665923|NCT03549130|452066216|FG001|Overall Study|Lost to Follow-up|1|||
125665924|NCT01113710|452066217|FG000|Overall Study|Adverse Event|64|||
125665925|NCT01113710|452066217|FG000|Overall Study|Lack of Efficacy|41|||
125665926|NCT01113710|452066217|FG000|Overall Study|No Information Available|40|||
125665927|NCT01113710|452066217|FG000|Overall Study|Withdrawal by Subject|28|||
125665928|NCT01113710|452066217|FG000|Overall Study|Lost to Follow-up|20|||
125665929|NCT01113710|452066217|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
125665930|NCT01113710|452066217|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
125665931|NCT01113710|452066217|FG000|Overall Study|Lack of Patient's Compliance|8|||
125665932|NCT01113710|452066217|FG000|Overall Study|Other|7|||
125665933|NCT01113710|452066217|FG000|Overall Study|Adverse Event/Other|5|||
125665934|NCT01113710|452066217|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
125665935|NCT01113710|452066217|FG000|Overall Study|Lack of Efficacy/Other|4|||
125665936|NCT01113710|452066217|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
125665937|NCT01113710|452066217|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
125665938|NCT01113710|452066217|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
125665939|NCT01113710|452066217|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
125665940|NCT01113710|452066217|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
125665941|NCT01113710|452066217|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
125665942|NCT01113710|452066217|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
125665943|NCT01113710|452066217|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
125665944|NCT01113710|452066217|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
125665945|NCT01113710|452066217|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
125665946|NCT01113710|452066217|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
125665947|NCT01113710|452066217|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
125665948|NCT01113710|452066217|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
125665949|NCT00623623|452066218|FG000|Overall Study|Previous enrolment into this study|1|||
125665950|NCT00623623|452066219|FG001|Overall Study|Previous enrolment into this study|1|||
125665951|NCT01078623|452066220|FG000|Treatment Period 1|Adverse Event|1|||
125665952|NCT01078623|452066221|FG001|Treatment Period 1|Adverse Event|1|||
125665953|NCT01078623|452066222|FG002|Treatment Period 1|Adverse Event|1|||
125665954|NCT01078623|452066223|FG003|Treatment Period 1|Adverse Event|0|||
125665955|NCT01078623|452066224|FG004|Treatment Period 1|Adverse Event|0|||
125329479|NCT00711191|450839110|FG002|Overall Study|Adverse Event|2|||
125329480|NCT00711191|450839108|FG000|Overall Study|Objective progression or relapse|2|||
125665956|NCT01078623|452066225|FG005|Treatment Period 1|Adverse Event|0|||
125665957|NCT01078623|452066226|FG006|Treatment Period 1|Adverse Event|1|||
125665958|NCT01078623|452066227|FG007|Treatment Period 1|Adverse Event|0|||
125665959|NCT01078623|452066228|FG008|Treatment Period 1|Adverse Event|1|||
125665960|NCT01078623|452066229|FG009|Treatment Period 1|Adverse Event|1|||
125665961|NCT01078623|452066230|FG010|Treatment Period 1|Adverse Event|0|||
125665962|NCT01078623|452066231|FG011|Treatment Period 1|Adverse Event|0|||
125665963|NCT01078623|452066232|FG012|Treatment Period 1|Adverse Event|0|||
125665964|NCT01078623|452066233|FG013|Treatment Period 1|Adverse Event|0|||
125665965|NCT01078623|452066234|FG014|Treatment Period 1|Adverse Event|0|||
125665966|NCT01078623|452066235|FG015|Treatment Period 1|Adverse Event|0|||
125665967|NCT01078623|452066236|FG016|Treatment Period 1|Adverse Event|0|||
125665968|NCT01078623|452066237|FG017|Treatment Period 1|Adverse Event|0|||
125665969|NCT01078623|452066238|FG018|Treatment Period 1|Adverse Event|0|||
125665970|NCT01078623|452066239|FG019|Treatment Period 1|Adverse Event|0|||
125665971|NCT01078623|452066220|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125665972|NCT01078623|452066221|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125665973|NCT01078623|452066222|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125665974|NCT01078623|452066223|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125665975|NCT01078623|452066224|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125665976|NCT01078623|452066225|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125665977|NCT01078623|452066226|FG006|Treatment Period 1|Withdrawal by Subject|0|||
125665978|NCT01078623|452066227|FG007|Treatment Period 1|Withdrawal by Subject|1|||
125665979|NCT01078623|452066228|FG008|Treatment Period 1|Withdrawal by Subject|0|||
125665980|NCT01078623|452066229|FG009|Treatment Period 1|Withdrawal by Subject|0|||
125665981|NCT01078623|452066230|FG010|Treatment Period 1|Withdrawal by Subject|1|||
125665982|NCT01078623|452066231|FG011|Treatment Period 1|Withdrawal by Subject|0|||
125665983|NCT01078623|452066232|FG012|Treatment Period 1|Withdrawal by Subject|0|||
125665984|NCT01078623|452066233|FG013|Treatment Period 1|Withdrawal by Subject|0|||
125665985|NCT01078623|452066234|FG014|Treatment Period 1|Withdrawal by Subject|0|||
125665986|NCT01078623|452066235|FG015|Treatment Period 1|Withdrawal by Subject|0|||
125665987|NCT01078623|452066236|FG016|Treatment Period 1|Withdrawal by Subject|0|||
125665988|NCT01078623|452066237|FG017|Treatment Period 1|Withdrawal by Subject|0|||
125665989|NCT01078623|452066238|FG018|Treatment Period 1|Withdrawal by Subject|0|||
125665990|NCT01078623|452066239|FG019|Treatment Period 1|Withdrawal by Subject|0|||
125665991|NCT01078623|452066220|FG000|Treatment Period 1|Protocol Violation|0|||
125665992|NCT01078623|452066221|FG001|Treatment Period 1|Protocol Violation|0|||
125665993|NCT01078623|452066222|FG002|Treatment Period 1|Protocol Violation|0|||
125665994|NCT01078623|452066223|FG003|Treatment Period 1|Protocol Violation|0|||
125665995|NCT01078623|452066224|FG004|Treatment Period 1|Protocol Violation|0|||
125665996|NCT01078623|452066225|FG005|Treatment Period 1|Protocol Violation|1|||
125665997|NCT01078623|452066226|FG006|Treatment Period 1|Protocol Violation|0|||
125665998|NCT01078623|452066227|FG007|Treatment Period 1|Protocol Violation|0|||
125665999|NCT01078623|452066228|FG008|Treatment Period 1|Protocol Violation|0|||
125666000|NCT01078623|452066229|FG009|Treatment Period 1|Protocol Violation|0|||
125666001|NCT01078623|452066230|FG010|Treatment Period 1|Protocol Violation|0|||
125666002|NCT01078623|452066231|FG011|Treatment Period 1|Protocol Violation|0|||
125666003|NCT01078623|452066232|FG012|Treatment Period 1|Protocol Violation|0|||
125666004|NCT01078623|452066233|FG013|Treatment Period 1|Protocol Violation|0|||
125666005|NCT01078623|452066234|FG014|Treatment Period 1|Protocol Violation|0|||
125666006|NCT01078623|452066235|FG015|Treatment Period 1|Protocol Violation|0|||
125666007|NCT01078623|452066236|FG016|Treatment Period 1|Protocol Violation|0|||
125666008|NCT01078623|452066237|FG017|Treatment Period 1|Protocol Violation|0|||
125666009|NCT01078623|452066238|FG018|Treatment Period 1|Protocol Violation|0|||
125666010|NCT01078623|452066239|FG019|Treatment Period 1|Protocol Violation|0|||
125666011|NCT01078623|452066220|FG000|Treatment Period 2|Adverse Event|0|||
125666012|NCT01078623|452066221|FG001|Treatment Period 2|Adverse Event|0|||
125666013|NCT01078623|452066222|FG002|Treatment Period 2|Adverse Event|0|||
125666014|NCT01078623|452066223|FG003|Treatment Period 2|Adverse Event|0|||
125666015|NCT01078623|452066224|FG004|Treatment Period 2|Adverse Event|0|||
125666016|NCT01078623|452066225|FG005|Treatment Period 2|Adverse Event|0|||
125666017|NCT01078623|452066226|FG006|Treatment Period 2|Adverse Event|1|||
125666018|NCT01078623|452066227|FG007|Treatment Period 2|Adverse Event|0|||
125329481|NCT00711191|450839109|FG001|Overall Study|Objective progression or relapse|3|||
125329482|NCT00711191|450839110|FG002|Overall Study|Objective progression or relapse|7|||
125666019|NCT01078623|452066228|FG008|Treatment Period 2|Adverse Event|0|||
125666020|NCT01078623|452066229|FG009|Treatment Period 2|Adverse Event|0|||
125666021|NCT01078623|452066230|FG010|Treatment Period 2|Adverse Event|0|||
125666022|NCT01078623|452066231|FG011|Treatment Period 2|Adverse Event|0|||
125329483|NCT00711191|450839108|FG000|Overall Study|Withdrawal by Subject|0|||
125666023|NCT01078623|452066232|FG012|Treatment Period 2|Adverse Event|0|||
125666024|NCT01078623|452066233|FG013|Treatment Period 2|Adverse Event|0|||
125666025|NCT01078623|452066234|FG014|Treatment Period 2|Adverse Event|0|||
125666026|NCT01078623|452066235|FG015|Treatment Period 2|Adverse Event|0|||
125666027|NCT01078623|452066236|FG016|Treatment Period 2|Adverse Event|0|||
125666028|NCT01078623|452066237|FG017|Treatment Period 2|Adverse Event|0|||
125666029|NCT01078623|452066238|FG018|Treatment Period 2|Adverse Event|1|||
125666030|NCT01078623|452066239|FG019|Treatment Period 2|Adverse Event|0|||
125666031|NCT01078623|452066220|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125666032|NCT01078623|452066221|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125666033|NCT01078623|452066222|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125666034|NCT01078623|452066223|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125329484|NCT00711191|450839109|FG001|Overall Study|Withdrawal by Subject|1|||
125666035|NCT01078623|452066224|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125666036|NCT01078623|452066225|FG005|Treatment Period 2|Withdrawal by Subject|1|||
125666037|NCT01078623|452066226|FG006|Treatment Period 2|Withdrawal by Subject|0|||
125666038|NCT01078623|452066227|FG007|Treatment Period 2|Withdrawal by Subject|0|||
125666039|NCT01078623|452066228|FG008|Treatment Period 2|Withdrawal by Subject|0|||
125666040|NCT01078623|452066229|FG009|Treatment Period 2|Withdrawal by Subject|0|||
125666041|NCT01078623|452066230|FG010|Treatment Period 2|Withdrawal by Subject|0|||
125666042|NCT01078623|452066231|FG011|Treatment Period 2|Withdrawal by Subject|0|||
125666043|NCT01078623|452066232|FG012|Treatment Period 2|Withdrawal by Subject|0|||
125666044|NCT01078623|452066233|FG013|Treatment Period 2|Withdrawal by Subject|0|||
125666045|NCT01078623|452066234|FG014|Treatment Period 2|Withdrawal by Subject|0|||
125666046|NCT01078623|452066235|FG015|Treatment Period 2|Withdrawal by Subject|0|||
125666047|NCT01078623|452066236|FG016|Treatment Period 2|Withdrawal by Subject|0|||
125666048|NCT01078623|452066237|FG017|Treatment Period 2|Withdrawal by Subject|0|||
125666049|NCT01078623|452066238|FG018|Treatment Period 2|Withdrawal by Subject|0|||
125666050|NCT01078623|452066239|FG019|Treatment Period 2|Withdrawal by Subject|0|||
125666051|NCT01078623|452066220|FG000|Treatment Period 3|Adverse Event|0|||
125666052|NCT01078623|452066221|FG001|Treatment Period 3|Adverse Event|0|||
125666053|NCT01078623|452066222|FG002|Treatment Period 3|Adverse Event|0|||
125666054|NCT01078623|452066223|FG003|Treatment Period 3|Adverse Event|0|||
125666055|NCT01078623|452066224|FG004|Treatment Period 3|Adverse Event|1|||
125666056|NCT01078623|452066225|FG005|Treatment Period 3|Adverse Event|0|||
125666057|NCT01078623|452066226|FG006|Treatment Period 3|Adverse Event|0|||
125666058|NCT01078623|452066227|FG007|Treatment Period 3|Adverse Event|0|||
125666059|NCT01078623|452066228|FG008|Treatment Period 3|Adverse Event|0|||
125666060|NCT01078623|452066229|FG009|Treatment Period 3|Adverse Event|0|||
125666061|NCT01078623|452066230|FG010|Treatment Period 3|Adverse Event|0|||
125666062|NCT01078623|452066231|FG011|Treatment Period 3|Adverse Event|0|||
125666063|NCT01078623|452066232|FG012|Treatment Period 3|Adverse Event|0|||
125666064|NCT01078623|452066233|FG013|Treatment Period 3|Adverse Event|1|||
125666065|NCT01078623|452066234|FG014|Treatment Period 3|Adverse Event|0|||
125666066|NCT01078623|452066235|FG015|Treatment Period 3|Adverse Event|0|||
125666067|NCT01078623|452066236|FG016|Treatment Period 3|Adverse Event|0|||
125666068|NCT01078623|452066237|FG017|Treatment Period 3|Adverse Event|0|||
125666069|NCT01078623|452066238|FG018|Treatment Period 3|Adverse Event|0|||
125666070|NCT01078623|452066239|FG019|Treatment Period 3|Adverse Event|0|||
125666071|NCT01078623|452066220|FG000|Treatment Period 4|Adverse Event|0|||
125666072|NCT01078623|452066221|FG001|Treatment Period 4|Adverse Event|0|||
125666073|NCT01078623|452066222|FG002|Treatment Period 4|Adverse Event|1|||
125666074|NCT01078623|452066223|FG003|Treatment Period 4|Adverse Event|0|||
125666075|NCT01078623|452066224|FG004|Treatment Period 4|Adverse Event|0|||
125666076|NCT01078623|452066225|FG005|Treatment Period 4|Adverse Event|0|||
125666077|NCT01078623|452066226|FG006|Treatment Period 4|Adverse Event|0|||
125666078|NCT01078623|452066227|FG007|Treatment Period 4|Adverse Event|0|||
125666079|NCT01078623|452066228|FG008|Treatment Period 4|Adverse Event|0|||
125666080|NCT01078623|452066229|FG009|Treatment Period 4|Adverse Event|0|||
125666081|NCT01078623|452066230|FG010|Treatment Period 4|Adverse Event|0|||
125666082|NCT01078623|452066231|FG011|Treatment Period 4|Adverse Event|0|||
125666083|NCT01078623|452066232|FG012|Treatment Period 4|Adverse Event|0|||
125666084|NCT01078623|452066233|FG013|Treatment Period 4|Adverse Event|0|||
125666085|NCT01078623|452066234|FG014|Treatment Period 4|Adverse Event|0|||
125666086|NCT01078623|452066235|FG015|Treatment Period 4|Adverse Event|0|||
125666087|NCT01078623|452066236|FG016|Treatment Period 4|Adverse Event|0|||
125666088|NCT01078623|452066237|FG017|Treatment Period 4|Adverse Event|0|||
125666089|NCT01078623|452066238|FG018|Treatment Period 4|Adverse Event|0|||
125666090|NCT01078623|452066239|FG019|Treatment Period 4|Adverse Event|0|||
125666091|NCT01078623|452066220|FG000|Treatment Period 4|Withdrawal by Subject|0|||
125666092|NCT01078623|452066221|FG001|Treatment Period 4|Withdrawal by Subject|0|||
125666093|NCT01078623|452066222|FG002|Treatment Period 4|Withdrawal by Subject|0|||
125666094|NCT01078623|452066223|FG003|Treatment Period 4|Withdrawal by Subject|0|||
125666095|NCT01078623|452066224|FG004|Treatment Period 4|Withdrawal by Subject|0|||
125329485|NCT00711191|450839110|FG002|Overall Study|Withdrawal by Subject|3|||
125666096|NCT01078623|452066225|FG005|Treatment Period 4|Withdrawal by Subject|0|||
125666097|NCT01078623|452066226|FG006|Treatment Period 4|Withdrawal by Subject|0|||
125666098|NCT01078623|452066227|FG007|Treatment Period 4|Withdrawal by Subject|0|||
125666099|NCT01078623|452066228|FG008|Treatment Period 4|Withdrawal by Subject|0|||
125666100|NCT01078623|452066229|FG009|Treatment Period 4|Withdrawal by Subject|0|||
125666101|NCT01078623|452066230|FG010|Treatment Period 4|Withdrawal by Subject|0|||
125666102|NCT01078623|452066231|FG011|Treatment Period 4|Withdrawal by Subject|0|||
125666103|NCT01078623|452066232|FG012|Treatment Period 4|Withdrawal by Subject|0|||
125666104|NCT01078623|452066233|FG013|Treatment Period 4|Withdrawal by Subject|0|||
125666105|NCT01078623|452066234|FG014|Treatment Period 4|Withdrawal by Subject|0|||
125666106|NCT01078623|452066235|FG015|Treatment Period 4|Withdrawal by Subject|1|||
125666107|NCT01078623|452066236|FG016|Treatment Period 4|Withdrawal by Subject|0|||
125666108|NCT01078623|452066237|FG017|Treatment Period 4|Withdrawal by Subject|0|||
125666109|NCT01078623|452066238|FG018|Treatment Period 4|Withdrawal by Subject|0|||
125666110|NCT01078623|452066239|FG019|Treatment Period 4|Withdrawal by Subject|0|||
125666111|NCT02424565|452066241|FG000|Period 1 (D0)|Protocol Violation|0|||
125666112|NCT02424565|452066242|FG001|Period 1 (D0)|Protocol Violation|1|||
125666113|NCT03650400|452066243|FG000|Overall Study|Study terminated by sponsor|0|||
125666114|NCT03650400|452066244|FG001|Overall Study|Study terminated by sponsor|5|||
125666115|NCT04132232|452066254|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
125666116|NCT04132232|452066255|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
125666117|NCT04132232|452066254|FG000|Overall Study|Lost to Follow-up|6|||
125666118|NCT04132232|452066255|FG001|Overall Study|Lost to Follow-up|7|||
125666119|NCT00368537|452066256|FG000|Randomization|No study drug dosed|13|||
125666120|NCT00368537|452066257|FG001|Randomization|No study drug dosed|6|||
125666121|NCT00368537|452066256|FG000|Baseline Participants|Lost to Follow-up|16|||
125666122|NCT00368537|452066257|FG001|Baseline Participants|Lost to Follow-up|17|||
125666123|NCT00368537|452066256|FG000|Baseline Participants|Withdrawal by Subject|6|||
125666124|NCT00368537|452066257|FG001|Baseline Participants|Withdrawal by Subject|4|||
125666125|NCT00368537|452066256|FG000|Baseline Participants|Death|1|||
125666126|NCT00368537|452066257|FG001|Baseline Participants|Death|2|||
125666127|NCT00368537|452066256|FG000|Baseline Participants|No susceptibility|1|||
125666128|NCT00368537|452066257|FG001|Baseline Participants|No susceptibility|0|||
125666129|NCT00368537|452066256|FG000|Baseline Participants|Patient uncompliant|0|||
125666130|NCT00368537|452066257|FG001|Baseline Participants|Patient uncompliant|1|||
125666131|NCT01368276|452066271|FG000|Overall Study|Death|1|||
125666132|NCT01368276|452066272|FG001|Overall Study|Death|10|||
125666133|NCT01427920|452066273|FG000|Overall Study|Adverse Event|1|||
125666134|NCT01427920|452066274|FG001|Overall Study|Adverse Event|2|||
125666135|NCT01427920|452066273|FG000|Overall Study|Lack of Efficacy|1|||
125666136|NCT01427920|452066274|FG001|Overall Study|Lack of Efficacy|0|||
125666137|NCT01427920|452066273|FG000|Overall Study|Protocol Violation|1|||
125666138|NCT01427920|452066274|FG001|Overall Study|Protocol Violation|3|||
125666139|NCT01427920|452066273|FG000|Overall Study|Withdrawal Criteria|4|||
125666140|NCT01427920|452066274|FG001|Overall Study|Withdrawal Criteria|4|||
125666141|NCT01427920|452066273|FG000|Overall Study|Unclassified|2|||
125666142|NCT01427920|452066274|FG001|Overall Study|Unclassified|8|||
125666143|NCT04228302|452066275|FG000|Overall Study|Adverse Event|0|||
125666144|NCT04228302|452066276|FG001|Overall Study|Adverse Event|0|||
125666145|NCT04228302|452066277|FG002|Overall Study|Adverse Event|0|||
125666146|NCT04228302|452066278|FG003|Overall Study|Adverse Event|0|||
125666147|NCT04228302|452066279|FG004|Overall Study|Adverse Event|1|||
125666148|NCT04228302|452066280|FG005|Overall Study|Adverse Event|0|||
125666149|NCT02732561|452066288|FG000|Overall Study|Lost to Follow-up|1|||
125666150|NCT02732561|452066289|FG001|Overall Study|Lost to Follow-up|1|||
125666151|NCT02732561|452066288|FG000|Overall Study|Withdrawal by Subject|1|||
125666152|NCT02732561|452066289|FG001|Overall Study|Withdrawal by Subject|0|||
125666153|NCT00837577|452066296|FG000|Double-blind Period|Clinical Adverse Event|1|||
125666154|NCT00837577|452066297|FG001|Double-blind Period|Clinical Adverse Event|0|||
125666155|NCT00837577|452066296|FG000|Double-blind Period|Withdrawal by Subject|1|||
125666156|NCT00837577|452066297|FG001|Double-blind Period|Withdrawal by Subject|0|||
125666157|NCT00837577|452066296|FG000|Open-label Period|Clinical Adverse Event|2|||
125666158|NCT00837577|452066297|FG001|Open-label Period|Clinical Adverse Event|2|||
125666159|NCT00837577|452066296|FG000|Open-label Period|Laboratory Adverse Event|0|||
125666160|NCT00837577|452066297|FG001|Open-label Period|Laboratory Adverse Event|1|||
125666161|NCT00837577|452066296|FG000|Open-label Period|Lack of Efficacy|4|||
125666162|NCT00837577|452066297|FG001|Open-label Period|Lack of Efficacy|3|||
125666163|NCT00837577|452066296|FG000|Open-label Period|Withdrawal by Subject|1|||
125666164|NCT00837577|452066297|FG001|Open-label Period|Withdrawal by Subject|2|||
125666165|NCT00837577|452066296|FG000|Open-label Period|Other Reason|1|||
125666166|NCT00837577|452066297|FG001|Open-label Period|Other Reason|1|||
125666167|NCT02065791|452066301|FG000|Overall Study|Closed Site|1|||
125329486|NCT03584789|450839111|FG000|Overall Study|refused EHR permission|19|||
125329487|NCT03584789|450839112|FG001|Overall Study|refused EHR permission|28|||
125329488|NCT03584789|450839113|FG002|Overall Study|refused EHR permission|23|||
125666168|NCT02065791|452066302|FG001|Overall Study|Closed Site|1|||
125666169|NCT02065791|452066301|FG000|Overall Study|Withdrawal by Subject|11|||
125666170|NCT02065791|452066302|FG001|Overall Study|Withdrawal by Subject|5|||
125666171|NCT02065791|452066301|FG000|Overall Study|Lost to Follow-up|13|||
125666172|NCT02065791|452066302|FG001|Overall Study|Lost to Follow-up|9|||
125666173|NCT00272961|452066303|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
125666174|NCT00272961|452066304|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
125666175|NCT00272961|452066305|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
125666176|NCT00272961|452066306|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
125666177|NCT00272961|452066307|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
125329489|NCT03584789|450839111|FG000|Overall Study|patients tied to a provider who retired|0|||
125666178|NCT00272961|452066303|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
125666179|NCT00272961|452066304|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
125666180|NCT00272961|452066305|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
125329490|NCT03584789|450839112|FG001|Overall Study|patients tied to a provider who retired|0|||
125329491|NCT03584789|450839113|FG002|Overall Study|patients tied to a provider who retired|3|||
125329492|NCT02035267|450839114|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
125329493|NCT02035267|450839115|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
125329494|NCT02035267|450839116|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
125329495|NCT02035267|450839117|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
125329496|NCT02035267|450839114|FG000|Overall Study|Adverse Event|0|||
125329497|NCT02035267|450839115|FG001|Overall Study|Adverse Event|0|||
125329498|NCT02035267|450839116|FG002|Overall Study|Adverse Event|1|||
125329499|NCT02035267|450839117|FG003|Overall Study|Adverse Event|0|||
125666181|NCT00272961|452066306|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
125666182|NCT00272961|452066307|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
125666183|NCT00272961|452066303|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
125666184|NCT00272961|452066304|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
125666185|NCT00272961|452066305|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
125666186|NCT00272961|452066306|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
125666187|NCT00272961|452066307|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
125666188|NCT00272961|452066303|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
125666189|NCT00272961|452066304|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
125666190|NCT00272961|452066305|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
125666191|NCT00272961|452066306|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
125666192|NCT00272961|452066307|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
125666193|NCT00272961|452066303|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
125666194|NCT00272961|452066304|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
125666195|NCT00272961|452066305|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
125666196|NCT00272961|452066306|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
125666197|NCT00272961|452066307|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
125666198|NCT00272961|452066303|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
125666199|NCT00272961|452066304|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
125666200|NCT00272961|452066305|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
125666201|NCT00272961|452066306|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
125666202|NCT00272961|452066307|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
125666203|NCT00272961|452066303|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
125666204|NCT00272961|452066304|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
125666205|NCT00272961|452066305|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
125666206|NCT00272961|452066306|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
125666207|NCT00272961|452066307|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
125666208|NCT00272961|452066303|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
125666209|NCT00272961|452066304|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
125666210|NCT00272961|452066305|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
125666211|NCT00272961|452066306|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
125666212|NCT00272961|452066307|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
125666213|NCT01890785|452066310|FG000|Third Intervention|Withdrawal by Subject|0|||
125666214|NCT01890785|452066311|FG001|Third Intervention|Withdrawal by Subject|1|||
125666215|NCT01890785|452066312|FG002|Third Intervention|Withdrawal by Subject|0|||
125666216|NCT01890785|452066313|FG003|Third Intervention|Withdrawal by Subject|0|||
125666217|NCT01890785|452066314|FG004|Third Intervention|Withdrawal by Subject|0|||
125666218|NCT01890785|452066315|FG005|Third Intervention|Withdrawal by Subject|0|||
125666219|NCT00575328|452066316|FG000|Overall Study|Adverse Event|1|||
125666220|NCT00575328|452066317|FG001|Overall Study|Adverse Event|1|||
125666221|NCT00575328|452066316|FG000|Overall Study|Lost to Follow-up|2|||
125666222|NCT00575328|452066317|FG001|Overall Study|Lost to Follow-up|1|||
125666223|NCT02124746|452066318|FG000|Overall Study|Adverse Event|2|||
125666224|NCT02124746|452066319|FG001|Overall Study|Adverse Event|1|||
125666225|NCT02124746|452066320|FG002|Overall Study|Adverse Event|2|||
125666226|NCT02124746|452066318|FG000|Overall Study|Death|2|||
125666227|NCT02124746|452066319|FG001|Overall Study|Death|1|||
125666228|NCT02124746|452066320|FG002|Overall Study|Death|3|||
125666229|NCT02124746|452066318|FG000|Overall Study|Lack of Efficacy|3|||
125666230|NCT02124746|452066319|FG001|Overall Study|Lack of Efficacy|2|||
125666231|NCT02124746|452066320|FG002|Overall Study|Lack of Efficacy|2|||
125666232|NCT02124746|452066318|FG000|Overall Study|Physician Decision|6|||
125666233|NCT02124746|452066319|FG001|Overall Study|Physician Decision|4|||
125666234|NCT02124746|452066320|FG002|Overall Study|Physician Decision|5|||
125666235|NCT02124746|452066318|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125666236|NCT02124746|452066319|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125666237|NCT02124746|452066320|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125666238|NCT02124746|452066318|FG000|Overall Study|Withdrawal by Subject|3|||
125666239|NCT02124746|452066319|FG001|Overall Study|Withdrawal by Subject|3|||
125329500|NCT02035267|450839114|FG000|Overall Study|Lost to Follow-up|0|||
125329501|NCT02035267|450839115|FG001|Overall Study|Lost to Follow-up|0|||
125666240|NCT02124746|452066320|FG002|Overall Study|Withdrawal by Subject|0|||
125666241|NCT02124746|452066318|FG000|Overall Study|Study Terminated by Sponsor|0|||
125666242|NCT02124746|452066319|FG001|Overall Study|Study Terminated by Sponsor|0|||
125666243|NCT02124746|452066320|FG002|Overall Study|Study Terminated by Sponsor|6|||
125666244|NCT02124746|452066318|FG000|Overall Study|Disease Progression|3|||
125666245|NCT02124746|452066319|FG001|Overall Study|Disease Progression|6|||
125666246|NCT02124746|452066320|FG002|Overall Study|Disease Progression|4|||
125329502|NCT02035267|450839116|FG002|Overall Study|Lost to Follow-up|0|||
125329503|NCT02035267|450839117|FG003|Overall Study|Lost to Follow-up|1|||
125329504|NCT02035267|450839114|FG000|Overall Study|Other unspecified|0|||
125329505|NCT02035267|450839115|FG001|Overall Study|Other unspecified|1|||
125329506|NCT02035267|450839116|FG002|Overall Study|Other unspecified|0|||
125329507|NCT02035267|450839117|FG003|Overall Study|Other unspecified|0|||
125329508|NCT02803580|450839119|FG000|Overall Study|Death|13|||
125329509|NCT02803580|450839119|FG000|Overall Study|Lost to Follow-up|19|||
125329510|NCT02803580|450839119|FG000|Overall Study|Withdrawal by Subject|3|||
125329511|NCT02803580|450839119|FG000|Overall Study|Inclusion in clinical trial|1|||
125329512|NCT00836693|450839125|FG000|Overall Study|Adverse Event|4|||
125329513|NCT00836693|450839126|FG001|Overall Study|Adverse Event|1|||
125329514|NCT00836693|450839125|FG000|Overall Study|Sponsor Decision|0|||
125329515|NCT00836693|450839126|FG001|Overall Study|Sponsor Decision|1|||
125329516|NCT00836693|450839125|FG000|Overall Study|Physician Decision|2|||
125329517|NCT00836693|450839126|FG001|Overall Study|Physician Decision|0|||
125329518|NCT00836693|450839125|FG000|Overall Study|Withdrawal by Subject|9|||
125329519|NCT00836693|450839126|FG001|Overall Study|Withdrawal by Subject|4|||
125329520|NCT00836693|450839125|FG000|Overall Study|Protocol Violation|1|||
125329521|NCT00836693|450839126|FG001|Overall Study|Protocol Violation|0|||
125329522|NCT00836693|450839125|FG000|Overall Study|Lost to Follow-up|1|||
125329523|NCT00836693|450839126|FG001|Overall Study|Lost to Follow-up|0|||
125329524|NCT02612779|450839127|FG000|Overall Study|Administrative reason by sponsor|4|||
125329525|NCT02612779|450839128|FG001|Overall Study|Administrative reason by sponsor|1|||
125329526|NCT02612779|450839127|FG000|Overall Study|No longer meet study criteria|0|||
125329527|NCT02612779|450839128|FG001|Overall Study|No longer meet study criteria|1|||
125329528|NCT02612779|450839127|FG000|Overall Study|Disease progression|29|||
125329529|NCT02612779|450839128|FG001|Overall Study|Disease progression|2|||
125329530|NCT02612779|450839127|FG000|Overall Study|Study drug toxicity|10|||
125329531|NCT02612779|450839128|FG001|Overall Study|Study drug toxicity|1|||
125329532|NCT02612779|450839127|FG000|Overall Study|Death|1|||
125329533|NCT02612779|450839128|FG001|Overall Study|Death|0|||
125329534|NCT02612779|450839127|FG000|Overall Study|Adverse event unrelated to study drug|5|||
125329535|NCT02612779|450839128|FG001|Overall Study|Adverse event unrelated to study drug|0|||
125329536|NCT02612779|450839127|FG000|Overall Study|Participant withdrew consent|4|||
125329537|NCT02612779|450839128|FG001|Overall Study|Participant withdrew consent|0|||
125329538|NCT02612779|450839127|FG000|Overall Study|Lost to Follow-up|1|||
125329539|NCT02612779|450839128|FG001|Overall Study|Lost to Follow-up|0|||
125329540|NCT02612779|450839127|FG000|Overall Study|Maximum clinical benefit|10|||
125329541|NCT02612779|450839128|FG001|Overall Study|Maximum clinical benefit|1|||
125329542|NCT02612779|450839127|FG000|Overall Study|Other reasons|4|||
125329543|NCT02612779|450839128|FG001|Overall Study|Other reasons|0|||
125329544|NCT02118961|450839129|FG000|Overall Study|Withdrawal by Subject|1|||
125329545|NCT02118961|450839130|FG001|Overall Study|Withdrawal by Subject|0|||
125329546|NCT01750229|450839131|FG000|Randomized Crossover Phase|Adverse Event|1|||
125329547|NCT01750229|450839131|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
125329548|NCT01750229|450839131|FG000|Long-term Follow-up Phase|Adverse Event|2|||
125329549|NCT01750229|450839131|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
125329550|NCT03722238|450839132|FG000|Overall Study|Protocol Violation|1|||
125329551|NCT03722238|450839133|FG001|Overall Study|Protocol Violation|0|||
125329552|NCT03722238|450839132|FG000|Overall Study|Physician Decision|1|||
125329553|NCT03722238|450839133|FG001|Overall Study|Physician Decision|0|||
125329554|NCT03722238|450839132|FG000|Overall Study|Death|1|||
125329555|NCT03722238|450839133|FG001|Overall Study|Death|0|||
125329556|NCT03722238|450839132|FG000|Overall Study|Lost to Follow-up|6|||
125329557|NCT03722238|450839133|FG001|Overall Study|Lost to Follow-up|0|||
125329558|NCT03722238|450839132|FG000|Overall Study|Partial missing data|44|||
125329559|NCT03722238|450839133|FG001|Overall Study|Partial missing data|1|||
125329560|NCT03722238|450839132|FG000|Overall Study|Withdrawal by Subject|2|||
125329561|NCT03722238|450839133|FG001|Overall Study|Withdrawal by Subject|0|||
125210687|NCT02638259|450395635|FG001|Treatment Period 2|Withdrawal by Subject|7|||
125329562|NCT03722238|450839132|FG000|Overall Study|Other|4|||
125329563|NCT03722238|450839133|FG001|Overall Study|Other|0|||
125329564|NCT03722238|450839132|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
125329565|NCT03722238|450839133|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
125329566|NCT03722238|450839132|FG000|Overall Study|Did not meet risk classification group criteria|90|||
125329567|NCT03722238|450839133|FG001|Overall Study|Did not meet risk classification group criteria|0|||
125329568|NCT03722238|450839132|FG000|Overall Study|Did not sign consent|17|||
125666247|NCT00571922|452066321|FG000|Overall Study|Completion unknown|36|||
125329569|NCT03722238|450839133|FG001|Overall Study|Did not sign consent|0|||
125329570|NCT03722238|450839132|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
125329571|NCT03722238|450839133|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
125329572|NCT03722238|450839132|FG000|Overall Study|Not willing to purchase study medication|142|||
125329573|NCT03722238|450839133|FG001|Overall Study|Not willing to purchase study medication|0|||
125329574|NCT03722238|450839132|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
125329575|NCT03722238|450839133|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
125329576|NCT03771664|450839134|FG000|Overall Study|Adverse Event|1|||
125329577|NCT03771664|450839135|FG001|Overall Study|Adverse Event|0|||
125329578|NCT03771664|450839134|FG000|Overall Study|Lost to Follow-up|1|||
125329579|NCT03771664|450839135|FG001|Overall Study|Lost to Follow-up|0|||
125329580|NCT03771664|450839134|FG000|Overall Study|Withdrawal by Participant|1|||
125329581|NCT03771664|450839135|FG001|Overall Study|Withdrawal by Participant|4|||
125329582|NCT03771664|450839134|FG000|Overall Study|Randomized but not Treated|0|||
125329583|NCT03771664|450839135|FG001|Overall Study|Randomized but not Treated|1|||
125329584|NCT00891904|450839136|FG000|Overall Study|Death|1|||
125329585|NCT00891904|450839136|FG000|Overall Study|Adverse Event|1|||
125329586|NCT03096288|450839138|FG000|Overall Study|Withdrawal by Subject|0|||
125329587|NCT03096288|450839139|FG001|Overall Study|Withdrawal by Subject|1|||
125329588|NCT03096288|450839140|FG002|Overall Study|Withdrawal by Subject|0|||
125329589|NCT03096288|450839141|FG003|Overall Study|Withdrawal by Subject|1|||
125425606|NCT01735201|451182285|FG006|Overall Study|Protocol Violation|0|||
125425607|NCT01735201|451182286|FG007|Overall Study|Protocol Violation|0|||
125425608|NCT01735201|451182279|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125425609|NCT01735201|451182280|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125425610|NCT01735201|451182281|FG002|Overall Study|Other Miscellaneous Reasons|0|||
125425611|NCT01735201|451182282|FG003|Overall Study|Other Miscellaneous Reasons|1|||
125425612|NCT01735201|451182283|FG004|Overall Study|Other Miscellaneous Reasons|0|||
125329597|NCT01411891|450839148|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
125329598|NCT01411891|450839149|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
125329599|NCT02004093|450839150|FG000|Overall Study|Death|2|||
125329600|NCT02004093|450839151|FG001|Overall Study|Death|1|||
125329601|NCT02004093|450839150|FG000|Overall Study|Lack of Efficacy|66|||
125329602|NCT02004093|450839151|FG001|Overall Study|Lack of Efficacy|62|||
125329603|NCT02004093|450839150|FG000|Overall Study|Protocol Violation|0|||
125329604|NCT02004093|450839151|FG001|Overall Study|Protocol Violation|1|||
125329605|NCT02004093|450839150|FG000|Overall Study|Lost to Follow-up|0|||
125329606|NCT02004093|450839151|FG001|Overall Study|Lost to Follow-up|1|||
125329607|NCT02004093|450839150|FG000|Overall Study|Withdrawal by Subject|3|||
125329608|NCT02004093|450839151|FG001|Overall Study|Withdrawal by Subject|7|||
125329609|NCT02004093|450839150|FG000|Overall Study|Other|3|||
125329610|NCT02004093|450839151|FG001|Overall Study|Other|1|||
125666248|NCT00571922|452066322|FG001|Overall Study|Completion unknown|36|||
125666249|NCT02191579|452066328|FG000|Treatment 1|Multiple Reasons Specified|27|||
125666250|NCT02191579|452066329|FG001|Treatment 1|Multiple Reasons Specified|58|||
125666251|NCT02191579|452066328|FG000|Treatment 2|Multiple Reasons Specified|0|||
125666252|NCT02191579|452066329|FG001|Treatment 2|Multiple Reasons Specified|25|||
125666253|NCT00964223|452066339|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
125666254|NCT00811070|452066340|FG000|Overall Study|Death|0|||
125666255|NCT00811070|452066341|FG001|Overall Study|Death|0|||
125666256|NCT00811070|452066342|FG002|Overall Study|Death|0|||
125666257|NCT00811070|452066343|FG003|Overall Study|Death|2|||
125666258|NCT00811070|452066344|FG004|Overall Study|Death|5|||
125666259|NCT00811070|452066345|FG005|Overall Study|Death|0|||
125666260|NCT00811070|452066340|FG000|Overall Study|Other|1|||
125666261|NCT00811070|452066341|FG001|Overall Study|Other|0|||
125666262|NCT00811070|452066342|FG002|Overall Study|Other|0|||
125666263|NCT00811070|452066343|FG003|Overall Study|Other|0|||
125666264|NCT00811070|452066344|FG004|Overall Study|Other|0|||
125666265|NCT00811070|452066345|FG005|Overall Study|Other|0|||
125666266|NCT00811070|452066340|FG000|Overall Study|Withdrawal by Subject|0|||
125666267|NCT00811070|452066341|FG001|Overall Study|Withdrawal by Subject|1|||
125329611|NCT04639258|450839152|FG000|Overall Study|Screen failure|5|||
125329612|NCT04639258|450839152|FG000|Overall Study|Physician Decision|2|||
125329613|NCT04639258|450839152|FG000|Overall Study|Early study termination|3|||
125329614|NCT04639258|450839152|FG000|Overall Study|Withdrawal by Subject|1|||
125329615|NCT00414596|450839153|FG000|Overall Study|Protocol Violation|2|||
125329616|NCT02558296|450839155|FG000|Completed the Study Through Week 24|Adverse Event|9|||
125329617|NCT02558296|450839156|FG001|Completed the Study Through Week 24|Adverse Event|3|||
125666268|NCT00811070|452066342|FG002|Overall Study|Withdrawal by Subject|0|||
125666269|NCT00811070|452066343|FG003|Overall Study|Withdrawal by Subject|0|||
125666270|NCT00811070|452066344|FG004|Overall Study|Withdrawal by Subject|0|||
125329618|NCT02558296|450839155|FG000|Completed the Study Through Week 24|Death|7|||
125666271|NCT00811070|452066345|FG005|Overall Study|Withdrawal by Subject|0|||
125666272|NCT00811070|452066340|FG000|Overall Study|Physician Decision|0|||
125666273|NCT00811070|452066341|FG001|Overall Study|Physician Decision|0|||
125666274|NCT00811070|452066342|FG002|Overall Study|Physician Decision|0|||
125329619|NCT02558296|450839156|FG001|Completed the Study Through Week 24|Death|7|||
125329620|NCT02558296|450839155|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
125540804|NCT01097707|451609448|FG001|Overall Study|Withdrawal by Subject|6|||
125540805|NCT01097707|451609449|FG002|Overall Study|Withdrawal by Subject|1|||
125540806|NCT01097707|451609450|FG003|Overall Study|Withdrawal by Subject|4|||
125540807|NCT01097707|451609451|FG004|Overall Study|Withdrawal by Subject|3|||
125540808|NCT01097707|451609447|FG000|Overall Study|Reason unknown|0|||
125540809|NCT01097707|451609448|FG001|Overall Study|Reason unknown|0|||
125540810|NCT01097707|451609449|FG002|Overall Study|Reason unknown|0|||
125540811|NCT01097707|451609450|FG003|Overall Study|Reason unknown|0|||
125540812|NCT01097707|451609451|FG004|Overall Study|Reason unknown|1|||
125540813|NCT00635427|451609454|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
125540814|NCT00635427|451609455|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
125540815|NCT00635427|451609456|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
125540816|NCT00635427|451609457|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
125540817|NCT00635427|451609458|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
125540818|NCT00635427|451609454|FG000|Overall Study|Death|0|||
125540819|NCT00635427|451609455|FG001|Overall Study|Death|0|||
125540820|NCT00635427|451609456|FG002|Overall Study|Death|0|||
125540821|NCT00635427|451609457|FG003|Overall Study|Death|1|||
125540822|NCT00635427|451609458|FG004|Overall Study|Death|0|||
125540823|NCT00635427|451609454|FG000|Overall Study|Termination Of Study By Sponsor|12|||
125540824|NCT00635427|451609455|FG001|Overall Study|Termination Of Study By Sponsor|6|||
125540825|NCT00635427|451609456|FG002|Overall Study|Termination Of Study By Sponsor|10|||
125540826|NCT00635427|451609457|FG003|Overall Study|Termination Of Study By Sponsor|6|||
125540827|NCT00635427|451609458|FG004|Overall Study|Termination Of Study By Sponsor|6|||
125540828|NCT00635427|451609454|FG000|Overall Study|Withdrawal Of Consent|0|||
125540829|NCT00635427|451609455|FG001|Overall Study|Withdrawal Of Consent|0|||
125540830|NCT00635427|451609456|FG002|Overall Study|Withdrawal Of Consent|0|||
125540831|NCT00635427|451609457|FG003|Overall Study|Withdrawal Of Consent|2|||
125540832|NCT00635427|451609458|FG004|Overall Study|Withdrawal Of Consent|2|||
125540833|NCT03484273|451609459|FG000|Overall Study|Equipment Malfunction|1|||
125540834|NCT03484273|451609459|FG000|Overall Study|Data excluded from analysis|1|||
125540835|NCT01157676|451609460|FG000|Randomization|Death|1|||
125540836|NCT01157676|451609461|FG001|Randomization|Death|1|||
125540837|NCT01157676|451609460|FG000|Randomization|unresectable|2|||
125540838|NCT01157676|451609461|FG001|Randomization|unresectable|3|||
125540839|NCT01157676|451609460|FG000|Randomization|Withdrawal by Subject|17|||
125540840|NCT01157676|451609461|FG001|Randomization|Withdrawal by Subject|13|||
125540841|NCT01157676|451609460|FG000|Randomization|Physician Decision|1|||
125540842|NCT01157676|451609461|FG001|Randomization|Physician Decision|0|||
125540843|NCT01157676|451609460|FG000|Surgery|underwent open cystectomy|0|||
125540844|NCT01157676|451609461|FG001|Surgery|underwent open cystectomy|4|||
125540845|NCT01157676|451609460|FG000|Surgery|converted to open procedure|0|||
125540846|NCT01157676|451609461|FG001|Surgery|converted to open procedure|5|||
125540847|NCT01157676|451609460|FG000|Surgery|underwent robotic cystectomy|1|||
125540848|NCT01157676|451609461|FG001|Surgery|underwent robotic cystectomy|0|||
125540849|NCT02706899|451609463|FG000|Overall Study|Withdrawal by Subject|1|||
125540850|NCT02706899|451609464|FG001|Overall Study|Withdrawal by Subject|0|||
125540851|NCT02706899|451609463|FG000|Overall Study|Death|8|||
125540852|NCT02706899|451609464|FG001|Overall Study|Death|0|||
125540853|NCT02706899|451609463|FG000|Overall Study|Study Termination by Sponsor|4|||
125540854|NCT02706899|451609464|FG001|Overall Study|Study Termination by Sponsor|6|||
125540855|NCT01435616|451609465|FG000|Overall Study|Adverse Event|39|||
125540856|NCT01435616|451609466|FG001|Overall Study|Adverse Event|21|||
125540857|NCT01435616|451609465|FG000|Overall Study|Death|7|||
125540858|NCT01435616|451609466|FG001|Overall Study|Death|2|||
125540859|NCT01435616|451609465|FG000|Overall Study|Lost to Follow-up|22|||
125540860|NCT01435616|451609466|FG001|Overall Study|Lost to Follow-up|13|||
125540861|NCT01435616|451609465|FG000|Overall Study|Protocol Violation|16|||
125540862|NCT01435616|451609466|FG001|Overall Study|Protocol Violation|13|||
125540863|NCT01435616|451609465|FG000|Overall Study|Withdrawal by Subject|66|||
125540864|NCT01435616|451609466|FG001|Overall Study|Withdrawal by Subject|24|||
125540865|NCT01435616|451609465|FG000|Overall Study|Physician Decision|20|||
125540866|NCT01435616|451609466|FG001|Overall Study|Physician Decision|7|||
125540867|NCT01435616|451609465|FG000|Overall Study|Sponsor Decision|1|||
125540868|NCT01435616|451609466|FG001|Overall Study|Sponsor Decision|0|||
125540869|NCT03122223|451609467|FG000|Overall Study|Withdrawal by Subject|2|||
125540870|NCT03122223|451609468|FG001|Overall Study|Withdrawal by Subject|2|||
125540871|NCT03122223|451609469|FG002|Overall Study|Withdrawal by Subject|1|||
125540872|NCT03122223|451609470|FG003|Overall Study|Withdrawal by Subject|0|||
125540873|NCT03122223|451609467|FG000|Overall Study|Lost to Follow-up|0|||
125540874|NCT03122223|451609468|FG001|Overall Study|Lost to Follow-up|2|||
125540875|NCT03122223|451609469|FG002|Overall Study|Lost to Follow-up|2|||
125540876|NCT03122223|451609470|FG003|Overall Study|Lost to Follow-up|0|||
125540877|NCT03122223|451609467|FG000|Overall Study|Participant unable to adhere|1|||
125540878|NCT03122223|451609468|FG001|Overall Study|Participant unable to adhere|1|||
125666275|NCT00811070|452066343|FG003|Overall Study|Physician Decision|0|||
125666276|NCT00811070|452066344|FG004|Overall Study|Physician Decision|0|||
125666277|NCT00811070|452066345|FG005|Overall Study|Physician Decision|1|||
125666278|NCT03120520|452066348|FG000|Overall Study|Lost to Follow-up|1|||
125666279|NCT03120520|452066349|FG001|Overall Study|Lost to Follow-up|1|||
125666280|NCT03120520|452066350|FG002|Overall Study|Lost to Follow-up|1|||
125666281|NCT03120520|452066351|FG003|Overall Study|Lost to Follow-up|1|||
125666282|NCT03120520|452066348|FG000|Overall Study|Withdrawal by Subject|3|||
125666283|NCT03120520|452066349|FG001|Overall Study|Withdrawal by Subject|2|||
125666284|NCT03120520|452066350|FG002|Overall Study|Withdrawal by Subject|3|||
125666285|NCT03120520|452066351|FG003|Overall Study|Withdrawal by Subject|2|||
125666286|NCT03120520|452066348|FG000|Overall Study|Other|0|||
125666287|NCT03120520|452066349|FG001|Overall Study|Other|1|||
125666288|NCT03120520|452066350|FG002|Overall Study|Other|0|||
125666289|NCT03120520|452066351|FG003|Overall Study|Other|0|||
125666290|NCT01759537|452066352|FG000|Overall Study|Death|1|||
125666291|NCT01759537|452066353|FG001|Overall Study|Death|1|||
125666292|NCT01759537|452066352|FG000|Overall Study|Pregnancy|1|||
125666293|NCT01759537|452066353|FG001|Overall Study|Pregnancy|1|||
125666294|NCT01759537|452066352|FG000|Overall Study|Lost to Follow-up|9|||
125666295|NCT01759537|452066353|FG001|Overall Study|Lost to Follow-up|9|||
125666296|NCT01759537|452066352|FG000|Overall Study|Accident involving jaw fracture|1|||
125666297|NCT01759537|452066353|FG001|Overall Study|Accident involving jaw fracture|1|||
125666298|NCT01759537|452066352|FG000|Overall Study|Subcrestal implant too coronal|1|||
125666299|NCT01759537|452066353|FG001|Overall Study|Subcrestal implant too coronal|1|||
125666300|NCT00420290|452066354|FG000|Overall Study|Adverse Event|3|||
125666301|NCT00420290|452066355|FG001|Overall Study|Adverse Event|1|||
125666302|NCT00420290|452066354|FG000|Overall Study|Withdrawal by Subject|0|||
125666303|NCT00420290|452066355|FG001|Overall Study|Withdrawal by Subject|2|||
125666304|NCT00420290|452066354|FG000|Overall Study|did not meet inclusion/exclusion|1|||
125666305|NCT00420290|452066355|FG001|Overall Study|did not meet inclusion/exclusion|1|||
125666306|NCT02092961|452067615|FG000|Overall Study|Not reported|1|||
125666307|NCT02092961|452067616|FG001|Overall Study|Not reported|0|||
125666308|NCT02092961|452067617|FG002|Overall Study|Not reported|1|||
125666309|NCT02092961|452067615|FG000|Overall Study|Study stopped|13|||
125666310|NCT02092961|452067616|FG001|Overall Study|Study stopped|9|||
125666311|NCT02092961|452067617|FG002|Overall Study|Study stopped|12|||
125666312|NCT02092961|452067615|FG000|Overall Study|Lack of therapeutic response|2|||
125666313|NCT02092961|452067616|FG001|Overall Study|Lack of therapeutic response|1|||
125666314|NCT02092961|452067617|FG002|Overall Study|Lack of therapeutic response|3|||
125666315|NCT02092961|452067615|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
125666316|NCT02092961|452067616|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
125666317|NCT02092961|452067617|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
125666318|NCT02092961|452067615|FG000|Overall Study|Adverse Event|2|||
125666319|NCT02092961|452067616|FG001|Overall Study|Adverse Event|4|||
125666320|NCT02092961|452067617|FG002|Overall Study|Adverse Event|0|||
125666321|NCT00854620|452067618|FG000|Overall Study|Adverse Event|1|||
125666322|NCT01623830|452067619|FG000|Overall Study|Withdrawal by Subject|6|||
125666323|NCT01623830|452067620|FG001|Overall Study|Withdrawal by Subject|7|||
125666324|NCT01623830|452067619|FG000|Overall Study|Exclusion from Study|1|||
125666325|NCT01623830|452067620|FG001|Overall Study|Exclusion from Study|2|||
125666326|NCT01792284|452067621|FG000|Lead-in Period|Adverse Event|15|||
125666327|NCT01792284|452067622|FG001|Lead-in Period|Adverse Event|0|||
125666328|NCT01792284|452067623|FG002|Lead-in Period|Adverse Event|0|||
125666329|NCT01792284|452067621|FG000|Lead-in Period|Lost to Follow-up|2|||
125666330|NCT01792284|452067622|FG001|Lead-in Period|Lost to Follow-up|0|||
125666331|NCT01792284|452067623|FG002|Lead-in Period|Lost to Follow-up|0|||
125666332|NCT01792284|452067621|FG000|Lead-in Period|Protocol Violation|1|||
125666333|NCT01792284|452067622|FG001|Lead-in Period|Protocol Violation|0|||
125666334|NCT01792284|452067623|FG002|Lead-in Period|Protocol Violation|0|||
125666335|NCT01792284|452067621|FG000|Lead-in Period|Withdrawal by Subject|10|||
125666336|NCT01792284|452067622|FG001|Lead-in Period|Withdrawal by Subject|0|||
125666337|NCT01792284|452067623|FG002|Lead-in Period|Withdrawal by Subject|0|||
125329621|NCT02558296|450839156|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
125666338|NCT01792284|452067621|FG000|Lead-in Period|Physician Decision|1|||
125666339|NCT01792284|452067622|FG001|Lead-in Period|Physician Decision|0|||
125329622|NCT02558296|450839155|FG000|Completed the Study Through Week 24|Physician Decision|1|||
125329623|NCT02558296|450839156|FG001|Completed the Study Through Week 24|Physician Decision|0|||
125666340|NCT01792284|452067623|FG002|Lead-in Period|Physician Decision|0|||
125666341|NCT01792284|452067621|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
125666342|NCT01792284|452067622|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
125666343|NCT01792284|452067623|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
125666344|NCT01792284|452067621|FG000|Randomization Period 1|Withdrawal by Subject|0|||
125666345|NCT01792284|452067622|FG001|Randomization Period 1|Withdrawal by Subject|1|||
125666346|NCT01792284|452067623|FG002|Randomization Period 1|Withdrawal by Subject|1|||
125666347|NCT01792284|452067621|FG000|Randomization Period 1|Physician Decision|0|||
125666348|NCT01792284|452067622|FG001|Randomization Period 1|Physician Decision|1|||
125666349|NCT01792284|452067623|FG002|Randomization Period 1|Physician Decision|1|||
125666350|NCT01792284|452067621|FG000|Randomization Period 1|Adverse Event|0|||
125666351|NCT01792284|452067622|FG001|Randomization Period 1|Adverse Event|0|||
125666352|NCT01792284|452067623|FG002|Randomization Period 1|Adverse Event|2|||
125666353|NCT01792284|452067621|FG000|Randomization Period 1|Lost to Follow-up|0|||
125666354|NCT01792284|452067622|FG001|Randomization Period 1|Lost to Follow-up|0|||
125666355|NCT01792284|452067623|FG002|Randomization Period 1|Lost to Follow-up|1|||
125666356|NCT01792284|452067621|FG000|Randomization Period 2|Protocol Violation|0|||
125666357|NCT01792284|452067622|FG001|Randomization Period 2|Protocol Violation|1|||
125666358|NCT01792284|452067623|FG002|Randomization Period 2|Protocol Violation|0|||
125666359|NCT01792284|452067621|FG000|Randomization Period 2|Withdrawal by Subject|0|||
125666360|NCT01792284|452067622|FG001|Randomization Period 2|Withdrawal by Subject|2|||
125666361|NCT01792284|452067623|FG002|Randomization Period 2|Withdrawal by Subject|0|||
125666362|NCT01169649|452067625|FG000|Overall Study|Patient Not Treated|3|||
125666363|NCT00515073|452067629|FG000|Overall Study|Withdrawal by Subject|1|||
125666364|NCT00515073|452067629|FG000|Overall Study|Physician Decision|1|||
125666365|NCT01456052|452067630|FG000|Overall Study|Adverse Event|1|||
125666366|NCT01456052|452067631|FG001|Overall Study|Adverse Event|1|||
125666367|NCT01456052|452067632|FG002|Overall Study|Adverse Event|2|||
125666368|NCT01456052|452067630|FG000|Overall Study|Consent withdrawn|0|||
125666369|NCT01456052|452067631|FG001|Overall Study|Consent withdrawn|2|||
125666370|NCT01456052|452067632|FG002|Overall Study|Consent withdrawn|1|||
125666371|NCT01456052|452067630|FG000|Overall Study|Protocol Violation|0|||
125666372|NCT01456052|452067631|FG001|Overall Study|Protocol Violation|1|||
125666373|NCT01456052|452067632|FG002|Overall Study|Protocol Violation|0|||
125666374|NCT01456052|452067630|FG000|Overall Study|Physician Decision|1|||
125666375|NCT01456052|452067631|FG001|Overall Study|Physician Decision|0|||
125666376|NCT01456052|452067632|FG002|Overall Study|Physician Decision|1|||
125666377|NCT01456052|452067630|FG000|Overall Study|Treatment Failure|0|||
125666378|NCT01456052|452067631|FG001|Overall Study|Treatment Failure|1|||
125666379|NCT01456052|452067632|FG002|Overall Study|Treatment Failure|1|||
125666380|NCT00463866|452067633|FG000|Overall Study|Adverse Event|70|||
125666381|NCT00463866|452067634|FG001|Overall Study|Adverse Event|93|||
125666382|NCT00463866|452067633|FG000|Overall Study|Withdrawal by Subject|81|||
125666383|NCT00463866|452067634|FG001|Overall Study|Withdrawal by Subject|79|||
125666384|NCT00463866|452067633|FG000|Overall Study|Lost to Follow-up|46|||
125666385|NCT00463866|452067634|FG001|Overall Study|Lost to Follow-up|55|||
125666386|NCT00463866|452067633|FG000|Overall Study|Incorrect Enrolment|64|||
125666387|NCT00463866|452067634|FG001|Overall Study|Incorrect Enrolment|66|||
125666388|NCT00463866|452067633|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
125666389|NCT00463866|452067634|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
125666390|NCT00463866|452067633|FG000|Overall Study|Safety Reason|1|||
125666391|NCT00463866|452067634|FG001|Overall Study|Safety Reason|3|||
125666392|NCT00463866|452067633|FG000|Overall Study|Mis-Randomization of subject|0|||
125666393|NCT00463866|452067634|FG001|Overall Study|Mis-Randomization of subject|1|||
125666394|NCT00463866|452067633|FG000|Overall Study|Other|22|||
125666395|NCT00463866|452067634|FG001|Overall Study|Other|22|||
125666396|NCT02265952|452067635|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
125666397|NCT02265952|452067636|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
125666398|NCT02265952|452067635|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
125666399|NCT02265952|452067636|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
125666400|NCT01042977|452067638|FG000|Overall Study|Adverse Event|4|||
125666401|NCT01042977|452067639|FG001|Overall Study|Adverse Event|12|||
125666402|NCT01042977|452067638|FG000|Overall Study|Death|2|||
125329624|NCT02558296|450839155|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
125329625|NCT02558296|450839156|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
125329626|NCT02558296|450839155|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
125329627|NCT02558296|450839156|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
125329628|NCT02558296|450839155|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
125378853|NCT01134783|451019170|FG000|Overall Study|Withdrawal by Subject|15|||
125666403|NCT01042977|452067639|FG001|Overall Study|Death|1|||
125666404|NCT01042977|452067638|FG000|Overall Study|Withdrawal by Subject|8|||
125666405|NCT01042977|452067639|FG001|Overall Study|Withdrawal by Subject|16|||
125666406|NCT01042977|452067638|FG000|Overall Study|Lost to Follow-up|0|||
125666407|NCT01042977|452067639|FG001|Overall Study|Lost to Follow-up|2|||
125666408|NCT01042977|452067638|FG000|Overall Study|Poor/non-compliance|3|||
125666409|NCT01042977|452067639|FG001|Overall Study|Poor/non-compliance|4|||
125666410|NCT01042977|452067638|FG000|Overall Study|Subject no longer meets study criteria|15|||
125666411|NCT01042977|452067639|FG001|Overall Study|Subject no longer meets study criteria|13|||
125666412|NCT01042977|452067638|FG000|Overall Study|Incorrect enrollment|6|||
125666413|NCT01042977|452067639|FG001|Overall Study|Incorrect enrollment|4|||
125666414|NCT01042977|452067638|FG000|Overall Study|Safety|0|||
125666415|NCT01042977|452067639|FG001|Overall Study|Safety|2|||
125666416|NCT01042977|452067638|FG000|Overall Study|Administrative reason by sponsor|0|||
125666417|NCT01042977|452067639|FG001|Overall Study|Administrative reason by sponsor|1|||
125666418|NCT01042977|452067638|FG000|Overall Study|Various|3|||
125329629|NCT02558296|450839156|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
125329630|NCT02558296|450839155|FG000|Completed the Study|Adverse Event|14|||
125329631|NCT02558296|450839156|FG001|Completed the Study|Adverse Event|5|||
125329632|NCT02558296|450839155|FG000|Completed the Study|Death|39|||
125329633|NCT02558296|450839156|FG001|Completed the Study|Death|25|||
125329634|NCT02558296|450839155|FG000|Completed the Study|Lost to Follow-up|31|||
125329635|NCT02558296|450839156|FG001|Completed the Study|Lost to Follow-up|23|||
125329636|NCT02558296|450839155|FG000|Completed the Study|Physician Decision|6|||
125329637|NCT02558296|450839156|FG001|Completed the Study|Physician Decision|0|||
125329638|NCT02558296|450839155|FG000|Completed the Study|Protocol Violation|2|||
125329639|NCT02558296|450839156|FG001|Completed the Study|Protocol Violation|1|||
125329640|NCT02558296|450839155|FG000|Completed the Study|Withdrawal by Subject|53|||
125666419|NCT01042977|452067639|FG001|Overall Study|Various|0|||
125666420|NCT04356573|452067642|FG000|Overall Study|Didn't Qualify|1|||
125329641|NCT02558296|450839156|FG001|Completed the Study|Withdrawal by Subject|31|||
125329642|NCT02558296|450839155|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
125329643|NCT02558296|450839156|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
125329644|NCT00297258|450839157|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
125329645|NCT00297258|450839157|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
125329646|NCT00297258|450839157|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
125329647|NCT00297258|450839157|FG000|Overall Study|Intercurrent Illness|3|||
125329648|NCT00297258|450839157|FG000|Overall Study|Intercurrent Death|2|||
125329649|NCT00297258|450839157|FG000|Overall Study|Deteriorization of General Condition|1|||
125329650|NCT00297258|450839157|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
125329651|NCT00297258|450839157|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
125329652|NCT00297258|450839157|FG000|Overall Study|Switch to Commercial Treatment|1|||
125329653|NCT00297258|450839157|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
125329654|NCT05038982|450839166|FG000|Overall Study|Withdrawal by Subject|0|||
125329655|NCT05038982|450839167|FG001|Overall Study|Withdrawal by Subject|2|||
125329656|NCT03133793|450839168|FG000|Overall Study|Withdrawal by Subject|0|||
125329657|NCT03133793|450839169|FG001|Overall Study|Withdrawal by Subject|4|||
125329658|NCT03133793|450839170|FG002|Overall Study|Withdrawal by Subject|2|||
125329659|NCT03133793|450839171|FG003|Overall Study|Withdrawal by Subject|4|||
125329660|NCT03133793|450839168|FG000|Overall Study|Lost to Follow-up|1|||
125329661|NCT03133793|450839169|FG001|Overall Study|Lost to Follow-up|0|||
125329662|NCT03133793|450839170|FG002|Overall Study|Lost to Follow-up|2|||
125329663|NCT03133793|450839171|FG003|Overall Study|Lost to Follow-up|0|||
125329664|NCT03133793|450839168|FG000|Overall Study|Death|0|||
125329665|NCT03133793|450839169|FG001|Overall Study|Death|0|||
125329666|NCT03133793|450839170|FG002|Overall Study|Death|0|||
125329667|NCT03133793|450839171|FG003|Overall Study|Death|1|||
125329668|NCT04476797|450839172|FG000|Overall Study|Withdrawal by Subject|1|||
125329669|NCT04476797|450839173|FG001|Overall Study|Withdrawal by Subject|0|||
125329670|NCT04476797|450839174|FG002|Overall Study|Withdrawal by Subject|0|||
125329671|NCT04476797|450839172|FG000|Overall Study|Death|0|||
125329672|NCT04476797|450839173|FG001|Overall Study|Death|1|||
125329673|NCT04476797|450839174|FG002|Overall Study|Death|2|||
125329674|NCT04476797|450839172|FG000|Overall Study|Sponsor Terminated Study|0|||
125329675|NCT04476797|450839173|FG001|Overall Study|Sponsor Terminated Study|18|||
125329676|NCT04476797|450839174|FG002|Overall Study|Sponsor Terminated Study|17|||
125666421|NCT04356573|452067643|FG001|Overall Study|Didn't Qualify|0|||
125666422|NCT03568500|452067644|FG000|Overall Study|Lost to Follow-up|1|||
125666423|NCT03568500|452067645|FG001|Overall Study|Lost to Follow-up|1|||
125666424|NCT03568500|452067646|FG002|Overall Study|Lost to Follow-up|2|||
125666425|NCT03568500|452067644|FG000|Overall Study|Adverse Event|1|||
125666426|NCT03568500|452067645|FG001|Overall Study|Adverse Event|1|||
125329677|NCT03614156|450839175|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
125329678|NCT03614156|450839176|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
125329679|NCT03614156|450839177|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
125329680|NCT03614156|450839178|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
125329681|NCT03614156|450839175|FG000|Open-Label Treatment Period|Adverse Event|7|||
125329682|NCT03614156|450839176|FG001|Open-Label Treatment Period|Adverse Event|0|||
125329683|NCT03614156|450839177|FG002|Open-Label Treatment Period|Adverse Event|0|||
125329684|NCT03614156|450839178|FG003|Open-Label Treatment Period|Adverse Event|0|||
125329685|NCT03614156|450839175|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
125329686|NCT03614156|450839176|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
125329687|NCT03614156|450839177|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
125329688|NCT03614156|450839178|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
125329689|NCT03614156|450839175|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
125329690|NCT03614156|450839176|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
125329691|NCT03614156|450839177|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
125666427|NCT03568500|452067646|FG002|Overall Study|Adverse Event|2|||
125666428|NCT03568500|452067644|FG000|Overall Study|Physician Decision|1|||
125666429|NCT03568500|452067645|FG001|Overall Study|Physician Decision|0|||
125666430|NCT03568500|452067646|FG002|Overall Study|Physician Decision|0|||
125666431|NCT03568500|452067644|FG000|Overall Study|Withdrawal by Subject|4|||
125666432|NCT03568500|452067645|FG001|Overall Study|Withdrawal by Subject|2|||
125666433|NCT03568500|452067646|FG002|Overall Study|Withdrawal by Subject|0|||
125666434|NCT03568500|452067644|FG000|Overall Study|Technical Problems|2|||
125666435|NCT03568500|452067645|FG001|Overall Study|Technical Problems|1|||
125666436|NCT03568500|452067646|FG002|Overall Study|Technical Problems|0|||
125666437|NCT03568500|452067644|FG000|Overall Study|Participant Noncompliance|1|||
125666438|NCT03568500|452067645|FG001|Overall Study|Participant Noncompliance|1|||
125666439|NCT03568500|452067646|FG002|Overall Study|Participant Noncompliance|0|||
125666440|NCT01886300|452067650|FG000|Overall Study|Trial terminated by sponsor|16|||
125666441|NCT02008721|452067651|FG000|Overall Study|Withdrawal by Subject|5|||
125666442|NCT02008721|452067652|FG001|Overall Study|Withdrawal by Subject|1|||
125666443|NCT02008721|452067651|FG000|Overall Study|Death|4|||
125666444|NCT02008721|452067652|FG001|Overall Study|Death|2|||
125666445|NCT02008721|452067651|FG000|Overall Study|Adverse Event|3|||
125666446|NCT02008721|452067652|FG001|Overall Study|Adverse Event|5|||
125666447|NCT02008721|452067651|FG000|Overall Study|Protocol Violation|3|||
125666448|NCT02008721|452067652|FG001|Overall Study|Protocol Violation|2|||
125666449|NCT00267007|452067655|FG000|Overall Study|Withdrawal by Subject|6|||
125666450|NCT00267007|452067656|FG001|Overall Study|Withdrawal by Subject|0|||
125666451|NCT00267007|452067655|FG000|Overall Study|Lost to Follow-up|1|||
125666452|NCT00267007|452067656|FG001|Overall Study|Lost to Follow-up|0|||
125666453|NCT00267007|452067655|FG000|Overall Study|Non-compliance|0|||
125666454|NCT00267007|452067656|FG001|Overall Study|Non-compliance|1|||
125666455|NCT00267007|452067655|FG000|Overall Study|Adverse Event|1|||
125666456|NCT00267007|452067656|FG001|Overall Study|Adverse Event|0|||
125666457|NCT01825876|452067657|FG000|Period 2|Withdrawal by Subject|0|||
125666458|NCT01825876|452067658|FG001|Period 2|Withdrawal by Subject|1|||
125666459|NCT04133519|452067663|FG000|Overall Study|Withdrawal by Subject|5|||
125666460|NCT04133519|452067664|FG001|Overall Study|Withdrawal by Subject|4|||
125666461|NCT04133519|452067663|FG000|Overall Study|Protocol Violation|0|||
125666462|NCT04133519|452067664|FG001|Overall Study|Protocol Violation|1|||
125666463|NCT04133519|452067663|FG000|Overall Study|Never started treatment|1|||
125666464|NCT04133519|452067664|FG001|Overall Study|Never started treatment|1|||
125666465|NCT02436135|452067665|FG000|Overall Study|Progressive Disease|3|||
125666466|NCT02436135|452067666|FG001|Overall Study|Progressive Disease|1|||
125666467|NCT02436135|452067665|FG000|Overall Study|Investigator Discretion|1|||
125666468|NCT02436135|452067666|FG001|Overall Study|Investigator Discretion|2|||
125666469|NCT02436135|452067665|FG000|Overall Study|Adverse Event|1|||
125666470|NCT02436135|452067666|FG001|Overall Study|Adverse Event|0|||
125666471|NCT02436135|452067665|FG000|Overall Study|Withdrawal by Participant|1|||
125666472|NCT02436135|452067666|FG001|Overall Study|Withdrawal by Participant|0|||
125666473|NCT02436135|452067665|FG000|Overall Study|Study Terminated By Sponsor|0|||
125666474|NCT02436135|452067666|FG001|Overall Study|Study Terminated By Sponsor|1|||
125666475|NCT00475852|452067669|FG000|Overall Study|Death|444|||
125666476|NCT00475852|452067670|FG001|Overall Study|Death|456|||
125666477|NCT00475852|452067669|FG000|Overall Study|Withdrawal by Subject|19|||
125666478|NCT00475852|452067670|FG001|Overall Study|Withdrawal by Subject|24|||
125666479|NCT00475852|452067669|FG000|Overall Study|Lost to Follow-up|54|||
125666480|NCT00475852|452067670|FG001|Overall Study|Lost to Follow-up|68|||
125666481|NCT00297479|452067672|FG000|Overall Study|Lost to Follow-up|37|||
125666482|NCT00297479|452067673|FG001|Overall Study|Lost to Follow-up|54|||
125666483|NCT00297479|452067674|FG002|Overall Study|Lost to Follow-up|51|||
125666484|NCT01664494|452067675|FG000|Overall Study|Withdrawal by Subject|27|||
125666485|NCT01664494|452067675|FG000|Overall Study|Death|18|||
125666486|NCT01664494|452067675|FG000|Overall Study|Other|49|||
125666487|NCT01664494|452067675|FG000|Overall Study|Lost to Follow-up|99|||
125666488|NCT03196791|452067676|FG000|Overall Study|Protocol Violation|7|||
125666489|NCT03196791|452067677|FG001|Overall Study|Protocol Violation|3|||
125666490|NCT03196791|452067676|FG000|Overall Study|Withdrawal by Subject|3|||
125666491|NCT03196791|452067677|FG001|Overall Study|Withdrawal by Subject|2|||
125666492|NCT00373685|452067682|FG000|Overall Study|Death|2|||
125666493|NCT00373685|452067683|FG001|Overall Study|Death|1|||
125666494|NCT00373685|452067682|FG000|Overall Study|Adverse Event|278|||
125666495|NCT00373685|452067683|FG001|Overall Study|Adverse Event|253|||
125666496|NCT00373685|452067682|FG000|Overall Study|Insufficient clinical response|169|||
125666497|NCT00373685|452067683|FG001|Overall Study|Insufficient clinical response|119|||
125666498|NCT00373685|452067682|FG000|Overall Study|Did not meet entrance criteria|167|||
125666499|NCT00373685|452067683|FG001|Overall Study|Did not meet entrance criteria|184|||
125666500|NCT00373685|452067682|FG000|Overall Study|Lost to follow up|83|||
125666501|NCT00373685|452067683|FG001|Overall Study|Lost to follow up|103|||
125666502|NCT00373685|452067682|FG000|Overall Study|No longer willing to participate|337|||
125666503|NCT00373685|452067683|FG001|Overall Study|No longer willing to participate|352|||
125666504|NCT00373685|452067682|FG000|Overall Study|Other|149|||
125666505|NCT00373685|452067683|FG001|Overall Study|Other|146|||
125666506|NCT00373685|452067682|FG000|Overall Study|Protocol Violation|191|||
125666507|NCT00373685|452067683|FG001|Overall Study|Protocol Violation|182|||
125666508|NCT00373685|452067682|FG000|Overall Study|Final Status Unknown|12|||
125666509|NCT00373685|452067683|FG001|Overall Study|Final Status Unknown|4|||
125666510|NCT00373685|452067682|FG000|Overall Study|Randomized, not treated|51|||
125666511|NCT00373685|452067683|FG001|Overall Study|Randomized, not treated|77|||
125666512|NCT01789281|452067684|FG000|Overall Study|Disease progression|15|||
125666513|NCT01789281|452067685|FG001|Overall Study|Disease progression|4|||
125666514|NCT01789281|452067684|FG000|Overall Study|Adverse Event|5|||
125329692|NCT03614156|450839178|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
125329693|NCT03614156|450839175|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
125329694|NCT03614156|450839176|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
125329695|NCT03614156|450839177|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
125329696|NCT03614156|450839178|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
125329697|NCT03614156|450839175|FG000|Open-Label Treatment Period|Protocol Violation|2|||
125329698|NCT03614156|450839176|FG001|Open-Label Treatment Period|Protocol Violation|0|||
125329699|NCT03614156|450839177|FG002|Open-Label Treatment Period|Protocol Violation|0|||
125329700|NCT03614156|450839178|FG003|Open-Label Treatment Period|Protocol Violation|0|||
125329701|NCT03614156|450839175|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
125329702|NCT03614156|450839176|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
125329703|NCT03614156|450839177|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
125329704|NCT03614156|450839178|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
125329705|NCT03614156|450839175|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
125329706|NCT03614156|450839176|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
125329707|NCT03614156|450839177|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
125329708|NCT03614156|450839178|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
125329709|NCT03614156|450839175|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
125329710|NCT03614156|450839176|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
125329711|NCT03614156|450839177|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
125329712|NCT03614156|450839178|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
125329713|NCT03614156|450839175|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125329714|NCT03614156|450839176|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
125329715|NCT03614156|450839177|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125329716|NCT03614156|450839178|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125329717|NCT03614156|450839175|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125329718|NCT03614156|450839176|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125329719|NCT03614156|450839177|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
125329720|NCT03614156|450839178|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
125329721|NCT03614156|450839175|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
125329722|NCT03614156|450839176|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
125329723|NCT03614156|450839177|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
125329724|NCT03614156|450839178|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
125329725|NCT03614156|450839175|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
125329726|NCT03614156|450839176|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
125329727|NCT03614156|450839177|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
125666515|NCT01789281|452067685|FG001|Overall Study|Adverse Event|5|||
125329728|NCT03614156|450839178|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
125329729|NCT03614156|450839175|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
125329730|NCT03614156|450839176|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
125329731|NCT03614156|450839177|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
125329732|NCT03614156|450839178|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
125329733|NCT03614156|450839175|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
125329734|NCT03614156|450839176|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
125329735|NCT03614156|450839177|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
125329736|NCT03614156|450839178|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
125329737|NCT03614156|450839175|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
125329738|NCT03614156|450839176|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
125329739|NCT03614156|450839177|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
125329740|NCT03614156|450839178|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
125329741|NCT03614156|450839175|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
125329742|NCT03614156|450839176|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
125329743|NCT03614156|450839177|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
125666516|NCT01789281|452067684|FG000|Overall Study|Withdrawal by Subject|1|||
125329744|NCT03614156|450839178|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
125329745|NCT04287517|450839180|FG000|Overall Study|Withdrawal by Subject|1|||
125329746|NCT04287517|450839181|FG001|Overall Study|Withdrawal by Subject|1|||
125329747|NCT03070964|450839182|FG000|Overall Study|Progressive disease|8|||
125329748|NCT03070964|450839182|FG000|Overall Study|Treatment-unrelated adverse event|2|||
125329749|NCT03070964|450839182|FG000|Overall Study|Never treated|1|||
125329750|NCT03070964|450839182|FG000|Overall Study|Physician Decision|1|||
125666517|NCT01789281|452067685|FG001|Overall Study|Withdrawal by Subject|0|||
125329751|NCT03070964|450839182|FG000|Overall Study|Withdrawal by Subject|1|||
125329752|NCT03070964|450839182|FG000|Overall Study|Adverse Event|1|||
125329753|NCT00834093|450839185|FG000|Overall Study|Progressive Disease|3|||
125329754|NCT00834093|450839185|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
125329755|NCT02425943|450839186|FG000|Overall Study|Adverse Event|3|||
125329756|NCT02425943|450839187|FG001|Overall Study|Adverse Event|1|||
125329757|NCT02425943|450839186|FG000|Overall Study|Lost to Follow-up|59|||
125666518|NCT01789281|452067684|FG000|Overall Study|Lost to Follow-up|1|||
125666519|NCT01789281|452067685|FG001|Overall Study|Lost to Follow-up|0|||
125666520|NCT01789281|452067684|FG000|Overall Study|Administrative problems|0|||
125666521|NCT01789281|452067685|FG001|Overall Study|Administrative problems|1|||
125666522|NCT02746705|452067686|FG000|Overall Study|Physician Decision|1|||
125666523|NCT02746705|452067687|FG001|Overall Study|Physician Decision|1|||
125666524|NCT02746705|452067686|FG000|Overall Study|Lost to Follow-up|1|||
125666525|NCT02746705|452067687|FG001|Overall Study|Lost to Follow-up|0|||
125666526|NCT02746705|452067686|FG000|Overall Study|outlier scores deemed not valid|0|||
125666527|NCT02746705|452067687|FG001|Overall Study|outlier scores deemed not valid|1|||
125666528|NCT03940586|452067695|FG000|Overall Study|Death|3|||
125666529|NCT03940586|452067696|FG001|Overall Study|Death|2|||
125666530|NCT03940586|452067697|FG002|Overall Study|Death|0|||
125666531|NCT03940586|452067695|FG000|Overall Study|Physician Decision|1|||
125666532|NCT03940586|452067696|FG001|Overall Study|Physician Decision|0|||
125666533|NCT03940586|452067697|FG002|Overall Study|Physician Decision|1|||
125666534|NCT03940586|452067695|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
125666535|NCT03940586|452067696|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
125666536|NCT03940586|452067697|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
125666537|NCT03940586|452067695|FG000|Overall Study|Not Treated|0|||
125666538|NCT03940586|452067696|FG001|Overall Study|Not Treated|2|||
125666539|NCT03940586|452067697|FG002|Overall Study|Not Treated|0|||
125666540|NCT02862535|452067698|FG000|Overall Study|Death|7|||
125666541|NCT02862535|452067699|FG001|Overall Study|Death|3|||
125666542|NCT02862535|452067700|FG002|Overall Study|Death|2|||
125666543|NCT02862535|452067701|FG003|Overall Study|Death|5|||
125666544|NCT02862535|452067698|FG000|Overall Study|Study Terminated by Sponsor|1|||
125666545|NCT02862535|452067699|FG001|Overall Study|Study Terminated by Sponsor|3|||
125666546|NCT02862535|452067700|FG002|Overall Study|Study Terminated by Sponsor|8|||
125666547|NCT02862535|452067701|FG003|Overall Study|Study Terminated by Sponsor|5|||
125666548|NCT02862535|452067698|FG000|Overall Study|Enrolled, not Treated|1|||
125666549|NCT02862535|452067699|FG001|Overall Study|Enrolled, not Treated|0|||
125666550|NCT02862535|452067700|FG002|Overall Study|Enrolled, not Treated|0|||
125666551|NCT02862535|452067701|FG003|Overall Study|Enrolled, not Treated|1|||
125666552|NCT04304950|452067704|FG000|Overall Study|Lost to Follow-up|1|||
125666553|NCT04304950|452067705|FG001|Overall Study|Lost to Follow-up|1|||
125666554|NCT03077828|452067706|FG000|Treatment Cycles|Death|1|||
125666555|NCT03077828|452067706|FG000|Treatment Cycles|Withdrawal by Subject|1|||
125666556|NCT03077828|452067706|FG000|Treatment Cycles|Screen Fail|2|||
125666557|NCT03077828|452067706|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
125666558|NCT03077828|452067706|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
125666559|NCT03077828|452067706|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
125666560|NCT03077828|452067706|FG000|Follow-up|Patients still in follow-up|15|||
125666561|NCT02418910|452067710|FG000|Overall Study|Lost to Follow-up|3|||
125666562|NCT02418910|452067710|FG000|Overall Study|Withdrawal by Subject|4|||
125666563|NCT00345683|452067712|FG000|Overall Study|Lost to Follow-up|19|||
125666564|NCT00345683|452067713|FG001|Overall Study|Lost to Follow-up|7|||
125666565|NCT00345683|452067712|FG000|Overall Study|Other|6|||
125666566|NCT00345683|452067713|FG001|Overall Study|Other|2|||
125666567|NCT04288115|452067714|FG000|Overall Study|Withdrawal by Subject|0|||
125666568|NCT04288115|452067715|FG001|Overall Study|Withdrawal by Subject|1|||
125666569|NCT04288115|452067714|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
125666570|NCT04288115|452067715|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
125666571|NCT03634488|452067716|FG000|Overall Study|Death|1|||
125666572|NCT03634488|452067717|FG001|Overall Study|Death|0|||
125666573|NCT03634488|452067718|FG002|Overall Study|Death|0|||
125666574|NCT03634488|452067716|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
125666575|NCT03634488|452067717|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
125666576|NCT03634488|452067718|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
125666577|NCT00729365|452067719|FG000|Overall Study|Physician Decision|33|||
125329758|NCT02425943|450839187|FG001|Overall Study|Lost to Follow-up|37|||
125666578|NCT00729365|452067720|FG001|Overall Study|Physician Decision|6|||
125666579|NCT00729365|452067721|FG002|Overall Study|Physician Decision|7|||
125666580|NCT01154127|452067723|FG000|Period 1 (21 Days)|Adverse Event|3|||
125666581|NCT01154127|452067724|FG001|Period 1 (21 Days)|Adverse Event|4|||
125329759|NCT02425943|450839186|FG000|Overall Study|Protocol Violation|4|||
125329760|NCT02425943|450839187|FG001|Overall Study|Protocol Violation|1|||
125666582|NCT01154127|452067723|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
125666583|NCT01154127|452067724|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
125666584|NCT01154127|452067723|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
125666585|NCT01154127|452067724|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
125666586|NCT01154127|452067723|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
125666587|NCT01154127|452067724|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
125666588|NCT01154127|452067723|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
125666589|NCT01154127|452067724|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
125666590|NCT01697449|452067725|FG000|Overall Study|Disease progression|47|||
125666591|NCT01697449|452067725|FG000|Overall Study|Adverse Event|7|||
125666592|NCT01697449|452067725|FG000|Overall Study|Lost to Follow-up|5|||
125666593|NCT01697449|452067725|FG000|Overall Study|Withdrawal by Subject|2|||
125666594|NCT01697449|452067725|FG000|Overall Study|Physician Decision|1|||
125666595|NCT01697449|452067725|FG000|Overall Study|Death|2|||
125666596|NCT01697449|452067725|FG000|Overall Study|Other|1|||
125666597|NCT01697449|452067725|FG000|Overall Study|Missing|25|||
125666598|NCT01169844|452067727|FG000|Overall Study|Adverse Event|0|||
125666599|NCT01169844|452067728|FG001|Overall Study|Adverse Event|1|||
125666600|NCT01169844|452067727|FG000|Overall Study|Patient withdrew consent|4|||
125666601|NCT01169844|452067728|FG001|Overall Study|Patient withdrew consent|0|||
125666602|NCT01169844|452067727|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125666603|NCT01169844|452067728|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125666604|NCT05037409|452067729|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
125666605|NCT05037409|452067730|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
125666606|NCT05037409|452067731|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
125666607|NCT00529568|452067732|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
125666608|NCT00529568|452067733|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
125666609|NCT00529568|452067734|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
125666610|NCT00529568|452067732|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
125666611|NCT00529568|452067733|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
125666612|NCT00529568|452067734|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
125666613|NCT00529568|452067732|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
125666614|NCT00529568|452067733|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
125666615|NCT00529568|452067734|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
125666616|NCT00529568|452067732|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
125666617|NCT00529568|452067733|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
125666618|NCT00529568|452067734|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
125666619|NCT00529568|452067732|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
125666620|NCT00529568|452067733|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
125666621|NCT00529568|452067734|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
125666622|NCT00529568|452067732|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
125666623|NCT00529568|452067733|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
125666624|NCT00529568|452067734|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
125666625|NCT00529568|452067732|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
125666626|NCT00529568|452067733|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
125666627|NCT00529568|452067734|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
125666628|NCT00529568|452067732|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
125666629|NCT00529568|452067733|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
125666630|NCT00529568|452067734|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
125666631|NCT00529568|452067732|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
125666632|NCT00529568|452067733|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
125666633|NCT00529568|452067734|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
125666634|NCT00529568|452067732|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
125666635|NCT00529568|452067733|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
125666636|NCT00529568|452067734|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
125666637|NCT00529568|452067732|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
125666638|NCT00529568|452067733|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
125666639|NCT00529568|452067734|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
125666640|NCT00931385|452067735|FG000|Overall Study|Adverse Event|2|||
125666641|NCT00931385|452067736|FG001|Overall Study|Adverse Event|1|||
125666642|NCT00931385|452067737|FG002|Overall Study|Adverse Event|0|||
125666643|NCT00931385|452067738|FG003|Overall Study|Adverse Event|3|||
125666644|NCT00931385|452067735|FG000|Overall Study|Protocol Violation|0|||
125666645|NCT00931385|452067736|FG001|Overall Study|Protocol Violation|0|||
125666646|NCT00931385|452067737|FG002|Overall Study|Protocol Violation|1|||
125666647|NCT00931385|452067738|FG003|Overall Study|Protocol Violation|0|||
125666648|NCT00931385|452067735|FG000|Overall Study|Withdrawal by Subject|0|||
125666649|NCT00931385|452067736|FG001|Overall Study|Withdrawal by Subject|1|||
125666650|NCT00931385|452067737|FG002|Overall Study|Withdrawal by Subject|0|||
125666651|NCT00931385|452067738|FG003|Overall Study|Withdrawal by Subject|1|||
125666652|NCT00931385|452067735|FG000|Overall Study|Lost to Follow-up|0|||
125329761|NCT02425943|450839186|FG000|Overall Study|Withdrawal by Subject|64|||
125329762|NCT02425943|450839187|FG001|Overall Study|Withdrawal by Subject|31|||
125329763|NCT02425943|450839186|FG000|Overall Study|Other|6|||
125329764|NCT02425943|450839187|FG001|Overall Study|Other|0|||
125329765|NCT02379091|450839188|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125329766|NCT02379091|450839189|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
125329767|NCT02379091|450839190|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
125329768|NCT02379091|450839191|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
125329769|NCT02379091|450839188|FG000|Overall Study|Principal Investigator Discretion|0|||
125329770|NCT02379091|450839189|FG001|Overall Study|Principal Investigator Discretion|1|||
125329771|NCT02379091|450839190|FG002|Overall Study|Principal Investigator Discretion|0|||
125329772|NCT02379091|450839191|FG003|Overall Study|Principal Investigator Discretion|0|||
125329773|NCT02379091|450839188|FG000|Overall Study|Lost to Follow-up|0|||
125329774|NCT02379091|450839189|FG001|Overall Study|Lost to Follow-up|0|||
125329775|NCT02379091|450839190|FG002|Overall Study|Lost to Follow-up|0|||
125329776|NCT02379091|450839191|FG003|Overall Study|Lost to Follow-up|1|||
125329777|NCT02379091|450839188|FG000|Overall Study|Voluntary Withdrawal|2|||
125329778|NCT02379091|450839189|FG001|Overall Study|Voluntary Withdrawal|5|||
125329779|NCT02379091|450839190|FG002|Overall Study|Voluntary Withdrawal|2|||
125329780|NCT02379091|450839191|FG003|Overall Study|Voluntary Withdrawal|4|||
125329781|NCT02379091|450839188|FG000|Overall Study|Study Termination|7|||
125329782|NCT02379091|450839189|FG001|Overall Study|Study Termination|2|||
125329783|NCT02379091|450839190|FG002|Overall Study|Study Termination|5|||
125329784|NCT02379091|450839191|FG003|Overall Study|Study Termination|8|||
125329785|NCT02379091|450839188|FG000|Overall Study|Lack of Efficacy|3|||
125329786|NCT02379091|450839189|FG001|Overall Study|Lack of Efficacy|0|||
125329787|NCT02379091|450839190|FG002|Overall Study|Lack of Efficacy|0|||
125329788|NCT02379091|450839191|FG003|Overall Study|Lack of Efficacy|0|||
125329789|NCT02129699|450839194|FG000|Overall Study|Did not start treatment|3|||
125329790|NCT02129699|450839195|FG001|Overall Study|Did not start treatment|2|||
125329791|NCT01076361|450839199|FG000|Overall Study|22 leads were excluded from analysis|21|||
125329792|NCT04801420|450839205|FG000|Overall Study|Other|1|||
125329793|NCT04801420|450839206|FG001|Overall Study|Other|2|||
125329794|NCT04801420|450839207|FG002|Overall Study|Other|1|||
125329795|NCT04801420|450839205|FG000|Overall Study|Lost to Follow-up|7|||
125329796|NCT04801420|450839206|FG001|Overall Study|Lost to Follow-up|9|||
125329797|NCT04801420|450839207|FG002|Overall Study|Lost to Follow-up|10|||
125329798|NCT04801420|450839205|FG000|Overall Study|Moved from study area|0|||
125329799|NCT04801420|450839206|FG001|Overall Study|Moved from study area|1|||
125329800|NCT04801420|450839207|FG002|Overall Study|Moved from study area|1|||
125329801|NCT04801420|450839205|FG000|Overall Study|Withdrawal by Subject|5|||
125329802|NCT04801420|450839206|FG001|Overall Study|Withdrawal by Subject|1|||
125329803|NCT04801420|450839207|FG002|Overall Study|Withdrawal by Subject|4|||
125329804|NCT04801420|450839205|FG000|Overall Study|Individual stopping criteria reached|0|||
125329805|NCT04801420|450839206|FG001|Overall Study|Individual stopping criteria reached|1|||
125329806|NCT04801420|450839207|FG002|Overall Study|Individual stopping criteria reached|0|||
125329807|NCT04801420|450839205|FG000|Overall Study|Ongoing in the study|195|||
125329808|NCT04801420|450839206|FG001|Overall Study|Ongoing in the study|195|||
125329809|NCT04801420|450839207|FG002|Overall Study|Ongoing in the study|192|||
125329810|NCT04774094|450839208|FG000|Overall Study|Other|2|||
125329811|NCT04774094|450839208|FG000|Overall Study|Withdrawal by Subject|9|||
125329812|NCT04774094|450839208|FG000|Overall Study|Lost to Follow-up|7|||
125329813|NCT04774094|450839208|FG000|Overall Study|Lack of Efficacy|5|||
125329814|NCT04774094|450839208|FG000|Overall Study|Death|17|||
125329815|NCT04774094|450839208|FG000|Overall Study|Adverse Event|4|||
125329816|NCT01357850|450841065|FG000|Overall Study|Lost to Follow-up|1|||
125329817|NCT01357850|450841066|FG001|Overall Study|Lost to Follow-up|0|||
125329818|NCT01357850|450841067|FG002|Overall Study|Lost to Follow-up|0|||
125329819|NCT01357850|450841068|FG003|Overall Study|Lost to Follow-up|0|||
125329820|NCT00815659|450841069|FG000|Overall Study|Adverse Event|9|||
125329821|NCT00815659|450841069|FG000|Overall Study|Withdrawal by Subject|9|||
125329822|NCT00815659|450841069|FG000|Overall Study|Lost to Follow-up|4|||
125329823|NCT00815659|450841069|FG000|Overall Study|Protocol Violation|1|||
125329824|NCT03847896|450841070|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
125329825|NCT03847896|450841071|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
125329826|NCT03847896|450841072|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
125329827|NCT03847896|450841073|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
125329828|NCT03847896|450841074|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
125329829|NCT03847896|450841070|FG000|Overall Study|Withdrawal by Subject|2|||
125329830|NCT03847896|450841071|FG001|Overall Study|Withdrawal by Subject|10|||
125210688|NCT04299048|450395637|FG000|Overall Study|Death|1|||
125329831|NCT03847896|450841072|FG002|Overall Study|Withdrawal by Subject|5|||
125329832|NCT03847896|450841073|FG003|Overall Study|Withdrawal by Subject|9|||
125329833|NCT03847896|450841074|FG004|Overall Study|Withdrawal by Subject|8|||
125329834|NCT03847896|450841070|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125666653|NCT00931385|452067736|FG001|Overall Study|Lost to Follow-up|0|||
125666654|NCT00931385|452067737|FG002|Overall Study|Lost to Follow-up|0|||
125666655|NCT00931385|452067738|FG003|Overall Study|Lost to Follow-up|1|||
125666656|NCT01201356|452067739|FG000|Overall Study|Adverse Event|170|||
125666657|NCT01201356|452067739|FG000|Overall Study|Abnormal laboratory value(s)|51|||
125666658|NCT01201356|452067739|FG000|Overall Study|Abnormal test procedure result(s)|3|||
125666659|NCT01201356|452067739|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
125666660|NCT01201356|452067739|FG000|Overall Study|Condition no longer requires study drug|12|||
125666661|NCT01201356|452067739|FG000|Overall Study|Withdrawal by Subject|144|||
125666662|NCT01201356|452067739|FG000|Overall Study|Lost to Follow-up|50|||
125666663|NCT01201356|452067739|FG000|Overall Study|administrative problems|74|||
125666664|NCT01201356|452067739|FG000|Overall Study|Death|16|||
125666665|NCT01201356|452067739|FG000|Overall Study|Protocol Violation|12|||
125666666|NCT00738920|452067741|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
125666667|NCT00738920|452067742|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
125666668|NCT00738920|452067743|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
125666669|NCT00738920|452067741|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
125666670|NCT00738920|452067742|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
125666671|NCT00738920|452067743|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
125666672|NCT00738920|452067741|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
125666673|NCT00738920|452067742|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
125666674|NCT00738920|452067743|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
125666675|NCT00738920|452067741|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
125666676|NCT00738920|452067742|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
125666677|NCT00738920|452067743|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
125666678|NCT00738920|452067741|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
125666679|NCT00738920|452067742|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
125666680|NCT00738920|452067743|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
125666681|NCT00738920|452067741|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
125666682|NCT00738920|452067742|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
125666683|NCT00738920|452067743|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
125666684|NCT00738920|452067741|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
125666685|NCT00738920|452067742|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
125666686|NCT00738920|452067743|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
125666687|NCT00738920|452067741|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
125666688|NCT00738920|452067742|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
125666689|NCT00738920|452067743|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
125666690|NCT00738920|452067741|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
125666691|NCT00738920|452067742|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
125666692|NCT00738920|452067743|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
125666693|NCT00738920|452067741|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
125666694|NCT00738920|452067742|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
125666695|NCT00738920|452067743|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
125666696|NCT04079842|452067745|FG000|Overall Study|Request of subject|2|||
125666697|NCT04079842|452067745|FG000|Overall Study|Unable to draw Arterial samples|1|||
125666698|NCT02904200|452067746|FG000|Overall Study|Withdrawal by Subject|1|||
125666699|NCT02904200|452067747|FG001|Overall Study|Withdrawal by Subject|0|||
125666700|NCT04444752|452067748|FG000|Overall Study|Adverse Event|1|||
125666701|NCT04444752|452067749|FG001|Overall Study|Adverse Event|0|||
125666702|NCT04444752|452067750|FG002|Overall Study|Adverse Event|0|||
125666703|NCT04444752|452067751|FG003|Overall Study|Adverse Event|2|||
125666704|NCT04444752|452067748|FG000|Overall Study|Lost to Follow-up|2|||
125666705|NCT04444752|452067749|FG001|Overall Study|Lost to Follow-up|6|||
125666706|NCT04444752|452067750|FG002|Overall Study|Lost to Follow-up|2|||
125666707|NCT04444752|452067751|FG003|Overall Study|Lost to Follow-up|5|||
125666708|NCT04444752|452067748|FG000|Overall Study|Physician Decision|0|||
125666709|NCT04444752|452067749|FG001|Overall Study|Physician Decision|0|||
125666710|NCT04444752|452067750|FG002|Overall Study|Physician Decision|0|||
125666711|NCT04444752|452067751|FG003|Overall Study|Physician Decision|2|||
125666712|NCT04444752|452067748|FG000|Overall Study|Pregnancy|0|||
125666713|NCT04444752|452067749|FG001|Overall Study|Pregnancy|0|||
125666714|NCT04444752|452067750|FG002|Overall Study|Pregnancy|0|||
125666715|NCT04444752|452067751|FG003|Overall Study|Pregnancy|1|||
125666716|NCT04444752|452067748|FG000|Overall Study|Withdrawal by Subject|6|||
125666717|NCT04444752|452067749|FG001|Overall Study|Withdrawal by Subject|5|||
125666718|NCT04444752|452067750|FG002|Overall Study|Withdrawal by Subject|3|||
125666719|NCT04444752|452067751|FG003|Overall Study|Withdrawal by Subject|4|||
125666720|NCT04444752|452067748|FG000|Overall Study|Protocol Violation|1|||
125329835|NCT03847896|450841071|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125329836|NCT03847896|450841072|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125540879|NCT03122223|451609469|FG002|Overall Study|Participant unable to adhere|1|||
125329837|NCT03847896|450841073|FG003|Overall Study|Withdrawal by parent/guardian|0|||
125329838|NCT03847896|450841074|FG004|Overall Study|Withdrawal by parent/guardian|0|||
125329839|NCT03847896|450841070|FG000|Overall Study|Adverse Event|2|||
125329840|NCT03847896|450841071|FG001|Overall Study|Adverse Event|1|||
125329841|NCT03847896|450841072|FG002|Overall Study|Adverse Event|3|||
125329842|NCT03847896|450841073|FG003|Overall Study|Adverse Event|2|||
125329843|NCT03847896|450841074|FG004|Overall Study|Adverse Event|4|||
125329844|NCT03847896|450841070|FG000|Overall Study|A severe exacerbation event|0|||
125329845|NCT03847896|450841071|FG001|Overall Study|A severe exacerbation event|0|||
125329846|NCT03847896|450841072|FG002|Overall Study|A severe exacerbation event|0|||
125329847|NCT03847896|450841073|FG003|Overall Study|A severe exacerbation event|0|||
125329848|NCT03847896|450841074|FG004|Overall Study|A severe exacerbation event|3|||
125329849|NCT03847896|450841070|FG000|Overall Study|Protocol Violation|0|||
125329850|NCT03847896|450841071|FG001|Overall Study|Protocol Violation|2|||
125329851|NCT03847896|450841072|FG002|Overall Study|Protocol Violation|1|||
125329852|NCT03847896|450841073|FG003|Overall Study|Protocol Violation|0|||
125329853|NCT03847896|450841074|FG004|Overall Study|Protocol Violation|2|||
125329854|NCT03847896|450841070|FG000|Overall Study|Lost to Follow-up|0|||
125329855|NCT03847896|450841071|FG001|Overall Study|Lost to Follow-up|0|||
125329856|NCT03847896|450841072|FG002|Overall Study|Lost to Follow-up|0|||
125329857|NCT03847896|450841073|FG003|Overall Study|Lost to Follow-up|1|||
125329858|NCT03847896|450841074|FG004|Overall Study|Lost to Follow-up|0|||
125329859|NCT03847896|450841070|FG000|Overall Study|Condition under investigation worsened|0|||
125329860|NCT03847896|450841071|FG001|Overall Study|Condition under investigation worsened|0|||
125329861|NCT03847896|450841072|FG002|Overall Study|Condition under investigation worsened|0|||
125329862|NCT03847896|450841073|FG003|Overall Study|Condition under investigation worsened|1|||
125329863|NCT03847896|450841074|FG004|Overall Study|Condition under investigation worsened|1|||
125329864|NCT03847896|450841070|FG000|Overall Study|Lack of Efficacy|0|||
125329865|NCT03847896|450841071|FG001|Overall Study|Lack of Efficacy|0|||
125329866|NCT03847896|450841072|FG002|Overall Study|Lack of Efficacy|0|||
125329867|NCT03847896|450841073|FG003|Overall Study|Lack of Efficacy|2|||
125329868|NCT03847896|450841074|FG004|Overall Study|Lack of Efficacy|2|||
125329869|NCT03847896|450841070|FG000|Overall Study|Other reasons|3|||
125329870|NCT03847896|450841071|FG001|Overall Study|Other reasons|3|||
125329871|NCT03847896|450841072|FG002|Overall Study|Other reasons|1|||
125329872|NCT03847896|450841073|FG003|Overall Study|Other reasons|2|||
125329873|NCT03847896|450841074|FG004|Overall Study|Other reasons|1|||
125329874|NCT00118417|450841075|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
125329875|NCT00118417|450841076|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
125329876|NCT00118417|450841075|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
125329877|NCT00118417|450841076|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
125329878|NCT00118417|450841075|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
125329879|NCT00118417|450841076|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
125329880|NCT00118417|450841075|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
125329881|NCT00118417|450841076|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
125329882|NCT00118417|450841075|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
125329883|NCT00118417|450841076|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
125329884|NCT02978781|450841077|FG000|Part A|Adverse Event|1|||
125329885|NCT02978781|450841078|FG001|Part A|Adverse Event|1|||
125329886|NCT02978781|450841079|FG002|Part A|Adverse Event|0|||
125329887|NCT02978781|450841080|FG003|Part A|Adverse Event|0|||
125329888|NCT02978781|450841081|FG004|Part A|Adverse Event|0|||
125329889|NCT02978781|450841077|FG000|Part A|Withdrawal by Subject|0|||
125329890|NCT02978781|450841078|FG001|Part A|Withdrawal by Subject|1|||
125329891|NCT02978781|450841079|FG002|Part A|Withdrawal by Subject|0|||
125329892|NCT02978781|450841080|FG003|Part A|Withdrawal by Subject|0|||
125329893|NCT02978781|450841081|FG004|Part A|Withdrawal by Subject|0|||
125329894|NCT02978781|450841077|FG000|Part B|Withdrawal by Subject|0|||
125329895|NCT02978781|450841078|FG001|Part B|Withdrawal by Subject|0|||
125329896|NCT02978781|450841079|FG002|Part B|Withdrawal by Subject|0|||
125329897|NCT02978781|450841080|FG003|Part B|Withdrawal by Subject|1|||
125329898|NCT02978781|450841081|FG004|Part B|Withdrawal by Subject|0|||
125329899|NCT02978781|450841077|FG000|Part C|Adverse Event|0|||
125329900|NCT02978781|450841078|FG001|Part C|Adverse Event|0|||
125329901|NCT02978781|450841079|FG002|Part C|Adverse Event|0|||
125329902|NCT02978781|450841080|FG003|Part C|Adverse Event|0|||
125329903|NCT02978781|450841081|FG004|Part C|Adverse Event|2|||
125329904|NCT02978781|450841077|FG000|Part C|Withdrawal by Subject|0|||
125329905|NCT02978781|450841078|FG001|Part C|Withdrawal by Subject|0|||
125329906|NCT02978781|450841079|FG002|Part C|Withdrawal by Subject|0|||
125329907|NCT02978781|450841080|FG003|Part C|Withdrawal by Subject|0|||
125329908|NCT02978781|450841081|FG004|Part C|Withdrawal by Subject|1|||
125329909|NCT02978781|450841077|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
125329910|NCT02978781|450841078|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
125329911|NCT02978781|450841079|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
125329912|NCT02978781|450841080|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
125329913|NCT02978781|450841081|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
125666721|NCT04444752|452067749|FG001|Overall Study|Protocol Violation|1|||
125666722|NCT04444752|452067750|FG002|Overall Study|Protocol Violation|0|||
125666723|NCT04444752|452067751|FG003|Overall Study|Protocol Violation|0|||
125666724|NCT04444752|452067748|FG000|Overall Study|Patient moving out of town|1|||
125666725|NCT04444752|452067749|FG001|Overall Study|Patient moving out of town|0|||
125666726|NCT04444752|452067750|FG002|Overall Study|Patient moving out of town|0|||
125666727|NCT04444752|452067751|FG003|Overall Study|Patient moving out of town|1|||
125666728|NCT04444752|452067748|FG000|Overall Study|Lack of Efficacy|0|||
125666729|NCT04444752|452067749|FG001|Overall Study|Lack of Efficacy|0|||
125666730|NCT04444752|452067750|FG002|Overall Study|Lack of Efficacy|0|||
125666731|NCT04444752|452067751|FG003|Overall Study|Lack of Efficacy|1|||
125666732|NCT04444752|452067748|FG000|Overall Study|Death|0|||
125666733|NCT04444752|452067749|FG001|Overall Study|Death|0|||
125666734|NCT04444752|452067750|FG002|Overall Study|Death|1|||
125666735|NCT04444752|452067751|FG003|Overall Study|Death|0|||
125666736|NCT02270983|452069990|FG000|Overall Study|Adverse Event|3|||
125666737|NCT02270983|452069991|FG001|Overall Study|Adverse Event|2|||
125666738|NCT02270983|452069992|FG002|Overall Study|Adverse Event|6|||
125666739|NCT02270983|452069990|FG000|Overall Study|Lack of Efficacy|2|||
125666740|NCT02270983|452069991|FG001|Overall Study|Lack of Efficacy|1|||
125666741|NCT02270983|452069992|FG002|Overall Study|Lack of Efficacy|1|||
125666742|NCT02270983|452069990|FG000|Overall Study|Withdrawal by Subject|1|||
125666743|NCT02270983|452069991|FG001|Overall Study|Withdrawal by Subject|0|||
125666744|NCT02270983|452069992|FG002|Overall Study|Withdrawal by Subject|2|||
125666745|NCT02270983|452069990|FG000|Overall Study|Lost to Follow-up|1|||
125666746|NCT02270983|452069991|FG001|Overall Study|Lost to Follow-up|1|||
125666747|NCT02270983|452069992|FG002|Overall Study|Lost to Follow-up|2|||
125666748|NCT02270983|452069990|FG000|Overall Study|Protocol Violation|1|||
125666749|NCT02270983|452069991|FG001|Overall Study|Protocol Violation|1|||
125666750|NCT02270983|452069992|FG002|Overall Study|Protocol Violation|1|||
125666751|NCT02270983|452069990|FG000|Overall Study|family emergency|0|||
125666752|NCT02270983|452069991|FG001|Overall Study|family emergency|1|||
125666753|NCT02270983|452069992|FG002|Overall Study|family emergency|0|||
125666754|NCT02270983|452069990|FG000|Overall Study|study procedure non-compliance|1|||
125666755|NCT02270983|452069991|FG001|Overall Study|study procedure non-compliance|0|||
125666756|NCT02270983|452069992|FG002|Overall Study|study procedure non-compliance|0|||
125666757|NCT02270983|452069990|FG000|Overall Study|moved away from study site|0|||
125666758|NCT02270983|452069991|FG001|Overall Study|moved away from study site|1|||
125666759|NCT02270983|452069992|FG002|Overall Study|moved away from study site|0|||
125666760|NCT00928252|452069998|FG000|Overall Study|Physician Decision|3|||
125666761|NCT01605461|452069999|FG000|Overall Study|Lost to Follow-up|3|||
125666762|NCT01605461|452069999|FG000|Overall Study|Withdrawal by Subject|1|||
125666763|NCT02024698|452070000|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
125666764|NCT02024698|452070001|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
125666765|NCT00331630|452070002|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
125666766|NCT00331630|452070002|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
125666767|NCT00331630|452070002|FG000|Follow up for 5 Years|Death|5|||
125666768|NCT00331630|452070002|FG000|Follow up for 5 Years|Data collection was stopped|24|||
125666769|NCT02764489|452070003|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
125666770|NCT02764489|452070004|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
125666771|NCT02764489|452070003|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
125329914|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
125329915|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
125666772|NCT02764489|452070004|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
125666773|NCT02764489|452070003|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
125666774|NCT02764489|452070004|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
125329916|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Adverse Event|31|||
125329917|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Adverse Event|21|||
125329918|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
125329919|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
125329920|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
125329921|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
125329922|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
125329923|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
125329924|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
125329925|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
125666775|NCT02764489|452070003|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
125666776|NCT02764489|452070004|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
125666777|NCT02038634|452070005|FG000|Overall Study|Lost to Follow-up|0|||
125666778|NCT02038634|452070006|FG001|Overall Study|Lost to Follow-up|1|||
125666779|NCT00693784|452070007|FG000|Overall Study|Lost to Follow-up|2|||
125666780|NCT00693784|452070007|FG000|Overall Study|Withdrawal by Subject|2|||
125666781|NCT01664052|452070010|FG000|Phase 1|No device placement|6|||
125666782|NCT01664052|452070011|FG001|Phase 1|No device placement|0|||
125666783|NCT01664052|452070010|FG000|Phase 1|No HSG 1 hr post placement|1|||
125666784|NCT01664052|452070011|FG001|Phase 1|No HSG 1 hr post placement|0|||
125329926|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Administrative problems|3|||
125329927|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Administrative problems|3|||
125329928|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Death|5|||
125329929|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Death|8|||
125329930|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Disease progression|139|||
125329931|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Disease progression|119|||
125329932|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
125329933|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
125329934|NCT00785785|450841082|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
125329935|NCT00785785|450841083|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
125329936|NCT00785785|450841082|FG000|Optional Extension Phase|Adverse Event|4|||
125329937|NCT00785785|450841083|FG001|Optional Extension Phase|Adverse Event|5|||
125329938|NCT00785785|450841082|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
125329939|NCT00785785|450841083|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
125329940|NCT00785785|450841082|FG000|Optional Extension Phase|Lost to Follow-up|1|||
125666785|NCT01664052|452070010|FG000|Phase 2|No device placement|0|||
125666786|NCT01664052|452070011|FG001|Phase 2|No device placement|4|||
125666787|NCT00326885|452070012|FG000|Overall Study|Adverse Event|1|||
125666788|NCT00326885|452070012|FG000|Overall Study|Withdrawal by Subject|3|||
125666789|NCT00326885|452070012|FG000|Overall Study|Physician Decision|1|||
125666790|NCT00326885|452070012|FG000|Overall Study|Hospice withdrew consent|2|||
125666791|NCT01706198|452070013|FG000|Overall Study|Adverse Event|12|||
125666792|NCT01706198|452070014|FG001|Overall Study|Adverse Event|15|||
125666793|NCT01706198|452070013|FG000|Overall Study|Protocol Violation|7|||
125666794|NCT01706198|452070014|FG001|Overall Study|Protocol Violation|5|||
125329941|NCT00785785|450841083|FG001|Optional Extension Phase|Lost to Follow-up|0|||
125329942|NCT00785785|450841082|FG000|Optional Extension Phase|Administrative problems|2|||
125329943|NCT00785785|450841083|FG001|Optional Extension Phase|Administrative problems|0|||
125329944|NCT00785785|450841082|FG000|Optional Extension Phase|Death|1|||
125329945|NCT00785785|450841083|FG001|Optional Extension Phase|Death|5|||
125329946|NCT00785785|450841082|FG000|Optional Extension Phase|Disease progression|22|||
125329947|NCT00785785|450841083|FG001|Optional Extension Phase|Disease progression|70|||
125329948|NCT00785785|450841082|FG000|Optional Extension Phase|Protocol deviation|0|||
125329949|NCT00785785|450841083|FG001|Optional Extension Phase|Protocol deviation|2|||
125329950|NCT00785785|450841082|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
125329951|NCT00785785|450841083|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
125329952|NCT02453321|450841084|FG000|Overall Study|Weakness|1|||
125329953|NCT02453321|450841085|FG001|Overall Study|Weakness|1|||
125329954|NCT02453321|450841086|FG002|Overall Study|Weakness|2|||
125329955|NCT02453321|450841084|FG000|Overall Study|Deep Venous Thrombosis|0|||
125329956|NCT02453321|450841085|FG001|Overall Study|Deep Venous Thrombosis|1|||
125329957|NCT02453321|450841086|FG002|Overall Study|Deep Venous Thrombosis|0|||
125329958|NCT00521404|450841087|FG000|Overall Study|Adverse Event|13|||
125329959|NCT00521404|450841087|FG000|Overall Study|Disease Progression|33|||
125329960|NCT00521404|450841087|FG000|Overall Study|Investigator decision|5|||
125329961|NCT00521404|450841087|FG000|Overall Study|Withdrawal of consent|3|||
125329962|NCT00521404|450841087|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
125329963|NCT00521404|450841087|FG000|Overall Study|Other|7|||
125329964|NCT02282605|450841089|FG000|Overall Study|negative SA result on Day -1|3|||
125329965|NCT02282605|450841090|FG001|Overall Study|negative SA result on Day -1|0|||
125329966|NCT02282605|450841091|FG002|Overall Study|negative SA result on Day -1|0|||
125329967|NCT04396639|450841096|FG000|Overall Study|Withdrawal by Subject|1|||
125329968|NCT04396639|450841096|FG000|Overall Study|Other|1|||
125329969|NCT01544335|450841097|FG000|Overall Study|Lost to Follow-up|27|||
125329970|NCT01544335|450841097|FG000|Overall Study|Death|4|||
125329971|NCT01544335|450841097|FG000|Overall Study|Disease progression|3|||
125329972|NCT01544335|450841097|FG000|Overall Study|Baseline Measurements not Available|19|||
125329973|NCT01532986|450841100|FG000|Overall Study|Death|9|||
125329974|NCT01532986|450841101|FG001|Overall Study|Death|9|||
125329975|NCT01532986|450841100|FG000|Overall Study|Withdrawal by Subject|7|||
125329976|NCT01532986|450841101|FG001|Overall Study|Withdrawal by Subject|10|||
125329977|NCT01532986|450841100|FG000|Overall Study|Physician Decision|7|||
125329978|NCT01532986|450841101|FG001|Overall Study|Physician Decision|5|||
125329979|NCT04614974|450841102|FG000|Overall Study|Lost to Follow-up|14|||
125329980|NCT04614974|450841103|FG001|Overall Study|Lost to Follow-up|11|||
125329981|NCT01635153|450841104|FG000|Overall Study|Lost to Follow-up|40|||
125329982|NCT01635153|450841105|FG001|Overall Study|Lost to Follow-up|43|||
125329983|NCT00658359|450841106|FG000|Overall Study|Death|3|||
125329984|NCT00658359|450841107|FG001|Overall Study|Death|1|||
125329985|NCT00658359|450841108|FG002|Overall Study|Death|2|||
125329986|NCT00658359|450841106|FG000|Overall Study|Adverse Event|13|||
125329987|NCT00658359|450841107|FG001|Overall Study|Adverse Event|6|||
125329988|NCT00658359|450841108|FG002|Overall Study|Adverse Event|9|||
125329989|NCT00658359|450841106|FG000|Overall Study|Protocol Violation|1|||
125666795|NCT01706198|452070013|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
125666796|NCT01706198|452070014|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
125666797|NCT01706198|452070013|FG000|Overall Study|Lost to Follow-up|97|||
125666798|NCT01706198|452070014|FG001|Overall Study|Lost to Follow-up|93|||
125666799|NCT01706198|452070013|FG000|Overall Study|Physician Decision|23|||
125666800|NCT01706198|452070014|FG001|Overall Study|Physician Decision|37|||
125329990|NCT00658359|450841107|FG001|Overall Study|Protocol Violation|0|||
125666801|NCT01706198|452070013|FG000|Overall Study|Withdrawal by Subject|23|||
125666802|NCT01706198|452070014|FG001|Overall Study|Withdrawal by Subject|31|||
125666803|NCT04313283|452070016|FG000|Overall Study|did not complete intervention|4|||
125666804|NCT01473758|452070021|FG000|Cycle 1|Adverse Event|10|||
125666805|NCT01473758|452070022|FG001|Cycle 1|Adverse Event|2|||
125666806|NCT01473758|452070023|FG002|Cycle 1|Adverse Event|0|||
125666807|NCT01473758|452070024|FG003|Cycle 1|Adverse Event|0|||
125666808|NCT01473758|452070021|FG000|Cycle 1|Withdrawal by Subject|1|||
125666809|NCT01473758|452070022|FG001|Cycle 1|Withdrawal by Subject|1|||
125666810|NCT01473758|452070023|FG002|Cycle 1|Withdrawal by Subject|0|||
125666811|NCT01473758|452070024|FG003|Cycle 1|Withdrawal by Subject|0|||
125666812|NCT01473758|452070021|FG000|Cycle 2|Adverse Event|0|||
125666813|NCT01473758|452070022|FG001|Cycle 2|Adverse Event|0|||
125666814|NCT01473758|452070023|FG002|Cycle 2|Adverse Event|5|||
125666815|NCT01473758|452070024|FG003|Cycle 2|Adverse Event|0|||
125666816|NCT01677910|452070025|FG000|Double-Blind Treatment Period|Adverse Event|6|||
125666817|NCT01677910|452070026|FG001|Double-Blind Treatment Period|Adverse Event|2|||
125666818|NCT01677910|452070027|FG002|Double-Blind Treatment Period|Adverse Event|3|||
125666819|NCT01677910|452070028|FG003|Double-Blind Treatment Period|Adverse Event|0|||
125666820|NCT01677910|452070025|FG000|Double-Blind Treatment Period|Physician Decision|0|||
125666821|NCT01677910|452070026|FG001|Double-Blind Treatment Period|Physician Decision|0|||
125666822|NCT01677910|452070027|FG002|Double-Blind Treatment Period|Physician Decision|1|||
125666823|NCT01677910|452070028|FG003|Double-Blind Treatment Period|Physician Decision|0|||
125666824|NCT01677910|452070025|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
125666825|NCT01677910|452070026|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
125666826|NCT01677910|452070027|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
125666827|NCT01677910|452070028|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
125666828|NCT01677910|452070025|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
125666829|NCT01677910|452070026|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
125666830|NCT01677910|452070027|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
125666831|NCT01677910|452070028|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
125666832|NCT01677910|452070025|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
125666833|NCT01677910|452070026|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
125666834|NCT01677910|452070027|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
125666835|NCT01677910|452070028|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
125666836|NCT01677910|452070025|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
125666837|NCT01677910|452070026|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
125666838|NCT01677910|452070027|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
125666839|NCT01677910|452070028|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
125666840|NCT01677910|452070025|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
125666841|NCT01677910|452070026|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
125666842|NCT01677910|452070027|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
125666843|NCT01677910|452070028|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
125666844|NCT01677910|452070025|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
125666845|NCT01677910|452070026|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
125666846|NCT01677910|452070027|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
125666847|NCT01677910|452070028|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
125666848|NCT01677910|452070025|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
125666849|NCT01677910|452070026|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
125666850|NCT01677910|452070027|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
125666851|NCT01677910|452070028|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
125666852|NCT01677910|452070025|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
125666853|NCT01677910|452070026|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
125666854|NCT01677910|452070027|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
125666855|NCT01677910|452070028|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
125666856|NCT00606684|452070038|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
125666857|NCT00606684|452070039|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
125666858|NCT00606684|452070040|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
125329991|NCT00658359|450841108|FG002|Overall Study|Protocol Violation|0|||
125666859|NCT00606684|452070041|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
125666860|NCT00606684|452070042|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
125329992|NCT00658359|450841106|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
125329993|NCT00658359|450841107|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
125666861|NCT00606684|452070043|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
125666862|NCT00606684|452070044|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
125329994|NCT00658359|450841108|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
125329995|NCT00658359|450841106|FG000|Overall Study|Withdrawal by Subject|7|||
125329996|NCT00658359|450841107|FG001|Overall Study|Withdrawal by Subject|4|||
125329997|NCT00658359|450841108|FG002|Overall Study|Withdrawal by Subject|2|||
125329998|NCT00658359|450841106|FG000|Overall Study|Lost to Follow-up|2|||
125329999|NCT00658359|450841107|FG001|Overall Study|Lost to Follow-up|2|||
125330000|NCT00658359|450841108|FG002|Overall Study|Lost to Follow-up|4|||
125330001|NCT00658359|450841106|FG000|Overall Study|Lack of Efficacy|0|||
125330002|NCT00658359|450841107|FG001|Overall Study|Lack of Efficacy|1|||
125330003|NCT00658359|450841108|FG002|Overall Study|Lack of Efficacy|0|||
125330004|NCT02754440|450841109|FG000|Overall Study|Protocol Violation|3|||
125330005|NCT02754440|450841110|FG001|Overall Study|Protocol Violation|2|||
125330006|NCT02754440|450841111|FG002|Overall Study|Protocol Violation|2|||
125330007|NCT02754440|450841112|FG003|Overall Study|Protocol Violation|6|||
125330008|NCT02754440|450841109|FG000|Overall Study|Adverse Event|3|||
125330009|NCT02754440|450841110|FG001|Overall Study|Adverse Event|1|||
125330010|NCT02754440|450841111|FG002|Overall Study|Adverse Event|0|||
125330011|NCT02754440|450841112|FG003|Overall Study|Adverse Event|9|||
125666863|NCT00606684|452070038|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
125330012|NCT02754440|450841109|FG000|Overall Study|Withdrawal by Subject|0|||
125330013|NCT02754440|450841110|FG001|Overall Study|Withdrawal by Subject|0|||
125330014|NCT02754440|450841111|FG002|Overall Study|Withdrawal by Subject|0|||
125330015|NCT02754440|450841112|FG003|Overall Study|Withdrawal by Subject|1|||
125330016|NCT02754440|450841109|FG000|Overall Study|Equipment failure|0|||
125330017|NCT02754440|450841110|FG001|Overall Study|Equipment failure|5|||
125330018|NCT02754440|450841111|FG002|Overall Study|Equipment failure|5|||
125330019|NCT02754440|450841112|FG003|Overall Study|Equipment failure|7|||
125330020|NCT02754440|450841109|FG000|Overall Study|Subject issues not resulting in AE|0|||
125330021|NCT02754440|450841110|FG001|Overall Study|Subject issues not resulting in AE|0|||
125330022|NCT02754440|450841111|FG002|Overall Study|Subject issues not resulting in AE|0|||
125330023|NCT02754440|450841112|FG003|Overall Study|Subject issues not resulting in AE|12|||
125330024|NCT02560558|450841113|FG000|Overall Study|Adverse Event|1|||
125666864|NCT00606684|452070039|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
125666865|NCT00606684|452070040|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
125666866|NCT00606684|452070041|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
125330025|NCT02560558|450841114|FG001|Overall Study|Adverse Event|0|||
125330026|NCT02560558|450841113|FG000|Overall Study|Death|0|||
125666867|NCT00606684|452070042|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
125666868|NCT00606684|452070043|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
125666869|NCT00606684|452070044|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
125666870|NCT00606684|452070038|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
125666871|NCT00606684|452070039|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
125666872|NCT00606684|452070040|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
125666873|NCT00606684|452070041|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
125666874|NCT00606684|452070042|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
125666875|NCT00606684|452070043|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
125666876|NCT00606684|452070044|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
125666877|NCT00606684|452070038|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
125666878|NCT00606684|452070039|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
125666879|NCT00606684|452070040|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
125666880|NCT00606684|452070041|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
125666881|NCT00606684|452070042|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
125666882|NCT00606684|452070043|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
125666883|NCT00606684|452070044|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
125666884|NCT00606684|452070038|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
125666885|NCT00606684|452070039|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
125666886|NCT00606684|452070040|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
125666887|NCT00606684|452070041|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
125666888|NCT00606684|452070042|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
125666889|NCT00606684|452070043|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
125330027|NCT02560558|450841114|FG001|Overall Study|Death|2|||
125330028|NCT02560558|450841113|FG000|Overall Study|Lost to Follow-up|0|||
125330029|NCT02560558|450841114|FG001|Overall Study|Lost to Follow-up|4|||
125330030|NCT02560558|450841113|FG000|Overall Study|Protocol Violation|3|||
125330031|NCT02560558|450841114|FG001|Overall Study|Protocol Violation|0|||
125330032|NCT02560558|450841113|FG000|Overall Study|Withdrawal by Subject|3|||
125330033|NCT02560558|450841114|FG001|Overall Study|Withdrawal by Subject|0|||
125330034|NCT01263197|450841121|FG000|First Intervention (Period 1)|Adverse Event|0|||
125330035|NCT01263197|450841122|FG001|First Intervention (Period 1)|Adverse Event|0|||
125330036|NCT01263197|450841123|FG002|First Intervention (Period 1)|Adverse Event|0|||
125330037|NCT01263197|450841124|FG003|First Intervention (Period 1)|Adverse Event|0|||
125330038|NCT01263197|450841125|FG004|First Intervention (Period 1)|Adverse Event|0|||
125666890|NCT00606684|452070044|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
125666891|NCT00606684|452070038|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
125666892|NCT00606684|452070039|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
125666893|NCT00606684|452070040|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
125666894|NCT00606684|452070041|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
125666895|NCT00606684|452070042|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
125666896|NCT00606684|452070043|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
125666897|NCT00606684|452070044|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
125666898|NCT00606684|452070038|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
125666899|NCT00606684|452070039|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
125666900|NCT00606684|452070040|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
125666901|NCT00606684|452070041|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
125666902|NCT00606684|452070042|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
125666903|NCT00606684|452070043|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
125666904|NCT00606684|452070044|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
125666905|NCT00606684|452070038|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125666906|NCT00606684|452070039|FG001|Double-Blind Treatment Period|Adverse Event|3|||
125666907|NCT00606684|452070040|FG002|Double-Blind Treatment Period|Adverse Event|2|||
125666908|NCT00606684|452070041|FG003|Double-Blind Treatment Period|Adverse Event|4|||
125666909|NCT00606684|452070042|FG004|Double-Blind Treatment Period|Adverse Event|2|||
125666910|NCT00606684|452070043|FG005|Double-Blind Treatment Period|Adverse Event|0|||
125666911|NCT00606684|452070044|FG006|Double-Blind Treatment Period|Adverse Event|1|||
125666912|NCT00606684|452070038|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
125666913|NCT00606684|452070039|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
125666914|NCT00606684|452070040|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
125666915|NCT00606684|452070041|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
125666916|NCT00606684|452070042|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
125666917|NCT00606684|452070043|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
125666918|NCT00606684|452070044|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
125666919|NCT00606684|452070038|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
125666920|NCT00606684|452070039|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
125666921|NCT00606684|452070040|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
125666922|NCT00606684|452070041|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
125666923|NCT00606684|452070042|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
125666924|NCT00606684|452070043|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
125666925|NCT00606684|452070044|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
125666926|NCT00606684|452070038|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
125666927|NCT00606684|452070039|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
125666928|NCT00606684|452070040|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
125666929|NCT00606684|452070041|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
125666930|NCT00606684|452070042|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
125666931|NCT00606684|452070043|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
125666932|NCT00606684|452070044|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
125666933|NCT00606684|452070038|FG000|Double-Blind Treatment Period|Physician Decision|0|||
125666934|NCT00606684|452070039|FG001|Double-Blind Treatment Period|Physician Decision|5|||
125666935|NCT00606684|452070040|FG002|Double-Blind Treatment Period|Physician Decision|1|||
125666936|NCT00606684|452070041|FG003|Double-Blind Treatment Period|Physician Decision|0|||
125666937|NCT00606684|452070042|FG004|Double-Blind Treatment Period|Physician Decision|3|||
125666938|NCT00606684|452070043|FG005|Double-Blind Treatment Period|Physician Decision|1|||
125666939|NCT00606684|452070044|FG006|Double-Blind Treatment Period|Physician Decision|2|||
125666940|NCT00606684|452070038|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125666941|NCT00606684|452070039|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125666942|NCT00606684|452070040|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125666943|NCT00606684|452070041|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
125666944|NCT00606684|452070042|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125666945|NCT00606684|452070043|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
125666946|NCT00606684|452070044|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125666947|NCT02763579|452070045|FG000|Global Period|Death|167|||
125666948|NCT02763579|452070046|FG001|Global Period|Death|151|||
125666949|NCT02763579|452070047|FG002|Global Period|Death|0|||
125666950|NCT02763579|452070048|FG003|Global Period|Death|0|||
125666951|NCT02763579|452070045|FG000|Global Period|Lost to Follow-up|2|||
125666952|NCT02763579|452070046|FG001|Global Period|Lost to Follow-up|4|||
125666953|NCT02763579|452070047|FG002|Global Period|Lost to Follow-up|0|||
125666954|NCT02763579|452070048|FG003|Global Period|Lost to Follow-up|0|||
125666955|NCT02763579|452070045|FG000|Global Period|Physician Decision|0|||
125666956|NCT02763579|452070046|FG001|Global Period|Physician Decision|2|||
125666957|NCT02763579|452070047|FG002|Global Period|Physician Decision|0|||
125666958|NCT02763579|452070048|FG003|Global Period|Physician Decision|0|||
125330039|NCT01263197|450841126|FG005|First Intervention (Period 1)|Adverse Event|1|||
125666959|NCT02763579|452070045|FG000|Global Period|Study Terminated By Sponsor|21|||
125330040|NCT01263197|450841121|FG000|Washout Period 1|Protocol Violation|0|||
125330041|NCT01263197|450841122|FG001|Washout Period 1|Protocol Violation|0|||
125330042|NCT01263197|450841123|FG002|Washout Period 1|Protocol Violation|0|||
125330043|NCT01263197|450841124|FG003|Washout Period 1|Protocol Violation|0|||
125330044|NCT01263197|450841125|FG004|Washout Period 1|Protocol Violation|1|||
125666960|NCT02763579|452070046|FG001|Global Period|Study Terminated By Sponsor|26|||
125666961|NCT02763579|452070047|FG002|Global Period|Study Terminated By Sponsor|0|||
125666962|NCT02763579|452070048|FG003|Global Period|Study Terminated By Sponsor|0|||
125330045|NCT01263197|450841126|FG005|Washout Period 1|Protocol Violation|0|||
125330046|NCT01263197|450841121|FG000|Washout Period 2|Physician Decision|0|||
125330047|NCT01263197|450841122|FG001|Washout Period 2|Physician Decision|0|||
125330048|NCT01263197|450841123|FG002|Washout Period 2|Physician Decision|0|||
125666963|NCT02763579|452070045|FG000|Global Period|Withdrawal by Subject|12|||
125666964|NCT02763579|452070046|FG001|Global Period|Withdrawal by Subject|18|||
125666965|NCT02763579|452070047|FG002|Global Period|Withdrawal by Subject|0|||
125666966|NCT02763579|452070048|FG003|Global Period|Withdrawal by Subject|0|||
125666967|NCT02763579|452070045|FG000|China Period|Death|0|||
125666968|NCT02763579|452070046|FG001|China Period|Death|0|||
125666969|NCT02763579|452070047|FG002|China Period|Death|46|||
125666970|NCT02763579|452070048|FG003|China Period|Death|48|||
125666971|NCT02763579|452070045|FG000|China Period|Lost to Follow-up|0|||
125666972|NCT02763579|452070046|FG001|China Period|Lost to Follow-up|0|||
125666973|NCT02763579|452070047|FG002|China Period|Lost to Follow-up|1|||
125666974|NCT02763579|452070048|FG003|China Period|Lost to Follow-up|1|||
125666975|NCT02763579|452070045|FG000|China Period|Physician Decision|0|||
125666976|NCT02763579|452070046|FG001|China Period|Physician Decision|0|||
125666977|NCT02763579|452070047|FG002|China Period|Physician Decision|0|||
125666978|NCT02763579|452070048|FG003|China Period|Physician Decision|1|||
125666979|NCT02763579|452070045|FG000|China Period|Study Terminated By Sponsor|0|||
125666980|NCT02763579|452070046|FG001|China Period|Study Terminated By Sponsor|0|||
125666981|NCT02763579|452070047|FG002|China Period|Study Terminated By Sponsor|3|||
125666982|NCT02763579|452070048|FG003|China Period|Study Terminated By Sponsor|4|||
125666983|NCT02763579|452070045|FG000|China Period|Withdrawal by Subject|0|||
125666984|NCT02763579|452070046|FG001|China Period|Withdrawal by Subject|0|||
125666985|NCT02763579|452070047|FG002|China Period|Withdrawal by Subject|3|||
125666986|NCT02763579|452070048|FG003|China Period|Withdrawal by Subject|3|||
125666987|NCT00910858|452070055|FG000|Pharmacokinetic Phase|Adverse Event|1|||
125666988|NCT00910858|452070056|FG001|Pharmacokinetic Phase|Adverse Event|0|||
125666989|NCT00910858|452070057|FG002|Pharmacokinetic Phase|Adverse Event|0|||
125666990|NCT00910858|452070055|FG000|Monotherapy Phase|Adverse Event|3|||
125666991|NCT00910858|452070056|FG001|Monotherapy Phase|Adverse Event|2|||
125666992|NCT00910858|452070057|FG002|Monotherapy Phase|Adverse Event|0|||
125666993|NCT00910858|452070055|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
125666994|NCT00910858|452070056|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
125666995|NCT00910858|452070057|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
125666996|NCT00910858|452070055|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
125666997|NCT00910858|452070056|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
125666998|NCT00910858|452070057|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
125666999|NCT00910858|452070055|FG000|Monotherapy Phase|Protocol Violation|1|||
125667000|NCT00910858|452070056|FG001|Monotherapy Phase|Protocol Violation|0|||
125667001|NCT00910858|452070057|FG002|Monotherapy Phase|Protocol Violation|0|||
125667002|NCT00910858|452070055|FG000|Monotherapy Phase|Other|3|||
125667003|NCT00910858|452070056|FG001|Monotherapy Phase|Other|4|||
125667004|NCT00910858|452070057|FG002|Monotherapy Phase|Other|2|||
125667005|NCT00910858|452070055|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
125667006|NCT00910858|452070056|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
125667007|NCT00910858|452070057|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
125667008|NCT00910858|452070055|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
125667009|NCT00910858|452070056|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
125667010|NCT00910858|452070057|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
125667011|NCT00910858|452070055|FG000|Combined Treatment Phase|Protocol Violation|1|||
125667012|NCT00910858|452070056|FG001|Combined Treatment Phase|Protocol Violation|0|||
125667013|NCT00910858|452070057|FG002|Combined Treatment Phase|Protocol Violation|0|||
125330049|NCT01263197|450841124|FG003|Washout Period 2|Physician Decision|0|||
125330050|NCT01263197|450841125|FG004|Washout Period 2|Physician Decision|0|||
125330051|NCT01263197|450841126|FG005|Washout Period 2|Physician Decision|1|||
125330052|NCT01263197|450841121|FG000|Washout Period 2|Protocol Violation|0|||
125667014|NCT00910858|452070055|FG000|Combined Treatment Phase|Other|0|||
125667015|NCT00910858|452070056|FG001|Combined Treatment Phase|Other|2|||
125667016|NCT00910858|452070057|FG002|Combined Treatment Phase|Other|1|||
125667017|NCT01703741|452070064|FG000|Overall Study|Withdrawal by Subject|6|||
125667018|NCT01703741|452070064|FG000|Overall Study|Adverse Event|2|||
125667019|NCT01703741|452070064|FG000|Overall Study|Physician Decision|2|||
125667020|NCT01703741|452070064|FG000|Overall Study|Protocol Violation|1|||
125667021|NCT01703741|452070064|FG000|Overall Study|Lost to Follow-up|3|||
125667022|NCT01703741|452070064|FG000|Overall Study|Subject did not want to continue|2|||
125667023|NCT01703741|452070064|FG000|Overall Study|Subject cannot comply with study visits|1|||
125667024|NCT01703741|452070064|FG000|Overall Study|Subject started testosterone injections|1|||
125667025|NCT01170364|452070065|FG000|Overall Study|Protocol Violation|4|||
125667026|NCT01170364|452070066|FG001|Overall Study|Protocol Violation|1|||
125667027|NCT01381900|452070067|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
125667028|NCT01381900|452070068|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
125667029|NCT01381900|452070069|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
125667030|NCT01381900|452070067|FG000|Overall Study|Adverse Event|4|||
125667031|NCT01381900|452070068|FG001|Overall Study|Adverse Event|6|||
125667032|NCT01381900|452070069|FG002|Overall Study|Adverse Event|7|||
125667033|NCT01381900|452070067|FG000|Overall Study|Noncompliance with study drug|0|||
125667034|NCT01381900|452070068|FG001|Overall Study|Noncompliance with study drug|0|||
125667035|NCT01381900|452070069|FG002|Overall Study|Noncompliance with study drug|1|||
125667036|NCT01381900|452070067|FG000|Overall Study|Physician Decision|0|||
125667037|NCT01381900|452070068|FG001|Overall Study|Physician Decision|1|||
125667038|NCT01381900|452070069|FG002|Overall Study|Physician Decision|1|||
125667039|NCT01381900|452070067|FG000|Overall Study|Protocol Violation|0|||
125667040|NCT01381900|452070068|FG001|Overall Study|Protocol Violation|1|||
125667041|NCT01381900|452070069|FG002|Overall Study|Protocol Violation|1|||
125667042|NCT01381900|452070067|FG000|Overall Study|Withdrawal by Subject|0|||
125667043|NCT01381900|452070068|FG001|Overall Study|Withdrawal by Subject|0|||
125667044|NCT01381900|452070069|FG002|Overall Study|Withdrawal by Subject|1|||
125667045|NCT01381900|452070067|FG000|Overall Study|Early withdraw|3|||
125667046|NCT01381900|452070068|FG001|Overall Study|Early withdraw|1|||
125667047|NCT01381900|452070069|FG002|Overall Study|Early withdraw|1|||
125667048|NCT02041494|452070071|FG000|Overall Study|Death|1|||
125667049|NCT02041494|452070072|FG001|Overall Study|Death|3|||
125667050|NCT02041494|452070071|FG000|Overall Study|Lost to Follow-up|2|||
125667051|NCT02041494|452070072|FG001|Overall Study|Lost to Follow-up|6|||
125667052|NCT02041494|452070071|FG000|Overall Study|study terminated|16|||
125667053|NCT02041494|452070072|FG001|Overall Study|study terminated|11|||
125667054|NCT03341273|452070073|FG000|Overall Study|Lost to Follow-up|7|||
125667055|NCT03341273|452070074|FG001|Overall Study|Lost to Follow-up|7|||
125667056|NCT03341273|452070073|FG000|Overall Study|Withdrawal by Subject|4|||
125667057|NCT03341273|452070074|FG001|Overall Study|Withdrawal by Subject|2|||
125667058|NCT03341273|452070073|FG000|Overall Study|Physician Decision|1|||
125667059|NCT03341273|452070074|FG001|Overall Study|Physician Decision|0|||
125667060|NCT03341273|452070073|FG000|Overall Study|Protocol Violation|0|||
125667061|NCT03341273|452070074|FG001|Overall Study|Protocol Violation|1|||
125667062|NCT03341273|452070073|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
125667063|NCT03341273|452070074|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
125667064|NCT03341273|452070073|FG000|Overall Study|Became ineligible after enrollment|1|||
125667065|NCT03341273|452070074|FG001|Overall Study|Became ineligible after enrollment|0|||
125667066|NCT03341273|452070073|FG000|Overall Study|Not Eligible at Enrollment|0|||
125667067|NCT03341273|452070074|FG001|Overall Study|Not Eligible at Enrollment|1|||
125667068|NCT03341273|452070073|FG000|Overall Study|Participant incarcerated|1|||
125667069|NCT03341273|452070074|FG001|Overall Study|Participant incarcerated|0|||
125667070|NCT00685919|452070075|FG000|Overall Study|Withdrawal by Subject|0|||
125667071|NCT00685919|452070076|FG001|Overall Study|Withdrawal by Subject|0|||
125667072|NCT00685919|452070077|FG002|Overall Study|Withdrawal by Subject|1|||
125667073|NCT00685919|452070078|FG003|Overall Study|Withdrawal by Subject|0|||
125667074|NCT00685919|452070075|FG000|Overall Study|Physician Decision|1|||
125667075|NCT00685919|452070076|FG001|Overall Study|Physician Decision|0|||
125667076|NCT00685919|452070077|FG002|Overall Study|Physician Decision|0|||
125667077|NCT00685919|452070078|FG003|Overall Study|Physician Decision|0|||
125667078|NCT01717456|452070079|FG000|End of Treatment|Physician Decision|0|||
125667079|NCT01717456|452070080|FG001|End of Treatment|Physician Decision|1|||
125667080|NCT01717456|452070079|FG000|End of Treatment|Lost to Follow-up|0|||
125667081|NCT01717456|452070080|FG001|End of Treatment|Lost to Follow-up|1|||
125667082|NCT01717456|452070079|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
125667083|NCT01717456|452070080|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
125667084|NCT03751020|452070083|FG000|Overall Study|Withdrawal by Subject|2|||
125667085|NCT03751020|452070084|FG001|Overall Study|Withdrawal by Subject|0|||
125667086|NCT03751020|452070085|FG002|Overall Study|Withdrawal by Subject|0|||
125667087|NCT03751020|452070083|FG000|Overall Study|Lost to Follow-up|7|||
125667088|NCT03751020|452070084|FG001|Overall Study|Lost to Follow-up|4|||
125667089|NCT03751020|452070085|FG002|Overall Study|Lost to Follow-up|10|||
125667090|NCT00033631|452070086|FG000|Overall Study|Protocol Violation|14|||
125667091|NCT00033631|452070087|FG001|Overall Study|Protocol Violation|11|||
125667092|NCT00033631|452070086|FG000|Overall Study|Withdrawal by Subject|4|||
125667093|NCT00033631|452070087|FG001|Overall Study|Withdrawal by Subject|4|||
125667094|NCT00528879|452070088|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
125667095|NCT00528879|452070089|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
125667096|NCT00528879|452070090|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
125667097|NCT00528879|452070091|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
125667098|NCT00528879|452070088|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
125667099|NCT00528879|452070089|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
125667100|NCT00528879|452070090|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
125667101|NCT00528879|452070091|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
125330053|NCT01263197|450841122|FG001|Washout Period 2|Protocol Violation|0|||
125330054|NCT01263197|450841123|FG002|Washout Period 2|Protocol Violation|0|||
125330055|NCT01263197|450841124|FG003|Washout Period 2|Protocol Violation|1|||
125330056|NCT01263197|450841125|FG004|Washout Period 2|Protocol Violation|0|||
125330057|NCT01263197|450841126|FG005|Washout Period 2|Protocol Violation|0|||
125330058|NCT01263197|450841121|FG000|Third Intervention (Period 3)|Adverse Event|0|||
125330059|NCT01263197|450841122|FG001|Third Intervention (Period 3)|Adverse Event|1|||
125330060|NCT01263197|450841123|FG002|Third Intervention (Period 3)|Adverse Event|0|||
125330061|NCT01263197|450841124|FG003|Third Intervention (Period 3)|Adverse Event|0|||
125330062|NCT01263197|450841125|FG004|Third Intervention (Period 3)|Adverse Event|0|||
125330063|NCT01263197|450841126|FG005|Third Intervention (Period 3)|Adverse Event|0|||
125330064|NCT01134055|450841127|FG000|Overall Study|Adverse Event|5|||
125330065|NCT01134055|450841128|FG001|Overall Study|Adverse Event|2|||
125330066|NCT01134055|450841129|FG002|Overall Study|Adverse Event|2|||
125330067|NCT01134055|450841130|FG003|Overall Study|Adverse Event|2|||
125330068|NCT01134055|450841131|FG004|Overall Study|Adverse Event|5|||
125330069|NCT01134055|450841132|FG005|Overall Study|Adverse Event|7|||
125330070|NCT01134055|450841133|FG006|Overall Study|Adverse Event|2|||
125330071|NCT01134055|450841127|FG000|Overall Study|Lost to Follow-up|0|||
125330072|NCT01134055|450841128|FG001|Overall Study|Lost to Follow-up|1|||
125330073|NCT01134055|450841129|FG002|Overall Study|Lost to Follow-up|0|||
125330074|NCT01134055|450841130|FG003|Overall Study|Lost to Follow-up|1|||
125330075|NCT01134055|450841131|FG004|Overall Study|Lost to Follow-up|0|||
125330076|NCT01134055|450841132|FG005|Overall Study|Lost to Follow-up|0|||
125330077|NCT01134055|450841133|FG006|Overall Study|Lost to Follow-up|0|||
125330078|NCT01134055|450841127|FG000|Overall Study|Withdrawal by Subject|3|||
125330079|NCT01134055|450841128|FG001|Overall Study|Withdrawal by Subject|3|||
125330080|NCT01134055|450841129|FG002|Overall Study|Withdrawal by Subject|1|||
125330081|NCT01134055|450841130|FG003|Overall Study|Withdrawal by Subject|2|||
125330082|NCT01134055|450841131|FG004|Overall Study|Withdrawal by Subject|0|||
125330083|NCT01134055|450841132|FG005|Overall Study|Withdrawal by Subject|0|||
125330084|NCT01134055|450841133|FG006|Overall Study|Withdrawal by Subject|8|||
125330085|NCT01134055|450841127|FG000|Overall Study|Protocol Violation|0|||
125330086|NCT01134055|450841128|FG001|Overall Study|Protocol Violation|0|||
125330087|NCT01134055|450841129|FG002|Overall Study|Protocol Violation|0|||
125330088|NCT01134055|450841130|FG003|Overall Study|Protocol Violation|1|||
125330089|NCT01134055|450841131|FG004|Overall Study|Protocol Violation|1|||
125330090|NCT01134055|450841132|FG005|Overall Study|Protocol Violation|0|||
125330091|NCT01134055|450841133|FG006|Overall Study|Protocol Violation|0|||
125330092|NCT01134055|450841127|FG000|Overall Study|Physician Decision|0|||
125330093|NCT01134055|450841128|FG001|Overall Study|Physician Decision|0|||
125330094|NCT01134055|450841129|FG002|Overall Study|Physician Decision|0|||
125330095|NCT01134055|450841130|FG003|Overall Study|Physician Decision|0|||
125330096|NCT01134055|450841131|FG004|Overall Study|Physician Decision|0|||
125330097|NCT01134055|450841132|FG005|Overall Study|Physician Decision|0|||
125330098|NCT01134055|450841133|FG006|Overall Study|Physician Decision|1|||
125330099|NCT03023397|450841138|FG000|Run-In|Failed screening allergen challenge|1|||
125330100|NCT03023397|450841139|FG001|Run-In|Failed screening allergen challenge|0|||
125330101|NCT03023397|450841140|FG002|Run-In|Failed screening allergen challenge|0|||
125330102|NCT03023397|450841138|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
125330103|NCT03023397|450841139|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
125330104|NCT03023397|450841140|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
125330105|NCT01146795|450841144|FG000|Overall Study|Withdrawal by Subject|4|||
125330106|NCT01146795|450841144|FG000|Overall Study|Adverse Event|6|||
125330107|NCT01146795|450841144|FG000|Overall Study|Still in treatment at study closure|10|||
125330108|NCT03853109|450841145|FG000|Overall Study|Withdrawal by Subject|0|||
125330109|NCT03853109|450841146|FG001|Overall Study|Withdrawal by Subject|0|||
125330110|NCT03853109|450841147|FG002|Overall Study|Withdrawal by Subject|1|||
125330111|NCT03853109|450841148|FG003|Overall Study|Withdrawal by Subject|2|||
125330112|NCT03853109|450841149|FG004|Overall Study|Withdrawal by Subject|1|||
125330113|NCT03853109|450841150|FG005|Overall Study|Withdrawal by Subject|4|||
125330114|NCT03853109|450841151|FG006|Overall Study|Withdrawal by Subject|5|||
125330115|NCT03853109|450841152|FG007|Overall Study|Withdrawal by Subject|3|||
125330116|NCT03853109|450841145|FG000|Overall Study|Decision by Sponsor|0|||
125330117|NCT03853109|450841146|FG001|Overall Study|Decision by Sponsor|0|||
125330118|NCT03853109|450841147|FG002|Overall Study|Decision by Sponsor|1|||
125330119|NCT03853109|450841148|FG003|Overall Study|Decision by Sponsor|0|||
125330120|NCT03853109|450841149|FG004|Overall Study|Decision by Sponsor|1|||
125330121|NCT03853109|450841150|FG005|Overall Study|Decision by Sponsor|1|||
125330122|NCT03853109|450841151|FG006|Overall Study|Decision by Sponsor|10|||
125667102|NCT00528879|452070088|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
125667103|NCT00528879|452070089|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
125667104|NCT00528879|452070090|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
125667105|NCT00528879|452070091|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
125667106|NCT00528879|452070088|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
125667107|NCT00528879|452070089|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
125667108|NCT00528879|452070090|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
125667109|NCT00528879|452070091|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
125667110|NCT00528879|452070088|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
125667111|NCT00528879|452070089|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
125667112|NCT00528879|452070090|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
125667113|NCT00528879|452070091|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
125667114|NCT00528879|452070088|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
125667115|NCT00528879|452070089|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
125667116|NCT00528879|452070090|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
125667117|NCT00528879|452070091|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
125667118|NCT00528879|452070088|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
125667119|NCT00528879|452070089|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
125667120|NCT00528879|452070090|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
125667121|NCT00528879|452070091|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
125667122|NCT00528879|452070088|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
125667123|NCT00528879|452070089|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
125667124|NCT00528879|452070090|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
125667125|NCT00528879|452070091|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
125667126|NCT00528879|452070088|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
125667127|NCT00528879|452070089|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
125667128|NCT00528879|452070090|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
125667129|NCT00528879|452070091|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
125667130|NCT00528879|452070088|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
125667131|NCT00528879|452070089|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
125667132|NCT00528879|452070090|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
125667133|NCT00528879|452070091|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
125667134|NCT00528879|452070088|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
125667135|NCT00528879|452070089|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
125667136|NCT00528879|452070090|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
125667137|NCT00528879|452070091|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
125667138|NCT00528879|452070088|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
125667139|NCT00528879|452070089|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
125667140|NCT00528879|452070090|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
125667141|NCT00528879|452070091|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
125667142|NCT00528879|452070088|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
125667143|NCT00528879|452070089|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
125667144|NCT00528879|452070090|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
125667145|NCT00528879|452070091|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
125667146|NCT00528879|452070088|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
125667147|NCT00528879|452070089|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
125667148|NCT00528879|452070090|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
125667149|NCT00528879|452070091|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
125667150|NCT00528879|452070088|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
125667151|NCT00528879|452070089|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
125667152|NCT00528879|452070090|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
125667153|NCT00528879|452070091|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
125667154|NCT00528879|452070088|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
125667155|NCT00528879|452070089|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
125667156|NCT00528879|452070090|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
125667157|NCT00528879|452070091|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
125667158|NCT00078819|452070092|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
125667159|NCT00078819|452070093|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
125667160|NCT00078819|452070094|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
125667161|NCT00078819|452070095|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
125330123|NCT03853109|450841152|FG007|Overall Study|Decision by Sponsor|2|||
125330124|NCT03853109|450841145|FG000|Overall Study|Lost to Follow-up|0|||
125330125|NCT03853109|450841146|FG001|Overall Study|Lost to Follow-up|0|||
125330126|NCT03853109|450841147|FG002|Overall Study|Lost to Follow-up|0|||
125330127|NCT03853109|450841148|FG003|Overall Study|Lost to Follow-up|0|||
125330128|NCT03853109|450841149|FG004|Overall Study|Lost to Follow-up|1|||
125330129|NCT03853109|450841150|FG005|Overall Study|Lost to Follow-up|3|||
125667162|NCT00078819|452070092|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
125667163|NCT00078819|452070093|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
125667164|NCT00078819|452070094|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
125667165|NCT00078819|452070095|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
125667166|NCT00078819|452070092|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
125667167|NCT00078819|452070093|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
125667168|NCT00078819|452070094|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
125667169|NCT00078819|452070095|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
125667170|NCT00078819|452070092|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
125667171|NCT00078819|452070093|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
125667172|NCT00078819|452070094|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
125667173|NCT00078819|452070095|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
125667174|NCT00078819|452070092|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
125667175|NCT00078819|452070093|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
125667176|NCT00078819|452070094|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
125667177|NCT00078819|452070095|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
125667178|NCT00078819|452070092|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
125667179|NCT00078819|452070093|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
125667180|NCT00078819|452070094|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
125667181|NCT00078819|452070095|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
125667182|NCT00078819|452070092|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
125667183|NCT00078819|452070093|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
125667184|NCT00078819|452070094|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
125667185|NCT00078819|452070095|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
125667186|NCT00078819|452070092|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
125667187|NCT00078819|452070093|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
125667188|NCT00078819|452070094|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
125667189|NCT00078819|452070095|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
125667190|NCT00323609|452070096|FG000|Overall Study|Death|16|||
125667191|NCT00323609|452070097|FG001|Overall Study|Death|21|||
125667192|NCT00323609|452070098|FG002|Overall Study|Death|0|||
125667193|NCT00323609|452070099|FG003|Overall Study|Death|0|||
125667194|NCT00323609|452070096|FG000|Overall Study|Lost to Follow-up|9|||
125667195|NCT00323609|452070097|FG001|Overall Study|Lost to Follow-up|10|||
125667196|NCT00323609|452070098|FG002|Overall Study|Lost to Follow-up|0|||
125667197|NCT00323609|452070099|FG003|Overall Study|Lost to Follow-up|0|||
125667198|NCT00323609|452070096|FG000|Overall Study|Physician Decision|2|||
125667199|NCT00323609|452070097|FG001|Overall Study|Physician Decision|0|||
125667200|NCT00323609|452070098|FG002|Overall Study|Physician Decision|0|||
125667201|NCT00323609|452070099|FG003|Overall Study|Physician Decision|1|||
125667202|NCT00323609|452070096|FG000|Overall Study|Withdrawal by Subject|11|||
125667203|NCT00323609|452070097|FG001|Overall Study|Withdrawal by Subject|23|||
125667204|NCT00323609|452070098|FG002|Overall Study|Withdrawal by Subject|4|||
125667205|NCT00323609|452070099|FG003|Overall Study|Withdrawal by Subject|4|||
125667206|NCT00323609|452070096|FG000|Overall Study|Other non-VCF-related medical condition|3|||
125667207|NCT00323609|452070097|FG001|Overall Study|Other non-VCF-related medical condition|2|||
125667208|NCT00323609|452070098|FG002|Overall Study|Other non-VCF-related medical condition|0|||
125667209|NCT00323609|452070099|FG003|Overall Study|Other non-VCF-related medical condition|0|||
125667210|NCT00323609|452070096|FG000|Overall Study|Sponsor discontinued trial|29|||
125667211|NCT00323609|452070097|FG001|Overall Study|Sponsor discontinued trial|29|||
125667212|NCT00323609|452070098|FG002|Overall Study|Sponsor discontinued trial|0|||
125667213|NCT00323609|452070099|FG003|Overall Study|Sponsor discontinued trial|0|||
125667214|NCT00323609|452070096|FG000|Overall Study|Unrelenting or severe back pain|1|||
125667215|NCT00323609|452070097|FG001|Overall Study|Unrelenting or severe back pain|1|||
125667216|NCT00323609|452070098|FG002|Overall Study|Unrelenting or severe back pain|0|||
125330130|NCT03853109|450841151|FG006|Overall Study|Lost to Follow-up|0|||
125330131|NCT03853109|450841152|FG007|Overall Study|Lost to Follow-up|0|||
125330132|NCT03853109|450841145|FG000|Overall Study|Death|2|||
125667217|NCT00323609|452070099|FG003|Overall Study|Unrelenting or severe back pain|0|||
125667218|NCT00323609|452070096|FG000|Overall Study|Logistical withdrawal|9|||
125667219|NCT00323609|452070097|FG001|Overall Study|Logistical withdrawal|5|||
125667220|NCT00323609|452070098|FG002|Overall Study|Logistical withdrawal|0|||
125330133|NCT03853109|450841146|FG001|Overall Study|Death|5|||
125667221|NCT00323609|452070099|FG003|Overall Study|Logistical withdrawal|1|||
125667222|NCT00323609|452070096|FG000|Overall Study|Other reason|11|||
125667223|NCT00323609|452070097|FG001|Overall Study|Other reason|8|||
125330134|NCT03853109|450841147|FG002|Overall Study|Death|8|||
125667224|NCT00323609|452070098|FG002|Overall Study|Other reason|4|||
125667225|NCT00323609|452070099|FG003|Overall Study|Other reason|9|||
125667226|NCT02217345|452070100|FG000|Overall Study|Lost to Follow-up|2|||
125667227|NCT02217345|452070101|FG001|Overall Study|Lost to Follow-up|1|||
125667228|NCT02217345|452070100|FG000|Overall Study|Withdrawal by Subject|3|||
125667229|NCT02217345|452070101|FG001|Overall Study|Withdrawal by Subject|2|||
125667230|NCT02217345|452070100|FG000|Overall Study|Adverse Event|2|||
125667231|NCT02217345|452070101|FG001|Overall Study|Adverse Event|1|||
125667232|NCT02217345|452070100|FG000|Overall Study|Physician Decision|0|||
125667233|NCT02217345|452070101|FG001|Overall Study|Physician Decision|1|||
125667234|NCT00950599|452070106|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125667235|NCT00950599|452070107|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125667236|NCT00950599|452070108|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125667237|NCT00950599|452070109|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
125667238|NCT00950599|452070110|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125667239|NCT00950599|452070111|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125667240|NCT00950599|452070112|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125667241|NCT00950599|452070113|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125667242|NCT00950599|452070114|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125330135|NCT03853109|450841148|FG003|Overall Study|Death|10|||
125667243|NCT00950599|452070115|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
125667244|NCT00950599|452070106|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125667245|NCT00950599|452070107|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125667246|NCT00950599|452070108|FG002|Double-Blind Treatment Period|Adverse Event|1|||
125667247|NCT00950599|452070109|FG003|Double-Blind Treatment Period|Adverse Event|1|||
125667248|NCT00950599|452070110|FG004|Double-Blind Treatment Period|Adverse Event|1|||
125667249|NCT00950599|452070111|FG005|Double-Blind Treatment Period|Adverse Event|1|||
125667250|NCT00950599|452070112|FG006|Double-Blind Treatment Period|Adverse Event|0|||
125667251|NCT00950599|452070113|FG007|Double-Blind Treatment Period|Adverse Event|0|||
125667252|NCT00950599|452070114|FG008|Double-Blind Treatment Period|Adverse Event|0|||
125667253|NCT00950599|452070115|FG009|Double-Blind Treatment Period|Adverse Event|0|||
125667254|NCT00950599|452070106|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
125667255|NCT00950599|452070107|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
125667256|NCT00950599|452070108|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
125667257|NCT00950599|452070109|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
125667258|NCT00950599|452070110|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
125667259|NCT00950599|452070111|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
125667260|NCT00950599|452070112|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
125667261|NCT00950599|452070113|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
125667262|NCT00950599|452070114|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
125667263|NCT00950599|452070115|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
125667264|NCT00950599|452070106|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125667265|NCT00950599|452070107|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
125667266|NCT00950599|452070108|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
125667267|NCT00950599|452070109|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
125667268|NCT00950599|452070110|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
125667269|NCT00950599|452070111|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
125667270|NCT00950599|452070112|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
125667271|NCT00950599|452070113|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
125667272|NCT00950599|452070114|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
125667273|NCT00950599|452070115|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
125667274|NCT00950599|452070106|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
125667275|NCT00950599|452070107|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
125667276|NCT00950599|452070108|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125667277|NCT00950599|452070109|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125667278|NCT00950599|452070110|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125667279|NCT00950599|452070111|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125330136|NCT03853109|450841149|FG004|Overall Study|Death|3|||
125330137|NCT03853109|450841150|FG005|Overall Study|Death|20|||
125330138|NCT03853109|450841151|FG006|Overall Study|Death|10|||
125330139|NCT03853109|450841152|FG007|Overall Study|Death|5|||
125330140|NCT01721044|450841155|FG000|Treatment Period|Adverse Event|7|||
125330141|NCT01721044|450841156|FG001|Treatment Period|Adverse Event|7|||
125667280|NCT00950599|452070112|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125667281|NCT00950599|452070113|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
125667282|NCT00950599|452070114|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125667283|NCT00950599|452070115|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
125667284|NCT00950599|452070106|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125330142|NCT01721044|450841157|FG002|Treatment Period|Adverse Event|10|||
125330143|NCT01721044|450841155|FG000|Treatment Period|Death|0|||
125330144|NCT01721044|450841156|FG001|Treatment Period|Death|0|||
125330145|NCT01721044|450841157|FG002|Treatment Period|Death|1|||
125330146|NCT01721044|450841155|FG000|Treatment Period|Lack of Efficacy|16|||
125330147|NCT01721044|450841156|FG001|Treatment Period|Lack of Efficacy|4|||
125330148|NCT01721044|450841157|FG002|Treatment Period|Lack of Efficacy|4|||
125330149|NCT01721044|450841155|FG000|Treatment Period|Lost to Follow-up|0|||
125330150|NCT01721044|450841156|FG001|Treatment Period|Lost to Follow-up|0|||
125330151|NCT01721044|450841157|FG002|Treatment Period|Lost to Follow-up|1|||
125330152|NCT01721044|450841155|FG000|Treatment Period|Physician Decision|1|||
125330153|NCT01721044|450841156|FG001|Treatment Period|Physician Decision|0|||
125667285|NCT00950599|452070107|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125667286|NCT00950599|452070108|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125667287|NCT00950599|452070109|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125667288|NCT00950599|452070110|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
125667289|NCT00950599|452070111|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
125667290|NCT00950599|452070112|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125667291|NCT00950599|452070113|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125667292|NCT00950599|452070114|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125667293|NCT00950599|452070115|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
125667294|NCT00950599|452070106|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
125667295|NCT00950599|452070107|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
125667296|NCT00950599|452070108|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
125667297|NCT00950599|452070109|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
125667298|NCT00950599|452070110|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
125667299|NCT00950599|452070111|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
125667300|NCT00950599|452070112|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
125667301|NCT00950599|452070113|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
125667302|NCT00950599|452070114|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
125667303|NCT00950599|452070115|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
125667304|NCT00950599|452070106|FG000|Follow-Up Period|Adverse Event|0|||
125667305|NCT00950599|452070107|FG001|Follow-Up Period|Adverse Event|0|||
125667306|NCT00950599|452070108|FG002|Follow-Up Period|Adverse Event|0|||
125667307|NCT00950599|452070109|FG003|Follow-Up Period|Adverse Event|0|||
125667308|NCT00950599|452070110|FG004|Follow-Up Period|Adverse Event|0|||
125667309|NCT00950599|452070111|FG005|Follow-Up Period|Adverse Event|0|||
125667310|NCT00950599|452070112|FG006|Follow-Up Period|Adverse Event|0|||
125667311|NCT00950599|452070113|FG007|Follow-Up Period|Adverse Event|0|||
125667312|NCT00950599|452070114|FG008|Follow-Up Period|Adverse Event|1|||
125667313|NCT00950599|452070115|FG009|Follow-Up Period|Adverse Event|0|||
125667314|NCT00950599|452070106|FG000|Follow-Up Period|Lack of Efficacy|0|||
125667315|NCT00950599|452070107|FG001|Follow-Up Period|Lack of Efficacy|0|||
125667316|NCT00950599|452070108|FG002|Follow-Up Period|Lack of Efficacy|0|||
125667317|NCT00950599|452070109|FG003|Follow-Up Period|Lack of Efficacy|0|||
125667318|NCT00950599|452070110|FG004|Follow-Up Period|Lack of Efficacy|0|||
125667319|NCT00950599|452070111|FG005|Follow-Up Period|Lack of Efficacy|0|||
125667320|NCT00950599|452070112|FG006|Follow-Up Period|Lack of Efficacy|0|||
125667321|NCT00950599|452070113|FG007|Follow-Up Period|Lack of Efficacy|0|||
125667322|NCT00950599|452070114|FG008|Follow-Up Period|Lack of Efficacy|3|||
125667323|NCT00950599|452070115|FG009|Follow-Up Period|Lack of Efficacy|0|||
125667324|NCT00950599|452070106|FG000|Follow-Up Period|Lost to Follow-up|0|||
125667325|NCT00950599|452070107|FG001|Follow-Up Period|Lost to Follow-up|0|||
125667326|NCT00950599|452070108|FG002|Follow-Up Period|Lost to Follow-up|0|||
125667327|NCT00950599|452070109|FG003|Follow-Up Period|Lost to Follow-up|0|||
125667328|NCT00950599|452070110|FG004|Follow-Up Period|Lost to Follow-up|0|||
125667329|NCT00950599|452070111|FG005|Follow-Up Period|Lost to Follow-up|0|||
125667330|NCT00950599|452070112|FG006|Follow-Up Period|Lost to Follow-up|0|||
125667331|NCT00950599|452070113|FG007|Follow-Up Period|Lost to Follow-up|0|||
125667332|NCT00950599|452070114|FG008|Follow-Up Period|Lost to Follow-up|5|||
125667333|NCT00950599|452070115|FG009|Follow-Up Period|Lost to Follow-up|1|||
125667334|NCT00950599|452070106|FG000|Follow-Up Period|Physician Decision|0|||
125667335|NCT00950599|452070107|FG001|Follow-Up Period|Physician Decision|0|||
125667336|NCT00950599|452070108|FG002|Follow-Up Period|Physician Decision|0|||
125667337|NCT00950599|452070109|FG003|Follow-Up Period|Physician Decision|0|||
125667338|NCT00950599|452070110|FG004|Follow-Up Period|Physician Decision|0|||
125667339|NCT00950599|452070111|FG005|Follow-Up Period|Physician Decision|0|||
125667340|NCT00950599|452070112|FG006|Follow-Up Period|Physician Decision|0|||
125667341|NCT00950599|452070113|FG007|Follow-Up Period|Physician Decision|0|||
125667342|NCT00950599|452070114|FG008|Follow-Up Period|Physician Decision|1|||
125667343|NCT00950599|452070115|FG009|Follow-Up Period|Physician Decision|0|||
125667344|NCT00950599|452070106|FG000|Follow-Up Period|Poor/Noncompliance|0|||
125667345|NCT00950599|452070107|FG001|Follow-Up Period|Poor/Noncompliance|0|||
125667346|NCT00950599|452070108|FG002|Follow-Up Period|Poor/Noncompliance|0|||
125667347|NCT00950599|452070109|FG003|Follow-Up Period|Poor/Noncompliance|0|||
125330154|NCT01721044|450841157|FG002|Treatment Period|Physician Decision|2|||
125667348|NCT00950599|452070110|FG004|Follow-Up Period|Poor/Noncompliance|0|||
125667349|NCT00950599|452070111|FG005|Follow-Up Period|Poor/Noncompliance|0|||
125667350|NCT00950599|452070112|FG006|Follow-Up Period|Poor/Noncompliance|0|||
125667351|NCT00950599|452070113|FG007|Follow-Up Period|Poor/Noncompliance|0|||
125667352|NCT00950599|452070114|FG008|Follow-Up Period|Poor/Noncompliance|1|||
125667353|NCT00950599|452070115|FG009|Follow-Up Period|Poor/Noncompliance|0|||
125667354|NCT00950599|452070106|FG000|Follow-Up Period|Subject withdrew Consent|0|||
125667355|NCT00950599|452070107|FG001|Follow-Up Period|Subject withdrew Consent|0|||
125667356|NCT00950599|452070108|FG002|Follow-Up Period|Subject withdrew Consent|0|||
125667357|NCT00950599|452070109|FG003|Follow-Up Period|Subject withdrew Consent|0|||
125667358|NCT00950599|452070110|FG004|Follow-Up Period|Subject withdrew Consent|0|||
125667359|NCT00950599|452070111|FG005|Follow-Up Period|Subject withdrew Consent|0|||
125667360|NCT00950599|452070112|FG006|Follow-Up Period|Subject withdrew Consent|0|||
125667361|NCT00950599|452070113|FG007|Follow-Up Period|Subject withdrew Consent|0|||
125667362|NCT00950599|452070114|FG008|Follow-Up Period|Subject withdrew Consent|2|||
125667363|NCT00950599|452070115|FG009|Follow-Up Period|Subject withdrew Consent|1|||
125667364|NCT00971204|452070116|FG000|Overall Study|Did not meet all criteria-not treated|14|||
125667365|NCT00971204|452070116|FG000|Overall Study|Lost to Follow-up|10|||
125667366|NCT02729194|452070117|FG000|Overall Study|Withdrawal by Subject|3|||
125667367|NCT01401478|452070120|FG000|Overall Study|Study drug not available|6|||
125667368|NCT01401478|452070120|FG000|Overall Study|Adverse Event|5|||
125667369|NCT01401478|452070120|FG000|Overall Study|Hyperphosphatemia|5|||
125667370|NCT01401478|452070120|FG000|Overall Study|Lost to Follow-up|5|||
125667371|NCT01401478|452070120|FG000|Overall Study|Kidney transplantation|3|||
125667372|NCT01401478|452070120|FG000|Overall Study|Withdrawal by Subject|3|||
125667373|NCT01401478|452070120|FG000|Overall Study|Blood samples not available|1|||
125667374|NCT01401478|452070120|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
125667375|NCT01401478|452070120|FG000|Overall Study|Low intact parathyroid hormone|1|||
125667376|NCT01401478|452070120|FG000|Overall Study|Serious adverse event|1|||
125667377|NCT01684722|452070121|FG000|Overall Study|Lost to Follow-up|78|||
125667378|NCT01684722|452070122|FG001|Overall Study|Lost to Follow-up|56|||
125667379|NCT01684722|452070123|FG002|Overall Study|Lost to Follow-up|75|||
125667380|NCT01684722|452070124|FG003|Overall Study|Lost to Follow-up|89|||
125330155|NCT01721044|450841155|FG000|Treatment Period|Protocol Violation|1|||
125330156|NCT01721044|450841156|FG001|Treatment Period|Protocol Violation|0|||
125330157|NCT01721044|450841157|FG002|Treatment Period|Protocol Violation|0|||
125330158|NCT01721044|450841155|FG000|Treatment Period|Withdrawal by Subject|7|||
125330159|NCT01721044|450841156|FG001|Treatment Period|Withdrawal by Subject|6|||
125330160|NCT01721044|450841157|FG002|Treatment Period|Withdrawal by Subject|1|||
125330161|NCT04032093|450841158|FG000|Overall Study|Lost to Follow-up|7|||
125330162|NCT04032093|450841159|FG001|Overall Study|Lost to Follow-up|7|||
125330163|NCT04032093|450841160|FG002|Overall Study|Lost to Follow-up|6|||
125330164|NCT04032093|450841161|FG003|Overall Study|Lost to Follow-up|10|||
125330165|NCT04032093|450841162|FG004|Overall Study|Lost to Follow-up|13|||
125330166|NCT04032093|450841163|FG005|Overall Study|Lost to Follow-up|7|||
125330167|NCT04032093|450841164|FG006|Overall Study|Lost to Follow-up|7|||
125330168|NCT04032093|450841165|FG007|Overall Study|Lost to Follow-up|5|||
125330169|NCT04032093|450841166|FG008|Overall Study|Lost to Follow-up|9|||
125330170|NCT04032093|450841167|FG009|Overall Study|Lost to Follow-up|12|||
125330171|NCT04032093|450841158|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125330172|NCT04032093|450841159|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125330173|NCT04032093|450841160|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
125330174|NCT04032093|450841161|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
125330175|NCT04032093|450841162|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
125330176|NCT04032093|450841163|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
125330177|NCT04032093|450841164|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
125330178|NCT04032093|450841165|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
125330179|NCT04032093|450841166|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
125330180|NCT04032093|450841167|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
125330181|NCT04032093|450841158|FG000|Overall Study|Other|1|||
125330182|NCT04032093|450841159|FG001|Overall Study|Other|0|||
125330183|NCT04032093|450841160|FG002|Overall Study|Other|0|||
125330184|NCT04032093|450841161|FG003|Overall Study|Other|1|||
125330185|NCT04032093|450841162|FG004|Overall Study|Other|1|||
125330186|NCT04032093|450841163|FG005|Overall Study|Other|0|||
125330187|NCT04032093|450841164|FG006|Overall Study|Other|0|||
125330188|NCT04032093|450841165|FG007|Overall Study|Other|0|||
125330189|NCT04032093|450841166|FG008|Overall Study|Other|0|||
125330190|NCT04032093|450841167|FG009|Overall Study|Other|1|||
125330191|NCT04032093|450841158|FG000|Overall Study|Withdrawal by Subject|1|||
125330192|NCT04032093|450841159|FG001|Overall Study|Withdrawal by Subject|3|||
125330193|NCT04032093|450841160|FG002|Overall Study|Withdrawal by Subject|2|||
125330194|NCT04032093|450841161|FG003|Overall Study|Withdrawal by Subject|2|||
125330195|NCT04032093|450841162|FG004|Overall Study|Withdrawal by Subject|3|||
125667381|NCT01684722|452070121|FG000|Overall Study|Death|19|||
125667382|NCT01684722|452070122|FG001|Overall Study|Death|21|||
125667383|NCT01684722|452070123|FG002|Overall Study|Death|19|||
125330196|NCT04032093|450841163|FG005|Overall Study|Withdrawal by Subject|0|||
125667384|NCT01684722|452070124|FG003|Overall Study|Death|21|||
125667385|NCT00863057|452070127|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
125667386|NCT00863057|452070128|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
125667387|NCT00863057|452070129|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
125667388|NCT00863057|452070130|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
125667389|NCT00863057|452070127|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
125667390|NCT00863057|452070128|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
125667391|NCT00863057|452070129|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
125667392|NCT00863057|452070130|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
125667393|NCT00863057|452070127|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
125667394|NCT00863057|452070128|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
125667395|NCT00863057|452070129|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
125667396|NCT00863057|452070130|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
125667397|NCT00863057|452070127|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
125667398|NCT00863057|452070128|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
125667399|NCT00863057|452070129|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
125667400|NCT00863057|452070130|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
125667401|NCT03063632|452070134|FG000|Overall Study|Death|4|||
125667402|NCT03063632|452070135|FG001|Overall Study|Death|6|||
125667403|NCT03063632|452070134|FG000|Overall Study|Lost to Follow-up|0|||
125667404|NCT03063632|452070135|FG001|Overall Study|Lost to Follow-up|1|||
125667405|NCT03063632|452070134|FG000|Overall Study|Withdrawal by Subject|0|||
125667406|NCT03063632|452070135|FG001|Overall Study|Withdrawal by Subject|2|||
125667407|NCT03063632|452070134|FG000|Overall Study|Physician Decision|2|||
125330197|NCT04032093|450841164|FG006|Overall Study|Withdrawal by Subject|0|||
125330198|NCT04032093|450841165|FG007|Overall Study|Withdrawal by Subject|0|||
125330199|NCT04032093|450841166|FG008|Overall Study|Withdrawal by Subject|0|||
125330200|NCT04032093|450841167|FG009|Overall Study|Withdrawal by Subject|0|||
125330201|NCT04032093|450841158|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125330202|NCT04032093|450841159|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125330203|NCT04032093|450841160|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125330204|NCT04032093|450841161|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125330205|NCT04032093|450841162|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125330206|NCT04032093|450841163|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
125330207|NCT04032093|450841164|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
125330208|NCT04032093|450841165|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
125330209|NCT04032093|450841166|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
125330210|NCT04032093|450841167|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
125330211|NCT04032093|450841158|FG000|Overall Study|Adverse Event|0|||
125330212|NCT04032093|450841159|FG001|Overall Study|Adverse Event|0|||
125330213|NCT04032093|450841160|FG002|Overall Study|Adverse Event|0|||
125330214|NCT04032093|450841161|FG003|Overall Study|Adverse Event|0|||
125330215|NCT04032093|450841162|FG004|Overall Study|Adverse Event|0|||
125330216|NCT04032093|450841163|FG005|Overall Study|Adverse Event|0|||
125330217|NCT04032093|450841164|FG006|Overall Study|Adverse Event|0|||
125330218|NCT04032093|450841165|FG007|Overall Study|Adverse Event|0|||
125330219|NCT04032093|450841166|FG008|Overall Study|Adverse Event|0|||
125330220|NCT04032093|450841167|FG009|Overall Study|Adverse Event|1|||
125330221|NCT04032093|450841158|FG000|Overall Study|Physician Decision|0|||
125330222|NCT04032093|450841159|FG001|Overall Study|Physician Decision|0|||
125330223|NCT04032093|450841160|FG002|Overall Study|Physician Decision|0|||
125330224|NCT04032093|450841161|FG003|Overall Study|Physician Decision|0|||
125330225|NCT04032093|450841162|FG004|Overall Study|Physician Decision|0|||
125330226|NCT04032093|450841163|FG005|Overall Study|Physician Decision|1|||
125330227|NCT04032093|450841164|FG006|Overall Study|Physician Decision|0|||
125330228|NCT04032093|450841165|FG007|Overall Study|Physician Decision|0|||
125330229|NCT04032093|450841166|FG008|Overall Study|Physician Decision|0|||
125330230|NCT04032093|450841167|FG009|Overall Study|Physician Decision|0|||
125330231|NCT01457703|450841172|FG000|Overall Study|Screen Failure|5|||
125330232|NCT01457703|450841173|FG001|Overall Study|Screen Failure|7|||
125330233|NCT01457703|450841172|FG000|Overall Study|Withdrawal by Subject|1|||
125330234|NCT01457703|450841173|FG001|Overall Study|Withdrawal by Subject|4|||
125330235|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
125330236|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
125330237|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
125330238|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
125330239|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
125667408|NCT03063632|452070135|FG001|Overall Study|Physician Decision|0|||
125667409|NCT03063632|452070134|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
125667410|NCT03063632|452070135|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
125330240|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
125330241|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
125330242|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
125667411|NCT02741271|452070138|FG000|Overall Study|Lost to Follow-up|2|||
125667412|NCT02741271|452070139|FG001|Overall Study|Lost to Follow-up|0|||
125667413|NCT02741271|452070138|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125667414|NCT02741271|452070139|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
125667415|NCT01612156|452070140|FG000|Overall Study|Protocol Violation|2|||
125667416|NCT01612156|452070141|FG001|Overall Study|Protocol Violation|0|||
125667417|NCT02570165|452070142|FG000|Overall Study|Adverse Event|1|||
125667418|NCT02570165|452070143|FG001|Overall Study|Adverse Event|0|||
125667419|NCT02570165|452070144|FG002|Overall Study|Adverse Event|2|||
125667420|NCT02570165|452070145|FG003|Overall Study|Adverse Event|0|||
125667421|NCT02570165|452070146|FG004|Overall Study|Adverse Event|0|||
125667422|NCT02570165|452070147|FG005|Overall Study|Adverse Event|0|||
125667423|NCT02570165|452070148|FG006|Overall Study|Adverse Event|0|||
125667424|NCT02570165|452070142|FG000|Overall Study|Lack of Efficacy|0|||
125667425|NCT02570165|452070143|FG001|Overall Study|Lack of Efficacy|1|||
125667426|NCT02570165|452070144|FG002|Overall Study|Lack of Efficacy|0|||
125667427|NCT02570165|452070145|FG003|Overall Study|Lack of Efficacy|0|||
125667428|NCT02570165|452070146|FG004|Overall Study|Lack of Efficacy|4|||
125667429|NCT02570165|452070147|FG005|Overall Study|Lack of Efficacy|0|||
125667430|NCT02570165|452070148|FG006|Overall Study|Lack of Efficacy|0|||
125667431|NCT02570165|452070142|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
125667432|NCT02570165|452070143|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
125667433|NCT02570165|452070144|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
125667434|NCT02570165|452070145|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
125667435|NCT02570165|452070146|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
125667436|NCT02570165|452070147|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
125667437|NCT02570165|452070148|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
125667438|NCT02570165|452070142|FG000|Overall Study|Lost to Follow-up|0|||
125667439|NCT02570165|452070143|FG001|Overall Study|Lost to Follow-up|0|||
125667440|NCT02570165|452070144|FG002|Overall Study|Lost to Follow-up|1|||
125667441|NCT02570165|452070145|FG003|Overall Study|Lost to Follow-up|1|||
125667442|NCT02570165|452070146|FG004|Overall Study|Lost to Follow-up|0|||
125667443|NCT02570165|452070147|FG005|Overall Study|Lost to Follow-up|0|||
125667444|NCT02570165|452070148|FG006|Overall Study|Lost to Follow-up|0|||
125667445|NCT02570165|452070142|FG000|Overall Study|Physician Decision|0|||
125667446|NCT02570165|452070143|FG001|Overall Study|Physician Decision|1|||
125667447|NCT02570165|452070144|FG002|Overall Study|Physician Decision|0|||
125667448|NCT02570165|452070145|FG003|Overall Study|Physician Decision|0|||
125667449|NCT02570165|452070146|FG004|Overall Study|Physician Decision|0|||
125667450|NCT02570165|452070147|FG005|Overall Study|Physician Decision|0|||
125667451|NCT02570165|452070148|FG006|Overall Study|Physician Decision|0|||
125667452|NCT02570165|452070142|FG000|Overall Study|Withdrawal by Subject|0|||
125667453|NCT02570165|452070143|FG001|Overall Study|Withdrawal by Subject|0|||
125667454|NCT02570165|452070144|FG002|Overall Study|Withdrawal by Subject|0|||
125667455|NCT02570165|452070145|FG003|Overall Study|Withdrawal by Subject|2|||
125667456|NCT02570165|452070146|FG004|Overall Study|Withdrawal by Subject|1|||
125667457|NCT02570165|452070147|FG005|Overall Study|Withdrawal by Subject|0|||
125667458|NCT02570165|452070148|FG006|Overall Study|Withdrawal by Subject|0|||
125667459|NCT02570165|452070142|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
125667460|NCT02570165|452070143|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
125667461|NCT02570165|452070144|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
125667462|NCT02570165|452070145|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
125667463|NCT02570165|452070146|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
125667464|NCT02570165|452070147|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
125667465|NCT02570165|452070148|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
125667466|NCT02570165|452070142|FG000|Overall Study|Withdrawal Request by GSK|0|||
125667467|NCT02570165|452070143|FG001|Overall Study|Withdrawal Request by GSK|0|||
125667468|NCT02570165|452070144|FG002|Overall Study|Withdrawal Request by GSK|2|||
125667469|NCT02570165|452070145|FG003|Overall Study|Withdrawal Request by GSK|0|||
125667470|NCT02570165|452070146|FG004|Overall Study|Withdrawal Request by GSK|0|||
125667471|NCT02570165|452070147|FG005|Overall Study|Withdrawal Request by GSK|0|||
125667472|NCT02570165|452070148|FG006|Overall Study|Withdrawal Request by GSK|0|||
125667473|NCT01430104|452070149|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
125330243|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
125330244|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
125667474|NCT02868281|452070150|FG000|Overall Study|Adverse Event|2|||
125667475|NCT02868281|452070151|FG001|Overall Study|Adverse Event|2|||
125667476|NCT02868281|452070150|FG000|Overall Study|Protocol Violation|13|||
125330245|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
125667477|NCT02868281|452070151|FG001|Overall Study|Protocol Violation|10|||
125667478|NCT02868281|452070150|FG000|Overall Study|Lost to Follow-up|3|||
125667479|NCT02868281|452070151|FG001|Overall Study|Lost to Follow-up|6|||
125667480|NCT02868281|452070150|FG000|Overall Study|Withdrawal by Subject|11|||
125667481|NCT02868281|452070151|FG001|Overall Study|Withdrawal by Subject|15|||
125667482|NCT02868281|452070150|FG000|Overall Study|Physician Decision|2|||
125667483|NCT02868281|452070151|FG001|Overall Study|Physician Decision|0|||
125667484|NCT02868281|452070150|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
125667485|NCT02868281|452070151|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
125667486|NCT02868281|452070150|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
125667487|NCT02868281|452070151|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
125667488|NCT02868281|452070150|FG000|Overall Study|Long journey/moving away|1|||
125667489|NCT02868281|452070151|FG001|Overall Study|Long journey/moving away|1|||
125667490|NCT05478603|452070157|FG000|Overall Study|Withdrawal by Subject|0|||
125667491|NCT05478603|452070158|FG001|Overall Study|Withdrawal by Subject|1|||
125667492|NCT05478603|452070159|FG002|Overall Study|Withdrawal by Subject|0|||
125667493|NCT05478603|452070160|FG003|Overall Study|Withdrawal by Subject|0|||
125667494|NCT02472977|452070161|FG000|Overall Study|Disease progression|4|||
125667495|NCT02472977|452070162|FG001|Overall Study|Disease progression|25|||
125667496|NCT02472977|452070163|FG002|Overall Study|Disease progression|6|||
125667497|NCT02472977|452070161|FG000|Overall Study|Withdrawal by Subject|0|||
125667498|NCT02472977|452070162|FG001|Overall Study|Withdrawal by Subject|1|||
125667499|NCT02472977|452070163|FG002|Overall Study|Withdrawal by Subject|0|||
125667500|NCT02472977|452070161|FG000|Overall Study|Study drug toxicity|2|||
125667501|NCT02472977|452070162|FG001|Overall Study|Study drug toxicity|0|||
125667502|NCT02472977|452070163|FG002|Overall Study|Study drug toxicity|2|||
125667503|NCT02472977|452070161|FG000|Overall Study|Subject request to discontinue treatment|0|||
125667504|NCT02472977|452070162|FG001|Overall Study|Subject request to discontinue treatment|1|||
125667505|NCT02472977|452070163|FG002|Overall Study|Subject request to discontinue treatment|0|||
125667506|NCT03182686|452070164|FG000|Overall Study|Lost to Follow-up|2|||
125667507|NCT03182686|452070165|FG001|Overall Study|Lost to Follow-up|0|||
125667508|NCT03182686|452070164|FG000|Overall Study|Adverse Event|2|||
125667509|NCT03182686|452070165|FG001|Overall Study|Adverse Event|0|||
125667510|NCT03182686|452070164|FG000|Overall Study|Withdrawal by Subject|3|||
125667511|NCT03182686|452070165|FG001|Overall Study|Withdrawal by Subject|0|||
125667512|NCT02390219|452070168|FG000|Overall Study|Death|1|||
125667513|NCT02390219|452070168|FG000|Overall Study|Physician Decision|1|||
125667514|NCT02390219|452070168|FG000|Overall Study|Adverse Event|6|||
125667515|NCT02390219|452070168|FG000|Overall Study|Withdrawal by Subject|1|||
125667516|NCT02390219|452070168|FG000|Overall Study|Lost to Follow-up|2|||
125667517|NCT02390219|452070168|FG000|Overall Study|Other|2|||
125667518|NCT01025193|452070169|FG000|Overall Study|Protocol Violation|1|||
125667519|NCT01025193|452070169|FG000|Overall Study|Adverse Event|3|||
125667520|NCT02378506|452070170|FG000|Overall Study|Lack of Efficacy|3|||
125667521|NCT02378506|452070170|FG000|Overall Study|Withdrawal by Subject|4|||
125667522|NCT02378506|452070170|FG000|Overall Study|Protocol Violation|2|||
125667523|NCT02378506|452070170|FG000|Overall Study|Death|1|||
125667524|NCT02378506|452070170|FG000|Overall Study|Adverse Event|14|||
125667525|NCT02378506|452070170|FG000|Overall Study|Randomized But Not Treated|1|||
125667526|NCT00185211|452070171|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
125667527|NCT00185211|452070172|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
125667528|NCT00185211|452070171|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
125667529|NCT00185211|452070172|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
125667530|NCT00185211|452070171|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
125667531|NCT00185211|452070172|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
125667532|NCT00185211|452070171|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
125667533|NCT00185211|452070172|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
125667534|NCT00185211|452070171|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
125667535|NCT00185211|452070172|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
125667536|NCT00185211|452070171|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
125667537|NCT00185211|452070172|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
125667538|NCT00185211|452070171|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
125667539|NCT00185211|452070172|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
125330246|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
125330247|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
125330248|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
125667540|NCT00185211|452070171|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
125667541|NCT00185211|452070172|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
125667542|NCT00185211|452070171|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
125667543|NCT00185211|452070172|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
125667544|NCT00185211|452070171|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
125667545|NCT00185211|452070172|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
125667546|NCT00185211|452070171|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
125667547|NCT00185211|452070172|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
125667548|NCT00185211|452070171|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
125667549|NCT00185211|452070172|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
125667550|NCT01606137|452070173|FG000|Overall Study|Adverse Event|85|||
125667551|NCT01606137|452070173|FG000|Overall Study|Withdrawal by Subject|74|||
125667552|NCT01606137|452070173|FG000|Overall Study|Lack of Efficacy|56|||
125667553|NCT01606137|452070173|FG000|Overall Study|Lost to Follow-up|15|||
125667554|NCT01606137|452070173|FG000|Overall Study|Protocol Violation|1|||
125667555|NCT01606137|452070173|FG000|Overall Study|Patient non-compliance|9|||
125667556|NCT01606137|452070173|FG000|Overall Study|Death|1|||
125667557|NCT01606137|452070173|FG000|Overall Study|Decreased/no pain|4|||
125667558|NCT01606137|452070173|FG000|Overall Study|Issues with driving|4|||
125667559|NCT01606137|452070173|FG000|Overall Study|multiple sclerosis less stable|1|||
125667560|NCT01606137|452070173|FG000|Overall Study|Increased bilirubin|1|||
125667561|NCT01606137|452070173|FG000|Overall Study|Spray causes nausea|1|||
125667562|NCT01606137|452070173|FG000|Overall Study|Not enough improvement|4|||
125667563|NCT01606137|452070173|FG000|Overall Study|Wanted to try another treatment|1|||
125667564|NCT01606137|452070173|FG000|Overall Study|Patient leaving country|1|||
125667565|NCT01606137|452070173|FG000|Overall Study|Personal reasons|1|||
125667566|NCT01606137|452070173|FG000|Overall Study|Unable to tolerate study med. taste|1|||
125330249|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
125330250|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
125330251|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
125330252|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
125330253|NCT02952820|450841174|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
125330254|NCT02952820|450841175|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
125330255|NCT02952820|450841176|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
125330256|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
125330257|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
125330258|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
125330259|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
125330260|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
125330261|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
125330262|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
125330263|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
125330264|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
125330265|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
125667567|NCT01606137|452070173|FG000|Overall Study|Patient moving|1|||
125330266|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
125330267|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
125330268|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
125330269|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
125330270|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
125330271|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
125330272|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
125330273|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
125330274|NCT02952820|450841174|FG000|Active Treatment Period (6 Months)|Not treated|0|||
125330275|NCT02952820|450841175|FG001|Active Treatment Period (6 Months)|Not treated|0|||
125330276|NCT02952820|450841176|FG002|Active Treatment Period (6 Months)|Not treated|1|||
125330277|NCT04139018|450841177|FG000|Overall Study|Screen fail|1|||
125330278|NCT04139018|450841178|FG001|Overall Study|Screen fail|0|||
125667568|NCT01606137|452070173|FG000|Overall Study|Unable to collect consistent data|1|||
125667569|NCT02266706|452071944|FG000|Overall Study|Withdrawal by Subject|0|||
125667570|NCT02266706|452071945|FG001|Overall Study|Withdrawal by Subject|1|||
125667571|NCT02266706|452071946|FG002|Overall Study|Withdrawal by Subject|1|||
125667572|NCT02266706|452071947|FG003|Overall Study|Withdrawal by Subject|0|||
125667573|NCT02266706|452071948|FG004|Overall Study|Withdrawal by Subject|0|||
125667574|NCT02266706|452071949|FG005|Overall Study|Withdrawal by Subject|1|||
125667575|NCT02266706|452071950|FG006|Overall Study|Withdrawal by Subject|0|||
125667576|NCT02266706|452071951|FG007|Overall Study|Withdrawal by Subject|0|||
125667577|NCT02266706|452071952|FG008|Overall Study|Withdrawal by Subject|0|||
125667578|NCT02266706|452071944|FG000|Overall Study|Screen failure|0|||
125667579|NCT02266706|452071945|FG001|Overall Study|Screen failure|0|||
125667580|NCT02266706|452071946|FG002|Overall Study|Screen failure|0|||
125667581|NCT02266706|452071947|FG003|Overall Study|Screen failure|0|||
125667582|NCT02266706|452071948|FG004|Overall Study|Screen failure|0|||
125330279|NCT04139018|450841177|FG000|Overall Study|Withdrawal by Subject|2|||
125330280|NCT04139018|450841178|FG001|Overall Study|Withdrawal by Subject|0|||
125667583|NCT02266706|452071949|FG005|Overall Study|Screen failure|1|||
125667584|NCT02266706|452071950|FG006|Overall Study|Screen failure|1|||
125330281|NCT04139018|450841177|FG000|Overall Study|Lost to Follow-up|0|||
125667585|NCT02266706|452071951|FG007|Overall Study|Screen failure|0|||
125667586|NCT02266706|452071952|FG008|Overall Study|Screen failure|0|||
125667587|NCT02266706|452071944|FG000|Overall Study|Enrollment in another study|0|||
125667588|NCT02266706|452071945|FG001|Overall Study|Enrollment in another study|0|||
125667589|NCT02266706|452071946|FG002|Overall Study|Enrollment in another study|0|||
125667590|NCT02266706|452071947|FG003|Overall Study|Enrollment in another study|1|||
125667591|NCT02266706|452071948|FG004|Overall Study|Enrollment in another study|0|||
125330282|NCT04139018|450841178|FG001|Overall Study|Lost to Follow-up|1|||
125330283|NCT03486834|450841179|FG000|Overall Study|Withdrawal by Subject|46|||
125330284|NCT03486834|450841180|FG001|Overall Study|Withdrawal by Subject|46|||
125330285|NCT03486834|450841181|FG002|Overall Study|Withdrawal by Subject|52|||
125330286|NCT03486834|450841179|FG000|Overall Study|Adverse Event|8|||
125330287|NCT03486834|450841180|FG001|Overall Study|Adverse Event|7|||
125330288|NCT03486834|450841181|FG002|Overall Study|Adverse Event|0|||
125330289|NCT03486834|450841179|FG000|Overall Study|Lost to Follow-up|41|||
125330290|NCT03486834|450841180|FG001|Overall Study|Lost to Follow-up|24|||
125330291|NCT03486834|450841181|FG002|Overall Study|Lost to Follow-up|39|||
125330292|NCT03486834|450841179|FG000|Overall Study|Non-compliance with Study Drug|2|||
125330293|NCT03486834|450841180|FG001|Overall Study|Non-compliance with Study Drug|2|||
125330294|NCT03486834|450841181|FG002|Overall Study|Non-compliance with Study Drug|0|||
125330295|NCT03486834|450841179|FG000|Overall Study|Physician Decision|5|||
125330296|NCT03486834|450841180|FG001|Overall Study|Physician Decision|2|||
125330297|NCT03486834|450841181|FG002|Overall Study|Physician Decision|3|||
125330298|NCT03486834|450841179|FG000|Overall Study|Pregnancy|10|||
125330299|NCT03486834|450841180|FG001|Overall Study|Pregnancy|12|||
125330300|NCT03486834|450841181|FG002|Overall Study|Pregnancy|12|||
125330301|NCT03486834|450841179|FG000|Overall Study|Protocol Deviation|2|||
125330302|NCT03486834|450841180|FG001|Overall Study|Protocol Deviation|3|||
125330303|NCT03486834|450841181|FG002|Overall Study|Protocol Deviation|3|||
125330304|NCT03486834|450841179|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125330305|NCT03486834|450841180|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
125330306|NCT03486834|450841181|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
125330307|NCT03486834|450841179|FG000|Overall Study|Randomized but not treated|4|||
125330308|NCT03486834|450841180|FG001|Overall Study|Randomized but not treated|4|||
125330309|NCT03486834|450841181|FG002|Overall Study|Randomized but not treated|1|||
125330310|NCT02745119|450841200|FG000|Overall Study|Adverse Event|1|||
125330311|NCT02745119|450841201|FG001|Overall Study|Adverse Event|0|||
125330312|NCT02745119|450841202|FG002|Overall Study|Adverse Event|1|||
125330313|NCT02745119|450841203|FG003|Overall Study|Adverse Event|3|||
125330314|NCT02745119|450841200|FG000|Overall Study|Death|3|||
125330315|NCT02745119|450841201|FG001|Overall Study|Death|3|||
125330316|NCT02745119|450841202|FG002|Overall Study|Death|0|||
125330317|NCT02745119|450841203|FG003|Overall Study|Death|4|||
125330318|NCT02745119|450841200|FG000|Overall Study|Lost to Follow-up|0|||
125330319|NCT02745119|450841201|FG001|Overall Study|Lost to Follow-up|0|||
125330320|NCT02745119|450841202|FG002|Overall Study|Lost to Follow-up|0|||
125330321|NCT02745119|450841203|FG003|Overall Study|Lost to Follow-up|1|||
125330322|NCT02745119|450841200|FG000|Overall Study|Protocol Deviation|0|||
125330323|NCT02745119|450841201|FG001|Overall Study|Protocol Deviation|0|||
125330324|NCT02745119|450841202|FG002|Overall Study|Protocol Deviation|0|||
125330325|NCT02745119|450841203|FG003|Overall Study|Protocol Deviation|1|||
125330326|NCT02745119|450841200|FG000|Overall Study|Withdrawal by Subject|7|||
125330327|NCT02745119|450841201|FG001|Overall Study|Withdrawal by Subject|15|||
125330328|NCT02745119|450841202|FG002|Overall Study|Withdrawal by Subject|8|||
125330329|NCT02745119|450841203|FG003|Overall Study|Withdrawal by Subject|14|||
125330330|NCT02745119|450841200|FG000|Overall Study|Study Terminated by Sponsor|134|||
125330331|NCT02745119|450841201|FG001|Overall Study|Study Terminated by Sponsor|252|||
125330332|NCT02745119|450841202|FG002|Overall Study|Study Terminated by Sponsor|135|||
125330333|NCT02745119|450841203|FG003|Overall Study|Study Terminated by Sponsor|251|||
125330334|NCT02745119|450841200|FG000|Overall Study|Physician Decision|0|||
125330335|NCT02745119|450841201|FG001|Overall Study|Physician Decision|2|||
125330336|NCT02745119|450841202|FG002|Overall Study|Physician Decision|2|||
125667592|NCT02266706|452071949|FG005|Overall Study|Enrollment in another study|0|||
125667593|NCT02266706|452071950|FG006|Overall Study|Enrollment in another study|0|||
125667594|NCT02266706|452071951|FG007|Overall Study|Enrollment in another study|0|||
125667595|NCT02266706|452071952|FG008|Overall Study|Enrollment in another study|0|||
125667596|NCT02544633|452071953|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
125667597|NCT02544633|452071954|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
125667598|NCT02544633|452071955|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
125667599|NCT02544633|452071956|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
125667600|NCT02544633|452071953|FG000|Treatment Period|Adverse Event|7|||
125667601|NCT02544633|452071954|FG001|Treatment Period|Adverse Event|4|||
125330337|NCT02745119|450841203|FG003|Overall Study|Physician Decision|2|||
125667602|NCT02544633|452071955|FG002|Treatment Period|Adverse Event|0|||
125330338|NCT02745119|450841200|FG000|Overall Study|Reason Not Specified|0|||
125330339|NCT02745119|450841201|FG001|Overall Study|Reason Not Specified|2|||
125330340|NCT02745119|450841202|FG002|Overall Study|Reason Not Specified|0|||
125330341|NCT02745119|450841203|FG003|Overall Study|Reason Not Specified|1|||
125330342|NCT01587924|450841204|FG000|Overall Study|Adverse Event|0|||
125330343|NCT01587924|450841205|FG001|Overall Study|Adverse Event|2|||
125330344|NCT01587924|450841206|FG002|Overall Study|Adverse Event|0|||
125330345|NCT01587924|450841207|FG003|Overall Study|Adverse Event|0|||
125330346|NCT01587924|450841204|FG000|Overall Study|Protocol Violation|2|||
125330347|NCT01587924|450841205|FG001|Overall Study|Protocol Violation|1|||
125667603|NCT02544633|452071956|FG003|Treatment Period|Adverse Event|5|||
125330348|NCT01587924|450841206|FG002|Overall Study|Protocol Violation|2|||
125330349|NCT01587924|450841207|FG003|Overall Study|Protocol Violation|1|||
125330350|NCT01587924|450841204|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
125330351|NCT01587924|450841205|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
125330352|NCT01587924|450841206|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
125330353|NCT01587924|450841207|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
125330354|NCT01587924|450841204|FG000|Overall Study|Withdrawal by Subject|0|||
125330355|NCT01587924|450841205|FG001|Overall Study|Withdrawal by Subject|1|||
125330356|NCT01587924|450841206|FG002|Overall Study|Withdrawal by Subject|1|||
125330357|NCT01587924|450841207|FG003|Overall Study|Withdrawal by Subject|0|||
125330358|NCT00432172|450841208|FG000|Overall Study|Physician Decision|0|||
125330359|NCT00432172|450841209|FG001|Overall Study|Physician Decision|0|||
125330360|NCT00432172|450841210|FG002|Overall Study|Physician Decision|2|||
125330361|NCT00432172|450841211|FG003|Overall Study|Physician Decision|0|||
125330362|NCT00432172|450841208|FG000|Overall Study|Adverse Event|4|||
125330363|NCT00432172|450841209|FG001|Overall Study|Adverse Event|2|||
125330364|NCT00432172|450841210|FG002|Overall Study|Adverse Event|4|||
125330365|NCT00432172|450841211|FG003|Overall Study|Adverse Event|3|||
125330366|NCT00432172|450841208|FG000|Overall Study|Disease progression|0|||
125330367|NCT00432172|450841209|FG001|Overall Study|Disease progression|2|||
125667604|NCT02544633|452071953|FG000|Treatment Period|Lack of Efficacy|17|||
125667605|NCT02544633|452071954|FG001|Treatment Period|Lack of Efficacy|11|||
125667606|NCT02544633|452071955|FG002|Treatment Period|Lack of Efficacy|5|||
125667607|NCT02544633|452071956|FG003|Treatment Period|Lack of Efficacy|5|||
125667608|NCT02544633|452071953|FG000|Treatment Period|Global Deterioration of Health|3|||
125667609|NCT02544633|452071954|FG001|Treatment Period|Global Deterioration of Health|3|||
125667610|NCT02544633|452071955|FG002|Treatment Period|Global Deterioration of Health|0|||
125667611|NCT02544633|452071956|FG003|Treatment Period|Global Deterioration of Health|1|||
125667612|NCT02544633|452071953|FG000|Treatment Period|Withdrawal by Subject|1|||
125667613|NCT02544633|452071954|FG001|Treatment Period|Withdrawal by Subject|0|||
125667614|NCT02544633|452071955|FG002|Treatment Period|Withdrawal by Subject|0|||
125667615|NCT02544633|452071956|FG003|Treatment Period|Withdrawal by Subject|0|||
125667616|NCT02544633|452071953|FG000|Treatment Period|Lost to Follow-up|0|||
125667617|NCT02544633|452071954|FG001|Treatment Period|Lost to Follow-up|1|||
125667618|NCT02544633|452071955|FG002|Treatment Period|Lost to Follow-up|0|||
125667619|NCT02544633|452071956|FG003|Treatment Period|Lost to Follow-up|0|||
125667620|NCT02544633|452071953|FG000|Treatment Period|Death|0|||
125667621|NCT02544633|452071954|FG001|Treatment Period|Death|0|||
125667622|NCT02544633|452071955|FG002|Treatment Period|Death|1|||
125667623|NCT02544633|452071956|FG003|Treatment Period|Death|0|||
125667624|NCT02544633|452071953|FG000|Treatment Period|Non-compliance|0|||
125667625|NCT02544633|452071954|FG001|Treatment Period|Non-compliance|0|||
125667626|NCT02544633|452071955|FG002|Treatment Period|Non-compliance|1|||
125667627|NCT02544633|452071956|FG003|Treatment Period|Non-compliance|0|||
125667628|NCT02544633|452071953|FG000|Treatment Period|Clinical Disease Progression|0|||
125667629|NCT02544633|452071954|FG001|Treatment Period|Clinical Disease Progression|0|||
125667630|NCT02544633|452071955|FG002|Treatment Period|Clinical Disease Progression|0|||
125667631|NCT02544633|452071956|FG003|Treatment Period|Clinical Disease Progression|1|||
125667632|NCT02544633|452071953|FG000|Survival Follow-up Period|Death|12|||
125667633|NCT02544633|452071954|FG001|Survival Follow-up Period|Death|14|||
125667634|NCT02544633|452071955|FG002|Survival Follow-up Period|Death|3|||
125667635|NCT02544633|452071956|FG003|Survival Follow-up Period|Death|9|||
125667636|NCT02544633|452071953|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
125667637|NCT02544633|452071954|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
125667638|NCT02544633|452071955|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
125667639|NCT02544633|452071956|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
125667640|NCT02544633|452071953|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
125667641|NCT02544633|452071954|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
125667642|NCT02544633|452071955|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
125667643|NCT02544633|452071956|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
125667644|NCT02544633|452071953|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
125667645|NCT02544633|452071954|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
125667646|NCT02544633|452071955|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
125667647|NCT02544633|452071956|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
125667648|NCT01977352|452071957|FG000|Overall Study|Lost to Follow-up|1|||
125667649|NCT01977352|452071958|FG001|Overall Study|Lost to Follow-up|2|||
125667650|NCT02257632|452071962|FG000|Overall Study|Withdrawal by Subject|0|||
125667651|NCT02257632|452071963|FG001|Overall Study|Withdrawal by Subject|1|||
125667652|NCT02257632|452071962|FG000|Overall Study|Adverse Event|1|||
125667653|NCT02257632|452071963|FG001|Overall Study|Adverse Event|2|||
125667654|NCT01059071|452071964|FG000|Overall Study|Lack of Efficacy|1|||
125667655|NCT01059071|452071965|FG001|Overall Study|Lack of Efficacy|4|||
125330368|NCT00432172|450841210|FG002|Overall Study|Disease progression|5|||
125330369|NCT00432172|450841211|FG003|Overall Study|Disease progression|1|||
125330370|NCT00432172|450841208|FG000|Overall Study|Withdrawal by Subject|0|||
125330371|NCT00432172|450841209|FG001|Overall Study|Withdrawal by Subject|1|||
125667656|NCT01059071|452071966|FG002|Overall Study|Lack of Efficacy|2|||
125330372|NCT00432172|450841210|FG002|Overall Study|Withdrawal by Subject|0|||
125330373|NCT00432172|450841211|FG003|Overall Study|Withdrawal by Subject|2|||
125330374|NCT00432172|450841208|FG000|Overall Study|No treatment received|2|||
125330375|NCT00432172|450841209|FG001|Overall Study|No treatment received|2|||
125330376|NCT00432172|450841210|FG002|Overall Study|No treatment received|0|||
125330377|NCT00432172|450841211|FG003|Overall Study|No treatment received|1|||
125330378|NCT01106248|450841213|FG000|Overall Study|Adverse Event|1|||
125330379|NCT01106248|450841213|FG000|Overall Study|Administrative|2|||
125667657|NCT01059071|452071967|FG003|Overall Study|Lack of Efficacy|3|||
125667658|NCT01059071|452071964|FG000|Overall Study|Withdrawal by Subject|1|||
125667659|NCT01059071|452071965|FG001|Overall Study|Withdrawal by Subject|0|||
125667660|NCT01059071|452071966|FG002|Overall Study|Withdrawal by Subject|0|||
125667661|NCT01059071|452071967|FG003|Overall Study|Withdrawal by Subject|2|||
125667662|NCT01059071|452071964|FG000|Overall Study|Physician Decision|0|||
125667663|NCT01059071|452071965|FG001|Overall Study|Physician Decision|0|||
125667664|NCT01059071|452071966|FG002|Overall Study|Physician Decision|0|||
125667665|NCT01059071|452071967|FG003|Overall Study|Physician Decision|1|||
125667666|NCT03763331|452071968|FG000|Overall Study|Lost to Follow-up|1|||
125667667|NCT03763331|452071969|FG001|Overall Study|Lost to Follow-up|0|||
125667668|NCT03763331|452071968|FG000|Overall Study|Withdrawal by Subject|1|||
125667669|NCT03763331|452071969|FG001|Overall Study|Withdrawal by Subject|0|||
125667670|NCT03763331|452071968|FG000|Overall Study|Non-compliance|0|||
125667671|NCT03763331|452071969|FG001|Overall Study|Non-compliance|3|||
125667672|NCT00936884|452071970|FG000|Double-blind|Withdrawal by Subject|6|||
125667673|NCT00936884|452071971|FG001|Double-blind|Withdrawal by Subject|4|||
125667674|NCT00936884|452071972|FG002|Double-blind|Withdrawal by Subject|0|||
125667675|NCT00936884|452071970|FG000|Double-blind|Death|2|||
125667676|NCT00936884|452071971|FG001|Double-blind|Death|1|||
125667677|NCT00936884|452071972|FG002|Double-blind|Death|0|||
125667678|NCT00936884|452071970|FG000|Double-blind|Lack of Efficacy|1|||
125667679|NCT00936884|452071971|FG001|Double-blind|Lack of Efficacy|1|||
125667680|NCT00936884|452071972|FG002|Double-blind|Lack of Efficacy|0|||
125667681|NCT00936884|452071970|FG000|Double-blind|Adverse Event|1|||
125667682|NCT00936884|452071971|FG001|Double-blind|Adverse Event|0|||
125667683|NCT00936884|452071972|FG002|Double-blind|Adverse Event|0|||
125667684|NCT00936884|452071970|FG000|Double-blind|Physician Decision|1|||
125667685|NCT00936884|452071971|FG001|Double-blind|Physician Decision|0|||
125667686|NCT00936884|452071972|FG002|Double-blind|Physician Decision|0|||
125667687|NCT00936884|452071970|FG000|Double-blind|No post baseline diary entry|1|||
125667688|NCT00936884|452071971|FG001|Double-blind|No post baseline diary entry|0|||
125667689|NCT00936884|452071972|FG002|Double-blind|No post baseline diary entry|0|||
125667690|NCT00936884|452071970|FG000|Double-blind|Did not receive study drug|0|||
125667691|NCT00936884|452071971|FG001|Double-blind|Did not receive study drug|1|||
125667692|NCT00936884|452071972|FG002|Double-blind|Did not receive study drug|0|||
125667693|NCT04741503|452071973|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
125667694|NCT04741503|452071974|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
125667695|NCT04741503|452071975|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
125667696|NCT04741503|452071973|FG000|Initial Enrollment|Overquotas removed|0|||
125667697|NCT04741503|452071974|FG001|Initial Enrollment|Overquotas removed|0|||
125667698|NCT04741503|452071975|FG002|Initial Enrollment|Overquotas removed|186|||
125667699|NCT04741503|452071973|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
125667700|NCT04741503|452071974|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
125667701|NCT04741503|452071975|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
125667702|NCT02280421|452071976|FG000|Washout (2 Weeks)|Adverse Event|0|||
125667703|NCT02280421|452071977|FG001|Washout (2 Weeks)|Adverse Event|1|||
125667704|NCT02280421|452071976|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
125667705|NCT02280421|452071977|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
125667706|NCT01859390|452071978|FG000|Overall Study|Insufficient Sputum Collected|1|||
125330380|NCT00357903|450841214|FG000|Overall Study|Adverse Event|87|||
125330381|NCT00357903|450841215|FG001|Overall Study|Adverse Event|4|||
125667707|NCT01859390|452071979|FG001|Overall Study|Insufficient Sputum Collected|3|||
125667708|NCT01859390|452071978|FG000|Overall Study|Sample Missing Collection Date|0|||
125667709|NCT01859390|452071979|FG001|Overall Study|Sample Missing Collection Date|1|||
125667710|NCT01859390|452071978|FG000|Overall Study|Tube Cracked|0|||
125667711|NCT01859390|452071979|FG001|Overall Study|Tube Cracked|2|||
125667712|NCT01859390|452071978|FG000|Overall Study|Shipment Error|0|||
125667713|NCT01859390|452071979|FG001|Overall Study|Shipment Error|1|||
125667714|NCT02965820|452071993|FG000|Period 2, Second 30 Days|Adverse Event|1|||
125667715|NCT02965820|452071994|FG001|Period 2, Second 30 Days|Adverse Event|1|||
125667716|NCT01967888|452071995|FG000|Overall Study|Lost to Follow-up|6|||
125667717|NCT01967888|452071996|FG001|Overall Study|Lost to Follow-up|4|||
125330382|NCT00357903|450841214|FG000|Overall Study|Death|33|||
125330383|NCT00357903|450841215|FG001|Overall Study|Death|0|||
125330384|NCT00357903|450841214|FG000|Overall Study|Lost to Follow-up|23|||
125667718|NCT01967888|452071995|FG000|Overall Study|Withdrawal by Subject|1|||
125667719|NCT01967888|452071996|FG001|Overall Study|Withdrawal by Subject|1|||
125667720|NCT01967888|452071995|FG000|Overall Study|Did Not Have Transplant|1|||
125667721|NCT01967888|452071996|FG001|Overall Study|Did Not Have Transplant|0|||
125667722|NCT01967888|452071995|FG000|Overall Study|Research visit not done, data recorded|1|||
125667723|NCT01967888|452071996|FG001|Overall Study|Research visit not done, data recorded|0|||
125667724|NCT01967888|452071995|FG000|Overall Study|Subject excluded after randomization|1|||
125667725|NCT01967888|452071996|FG001|Overall Study|Subject excluded after randomization|0|||
125330385|NCT00357903|450841215|FG001|Overall Study|Lost to Follow-up|4|||
125330386|NCT00357903|450841214|FG000|Overall Study|Physician Decision|39|||
125330387|NCT00357903|450841215|FG001|Overall Study|Physician Decision|5|||
125330388|NCT00357903|450841214|FG000|Overall Study|Withdrawal by Subject|57|||
125330389|NCT00357903|450841215|FG001|Overall Study|Withdrawal by Subject|7|||
125330390|NCT00357903|450841214|FG000|Overall Study|Completed month 12 only|0|||
125330391|NCT00357903|450841215|FG001|Overall Study|Completed month 12 only|1|||
125330392|NCT00357903|450841214|FG000|Overall Study|Protocol issues|14|||
125330393|NCT00357903|450841215|FG001|Overall Study|Protocol issues|3|||
125330394|NCT00357903|450841214|FG000|Overall Study|Response status|61|||
125330395|NCT00357903|450841215|FG001|Overall Study|Response status|9|||
125330396|NCT00357903|450841214|FG000|Overall Study|Other|49|||
125330397|NCT00357903|450841215|FG001|Overall Study|Other|10|||
125330398|NCT00606593|450841216|FG000|Overall Study|Adverse Event|0|||
125330399|NCT00606593|450841217|FG001|Overall Study|Adverse Event|0|||
125330400|NCT00606593|450841218|FG002|Overall Study|Adverse Event|0|||
125330401|NCT00606593|450841219|FG003|Overall Study|Adverse Event|1|||
125330402|NCT00606593|450841220|FG004|Overall Study|Adverse Event|1|||
125330403|NCT00606593|450841221|FG005|Overall Study|Adverse Event|0|||
125330404|NCT00606593|450841222|FG006|Overall Study|Adverse Event|1|||
125330405|NCT00606593|450841223|FG007|Overall Study|Adverse Event|2|||
125330406|NCT00606593|450841224|FG008|Overall Study|Adverse Event|1|||
125330407|NCT00606593|450841225|FG009|Overall Study|Adverse Event|0|||
125330408|NCT00606593|450841216|FG000|Overall Study|Withdrawal of consent|1|||
125330409|NCT00606593|450841217|FG001|Overall Study|Withdrawal of consent|0|||
125330410|NCT00606593|450841218|FG002|Overall Study|Withdrawal of consent|1|||
125330411|NCT00606593|450841219|FG003|Overall Study|Withdrawal of consent|0|||
125330412|NCT00606593|450841220|FG004|Overall Study|Withdrawal of consent|0|||
125330413|NCT00606593|450841221|FG005|Overall Study|Withdrawal of consent|0|||
125330414|NCT00606593|450841222|FG006|Overall Study|Withdrawal of consent|0|||
125330415|NCT00606593|450841223|FG007|Overall Study|Withdrawal of consent|0|||
125330416|NCT00606593|450841224|FG008|Overall Study|Withdrawal of consent|0|||
125330417|NCT00606593|450841225|FG009|Overall Study|Withdrawal of consent|0|||
125330418|NCT00606593|450841216|FG000|Overall Study|Administrative/Other|0|||
125330419|NCT00606593|450841217|FG001|Overall Study|Administrative/Other|0|||
125330420|NCT00606593|450841218|FG002|Overall Study|Administrative/Other|1|||
125330421|NCT00606593|450841219|FG003|Overall Study|Administrative/Other|0|||
125330422|NCT00606593|450841220|FG004|Overall Study|Administrative/Other|0|||
125330423|NCT00606593|450841221|FG005|Overall Study|Administrative/Other|0|||
125330424|NCT00606593|450841222|FG006|Overall Study|Administrative/Other|0|||
125330425|NCT00606593|450841223|FG007|Overall Study|Administrative/Other|0|||
125330426|NCT00606593|450841224|FG008|Overall Study|Administrative/Other|0|||
125330427|NCT00606593|450841225|FG009|Overall Study|Administrative/Other|0|||
125330428|NCT03181529|450841228|FG000|Overall Study|Withdrawal by Subject|1|||
125330429|NCT03181529|450841229|FG001|Overall Study|Withdrawal by Subject|1|||
125330430|NCT03181529|450841228|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
125330431|NCT03181529|450841229|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
125330432|NCT06042855|450841236|FG000|Overall Study|No Receipt of Study Drug|48|||
125330433|NCT06042855|450841237|FG001|Overall Study|No Receipt of Study Drug|57|||
125330434|NCT06042855|450841236|FG000|Overall Study|Administratively Withdrawn|59|||
125667726|NCT01967888|452071995|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
125667727|NCT01967888|452071996|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
125667728|NCT01967888|452071995|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
125667729|NCT01967888|452071996|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
125667730|NCT00553540|452071999|FG000|Overall Study|discharged after first visit|2|||
125667731|NCT00553540|452072000|FG001|Overall Study|discharged after first visit|5|||
125667732|NCT02622074|452072001|FG000|Overall Study|Death|4|||
125667733|NCT02622074|452072002|FG001|Overall Study|Death|0|||
125667734|NCT02622074|452072003|FG002|Overall Study|Death|0|||
125667735|NCT02622074|452072004|FG003|Overall Study|Death|1|||
125667736|NCT02622074|452072005|FG004|Overall Study|Death|1|||
125330435|NCT06042855|450841237|FG001|Overall Study|Administratively Withdrawn|59|||
125330436|NCT03313037|450841238|FG000|Overall Study|Protocol Violation|4|||
125667737|NCT02622074|452072006|FG005|Overall Study|Death|0|||
125330437|NCT03313037|450841239|FG001|Overall Study|Protocol Violation|1|||
125667738|NCT02622074|452072001|FG000|Overall Study|Withdrawal by Subject|0|||
125667739|NCT02622074|452072002|FG001|Overall Study|Withdrawal by Subject|1|||
125330438|NCT03313037|450841238|FG000|Overall Study|Other|1|||
125330439|NCT03313037|450841239|FG001|Overall Study|Other|1|||
125330440|NCT03313037|450841238|FG000|Overall Study|Withdrawal by Subject|4|||
125330441|NCT03313037|450841239|FG001|Overall Study|Withdrawal by Subject|3|||
125330442|NCT03313037|450841238|FG000|Overall Study|No longer meets eligibility criteria|1|||
125330443|NCT03313037|450841239|FG001|Overall Study|No longer meets eligibility criteria|7|||
125330444|NCT03313037|450841238|FG000|Overall Study|Lost to Follow-up|9|||
125330445|NCT03313037|450841239|FG001|Overall Study|Lost to Follow-up|8|||
125330446|NCT03313037|450841238|FG000|Overall Study|Randomized but not treated|1|||
125330447|NCT03313037|450841239|FG001|Overall Study|Randomized but not treated|0|||
125330448|NCT00525161|450841246|FG000|Overall Study|Adverse Event|1|||
125330449|NCT02447003|450841247|FG000|Overall Study|Other|0|||
125330450|NCT02447003|450841248|FG001|Overall Study|Other|4|||
125330451|NCT02447003|450841247|FG000|Overall Study|Site discontinued|0|||
125330452|NCT02447003|450841248|FG001|Overall Study|Site discontinued|2|||
125330453|NCT02447003|450841247|FG000|Overall Study|Physician Decision|0|||
125330454|NCT02447003|450841248|FG001|Overall Study|Physician Decision|1|||
125330455|NCT02447003|450841247|FG000|Overall Study|Withdrawal by Subject|4|||
125330456|NCT02447003|450841248|FG001|Overall Study|Withdrawal by Subject|3|||
125330457|NCT02447003|450841247|FG000|Overall Study|Sponsor Decision|6|||
125330458|NCT02447003|450841248|FG001|Overall Study|Sponsor Decision|11|||
125330459|NCT02447003|450841247|FG000|Overall Study|Progressive Disease|1|||
125330460|NCT02447003|450841248|FG001|Overall Study|Progressive Disease|0|||
125330461|NCT02447003|450841247|FG000|Overall Study|Lost to Follow-up|5|||
125330462|NCT02447003|450841248|FG001|Overall Study|Lost to Follow-up|0|||
125330463|NCT02447003|450841247|FG000|Overall Study|Death|154|||
125330464|NCT02447003|450841248|FG001|Overall Study|Death|63|||
125330465|NCT03848728|450841249|FG000|Overall Study|Death|16|||
125330466|NCT03848728|450841250|FG001|Overall Study|Death|13|||
125330467|NCT03848728|450841249|FG000|Overall Study|Outmigrated to non-study community|98|||
125330468|NCT03848728|450841250|FG001|Overall Study|Outmigrated to non-study community|106|||
125330469|NCT03848728|450841249|FG000|Overall Study|Transfered to non-study clinic|32|||
125330470|NCT03848728|450841250|FG001|Overall Study|Transfered to non-study clinic|48|||
125330471|NCT03848728|450841249|FG000|Overall Study|Withdrawal by Subject|1|||
125330472|NCT03848728|450841250|FG001|Overall Study|Withdrawal by Subject|0|||
125330473|NCT04161157|450841251|FG000|Overall Study|Lost to Follow-up|4|||
125330474|NCT04161157|450841251|FG000|Overall Study|Death|3|||
125330475|NCT04161157|450841251|FG000|Overall Study|Ineligible|2|||
125330476|NCT04161157|450841251|FG000|Overall Study|Withdrawal by Subject|4|||
125330477|NCT01108185|450841252|FG000|Overall Study|Non-compliance|15|||
125330478|NCT01108185|450841252|FG000|Overall Study|Lost to Follow-up|12|||
125330479|NCT02581410|450841253|FG000|Vaccination Phase|Adverse Event|2|||
125330480|NCT02581410|450841254|FG001|Vaccination Phase|Adverse Event|1|||
125330481|NCT02581410|450841253|FG000|Vaccination Phase|Withdrawal by Subject|0|||
125330482|NCT02581410|450841254|FG001|Vaccination Phase|Withdrawal by Subject|1|||
125330483|NCT02581410|450841253|FG000|Vaccination Phase|Migrated/moved from study area|0|||
125330484|NCT02581410|450841254|FG001|Vaccination Phase|Migrated/moved from study area|1|||
125330485|NCT02581410|450841253|FG000|End of Study Phase|Adverse Event|4|||
125330486|NCT02581410|450841254|FG001|End of Study Phase|Adverse Event|3|||
125330487|NCT02581410|450841253|FG000|End of Study Phase|Withdrawal by Subject|1|||
125330488|NCT02581410|450841254|FG001|End of Study Phase|Withdrawal by Subject|2|||
125330489|NCT02581410|450841253|FG000|End of Study Phase|Migrated/moved from study area|0|||
125330490|NCT02581410|450841254|FG001|End of Study Phase|Migrated/moved from study area|3|||
125330491|NCT02581410|450841253|FG000|End of Study Phase|Lost to Follow-up|0|||
125330492|NCT02581410|450841254|FG001|End of Study Phase|Lost to Follow-up|2|||
125330493|NCT02581410|450841253|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
125330494|NCT02581410|450841254|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
125330495|NCT06083506|450841260|FG000|Overall Study|Physician Decision|2|||
125330496|NCT06083506|450841260|FG000|Overall Study|Lack of Efficacy|1|||
125330497|NCT02000115|450841261|FG000|Overall Study|Death|56|||
125330498|NCT02000115|450841262|FG001|Overall Study|Death|45|||
125330499|NCT02000115|450841263|FG002|Overall Study|Death|0|||
125330500|NCT02000115|450841264|FG003|Overall Study|Death|0|||
125330501|NCT02000115|450841261|FG000|Overall Study|Missed Visit|6|||
125330502|NCT02000115|450841262|FG001|Overall Study|Missed Visit|8|||
125330503|NCT02000115|450841263|FG002|Overall Study|Missed Visit|1|||
125330504|NCT02000115|450841264|FG003|Overall Study|Missed Visit|0|||
125330505|NCT02000115|450841261|FG000|Overall Study|Protocol Violation|2|||
125330506|NCT02000115|450841262|FG001|Overall Study|Protocol Violation|1|||
125330507|NCT02000115|450841263|FG002|Overall Study|Protocol Violation|0|||
125330508|NCT02000115|450841264|FG003|Overall Study|Protocol Violation|0|||
125330509|NCT02000115|450841261|FG000|Overall Study|Physician Decision|2|||
125330510|NCT02000115|450841262|FG001|Overall Study|Physician Decision|0|||
125330511|NCT02000115|450841263|FG002|Overall Study|Physician Decision|0|||
125330512|NCT02000115|450841264|FG003|Overall Study|Physician Decision|0|||
125330513|NCT02000115|450841261|FG000|Overall Study|Withdrawal by Subject|11|||
125330514|NCT02000115|450841262|FG001|Overall Study|Withdrawal by Subject|11|||
125330515|NCT02000115|450841263|FG002|Overall Study|Withdrawal by Subject|0|||
125667740|NCT02622074|452072003|FG002|Overall Study|Withdrawal by Subject|0|||
125667741|NCT02622074|452072004|FG003|Overall Study|Withdrawal by Subject|0|||
125667742|NCT02622074|452072005|FG004|Overall Study|Withdrawal by Subject|0|||
125667743|NCT02622074|452072006|FG005|Overall Study|Withdrawal by Subject|0|||
125667744|NCT02114931|452072007|FG000|Overall Study|Withdrawal by Subject|15|||
125667745|NCT02114931|452072008|FG001|Overall Study|Withdrawal by Subject|18|||
125667746|NCT02114931|452072007|FG000|Overall Study|Adverse Event|4|||
125667747|NCT02114931|452072008|FG001|Overall Study|Adverse Event|6|||
125667748|NCT02114931|452072007|FG000|Overall Study|Lost to Follow-up|3|||
125667749|NCT02114931|452072008|FG001|Overall Study|Lost to Follow-up|3|||
125667750|NCT02114931|452072007|FG000|Overall Study|Physician Decision|1|||
125667751|NCT02114931|452072008|FG001|Overall Study|Physician Decision|2|||
125667752|NCT02114931|452072007|FG000|Overall Study|Other|2|||
125667753|NCT02114931|452072008|FG001|Overall Study|Other|1|||
125667754|NCT03870997|452072010|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
125667755|NCT03870997|452072011|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
125667756|NCT03870997|452072012|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
125667757|NCT03870997|452072013|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
125667758|NCT03870997|452072014|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
125667759|NCT03870997|452072015|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
125667760|NCT03565211|452072019|FG000|Overall Study|Withdrawal by Subject|2|||
125667761|NCT03565211|452072019|FG000|Overall Study|Lost to Follow-up|1|||
125667762|NCT03565211|452072019|FG000|Overall Study|Adverse Event|44|||
125667763|NCT03565211|452072019|FG000|Overall Study|Personal issues|1|||
125667764|NCT01894984|452072020|FG000|Overall Study|Other|314|||
125667765|NCT01894984|452072021|FG001|Overall Study|Other|175|||
125667766|NCT03840135|452072023|FG000|Overall Study|Protocol Violation|6|||
125667767|NCT03840135|452072024|FG001|Overall Study|Protocol Violation|1|||
125667768|NCT03840135|452072023|FG000|Overall Study|Withdrawal by Subject|1|||
125667769|NCT03840135|452072024|FG001|Overall Study|Withdrawal by Subject|0|||
125667770|NCT00667719|452072025|FG000|Overall Study|Adverse Event|39|||
125667771|NCT00667719|452072025|FG000|Overall Study|Abnormal Test Procedure|1|||
125667772|NCT00667719|452072025|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125667773|NCT00667719|452072025|FG000|Overall Study|Protocol Violation|3|||
125667774|NCT00667719|452072025|FG000|Overall Study|Withdrawal by Subject|17|||
125667775|NCT00667719|452072025|FG000|Overall Study|Lost to Follow-up|8|||
125667776|NCT01827371|452072026|FG000|Overall Study|Adverse Event|0|||
125667777|NCT01827371|452072027|FG001|Overall Study|Adverse Event|0|||
125667778|NCT01827371|452072028|FG002|Overall Study|Adverse Event|4|||
125667779|NCT01827371|452072029|FG003|Overall Study|Adverse Event|2|||
125667780|NCT01827371|452072026|FG000|Overall Study|Lost to Follow-up|0|||
125667781|NCT01827371|452072027|FG001|Overall Study|Lost to Follow-up|2|||
125667782|NCT01827371|452072028|FG002|Overall Study|Lost to Follow-up|0|||
125667783|NCT01827371|452072029|FG003|Overall Study|Lost to Follow-up|4|||
125667784|NCT01827371|452072026|FG000|Overall Study|Protocol Violation|1|||
125667785|NCT01827371|452072027|FG001|Overall Study|Protocol Violation|0|||
125667786|NCT01827371|452072028|FG002|Overall Study|Protocol Violation|0|||
125667787|NCT01827371|452072029|FG003|Overall Study|Protocol Violation|0|||
125667788|NCT01827371|452072026|FG000|Overall Study|Withdrawal by Subject|1|||
125667789|NCT01827371|452072027|FG001|Overall Study|Withdrawal by Subject|2|||
125667790|NCT01827371|452072028|FG002|Overall Study|Withdrawal by Subject|2|||
125667791|NCT01827371|452072029|FG003|Overall Study|Withdrawal by Subject|3|||
125667792|NCT01827371|452072026|FG000|Overall Study|Physician Decision|0|||
125667793|NCT01827371|452072027|FG001|Overall Study|Physician Decision|1|||
125667794|NCT01827371|452072028|FG002|Overall Study|Physician Decision|0|||
125667795|NCT01827371|452072029|FG003|Overall Study|Physician Decision|1|||
125667796|NCT01827371|452072026|FG000|Overall Study|Temporary study halt to vaccinations|11|||
125667797|NCT01827371|452072027|FG001|Overall Study|Temporary study halt to vaccinations|2|||
125667798|NCT01827371|452072028|FG002|Overall Study|Temporary study halt to vaccinations|5|||
125667799|NCT01827371|452072029|FG003|Overall Study|Temporary study halt to vaccinations|13|||
125667800|NCT01361607|452072032|FG000|Overall Study|Adverse Event|38|||
125330516|NCT02000115|450841264|FG003|Overall Study|Withdrawal by Subject|0|||
125330517|NCT02000115|450841261|FG000|Overall Study|Lost to Follow-up|0|||
125667801|NCT01361607|452072033|FG001|Overall Study|Adverse Event|29|||
125667802|NCT01361607|452072032|FG000|Overall Study|Withdrawal by Subject|19|||
125667803|NCT01361607|452072033|FG001|Overall Study|Withdrawal by Subject|8|||
125667804|NCT01361607|452072032|FG000|Overall Study|Withdrawal by Investigator|5|||
125667805|NCT01361607|452072033|FG001|Overall Study|Withdrawal by Investigator|3|||
125667806|NCT01361607|452072032|FG000|Overall Study|Lost to Follow-up|1|||
125667807|NCT01361607|452072033|FG001|Overall Study|Lost to Follow-up|0|||
125667808|NCT01361607|452072032|FG000|Overall Study|Met Withdrawal Criteria|1|||
125667809|NCT01361607|452072033|FG001|Overall Study|Met Withdrawal Criteria|1|||
125667810|NCT01809314|452072034|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
125330518|NCT02000115|450841262|FG001|Overall Study|Lost to Follow-up|1|||
125667811|NCT01809314|452072034|FG000|Overall Study|Adverse Event|6|||
125667812|NCT01809314|452072034|FG000|Overall Study|Insufficient Therapeutic Response|14|||
125667813|NCT01809314|452072034|FG000|Overall Study|Lost to Follow-up|724|||
125667814|NCT01814137|452072035|FG000|Overall Study|Adverse Event|0|||
125667815|NCT01814137|452072036|FG001|Overall Study|Adverse Event|1|||
125667816|NCT01814137|452072035|FG000|Overall Study|Withdrawal by Subject|2|||
125667817|NCT01814137|452072036|FG001|Overall Study|Withdrawal by Subject|2|||
125667818|NCT01814137|452072035|FG000|Overall Study|Physician Decision|1|||
125667819|NCT01814137|452072036|FG001|Overall Study|Physician Decision|1|||
125667820|NCT01814137|452072035|FG000|Overall Study|Unclassified|2|||
125667821|NCT01814137|452072036|FG001|Overall Study|Unclassified|1|||
125667822|NCT00219557|452072037|FG000|Phase 1|Lack of Efficacy|3|||
125667823|NCT00219557|452072038|FG001|Phase 1|Lack of Efficacy|0|||
125667824|NCT00219557|452072039|FG002|Phase 1|Lack of Efficacy|0|||
125667825|NCT00219557|452072037|FG000|Phase 1|Adverse Event|2|||
125667826|NCT00219557|452072038|FG001|Phase 1|Adverse Event|0|||
125667827|NCT00219557|452072039|FG002|Phase 1|Adverse Event|0|||
125667828|NCT00219557|452072037|FG000|Phase 1|Withdrawal by Subject|1|||
125667829|NCT00219557|452072038|FG001|Phase 1|Withdrawal by Subject|0|||
125667830|NCT00219557|452072039|FG002|Phase 1|Withdrawal by Subject|0|||
125667831|NCT00219557|452072037|FG000|Phase 1|Started chemotherapy at other institute|1|||
125667832|NCT00219557|452072038|FG001|Phase 1|Started chemotherapy at other institute|0|||
125667833|NCT00219557|452072039|FG002|Phase 1|Started chemotherapy at other institute|0|||
125667834|NCT00219557|452072037|FG000|Phase 2|Lack of Efficacy|0|||
125667835|NCT00219557|452072038|FG001|Phase 2|Lack of Efficacy|21|||
125667836|NCT00219557|452072039|FG002|Phase 2|Lack of Efficacy|15|||
125667837|NCT00219557|452072037|FG000|Phase 2|Adverse Event|0|||
125667838|NCT00219557|452072038|FG001|Phase 2|Adverse Event|22|||
125667839|NCT00219557|452072039|FG002|Phase 2|Adverse Event|2|||
125667840|NCT00219557|452072037|FG000|Phase 2|Death|0|||
125667841|NCT00219557|452072038|FG001|Phase 2|Death|8|||
125667842|NCT00219557|452072039|FG002|Phase 2|Death|2|||
125667843|NCT00219557|452072037|FG000|Phase 2|Other|0|||
125667844|NCT00219557|452072038|FG001|Phase 2|Other|8|||
125667845|NCT00219557|452072039|FG002|Phase 2|Other|6|||
125667846|NCT00219557|452072037|FG000|Phase 2|Withdrawal by Subject|0|||
125667847|NCT00219557|452072038|FG001|Phase 2|Withdrawal by Subject|9|||
125667848|NCT00219557|452072039|FG002|Phase 2|Withdrawal by Subject|5|||
125667849|NCT00219557|452072037|FG000|Phase 2|Treatment not received|0|||
125667850|NCT00219557|452072038|FG001|Phase 2|Treatment not received|1|||
125667851|NCT00219557|452072039|FG002|Phase 2|Treatment not received|3|||
125667852|NCT01427803|452072044|FG000|Overall Study|Lost to Follow-up|32|||
125667853|NCT01427803|452072045|FG001|Overall Study|Lost to Follow-up|26|||
125667854|NCT01427803|452072044|FG000|Overall Study|Withdrawal by Subject|20|||
125667855|NCT01427803|452072045|FG001|Overall Study|Withdrawal by Subject|0|||
125667856|NCT01427803|452072044|FG000|Overall Study|Unable to complete full treatment period|6|||
125667857|NCT01427803|452072045|FG001|Overall Study|Unable to complete full treatment period|0|||
125667858|NCT01427803|452072044|FG000|Overall Study|Protocol Violation|1|||
125667859|NCT01427803|452072045|FG001|Overall Study|Protocol Violation|0|||
125667860|NCT01427803|452072044|FG000|Overall Study|Physician Decision|3|||
125667861|NCT01427803|452072045|FG001|Overall Study|Physician Decision|0|||
125667862|NCT01427803|452072044|FG000|Overall Study|did not take product|1|||
125667863|NCT01427803|452072045|FG001|Overall Study|did not take product|0|||
125667864|NCT03412019|452072046|FG000|Overall Study|Withdrawal by Subject|1|||
125667865|NCT03412019|452072047|FG001|Overall Study|Withdrawal by Subject|1|||
125667866|NCT01023269|452072052|FG000|Overall Study|early termination of the study|2|||
125667867|NCT01023269|452072053|FG001|Overall Study|early termination of the study|0|||
125667868|NCT00947011|452072055|FG000|Overall Study|Study was terminated,PI left institution|12|||
125667869|NCT00814658|452072056|FG000|Overall Study|Lost to Follow-up|0|||
125667870|NCT00814658|452072057|FG001|Overall Study|Lost to Follow-up|1|||
125667871|NCT00814658|452072056|FG000|Overall Study|Physician Decision|1|||
125667872|NCT00814658|452072057|FG001|Overall Study|Physician Decision|0|||
125667873|NCT00814658|452072056|FG000|Overall Study|Adverse Event|3|||
125667874|NCT00814658|452072057|FG001|Overall Study|Adverse Event|3|||
125667875|NCT05266456|452072058|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
125667876|NCT05266456|452072059|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
125330519|NCT02000115|450841263|FG002|Overall Study|Lost to Follow-up|0|||
125667877|NCT05266456|452072060|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
125667878|NCT05266456|452072061|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
125667879|NCT05266456|452072058|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
125667880|NCT05266456|452072059|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
125667881|NCT05266456|452072060|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
125667882|NCT05266456|452072061|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
125667883|NCT05266456|452072058|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
125667884|NCT05266456|452072059|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
125667885|NCT05266456|452072060|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
125667886|NCT05266456|452072061|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
125667887|NCT05266456|452072058|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
125667888|NCT05266456|452072059|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
125667889|NCT05266456|452072060|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
125667890|NCT05266456|452072061|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
125330520|NCT02000115|450841264|FG003|Overall Study|Lost to Follow-up|0|||
125330521|NCT02000115|450841261|FG000|Overall Study|Non-compliance|2|||
125330522|NCT02000115|450841262|FG001|Overall Study|Non-compliance|1|||
125330523|NCT02000115|450841263|FG002|Overall Study|Non-compliance|0|||
125330524|NCT02000115|450841264|FG003|Overall Study|Non-compliance|0|||
125330525|NCT02000115|450841261|FG000|Overall Study|Withdrawn on day of randomization|0|||
125330526|NCT02000115|450841262|FG001|Overall Study|Withdrawn on day of randomization|1|||
125330527|NCT02000115|450841263|FG002|Overall Study|Withdrawn on day of randomization|0|||
125330528|NCT02000115|450841264|FG003|Overall Study|Withdrawn on day of randomization|0|||
125330529|NCT02000115|450841261|FG000|Overall Study|Still on Study|0|||
125330530|NCT02000115|450841262|FG001|Overall Study|Still on Study|0|||
125330531|NCT02000115|450841263|FG002|Overall Study|Still on Study|0|||
125330532|NCT02000115|450841264|FG003|Overall Study|Still on Study|53|||
125330533|NCT03493464|450841269|FG000|Overall Study|Surgery not performed|1|||
125330534|NCT02374450|450841270|FG000|Overall Study|Protocol Violation|0|||
125330535|NCT02374450|450841271|FG001|Overall Study|Protocol Violation|1|||
125667891|NCT05266456|452072058|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
125667892|NCT05266456|452072059|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
125667893|NCT05266456|452072060|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
125667894|NCT05266456|452072061|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
125667895|NCT01141283|452072062|FG000|Overall Study|Adverse Event|56|||
125667896|NCT01141283|452072062|FG000|Overall Study|Lost to Follow-up|4|||
125667897|NCT01141283|452072062|FG000|Overall Study|Withdrawal by Subject|14|||
125330536|NCT02374450|450841272|FG002|Overall Study|Protocol Violation|0|||
125330537|NCT02374450|450841270|FG000|Overall Study|Withdrawal by Subject|91|||
125330538|NCT02374450|450841271|FG001|Overall Study|Withdrawal by Subject|110|||
125667898|NCT01141283|452072062|FG000|Overall Study|Administrative|4|||
125667899|NCT01141283|452072062|FG000|Overall Study|Lack of Efficacy|10|||
125667900|NCT00479401|452072066|FG000|Overall Study|Adverse Event|24|||
125667901|NCT00479401|452072067|FG001|Overall Study|Adverse Event|20|||
125667902|NCT00479401|452072068|FG002|Overall Study|Adverse Event|4|||
125667903|NCT00479401|452072066|FG000|Overall Study|Lack of Efficacy|2|||
125667904|NCT00479401|452072067|FG001|Overall Study|Lack of Efficacy|2|||
125667905|NCT00479401|452072068|FG002|Overall Study|Lack of Efficacy|4|||
125667906|NCT00479401|452072066|FG000|Overall Study|Protocol Violation|2|||
125667907|NCT00479401|452072067|FG001|Overall Study|Protocol Violation|1|||
125667908|NCT00479401|452072068|FG002|Overall Study|Protocol Violation|1|||
125667909|NCT00479401|452072066|FG000|Overall Study|Lost to Follow-up|1|||
125667910|NCT00479401|452072067|FG001|Overall Study|Lost to Follow-up|1|||
125667911|NCT00479401|452072068|FG002|Overall Study|Lost to Follow-up|1|||
125667912|NCT00479401|452072066|FG000|Overall Study|Withdrawal by Subject|16|||
125667913|NCT00479401|452072067|FG001|Overall Study|Withdrawal by Subject|10|||
125667914|NCT00479401|452072068|FG002|Overall Study|Withdrawal by Subject|2|||
125667915|NCT00479401|452072066|FG000|Overall Study|Exclusion criteria, relocation|4|||
125667916|NCT00479401|452072067|FG001|Overall Study|Exclusion criteria, relocation|3|||
125667917|NCT00479401|452072068|FG002|Overall Study|Exclusion criteria, relocation|0|||
125667918|NCT01571635|452072071|FG000|Overall Study|Adverse Event|3|||
125667919|NCT01571635|452072072|FG001|Overall Study|Adverse Event|0|||
125667920|NCT01571635|452072073|FG002|Overall Study|Adverse Event|2|||
125667921|NCT01571635|452072074|FG003|Overall Study|Adverse Event|3|||
125667922|NCT01571635|452072075|FG004|Overall Study|Adverse Event|5|||
125667923|NCT01571635|452072071|FG000|Overall Study|Other reasons|2|||
125667924|NCT01571635|452072072|FG001|Overall Study|Other reasons|1|||
125667925|NCT01571635|452072073|FG002|Overall Study|Other reasons|2|||
125667926|NCT01571635|452072074|FG003|Overall Study|Other reasons|2|||
125667927|NCT01571635|452072075|FG004|Overall Study|Other reasons|1|||
125667928|NCT01571635|452072071|FG000|Overall Study|Study terminated by sponsor|0|||
125667929|NCT01571635|452072072|FG001|Overall Study|Study terminated by sponsor|4|||
125667930|NCT01571635|452072073|FG002|Overall Study|Study terminated by sponsor|1|||
125667931|NCT01571635|452072074|FG003|Overall Study|Study terminated by sponsor|3|||
125667932|NCT01571635|452072075|FG004|Overall Study|Study terminated by sponsor|1|||
125667933|NCT01571635|452072071|FG000|Overall Study|Withdrew consent|1|||
125667934|NCT01571635|452072072|FG001|Overall Study|Withdrew consent|1|||
125667935|NCT01571635|452072073|FG002|Overall Study|Withdrew consent|2|||
125667936|NCT01571635|452072074|FG003|Overall Study|Withdrew consent|3|||
125667937|NCT01571635|452072075|FG004|Overall Study|Withdrew consent|0|||
125330539|NCT02374450|450841272|FG002|Overall Study|Withdrawal by Subject|4|||
125330540|NCT02374450|450841270|FG000|Overall Study|Lost to Follow-up|168|||
125330541|NCT02374450|450841271|FG001|Overall Study|Lost to Follow-up|194|||
125330542|NCT02374450|450841272|FG002|Overall Study|Lost to Follow-up|138|||
125667938|NCT01571635|452072071|FG000|Overall Study|Lack of Efficacy|0|||
125667939|NCT01571635|452072072|FG001|Overall Study|Lack of Efficacy|2|||
125667940|NCT01571635|452072073|FG002|Overall Study|Lack of Efficacy|0|||
125667941|NCT01571635|452072074|FG003|Overall Study|Lack of Efficacy|1|||
125667942|NCT01571635|452072075|FG004|Overall Study|Lack of Efficacy|2|||
125667943|NCT01722266|452072076|FG000|Overall Study|Withdrawal by Subject|1|||
125667944|NCT01722266|452072077|FG001|Overall Study|Withdrawal by Subject|2|||
125667945|NCT01722266|452072078|FG002|Overall Study|Withdrawal by Subject|0|||
125667946|NCT01722266|452072079|FG003|Overall Study|Withdrawal by Subject|0|||
125667947|NCT01722266|452072076|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
125667948|NCT01722266|452072077|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
125667949|NCT01722266|452072078|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
125667950|NCT01722266|452072079|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
125667951|NCT01722266|452072076|FG000|Overall Study|Dropped out due to Nausea|0|||
125667952|NCT01722266|452072077|FG001|Overall Study|Dropped out due to Nausea|0|||
125667953|NCT01722266|452072078|FG002|Overall Study|Dropped out due to Nausea|2|||
125667954|NCT01722266|452072079|FG003|Overall Study|Dropped out due to Nausea|0|||
125667955|NCT03124381|452072080|FG000|Overall Study|Lost to Follow-up|1|||
125667956|NCT03124381|452072081|FG001|Overall Study|Lost to Follow-up|1|||
125667957|NCT03124381|452072080|FG000|Overall Study|Withdrawal by Subject|6|||
125667958|NCT03124381|452072081|FG001|Overall Study|Withdrawal by Subject|3|||
125667959|NCT03124381|452072080|FG000|Overall Study|Protocol Violation|0|||
125667960|NCT03124381|452072081|FG001|Overall Study|Protocol Violation|1|||
125667961|NCT03124381|452072080|FG000|Overall Study|Adverse Event|1|||
125667962|NCT03124381|452072081|FG001|Overall Study|Adverse Event|1|||
125667963|NCT03124381|452072080|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
125667964|NCT03124381|452072081|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
125667965|NCT02533999|452072084|FG000|Overall Study|Lost to Follow-up|3|||
125330543|NCT02374450|450841270|FG000|Overall Study|Death|173|||
125330544|NCT02374450|450841271|FG001|Overall Study|Death|185|||
125330545|NCT02374450|450841272|FG002|Overall Study|Death|81|||
125330546|NCT02374450|450841270|FG000|Overall Study|Migrated from the study area|538|||
125330547|NCT02374450|450841271|FG001|Overall Study|Migrated from the study area|648|||
125330548|NCT02374450|450841272|FG002|Overall Study|Migrated from the study area|181|||
125330549|NCT02374450|450841270|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
125330550|NCT02374450|450841271|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
125330551|NCT02374450|450841272|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
125330552|NCT02374450|450841270|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
125330553|NCT02374450|450841271|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
125330554|NCT02374450|450841272|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
125330555|NCT02374450|450841270|FG000|Overall Study|Other|0|||
125330556|NCT02374450|450841271|FG001|Overall Study|Other|21|||
125330557|NCT02374450|450841272|FG002|Overall Study|Other|79|||
125330558|NCT04145349|450842568|FG000|Overall Study|Withdrawal by Subject|3|||
125330559|NCT04145349|450842569|FG001|Overall Study|Withdrawal by Subject|0|||
125330560|NCT04145349|450842568|FG000|Overall Study|Lost to Follow-up|0|||
125330561|NCT04145349|450842569|FG001|Overall Study|Lost to Follow-up|1|||
125330562|NCT04145349|450842568|FG000|Overall Study|On study treatment (Ongoing)|0|||
125330563|NCT04145349|450842569|FG001|Overall Study|On study treatment (Ongoing)|1|||
125330564|NCT01148979|450842570|FG000|Overall Study|Lost to Follow-up|0|||
125330565|NCT01148979|450842571|FG001|Overall Study|Lost to Follow-up|1|||
125330566|NCT01376804|450842572|FG000|Treatment Period|Withdrawal by Subject|1|||
125330567|NCT01376804|450842572|FG000|Treatment Period|Adverse Event|6|||
125330568|NCT01376804|450842572|FG000|Treatment Period|Patient did not receive study drug|1|||
125330569|NCT00882557|450842573|FG000|Overall Study|Withdrawal by Subject|1|||
125330570|NCT00882557|450842574|FG001|Overall Study|Withdrawal by Subject|0|||
125330571|NCT00882557|450842573|FG000|Overall Study|Trouble with Vein Access|1|||
125330572|NCT00882557|450842574|FG001|Overall Study|Trouble with Vein Access|0|||
125330573|NCT00882557|450842573|FG000|Overall Study|Randomized Not Treated|0|||
125330574|NCT00882557|450842574|FG001|Overall Study|Randomized Not Treated|1|||
125330575|NCT01383356|450842579|FG000|Period 1|Adverse Event|5|||
125330576|NCT01383356|450842580|FG001|Period 1|Adverse Event|3|||
125330577|NCT01383356|450842579|FG000|Period 1|Non-compliance|3|||
125330578|NCT01383356|450842580|FG001|Period 1|Non-compliance|0|||
125330579|NCT01383356|450842579|FG000|Period 1|Out of Range Mid-study-Test|0|||
125330580|NCT01383356|450842580|FG001|Period 1|Out of Range Mid-study-Test|1|||
125330581|NCT01383356|450842579|FG000|Period 1|Personal|0|||
125330582|NCT01383356|450842580|FG001|Period 1|Personal|2|||
125330583|NCT00602472|450842586|FG000|Overall Study|Adverse Event|5|||
125667966|NCT02533999|452072085|FG001|Overall Study|Lost to Follow-up|5|||
125667967|NCT02533999|452072084|FG000|Overall Study|Protocol Violation|3|||
125667968|NCT02533999|452072085|FG001|Overall Study|Protocol Violation|0|||
125330584|NCT00602472|450842587|FG001|Overall Study|Adverse Event|23|||
125330585|NCT00602472|450842586|FG000|Overall Study|Protocol Violation|4|||
125330586|NCT00602472|450842587|FG001|Overall Study|Protocol Violation|19|||
125330587|NCT00602472|450842586|FG000|Overall Study|Withdrawal by Subject|8|||
125330588|NCT00602472|450842587|FG001|Overall Study|Withdrawal by Subject|14|||
125330589|NCT00602472|450842586|FG000|Overall Study|Other incl. lack of efficacy|4|||
125330590|NCT00602472|450842587|FG001|Overall Study|Other incl. lack of efficacy|2|||
125330591|NCT03038880|450842588|FG000|Overall Study|Death|1|||
125667969|NCT02533999|452072084|FG000|Overall Study|Adverse Event|0|||
125667970|NCT02533999|452072085|FG001|Overall Study|Adverse Event|1|||
125667971|NCT02533999|452072084|FG000|Overall Study|Randomized but intervention not received|0|||
125667972|NCT02533999|452072085|FG001|Overall Study|Randomized but intervention not received|1|||
125667973|NCT01875445|452072086|FG000|Overall Study|Lost to Follow-up|5|||
125667974|NCT01875445|452072087|FG001|Overall Study|Lost to Follow-up|0|||
125667975|NCT01875445|452072086|FG000|Overall Study|Withdrawal by Subject|2|||
125667976|NCT01875445|452072087|FG001|Overall Study|Withdrawal by Subject|0|||
125667977|NCT03760510|452072090|FG000|Overall Study|Not ventilated for 24 hours|105|||
125667978|NCT03760510|452072091|FG001|Overall Study|Not ventilated for 24 hours|97|||
125667979|NCT00291330|452072093|FG000|Overall Study|Adverse Event|47|||
125667980|NCT00291330|452072094|FG001|Overall Study|Adverse Event|40|||
125667981|NCT00291330|452072093|FG000|Overall Study|Protocol Violation|13|||
125667982|NCT00291330|452072094|FG001|Overall Study|Protocol Violation|20|||
125667983|NCT00291330|452072093|FG000|Overall Study|Lost to Follow-up|16|||
125667984|NCT00291330|452072094|FG001|Overall Study|Lost to Follow-up|11|||
125667985|NCT00291330|452072093|FG000|Overall Study|Withdrawal by Subject|22|||
125667986|NCT00291330|452072094|FG001|Overall Study|Withdrawal by Subject|25|||
125667987|NCT00291330|452072093|FG000|Overall Study|Other|3|||
125667988|NCT00291330|452072094|FG001|Overall Study|Other|1|||
125667989|NCT00566709|452072095|FG000|Overall Study|Protocol Violation|5|||
125667990|NCT00566709|452072096|FG001|Overall Study|Protocol Violation|0|||
125667991|NCT01829295|452072097|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
125667992|NCT01829295|452072098|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
125667993|NCT01829295|452072099|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
125667994|NCT01829295|452072100|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
125667995|NCT01829295|452072097|FG000|6-12 Months|Adverse Event|0|||
125667996|NCT01829295|452072098|FG001|6-12 Months|Adverse Event|0|||
125667997|NCT01829295|452072099|FG002|6-12 Months|Adverse Event|3|||
125667998|NCT01829295|452072100|FG003|6-12 Months|Adverse Event|2|||
125667999|NCT01829295|452072097|FG000|6-12 Months|Lost to Follow-up|2|||
125668000|NCT01829295|452072098|FG001|6-12 Months|Lost to Follow-up|0|||
125668001|NCT01829295|452072099|FG002|6-12 Months|Lost to Follow-up|0|||
125668002|NCT01829295|452072100|FG003|6-12 Months|Lost to Follow-up|0|||
125668003|NCT01829295|452072097|FG000|6-12 Months|Withdrawal by Subject|2|||
125668004|NCT01829295|452072098|FG001|6-12 Months|Withdrawal by Subject|2|||
125668005|NCT01829295|452072099|FG002|6-12 Months|Withdrawal by Subject|0|||
125668006|NCT01829295|452072100|FG003|6-12 Months|Withdrawal by Subject|0|||
125668007|NCT01360632|452072111|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
125668008|NCT01360632|452072112|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
125668009|NCT01360632|452072113|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
125668010|NCT01360632|452072114|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
125668011|NCT01360632|452072115|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
125668012|NCT01360632|452072111|FG000|Phase A (8 Weeks)|Adverse Event|60|||
125668013|NCT01360632|452072112|FG001|Phase A (8 Weeks)|Adverse Event|0|||
125668014|NCT01360632|452072113|FG002|Phase A (8 Weeks)|Adverse Event|0|||
125668015|NCT01360632|452072114|FG003|Phase A (8 Weeks)|Adverse Event|0|||
125668016|NCT01360632|452072115|FG004|Phase A (8 Weeks)|Adverse Event|0|||
125668017|NCT01360632|452072111|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
125668018|NCT01360632|452072112|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
125668019|NCT01360632|452072113|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
125668020|NCT01360632|452072114|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
125330592|NCT03038880|450842589|FG001|Overall Study|Death|2|||
125330593|NCT03038880|450842590|FG002|Overall Study|Death|0|||
125330594|NCT03038880|450842588|FG000|Overall Study|Physician Decision|2|||
125330595|NCT03038880|450842589|FG001|Overall Study|Physician Decision|1|||
125330596|NCT03038880|450842590|FG002|Overall Study|Physician Decision|0|||
125330597|NCT02054104|450842597|FG000|Overall Study|Did not want to continue due to college classes|1|||
125330598|NCT02054104|450842598|FG001|Overall Study|Did not want to continue due to college classes|0|||
125330599|NCT02054104|450842597|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
125330600|NCT02054104|450842598|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
125330601|NCT02054104|450842597|FG000|Overall Study|No evidence of immunologic response|2|||
125330602|NCT02054104|450842598|FG001|Overall Study|No evidence of immunologic response|2|||
125330603|NCT02054104|450842597|FG000|Overall Study|Disease Progression On Study|4|||
125330604|NCT02054104|450842598|FG001|Overall Study|Disease Progression On Study|5|||
125330605|NCT02054104|450842597|FG000|Overall Study|Diagnosis of lymphoma|0|||
125330606|NCT02054104|450842598|FG001|Overall Study|Diagnosis of lymphoma|1|||
125330607|NCT02054104|450842597|FG000|Overall Study|Inconclusive response|0|||
125330608|NCT02054104|450842598|FG001|Overall Study|Inconclusive response|1|||
125330609|NCT00823615|450842599|FG000|Period 2|Lost to Follow-up|2|||
125668021|NCT01360632|452072115|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
125668022|NCT01360632|452072111|FG000|Phase A (8 Weeks)|Physician Decision|10|||
125668023|NCT01360632|452072112|FG001|Phase A (8 Weeks)|Physician Decision|0|||
125668024|NCT01360632|452072113|FG002|Phase A (8 Weeks)|Physician Decision|0|||
125330610|NCT00823615|450842600|FG001|Period 2|Lost to Follow-up|0|||
125668025|NCT01360632|452072114|FG003|Phase A (8 Weeks)|Physician Decision|0|||
125330611|NCT00823615|450842599|FG000|Period 2|Time/Job Conflict|1|||
125668026|NCT01360632|452072115|FG004|Phase A (8 Weeks)|Physician Decision|0|||
125668027|NCT01360632|452072111|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
125668028|NCT01360632|452072112|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
125668029|NCT01360632|452072113|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
125668030|NCT01360632|452072114|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
125668031|NCT01360632|452072115|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
125668032|NCT01360632|452072111|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
125668033|NCT01360632|452072112|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
125668034|NCT01360632|452072113|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
125668035|NCT01360632|452072114|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
125668036|NCT01360632|452072115|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
125668037|NCT01360632|452072111|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
125668038|NCT01360632|452072112|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
125668039|NCT01360632|452072113|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
125668040|NCT01360632|452072114|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
125668041|NCT01360632|452072115|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
125668042|NCT01360632|452072111|FG000|Phase B (6 Weeks)|Adverse Event|0|||
125668043|NCT01360632|452072112|FG001|Phase B (6 Weeks)|Adverse Event|3|||
125668044|NCT01360632|452072113|FG002|Phase B (6 Weeks)|Adverse Event|9|||
125668045|NCT01360632|452072114|FG003|Phase B (6 Weeks)|Adverse Event|3|||
125668046|NCT01360632|452072115|FG004|Phase B (6 Weeks)|Adverse Event|0|||
125668047|NCT01360632|452072111|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
125668048|NCT01360632|452072112|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
125668049|NCT01360632|452072113|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
125330612|NCT00823615|450842600|FG001|Period 2|Time/Job Conflict|2|||
125330613|NCT03926611|450842601|FG000|Overall Study|Adverse Event|0|||
125330614|NCT03926611|450842602|FG001|Overall Study|Adverse Event|0|||
125330615|NCT03926611|450842603|FG002|Overall Study|Adverse Event|0|||
125330616|NCT03926611|450842604|FG003|Overall Study|Adverse Event|3|||
125330617|NCT03926611|450842605|FG004|Overall Study|Adverse Event|1|||
125330618|NCT03926611|450842606|FG005|Overall Study|Adverse Event|3|||
125330619|NCT03926611|450842607|FG006|Overall Study|Adverse Event|0|||
125330620|NCT03926611|450842601|FG000|Overall Study|Lack of Efficacy|1|||
125330621|NCT03926611|450842602|FG001|Overall Study|Lack of Efficacy|2|||
125330622|NCT03926611|450842603|FG002|Overall Study|Lack of Efficacy|0|||
125330623|NCT03926611|450842604|FG003|Overall Study|Lack of Efficacy|0|||
125330624|NCT03926611|450842605|FG004|Overall Study|Lack of Efficacy|1|||
125330625|NCT03926611|450842606|FG005|Overall Study|Lack of Efficacy|0|||
125330626|NCT03926611|450842607|FG006|Overall Study|Lack of Efficacy|1|||
125330627|NCT03926611|450842601|FG000|Overall Study|Physician Decision|0|||
125330628|NCT03926611|450842602|FG001|Overall Study|Physician Decision|0|||
125668050|NCT01360632|452072114|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
125668051|NCT01360632|452072115|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
125668052|NCT01360632|452072111|FG000|Phase B (6 Weeks)|Physician Decision|0|||
125668053|NCT01360632|452072112|FG001|Phase B (6 Weeks)|Physician Decision|0|||
125668054|NCT01360632|452072113|FG002|Phase B (6 Weeks)|Physician Decision|0|||
125668055|NCT01360632|452072114|FG003|Phase B (6 Weeks)|Physician Decision|1|||
125668056|NCT01360632|452072115|FG004|Phase B (6 Weeks)|Physician Decision|0|||
125668057|NCT01360632|452072111|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
125668058|NCT01360632|452072112|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
125668059|NCT01360632|452072113|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
125668060|NCT01360632|452072114|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
125668061|NCT01360632|452072115|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
125668062|NCT01360632|452072111|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
125668063|NCT01360632|452072112|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
125668064|NCT01360632|452072113|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
125668065|NCT01360632|452072114|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
125668066|NCT01360632|452072115|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
125668067|NCT01360632|452072111|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
125668068|NCT01360632|452072112|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
125668069|NCT01360632|452072113|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
125668070|NCT01360632|452072114|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
125668071|NCT01360632|452072115|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
125668072|NCT01360632|452072111|FG000|Phase A+|Lost to Follow-up|0|||
125668073|NCT01360632|452072112|FG001|Phase A+|Lost to Follow-up|0|||
125668074|NCT01360632|452072113|FG002|Phase A+|Lost to Follow-up|0|||
125668075|NCT01360632|452072114|FG003|Phase A+|Lost to Follow-up|0|||
125668076|NCT01360632|452072115|FG004|Phase A+|Lost to Follow-up|2|||
125330629|NCT03926611|450842603|FG002|Overall Study|Physician Decision|0|||
125330630|NCT03926611|450842604|FG003|Overall Study|Physician Decision|0|||
125668077|NCT01360632|452072111|FG000|Phase A+|Adverse Event|0|||
125668078|NCT01360632|452072112|FG001|Phase A+|Adverse Event|0|||
125668079|NCT01360632|452072113|FG002|Phase A+|Adverse Event|0|||
125668080|NCT01360632|452072114|FG003|Phase A+|Adverse Event|0|||
125668081|NCT01360632|452072115|FG004|Phase A+|Adverse Event|2|||
125668082|NCT01360632|452072111|FG000|Phase A+|Met Withdrawal Criteria|0|||
125668083|NCT01360632|452072112|FG001|Phase A+|Met Withdrawal Criteria|0|||
125668084|NCT01360632|452072113|FG002|Phase A+|Met Withdrawal Criteria|0|||
125668085|NCT01360632|452072114|FG003|Phase A+|Met Withdrawal Criteria|0|||
125668086|NCT01360632|452072115|FG004|Phase A+|Met Withdrawal Criteria|7|||
125330631|NCT03926611|450842605|FG004|Overall Study|Physician Decision|0|||
125330632|NCT03926611|450842606|FG005|Overall Study|Physician Decision|1|||
125330633|NCT03926611|450842607|FG006|Overall Study|Physician Decision|0|||
125668087|NCT01360632|452072111|FG000|Phase A+|Physician Decision|0|||
125668088|NCT01360632|452072112|FG001|Phase A+|Physician Decision|0|||
125668089|NCT01360632|452072113|FG002|Phase A+|Physician Decision|0|||
125668090|NCT01360632|452072114|FG003|Phase A+|Physician Decision|0|||
125668091|NCT01360632|452072115|FG004|Phase A+|Physician Decision|3|||
125668092|NCT01360632|452072111|FG000|Phase A+|Withdrawal by Subject|0|||
125668093|NCT01360632|452072112|FG001|Phase A+|Withdrawal by Subject|0|||
125668094|NCT01360632|452072113|FG002|Phase A+|Withdrawal by Subject|0|||
125668095|NCT01360632|452072114|FG003|Phase A+|Withdrawal by Subject|0|||
125668096|NCT01360632|452072115|FG004|Phase A+|Withdrawal by Subject|8|||
125668097|NCT01360632|452072111|FG000|Phase A+|Protocol Deviation|0|||
125668098|NCT01360632|452072112|FG001|Phase A+|Protocol Deviation|0|||
125668099|NCT01360632|452072113|FG002|Phase A+|Protocol Deviation|0|||
125668100|NCT01360632|452072114|FG003|Phase A+|Protocol Deviation|0|||
125668101|NCT01360632|452072115|FG004|Phase A+|Protocol Deviation|3|||
125668102|NCT01084005|452073800|FG000|Overall Study|Adverse Event|1|||
125668103|NCT01084005|452073801|FG001|Overall Study|Adverse Event|8|||
125668104|NCT01084005|452073800|FG000|Overall Study|Protocol Violation|3|||
125668105|NCT01084005|452073801|FG001|Overall Study|Protocol Violation|7|||
125668106|NCT01084005|452073800|FG000|Overall Study|Withdrawal by Subject|1|||
125668107|NCT01084005|452073801|FG001|Overall Study|Withdrawal by Subject|1|||
125668108|NCT02480010|452073802|FG000|Overall Study|Adverse Event|3|||
125668109|NCT02480010|452073803|FG001|Overall Study|Adverse Event|1|||
125668110|NCT02480010|452073802|FG000|Overall Study|Death|1|||
125668111|NCT02480010|452073803|FG001|Overall Study|Death|0|||
125668112|NCT02480010|452073802|FG000|Overall Study|Insufficient therapeutic response|31|||
125668113|NCT02480010|452073803|FG001|Overall Study|Insufficient therapeutic response|29|||
125668114|NCT02480010|452073802|FG000|Overall Study|Refused Treatment|0|||
125668115|NCT02480010|452073803|FG001|Overall Study|Refused Treatment|3|||
125668116|NCT01034137|452073807|FG000|Overall Study|Adverse Event|9|||
125668117|NCT01034137|452073808|FG001|Overall Study|Adverse Event|10|||
125668118|NCT01034137|452073809|FG002|Overall Study|Adverse Event|8|||
125668119|NCT01034137|452073807|FG000|Overall Study|Withdrawal by Subject|4|||
125668120|NCT01034137|452073808|FG001|Overall Study|Withdrawal by Subject|3|||
125668121|NCT01034137|452073809|FG002|Overall Study|Withdrawal by Subject|3|||
125668122|NCT01034137|452073807|FG000|Overall Study|Lack of Efficacy|9|||
125668123|NCT01034137|452073808|FG001|Overall Study|Lack of Efficacy|4|||
125668124|NCT01034137|452073809|FG002|Overall Study|Lack of Efficacy|13|||
125668125|NCT01034137|452073807|FG000|Overall Study|Protocol Violation|2|||
125668126|NCT01034137|452073808|FG001|Overall Study|Protocol Violation|2|||
125668127|NCT01034137|452073809|FG002|Overall Study|Protocol Violation|1|||
125668128|NCT01034137|452073807|FG000|Overall Study|Refused treatment or did not cooperate|2|||
125330634|NCT03926611|450842601|FG000|Overall Study|Protocol Violation|1|||
125330635|NCT03926611|450842602|FG001|Overall Study|Protocol Violation|0|||
125330636|NCT03926611|450842603|FG002|Overall Study|Protocol Violation|0|||
125330637|NCT03926611|450842604|FG003|Overall Study|Protocol Violation|1|||
125330638|NCT03926611|450842605|FG004|Overall Study|Protocol Violation|1|||
125330639|NCT03926611|450842606|FG005|Overall Study|Protocol Violation|1|||
125330640|NCT03926611|450842607|FG006|Overall Study|Protocol Violation|1|||
125330641|NCT03926611|450842601|FG000|Overall Study|Technical problems|0|||
125330642|NCT03926611|450842602|FG001|Overall Study|Technical problems|0|||
125330643|NCT03926611|450842603|FG002|Overall Study|Technical problems|0|||
125330644|NCT03926611|450842604|FG003|Overall Study|Technical problems|0|||
125330645|NCT03926611|450842605|FG004|Overall Study|Technical problems|0|||
125330646|NCT03926611|450842606|FG005|Overall Study|Technical problems|1|||
125330647|NCT03926611|450842607|FG006|Overall Study|Technical problems|0|||
125330648|NCT03926611|450842601|FG000|Overall Study|Withdrawal by Subject|1|||
125330649|NCT03926611|450842602|FG001|Overall Study|Withdrawal by Subject|1|||
125330650|NCT03926611|450842603|FG002|Overall Study|Withdrawal by Subject|1|||
125330651|NCT03926611|450842604|FG003|Overall Study|Withdrawal by Subject|0|||
125330652|NCT03926611|450842605|FG004|Overall Study|Withdrawal by Subject|0|||
125330653|NCT03926611|450842606|FG005|Overall Study|Withdrawal by Subject|1|||
125330654|NCT03926611|450842607|FG006|Overall Study|Withdrawal by Subject|3|||
125330655|NCT03926611|450842601|FG000|Overall Study|Covid-19 pandemic|0|||
125668129|NCT01034137|452073808|FG001|Overall Study|Refused treatment or did not cooperate|0|||
125330656|NCT03926611|450842602|FG001|Overall Study|Covid-19 pandemic|0|||
125330657|NCT03926611|450842603|FG002|Overall Study|Covid-19 pandemic|1|||
125668130|NCT01034137|452073809|FG002|Overall Study|Refused treatment or did not cooperate|1|||
125668131|NCT01034137|452073807|FG000|Overall Study|Administrative or other|2|||
125668132|NCT01034137|452073808|FG001|Overall Study|Administrative or other|3|||
125668133|NCT01034137|452073809|FG002|Overall Study|Administrative or other|4|||
125668134|NCT01764854|452073810|FG000|Overall Study|Adverse Event|0|||
125668135|NCT01764854|452073811|FG001|Overall Study|Adverse Event|0|||
125668136|NCT01764854|452073812|FG002|Overall Study|Adverse Event|2|||
125330658|NCT03926611|450842604|FG003|Overall Study|Covid-19 pandemic|0|||
125330659|NCT03926611|450842605|FG004|Overall Study|Covid-19 pandemic|1|||
125668137|NCT01764854|452073813|FG003|Overall Study|Adverse Event|0|||
125668138|NCT01764854|452073810|FG000|Overall Study|Withdrawal by Subject|0|||
125668139|NCT01764854|452073811|FG001|Overall Study|Withdrawal by Subject|0|||
125330660|NCT03926611|450842606|FG005|Overall Study|Covid-19 pandemic|2|||
125330661|NCT03926611|450842607|FG006|Overall Study|Covid-19 pandemic|0|||
125330662|NCT00084136|450842608|FG000|PI Comparison|Death|10|||
125668140|NCT01764854|452073812|FG002|Overall Study|Withdrawal by Subject|1|||
125668141|NCT01764854|452073813|FG003|Overall Study|Withdrawal by Subject|0|||
125668142|NCT01764854|452073810|FG000|Overall Study|relocation|0|||
125668143|NCT01764854|452073811|FG001|Overall Study|relocation|0|||
125668144|NCT01764854|452073812|FG002|Overall Study|relocation|2|||
125668145|NCT01764854|452073813|FG003|Overall Study|relocation|0|||
125668146|NCT01764854|452073810|FG000|Overall Study|Protocol Violation|0|||
125668147|NCT01764854|452073811|FG001|Overall Study|Protocol Violation|0|||
125668148|NCT01764854|452073812|FG002|Overall Study|Protocol Violation|1|||
125668149|NCT01764854|452073813|FG003|Overall Study|Protocol Violation|2|||
125668150|NCT03377556|452073825|FG000|Overall Study|Adverse Event|5|||
125668151|NCT03377556|452073825|FG000|Overall Study|Refusal unrelated to adverse events|1|||
125668152|NCT03377556|452073825|FG000|Overall Study|Progression/relapse|38|||
125668153|NCT03377556|452073825|FG000|Overall Study|Death|3|||
125668154|NCT02736227|452073834|FG000|Overall Study|Withdrawal by Subject|0|||
125668155|NCT02736227|452073835|FG001|Overall Study|Withdrawal by Subject|0|||
125668156|NCT02736227|452073836|FG002|Overall Study|Withdrawal by Subject|1|||
125668157|NCT02736227|452073834|FG000|Overall Study|Physician Decision|0|||
125668158|NCT02736227|452073835|FG001|Overall Study|Physician Decision|0|||
125668159|NCT02736227|452073836|FG002|Overall Study|Physician Decision|5|||
125668160|NCT02736227|452073834|FG000|Overall Study|Non Compliant|0|||
125330663|NCT00084136|450842609|FG001|PI Comparison|Death|9|||
125330664|NCT00084136|450842610|FG002|PI Comparison|Death|0|||
125330665|NCT00084136|450842608|FG000|PI Comparison|Lost to Follow-up|11|||
125330666|NCT00084136|450842609|FG001|PI Comparison|Lost to Follow-up|8|||
125330667|NCT00084136|450842610|FG002|PI Comparison|Lost to Follow-up|0|||
125330668|NCT00084136|450842608|FG000|PI Comparison|Withdrawal by Subject|33|||
125330669|NCT00084136|450842609|FG001|PI Comparison|Withdrawal by Subject|30|||
125330670|NCT00084136|450842610|FG002|PI Comparison|Withdrawal by Subject|0|||
125330671|NCT00084136|450842608|FG000|PI Comparison|Clinic site closed|1|||
125330672|NCT00084136|450842609|FG001|PI Comparison|Clinic site closed|0|||
125330673|NCT00084136|450842610|FG002|PI Comparison|Clinic site closed|0|||
125330674|NCT00084136|450842608|FG000|NRTI Comparison|Death|20|||
125330675|NCT00084136|450842609|FG001|NRTI Comparison|Death|0|||
125330676|NCT00084136|450842610|FG002|NRTI Comparison|Death|18|||
125330677|NCT00084136|450842608|FG000|NRTI Comparison|Lost to Follow-up|14|||
125330678|NCT00084136|450842609|FG001|NRTI Comparison|Lost to Follow-up|0|||
125330679|NCT00084136|450842610|FG002|NRTI Comparison|Lost to Follow-up|12|||
125330680|NCT00084136|450842608|FG000|NRTI Comparison|Withdrawal by Subject|54|||
125330681|NCT00084136|450842609|FG001|NRTI Comparison|Withdrawal by Subject|0|||
125330682|NCT00084136|450842610|FG002|NRTI Comparison|Withdrawal by Subject|38|||
125330683|NCT00084136|450842608|FG000|NRTI Comparison|Clinic site closed|12|||
125330684|NCT00084136|450842609|FG001|NRTI Comparison|Clinic site closed|0|||
125330685|NCT00084136|450842610|FG002|NRTI Comparison|Clinic site closed|14|||
125330686|NCT00084136|450842608|FG000|NRTI Comparison|Not reason above|1|||
125330687|NCT00084136|450842609|FG001|NRTI Comparison|Not reason above|0|||
125330688|NCT00084136|450842610|FG002|NRTI Comparison|Not reason above|0|||
125330689|NCT02230670|450842611|FG000|Overall Study|Adverse Event|1|||
125330690|NCT02230670|450842612|FG001|Overall Study|Adverse Event|2|||
125330691|NCT02230670|450842611|FG000|Overall Study|Withdrawal by Subject|2|||
125330692|NCT02230670|450842612|FG001|Overall Study|Withdrawal by Subject|2|||
125330693|NCT02230670|450842611|FG000|Overall Study|Physician Decision|0|||
125330694|NCT02230670|450842612|FG001|Overall Study|Physician Decision|1|||
125330695|NCT02230670|450842611|FG000|Overall Study|Protocol Violation|0|||
125330696|NCT02230670|450842612|FG001|Overall Study|Protocol Violation|1|||
125330697|NCT02230670|450842611|FG000|Overall Study|Progression to Child-Pugh C|1|||
125330698|NCT02230670|450842612|FG001|Overall Study|Progression to Child-Pugh C|2|||
125330699|NCT00892099|450842614|FG000|Overall Study|Death|1|||
125330700|NCT00892099|450842615|FG001|Overall Study|Death|0|||
125330701|NCT00892099|450842616|FG002|Overall Study|Death|1|||
125330702|NCT00892099|450842614|FG000|Overall Study|Adverse Event|1|||
125330703|NCT00892099|450842615|FG001|Overall Study|Adverse Event|0|||
125330704|NCT00892099|450842616|FG002|Overall Study|Adverse Event|0|||
125330705|NCT00892099|450842614|FG000|Overall Study|replocated|1|||
125330706|NCT00892099|450842615|FG001|Overall Study|replocated|0|||
125330707|NCT00892099|450842616|FG002|Overall Study|replocated|2|||
125330708|NCT00892099|450842614|FG000|Overall Study|Prolonged hospitalization|1|||
125330709|NCT00892099|450842615|FG001|Overall Study|Prolonged hospitalization|0|||
125330710|NCT00892099|450842616|FG002|Overall Study|Prolonged hospitalization|1|||
125668161|NCT02736227|452073835|FG001|Overall Study|Non Compliant|0|||
125668162|NCT02736227|452073836|FG002|Overall Study|Non Compliant|2|||
125668163|NCT04120194|452073837|FG000|Overall Study|Lost to Follow-up|11|||
125668164|NCT04120194|452073838|FG001|Overall Study|Lost to Follow-up|8|||
125668165|NCT04120194|452073837|FG000|Overall Study|Adverse Event|4|||
125668166|NCT04120194|452073838|FG001|Overall Study|Adverse Event|5|||
125668167|NCT04120194|452073837|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
125330711|NCT00892099|450842614|FG000|Overall Study|no further details|1|||
125330712|NCT00892099|450842615|FG001|Overall Study|no further details|0|||
125330713|NCT00892099|450842616|FG002|Overall Study|no further details|1|||
125330714|NCT00892099|450842614|FG000|Overall Study|kidney function recovered|0|||
125330715|NCT00892099|450842615|FG001|Overall Study|kidney function recovered|1|||
125330716|NCT00892099|450842616|FG002|Overall Study|kidney function recovered|0|||
125330717|NCT00892099|450842614|FG000|Overall Study|investigator decision|0|||
125330718|NCT00892099|450842615|FG001|Overall Study|investigator decision|0|||
125330719|NCT00892099|450842616|FG002|Overall Study|investigator decision|1|||
125330720|NCT00892099|450842614|FG000|Overall Study|Lost to Follow-up|0|||
125330721|NCT00892099|450842615|FG001|Overall Study|Lost to Follow-up|0|||
125330722|NCT00892099|450842616|FG002|Overall Study|Lost to Follow-up|1|||
125330723|NCT01657019|450842617|FG000|Overall Study|Withdrawal by Subject|65|||
125330724|NCT01657019|450842617|FG000|Overall Study|Adverse Event|55|||
125330725|NCT01657019|450842617|FG000|Overall Study|Lost to Follow-up|48|||
125330726|NCT01657019|450842617|FG000|Overall Study|Protocol Violation|6|||
125330727|NCT01657019|450842617|FG000|Overall Study|Lack of Efficacy|3|||
125330728|NCT01657019|450842617|FG000|Overall Study|Other|58|||
125330729|NCT00998296|450842618|FG000|Overall Study|Progressive disease|0|||
125330730|NCT00998296|450842619|FG001|Overall Study|Progressive disease|1|||
125668168|NCT04120194|452073838|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
125668169|NCT04120194|452073837|FG000|Overall Study|Miscellaneous|4|||
125668170|NCT04120194|452073838|FG001|Overall Study|Miscellaneous|5|||
125668171|NCT00827359|452073842|FG000|Overall Study|Progressive Diseas|19|||
125668172|NCT00827359|452073842|FG000|Overall Study|Unacceptable Toxicity|5|||
125668173|NCT00827359|452073842|FG000|Overall Study|Ineligible|1|||
125668174|NCT01159769|452073843|FG000|Overall Study|Adverse Event|1|||
125668175|NCT02555618|452073844|FG000|Overall Study|Sponsor's Circumstances|1|||
125668176|NCT02555618|452073845|FG001|Overall Study|Sponsor's Circumstances|0|||
125668177|NCT02063698|452073846|FG000|Overall Study|did not complete booklet for days 2-8|1|||
125668178|NCT02063698|452073847|FG001|Overall Study|did not complete booklet for days 2-8|2|||
125668179|NCT00410410|452073848|FG000|Induction Period (IP)|Death|1|||
125668180|NCT00410410|452073849|FG001|Induction Period (IP)|Death|0|||
125668181|NCT00410410|452073850|FG002|Induction Period (IP)|Death|0|||
125668182|NCT00410410|452073851|FG003|Induction Period (IP)|Death|0|||
125668183|NCT00410410|452073852|FG004|Induction Period (IP)|Death|0|||
125668184|NCT00410410|452073853|FG005|Induction Period (IP)|Death|0|||
125668185|NCT00410410|452073854|FG006|Induction Period (IP)|Death|0|||
125668186|NCT00410410|452073855|FG007|Induction Period (IP)|Death|0|||
125668187|NCT00410410|452073856|FG008|Induction Period (IP)|Death|0|||
125668188|NCT00410410|452073848|FG000|Induction Period (IP)|Adverse Event|3|||
125668189|NCT00410410|452073849|FG001|Induction Period (IP)|Adverse Event|4|||
125668190|NCT00410410|452073850|FG002|Induction Period (IP)|Adverse Event|2|||
125668191|NCT00410410|452073851|FG003|Induction Period (IP)|Adverse Event|4|||
125668192|NCT00410410|452073852|FG004|Induction Period (IP)|Adverse Event|1|||
125668193|NCT00410410|452073853|FG005|Induction Period (IP)|Adverse Event|0|||
125668194|NCT00410410|452073854|FG006|Induction Period (IP)|Adverse Event|0|||
125668195|NCT00410410|452073855|FG007|Induction Period (IP)|Adverse Event|0|||
125668196|NCT00410410|452073856|FG008|Induction Period (IP)|Adverse Event|0|||
125668197|NCT00410410|452073848|FG000|Induction Period (IP)|Lack of Efficacy|26|||
125668198|NCT00410410|452073849|FG001|Induction Period (IP)|Lack of Efficacy|24|||
125668199|NCT00410410|452073850|FG002|Induction Period (IP)|Lack of Efficacy|8|||
125668200|NCT00410410|452073851|FG003|Induction Period (IP)|Lack of Efficacy|8|||
125668201|NCT00410410|452073852|FG004|Induction Period (IP)|Lack of Efficacy|7|||
125668202|NCT00410410|452073853|FG005|Induction Period (IP)|Lack of Efficacy|7|||
125668203|NCT00410410|452073854|FG006|Induction Period (IP)|Lack of Efficacy|0|||
125668204|NCT00410410|452073855|FG007|Induction Period (IP)|Lack of Efficacy|0|||
125668205|NCT00410410|452073856|FG008|Induction Period (IP)|Lack of Efficacy|0|||
125668206|NCT00410410|452073848|FG000|Induction Period (IP)|Lost to Follow-up|2|||
125668207|NCT00410410|452073849|FG001|Induction Period (IP)|Lost to Follow-up|2|||
125668208|NCT00410410|452073850|FG002|Induction Period (IP)|Lost to Follow-up|2|||
125668209|NCT00410410|452073851|FG003|Induction Period (IP)|Lost to Follow-up|3|||
125668210|NCT00410410|452073852|FG004|Induction Period (IP)|Lost to Follow-up|0|||
125668211|NCT00410410|452073853|FG005|Induction Period (IP)|Lost to Follow-up|1|||
125668212|NCT00410410|452073854|FG006|Induction Period (IP)|Lost to Follow-up|0|||
125668213|NCT00410410|452073855|FG007|Induction Period (IP)|Lost to Follow-up|0|||
125668214|NCT00410410|452073856|FG008|Induction Period (IP)|Lost to Follow-up|0|||
125668215|NCT00410410|452073848|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
125668216|NCT00410410|452073849|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
125668217|NCT00410410|452073850|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
125330731|NCT00998296|450842620|FG002|Overall Study|Progressive disease|0|||
125330732|NCT00998296|450842621|FG003|Overall Study|Progressive disease|0|||
125330733|NCT00998296|450842622|FG004|Overall Study|Progressive disease|0|||
125330734|NCT00998296|450842623|FG005|Overall Study|Progressive disease|0|||
125668218|NCT00410410|452073851|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
125668219|NCT00410410|452073852|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
125668220|NCT00410410|452073853|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
125668221|NCT00410410|452073854|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
125668222|NCT00410410|452073855|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
125668223|NCT00410410|452073856|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
125668224|NCT00410410|452073848|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125668225|NCT00410410|452073849|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125668226|NCT00410410|452073850|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
125668227|NCT00410410|452073851|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125668228|NCT00410410|452073852|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125668229|NCT00410410|452073853|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125668230|NCT00410410|452073854|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125668231|NCT00410410|452073855|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125668232|NCT00410410|452073856|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
125668233|NCT00410410|452073848|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
125668234|NCT00410410|452073849|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
125668235|NCT00410410|452073850|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
125668236|NCT00410410|452073851|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
125668237|NCT00410410|452073852|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
125668238|NCT00410410|452073853|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
125668239|NCT00410410|452073854|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
125668240|NCT00410410|452073855|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
125668241|NCT00410410|452073856|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
125668242|NCT00410410|452073848|FG000|Induction Period (IP)|Other|0|||
125668243|NCT00410410|452073849|FG001|Induction Period (IP)|Other|0|||
125668244|NCT00410410|452073850|FG002|Induction Period (IP)|Other|1|||
125668245|NCT00410410|452073851|FG003|Induction Period (IP)|Other|0|||
125668246|NCT00410410|452073852|FG004|Induction Period (IP)|Other|0|||
125330735|NCT00998296|450842624|FG006|Overall Study|Progressive disease|1|||
125330736|NCT00998296|450842625|FG007|Overall Study|Progressive disease|0|||
125330737|NCT00998296|450842626|FG008|Overall Study|Progressive disease|0|||
125330738|NCT00998296|450842627|FG009|Overall Study|Progressive disease|14|||
125330739|NCT00998296|450842628|FG010|Overall Study|Progressive disease|5|||
125330740|NCT00998296|450842618|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330741|NCT00998296|450842619|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330742|NCT00998296|450842620|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330743|NCT00998296|450842621|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330744|NCT00998296|450842622|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
125330745|NCT00998296|450842623|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330746|NCT00998296|450842624|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330747|NCT00998296|450842625|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
125330748|NCT00998296|450842626|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
125330749|NCT00998296|450842627|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330750|NCT00998296|450842628|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
125330751|NCT00998296|450842618|FG000|Overall Study|Other adverse event|0|||
125330752|NCT00998296|450842619|FG001|Overall Study|Other adverse event|0|||
125330753|NCT00998296|450842620|FG002|Overall Study|Other adverse event|0|||
125330754|NCT00998296|450842621|FG003|Overall Study|Other adverse event|0|||
125330755|NCT00998296|450842622|FG004|Overall Study|Other adverse event|1|||
125330756|NCT00998296|450842623|FG005|Overall Study|Other adverse event|0|||
125330757|NCT00998296|450842624|FG006|Overall Study|Other adverse event|0|||
125330758|NCT00998296|450842625|FG007|Overall Study|Other adverse event|0|||
125330759|NCT00998296|450842626|FG008|Overall Study|Other adverse event|0|||
125330760|NCT00998296|450842627|FG009|Overall Study|Other adverse event|1|||
125330761|NCT00998296|450842628|FG010|Overall Study|Other adverse event|2|||
125330762|NCT00998296|450842618|FG000|Overall Study|Refused to continue taking trial med.|0|||
125330763|NCT00998296|450842619|FG001|Overall Study|Refused to continue taking trial med.|0|||
125330764|NCT00998296|450842620|FG002|Overall Study|Refused to continue taking trial med.|0|||
125330765|NCT00998296|450842621|FG003|Overall Study|Refused to continue taking trial med.|0|||
125330766|NCT00998296|450842622|FG004|Overall Study|Refused to continue taking trial med.|0|||
125330767|NCT00998296|450842623|FG005|Overall Study|Refused to continue taking trial med.|0|||
125330768|NCT00998296|450842624|FG006|Overall Study|Refused to continue taking trial med.|0|||
125330769|NCT00998296|450842625|FG007|Overall Study|Refused to continue taking trial med.|0|||
125330770|NCT00998296|450842626|FG008|Overall Study|Refused to continue taking trial med.|0|||
125330771|NCT00998296|450842627|FG009|Overall Study|Refused to continue taking trial med.|2|||
125330772|NCT00998296|450842628|FG010|Overall Study|Refused to continue taking trial med.|0|||
125330773|NCT00998296|450842618|FG000|Overall Study|Reason other than those specified above|0|||
125668247|NCT00410410|452073853|FG005|Induction Period (IP)|Other|0|||
125330774|NCT00998296|450842619|FG001|Overall Study|Reason other than those specified above|0|||
125330775|NCT00998296|450842620|FG002|Overall Study|Reason other than those specified above|0|||
125330776|NCT00998296|450842621|FG003|Overall Study|Reason other than those specified above|0|||
125668248|NCT00410410|452073854|FG006|Induction Period (IP)|Other|0|||
125668249|NCT00410410|452073855|FG007|Induction Period (IP)|Other|0|||
125668250|NCT00410410|452073856|FG008|Induction Period (IP)|Other|0|||
125668251|NCT00410410|452073848|FG000|Maintenance Period (MP)|Death|0|||
125668252|NCT00410410|452073849|FG001|Maintenance Period (MP)|Death|0|||
125668253|NCT00410410|452073850|FG002|Maintenance Period (MP)|Death|0|||
125668254|NCT00410410|452073851|FG003|Maintenance Period (MP)|Death|0|||
125668255|NCT00410410|452073852|FG004|Maintenance Period (MP)|Death|0|||
125668256|NCT00410410|452073853|FG005|Maintenance Period (MP)|Death|0|||
125668257|NCT00410410|452073854|FG006|Maintenance Period (MP)|Death|1|||
125668258|NCT00410410|452073855|FG007|Maintenance Period (MP)|Death|0|||
125668259|NCT00410410|452073856|FG008|Maintenance Period (MP)|Death|0|||
125668260|NCT00410410|452073848|FG000|Maintenance Period (MP)|Adverse Event|0|||
125668261|NCT00410410|452073849|FG001|Maintenance Period (MP)|Adverse Event|0|||
125668262|NCT00410410|452073850|FG002|Maintenance Period (MP)|Adverse Event|0|||
125668263|NCT00410410|452073851|FG003|Maintenance Period (MP)|Adverse Event|0|||
125668264|NCT00410410|452073852|FG004|Maintenance Period (MP)|Adverse Event|0|||
125668265|NCT00410410|452073853|FG005|Maintenance Period (MP)|Adverse Event|0|||
125668266|NCT00410410|452073854|FG006|Maintenance Period (MP)|Adverse Event|1|||
125668267|NCT00410410|452073855|FG007|Maintenance Period (MP)|Adverse Event|3|||
125668268|NCT00410410|452073856|FG008|Maintenance Period (MP)|Adverse Event|0|||
125668269|NCT00410410|452073848|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
125668270|NCT00410410|452073849|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
125668271|NCT00410410|452073850|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
125668272|NCT00410410|452073851|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
125668273|NCT00410410|452073852|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
125668274|NCT00410410|452073853|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
125668275|NCT00410410|452073854|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
125668276|NCT00410410|452073855|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
125668277|NCT00410410|452073856|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
125668278|NCT00410410|452073848|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
125668279|NCT00410410|452073849|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
125668280|NCT00410410|452073850|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
125668281|NCT00410410|452073851|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
125668282|NCT00410410|452073852|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
125668283|NCT00410410|452073853|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
125668284|NCT00410410|452073854|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
125668285|NCT00410410|452073855|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
125668286|NCT00410410|452073856|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
125668287|NCT00410410|452073848|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
125668288|NCT00410410|452073849|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
125668289|NCT00410410|452073850|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
125668290|NCT00410410|452073851|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
125668291|NCT00410410|452073852|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
125668292|NCT00410410|452073853|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
125668293|NCT00410410|452073854|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
125668294|NCT00410410|452073855|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
125668295|NCT00410410|452073856|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
125668296|NCT00410410|452073848|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125668297|NCT00410410|452073849|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125668298|NCT00410410|452073850|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125668299|NCT00410410|452073851|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125668300|NCT00410410|452073852|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125668301|NCT00410410|452073853|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125668302|NCT00410410|452073854|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
125668303|NCT00410410|452073855|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
125668304|NCT00410410|452073856|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
125668305|NCT00410410|452073848|FG000|Open-Label Period (OL)|Death|0|||
125668306|NCT00410410|452073849|FG001|Open-Label Period (OL)|Death|0|||
125668307|NCT00410410|452073850|FG002|Open-Label Period (OL)|Death|0|||
125668308|NCT00410410|452073851|FG003|Open-Label Period (OL)|Death|0|||
125668309|NCT00410410|452073852|FG004|Open-Label Period (OL)|Death|0|||
125668310|NCT00410410|452073853|FG005|Open-Label Period (OL)|Death|0|||
125668311|NCT00410410|452073854|FG006|Open-Label Period (OL)|Death|0|||
125668312|NCT00410410|452073855|FG007|Open-Label Period (OL)|Death|0|||
125668313|NCT00410410|452073856|FG008|Open-Label Period (OL)|Death|1|||
125668314|NCT00410410|452073848|FG000|Open-Label Period (OL)|Adverse Event|0|||
125668315|NCT00410410|452073849|FG001|Open-Label Period (OL)|Adverse Event|0|||
125668316|NCT00410410|452073850|FG002|Open-Label Period (OL)|Adverse Event|0|||
125668317|NCT00410410|452073851|FG003|Open-Label Period (OL)|Adverse Event|0|||
125668318|NCT00410410|452073852|FG004|Open-Label Period (OL)|Adverse Event|0|||
125668319|NCT00410410|452073853|FG005|Open-Label Period (OL)|Adverse Event|0|||
125668320|NCT00410410|452073854|FG006|Open-Label Period (OL)|Adverse Event|0|||
125668321|NCT00410410|452073855|FG007|Open-Label Period (OL)|Adverse Event|0|||
125668322|NCT00410410|452073856|FG008|Open-Label Period (OL)|Adverse Event|10|||
125668323|NCT00410410|452073848|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
125668324|NCT00410410|452073849|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
125668325|NCT00410410|452073850|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
125668326|NCT00410410|452073851|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
125668327|NCT00410410|452073852|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
125668328|NCT00410410|452073853|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
125668329|NCT00410410|452073854|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
125668330|NCT00410410|452073855|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
125668331|NCT00410410|452073856|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
125668332|NCT00410410|452073848|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
125668333|NCT00410410|452073849|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
125668334|NCT00410410|452073850|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
125668335|NCT00410410|452073851|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
125668336|NCT00410410|452073852|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
125330777|NCT00998296|450842622|FG004|Overall Study|Reason other than those specified above|0|||
125330778|NCT00998296|450842623|FG005|Overall Study|Reason other than those specified above|0|||
125668337|NCT00410410|452073853|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
125668338|NCT00410410|452073854|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
125668339|NCT00410410|452073855|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
125668340|NCT00410410|452073856|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
125668341|NCT00410410|452073848|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
125668342|NCT00410410|452073849|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
125668343|NCT00410410|452073850|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
125668344|NCT00410410|452073851|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
125668345|NCT00410410|452073852|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
125668346|NCT00410410|452073853|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
125668347|NCT00410410|452073854|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
125668348|NCT00410410|452073855|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
125668349|NCT00410410|452073856|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
125668350|NCT00410410|452073848|FG000|Open-Label Period (OL)|Pregnancy|0|||
125668351|NCT00410410|452073849|FG001|Open-Label Period (OL)|Pregnancy|0|||
125668352|NCT00410410|452073850|FG002|Open-Label Period (OL)|Pregnancy|0|||
125668353|NCT00410410|452073851|FG003|Open-Label Period (OL)|Pregnancy|0|||
125668354|NCT00410410|452073852|FG004|Open-Label Period (OL)|Pregnancy|0|||
125668355|NCT00410410|452073853|FG005|Open-Label Period (OL)|Pregnancy|0|||
125668356|NCT00410410|452073854|FG006|Open-Label Period (OL)|Pregnancy|0|||
125668357|NCT00410410|452073855|FG007|Open-Label Period (OL)|Pregnancy|0|||
125668358|NCT00410410|452073856|FG008|Open-Label Period (OL)|Pregnancy|1|||
125668359|NCT00410410|452073848|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125668360|NCT00410410|452073849|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125330779|NCT00998296|450842624|FG006|Overall Study|Reason other than those specified above|0|||
125330780|NCT00998296|450842625|FG007|Overall Study|Reason other than those specified above|0|||
125330781|NCT00998296|450842626|FG008|Overall Study|Reason other than those specified above|0|||
125330782|NCT00998296|450842627|FG009|Overall Study|Reason other than those specified above|1|||
125330783|NCT00998296|450842628|FG010|Overall Study|Reason other than those specified above|0|||
125330784|NCT02346721|450842629|FG000|Overall Study|Withdrew Consent|3|||
125330785|NCT02346721|450842629|FG000|Overall Study|Lack of Efficacy|1|||
125330786|NCT03219528|450842635|FG000|Overall Study|Lost to Follow-up|5|||
125330787|NCT03219528|450842636|FG001|Overall Study|Lost to Follow-up|4|||
125330788|NCT03219528|450842635|FG000|Overall Study|Withdrawal by Subject|4|||
125330789|NCT03219528|450842636|FG001|Overall Study|Withdrawal by Subject|4|||
125330790|NCT02120898|450842637|FG000|Overall Study|Withdrawal by Subject|4|||
125330791|NCT02120898|450842638|FG001|Overall Study|Withdrawal by Subject|2|||
125330792|NCT02120898|450842639|FG002|Overall Study|Withdrawal by Subject|2|||
125330793|NCT02120898|450842637|FG000|Overall Study|Non-compliance with study drug|3|||
125330794|NCT02120898|450842638|FG001|Overall Study|Non-compliance with study drug|0|||
125330795|NCT02120898|450842639|FG002|Overall Study|Non-compliance with study drug|0|||
125330796|NCT02120898|450842637|FG000|Overall Study|Adverse Event|1|||
125330797|NCT02120898|450842638|FG001|Overall Study|Adverse Event|2|||
125330798|NCT02120898|450842639|FG002|Overall Study|Adverse Event|1|||
125330799|NCT02120898|450842637|FG000|Overall Study|Protocol Violation|1|||
125330800|NCT02120898|450842638|FG001|Overall Study|Protocol Violation|2|||
125330801|NCT02120898|450842639|FG002|Overall Study|Protocol Violation|0|||
125668361|NCT00410410|452073850|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125668362|NCT00410410|452073851|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125668363|NCT00410410|452073852|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125668364|NCT00410410|452073853|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125668365|NCT00410410|452073854|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125668366|NCT00410410|452073855|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
125668367|NCT00410410|452073856|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
125668368|NCT00410410|452073848|FG000|Open-Label Period (OL)|Other|0|||
125668369|NCT00410410|452073849|FG001|Open-Label Period (OL)|Other|0|||
125330802|NCT02120898|450842637|FG000|Overall Study|Lost to Follow-up|0|||
125330803|NCT02120898|450842638|FG001|Overall Study|Lost to Follow-up|0|||
125668370|NCT00410410|452073850|FG002|Open-Label Period (OL)|Other|0|||
125668371|NCT00410410|452073851|FG003|Open-Label Period (OL)|Other|0|||
125668372|NCT00410410|452073852|FG004|Open-Label Period (OL)|Other|0|||
125668373|NCT00410410|452073853|FG005|Open-Label Period (OL)|Other|0|||
125668374|NCT00410410|452073854|FG006|Open-Label Period (OL)|Other|0|||
125668375|NCT00410410|452073855|FG007|Open-Label Period (OL)|Other|0|||
125668376|NCT00410410|452073856|FG008|Open-Label Period (OL)|Other|7|||
125668377|NCT01953783|452073857|FG000|Overall Study|Progressive disease|2|||
125668378|NCT01271933|452073862|FG000|Single-Blind Phase|Lack of Efficacy|37|||
125668379|NCT01271933|452073863|FG001|Single-Blind Phase|Lack of Efficacy|0|||
125668380|NCT01271933|452073864|FG002|Single-Blind Phase|Lack of Efficacy|0|||
125668381|NCT01271933|452073862|FG000|Single-Blind Phase|Lost to Follow-up|10|||
125668382|NCT01271933|452073863|FG001|Single-Blind Phase|Lost to Follow-up|0|||
125668383|NCT01271933|452073864|FG002|Single-Blind Phase|Lost to Follow-up|0|||
125668384|NCT01271933|452073862|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
125668385|NCT01271933|452073863|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
125668386|NCT01271933|452073864|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
125668387|NCT01271933|452073862|FG000|Single-Blind Phase|Protocol Violation|3|||
125668388|NCT01271933|452073863|FG001|Single-Blind Phase|Protocol Violation|0|||
125668389|NCT01271933|452073864|FG002|Single-Blind Phase|Protocol Violation|0|||
125668390|NCT01271933|452073862|FG000|Single-Blind Phase|Adverse Event|52|||
125668391|NCT01271933|452073863|FG001|Single-Blind Phase|Adverse Event|0|||
125668392|NCT01271933|452073864|FG002|Single-Blind Phase|Adverse Event|0|||
125668393|NCT01271933|452073862|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
125668394|NCT01271933|452073863|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
125668395|NCT01271933|452073864|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
125668396|NCT01271933|452073862|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
125668397|NCT01271933|452073863|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
125668398|NCT01271933|452073864|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
125668399|NCT01271933|452073862|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
125668400|NCT01271933|452073863|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
125668401|NCT01271933|452073864|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
125668402|NCT01271933|452073862|FG000|Double-Blind Phase|Randomized but not treated|0|||
125668403|NCT01271933|452073863|FG001|Double-Blind Phase|Randomized but not treated|0|||
125668404|NCT01271933|452073864|FG002|Double-Blind Phase|Randomized but not treated|1|||
125668405|NCT01271933|452073862|FG000|Double-Blind Phase|Lack of Efficacy|0|||
125668406|NCT01271933|452073863|FG001|Double-Blind Phase|Lack of Efficacy|6|||
125668407|NCT01271933|452073864|FG002|Double-Blind Phase|Lack of Efficacy|9|||
125668408|NCT01271933|452073862|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125668409|NCT01271933|452073863|FG001|Double-Blind Phase|Lost to Follow-up|1|||
125668410|NCT01271933|452073864|FG002|Double-Blind Phase|Lost to Follow-up|1|||
125668411|NCT01271933|452073862|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
125668412|NCT01271933|452073863|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
125668413|NCT01271933|452073864|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
125668414|NCT01271933|452073862|FG000|Double-Blind Phase|Adverse Event|0|||
125668415|NCT01271933|452073863|FG001|Double-Blind Phase|Adverse Event|3|||
125668416|NCT01271933|452073864|FG002|Double-Blind Phase|Adverse Event|0|||
125668417|NCT01271933|452073862|FG000|Double-Blind Phase|Participant request-personal reason|0|||
125668418|NCT01271933|452073863|FG001|Double-Blind Phase|Participant request-personal reason|1|||
125668419|NCT01271933|452073864|FG002|Double-Blind Phase|Participant request-personal reason|0|||
125668420|NCT01138150|452073865|FG000|Overall Study|blood unable to be processed|0|||
125668421|NCT01138150|452073866|FG001|Overall Study|blood unable to be processed|1|||
125668422|NCT01138150|452073865|FG000|Overall Study|Physician Decision|1|||
125668423|NCT01138150|452073866|FG001|Overall Study|Physician Decision|0|||
125668424|NCT05085964|452073867|FG000|Overall Study|Premature termination of study|21|||
125668425|NCT05085964|452073868|FG001|Overall Study|Premature termination of study|0|||
125668426|NCT03156270|452073871|FG000|Overall Study|Failed pre-treatment screening|1|||
125668427|NCT03156270|452073871|FG000|Overall Study|Lost to Follow-up|1|||
125668428|NCT00591253|452073872|FG000|Overall Study|Adverse Event|3|||
125668429|NCT00591253|452073873|FG001|Overall Study|Adverse Event|3|||
125668430|NCT00591253|452073874|FG002|Overall Study|Adverse Event|1|||
125668431|NCT00591253|452073872|FG000|Overall Study|Protocol Violation|2|||
125668432|NCT00591253|452073873|FG001|Overall Study|Protocol Violation|2|||
125668433|NCT00591253|452073874|FG002|Overall Study|Protocol Violation|2|||
125668434|NCT00591253|452073872|FG000|Overall Study|Lost to Follow-up|2|||
125668435|NCT00591253|452073873|FG001|Overall Study|Lost to Follow-up|4|||
125668436|NCT00591253|452073874|FG002|Overall Study|Lost to Follow-up|0|||
125668437|NCT00591253|452073872|FG000|Overall Study|Withdrawal by Subject|1|||
125668438|NCT00591253|452073873|FG001|Overall Study|Withdrawal by Subject|7|||
125668439|NCT00591253|452073874|FG002|Overall Study|Withdrawal by Subject|6|||
125668440|NCT00591253|452073872|FG000|Overall Study|Lack of Efficacy|1|||
125668441|NCT00591253|452073873|FG001|Overall Study|Lack of Efficacy|0|||
125668442|NCT00591253|452073874|FG002|Overall Study|Lack of Efficacy|3|||
125668443|NCT00591253|452073872|FG000|Overall Study|Other|5|||
125668444|NCT00591253|452073873|FG001|Overall Study|Other|5|||
125668445|NCT00591253|452073874|FG002|Overall Study|Other|3|||
125668446|NCT01783730|452073880|FG000|Overall Study|Failed to meet inclusion criteria|6|||
125668447|NCT01841359|452073881|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
125668448|NCT01841359|452073881|FG000|Overall Study|Concommitant medical issues|2|||
125668449|NCT01841359|452073881|FG000|Overall Study|Adverse Event|3|||
125668450|NCT01841359|452073881|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
125668451|NCT02151461|452073882|FG000|Overall Study|Adverse Event|5|||
125668452|NCT02151461|452073883|FG001|Overall Study|Adverse Event|1|||
125668453|NCT02151461|452073884|FG002|Overall Study|Adverse Event|0|||
125668454|NCT02151461|452073885|FG003|Overall Study|Adverse Event|2|||
125668455|NCT02151461|452073882|FG000|Overall Study|Lost to Follow-up|0|||
125668456|NCT02151461|452073883|FG001|Overall Study|Lost to Follow-up|0|||
125668457|NCT02151461|452073884|FG002|Overall Study|Lost to Follow-up|1|||
125668458|NCT02151461|452073885|FG003|Overall Study|Lost to Follow-up|1|||
125668459|NCT02151461|452073882|FG000|Overall Study|Withdrawal by Subject|1|||
125668460|NCT02151461|452073883|FG001|Overall Study|Withdrawal by Subject|0|||
125668461|NCT02151461|452073884|FG002|Overall Study|Withdrawal by Subject|1|||
125668462|NCT02151461|452073885|FG003|Overall Study|Withdrawal by Subject|1|||
125668463|NCT02151461|452073882|FG000|Overall Study|Treatment discontinuation|0|||
125668464|NCT02151461|452073883|FG001|Overall Study|Treatment discontinuation|0|||
125668465|NCT02151461|452073884|FG002|Overall Study|Treatment discontinuation|1|||
125330804|NCT02120898|450842639|FG002|Overall Study|Lost to Follow-up|1|||
125330805|NCT00831181|450842640|FG000|Overall Study|Adverse Event|12|||
125668466|NCT02151461|452073885|FG003|Overall Study|Treatment discontinuation|0|||
125668467|NCT02168270|452073886|FG000|Overall Study|Lack of Efficacy|4|||
125668468|NCT01102777|452073887|FG000|Overall Study|Death|2|||
125668469|NCT01102777|452073888|FG001|Overall Study|Death|6|||
125668470|NCT01102777|452073887|FG000|Overall Study|Lost to Follow-up|7|||
125668471|NCT01102777|452073888|FG001|Overall Study|Lost to Follow-up|10|||
125668472|NCT00771901|452073889|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
125668473|NCT00771901|452073890|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
125668474|NCT00771901|452073891|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
125668475|NCT01965652|452073892|FG000|Overall Study|Adverse Event|40|||
125668476|NCT01965652|452073893|FG001|Overall Study|Adverse Event|37|||
125668477|NCT01965652|452073892|FG000|Overall Study|Withdrawal by Subject|62|||
125668478|NCT01965652|452073893|FG001|Overall Study|Withdrawal by Subject|69|||
125668479|NCT01965652|452073892|FG000|Overall Study|Lost to Follow-up|53|||
125668480|NCT01965652|452073893|FG001|Overall Study|Lost to Follow-up|40|||
125668481|NCT01965652|452073892|FG000|Overall Study|Protocol Violation|34|||
125668482|NCT01965652|452073893|FG001|Overall Study|Protocol Violation|38|||
125330806|NCT00196313|450842643|FG000|Overall Study|Protocol Violation|2|||
125330807|NCT00196313|450842644|FG001|Overall Study|Protocol Violation|3|||
125330808|NCT00196313|450842643|FG000|Overall Study|Withdrawal by Subject|3|||
125330809|NCT00196313|450842644|FG001|Overall Study|Withdrawal by Subject|1|||
125330810|NCT00196313|450842643|FG000|Overall Study|Adverse Event|3|||
125330811|NCT00196313|450842644|FG001|Overall Study|Adverse Event|1|||
125330812|NCT00196313|450842643|FG000|Overall Study|Subject Pregnant|1|||
125330813|NCT00196313|450842644|FG001|Overall Study|Subject Pregnant|1|||
125330814|NCT00196313|450842643|FG000|Overall Study|Lost to Follow-up|2|||
125330815|NCT00196313|450842644|FG001|Overall Study|Lost to Follow-up|2|||
125330816|NCT00043979|450842645|FG000|Period 1|recipient with progressive disease|7|||
125330817|NCT00043979|450842646|FG001|Period 1|recipient with progressive disease|4|||
125330818|NCT00043979|450842647|FG002|Period 1|recipient with progressive disease|3|||
125330819|NCT04085289|450842648|FG000|Overall Study|Withdrawal by Subject|0|||
125330820|NCT04085289|450842649|FG001|Overall Study|Withdrawal by Subject|0|||
125330821|NCT04085289|450842650|FG002|Overall Study|Withdrawal by Subject|1|||
125668483|NCT01965652|452073892|FG000|Overall Study|Death|3|||
125668484|NCT01965652|452073893|FG001|Overall Study|Death|4|||
125668485|NCT01965652|452073892|FG000|Overall Study|Other - Miscellaneous|18|||
125668486|NCT01965652|452073893|FG001|Overall Study|Other - Miscellaneous|21|||
125668487|NCT01965652|452073892|FG000|Overall Study|Pregnancy|0|||
125668488|NCT01965652|452073893|FG001|Overall Study|Pregnancy|1|||
125668489|NCT01121900|452073894|FG000|First Intervention Period|Adverse Event|1|||
125668490|NCT01121900|452073895|FG001|First Intervention Period|Adverse Event|1|||
125668491|NCT01121900|452073894|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
125668492|NCT01121900|452073895|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125668493|NCT01328054|452073896|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
125668494|NCT01328054|452073897|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
125668495|NCT01328054|452073896|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
125668496|NCT01328054|452073897|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
125668497|NCT01328054|452073896|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
125330822|NCT02919995|450842654|FG000|Overall Study|Adverse Event|0|||
125330823|NCT02919995|450842655|FG001|Overall Study|Adverse Event|0|||
125330824|NCT02919995|450842656|FG002|Overall Study|Adverse Event|0|||
125330825|NCT02919995|450842657|FG003|Overall Study|Adverse Event|0|||
125330826|NCT02919995|450842658|FG004|Overall Study|Adverse Event|0|||
125330827|NCT02919995|450842659|FG005|Overall Study|Adverse Event|1|||
125330828|NCT03196349|450842660|FG000|Overall Study|Did not receive study drug|0|||
125330829|NCT03196349|450842661|FG001|Overall Study|Did not receive study drug|1|||
125330830|NCT03196349|450842662|FG002|Overall Study|Did not receive study drug|2|||
125330831|NCT03196349|450842660|FG000|Overall Study|No data entered|2|||
125330832|NCT03196349|450842661|FG001|Overall Study|No data entered|4|||
125330833|NCT03196349|450842662|FG002|Overall Study|No data entered|0|||
125330834|NCT03196349|450842660|FG000|Overall Study|Study Terminated early|15|||
125330835|NCT03196349|450842661|FG001|Overall Study|Study Terminated early|9|||
125330836|NCT03196349|450842662|FG002|Overall Study|Study Terminated early|11|||
125330837|NCT02892448|450842672|FG000|Overall Study|Screening failure|2|||
125330838|NCT02892448|450842673|FG001|Overall Study|Screening failure|2|||
125330839|NCT02892448|450842674|FG002|Overall Study|Screening failure|1|||
125330840|NCT01012440|450842675|FG000|Overall Study|Withdrawal by Subject|2|||
125330841|NCT00594815|450842676|FG000|Overall Study|Never Treated|3|||
125330842|NCT00594815|450842676|FG000|Overall Study|Withdrawal by Subject|2|||
125330843|NCT00594815|450842676|FG000|Overall Study|Toxicity|4|||
125330844|NCT02691507|450842677|FG000|Overall Study|Missed Visit 3|0|||
125330845|NCT02691507|450842678|FG001|Overall Study|Missed Visit 3|1|||
125330846|NCT01812252|450842679|FG000|Overall Study|Persistent Disease|1|||
125330847|NCT01812252|450842680|FG001|Overall Study|Persistent Disease|0|||
125330848|NCT01812252|450842679|FG000|Overall Study|Not transplanted|11|||
125330849|NCT01812252|450842680|FG001|Overall Study|Not transplanted|11|||
125330850|NCT01812252|450842679|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
125330851|NCT01812252|450842680|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
125330852|NCT01812252|450842679|FG000|Overall Study|Withdrawal by Subject|1|||
125330853|NCT01812252|450842680|FG001|Overall Study|Withdrawal by Subject|1|||
125330854|NCT01812252|450842679|FG000|Overall Study|Screen Failure|1|||
125330855|NCT01812252|450842680|FG001|Overall Study|Screen Failure|0|||
125330856|NCT04634253|450842682|FG000|Overall Study|Adverse Event|1|||
125330857|NCT04634253|450842683|FG001|Overall Study|Adverse Event|1|||
125330858|NCT04634253|450842684|FG002|Overall Study|Adverse Event|0|||
125330859|NCT04634253|450842682|FG000|Overall Study|Physician Decision|0|||
125330860|NCT04634253|450842683|FG001|Overall Study|Physician Decision|1|||
125330861|NCT04634253|450842684|FG002|Overall Study|Physician Decision|0|||
125330862|NCT04634253|450842682|FG000|Overall Study|Withdrawal by Subject|1|||
125330863|NCT04634253|450842683|FG001|Overall Study|Withdrawal by Subject|0|||
125330864|NCT04634253|450842684|FG002|Overall Study|Withdrawal by Subject|3|||
125330865|NCT03155841|450842685|FG000|Overall Study|Protocol Violation|3|||
125668498|NCT01328054|452073897|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
125668499|NCT03493698|452073898|FG000|Treatment Period C|Adverse Event|1|||
125668500|NCT03493698|452073898|FG000|Treatment Period C|Withdrawal by Subject|1|||
125668501|NCT03443869|452073903|FG000|Overall Study|Death|3|||
125668502|NCT03443869|452073904|FG001|Overall Study|Death|3|||
125668503|NCT03443869|452073903|FG000|Overall Study|Withdrawal by Subject|34|||
125668504|NCT03443869|452073904|FG001|Overall Study|Withdrawal by Subject|22|||
125668505|NCT03443869|452073903|FG000|Overall Study|Lost to Follow-up|1|||
125668506|NCT03443869|452073904|FG001|Overall Study|Lost to Follow-up|2|||
125668507|NCT03443869|452073903|FG000|Overall Study|Physician Decision|3|||
125668508|NCT03443869|452073904|FG001|Overall Study|Physician Decision|3|||
125668509|NCT03443869|452073903|FG000|Overall Study|Other|4|||
125668510|NCT03443869|452073904|FG001|Overall Study|Other|4|||
125668511|NCT00299728|452073905|FG000|Overall Study|Lost to Follow-up|0|||
125668512|NCT00299728|452073906|FG001|Overall Study|Lost to Follow-up|1|||
125668513|NCT00299728|452073905|FG000|Overall Study|Withdrawal by Subject|0|||
125668514|NCT00299728|452073906|FG001|Overall Study|Withdrawal by Subject|1|||
125668515|NCT00299728|452073905|FG000|Overall Study|Progressive disease|0|||
125668516|NCT00299728|452073906|FG001|Overall Study|Progressive disease|1|||
125668517|NCT02826603|452073907|FG000|Overall Study|Adverse Event|17|||
125668518|NCT02826603|452073908|FG001|Overall Study|Adverse Event|9|||
125668519|NCT02826603|452073907|FG000|Overall Study|Lack of Efficacy|4|||
125668520|NCT02826603|452073908|FG001|Overall Study|Lack of Efficacy|9|||
125668521|NCT02826603|452073907|FG000|Overall Study|Lost to Follow-up|13|||
125668522|NCT02826603|452073908|FG001|Overall Study|Lost to Follow-up|12|||
125668523|NCT02826603|452073907|FG000|Overall Study|Noncompliance with treatment|0|||
125668524|NCT02826603|452073908|FG001|Overall Study|Noncompliance with treatment|2|||
125668525|NCT02826603|452073907|FG000|Overall Study|Physician Decision|1|||
125330866|NCT03155841|450842686|FG001|Overall Study|Protocol Violation|4|||
125330867|NCT03529422|450842691|FG000|Overall Study|Withdrawal by Subject|1|||
125330868|NCT03529422|450842691|FG000|Overall Study|Protocol Violation|1|||
125668526|NCT02826603|452073908|FG001|Overall Study|Physician Decision|7|||
125668527|NCT02826603|452073907|FG000|Overall Study|Pregnancy|1|||
125668528|NCT02826603|452073908|FG001|Overall Study|Pregnancy|2|||
125668529|NCT02826603|452073907|FG000|Overall Study|Protocol Violation|3|||
125668530|NCT02826603|452073908|FG001|Overall Study|Protocol Violation|3|||
125330869|NCT03529422|450842691|FG000|Overall Study|Disease progression|2|||
125330870|NCT05006573|450842692|FG000|Double-blind Treatment Period|Physician Decision|2|||
125330871|NCT05006573|450842693|FG001|Double-blind Treatment Period|Physician Decision|0|||
125330872|NCT05006573|450842692|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
125668531|NCT02826603|452073907|FG000|Overall Study|Withdrawal by Subject|20|||
125668532|NCT02826603|452073908|FG001|Overall Study|Withdrawal by Subject|19|||
125668533|NCT02826603|452073907|FG000|Overall Study|Death|2|||
125668534|NCT02826603|452073908|FG001|Overall Study|Death|0|||
125668535|NCT02826603|452073907|FG000|Overall Study|New therapy for study indication|0|||
125668536|NCT02826603|452073908|FG001|Overall Study|New therapy for study indication|1|||
125668537|NCT01337050|452073912|FG000|Overall Study|Death|0|||
125668538|NCT01337050|452073913|FG001|Overall Study|Death|0|||
125668539|NCT01337050|452073914|FG002|Overall Study|Death|4|||
125668540|NCT01337050|452073912|FG000|Overall Study|Other|4|||
125668541|NCT01337050|452073913|FG001|Overall Study|Other|6|||
125330873|NCT05006573|450842693|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
125330874|NCT05006573|450842692|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
125330875|NCT05006573|450842693|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
125330876|NCT05006573|450842692|FG000|Double-blind Treatment Period|Protocol Violation|2|||
125330877|NCT05006573|450842693|FG001|Double-blind Treatment Period|Protocol Violation|0|||
125668542|NCT01337050|452073914|FG002|Overall Study|Other|8|||
125668543|NCT01337050|452073912|FG000|Overall Study|Participants refused further follow-up|0|||
125668544|NCT01337050|452073913|FG001|Overall Study|Participants refused further follow-up|7|||
125668545|NCT01337050|452073914|FG002|Overall Study|Participants refused further follow-up|7|||
125668546|NCT00003102|452073915|FG000|Overall Study|Physician Decision|1|||
125668547|NCT00003102|452073916|FG001|Overall Study|Physician Decision|1|||
125668548|NCT00003102|452073917|FG002|Overall Study|Physician Decision|0|||
125668549|NCT00003102|452073915|FG000|Overall Study|Progressive Disease|0|||
125668550|NCT00003102|452073916|FG001|Overall Study|Progressive Disease|1|||
125668551|NCT00003102|452073917|FG002|Overall Study|Progressive Disease|0|||
125668552|NCT00003102|452073915|FG000|Overall Study|Adverse Event|0|||
125668553|NCT00003102|452073916|FG001|Overall Study|Adverse Event|1|||
125668554|NCT00003102|452073917|FG002|Overall Study|Adverse Event|1|||
125668555|NCT00003102|452073915|FG000|Overall Study|Death|0|||
125668556|NCT00003102|452073916|FG001|Overall Study|Death|0|||
125668557|NCT00003102|452073917|FG002|Overall Study|Death|1|||
125668558|NCT00583596|452073918|FG000|Overall Study|Lost to Follow-up|110|||
125668559|NCT00583596|452073918|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
125330878|NCT05006573|450842692|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
125330879|NCT05006573|450842693|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
125330880|NCT05006573|450842692|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
125330881|NCT05006573|450842693|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
125330882|NCT01967238|450842694|FG000|Overall Study|Adverse Event|1|||
125330883|NCT01967238|450842695|FG001|Overall Study|Adverse Event|1|||
125330884|NCT01967238|450842696|FG002|Overall Study|Adverse Event|0|||
125330885|NCT01967238|450842694|FG000|Overall Study|Lost to Follow-up|1|||
125330886|NCT01967238|450842695|FG001|Overall Study|Lost to Follow-up|0|||
125330887|NCT01967238|450842696|FG002|Overall Study|Lost to Follow-up|1|||
125330888|NCT01967238|450842694|FG000|Overall Study|Withdrawal by Subject|0|||
125330889|NCT01967238|450842695|FG001|Overall Study|Withdrawal by Subject|0|||
125330890|NCT01967238|450842696|FG002|Overall Study|Withdrawal by Subject|1|||
125330891|NCT05232682|450842697|FG000|Overall Study|Lost to Follow-up|2|||
125330892|NCT03387085|450842698|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
125330893|NCT01442103|450843983|FG000|Overall Study|Lost to Follow-up|2|||
125330894|NCT02202759|450843984|FG000|Overall Study|Study Terminated by Sponsor|3|||
125330895|NCT02202759|450843985|FG001|Overall Study|Study Terminated by Sponsor|3|||
125330896|NCT02202759|450843986|FG002|Overall Study|Study Terminated by Sponsor|3|||
125330897|NCT02202759|450843984|FG000|Overall Study|Withdrawal by Subject|2|||
125330898|NCT02202759|450843985|FG001|Overall Study|Withdrawal by Subject|1|||
125668560|NCT00583596|452073918|FG000|Overall Study|Death|2|||
125668561|NCT00583596|452073918|FG000|Overall Study|Withdrawal by Subject|6|||
125668562|NCT00583596|452073918|FG000|Overall Study|Lost to Follow-up|94|||
125668563|NCT00583596|452073918|FG000|Overall Study|Data not complete|1|||
125668564|NCT00583596|452073918|FG000|Overall Study|Not consented|15|||
125668565|NCT00583596|452073918|FG000|Overall Study|Outside f-up window|26|||
125668566|NCT00656019|452073919|FG000|Overall Study|Not Eligible|10|||
125668567|NCT00656019|452073920|FG001|Overall Study|Not Eligible|0|||
125330899|NCT02202759|450843986|FG002|Overall Study|Withdrawal by Subject|1|||
125330900|NCT02202759|450843984|FG000|Overall Study|Reason not Specified|4|||
125330901|NCT02202759|450843985|FG001|Overall Study|Reason not Specified|11|||
125668568|NCT00656019|452073921|FG002|Overall Study|Not Eligible|0|||
125668569|NCT00656019|452073922|FG003|Overall Study|Not Eligible|0|||
125330902|NCT02202759|450843986|FG002|Overall Study|Reason not Specified|10|||
125668570|NCT00656019|452073919|FG000|Overall Study|Withdrawal by Subject|2|||
125668571|NCT00656019|452073920|FG001|Overall Study|Withdrawal by Subject|0|||
125668572|NCT00656019|452073921|FG002|Overall Study|Withdrawal by Subject|0|||
125668573|NCT00656019|452073922|FG003|Overall Study|Withdrawal by Subject|0|||
125668574|NCT00656019|452073919|FG000|Overall Study|Lost to Follow-up|2|||
125668575|NCT00656019|452073920|FG001|Overall Study|Lost to Follow-up|1|||
125668576|NCT00656019|452073921|FG002|Overall Study|Lost to Follow-up|0|||
125668577|NCT00656019|452073922|FG003|Overall Study|Lost to Follow-up|0|||
125668578|NCT00096486|452073923|FG000|Overall Study|Withdrawal by Subject|0|||
125668579|NCT00096486|452073924|FG001|Overall Study|Withdrawal by Subject|0|||
125668580|NCT00096486|452073925|FG002|Overall Study|Withdrawal by Subject|1|||
125668581|NCT00096486|452073926|FG003|Overall Study|Withdrawal by Subject|1|||
125668582|NCT00096486|452073923|FG000|Overall Study|Not Treated|0|||
125668583|NCT00096486|452073924|FG001|Overall Study|Not Treated|0|||
125668584|NCT00096486|452073925|FG002|Overall Study|Not Treated|1|||
125668585|NCT00096486|452073926|FG003|Overall Study|Not Treated|1|||
125668586|NCT03558997|452073927|FG000|Overall Study|Adverse Event|0|||
125668587|NCT03558997|452073928|FG001|Overall Study|Adverse Event|2|||
125668588|NCT03558997|452073929|FG002|Overall Study|Adverse Event|5|||
125668589|NCT03558997|452073930|FG003|Overall Study|Adverse Event|1|||
125668590|NCT03558997|452073927|FG000|Overall Study|Physician Decision|0|||
125668591|NCT03558997|452073928|FG001|Overall Study|Physician Decision|0|||
125668592|NCT03558997|452073929|FG002|Overall Study|Physician Decision|1|||
125668593|NCT03558997|452073930|FG003|Overall Study|Physician Decision|0|||
125668594|NCT03558997|452073927|FG000|Overall Study|Withdrawal by Subject|1|||
125668595|NCT03558997|452073928|FG001|Overall Study|Withdrawal by Subject|0|||
125668596|NCT03558997|452073929|FG002|Overall Study|Withdrawal by Subject|1|||
125668597|NCT03558997|452073930|FG003|Overall Study|Withdrawal by Subject|1|||
125668598|NCT03558997|452073927|FG000|Overall Study|Lost to Follow-up|0|||
125668599|NCT03558997|452073928|FG001|Overall Study|Lost to Follow-up|0|||
125668600|NCT03558997|452073929|FG002|Overall Study|Lost to Follow-up|1|||
125668601|NCT03558997|452073930|FG003|Overall Study|Lost to Follow-up|0|||
125668602|NCT02230085|452073931|FG000|Overall Study|Physician Decision|1|||
125668603|NCT02230085|452073931|FG000|Overall Study|Withdrawal by Subject|3|||
125668604|NCT02173301|452073935|FG000|Overall Study|Adverse Event|7|||
125668605|NCT02173301|452073936|FG001|Overall Study|Adverse Event|8|||
125668606|NCT02173301|452073937|FG002|Overall Study|Adverse Event|13|||
125668607|NCT02173301|452073938|FG003|Overall Study|Adverse Event|5|||
125668608|NCT02173301|452073935|FG000|Overall Study|Withdrawal by Subject|8|||
125668609|NCT02173301|452073936|FG001|Overall Study|Withdrawal by Subject|10|||
125668610|NCT02173301|452073937|FG002|Overall Study|Withdrawal by Subject|4|||
125668611|NCT02173301|452073938|FG003|Overall Study|Withdrawal by Subject|8|||
125668612|NCT02173301|452073935|FG000|Overall Study|Lost to Follow-up|4|||
125668613|NCT02173301|452073936|FG001|Overall Study|Lost to Follow-up|4|||
125668614|NCT02173301|452073937|FG002|Overall Study|Lost to Follow-up|2|||
125668615|NCT02173301|452073938|FG003|Overall Study|Lost to Follow-up|2|||
125668616|NCT02173301|452073935|FG000|Overall Study|Protocol Violation|0|||
125668617|NCT02173301|452073936|FG001|Overall Study|Protocol Violation|1|||
125668618|NCT02173301|452073937|FG002|Overall Study|Protocol Violation|0|||
125668619|NCT02173301|452073938|FG003|Overall Study|Protocol Violation|0|||
125668620|NCT02173301|452073935|FG000|Overall Study|Physician Decision|0|||
125668621|NCT02173301|452073936|FG001|Overall Study|Physician Decision|0|||
125668622|NCT02173301|452073937|FG002|Overall Study|Physician Decision|1|||
125668623|NCT02173301|452073938|FG003|Overall Study|Physician Decision|0|||
125668624|NCT02173301|452073935|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
125668625|NCT02173301|452073936|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
125668626|NCT02173301|452073937|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
125668627|NCT02173301|452073938|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
125668628|NCT03016078|452073940|FG000|Overall Study|Protocol Violation|1|||
125668629|NCT03016078|452073940|FG000|Overall Study|Protocol Violation|1|||
125668630|NCT02123459|452073943|FG000|Washout Period (1 Day)|Adverse Event|1|||
125668631|NCT02123459|452073944|FG001|Washout Period (1 Day)|Adverse Event|0|||
125668632|NCT00254397|452073945|FG000|Overall Study|Disease Progression|4|||
125668633|NCT00254397|452073946|FG001|Overall Study|Disease Progression|1|||
125330903|NCT01987453|450843987|FG000|Overall Study|Death|0|||
125330904|NCT01987453|450843988|FG001|Overall Study|Death|0|||
125330905|NCT01987453|450843989|FG002|Overall Study|Death|1|||
125330906|NCT01987453|450843987|FG000|Overall Study|Lack of Efficacy|1|||
125330907|NCT01987453|450843988|FG001|Overall Study|Lack of Efficacy|12|||
125330908|NCT01987453|450843989|FG002|Overall Study|Lack of Efficacy|0|||
125330909|NCT01590888|450843991|FG000|Overall Study|Adverse Event|3|||
125330910|NCT01590888|450843992|FG001|Overall Study|Adverse Event|0|||
125330911|NCT01590888|450843993|FG002|Overall Study|Adverse Event|1|||
125330912|NCT01590888|450843991|FG000|Overall Study|Lost to Follow-up|1|||
125330913|NCT01590888|450843992|FG001|Overall Study|Lost to Follow-up|0|||
125330914|NCT01590888|450843993|FG002|Overall Study|Lost to Follow-up|0|||
125330915|NCT01646125|450843994|FG000|Overall Study|Untreated|2|||
125330916|NCT01646125|450843995|FG001|Overall Study|Untreated|5|||
125330917|NCT01646125|450843994|FG000|Overall Study|Adverse Event|2|||
125668634|NCT00254397|452073947|FG002|Overall Study|Disease Progression|16|||
125668635|NCT00254397|452073948|FG003|Overall Study|Disease Progression|23|||
125668636|NCT00254397|452073945|FG000|Overall Study|Non-Compliant|0|||
125668637|NCT00254397|452073946|FG001|Overall Study|Non-Compliant|0|||
125668638|NCT00254397|452073947|FG002|Overall Study|Non-Compliant|0|||
125330918|NCT01646125|450843995|FG001|Overall Study|Adverse Event|1|||
125330919|NCT01646125|450843994|FG000|Overall Study|Death|1|||
125330920|NCT01646125|450843995|FG001|Overall Study|Death|1|||
125330921|NCT01646125|450843994|FG000|Overall Study|Physician Decision|1|||
125330922|NCT01646125|450843995|FG001|Overall Study|Physician Decision|3|||
125330923|NCT01646125|450843994|FG000|Overall Study|Progressive disease|22|||
125330924|NCT01646125|450843995|FG001|Overall Study|Progressive disease|16|||
125330925|NCT01646125|450843994|FG000|Overall Study|Study terminated by sponsor|2|||
125330926|NCT01646125|450843995|FG001|Overall Study|Study terminated by sponsor|1|||
125330927|NCT01646125|450843994|FG000|Overall Study|Subject/Guardian decision|1|||
125330928|NCT01646125|450843995|FG001|Overall Study|Subject/Guardian decision|1|||
125330929|NCT05462756|450843998|FG000|Treatment Period|Adverse Event|3|||
125330930|NCT05462756|450843999|FG001|Treatment Period|Adverse Event|0|||
125330931|NCT05462756|450843998|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
125330932|NCT05462756|450843999|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
125330933|NCT05462756|450843998|FG000|Treatment Period|Death|0|||
125330934|NCT05462756|450843999|FG001|Treatment Period|Death|1|||
125330935|NCT05462756|450843998|FG000|Treatment Period|Lost to Follow-up|2|||
125330936|NCT05462756|450843999|FG001|Treatment Period|Lost to Follow-up|1|||
125330937|NCT05462756|450843998|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
125330938|NCT05462756|450843999|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
125330939|NCT05462756|450843998|FG000|Treatment Period|Physician Decision|2|||
125668639|NCT00254397|452073948|FG003|Overall Study|Non-Compliant|1|||
125668640|NCT00254397|452073945|FG000|Overall Study|Adverse Event|2|||
125668641|NCT00254397|452073946|FG001|Overall Study|Adverse Event|0|||
125668642|NCT00254397|452073947|FG002|Overall Study|Adverse Event|3|||
125668643|NCT00254397|452073948|FG003|Overall Study|Adverse Event|1|||
125668644|NCT00972153|452073961|FG000|Overall Study|Equipment malfunction during case|0|||
125668645|NCT00972153|452073962|FG001|Overall Study|Equipment malfunction during case|1|||
125668646|NCT00972153|452073963|FG002|Overall Study|Equipment malfunction during case|0|||
125668647|NCT04136626|452073964|FG000|Treatment Phase|Withdrawal by Subject|1|||
125668648|NCT04136626|452073965|FG001|Treatment Phase|Withdrawal by Subject|9|||
125668649|NCT04136626|452073964|FG000|Treatment Phase|Adverse Event|1|||
125668650|NCT04136626|452073965|FG001|Treatment Phase|Adverse Event|0|||
125668651|NCT04136626|452073964|FG000|Treatment Phase|Lost to Follow-up|1|||
125668652|NCT04136626|452073965|FG001|Treatment Phase|Lost to Follow-up|5|||
125668653|NCT04136626|452073964|FG000|12-month Follow-up|Lost to Follow-up|8|||
125668654|NCT04136626|452073965|FG001|12-month Follow-up|Lost to Follow-up|7|||
125668655|NCT00409188|452075817|FG000|Overall Study|Ongoing at data cut-off|383|||
125668656|NCT00409188|452075818|FG001|Overall Study|Ongoing at data cut-off|175|||
125668657|NCT01393990|452075822|FG000|Overall Study|Adverse Event|0|||
125668658|NCT01393990|452075823|FG001|Overall Study|Adverse Event|0|||
125668659|NCT01393990|452075824|FG002|Overall Study|Adverse Event|0|||
125668660|NCT01393990|452075825|FG003|Overall Study|Adverse Event|0|||
125668661|NCT01393990|452075826|FG004|Overall Study|Adverse Event|0|||
125668662|NCT01393990|452075827|FG005|Overall Study|Adverse Event|0|||
125668663|NCT01393990|452075828|FG006|Overall Study|Adverse Event|0|||
125668664|NCT01393990|452075829|FG007|Overall Study|Adverse Event|0|||
125668665|NCT01393990|452075830|FG008|Overall Study|Adverse Event|0|||
125668666|NCT01393990|452075831|FG009|Overall Study|Adverse Event|0|||
125668667|NCT01393990|452075832|FG010|Overall Study|Adverse Event|0|||
125668668|NCT01393990|452075833|FG011|Overall Study|Adverse Event|0|||
125668669|NCT01393990|452075834|FG012|Overall Study|Adverse Event|0|||
125668670|NCT01393990|452075835|FG013|Overall Study|Adverse Event|0|||
125668671|NCT01393990|452075836|FG014|Overall Study|Adverse Event|1|||
125668672|NCT01393990|452075837|FG015|Overall Study|Adverse Event|1|||
125668673|NCT01393990|452075838|FG016|Overall Study|Adverse Event|0|||
125668674|NCT01393990|452075839|FG017|Overall Study|Adverse Event|0|||
125668675|NCT01393990|452075822|FG000|Overall Study|Progressive Disease|1|||
125668676|NCT01393990|452075823|FG001|Overall Study|Progressive Disease|0|||
125668677|NCT01393990|452075824|FG002|Overall Study|Progressive Disease|0|||
125668678|NCT01393990|452075825|FG003|Overall Study|Progressive Disease|1|||
125668679|NCT01393990|452075826|FG004|Overall Study|Progressive Disease|1|||
125668680|NCT01393990|452075827|FG005|Overall Study|Progressive Disease|1|||
125330940|NCT05462756|450843999|FG001|Treatment Period|Physician Decision|0|||
125330941|NCT05462756|450843998|FG000|Treatment Period|Protocol Violation|0|||
125330942|NCT05462756|450843999|FG001|Treatment Period|Protocol Violation|1|||
125330943|NCT05462756|450843998|FG000|Treatment Period|Withdrawal by Subject|5|||
125330944|NCT05462756|450843999|FG001|Treatment Period|Withdrawal by Subject|12|||
125330945|NCT05462756|450843998|FG000|Follow-Up Period|Adverse Event|1|||
125668681|NCT01393990|452075828|FG006|Overall Study|Progressive Disease|1|||
125668682|NCT01393990|452075829|FG007|Overall Study|Progressive Disease|1|||
125330946|NCT05462756|450843999|FG001|Follow-Up Period|Adverse Event|0|||
125668683|NCT01393990|452075830|FG008|Overall Study|Progressive Disease|3|||
125668684|NCT01393990|452075831|FG009|Overall Study|Progressive Disease|1|||
125668685|NCT01393990|452075832|FG010|Overall Study|Progressive Disease|0|||
125668686|NCT01393990|452075833|FG011|Overall Study|Progressive Disease|0|||
125668687|NCT01393990|452075834|FG012|Overall Study|Progressive Disease|0|||
125668688|NCT01393990|452075835|FG013|Overall Study|Progressive Disease|1|||
125668689|NCT01393990|452075836|FG014|Overall Study|Progressive Disease|6|||
125668690|NCT01393990|452075837|FG015|Overall Study|Progressive Disease|1|||
125668691|NCT01393990|452075838|FG016|Overall Study|Progressive Disease|0|||
125668692|NCT01393990|452075839|FG017|Overall Study|Progressive Disease|0|||
125668693|NCT01393990|452075822|FG000|Overall Study|Death|0|||
125668694|NCT01393990|452075823|FG001|Overall Study|Death|0|||
125668695|NCT01393990|452075824|FG002|Overall Study|Death|0|||
125668696|NCT01393990|452075825|FG003|Overall Study|Death|0|||
125668697|NCT01393990|452075826|FG004|Overall Study|Death|1|||
125668698|NCT01393990|452075827|FG005|Overall Study|Death|0|||
125668699|NCT01393990|452075828|FG006|Overall Study|Death|0|||
125668700|NCT01393990|452075829|FG007|Overall Study|Death|0|||
125668701|NCT01393990|452075830|FG008|Overall Study|Death|0|||
125668702|NCT01393990|452075831|FG009|Overall Study|Death|0|||
125668703|NCT01393990|452075832|FG010|Overall Study|Death|0|||
125668704|NCT01393990|452075833|FG011|Overall Study|Death|0|||
125668705|NCT01393990|452075834|FG012|Overall Study|Death|0|||
125668706|NCT01393990|452075835|FG013|Overall Study|Death|1|||
125668707|NCT01393990|452075836|FG014|Overall Study|Death|1|||
125668708|NCT01393990|452075837|FG015|Overall Study|Death|0|||
125668709|NCT01393990|452075838|FG016|Overall Study|Death|0|||
125668710|NCT01393990|452075839|FG017|Overall Study|Death|0|||
125668711|NCT01393990|452075822|FG000|Overall Study|Withdrawal by Subject|0|||
125668712|NCT01393990|452075823|FG001|Overall Study|Withdrawal by Subject|0|||
125668713|NCT01393990|452075824|FG002|Overall Study|Withdrawal by Subject|0|||
125668714|NCT01393990|452075825|FG003|Overall Study|Withdrawal by Subject|0|||
125668715|NCT01393990|452075826|FG004|Overall Study|Withdrawal by Subject|0|||
125668716|NCT01393990|452075827|FG005|Overall Study|Withdrawal by Subject|0|||
125668717|NCT01393990|452075828|FG006|Overall Study|Withdrawal by Subject|0|||
125668718|NCT01393990|452075829|FG007|Overall Study|Withdrawal by Subject|0|||
125668719|NCT01393990|452075830|FG008|Overall Study|Withdrawal by Subject|0|||
125668720|NCT01393990|452075831|FG009|Overall Study|Withdrawal by Subject|0|||
125668721|NCT01393990|452075832|FG010|Overall Study|Withdrawal by Subject|0|||
125668722|NCT01393990|452075833|FG011|Overall Study|Withdrawal by Subject|0|||
125668723|NCT01393990|452075834|FG012|Overall Study|Withdrawal by Subject|0|||
125668724|NCT01393990|452075835|FG013|Overall Study|Withdrawal by Subject|0|||
125668725|NCT01393990|452075836|FG014|Overall Study|Withdrawal by Subject|1|||
125668726|NCT01393990|452075837|FG015|Overall Study|Withdrawal by Subject|1|||
125668727|NCT01393990|452075838|FG016|Overall Study|Withdrawal by Subject|0|||
125668728|NCT01393990|452075839|FG017|Overall Study|Withdrawal by Subject|0|||
125668729|NCT00275028|452075840|FG000|Overall Study|Withdrew consent before treatment began|1|||
125668730|NCT00275028|452075840|FG000|Overall Study|Withdrawal by Subject|5|||
125668731|NCT00275028|452075840|FG000|Overall Study|Adverse Event|9|||
125668732|NCT00275028|452075840|FG000|Overall Study|Progressive Disease|30|||
125668733|NCT00275028|452075840|FG000|Overall Study|Physician Decision|2|||
125668734|NCT00720798|452075842|FG000|Overall Study|Adverse Event|304|||
125668735|NCT00720798|452075842|FG000|Overall Study|Death|39|||
125668736|NCT00720798|452075842|FG000|Overall Study|Insufficient Therapeutic Response|129|||
125668737|NCT00720798|452075842|FG000|Overall Study|Protocol Violation|4|||
125668738|NCT00720798|452075842|FG000|Overall Study|Refused Treatment|151|||
125668739|NCT00720798|452075842|FG000|Overall Study|Failure to Return|46|||
125668740|NCT00720798|452075842|FG000|Overall Study|Reason not Specified|83|||
125668741|NCT00433381|452075843|FG000|Overall Study|Ineligible / no protocol treatment|3|||
125668742|NCT00433381|452075844|FG001|Overall Study|Ineligible / no protocol treatment|3|||
125668743|NCT00549198|452075849|FG000|Overall Study|Adverse Event|28|||
125668744|NCT00549198|452075850|FG001|Overall Study|Adverse Event|26|||
125668745|NCT00549198|452075849|FG000|Overall Study|Insufficient Viral Load Response|4|||
125668746|NCT00549198|452075850|FG001|Overall Study|Insufficient Viral Load Response|2|||
125668747|NCT00549198|452075849|FG000|Overall Study|Protocol-defined Virological Failure|7|||
125668748|NCT00549198|452075850|FG001|Overall Study|Protocol-defined Virological Failure|0|||
125668749|NCT00549198|452075849|FG000|Overall Study|Non-compliance|2|||
125668750|NCT00549198|452075850|FG001|Overall Study|Non-compliance|4|||
125668751|NCT00549198|452075849|FG000|Overall Study|Lost to Follow-up|7|||
125668752|NCT00549198|452075850|FG001|Overall Study|Lost to Follow-up|8|||
125668753|NCT00549198|452075849|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
125668754|NCT00549198|452075850|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
125668755|NCT00549198|452075849|FG000|Overall Study|Protocol Violation|7|||
125668756|NCT00549198|452075850|FG001|Overall Study|Protocol Violation|2|||
125668757|NCT00549198|452075849|FG000|Overall Study|Investigator Decision|4|||
125668758|NCT00549198|452075850|FG001|Overall Study|Investigator Decision|3|||
125668759|NCT00549198|452075849|FG000|Overall Study|Withdrawal by Subject|7|||
125668760|NCT00549198|452075850|FG001|Overall Study|Withdrawal by Subject|7|||
125668761|NCT00549198|452075849|FG000|Overall Study|Disease Progression|1|||
125668762|NCT00549198|452075850|FG001|Overall Study|Disease Progression|0|||
125668763|NCT00549198|452075849|FG000|Overall Study|Participant Moved|2|||
125668764|NCT00549198|452075850|FG001|Overall Study|Participant Moved|0|||
125668765|NCT00549198|452075849|FG000|Overall Study|Participant not able to perform Week 96|1|||
125668766|NCT00549198|452075850|FG001|Overall Study|Participant not able to perform Week 96|0|||
125668767|NCT00549198|452075849|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
125330947|NCT05462756|450843998|FG000|Follow-Up Period|Death|1|||
125330948|NCT05462756|450843999|FG001|Follow-Up Period|Death|0|||
125330949|NCT05462756|450843998|FG000|Follow-Up Period|Lost to Follow-up|3|||
125330950|NCT05462756|450843999|FG001|Follow-Up Period|Lost to Follow-up|1|||
125330951|NCT05462756|450843998|FG000|Follow-Up Period|Withdrawal by Subject|0|||
125330952|NCT05462756|450843999|FG001|Follow-Up Period|Withdrawal by Subject|4|||
125668768|NCT00549198|452075850|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
125668769|NCT00549198|452075849|FG000|Overall Study|Prohibited Medication|1|||
125668770|NCT00549198|452075850|FG001|Overall Study|Prohibited Medication|2|||
125668771|NCT00549198|452075849|FG000|Overall Study|Participant planning pregnancy|1|||
125668772|NCT00549198|452075850|FG001|Overall Study|Participant planning pregnancy|0|||
125668773|NCT00549198|452075849|FG000|Overall Study|Participant overweight, no scan possible|1|||
125668774|NCT00549198|452075850|FG001|Overall Study|Participant overweight, no scan possible|0|||
125668775|NCT00549198|452075849|FG000|Overall Study|No scan facilities|0|||
125668776|NCT00549198|452075850|FG001|Overall Study|No scan facilities|2|||
125668777|NCT00549198|452075849|FG000|Overall Study|Pregnancy|0|||
125668778|NCT00549198|452075850|FG001|Overall Study|Pregnancy|3|||
125668779|NCT00549198|452075849|FG000|Overall Study|Not Exposed to Study Drug|3|||
125668780|NCT00549198|452075850|FG001|Overall Study|Not Exposed to Study Drug|4|||
125668781|NCT00472446|452075851|FG000|Overall Study|Protocol Violation|0|||
125668782|NCT00472446|452075852|FG001|Overall Study|Protocol Violation|0|||
125668783|NCT00472446|452075853|FG002|Overall Study|Protocol Violation|0|||
125668784|NCT00472446|452075854|FG003|Overall Study|Protocol Violation|1|||
125668785|NCT00472446|452075851|FG000|Overall Study|Reintervention|0|||
125668786|NCT00472446|452075852|FG001|Overall Study|Reintervention|0|||
125668787|NCT00472446|452075853|FG002|Overall Study|Reintervention|1|||
125668788|NCT00472446|452075854|FG003|Overall Study|Reintervention|1|||
125668789|NCT00472446|452075851|FG000|Overall Study|Questionnaires not returned|5|||
125668790|NCT00472446|452075852|FG001|Overall Study|Questionnaires not returned|6|||
125668791|NCT00472446|452075853|FG002|Overall Study|Questionnaires not returned|6|||
125668792|NCT00472446|452075854|FG003|Overall Study|Questionnaires not returned|4|||
125668793|NCT01165684|452075855|FG000|Overall Study|Adverse Event|1|||
125668794|NCT01165684|452075856|FG001|Overall Study|Adverse Event|1|||
125668795|NCT01165684|452075855|FG000|Overall Study|Lack of Efficacy|2|||
125668796|NCT01165684|452075856|FG001|Overall Study|Lack of Efficacy|1|||
125668797|NCT01165684|452075855|FG000|Overall Study|Protocol Violation|7|||
125668798|NCT01165684|452075856|FG001|Overall Study|Protocol Violation|15|||
125668799|NCT01165684|452075855|FG000|Overall Study|Withdrawal Criteria|2|||
125668800|NCT01165684|452075856|FG001|Overall Study|Withdrawal Criteria|13|||
125668801|NCT01165684|452075855|FG000|Overall Study|Unclassified|16|||
125668802|NCT01165684|452075856|FG001|Overall Study|Unclassified|22|||
125668803|NCT00671879|452075857|FG000|Overall Study|Withdrawal by Subject|0|||
125668804|NCT00671879|452075858|FG001|Overall Study|Withdrawal by Subject|4|||
125668805|NCT00671879|452075859|FG002|Overall Study|Withdrawal by Subject|6|||
125668806|NCT04633837|452075862|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
125668807|NCT04633837|452075863|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
125668808|NCT00901628|452075864|FG000|Overall Study|disconnection of catheter|4|||
125668809|NCT00901628|452075865|FG001|Overall Study|disconnection of catheter|8|||
125668810|NCT00901628|452075864|FG000|Overall Study|disconnection of drain|0|||
125668811|NCT00901628|452075865|FG001|Overall Study|disconnection of drain|1|||
125668812|NCT00901628|452075864|FG000|Overall Study|peroneal nerve palsy|0|||
125668813|NCT00901628|452075865|FG001|Overall Study|peroneal nerve palsy|1|||
125668814|NCT00608205|452075868|FG000|Overall Study|Adverse Event|3|||
125668815|NCT00608205|452075869|FG001|Overall Study|Adverse Event|2|||
125668816|NCT00608205|452075868|FG000|Overall Study|Patient non-compliant|0|||
125668817|NCT00608205|452075869|FG001|Overall Study|Patient non-compliant|1|||
125668818|NCT01797120|452075870|FG000|Overall Study|Disesae progression|37|||
125668819|NCT01797120|452075871|FG001|Overall Study|Disesae progression|49|||
125668820|NCT01797120|452075870|FG000|Overall Study|Adverse Event|13|||
125668821|NCT01797120|452075871|FG001|Overall Study|Adverse Event|5|||
125668822|NCT01797120|452075870|FG000|Overall Study|Withdrawal by Subject|6|||
125668823|NCT01797120|452075871|FG001|Overall Study|Withdrawal by Subject|6|||
125668824|NCT01797120|452075870|FG000|Overall Study|Symptomatic progression|2|||
125668825|NCT01797120|452075871|FG001|Overall Study|Symptomatic progression|1|||
125668826|NCT01797120|452075870|FG000|Overall Study|Non-compliance|1|||
125668827|NCT01797120|452075871|FG001|Overall Study|Non-compliance|0|||
125668828|NCT01797120|452075870|FG000|Overall Study|Physician Decision|3|||
125668829|NCT01797120|452075871|FG001|Overall Study|Physician Decision|0|||
125668830|NCT01797120|452075870|FG000|Overall Study|still on treatment|2|||
125668831|NCT01797120|452075871|FG001|Overall Study|still on treatment|4|||
125668832|NCT01797120|452075870|FG000|Overall Study|never start protocol therapy|2|||
125668833|NCT01797120|452075871|FG001|Overall Study|never start protocol therapy|0|||
125668834|NCT01909466|452075877|FG000|Overall Study|Lost to Follow-up|5|||
125668835|NCT01909466|452075878|FG001|Overall Study|Lost to Follow-up|7|||
125668836|NCT01909466|452075877|FG000|Overall Study|Adverse Event|3|||
125668837|NCT01909466|452075878|FG001|Overall Study|Adverse Event|4|||
125330953|NCT04040933|450844001|FG000|Overall Study|Protocol Violation|1|||
125668838|NCT01909466|452075877|FG000|Overall Study|Met Withdrawal Criteria|0|||
125668839|NCT01909466|452075878|FG001|Overall Study|Met Withdrawal Criteria|3|||
125668840|NCT01909466|452075877|FG000|Overall Study|Physician Decision|2|||
125668841|NCT01909466|452075878|FG001|Overall Study|Physician Decision|0|||
125668842|NCT01909466|452075877|FG000|Overall Study|Withdrawal by Subject|11|||
125668843|NCT01909466|452075878|FG001|Overall Study|Withdrawal by Subject|9|||
125668844|NCT01909466|452075877|FG000|Overall Study|Lack of Efficacy|1|||
125668845|NCT01909466|452075878|FG001|Overall Study|Lack of Efficacy|0|||
125668846|NCT01339910|452075879|FG000|Overall Study|Withdrawal by Subject|1|||
125668847|NCT01339910|452075880|FG001|Overall Study|Withdrawal by Subject|0|||
125668848|NCT01339910|452075879|FG000|Overall Study|Physician Decision|1|||
125668849|NCT01339910|452075880|FG001|Overall Study|Physician Decision|0|||
125668850|NCT01339910|452075879|FG000|Overall Study|Disease relapse|1|||
125668851|NCT01339910|452075880|FG001|Overall Study|Disease relapse|4|||
125668852|NCT01567306|452075882|FG000|Overall Study|Protocol Violation|2|||
125668853|NCT01567306|452075883|FG001|Overall Study|Protocol Violation|2|||
125668854|NCT01567306|452075884|FG002|Overall Study|Protocol Violation|0|||
125668855|NCT01567306|452075885|FG003|Overall Study|Protocol Violation|3|||
125668856|NCT01567306|452075886|FG004|Overall Study|Protocol Violation|1|||
125668857|NCT01567306|452075887|FG005|Overall Study|Protocol Violation|1|||
125668858|NCT01567306|452075882|FG000|Overall Study|Change site living|1|||
125668859|NCT01567306|452075883|FG001|Overall Study|Change site living|0|||
125668860|NCT01567306|452075884|FG002|Overall Study|Change site living|0|||
125668861|NCT01567306|452075885|FG003|Overall Study|Change site living|0|||
125668862|NCT01567306|452075886|FG004|Overall Study|Change site living|0|||
125668863|NCT01567306|452075887|FG005|Overall Study|Change site living|0|||
125668864|NCT01567306|452075882|FG000|Overall Study|Adverse Event|0|||
125668865|NCT01567306|452075883|FG001|Overall Study|Adverse Event|0|||
125668866|NCT01567306|452075884|FG002|Overall Study|Adverse Event|0|||
125668867|NCT01567306|452075885|FG003|Overall Study|Adverse Event|2|||
125668868|NCT01567306|452075886|FG004|Overall Study|Adverse Event|4|||
125668869|NCT01567306|452075887|FG005|Overall Study|Adverse Event|1|||
125668870|NCT01567306|452075882|FG000|Overall Study|Lost to Follow-up|0|||
125668871|NCT01567306|452075883|FG001|Overall Study|Lost to Follow-up|0|||
125668872|NCT01567306|452075884|FG002|Overall Study|Lost to Follow-up|0|||
125668873|NCT01567306|452075885|FG003|Overall Study|Lost to Follow-up|0|||
125668874|NCT01567306|452075886|FG004|Overall Study|Lost to Follow-up|2|||
125668875|NCT01567306|452075887|FG005|Overall Study|Lost to Follow-up|0|||
125668876|NCT01567306|452075882|FG000|Overall Study|Withdrawal by Subject|0|||
125668877|NCT01567306|452075883|FG001|Overall Study|Withdrawal by Subject|0|||
125668878|NCT01567306|452075884|FG002|Overall Study|Withdrawal by Subject|0|||
125668879|NCT01567306|452075885|FG003|Overall Study|Withdrawal by Subject|0|||
125668880|NCT01567306|452075886|FG004|Overall Study|Withdrawal by Subject|0|||
125668881|NCT01567306|452075887|FG005|Overall Study|Withdrawal by Subject|1|||
125668882|NCT00738673|452075888|FG000|Overall Study|Adverse Event|1|||
125668883|NCT00738673|452075889|FG001|Overall Study|Adverse Event|0|||
125668884|NCT00738673|452075888|FG000|Overall Study|Lack of Efficacy|19|||
125668885|NCT00738673|452075889|FG001|Overall Study|Lack of Efficacy|8|||
125668886|NCT00738673|452075888|FG000|Overall Study|Protocol Violation|1|||
125668887|NCT00738673|452075889|FG001|Overall Study|Protocol Violation|2|||
125668888|NCT00738673|452075888|FG000|Overall Study|Withdrawal by Subject|3|||
125330954|NCT04040933|450844001|FG000|Overall Study|Withdrawal by Subject|2|||
125330955|NCT01705509|450844006|FG000|Inclusion CPET|Screen Failure|5|||
125668889|NCT00738673|452075889|FG001|Overall Study|Withdrawal by Subject|1|||
125668890|NCT03038113|452075890|FG000|Overall Study|Withdrawal by Subject|0|||
125668891|NCT03038113|452075891|FG001|Overall Study|Withdrawal by Subject|0|||
125330956|NCT01705509|450844006|FG000|Inclusion CPET|Withdrawal by Subject|2|||
125330957|NCT01705509|450844006|FG000|CPET w/ Ranexa|Screen Failure|2|||
125330958|NCT01528969|450844009|FG000|Overall Study|absent from the school at baseline|2|||
125330959|NCT01528969|450844010|FG001|Overall Study|absent from the school at baseline|0|||
125330960|NCT01662102|450844011|FG000|Overall Study|Sponsor's decision|1|||
125668892|NCT03038113|452075892|FG002|Overall Study|Withdrawal by Subject|1|||
125668893|NCT03038113|452075893|FG003|Overall Study|Withdrawal by Subject|0|||
125330961|NCT01662102|450844012|FG001|Overall Study|Sponsor's decision|0|||
125668894|NCT03038113|452075894|FG004|Overall Study|Withdrawal by Subject|0|||
125668895|NCT03038113|452075895|FG005|Overall Study|Withdrawal by Subject|0|||
125668896|NCT03038113|452075896|FG006|Overall Study|Withdrawal by Subject|0|||
125668897|NCT03038113|452075897|FG007|Overall Study|Withdrawal by Subject|0|||
125668898|NCT03038113|452075898|FG008|Overall Study|Withdrawal by Subject|0|||
125668899|NCT03038113|452075899|FG009|Overall Study|Withdrawal by Subject|0|||
125668900|NCT03038113|452075900|FG010|Overall Study|Withdrawal by Subject|0|||
125668901|NCT03038113|452075901|FG011|Overall Study|Withdrawal by Subject|0|||
125668902|NCT03038113|452075902|FG012|Overall Study|Withdrawal by Subject|0|||
125668903|NCT03038113|452075903|FG013|Overall Study|Withdrawal by Subject|1|||
125668904|NCT03038113|452075890|FG000|Overall Study|Lost to Follow-up|0|||
125668905|NCT03038113|452075891|FG001|Overall Study|Lost to Follow-up|0|||
125668906|NCT03038113|452075892|FG002|Overall Study|Lost to Follow-up|0|||
125668907|NCT03038113|452075893|FG003|Overall Study|Lost to Follow-up|0|||
125668908|NCT03038113|452075894|FG004|Overall Study|Lost to Follow-up|0|||
125668909|NCT03038113|452075895|FG005|Overall Study|Lost to Follow-up|0|||
125668910|NCT03038113|452075896|FG006|Overall Study|Lost to Follow-up|1|||
125668911|NCT03038113|452075897|FG007|Overall Study|Lost to Follow-up|0|||
125668912|NCT03038113|452075898|FG008|Overall Study|Lost to Follow-up|0|||
125668913|NCT03038113|452075899|FG009|Overall Study|Lost to Follow-up|0|||
125668914|NCT03038113|452075900|FG010|Overall Study|Lost to Follow-up|0|||
125668915|NCT03038113|452075901|FG011|Overall Study|Lost to Follow-up|0|||
125668916|NCT03038113|452075902|FG012|Overall Study|Lost to Follow-up|0|||
125668917|NCT03038113|452075903|FG013|Overall Study|Lost to Follow-up|0|||
125668918|NCT01418352|452075906|FG000|Overall Study|Lost to Follow-up|2|||
125668919|NCT01418352|452075907|FG001|Overall Study|Lost to Follow-up|0|||
125668920|NCT01418352|452075908|FG002|Overall Study|Lost to Follow-up|0|||
125668921|NCT01418352|452075909|FG003|Overall Study|Lost to Follow-up|0|||
125668922|NCT01418352|452075906|FG000|Overall Study|Adverse Event|0|||
125668923|NCT01418352|452075907|FG001|Overall Study|Adverse Event|1|||
125668924|NCT01418352|452075908|FG002|Overall Study|Adverse Event|0|||
125668925|NCT01418352|452075909|FG003|Overall Study|Adverse Event|0|||
125668926|NCT01418352|452075906|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
125668927|NCT01418352|452075907|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
125668928|NCT01418352|452075908|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
125668929|NCT01418352|452075909|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
125668930|NCT01418352|452075906|FG000|Overall Study|Subject Withdrew Consent|0|||
125668931|NCT01418352|452075907|FG001|Overall Study|Subject Withdrew Consent|1|||
125668932|NCT01418352|452075908|FG002|Overall Study|Subject Withdrew Consent|2|||
125668933|NCT01418352|452075909|FG003|Overall Study|Subject Withdrew Consent|1|||
125668934|NCT01418352|452075906|FG000|Overall Study|Protocol Deviation|0|||
125668935|NCT01418352|452075907|FG001|Overall Study|Protocol Deviation|0|||
125668936|NCT01418352|452075908|FG002|Overall Study|Protocol Deviation|1|||
125668937|NCT01418352|452075909|FG003|Overall Study|Protocol Deviation|0|||
125668938|NCT01418352|452075906|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
125668939|NCT01418352|452075907|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
125668940|NCT01418352|452075908|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
125668941|NCT01418352|452075909|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
125668942|NCT00619619|452075910|FG000|Overall Study|Physician Decision|0|||
125668943|NCT00619619|452075911|FG001|Overall Study|Physician Decision|0|||
125668944|NCT00619619|452075912|FG002|Overall Study|Physician Decision|1|||
125668945|NCT00619619|452075913|FG003|Overall Study|Physician Decision|0|||
125668946|NCT00619619|452075914|FG004|Overall Study|Physician Decision|0|||
125668947|NCT00619619|452075915|FG005|Overall Study|Physician Decision|0|||
125668948|NCT00619619|452075916|FG006|Overall Study|Physician Decision|0|||
125668949|NCT00619619|452075917|FG007|Overall Study|Physician Decision|0|||
125668950|NCT00619619|452075910|FG000|Overall Study|Protocol Violation|0|||
125668951|NCT00619619|452075911|FG001|Overall Study|Protocol Violation|0|||
125668952|NCT00619619|452075912|FG002|Overall Study|Protocol Violation|0|||
125668953|NCT00619619|452075913|FG003|Overall Study|Protocol Violation|1|||
125668954|NCT00619619|452075914|FG004|Overall Study|Protocol Violation|0|||
125668955|NCT00619619|452075915|FG005|Overall Study|Protocol Violation|0|||
125668956|NCT00619619|452075916|FG006|Overall Study|Protocol Violation|1|||
125668957|NCT00619619|452075917|FG007|Overall Study|Protocol Violation|1|||
125668958|NCT00619619|452075910|FG000|Overall Study|Adverse Event|0|||
125668959|NCT00619619|452075911|FG001|Overall Study|Adverse Event|0|||
125668960|NCT00619619|452075912|FG002|Overall Study|Adverse Event|0|||
125668961|NCT00619619|452075913|FG003|Overall Study|Adverse Event|0|||
125668962|NCT00619619|452075914|FG004|Overall Study|Adverse Event|2|||
125668963|NCT00619619|452075915|FG005|Overall Study|Adverse Event|0|||
125668964|NCT00619619|452075916|FG006|Overall Study|Adverse Event|0|||
125668965|NCT00619619|452075917|FG007|Overall Study|Adverse Event|2|||
125668966|NCT01092702|452075918|FG000|Overall Study|Withdrawal by Subject|7|||
125668967|NCT01092702|452075918|FG000|Overall Study|Lost to Follow-up|2|||
125668968|NCT03263819|452075919|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
125668969|NCT03263819|452075920|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
125668970|NCT03652961|452075923|FG000|Overall Study|Lost to Follow-up|3|||
125668971|NCT03652961|452075923|FG000|Overall Study|Screen Failure|1|||
125668972|NCT01783496|452075924|FG000|Overall Study|Lost to Follow-up|0|||
125668973|NCT01783496|452075925|FG001|Overall Study|Lost to Follow-up|0|||
125668974|NCT01783496|452075926|FG002|Overall Study|Lost to Follow-up|0|||
125668975|NCT01783496|452075927|FG003|Overall Study|Lost to Follow-up|2|||
125668976|NCT01783496|452075928|FG004|Overall Study|Lost to Follow-up|0|||
125668977|NCT01783496|452075929|FG005|Overall Study|Lost to Follow-up|1|||
125668978|NCT01783496|452075924|FG000|Overall Study|Withdrawal by Subject|1|||
125668979|NCT01783496|452075925|FG001|Overall Study|Withdrawal by Subject|0|||
125668980|NCT01783496|452075926|FG002|Overall Study|Withdrawal by Subject|0|||
125668981|NCT01783496|452075927|FG003|Overall Study|Withdrawal by Subject|0|||
125668982|NCT01783496|452075928|FG004|Overall Study|Withdrawal by Subject|0|||
125668983|NCT01783496|452075929|FG005|Overall Study|Withdrawal by Subject|0|||
125668984|NCT00686920|452075933|FG000|Overall Study|Death|45|||
125330962|NCT00275509|450844015|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
125330963|NCT00275509|450844016|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
125330964|NCT03388164|450844017|FG000|Overall Study|Withdrawal by Subject|3|||
125330965|NCT03388164|450844018|FG001|Overall Study|Withdrawal by Subject|1|||
125330966|NCT03967444|450844019|FG000|Overall Study|Lost to Follow-up|1|||
125330967|NCT03967444|450844020|FG001|Overall Study|Lost to Follow-up|2|||
125330968|NCT01821118|450844022|FG000|Overall Study|Death|0|||
125330969|NCT01821118|450844023|FG001|Overall Study|Death|1|||
125330970|NCT01605799|450844024|FG000|Overall Study|Withdrawal by Subject|2|||
125330971|NCT01605799|450844025|FG001|Overall Study|Withdrawal by Subject|1|||
125330972|NCT00345358|450844026|FG000|Primary Vaccination Phase|Other|0|||
125330973|NCT00345358|450844027|FG001|Primary Vaccination Phase|Other|1|||
125330974|NCT00345358|450844028|FG002|Primary Vaccination Phase|Other|1|||
125330975|NCT00345358|450844029|FG003|Primary Vaccination Phase|Other|0|||
125330976|NCT00345358|450844026|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
125330977|NCT00345358|450844027|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
125330978|NCT00345358|450844028|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
125330979|NCT00345358|450844029|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
125330980|NCT00345358|450844026|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
125668985|NCT00686920|452075934|FG001|Overall Study|Death|14|||
125668986|NCT00686920|452075933|FG000|Overall Study|Liver Transplant|23|||
125668987|NCT00686920|452075934|FG001|Overall Study|Liver Transplant|8|||
125668988|NCT00686920|452075933|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
125668989|NCT00686920|452075934|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
125668990|NCT00686920|452075933|FG000|Overall Study|Withdrawal by Subject|23|||
125668991|NCT00686920|452075934|FG001|Overall Study|Withdrawal by Subject|5|||
125668992|NCT00686920|452075933|FG000|Overall Study|Protocol Violation|2|||
125668993|NCT00686920|452075934|FG001|Overall Study|Protocol Violation|1|||
125668994|NCT00686920|452075933|FG000|Overall Study|Adverse Event|10|||
125668995|NCT00686920|452075934|FG001|Overall Study|Adverse Event|2|||
125668996|NCT00686920|452075933|FG000|Overall Study|Personal Reason|0|||
125668997|NCT00686920|452075934|FG001|Overall Study|Personal Reason|1|||
125668998|NCT00686920|452075933|FG000|Overall Study|Lost to Follow-up|15|||
125668999|NCT00686920|452075934|FG001|Overall Study|Lost to Follow-up|3|||
125669000|NCT00686920|452075933|FG000|Overall Study|Moved to Another State|1|||
125669001|NCT00686920|452075934|FG001|Overall Study|Moved to Another State|0|||
125669002|NCT00686920|452075933|FG000|Overall Study|Transferred to Nursing Home|1|||
125669003|NCT00686920|452075934|FG001|Overall Study|Transferred to Nursing Home|0|||
125669004|NCT00686920|452075933|FG000|Overall Study|Noncompliance|9|||
125669005|NCT00686920|452075934|FG001|Overall Study|Noncompliance|0|||
125669006|NCT00686920|452075933|FG000|Overall Study|Principal Investigator Decision|2|||
125669007|NCT00686920|452075934|FG001|Overall Study|Principal Investigator Decision|0|||
125669008|NCT01620983|452075939|FG000|Overall Study|Lost to Follow-up|8|||
125669009|NCT01620983|452075940|FG001|Overall Study|Lost to Follow-up|4|||
125669010|NCT01620983|452075941|FG002|Overall Study|Lost to Follow-up|9|||
125669011|NCT01620983|452075939|FG000|Overall Study|Withdrawal by Subject|6|||
125669012|NCT01620983|452075940|FG001|Overall Study|Withdrawal by Subject|8|||
125669013|NCT01620983|452075941|FG002|Overall Study|Withdrawal by Subject|1|||
125669014|NCT01620983|452075939|FG000|Overall Study|Death|2|||
125669015|NCT01620983|452075940|FG001|Overall Study|Death|0|||
125669016|NCT01620983|452075941|FG002|Overall Study|Death|0|||
125669017|NCT01620983|452075939|FG000|Overall Study|Physician Decision|3|||
125669018|NCT01620983|452075940|FG001|Overall Study|Physician Decision|10|||
125669019|NCT01620983|452075941|FG002|Overall Study|Physician Decision|5|||
125669020|NCT00545233|452075943|FG000|Overall Study|Adverse Event|10|||
125669021|NCT00545233|452075944|FG001|Overall Study|Adverse Event|5|||
125669022|NCT00545233|452075943|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
125669023|NCT00545233|452075944|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
125669024|NCT00545233|452075943|FG000|Overall Study|Protocol Violation|2|||
125669025|NCT00545233|452075944|FG001|Overall Study|Protocol Violation|0|||
125669026|NCT00545233|452075943|FG000|Overall Study|Refused Treatment|9|||
125669027|NCT00545233|452075944|FG001|Overall Study|Refused Treatment|7|||
125669028|NCT00545233|452075943|FG000|Overall Study|Failure to Return|4|||
125330981|NCT00345358|450844027|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
125330982|NCT00345358|450844028|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
125669029|NCT00545233|452075944|FG001|Overall Study|Failure to Return|6|||
125669030|NCT00545233|452075943|FG000|Overall Study|Insufficient response|14|||
125669031|NCT00545233|452075944|FG001|Overall Study|Insufficient response|15|||
125669032|NCT00545233|452075943|FG000|Overall Study|Physician Decision|2|||
125669033|NCT00545233|452075944|FG001|Overall Study|Physician Decision|1|||
125669034|NCT00446654|452075945|FG000|Overall Study|Withdrawal by Subject|1|||
125669035|NCT00446654|452075946|FG001|Overall Study|Withdrawal by Subject|0|||
125669036|NCT00446654|452075945|FG000|Overall Study|Adverse Event|1|||
125669037|NCT00446654|452075946|FG001|Overall Study|Adverse Event|0|||
125669038|NCT01504867|452075950|FG000|Overall Study|Inclusion criteria not met|2|||
125669039|NCT01504867|452075951|FG001|Overall Study|Inclusion criteria not met|2|||
125669040|NCT01504867|452075950|FG000|Overall Study|Consent revoked|5|||
125669041|NCT01504867|452075951|FG001|Overall Study|Consent revoked|1|||
125669042|NCT00871169|452075953|FG000|Overall Study|Protocol Violation|1|||
125669043|NCT00871169|452075953|FG000|Overall Study|Patient did not receive study treatment|2|||
125669044|NCT03210259|452075957|FG000|12-Week Run-in Period|Adverse Event|1|||
125669045|NCT03210259|452075958|FG001|12-Week Run-in Period|Adverse Event|0|||
125669046|NCT03210259|452075959|FG002|12-Week Run-in Period|Adverse Event|0|||
125669047|NCT03210259|452075957|FG000|12-Week Run-in Period|Death|1|||
125669048|NCT03210259|452075958|FG001|12-Week Run-in Period|Death|0|||
125669049|NCT03210259|452075959|FG002|12-Week Run-in Period|Death|0|||
125669050|NCT03210259|452075957|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
125669051|NCT03210259|452075958|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
125669052|NCT03210259|452075959|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
125669053|NCT03210259|452075957|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
125669054|NCT03210259|452075958|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
125669055|NCT03210259|452075959|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
125669056|NCT03210259|452075957|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
125669057|NCT03210259|452075958|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
125669058|NCT03210259|452075959|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
125669059|NCT03210259|452075957|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
125669060|NCT03210259|452075958|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
125669061|NCT03210259|452075959|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
125669062|NCT03210259|452075957|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
125669063|NCT03210259|452075958|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
125669064|NCT03210259|452075959|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
125669065|NCT03210259|452075957|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
125669066|NCT03210259|452075958|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
125669067|NCT03210259|452075959|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
125669068|NCT03210259|452075957|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
125669069|NCT03210259|452075958|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
125669070|NCT03210259|452075959|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
125669071|NCT03210259|452075957|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
125669072|NCT03210259|452075958|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
125669073|NCT03210259|452075959|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
125669074|NCT03210259|452075957|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
125669075|NCT03210259|452075958|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
125669076|NCT03210259|452075959|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
125669077|NCT02110706|452075960|FG000|Overall Study|Adverse Event|2|||
125669078|NCT02110706|452075961|FG001|Overall Study|Adverse Event|3|||
125669079|NCT02110706|452075960|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
125669080|NCT02110706|452075961|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
125669081|NCT02087059|452075962|FG000|Overall Study|Disease Progression|1|||
125669082|NCT02087059|452075962|FG000|Overall Study|Adverse Event|5|||
125669083|NCT02087059|452075962|FG000|Overall Study|Lost to Follow-up|1|||
125330983|NCT00345358|450844029|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
125330984|NCT00345358|450844026|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
125330985|NCT00345358|450844027|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
125330986|NCT00345358|450844028|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
125330987|NCT00345358|450844029|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
125330988|NCT00345358|450844026|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
125330989|NCT00345358|450844027|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
125330990|NCT00345358|450844028|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
125330991|NCT00345358|450844029|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
125330992|NCT00345358|450844026|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
125330993|NCT00345358|450844027|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
125330994|NCT00345358|450844028|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
125330995|NCT00345358|450844029|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
125330996|NCT00499083|450844030|FG000|Overall Study|Not evaluable|3|||
125330997|NCT00686686|450844031|FG000|Overall Study|Non-compliance|1|||
125330998|NCT00686686|450844031|FG000|Overall Study|Adverse Event|2|||
125330999|NCT00686686|450844031|FG000|Overall Study|Lost to Follow-up|3|||
125331000|NCT00131248|450844035|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
125331001|NCT00131248|450844036|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
125331002|NCT00477386|450844037|FG000|Overall Study|Adverse Event|4|||
125331003|NCT00477386|450844038|FG001|Overall Study|Adverse Event|8|||
125331004|NCT00477386|450844037|FG000|Overall Study|Disease progression, relapse|3|||
125669084|NCT00252187|452075963|FG000|Overall Study|Adverse Event|3|||
125669085|NCT00252187|452075964|FG001|Overall Study|Adverse Event|1|||
125669086|NCT00252187|452075963|FG000|Overall Study|Withdrawal by Subject|1|||
125669087|NCT00252187|452075964|FG001|Overall Study|Withdrawal by Subject|0|||
125669088|NCT00706706|452075967|FG000|Overall Study|Death|53|||
125331005|NCT00477386|450844038|FG001|Overall Study|Disease progression, relapse|4|||
125331006|NCT00477386|450844037|FG000|Overall Study|Disease progression, refractory|1|||
125669089|NCT00706706|452075967|FG000|Overall Study|Lost to Follow-up|7|||
125669090|NCT00706706|452075967|FG000|Overall Study|Study endpoint had reached|45|||
125669091|NCT05017493|452075968|FG000|Overall Study|Withdrawal by Subject|26|||
125669092|NCT05017493|452075969|FG001|Overall Study|Withdrawal by Subject|0|||
125669093|NCT05017493|452075968|FG000|Overall Study|Physician Decision|15|||
125669094|NCT05017493|452075969|FG001|Overall Study|Physician Decision|0|||
125669095|NCT05017493|452075968|FG000|Overall Study|Protocol Violation|81|||
125669096|NCT05017493|452075969|FG001|Overall Study|Protocol Violation|0|||
125669097|NCT01261325|452075980|FG000|Overall Study|Lack of Efficacy|1|||
125669098|NCT01261325|452075981|FG001|Overall Study|Lack of Efficacy|1|||
125669099|NCT01261325|452075982|FG002|Overall Study|Lack of Efficacy|0|||
125669100|NCT01261325|452075980|FG000|Overall Study|Withdrawal by Subject|2|||
125669101|NCT01261325|452075981|FG001|Overall Study|Withdrawal by Subject|2|||
125669102|NCT01261325|452075982|FG002|Overall Study|Withdrawal by Subject|4|||
125669103|NCT01261325|452075980|FG000|Overall Study|SAE, non-fatal|1|||
125669104|NCT01261325|452075981|FG001|Overall Study|SAE, non-fatal|5|||
125669105|NCT01261325|452075982|FG002|Overall Study|SAE, non-fatal|1|||
125669106|NCT01261325|452075980|FG000|Overall Study|AE, non-serious non-fatal|9|||
125669107|NCT01261325|452075981|FG001|Overall Study|AE, non-serious non-fatal|15|||
125669108|NCT01261325|452075982|FG002|Overall Study|AE, non-serious non-fatal|13|||
125669109|NCT01261325|452075980|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
125669110|NCT01261325|452075981|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125669111|NCT01261325|452075982|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125669112|NCT01261325|452075980|FG000|Overall Study|Non Compliance|2|||
125669113|NCT01261325|452075981|FG001|Overall Study|Non Compliance|0|||
125669114|NCT01261325|452075982|FG002|Overall Study|Non Compliance|0|||
125669115|NCT01261325|452075980|FG000|Overall Study|Patient Randomized by Mistake|0|||
125669116|NCT01261325|452075981|FG001|Overall Study|Patient Randomized by Mistake|1|||
125669117|NCT01261325|452075982|FG002|Overall Study|Patient Randomized by Mistake|0|||
125669118|NCT01261325|452075980|FG000|Overall Study|Erroneously Randomized|1|||
125669119|NCT01261325|452075981|FG001|Overall Study|Erroneously Randomized|0|||
125669120|NCT01261325|452075982|FG002|Overall Study|Erroneously Randomized|0|||
125669121|NCT01261325|452075980|FG000|Overall Study|Screen Failure|1|||
125669122|NCT01261325|452075981|FG001|Overall Study|Screen Failure|0|||
125669123|NCT01261325|452075982|FG002|Overall Study|Screen Failure|0|||
125669124|NCT01261325|452075980|FG000|Overall Study|Randomized in Error|0|||
125669125|NCT01261325|452075981|FG001|Overall Study|Randomized in Error|0|||
125669126|NCT01261325|452075982|FG002|Overall Study|Randomized in Error|1|||
125669127|NCT01261325|452075980|FG000|Overall Study|Protocol Violation|0|||
125669128|NCT01261325|452075981|FG001|Overall Study|Protocol Violation|3|||
125669129|NCT01261325|452075982|FG002|Overall Study|Protocol Violation|1|||
125669130|NCT01261325|452075980|FG000|Overall Study|Lost to Follow-up|0|||
125669131|NCT01261325|452075981|FG001|Overall Study|Lost to Follow-up|1|||
125669132|NCT01261325|452075982|FG002|Overall Study|Lost to Follow-up|3|||
125669133|NCT01261325|452075980|FG000|Overall Study|AE, serious fatal|0|||
125669134|NCT01261325|452075981|FG001|Overall Study|AE, serious fatal|0|||
125669135|NCT01261325|452075982|FG002|Overall Study|AE, serious fatal|2|||
125669136|NCT03469271|452075987|FG000|Overall Study|Withdrawal by Subject|2|||
125669137|NCT03469271|452075988|FG001|Overall Study|Withdrawal by Subject|0|||
125669138|NCT03469271|452075989|FG002|Overall Study|Withdrawal by Subject|0|||
125669139|NCT03469271|452075990|FG003|Overall Study|Withdrawal by Subject|1|||
125669140|NCT03404206|452075995|FG000|Overall Study|Withdrawal by Subject|1|||
125669141|NCT03404206|452075996|FG001|Overall Study|Withdrawal by Subject|1|||
125669142|NCT03404206|452075997|FG002|Overall Study|Withdrawal by Subject|0|||
125669143|NCT03404206|452075995|FG000|Overall Study|Lost to Follow-up|3|||
125669144|NCT03404206|452075996|FG001|Overall Study|Lost to Follow-up|1|||
125669145|NCT03404206|452075997|FG002|Overall Study|Lost to Follow-up|0|||
125669146|NCT02330081|452076008|FG000|Overall Study|Adverse Event|1|||
125669147|NCT02330081|452076008|FG000|Overall Study|Donation did not meet criteria|1|||
125669148|NCT02330081|452076008|FG000|Overall Study|Protocol Violation|6|||
125669149|NCT00616928|452076016|FG000|Overall Study|Adverse Event|6|||
125669150|NCT00616928|452076017|FG001|Overall Study|Adverse Event|3|||
125669151|NCT00616928|452076018|FG002|Overall Study|Adverse Event|2|||
125669152|NCT00616928|452076019|FG003|Overall Study|Adverse Event|2|||
125669153|NCT00616928|452076016|FG000|Overall Study|Other|51|||
125669154|NCT00616928|452076017|FG001|Overall Study|Other|8|||
125669155|NCT00616928|452076018|FG002|Overall Study|Other|15|||
125669156|NCT00616928|452076019|FG003|Overall Study|Other|5|||
125669157|NCT00616928|452076016|FG000|Overall Study|Lost to Follow-up|5|||
125669158|NCT00616928|452076017|FG001|Overall Study|Lost to Follow-up|7|||
125669159|NCT00616928|452076018|FG002|Overall Study|Lost to Follow-up|0|||
125669160|NCT00616928|452076019|FG003|Overall Study|Lost to Follow-up|0|||
125669161|NCT03372083|452078118|FG000|Overall Study|Adverse Event|3|||
125669162|NCT03372083|452078118|FG000|Overall Study|Physician Decision|1|||
125669163|NCT03372083|452078118|FG000|Overall Study|Withdrawal by Subject|1|||
125669164|NCT00598559|452078119|FG000|Overall Study|Adverse Event|11|||
125669165|NCT00598559|452078120|FG001|Overall Study|Adverse Event|7|||
125669166|NCT00598559|452078121|FG002|Overall Study|Adverse Event|0|||
125331007|NCT00477386|450844038|FG001|Overall Study|Disease progression, refractory|3|||
125331008|NCT00477386|450844037|FG000|Overall Study|Other|1|||
125331009|NCT00477386|450844038|FG001|Overall Study|Other|2|||
125331010|NCT00477386|450844037|FG000|Overall Study|Physician Decision|1|||
125331011|NCT00477386|450844038|FG001|Overall Study|Physician Decision|0|||
125331012|NCT00477386|450844037|FG000|Overall Study|Withdrawal by Subject|1|||
125331013|NCT00477386|450844038|FG001|Overall Study|Withdrawal by Subject|0|||
125331014|NCT01254422|450844039|FG000|Overall Study|Protocol Violation|1|||
125331015|NCT01254422|450844040|FG001|Overall Study|Protocol Violation|0|||
125331016|NCT01254422|450844039|FG000|Overall Study|Adverse Event|1|||
125331017|NCT01254422|450844040|FG001|Overall Study|Adverse Event|0|||
125331018|NCT01254422|450844039|FG000|Overall Study|Serious adverse event|0|||
125331019|NCT01254422|450844040|FG001|Overall Study|Serious adverse event|1|||
125331020|NCT01254422|450844039|FG000|Overall Study|Lost to Follow-up|1|||
125331021|NCT01254422|450844040|FG001|Overall Study|Lost to Follow-up|0|||
125331022|NCT02207088|450844041|FG000|Overall Study|Adverse Event|2|||
125331023|NCT00643162|450844042|FG000|Overall Study|Withdrawal by Subject|1|||
125331024|NCT00643162|450844043|FG001|Overall Study|Withdrawal by Subject|1|||
125331025|NCT02284243|450844044|FG000|Overall Study|Lack of Efficacy|3|||
125331026|NCT02284243|450844045|FG001|Overall Study|Lack of Efficacy|3|||
125331027|NCT02284243|450844044|FG000|Overall Study|Adverse Event|1|||
125331028|NCT02284243|450844045|FG001|Overall Study|Adverse Event|0|||
125331029|NCT02699749|450844050|FG000|Overall Study|Other|0|||
125669167|NCT00598559|452078119|FG000|Overall Study|Withdrawal by Subject|2|||
125669168|NCT00598559|452078120|FG001|Overall Study|Withdrawal by Subject|2|||
125669169|NCT00598559|452078121|FG002|Overall Study|Withdrawal by Subject|0|||
125669170|NCT00598559|452078119|FG000|Overall Study|Protocol Non-compliance|1|||
125669171|NCT00598559|452078120|FG001|Overall Study|Protocol Non-compliance|0|||
125669172|NCT00598559|452078121|FG002|Overall Study|Protocol Non-compliance|0|||
125669173|NCT00598559|452078119|FG000|Overall Study|Early discharge from hospital|9|||
125669174|NCT00598559|452078120|FG001|Overall Study|Early discharge from hospital|12|||
125669175|NCT00598559|452078121|FG002|Overall Study|Early discharge from hospital|3|||
125669176|NCT00598559|452078119|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
125669177|NCT00598559|452078120|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
125669178|NCT00598559|452078121|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
125669179|NCT03381248|452078122|FG000|0-6 Months|Withdrawal by Subject|4|||
125669180|NCT03381248|452078123|FG001|0-6 Months|Withdrawal by Subject|1|||
125669181|NCT03381248|452078122|FG000|0-6 Months|Lost to Follow-up|3|||
125669182|NCT03381248|452078123|FG001|0-6 Months|Lost to Follow-up|2|||
125331030|NCT02699749|450844051|FG001|Overall Study|Other|0|||
125331031|NCT02699749|450844052|FG002|Overall Study|Other|2|||
125331032|NCT02699749|450844053|FG003|Overall Study|Other|0|||
125331033|NCT02699749|450844054|FG004|Overall Study|Other|0|||
125331034|NCT02699749|450844055|FG005|Overall Study|Other|1|||
125331035|NCT02699749|450844056|FG006|Overall Study|Other|1|||
125331036|NCT02699749|450844057|FG007|Overall Study|Other|0|||
125331037|NCT02699749|450844058|FG008|Overall Study|Other|0|||
125331038|NCT02699749|450844059|FG009|Overall Study|Other|0|||
125331039|NCT02699749|450844060|FG010|Overall Study|Other|1|||
125331040|NCT02699749|450844061|FG011|Overall Study|Other|0|||
125331041|NCT02699749|450844062|FG012|Overall Study|Other|0|||
125331042|NCT02699749|450844063|FG013|Overall Study|Other|0|||
125331043|NCT02699749|450844050|FG000|Overall Study|Progressive Disease|3|||
125331044|NCT02699749|450844051|FG001|Overall Study|Progressive Disease|3|||
125331045|NCT02699749|450844052|FG002|Overall Study|Progressive Disease|14|||
125331046|NCT02699749|450844053|FG003|Overall Study|Progressive Disease|3|||
125331047|NCT02699749|450844054|FG004|Overall Study|Progressive Disease|3|||
125331048|NCT02699749|450844055|FG005|Overall Study|Progressive Disease|7|||
125331049|NCT02699749|450844056|FG006|Overall Study|Progressive Disease|5|||
125331050|NCT02699749|450844057|FG007|Overall Study|Progressive Disease|5|||
125669183|NCT03381248|452078122|FG000|0-6 Months|Lack of Efficacy|1|||
125669184|NCT03381248|452078123|FG001|0-6 Months|Lack of Efficacy|0|||
125331051|NCT02699749|450844058|FG008|Overall Study|Progressive Disease|6|||
125331052|NCT02699749|450844059|FG009|Overall Study|Progressive Disease|6|||
125331053|NCT02699749|450844060|FG010|Overall Study|Progressive Disease|5|||
125331054|NCT02699749|450844061|FG011|Overall Study|Progressive Disease|4|||
125331055|NCT02699749|450844062|FG012|Overall Study|Progressive Disease|3|||
125331056|NCT02699749|450844063|FG013|Overall Study|Progressive Disease|5|||
125331057|NCT02699749|450844050|FG000|Overall Study|Death|0|||
125331058|NCT02699749|450844051|FG001|Overall Study|Death|0|||
125331059|NCT02699749|450844052|FG002|Overall Study|Death|0|||
125331060|NCT02699749|450844053|FG003|Overall Study|Death|0|||
125331061|NCT02699749|450844054|FG004|Overall Study|Death|0|||
125331062|NCT02699749|450844055|FG005|Overall Study|Death|0|||
125331063|NCT02699749|450844056|FG006|Overall Study|Death|0|||
125331064|NCT02699749|450844057|FG007|Overall Study|Death|0|||
125331065|NCT02699749|450844058|FG008|Overall Study|Death|0|||
125669185|NCT03381248|452078122|FG000|0-6 Months|Adverse Event|1|||
125669186|NCT03381248|452078123|FG001|0-6 Months|Adverse Event|0|||
125669187|NCT03381248|452078122|FG000|0-6 Months|Protocol Violation|2|||
125669188|NCT03381248|452078123|FG001|0-6 Months|Protocol Violation|1|||
125331066|NCT02699749|450844059|FG009|Overall Study|Death|0|||
125331067|NCT02699749|450844060|FG010|Overall Study|Death|0|||
125331068|NCT02699749|450844061|FG011|Overall Study|Death|0|||
125331069|NCT02699749|450844062|FG012|Overall Study|Death|0|||
125331070|NCT02699749|450844063|FG013|Overall Study|Death|1|||
125331071|NCT02699749|450844050|FG000|Overall Study|Lost to Follow-up|0|||
125331072|NCT02699749|450844051|FG001|Overall Study|Lost to Follow-up|0|||
125331073|NCT02699749|450844052|FG002|Overall Study|Lost to Follow-up|0|||
125331074|NCT02699749|450844053|FG003|Overall Study|Lost to Follow-up|0|||
125331075|NCT02699749|450844054|FG004|Overall Study|Lost to Follow-up|0|||
125331076|NCT02699749|450844055|FG005|Overall Study|Lost to Follow-up|1|||
125331077|NCT02699749|450844056|FG006|Overall Study|Lost to Follow-up|0|||
125331078|NCT02699749|450844057|FG007|Overall Study|Lost to Follow-up|1|||
125331079|NCT02699749|450844058|FG008|Overall Study|Lost to Follow-up|0|||
125331080|NCT02699749|450844059|FG009|Overall Study|Lost to Follow-up|0|||
125331081|NCT02699749|450844060|FG010|Overall Study|Lost to Follow-up|0|||
125331082|NCT02699749|450844061|FG011|Overall Study|Lost to Follow-up|0|||
125331083|NCT02699749|450844062|FG012|Overall Study|Lost to Follow-up|0|||
125331084|NCT02699749|450844063|FG013|Overall Study|Lost to Follow-up|0|||
125331085|NCT02721966|450844065|FG000|Overall Study|Protocol Violation|1|||
125331086|NCT02721966|450844066|FG001|Overall Study|Protocol Violation|0|||
125331087|NCT02721966|450844067|FG002|Overall Study|Protocol Violation|0|||
125331088|NCT02721966|450844068|FG003|Overall Study|Protocol Violation|0|||
125331089|NCT02721966|450844069|FG004|Overall Study|Protocol Violation|0|||
125331090|NCT02721966|450844065|FG000|Overall Study|Withdrawal by Subject|9|||
125331091|NCT02721966|450844066|FG001|Overall Study|Withdrawal by Subject|2|||
125331092|NCT02721966|450844067|FG002|Overall Study|Withdrawal by Subject|3|||
125331093|NCT02721966|450844068|FG003|Overall Study|Withdrawal by Subject|7|||
125331094|NCT02721966|450844069|FG004|Overall Study|Withdrawal by Subject|0|||
125331095|NCT02721966|450844065|FG000|Overall Study|Adverse Event|4|||
125331096|NCT02721966|450844066|FG001|Overall Study|Adverse Event|4|||
125331097|NCT02721966|450844067|FG002|Overall Study|Adverse Event|3|||
125331098|NCT02721966|450844068|FG003|Overall Study|Adverse Event|0|||
125331099|NCT02721966|450844069|FG004|Overall Study|Adverse Event|0|||
125331100|NCT02721966|450844065|FG000|Overall Study|Death|1|||
125331101|NCT02721966|450844066|FG001|Overall Study|Death|0|||
125331102|NCT02721966|450844067|FG002|Overall Study|Death|0|||
125331103|NCT02721966|450844068|FG003|Overall Study|Death|0|||
125331104|NCT02721966|450844069|FG004|Overall Study|Death|0|||
125331105|NCT02721966|450844065|FG000|Overall Study|Lack of Efficacy|7|||
125331106|NCT02721966|450844066|FG001|Overall Study|Lack of Efficacy|4|||
125331107|NCT02721966|450844067|FG002|Overall Study|Lack of Efficacy|0|||
125331108|NCT02721966|450844068|FG003|Overall Study|Lack of Efficacy|0|||
125331109|NCT02721966|450844069|FG004|Overall Study|Lack of Efficacy|0|||
125331110|NCT02721966|450844065|FG000|Overall Study|Lost to Follow-up|0|||
125331111|NCT02721966|450844066|FG001|Overall Study|Lost to Follow-up|0|||
125331112|NCT02721966|450844067|FG002|Overall Study|Lost to Follow-up|3|||
125331113|NCT02721966|450844068|FG003|Overall Study|Lost to Follow-up|0|||
125331114|NCT02721966|450844069|FG004|Overall Study|Lost to Follow-up|0|||
125331115|NCT02721966|450844065|FG000|Overall Study|Physician Decision|1|||
125331116|NCT02721966|450844066|FG001|Overall Study|Physician Decision|1|||
125331117|NCT02721966|450844067|FG002|Overall Study|Physician Decision|0|||
125331118|NCT02721966|450844068|FG003|Overall Study|Physician Decision|0|||
125331119|NCT02721966|450844069|FG004|Overall Study|Physician Decision|0|||
125331120|NCT02721966|450844065|FG000|Overall Study|Pregnancy|1|||
125331121|NCT02721966|450844066|FG001|Overall Study|Pregnancy|0|||
125331122|NCT02721966|450844067|FG002|Overall Study|Pregnancy|0|||
125331123|NCT02721966|450844068|FG003|Overall Study|Pregnancy|0|||
125331124|NCT02721966|450844069|FG004|Overall Study|Pregnancy|0|||
125331125|NCT02721966|450844065|FG000|Overall Study|Did not continue to period 2|5|||
125331126|NCT02721966|450844066|FG001|Overall Study|Did not continue to period 2|12|||
125331127|NCT02721966|450844067|FG002|Overall Study|Did not continue to period 2|0|||
125331128|NCT02721966|450844068|FG003|Overall Study|Did not continue to period 2|0|||
125331129|NCT02721966|450844069|FG004|Overall Study|Did not continue to period 2|5|||
125331130|NCT03857867|450844070|FG000|Overall Study|Physician Decision|1|||
125331131|NCT02157883|450844071|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
125331132|NCT02157883|450844071|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
125331133|NCT02157883|450844071|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
125331134|NCT02157883|450844071|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
125331135|NCT02157883|450844071|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
125331136|NCT00888940|450844072|FG000|Overall Study|Adverse Event|12|||
125331137|NCT00888940|450844073|FG001|Overall Study|Adverse Event|3|||
125331138|NCT00888940|450844072|FG000|Overall Study|Lost to Follow-up|5|||
125331139|NCT00888940|450844073|FG001|Overall Study|Lost to Follow-up|5|||
125331140|NCT00888940|450844072|FG000|Overall Study|Randomized Not Treated|11|||
125331141|NCT00888940|450844073|FG001|Overall Study|Randomized Not Treated|13|||
125331142|NCT00607373|450844074|FG000|Treatment Period|Adverse Event|0|||
125331143|NCT00607373|450844075|FG001|Treatment Period|Adverse Event|4|||
125331144|NCT00607373|450844074|FG000|Treatment Period|Physician Decision|0|||
125331145|NCT00607373|450844075|FG001|Treatment Period|Physician Decision|1|||
125331146|NCT00607373|450844074|FG000|Treatment Period|Withdrawal by Subject|0|||
125331147|NCT00607373|450844075|FG001|Treatment Period|Withdrawal by Subject|1|||
125331148|NCT00607373|450844074|FG000|Follow-up Period|Other|0|||
125331149|NCT00607373|450844075|FG001|Follow-up Period|Other|1|||
125331150|NCT00607373|450844074|FG000|Follow-up Period|Protocol Violation|0|||
125331151|NCT00607373|450844075|FG001|Follow-up Period|Protocol Violation|1|||
125331152|NCT00607373|450844074|FG000|Follow-up Period|Withdrawal by Subject|1|||
125331153|NCT00607373|450844075|FG001|Follow-up Period|Withdrawal by Subject|3|||
125331154|NCT01918306|450844076|FG000|Overall Study|progresive disease|4|||
125331155|NCT01918306|450844077|FG001|Overall Study|progresive disease|0|||
125331156|NCT01918306|450844078|FG002|Overall Study|progresive disease|1|||
125331157|NCT01918306|450844079|FG003|Overall Study|progresive disease|1|||
125331158|NCT01918306|450844076|FG000|Overall Study|Withdrawal by Subject|0|||
125331159|NCT01918306|450844077|FG001|Overall Study|Withdrawal by Subject|0|||
125331160|NCT01918306|450844078|FG002|Overall Study|Withdrawal by Subject|0|||
125331161|NCT01918306|450844079|FG003|Overall Study|Withdrawal by Subject|2|||
125331162|NCT01918306|450844076|FG000|Overall Study|neutropenia|1|||
125331163|NCT01918306|450844077|FG001|Overall Study|neutropenia|0|||
125331164|NCT01918306|450844078|FG002|Overall Study|neutropenia|0|||
125331165|NCT01918306|450844079|FG003|Overall Study|neutropenia|0|||
125331166|NCT01918306|450844076|FG000|Overall Study|Lack of Efficacy|1|||
125331167|NCT01918306|450844077|FG001|Overall Study|Lack of Efficacy|0|||
125331168|NCT01918306|450844078|FG002|Overall Study|Lack of Efficacy|0|||
125331169|NCT01918306|450844079|FG003|Overall Study|Lack of Efficacy|0|||
125331170|NCT01918306|450844076|FG000|Overall Study|progress disease, crossover|0|||
125331171|NCT01918306|450844077|FG001|Overall Study|progress disease, crossover|0|||
125331172|NCT01918306|450844078|FG002|Overall Study|progress disease, crossover|1|||
125331173|NCT01918306|450844079|FG003|Overall Study|progress disease, crossover|0|||
125331174|NCT02170077|450844080|FG000|Overall Study|Withdrawal by Subject|3|||
125331175|NCT02170077|450844081|FG001|Overall Study|Withdrawal by Subject|4|||
125331176|NCT02170077|450844082|FG002|Overall Study|Withdrawal by Subject|2|||
125331177|NCT02170077|450844080|FG000|Overall Study|Adverse Event|4|||
125331178|NCT02170077|450844081|FG001|Overall Study|Adverse Event|4|||
125331179|NCT02170077|450844082|FG002|Overall Study|Adverse Event|4|||
125331180|NCT02170077|450844080|FG000|Overall Study|Lost to Follow-up|0|||
125331181|NCT02170077|450844081|FG001|Overall Study|Lost to Follow-up|1|||
125331182|NCT02170077|450844082|FG002|Overall Study|Lost to Follow-up|0|||
125331183|NCT02170077|450844080|FG000|Overall Study|Exclusion criteria|2|||
125331184|NCT02170077|450844081|FG001|Overall Study|Exclusion criteria|2|||
125331185|NCT02170077|450844082|FG002|Overall Study|Exclusion criteria|5|||
125331186|NCT02170077|450844080|FG000|Overall Study|Exacerbation of seizures|0|||
125331187|NCT02170077|450844081|FG001|Overall Study|Exacerbation of seizures|2|||
125331188|NCT02170077|450844082|FG002|Overall Study|Exacerbation of seizures|1|||
125331189|NCT01780974|450844083|FG000|Overall Study|Death|1|||
125331190|NCT01780974|450844084|FG001|Overall Study|Death|0|||
125331191|NCT01780974|450844083|FG000|Overall Study|Adverse Event|1|||
125331192|NCT01780974|450844084|FG001|Overall Study|Adverse Event|3|||
125331193|NCT01724346|450844085|FG000|Overall Study|Death|42|||
125331194|NCT01724346|450844086|FG001|Overall Study|Death|42|||
125331195|NCT01724346|450844085|FG000|Overall Study|Lost to Follow-up|5|||
125331196|NCT01724346|450844086|FG001|Overall Study|Lost to Follow-up|1|||
125331197|NCT01724346|450844085|FG000|Overall Study|Withdrawal by Subject|27|||
125331198|NCT01724346|450844086|FG001|Overall Study|Withdrawal by Subject|19|||
125331199|NCT01724346|450844085|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
125331200|NCT01724346|450844086|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
125331201|NCT02876601|450844087|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
125331202|NCT02876601|450844088|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
125331203|NCT02876601|450844089|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
125669189|NCT03381248|452078122|FG000|0-6 Months|Physician Decision|1|||
125669190|NCT03381248|452078123|FG001|0-6 Months|Physician Decision|0|||
125669191|NCT03381248|452078122|FG000|0-6 Months|Planning another procedure|1|||
125331204|NCT02876601|450844090|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
125331205|NCT00256997|450844091|FG000|Overall Study|Protocol Violation|1|||
125331206|NCT00256997|450844092|FG001|Overall Study|Protocol Violation|4|||
125331207|NCT00256997|450844091|FG000|Overall Study|Lack of Efficacy|1|||
125331208|NCT00256997|450844092|FG001|Overall Study|Lack of Efficacy|4|||
125331209|NCT00256997|450844091|FG000|Overall Study|Death|2|||
125331210|NCT00256997|450844092|FG001|Overall Study|Death|0|||
125331211|NCT00256997|450844091|FG000|Overall Study|Adverse Event|4|||
125331212|NCT00256997|450844092|FG001|Overall Study|Adverse Event|0|||
125331213|NCT00256997|450844091|FG000|Overall Study|Lost to Follow-up|3|||
125331214|NCT00256997|450844092|FG001|Overall Study|Lost to Follow-up|5|||
125331215|NCT00256997|450844091|FG000|Overall Study|Withdrawal by Subject|13|||
125331216|NCT00256997|450844092|FG001|Overall Study|Withdrawal by Subject|3|||
125331217|NCT00256997|450844091|FG000|Overall Study|Started but not treated|2|||
125331218|NCT00256997|450844092|FG001|Overall Study|Started but not treated|0|||
125331219|NCT00256997|450844091|FG000|Overall Study|Other|5|||
125331220|NCT00256997|450844092|FG001|Overall Study|Other|8|||
125669192|NCT03381248|452078123|FG001|0-6 Months|Planning another procedure|2|||
125331221|NCT00256997|450844091|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
125331222|NCT00256997|450844092|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
125331223|NCT00256997|450844091|FG000|Overall Study|Participant Non-compliant|3|||
125331224|NCT00256997|450844092|FG001|Overall Study|Participant Non-compliant|6|||
125331225|NCT00256997|450844091|FG000|Overall Study|Investigator Withdrew Participant|2|||
125331226|NCT00256997|450844092|FG001|Overall Study|Investigator Withdrew Participant|1|||
125331227|NCT00354432|450844093|FG000|Overall Study|Adverse Event|3|||
125669193|NCT03381248|452078122|FG000|6-12 Months|Withdrawal by Subject|1|||
125669194|NCT03381248|452078123|FG001|6-12 Months|Withdrawal by Subject|3|||
125669195|NCT03381248|452078122|FG000|6-12 Months|Lost to Follow-up|0|||
125669196|NCT03381248|452078123|FG001|6-12 Months|Lost to Follow-up|2|||
125669197|NCT03381248|452078122|FG000|6-12 Months|Protocol Violation|3|||
125669198|NCT03381248|452078123|FG001|6-12 Months|Protocol Violation|2|||
125669199|NCT03381248|452078122|FG000|6-12 Months|Planning another procedure|6|||
125331228|NCT00354432|450844094|FG001|Overall Study|Adverse Event|1|||
125331229|NCT00354432|450844095|FG002|Overall Study|Adverse Event|5|||
125331230|NCT00354432|450844096|FG003|Overall Study|Adverse Event|5|||
125331231|NCT00354432|450844093|FG000|Overall Study|Off/Toxicity|3|||
125331232|NCT00354432|450844094|FG001|Overall Study|Off/Toxicity|7|||
125331233|NCT00354432|450844095|FG002|Overall Study|Off/Toxicity|5|||
125331234|NCT00354432|450844096|FG003|Overall Study|Off/Toxicity|5|||
125331235|NCT02736578|450844097|FG000|Overall Study|Adverse Event|1|||
125331236|NCT02736578|450844098|FG001|Overall Study|Adverse Event|0|||
125331237|NCT02827877|450844099|FG000|Overall Study|Withdrawal by Subject|1|||
125331238|NCT04953728|450845626|FG000|Overall Study|Withdrawal by Subject|3|||
125331239|NCT04953728|450845626|FG000|Overall Study|Physician Decision|1|||
125331240|NCT02105662|450845629|FG000|Overall Study|Lost to Follow-up|5|||
125331241|NCT02105662|450845629|FG000|Overall Study|Withdrawal by Subject|1|||
125331242|NCT02331277|450845630|FG000|Overall Study|Withdrawal by Subject|1|||
125331243|NCT02331277|450845631|FG001|Overall Study|Withdrawal by Subject|0|||
125331244|NCT03978117|450845632|FG000|Overall Study|Non-Compliance|26|||
125331245|NCT03978117|450845633|FG001|Overall Study|Non-Compliance|26|||
125331246|NCT03978117|450845632|FG000|Overall Study|Lost to Follow-up|4|||
125331247|NCT03978117|450845633|FG001|Overall Study|Lost to Follow-up|4|||
125331248|NCT00990704|450845635|FG000|Overall Study|Adverse Event|1|||
125331249|NCT00990704|450845636|FG001|Overall Study|Adverse Event|1|||
125331250|NCT00990704|450845635|FG000|Overall Study|Physician Decision|0|||
125331251|NCT00990704|450845636|FG001|Overall Study|Physician Decision|1|||
125331252|NCT01354899|450845640|FG000|Overall Study|discharge from the hospital|2|||
125331253|NCT01354899|450845640|FG000|Overall Study|Protocol Violation|1|||
125331254|NCT00641667|450845641|FG000|Overall Study|Withdrawal by Subject|1|||
125331255|NCT00641667|450845641|FG000|Overall Study|Adverse Event|1|||
125331256|NCT00641667|450845641|FG000|Overall Study|Physician Decision|1|||
125331257|NCT00641667|450845641|FG000|Overall Study|Worsening of underlying disease|3|||
125331258|NCT01235741|450845642|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
125331259|NCT01235741|450845643|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
125331260|NCT01235741|450845644|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
125331261|NCT01235741|450845642|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
125669200|NCT03381248|452078123|FG001|6-12 Months|Planning another procedure|2|||
125669201|NCT03381248|452078122|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
125669202|NCT03381248|452078123|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
125669203|NCT03381248|452078122|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
125669204|NCT03381248|452078123|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
125669205|NCT03381248|452078122|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
125669206|NCT03381248|452078123|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
125669207|NCT01466686|452078130|FG000|Overall Study|Withdrawal by Subject|1|||
125669208|NCT00827827|452078131|FG000|Overall Study|Lost to Follow-up|3|||
125669209|NCT00827827|452078132|FG001|Overall Study|Lost to Follow-up|0|||
125331262|NCT01235741|450845643|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
125331263|NCT01235741|450845644|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
125331264|NCT01235741|450845642|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
125331265|NCT01235741|450845643|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
125331266|NCT01235741|450845644|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
125331267|NCT01235741|450845642|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
125331268|NCT01235741|450845643|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
125331269|NCT01235741|450845644|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
125331270|NCT01235741|450845642|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
125331271|NCT01235741|450845643|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
125331272|NCT01235741|450845644|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
125669210|NCT00827827|452078131|FG000|Overall Study|Fall at home- hospitalization|1|||
125669211|NCT00827827|452078132|FG001|Overall Study|Fall at home- hospitalization|0|||
125669212|NCT00827827|452078131|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
125331273|NCT01235741|450845642|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
125331274|NCT01235741|450845643|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
125331275|NCT01235741|450845644|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
125331276|NCT01235741|450845642|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
125669213|NCT00827827|452078132|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
125669214|NCT00827827|452078131|FG000|Overall Study|Gout|1|||
125331277|NCT01235741|450845643|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
125331278|NCT01235741|450845644|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
125331279|NCT01235741|450845642|FG000|Randomized to Treatment|Adverse Event|0|||
125331280|NCT01235741|450845643|FG001|Randomized to Treatment|Adverse Event|1|||
125669215|NCT00827827|452078132|FG001|Overall Study|Gout|0|||
125669216|NCT00827827|452078131|FG000|Overall Study|Transportation issues|1|||
125669217|NCT00827827|452078132|FG001|Overall Study|Transportation issues|0|||
125331281|NCT01235741|450845644|FG002|Randomized to Treatment|Adverse Event|1|||
125331282|NCT01235741|450845642|FG000|Randomized to Treatment|Sponsor terminated study|0|||
125331283|NCT01235741|450845643|FG001|Randomized to Treatment|Sponsor terminated study|35|||
125331284|NCT01235741|450845644|FG002|Randomized to Treatment|Sponsor terminated study|34|||
125331285|NCT01235741|450845642|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
125331286|NCT01235741|450845643|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
125331287|NCT01235741|450845644|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
125331288|NCT01235741|450845642|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
125331289|NCT01235741|450845643|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
125331290|NCT01235741|450845644|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
125331291|NCT01235741|450845642|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
125331292|NCT01235741|450845643|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
125331293|NCT01235741|450845644|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
125331294|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
125331295|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
125331296|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
125331297|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
125331298|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
125331299|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
125331300|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
125331301|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
125331302|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
125331303|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
125331304|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
125331305|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
125331306|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
125331307|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
125331308|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
125331309|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125331310|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
125331311|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125331312|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
125331313|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125331314|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125331315|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
125331316|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
125331317|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
125331318|NCT01106690|450845645|FG000|Core Period: Baseline to Week 26|Other|10|||
125331319|NCT01106690|450845646|FG001|Core Period: Baseline to Week 26|Other|2|||
125331320|NCT01106690|450845647|FG002|Core Period: Baseline to Week 26|Other|6|||
125331321|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
125331322|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
125331323|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
125331324|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125331325|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125331326|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125331327|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125331328|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
125331329|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
125331330|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
125669218|NCT00827827|452078131|FG000|Overall Study|Burned with water at home|1|||
125669219|NCT00827827|452078132|FG001|Overall Study|Burned with water at home|0|||
125669220|NCT01405950|452078133|FG000|Overall Study|Withdrawal by Subject|1|||
125331331|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
125331332|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
125331333|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
125331334|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
125331335|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125331336|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Other|8|||
125331337|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Other|3|||
125331338|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Other|4|||
125331339|NCT01106690|450845645|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
125331340|NCT01106690|450845646|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125331341|NCT01106690|450845647|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125331342|NCT02863419|450845648|FG000|Overall Study|Lost to Follow-up|0|||
125331343|NCT02863419|450845649|FG001|Overall Study|Lost to Follow-up|1|||
125331344|NCT02863419|450845650|FG002|Overall Study|Lost to Follow-up|4|||
125331345|NCT02863419|450845648|FG000|Overall Study|Withdrawal by Subject|5|||
125331346|NCT02863419|450845649|FG001|Overall Study|Withdrawal by Subject|5|||
125331347|NCT02863419|450845650|FG002|Overall Study|Withdrawal by Subject|3|||
125331348|NCT02863419|450845648|FG000|Overall Study|Died|3|||
125331349|NCT02863419|450845649|FG001|Overall Study|Died|4|||
125331350|NCT02863419|450845650|FG002|Overall Study|Died|1|||
125331351|NCT02454517|450845664|FG000|Overall Study|Withdrawal by Subject|3|||
125331352|NCT02454517|450845665|FG001|Overall Study|Withdrawal by Subject|0|||
125331353|NCT02454517|450845664|FG000|Overall Study|Lost to Follow-up|4|||
125331354|NCT02454517|450845665|FG001|Overall Study|Lost to Follow-up|7|||
125331355|NCT02454517|450845664|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
125331356|NCT02454517|450845665|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
125331357|NCT00473382|450845666|FG000|Core Study|Adverse Event|3|||
125331358|NCT00473382|450845667|FG001|Core Study|Adverse Event|1|||
125331359|NCT00473382|450845668|FG002|Core Study|Adverse Event|1|||
125331360|NCT00473382|450845666|FG000|Core Study|Death|3|||
125331361|NCT00473382|450845667|FG001|Core Study|Death|5|||
125331362|NCT00473382|450845668|FG002|Core Study|Death|10|||
125331363|NCT00473382|450845666|FG000|Core Study|Lost to Follow-up|3|||
125331364|NCT00473382|450845667|FG001|Core Study|Lost to Follow-up|3|||
125331365|NCT00473382|450845668|FG002|Core Study|Lost to Follow-up|3|||
125331366|NCT00473382|450845666|FG000|Core Study|Physician Decision|1|||
125331367|NCT00473382|450845667|FG001|Core Study|Physician Decision|2|||
125331368|NCT00473382|450845668|FG002|Core Study|Physician Decision|2|||
125331369|NCT00473382|450845666|FG000|Core Study|Subject non-compliance|5|||
125331370|NCT00473382|450845667|FG001|Core Study|Subject non-compliance|2|||
125331371|NCT00473382|450845668|FG002|Core Study|Subject non-compliance|1|||
125331372|NCT00473382|450845666|FG000|Core Study|Subject needed other treatment|1|||
125331373|NCT00473382|450845667|FG001|Core Study|Subject needed other treatment|3|||
125331374|NCT00473382|450845668|FG002|Core Study|Subject needed other treatment|2|||
125331375|NCT00473382|450845666|FG000|Core Study|Subject's decision|12|||
125331376|NCT00473382|450845667|FG001|Core Study|Subject's decision|11|||
125331377|NCT00473382|450845668|FG002|Core Study|Subject's decision|10|||
125331378|NCT00473382|450845666|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
125331379|NCT00473382|450845667|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
125331380|NCT00473382|450845668|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
125331381|NCT00473382|450845666|FG000|Open-label Extension Through Month 48|Death|1|||
125331382|NCT00473382|450845667|FG001|Open-label Extension Through Month 48|Death|3|||
125331383|NCT00473382|450845668|FG002|Open-label Extension Through Month 48|Death|3|||
125331384|NCT00473382|450845666|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
125331385|NCT00473382|450845667|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
125331386|NCT00473382|450845668|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
125331387|NCT00473382|450845666|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
125331388|NCT00473382|450845667|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
125331389|NCT00473382|450845668|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
125331390|NCT00473382|450845666|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
125331391|NCT00473382|450845667|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
125331392|NCT00473382|450845668|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
125331393|NCT00473382|450845666|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
125331394|NCT00473382|450845667|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
125331395|NCT00473382|450845668|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
125669221|NCT01405950|452078134|FG001|Overall Study|Withdrawal by Subject|0|||
125331396|NCT00473382|450845666|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
125331397|NCT00473382|450845667|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
125331398|NCT00473382|450845668|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
125331399|NCT00473382|450845666|FG000|Open-label Extension Through Month 60|Death|1|||
125331400|NCT00473382|450845667|FG001|Open-label Extension Through Month 60|Death|7|||
125331401|NCT00473382|450845668|FG002|Open-label Extension Through Month 60|Death|4|||
125331402|NCT00473382|450845666|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
125331403|NCT00473382|450845667|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
125331404|NCT00473382|450845668|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
125331405|NCT00473382|450845666|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
125331406|NCT00473382|450845667|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
125331407|NCT00473382|450845668|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
125331408|NCT00473382|450845666|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
125331409|NCT00473382|450845667|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
125331410|NCT00473382|450845668|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
125331411|NCT00473382|450845666|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
125331412|NCT00473382|450845667|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
125331413|NCT00473382|450845668|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
125331414|NCT01189032|450845669|FG000|Overall Study|Adverse Event|1|||
125331415|NCT01189032|450845670|FG001|Overall Study|Adverse Event|3|||
125331416|NCT01189032|450845671|FG002|Overall Study|Adverse Event|4|||
125331417|NCT01189032|450845669|FG000|Overall Study|Lack of Efficacy|2|||
125331418|NCT01189032|450845670|FG001|Overall Study|Lack of Efficacy|3|||
125331419|NCT01189032|450845671|FG002|Overall Study|Lack of Efficacy|0|||
125331420|NCT01189032|450845669|FG000|Overall Study|Withdrawal by Subject|1|||
125331421|NCT01189032|450845670|FG001|Overall Study|Withdrawal by Subject|0|||
125331422|NCT01189032|450845671|FG002|Overall Study|Withdrawal by Subject|1|||
125331423|NCT01189032|450845669|FG000|Overall Study|Protocol Violation|1|||
125331424|NCT01189032|450845670|FG001|Overall Study|Protocol Violation|1|||
125331425|NCT01189032|450845671|FG002|Overall Study|Protocol Violation|1|||
125331426|NCT01470326|450845672|FG000|Overall Study|Protocol Violation|32|||
125331427|NCT01470326|450845672|FG000|Overall Study|No Drug Administration Information|2|||
125331428|NCT01470326|450845672|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
125331429|NCT01166282|450845673|FG000|Open-label Period|Adverse Event|0|||
125331430|NCT01166282|450845674|FG001|Open-label Period|Adverse Event|0|||
125331431|NCT01166282|450845675|FG002|Open-label Period|Adverse Event|6|||
125331432|NCT01166282|450845673|FG000|Open-label Period|Withdrawal by Subject|0|||
125331433|NCT01166282|450845674|FG001|Open-label Period|Withdrawal by Subject|0|||
125331434|NCT01166282|450845675|FG002|Open-label Period|Withdrawal by Subject|4|||
125331435|NCT01166282|450845673|FG000|Open-label Period|Lack of Efficacy|0|||
125331436|NCT01166282|450845674|FG001|Open-label Period|Lack of Efficacy|0|||
125331437|NCT01166282|450845675|FG002|Open-label Period|Lack of Efficacy|2|||
125331438|NCT01166282|450845673|FG000|Open-label Period|Remission|0|||
125331439|NCT01166282|450845674|FG001|Open-label Period|Remission|0|||
125331440|NCT01166282|450845675|FG002|Open-label Period|Remission|4|||
125669222|NCT01405950|452078135|FG002|Overall Study|Withdrawal by Subject|0|||
125669223|NCT01405950|452078136|FG003|Overall Study|Withdrawal by Subject|0|||
125669224|NCT02410252|452078137|FG000|Overall Study|Withdrawal by Subject|4|||
125669225|NCT02410252|452078137|FG000|Overall Study|Physician Decision|2|||
125669226|NCT02884206|452078158|FG000|Valsartan Run-in Period|Death|1|||
125669227|NCT02884206|452078159|FG001|Valsartan Run-in Period|Death|0|||
125669228|NCT02884206|452078160|FG002|Valsartan Run-in Period|Death|0|||
125669229|NCT02884206|452078158|FG000|Valsartan Run-in Period|Adverse Event|31|||
125669230|NCT02884206|452078159|FG001|Valsartan Run-in Period|Adverse Event|0|||
125669231|NCT02884206|452078160|FG002|Valsartan Run-in Period|Adverse Event|0|||
125669232|NCT02884206|452078158|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
125669233|NCT02884206|452078159|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
125669234|NCT02884206|452078160|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
125669235|NCT02884206|452078158|FG000|Valsartan Run-in Period|Protocol deviation|4|||
125669236|NCT02884206|452078159|FG001|Valsartan Run-in Period|Protocol deviation|0|||
125669237|NCT02884206|452078160|FG002|Valsartan Run-in Period|Protocol deviation|0|||
125669238|NCT02884206|452078158|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
125669239|NCT02884206|452078159|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
125669240|NCT02884206|452078160|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
125669241|NCT02884206|452078158|FG000|Valsartan Run-in Period|Physician Decision|1|||
125669242|NCT02884206|452078159|FG001|Valsartan Run-in Period|Physician Decision|0|||
125669243|NCT02884206|452078160|FG002|Valsartan Run-in Period|Physician Decision|0|||
125331441|NCT01166282|450845673|FG000|Open-label Period|Irregular Compliance|0|||
125331442|NCT01166282|450845674|FG001|Open-label Period|Irregular Compliance|0|||
125669244|NCT02884206|452078158|FG000|LCZ696 Run-in Period|Adverse Event|38|||
125331443|NCT01166282|450845675|FG002|Open-label Period|Irregular Compliance|1|||
125331444|NCT02577718|450845676|FG000|Overall Study|Death|6|||
125331445|NCT02577718|450845676|FG000|Overall Study|Withdrawal by Subject|2|||
125331446|NCT01995838|450845677|FG000|Overall Study|Lost to Follow-up|0|||
125331447|NCT01995838|450845678|FG001|Overall Study|Lost to Follow-up|1|||
125331448|NCT01995838|450845679|FG002|Overall Study|Lost to Follow-up|0|||
125331449|NCT01995838|450845680|FG003|Overall Study|Lost to Follow-up|0|||
125669245|NCT02884206|452078159|FG001|LCZ696 Run-in Period|Adverse Event|0|||
125331450|NCT01995838|450845681|FG004|Overall Study|Lost to Follow-up|0|||
125331451|NCT01995838|450845682|FG005|Overall Study|Lost to Follow-up|0|||
125331452|NCT01995838|450845683|FG006|Overall Study|Lost to Follow-up|1|||
125331453|NCT01995838|450845677|FG000|Overall Study|Participant choice|2|||
125331454|NCT01995838|450845678|FG001|Overall Study|Participant choice|0|||
125331455|NCT01995838|450845679|FG002|Overall Study|Participant choice|0|||
125331456|NCT01995838|450845680|FG003|Overall Study|Participant choice|0|||
125331457|NCT01995838|450845681|FG004|Overall Study|Participant choice|0|||
125331458|NCT01995838|450845682|FG005|Overall Study|Participant choice|1|||
125669246|NCT02884206|452078160|FG002|LCZ696 Run-in Period|Adverse Event|0|||
125669247|NCT02884206|452078158|FG000|LCZ696 Run-in Period|Death|2|||
125331459|NCT01995838|450845683|FG006|Overall Study|Participant choice|1|||
125331460|NCT01995838|450845677|FG000|Overall Study|Adverse Event|0|||
125331461|NCT01995838|450845678|FG001|Overall Study|Adverse Event|0|||
125331462|NCT01995838|450845679|FG002|Overall Study|Adverse Event|0|||
125331463|NCT01995838|450845680|FG003|Overall Study|Adverse Event|0|||
125331464|NCT01995838|450845681|FG004|Overall Study|Adverse Event|0|||
125331465|NCT01995838|450845682|FG005|Overall Study|Adverse Event|0|||
125331466|NCT01995838|450845683|FG006|Overall Study|Adverse Event|1|||
125331467|NCT01995838|450845677|FG000|Overall Study|Withdrawal by Subject|0|||
125331468|NCT01995838|450845678|FG001|Overall Study|Withdrawal by Subject|0|||
125331469|NCT01995838|450845679|FG002|Overall Study|Withdrawal by Subject|0|||
125331470|NCT01995838|450845680|FG003|Overall Study|Withdrawal by Subject|0|||
125331471|NCT01995838|450845681|FG004|Overall Study|Withdrawal by Subject|1|||
125331472|NCT01995838|450845682|FG005|Overall Study|Withdrawal by Subject|0|||
125331473|NCT01995838|450845683|FG006|Overall Study|Withdrawal by Subject|0|||
125331474|NCT01995838|450845677|FG000|Overall Study|Other|3|||
125331475|NCT01995838|450845678|FG001|Overall Study|Other|1|||
125331476|NCT01995838|450845679|FG002|Overall Study|Other|0|||
125331477|NCT01995838|450845680|FG003|Overall Study|Other|2|||
125331478|NCT01995838|450845681|FG004|Overall Study|Other|1|||
125669248|NCT02884206|452078159|FG001|LCZ696 Run-in Period|Death|0|||
125669249|NCT02884206|452078160|FG002|LCZ696 Run-in Period|Death|0|||
125669250|NCT02884206|452078158|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
125669251|NCT02884206|452078159|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
125669252|NCT02884206|452078160|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
125669253|NCT02884206|452078158|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
125669254|NCT02884206|452078159|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
125669255|NCT02884206|452078160|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
125669256|NCT02884206|452078158|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
125669257|NCT02884206|452078159|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
125669258|NCT02884206|452078160|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
125669259|NCT02884206|452078158|FG000|LCZ696 Run-in Period|Physician Decision|1|||
125669260|NCT02884206|452078159|FG001|LCZ696 Run-in Period|Physician Decision|0|||
125669261|NCT02884206|452078160|FG002|LCZ696 Run-in Period|Physician Decision|0|||
125669262|NCT02884206|452078158|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
125669263|NCT02884206|452078159|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
125669264|NCT02884206|452078160|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
125669265|NCT02884206|452078158|FG000|Double-Blind Period|Death|0|||
125669266|NCT02884206|452078159|FG001|Double-Blind Period|Death|28|||
125669267|NCT02884206|452078160|FG002|Double-Blind Period|Death|39|||
125669268|NCT02884206|452078158|FG000|Double-Blind Period|Patient/guardian decision|0|||
125669269|NCT02884206|452078159|FG001|Double-Blind Period|Patient/guardian decision|10|||
125669270|NCT02884206|452078160|FG002|Double-Blind Period|Patient/guardian decision|13|||
125669271|NCT02884206|452078158|FG000|Double-Blind Period|Lost to Follow-up|0|||
125669272|NCT02884206|452078159|FG001|Double-Blind Period|Lost to Follow-up|4|||
125669273|NCT02884206|452078160|FG002|Double-Blind Period|Lost to Follow-up|4|||
125669274|NCT02884206|452078158|FG000|Double-Blind Period|Physician Decision|0|||
125669275|NCT02884206|452078159|FG001|Double-Blind Period|Physician Decision|2|||
125669276|NCT02884206|452078160|FG002|Double-Blind Period|Physician Decision|0|||
125669277|NCT02884206|452078158|FG000|Double-Blind Period|Adverse Event|0|||
125669278|NCT02884206|452078159|FG001|Double-Blind Period|Adverse Event|0|||
125669279|NCT02884206|452078160|FG002|Double-Blind Period|Adverse Event|3|||
125669280|NCT02884206|452078158|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
125669281|NCT02884206|452078159|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
125669282|NCT02884206|452078160|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
125669283|NCT00112489|452078161|FG000|Overall Study|Refused further treatment|8|||
125669284|NCT00112489|452078161|FG000|Overall Study|Adverse Event|12|||
125669285|NCT00112489|452078161|FG000|Overall Study|Death|2|||
125331479|NCT01995838|450845682|FG005|Overall Study|Other|1|||
125331480|NCT01995838|450845683|FG006|Overall Study|Other|2|||
125331481|NCT01967576|450845684|FG000|Overall Study|Withdrawal by Subject|3|||
125331482|NCT01967576|450845684|FG000|Overall Study|Progressed/Removed from treatment|1|||
125331483|NCT01967576|450845684|FG000|Overall Study|Study closing at site|1|||
125331484|NCT01967576|450845684|FG000|Overall Study|Adverse Event|1|||
125331485|NCT01967576|450845684|FG000|Overall Study|Refused further treatment|1|||
125331486|NCT00380367|450845687|FG000|Overall Study|Lost to Follow-up|1|||
125669286|NCT00112489|452078161|FG000|Overall Study|Other, Not Specified|9|||
125669287|NCT00112489|452078161|FG000|Overall Study|Patient never treated|2|||
125669288|NCT00112489|452078161|FG000|Overall Study|Ineligible|7|||
125669289|NCT05751629|452078162|FG000|Overall Study|Withdrawal by Subject|6|||
125669290|NCT05751629|452078162|FG000|Overall Study|Death|25|||
125669291|NCT05751629|452078162|FG000|Overall Study|Study Site Closed|9|||
125669292|NCT05751629|452078162|FG000|Overall Study|Physician Decision|1|||
125669293|NCT02231710|452078164|FG000|Overall Study|Physician Decision|1|||
125669294|NCT00295854|452078166|FG000|Overall Study|Adverse Event|7|||
125669295|NCT00295854|452078167|FG001|Overall Study|Adverse Event|7|||
125669296|NCT00295854|452078168|FG002|Overall Study|Adverse Event|6|||
125669297|NCT00295854|452078166|FG000|Overall Study|Protocol Violation|1|||
125669298|NCT00295854|452078167|FG001|Overall Study|Protocol Violation|1|||
125669299|NCT00295854|452078168|FG002|Overall Study|Protocol Violation|1|||
125669300|NCT00295854|452078166|FG000|Overall Study|Lost to Follow-up|2|||
125669301|NCT00295854|452078167|FG001|Overall Study|Lost to Follow-up|0|||
125669302|NCT00295854|452078168|FG002|Overall Study|Lost to Follow-up|1|||
125669303|NCT00295854|452078166|FG000|Overall Study|Withdrawal by Subject|3|||
125669304|NCT00295854|452078167|FG001|Overall Study|Withdrawal by Subject|7|||
125331487|NCT00380367|450845687|FG000|Overall Study|Withdrawal by Subject|1|||
125669305|NCT00295854|452078168|FG002|Overall Study|Withdrawal by Subject|4|||
125669306|NCT00295854|452078166|FG000|Overall Study|did not continue to meet criteria|1|||
125669307|NCT00295854|452078167|FG001|Overall Study|did not continue to meet criteria|1|||
125669308|NCT00295854|452078168|FG002|Overall Study|did not continue to meet criteria|2|||
125669309|NCT00295854|452078166|FG000|Overall Study|required a prohibited medication|1|||
125669310|NCT00295854|452078167|FG001|Overall Study|required a prohibited medication|0|||
125669311|NCT00295854|452078168|FG002|Overall Study|required a prohibited medication|0|||
125669312|NCT00295854|452078166|FG000|Overall Study|Other|3|||
125669313|NCT00295854|452078167|FG001|Overall Study|Other|5|||
125669314|NCT00295854|452078168|FG002|Overall Study|Other|1|||
125669315|NCT00672620|452078169|FG000|Overall Study|Adverse Event|7|||
125669316|NCT00672620|452078170|FG001|Overall Study|Adverse Event|7|||
125669317|NCT00672620|452078171|FG002|Overall Study|Adverse Event|12|||
125669318|NCT00672620|452078172|FG003|Overall Study|Adverse Event|17|||
125669319|NCT00672620|452078169|FG000|Overall Study|Lack of Efficacy|1|||
125669320|NCT00672620|452078170|FG001|Overall Study|Lack of Efficacy|2|||
125669321|NCT00672620|452078171|FG002|Overall Study|Lack of Efficacy|2|||
125669322|NCT00672620|452078172|FG003|Overall Study|Lack of Efficacy|0|||
125669323|NCT00672620|452078169|FG000|Overall Study|Noncompliance with Study Drug|3|||
125669324|NCT00672620|452078170|FG001|Overall Study|Noncompliance with Study Drug|4|||
125669325|NCT00672620|452078171|FG002|Overall Study|Noncompliance with Study Drug|0|||
125669326|NCT00672620|452078172|FG003|Overall Study|Noncompliance with Study Drug|2|||
125669327|NCT00672620|452078169|FG000|Overall Study|Protocol Deviations|5|||
125669328|NCT00672620|452078170|FG001|Overall Study|Protocol Deviations|7|||
125669329|NCT00672620|452078171|FG002|Overall Study|Protocol Deviations|2|||
125669330|NCT00672620|452078172|FG003|Overall Study|Protocol Deviations|5|||
125669331|NCT00672620|452078169|FG000|Overall Study|Withdrawal of Consent|6|||
125669332|NCT00672620|452078170|FG001|Overall Study|Withdrawal of Consent|12|||
125669333|NCT00672620|452078171|FG002|Overall Study|Withdrawal of Consent|5|||
125669334|NCT00672620|452078172|FG003|Overall Study|Withdrawal of Consent|6|||
125669335|NCT00672620|452078169|FG000|Overall Study|Lost to Follow-up|8|||
125669336|NCT00672620|452078170|FG001|Overall Study|Lost to Follow-up|19|||
125669337|NCT00672620|452078171|FG002|Overall Study|Lost to Follow-up|8|||
125331488|NCT00392769|450845691|FG000|Overall Study|Clinical Deterioration|9|||
125331489|NCT00392769|450845691|FG000|Overall Study|Adverse Event|1|||
125331490|NCT00060840|450845700|FG000|Overall Study|Change in surgical plan|2|||
125331491|NCT00060840|450845701|FG001|Overall Study|Change in surgical plan|6|||
125331492|NCT00060840|450845700|FG000|Overall Study|Death|0|||
125331493|NCT00060840|450845701|FG001|Overall Study|Death|1|||
125331494|NCT00060840|450845700|FG000|Overall Study|Withdrawal by Subject|0|||
125331495|NCT00060840|450845701|FG001|Overall Study|Withdrawal by Subject|1|||
125331496|NCT00060840|450845700|FG000|Overall Study|Subinvestigator unavailable|0|||
125331497|NCT00060840|450845701|FG001|Overall Study|Subinvestigator unavailable|1|||
125669338|NCT00672620|452078172|FG003|Overall Study|Lost to Follow-up|11|||
125669339|NCT00672620|452078169|FG000|Overall Study|Reason not Specified|3|||
125669340|NCT00672620|452078170|FG001|Overall Study|Reason not Specified|3|||
125669341|NCT00672620|452078171|FG002|Overall Study|Reason not Specified|2|||
125669342|NCT00672620|452078172|FG003|Overall Study|Reason not Specified|1|||
125669343|NCT00772577|452078173|FG000|Overall Study|Adverse Event|6|||
125669344|NCT00772577|452078174|FG001|Overall Study|Adverse Event|3|||
125669345|NCT00772577|452078173|FG000|Overall Study|Abnormal laboratory values|0|||
125669346|NCT00772577|452078174|FG001|Overall Study|Abnormal laboratory values|1|||
125669347|NCT00772577|452078173|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125331498|NCT00060840|450845700|FG000|Overall Study|Physician Decision|1|||
125331499|NCT00060840|450845701|FG001|Overall Study|Physician Decision|0|||
125331500|NCT00060840|450845700|FG000|Overall Study|Other|1|||
125669348|NCT00772577|452078174|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
125669349|NCT00772577|452078173|FG000|Overall Study|Patient withdrew consent|8|||
125331501|NCT00060840|450845701|FG001|Overall Study|Other|0|||
125331502|NCT03710161|450845703|FG000|Overall Study|Study halted due to COVID pandemic|3|||
125331503|NCT03710161|450845704|FG001|Overall Study|Study halted due to COVID pandemic|2|||
125331504|NCT00541385|450845706|FG000|Overall Study|Adverse Event|6|||
125331505|NCT00541385|450845707|FG001|Overall Study|Adverse Event|3|||
125331506|NCT00541385|450845706|FG000|Overall Study|Withdrawal by Subject|2|||
125669350|NCT00772577|452078174|FG001|Overall Study|Patient withdrew consent|5|||
125669351|NCT00772577|452078173|FG000|Overall Study|Lost to Follow-up|4|||
125669352|NCT00772577|452078174|FG001|Overall Study|Lost to Follow-up|3|||
125669353|NCT00772577|452078173|FG000|Overall Study|Administrative problems|2|||
125669354|NCT00772577|452078174|FG001|Overall Study|Administrative problems|1|||
125669355|NCT00772577|452078173|FG000|Overall Study|Protocol Deviation|3|||
125669356|NCT00772577|452078174|FG001|Overall Study|Protocol Deviation|2|||
125669357|NCT03211156|452078175|FG000|Overall Study|Withdrawal by Subject|0|||
125669358|NCT03211156|452078176|FG001|Overall Study|Withdrawal by Subject|2|||
125669359|NCT03211156|452078175|FG000|Overall Study|Lost to Follow-up|1|||
125669360|NCT03211156|452078176|FG001|Overall Study|Lost to Follow-up|1|||
125669361|NCT03211156|452078175|FG000|Overall Study|Adverse Event|1|||
125669362|NCT03211156|452078176|FG001|Overall Study|Adverse Event|0|||
125669363|NCT03487796|452078178|FG000|Overall Study|Lost to Follow-up|18|||
125669364|NCT03487796|452078179|FG001|Overall Study|Lost to Follow-up|6|||
125669365|NCT01489956|452078180|FG000|Overall Study|Lost to Follow-up|1|||
125669366|NCT01489956|452078181|FG001|Overall Study|Lost to Follow-up|0|||
125669367|NCT01489956|452078182|FG002|Overall Study|Lost to Follow-up|0|||
125669368|NCT01489956|452078180|FG000|Overall Study|Withdrawal by Subject|0|||
125669369|NCT01489956|452078181|FG001|Overall Study|Withdrawal by Subject|0|||
125669370|NCT01489956|452078182|FG002|Overall Study|Withdrawal by Subject|1|||
125669371|NCT03255031|452078183|FG000|Overall Study|Adverse Event|5|||
125669372|NCT03255031|452078184|FG001|Overall Study|Adverse Event|3|||
125669373|NCT03255031|452078183|FG000|Overall Study|Physician Decision|2|||
125669374|NCT03255031|452078184|FG001|Overall Study|Physician Decision|1|||
125669375|NCT03255031|452078183|FG000|Overall Study|Withdrawal by Subject|9|||
125669376|NCT03255031|452078184|FG001|Overall Study|Withdrawal by Subject|3|||
125669377|NCT00415532|452078188|FG000|Treatment Period|Adverse Event|2|||
125669378|NCT00415532|452078189|FG001|Treatment Period|Adverse Event|3|||
125669379|NCT00415532|452078188|FG000|Treatment Period|Death|2|||
125669380|NCT00415532|452078189|FG001|Treatment Period|Death|1|||
125669381|NCT00415532|452078188|FG000|Treatment Period|Lost to Follow-up|1|||
125669382|NCT00415532|452078189|FG001|Treatment Period|Lost to Follow-up|1|||
125669383|NCT00415532|452078188|FG000|Treatment Period|Protocol Violation|1|||
125669384|NCT00415532|452078189|FG001|Treatment Period|Protocol Violation|0|||
125669385|NCT00415532|452078188|FG000|Treatment Period|Withdrawal by Subject|6|||
125669386|NCT00415532|452078189|FG001|Treatment Period|Withdrawal by Subject|6|||
125669387|NCT00415532|452078188|FG000|Treatment Period|Other|2|||
125669388|NCT00415532|452078189|FG001|Treatment Period|Other|2|||
125669389|NCT00415532|452078188|FG000|Treatment Period|Ineligibility determined|1|||
125669390|NCT00415532|452078189|FG001|Treatment Period|Ineligibility determined|1|||
125669391|NCT00415532|452078188|FG000|Treatment Period|Noncompliance|1|||
125669392|NCT00415532|452078189|FG001|Treatment Period|Noncompliance|1|||
125669393|NCT00415532|452078188|FG000|Treatment Period|Requirement for alternative therapy|1|||
125669394|NCT00415532|452078189|FG001|Treatment Period|Requirement for alternative therapy|0|||
125669395|NCT00415532|452078188|FG000|Safety Follow Up Period|Adverse Event|1|||
125669396|NCT00415532|452078189|FG001|Safety Follow Up Period|Adverse Event|3|||
125669397|NCT00415532|452078188|FG000|Safety Follow Up Period|Death|3|||
125669398|NCT00415532|452078189|FG001|Safety Follow Up Period|Death|0|||
125669399|NCT00415532|452078188|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
125669400|NCT00415532|452078189|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
125669401|NCT00415532|452078188|FG000|Safety Follow Up Period|Other|1|||
125669402|NCT00415532|452078189|FG001|Safety Follow Up Period|Other|4|||
125669403|NCT00415532|452078188|FG000|Safety Follow Up Period|Ineligibility determined|1|||
125331507|NCT00541385|450845707|FG001|Overall Study|Withdrawal by Subject|2|||
125331508|NCT00541385|450845706|FG000|Overall Study|Lost to Follow-up|6|||
125331509|NCT00541385|450845707|FG001|Overall Study|Lost to Follow-up|1|||
125669404|NCT00415532|452078189|FG001|Safety Follow Up Period|Ineligibility determined|1|||
125669405|NCT00415532|452078188|FG000|Safety Follow Up Period|Noncompliance|1|||
125669406|NCT00415532|452078189|FG001|Safety Follow Up Period|Noncompliance|0|||
125669407|NCT00415532|452078188|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
125669408|NCT00415532|452078189|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
125669409|NCT01698320|452078190|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
125669410|NCT01698320|452078191|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
125669411|NCT01698320|452078192|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
125669412|NCT01698320|452078190|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
125669413|NCT01698320|452078191|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
125669414|NCT01698320|452078192|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
125331510|NCT00541385|450845706|FG000|Overall Study|Parasite reappearance/malaria|67|||
125331511|NCT00541385|450845707|FG001|Overall Study|Parasite reappearance/malaria|32|||
125331512|NCT01499355|450845710|FG000|Run-In Period|Study Termination|15|||
125331513|NCT01499355|450845711|FG001|Run-In Period|Study Termination|0|||
125331514|NCT01499355|450845712|FG002|Run-In Period|Study Termination|0|||
125331515|NCT01499355|450845713|FG003|Run-In Period|Study Termination|0|||
125331516|NCT01499355|450845710|FG000|Run-In Period|Other|3|||
125331517|NCT01499355|450845711|FG001|Run-In Period|Other|0|||
125331518|NCT01499355|450845712|FG002|Run-In Period|Other|0|||
125331519|NCT01499355|450845713|FG003|Run-In Period|Other|0|||
125331520|NCT01499355|450845710|FG000|Run-In Period|Death|2|||
125331521|NCT01499355|450845711|FG001|Run-In Period|Death|0|||
125331522|NCT01499355|450845712|FG002|Run-In Period|Death|0|||
125331523|NCT01499355|450845713|FG003|Run-In Period|Death|0|||
125331524|NCT01499355|450845710|FG000|Run-In Period|Investigator Decision|2|||
125331525|NCT01499355|450845711|FG001|Run-In Period|Investigator Decision|0|||
125331526|NCT01499355|450845712|FG002|Run-In Period|Investigator Decision|0|||
125331527|NCT01499355|450845713|FG003|Run-In Period|Investigator Decision|0|||
125331528|NCT01499355|450845710|FG000|Run-In Period|Consent Withdrawn|1|||
125331529|NCT01499355|450845711|FG001|Run-In Period|Consent Withdrawn|0|||
125331530|NCT01499355|450845712|FG002|Run-In Period|Consent Withdrawn|0|||
125331531|NCT01499355|450845713|FG003|Run-In Period|Consent Withdrawn|0|||
125331532|NCT01499355|450845710|FG000|Run-In Period|Adverse Event|8|||
125331533|NCT01499355|450845711|FG001|Run-In Period|Adverse Event|0|||
125331534|NCT01499355|450845712|FG002|Run-In Period|Adverse Event|0|||
125331535|NCT01499355|450845713|FG003|Run-In Period|Adverse Event|0|||
125331536|NCT01499355|450845710|FG000|Double-Blind Period|Adverse Event|0|||
125331537|NCT01499355|450845711|FG001|Double-Blind Period|Adverse Event|2|||
125331538|NCT01499355|450845712|FG002|Double-Blind Period|Adverse Event|3|||
125331539|NCT01499355|450845713|FG003|Double-Blind Period|Adverse Event|2|||
125669415|NCT01698320|452078190|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
125669416|NCT01698320|452078191|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
125669417|NCT01698320|452078192|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
125669418|NCT01698320|452078190|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
125669419|NCT01698320|452078191|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
125669420|NCT01698320|452078192|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
125669421|NCT01698320|452078190|FG000|12-Week Double-Blind Period|Adverse Event|0|||
125669422|NCT01698320|452078191|FG001|12-Week Double-Blind Period|Adverse Event|1|||
125669423|NCT01698320|452078192|FG002|12-Week Double-Blind Period|Adverse Event|1|||
125669424|NCT01698320|452078190|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
125669425|NCT01698320|452078191|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
125669426|NCT01698320|452078192|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
125669427|NCT01698320|452078190|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
125669428|NCT01698320|452078191|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
125669429|NCT01698320|452078192|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
125669430|NCT01698320|452078190|FG000|12-Week Double-Blind Period|Pregnancy|0|||
125669431|NCT01698320|452078191|FG001|12-Week Double-Blind Period|Pregnancy|1|||
125669432|NCT01698320|452078192|FG002|12-Week Double-Blind Period|Pregnancy|1|||
125669433|NCT01698320|452078190|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
125669434|NCT01698320|452078191|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
125669435|NCT01698320|452078192|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
125669436|NCT01698320|452078190|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
125669437|NCT01698320|452078191|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
125669438|NCT01698320|452078192|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
125669439|NCT01698320|452078190|FG000|40-Week Open-Label Period|Adverse Event|0|||
125669440|NCT01698320|452078191|FG001|40-Week Open-Label Period|Adverse Event|3|||
125669441|NCT01698320|452078192|FG002|40-Week Open-Label Period|Adverse Event|2|||
125669442|NCT01698320|452078190|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
125669443|NCT01698320|452078191|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
125669444|NCT01698320|452078192|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
125669445|NCT01698320|452078190|FG000|40-Week Open-Label Period|Pregnancy|0|||
125669446|NCT01698320|452078191|FG001|40-Week Open-Label Period|Pregnancy|2|||
125669447|NCT01698320|452078192|FG002|40-Week Open-Label Period|Pregnancy|1|||
125669448|NCT01698320|452078190|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
125669449|NCT01698320|452078191|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
125669450|NCT01698320|452078192|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
125669451|NCT01698320|452078190|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
125331540|NCT01499355|450845710|FG000|Double-Blind Period|Study Termination|0|||
125331541|NCT01499355|450845711|FG001|Double-Blind Period|Study Termination|18|||
125331542|NCT01499355|450845712|FG002|Double-Blind Period|Study Termination|16|||
125331543|NCT01499355|450845713|FG003|Double-Blind Period|Study Termination|14|||
125331544|NCT01499355|450845710|FG000|Double-Blind Period|Other|0|||
125331545|NCT01499355|450845711|FG001|Double-Blind Period|Other|1|||
125331546|NCT01499355|450845712|FG002|Double-Blind Period|Other|2|||
125331547|NCT01499355|450845713|FG003|Double-Blind Period|Other|2|||
125331548|NCT01499355|450845710|FG000|Double-Blind Period|Death|0|||
125331549|NCT01499355|450845711|FG001|Double-Blind Period|Death|1|||
125331550|NCT01499355|450845712|FG002|Double-Blind Period|Death|0|||
125669452|NCT01698320|452078191|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
125669453|NCT01698320|452078192|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
125669454|NCT01208402|452078197|FG000|Overall Study|Withdrawal by Subject|1|||
125669455|NCT01208402|452078198|FG001|Overall Study|Withdrawal by Subject|0|||
125669456|NCT03811249|452078199|FG000|Overall Study|Withdrawal by Subject|44|||
125669457|NCT03811249|452078199|FG000|Overall Study|Missed Visit|24|||
125669458|NCT02175966|452078200|FG000|Follow-up Period|Lack of Efficacy|10|||
125669459|NCT02175966|452078201|FG001|Follow-up Period|Lack of Efficacy|6|||
125669460|NCT01154153|452078202|FG000|Overall Study|Poor compliance to protocol|2|||
125331551|NCT01499355|450845713|FG003|Double-Blind Period|Death|0|||
125331552|NCT01499355|450845710|FG000|Double-Blind Period|Investigator Decision|0|||
125331553|NCT01499355|450845711|FG001|Double-Blind Period|Investigator Decision|0|||
125331554|NCT01499355|450845712|FG002|Double-Blind Period|Investigator Decision|3|||
125331555|NCT01499355|450845713|FG003|Double-Blind Period|Investigator Decision|3|||
125331556|NCT01499355|450845710|FG000|Double-Blind Period|Consent Withdrawn|0|||
125331557|NCT01499355|450845711|FG001|Double-Blind Period|Consent Withdrawn|0|||
125331558|NCT01499355|450845712|FG002|Double-Blind Period|Consent Withdrawn|1|||
125331559|NCT01499355|450845713|FG003|Double-Blind Period|Consent Withdrawn|2|||
125331560|NCT01499355|450845710|FG000|Double-Blind Period|Lost to Follow-up|0|||
125331561|NCT01499355|450845711|FG001|Double-Blind Period|Lost to Follow-up|1|||
125331562|NCT01499355|450845712|FG002|Double-Blind Period|Lost to Follow-up|0|||
125331563|NCT01499355|450845713|FG003|Double-Blind Period|Lost to Follow-up|0|||
125331564|NCT01526733|450845714|FG000|Phase 1|Protocol Violation|1|||
125331565|NCT01526733|450845715|FG001|Phase 1|Protocol Violation|0|||
125331566|NCT01526733|450845714|FG000|Phase 1|Withdrawal by Subject|1|||
125331567|NCT01526733|450845715|FG001|Phase 1|Withdrawal by Subject|1|||
125331568|NCT01599637|450845716|FG000|Overall Study|administrative problems|0|||
125540880|NCT03122223|451609470|FG003|Overall Study|Participant unable to adhere|0|||
125540881|NCT01151410|451609471|FG000|Overall Study|Withdrawal by Subject|3|||
125540882|NCT01151410|451609472|FG001|Overall Study|Withdrawal by Subject|5|||
125540883|NCT01151410|451609471|FG000|Overall Study|Lost to Follow-up|3|||
125540884|NCT01151410|451609472|FG001|Overall Study|Lost to Follow-up|4|||
125540885|NCT01151410|451609471|FG000|Overall Study|Adverse Event|1|||
125540886|NCT01151410|451609472|FG001|Overall Study|Adverse Event|2|||
125540887|NCT01151410|451609471|FG000|Overall Study|Protocol deviation|2|||
125540888|NCT01151410|451609472|FG001|Overall Study|Protocol deviation|1|||
125540889|NCT01151410|451609471|FG000|Overall Study|Administrative problems|1|||
125540890|NCT01151410|451609472|FG001|Overall Study|Administrative problems|1|||
125540891|NCT01151410|451609471|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125540892|NCT01151410|451609472|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125540893|NCT01151410|451609471|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125540894|NCT01151410|451609472|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125540895|NCT01237587|451609478|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
125540896|NCT01237587|451609479|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
125669461|NCT01154153|452078203|FG001|Overall Study|Poor compliance to protocol|0|||
125669462|NCT01154153|452078202|FG000|Overall Study|Unable to use labs|2|||
125331569|NCT01599637|450845717|FG001|Overall Study|administrative problems|2|||
125331570|NCT01599637|450845718|FG002|Overall Study|administrative problems|0|||
125331571|NCT01599637|450845716|FG000|Overall Study|Adverse Event|1|||
125331572|NCT01599637|450845717|FG001|Overall Study|Adverse Event|0|||
125331573|NCT01599637|450845718|FG002|Overall Study|Adverse Event|0|||
125331574|NCT02565108|450845719|FG000|Overall Study|Adverse Event|1|||
125331575|NCT02565108|450845720|FG001|Overall Study|Adverse Event|0|||
125331576|NCT02565108|450845719|FG000|Overall Study|Withdrew Consent|1|||
125331577|NCT02565108|450845720|FG001|Overall Study|Withdrew Consent|0|||
125331578|NCT01310075|450845721|FG000|Overall Study|Lost to Follow-up|1|||
125331579|NCT01310075|450845722|FG001|Overall Study|Lost to Follow-up|0|||
125331580|NCT01310075|450845721|FG000|Overall Study|Physician Decision|10|||
125331581|NCT01310075|450845722|FG001|Overall Study|Physician Decision|7|||
125331582|NCT01310075|450845721|FG000|Overall Study|Protocol Violation|2|||
125331583|NCT01310075|450845722|FG001|Overall Study|Protocol Violation|2|||
125331584|NCT01310075|450845721|FG000|Overall Study|Withdrawal by Subject|1|||
125331585|NCT01310075|450845722|FG001|Overall Study|Withdrawal by Subject|1|||
125331586|NCT02395081|450845723|FG000|Overall Study|Withdrawal by Subject|1|||
125331587|NCT02395081|450845724|FG001|Overall Study|Withdrawal by Subject|1|||
125331588|NCT02395081|450845725|FG002|Overall Study|Withdrawal by Subject|0|||
125331589|NCT02395081|450845723|FG000|Overall Study|Moved where blood couldn't be collected|4|||
125331590|NCT02395081|450845724|FG001|Overall Study|Moved where blood couldn't be collected|1|||
125669463|NCT01154153|452078203|FG001|Overall Study|Unable to use labs|3|||
125331591|NCT02395081|450845725|FG002|Overall Study|Moved where blood couldn't be collected|3|||
125331592|NCT02395081|450845723|FG000|Overall Study|Fetal Loss|2|||
125331593|NCT02395081|450845724|FG001|Overall Study|Fetal Loss|3|||
125331594|NCT02395081|450845725|FG002|Overall Study|Fetal Loss|1|||
125331595|NCT02991040|450845726|FG000|Overall Study|Withdrawal by Subject|2|||
125540897|NCT01237587|451609478|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
125540898|NCT01237587|451609479|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
125669464|NCT01154153|452078202|FG000|Overall Study|Withdrew consent|1|||
125669465|NCT01154153|452078203|FG001|Overall Study|Withdrew consent|0|||
125669466|NCT00210626|452078204|FG000|Overall Study|Adverse Event|1|||
125669467|NCT00210626|452078205|FG001|Overall Study|Adverse Event|2|||
125669468|NCT00210626|452078204|FG000|Overall Study|Protocol Violation|1|||
125669469|NCT00210626|452078205|FG001|Overall Study|Protocol Violation|5|||
125669470|NCT00210626|452078204|FG000|Overall Study|Lost to Follow-up|11|||
125669471|NCT00210626|452078205|FG001|Overall Study|Lost to Follow-up|11|||
125669472|NCT00210626|452078204|FG000|Overall Study|Death|1|||
125669473|NCT00210626|452078205|FG001|Overall Study|Death|0|||
125669474|NCT00210626|452078204|FG000|Overall Study|Withdrawal by Subject|29|||
125669475|NCT00210626|452078205|FG001|Overall Study|Withdrawal by Subject|20|||
125669476|NCT00210626|452078204|FG000|Overall Study|Physician Decision|0|||
125669477|NCT00210626|452078205|FG001|Overall Study|Physician Decision|2|||
125669478|NCT00210626|452078204|FG000|Overall Study|Sponser Request|1|||
125669479|NCT00210626|452078205|FG001|Overall Study|Sponser Request|0|||
125669480|NCT00210626|452078204|FG000|Overall Study|Other|4|||
125669481|NCT00210626|452078205|FG001|Overall Study|Other|5|||
125669482|NCT01227668|452078206|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
125669483|NCT01227668|452078207|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
125669484|NCT01227668|452078206|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
125669485|NCT01227668|452078207|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
125669486|NCT01227668|452078206|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
125669487|NCT01227668|452078207|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
125669488|NCT01227668|452078206|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
125669489|NCT01227668|452078207|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
125669490|NCT01227668|452078206|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
125669491|NCT01227668|452078207|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
125669492|NCT01227668|452078206|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
125669493|NCT01227668|452078207|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
125669494|NCT01227668|452078206|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
125669495|NCT01227668|452078207|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
125331596|NCT02991040|450845726|FG000|Overall Study|Lost to Follow-up|2|||
125331597|NCT01286480|450845727|FG000|Overall Study|Withdrawal by Subject|5|||
125331598|NCT01286480|450845728|FG001|Overall Study|Withdrawal by Subject|3|||
125669496|NCT01227668|452078206|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
125669497|NCT01227668|452078207|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
125331599|NCT02536963|450845729|FG000|Overall Study|Withdrawal by Subject|18|||
125331600|NCT02668393|450845731|FG000|Overall Study|Progressive disease|6|||
125331601|NCT02668393|450845732|FG001|Overall Study|Progressive disease|3|||
125331602|NCT02668393|450845731|FG000|Overall Study|Adverse Event|0|||
125331603|NCT02668393|450845732|FG001|Overall Study|Adverse Event|2|||
125331604|NCT02668393|450845731|FG000|Overall Study|Withdrawal from the trial|0|||
125331605|NCT02668393|450845732|FG001|Overall Study|Withdrawal from the trial|1|||
125331606|NCT02668393|450845731|FG000|Overall Study|Lack of benefit and side effects|1|||
125331607|NCT02668393|450845732|FG001|Overall Study|Lack of benefit and side effects|0|||
125331608|NCT02141204|450845733|FG000|Overall Study|Lost to Follow-up|2|||
125331609|NCT02141204|450845734|FG001|Overall Study|Lost to Follow-up|1|||
125331610|NCT02141204|450845733|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
125331611|NCT02141204|450845734|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
125331612|NCT02141204|450845733|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
125331613|NCT02141204|450845734|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
125331614|NCT02141204|450845733|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
125331615|NCT02141204|450845734|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
125331616|NCT02963506|450845736|FG000|Double-Blind Period|Adverse Event|0|||
125331617|NCT02963506|450845737|FG001|Double-Blind Period|Adverse Event|0|||
125331618|NCT02963506|450845738|FG002|Double-Blind Period|Adverse Event|1|||
125331619|NCT02963506|450845739|FG003|Double-Blind Period|Adverse Event|0|||
125331620|NCT02963506|450845740|FG004|Double-Blind Period|Adverse Event|0|||
125331621|NCT02963506|450845741|FG005|Double-Blind Period|Adverse Event|0|||
125331622|NCT02963506|450845742|FG006|Double-Blind Period|Adverse Event|0|||
125331623|NCT02963506|450845743|FG007|Double-Blind Period|Adverse Event|0|||
125331624|NCT02963506|450845744|FG008|Double-Blind Period|Adverse Event|0|||
125331625|NCT02963506|450845745|FG009|Double-Blind Period|Adverse Event|0|||
125331626|NCT02963506|450845746|FG010|Double-Blind Period|Adverse Event|0|||
125331627|NCT02963506|450845747|FG011|Double-Blind Period|Adverse Event|0|||
125331628|NCT02963506|450845748|FG012|Double-Blind Period|Adverse Event|0|||
125669498|NCT01227668|452078206|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
125669499|NCT01227668|452078207|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
125669500|NCT01227668|452078206|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
125669501|NCT01227668|452078207|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
125669502|NCT01227668|452078206|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
125669503|NCT01227668|452078207|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
125331629|NCT02963506|450845736|FG000|Double-Blind Period|Death|0|||
125331630|NCT02963506|450845737|FG001|Double-Blind Period|Death|0|||
125331631|NCT02963506|450845738|FG002|Double-Blind Period|Death|0|||
125331632|NCT02963506|450845739|FG003|Double-Blind Period|Death|1|||
125331633|NCT02963506|450845740|FG004|Double-Blind Period|Death|0|||
125331634|NCT02963506|450845741|FG005|Double-Blind Period|Death|0|||
125331635|NCT02963506|450845742|FG006|Double-Blind Period|Death|0|||
125331636|NCT02963506|450845743|FG007|Double-Blind Period|Death|0|||
125669504|NCT01227668|452078206|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
125669505|NCT01227668|452078207|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
125669506|NCT02473510|452078208|FG000|Overall Study|Lost to Follow-up|1|||
125669507|NCT02473510|452078209|FG001|Overall Study|Lost to Follow-up|2|||
125669508|NCT01306253|452078210|FG000|Overall Study|Lost to Follow-up|1|||
125669509|NCT01306253|452078211|FG001|Overall Study|Lost to Follow-up|1|||
125669510|NCT02280356|452078215|FG000|Overall Study|Not Treated|2|||
125669511|NCT02280356|452078215|FG000|Overall Study|Withdrawal by Subject|1|||
125669512|NCT02280356|452078215|FG000|Overall Study|Not evaluable|2|||
125669513|NCT01086215|452078216|FG000|Overall Study|Death|14|||
125669514|NCT01086215|452078217|FG001|Overall Study|Death|8|||
125669515|NCT01086215|452078218|FG002|Overall Study|Death|8|||
125669516|NCT01086215|452078219|FG003|Overall Study|Death|1|||
125669517|NCT01086215|452078216|FG000|Overall Study|Lost to Follow-up|22|||
125669518|NCT01086215|452078217|FG001|Overall Study|Lost to Follow-up|39|||
125669519|NCT01086215|452078218|FG002|Overall Study|Lost to Follow-up|18|||
125669520|NCT01086215|452078219|FG003|Overall Study|Lost to Follow-up|2|||
125669521|NCT02006147|452078220|FG000|Overall Study|Protocol Violation|1|||
125669522|NCT02006147|452078221|FG001|Overall Study|Protocol Violation|1|||
125669523|NCT02006147|452078222|FG002|Overall Study|Protocol Violation|0|||
125669524|NCT02006147|452078223|FG003|Overall Study|Protocol Violation|0|||
125669525|NCT02006147|452078220|FG000|Overall Study|Withdrawal by Subject|0|||
125669526|NCT02006147|452078221|FG001|Overall Study|Withdrawal by Subject|1|||
125669527|NCT02006147|452078222|FG002|Overall Study|Withdrawal by Subject|0|||
125669528|NCT02006147|452078223|FG003|Overall Study|Withdrawal by Subject|0|||
125669529|NCT02006147|452078220|FG000|Overall Study|Withdrawal by Sponsor|1|||
125669530|NCT02006147|452078221|FG001|Overall Study|Withdrawal by Sponsor|0|||
125669531|NCT02006147|452078222|FG002|Overall Study|Withdrawal by Sponsor|0|||
125669532|NCT02006147|452078223|FG003|Overall Study|Withdrawal by Sponsor|0|||
125669533|NCT00408876|452078224|FG000|Overall Study|Adverse Event|9|||
125669534|NCT00408876|452078225|FG001|Overall Study|Adverse Event|17|||
125669535|NCT00408876|452078226|FG002|Overall Study|Adverse Event|27|||
125669536|NCT00408876|452078227|FG003|Overall Study|Adverse Event|10|||
125669537|NCT00408876|452078224|FG000|Overall Study|Withdrawal by Subject|3|||
125669538|NCT00408876|452078225|FG001|Overall Study|Withdrawal by Subject|6|||
125669539|NCT00408876|452078226|FG002|Overall Study|Withdrawal by Subject|6|||
125669540|NCT00408876|452078227|FG003|Overall Study|Withdrawal by Subject|14|||
125669541|NCT00408876|452078224|FG000|Overall Study|Lack of Efficacy|2|||
125669542|NCT00408876|452078225|FG001|Overall Study|Lack of Efficacy|4|||
125669543|NCT00408876|452078226|FG002|Overall Study|Lack of Efficacy|5|||
125669544|NCT00408876|452078227|FG003|Overall Study|Lack of Efficacy|6|||
125669545|NCT00408876|452078224|FG000|Overall Study|Lost to Follow-up|1|||
125669546|NCT00408876|452078225|FG001|Overall Study|Lost to Follow-up|6|||
125669547|NCT00408876|452078226|FG002|Overall Study|Lost to Follow-up|5|||
125669548|NCT00408876|452078227|FG003|Overall Study|Lost to Follow-up|2|||
125669549|NCT00408876|452078224|FG000|Overall Study|Protocol Violation|0|||
125669550|NCT00408876|452078225|FG001|Overall Study|Protocol Violation|3|||
125669551|NCT00408876|452078226|FG002|Overall Study|Protocol Violation|4|||
125669552|NCT00408876|452078227|FG003|Overall Study|Protocol Violation|3|||
125669553|NCT00408876|452078224|FG000|Overall Study|Physician Decision|1|||
125669554|NCT00408876|452078225|FG001|Overall Study|Physician Decision|0|||
125669555|NCT00408876|452078226|FG002|Overall Study|Physician Decision|3|||
125669556|NCT00408876|452078227|FG003|Overall Study|Physician Decision|0|||
125669557|NCT03361956|452078228|FG000|Overall Study|Adverse Event|1|||
125669558|NCT03361956|452078229|FG001|Overall Study|Adverse Event|0|||
125669559|NCT03361956|452078230|FG002|Overall Study|Adverse Event|1|||
125669560|NCT03361956|452078231|FG003|Overall Study|Adverse Event|1|||
125669561|NCT03361956|452078232|FG004|Overall Study|Adverse Event|0|||
125669562|NCT03361956|452078228|FG000|Overall Study|Other|0|||
125331637|NCT02963506|450845744|FG008|Double-Blind Period|Death|0|||
125331638|NCT02963506|450845745|FG009|Double-Blind Period|Death|0|||
125669563|NCT03361956|452078229|FG001|Overall Study|Other|0|||
125669564|NCT03361956|452078230|FG002|Overall Study|Other|0|||
125669565|NCT03361956|452078231|FG003|Overall Study|Other|1|||
125669566|NCT03361956|452078232|FG004|Overall Study|Other|0|||
125331639|NCT02963506|450845746|FG010|Double-Blind Period|Death|0|||
125331640|NCT02963506|450845747|FG011|Double-Blind Period|Death|0|||
125669567|NCT03361956|452078228|FG000|Overall Study|Withdrawal by Subject|2|||
125669568|NCT03361956|452078229|FG001|Overall Study|Withdrawal by Subject|2|||
125669569|NCT03361956|452078230|FG002|Overall Study|Withdrawal by Subject|2|||
125669570|NCT03361956|452078231|FG003|Overall Study|Withdrawal by Subject|0|||
125669571|NCT03361956|452078232|FG004|Overall Study|Withdrawal by Subject|3|||
125669572|NCT03361956|452078228|FG000|Overall Study|Disease Relapse|0|||
125669573|NCT03361956|452078229|FG001|Overall Study|Disease Relapse|0|||
125669574|NCT03361956|452078230|FG002|Overall Study|Disease Relapse|1|||
125331641|NCT02963506|450845748|FG012|Double-Blind Period|Death|0|||
125331642|NCT02963506|450845736|FG000|Double-Blind Period|Lost to Follow-up|0|||
125669575|NCT03361956|452078231|FG003|Overall Study|Disease Relapse|0|||
125331643|NCT02963506|450845737|FG001|Double-Blind Period|Lost to Follow-up|1|||
125331644|NCT02963506|450845738|FG002|Double-Blind Period|Lost to Follow-up|0|||
125331645|NCT02963506|450845739|FG003|Double-Blind Period|Lost to Follow-up|0|||
125331646|NCT02963506|450845740|FG004|Double-Blind Period|Lost to Follow-up|0|||
125331647|NCT02963506|450845741|FG005|Double-Blind Period|Lost to Follow-up|0|||
125331648|NCT02963506|450845742|FG006|Double-Blind Period|Lost to Follow-up|0|||
125331649|NCT02963506|450845743|FG007|Double-Blind Period|Lost to Follow-up|0|||
125331650|NCT02963506|450845744|FG008|Double-Blind Period|Lost to Follow-up|0|||
125331651|NCT02963506|450845745|FG009|Double-Blind Period|Lost to Follow-up|0|||
125331652|NCT02963506|450845746|FG010|Double-Blind Period|Lost to Follow-up|0|||
125331653|NCT02963506|450845747|FG011|Double-Blind Period|Lost to Follow-up|0|||
125331654|NCT02963506|450845748|FG012|Double-Blind Period|Lost to Follow-up|0|||
125331655|NCT02963506|450845736|FG000|Double-Blind Period|Withdrawal by Subject|0|||
125331656|NCT02963506|450845737|FG001|Double-Blind Period|Withdrawal by Subject|0|||
125331657|NCT02963506|450845738|FG002|Double-Blind Period|Withdrawal by Subject|1|||
125331658|NCT02963506|450845739|FG003|Double-Blind Period|Withdrawal by Subject|1|||
125331659|NCT02963506|450845740|FG004|Double-Blind Period|Withdrawal by Subject|0|||
125331660|NCT02963506|450845741|FG005|Double-Blind Period|Withdrawal by Subject|0|||
125331661|NCT02963506|450845742|FG006|Double-Blind Period|Withdrawal by Subject|0|||
125331662|NCT02963506|450845743|FG007|Double-Blind Period|Withdrawal by Subject|0|||
125331663|NCT02963506|450845744|FG008|Double-Blind Period|Withdrawal by Subject|0|||
125331664|NCT02963506|450845745|FG009|Double-Blind Period|Withdrawal by Subject|0|||
125331665|NCT02963506|450845746|FG010|Double-Blind Period|Withdrawal by Subject|0|||
125331666|NCT02963506|450845747|FG011|Double-Blind Period|Withdrawal by Subject|0|||
125331667|NCT02963506|450845748|FG012|Double-Blind Period|Withdrawal by Subject|0|||
125331668|NCT02963506|450845736|FG000|Double-Blind Period|No compliance|0|||
125331669|NCT02963506|450845737|FG001|Double-Blind Period|No compliance|1|||
125331670|NCT02963506|450845738|FG002|Double-Blind Period|No compliance|0|||
125331671|NCT02963506|450845739|FG003|Double-Blind Period|No compliance|0|||
125331672|NCT02963506|450845740|FG004|Double-Blind Period|No compliance|0|||
125331673|NCT02963506|450845741|FG005|Double-Blind Period|No compliance|0|||
125331674|NCT02963506|450845742|FG006|Double-Blind Period|No compliance|0|||
125331675|NCT02963506|450845743|FG007|Double-Blind Period|No compliance|0|||
125331676|NCT02963506|450845744|FG008|Double-Blind Period|No compliance|0|||
125331677|NCT02963506|450845745|FG009|Double-Blind Period|No compliance|0|||
125331678|NCT02963506|450845746|FG010|Double-Blind Period|No compliance|0|||
125331679|NCT02963506|450845747|FG011|Double-Blind Period|No compliance|0|||
125331680|NCT02963506|450845748|FG012|Double-Blind Period|No compliance|0|||
125331681|NCT02963506|450845736|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331682|NCT02963506|450845737|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
125331683|NCT02963506|450845738|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331684|NCT02963506|450845739|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331685|NCT02963506|450845740|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331686|NCT02963506|450845741|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331687|NCT02963506|450845742|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331688|NCT02963506|450845743|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331689|NCT02963506|450845744|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331690|NCT02963506|450845745|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331691|NCT02963506|450845746|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331692|NCT02963506|450845747|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125331693|NCT02963506|450845748|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
125669576|NCT03361956|452078232|FG004|Overall Study|Disease Relapse|0|||
125669577|NCT03361956|452078228|FG000|Overall Study|Physician Decision|0|||
125669578|NCT03361956|452078229|FG001|Overall Study|Physician Decision|2|||
125669579|NCT03361956|452078230|FG002|Overall Study|Physician Decision|0|||
125669580|NCT03361956|452078231|FG003|Overall Study|Physician Decision|1|||
125669581|NCT03361956|452078232|FG004|Overall Study|Physician Decision|0|||
125331694|NCT02963506|450845736|FG000|Dose-Blind Period|Adverse Event|0|||
125331695|NCT02963506|450845737|FG001|Dose-Blind Period|Adverse Event|0|||
125331696|NCT02963506|450845738|FG002|Dose-Blind Period|Adverse Event|0|||
125331697|NCT02963506|450845739|FG003|Dose-Blind Period|Adverse Event|0|||
125331698|NCT02963506|450845740|FG004|Dose-Blind Period|Adverse Event|0|||
125331699|NCT02963506|450845741|FG005|Dose-Blind Period|Adverse Event|1|||
125331700|NCT02963506|450845742|FG006|Dose-Blind Period|Adverse Event|3|||
125331701|NCT02963506|450845743|FG007|Dose-Blind Period|Adverse Event|2|||
125331702|NCT02963506|450845744|FG008|Dose-Blind Period|Adverse Event|2|||
125331703|NCT02963506|450845745|FG009|Dose-Blind Period|Adverse Event|2|||
125331704|NCT02963506|450845746|FG010|Dose-Blind Period|Adverse Event|1|||
125669582|NCT03361956|452078228|FG000|Overall Study|Lost to Follow-up|0|||
125669583|NCT03361956|452078229|FG001|Overall Study|Lost to Follow-up|0|||
125331705|NCT02963506|450845747|FG011|Dose-Blind Period|Adverse Event|1|||
125669584|NCT03361956|452078230|FG002|Overall Study|Lost to Follow-up|1|||
125669585|NCT03361956|452078231|FG003|Overall Study|Lost to Follow-up|1|||
125331706|NCT02963506|450845748|FG012|Dose-Blind Period|Adverse Event|6|||
125331707|NCT02963506|450845736|FG000|Dose-Blind Period|Lack of Efficacy|0|||
125331708|NCT02963506|450845737|FG001|Dose-Blind Period|Lack of Efficacy|0|||
125331709|NCT02963506|450845738|FG002|Dose-Blind Period|Lack of Efficacy|0|||
125331710|NCT02963506|450845739|FG003|Dose-Blind Period|Lack of Efficacy|0|||
125331711|NCT02963506|450845740|FG004|Dose-Blind Period|Lack of Efficacy|0|||
125331712|NCT02963506|450845741|FG005|Dose-Blind Period|Lack of Efficacy|0|||
125331713|NCT02963506|450845742|FG006|Dose-Blind Period|Lack of Efficacy|0|||
125331714|NCT02963506|450845743|FG007|Dose-Blind Period|Lack of Efficacy|1|||
125331715|NCT02963506|450845744|FG008|Dose-Blind Period|Lack of Efficacy|0|||
125331716|NCT02963506|450845745|FG009|Dose-Blind Period|Lack of Efficacy|1|||
125331717|NCT02963506|450845746|FG010|Dose-Blind Period|Lack of Efficacy|0|||
125331718|NCT02963506|450845747|FG011|Dose-Blind Period|Lack of Efficacy|0|||
125331719|NCT02963506|450845748|FG012|Dose-Blind Period|Lack of Efficacy|0|||
125331720|NCT02963506|450845736|FG000|Dose-Blind Period|Lost to Follow-up|0|||
125331721|NCT02963506|450845737|FG001|Dose-Blind Period|Lost to Follow-up|0|||
125331722|NCT02963506|450845738|FG002|Dose-Blind Period|Lost to Follow-up|0|||
125331723|NCT02963506|450845739|FG003|Dose-Blind Period|Lost to Follow-up|0|||
125331724|NCT02963506|450845740|FG004|Dose-Blind Period|Lost to Follow-up|0|||
125331725|NCT02963506|450845741|FG005|Dose-Blind Period|Lost to Follow-up|1|||
125331726|NCT02963506|450845742|FG006|Dose-Blind Period|Lost to Follow-up|0|||
125331727|NCT02963506|450845743|FG007|Dose-Blind Period|Lost to Follow-up|0|||
125331728|NCT02963506|450845744|FG008|Dose-Blind Period|Lost to Follow-up|1|||
125331729|NCT02963506|450845745|FG009|Dose-Blind Period|Lost to Follow-up|0|||
125331730|NCT02963506|450845746|FG010|Dose-Blind Period|Lost to Follow-up|0|||
125331731|NCT02963506|450845747|FG011|Dose-Blind Period|Lost to Follow-up|1|||
125331732|NCT02963506|450845748|FG012|Dose-Blind Period|Lost to Follow-up|0|||
125331733|NCT02963506|450845736|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
125669586|NCT03361956|452078232|FG004|Overall Study|Lost to Follow-up|2|||
125669587|NCT00871728|452078236|FG000|Overall Study|Adverse Event|1|||
125331734|NCT02963506|450845737|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
125331735|NCT02963506|450845738|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
125331736|NCT02963506|450845739|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
125331737|NCT02963506|450845740|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
125331738|NCT02963506|450845741|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
125331739|NCT02963506|450845742|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
125331740|NCT02963506|450845743|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
125331741|NCT02963506|450845744|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
125331742|NCT02963506|450845745|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
125331743|NCT02963506|450845746|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
125331744|NCT02963506|450845747|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
125331745|NCT02963506|450845748|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
125331746|NCT02963506|450845736|FG000|Dose-Blind Period|Sponsor decision|0|||
125331747|NCT02963506|450845737|FG001|Dose-Blind Period|Sponsor decision|0|||
125331748|NCT02963506|450845738|FG002|Dose-Blind Period|Sponsor decision|0|||
125331749|NCT02963506|450845739|FG003|Dose-Blind Period|Sponsor decision|0|||
125331750|NCT02963506|450845740|FG004|Dose-Blind Period|Sponsor decision|0|||
125331751|NCT02963506|450845741|FG005|Dose-Blind Period|Sponsor decision|1|||
125331752|NCT02963506|450845742|FG006|Dose-Blind Period|Sponsor decision|0|||
125331753|NCT02963506|450845743|FG007|Dose-Blind Period|Sponsor decision|0|||
125331754|NCT02963506|450845744|FG008|Dose-Blind Period|Sponsor decision|0|||
125331755|NCT02963506|450845745|FG009|Dose-Blind Period|Sponsor decision|0|||
125331756|NCT02963506|450845746|FG010|Dose-Blind Period|Sponsor decision|0|||
125331757|NCT02963506|450845747|FG011|Dose-Blind Period|Sponsor decision|0|||
125331758|NCT02963506|450845748|FG012|Dose-Blind Period|Sponsor decision|0|||
125331759|NCT02963506|450845736|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331760|NCT02963506|450845737|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331761|NCT02963506|450845738|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331762|NCT02963506|450845739|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331763|NCT02963506|450845740|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331764|NCT02963506|450845741|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125669588|NCT00871728|452078236|FG000|Overall Study|Protocol Violation|7|||
125669589|NCT00871728|452078236|FG000|Overall Study|Lost to Follow-up|2|||
125669590|NCT00871728|452078236|FG000|Overall Study|Failed to Visit Hospital|4|||
125331765|NCT02963506|450845742|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331766|NCT02963506|450845743|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331767|NCT02963506|450845744|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331768|NCT02963506|450845745|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331769|NCT02963506|450845746|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125331770|NCT02963506|450845747|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
125669591|NCT00871728|452078236|FG000|Overall Study|Participant Non-compliance|1|||
125331771|NCT02963506|450845748|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
125669592|NCT00871728|452078236|FG000|Overall Study|Withdrawal of Informed Consent|5|||
125331772|NCT00750438|450845749|FG000|Overall Study|Protocol Violation|4|||
125669593|NCT04147715|452078239|FG000|Overall Study|Adverse Event|0|||
125669594|NCT04147715|452078240|FG001|Overall Study|Adverse Event|0|||
125669595|NCT04147715|452078241|FG002|Overall Study|Adverse Event|0|||
125669596|NCT04147715|452078242|FG003|Overall Study|Adverse Event|0|||
125669597|NCT04147715|452078243|FG004|Overall Study|Adverse Event|0|||
125669598|NCT04147715|452078244|FG005|Overall Study|Adverse Event|0|||
125669599|NCT04147715|452078245|FG006|Overall Study|Adverse Event|0|||
125669600|NCT04147715|452078246|FG007|Overall Study|Adverse Event|2|||
125669601|NCT04147715|452078247|FG008|Overall Study|Adverse Event|1|||
125669602|NCT04147715|452078248|FG009|Overall Study|Adverse Event|0|||
125669603|NCT04147715|452078249|FG010|Overall Study|Adverse Event|0|||
125669604|NCT04147715|452078250|FG011|Overall Study|Adverse Event|0|||
125669605|NCT01626859|452078251|FG000|Overall Study|Adverse Event|1|||
125669606|NCT01626859|452078252|FG001|Overall Study|Adverse Event|3|||
125669607|NCT01626859|452078253|FG002|Overall Study|Adverse Event|2|||
125669608|NCT01626859|452078251|FG000|Overall Study|Physician Decision|0|||
125669609|NCT01626859|452078252|FG001|Overall Study|Physician Decision|1|||
125669610|NCT01626859|452078253|FG002|Overall Study|Physician Decision|0|||
125331773|NCT00750438|450845750|FG001|Overall Study|Protocol Violation|1|||
125331774|NCT00750438|450845749|FG000|Overall Study|Physician Decision|2|||
125331775|NCT00750438|450845750|FG001|Overall Study|Physician Decision|2|||
125331776|NCT00750438|450845749|FG000|Overall Study|Withdrawal by Subject|1|||
125669611|NCT01626859|452078251|FG000|Overall Study|Withdrawal by Subject|1|||
125669612|NCT01626859|452078252|FG001|Overall Study|Withdrawal by Subject|4|||
125669613|NCT01626859|452078253|FG002|Overall Study|Withdrawal by Subject|2|||
125669614|NCT02629965|452078254|FG000|Period 1|Adverse Event|1|||
125669615|NCT02629965|452078255|FG001|Period 1|Adverse Event|0|||
125669616|NCT02629965|452078254|FG000|Period 1|Unexpected worsening of disease|2|||
125669617|NCT02629965|452078255|FG001|Period 1|Unexpected worsening of disease|0|||
125669618|NCT02629965|452078254|FG000|Period 1|Other than listed above|1|||
125669619|NCT02629965|452078255|FG001|Period 1|Other than listed above|2|||
125669620|NCT02629965|452078254|FG000|Period 2|Adverse Event|1|||
125669621|NCT02629965|452078255|FG001|Period 2|Adverse Event|0|||
125669622|NCT00905489|452078256|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
125669623|NCT00905489|452078256|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
125669624|NCT00905489|452078256|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
125669625|NCT00895583|452078261|FG000|Overall Study|Adverse Event|28|||
125669626|NCT00895583|452078262|FG001|Overall Study|Adverse Event|4|||
125669627|NCT00895583|452078261|FG000|Overall Study|Death|2|||
125669628|NCT00895583|452078262|FG001|Overall Study|Death|1|||
125669629|NCT00895583|452078261|FG000|Overall Study|Physician Decision|3|||
125669630|NCT00895583|452078262|FG001|Overall Study|Physician Decision|1|||
125669631|NCT00895583|452078261|FG000|Overall Study|Lost to Follow-up|1|||
125669632|NCT00895583|452078262|FG001|Overall Study|Lost to Follow-up|3|||
125669633|NCT00895583|452078261|FG000|Overall Study|Protocol Violation|1|||
125669634|NCT00895583|452078262|FG001|Overall Study|Protocol Violation|0|||
125669635|NCT00895583|452078261|FG000|Overall Study|Withdrawal by Subject|4|||
125669636|NCT00895583|452078262|FG001|Overall Study|Withdrawal by Subject|2|||
125331777|NCT00750438|450845750|FG001|Overall Study|Withdrawal by Subject|1|||
125331778|NCT00928408|450845755|FG000|Overall Study|Other|2|||
125331779|NCT00928408|450845755|FG000|Overall Study|Withdrawal by Subject|4|||
125331780|NCT00928408|450845755|FG000|Overall Study|Death|5|||
125331781|NCT00928408|450845755|FG000|Overall Study|Lost to Follow-up|12|||
125331782|NCT00536744|450845756|FG000|Overall Study|Adverse Event|13|||
125331783|NCT00536744|450845757|FG001|Overall Study|Adverse Event|10|||
125331784|NCT00536744|450845756|FG000|Overall Study|Death|2|||
125331785|NCT00536744|450845757|FG001|Overall Study|Death|1|||
125331786|NCT00536744|450845756|FG000|Overall Study|Physician Decision|3|||
125331787|NCT00536744|450845757|FG001|Overall Study|Physician Decision|1|||
125331788|NCT00536744|450845756|FG000|Overall Study|Lost to Follow-up|3|||
125331789|NCT00536744|450845757|FG001|Overall Study|Lost to Follow-up|5|||
125331790|NCT00536744|450845756|FG000|Overall Study|Withdrawal by Subject|7|||
125331791|NCT00536744|450845757|FG001|Overall Study|Withdrawal by Subject|8|||
125331792|NCT00536744|450845756|FG000|Overall Study|PI tried alternative treatment|1|||
125331793|NCT00536744|450845757|FG001|Overall Study|PI tried alternative treatment|3|||
125331794|NCT00787644|450845758|FG000|Overall Study|Lost to Follow-up|1|||
125331795|NCT00787644|450845759|FG001|Overall Study|Lost to Follow-up|1|||
125331796|NCT00787644|450845758|FG000|Overall Study|Withdrawal by Subject|1|||
125669637|NCT00895583|452078261|FG000|Overall Study|Lack of Efficacy|5|||
125669638|NCT00895583|452078262|FG001|Overall Study|Lack of Efficacy|0|||
125669639|NCT00895583|452078261|FG000|Overall Study|Other|0|||
125331797|NCT00787644|450845759|FG001|Overall Study|Withdrawal by Subject|1|||
125669640|NCT00895583|452078262|FG001|Overall Study|Other|1|||
125669641|NCT04535583|452078263|FG000|Overall Study|Lost to Follow-up|1|||
125669642|NCT04535583|452078263|FG000|Overall Study|Physician Decision|1|||
125669643|NCT04535583|452078263|FG000|Overall Study|Withdrawal by Subject|1|||
125669644|NCT04049552|452078265|FG000|Overall Study|Lost to Follow-up|1|||
125669645|NCT02196506|452078270|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
125669646|NCT02196506|452078271|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
125331798|NCT02908672|450845760|FG000|Run-in Period|Death|12|||
125331799|NCT02908672|450845761|FG001|Run-in Period|Death|10|||
125331800|NCT02908672|450845762|FG002|Run-in Period|Death|0|||
125331801|NCT02908672|450845763|FG003|Run-in Period|Death|0|||
125331802|NCT02908672|450845760|FG000|Run-in Period|Lost to Follow-up|1|||
125331803|NCT02908672|450845761|FG001|Run-in Period|Lost to Follow-up|1|||
125331804|NCT02908672|450845762|FG002|Run-in Period|Lost to Follow-up|0|||
125331805|NCT02908672|450845763|FG003|Run-in Period|Lost to Follow-up|0|||
125331806|NCT02908672|450845760|FG000|Run-in Period|Reason Not Specified|2|||
125331807|NCT02908672|450845761|FG001|Run-in Period|Reason Not Specified|0|||
125331808|NCT02908672|450845762|FG002|Run-in Period|Reason Not Specified|0|||
125331809|NCT02908672|450845763|FG003|Run-in Period|Reason Not Specified|0|||
125331810|NCT02908672|450845760|FG000|Run-in Period|Protocol Violation|1|||
125331811|NCT02908672|450845761|FG001|Run-in Period|Protocol Violation|1|||
125331812|NCT02908672|450845762|FG002|Run-in Period|Protocol Violation|0|||
125331813|NCT02908672|450845763|FG003|Run-in Period|Protocol Violation|0|||
125331814|NCT02908672|450845760|FG000|Run-in Period|Study Ended by Sponsor|5|||
125331815|NCT02908672|450845761|FG001|Run-in Period|Study Ended by Sponsor|1|||
125331816|NCT02908672|450845762|FG002|Run-in Period|Study Ended by Sponsor|0|||
125331817|NCT02908672|450845763|FG003|Run-in Period|Study Ended by Sponsor|0|||
125331818|NCT02908672|450845760|FG000|Run-in Period|Withdrawal by Subject|3|||
125331819|NCT02908672|450845761|FG001|Run-in Period|Withdrawal by Subject|9|||
125331820|NCT02908672|450845762|FG002|Run-in Period|Withdrawal by Subject|0|||
125331821|NCT02908672|450845763|FG003|Run-in Period|Withdrawal by Subject|0|||
125331822|NCT02908672|450845760|FG000|Triple Combination Period|Death|0|||
125669647|NCT02196506|452078272|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
125669648|NCT02196506|452078273|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
125669649|NCT02196506|452078270|FG000|Phase A|Withdrawal by Subject|34|||
125669650|NCT02196506|452078271|FG001|Phase A|Withdrawal by Subject|0|||
125669651|NCT02196506|452078272|FG002|Phase A|Withdrawal by Subject|0|||
125669652|NCT02196506|452078273|FG003|Phase A|Withdrawal by Subject|0|||
125669653|NCT02196506|452078270|FG000|Phase A|Adverse Event|22|||
125669654|NCT02196506|452078271|FG001|Phase A|Adverse Event|0|||
125669655|NCT02196506|452078272|FG002|Phase A|Adverse Event|0|||
125669656|NCT02196506|452078273|FG003|Phase A|Adverse Event|0|||
125669657|NCT02196506|452078270|FG000|Phase A|Lost to Follow-up|9|||
125669658|NCT02196506|452078271|FG001|Phase A|Lost to Follow-up|0|||
125669659|NCT02196506|452078272|FG002|Phase A|Lost to Follow-up|0|||
125669660|NCT02196506|452078273|FG003|Phase A|Lost to Follow-up|0|||
125669661|NCT02196506|452078270|FG000|Phase A|Protocol deviation|12|||
125669662|NCT02196506|452078271|FG001|Phase A|Protocol deviation|0|||
125669663|NCT02196506|452078272|FG002|Phase A|Protocol deviation|0|||
125669664|NCT02196506|452078273|FG003|Phase A|Protocol deviation|0|||
125669665|NCT02196506|452078270|FG000|Phase A|Participant withdrawn by investigator|10|||
125669666|NCT02196506|452078271|FG001|Phase A|Participant withdrawn by investigator|0|||
125669667|NCT02196506|452078272|FG002|Phase A|Participant withdrawn by investigator|0|||
125669668|NCT02196506|452078273|FG003|Phase A|Participant withdrawn by investigator|0|||
125669669|NCT02196506|452078270|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
125669670|NCT02196506|452078271|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
125669671|NCT02196506|452078272|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
125669672|NCT02196506|452078273|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
125669673|NCT02196506|452078270|FG000|Phase B|Lack of Efficacy|0|||
125669674|NCT02196506|452078271|FG001|Phase B|Lack of Efficacy|1|||
125669675|NCT02196506|452078272|FG002|Phase B|Lack of Efficacy|2|||
125669676|NCT02196506|452078273|FG003|Phase B|Lack of Efficacy|0|||
125669677|NCT02196506|452078270|FG000|Phase B|Withdrawal by Participant|0|||
125669678|NCT02196506|452078271|FG001|Phase B|Withdrawal by Participant|8|||
125669679|NCT02196506|452078272|FG002|Phase B|Withdrawal by Participant|1|||
125669680|NCT02196506|452078273|FG003|Phase B|Withdrawal by Participant|0|||
125669681|NCT02196506|452078270|FG000|Phase B|Adverse Event|0|||
125669682|NCT02196506|452078271|FG001|Phase B|Adverse Event|4|||
125331823|NCT02908672|450845761|FG001|Triple Combination Period|Death|0|||
125331824|NCT02908672|450845762|FG002|Triple Combination Period|Death|150|||
125331825|NCT02908672|450845763|FG003|Triple Combination Period|Death|127|||
125331826|NCT02908672|450845760|FG000|Triple Combination Period|Lost to Follow-up|0|||
125669683|NCT02196506|452078272|FG002|Phase B|Adverse Event|1|||
125669684|NCT02196506|452078273|FG003|Phase B|Adverse Event|0|||
125669685|NCT02196506|452078270|FG000|Phase B|Lost to Follow-up|0|||
125669686|NCT02196506|452078271|FG001|Phase B|Lost to Follow-up|2|||
125669687|NCT02196506|452078272|FG002|Phase B|Lost to Follow-up|1|||
125669688|NCT02196506|452078273|FG003|Phase B|Lost to Follow-up|0|||
125669689|NCT02196506|452078270|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
125669690|NCT02196506|452078271|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
125669691|NCT02196506|452078272|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
125669692|NCT02196506|452078273|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
125331827|NCT02908672|450845761|FG001|Triple Combination Period|Lost to Follow-up|0|||
125669693|NCT02196506|452078270|FG000|Phase A+|Withdrawal by Participant|0|||
125331828|NCT02908672|450845762|FG002|Triple Combination Period|Lost to Follow-up|6|||
125331829|NCT02908672|450845763|FG003|Triple Combination Period|Lost to Follow-up|8|||
125669694|NCT02196506|452078271|FG001|Phase A+|Withdrawal by Participant|0|||
125669695|NCT02196506|452078272|FG002|Phase A+|Withdrawal by Participant|0|||
125331830|NCT02908672|450845760|FG000|Triple Combination Period|Reason Not Specified|0|||
125331831|NCT02908672|450845761|FG001|Triple Combination Period|Reason Not Specified|0|||
125331832|NCT02908672|450845762|FG002|Triple Combination Period|Reason Not Specified|0|||
125331833|NCT02908672|450845763|FG003|Triple Combination Period|Reason Not Specified|1|||
125331834|NCT02908672|450845760|FG000|Triple Combination Period|Physician Decision|0|||
125331835|NCT02908672|450845761|FG001|Triple Combination Period|Physician Decision|0|||
125331836|NCT02908672|450845762|FG002|Triple Combination Period|Physician Decision|1|||
125331837|NCT02908672|450845763|FG003|Triple Combination Period|Physician Decision|1|||
125331838|NCT02908672|450845760|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
125331839|NCT02908672|450845761|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
125331840|NCT02908672|450845762|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
125331841|NCT02908672|450845763|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
125331842|NCT02908672|450845760|FG000|Triple Combination Period|Withdrawal by Subject|0|||
125331843|NCT02908672|450845761|FG001|Triple Combination Period|Withdrawal by Subject|0|||
125331844|NCT02908672|450845762|FG002|Triple Combination Period|Withdrawal by Subject|13|||
125331845|NCT02908672|450845763|FG003|Triple Combination Period|Withdrawal by Subject|16|||
125331846|NCT04163016|450845764|FG000|Enrollment|Adverse Event|1|||
125331847|NCT04163016|450845765|FG001|Enrollment|Adverse Event|0|||
125331848|NCT04163016|450845766|FG002|Enrollment|Adverse Event|0|||
125331849|NCT04163016|450845767|FG003|Enrollment|Adverse Event|0|||
125331850|NCT04163016|450845764|FG000|Treatment|Adverse Event|0|||
125331851|NCT04163016|450845765|FG001|Treatment|Adverse Event|1|||
125331852|NCT04163016|450845766|FG002|Treatment|Adverse Event|0|||
125331853|NCT04163016|450845767|FG003|Treatment|Adverse Event|0|||
125331854|NCT04163016|450845764|FG000|Treatment|Withdrawal by Subject|0|||
125331855|NCT04163016|450845765|FG001|Treatment|Withdrawal by Subject|2|||
125331856|NCT04163016|450845766|FG002|Treatment|Withdrawal by Subject|0|||
125331857|NCT04163016|450845767|FG003|Treatment|Withdrawal by Subject|0|||
125331858|NCT04163016|450845764|FG000|Treatment|Indeterminate TB-test|0|||
125331859|NCT04163016|450845765|FG001|Treatment|Indeterminate TB-test|0|||
125331860|NCT04163016|450845766|FG002|Treatment|Indeterminate TB-test|0|||
125331861|NCT04163016|450845767|FG003|Treatment|Indeterminate TB-test|1|||
125331862|NCT04163016|450845764|FG000|Treatment|Participant did not want to continue in study|0|||
125331863|NCT04163016|450845765|FG001|Treatment|Participant did not want to continue in study|0|||
125331864|NCT04163016|450845766|FG002|Treatment|Participant did not want to continue in study|0|||
125331865|NCT04163016|450845767|FG003|Treatment|Participant did not want to continue in study|1|||
125331866|NCT01071798|450846978|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
125331867|NCT01071798|450846978|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
125331868|NCT01071798|450846978|FG000|Participants Who Received One Cycle|Patient requirement|20|||
125331869|NCT01071798|450846978|FG000|Participants Who Received One Cycle|Death|5|||
125331870|NCT01071798|450846978|FG000|Participants Who Received One Cycle|Change of therapy|6|||
125331871|NCT01071798|450846978|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
125331872|NCT01071798|450846978|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
125331873|NCT01071798|450846978|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
125331874|NCT01071798|450846978|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
125331875|NCT01071798|450846978|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
125331876|NCT00145158|450846981|FG000|Overall Study|premature withdrawal|2|||
125331877|NCT00145158|450846982|FG001|Overall Study|premature withdrawal|3|||
125331878|NCT01227018|450846986|FG000|Overall Study|Disease progression|9|||
125331879|NCT01227018|450846986|FG000|Overall Study|Toxicity|2|||
125331880|NCT01227018|450846986|FG000|Overall Study|Withdrew after beginning treatment|4|||
125331881|NCT00753649|450846987|FG000|Overall Study|Migrated/moved from study area|1|||
125331882|NCT00753649|450846988|FG001|Overall Study|Migrated/moved from study area|0|||
125331883|NCT00753649|450846987|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
125331884|NCT00753649|450846988|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
125331885|NCT00753649|450846987|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
125331886|NCT00753649|450846988|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
125331887|NCT00753649|450846987|FG000|Overall Study|Protocol Violation|2|||
125331888|NCT00753649|450846988|FG001|Overall Study|Protocol Violation|0|||
125331889|NCT00499616|450846989|FG000|Overall Study|Death|1|||
125331890|NCT00499616|450846990|FG001|Overall Study|Death|5|||
125331891|NCT00499616|450846991|FG002|Overall Study|Death|3|||
125331892|NCT00499616|450846992|FG003|Overall Study|Death|1|||
125331893|NCT00499616|450846989|FG000|Overall Study|Lack of Efficacy|5|||
125331894|NCT00499616|450846990|FG001|Overall Study|Lack of Efficacy|0|||
125331895|NCT00499616|450846991|FG002|Overall Study|Lack of Efficacy|19|||
125331896|NCT00499616|450846992|FG003|Overall Study|Lack of Efficacy|0|||
125331897|NCT00499616|450846989|FG000|Overall Study|Lost to Follow-up|0|||
125331898|NCT00499616|450846990|FG001|Overall Study|Lost to Follow-up|0|||
125331899|NCT00499616|450846991|FG002|Overall Study|Lost to Follow-up|1|||
125331900|NCT00499616|450846992|FG003|Overall Study|Lost to Follow-up|0|||
125331901|NCT00499616|450846989|FG000|Overall Study|Physician Decision|6|||
125331902|NCT00499616|450846990|FG001|Overall Study|Physician Decision|16|||
125331903|NCT00499616|450846991|FG002|Overall Study|Physician Decision|9|||
125331904|NCT00499616|450846992|FG003|Overall Study|Physician Decision|0|||
125331905|NCT00499616|450846989|FG000|Overall Study|Withdrawal by Subject|1|||
125331906|NCT00499616|450846990|FG001|Overall Study|Withdrawal by Subject|0|||
125331907|NCT00499616|450846991|FG002|Overall Study|Withdrawal by Subject|1|||
125331908|NCT00499616|450846992|FG003|Overall Study|Withdrawal by Subject|0|||
125331909|NCT00499616|450846989|FG000|Overall Study|Ineligible|1|||
125331910|NCT00499616|450846990|FG001|Overall Study|Ineligible|2|||
125331911|NCT00499616|450846991|FG002|Overall Study|Ineligible|0|||
125331912|NCT00499616|450846992|FG003|Overall Study|Ineligible|15|||
125331913|NCT00499616|450846989|FG000|Overall Study|Not evaluable|0|||
125331914|NCT00499616|450846990|FG001|Overall Study|Not evaluable|0|||
125331915|NCT00499616|450846991|FG002|Overall Study|Not evaluable|0|||
125331916|NCT00499616|450846992|FG003|Overall Study|Not evaluable|41|||
125331917|NCT00499616|450846989|FG000|Overall Study|Patient/Parent Refusal|1|||
125331918|NCT00499616|450846990|FG001|Overall Study|Patient/Parent Refusal|5|||
125331919|NCT00499616|450846991|FG002|Overall Study|Patient/Parent Refusal|3|||
125331920|NCT00499616|450846992|FG003|Overall Study|Patient/Parent Refusal|0|||
125331921|NCT01938716|450847000|FG000|Overall Study|Physician Decision|2|||
125331922|NCT01938716|450847000|FG000|Overall Study|Withdrawal by Subject|2|||
125331923|NCT00098813|450847001|FG000|Overall Study|Death|8|||
125331924|NCT00098813|450847001|FG000|Overall Study|Protocol Violation|1|||
125331925|NCT00098813|450847001|FG000|Overall Study|Withdrawal by Subject|7|||
125331926|NCT00098813|450847001|FG000|Overall Study|Progression of Disease|1|||
125331927|NCT00098813|450847001|FG000|Overall Study|Other complicating disease|1|||
125331928|NCT00098813|450847001|FG000|Overall Study|Reversal of RAI resistance|1|||
125331929|NCT00433004|450847004|FG000|Overall Study|Lost to Follow-up|5|||
125331930|NCT00433004|450847005|FG001|Overall Study|Lost to Follow-up|7|||
125331931|NCT00220636|450847006|FG000|Overall Study|Withdrawal by Subject|4|||
125331932|NCT00330967|450847007|FG000|Overall Study|Withdrawal by Subject|0|||
125331933|NCT00330967|450847008|FG001|Overall Study|Withdrawal by Subject|5|||
125331934|NCT00330967|450847007|FG000|Overall Study|Physician Decision|0|||
125331935|NCT00330967|450847008|FG001|Overall Study|Physician Decision|9|||
125331936|NCT00790088|450847011|FG000|Overall Study|Protocol Violation|11|||
125331937|NCT00790088|450847011|FG000|Overall Study|Withdrawal by Subject|17|||
125331938|NCT00790088|450847011|FG000|Overall Study|Lost to Follow-up|7|||
125331939|NCT00790088|450847011|FG000|Overall Study|Physician Decision|4|||
125331940|NCT04329806|450847012|FG000|Overall Study|Physician Decision|3|||
125331941|NCT04329806|450847013|FG001|Overall Study|Physician Decision|4|||
125331942|NCT02636595|450847016|FG000|Overall Study|Lost to Follow-up|1|||
125331943|NCT02636595|450847016|FG000|Overall Study|Other|1|||
125331944|NCT02578706|450847020|FG000|Overall Study|Withdrawal by Subject|1|||
125331945|NCT02578706|450847021|FG001|Overall Study|Withdrawal by Subject|0|||
125331946|NCT02578706|450847022|FG002|Overall Study|Withdrawal by Subject|0|||
125331947|NCT02578706|450847020|FG000|Overall Study|Lost to Follow-up|0|||
125331948|NCT02578706|450847021|FG001|Overall Study|Lost to Follow-up|4|||
125331949|NCT02578706|450847022|FG002|Overall Study|Lost to Follow-up|0|||
125331950|NCT02578706|450847020|FG000|Overall Study|Physician Decision|0|||
125331951|NCT02578706|450847021|FG001|Overall Study|Physician Decision|1|||
125331952|NCT02578706|450847022|FG002|Overall Study|Physician Decision|0|||
125331953|NCT02015637|450847026|FG000|Overall Study|Lost to Follow-up|3|||
125331954|NCT02015637|450847027|FG001|Overall Study|Lost to Follow-up|5|||
125331955|NCT02015637|450847026|FG000|Overall Study|Adverse Event|3|||
125331956|NCT02015637|450847027|FG001|Overall Study|Adverse Event|0|||
125331957|NCT02015637|450847026|FG000|Overall Study|Did not take study drug|2|||
125331958|NCT02015637|450847027|FG001|Overall Study|Did not take study drug|0|||
125331959|NCT04455815|450847032|FG000|Randomisation Phase|Adverse Event|1|||
125331960|NCT04455815|450847033|FG001|Randomisation Phase|Adverse Event|0|||
125331961|NCT04455815|450847032|FG000|Treatment Phase|Adverse Event|0|||
125331962|NCT04455815|450847033|FG001|Treatment Phase|Adverse Event|1|||
125331963|NCT04455815|450847032|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
125331964|NCT04455815|450847033|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
125331965|NCT04455815|450847032|FG000|Treatment Phase|Withdrawal by Subject|1|||
125331966|NCT04455815|450847033|FG001|Treatment Phase|Withdrawal by Subject|1|||
125331967|NCT02106390|450847034|FG000|Overall Study|Withdrawal by Subject|15|||
125331968|NCT02106390|450847035|FG001|Overall Study|Withdrawal by Subject|16|||
125669696|NCT02196506|452078273|FG003|Phase A+|Withdrawal by Participant|5|||
125331969|NCT02106390|450847036|FG002|Overall Study|Withdrawal by Subject|15|||
125331970|NCT02106390|450847034|FG000|Overall Study|Lost to Follow-up|25|||
125331971|NCT02106390|450847035|FG001|Overall Study|Lost to Follow-up|20|||
125331972|NCT02106390|450847036|FG002|Overall Study|Lost to Follow-up|13|||
125331973|NCT02106390|450847034|FG000|Overall Study|Other: Administrative Reason|8|||
125331974|NCT02106390|450847035|FG001|Overall Study|Other: Administrative Reason|5|||
125331975|NCT02106390|450847036|FG002|Overall Study|Other: Administrative Reason|12|||
125331976|NCT02106390|450847034|FG000|Overall Study|Other: Unspecified|1|||
125331977|NCT02106390|450847035|FG001|Overall Study|Other: Unspecified|4|||
125331978|NCT02106390|450847036|FG002|Overall Study|Other: Unspecified|2|||
125331979|NCT02106390|450847034|FG000|Overall Study|Adverse Event|0|||
125669697|NCT02196506|452078270|FG000|Phase A+|Adverse Event|0|||
125331980|NCT02106390|450847035|FG001|Overall Study|Adverse Event|2|||
125331981|NCT02106390|450847036|FG002|Overall Study|Adverse Event|1|||
125331982|NCT02106390|450847034|FG000|Overall Study|Protocol Violation|0|||
125331983|NCT02106390|450847035|FG001|Overall Study|Protocol Violation|1|||
125331984|NCT02106390|450847036|FG002|Overall Study|Protocol Violation|0|||
125331985|NCT03198507|450847037|FG000|Overall Study|Withdrawal by Subject|1|||
125331986|NCT03198507|450847038|FG001|Overall Study|Withdrawal by Subject|0|||
125331987|NCT00241839|450847043|FG000|Overall Study|Withdrawal by Subject|18|||
125331988|NCT00241839|450847044|FG001|Overall Study|Withdrawal by Subject|17|||
125331989|NCT00241839|450847043|FG000|Overall Study|Adverse Event|1|||
125331990|NCT00241839|450847044|FG001|Overall Study|Adverse Event|1|||
125331991|NCT00439517|450847045|FG000|Overall Study|Subject on treatment|1|||
125331992|NCT00439517|450847046|FG001|Overall Study|Subject on treatment|0|||
125331993|NCT00439517|450847045|FG000|Overall Study|Subject in survival follow-up|1|||
125331994|NCT00439517|450847046|FG001|Overall Study|Subject in survival follow-up|0|||
125331995|NCT02304367|450847047|FG000|Overall Study|Lack of Response to Bruosumab|1|||
125331996|NCT02304367|450847047|FG000|Overall Study|Sponsor Decision|3|||
125331997|NCT02304367|450847047|FG000|Overall Study|Death|2|||
125331998|NCT02304367|450847047|FG000|Overall Study|Physician Decision|1|||
125331999|NCT02304367|450847047|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
125332000|NCT00526071|450847048|FG000|Overall Study|Adverse Event|1|||
125332001|NCT00526071|450847048|FG000|Overall Study|Withdrawal by Subject|1|||
125332002|NCT00526071|450847048|FG000|Overall Study|Lack of Response to Study Drug|4|||
125332003|NCT00467753|450847049|FG000|Overall Study|Lost to Follow-up|1|||
125332004|NCT00467753|450847050|FG001|Overall Study|Lost to Follow-up|2|||
125332005|NCT00467753|450847049|FG000|Overall Study|Adverse Event|2|||
125332006|NCT00467753|450847050|FG001|Overall Study|Adverse Event|0|||
125332007|NCT01869764|450847051|FG000|Overall Study|Withdrawal by Subject|0|||
125332008|NCT01869764|450847052|FG001|Overall Study|Withdrawal by Subject|2|||
125332009|NCT01626872|450847053|FG000|Overall Study|Physician Decision|13|||
125332010|NCT01626872|450847054|FG001|Overall Study|Physician Decision|9|||
125332011|NCT01626872|450847055|FG002|Overall Study|Physician Decision|6|||
125332012|NCT01626872|450847053|FG000|Overall Study|Withdrawal by Subject|19|||
125332013|NCT01626872|450847054|FG001|Overall Study|Withdrawal by Subject|27|||
125332014|NCT01626872|450847055|FG002|Overall Study|Withdrawal by Subject|8|||
125332015|NCT01626872|450847053|FG000|Overall Study|Adverse Event (including Death)|20|||
125332016|NCT01626872|450847054|FG001|Overall Study|Adverse Event (including Death)|28|||
125332017|NCT01626872|450847055|FG002|Overall Study|Adverse Event (including Death)|8|||
125332018|NCT01626872|450847053|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
125332019|NCT01626872|450847054|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
125332020|NCT01626872|450847055|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
125332021|NCT00960999|450847056|FG000|Overall Study|Withdrawal by Subject|1|||
125332022|NCT00960999|450847057|FG001|Overall Study|Withdrawal by Subject|0|||
125332023|NCT00960999|450847056|FG000|Overall Study|Protocol Violation|5|||
125669698|NCT02196506|452078271|FG001|Phase A+|Adverse Event|0|||
125669699|NCT02196506|452078272|FG002|Phase A+|Adverse Event|0|||
125669700|NCT02196506|452078273|FG003|Phase A+|Adverse Event|1|||
125669701|NCT02196506|452078270|FG000|Phase A+|Lost to Follow-up|0|||
125669702|NCT02196506|452078271|FG001|Phase A+|Lost to Follow-up|0|||
125669703|NCT02196506|452078272|FG002|Phase A+|Lost to Follow-up|0|||
125669704|NCT02196506|452078273|FG003|Phase A+|Lost to Follow-up|6|||
125669705|NCT02196506|452078270|FG000|Phase A+|Participant withdrawn by investigator|0|||
125669706|NCT02196506|452078271|FG001|Phase A+|Participant withdrawn by investigator|0|||
125669707|NCT02196506|452078272|FG002|Phase A+|Participant withdrawn by investigator|0|||
125669708|NCT02196506|452078273|FG003|Phase A+|Participant withdrawn by investigator|1|||
125669709|NCT01715415|452078274|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
125669710|NCT01715415|452078275|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
125669711|NCT01715415|452078274|FG000|Double-blind Treatment|Adverse Event|3|||
125669712|NCT01715415|452078275|FG001|Double-blind Treatment|Adverse Event|0|||
125669713|NCT01715415|452078274|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
125669714|NCT01715415|452078275|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
125669715|NCT01715415|452078274|FG000|Double-blind Treatment|Other|1|||
125669716|NCT01715415|452078275|FG001|Double-blind Treatment|Other|0|||
125669717|NCT01715415|452078274|FG000|Open-label Treatment|Adverse Event|0|||
125669718|NCT01715415|452078275|FG001|Open-label Treatment|Adverse Event|1|||
125332024|NCT00960999|450847057|FG001|Overall Study|Protocol Violation|2|||
125332025|NCT00960999|450847056|FG000|Overall Study|RT dose constraints not met|2|||
125332026|NCT00960999|450847057|FG001|Overall Study|RT dose constraints not met|0|||
125332027|NCT01696188|450847058|FG000|Overall Study|Protocol Violation|1|||
125332028|NCT01696188|450847059|FG001|Overall Study|Protocol Violation|1|||
125332029|NCT01578486|450847060|FG000|Overall Study|Physician Decision|3|||
125669719|NCT01715415|452078274|FG000|Open-label Treatment|Subject Noncompliant|0|||
125669720|NCT01715415|452078275|FG001|Open-label Treatment|Subject Noncompliant|1|||
125669721|NCT01015612|452078276|FG000|Overall Study|Death|113|||
125669722|NCT01015612|452078276|FG000|Overall Study|Withdrawal by Subject|40|||
125669723|NCT00066807|452078277|FG000|Overall Study|Study was terminated early|14|||
125669724|NCT00066807|452078278|FG001|Overall Study|Study was terminated early|15|||
125332030|NCT01578486|450847060|FG000|Overall Study|Withdrawal by Subject|2|||
125332031|NCT01958164|450847061|FG000|Overall Study|Adverse Event|0|||
125332032|NCT01958164|450847062|FG001|Overall Study|Adverse Event|2|||
125332033|NCT01958164|450847061|FG000|Overall Study|Lost to Follow-up|2|||
125332034|NCT01958164|450847062|FG001|Overall Study|Lost to Follow-up|3|||
125332035|NCT00828204|450847065|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
125332036|NCT00828204|450847066|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
125332037|NCT00828204|450847065|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
125332038|NCT00828204|450847066|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
125332039|NCT00828204|450847065|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
125332040|NCT00828204|450847066|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
125332041|NCT00828204|450847065|FG000|Main Study: After Study Restart|Adverse Event|0|||
125332042|NCT00828204|450847066|FG001|Main Study: After Study Restart|Adverse Event|2|||
125332043|NCT00828204|450847065|FG000|Main Study: After Study Restart|Noncompliance|0|||
125332044|NCT00828204|450847066|FG001|Main Study: After Study Restart|Noncompliance|1|||
125332045|NCT00828204|450847065|FG000|Extension Study|Lost to Follow-up|0|||
125332046|NCT00828204|450847066|FG001|Extension Study|Lost to Follow-up|1|||
125332047|NCT00828204|450847065|FG000|Extension Study|Physician Decision|0|||
125332048|NCT00828204|450847066|FG001|Extension Study|Physician Decision|2|||
125332049|NCT02302339|450847069|FG000|Overall Study|Lost to Follow-up|1|||
125332050|NCT02302339|450847070|FG001|Overall Study|Lost to Follow-up|0|||
125332051|NCT02302339|450847071|FG002|Overall Study|Lost to Follow-up|0|||
125332052|NCT02302339|450847072|FG003|Overall Study|Lost to Follow-up|0|||
125332053|NCT02302339|450847069|FG000|Overall Study|Withdrawal by Subject|0|||
125332054|NCT02302339|450847070|FG001|Overall Study|Withdrawal by Subject|2|||
125332055|NCT02302339|450847071|FG002|Overall Study|Withdrawal by Subject|1|||
125332056|NCT02302339|450847072|FG003|Overall Study|Withdrawal by Subject|0|||
125332057|NCT01642589|450847076|FG000|Overall Study|Withdrawal by Subject|1|||
125332058|NCT01642589|450847077|FG001|Overall Study|Withdrawal by Subject|1|||
125332059|NCT01185080|450847082|FG000|Overall Study|Adverse Event|1|||
125332060|NCT01185080|450847083|FG001|Overall Study|Adverse Event|1|||
125332061|NCT01185080|450847084|FG002|Overall Study|Adverse Event|0|||
125332062|NCT01185080|450847082|FG000|Overall Study|Personal reasons|0|||
125332063|NCT01185080|450847083|FG001|Overall Study|Personal reasons|0|||
125332064|NCT01185080|450847084|FG002|Overall Study|Personal reasons|1|||
125332065|NCT01104311|450847089|FG000|Overall Study|Withdrawal by Subject|6|||
125332066|NCT01104311|450847090|FG001|Overall Study|Withdrawal by Subject|6|||
125332067|NCT01104311|450847089|FG000|Overall Study|Protocol Violation|0|||
125332068|NCT01104311|450847090|FG001|Overall Study|Protocol Violation|1|||
125332069|NCT01104311|450847089|FG000|Overall Study|Physician Decision|2|||
125332070|NCT01104311|450847090|FG001|Overall Study|Physician Decision|2|||
125332071|NCT01104311|450847089|FG000|Overall Study|low compliance|1|||
125332072|NCT01104311|450847090|FG001|Overall Study|low compliance|1|||
125332073|NCT01104311|450847089|FG000|Overall Study|Adverse Event|1|||
125332074|NCT01104311|450847090|FG001|Overall Study|Adverse Event|2|||
125332075|NCT01255436|450848948|FG000|Overall Study|Lost to Follow-up|178|||
125332076|NCT01255436|450848949|FG001|Overall Study|Lost to Follow-up|191|||
125332077|NCT01255436|450848948|FG000|Overall Study|Death, stroke, or MI|4|||
125332078|NCT01255436|450848949|FG001|Overall Study|Death, stroke, or MI|3|||
125669725|NCT05028751|452078279|FG000|Overall Study|Study Terminated by Sponsor|3|||
125669726|NCT05028751|452078280|FG001|Overall Study|Study Terminated by Sponsor|0|||
125669727|NCT05028751|452078281|FG002|Overall Study|Study Terminated by Sponsor|0|||
125669728|NCT05028751|452078282|FG003|Overall Study|Study Terminated by Sponsor|0|||
125669729|NCT05028751|452078279|FG000|Overall Study|Death|9|||
125669730|NCT05028751|452078280|FG001|Overall Study|Death|3|||
125669731|NCT05028751|452078281|FG002|Overall Study|Death|2|||
125669732|NCT05028751|452078282|FG003|Overall Study|Death|4|||
125669733|NCT05028751|452078279|FG000|Overall Study|Withdrawal by Subject|0|||
125669734|NCT05028751|452078280|FG001|Overall Study|Withdrawal by Subject|0|||
125669735|NCT05028751|452078281|FG002|Overall Study|Withdrawal by Subject|1|||
125669736|NCT05028751|452078282|FG003|Overall Study|Withdrawal by Subject|0|||
125669737|NCT05028751|452078279|FG000|Overall Study|Miscellaneous|2|||
125669738|NCT05028751|452078280|FG001|Overall Study|Miscellaneous|0|||
125669739|NCT05028751|452078281|FG002|Overall Study|Miscellaneous|0|||
125669740|NCT05028751|452078282|FG003|Overall Study|Miscellaneous|0|||
125669741|NCT03586830|452078283|FG000|Overall Study|Site terminated by Sponsor|1|||
125332079|NCT00372593|450848950|FG000|Overall Study|Adverse Event|43|||
125332080|NCT00372593|450848951|FG001|Overall Study|Adverse Event|45|||
125332081|NCT00372593|450848952|FG002|Overall Study|Adverse Event|0|||
125332082|NCT00372593|450848950|FG000|Overall Study|Death|16|||
125332083|NCT00372593|450848951|FG001|Overall Study|Death|20|||
125332084|NCT00372593|450848952|FG002|Overall Study|Death|1|||
125669742|NCT03586830|452078284|FG001|Overall Study|Site terminated by Sponsor|4|||
125669743|NCT03586830|452078285|FG002|Overall Study|Site terminated by Sponsor|3|||
125669744|NCT03586830|452078286|FG003|Overall Study|Site terminated by Sponsor|3|||
125669745|NCT03586830|452078283|FG000|Overall Study|Lost to Follow-up|0|||
125669746|NCT03586830|452078284|FG001|Overall Study|Lost to Follow-up|2|||
125669747|NCT03586830|452078285|FG002|Overall Study|Lost to Follow-up|2|||
125669748|NCT03586830|452078286|FG003|Overall Study|Lost to Follow-up|1|||
125669749|NCT03586830|452078283|FG000|Overall Study|Withdrawal by Subject|1|||
125669750|NCT03586830|452078284|FG001|Overall Study|Withdrawal by Subject|0|||
125669751|NCT03586830|452078285|FG002|Overall Study|Withdrawal by Subject|3|||
125669752|NCT03586830|452078286|FG003|Overall Study|Withdrawal by Subject|1|||
125669753|NCT04578548|452078287|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
125669754|NCT04578548|452078288|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
125669755|NCT04578548|452078287|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
125669756|NCT04578548|452078288|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
125669757|NCT04578548|452078287|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
125669758|NCT04578548|452078288|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
125669759|NCT04578548|452078287|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
125669760|NCT04578548|452078288|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
125669761|NCT04578548|452078287|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
125669762|NCT04578548|452078288|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
125669763|NCT04578548|452078287|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
125669764|NCT04578548|452078288|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
125669765|NCT00395083|452078291|FG000|Overall Study|Withdrawal by Subject|6|||
125669766|NCT00395083|452078292|FG001|Overall Study|Withdrawal by Subject|5|||
125669767|NCT00395083|452078291|FG000|Overall Study|Developed another disease|4|||
125669768|NCT00395083|452078292|FG001|Overall Study|Developed another disease|3|||
125669769|NCT00628745|452078293|FG000|Overall Study|Withdrawal by Subject|63|||
125669770|NCT00628745|452078294|FG001|Overall Study|Withdrawal by Subject|3|||
125669771|NCT00628745|452078295|FG002|Overall Study|Withdrawal by Subject|9|||
125669772|NCT00628745|452078296|FG003|Overall Study|Withdrawal by Subject|2|||
125669773|NCT00628745|452078297|FG004|Overall Study|Withdrawal by Subject|69|||
125669774|NCT00628745|452078293|FG000|Overall Study|Does not meet inclusion criteria|0|||
125669775|NCT00628745|452078294|FG001|Overall Study|Does not meet inclusion criteria|12|||
125669776|NCT00628745|452078295|FG002|Overall Study|Does not meet inclusion criteria|0|||
125669777|NCT00628745|452078296|FG003|Overall Study|Does not meet inclusion criteria|0|||
125332085|NCT00372593|450848950|FG000|Overall Study|Lack of Efficacy|82|||
125332086|NCT00372593|450848951|FG001|Overall Study|Lack of Efficacy|71|||
125332087|NCT00372593|450848952|FG002|Overall Study|Lack of Efficacy|2|||
125332088|NCT00372593|450848950|FG000|Overall Study|Lost to Follow-up|1|||
125332089|NCT00372593|450848951|FG001|Overall Study|Lost to Follow-up|0|||
125332090|NCT00372593|450848952|FG002|Overall Study|Lost to Follow-up|0|||
125332091|NCT00372593|450848950|FG000|Overall Study|Physician Decision|42|||
125332092|NCT00372593|450848951|FG001|Overall Study|Physician Decision|41|||
125332093|NCT00372593|450848952|FG002|Overall Study|Physician Decision|0|||
125332094|NCT00372593|450848950|FG000|Overall Study|Ineligible|20|||
125332095|NCT00372593|450848951|FG001|Overall Study|Ineligible|21|||
125332096|NCT00372593|450848952|FG002|Overall Study|Ineligible|1|||
125332097|NCT03534180|450848953|FG000|Overall Study|Withdrawal by Subject|1|||
125332098|NCT04439136|450848954|FG000|Overall Study|Ineligible|1|||
125332099|NCT04439136|450848954|FG000|Overall Study|Never Started Treatment|2|||
125332100|NCT04439136|450848954|FG000|Overall Study|Adverse Event|4|||
125669778|NCT00628745|452078297|FG004|Overall Study|Does not meet inclusion criteria|18|||
125669779|NCT00628745|452078293|FG000|Overall Study|Participation in an interventional clinical trial|81|||
125669780|NCT00628745|452078294|FG001|Overall Study|Participation in an interventional clinical trial|4|||
125669781|NCT00628745|452078295|FG002|Overall Study|Participation in an interventional clinical trial|7|||
125669782|NCT00628745|452078296|FG003|Overall Study|Participation in an interventional clinical trial|0|||
125669783|NCT00628745|452078297|FG004|Overall Study|Participation in an interventional clinical trial|63|||
125669784|NCT00628745|452078293|FG000|Overall Study|Physician Decision|8|||
125669785|NCT00628745|452078294|FG001|Overall Study|Physician Decision|4|||
125669786|NCT00628745|452078295|FG002|Overall Study|Physician Decision|3|||
125669787|NCT00628745|452078296|FG003|Overall Study|Physician Decision|0|||
125669788|NCT00628745|452078297|FG004|Overall Study|Physician Decision|30|||
125669789|NCT00628745|452078293|FG000|Overall Study|Lost to Follow-up|109|||
125669790|NCT00628745|452078294|FG001|Overall Study|Lost to Follow-up|7|||
125669791|NCT00628745|452078295|FG002|Overall Study|Lost to Follow-up|7|||
125669792|NCT00628745|452078296|FG003|Overall Study|Lost to Follow-up|0|||
125669793|NCT00628745|452078297|FG004|Overall Study|Lost to Follow-up|498|||
125332101|NCT04439136|450848954|FG000|Overall Study|Death|3|||
125332102|NCT04439136|450848954|FG000|Overall Study|Disease Progression|27|||
125332103|NCT04439136|450848954|FG000|Overall Study|Alternative Therapy|1|||
125332104|NCT04439136|450848954|FG000|Overall Study|Increased Tumor Burden|1|||
125332105|NCT04439136|450848954|FG000|Overall Study|Symptomatic Detrioration|1|||
125669794|NCT00628745|452078293|FG000|Overall Study|Death|197|||
125669795|NCT00628745|452078294|FG001|Overall Study|Death|81|||
125669796|NCT00628745|452078295|FG002|Overall Study|Death|12|||
125669797|NCT00628745|452078296|FG003|Overall Study|Death|4|||
125669798|NCT00628745|452078297|FG004|Overall Study|Death|939|||
125669799|NCT00628745|452078293|FG000|Overall Study|Participant transferred to another THAOS site|6|||
125332106|NCT02223858|450848955|FG000|Overall Study|Death|1|||
125332107|NCT02223858|450848956|FG001|Overall Study|Death|1|||
125332108|NCT02223858|450848955|FG000|Overall Study|Lost to Follow-up|6|||
125332109|NCT02223858|450848956|FG001|Overall Study|Lost to Follow-up|11|||
125332110|NCT02223858|450848955|FG000|Overall Study|Withdrawal by Subject|8|||
125332111|NCT02223858|450848956|FG001|Overall Study|Withdrawal by Subject|5|||
125332112|NCT02223858|450848955|FG000|Overall Study|Refused|9|||
125332113|NCT02223858|450848956|FG001|Overall Study|Refused|9|||
125332114|NCT03682770|450848959|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125332115|NCT03682770|450848960|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
125332116|NCT03682770|450848961|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125332117|NCT03682770|450848962|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125332118|NCT03682770|450848963|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125332119|NCT03682770|450848964|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125332120|NCT03682770|450848965|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
125332121|NCT03682770|450848959|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
125332122|NCT03682770|450848960|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
125332123|NCT03682770|450848961|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
125669800|NCT00628745|452078294|FG001|Overall Study|Participant transferred to another THAOS site|0|||
125669801|NCT00628745|452078295|FG002|Overall Study|Participant transferred to another THAOS site|0|||
125669802|NCT00628745|452078296|FG003|Overall Study|Participant transferred to another THAOS site|0|||
125669803|NCT00628745|452078297|FG004|Overall Study|Participant transferred to another THAOS site|7|||
125669804|NCT00628745|452078293|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
125669805|NCT00628745|452078294|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
125669806|NCT00628745|452078295|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
125669807|NCT00628745|452078296|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
125669808|NCT00628745|452078297|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
125669809|NCT00628745|452078293|FG000|Overall Study|Site closure|152|||
125669810|NCT00628745|452078294|FG001|Overall Study|Site closure|146|||
125669811|NCT00628745|452078295|FG002|Overall Study|Site closure|6|||
125669812|NCT00628745|452078296|FG003|Overall Study|Site closure|8|||
125669813|NCT00628745|452078297|FG004|Overall Study|Site closure|691|||
125669814|NCT00628745|452078293|FG000|Overall Study|Duplicate participant|0|||
125669815|NCT00628745|452078294|FG001|Overall Study|Duplicate participant|0|||
125669816|NCT00628745|452078295|FG002|Overall Study|Duplicate participant|0|||
125669817|NCT00628745|452078296|FG003|Overall Study|Duplicate participant|0|||
125669818|NCT00628745|452078297|FG004|Overall Study|Duplicate participant|1|||
125669819|NCT00628745|452078293|FG000|Overall Study|Missing|4|||
125669820|NCT00628745|452078294|FG001|Overall Study|Missing|3|||
125669821|NCT00628745|452078295|FG002|Overall Study|Missing|0|||
125669822|NCT00628745|452078296|FG003|Overall Study|Missing|0|||
125669823|NCT00628745|452078297|FG004|Overall Study|Missing|10|||
125669824|NCT00628745|452078293|FG000|Overall Study|Othe reasons|987|||
125669825|NCT00628745|452078294|FG001|Overall Study|Othe reasons|373|||
125669826|NCT00628745|452078295|FG002|Overall Study|Othe reasons|105|||
125669827|NCT00628745|452078296|FG003|Overall Study|Othe reasons|1|||
125669828|NCT00628745|452078297|FG004|Overall Study|Othe reasons|1772|||
125669829|NCT03322462|452079672|FG000|Overall Study|Technical difficulties|2|||
125669830|NCT03322462|452079672|FG000|Overall Study|Other|1|||
125669831|NCT01133821|452079677|FG000|Overall Study|Lost to Follow-up|8|||
125669832|NCT01133821|452079678|FG001|Overall Study|Lost to Follow-up|11|||
125669833|NCT01133821|452079677|FG000|Overall Study|Withdrawal by Subject|8|||
125669834|NCT01133821|452079678|FG001|Overall Study|Withdrawal by Subject|3|||
125669835|NCT01133821|452079677|FG000|Overall Study|preferred other treatment|1|||
125669836|NCT01133821|452079678|FG001|Overall Study|preferred other treatment|1|||
125669837|NCT01133821|452079677|FG000|Overall Study|Protocol Violation|0|||
125669838|NCT01133821|452079678|FG001|Overall Study|Protocol Violation|1|||
125669839|NCT01133821|452079677|FG000|Overall Study|Refused participation|1|||
125669840|NCT01133821|452079678|FG001|Overall Study|Refused participation|3|||
125669841|NCT03572933|452079682|FG000|Overall Study|Adverse Event|4|||
125669842|NCT03572933|452079683|FG001|Overall Study|Adverse Event|1|||
125669843|NCT03572933|452079682|FG000|Overall Study|Withdrawal by Subject|0|||
125669844|NCT03572933|452079683|FG001|Overall Study|Withdrawal by Subject|1|||
125669845|NCT00633152|452079688|FG000|Overall Study|Adverse Event|1|||
125669846|NCT00633152|452079689|FG001|Overall Study|Adverse Event|0|||
125669847|NCT00633152|452079688|FG000|Overall Study|Randomized, did not receive study drug|5|||
125669848|NCT00633152|452079689|FG001|Overall Study|Randomized, did not receive study drug|2|||
125669849|NCT00633152|452079688|FG000|Overall Study|Withdrawal by Subject|1|||
125669850|NCT00633152|452079689|FG001|Overall Study|Withdrawal by Subject|1|||
125332124|NCT03682770|450848962|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
125669851|NCT00633152|452079688|FG000|Overall Study|Lost to Follow-up|4|||
125669852|NCT00633152|452079689|FG001|Overall Study|Lost to Follow-up|1|||
125669853|NCT00633152|452079688|FG000|Overall Study|Miscellaneous Other|3|||
125669854|NCT00633152|452079689|FG001|Overall Study|Miscellaneous Other|2|||
125332125|NCT03682770|450848963|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
125332126|NCT03682770|450848964|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
125332127|NCT03682770|450848965|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
125332128|NCT03682770|450848959|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125332129|NCT03682770|450848960|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125332130|NCT03682770|450848961|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
125332131|NCT03682770|450848962|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
125669855|NCT03273387|452079690|FG000|Overall Study|Death|2|||
125669856|NCT03273387|452079691|FG001|Overall Study|Death|2|||
125669857|NCT03273387|452079690|FG000|Overall Study|Withdrawal by Subject|1|||
125332132|NCT03682770|450848963|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125332133|NCT03682770|450848964|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125332134|NCT03682770|450848965|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
125332135|NCT03682770|450848959|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125332136|NCT03682770|450848960|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125332137|NCT03682770|450848961|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125332138|NCT03682770|450848962|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
125332139|NCT03682770|450848963|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125332140|NCT03682770|450848964|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125332141|NCT03682770|450848965|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
125332142|NCT03682770|450848959|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125332143|NCT03682770|450848960|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125332144|NCT03682770|450848961|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
125332145|NCT03682770|450848962|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
125332146|NCT03682770|450848963|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125332147|NCT03682770|450848964|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125332148|NCT03682770|450848965|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
125332149|NCT03682770|450848959|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125332150|NCT03682770|450848960|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125332151|NCT03682770|450848961|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
125332152|NCT03682770|450848962|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125332153|NCT03682770|450848963|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125332154|NCT03682770|450848964|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125332155|NCT03682770|450848965|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
125332156|NCT03682770|450848959|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125332157|NCT03682770|450848960|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125332158|NCT03682770|450848961|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
125332159|NCT03682770|450848962|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125332160|NCT03682770|450848963|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125332161|NCT03682770|450848964|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125332162|NCT03682770|450848965|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
125332163|NCT03682770|450848959|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125332164|NCT03682770|450848960|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125332165|NCT03682770|450848961|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125332166|NCT03682770|450848962|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
125332167|NCT03682770|450848963|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125332168|NCT03682770|450848964|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125332169|NCT03682770|450848965|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
125332170|NCT03682770|450848959|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
125332171|NCT03682770|450848960|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
125332172|NCT03682770|450848961|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
125332173|NCT03682770|450848962|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
125332174|NCT03682770|450848963|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
125332175|NCT03682770|450848964|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
125332176|NCT03682770|450848965|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
125332177|NCT03682770|450848959|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125332178|NCT03682770|450848960|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125332179|NCT03682770|450848961|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125332180|NCT03682770|450848962|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125669858|NCT03273387|452079691|FG001|Overall Study|Withdrawal by Subject|1|||
125669859|NCT01907087|452079692|FG000|Overall Study|Withdrawal by Subject|1|||
125669860|NCT02049359|452079693|FG000|Overall Study|Lost to Follow-up|26|||
125669861|NCT02049359|452079694|FG001|Overall Study|Lost to Follow-up|19|||
125332181|NCT03682770|450848963|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
125669862|NCT05216978|452079695|FG000|Overall Study|Withdrawal by Subject|3|||
125669863|NCT05216978|452079695|FG000|Overall Study|Lost to Follow-up|5|||
125332182|NCT03682770|450848964|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125332183|NCT03682770|450848965|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
125332184|NCT03682770|450848959|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125332185|NCT03682770|450848960|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125332186|NCT03682770|450848961|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125332187|NCT03682770|450848962|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125332188|NCT03682770|450848963|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125332189|NCT03682770|450848964|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
125332190|NCT03682770|450848965|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
125332191|NCT03682770|450848959|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
125332192|NCT03682770|450848960|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
125332193|NCT03682770|450848961|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
125332194|NCT03682770|450848962|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
125332195|NCT03682770|450848963|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
125332196|NCT03682770|450848964|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
125332197|NCT03682770|450848965|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
125332198|NCT02362282|450848966|FG000|Overall Study|Withdrawal by Subject|1|||
125332199|NCT02362282|450848967|FG001|Overall Study|Withdrawal by Subject|0|||
125332200|NCT03599089|450848974|FG000|Overall Study|Lost to Follow-up|1|||
125332201|NCT03599089|450848975|FG001|Overall Study|Lost to Follow-up|0|||
125332202|NCT03599089|450848976|FG002|Overall Study|Lost to Follow-up|0|||
125332203|NCT03599089|450848977|FG003|Overall Study|Lost to Follow-up|0|||
125332204|NCT03599089|450848974|FG000|Overall Study|Withdrawal by Subject|2|||
125332205|NCT03599089|450848975|FG001|Overall Study|Withdrawal by Subject|1|||
125332206|NCT03599089|450848976|FG002|Overall Study|Withdrawal by Subject|0|||
125332207|NCT03599089|450848977|FG003|Overall Study|Withdrawal by Subject|0|||
125332208|NCT03599089|450848974|FG000|Overall Study|Lack of Efficacy|0|||
125332209|NCT03599089|450848975|FG001|Overall Study|Lack of Efficacy|0|||
125332210|NCT03599089|450848976|FG002|Overall Study|Lack of Efficacy|1|||
125332211|NCT03599089|450848977|FG003|Overall Study|Lack of Efficacy|2|||
125332212|NCT03214666|450848978|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125332213|NCT03214666|450848979|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125332214|NCT03214666|450848980|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125332215|NCT03214666|450848981|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125332216|NCT03214666|450848982|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
125332217|NCT03214666|450848983|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
125332218|NCT00470275|450848984|FG000|Overall Study|Death|1|||
125332219|NCT00470275|450848984|FG000|Overall Study|Lack of Efficacy|7|||
125332220|NCT00470275|450848984|FG000|Overall Study|Withdrawal by Subject|2|||
125332221|NCT00318643|450848990|FG000|Overall Study|Adverse Event|0|||
125332222|NCT00318643|450848991|FG001|Overall Study|Adverse Event|0|||
125332223|NCT00318643|450848992|FG002|Overall Study|Adverse Event|0|||
125332224|NCT00318643|450848993|FG003|Overall Study|Adverse Event|0|||
125332225|NCT00318643|450848994|FG004|Overall Study|Adverse Event|1|||
125332226|NCT00318643|450848990|FG000|Overall Study|Participant's Decision|0|||
125332227|NCT00318643|450848991|FG001|Overall Study|Participant's Decision|0|||
125332228|NCT00318643|450848992|FG002|Overall Study|Participant's Decision|0|||
125332229|NCT00318643|450848993|FG003|Overall Study|Participant's Decision|0|||
125332230|NCT00318643|450848994|FG004|Overall Study|Participant's Decision|1|||
125332231|NCT00318643|450848990|FG000|Overall Study|Investigator's Decision|0|||
125332232|NCT00318643|450848991|FG001|Overall Study|Investigator's Decision|0|||
125332233|NCT00318643|450848992|FG002|Overall Study|Investigator's Decision|0|||
125332234|NCT00318643|450848993|FG003|Overall Study|Investigator's Decision|0|||
125332235|NCT00318643|450848994|FG004|Overall Study|Investigator's Decision|1|||
125332236|NCT01519921|450848997|FG000|Overall Study|Adverse Event|10|||
125332237|NCT01519921|450848998|FG001|Overall Study|Adverse Event|9|||
125332238|NCT01519921|450848997|FG000|Overall Study|Lack of Efficacy|4|||
125332239|NCT01519921|450848998|FG001|Overall Study|Lack of Efficacy|3|||
125332240|NCT01519921|450848997|FG000|Overall Study|Withdrawal by Subject|3|||
125332241|NCT01519921|450848998|FG001|Overall Study|Withdrawal by Subject|0|||
125332242|NCT01519921|450848997|FG000|Overall Study|Lost to Follow-up|2|||
125332243|NCT01519921|450848998|FG001|Overall Study|Lost to Follow-up|1|||
125332244|NCT01519921|450848997|FG000|Overall Study|Treatment refusal|2|||
125669864|NCT02180061|452079696|FG000|Overall Study|Adverse Event|4|||
125669865|NCT02180061|452079697|FG001|Overall Study|Adverse Event|2|||
125669866|NCT02180061|452079696|FG000|Overall Study|Clinical Progression|5|||
125669867|NCT02180061|452079697|FG001|Overall Study|Clinical Progression|1|||
125669868|NCT02180061|452079696|FG000|Overall Study|Progressive Disease|15|||
125332245|NCT01519921|450848998|FG001|Overall Study|Treatment refusal|1|||
125332246|NCT01519921|450848997|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
125332247|NCT01519921|450848998|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
125332248|NCT02500797|450848999|FG000|Overall Study|Cancel (rapid disease progression)|0|||
125669869|NCT02180061|452079697|FG001|Overall Study|Progressive Disease|5|||
125332249|NCT02500797|450849000|FG001|Overall Study|Cancel (rapid disease progression)|0|||
125332250|NCT02500797|450849001|FG002|Overall Study|Cancel (rapid disease progression)|0|||
125332251|NCT02500797|450849002|FG003|Overall Study|Cancel (rapid disease progression)|0|||
125332252|NCT02500797|450849003|FG004|Overall Study|Cancel (rapid disease progression)|1|||
125332253|NCT02500797|450849004|FG005|Overall Study|Cancel (rapid disease progression)|1|||
125332254|NCT02500797|450849005|FG006|Overall Study|Cancel (rapid disease progression)|0|||
125332255|NCT02500797|450849006|FG007|Overall Study|Cancel (rapid disease progression)|0|||
125332256|NCT02500797|450848999|FG000|Overall Study|Withdrawal by Subject|1|||
125332257|NCT02500797|450849000|FG001|Overall Study|Withdrawal by Subject|0|||
125332258|NCT02500797|450849001|FG002|Overall Study|Withdrawal by Subject|0|||
125332259|NCT02500797|450849002|FG003|Overall Study|Withdrawal by Subject|0|||
125332260|NCT02500797|450849003|FG004|Overall Study|Withdrawal by Subject|0|||
125332261|NCT02500797|450849004|FG005|Overall Study|Withdrawal by Subject|0|||
125332262|NCT02500797|450849005|FG006|Overall Study|Withdrawal by Subject|0|||
125669870|NCT02180061|452079696|FG000|Overall Study|Physician Decision|1|||
125332263|NCT02500797|450849006|FG007|Overall Study|Withdrawal by Subject|0|||
125332264|NCT01415882|450849009|FG000|Overall Study|Ineligible|1|||
125332265|NCT01415882|450849010|FG001|Overall Study|Ineligible|0|||
125332266|NCT01415882|450849011|FG002|Overall Study|Ineligible|0|||
125332267|NCT01415882|450849012|FG003|Overall Study|Ineligible|3|||
125332268|NCT01415882|450849013|FG004|Overall Study|Ineligible|0|||
125332269|NCT01415882|450849009|FG000|Overall Study|Withdrawal by Subject|0|||
125332270|NCT01415882|450849010|FG001|Overall Study|Withdrawal by Subject|1|||
125332271|NCT01415882|450849011|FG002|Overall Study|Withdrawal by Subject|0|||
125332272|NCT01415882|450849012|FG003|Overall Study|Withdrawal by Subject|1|||
125332273|NCT01415882|450849013|FG004|Overall Study|Withdrawal by Subject|0|||
125332274|NCT00357006|450849018|FG000|Overall Study|Lost to Follow-up|1|||
125332275|NCT00357006|450849019|FG001|Overall Study|Lost to Follow-up|2|||
125332276|NCT00357006|450849020|FG002|Overall Study|Lost to Follow-up|1|||
125332277|NCT00357006|450849018|FG000|Overall Study|Withdrawal by Subject|1|||
125332278|NCT00357006|450849019|FG001|Overall Study|Withdrawal by Subject|3|||
125332279|NCT00357006|450849020|FG002|Overall Study|Withdrawal by Subject|2|||
125332280|NCT00976560|450849021|FG000|Overall Study|Adverse Event|5|||
125332281|NCT00976560|450849022|FG001|Overall Study|Adverse Event|5|||
125332282|NCT00976560|450849021|FG000|Overall Study|Lack of Efficacy|3|||
125332283|NCT00976560|450849022|FG001|Overall Study|Lack of Efficacy|5|||
125332284|NCT00976560|450849021|FG000|Overall Study|Protocol Violation|1|||
125332285|NCT00976560|450849022|FG001|Overall Study|Protocol Violation|0|||
125332286|NCT00976560|450849021|FG000|Overall Study|Lost to Follow-up|1|||
125332287|NCT00976560|450849022|FG001|Overall Study|Lost to Follow-up|0|||
125332288|NCT00976560|450849021|FG000|Overall Study|Physician Decision|2|||
125332289|NCT00976560|450849022|FG001|Overall Study|Physician Decision|0|||
125332290|NCT00976560|450849021|FG000|Overall Study|Withdrawal by Subject|2|||
125332291|NCT00976560|450849022|FG001|Overall Study|Withdrawal by Subject|3|||
125332292|NCT01216189|450849023|FG000|Overall Study|Lost to Follow-up|21|||
125332293|NCT01216189|450849024|FG001|Overall Study|Lost to Follow-up|3|||
125332294|NCT01216189|450849023|FG000|Overall Study|Death|4|||
125332295|NCT01216189|450849024|FG001|Overall Study|Death|2|||
125332296|NCT00125164|450849027|FG000|Overall Study|Adverse Event|0|||
125332297|NCT00125164|450849028|FG001|Overall Study|Adverse Event|0|||
125332298|NCT00125164|450849029|FG002|Overall Study|Adverse Event|2|||
125669871|NCT02180061|452079697|FG001|Overall Study|Physician Decision|0|||
125332299|NCT00125164|450849030|FG003|Overall Study|Adverse Event|4|||
125332300|NCT00125164|450849027|FG000|Overall Study|Lost to Follow-up|0|||
125332301|NCT00125164|450849028|FG001|Overall Study|Lost to Follow-up|0|||
125332302|NCT00125164|450849029|FG002|Overall Study|Lost to Follow-up|1|||
125332303|NCT00125164|450849030|FG003|Overall Study|Lost to Follow-up|1|||
125332304|NCT00125164|450849027|FG000|Overall Study|Withdrawal by Subject|2|||
125332305|NCT00125164|450849028|FG001|Overall Study|Withdrawal by Subject|0|||
125332306|NCT00125164|450849029|FG002|Overall Study|Withdrawal by Subject|1|||
125332307|NCT00125164|450849030|FG003|Overall Study|Withdrawal by Subject|1|||
125332308|NCT01339052|450849031|FG000|Overall Study|Disease progression|13|||
125669872|NCT01772368|452079698|FG000|Overall Study|Adverse Event|1|||
125669873|NCT01772368|452079698|FG000|Overall Study|Withdrawal by Subject|3|||
125332309|NCT01339052|450849032|FG001|Overall Study|Disease progression|46|||
125332310|NCT01339052|450849031|FG000|Overall Study|Adverse Event|1|||
125332311|NCT01339052|450849032|FG001|Overall Study|Adverse Event|1|||
125332312|NCT01339052|450849031|FG000|Overall Study|Withdrawal by Subject|0|||
125332313|NCT01339052|450849032|FG001|Overall Study|Withdrawal by Subject|3|||
125332314|NCT01339052|450849031|FG000|Overall Study|Physician Decision|1|||
125332315|NCT01339052|450849032|FG001|Overall Study|Physician Decision|0|||
125332316|NCT02637037|450849033|FG000|Overall Study|Positive drug screen at admission|1|||
125332317|NCT02637037|450849034|FG001|Overall Study|Positive drug screen at admission|0|||
125332318|NCT02637037|450849033|FG000|Overall Study|Withdrawal by Subject|2|||
125332319|NCT02637037|450849034|FG001|Overall Study|Withdrawal by Subject|1|||
125332320|NCT02637037|450849033|FG000|Overall Study|Adverse Event|1|||
125332321|NCT02637037|450849034|FG001|Overall Study|Adverse Event|0|||
125669874|NCT01772368|452079698|FG000|Overall Study|Protocol Violation|2|||
125332322|NCT03339219|450849035|FG000|Overall Study|Death|12|||
125332323|NCT03339219|450849035|FG000|Overall Study|Site Terminated by Sponsor|22|||
125332324|NCT03339219|450849035|FG000|Overall Study|Withdrawal by Subject|1|||
125332325|NCT01469377|450849037|FG000|Overall Study|Protocol Deviation|7|||
125332326|NCT01469377|450849038|FG001|Overall Study|Protocol Deviation|10|||
125332327|NCT01469377|450849039|FG002|Overall Study|Protocol Deviation|10|||
125332328|NCT01469377|450849037|FG000|Overall Study|Lost to Follow-up|3|||
125332329|NCT01469377|450849038|FG001|Overall Study|Lost to Follow-up|2|||
125332330|NCT01469377|450849039|FG002|Overall Study|Lost to Follow-up|5|||
125332331|NCT01469377|450849037|FG000|Overall Study|Withdrawal of Consent|12|||
125332332|NCT01469377|450849038|FG001|Overall Study|Withdrawal of Consent|14|||
125332333|NCT01469377|450849039|FG002|Overall Study|Withdrawal of Consent|15|||
125332334|NCT01469377|450849037|FG000|Overall Study|Adverse Event|8|||
125332335|NCT01469377|450849038|FG001|Overall Study|Adverse Event|18|||
125332336|NCT01469377|450849039|FG002|Overall Study|Adverse Event|36|||
125332337|NCT01469377|450849037|FG000|Overall Study|Insufficient Therapeutic Response|3|||
125332338|NCT01469377|450849038|FG001|Overall Study|Insufficient Therapeutic Response|4|||
125332339|NCT01469377|450849039|FG002|Overall Study|Insufficient Therapeutic Response|0|||
125332340|NCT01469377|450849037|FG000|Overall Study|Other Miscellaneous Reasons|2|||
125332341|NCT01469377|450849038|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125332342|NCT01469377|450849039|FG002|Overall Study|Other Miscellaneous Reasons|0|||
125332343|NCT01733680|450849040|FG000|Overall Study|Withdrawal by Subject|0|||
125332344|NCT01733680|450849041|FG001|Overall Study|Withdrawal by Subject|1|||
125332345|NCT04139798|450849046|FG000|Overall Study|Withdrawal by Subject|6|||
125332346|NCT04139798|450849047|FG001|Overall Study|Withdrawal by Subject|5|||
125332347|NCT04139798|450849046|FG000|Overall Study|Lost to Follow-up|2|||
125332348|NCT04139798|450849047|FG001|Overall Study|Lost to Follow-up|5|||
125332349|NCT04139798|450849046|FG000|Overall Study|Discontinued|4|||
125332350|NCT04139798|450849047|FG001|Overall Study|Discontinued|2|||
125332351|NCT04139798|450849046|FG000|Overall Study|Adverse Event|1|||
125332352|NCT04139798|450849047|FG001|Overall Study|Adverse Event|3|||
125332353|NCT04139798|450849046|FG000|Overall Study|Protocol Violation|1|||
125332354|NCT04139798|450849047|FG001|Overall Study|Protocol Violation|0|||
125332355|NCT04269889|450849048|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
125332356|NCT04308291|450849051|FG000|Run-In Phase|Withdrawal by Subject|4|||
125332357|NCT04308291|450849051|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
125332358|NCT04308291|450849051|FG000|Study Phase 6-M|Physician Decision|2|||
125332359|NCT04308291|450849051|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
125332360|NCT04308291|450849051|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
125332361|NCT04308291|450849051|FG000|Study Phase 12-M|Physician Decision|2|||
125332362|NCT04308291|450849051|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
125332363|NCT03610269|450849053|FG000|Overall Study|Physician Decision|10|||
125332364|NCT03610269|450849053|FG000|Overall Study|Protocol Violation|1|||
125332365|NCT03610269|450849053|FG000|Overall Study|Unable to draw blood|1|||
125332366|NCT03610269|450849053|FG000|Overall Study|Screen fail|4|||
125332367|NCT04411667|450849056|FG000|Overall Study|Physician Decision|1|||
125332368|NCT04411667|450849057|FG001|Overall Study|Physician Decision|0|||
125332369|NCT00067002|450849058|FG000|Overall Study|Early Death|1|||
125332370|NCT00067002|450849059|FG001|Overall Study|Early Death|2|||
125332371|NCT00067002|450849058|FG000|Overall Study|Delayed|1|||
125332372|NCT00067002|450849059|FG001|Overall Study|Delayed|1|||
125332373|NCT00067002|450849058|FG000|Overall Study|Graft Failure|5|||
125332374|NCT00067002|450849059|FG001|Overall Study|Graft Failure|6|||
125332375|NCT01354314|450849064|FG000|Overall Study|Lost to Follow-up|1|||
125332376|NCT01354314|450849065|FG001|Overall Study|Lost to Follow-up|0|||
125332377|NCT01354314|450849066|FG002|Overall Study|Lost to Follow-up|1|||
125332378|NCT01354314|450849067|FG003|Overall Study|Lost to Follow-up|1|||
125332379|NCT01354314|450849064|FG000|Overall Study|Withdrawal by Subject|0|||
125332380|NCT01354314|450849065|FG001|Overall Study|Withdrawal by Subject|0|||
125332381|NCT01354314|450849066|FG002|Overall Study|Withdrawal by Subject|1|||
125332382|NCT01354314|450849067|FG003|Overall Study|Withdrawal by Subject|0|||
125332383|NCT01354314|450849064|FG000|Overall Study|Adverse Event|0|||
125332384|NCT01354314|450849065|FG001|Overall Study|Adverse Event|0|||
125332385|NCT01354314|450849066|FG002|Overall Study|Adverse Event|0|||
125332386|NCT01354314|450849067|FG003|Overall Study|Adverse Event|1|||
125332387|NCT01354314|450849064|FG000|Overall Study|Protocol Violation|1|||
125332388|NCT01354314|450849065|FG001|Overall Study|Protocol Violation|1|||
125332389|NCT01354314|450849066|FG002|Overall Study|Protocol Violation|0|||
125332390|NCT01354314|450849067|FG003|Overall Study|Protocol Violation|0|||
125332391|NCT01354314|450849064|FG000|Overall Study|Less than 90% Adherence|4|||
125332392|NCT01354314|450849065|FG001|Overall Study|Less than 90% Adherence|2|||
125332393|NCT01354314|450849066|FG002|Overall Study|Less than 90% Adherence|6|||
125332394|NCT01354314|450849067|FG003|Overall Study|Less than 90% Adherence|4|||
125332395|NCT00478023|450849069|FG000|Overall Study|Adverse Event|11|||
125332396|NCT00478023|450849070|FG001|Overall Study|Adverse Event|7|||
125332397|NCT00478023|450849071|FG002|Overall Study|Adverse Event|8|||
125332398|NCT00478023|450849072|FG003|Overall Study|Adverse Event|14|||
125332399|NCT00478023|450849073|FG004|Overall Study|Adverse Event|6|||
125332400|NCT00478023|450849069|FG000|Overall Study|Death|1|||
125669875|NCT01772368|452079698|FG000|Overall Study|Other|1|||
125669876|NCT01452529|452079699|FG000|Run-in Period|Adverse Event|96|||
125669877|NCT01452529|452079700|FG001|Run-in Period|Adverse Event|0|||
125669878|NCT01452529|452079701|FG002|Run-in Period|Adverse Event|0|||
125669879|NCT01452529|452079699|FG000|Run-in Period|Withdrawal by Subject|49|||
125669880|NCT01452529|452079700|FG001|Run-in Period|Withdrawal by Subject|0|||
125669881|NCT01452529|452079701|FG002|Run-in Period|Withdrawal by Subject|0|||
125669882|NCT01452529|452079699|FG000|Run-in Period|Lost to Follow-up|19|||
125669883|NCT01452529|452079700|FG001|Run-in Period|Lost to Follow-up|0|||
125669884|NCT01452529|452079701|FG002|Run-in Period|Lost to Follow-up|0|||
125669885|NCT01452529|452079699|FG000|Run-in Period|Lack of Efficacy|46|||
125332401|NCT00478023|450849070|FG001|Overall Study|Death|0|||
125332402|NCT00478023|450849071|FG002|Overall Study|Death|0|||
125332403|NCT00478023|450849072|FG003|Overall Study|Death|0|||
125332404|NCT00478023|450849073|FG004|Overall Study|Death|0|||
125332405|NCT00478023|450849069|FG000|Overall Study|Lack of Efficacy|11|||
125332406|NCT00478023|450849070|FG001|Overall Study|Lack of Efficacy|10|||
125332407|NCT00478023|450849071|FG002|Overall Study|Lack of Efficacy|4|||
125332408|NCT00478023|450849072|FG003|Overall Study|Lack of Efficacy|5|||
125332409|NCT00478023|450849073|FG004|Overall Study|Lack of Efficacy|41|||
125332410|NCT00478023|450849069|FG000|Overall Study|Lost to Follow-up|3|||
125332411|NCT00478023|450849070|FG001|Overall Study|Lost to Follow-up|1|||
125332412|NCT00478023|450849071|FG002|Overall Study|Lost to Follow-up|1|||
125332413|NCT00478023|450849072|FG003|Overall Study|Lost to Follow-up|1|||
125332414|NCT00478023|450849073|FG004|Overall Study|Lost to Follow-up|0|||
125332415|NCT00478023|450849069|FG000|Overall Study|Withdrawal by Subject|2|||
125332416|NCT00478023|450849070|FG001|Overall Study|Withdrawal by Subject|3|||
125332417|NCT00478023|450849071|FG002|Overall Study|Withdrawal by Subject|2|||
125332418|NCT00478023|450849072|FG003|Overall Study|Withdrawal by Subject|4|||
125332419|NCT00478023|450849073|FG004|Overall Study|Withdrawal by Subject|5|||
125332420|NCT00478023|450849069|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
125332421|NCT00478023|450849070|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
125332422|NCT00478023|450849071|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
125332423|NCT00478023|450849072|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
125332424|NCT00478023|450849073|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
125332425|NCT00714870|450849075|FG000|Overall Study|Lost to Follow-up|22|||
125332426|NCT00714870|450849076|FG001|Overall Study|Lost to Follow-up|5|||
125332427|NCT00714870|450849075|FG000|Overall Study|patient unable to come b/c back pain|1|||
125332428|NCT00714870|450849076|FG001|Overall Study|patient unable to come b/c back pain|0|||
125669886|NCT01452529|452079700|FG001|Run-in Period|Lack of Efficacy|0|||
125669887|NCT01452529|452079701|FG002|Run-in Period|Lack of Efficacy|0|||
125669888|NCT01452529|452079699|FG000|Run-in Period|Confirmed or suspected diversion|23|||
125332429|NCT00714870|450849075|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
125332430|NCT00714870|450849076|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
125332431|NCT02357368|450849077|FG000|Overall Study|Lost to Follow-up|0|||
125332432|NCT02357368|450849078|FG001|Overall Study|Lost to Follow-up|0|||
125332433|NCT02357368|450849079|FG002|Overall Study|Lost to Follow-up|0|||
125332434|NCT02357368|450849080|FG003|Overall Study|Lost to Follow-up|1|||
125332435|NCT02357368|450849077|FG000|Overall Study|Pregnancy|3|||
125332436|NCT02357368|450849078|FG001|Overall Study|Pregnancy|2|||
125332437|NCT02357368|450849079|FG002|Overall Study|Pregnancy|0|||
125332438|NCT02357368|450849080|FG003|Overall Study|Pregnancy|0|||
125332439|NCT02357368|450849077|FG000|Overall Study|Withdrawal by Subject|3|||
125332440|NCT02357368|450849078|FG001|Overall Study|Withdrawal by Subject|1|||
125669889|NCT01452529|452079700|FG001|Run-in Period|Confirmed or suspected diversion|0|||
125669890|NCT01452529|452079701|FG002|Run-in Period|Confirmed or suspected diversion|0|||
125669891|NCT01452529|452079699|FG000|Run-in Period|Administrative|21|||
125332441|NCT02357368|450849079|FG002|Overall Study|Withdrawal by Subject|1|||
125332442|NCT02357368|450849080|FG003|Overall Study|Withdrawal by Subject|2|||
125332443|NCT02377817|450849081|FG000|Overall Study|Transportation/childcare barriers.|2|||
125332444|NCT02377817|450849082|FG001|Overall Study|Transportation/childcare barriers.|0|||
125332445|NCT02377817|450849081|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
125669892|NCT01452529|452079700|FG001|Run-in Period|Administrative|0|||
125332446|NCT02377817|450849082|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
125332447|NCT03895840|450849083|FG000|Overall Study|Withdrawal by Subject|21|||
125332448|NCT01147874|450849086|FG000|Overall Study|Adverse Event|5|||
125669893|NCT01452529|452079701|FG002|Run-in Period|Administrative|0|||
125332449|NCT01147874|450849086|FG000|Overall Study|Investigator's Request|1|||
125332450|NCT01147874|450849086|FG000|Overall Study|Lost to Follow-up|25|||
125332451|NCT01147874|450849086|FG000|Overall Study|Other|5|||
125669894|NCT01452529|452079699|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
125332452|NCT01147874|450849086|FG000|Overall Study|Protocol Violation|5|||
125332453|NCT01147874|450849086|FG000|Overall Study|Sponsor's Decision|2|||
125669895|NCT01452529|452079700|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
125669896|NCT01452529|452079701|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
125669897|NCT01452529|452079699|FG000|Double-blind (DB) Period|Adverse Event|0|||
125332454|NCT01147874|450849086|FG000|Overall Study|Withdrawal by Subject|24|||
125332455|NCT02175030|450849088|FG000|Overall Study|Failed screen after consent|7|||
125332456|NCT02175030|450849089|FG001|Overall Study|Failed screen after consent|6|||
125332457|NCT02175030|450849088|FG000|Overall Study|Failed IUD Insertion|20|||
125332458|NCT02175030|450849089|FG001|Overall Study|Failed IUD Insertion|21|||
125332459|NCT02175030|450849088|FG000|Overall Study|Physician Decision|1|||
125332460|NCT02175030|450849089|FG001|Overall Study|Physician Decision|1|||
125332461|NCT02175030|450849088|FG000|Overall Study|Lost to Follow-up|6|||
125332462|NCT02175030|450849089|FG001|Overall Study|Lost to Follow-up|6|||
125332463|NCT02175030|450849088|FG000|Overall Study|Withdrawal by Subject|1|||
125332464|NCT02175030|450849089|FG001|Overall Study|Withdrawal by Subject|4|||
125332465|NCT02817464|450849090|FG000|Overall Study|Lost to Follow-up|1|||
125332466|NCT02817464|450849091|FG001|Overall Study|Lost to Follow-up|0|||
125332467|NCT02817464|450849090|FG000|Overall Study|Discontinued early due to personal decision|1|||
125332468|NCT02817464|450849091|FG001|Overall Study|Discontinued early due to personal decision|1|||
125332469|NCT00885534|450849092|FG000|Overall Study|Patient deemed ineligible|1|||
125332470|NCT02453711|450849093|FG000|Overall Study|Withdrawal by Subject|5|||
125332471|NCT02453711|450849094|FG001|Overall Study|Withdrawal by Subject|4|||
125332472|NCT02453711|450849095|FG002|Overall Study|Withdrawal by Subject|6|||
125332473|NCT02453711|450849096|FG003|Overall Study|Withdrawal by Subject|4|||
125332474|NCT02453711|450849097|FG004|Overall Study|Withdrawal by Subject|1|||
125332475|NCT02453711|450849098|FG005|Overall Study|Withdrawal by Subject|1|||
125332476|NCT02453711|450849099|FG006|Overall Study|Withdrawal by Subject|0|||
125332477|NCT02453711|450849100|FG007|Overall Study|Withdrawal by Subject|1|||
125332478|NCT02453711|450849101|FG008|Overall Study|Withdrawal by Subject|7|||
125332479|NCT02453711|450849093|FG000|Overall Study|Lost to Follow-up|5|||
125332480|NCT02453711|450849094|FG001|Overall Study|Lost to Follow-up|3|||
125332481|NCT02453711|450849095|FG002|Overall Study|Lost to Follow-up|2|||
125332482|NCT02453711|450849096|FG003|Overall Study|Lost to Follow-up|3|||
125332483|NCT02453711|450849097|FG004|Overall Study|Lost to Follow-up|1|||
125332484|NCT02453711|450849098|FG005|Overall Study|Lost to Follow-up|5|||
125332485|NCT02453711|450849099|FG006|Overall Study|Lost to Follow-up|2|||
125332486|NCT02453711|450849100|FG007|Overall Study|Lost to Follow-up|6|||
125332487|NCT02453711|450849101|FG008|Overall Study|Lost to Follow-up|6|||
125332488|NCT02453711|450849093|FG000|Overall Study|Death|0|||
125332489|NCT02453711|450849094|FG001|Overall Study|Death|0|||
125332490|NCT02453711|450849095|FG002|Overall Study|Death|0|||
125332491|NCT02453711|450849096|FG003|Overall Study|Death|0|||
125332492|NCT02453711|450849097|FG004|Overall Study|Death|0|||
125332493|NCT02453711|450849098|FG005|Overall Study|Death|0|||
125332494|NCT02453711|450849099|FG006|Overall Study|Death|1|||
125332495|NCT02453711|450849100|FG007|Overall Study|Death|0|||
125332496|NCT02453711|450849101|FG008|Overall Study|Death|0|||
125332497|NCT02453711|450849093|FG000|Overall Study|Unclassified|1|||
125332498|NCT02453711|450849094|FG001|Overall Study|Unclassified|0|||
125332499|NCT02453711|450849095|FG002|Overall Study|Unclassified|1|||
125332500|NCT02453711|450849096|FG003|Overall Study|Unclassified|0|||
125332501|NCT02453711|450849097|FG004|Overall Study|Unclassified|0|||
125332502|NCT02453711|450849098|FG005|Overall Study|Unclassified|0|||
125332503|NCT02453711|450849099|FG006|Overall Study|Unclassified|0|||
125332504|NCT02453711|450849100|FG007|Overall Study|Unclassified|0|||
125332505|NCT02453711|450849101|FG008|Overall Study|Unclassified|0|||
125332506|NCT01273519|450849104|FG000|Overall Study|Adverse Event|3|||
125332507|NCT01273519|450849105|FG001|Overall Study|Adverse Event|0|||
125332508|NCT01273519|450849106|FG002|Overall Study|Adverse Event|0|||
125332509|NCT01273519|450849104|FG000|Overall Study|Lost to Follow-up|2|||
125332510|NCT01273519|450849105|FG001|Overall Study|Lost to Follow-up|1|||
125332511|NCT01273519|450849106|FG002|Overall Study|Lost to Follow-up|3|||
125332512|NCT01273519|450849104|FG000|Overall Study|Lack of Efficacy|8|||
125332513|NCT01273519|450849105|FG001|Overall Study|Lack of Efficacy|3|||
125332514|NCT01273519|450849106|FG002|Overall Study|Lack of Efficacy|4|||
125332515|NCT01273519|450849104|FG000|Overall Study|Other|6|||
125332516|NCT01273519|450849105|FG001|Overall Study|Other|1|||
125332517|NCT01273519|450849106|FG002|Overall Study|Other|1|||
125332518|NCT04292899|450849107|FG000|Overall Study|Death|21|||
125332519|NCT04292899|450849108|FG001|Overall Study|Death|28|||
125332520|NCT04292899|450849109|FG002|Overall Study|Death|188|||
125332521|NCT04292899|450849110|FG003|Overall Study|Death|371|||
125669898|NCT01452529|452079700|FG001|Double-blind (DB) Period|Adverse Event|18|||
125332522|NCT04292899|450849107|FG000|Overall Study|Lost to Follow-up|8|||
125332523|NCT04292899|450849108|FG001|Overall Study|Lost to Follow-up|4|||
125332524|NCT04292899|450849109|FG002|Overall Study|Lost to Follow-up|22|||
125332525|NCT04292899|450849110|FG003|Overall Study|Lost to Follow-up|235|||
125332526|NCT04292899|450849107|FG000|Overall Study|Withdrew consent|1|||
125332527|NCT04292899|450849108|FG001|Overall Study|Withdrew consent|0|||
125332528|NCT04292899|450849109|FG002|Overall Study|Withdrew consent|11|||
125332529|NCT04292899|450849110|FG003|Overall Study|Withdrew consent|32|||
125332530|NCT04292899|450849107|FG000|Overall Study|Adverse Event|2|||
125332531|NCT04292899|450849108|FG001|Overall Study|Adverse Event|1|||
125332532|NCT04292899|450849109|FG002|Overall Study|Adverse Event|2|||
125332533|NCT04292899|450849110|FG003|Overall Study|Adverse Event|2|||
125332534|NCT04292899|450849107|FG000|Overall Study|Investigator's Discretion|0|||
125332535|NCT04292899|450849108|FG001|Overall Study|Investigator's Discretion|0|||
125332536|NCT04292899|450849109|FG002|Overall Study|Investigator's Discretion|0|||
125332537|NCT04292899|450849110|FG003|Overall Study|Investigator's Discretion|3|||
125332538|NCT04292899|450849107|FG000|Overall Study|Non-compliance With Study Drug|0|||
125332539|NCT04292899|450849108|FG001|Overall Study|Non-compliance With Study Drug|0|||
125332540|NCT04292899|450849109|FG002|Overall Study|Non-compliance With Study Drug|0|||
125332541|NCT04292899|450849110|FG003|Overall Study|Non-compliance With Study Drug|1|||
125332542|NCT04292899|450849107|FG000|Overall Study|Protocol Violation|0|||
125332543|NCT04292899|450849108|FG001|Overall Study|Protocol Violation|0|||
125332544|NCT04292899|450849109|FG002|Overall Study|Protocol Violation|0|||
125332545|NCT04292899|450849110|FG003|Overall Study|Protocol Violation|1|||
125332546|NCT03695367|450849111|FG000|Overall Study|Missed the Day 28 visit.|1|||
125332547|NCT03695367|450849112|FG001|Overall Study|Missed the Day 28 visit.|0|||
125332548|NCT03695367|450849111|FG000|Overall Study|Lost to Follow-up|0|||
125332549|NCT03695367|450849112|FG001|Overall Study|Lost to Follow-up|1|||
125332550|NCT03695367|450849111|FG000|Overall Study|Withdrawal by Subject|0|||
125332551|NCT03695367|450849112|FG001|Overall Study|Withdrawal by Subject|1|||
125332552|NCT03695367|450849111|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
125332553|NCT03695367|450849112|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
125332554|NCT01209325|450849116|FG000|Overall Study|Lost to Follow-up|24|||
125332555|NCT01209325|450849116|FG000|Overall Study|Adverse Event|1|||
125332556|NCT01209325|450849116|FG000|Overall Study|Relocated|3|||
125332557|NCT01209325|450849116|FG000|Overall Study|Refusal after starting therapy|8|||
125332558|NCT01209325|450849116|FG000|Overall Study|Protocol Violation|4|||
125332559|NCT01209325|450849116|FG000|Overall Study|Refusal prior to therapy|1|||
125332560|NCT01209325|450849116|FG000|Overall Study|Incarceration|2|||
125332561|NCT00396253|450849117|FG000|Overall Study|Protocol Violation|1|||
125332562|NCT00396253|450849117|FG000|Overall Study|Withdrawal by Subject|7|||
125332563|NCT00396253|450849117|FG000|Overall Study|Death|3|||
125332564|NCT00396253|450849117|FG000|Overall Study|Physician Decision|1|||
125332565|NCT00396253|450849117|FG000|Overall Study|Change in eligibility status|1|||
125332566|NCT05340478|450849119|FG000|Overall Study|Scheduling Issues|10|||
125332567|NCT05340478|450849120|FG001|Overall Study|Scheduling Issues|4|||
125332568|NCT05340478|450849119|FG000|Overall Study|Neither member of dyad started treatment|2|||
125332569|NCT05340478|450849120|FG001|Overall Study|Neither member of dyad started treatment|2|||
125332570|NCT05340478|450849119|FG000|Overall Study|Withdrawn from study|2|||
125332571|NCT05340478|450849120|FG001|Overall Study|Withdrawn from study|2|||
125332572|NCT05340478|450849119|FG000|Overall Study|Lost to Follow-up|1|||
125332573|NCT05340478|450849120|FG001|Overall Study|Lost to Follow-up|4|||
125332574|NCT00092443|450849123|FG000|Overall Study|Adverse Event|9|||
125332575|NCT00092443|450849124|FG001|Overall Study|Adverse Event|13|||
125332576|NCT00092443|450849123|FG000|Overall Study|Lost to Follow-up|7|||
125332577|NCT00092443|450849124|FG001|Overall Study|Lost to Follow-up|3|||
125332578|NCT00092443|450849123|FG000|Overall Study|Protocol Violation|11|||
125332579|NCT00092443|450849124|FG001|Overall Study|Protocol Violation|9|||
125669899|NCT01452529|452079701|FG002|Double-blind (DB) Period|Adverse Event|11|||
125669900|NCT01452529|452079699|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
125669901|NCT01452529|452079700|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
125669902|NCT01452529|452079701|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
125669903|NCT01452529|452079699|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
125669904|NCT01452529|452079700|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
125669905|NCT01452529|452079701|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
125669906|NCT01452529|452079699|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
125669907|NCT01452529|452079700|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
125669908|NCT01452529|452079701|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
125669909|NCT01452529|452079699|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
125669910|NCT01452529|452079700|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
125669911|NCT01452529|452079701|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
125669912|NCT01452529|452079699|FG000|Double-blind (DB) Period|Administrative|0|||
125669913|NCT01452529|452079700|FG001|Double-blind (DB) Period|Administrative|11|||
125669914|NCT01452529|452079701|FG002|Double-blind (DB) Period|Administrative|7|||
125669915|NCT03551730|452079702|FG000|Overall Study|Adverse Event|1|||
125669916|NCT03551730|452079703|FG001|Overall Study|Adverse Event|0|||
125669917|NCT03551730|452079704|FG002|Overall Study|Adverse Event|0|||
125669918|NCT03551730|452079705|FG003|Overall Study|Adverse Event|0|||
125669919|NCT03347695|452079709|FG000|Overall Study|Death|0|||
125332580|NCT00092443|450849123|FG000|Overall Study|Withdrawal by Subject|9|||
125332581|NCT00092443|450849124|FG001|Overall Study|Withdrawal by Subject|11|||
125332582|NCT00092443|450849123|FG000|Overall Study|Moved|5|||
125332583|NCT00092443|450849124|FG001|Overall Study|Moved|5|||
125332584|NCT00092443|450849123|FG000|Overall Study|Other|17|||
125669920|NCT03347695|452079710|FG001|Overall Study|Death|4|||
125669921|NCT03347695|452079709|FG000|Overall Study|Lost to Follow-up|0|||
125669922|NCT03347695|452079710|FG001|Overall Study|Lost to Follow-up|1|||
125669923|NCT01003886|452079715|FG000|Overall Study|Lack of Efficacy|5|||
125669924|NCT01003886|452079715|FG000|Overall Study|Lost to Follow-up|169|||
125669925|NCT01003886|452079715|FG000|Overall Study|Withdrawal by Subject|39|||
125669926|NCT01003886|452079715|FG000|Overall Study|Other|14|||
125669927|NCT01003886|452079715|FG000|Overall Study|Adverse Event|3|||
125669928|NCT03907280|452079716|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
125669929|NCT03907280|452079717|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
125669930|NCT03907280|452079718|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
125669931|NCT00673361|452079723|FG000|Overall Study|Screen Failure|2|||
125669932|NCT00829413|452079724|FG000|Overall Study|No study drug admimnistered|13|||
125669933|NCT00829413|452079724|FG000|Overall Study|Training Patients|67|||
125669934|NCT00829413|452079724|FG000|Overall Study|No truth standard procedure available|9|||
125669935|NCT00829413|452079724|FG000|Overall Study|Technically inadequate truth standard|2|||
125669936|NCT00829413|452079724|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
125669937|NCT01464827|452079725|FG000|Overall Study|Adverse Event|0|||
125669938|NCT01464827|452079726|FG001|Overall Study|Adverse Event|0|||
125669939|NCT01464827|452079727|FG002|Overall Study|Adverse Event|0|||
125669940|NCT01464827|452079728|FG003|Overall Study|Adverse Event|0|||
125669941|NCT01464827|452079729|FG004|Overall Study|Adverse Event|0|||
125332585|NCT00092443|450849124|FG001|Overall Study|Other|13|||
125332586|NCT03207763|450850505|FG000|Overall Study|Lost to Follow-up|1|||
125332587|NCT03207763|450850506|FG001|Overall Study|Lost to Follow-up|0|||
125332588|NCT02605122|450850507|FG000|Overall Study|Withdrawal by Subject|4|||
125332589|NCT02605122|450850508|FG001|Overall Study|Withdrawal by Subject|1|||
125332590|NCT02605122|450850507|FG000|Overall Study|Lost to Follow-up|1|||
125332591|NCT02605122|450850508|FG001|Overall Study|Lost to Follow-up|1|||
125332592|NCT00807001|450850510|FG000|Overall Study|Non-compliance|0|||
125332593|NCT00807001|450850511|FG001|Overall Study|Non-compliance|1|||
125332594|NCT00807001|450850512|FG002|Overall Study|Non-compliance|0|||
125332595|NCT00807001|450850513|FG003|Overall Study|Non-compliance|0|||
125332596|NCT00807001|450850514|FG004|Overall Study|Non-compliance|0|||
125332597|NCT00854113|450850515|FG000|Overall Study|Adverse Event|0|||
125332598|NCT00854113|450850516|FG001|Overall Study|Adverse Event|0|||
125332599|NCT00854113|450850517|FG002|Overall Study|Adverse Event|0|||
125332600|NCT00854113|450850518|FG003|Overall Study|Adverse Event|0|||
125332601|NCT00854113|450850519|FG004|Overall Study|Adverse Event|0|||
125332602|NCT00854113|450850520|FG005|Overall Study|Adverse Event|0|||
125332603|NCT00854113|450850521|FG006|Overall Study|Adverse Event|0|||
125332604|NCT00854113|450850522|FG007|Overall Study|Adverse Event|2|||
125332605|NCT00854113|450850523|FG008|Overall Study|Adverse Event|0|||
125332606|NCT00854113|450850524|FG009|Overall Study|Adverse Event|0|||
125332607|NCT00854113|450850525|FG010|Overall Study|Adverse Event|0|||
125332608|NCT00854113|450850515|FG000|Overall Study|Withdrawal by Subject|0|||
125332609|NCT00854113|450850516|FG001|Overall Study|Withdrawal by Subject|0|||
125332610|NCT00854113|450850517|FG002|Overall Study|Withdrawal by Subject|0|||
125332611|NCT00854113|450850518|FG003|Overall Study|Withdrawal by Subject|0|||
125332612|NCT00854113|450850519|FG004|Overall Study|Withdrawal by Subject|0|||
125332613|NCT00854113|450850520|FG005|Overall Study|Withdrawal by Subject|0|||
125332614|NCT00854113|450850521|FG006|Overall Study|Withdrawal by Subject|0|||
125332615|NCT00854113|450850522|FG007|Overall Study|Withdrawal by Subject|1|||
125332616|NCT00854113|450850523|FG008|Overall Study|Withdrawal by Subject|1|||
125332617|NCT00854113|450850524|FG009|Overall Study|Withdrawal by Subject|0|||
125332618|NCT00854113|450850525|FG010|Overall Study|Withdrawal by Subject|0|||
125332619|NCT02273596|450850529|FG000|24-Week Treatment Period|Adverse Event|3|||
125332620|NCT02273596|450850529|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
125332621|NCT02273596|450850529|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
125332622|NCT02273596|450850529|FG000|24-Week Treatment Period|Physician Decision|1|||
125332623|NCT02273596|450850529|FG000|24-Week Treatment Period|Protocol Deviation|1|||
125332624|NCT02273596|450850529|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
125332625|NCT02273596|450850529|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
125332626|NCT02273596|450850529|FG000|Extension Period|Lost to Follow-up|1|||
125332627|NCT02273596|450850529|FG000|Extension Period|Protocol Deviation|1|||
125332628|NCT02604160|450850530|FG000|Overall Study|Protocol Violation|0|||
125332629|NCT02604160|450850531|FG001|Overall Study|Protocol Violation|1|||
125332630|NCT02604160|450850530|FG000|Overall Study|Physician Decision|0|||
125332631|NCT02604160|450850531|FG001|Overall Study|Physician Decision|1|||
125332632|NCT01596062|450850532|FG000|Overall Study|Adverse Event|1|||
125332633|NCT01596062|450850533|FG001|Overall Study|Adverse Event|0|||
125332634|NCT01596062|450850534|FG002|Overall Study|Adverse Event|2|||
125332635|NCT01596062|450850532|FG000|Overall Study|Lack of Efficacy|0|||
125332636|NCT01596062|450850533|FG001|Overall Study|Lack of Efficacy|0|||
125332637|NCT01596062|450850534|FG002|Overall Study|Lack of Efficacy|1|||
125332638|NCT02139592|450850535|FG000|Overall Study|Case Report Forms Uncollected|8|||
125669942|NCT01464827|452079730|FG005|Overall Study|Adverse Event|0|||
125669943|NCT01464827|452079731|FG006|Overall Study|Adverse Event|0|||
125332639|NCT03180840|450850536|FG000|Overall Study|Withdrawal by Subject|1|||
125332640|NCT01413204|450850546|FG000|Overall Study|Adverse Event|1|||
125332641|NCT01413204|450850547|FG001|Overall Study|Adverse Event|2|||
125332642|NCT01413204|450850548|FG002|Overall Study|Adverse Event|2|||
125332643|NCT01413204|450850546|FG000|Overall Study|Physician Decision|3|||
125332644|NCT01413204|450850547|FG001|Overall Study|Physician Decision|0|||
125332645|NCT01413204|450850548|FG002|Overall Study|Physician Decision|2|||
125332646|NCT01413204|450850546|FG000|Overall Study|Withdrawal by Subject|1|||
125332647|NCT01413204|450850547|FG001|Overall Study|Withdrawal by Subject|4|||
125332648|NCT01413204|450850548|FG002|Overall Study|Withdrawal by Subject|4|||
125332649|NCT01413204|450850546|FG000|Overall Study|Clearly not eligible for the study|0|||
125332650|NCT01413204|450850547|FG001|Overall Study|Clearly not eligible for the study|0|||
125332651|NCT01413204|450850548|FG002|Overall Study|Clearly not eligible for the study|1|||
125332652|NCT01413204|450850546|FG000|Overall Study|Fasting plasma glucose level increased|1|||
125332653|NCT01413204|450850547|FG001|Overall Study|Fasting plasma glucose level increased|0|||
125332654|NCT01413204|450850548|FG002|Overall Study|Fasting plasma glucose level increased|10|||
125332655|NCT00123422|450850549|FG000|Overall Study|Physician Decision|2|||
125332656|NCT00123422|450850550|FG001|Overall Study|Physician Decision|2|||
125332657|NCT00123422|450850551|FG002|Overall Study|Physician Decision|6|||
125332658|NCT00123422|450850549|FG000|Overall Study|Withdrawal by Subject|1|||
125332659|NCT00123422|450850550|FG001|Overall Study|Withdrawal by Subject|2|||
125332660|NCT00123422|450850551|FG002|Overall Study|Withdrawal by Subject|2|||
125332661|NCT00123422|450850549|FG000|Overall Study|Lost to Follow-up|1|||
125332662|NCT00123422|450850550|FG001|Overall Study|Lost to Follow-up|2|||
125332663|NCT00123422|450850551|FG002|Overall Study|Lost to Follow-up|2|||
125332664|NCT04555616|450850552|FG000|Overall Study|Death|1|||
125332665|NCT04555616|450850553|FG001|Overall Study|Death|0|||
125332666|NCT04555616|450850554|FG002|Overall Study|Death|1|||
125332667|NCT04555616|450850552|FG000|Overall Study|Withdrawal by Subject|2|||
125332668|NCT04555616|450850553|FG001|Overall Study|Withdrawal by Subject|1|||
125332669|NCT04555616|450850554|FG002|Overall Study|Withdrawal by Subject|0|||
125332670|NCT04816669|450850557|FG000|Part 1|Adverse Event|1|||
125332671|NCT04816669|450850558|FG001|Part 1|Adverse Event|1|||
125332672|NCT04816669|450850559|FG002|Part 1|Adverse Event|0|||
125332673|NCT04816669|450850560|FG003|Part 1|Adverse Event|0|||
125332674|NCT04816669|450850557|FG000|Part 1|Lost to Follow-up|2|||
125332675|NCT04816669|450850558|FG001|Part 1|Lost to Follow-up|2|||
125332676|NCT04816669|450850559|FG002|Part 1|Lost to Follow-up|0|||
125332677|NCT04816669|450850560|FG003|Part 1|Lost to Follow-up|0|||
125332678|NCT04816669|450850557|FG000|Part 1|Protocol Violation|0|||
125332679|NCT04816669|450850558|FG001|Part 1|Protocol Violation|1|||
125332680|NCT04816669|450850559|FG002|Part 1|Protocol Violation|0|||
125332681|NCT04816669|450850560|FG003|Part 1|Protocol Violation|0|||
125332682|NCT04816669|450850557|FG000|Part 1|Withdrawal by Subject|1|||
125332683|NCT04816669|450850558|FG001|Part 1|Withdrawal by Subject|2|||
125332684|NCT04816669|450850559|FG002|Part 1|Withdrawal by Subject|0|||
125332685|NCT04816669|450850560|FG003|Part 1|Withdrawal by Subject|0|||
125332686|NCT04816669|450850557|FG000|Part 2|Other|0|||
125332687|NCT04816669|450850558|FG001|Part 2|Other|0|||
125332688|NCT04816669|450850559|FG002|Part 2|Other|1|||
125332689|NCT04816669|450850560|FG003|Part 2|Other|0|||
125332690|NCT04816669|450850557|FG000|Part 2|Withdrawal by Subject|0|||
125332691|NCT04816669|450850558|FG001|Part 2|Withdrawal by Subject|0|||
125332692|NCT04816669|450850559|FG002|Part 2|Withdrawal by Subject|0|||
125332693|NCT04816669|450850560|FG003|Part 2|Withdrawal by Subject|1|||
125332694|NCT04816669|450850557|FG000|Part 2|Lost to Follow-up|0|||
125332695|NCT04816669|450850558|FG001|Part 2|Lost to Follow-up|0|||
125332696|NCT04816669|450850559|FG002|Part 2|Lost to Follow-up|1|||
125332697|NCT04816669|450850560|FG003|Part 2|Lost to Follow-up|0|||
125332698|NCT01229267|450850561|FG000|Overall Study|Adverse Event|4|||
125669944|NCT01464827|452079732|FG007|Overall Study|Adverse Event|0|||
125669945|NCT01464827|452079733|FG008|Overall Study|Adverse Event|0|||
125669946|NCT01464827|452079734|FG009|Overall Study|Adverse Event|0|||
125669947|NCT01464827|452079735|FG010|Overall Study|Adverse Event|0|||
125669948|NCT01464827|452079736|FG011|Overall Study|Adverse Event|0|||
125669949|NCT01464827|452079737|FG012|Overall Study|Adverse Event|1|||
125332699|NCT01229267|450850562|FG001|Overall Study|Adverse Event|6|||
125332700|NCT01229267|450850563|FG002|Overall Study|Adverse Event|3|||
125332701|NCT01229267|450850564|FG003|Overall Study|Adverse Event|2|||
125332702|NCT01229267|450850565|FG004|Overall Study|Adverse Event|10|||
125332703|NCT01229267|450850561|FG000|Overall Study|Death|40|||
125332704|NCT01229267|450850562|FG001|Overall Study|Death|37|||
125332705|NCT01229267|450850563|FG002|Overall Study|Death|35|||
125332706|NCT01229267|450850564|FG003|Overall Study|Death|13|||
125332707|NCT01229267|450850565|FG004|Overall Study|Death|103|||
125332708|NCT01229267|450850561|FG000|Overall Study|Withdrawal by Subject|23|||
125332709|NCT01229267|450850562|FG001|Overall Study|Withdrawal by Subject|22|||
125332710|NCT01229267|450850563|FG002|Overall Study|Withdrawal by Subject|32|||
125332711|NCT01229267|450850564|FG003|Overall Study|Withdrawal by Subject|14|||
125332712|NCT01229267|450850565|FG004|Overall Study|Withdrawal by Subject|59|||
125669950|NCT01464827|452079738|FG013|Overall Study|Adverse Event|0|||
125332713|NCT01229267|450850561|FG000|Overall Study|Protocol Violation|0|||
125332714|NCT01229267|450850562|FG001|Overall Study|Protocol Violation|1|||
125332715|NCT01229267|450850563|FG002|Overall Study|Protocol Violation|0|||
125332716|NCT01229267|450850564|FG003|Overall Study|Protocol Violation|0|||
125332717|NCT01229267|450850565|FG004|Overall Study|Protocol Violation|0|||
125332718|NCT01229267|450850561|FG000|Overall Study|Progressive disease|0|||
125332719|NCT01229267|450850562|FG001|Overall Study|Progressive disease|0|||
125332720|NCT01229267|450850563|FG002|Overall Study|Progressive disease|0|||
125332721|NCT01229267|450850564|FG003|Overall Study|Progressive disease|0|||
125332722|NCT01229267|450850565|FG004|Overall Study|Progressive disease|1|||
125332723|NCT01229267|450850561|FG000|Overall Study|Physician Decision|8|||
125332724|NCT01229267|450850562|FG001|Overall Study|Physician Decision|11|||
125332725|NCT01229267|450850563|FG002|Overall Study|Physician Decision|8|||
125332726|NCT01229267|450850564|FG003|Overall Study|Physician Decision|3|||
125332727|NCT01229267|450850565|FG004|Overall Study|Physician Decision|25|||
125332728|NCT01229267|450850561|FG000|Overall Study|Lost to Follow-up|6|||
125332729|NCT01229267|450850562|FG001|Overall Study|Lost to Follow-up|5|||
125332730|NCT01229267|450850563|FG002|Overall Study|Lost to Follow-up|8|||
125332731|NCT01229267|450850564|FG003|Overall Study|Lost to Follow-up|3|||
125332732|NCT01229267|450850565|FG004|Overall Study|Lost to Follow-up|22|||
125332733|NCT01358721|450850568|FG000|Overall Study|Withdrawal by Subject|0|||
125332734|NCT01358721|450850569|FG001|Overall Study|Withdrawal by Subject|0|||
125332735|NCT01358721|450850570|FG002|Overall Study|Withdrawal by Subject|0|||
125332736|NCT01358721|450850571|FG003|Overall Study|Withdrawal by Subject|1|||
125332737|NCT01358721|450850568|FG000|Overall Study|Death|0|||
125332738|NCT01358721|450850569|FG001|Overall Study|Death|2|||
125332739|NCT01358721|450850570|FG002|Overall Study|Death|0|||
125332740|NCT01358721|450850571|FG003|Overall Study|Death|0|||
125332741|NCT01358721|450850568|FG000|Overall Study|Study Drug Toxicity|1|||
125332742|NCT01358721|450850569|FG001|Overall Study|Study Drug Toxicity|3|||
125332743|NCT01358721|450850570|FG002|Overall Study|Study Drug Toxicity|4|||
125332744|NCT01358721|450850571|FG003|Overall Study|Study Drug Toxicity|5|||
125332745|NCT01358721|450850568|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
125332746|NCT01358721|450850569|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
125332747|NCT01358721|450850570|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
125332748|NCT01358721|450850571|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
125332749|NCT01358721|450850568|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
125332750|NCT01358721|450850569|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
125332751|NCT01358721|450850570|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
125332752|NCT01358721|450850571|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
125332753|NCT01358721|450850568|FG000|Overall Study|Adverse Event related to study drug|1|||
125332754|NCT01358721|450850569|FG001|Overall Study|Adverse Event related to study drug|0|||
125332755|NCT01358721|450850570|FG002|Overall Study|Adverse Event related to study drug|0|||
125332756|NCT01358721|450850571|FG003|Overall Study|Adverse Event related to study drug|1|||
125332757|NCT01358721|450850568|FG000|Overall Study|Disease Progression|19|||
125332758|NCT01358721|450850569|FG001|Overall Study|Disease Progression|15|||
125332759|NCT01358721|450850570|FG002|Overall Study|Disease Progression|17|||
125332760|NCT01358721|450850571|FG003|Overall Study|Disease Progression|15|||
125332761|NCT01358721|450850568|FG000|Overall Study|Out of State/Unmet Criteria|0|||
125332762|NCT01358721|450850569|FG001|Overall Study|Out of State/Unmet Criteria|0|||
125332763|NCT01358721|450850570|FG002|Overall Study|Out of State/Unmet Criteria|1|||
125332764|NCT01358721|450850571|FG003|Overall Study|Out of State/Unmet Criteria|0|||
125332765|NCT01908803|450850572|FG000|Overall Study|Adverse Event|1|||
125332766|NCT01908803|450850573|FG001|Overall Study|Adverse Event|0|||
125332767|NCT01908803|450850572|FG000|Overall Study|Physician Decision|0|||
125332768|NCT01908803|450850573|FG001|Overall Study|Physician Decision|1|||
125332769|NCT01908803|450850572|FG000|Overall Study|Withdrawal by Subject|1|||
125332770|NCT01908803|450850573|FG001|Overall Study|Withdrawal by Subject|0|||
125332771|NCT01908803|450850572|FG000|Overall Study|Randomization Error|1|||
125332772|NCT01908803|450850573|FG001|Overall Study|Randomization Error|0|||
125332773|NCT01908803|450850572|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
125332774|NCT01908803|450850573|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
125332775|NCT00867815|450850574|FG000|Overall Study|Lost to Follow-up|1|||
125332776|NCT01864603|450850575|FG000|Stage 2|DSMB design modification|86056|||
125332777|NCT01864603|450850576|FG001|Stage 2|DSMB design modification|92558|||
125332778|NCT02446899|450850577|FG000|Overall Study|Adverse Event|4|||
125332779|NCT02446899|450850578|FG001|Overall Study|Adverse Event|7|||
125332780|NCT02446899|450850577|FG000|Overall Study|Condition Under Investigation Worsened|1|||
125332781|NCT02446899|450850578|FG001|Overall Study|Condition Under Investigation Worsened|4|||
125332782|NCT02446899|450850577|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
125332783|NCT02446899|450850578|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
125332784|NCT02446899|450850577|FG000|Overall Study|Lack of Efficacy|2|||
125332785|NCT02446899|450850578|FG001|Overall Study|Lack of Efficacy|8|||
125332786|NCT02446899|450850577|FG000|Overall Study|Lost to Follow-up|1|||
125332787|NCT02446899|450850578|FG001|Overall Study|Lost to Follow-up|3|||
125332788|NCT02446899|450850577|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
125332789|NCT02446899|450850578|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
125332790|NCT02446899|450850577|FG000|Overall Study|Withdrawal by Subject|11|||
125332791|NCT02446899|450850578|FG001|Overall Study|Withdrawal by Subject|19|||
125332792|NCT02446899|450850577|FG000|Overall Study|Miscellaneous|5|||
125332793|NCT02446899|450850578|FG001|Overall Study|Miscellaneous|4|||
125332794|NCT02446899|450850577|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
125332795|NCT02446899|450850578|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
125332796|NCT04050202|450850579|FG000|Overall Study|Lost to Follow-up|2|||
125332797|NCT00001213|450850580|FG000|Overall Study|Death|18|||
125332798|NCT01554241|450850582|FG000|Overall Study|Death|3|||
125332799|NCT01554241|450850583|FG001|Overall Study|Death|1|||
125332800|NCT01554241|450850584|FG002|Overall Study|Death|1|||
125669951|NCT01464827|452079725|FG000|Overall Study|Withdrawal by Subject|1|||
125669952|NCT01464827|452079726|FG001|Overall Study|Withdrawal by Subject|0|||
125669953|NCT01464827|452079727|FG002|Overall Study|Withdrawal by Subject|0|||
125669954|NCT01464827|452079728|FG003|Overall Study|Withdrawal by Subject|0|||
125669955|NCT01464827|452079729|FG004|Overall Study|Withdrawal by Subject|1|||
125669956|NCT01464827|452079730|FG005|Overall Study|Withdrawal by Subject|0|||
125332801|NCT01554241|450850585|FG003|Overall Study|Death|0|||
125332802|NCT01554241|450850582|FG000|Overall Study|protocol specified renal stone|0|||
125332803|NCT01554241|450850583|FG001|Overall Study|protocol specified renal stone|0|||
125332804|NCT01554241|450850584|FG002|Overall Study|protocol specified renal stone|0|||
125332805|NCT01554241|450850585|FG003|Overall Study|protocol specified renal stone|1|||
125332806|NCT01554241|450850582|FG000|Overall Study|protocol specified change in eGFR|0|||
125332807|NCT01554241|450850583|FG001|Overall Study|protocol specified change in eGFR|0|||
125332808|NCT01554241|450850584|FG002|Overall Study|protocol specified change in eGFR|1|||
125332809|NCT01554241|450850585|FG003|Overall Study|protocol specified change in eGFR|0|||
125332810|NCT01554241|450850582|FG000|Overall Study|Withdrawal by Subject|0|||
125332811|NCT01554241|450850583|FG001|Overall Study|Withdrawal by Subject|0|||
125332812|NCT01554241|450850584|FG002|Overall Study|Withdrawal by Subject|2|||
125332813|NCT01554241|450850585|FG003|Overall Study|Withdrawal by Subject|0|||
125332814|NCT02974543|450850590|FG000|Overall Study|Withdrawal by Subject|1|||
125332815|NCT02974543|450850591|FG001|Overall Study|Withdrawal by Subject|0|||
125332816|NCT00742235|450850592|FG000|Overall Study|Lost to Follow-up|0|||
125332817|NCT00742235|450850593|FG001|Overall Study|Lost to Follow-up|31|||
125332818|NCT01237899|450850594|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
125332819|NCT01237899|450850595|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
125332820|NCT01237899|450850596|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
125332821|NCT01237899|450850597|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
125332822|NCT01237899|450850598|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
125332823|NCT01237899|450850599|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
125332824|NCT01237899|450850600|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
125332825|NCT01237899|450850601|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
125332826|NCT01237899|450850602|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
125669957|NCT01464827|452079731|FG006|Overall Study|Withdrawal by Subject|0|||
125669958|NCT01464827|452079732|FG007|Overall Study|Withdrawal by Subject|1|||
125669959|NCT01464827|452079733|FG008|Overall Study|Withdrawal by Subject|0|||
125669960|NCT01464827|452079734|FG009|Overall Study|Withdrawal by Subject|0|||
125669961|NCT01464827|452079735|FG010|Overall Study|Withdrawal by Subject|0|||
125669962|NCT01464827|452079736|FG011|Overall Study|Withdrawal by Subject|0|||
125669963|NCT01464827|452079737|FG012|Overall Study|Withdrawal by Subject|0|||
125669964|NCT01464827|452079738|FG013|Overall Study|Withdrawal by Subject|0|||
125669965|NCT01464827|452079725|FG000|Overall Study|Lost to Follow-up|0|||
125669966|NCT01464827|452079726|FG001|Overall Study|Lost to Follow-up|2|||
125669967|NCT01464827|452079727|FG002|Overall Study|Lost to Follow-up|0|||
125669968|NCT01464827|452079728|FG003|Overall Study|Lost to Follow-up|2|||
125669969|NCT01464827|452079729|FG004|Overall Study|Lost to Follow-up|3|||
125669970|NCT01464827|452079730|FG005|Overall Study|Lost to Follow-up|1|||
125669971|NCT01464827|452079731|FG006|Overall Study|Lost to Follow-up|2|||
125669972|NCT01464827|452079732|FG007|Overall Study|Lost to Follow-up|2|||
125669973|NCT01464827|452079733|FG008|Overall Study|Lost to Follow-up|0|||
125669974|NCT01464827|452079734|FG009|Overall Study|Lost to Follow-up|0|||
125669975|NCT01464827|452079735|FG010|Overall Study|Lost to Follow-up|0|||
125669976|NCT01464827|452079736|FG011|Overall Study|Lost to Follow-up|1|||
125669977|NCT01464827|452079737|FG012|Overall Study|Lost to Follow-up|0|||
125669978|NCT01464827|452079738|FG013|Overall Study|Lost to Follow-up|1|||
125669979|NCT01464827|452079725|FG000|Overall Study|Other|2|||
125669980|NCT01464827|452079726|FG001|Overall Study|Other|3|||
125669981|NCT01464827|452079727|FG002|Overall Study|Other|0|||
125332827|NCT01237899|450850603|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
125332828|NCT01237899|450850604|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
125669982|NCT01464827|452079728|FG003|Overall Study|Other|2|||
125669983|NCT01464827|452079729|FG004|Overall Study|Other|3|||
125669984|NCT01464827|452079730|FG005|Overall Study|Other|0|||
125669985|NCT01464827|452079731|FG006|Overall Study|Other|1|||
125669986|NCT01464827|452079732|FG007|Overall Study|Other|0|||
125669987|NCT01464827|452079733|FG008|Overall Study|Other|3|||
125669988|NCT01464827|452079734|FG009|Overall Study|Other|1|||
125332829|NCT02141438|450850606|FG000|Overall Study|Death|1308|||
125332830|NCT02141438|450850606|FG000|Overall Study|Lost to Follow-up|84|||
125332831|NCT02141438|450850606|FG000|Overall Study|Withdrawal by Subject|52|||
125332832|NCT02141438|450850606|FG000|Overall Study|Physician Decision|1|||
125332833|NCT02141438|450850606|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
125332834|NCT05661409|450850607|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
125332835|NCT05661409|450850608|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
125332836|NCT05661409|450850609|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
125332837|NCT05661409|450850610|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
125332838|NCT05661409|450850611|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
125332839|NCT05661409|450850612|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
125332840|NCT05661409|450850607|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
125332841|NCT05661409|450850608|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
125332842|NCT05661409|450850609|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
125332843|NCT05661409|450850610|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
125332844|NCT05661409|450850611|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
125332845|NCT05661409|450850612|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
125332846|NCT05661409|450850607|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
125332847|NCT05661409|450850608|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
125332848|NCT05661409|450850609|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
125332849|NCT05661409|450850610|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
125332850|NCT05661409|450850611|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
125332851|NCT05661409|450850612|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
125332852|NCT05661409|450850607|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
125332853|NCT05661409|450850608|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
125332854|NCT05661409|450850609|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
125332855|NCT05661409|450850610|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
125332856|NCT05661409|450850611|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
125332857|NCT05661409|450850612|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
125332858|NCT05661409|450850607|FG000|Overall Study|Miscommu-nication about administration|0|||
125332859|NCT05661409|450850608|FG001|Overall Study|Miscommu-nication about administration|0|||
125332860|NCT05661409|450850609|FG002|Overall Study|Miscommu-nication about administration|0|||
125332861|NCT05661409|450850610|FG003|Overall Study|Miscommu-nication about administration|0|||
125332862|NCT05661409|450850611|FG004|Overall Study|Miscommu-nication about administration|0|||
125332863|NCT05661409|450850612|FG005|Overall Study|Miscommu-nication about administration|1|||
125332864|NCT05782179|450850613|FG000|Overall Study|Adverse Event|0|||
125332865|NCT05782179|450850614|FG001|Overall Study|Adverse Event|0|||
125332866|NCT05782179|450850615|FG002|Overall Study|Adverse Event|2|||
125332867|NCT05782179|450850616|FG003|Overall Study|Adverse Event|0|||
125332868|NCT05782179|450850617|FG004|Overall Study|Adverse Event|0|||
125332869|NCT05782179|450850618|FG005|Overall Study|Adverse Event|0|||
125332870|NCT03675321|450850619|FG000|Overall Study|Lack of Efficacy|2|||
125332871|NCT03675321|450850620|FG001|Overall Study|Lack of Efficacy|2|||
125332872|NCT03675321|450850619|FG000|Overall Study|Withdrawal by Subject|1|||
125332873|NCT03675321|450850620|FG001|Overall Study|Withdrawal by Subject|3|||
125332874|NCT02999672|450850626|FG000|Overall Study|Death|0|||
125332875|NCT02999672|450850627|FG001|Overall Study|Death|1|||
125332876|NCT02999672|450850626|FG000|Overall Study|Study Terminated by Sponsor|0|||
125332877|NCT02999672|450850627|FG001|Overall Study|Study Terminated by Sponsor|1|||
125332878|NCT02999672|450850626|FG000|Overall Study|Progressive Disease|9|||
125332879|NCT02999672|450850627|FG001|Overall Study|Progressive Disease|5|||
125669989|NCT01464827|452079735|FG010|Overall Study|Other|2|||
125669990|NCT01464827|452079736|FG011|Overall Study|Other|0|||
125669991|NCT01464827|452079737|FG012|Overall Study|Other|1|||
125669992|NCT01464827|452079738|FG013|Overall Study|Other|0|||
125669993|NCT01464827|452079725|FG000|Overall Study|Not Treated|0|||
125669994|NCT01464827|452079726|FG001|Overall Study|Not Treated|2|||
125669995|NCT01464827|452079727|FG002|Overall Study|Not Treated|0|||
125669996|NCT01464827|452079728|FG003|Overall Study|Not Treated|0|||
125669997|NCT01464827|452079729|FG004|Overall Study|Not Treated|1|||
125669998|NCT01464827|452079730|FG005|Overall Study|Not Treated|0|||
125669999|NCT01464827|452079731|FG006|Overall Study|Not Treated|1|||
125670000|NCT01464827|452079732|FG007|Overall Study|Not Treated|0|||
125332880|NCT02999672|450850626|FG000|Overall Study|Adverse Event|4|||
125332881|NCT02999672|450850627|FG001|Overall Study|Adverse Event|0|||
125332882|NCT03565497|450850628|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
125332883|NCT03565497|450850629|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
125332884|NCT03565497|450850630|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
125332885|NCT03565497|450850628|FG000|Overall Study|Lost to Follow-up|1|||
125332886|NCT03565497|450850629|FG001|Overall Study|Lost to Follow-up|1|||
125670001|NCT01464827|452079733|FG008|Overall Study|Not Treated|0|||
125670002|NCT01464827|452079734|FG009|Overall Study|Not Treated|2|||
125670003|NCT01464827|452079735|FG010|Overall Study|Not Treated|0|||
125670004|NCT01464827|452079736|FG011|Overall Study|Not Treated|1|||
125332887|NCT03565497|450850630|FG002|Overall Study|Lost to Follow-up|2|||
125332888|NCT03565497|450850628|FG000|Overall Study|Withdrawal by Subject|1|||
125332889|NCT03565497|450850629|FG001|Overall Study|Withdrawal by Subject|1|||
125332890|NCT03565497|450850630|FG002|Overall Study|Withdrawal by Subject|1|||
125332891|NCT02194985|450850633|FG000|Overall Study|Adverse Event|1|||
125332892|NCT02194985|450850633|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
125332893|NCT02194985|450850633|FG000|Overall Study|Physician Decision|4|||
125332894|NCT02194985|450850633|FG000|Overall Study|Lost to Follow-up|1|||
125332895|NCT02194985|450850633|FG000|Overall Study|Withdrawal by Subject|2|||
125332896|NCT02561832|450850634|FG000|Overall Study|Withdrawal by Subject|1|||
125332897|NCT02561832|450850635|FG001|Overall Study|Withdrawal by Subject|1|||
125332898|NCT02561832|450850634|FG000|Overall Study|Adverse Event|3|||
125670005|NCT01464827|452079737|FG012|Overall Study|Not Treated|0|||
125670006|NCT01464827|452079738|FG013|Overall Study|Not Treated|2|||
125670007|NCT04272775|452079739|FG000|Overall Study|Study Terminated by Sponsor|1|||
125670008|NCT04272775|452079740|FG001|Overall Study|Study Terminated by Sponsor|0|||
125670009|NCT04272775|452079739|FG000|Overall Study|Protocol Violation|0|||
125670010|NCT04272775|452079740|FG001|Overall Study|Protocol Violation|1|||
125670011|NCT04272775|452079739|FG000|Overall Study|Symptomatic Deterioration|1|||
125670012|NCT04272775|452079740|FG001|Overall Study|Symptomatic Deterioration|1|||
125670013|NCT04272775|452079739|FG000|Overall Study|Withdrawal by Subject|1|||
125670014|NCT04272775|452079740|FG001|Overall Study|Withdrawal by Subject|2|||
125670015|NCT04272775|452079739|FG000|Overall Study|Adverse Event|1|||
125670016|NCT04272775|452079740|FG001|Overall Study|Adverse Event|2|||
125670017|NCT04272775|452079739|FG000|Overall Study|Progressive Disease|3|||
125332899|NCT02561832|450850635|FG001|Overall Study|Adverse Event|0|||
125332900|NCT02561832|450850634|FG000|Overall Study|Disease progression|3|||
125332901|NCT02561832|450850635|FG001|Overall Study|Disease progression|3|||
125332902|NCT03048578|450850637|FG000|Overall Study|Withdrawal by Subject|5|||
125332903|NCT03048578|450850638|FG001|Overall Study|Withdrawal by Subject|6|||
125332904|NCT03048578|450850637|FG000|Overall Study|Lost to Follow-up|22|||
125332905|NCT03048578|450850638|FG001|Overall Study|Lost to Follow-up|10|||
125332906|NCT03048578|450850637|FG000|Overall Study|Adverse Event|1|||
125332907|NCT03048578|450850638|FG001|Overall Study|Adverse Event|2|||
125332908|NCT03048578|450850637|FG000|Overall Study|Terminated|3|||
125332909|NCT03048578|450850638|FG001|Overall Study|Terminated|2|||
125332910|NCT00996333|450850643|FG000|Overall Study|Screen failure|1|||
125332911|NCT00996333|450850643|FG000|Overall Study|Withdrawal by Subject|1|||
125332912|NCT00996333|450850643|FG000|Overall Study|Death|4|||
125332913|NCT00996333|450850643|FG000|Overall Study|Adverse Event|1|||
125332914|NCT00996333|450850643|FG000|Overall Study|Physician Decision|1|||
125332915|NCT00996333|450850643|FG000|Overall Study|Other|5|||
125332916|NCT01301027|450850645|FG000|Overall Study|Physician Decision|2|||
125332917|NCT01301027|450850646|FG001|Overall Study|Physician Decision|0|||
125332918|NCT01301027|450850645|FG000|Overall Study|Withdrawal by Subject|2|||
125332919|NCT01301027|450850646|FG001|Overall Study|Withdrawal by Subject|3|||
125332920|NCT01301027|450850645|FG000|Overall Study|Adverse Event|0|||
125332921|NCT01301027|450850646|FG001|Overall Study|Adverse Event|2|||
125332922|NCT01301027|450850645|FG000|Overall Study|Fracture|1|||
125332923|NCT01301027|450850646|FG001|Overall Study|Fracture|3|||
125332924|NCT01301027|450850645|FG000|Overall Study|Transplant|0|||
125332925|NCT01301027|450850646|FG001|Overall Study|Transplant|2|||
125332926|NCT01301027|450850645|FG000|Overall Study|Volume Overload|3|||
125332927|NCT01301027|450850646|FG001|Overall Study|Volume Overload|0|||
125332928|NCT00074490|450850647|FG000|Overall Study|Progressive malignancy|0|||
125332929|NCT00074490|450850648|FG001|Overall Study|Progressive malignancy|7|||
125332930|NCT00074490|450850649|FG002|Overall Study|Progressive malignancy|0|||
125332931|NCT00074490|450850650|FG003|Overall Study|Progressive malignancy|0|||
125332932|NCT00074490|450850651|FG004|Overall Study|Progressive malignancy|3|||
125332933|NCT00074490|450850652|FG005|Overall Study|Progressive malignancy|0|||
125670018|NCT04272775|452079740|FG001|Overall Study|Progressive Disease|1|||
125670019|NCT00124020|452079741|FG000|Overall Study|Death|67|||
125670020|NCT00124020|452079742|FG001|Overall Study|Death|71|||
125332934|NCT02722499|450850653|FG000|Overall Study|Lost to Follow-up|2|||
125332935|NCT02722499|450850654|FG001|Overall Study|Lost to Follow-up|0|||
125332936|NCT02722499|450850655|FG002|Overall Study|Lost to Follow-up|1|||
125332937|NCT03566485|450850657|FG000|Overall Study|Disease progression|5|||
125332938|NCT03566485|450850658|FG001|Overall Study|Disease progression|4|||
125332939|NCT03566485|450850657|FG000|Overall Study|Clinical progression|0|||
125332940|NCT03566485|450850658|FG001|Overall Study|Clinical progression|1|||
125332941|NCT03566485|450850657|FG000|Overall Study|Toxicity|0|||
125332942|NCT03566485|450850658|FG001|Overall Study|Toxicity|2|||
125332943|NCT04999852|450850659|FG000|Overall Study|Withdrawal by Subject|11|||
125332944|NCT04999852|450850660|FG001|Overall Study|Withdrawal by Subject|1|||
125332945|NCT04999852|450850659|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
125332946|NCT04999852|450850660|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
125670021|NCT00124020|452079741|FG000|Overall Study|Withdrawal by Subject|13|||
125670022|NCT00124020|452079742|FG001|Overall Study|Withdrawal by Subject|11|||
125670023|NCT00124020|452079741|FG000|Overall Study|Lost to Follow-up|5|||
125670024|NCT00124020|452079742|FG001|Overall Study|Lost to Follow-up|8|||
125670025|NCT00124020|452079741|FG000|Overall Study|Other|1|||
125670026|NCT00124020|452079742|FG001|Overall Study|Other|1|||
125332947|NCT02506244|450850661|FG000|Overall Study|Did not undergo active monitoring|458|||
125332948|NCT02506244|450850662|FG001|Overall Study|Did not undergo active monitoring|459|||
125332949|NCT02506244|450850663|FG002|Overall Study|Did not undergo active monitoring|0|||
125332950|NCT02840461|450850672|FG000|Overall Study|Adverse Event|1|||
125332951|NCT02840461|450850673|FG001|Overall Study|Adverse Event|5|||
125332952|NCT02840461|450850674|FG002|Overall Study|Adverse Event|3|||
125332953|NCT02840461|450850672|FG000|Overall Study|Lost to Follow-up|10|||
125332954|NCT02840461|450850673|FG001|Overall Study|Lost to Follow-up|7|||
125332955|NCT02840461|450850674|FG002|Overall Study|Lost to Follow-up|6|||
125332956|NCT02840461|450850672|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
125332957|NCT02840461|450850673|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
125332958|NCT02840461|450850674|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
125332959|NCT02840461|450850672|FG000|Overall Study|Protocol Violation|2|||
125332960|NCT02840461|450850673|FG001|Overall Study|Protocol Violation|3|||
125332961|NCT02840461|450850674|FG002|Overall Study|Protocol Violation|1|||
125332962|NCT02840461|450850672|FG000|Overall Study|Withdrawal by Subject|10|||
125332963|NCT02840461|450850673|FG001|Overall Study|Withdrawal by Subject|6|||
125332964|NCT02840461|450850674|FG002|Overall Study|Withdrawal by Subject|2|||
125332965|NCT02840461|450850672|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
125332966|NCT02840461|450850673|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
125332967|NCT02840461|450850674|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
125332968|NCT01737502|450850675|FG000|Phase I|Disease progression|2|||
125332969|NCT01737502|450850676|FG001|Phase I|Disease progression|3|||
125332970|NCT01737502|450850675|FG000|Phase I|Complicating disease|1|||
125332971|NCT01737502|450850676|FG001|Phase I|Complicating disease|0|||
125332972|NCT01737502|450850675|FG000|Phase II|Adverse Event|0|||
125332973|NCT01737502|450850676|FG001|Phase II|Adverse Event|3|||
125332974|NCT01737502|450850675|FG000|Phase II|Disease progression|0|||
125332975|NCT01737502|450850676|FG001|Phase II|Disease progression|18|||
125332976|NCT01737502|450850675|FG000|Phase II|Death|0|||
125332977|NCT01737502|450850676|FG001|Phase II|Death|1|||
125332978|NCT01737502|450850675|FG000|Phase II|Transition to hospice care|0|||
125332979|NCT01737502|450850676|FG001|Phase II|Transition to hospice care|1|||
125332980|NCT04672655|450850680|FG000|Overall Study|Lost to Follow-up|12|||
125332981|NCT04672655|450850681|FG001|Overall Study|Lost to Follow-up|17|||
125332982|NCT04672655|450850680|FG000|Overall Study|Withdrawal by Subject|1|||
125332983|NCT04672655|450850681|FG001|Overall Study|Withdrawal by Subject|0|||
125332984|NCT04672655|450850680|FG000|Overall Study|Withdrawal by Study|1|||
125332985|NCT04672655|450850681|FG001|Overall Study|Withdrawal by Study|0|||
125332986|NCT00494676|450850682|FG000|Allocation|Withdrawal by Subject|2|||
125332987|NCT00494676|450850683|FG001|Allocation|Withdrawal by Subject|4|||
125332988|NCT00494676|450850682|FG000|First Intervention|Withdrawal by Subject|1|||
125332989|NCT00494676|450850683|FG001|First Intervention|Withdrawal by Subject|3|||
125332990|NCT00494676|450850682|FG000|Second Intervention|Withdrawal by Subject|1|||
125332991|NCT00494676|450850683|FG001|Second Intervention|Withdrawal by Subject|1|||
125332992|NCT01932437|450852101|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125332993|NCT01932437|450852102|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125332994|NCT01932437|450852103|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125332995|NCT01932437|450852104|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125332996|NCT01932437|450852105|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
125332997|NCT01932437|450852106|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
125332998|NCT04638660|450852116|FG000|Overall Study|Withdrawal by Subject|2|||
125332999|NCT04638660|450852117|FG001|Overall Study|Withdrawal by Subject|0|||
125333000|NCT04638660|450852116|FG000|Overall Study|Lost to Follow-up|1|||
125333001|NCT04638660|450852117|FG001|Overall Study|Lost to Follow-up|0|||
125333002|NCT04939415|450852118|FG000|Overall Study|Withdrawal by Subject|1|||
125333003|NCT04939415|450852119|FG001|Overall Study|Withdrawal by Subject|3|||
125333004|NCT04939415|450852118|FG000|Overall Study|Lost to Follow-up|0|||
125333005|NCT04939415|450852119|FG001|Overall Study|Lost to Follow-up|2|||
125333006|NCT03399552|450852121|FG000|Overall Study|No evidence of disease|1|||
125333007|NCT03399552|450852121|FG000|Overall Study|Unevaluable|1|||
125333008|NCT01931566|450852122|FG000|Overall Study|Randomized But Not Treated|6|||
125333009|NCT01931566|450852123|FG001|Overall Study|Randomized But Not Treated|9|||
125333010|NCT01931566|450852124|FG002|Overall Study|Randomized But Not Treated|14|||
125333011|NCT01931566|450852122|FG000|Overall Study|Adverse Event|37|||
125333012|NCT01931566|450852123|FG001|Overall Study|Adverse Event|167|||
125670027|NCT00124020|452079741|FG000|Overall Study|Transfer to another hospital|2|||
125333013|NCT01931566|450852124|FG002|Overall Study|Adverse Event|132|||
125333014|NCT01931566|450852122|FG000|Overall Study|Major Protocol Deviation|5|||
125333015|NCT01931566|450852123|FG001|Overall Study|Major Protocol Deviation|14|||
125333016|NCT01931566|450852124|FG002|Overall Study|Major Protocol Deviation|21|||
125333017|NCT01931566|450852122|FG000|Overall Study|Lost to Follow-up|3|||
125333018|NCT01931566|450852123|FG001|Overall Study|Lost to Follow-up|26|||
125670028|NCT00124020|452079742|FG001|Overall Study|Transfer to another hospital|0|||
125333019|NCT01931566|450852124|FG002|Overall Study|Lost to Follow-up|23|||
125333020|NCT01931566|450852122|FG000|Overall Study|Voluntary Withdrawal|78|||
125333021|NCT01931566|450852123|FG001|Overall Study|Voluntary Withdrawal|245|||
125333022|NCT01931566|450852124|FG002|Overall Study|Voluntary Withdrawal|225|||
125333023|NCT01931566|450852122|FG000|Overall Study|Study Termination|289|||
125333024|NCT01931566|450852123|FG001|Overall Study|Study Termination|968|||
125333025|NCT01931566|450852124|FG002|Overall Study|Study Termination|1037|||
125333026|NCT01931566|450852122|FG000|Overall Study|Reason Not Specified|11|||
125333027|NCT01931566|450852123|FG001|Overall Study|Reason Not Specified|47|||
125333028|NCT01931566|450852124|FG002|Overall Study|Reason Not Specified|53|||
125333029|NCT01931566|450852122|FG000|Overall Study|Missing|0|||
125333030|NCT01931566|450852123|FG001|Overall Study|Missing|0|||
125333031|NCT01931566|450852124|FG002|Overall Study|Missing|1|||
125333032|NCT00611026|450852128|FG000|Randomized to Double-blind Treatment|Not treated|2|||
125333033|NCT00611026|450852129|FG001|Randomized to Double-blind Treatment|Not treated|1|||
125333034|NCT00611026|450852130|FG002|Randomized to Double-blind Treatment|Not treated|3|||
125333035|NCT00611026|450852128|FG000|Double-blind Treatment Period|Death|1|||
125333036|NCT00611026|450852129|FG001|Double-blind Treatment Period|Death|0|||
125333037|NCT00611026|450852130|FG002|Double-blind Treatment Period|Death|0|||
125333038|NCT00611026|450852128|FG000|Double-blind Treatment Period|Adverse Event|9|||
125333039|NCT00611026|450852129|FG001|Double-blind Treatment Period|Adverse Event|28|||
125333040|NCT00611026|450852130|FG002|Double-blind Treatment Period|Adverse Event|46|||
125333041|NCT00611026|450852128|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
125333042|NCT00611026|450852129|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
125333043|NCT00611026|450852130|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
125333044|NCT00611026|450852128|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
125333045|NCT00611026|450852129|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
125333046|NCT00611026|450852130|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
125333047|NCT00611026|450852128|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
125333048|NCT00611026|450852129|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
125333049|NCT00611026|450852130|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
125333050|NCT00611026|450852128|FG000|Double-blind Treatment Period|Other|13|||
125333051|NCT00611026|450852129|FG001|Double-blind Treatment Period|Other|20|||
125333052|NCT00611026|450852130|FG002|Double-blind Treatment Period|Other|18|||
125333053|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
125333054|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
125333055|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
125333056|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
125333057|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
125333058|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
125333059|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
125333060|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125333061|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125333062|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333063|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
125333064|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333065|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333066|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333067|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
125333068|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
125333069|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
125333070|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
125333071|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125333072|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125333073|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125333074|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
125333075|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125333076|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
125333077|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125333078|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125333079|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125333080|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
125333081|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
125333082|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
125670029|NCT02043366|452079743|FG000|Overall Study|Lost to Follow-up|2|||
125670030|NCT02043366|452079744|FG001|Overall Study|Lost to Follow-up|2|||
125670031|NCT02043366|452079745|FG002|Overall Study|Lost to Follow-up|2|||
125333083|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
125670032|NCT02043366|452079746|FG003|Overall Study|Lost to Follow-up|2|||
125670033|NCT02043366|452079747|FG004|Overall Study|Lost to Follow-up|2|||
125333084|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
125333085|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
125333086|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
125333087|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
125333088|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
125333089|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333090|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333091|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333092|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333093|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333094|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333095|NCT05019521|450852131|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
125333096|NCT05019521|450852132|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333097|NCT05019521|450852133|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
125333098|NCT05019521|450852134|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
125333099|NCT05019521|450852135|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333100|NCT05019521|450852136|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333101|NCT05019521|450852137|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333102|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
125333103|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
125333104|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
125333105|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
125333106|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
125333107|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
125333108|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
125333109|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125333110|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
125333111|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125333112|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333113|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333114|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
125333115|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
125333116|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
125333117|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125333118|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125333119|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
125333120|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
125333121|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
125333122|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
125333123|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125333124|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
125333125|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
125333126|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125333127|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125333128|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125333129|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
125333130|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
125333131|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
125333132|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
125333133|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
125333134|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
125333135|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
125333136|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
125333137|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333138|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333139|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333140|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333141|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125333142|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
125333143|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
125670034|NCT02043366|452079748|FG005|Overall Study|Lost to Follow-up|2|||
125670035|NCT00891774|452079751|FG000|Overall Study|Lost to Follow-up|5|||
125333144|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
125333145|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
125333146|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
125333147|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333148|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333149|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
125333150|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
125333151|NCT05019521|450852131|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
125333152|NCT05019521|450852132|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
125333153|NCT05019521|450852133|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
125333154|NCT05019521|450852134|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
125333155|NCT05019521|450852135|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
125333156|NCT05019521|450852136|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
125333157|NCT05019521|450852137|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
125333158|NCT00760617|450852138|FG000|Overall Study|Adverse Event|5|||
125333159|NCT00760617|450852139|FG001|Overall Study|Adverse Event|2|||
125333160|NCT00760617|450852140|FG002|Overall Study|Adverse Event|0|||
125333161|NCT00760617|450852138|FG000|Overall Study|Lost to Follow-up|0|||
125333162|NCT00760617|450852139|FG001|Overall Study|Lost to Follow-up|0|||
125333163|NCT00760617|450852140|FG002|Overall Study|Lost to Follow-up|5|||
125333164|NCT04625101|450852141|FG000|Overall Study|Withdrawal by Subject|0|||
125333165|NCT04625101|450852142|FG001|Overall Study|Withdrawal by Subject|1|||
125333166|NCT04625101|450852141|FG000|Overall Study|Protocol Deviation|1|||
125333167|NCT04625101|450852142|FG001|Overall Study|Protocol Deviation|0|||
125333168|NCT02533453|450852150|FG000|Overall Study|Adverse Event|6|||
125333169|NCT02533453|450852150|FG000|Overall Study|Protocol Violation|1|||
125333170|NCT02533453|450852150|FG000|Overall Study|Withdrawal by Subject|2|||
125333171|NCT02039843|450852160|FG000|Randomization and Observation Period|Adverse Event|2|||
125333172|NCT02039843|450852161|FG001|Randomization and Observation Period|Adverse Event|0|||
125333173|NCT02039843|450852160|FG000|Randomization and Observation Period|Death|1|||
125333174|NCT02039843|450852161|FG001|Randomization and Observation Period|Death|0|||
125333175|NCT02039843|450852160|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
125333176|NCT02039843|450852161|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
125333177|NCT02039843|450852160|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
125333178|NCT02039843|450852161|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
125333179|NCT02039843|450852160|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
125333180|NCT02039843|450852161|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
125333181|NCT02039843|450852160|FG000|Pairing With a Study Dog|Death|1|||
125333182|NCT02039843|450852161|FG001|Pairing With a Study Dog|Death|0|||
125333183|NCT02039843|450852160|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
125333184|NCT02039843|450852161|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
125333185|NCT02039843|450852160|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
125333186|NCT02039843|450852161|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
125333187|NCT02039843|450852160|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
125333188|NCT02039843|450852161|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
125333189|NCT00806819|450852166|FG000|Overall Study|progressive disease (modified RECIST )|217|||
125333190|NCT00806819|450852167|FG001|Overall Study|progressive disease (modified RECIST )|216|||
125333191|NCT00806819|450852166|FG000|Overall Study|Worsening or AE of underlying disease|18|||
125333192|NCT00806819|450852167|FG001|Overall Study|Worsening or AE of underlying disease|25|||
125333193|NCT00806819|450852166|FG000|Overall Study|Other AE|38|||
125333194|NCT00806819|450852167|FG001|Overall Study|Other AE|40|||
125333195|NCT00806819|450852166|FG000|Overall Study|Protocol Violation|9|||
125333196|NCT00806819|450852167|FG001|Overall Study|Protocol Violation|4|||
125333197|NCT00806819|450852166|FG000|Overall Study|Lost to Follow-up|1|||
125333198|NCT00806819|450852167|FG001|Overall Study|Lost to Follow-up|0|||
125333199|NCT00806819|450852166|FG000|Overall Study|Withdrawal by Subject|32|||
125333200|NCT00806819|450852167|FG001|Overall Study|Withdrawal by Subject|29|||
125333201|NCT00806819|450852166|FG000|Overall Study|Not treated|6|||
125333202|NCT00806819|450852167|FG001|Overall Study|Not treated|3|||
125333203|NCT00806819|450852166|FG000|Overall Study|Reasons other than stated above|25|||
125333204|NCT00806819|450852167|FG001|Overall Study|Reasons other than stated above|41|||
125333205|NCT02752165|450852173|FG000|Overall Study|Withdrawal by Subject|6|||
125333206|NCT02752165|450852174|FG001|Overall Study|Withdrawal by Subject|6|||
125333207|NCT02752165|450852173|FG000|Overall Study|Protocol Violation|6|||
125333208|NCT02752165|450852174|FG001|Overall Study|Protocol Violation|5|||
125333209|NCT02752165|450852173|FG000|Overall Study|Lost to Follow-up|33|||
125670036|NCT00891774|452079751|FG000|Overall Study|Illness (Self/Mother)|3|||
125670037|NCT00891774|452079751|FG000|Overall Study|Withdrawal by Subject|2|||
125670038|NCT00891774|452079751|FG000|Overall Study|Protocol Violation|4|||
125333210|NCT02752165|450852174|FG001|Overall Study|Lost to Follow-up|38|||
125333211|NCT01704599|450852175|FG000|Overall Study|Adverse Event|1|||
125333212|NCT03843541|450852183|FG000|Overall Study|Adverse Event|4|||
125333213|NCT03843541|450852184|FG001|Overall Study|Adverse Event|2|||
125333214|NCT03843541|450852185|FG002|Overall Study|Adverse Event|3|||
125333215|NCT03843541|450852183|FG000|Overall Study|Death|1|||
125333216|NCT03843541|450852184|FG001|Overall Study|Death|0|||
125333217|NCT03843541|450852185|FG002|Overall Study|Death|0|||
125333218|NCT03843541|450852183|FG000|Overall Study|Lack of adherence to study medication|0|||
125333219|NCT03843541|450852184|FG001|Overall Study|Lack of adherence to study medication|0|||
125333220|NCT03843541|450852185|FG002|Overall Study|Lack of adherence to study medication|1|||
125333221|NCT03843541|450852183|FG000|Overall Study|Physician Decision|1|||
125333222|NCT03843541|450852184|FG001|Overall Study|Physician Decision|2|||
125333223|NCT03843541|450852185|FG002|Overall Study|Physician Decision|2|||
125333224|NCT03843541|450852183|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
125333225|NCT03843541|450852184|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
125670039|NCT01977092|452079753|FG000|Overall Study|Death|3|||
125670040|NCT01977092|452079754|FG001|Overall Study|Death|4|||
125670041|NCT01977092|452079753|FG000|Overall Study|Lost to Follow-up|23|||
125670042|NCT01977092|452079754|FG001|Overall Study|Lost to Follow-up|14|||
125333226|NCT03843541|450852185|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
125333227|NCT03843541|450852183|FG000|Overall Study|Withdrawal by Subject|6|||
125333228|NCT03843541|450852184|FG001|Overall Study|Withdrawal by Subject|9|||
125333229|NCT03843541|450852185|FG002|Overall Study|Withdrawal by Subject|7|||
125333230|NCT03843541|450852183|FG000|Overall Study|Administration of rescue mucolytic|0|||
125333231|NCT03843541|450852184|FG001|Overall Study|Administration of rescue mucolytic|0|||
125333232|NCT03843541|450852185|FG002|Overall Study|Administration of rescue mucolytic|1|||
125333233|NCT03843541|450852183|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
125333234|NCT03843541|450852184|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
125333235|NCT03843541|450852185|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
125333236|NCT05767749|450852194|FG000|Overall Study|Withdrawal by Subject|0|||
125333237|NCT05767749|450852195|FG001|Overall Study|Withdrawal by Subject|0|||
125333238|NCT05767749|450852196|FG002|Overall Study|Withdrawal by Subject|2|||
125333239|NCT05767749|450852197|FG003|Overall Study|Withdrawal by Subject|2|||
125333240|NCT05767749|450852198|FG004|Overall Study|Withdrawal by Subject|2|||
125333241|NCT05767749|450852199|FG005|Overall Study|Withdrawal by Subject|2|||
125333242|NCT01077050|450854007|FG000|Overall Study|Subjects signed ICF could not be located|1|||
125333243|NCT01077050|450854007|FG000|Overall Study|Screen failure|8|||
125333244|NCT03894813|450854008|FG000|Overall Study|Adverse Event|1|||
125333245|NCT03894813|450854009|FG001|Overall Study|Adverse Event|1|||
125333246|NCT03894813|450854008|FG000|Overall Study|Lack of Efficacy|3|||
125333247|NCT03894813|450854009|FG001|Overall Study|Lack of Efficacy|3|||
125333248|NCT03894813|450854008|FG000|Overall Study|Lost to Follow-up|1|||
125333249|NCT03894813|450854009|FG001|Overall Study|Lost to Follow-up|0|||
125333250|NCT03894813|450854008|FG000|Overall Study|Pregnancy|2|||
125333251|NCT03894813|450854009|FG001|Overall Study|Pregnancy|1|||
125333252|NCT03894813|450854008|FG000|Overall Study|Protocol Violation|3|||
125333253|NCT03894813|450854009|FG001|Overall Study|Protocol Violation|7|||
125333254|NCT03894813|450854008|FG000|Overall Study|Withdrawal by Subject|1|||
125333255|NCT03894813|450854009|FG001|Overall Study|Withdrawal by Subject|3|||
125333256|NCT03894813|450854008|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
125333257|NCT03894813|450854009|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
125333258|NCT03083873|450854011|FG000|Overall Study|Death|6|||
125333259|NCT03083873|450854012|FG001|Overall Study|Death|15|||
125333260|NCT03083873|450854013|FG002|Overall Study|Death|13|||
125333261|NCT03083873|450854014|FG003|Overall Study|Death|9|||
125333262|NCT03083873|450854015|FG004|Overall Study|Death|0|||
125333263|NCT03083873|450854011|FG000|Overall Study|Sponsor Terminated Study|0|||
125670043|NCT01977092|452079753|FG000|Overall Study|Withdrawal by Subject|2|||
125670044|NCT01977092|452079754|FG001|Overall Study|Withdrawal by Subject|1|||
125670045|NCT01977092|452079753|FG000|Overall Study|In prison|3|||
125670046|NCT01977092|452079754|FG001|Overall Study|In prison|11|||
125670047|NCT02927847|452079755|FG000|Overall Study|Lost to Follow-up|1|||
125670048|NCT02927847|452079756|FG001|Overall Study|Lost to Follow-up|0|||
125670049|NCT02927847|452079755|FG000|Overall Study|Withdrawal by Subject|4|||
125670050|NCT02927847|452079756|FG001|Overall Study|Withdrawal by Subject|2|||
125333264|NCT03083873|450854012|FG001|Overall Study|Sponsor Terminated Study|1|||
125333265|NCT03083873|450854013|FG002|Overall Study|Sponsor Terminated Study|2|||
125333266|NCT03083873|450854014|FG003|Overall Study|Sponsor Terminated Study|3|||
125333267|NCT03083873|450854015|FG004|Overall Study|Sponsor Terminated Study|0|||
125333268|NCT03083873|450854011|FG000|Overall Study|Lost to Follow-up|0|||
125333269|NCT03083873|450854012|FG001|Overall Study|Lost to Follow-up|1|||
125333270|NCT03083873|450854013|FG002|Overall Study|Lost to Follow-up|1|||
125670051|NCT02927847|452079755|FG000|Overall Study|PI withdrawn due to missed visits|1|||
125670052|NCT02927847|452079756|FG001|Overall Study|PI withdrawn due to missed visits|1|||
125333271|NCT03083873|450854014|FG003|Overall Study|Lost to Follow-up|0|||
125333272|NCT03083873|450854015|FG004|Overall Study|Lost to Follow-up|0|||
125333273|NCT03083873|450854011|FG000|Overall Study|Withdrawal by Subject|2|||
125333274|NCT03083873|450854012|FG001|Overall Study|Withdrawal by Subject|0|||
125333275|NCT03083873|450854013|FG002|Overall Study|Withdrawal by Subject|0|||
125333276|NCT03083873|450854014|FG003|Overall Study|Withdrawal by Subject|0|||
125333277|NCT03083873|450854015|FG004|Overall Study|Withdrawal by Subject|0|||
125333278|NCT03083873|450854011|FG000|Overall Study|Did Not Receive TIL|2|||
125333279|NCT03083873|450854012|FG001|Overall Study|Did Not Receive TIL|5|||
125333280|NCT03083873|450854013|FG002|Overall Study|Did Not Receive TIL|3|||
125333281|NCT03083873|450854014|FG003|Overall Study|Did Not Receive TIL|1|||
125333282|NCT03083873|450854015|FG004|Overall Study|Did Not Receive TIL|0|||
125333283|NCT01677377|450854016|FG000|Overall Study|Protocol Violation|1|||
125333284|NCT01677377|450854017|FG001|Overall Study|Protocol Violation|0|||
125333285|NCT01677377|450854018|FG002|Overall Study|Protocol Violation|0|||
125333286|NCT01677377|450854016|FG000|Overall Study|Lost to Follow-up|0|||
125333287|NCT01677377|450854017|FG001|Overall Study|Lost to Follow-up|1|||
125333288|NCT01677377|450854018|FG002|Overall Study|Lost to Follow-up|1|||
125333289|NCT01677377|450854016|FG000|Overall Study|Withdrawal by Subject|0|||
125333290|NCT01677377|450854017|FG001|Overall Study|Withdrawal by Subject|0|||
125333291|NCT01677377|450854018|FG002|Overall Study|Withdrawal by Subject|3|||
125333292|NCT01677377|450854016|FG000|Overall Study|Lack of Efficacy|0|||
125333293|NCT01677377|450854017|FG001|Overall Study|Lack of Efficacy|0|||
125333294|NCT01677377|450854018|FG002|Overall Study|Lack of Efficacy|1|||
125333295|NCT01677377|450854016|FG000|Overall Study|Pregnancy|0|||
125333296|NCT01677377|450854017|FG001|Overall Study|Pregnancy|0|||
125333297|NCT01677377|450854018|FG002|Overall Study|Pregnancy|1|||
125333298|NCT02656693|450854032|FG000|Overall Study|Pregnancy|1|||
125333299|NCT02656693|450854033|FG001|Overall Study|Pregnancy|1|||
125333300|NCT02656693|450854034|FG002|Overall Study|Pregnancy|1|||
125333301|NCT02656693|450854032|FG000|Overall Study|Bariatric surgery|0|||
125333302|NCT02656693|450854033|FG001|Overall Study|Bariatric surgery|1|||
125333303|NCT02656693|450854034|FG002|Overall Study|Bariatric surgery|2|||
125333304|NCT02269267|450854036|FG000|Overall Study|Death|5|||
125333305|NCT03773796|450854037|FG000|Overall Study|Adverse Event|1|||
125333306|NCT03773796|450854037|FG000|Overall Study|Withdrawal by Subject|1|||
125333307|NCT03773796|450854037|FG000|Overall Study|Lack of Efficacy|1|||
125333308|NCT03805659|450854039|FG000|Overall Study|Withdrawal by Subject|0|||
125333309|NCT03805659|450854040|FG001|Overall Study|Withdrawal by Subject|1|||
125333310|NCT00796419|450854041|FG000|Overall Study|Death|0|||
125333311|NCT00796419|450854042|FG001|Overall Study|Death|1|||
125333312|NCT01250145|450854043|FG000|Overall Study|Adverse Event|2|||
125333313|NCT01250145|450854044|FG001|Overall Study|Adverse Event|1|||
125333314|NCT01250145|450854043|FG000|Overall Study|Withdrawal by Subject|0|||
125333315|NCT01250145|450854044|FG001|Overall Study|Withdrawal by Subject|4|||
125333316|NCT01069900|450854046|FG000|Overall Study|Technical problems|0|||
125333317|NCT01069900|450854047|FG001|Overall Study|Technical problems|1|||
125333318|NCT01069900|450854046|FG000|Overall Study|Lost to Follow-up|7|||
125333319|NCT01069900|450854047|FG001|Overall Study|Lost to Follow-up|1|||
125333320|NCT01069900|450854046|FG000|Overall Study|Withdrawal by Subject|6|||
125333321|NCT01069900|450854047|FG001|Overall Study|Withdrawal by Subject|1|||
125333322|NCT01069900|450854046|FG000|Overall Study|Protocol Violation|4|||
125333323|NCT01069900|450854047|FG001|Overall Study|Protocol Violation|1|||
125333324|NCT01069900|450854046|FG000|Overall Study|Insufficient Therapeutic effect|1|||
125333325|NCT01069900|450854047|FG001|Overall Study|Insufficient Therapeutic effect|0|||
125333326|NCT02687191|450854049|FG000|Overall Study|Death|0|||
125333327|NCT02687191|450854050|FG001|Overall Study|Death|1|||
125333328|NCT02687191|450854051|FG002|Overall Study|Death|1|||
125333329|NCT02687191|450854052|FG003|Overall Study|Death|0|||
125333330|NCT02687191|450854053|FG004|Overall Study|Death|1|||
125333331|NCT02687191|450854054|FG005|Overall Study|Death|1|||
125333332|NCT02687191|450854049|FG000|Overall Study|Withdrawal by Subject|0|||
125333333|NCT02687191|450854050|FG001|Overall Study|Withdrawal by Subject|0|||
125670053|NCT00723554|452079757|FG000|Overall Study|Adverse Event|12|||
125670054|NCT00723554|452079757|FG000|Overall Study|Investigator's judgement|5|||
125670055|NCT00723554|452079757|FG000|Overall Study|Inhaled medication other than iloprost|4|||
125333334|NCT02687191|450854051|FG002|Overall Study|Withdrawal by Subject|0|||
125333335|NCT02687191|450854052|FG003|Overall Study|Withdrawal by Subject|1|||
125333336|NCT02687191|450854053|FG004|Overall Study|Withdrawal by Subject|0|||
125333337|NCT02687191|450854054|FG005|Overall Study|Withdrawal by Subject|0|||
125333338|NCT01788358|450854060|FG000|Overall Study|Other|11|||
125333339|NCT01788358|450854060|FG000|Overall Study|Logistical difficulties|1|||
125333340|NCT01788358|450854060|FG000|Overall Study|Lost to Follow-up|5|||
125333341|NCT01788358|450854060|FG000|Overall Study|Protocol Violation|3|||
125333342|NCT01788358|450854060|FG000|Overall Study|Withdrawal by Subject|26|||
125333343|NCT01788358|450854060|FG000|Overall Study|Lack of Efficacy|1|||
125333344|NCT01788358|450854060|FG000|Overall Study|Adverse Event|51|||
125333345|NCT01168219|450854061|FG000|Overall Study|off study before starting treatment|2|||
125333346|NCT01168219|450854061|FG000|Overall Study|withdrew before transplant|1|||
125670056|NCT00723554|452079757|FG000|Overall Study|Withdrawal of consent|3|||
125333347|NCT01168219|450854061|FG000|Overall Study|ineligible due to CML|2|||
125333348|NCT02736890|450854064|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
125333349|NCT02736890|450854065|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
125333350|NCT02736890|450854064|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
125333351|NCT02736890|450854065|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
125333352|NCT02873702|450854066|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
125333353|NCT02873702|450854067|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
125333354|NCT02873702|450854068|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
125333355|NCT02873702|450854069|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
125333356|NCT02873702|450854066|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
125333357|NCT02873702|450854067|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
125333358|NCT02873702|450854068|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
125333359|NCT02873702|450854069|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
125333360|NCT02873702|450854066|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
125333361|NCT02873702|450854067|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
125333362|NCT02873702|450854068|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
125333363|NCT02873702|450854069|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
125333364|NCT02873702|450854066|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
125333365|NCT02873702|450854067|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
125333366|NCT02873702|450854068|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
125333367|NCT02873702|450854069|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
125333368|NCT02873702|450854066|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
125333369|NCT02873702|450854067|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
125333370|NCT02873702|450854068|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
125333371|NCT02873702|450854069|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
125333372|NCT01039376|450854072|FG000|Overall Study|Lost to Follow-up|5|||
125333373|NCT01039376|450854073|FG001|Overall Study|Lost to Follow-up|12|||
125333374|NCT01039376|450854072|FG000|Overall Study|Physician Decision|15|||
125333375|NCT01039376|450854073|FG001|Overall Study|Physician Decision|10|||
125333376|NCT01039376|450854072|FG000|Overall Study|Withdrawal by Subject|20|||
125333377|NCT01039376|450854073|FG001|Overall Study|Withdrawal by Subject|32|||
125333378|NCT01039376|450854072|FG000|Overall Study|Study terminated by Sponsor|90|||
125333379|NCT01039376|450854073|FG001|Overall Study|Study terminated by Sponsor|72|||
125333380|NCT03252925|450854074|FG000|Overall Study|Withdrawal by Subject|1|||
125333381|NCT03252925|450854075|FG001|Overall Study|Withdrawal by Subject|0|||
125333382|NCT03252925|450854074|FG000|Overall Study|Protocol Violation|6|||
125333383|NCT03252925|450854075|FG001|Overall Study|Protocol Violation|0|||
125333384|NCT03252925|450854074|FG000|Overall Study|Adverse Event|1|||
125333385|NCT03252925|450854075|FG001|Overall Study|Adverse Event|0|||
125333386|NCT03252925|450854074|FG000|Overall Study|Lost to Follow-up|6|||
125333387|NCT03252925|450854075|FG001|Overall Study|Lost to Follow-up|6|||
125333388|NCT03830892|450854083|FG000|Overall Study|Physician Decision|2|||
125333389|NCT03830892|450854084|FG001|Overall Study|Physician Decision|3|||
125333390|NCT03830892|450854083|FG000|Overall Study|Study terminated due to COVID|4|||
125333391|NCT03830892|450854084|FG001|Overall Study|Study terminated due to COVID|0|||
125333392|NCT03830892|450854083|FG000|Overall Study|Protocol Violation|0|||
125333393|NCT03830892|450854084|FG001|Overall Study|Protocol Violation|1|||
125333394|NCT03830892|450854083|FG000|Overall Study|Withdrawal by Subject|0|||
125333395|NCT03830892|450854084|FG001|Overall Study|Withdrawal by Subject|2|||
125333396|NCT01499277|450854085|FG000|Overall Study|Adverse Event|3|||
125333397|NCT01499277|450854086|FG001|Overall Study|Adverse Event|6|||
125333398|NCT01499277|450854085|FG000|Overall Study|Death|3|||
125333399|NCT01499277|450854086|FG001|Overall Study|Death|2|||
125333400|NCT01499277|450854085|FG000|Overall Study|Lost to Follow-up|15|||
125333401|NCT01499277|450854086|FG001|Overall Study|Lost to Follow-up|8|||
125333402|NCT01499277|450854085|FG000|Overall Study|Protocol Violation|2|||
125333403|NCT01499277|450854086|FG001|Overall Study|Protocol Violation|3|||
125333404|NCT01499277|450854085|FG000|Overall Study|Withdrawal by Subject|16|||
125333405|NCT01499277|450854086|FG001|Overall Study|Withdrawal by Subject|6|||
125333406|NCT01499277|450854085|FG000|Overall Study|Lack of therapeutic response and other|8|||
125333407|NCT01499277|450854086|FG001|Overall Study|Lack of therapeutic response and other|7|||
125333408|NCT04661579|450854087|FG000|Overall Study|Lost to Follow-up|19|||
125333409|NCT04661579|450854088|FG001|Overall Study|Lost to Follow-up|10|||
125333410|NCT04661579|450854089|FG002|Overall Study|Lost to Follow-up|2|||
125670057|NCT00723554|452079757|FG000|Overall Study|Other|3|||
125670058|NCT00723554|452079757|FG000|Overall Study|Lost to Follow-up|1|||
125670059|NCT00723554|452079757|FG000|Overall Study|Non-compliance|1|||
125333411|NCT04661579|450854090|FG003|Overall Study|Lost to Follow-up|7|||
125670060|NCT01405820|452079758|FG000|Randomized Treatment Period|Adverse Event|3|||
125670061|NCT01405820|452079759|FG001|Randomized Treatment Period|Adverse Event|3|||
125333412|NCT04661579|450854091|FG004|Overall Study|Lost to Follow-up|11|||
125333413|NCT04661579|450854087|FG000|Overall Study|Physician Decision|2|||
125333414|NCT04661579|450854088|FG001|Overall Study|Physician Decision|0|||
125333415|NCT04661579|450854089|FG002|Overall Study|Physician Decision|0|||
125670062|NCT01405820|452079760|FG002|Randomized Treatment Period|Adverse Event|3|||
125333416|NCT04661579|450854090|FG003|Overall Study|Physician Decision|1|||
125333417|NCT04661579|450854091|FG004|Overall Study|Physician Decision|0|||
125333418|NCT04661579|450854087|FG000|Overall Study|Withdrawal by Subject|1|||
125333419|NCT04661579|450854088|FG001|Overall Study|Withdrawal by Subject|4|||
125333420|NCT04661579|450854089|FG002|Overall Study|Withdrawal by Subject|0|||
125333421|NCT04661579|450854090|FG003|Overall Study|Withdrawal by Subject|2|||
125333422|NCT04661579|450854091|FG004|Overall Study|Withdrawal by Subject|0|||
125333423|NCT04661579|450854087|FG000|Overall Study|Death|1|||
125333424|NCT04661579|450854088|FG001|Overall Study|Death|0|||
125333425|NCT04661579|450854089|FG002|Overall Study|Death|0|||
125333426|NCT04661579|450854090|FG003|Overall Study|Death|0|||
125333427|NCT04661579|450854091|FG004|Overall Study|Death|0|||
125333428|NCT04661579|450854087|FG000|Overall Study|Other|1|||
125333429|NCT04661579|450854088|FG001|Overall Study|Other|2|||
125333430|NCT04661579|450854089|FG002|Overall Study|Other|1|||
125333431|NCT04661579|450854090|FG003|Overall Study|Other|1|||
125333432|NCT04661579|450854091|FG004|Overall Study|Other|1|||
125333433|NCT04661579|450854087|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
125333434|NCT04661579|450854088|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
125333435|NCT04661579|450854089|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
125333436|NCT04661579|450854090|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
125333437|NCT04661579|450854091|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
125333438|NCT04730271|450854093|FG000|Overall Study|Adverse Event|0|||
125333439|NCT04730271|450854094|FG001|Overall Study|Adverse Event|2|||
125333440|NCT04730271|450854093|FG000|Overall Study|Withdrawal by Subject|1|||
125333441|NCT04730271|450854094|FG001|Overall Study|Withdrawal by Subject|1|||
125333442|NCT04730271|450854093|FG000|Overall Study|Protocol Violation|7|||
125333443|NCT04730271|450854094|FG001|Overall Study|Protocol Violation|13|||
125333444|NCT04730271|450854093|FG000|Overall Study|Lost to Follow-up|3|||
125333445|NCT04730271|450854094|FG001|Overall Study|Lost to Follow-up|3|||
125333446|NCT04730271|450854093|FG000|Overall Study|Death|1|||
125333447|NCT04730271|450854094|FG001|Overall Study|Death|0|||
125333448|NCT02023697|450854099|FG000|Treatment Period|Radiological progression|13|||
125333449|NCT02023697|450854100|FG001|Treatment Period|Radiological progression|17|||
125670063|NCT01405820|452079761|FG003|Randomized Treatment Period|Adverse Event|0|||
125333450|NCT02023697|450854101|FG002|Treatment Period|Radiological progression|26|||
125333451|NCT02023697|450854099|FG000|Treatment Period|Never Treated|5|||
125333452|NCT02023697|450854100|FG001|Treatment Period|Never Treated|6|||
125333453|NCT02023697|450854101|FG002|Treatment Period|Never Treated|10|||
125333454|NCT02023697|450854099|FG000|Treatment Period|Adverse Event|13|||
125333455|NCT02023697|450854100|FG001|Treatment Period|Adverse Event|25|||
125333456|NCT02023697|450854101|FG002|Treatment Period|Adverse Event|23|||
125333457|NCT02023697|450854099|FG000|Treatment Period|Logistical difficulties|1|||
125333458|NCT02023697|450854100|FG001|Treatment Period|Logistical difficulties|1|||
125333459|NCT02023697|450854101|FG002|Treatment Period|Logistical difficulties|1|||
125333460|NCT02023697|450854099|FG000|Treatment Period|Clinical progression|10|||
125333461|NCT02023697|450854100|FG001|Treatment Period|Clinical progression|8|||
125333462|NCT02023697|450854101|FG002|Treatment Period|Clinical progression|28|||
125670064|NCT01405820|452079762|FG004|Randomized Treatment Period|Adverse Event|2|||
125670065|NCT01405820|452079763|FG005|Randomized Treatment Period|Adverse Event|1|||
125670066|NCT01405820|452079758|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
125670067|NCT01405820|452079759|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
125670068|NCT01405820|452079760|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
125670069|NCT01405820|452079761|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
125670070|NCT01405820|452079762|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
125670071|NCT01405820|452079763|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
125670072|NCT01405820|452079758|FG000|Randomized Treatment Period|Other|2|||
125670073|NCT01405820|452079759|FG001|Randomized Treatment Period|Other|2|||
125670074|NCT01405820|452079760|FG002|Randomized Treatment Period|Other|1|||
125670075|NCT01405820|452079761|FG003|Randomized Treatment Period|Other|1|||
125670076|NCT01405820|452079762|FG004|Randomized Treatment Period|Other|0|||
125670077|NCT01405820|452079763|FG005|Randomized Treatment Period|Other|0|||
125670078|NCT01405820|452079758|FG000|Randomized Treatment Period|Physician Decision|0|||
125670079|NCT01405820|452079759|FG001|Randomized Treatment Period|Physician Decision|2|||
125670080|NCT01405820|452079760|FG002|Randomized Treatment Period|Physician Decision|1|||
125333463|NCT02023697|450854099|FG000|Treatment Period|Withdrawal by Subject|4|||
125333464|NCT02023697|450854100|FG001|Treatment Period|Withdrawal by Subject|5|||
125333465|NCT02023697|450854101|FG002|Treatment Period|Withdrawal by Subject|13|||
125333466|NCT02023697|450854099|FG000|Treatment Period|Safety outcome reached|0|||
125333467|NCT02023697|450854100|FG001|Treatment Period|Safety outcome reached|1|||
125333468|NCT02023697|450854101|FG002|Treatment Period|Safety outcome reached|0|||
125333469|NCT02023697|450854099|FG000|Treatment Period|Physician Decision|0|||
125333470|NCT02023697|450854100|FG001|Treatment Period|Physician Decision|0|||
125333471|NCT02023697|450854101|FG002|Treatment Period|Physician Decision|1|||
125670081|NCT01405820|452079761|FG003|Randomized Treatment Period|Physician Decision|0|||
125670082|NCT01405820|452079762|FG004|Randomized Treatment Period|Physician Decision|0|||
125333472|NCT02023697|450854099|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
125333473|NCT02023697|450854100|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
125333474|NCT02023697|450854101|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
125333475|NCT02023697|450854099|FG000|Active Follow-up Period|Lost to Follow-up|1|||
125333476|NCT02023697|450854100|FG001|Active Follow-up Period|Lost to Follow-up|1|||
125333477|NCT02023697|450854101|FG002|Active Follow-up Period|Lost to Follow-up|1|||
125333478|NCT02023697|450854099|FG000|Active Follow-up Period|Deterioration of general condition|1|||
125333479|NCT02023697|450854100|FG001|Active Follow-up Period|Deterioration of general condition|1|||
125333480|NCT02023697|450854101|FG002|Active Follow-up Period|Deterioration of general condition|1|||
125333481|NCT02023697|450854099|FG000|Active Follow-up Period|Other unspecified|2|||
125333482|NCT02023697|450854100|FG001|Active Follow-up Period|Other unspecified|0|||
125333483|NCT02023697|450854101|FG002|Active Follow-up Period|Other unspecified|1|||
125333484|NCT02023697|450854099|FG000|Active Follow-up Period|Clinical progression|0|||
125670083|NCT01405820|452079763|FG005|Randomized Treatment Period|Physician Decision|0|||
125670084|NCT01405820|452079758|FG000|Randomized Treatment Period|Rescue|0|||
125670085|NCT01405820|452079759|FG001|Randomized Treatment Period|Rescue|1|||
125670086|NCT01405820|452079760|FG002|Randomized Treatment Period|Rescue|13|||
125670087|NCT01405820|452079761|FG003|Randomized Treatment Period|Rescue|10|||
125670088|NCT01405820|452079762|FG004|Randomized Treatment Period|Rescue|8|||
125670089|NCT01405820|452079763|FG005|Randomized Treatment Period|Rescue|8|||
125670090|NCT01405820|452079758|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
125670091|NCT01405820|452079759|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
125670092|NCT01405820|452079760|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
125670093|NCT01405820|452079761|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
125670094|NCT01405820|452079762|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
125670095|NCT01405820|452079763|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
125670096|NCT01405820|452079758|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
125670097|NCT01405820|452079759|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
125670098|NCT01405820|452079760|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
125670099|NCT01405820|452079761|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
125670100|NCT01405820|452079762|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
125670101|NCT01405820|452079763|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
125670102|NCT01405820|452079758|FG000|Randomized Treatment Period|Death|0|||
125670103|NCT01405820|452079759|FG001|Randomized Treatment Period|Death|0|||
125670104|NCT01405820|452079760|FG002|Randomized Treatment Period|Death|0|||
125670105|NCT01405820|452079761|FG003|Randomized Treatment Period|Death|1|||
125670106|NCT01405820|452079762|FG004|Randomized Treatment Period|Death|0|||
125670107|NCT01405820|452079763|FG005|Randomized Treatment Period|Death|0|||
125670108|NCT01405820|452079758|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
125670109|NCT01405820|452079759|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
125670110|NCT01405820|452079760|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
125670111|NCT01405820|452079761|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
125670112|NCT01405820|452079762|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
125670113|NCT01405820|452079763|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
125670114|NCT01405820|452079758|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
125670115|NCT01405820|452079759|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
125670116|NCT01405820|452079760|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
125670117|NCT01405820|452079761|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
125670118|NCT01405820|452079762|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
125670119|NCT01405820|452079763|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
125670120|NCT01405820|452079758|FG000|Open-Label Treatment Period|Other|1|||
125670121|NCT01405820|452079759|FG001|Open-Label Treatment Period|Other|1|||
125670122|NCT01405820|452079760|FG002|Open-Label Treatment Period|Other|1|||
125670123|NCT01405820|452079761|FG003|Open-Label Treatment Period|Other|1|||
125670124|NCT01405820|452079762|FG004|Open-Label Treatment Period|Other|1|||
125670125|NCT01405820|452079763|FG005|Open-Label Treatment Period|Other|1|||
125670126|NCT01405820|452079758|FG000|Open-Label Treatment Period|Physician Decision|0|||
125670127|NCT01405820|452079759|FG001|Open-Label Treatment Period|Physician Decision|0|||
125670128|NCT01405820|452079760|FG002|Open-Label Treatment Period|Physician Decision|1|||
125670129|NCT01405820|452079761|FG003|Open-Label Treatment Period|Physician Decision|2|||
125670130|NCT01405820|452079762|FG004|Open-Label Treatment Period|Physician Decision|1|||
125670131|NCT01405820|452079763|FG005|Open-Label Treatment Period|Physician Decision|0|||
125670132|NCT01405820|452079758|FG000|Open-Label Treatment Period|Adverse Event|0|||
125670133|NCT01405820|452079759|FG001|Open-Label Treatment Period|Adverse Event|0|||
125670134|NCT01405820|452079760|FG002|Open-Label Treatment Period|Adverse Event|0|||
125670135|NCT01405820|452079761|FG003|Open-Label Treatment Period|Adverse Event|1|||
125670136|NCT01405820|452079762|FG004|Open-Label Treatment Period|Adverse Event|0|||
125670137|NCT01405820|452079763|FG005|Open-Label Treatment Period|Adverse Event|0|||
125670138|NCT01689974|452079770|FG000|Overall Study|Termination of Study|5|||
125670139|NCT01689974|452079771|FG001|Overall Study|Termination of Study|5|||
125670140|NCT01952574|452079772|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
125670141|NCT01952574|452079773|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
125333485|NCT02023697|450854100|FG001|Active Follow-up Period|Clinical progression|2|||
125333486|NCT02023697|450854101|FG002|Active Follow-up Period|Clinical progression|1|||
125333487|NCT02023697|450854099|FG000|Active Follow-up Period|Radiological progression|0|||
125333488|NCT02023697|450854100|FG001|Active Follow-up Period|Radiological progression|0|||
125333489|NCT02023697|450854101|FG002|Active Follow-up Period|Radiological progression|1|||
125333490|NCT02023697|450854099|FG000|Active Follow-up Period|Death|83|||
125333491|NCT02023697|450854100|FG001|Active Follow-up Period|Death|82|||
125333492|NCT02023697|450854101|FG002|Active Follow-up Period|Death|87|||
125333493|NCT02023697|450854099|FG000|Long-term Follow-up Period|Death|9|||
125333494|NCT02023697|450854100|FG001|Long-term Follow-up Period|Death|6|||
125333495|NCT02023697|450854101|FG002|Long-term Follow-up Period|Death|4|||
125333496|NCT02023697|450854099|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
125333497|NCT02023697|450854100|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
125333498|NCT02023697|450854101|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
125333499|NCT02023697|450854099|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
125333500|NCT02023697|450854100|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
125333501|NCT02023697|450854101|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
125333502|NCT02023697|450854099|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
125333503|NCT02023697|450854100|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
125333504|NCT02023697|450854101|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
125670142|NCT01952574|452079774|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
125670143|NCT01952574|452079775|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
125670144|NCT01952574|452079776|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125670145|NCT01952574|452079777|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125670146|NCT01952574|452079778|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125333505|NCT02023697|450854099|FG000|Long-term Follow-up Period|Technical problems|0|||
125333506|NCT02023697|450854100|FG001|Long-term Follow-up Period|Technical problems|0|||
125333507|NCT02023697|450854101|FG002|Long-term Follow-up Period|Technical problems|1|||
125333508|NCT02023697|450854099|FG000|Long-term Follow-up Period|Other unspecified|6|||
125333509|NCT02023697|450854100|FG001|Long-term Follow-up Period|Other unspecified|3|||
125333510|NCT02023697|450854101|FG002|Long-term Follow-up Period|Other unspecified|5|||
125333511|NCT00845897|450854102|FG000|Overall Study|Lost to Follow-up|1|||
125333512|NCT00845897|450854103|FG001|Overall Study|Lost to Follow-up|1|||
125333513|NCT00845897|450854104|FG002|Overall Study|Lost to Follow-up|0|||
125333514|NCT00845897|450854102|FG000|Overall Study|Withdrawal by Subject|0|||
125333515|NCT00845897|450854103|FG001|Overall Study|Withdrawal by Subject|3|||
125333516|NCT00845897|450854104|FG002|Overall Study|Withdrawal by Subject|2|||
125333517|NCT00845897|450854102|FG000|Overall Study|Ulcer did not heal|1|||
125333518|NCT00845897|450854103|FG001|Overall Study|Ulcer did not heal|0|||
125333519|NCT00845897|450854104|FG002|Overall Study|Ulcer did not heal|1|||
125333520|NCT00845897|450854102|FG000|Overall Study|Too ill to participate|0|||
125333521|NCT00845897|450854103|FG001|Overall Study|Too ill to participate|1|||
125333522|NCT00845897|450854104|FG002|Overall Study|Too ill to participate|0|||
125333523|NCT03904693|450854105|FG000|Overall Study|Death|0|||
125333524|NCT03904693|450854106|FG001|Overall Study|Death|0|||
125670147|NCT01952574|452079772|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
125670148|NCT01952574|452079773|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
125670149|NCT01952574|452079774|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
125333525|NCT03904693|450854107|FG002|Overall Study|Death|3|||
125333526|NCT03904693|450854105|FG000|Overall Study|Physician Decision|0|||
125670150|NCT01952574|452079775|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
125670151|NCT01952574|452079776|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
125670152|NCT01952574|452079777|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
125670153|NCT01952574|452079778|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
125670154|NCT01952574|452079772|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
125670155|NCT01952574|452079773|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
125670156|NCT01952574|452079774|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
125670157|NCT01952574|452079775|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
125670158|NCT01952574|452079776|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
125670159|NCT01952574|452079777|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
125670160|NCT01952574|452079778|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
125670161|NCT01952574|452079772|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
125670162|NCT01952574|452079773|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
125670163|NCT01952574|452079774|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
125670164|NCT01952574|452079775|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
125333527|NCT03904693|450854106|FG001|Overall Study|Physician Decision|0|||
125333528|NCT03904693|450854107|FG002|Overall Study|Physician Decision|2|||
125333529|NCT03904693|450854105|FG000|Overall Study|Withdrawal by Subject|0|||
125333530|NCT03904693|450854106|FG001|Overall Study|Withdrawal by Subject|1|||
125333531|NCT03904693|450854107|FG002|Overall Study|Withdrawal by Subject|4|||
125333532|NCT00068419|450854108|FG000|Overall Study|Adverse Event|3|||
125333533|NCT00068419|450854108|FG000|Overall Study|Lack of Efficacy|24|||
125333534|NCT00068419|450854108|FG000|Overall Study|Lost to Follow-up|1|||
125333535|NCT00068419|450854108|FG000|Overall Study|Physician Decision|7|||
125333536|NCT00068419|450854108|FG000|Overall Study|Withdrawal by Subject|14|||
125333537|NCT00068419|450854108|FG000|Overall Study|Ineligible|11|||
125333538|NCT01160822|450854115|FG000|Overall Study|Adverse Event|0|||
125333539|NCT01160822|450854116|FG001|Overall Study|Adverse Event|0|||
125333540|NCT01160822|450854117|FG002|Overall Study|Adverse Event|0|||
125333541|NCT01160822|450854118|FG003|Overall Study|Adverse Event|0|||
125333542|NCT01160822|450854119|FG004|Overall Study|Adverse Event|1|||
125333543|NCT01160822|450854120|FG005|Overall Study|Adverse Event|2|||
125333544|NCT01160822|450854121|FG006|Overall Study|Adverse Event|5|||
125333545|NCT01160822|450854115|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125333546|NCT01160822|450854116|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125333547|NCT01160822|450854117|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125333548|NCT01160822|450854118|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
125333549|NCT01160822|450854119|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
125333550|NCT01160822|450854120|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
125333551|NCT01160822|450854121|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
125333552|NCT01160822|450854115|FG000|Overall Study|Withdrawal by Subject|0|||
125333553|NCT01160822|450854116|FG001|Overall Study|Withdrawal by Subject|0|||
125333554|NCT01160822|450854117|FG002|Overall Study|Withdrawal by Subject|0|||
125333555|NCT01160822|450854118|FG003|Overall Study|Withdrawal by Subject|0|||
125333556|NCT01160822|450854119|FG004|Overall Study|Withdrawal by Subject|0|||
125333557|NCT01160822|450854120|FG005|Overall Study|Withdrawal by Subject|0|||
125333558|NCT01160822|450854121|FG006|Overall Study|Withdrawal by Subject|1|||
125333559|NCT01160822|450854115|FG000|Overall Study|Lost to Follow-up|0|||
125333560|NCT01160822|450854116|FG001|Overall Study|Lost to Follow-up|0|||
125333561|NCT01160822|450854117|FG002|Overall Study|Lost to Follow-up|0|||
125333562|NCT01160822|450854118|FG003|Overall Study|Lost to Follow-up|0|||
125333563|NCT01160822|450854119|FG004|Overall Study|Lost to Follow-up|1|||
125333564|NCT01160822|450854120|FG005|Overall Study|Lost to Follow-up|0|||
125333565|NCT01160822|450854121|FG006|Overall Study|Lost to Follow-up|0|||
125333566|NCT01160822|450854115|FG000|Overall Study|Administrative problems|0|||
125333567|NCT01160822|450854116|FG001|Overall Study|Administrative problems|0|||
125333568|NCT01160822|450854117|FG002|Overall Study|Administrative problems|0|||
125333569|NCT01160822|450854118|FG003|Overall Study|Administrative problems|0|||
125333570|NCT01160822|450854119|FG004|Overall Study|Administrative problems|1|||
125333571|NCT01160822|450854120|FG005|Overall Study|Administrative problems|0|||
125333572|NCT01160822|450854121|FG006|Overall Study|Administrative problems|0|||
125333573|NCT01160822|450854115|FG000|Overall Study|Protocol deviation|0|||
125333574|NCT01160822|450854116|FG001|Overall Study|Protocol deviation|0|||
125333575|NCT01160822|450854117|FG002|Overall Study|Protocol deviation|0|||
125333576|NCT01160822|450854118|FG003|Overall Study|Protocol deviation|0|||
125333577|NCT01160822|450854119|FG004|Overall Study|Protocol deviation|2|||
125333578|NCT01160822|450854120|FG005|Overall Study|Protocol deviation|0|||
125333579|NCT01160822|450854121|FG006|Overall Study|Protocol deviation|0|||
125333580|NCT00314795|450854124|FG000|Overall Study|Adverse Event|8|||
125333581|NCT00314795|450854124|FG000|Overall Study|Death|4|||
125333582|NCT00314795|450854124|FG000|Overall Study|Reason not Specified|3|||
125333583|NCT00314795|450854124|FG000|Overall Study|Renal Transplant|3|||
125333584|NCT00314795|450854124|FG000|Overall Study|Participants Withdrew Consent|2|||
125333585|NCT04717336|450854126|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
125333586|NCT04717336|450854127|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
125333587|NCT04717336|450854126|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
125333588|NCT04717336|450854127|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
125333589|NCT01500720|450854128|FG000|Overall Study|Randomized But Not Treated|1|||
125333590|NCT01500720|450854129|FG001|Overall Study|Randomized But Not Treated|1|||
125333591|NCT01500720|450854128|FG000|Overall Study|Other|4|||
125333592|NCT01500720|450854129|FG001|Overall Study|Other|8|||
125333593|NCT02624986|450854130|FG000|Overall Study|Death|0|||
125333594|NCT02624986|450854131|FG001|Overall Study|Death|1|||
125333595|NCT02624986|450854132|FG002|Overall Study|Death|2|||
125333596|NCT02624986|450854133|FG003|Overall Study|Death|2|||
125333597|NCT02624986|450854134|FG004|Overall Study|Death|2|||
125333598|NCT02624986|450854135|FG005|Overall Study|Death|0|||
125333599|NCT02624986|450854136|FG006|Overall Study|Death|0|||
125333600|NCT02624986|450854137|FG007|Overall Study|Death|1|||
125333601|NCT02624986|450854130|FG000|Overall Study|Study Terminated by Sponsor|1|||
125333602|NCT02624986|450854131|FG001|Overall Study|Study Terminated by Sponsor|1|||
125333603|NCT02624986|450854132|FG002|Overall Study|Study Terminated by Sponsor|0|||
125333604|NCT02624986|450854133|FG003|Overall Study|Study Terminated by Sponsor|1|||
125333605|NCT02624986|450854134|FG004|Overall Study|Study Terminated by Sponsor|2|||
125333606|NCT02624986|450854135|FG005|Overall Study|Study Terminated by Sponsor|2|||
125333607|NCT02624986|450854136|FG006|Overall Study|Study Terminated by Sponsor|4|||
125333608|NCT02624986|450854137|FG007|Overall Study|Study Terminated by Sponsor|3|||
125333609|NCT02624986|450854130|FG000|Overall Study|Progressive Disease|0|||
125333610|NCT02624986|450854131|FG001|Overall Study|Progressive Disease|1|||
125333611|NCT02624986|450854132|FG002|Overall Study|Progressive Disease|0|||
125333612|NCT02624986|450854133|FG003|Overall Study|Progressive Disease|0|||
125333613|NCT02624986|450854134|FG004|Overall Study|Progressive Disease|0|||
125333614|NCT02624986|450854135|FG005|Overall Study|Progressive Disease|0|||
125333615|NCT02624986|450854136|FG006|Overall Study|Progressive Disease|0|||
125333616|NCT02624986|450854137|FG007|Overall Study|Progressive Disease|0|||
125333617|NCT02624986|450854130|FG000|Overall Study|Protocol Violation|1|||
125333618|NCT02624986|450854131|FG001|Overall Study|Protocol Violation|0|||
125333619|NCT02624986|450854132|FG002|Overall Study|Protocol Violation|0|||
125333620|NCT02624986|450854133|FG003|Overall Study|Protocol Violation|0|||
125333621|NCT02624986|450854134|FG004|Overall Study|Protocol Violation|0|||
125333622|NCT02624986|450854135|FG005|Overall Study|Protocol Violation|0|||
125333623|NCT02624986|450854136|FG006|Overall Study|Protocol Violation|0|||
125333624|NCT02624986|450854137|FG007|Overall Study|Protocol Violation|0|||
125333625|NCT02624986|450854130|FG000|Overall Study|Withdrawal by Subject|0|||
125333626|NCT02624986|450854131|FG001|Overall Study|Withdrawal by Subject|0|||
125333627|NCT02624986|450854132|FG002|Overall Study|Withdrawal by Subject|0|||
125333628|NCT02624986|450854133|FG003|Overall Study|Withdrawal by Subject|0|||
125333629|NCT02624986|450854134|FG004|Overall Study|Withdrawal by Subject|0|||
125333630|NCT02624986|450854135|FG005|Overall Study|Withdrawal by Subject|0|||
125670165|NCT01952574|452079776|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
125670166|NCT01952574|452079777|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
125670167|NCT01952574|452079778|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
125333631|NCT02624986|450854136|FG006|Overall Study|Withdrawal by Subject|0|||
125333632|NCT02624986|450854137|FG007|Overall Study|Withdrawal by Subject|1|||
125333633|NCT02527421|450854138|FG000|Overall Study|Withdrawal by Subject|1|||
125333634|NCT02527421|450854139|FG001|Overall Study|Withdrawal by Subject|0|||
125333635|NCT02116205|450854140|FG000|Overall Study|Withdrawal by Subject|2|||
125333636|NCT02116205|450854141|FG001|Overall Study|Withdrawal by Subject|4|||
125333637|NCT02116205|450854142|FG002|Overall Study|Withdrawal by Subject|1|||
125333638|NCT02116205|450854143|FG003|Overall Study|Withdrawal by Subject|3|||
125333639|NCT02116205|450854140|FG000|Overall Study|Lost to Follow-up|0|||
125333640|NCT02116205|450854141|FG001|Overall Study|Lost to Follow-up|2|||
125333641|NCT02116205|450854142|FG002|Overall Study|Lost to Follow-up|1|||
125333642|NCT02116205|450854143|FG003|Overall Study|Lost to Follow-up|2|||
125333643|NCT02116205|450854140|FG000|Overall Study|Physician Decision|0|||
125333644|NCT02116205|450854141|FG001|Overall Study|Physician Decision|1|||
125333645|NCT02116205|450854142|FG002|Overall Study|Physician Decision|1|||
125333646|NCT02116205|450854143|FG003|Overall Study|Physician Decision|1|||
125333647|NCT02116205|450854140|FG000|Overall Study|Exclusion criteria|0|||
125333648|NCT02116205|450854141|FG001|Overall Study|Exclusion criteria|0|||
125333649|NCT02116205|450854142|FG002|Overall Study|Exclusion criteria|1|||
125333650|NCT02116205|450854143|FG003|Overall Study|Exclusion criteria|0|||
125333651|NCT02541604|450854144|FG000|Overall Study|Death|6|||
125333652|NCT02541604|450854145|FG001|Overall Study|Death|5|||
125333653|NCT02541604|450854146|FG002|Overall Study|Death|7|||
125333654|NCT02541604|450854147|FG003|Overall Study|Death|2|||
125333655|NCT02541604|450854148|FG004|Overall Study|Death|9|||
125333656|NCT02541604|450854149|FG005|Overall Study|Death|8|||
125333657|NCT02541604|450854150|FG006|Overall Study|Death|9|||
125333658|NCT02541604|450854151|FG007|Overall Study|Death|9|||
125333659|NCT02541604|450854152|FG008|Overall Study|Death|3|||
125333660|NCT02541604|450854153|FG009|Overall Study|Death|4|||
125333661|NCT02541604|450854154|FG010|Overall Study|Death|2|||
125333662|NCT02541604|450854155|FG011|Overall Study|Death|3|||
125333663|NCT02541604|450854144|FG000|Overall Study|Lost to Follow-up|2|||
125333664|NCT02541604|450854145|FG001|Overall Study|Lost to Follow-up|0|||
125333665|NCT02541604|450854146|FG002|Overall Study|Lost to Follow-up|1|||
125333666|NCT02541604|450854147|FG003|Overall Study|Lost to Follow-up|0|||
125333667|NCT02541604|450854148|FG004|Overall Study|Lost to Follow-up|0|||
125333668|NCT02541604|450854149|FG005|Overall Study|Lost to Follow-up|1|||
125333669|NCT02541604|450854150|FG006|Overall Study|Lost to Follow-up|1|||
125333670|NCT02541604|450854151|FG007|Overall Study|Lost to Follow-up|0|||
125333671|NCT02541604|450854152|FG008|Overall Study|Lost to Follow-up|0|||
125333672|NCT02541604|450854153|FG009|Overall Study|Lost to Follow-up|0|||
125333673|NCT02541604|450854154|FG010|Overall Study|Lost to Follow-up|0|||
125333674|NCT02541604|450854155|FG011|Overall Study|Lost to Follow-up|0|||
125333675|NCT02541604|450854144|FG000|Overall Study|Withdrawal by Subject|2|||
125333676|NCT02541604|450854145|FG001|Overall Study|Withdrawal by Subject|0|||
125333677|NCT02541604|450854146|FG002|Overall Study|Withdrawal by Subject|1|||
125670168|NCT01952574|452079772|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
125670169|NCT01952574|452079773|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
125333678|NCT02541604|450854147|FG003|Overall Study|Withdrawal by Subject|0|||
125333679|NCT02541604|450854148|FG004|Overall Study|Withdrawal by Subject|1|||
125333680|NCT02541604|450854149|FG005|Overall Study|Withdrawal by Subject|1|||
125333681|NCT02541604|450854150|FG006|Overall Study|Withdrawal by Subject|0|||
125333682|NCT02541604|450854151|FG007|Overall Study|Withdrawal by Subject|0|||
125333683|NCT02541604|450854152|FG008|Overall Study|Withdrawal by Subject|1|||
125333684|NCT02541604|450854153|FG009|Overall Study|Withdrawal by Subject|0|||
125333685|NCT02541604|450854154|FG010|Overall Study|Withdrawal by Subject|0|||
125333686|NCT02541604|450854155|FG011|Overall Study|Withdrawal by Subject|0|||
125670170|NCT01952574|452079774|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
125670171|NCT01952574|452079775|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
125670172|NCT01952574|452079776|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
125670173|NCT01952574|452079777|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
125670174|NCT01952574|452079778|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
125670175|NCT01952574|452079772|FG000|Open-label Treatment Phase|Missing|0|||
125670176|NCT01952574|452079773|FG001|Open-label Treatment Phase|Missing|0|||
125670177|NCT01952574|452079774|FG002|Open-label Treatment Phase|Missing|0|||
125670178|NCT01952574|452079775|FG003|Open-label Treatment Phase|Missing|0|||
125670179|NCT01952574|452079776|FG004|Open-label Treatment Phase|Missing|4|||
125670180|NCT01952574|452079777|FG005|Open-label Treatment Phase|Missing|0|||
125670181|NCT01952574|452079778|FG006|Open-label Treatment Phase|Missing|0|||
125670182|NCT01952574|452079772|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
125670183|NCT01952574|452079773|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
125670184|NCT01952574|452079774|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
125670185|NCT01952574|452079775|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
125670186|NCT01952574|452079776|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
125670187|NCT01952574|452079777|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
125333687|NCT02541604|450854144|FG000|Overall Study|Study Terminated by Sponsor|1|||
125333688|NCT02541604|450854145|FG001|Overall Study|Study Terminated by Sponsor|4|||
125333689|NCT02541604|450854146|FG002|Overall Study|Study Terminated by Sponsor|2|||
125333690|NCT02541604|450854147|FG003|Overall Study|Study Terminated by Sponsor|1|||
125333691|NCT02541604|450854148|FG004|Overall Study|Study Terminated by Sponsor|0|||
125333692|NCT02541604|450854149|FG005|Overall Study|Study Terminated by Sponsor|0|||
125333693|NCT02541604|450854150|FG006|Overall Study|Study Terminated by Sponsor|0|||
125333694|NCT02541604|450854151|FG007|Overall Study|Study Terminated by Sponsor|0|||
125333695|NCT02541604|450854152|FG008|Overall Study|Study Terminated by Sponsor|0|||
125333696|NCT02541604|450854153|FG009|Overall Study|Study Terminated by Sponsor|0|||
125333697|NCT02541604|450854154|FG010|Overall Study|Study Terminated by Sponsor|0|||
125333698|NCT02541604|450854155|FG011|Overall Study|Study Terminated by Sponsor|0|||
125333699|NCT02541604|450854144|FG000|Overall Study|Medical condition may jeopardize safety|0|||
125333700|NCT02541604|450854145|FG001|Overall Study|Medical condition may jeopardize safety|0|||
125333701|NCT02541604|450854146|FG002|Overall Study|Medical condition may jeopardize safety|0|||
125333702|NCT02541604|450854147|FG003|Overall Study|Medical condition may jeopardize safety|0|||
125333703|NCT02541604|450854148|FG004|Overall Study|Medical condition may jeopardize safety|0|||
125333704|NCT02541604|450854149|FG005|Overall Study|Medical condition may jeopardize safety|0|||
125333705|NCT02541604|450854150|FG006|Overall Study|Medical condition may jeopardize safety|0|||
125333706|NCT02541604|450854151|FG007|Overall Study|Medical condition may jeopardize safety|1|||
125333707|NCT02541604|450854152|FG008|Overall Study|Medical condition may jeopardize safety|0|||
125333708|NCT02541604|450854153|FG009|Overall Study|Medical condition may jeopardize safety|0|||
125333709|NCT02541604|450854154|FG010|Overall Study|Medical condition may jeopardize safety|0|||
125333710|NCT02541604|450854155|FG011|Overall Study|Medical condition may jeopardize safety|0|||
125333711|NCT00560352|450854159|FG000|Overall Study|Adverse event unrelated to study drug|2|||
125333712|NCT00560352|450854160|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125333713|NCT00560352|450854161|FG002|Overall Study|Adverse event unrelated to study drug|1|||
125333714|NCT00560352|450854159|FG000|Overall Study|Study drug toxicity|3|||
125333715|NCT00560352|450854160|FG001|Overall Study|Study drug toxicity|0|||
125333716|NCT00560352|450854161|FG002|Overall Study|Study drug toxicity|1|||
125333717|NCT00560352|450854159|FG000|Overall Study|Disease progression|0|||
125333718|NCT00560352|450854160|FG001|Overall Study|Disease progression|1|||
125333719|NCT00560352|450854161|FG002|Overall Study|Disease progression|1|||
125333720|NCT00560352|450854159|FG000|Overall Study|Withdrawal by Subject|1|||
125333721|NCT00560352|450854160|FG001|Overall Study|Withdrawal by Subject|1|||
125333722|NCT00560352|450854161|FG002|Overall Study|Withdrawal by Subject|1|||
125333723|NCT00560352|450854159|FG000|Overall Study|Maximum clinical benefit|1|||
125333724|NCT00560352|450854160|FG001|Overall Study|Maximum clinical benefit|0|||
125333725|NCT00560352|450854161|FG002|Overall Study|Maximum clinical benefit|0|||
125333726|NCT04434937|450854162|FG000|Overall Study|Death|4|||
125333727|NCT04434937|450854162|FG000|Overall Study|Withdrawal by Subject|1|||
125333728|NCT04434937|450854162|FG000|Overall Study|Transitioned to Rollover Study|19|||
125333729|NCT04434937|450854162|FG000|Overall Study|Progressive Disease|18|||
125333730|NCT00924027|450854163|FG000|Overall Study|Lost to Further Follow-Up|4|||
125333731|NCT00924027|450854164|FG001|Overall Study|Lost to Further Follow-Up|0|||
125333732|NCT00924027|450854165|FG002|Overall Study|Lost to Further Follow-Up|0|||
125670188|NCT01952574|452079778|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
125670189|NCT01952574|452079772|FG000|Open-label Treatment Phase|Death|0|||
125333733|NCT00924027|450854166|FG003|Overall Study|Lost to Further Follow-Up|0|||
125333734|NCT00924027|450854163|FG000|Overall Study|Physician Decision|1|||
125333735|NCT00924027|450854164|FG001|Overall Study|Physician Decision|0|||
125333736|NCT00924027|450854165|FG002|Overall Study|Physician Decision|0|||
125333737|NCT00924027|450854166|FG003|Overall Study|Physician Decision|1|||
125333738|NCT00924027|450854163|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
125333739|NCT00924027|450854164|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
125333740|NCT00924027|450854165|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
125333741|NCT00924027|450854166|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
125333742|NCT00924027|450854163|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
125333743|NCT00924027|450854164|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
125333744|NCT00924027|450854165|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
125333745|NCT00924027|450854166|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
125333746|NCT00924027|450854163|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
125333747|NCT00924027|450854164|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
125333748|NCT00924027|450854165|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
125333749|NCT00924027|450854166|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
125333750|NCT04695977|450854167|FG000|Overall Study|Sponsor Decision|9|||
125333751|NCT04695977|450854168|FG001|Overall Study|Sponsor Decision|4|||
125333752|NCT04695977|450854167|FG000|Overall Study|Death|2|||
125333753|NCT04695977|450854168|FG001|Overall Study|Death|5|||
125333754|NCT03474965|450854169|FG000|Overall Study|Pregnancy|1|||
125333755|NCT03474965|450854170|FG001|Overall Study|Pregnancy|0|||
125333756|NCT03474965|450854171|FG002|Overall Study|Pregnancy|0|||
125333757|NCT03474965|450854172|FG003|Overall Study|Pregnancy|0|||
125333758|NCT03474965|450854169|FG000|Overall Study|Lost to Follow-up|0|||
125333759|NCT03474965|450854170|FG001|Overall Study|Lost to Follow-up|0|||
125333760|NCT03474965|450854171|FG002|Overall Study|Lost to Follow-up|1|||
125333761|NCT03474965|450854172|FG003|Overall Study|Lost to Follow-up|0|||
125333762|NCT03474965|450854169|FG000|Overall Study|Death|1|||
125333763|NCT03474965|450854170|FG001|Overall Study|Death|0|||
125333764|NCT03474965|450854171|FG002|Overall Study|Death|0|||
125333765|NCT03474965|450854172|FG003|Overall Study|Death|0|||
125333766|NCT03474965|450854169|FG000|Overall Study|Adverse Event|1|||
125333767|NCT03474965|450854170|FG001|Overall Study|Adverse Event|0|||
125333768|NCT03474965|450854171|FG002|Overall Study|Adverse Event|0|||
125333769|NCT03474965|450854172|FG003|Overall Study|Adverse Event|1|||
125333770|NCT03474965|450854169|FG000|Overall Study|Physician Decision|3|||
125333771|NCT03474965|450854170|FG001|Overall Study|Physician Decision|1|||
125333772|NCT03474965|450854171|FG002|Overall Study|Physician Decision|2|||
125333773|NCT03474965|450854172|FG003|Overall Study|Physician Decision|0|||
125333774|NCT03474965|450854169|FG000|Overall Study|Participant Decision|7|||
125333775|NCT03474965|450854170|FG001|Overall Study|Participant Decision|0|||
125333776|NCT03474965|450854171|FG002|Overall Study|Participant Decision|1|||
125333777|NCT03474965|450854172|FG003|Overall Study|Participant Decision|0|||
125333778|NCT03474965|450854169|FG000|Overall Study|Guardian Decision|4|||
125333779|NCT03474965|450854170|FG001|Overall Study|Guardian Decision|2|||
125333780|NCT03474965|450854171|FG002|Overall Study|Guardian Decision|7|||
125333781|NCT03474965|450854172|FG003|Overall Study|Guardian Decision|2|||
125333782|NCT00684060|450856034|FG000|Overall Study|Lost to Follow-up|1|||
125333783|NCT00684060|450856035|FG001|Overall Study|Lost to Follow-up|0|||
125333784|NCT00684060|450856034|FG000|Overall Study|New stenosis identified|1|||
125333785|NCT00684060|450856035|FG001|Overall Study|New stenosis identified|0|||
125333786|NCT00684060|450856034|FG000|Overall Study|Unable to collect MRI|1|||
125333787|NCT00684060|450856035|FG001|Overall Study|Unable to collect MRI|2|||
125333788|NCT00684060|450856034|FG000|Overall Study|Death|0|||
125333789|NCT00684060|450856035|FG001|Overall Study|Death|1|||
125333790|NCT03751657|450856036|FG000|Overall Study|Physician Decision|0|||
125333791|NCT03751657|450856037|FG001|Overall Study|Physician Decision|1|||
125333792|NCT03751657|450856036|FG000|Overall Study|Withdrawal by Subject|1|||
125333793|NCT03751657|450856037|FG001|Overall Study|Withdrawal by Subject|1|||
125333794|NCT03751657|450856036|FG000|Overall Study|Lost to Follow-up|2|||
125333795|NCT03751657|450856037|FG001|Overall Study|Lost to Follow-up|1|||
125333796|NCT02600819|450856038|FG000|GEN Phase|Adverse Event|2|||
125333797|NCT02600819|450856039|FG001|GEN Phase|Adverse Event|0|||
125333798|NCT02600819|450856038|FG000|GEN Phase|Death|2|||
125333799|NCT02600819|450856039|FG001|GEN Phase|Death|0|||
125333800|NCT02600819|450856038|FG000|GEN Phase|Investigator's Discretion|4|||
125333801|NCT02600819|450856039|FG001|GEN Phase|Investigator's Discretion|0|||
125333802|NCT02600819|450856038|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
125333803|NCT02600819|450856039|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
125333804|NCT02600819|450856038|FG000|GEN Phase|Withdrew Consent|5|||
125333805|NCT02600819|450856039|FG001|GEN Phase|Withdrew Consent|0|||
125333806|NCT02600819|450856038|FG000|GEN Phase|Lost to Follow-up|2|||
125333807|NCT02600819|450856039|FG001|GEN Phase|Lost to Follow-up|0|||
125333808|NCT01027273|450856040|FG000|Overall Study|Lost to Follow-up|57|||
125333809|NCT01027273|450856041|FG001|Overall Study|Lost to Follow-up|31|||
125333810|NCT01027273|450856040|FG000|Overall Study|Death|2|||
125333811|NCT01027273|450856041|FG001|Overall Study|Death|2|||
125333812|NCT02904954|450856043|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
125333813|NCT02904954|450856044|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
125333814|NCT02904954|450856043|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
125333815|NCT02904954|450856044|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
125333816|NCT02904954|450856043|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
125333817|NCT02904954|450856044|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
125333818|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Recurrence|2|||
125333819|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Recurrence|0|||
125333820|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Adverse Event|2|||
125333821|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Adverse Event|6|||
125333822|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Participant wishes|12|||
125333823|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Participant wishes|7|||
125333824|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Physician Decision|2|||
125333825|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Physician Decision|1|||
125333826|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
125333827|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
125333828|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Death|0|||
125333829|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Death|1|||
125333830|NCT02904954|450856043|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
125333831|NCT02904954|450856044|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
125333832|NCT05097963|450856045|FG000|Overall Study|Protocol Violation|13|||
125333833|NCT05097963|450856045|FG000|Overall Study|Withdrawal by Subject|21|||
125333834|NCT00859456|450856046|FG000|Overall Study|Adverse Event|3|||
125333835|NCT00859456|450856046|FG000|Overall Study|Progressive disease|2|||
125333836|NCT00859456|450856046|FG000|Overall Study|Non-compliance|3|||
125333837|NCT00337675|450856047|FG000|Overall Study|Adverse Event|10|||
125333838|NCT00337675|450856048|FG001|Overall Study|Adverse Event|9|||
125333839|NCT00337675|450856049|FG002|Overall Study|Adverse Event|19|||
125333840|NCT00337675|450856047|FG000|Overall Study|Lack of Efficacy|10|||
125333841|NCT00337675|450856048|FG001|Overall Study|Lack of Efficacy|7|||
125333842|NCT00337675|450856049|FG002|Overall Study|Lack of Efficacy|9|||
125333843|NCT00337675|450856047|FG000|Overall Study|Lost to Follow-up|22|||
125333844|NCT00337675|450856048|FG001|Overall Study|Lost to Follow-up|19|||
125333845|NCT00337675|450856049|FG002|Overall Study|Lost to Follow-up|17|||
125333846|NCT00337675|450856047|FG000|Overall Study|Physician Decision|9|||
125333847|NCT00337675|450856048|FG001|Overall Study|Physician Decision|17|||
125333848|NCT00337675|450856049|FG002|Overall Study|Physician Decision|14|||
125333849|NCT00337675|450856047|FG000|Overall Study|Protocol Violation|21|||
125333850|NCT00337675|450856048|FG001|Overall Study|Protocol Violation|24|||
125333851|NCT00337675|450856049|FG002|Overall Study|Protocol Violation|19|||
125333852|NCT00337675|450856047|FG000|Overall Study|Withdrawal by Subject|25|||
125333853|NCT00337675|450856048|FG001|Overall Study|Withdrawal by Subject|25|||
125333854|NCT00337675|450856049|FG002|Overall Study|Withdrawal by Subject|19|||
125333855|NCT00337675|450856047|FG000|Overall Study|Progressive Disease|0|||
125333856|NCT00337675|450856048|FG001|Overall Study|Progressive Disease|2|||
125333857|NCT00337675|450856049|FG002|Overall Study|Progressive Disease|0|||
125333858|NCT00337675|450856047|FG000|Overall Study|Trial Terminated|0|||
125333859|NCT00337675|450856048|FG001|Overall Study|Trial Terminated|0|||
125333860|NCT00337675|450856049|FG002|Overall Study|Trial Terminated|2|||
125333861|NCT01491607|450856054|FG000|Overall Study|Lost to Follow-up|7|||
125333862|NCT01491607|450856054|FG000|Overall Study|Withdrawal by Subject|3|||
125333863|NCT01317277|450856055|FG000|Overall Study|Lost to Follow-up|3|||
125333864|NCT01317277|450856056|FG001|Overall Study|Lost to Follow-up|1|||
125333865|NCT01317277|450856055|FG000|Overall Study|Lost MEMS|1|||
125333866|NCT01317277|450856056|FG001|Overall Study|Lost MEMS|1|||
125333867|NCT01317277|450856055|FG000|Overall Study|Unable to comply with intervention|1|||
125333868|NCT01317277|450856056|FG001|Overall Study|Unable to comply with intervention|0|||
125333869|NCT01317277|450856055|FG000|Overall Study|Withdrawal by Subject|1|||
125333870|NCT01317277|450856056|FG001|Overall Study|Withdrawal by Subject|0|||
125333871|NCT01317277|450856055|FG000|Overall Study|Adverse Event|1|||
125333872|NCT01317277|450856056|FG001|Overall Study|Adverse Event|0|||
125333873|NCT00774566|450856057|FG000|Overall Study|Protocol Violation|18|||
125333874|NCT00774566|450856058|FG001|Overall Study|Protocol Violation|15|||
125333875|NCT01075685|450856061|FG000|Overall Study|Protocol Violation|9|||
125333876|NCT01075685|450856062|FG001|Overall Study|Protocol Violation|1|||
125333877|NCT01075685|450856061|FG000|Overall Study|Withdrawal by Subject|20|||
125333878|NCT01075685|450856062|FG001|Overall Study|Withdrawal by Subject|5|||
125333879|NCT01075685|450856061|FG000|Overall Study|Lost to Follow-up|563|||
125333880|NCT01075685|450856062|FG001|Overall Study|Lost to Follow-up|220|||
125333881|NCT02858362|450856063|FG000|Overall Study|Protocol Violation|0|||
125333882|NCT02858362|450856064|FG001|Overall Study|Protocol Violation|1|||
125333883|NCT02858362|450856065|FG002|Overall Study|Protocol Violation|0|||
125333884|NCT02858362|450856063|FG000|Overall Study|Withdrawal by Subject|1|||
125333885|NCT02858362|450856064|FG001|Overall Study|Withdrawal by Subject|0|||
125333886|NCT02858362|450856065|FG002|Overall Study|Withdrawal by Subject|0|||
125333887|NCT02858362|450856063|FG000|Overall Study|Early Study Termination|0|||
125333888|NCT02858362|450856064|FG001|Overall Study|Early Study Termination|0|||
125333889|NCT02858362|450856065|FG002|Overall Study|Early Study Termination|3|||
125333890|NCT02858362|450856063|FG000|Overall Study|Lost to Follow-up|1|||
125333891|NCT02858362|450856064|FG001|Overall Study|Lost to Follow-up|0|||
125333892|NCT02858362|450856065|FG002|Overall Study|Lost to Follow-up|0|||
125333893|NCT01262989|450856066|FG000|Period 1|Lost to Follow-up|1|||
125333894|NCT01262989|450856067|FG001|Period 1|Lost to Follow-up|1|||
125333895|NCT01262989|450856066|FG000|Period 1|Intercurrent disease|0|||
125333896|NCT01262989|450856067|FG001|Period 1|Intercurrent disease|1|||
125333897|NCT01262989|450856066|FG000|Period 1|Positive answer for exclusion criteria|0|||
125333898|NCT01262989|450856067|FG001|Period 1|Positive answer for exclusion criteria|1|||
125333899|NCT01262989|450856066|FG000|Period 2|Intercurrent disease|0|||
125333900|NCT01262989|450856067|FG001|Period 2|Intercurrent disease|1|||
125333901|NCT02813577|450856068|FG000|Overall Study|Study terminated|4|||
125333902|NCT00775593|450856074|FG000|Overall Study|Unmet eligibility criteria|6|||
125333903|NCT00775593|450856074|FG000|Overall Study|Death|1|||
125333904|NCT02067676|450856075|FG000|Overall Study|Withdrawal by Subject|1|||
125333905|NCT02067676|450856076|FG001|Overall Study|Withdrawal by Subject|0|||
125333906|NCT02067676|450856077|FG002|Overall Study|Withdrawal by Subject|0|||
125333907|NCT02067676|450856078|FG003|Overall Study|Withdrawal by Subject|0|||
125333908|NCT02067676|450856079|FG004|Overall Study|Withdrawal by Subject|0|||
125333909|NCT02067676|450856080|FG005|Overall Study|Withdrawal by Subject|0|||
125333910|NCT02164461|450856088|FG000|Overall Study|Adverse Event|0|||
125333911|NCT02164461|450856089|FG001|Overall Study|Adverse Event|0|||
125333912|NCT02164461|450856090|FG002|Overall Study|Adverse Event|1|||
125333913|NCT02164461|450856088|FG000|Overall Study|Disease Progression|1|||
125333914|NCT02164461|450856089|FG001|Overall Study|Disease Progression|3|||
125333915|NCT02164461|450856090|FG002|Overall Study|Disease Progression|4|||
125333916|NCT02164461|450856088|FG000|Overall Study|Withdrawal by Subject|0|||
125333917|NCT02164461|450856089|FG001|Overall Study|Withdrawal by Subject|3|||
125333918|NCT02164461|450856090|FG002|Overall Study|Withdrawal by Subject|0|||
125333919|NCT02100696|450856092|FG000|Induction Phase|Adverse Event|0|||
125333920|NCT02100696|450856093|FG001|Induction Phase|Adverse Event|0|||
125333921|NCT02100696|450856094|FG002|Induction Phase|Adverse Event|1|||
125333922|NCT02100696|450856095|FG003|Induction Phase|Adverse Event|0|||
125333923|NCT02100696|450856096|FG004|Induction Phase|Adverse Event|0|||
125333924|NCT02100696|450856097|FG005|Induction Phase|Adverse Event|0|||
125333925|NCT02100696|450856092|FG000|Induction Phase|Lost to Follow-up|1|||
125333926|NCT02100696|450856093|FG001|Induction Phase|Lost to Follow-up|0|||
125333927|NCT02100696|450856094|FG002|Induction Phase|Lost to Follow-up|1|||
125333928|NCT02100696|450856095|FG003|Induction Phase|Lost to Follow-up|0|||
125333929|NCT02100696|450856096|FG004|Induction Phase|Lost to Follow-up|0|||
125333930|NCT02100696|450856097|FG005|Induction Phase|Lost to Follow-up|0|||
125333931|NCT02100696|450856092|FG000|Induction Phase|Protocol Violation|0|||
125333932|NCT02100696|450856093|FG001|Induction Phase|Protocol Violation|1|||
125333933|NCT02100696|450856094|FG002|Induction Phase|Protocol Violation|1|||
125333934|NCT02100696|450856095|FG003|Induction Phase|Protocol Violation|0|||
125333935|NCT02100696|450856096|FG004|Induction Phase|Protocol Violation|0|||
125333936|NCT02100696|450856097|FG005|Induction Phase|Protocol Violation|0|||
125333937|NCT02100696|450856092|FG000|Induction Phase|Withdrawal by Subject|8|||
125333938|NCT02100696|450856093|FG001|Induction Phase|Withdrawal by Subject|2|||
125333939|NCT02100696|450856094|FG002|Induction Phase|Withdrawal by Subject|13|||
125333940|NCT02100696|450856095|FG003|Induction Phase|Withdrawal by Subject|0|||
125333941|NCT02100696|450856096|FG004|Induction Phase|Withdrawal by Subject|0|||
125333942|NCT02100696|450856097|FG005|Induction Phase|Withdrawal by Subject|0|||
125333943|NCT02100696|450856092|FG000|Induction Phase|Physician Decision|1|||
125333944|NCT02100696|450856093|FG001|Induction Phase|Physician Decision|0|||
125333945|NCT02100696|450856094|FG002|Induction Phase|Physician Decision|2|||
125333946|NCT02100696|450856095|FG003|Induction Phase|Physician Decision|0|||
125333947|NCT02100696|450856096|FG004|Induction Phase|Physician Decision|0|||
125333948|NCT02100696|450856097|FG005|Induction Phase|Physician Decision|0|||
125333949|NCT02100696|450856092|FG000|Induction Phase|Multiple Reasons|5|||
125333950|NCT02100696|450856093|FG001|Induction Phase|Multiple Reasons|2|||
125333951|NCT02100696|450856094|FG002|Induction Phase|Multiple Reasons|8|||
125333952|NCT02100696|450856095|FG003|Induction Phase|Multiple Reasons|0|||
125333953|NCT02100696|450856096|FG004|Induction Phase|Multiple Reasons|0|||
125333954|NCT02100696|450856097|FG005|Induction Phase|Multiple Reasons|0|||
125333955|NCT02100696|450856092|FG000|Maintenance Phase|Adverse Event|0|||
125333956|NCT02100696|450856093|FG001|Maintenance Phase|Adverse Event|0|||
125333957|NCT02100696|450856094|FG002|Maintenance Phase|Adverse Event|0|||
125333958|NCT02100696|450856095|FG003|Maintenance Phase|Adverse Event|0|||
125333959|NCT02100696|450856096|FG004|Maintenance Phase|Adverse Event|0|||
125333960|NCT02100696|450856097|FG005|Maintenance Phase|Adverse Event|2|||
125333961|NCT02100696|450856092|FG000|Maintenance Phase|Lost to Follow-up|0|||
125333962|NCT02100696|450856093|FG001|Maintenance Phase|Lost to Follow-up|0|||
125333963|NCT02100696|450856094|FG002|Maintenance Phase|Lost to Follow-up|0|||
125333964|NCT02100696|450856095|FG003|Maintenance Phase|Lost to Follow-up|0|||
125333965|NCT02100696|450856096|FG004|Maintenance Phase|Lost to Follow-up|1|||
125333966|NCT02100696|450856097|FG005|Maintenance Phase|Lost to Follow-up|0|||
125333967|NCT02100696|450856092|FG000|Maintenance Phase|Protocol Violation|0|||
125333968|NCT02100696|450856093|FG001|Maintenance Phase|Protocol Violation|0|||
125333969|NCT02100696|450856094|FG002|Maintenance Phase|Protocol Violation|0|||
125333970|NCT02100696|450856095|FG003|Maintenance Phase|Protocol Violation|0|||
125333971|NCT02100696|450856096|FG004|Maintenance Phase|Protocol Violation|1|||
125333972|NCT02100696|450856097|FG005|Maintenance Phase|Protocol Violation|0|||
125333973|NCT02100696|450856092|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125333974|NCT02100696|450856093|FG001|Maintenance Phase|Withdrawal by Subject|0|||
125333975|NCT02100696|450856094|FG002|Maintenance Phase|Withdrawal by Subject|0|||
125333976|NCT02100696|450856095|FG003|Maintenance Phase|Withdrawal by Subject|1|||
125333977|NCT02100696|450856096|FG004|Maintenance Phase|Withdrawal by Subject|4|||
125333978|NCT02100696|450856097|FG005|Maintenance Phase|Withdrawal by Subject|2|||
125333979|NCT02100696|450856092|FG000|Maintenance Phase|Physician Decision|0|||
125333980|NCT02100696|450856093|FG001|Maintenance Phase|Physician Decision|0|||
125333981|NCT02100696|450856094|FG002|Maintenance Phase|Physician Decision|0|||
125333982|NCT02100696|450856095|FG003|Maintenance Phase|Physician Decision|0|||
125333983|NCT02100696|450856096|FG004|Maintenance Phase|Physician Decision|1|||
125333984|NCT02100696|450856097|FG005|Maintenance Phase|Physician Decision|0|||
125333985|NCT02100696|450856092|FG000|Maintenance Phase|Multiple Reasons|0|||
125333986|NCT02100696|450856093|FG001|Maintenance Phase|Multiple Reasons|0|||
125333987|NCT02100696|450856094|FG002|Maintenance Phase|Multiple Reasons|0|||
125333988|NCT02100696|450856095|FG003|Maintenance Phase|Multiple Reasons|0|||
125333989|NCT02100696|450856096|FG004|Maintenance Phase|Multiple Reasons|2|||
125333990|NCT02100696|450856097|FG005|Maintenance Phase|Multiple Reasons|1|||
125333991|NCT03865381|450856100|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
125333992|NCT03865381|450856100|FG000|Overall Study|Withdrawal by Subject|2|||
125333993|NCT05626322|450856101|FG000|Overall Study|Death|2|||
125333994|NCT05626322|450856102|FG001|Overall Study|Death|0|||
125333995|NCT05626322|450856103|FG002|Overall Study|Death|0|||
125333996|NCT05626322|450856101|FG000|Overall Study|Physician Decision|1|||
125333997|NCT05626322|450856102|FG001|Overall Study|Physician Decision|0|||
125333998|NCT05626322|450856103|FG002|Overall Study|Physician Decision|0|||
125333999|NCT05626322|450856101|FG000|Overall Study|Progressive Disease|0|||
125334000|NCT05626322|450856102|FG001|Overall Study|Progressive Disease|1|||
125334001|NCT05626322|450856103|FG002|Overall Study|Progressive Disease|1|||
125334002|NCT05626322|450856101|FG000|Overall Study|Study terminated by sponsor|0|||
125334003|NCT05626322|450856102|FG001|Overall Study|Study terminated by sponsor|1|||
125334004|NCT05626322|450856103|FG002|Overall Study|Study terminated by sponsor|0|||
125334005|NCT00369265|450856104|FG000|Overall Study|Study terminated|4|||
125334006|NCT00369265|450856105|FG001|Overall Study|Study terminated|7|||
125334007|NCT00048074|450856108|FG000|Overall Study|Adverse Event|46|||
125334008|NCT00048074|450856109|FG001|Overall Study|Adverse Event|41|||
125334009|NCT00048074|450856110|FG002|Overall Study|Adverse Event|53|||
125334010|NCT00048074|450856108|FG000|Overall Study|Death|3|||
125334011|NCT00048074|450856109|FG001|Overall Study|Death|3|||
125334012|NCT00048074|450856110|FG002|Overall Study|Death|2|||
125334013|NCT00048074|450856108|FG000|Overall Study|Lost to Follow-up|2|||
125334014|NCT00048074|450856109|FG001|Overall Study|Lost to Follow-up|6|||
125334015|NCT00048074|450856110|FG002|Overall Study|Lost to Follow-up|6|||
125334016|NCT00048074|450856108|FG000|Overall Study|Withdrawal by Subject|28|||
125334017|NCT00048074|450856109|FG001|Overall Study|Withdrawal by Subject|30|||
125334018|NCT00048074|450856110|FG002|Overall Study|Withdrawal by Subject|35|||
125334019|NCT00048074|450856108|FG000|Overall Study|Protocol Violation|1|||
125334020|NCT00048074|450856109|FG001|Overall Study|Protocol Violation|3|||
125334021|NCT00048074|450856110|FG002|Overall Study|Protocol Violation|0|||
125334022|NCT00048074|450856108|FG000|Overall Study|Study participation was terminated|0|||
125334023|NCT00048074|450856109|FG001|Overall Study|Study participation was terminated|1|||
125334024|NCT00048074|450856110|FG002|Overall Study|Study participation was terminated|0|||
125334025|NCT00048074|450856108|FG000|Overall Study|Husband ill|0|||
125334026|NCT00048074|450856109|FG001|Overall Study|Husband ill|1|||
125334027|NCT00048074|450856110|FG002|Overall Study|Husband ill|0|||
125334028|NCT00048074|450856108|FG000|Overall Study|Poor compliance|0|||
125334029|NCT00048074|450856109|FG001|Overall Study|Poor compliance|1|||
125334030|NCT00048074|450856110|FG002|Overall Study|Poor compliance|0|||
125334031|NCT00048074|450856108|FG000|Overall Study|Out of station|0|||
125334032|NCT00048074|450856109|FG001|Overall Study|Out of station|1|||
125334033|NCT00048074|450856110|FG002|Overall Study|Out of station|1|||
125334034|NCT00048074|450856108|FG000|Overall Study|Social reasons|1|||
125334035|NCT00048074|450856109|FG001|Overall Study|Social reasons|0|||
125334036|NCT00048074|450856110|FG002|Overall Study|Social reasons|0|||
125334037|NCT02873377|450856111|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
125334038|NCT02873377|450856112|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
125334039|NCT02873377|450856111|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
125334040|NCT02873377|450856112|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
125334041|NCT00740857|450856121|FG000|Overall Study|Withdrawal by Subject|1|||
125334042|NCT00740857|450856122|FG001|Overall Study|Withdrawal by Subject|0|||
125334043|NCT00740857|450856123|FG002|Overall Study|Withdrawal by Subject|0|||
125334044|NCT03532451|450856127|FG000|Overall Study|Withdrawal by Subject|0|||
125334045|NCT03532451|450856128|FG001|Overall Study|Withdrawal by Subject|1|||
125334046|NCT03532451|450856127|FG000|Overall Study|Did not undergo surgery|1|||
125334047|NCT03532451|450856128|FG001|Overall Study|Did not undergo surgery|1|||
125334048|NCT01519167|450856129|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
125334049|NCT01519167|450856130|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
125334050|NCT01519167|450856129|FG000|Overall Study|Adverse Event|0|||
125334051|NCT01519167|450856130|FG001|Overall Study|Adverse Event|1|||
125334052|NCT01519167|450856129|FG000|Overall Study|Lack of Efficacy|0|||
125334053|NCT01519167|450856130|FG001|Overall Study|Lack of Efficacy|1|||
125334054|NCT01519167|450856129|FG000|Overall Study|Medical condition changes&deep sedation|0|||
125334055|NCT01519167|450856130|FG001|Overall Study|Medical condition changes&deep sedation|2|||
125334056|NCT01519167|450856129|FG000|Overall Study|Physician Decision|0|||
125334057|NCT01519167|450856130|FG001|Overall Study|Physician Decision|1|||
125334058|NCT04200352|450856141|FG000|Overall Study|Death|1|||
125334059|NCT04200352|450856141|FG000|Overall Study|Adverse Event|6|||
125334060|NCT04200352|450856141|FG000|Overall Study|Withdrawal by parent/guardian|6|||
125334061|NCT04200352|450856141|FG000|Overall Study|Lack of Efficacy|1|||
125334062|NCT04200352|450856141|FG000|Overall Study|Other than specified|6|||
125334063|NCT00233064|450856142|FG000|Overall Study|Lost to Follow-up|7|||
125334064|NCT00233064|450856143|FG001|Overall Study|Lost to Follow-up|7|||
125334065|NCT00233064|450856142|FG000|Overall Study|Withdrawal by Subject|5|||
125334066|NCT00233064|450856143|FG001|Overall Study|Withdrawal by Subject|3|||
125334067|NCT00233064|450856142|FG000|Overall Study|Death|0|||
125334068|NCT00233064|450856143|FG001|Overall Study|Death|1|||
125334069|NCT00233064|450856142|FG000|Overall Study|Relocation|0|||
125334070|NCT00233064|450856143|FG001|Overall Study|Relocation|1|||
125334071|NCT00233064|450856142|FG000|Overall Study|Protocol Violation|1|||
125334072|NCT00233064|450856143|FG001|Overall Study|Protocol Violation|0|||
125334073|NCT00233064|450856142|FG000|Overall Study|Moved to Dom. Republic|1|||
125334074|NCT00233064|450856143|FG001|Overall Study|Moved to Dom. Republic|0|||
125334075|NCT01120964|450856150|FG000|Overall Study|Did not receive full treatment|1|||
125334076|NCT01120964|450856151|FG001|Overall Study|Did not receive full treatment|0|||
125334077|NCT04237116|450856155|FG000|Overall Study|Adverse Event|0|||
125334078|NCT04237116|450856156|FG001|Overall Study|Adverse Event|1|||
125334079|NCT04237116|450856155|FG000|Overall Study|Study terminated by Sponsor|4|||
125334080|NCT04237116|450856156|FG001|Overall Study|Study terminated by Sponsor|1|||
125334081|NCT00829504|450856157|FG000|First Intervention|Adverse Event|1|||
125334082|NCT00829504|450856158|FG001|First Intervention|Adverse Event|0|||
125334083|NCT00829504|450856157|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125334084|NCT00829504|450856158|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125334085|NCT00829504|450856157|FG000|Second Intervention|Physician Decision|1|||
125334086|NCT00829504|450856158|FG001|Second Intervention|Physician Decision|0|||
125334087|NCT03212144|450856159|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
125334088|NCT03212144|450856160|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
125334089|NCT03212144|450856159|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
125334090|NCT03212144|450856160|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
125334091|NCT00599339|450856161|FG000|Overall Study|Adverse Event|79|||
125334092|NCT00599339|450856161|FG000|Overall Study|Withdrawal by Subject|137|||
125334093|NCT00599339|450856161|FG000|Overall Study|Other Reason|179|||
125334094|NCT00599339|450856161|FG000|Overall Study|Lost to Follow-up|221|||
125334095|NCT00599339|450856161|FG000|Overall Study|No valid data consent|36|||
125334096|NCT00599339|450856161|FG000|Overall Study|Study Termination Status Unknown|12|||
125334097|NCT05307692|450856163|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
125334098|NCT05307692|450856164|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
125334099|NCT05307692|450856165|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
125334100|NCT05307692|450856166|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
125334101|NCT05307692|450856163|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
125334102|NCT05307692|450856164|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
125334103|NCT05307692|450856165|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
125334104|NCT05307692|450856166|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
125334105|NCT05307692|450856163|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
125334106|NCT05307692|450856164|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
125334107|NCT05307692|450856165|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
125334108|NCT05307692|450856166|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
125334109|NCT05307692|450856163|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
125334110|NCT05307692|450856164|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
125334111|NCT05307692|450856165|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
125334112|NCT05307692|450856166|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
125334113|NCT05307692|450856163|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
125334114|NCT05307692|450856164|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
125334115|NCT05307692|450856165|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
125334116|NCT05307692|450856166|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
125334117|NCT05307692|450856163|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
125334118|NCT05307692|450856164|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
125334119|NCT05307692|450856165|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
125334120|NCT05307692|450856166|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
125334121|NCT05307692|450856163|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
125670190|NCT01952574|452079773|FG001|Open-label Treatment Phase|Death|0|||
125334122|NCT05307692|450856164|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
125334123|NCT05307692|450856165|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
125334124|NCT05307692|450856166|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
125334125|NCT05307692|450856163|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
125334126|NCT05307692|450856164|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
125334127|NCT05307692|450856165|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
125334128|NCT05307692|450856166|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
125334129|NCT02003924|450856173|FG000|Double-blind Phase|Lost to Follow-up|2|||
125334130|NCT02003924|450856174|FG001|Double-blind Phase|Lost to Follow-up|1|||
125334131|NCT02003924|450856175|FG002|Double-blind Phase|Lost to Follow-up|0|||
125334132|NCT02003924|450856173|FG000|Double-blind Phase|Protocol Violation|1|||
125334133|NCT02003924|450856174|FG001|Double-blind Phase|Protocol Violation|2|||
125334134|NCT02003924|450856175|FG002|Double-blind Phase|Protocol Violation|0|||
125334135|NCT02003924|450856173|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
125334136|NCT02003924|450856174|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
125334137|NCT02003924|450856175|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
125334138|NCT02003924|450856173|FG000|Double-blind Phase|Disease Progression|229|||
125334139|NCT02003924|450856174|FG001|Double-blind Phase|Disease Progression|247|||
125334140|NCT02003924|450856175|FG002|Double-blind Phase|Disease Progression|0|||
125334141|NCT02003924|450856173|FG000|Double-blind Phase|Adverse Event|120|||
125334142|NCT02003924|450856174|FG001|Double-blind Phase|Adverse Event|31|||
125334143|NCT02003924|450856175|FG002|Double-blind Phase|Adverse Event|0|||
125334144|NCT02003924|450856173|FG000|Double-blind Phase|Randomized But not Treated|3|||
125334145|NCT02003924|450856174|FG001|Double-blind Phase|Randomized But not Treated|3|||
125334146|NCT02003924|450856175|FG002|Double-blind Phase|Randomized But not Treated|0|||
125334147|NCT02003924|450856173|FG000|Double-blind Phase|Other|29|||
125334148|NCT02003924|450856174|FG001|Double-blind Phase|Other|50|||
125334149|NCT02003924|450856175|FG002|Double-blind Phase|Other|0|||
125334150|NCT02003924|450856173|FG000|Open-label Phase|Lost to Follow-up|0|||
125334151|NCT02003924|450856174|FG001|Open-label Phase|Lost to Follow-up|0|||
125334152|NCT02003924|450856175|FG002|Open-label Phase|Lost to Follow-up|1|||
125334153|NCT02003924|450856173|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
125334154|NCT02003924|450856174|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
125334155|NCT02003924|450856175|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
125334156|NCT02003924|450856173|FG000|Open-label Phase|Disease Progression|59|||
125334157|NCT02003924|450856174|FG001|Open-label Phase|Disease Progression|0|||
125334158|NCT02003924|450856175|FG002|Open-label Phase|Disease Progression|5|||
125334159|NCT02003924|450856173|FG000|Open-label Phase|Adverse Event|25|||
125334160|NCT02003924|450856174|FG001|Open-label Phase|Adverse Event|0|||
125334161|NCT02003924|450856175|FG002|Open-label Phase|Adverse Event|10|||
125334162|NCT02003924|450856173|FG000|Open-label Phase|Other|7|||
125334163|NCT02003924|450856174|FG001|Open-label Phase|Other|0|||
125334164|NCT02003924|450856175|FG002|Open-label Phase|Other|0|||
125334165|NCT02003924|450856173|FG000|Long-term Follow-up Phase|Death|288|||
125334166|NCT02003924|450856174|FG001|Long-term Follow-up Phase|Death|174|||
125334167|NCT02003924|450856175|FG002|Long-term Follow-up Phase|Death|4|||
125334168|NCT02003924|450856173|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
125334169|NCT02003924|450856174|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
125334170|NCT02003924|450856175|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
125334171|NCT02003924|450856173|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
125334172|NCT02003924|450856174|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
125334173|NCT02003924|450856175|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
125334174|NCT02003924|450856173|FG000|Long-term Follow-up Phase|Other|5|||
125334175|NCT02003924|450856174|FG001|Long-term Follow-up Phase|Other|2|||
125334176|NCT02003924|450856175|FG002|Long-term Follow-up Phase|Other|1|||
125334177|NCT00114517|450856182|FG000|Overall Study|Adverse Event|6|||
125334178|NCT00114517|450856183|FG001|Overall Study|Adverse Event|1|||
125334179|NCT00114517|450856184|FG002|Overall Study|Adverse Event|6|||
125334180|NCT00114517|450856185|FG003|Overall Study|Adverse Event|3|||
125334181|NCT00114517|450856182|FG000|Overall Study|Lost to Follow-up|2|||
125334182|NCT00114517|450856183|FG001|Overall Study|Lost to Follow-up|2|||
125670191|NCT01952574|452079774|FG002|Open-label Treatment Phase|Death|0|||
125670192|NCT01952574|452079775|FG003|Open-label Treatment Phase|Death|0|||
125334183|NCT00114517|450856184|FG002|Overall Study|Lost to Follow-up|2|||
125670193|NCT01952574|452079776|FG004|Open-label Treatment Phase|Death|1|||
125334184|NCT00114517|450856185|FG003|Overall Study|Lost to Follow-up|1|||
125334185|NCT00114517|450856182|FG000|Overall Study|Too busy|3|||
125334186|NCT00114517|450856183|FG001|Overall Study|Too busy|1|||
125334187|NCT00114517|450856184|FG002|Overall Study|Too busy|1|||
125334188|NCT00114517|450856185|FG003|Overall Study|Too busy|2|||
125334189|NCT00114517|450856182|FG000|Overall Study|Moved from area|0|||
125334190|NCT00114517|450856183|FG001|Overall Study|Moved from area|3|||
125334191|NCT00114517|450856184|FG002|Overall Study|Moved from area|2|||
125334192|NCT00114517|450856185|FG003|Overall Study|Moved from area|1|||
125334193|NCT00114517|450856182|FG000|Overall Study|Did not want estradiol|1|||
125670194|NCT01952574|452079777|FG005|Open-label Treatment Phase|Death|0|||
125334194|NCT00114517|450856183|FG001|Overall Study|Did not want estradiol|1|||
125334195|NCT00114517|450856184|FG002|Overall Study|Did not want estradiol|0|||
125334196|NCT00114517|450856185|FG003|Overall Study|Did not want estradiol|0|||
125334197|NCT00114517|450856182|FG000|Overall Study|Armed-services duty|0|||
125334198|NCT00114517|450856183|FG001|Overall Study|Armed-services duty|1|||
125334199|NCT00114517|450856184|FG002|Overall Study|Armed-services duty|0|||
125334200|NCT00114517|450856185|FG003|Overall Study|Armed-services duty|1|||
125334201|NCT00114517|450856182|FG000|Overall Study|Competing family issue|0|||
125334202|NCT00114517|450856183|FG001|Overall Study|Competing family issue|1|||
125334203|NCT00114517|450856184|FG002|Overall Study|Competing family issue|0|||
125334204|NCT00114517|450856185|FG003|Overall Study|Competing family issue|1|||
125334205|NCT00114517|450856182|FG000|Overall Study|Physician Decision|0|||
125334206|NCT00114517|450856183|FG001|Overall Study|Physician Decision|1|||
125334207|NCT00114517|450856184|FG002|Overall Study|Physician Decision|0|||
125334208|NCT00114517|450856185|FG003|Overall Study|Physician Decision|0|||
125334209|NCT00114517|450856182|FG000|Overall Study|Lost interest|0|||
125334210|NCT00114517|450856183|FG001|Overall Study|Lost interest|0|||
125334211|NCT00114517|450856184|FG002|Overall Study|Lost interest|1|||
125334212|NCT00114517|450856185|FG003|Overall Study|Lost interest|0|||
125334213|NCT00114517|450856182|FG000|Overall Study|Weight increase|0|||
125334214|NCT00114517|450856183|FG001|Overall Study|Weight increase|0|||
125334215|NCT00114517|450856184|FG002|Overall Study|Weight increase|1|||
125334216|NCT00114517|450856185|FG003|Overall Study|Weight increase|0|||
125334217|NCT00114517|450856182|FG000|Overall Study|Concern about blood clots|0|||
125334218|NCT00114517|450856183|FG001|Overall Study|Concern about blood clots|0|||
125334219|NCT00114517|450856184|FG002|Overall Study|Concern about blood clots|1|||
125334220|NCT00114517|450856185|FG003|Overall Study|Concern about blood clots|0|||
125334221|NCT00114517|450856182|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
125334222|NCT00114517|450856183|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
125334223|NCT00114517|450856184|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
125334224|NCT00114517|450856185|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
125334225|NCT00702715|450857988|FG000|Overall Study|Lost to Follow-up|1|||
125334226|NCT00702715|450857989|FG001|Overall Study|Lost to Follow-up|0|||
125334227|NCT02840799|450857992|FG000|Phase 1|Physician Decision|1|||
125334228|NCT02840799|450857993|FG001|Phase 1|Physician Decision|3|||
125334229|NCT02840799|450857992|FG000|Phase 1|Withdrawal by Subject|4|||
125334230|NCT02840799|450857993|FG001|Phase 1|Withdrawal by Subject|0|||
125334231|NCT02840799|450857992|FG000|Phase 2 (Crossover)|Adverse Event|0|||
125334232|NCT02840799|450857993|FG001|Phase 2 (Crossover)|Adverse Event|1|||
125334233|NCT02840799|450857992|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
125334234|NCT02840799|450857993|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
125334235|NCT01193257|450857999|FG000|Overall Study|Death|202|||
125334236|NCT01193257|450858000|FG001|Overall Study|Death|391|||
125334237|NCT01193257|450857999|FG000|Overall Study|Study termination by sponsor|0|||
125670195|NCT01952574|452079778|FG006|Open-label Treatment Phase|Death|0|||
125670196|NCT01952574|452079772|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
125670197|NCT01952574|452079773|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
125670198|NCT01952574|452079774|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
125670199|NCT01952574|452079775|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
125670200|NCT01952574|452079776|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
125670201|NCT01952574|452079777|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
125670202|NCT01952574|452079778|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
125670203|NCT01952574|452079772|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
125670204|NCT01952574|452079773|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
125670205|NCT01952574|452079774|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
125670206|NCT01952574|452079775|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
125670207|NCT01952574|452079776|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
125670208|NCT01952574|452079777|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
125670209|NCT01952574|452079778|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
125670210|NCT02974114|452079780|FG000|Overall Study|Other (Not specified)|0|||
125670211|NCT02974114|452079781|FG001|Overall Study|Other (Not specified)|1|||
125334238|NCT01193257|450858000|FG001|Overall Study|Study termination by sponsor|3|||
125334239|NCT01193257|450857999|FG000|Overall Study|Withdrawal by Subject|26|||
125334240|NCT01193257|450858000|FG001|Overall Study|Withdrawal by Subject|86|||
125334241|NCT01193257|450857999|FG000|Overall Study|Lost to Follow-up|2|||
125334242|NCT01193257|450858000|FG001|Overall Study|Lost to Follow-up|3|||
125334243|NCT01193257|450857999|FG000|Overall Study|Unblinded due to futility|135|||
125334244|NCT01193257|450858000|FG001|Overall Study|Unblinded due to futility|251|||
125334245|NCT01621802|450858004|FG000|Overall Study|Protocol Violation|0|||
125334246|NCT01621802|450858005|FG001|Overall Study|Protocol Violation|0|||
125334247|NCT01621802|450858006|FG002|Overall Study|Protocol Violation|0|||
125334248|NCT01621802|450858007|FG003|Overall Study|Protocol Violation|0|||
125334249|NCT01621802|450858008|FG004|Overall Study|Protocol Violation|0|||
125334250|NCT01621802|450858009|FG005|Overall Study|Protocol Violation|1|||
125334251|NCT01621802|450858004|FG000|Overall Study|Withdrawal by Subject|8|||
125334252|NCT01621802|450858005|FG001|Overall Study|Withdrawal by Subject|4|||
125334253|NCT01621802|450858006|FG002|Overall Study|Withdrawal by Subject|4|||
125334254|NCT01621802|450858007|FG003|Overall Study|Withdrawal by Subject|2|||
125334255|NCT01621802|450858008|FG004|Overall Study|Withdrawal by Subject|2|||
125334256|NCT01621802|450858009|FG005|Overall Study|Withdrawal by Subject|0|||
125334257|NCT01621802|450858004|FG000|Overall Study|Migrated/moved from study area|0|||
125334258|NCT01621802|450858005|FG001|Overall Study|Migrated/moved from study area|0|||
125334259|NCT01621802|450858006|FG002|Overall Study|Migrated/moved from study area|2|||
125334260|NCT01621802|450858007|FG003|Overall Study|Migrated/moved from study area|0|||
125334261|NCT01621802|450858008|FG004|Overall Study|Migrated/moved from study area|1|||
125334262|NCT01621802|450858009|FG005|Overall Study|Migrated/moved from study area|0|||
125334263|NCT01621802|450858004|FG000|Overall Study|Others|3|||
125334264|NCT01621802|450858005|FG001|Overall Study|Others|3|||
125334265|NCT01621802|450858006|FG002|Overall Study|Others|3|||
125334266|NCT01621802|450858007|FG003|Overall Study|Others|2|||
125334267|NCT01621802|450858008|FG004|Overall Study|Others|1|||
125334268|NCT01621802|450858009|FG005|Overall Study|Others|0|||
125334269|NCT01621802|450858004|FG000|Overall Study|Lost to Follow-up|36|||
125334270|NCT01621802|450858005|FG001|Overall Study|Lost to Follow-up|16|||
125334271|NCT01621802|450858006|FG002|Overall Study|Lost to Follow-up|24|||
125334272|NCT01621802|450858007|FG003|Overall Study|Lost to Follow-up|7|||
125334273|NCT01621802|450858008|FG004|Overall Study|Lost to Follow-up|31|||
125334274|NCT01621802|450858009|FG005|Overall Study|Lost to Follow-up|11|||
125334275|NCT02948634|450858010|FG000|Overall Study|Lack of efficacy and study suspended|10|||
125334276|NCT02948634|450858011|FG001|Overall Study|Lack of efficacy and study suspended|2|||
125334277|NCT03052400|450858014|FG000|Overall Study|Lost to Follow-up|1|||
125334278|NCT03052400|450858015|FG001|Overall Study|Lost to Follow-up|0|||
125334279|NCT03052400|450858014|FG000|Overall Study|Withdrawal by Subject|0|||
125334280|NCT03052400|450858015|FG001|Overall Study|Withdrawal by Subject|1|||
125334281|NCT00555061|450858016|FG000|Overall Study|Adverse Event|3|||
125334282|NCT00555061|450858016|FG000|Overall Study|Protocol Violation|1|||
125334283|NCT00555061|450858016|FG000|Overall Study|Lost to Follow-up|2|||
125334284|NCT00555061|450858016|FG000|Overall Study|Withdrawal by Subject|2|||
125334285|NCT00555061|450858016|FG000|Overall Study|Participant enrolled, but never treated|1|||
125334286|NCT00485134|450858018|FG000|Overall Study|Lost to Follow-up|1|||
125334287|NCT00485134|450858019|FG001|Overall Study|Lost to Follow-up|0|||
125334288|NCT00485134|450858020|FG002|Overall Study|Lost to Follow-up|0|||
125334289|NCT00485134|450858021|FG003|Overall Study|Lost to Follow-up|0|||
125334290|NCT00485134|450858022|FG004|Overall Study|Lost to Follow-up|0|||
125334291|NCT00485134|450858023|FG005|Overall Study|Lost to Follow-up|0|||
125334292|NCT00485134|450858024|FG006|Overall Study|Lost to Follow-up|0|||
125334293|NCT00485134|450858025|FG007|Overall Study|Lost to Follow-up|0|||
125334294|NCT00485134|450858018|FG000|Overall Study|Withdrawal by Subject|0|||
125334295|NCT00485134|450858019|FG001|Overall Study|Withdrawal by Subject|1|||
125334296|NCT00485134|450858020|FG002|Overall Study|Withdrawal by Subject|0|||
125334297|NCT00485134|450858021|FG003|Overall Study|Withdrawal by Subject|0|||
125334298|NCT00485134|450858022|FG004|Overall Study|Withdrawal by Subject|0|||
125334299|NCT00485134|450858023|FG005|Overall Study|Withdrawal by Subject|0|||
125334300|NCT00485134|450858024|FG006|Overall Study|Withdrawal by Subject|0|||
125334301|NCT00485134|450858025|FG007|Overall Study|Withdrawal by Subject|0|||
125334302|NCT00485134|450858018|FG000|Overall Study|Change in health status|0|||
125334303|NCT00485134|450858019|FG001|Overall Study|Change in health status|1|||
125334304|NCT00485134|450858020|FG002|Overall Study|Change in health status|2|||
125334305|NCT00485134|450858021|FG003|Overall Study|Change in health status|1|||
125334306|NCT00485134|450858022|FG004|Overall Study|Change in health status|0|||
125334307|NCT00485134|450858023|FG005|Overall Study|Change in health status|1|||
125334308|NCT00485134|450858024|FG006|Overall Study|Change in health status|0|||
125334309|NCT00485134|450858025|FG007|Overall Study|Change in health status|0|||
125334310|NCT00485134|450858018|FG000|Overall Study|Withdrew for adverse event|0|||
125334311|NCT00485134|450858019|FG001|Overall Study|Withdrew for adverse event|0|||
125334312|NCT00485134|450858020|FG002|Overall Study|Withdrew for adverse event|1|||
125334313|NCT00485134|450858021|FG003|Overall Study|Withdrew for adverse event|0|||
125334314|NCT00485134|450858022|FG004|Overall Study|Withdrew for adverse event|0|||
125334315|NCT00485134|450858023|FG005|Overall Study|Withdrew for adverse event|0|||
125334316|NCT00485134|450858024|FG006|Overall Study|Withdrew for adverse event|0|||
125334317|NCT00485134|450858025|FG007|Overall Study|Withdrew for adverse event|0|||
125334318|NCT00485134|450858018|FG000|Overall Study|Positive drug test|0|||
125334319|NCT00485134|450858019|FG001|Overall Study|Positive drug test|0|||
125334320|NCT00485134|450858020|FG002|Overall Study|Positive drug test|0|||
125334321|NCT00485134|450858021|FG003|Overall Study|Positive drug test|0|||
125334322|NCT00485134|450858022|FG004|Overall Study|Positive drug test|2|||
125334323|NCT00485134|450858023|FG005|Overall Study|Positive drug test|1|||
125334324|NCT00485134|450858024|FG006|Overall Study|Positive drug test|0|||
125334325|NCT00485134|450858025|FG007|Overall Study|Positive drug test|0|||
125334326|NCT00485134|450858018|FG000|Overall Study|Non-compliance|0|||
125334327|NCT00485134|450858019|FG001|Overall Study|Non-compliance|0|||
125334328|NCT00485134|450858020|FG002|Overall Study|Non-compliance|0|||
125334329|NCT00485134|450858021|FG003|Overall Study|Non-compliance|0|||
125334330|NCT00485134|450858022|FG004|Overall Study|Non-compliance|1|||
125334331|NCT00485134|450858023|FG005|Overall Study|Non-compliance|2|||
125334332|NCT00485134|450858024|FG006|Overall Study|Non-compliance|2|||
125334333|NCT00485134|450858025|FG007|Overall Study|Non-compliance|0|||
125334334|NCT00485134|450858018|FG000|Overall Study|Unable to comply with study schedule|0|||
125334335|NCT00485134|450858019|FG001|Overall Study|Unable to comply with study schedule|0|||
125334336|NCT00485134|450858020|FG002|Overall Study|Unable to comply with study schedule|0|||
125334337|NCT00485134|450858021|FG003|Overall Study|Unable to comply with study schedule|0|||
125334338|NCT00485134|450858022|FG004|Overall Study|Unable to comply with study schedule|0|||
125334339|NCT00485134|450858023|FG005|Overall Study|Unable to comply with study schedule|0|||
125334340|NCT00485134|450858024|FG006|Overall Study|Unable to comply with study schedule|0|||
125334341|NCT00485134|450858025|FG007|Overall Study|Unable to comply with study schedule|1|||
125334342|NCT00485134|450858018|FG000|Overall Study|Pregnancy|0|||
125334343|NCT00485134|450858019|FG001|Overall Study|Pregnancy|0|||
125334344|NCT00485134|450858020|FG002|Overall Study|Pregnancy|0|||
125334345|NCT00485134|450858021|FG003|Overall Study|Pregnancy|0|||
125334346|NCT00485134|450858022|FG004|Overall Study|Pregnancy|0|||
125334347|NCT00485134|450858023|FG005|Overall Study|Pregnancy|0|||
125334348|NCT00485134|450858024|FG006|Overall Study|Pregnancy|1|||
125334349|NCT00485134|450858025|FG007|Overall Study|Pregnancy|0|||
125334350|NCT00970684|450858026|FG000|Overall Study|Lack of Efficacy|5|||
125334351|NCT00970684|450858026|FG000|Overall Study|Adverse Event|4|||
125334352|NCT00970684|450858026|FG000|Overall Study|Withdrawal by Subject|1|||
125334353|NCT00481091|450858027|FG000|Overall Study|Withdrawal by Subject|0|||
125334354|NCT00481091|450858028|FG001|Overall Study|Withdrawal by Subject|1|||
125334355|NCT00481091|450858029|FG002|Overall Study|Withdrawal by Subject|1|||
125334356|NCT00481091|450858030|FG003|Overall Study|Withdrawal by Subject|0|||
125334357|NCT00481091|450858031|FG004|Overall Study|Withdrawal by Subject|0|||
125334358|NCT00481091|450858032|FG005|Overall Study|Withdrawal by Subject|0|||
125334359|NCT00481091|450858033|FG006|Overall Study|Withdrawal by Subject|0|||
125334360|NCT00481091|450858034|FG007|Overall Study|Withdrawal by Subject|0|||
125334361|NCT00481091|450858035|FG008|Overall Study|Withdrawal by Subject|1|||
125334362|NCT00481091|450858036|FG009|Overall Study|Withdrawal by Subject|6|||
125334363|NCT00481091|450858027|FG000|Overall Study|Other, Not Specified|0|||
125334364|NCT00481091|450858028|FG001|Overall Study|Other, Not Specified|1|||
125334365|NCT00481091|450858029|FG002|Overall Study|Other, Not Specified|1|||
125670212|NCT02974114|452079782|FG002|Overall Study|Other (Not specified)|2|||
125670213|NCT01580020|452079783|FG000|Overall Study|Lack of Efficacy|0|||
125670214|NCT01580020|452079784|FG001|Overall Study|Lack of Efficacy|5|||
125670215|NCT01580020|452079785|FG002|Overall Study|Lack of Efficacy|0|||
125670216|NCT01580020|452079786|FG003|Overall Study|Lack of Efficacy|1|||
125670217|NCT01580020|452079783|FG000|Overall Study|Withdrawal by Subject|0|||
125670218|NCT01580020|452079784|FG001|Overall Study|Withdrawal by Subject|1|||
125670219|NCT01580020|452079785|FG002|Overall Study|Withdrawal by Subject|1|||
125334366|NCT00481091|450858030|FG003|Overall Study|Other, Not Specified|0|||
125334367|NCT00481091|450858031|FG004|Overall Study|Other, Not Specified|0|||
125334368|NCT00481091|450858032|FG005|Overall Study|Other, Not Specified|1|||
125334369|NCT00481091|450858033|FG006|Overall Study|Other, Not Specified|0|||
125334370|NCT00481091|450858034|FG007|Overall Study|Other, Not Specified|0|||
125334371|NCT00481091|450858035|FG008|Overall Study|Other, Not Specified|0|||
125334372|NCT00481091|450858036|FG009|Overall Study|Other, Not Specified|4|||
125334373|NCT00481091|450858027|FG000|Overall Study|Adverse Event|1|||
125334374|NCT00481091|450858028|FG001|Overall Study|Adverse Event|2|||
125334375|NCT00481091|450858029|FG002|Overall Study|Adverse Event|0|||
125334376|NCT00481091|450858030|FG003|Overall Study|Adverse Event|1|||
125334377|NCT00481091|450858031|FG004|Overall Study|Adverse Event|1|||
125334378|NCT00481091|450858032|FG005|Overall Study|Adverse Event|1|||
125334379|NCT00481091|450858033|FG006|Overall Study|Adverse Event|2|||
125334380|NCT00481091|450858034|FG007|Overall Study|Adverse Event|1|||
125334381|NCT00481091|450858035|FG008|Overall Study|Adverse Event|1|||
125334382|NCT00481091|450858036|FG009|Overall Study|Adverse Event|6|||
125334383|NCT00481091|450858027|FG000|Overall Study|Progressive disease clinical|0|||
125334384|NCT00481091|450858028|FG001|Overall Study|Progressive disease clinical|0|||
125334385|NCT00481091|450858029|FG002|Overall Study|Progressive disease clinical|0|||
125334386|NCT00481091|450858030|FG003|Overall Study|Progressive disease clinical|0|||
125334387|NCT00481091|450858031|FG004|Overall Study|Progressive disease clinical|0|||
125670220|NCT01580020|452079786|FG003|Overall Study|Withdrawal by Subject|0|||
125670221|NCT01580020|452079783|FG000|Overall Study|Adverse Event|1|||
125334388|NCT00481091|450858032|FG005|Overall Study|Progressive disease clinical|0|||
125334389|NCT00481091|450858033|FG006|Overall Study|Progressive disease clinical|0|||
125334390|NCT00481091|450858034|FG007|Overall Study|Progressive disease clinical|0|||
125334391|NCT00481091|450858035|FG008|Overall Study|Progressive disease clinical|1|||
125334392|NCT00481091|450858036|FG009|Overall Study|Progressive disease clinical|7|||
125334393|NCT00481091|450858027|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
125334394|NCT00481091|450858028|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
125670222|NCT01580020|452079784|FG001|Overall Study|Adverse Event|1|||
125334395|NCT00481091|450858029|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334396|NCT00481091|450858030|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334397|NCT00481091|450858031|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334398|NCT00481091|450858032|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
125334399|NCT00481091|450858033|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334400|NCT00481091|450858034|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334401|NCT00481091|450858035|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334402|NCT00481091|450858036|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
125334403|NCT00481091|450858027|FG000|Overall Study|Progressive disease other|1|||
125334404|NCT00481091|450858028|FG001|Overall Study|Progressive disease other|1|||
125334405|NCT00481091|450858029|FG002|Overall Study|Progressive disease other|0|||
125334406|NCT00481091|450858030|FG003|Overall Study|Progressive disease other|1|||
125334407|NCT00481091|450858031|FG004|Overall Study|Progressive disease other|1|||
125334408|NCT00481091|450858032|FG005|Overall Study|Progressive disease other|1|||
125334409|NCT00481091|450858033|FG006|Overall Study|Progressive disease other|0|||
125334410|NCT00481091|450858034|FG007|Overall Study|Progressive disease other|2|||
125334411|NCT00481091|450858035|FG008|Overall Study|Progressive disease other|0|||
125334412|NCT00481091|450858036|FG009|Overall Study|Progressive disease other|0|||
125334413|NCT00481091|450858027|FG000|Overall Study|No reason given|0|||
125334414|NCT00481091|450858028|FG001|Overall Study|No reason given|0|||
125334415|NCT00481091|450858029|FG002|Overall Study|No reason given|1|||
125334416|NCT00481091|450858030|FG003|Overall Study|No reason given|1|||
125334417|NCT00481091|450858031|FG004|Overall Study|No reason given|1|||
125334418|NCT00481091|450858032|FG005|Overall Study|No reason given|0|||
125334419|NCT00481091|450858033|FG006|Overall Study|No reason given|1|||
125334420|NCT00481091|450858034|FG007|Overall Study|No reason given|1|||
125334421|NCT00481091|450858035|FG008|Overall Study|No reason given|1|||
125334422|NCT00481091|450858036|FG009|Overall Study|No reason given|4|||
125334423|NCT04294680|450858037|FG000|Overall Study|Withdrawal by Subject|2|||
125334424|NCT04294680|450858038|FG001|Overall Study|Withdrawal by Subject|1|||
125334425|NCT04294680|450858037|FG000|Overall Study|Follow-up visits completed outside of window|1|||
125334426|NCT04294680|450858038|FG001|Overall Study|Follow-up visits completed outside of window|0|||
125334427|NCT01296672|450858039|FG000|Overall Study|Lost to Follow-up|73|||
125334428|NCT01296672|450858040|FG001|Overall Study|Lost to Follow-up|18|||
125334429|NCT04027608|450858041|FG000|Overall Study|Withdrawal by Subject|13|||
125334430|NCT04027608|450858042|FG001|Overall Study|Withdrawal by Subject|2|||
125334431|NCT04027608|450858041|FG000|Overall Study|Protocol Violation|2|||
125334432|NCT04027608|450858042|FG001|Overall Study|Protocol Violation|1|||
125334433|NCT04027608|450858041|FG000|Overall Study|Physician Decision|1|||
125334434|NCT04027608|450858042|FG001|Overall Study|Physician Decision|0|||
125334435|NCT04027608|450858041|FG000|Overall Study|Lost to Follow-up|20|||
125334436|NCT04027608|450858042|FG001|Overall Study|Lost to Follow-up|4|||
125334437|NCT01386970|450858044|FG000|Overall Study|Withdrawal by Subject|0|||
125334438|NCT01386970|450858045|FG001|Overall Study|Withdrawal by Subject|1|||
125334439|NCT01386970|450858044|FG000|Overall Study|Adverse Event|4|||
125334440|NCT01386970|450858045|FG001|Overall Study|Adverse Event|1|||
125334441|NCT04881942|450858046|FG000|Overall Study|Adverse Event|0|||
125334442|NCT04881942|450858047|FG001|Overall Study|Adverse Event|0|||
125334443|NCT04881942|450858048|FG002|Overall Study|Adverse Event|0|||
125334444|NCT04881942|450858049|FG003|Overall Study|Adverse Event|0|||
125334445|NCT04881942|450858050|FG004|Overall Study|Adverse Event|1|||
125334446|NCT04881942|450858046|FG000|Overall Study|Alternates|0|||
125334447|NCT04881942|450858047|FG001|Overall Study|Alternates|0|||
125334448|NCT04881942|450858048|FG002|Overall Study|Alternates|0|||
125334449|NCT04881942|450858049|FG003|Overall Study|Alternates|0|||
125334450|NCT04881942|450858050|FG004|Overall Study|Alternates|2|||
125334451|NCT01349959|450858051|FG000|Overall Study|Adverse Event|7|||
125334452|NCT02675634|450858052|FG000|Test Period 1|Adverse Event|0|||
125334453|NCT02675634|450858053|FG001|Test Period 1|Adverse Event|1|||
125334454|NCT02675634|450858054|FG002|Test Period 1|Adverse Event|0|||
125334455|NCT02675634|450858055|FG003|Test Period 1|Adverse Event|1|||
125334456|NCT02675634|450858056|FG004|Test Period 1|Adverse Event|0|||
125334457|NCT02675634|450858057|FG005|Test Period 1|Adverse Event|0|||
125334458|NCT02675634|450858052|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
125334459|NCT02675634|450858053|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
125334460|NCT02675634|450858054|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
125334461|NCT02675634|450858055|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
125334462|NCT02675634|450858056|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
125334463|NCT02675634|450858057|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
125334464|NCT02675634|450858052|FG000|Test Period 2|Lack of Efficacy|1|||
125334465|NCT02675634|450858053|FG001|Test Period 2|Lack of Efficacy|0|||
125334466|NCT02675634|450858054|FG002|Test Period 2|Lack of Efficacy|0|||
125334467|NCT02675634|450858055|FG003|Test Period 2|Lack of Efficacy|0|||
125334468|NCT02675634|450858056|FG004|Test Period 2|Lack of Efficacy|0|||
125334469|NCT02675634|450858057|FG005|Test Period 2|Lack of Efficacy|0|||
125334470|NCT02675634|450858052|FG000|Test Period 2|Adverse Event|0|||
125334471|NCT02675634|450858053|FG001|Test Period 2|Adverse Event|0|||
125670223|NCT01580020|452079785|FG002|Overall Study|Adverse Event|1|||
125670224|NCT01580020|452079786|FG003|Overall Study|Adverse Event|1|||
125334472|NCT02675634|450858054|FG002|Test Period 2|Adverse Event|0|||
125334473|NCT02675634|450858055|FG003|Test Period 2|Adverse Event|0|||
125334474|NCT02675634|450858056|FG004|Test Period 2|Adverse Event|0|||
125334475|NCT02675634|450858057|FG005|Test Period 2|Adverse Event|1|||
125334476|NCT01652534|450858058|FG000|Overall Study|Lack of Efficacy|1|||
125334477|NCT01652534|450858059|FG001|Overall Study|Lack of Efficacy|0|||
125334478|NCT03860259|450858060|FG000|Overall Study|Lost to Follow-up|5|||
125334479|NCT03860259|450858061|FG001|Overall Study|Lost to Follow-up|5|||
125334480|NCT03860259|450858060|FG000|Overall Study|Protocol Violation|1|||
125334481|NCT03860259|450858061|FG001|Overall Study|Protocol Violation|0|||
125334482|NCT00811018|450858062|FG000|Overall Study|Additional Chronic Treatment|31|||
125334483|NCT00811018|450858062|FG000|Overall Study|Adverse Event|79|||
125334484|NCT00811018|450858062|FG000|Overall Study|Death|147|||
125334485|NCT00811018|450858062|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
125334486|NCT00811018|450858062|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
125334487|NCT00811018|450858062|FG000|Overall Study|Investigator Decision|57|||
125334488|NCT00811018|450858062|FG000|Overall Study|Lost to Follow-up|19|||
125334489|NCT00811018|450858062|FG000|Overall Study|Pregnancy|6|||
125334490|NCT00811018|450858062|FG000|Overall Study|Sponsor Decision|450|||
125334491|NCT00811018|450858062|FG000|Overall Study|Withdrawal by Subject|70|||
125334492|NCT00811018|450858062|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
125334493|NCT00811018|450858062|FG000|Overall Study|Other|26|||
125334494|NCT00934362|450858066|FG000|Overall Study|Adverse Event|1|||
125334495|NCT00934362|450858067|FG001|Overall Study|Adverse Event|0|||
125334496|NCT03527732|450858068|FG000|Overall Study|Lost to Follow-up|21|||
125334497|NCT03527732|450858069|FG001|Overall Study|Lost to Follow-up|23|||
125334498|NCT03527732|450858070|FG002|Overall Study|Lost to Follow-up|80|||
125334499|NCT03527732|450858071|FG003|Overall Study|Lost to Follow-up|62|||
125334500|NCT03527732|450858072|FG004|Overall Study|Lost to Follow-up|12|||
125334501|NCT03527732|450858073|FG005|Overall Study|Lost to Follow-up|20|||
125334502|NCT02280408|450858074|FG000|Overall Study|Lost to Follow-up|0|||
125334503|NCT02280408|450858075|FG001|Overall Study|Lost to Follow-up|2|||
125334504|NCT02280408|450858076|FG002|Overall Study|Lost to Follow-up|0|||
125334505|NCT02280408|450858077|FG003|Overall Study|Lost to Follow-up|0|||
125334506|NCT01092117|450858078|FG000|Index Procedure to 1 Month|Death|1|||
125334507|NCT01092117|450858078|FG000|1 Month|Death|1|||
125334508|NCT01092117|450858078|FG000|1 Month|Withdrawal by Subject|1|||
125334509|NCT01092117|450858078|FG000|1 Month|Lost to Follow-up|1|||
125334510|NCT01092117|450858078|FG000|6 Months|Death|2|||
125334511|NCT01092117|450858078|FG000|6 Months|Withdrawal by Subject|3|||
125334512|NCT01092117|450858078|FG000|12 Month|Death|11|||
125334513|NCT01092117|450858078|FG000|12 Month|Withdrawal by Subject|2|||
125334514|NCT01092117|450858078|FG000|12 Month|Lost to Follow-up|1|||
125334515|NCT01092117|450858078|FG000|Year 2|Death|5|||
125334516|NCT01092117|450858078|FG000|Year 2|Withdrawal by Subject|4|||
125334517|NCT01092117|450858078|FG000|Year 2|Lost to Follow-up|1|||
125334518|NCT01092117|450858078|FG000|Year 3|Death|7|||
125334519|NCT01092117|450858078|FG000|Year 3|Withdrawal by Subject|9|||
125334520|NCT01092117|450858078|FG000|Year 3|Lost to Follow-up|3|||
125334521|NCT01092117|450858078|FG000|Year 4|Death|8|||
125334522|NCT01092117|450858078|FG000|Year 4|Withdrawal by Subject|4|||
125334523|NCT01092117|450858078|FG000|Year 4|Lost to Follow-up|4|||
125334524|NCT03710083|450858079|FG000|Overall Study|Withdrawal by Subject|2|||
125334525|NCT03710083|450858079|FG000|Overall Study|Unsuccessful Procedure|1|||
125334526|NCT05300763|450858080|FG000|Overall Study|Adverse Event|0|||
125334527|NCT05300763|450858081|FG001|Overall Study|Adverse Event|1|||
125334528|NCT05300763|450858080|FG000|Overall Study|Major Protocol Deviation|1|||
125670225|NCT01580020|452079783|FG000|Overall Study|Administrative Problems|0|||
125334529|NCT05300763|450858081|FG001|Overall Study|Major Protocol Deviation|0|||
125334530|NCT05300763|450858080|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
125334531|NCT05300763|450858081|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
125334532|NCT00441064|450858086|FG000|Overall Study|Adverse Event|1|||
125670226|NCT01580020|452079784|FG001|Overall Study|Administrative Problems|0|||
125670227|NCT01580020|452079785|FG002|Overall Study|Administrative Problems|1|||
125334533|NCT00441064|450858087|FG001|Overall Study|Adverse Event|0|||
125334534|NCT00441064|450858086|FG000|Overall Study|Abnormal laboratory values|0|||
125334535|NCT00441064|450858087|FG001|Overall Study|Abnormal laboratory values|2|||
125334536|NCT00441064|450858086|FG000|Overall Study|Abnormal test procedure results|0|||
125334537|NCT00441064|450858087|FG001|Overall Study|Abnormal test procedure results|1|||
125334538|NCT00441064|450858086|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125334539|NCT00441064|450858087|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125334540|NCT00441064|450858086|FG000|Overall Study|Protocol Deviation|3|||
125334541|NCT00441064|450858087|FG001|Overall Study|Protocol Deviation|2|||
125334542|NCT00441064|450858086|FG000|Overall Study|Patient withdrew consent|5|||
125334543|NCT00441064|450858087|FG001|Overall Study|Patient withdrew consent|2|||
125334544|NCT00953056|450858088|FG000|Overall Study|Withdrew Consent|0|||
125670228|NCT01580020|452079786|FG003|Overall Study|Administrative Problems|0|||
125670229|NCT01580020|452079783|FG000|Overall Study|Lost to Follow-up|0|||
125334545|NCT00953056|450858089|FG001|Overall Study|Withdrew Consent|0|||
125334546|NCT00953056|450858090|FG002|Overall Study|Withdrew Consent|0|||
125670230|NCT01580020|452079784|FG001|Overall Study|Lost to Follow-up|0|||
125670231|NCT01580020|452079785|FG002|Overall Study|Lost to Follow-up|1|||
125670232|NCT01580020|452079786|FG003|Overall Study|Lost to Follow-up|0|||
125670233|NCT01724359|452079787|FG000|Overall Study|Adverse Event|10|||
125670234|NCT01724359|452079787|FG000|Overall Study|Death|1|||
125670235|NCT01724359|452079787|FG000|Overall Study|Other|20|||
125670236|NCT01335464|452079794|FG000|Overall Study|Adverse Event|15|||
125670237|NCT01335464|452079795|FG001|Overall Study|Adverse Event|25|||
125670238|NCT01335464|452079794|FG000|Overall Study|Non compliant with protocol|2|||
125670239|NCT01335464|452079795|FG001|Overall Study|Non compliant with protocol|0|||
125670240|NCT01335464|452079794|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
125670241|NCT01335464|452079795|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
125670242|NCT01335464|452079794|FG000|Overall Study|Not treated|2|||
125670243|NCT01335464|452079795|FG001|Overall Study|Not treated|0|||
125670244|NCT01335464|452079794|FG000|Overall Study|Reason other than those stated above|1|||
125670245|NCT01335464|452079795|FG001|Overall Study|Reason other than those stated above|1|||
125670246|NCT00593333|452079799|FG000|Overall Study|Lost to Follow-up|10|||
125334547|NCT00953056|450858091|FG003|Overall Study|Withdrew Consent|0|||
125334548|NCT00953056|450858092|FG004|Overall Study|Withdrew Consent|2|||
125334549|NCT00953056|450858093|FG005|Overall Study|Withdrew Consent|3|||
125334550|NCT00953056|450858088|FG000|Overall Study|Serious Adverse Event|0|||
125334551|NCT00953056|450858089|FG001|Overall Study|Serious Adverse Event|0|||
125334552|NCT00953056|450858090|FG002|Overall Study|Serious Adverse Event|0|||
125334553|NCT00953056|450858091|FG003|Overall Study|Serious Adverse Event|0|||
125334554|NCT00953056|450858092|FG004|Overall Study|Serious Adverse Event|0|||
125334555|NCT00953056|450858093|FG005|Overall Study|Serious Adverse Event|1|||
125334556|NCT03962504|450858094|FG000|Overall Study|Other|11|||
125334557|NCT03962504|450858095|FG001|Overall Study|Other|32|||
125334558|NCT01077076|450858096|FG000|First Intervention|Withdrawal by Subject|1|||
125334559|NCT01077076|450858097|FG001|First Intervention|Withdrawal by Subject|0|||
125334560|NCT01077076|450858098|FG002|First Intervention|Withdrawal by Subject|0|||
125334561|NCT01077076|450858099|FG003|First Intervention|Withdrawal by Subject|0|||
125334562|NCT01077076|450858100|FG004|First Intervention|Withdrawal by Subject|0|||
125334563|NCT01077076|450858101|FG005|First Intervention|Withdrawal by Subject|0|||
125334564|NCT01077076|450858096|FG000|Third Intervention|Death in the participant's family|0|||
125334565|NCT01077076|450858097|FG001|Third Intervention|Death in the participant's family|0|||
125334566|NCT01077076|450858098|FG002|Third Intervention|Death in the participant's family|0|||
125334567|NCT01077076|450858099|FG003|Third Intervention|Death in the participant's family|0|||
125334568|NCT01077076|450858100|FG004|Third Intervention|Death in the participant's family|0|||
125334569|NCT01077076|450858101|FG005|Third Intervention|Death in the participant's family|1|||
125334570|NCT01976741|450858102|FG000|Overall Study|Withdrawal by Subject|1|||
125334571|NCT01976741|450858103|FG001|Overall Study|Withdrawal by Subject|0|||
125334572|NCT01976741|450858104|FG002|Overall Study|Withdrawal by Subject|1|||
125334573|NCT01976741|450858105|FG003|Overall Study|Withdrawal by Subject|1|||
125334574|NCT01976741|450858106|FG004|Overall Study|Withdrawal by Subject|0|||
125334575|NCT01976741|450858107|FG005|Overall Study|Withdrawal by Subject|0|||
125334576|NCT01976741|450858108|FG006|Overall Study|Withdrawal by Subject|1|||
125334577|NCT01976741|450858109|FG007|Overall Study|Withdrawal by Subject|4|||
125334578|NCT01976741|450858110|FG008|Overall Study|Withdrawal by Subject|0|||
125334579|NCT01976741|450858111|FG009|Overall Study|Withdrawal by Subject|0|||
125334580|NCT01976741|450858102|FG000|Overall Study|Adverse Event|0|||
125334581|NCT01976741|450858103|FG001|Overall Study|Adverse Event|0|||
125334582|NCT01976741|450858104|FG002|Overall Study|Adverse Event|2|||
125334583|NCT01976741|450858105|FG003|Overall Study|Adverse Event|0|||
125334584|NCT01976741|450858106|FG004|Overall Study|Adverse Event|0|||
125334585|NCT01976741|450858107|FG005|Overall Study|Adverse Event|0|||
125334586|NCT01976741|450858108|FG006|Overall Study|Adverse Event|3|||
125334587|NCT01976741|450858109|FG007|Overall Study|Adverse Event|8|||
125670247|NCT00593333|452079800|FG001|Overall Study|Lost to Follow-up|11|||
125670248|NCT01752920|452079801|FG000|Overall Study|Adverse Event|1|||
125334588|NCT01976741|450858110|FG008|Overall Study|Adverse Event|1|||
125334589|NCT01976741|450858111|FG009|Overall Study|Adverse Event|4|||
125334590|NCT00889720|450858112|FG000|Overall Study|Withdrawal by Subject|4|||
125670249|NCT01752920|452079802|FG001|Overall Study|Adverse Event|0|||
125670250|NCT01752920|452079803|FG002|Overall Study|Adverse Event|5|||
125334591|NCT00889720|450858112|FG000|Overall Study|Other|4|||
125334592|NCT00670306|450858113|FG000|Overall Study|Adverse Event|8|||
125334593|NCT00670306|450858113|FG000|Overall Study|Lack of Efficacy|10|||
125334594|NCT00670306|450858113|FG000|Overall Study|Withdrawal by Subject|9|||
125334595|NCT00670306|450858113|FG000|Overall Study|Physician Decision|1|||
125334596|NCT00670306|450858113|FG000|Overall Study|Lost to Follow-up|8|||
125334597|NCT00670306|450858113|FG000|Overall Study|incl/excl criterias did not meet|19|||
125670251|NCT01752920|452079804|FG003|Overall Study|Adverse Event|10|||
125670252|NCT01752920|452079801|FG000|Overall Study|Clinical Disease Progression|6|||
125670253|NCT01752920|452079802|FG001|Overall Study|Clinical Disease Progression|4|||
125670254|NCT01752920|452079803|FG002|Overall Study|Clinical Disease Progression|1|||
125670255|NCT01752920|452079804|FG003|Overall Study|Clinical Disease Progression|13|||
125670256|NCT01752920|452079801|FG000|Overall Study|Physician Decision|1|||
125670257|NCT01752920|452079802|FG001|Overall Study|Physician Decision|0|||
125670258|NCT01752920|452079803|FG002|Overall Study|Physician Decision|0|||
125670259|NCT01752920|452079804|FG003|Overall Study|Physician Decision|3|||
125670260|NCT01752920|452079801|FG000|Overall Study|Radiographic Disease Progression|20|||
125670261|NCT01752920|452079802|FG001|Overall Study|Radiographic Disease Progression|7|||
125670262|NCT01752920|452079803|FG002|Overall Study|Radiographic Disease Progression|12|||
125670263|NCT01752920|452079804|FG003|Overall Study|Radiographic Disease Progression|29|||
125670264|NCT01752920|452079801|FG000|Overall Study|Study Terminated by Sponsor|0|||
125670265|NCT01752920|452079802|FG001|Overall Study|Study Terminated by Sponsor|0|||
125670266|NCT01752920|452079803|FG002|Overall Study|Study Terminated by Sponsor|0|||
125670267|NCT01752920|452079804|FG003|Overall Study|Study Terminated by Sponsor|1|||
125670268|NCT01752920|452079801|FG000|Overall Study|Withdrawal by Subject|0|||
125670269|NCT01752920|452079802|FG001|Overall Study|Withdrawal by Subject|1|||
125670270|NCT01752920|452079803|FG002|Overall Study|Withdrawal by Subject|0|||
125670271|NCT01752920|452079804|FG003|Overall Study|Withdrawal by Subject|1|||
125670272|NCT01752920|452079801|FG000|Overall Study|Lack of clinical benefit|1|||
125670273|NCT01752920|452079802|FG001|Overall Study|Lack of clinical benefit|1|||
125670274|NCT01752920|452079803|FG002|Overall Study|Lack of clinical benefit|1|||
125670275|NCT01752920|452079804|FG003|Overall Study|Lack of clinical benefit|1|||
125670276|NCT01738581|452079805|FG000|Overall Study|Lost to Follow-up|1|||
125670277|NCT01738581|452079806|FG001|Overall Study|Lost to Follow-up|0|||
125670278|NCT00696709|452079807|FG000|Overall Study|Withdrawal by Subject|1|||
125670279|NCT00696709|452079808|FG001|Overall Study|Withdrawal by Subject|2|||
125670280|NCT00696709|452079809|FG002|Overall Study|Withdrawal by Subject|1|||
125334598|NCT01327482|450858114|FG000|Overall Study|Adverse Event|1|||
125334599|NCT00476229|450858115|FG000|Overall Study|Progressive shortness of breath|1|||
125334600|NCT01032889|450858116|FG000|Overall Study|Adverse Event|2|||
125334601|NCT01032889|450858117|FG001|Overall Study|Adverse Event|2|||
125334602|NCT01032889|450858118|FG002|Overall Study|Adverse Event|0|||
125334603|NCT01032889|450858116|FG000|Overall Study|Withdrawal of Consent|1|||
125334604|NCT01032889|450858117|FG001|Overall Study|Withdrawal of Consent|2|||
125334605|NCT01032889|450858118|FG002|Overall Study|Withdrawal of Consent|1|||
125334606|NCT01032889|450858116|FG000|Overall Study|Patient Request|0|||
125334607|NCT01032889|450858117|FG001|Overall Study|Patient Request|1|||
125334608|NCT01032889|450858118|FG002|Overall Study|Patient Request|0|||
125334609|NCT01032889|450858116|FG000|Overall Study|Lost to Follow-up|1|||
125334610|NCT01032889|450858117|FG001|Overall Study|Lost to Follow-up|1|||
125334611|NCT01032889|450858118|FG002|Overall Study|Lost to Follow-up|0|||
125334612|NCT01032889|450858116|FG000|Overall Study|Lack of Submental Fat|2|||
125334613|NCT01032889|450858117|FG001|Overall Study|Lack of Submental Fat|8|||
125334614|NCT01032889|450858118|FG002|Overall Study|Lack of Submental Fat|1|||
125334615|NCT01032889|450858116|FG000|Overall Study|Miscellaneous Reasons|2|||
125334616|NCT01032889|450858117|FG001|Overall Study|Miscellaneous Reasons|1|||
125334617|NCT01032889|450858118|FG002|Overall Study|Miscellaneous Reasons|1|||
125334618|NCT00993148|450858120|FG000|Overall Study|Lost to Follow-up|2|||
125334619|NCT00993148|450858120|FG000|Overall Study|never initiated treatment|1|||
125334620|NCT00472030|450858121|FG000|Overall Study|Physician Decision|1|||
125334621|NCT00472030|450858122|FG001|Overall Study|Physician Decision|0|||
125334622|NCT00912197|450858125|FG000|Overall Study|Withdrawal by Subject|3|||
125334623|NCT00912197|450858126|FG001|Overall Study|Withdrawal by Subject|3|||
125334624|NCT01615029|450858132|FG000|Overall Study|Adverse Event|0|||
125334625|NCT01615029|450858133|FG001|Overall Study|Adverse Event|0|||
125334626|NCT01615029|450858134|FG002|Overall Study|Adverse Event|0|||
125334627|NCT01615029|450858135|FG003|Overall Study|Adverse Event|0|||
125334628|NCT01615029|450858136|FG004|Overall Study|Adverse Event|1|||
125334629|NCT01615029|450858132|FG000|Overall Study|Death|0|||
125334630|NCT01615029|450858133|FG001|Overall Study|Death|0|||
125334631|NCT01615029|450858134|FG002|Overall Study|Death|0|||
125334632|NCT01615029|450858135|FG003|Overall Study|Death|0|||
125334633|NCT01615029|450858136|FG004|Overall Study|Death|1|||
125334634|NCT01615029|450858132|FG000|Overall Study|Lost to Follow-up|0|||
125670281|NCT00696709|452079810|FG003|Overall Study|Withdrawal by Subject|4|||
125334635|NCT01615029|450858133|FG001|Overall Study|Lost to Follow-up|0|||
125334636|NCT01615029|450858134|FG002|Overall Study|Lost to Follow-up|0|||
125334637|NCT01615029|450858135|FG003|Overall Study|Lost to Follow-up|0|||
125334638|NCT01615029|450858136|FG004|Overall Study|Lost to Follow-up|1|||
125334639|NCT01615029|450858132|FG000|Overall Study|Progressive disease|2|||
125670282|NCT00696709|452079811|FG004|Overall Study|Withdrawal by Subject|3|||
125670283|NCT00696709|452079807|FG000|Overall Study|Protocol Violation|1|||
125670284|NCT00696709|452079808|FG001|Overall Study|Protocol Violation|0|||
125670285|NCT00696709|452079809|FG002|Overall Study|Protocol Violation|0|||
125670286|NCT00696709|452079810|FG003|Overall Study|Protocol Violation|0|||
125670287|NCT00696709|452079811|FG004|Overall Study|Protocol Violation|0|||
125670288|NCT00696709|452079807|FG000|Overall Study|Lost to Follow-up|1|||
125670289|NCT00696709|452079808|FG001|Overall Study|Lost to Follow-up|1|||
125670290|NCT00696709|452079809|FG002|Overall Study|Lost to Follow-up|0|||
125670291|NCT00696709|452079810|FG003|Overall Study|Lost to Follow-up|0|||
125670292|NCT00696709|452079811|FG004|Overall Study|Lost to Follow-up|0|||
125670293|NCT00696709|452079807|FG000|Overall Study|Adverse Event|0|||
125670294|NCT00696709|452079808|FG001|Overall Study|Adverse Event|0|||
125670295|NCT00696709|452079809|FG002|Overall Study|Adverse Event|0|||
125670296|NCT00696709|452079810|FG003|Overall Study|Adverse Event|1|||
125670297|NCT00696709|452079811|FG004|Overall Study|Adverse Event|0|||
125670298|NCT01186978|452079812|FG000|Overall Study|Withdrawal by Subject|1|||
125670299|NCT01709383|452079822|FG000|Overall Study|Lost to Follow-up|1|||
125670300|NCT01709383|452079823|FG001|Overall Study|Lost to Follow-up|0|||
125670301|NCT03264066|452079824|FG000|Overall Study|Adverse Event|1|||
125670302|NCT03264066|452079825|FG001|Overall Study|Adverse Event|1|||
125670303|NCT03264066|452079826|FG002|Overall Study|Adverse Event|0|||
125670304|NCT03264066|452079827|FG003|Overall Study|Adverse Event|0|||
125670305|NCT03264066|452079828|FG004|Overall Study|Adverse Event|0|||
125670306|NCT03264066|452079829|FG005|Overall Study|Adverse Event|0|||
125670307|NCT03264066|452079824|FG000|Overall Study|Death|12|||
125670308|NCT03264066|452079825|FG001|Overall Study|Death|12|||
125670309|NCT03264066|452079826|FG002|Overall Study|Death|8|||
125670310|NCT03264066|452079827|FG003|Overall Study|Death|10|||
125670311|NCT03264066|452079828|FG004|Overall Study|Death|6|||
125670312|NCT03264066|452079829|FG005|Overall Study|Death|1|||
125670313|NCT03264066|452079824|FG000|Overall Study|Lost to Follow-up|1|||
125670314|NCT03264066|452079825|FG001|Overall Study|Lost to Follow-up|0|||
125670315|NCT03264066|452079826|FG002|Overall Study|Lost to Follow-up|0|||
125670316|NCT03264066|452079827|FG003|Overall Study|Lost to Follow-up|0|||
125670317|NCT03264066|452079828|FG004|Overall Study|Lost to Follow-up|0|||
125670318|NCT03264066|452079829|FG005|Overall Study|Lost to Follow-up|0|||
125670319|NCT03264066|452079824|FG000|Overall Study|Progressive Disease|0|||
125670320|NCT03264066|452079825|FG001|Overall Study|Progressive Disease|2|||
125670321|NCT03264066|452079826|FG002|Overall Study|Progressive Disease|1|||
125670322|NCT03264066|452079827|FG003|Overall Study|Progressive Disease|0|||
125670323|NCT03264066|452079828|FG004|Overall Study|Progressive Disease|0|||
125670324|NCT03264066|452079829|FG005|Overall Study|Progressive Disease|0|||
125670325|NCT03264066|452079824|FG000|Overall Study|Study Terminated by Sponsor|5|||
125670326|NCT03264066|452079825|FG001|Overall Study|Study Terminated by Sponsor|5|||
125670327|NCT03264066|452079826|FG002|Overall Study|Study Terminated by Sponsor|8|||
125670328|NCT03264066|452079827|FG003|Overall Study|Study Terminated by Sponsor|5|||
125670329|NCT03264066|452079828|FG004|Overall Study|Study Terminated by Sponsor|1|||
125670330|NCT03264066|452079829|FG005|Overall Study|Study Terminated by Sponsor|2|||
125670331|NCT03264066|452079824|FG000|Overall Study|Withdrawal by Subject|1|||
125670332|NCT03264066|452079825|FG001|Overall Study|Withdrawal by Subject|0|||
125670333|NCT03264066|452079826|FG002|Overall Study|Withdrawal by Subject|0|||
125670334|NCT03264066|452079827|FG003|Overall Study|Withdrawal by Subject|5|||
125670335|NCT03264066|452079828|FG004|Overall Study|Withdrawal by Subject|0|||
125334640|NCT01615029|450858133|FG001|Overall Study|Progressive disease|1|||
125334641|NCT01615029|450858134|FG002|Overall Study|Progressive disease|1|||
125334642|NCT01615029|450858135|FG003|Overall Study|Progressive disease|1|||
125334643|NCT01615029|450858136|FG004|Overall Study|Progressive disease|5|||
125334644|NCT01615029|450858132|FG000|Overall Study|Physician Decision|0|||
125334645|NCT01615029|450858133|FG001|Overall Study|Physician Decision|0|||
125334646|NCT01615029|450858134|FG002|Overall Study|Physician Decision|0|||
125334647|NCT01615029|450858135|FG003|Overall Study|Physician Decision|0|||
125334648|NCT01615029|450858136|FG004|Overall Study|Physician Decision|1|||
125334649|NCT01615029|450858132|FG000|Overall Study|Ongoing|1|||
125334650|NCT01615029|450858133|FG001|Overall Study|Ongoing|2|||
125334651|NCT01615029|450858134|FG002|Overall Study|Ongoing|3|||
125334652|NCT01615029|450858135|FG003|Overall Study|Ongoing|2|||
125334653|NCT01615029|450858136|FG004|Overall Study|Ongoing|23|||
125334654|NCT01326104|450858137|FG000|Overall Study|progressed prior to vaccine|0|||
125334655|NCT01326104|450858138|FG001|Overall Study|progressed prior to vaccine|2|||
125334656|NCT01326104|450858137|FG000|Overall Study|unable to make vaccine|0|||
125334657|NCT01326104|450858138|FG001|Overall Study|unable to make vaccine|2|||
125334658|NCT01287741|450858139|FG000|Overall Study|Withdrawal by Subject|35|||
125670336|NCT03264066|452079829|FG005|Overall Study|Withdrawal by Subject|0|||
125334659|NCT01287741|450858140|FG001|Overall Study|Withdrawal by Subject|38|||
125334660|NCT01287741|450858139|FG000|Overall Study|Protocol Violation|2|||
125334661|NCT01287741|450858140|FG001|Overall Study|Protocol Violation|0|||
125334662|NCT01287741|450858139|FG000|Overall Study|Physician Decision|15|||
125334663|NCT01287741|450858140|FG001|Overall Study|Physician Decision|23|||
125670337|NCT00926289|452079830|FG000|Overall Study|Adverse Event|9|||
125670338|NCT00926289|452079831|FG001|Overall Study|Adverse Event|11|||
125670339|NCT00926289|452079830|FG000|Overall Study|Protocol Violation|8|||
125670340|NCT00926289|452079831|FG001|Overall Study|Protocol Violation|12|||
125670341|NCT00926289|452079830|FG000|Overall Study|Lost to Follow-up|3|||
125670342|NCT00926289|452079831|FG001|Overall Study|Lost to Follow-up|6|||
125334664|NCT01287741|450858139|FG000|Overall Study|Non-compliance|8|||
125334665|NCT01287741|450858140|FG001|Overall Study|Non-compliance|6|||
125334666|NCT01287741|450858139|FG000|Overall Study|Lost to Follow-up|10|||
125670343|NCT00926289|452079830|FG000|Overall Study|Withdrawal by Subject|4|||
125670344|NCT00926289|452079831|FG001|Overall Study|Withdrawal by Subject|4|||
125670345|NCT00926289|452079830|FG000|Overall Study|Other|1|||
125670346|NCT00926289|452079831|FG001|Overall Study|Other|3|||
125670347|NCT01193517|452079835|FG000|Overall Study|Early Progression|1|||
125670348|NCT01193517|452079836|FG001|Overall Study|Early Progression|0|||
125670349|NCT01193517|452079837|FG002|Overall Study|Early Progression|0|||
125670350|NCT02115256|452079840|FG000|Overall Study|Withdrawal by Subject|0|||
125670351|NCT02115256|452079841|FG001|Overall Study|Withdrawal by Subject|1|||
125670352|NCT02668302|452079843|FG000|Overall Study|Withdrawal by Subject|1|||
125670353|NCT02668302|452079844|FG001|Overall Study|Withdrawal by Subject|0|||
125670354|NCT01078090|452079845|FG000|Overall Study|Lost to Follow-up|2363|||
125670355|NCT01078090|452079845|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
125670356|NCT01078090|452079845|FG000|Overall Study|Lack of Efficacy|1193|||
125670357|NCT01078090|452079845|FG000|Overall Study|ADR and lack of efficacy|61|||
125670358|NCT01078090|452079845|FG000|Overall Study|Other|523|||
125670359|NCT00526890|452079846|FG000|Overall Study|Adverse Event|2|||
125334667|NCT01287741|450858140|FG001|Overall Study|Lost to Follow-up|8|||
125334668|NCT01287741|450858139|FG000|Overall Study|Death|32|||
125334669|NCT01287741|450858140|FG001|Overall Study|Death|44|||
125334670|NCT01287741|450858139|FG000|Overall Study|Adverse Event|4|||
125334671|NCT01287741|450858140|FG001|Overall Study|Adverse Event|6|||
125334672|NCT01287741|450858139|FG000|Overall Study|Study terminated by Sponsor|307|||
125334673|NCT01287741|450858140|FG001|Overall Study|Study terminated by Sponsor|315|||
125334674|NCT01287741|450858139|FG000|Overall Study|Progressive disease|190|||
125334675|NCT01287741|450858140|FG001|Overall Study|Progressive disease|166|||
125334676|NCT01287741|450858139|FG000|Overall Study|Reason not specified|23|||
125334677|NCT01287741|450858140|FG001|Overall Study|Reason not specified|9|||
125670360|NCT03529955|452079847|FG000|Overall Study|Adverse Event|1|||
125670361|NCT03529955|452079847|FG000|Overall Study|Lack of Efficacy|1|||
125670362|NCT00580983|452079848|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
125670363|NCT03740100|452079849|FG000|Overall Study|Adverse Event|1|||
125670364|NCT03740100|452079849|FG000|Overall Study|Death|1|||
125670365|NCT03387059|452079851|FG000|Overall Study|Study termination|5|||
125670366|NCT03387059|452079852|FG001|Overall Study|Study termination|4|||
125670367|NCT01859702|452079853|FG000|Overall Study|Protocol deviation|3|||
125670368|NCT01859702|452079853|FG000|Overall Study|Adverse Event|2|||
125670369|NCT02468557|452081462|FG000|Overall Study|Adverse Event|1|||
125670370|NCT02468557|452081462|FG000|Overall Study|Death|1|||
125670371|NCT02468557|452081462|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
125670372|NCT02468557|452081462|FG000|Overall Study|All Enrolled but Never Dosed|4|||
125670373|NCT00982410|452081463|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
125670374|NCT00982410|452081464|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
125670375|NCT00982410|452081463|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
125670376|NCT00982410|452081464|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
125670377|NCT00982410|452081463|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
125670378|NCT00982410|452081464|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
125670379|NCT00982410|452081463|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
125670380|NCT00982410|452081464|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
125670381|NCT00982410|452081463|FG000|6-month Follow-up Assessment|participant no transportation|1|||
125670382|NCT00982410|452081464|FG001|6-month Follow-up Assessment|participant no transportation|0|||
125670383|NCT00982410|452081463|FG000|6-month Follow-up Assessment|incarceration|0|||
125670384|NCT00982410|452081464|FG001|6-month Follow-up Assessment|incarceration|2|||
125670385|NCT00982410|452081463|FG000|6-month Follow-up Assessment|patent surgery|0|||
125670386|NCT00982410|452081464|FG001|6-month Follow-up Assessment|patent surgery|1|||
125670387|NCT00982410|452081463|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
125334678|NCT04421027|450858141|FG000|Treatment Period|Adverse Event|5|||
125334679|NCT04421027|450858142|FG001|Treatment Period|Adverse Event|3|||
125334680|NCT04421027|450858143|FG002|Treatment Period|Adverse Event|0|||
125334681|NCT04421027|450858144|FG003|Treatment Period|Adverse Event|0|||
125334682|NCT04421027|450858141|FG000|Treatment Period|Death|98|||
125334683|NCT04421027|450858142|FG001|Treatment Period|Death|61|||
125334684|NCT04421027|450858143|FG002|Treatment Period|Death|0|||
125334685|NCT04421027|450858144|FG003|Treatment Period|Death|0|||
125334686|NCT04421027|450858141|FG000|Treatment Period|Lost to Follow-up|22|||
125334687|NCT04421027|450858142|FG001|Treatment Period|Lost to Follow-up|20|||
125334688|NCT04421027|450858143|FG002|Treatment Period|Lost to Follow-up|0|||
125334689|NCT04421027|450858144|FG003|Treatment Period|Lost to Follow-up|0|||
125334690|NCT04421027|450858141|FG000|Treatment Period|Other-Unknown|15|||
125334691|NCT04421027|450858142|FG001|Treatment Period|Other-Unknown|9|||
125334692|NCT04421027|450858143|FG002|Treatment Period|Other-Unknown|0|||
125334693|NCT04421027|450858144|FG003|Treatment Period|Other-Unknown|0|||
125334694|NCT04421027|450858141|FG000|Treatment Period|Physician Decision|1|||
125334695|NCT04421027|450858142|FG001|Treatment Period|Physician Decision|1|||
125334696|NCT04421027|450858143|FG002|Treatment Period|Physician Decision|0|||
125334697|NCT04421027|450858144|FG003|Treatment Period|Physician Decision|0|||
125334698|NCT04421027|450858141|FG000|Treatment Period|Withdrawal by Subject|7|||
125334699|NCT04421027|450858142|FG001|Treatment Period|Withdrawal by Subject|12|||
125334700|NCT04421027|450858143|FG002|Treatment Period|Withdrawal by Subject|0|||
125334701|NCT04421027|450858144|FG003|Treatment Period|Withdrawal by Subject|0|||
125334702|NCT04421027|450858141|FG000|Treatment Period|Randomized Not Dosed|9|||
125334703|NCT04421027|450858142|FG001|Treatment Period|Randomized Not Dosed|14|||
125334704|NCT04421027|450858143|FG002|Treatment Period|Randomized Not Dosed|0|||
125334705|NCT04421027|450858144|FG003|Treatment Period|Randomized Not Dosed|0|||
125334706|NCT04421027|450858141|FG000|Follow-Up Period|Adverse Event|0|||
125334707|NCT04421027|450858142|FG001|Follow-Up Period|Adverse Event|0|||
125334708|NCT04421027|450858143|FG002|Follow-Up Period|Adverse Event|0|||
125334709|NCT04421027|450858144|FG003|Follow-Up Period|Adverse Event|3|||
125334710|NCT04421027|450858141|FG000|Follow-Up Period|Death|0|||
125334711|NCT04421027|450858142|FG001|Follow-Up Period|Death|0|||
125334712|NCT04421027|450858143|FG002|Follow-Up Period|Death|16|||
125334713|NCT04421027|450858144|FG003|Follow-Up Period|Death|17|||
125334714|NCT04421027|450858141|FG000|Follow-Up Period|Lost to Follow-up|0|||
125334715|NCT04421027|450858142|FG001|Follow-Up Period|Lost to Follow-up|0|||
125334716|NCT04421027|450858143|FG002|Follow-Up Period|Lost to Follow-up|7|||
125334717|NCT04421027|450858144|FG003|Follow-Up Period|Lost to Follow-up|7|||
125334718|NCT04421027|450858141|FG000|Follow-Up Period|Protocol Deviation|0|||
125334719|NCT04421027|450858142|FG001|Follow-Up Period|Protocol Deviation|0|||
125334720|NCT04421027|450858143|FG002|Follow-Up Period|Protocol Deviation|1|||
125334721|NCT04421027|450858144|FG003|Follow-Up Period|Protocol Deviation|0|||
125334722|NCT04421027|450858141|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
125334723|NCT04421027|450858142|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
125334724|NCT04421027|450858143|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
125334725|NCT04421027|450858144|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
125334726|NCT04421027|450858141|FG000|Follow-Up Period|Left message, participant did not call back|0|||
125334727|NCT04421027|450858142|FG001|Follow-Up Period|Left message, participant did not call back|0|||
125334728|NCT04421027|450858143|FG002|Follow-Up Period|Left message, participant did not call back|0|||
125334729|NCT04421027|450858144|FG003|Follow-Up Period|Left message, participant did not call back|1|||
125334730|NCT04421027|450858141|FG000|Follow-Up Period|Participant died|0|||
125334731|NCT04421027|450858142|FG001|Follow-Up Period|Participant died|0|||
125334732|NCT04421027|450858143|FG002|Follow-Up Period|Participant died|0|||
125334733|NCT04421027|450858144|FG003|Follow-Up Period|Participant died|1|||
125334734|NCT04421027|450858141|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
125334735|NCT04421027|450858142|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
125334736|NCT04421027|450858143|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
125334737|NCT04421027|450858144|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
125334738|NCT00802945|450858145|FG000|Overall Study|Death|27|||
125334739|NCT00802945|450858146|FG001|Overall Study|Death|23|||
125334740|NCT00802945|450858145|FG000|Overall Study|Terminated by sponsor|8|||
125334741|NCT00802945|450858146|FG001|Overall Study|Terminated by sponsor|12|||
125334742|NCT02930018|450858148|FG000|Overall Study|Lost to Follow-up|1|||
125334743|NCT02930018|450858149|FG001|Overall Study|Lost to Follow-up|1|||
125334744|NCT02930018|450858148|FG000|Overall Study|Withdrawal by Subject|5|||
125334745|NCT02930018|450858149|FG001|Overall Study|Withdrawal by Subject|2|||
125334746|NCT04193189|450858151|FG000|Overall Study|Lost to Follow-up|9|||
125334747|NCT04193189|450858152|FG001|Overall Study|Lost to Follow-up|7|||
125334748|NCT04193189|450858153|FG002|Overall Study|Lost to Follow-up|9|||
125334749|NCT04193189|450858154|FG003|Overall Study|Lost to Follow-up|0|||
125334750|NCT04193189|450858151|FG000|Overall Study|Withdrawal by Subject|1|||
125334751|NCT04193189|450858152|FG001|Overall Study|Withdrawal by Subject|2|||
125334752|NCT04193189|450858153|FG002|Overall Study|Withdrawal by Subject|2|||
125334753|NCT04193189|450858154|FG003|Overall Study|Withdrawal by Subject|0|||
125334754|NCT04193189|450858151|FG000|Overall Study|Death|1|||
125334755|NCT04193189|450858152|FG001|Overall Study|Death|1|||
125334756|NCT04193189|450858153|FG002|Overall Study|Death|0|||
125334757|NCT04193189|450858154|FG003|Overall Study|Death|0|||
125334758|NCT04193189|450858151|FG000|Overall Study|Protocol Violation|0|||
125334759|NCT04193189|450858152|FG001|Overall Study|Protocol Violation|0|||
125334760|NCT04193189|450858153|FG002|Overall Study|Protocol Violation|0|||
125334761|NCT04193189|450858154|FG003|Overall Study|Protocol Violation|1|||
125334762|NCT00539864|450859706|FG000|Overall Study|Lost to Follow-up|0|||
125334763|NCT00539864|450859707|FG001|Overall Study|Lost to Follow-up|1|||
125334764|NCT00539864|450859706|FG000|Overall Study|Withdrawal by Subject|1|||
125334765|NCT00539864|450859707|FG001|Overall Study|Withdrawal by Subject|1|||
125334766|NCT02565784|450859708|FG000|First Treatment|Adverse Event|1|||
125334767|NCT02565784|450859708|FG000|First Treatment|Withdrawal by Subject|1|||
125334768|NCT02565784|450859708|FG000|Second Treatment|Withdrawal by Subject|2|||
125334769|NCT00943072|450859714|FG000|Overall Study|Adverse Event|0|||
125334770|NCT00943072|450859715|FG001|Overall Study|Adverse Event|3|||
125334771|NCT00943072|450859714|FG000|Overall Study|Death|0|||
125334772|NCT00943072|450859715|FG001|Overall Study|Death|2|||
125334773|NCT00943072|450859714|FG000|Overall Study|Withdrawal by Subject|3|||
125334774|NCT00943072|450859715|FG001|Overall Study|Withdrawal by Subject|1|||
125334775|NCT00943072|450859714|FG000|Overall Study|Protocol Violation|0|||
125334776|NCT00943072|450859715|FG001|Overall Study|Protocol Violation|1|||
125334777|NCT00943072|450859714|FG000|Overall Study|Lost to Follow-up|1|||
125334778|NCT00943072|450859715|FG001|Overall Study|Lost to Follow-up|2|||
125334779|NCT00943072|450859714|FG000|Overall Study|Lack of Efficacy|0|||
125334780|NCT00943072|450859715|FG001|Overall Study|Lack of Efficacy|4|||
125334781|NCT00943072|450859714|FG000|Overall Study|Other|1|||
125334782|NCT00943072|450859715|FG001|Overall Study|Other|1|||
125334783|NCT00552188|450859716|FG000|Overall Study|Adverse Event|0|||
125334784|NCT00552188|450859717|FG001|Overall Study|Adverse Event|2|||
125334785|NCT00552188|450859716|FG000|Overall Study|Lost to Follow-up|2|||
125334786|NCT00552188|450859717|FG001|Overall Study|Lost to Follow-up|1|||
125334787|NCT00552188|450859716|FG000|Overall Study|Withdrawal of consent|0|||
125334788|NCT00552188|450859717|FG001|Overall Study|Withdrawal of consent|1|||
125334789|NCT00552188|450859716|FG000|Overall Study|Subject returned to home country|0|||
125334790|NCT00552188|450859717|FG001|Overall Study|Subject returned to home country|1|||
125334791|NCT03887702|450859718|FG000|Overall Study|Study terminated|0|||
125334792|NCT03887702|450859719|FG001|Overall Study|Study terminated|0|||
125334793|NCT03887702|450859720|FG002|Overall Study|Study terminated|2|||
125334794|NCT03887702|450859721|FG003|Overall Study|Study terminated|2|||
125334795|NCT01675544|450859724|FG000|Overall Study|Withdrawal by Subject|2|||
125334796|NCT00476008|450859729|FG000|Overall Study|Adverse Event|4|||
125334797|NCT00476008|450859730|FG001|Overall Study|Adverse Event|4|||
125334798|NCT00476008|450859729|FG000|Overall Study|Placebo concerns|2|||
125334799|NCT00476008|450859730|FG001|Overall Study|Placebo concerns|2|||
125334800|NCT00476008|450859729|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
125334801|NCT00476008|450859730|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
125334802|NCT00476008|450859729|FG000|Overall Study|Withdrawal by Subject|0|||
125334803|NCT00476008|450859730|FG001|Overall Study|Withdrawal by Subject|1|||
125334804|NCT00476008|450859729|FG000|Overall Study|Death|1|||
125334805|NCT00476008|450859730|FG001|Overall Study|Death|0|||
125334806|NCT00792571|450859736|FG000|Overall Study|Death|1|||
125334807|NCT00792571|450859736|FG000|Overall Study|Adverse Event|4|||
125334808|NCT00792571|450859736|FG000|Overall Study|Withdrawal by Subject|1|||
125334809|NCT00792571|450859736|FG000|Overall Study|Other|4|||
125334810|NCT03790696|450859738|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
125334811|NCT03790696|450859739|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
125334812|NCT01149148|450859740|FG000|Overall Study|Lost to Follow-up|1|||
125334813|NCT01149148|450859741|FG001|Overall Study|Lost to Follow-up|2|||
125334814|NCT01149148|450859740|FG000|Overall Study|Death|1|||
125334815|NCT01149148|450859741|FG001|Overall Study|Death|0|||
125334816|NCT03436082|450859742|FG000|Overall Study|Did not undergo procedure|1|||
125334817|NCT03436082|450859743|FG001|Overall Study|Did not undergo procedure|0|||
125334818|NCT00950859|450859746|FG000|Overall Study|Adverse Event|3|||
125334819|NCT00950859|450859747|FG001|Overall Study|Adverse Event|3|||
125334820|NCT00950859|450859746|FG000|Overall Study|Insufficient Viral Load Response|12|||
125334821|NCT00950859|450859747|FG001|Overall Study|Insufficient Viral Load Response|3|||
125334822|NCT00950859|450859746|FG000|Overall Study|Protocol Violation|1|||
125334823|NCT00950859|450859747|FG001|Overall Study|Protocol Violation|1|||
125334824|NCT00950859|450859746|FG000|Overall Study|Lost to Follow-up|0|||
125334825|NCT00950859|450859747|FG001|Overall Study|Lost to Follow-up|3|||
125334826|NCT04896086|450859748|FG000|Overall Study|Lost to Follow-up|0|||
125334827|NCT04896086|450859749|FG001|Overall Study|Lost to Follow-up|2|||
125334828|NCT04896086|450859750|FG002|Overall Study|Lost to Follow-up|1|||
125334829|NCT04896086|450859751|FG003|Overall Study|Lost to Follow-up|0|||
125334830|NCT04896086|450859752|FG004|Overall Study|Lost to Follow-up|0|||
125334831|NCT04896086|450859748|FG000|Overall Study|Physician Decision|0|||
125334832|NCT04896086|450859749|FG001|Overall Study|Physician Decision|1|||
125334833|NCT04896086|450859750|FG002|Overall Study|Physician Decision|0|||
125334834|NCT04896086|450859751|FG003|Overall Study|Physician Decision|0|||
125334835|NCT04896086|450859752|FG004|Overall Study|Physician Decision|0|||
125334836|NCT04896086|450859748|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
125334837|NCT04896086|450859749|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
125334838|NCT04896086|450859750|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
125334839|NCT04896086|450859751|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
125334840|NCT04896086|450859752|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
125334841|NCT04896086|450859748|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
125334842|NCT04896086|450859749|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
125334843|NCT04896086|450859750|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
125334844|NCT04896086|450859751|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
125334845|NCT04896086|450859752|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
125334846|NCT02249832|450859755|FG000|Overall Study|Withdrawal by Subject|3|||
125334847|NCT02249832|450859755|FG000|Overall Study|Lost to Follow-up|10|||
125334848|NCT02563067|450859762|FG000|Overall Study|Subject/guardian decision|14|||
125334849|NCT02563067|450859763|FG001|Overall Study|Subject/guardian decision|20|||
125334850|NCT02563067|450859764|FG002|Overall Study|Subject/guardian decision|16|||
125334851|NCT02563067|450859762|FG000|Overall Study|Physician Decision|0|||
125334852|NCT02563067|450859763|FG001|Overall Study|Physician Decision|1|||
125334853|NCT02563067|450859764|FG002|Overall Study|Physician Decision|3|||
125334854|NCT02563067|450859762|FG000|Overall Study|Lost to Follow-up|1|||
125334855|NCT02563067|450859763|FG001|Overall Study|Lost to Follow-up|2|||
125334856|NCT02563067|450859764|FG002|Overall Study|Lost to Follow-up|0|||
125334857|NCT02563067|450859762|FG000|Overall Study|Technical problems|0|||
125334858|NCT02563067|450859763|FG001|Overall Study|Technical problems|1|||
125334859|NCT02563067|450859764|FG002|Overall Study|Technical problems|0|||
125334860|NCT02563067|450859762|FG000|Overall Study|Lack of Efficacy|1|||
125334861|NCT02563067|450859763|FG001|Overall Study|Lack of Efficacy|0|||
125334862|NCT02563067|450859764|FG002|Overall Study|Lack of Efficacy|0|||
125334863|NCT02563067|450859762|FG000|Overall Study|Death|0|||
125334864|NCT02563067|450859763|FG001|Overall Study|Death|1|||
125334865|NCT02563067|450859764|FG002|Overall Study|Death|1|||
125334866|NCT02563067|450859762|FG000|Overall Study|Adverse Event|2|||
125334867|NCT02563067|450859763|FG001|Overall Study|Adverse Event|1|||
125334868|NCT02563067|450859764|FG002|Overall Study|Adverse Event|0|||
125334869|NCT02563067|450859762|FG000|Overall Study|Death post Treatment/safety period|1|||
125334870|NCT02563067|450859763|FG001|Overall Study|Death post Treatment/safety period|0|||
125334871|NCT02563067|450859764|FG002|Overall Study|Death post Treatment/safety period|0|||
125334872|NCT03544333|450859774|FG000|Overall Study|Withdrawal by Subject|1|||
125334873|NCT03544333|450859775|FG001|Overall Study|Withdrawal by Subject|0|||
125334874|NCT01039519|450859779|FG000|Treatment|Progressive disease|20|||
125334875|NCT01039519|450859779|FG000|Treatment|Treatment failure|2|||
125334876|NCT01039519|450859779|FG000|Treatment|Adverse Event|3|||
125334877|NCT01039519|450859779|FG000|Treatment|Physician Decision|2|||
125334878|NCT01039519|450859779|FG000|Survival Follow-up|Death|23|||
125334879|NCT01039519|450859779|FG000|Survival Follow-up|Sponsor decision|4|||
125334880|NCT00808080|450859780|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
125334881|NCT00423917|450859783|FG000|Overall Study|Cancel|2|||
125334882|NCT00423917|450859783|FG000|Overall Study|Ineligible|1|||
125334883|NCT01396447|450859786|FG000|Overall Study|Did Not Receive Treatment|3|||
125334884|NCT01396447|450859787|FG001|Overall Study|Did Not Receive Treatment|2|||
125334885|NCT01396447|450859788|FG002|Overall Study|Did Not Receive Treatment|1|||
125334886|NCT01396447|450859789|FG003|Overall Study|Did Not Receive Treatment|0|||
125334887|NCT01396447|450859786|FG000|Overall Study|Adverse Event|15|||
125334888|NCT01396447|450859787|FG001|Overall Study|Adverse Event|12|||
125334889|NCT01396447|450859788|FG002|Overall Study|Adverse Event|12|||
125334890|NCT01396447|450859789|FG003|Overall Study|Adverse Event|17|||
125334891|NCT01396447|450859786|FG000|Overall Study|Insufficient Therapeutic Response|5|||
125334892|NCT01396447|450859787|FG001|Overall Study|Insufficient Therapeutic Response|5|||
125334893|NCT01396447|450859788|FG002|Overall Study|Insufficient Therapeutic Response|2|||
125334894|NCT01396447|450859789|FG003|Overall Study|Insufficient Therapeutic Response|4|||
125334895|NCT01396447|450859786|FG000|Overall Study|Protocol Violation|5|||
125334896|NCT01396447|450859787|FG001|Overall Study|Protocol Violation|2|||
125334897|NCT01396447|450859788|FG002|Overall Study|Protocol Violation|3|||
125334898|NCT01396447|450859789|FG003|Overall Study|Protocol Violation|7|||
125334899|NCT01396447|450859786|FG000|Overall Study|Withdrawal of Consent|11|||
125334900|NCT01396447|450859787|FG001|Overall Study|Withdrawal of Consent|9|||
125334901|NCT01396447|450859788|FG002|Overall Study|Withdrawal of Consent|4|||
125334902|NCT01396447|450859789|FG003|Overall Study|Withdrawal of Consent|15|||
125334903|NCT01396447|450859786|FG000|Overall Study|Lost to Follow-up|4|||
125334904|NCT01396447|450859787|FG001|Overall Study|Lost to Follow-up|8|||
125334905|NCT01396447|450859788|FG002|Overall Study|Lost to Follow-up|7|||
125334906|NCT01396447|450859789|FG003|Overall Study|Lost to Follow-up|9|||
125334907|NCT01396447|450859786|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125334908|NCT01396447|450859787|FG001|Overall Study|Other Miscellaneous Reasons|2|||
125334909|NCT01396447|450859788|FG002|Overall Study|Other Miscellaneous Reasons|1|||
125334910|NCT01396447|450859789|FG003|Overall Study|Other Miscellaneous Reasons|0|||
125334911|NCT00578292|450859790|FG000|Overall Study|Death|1|||
125334912|NCT00578292|450859790|FG000|Overall Study|Graft failure|2|||
125334913|NCT00856518|450859794|FG000|Overall Study|Lost to Follow-up|4|||
125334914|NCT00856518|450859795|FG001|Overall Study|Lost to Follow-up|2|||
125334915|NCT04849559|450859796|FG000|Overall Study|Withdrawal by Subject|2|||
125334916|NCT04849559|450859797|FG001|Overall Study|Withdrawal by Subject|1|||
125334917|NCT00947193|450859798|FG000|Overall Study|Lost to Follow-up|1|||
125334918|NCT00947193|450859799|FG001|Overall Study|Lost to Follow-up|0|||
125334919|NCT00947193|450859798|FG000|Overall Study|Withdrawal by Subject|1|||
125334920|NCT00947193|450859799|FG001|Overall Study|Withdrawal by Subject|0|||
125334921|NCT00947193|450859798|FG000|Overall Study|Factor VIII >1%|1|||
125334922|NCT00947193|450859799|FG001|Overall Study|Factor VIII >1%|0|||
125334923|NCT02105961|450859800|FG000|Overall Study|Adverse Event|18|||
125334924|NCT02105961|450859801|FG001|Overall Study|Adverse Event|7|||
125334925|NCT02105961|450859802|FG002|Overall Study|Adverse Event|13|||
125334926|NCT02105961|450859800|FG000|Overall Study|Lack of Efficacy|3|||
125334927|NCT02105961|450859801|FG001|Overall Study|Lack of Efficacy|0|||
125334928|NCT02105961|450859802|FG002|Overall Study|Lack of Efficacy|3|||
125334929|NCT02105961|450859800|FG000|Overall Study|Lost to Follow-up|2|||
125334930|NCT02105961|450859801|FG001|Overall Study|Lost to Follow-up|0|||
125334931|NCT02105961|450859802|FG002|Overall Study|Lost to Follow-up|1|||
125334932|NCT02105961|450859800|FG000|Overall Study|Physician Decision|3|||
125334933|NCT02105961|450859801|FG001|Overall Study|Physician Decision|3|||
125334934|NCT02105961|450859802|FG002|Overall Study|Physician Decision|2|||
125334935|NCT02105961|450859800|FG000|Overall Study|Withdrawal by Subject|15|||
125334936|NCT02105961|450859801|FG001|Overall Study|Withdrawal by Subject|7|||
125334937|NCT02105961|450859802|FG002|Overall Study|Withdrawal by Subject|11|||
125334938|NCT00459186|450859803|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
125334939|NCT00459186|450859803|FG000|PET Imaging and Assessment|Adverse Event|3|||
125334940|NCT01485172|450859804|FG000|Overall Study|Adverse Event|2|||
125334941|NCT01485172|450859805|FG001|Overall Study|Adverse Event|1|||
125334942|NCT01485172|450859806|FG002|Overall Study|Adverse Event|2|||
125334943|NCT01485172|450859807|FG003|Overall Study|Adverse Event|2|||
125334944|NCT01485172|450859808|FG004|Overall Study|Adverse Event|1|||
125334945|NCT01485172|450859809|FG005|Overall Study|Adverse Event|2|||
125334946|NCT01485172|450859804|FG000|Overall Study|Lack of Efficacy|2|||
125334947|NCT01485172|450859805|FG001|Overall Study|Lack of Efficacy|0|||
125334948|NCT01485172|450859806|FG002|Overall Study|Lack of Efficacy|0|||
125334949|NCT01485172|450859807|FG003|Overall Study|Lack of Efficacy|0|||
125334950|NCT01485172|450859808|FG004|Overall Study|Lack of Efficacy|0|||
125334951|NCT01485172|450859809|FG005|Overall Study|Lack of Efficacy|0|||
125334952|NCT01485172|450859804|FG000|Overall Study|Protocol Violation|0|||
125334953|NCT01485172|450859805|FG001|Overall Study|Protocol Violation|0|||
125334954|NCT01485172|450859806|FG002|Overall Study|Protocol Violation|4|||
125334955|NCT01485172|450859807|FG003|Overall Study|Protocol Violation|5|||
125334956|NCT01485172|450859808|FG004|Overall Study|Protocol Violation|1|||
125334957|NCT01485172|450859809|FG005|Overall Study|Protocol Violation|0|||
125334958|NCT01485172|450859804|FG000|Overall Study|Protocol defined stopping criteria|1|||
125334959|NCT01485172|450859805|FG001|Overall Study|Protocol defined stopping criteria|0|||
125334960|NCT01485172|450859806|FG002|Overall Study|Protocol defined stopping criteria|0|||
125334961|NCT01485172|450859807|FG003|Overall Study|Protocol defined stopping criteria|0|||
125334962|NCT01485172|450859808|FG004|Overall Study|Protocol defined stopping criteria|1|||
125334963|NCT01485172|450859809|FG005|Overall Study|Protocol defined stopping criteria|0|||
125334964|NCT01485172|450859804|FG000|Overall Study|Lost to Follow-up|0|||
125334965|NCT01485172|450859805|FG001|Overall Study|Lost to Follow-up|0|||
125334966|NCT01485172|450859806|FG002|Overall Study|Lost to Follow-up|1|||
125334967|NCT01485172|450859807|FG003|Overall Study|Lost to Follow-up|0|||
125334968|NCT01485172|450859808|FG004|Overall Study|Lost to Follow-up|0|||
125334969|NCT01485172|450859809|FG005|Overall Study|Lost to Follow-up|1|||
125334970|NCT01485172|450859804|FG000|Overall Study|Physician Decision|0|||
125334971|NCT01485172|450859805|FG001|Overall Study|Physician Decision|0|||
125334972|NCT01485172|450859806|FG002|Overall Study|Physician Decision|0|||
125334973|NCT01485172|450859807|FG003|Overall Study|Physician Decision|0|||
125334974|NCT01485172|450859808|FG004|Overall Study|Physician Decision|1|||
125334975|NCT01485172|450859809|FG005|Overall Study|Physician Decision|0|||
125334976|NCT01485172|450859804|FG000|Overall Study|Withdrawal by Subject|2|||
125334977|NCT01485172|450859805|FG001|Overall Study|Withdrawal by Subject|0|||
125334978|NCT01485172|450859806|FG002|Overall Study|Withdrawal by Subject|0|||
125334979|NCT01485172|450859807|FG003|Overall Study|Withdrawal by Subject|1|||
125334980|NCT01485172|450859808|FG004|Overall Study|Withdrawal by Subject|1|||
125334981|NCT01485172|450859809|FG005|Overall Study|Withdrawal by Subject|1|||
125334982|NCT02920242|450859813|FG000|Overall Study|Withdrawal by Subject|1|||
125334983|NCT02920242|450859814|FG001|Overall Study|Withdrawal by Subject|0|||
125334984|NCT02920242|450859815|FG002|Overall Study|Withdrawal by Subject|1|||
125334985|NCT02920242|450859813|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
125334986|NCT02920242|450859814|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
125334987|NCT02920242|450859815|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
125334988|NCT01587014|450859816|FG000|Overall Study|Death|2|||
125334989|NCT02948088|450859817|FG000|Overall Study|Lost to Follow-up|8|||
125334990|NCT02948088|450859817|FG000|Overall Study|Death|1|||
125334991|NCT02948088|450859817|FG000|Overall Study|Withdrawal by Subject|4|||
125334992|NCT02948088|450859817|FG000|Overall Study|Other|2|||
125334993|NCT01409811|450859818|FG000|Overall Study|Insurance denial|1|||
125334994|NCT01942733|450859819|FG000|Overall Study|Lost to Follow-up|1|||
125334995|NCT01942733|450859819|FG000|Overall Study|Non-compliance with IMP|1|||
125334996|NCT01942733|450859819|FG000|Overall Study|Administrative|1|||
125334997|NCT00634101|450859820|FG000|Overall Study|Study Terminated|3|||
125334998|NCT00634101|450859821|FG001|Overall Study|Study Terminated|3|||
125334999|NCT00634101|450859820|FG000|Overall Study|Lost to Follow-up|2|||
125335000|NCT00634101|450859821|FG001|Overall Study|Lost to Follow-up|0|||
125335001|NCT00838513|450859823|FG000|Screening Period|Screen Failure|3|||
125335002|NCT00838513|450859823|FG000|Extension Treatment Period|Death|1|||
125335003|NCT00838513|450859823|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
125335004|NCT00139477|450859827|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
125335005|NCT00139477|450859828|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
125335006|NCT00139477|450859827|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
125335007|NCT00139477|450859828|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
125335008|NCT00139477|450859827|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
125335009|NCT00139477|450859828|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
125335010|NCT00139477|450859827|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
125335011|NCT00139477|450859828|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
125335012|NCT00139477|450859827|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
125335013|NCT00139477|450859828|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
125335014|NCT00139477|450859827|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
125335015|NCT00139477|450859828|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
125335016|NCT00139477|450859827|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
125335017|NCT00139477|450859828|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
125335018|NCT00573144|450859831|FG000|Overall Study|Withdrawal by Subject|2|||
125335019|NCT00573144|450859832|FG001|Overall Study|Withdrawal by Subject|3|||
125335020|NCT02625909|450859833|FG000|Overall Study|Death|2|||
125335021|NCT02625909|450859834|FG001|Overall Study|Death|0|||
125335022|NCT02625909|450859833|FG000|Overall Study|Lost to Follow-up|3|||
125335023|NCT02625909|450859834|FG001|Overall Study|Lost to Follow-up|5|||
125335024|NCT02625909|450859833|FG000|Overall Study|Lack of Efficacy|9|||
125335025|NCT02625909|450859834|FG001|Overall Study|Lack of Efficacy|2|||
125335026|NCT02625909|450859833|FG000|Overall Study|Reinfection|3|||
125335027|NCT02625909|450859834|FG001|Overall Study|Reinfection|2|||
125335028|NCT02367833|450859835|FG000|Overall Study|Withdrawal by Subject|1|||
125335029|NCT02367833|450859836|FG001|Overall Study|Withdrawal by Subject|1|||
125335030|NCT02367833|450859837|FG002|Overall Study|Withdrawal by Subject|0|||
125335031|NCT00035932|450859840|FG000|Overall Study|Adverse Event|10|||
125335032|NCT00035932|450859841|FG001|Overall Study|Adverse Event|9|||
125335033|NCT00035932|450859842|FG002|Overall Study|Adverse Event|9|||
125335034|NCT00035932|450859840|FG000|Overall Study|Death|0|||
125335035|NCT00035932|450859841|FG001|Overall Study|Death|0|||
125335036|NCT00035932|450859842|FG002|Overall Study|Death|1|||
125335037|NCT00035932|450859840|FG000|Overall Study|Disease Progression / Relapse|1|||
125335038|NCT00035932|450859841|FG001|Overall Study|Disease Progression / Relapse|1|||
125335039|NCT00035932|450859842|FG002|Overall Study|Disease Progression / Relapse|0|||
125335040|NCT00035932|450859840|FG000|Overall Study|Lost to Follow-up|4|||
125335041|NCT00035932|450859841|FG001|Overall Study|Lost to Follow-up|4|||
125335042|NCT00035932|450859842|FG002|Overall Study|Lost to Follow-up|3|||
125335043|NCT00035932|450859840|FG000|Overall Study|Noncompliance|6|||
125335044|NCT00035932|450859841|FG001|Overall Study|Noncompliance|7|||
125335045|NCT00035932|450859842|FG002|Overall Study|Noncompliance|6|||
125335046|NCT00035932|450859840|FG000|Overall Study|Protocol Violation While on Study|0|||
125335047|NCT00035932|450859841|FG001|Overall Study|Protocol Violation While on Study|1|||
125335048|NCT00035932|450859842|FG002|Overall Study|Protocol Violation While on Study|2|||
125335049|NCT00035932|450859840|FG000|Overall Study|Withdrawal by Subject|1|||
125335050|NCT00035932|450859841|FG001|Overall Study|Withdrawal by Subject|5|||
125335051|NCT00035932|450859842|FG002|Overall Study|Withdrawal by Subject|0|||
125335052|NCT00035932|450859840|FG000|Overall Study|Study Termination by Sponsor|1|||
125335053|NCT00035932|450859841|FG001|Overall Study|Study Termination by Sponsor|0|||
125335054|NCT00035932|450859842|FG002|Overall Study|Study Termination by Sponsor|0|||
125335055|NCT00035932|450859840|FG000|Overall Study|Lack of Efficacy|33|||
125335056|NCT00035932|450859841|FG001|Overall Study|Lack of Efficacy|33|||
125335057|NCT00035932|450859842|FG002|Overall Study|Lack of Efficacy|28|||
125335058|NCT01459497|450859843|FG000|Overall Study|Inability to meet trial constraints.|1|||
125335059|NCT01459497|450859844|FG001|Overall Study|Inability to meet trial constraints.|0|||
125335060|NCT01459497|450859843|FG000|Overall Study|Physician Decision|1|||
125335061|NCT01459497|450859844|FG001|Overall Study|Physician Decision|1|||
125335062|NCT01459497|450859843|FG000|Overall Study|Hospitalization.|0|||
125335063|NCT01459497|450859844|FG001|Overall Study|Hospitalization.|3|||
125335064|NCT01459497|450859843|FG000|Overall Study|Disease progression.|0|||
125335065|NCT01459497|450859844|FG001|Overall Study|Disease progression.|1|||
125335066|NCT01192191|450859845|FG000|Overall Study|Adverse Event|7|||
125335067|NCT01192191|450859846|FG001|Overall Study|Adverse Event|12|||
125335068|NCT01192191|450859845|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
125335069|NCT01192191|450859846|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
125335070|NCT01192191|450859845|FG000|Overall Study|Lost to Follow-up|0|||
125335071|NCT01192191|450859846|FG001|Overall Study|Lost to Follow-up|1|||
125335072|NCT01192191|450859845|FG000|Overall Study|Withdrawal by Subject|1|||
125335073|NCT01192191|450859846|FG001|Overall Study|Withdrawal by Subject|6|||
125335074|NCT03179319|450859847|FG000|Overall Study|Lost to Follow-up|6|||
125335075|NCT03179319|450859848|FG001|Overall Study|Lost to Follow-up|0|||
125335076|NCT04393454|450859851|FG000|Overall Study|Death|1|||
125335077|NCT04393454|450859851|FG000|Overall Study|Lost to Follow-up|1|||
125335078|NCT02260180|450861756|FG000|Overall Study|Adverse Event|2|||
125335079|NCT02260180|450861757|FG001|Overall Study|Adverse Event|0|||
125335080|NCT02260180|450861758|FG002|Overall Study|Adverse Event|1|||
125335081|NCT03860818|450861769|FG000|Overall Study|Death|144|||
125335082|NCT03860818|450861770|FG001|Overall Study|Death|195|||
125335083|NCT03860818|450861769|FG000|Overall Study|Graft Loss|32|||
125335084|NCT03860818|450861770|FG001|Overall Study|Graft Loss|45|||
125335085|NCT03126344|450861771|FG000|Overall Study|Lost to Follow-up|0|||
125335086|NCT03126344|450861772|FG001|Overall Study|Lost to Follow-up|0|||
125335087|NCT03126344|450861773|FG002|Overall Study|Lost to Follow-up|5|||
125335088|NCT05367492|450861774|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
125335089|NCT05367492|450861775|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
125335090|NCT05367492|450861776|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
125335091|NCT05367492|450861774|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
125335092|NCT05367492|450861775|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
125335093|NCT05367492|450861776|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
125335094|NCT05367492|450861774|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
125335095|NCT05367492|450861775|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
125335096|NCT05367492|450861776|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
125335097|NCT05367492|450861774|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
125335098|NCT05367492|450861775|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
125335099|NCT05367492|450861776|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
125335100|NCT01088048|450861777|FG000|Overall Study|Adverse Event|7|||
125335101|NCT01088048|450861778|FG001|Overall Study|Adverse Event|9|||
125335102|NCT01088048|450861779|FG002|Overall Study|Adverse Event|7|||
125335103|NCT01088048|450861780|FG003|Overall Study|Adverse Event|5|||
125335104|NCT01088048|450861781|FG004|Overall Study|Adverse Event|6|||
125335105|NCT01088048|450861782|FG005|Overall Study|Adverse Event|3|||
125335106|NCT01088048|450861783|FG006|Overall Study|Adverse Event|3|||
125335107|NCT01088048|450861784|FG007|Overall Study|Adverse Event|0|||
125335108|NCT01088048|450861785|FG008|Overall Study|Adverse Event|2|||
125335109|NCT01088048|450861786|FG009|Overall Study|Adverse Event|2|||
125335110|NCT01088048|450861777|FG000|Overall Study|Withdrew Consent|1|||
125335111|NCT01088048|450861778|FG001|Overall Study|Withdrew Consent|1|||
125335112|NCT01088048|450861779|FG002|Overall Study|Withdrew Consent|1|||
125335113|NCT01088048|450861780|FG003|Overall Study|Withdrew Consent|1|||
125335114|NCT01088048|450861781|FG004|Overall Study|Withdrew Consent|2|||
125335115|NCT01088048|450861782|FG005|Overall Study|Withdrew Consent|1|||
125335116|NCT01088048|450861783|FG006|Overall Study|Withdrew Consent|0|||
125335117|NCT01088048|450861784|FG007|Overall Study|Withdrew Consent|2|||
125335118|NCT01088048|450861785|FG008|Overall Study|Withdrew Consent|2|||
125335119|NCT01088048|450861786|FG009|Overall Study|Withdrew Consent|1|||
125335120|NCT01088048|450861777|FG000|Overall Study|Concomitant Medication Prohibited|1|||
125335121|NCT01088048|450861778|FG001|Overall Study|Concomitant Medication Prohibited|0|||
125335122|NCT01088048|450861779|FG002|Overall Study|Concomitant Medication Prohibited|0|||
125335123|NCT01088048|450861780|FG003|Overall Study|Concomitant Medication Prohibited|0|||
125335124|NCT01088048|450861781|FG004|Overall Study|Concomitant Medication Prohibited|0|||
125335125|NCT01088048|450861782|FG005|Overall Study|Concomitant Medication Prohibited|0|||
125335126|NCT01088048|450861783|FG006|Overall Study|Concomitant Medication Prohibited|0|||
125335127|NCT01088048|450861784|FG007|Overall Study|Concomitant Medication Prohibited|0|||
125335128|NCT01088048|450861785|FG008|Overall Study|Concomitant Medication Prohibited|0|||
125335129|NCT01088048|450861786|FG009|Overall Study|Concomitant Medication Prohibited|0|||
125335130|NCT01088048|450861777|FG000|Overall Study|Investigator Request|2|||
125335131|NCT01088048|450861778|FG001|Overall Study|Investigator Request|2|||
125335132|NCT01088048|450861779|FG002|Overall Study|Investigator Request|0|||
125335133|NCT01088048|450861780|FG003|Overall Study|Investigator Request|0|||
125335134|NCT01088048|450861781|FG004|Overall Study|Investigator Request|3|||
125335135|NCT01088048|450861782|FG005|Overall Study|Investigator Request|1|||
125335136|NCT01088048|450861783|FG006|Overall Study|Investigator Request|1|||
125335137|NCT01088048|450861784|FG007|Overall Study|Investigator Request|0|||
125335138|NCT01088048|450861785|FG008|Overall Study|Investigator Request|0|||
125335139|NCT01088048|450861786|FG009|Overall Study|Investigator Request|0|||
125335140|NCT01088048|450861777|FG000|Overall Study|Patient Non-compliance|0|||
125335141|NCT01088048|450861778|FG001|Overall Study|Patient Non-compliance|1|||
125335142|NCT01088048|450861779|FG002|Overall Study|Patient Non-compliance|0|||
125335143|NCT01088048|450861780|FG003|Overall Study|Patient Non-compliance|0|||
125335144|NCT01088048|450861781|FG004|Overall Study|Patient Non-compliance|0|||
125335145|NCT01088048|450861782|FG005|Overall Study|Patient Non-compliance|0|||
125335146|NCT01088048|450861783|FG006|Overall Study|Patient Non-compliance|0|||
125335147|NCT01088048|450861784|FG007|Overall Study|Patient Non-compliance|0|||
125335148|NCT01088048|450861785|FG008|Overall Study|Patient Non-compliance|0|||
125335149|NCT01088048|450861786|FG009|Overall Study|Patient Non-compliance|0|||
125335150|NCT01088048|450861777|FG000|Overall Study|Disease Progression|7|||
125335151|NCT01088048|450861778|FG001|Overall Study|Disease Progression|4|||
125335152|NCT01088048|450861779|FG002|Overall Study|Disease Progression|3|||
125335153|NCT01088048|450861780|FG003|Overall Study|Disease Progression|5|||
125335154|NCT01088048|450861781|FG004|Overall Study|Disease Progression|3|||
125335155|NCT01088048|450861782|FG005|Overall Study|Disease Progression|3|||
125335156|NCT01088048|450861783|FG006|Overall Study|Disease Progression|2|||
125335157|NCT01088048|450861784|FG007|Overall Study|Disease Progression|1|||
125335158|NCT01088048|450861785|FG008|Overall Study|Disease Progression|0|||
125335159|NCT01088048|450861786|FG009|Overall Study|Disease Progression|0|||
125335160|NCT01088048|450861777|FG000|Overall Study|Death|1|||
125335161|NCT01088048|450861778|FG001|Overall Study|Death|5|||
125335162|NCT01088048|450861779|FG002|Overall Study|Death|3|||
125335163|NCT01088048|450861780|FG003|Overall Study|Death|3|||
125335164|NCT01088048|450861781|FG004|Overall Study|Death|1|||
125335165|NCT01088048|450861782|FG005|Overall Study|Death|3|||
125335166|NCT01088048|450861783|FG006|Overall Study|Death|0|||
125335167|NCT01088048|450861784|FG007|Overall Study|Death|0|||
125335168|NCT01088048|450861785|FG008|Overall Study|Death|3|||
125335169|NCT01088048|450861786|FG009|Overall Study|Death|1|||
125335170|NCT01088048|450861777|FG000|Overall Study|Other|3|||
125335171|NCT01088048|450861778|FG001|Overall Study|Other|5|||
125335172|NCT01088048|450861779|FG002|Overall Study|Other|0|||
125335173|NCT01088048|450861780|FG003|Overall Study|Other|0|||
125335174|NCT01088048|450861781|FG004|Overall Study|Other|2|||
125335175|NCT01088048|450861782|FG005|Overall Study|Other|0|||
125335176|NCT01088048|450861783|FG006|Overall Study|Other|0|||
125335177|NCT01088048|450861784|FG007|Overall Study|Other|2|||
125335178|NCT01088048|450861785|FG008|Overall Study|Other|0|||
125335179|NCT01088048|450861786|FG009|Overall Study|Other|0|||
125335180|NCT01330108|450861790|FG000|Overall Study|Withdrawal by Subject|4|||
125670388|NCT00982410|452081464|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
125335181|NCT00243269|450861791|FG000|Overall Study|Protocol Violation|2|||
125335182|NCT00243269|450861792|FG001|Overall Study|Protocol Violation|1|||
125335183|NCT00243269|450861793|FG002|Overall Study|Protocol Violation|0|||
125335184|NCT00243269|450861794|FG003|Overall Study|Protocol Violation|1|||
125335185|NCT00243269|450861791|FG000|Overall Study|Lost to Follow-up|1|||
125335186|NCT00243269|450861792|FG001|Overall Study|Lost to Follow-up|0|||
125335187|NCT00243269|450861793|FG002|Overall Study|Lost to Follow-up|1|||
125335188|NCT00243269|450861794|FG003|Overall Study|Lost to Follow-up|3|||
125335189|NCT03085797|450861796|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
125335190|NCT03085797|450861797|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
125670389|NCT00982410|452081463|FG000|12-month Follow-up Assessment|Death|0|||
125670390|NCT00982410|452081464|FG001|12-month Follow-up Assessment|Death|2|||
125670391|NCT00982410|452081463|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
125335191|NCT03085797|450861796|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
125335192|NCT03085797|450861797|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
125335193|NCT03085797|450861796|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
125335194|NCT03085797|450861797|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
125335195|NCT00545272|450861798|FG000|Overall Study|Protocol deviation|0|||
125335196|NCT00545272|450861799|FG001|Overall Study|Protocol deviation|1|||
125335197|NCT00545272|450861800|FG002|Overall Study|Protocol deviation|0|||
125335198|NCT00545272|450861801|FG003|Overall Study|Protocol deviation|1|||
125335199|NCT00545272|450861802|FG004|Overall Study|Protocol deviation|0|||
125335200|NCT00545272|450861803|FG005|Overall Study|Protocol deviation|1|||
125335201|NCT00545272|450861798|FG000|Overall Study|Adverse Event|0|||
125335202|NCT00545272|450861799|FG001|Overall Study|Adverse Event|0|||
125335203|NCT00545272|450861800|FG002|Overall Study|Adverse Event|1|||
125335204|NCT00545272|450861801|FG003|Overall Study|Adverse Event|0|||
125335205|NCT00545272|450861802|FG004|Overall Study|Adverse Event|0|||
125335206|NCT00545272|450861803|FG005|Overall Study|Adverse Event|1|||
125335207|NCT00545272|450861798|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125335208|NCT00545272|450861799|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125335209|NCT00545272|450861800|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125335210|NCT00545272|450861801|FG003|Overall Study|Abnormal laboratory value(s)|0|||
125335211|NCT00545272|450861802|FG004|Overall Study|Abnormal laboratory value(s)|0|||
125335212|NCT00545272|450861803|FG005|Overall Study|Abnormal laboratory value(s)|1|||
125335213|NCT00545272|450861798|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125335214|NCT00545272|450861799|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125335215|NCT00545272|450861800|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125335216|NCT00545272|450861801|FG003|Overall Study|Abnormal test procedure result(s)|0|||
125335217|NCT00545272|450861802|FG004|Overall Study|Abnormal test procedure result(s)|1|||
125335218|NCT00545272|450861803|FG005|Overall Study|Abnormal test procedure result(s)|0|||
125335219|NCT00545272|450861798|FG000|Overall Study|Lost to Follow-up|0|||
125335220|NCT00545272|450861799|FG001|Overall Study|Lost to Follow-up|0|||
125335221|NCT00545272|450861800|FG002|Overall Study|Lost to Follow-up|0|||
125335222|NCT00545272|450861801|FG003|Overall Study|Lost to Follow-up|0|||
125335223|NCT00545272|450861802|FG004|Overall Study|Lost to Follow-up|1|||
125335224|NCT00545272|450861803|FG005|Overall Study|Lost to Follow-up|0|||
125335225|NCT01837823|450861804|FG000|Overall Study|Lost to Follow-up|6|||
125335226|NCT00436345|450861809|FG000|Overall Study|ICU resident beyond follow-up period|3|||
125335227|NCT00436345|450861810|FG001|Overall Study|ICU resident beyond follow-up period|0|||
125335228|NCT01175083|450861811|FG000|Primary Epoch|Withdrawal by Subject|0|||
125335229|NCT01175083|450861812|FG001|Primary Epoch|Withdrawal by Subject|0|||
125335230|NCT01175083|450861813|FG002|Primary Epoch|Withdrawal by Subject|0|||
125335231|NCT01175083|450861814|FG003|Primary Epoch|Withdrawal by Subject|0|||
125335232|NCT01175083|450861815|FG004|Primary Epoch|Withdrawal by Subject|0|||
125335233|NCT01175083|450861816|FG005|Primary Epoch|Withdrawal by Subject|2|||
125335234|NCT01175083|450861811|FG000|Primary Epoch|Lost to Follow-up|0|||
125335235|NCT01175083|450861812|FG001|Primary Epoch|Lost to Follow-up|0|||
125335236|NCT01175083|450861813|FG002|Primary Epoch|Lost to Follow-up|0|||
125335237|NCT01175083|450861814|FG003|Primary Epoch|Lost to Follow-up|0|||
125335238|NCT01175083|450861815|FG004|Primary Epoch|Lost to Follow-up|0|||
125335239|NCT01175083|450861816|FG005|Primary Epoch|Lost to Follow-up|1|||
125335240|NCT01175083|450861811|FG000|Booster Epoch|Death|0|||
125335241|NCT01175083|450861812|FG001|Booster Epoch|Death|0|||
125335242|NCT01175083|450861813|FG002|Booster Epoch|Death|1|||
125335243|NCT01175083|450861814|FG003|Booster Epoch|Death|0|||
125335244|NCT01175083|450861815|FG004|Booster Epoch|Death|0|||
125335245|NCT01175083|450861816|FG005|Booster Epoch|Death|0|||
125335246|NCT01175083|450861811|FG000|Booster Epoch|Withdrawal by Subject|0|||
125335247|NCT01175083|450861812|FG001|Booster Epoch|Withdrawal by Subject|0|||
125335248|NCT01175083|450861813|FG002|Booster Epoch|Withdrawal by Subject|0|||
125335249|NCT01175083|450861814|FG003|Booster Epoch|Withdrawal by Subject|1|||
125335250|NCT01175083|450861815|FG004|Booster Epoch|Withdrawal by Subject|0|||
125335251|NCT01175083|450861816|FG005|Booster Epoch|Withdrawal by Subject|0|||
125335252|NCT00475306|450861817|FG000|Overall Study|Protocol Violation|1|||
125335253|NCT00475306|450861818|FG001|Overall Study|Protocol Violation|1|||
125335254|NCT00475306|450861819|FG002|Overall Study|Protocol Violation|0|||
125335255|NCT00475306|450861820|FG003|Overall Study|Protocol Violation|1|||
125335256|NCT01716052|450861821|FG000|Overall Study|Withdrawal of funding|1|||
125335257|NCT01716052|450861822|FG001|Overall Study|Withdrawal of funding|1|||
125335258|NCT02405442|450861823|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
125335259|NCT02405442|450861824|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
125335260|NCT02405442|450861825|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
125335261|NCT02405442|450861826|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
125335262|NCT02405442|450861823|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
125335263|NCT02405442|450861824|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
125335264|NCT02405442|450861825|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
125335265|NCT02405442|450861826|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
125335266|NCT02405442|450861823|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
125335267|NCT02405442|450861824|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
125335268|NCT02405442|450861825|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
125335269|NCT02405442|450861826|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
125335270|NCT02405442|450861823|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
125335271|NCT02405442|450861824|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
125335272|NCT02405442|450861825|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
125335273|NCT02405442|450861826|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
125335274|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
125335275|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
125335276|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
125335277|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
125335278|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
125335279|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
125335280|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
125335281|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
125335282|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
125335283|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
125335284|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
125335285|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
125335286|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
125335287|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
125335288|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
125335289|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
125335290|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
125335291|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
125335292|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
125335293|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
125335294|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
125335295|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
125335296|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
125335297|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
125335298|NCT02405442|450861823|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
125335299|NCT02405442|450861824|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
125335300|NCT02405442|450861825|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
125335301|NCT02405442|450861826|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
125335302|NCT02405442|450861823|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
125335303|NCT02405442|450861824|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
125335304|NCT02405442|450861825|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
125335305|NCT02405442|450861826|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
125335306|NCT02405442|450861823|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
125335307|NCT02405442|450861824|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
125335308|NCT02405442|450861825|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
125335309|NCT02405442|450861826|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
125335310|NCT02405442|450861823|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
125335311|NCT02405442|450861824|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
125335312|NCT02405442|450861825|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
125335313|NCT02405442|450861826|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
125335314|NCT03275350|450861828|FG000|Overall Study|Lost to Follow-up|4|||
125335315|NCT03275350|450861829|FG001|Overall Study|Lost to Follow-up|6|||
125335316|NCT03275350|450861828|FG000|Overall Study|Death|2|||
125335317|NCT03275350|450861829|FG001|Overall Study|Death|1|||
125335318|NCT03275350|450861828|FG000|Overall Study|Physician Decision|1|||
125335319|NCT03275350|450861829|FG001|Overall Study|Physician Decision|0|||
125335320|NCT03275350|450861828|FG000|Overall Study|Incarcerated|1|||
125335321|NCT03275350|450861829|FG001|Overall Study|Incarcerated|1|||
125335322|NCT00926029|450861830|FG000|Overall Study|Lost to Follow-up|2|||
125335323|NCT00926029|450861831|FG001|Overall Study|Lost to Follow-up|1|||
125335324|NCT00926029|450861832|FG002|Overall Study|Lost to Follow-up|1|||
125335325|NCT04154189|450861835|FG000|Overall Study|Withdrawal by Subject|4|||
125335326|NCT04154189|450861836|FG001|Overall Study|Withdrawal by Subject|6|||
125335327|NCT04154189|450861835|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
125335328|NCT04154189|450861836|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
125335329|NCT04154189|450861835|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
125335330|NCT04154189|450861836|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
125335331|NCT04154189|450861835|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
125335332|NCT04154189|450861836|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
125335333|NCT04154189|450861835|FG000|Overall Study|Death|25|||
125335334|NCT04154189|450861836|FG001|Overall Study|Death|25|||
125335335|NCT02147561|450861839|FG000|Overall Study|Lost to Follow-up|3|||
125335336|NCT02147561|450861839|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
125335337|NCT01191762|450861840|FG000|Overall Study|Adverse Event|1|||
125335338|NCT01191762|450861841|FG001|Overall Study|Adverse Event|0|||
125335339|NCT02283762|450861844|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
125335340|NCT02283762|450861845|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
125335341|NCT02283762|450861844|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
125335342|NCT02283762|450861845|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
125335343|NCT02283762|450861844|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
125335344|NCT02283762|450861845|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
125335345|NCT02283762|450861844|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
125335346|NCT02283762|450861845|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
125335347|NCT02283762|450861844|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
125335348|NCT02283762|450861845|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
125335349|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
125335350|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
125335351|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
125335352|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
125335353|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
125335354|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
125335355|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
125335356|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
125335357|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
125335358|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
125335359|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
125335360|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
125335361|NCT02283762|450861844|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
125335362|NCT02283762|450861845|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
125335363|NCT00202878|450861846|FG000|Overall Study|Death|964|||
125335364|NCT00202878|450861847|FG001|Overall Study|Death|968|||
125335365|NCT00202878|450861846|FG000|Overall Study|Only Vital Status Known|357|||
125335366|NCT00202878|450861847|FG001|Overall Study|Only Vital Status Known|356|||
125335367|NCT00202878|450861846|FG000|Overall Study|Lost to Follow-up|44|||
125335368|NCT00202878|450861847|FG001|Overall Study|Lost to Follow-up|49|||
125335369|NCT00202878|450861846|FG000|Overall Study|Site Closure|39|||
125335370|NCT00202878|450861847|FG001|Overall Study|Site Closure|36|||
125335371|NCT00202878|450861846|FG000|Overall Study|Withdrawal by Subject|795|||
125335372|NCT00202878|450861847|FG001|Overall Study|Withdrawal by Subject|808|||
125335373|NCT03801031|450861852|FG000|Overall Study|Lost to Follow-up|1|||
125335374|NCT03801031|450861853|FG001|Overall Study|Lost to Follow-up|0|||
125335375|NCT03801031|450861852|FG000|Overall Study|Unable to comply|1|||
125335376|NCT03801031|450861853|FG001|Overall Study|Unable to comply|0|||
125335377|NCT03801031|450861852|FG000|Overall Study|Withdrawal by Subject|0|||
125335378|NCT03801031|450861853|FG001|Overall Study|Withdrawal by Subject|1|||
125335379|NCT00486291|450861854|FG000|Overall Study|Adverse Event|3|||
125335380|NCT00486291|450861855|FG001|Overall Study|Adverse Event|4|||
125335381|NCT00486291|450861854|FG000|Overall Study|Lost to Follow-up|3|||
125335382|NCT00486291|450861855|FG001|Overall Study|Lost to Follow-up|7|||
125335383|NCT00486291|450861854|FG000|Overall Study|protocol non-compliance|10|||
125335384|NCT00486291|450861855|FG001|Overall Study|protocol non-compliance|15|||
125335385|NCT00486291|450861854|FG000|Overall Study|requirement for restricted medication|0|||
125335386|NCT00486291|450861855|FG001|Overall Study|requirement for restricted medication|3|||
125335387|NCT00126490|450861861|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
125335388|NCT00975780|450861862|FG000|Follow Up|Death|88|||
125335389|NCT00975780|450861863|FG001|Follow Up|Death|122|||
125335390|NCT00975780|450861862|FG000|Follow Up|Facility Withdrawal|7|||
125335391|NCT00975780|450861863|FG001|Follow Up|Facility Withdrawal|23|||
125335392|NCT00975780|450861862|FG000|Follow Up|Discharged from Facility|7|||
125335393|NCT00975780|450861863|FG001|Follow Up|Discharged from Facility|12|||
125335394|NCT03051178|450861866|FG000|Overall Study|Withdrawal by Subject|5|||
125335395|NCT01598506|450861867|FG000|Overall Study|Withdrawal by Subject|2|||
125335396|NCT04080167|450861872|FG000|Overall Study|Lost to Follow-up-Patients|7|||
125335397|NCT04080167|450861873|FG001|Overall Study|Lost to Follow-up-Patients|14|||
125335398|NCT04080167|450861874|FG002|Overall Study|Lost to Follow-up-Patients|0|||
125335399|NCT04080167|450861872|FG000|Overall Study|Lost to Follow-up-Providers|2|||
125335400|NCT04080167|450861873|FG001|Overall Study|Lost to Follow-up-Providers|2|||
125335401|NCT04080167|450861874|FG002|Overall Study|Lost to Follow-up-Providers|0|||
125335402|NCT04080167|450861872|FG000|Overall Study|Withdrawal by Subject|1|||
125335403|NCT04080167|450861873|FG001|Overall Study|Withdrawal by Subject|2|||
125335404|NCT04080167|450861874|FG002|Overall Study|Withdrawal by Subject|0|||
125335405|NCT04080167|450861872|FG000|Overall Study|Withdrawal by Provider|0|||
125335406|NCT04080167|450861873|FG001|Overall Study|Withdrawal by Provider|0|||
125335407|NCT04080167|450861874|FG002|Overall Study|Withdrawal by Provider|4|||
125335408|NCT04080167|450861872|FG000|Overall Study|Death-Patient|2|||
125335409|NCT04080167|450861873|FG001|Overall Study|Death-Patient|1|||
125335410|NCT04080167|450861874|FG002|Overall Study|Death-Patient|0|||
125335411|NCT04080167|450861872|FG000|Overall Study|Hydroxyurea New Starts|0|||
125335412|NCT04080167|450861873|FG001|Overall Study|Hydroxyurea New Starts|0|||
125335413|NCT04080167|450861874|FG002|Overall Study|Hydroxyurea New Starts|1|||
125335414|NCT04080167|450861872|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
125335415|NCT04080167|450861873|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
125335416|NCT04080167|450861874|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
125335417|NCT03530124|450861877|FG000|Overall Study|Withdrawal by Subject|0|||
125335418|NCT03530124|450861878|FG001|Overall Study|Withdrawal by Subject|1|||
125335419|NCT03530124|450861877|FG000|Overall Study|Protocol Violation|1|||
125335420|NCT03530124|450861878|FG001|Overall Study|Protocol Violation|0|||
125335421|NCT03530124|450861877|FG000|Overall Study|Discharged prior to study completion|1|||
125335422|NCT03530124|450861878|FG001|Overall Study|Discharged prior to study completion|0|||
125335423|NCT01047553|450861879|FG000|Overall Study|Adverse Event|10|||
125335424|NCT01047553|450861880|FG001|Overall Study|Adverse Event|5|||
125335425|NCT01047553|450861879|FG000|Overall Study|Withdrawal by Subject|4|||
125335426|NCT01047553|450861880|FG001|Overall Study|Withdrawal by Subject|2|||
125335427|NCT01047553|450861879|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
125335428|NCT01047553|450861880|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
125335429|NCT01047553|450861879|FG000|Overall Study|Lost to Follow-up|1|||
125335430|NCT01047553|450861880|FG001|Overall Study|Lost to Follow-up|0|||
125335431|NCT01047553|450861879|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
125335432|NCT01047553|450861880|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
125335433|NCT01047553|450861879|FG000|Overall Study|PI's decision|0|||
125335434|NCT01047553|450861880|FG001|Overall Study|PI's decision|1|||
125335435|NCT01583296|450861881|FG000|Overall Study|Withdrawal by Subject|11|||
125335436|NCT01583296|450861882|FG001|Overall Study|Withdrawal by Subject|10|||
125335437|NCT01063283|450861883|FG000|Cycle 1|Adverse Event|2|||
125335438|NCT01063283|450861884|FG001|Cycle 1|Adverse Event|0|||
125335439|NCT01063283|450861885|FG002|Cycle 1|Adverse Event|0|||
125335440|NCT01063283|450861883|FG000|Cycle 1|Technical failure in data collection|1|||
125335441|NCT01063283|450861884|FG001|Cycle 1|Technical failure in data collection|0|||
125335442|NCT01063283|450861885|FG002|Cycle 1|Technical failure in data collection|0|||
125335443|NCT05343624|450861886|FG000|Overall Study|Chart review not completed|1|||
125335444|NCT01120717|450861887|FG000|Overall Study|Withdrawal by Subject|11|||
125335445|NCT01120717|450861888|FG001|Overall Study|Withdrawal by Subject|6|||
125335446|NCT01120717|450861887|FG000|Overall Study|Adverse Event|10|||
125335447|NCT01120717|450861888|FG001|Overall Study|Adverse Event|6|||
125335448|NCT01120717|450861887|FG000|Overall Study|Protocol Deviation|2|||
125335449|NCT01120717|450861888|FG001|Overall Study|Protocol Deviation|5|||
125335450|NCT01120717|450861887|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125335451|NCT01120717|450861888|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125335452|NCT01120717|450861887|FG000|Overall Study|Lost to Follow-up|2|||
125335453|NCT01120717|450861888|FG001|Overall Study|Lost to Follow-up|3|||
125335454|NCT01120717|450861887|FG000|Overall Study|Death|3|||
125335455|NCT01120717|450861888|FG001|Overall Study|Death|1|||
125335456|NCT01120717|450861887|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
125335457|NCT01120717|450861888|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
125335458|NCT02504216|450861893|FG000|Overall Study|Lost to Follow-up|3|||
125335459|NCT02504216|450861894|FG001|Overall Study|Lost to Follow-up|3|||
125335460|NCT02504216|450861893|FG000|Overall Study|Withdrawal by Subject|8|||
125335461|NCT02504216|450861894|FG001|Overall Study|Withdrawal by Subject|12|||
125335462|NCT00862082|450861895|FG000|Overall Study|Sponsor decision to terminate the study|5|||
125335463|NCT00862082|450861896|FG001|Overall Study|Sponsor decision to terminate the study|0|||
125335464|NCT00862082|450861895|FG000|Overall Study|Withdrawal by Subject|0|||
125335465|NCT00862082|450861896|FG001|Overall Study|Withdrawal by Subject|1|||
125335466|NCT02598583|450861897|FG000|Extension Period|Withdrawal by Subject|1|||
125335467|NCT02598583|450861898|FG001|Extension Period|Withdrawal by Subject|0|||
125335468|NCT05334212|450861907|FG000|Overall Study|Study terminated prematurely|7|||
125335469|NCT02152956|450861908|FG000|Overall Study|Adverse Event|0|||
125335470|NCT02152956|450861909|FG001|Overall Study|Adverse Event|0|||
125335471|NCT02152956|450861910|FG002|Overall Study|Adverse Event|0|||
125335472|NCT02152956|450861911|FG003|Overall Study|Adverse Event|0|||
125335473|NCT02152956|450861912|FG004|Overall Study|Adverse Event|0|||
125335474|NCT02152956|450861913|FG005|Overall Study|Adverse Event|0|||
125335475|NCT02152956|450861914|FG006|Overall Study|Adverse Event|0|||
125335476|NCT02152956|450861915|FG007|Overall Study|Adverse Event|0|||
125335477|NCT02152956|450861916|FG008|Overall Study|Adverse Event|0|||
125335478|NCT02152956|450861917|FG009|Overall Study|Adverse Event|0|||
125335479|NCT02152956|450861918|FG010|Overall Study|Adverse Event|0|||
125335480|NCT02152956|450861919|FG011|Overall Study|Adverse Event|4|||
125335481|NCT02152956|450861920|FG012|Overall Study|Adverse Event|0|||
125335482|NCT02152956|450861908|FG000|Overall Study|Death|0|||
125335483|NCT02152956|450861909|FG001|Overall Study|Death|3|||
125335484|NCT02152956|450861910|FG002|Overall Study|Death|3|||
125335485|NCT02152956|450861911|FG003|Overall Study|Death|4|||
125335486|NCT02152956|450861912|FG004|Overall Study|Death|1|||
125335487|NCT02152956|450861913|FG005|Overall Study|Death|2|||
125335488|NCT02152956|450861914|FG006|Overall Study|Death|6|||
125335489|NCT02152956|450861915|FG007|Overall Study|Death|6|||
125335490|NCT02152956|450861916|FG008|Overall Study|Death|4|||
125335491|NCT02152956|450861917|FG009|Overall Study|Death|5|||
125335492|NCT02152956|450861918|FG010|Overall Study|Death|3|||
125335493|NCT02152956|450861919|FG011|Overall Study|Death|143|||
125335494|NCT02152956|450861920|FG012|Overall Study|Death|12|||
125335495|NCT02152956|450861908|FG000|Overall Study|Lost to Follow-up|0|||
125335496|NCT02152956|450861909|FG001|Overall Study|Lost to Follow-up|1|||
125335497|NCT02152956|450861910|FG002|Overall Study|Lost to Follow-up|0|||
125335498|NCT02152956|450861911|FG003|Overall Study|Lost to Follow-up|0|||
125335499|NCT02152956|450861912|FG004|Overall Study|Lost to Follow-up|0|||
125335500|NCT02152956|450861913|FG005|Overall Study|Lost to Follow-up|0|||
125335501|NCT02152956|450861914|FG006|Overall Study|Lost to Follow-up|0|||
125335502|NCT02152956|450861915|FG007|Overall Study|Lost to Follow-up|0|||
125335503|NCT02152956|450861916|FG008|Overall Study|Lost to Follow-up|0|||
125335504|NCT02152956|450861917|FG009|Overall Study|Lost to Follow-up|0|||
125335505|NCT02152956|450861918|FG010|Overall Study|Lost to Follow-up|0|||
125335506|NCT02152956|450861919|FG011|Overall Study|Lost to Follow-up|3|||
125335507|NCT02152956|450861920|FG012|Overall Study|Lost to Follow-up|0|||
125335508|NCT02152956|450861908|FG000|Overall Study|Withdrawal by Subject|1|||
125335509|NCT02152956|450861909|FG001|Overall Study|Withdrawal by Subject|0|||
125335510|NCT02152956|450861910|FG002|Overall Study|Withdrawal by Subject|1|||
125335511|NCT02152956|450861911|FG003|Overall Study|Withdrawal by Subject|0|||
125335512|NCT02152956|450861912|FG004|Overall Study|Withdrawal by Subject|2|||
125335513|NCT02152956|450861913|FG005|Overall Study|Withdrawal by Subject|2|||
125335514|NCT02152956|450861914|FG006|Overall Study|Withdrawal by Subject|0|||
125335515|NCT02152956|450861915|FG007|Overall Study|Withdrawal by Subject|0|||
125335516|NCT02152956|450861916|FG008|Overall Study|Withdrawal by Subject|1|||
125335517|NCT02152956|450861917|FG009|Overall Study|Withdrawal by Subject|0|||
125335518|NCT02152956|450861918|FG010|Overall Study|Withdrawal by Subject|0|||
125335519|NCT02152956|450861919|FG011|Overall Study|Withdrawal by Subject|4|||
125335520|NCT02152956|450861920|FG012|Overall Study|Withdrawal by Subject|0|||
125335521|NCT02152956|450861908|FG000|Overall Study|Physician Decision|0|||
125335522|NCT02152956|450861909|FG001|Overall Study|Physician Decision|0|||
125335523|NCT02152956|450861910|FG002|Overall Study|Physician Decision|0|||
125335524|NCT02152956|450861911|FG003|Overall Study|Physician Decision|0|||
125335525|NCT02152956|450861912|FG004|Overall Study|Physician Decision|0|||
125335526|NCT02152956|450861913|FG005|Overall Study|Physician Decision|0|||
125335527|NCT02152956|450861914|FG006|Overall Study|Physician Decision|0|||
125335528|NCT02152956|450861915|FG007|Overall Study|Physician Decision|0|||
125335529|NCT02152956|450861916|FG008|Overall Study|Physician Decision|0|||
125335530|NCT02152956|450861917|FG009|Overall Study|Physician Decision|0|||
125335531|NCT02152956|450861918|FG010|Overall Study|Physician Decision|0|||
125335532|NCT02152956|450861919|FG011|Overall Study|Physician Decision|1|||
125335533|NCT02152956|450861920|FG012|Overall Study|Physician Decision|0|||
125335534|NCT02152956|450861908|FG000|Overall Study|Study terminated by sponsor|0|||
125335535|NCT02152956|450861909|FG001|Overall Study|Study terminated by sponsor|0|||
125335536|NCT02152956|450861910|FG002|Overall Study|Study terminated by sponsor|0|||
125335537|NCT02152956|450861911|FG003|Overall Study|Study terminated by sponsor|0|||
125335538|NCT02152956|450861912|FG004|Overall Study|Study terminated by sponsor|0|||
125335539|NCT02152956|450861913|FG005|Overall Study|Study terminated by sponsor|0|||
125335540|NCT02152956|450861914|FG006|Overall Study|Study terminated by sponsor|0|||
125335541|NCT02152956|450861915|FG007|Overall Study|Study terminated by sponsor|0|||
125335542|NCT02152956|450861916|FG008|Overall Study|Study terminated by sponsor|0|||
125335543|NCT02152956|450861917|FG009|Overall Study|Study terminated by sponsor|0|||
125335544|NCT02152956|450861918|FG010|Overall Study|Study terminated by sponsor|0|||
125335545|NCT02152956|450861919|FG011|Overall Study|Study terminated by sponsor|29|||
125335546|NCT02152956|450861920|FG012|Overall Study|Study terminated by sponsor|0|||
125335547|NCT02152956|450861908|FG000|Overall Study|progressive disease|0|||
125335548|NCT02152956|450861909|FG001|Overall Study|progressive disease|0|||
125335549|NCT02152956|450861910|FG002|Overall Study|progressive disease|0|||
125335550|NCT02152956|450861911|FG003|Overall Study|progressive disease|0|||
125335551|NCT02152956|450861912|FG004|Overall Study|progressive disease|0|||
125335552|NCT02152956|450861913|FG005|Overall Study|progressive disease|0|||
125335553|NCT02152956|450861914|FG006|Overall Study|progressive disease|0|||
125335554|NCT02152956|450861915|FG007|Overall Study|progressive disease|0|||
125335555|NCT02152956|450861916|FG008|Overall Study|progressive disease|1|||
125335556|NCT02152956|450861917|FG009|Overall Study|progressive disease|0|||
125335557|NCT02152956|450861918|FG010|Overall Study|progressive disease|0|||
125335558|NCT02152956|450861919|FG011|Overall Study|progressive disease|1|||
125335559|NCT02152956|450861920|FG012|Overall Study|progressive disease|0|||
125335560|NCT02445794|450861921|FG000|Overall Study|Adverse Event|0|||
125335561|NCT02445794|450861922|FG001|Overall Study|Adverse Event|0|||
125335562|NCT02445794|450861923|FG002|Overall Study|Adverse Event|2|||
125335563|NCT02445794|450861924|FG003|Overall Study|Adverse Event|0|||
125335564|NCT01668589|450861925|FG000|Overall Study|Lost to Follow-up|29|||
125335565|NCT01668589|450861926|FG001|Overall Study|Lost to Follow-up|37|||
125335566|NCT01668589|450861927|FG002|Overall Study|Lost to Follow-up|15|||
125335567|NCT01668589|450861928|FG003|Overall Study|Lost to Follow-up|5|||
125335568|NCT01668589|450861925|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
125335569|NCT01668589|450861926|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
125335570|NCT01668589|450861927|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
125335571|NCT01668589|450861928|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
125335572|NCT01668589|450861925|FG000|Overall Study|Death|12|||
125335573|NCT01668589|450861926|FG001|Overall Study|Death|3|||
125335574|NCT01668589|450861927|FG002|Overall Study|Death|2|||
125335575|NCT01668589|450861928|FG003|Overall Study|Death|11|||
125335576|NCT01668589|450861925|FG000|Overall Study|Other|44|||
125335577|NCT01668589|450861926|FG001|Overall Study|Other|10|||
125335578|NCT01668589|450861927|FG002|Overall Study|Other|7|||
125335579|NCT01668589|450861928|FG003|Overall Study|Other|15|||
125335580|NCT00661427|450861931|FG000|Overall Study|Adverse Event|5|||
125335581|NCT00661427|450861932|FG001|Overall Study|Adverse Event|5|||
125335582|NCT00661427|450861931|FG000|Overall Study|Patient not treated|0|||
125335583|NCT00661427|450861932|FG001|Overall Study|Patient not treated|2|||
125335584|NCT00488683|450861933|FG000|Overall Study|Withdrawal by Subject|1|||
125335585|NCT00488683|450861934|FG001|Overall Study|Withdrawal by Subject|2|||
125335586|NCT00488683|450861935|FG002|Overall Study|Withdrawal by Subject|2|||
125335587|NCT00488683|450861933|FG000|Overall Study|Lost to Follow-up|5|||
125335588|NCT00488683|450861934|FG001|Overall Study|Lost to Follow-up|3|||
125335589|NCT00488683|450861935|FG002|Overall Study|Lost to Follow-up|0|||
125670392|NCT00982410|452081464|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
125670393|NCT00982410|452081463|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
125670394|NCT00982410|452081464|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
125670395|NCT00982410|452081463|FG000|12-month Follow-up Assessment|incarceration|2|||
125670396|NCT00982410|452081464|FG001|12-month Follow-up Assessment|incarceration|1|||
125670397|NCT00982410|452081463|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
125670398|NCT00982410|452081464|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
125670399|NCT04014959|452081468|FG000|Baseline MRI and Assessments|Physician Decision|2|||
125670400|NCT04014959|452081468|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
125670401|NCT04014959|452081468|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
125670402|NCT02034799|452081472|FG000|Overall Study|Withdrawal by Subject|0|||
125670403|NCT02034799|452081473|FG001|Overall Study|Withdrawal by Subject|2|||
125670404|NCT02034799|452081472|FG000|Overall Study|Lost to Follow-up|0|||
125670405|NCT02034799|452081473|FG001|Overall Study|Lost to Follow-up|1|||
125670406|NCT02034799|452081472|FG000|Overall Study|Death|2|||
125670407|NCT02034799|452081473|FG001|Overall Study|Death|1|||
125670408|NCT02806232|452081482|FG000|Overall Study|Lost to Follow-up|1|||
125670409|NCT02806232|452081483|FG001|Overall Study|Lost to Follow-up|2|||
125670410|NCT02806232|452081484|FG002|Overall Study|Lost to Follow-up|1|||
125670411|NCT02806232|452081485|FG003|Overall Study|Lost to Follow-up|0|||
125670412|NCT02806232|452081486|FG004|Overall Study|Lost to Follow-up|0|||
125670413|NCT02806232|452081487|FG005|Overall Study|Lost to Follow-up|1|||
125670414|NCT02806232|452081488|FG006|Overall Study|Lost to Follow-up|0|||
125670415|NCT02806232|452081489|FG007|Overall Study|Lost to Follow-up|0|||
125670416|NCT02806232|452081490|FG008|Overall Study|Lost to Follow-up|0|||
125670417|NCT02806232|452081482|FG000|Overall Study|Withdrawal by Subject|0|||
125670418|NCT02806232|452081483|FG001|Overall Study|Withdrawal by Subject|2|||
125670419|NCT02806232|452081484|FG002|Overall Study|Withdrawal by Subject|0|||
125335590|NCT00488683|450861933|FG000|Overall Study|Protocol Violation|5|||
125335591|NCT00488683|450861934|FG001|Overall Study|Protocol Violation|1|||
125335592|NCT00488683|450861935|FG002|Overall Study|Protocol Violation|0|||
125335593|NCT00488683|450861933|FG000|Overall Study|Unable to Classify|1|||
125335594|NCT00488683|450861934|FG001|Overall Study|Unable to Classify|0|||
125335595|NCT00488683|450861935|FG002|Overall Study|Unable to Classify|0|||
125670420|NCT02806232|452081485|FG003|Overall Study|Withdrawal by Subject|0|||
125670421|NCT02806232|452081486|FG004|Overall Study|Withdrawal by Subject|2|||
125670422|NCT02806232|452081487|FG005|Overall Study|Withdrawal by Subject|1|||
125670423|NCT02806232|452081488|FG006|Overall Study|Withdrawal by Subject|0|||
125670424|NCT02806232|452081489|FG007|Overall Study|Withdrawal by Subject|0|||
125670425|NCT02806232|452081490|FG008|Overall Study|Withdrawal by Subject|0|||
125670426|NCT00434161|452081491|FG000|Overall Study|Adverse Event|5|||
125670427|NCT00434161|452081492|FG001|Overall Study|Adverse Event|1|||
125670428|NCT00434161|452081493|FG002|Overall Study|Adverse Event|4|||
125670429|NCT00434161|452081491|FG000|Overall Study|Lost to Follow-up|0|||
125670430|NCT00434161|452081492|FG001|Overall Study|Lost to Follow-up|1|||
125670431|NCT00434161|452081493|FG002|Overall Study|Lost to Follow-up|0|||
125670432|NCT00434161|452081491|FG000|Overall Study|Death|1|||
125670433|NCT00434161|452081492|FG001|Overall Study|Death|0|||
125670434|NCT00434161|452081493|FG002|Overall Study|Death|1|||
125670435|NCT00434161|452081491|FG000|Overall Study|Non-Compliance|1|||
125670436|NCT00434161|452081492|FG001|Overall Study|Non-Compliance|1|||
125670437|NCT00434161|452081493|FG002|Overall Study|Non-Compliance|0|||
125670438|NCT00434161|452081491|FG000|Overall Study|Withdrawal by Subject|2|||
125670439|NCT00434161|452081492|FG001|Overall Study|Withdrawal by Subject|0|||
125670440|NCT00434161|452081493|FG002|Overall Study|Withdrawal by Subject|3|||
125670441|NCT00434161|452081491|FG000|Overall Study|Logistical error study assessments|1|||
125670442|NCT00434161|452081492|FG001|Overall Study|Logistical error study assessments|0|||
125670443|NCT00434161|452081493|FG002|Overall Study|Logistical error study assessments|3|||
125670444|NCT01387282|452081494|FG000|Overall Study|Death|47|||
125670445|NCT01387282|452081495|FG001|Overall Study|Death|16|||
125670446|NCT01387282|452081494|FG000|Overall Study|Other|5|||
125670447|NCT01387282|452081495|FG001|Overall Study|Other|1|||
125670448|NCT01387282|452081494|FG000|Overall Study|Unrelated AE|6|||
125670449|NCT01387282|452081495|FG001|Overall Study|Unrelated AE|4|||
125670450|NCT01387282|452081494|FG000|Overall Study|Withdrawal by patient|33|||
125670451|NCT01387282|452081495|FG001|Overall Study|Withdrawal by patient|23|||
125670452|NCT01387282|452081494|FG000|Overall Study|Study drug-related AE|2|||
125670453|NCT01387282|452081495|FG001|Overall Study|Study drug-related AE|2|||
125670454|NCT01387282|452081494|FG000|Overall Study|Lost to Follow-up|4|||
125670455|NCT01387282|452081495|FG001|Overall Study|Lost to Follow-up|1|||
125670456|NCT01267266|452081496|FG000|Enrollment Phase|Withdrawal by Subject|2|||
125670457|NCT01267266|452081497|FG001|Enrollment Phase|Withdrawal by Subject|0|||
125670458|NCT01267266|452081496|FG000|Lead-in Phase|Lack of Efficacy|20|||
125670459|NCT01267266|452081497|FG001|Lead-in Phase|Lack of Efficacy|0|||
125670460|NCT01267266|452081496|FG000|Lead-in Phase|Adverse Event|2|||
125670461|NCT01267266|452081497|FG001|Lead-in Phase|Adverse Event|0|||
125670462|NCT01267266|452081496|FG000|Lead-in Phase|Withdrawal by Subject|1|||
125670463|NCT01267266|452081497|FG001|Lead-in Phase|Withdrawal by Subject|0|||
125670464|NCT02497391|452081498|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
125670465|NCT02497391|452081499|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
125670466|NCT02497391|452081500|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
125670467|NCT02497391|452081501|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
125670468|NCT02497391|452081502|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
125670469|NCT02497391|452081503|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
125670470|NCT02497391|452081498|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
125670471|NCT02497391|452081499|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
125670472|NCT02497391|452081500|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
125670473|NCT02497391|452081501|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
125670474|NCT02497391|452081502|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
125670475|NCT02497391|452081503|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
125670476|NCT02497391|452081498|FG000|Period 3 (14 Days)|Adverse Event|0|||
125670477|NCT02497391|452081499|FG001|Period 3 (14 Days)|Adverse Event|1|||
125670478|NCT02497391|452081500|FG002|Period 3 (14 Days)|Adverse Event|0|||
125670479|NCT02497391|452081501|FG003|Period 3 (14 Days)|Adverse Event|0|||
125670480|NCT02497391|452081502|FG004|Period 3 (14 Days)|Adverse Event|0|||
125670481|NCT02497391|452081503|FG005|Period 3 (14 Days)|Adverse Event|0|||
125670482|NCT02497391|452081498|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
125670483|NCT02497391|452081499|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
125670484|NCT02497391|452081500|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
125670485|NCT02497391|452081501|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
125670486|NCT02497391|452081502|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
125670487|NCT02497391|452081503|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
125670488|NCT02497391|452081498|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
125670489|NCT02497391|452081499|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
125670490|NCT02497391|452081500|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
125670491|NCT02497391|452081501|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
125670492|NCT02497391|452081502|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
125670493|NCT02497391|452081503|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
125670494|NCT00658320|452081513|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
125670495|NCT00658320|452081514|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
125670496|NCT00658320|452081513|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
125670497|NCT00658320|452081514|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
125670498|NCT00658320|452081513|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
125670499|NCT00658320|452081514|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
125670500|NCT00658320|452081513|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
125670501|NCT00658320|452081514|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
125670502|NCT00387712|452081533|FG000|Overall Study|Physician Decision|6|||
125670503|NCT00387712|452081534|FG001|Overall Study|Physician Decision|4|||
125670504|NCT00387712|452081533|FG000|Overall Study|Lost to Follow-up|17|||
125670505|NCT00387712|452081534|FG001|Overall Study|Lost to Follow-up|20|||
125670506|NCT00387712|452081533|FG000|Overall Study|Withdrawal by Subject|6|||
125670507|NCT00387712|452081534|FG001|Overall Study|Withdrawal by Subject|12|||
125670508|NCT01907737|452081539|FG000|Overall Study|Withdrawal by Subject|1|||
125670509|NCT02668783|452081544|FG000|Overall Study|Pregnancy|0|||
125670510|NCT02668783|452081545|FG001|Overall Study|Pregnancy|1|||
125670511|NCT02668783|452081544|FG000|Overall Study|Protocol Violation|2|||
125670512|NCT02668783|452081545|FG001|Overall Study|Protocol Violation|1|||
125670513|NCT02668783|452081544|FG000|Overall Study|Study terminated by sponsor|9|||
125670514|NCT02668783|452081545|FG001|Overall Study|Study terminated by sponsor|10|||
125670515|NCT02668783|452081544|FG000|Overall Study|Subject moved|1|||
125670516|NCT02668783|452081545|FG001|Overall Study|Subject moved|0|||
125670517|NCT02668783|452081544|FG000|Overall Study|Withdrawal by Subject|1|||
125670518|NCT02668783|452081545|FG001|Overall Study|Withdrawal by Subject|0|||
125670519|NCT04467697|452081548|FG000|Overall Study|Adverse Event|2|||
125670520|NCT04467697|452081548|FG000|Overall Study|Lost to Follow-up|6|||
125670521|NCT04467697|452081548|FG000|Overall Study|Withdrawal by Subject|9|||
125670522|NCT04467697|452081548|FG000|Overall Study|Protocol Violation|3|||
125670523|NCT00909727|452081551|FG000|Overall Study|Adverse Event|1|||
125670524|NCT00909727|452081552|FG001|Overall Study|Adverse Event|0|||
125670525|NCT00909727|452081551|FG000|Overall Study|Wrong Genotype|1|||
125670526|NCT00909727|452081552|FG001|Overall Study|Wrong Genotype|0|||
125670527|NCT00909727|452081551|FG000|Overall Study|Withdrawal of Consent|1|||
125670528|NCT00909727|452081552|FG001|Overall Study|Withdrawal of Consent|0|||
125670529|NCT00909727|452081551|FG000|Overall Study|Prohibited Medication|1|||
125670530|NCT00909727|452081552|FG001|Overall Study|Prohibited Medication|0|||
125670531|NCT04081337|452081553|FG000|Overall Study|Adverse Event|0|||
125670532|NCT04081337|452081554|FG001|Overall Study|Adverse Event|1|||
125670533|NCT04081337|452081553|FG000|Overall Study|Withdrawal by Subject|2|||
125670534|NCT04081337|452081554|FG001|Overall Study|Withdrawal by Subject|0|||
125670535|NCT04081337|452081553|FG000|Overall Study|Physician Decision|1|||
125670536|NCT04081337|452081554|FG001|Overall Study|Physician Decision|2|||
125670537|NCT04081337|452081553|FG000|Overall Study|Lost to Follow-up|1|||
125670538|NCT04081337|452081554|FG001|Overall Study|Lost to Follow-up|0|||
125670539|NCT01799590|452081559|FG000|Overall Study|Adverse Event|13|||
125670540|NCT01799590|452081560|FG001|Overall Study|Adverse Event|7|||
125670541|NCT01799590|452081561|FG002|Overall Study|Adverse Event|5|||
125670542|NCT01799590|452081559|FG000|Overall Study|Pregnancy|2|||
125670543|NCT01799590|452081560|FG001|Overall Study|Pregnancy|0|||
125670544|NCT01799590|452081561|FG002|Overall Study|Pregnancy|0|||
125670545|NCT01799590|452081559|FG000|Overall Study|Lack of Efficacy|3|||
125670546|NCT01799590|452081560|FG001|Overall Study|Lack of Efficacy|1|||
125670547|NCT01799590|452081561|FG002|Overall Study|Lack of Efficacy|3|||
125670548|NCT01799590|452081559|FG000|Overall Study|Participants convenience|4|||
125670549|NCT01799590|452081560|FG001|Overall Study|Participants convenience|4|||
125670550|NCT01799590|452081561|FG002|Overall Study|Participants convenience|2|||
125670551|NCT01799590|452081559|FG000|Overall Study|Aggravation of complications|0|||
125670552|NCT01799590|452081560|FG001|Overall Study|Aggravation of complications|1|||
125670553|NCT01799590|452081561|FG002|Overall Study|Aggravation of complications|1|||
125670554|NCT01799590|452081559|FG000|Overall Study|Using drugs with restricted days of use|0|||
125670555|NCT01799590|452081560|FG001|Overall Study|Using drugs with restricted days of use|3|||
125670556|NCT01799590|452081561|FG002|Overall Study|Using drugs with restricted days of use|2|||
125670557|NCT01799590|452081559|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
125670558|NCT01799590|452081560|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
125670559|NCT01799590|452081561|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
125670560|NCT01799590|452081559|FG000|Overall Study|Other|3|||
125670561|NCT01799590|452081560|FG001|Overall Study|Other|0|||
125670562|NCT01799590|452081561|FG002|Overall Study|Other|1|||
125670563|NCT03175120|452081564|FG000|Overall Study|Adverse Event|2|||
125670564|NCT03175120|452081565|FG001|Overall Study|Adverse Event|2|||
125670565|NCT03175120|452081564|FG000|Overall Study|Protocol Violation|5|||
125670566|NCT03175120|452081565|FG001|Overall Study|Protocol Violation|2|||
125670567|NCT03175120|452081564|FG000|Overall Study|Lost to Follow-up|1|||
125670568|NCT03175120|452081565|FG001|Overall Study|Lost to Follow-up|0|||
125670569|NCT03175120|452081564|FG000|Overall Study|Withdrawal by Subject|2|||
125670570|NCT03175120|452081565|FG001|Overall Study|Withdrawal by Subject|5|||
125670571|NCT03175120|452081564|FG000|Overall Study|Other|2|||
125670572|NCT03175120|452081565|FG001|Overall Study|Other|3|||
125670573|NCT00678392|452081566|FG000|Overall Study|Adverse Event|0|||
125670574|NCT00678392|452081567|FG001|Overall Study|Adverse Event|6|||
125670575|NCT00678392|452081566|FG000|Overall Study|Death|280|||
125670576|NCT00678392|452081567|FG001|Overall Study|Death|269|||
125670577|NCT00678392|452081566|FG000|Overall Study|Lost to Follow-up|15|||
125670578|NCT00678392|452081567|FG001|Overall Study|Lost to Follow-up|13|||
125670579|NCT00678392|452081566|FG000|Overall Study|Objective Progression or Relapse|3|||
125670580|NCT00678392|452081567|FG001|Overall Study|Objective Progression or Relapse|8|||
125670581|NCT00678392|452081566|FG000|Overall Study|Sponsor's Decision|1|||
125670582|NCT00678392|452081567|FG001|Overall Study|Sponsor's Decision|2|||
125670583|NCT00678392|452081566|FG000|Overall Study|Withdrawal by Subject|4|||
125670584|NCT00678392|452081567|FG001|Overall Study|Withdrawal by Subject|4|||
125670585|NCT00678392|452081566|FG000|Overall Study|Randomized But Not Treated|2|||
125670586|NCT00678392|452081567|FG001|Overall Study|Randomized But Not Treated|7|||
125670587|NCT00678392|452081566|FG000|Overall Study|Other|56|||
125670588|NCT00678392|452081567|FG001|Overall Study|Other|53|||
125670589|NCT03341507|452081568|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
125670590|NCT03882047|452081570|FG000|Overall Study|Adverse Event|0|||
125670591|NCT03882047|452081571|FG001|Overall Study|Adverse Event|2|||
125670592|NCT03882047|452081572|FG002|Overall Study|Adverse Event|2|||
125670593|NCT03882047|452081570|FG000|Overall Study|Treatment Failure|3|||
125670594|NCT03882047|452081571|FG001|Overall Study|Treatment Failure|3|||
125670595|NCT03882047|452081572|FG002|Overall Study|Treatment Failure|12|||
125670596|NCT03882047|452081570|FG000|Overall Study|Lost to Follow-up|0|||
125670597|NCT03882047|452081571|FG001|Overall Study|Lost to Follow-up|1|||
125670598|NCT03882047|452081572|FG002|Overall Study|Lost to Follow-up|0|||
125670599|NCT03882047|452081570|FG000|Overall Study|Did Not Wish to Continue|1|||
125670600|NCT03882047|452081571|FG001|Overall Study|Did Not Wish to Continue|4|||
125670601|NCT03882047|452081572|FG002|Overall Study|Did Not Wish to Continue|1|||
125670602|NCT03882047|452081570|FG000|Overall Study|Noncompliance With Protocol|2|||
125670603|NCT03882047|452081571|FG001|Overall Study|Noncompliance With Protocol|0|||
125670604|NCT03882047|452081572|FG002|Overall Study|Noncompliance With Protocol|0|||
125670605|NCT03882047|452081570|FG000|Overall Study|Did Not Meet Eligibility|0|||
125670606|NCT03882047|452081571|FG001|Overall Study|Did Not Meet Eligibility|0|||
125670607|NCT03882047|452081572|FG002|Overall Study|Did Not Meet Eligibility|1|||
125670608|NCT00441584|452081575|FG000|Overall Study|Lack of Efficacy|79|||
125670609|NCT00441584|452081575|FG000|Overall Study|Withdrawal by Subject|8|||
125670610|NCT00441584|452081575|FG000|Overall Study|Adverse Event|6|||
125670611|NCT00441584|452081575|FG000|Overall Study|Protocol Violation|5|||
125670612|NCT00441584|452081575|FG000|Overall Study|Lost to Follow-up|4|||
125670613|NCT00441584|452081575|FG000|Overall Study|Failure to meet eligibility criteria|3|||
125670614|NCT00770991|452081580|FG000|Overall Study|Physician Decision|2|||
125670615|NCT00770991|452081581|FG001|Overall Study|Physician Decision|0|||
125670616|NCT00770991|452081580|FG000|Overall Study|Withdrawal by Subject|1|||
125670617|NCT00770991|452081581|FG001|Overall Study|Withdrawal by Subject|0|||
125670618|NCT00770991|452081580|FG000|Overall Study|Adverse Event|1|||
125670619|NCT00770991|452081581|FG001|Overall Study|Adverse Event|5|||
125670620|NCT00770991|452081580|FG000|Overall Study|Pregnancy|1|||
125670621|NCT00770991|452081581|FG001|Overall Study|Pregnancy|0|||
125670622|NCT03465891|452081582|FG000|Overall Study|Withdrawal by Subject|0|||
125670623|NCT03465891|452081583|FG001|Overall Study|Withdrawal by Subject|1|||
125670624|NCT03465891|452081582|FG000|Overall Study|Disease progression|1|||
125670625|NCT03465891|452081583|FG001|Overall Study|Disease progression|0|||
125670626|NCT01001169|452081584|FG000|Overall Study|Withdrawal by Subject|2|||
125670627|NCT01001169|452081585|FG001|Overall Study|Withdrawal by Subject|1|||
125670628|NCT02040766|452081588|FG000|Overall Study|Adverse Event|1|||
125670629|NCT02040766|452081589|FG001|Overall Study|Adverse Event|1|||
125670630|NCT02040766|452081590|FG002|Overall Study|Adverse Event|1|||
125670631|NCT02040766|452081591|FG003|Overall Study|Adverse Event|0|||
125670632|NCT02040766|452081592|FG004|Overall Study|Adverse Event|2|||
125670633|NCT02040766|452081588|FG000|Overall Study|Withdrawal by Subject|4|||
125670634|NCT02040766|452081589|FG001|Overall Study|Withdrawal by Subject|3|||
125670635|NCT02040766|452081590|FG002|Overall Study|Withdrawal by Subject|2|||
125670636|NCT02040766|452081591|FG003|Overall Study|Withdrawal by Subject|3|||
125670637|NCT02040766|452081592|FG004|Overall Study|Withdrawal by Subject|2|||
125670638|NCT02040766|452081588|FG000|Overall Study|Non-compliance|0|||
125670639|NCT02040766|452081589|FG001|Overall Study|Non-compliance|1|||
125670640|NCT02040766|452081590|FG002|Overall Study|Non-compliance|0|||
125670641|NCT02040766|452081591|FG003|Overall Study|Non-compliance|0|||
125670642|NCT02040766|452081592|FG004|Overall Study|Non-compliance|0|||
125670643|NCT02040766|452081588|FG000|Overall Study|Protocol Violation|2|||
125670644|NCT02040766|452081589|FG001|Overall Study|Protocol Violation|1|||
125670645|NCT02040766|452081590|FG002|Overall Study|Protocol Violation|2|||
125670646|NCT02040766|452081591|FG003|Overall Study|Protocol Violation|3|||
125670647|NCT02040766|452081592|FG004|Overall Study|Protocol Violation|0|||
125670648|NCT02040766|452081588|FG000|Overall Study|Lost to Follow-up|4|||
125670649|NCT02040766|452081589|FG001|Overall Study|Lost to Follow-up|1|||
125670650|NCT02040766|452081590|FG002|Overall Study|Lost to Follow-up|3|||
125670651|NCT02040766|452081591|FG003|Overall Study|Lost to Follow-up|1|||
125670652|NCT02040766|452081592|FG004|Overall Study|Lost to Follow-up|4|||
125670653|NCT02040766|452081588|FG000|Overall Study|Not reported|1|||
125670654|NCT02040766|452081589|FG001|Overall Study|Not reported|0|||
125670655|NCT02040766|452081590|FG002|Overall Study|Not reported|0|||
125670656|NCT02040766|452081591|FG003|Overall Study|Not reported|0|||
125670657|NCT02040766|452081592|FG004|Overall Study|Not reported|0|||
125670658|NCT02040766|452081588|FG000|Overall Study|Lack of Efficacy|6|||
125670659|NCT02040766|452081589|FG001|Overall Study|Lack of Efficacy|3|||
125670660|NCT02040766|452081590|FG002|Overall Study|Lack of Efficacy|4|||
125670661|NCT02040766|452081591|FG003|Overall Study|Lack of Efficacy|6|||
125670662|NCT02040766|452081592|FG004|Overall Study|Lack of Efficacy|5|||
125670663|NCT00481247|452081602|FG000|Overall Study|Death|0|||
125670664|NCT00481247|452081603|FG001|Overall Study|Death|1|||
125670665|NCT00481247|452081602|FG000|Overall Study|Disease progression|18|||
125670666|NCT00481247|452081603|FG001|Overall Study|Disease progression|22|||
125670667|NCT00481247|452081602|FG000|Overall Study|Intolerance|42|||
125670668|NCT00481247|452081603|FG001|Overall Study|Intolerance|17|||
125670669|NCT00481247|452081602|FG000|Overall Study|Treatment failure|10|||
125670670|NCT00481247|452081603|FG001|Overall Study|Treatment failure|14|||
125670671|NCT00481247|452081602|FG000|Overall Study|AE unrelated to study drug|13|||
125670672|NCT00481247|452081603|FG001|Overall Study|AE unrelated to study drug|4|||
125670673|NCT00481247|452081602|FG000|Overall Study|Withdrawal by Subject|8|||
125670674|NCT00481247|452081603|FG001|Overall Study|Withdrawal by Subject|13|||
125670675|NCT00481247|452081602|FG000|Overall Study|Pregnancy|2|||
125670676|NCT00481247|452081603|FG001|Overall Study|Pregnancy|1|||
125670677|NCT00481247|452081602|FG000|Overall Study|Lost to Follow-up|1|||
125670678|NCT00481247|452081603|FG001|Overall Study|Lost to Follow-up|2|||
125670679|NCT00481247|452081602|FG000|Overall Study|Poor compliance/noncompliance|1|||
125670680|NCT00481247|452081603|FG001|Overall Study|Poor compliance/noncompliance|7|||
125670681|NCT00481247|452081602|FG000|Overall Study|Administrative reason by sponsor|157|||
125670682|NCT00481247|452081603|FG001|Overall Study|Administrative reason by sponsor|162|||
125670683|NCT00481247|452081602|FG000|Overall Study|Varied|6|||
125670684|NCT00481247|452081603|FG001|Overall Study|Varied|15|||
125670685|NCT00481247|452081602|FG000|Overall Study|Did not receive treatment|1|||
125670686|NCT00481247|452081603|FG001|Overall Study|Did not receive treatment|2|||
125670687|NCT02535000|452081604|FG000|Overall Study|Cancellation of surgery.|1|||
125670688|NCT02535000|452081605|FG001|Overall Study|Cancellation of surgery.|2|||
125670689|NCT04317781|452081606|FG000|Overall Study|Adverse Event|1|||
125670690|NCT04317781|452081606|FG000|Overall Study|Disease relapse|1|||
125670691|NCT04317781|452081606|FG000|Overall Study|Withdrawal by Subject|1|||
125670692|NCT01620489|452081607|FG000|Overall Study|Adverse Event|17|||
125670693|NCT01620489|452081608|FG001|Overall Study|Adverse Event|4|||
125670694|NCT01620489|452081607|FG000|Overall Study|Protocol Violation|0|||
125670695|NCT01620489|452081608|FG001|Overall Study|Protocol Violation|3|||
125670696|NCT01620489|452081607|FG000|Overall Study|Withdrawal Criteria|17|||
125670697|NCT01620489|452081608|FG001|Overall Study|Withdrawal Criteria|25|||
125670698|NCT01620489|452081607|FG000|Overall Study|Unclassified|1|||
125670699|NCT01620489|452081608|FG001|Overall Study|Unclassified|2|||
125670700|NCT00947856|452081609|FG000|Treatment Period|Progressive Disease|33|||
125670701|NCT00947856|452081610|FG001|Treatment Period|Progressive Disease|12|||
125670702|NCT00947856|452081609|FG000|Treatment Period|Adverse Event|15|||
125670703|NCT00947856|452081610|FG001|Treatment Period|Adverse Event|9|||
125670704|NCT00947856|452081609|FG000|Treatment Period|Physician Decision|14|||
125670705|NCT00947856|452081610|FG001|Treatment Period|Physician Decision|6|||
125670706|NCT00947856|452081609|FG000|Treatment Period|Study Stopped by Sponsor|4|||
125670707|NCT00947856|452081610|FG001|Treatment Period|Study Stopped by Sponsor|4|||
125670708|NCT00947856|452081609|FG000|Treatment Period|Withdrawal by Subject|12|||
125670709|NCT00947856|452081610|FG001|Treatment Period|Withdrawal by Subject|1|||
125670710|NCT00947856|452081609|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
125670711|NCT00947856|452081610|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
125670712|NCT00947856|452081609|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
125670713|NCT00947856|452081610|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
125670714|NCT00947856|452081609|FG000|Follow-up Period|Lost to Follow-up|7|||
125670715|NCT00947856|452081610|FG001|Follow-up Period|Lost to Follow-up|0|||
125670716|NCT00947856|452081609|FG000|Follow-up Period|Patient unavailable for site visits|1|||
125670717|NCT00947856|452081610|FG001|Follow-up Period|Patient unavailable for site visits|0|||
125670718|NCT00947856|452081609|FG000|Follow-up Period|Withdrawal by Subject|1|||
125670719|NCT00947856|452081610|FG001|Follow-up Period|Withdrawal by Subject|0|||
125670720|NCT01512979|452081617|FG000|Overall Study|Adverse Event|2|||
125670721|NCT01512979|452081618|FG001|Overall Study|Adverse Event|2|||
125670722|NCT01512979|452081617|FG000|Overall Study|Protocol Violation|1|||
125670723|NCT01512979|452081618|FG001|Overall Study|Protocol Violation|4|||
125670724|NCT01512979|452081617|FG000|Overall Study|Lost to Follow-up|2|||
125378854|NCT01134783|451019171|FG001|Overall Study|Withdrawal by Subject|9|||
125378855|NCT01134783|451019170|FG000|Overall Study|Lost to Follow-up|5|||
125378856|NCT01134783|451019171|FG001|Overall Study|Lost to Follow-up|20|||
125378857|NCT04221009|451019172|FG000|Overall Study|Withdrawal by Subject|4|||
125378858|NCT02762266|451019173|FG000|Overall Study|Physician Decision|2|||
125378859|NCT02762266|451019174|FG001|Overall Study|Physician Decision|0|||
125378860|NCT01438424|451019175|FG000|Overall Study|Continuing treatment|29|||
125378861|NCT01438424|451019175|FG000|Overall Study|Minimal virologic response|95|||
125378862|NCT01438424|451019175|FG000|Overall Study|Not identified|55|||
125378863|NCT01438424|451019175|FG000|Overall Study|Withdrawal by Subject|104|||
125378864|NCT01438424|451019175|FG000|Overall Study|Progression of chronic hepatitis B|22|||
125378865|NCT01438424|451019175|FG000|Overall Study|Death|22|||
125378866|NCT01438424|451019175|FG000|Overall Study|Adverse Event|17|||
125378867|NCT01438424|451019175|FG000|Overall Study|Lost to Follow-up|17|||
125378868|NCT01438424|451019175|FG000|Overall Study|Abnormal laboratory test result|14|||
125378869|NCT01438424|451019175|FG000|Overall Study|Need for drug prohibited by protocol|14|||
125378870|NCT01438424|451019175|FG000|Overall Study|Pregnancy|7|||
125378871|NCT01438424|451019175|FG000|Overall Study|No longer met inclusion criteria|1|||
125378872|NCT01438424|451019175|FG000|Overall Study|Participant noncompliance|20|||
125378873|NCT04232124|451019176|FG000|Overall Study|Lost to Follow-up|3|||
125378874|NCT02392247|451019181|FG000|Overall Study|Withdrawal by Subject|1|||
125378875|NCT02392247|451019181|FG000|Overall Study|Surgery cancelled; no data|1|||
125378876|NCT00848081|451019190|FG000|Overall Study|Adverse Event|6|||
125378877|NCT00848081|451019191|FG001|Overall Study|Adverse Event|7|||
125378878|NCT00848081|451019190|FG000|Overall Study|Protocol Violation|8|||
125378879|NCT00848081|451019191|FG001|Overall Study|Protocol Violation|5|||
125378880|NCT00848081|451019190|FG000|Overall Study|Lost to Follow-up|1|||
125378881|NCT00848081|451019191|FG001|Overall Study|Lost to Follow-up|0|||
125378882|NCT00848081|451019190|FG000|Overall Study|Physician Decision|0|||
125378883|NCT00848081|451019191|FG001|Overall Study|Physician Decision|3|||
125378884|NCT00848081|451019190|FG000|Overall Study|Withdrawal by Subject|5|||
125378885|NCT00848081|451019191|FG001|Overall Study|Withdrawal by Subject|3|||
125378886|NCT02064868|451019192|FG000|Overall Study|Lost to Follow-up|14|||
125378887|NCT02064868|451019193|FG001|Overall Study|Lost to Follow-up|8|||
125378888|NCT02064868|451019192|FG000|Overall Study|Physician Decision|1|||
125378889|NCT02064868|451019193|FG001|Overall Study|Physician Decision|0|||
125378890|NCT02064868|451019192|FG000|Overall Study|Withdrawal by Subject|14|||
125378891|NCT02064868|451019193|FG001|Overall Study|Withdrawal by Subject|3|||
125378892|NCT02064868|451019192|FG000|Overall Study|Technical Problems or Missing|5|||
125378893|NCT02064868|451019193|FG001|Overall Study|Technical Problems or Missing|2|||
125378894|NCT00754624|451019197|FG000|Overall Study|Adverse Event|16|||
125378895|NCT00754624|451019197|FG000|Overall Study|Death|1|||
125378896|NCT00754624|451019197|FG000|Overall Study|Physician Decision|8|||
125378897|NCT00754624|451019197|FG000|Overall Study|Protocol Violation|1|||
125670725|NCT01512979|452081618|FG001|Overall Study|Lost to Follow-up|5|||
125336602|NCT02102204|450867142|FG000|Overall Study|Withdrawal by Subject|137|||
125336603|NCT02102204|450867142|FG000|Overall Study|Death|92|||
125336604|NCT02102204|450867142|FG000|Overall Study|Lost to Follow-up|65|||
125336605|NCT02102204|450867142|FG000|Overall Study|Sponsor Decision|5|||
125336606|NCT02102204|450867142|FG000|Overall Study|Ongoing|5|||
125336607|NCT02741518|450867143|FG000|Overall Study|Withdrawal by Subject|1|||
125336608|NCT02741518|450867144|FG001|Overall Study|Withdrawal by Subject|1|||
125336609|NCT02810444|450867147|FG000|Overall Study|Screen Failures|14|||
125336610|NCT02810444|450867147|FG000|Overall Study|Withdrawal by Subject|4|||
125336611|NCT02810444|450867147|FG000|Overall Study|Adverse Event|3|||
125336612|NCT01139008|450867148|FG000|Overall Study|Withdrawal by Subject|5|||
125336613|NCT01139008|450867148|FG000|Overall Study|Non-compliant, lost product|1|||
125336614|NCT01715857|450867149|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
125336615|NCT02785770|450867150|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
125336616|NCT02785770|450867151|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
125336617|NCT02785770|450867152|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
125336618|NCT02785770|450867153|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
125336619|NCT02785770|450867150|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
125336620|NCT02785770|450867151|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
125336621|NCT02785770|450867152|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
125336622|NCT02785770|450867153|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
125336623|NCT02785770|450867150|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
125336624|NCT02785770|450867151|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
125336625|NCT02785770|450867152|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
125336626|NCT02785770|450867153|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
125336627|NCT00505778|450867157|FG000|Overall Study|Adverse Event|2|||
125336628|NCT00505778|450867158|FG001|Overall Study|Adverse Event|7|||
125336629|NCT00505778|450867157|FG000|Overall Study|Physician Decision|8|||
125336630|NCT00505778|450867158|FG001|Overall Study|Physician Decision|14|||
125336631|NCT00505778|450867157|FG000|Overall Study|Lost to Follow-up|17|||
125336632|NCT00505778|450867158|FG001|Overall Study|Lost to Follow-up|23|||
125336633|NCT00505778|450867157|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
125336634|NCT00505778|450867158|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
125336635|NCT00505778|450867157|FG000|Overall Study|Protocol Violation|7|||
125336636|NCT00505778|450867158|FG001|Overall Study|Protocol Violation|9|||
125336637|NCT00505778|450867157|FG000|Overall Study|Withdrawal by Subject|29|||
125336638|NCT00505778|450867158|FG001|Overall Study|Withdrawal by Subject|14|||
125336639|NCT00505778|450867157|FG000|Overall Study|Relapse|65|||
125336640|NCT00505778|450867158|FG001|Overall Study|Relapse|65|||
125336641|NCT00505778|450867157|FG000|Overall Study|Took No Study Drug|2|||
125336642|NCT00505778|450867158|FG001|Overall Study|Took No Study Drug|2|||
125336643|NCT02136069|450867161|FG000|Overall Study|UC flare-up|1|||
125336644|NCT02136069|450867162|FG001|Overall Study|UC flare-up|0|||
125336645|NCT02136069|450867161|FG000|Overall Study|Adverse Event|6|||
125336646|NCT02136069|450867162|FG001|Overall Study|Adverse Event|8|||
125336647|NCT02136069|450867161|FG000|Overall Study|Death|0|||
125336648|NCT02136069|450867162|FG001|Overall Study|Death|1|||
125336649|NCT02136069|450867161|FG000|Overall Study|Lack of Efficacy|10|||
125336650|NCT02136069|450867162|FG001|Overall Study|Lack of Efficacy|4|||
125336651|NCT02136069|450867161|FG000|Overall Study|Lost to Follow-up|1|||
125336652|NCT02136069|450867162|FG001|Overall Study|Lost to Follow-up|0|||
125336653|NCT02136069|450867161|FG000|Overall Study|Non-Compliance|1|||
125336654|NCT02136069|450867162|FG001|Overall Study|Non-Compliance|0|||
125336655|NCT02136069|450867161|FG000|Overall Study|Physician Decision|5|||
125336656|NCT02136069|450867162|FG001|Overall Study|Physician Decision|4|||
125336657|NCT02136069|450867161|FG000|Overall Study|Withdrawal by Subject|10|||
125336658|NCT02136069|450867162|FG001|Overall Study|Withdrawal by Subject|11|||
125336659|NCT01092546|450867163|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
125336660|NCT01667419|450867164|FG000|Overall Study|Reason Not Specified|1|||
125336661|NCT01667419|450867165|FG001|Overall Study|Reason Not Specified|0|||
125336662|NCT01667419|450867166|FG002|Overall Study|Reason Not Specified|0|||
125336663|NCT01667419|450867167|FG003|Overall Study|Reason Not Specified|0|||
125336664|NCT01667419|450867164|FG000|Overall Study|Withdrawal by Subject|16|||
125336665|NCT01667419|450867165|FG001|Overall Study|Withdrawal by Subject|8|||
125336666|NCT01667419|450867166|FG002|Overall Study|Withdrawal by Subject|9|||
125336667|NCT01667419|450867167|FG003|Overall Study|Withdrawal by Subject|8|||
125336668|NCT01667419|450867164|FG000|Overall Study|Non-compliance|0|||
125336669|NCT01667419|450867165|FG001|Overall Study|Non-compliance|0|||
125336670|NCT01667419|450867166|FG002|Overall Study|Non-compliance|0|||
125336671|NCT01667419|450867167|FG003|Overall Study|Non-compliance|1|||
125336672|NCT01667419|450867164|FG000|Overall Study|Protocol Violation|1|||
125336673|NCT01667419|450867165|FG001|Overall Study|Protocol Violation|0|||
125336674|NCT01667419|450867166|FG002|Overall Study|Protocol Violation|0|||
125336675|NCT01667419|450867167|FG003|Overall Study|Protocol Violation|0|||
125336676|NCT01667419|450867164|FG000|Overall Study|Lost to Follow-up|7|||
125336677|NCT01667419|450867165|FG001|Overall Study|Lost to Follow-up|6|||
125336678|NCT01667419|450867166|FG002|Overall Study|Lost to Follow-up|2|||
125336679|NCT01667419|450867167|FG003|Overall Study|Lost to Follow-up|4|||
125336680|NCT01667419|450867164|FG000|Overall Study|Death|18|||
125336681|NCT01667419|450867165|FG001|Overall Study|Death|33|||
125336682|NCT01667419|450867166|FG002|Overall Study|Death|25|||
125336683|NCT01667419|450867167|FG003|Overall Study|Death|26|||
125336684|NCT04364984|450867169|FG000|Overall Study|Death|2|||
125336685|NCT04364984|450867170|FG001|Overall Study|Death|2|||
125336686|NCT04364984|450867171|FG002|Overall Study|Death|0|||
125336687|NCT01941186|450867172|FG000|Follow-up|Lost to Follow-up|1|||
125336688|NCT01941186|450867173|FG001|Follow-up|Lost to Follow-up|0|||
125336689|NCT04380519|450867174|FG000|Overall Study|Withdrawal by Subject|4|||
125336690|NCT04380519|450867175|FG001|Overall Study|Withdrawal by Subject|0|||
125336691|NCT04380519|450867176|FG002|Overall Study|Withdrawal by Subject|1|||
125336692|NCT04380519|450867174|FG000|Overall Study|Death|14|||
125336693|NCT04380519|450867175|FG001|Overall Study|Death|9|||
125336694|NCT04380519|450867176|FG002|Overall Study|Death|6|||
125336695|NCT04380519|450867174|FG000|Overall Study|Adverse Event|0|||
125336696|NCT04380519|450867175|FG001|Overall Study|Adverse Event|1|||
125336697|NCT04380519|450867176|FG002|Overall Study|Adverse Event|0|||
125336698|NCT04380519|450867174|FG000|Overall Study|relatives' decision|0|||
125336699|NCT04380519|450867175|FG001|Overall Study|relatives' decision|1|||
125336700|NCT04380519|450867176|FG002|Overall Study|relatives' decision|0|||
125336701|NCT02474069|450867177|FG000|Selection Phase (SP)|Adverse Event|8|||
125336702|NCT02474069|450867178|FG001|Selection Phase (SP)|Adverse Event|0|||
125336703|NCT02474069|450867179|FG002|Selection Phase (SP)|Adverse Event|0|||
125336704|NCT02474069|450867177|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
125336705|NCT02474069|450867178|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
125336706|NCT02474069|450867179|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
125336707|NCT02474069|450867177|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
125336708|NCT02474069|450867178|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
125336709|NCT02474069|450867179|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
125336710|NCT02474069|450867177|FG000|Selection Phase (SP)|Physician Decision|1|||
125336711|NCT02474069|450867178|FG001|Selection Phase (SP)|Physician Decision|0|||
125336712|NCT02474069|450867179|FG002|Selection Phase (SP)|Physician Decision|0|||
125336713|NCT02474069|450867177|FG000|Selection Phase (SP)|Protocol Violation|1|||
125336714|NCT02474069|450867178|FG001|Selection Phase (SP)|Protocol Violation|0|||
125336715|NCT02474069|450867179|FG002|Selection Phase (SP)|Protocol Violation|0|||
125336716|NCT02474069|450867177|FG000|Selection Phase (SP)|No longer requires treatment|1|||
125336717|NCT02474069|450867178|FG001|Selection Phase (SP)|No longer requires treatment|0|||
125336718|NCT02474069|450867179|FG002|Selection Phase (SP)|No longer requires treatment|0|||
125336719|NCT02474069|450867177|FG000|Selection Phase (SP)|Technical Problem|1|||
125336720|NCT02474069|450867178|FG001|Selection Phase (SP)|Technical Problem|0|||
125336721|NCT02474069|450867179|FG002|Selection Phase (SP)|Technical Problem|0|||
125336722|NCT02474069|450867177|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
125336723|NCT02474069|450867178|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
125336724|NCT02474069|450867179|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
125336725|NCT02474069|450867177|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
125336726|NCT02474069|450867178|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
125336727|NCT02474069|450867179|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
125336728|NCT02474069|450867177|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
125336729|NCT02474069|450867178|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
125336730|NCT02474069|450867179|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
125336731|NCT02474069|450867177|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
125336732|NCT02474069|450867178|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
125336733|NCT02474069|450867179|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
125670726|NCT01512979|452081617|FG000|Overall Study|Withdrawal by Subject|1|||
125670727|NCT01512979|452081618|FG001|Overall Study|Withdrawal by Subject|2|||
125670728|NCT01512979|452081617|FG000|Overall Study|Reason other than stated above|13|||
125670729|NCT01512979|452081618|FG001|Overall Study|Reason other than stated above|9|||
125670730|NCT00874757|452081625|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
125670731|NCT02004847|452083328|FG000|Overall Study|Protocol Violation|1|||
125670732|NCT02004847|452083329|FG001|Overall Study|Protocol Violation|1|||
125670733|NCT00759148|452083330|FG000|Overall Study|Adverse Event|1|||
125670734|NCT00759148|452083331|FG001|Overall Study|Adverse Event|6|||
125670735|NCT00759148|452083330|FG000|Overall Study|Withdrawal by Subject|3|||
125670736|NCT00759148|452083331|FG001|Overall Study|Withdrawal by Subject|7|||
125670737|NCT00759148|452083330|FG000|Overall Study|Lost to Follow-up|3|||
125336734|NCT02474069|450867177|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
125336735|NCT02474069|450867178|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
125336736|NCT02474069|450867179|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
125336737|NCT02474069|450867177|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
125336738|NCT02474069|450867178|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
125336739|NCT02474069|450867179|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
125670738|NCT00759148|452083331|FG001|Overall Study|Lost to Follow-up|9|||
125336740|NCT04173494|450867180|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
125670739|NCT00759148|452083330|FG000|Overall Study|Treatment Failure|6|||
125336741|NCT04173494|450867181|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
125336742|NCT04173494|450867180|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
125336743|NCT04173494|450867181|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
125336744|NCT04173494|450867180|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
125336745|NCT04173494|450867181|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
125336746|NCT04173494|450867180|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
125336747|NCT04173494|450867181|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
125336748|NCT04173494|450867180|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
125336749|NCT04173494|450867181|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
125336750|NCT04173494|450867180|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
125336751|NCT04173494|450867181|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
125336752|NCT04173494|450867180|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
125336753|NCT04173494|450867181|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
125336754|NCT04173494|450867180|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
125336755|NCT04173494|450867181|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
125336756|NCT04173494|450867180|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
125336757|NCT04173494|450867181|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
125336758|NCT04173494|450867180|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
125336759|NCT04173494|450867181|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
125670740|NCT00759148|452083331|FG001|Overall Study|Treatment Failure|10|||
125670741|NCT00759148|452083330|FG000|Overall Study|Reason not given|1|||
125336760|NCT04173494|450867180|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
125336761|NCT04173494|450867181|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
125336762|NCT04173494|450867180|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
125336763|NCT04173494|450867181|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
125336764|NCT04173494|450867180|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
125336765|NCT04173494|450867181|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
125336766|NCT04173494|450867180|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
125336767|NCT04173494|450867181|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
125336768|NCT04173494|450867180|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
125336769|NCT04173494|450867181|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
125336770|NCT04173494|450867180|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
125336771|NCT04173494|450867181|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
125336772|NCT01623050|450867184|FG000|Overall Study|Lost to Follow-up|9|||
125336773|NCT00393861|450867185|FG000|Overall Study|Adverse Event|2|||
125336774|NCT00393861|450867185|FG000|Overall Study|Disease Progression|24|||
125336775|NCT01388335|450867188|FG000|Period 1|Progressive Disease|1|||
125336776|NCT01388335|450867188|FG000|Period 2|Progressive Disease|2|||
125336777|NCT01388335|450867188|FG000|Period 2|Sponsor Decision|1|||
125336778|NCT01388335|450867188|FG000|Safety Extension|Progressive Disease|7|||
125336779|NCT04413617|450867194|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
125336780|NCT04413617|450867195|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
125336781|NCT04413617|450867196|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
125336782|NCT04413617|450867197|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
125336783|NCT04413617|450867198|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
125336784|NCT04413617|450867194|FG000|Overall Study|Protocol Violation|0|||
125336785|NCT04413617|450867195|FG001|Overall Study|Protocol Violation|1|||
125336786|NCT04413617|450867196|FG002|Overall Study|Protocol Violation|0|||
125336787|NCT04413617|450867197|FG003|Overall Study|Protocol Violation|0|||
125336788|NCT04413617|450867198|FG004|Overall Study|Protocol Violation|1|||
125336789|NCT04413617|450867194|FG000|Overall Study|Lack of Efficacy|2|||
125336790|NCT04413617|450867195|FG001|Overall Study|Lack of Efficacy|0|||
125336791|NCT04413617|450867196|FG002|Overall Study|Lack of Efficacy|2|||
125670742|NCT00759148|452083331|FG001|Overall Study|Reason not given|0|||
125670743|NCT03342898|452083334|FG000|Overall Study|Adverse Event|3|||
125670744|NCT03342898|452083335|FG001|Overall Study|Adverse Event|1|||
125670745|NCT03342898|452083336|FG002|Overall Study|Adverse Event|0|||
125670746|NCT03342898|452083334|FG000|Overall Study|Lost to Follow-up|44|||
125670747|NCT03342898|452083335|FG001|Overall Study|Lost to Follow-up|40|||
125670748|NCT03342898|452083336|FG002|Overall Study|Lost to Follow-up|42|||
125670749|NCT03342898|452083334|FG000|Overall Study|Withdrawal of Consent|5|||
125670750|NCT03342898|452083335|FG001|Overall Study|Withdrawal of Consent|9|||
125670751|NCT03342898|452083336|FG002|Overall Study|Withdrawal of Consent|11|||
125670752|NCT03342898|452083334|FG000|Overall Study|Death|0|||
125336792|NCT04413617|450867197|FG003|Overall Study|Lack of Efficacy|1|||
125336793|NCT04413617|450867198|FG004|Overall Study|Lack of Efficacy|0|||
125336794|NCT04413617|450867194|FG000|Overall Study|Withdrawal by Subject|3|||
125670753|NCT03342898|452083335|FG001|Overall Study|Death|1|||
125670754|NCT03342898|452083336|FG002|Overall Study|Death|1|||
125670755|NCT03342898|452083334|FG000|Overall Study|Reason not Specified|2|||
125670756|NCT03342898|452083335|FG001|Overall Study|Reason not Specified|2|||
125336795|NCT04413617|450867195|FG001|Overall Study|Withdrawal by Subject|4|||
125336796|NCT04413617|450867196|FG002|Overall Study|Withdrawal by Subject|2|||
125336797|NCT04413617|450867197|FG003|Overall Study|Withdrawal by Subject|5|||
125336798|NCT04413617|450867198|FG004|Overall Study|Withdrawal by Subject|3|||
125336799|NCT04413617|450867194|FG000|Overall Study|Death|1|||
125336800|NCT04413617|450867195|FG001|Overall Study|Death|0|||
125336801|NCT04413617|450867196|FG002|Overall Study|Death|0|||
125336802|NCT04413617|450867197|FG003|Overall Study|Death|0|||
125336803|NCT04413617|450867198|FG004|Overall Study|Death|0|||
125336804|NCT04413617|450867194|FG000|Overall Study|Adverse Event|1|||
125336805|NCT04413617|450867195|FG001|Overall Study|Adverse Event|0|||
125336806|NCT04413617|450867196|FG002|Overall Study|Adverse Event|0|||
125336807|NCT04413617|450867197|FG003|Overall Study|Adverse Event|1|||
125336808|NCT04413617|450867198|FG004|Overall Study|Adverse Event|1|||
125336809|NCT04413617|450867194|FG000|Overall Study|COVID-19|0|||
125336810|NCT04413617|450867195|FG001|Overall Study|COVID-19|1|||
125336811|NCT04413617|450867196|FG002|Overall Study|COVID-19|0|||
125336812|NCT04413617|450867197|FG003|Overall Study|COVID-19|0|||
125336813|NCT04413617|450867198|FG004|Overall Study|COVID-19|0|||
125336814|NCT02657408|450867199|FG000|Overall Study|Adverse Event|3|||
125336815|NCT02657408|450867200|FG001|Overall Study|Adverse Event|7|||
125336816|NCT00324961|450867202|FG000|Overall Study|Adverse Event|5|||
125336817|NCT00324961|450867202|FG000|Overall Study|Consent Withdrawn|11|||
125336818|NCT00324961|450867202|FG000|Overall Study|Lost to Follow-up|22|||
125336819|NCT00324961|450867202|FG000|Overall Study|Protocol Violation|3|||
125336820|NCT00324961|450867202|FG000|Overall Study|Other|2|||
125336821|NCT03350672|450867206|FG000|Overall Study|Withdrawal by Subject|7|||
125336822|NCT03350672|450867207|FG001|Overall Study|Withdrawal by Subject|0|||
125336823|NCT03350672|450867208|FG002|Overall Study|Withdrawal by Subject|0|||
125336824|NCT00223080|450867211|FG000|Overall Study|Withdrawal by Subject|253|||
125336825|NCT00223080|450867212|FG001|Overall Study|Withdrawal by Subject|232|||
125336826|NCT00223080|450867211|FG000|Overall Study|Required contraindicated med|0|||
125336827|NCT00223080|450867212|FG001|Overall Study|Required contraindicated med|1|||
125336828|NCT00223080|450867211|FG000|Overall Study|Non-compliant|7|||
125336829|NCT00223080|450867212|FG001|Overall Study|Non-compliant|7|||
125336830|NCT00223080|450867211|FG000|Overall Study|Moved from study area|37|||
125336831|NCT00223080|450867212|FG001|Overall Study|Moved from study area|47|||
125336832|NCT00223080|450867211|FG000|Overall Study|Lost to Follow-up|259|||
125336833|NCT00223080|450867212|FG001|Overall Study|Lost to Follow-up|284|||
125336834|NCT00223080|450867211|FG000|Overall Study|Death|85|||
125336835|NCT00223080|450867212|FG001|Overall Study|Death|74|||
125336836|NCT00223080|450867211|FG000|Overall Study|Other|14|||
125336837|NCT00223080|450867212|FG001|Overall Study|Other|11|||
125336838|NCT00223080|450867211|FG000|Overall Study|Reason not provided|141|||
125336839|NCT00223080|450867212|FG001|Overall Study|Reason not provided|140|||
125336840|NCT00223080|450867211|FG000|Overall Study|Adverse Event|0|||
125336841|NCT00223080|450867212|FG001|Overall Study|Adverse Event|1|||
125336842|NCT03237286|450867213|FG000|Overall Study|Withdrawal by Subject|1|||
125336843|NCT03237286|450867214|FG001|Overall Study|Withdrawal by Subject|0|||
125336844|NCT03237286|450867215|FG002|Overall Study|Withdrawal by Subject|2|||
125336845|NCT03237286|450867213|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
125336846|NCT03237286|450867214|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
125336847|NCT03237286|450867215|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
125336848|NCT00948441|450867223|FG000|Overall Study|no longer meet inclusion criteria|1|||
125336849|NCT00948441|450867224|FG001|Overall Study|no longer meet inclusion criteria|4|||
125336850|NCT00947882|450867227|FG000|Overall Study|Adverse Event|0|||
125336851|NCT00947882|450867228|FG001|Overall Study|Adverse Event|1|||
125336852|NCT00947882|450867229|FG002|Overall Study|Adverse Event|4|||
125336853|NCT00947882|450867230|FG003|Overall Study|Adverse Event|4|||
125336854|NCT00947882|450867227|FG000|Overall Study|Withdrawal by Subject|2|||
125336855|NCT00947882|450867228|FG001|Overall Study|Withdrawal by Subject|0|||
125336856|NCT00947882|450867229|FG002|Overall Study|Withdrawal by Subject|8|||
125336857|NCT00947882|450867230|FG003|Overall Study|Withdrawal by Subject|2|||
125336858|NCT00947882|450867227|FG000|Overall Study|Protocol Violation|0|||
125336859|NCT00947882|450867228|FG001|Overall Study|Protocol Violation|0|||
125670757|NCT03342898|452083336|FG002|Overall Study|Reason not Specified|0|||
125670758|NCT03997448|452083339|FG000|Study Treatment|Disease Progression|1|||
125670759|NCT03997448|452083339|FG000|Study Treatment|Symptomatic Deterioration|1|||
125670760|NCT03997448|452083339|FG000|Follow up|Death|2|||
125670761|NCT03997448|452083339|FG000|Follow up|study terminated|1|||
125670762|NCT03433001|452083349|FG000|Overall Study|Lack of Efficacy|109|||
125670763|NCT03433001|452083349|FG000|Overall Study|Adverse Event|69|||
125670764|NCT03433001|452083349|FG000|Overall Study|Withdrawal by Subject|10|||
125670765|NCT03433001|452083349|FG000|Overall Study|Death|12|||
125670766|NCT03433001|452083349|FG000|Overall Study|Lost to Follow-up|4|||
125670767|NCT03433001|452083349|FG000|Overall Study|Other|25|||
125670768|NCT01165996|452083360|FG000|Overall Study|Death|1|||
125670769|NCT01165996|452083360|FG000|Overall Study|Physician Decision|1|||
125670770|NCT01399723|452083361|FG000|Overall Study|Lost to Follow-up|0|||
125670771|NCT01399723|452083362|FG001|Overall Study|Lost to Follow-up|1|||
125670772|NCT00268346|452083366|FG000|Overall Study|Adverse Event|0|||
125670773|NCT00268346|452083367|FG001|Overall Study|Adverse Event|1|||
125670774|NCT00268346|452083366|FG000|Overall Study|Death|0|||
125670775|NCT00268346|452083367|FG001|Overall Study|Death|1|||
125670776|NCT00268346|452083366|FG000|Overall Study|Withdrawal by Subject|0|||
125670777|NCT00268346|452083367|FG001|Overall Study|Withdrawal by Subject|1|||
125670778|NCT05487456|452083368|FG000|Overall Study|Withdrawal by Subject|0|||
125670779|NCT05487456|452083369|FG001|Overall Study|Withdrawal by Subject|0|||
125670780|NCT05487456|452083370|FG002|Overall Study|Withdrawal by Subject|1|||
125670781|NCT05487456|452083371|FG003|Overall Study|Withdrawal by Subject|0|||
125670782|NCT00294723|452083374|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
125670783|NCT00294723|452083375|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
125670784|NCT00294723|452083376|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
125670785|NCT00294723|452083374|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
125670786|NCT00294723|452083375|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
125670787|NCT00294723|452083376|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
125670788|NCT00294723|452083374|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
125670789|NCT00294723|452083375|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
125670790|NCT00294723|452083376|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
125670791|NCT00294723|452083374|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
125670792|NCT00294723|452083375|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
125670793|NCT00294723|452083376|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
125670794|NCT00294723|452083374|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
125670795|NCT00294723|452083375|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
125670796|NCT00294723|452083376|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
125670797|NCT00294723|452083374|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
125670798|NCT00294723|452083375|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
125670799|NCT00294723|452083376|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
125670800|NCT00294723|452083374|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
125670801|NCT00294723|452083375|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
125670802|NCT00294723|452083376|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
125670803|NCT00294723|452083374|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
125670804|NCT00294723|452083375|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
125670805|NCT00294723|452083376|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
125670806|NCT00294723|452083374|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
125670807|NCT00294723|452083375|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
125670808|NCT00294723|452083376|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
125670809|NCT00294723|452083374|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
125670810|NCT00294723|452083375|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
125670811|NCT00294723|452083376|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
125670812|NCT00294723|452083374|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
125670813|NCT00294723|452083375|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
125670814|NCT00294723|452083376|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
125670815|NCT00294723|452083374|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
125670816|NCT00294723|452083375|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
125670817|NCT00294723|452083376|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
125336860|NCT00947882|450867229|FG002|Overall Study|Protocol Violation|1|||
125336861|NCT00947882|450867230|FG003|Overall Study|Protocol Violation|0|||
125336862|NCT00947882|450867227|FG000|Overall Study|Lost to Follow-up|0|||
125336863|NCT00947882|450867228|FG001|Overall Study|Lost to Follow-up|2|||
125336864|NCT00947882|450867229|FG002|Overall Study|Lost to Follow-up|1|||
125336865|NCT00947882|450867230|FG003|Overall Study|Lost to Follow-up|0|||
125336866|NCT00947882|450867227|FG000|Overall Study|Other/Unknown|10|||
125336867|NCT00947882|450867228|FG001|Overall Study|Other/Unknown|13|||
125336868|NCT00947882|450867229|FG002|Overall Study|Other/Unknown|3|||
125336869|NCT00947882|450867230|FG003|Overall Study|Other/Unknown|6|||
125336870|NCT00947882|450867227|FG000|Overall Study|Trial Terminated by Sponsor|62|||
125336871|NCT00947882|450867228|FG001|Overall Study|Trial Terminated by Sponsor|61|||
125336872|NCT00947882|450867229|FG002|Overall Study|Trial Terminated by Sponsor|62|||
125336873|NCT00947882|450867230|FG003|Overall Study|Trial Terminated by Sponsor|70|||
125336874|NCT01396057|450867231|FG000|Overall Study|Adverse Event|2|||
125336875|NCT01396057|450867232|FG001|Overall Study|Adverse Event|6|||
125336876|NCT01396057|450867231|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125336877|NCT01396057|450867232|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
125336878|NCT01396057|450867231|FG000|Overall Study|Protocol deviation|4|||
125336879|NCT01396057|450867232|FG001|Overall Study|Protocol deviation|4|||
125336880|NCT01396057|450867231|FG000|Overall Study|Consent withdrawn|3|||
125336881|NCT01396057|450867232|FG001|Overall Study|Consent withdrawn|2|||
125336882|NCT03037580|450867235|FG000|Overall Study|Withdrawal by Subject|3|||
125336883|NCT03037580|450867236|FG001|Overall Study|Withdrawal by Subject|0|||
125336884|NCT03037580|450867235|FG000|Overall Study|Adverse Event|1|||
125336885|NCT03037580|450867236|FG001|Overall Study|Adverse Event|0|||
125336886|NCT03037580|450867235|FG000|Overall Study|Study Terminated by Sponsor|12|||
125336887|NCT03037580|450867236|FG001|Overall Study|Study Terminated by Sponsor|15|||
125336888|NCT03037580|450867235|FG000|Overall Study|Death|0|||
125336889|NCT03037580|450867236|FG001|Overall Study|Death|1|||
125336890|NCT02087423|450867237|FG000|Overall Study|Withdrawal by Subject|20|||
125336891|NCT02087423|450867238|FG001|Overall Study|Withdrawal by Subject|20|||
125336892|NCT02087423|450867239|FG002|Overall Study|Withdrawal by Subject|3|||
125336893|NCT02087423|450867237|FG000|Overall Study|Death|68|||
125336894|NCT02087423|450867238|FG001|Overall Study|Death|207|||
125336895|NCT02087423|450867239|FG002|Overall Study|Death|40|||
125336896|NCT02087423|450867237|FG000|Overall Study|Lost to Follow-up|0|||
125336897|NCT02087423|450867238|FG001|Overall Study|Lost to Follow-up|2|||
125336898|NCT02087423|450867239|FG002|Overall Study|Lost to Follow-up|0|||
125336899|NCT02087423|450867237|FG000|Overall Study|Terminated from study at final DCO|23|||
125336900|NCT02087423|450867238|FG001|Overall Study|Terminated from study at final DCO|36|||
125336901|NCT02087423|450867239|FG002|Overall Study|Terminated from study at final DCO|25|||
125336902|NCT03500224|450867240|FG000|Overall Study|Withdrawal by Subject|2|||
125336903|NCT01324401|450867243|FG000|Overall Study|Withdrawn before any treatment|0|||
125336904|NCT01324401|450867244|FG001|Overall Study|Withdrawn before any treatment|3|||
125336905|NCT01324401|450867243|FG000|Overall Study|Adverse Event|1|||
125336906|NCT01324401|450867244|FG001|Overall Study|Adverse Event|3|||
125336907|NCT01708902|450867246|FG000|Overall Study|Adverse Event|3|||
125336908|NCT01708902|450867247|FG001|Overall Study|Adverse Event|4|||
125336909|NCT01708902|450867248|FG002|Overall Study|Adverse Event|9|||
125336910|NCT01708902|450867249|FG003|Overall Study|Adverse Event|2|||
125336911|NCT01708902|450867250|FG004|Overall Study|Adverse Event|7|||
125336912|NCT01708902|450867251|FG005|Overall Study|Adverse Event|3|||
125336913|NCT01708902|450867252|FG006|Overall Study|Adverse Event|5|||
125336914|NCT01708902|450867246|FG000|Overall Study|Lack of Efficacy|3|||
125336915|NCT01708902|450867247|FG001|Overall Study|Lack of Efficacy|1|||
125336916|NCT01708902|450867248|FG002|Overall Study|Lack of Efficacy|0|||
125336917|NCT01708902|450867249|FG003|Overall Study|Lack of Efficacy|0|||
125336918|NCT01708902|450867250|FG004|Overall Study|Lack of Efficacy|0|||
125336919|NCT01708902|450867251|FG005|Overall Study|Lack of Efficacy|1|||
125336920|NCT01708902|450867252|FG006|Overall Study|Lack of Efficacy|0|||
125336921|NCT01708902|450867246|FG000|Overall Study|Non compliance with protocol|0|||
125336922|NCT01708902|450867247|FG001|Overall Study|Non compliance with protocol|2|||
125336923|NCT01708902|450867248|FG002|Overall Study|Non compliance with protocol|1|||
125336924|NCT01708902|450867249|FG003|Overall Study|Non compliance with protocol|3|||
125336925|NCT01708902|450867250|FG004|Overall Study|Non compliance with protocol|0|||
125336926|NCT01708902|450867251|FG005|Overall Study|Non compliance with protocol|0|||
125336927|NCT01708902|450867252|FG006|Overall Study|Non compliance with protocol|0|||
125336928|NCT01708902|450867246|FG000|Overall Study|Lost to Follow-up|2|||
125336929|NCT01708902|450867247|FG001|Overall Study|Lost to Follow-up|1|||
125336930|NCT01708902|450867248|FG002|Overall Study|Lost to Follow-up|2|||
125336931|NCT01708902|450867249|FG003|Overall Study|Lost to Follow-up|2|||
125336932|NCT01708902|450867250|FG004|Overall Study|Lost to Follow-up|0|||
125336933|NCT01708902|450867251|FG005|Overall Study|Lost to Follow-up|0|||
125336934|NCT01708902|450867252|FG006|Overall Study|Lost to Follow-up|1|||
125336935|NCT01708902|450867246|FG000|Overall Study|Refused to continue trial medication|8|||
125336936|NCT01708902|450867247|FG001|Overall Study|Refused to continue trial medication|0|||
125336937|NCT01708902|450867248|FG002|Overall Study|Refused to continue trial medication|4|||
125336938|NCT01708902|450867249|FG003|Overall Study|Refused to continue trial medication|2|||
125336939|NCT01708902|450867250|FG004|Overall Study|Refused to continue trial medication|8|||
125336940|NCT01708902|450867251|FG005|Overall Study|Refused to continue trial medication|1|||
125336941|NCT01708902|450867252|FG006|Overall Study|Refused to continue trial medication|1|||
125336942|NCT01708902|450867246|FG000|Overall Study|Other Reason|1|||
125336943|NCT01708902|450867247|FG001|Overall Study|Other Reason|0|||
125336944|NCT01708902|450867248|FG002|Overall Study|Other Reason|1|||
125336945|NCT01708902|450867249|FG003|Overall Study|Other Reason|1|||
125336946|NCT01708902|450867250|FG004|Overall Study|Other Reason|1|||
125336947|NCT01708902|450867251|FG005|Overall Study|Other Reason|2|||
125336948|NCT01708902|450867252|FG006|Overall Study|Other Reason|0|||
125336949|NCT00530816|450867254|FG000|Overall Study|Progressive Disease|16|||
125336950|NCT00530816|450867255|FG001|Overall Study|Progressive Disease|24|||
125336951|NCT00530816|450867256|FG002|Overall Study|Progressive Disease|24|||
125336952|NCT00530816|450867254|FG000|Overall Study|Adverse Event|6|||
125336953|NCT00530816|450867255|FG001|Overall Study|Adverse Event|13|||
125336954|NCT00530816|450867256|FG002|Overall Study|Adverse Event|7|||
125336955|NCT00530816|450867254|FG000|Overall Study|Other|3|||
125336956|NCT00530816|450867255|FG001|Overall Study|Other|3|||
125336957|NCT00530816|450867256|FG002|Overall Study|Other|4|||
125336958|NCT00530816|450867254|FG000|Overall Study|Withdrawal by Subject|1|||
125336959|NCT00530816|450867255|FG001|Overall Study|Withdrawal by Subject|2|||
125336960|NCT00530816|450867256|FG002|Overall Study|Withdrawal by Subject|6|||
125336961|NCT01388985|450867259|FG000|Overall Study|Death|0|||
125336962|NCT01388985|450867260|FG001|Overall Study|Death|1|||
125336963|NCT01388985|450867259|FG000|Overall Study|Lost to Follow-up|30|||
125336964|NCT01388985|450867260|FG001|Overall Study|Lost to Follow-up|30|||
125336965|NCT01388985|450867259|FG000|Overall Study|Withdrawal by Subject|13|||
125336966|NCT01388985|450867260|FG001|Overall Study|Withdrawal by Subject|4|||
125336967|NCT01388985|450867259|FG000|Overall Study|Subject unavailable|1|||
125336968|NCT01388985|450867260|FG001|Overall Study|Subject unavailable|1|||
125336969|NCT01388985|450867259|FG000|Overall Study|Other (no reason)|0|||
125336970|NCT01388985|450867260|FG001|Overall Study|Other (no reason)|1|||
125336971|NCT01388985|450867259|FG000|Overall Study|Error of nurse|5|||
125336972|NCT01388985|450867260|FG001|Overall Study|Error of nurse|1|||
125336973|NCT01057589|450867261|FG000|Overall Study|Disease Progression|35|||
125336974|NCT01057589|450867261|FG000|Overall Study|Adverse Event|10|||
125336975|NCT01057589|450867261|FG000|Overall Study|Physician Decision|8|||
125336976|NCT01057589|450867261|FG000|Overall Study|Withdrawal by Subject|3|||
125336977|NCT01057589|450867261|FG000|Overall Study|Sponsor Decision|1|||
125336978|NCT01057589|450867261|FG000|Overall Study|Death|8|||
125336979|NCT01057589|450867261|FG000|Overall Study|Lost to Follow-up|1|||
125336980|NCT00899431|450867264|FG000|Overall Study|Physician Decision|1|||
125336981|NCT00899431|450867265|FG001|Overall Study|Physician Decision|0|||
125336982|NCT00899431|450867266|FG002|Overall Study|Physician Decision|0|||
125336983|NCT03304249|450867270|FG000|Overall Study|Lost to Follow-up|8|||
125336984|NCT03304249|450867271|FG001|Overall Study|Lost to Follow-up|10|||
125336985|NCT03304249|450867270|FG000|Overall Study|Withdrawal by Subject|12|||
125336986|NCT03304249|450867271|FG001|Overall Study|Withdrawal by Subject|2|||
125336987|NCT03304249|450867270|FG000|Overall Study|Moved Out of District|4|||
125336988|NCT03304249|450867271|FG001|Overall Study|Moved Out of District|2|||
125336989|NCT01253577|450867272|FG000|Overall Study|Lost to Follow-up|3|||
125336990|NCT00334113|450867273|FG000|Overall Study|Lost to Follow-up|2|||
125670818|NCT00752791|452083377|FG000|Overall Study|Adverse Event|7|||
125670819|NCT00752791|452083377|FG000|Overall Study|Withdrawal by Subject|1|||
125670820|NCT00752791|452083377|FG000|Overall Study|Physician Decision|1|||
125670821|NCT00752791|452083377|FG000|Overall Study|Death|1|||
125670822|NCT00752791|452083377|FG000|Overall Study|Renal transplant|3|||
125336991|NCT00334113|450867274|FG001|Overall Study|Lost to Follow-up|2|||
125336992|NCT00334113|450867273|FG000|Overall Study|Withdrawal by Subject|0|||
125336993|NCT00334113|450867274|FG001|Overall Study|Withdrawal by Subject|1|||
125336994|NCT04189224|450867275|FG000|Period 2|Adverse Event|0|||
125336995|NCT04189224|450867276|FG001|Period 2|Adverse Event|1|||
125336996|NCT02509026|450867277|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
125336997|NCT02509026|450867277|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
125336998|NCT02509026|450867277|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
125336999|NCT02509026|450867277|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
125337000|NCT02509026|450867277|FG000|Induction Period (24 Weeks)|Other|2|||
125670823|NCT00752791|452083377|FG000|Overall Study|Switched to hemodialysis|2|||
125337001|NCT02509026|450867277|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
125337002|NCT02509026|450867277|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
125337003|NCT02509026|450867277|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
125337004|NCT02509026|450867277|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
125337005|NCT02509026|450867277|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
125337006|NCT02509026|450867277|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
125337007|NCT02509026|450867277|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
125337008|NCT02509026|450867277|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
125337009|NCT00721968|450867278|FG000|Overall Study|Lost to Follow-up|2|||
125337010|NCT00721968|450867279|FG001|Overall Study|Lost to Follow-up|0|||
125337011|NCT04198714|450867280|FG000|Overall Study|Physician Decision|0|||
125337012|NCT04198714|450867281|FG001|Overall Study|Physician Decision|1|||
125337013|NCT01064947|450867282|FG000|Overall Study|negative culture|41|||
125337014|NCT02970942|450867283|FG000|Overall Study|Death|0|||
125337015|NCT02970942|450867284|FG001|Overall Study|Death|1|||
125337016|NCT02970942|450867285|FG002|Overall Study|Death|0|||
125337017|NCT02970942|450867286|FG003|Overall Study|Death|0|||
125337018|NCT02970942|450867283|FG000|Overall Study|Lost to Follow-up|1|||
125337019|NCT02970942|450867284|FG001|Overall Study|Lost to Follow-up|0|||
125337020|NCT02970942|450867285|FG002|Overall Study|Lost to Follow-up|2|||
125337021|NCT02970942|450867286|FG003|Overall Study|Lost to Follow-up|1|||
125337022|NCT02970942|450867283|FG000|Overall Study|Withdrawal by Subject|3|||
125337023|NCT02970942|450867284|FG001|Overall Study|Withdrawal by Subject|5|||
125337024|NCT02970942|450867285|FG002|Overall Study|Withdrawal by Subject|3|||
125337025|NCT02970942|450867286|FG003|Overall Study|Withdrawal by Subject|2|||
125337026|NCT02529553|450867289|FG000|Overall Study|Progressive Disease|1|||
125670824|NCT00752791|452083377|FG000|Overall Study|Protocol deviation|1|||
125670825|NCT01958281|452083378|FG000|Overall Study|Lack of Efficacy|5|||
125670826|NCT01958281|452083379|FG001|Overall Study|Lack of Efficacy|2|||
125670827|NCT01958281|452083380|FG002|Overall Study|Lack of Efficacy|0|||
125670828|NCT01958281|452083378|FG000|Overall Study|Adverse Event|0|||
125670829|NCT01958281|452083379|FG001|Overall Study|Adverse Event|2|||
125670830|NCT01958281|452083380|FG002|Overall Study|Adverse Event|0|||
125670831|NCT01958281|452083378|FG000|Overall Study|Withdrew Consent|1|||
125670832|NCT01958281|452083379|FG001|Overall Study|Withdrew Consent|0|||
125670833|NCT01958281|452083380|FG002|Overall Study|Withdrew Consent|0|||
125670834|NCT02784106|452083381|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
125670835|NCT02784106|452083382|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
125670836|NCT02784106|452083383|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125670837|NCT02784106|452083384|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125670838|NCT02784106|452083381|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
125670839|NCT02784106|452083382|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
125670840|NCT02784106|452083383|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
125670841|NCT02784106|452083384|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
125670842|NCT02784106|452083381|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
125670843|NCT02784106|452083382|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
125670844|NCT02784106|452083383|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
125670845|NCT02784106|452083384|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
125670846|NCT02784106|452083381|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
125670847|NCT02784106|452083382|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
125670848|NCT02784106|452083383|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
125670849|NCT02784106|452083384|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
125670850|NCT02784106|452083381|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
125670851|NCT02784106|452083382|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
125670852|NCT02784106|452083383|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
125670853|NCT02784106|452083384|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
125670854|NCT02784106|452083381|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
125670855|NCT02784106|452083382|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
125670856|NCT02784106|452083383|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
125670857|NCT02784106|452083384|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
125670858|NCT03222141|452083385|FG000|Overall Study|Death|15|||
125670859|NCT03222141|452083385|FG000|Overall Study|Lost to Follow-up|3|||
125670860|NCT02536378|452083386|FG000|Overall Study|Physician Decision|0|||
125670861|NCT02536378|452083387|FG001|Overall Study|Physician Decision|2|||
125670862|NCT02536378|452083386|FG000|Overall Study|Withdrawal by Subject|0|||
125670863|NCT02536378|452083387|FG001|Overall Study|Withdrawal by Subject|1|||
125670864|NCT02536378|452083386|FG000|Overall Study|Death|1|||
125337027|NCT02529553|450867290|FG001|Overall Study|Progressive Disease|0|||
125337028|NCT02529553|450867291|FG002|Overall Study|Progressive Disease|1|||
125337029|NCT02529553|450867292|FG003|Overall Study|Progressive Disease|3|||
125337030|NCT02529553|450867293|FG004|Overall Study|Progressive Disease|2|||
125337031|NCT02529553|450867294|FG005|Overall Study|Progressive Disease|3|||
125670865|NCT02536378|452083387|FG001|Overall Study|Death|2|||
125670866|NCT02536378|452083386|FG000|Overall Study|Patient refused further follow up|6|||
125337032|NCT02529553|450867295|FG006|Overall Study|Progressive Disease|3|||
125337033|NCT02529553|450867296|FG007|Overall Study|Progressive Disease|5|||
125337034|NCT02529553|450867297|FG008|Overall Study|Progressive Disease|3|||
125337035|NCT02529553|450867289|FG000|Overall Study|Physician Decision|0|||
125337036|NCT02529553|450867290|FG001|Overall Study|Physician Decision|1|||
125337037|NCT02529553|450867291|FG002|Overall Study|Physician Decision|0|||
125337038|NCT02529553|450867292|FG003|Overall Study|Physician Decision|0|||
125337039|NCT02529553|450867293|FG004|Overall Study|Physician Decision|1|||
125337040|NCT02529553|450867294|FG005|Overall Study|Physician Decision|0|||
125337041|NCT02529553|450867295|FG006|Overall Study|Physician Decision|0|||
125337042|NCT02529553|450867296|FG007|Overall Study|Physician Decision|0|||
125337043|NCT02529553|450867297|FG008|Overall Study|Physician Decision|0|||
125337044|NCT02529553|450867289|FG000|Overall Study|Withdrawal by Subject|0|||
125337045|NCT02529553|450867290|FG001|Overall Study|Withdrawal by Subject|0|||
125337046|NCT02529553|450867291|FG002|Overall Study|Withdrawal by Subject|0|||
125337047|NCT02529553|450867292|FG003|Overall Study|Withdrawal by Subject|0|||
125337048|NCT02529553|450867293|FG004|Overall Study|Withdrawal by Subject|0|||
125337049|NCT02529553|450867294|FG005|Overall Study|Withdrawal by Subject|1|||
125337050|NCT02529553|450867295|FG006|Overall Study|Withdrawal by Subject|0|||
125337051|NCT02529553|450867296|FG007|Overall Study|Withdrawal by Subject|1|||
125337052|NCT02529553|450867297|FG008|Overall Study|Withdrawal by Subject|0|||
125337053|NCT04549545|450868753|FG000|Initial Period|Withdrawal by Subject|4|||
125337054|NCT04549545|450868754|FG001|Initial Period|Withdrawal by Subject|0|||
125337055|NCT04549545|450868753|FG000|Initial Period|Additional ENT Procedure|3|||
125337056|NCT04549545|450868754|FG001|Initial Period|Additional ENT Procedure|0|||
125337057|NCT04549545|450868753|FG000|Initial Period|Lost to Follow-up|3|||
125337058|NCT04549545|450868754|FG001|Initial Period|Lost to Follow-up|1|||
125337059|NCT04549545|450868753|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
125337060|NCT04549545|450868754|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
125337061|NCT04549545|450868753|FG000|Crossover Period|Additional ENT Procedure|0|||
125337062|NCT04549545|450868754|FG001|Crossover Period|Additional ENT Procedure|6|||
125337063|NCT04549545|450868753|FG000|Crossover Period|Lost to Follow-up|0|||
125337064|NCT04549545|450868754|FG001|Crossover Period|Lost to Follow-up|1|||
125337065|NCT04549545|450868753|FG000|Crossover Period|Withdrawal by Subject|0|||
125337066|NCT04549545|450868754|FG001|Crossover Period|Withdrawal by Subject|4|||
125337067|NCT01006291|450868758|FG000|Overall Study|Adverse Event|2|||
125337068|NCT01006291|450868759|FG001|Overall Study|Adverse Event|1|||
125337069|NCT01006291|450868760|FG002|Overall Study|Adverse Event|2|||
125337070|NCT01006291|450868758|FG000|Overall Study|Lack of Efficacy|2|||
125337071|NCT01006291|450868759|FG001|Overall Study|Lack of Efficacy|2|||
125337072|NCT01006291|450868760|FG002|Overall Study|Lack of Efficacy|1|||
125337073|NCT01006291|450868758|FG000|Overall Study|Protocol Violation|3|||
125337074|NCT01006291|450868759|FG001|Overall Study|Protocol Violation|3|||
125337075|NCT01006291|450868760|FG002|Overall Study|Protocol Violation|3|||
125337076|NCT01006291|450868758|FG000|Overall Study|Withdrawal criteria|5|||
125337077|NCT01006291|450868759|FG001|Overall Study|Withdrawal criteria|4|||
125337078|NCT01006291|450868760|FG002|Overall Study|Withdrawal criteria|4|||
125337079|NCT01006291|450868758|FG000|Overall Study|Other|14|||
125337080|NCT01006291|450868759|FG001|Overall Study|Other|14|||
125337081|NCT01006291|450868760|FG002|Overall Study|Other|17|||
125337082|NCT01865552|450868761|FG000|Period 1|Adverse Event|1|||
125337083|NCT01865552|450868762|FG001|Period 1|Adverse Event|0|||
125337084|NCT01865552|450868763|FG002|Period 1|Adverse Event|0|||
125337085|NCT01865552|450868764|FG003|Period 1|Adverse Event|1|||
125337086|NCT01865552|450868765|FG004|Period 1|Adverse Event|1|||
125337087|NCT01865552|450868766|FG005|Period 1|Adverse Event|1|||
125670867|NCT02536378|452083387|FG001|Overall Study|Patient refused further follow up|2|||
125337088|NCT01865552|450868761|FG000|Period 1|Pathological lab|0|||
125337089|NCT01865552|450868762|FG001|Period 1|Pathological lab|0|||
125337090|NCT01865552|450868763|FG002|Period 1|Pathological lab|0|||
125670868|NCT00798889|452083388|FG000|Overall Study|Adverse Event|53|||
125670869|NCT00798889|452083388|FG000|Overall Study|Protocol Violation|2|||
125670870|NCT00798889|452083388|FG000|Overall Study|Withdrawal by Subject|31|||
125670871|NCT00798889|452083388|FG000|Overall Study|Lost to Follow-up|1|||
125670872|NCT00798889|452083388|FG000|Overall Study|Lack of Efficacy|213|||
125670873|NCT00798889|452083388|FG000|Overall Study|Decision of Sponsor|11|||
125337091|NCT01865552|450868764|FG003|Period 1|Pathological lab|0|||
125337092|NCT01865552|450868765|FG004|Period 1|Pathological lab|1|||
125670874|NCT00798889|452083388|FG000|Overall Study|Enrolled, Not treated|3|||
125337093|NCT01865552|450868766|FG005|Period 1|Pathological lab|0|||
125337094|NCT01865552|450868761|FG000|Period 1|Other|0|||
125337095|NCT01865552|450868762|FG001|Period 1|Other|0|||
125337096|NCT01865552|450868763|FG002|Period 1|Other|0|||
125670875|NCT00617461|452083389|FG000|First Treatment Intervention Period|Adverse Event|2|||
125337097|NCT01865552|450868764|FG003|Period 1|Other|0|||
125337098|NCT01865552|450868765|FG004|Period 1|Other|1|||
125337099|NCT01865552|450868766|FG005|Period 1|Other|0|||
125337100|NCT03079102|450868767|FG000|Overall Study|Physician Decision|0|||
125337101|NCT03079102|450868768|FG001|Overall Study|Physician Decision|1|||
125337102|NCT02923921|450868769|FG000|Overall Study|Sponsor Decision|39|||
125337103|NCT02923921|450868770|FG001|Overall Study|Sponsor Decision|38|||
125337104|NCT02923921|450868769|FG000|Overall Study|Lost to Follow-up|1|||
125337105|NCT02923921|450868770|FG001|Overall Study|Lost to Follow-up|0|||
125337106|NCT02923921|450868769|FG000|Overall Study|Withdrawal by Subject|6|||
125337107|NCT02923921|450868770|FG001|Overall Study|Withdrawal by Subject|13|||
125337108|NCT02923921|450868769|FG000|Overall Study|Unknown, Not Collected|7|||
125337109|NCT02923921|450868770|FG001|Overall Study|Unknown, Not Collected|6|||
125337110|NCT00479687|450868771|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
125337111|NCT00479687|450868772|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
125337112|NCT00479687|450868773|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
125337113|NCT00479687|450868771|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
125337114|NCT00479687|450868772|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
125337115|NCT00479687|450868773|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
125337116|NCT00479687|450868771|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
125337117|NCT00479687|450868772|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
125337118|NCT00479687|450868773|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
125337119|NCT00479687|450868771|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
125337120|NCT00479687|450868772|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
125337121|NCT00479687|450868773|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
125337122|NCT00479687|450868771|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
125337123|NCT00479687|450868772|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
125337124|NCT00479687|450868773|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
125337125|NCT00479687|450868771|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
125337126|NCT00479687|450868772|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
125337127|NCT00479687|450868773|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
125337128|NCT00479687|450868771|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
125337129|NCT00479687|450868772|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
125337130|NCT00479687|450868773|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
125337131|NCT00479687|450868771|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
125337132|NCT00479687|450868772|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
125337133|NCT00479687|450868773|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
125337134|NCT00479687|450868771|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
125337135|NCT00479687|450868772|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
125337136|NCT00479687|450868773|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
125337137|NCT01474239|450868774|FG000|Overall Study|Disease Progression|37|||
125337138|NCT01474239|450868775|FG001|Overall Study|Disease Progression|25|||
125337139|NCT01474239|450868774|FG000|Overall Study|Adverse Event|12|||
125337140|NCT01474239|450868775|FG001|Overall Study|Adverse Event|3|||
125337141|NCT01474239|450868774|FG000|Overall Study|Withdrawal by Subject|1|||
125337142|NCT01474239|450868775|FG001|Overall Study|Withdrawal by Subject|2|||
125337143|NCT01474239|450868774|FG000|Overall Study|Death|1|||
125337144|NCT01474239|450868775|FG001|Overall Study|Death|1|||
125337145|NCT01474239|450868774|FG000|Overall Study|Clinical Disease Progression|7|||
125337146|NCT01474239|450868775|FG001|Overall Study|Clinical Disease Progression|1|||
125337147|NCT01474239|450868774|FG000|Overall Study|Withdrawal for Economic Reason|1|||
125337148|NCT01474239|450868775|FG001|Overall Study|Withdrawal for Economic Reason|0|||
125337149|NCT02175199|450868778|FG000|Overall Study|Withdrawal by Subject|1|||
125337150|NCT02175199|450868779|FG001|Overall Study|Withdrawal by Subject|5|||
125337151|NCT02175199|450868778|FG000|Overall Study|Randomized in Error|1|||
125337152|NCT02175199|450868779|FG001|Overall Study|Randomized in Error|0|||
125337153|NCT02175199|450868778|FG000|Overall Study|Sponsor Decision|1|||
125337154|NCT02175199|450868779|FG001|Overall Study|Sponsor Decision|0|||
125337155|NCT03983317|450868784|FG000|Overall Study|Physician Decision|5|||
125337156|NCT01349049|450868785|FG000|Overall Study|Disease progression|3|||
125337157|NCT01349049|450868786|FG001|Overall Study|Disease progression|5|||
125337158|NCT01349049|450868787|FG002|Overall Study|Disease progression|3|||
125337159|NCT01349049|450868788|FG003|Overall Study|Disease progression|2|||
125337160|NCT01349049|450868789|FG004|Overall Study|Disease progression|2|||
125337161|NCT01349049|450868790|FG005|Overall Study|Disease progression|2|||
125337162|NCT01349049|450868791|FG006|Overall Study|Disease progression|3|||
125337163|NCT01349049|450868792|FG007|Overall Study|Disease progression|2|||
125337164|NCT01349049|450868793|FG008|Overall Study|Disease progression|33|||
125337165|NCT01349049|450868785|FG000|Overall Study|Adverse Event|0|||
125337166|NCT01349049|450868786|FG001|Overall Study|Adverse Event|1|||
125337167|NCT01349049|450868787|FG002|Overall Study|Adverse Event|0|||
125337168|NCT01349049|450868788|FG003|Overall Study|Adverse Event|0|||
125337169|NCT01349049|450868789|FG004|Overall Study|Adverse Event|0|||
125337170|NCT01349049|450868790|FG005|Overall Study|Adverse Event|3|||
125337171|NCT01349049|450868791|FG006|Overall Study|Adverse Event|1|||
125337172|NCT01349049|450868792|FG007|Overall Study|Adverse Event|0|||
125337173|NCT01349049|450868793|FG008|Overall Study|Adverse Event|4|||
125337174|NCT01349049|450868785|FG000|Overall Study|Physician Decision|0|||
125337175|NCT01349049|450868786|FG001|Overall Study|Physician Decision|1|||
125337176|NCT01349049|450868787|FG002|Overall Study|Physician Decision|0|||
125337177|NCT01349049|450868788|FG003|Overall Study|Physician Decision|0|||
125337178|NCT01349049|450868789|FG004|Overall Study|Physician Decision|0|||
125337179|NCT01349049|450868790|FG005|Overall Study|Physician Decision|0|||
125337180|NCT01349049|450868791|FG006|Overall Study|Physician Decision|0|||
125337181|NCT01349049|450868792|FG007|Overall Study|Physician Decision|0|||
125337182|NCT01349049|450868793|FG008|Overall Study|Physician Decision|2|||
125337183|NCT01349049|450868785|FG000|Overall Study|Protocol Violation|0|||
125337184|NCT01349049|450868786|FG001|Overall Study|Protocol Violation|0|||
125337185|NCT01349049|450868787|FG002|Overall Study|Protocol Violation|0|||
125337186|NCT01349049|450868788|FG003|Overall Study|Protocol Violation|0|||
125337187|NCT01349049|450868789|FG004|Overall Study|Protocol Violation|0|||
125337188|NCT01349049|450868790|FG005|Overall Study|Protocol Violation|0|||
125337189|NCT01349049|450868791|FG006|Overall Study|Protocol Violation|0|||
125337190|NCT01349049|450868792|FG007|Overall Study|Protocol Violation|0|||
125337191|NCT01349049|450868793|FG008|Overall Study|Protocol Violation|1|||
125337192|NCT01349049|450868785|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
125337193|NCT01349049|450868786|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
125337194|NCT01349049|450868787|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
125337195|NCT01349049|450868788|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
125337196|NCT01349049|450868789|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
125337197|NCT01349049|450868790|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
125337198|NCT01349049|450868791|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
125337199|NCT01349049|450868792|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
125337200|NCT01349049|450868793|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
125337201|NCT01349049|450868785|FG000|Overall Study|Other|0|||
125337202|NCT01349049|450868786|FG001|Overall Study|Other|0|||
125337203|NCT01349049|450868787|FG002|Overall Study|Other|0|||
125337204|NCT01349049|450868788|FG003|Overall Study|Other|0|||
125337205|NCT01349049|450868789|FG004|Overall Study|Other|0|||
125337206|NCT01349049|450868790|FG005|Overall Study|Other|1|||
125337207|NCT01349049|450868791|FG006|Overall Study|Other|0|||
125337208|NCT01349049|450868792|FG007|Overall Study|Other|0|||
125337209|NCT01349049|450868793|FG008|Overall Study|Other|4|||
125337210|NCT01349049|450868785|FG000|Overall Study|Death|0|||
125337211|NCT01349049|450868786|FG001|Overall Study|Death|0|||
125337212|NCT01349049|450868787|FG002|Overall Study|Death|0|||
125337213|NCT01349049|450868788|FG003|Overall Study|Death|0|||
125337214|NCT01349049|450868789|FG004|Overall Study|Death|0|||
125337215|NCT01349049|450868790|FG005|Overall Study|Death|0|||
125337216|NCT01349049|450868791|FG006|Overall Study|Death|0|||
125337217|NCT01349049|450868792|FG007|Overall Study|Death|1|||
125337218|NCT01349049|450868793|FG008|Overall Study|Death|5|||
125337219|NCT01349049|450868785|FG000|Overall Study|Non-compliance|0|||
125337220|NCT01349049|450868786|FG001|Overall Study|Non-compliance|0|||
125337221|NCT01349049|450868787|FG002|Overall Study|Non-compliance|0|||
125337222|NCT01349049|450868788|FG003|Overall Study|Non-compliance|1|||
125337223|NCT01349049|450868789|FG004|Overall Study|Non-compliance|0|||
125337224|NCT01349049|450868790|FG005|Overall Study|Non-compliance|0|||
125337225|NCT01349049|450868791|FG006|Overall Study|Non-compliance|0|||
125337226|NCT01349049|450868792|FG007|Overall Study|Non-compliance|0|||
125337227|NCT01349049|450868793|FG008|Overall Study|Non-compliance|0|||
125337228|NCT01349049|450868785|FG000|Overall Study|Withdrawal by Subject|0|||
125337229|NCT01349049|450868786|FG001|Overall Study|Withdrawal by Subject|0|||
125337230|NCT01349049|450868787|FG002|Overall Study|Withdrawal by Subject|0|||
125337231|NCT01349049|450868788|FG003|Overall Study|Withdrawal by Subject|0|||
125337232|NCT01349049|450868789|FG004|Overall Study|Withdrawal by Subject|0|||
125337233|NCT01349049|450868790|FG005|Overall Study|Withdrawal by Subject|0|||
125337234|NCT01349049|450868791|FG006|Overall Study|Withdrawal by Subject|0|||
125337235|NCT01349049|450868792|FG007|Overall Study|Withdrawal by Subject|0|||
125337236|NCT01349049|450868793|FG008|Overall Study|Withdrawal by Subject|6|||
125337237|NCT02881567|450868800|FG000|Overall Study|Adverse Event|1|||
125337238|NCT02881567|450868800|FG000|Overall Study|Lost to Follow-up|3|||
125337239|NCT02881567|450868800|FG000|Overall Study|Consent withdrawn|1|||
125337240|NCT02881567|450868800|FG000|Overall Study|Investigator decision|1|||
125337241|NCT02881567|450868800|FG000|Overall Study|Study terminated by sponsor|9|||
125337242|NCT02881567|450868800|FG000|Overall Study|Reason not Specified|3|||
125337243|NCT02078960|450868804|FG000|Treatment Period|Other|0|||
125337244|NCT02078960|450868805|FG001|Treatment Period|Other|0|||
125337245|NCT02078960|450868806|FG002|Treatment Period|Other|1|||
125337246|NCT02078960|450868804|FG000|Treatment Period|Lack of Efficacy|0|||
125337247|NCT02078960|450868805|FG001|Treatment Period|Lack of Efficacy|1|||
125337248|NCT02078960|450868806|FG002|Treatment Period|Lack of Efficacy|0|||
125337249|NCT02078960|450868804|FG000|Treatment Period|Disease progression - accelerated phase|0|||
125337250|NCT02078960|450868805|FG001|Treatment Period|Disease progression - accelerated phase|1|||
125337251|NCT02078960|450868806|FG002|Treatment Period|Disease progression - accelerated phase|0|||
125337252|NCT02078960|450868804|FG000|Treatment Period|Disease progression - blast phase|1|||
125337253|NCT02078960|450868805|FG001|Treatment Period|Disease progression - blast phase|0|||
125337254|NCT02078960|450868806|FG002|Treatment Period|Disease progression - blast phase|0|||
125337255|NCT02078960|450868804|FG000|Treatment Period|Withdrawal by Subject|0|||
125337256|NCT02078960|450868805|FG001|Treatment Period|Withdrawal by Subject|1|||
125337257|NCT02078960|450868806|FG002|Treatment Period|Withdrawal by Subject|1|||
125337258|NCT02078960|450868804|FG000|Treatment Period|Adverse Event|1|||
125337259|NCT02078960|450868805|FG001|Treatment Period|Adverse Event|0|||
125337260|NCT02078960|450868806|FG002|Treatment Period|Adverse Event|0|||
125337261|NCT02078960|450868804|FG000|Treatment Period|Death|0|||
125337262|NCT02078960|450868805|FG001|Treatment Period|Death|0|||
125337263|NCT02078960|450868806|FG002|Treatment Period|Death|1|||
125337264|NCT02078960|450868804|FG000|Follow-up Period|Death|2|||
125337265|NCT02078960|450868805|FG001|Follow-up Period|Death|0|||
125337266|NCT02078960|450868806|FG002|Follow-up Period|Death|0|||
125337267|NCT02078960|450868804|FG000|Follow-up Period|Lost to Follow-up|0|||
125670876|NCT00617461|452083390|FG001|First Treatment Intervention Period|Adverse Event|0|||
125337268|NCT02078960|450868805|FG001|Follow-up Period|Lost to Follow-up|1|||
125337269|NCT02078960|450868806|FG002|Follow-up Period|Lost to Follow-up|0|||
125337270|NCT04335136|450868812|FG000|Overall Study|Death|8|||
125337271|NCT04335136|450868813|FG001|Overall Study|Death|4|||
125337272|NCT04335136|450868812|FG000|Overall Study|Lost to Follow-up|2|||
125337273|NCT04335136|450868813|FG001|Overall Study|Lost to Follow-up|0|||
125337274|NCT04335136|450868812|FG000|Overall Study|Protocol Violation|1|||
125337275|NCT04335136|450868813|FG001|Overall Study|Protocol Violation|0|||
125337276|NCT04335136|450868812|FG000|Overall Study|Withdrawal by Subject|1|||
125337277|NCT04335136|450868813|FG001|Overall Study|Withdrawal by Subject|1|||
125337278|NCT04335136|450868812|FG000|Overall Study|Health-threatening condition|0|||
125337279|NCT04335136|450868813|FG001|Overall Study|Health-threatening condition|1|||
125337280|NCT04335136|450868812|FG000|Overall Study|Adverse Event|0|||
125337281|NCT04335136|450868813|FG001|Overall Study|Adverse Event|1|||
125337282|NCT04335136|450868812|FG000|Overall Study|Erroneously randomized|2|||
125337283|NCT04335136|450868813|FG001|Overall Study|Erroneously randomized|0|||
125337284|NCT00975689|450868814|FG000|Overall Study|Adverse Event|0|||
125337285|NCT00975689|450868815|FG001|Overall Study|Adverse Event|3|||
125337286|NCT00975689|450868814|FG000|Overall Study|Withdrawal by Subject|1|||
125337287|NCT00975689|450868815|FG001|Overall Study|Withdrawal by Subject|0|||
125337288|NCT00975689|450868814|FG000|Overall Study|Physician Decision|1|||
125337289|NCT00975689|450868815|FG001|Overall Study|Physician Decision|0|||
125337290|NCT01305577|450868819|FG000|Overall Study|Adverse Event|2|||
125337291|NCT01305577|450868820|FG001|Overall Study|Adverse Event|2|||
125337292|NCT01305577|450868821|FG002|Overall Study|Adverse Event|1|||
125337293|NCT01305577|450868819|FG000|Overall Study|Withdrawal by Subject|7|||
125337294|NCT01305577|450868820|FG001|Overall Study|Withdrawal by Subject|5|||
125337295|NCT01305577|450868821|FG002|Overall Study|Withdrawal by Subject|6|||
125337296|NCT01305577|450868819|FG000|Overall Study|Lost to Follow-up|4|||
125337297|NCT01305577|450868820|FG001|Overall Study|Lost to Follow-up|3|||
125337298|NCT01305577|450868821|FG002|Overall Study|Lost to Follow-up|2|||
125337299|NCT01305577|450868819|FG000|Overall Study|Protocol Deviation|0|||
125337300|NCT01305577|450868820|FG001|Overall Study|Protocol Deviation|1|||
125337301|NCT01305577|450868821|FG002|Overall Study|Protocol Deviation|1|||
125337302|NCT00796978|450868822|FG000|Overall Study|Cardiac adverse event|5|||
125670877|NCT00617461|452083389|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
125670878|NCT00617461|452083390|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
125670879|NCT00617461|452083389|FG000|First Treatment Intervention Period|Protocol Violation|2|||
125337303|NCT00796978|450868822|FG000|Overall Study|Adverse Event|4|||
125337304|NCT00796978|450868822|FG000|Overall Study|Withdrawal by Subject|3|||
125337305|NCT02364336|450868823|FG000|Overall Study|Adverse Event|0|||
125337306|NCT02364336|450868824|FG001|Overall Study|Adverse Event|1|||
125337307|NCT05246514|450868825|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
125337308|NCT05246514|450868825|FG000|Overall Study|Withdrawal by Subject|1|||
125337309|NCT05246514|450868825|FG000|Overall Study|Death|13|||
125337310|NCT02910986|450868826|FG000|Overall Study|non-Latina|14|||
125337311|NCT02910986|450868827|FG001|Overall Study|non-Latina|13|||
125337312|NCT02910986|450868828|FG002|Overall Study|non-Latina|12|||
125337313|NCT02910986|450868826|FG000|Overall Study|Failure to return T! survey|72|||
125337314|NCT02910986|450868827|FG001|Overall Study|Failure to return T! survey|84|||
125337315|NCT02910986|450868828|FG002|Overall Study|Failure to return T! survey|72|||
125337316|NCT02910986|450868826|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
125337317|NCT02910986|450868827|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
125337318|NCT02910986|450868828|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
125337319|NCT02910986|450868826|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
125337320|NCT02910986|450868827|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
125337321|NCT02910986|450868828|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
125337322|NCT01068600|450868829|FG000|Overall Study|Withdrawal by Subject|5|||
125337323|NCT01068600|450868830|FG001|Overall Study|Withdrawal by Subject|6|||
125337324|NCT01068600|450868829|FG000|Overall Study|Adverse Event|3|||
125337325|NCT01068600|450868830|FG001|Overall Study|Adverse Event|3|||
125337326|NCT01068600|450868829|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125337327|NCT01068600|450868830|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125337328|NCT01068600|450868829|FG000|Overall Study|Lost to Follow-up|1|||
125337329|NCT01068600|450868830|FG001|Overall Study|Lost to Follow-up|2|||
125337330|NCT01068600|450868829|FG000|Overall Study|Protocol deviation|1|||
125337331|NCT01068600|450868830|FG001|Overall Study|Protocol deviation|1|||
125337332|NCT01068600|450868829|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125337333|NCT01068600|450868830|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
125337334|NCT01068600|450868829|FG000|Overall Study|Administrative problems|0|||
125337335|NCT01068600|450868830|FG001|Overall Study|Administrative problems|1|||
125337336|NCT01727024|450868831|FG000|Period 1|Lost to Follow-up|1|||
125337337|NCT01727024|450868832|FG001|Period 1|Lost to Follow-up|1|||
125337338|NCT01727024|450868831|FG000|Period 1|Withdrawal by Subject|2|||
125337339|NCT01727024|450868832|FG001|Period 1|Withdrawal by Subject|3|||
125337340|NCT02167139|450868833|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
125337341|NCT02167139|450868834|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
125337342|NCT02167139|450868835|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
125337343|NCT02167139|450868836|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
125337344|NCT02167139|450868833|FG000|Randomised, Double-blind|Adverse Event|2|||
125337345|NCT02167139|450868834|FG001|Randomised, Double-blind|Adverse Event|9|||
125337346|NCT02167139|450868835|FG002|Randomised, Double-blind|Adverse Event|0|||
125337347|NCT02167139|450868836|FG003|Randomised, Double-blind|Adverse Event|0|||
125337348|NCT02167139|450868833|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
125337349|NCT02167139|450868834|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
125337350|NCT02167139|450868835|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
125337351|NCT02167139|450868836|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
125337352|NCT02167139|450868833|FG000|Randomised, Double-blind|Other|3|||
125337353|NCT02167139|450868834|FG001|Randomised, Double-blind|Other|0|||
125337354|NCT02167139|450868835|FG002|Randomised, Double-blind|Other|0|||
125337355|NCT02167139|450868836|FG003|Randomised, Double-blind|Other|0|||
125337356|NCT02167139|450868833|FG000|Transition-extension|Adverse Event|2|||
125337357|NCT02167139|450868834|FG001|Transition-extension|Adverse Event|0|||
125337358|NCT02167139|450868835|FG002|Transition-extension|Adverse Event|2|||
125337359|NCT02167139|450868836|FG003|Transition-extension|Adverse Event|3|||
125337360|NCT02167139|450868833|FG000|Transition-extension|Withdrawal by Subject|2|||
125337361|NCT02167139|450868834|FG001|Transition-extension|Withdrawal by Subject|0|||
125337362|NCT02167139|450868835|FG002|Transition-extension|Withdrawal by Subject|4|||
125337363|NCT02167139|450868836|FG003|Transition-extension|Withdrawal by Subject|1|||
125337364|NCT02167139|450868833|FG000|Transition-extension|Lack of Efficacy|0|||
125337365|NCT02167139|450868834|FG001|Transition-extension|Lack of Efficacy|0|||
125337366|NCT02167139|450868835|FG002|Transition-extension|Lack of Efficacy|1|||
125337367|NCT02167139|450868836|FG003|Transition-extension|Lack of Efficacy|1|||
125337368|NCT02167139|450868833|FG000|Transition-extension|Other|1|||
125337369|NCT02167139|450868834|FG001|Transition-extension|Other|0|||
125337370|NCT02167139|450868835|FG002|Transition-extension|Other|1|||
125337371|NCT02167139|450868836|FG003|Transition-extension|Other|0|||
125337372|NCT02167139|450868833|FG000|Transition-extension|Lost to Follow-up|1|||
125337373|NCT02167139|450868834|FG001|Transition-extension|Lost to Follow-up|0|||
125337374|NCT02167139|450868835|FG002|Transition-extension|Lost to Follow-up|0|||
125670880|NCT00617461|452083390|FG001|First Treatment Intervention Period|Protocol Violation|1|||
125337375|NCT02167139|450868836|FG003|Transition-extension|Lost to Follow-up|0|||
125337376|NCT00329797|450868837|FG000|Overall Study|Protocol Violation|1|||
125337377|NCT00329797|450868838|FG001|Overall Study|Protocol Violation|0|||
125337378|NCT00329797|450868837|FG000|Overall Study|Withdrawal by Subject|6|||
125337379|NCT00329797|450868838|FG001|Overall Study|Withdrawal by Subject|6|||
125337380|NCT00104520|450868839|FG000|Overall Study|Unrelated adverse event|34|||
125337381|NCT00104520|450868840|FG001|Overall Study|Unrelated adverse event|47|||
125337382|NCT00104520|450868839|FG000|Overall Study|Study drug intolerance|0|||
125337383|NCT00104520|450868840|FG001|Overall Study|Study drug intolerance|1|||
125337384|NCT00104520|450868839|FG000|Overall Study|Related adverse event|13|||
125337385|NCT00104520|450868840|FG001|Overall Study|Related adverse event|15|||
125337386|NCT00104520|450868839|FG000|Overall Study|Lost to Follow-up|1|||
125337387|NCT00104520|450868840|FG001|Overall Study|Lost to Follow-up|0|||
125337388|NCT00104520|450868839|FG000|Overall Study|Noncompliance|0|||
125337389|NCT00104520|450868840|FG001|Overall Study|Noncompliance|2|||
125337390|NCT00104520|450868839|FG000|Overall Study|Personal/administrative|1|||
125337391|NCT00104520|450868840|FG001|Overall Study|Personal/administrative|1|||
125337392|NCT00104520|450868839|FG000|Overall Study|Other|1|||
125337393|NCT00104520|450868840|FG001|Overall Study|Other|5|||
125337394|NCT01026324|450868842|FG000|Follow up/Survival|Withdrawal by Subject|1|||
125337395|NCT01026324|450868843|FG001|Follow up/Survival|Withdrawal by Subject|0|||
125337396|NCT01026324|450868844|FG002|Follow up/Survival|Withdrawal by Subject|0|||
125337397|NCT05188053|450868845|FG000|Overall Study|Lost to Follow-up|23|||
125337398|NCT05188053|450868846|FG001|Overall Study|Lost to Follow-up|30|||
125337399|NCT05188053|450868845|FG000|Overall Study|Protocol Violation|16|||
125337400|NCT05188053|450868846|FG001|Overall Study|Protocol Violation|16|||
125337401|NCT05188053|450868845|FG000|Overall Study|Physician Decision|3|||
125337402|NCT05188053|450868846|FG001|Overall Study|Physician Decision|0|||
125337403|NCT05188053|450868845|FG000|Overall Study|Withdrawal by Subject|0|||
125337404|NCT05188053|450868846|FG001|Overall Study|Withdrawal by Subject|1|||
125337405|NCT02447302|450868850|FG000|Overall Study|Physician Decision|1|||
125337406|NCT02447302|450868851|FG001|Overall Study|Physician Decision|0|||
125337407|NCT02447302|450868852|FG002|Overall Study|Physician Decision|0|||
125337408|NCT02447302|450868850|FG000|Overall Study|Adverse Event|4|||
125337409|NCT02447302|450868851|FG001|Overall Study|Adverse Event|3|||
125337410|NCT02447302|450868852|FG002|Overall Study|Adverse Event|0|||
125337411|NCT02447302|450868850|FG000|Overall Study|Withdrawal by Subject|0|||
125337412|NCT02447302|450868851|FG001|Overall Study|Withdrawal by Subject|1|||
125337413|NCT02447302|450868852|FG002|Overall Study|Withdrawal by Subject|5|||
125337414|NCT02447302|450868850|FG000|Overall Study|Sponsor Decision|0|||
125337415|NCT02447302|450868851|FG001|Overall Study|Sponsor Decision|0|||
125337416|NCT02447302|450868852|FG002|Overall Study|Sponsor Decision|1|||
125337417|NCT01456897|450868857|FG000|Overall Study|Adverse Event|19|||
125337418|NCT01456897|450868858|FG001|Overall Study|Adverse Event|22|||
125337419|NCT01456897|450868857|FG000|Overall Study|Protocol Violation|3|||
125337420|NCT01456897|450868858|FG001|Overall Study|Protocol Violation|4|||
125337421|NCT01456897|450868857|FG000|Overall Study|Physician Decision|5|||
125337422|NCT01456897|450868858|FG001|Overall Study|Physician Decision|3|||
125337423|NCT01456897|450868857|FG000|Overall Study|Withdrawal by Subject|44|||
125337424|NCT01456897|450868858|FG001|Overall Study|Withdrawal by Subject|17|||
125337425|NCT01456897|450868857|FG000|Overall Study|Lack of Efficacy|4|||
125337426|NCT01456897|450868858|FG001|Overall Study|Lack of Efficacy|11|||
125337427|NCT01396070|450868864|FG000|Overall Study|Withdrawal by Subject|2|||
125337428|NCT01396070|450868864|FG000|Overall Study|Death|2|||
125337429|NCT01396070|450868864|FG000|Overall Study|Adverse Event|8|||
125337430|NCT01396070|450868864|FG000|Overall Study|Physician Decision|3|||
125337431|NCT01396070|450868864|FG000|Overall Study|Lack of Efficacy|4|||
125337432|NCT01561313|450868866|FG000|Overall Study|Withdrawal by Subject|1|||
125337433|NCT01561313|450868867|FG001|Overall Study|Withdrawal by Subject|0|||
125337434|NCT01561313|450868866|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
125337435|NCT01561313|450868867|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
125337436|NCT04254913|450868868|FG000|Overall Study|Adverse Event|1|||
125337437|NCT02695420|450868869|FG000|Overall Study|Death|0|||
125337438|NCT02695420|450868870|FG001|Overall Study|Death|1|||
125337439|NCT02695420|450868871|FG002|Overall Study|Death|0|||
125337440|NCT02695420|450868872|FG003|Overall Study|Death|0|||
125337441|NCT04535453|450868873|FG000|Overall Study|Death|0|||
125337442|NCT04535453|450868874|FG001|Overall Study|Death|1|||
125337443|NCT04535453|450868875|FG002|Overall Study|Death|0|||
125337444|NCT04535453|450868876|FG003|Overall Study|Death|0|||
125337445|NCT04535453|450868877|FG004|Overall Study|Death|0|||
125337446|NCT04535453|450868878|FG005|Overall Study|Death|0|||
125337447|NCT04535453|450868879|FG006|Overall Study|Death|0|||
125337448|NCT04535453|450868880|FG007|Overall Study|Death|0|||
125337449|NCT04535453|450868881|FG008|Overall Study|Death|0|||
125337450|NCT04535453|450868882|FG009|Overall Study|Death|0|||
125337451|NCT04535453|450868883|FG010|Overall Study|Death|0|||
125337452|NCT04535453|450868884|FG011|Overall Study|Death|0|||
125337453|NCT04535453|450868873|FG000|Overall Study|Lost to Follow-up|1|||
125337454|NCT04535453|450868874|FG001|Overall Study|Lost to Follow-up|1|||
125337455|NCT04535453|450868875|FG002|Overall Study|Lost to Follow-up|1|||
125337456|NCT04535453|450868876|FG003|Overall Study|Lost to Follow-up|0|||
125337457|NCT04535453|450868877|FG004|Overall Study|Lost to Follow-up|3|||
125337458|NCT04535453|450868878|FG005|Overall Study|Lost to Follow-up|1|||
125337459|NCT04535453|450868879|FG006|Overall Study|Lost to Follow-up|0|||
125670881|NCT00617461|452083389|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
125670882|NCT00617461|452083390|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
125670883|NCT00617461|452083389|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
125670884|NCT00617461|452083390|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
125670885|NCT00617461|452083389|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
125670886|NCT00617461|452083390|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
125670887|NCT00617461|452083389|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
125670888|NCT00617461|452083390|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
125670889|NCT00617461|452083389|FG000|Second Treatment Intervention Period|Adverse Event|0|||
125670890|NCT00617461|452083390|FG001|Second Treatment Intervention Period|Adverse Event|1|||
125670891|NCT00617461|452083389|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
125670892|NCT00617461|452083390|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
125670893|NCT00617461|452083389|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
125670894|NCT00617461|452083390|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
125670895|NCT00617461|452083389|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
125670896|NCT00617461|452083390|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
125670897|NCT00358826|452083391|FG000|Core Study|Adverse Event|1|||
125670898|NCT00358826|452083392|FG001|Core Study|Adverse Event|3|||
125670899|NCT00358826|452083393|FG002|Core Study|Adverse Event|1|||
125670900|NCT00358826|452083394|FG003|Core Study|Adverse Event|1|||
125670901|NCT00358826|452083395|FG004|Core Study|Adverse Event|0|||
125670902|NCT00358826|452083396|FG005|Core Study|Adverse Event|0|||
125670903|NCT00358826|452083397|FG006|Core Study|Adverse Event|0|||
125670904|NCT00358826|452083398|FG007|Core Study|Adverse Event|0|||
125670905|NCT00358826|452083391|FG000|Core Study|Withdrawal by Subject|2|||
125670906|NCT00358826|452083392|FG001|Core Study|Withdrawal by Subject|2|||
125670907|NCT00358826|452083393|FG002|Core Study|Withdrawal by Subject|0|||
125670908|NCT00358826|452083394|FG003|Core Study|Withdrawal by Subject|0|||
125670909|NCT00358826|452083395|FG004|Core Study|Withdrawal by Subject|0|||
125670910|NCT00358826|452083396|FG005|Core Study|Withdrawal by Subject|0|||
125670911|NCT00358826|452083397|FG006|Core Study|Withdrawal by Subject|0|||
125670912|NCT00358826|452083398|FG007|Core Study|Withdrawal by Subject|0|||
125670913|NCT00358826|452083391|FG000|Core Study|Lost to Follow-up|0|||
125670914|NCT00358826|452083392|FG001|Core Study|Lost to Follow-up|0|||
125670915|NCT00358826|452083393|FG002|Core Study|Lost to Follow-up|0|||
125670916|NCT00358826|452083394|FG003|Core Study|Lost to Follow-up|1|||
125670917|NCT00358826|452083395|FG004|Core Study|Lost to Follow-up|0|||
125670918|NCT00358826|452083396|FG005|Core Study|Lost to Follow-up|0|||
125670919|NCT00358826|452083397|FG006|Core Study|Lost to Follow-up|0|||
125670920|NCT00358826|452083398|FG007|Core Study|Lost to Follow-up|0|||
125670921|NCT00358826|452083391|FG000|Core Study|Physician Decision|0|||
125670922|NCT00358826|452083392|FG001|Core Study|Physician Decision|0|||
125670923|NCT00358826|452083393|FG002|Core Study|Physician Decision|1|||
125670924|NCT00358826|452083394|FG003|Core Study|Physician Decision|0|||
125670925|NCT00358826|452083395|FG004|Core Study|Physician Decision|0|||
125670926|NCT00358826|452083396|FG005|Core Study|Physician Decision|0|||
125670927|NCT00358826|452083397|FG006|Core Study|Physician Decision|0|||
125670928|NCT00358826|452083398|FG007|Core Study|Physician Decision|0|||
125670929|NCT00358826|452083391|FG000|MDCT Substudy|Adverse Event|0|||
125670930|NCT00358826|452083392|FG001|MDCT Substudy|Adverse Event|0|||
125670931|NCT00358826|452083393|FG002|MDCT Substudy|Adverse Event|0|||
125670932|NCT00358826|452083394|FG003|MDCT Substudy|Adverse Event|0|||
125670933|NCT00358826|452083395|FG004|MDCT Substudy|Adverse Event|1|||
125670934|NCT00358826|452083396|FG005|MDCT Substudy|Adverse Event|0|||
125670935|NCT00358826|452083397|FG006|MDCT Substudy|Adverse Event|0|||
125670936|NCT00358826|452083398|FG007|MDCT Substudy|Adverse Event|0|||
125670937|NCT00358826|452083391|FG000|MDCT Substudy|Lost to Follow-up|0|||
125670938|NCT00358826|452083392|FG001|MDCT Substudy|Lost to Follow-up|0|||
125670939|NCT00358826|452083393|FG002|MDCT Substudy|Lost to Follow-up|0|||
125670940|NCT00358826|452083394|FG003|MDCT Substudy|Lost to Follow-up|0|||
125670941|NCT00358826|452083395|FG004|MDCT Substudy|Lost to Follow-up|0|||
125670942|NCT00358826|452083396|FG005|MDCT Substudy|Lost to Follow-up|1|||
125670943|NCT00358826|452083397|FG006|MDCT Substudy|Lost to Follow-up|0|||
125337460|NCT04535453|450868880|FG007|Overall Study|Lost to Follow-up|0|||
125337461|NCT04535453|450868881|FG008|Overall Study|Lost to Follow-up|1|||
125337462|NCT04535453|450868882|FG009|Overall Study|Lost to Follow-up|1|||
125337463|NCT04535453|450868883|FG010|Overall Study|Lost to Follow-up|0|||
125337464|NCT04535453|450868884|FG011|Overall Study|Lost to Follow-up|0|||
125337465|NCT04535453|450868873|FG000|Overall Study|Physician Decision|0|||
125337466|NCT04535453|450868874|FG001|Overall Study|Physician Decision|0|||
125337467|NCT04535453|450868875|FG002|Overall Study|Physician Decision|0|||
125670944|NCT00358826|452083398|FG007|MDCT Substudy|Lost to Follow-up|0|||
125670945|NCT00358826|452083391|FG000|MDCT Substudy|Withdrawal by Subject|0|||
125670946|NCT00358826|452083392|FG001|MDCT Substudy|Withdrawal by Subject|0|||
125670947|NCT00358826|452083393|FG002|MDCT Substudy|Withdrawal by Subject|0|||
125670948|NCT00358826|452083394|FG003|MDCT Substudy|Withdrawal by Subject|0|||
125670949|NCT00358826|452083395|FG004|MDCT Substudy|Withdrawal by Subject|0|||
125670950|NCT00358826|452083396|FG005|MDCT Substudy|Withdrawal by Subject|1|||
125670951|NCT00358826|452083397|FG006|MDCT Substudy|Withdrawal by Subject|0|||
125670952|NCT00358826|452083398|FG007|MDCT Substudy|Withdrawal by Subject|0|||
125670953|NCT00903383|452083399|FG000|Overall Study|Adverse Event|1|||
125670954|NCT00903383|452083400|FG001|Overall Study|Adverse Event|2|||
125670955|NCT00903383|452083401|FG002|Overall Study|Adverse Event|3|||
125670956|NCT00903383|452083402|FG003|Overall Study|Adverse Event|1|||
125670957|NCT00903383|452083399|FG000|Overall Study|Physician Decision|1|||
125670958|NCT00903383|452083400|FG001|Overall Study|Physician Decision|2|||
125670959|NCT00903383|452083401|FG002|Overall Study|Physician Decision|0|||
125670960|NCT00903383|452083402|FG003|Overall Study|Physician Decision|0|||
125670961|NCT00903383|452083399|FG000|Overall Study|Lost to Follow-up|0|||
125670962|NCT00903383|452083400|FG001|Overall Study|Lost to Follow-up|0|||
125670963|NCT00903383|452083401|FG002|Overall Study|Lost to Follow-up|0|||
125670964|NCT00903383|452083402|FG003|Overall Study|Lost to Follow-up|1|||
125670965|NCT00903383|452083399|FG000|Overall Study|Decision of Sponsor|1|||
125670966|NCT00903383|452083400|FG001|Overall Study|Decision of Sponsor|0|||
125670967|NCT00903383|452083401|FG002|Overall Study|Decision of Sponsor|0|||
125670968|NCT00903383|452083402|FG003|Overall Study|Decision of Sponsor|0|||
125670969|NCT00903383|452083399|FG000|Overall Study|Withdrawal by Subject|4|||
125670970|NCT00903383|452083400|FG001|Overall Study|Withdrawal by Subject|1|||
125670971|NCT00903383|452083401|FG002|Overall Study|Withdrawal by Subject|0|||
125670972|NCT00903383|452083402|FG003|Overall Study|Withdrawal by Subject|2|||
125670973|NCT00903383|452083399|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
125670974|NCT00903383|452083400|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
125670975|NCT00903383|452083401|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
125670976|NCT00903383|452083402|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
125670977|NCT00903383|452083399|FG000|Overall Study|Patient Decision|0|||
125670978|NCT00903383|452083400|FG001|Overall Study|Patient Decision|0|||
125670979|NCT00903383|452083401|FG002|Overall Study|Patient Decision|0|||
125670980|NCT00903383|452083402|FG003|Overall Study|Patient Decision|1|||
125670981|NCT01821625|452083405|FG000|Overall Study|Withdrawal by Subject|2|||
125670982|NCT01821625|452083405|FG000|Overall Study|Lack of Efficacy|2|||
125670983|NCT01821625|452083405|FG000|Overall Study|Adverse Event|1|||
125670984|NCT01821625|452083405|FG000|Overall Study|Medical contraindication|1|||
125670985|NCT00320593|452083408|FG000|Overall Study|Lost to Follow-up|3|||
125670986|NCT00320593|452083409|FG001|Overall Study|Lost to Follow-up|0|||
125670987|NCT00320593|452083408|FG000|Overall Study|Moved to another state|1|||
125670988|NCT00320593|452083409|FG001|Overall Study|Moved to another state|0|||
125670989|NCT00320593|452083408|FG000|Overall Study|Withdrawal by Subject|2|||
125670990|NCT00320593|452083409|FG001|Overall Study|Withdrawal by Subject|1|||
125670991|NCT00320593|452083408|FG000|Overall Study|Withdrawal by clinical center|1|||
125670992|NCT00320593|452083409|FG001|Overall Study|Withdrawal by clinical center|0|||
125670993|NCT00457665|452083410|FG000|12 Months|Drug allergy|1|||
125670994|NCT00457665|452083411|FG001|12 Months|Drug allergy|1|||
125670995|NCT00457665|452083410|FG000|12 Months|High HIV viral load|5|||
125670996|NCT00457665|452083411|FG001|12 Months|High HIV viral load|1|||
125670997|NCT00457665|452083410|FG000|12 Months|Lipodystrophy|2|||
125670998|NCT00457665|452083411|FG001|12 Months|Lipodystrophy|0|||
125670999|NCT00457665|452083410|FG000|12 Months|Withdrawal by Subject|0|||
125671000|NCT00457665|452083411|FG001|12 Months|Withdrawal by Subject|2|||
125671001|NCT00457665|452083410|FG000|12 Months|Abnormal Liver function tests|0|||
125671002|NCT00457665|452083411|FG001|12 Months|Abnormal Liver function tests|5|||
125671003|NCT00457665|452083410|FG000|24 Months|Withdrawal by Subject|3|||
125671004|NCT00457665|452083411|FG001|24 Months|Withdrawal by Subject|2|||
125671005|NCT00457665|452083410|FG000|24 Months|Lipodystrophy|1|||
125671006|NCT00457665|452083411|FG001|24 Months|Lipodystrophy|1|||
125671007|NCT00457665|452083410|FG000|24 Months|Abnormal liver function tests|1|||
125671008|NCT00457665|452083411|FG001|24 Months|Abnormal liver function tests|5|||
125671009|NCT01716754|452083412|FG000|Overall Study|Death|0|||
125671010|NCT01716754|452083413|FG001|Overall Study|Death|0|||
125671011|NCT01716754|452083414|FG002|Overall Study|Death|0|||
125671012|NCT01716754|452083415|FG003|Overall Study|Death|1|||
125671013|NCT01716754|452083412|FG000|Overall Study|Protocol deviation|0|||
125671014|NCT01716754|452083413|FG001|Overall Study|Protocol deviation|2|||
125671015|NCT01716754|452083414|FG002|Overall Study|Protocol deviation|7|||
125671016|NCT01716754|452083415|FG003|Overall Study|Protocol deviation|2|||
125671017|NCT01716754|452083412|FG000|Overall Study|Non-compliance with study treatment|0|||
125671018|NCT01716754|452083413|FG001|Overall Study|Non-compliance with study treatment|0|||
125337468|NCT04535453|450868876|FG003|Overall Study|Physician Decision|1|||
125337469|NCT04535453|450868877|FG004|Overall Study|Physician Decision|0|||
125337470|NCT04535453|450868878|FG005|Overall Study|Physician Decision|0|||
125337471|NCT04535453|450868879|FG006|Overall Study|Physician Decision|0|||
125337472|NCT04535453|450868880|FG007|Overall Study|Physician Decision|0|||
125337473|NCT04535453|450868881|FG008|Overall Study|Physician Decision|0|||
125337474|NCT04535453|450868882|FG009|Overall Study|Physician Decision|0|||
125337475|NCT04535453|450868883|FG010|Overall Study|Physician Decision|0|||
125337476|NCT04535453|450868884|FG011|Overall Study|Physician Decision|0|||
125337477|NCT04535453|450868873|FG000|Overall Study|Withdrawal by Subject|3|||
125337478|NCT04535453|450868874|FG001|Overall Study|Withdrawal by Subject|6|||
125337479|NCT04535453|450868875|FG002|Overall Study|Withdrawal by Subject|3|||
125337480|NCT04535453|450868876|FG003|Overall Study|Withdrawal by Subject|3|||
125337481|NCT04535453|450868877|FG004|Overall Study|Withdrawal by Subject|2|||
125337482|NCT04535453|450868878|FG005|Overall Study|Withdrawal by Subject|1|||
125337483|NCT04535453|450868879|FG006|Overall Study|Withdrawal by Subject|1|||
125337484|NCT04535453|450868880|FG007|Overall Study|Withdrawal by Subject|1|||
125337485|NCT04535453|450868881|FG008|Overall Study|Withdrawal by Subject|1|||
125337486|NCT04535453|450868882|FG009|Overall Study|Withdrawal by Subject|1|||
125337487|NCT04535453|450868883|FG010|Overall Study|Withdrawal by Subject|0|||
125337488|NCT04535453|450868884|FG011|Overall Study|Withdrawal by Subject|1|||
125337489|NCT04535453|450868873|FG000|Overall Study|Other|0|||
125337490|NCT04535453|450868874|FG001|Overall Study|Other|0|||
125337491|NCT04535453|450868875|FG002|Overall Study|Other|1|||
125671019|NCT01716754|452083414|FG002|Overall Study|Non-compliance with study treatment|1|||
125671020|NCT01716754|452083415|FG003|Overall Study|Non-compliance with study treatment|0|||
125671021|NCT01716754|452083412|FG000|Overall Study|Physician Decision|1|||
125671022|NCT01716754|452083413|FG001|Overall Study|Physician Decision|0|||
125671023|NCT01716754|452083414|FG002|Overall Study|Physician Decision|0|||
125671024|NCT01716754|452083415|FG003|Overall Study|Physician Decision|0|||
125671025|NCT01716754|452083412|FG000|Overall Study|Lost to Follow-up|1|||
125671026|NCT01716754|452083413|FG001|Overall Study|Lost to Follow-up|0|||
125671027|NCT01716754|452083414|FG002|Overall Study|Lost to Follow-up|0|||
125671028|NCT01716754|452083415|FG003|Overall Study|Lost to Follow-up|1|||
125671029|NCT01716754|452083412|FG000|Overall Study|Adverse Event|4|||
125671030|NCT01716754|452083413|FG001|Overall Study|Adverse Event|2|||
125671031|NCT01716754|452083414|FG002|Overall Study|Adverse Event|2|||
125671032|NCT01716754|452083415|FG003|Overall Study|Adverse Event|1|||
125671033|NCT01716754|452083412|FG000|Overall Study|Withdrawal by Subject|5|||
125671034|NCT01716754|452083413|FG001|Overall Study|Withdrawal by Subject|0|||
125671035|NCT01716754|452083414|FG002|Overall Study|Withdrawal by Subject|4|||
125671036|NCT01716754|452083415|FG003|Overall Study|Withdrawal by Subject|3|||
125671037|NCT00638157|452083437|FG000|Overall Study|Adverse Event|0|||
125671038|NCT00638157|452083438|FG001|Overall Study|Adverse Event|1|||
125671039|NCT00638157|452083437|FG000|Overall Study|Clinical (symptomatic) failure|1|||
125671040|NCT00638157|452083438|FG001|Overall Study|Clinical (symptomatic) failure|1|||
125671041|NCT00638157|452083437|FG000|Overall Study|Microbiological failure|1|||
125671042|NCT00638157|452083438|FG001|Overall Study|Microbiological failure|0|||
125671043|NCT00638157|452083437|FG000|Overall Study|Lost to Follow-up|1|||
125671044|NCT00638157|452083438|FG001|Overall Study|Lost to Follow-up|0|||
125671045|NCT00638157|452083437|FG000|Overall Study|Physician Decision|1|||
125671046|NCT00638157|452083438|FG001|Overall Study|Physician Decision|0|||
125671047|NCT00638157|452083437|FG000|Overall Study|Other|1|||
125671048|NCT00638157|452083438|FG001|Overall Study|Other|2|||
125671049|NCT00638157|452083437|FG000|Overall Study|Randomized, not treated|2|||
125671050|NCT00638157|452083438|FG001|Overall Study|Randomized, not treated|0|||
125671051|NCT01851590|452083441|FG000|Overall Study|Withdrawal by Subject|0|||
125671052|NCT01851590|452083442|FG001|Overall Study|Withdrawal by Subject|0|||
125671053|NCT01851590|452083443|FG002|Overall Study|Withdrawal by Subject|1|||
125671054|NCT01851590|452083441|FG000|Overall Study|Adverse Event|0|||
125671055|NCT01851590|452083442|FG001|Overall Study|Adverse Event|0|||
125671056|NCT01851590|452083443|FG002|Overall Study|Adverse Event|2|||
125671057|NCT01851590|452083441|FG000|Overall Study|Lack of Efficacy|0|||
125671058|NCT01851590|452083442|FG001|Overall Study|Lack of Efficacy|1|||
125671059|NCT01851590|452083443|FG002|Overall Study|Lack of Efficacy|0|||
125671060|NCT02611752|452083447|FG000|Overall Study|Adverse Event|0|||
125671061|NCT02611752|452083448|FG001|Overall Study|Adverse Event|1|||
125671062|NCT00310856|452083449|FG000|Overall Study|Withdrawal by Subject|2|||
125671063|NCT00310856|452083450|FG001|Overall Study|Withdrawal by Subject|2|||
125671064|NCT00310856|452083451|FG002|Overall Study|Withdrawal by Subject|2|||
125671065|NCT00310856|452083449|FG000|Overall Study|Lost to Follow-up|1|||
125671066|NCT00310856|452083450|FG001|Overall Study|Lost to Follow-up|2|||
125671067|NCT00310856|452083451|FG002|Overall Study|Lost to Follow-up|6|||
125671068|NCT00310856|452083449|FG000|Overall Study|Inappropriate enrollment|1|||
125671069|NCT00310856|452083450|FG001|Overall Study|Inappropriate enrollment|1|||
125671070|NCT00310856|452083451|FG002|Overall Study|Inappropriate enrollment|0|||
125671071|NCT00310856|452083449|FG000|Overall Study|Unable to classify|1|||
125671072|NCT00310856|452083450|FG001|Overall Study|Unable to classify|0|||
125671073|NCT00310856|452083451|FG002|Overall Study|Unable to classify|0|||
125671074|NCT00321711|452083455|FG000|Part A|Adverse Event|3|||
125671075|NCT00321711|452083456|FG001|Part A|Adverse Event|3|||
125671076|NCT00321711|452083457|FG002|Part A|Adverse Event|2|||
125671077|NCT00321711|452083458|FG003|Part A|Adverse Event|0|||
125671078|NCT00321711|452083459|FG004|Part A|Adverse Event|0|||
125671079|NCT00321711|452083455|FG000|Part A|Withdrawal by Subject|1|||
125671080|NCT00321711|452083456|FG001|Part A|Withdrawal by Subject|1|||
125671081|NCT00321711|452083457|FG002|Part A|Withdrawal by Subject|1|||
125671082|NCT00321711|452083458|FG003|Part A|Withdrawal by Subject|0|||
125671083|NCT00321711|452083459|FG004|Part A|Withdrawal by Subject|0|||
125671084|NCT00321711|452083455|FG000|Part A|Disease progression|0|||
125671085|NCT00321711|452083456|FG001|Part A|Disease progression|1|||
125671086|NCT00321711|452083457|FG002|Part A|Disease progression|0|||
125671087|NCT00321711|452083458|FG003|Part A|Disease progression|0|||
125671088|NCT00321711|452083459|FG004|Part A|Disease progression|0|||
125671089|NCT00321711|452083455|FG000|Part A|Requirement for alternative therapy|0|||
125337492|NCT04535453|450868876|FG003|Overall Study|Other|0|||
125337493|NCT04535453|450868877|FG004|Overall Study|Other|1|||
125671090|NCT00321711|452083456|FG001|Part A|Requirement for alternative therapy|2|||
125337494|NCT04535453|450868878|FG005|Overall Study|Other|0|||
125337495|NCT04535453|450868879|FG006|Overall Study|Other|1|||
125337496|NCT04535453|450868880|FG007|Overall Study|Other|1|||
125337497|NCT04535453|450868881|FG008|Overall Study|Other|1|||
125337498|NCT04535453|450868882|FG009|Overall Study|Other|0|||
125337499|NCT04535453|450868883|FG010|Overall Study|Other|0|||
125337500|NCT04535453|450868884|FG011|Overall Study|Other|0|||
125337501|NCT00916929|450868885|FG000|Overall Study|Lost to Follow-up|1|||
125337502|NCT00916929|450868886|FG001|Overall Study|Lost to Follow-up|3|||
125337503|NCT00916929|450868885|FG000|Overall Study|Death|5|||
125337504|NCT00916929|450868886|FG001|Overall Study|Death|10|||
125337505|NCT00916929|450868885|FG000|Overall Study|Withdrawal by Subject|1|||
125337506|NCT00916929|450868886|FG001|Overall Study|Withdrawal by Subject|5|||
125337507|NCT00916929|450868885|FG000|Overall Study|Left ventricular epicardial lead|1|||
125337508|NCT00916929|450868886|FG001|Overall Study|Left ventricular epicardial lead|2|||
125337509|NCT00916929|450868885|FG000|Overall Study|Transferred to hospice care|1|||
125337510|NCT00916929|450868886|FG001|Overall Study|Transferred to hospice care|1|||
125337511|NCT00916929|450868885|FG000|Overall Study|System explant|1|||
125337512|NCT00916929|450868886|FG001|Overall Study|System explant|0|||
125337513|NCT00916929|450868885|FG000|Overall Study|Moved to another state|0|||
125337514|NCT00916929|450868886|FG001|Overall Study|Moved to another state|1|||
125337515|NCT00916929|450868885|FG000|Overall Study|Device unable to process impedance data|0|||
125337516|NCT00916929|450868886|FG001|Overall Study|Device unable to process impedance data|7|||
125671091|NCT00321711|452083457|FG002|Part A|Requirement for alternative therapy|1|||
125671092|NCT00321711|452083458|FG003|Part A|Requirement for alternative therapy|0|||
125671093|NCT00321711|452083459|FG004|Part A|Requirement for alternative therapy|0|||
125671094|NCT00321711|452083455|FG000|Part A|Physician Decision|0|||
125671095|NCT00321711|452083456|FG001|Part A|Physician Decision|1|||
125671096|NCT00321711|452083457|FG002|Part A|Physician Decision|3|||
125671097|NCT00321711|452083458|FG003|Part A|Physician Decision|0|||
125671098|NCT00321711|452083459|FG004|Part A|Physician Decision|0|||
125671099|NCT00321711|452083455|FG000|Part A|Other|1|||
125671100|NCT00321711|452083456|FG001|Part A|Other|2|||
125671101|NCT00321711|452083457|FG002|Part A|Other|3|||
125671102|NCT00321711|452083458|FG003|Part A|Other|0|||
125671103|NCT00321711|452083459|FG004|Part A|Other|0|||
125671104|NCT00321711|452083455|FG000|Part A|Protocol deviation|0|||
125671105|NCT00321711|452083456|FG001|Part A|Protocol deviation|0|||
125671106|NCT00321711|452083457|FG002|Part A|Protocol deviation|1|||
125671107|NCT00321711|452083458|FG003|Part A|Protocol deviation|0|||
125671108|NCT00321711|452083459|FG004|Part A|Protocol deviation|0|||
125671109|NCT00321711|452083455|FG000|Part B|Noncompliance|0|||
125671110|NCT00321711|452083456|FG001|Part B|Noncompliance|0|||
125671111|NCT00321711|452083457|FG002|Part B|Noncompliance|0|||
125671112|NCT00321711|452083458|FG003|Part B|Noncompliance|0|||
125671113|NCT00321711|452083459|FG004|Part B|Noncompliance|1|||
125671114|NCT00321711|452083455|FG000|Part B|Adverse Event|0|||
125671115|NCT00321711|452083456|FG001|Part B|Adverse Event|0|||
125671116|NCT00321711|452083457|FG002|Part B|Adverse Event|0|||
125671117|NCT00321711|452083458|FG003|Part B|Adverse Event|2|||
125671118|NCT00321711|452083459|FG004|Part B|Adverse Event|1|||
125671119|NCT00321711|452083455|FG000|Part B|Disease progression|0|||
125671120|NCT00321711|452083456|FG001|Part B|Disease progression|0|||
125671121|NCT00321711|452083457|FG002|Part B|Disease progression|0|||
125671122|NCT00321711|452083458|FG003|Part B|Disease progression|1|||
125671123|NCT00321711|452083459|FG004|Part B|Disease progression|0|||
125671124|NCT00321711|452083455|FG000|Part B|Physician Decision|0|||
125671125|NCT00321711|452083456|FG001|Part B|Physician Decision|0|||
125671126|NCT00321711|452083457|FG002|Part B|Physician Decision|0|||
125671127|NCT00321711|452083458|FG003|Part B|Physician Decision|1|||
125671128|NCT00321711|452083459|FG004|Part B|Physician Decision|2|||
125671129|NCT00321711|452083455|FG000|Part B|Death|0|||
125671130|NCT00321711|452083456|FG001|Part B|Death|0|||
125671131|NCT00321711|452083457|FG002|Part B|Death|0|||
125671132|NCT00321711|452083458|FG003|Part B|Death|2|||
125671133|NCT00321711|452083459|FG004|Part B|Death|1|||
125671134|NCT02843074|452083460|FG000|Overall Study|Withdrawal by Subject|5|||
125671135|NCT02843074|452083460|FG000|Overall Study|Progressive disease|1|||
125671136|NCT02843074|452083460|FG000|Overall Study|Physician Decision|1|||
125671137|NCT02843074|452083460|FG000|Overall Study|Lost to Follow-up|1|||
125337517|NCT02929407|450868887|FG000|Overall Study|Adverse Event|1|||
125337518|NCT02442804|450868891|FG000|Overall Study|Withdrawal by Subject|0|||
125337519|NCT02442804|450868892|FG001|Overall Study|Withdrawal by Subject|1|||
125337520|NCT02442804|450868891|FG000|Overall Study|Adverse Event|1|||
125337521|NCT02442804|450868892|FG001|Overall Study|Adverse Event|0|||
125337522|NCT02036853|450868893|FG000|Overall Study|Adverse Event|0|||
125671138|NCT02843074|452083460|FG000|Overall Study|Death|9|||
125671139|NCT01211769|452083463|FG000|Overall Study|Lost to Follow-up|7|||
125671140|NCT01211769|452083464|FG001|Overall Study|Lost to Follow-up|9|||
125671141|NCT01211769|452083465|FG002|Overall Study|Lost to Follow-up|5|||
125671142|NCT01211769|452083466|FG003|Overall Study|Lost to Follow-up|9|||
125671143|NCT01211769|452083463|FG000|Overall Study|Physician Decision|2|||
125671144|NCT01211769|452083464|FG001|Overall Study|Physician Decision|0|||
125671145|NCT01211769|452083465|FG002|Overall Study|Physician Decision|2|||
125337523|NCT02036853|450868894|FG001|Overall Study|Adverse Event|2|||
125337524|NCT02036853|450868893|FG000|Overall Study|Lack of Efficacy|0|||
125337525|NCT02036853|450868894|FG001|Overall Study|Lack of Efficacy|2|||
125337526|NCT02036853|450868893|FG000|Overall Study|Physician Decision|0|||
125337527|NCT02036853|450868894|FG001|Overall Study|Physician Decision|1|||
125337528|NCT02036853|450868893|FG000|Overall Study|Withdrawal by Subject|0|||
125337529|NCT02036853|450868894|FG001|Overall Study|Withdrawal by Subject|1|||
125337530|NCT01742286|450868895|FG000|Escalation Phase|Administrative problems|1|||
125337531|NCT01742286|450868896|FG001|Escalation Phase|Administrative problems|1|||
125337532|NCT01742286|450868897|FG002|Escalation Phase|Administrative problems|0|||
125337533|NCT01742286|450868898|FG003|Escalation Phase|Administrative problems|0|||
125337534|NCT01742286|450868899|FG004|Escalation Phase|Administrative problems|0|||
125337535|NCT01742286|450868900|FG005|Escalation Phase|Administrative problems|0|||
125337536|NCT01742286|450868901|FG006|Escalation Phase|Administrative problems|2|||
125337537|NCT01742286|450868895|FG000|Escalation Phase|Adverse Event|0|||
125337538|NCT01742286|450868896|FG001|Escalation Phase|Adverse Event|1|||
125337539|NCT01742286|450868897|FG002|Escalation Phase|Adverse Event|2|||
125337540|NCT01742286|450868898|FG003|Escalation Phase|Adverse Event|0|||
125337541|NCT01742286|450868899|FG004|Escalation Phase|Adverse Event|0|||
125337542|NCT01742286|450868900|FG005|Escalation Phase|Adverse Event|1|||
125337543|NCT01742286|450868901|FG006|Escalation Phase|Adverse Event|0|||
125337544|NCT01742286|450868895|FG000|Escalation Phase|Disease progression|3|||
125337545|NCT01742286|450868896|FG001|Escalation Phase|Disease progression|7|||
125337546|NCT01742286|450868897|FG002|Escalation Phase|Disease progression|4|||
125337547|NCT01742286|450868898|FG003|Escalation Phase|Disease progression|1|||
125337548|NCT01742286|450868899|FG004|Escalation Phase|Disease progression|4|||
125337549|NCT01742286|450868900|FG005|Escalation Phase|Disease progression|3|||
125337550|NCT01742286|450868901|FG006|Escalation Phase|Disease progression|2|||
125337551|NCT01742286|450868895|FG000|Escalation Phase|Death|0|||
125337552|NCT01742286|450868896|FG001|Escalation Phase|Death|0|||
125337553|NCT01742286|450868897|FG002|Escalation Phase|Death|0|||
125337554|NCT01742286|450868898|FG003|Escalation Phase|Death|0|||
125337555|NCT01742286|450868899|FG004|Escalation Phase|Death|0|||
125337556|NCT01742286|450868900|FG005|Escalation Phase|Death|1|||
125337557|NCT01742286|450868901|FG006|Escalation Phase|Death|0|||
125337558|NCT01742286|450868895|FG000|Escalation Phase|Physician Decision|0|||
125337559|NCT01742286|450868896|FG001|Escalation Phase|Physician Decision|3|||
125337560|NCT01742286|450868897|FG002|Escalation Phase|Physician Decision|0|||
125337561|NCT01742286|450868898|FG003|Escalation Phase|Physician Decision|1|||
125337562|NCT01742286|450868899|FG004|Escalation Phase|Physician Decision|0|||
125337563|NCT01742286|450868900|FG005|Escalation Phase|Physician Decision|0|||
125337564|NCT01742286|450868901|FG006|Escalation Phase|Physician Decision|2|||
125337565|NCT01742286|450868895|FG000|Escalation Phase|Subject/guardian decision|1|||
125337566|NCT01742286|450868896|FG001|Escalation Phase|Subject/guardian decision|0|||
125337567|NCT01742286|450868897|FG002|Escalation Phase|Subject/guardian decision|0|||
125337568|NCT01742286|450868898|FG003|Escalation Phase|Subject/guardian decision|0|||
125337569|NCT01742286|450868899|FG004|Escalation Phase|Subject/guardian decision|0|||
125671146|NCT01211769|452083466|FG003|Overall Study|Physician Decision|1|||
125671147|NCT01211769|452083463|FG000|Overall Study|Adverse Event|0|||
125671148|NCT01211769|452083464|FG001|Overall Study|Adverse Event|1|||
125671149|NCT01211769|452083465|FG002|Overall Study|Adverse Event|1|||
125671150|NCT01211769|452083466|FG003|Overall Study|Adverse Event|1|||
125671151|NCT01214330|452083467|FG000|Overall Study|Withdrawal by Subject|2|||
125671152|NCT01214330|452083467|FG000|Overall Study|Withdrawal by Subject|2|||
125671153|NCT01348542|452083468|FG000|Overall Study|Withdrawal by Subject|3|||
125671154|NCT01348542|452083469|FG001|Overall Study|Withdrawal by Subject|0|||
125671155|NCT03402893|452083470|FG000|Overall Study|Withdrawal by Subject|1|||
125671156|NCT01484028|452083471|FG000|Period 1|Lost to Follow-up|0|||
125671157|NCT01484028|452083472|FG001|Period 1|Lost to Follow-up|1|||
125671158|NCT01484028|452083473|FG002|Period 1|Lost to Follow-up|0|||
125671159|NCT01484028|452083474|FG003|Period 1|Lost to Follow-up|0|||
125671160|NCT01484028|452083471|FG000|Period 1|Non-Compliance to Protocol|0|||
125671161|NCT01484028|452083472|FG001|Period 1|Non-Compliance to Protocol|1|||
125671162|NCT01484028|452083473|FG002|Period 1|Non-Compliance to Protocol|0|||
125337570|NCT01742286|450868900|FG005|Escalation Phase|Subject/guardian decision|0|||
125337571|NCT01742286|450868901|FG006|Escalation Phase|Subject/guardian decision|0|||
125337572|NCT01742286|450868895|FG000|Expansion Phase|Administrative problems|0|||
125337573|NCT01742286|450868896|FG001|Expansion Phase|Administrative problems|0|||
125337574|NCT01742286|450868897|FG002|Expansion Phase|Administrative problems|0|||
125337575|NCT01742286|450868898|FG003|Expansion Phase|Administrative problems|0|||
125671163|NCT01484028|452083474|FG003|Period 1|Non-Compliance to Protocol|1|||
125671164|NCT01484028|452083471|FG000|Period 1|Lens Discomfort|0|||
125337576|NCT01742286|450868899|FG004|Expansion Phase|Administrative problems|0|||
125337577|NCT01742286|450868900|FG005|Expansion Phase|Administrative problems|0|||
125337578|NCT01742286|450868901|FG006|Expansion Phase|Administrative problems|5|||
125671165|NCT01484028|452083472|FG001|Period 1|Lens Discomfort|1|||
125671166|NCT01484028|452083473|FG002|Period 1|Lens Discomfort|0|||
125337579|NCT01742286|450868895|FG000|Expansion Phase|Physician Decision|0|||
125337580|NCT01742286|450868896|FG001|Expansion Phase|Physician Decision|0|||
125337581|NCT01742286|450868897|FG002|Expansion Phase|Physician Decision|4|||
125337582|NCT01742286|450868898|FG003|Expansion Phase|Physician Decision|0|||
125337583|NCT01742286|450868899|FG004|Expansion Phase|Physician Decision|0|||
125337584|NCT01742286|450868900|FG005|Expansion Phase|Physician Decision|0|||
125337585|NCT01742286|450868901|FG006|Expansion Phase|Physician Decision|9|||
125337586|NCT01742286|450868895|FG000|Expansion Phase|Adverse Event|0|||
125337587|NCT01742286|450868896|FG001|Expansion Phase|Adverse Event|0|||
125337588|NCT01742286|450868897|FG002|Expansion Phase|Adverse Event|0|||
125337589|NCT01742286|450868898|FG003|Expansion Phase|Adverse Event|0|||
125337590|NCT01742286|450868899|FG004|Expansion Phase|Adverse Event|0|||
125337591|NCT01742286|450868900|FG005|Expansion Phase|Adverse Event|0|||
125337592|NCT01742286|450868901|FG006|Expansion Phase|Adverse Event|6|||
125337593|NCT01742286|450868895|FG000|Expansion Phase|Disease progression|0|||
125337594|NCT01742286|450868896|FG001|Expansion Phase|Disease progression|0|||
125337595|NCT01742286|450868897|FG002|Expansion Phase|Disease progression|3|||
125337596|NCT01742286|450868898|FG003|Expansion Phase|Disease progression|0|||
125337597|NCT01742286|450868899|FG004|Expansion Phase|Disease progression|0|||
125337598|NCT01742286|450868900|FG005|Expansion Phase|Disease progression|0|||
125337599|NCT01742286|450868901|FG006|Expansion Phase|Disease progression|15|||
125337600|NCT01742286|450868895|FG000|Expansion Phase|Withdrawal by Subject|0|||
125337601|NCT01742286|450868896|FG001|Expansion Phase|Withdrawal by Subject|0|||
125337602|NCT01742286|450868897|FG002|Expansion Phase|Withdrawal by Subject|0|||
125337603|NCT01742286|450868898|FG003|Expansion Phase|Withdrawal by Subject|0|||
125337604|NCT01742286|450868899|FG004|Expansion Phase|Withdrawal by Subject|0|||
125337605|NCT01742286|450868900|FG005|Expansion Phase|Withdrawal by Subject|0|||
125337606|NCT01742286|450868901|FG006|Expansion Phase|Withdrawal by Subject|1|||
125337607|NCT02633020|450868902|FG000|Overall Study|Adverse Event|1|||
125337608|NCT02633020|450868903|FG001|Overall Study|Adverse Event|0|||
125337609|NCT01136785|450868904|FG000|Overall Study|Protocol Violation|2|||
125337610|NCT01136785|450868905|FG001|Overall Study|Protocol Violation|1|||
125337611|NCT02954172|450868906|FG000|Overall Study|Protocol Violation|3|||
125337612|NCT02954172|450868907|FG001|Overall Study|Protocol Violation|0|||
125337613|NCT02954172|450868906|FG000|Overall Study|allergic reaction|2|||
125337614|NCT02954172|450868907|FG001|Overall Study|allergic reaction|1|||
125337615|NCT02954172|450868906|FG000|Overall Study|non-measurable lesions at baseline|1|||
125337616|NCT02954172|450868907|FG001|Overall Study|non-measurable lesions at baseline|2|||
125337617|NCT00853567|450868910|FG000|Overall Study|Study prematurely terminated|71|||
125337618|NCT03818035|450868911|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
125671167|NCT01484028|452083474|FG003|Period 1|Lens Discomfort|0|||
125671168|NCT01199601|452083478|FG000|Overall Study|Lost to Follow-up|47|||
125671169|NCT01199601|452083479|FG001|Overall Study|Lost to Follow-up|66|||
125671170|NCT01199601|452083478|FG000|Overall Study|Withdrawal by Subject|15|||
125671171|NCT01199601|452083479|FG001|Overall Study|Withdrawal by Subject|3|||
125671172|NCT01199601|452083478|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
125671173|NCT01199601|452083479|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
125671174|NCT00146770|452083480|FG000|Overall Study|Adverse Event|2|||
125671175|NCT00146770|452083481|FG001|Overall Study|Adverse Event|0|||
125671176|NCT00146770|452083480|FG000|Overall Study|Pregnancy|1|||
125671177|NCT00146770|452083481|FG001|Overall Study|Pregnancy|0|||
125671178|NCT00146770|452083480|FG000|Overall Study|Withdrawal by Subject|2|||
125671179|NCT00146770|452083481|FG001|Overall Study|Withdrawal by Subject|0|||
125671180|NCT03775681|452083486|FG000|Overall Study|Physician Decision|3|||
125671181|NCT01855126|452083487|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
125671182|NCT01855126|452083488|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
125671183|NCT01855126|452083487|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
125671184|NCT01855126|452083488|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
125337619|NCT03818035|450868912|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
125337620|NCT03818035|450868913|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
125337621|NCT03818035|450868914|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
125337622|NCT03818035|450868911|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
125337623|NCT03818035|450868912|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
125337624|NCT03818035|450868913|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
125337625|NCT03818035|450868914|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
125337626|NCT03818035|450868911|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
125337627|NCT03818035|450868912|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
125337628|NCT03818035|450868913|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
125337629|NCT03818035|450868914|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
125671185|NCT01748890|452083498|FG000|Overall Study|Insufficient recruitment for analysis|4|||
125671186|NCT02669264|452083499|FG000|Overall Study|Death|5|||
125671187|NCT02669264|452083500|FG001|Overall Study|Death|5|||
125337630|NCT03818035|450868911|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
125337631|NCT03818035|450868912|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
125337632|NCT03818035|450868913|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
125671188|NCT02669264|452083501|FG002|Overall Study|Death|3|||
125337633|NCT03818035|450868914|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
125337634|NCT03818035|450868911|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
125337635|NCT03818035|450868912|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
125337636|NCT03818035|450868913|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
125337637|NCT03818035|450868914|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
125337638|NCT03818035|450868911|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
125337639|NCT03818035|450868912|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
125337640|NCT03818035|450868913|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
125337641|NCT03818035|450868914|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
125337642|NCT03818035|450868911|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
125337643|NCT03818035|450868912|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
125337644|NCT03818035|450868913|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
125337645|NCT03818035|450868914|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
125337646|NCT03818035|450868911|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
125337647|NCT03818035|450868912|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
125337648|NCT03818035|450868913|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
125337649|NCT03818035|450868914|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
125337650|NCT03818035|450868911|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
125337651|NCT03818035|450868912|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
125337652|NCT03818035|450868913|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
125337653|NCT03818035|450868914|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
125337654|NCT03818035|450868911|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
125337655|NCT03818035|450868912|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
125337656|NCT03818035|450868913|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
125337657|NCT03818035|450868914|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
125337658|NCT03818035|450868911|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
125337659|NCT03818035|450868912|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
125337660|NCT03818035|450868913|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
125337661|NCT03818035|450868914|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
125337662|NCT03818035|450868911|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
125337663|NCT03818035|450868912|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
125337664|NCT03818035|450868913|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
125337665|NCT03818035|450868914|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
125337666|NCT03818035|450868911|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
125337667|NCT03818035|450868912|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
125337668|NCT03818035|450868913|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
125337669|NCT03818035|450868914|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
125337670|NCT03818035|450868911|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
125671189|NCT02669264|452083502|FG003|Overall Study|Death|3|||
125671190|NCT02669264|452083503|FG004|Overall Study|Death|3|||
125671191|NCT02669264|452083504|FG005|Overall Study|Death|6|||
125671192|NCT02669264|452083505|FG006|Overall Study|Death|3|||
125671193|NCT02669264|452083499|FG000|Overall Study|Withdrawal by Subject|0|||
125671194|NCT02669264|452083500|FG001|Overall Study|Withdrawal by Subject|1|||
125671195|NCT02669264|452083501|FG002|Overall Study|Withdrawal by Subject|0|||
125671196|NCT02669264|452083502|FG003|Overall Study|Withdrawal by Subject|0|||
125671197|NCT02669264|452083503|FG004|Overall Study|Withdrawal by Subject|1|||
125671198|NCT02669264|452083504|FG005|Overall Study|Withdrawal by Subject|0|||
125671199|NCT02669264|452083505|FG006|Overall Study|Withdrawal by Subject|0|||
125671200|NCT02669264|452083499|FG000|Overall Study|Lost to Follow-up|0|||
125671201|NCT02669264|452083500|FG001|Overall Study|Lost to Follow-up|0|||
125671202|NCT02669264|452083501|FG002|Overall Study|Lost to Follow-up|0|||
125671203|NCT02669264|452083502|FG003|Overall Study|Lost to Follow-up|0|||
125671204|NCT02669264|452083503|FG004|Overall Study|Lost to Follow-up|1|||
125671205|NCT02669264|452083504|FG005|Overall Study|Lost to Follow-up|0|||
125671206|NCT02669264|452083505|FG006|Overall Study|Lost to Follow-up|0|||
125671207|NCT02669264|452083499|FG000|Overall Study|Miscellaneous|0|||
125671208|NCT02669264|452083500|FG001|Overall Study|Miscellaneous|0|||
125671209|NCT02669264|452083501|FG002|Overall Study|Miscellaneous|0|||
125671210|NCT02669264|452083502|FG003|Overall Study|Miscellaneous|0|||
125671211|NCT02669264|452083503|FG004|Overall Study|Miscellaneous|0|||
125671212|NCT02669264|452083504|FG005|Overall Study|Miscellaneous|0|||
125671213|NCT02669264|452083505|FG006|Overall Study|Miscellaneous|2|||
125671214|NCT01688037|452083506|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
125671215|NCT01688037|452083507|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
125671216|NCT01688037|452083508|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
125671217|NCT01688037|452083506|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
125671218|NCT01688037|452083507|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
125671219|NCT01688037|452083508|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
125671220|NCT01688037|452083506|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
125671221|NCT01688037|452083507|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
125671222|NCT01688037|452083508|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
125337671|NCT03818035|450868912|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
125337672|NCT03818035|450868913|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
125337673|NCT03818035|450868914|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
125337674|NCT03818035|450868911|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
125337675|NCT03818035|450868912|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
125337676|NCT03818035|450868913|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
125337677|NCT03818035|450868914|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
125337678|NCT03374202|450868917|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
125337679|NCT03374202|450868918|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
125337680|NCT03374202|450868919|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
125337681|NCT03374202|450868917|FG000|Five Year Long Term Follow Up|Death|0|||
125337682|NCT03374202|450868918|FG001|Five Year Long Term Follow Up|Death|1|||
125337683|NCT03374202|450868919|FG002|Five Year Long Term Follow Up|Death|0|||
125337684|NCT01395524|450870292|FG000|Overall Study|Non-compliance with study schedule|1|||
125671223|NCT01688037|452083506|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
125671224|NCT01688037|452083507|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
125671225|NCT01688037|452083508|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
125671226|NCT01688037|452083506|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
125671227|NCT01688037|452083507|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
125671228|NCT01688037|452083508|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
125671229|NCT01688037|452083506|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
125671230|NCT01688037|452083507|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
125671231|NCT01688037|452083508|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
125671232|NCT01688037|452083506|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
125671233|NCT01688037|452083507|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
125671234|NCT01688037|452083508|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
125671235|NCT01688037|452083506|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
125671236|NCT01688037|452083507|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
125671237|NCT01688037|452083508|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
125671238|NCT01688037|452083506|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
125671239|NCT01688037|452083507|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
125671240|NCT01688037|452083508|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
125671241|NCT01688037|452083506|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
125671242|NCT01688037|452083507|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
125671243|NCT01688037|452083508|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
125671244|NCT03280537|452083511|FG000|Overall Study|Withdrawal by Subject|2|||
125671245|NCT03280537|452083512|FG001|Overall Study|Withdrawal by Subject|4|||
125671246|NCT01588106|452083513|FG000|Overall Study|Withdrawal by Subject|5|||
125671247|NCT01588106|452083514|FG001|Overall Study|Withdrawal by Subject|4|||
125671248|NCT03083132|452083515|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
125671249|NCT03083132|452083516|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
125671250|NCT03083132|452083515|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
125671251|NCT03083132|452083516|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
125671252|NCT03083132|452083515|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
125671253|NCT03083132|452083516|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
125671254|NCT02995837|452083517|FG000|Overall Study|Lost to Follow-up|9|||
125671255|NCT02995837|452083518|FG001|Overall Study|Lost to Follow-up|8|||
125671256|NCT02482805|452085118|FG000|Overall Study|Lost to Follow-up|4|||
125671257|NCT02482805|452085119|FG001|Overall Study|Lost to Follow-up|4|||
125671258|NCT02482805|452085120|FG002|Overall Study|Lost to Follow-up|0|||
125671259|NCT01144663|452085123|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
125671260|NCT01144663|452085124|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
125671261|NCT01144663|452085125|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
125671262|NCT01144663|452085126|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
125671263|NCT01144663|452085123|FG000|Primary Vaccination Phase|Adverse Event|1|||
125671264|NCT01144663|452085124|FG001|Primary Vaccination Phase|Adverse Event|0|||
125671265|NCT01144663|452085125|FG002|Primary Vaccination Phase|Adverse Event|0|||
125671266|NCT01144663|452085126|FG003|Primary Vaccination Phase|Adverse Event|1|||
125671267|NCT01144663|452085123|FG000|Primary Vaccination Phase|Protocol Violation|2|||
125671268|NCT01144663|452085124|FG001|Primary Vaccination Phase|Protocol Violation|0|||
125671269|NCT01144663|452085125|FG002|Primary Vaccination Phase|Protocol Violation|1|||
125671270|NCT01144663|452085126|FG003|Primary Vaccination Phase|Protocol Violation|0|||
125671271|NCT01144663|452085123|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
125671272|NCT01144663|452085124|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
125671273|NCT01144663|452085125|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
125671274|NCT01144663|452085126|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
125671275|NCT01144663|452085123|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
125671276|NCT01144663|452085124|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
125671277|NCT01144663|452085125|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
125671278|NCT01144663|452085126|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
125671279|NCT01144663|452085123|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
125671280|NCT01144663|452085124|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
125671281|NCT01144663|452085125|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
125671282|NCT01144663|452085126|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
125671283|NCT01144663|452085123|FG000|Primary Vaccination Phase|Other|0|||
125671284|NCT01144663|452085124|FG001|Primary Vaccination Phase|Other|1|||
125671285|NCT01144663|452085125|FG002|Primary Vaccination Phase|Other|0|||
125671286|NCT01144663|452085126|FG003|Primary Vaccination Phase|Other|2|||
125671287|NCT01144663|452085123|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
125671288|NCT01144663|452085124|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
125671289|NCT01144663|452085125|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
125671290|NCT01144663|452085126|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
125671291|NCT01144663|452085123|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
125671292|NCT01144663|452085124|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
125671293|NCT01144663|452085125|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
125671294|NCT01144663|452085126|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
125671295|NCT01144663|452085123|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
125671296|NCT01144663|452085124|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
125671297|NCT01144663|452085125|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
125671298|NCT01144663|452085126|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
125671299|NCT01144663|452085123|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
125671300|NCT01144663|452085124|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
125671301|NCT01144663|452085125|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
125671302|NCT01144663|452085126|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
125671303|NCT01144663|452085123|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
125671304|NCT01144663|452085124|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
125671305|NCT01144663|452085125|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
125671306|NCT01144663|452085126|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
125671307|NCT01144663|452085123|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
125671308|NCT01144663|452085124|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
125671309|NCT01144663|452085125|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
125671310|NCT01144663|452085126|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
125671311|NCT01335477|452085128|FG000|Overall Study|Adverse Event|30|||
125671312|NCT01335477|452085129|FG001|Overall Study|Adverse Event|42|||
125671313|NCT01335477|452085128|FG000|Overall Study|Non compliant with protocol|0|||
125671314|NCT01335477|452085129|FG001|Overall Study|Non compliant with protocol|2|||
125671315|NCT01335477|452085128|FG000|Overall Study|Lost to Follow-up|1|||
125671316|NCT01335477|452085129|FG001|Overall Study|Lost to Follow-up|2|||
125671317|NCT01335477|452085128|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
125671318|NCT01335477|452085129|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
125671319|NCT01335477|452085128|FG000|Overall Study|Not treated|1|||
125671320|NCT01335477|452085129|FG001|Overall Study|Not treated|2|||
125671321|NCT01335477|452085128|FG000|Overall Study|Reason other than those stated above|2|||
125671322|NCT01335477|452085129|FG001|Overall Study|Reason other than those stated above|2|||
125671323|NCT01007916|452085130|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
125671324|NCT01007916|452085131|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
125671325|NCT01007916|452085130|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
125671326|NCT01007916|452085131|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
125671327|NCT02040428|452085135|FG000|Overall Study|Death|4|||
125671328|NCT02040428|452085136|FG001|Overall Study|Death|3|||
125671329|NCT02040428|452085135|FG000|Overall Study|Withdrawal by Subject|1|||
125671330|NCT02040428|452085136|FG001|Overall Study|Withdrawal by Subject|1|||
125671331|NCT01927757|452085156|FG000|Overall Study|Withdrawal by Subject|14|||
125671332|NCT01927757|452085156|FG000|Overall Study|Lost to Follow-up|2|||
125671333|NCT01927757|452085156|FG000|Overall Study|Decision by Sponsor|2|||
125671334|NCT01927757|452085156|FG000|Overall Study|Other|1|||
125671335|NCT01927757|452085156|FG000|Overall Study|Ethical Reasons|4|||
125671336|NCT00449072|452085158|FG000|Overall Study|Adverse Event|3|||
125671337|NCT00449072|452085159|FG001|Overall Study|Adverse Event|1|||
125671338|NCT00449072|452085158|FG000|Overall Study|Protocol Violation|14|||
125671339|NCT00449072|452085159|FG001|Overall Study|Protocol Violation|12|||
125671340|NCT00449072|452085158|FG000|Overall Study|Lost to Follow-up|5|||
125671341|NCT00449072|452085159|FG001|Overall Study|Lost to Follow-up|7|||
125671342|NCT00449072|452085158|FG000|Overall Study|Withdrawal by Subject|11|||
125671343|NCT00449072|452085159|FG001|Overall Study|Withdrawal by Subject|8|||
125671344|NCT00449072|452085158|FG000|Overall Study|Lack of Efficacy|1|||
125671345|NCT00449072|452085159|FG001|Overall Study|Lack of Efficacy|1|||
125671346|NCT00449072|452085158|FG000|Overall Study|Physician Decision|1|||
125671347|NCT00449072|452085159|FG001|Overall Study|Physician Decision|0|||
125671348|NCT00449072|452085158|FG000|Overall Study|Not treated|0|||
125671349|NCT00449072|452085159|FG001|Overall Study|Not treated|1|||
125671350|NCT00449072|452085158|FG000|Overall Study|Excluded medication|0|||
125671351|NCT00449072|452085159|FG001|Overall Study|Excluded medication|2|||
125671352|NCT00449072|452085158|FG000|Overall Study|Non-compliance|2|||
125671353|NCT00449072|452085159|FG001|Overall Study|Non-compliance|5|||
125671354|NCT00449072|452085158|FG000|Overall Study|Sponsor decision|1|||
125671355|NCT00449072|452085159|FG001|Overall Study|Sponsor decision|3|||
125671356|NCT00449072|452085158|FG000|Overall Study|Relocation|3|||
125671357|NCT00449072|452085159|FG001|Overall Study|Relocation|2|||
125671358|NCT02022007|452085162|FG000|Overall Study|Withdrawal by Subject|1|||
125671359|NCT02022007|452085163|FG001|Overall Study|Withdrawal by Subject|1|||
125671360|NCT02022007|452085164|FG002|Overall Study|Withdrawal by Subject|1|||
125671361|NCT02022007|452085162|FG000|Overall Study|Noncompliant|0|||
125671362|NCT02022007|452085163|FG001|Overall Study|Noncompliant|0|||
125671363|NCT02022007|452085164|FG002|Overall Study|Noncompliant|1|||
125671364|NCT02087046|452085165|FG000|Overall Study|Adverse Event|4|||
125671365|NCT02087046|452085165|FG000|Overall Study|Death|1|||
125671366|NCT02087046|452085165|FG000|Overall Study|Lost to Follow-up|3|||
125671367|NCT02087046|452085165|FG000|Overall Study|Withdrawal by Subject|2|||
125671368|NCT02087046|452085165|FG000|Overall Study|Physician Decision|1|||
125671369|NCT01107535|452085166|FG000|Overall Study|Death|5|||
125671370|NCT01507896|452085167|FG000|Overall Study|Withdrawal by Subject|1|||
125671371|NCT01507896|452085167|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
125671372|NCT00192296|452085174|FG000|Overall Study|Withdrawal by Subject|0|||
125671373|NCT00192296|452085175|FG001|Overall Study|Withdrawal by Subject|1|||
125671374|NCT00192296|452085176|FG002|Overall Study|Withdrawal by Subject|0|||
125337685|NCT01395524|450870293|FG001|Overall Study|Non-compliance with study schedule|0|||
125337686|NCT01395524|450870294|FG002|Overall Study|Non-compliance with study schedule|1|||
125337687|NCT01395524|450870292|FG000|Overall Study|Lost to Follow-up|3|||
125337688|NCT01395524|450870293|FG001|Overall Study|Lost to Follow-up|1|||
125337689|NCT01395524|450870294|FG002|Overall Study|Lost to Follow-up|1|||
125337690|NCT01395524|450870292|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
125337691|NCT01395524|450870293|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
125337692|NCT01395524|450870294|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
125337693|NCT01395524|450870292|FG000|Overall Study|Severe noncompliance with protocol|1|||
125337694|NCT01395524|450870293|FG001|Overall Study|Severe noncompliance with protocol|0|||
125337695|NCT01395524|450870294|FG002|Overall Study|Severe noncompliance with protocol|0|||
125337696|NCT01395524|450870292|FG000|Overall Study|Adverse Event|4|||
125337697|NCT01395524|450870293|FG001|Overall Study|Adverse Event|4|||
125337698|NCT01395524|450870294|FG002|Overall Study|Adverse Event|3|||
125337699|NCT01395524|450870292|FG000|Overall Study|Death|1|||
125337700|NCT01395524|450870293|FG001|Overall Study|Death|0|||
125337701|NCT01395524|450870294|FG002|Overall Study|Death|0|||
125337702|NCT01395524|450870292|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
125337703|NCT01395524|450870293|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
125337704|NCT01395524|450870294|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
125337705|NCT01395524|450870292|FG000|Overall Study|Withdrawal by Subject|4|||
125337706|NCT01395524|450870293|FG001|Overall Study|Withdrawal by Subject|8|||
125337707|NCT01395524|450870294|FG002|Overall Study|Withdrawal by Subject|8|||
125337708|NCT01395524|450870292|FG000|Overall Study|Did not receive treatment|1|||
125337709|NCT01395524|450870293|FG001|Overall Study|Did not receive treatment|1|||
125337710|NCT01395524|450870294|FG002|Overall Study|Did not receive treatment|3|||
125337711|NCT01395524|450870292|FG000|Overall Study|Subject had spinal surgery|0|||
125337712|NCT01395524|450870293|FG001|Overall Study|Subject had spinal surgery|0|||
125337713|NCT01395524|450870294|FG002|Overall Study|Subject had spinal surgery|1|||
125337714|NCT01657461|450870295|FG000|Overall Study|Death|9|||
125337715|NCT01657461|450870296|FG001|Overall Study|Death|12|||
125337716|NCT01657461|450870295|FG000|Overall Study|Lost to Follow-up|0|||
125337717|NCT01657461|450870296|FG001|Overall Study|Lost to Follow-up|3|||
125337718|NCT01657461|450870295|FG000|Overall Study|Physician Decision|0|||
125337719|NCT01657461|450870296|FG001|Overall Study|Physician Decision|2|||
125337720|NCT01657461|450870295|FG000|Overall Study|Withdrawal by Subject|1|||
125337721|NCT01657461|450870296|FG001|Overall Study|Withdrawal by Subject|3|||
125337722|NCT00295880|450870305|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
125337723|NCT00295880|450870305|FG000|Overall Study|Unit randomization did not occur|1|||
125337724|NCT00843284|450870306|FG000|Overall Study|Adverse Event|39|||
125671375|NCT00192296|452085177|FG003|Overall Study|Withdrawal by Subject|0|||
125671376|NCT00818623|452085178|FG000|Overall Study|Adverse Event|1|||
125671377|NCT00818623|452085179|FG001|Overall Study|Adverse Event|0|||
125671378|NCT00818623|452085180|FG002|Overall Study|Adverse Event|1|||
125671379|NCT00818623|452085181|FG003|Overall Study|Adverse Event|0|||
125671380|NCT00818623|452085182|FG004|Overall Study|Adverse Event|0|||
125671381|NCT00818623|452085183|FG005|Overall Study|Adverse Event|1|||
125671382|NCT00818623|452085184|FG006|Overall Study|Adverse Event|0|||
125671383|NCT00818623|452085185|FG007|Overall Study|Adverse Event|0|||
125671384|NCT00818623|452085178|FG000|Overall Study|Bad prostate specific antigen response|0|||
125671385|NCT00818623|452085179|FG001|Overall Study|Bad prostate specific antigen response|3|||
125671386|NCT00818623|452085180|FG002|Overall Study|Bad prostate specific antigen response|2|||
125671387|NCT00818623|452085181|FG003|Overall Study|Bad prostate specific antigen response|5|||
125671388|NCT00818623|452085182|FG004|Overall Study|Bad prostate specific antigen response|0|||
125671389|NCT00818623|452085183|FG005|Overall Study|Bad prostate specific antigen response|1|||
125671390|NCT00818623|452085184|FG006|Overall Study|Bad prostate specific antigen response|0|||
125671391|NCT00818623|452085185|FG007|Overall Study|Bad prostate specific antigen response|0|||
125671392|NCT00818623|452085178|FG000|Overall Study|Withdrawal by Subject|0|||
125671393|NCT00818623|452085179|FG001|Overall Study|Withdrawal by Subject|1|||
125671394|NCT00818623|452085180|FG002|Overall Study|Withdrawal by Subject|1|||
125671395|NCT00818623|452085181|FG003|Overall Study|Withdrawal by Subject|0|||
125671396|NCT00818623|452085182|FG004|Overall Study|Withdrawal by Subject|0|||
125671397|NCT00818623|452085183|FG005|Overall Study|Withdrawal by Subject|1|||
125671398|NCT00818623|452085184|FG006|Overall Study|Withdrawal by Subject|1|||
125671399|NCT00818623|452085185|FG007|Overall Study|Withdrawal by Subject|1|||
125671400|NCT00818623|452085178|FG000|Overall Study|Protocol Violation|1|||
125671401|NCT00818623|452085179|FG001|Overall Study|Protocol Violation|0|||
125671402|NCT00818623|452085180|FG002|Overall Study|Protocol Violation|0|||
125671403|NCT00818623|452085181|FG003|Overall Study|Protocol Violation|0|||
125671404|NCT00818623|452085182|FG004|Overall Study|Protocol Violation|1|||
125671405|NCT00818623|452085183|FG005|Overall Study|Protocol Violation|0|||
125671406|NCT00818623|452085184|FG006|Overall Study|Protocol Violation|1|||
125671407|NCT00818623|452085185|FG007|Overall Study|Protocol Violation|0|||
125671408|NCT00818623|452085178|FG000|Overall Study|Need of additional treatment|0|||
125671409|NCT00818623|452085179|FG001|Overall Study|Need of additional treatment|0|||
125671410|NCT00818623|452085180|FG002|Overall Study|Need of additional treatment|0|||
125671411|NCT00818623|452085181|FG003|Overall Study|Need of additional treatment|0|||
125671412|NCT00818623|452085182|FG004|Overall Study|Need of additional treatment|1|||
125671413|NCT00818623|452085183|FG005|Overall Study|Need of additional treatment|0|||
125671414|NCT00818623|452085184|FG006|Overall Study|Need of additional treatment|0|||
125671415|NCT00818623|452085185|FG007|Overall Study|Need of additional treatment|0|||
125671416|NCT00818623|452085178|FG000|Overall Study|Lack of trial drug at site|0|||
125671417|NCT00818623|452085179|FG001|Overall Study|Lack of trial drug at site|0|||
125671418|NCT00818623|452085180|FG002|Overall Study|Lack of trial drug at site|0|||
125671419|NCT00818623|452085181|FG003|Overall Study|Lack of trial drug at site|0|||
125671420|NCT00818623|452085182|FG004|Overall Study|Lack of trial drug at site|2|||
125671421|NCT00818623|452085183|FG005|Overall Study|Lack of trial drug at site|0|||
125337725|NCT00843284|450870306|FG000|Overall Study|Lack of Efficacy|5|||
125337726|NCT00843284|450870306|FG000|Overall Study|Lost to Follow-up|11|||
125671422|NCT00818623|452085184|FG006|Overall Study|Lack of trial drug at site|1|||
125671423|NCT00818623|452085185|FG007|Overall Study|Lack of trial drug at site|0|||
125671424|NCT00818623|452085178|FG000|Overall Study|Disease progression|0|||
125337727|NCT00843284|450870306|FG000|Overall Study|Other|10|||
125337728|NCT00843284|450870306|FG000|Overall Study|Withdrawal by Subject|4|||
125337729|NCT00843284|450870306|FG000|Overall Study|Death|3|||
125337730|NCT01761162|450870313|FG000|Overall Study|Withdrawal by Subject|3|||
125337731|NCT02160899|450870322|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
125337732|NCT02160899|450870323|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
125671425|NCT00818623|452085179|FG001|Overall Study|Disease progression|0|||
125671426|NCT00818623|452085180|FG002|Overall Study|Disease progression|0|||
125671427|NCT00818623|452085181|FG003|Overall Study|Disease progression|0|||
125671428|NCT00818623|452085182|FG004|Overall Study|Disease progression|0|||
125671429|NCT00818623|452085183|FG005|Overall Study|Disease progression|0|||
125671430|NCT00818623|452085184|FG006|Overall Study|Disease progression|1|||
125671431|NCT00818623|452085185|FG007|Overall Study|Disease progression|0|||
125671432|NCT02649231|452085189|FG000|Overall Study|Adverse Event|0|||
125671433|NCT02649231|452085190|FG001|Overall Study|Adverse Event|0|||
125671434|NCT02649231|452085191|FG002|Overall Study|Adverse Event|0|||
125671435|NCT02649231|452085192|FG003|Overall Study|Adverse Event|1|||
125671436|NCT02649231|452085189|FG000|Overall Study|Lost to Follow-up|2|||
125671437|NCT02649231|452085190|FG001|Overall Study|Lost to Follow-up|1|||
125671438|NCT02649231|452085191|FG002|Overall Study|Lost to Follow-up|1|||
125671439|NCT02649231|452085192|FG003|Overall Study|Lost to Follow-up|0|||
125671440|NCT02649231|452085189|FG000|Overall Study|Withdrawal by Subject|0|||
125671441|NCT02649231|452085190|FG001|Overall Study|Withdrawal by Subject|1|||
125671442|NCT02649231|452085191|FG002|Overall Study|Withdrawal by Subject|0|||
125671443|NCT02649231|452085192|FG003|Overall Study|Withdrawal by Subject|1|||
125671444|NCT02649231|452085189|FG000|Overall Study|Protocol Violation|2|||
125671445|NCT02649231|452085190|FG001|Overall Study|Protocol Violation|1|||
125671446|NCT02649231|452085191|FG002|Overall Study|Protocol Violation|1|||
125671447|NCT02649231|452085192|FG003|Overall Study|Protocol Violation|0|||
125671448|NCT00543439|452085194|FG000|Period 1|Adverse Event|0|||
125671449|NCT00543439|452085195|FG001|Period 1|Adverse Event|2|||
125671450|NCT00543439|452085196|FG002|Period 1|Adverse Event|1|||
125671451|NCT00543439|452085194|FG000|Period 1|Withdrawal by Subject|1|||
125671452|NCT00543439|452085195|FG001|Period 1|Withdrawal by Subject|1|||
125671453|NCT00543439|452085196|FG002|Period 1|Withdrawal by Subject|0|||
125671454|NCT00543439|452085194|FG000|Period 1|Physician Decision|0|||
125671455|NCT00543439|452085195|FG001|Period 1|Physician Decision|0|||
125671456|NCT00543439|452085196|FG002|Period 1|Physician Decision|1|||
125671457|NCT00543439|452085194|FG000|Period 2|Protocol Violation|1|||
125671458|NCT00543439|452085195|FG001|Period 2|Protocol Violation|0|||
125671459|NCT00543439|452085196|FG002|Period 2|Protocol Violation|1|||
125671460|NCT00543439|452085194|FG000|Period 2|Adverse Event|0|||
125671461|NCT00543439|452085195|FG001|Period 2|Adverse Event|1|||
125671462|NCT00543439|452085196|FG002|Period 2|Adverse Event|1|||
125671463|NCT00686036|452085198|FG000|Overall Study|Adverse Event|3|||
125671464|NCT00686036|452085199|FG001|Overall Study|Adverse Event|0|||
125671465|NCT00686036|452085198|FG000|Overall Study|Withdrawal by Subject|3|||
125671466|NCT00686036|452085199|FG001|Overall Study|Withdrawal by Subject|1|||
125671467|NCT00686036|452085198|FG000|Overall Study|Study terminated by AstraZeneca|2|||
125671468|NCT00686036|452085199|FG001|Overall Study|Study terminated by AstraZeneca|1|||
125671469|NCT00686036|452085198|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
125671470|NCT00686036|452085199|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
125671471|NCT00686036|452085198|FG000|Overall Study|Other reasons not identified|0|||
125671472|NCT00686036|452085199|FG001|Overall Study|Other reasons not identified|4|||
125671473|NCT01185288|452085202|FG000|Overall Study|Adverse Event|7|||
125671474|NCT01185288|452085203|FG001|Overall Study|Adverse Event|6|||
125671475|NCT01185288|452085202|FG000|Overall Study|Withdrawal by Subject|6|||
125671476|NCT01185288|452085203|FG001|Overall Study|Withdrawal by Subject|4|||
125671477|NCT01185288|452085202|FG000|Overall Study|Lost to Follow-up|2|||
125671478|NCT01185288|452085203|FG001|Overall Study|Lost to Follow-up|5|||
125671479|NCT01185288|452085202|FG000|Overall Study|Lack of Efficacy|2|||
125671480|NCT01185288|452085203|FG001|Overall Study|Lack of Efficacy|0|||
125671481|NCT01185288|452085202|FG000|Overall Study|Investigator discretion|1|||
125671482|NCT01185288|452085203|FG001|Overall Study|Investigator discretion|0|||
125671483|NCT01185288|452085202|FG000|Overall Study|Did not meet inclusion criteria|1|||
125671484|NCT01185288|452085203|FG001|Overall Study|Did not meet inclusion criteria|0|||
125671485|NCT01185288|452085202|FG000|Overall Study|Noncompliance|0|||
125671486|NCT01185288|452085203|FG001|Overall Study|Noncompliance|1|||
125671487|NCT01626885|452085206|FG000|Overall Study|Adverse Event|8|||
125671488|NCT01626885|452085206|FG000|Overall Study|Withdrawal by Subject|4|||
125671489|NCT00673790|452085207|FG000|Overall Study|Adverse Event|23|||
125671490|NCT00673790|452085208|FG001|Overall Study|Adverse Event|14|||
125671491|NCT00673790|452085209|FG002|Overall Study|Adverse Event|2|||
125671492|NCT00673790|452085207|FG000|Overall Study|Lack of Efficacy|2|||
125671493|NCT00673790|452085208|FG001|Overall Study|Lack of Efficacy|2|||
125671494|NCT00673790|452085209|FG002|Overall Study|Lack of Efficacy|2|||
125337733|NCT02160899|450870324|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
125671495|NCT00673790|452085207|FG000|Overall Study|Protocol Violation|6|||
125671496|NCT00673790|452085208|FG001|Overall Study|Protocol Violation|9|||
125671497|NCT00673790|452085209|FG002|Overall Study|Protocol Violation|1|||
125337734|NCT02160899|450870325|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
125337735|NCT02160899|450870326|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
125337736|NCT02160899|450870327|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
125671498|NCT00673790|452085207|FG000|Overall Study|Withdrawal by Subject|7|||
125671499|NCT00673790|452085208|FG001|Overall Study|Withdrawal by Subject|4|||
125671500|NCT00673790|452085209|FG002|Overall Study|Withdrawal by Subject|1|||
125671501|NCT00673790|452085207|FG000|Overall Study|Lost to Follow-up|6|||
125671502|NCT00673790|452085208|FG001|Overall Study|Lost to Follow-up|6|||
125671503|NCT00673790|452085209|FG002|Overall Study|Lost to Follow-up|5|||
125671504|NCT00673790|452085207|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
125671505|NCT00673790|452085208|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
125671506|NCT00673790|452085209|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
125671507|NCT00673790|452085207|FG000|Overall Study|Poor compliance|1|||
125671508|NCT00673790|452085208|FG001|Overall Study|Poor compliance|0|||
125671509|NCT00673790|452085209|FG002|Overall Study|Poor compliance|0|||
125671510|NCT00673790|452085207|FG000|Overall Study|Participated in two Nebivolol studies|0|||
125671511|NCT00673790|452085208|FG001|Overall Study|Participated in two Nebivolol studies|0|||
125671512|NCT00673790|452085209|FG002|Overall Study|Participated in two Nebivolol studies|1|||
125671513|NCT00673790|452085207|FG000|Overall Study|Unconfirmed pregnancy|0|||
125671514|NCT00673790|452085208|FG001|Overall Study|Unconfirmed pregnancy|1|||
125671515|NCT00673790|452085209|FG002|Overall Study|Unconfirmed pregnancy|0|||
125671516|NCT00673790|452085207|FG000|Overall Study|Randomization criteria not met|0|||
125671517|NCT00673790|452085208|FG001|Overall Study|Randomization criteria not met|1|||
125671518|NCT00673790|452085209|FG002|Overall Study|Randomization criteria not met|0|||
125671519|NCT01533428|452085210|FG000|Overall Study|Adverse Event|0|||
125671520|NCT01533428|452085211|FG001|Overall Study|Adverse Event|1|||
125671521|NCT01533428|452085210|FG000|Overall Study|Lost to Follow-up|2|||
125671522|NCT01533428|452085211|FG001|Overall Study|Lost to Follow-up|1|||
125671523|NCT01533428|452085210|FG000|Overall Study|Withdrawal by Subject|7|||
125671524|NCT01533428|452085211|FG001|Overall Study|Withdrawal by Subject|6|||
125671525|NCT01364870|452085212|FG000|Overall Study|Withdrawal by Subject|13|||
125671526|NCT01364870|452085213|FG001|Overall Study|Withdrawal by Subject|24|||
125671527|NCT01364870|452085214|FG002|Overall Study|Withdrawal by Subject|10|||
125671528|NCT01364870|452085212|FG000|Overall Study|Adverse Event|8|||
125671529|NCT01364870|452085213|FG001|Overall Study|Adverse Event|6|||
125671530|NCT01364870|452085214|FG002|Overall Study|Adverse Event|4|||
125671531|NCT01364870|452085212|FG000|Overall Study|Protocol Violation|1|||
125671532|NCT01364870|452085213|FG001|Overall Study|Protocol Violation|0|||
125671533|NCT01364870|452085214|FG002|Overall Study|Protocol Violation|0|||
125671534|NCT01200394|452085215|FG000|Overall Study|Adverse Event|0|||
125671535|NCT01200394|452085216|FG001|Overall Study|Adverse Event|14|||
125671536|NCT01200394|452085215|FG000|Overall Study|Death|1|||
125671537|NCT01200394|452085216|FG001|Overall Study|Death|0|||
125671538|NCT01200394|452085215|FG000|Overall Study|Lost to Follow-up|0|||
125671539|NCT01200394|452085216|FG001|Overall Study|Lost to Follow-up|1|||
125671540|NCT01200394|452085215|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
125671541|NCT01200394|452085216|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
125671542|NCT01200394|452085215|FG000|Overall Study|Protocol Violation|0|||
125671543|NCT01200394|452085216|FG001|Overall Study|Protocol Violation|3|||
125671544|NCT01200394|452085215|FG000|Overall Study|Withdrawal by Subject|0|||
125671545|NCT01200394|452085216|FG001|Overall Study|Withdrawal by Subject|5|||
125671546|NCT01200394|452085215|FG000|Overall Study|Other|0|||
125671547|NCT01200394|452085216|FG001|Overall Study|Other|1|||
125337737|NCT00798759|450870328|FG000|Overall Study|Adverse Event|3|||
125337738|NCT00798759|450870329|FG001|Overall Study|Adverse Event|3|||
125337739|NCT00798759|450870328|FG000|Overall Study|Lost to Follow-up|1|||
125337740|NCT00798759|450870329|FG001|Overall Study|Lost to Follow-up|1|||
125671548|NCT02666430|452085217|FG000|Period 1|Lost to Follow-up|1|||
125671549|NCT02666430|452085218|FG001|Period 1|Lost to Follow-up|0|||
125671550|NCT02666430|452085217|FG000|Period 1|Adverse Event|0|||
125671551|NCT02666430|452085218|FG001|Period 1|Adverse Event|1|||
125671552|NCT02666430|452085217|FG000|Period 2|Withdrawal by Subject|1|||
125671553|NCT02666430|452085218|FG001|Period 2|Withdrawal by Subject|4|||
125671554|NCT02666430|452085217|FG000|Period 3|Lost to Follow-up|1|||
125671555|NCT02666430|452085218|FG001|Period 3|Lost to Follow-up|0|||
125671556|NCT03828461|452085219|FG000|Overall Study|Lost to Follow-up|1|||
125671557|NCT03828461|452085219|FG000|Overall Study|Withdrawal by Subject|3|||
125671558|NCT00576199|452085220|FG000|Overall Study|Adverse Event|12|||
125671559|NCT00576199|452085220|FG000|Overall Study|Insufficient Therapeutic Response|14|||
125671560|NCT00576199|452085220|FG000|Overall Study|Refused Treatment|2|||
125671561|NCT00576199|452085220|FG000|Overall Study|Reason Unspecified|2|||
125671562|NCT03035227|452085221|FG000|Overall Study|study stopped due to PI leaving institut|1|||
125671563|NCT03035227|452085222|FG001|Overall Study|study stopped due to PI leaving institut|1|||
125671564|NCT02100956|452085223|FG000|At Least One Week Between Injections|Adverse Event|0|||
125671565|NCT02100956|452085224|FG001|At Least One Week Between Injections|Adverse Event|1|||
125671566|NCT00859469|452085226|FG000|Overall Study|Adverse Event|2|||
125671567|NCT00859469|452085226|FG000|Overall Study|Lack of Efficacy|9|||
125671568|NCT00859469|452085226|FG000|Overall Study|Withdrawal by Subject|1|||
125671569|NCT00859469|452085226|FG000|Overall Study|Death|16|||
125671570|NCT02220907|452085227|FG000|Overall Study|Adverse Event|7|||
125671571|NCT02220907|452085227|FG000|Overall Study|Physician Decision|1|||
125671572|NCT02220907|452085227|FG000|Overall Study|Withdrawal by Subject|2|||
125671573|NCT02220907|452085227|FG000|Overall Study|Conflict with the stopping criteria|1|||
125671574|NCT03111147|452085228|FG000|Overall Study|Lost to Follow-up|2|||
125671575|NCT03111147|452085229|FG001|Overall Study|Lost to Follow-up|5|||
125671576|NCT03111147|452085228|FG000|Overall Study|Withdrawal by Subject|4|||
125671577|NCT03111147|452085229|FG001|Overall Study|Withdrawal by Subject|3|||
125671578|NCT03111147|452085228|FG000|Overall Study|Protocol Violation|2|||
125671579|NCT03111147|452085229|FG001|Overall Study|Protocol Violation|1|||
125671580|NCT03111147|452085228|FG000|Overall Study|Death|1|||
125671581|NCT03111147|452085229|FG001|Overall Study|Death|1|||
125671582|NCT00095199|452085232|FG000|Overall Study|Adverse Event|40|||
125671583|NCT00095199|452085233|FG001|Overall Study|Adverse Event|22|||
125671584|NCT00095199|452085234|FG002|Overall Study|Adverse Event|26|||
125671585|NCT00095199|452085235|FG003|Overall Study|Adverse Event|11|||
125671586|NCT00095199|452085232|FG000|Overall Study|Progressive disease|213|||
125671587|NCT00095199|452085233|FG001|Overall Study|Progressive disease|179|||
125671588|NCT00095199|452085234|FG002|Overall Study|Progressive disease|105|||
125671589|NCT00095199|452085235|FG003|Overall Study|Progressive disease|98|||
125671590|NCT00095199|452085232|FG000|Overall Study|Death|10|||
125671591|NCT00095199|452085233|FG001|Overall Study|Death|6|||
125671592|NCT00095199|452085234|FG002|Overall Study|Death|11|||
125671593|NCT00095199|452085235|FG003|Overall Study|Death|9|||
125671594|NCT00095199|452085232|FG000|Overall Study|Withdrawal by Subject|21|||
125671595|NCT00095199|452085233|FG001|Overall Study|Withdrawal by Subject|16|||
125671596|NCT00095199|452085234|FG002|Overall Study|Withdrawal by Subject|13|||
125671597|NCT00095199|452085235|FG003|Overall Study|Withdrawal by Subject|22|||
125671598|NCT00095199|452085232|FG000|Overall Study|Protocol Violation|4|||
125671599|NCT00095199|452085233|FG001|Overall Study|Protocol Violation|4|||
125671600|NCT00095199|452085234|FG002|Overall Study|Protocol Violation|2|||
125671601|NCT00095199|452085235|FG003|Overall Study|Protocol Violation|0|||
125671602|NCT00095199|452085232|FG000|Overall Study|Liver function test results elevated|0|||
125671603|NCT00095199|452085233|FG001|Overall Study|Liver function test results elevated|0|||
125671604|NCT00095199|452085234|FG002|Overall Study|Liver function test results elevated|1|||
125671605|NCT00095199|452085235|FG003|Overall Study|Liver function test results elevated|1|||
125671606|NCT00095199|452085232|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
125671607|NCT00095199|452085233|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
125671608|NCT00095199|452085234|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
125671609|NCT00095199|452085235|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
125671610|NCT00095199|452085232|FG000|Overall Study|Physician Decision|5|||
125671611|NCT00095199|452085233|FG001|Overall Study|Physician Decision|6|||
125671612|NCT00095199|452085234|FG002|Overall Study|Physician Decision|1|||
125671613|NCT00095199|452085235|FG003|Overall Study|Physician Decision|1|||
125671614|NCT00095199|452085232|FG000|Overall Study|Not eligible|1|||
125671615|NCT00095199|452085233|FG001|Overall Study|Not eligible|7|||
125671616|NCT00095199|452085234|FG002|Overall Study|Not eligible|0|||
125671617|NCT00095199|452085235|FG003|Overall Study|Not eligible|1|||
125671618|NCT00095199|452085232|FG000|Overall Study|Started Palliative Radiotherapy|1|||
125671619|NCT00095199|452085233|FG001|Overall Study|Started Palliative Radiotherapy|0|||
125671620|NCT00095199|452085234|FG002|Overall Study|Started Palliative Radiotherapy|0|||
125671621|NCT00095199|452085235|FG003|Overall Study|Started Palliative Radiotherapy|0|||
125671622|NCT00095199|452085232|FG000|Overall Study|Started radiotherapy regimen|0|||
125337741|NCT00798759|450870328|FG000|Overall Study|Protocol Violation|4|||
125337742|NCT00798759|450870329|FG001|Overall Study|Protocol Violation|8|||
125337743|NCT00798759|450870328|FG000|Overall Study|Other|0|||
125337744|NCT00798759|450870329|FG001|Overall Study|Other|1|||
125337745|NCT01754727|450870330|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
125337746|NCT04518995|450870333|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
125337747|NCT04518995|450870334|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
125337748|NCT04518995|450870335|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
125337749|NCT04518995|450870333|FG000|Overall Study|Lack of Efficacy|2|||
125337750|NCT04518995|450870334|FG001|Overall Study|Lack of Efficacy|1|||
125671623|NCT00095199|452085233|FG001|Overall Study|Started radiotherapy regimen|1|||
125671624|NCT00095199|452085234|FG002|Overall Study|Started radiotherapy regimen|0|||
125671625|NCT00095199|452085235|FG003|Overall Study|Started radiotherapy regimen|0|||
125671626|NCT00095199|452085232|FG000|Overall Study|Primary tumor removed in other surgery|0|||
125671627|NCT00095199|452085233|FG001|Overall Study|Primary tumor removed in other surgery|1|||
125671628|NCT00095199|452085234|FG002|Overall Study|Primary tumor removed in other surgery|0|||
125671629|NCT00095199|452085235|FG003|Overall Study|Primary tumor removed in other surgery|0|||
125671630|NCT00095199|452085232|FG000|Overall Study|Data inadvertently lost by site|1|||
125671631|NCT00095199|452085233|FG001|Overall Study|Data inadvertently lost by site|0|||
125671632|NCT00095199|452085234|FG002|Overall Study|Data inadvertently lost by site|0|||
125671633|NCT00095199|452085235|FG003|Overall Study|Data inadvertently lost by site|0|||
125671634|NCT01896297|452085236|FG000|Overall Study|Died in post treatment phase|1|||
125671635|NCT01070394|452085237|FG000|Overall Study|Adverse Event|6|||
125671636|NCT01070394|452085237|FG000|Overall Study|Withdrawal by Subject|1|||
125671637|NCT01098240|452085238|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
125671638|NCT01098240|452085239|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
125671639|NCT01098240|452085240|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
125671640|NCT01098240|452085238|FG000|Open-Label Phase|Protocol Violation|4|||
125671641|NCT01098240|452085239|FG001|Open-Label Phase|Protocol Violation|0|||
125671642|NCT01098240|452085240|FG002|Open-Label Phase|Protocol Violation|0|||
125671643|NCT01098240|452085238|FG000|Open-Label Phase|Lost to Follow-up|13|||
125671644|NCT01098240|452085239|FG001|Open-Label Phase|Lost to Follow-up|0|||
125671645|NCT01098240|452085240|FG002|Open-Label Phase|Lost to Follow-up|0|||
125671646|NCT01098240|452085238|FG000|Open-Label Phase|Other|19|||
125671647|NCT01098240|452085239|FG001|Open-Label Phase|Other|0|||
125671648|NCT01098240|452085240|FG002|Open-Label Phase|Other|0|||
125671649|NCT01098240|452085238|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
125671650|NCT01098240|452085239|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
125671651|NCT01098240|452085240|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
125671652|NCT01098240|452085238|FG000|Open-Label Phase|Pregnancy|1|||
125671653|NCT01098240|452085239|FG001|Open-Label Phase|Pregnancy|0|||
125671654|NCT01098240|452085240|FG002|Open-Label Phase|Pregnancy|0|||
125671655|NCT01098240|452085238|FG000|Open-Label Phase|Withdrawal by Subject|9|||
125671656|NCT01098240|452085239|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125671657|NCT01098240|452085240|FG002|Open-Label Phase|Withdrawal by Subject|0|||
125671658|NCT01098240|452085238|FG000|Open-Label Phase|Adverse Event|12|||
125671659|NCT01098240|452085239|FG001|Open-Label Phase|Adverse Event|0|||
125671660|NCT01098240|452085240|FG002|Open-Label Phase|Adverse Event|0|||
125671661|NCT01098240|452085238|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
125671662|NCT01098240|452085239|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
125671663|NCT01098240|452085240|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
125671664|NCT01098240|452085238|FG000|Double-Blind Phase|Protocol Violation|0|||
125671665|NCT01098240|452085239|FG001|Double-Blind Phase|Protocol Violation|2|||
125671666|NCT01098240|452085240|FG002|Double-Blind Phase|Protocol Violation|4|||
125671667|NCT01098240|452085238|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125671668|NCT01098240|452085239|FG001|Double-Blind Phase|Lost to Follow-up|2|||
125671669|NCT01098240|452085240|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125671670|NCT01098240|452085238|FG000|Double-Blind Phase|Other|0|||
125671671|NCT01098240|452085239|FG001|Double-Blind Phase|Other|2|||
125671672|NCT01098240|452085240|FG002|Double-Blind Phase|Other|2|||
125337751|NCT04518995|450870335|FG002|Overall Study|Lack of Efficacy|0|||
125337752|NCT04518995|450870333|FG000|Overall Study|Non-compliance With Study Drug|0|||
125671673|NCT01098240|452085238|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
125671674|NCT01098240|452085239|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
125337753|NCT04518995|450870334|FG001|Overall Study|Non-compliance With Study Drug|3|||
125671675|NCT01098240|452085240|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
125671676|NCT01098240|452085238|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
125671677|NCT01098240|452085239|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
125540899|NCT01237587|451609478|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
125540900|NCT01237587|451609479|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
125540901|NCT01237587|451609478|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
125540902|NCT01237587|451609479|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
125540903|NCT01237587|451609478|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
125540904|NCT01237587|451609479|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
125540905|NCT01237587|451609478|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
125671678|NCT01098240|452085240|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
125671679|NCT01098240|452085238|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
125671680|NCT01098240|452085239|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
125671681|NCT01098240|452085240|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
125671682|NCT01098240|452085238|FG000|Double-Blind Phase|Adverse Event|0|||
125671683|NCT01098240|452085239|FG001|Double-Blind Phase|Adverse Event|3|||
125671684|NCT01098240|452085240|FG002|Double-Blind Phase|Adverse Event|3|||
125671685|NCT03118739|452085242|FG000|Overall Study|Physician Decision|0|||
125671686|NCT03118739|452085243|FG001|Overall Study|Physician Decision|1|||
125671687|NCT03118739|452085242|FG000|Overall Study|Withdrawal by Subject|5|||
125671688|NCT03118739|452085243|FG001|Overall Study|Withdrawal by Subject|3|||
125671689|NCT03118739|452085242|FG000|Overall Study|Lost to Follow-up|2|||
125337754|NCT04518995|450870335|FG002|Overall Study|Non-compliance With Study Drug|2|||
125337755|NCT04518995|450870333|FG000|Overall Study|Pregnancy|0|||
125337756|NCT04518995|450870334|FG001|Overall Study|Pregnancy|0|||
125337757|NCT04518995|450870335|FG002|Overall Study|Pregnancy|1|||
125337758|NCT04518995|450870333|FG000|Overall Study|Protocol Violation|2|||
125337759|NCT04518995|450870334|FG001|Overall Study|Protocol Violation|0|||
125337760|NCT04518995|450870335|FG002|Overall Study|Protocol Violation|1|||
125337761|NCT04518995|450870333|FG000|Overall Study|Reason not Specified|4|||
125337762|NCT04518995|450870334|FG001|Overall Study|Reason not Specified|11|||
125337763|NCT04518995|450870335|FG002|Overall Study|Reason not Specified|2|||
125337764|NCT04518995|450870333|FG000|Overall Study|Lost to Follow-up|1|||
125337765|NCT04518995|450870334|FG001|Overall Study|Lost to Follow-up|10|||
125337766|NCT04518995|450870335|FG002|Overall Study|Lost to Follow-up|6|||
125337767|NCT02891070|450870337|FG000|Overall Study|Adverse Event|1|||
125337768|NCT02891070|450870338|FG001|Overall Study|Adverse Event|0|||
125337769|NCT02891070|450870337|FG000|Overall Study|Physician Decision|0|||
125337770|NCT02891070|450870338|FG001|Overall Study|Physician Decision|1|||
125337771|NCT02891070|450870337|FG000|Overall Study|Lost to Follow-up|4|||
125337772|NCT02891070|450870338|FG001|Overall Study|Lost to Follow-up|4|||
125671690|NCT03118739|452085243|FG001|Overall Study|Lost to Follow-up|0|||
125671691|NCT00669955|452085244|FG000|Overall Study|Adverse Event|3|||
125671692|NCT00669955|452085245|FG001|Overall Study|Adverse Event|5|||
125671693|NCT00669955|452085244|FG000|Overall Study|Death|0|||
125671694|NCT00669955|452085245|FG001|Overall Study|Death|1|||
125671695|NCT00669955|452085244|FG000|Overall Study|Withdrawal by Subject|2|||
125671696|NCT00669955|452085245|FG001|Overall Study|Withdrawal by Subject|3|||
125671697|NCT00669955|452085244|FG000|Overall Study|Lost to Follow-up|5|||
125671698|NCT00669955|452085245|FG001|Overall Study|Lost to Follow-up|7|||
125671699|NCT00669955|452085244|FG000|Overall Study|Protocol Violation|2|||
125671700|NCT00669955|452085245|FG001|Overall Study|Protocol Violation|7|||
125671701|NCT00669955|452085244|FG000|Overall Study|Investigator Sponsor Judgement|0|||
125671702|NCT00669955|452085245|FG001|Overall Study|Investigator Sponsor Judgement|1|||
125671703|NCT00669955|452085244|FG000|Overall Study|not compliant with study drug/visit|2|||
125671704|NCT00669955|452085245|FG001|Overall Study|not compliant with study drug/visit|3|||
125671705|NCT04317053|452085250|FG000|Overall Study|Withdrawn (screen failure)|4|||
125671706|NCT04317053|452085251|FG001|Overall Study|Withdrawn (screen failure)|2|||
125671707|NCT01077713|452085252|FG000|Overall Study|Withdrawal by Subject|1|||
125671708|NCT01077713|452085253|FG001|Overall Study|Withdrawal by Subject|2|||
125671709|NCT01077713|452085252|FG000|Overall Study|Progressive Disease (PD)|0|||
125671710|NCT01077713|452085253|FG001|Overall Study|Progressive Disease (PD)|1|||
125671711|NCT01077713|452085252|FG000|Overall Study|Death|28|||
125671712|NCT01077713|452085253|FG001|Overall Study|Death|29|||
125671713|NCT01077713|452085252|FG000|Overall Study|Lost to Follow-up|1|||
125671714|NCT01077713|452085253|FG001|Overall Study|Lost to Follow-up|1|||
125671715|NCT01077713|452085252|FG000|Overall Study|Adverse Event|2|||
125671716|NCT01077713|452085253|FG001|Overall Study|Adverse Event|1|||
125671717|NCT01077713|452085252|FG000|Overall Study|Other|4|||
125671718|NCT01077713|452085253|FG001|Overall Study|Other|2|||
125671719|NCT03507439|452085254|FG000|Overall Study|Other|2|||
125671720|NCT03507439|452085255|FG001|Overall Study|Other|1|||
125671721|NCT03507439|452085254|FG000|Overall Study|Withdrawal by Subject|1|||
125671722|NCT03507439|452085255|FG001|Overall Study|Withdrawal by Subject|0|||
125671723|NCT03507439|452085254|FG000|Overall Study|Death|1|||
125671724|NCT03507439|452085255|FG001|Overall Study|Death|1|||
125671725|NCT00289458|452085256|FG000|Overall Study|Death|1|||
125671726|NCT00289458|452085257|FG001|Overall Study|Death|0|||
125671727|NCT00289458|452085258|FG002|Overall Study|Death|0|||
125671728|NCT00289458|452085256|FG000|Overall Study|Physician Decision|3|||
125671729|NCT00289458|452085257|FG001|Overall Study|Physician Decision|4|||
125671730|NCT00289458|452085258|FG002|Overall Study|Physician Decision|2|||
125671731|NCT00289458|452085256|FG000|Overall Study|Withdrawal by Subject|2|||
125671732|NCT00289458|452085257|FG001|Overall Study|Withdrawal by Subject|2|||
125671733|NCT00289458|452085258|FG002|Overall Study|Withdrawal by Subject|4|||
125671734|NCT04274192|452085259|FG000|Overall Study|Protocol Violation|1|||
125671735|NCT04274192|452085260|FG001|Overall Study|Protocol Violation|0|||
125671736|NCT01621490|452086911|FG000|Overall Study|Subject no longer meets study criteria|0|||
125671737|NCT01621490|452086912|FG001|Overall Study|Subject no longer meets study criteria|0|||
125671738|NCT01621490|452086913|FG002|Overall Study|Subject no longer meets study criteria|0|||
125671739|NCT01621490|452086914|FG003|Overall Study|Subject no longer meets study criteria|0|||
125671740|NCT01621490|452086915|FG004|Overall Study|Subject no longer meets study criteria|1|||
125671741|NCT01621490|452086916|FG005|Overall Study|Subject no longer meets study criteria|0|||
125671742|NCT01621490|452086917|FG006|Overall Study|Subject no longer meets study criteria|0|||
125671743|NCT01621490|452086918|FG007|Overall Study|Subject no longer meets study criteria|0|||
125671744|NCT01621490|452086919|FG008|Overall Study|Subject no longer meets study criteria|0|||
125671745|NCT01621490|452086920|FG009|Overall Study|Subject no longer meets study criteria|0|||
125671746|NCT01621490|452086921|FG010|Overall Study|Subject no longer meets study criteria|0|||
125671747|NCT01621490|452086911|FG000|Overall Study|Maximum clinical benefit|3|||
125671748|NCT01621490|452086912|FG001|Overall Study|Maximum clinical benefit|2|||
125671749|NCT01621490|452086913|FG002|Overall Study|Maximum clinical benefit|0|||
125671750|NCT01621490|452086914|FG003|Overall Study|Maximum clinical benefit|0|||
125671751|NCT01621490|452086915|FG004|Overall Study|Maximum clinical benefit|0|||
125671752|NCT01621490|452086916|FG005|Overall Study|Maximum clinical benefit|0|||
125671753|NCT01621490|452086917|FG006|Overall Study|Maximum clinical benefit|1|||
125671754|NCT01621490|452086918|FG007|Overall Study|Maximum clinical benefit|2|||
125337773|NCT02891070|450870337|FG000|Overall Study|Other|1|||
125671755|NCT01621490|452086919|FG008|Overall Study|Maximum clinical benefit|2|||
125671756|NCT01621490|452086920|FG009|Overall Study|Maximum clinical benefit|0|||
125671757|NCT01621490|452086921|FG010|Overall Study|Maximum clinical benefit|0|||
125337774|NCT02891070|450870338|FG001|Overall Study|Other|0|||
125671758|NCT01621490|452086911|FG000|Overall Study|Withdrawal by Subject|1|||
125671759|NCT01621490|452086912|FG001|Overall Study|Withdrawal by Subject|0|||
125671760|NCT01621490|452086913|FG002|Overall Study|Withdrawal by Subject|0|||
125671761|NCT01621490|452086914|FG003|Overall Study|Withdrawal by Subject|0|||
125337775|NCT02891070|450870337|FG000|Overall Study|Protocol Violation|0|||
125337776|NCT02891070|450870338|FG001|Overall Study|Protocol Violation|1|||
125337777|NCT02891070|450870337|FG000|Overall Study|Withdrawal by Subject|1|||
125337778|NCT02891070|450870338|FG001|Overall Study|Withdrawal by Subject|2|||
125337779|NCT02891070|450870337|FG000|Overall Study|Death|3|||
125337780|NCT02891070|450870338|FG001|Overall Study|Death|0|||
125337781|NCT04491604|450870339|FG000|Overall Study|Withdrawal by Subject|3|||
125337782|NCT02934503|450870340|FG000|Overall Study|progression of disease|3|||
125337783|NCT02934503|450870340|FG000|Overall Study|Withdrawal by Subject|1|||
125337784|NCT04248491|450870341|FG000|Overall Study|Lost to Follow-up|1|||
125337785|NCT04248491|450870342|FG001|Overall Study|Lost to Follow-up|0|||
125337786|NCT02597478|450870343|FG000|Overall Study|Withdrawal by Subject|2|||
125337787|NCT02597478|450870344|FG001|Overall Study|Withdrawal by Subject|0|||
125337788|NCT02597478|450870343|FG000|Overall Study|Change of opioid dose|1|||
125671762|NCT01621490|452086915|FG004|Overall Study|Withdrawal by Subject|0|||
125671763|NCT01621490|452086916|FG005|Overall Study|Withdrawal by Subject|1|||
125671764|NCT01621490|452086917|FG006|Overall Study|Withdrawal by Subject|0|||
125671765|NCT01621490|452086918|FG007|Overall Study|Withdrawal by Subject|0|||
125671766|NCT01621490|452086919|FG008|Overall Study|Withdrawal by Subject|0|||
125671767|NCT01621490|452086920|FG009|Overall Study|Withdrawal by Subject|0|||
125671768|NCT01621490|452086921|FG010|Overall Study|Withdrawal by Subject|0|||
125671769|NCT01621490|452086911|FG000|Overall Study|Subject request to discontinue study|1|||
125671770|NCT01621490|452086912|FG001|Overall Study|Subject request to discontinue study|3|||
125671771|NCT01621490|452086913|FG002|Overall Study|Subject request to discontinue study|1|||
125671772|NCT01621490|452086914|FG003|Overall Study|Subject request to discontinue study|1|||
125671773|NCT01621490|452086915|FG004|Overall Study|Subject request to discontinue study|0|||
125671774|NCT01621490|452086916|FG005|Overall Study|Subject request to discontinue study|2|||
125671775|NCT01621490|452086917|FG006|Overall Study|Subject request to discontinue study|1|||
125671776|NCT01621490|452086918|FG007|Overall Study|Subject request to discontinue study|0|||
125671777|NCT01621490|452086919|FG008|Overall Study|Subject request to discontinue study|1|||
125671778|NCT01621490|452086920|FG009|Overall Study|Subject request to discontinue study|0|||
125671779|NCT01621490|452086921|FG010|Overall Study|Subject request to discontinue study|0|||
125671780|NCT01621490|452086911|FG000|Overall Study|Adverse event unrelated to study drug|1|||
125671781|NCT01621490|452086912|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125671782|NCT01621490|452086913|FG002|Overall Study|Adverse event unrelated to study drug|0|||
125671783|NCT01621490|452086914|FG003|Overall Study|Adverse event unrelated to study drug|0|||
125671784|NCT01621490|452086915|FG004|Overall Study|Adverse event unrelated to study drug|0|||
125671785|NCT01621490|452086916|FG005|Overall Study|Adverse event unrelated to study drug|0|||
125671786|NCT01621490|452086917|FG006|Overall Study|Adverse event unrelated to study drug|0|||
125671787|NCT01621490|452086918|FG007|Overall Study|Adverse event unrelated to study drug|2|||
125671788|NCT01621490|452086919|FG008|Overall Study|Adverse event unrelated to study drug|0|||
125671789|NCT01621490|452086920|FG009|Overall Study|Adverse event unrelated to study drug|0|||
125671790|NCT01621490|452086921|FG010|Overall Study|Adverse event unrelated to study drug|0|||
125671791|NCT01621490|452086911|FG000|Overall Study|Disease progression|27|||
125671792|NCT01621490|452086912|FG001|Overall Study|Disease progression|28|||
125671793|NCT01621490|452086913|FG002|Overall Study|Disease progression|1|||
125671794|NCT01621490|452086914|FG003|Overall Study|Disease progression|5|||
125671795|NCT01621490|452086915|FG004|Overall Study|Disease progression|3|||
125671796|NCT01621490|452086916|FG005|Overall Study|Disease progression|8|||
125671797|NCT01621490|452086917|FG006|Overall Study|Disease progression|7|||
125671798|NCT01621490|452086918|FG007|Overall Study|Disease progression|1|||
125671799|NCT01621490|452086919|FG008|Overall Study|Disease progression|4|||
125671800|NCT01621490|452086920|FG009|Overall Study|Disease progression|1|||
125671801|NCT01621490|452086921|FG010|Overall Study|Disease progression|1|||
125671802|NCT01621490|452086911|FG000|Overall Study|Study drug toxicity|1|||
125671803|NCT01621490|452086912|FG001|Overall Study|Study drug toxicity|4|||
125671804|NCT01621490|452086913|FG002|Overall Study|Study drug toxicity|5|||
125671805|NCT01621490|452086914|FG003|Overall Study|Study drug toxicity|3|||
125671806|NCT01621490|452086915|FG004|Overall Study|Study drug toxicity|1|||
125671807|NCT01621490|452086916|FG005|Overall Study|Study drug toxicity|10|||
125671808|NCT01621490|452086917|FG006|Overall Study|Study drug toxicity|1|||
125671809|NCT01621490|452086918|FG007|Overall Study|Study drug toxicity|4|||
125671810|NCT01621490|452086919|FG008|Overall Study|Study drug toxicity|1|||
125671811|NCT01621490|452086920|FG009|Overall Study|Study drug toxicity|0|||
125671812|NCT01621490|452086921|FG010|Overall Study|Study drug toxicity|0|||
125337789|NCT02597478|450870344|FG001|Overall Study|Change of opioid dose|0|||
125337790|NCT02597478|450870343|FG000|Overall Study|Insufficient exertional dyspnea|0|||
125337791|NCT02597478|450870344|FG001|Overall Study|Insufficient exertional dyspnea|1|||
125671813|NCT01621490|452086911|FG000|Overall Study|Death|0|||
125671814|NCT01621490|452086912|FG001|Overall Study|Death|0|||
125671815|NCT01621490|452086913|FG002|Overall Study|Death|0|||
125671816|NCT01621490|452086914|FG003|Overall Study|Death|0|||
125671817|NCT01621490|452086915|FG004|Overall Study|Death|0|||
125337792|NCT01536067|450870345|FG000|Overall Study|Disease Progression|1|||
125337793|NCT01652469|450870346|FG000|Overall Study|Withdrawal by Subject|1|||
125337794|NCT01652469|450870347|FG001|Overall Study|Withdrawal by Subject|4|||
125337795|NCT01652469|450870346|FG000|Overall Study|Lost to Follow-up|0|||
125337796|NCT01652469|450870347|FG001|Overall Study|Lost to Follow-up|2|||
125337797|NCT01402102|450870348|FG000|Overall Study|Protocol Violation|1|||
125337798|NCT01402102|450870349|FG001|Overall Study|Protocol Violation|0|||
125337799|NCT01402102|450870348|FG000|Overall Study|Insufficiency of compliance|1|||
125337800|NCT01402102|450870349|FG001|Overall Study|Insufficiency of compliance|1|||
125337801|NCT01402102|450870348|FG000|Overall Study|Withdrawal by Subject|0|||
125337802|NCT01402102|450870349|FG001|Overall Study|Withdrawal by Subject|2|||
125337803|NCT00905645|450870351|FG000|Overall Study|Death (not device related)|10|||
125337804|NCT00905645|450870352|FG001|Overall Study|Death (not device related)|4|||
125337805|NCT00905645|450870353|FG002|Overall Study|Death (not device related)|15|||
125337806|NCT00905645|450870354|FG003|Overall Study|Death (not device related)|8|||
125671818|NCT01621490|452086916|FG005|Overall Study|Death|0|||
125671819|NCT01621490|452086917|FG006|Overall Study|Death|0|||
125671820|NCT01621490|452086918|FG007|Overall Study|Death|0|||
125671821|NCT01621490|452086919|FG008|Overall Study|Death|1|||
125671822|NCT01621490|452086920|FG009|Overall Study|Death|0|||
125671823|NCT01621490|452086921|FG010|Overall Study|Death|0|||
125671824|NCT01621490|452086911|FG000|Overall Study|Other reasons|7|||
125671825|NCT01621490|452086912|FG001|Overall Study|Other reasons|6|||
125671826|NCT01621490|452086913|FG002|Overall Study|Other reasons|4|||
125671827|NCT01621490|452086914|FG003|Overall Study|Other reasons|1|||
125671828|NCT01621490|452086915|FG004|Overall Study|Other reasons|1|||
125671829|NCT01621490|452086916|FG005|Overall Study|Other reasons|3|||
125671830|NCT01621490|452086917|FG006|Overall Study|Other reasons|1|||
125671831|NCT01621490|452086918|FG007|Overall Study|Other reasons|1|||
125671832|NCT01621490|452086919|FG008|Overall Study|Other reasons|1|||
125671833|NCT01621490|452086920|FG009|Overall Study|Other reasons|0|||
125671834|NCT01621490|452086921|FG010|Overall Study|Other reasons|0|||
125671835|NCT00461500|452086922|FG000|Overall Study|Adverse Event|1|||
125671836|NCT00461500|452086923|FG001|Overall Study|Adverse Event|0|||
125671837|NCT00461500|452086922|FG000|Overall Study|Lack of Efficacy|0|||
125671838|NCT00461500|452086923|FG001|Overall Study|Lack of Efficacy|1|||
125671839|NCT00461500|452086922|FG000|Overall Study|Expired Drug Treatment|1|||
125671840|NCT00461500|452086923|FG001|Overall Study|Expired Drug Treatment|1|||
125671841|NCT00461500|452086922|FG000|Overall Study|Study Stopped|1|||
125671842|NCT00461500|452086923|FG001|Overall Study|Study Stopped|2|||
125671843|NCT00461500|452086922|FG000|Overall Study|Drug Treatment Misuse|1|||
125671844|NCT00461500|452086923|FG001|Overall Study|Drug Treatment Misuse|0|||
125671845|NCT00461500|452086922|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
125671846|NCT00461500|452086923|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
125671847|NCT00461500|452086922|FG000|Overall Study|Lost to Follow-up|2|||
125671848|NCT00461500|452086923|FG001|Overall Study|Lost to Follow-up|2|||
125671849|NCT01806597|452086924|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
125671850|NCT01806597|452086925|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
125671851|NCT01806597|452086926|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
125671852|NCT01806597|452086927|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
125671853|NCT01806597|452086928|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
125671854|NCT01806597|452086929|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
125671855|NCT01806597|452086924|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
125671856|NCT01806597|452086925|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
125671857|NCT01806597|452086926|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
125671858|NCT01806597|452086927|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
125671859|NCT01806597|452086928|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
125671860|NCT01806597|452086929|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
125671861|NCT01806597|452086924|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
125671862|NCT01806597|452086925|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
125671863|NCT01806597|452086926|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
125671864|NCT01806597|452086927|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
125671865|NCT01806597|452086928|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
125337807|NCT00905645|450870351|FG000|Overall Study|Explantation of study device(s)|78|||
125337808|NCT00905645|450870352|FG001|Overall Study|Explantation of study device(s)|47|||
125337809|NCT00905645|450870353|FG002|Overall Study|Explantation of study device(s)|28|||
125337810|NCT00905645|450870354|FG003|Overall Study|Explantation of study device(s)|21|||
125337811|NCT00905645|450870351|FG000|Overall Study|Subject Request|41|||
125671866|NCT01806597|452086929|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
125671867|NCT01806597|452086924|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
125671868|NCT01806597|452086925|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
125671869|NCT01806597|452086926|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
125671870|NCT01806597|452086927|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
125671871|NCT01806597|452086928|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
125671872|NCT01806597|452086929|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
125671873|NCT01806597|452086924|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
125337812|NCT00905645|450870352|FG001|Overall Study|Subject Request|17|||
125337813|NCT00905645|450870353|FG002|Overall Study|Subject Request|13|||
125337814|NCT00905645|450870354|FG003|Overall Study|Subject Request|11|||
125337815|NCT00905645|450870351|FG000|Overall Study|Lost to Follow-up|299|||
125337816|NCT00905645|450870352|FG001|Overall Study|Lost to Follow-up|103|||
125337817|NCT00905645|450870353|FG002|Overall Study|Lost to Follow-up|51|||
125337818|NCT00905645|450870354|FG003|Overall Study|Lost to Follow-up|12|||
125337819|NCT01731938|450870355|FG000|Preliminary Part I|Withdrawal by Subject|2|||
125337820|NCT01731938|450870356|FG001|Preliminary Part I|Withdrawal by Subject|2|||
125337821|NCT01731938|450870355|FG000|Preliminary Part I|Physician Decision|1|||
125337822|NCT01731938|450870356|FG001|Preliminary Part I|Physician Decision|0|||
125337823|NCT01731938|450870355|FG000|Preliminary Part I|Lost to Follow-up|0|||
125337824|NCT01731938|450870356|FG001|Preliminary Part I|Lost to Follow-up|3|||
125337825|NCT01731938|450870355|FG000|Preliminary Part I|Missed Week 6 visit|0|||
125337826|NCT01731938|450870356|FG001|Preliminary Part I|Missed Week 6 visit|3|||
125337827|NCT01731938|450870355|FG000|Primary Part II|Withdrawal by Subject|5|||
125337828|NCT01731938|450870356|FG001|Primary Part II|Withdrawal by Subject|4|||
125337829|NCT01731938|450870355|FG000|Primary Part II|Lost to Follow-up|4|||
125337830|NCT01731938|450870356|FG001|Primary Part II|Lost to Follow-up|5|||
125337831|NCT01731938|450870355|FG000|Primary Part II|Death|2|||
125337832|NCT01731938|450870356|FG001|Primary Part II|Death|1|||
125337833|NCT01731938|450870355|FG000|Primary Part II|Missed Week 6 visit|2|||
125337834|NCT01731938|450870356|FG001|Primary Part II|Missed Week 6 visit|3|||
125337835|NCT04931888|450870357|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
125337836|NCT04931888|450870358|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
125337837|NCT04931888|450870359|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
125337838|NCT04931888|450870360|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
125337839|NCT04538144|450870361|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
125337840|NCT04538144|450870362|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
125337841|NCT04538144|450870363|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
125337842|NCT04538144|450870364|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
125337843|NCT02350478|450870365|FG000|Overall Study|Lost to Follow-up|5|||
125337844|NCT02350478|450870366|FG001|Overall Study|Lost to Follow-up|1|||
125337845|NCT00771953|450870367|FG000|Overall Study|Adverse Event|5|||
125337846|NCT00771953|450870368|FG001|Overall Study|Adverse Event|3|||
125337847|NCT00771953|450870367|FG000|Overall Study|Death|2|||
125337848|NCT00771953|450870368|FG001|Overall Study|Death|2|||
125337849|NCT00771953|450870367|FG000|Overall Study|Progression before active Tx|1|||
125337850|NCT00771953|450870368|FG001|Overall Study|Progression before active Tx|2|||
125337851|NCT00771953|450870367|FG000|Overall Study|Sponsor decision|1|||
125337852|NCT00771953|450870368|FG001|Overall Study|Sponsor decision|0|||
125337853|NCT00771953|450870367|FG000|Overall Study|Other complicating disease|1|||
125337854|NCT00771953|450870368|FG001|Overall Study|Other complicating disease|0|||
125337855|NCT00771953|450870367|FG000|Overall Study|Withdrawal by Subject|0|||
125337856|NCT00771953|450870368|FG001|Overall Study|Withdrawal by Subject|3|||
125337857|NCT02722304|450870373|FG000|Overall Study|Study Terminated by Sponsor|1|||
125337858|NCT02722304|450870374|FG001|Overall Study|Study Terminated by Sponsor|0|||
125671874|NCT01806597|452086925|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
125671875|NCT01806597|452086926|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
125671876|NCT01806597|452086927|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
125671877|NCT01806597|452086928|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
125671878|NCT01806597|452086929|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
125671879|NCT01806597|452086924|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
125671880|NCT01806597|452086925|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
125671881|NCT01806597|452086926|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
125671882|NCT01806597|452086927|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
125671883|NCT01806597|452086928|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
125671884|NCT01806597|452086929|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
125671885|NCT01806597|452086924|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
125671886|NCT01806597|452086925|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
125671887|NCT01806597|452086926|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
125671888|NCT01806597|452086927|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
125671889|NCT01806597|452086928|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
125671890|NCT01806597|452086929|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
125671891|NCT01806597|452086924|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
125671892|NCT01806597|452086925|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
125671893|NCT01806597|452086926|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
125671894|NCT01806597|452086927|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
125671895|NCT01806597|452086928|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
125671896|NCT01806597|452086929|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
125671897|NCT01806597|452086924|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
125671898|NCT01806597|452086925|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
125671899|NCT01806597|452086926|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
125671900|NCT01806597|452086927|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
125671901|NCT01806597|452086928|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
125671902|NCT01806597|452086929|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
125671903|NCT01806597|452086924|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
125671904|NCT01806597|452086925|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
125671905|NCT01806597|452086926|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
125671906|NCT01806597|452086927|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
125671907|NCT01806597|452086928|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
125671908|NCT01806597|452086929|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
125671909|NCT01806597|452086924|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
125671910|NCT01806597|452086925|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
125671911|NCT01806597|452086926|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
125671912|NCT01806597|452086927|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
125671913|NCT01806597|452086928|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
125671914|NCT01806597|452086929|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
125671915|NCT01806597|452086924|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
125671916|NCT01806597|452086925|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
125671917|NCT01806597|452086926|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
125671918|NCT01806597|452086927|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
125671919|NCT01806597|452086928|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
125671920|NCT01806597|452086929|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
125671921|NCT01806597|452086924|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
125671922|NCT01806597|452086925|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
125671923|NCT01806597|452086926|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
125671924|NCT01806597|452086927|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
125337859|NCT02722304|450870375|FG002|Overall Study|Study Terminated by Sponsor|2|||
125337860|NCT02722304|450870376|FG003|Overall Study|Study Terminated by Sponsor|1|||
125337861|NCT02722304|450870377|FG004|Overall Study|Study Terminated by Sponsor|1|||
125337862|NCT02722304|450870373|FG000|Overall Study|Other|0|||
125337863|NCT02722304|450870374|FG001|Overall Study|Other|0|||
125337864|NCT02722304|450870375|FG002|Overall Study|Other|0|||
125337865|NCT02722304|450870376|FG003|Overall Study|Other|1|||
125337866|NCT02722304|450870377|FG004|Overall Study|Other|1|||
125337867|NCT02644109|450870378|FG000|Overall Study|Adverse Event|0|||
125337868|NCT02644109|450870379|FG001|Overall Study|Adverse Event|4|||
125337869|NCT01519869|450870382|FG000|Overall Study|Lost to Follow-up|1|||
125337870|NCT03023813|450870383|FG000|Overall Study|Lost to Follow-up|1|||
125337871|NCT03023813|450870384|FG001|Overall Study|Lost to Follow-up|2|||
125337872|NCT03023813|450870385|FG002|Overall Study|Lost to Follow-up|0|||
125337873|NCT02433080|450870387|FG000|Overall Study|Lost to Follow-up|1|||
125337874|NCT02433080|450870388|FG001|Overall Study|Lost to Follow-up|2|||
125337875|NCT02433080|450870387|FG000|Overall Study|Withdrawal by Subject|0|||
125337876|NCT02433080|450870388|FG001|Overall Study|Withdrawal by Subject|2|||
125337877|NCT04530136|450870389|FG000|Overall Study|Lost to Follow-up|2|||
125337878|NCT04530136|450870390|FG001|Overall Study|Lost to Follow-up|3|||
125337879|NCT04530136|450870389|FG000|Overall Study|Withdrawal by Subject|1|||
125337880|NCT04530136|450870390|FG001|Overall Study|Withdrawal by Subject|0|||
125337881|NCT04530136|450870389|FG000|Overall Study|Death|0|||
125337882|NCT04530136|450870390|FG001|Overall Study|Death|1|||
125337883|NCT01309282|450870391|FG000|Overall Study|Lost to Follow-up|1|||
125337884|NCT01387542|450870392|FG000|Overall Study|Adverse Event|3|||
125337885|NCT01387542|450870392|FG000|Overall Study|Withdrawal by Subject|1|||
125337886|NCT01387542|450870392|FG000|Overall Study|Changed diagnosis|1|||
125337887|NCT01387542|450870392|FG000|Overall Study|Insufficient response|1|||
125337888|NCT01387542|450870392|FG000|Overall Study|Non-compliant|1|||
125337889|NCT01387542|450870392|FG000|Overall Study|Lost to Follow-up|1|||
125337890|NCT01010867|450870395|FG000|Overall Study|< 50% adherence to probiotic|1|||
125337891|NCT00884741|450870396|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
125337892|NCT00884741|450870397|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
125337893|NCT00884741|450870398|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
125337894|NCT00884741|450870399|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
125337895|NCT00884741|450870396|FG000|Step 1 Registration: Tissue Screening|Death|3|||
125540906|NCT01237587|451609479|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
125540907|NCT01237587|451609478|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
125337896|NCT00884741|450870397|FG001|Step 1 Registration: Tissue Screening|Death|0|||
125337897|NCT00884741|450870398|FG002|Step 1 Registration: Tissue Screening|Death|0|||
125337898|NCT00884741|450870399|FG003|Step 1 Registration: Tissue Screening|Death|0|||
125337899|NCT00884741|450870396|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
125337900|NCT00884741|450870397|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
125337901|NCT00884741|450870398|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
125337902|NCT00884741|450870399|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
125337903|NCT00884741|450870396|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
125337904|NCT00884741|450870397|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
125337905|NCT00884741|450870398|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
125337906|NCT00884741|450870399|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
125337907|NCT00884741|450870396|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
125337908|NCT00884741|450870397|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
125337909|NCT00884741|450870398|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
125337910|NCT00884741|450870399|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
125337911|NCT00884741|450870396|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
125337912|NCT00884741|450870397|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
125337913|NCT00884741|450870398|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
125337914|NCT00884741|450870399|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
125337915|NCT00884741|450870396|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
125337916|NCT00884741|450870397|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
125337917|NCT00884741|450870398|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
125337918|NCT00884741|450870399|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
125337919|NCT00884741|450870396|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
125337920|NCT00884741|450870397|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
125337921|NCT00884741|450870398|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
125337922|NCT00884741|450870399|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
125337923|NCT00884741|450870396|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
125337924|NCT00884741|450870397|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
125337925|NCT00884741|450870398|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
125337926|NCT00884741|450870399|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
125337927|NCT00884741|450870396|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
125337928|NCT00884741|450870397|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
125337929|NCT00884741|450870398|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
125337930|NCT00884741|450870399|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
125337931|NCT00884741|450870396|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
125337932|NCT00884741|450870397|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
125337933|NCT00884741|450870398|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
125337934|NCT00884741|450870399|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
125337935|NCT00884741|450870396|FG000|Randomization|Protocol Violation|0|||
125337936|NCT00884741|450870397|FG001|Randomization|Protocol Violation|0|||
125337937|NCT00884741|450870398|FG002|Randomization|Protocol Violation|8|||
125337938|NCT00884741|450870399|FG003|Randomization|Protocol Violation|8|||
125337939|NCT01233232|450870400|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
125337940|NCT01233232|450870401|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
125337941|NCT01233232|450870402|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
125337942|NCT02762370|450870403|FG000|Overall Study|Protocol Violation|1|||
125337943|NCT02762370|450870404|FG001|Overall Study|Protocol Violation|0|||
125337944|NCT00101452|450870409|FG000|Overall Study|Adverse Event|2|||
125337945|NCT00101452|450870410|FG001|Overall Study|Adverse Event|0|||
125337946|NCT00101452|450870411|FG002|Overall Study|Adverse Event|1|||
125337947|NCT00101452|450870409|FG000|Overall Study|Lost to Follow-up|13|||
125337948|NCT00101452|450870410|FG001|Overall Study|Lost to Follow-up|8|||
125337949|NCT00101452|450870411|FG002|Overall Study|Lost to Follow-up|14|||
125337950|NCT00101452|450870409|FG000|Overall Study|Withdrawal by Subject|10|||
125337951|NCT00101452|450870410|FG001|Overall Study|Withdrawal by Subject|14|||
125337952|NCT00101452|450870411|FG002|Overall Study|Withdrawal by Subject|9|||
125337953|NCT00101452|450870409|FG000|Overall Study|Baseline Fail|2|||
125337954|NCT00101452|450870410|FG001|Overall Study|Baseline Fail|1|||
125337955|NCT00101452|450870411|FG002|Overall Study|Baseline Fail|2|||
125337956|NCT00101452|450870409|FG000|Overall Study|Physician Decision|0|||
125337957|NCT00101452|450870410|FG001|Overall Study|Physician Decision|3|||
125337958|NCT00101452|450870411|FG002|Overall Study|Physician Decision|2|||
125337959|NCT00101452|450870409|FG000|Overall Study|Protocol Violation|2|||
125540908|NCT01237587|451609479|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
125337960|NCT00101452|450870410|FG001|Overall Study|Protocol Violation|1|||
125337961|NCT00101452|450870411|FG002|Overall Study|Protocol Violation|3|||
125337962|NCT00101452|450870409|FG000|Overall Study|Other|15|||
125337963|NCT00101452|450870410|FG001|Overall Study|Other|16|||
125337964|NCT00101452|450870411|FG002|Overall Study|Other|12|||
125337965|NCT00499590|450870412|FG000|Overall Study|Study Terminated|112|||
125337966|NCT00499590|450870413|FG001|Overall Study|Study Terminated|112|||
125337967|NCT00499590|450870414|FG002|Overall Study|Study Terminated|112|||
125337968|NCT00499590|450870412|FG000|Overall Study|Not treated|1|||
125337969|NCT00499590|450870413|FG001|Overall Study|Not treated|0|||
125337970|NCT00499590|450870414|FG002|Overall Study|Not treated|1|||
125337971|NCT05661851|450870415|FG000|Overall Study|Protocol Violation|1|||
125337972|NCT05661851|450870416|FG001|Overall Study|Protocol Violation|1|||
125337973|NCT05661851|450870415|FG000|Overall Study|Covid-19 Related|3|||
125337974|NCT05661851|450870416|FG001|Overall Study|Covid-19 Related|4|||
125337975|NCT05661851|450870415|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
125337976|NCT05661851|450870416|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
125337977|NCT05661851|450870415|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
125337978|NCT05661851|450870416|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
125337979|NCT01014910|450870417|FG000|Overall Study|Withdrawal by Subject|0|||
125337980|NCT01014910|450870418|FG001|Overall Study|Withdrawal by Subject|2|||
125337981|NCT00612807|450870419|FG000|Overall Study|Withdrawal by Subject|2|||
125337982|NCT00612807|450870420|FG001|Overall Study|Withdrawal by Subject|0|||
125337983|NCT01215097|450870421|FG000|Overall Study|Adverse Event|1|||
125337984|NCT01215097|450870422|FG001|Overall Study|Adverse Event|3|||
125337985|NCT01215097|450870421|FG000|Overall Study|Protocol Violation|0|||
125337986|NCT01215097|450870422|FG001|Overall Study|Protocol Violation|2|||
125337987|NCT01215097|450870421|FG000|Overall Study|Lost to Follow-up|2|||
125337988|NCT01215097|450870422|FG001|Overall Study|Lost to Follow-up|0|||
125337989|NCT01215097|450870421|FG000|Overall Study|Withdrawal by Subject|6|||
125337990|NCT01215097|450870422|FG001|Overall Study|Withdrawal by Subject|3|||
125337991|NCT01215097|450870421|FG000|Overall Study|Lack of Efficacy|0|||
125337992|NCT01215097|450870422|FG001|Overall Study|Lack of Efficacy|3|||
125337993|NCT01215097|450870421|FG000|Overall Study|patient's refusal to come|2|||
125337994|NCT01215097|450870422|FG001|Overall Study|patient's refusal to come|2|||
125337995|NCT01215097|450870421|FG000|Overall Study|patient's private reason|1|||
125337996|NCT01215097|450870422|FG001|Overall Study|patient's private reason|1|||
125337997|NCT02252939|450870423|FG000|Overall Study|Lost to Follow-up|3|||
125337998|NCT00870584|450870427|FG000|Overall Study|Adverse Event|3|||
125337999|NCT00870584|450870428|FG001|Overall Study|Adverse Event|3|||
125338000|NCT00870584|450870427|FG000|Overall Study|Withdrawal by Subject|6|||
125338001|NCT00870584|450870428|FG001|Overall Study|Withdrawal by Subject|7|||
125338002|NCT00870584|450870427|FG000|Overall Study|Lost to Follow-up|5|||
125338003|NCT00870584|450870428|FG001|Overall Study|Lost to Follow-up|1|||
125338004|NCT00870584|450870427|FG000|Overall Study|Protocol Deviation|2|||
125338005|NCT00870584|450870428|FG001|Overall Study|Protocol Deviation|2|||
125338006|NCT01497366|450870429|FG000|Overall Study|Virologic failure|2|||
125338007|NCT01497366|450870430|FG001|Overall Study|Virologic failure|50|||
125338008|NCT01497366|450870429|FG000|Overall Study|Lost to Follow-up|11|||
125338009|NCT01497366|450870430|FG001|Overall Study|Lost to Follow-up|10|||
125338010|NCT01497366|450870429|FG000|Overall Study|Withdrawal by Subject|6|||
125338011|NCT01497366|450870430|FG001|Overall Study|Withdrawal by Subject|6|||
125338012|NCT01497366|450870429|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
125338013|NCT01497366|450870430|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
125338014|NCT01497366|450870429|FG000|Overall Study|Other|5|||
125338015|NCT01497366|450870430|FG001|Overall Study|Other|0|||
125338016|NCT01497366|450870429|FG000|Overall Study|Death|1|||
125338017|NCT01497366|450870430|FG001|Overall Study|Death|1|||
125338018|NCT01497366|450870429|FG000|Overall Study|Randomized but not treated|7|||
125338019|NCT01497366|450870430|FG001|Overall Study|Randomized but not treated|21|||
125338020|NCT02745080|450870444|FG000|Overall Study|Adverse Event|13|||
125338021|NCT02745080|450870445|FG001|Overall Study|Adverse Event|21|||
125338022|NCT02745080|450870444|FG000|Overall Study|Lack of Efficacy|11|||
125338023|NCT02745080|450870445|FG001|Overall Study|Lack of Efficacy|23|||
125338024|NCT02745080|450870444|FG000|Overall Study|Lost to Follow-up|3|||
125338025|NCT02745080|450870445|FG001|Overall Study|Lost to Follow-up|3|||
125338026|NCT02745080|450870444|FG000|Overall Study|Physician Decision|3|||
125338027|NCT02745080|450870445|FG001|Overall Study|Physician Decision|0|||
125338028|NCT02745080|450870444|FG000|Overall Study|Protocol Violation|3|||
125338029|NCT02745080|450870445|FG001|Overall Study|Protocol Violation|1|||
125338030|NCT02745080|450870444|FG000|Overall Study|Withdrawal by Subject|22|||
125338031|NCT02745080|450870445|FG001|Overall Study|Withdrawal by Subject|41|||
125338032|NCT01821560|450870448|FG000|Overall Study|Lost to Follow-up|5|||
125338033|NCT01821560|450870449|FG001|Overall Study|Lost to Follow-up|5|||
125338034|NCT01821560|450870448|FG000|Overall Study|Withdrawal by Subject|1|||
125338035|NCT01821560|450870449|FG001|Overall Study|Withdrawal by Subject|1|||
125338036|NCT01821560|450870448|FG000|Overall Study|Protocol Violation|0|||
125338037|NCT01821560|450870449|FG001|Overall Study|Protocol Violation|1|||
125338038|NCT01338298|450870452|FG000|Overall Study|Withdrawal by Subject|1|||
125338039|NCT01338298|450870453|FG001|Overall Study|Withdrawal by Subject|1|||
125338040|NCT01338298|450870452|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
125338041|NCT01338298|450870453|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
125671925|NCT01806597|452086928|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
125671926|NCT01806597|452086929|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
125671927|NCT01806597|452086924|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
125671928|NCT01806597|452086925|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
125671929|NCT01806597|452086926|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
125671930|NCT01806597|452086927|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
125671931|NCT01806597|452086928|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
125671932|NCT01806597|452086929|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
125671933|NCT01806597|452086924|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
125671934|NCT01806597|452086925|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
125671935|NCT01806597|452086926|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
125671936|NCT01806597|452086927|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
125671937|NCT01806597|452086928|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
125671938|NCT01806597|452086929|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
125671939|NCT01806597|452086924|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
125671940|NCT01806597|452086925|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
125671941|NCT01806597|452086926|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
125671942|NCT01806597|452086927|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
125671943|NCT01806597|452086928|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
125671944|NCT01806597|452086929|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
125671945|NCT01806597|452086924|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
125671946|NCT01806597|452086925|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
125671947|NCT01806597|452086926|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
125671948|NCT01806597|452086927|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
125671949|NCT01806597|452086928|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
125671950|NCT01806597|452086929|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
125671951|NCT01806597|452086924|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
125671952|NCT01806597|452086925|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
125671953|NCT01806597|452086926|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
125671954|NCT01806597|452086927|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
125671955|NCT01806597|452086928|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
125671956|NCT01806597|452086929|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
125671957|NCT01806597|452086924|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
125671958|NCT01806597|452086925|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
125671959|NCT01806597|452086926|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
125671960|NCT01806597|452086927|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
125671961|NCT01806597|452086928|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
125671962|NCT01806597|452086929|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
125671963|NCT02247479|452086931|FG000|Overall Study|Adverse Event|8|||
125671964|NCT02247479|452086932|FG001|Overall Study|Adverse Event|9|||
125671965|NCT02247479|452086933|FG002|Overall Study|Adverse Event|8|||
125671966|NCT02247479|452086931|FG000|Overall Study|Death|5|||
125671967|NCT02247479|452086932|FG001|Overall Study|Death|4|||
125671968|NCT02247479|452086933|FG002|Overall Study|Death|6|||
125671969|NCT02247479|452086931|FG000|Overall Study|Lost to Follow-up|3|||
125671970|NCT02247479|452086932|FG001|Overall Study|Lost to Follow-up|3|||
125671971|NCT02247479|452086933|FG002|Overall Study|Lost to Follow-up|1|||
125671972|NCT02247479|452086931|FG000|Overall Study|Non-compliance|0|||
125671973|NCT02247479|452086932|FG001|Overall Study|Non-compliance|0|||
125671974|NCT02247479|452086933|FG002|Overall Study|Non-compliance|1|||
125671975|NCT02247479|452086931|FG000|Overall Study|Withdrawal by Subject|25|||
125671976|NCT02247479|452086932|FG001|Overall Study|Withdrawal by Subject|29|||
125671977|NCT02247479|452086933|FG002|Overall Study|Withdrawal by Subject|24|||
125671978|NCT02247479|452086931|FG000|Overall Study|Study Terminated by Sponsor|98|||
125671979|NCT02247479|452086932|FG001|Overall Study|Study Terminated by Sponsor|88|||
125671980|NCT02247479|452086933|FG002|Overall Study|Study Terminated by Sponsor|94|||
125671981|NCT02247479|452086931|FG000|Overall Study|Physician Decision|1|||
125671982|NCT02247479|452086932|FG001|Overall Study|Physician Decision|0|||
125671983|NCT02247479|452086933|FG002|Overall Study|Physician Decision|2|||
125671984|NCT02247479|452086931|FG000|Overall Study|Unspecified Reason|2|||
125671985|NCT02247479|452086932|FG001|Overall Study|Unspecified Reason|5|||
125671986|NCT02247479|452086933|FG002|Overall Study|Unspecified Reason|2|||
125671987|NCT01073020|452086934|FG000|Overall Study|Withdrawal by Subject|6|||
125671988|NCT01073020|452086935|FG001|Overall Study|Withdrawal by Subject|4|||
125671989|NCT01073020|452086936|FG002|Overall Study|Withdrawal by Subject|1|||
125671990|NCT01073020|452086937|FG003|Overall Study|Withdrawal by Subject|2|||
125338042|NCT01338298|450870452|FG000|Overall Study|Administrative error|0|||
125338043|NCT01338298|450870453|FG001|Overall Study|Administrative error|1|||
125338044|NCT01338298|450870452|FG000|Overall Study|Positive symptom worsening|1|||
125338045|NCT01338298|450870453|FG001|Overall Study|Positive symptom worsening|0|||
125338046|NCT01338298|450870452|FG000|Overall Study|Depressive symptoms and nausea|1|||
125338047|NCT01338298|450870453|FG001|Overall Study|Depressive symptoms and nausea|0|||
125338048|NCT01338298|450870452|FG000|Overall Study|Non-adherence|1|||
125338049|NCT01338298|450870453|FG001|Overall Study|Non-adherence|0|||
125338050|NCT05601544|450870454|FG000|Phase 2 Period 1|Adverse Event|0|||
125338051|NCT05601544|450870455|FG001|Phase 2 Period 1|Adverse Event|1|||
125338052|NCT05601544|450870456|FG002|Phase 2 Period 1|Adverse Event|0|||
125338053|NCT05601544|450870457|FG003|Phase 2 Period 1|Adverse Event|0|||
125338054|NCT05601544|450870458|FG004|Phase 2 Period 1|Adverse Event|0|||
125338055|NCT05601544|450870459|FG005|Phase 2 Period 1|Adverse Event|0|||
125338056|NCT01256294|450871926|FG000|Overall Study|Adverse Event|1|||
125338057|NCT01256294|450871927|FG001|Overall Study|Adverse Event|0|||
125338058|NCT01256294|450871926|FG000|Overall Study|Withdrawal by Subject|1|||
125338059|NCT01256294|450871927|FG001|Overall Study|Withdrawal by Subject|1|||
125671991|NCT01073020|452086934|FG000|Overall Study|Physician Decision|1|||
125671992|NCT01073020|452086935|FG001|Overall Study|Physician Decision|0|||
125671993|NCT01073020|452086936|FG002|Overall Study|Physician Decision|2|||
125671994|NCT01073020|452086937|FG003|Overall Study|Physician Decision|0|||
125671995|NCT01073020|452086934|FG000|Overall Study|Death|0|||
125671996|NCT01073020|452086935|FG001|Overall Study|Death|1|||
125671997|NCT01073020|452086936|FG002|Overall Study|Death|0|||
125671998|NCT01073020|452086937|FG003|Overall Study|Death|0|||
125671999|NCT03031899|452086944|FG000|Overall Study|Protocol Violation|1|||
125672000|NCT03031899|452086944|FG000|Overall Study|lesion disappeared after stopping habit|1|||
125672001|NCT03740698|452086946|FG000|Overall Study|Physician Decision|0|||
125672002|NCT03740698|452086947|FG001|Overall Study|Physician Decision|1|||
125672003|NCT03740698|452086948|FG002|Overall Study|Physician Decision|1|||
125672004|NCT01469364|452086950|FG000|Overall Study|Adverse Event|1|||
125672005|NCT01469364|452086950|FG000|Overall Study|Withdrawal by Subject|1|||
125672006|NCT01162499|452086953|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
125672007|NCT01162499|452086954|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
125672008|NCT01590433|452086955|FG000|Overall Study|Lost to Follow-up|20|||
125672009|NCT01590433|452086956|FG001|Overall Study|Lost to Follow-up|8|||
125672010|NCT01590433|452086955|FG000|Overall Study|Withdrawal by Subject|21|||
125672011|NCT01590433|452086956|FG001|Overall Study|Withdrawal by Subject|11|||
125672012|NCT01590433|452086955|FG000|Overall Study|Adverse Event|11|||
125672013|NCT01590433|452086956|FG001|Overall Study|Adverse Event|3|||
125672014|NCT00555009|452086957|FG000|Overall Study|Withdrawal by Subject|0|||
125672015|NCT00555009|452086958|FG001|Overall Study|Withdrawal by Subject|1|||
125672016|NCT00555009|452086957|FG000|Overall Study|Terminated by Sponsor|2|||
125672017|NCT00555009|452086958|FG001|Overall Study|Terminated by Sponsor|5|||
125672018|NCT00989261|452086959|FG000|Overall Study|Still in follow up|12|||
125672019|NCT00989261|452086960|FG001|Overall Study|Still in follow up|21|||
125672020|NCT00989261|452086959|FG000|Overall Study|Withdrawal by Subject|0|||
125672021|NCT00989261|452086960|FG001|Overall Study|Withdrawal by Subject|1|||
125672022|NCT00989261|452086959|FG000|Overall Study|Lost to Follow-up|3|||
125672023|NCT00989261|452086960|FG001|Overall Study|Lost to Follow-up|0|||
125672024|NCT00718159|452086961|FG000|Overall Study|Progressive Disease|3|||
125672025|NCT00718159|452086962|FG001|Overall Study|Progressive Disease|3|||
125672026|NCT00718159|452086963|FG002|Overall Study|Progressive Disease|2|||
125672027|NCT00718159|452086964|FG003|Overall Study|Progressive Disease|0|||
125672028|NCT00718159|452086965|FG004|Overall Study|Progressive Disease|6|||
125672029|NCT00718159|452086966|FG005|Overall Study|Progressive Disease|0|||
125672030|NCT00718159|452086967|FG006|Overall Study|Progressive Disease|0|||
125672031|NCT00718159|452086961|FG000|Overall Study|Death due to Adverse Event|0|||
125672032|NCT00718159|452086962|FG001|Overall Study|Death due to Adverse Event|0|||
125672033|NCT00718159|452086963|FG002|Overall Study|Death due to Adverse Event|0|||
125672034|NCT00718159|452086964|FG003|Overall Study|Death due to Adverse Event|2|||
125672035|NCT00718159|452086965|FG004|Overall Study|Death due to Adverse Event|2|||
125672036|NCT00718159|452086966|FG005|Overall Study|Death due to Adverse Event|0|||
125672037|NCT00718159|452086967|FG006|Overall Study|Death due to Adverse Event|0|||
125672038|NCT00718159|452086961|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
125672039|NCT00718159|452086962|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
125672040|NCT00718159|452086963|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
125672041|NCT00718159|452086964|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
125672042|NCT00718159|452086965|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
125672043|NCT00718159|452086966|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
125672044|NCT00718159|452086967|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
125672045|NCT00718159|452086961|FG000|Overall Study|Investigator Decision|0|||
125672046|NCT00718159|452086962|FG001|Overall Study|Investigator Decision|0|||
125672047|NCT00718159|452086963|FG002|Overall Study|Investigator Decision|0|||
125672048|NCT00718159|452086964|FG003|Overall Study|Investigator Decision|0|||
125672049|NCT00718159|452086965|FG004|Overall Study|Investigator Decision|0|||
125672050|NCT00718159|452086966|FG005|Overall Study|Investigator Decision|1|||
125672051|NCT00718159|452086967|FG006|Overall Study|Investigator Decision|1|||
125672052|NCT03532009|452086970|FG000|Overall Study|Other|1|||
125672053|NCT03532009|452086971|FG001|Overall Study|Other|1|||
125672054|NCT03532009|452086970|FG000|Overall Study|Death|1|||
125672055|NCT03532009|452086971|FG001|Overall Study|Death|1|||
125338060|NCT01256294|450871926|FG000|Overall Study|Protocol deviation|2|||
125672056|NCT03532009|452086970|FG000|Overall Study|Withdrawal by Patient|0|||
125672057|NCT03532009|452086971|FG001|Overall Study|Withdrawal by Patient|2|||
125672058|NCT01798485|452086974|FG000|Overall Study|Adverse Event|32|||
125338061|NCT01256294|450871927|FG001|Overall Study|Protocol deviation|1|||
125338062|NCT04681352|450871928|FG000|Overall Study|Lost to Follow-up|2|||
125672059|NCT01798485|452086975|FG001|Overall Study|Adverse Event|40|||
125672060|NCT01798485|452086974|FG000|Overall Study|Withdrawal by Subject|27|||
125672061|NCT01798485|452086975|FG001|Overall Study|Withdrawal by Subject|31|||
125338063|NCT04681352|450871928|FG000|Overall Study|Withdrawal by Subject|22|||
125338064|NCT01643772|450871929|FG000|Overall Study|Protocol Violation|0|||
125338065|NCT01643772|450871930|FG001|Overall Study|Protocol Violation|0|||
125338066|NCT01643772|450871931|FG002|Overall Study|Protocol Violation|0|||
125338067|NCT01643772|450871932|FG003|Overall Study|Protocol Violation|1|||
125338068|NCT01643772|450871929|FG000|Overall Study|Adverse Event|0|||
125672062|NCT01798485|452086974|FG000|Overall Study|Lost to Follow-up|0|||
125672063|NCT01798485|452086975|FG001|Overall Study|Lost to Follow-up|3|||
125672064|NCT01798485|452086974|FG000|Overall Study|Physician Decision|14|||
125672065|NCT01798485|452086975|FG001|Overall Study|Physician Decision|10|||
125672066|NCT01798485|452086974|FG000|Overall Study|Objective Disease Progression|152|||
125672067|NCT01798485|452086975|FG001|Overall Study|Objective Disease Progression|106|||
125672068|NCT01798485|452086974|FG000|Overall Study|Death|25|||
125672069|NCT01798485|452086975|FG001|Overall Study|Death|22|||
125672070|NCT01798485|452086974|FG000|Overall Study|Sponsor Decision|61|||
125672071|NCT01798485|452086975|FG001|Overall Study|Sponsor Decision|54|||
125672072|NCT01798485|452086974|FG000|Overall Study|Clinical Progression|35|||
125672073|NCT01798485|452086975|FG001|Overall Study|Clinical Progression|24|||
125672074|NCT00681863|452086976|FG000|Overall Study|Adverse Event|1|||
125672075|NCT00681863|452086976|FG000|Overall Study|Lost to Follow-up|2|||
125672076|NCT00681863|452086976|FG000|Overall Study|Lack of Efficacy|2|||
125672077|NCT00681863|452086976|FG000|Overall Study|Other|18|||
125672078|NCT01333033|452086977|FG000|Overall Study|Ineligible|0|||
125672079|NCT01333033|452086978|FG001|Overall Study|Ineligible|0|||
125672080|NCT01333033|452086979|FG002|Overall Study|Ineligible|0|||
125672081|NCT01333033|452086980|FG003|Overall Study|Ineligible|0|||
125672082|NCT01333033|452086981|FG004|Overall Study|Ineligible|6|||
125672083|NCT01333033|452086982|FG005|Overall Study|Ineligible|8|||
125672084|NCT01333033|452086977|FG000|Overall Study|Withdrawal by Subject|0|||
125672085|NCT01333033|452086978|FG001|Overall Study|Withdrawal by Subject|0|||
125672086|NCT01333033|452086979|FG002|Overall Study|Withdrawal by Subject|0|||
125672087|NCT01333033|452086980|FG003|Overall Study|Withdrawal by Subject|0|||
125672088|NCT01333033|452086981|FG004|Overall Study|Withdrawal by Subject|4|||
125672089|NCT01333033|452086982|FG005|Overall Study|Withdrawal by Subject|2|||
125672090|NCT01333033|452086977|FG000|Overall Study|PET inevaluable|0|||
125672091|NCT01333033|452086978|FG001|Overall Study|PET inevaluable|0|||
125672092|NCT01333033|452086979|FG002|Overall Study|PET inevaluable|0|||
125672093|NCT01333033|452086980|FG003|Overall Study|PET inevaluable|0|||
125672094|NCT01333033|452086981|FG004|Overall Study|PET inevaluable|2|||
125672095|NCT01333033|452086982|FG005|Overall Study|PET inevaluable|4|||
125672096|NCT01333033|452086977|FG000|Overall Study|Adverse Event|0|||
125672097|NCT01333033|452086978|FG001|Overall Study|Adverse Event|0|||
125672098|NCT01333033|452086979|FG002|Overall Study|Adverse Event|0|||
125672099|NCT01333033|452086980|FG003|Overall Study|Adverse Event|0|||
125672100|NCT01333033|452086981|FG004|Overall Study|Adverse Event|2|||
125672101|NCT01333033|452086982|FG005|Overall Study|Adverse Event|1|||
125672102|NCT01333033|452086977|FG000|Overall Study|Progression|0|||
125672103|NCT01333033|452086978|FG001|Overall Study|Progression|0|||
125672104|NCT01333033|452086979|FG002|Overall Study|Progression|0|||
125672105|NCT01333033|452086980|FG003|Overall Study|Progression|0|||
125672106|NCT01333033|452086981|FG004|Overall Study|Progression|0|||
125672107|NCT01333033|452086982|FG005|Overall Study|Progression|1|||
125672108|NCT01333033|452086977|FG000|Overall Study|MD Decision|0|||
125672109|NCT01333033|452086978|FG001|Overall Study|MD Decision|0|||
125672110|NCT01333033|452086979|FG002|Overall Study|MD Decision|0|||
125672111|NCT01333033|452086980|FG003|Overall Study|MD Decision|0|||
125672112|NCT01333033|452086981|FG004|Overall Study|MD Decision|0|||
125672113|NCT01333033|452086982|FG005|Overall Study|MD Decision|2|||
125672114|NCT03687125|452086983|FG000|Overall Study|Progressive Disease|2|||
125672115|NCT03687125|452086984|FG001|Overall Study|Progressive Disease|1|||
125672116|NCT03687125|452086983|FG000|Overall Study|Protocol Violation|1|||
125672117|NCT03687125|452086984|FG001|Overall Study|Protocol Violation|0|||
125672118|NCT01992107|452086985|FG000|Overall Study|Administrative reasons|2|||
125672119|NCT01992107|452086986|FG001|Overall Study|Administrative reasons|0|||
125672120|NCT01992107|452086987|FG002|Overall Study|Administrative reasons|0|||
125672121|NCT01992107|452086985|FG000|Overall Study|Adverse Event|0|||
125672122|NCT01992107|452086986|FG001|Overall Study|Adverse Event|1|||
125672123|NCT01992107|452086987|FG002|Overall Study|Adverse Event|0|||
125672124|NCT01992107|452086985|FG000|Overall Study|Lost to Follow-up|46|||
125672125|NCT01992107|452086986|FG001|Overall Study|Lost to Follow-up|22|||
125672126|NCT01992107|452086987|FG002|Overall Study|Lost to Follow-up|26|||
125672127|NCT01992107|452086985|FG000|Overall Study|noncompliance and were unavailable|7|||
125672128|NCT01992107|452086986|FG001|Overall Study|noncompliance and were unavailable|3|||
125672129|NCT01992107|452086987|FG002|Overall Study|noncompliance and were unavailable|2|||
125338069|NCT01643772|450871930|FG001|Overall Study|Adverse Event|0|||
125672130|NCT01992107|452086985|FG000|Overall Study|Withdrawal by Subject|13|||
125672131|NCT01992107|452086986|FG001|Overall Study|Withdrawal by Subject|7|||
125672132|NCT01992107|452086987|FG002|Overall Study|Withdrawal by Subject|8|||
125672133|NCT02035137|452086990|FG000|Overall Study|Physician Decision|0|||
125672134|NCT02035137|452086991|FG001|Overall Study|Physician Decision|0|||
125672135|NCT02035137|452086992|FG002|Overall Study|Physician Decision|1|||
125672136|NCT02035137|452086990|FG000|Overall Study|Withdrawal by Subject|0|||
125672137|NCT02035137|452086991|FG001|Overall Study|Withdrawal by Subject|1|||
125338070|NCT01643772|450871931|FG002|Overall Study|Adverse Event|0|||
125338071|NCT01643772|450871932|FG003|Overall Study|Adverse Event|1|||
125338072|NCT02338882|450871934|FG000|Overall Study|Death|1|||
125338073|NCT02338882|450871935|FG001|Overall Study|Death|0|||
125338074|NCT02338882|450871934|FG000|Overall Study|Lost to Follow-up|6|||
125672138|NCT02035137|452086992|FG002|Overall Study|Withdrawal by Subject|2|||
125672139|NCT02035137|452086990|FG000|Overall Study|Ineligible|0|||
125672140|NCT02035137|452086991|FG001|Overall Study|Ineligible|1|||
125672141|NCT02035137|452086992|FG002|Overall Study|Ineligible|2|||
125672142|NCT02035137|452086990|FG000|Overall Study|Disease progression prior to treatment start|2|||
125672143|NCT02035137|452086991|FG001|Overall Study|Disease progression prior to treatment start|0|||
125672144|NCT02035137|452086992|FG002|Overall Study|Disease progression prior to treatment start|0|||
125672145|NCT01214603|452087008|FG000|Overall Study|Adverse Event|0|||
125672146|NCT01214603|452087009|FG001|Overall Study|Adverse Event|0|||
125672147|NCT01214603|452087010|FG002|Overall Study|Adverse Event|1|||
125672148|NCT01214603|452087008|FG000|Overall Study|Death|1|||
125672149|NCT01214603|452087009|FG001|Overall Study|Death|0|||
125672150|NCT01214603|452087010|FG002|Overall Study|Death|0|||
125672151|NCT01214603|452087008|FG000|Overall Study|Progressive Disease|4|||
125672152|NCT01214603|452087009|FG001|Overall Study|Progressive Disease|1|||
125672153|NCT01214603|452087010|FG002|Overall Study|Progressive Disease|3|||
125672154|NCT01388647|452087011|FG000|Overall Study|Adverse Event|1|||
125672155|NCT01388647|452087012|FG001|Overall Study|Adverse Event|2|||
125672156|NCT02444533|452087013|FG000|Overall Study|Not able to complete forms|0|||
125672157|NCT02444533|452087014|FG001|Overall Study|Not able to complete forms|2|||
125672158|NCT02444533|452087013|FG000|Overall Study|Only gave post-procedure complications|2|||
125672159|NCT02444533|452087014|FG001|Overall Study|Only gave post-procedure complications|2|||
125672160|NCT03567057|452087016|FG000|Overall Study|Adverse Event|56|||
125672161|NCT03567057|452087017|FG001|Overall Study|Adverse Event|53|||
125672162|NCT03567057|452087018|FG002|Overall Study|Adverse Event|28|||
125672163|NCT03567057|452087016|FG000|Overall Study|Withdrawal by Subject|22|||
125672164|NCT03567057|452087017|FG001|Overall Study|Withdrawal by Subject|24|||
125672165|NCT03567057|452087018|FG002|Overall Study|Withdrawal by Subject|13|||
125672166|NCT03567057|452087016|FG000|Overall Study|Lost to Follow-up|3|||
125672167|NCT03567057|452087017|FG001|Overall Study|Lost to Follow-up|5|||
125672168|NCT03567057|452087018|FG002|Overall Study|Lost to Follow-up|2|||
125672169|NCT03567057|452087016|FG000|Overall Study|COVID-19 pandemic|4|||
125672170|NCT03567057|452087017|FG001|Overall Study|COVID-19 pandemic|3|||
125672171|NCT03567057|452087018|FG002|Overall Study|COVID-19 pandemic|0|||
125672172|NCT03567057|452087016|FG000|Overall Study|Non-compliance with study drug|4|||
125672173|NCT03567057|452087017|FG001|Overall Study|Non-compliance with study drug|2|||
125338075|NCT02338882|450871935|FG001|Overall Study|Lost to Follow-up|3|||
125338076|NCT04838977|450871938|FG000|Overall Study|Lost to Follow-up|2|||
125672174|NCT03567057|452087018|FG002|Overall Study|Non-compliance with study drug|0|||
125672175|NCT03567057|452087016|FG000|Overall Study|Lack of Efficacy|3|||
125672176|NCT03567057|452087017|FG001|Overall Study|Lack of Efficacy|0|||
125672177|NCT03567057|452087018|FG002|Overall Study|Lack of Efficacy|1|||
125672178|NCT03567057|452087016|FG000|Overall Study|Death|1|||
125672179|NCT03567057|452087017|FG001|Overall Study|Death|0|||
125338077|NCT04838977|450871939|FG001|Overall Study|Lost to Follow-up|3|||
125338078|NCT04838977|450871938|FG000|Overall Study|Withdrawal by Subject|1|||
125672180|NCT03567057|452087018|FG002|Overall Study|Death|0|||
125672181|NCT03567057|452087016|FG000|Overall Study|Physician Decision|1|||
125672182|NCT03567057|452087017|FG001|Overall Study|Physician Decision|0|||
125672183|NCT03567057|452087018|FG002|Overall Study|Physician Decision|0|||
125672184|NCT03567057|452087016|FG000|Overall Study|Unstable medical condition|1|||
125672185|NCT03567057|452087017|FG001|Overall Study|Unstable medical condition|0|||
125672186|NCT03567057|452087018|FG002|Overall Study|Unstable medical condition|0|||
125672187|NCT03567057|452087016|FG000|Overall Study|Medical history event|0|||
125672188|NCT03567057|452087017|FG001|Overall Study|Medical history event|0|||
125672189|NCT03567057|452087018|FG002|Overall Study|Medical history event|1|||
125672190|NCT03567057|452087016|FG000|Overall Study|Other|0|||
125672191|NCT03567057|452087017|FG001|Overall Study|Other|0|||
125672192|NCT03567057|452087018|FG002|Overall Study|Other|1|||
125672193|NCT01006707|452087019|FG000|Study Session 1|Lost to Follow-up|2|||
125672194|NCT01006707|452087020|FG001|Study Session 1|Lost to Follow-up|0|||
125672195|NCT01006707|452087021|FG002|Study Session 1|Lost to Follow-up|0|||
125672196|NCT01006707|452087019|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
125672197|NCT01006707|452087020|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
125672198|NCT01006707|452087021|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
125672199|NCT00490061|452087022|FG000|Overall Study|Physician Decision|1|||
125672200|NCT01155583|452087023|FG000|Phase I|Screen failure - did not start treatment|0|||
125672201|NCT01155583|452087024|FG001|Phase I|Screen failure - did not start treatment|0|||
125672202|NCT01155583|452087025|FG002|Phase I|Screen failure - did not start treatment|0|||
125672203|NCT01155583|452087026|FG003|Phase I|Screen failure - did not start treatment|0|||
125672204|NCT01155583|452087027|FG004|Phase I|Screen failure - did not start treatment|1|||
125672205|NCT01155583|452087028|FG005|Phase I|Screen failure - did not start treatment|0|||
125672206|NCT01155583|452087029|FG006|Phase I|Screen failure - did not start treatment|0|||
125672207|NCT01155583|452087030|FG007|Phase I|Screen failure - did not start treatment|2|||
125672208|NCT01155583|452087031|FG008|Phase I|Screen failure - did not start treatment|0|||
125672209|NCT01155583|452087023|FG000|Phase I|Withdrawal by Subject|0|||
125672210|NCT01155583|452087024|FG001|Phase I|Withdrawal by Subject|0|||
125672211|NCT01155583|452087025|FG002|Phase I|Withdrawal by Subject|0|||
125672212|NCT01155583|452087026|FG003|Phase I|Withdrawal by Subject|0|||
125672213|NCT01155583|452087027|FG004|Phase I|Withdrawal by Subject|0|||
125672214|NCT01155583|452087028|FG005|Phase I|Withdrawal by Subject|0|||
125672215|NCT01155583|452087029|FG006|Phase I|Withdrawal by Subject|0|||
125672216|NCT01155583|452087030|FG007|Phase I|Withdrawal by Subject|1|||
125672217|NCT01155583|452087031|FG008|Phase I|Withdrawal by Subject|0|||
125672218|NCT00952484|452087032|FG000|Overall Study|Withdrawal by Subject|0|||
125672219|NCT00952484|452087033|FG001|Overall Study|Withdrawal by Subject|1|||
125672220|NCT00952484|452087034|FG002|Overall Study|Withdrawal by Subject|0|||
125338079|NCT04838977|450871939|FG001|Overall Study|Withdrawal by Subject|1|||
125338080|NCT02314637|450871946|FG000|Overall Study|Adverse Event|4|||
125338081|NCT02314637|450871947|FG001|Overall Study|Adverse Event|8|||
125338082|NCT02314637|450871946|FG000|Overall Study|Lack of Efficacy|1|||
125338083|NCT02314637|450871947|FG001|Overall Study|Lack of Efficacy|0|||
125338084|NCT02314637|450871946|FG000|Overall Study|Physician Decision|5|||
125338085|NCT02314637|450871947|FG001|Overall Study|Physician Decision|2|||
125338086|NCT02314637|450871946|FG000|Overall Study|Withdrawal by Subject|5|||
125672221|NCT00886483|452087040|FG000|Overall Study|Lost to Follow-up|0|||
125672222|NCT00886483|452087041|FG001|Overall Study|Lost to Follow-up|1|||
125672223|NCT00886483|452087040|FG000|Overall Study|Pursue medications|1|||
125672224|NCT00886483|452087041|FG001|Overall Study|Pursue medications|2|||
125672225|NCT00886483|452087040|FG000|Overall Study|Distance to center, poor grades|1|||
125672226|NCT00886483|452087041|FG001|Overall Study|Distance to center, poor grades|0|||
125672227|NCT00585351|452087044|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
125672228|NCT00585351|452087045|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
125672229|NCT00585351|452087046|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
125338087|NCT02314637|450871947|FG001|Overall Study|Withdrawal by Subject|4|||
125338088|NCT02314637|450871946|FG000|Overall Study|Other Reason|1|||
125338089|NCT02314637|450871947|FG001|Overall Study|Other Reason|0|||
125338090|NCT00724867|450871950|FG000|Overall Study|Adverse Event|25|||
125338091|NCT00724867|450871950|FG000|Overall Study|Lack of Efficacy|14|||
125338092|NCT00724867|450871950|FG000|Overall Study|Lost to Follow-up|12|||
125338093|NCT00724867|450871950|FG000|Overall Study|Non-compliance with study drug|6|||
125338094|NCT00724867|450871950|FG000|Overall Study|Physician Decision|17|||
125338095|NCT00724867|450871950|FG000|Overall Study|Protocol Violation|1|||
125338096|NCT00724867|450871950|FG000|Overall Study|Withdrawal by Subject|31|||
125338097|NCT00724867|450871950|FG000|Overall Study|Sponsor decision to end study|14|||
125338098|NCT00724867|450871950|FG000|Overall Study|Subject incarcerated|1|||
125338099|NCT00724867|450871950|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
125338100|NCT00724867|450871950|FG000|Overall Study|Subject moved out of state|1|||
125338101|NCT00724867|450871950|FG000|Overall Study|Elected to exit due to site closure|2|||
125338102|NCT00373113|450871951|FG000|Overall Study|Death|1|||
125338103|NCT00373113|450871952|FG001|Overall Study|Death|7|||
125338104|NCT00373113|450871951|FG000|Overall Study|Adverse Event|38|||
125338105|NCT00373113|450871952|FG001|Overall Study|Adverse Event|24|||
125338106|NCT00373113|450871951|FG000|Overall Study|Study terminated by sponsor|9|||
125338107|NCT00373113|450871952|FG001|Overall Study|Study terminated by sponsor|1|||
125338108|NCT00373113|450871951|FG000|Overall Study|Global deterioration of health status|10|||
125338109|NCT00373113|450871952|FG001|Overall Study|Global deterioration of health status|7|||
125338110|NCT00373113|450871951|FG000|Overall Study|Lost to Follow-up|1|||
125338111|NCT00373113|450871952|FG001|Overall Study|Lost to Follow-up|3|||
125338112|NCT00373113|450871951|FG000|Overall Study|Objective progression or relapse|150|||
125338113|NCT00373113|450871952|FG001|Overall Study|Objective progression or relapse|169|||
125338114|NCT00373113|450871951|FG000|Overall Study|Other|14|||
125338115|NCT00373113|450871952|FG001|Overall Study|Other|17|||
125338116|NCT00373113|450871951|FG000|Overall Study|Protocol Violation|5|||
125338117|NCT00373113|450871952|FG001|Overall Study|Protocol Violation|1|||
125338118|NCT00373113|450871951|FG000|Overall Study|Withdrawal by Subject|10|||
125338119|NCT00373113|450871952|FG001|Overall Study|Withdrawal by Subject|15|||
125338120|NCT03120351|450871961|FG000|Overall Study|Physician Decision|1|||
125338121|NCT03120351|450871962|FG001|Overall Study|Physician Decision|1|||
125338122|NCT01256190|450871963|FG000|Overall Study|Lost to Follow-up|2|||
125338123|NCT01256190|450871964|FG001|Overall Study|Lost to Follow-up|0|||
125338124|NCT02834793|450871965|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
125338125|NCT02834793|450871966|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
125338126|NCT02834793|450871967|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
125338127|NCT02834793|450871968|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
125338128|NCT02834793|450871965|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
125338129|NCT02834793|450871966|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
125338130|NCT02834793|450871967|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
125338131|NCT02834793|450871968|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
125338132|NCT02834793|450871965|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
125338133|NCT02834793|450871966|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
125338134|NCT02834793|450871967|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
125338135|NCT02834793|450871968|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
125338136|NCT02834793|450871965|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
125338137|NCT02834793|450871966|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
125338138|NCT02834793|450871967|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
125338139|NCT02834793|450871968|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
125338140|NCT02834793|450871965|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
125338141|NCT02834793|450871966|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
125338142|NCT02834793|450871967|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
125338143|NCT02834793|450871968|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
125338144|NCT02834793|450871965|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
125338145|NCT02834793|450871966|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
125338146|NCT02834793|450871967|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
125338147|NCT02834793|450871968|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
125338148|NCT02834793|450871965|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
125338149|NCT02834793|450871966|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
125338150|NCT02834793|450871967|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
125338151|NCT02834793|450871968|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
125338152|NCT02834793|450871965|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
125338153|NCT02834793|450871966|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
125338154|NCT02834793|450871967|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
125338155|NCT02834793|450871968|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
125338156|NCT02834793|450871965|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
125338157|NCT02834793|450871966|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
125338158|NCT02834793|450871967|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
125338159|NCT02834793|450871968|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
125338160|NCT02834793|450871965|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
125338161|NCT02834793|450871966|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
125338162|NCT02834793|450871967|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
125338163|NCT02834793|450871968|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
125338164|NCT02834793|450871965|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
125338165|NCT02834793|450871966|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
125338166|NCT02834793|450871967|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
125338167|NCT02834793|450871968|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
125338168|NCT02834793|450871965|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
125338169|NCT02834793|450871966|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
125338170|NCT02834793|450871967|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
125338171|NCT02834793|450871968|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
125338172|NCT02834793|450871965|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
125338173|NCT02834793|450871966|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
125338174|NCT02834793|450871967|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
125338175|NCT02834793|450871968|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
125338176|NCT02834793|450871965|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
125338177|NCT02834793|450871966|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
125338178|NCT02834793|450871967|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
125338179|NCT02834793|450871968|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
125338180|NCT02834793|450871965|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
125338181|NCT02834793|450871966|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
125338182|NCT02834793|450871967|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
125338183|NCT02834793|450871968|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
125338184|NCT01049009|450871969|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
125338185|NCT01049009|450871970|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
125338186|NCT01049009|450871969|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125338187|NCT01049009|450871970|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
125338188|NCT01049009|450871969|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
125338189|NCT01049009|450871970|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
125338190|NCT01049009|450871969|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
125338191|NCT01049009|450871970|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
125338192|NCT02423902|450871971|FG000|Overall Study|Disease progression|1|||
125338193|NCT02423902|450871972|FG001|Overall Study|Disease progression|4|||
125338194|NCT00622440|450871985|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
125338195|NCT00622440|450871986|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
125338196|NCT00622440|450871985|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
125338197|NCT00622440|450871986|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
125338198|NCT00622440|450871985|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
125338199|NCT00622440|450871986|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
125338200|NCT00622440|450871985|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
125338201|NCT00622440|450871986|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
125672230|NCT00585351|452087047|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
125672231|NCT00585351|452087048|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
125672232|NCT00585351|452087049|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
125672233|NCT00585351|452087050|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
125672234|NCT00585351|452087051|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
125672235|NCT00585351|452087044|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
125672236|NCT00585351|452087045|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
125672237|NCT00585351|452087046|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
125672238|NCT00585351|452087047|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
125672239|NCT00585351|452087048|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
125672240|NCT00585351|452087049|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
125672241|NCT00585351|452087050|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
125672242|NCT00585351|452087051|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
125672243|NCT00585351|452087044|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
125672244|NCT00585351|452087045|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
125672245|NCT00585351|452087046|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
125672246|NCT00585351|452087047|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
125672247|NCT00585351|452087048|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
125672248|NCT00585351|452087049|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
125672249|NCT00585351|452087050|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
125672250|NCT00585351|452087051|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
125672251|NCT00585351|452087044|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
125672252|NCT00585351|452087045|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
125672253|NCT00585351|452087046|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
125672254|NCT00585351|452087047|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
125672255|NCT00585351|452087048|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
125672256|NCT00585351|452087049|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
125672257|NCT00585351|452087050|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
125672258|NCT00585351|452087051|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
125672259|NCT00585351|452087044|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
125672260|NCT00585351|452087045|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
125672261|NCT00585351|452087046|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
125672262|NCT00585351|452087047|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
125672263|NCT00585351|452087048|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
125672264|NCT00585351|452087049|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
125672265|NCT00585351|452087050|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
125672266|NCT00585351|452087051|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
125672267|NCT00585351|452087044|FG000|Enrollment Period (Intervention)|Death|0|||
125672268|NCT00585351|452087045|FG001|Enrollment Period (Intervention)|Death|0|||
125672269|NCT00585351|452087046|FG002|Enrollment Period (Intervention)|Death|0|||
125672270|NCT00585351|452087047|FG003|Enrollment Period (Intervention)|Death|0|||
125672271|NCT00585351|452087048|FG004|Enrollment Period (Intervention)|Death|1|||
125672272|NCT00585351|452087049|FG005|Enrollment Period (Intervention)|Death|0|||
125672273|NCT00585351|452087050|FG006|Enrollment Period (Intervention)|Death|1|||
125672274|NCT00585351|452087051|FG007|Enrollment Period (Intervention)|Death|0|||
125672275|NCT00585351|452087044|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
125672276|NCT00585351|452087045|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
125672277|NCT00585351|452087046|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
125672278|NCT00585351|452087047|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
125672279|NCT00585351|452087048|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
125672280|NCT00585351|452087049|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
125672281|NCT00585351|452087050|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
125672282|NCT00585351|452087051|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
125338202|NCT04195893|450871995|FG000|Second Intervention|Withdrawal by Subject|1|||
125338203|NCT04195893|450871996|FG001|Second Intervention|Withdrawal by Subject|0|||
125338204|NCT01802073|450871999|FG000|Overall Study|Lost to Follow-up|0|||
125338205|NCT01802073|450872000|FG001|Overall Study|Lost to Follow-up|1|||
125338206|NCT01802073|450871999|FG000|Overall Study|Non-compliant|4|||
125338207|NCT01802073|450872000|FG001|Overall Study|Non-compliant|2|||
125338208|NCT01802073|450871999|FG000|Overall Study|Withdrawal by Subject|1|||
125338209|NCT01802073|450872000|FG001|Overall Study|Withdrawal by Subject|1|||
125338210|NCT01802073|450871999|FG000|Overall Study|Physician Decision|0|||
125338211|NCT01802073|450872000|FG001|Overall Study|Physician Decision|7|||
125338212|NCT02123472|450872004|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
125338213|NCT02123472|450872005|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
125338214|NCT00918736|450872006|FG000|Overall Study|Withdrawal by Subject|4|||
125338215|NCT01474018|450872007|FG000|Overall Study|Lost to Follow-up|0|||
125338216|NCT01474018|450872008|FG001|Overall Study|Lost to Follow-up|1|||
125338217|NCT01474018|450872007|FG000|Overall Study|Withdrawal by Subject|0|||
125338218|NCT01474018|450872008|FG001|Overall Study|Withdrawal by Subject|2|||
125338219|NCT01137604|450872009|FG000|Overall Study|Adverse Event|3|||
125672283|NCT01842958|452087053|FG000|Overall Study|Lost to Follow-up|1|||
125672284|NCT01842958|452087054|FG001|Overall Study|Lost to Follow-up|1|||
125672285|NCT01829477|452087055|FG000|Overall Study|Study Terminated by Sponsor|15|||
125672286|NCT01829477|452087056|FG001|Overall Study|Study Terminated by Sponsor|15|||
125672287|NCT01829477|452087055|FG000|Overall Study|Withdrawal by Subject|1|||
125672288|NCT01829477|452087056|FG001|Overall Study|Withdrawal by Subject|0|||
125672289|NCT03361423|452087059|FG000|Overall Study|Withdrawal by Subject|4|||
125672290|NCT03361423|452087060|FG001|Overall Study|Withdrawal by Subject|3|||
125672291|NCT03361423|452087059|FG000|Overall Study|Did not treat|19|||
125672292|NCT03361423|452087060|FG001|Overall Study|Did not treat|18|||
125672293|NCT03361423|452087059|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
125672294|NCT03361423|452087060|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
125672295|NCT03361423|452087059|FG000|Overall Study|Missing data|4|||
125672296|NCT03361423|452087060|FG001|Overall Study|Missing data|1|||
125672297|NCT01336894|452087061|FG000|Follow-up|Study terminated prematurely|2|||
125672298|NCT01336894|452087062|FG001|Follow-up|Study terminated prematurely|7|||
125672299|NCT05034731|452087063|FG000|Overall Study|Screen fail|1|||
125672300|NCT05034731|452087064|FG001|Overall Study|Screen fail|1|||
125672301|NCT01325207|452087067|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
125672302|NCT01325207|452087068|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
125672303|NCT01325207|452087069|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
125672304|NCT01325207|452087070|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
125672305|NCT01325207|452087071|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
125672306|NCT01325207|452087072|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
125672307|NCT01325207|452087067|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
125672308|NCT01325207|452087068|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
125672309|NCT01325207|452087069|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
125672310|NCT01325207|452087070|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
125672311|NCT01325207|452087071|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
125672312|NCT01325207|452087072|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
125672313|NCT01325207|452087067|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
125672314|NCT01325207|452087068|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
125672315|NCT01325207|452087069|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
125672316|NCT01325207|452087070|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
125672317|NCT01325207|452087071|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
125672318|NCT01325207|452087072|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
125672319|NCT01325207|452087067|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
125672320|NCT01325207|452087068|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
125672321|NCT01325207|452087069|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
125672322|NCT01325207|452087070|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
125672323|NCT01325207|452087071|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
125672324|NCT01325207|452087072|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
125672325|NCT01325207|452087067|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
125672326|NCT01325207|452087068|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
125672327|NCT01325207|452087069|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
125672328|NCT01325207|452087070|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
125672329|NCT01325207|452087071|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
125672330|NCT01325207|452087072|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
125672331|NCT01325207|452087067|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
125672332|NCT01325207|452087068|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
125672333|NCT01325207|452087069|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
125338220|NCT01137604|450872010|FG001|Overall Study|Adverse Event|6|||
125338221|NCT01137604|450872011|FG002|Overall Study|Adverse Event|9|||
125338222|NCT01137604|450872012|FG003|Overall Study|Adverse Event|9|||
125338223|NCT01137604|450872009|FG000|Overall Study|Participant Choice|0|||
125338224|NCT01137604|450872010|FG001|Overall Study|Participant Choice|2|||
125338225|NCT01137604|450872011|FG002|Overall Study|Participant Choice|2|||
125338226|NCT01137604|450872012|FG003|Overall Study|Participant Choice|0|||
125338227|NCT01137604|450872009|FG000|Overall Study|Withdrawal of consent|0|||
125338228|NCT01137604|450872010|FG001|Overall Study|Withdrawal of consent|0|||
125338229|NCT01137604|450872011|FG002|Overall Study|Withdrawal of consent|0|||
125338230|NCT01137604|450872012|FG003|Overall Study|Withdrawal of consent|2|||
125338231|NCT01137604|450872009|FG000|Overall Study|Clinical progression/deterioration|1|||
125338232|NCT01137604|450872010|FG001|Overall Study|Clinical progression/deterioration|2|||
125338233|NCT01137604|450872011|FG002|Overall Study|Clinical progression/deterioration|2|||
125338234|NCT01137604|450872012|FG003|Overall Study|Clinical progression/deterioration|0|||
125338235|NCT01297491|450872013|FG000|Overall Study|Adverse Event|11|||
125338236|NCT01297491|450872014|FG001|Overall Study|Adverse Event|6|||
125338237|NCT01297491|450872013|FG000|Overall Study|Physician Decision|3|||
125338238|NCT01297491|450872014|FG001|Overall Study|Physician Decision|2|||
125338239|NCT01297491|450872013|FG000|Overall Study|Progressive disease|11|||
125338240|NCT01297491|450872014|FG001|Overall Study|Progressive disease|20|||
125338241|NCT01297491|450872013|FG000|Overall Study|Patient/Guardian decision|3|||
125338242|NCT01297491|450872014|FG001|Overall Study|Patient/Guardian decision|4|||
125338243|NCT01297491|450872013|FG000|Overall Study|Death|2|||
125338244|NCT01297491|450872014|FG001|Overall Study|Death|1|||
125338245|NCT00312195|450872015|FG000|Overall Study|Adverse Event|4|||
125540909|NCT01237587|451609478|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
125338246|NCT00312195|450872016|FG001|Overall Study|Adverse Event|6|||
125338247|NCT00312195|450872015|FG000|Overall Study|Lost to Follow-up|1|||
125338248|NCT00312195|450872016|FG001|Overall Study|Lost to Follow-up|0|||
125338249|NCT00312195|450872015|FG000|Overall Study|Protocol Violation|1|||
125338250|NCT00312195|450872016|FG001|Overall Study|Protocol Violation|0|||
125338251|NCT02511106|450872017|FG000|Overall Study|Lost to Follow-up|6|||
125338252|NCT02511106|450872018|FG001|Overall Study|Lost to Follow-up|4|||
125338253|NCT02511106|450872017|FG000|Overall Study|Withdrawal by Subject|24|||
125338254|NCT02511106|450872018|FG001|Overall Study|Withdrawal by Subject|21|||
125338255|NCT02511106|450872017|FG000|Overall Study|Death|42|||
125672334|NCT01325207|452087070|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
125672335|NCT01325207|452087071|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
125672336|NCT01325207|452087072|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
125672337|NCT01325207|452087067|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
125672338|NCT01325207|452087068|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
125672339|NCT01325207|452087069|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
125672340|NCT01325207|452087070|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
125672341|NCT01325207|452087071|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
125672342|NCT01325207|452087072|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
125672343|NCT00602030|452087073|FG000|Lead-in Phase|Disease Progression|2|||
125672344|NCT00602030|452087074|FG001|Lead-in Phase|Disease Progression|3|||
125672345|NCT00602030|452087075|FG002|Lead-in Phase|Disease Progression|0|||
125672346|NCT00602030|452087076|FG003|Lead-in Phase|Disease Progression|0|||
125672347|NCT00602030|452087077|FG004|Lead-in Phase|Disease Progression|0|||
125672348|NCT00602030|452087073|FG000|Lead-in Phase|Adverse Event|0|||
125672349|NCT00602030|452087074|FG001|Lead-in Phase|Adverse Event|2|||
125672350|NCT00602030|452087075|FG002|Lead-in Phase|Adverse Event|0|||
125672351|NCT00602030|452087076|FG003|Lead-in Phase|Adverse Event|0|||
125672352|NCT00602030|452087077|FG004|Lead-in Phase|Adverse Event|0|||
125672353|NCT00602030|452087073|FG000|Double-blind Phase|Disease progression|0|||
125672354|NCT00602030|452087074|FG001|Double-blind Phase|Disease progression|0|||
125672355|NCT00602030|452087075|FG002|Double-blind Phase|Disease progression|33|||
125672356|NCT00602030|452087076|FG003|Double-blind Phase|Disease progression|30|||
125672357|NCT00602030|452087077|FG004|Double-blind Phase|Disease progression|0|||
125672358|NCT00602030|452087073|FG000|Double-blind Phase|Adverse Event|0|||
125672359|NCT00602030|452087074|FG001|Double-blind Phase|Adverse Event|0|||
125672360|NCT00602030|452087075|FG002|Double-blind Phase|Adverse Event|9|||
125672361|NCT00602030|452087076|FG003|Double-blind Phase|Adverse Event|18|||
125672362|NCT00602030|452087077|FG004|Double-blind Phase|Adverse Event|0|||
125672363|NCT00602030|452087073|FG000|Double-blind Phase|Consent withdrawal|0|||
125672364|NCT00602030|452087074|FG001|Double-blind Phase|Consent withdrawal|0|||
125672365|NCT00602030|452087075|FG002|Double-blind Phase|Consent withdrawal|4|||
125672366|NCT00602030|452087076|FG003|Double-blind Phase|Consent withdrawal|3|||
125672367|NCT00602030|452087077|FG004|Double-blind Phase|Consent withdrawal|0|||
125672368|NCT00602030|452087073|FG000|Double-blind Phase|Death|0|||
125672369|NCT00602030|452087074|FG001|Double-blind Phase|Death|0|||
125672370|NCT00602030|452087075|FG002|Double-blind Phase|Death|3|||
125672371|NCT00602030|452087076|FG003|Double-blind Phase|Death|3|||
125672372|NCT00602030|452087077|FG004|Double-blind Phase|Death|0|||
125672373|NCT00602030|452087073|FG000|Double-blind Phase|Administrative decision|0|||
125672374|NCT00602030|452087074|FG001|Double-blind Phase|Administrative decision|0|||
125672375|NCT00602030|452087075|FG002|Double-blind Phase|Administrative decision|0|||
125672376|NCT00602030|452087076|FG003|Double-blind Phase|Administrative decision|2|||
125672377|NCT00602030|452087077|FG004|Double-blind Phase|Administrative decision|0|||
125672378|NCT00602030|452087073|FG000|Double-blind Phase|Ineligibility|0|||
125672379|NCT00602030|452087074|FG001|Double-blind Phase|Ineligibility|0|||
125672380|NCT00602030|452087075|FG002|Double-blind Phase|Ineligibility|0|||
125672381|NCT00602030|452087076|FG003|Double-blind Phase|Ineligibility|1|||
125672382|NCT00602030|452087077|FG004|Double-blind Phase|Ineligibility|0|||
125672383|NCT00602030|452087073|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
125672384|NCT00602030|452087074|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
125672385|NCT00602030|452087075|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
125672386|NCT00602030|452087076|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
125672387|NCT00602030|452087077|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
125672388|NCT00602030|452087073|FG000|Double-blind Phase|Reason not specified|0|||
125672389|NCT00602030|452087074|FG001|Double-blind Phase|Reason not specified|0|||
125672390|NCT00602030|452087075|FG002|Double-blind Phase|Reason not specified|4|||
125672391|NCT00602030|452087076|FG003|Double-blind Phase|Reason not specified|2|||
125672392|NCT00602030|452087077|FG004|Double-blind Phase|Reason not specified|0|||
125672393|NCT00602030|452087073|FG000|Crossover Phase|Disease Progression|0|||
125672394|NCT00602030|452087074|FG001|Crossover Phase|Disease Progression|0|||
125338256|NCT02511106|450872018|FG001|Overall Study|Death|82|||
125338257|NCT02511106|450872017|FG000|Overall Study|Ongoing study at data cut-off|3|||
125672395|NCT00602030|452087075|FG002|Crossover Phase|Disease Progression|0|||
125672396|NCT00602030|452087076|FG003|Crossover Phase|Disease Progression|0|||
125338258|NCT02511106|450872018|FG001|Overall Study|Ongoing study at data cut-off|2|||
125338259|NCT02511106|450872017|FG000|Overall Study|Without specified reason|3|||
125338260|NCT02511106|450872018|FG001|Overall Study|Without specified reason|0|||
125338261|NCT00344487|450872024|FG000|Overall Study|immunologic failure|1|||
125338262|NCT03679754|450872025|FG000|Overall Study|Investigator request|1|||
125338263|NCT01262820|450872026|FG000|Overall Study|Adverse Event|5|||
125338264|NCT01262820|450872026|FG000|Overall Study|Lack of Efficacy|9|||
125338265|NCT01262820|450872026|FG000|Overall Study|Drug held for 21+ days|1|||
125338266|NCT00711477|450872027|FG000|Overall Study|Adverse Event|3|||
125338267|NCT00711477|450872028|FG001|Overall Study|Adverse Event|1|||
125338268|NCT00711477|450872027|FG000|Overall Study|Lost to Follow-up|0|||
125338269|NCT00711477|450872028|FG001|Overall Study|Lost to Follow-up|1|||
125338270|NCT00711477|450872027|FG000|Overall Study|Noncompliance|0|||
125338271|NCT00711477|450872028|FG001|Overall Study|Noncompliance|1|||
125338272|NCT00145977|450872034|FG000|Overall Study|Lack of Efficacy|0|||
125338273|NCT00145977|450872035|FG001|Overall Study|Lack of Efficacy|4|||
125338274|NCT00145977|450872034|FG000|Overall Study|Lost to Follow-up|1|||
125338275|NCT00145977|450872035|FG001|Overall Study|Lost to Follow-up|0|||
125338276|NCT00145977|450872034|FG000|Overall Study|Withdrawal by Subject|1|||
125338277|NCT00145977|450872035|FG001|Overall Study|Withdrawal by Subject|0|||
125338278|NCT00782834|450872042|FG000|Treatment Phase|fibrous tumor not GIST|1|||
125338279|NCT02055118|450872043|FG000|Overall Study|Withdrawal by Subject|0|||
125338280|NCT02055118|450872044|FG001|Overall Study|Withdrawal by Subject|2|||
125338281|NCT02055118|450872045|FG002|Overall Study|Withdrawal by Subject|0|||
125338282|NCT02281383|450872046|FG000|Overall Study|Progressive Disease|1|||
125338283|NCT02281383|450872046|FG000|Overall Study|Withdrawal by Subject|6|||
125338284|NCT02281383|450872046|FG000|Overall Study|Protocol Violation|2|||
125338285|NCT02281383|450872046|FG000|Overall Study|Death|1|||
125338286|NCT02281383|450872046|FG000|Overall Study|Adverse Event|2|||
125338287|NCT02560025|450872049|FG000|Overall Study|Ineligible after consent/ registration|3|||
125338288|NCT02703337|450872050|FG000|Period One (Part A)|Withdrawal by Subject|0|||
125338289|NCT02703337|450872051|FG001|Period One (Part A)|Withdrawal by Subject|0|||
125338290|NCT02703337|450872052|FG002|Period One (Part A)|Withdrawal by Subject|0|||
125338291|NCT02703337|450872053|FG003|Period One (Part A)|Withdrawal by Subject|0|||
125338292|NCT02703337|450872054|FG004|Period One (Part A)|Withdrawal by Subject|1|||
125338293|NCT02703337|450872055|FG005|Period One (Part A)|Withdrawal by Subject|0|||
125338294|NCT02703337|450872056|FG006|Period One (Part A)|Withdrawal by Subject|0|||
125338295|NCT02703337|450872057|FG007|Period One (Part A)|Withdrawal by Subject|0|||
125338296|NCT00282308|450872058|FG000|Treatment Period|Lost to Follow-up|1|||
125338297|NCT00282308|450872059|FG001|Treatment Period|Lost to Follow-up|0|||
125338298|NCT00282308|450872060|FG002|Treatment Period|Lost to Follow-up|0|||
125338299|NCT00282308|450872058|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
125338300|NCT00282308|450872059|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
125338301|NCT00282308|450872060|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
125338302|NCT00282308|450872058|FG000|Treatment Period|Adverse Event|0|||
125338303|NCT00282308|450872059|FG001|Treatment Period|Adverse Event|2|||
125338304|NCT00282308|450872060|FG002|Treatment Period|Adverse Event|0|||
125338305|NCT00282308|450872058|FG000|Treatment Period|Not Treated with Study Drug|1|||
125338306|NCT00282308|450872059|FG001|Treatment Period|Not Treated with Study Drug|0|||
125338307|NCT00282308|450872060|FG002|Treatment Period|Not Treated with Study Drug|0|||
125338308|NCT00282308|450872058|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
125338309|NCT00282308|450872059|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
125338310|NCT00282308|450872060|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
125338311|NCT00282308|450872058|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
125338312|NCT00282308|450872059|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
125338313|NCT00282308|450872060|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
125338314|NCT00282308|450872058|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
125338315|NCT00282308|450872059|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
125338316|NCT00282308|450872060|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
125338317|NCT00282308|450872058|FG000|Safety Follow-up Period|Adverse Event|0|||
125338318|NCT00282308|450872059|FG001|Safety Follow-up Period|Adverse Event|0|||
125338319|NCT00282308|450872060|FG002|Safety Follow-up Period|Adverse Event|1|||
125338320|NCT00282308|450872058|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
125338321|NCT00282308|450872059|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
125338322|NCT00282308|450872060|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
125338323|NCT00282308|450872058|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
125338324|NCT00282308|450872059|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
125338325|NCT00282308|450872060|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
125338326|NCT00282308|450872058|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
125338327|NCT00282308|450872059|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
125338328|NCT00282308|450872060|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
125338329|NCT01001325|450872061|FG000|Overall Study|Lost to Follow-up|16|||
125338330|NCT01001325|450872062|FG001|Overall Study|Lost to Follow-up|10|||
125338331|NCT01001325|450872061|FG000|Overall Study|Protocol Violation|2|||
125338332|NCT01001325|450872062|FG001|Overall Study|Protocol Violation|0|||
125338333|NCT01584440|450872063|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
125338334|NCT01584440|450872064|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
125338335|NCT01584440|450872065|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
125338336|NCT01584440|450872066|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
125338337|NCT01584440|450872067|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
125338338|NCT01584440|450872063|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
125338339|NCT01584440|450872064|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
125338340|NCT01584440|450872065|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
125338341|NCT01584440|450872066|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
125338342|NCT01584440|450872067|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
125338343|NCT01584440|450872063|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
125338344|NCT01584440|450872064|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
125338345|NCT01584440|450872065|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
125338346|NCT01584440|450872066|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
125338347|NCT01584440|450872067|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
125338348|NCT01584440|450872063|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
125338349|NCT01584440|450872064|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
125338350|NCT01584440|450872065|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
125338351|NCT01584440|450872066|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
125338352|NCT01584440|450872067|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
125338353|NCT01584440|450872063|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
125338354|NCT01584440|450872064|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
125338355|NCT01584440|450872065|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
125338356|NCT01584440|450872066|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
125338357|NCT01584440|450872067|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
125338358|NCT01584440|450872063|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
125338359|NCT01584440|450872064|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
125338360|NCT01584440|450872065|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
125338361|NCT01584440|450872066|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
125338362|NCT01584440|450872067|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
125338363|NCT01584440|450872063|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
125338364|NCT01584440|450872064|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
125338365|NCT01584440|450872065|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
125338366|NCT01584440|450872066|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
125338367|NCT01584440|450872067|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
125338368|NCT01584440|450872063|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
125338369|NCT01584440|450872064|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
125338370|NCT01584440|450872065|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
125338371|NCT01584440|450872066|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
125338372|NCT01584440|450872067|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
125338373|NCT01584440|450872063|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
125338374|NCT01584440|450872064|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
125338375|NCT01584440|450872065|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
125338376|NCT01584440|450872066|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
125338377|NCT01584440|450872067|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
125338378|NCT00531427|450872068|FG000|Overall Study|Withdrawal by Subject|7|||
125338379|NCT00531427|450872069|FG001|Overall Study|Withdrawal by Subject|13|||
125338380|NCT00531427|450872068|FG000|Overall Study|Adverse Event|44|||
125338381|NCT00531427|450872069|FG001|Overall Study|Adverse Event|30|||
125338382|NCT00531427|450872068|FG000|Overall Study|Lost to Follow-up|4|||
125338383|NCT00531427|450872069|FG001|Overall Study|Lost to Follow-up|3|||
125338384|NCT00531427|450872068|FG000|Overall Study|Lack of Efficacy|14|||
125338385|NCT00531427|450872069|FG001|Overall Study|Lack of Efficacy|39|||
125338386|NCT00531427|450872068|FG000|Overall Study|Administrative|4|||
125338387|NCT00531427|450872069|FG001|Overall Study|Administrative|9|||
125338388|NCT02626624|450872084|FG000|Overall Study|Adverse Event|1|||
125338389|NCT02626624|450872084|FG000|Overall Study|Lost to Follow-up|3|||
125338390|NCT02626624|450872084|FG000|Overall Study|Protocol Violation|4|||
125338391|NCT02626624|450872084|FG000|Overall Study|Death|2|||
125338392|NCT00122980|450874169|FG000|Overall Study|Death|0|||
125338393|NCT00122980|450874170|FG001|Overall Study|Death|1|||
125338394|NCT00122980|450874169|FG000|Overall Study|Physician Decision|2|||
125338395|NCT00122980|450874170|FG001|Overall Study|Physician Decision|0|||
125338396|NCT00122980|450874169|FG000|Overall Study|Protocol Violation|5|||
125338397|NCT00122980|450874170|FG001|Overall Study|Protocol Violation|1|||
125338398|NCT00122980|450874169|FG000|Overall Study|Withdrawal by Subject|2|||
125338399|NCT00122980|450874170|FG001|Overall Study|Withdrawal by Subject|3|||
125338400|NCT00122980|450874169|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
125338401|NCT00122980|450874170|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
125338402|NCT00122980|450874169|FG000|Overall Study|Study termination|27|||
125338403|NCT00122980|450874170|FG001|Overall Study|Study termination|35|||
125338404|NCT01124864|450874171|FG000|Overall Study|Follow up phase competed as per protocol|18|||
125338405|NCT01124864|450874172|FG001|Overall Study|Follow up phase competed as per protocol|22|||
125338406|NCT01124864|450874173|FG002|Overall Study|Follow up phase competed as per protocol|24|||
125338407|NCT01124864|450874174|FG003|Overall Study|Follow up phase competed as per protocol|18|||
125338408|NCT01124864|450874175|FG004|Overall Study|Follow up phase competed as per protocol|26|||
125338409|NCT01124864|450874176|FG005|Overall Study|Follow up phase competed as per protocol|2|||
125338410|NCT01124864|450874171|FG000|Overall Study|Death|6|||
125338411|NCT01124864|450874172|FG001|Overall Study|Death|9|||
125338412|NCT01124864|450874173|FG002|Overall Study|Death|6|||
125338413|NCT01124864|450874174|FG003|Overall Study|Death|2|||
125338414|NCT01124864|450874175|FG004|Overall Study|Death|1|||
125338415|NCT01124864|450874176|FG005|Overall Study|Death|0|||
125338416|NCT01124864|450874171|FG000|Overall Study|Withdrawal by Subject|2|||
125672397|NCT00602030|452087077|FG004|Crossover Phase|Disease Progression|11|||
125672398|NCT00602030|452087073|FG000|Crossover Phase|Adverse Event|0|||
125672399|NCT00602030|452087074|FG001|Crossover Phase|Adverse Event|0|||
125672400|NCT00602030|452087075|FG002|Crossover Phase|Adverse Event|0|||
125338417|NCT01124864|450874172|FG001|Overall Study|Withdrawal by Subject|3|||
125338418|NCT01124864|450874173|FG002|Overall Study|Withdrawal by Subject|4|||
125338419|NCT01124864|450874174|FG003|Overall Study|Withdrawal by Subject|0|||
125338420|NCT01124864|450874175|FG004|Overall Study|Withdrawal by Subject|2|||
125338421|NCT01124864|450874176|FG005|Overall Study|Withdrawal by Subject|1|||
125338422|NCT01124864|450874171|FG000|Overall Study|Lost to Follow-up|1|||
125672401|NCT00602030|452087076|FG003|Crossover Phase|Adverse Event|0|||
125338423|NCT01124864|450874172|FG001|Overall Study|Lost to Follow-up|1|||
125338424|NCT01124864|450874173|FG002|Overall Study|Lost to Follow-up|0|||
125338425|NCT01124864|450874174|FG003|Overall Study|Lost to Follow-up|1|||
125338426|NCT01124864|450874175|FG004|Overall Study|Lost to Follow-up|0|||
125338427|NCT01124864|450874176|FG005|Overall Study|Lost to Follow-up|0|||
125672402|NCT00602030|452087077|FG004|Crossover Phase|Adverse Event|3|||
125338428|NCT01124864|450874171|FG000|Overall Study|Protocol Violation|1|||
125672403|NCT00602030|452087073|FG000|Crossover Phase|Consent withdrawal|0|||
125672404|NCT00602030|452087074|FG001|Crossover Phase|Consent withdrawal|0|||
125672405|NCT00602030|452087075|FG002|Crossover Phase|Consent withdrawal|0|||
125672406|NCT00602030|452087076|FG003|Crossover Phase|Consent withdrawal|0|||
125672407|NCT00602030|452087077|FG004|Crossover Phase|Consent withdrawal|2|||
125672408|NCT00283686|452087079|FG000|Overall Study|Death|1|||
125672409|NCT00283686|452087080|FG001|Overall Study|Death|1|||
125672410|NCT00283686|452087081|FG002|Overall Study|Death|1|||
125672411|NCT00283686|452087082|FG003|Overall Study|Death|0|||
125672412|NCT00283686|452087079|FG000|Overall Study|Lost to Follow-up|21|||
125672413|NCT00283686|452087080|FG001|Overall Study|Lost to Follow-up|31|||
125672414|NCT00283686|452087081|FG002|Overall Study|Lost to Follow-up|26|||
125672415|NCT00283686|452087082|FG003|Overall Study|Lost to Follow-up|20|||
125672416|NCT00283686|452087079|FG000|Overall Study|Less than full participation|7|||
125672417|NCT00283686|452087080|FG001|Overall Study|Less than full participation|9|||
125672418|NCT00283686|452087081|FG002|Overall Study|Less than full participation|6|||
125672419|NCT00283686|452087082|FG003|Overall Study|Less than full participation|12|||
125672420|NCT00876733|452087085|FG000|Overall Study|Adverse Event|34|||
125672421|NCT00876733|452087086|FG001|Overall Study|Adverse Event|20|||
125672422|NCT00876733|452087087|FG002|Overall Study|Adverse Event|10|||
125672423|NCT00876733|452087088|FG003|Overall Study|Adverse Event|3|||
125672424|NCT00876733|452087085|FG000|Overall Study|Lack of Efficacy|17|||
125672425|NCT00876733|452087086|FG001|Overall Study|Lack of Efficacy|9|||
125672426|NCT00876733|452087087|FG002|Overall Study|Lack of Efficacy|10|||
125672427|NCT00876733|452087088|FG003|Overall Study|Lack of Efficacy|1|||
125672428|NCT00876733|452087085|FG000|Overall Study|Lost to Follow-up|26|||
125672429|NCT00876733|452087086|FG001|Overall Study|Lost to Follow-up|10|||
125672430|NCT00876733|452087087|FG002|Overall Study|Lost to Follow-up|3|||
125672431|NCT00876733|452087088|FG003|Overall Study|Lost to Follow-up|2|||
125672432|NCT00876733|452087085|FG000|Overall Study|Data not available|14|||
125672433|NCT00876733|452087086|FG001|Overall Study|Data not available|3|||
125672434|NCT00876733|452087087|FG002|Overall Study|Data not available|7|||
125672435|NCT00876733|452087088|FG003|Overall Study|Data not available|1|||
125672436|NCT05476679|452087089|FG000|Overall Study|Withdrawal by Subject|0|||
125672437|NCT05476679|452087090|FG001|Overall Study|Withdrawal by Subject|0|||
125672438|NCT05476679|452087091|FG002|Overall Study|Withdrawal by Subject|0|||
125672439|NCT05476679|452087092|FG003|Overall Study|Withdrawal by Subject|1|||
125672440|NCT05476679|452087093|FG004|Overall Study|Withdrawal by Subject|0|||
125672441|NCT05476679|452087089|FG000|Overall Study|Lost to Follow-up|0|||
125672442|NCT05476679|452087090|FG001|Overall Study|Lost to Follow-up|0|||
125672443|NCT05476679|452087091|FG002|Overall Study|Lost to Follow-up|0|||
125672444|NCT05476679|452087092|FG003|Overall Study|Lost to Follow-up|1|||
125672445|NCT05476679|452087093|FG004|Overall Study|Lost to Follow-up|0|||
125672446|NCT00467584|452087098|FG000|Overall Study|Withdrawal by Subject|4|||
125672447|NCT00467584|452087099|FG001|Overall Study|Withdrawal by Subject|5|||
125672448|NCT00467584|452087100|FG002|Overall Study|Withdrawal by Subject|1|||
125672449|NCT00319956|452087101|FG000|Overall Study|Death|20|||
125672450|NCT00319956|452087102|FG001|Overall Study|Death|24|||
125672451|NCT02607800|452087104|FG000|Overall Study|Lost to Follow-up|7|||
125672452|NCT02607800|452087105|FG001|Overall Study|Lost to Follow-up|10|||
125672453|NCT02607800|452087104|FG000|Overall Study|Withdrew Consent|2|||
125672454|NCT02607800|452087105|FG001|Overall Study|Withdrew Consent|0|||
125672455|NCT02607800|452087104|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
125672456|NCT02607800|452087105|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
125672457|NCT00753714|452087106|FG000|Overall Study|Lack of Efficacy|21|||
125672458|NCT00753714|452087107|FG001|Overall Study|Lack of Efficacy|34|||
125672459|NCT00753714|452087106|FG000|Overall Study|Adverse Event|26|||
125672460|NCT00753714|452087107|FG001|Overall Study|Adverse Event|18|||
125672461|NCT00753714|452087106|FG000|Overall Study|Protocol Violation|1|||
125672462|NCT00753714|452087107|FG001|Overall Study|Protocol Violation|0|||
125672463|NCT00753714|452087106|FG000|Overall Study|Lost to Follow-up|0|||
125672464|NCT00753714|452087107|FG001|Overall Study|Lost to Follow-up|1|||
125672465|NCT00753714|452087106|FG000|Overall Study|Withdrawal by Subject|2|||
125672466|NCT00753714|452087107|FG001|Overall Study|Withdrawal by Subject|1|||
125672467|NCT00753714|452087106|FG000|Overall Study|Death|3|||
125672468|NCT00753714|452087107|FG001|Overall Study|Death|3|||
125672469|NCT00753714|452087106|FG000|Overall Study|Other|7|||
125672470|NCT00753714|452087107|FG001|Overall Study|Other|5|||
125672471|NCT02486796|452087108|FG000|Overall Study|Withdrawal by Subject|1|||
125672472|NCT02486796|452087109|FG001|Overall Study|Withdrawal by Subject|1|||
125672473|NCT02486796|452087108|FG000|Overall Study|Physician Decision|1|||
125672474|NCT02486796|452087109|FG001|Overall Study|Physician Decision|0|||
125672475|NCT02789111|452087110|FG000|Overall Study|Withdrawal by Subject|1|||
125672476|NCT02789111|452087111|FG001|Overall Study|Withdrawal by Subject|4|||
125672477|NCT01118728|452087116|FG000|Overall Study|Adverse Event|17|||
125540910|NCT01237587|451609479|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
125672478|NCT01118728|452087116|FG000|Overall Study|Lack of Efficacy|27|||
125672479|NCT01118728|452087116|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
125338429|NCT01124864|450874172|FG001|Overall Study|Protocol Violation|0|||
125338430|NCT01124864|450874173|FG002|Overall Study|Protocol Violation|0|||
125338431|NCT01124864|450874174|FG003|Overall Study|Protocol Violation|0|||
125338432|NCT01124864|450874175|FG004|Overall Study|Protocol Violation|1|||
125338433|NCT01124864|450874176|FG005|Overall Study|Protocol Violation|0|||
125338434|NCT01243242|450874177|FG000|Overall Study|Adverse Event|1|||
125338435|NCT01243242|450874178|FG001|Overall Study|Adverse Event|1|||
125338436|NCT01243242|450874177|FG000|Overall Study|Withdrawal by Subject|1|||
125338437|NCT01243242|450874178|FG001|Overall Study|Withdrawal by Subject|1|||
125338438|NCT01243242|450874177|FG000|Overall Study|Physician Decision|0|||
125338439|NCT01243242|450874178|FG001|Overall Study|Physician Decision|1|||
125338440|NCT01243242|450874177|FG000|Overall Study|sponsor decision|0|||
125338441|NCT01243242|450874178|FG001|Overall Study|sponsor decision|1|||
125338442|NCT01243242|450874177|FG000|Overall Study|non compliance|1|||
125338443|NCT01243242|450874178|FG001|Overall Study|non compliance|0|||
125338444|NCT00724711|450874179|FG000|Overall Study|Adverse Event|7|||
125338445|NCT00724711|450874180|FG001|Overall Study|Adverse Event|3|||
125338446|NCT00724711|450874179|FG000|Overall Study|Pregnancy|0|||
125338447|NCT00724711|450874180|FG001|Overall Study|Pregnancy|1|||
125338448|NCT00724711|450874179|FG000|Overall Study|Lack of Efficacy|0|||
125338449|NCT00724711|450874180|FG001|Overall Study|Lack of Efficacy|1|||
125338450|NCT00724711|450874179|FG000|Overall Study|Physician Decision|0|||
125540911|NCT01237587|451609478|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
125672480|NCT01118728|452087116|FG000|Overall Study|Withdrawal by Subject|3|||
125672481|NCT01118728|452087116|FG000|Overall Study|Lost to Follow-up|4|||
125672482|NCT04345471|452087117|FG000|Overall Study|Adverse Event|8|||
125672483|NCT04345471|452087118|FG001|Overall Study|Adverse Event|5|||
125672484|NCT04345471|452087119|FG002|Overall Study|Adverse Event|6|||
125672485|NCT04345471|452087117|FG000|Overall Study|Lack of Efficacy|1|||
125672486|NCT04345471|452087118|FG001|Overall Study|Lack of Efficacy|1|||
125672487|NCT04345471|452087119|FG002|Overall Study|Lack of Efficacy|0|||
125672488|NCT04345471|452087117|FG000|Overall Study|Protocol Violation|0|||
125672489|NCT04345471|452087118|FG001|Overall Study|Protocol Violation|1|||
125672490|NCT04345471|452087119|FG002|Overall Study|Protocol Violation|2|||
125672491|NCT04345471|452087117|FG000|Overall Study|Withdrawal by Subject|10|||
125672492|NCT04345471|452087118|FG001|Overall Study|Withdrawal by Subject|5|||
125672493|NCT04345471|452087119|FG002|Overall Study|Withdrawal by Subject|10|||
125672494|NCT01890707|452087120|FG000|Overall Study|Lost to Follow-up|1|||
125672495|NCT01890707|452087121|FG001|Overall Study|Lost to Follow-up|1|||
125672496|NCT00385541|452087122|FG000|Overall Study|severe pain, clinician requested unblind|0|||
125672497|NCT00385541|452087123|FG001|Overall Study|severe pain, clinician requested unblind|1|||
125338451|NCT00724711|450874180|FG001|Overall Study|Physician Decision|3|||
125338452|NCT00724711|450874179|FG000|Overall Study|Withdrawal by Subject|5|||
125338453|NCT00724711|450874180|FG001|Overall Study|Withdrawal by Subject|4|||
125338454|NCT00724711|450874179|FG000|Overall Study|Lost to Follow-up|4|||
125338455|NCT00724711|450874180|FG001|Overall Study|Lost to Follow-up|5|||
125338456|NCT00724711|450874179|FG000|Overall Study|Protocol Violation|1|||
125672498|NCT00506753|452088824|FG000|Overall Study|Lost to Follow-up|21|||
125672499|NCT00506753|452088825|FG001|Overall Study|Lost to Follow-up|15|||
125672500|NCT00125359|452088826|FG000|Overall Study|Death|4|||
125672501|NCT00125359|452088826|FG000|Overall Study|Adverse Event|5|||
125672502|NCT00125359|452088826|FG000|Overall Study|Physician Decision|14|||
125672503|NCT02451670|452088827|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
125672504|NCT02451670|452088828|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
125672505|NCT01513551|452088829|FG000|Overall Study|Death|0|||
125672506|NCT01513551|452088830|FG001|Overall Study|Death|1|||
125672507|NCT01513551|452088831|FG002|Overall Study|Death|0|||
125672508|NCT01513551|452088829|FG000|Overall Study|Lost to Follow-up|3|||
125672509|NCT01513551|452088830|FG001|Overall Study|Lost to Follow-up|5|||
125672510|NCT01513551|452088831|FG002|Overall Study|Lost to Follow-up|2|||
125672511|NCT01513551|452088829|FG000|Overall Study|Withdrawal by Subject|1|||
125672512|NCT01513551|452088830|FG001|Overall Study|Withdrawal by Subject|0|||
125672513|NCT01513551|452088831|FG002|Overall Study|Withdrawal by Subject|2|||
125672514|NCT01513551|452088829|FG000|Overall Study|Randomized but not vaccinated|0|||
125672515|NCT01513551|452088830|FG001|Overall Study|Randomized but not vaccinated|0|||
125672516|NCT01513551|452088831|FG002|Overall Study|Randomized but not vaccinated|1|||
125672517|NCT00094302|452088833|FG000|Overall Study|Lost to Follow-up|43|||
125672518|NCT00094302|452088834|FG001|Overall Study|Lost to Follow-up|41|||
125672519|NCT00094302|452088833|FG000|Overall Study|Physician Decision|5|||
125672520|NCT00094302|452088834|FG001|Overall Study|Physician Decision|8|||
125672521|NCT00094302|452088833|FG000|Overall Study|Withdrawal by Subject|103|||
125672522|NCT00094302|452088834|FG001|Overall Study|Withdrawal by Subject|111|||
125672523|NCT00094302|452088833|FG000|Overall Study|Death|266|||
125672524|NCT00094302|452088834|FG001|Overall Study|Death|246|||
125672525|NCT03705351|452088835|FG000|Overall Study|Study termination|3|||
125672526|NCT03705351|452088835|FG000|Overall Study|Death|1|||
125672527|NCT03705351|452088835|FG000|Overall Study|Lack of Efficacy|2|||
125338457|NCT00724711|450874180|FG001|Overall Study|Protocol Violation|0|||
125338458|NCT01945710|450874181|FG000|Overall Study|Progressive Disease|5|||
125338459|NCT01945710|450874182|FG001|Overall Study|Progressive Disease|4|||
125338460|NCT01945710|450874183|FG002|Overall Study|Progressive Disease|3|||
125672528|NCT03705351|452088835|FG000|Overall Study|Withdrawal by Subject|1|||
125672529|NCT00322556|452088845|FG000|Overall Study|Adverse Event|1|||
125338461|NCT01945710|450874184|FG003|Overall Study|Progressive Disease|2|||
125672530|NCT00322556|452088845|FG000|Overall Study|Withdrawal by Subject|1|||
125672531|NCT00322556|452088845|FG000|Overall Study|Lost to Follow-up|3|||
125672532|NCT00322556|452088845|FG000|Overall Study|Other Reason|7|||
125672533|NCT02058628|452088846|FG000|Overall Study|Adverse Event|1|||
125672534|NCT02058628|452088847|FG001|Overall Study|Adverse Event|0|||
125338462|NCT01945710|450874185|FG004|Overall Study|Progressive Disease|7|||
125338463|NCT01945710|450874186|FG005|Overall Study|Progressive Disease|3|||
125338464|NCT01945710|450874187|FG006|Overall Study|Progressive Disease|19|||
125338465|NCT01945710|450874181|FG000|Overall Study|Adverse Event|0|||
125338466|NCT01945710|450874182|FG001|Overall Study|Adverse Event|1|||
125338467|NCT01945710|450874183|FG002|Overall Study|Adverse Event|0|||
125338468|NCT01945710|450874184|FG003|Overall Study|Adverse Event|0|||
125338469|NCT01945710|450874185|FG004|Overall Study|Adverse Event|0|||
125338470|NCT01945710|450874186|FG005|Overall Study|Adverse Event|0|||
125338471|NCT01945710|450874187|FG006|Overall Study|Adverse Event|0|||
125338472|NCT01945710|450874181|FG000|Overall Study|Other|2|||
125338473|NCT01945710|450874182|FG001|Overall Study|Other|0|||
125338474|NCT01945710|450874183|FG002|Overall Study|Other|3|||
125338475|NCT01945710|450874184|FG003|Overall Study|Other|1|||
125338476|NCT01945710|450874185|FG004|Overall Study|Other|1|||
125338477|NCT01945710|450874186|FG005|Overall Study|Other|0|||
125338478|NCT01945710|450874187|FG006|Overall Study|Other|4|||
125338479|NCT01945710|450874181|FG000|Overall Study|Withdrawal by Subject|0|||
125338480|NCT01945710|450874182|FG001|Overall Study|Withdrawal by Subject|1|||
125338481|NCT01945710|450874183|FG002|Overall Study|Withdrawal by Subject|1|||
125338482|NCT01945710|450874184|FG003|Overall Study|Withdrawal by Subject|0|||
125338483|NCT01945710|450874185|FG004|Overall Study|Withdrawal by Subject|1|||
125338484|NCT01945710|450874186|FG005|Overall Study|Withdrawal by Subject|0|||
125338485|NCT01945710|450874187|FG006|Overall Study|Withdrawal by Subject|0|||
125338486|NCT00375609|450874188|FG000|Overall Study|Did not receive treatment|1|||
125338487|NCT00375609|450874189|FG001|Overall Study|Did not receive treatment|0|||
125338488|NCT00375609|450874190|FG002|Overall Study|Did not receive treatment|0|||
125338489|NCT00375609|450874188|FG000|Overall Study|Adverse Event|0|||
125338490|NCT00375609|450874189|FG001|Overall Study|Adverse Event|3|||
125338491|NCT00375609|450874190|FG002|Overall Study|Adverse Event|0|||
125338492|NCT00375609|450874188|FG000|Overall Study|Lost to Follow-up|1|||
125338493|NCT00375609|450874189|FG001|Overall Study|Lost to Follow-up|0|||
125338494|NCT00375609|450874190|FG002|Overall Study|Lost to Follow-up|0|||
125338495|NCT00375609|450874188|FG000|Overall Study|Physician Decision|0|||
125338496|NCT00375609|450874189|FG001|Overall Study|Physician Decision|0|||
125338497|NCT00375609|450874190|FG002|Overall Study|Physician Decision|1|||
125338498|NCT00375609|450874188|FG000|Overall Study|Withdrawal by Subject|1|||
125338499|NCT00375609|450874189|FG001|Overall Study|Withdrawal by Subject|4|||
125338500|NCT00375609|450874190|FG002|Overall Study|Withdrawal by Subject|0|||
125672535|NCT02058628|452088846|FG000|Overall Study|Withdrawal by Subject|2|||
125672536|NCT02058628|452088847|FG001|Overall Study|Withdrawal by Subject|2|||
125672537|NCT02058628|452088846|FG000|Overall Study|Lost to Follow-up|2|||
125672538|NCT02058628|452088847|FG001|Overall Study|Lost to Follow-up|4|||
125672539|NCT02058628|452088846|FG000|Overall Study|Not in time schedule|0|||
125672540|NCT02058628|452088847|FG001|Overall Study|Not in time schedule|1|||
125672541|NCT02058628|452088846|FG000|Overall Study|The visit date was not in timeline|0|||
125672542|NCT02058628|452088847|FG001|Overall Study|The visit date was not in timeline|1|||
125672543|NCT02058628|452088846|FG000|Overall Study|A lot of time for study for participant|1|||
125672544|NCT02058628|452088847|FG001|Overall Study|A lot of time for study for participant|0|||
125672545|NCT02058628|452088846|FG000|Overall Study|Non compliance|1|||
125672546|NCT02058628|452088847|FG001|Overall Study|Non compliance|0|||
125672547|NCT01767597|452088848|FG000|Overall Study|Incomplete intervention|3|||
125672548|NCT01767597|452088849|FG001|Overall Study|Incomplete intervention|1|||
125672549|NCT01767597|452088848|FG000|Overall Study|Withdrawal by Subject|1|||
125672550|NCT01767597|452088849|FG001|Overall Study|Withdrawal by Subject|0|||
125672551|NCT02961920|452088850|FG000|Overall Study|did not achive stydy protocol schedule|1|||
125672552|NCT02961920|452088851|FG001|Overall Study|did not achive stydy protocol schedule|1|||
125672553|NCT04527471|452088854|FG000|Overall Study|Adverse Event|1|||
125672554|NCT04527471|452088855|FG001|Overall Study|Adverse Event|0|||
125672555|NCT04527471|452088854|FG000|Overall Study|Lost to Follow-up|1|||
125672556|NCT04527471|452088855|FG001|Overall Study|Lost to Follow-up|0|||
125672557|NCT00096265|452088857|FG000|Overall Study|Ineligible|1|||
125672558|NCT00096265|452088858|FG001|Overall Study|Ineligible|0|||
125672559|NCT00096265|452088859|FG002|Overall Study|Ineligible|0|||
125672560|NCT01506323|452088860|FG000|Overall Study|Lost to Follow-up|5|||
125672561|NCT01506323|452088861|FG001|Overall Study|Lost to Follow-up|4|||
125672562|NCT01506323|452088860|FG000|Overall Study|Withdrawal by Subject|4|||
125672563|NCT01506323|452088861|FG001|Overall Study|Withdrawal by Subject|4|||
125672564|NCT01506323|452088860|FG000|Overall Study|Lack of Efficacy|1|||
125672565|NCT01506323|452088861|FG001|Overall Study|Lack of Efficacy|3|||
125672566|NCT01506323|452088860|FG000|Overall Study|Moved out of area|5|||
125672567|NCT01506323|452088861|FG001|Overall Study|Moved out of area|2|||
125672568|NCT01506323|452088860|FG000|Overall Study|Schedule or Transportation conflict|8|||
125672569|NCT01506323|452088861|FG001|Overall Study|Schedule or Transportation conflict|0|||
125672570|NCT01506323|452088860|FG000|Overall Study|Started another treatment|1|||
125338501|NCT00375609|450874188|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
125672571|NCT01506323|452088861|FG001|Overall Study|Started another treatment|0|||
125338502|NCT00375609|450874189|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
125338503|NCT00375609|450874190|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
125338504|NCT01368562|450874191|FG000|Overall Study|Adverse Event|1|||
125338505|NCT01368562|450874191|FG000|Overall Study|Disease progression|1|||
125338506|NCT01368562|450874191|FG000|Overall Study|Lost to Follow-up|1|||
125338507|NCT01368562|450874191|FG000|Overall Study|Death|6|||
125338508|NCT01368562|450874191|FG000|Overall Study|Unresponsive to treatment|5|||
125338509|NCT01368562|450874191|FG000|Overall Study|Other|3|||
125338510|NCT01368562|450874191|FG000|Overall Study|Other than specified|2|||
125338511|NCT00669409|450874194|FG000|Part 2|Withdrawal by Subject|0|||
125338512|NCT00669409|450874195|FG001|Part 2|Withdrawal by Subject|0|||
125338513|NCT00669409|450874196|FG002|Part 2|Withdrawal by Subject|0|||
125338514|NCT00669409|450874197|FG003|Part 2|Withdrawal by Subject|0|||
125338515|NCT00669409|450874198|FG004|Part 2|Withdrawal by Subject|0|||
125338516|NCT00669409|450874199|FG005|Part 2|Withdrawal by Subject|0|||
125338517|NCT00669409|450874200|FG006|Part 2|Withdrawal by Subject|0|||
125338518|NCT00669409|450874201|FG007|Part 2|Withdrawal by Subject|0|||
125338519|NCT00669409|450874202|FG008|Part 2|Withdrawal by Subject|0|||
125338520|NCT00669409|450874203|FG009|Part 2|Withdrawal by Subject|1|||
125338521|NCT00669409|450874204|FG010|Part 2|Withdrawal by Subject|0|||
125338522|NCT03583385|450874205|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125338523|NCT03583385|450874206|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125338524|NCT03583385|450874205|FG000|Treatment Period 2|Adverse Event|1|||
125338525|NCT03583385|450874206|FG001|Treatment Period 2|Adverse Event|0|||
125338526|NCT00095940|450874207|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
125338527|NCT00095940|450874208|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
125338528|NCT00095940|450874209|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
125338529|NCT00095940|450874210|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
125338530|NCT00095940|450874211|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
125338531|NCT00095940|450874212|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
125338532|NCT00095940|450874213|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
125338533|NCT00095940|450874214|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
125338534|NCT00095940|450874215|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
125338535|NCT00095940|450874207|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
125338536|NCT00095940|450874208|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
125338537|NCT00095940|450874209|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
125338538|NCT00095940|450874210|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
125338539|NCT00095940|450874211|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
125338540|NCT00095940|450874212|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
125338541|NCT00095940|450874213|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
125338542|NCT00095940|450874214|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
125338543|NCT00095940|450874215|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
125338544|NCT00095940|450874207|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
125338545|NCT00095940|450874208|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
125338546|NCT00095940|450874209|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
125338547|NCT00095940|450874210|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
125338548|NCT00095940|450874211|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
125338549|NCT00095940|450874212|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
125338550|NCT00095940|450874213|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
125338551|NCT00095940|450874214|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
125338552|NCT00095940|450874215|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
125338553|NCT03539549|450874217|FG000|Overall Study|Adverse Event|12|||
125338554|NCT03539549|450874217|FG000|Overall Study|Lost to Follow-up|1|||
125338555|NCT03539549|450874217|FG000|Overall Study|Death|2|||
125338556|NCT03539549|450874217|FG000|Overall Study|Progressive Disease|1|||
125338557|NCT03539549|450874217|FG000|Overall Study|Reason not Specified|1|||
125338558|NCT02864862|450874218|FG000|Overall Study|Lost to Follow-up|1|||
125338559|NCT02864862|450874219|FG001|Overall Study|Lost to Follow-up|0|||
125338560|NCT02864862|450874220|FG002|Overall Study|Lost to Follow-up|1|||
125338561|NCT02864862|450874218|FG000|Overall Study|Protocol Violation|0|||
125338562|NCT02864862|450874219|FG001|Overall Study|Protocol Violation|0|||
125338563|NCT02864862|450874220|FG002|Overall Study|Protocol Violation|1|||
125338564|NCT04693234|450874224|FG000|Overall Study|Death|79|||
125338565|NCT04693234|450874225|FG001|Overall Study|Death|19|||
125338566|NCT04693234|450874224|FG000|Overall Study|Sponsor Ended Study|47|||
125338567|NCT04693234|450874225|FG001|Overall Study|Sponsor Ended Study|18|||
125338568|NCT04693234|450874224|FG000|Overall Study|Withdrawal by Subject|10|||
125338569|NCT04693234|450874225|FG001|Overall Study|Withdrawal by Subject|2|||
125338570|NCT04693234|450874224|FG000|Overall Study|Lost to Follow-up|2|||
125338571|NCT04693234|450874225|FG001|Overall Study|Lost to Follow-up|1|||
125338572|NCT04643158|450874226|FG000|Overall Study|Study terminated by sponsor|0|||
125338573|NCT04643158|450874227|FG001|Overall Study|Study terminated by sponsor|0|||
125338574|NCT04643158|450874228|FG002|Overall Study|Study terminated by sponsor|1|||
125338575|NCT04643158|450874229|FG003|Overall Study|Study terminated by sponsor|0|||
125338576|NCT04643158|450874230|FG004|Overall Study|Study terminated by sponsor|0|||
125338577|NCT04643158|450874231|FG005|Overall Study|Study terminated by sponsor|1|||
125338578|NCT04643158|450874232|FG006|Overall Study|Study terminated by sponsor|0|||
125338579|NCT04643158|450874226|FG000|Overall Study|Global/country situation|0|||
125338580|NCT04643158|450874227|FG001|Overall Study|Global/country situation|0|||
125338581|NCT04643158|450874228|FG002|Overall Study|Global/country situation|1|||
125338582|NCT04643158|450874229|FG003|Overall Study|Global/country situation|0|||
125338583|NCT04643158|450874230|FG004|Overall Study|Global/country situation|0|||
125338584|NCT04643158|450874231|FG005|Overall Study|Global/country situation|0|||
125338585|NCT04643158|450874232|FG006|Overall Study|Global/country situation|0|||
125338586|NCT04643158|450874226|FG000|Overall Study|Withdrawal by Subject|0|||
125338587|NCT04643158|450874227|FG001|Overall Study|Withdrawal by Subject|0|||
125338588|NCT04643158|450874228|FG002|Overall Study|Withdrawal by Subject|0|||
125338589|NCT04643158|450874229|FG003|Overall Study|Withdrawal by Subject|0|||
125338590|NCT04643158|450874230|FG004|Overall Study|Withdrawal by Subject|0|||
125338591|NCT04643158|450874231|FG005|Overall Study|Withdrawal by Subject|1|||
125338592|NCT04643158|450874232|FG006|Overall Study|Withdrawal by Subject|0|||
125338593|NCT04540198|450874233|FG000|Overall Study|Lost to Follow-up|25|||
125338594|NCT04540198|450874234|FG001|Overall Study|Lost to Follow-up|23|||
125338595|NCT04540198|450874233|FG000|Overall Study|Withdrawal by Subject|15|||
125338596|NCT04540198|450874234|FG001|Overall Study|Withdrawal by Subject|9|||
125338597|NCT04540198|450874233|FG000|Overall Study|Discontinued|1|||
125338598|NCT04540198|450874234|FG001|Overall Study|Discontinued|0|||
125338599|NCT02888119|450874235|FG000|Overall Study|Lost to Follow-up|5|||
125338600|NCT02888119|450874236|FG001|Overall Study|Lost to Follow-up|4|||
125338601|NCT02888119|450874237|FG002|Overall Study|Lost to Follow-up|0|||
125338602|NCT05573386|450874238|FG000|Overall Study|Withdrawal by Subject|3|||
125338603|NCT05573386|450874239|FG001|Overall Study|Withdrawal by Subject|2|||
125338604|NCT03646123|450874240|FG000|Overall Study|Withdrawal by Subject|2|||
125338605|NCT03646123|450874241|FG001|Overall Study|Withdrawal by Subject|2|||
125338606|NCT03646123|450874242|FG002|Overall Study|Withdrawal by Subject|3|||
125338607|NCT03646123|450874240|FG000|Overall Study|Study termination by sponsor|0|||
125338608|NCT03646123|450874241|FG001|Overall Study|Study termination by sponsor|45|||
125338609|NCT03646123|450874242|FG002|Overall Study|Study termination by sponsor|139|||
125338610|NCT03646123|450874240|FG000|Overall Study|Lost to Follow-up|4|||
125338611|NCT03646123|450874241|FG001|Overall Study|Lost to Follow-up|10|||
125338612|NCT03646123|450874242|FG002|Overall Study|Lost to Follow-up|10|||
125338613|NCT03646123|450874240|FG000|Overall Study|Death|2|||
125338614|NCT03646123|450874241|FG001|Overall Study|Death|1|||
125338615|NCT03646123|450874242|FG002|Overall Study|Death|1|||
125672572|NCT02192905|452088862|FG000|Overall Study|Lost to Follow-up|1|||
125672573|NCT04604184|452088874|FG000|Overall Study|Adverse Event|5|||
125672574|NCT04604184|452088875|FG001|Overall Study|Adverse Event|5|||
125672575|NCT04604184|452088874|FG000|Overall Study|Death|2|||
125672576|NCT04604184|452088875|FG001|Overall Study|Death|1|||
125672577|NCT04604184|452088874|FG000|Overall Study|Withdrawal by Subject|1|||
125672578|NCT04604184|452088875|FG001|Overall Study|Withdrawal by Subject|3|||
125672579|NCT04604184|452088874|FG000|Overall Study|Not treated|2|||
125672580|NCT04604184|452088875|FG001|Overall Study|Not treated|2|||
125672581|NCT04604184|452088874|FG000|Overall Study|Due to sponsor decision|9|||
125672582|NCT04604184|452088875|FG001|Overall Study|Due to sponsor decision|7|||
125672583|NCT04604184|452088874|FG000|Overall Study|Physician Decision|0|||
125672584|NCT04604184|452088875|FG001|Overall Study|Physician Decision|1|||
125672585|NCT04604184|452088874|FG000|Overall Study|Transfer to healthcare|1|||
125672586|NCT04604184|452088875|FG001|Overall Study|Transfer to healthcare|0|||
125672587|NCT03294538|452088878|FG000|Overall Study|Adverse Event|0|||
125672588|NCT03294538|452088879|FG001|Overall Study|Adverse Event|1|||
125672589|NCT03294538|452088880|FG002|Overall Study|Adverse Event|1|||
125672590|NCT03294538|452088878|FG000|Overall Study|Lost to Follow-up|1|||
125672591|NCT03294538|452088879|FG001|Overall Study|Lost to Follow-up|0|||
125672592|NCT03294538|452088880|FG002|Overall Study|Lost to Follow-up|0|||
125672593|NCT03294538|452088878|FG000|Overall Study|Outside of Visit Window|4|||
125672594|NCT03294538|452088879|FG001|Overall Study|Outside of Visit Window|4|||
125672595|NCT03294538|452088880|FG002|Overall Study|Outside of Visit Window|1|||
125672596|NCT01787825|452088882|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
125672597|NCT01787825|452088883|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
125672598|NCT01787825|452088882|FG000|Overall Study|Data Not Analyzable|5|||
125672599|NCT01787825|452088883|FG001|Overall Study|Data Not Analyzable|1|||
125672600|NCT01338636|452088892|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
125672601|NCT02385526|452088893|FG000|Overall Study|Withdrawal by Subject|0|||
125672602|NCT02385526|452088894|FG001|Overall Study|Withdrawal by Subject|2|||
125672603|NCT02385526|452088895|FG002|Overall Study|Withdrawal by Subject|0|||
125672604|NCT02385526|452088893|FG000|Overall Study|Lost to Follow-up|0|||
125672605|NCT02385526|452088894|FG001|Overall Study|Lost to Follow-up|1|||
125672606|NCT02385526|452088895|FG002|Overall Study|Lost to Follow-up|0|||
125672607|NCT02385526|452088893|FG000|Overall Study|Physician Decision|1|||
125672608|NCT02385526|452088894|FG001|Overall Study|Physician Decision|0|||
125672609|NCT02385526|452088895|FG002|Overall Study|Physician Decision|0|||
125672610|NCT02385526|452088893|FG000|Overall Study|Protocol Violation|1|||
125672611|NCT02385526|452088894|FG001|Overall Study|Protocol Violation|0|||
125672612|NCT02385526|452088895|FG002|Overall Study|Protocol Violation|0|||
125672613|NCT01254409|452088900|FG000|Overall Study|Adverse Event|0|||
125672614|NCT01254409|452088901|FG001|Overall Study|Adverse Event|1|||
125672615|NCT01254409|452088902|FG002|Overall Study|Adverse Event|0|||
125672616|NCT01254409|452088903|FG003|Overall Study|Adverse Event|0|||
125672617|NCT01076166|452088904|FG000|Overall Study|Adverse Event|3|||
125672618|NCT01076166|452088904|FG000|Overall Study|Symptoms improved/resolved|6|||
125672619|NCT02970669|452088907|FG000|Double-blind Period|Adverse Event|4|||
125672620|NCT02970669|452088908|FG001|Double-blind Period|Adverse Event|0|||
125672621|NCT02970669|452088907|FG000|Double-blind Period|Death|1|||
125672622|NCT02970669|452088908|FG001|Double-blind Period|Death|0|||
125672623|NCT02970669|452088907|FG000|Double-blind Period|Study terminated by sponsor|1|||
125672624|NCT02970669|452088908|FG001|Double-blind Period|Study terminated by sponsor|2|||
125672625|NCT02970669|452088907|FG000|Double-blind Period|Physician Decision|0|||
125672626|NCT02970669|452088908|FG001|Double-blind Period|Physician Decision|2|||
125672627|NCT02970669|452088907|FG000|Double-blind Period|Withdrawal by Subject|2|||
125672628|NCT02970669|452088908|FG001|Double-blind Period|Withdrawal by Subject|2|||
125672629|NCT02970669|452088907|FG000|Open-label Period|Withdrawal by Subject|2|||
125672630|NCT02970669|452088908|FG001|Open-label Period|Withdrawal by Subject|2|||
125672631|NCT02970669|452088907|FG000|Open-label Period|Adverse Event|1|||
125672632|NCT02970669|452088908|FG001|Open-label Period|Adverse Event|0|||
125672633|NCT02970669|452088907|FG000|Open-label Period|Physician Decision|1|||
125540912|NCT01237587|451609479|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
125672634|NCT02970669|452088908|FG001|Open-label Period|Physician Decision|0|||
125672635|NCT03521999|452088909|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
125672636|NCT03521999|452088910|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
125338616|NCT03646123|450874240|FG000|Overall Study|Other|2|||
125672637|NCT03521999|452088909|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
125672638|NCT03521999|452088910|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
125672639|NCT03521999|452088909|FG000|Completed 3 Month Follow up|Death|0|||
125672640|NCT03521999|452088910|FG001|Completed 3 Month Follow up|Death|1|||
125672641|NCT03521999|452088909|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
125672642|NCT03521999|452088910|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
125338617|NCT03646123|450874241|FG001|Overall Study|Other|0|||
125338618|NCT03646123|450874242|FG002|Overall Study|Other|2|||
125338619|NCT03462511|450874248|FG000|Overall Study|Withdrawal by Subject|2|||
125338620|NCT03462511|450874249|FG001|Overall Study|Withdrawal by Subject|3|||
125338621|NCT02925416|450874250|FG000|Overall Study|Adverse Event|2|||
125338622|NCT02925416|450874251|FG001|Overall Study|Adverse Event|0|||
125338623|NCT03595228|450874252|FG000|Overall Study|Death|2|||
125338624|NCT03595228|450874252|FG000|Overall Study|Lack of Efficacy|13|||
125338625|NCT03595228|450874252|FG000|Overall Study|Withdrawal by Subject|3|||
125338626|NCT03595228|450874252|FG000|Overall Study|Withdrawal by Sponsor|1|||
125338627|NCT00200356|450874253|FG000|Overall Study|Lack of Efficacy|3|||
125338628|NCT00200356|450874254|FG001|Overall Study|Lack of Efficacy|3|||
125672643|NCT01564758|452088911|FG000|Overall Study|Death|8|||
125672644|NCT01564758|452088911|FG000|Overall Study|Adverse Event|3|||
125672645|NCT01564758|452088911|FG000|Overall Study|Other|3|||
125672646|NCT00249821|452088912|FG000|Overall Study|Technical problem|0|||
125672647|NCT00249821|452088913|FG001|Overall Study|Technical problem|1|||
125672648|NCT01498484|452088919|FG000|Overall Study|Death|6|||
125672649|NCT01498484|452088920|FG001|Overall Study|Death|3|||
125672650|NCT01498484|452088921|FG002|Overall Study|Death|1|||
125672651|NCT01498484|452088922|FG003|Overall Study|Death|1|||
125672652|NCT01498484|452088923|FG004|Overall Study|Death|0|||
125672653|NCT01498484|452088924|FG005|Overall Study|Death|0|||
125672654|NCT01498484|452088925|FG006|Overall Study|Death|10|||
125672655|NCT01498484|452088926|FG007|Overall Study|Death|1|||
125672656|NCT01498484|452088927|FG008|Overall Study|Death|0|||
125672657|NCT01498484|452088919|FG000|Overall Study|Physician Decision|3|||
125672658|NCT01498484|452088920|FG001|Overall Study|Physician Decision|2|||
125672659|NCT01498484|452088921|FG002|Overall Study|Physician Decision|1|||
125672660|NCT01498484|452088922|FG003|Overall Study|Physician Decision|1|||
125672661|NCT01498484|452088923|FG004|Overall Study|Physician Decision|0|||
125672662|NCT01498484|452088924|FG005|Overall Study|Physician Decision|0|||
125672663|NCT01498484|452088925|FG006|Overall Study|Physician Decision|8|||
125672664|NCT01498484|452088926|FG007|Overall Study|Physician Decision|13|||
125672665|NCT01498484|452088927|FG008|Overall Study|Physician Decision|1|||
125672666|NCT01498484|452088919|FG000|Overall Study|Adverse Event|0|||
125672667|NCT01498484|452088920|FG001|Overall Study|Adverse Event|0|||
125672668|NCT01498484|452088921|FG002|Overall Study|Adverse Event|0|||
125672669|NCT01498484|452088922|FG003|Overall Study|Adverse Event|0|||
125672670|NCT01498484|452088923|FG004|Overall Study|Adverse Event|0|||
125672671|NCT01498484|452088924|FG005|Overall Study|Adverse Event|1|||
125672672|NCT01498484|452088925|FG006|Overall Study|Adverse Event|0|||
125672673|NCT01498484|452088926|FG007|Overall Study|Adverse Event|0|||
125672674|NCT01498484|452088927|FG008|Overall Study|Adverse Event|0|||
125672675|NCT01498484|452088919|FG000|Overall Study|Withdrawal by Subject|0|||
125672676|NCT01498484|452088920|FG001|Overall Study|Withdrawal by Subject|0|||
125672677|NCT01498484|452088921|FG002|Overall Study|Withdrawal by Subject|0|||
125672678|NCT01498484|452088922|FG003|Overall Study|Withdrawal by Subject|1|||
125672679|NCT01498484|452088923|FG004|Overall Study|Withdrawal by Subject|0|||
125672680|NCT01498484|452088924|FG005|Overall Study|Withdrawal by Subject|0|||
125672681|NCT01498484|452088925|FG006|Overall Study|Withdrawal by Subject|1|||
125672682|NCT01498484|452088926|FG007|Overall Study|Withdrawal by Subject|0|||
125672683|NCT01498484|452088927|FG008|Overall Study|Withdrawal by Subject|0|||
125672684|NCT01498484|452088919|FG000|Overall Study|Other|5|||
125672685|NCT01498484|452088920|FG001|Overall Study|Other|2|||
125672686|NCT01498484|452088921|FG002|Overall Study|Other|0|||
125672687|NCT01498484|452088922|FG003|Overall Study|Other|0|||
125672688|NCT01498484|452088923|FG004|Overall Study|Other|1|||
125672689|NCT01498484|452088924|FG005|Overall Study|Other|0|||
125672690|NCT01498484|452088925|FG006|Overall Study|Other|3|||
125672691|NCT01498484|452088926|FG007|Overall Study|Other|0|||
125672692|NCT01498484|452088927|FG008|Overall Study|Other|1|||
125672693|NCT00278512|452088928|FG000|Overall Study|Death|1|||
125672694|NCT00278512|452088929|FG001|Overall Study|Death|0|||
125672695|NCT01202747|452088930|FG000|Overall Study|Withdrawal by Subject|1|||
125672696|NCT01620177|452088931|FG000|Overall Study|Failure at Screening Visit|43|||
125672697|NCT01620177|452088931|FG000|Overall Study|Withdrawal by Subject|26|||
125672698|NCT01620177|452088931|FG000|Overall Study|Lost to Follow-up|7|||
125672699|NCT01620177|452088931|FG000|Overall Study|Physician Decision|2|||
125672700|NCT01620177|452088931|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
125672701|NCT02292238|452088935|FG000|Overall Study|Protocol Violation|1|||
125672702|NCT02292238|452088936|FG001|Overall Study|Protocol Violation|2|||
125672703|NCT02292238|452088935|FG000|Overall Study|Withdrawal by Subject|2|||
125672704|NCT02292238|452088936|FG001|Overall Study|Withdrawal by Subject|1|||
125672705|NCT02292238|452088935|FG000|Overall Study|Lost to Follow-up|1|||
125672706|NCT02292238|452088936|FG001|Overall Study|Lost to Follow-up|0|||
125672707|NCT02292238|452088935|FG000|Overall Study|Physician Decision|0|||
125672708|NCT02292238|452088936|FG001|Overall Study|Physician Decision|1|||
125672709|NCT01789320|452088937|FG000|Overall Study|Re-enrolled into study|1|||
125672710|NCT01789320|452088937|FG000|Overall Study|Lost to Follow-up|1|||
125338629|NCT00200356|450874253|FG000|Overall Study|Protocol Violation|4|||
125338630|NCT00200356|450874254|FG001|Overall Study|Protocol Violation|4|||
125338631|NCT00200356|450874253|FG000|Overall Study|Nontreatment|1|||
125338632|NCT00200356|450874254|FG001|Overall Study|Nontreatment|0|||
125672711|NCT00814320|452088940|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
125672712|NCT00814320|452088941|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
125672713|NCT00814320|452088940|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
125672714|NCT00814320|452088941|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
125672715|NCT00814320|452088940|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
125672716|NCT00814320|452088941|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
125672717|NCT00814320|452088940|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
125672718|NCT00814320|452088941|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
125672719|NCT00814320|452088940|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
125672720|NCT00814320|452088941|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
125672721|NCT00814320|452088940|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
125672722|NCT00814320|452088941|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
125672723|NCT00814320|452088940|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
125672724|NCT00814320|452088941|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
125672725|NCT00814320|452088940|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
125672726|NCT00814320|452088941|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
125672727|NCT00814320|452088940|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
125672728|NCT00814320|452088941|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
125672729|NCT00814320|452088940|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
125672730|NCT00814320|452088941|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
125672731|NCT00491504|452088942|FG000|Overall Study|Adverse Event|0|||
125672732|NCT00491504|452088943|FG001|Overall Study|Adverse Event|1|||
125672733|NCT00491504|452088944|FG002|Overall Study|Adverse Event|0|||
125672734|NCT00491504|452088945|FG003|Overall Study|Adverse Event|0|||
125672735|NCT00491504|452088942|FG000|Overall Study|Withdrawal by Subject|0|||
125672736|NCT00491504|452088943|FG001|Overall Study|Withdrawal by Subject|0|||
125672737|NCT00491504|452088944|FG002|Overall Study|Withdrawal by Subject|1|||
125672738|NCT00491504|452088945|FG003|Overall Study|Withdrawal by Subject|2|||
125672739|NCT00491504|452088942|FG000|Overall Study|Protocol Violation|0|||
125672740|NCT00491504|452088943|FG001|Overall Study|Protocol Violation|0|||
125672741|NCT00491504|452088944|FG002|Overall Study|Protocol Violation|3|||
125672742|NCT00491504|452088945|FG003|Overall Study|Protocol Violation|2|||
125672743|NCT00601484|452088951|FG000|Overall Study|Adverse Event|0|||
125672744|NCT00601484|452088952|FG001|Overall Study|Adverse Event|1|||
125672745|NCT00601484|452088951|FG000|Overall Study|Lost to Follow-up|4|||
125672746|NCT00601484|452088952|FG001|Overall Study|Lost to Follow-up|3|||
125672747|NCT00601484|452088951|FG000|Overall Study|Lack of Efficacy|0|||
125672748|NCT00601484|452088952|FG001|Overall Study|Lack of Efficacy|2|||
125672749|NCT00601484|452088951|FG000|Overall Study|Withdrawal by Subject|1|||
125672750|NCT00601484|452088952|FG001|Overall Study|Withdrawal by Subject|1|||
125672751|NCT00601484|452088951|FG000|Overall Study|Randomized, but not treated|0|||
125672752|NCT00601484|452088952|FG001|Overall Study|Randomized, but not treated|1|||
125672753|NCT01463683|452088957|FG000|Overall Study|Adverse Event|2|||
125672754|NCT01463683|452088958|FG001|Overall Study|Adverse Event|0|||
125672755|NCT01463683|452088959|FG002|Overall Study|Adverse Event|0|||
125672756|NCT01463683|452088957|FG000|Overall Study|Lost to Follow-up|10|||
125672757|NCT01463683|452088958|FG001|Overall Study|Lost to Follow-up|9|||
125672758|NCT01463683|452088959|FG002|Overall Study|Lost to Follow-up|7|||
125672759|NCT01463683|452088957|FG000|Overall Study|Physician Decision|0|||
125672760|NCT01463683|452088958|FG001|Overall Study|Physician Decision|3|||
125672761|NCT01463683|452088959|FG002|Overall Study|Physician Decision|1|||
125672762|NCT01463683|452088957|FG000|Overall Study|Pregnancy|2|||
125672763|NCT01463683|452088958|FG001|Overall Study|Pregnancy|2|||
125672764|NCT01463683|452088959|FG002|Overall Study|Pregnancy|1|||
125672765|NCT01463683|452088957|FG000|Overall Study|Withdrawal by Subject|5|||
125672766|NCT01463683|452088958|FG001|Overall Study|Withdrawal by Subject|17|||
125672767|NCT01463683|452088959|FG002|Overall Study|Withdrawal by Subject|2|||
125672768|NCT01618305|452088961|FG000|Overall Study|Death|0|||
125672769|NCT01618305|452088962|FG001|Overall Study|Death|1|||
125672770|NCT01618305|452088961|FG000|Overall Study|Lost to Follow-up|11|||
125672771|NCT01618305|452088962|FG001|Overall Study|Lost to Follow-up|7|||
125672772|NCT01618305|452088961|FG000|Overall Study|Protocol Violation|1|||
125672773|NCT01618305|452088962|FG001|Overall Study|Protocol Violation|0|||
125672774|NCT01618305|452088961|FG000|Overall Study|Withdrawal by Subject|3|||
125338633|NCT00435045|450874256|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
125338634|NCT00435045|450874257|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
125672775|NCT01618305|452088962|FG001|Overall Study|Withdrawal by Subject|2|||
125672776|NCT02708277|452088963|FG000|Overall Study|Lost to Follow-up|7|||
125672777|NCT02708277|452088964|FG001|Overall Study|Lost to Follow-up|4|||
125672778|NCT01960816|452088965|FG000|Overall Study|Lost to Follow-up|1|||
125672779|NCT03896490|452089003|FG000|Overall Study|Withdrawal by Subject|1|||
125338635|NCT00435045|450874256|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
125338636|NCT00435045|450874257|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
125338637|NCT00435045|450874256|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
125338638|NCT00435045|450874257|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
125338639|NCT00435045|450874256|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
125338640|NCT00435045|450874257|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
125338641|NCT00435045|450874256|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
125338642|NCT00435045|450874257|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
125672780|NCT03896490|452089004|FG001|Overall Study|Withdrawal by Subject|1|||
125672781|NCT00003782|452089005|FG000|Overall Study|No follow up data|30|||
125672782|NCT00003782|452089006|FG001|Overall Study|No follow up data|31|||
125672783|NCT00003782|452089007|FG002|Overall Study|No follow up data|26|||
125672784|NCT00929708|452089009|FG000|Overall Study|Protocol Violation|2|||
125672785|NCT00929708|452089010|FG001|Overall Study|Protocol Violation|1|||
125672786|NCT00929708|452089011|FG002|Overall Study|Protocol Violation|1|||
125672787|NCT00929708|452089012|FG003|Overall Study|Protocol Violation|1|||
125672788|NCT00929708|452089013|FG004|Overall Study|Protocol Violation|1|||
125672789|NCT00929708|452089009|FG000|Overall Study|Withdrawal by Subject|2|||
125672790|NCT00929708|452089010|FG001|Overall Study|Withdrawal by Subject|0|||
125672791|NCT00929708|452089011|FG002|Overall Study|Withdrawal by Subject|0|||
125672792|NCT00929708|452089012|FG003|Overall Study|Withdrawal by Subject|2|||
125672793|NCT00929708|452089013|FG004|Overall Study|Withdrawal by Subject|1|||
125672794|NCT00929708|452089009|FG000|Overall Study|Adverse Event|0|||
125672795|NCT00929708|452089010|FG001|Overall Study|Adverse Event|0|||
125672796|NCT00929708|452089011|FG002|Overall Study|Adverse Event|0|||
125672797|NCT00929708|452089012|FG003|Overall Study|Adverse Event|0|||
125672798|NCT00929708|452089013|FG004|Overall Study|Adverse Event|3|||
125672799|NCT00929708|452089009|FG000|Overall Study|Physician Decision|0|||
125672800|NCT00929708|452089010|FG001|Overall Study|Physician Decision|2|||
125672801|NCT00929708|452089011|FG002|Overall Study|Physician Decision|2|||
125672802|NCT00929708|452089012|FG003|Overall Study|Physician Decision|2|||
125672803|NCT00929708|452089013|FG004|Overall Study|Physician Decision|1|||
125672804|NCT00929708|452089009|FG000|Overall Study|Lost to Follow-up|0|||
125672805|NCT00929708|452089010|FG001|Overall Study|Lost to Follow-up|0|||
125672806|NCT00929708|452089011|FG002|Overall Study|Lost to Follow-up|0|||
125672807|NCT00929708|452089012|FG003|Overall Study|Lost to Follow-up|1|||
125672808|NCT00929708|452089013|FG004|Overall Study|Lost to Follow-up|0|||
125672809|NCT01893138|452089014|FG000|Double-Blind Period|Withdrawal by Subject|1|||
125672810|NCT01893138|452089015|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125672811|NCT01893138|452089014|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
125672812|NCT01893138|452089015|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
125672813|NCT01893138|452089014|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
125672814|NCT01893138|452089015|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
125672815|NCT01893138|452089014|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
125672816|NCT01893138|452089015|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
125672817|NCT01893138|452089014|FG000|Open Label - Unblinded Period|Adverse Event|1|||
125672818|NCT01893138|452089015|FG001|Open Label - Unblinded Period|Adverse Event|0|||
125672819|NCT01326026|452089016|FG000|Overall Study|Adverse Event|4|||
125672820|NCT01326026|452089017|FG001|Overall Study|Adverse Event|3|||
125672821|NCT01326026|452089016|FG000|Overall Study|Withdrawal Criteria|5|||
125672822|NCT01326026|452089017|FG001|Overall Study|Withdrawal Criteria|7|||
125672823|NCT01326026|452089016|FG000|Overall Study|Other|3|||
125672824|NCT01326026|452089017|FG001|Overall Study|Other|3|||
125672825|NCT05188521|452090807|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
125672826|NCT05188521|452090808|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
125672827|NCT01341639|452090809|FG000|Infant Series|Protocol Violation|1|||
125672828|NCT01341639|452090810|FG001|Infant Series|Protocol Violation|0|||
125672829|NCT01341639|452090809|FG000|Infant Series|Not Vaccinated|0|||
125672830|NCT01341639|452090810|FG001|Infant Series|Not Vaccinated|1|||
125672831|NCT01341639|452090809|FG000|Infant Series|Adverse Event|0|||
125672832|NCT01341639|452090810|FG001|Infant Series|Adverse Event|5|||
125672833|NCT01341639|452090809|FG000|Infant Series|Withdrawal by Subject|11|||
125672834|NCT01341639|452090810|FG001|Infant Series|Withdrawal by Subject|8|||
125672835|NCT01341639|452090809|FG000|Infant Series|Lost to Follow-up|0|||
125672836|NCT01341639|452090810|FG001|Infant Series|Lost to Follow-up|2|||
125672837|NCT01341639|452090809|FG000|Infant Series|Site 0048 Participants|17|||
125672838|NCT01341639|452090810|FG001|Infant Series|Site 0048 Participants|16|||
125672839|NCT01341639|452090809|FG000|Interim Period|Withdrawal by Subject|6|||
125672840|NCT01341639|452090810|FG001|Interim Period|Withdrawal by Subject|7|||
125672841|NCT01341639|452090809|FG000|Interim Period|Lost to Follow-up|2|||
125672842|NCT01341639|452090810|FG001|Interim Period|Lost to Follow-up|0|||
125672843|NCT01341639|452090809|FG000|Interim Period|Physician Decision|0|||
125672844|NCT01341639|452090810|FG001|Interim Period|Physician Decision|1|||
125672845|NCT01341639|452090809|FG000|Interim Period|Protocol Violation|0|||
125672846|NCT01341639|452090810|FG001|Interim Period|Protocol Violation|1|||
125672847|NCT01341639|452090809|FG000|Post-Treatment|Withdrawal by Subject|0|||
125338643|NCT00435045|450874256|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
125338644|NCT00435045|450874257|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
125338645|NCT00435045|450874256|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
125338646|NCT00435045|450874257|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
125338647|NCT00435045|450874256|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
125338648|NCT00435045|450874257|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
125338649|NCT00435045|450874256|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
125338650|NCT00435045|450874257|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
125338651|NCT00435045|450874256|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
125338652|NCT00435045|450874257|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
125338653|NCT00435045|450874256|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
125338654|NCT00435045|450874257|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
125338655|NCT01015638|450874260|FG000|Overall Study|Withdrawal by Subject|1|||
125338656|NCT01015638|450874261|FG001|Overall Study|Withdrawal by Subject|0|||
125338657|NCT01703754|450874265|FG000|Overall Study|Clinically significant disease progression|2|||
125338658|NCT01703754|450874266|FG001|Overall Study|Clinically significant disease progression|2|||
125338659|NCT01703754|450874267|FG002|Overall Study|Clinically significant disease progression|1|||
125338660|NCT01703754|450874265|FG000|Overall Study|Adverse Event|1|||
125338661|NCT01703754|450874266|FG001|Overall Study|Adverse Event|1|||
125338662|NCT01703754|450874267|FG002|Overall Study|Adverse Event|0|||
125338663|NCT01703754|450874265|FG000|Overall Study|Withdrawal by Subject|2|||
125338664|NCT01703754|450874266|FG001|Overall Study|Withdrawal by Subject|0|||
125338665|NCT01703754|450874267|FG002|Overall Study|Withdrawal by Subject|0|||
125338666|NCT00964171|450874270|FG000|Overall Study|Death|5|||
125338667|NCT02872935|450874276|FG000|Overall Study|Other|0|||
125338668|NCT02872935|450874277|FG001|Overall Study|Other|1|||
125338669|NCT02792829|450874278|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125338670|NCT02792829|450874279|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
125338671|NCT02792829|450874280|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125338672|NCT02792829|450874281|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125338673|NCT02792829|450874282|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125338674|NCT02792829|450874283|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125338675|NCT02792829|450874284|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125338676|NCT02792829|450874285|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
125338677|NCT02792829|450874278|FG000|Treatment Period 2|Adverse Event|0|||
125338678|NCT02792829|450874279|FG001|Treatment Period 2|Adverse Event|0|||
125338679|NCT02792829|450874280|FG002|Treatment Period 2|Adverse Event|0|||
125338680|NCT02792829|450874281|FG003|Treatment Period 2|Adverse Event|0|||
125338681|NCT02792829|450874282|FG004|Treatment Period 2|Adverse Event|1|||
125338682|NCT02792829|450874283|FG005|Treatment Period 2|Adverse Event|0|||
125338683|NCT02792829|450874284|FG006|Treatment Period 2|Adverse Event|1|||
125338684|NCT02792829|450874285|FG007|Treatment Period 2|Adverse Event|1|||
125672848|NCT01341639|452090810|FG001|Post-Treatment|Withdrawal by Subject|1|||
125672849|NCT01341639|452090809|FG000|Post-Treatment|Adverse Event|0|||
125672850|NCT01341639|452090810|FG001|Post-Treatment|Adverse Event|2|||
125672851|NCT04582266|452090811|FG000|Overall Study|Lost to Follow-up|7|||
125338685|NCT02792829|450874278|FG000|Treatment Period 2|Use of proscribed medications|0|||
125338686|NCT02792829|450874279|FG001|Treatment Period 2|Use of proscribed medications|0|||
125338687|NCT02792829|450874280|FG002|Treatment Period 2|Use of proscribed medications|0|||
125338688|NCT02792829|450874281|FG003|Treatment Period 2|Use of proscribed medications|0|||
125338689|NCT02792829|450874282|FG004|Treatment Period 2|Use of proscribed medications|0|||
125338690|NCT02792829|450874283|FG005|Treatment Period 2|Use of proscribed medications|0|||
125672852|NCT04582266|452090812|FG001|Overall Study|Lost to Follow-up|5|||
125672853|NCT04582266|452090811|FG000|Overall Study|Withdrawal by Subject|1|||
125672854|NCT04582266|452090812|FG001|Overall Study|Withdrawal by Subject|0|||
125672855|NCT04582266|452090811|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
125672856|NCT04582266|452090812|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
125672857|NCT01132118|452090813|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
125672858|NCT01132118|452090814|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
125672859|NCT01132118|452090813|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
125672860|NCT01132118|452090814|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
125672861|NCT01132118|452090813|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
125672862|NCT01132118|452090814|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
125672863|NCT02742090|452090819|FG000|Overall Study|Adverse Event|10|||
125672864|NCT02742090|452090819|FG000|Overall Study|Death|3|||
125338691|NCT02792829|450874284|FG006|Treatment Period 2|Use of proscribed medications|0|||
125338692|NCT02792829|450874285|FG007|Treatment Period 2|Use of proscribed medications|1|||
125338693|NCT03116152|450874286|FG000|Overall Study|Disease Progression|49|||
125338694|NCT03116152|450874287|FG001|Overall Study|Disease Progression|47|||
125338695|NCT03116152|450874286|FG000|Overall Study|Death|5|||
125338696|NCT03116152|450874287|FG001|Overall Study|Death|2|||
125672865|NCT02742090|452090819|FG000|Overall Study|Disease Progression|25|||
125338697|NCT03116152|450874286|FG000|Overall Study|Adverse Event|21|||
125338698|NCT03116152|450874287|FG001|Overall Study|Adverse Event|7|||
125338699|NCT03116152|450874286|FG000|Overall Study|Protocol Violation|2|||
125338700|NCT03116152|450874287|FG001|Overall Study|Protocol Violation|2|||
125672866|NCT02742090|452090819|FG000|Overall Study|Investigator's Decision|1|||
125672867|NCT02742090|452090819|FG000|Overall Study|Lost to Follow-up|1|||
125672868|NCT02742090|452090819|FG000|Overall Study|Non-compliance with Study|1|||
125672869|NCT02742090|452090819|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
125672870|NCT02742090|452090819|FG000|Overall Study|Withdrawal by Subject|4|||
125672871|NCT02742090|452090819|FG000|Overall Study|Reason Not Specified|1|||
125672872|NCT01299038|452090820|FG000|Overall Study|Withdrawal by Subject|1|||
125672873|NCT01299038|452090821|FG001|Overall Study|Withdrawal by Subject|0|||
125672874|NCT00832078|452090822|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
125672875|NCT00832078|452090823|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
125672876|NCT00832078|452090822|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
125672877|NCT00832078|452090823|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
125672878|NCT03355742|452090824|FG000|Overall Study|Lost to Follow-up|4|||
125672879|NCT03355742|452090824|FG000|Overall Study|Withdrawal by Subject|29|||
125672880|NCT03355742|452090824|FG000|Overall Study|Physician Decision|6|||
125672881|NCT03355742|452090824|FG000|Overall Study|Death|55|||
125672882|NCT03355742|452090824|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
125672883|NCT02891200|452090834|FG000|Overall Study|Lost to Follow-up|31|||
125672884|NCT02891200|452090835|FG001|Overall Study|Lost to Follow-up|36|||
125672885|NCT02891200|452090834|FG000|Overall Study|Death|10|||
125672886|NCT02891200|452090835|FG001|Overall Study|Death|9|||
125672887|NCT02891200|452090834|FG000|Overall Study|Withdrawal by Subject|1|||
125672888|NCT02891200|452090835|FG001|Overall Study|Withdrawal by Subject|4|||
125672889|NCT04480463|452090839|FG000|Overall Study|Death|0|||
125672890|NCT04480463|452090840|FG001|Overall Study|Death|1|||
125672891|NCT04480463|452090839|FG000|Overall Study|Adverse Event|6|||
125672892|NCT04480463|452090840|FG001|Overall Study|Adverse Event|8|||
125672893|NCT04480463|452090839|FG000|Overall Study|Lost to Follow-up|3|||
125672894|NCT04480463|452090840|FG001|Overall Study|Lost to Follow-up|2|||
125672895|NCT04480463|452090839|FG000|Overall Study|Physician Decision|2|||
125672896|NCT04480463|452090840|FG001|Overall Study|Physician Decision|5|||
125672897|NCT04480463|452090839|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
125672898|NCT04480463|452090840|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
125672899|NCT04480463|452090839|FG000|Overall Study|Protocol Violation|2|||
125672900|NCT04480463|452090840|FG001|Overall Study|Protocol Violation|1|||
125672901|NCT04480463|452090839|FG000|Overall Study|Withdrawal by Subject|6|||
125672902|NCT04480463|452090840|FG001|Overall Study|Withdrawal by Subject|7|||
125672903|NCT04480463|452090839|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
125672904|NCT04480463|452090840|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
125672905|NCT04480463|452090839|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
125672906|NCT04480463|452090840|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
125672907|NCT04480463|452090839|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
125672908|NCT04480463|452090840|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
125672909|NCT04480463|452090839|FG000|Overall Study|Other|6|||
125672910|NCT04480463|452090840|FG001|Overall Study|Other|4|||
125672911|NCT00444795|452090841|FG000|Overall Study|Not Treated|1|||
125672912|NCT00444795|452090841|FG000|Overall Study|Treated Prior to the Contract Date|2|||
125672913|NCT00988169|452090842|FG000|Overall Study|Withdrawal by Subject|1|||
125672914|NCT00704418|452090844|FG000|Overall Study|Withdrawal by Subject|2|||
125672915|NCT00704418|452090845|FG001|Overall Study|Withdrawal by Subject|0|||
125672916|NCT00704418|452090844|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
125672917|NCT00704418|452090845|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
125672918|NCT02322879|452090846|FG000|First Intervention|Physician Decision|1|||
125672919|NCT02322879|452090847|FG001|First Intervention|Physician Decision|0|||
125672920|NCT02637076|452090848|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
125672921|NCT02637076|452090849|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
125672922|NCT02637076|452090848|FG000|Overall Study|Withdrawal by Subject|0|||
125672923|NCT02637076|452090849|FG001|Overall Study|Withdrawal by Subject|4|||
125672924|NCT02710071|452090851|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
125672925|NCT02710071|452090852|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
125672926|NCT02710071|452090851|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
125672927|NCT02710071|452090852|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
125672928|NCT02637557|452090856|FG000|Overall Study|Adverse Event|3|||
125338701|NCT03116152|450874286|FG000|Overall Study|Withdrawal by Subject|0|||
125672929|NCT02637557|452090857|FG001|Overall Study|Adverse Event|1|||
125672930|NCT02637557|452090858|FG002|Overall Study|Adverse Event|3|||
125338702|NCT03116152|450874287|FG001|Overall Study|Withdrawal by Subject|1|||
125338703|NCT03116152|450874286|FG000|Overall Study|Physician Decision|3|||
125338704|NCT03116152|450874287|FG001|Overall Study|Physician Decision|2|||
125338705|NCT03116152|450874286|FG000|Overall Study|other|11|||
125338706|NCT03116152|450874287|FG001|Overall Study|other|34|||
125338707|NCT03179605|450874288|FG000|Overall Study|Withdrawal by Subject|1|||
125338708|NCT00910299|450874289|FG000|Overall Study|Withdrawal by Subject|16|||
125338709|NCT00910299|450874290|FG001|Overall Study|Withdrawal by Subject|13|||
125338710|NCT00910299|450874289|FG000|Overall Study|Sponsor Decision|58|||
125338711|NCT00910299|450874290|FG001|Overall Study|Sponsor Decision|60|||
125338712|NCT00910299|450874289|FG000|Overall Study|Didn't receive any study drug|2|||
125338713|NCT00910299|450874290|FG001|Overall Study|Didn't receive any study drug|1|||
125338714|NCT02873429|450874295|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
125672931|NCT02637557|452090859|FG003|Overall Study|Adverse Event|3|||
125672932|NCT02637557|452090856|FG000|Overall Study|Lost to Follow-up|1|||
125672933|NCT02637557|452090857|FG001|Overall Study|Lost to Follow-up|1|||
125672934|NCT02637557|452090858|FG002|Overall Study|Lost to Follow-up|0|||
125672935|NCT02637557|452090859|FG003|Overall Study|Lost to Follow-up|1|||
125672936|NCT02637557|452090856|FG000|Overall Study|Physician Decision|1|||
125672937|NCT02637557|452090857|FG001|Overall Study|Physician Decision|0|||
125672938|NCT02637557|452090858|FG002|Overall Study|Physician Decision|0|||
125672939|NCT02637557|452090859|FG003|Overall Study|Physician Decision|0|||
125672940|NCT02637557|452090856|FG000|Overall Study|Protocol Violation|2|||
125672941|NCT02637557|452090857|FG001|Overall Study|Protocol Violation|0|||
125672942|NCT02637557|452090858|FG002|Overall Study|Protocol Violation|2|||
125672943|NCT02637557|452090859|FG003|Overall Study|Protocol Violation|1|||
125672944|NCT02637557|452090856|FG000|Overall Study|Withdrawal by Subject|1|||
125672945|NCT02637557|452090857|FG001|Overall Study|Withdrawal by Subject|3|||
125672946|NCT02637557|452090858|FG002|Overall Study|Withdrawal by Subject|4|||
125672947|NCT02637557|452090859|FG003|Overall Study|Withdrawal by Subject|2|||
125672948|NCT00613574|452090860|FG000|Overall Study|Adverse Event|3|||
125672949|NCT00613574|452090860|FG000|Overall Study|Lost to Follow-up|2|||
125672950|NCT00613574|452090860|FG000|Overall Study|Other|1|||
125672951|NCT01751412|452090862|FG000|Overall Study|Disease Progression Before Treatment|1|||
125672952|NCT03734237|452090865|FG000|Overall Study|Lost to Follow-up|1|||
125672953|NCT03734237|452090866|FG001|Overall Study|Lost to Follow-up|3|||
125672954|NCT03734237|452090867|FG002|Overall Study|Lost to Follow-up|0|||
125672955|NCT03734237|452090865|FG000|Overall Study|Withdrawal by Subject|7|||
125672956|NCT03734237|452090866|FG001|Overall Study|Withdrawal by Subject|9|||
125672957|NCT03734237|452090867|FG002|Overall Study|Withdrawal by Subject|10|||
125672958|NCT02711956|452090868|FG000|Overall Study|Adverse Event|0|||
125672959|NCT02711956|452090869|FG001|Overall Study|Adverse Event|0|||
125672960|NCT02711956|452090870|FG002|Overall Study|Adverse Event|0|||
125672961|NCT02711956|452090871|FG003|Overall Study|Adverse Event|1|||
125672962|NCT02711956|452090872|FG004|Overall Study|Adverse Event|2|||
125672963|NCT02711956|452090873|FG005|Overall Study|Adverse Event|0|||
125672964|NCT02711956|452090874|FG006|Overall Study|Adverse Event|0|||
125672965|NCT02711956|452090875|FG007|Overall Study|Adverse Event|1|||
125672966|NCT02711956|452090876|FG008|Overall Study|Adverse Event|1|||
125672967|NCT02711956|452090877|FG009|Overall Study|Adverse Event|1|||
125672968|NCT02711956|452090878|FG010|Overall Study|Adverse Event|1|||
125672969|NCT02711956|452090879|FG011|Overall Study|Adverse Event|0|||
125672970|NCT02711956|452090880|FG012|Overall Study|Adverse Event|0|||
125672971|NCT02711956|452090881|FG013|Overall Study|Adverse Event|0|||
125672972|NCT02711956|452090882|FG014|Overall Study|Adverse Event|2|||
125672973|NCT02711956|452090868|FG000|Overall Study|Physician Decision|0|||
125672974|NCT02711956|452090869|FG001|Overall Study|Physician Decision|0|||
125672975|NCT02711956|452090870|FG002|Overall Study|Physician Decision|0|||
125672976|NCT02711956|452090871|FG003|Overall Study|Physician Decision|2|||
125672977|NCT02711956|452090872|FG004|Overall Study|Physician Decision|0|||
125338715|NCT02873429|450874296|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
125338716|NCT02873429|450874295|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
125672978|NCT02711956|452090873|FG005|Overall Study|Physician Decision|0|||
125338717|NCT02873429|450874296|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
125338718|NCT02873429|450874295|FG000|16 Weeks|Lost to Follow-up|3|||
125338719|NCT02873429|450874296|FG001|16 Weeks|Lost to Follow-up|0|||
125672979|NCT02711956|452090874|FG006|Overall Study|Physician Decision|0|||
125672980|NCT02711956|452090875|FG007|Overall Study|Physician Decision|0|||
125672981|NCT02711956|452090876|FG008|Overall Study|Physician Decision|0|||
125672982|NCT02711956|452090877|FG009|Overall Study|Physician Decision|0|||
125672983|NCT02711956|452090878|FG010|Overall Study|Physician Decision|0|||
125672984|NCT02711956|452090879|FG011|Overall Study|Physician Decision|0|||
125672985|NCT02711956|452090880|FG012|Overall Study|Physician Decision|0|||
125672986|NCT02711956|452090881|FG013|Overall Study|Physician Decision|0|||
125338720|NCT04270370|450874297|FG000|Overall Study|Lost to Follow-up|1|||
125338721|NCT04270370|450874298|FG001|Overall Study|Lost to Follow-up|0|||
125338722|NCT04270370|450874299|FG002|Overall Study|Lost to Follow-up|0|||
125338723|NCT04270370|450874300|FG003|Overall Study|Lost to Follow-up|0|||
125338724|NCT04270370|450874301|FG004|Overall Study|Lost to Follow-up|0|||
125338725|NCT04270370|450874302|FG005|Overall Study|Lost to Follow-up|0|||
125338726|NCT04270370|450874303|FG006|Overall Study|Lost to Follow-up|0|||
125338727|NCT04270370|450874304|FG007|Overall Study|Lost to Follow-up|0|||
125338728|NCT04270370|450874305|FG008|Overall Study|Lost to Follow-up|1|||
125338729|NCT04270370|450874306|FG009|Overall Study|Lost to Follow-up|0|||
125338730|NCT04270370|450874307|FG010|Overall Study|Lost to Follow-up|0|||
125338731|NCT04270370|450874308|FG011|Overall Study|Lost to Follow-up|0|||
125338732|NCT00530504|450874311|FG000|Overall Study|Death|54|||
125338733|NCT00530504|450874311|FG000|Overall Study|Lost to Follow-up|26|||
125338734|NCT00530504|450874311|FG000|Overall Study|Withdrawal by Subject|39|||
125338735|NCT00530504|450874311|FG000|Overall Study|Exited study due to other reasons|33|||
125338736|NCT02872285|450874314|FG000|Overall Study|Withdrawal by Subject|2|||
125338737|NCT02872285|450874315|FG001|Overall Study|Withdrawal by Subject|0|||
125338738|NCT02872285|450874314|FG000|Overall Study|Lost to Follow-up|2|||
125338739|NCT02872285|450874315|FG001|Overall Study|Lost to Follow-up|2|||
125338740|NCT02872285|450874314|FG000|Overall Study|Discontinued due to back surgery|1|||
125338741|NCT02872285|450874315|FG001|Overall Study|Discontinued due to back surgery|0|||
125338742|NCT05477108|450874316|FG000|Overall Study|Participants randomized, not treated|1|||
125338743|NCT05477108|450874317|FG001|Overall Study|Participants randomized, not treated|1|||
125338744|NCT05477108|450874318|FG002|Overall Study|Participants randomized, not treated|1|||
125338745|NCT05477108|450874316|FG000|Overall Study|Physician Decision|0|||
125338746|NCT05477108|450874317|FG001|Overall Study|Physician Decision|0|||
125338747|NCT05477108|450874318|FG002|Overall Study|Physician Decision|1|||
125338748|NCT05477108|450874316|FG000|Overall Study|withdrawn from study|0|||
125338749|NCT05477108|450874317|FG001|Overall Study|withdrawn from study|0|||
125672987|NCT02711956|452090882|FG014|Overall Study|Physician Decision|0|||
125672988|NCT02711956|452090868|FG000|Overall Study|Withdrawal by Subject|0|||
125672989|NCT02711956|452090869|FG001|Overall Study|Withdrawal by Subject|0|||
125672990|NCT02711956|452090870|FG002|Overall Study|Withdrawal by Subject|0|||
125672991|NCT02711956|452090871|FG003|Overall Study|Withdrawal by Subject|0|||
125672992|NCT02711956|452090872|FG004|Overall Study|Withdrawal by Subject|0|||
125672993|NCT02711956|452090873|FG005|Overall Study|Withdrawal by Subject|0|||
125672994|NCT02711956|452090874|FG006|Overall Study|Withdrawal by Subject|1|||
125672995|NCT02711956|452090875|FG007|Overall Study|Withdrawal by Subject|0|||
125672996|NCT02711956|452090876|FG008|Overall Study|Withdrawal by Subject|0|||
125338750|NCT05477108|450874318|FG002|Overall Study|withdrawn from study|1|||
125672997|NCT02711956|452090877|FG009|Overall Study|Withdrawal by Subject|0|||
125672998|NCT02711956|452090878|FG010|Overall Study|Withdrawal by Subject|0|||
125672999|NCT02711956|452090879|FG011|Overall Study|Withdrawal by Subject|1|||
125673000|NCT02711956|452090880|FG012|Overall Study|Withdrawal by Subject|6|||
125673001|NCT02711956|452090881|FG013|Overall Study|Withdrawal by Subject|0|||
125673002|NCT02711956|452090882|FG014|Overall Study|Withdrawal by Subject|1|||
125673003|NCT02711956|452090868|FG000|Overall Study|Clinical progression|1|||
125673004|NCT02711956|452090869|FG001|Overall Study|Clinical progression|0|||
125673005|NCT02711956|452090870|FG002|Overall Study|Clinical progression|0|||
125673006|NCT02711956|452090871|FG003|Overall Study|Clinical progression|0|||
125673007|NCT02711956|452090872|FG004|Overall Study|Clinical progression|0|||
125673008|NCT02711956|452090873|FG005|Overall Study|Clinical progression|0|||
125673009|NCT02711956|452090874|FG006|Overall Study|Clinical progression|1|||
125673010|NCT02711956|452090875|FG007|Overall Study|Clinical progression|0|||
125673011|NCT02711956|452090876|FG008|Overall Study|Clinical progression|1|||
125673012|NCT02711956|452090877|FG009|Overall Study|Clinical progression|0|||
125673013|NCT02711956|452090878|FG010|Overall Study|Clinical progression|0|||
125673014|NCT02711956|452090879|FG011|Overall Study|Clinical progression|2|||
125673015|NCT02711956|452090880|FG012|Overall Study|Clinical progression|4|||
125673016|NCT02711956|452090881|FG013|Overall Study|Clinical progression|1|||
125673017|NCT02711956|452090882|FG014|Overall Study|Clinical progression|1|||
125673018|NCT02711956|452090868|FG000|Overall Study|Radiographic progression|1|||
125673019|NCT02711956|452090869|FG001|Overall Study|Radiographic progression|1|||
125673020|NCT02711956|452090870|FG002|Overall Study|Radiographic progression|2|||
125673021|NCT02711956|452090871|FG003|Overall Study|Radiographic progression|0|||
125673022|NCT02711956|452090872|FG004|Overall Study|Radiographic progression|1|||
125673023|NCT02711956|452090873|FG005|Overall Study|Radiographic progression|0|||
125673024|NCT02711956|452090874|FG006|Overall Study|Radiographic progression|0|||
125673025|NCT02711956|452090875|FG007|Overall Study|Radiographic progression|0|||
125673026|NCT02711956|452090876|FG008|Overall Study|Radiographic progression|2|||
125673027|NCT02711956|452090877|FG009|Overall Study|Radiographic progression|1|||
125673028|NCT02711956|452090878|FG010|Overall Study|Radiographic progression|0|||
125673029|NCT02711956|452090879|FG011|Overall Study|Radiographic progression|5|||
125673030|NCT02711956|452090880|FG012|Overall Study|Radiographic progression|3|||
125673031|NCT02711956|452090881|FG013|Overall Study|Radiographic progression|0|||
125673032|NCT02711956|452090882|FG014|Overall Study|Radiographic progression|1|||
125673033|NCT02711956|452090868|FG000|Overall Study|PSA progression with clinical progression|0|||
125673034|NCT02711956|452090869|FG001|Overall Study|PSA progression with clinical progression|0|||
125673035|NCT02711956|452090870|FG002|Overall Study|PSA progression with clinical progression|0|||
125673036|NCT02711956|452090871|FG003|Overall Study|PSA progression with clinical progression|0|||
125673037|NCT02711956|452090872|FG004|Overall Study|PSA progression with clinical progression|1|||
125673038|NCT02711956|452090873|FG005|Overall Study|PSA progression with clinical progression|0|||
125673039|NCT02711956|452090874|FG006|Overall Study|PSA progression with clinical progression|0|||
125673040|NCT02711956|452090875|FG007|Overall Study|PSA progression with clinical progression|0|||
125673041|NCT02711956|452090876|FG008|Overall Study|PSA progression with clinical progression|0|||
125673042|NCT02711956|452090877|FG009|Overall Study|PSA progression with clinical progression|0|||
125673043|NCT02711956|452090878|FG010|Overall Study|PSA progression with clinical progression|0|||
125673044|NCT02711956|452090879|FG011|Overall Study|PSA progression with clinical progression|0|||
125673045|NCT02711956|452090880|FG012|Overall Study|PSA progression with clinical progression|1|||
125673046|NCT02711956|452090881|FG013|Overall Study|PSA progression with clinical progression|1|||
125673047|NCT02711956|452090882|FG014|Overall Study|PSA progression with clinical progression|0|||
125673048|NCT02711956|452090868|FG000|Overall Study|PSA progression with radiographic progression|0|||
125673049|NCT02711956|452090869|FG001|Overall Study|PSA progression with radiographic progression|1|||
125673050|NCT02711956|452090870|FG002|Overall Study|PSA progression with radiographic progression|0|||
125673051|NCT02711956|452090871|FG003|Overall Study|PSA progression with radiographic progression|0|||
125673052|NCT02711956|452090872|FG004|Overall Study|PSA progression with radiographic progression|0|||
125673053|NCT02711956|452090873|FG005|Overall Study|PSA progression with radiographic progression|2|||
125673054|NCT02711956|452090874|FG006|Overall Study|PSA progression with radiographic progression|2|||
125673055|NCT02711956|452090875|FG007|Overall Study|PSA progression with radiographic progression|1|||
125673056|NCT02711956|452090876|FG008|Overall Study|PSA progression with radiographic progression|0|||
125673057|NCT02711956|452090877|FG009|Overall Study|PSA progression with radiographic progression|1|||
125673058|NCT02711956|452090878|FG010|Overall Study|PSA progression with radiographic progression|0|||
125673059|NCT02711956|452090879|FG011|Overall Study|PSA progression with radiographic progression|1|||
125673060|NCT02711956|452090880|FG012|Overall Study|PSA progression with radiographic progression|2|||
125673061|NCT02711956|452090881|FG013|Overall Study|PSA progression with radiographic progression|3|||
125673062|NCT02711956|452090882|FG014|Overall Study|PSA progression with radiographic progression|3|||
125673063|NCT01844583|452090883|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
125673064|NCT01844583|452090884|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
125673065|NCT01625377|452090885|FG000|Overall Study|Death|1|||
125673066|NCT01625377|452090886|FG001|Overall Study|Death|1|||
125338751|NCT02660983|450874319|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
125338752|NCT02660983|450874320|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
125338753|NCT02660983|450874319|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
125338754|NCT02660983|450874320|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
125338755|NCT02660983|450874319|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
125338756|NCT02660983|450874320|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
125338757|NCT02660983|450874319|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
125338758|NCT02660983|450874320|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
125338759|NCT02660983|450874319|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
125338760|NCT02660983|450874320|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
125673067|NCT01625377|452090885|FG000|Overall Study|Administrative Problem|1|||
125673068|NCT01625377|452090886|FG001|Overall Study|Administrative Problem|1|||
125673069|NCT01625377|452090885|FG000|Overall Study|Protocol Violation|0|||
125673070|NCT01625377|452090886|FG001|Overall Study|Protocol Violation|3|||
125673071|NCT01625377|452090885|FG000|Overall Study|Adverse Event|3|||
125673072|NCT01625377|452090886|FG001|Overall Study|Adverse Event|16|||
125673073|NCT01625377|452090885|FG000|Overall Study|Graft loss|1|||
125673074|NCT01625377|452090886|FG001|Overall Study|Graft loss|0|||
125673075|NCT01625377|452090885|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125673076|NCT01625377|452090886|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125673077|NCT01625377|452090885|FG000|Overall Study|Abnormal laboratory values|1|||
125673078|NCT01625377|452090886|FG001|Overall Study|Abnormal laboratory values|0|||
125673079|NCT02207621|452090891|FG000|Overall Study|Adverse Event|71|||
125673080|NCT02207621|452090892|FG001|Overall Study|Adverse Event|15|||
125673081|NCT02207621|452090893|FG002|Overall Study|Adverse Event|132|||
125673082|NCT02207621|452090891|FG000|Overall Study|Withdrawal by Subject|9|||
125673083|NCT02207621|452090892|FG001|Overall Study|Withdrawal by Subject|9|||
125673084|NCT02207621|452090893|FG002|Overall Study|Withdrawal by Subject|13|||
125673085|NCT02207621|452090891|FG000|Overall Study|Non-Compliant|3|||
125673086|NCT02207621|452090892|FG001|Overall Study|Non-Compliant|3|||
125673087|NCT02207621|452090893|FG002|Overall Study|Non-Compliant|1|||
125673088|NCT02207621|452090891|FG000|Overall Study|Lost to Follow-up|1|||
125673089|NCT02207621|452090892|FG001|Overall Study|Lost to Follow-up|0|||
125673090|NCT02207621|452090893|FG002|Overall Study|Lost to Follow-up|3|||
125673091|NCT02207621|452090891|FG000|Overall Study|Lack of Efficacy|10|||
125673092|NCT02207621|452090892|FG001|Overall Study|Lack of Efficacy|2|||
125673093|NCT02207621|452090893|FG002|Overall Study|Lack of Efficacy|4|||
125673094|NCT02207621|452090891|FG000|Overall Study|Disallowed Concurrent Medication|2|||
125673095|NCT02207621|452090892|FG001|Overall Study|Disallowed Concurrent Medication|5|||
125673096|NCT02207621|452090893|FG002|Overall Study|Disallowed Concurrent Medication|2|||
125673097|NCT02207621|452090891|FG000|Overall Study|Physician Decision|1|||
125673098|NCT02207621|452090892|FG001|Overall Study|Physician Decision|2|||
125673099|NCT02207621|452090893|FG002|Overall Study|Physician Decision|2|||
125673100|NCT02207621|452090891|FG000|Overall Study|Protocol Violation|4|||
125673101|NCT02207621|452090892|FG001|Overall Study|Protocol Violation|10|||
125673102|NCT02207621|452090893|FG002|Overall Study|Protocol Violation|6|||
125673103|NCT02207621|452090891|FG000|Overall Study|Death|2|||
125673104|NCT02207621|452090892|FG001|Overall Study|Death|0|||
125673105|NCT02207621|452090893|FG002|Overall Study|Death|0|||
125673106|NCT02207621|452090891|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
125673107|NCT02207621|452090892|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
125673108|NCT02207621|452090893|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
125673109|NCT01769378|452090896|FG000|Overall Study|Adverse Event|10|||
125673110|NCT01769378|452090897|FG001|Overall Study|Adverse Event|0|||
125673111|NCT01769378|452090896|FG000|Overall Study|Entry criteria not met|1|||
125673112|NCT01769378|452090897|FG001|Overall Study|Entry criteria not met|0|||
125673113|NCT01769378|452090896|FG000|Overall Study|Protocol Violation|1|||
125673114|NCT01769378|452090897|FG001|Overall Study|Protocol Violation|1|||
125673115|NCT01769378|452090896|FG000|Overall Study|Withdrawal by Subject|10|||
125673116|NCT01769378|452090897|FG001|Overall Study|Withdrawal by Subject|3|||
125673117|NCT01769378|452090896|FG000|Overall Study|Sponsor Decision|1|||
125673118|NCT01769378|452090897|FG001|Overall Study|Sponsor Decision|0|||
125673119|NCT01769378|452090896|FG000|Overall Study|Lost to Follow-up|2|||
125673120|NCT01769378|452090897|FG001|Overall Study|Lost to Follow-up|0|||
125673121|NCT01238848|452090902|FG000|Overall Study|Physician Decision|13|||
125673122|NCT01238848|452090903|FG001|Overall Study|Physician Decision|5|||
125673123|NCT00576901|452090904|FG000|Overall Study|Withdrawal by Subject|1|||
125673124|NCT00576901|452090904|FG000|Overall Study|Disease course|1|||
125673125|NCT00576901|452090904|FG000|Overall Study|Protocol Violation|1|||
125673126|NCT01755858|452090907|FG000|Overall Study|Adverse Event|1|||
125673127|NCT01755858|452090908|FG001|Overall Study|Adverse Event|1|||
125673128|NCT01259869|452090909|FG000|Overall Study|Duplicated registration|1|||
125673129|NCT00175019|452090910|FG000|Overall Study|Adverse Event|54|||
125673130|NCT00175019|452090911|FG001|Overall Study|Adverse Event|22|||
125673131|NCT00175019|452090912|FG002|Overall Study|Adverse Event|2|||
125673132|NCT00175019|452090910|FG000|Overall Study|Protocol Violation|6|||
125673133|NCT00175019|452090911|FG001|Overall Study|Protocol Violation|3|||
125673134|NCT00175019|452090912|FG002|Overall Study|Protocol Violation|3|||
125673135|NCT00175019|452090910|FG000|Overall Study|Lost to Follow-up|42|||
125673136|NCT00175019|452090911|FG001|Overall Study|Lost to Follow-up|39|||
125673137|NCT00175019|452090912|FG002|Overall Study|Lost to Follow-up|9|||
125673138|NCT00175019|452090910|FG000|Overall Study|Did not continue under Amendment 4|1|||
125673139|NCT00175019|452090911|FG001|Overall Study|Did not continue under Amendment 4|1|||
125338761|NCT02660983|450874319|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
125338762|NCT02660983|450874320|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
125338763|NCT02660983|450874319|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
125338764|NCT02660983|450874320|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
125338765|NCT04303195|450874325|FG000|Overall Study|Adverse Event|1|||
125338766|NCT04303195|450874326|FG001|Overall Study|Adverse Event|3|||
125338767|NCT04303195|450874327|FG002|Overall Study|Adverse Event|7|||
125338768|NCT04303195|450874328|FG003|Overall Study|Adverse Event|0|||
125338769|NCT04303195|450874325|FG000|Overall Study|Lost to Follow-up|1|||
125338770|NCT04303195|450874326|FG001|Overall Study|Lost to Follow-up|0|||
125338771|NCT04303195|450874327|FG002|Overall Study|Lost to Follow-up|1|||
125338772|NCT04303195|450874328|FG003|Overall Study|Lost to Follow-up|4|||
125338773|NCT04303195|450874325|FG000|Overall Study|Withdrawal by Subject|3|||
125338774|NCT04303195|450874326|FG001|Overall Study|Withdrawal by Subject|1|||
125338775|NCT04303195|450874327|FG002|Overall Study|Withdrawal by Subject|1|||
125338776|NCT04303195|450874328|FG003|Overall Study|Withdrawal by Subject|1|||
125338777|NCT04303195|450874325|FG000|Overall Study|No study drug administered or protocol deviation|0|||
125338778|NCT04303195|450874326|FG001|Overall Study|No study drug administered or protocol deviation|2|||
125338779|NCT04303195|450874327|FG002|Overall Study|No study drug administered or protocol deviation|0|||
125673140|NCT00175019|452090912|FG002|Overall Study|Did not continue under Amendment 4|2|||
125673141|NCT00175019|452090910|FG000|Overall Study|Personal Reason(s)|39|||
125673142|NCT00175019|452090911|FG001|Overall Study|Personal Reason(s)|31|||
125673143|NCT00175019|452090912|FG002|Overall Study|Personal Reason(s)|8|||
125673144|NCT00175019|452090910|FG000|Overall Study|Therapeutic Failure|10|||
125673145|NCT00175019|452090911|FG001|Overall Study|Therapeutic Failure|38|||
125673146|NCT00175019|452090912|FG002|Overall Study|Therapeutic Failure|22|||
125673147|NCT00175019|452090910|FG000|Overall Study|Gout Flare|2|||
125673148|NCT00175019|452090911|FG001|Overall Study|Gout Flare|3|||
125673149|NCT00175019|452090912|FG002|Overall Study|Gout Flare|0|||
125673150|NCT00175019|452090910|FG000|Overall Study|Reason Not Specified|40|||
125673151|NCT00175019|452090911|FG001|Overall Study|Reason Not Specified|34|||
125673152|NCT00175019|452090912|FG002|Overall Study|Reason Not Specified|11|||
125673153|NCT03209570|452090913|FG000|Overall Study|Death|1|||
125673154|NCT03209570|452090914|FG001|Overall Study|Death|0|||
125673155|NCT03209570|452090913|FG000|Overall Study|Incomplete Data|8|||
125673156|NCT03209570|452090914|FG001|Overall Study|Incomplete Data|10|||
125673157|NCT03209570|452090913|FG000|Overall Study|Protocol Violation|1|||
125673158|NCT03209570|452090914|FG001|Overall Study|Protocol Violation|0|||
125673159|NCT03209570|452090913|FG000|Overall Study|Withdrawal by Subject|0|||
125673160|NCT03209570|452090914|FG001|Overall Study|Withdrawal by Subject|3|||
125673161|NCT00220701|452090925|FG000|Overall Study|Lost to Follow-up|5|||
125673162|NCT00220701|452090926|FG001|Overall Study|Lost to Follow-up|4|||
125673163|NCT00755326|452090927|FG000|Overall Study|Lost to Follow-up|2|||
125673164|NCT00755326|452090928|FG001|Overall Study|Lost to Follow-up|3|||
125673165|NCT04041570|452090931|FG000|Overall Study|Moved from Area|0|||
125673166|NCT04041570|452090932|FG001|Overall Study|Moved from Area|2|||
125673167|NCT00384033|452090936|FG000|Overall Study|Adverse Event|10|||
125673168|NCT00384033|452090937|FG001|Overall Study|Adverse Event|8|||
125673169|NCT00384033|452090938|FG002|Overall Study|Adverse Event|11|||
125673170|NCT00384033|452090939|FG003|Overall Study|Adverse Event|20|||
125673171|NCT00384033|452090936|FG000|Overall Study|Failed to return|1|||
125673172|NCT00384033|452090937|FG001|Overall Study|Failed to return|3|||
125673173|NCT00384033|452090938|FG002|Overall Study|Failed to return|2|||
125673174|NCT00384033|452090939|FG003|Overall Study|Failed to return|2|||
125673175|NCT00384033|452090936|FG000|Overall Study|Physician Decision|1|||
125673176|NCT00384033|452090937|FG001|Overall Study|Physician Decision|0|||
125673177|NCT00384033|452090938|FG002|Overall Study|Physician Decision|0|||
125673178|NCT00384033|452090939|FG003|Overall Study|Physician Decision|0|||
125673179|NCT00384033|452090936|FG000|Overall Study|Lost to Follow-up|6|||
125673180|NCT00384033|452090937|FG001|Overall Study|Lost to Follow-up|12|||
125673181|NCT00384033|452090938|FG002|Overall Study|Lost to Follow-up|7|||
125673182|NCT00384033|452090939|FG003|Overall Study|Lost to Follow-up|7|||
125673183|NCT00384033|452090936|FG000|Overall Study|Other|2|||
125673184|NCT00384033|452090937|FG001|Overall Study|Other|0|||
125673185|NCT00384033|452090938|FG002|Overall Study|Other|0|||
125673186|NCT00384033|452090939|FG003|Overall Study|Other|0|||
125673187|NCT00384033|452090936|FG000|Overall Study|Protocol Violation|5|||
125673188|NCT00384033|452090937|FG001|Overall Study|Protocol Violation|0|||
125673189|NCT00384033|452090938|FG002|Overall Study|Protocol Violation|5|||
125673190|NCT00384033|452090939|FG003|Overall Study|Protocol Violation|6|||
125673191|NCT00384033|452090936|FG000|Overall Study|Withdrawal by Subject|6|||
125673192|NCT00384033|452090937|FG001|Overall Study|Withdrawal by Subject|2|||
125673193|NCT00384033|452090938|FG002|Overall Study|Withdrawal by Subject|5|||
125673194|NCT00384033|452090939|FG003|Overall Study|Withdrawal by Subject|2|||
125673195|NCT00384033|452090936|FG000|Overall Study|Lack of Efficacy|7|||
125673196|NCT00384033|452090937|FG001|Overall Study|Lack of Efficacy|3|||
125673197|NCT00384033|452090938|FG002|Overall Study|Lack of Efficacy|3|||
125673198|NCT00384033|452090939|FG003|Overall Study|Lack of Efficacy|1|||
125673199|NCT00384033|452090936|FG000|Overall Study|Randomized but not treated|3|||
125673200|NCT00384033|452090937|FG001|Overall Study|Randomized but not treated|7|||
125673201|NCT00384033|452090938|FG002|Overall Study|Randomized but not treated|10|||
125673202|NCT00384033|452090939|FG003|Overall Study|Randomized but not treated|2|||
125673203|NCT00290745|452090940|FG000|Overall Study|Withdrawal by Subject|4|||
125673204|NCT00290745|452090940|FG000|Overall Study|Physician Decision|2|||
125673205|NCT00290745|452090940|FG000|Overall Study|Surgery after 3 months for progression|3|||
125673206|NCT00290745|452090940|FG000|Overall Study|Baseline MRI not available|3|||
125673207|NCT02750306|452090941|FG000|Overall Study|Withdrawal by Subject|5|||
125673208|NCT02750306|452090942|FG001|Overall Study|Withdrawal by Subject|2|||
125673209|NCT02750306|452090941|FG000|Overall Study|Protocol Violation|1|||
125673210|NCT02750306|452090942|FG001|Overall Study|Protocol Violation|0|||
125673211|NCT02737306|452090943|FG000|Overall Study|Adverse Event|3|||
125673212|NCT02737306|452090944|FG001|Overall Study|Adverse Event|0|||
125673213|NCT02737306|452090943|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
125673214|NCT02737306|452090944|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
125673215|NCT01915732|452090947|FG000|Overall Study|Withdrawal by Subject|18|||
125673216|NCT01915732|452090948|FG001|Overall Study|Withdrawal by Subject|18|||
125673217|NCT01915732|452090947|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
125673218|NCT01915732|452090948|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
125338780|NCT04303195|450874328|FG003|Overall Study|No study drug administered or protocol deviation|2|||
125338781|NCT01065454|450874329|FG000|Treatment|Adverse Event|7|||
125338782|NCT01065454|450874330|FG001|Treatment|Adverse Event|4|||
125338783|NCT01065454|450874331|FG002|Treatment|Adverse Event|3|||
125338784|NCT01065454|450874332|FG003|Treatment|Adverse Event|6|||
125338785|NCT01065454|450874329|FG000|Treatment|Death|1|||
125338786|NCT01065454|450874330|FG001|Treatment|Death|0|||
125338787|NCT01065454|450874331|FG002|Treatment|Death|0|||
125338788|NCT01065454|450874332|FG003|Treatment|Death|0|||
125338789|NCT01065454|450874329|FG000|Treatment|Non-compliance|1|||
125338790|NCT01065454|450874330|FG001|Treatment|Non-compliance|0|||
125338791|NCT01065454|450874331|FG002|Treatment|Non-compliance|0|||
125338792|NCT01065454|450874332|FG003|Treatment|Non-compliance|1|||
125338793|NCT01065454|450874329|FG000|Treatment|Protocol Decision|0|||
125338794|NCT01065454|450874330|FG001|Treatment|Protocol Decision|0|||
125338795|NCT01065454|450874331|FG002|Treatment|Protocol Decision|3|||
125338796|NCT01065454|450874332|FG003|Treatment|Protocol Decision|2|||
125338797|NCT01065454|450874329|FG000|Treatment|Protocol Violation|1|||
125338798|NCT01065454|450874330|FG001|Treatment|Protocol Violation|0|||
125338799|NCT01065454|450874331|FG002|Treatment|Protocol Violation|1|||
125338800|NCT01065454|450874332|FG003|Treatment|Protocol Violation|0|||
125338801|NCT01065454|450874329|FG000|Treatment|Withdrawal by Subject|3|||
125338802|NCT01065454|450874330|FG001|Treatment|Withdrawal by Subject|1|||
125338803|NCT01065454|450874331|FG002|Treatment|Withdrawal by Subject|2|||
125338804|NCT01065454|450874332|FG003|Treatment|Withdrawal by Subject|3|||
125338805|NCT01065454|450874329|FG000|Follow up|Adverse Event|1|||
125338806|NCT01065454|450874330|FG001|Follow up|Adverse Event|0|||
125338807|NCT01065454|450874331|FG002|Follow up|Adverse Event|0|||
125338808|NCT01065454|450874332|FG003|Follow up|Adverse Event|1|||
125338809|NCT01065454|450874329|FG000|Follow up|Death|0|||
125338810|NCT01065454|450874330|FG001|Follow up|Death|1|||
125338811|NCT01065454|450874331|FG002|Follow up|Death|1|||
125338812|NCT01065454|450874332|FG003|Follow up|Death|0|||
125338813|NCT01065454|450874329|FG000|Follow up|Lost to Follow-up|0|||
125338814|NCT01065454|450874330|FG001|Follow up|Lost to Follow-up|0|||
125338815|NCT01065454|450874331|FG002|Follow up|Lost to Follow-up|0|||
125338816|NCT01065454|450874332|FG003|Follow up|Lost to Follow-up|1|||
125338817|NCT01065454|450874329|FG000|Follow up|Progressive disease|0|||
125338818|NCT01065454|450874330|FG001|Follow up|Progressive disease|0|||
125338819|NCT01065454|450874331|FG002|Follow up|Progressive disease|0|||
125338820|NCT01065454|450874332|FG003|Follow up|Progressive disease|1|||
125338821|NCT01065454|450874329|FG000|Follow up|Withdrawal by Subject|1|||
125338822|NCT01065454|450874330|FG001|Follow up|Withdrawal by Subject|1|||
125338823|NCT01065454|450874331|FG002|Follow up|Withdrawal by Subject|1|||
125338824|NCT01065454|450874332|FG003|Follow up|Withdrawal by Subject|0|||
125338825|NCT01065454|450874329|FG000|Follow up|study ongoing|37|||
125338826|NCT01065454|450874330|FG001|Follow up|study ongoing|22|||
125338827|NCT01065454|450874331|FG002|Follow up|study ongoing|15|||
125338828|NCT01065454|450874332|FG003|Follow up|study ongoing|41|||
125338829|NCT01601652|450874333|FG000|Overall Study|Death|1|||
125338830|NCT05688670|450874334|FG000|Overall Study|Change in surgery plan|1|||
125338831|NCT05688670|450874335|FG001|Overall Study|Change in surgery plan|4|||
125338832|NCT05688670|450874334|FG000|Overall Study|Inability to extubate|1|||
125338833|NCT05688670|450874335|FG001|Overall Study|Inability to extubate|2|||
125338834|NCT05688670|450874334|FG000|Overall Study|Day of surgery cancellation|0|||
125338835|NCT05688670|450874335|FG001|Overall Study|Day of surgery cancellation|1|||
125338836|NCT05688670|450874334|FG000|Overall Study|Reintubated on PCICU arrival|0|||
125338837|NCT05688670|450874335|FG001|Overall Study|Reintubated on PCICU arrival|1|||
125338838|NCT01097005|450874336|FG000|Overall Study|Case Report Form not collected|18|||
125338839|NCT01097005|450874336|FG000|Overall Study|Subjects cannot visit the hospital|1|||
125338840|NCT01097005|450874336|FG000|Overall Study|Poor medication compliance|1|||
125338841|NCT01097005|450874336|FG000|Overall Study|No examination data available|244|||
125673219|NCT01915732|452090947|FG000|Overall Study|Adverse Event|12|||
125338842|NCT01097005|450874336|FG000|Overall Study|Deviation from exclusion criteria|37|||
125338843|NCT01097005|450874336|FG000|Overall Study|Adverse Event|14|||
125338844|NCT01097005|450874336|FG000|Overall Study|Discontinuance by complication|50|||
125338845|NCT03425253|450874337|FG000|Overall Study|Adverse Event|2|||
125338846|NCT03425253|450874337|FG000|Overall Study|Lost to Follow-up|3|||
125338847|NCT03425253|450874337|FG000|Overall Study|Withdrew Consent|6|||
125338848|NCT03425253|450874337|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
125338849|NCT05009979|450874338|FG000|Overall Study|Withdrawal by Subject|1|||
125378898|NCT00754624|451019197|FG000|Overall Study|Withdrawal by Subject|28|||
125673220|NCT01915732|452090948|FG001|Overall Study|Adverse Event|4|||
125378899|NCT00754624|451019197|FG000|Overall Study|Various|12|||
125378900|NCT00754624|451019197|FG000|Overall Study|Lost to Follow-up|3|||
125378901|NCT00418314|451019198|FG000|Overall Study|Withdrawal by Subject|1|||
125673221|NCT01915732|452090947|FG000|Overall Study|Protocol Violation|5|||
125378902|NCT00418314|451019199|FG001|Overall Study|Withdrawal by Subject|2|||
125378903|NCT01500629|451019202|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
125378904|NCT01500629|451019203|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
125378905|NCT00588848|451019204|FG000|Overall Study|Physician Decision|0|||
125338850|NCT03844945|450876056|FG000|Overall Study|Adverse Event|1|||
125338851|NCT03844945|450876057|FG001|Overall Study|Adverse Event|1|||
125338852|NCT03844945|450876058|FG002|Overall Study|Adverse Event|4|||
125338853|NCT03844945|450876059|FG003|Overall Study|Adverse Event|0|||
125338854|NCT03844945|450876056|FG000|Overall Study|Withdrawal by Subject|0|||
125338855|NCT03844945|450876057|FG001|Overall Study|Withdrawal by Subject|0|||
125338856|NCT03844945|450876058|FG002|Overall Study|Withdrawal by Subject|1|||
125338857|NCT03844945|450876059|FG003|Overall Study|Withdrawal by Subject|0|||
125338858|NCT03844945|450876056|FG000|Overall Study|Lack of Efficacy|0|||
125338859|NCT03844945|450876057|FG001|Overall Study|Lack of Efficacy|0|||
125338860|NCT03844945|450876058|FG002|Overall Study|Lack of Efficacy|0|||
125338861|NCT03844945|450876059|FG003|Overall Study|Lack of Efficacy|1|||
125338862|NCT04129151|450876066|FG000|Overall Study|Adverse Event|1|||
125338863|NCT04129151|450876066|FG000|Overall Study|Disease Progression|7|||
125338864|NCT04129151|450876066|FG000|Overall Study|Study closure|1|||
125338865|NCT02051933|450876067|FG000|Overall Study|Physician Decision|0|||
125338866|NCT02051933|450876068|FG001|Overall Study|Physician Decision|1|||
125338867|NCT00588861|450876072|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
125338868|NCT00588861|450876073|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
125338869|NCT00588861|450876072|FG000|6 Months|Patients did not return for follow-up|98|||
125338870|NCT00588861|450876073|FG001|6 Months|Patients did not return for follow-up|73|||
125338871|NCT00588861|450876072|FG000|1 Year|Patients did not return for follow-up|89|||
125338872|NCT00588861|450876073|FG001|1 Year|Patients did not return for follow-up|82|||
125338873|NCT00588861|450876072|FG000|2 Years|Patients did not return for follow-up|92|||
125338874|NCT00588861|450876073|FG001|2 Years|Patients did not return for follow-up|87|||
125338875|NCT00588861|450876072|FG000|4 Years|Patients did not return for follow-up|91|||
125338876|NCT00588861|450876073|FG001|4 Years|Patients did not return for follow-up|103|||
125338877|NCT00588861|450876072|FG000|6 Years|Patients did not return for follow-up|104|||
125338878|NCT00588861|450876073|FG001|6 Years|Patients did not return for follow-up|109|||
125338879|NCT00588861|450876072|FG000|8 Years|Patients did not return for follow-up|105|||
125338880|NCT00588861|450876073|FG001|8 Years|Patients did not return for follow-up|114|||
125338881|NCT00588861|450876072|FG000|10 Years|Incomplete due to study termination|107|||
125338882|NCT00588861|450876073|FG001|10 Years|Incomplete due to study termination|114|||
125338883|NCT02730195|450876074|FG000|Overall Study|Withdrawal by Subject|1|||
125338884|NCT00265148|450876075|FG000|Overall Study|Adverse Event|2|||
125338885|NCT00265148|450876076|FG001|Overall Study|Adverse Event|2|||
125338886|NCT00265148|450876075|FG000|Overall Study|Lack of Efficacy|0|||
125338887|NCT00265148|450876076|FG001|Overall Study|Lack of Efficacy|2|||
125338888|NCT00265148|450876075|FG000|Overall Study|Protocol Violation|3|||
125338889|NCT00265148|450876076|FG001|Overall Study|Protocol Violation|2|||
125338890|NCT00265148|450876075|FG000|Overall Study|Lost to Follow-up|0|||
125338891|NCT00265148|450876076|FG001|Overall Study|Lost to Follow-up|1|||
125338892|NCT00265148|450876075|FG000|Overall Study|Withdrawal by Subject|2|||
125338893|NCT00265148|450876076|FG001|Overall Study|Withdrawal by Subject|1|||
125338894|NCT00265148|450876075|FG000|Overall Study|Physician Decision|1|||
125338895|NCT00265148|450876076|FG001|Overall Study|Physician Decision|0|||
125338896|NCT00265148|450876075|FG000|Overall Study|Increasing frailty|0|||
125338897|NCT00265148|450876076|FG001|Overall Study|Increasing frailty|1|||
125338898|NCT00265148|450876075|FG000|Overall Study|Subject chose to change of the dose|1|||
125338899|NCT00265148|450876076|FG001|Overall Study|Subject chose to change of the dose|0|||
125338900|NCT00942994|450876081|FG000|Overall Study|Adverse Event|7|||
125338901|NCT00942994|450876082|FG001|Overall Study|Adverse Event|4|||
125338902|NCT00942994|450876081|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125338903|NCT00942994|450876082|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125338904|NCT00942994|450876081|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125338905|NCT00942994|450876082|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125338906|NCT00942994|450876081|FG000|Overall Study|Patient withdrew consent|5|||
125338907|NCT00942994|450876082|FG001|Overall Study|Patient withdrew consent|8|||
125338908|NCT00942994|450876081|FG000|Overall Study|Lost to Follow-up|1|||
125338909|NCT00942994|450876082|FG001|Overall Study|Lost to Follow-up|4|||
125338910|NCT00942994|450876081|FG000|Overall Study|Protocol deviation|1|||
125338911|NCT00942994|450876082|FG001|Overall Study|Protocol deviation|2|||
125338912|NCT01874340|450876085|FG000|Overall Study|Study terminated by Sponsor|6|||
125338913|NCT01874340|450876086|FG001|Overall Study|Study terminated by Sponsor|8|||
125338914|NCT01874340|450876087|FG002|Overall Study|Study terminated by Sponsor|8|||
125338915|NCT01874340|450876088|FG003|Overall Study|Study terminated by Sponsor|4|||
125338916|NCT01874340|450876085|FG000|Overall Study|Withdrawal by Subject|0|||
125338917|NCT01874340|450876086|FG001|Overall Study|Withdrawal by Subject|0|||
125338918|NCT01874340|450876087|FG002|Overall Study|Withdrawal by Subject|0|||
125338919|NCT01874340|450876088|FG003|Overall Study|Withdrawal by Subject|1|||
125338920|NCT01311024|450876096|FG000|Overall Study|Protocol Violation|35|||
125338921|NCT01311024|450876097|FG001|Overall Study|Protocol Violation|22|||
125338922|NCT01523275|450876100|FG000|Overall Study|Lost to Follow-up|1|||
125338923|NCT01523275|450876101|FG001|Overall Study|Lost to Follow-up|2|||
125338924|NCT01523275|450876100|FG000|Overall Study|Withdrawal by Subject|1|||
125338925|NCT01523275|450876101|FG001|Overall Study|Withdrawal by Subject|0|||
125338926|NCT01206322|450876102|FG000|Overall Study|Adverse Event|0|||
125338927|NCT01206322|450876103|FG001|Overall Study|Adverse Event|0|||
125338928|NCT01206322|450876104|FG002|Overall Study|Adverse Event|0|||
125338929|NCT01206322|450876105|FG003|Overall Study|Adverse Event|1|||
125338930|NCT00689117|450876106|FG000|Overall Study|Adverse Event|6|||
125338931|NCT00689117|450876107|FG001|Overall Study|Adverse Event|0|||
125338932|NCT00689117|450876108|FG002|Overall Study|Adverse Event|5|||
125338933|NCT00689117|450876109|FG003|Overall Study|Adverse Event|0|||
125338934|NCT00689117|450876106|FG000|Overall Study|Lost to Follow-up|26|||
125338935|NCT00689117|450876107|FG001|Overall Study|Lost to Follow-up|19|||
125338936|NCT00689117|450876108|FG002|Overall Study|Lost to Follow-up|17|||
125338937|NCT00689117|450876109|FG003|Overall Study|Lost to Follow-up|11|||
125338938|NCT00689117|450876106|FG000|Overall Study|Lack of Efficacy|1|||
125338939|NCT00689117|450876107|FG001|Overall Study|Lack of Efficacy|2|||
125338940|NCT00689117|450876108|FG002|Overall Study|Lack of Efficacy|2|||
125338941|NCT00689117|450876109|FG003|Overall Study|Lack of Efficacy|2|||
125338942|NCT00689117|450876106|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
125338943|NCT00689117|450876107|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
125338944|NCT00689117|450876108|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
125338945|NCT00689117|450876109|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
125338946|NCT00689117|450876106|FG000|Overall Study|Withdrawal by Subject|19|||
125338947|NCT00689117|450876107|FG001|Overall Study|Withdrawal by Subject|18|||
125338948|NCT00689117|450876108|FG002|Overall Study|Withdrawal by Subject|26|||
125338949|NCT00689117|450876109|FG003|Overall Study|Withdrawal by Subject|13|||
125338950|NCT00689117|450876106|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
125338951|NCT00689117|450876107|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
125338952|NCT00689117|450876108|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
125338953|NCT00689117|450876109|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
125338954|NCT00689117|450876106|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
125338955|NCT00689117|450876107|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
125338956|NCT00689117|450876108|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125338957|NCT00689117|450876109|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125338958|NCT00689117|450876106|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
125338959|NCT00689117|450876107|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
125338960|NCT00689117|450876108|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
125338961|NCT00689117|450876109|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
125338962|NCT00689117|450876106|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
125338963|NCT00689117|450876107|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
125338964|NCT00689117|450876108|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
125338965|NCT00689117|450876109|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
125338966|NCT00689117|450876106|FG000|Overall Study|Use of Prohibitive Medication|2|||
125338967|NCT00689117|450876107|FG001|Overall Study|Use of Prohibitive Medication|1|||
125338968|NCT00689117|450876108|FG002|Overall Study|Use of Prohibitive Medication|3|||
125338969|NCT00689117|450876109|FG003|Overall Study|Use of Prohibitive Medication|0|||
125338970|NCT00689117|450876106|FG000|Overall Study|Pregnancy|0|||
125338971|NCT00689117|450876107|FG001|Overall Study|Pregnancy|2|||
125338972|NCT00689117|450876108|FG002|Overall Study|Pregnancy|0|||
125338973|NCT00689117|450876109|FG003|Overall Study|Pregnancy|2|||
125338974|NCT00689117|450876106|FG000|Overall Study|Incarceration|2|||
125338975|NCT00689117|450876107|FG001|Overall Study|Incarceration|0|||
125338976|NCT00689117|450876108|FG002|Overall Study|Incarceration|0|||
125338977|NCT00689117|450876109|FG003|Overall Study|Incarceration|0|||
125338978|NCT00689117|450876106|FG000|Overall Study|Fear of Birth Defects|0|||
125338979|NCT00689117|450876107|FG001|Overall Study|Fear of Birth Defects|0|||
125338980|NCT00689117|450876108|FG002|Overall Study|Fear of Birth Defects|1|||
125338981|NCT00689117|450876109|FG003|Overall Study|Fear of Birth Defects|0|||
125338982|NCT00689117|450876106|FG000|Overall Study|Transportation|1|||
125338983|NCT00689117|450876107|FG001|Overall Study|Transportation|0|||
125338984|NCT00689117|450876108|FG002|Overall Study|Transportation|0|||
125338985|NCT00689117|450876109|FG003|Overall Study|Transportation|0|||
125338986|NCT00689117|450876106|FG000|Overall Study|Patient Withdrew from Study|0|||
125338987|NCT00689117|450876107|FG001|Overall Study|Patient Withdrew from Study|0|||
125338988|NCT00689117|450876108|FG002|Overall Study|Patient Withdrew from Study|0|||
125338989|NCT00689117|450876109|FG003|Overall Study|Patient Withdrew from Study|1|||
125338990|NCT00689117|450876106|FG000|Overall Study|Personal Reason|0|||
125338991|NCT00689117|450876107|FG001|Overall Study|Personal Reason|1|||
125338992|NCT00689117|450876108|FG002|Overall Study|Personal Reason|0|||
125338993|NCT00689117|450876109|FG003|Overall Study|Personal Reason|0|||
125338994|NCT00689117|450876106|FG000|Overall Study|Dispensing Error|0|||
125338995|NCT00689117|450876107|FG001|Overall Study|Dispensing Error|1|||
125338996|NCT00689117|450876108|FG002|Overall Study|Dispensing Error|0|||
125338997|NCT00689117|450876109|FG003|Overall Study|Dispensing Error|0|||
125338998|NCT01086358|450876112|FG000|First Intervention|Lost to Follow-up|9|||
125338999|NCT01086358|450876113|FG001|First Intervention|Lost to Follow-up|4|||
125339000|NCT01086358|450876112|FG000|First Intervention|Withdrawal by Subject|0|||
125339001|NCT01086358|450876113|FG001|First Intervention|Withdrawal by Subject|1|||
125339002|NCT01086358|450876112|FG000|Second Intervention|Lost to Follow-up|4|||
125339003|NCT01086358|450876113|FG001|Second Intervention|Lost to Follow-up|4|||
125339004|NCT03206788|450876116|FG000|Overall Study|Withdrawal by Subject|0|||
125339005|NCT03206788|450876117|FG001|Overall Study|Withdrawal by Subject|1|||
125339006|NCT03206788|450876116|FG000|Overall Study|Adverse Event|0|||
125339007|NCT03206788|450876117|FG001|Overall Study|Adverse Event|1|||
125673222|NCT01915732|452090948|FG001|Overall Study|Protocol Violation|5|||
125673223|NCT01915732|452090947|FG000|Overall Study|Lack of Efficacy|6|||
125673224|NCT01915732|452090948|FG001|Overall Study|Lack of Efficacy|11|||
125673225|NCT01915732|452090947|FG000|Overall Study|Lost to Follow-up|22|||
125673226|NCT01915732|452090948|FG001|Overall Study|Lost to Follow-up|26|||
125673227|NCT01915732|452090947|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
125673228|NCT01915732|452090948|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
125673229|NCT01915732|452090947|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
125673230|NCT01915732|452090948|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
125673231|NCT01915732|452090947|FG000|Overall Study|Drug Release Error|1|||
125673232|NCT01915732|452090948|FG001|Overall Study|Drug Release Error|0|||
125673233|NCT01915732|452090947|FG000|Overall Study|Recovered|1|||
125673234|NCT01915732|452090948|FG001|Overall Study|Recovered|0|||
125673235|NCT01915732|452090947|FG000|Overall Study|Pregnancy|1|||
125673236|NCT01915732|452090948|FG001|Overall Study|Pregnancy|0|||
125673237|NCT01915732|452090947|FG000|Overall Study|Poor Perceived Efficacy|1|||
125673238|NCT01915732|452090948|FG001|Overall Study|Poor Perceived Efficacy|0|||
125673239|NCT01915732|452090947|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
125673240|NCT01915732|452090948|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
125673241|NCT01915732|452090947|FG000|Overall Study|Got Well|0|||
125673242|NCT01915732|452090948|FG001|Overall Study|Got Well|1|||
125673243|NCT01915732|452090947|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
125673244|NCT01915732|452090948|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
125673245|NCT01915732|452090947|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
125673246|NCT01915732|452090948|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
125673247|NCT01915732|452090947|FG000|Overall Study|Job Transfer|0|||
125673248|NCT01915732|452090948|FG001|Overall Study|Job Transfer|1|||
125673249|NCT01915732|452090947|FG000|Overall Study|Improper Facial Procedure|0|||
125673250|NCT01915732|452090948|FG001|Overall Study|Improper Facial Procedure|1|||
125673251|NCT01915732|452090947|FG000|Overall Study|Poor Conscious Effect|0|||
125673252|NCT01915732|452090948|FG001|Overall Study|Poor Conscious Effect|1|||
125673253|NCT02015793|452090950|FG000|Overall Study|Adverse Event|3|||
125673254|NCT02015793|452090951|FG001|Overall Study|Adverse Event|3|||
125673255|NCT02015793|452090950|FG000|Overall Study|Withdrawal by Subject|1|||
125673256|NCT02015793|452090951|FG001|Overall Study|Withdrawal by Subject|1|||
125673257|NCT01862328|452090952|FG000|Overall Study|Progressive Disease|3|||
125673258|NCT01862328|452090953|FG001|Overall Study|Progressive Disease|11|||
125673259|NCT01862328|452090954|FG002|Overall Study|Progressive Disease|5|||
125673260|NCT01862328|452090955|FG003|Overall Study|Progressive Disease|6|||
125673261|NCT01862328|452090956|FG004|Overall Study|Progressive Disease|7|||
125673262|NCT01862328|452090957|FG005|Overall Study|Progressive Disease|4|||
125673263|NCT01862328|452090958|FG006|Overall Study|Progressive Disease|3|||
125673264|NCT01862328|452090952|FG000|Overall Study|Adverse Event|0|||
125673265|NCT01862328|452090953|FG001|Overall Study|Adverse Event|4|||
125673266|NCT01862328|452090954|FG002|Overall Study|Adverse Event|0|||
125673267|NCT01862328|452090955|FG003|Overall Study|Adverse Event|1|||
125673268|NCT01862328|452090956|FG004|Overall Study|Adverse Event|0|||
125673269|NCT01862328|452090957|FG005|Overall Study|Adverse Event|2|||
125673270|NCT01862328|452090958|FG006|Overall Study|Adverse Event|4|||
125339008|NCT03206788|450876116|FG000|Overall Study|Physician Decision|0|||
125673271|NCT01862328|452090952|FG000|Overall Study|Other|0|||
125673272|NCT01862328|452090953|FG001|Overall Study|Other|2|||
125673273|NCT01862328|452090954|FG002|Overall Study|Other|1|||
125673274|NCT01862328|452090955|FG003|Overall Study|Other|0|||
125673275|NCT01862328|452090956|FG004|Overall Study|Other|4|||
125673276|NCT01862328|452090957|FG005|Overall Study|Other|0|||
125673277|NCT01862328|452090958|FG006|Overall Study|Other|1|||
125673278|NCT01862328|452090952|FG000|Overall Study|Withdrawal by Subject|1|||
125673279|NCT01862328|452090953|FG001|Overall Study|Withdrawal by Subject|1|||
125673280|NCT01862328|452090954|FG002|Overall Study|Withdrawal by Subject|0|||
125673281|NCT01862328|452090955|FG003|Overall Study|Withdrawal by Subject|0|||
125673282|NCT01862328|452090956|FG004|Overall Study|Withdrawal by Subject|1|||
125673283|NCT01862328|452090957|FG005|Overall Study|Withdrawal by Subject|1|||
125673284|NCT01862328|452090958|FG006|Overall Study|Withdrawal by Subject|1|||
125673285|NCT01862328|452090952|FG000|Overall Study|Symptomatic Deterioration|0|||
125673286|NCT01862328|452090953|FG001|Overall Study|Symptomatic Deterioration|0|||
125673287|NCT01862328|452090954|FG002|Overall Study|Symptomatic Deterioration|0|||
125673288|NCT01862328|452090955|FG003|Overall Study|Symptomatic Deterioration|0|||
125673289|NCT01862328|452090956|FG004|Overall Study|Symptomatic Deterioration|0|||
125673290|NCT01862328|452090957|FG005|Overall Study|Symptomatic Deterioration|0|||
125673291|NCT01862328|452090958|FG006|Overall Study|Symptomatic Deterioration|1|||
125673292|NCT02482571|452090959|FG000|Overall Study|Adverse Event|1|||
125673293|NCT02482571|452090959|FG000|Overall Study|Scanner or Respiract failure|3|||
125673294|NCT02482571|452090959|FG000|Overall Study|Withdrawal by Subject|4|||
125673295|NCT01446913|452090960|FG000|Overall Study|Significant illness|1|||
125673296|NCT01446913|452090961|FG001|Overall Study|Significant illness|1|||
125673297|NCT01446913|452090962|FG002|Overall Study|Significant illness|1|||
125673298|NCT01446913|452090960|FG000|Overall Study|Withdrawal by Subject|5|||
125673299|NCT01446913|452090961|FG001|Overall Study|Withdrawal by Subject|3|||
125673300|NCT01446913|452090962|FG002|Overall Study|Withdrawal by Subject|5|||
125673301|NCT01446913|452090960|FG000|Overall Study|Physician Decision|0|||
125673302|NCT01446913|452090961|FG001|Overall Study|Physician Decision|0|||
125673303|NCT01446913|452090962|FG002|Overall Study|Physician Decision|2|||
125673304|NCT01446913|452090960|FG000|Overall Study|Lost to Follow-up|3|||
125673305|NCT01446913|452090961|FG001|Overall Study|Lost to Follow-up|5|||
125673306|NCT01446913|452090962|FG002|Overall Study|Lost to Follow-up|3|||
125673307|NCT02521948|452090963|FG000|Overall Study|Adverse Event|2|||
125673308|NCT02521948|452090963|FG000|Overall Study|Death|4|||
125673309|NCT02521948|452090963|FG000|Overall Study|Lost to Follow-up|1|||
125673310|NCT02521948|452090963|FG000|Overall Study|Did not attend one or both follow-ups|6|||
125673311|NCT02427607|452090964|FG000|Overall Study|Withdrawal by Subject|1|||
125673312|NCT04000009|452090965|FG000|Overall Study|Adverse Event|13|||
125673313|NCT04000009|452090965|FG000|Overall Study|Lack of Efficacy|7|||
125673314|NCT04000009|452090965|FG000|Overall Study|Lost to Follow-up|8|||
125673315|NCT04000009|452090965|FG000|Overall Study|Noncompliance with study drug|4|||
125673316|NCT04000009|452090965|FG000|Overall Study|Physician Decision|1|||
125673317|NCT04000009|452090965|FG000|Overall Study|Use of prohibited medication|3|||
125673318|NCT04000009|452090965|FG000|Overall Study|Pregnancy|1|||
125673319|NCT04000009|452090965|FG000|Overall Study|Withdrawal by Subject|22|||
125673320|NCT04000009|452090965|FG000|Overall Study|Study terminated by sponsor|98|||
125673321|NCT04000009|452090965|FG000|Overall Study|Not further specified|8|||
125673322|NCT00679783|452090966|FG000|Overall Study|Adverse Event|0|||
125673323|NCT00679783|452090967|FG001|Overall Study|Adverse Event|0|||
125673324|NCT00679783|452090968|FG002|Overall Study|Adverse Event|0|||
125673325|NCT00679783|452090969|FG003|Overall Study|Adverse Event|3|||
125673326|NCT00679783|452090970|FG004|Overall Study|Adverse Event|0|||
125673327|NCT00679783|452090971|FG005|Overall Study|Adverse Event|0|||
125673328|NCT00679783|452090972|FG006|Overall Study|Adverse Event|1|||
125673329|NCT00679783|452090966|FG000|Overall Study|Lack of Efficacy|0|||
125673330|NCT00679783|452090967|FG001|Overall Study|Lack of Efficacy|1|||
125673331|NCT00679783|452090968|FG002|Overall Study|Lack of Efficacy|0|||
125673332|NCT00679783|452090969|FG003|Overall Study|Lack of Efficacy|2|||
125673333|NCT00679783|452090970|FG004|Overall Study|Lack of Efficacy|0|||
125673334|NCT00679783|452090971|FG005|Overall Study|Lack of Efficacy|0|||
125673335|NCT00679783|452090972|FG006|Overall Study|Lack of Efficacy|0|||
125673336|NCT00679783|452090966|FG000|Overall Study|Withdrawal by Subject|0|||
125673337|NCT00679783|452090967|FG001|Overall Study|Withdrawal by Subject|0|||
125673338|NCT00679783|452090968|FG002|Overall Study|Withdrawal by Subject|1|||
125673339|NCT00679783|452090969|FG003|Overall Study|Withdrawal by Subject|1|||
125673340|NCT00679783|452090970|FG004|Overall Study|Withdrawal by Subject|0|||
125673341|NCT00679783|452090971|FG005|Overall Study|Withdrawal by Subject|0|||
125673342|NCT00679783|452090972|FG006|Overall Study|Withdrawal by Subject|0|||
125673343|NCT00679783|452090966|FG000|Overall Study|Not Captured|0|||
125673344|NCT00679783|452090967|FG001|Overall Study|Not Captured|0|||
125673345|NCT00679783|452090968|FG002|Overall Study|Not Captured|0|||
125673346|NCT00679783|452090969|FG003|Overall Study|Not Captured|5|||
125673347|NCT00679783|452090970|FG004|Overall Study|Not Captured|0|||
125673348|NCT00679783|452090971|FG005|Overall Study|Not Captured|0|||
125673349|NCT00679783|452090972|FG006|Overall Study|Not Captured|0|||
125673350|NCT00679783|452090966|FG000|Overall Study|Ongoing at data cut-off|2|||
125673351|NCT00679783|452090967|FG001|Overall Study|Ongoing at data cut-off|2|||
125673352|NCT00679783|452090968|FG002|Overall Study|Ongoing at data cut-off|0|||
125673353|NCT00679783|452090969|FG003|Overall Study|Ongoing at data cut-off|9|||
125673354|NCT00679783|452090970|FG004|Overall Study|Ongoing at data cut-off|1|||
125673355|NCT00679783|452090971|FG005|Overall Study|Ongoing at data cut-off|0|||
125339009|NCT03206788|450876117|FG001|Overall Study|Physician Decision|1|||
125339010|NCT02471612|450876118|FG000|Overall Study|Lost to Follow-up|2|||
125339011|NCT03899805|450876119|FG000|Overall Study|Physician Decision|3|||
125339012|NCT03899805|450876120|FG001|Overall Study|Physician Decision|0|||
125339013|NCT03899805|450876121|FG002|Overall Study|Physician Decision|2|||
125339014|NCT03899805|450876119|FG000|Overall Study|Withdrawal by Subject|1|||
125339015|NCT03899805|450876120|FG001|Overall Study|Withdrawal by Subject|0|||
125339016|NCT03899805|450876121|FG002|Overall Study|Withdrawal by Subject|2|||
125339017|NCT03899805|450876119|FG000|Overall Study|Progressive Disease|10|||
125339018|NCT03899805|450876120|FG001|Overall Study|Progressive Disease|18|||
125339019|NCT03899805|450876121|FG002|Overall Study|Progressive Disease|12|||
125339020|NCT03899805|450876119|FG000|Overall Study|Adverse Event|3|||
125339021|NCT03899805|450876120|FG001|Overall Study|Adverse Event|1|||
125339022|NCT03899805|450876121|FG002|Overall Study|Adverse Event|0|||
125339023|NCT03899805|450876119|FG000|Overall Study|Death|2|||
125673356|NCT00679783|452090972|FG006|Overall Study|Ongoing at data cut-off|0|||
125673357|NCT01754259|452090975|FG000|Overall Study|Withdrawal by Subject|2|||
125673358|NCT01754259|452090976|FG001|Overall Study|Withdrawal by Subject|4|||
125673359|NCT01754259|452090975|FG000|Overall Study|Adverse Event|3|||
125673360|NCT01754259|452090976|FG001|Overall Study|Adverse Event|1|||
125673361|NCT01754259|452090975|FG000|Overall Study|Lost to Follow-up|0|||
125673362|NCT01754259|452090976|FG001|Overall Study|Lost to Follow-up|1|||
125673363|NCT00306384|452090977|FG000|Overall Study|Adverse Event|103|||
125673364|NCT00306384|452090978|FG001|Overall Study|Adverse Event|87|||
125673365|NCT00306384|452090979|FG002|Overall Study|Adverse Event|40|||
125673366|NCT00306384|452090977|FG000|Overall Study|Major protocol deviation|43|||
125673367|NCT00306384|452090978|FG001|Overall Study|Major protocol deviation|51|||
125673368|NCT00306384|452090979|FG002|Overall Study|Major protocol deviation|18|||
125673369|NCT00306384|452090977|FG000|Overall Study|Lost to Follow-up|57|||
125673370|NCT00306384|452090978|FG001|Overall Study|Lost to Follow-up|41|||
125673371|NCT00306384|452090979|FG002|Overall Study|Lost to Follow-up|35|||
125673372|NCT00306384|452090977|FG000|Overall Study|Voluntary withdrawal|199|||
125673373|NCT00306384|452090978|FG001|Overall Study|Voluntary withdrawal|187|||
125673374|NCT00306384|452090979|FG002|Overall Study|Voluntary withdrawal|91|||
125673375|NCT00306384|452090977|FG000|Overall Study|Study termination|1|||
125673376|NCT00306384|452090978|FG001|Overall Study|Study termination|0|||
125673377|NCT00306384|452090979|FG002|Overall Study|Study termination|1|||
125673378|NCT00306384|452090977|FG000|Overall Study|Pregnancy|3|||
125673379|NCT00306384|452090978|FG001|Overall Study|Pregnancy|1|||
125673380|NCT00306384|452090979|FG002|Overall Study|Pregnancy|1|||
125673381|NCT00306384|452090977|FG000|Overall Study|Lack of Efficacy|26|||
125673382|NCT00306384|452090978|FG001|Overall Study|Lack of Efficacy|40|||
125673383|NCT00306384|452090979|FG002|Overall Study|Lack of Efficacy|38|||
125673384|NCT00306384|452090977|FG000|Overall Study|Investigator discretion|28|||
125673385|NCT00306384|452090978|FG001|Overall Study|Investigator discretion|31|||
125673386|NCT00306384|452090979|FG002|Overall Study|Investigator discretion|21|||
125673387|NCT00306384|452090977|FG000|Overall Study|Other|80|||
125673388|NCT00306384|452090978|FG001|Overall Study|Other|70|||
125673389|NCT00306384|452090979|FG002|Overall Study|Other|32|||
125673390|NCT00306384|452090977|FG000|Overall Study|Site closure|2|||
125673391|NCT00306384|452090978|FG001|Overall Study|Site closure|0|||
125673392|NCT00306384|452090979|FG002|Overall Study|Site closure|0|||
125673393|NCT00745251|452090980|FG000|Overall Study|Adverse Event|1|||
125673394|NCT00745251|452090981|FG001|Overall Study|Adverse Event|2|||
125673395|NCT00745251|452090980|FG000|Overall Study|Withdrawal by Subject|1|||
125673396|NCT00745251|452090981|FG001|Overall Study|Withdrawal by Subject|1|||
125673397|NCT02154529|452090982|FG000|Overall Study|Death|1|||
125673398|NCT02154529|452090983|FG001|Overall Study|Death|1|||
125673399|NCT02154529|452090984|FG002|Overall Study|Death|5|||
125673400|NCT02154529|452090985|FG003|Overall Study|Death|1|||
125673401|NCT02154529|452090982|FG000|Overall Study|Termination of study by sponsor|2|||
125673402|NCT02154529|452090983|FG001|Overall Study|Termination of study by sponsor|2|||
125339024|NCT03899805|450876120|FG001|Overall Study|Death|0|||
125339025|NCT03899805|450876121|FG002|Overall Study|Death|0|||
125339026|NCT03899805|450876119|FG000|Overall Study|Came off for surgery|0|||
125339027|NCT03899805|450876120|FG001|Overall Study|Came off for surgery|0|||
125673403|NCT02154529|452090984|FG002|Overall Study|Termination of study by sponsor|3|||
125673404|NCT02154529|452090985|FG003|Overall Study|Termination of study by sponsor|1|||
125673405|NCT02154529|452090982|FG000|Overall Study|Lost to Follow-up|1|||
125673406|NCT02154529|452090983|FG001|Overall Study|Lost to Follow-up|0|||
125673407|NCT02154529|452090984|FG002|Overall Study|Lost to Follow-up|0|||
125673408|NCT02154529|452090985|FG003|Overall Study|Lost to Follow-up|0|||
125673409|NCT01628120|452092913|FG000|Overall Study|Withdrawal by Subject|7|||
125673410|NCT01628120|452092913|FG000|Overall Study|Adverse Event|12|||
125673411|NCT01628120|452092913|FG000|Overall Study|Lost to Follow-up|1|||
125673412|NCT01628120|452092913|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
125673413|NCT01628120|452092913|FG000|Overall Study|Non-compliant with Study Procedures|1|||
125673414|NCT01628120|452092913|FG000|Overall Study|Not Treated|3|||
125339028|NCT03899805|450876121|FG002|Overall Study|Came off for surgery|1|||
125673415|NCT01628120|452092913|FG000|Overall Study|Sponsor Decision|5|||
125339029|NCT03317405|450876122|FG000|Overall Study|Withdrawal by Subject|1|||
125339030|NCT03317405|450876123|FG001|Overall Study|Withdrawal by Subject|0|||
125339031|NCT03317405|450876124|FG002|Overall Study|Withdrawal by Subject|0|||
125339032|NCT03317405|450876122|FG000|Overall Study|Physician Decision|0|||
125339033|NCT03317405|450876123|FG001|Overall Study|Physician Decision|0|||
125339034|NCT03317405|450876124|FG002|Overall Study|Physician Decision|1|||
125339035|NCT03317405|450876122|FG000|Overall Study|Surgery Rescheduled|0|||
125339036|NCT03317405|450876123|FG001|Overall Study|Surgery Rescheduled|1|||
125339037|NCT03317405|450876124|FG002|Overall Study|Surgery Rescheduled|0|||
125339038|NCT01018810|450876127|FG000|Overall Study|Withdrawal by Subject|0|||
125339039|NCT01018810|450876128|FG001|Overall Study|Withdrawal by Subject|1|||
125339040|NCT01018810|450876129|FG002|Overall Study|Withdrawal by Subject|0|||
125339041|NCT01018810|450876130|FG003|Overall Study|Withdrawal by Subject|0|||
125339042|NCT01018810|450876131|FG004|Overall Study|Withdrawal by Subject|0|||
125339043|NCT01018810|450876127|FG000|Overall Study|Sponsor Decision|2|||
125339044|NCT01018810|450876128|FG001|Overall Study|Sponsor Decision|0|||
125339045|NCT01018810|450876129|FG002|Overall Study|Sponsor Decision|1|||
125339046|NCT01018810|450876130|FG003|Overall Study|Sponsor Decision|1|||
125339047|NCT01018810|450876131|FG004|Overall Study|Sponsor Decision|1|||
125339048|NCT01640314|450876132|FG000|Overall Study|Protocol Violation|0|||
125339049|NCT01640314|450876133|FG001|Overall Study|Protocol Violation|1|||
125339050|NCT04450381|450876134|FG000|Overall Study|Protocol Violation|4|||
125339051|NCT04450381|450876134|FG000|Overall Study|Wrong device setting|2|||
125339052|NCT01989208|450876135|FG000|200 mg (7 Days)|Protocol Violation|0|||
125339053|NCT01989208|450876136|FG001|200 mg (7 Days)|Protocol Violation|1|||
125339054|NCT04973436|450876137|FG000|Overall Study|Lost to Follow-up|3|||
125339055|NCT04973436|450876137|FG000|Overall Study|Withdrawal by Subject|1|||
125339056|NCT04973436|450876137|FG000|Overall Study|Death|2|||
125339057|NCT00566696|450876138|FG000|Overall Study|Met Exclusion Criteria|2|||
125339058|NCT00566696|450876138|FG000|Overall Study|Muromonab not available|1|||
125339059|NCT00566696|450876138|FG000|Overall Study|Health Status Change|1|||
125339060|NCT00566696|450876138|FG000|Overall Study|Physician Decision|1|||
125339061|NCT00566696|450876138|FG000|Overall Study|Non-Patient Donors|37|||
125339062|NCT06338462|450876139|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
125339063|NCT01276054|450876142|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
125339064|NCT01276054|450876143|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
125339065|NCT00452361|450876144|FG000|Overall Study|Adverse Event|8|||
125339066|NCT00452361|450876145|FG001|Overall Study|Adverse Event|0|||
125339067|NCT00452361|450876144|FG000|Overall Study|Withdrawal by Subject|0|||
125339068|NCT00452361|450876145|FG001|Overall Study|Withdrawal by Subject|1|||
125339069|NCT00452361|450876144|FG000|Overall Study|Premature termination|13|||
125339070|NCT00452361|450876145|FG001|Overall Study|Premature termination|9|||
125339071|NCT00776919|450876146|FG000|Overall Study|Withdrawal by Subject|16|||
125339072|NCT00776919|450876147|FG001|Overall Study|Withdrawal by Subject|14|||
125339073|NCT00776919|450876148|FG002|Overall Study|Withdrawal by Subject|15|||
125339074|NCT00776919|450876149|FG003|Overall Study|Withdrawal by Subject|26|||
125339075|NCT00776919|450876146|FG000|Overall Study|Lost to Follow-up|8|||
125339076|NCT00776919|450876147|FG001|Overall Study|Lost to Follow-up|12|||
125339077|NCT00776919|450876148|FG002|Overall Study|Lost to Follow-up|11|||
125339078|NCT00776919|450876149|FG003|Overall Study|Lost to Follow-up|8|||
125339079|NCT00776919|450876146|FG000|Overall Study|Adverse Event|1|||
125339080|NCT00776919|450876147|FG001|Overall Study|Adverse Event|0|||
125339081|NCT00776919|450876148|FG002|Overall Study|Adverse Event|2|||
125339082|NCT00776919|450876149|FG003|Overall Study|Adverse Event|2|||
125339083|NCT00776919|450876146|FG000|Overall Study|Protocol Violation|1|||
125339084|NCT00776919|450876147|FG001|Overall Study|Protocol Violation|2|||
125339085|NCT00776919|450876148|FG002|Overall Study|Protocol Violation|0|||
125673416|NCT01628120|452092913|FG000|Overall Study|Switched Dialysis Method|2|||
125673417|NCT01628120|452092913|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
125673418|NCT01628120|452092913|FG000|Overall Study|Moved or Relocated|5|||
125673419|NCT01628120|452092913|FG000|Overall Study|Kidney Transplant|2|||
125673420|NCT01628120|452092913|FG000|Overall Study|Use of Standard of Care|1|||
125673421|NCT02232074|452092914|FG000|Overall Study|Withdrawal by Subject|5|||
125673422|NCT02232074|452092915|FG001|Overall Study|Withdrawal by Subject|3|||
125339086|NCT00776919|450876149|FG003|Overall Study|Protocol Violation|1|||
125339087|NCT00776919|450876146|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
125339088|NCT00776919|450876147|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
125339089|NCT00776919|450876148|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
125339090|NCT00776919|450876149|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
125339091|NCT00635999|450876152|FG000|Overall Study|Withdrawal by Subject|4|||
125339092|NCT00635999|450876153|FG001|Overall Study|Withdrawal by Subject|2|||
125339093|NCT00635999|450876154|FG002|Overall Study|Withdrawal by Subject|1|||
125339094|NCT00228553|450876155|FG000|Overall Study|Adverse Event|112|||
125339095|NCT00228553|450876155|FG000|Overall Study|Lack of Efficacy|34|||
125339096|NCT00228553|450876155|FG000|Overall Study|Lost to Follow-up|67|||
125339097|NCT00228553|450876155|FG000|Overall Study|Physician Decision|48|||
125339098|NCT00228553|450876155|FG000|Overall Study|Protocol Violation|6|||
125339099|NCT00228553|450876155|FG000|Overall Study|Withdrawal by Subject|115|||
125339100|NCT00228553|450876155|FG000|Overall Study|Pregnancy|2|||
125339101|NCT00228553|450876155|FG000|Overall Study|Miscellaneous|46|||
125339102|NCT02878798|450876156|FG000|Overall Study|Withdrawal by Subject|5|||
125339103|NCT02878798|450876157|FG001|Overall Study|Withdrawal by Subject|4|||
125339104|NCT02878798|450876156|FG000|Overall Study|Lost to Follow-up|2|||
125339105|NCT02878798|450876157|FG001|Overall Study|Lost to Follow-up|2|||
125339106|NCT02878798|450876156|FG000|Overall Study|Protocol Violation|0|||
125339107|NCT02878798|450876157|FG001|Overall Study|Protocol Violation|1|||
125339108|NCT01536392|450876158|FG000|Overall Study|Adverse Event|2|||
125339109|NCT01536392|450876159|FG001|Overall Study|Adverse Event|2|||
125339110|NCT01536392|450876158|FG000|Overall Study|Physician Decision|2|||
125339111|NCT01536392|450876159|FG001|Overall Study|Physician Decision|3|||
125339112|NCT01536392|450876158|FG000|Overall Study|Withdrawal by Subject|3|||
125339113|NCT01536392|450876159|FG001|Overall Study|Withdrawal by Subject|6|||
125339114|NCT01536392|450876158|FG000|Overall Study|Non Compliance|3|||
125339115|NCT01536392|450876159|FG001|Overall Study|Non Compliance|4|||
125339116|NCT01536392|450876158|FG000|Overall Study|Completed therapy early|3|||
125339117|NCT01536392|450876159|FG001|Overall Study|Completed therapy early|0|||
125339118|NCT02259088|450876161|FG000|Overall Study|Adverse Event|6|||
125339119|NCT02259088|450876162|FG001|Overall Study|Adverse Event|4|||
125339120|NCT02259088|450876161|FG000|Overall Study|Lost to Follow-up|2|||
125339121|NCT02259088|450876162|FG001|Overall Study|Lost to Follow-up|0|||
125339122|NCT02259088|450876161|FG000|Overall Study|Death|2|||
125339123|NCT02259088|450876162|FG001|Overall Study|Death|0|||
125339124|NCT02259088|450876161|FG000|Overall Study|Physician Decision|5|||
125339125|NCT02259088|450876162|FG001|Overall Study|Physician Decision|2|||
125339126|NCT02259088|450876161|FG000|Overall Study|Protocol deviation|5|||
125339127|NCT02259088|450876162|FG001|Overall Study|Protocol deviation|0|||
125339128|NCT02259088|450876161|FG000|Overall Study|Subject/guardian decision|8|||
125339129|NCT02259088|450876162|FG001|Overall Study|Subject/guardian decision|8|||
125339130|NCT01818752|450876164|FG000|Overall Study|Adverse Event|64|||
125673423|NCT02232074|452092914|FG000|Overall Study|No legal concerns at baseline|36|||
125673424|NCT02232074|452092915|FG001|Overall Study|No legal concerns at baseline|41|||
125673425|NCT02232074|452092914|FG000|Overall Study|deemed ineligible|0|||
125673426|NCT02232074|452092915|FG001|Overall Study|deemed ineligible|1|||
125673427|NCT01296932|452092918|FG000|Overall Study|Dose limiting toxicity|0|||
125673428|NCT01296932|452092919|FG001|Overall Study|Dose limiting toxicity|0|||
125673429|NCT01296932|452092920|FG002|Overall Study|Dose limiting toxicity|0|||
125673430|NCT01296932|452092921|FG003|Overall Study|Dose limiting toxicity|0|||
125673431|NCT01296932|452092922|FG004|Overall Study|Dose limiting toxicity|0|||
125673432|NCT01296932|452092923|FG005|Overall Study|Dose limiting toxicity|0|||
125673433|NCT01296932|452092924|FG006|Overall Study|Dose limiting toxicity|1|||
125673434|NCT01296932|452092925|FG007|Overall Study|Dose limiting toxicity|0|||
125673435|NCT01296932|452092926|FG008|Overall Study|Dose limiting toxicity|1|||
125673436|NCT01296932|452092918|FG000|Overall Study|Progressive disease|2|||
125673437|NCT01296932|452092919|FG001|Overall Study|Progressive disease|0|||
125673438|NCT01296932|452092920|FG002|Overall Study|Progressive disease|1|||
125673439|NCT01296932|452092921|FG003|Overall Study|Progressive disease|1|||
125673440|NCT01296932|452092922|FG004|Overall Study|Progressive disease|2|||
125673441|NCT01296932|452092923|FG005|Overall Study|Progressive disease|3|||
125673442|NCT01296932|452092924|FG006|Overall Study|Progressive disease|1|||
125673443|NCT01296932|452092925|FG007|Overall Study|Progressive disease|0|||
125673444|NCT01296932|452092926|FG008|Overall Study|Progressive disease|0|||
125673445|NCT01296932|452092918|FG000|Overall Study|Withdrawal by Subject|0|||
125673446|NCT01296932|452092919|FG001|Overall Study|Withdrawal by Subject|0|||
125673447|NCT01296932|452092920|FG002|Overall Study|Withdrawal by Subject|1|||
125339131|NCT01818752|450876165|FG001|Overall Study|Adverse Event|74|||
125339132|NCT01818752|450876164|FG000|Overall Study|Death|14|||
125673448|NCT01296932|452092921|FG003|Overall Study|Withdrawal by Subject|1|||
125673449|NCT01296932|452092922|FG004|Overall Study|Withdrawal by Subject|0|||
125339133|NCT01818752|450876165|FG001|Overall Study|Death|18|||
125339134|NCT01818752|450876164|FG000|Overall Study|Non-compliance|16|||
125339135|NCT01818752|450876165|FG001|Overall Study|Non-compliance|20|||
125339136|NCT01818752|450876164|FG000|Overall Study|Withdrawal by Subject|15|||
125673450|NCT01296932|452092923|FG005|Overall Study|Withdrawal by Subject|0|||
125673451|NCT01296932|452092924|FG006|Overall Study|Withdrawal by Subject|3|||
125673452|NCT01296932|452092925|FG007|Overall Study|Withdrawal by Subject|0|||
125673453|NCT01296932|452092926|FG008|Overall Study|Withdrawal by Subject|0|||
125339137|NCT01818752|450876165|FG001|Overall Study|Withdrawal by Subject|14|||
125339138|NCT01818752|450876164|FG000|Overall Study|Physician Decision|9|||
125339139|NCT01818752|450876165|FG001|Overall Study|Physician Decision|8|||
125339140|NCT01818752|450876164|FG000|Overall Study|Disease Progression|54|||
125339141|NCT01818752|450876165|FG001|Overall Study|Disease Progression|48|||
125339142|NCT01818752|450876164|FG000|Overall Study|Other|7|||
125339143|NCT01818752|450876165|FG001|Overall Study|Other|8|||
125339144|NCT01818752|450876164|FG000|Overall Study|Continuing Treatment|1|||
125339145|NCT01818752|450876165|FG001|Overall Study|Continuing Treatment|4|||
125339146|NCT01818752|450876164|FG000|Overall Study|Randomized but not Dosed|7|||
125339147|NCT01818752|450876165|FG001|Overall Study|Randomized but not Dosed|4|||
125339148|NCT01033448|450876166|FG000|Overall Study|Withdrawal by Subject|4|||
125339149|NCT01033448|450876166|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
125339150|NCT01033448|450876166|FG000|Overall Study|Lost to Follow-up|3|||
125339151|NCT01033448|450876166|FG000|Overall Study|Withdrew due to other reasons|3|||
125339152|NCT01033448|450876166|FG000|Overall Study|Unknown disposition|1|||
125339153|NCT01324141|450876167|FG000|Overall Study|Declined to participate before treatment started|1|||
125339154|NCT01324141|450876167|FG000|Overall Study|Disease progression on study|1|||
125339155|NCT04629066|450876168|FG000|Overall Study|Lost to Follow-up|3|||
125339156|NCT04629066|450876169|FG001|Overall Study|Lost to Follow-up|2|||
125339157|NCT01165216|450876175|FG000|Overall Study|Adverse Event|6|||
125339158|NCT01165216|450876176|FG001|Overall Study|Adverse Event|3|||
125339159|NCT01165216|450876175|FG000|Overall Study|Withdrawal by Subject|1|||
125339160|NCT01165216|450876176|FG001|Overall Study|Withdrawal by Subject|1|||
125339161|NCT01165216|450876175|FG000|Overall Study|Disease progression|1|||
125339162|NCT01165216|450876176|FG001|Overall Study|Disease progression|3|||
125339163|NCT06457204|450876178|FG000|Washout|Adverse Event|0|||
125339164|NCT06457204|450876179|FG001|Washout|Adverse Event|2|||
125339165|NCT01808092|450876180|FG000|Overall Study|Death|39|||
125339166|NCT01808092|450876181|FG001|Overall Study|Death|29|||
125339167|NCT01808092|450876180|FG000|Overall Study|Lost to Follow-up|3|||
125339168|NCT01808092|450876181|FG001|Overall Study|Lost to Follow-up|7|||
125339169|NCT01808092|450876180|FG000|Overall Study|Withdrawal by Subject|9|||
125339170|NCT01808092|450876181|FG001|Overall Study|Withdrawal by Subject|4|||
125339171|NCT01808092|450876180|FG000|Overall Study|Other Eligibility criteria|3|||
125339172|NCT01808092|450876181|FG001|Overall Study|Other Eligibility criteria|5|||
125339173|NCT05289037|450876186|FG000|Overall Study|Withdrawal by Subject|7|||
125339174|NCT05289037|450876187|FG001|Overall Study|Withdrawal by Subject|0|||
125339175|NCT05289037|450876188|FG002|Overall Study|Withdrawal by Subject|3|||
125339176|NCT05289037|450876189|FG003|Overall Study|Withdrawal by Subject|3|||
125339177|NCT05289037|450876190|FG004|Overall Study|Withdrawal by Subject|1|||
125339178|NCT05289037|450876191|FG005|Overall Study|Withdrawal by Subject|5|||
125339179|NCT05289037|450876192|FG006|Overall Study|Withdrawal by Subject|2|||
125339180|NCT05289037|450876193|FG007|Overall Study|Withdrawal by Subject|1|||
125339181|NCT05289037|450876194|FG008|Overall Study|Withdrawal by Subject|2|||
125339182|NCT05289037|450876195|FG009|Overall Study|Withdrawal by Subject|2|||
125339183|NCT05289037|450876196|FG010|Overall Study|Withdrawal by Subject|1|||
125673454|NCT01296932|452092918|FG000|Overall Study|Adverse Event|1|||
125673455|NCT01296932|452092919|FG001|Overall Study|Adverse Event|1|||
125673456|NCT01296932|452092920|FG002|Overall Study|Adverse Event|1|||
125673457|NCT01296932|452092921|FG003|Overall Study|Adverse Event|2|||
125673458|NCT01296932|452092922|FG004|Overall Study|Adverse Event|1|||
125673459|NCT01296932|452092923|FG005|Overall Study|Adverse Event|0|||
125673460|NCT01296932|452092924|FG006|Overall Study|Adverse Event|0|||
125673461|NCT01296932|452092925|FG007|Overall Study|Adverse Event|0|||
125673462|NCT01296932|452092926|FG008|Overall Study|Adverse Event|1|||
125673463|NCT01296932|452092918|FG000|Overall Study|Investigator decision|0|||
125673464|NCT01296932|452092919|FG001|Overall Study|Investigator decision|1|||
125673465|NCT01296932|452092920|FG002|Overall Study|Investigator decision|0|||
125673466|NCT01296932|452092921|FG003|Overall Study|Investigator decision|1|||
125673467|NCT01296932|452092922|FG004|Overall Study|Investigator decision|0|||
125673468|NCT01296932|452092923|FG005|Overall Study|Investigator decision|0|||
125673469|NCT01296932|452092924|FG006|Overall Study|Investigator decision|1|||
125673470|NCT01296932|452092925|FG007|Overall Study|Investigator decision|0|||
125673471|NCT01296932|452092926|FG008|Overall Study|Investigator decision|1|||
125673472|NCT01296932|452092918|FG000|Overall Study|No clinical benefit anymore|0|||
125673473|NCT01296932|452092919|FG001|Overall Study|No clinical benefit anymore|1|||
125673474|NCT01296932|452092920|FG002|Overall Study|No clinical benefit anymore|0|||
125673475|NCT01296932|452092921|FG003|Overall Study|No clinical benefit anymore|0|||
125673476|NCT01296932|452092922|FG004|Overall Study|No clinical benefit anymore|0|||
125673477|NCT01296932|452092923|FG005|Overall Study|No clinical benefit anymore|0|||
125673478|NCT01296932|452092924|FG006|Overall Study|No clinical benefit anymore|0|||
125673479|NCT01296932|452092925|FG007|Overall Study|No clinical benefit anymore|0|||
125673480|NCT01296932|452092926|FG008|Overall Study|No clinical benefit anymore|0|||
125673481|NCT01296932|452092918|FG000|Overall Study|Physician Decision|0|||
125673482|NCT01296932|452092919|FG001|Overall Study|Physician Decision|0|||
125673483|NCT01296932|452092920|FG002|Overall Study|Physician Decision|1|||
125673484|NCT01296932|452092921|FG003|Overall Study|Physician Decision|0|||
125673485|NCT01296932|452092922|FG004|Overall Study|Physician Decision|0|||
125673486|NCT01296932|452092923|FG005|Overall Study|Physician Decision|0|||
125673487|NCT01296932|452092924|FG006|Overall Study|Physician Decision|0|||
125673488|NCT01296932|452092925|FG007|Overall Study|Physician Decision|0|||
125673489|NCT01296932|452092926|FG008|Overall Study|Physician Decision|0|||
125673490|NCT01296932|452092918|FG000|Overall Study|IV problems, administration not possible|0|||
125673491|NCT01296932|452092919|FG001|Overall Study|IV problems, administration not possible|0|||
125673492|NCT01296932|452092920|FG002|Overall Study|IV problems, administration not possible|1|||
125673493|NCT01296932|452092921|FG003|Overall Study|IV problems, administration not possible|0|||
125673494|NCT01296932|452092922|FG004|Overall Study|IV problems, administration not possible|0|||
125673495|NCT01296932|452092923|FG005|Overall Study|IV problems, administration not possible|0|||
125673496|NCT01296932|452092924|FG006|Overall Study|IV problems, administration not possible|0|||
125673497|NCT01296932|452092925|FG007|Overall Study|IV problems, administration not possible|0|||
125673498|NCT01296932|452092926|FG008|Overall Study|IV problems, administration not possible|0|||
125339184|NCT05289037|450876197|FG011|Overall Study|Withdrawal by Subject|0|||
125673499|NCT01296932|452092918|FG000|Overall Study|per protocol|0|||
125673500|NCT01296932|452092919|FG001|Overall Study|per protocol|0|||
125673501|NCT01296932|452092920|FG002|Overall Study|per protocol|1|||
125339185|NCT05289037|450876198|FG012|Overall Study|Withdrawal by Subject|1|||
125339186|NCT05289037|450876199|FG013|Overall Study|Withdrawal by Subject|2|||
125673502|NCT01296932|452092921|FG003|Overall Study|per protocol|1|||
125673503|NCT01296932|452092922|FG004|Overall Study|per protocol|0|||
125339187|NCT05289037|450876200|FG014|Overall Study|Withdrawal by Subject|0|||
125339188|NCT05289037|450876201|FG015|Overall Study|Withdrawal by Subject|3|||
125339189|NCT05289037|450876202|FG016|Overall Study|Withdrawal by Subject|3|||
125339190|NCT05289037|450876186|FG000|Overall Study|Lost to Follow-up|1|||
125339191|NCT05289037|450876187|FG001|Overall Study|Lost to Follow-up|4|||
125339192|NCT05289037|450876188|FG002|Overall Study|Lost to Follow-up|3|||
125339193|NCT05289037|450876189|FG003|Overall Study|Lost to Follow-up|3|||
125339194|NCT05289037|450876190|FG004|Overall Study|Lost to Follow-up|3|||
125339195|NCT05289037|450876191|FG005|Overall Study|Lost to Follow-up|2|||
125339196|NCT05289037|450876192|FG006|Overall Study|Lost to Follow-up|3|||
125339197|NCT05289037|450876193|FG007|Overall Study|Lost to Follow-up|2|||
125339198|NCT05289037|450876194|FG008|Overall Study|Lost to Follow-up|2|||
125339199|NCT05289037|450876195|FG009|Overall Study|Lost to Follow-up|1|||
125339200|NCT05289037|450876196|FG010|Overall Study|Lost to Follow-up|3|||
125339201|NCT05289037|450876197|FG011|Overall Study|Lost to Follow-up|4|||
125339202|NCT05289037|450876198|FG012|Overall Study|Lost to Follow-up|2|||
125339203|NCT05289037|450876199|FG013|Overall Study|Lost to Follow-up|7|||
125339204|NCT05289037|450876200|FG014|Overall Study|Lost to Follow-up|4|||
125339205|NCT05289037|450876201|FG015|Overall Study|Lost to Follow-up|6|||
125339206|NCT05289037|450876202|FG016|Overall Study|Lost to Follow-up|4|||
125339207|NCT05289037|450876186|FG000|Overall Study|Death|0|||
125339208|NCT05289037|450876187|FG001|Overall Study|Death|0|||
125339209|NCT05289037|450876188|FG002|Overall Study|Death|0|||
125339210|NCT05289037|450876189|FG003|Overall Study|Death|0|||
125339211|NCT05289037|450876190|FG004|Overall Study|Death|0|||
125339212|NCT05289037|450876191|FG005|Overall Study|Death|1|||
125339213|NCT05289037|450876192|FG006|Overall Study|Death|0|||
125339214|NCT05289037|450876193|FG007|Overall Study|Death|0|||
125339215|NCT05289037|450876194|FG008|Overall Study|Death|0|||
125339216|NCT05289037|450876195|FG009|Overall Study|Death|0|||
125339217|NCT05289037|450876196|FG010|Overall Study|Death|0|||
125339218|NCT05289037|450876197|FG011|Overall Study|Death|0|||
125339219|NCT05289037|450876198|FG012|Overall Study|Death|0|||
125339220|NCT05289037|450876199|FG013|Overall Study|Death|0|||
125339221|NCT05289037|450876200|FG014|Overall Study|Death|1|||
125339222|NCT05289037|450876201|FG015|Overall Study|Death|0|||
125339223|NCT05289037|450876202|FG016|Overall Study|Death|0|||
125339224|NCT05289037|450876186|FG000|Overall Study|Did not receive vaccine|0|||
125339225|NCT05289037|450876187|FG001|Overall Study|Did not receive vaccine|3|||
125339226|NCT05289037|450876188|FG002|Overall Study|Did not receive vaccine|0|||
125339227|NCT05289037|450876189|FG003|Overall Study|Did not receive vaccine|0|||
125339228|NCT05289037|450876190|FG004|Overall Study|Did not receive vaccine|1|||
125339229|NCT05289037|450876191|FG005|Overall Study|Did not receive vaccine|1|||
125339230|NCT05289037|450876192|FG006|Overall Study|Did not receive vaccine|1|||
125339231|NCT05289037|450876193|FG007|Overall Study|Did not receive vaccine|0|||
125339232|NCT05289037|450876194|FG008|Overall Study|Did not receive vaccine|0|||
125339233|NCT05289037|450876195|FG009|Overall Study|Did not receive vaccine|0|||
125339234|NCT05289037|450876196|FG010|Overall Study|Did not receive vaccine|0|||
125339235|NCT05289037|450876197|FG011|Overall Study|Did not receive vaccine|0|||
125339236|NCT05289037|450876198|FG012|Overall Study|Did not receive vaccine|0|||
125339237|NCT05289037|450876199|FG013|Overall Study|Did not receive vaccine|0|||
125339238|NCT05289037|450876200|FG014|Overall Study|Did not receive vaccine|1|||
125339239|NCT05289037|450876201|FG015|Overall Study|Did not receive vaccine|0|||
125339240|NCT05289037|450876202|FG016|Overall Study|Did not receive vaccine|0|||
125339241|NCT05289037|450876186|FG000|Overall Study|Unable to make last visit|0|||
125339242|NCT05289037|450876187|FG001|Overall Study|Unable to make last visit|0|||
125339243|NCT05289037|450876188|FG002|Overall Study|Unable to make last visit|1|||
125339244|NCT05289037|450876189|FG003|Overall Study|Unable to make last visit|0|||
125339245|NCT05289037|450876190|FG004|Overall Study|Unable to make last visit|0|||
125339246|NCT05289037|450876191|FG005|Overall Study|Unable to make last visit|0|||
125339247|NCT05289037|450876192|FG006|Overall Study|Unable to make last visit|0|||
125339248|NCT05289037|450876193|FG007|Overall Study|Unable to make last visit|0|||
125339249|NCT05289037|450876194|FG008|Overall Study|Unable to make last visit|0|||
125339250|NCT05289037|450876195|FG009|Overall Study|Unable to make last visit|0|||
125339251|NCT05289037|450876196|FG010|Overall Study|Unable to make last visit|0|||
125339252|NCT05289037|450876197|FG011|Overall Study|Unable to make last visit|0|||
125339253|NCT05289037|450876198|FG012|Overall Study|Unable to make last visit|0|||
125339254|NCT05289037|450876199|FG013|Overall Study|Unable to make last visit|0|||
125339255|NCT05289037|450876200|FG014|Overall Study|Unable to make last visit|0|||
125339256|NCT05289037|450876201|FG015|Overall Study|Unable to make last visit|0|||
125339257|NCT05289037|450876202|FG016|Overall Study|Unable to make last visit|0|||
125339258|NCT05289037|450876186|FG000|Overall Study|Protocol deviation|0|||
125339259|NCT05289037|450876187|FG001|Overall Study|Protocol deviation|0|||
125339260|NCT05289037|450876188|FG002|Overall Study|Protocol deviation|0|||
125339261|NCT05289037|450876189|FG003|Overall Study|Protocol deviation|0|||
125339262|NCT05289037|450876190|FG004|Overall Study|Protocol deviation|0|||
125339263|NCT05289037|450876191|FG005|Overall Study|Protocol deviation|0|||
125339264|NCT05289037|450876192|FG006|Overall Study|Protocol deviation|0|||
125339265|NCT05289037|450876193|FG007|Overall Study|Protocol deviation|0|||
125339266|NCT05289037|450876194|FG008|Overall Study|Protocol deviation|0|||
125339267|NCT05289037|450876195|FG009|Overall Study|Protocol deviation|0|||
125339268|NCT05289037|450876196|FG010|Overall Study|Protocol deviation|0|||
125339269|NCT05289037|450876197|FG011|Overall Study|Protocol deviation|0|||
125673504|NCT01296932|452092923|FG005|Overall Study|per protocol|0|||
125673505|NCT01296932|452092924|FG006|Overall Study|per protocol|0|||
125673506|NCT01296932|452092925|FG007|Overall Study|per protocol|0|||
125673507|NCT01296932|452092926|FG008|Overall Study|per protocol|0|||
125673508|NCT01296932|452092918|FG000|Overall Study|Low benefit and too many side effects|0|||
125673509|NCT01296932|452092919|FG001|Overall Study|Low benefit and too many side effects|0|||
125673510|NCT01296932|452092920|FG002|Overall Study|Low benefit and too many side effects|0|||
125673511|NCT01296932|452092921|FG003|Overall Study|Low benefit and too many side effects|0|||
125673512|NCT01296932|452092922|FG004|Overall Study|Low benefit and too many side effects|0|||
125673513|NCT01296932|452092923|FG005|Overall Study|Low benefit and too many side effects|0|||
125673514|NCT01296932|452092924|FG006|Overall Study|Low benefit and too many side effects|0|||
125673515|NCT01296932|452092925|FG007|Overall Study|Low benefit and too many side effects|1|||
125673516|NCT01296932|452092926|FG008|Overall Study|Low benefit and too many side effects|0|||
125673517|NCT01296932|452092918|FG000|Overall Study|No adequate treatment response|0|||
125673518|NCT01296932|452092919|FG001|Overall Study|No adequate treatment response|0|||
125673519|NCT01296932|452092920|FG002|Overall Study|No adequate treatment response|0|||
125673520|NCT01296932|452092921|FG003|Overall Study|No adequate treatment response|0|||
125673521|NCT01296932|452092922|FG004|Overall Study|No adequate treatment response|0|||
125673522|NCT01296932|452092923|FG005|Overall Study|No adequate treatment response|0|||
125673523|NCT01296932|452092924|FG006|Overall Study|No adequate treatment response|0|||
125673524|NCT01296932|452092925|FG007|Overall Study|No adequate treatment response|1|||
125673525|NCT01296932|452092926|FG008|Overall Study|No adequate treatment response|0|||
125673526|NCT01296932|452092918|FG000|Overall Study|Dosage already reduced, AE still present|0|||
125673527|NCT01296932|452092919|FG001|Overall Study|Dosage already reduced, AE still present|0|||
125673528|NCT01296932|452092920|FG002|Overall Study|Dosage already reduced, AE still present|0|||
125673529|NCT01296932|452092921|FG003|Overall Study|Dosage already reduced, AE still present|0|||
125673530|NCT01296932|452092922|FG004|Overall Study|Dosage already reduced, AE still present|0|||
125673531|NCT01296932|452092923|FG005|Overall Study|Dosage already reduced, AE still present|0|||
125673532|NCT01296932|452092924|FG006|Overall Study|Dosage already reduced, AE still present|0|||
125673533|NCT01296932|452092925|FG007|Overall Study|Dosage already reduced, AE still present|0|||
125673534|NCT01296932|452092926|FG008|Overall Study|Dosage already reduced, AE still present|1|||
125673535|NCT01579474|452092929|FG000|Overall Study|Adverse Event|1|||
125673536|NCT01579474|452092930|FG001|Overall Study|Adverse Event|13|||
125673537|NCT01579474|452092931|FG002|Overall Study|Adverse Event|2|||
125673538|NCT01579474|452092932|FG003|Overall Study|Adverse Event|0|||
125673539|NCT01579474|452092933|FG004|Overall Study|Adverse Event|0|||
125673540|NCT01579474|452092934|FG005|Overall Study|Adverse Event|1|||
125673541|NCT01579474|452092929|FG000|Overall Study|Lack of Efficacy|1|||
125673542|NCT01579474|452092930|FG001|Overall Study|Lack of Efficacy|0|||
125673543|NCT01579474|452092931|FG002|Overall Study|Lack of Efficacy|0|||
125673544|NCT01579474|452092932|FG003|Overall Study|Lack of Efficacy|0|||
125673545|NCT01579474|452092933|FG004|Overall Study|Lack of Efficacy|1|||
125673546|NCT01579474|452092934|FG005|Overall Study|Lack of Efficacy|0|||
125673547|NCT01579474|452092929|FG000|Overall Study|Withdrawal by Subject|1|||
125673548|NCT01579474|452092930|FG001|Overall Study|Withdrawal by Subject|0|||
125673549|NCT01579474|452092931|FG002|Overall Study|Withdrawal by Subject|0|||
125673550|NCT01579474|452092932|FG003|Overall Study|Withdrawal by Subject|0|||
125673551|NCT01579474|452092933|FG004|Overall Study|Withdrawal by Subject|0|||
125339270|NCT05289037|450876198|FG012|Overall Study|Protocol deviation|0|||
125339271|NCT05289037|450876199|FG013|Overall Study|Protocol deviation|0|||
125339272|NCT05289037|450876200|FG014|Overall Study|Protocol deviation|0|||
125339273|NCT05289037|450876201|FG015|Overall Study|Protocol deviation|1|||
125339274|NCT05289037|450876202|FG016|Overall Study|Protocol deviation|0|||
125339275|NCT05141448|450876203|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
125339276|NCT05141448|450876204|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
125339277|NCT05141448|450876205|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
125339278|NCT05141448|450876206|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
125339279|NCT05141448|450876207|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
125339280|NCT05141448|450876208|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
125339281|NCT05141448|450876203|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125339282|NCT05141448|450876204|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125339283|NCT05141448|450876205|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125339284|NCT05141448|450876206|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125339285|NCT05141448|450876207|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
125339286|NCT05141448|450876208|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125339287|NCT05141448|450876203|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125339288|NCT05141448|450876204|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
125339289|NCT05141448|450876205|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125339290|NCT05141448|450876206|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125339291|NCT05141448|450876207|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125339292|NCT05141448|450876208|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125339293|NCT05141448|450876203|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125339294|NCT05141448|450876204|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125339295|NCT05141448|450876205|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125339296|NCT05141448|450876206|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125339297|NCT05141448|450876207|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125339298|NCT05141448|450876208|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
125339299|NCT05141448|450876203|FG000|Period 2|COVID-19 Related|0|||
125339300|NCT05141448|450876204|FG001|Period 2|COVID-19 Related|0|||
125339301|NCT05141448|450876205|FG002|Period 2|COVID-19 Related|0|||
125339302|NCT05141448|450876206|FG003|Period 2|COVID-19 Related|1|||
125339303|NCT05141448|450876207|FG004|Period 2|COVID-19 Related|0|||
125339304|NCT05141448|450876208|FG005|Period 2|COVID-19 Related|1|||
125339305|NCT05141448|450876203|FG000|3|Covid-19 related|2|||
125339306|NCT05141448|450876204|FG001|3|Covid-19 related|0|||
125339307|NCT05141448|450876205|FG002|3|Covid-19 related|0|||
125339308|NCT05141448|450876206|FG003|3|Covid-19 related|0|||
125339309|NCT05141448|450876207|FG004|3|Covid-19 related|0|||
125339310|NCT05141448|450876208|FG005|3|Covid-19 related|1|||
125339311|NCT05141448|450876203|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
125339312|NCT05141448|450876204|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
125339313|NCT05141448|450876205|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
125339314|NCT05141448|450876206|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
125339315|NCT05141448|450876207|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
125339316|NCT05141448|450876208|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
125339317|NCT01217307|450877505|FG000|Overall Study|Withdrawal by Subject|0|||
125339318|NCT01217307|450877506|FG001|Overall Study|Withdrawal by Subject|1|||
125339319|NCT01868542|450877507|FG000|Overall Study|Protocol Violation|0|||
125339320|NCT01868542|450877508|FG001|Overall Study|Protocol Violation|1|||
125339321|NCT01868542|450877507|FG000|Overall Study|Unclassified|0|||
125339322|NCT01868542|450877508|FG001|Overall Study|Unclassified|1|||
125339323|NCT02248675|450877509|FG000|Overall Study|Lost to Follow-up|3|||
125339324|NCT02248675|450877510|FG001|Overall Study|Lost to Follow-up|1|||
125339325|NCT00813943|450877518|FG000|Overall Study|Ongoing at cut-off date|5|||
125339326|NCT00813943|450877519|FG001|Overall Study|Ongoing at cut-off date|5|||
125339327|NCT00813943|450877520|FG002|Overall Study|Ongoing at cut-off date|3|||
125339328|NCT02551991|450877521|FG000|Overall Study|Death|5|||
125339329|NCT02551991|450877522|FG001|Overall Study|Death|7|||
125339330|NCT02551991|450877523|FG002|Overall Study|Death|8|||
125339331|NCT02551991|450877524|FG003|Overall Study|Death|7|||
125339332|NCT02551991|450877525|FG004|Overall Study|Death|17|||
125339333|NCT02551991|450877521|FG000|Overall Study|Withdrawal by Subject|1|||
125339334|NCT02551991|450877522|FG001|Overall Study|Withdrawal by Subject|0|||
125339335|NCT02551991|450877523|FG002|Overall Study|Withdrawal by Subject|0|||
125339336|NCT02551991|450877524|FG003|Overall Study|Withdrawal by Subject|0|||
125339337|NCT02551991|450877525|FG004|Overall Study|Withdrawal by Subject|2|||
125339338|NCT02551991|450877521|FG000|Overall Study|Lost to Follow-up|0|||
125339339|NCT02551991|450877522|FG001|Overall Study|Lost to Follow-up|0|||
125339340|NCT02551991|450877523|FG002|Overall Study|Lost to Follow-up|1|||
125339341|NCT02551991|450877524|FG003|Overall Study|Lost to Follow-up|0|||
125339342|NCT02551991|450877525|FG004|Overall Study|Lost to Follow-up|0|||
125339343|NCT02551991|450877521|FG000|Overall Study|Sponsor Decision|1|||
125339344|NCT02551991|450877522|FG001|Overall Study|Sponsor Decision|0|||
125339345|NCT02551991|450877523|FG002|Overall Study|Sponsor Decision|1|||
125339346|NCT02551991|450877524|FG003|Overall Study|Sponsor Decision|0|||
125339347|NCT02551991|450877525|FG004|Overall Study|Sponsor Decision|5|||
125339348|NCT02551991|450877521|FG000|Overall Study|Other|0|||
125339349|NCT02551991|450877522|FG001|Overall Study|Other|0|||
125339350|NCT02551991|450877523|FG002|Overall Study|Other|0|||
125339351|NCT02551991|450877524|FG003|Overall Study|Other|0|||
125339352|NCT02551991|450877525|FG004|Overall Study|Other|1|||
125339353|NCT00984620|450877526|FG000|Overall Study|Adverse Event|5|||
125339354|NCT00984620|450877527|FG001|Overall Study|Adverse Event|5|||
125339355|NCT00984620|450877526|FG000|Overall Study|Lost to Follow-up|1|||
125339356|NCT00984620|450877527|FG001|Overall Study|Lost to Follow-up|1|||
125339357|NCT00984620|450877526|FG000|Overall Study|Withdrawal by Subject|0|||
125339358|NCT00984620|450877527|FG001|Overall Study|Withdrawal by Subject|2|||
125339359|NCT00984620|450877526|FG000|Overall Study|reason other than listed above|0|||
125339360|NCT00984620|450877527|FG001|Overall Study|reason other than listed above|4|||
125339361|NCT02424578|450877529|FG000|Overall Study|Withdrawal by Subject|0|||
125339362|NCT02424578|450877530|FG001|Overall Study|Withdrawal by Subject|1|||
125339363|NCT00470834|450877533|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
125339364|NCT00470834|450877534|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
125339365|NCT00470834|450877533|FG000|Treatment Period (18 Months)|Adverse Event|7|||
125339366|NCT00470834|450877534|FG001|Treatment Period (18 Months)|Adverse Event|6|||
125339367|NCT00470834|450877533|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
125339368|NCT00470834|450877534|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
125339369|NCT00470834|450877533|FG000|Treatment Period (18 Months)|Physician Decision|4|||
125339370|NCT00470834|450877534|FG001|Treatment Period (18 Months)|Physician Decision|4|||
125339371|NCT00470834|450877533|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
125339372|NCT00470834|450877534|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
125339373|NCT00470834|450877533|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
125339374|NCT00470834|450877534|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
125339375|NCT00470834|450877533|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
125339376|NCT00470834|450877534|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
125339377|NCT00470834|450877533|FG000|Treatment Period (18 Months)|Non-compliance|1|||
125339378|NCT00470834|450877534|FG001|Treatment Period (18 Months)|Non-compliance|0|||
125339379|NCT00470834|450877533|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
125339380|NCT00470834|450877534|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
125339381|NCT00470834|450877533|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
125339382|NCT00470834|450877534|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
125339383|NCT00470834|450877533|FG000|Extension Period (24 Months)|Adverse Event|3|||
125339384|NCT00470834|450877534|FG001|Extension Period (24 Months)|Adverse Event|4|||
125339385|NCT00470834|450877533|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
125339386|NCT00470834|450877534|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
125339387|NCT00470834|450877533|FG000|Extension Period (24 Months)|Physician Decision|4|||
125339388|NCT00470834|450877534|FG001|Extension Period (24 Months)|Physician Decision|3|||
125339389|NCT00470834|450877533|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
125339390|NCT00470834|450877534|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
125339391|NCT00470834|450877533|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
125339392|NCT00470834|450877534|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
125339393|NCT00470834|450877533|FG000|Extension Period (24 Months)|Non-compliance|0|||
125339394|NCT00470834|450877534|FG001|Extension Period (24 Months)|Non-compliance|1|||
125339395|NCT00470834|450877533|FG000|Extension Period (24 Months)|Disease Progression|0|||
125339396|NCT00470834|450877534|FG001|Extension Period (24 Months)|Disease Progression|1|||
125339397|NCT04975438|450877538|FG000|Overall Study|Lost to Follow-up|1|||
125339398|NCT04975438|450877539|FG001|Overall Study|Lost to Follow-up|0|||
125339399|NCT04975438|450877540|FG002|Overall Study|Lost to Follow-up|1|||
125339400|NCT04975438|450877541|FG003|Overall Study|Lost to Follow-up|0|||
125339401|NCT04975438|450877538|FG000|Overall Study|Withdrawal by Subject|1|||
125339402|NCT04975438|450877539|FG001|Overall Study|Withdrawal by Subject|0|||
125339403|NCT04975438|450877540|FG002|Overall Study|Withdrawal by Subject|0|||
125339404|NCT04975438|450877541|FG003|Overall Study|Withdrawal by Subject|0|||
125339405|NCT02640508|450877546|FG000|Overall Study|Death|19|||
125339406|NCT02640508|450877546|FG000|Overall Study|Withdrawal by Subject|8|||
125339407|NCT02640508|450877546|FG000|Overall Study|Physician Decision|1|||
125339408|NCT02640508|450877546|FG000|Overall Study|Lost to Follow-up|1|||
125339409|NCT05405257|450877550|FG000|Overall Study|Withdrawal by Subject|1|||
125339410|NCT00275340|450877551|FG000|Overall Study|Lost to Follow-up|2|||
125339411|NCT00275340|450877552|FG001|Overall Study|Lost to Follow-up|4|||
125339412|NCT02379637|450877556|FG000|Overall Study|Protocol Violation|0|||
125339413|NCT02379637|450877557|FG001|Overall Study|Protocol Violation|1|||
125339414|NCT02379637|450877556|FG000|Overall Study|Adverse Event|1|||
125339415|NCT02379637|450877557|FG001|Overall Study|Adverse Event|0|||
125339416|NCT02379637|450877556|FG000|Overall Study|Withdrawal by Subject|1|||
125339417|NCT02379637|450877557|FG001|Overall Study|Withdrawal by Subject|0|||
125339418|NCT00862641|450877558|FG000|Overall Study|Randomized, but drug not received|1|||
125339419|NCT00862641|450877559|FG001|Overall Study|Randomized, but drug not received|4|||
125339420|NCT00862641|450877560|FG002|Overall Study|Randomized, but drug not received|1|||
125673552|NCT01579474|452092934|FG005|Overall Study|Withdrawal by Subject|0|||
125673553|NCT00130520|452092935|FG000|Overall Study|Adverse Event|11|||
125673554|NCT00130520|452092935|FG000|Overall Study|Death|1|||
125673555|NCT00130520|452092935|FG000|Overall Study|Physician Decision|1|||
125673556|NCT00130520|452092935|FG000|Overall Study|Withdrawal by Subject|1|||
125673557|NCT00130520|452092935|FG000|Overall Study|Disease Progression|23|||
125673558|NCT00130520|452092935|FG000|Overall Study|Protocol non-compliance|1|||
125673559|NCT00130520|452092935|FG000|Overall Study|Did not meet re-treatment criteria|1|||
125673560|NCT02688400|452092937|FG000|Overall Study|Protocol Violation|2|||
125673561|NCT02688400|452092938|FG001|Overall Study|Protocol Violation|5|||
125673562|NCT02688400|452092937|FG000|Overall Study|Lack of Efficacy|7|||
125673563|NCT02688400|452092938|FG001|Overall Study|Lack of Efficacy|7|||
125673564|NCT02688400|452092937|FG000|Overall Study|Adverse Event|21|||
125673565|NCT02688400|452092938|FG001|Overall Study|Adverse Event|12|||
125673566|NCT02688400|452092937|FG000|Overall Study|Withdrawal by Subject|15|||
125673567|NCT02688400|452092938|FG001|Overall Study|Withdrawal by Subject|13|||
125673568|NCT02688400|452092937|FG000|Overall Study|No study medication intake|1|||
125673569|NCT02688400|452092938|FG001|Overall Study|No study medication intake|4|||
125673570|NCT02688400|452092937|FG000|Overall Study|Lost to Follow-up|0|||
125673571|NCT02688400|452092938|FG001|Overall Study|Lost to Follow-up|3|||
125673572|NCT02295774|452092940|FG000|Overall Study|Physician Decision|1|||
125673573|NCT02295774|452092940|FG000|Overall Study|Withdrawal by Subject|2|||
125673574|NCT01075763|452092941|FG000|Overall Study|Lost to Follow-up|2|||
125673575|NCT01075763|452092942|FG001|Overall Study|Lost to Follow-up|1|||
125673576|NCT01075763|452092941|FG000|Overall Study|Lack of Efficacy|0|||
125673577|NCT01075763|452092942|FG001|Overall Study|Lack of Efficacy|1|||
125673578|NCT01075763|452092941|FG000|Overall Study|Withdrawal by Subject|2|||
125673579|NCT01075763|452092942|FG001|Overall Study|Withdrawal by Subject|2|||
125673580|NCT00586521|452092943|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
125673581|NCT03083483|452092953|FG000|Overall Study|Adverse Event|1|||
125673582|NCT03083483|452092954|FG001|Overall Study|Adverse Event|1|||
125673583|NCT03083483|452092955|FG002|Overall Study|Adverse Event|1|||
125673584|NCT03083483|452092953|FG000|Overall Study|Lost to Follow-up|2|||
125673585|NCT03083483|452092954|FG001|Overall Study|Lost to Follow-up|1|||
125673586|NCT03083483|452092955|FG002|Overall Study|Lost to Follow-up|1|||
125673587|NCT03083483|452092953|FG000|Overall Study|technological issues|1|||
125673588|NCT03083483|452092954|FG001|Overall Study|technological issues|0|||
125673589|NCT03083483|452092955|FG002|Overall Study|technological issues|1|||
125673590|NCT03731182|452092958|FG000|Overall Study|Lost to Follow-up|2|||
125673591|NCT03731182|452092959|FG001|Overall Study|Lost to Follow-up|0|||
125673592|NCT03731182|452092958|FG000|Overall Study|Physician Decision|1|||
125673593|NCT03731182|452092959|FG001|Overall Study|Physician Decision|0|||
125673594|NCT03731182|452092958|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
125673595|NCT03731182|452092959|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
125673596|NCT02006706|452092960|FG000|Overall Study|Lost to Follow-up|1|||
125673597|NCT00582036|452092961|FG000|Overall Study|Withdrawal by Subject|0|||
125673598|NCT00582036|452092962|FG001|Overall Study|Withdrawal by Subject|1|||
125673599|NCT01673009|452092963|FG000|Overall Study|Physician Decision|5|||
125673600|NCT01673009|452092963|FG000|Overall Study|Withdrawal by Subject|8|||
125673601|NCT04161144|452092965|FG000|Overall Study|Withdrawal by Subject|0|||
125339421|NCT00862641|450877561|FG003|Overall Study|Randomized, but drug not received|4|||
125339422|NCT02365480|450877562|FG000|Overall Study|Withdrawal by Subject|2|||
125339423|NCT02365480|450877563|FG001|Overall Study|Withdrawal by Subject|0|||
125339424|NCT03091348|450877564|FG000|Overall Study|Lost to Follow-up|2|||
125339425|NCT03091348|450877565|FG001|Overall Study|Lost to Follow-up|1|||
125339426|NCT02791763|450877566|FG000|Overall Study|Protocol Violation|0|||
125339427|NCT02791763|450877567|FG001|Overall Study|Protocol Violation|0|||
125339428|NCT02791763|450877568|FG002|Overall Study|Protocol Violation|1|||
125339429|NCT02791763|450877566|FG000|Overall Study|Withdrawal by Subject|5|||
125339430|NCT02791763|450877567|FG001|Overall Study|Withdrawal by Subject|1|||
125339431|NCT02791763|450877568|FG002|Overall Study|Withdrawal by Subject|0|||
125339432|NCT02791763|450877566|FG000|Overall Study|Physician Decision|0|||
125339433|NCT02791763|450877567|FG001|Overall Study|Physician Decision|1|||
125339434|NCT02791763|450877568|FG002|Overall Study|Physician Decision|0|||
125339435|NCT02791763|450877566|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
125339436|NCT02791763|450877567|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
125673602|NCT04161144|452092966|FG001|Overall Study|Withdrawal by Subject|1|||
125673603|NCT04161144|452092965|FG000|Overall Study|Protocol Violation|1|||
125673604|NCT04161144|452092966|FG001|Overall Study|Protocol Violation|0|||
125673605|NCT00958256|452092967|FG000|Overall Study|Adverse Event|3|||
125339437|NCT02791763|450877568|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
125673606|NCT00782509|452092970|FG000|Overall Study|Adverse Event|20|||
125673607|NCT00782509|452092971|FG001|Overall Study|Adverse Event|10|||
125673608|NCT00782509|452092972|FG002|Overall Study|Adverse Event|20|||
125673609|NCT00782509|452092970|FG000|Overall Study|Lost to Follow-up|1|||
125673610|NCT00782509|452092971|FG001|Overall Study|Lost to Follow-up|2|||
125673611|NCT00782509|452092972|FG002|Overall Study|Lost to Follow-up|3|||
125673612|NCT00782509|452092970|FG000|Overall Study|Withdrawal by Subject|3|||
125339438|NCT02791763|450877566|FG000|Overall Study|Cancer event|1|||
125339439|NCT02791763|450877567|FG001|Overall Study|Cancer event|3|||
125339440|NCT02791763|450877568|FG002|Overall Study|Cancer event|0|||
125339441|NCT02791763|450877566|FG000|Overall Study|Participant had renal transplant|3|||
125339442|NCT02791763|450877567|FG001|Overall Study|Participant had renal transplant|0|||
125339443|NCT02791763|450877568|FG002|Overall Study|Participant had renal transplant|0|||
125339444|NCT02791763|450877566|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
125339445|NCT02791763|450877567|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
125339446|NCT02791763|450877568|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
125339447|NCT02791763|450877566|FG000|Overall Study|Adverse Event|12|||
125339448|NCT02791763|450877567|FG001|Overall Study|Adverse Event|13|||
125339449|NCT02791763|450877568|FG002|Overall Study|Adverse Event|7|||
125339450|NCT04534686|450877569|FG000|Baseline Measurement|Lost to Follow-up|4|||
125339451|NCT04534686|450877570|FG001|Baseline Measurement|Lost to Follow-up|6|||
125339452|NCT04534686|450877569|FG000|Baseline Measurement|Withdrawal by Subject|3|||
125339453|NCT04534686|450877570|FG001|Baseline Measurement|Withdrawal by Subject|1|||
125339454|NCT04534686|450877569|FG000|Intervention|Withdrawal by Subject|2|||
125339455|NCT04534686|450877570|FG001|Intervention|Withdrawal by Subject|2|||
125339456|NCT00706342|450877571|FG000|Overall Study|Adverse Event|3|||
125339457|NCT00706342|450877571|FG000|Overall Study|Not responding to treatment|2|||
125339458|NCT00706342|450877571|FG000|Overall Study|Withdrawn due to failure to respond|1|||
125339459|NCT00706342|450877571|FG000|Overall Study|Death|1|||
125339460|NCT00706342|450877571|FG000|Overall Study|Withdrew from the study on his own.|1|||
125339461|NCT00706342|450877571|FG000|Overall Study|Investigator discretion|2|||
125339462|NCT00706342|450877571|FG000|Overall Study|Non-responder Week 12|1|||
125339463|NCT00706342|450877571|FG000|Overall Study|Ongoing|6|||
125339464|NCT00706342|450877571|FG000|Overall Study|WIthdrawal of consent|1|||
125339465|NCT01419197|450877576|FG000|Overall Study|Death|247|||
125339466|NCT01419197|450877577|FG001|Overall Study|Death|122|||
125339467|NCT01419197|450877576|FG000|Overall Study|Physician Decision|4|||
125339468|NCT01419197|450877577|FG001|Overall Study|Physician Decision|4|||
125339469|NCT01419197|450877576|FG000|Overall Study|Non-compliance|3|||
125339470|NCT01419197|450877577|FG001|Overall Study|Non-compliance|1|||
125339471|NCT01419197|450877576|FG000|Overall Study|Withdrawal by Subject|33|||
125339472|NCT01419197|450877577|FG001|Overall Study|Withdrawal by Subject|32|||
125339473|NCT01419197|450877576|FG000|Overall Study|Study Completed by Sponsor|103|||
125339474|NCT01419197|450877577|FG001|Overall Study|Study Completed by Sponsor|34|||
125339475|NCT01419197|450877576|FG000|Overall Study|Reason Not Specified|0|||
125339476|NCT01419197|450877577|FG001|Overall Study|Reason Not Specified|1|||
125339477|NCT01419197|450877576|FG000|Overall Study|Lost to Follow-up|14|||
125339478|NCT01419197|450877577|FG001|Overall Study|Lost to Follow-up|4|||
125339479|NCT02410343|450877578|FG000|Core Period (24 Weeks)|Adverse Event|1|||
125339480|NCT02410343|450877579|FG001|Core Period (24 Weeks)|Adverse Event|0|||
125339481|NCT02410343|450877578|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
125339482|NCT02410343|450877579|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
125339483|NCT02410343|450877578|FG000|Extension Period (12 Months)|Adverse Event|1|||
125673613|NCT00782509|452092971|FG001|Overall Study|Withdrawal by Subject|5|||
125673614|NCT00782509|452092972|FG002|Overall Study|Withdrawal by Subject|8|||
125673615|NCT00782509|452092970|FG000|Overall Study|Non compliance with protocol|2|||
125673616|NCT00782509|452092971|FG001|Overall Study|Non compliance with protocol|0|||
125673617|NCT00782509|452092972|FG002|Overall Study|Non compliance with protocol|0|||
125673618|NCT00782509|452092970|FG000|Overall Study|Other reasons not stated above|5|||
125673619|NCT00782509|452092971|FG001|Overall Study|Other reasons not stated above|2|||
125673620|NCT00782509|452092972|FG002|Overall Study|Other reasons not stated above|3|||
125673621|NCT00782509|452092970|FG000|Overall Study|Lack of Efficacy|10|||
125673622|NCT00782509|452092971|FG001|Overall Study|Lack of Efficacy|5|||
125673623|NCT00782509|452092972|FG002|Overall Study|Lack of Efficacy|2|||
125673624|NCT02398188|452092973|FG000|Overall Study|Adverse Event|2|||
125673625|NCT02398188|452092974|FG001|Overall Study|Adverse Event|3|||
125673626|NCT02398188|452092973|FG000|Overall Study|Lost to Follow-up|5|||
125673627|NCT02398188|452092974|FG001|Overall Study|Lost to Follow-up|0|||
125673628|NCT02398188|452092973|FG000|Overall Study|Non-compliance|4|||
125673629|NCT02398188|452092974|FG001|Overall Study|Non-compliance|4|||
125673630|NCT02398188|452092973|FG000|Overall Study|Protocol Violation|6|||
125673631|NCT02398188|452092974|FG001|Overall Study|Protocol Violation|10|||
125673632|NCT02398188|452092973|FG000|Overall Study|Sponsor Decision|2|||
125673633|NCT02398188|452092974|FG001|Overall Study|Sponsor Decision|1|||
125673634|NCT02398188|452092973|FG000|Overall Study|Pregnancy|1|||
125673635|NCT02398188|452092974|FG001|Overall Study|Pregnancy|0|||
125673636|NCT02398188|452092973|FG000|Overall Study|Withdrawal by Subject|7|||
125673637|NCT02398188|452092974|FG001|Overall Study|Withdrawal by Subject|16|||
125673638|NCT01000337|452092979|FG000|Overall Study|Lost to Follow-up|4|||
125673639|NCT01000337|452092980|FG001|Overall Study|Lost to Follow-up|3|||
125673640|NCT01612000|452092981|FG000|Overall Study|Lost to Follow-up|6|||
125673641|NCT01612000|452092982|FG001|Overall Study|Lost to Follow-up|4|||
125673642|NCT01612000|452092983|FG002|Overall Study|Lost to Follow-up|4|||
125673643|NCT01612000|452092984|FG003|Overall Study|Lost to Follow-up|8|||
125339484|NCT02410343|450877579|FG001|Extension Period (12 Months)|Adverse Event|0|||
125339485|NCT02410343|450877578|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
125339486|NCT02410343|450877579|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
125339487|NCT00246740|450877584|FG000|Initial Enrollment|Death|1|||
125339488|NCT00246740|450877585|FG001|Initial Enrollment|Death|0|||
125339489|NCT00246740|450877584|FG000|Initial Enrollment|Additional surgery scheduled|0|||
125339490|NCT00246740|450877585|FG001|Initial Enrollment|Additional surgery scheduled|2|||
125339491|NCT00246740|450877584|FG000|Initial Enrollment|Surgery schedule change|4|||
125339492|NCT00246740|450877585|FG001|Initial Enrollment|Surgery schedule change|4|||
125339493|NCT00246740|450877584|FG000|Initial Enrollment|Other|1|||
125339494|NCT00246740|450877585|FG001|Initial Enrollment|Other|2|||
125339495|NCT01510769|450877586|FG000|Overall Study|Adverse Event|7|||
125339496|NCT01510769|450877587|FG001|Overall Study|Adverse Event|6|||
125339497|NCT01510769|450877588|FG002|Overall Study|Adverse Event|4|||
125339498|NCT01510769|450877586|FG000|Overall Study|Gout Flare|0|||
125339499|NCT01510769|450877587|FG001|Overall Study|Gout Flare|3|||
125339500|NCT01510769|450877588|FG002|Overall Study|Gout Flare|1|||
125339501|NCT01510769|450877586|FG000|Overall Study|Protocol Violation|11|||
125339502|NCT01510769|450877587|FG001|Overall Study|Protocol Violation|10|||
125339503|NCT01510769|450877588|FG002|Overall Study|Protocol Violation|9|||
125339504|NCT01510769|450877586|FG000|Overall Study|Lost to Follow-up|5|||
125339505|NCT01510769|450877587|FG001|Overall Study|Lost to Follow-up|1|||
125339506|NCT01510769|450877588|FG002|Overall Study|Lost to Follow-up|5|||
125339507|NCT01510769|450877586|FG000|Overall Study|Withdrawal by Subject|3|||
125339508|NCT01510769|450877587|FG001|Overall Study|Withdrawal by Subject|4|||
125339509|NCT01510769|450877588|FG002|Overall Study|Withdrawal by Subject|3|||
125339510|NCT01510769|450877586|FG000|Overall Study|Death|1|||
125339511|NCT01510769|450877587|FG001|Overall Study|Death|1|||
125339512|NCT01510769|450877588|FG002|Overall Study|Death|0|||
125339513|NCT00335764|450877591|FG000|Overall Study|wrong histology|1|||
125339514|NCT00335764|450877592|FG001|Overall Study|wrong histology|0|||
125339515|NCT00335764|450877593|FG002|Overall Study|wrong histology|0|||
125339516|NCT00335764|450877594|FG003|Overall Study|wrong histology|0|||
125339517|NCT00335764|450877595|FG004|Overall Study|wrong histology|1|||
125339518|NCT02466659|450877596|FG000|Overall Study|Lost to Follow-up|5|||
125339519|NCT02466659|450877597|FG001|Overall Study|Lost to Follow-up|2|||
125339520|NCT00929643|450877598|FG000|Overall Study|Protocol Violation|2|||
125339521|NCT00934440|450877601|FG000|Overall Study|Lost to Follow-up|1|||
125339522|NCT00744042|450877602|FG000|Overall Study|Withdrawal by Subject|1|||
125339523|NCT00750152|450877603|FG000|Overall Study|Adverse Event|2|||
125339524|NCT00750152|450877604|FG001|Overall Study|Adverse Event|1|||
125339525|NCT00750152|450877603|FG000|Overall Study|Lost to Follow-up|8|||
125339526|NCT00750152|450877604|FG001|Overall Study|Lost to Follow-up|13|||
125339527|NCT00750152|450877603|FG000|Overall Study|Withdrawal by Subject|3|||
125339528|NCT00750152|450877604|FG001|Overall Study|Withdrawal by Subject|3|||
125339529|NCT00750152|450877603|FG000|Overall Study|Physician Decision|1|||
125339530|NCT00750152|450877604|FG001|Overall Study|Physician Decision|1|||
125339531|NCT00750152|450877603|FG000|Overall Study|Non-compliance|0|||
125339532|NCT00750152|450877604|FG001|Overall Study|Non-compliance|1|||
125339533|NCT00750152|450877603|FG000|Overall Study|Termination by sponsor|1|||
125339534|NCT00750152|450877604|FG001|Overall Study|Termination by sponsor|0|||
125339535|NCT00750152|450877603|FG000|Overall Study|Other|7|||
125339536|NCT00750152|450877604|FG001|Overall Study|Other|8|||
125339537|NCT01028300|450877607|FG000|Overall Study|Study Terminated|4|||
125339538|NCT01214395|450877610|FG000|Overall Study|All patients had infection|5|||
125339539|NCT00715910|450877614|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
125339540|NCT00715910|450877615|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
125339541|NCT00715910|450877616|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
125339542|NCT00715910|450877617|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
125339543|NCT00715910|450877618|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
125339544|NCT00715910|450877619|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
125339545|NCT00715910|450877614|FG000|Booster and ESFU Phase|Other|0|||
125339546|NCT00715910|450877615|FG001|Booster and ESFU Phase|Other|0|||
125339547|NCT00715910|450877616|FG002|Booster and ESFU Phase|Other|0|||
125339548|NCT00715910|450877617|FG003|Booster and ESFU Phase|Other|5|||
125339549|NCT00715910|450877618|FG004|Booster and ESFU Phase|Other|1|||
125339550|NCT00715910|450877619|FG005|Booster and ESFU Phase|Other|0|||
125339551|NCT02034409|450877620|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
125339552|NCT02034409|450877621|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
125339553|NCT02034409|450877620|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
125339554|NCT02034409|450877621|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
125339555|NCT02034409|450877620|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
125339556|NCT02034409|450877621|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
125339557|NCT02034409|450877620|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
125339558|NCT02034409|450877621|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
125339559|NCT02034409|450877620|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
125378906|NCT00588848|451019205|FG001|Overall Study|Physician Decision|3|||
125339560|NCT02034409|450877621|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
125339561|NCT02034409|450877620|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
125339562|NCT02034409|450877621|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
125339563|NCT05092360|450877623|FG000|Overall Study|Withdrawal by Subject|21|||
125339564|NCT05092360|450877624|FG001|Overall Study|Withdrawal by Subject|4|||
125339565|NCT05092360|450877625|FG002|Overall Study|Withdrawal by Subject|9|||
125339566|NCT05092360|450877626|FG003|Overall Study|Withdrawal by Subject|26|||
125339567|NCT05092360|450877623|FG000|Overall Study|Death|97|||
125339568|NCT05092360|450877624|FG001|Overall Study|Death|14|||
125339569|NCT05092360|450877625|FG002|Overall Study|Death|31|||
125339570|NCT05092360|450877626|FG003|Overall Study|Death|101|||
125339571|NCT05092360|450877623|FG000|Overall Study|Lost to Follow-up|1|||
125339572|NCT05092360|450877624|FG001|Overall Study|Lost to Follow-up|2|||
125339573|NCT05092360|450877625|FG002|Overall Study|Lost to Follow-up|2|||
125339574|NCT05092360|450877626|FG003|Overall Study|Lost to Follow-up|2|||
125339575|NCT05092360|450877623|FG000|Overall Study|Study terminated by sponsor|65|||
125339576|NCT05092360|450877624|FG001|Overall Study|Study terminated by sponsor|7|||
125339577|NCT05092360|450877625|FG002|Overall Study|Study terminated by sponsor|13|||
125339578|NCT05092360|450877626|FG003|Overall Study|Study terminated by sponsor|61|||
125339579|NCT03952039|450877629|FG000|Overall Study|Adverse Event|22|||
125339580|NCT03952039|450877630|FG001|Overall Study|Adverse Event|8|||
125339581|NCT03952039|450877629|FG000|Overall Study|Withdrawal by Participant|17|||
125339582|NCT03952039|450877630|FG001|Overall Study|Withdrawal by Participant|12|||
125339583|NCT03952039|450877629|FG000|Overall Study|Death|13|||
125339584|NCT03952039|450877630|FG001|Overall Study|Death|6|||
125339585|NCT03952039|450877629|FG000|Overall Study|Lack of Efficacy|12|||
125339586|NCT03952039|450877630|FG001|Overall Study|Lack of Efficacy|2|||
125339587|NCT03952039|450877629|FG000|Overall Study|Physician Decision|9|||
125339588|NCT03952039|450877630|FG001|Overall Study|Physician Decision|3|||
125339589|NCT03952039|450877629|FG000|Overall Study|Progressive Disease|6|||
125339590|NCT03952039|450877630|FG001|Overall Study|Progressive Disease|4|||
125339591|NCT03952039|450877629|FG000|Overall Study|Other Reasons|12|||
125339592|NCT03952039|450877630|FG001|Overall Study|Other Reasons|4|||
125339593|NCT04614324|450877636|FG000|Overall Study|Lost to Follow-up|3|||
125339594|NCT04614324|450877636|FG000|Overall Study|Physician Decision|1|||
125339595|NCT04614324|450877636|FG000|Overall Study|Withdrawal by Subject|2|||
125339596|NCT04614324|450877636|FG000|Overall Study|Remaining in Follow up|123|||
125339597|NCT04627285|450877637|FG000|Overall Study|Adverse Event|0|||
125339598|NCT04627285|450877638|FG001|Overall Study|Adverse Event|2|||
125339599|NCT04627285|450877637|FG000|Overall Study|Lost to Follow-up|1|||
125339600|NCT04627285|450877638|FG001|Overall Study|Lost to Follow-up|0|||
125339601|NCT04627285|450877637|FG000|Overall Study|Withdrawal by Subject|1|||
125339602|NCT04627285|450877638|FG001|Overall Study|Withdrawal by Subject|1|||
125339603|NCT04627285|450877637|FG000|Overall Study|Sponsor decision|5|||
125339604|NCT04627285|450877638|FG001|Overall Study|Sponsor decision|0|||
125339605|NCT04627285|450877637|FG000|Overall Study|Participant left country; aunt informed the site|0|||
125339606|NCT04627285|450877638|FG001|Overall Study|Participant left country; aunt informed the site|1|||
125339607|NCT03703297|450877639|FG000|Overall Study|Death|115|||
125339608|NCT03703297|450877640|FG001|Overall Study|Death|0|||
125339609|NCT03703297|450877641|FG002|Overall Study|Death|144|||
125339610|NCT03703297|450877639|FG000|Overall Study|Withdrawal by Subject|9|||
125339611|NCT03703297|450877640|FG001|Overall Study|Withdrawal by Subject|0|||
125339612|NCT03703297|450877641|FG002|Overall Study|Withdrawal by Subject|11|||
125339613|NCT03703297|450877639|FG000|Overall Study|Ongoing at the time of DCO|140|||
125339614|NCT03703297|450877640|FG001|Overall Study|Ongoing at the time of DCO|200|||
125339615|NCT03703297|450877641|FG002|Overall Study|Ongoing at the time of DCO|111|||
125339616|NCT04473235|450879808|FG000|Overall Study|Lost to Follow-up|6|||
125339617|NCT04473235|450879809|FG001|Overall Study|Lost to Follow-up|5|||
125339618|NCT04473235|450879808|FG000|Overall Study|Declined continuation|2|||
125339619|NCT04473235|450879809|FG001|Overall Study|Declined continuation|0|||
125339620|NCT04473235|450879808|FG000|Overall Study|Physician Decision|1|||
125339621|NCT04473235|450879809|FG001|Overall Study|Physician Decision|1|||
125339622|NCT04473235|450879808|FG000|Overall Study|Protocol Violation|10|||
125339623|NCT04473235|450879809|FG001|Overall Study|Protocol Violation|6|||
125339624|NCT01754402|450879810|FG000|Overall Study|Death|0|||
125339625|NCT01754402|450879811|FG001|Overall Study|Death|0|||
125339626|NCT01754402|450879812|FG002|Overall Study|Death|1|||
125339627|NCT01754402|450879810|FG000|Overall Study|Adverse Event|2|||
125339628|NCT01754402|450879811|FG001|Overall Study|Adverse Event|2|||
125339629|NCT01754402|450879812|FG002|Overall Study|Adverse Event|1|||
125339630|NCT01754402|450879810|FG000|Overall Study|Withdrawal by Subject|0|||
125339631|NCT01754402|450879811|FG001|Overall Study|Withdrawal by Subject|0|||
125339632|NCT01754402|450879812|FG002|Overall Study|Withdrawal by Subject|1|||
125339633|NCT01754402|450879810|FG000|Overall Study|Lack of Efficacy|0|||
125339634|NCT01754402|450879811|FG001|Overall Study|Lack of Efficacy|0|||
125339635|NCT01754402|450879812|FG002|Overall Study|Lack of Efficacy|1|||
125673644|NCT01612000|452092981|FG000|Overall Study|Physician Decision|0|||
125673645|NCT01612000|452092982|FG001|Overall Study|Physician Decision|0|||
125673646|NCT01612000|452092983|FG002|Overall Study|Physician Decision|1|||
125673647|NCT01612000|452092984|FG003|Overall Study|Physician Decision|0|||
125673648|NCT01612000|452092981|FG000|Overall Study|Withdrawal by Subject|3|||
125673649|NCT01612000|452092982|FG001|Overall Study|Withdrawal by Subject|1|||
125673650|NCT01612000|452092983|FG002|Overall Study|Withdrawal by Subject|2|||
125673651|NCT01612000|452092984|FG003|Overall Study|Withdrawal by Subject|2|||
125673652|NCT02173704|452092986|FG000|Overall Study|Adverse Event|1|||
125673653|NCT02173704|452092987|FG001|Overall Study|Adverse Event|0|||
125673654|NCT02173704|452092986|FG000|Overall Study|Lost to Follow-up|1|||
125673655|NCT02173704|452092987|FG001|Overall Study|Lost to Follow-up|0|||
125673656|NCT02173704|452092986|FG000|Overall Study|Other|1|||
125673657|NCT02173704|452092987|FG001|Overall Study|Other|0|||
125673658|NCT02173704|452092986|FG000|Overall Study|Protocol Violation|1|||
125673659|NCT02173704|452092987|FG001|Overall Study|Protocol Violation|0|||
125673660|NCT02173704|452092986|FG000|Overall Study|Withdrawal by Subject|9|||
125673661|NCT02173704|452092987|FG001|Overall Study|Withdrawal by Subject|4|||
125673662|NCT00419926|452092988|FG000|Overall Study|Withdrawal by Subject|7|||
125673663|NCT00419926|452092989|FG001|Overall Study|Withdrawal by Subject|3|||
125673664|NCT00419926|452092988|FG000|Overall Study|Administrative Problem|4|||
125673665|NCT00419926|452092989|FG001|Overall Study|Administrative Problem|4|||
125673666|NCT00419926|452092988|FG000|Overall Study|Lost to Follow-up|1|||
125673667|NCT00419926|452092989|FG001|Overall Study|Lost to Follow-up|2|||
125673668|NCT00419926|452092988|FG000|Overall Study|Death|2|||
125673669|NCT00419926|452092989|FG001|Overall Study|Death|1|||
125673670|NCT01180244|452092996|FG000|Overall Study|Lack of Efficacy|0|||
125673671|NCT01180244|452092997|FG001|Overall Study|Lack of Efficacy|7|||
125673672|NCT01180244|452092996|FG000|Overall Study|Physician Decision|3|||
125673673|NCT01180244|452092997|FG001|Overall Study|Physician Decision|0|||
125673674|NCT01180244|452092996|FG000|Overall Study|Adverse Event|1|||
125673675|NCT01180244|452092997|FG001|Overall Study|Adverse Event|0|||
125673676|NCT01180244|452092996|FG000|Overall Study|Withdrawal by Subject|0|||
125673677|NCT01180244|452092997|FG001|Overall Study|Withdrawal by Subject|1|||
125339636|NCT01282463|450879813|FG000|Overall Study|Lost to Follow-up|1|||
125339637|NCT01282463|450879814|FG001|Overall Study|Lost to Follow-up|0|||
125673678|NCT01180244|452092996|FG000|Overall Study|Protocol Violation|1|||
125339638|NCT01282463|450879815|FG002|Overall Study|Lost to Follow-up|0|||
125339639|NCT01282463|450879813|FG000|Overall Study|Withdrawal by Subject|6|||
125339640|NCT01282463|450879814|FG001|Overall Study|Withdrawal by Subject|2|||
125339641|NCT01282463|450879815|FG002|Overall Study|Withdrawal by Subject|3|||
125339642|NCT01282463|450879813|FG000|Overall Study|"Never Treated Death"|0|||
125339643|NCT01282463|450879814|FG001|Overall Study|"Never Treated Death"|1|||
125339644|NCT01282463|450879815|FG002|Overall Study|"Never Treated Death"|0|||
125339645|NCT01282463|450879813|FG000|Overall Study|"Never Treated PD"|0|||
125339646|NCT01282463|450879814|FG001|Overall Study|"Never Treated PD"|1|||
125339647|NCT01282463|450879815|FG002|Overall Study|"Never Treated PD"|0|||
125339648|NCT01282463|450879813|FG000|Overall Study|Protocol Violation|0|||
125339649|NCT01282463|450879814|FG001|Overall Study|Protocol Violation|0|||
125339650|NCT01282463|450879815|FG002|Overall Study|Protocol Violation|1|||
125339651|NCT01282463|450879813|FG000|Overall Study|Physician Decision|1|||
125339652|NCT01282463|450879814|FG001|Overall Study|Physician Decision|0|||
125339653|NCT01282463|450879815|FG002|Overall Study|Physician Decision|0|||
125339654|NCT01221285|450879818|FG000|Overall Study|Withdrawal by Subject|1|||
125339655|NCT01239992|450879820|FG000|Overall Study|Withdrawal by Subject|2|||
125339656|NCT00220779|450879826|FG000|Overall Study|Adverse Event|1|||
125339657|NCT00220779|450879827|FG001|Overall Study|Adverse Event|0|||
125339658|NCT00220779|450879828|FG002|Overall Study|Adverse Event|0|||
125339659|NCT00220779|450879826|FG000|Overall Study|Withdrawal by Subject|1|||
125339660|NCT00220779|450879827|FG001|Overall Study|Withdrawal by Subject|4|||
125339661|NCT00220779|450879828|FG002|Overall Study|Withdrawal by Subject|1|||
125339662|NCT00220779|450879826|FG000|Overall Study|Non-compliance|1|||
125339663|NCT00220779|450879827|FG001|Overall Study|Non-compliance|0|||
125339664|NCT00220779|450879828|FG002|Overall Study|Non-compliance|0|||
125339665|NCT00220779|450879826|FG000|Overall Study|Too time consuming|1|||
125339666|NCT00220779|450879827|FG001|Overall Study|Too time consuming|0|||
125339667|NCT00220779|450879828|FG002|Overall Study|Too time consuming|0|||
125339668|NCT00220779|450879826|FG000|Overall Study|Pregnancy|0|||
125339669|NCT00220779|450879827|FG001|Overall Study|Pregnancy|0|||
125339670|NCT00220779|450879828|FG002|Overall Study|Pregnancy|2|||
125339671|NCT00220779|450879826|FG000|Overall Study|Lack of Efficacy|3|||
125339672|NCT00220779|450879827|FG001|Overall Study|Lack of Efficacy|0|||
125339673|NCT00220779|450879828|FG002|Overall Study|Lack of Efficacy|1|||
125339674|NCT03390101|450879829|FG000|Weeks 0-12|Withdrawal by Subject|0|||
125339675|NCT03390101|450879830|FG001|Weeks 0-12|Withdrawal by Subject|1|||
125339676|NCT03390101|450879831|FG002|Weeks 0-12|Withdrawal by Subject|1|||
125339677|NCT03390101|450879829|FG000|Weeks 0-12|Lost to Follow-up|0|||
125339678|NCT03390101|450879830|FG001|Weeks 0-12|Lost to Follow-up|1|||
125339679|NCT03390101|450879831|FG002|Weeks 0-12|Lost to Follow-up|0|||
125339680|NCT03390101|450879829|FG000|Weeks 12-54|Withdrawal by Subject|0|||
125339681|NCT03390101|450879830|FG001|Weeks 12-54|Withdrawal by Subject|3|||
125339682|NCT03390101|450879831|FG002|Weeks 12-54|Withdrawal by Subject|1|||
125339683|NCT03390101|450879829|FG000|Weeks 12-54|Pregnancy|1|||
125339684|NCT03390101|450879830|FG001|Weeks 12-54|Pregnancy|0|||
125339685|NCT03390101|450879831|FG002|Weeks 12-54|Pregnancy|0|||
125339686|NCT03390101|450879829|FG000|Weeks 12-54|Adverse Event|2|||
125339687|NCT03390101|450879830|FG001|Weeks 12-54|Adverse Event|1|||
125339688|NCT03390101|450879831|FG002|Weeks 12-54|Adverse Event|1|||
125339689|NCT00281658|450879832|FG000|Randomized Phase|Adverse Event|0|||
125339690|NCT00281658|450879833|FG001|Randomized Phase|Adverse Event|2|||
125339691|NCT00281658|450879834|FG002|Randomized Phase|Adverse Event|0|||
125339692|NCT00281658|450879835|FG003|Randomized Phase|Adverse Event|0|||
125339693|NCT00281658|450879832|FG000|Randomized Phase|Lost to Follow-up|34|||
125339694|NCT00281658|450879833|FG001|Randomized Phase|Lost to Follow-up|27|||
125339695|NCT00281658|450879834|FG002|Randomized Phase|Lost to Follow-up|0|||
125339696|NCT00281658|450879835|FG003|Randomized Phase|Lost to Follow-up|0|||
125339697|NCT00281658|450879832|FG000|Randomized Phase|Withdrawal by Subject|8|||
125339698|NCT00281658|450879833|FG001|Randomized Phase|Withdrawal by Subject|7|||
125339699|NCT00281658|450879834|FG002|Randomized Phase|Withdrawal by Subject|0|||
125339700|NCT00281658|450879835|FG003|Randomized Phase|Withdrawal by Subject|0|||
125339701|NCT00281658|450879832|FG000|Randomized Phase|Study closed/terminated|1|||
125339702|NCT00281658|450879833|FG001|Randomized Phase|Study closed/terminated|1|||
125339703|NCT00281658|450879834|FG002|Randomized Phase|Study closed/terminated|0|||
125339704|NCT00281658|450879835|FG003|Randomized Phase|Study closed/terminated|0|||
125339705|NCT00281658|450879832|FG000|Randomized Phase|Disease progression|36|||
125339706|NCT00281658|450879833|FG001|Randomized Phase|Disease progression|27|||
125339707|NCT00281658|450879834|FG002|Randomized Phase|Disease progression|0|||
125339708|NCT00281658|450879835|FG003|Randomized Phase|Disease progression|0|||
125339709|NCT00281658|450879832|FG000|Randomized Phase|Physician Decision|1|||
125339710|NCT00281658|450879833|FG001|Randomized Phase|Physician Decision|1|||
125339711|NCT00281658|450879834|FG002|Randomized Phase|Physician Decision|0|||
125339712|NCT00281658|450879835|FG003|Randomized Phase|Physician Decision|0|||
125339713|NCT00281658|450879832|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
125339714|NCT00281658|450879833|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
125339715|NCT00281658|450879834|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
125378907|NCT00589914|451019206|FG000|Overall Study|Adverse Event|19|||
125673679|NCT01180244|452092997|FG001|Overall Study|Protocol Violation|0|||
125673680|NCT01180244|452092996|FG000|Overall Study|Lost to Follow-up|1|||
125673681|NCT01180244|452092997|FG001|Overall Study|Lost to Follow-up|0|||
125673682|NCT00729859|452092998|FG000|Overall Study|Adverse Event|0|||
125673683|NCT00729859|452092999|FG001|Overall Study|Adverse Event|1|||
125673684|NCT00729859|452093000|FG002|Overall Study|Adverse Event|0|||
125673685|NCT00729859|452092998|FG000|Overall Study|Withdrawal by Subject|0|||
125673686|NCT00729859|452092999|FG001|Overall Study|Withdrawal by Subject|1|||
125673687|NCT00729859|452093000|FG002|Overall Study|Withdrawal by Subject|0|||
125673688|NCT02623829|452093001|FG000|Overall Study|Lost to Follow-up|1|||
125339716|NCT00281658|450879835|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
125673689|NCT02623829|452093002|FG001|Overall Study|Lost to Follow-up|1|||
125673690|NCT03349333|452093003|FG000|Overall Study|Progression of Disease|36|||
125673691|NCT03349333|452093003|FG000|Overall Study|Adverse Event|11|||
125673692|NCT03349333|452093003|FG000|Overall Study|Other|6|||
125673693|NCT03349333|452093003|FG000|Overall Study|Withdrawal by Subject|5|||
125673694|NCT03349333|452093003|FG000|Overall Study|Conditions interfere with participation|2|||
125673695|NCT03349333|452093003|FG000|Overall Study|Physician Decision|2|||
125673696|NCT03349333|452093003|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
125673697|NCT03349333|452093003|FG000|Overall Study|Patients in treatment less than 24 month|8|||
125673698|NCT03267264|452093005|FG000|Overall Study|Withdrawal by Subject|1|||
125673699|NCT03267264|452093006|FG001|Overall Study|Withdrawal by Subject|0|||
125673700|NCT03267264|452093007|FG002|Overall Study|Withdrawal by Subject|2|||
125673701|NCT03267264|452093008|FG003|Overall Study|Withdrawal by Subject|4|||
125673702|NCT00622908|452093009|FG000|Overall Study|Protocol Violation|1|||
125673703|NCT00622908|452093010|FG001|Overall Study|Protocol Violation|0|||
125673704|NCT00622908|452093009|FG000|Overall Study|Adverse Event|0|||
125673705|NCT00622908|452093010|FG001|Overall Study|Adverse Event|1|||
125673706|NCT00622908|452093009|FG000|Overall Study|Lack of Efficacy|1|||
125339717|NCT00281658|450879832|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
125339718|NCT00281658|450879833|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
125339719|NCT00281658|450879834|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
125339720|NCT00281658|450879835|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
125339721|NCT00281658|450879832|FG000|Randomized Phase|Treatment ongoing|1|||
125339722|NCT00281658|450879833|FG001|Randomized Phase|Treatment ongoing|0|||
125673707|NCT00622908|452093010|FG001|Overall Study|Lack of Efficacy|7|||
125673708|NCT00622908|452093009|FG000|Overall Study|Lost to Follow-up|1|||
125673709|NCT00622908|452093010|FG001|Overall Study|Lost to Follow-up|0|||
125673710|NCT00622908|452093009|FG000|Overall Study|Refusal|0|||
125673711|NCT00622908|452093010|FG001|Overall Study|Refusal|1|||
125673712|NCT00622908|452093009|FG000|Overall Study|Termination by study sponser|0|||
125673713|NCT00622908|452093010|FG001|Overall Study|Termination by study sponser|1|||
125673714|NCT03937466|452093011|FG000|Overall Study|not eligbile after the 2-week diary|9|||
125673715|NCT03937466|452093011|FG000|Overall Study|never returned their diary|6|||
125673716|NCT03937466|452093011|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
125673717|NCT03937466|452093011|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
125673718|NCT00113490|452093012|FG000|Overall Study|Withdrawal by Subject|1|||
125673719|NCT00113490|452093013|FG001|Overall Study|Withdrawal by Subject|3|||
125673720|NCT00113490|452093012|FG000|Overall Study|Lost to Follow-up|1|||
125673721|NCT00113490|452093013|FG001|Overall Study|Lost to Follow-up|0|||
125673722|NCT02162758|452093014|FG000|Overall Study|Study termination|0|||
125673723|NCT02162758|452093015|FG001|Overall Study|Study termination|1|||
125673724|NCT04471935|452093016|FG000|Overall Study|Withdrawal by Subject|1|||
125673725|NCT04471935|452093016|FG000|Overall Study|Deemed ineligible to participate|1|||
125673726|NCT01659567|452093017|FG000|Overall Study|Lack of Efficacy|22|||
125673727|NCT01659567|452093017|FG000|Overall Study|Switched to Pegferon|6|||
125673728|NCT01659567|452093017|FG000|Overall Study|Adverse Event|12|||
125673729|NCT01659567|452093017|FG000|Overall Study|Good result at early stage of treatment|5|||
125673730|NCT01659567|452093017|FG000|Overall Study|Withdrawal by Subject|64|||
125673731|NCT01659567|452093017|FG000|Overall Study|Progression of the main disease|1|||
125673732|NCT01659567|452093017|FG000|Overall Study|Other|13|||
125673733|NCT03019965|452093018|FG000|Overall Study|Withdrawal by Subject|1|||
125339723|NCT00281658|450879834|FG002|Randomized Phase|Treatment ongoing|0|||
125339724|NCT00281658|450879835|FG003|Randomized Phase|Treatment ongoing|0|||
125339725|NCT00281658|450879832|FG000|Open Label Phase|Adverse Event|0|||
125339726|NCT00281658|450879833|FG001|Open Label Phase|Adverse Event|0|||
125339727|NCT00281658|450879834|FG002|Open Label Phase|Adverse Event|1|||
125339728|NCT00281658|450879835|FG003|Open Label Phase|Adverse Event|0|||
125339729|NCT00281658|450879832|FG000|Open Label Phase|Lost to Follow-up|0|||
125339730|NCT00281658|450879833|FG001|Open Label Phase|Lost to Follow-up|0|||
125339731|NCT00281658|450879834|FG002|Open Label Phase|Lost to Follow-up|16|||
125339732|NCT00281658|450879835|FG003|Open Label Phase|Lost to Follow-up|2|||
125339733|NCT00281658|450879832|FG000|Open Label Phase|Withdrawal by Subject|0|||
125339734|NCT00281658|450879833|FG001|Open Label Phase|Withdrawal by Subject|0|||
125339735|NCT00281658|450879834|FG002|Open Label Phase|Withdrawal by Subject|3|||
125339736|NCT00281658|450879835|FG003|Open Label Phase|Withdrawal by Subject|2|||
125339737|NCT00281658|450879832|FG000|Open Label Phase|Disease progression|0|||
125339738|NCT00281658|450879833|FG001|Open Label Phase|Disease progression|0|||
125339739|NCT00281658|450879834|FG002|Open Label Phase|Disease progression|18|||
125339740|NCT00281658|450879835|FG003|Open Label Phase|Disease progression|0|||
125339741|NCT00281658|450879832|FG000|Open Label Phase|Physician Decision|0|||
125339742|NCT00281658|450879833|FG001|Open Label Phase|Physician Decision|0|||
125339743|NCT00281658|450879834|FG002|Open Label Phase|Physician Decision|1|||
125339744|NCT00281658|450879835|FG003|Open Label Phase|Physician Decision|0|||
125339745|NCT00281658|450879832|FG000|Open Label Phase|Relocation of patient|0|||
125339746|NCT00281658|450879833|FG001|Open Label Phase|Relocation of patient|0|||
125339747|NCT00281658|450879834|FG002|Open Label Phase|Relocation of patient|1|||
125339748|NCT00281658|450879835|FG003|Open Label Phase|Relocation of patient|0|||
125339749|NCT00281658|450879832|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
125339750|NCT00281658|450879833|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
125339751|NCT00281658|450879834|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
125339752|NCT00281658|450879835|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
125339753|NCT01343693|450879836|FG000|Overall Study|Lost to Follow-up|9|||
125339754|NCT02704143|450879837|FG000|Overall Study|disease progression|10|||
125339755|NCT01235598|450879838|FG000|Overall Study|Adverse Event|0|||
125339756|NCT01235598|450879839|FG001|Overall Study|Adverse Event|3|||
125339757|NCT01235598|450879838|FG000|Overall Study|Lack of Efficacy|0|||
125339758|NCT01235598|450879839|FG001|Overall Study|Lack of Efficacy|1|||
125339759|NCT01235598|450879838|FG000|Overall Study|Withdrawal by Subject|1|||
125339760|NCT01235598|450879839|FG001|Overall Study|Withdrawal by Subject|0|||
125339761|NCT02151773|450879840|FG000|Overall Study|Protocol Deviation|64|||
125339762|NCT00395343|450879841|FG000|Overall Study|Adverse Event|13|||
125339763|NCT00395343|450879842|FG001|Overall Study|Adverse Event|5|||
125339764|NCT00395343|450879841|FG000|Overall Study|Lack of Efficacy|0|||
125673734|NCT03019965|452093019|FG001|Overall Study|Withdrawal by Subject|0|||
125673735|NCT03019965|452093018|FG000|Overall Study|Protocol Violation|1|||
125339765|NCT00395343|450879842|FG001|Overall Study|Lack of Efficacy|1|||
125339766|NCT00395343|450879841|FG000|Overall Study|Lost to Follow-up|4|||
125339767|NCT00395343|450879842|FG001|Overall Study|Lost to Follow-up|4|||
125339768|NCT00395343|450879841|FG000|Overall Study|Physician Decision|2|||
125339769|NCT00395343|450879842|FG001|Overall Study|Physician Decision|4|||
125540913|NCT01237587|451609478|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
125339770|NCT00395343|450879841|FG000|Overall Study|Protocol Violation|6|||
125339771|NCT00395343|450879842|FG001|Overall Study|Protocol Violation|8|||
125339772|NCT00395343|450879841|FG000|Overall Study|Withdrawal by Subject|11|||
125339773|NCT00395343|450879842|FG001|Overall Study|Withdrawal by Subject|12|||
125673736|NCT03019965|452093019|FG001|Overall Study|Protocol Violation|3|||
125339774|NCT00395343|450879841|FG000|Overall Study|Other|5|||
125339775|NCT00395343|450879842|FG001|Overall Study|Other|2|||
125339776|NCT01463007|450879843|FG000|Overall Study|Physician Decision|1|||
125339777|NCT00387790|450879845|FG000|Overall Study|Adverse Event|5|||
125339778|NCT00387790|450879845|FG000|Overall Study|Lack of Efficacy|2|||
125339779|NCT00387790|450879845|FG000|Overall Study|Physician Decision|2|||
125339780|NCT00387790|450879845|FG000|Overall Study|Withdrawal by Subject|3|||
125339781|NCT00387790|450879845|FG000|Overall Study|Ineligible for study|2|||
125339782|NCT00444678|450879846|FG000|Overall Study|Toxicity|11|||
125339783|NCT00444678|450879846|FG000|Overall Study|Disease Progression|12|||
125339784|NCT00444678|450879846|FG000|Overall Study|Death|3|||
125339785|NCT00444678|450879846|FG000|Overall Study|Physician Decision|3|||
125339786|NCT00444678|450879846|FG000|Overall Study|Withdrawal by Subject|2|||
125339787|NCT02779556|450879849|FG000|Baseline|Partial baseline interview completed|1|||
125339788|NCT02779556|450879850|FG001|Baseline|Partial baseline interview completed|0|||
125339789|NCT02779556|450879849|FG000|3 Months|Lost to Follow-up|40|||
125339790|NCT02779556|450879850|FG001|3 Months|Lost to Follow-up|29|||
125339791|NCT02779556|450879849|FG000|3 Months|Missed 3 month clinic visit|27|||
125339792|NCT02779556|450879850|FG001|3 Months|Missed 3 month clinic visit|19|||
125339793|NCT02779556|450879849|FG000|6 Month|Lost to Follow-up|33|||
125339794|NCT02779556|450879850|FG001|6 Month|Lost to Follow-up|39|||
125540914|NCT01237587|451609479|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
125673737|NCT03019965|452093018|FG000|Overall Study|viral or fungal infection|3|||
125673738|NCT03019965|452093019|FG001|Overall Study|viral or fungal infection|4|||
125673739|NCT03019965|452093018|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
125673740|NCT03019965|452093019|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
125673741|NCT03019965|452093018|FG000|Overall Study|Physician Decision|1|||
125673742|NCT03019965|452093019|FG001|Overall Study|Physician Decision|1|||
125673743|NCT03213210|452093020|FG000|Overall Study|Lost to Follow-up|2|||
125673744|NCT03213210|452093020|FG000|Overall Study|Study termination|3|||
125673745|NCT00708422|452093028|FG000|Overall Study|Adverse Event|3|||
125673746|NCT00708422|452093029|FG001|Overall Study|Adverse Event|1|||
125673747|NCT00708422|452093028|FG000|Overall Study|Withdrawal by Subject|1|||
125339795|NCT02779556|450879849|FG000|6 Month HbA1c|No value collected during window|69|||
125339796|NCT02779556|450879850|FG001|6 Month HbA1c|No value collected during window|50|||
125339797|NCT02779556|450879849|FG000|12 Month HbA1c|No value collected during window|138|||
125339798|NCT02779556|450879850|FG001|12 Month HbA1c|No value collected during window|102|||
125673748|NCT00708422|452093029|FG001|Overall Study|Withdrawal by Subject|0|||
125673749|NCT00299156|452093032|FG000|Period 2 (Randomized)|Screen Failure|0|||
125673750|NCT00299156|452093033|FG001|Period 2 (Randomized)|Screen Failure|1|||
125673751|NCT00299156|452093034|FG002|Period 2 (Randomized)|Screen Failure|0|||
125673752|NCT01166568|452093048|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
125673753|NCT01166568|452093049|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
125673754|NCT01166568|452093050|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
125673755|NCT01166568|452093048|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
125673756|NCT01166568|452093049|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
125673757|NCT01166568|452093050|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
125673758|NCT01166568|452093048|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
125673759|NCT01166568|452093049|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
125673760|NCT01166568|452093050|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
125673761|NCT01654380|452093051|FG000|Part B, Period 1|Physician Decision|0|||
125673762|NCT01654380|452093052|FG001|Part B, Period 1|Physician Decision|0|||
125673763|NCT01654380|452093053|FG002|Part B, Period 1|Physician Decision|1|||
125673764|NCT01654380|452093054|FG003|Part B, Period 1|Physician Decision|0|||
125673765|NCT03335371|452093055|FG000|Overall Study|Lost to Follow-up|0|||
125673766|NCT03335371|452093056|FG001|Overall Study|Lost to Follow-up|0|||
125673767|NCT03335371|452093057|FG002|Overall Study|Lost to Follow-up|0|||
125673768|NCT03335371|452093058|FG003|Overall Study|Lost to Follow-up|0|||
125673769|NCT03335371|452093059|FG004|Overall Study|Lost to Follow-up|1|||
125673770|NCT03335371|452093055|FG000|Overall Study|Withdrawal by Subject|0|||
125673771|NCT03335371|452093056|FG001|Overall Study|Withdrawal by Subject|0|||
125673772|NCT03335371|452093057|FG002|Overall Study|Withdrawal by Subject|0|||
125673773|NCT03335371|452093058|FG003|Overall Study|Withdrawal by Subject|0|||
125673774|NCT03335371|452093059|FG004|Overall Study|Withdrawal by Subject|1|||
125673775|NCT03335371|452093055|FG000|Overall Study|Randomization Error|0|||
125673776|NCT03335371|452093056|FG001|Overall Study|Randomization Error|0|||
125673777|NCT03335371|452093057|FG002|Overall Study|Randomization Error|1|||
125673778|NCT03335371|452093058|FG003|Overall Study|Randomization Error|0|||
125673779|NCT03335371|452093059|FG004|Overall Study|Randomization Error|0|||
125673780|NCT00684671|452093060|FG000|Overall Study|Adverse Event|1|||
125673781|NCT00684671|452093061|FG001|Overall Study|Adverse Event|0|||
125673782|NCT00684671|452093062|FG002|Overall Study|Adverse Event|0|||
125339799|NCT03110770|450879854|FG000|Overall Study|Death|1|||
125339800|NCT03110770|450879855|FG001|Overall Study|Death|0|||
125339801|NCT03110770|450879856|FG002|Overall Study|Death|0|||
125339802|NCT03110770|450879857|FG003|Overall Study|Death|1|||
125339803|NCT03110770|450879858|FG004|Overall Study|Death|0|||
125339804|NCT03110770|450879854|FG000|Overall Study|Enrolled but did not receive product|0|||
125339805|NCT03110770|450879855|FG001|Overall Study|Enrolled but did not receive product|0|||
125339806|NCT03110770|450879856|FG002|Overall Study|Enrolled but did not receive product|0|||
125673783|NCT00684671|452093060|FG000|Overall Study|Lost to Follow-up|1|||
125673784|NCT00684671|452093061|FG001|Overall Study|Lost to Follow-up|0|||
125673785|NCT00684671|452093062|FG002|Overall Study|Lost to Follow-up|0|||
125673786|NCT00684671|452093060|FG000|Overall Study|Alcoholic dependance|1|||
125673787|NCT00684671|452093061|FG001|Overall Study|Alcoholic dependance|0|||
125673788|NCT00684671|452093062|FG002|Overall Study|Alcoholic dependance|0|||
125673789|NCT01725451|452093064|FG000|Period 1|Withdrawal by Subject|1|||
125673790|NCT01725451|452093065|FG001|Period 1|Withdrawal by Subject|0|||
125673791|NCT01725451|452093066|FG002|Period 1|Withdrawal by Subject|0|||
125673792|NCT01725451|452093067|FG003|Period 1|Withdrawal by Subject|0|||
125673793|NCT01725451|452093064|FG000|Washout From Period 3|Protocol Violation|0|||
125673794|NCT01725451|452093065|FG001|Washout From Period 3|Protocol Violation|0|||
125673795|NCT01725451|452093066|FG002|Washout From Period 3|Protocol Violation|1|||
125339807|NCT03110770|450879857|FG003|Overall Study|Enrolled but did not receive product|8|||
125339808|NCT03110770|450879858|FG004|Overall Study|Enrolled but did not receive product|7|||
125673796|NCT01725451|452093067|FG003|Washout From Period 3|Protocol Violation|0|||
125339809|NCT03110770|450879854|FG000|Overall Study|Lost to Follow-up|0|||
125339810|NCT03110770|450879855|FG001|Overall Study|Lost to Follow-up|0|||
125339811|NCT03110770|450879856|FG002|Overall Study|Lost to Follow-up|0|||
125339812|NCT03110770|450879857|FG003|Overall Study|Lost to Follow-up|53|||
125339813|NCT03110770|450879858|FG004|Overall Study|Lost to Follow-up|45|||
125339814|NCT03110770|450879854|FG000|Overall Study|Investigator Decision|0|||
125339815|NCT03110770|450879855|FG001|Overall Study|Investigator Decision|0|||
125339816|NCT03110770|450879856|FG002|Overall Study|Investigator Decision|0|||
125339817|NCT03110770|450879857|FG003|Overall Study|Investigator Decision|5|||
125339818|NCT03110770|450879858|FG004|Overall Study|Investigator Decision|3|||
125339819|NCT03110770|450879854|FG000|Overall Study|Withdrawal by Subject|0|||
125339820|NCT03110770|450879855|FG001|Overall Study|Withdrawal by Subject|0|||
125339821|NCT03110770|450879856|FG002|Overall Study|Withdrawal by Subject|0|||
125339822|NCT03110770|450879857|FG003|Overall Study|Withdrawal by Subject|24|||
125339823|NCT03110770|450879858|FG004|Overall Study|Withdrawal by Subject|24|||
125339824|NCT03110770|450879854|FG000|Overall Study|Moved from area|5|||
125339825|NCT03110770|450879855|FG001|Overall Study|Moved from area|0|||
125339826|NCT03110770|450879856|FG002|Overall Study|Moved from area|2|||
125339827|NCT03110770|450879857|FG003|Overall Study|Moved from area|42|||
125339828|NCT03110770|450879858|FG004|Overall Study|Moved from area|43|||
125339829|NCT03110770|450879854|FG000|Overall Study|Illness/Injury unrelated to product|0|||
125339830|NCT03110770|450879855|FG001|Overall Study|Illness/Injury unrelated to product|0|||
125339831|NCT03110770|450879856|FG002|Overall Study|Illness/Injury unrelated to product|0|||
125339832|NCT03110770|450879857|FG003|Overall Study|Illness/Injury unrelated to product|0|||
125339833|NCT03110770|450879858|FG004|Overall Study|Illness/Injury unrelated to product|1|||
125339834|NCT02082340|450879866|FG000|Overall Study|Lost to Follow-up|1|||
125339835|NCT02082340|450879867|FG001|Overall Study|Lost to Follow-up|1|||
125339836|NCT01625260|450879868|FG000|Overall Study|Adverse Event|3|||
125339837|NCT01625260|450879869|FG001|Overall Study|Adverse Event|0|||
125339838|NCT01625260|450879868|FG000|Overall Study|Study Terminated by Investigator|2|||
125339839|NCT01625260|450879869|FG001|Overall Study|Study Terminated by Investigator|0|||
125339840|NCT01625260|450879868|FG000|Overall Study|Disease Progression|2|||
125339841|NCT01625260|450879869|FG001|Overall Study|Disease Progression|0|||
125339842|NCT01625260|450879868|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
125339843|NCT01625260|450879869|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
125339844|NCT02937584|450879870|FG000|Period 1|Adverse Event|1|||
125339845|NCT02937584|450879871|FG001|Period 1|Adverse Event|2|||
125339846|NCT02937584|450879870|FG000|Washout|Adverse Event|0|||
125339847|NCT02937584|450879871|FG001|Washout|Adverse Event|1|||
125339848|NCT00635219|450879872|FG000|Overall Study|Adverse Event|12|||
125339849|NCT00635219|450879873|FG001|Overall Study|Adverse Event|10|||
125339850|NCT00635219|450879874|FG002|Overall Study|Adverse Event|18|||
125540915|NCT01237587|451609478|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
125339851|NCT00635219|450879875|FG003|Overall Study|Adverse Event|15|||
125339852|NCT00635219|450879876|FG004|Overall Study|Adverse Event|19|||
125339853|NCT00635219|450879872|FG000|Overall Study|Lack of Efficacy|5|||
125339854|NCT00635219|450879873|FG001|Overall Study|Lack of Efficacy|6|||
125339855|NCT00635219|450879874|FG002|Overall Study|Lack of Efficacy|3|||
125339856|NCT00635219|450879875|FG003|Overall Study|Lack of Efficacy|4|||
125339857|NCT00635219|450879876|FG004|Overall Study|Lack of Efficacy|6|||
125339858|NCT00635219|450879872|FG000|Overall Study|Non-compliance With Study Product|0|||
125339859|NCT00635219|450879873|FG001|Overall Study|Non-compliance With Study Product|0|||
125339860|NCT00635219|450879874|FG002|Overall Study|Non-compliance With Study Product|0|||
125339861|NCT00635219|450879875|FG003|Overall Study|Non-compliance With Study Product|2|||
125339862|NCT00635219|450879876|FG004|Overall Study|Non-compliance With Study Product|1|||
125339863|NCT00635219|450879872|FG000|Overall Study|Protocol Violation|0|||
125339864|NCT00635219|450879873|FG001|Overall Study|Protocol Violation|2|||
125339865|NCT00635219|450879874|FG002|Overall Study|Protocol Violation|3|||
125339866|NCT00635219|450879875|FG003|Overall Study|Protocol Violation|2|||
125339867|NCT00635219|450879876|FG004|Overall Study|Protocol Violation|4|||
125339868|NCT00635219|450879872|FG000|Overall Study|Withdrawal of Consent|8|||
125339869|NCT00635219|450879873|FG001|Overall Study|Withdrawal of Consent|6|||
125339870|NCT00635219|450879874|FG002|Overall Study|Withdrawal of Consent|8|||
125339871|NCT00635219|450879875|FG003|Overall Study|Withdrawal of Consent|11|||
125339872|NCT00635219|450879876|FG004|Overall Study|Withdrawal of Consent|8|||
125339873|NCT00635219|450879872|FG000|Overall Study|Lost to Follow-up|0|||
125339874|NCT00635219|450879873|FG001|Overall Study|Lost to Follow-up|0|||
125339875|NCT00635219|450879874|FG002|Overall Study|Lost to Follow-up|2|||
125673797|NCT01725451|452093064|FG000|Washout From Period 3|Adverse Event|0|||
125673798|NCT01725451|452093065|FG001|Washout From Period 3|Adverse Event|1|||
125673799|NCT01725451|452093066|FG002|Washout From Period 3|Adverse Event|0|||
125673800|NCT01725451|452093067|FG003|Washout From Period 3|Adverse Event|0|||
125673801|NCT01725451|452093064|FG000|Period 4|Adverse Event|0|||
125673802|NCT01725451|452093065|FG001|Period 4|Adverse Event|0|||
125673803|NCT01725451|452093066|FG002|Period 4|Adverse Event|1|||
125673804|NCT01725451|452093067|FG003|Period 4|Adverse Event|0|||
125673805|NCT00437281|452093068|FG000|Overall Study|Adverse Event|0|||
125673806|NCT00437281|452093069|FG001|Overall Study|Adverse Event|0|||
125673807|NCT00437281|452093070|FG002|Overall Study|Adverse Event|0|||
125673808|NCT00437281|452093071|FG003|Overall Study|Adverse Event|1|||
125673809|NCT00437281|452093072|FG004|Overall Study|Adverse Event|0|||
125673810|NCT00437281|452093073|FG005|Overall Study|Adverse Event|1|||
125673811|NCT00437281|452093074|FG006|Overall Study|Adverse Event|0|||
125673812|NCT00437281|452093075|FG007|Overall Study|Adverse Event|0|||
125673813|NCT00437281|452093076|FG008|Overall Study|Adverse Event|0|||
125673814|NCT00437281|452093077|FG009|Overall Study|Adverse Event|1|||
125673815|NCT00437281|452093078|FG010|Overall Study|Adverse Event|0|||
125673816|NCT00437281|452093079|FG011|Overall Study|Adverse Event|0|||
125673817|NCT00437281|452093080|FG012|Overall Study|Adverse Event|0|||
125673818|NCT00437281|452093081|FG013|Overall Study|Adverse Event|1|||
125673819|NCT00437281|452093082|FG014|Overall Study|Adverse Event|1|||
125673820|NCT00437281|452093083|FG015|Overall Study|Adverse Event|0|||
125673821|NCT00437281|452093084|FG016|Overall Study|Adverse Event|0|||
125673822|NCT00437281|452093085|FG017|Overall Study|Adverse Event|0|||
125673823|NCT00437281|452093086|FG018|Overall Study|Adverse Event|1|||
125673824|NCT00437281|452093087|FG019|Overall Study|Adverse Event|0|||
125673825|NCT00437281|452093068|FG000|Overall Study|Lost to Follow-up|0|||
125673826|NCT00437281|452093069|FG001|Overall Study|Lost to Follow-up|0|||
125673827|NCT00437281|452093070|FG002|Overall Study|Lost to Follow-up|0|||
125673828|NCT00437281|452093071|FG003|Overall Study|Lost to Follow-up|0|||
125673829|NCT00437281|452093072|FG004|Overall Study|Lost to Follow-up|0|||
125673830|NCT00437281|452093073|FG005|Overall Study|Lost to Follow-up|0|||
125673831|NCT00437281|452093074|FG006|Overall Study|Lost to Follow-up|0|||
125673832|NCT00437281|452093075|FG007|Overall Study|Lost to Follow-up|0|||
125673833|NCT00437281|452093076|FG008|Overall Study|Lost to Follow-up|0|||
125673834|NCT00437281|452093077|FG009|Overall Study|Lost to Follow-up|0|||
125673835|NCT00437281|452093078|FG010|Overall Study|Lost to Follow-up|0|||
125673836|NCT00437281|452093079|FG011|Overall Study|Lost to Follow-up|0|||
125673837|NCT00437281|452093080|FG012|Overall Study|Lost to Follow-up|0|||
125673838|NCT00437281|452093081|FG013|Overall Study|Lost to Follow-up|0|||
125673839|NCT00437281|452093082|FG014|Overall Study|Lost to Follow-up|0|||
125673840|NCT00437281|452093083|FG015|Overall Study|Lost to Follow-up|0|||
125673841|NCT00437281|452093084|FG016|Overall Study|Lost to Follow-up|0|||
125673842|NCT00437281|452093085|FG017|Overall Study|Lost to Follow-up|0|||
125673843|NCT00437281|452093086|FG018|Overall Study|Lost to Follow-up|0|||
125673844|NCT00437281|452093087|FG019|Overall Study|Lost to Follow-up|1|||
125673845|NCT00601354|452093088|FG000|Overall Study|Lost to Follow-up|4|||
125673846|NCT00601354|452093089|FG001|Overall Study|Lost to Follow-up|5|||
125673847|NCT01656889|452093091|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
125673848|NCT01656889|452093092|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
125673849|NCT01656889|452093091|FG000|Treatment Period, 12 Weeks|Death|0|||
125673850|NCT01656889|452093092|FG001|Treatment Period, 12 Weeks|Death|1|||
125673851|NCT01656889|452093091|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
125673852|NCT01656889|452093092|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
125673853|NCT01656889|452093091|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
125673854|NCT01656889|452093092|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
125673855|NCT01656889|452093091|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
125339876|NCT00635219|450879875|FG003|Overall Study|Lost to Follow-up|0|||
125339877|NCT00635219|450879876|FG004|Overall Study|Lost to Follow-up|3|||
125339878|NCT00635219|450879872|FG000|Overall Study|Administrative or Other Reasons|0|||
125673856|NCT01656889|452093092|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
125339879|NCT00635219|450879873|FG001|Overall Study|Administrative or Other Reasons|1|||
125339880|NCT00635219|450879874|FG002|Overall Study|Administrative or Other Reasons|1|||
125339881|NCT00635219|450879875|FG003|Overall Study|Administrative or Other Reasons|0|||
125339882|NCT00635219|450879876|FG004|Overall Study|Administrative or Other Reasons|1|||
125339883|NCT01598129|450879885|FG000|Overall Study|Disease progression|6|||
125339884|NCT01598129|450879885|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
125339885|NCT01598129|450879885|FG000|Overall Study|Withdrawal by Subject|1|||
125339886|NCT00591318|450879886|FG000|Overall Study|Lack of Efficacy|2|||
125339887|NCT00591318|450879887|FG001|Overall Study|Lack of Efficacy|0|||
125339888|NCT00591318|450879886|FG000|Overall Study|Adverse Event|2|||
125339889|NCT00591318|450879887|FG001|Overall Study|Adverse Event|0|||
125339890|NCT04074161|450879890|FG000|Overall Study|Withdrawal by Subject|2|||
125339891|NCT04074161|450879891|FG001|Overall Study|Withdrawal by Subject|4|||
125339892|NCT04074161|450879892|FG002|Overall Study|Withdrawal by Subject|1|||
125339893|NCT04074161|450879890|FG000|Overall Study|Lost to Follow-up|4|||
125339894|NCT04074161|450879891|FG001|Overall Study|Lost to Follow-up|5|||
125339895|NCT04074161|450879892|FG002|Overall Study|Lost to Follow-up|3|||
125339896|NCT03890666|450879897|FG000|Overall Study|Withdrawal by Subject|0|||
125339897|NCT03890666|450879898|FG001|Overall Study|Withdrawal by Subject|1|||
125339898|NCT03890666|450879897|FG000|Overall Study|Protocol deviation|1|||
125339899|NCT03890666|450879898|FG001|Overall Study|Protocol deviation|4|||
125339900|NCT03890666|450879897|FG000|Overall Study|Lost to Follow-up|2|||
125339901|NCT03890666|450879898|FG001|Overall Study|Lost to Follow-up|5|||
125339902|NCT03890666|450879897|FG000|Overall Study|Other than specified|1|||
125339903|NCT03890666|450879898|FG001|Overall Study|Other than specified|8|||
125339904|NCT01639729|450879899|FG000|Overall Study|Withdrawal by Subject|1|||
125339905|NCT01639729|450879900|FG001|Overall Study|Withdrawal by Subject|0|||
125339906|NCT01639729|450879901|FG002|Overall Study|Withdrawal by Subject|1|||
125339907|NCT01639729|450879902|FG003|Overall Study|Withdrawal by Subject|1|||
125339908|NCT01639729|450879903|FG004|Overall Study|Withdrawal by Subject|0|||
125339909|NCT01639729|450879904|FG005|Overall Study|Withdrawal by Subject|0|||
125339910|NCT03052426|450879905|FG000|Overall Study|Withdrawal by Subject|0|||
125339911|NCT03052426|450879906|FG001|Overall Study|Withdrawal by Subject|1|||
125339912|NCT03052426|450879907|FG002|Overall Study|Withdrawal by Subject|0|||
125339913|NCT03052426|450879905|FG000|Overall Study|Lost to Follow-up|2|||
125339914|NCT03052426|450879906|FG001|Overall Study|Lost to Follow-up|0|||
125339915|NCT03052426|450879907|FG002|Overall Study|Lost to Follow-up|1|||
125339916|NCT03083990|450879910|FG000|Overall Study|Adverse Event|1|||
125339917|NCT03083990|450879911|FG001|Overall Study|Adverse Event|0|||
125339918|NCT03672097|450879912|FG000|Period 1|Withdrawal by Subject|2|||
125339919|NCT03672097|450879912|FG000|Period 1|Adverse Event|1|||
125339920|NCT03672097|450879912|FG000|Period 1|Did not receive treatment|1|||
125339921|NCT03672097|450879912|FG000|Period 2|Withdrawal by Subject|3|||
125339922|NCT03672097|450879912|FG000|Period 2|Other|1|||
125339923|NCT01781299|450879913|FG000|Overall Study|Withdrawal by Subject|0|||
125339924|NCT01781299|450879914|FG001|Overall Study|Withdrawal by Subject|1|||
125339925|NCT00146848|450879915|FG000|Pre-randomization|Death|19|||
125339926|NCT00146848|450879916|FG001|Pre-randomization|Death|0|||
125339927|NCT00146848|450879917|FG002|Pre-randomization|Death|0|||
125339928|NCT00146848|450879915|FG000|Pre-randomization|Lost to Follow-up|70|||
125339929|NCT00146848|450879916|FG001|Pre-randomization|Lost to Follow-up|0|||
125339930|NCT00146848|450879917|FG002|Pre-randomization|Lost to Follow-up|0|||
125339931|NCT00146848|450879915|FG000|Pre-randomization|Physician Decision|8|||
125339932|NCT00146848|450879916|FG001|Pre-randomization|Physician Decision|0|||
125339933|NCT00146848|450879917|FG002|Pre-randomization|Physician Decision|0|||
125339934|NCT00146848|450879915|FG000|Pre-randomization|Protocol Violation|172|||
125339935|NCT00146848|450879916|FG001|Pre-randomization|Protocol Violation|0|||
125339936|NCT00146848|450879917|FG002|Pre-randomization|Protocol Violation|0|||
125339937|NCT00146848|450879915|FG000|Pre-randomization|Withdrawal by Subject|40|||
125339938|NCT00146848|450879916|FG001|Pre-randomization|Withdrawal by Subject|0|||
125339939|NCT00146848|450879917|FG002|Pre-randomization|Withdrawal by Subject|0|||
125339940|NCT00146848|450879915|FG000|Post-randomization|Lost to Follow-up|12|||
125339941|NCT00146848|450879916|FG001|Post-randomization|Lost to Follow-up|15|||
125339942|NCT00146848|450879917|FG002|Post-randomization|Lost to Follow-up|12|||
125339943|NCT00146848|450879915|FG000|Post-randomization|Withdrawn|26|||
125339944|NCT00146848|450879916|FG001|Post-randomization|Withdrawn|32|||
125339945|NCT00146848|450879917|FG002|Post-randomization|Withdrawn|27|||
125339946|NCT01798849|450879918|FG000|Overall Study|Physician Decision|0|||
125339947|NCT01798849|450879919|FG001|Overall Study|Physician Decision|0|||
125339948|NCT01798849|450879920|FG002|Overall Study|Physician Decision|1|||
125339949|NCT02636361|450879921|FG000|Period 4|Physician Decision|0|||
125339950|NCT02636361|450879922|FG001|Period 4|Physician Decision|0|||
125339951|NCT02636361|450879923|FG002|Period 4|Physician Decision|0|||
125339952|NCT02636361|450879924|FG003|Period 4|Physician Decision|1|||
125339953|NCT02636361|450879925|FG004|Period 4|Physician Decision|0|||
125339954|NCT02032238|450879926|FG000|Overall Study|Lost to Follow-up|2|||
125339955|NCT02032238|450879927|FG001|Overall Study|Lost to Follow-up|0|||
125339956|NCT00119678|450879928|FG000|Double-blind Treatment Period|Death|1|||
125339957|NCT00119678|450879929|FG001|Double-blind Treatment Period|Death|0|||
125339958|NCT00119678|450879928|FG000|Double-blind Treatment Period|Adverse Event|7|||
125339959|NCT00119678|450879929|FG001|Double-blind Treatment Period|Adverse Event|1|||
125339960|NCT00119678|450879928|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
125339961|NCT00119678|450879929|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
125339962|NCT00119678|450879928|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
125339963|NCT00119678|450879929|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
125339964|NCT00119678|450879928|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
125339965|NCT00119678|450879929|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
125339966|NCT00119678|450879928|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
125339967|NCT00119678|450879929|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
125339968|NCT00119678|450879928|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
125339969|NCT00119678|450879929|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
125339970|NCT00119678|450879928|FG000|Double-blind Treatment Period|Pregnancy|0|||
125339971|NCT00119678|450879929|FG001|Double-blind Treatment Period|Pregnancy|2|||
125339972|NCT00119678|450879928|FG000|Double-blind Treatment Period|Not treated|1|||
125339973|NCT00119678|450879929|FG001|Double-blind Treatment Period|Not treated|2|||
125339974|NCT00119678|450879928|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
125339975|NCT00119678|450879929|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
125339976|NCT00119678|450879928|FG000|Open-label Treatment Period|Death|1|||
125339977|NCT00119678|450879929|FG001|Open-label Treatment Period|Death|0|||
125339978|NCT00119678|450879928|FG000|Open-label Treatment Period|Adverse Event|3|||
125339979|NCT00119678|450879929|FG001|Open-label Treatment Period|Adverse Event|0|||
125339980|NCT00119678|450879928|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
125339981|NCT00119678|450879929|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
125339982|NCT00119678|450879928|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
125339983|NCT00119678|450879929|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
125339984|NCT00119678|450879928|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
125339985|NCT00119678|450879929|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
125339986|NCT00119678|450879928|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
125339987|NCT00119678|450879929|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
125339988|NCT00119678|450879928|FG000|Open-label Treatment Period|Pregnancy|1|||
125339989|NCT00119678|450879929|FG001|Open-label Treatment Period|Pregnancy|0|||
125339990|NCT00119678|450879928|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
125339991|NCT00119678|450879929|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
125339992|NCT02720042|450879937|FG000|Overall Study|Death|3|||
125339993|NCT02720042|450879937|FG000|Overall Study|Lost to Follow-up|4|||
125339994|NCT02720042|450879937|FG000|Overall Study|Withdrawal by Subject|1|||
125339995|NCT02720042|450879937|FG000|Overall Study|Physician Decision|3|||
125339996|NCT02720042|450879937|FG000|Overall Study|Phasix Mesh explanted|1|||
125339997|NCT02720042|450879937|FG000|Overall Study|unable due to non-study-related illness|3|||
125339998|NCT01761240|450879938|FG000|Overall Study|Progressive disease:radiology assessment|3|||
125339999|NCT01761240|450879939|FG001|Overall Study|Progressive disease:radiology assessment|3|||
125673857|NCT01656889|452093091|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
125673858|NCT01656889|452093092|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
125673859|NCT01656889|452093091|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
125340000|NCT01761240|450879940|FG002|Overall Study|Progressive disease:radiology assessment|0|||
125340001|NCT01761240|450879941|FG003|Overall Study|Progressive disease:radiology assessment|0|||
125673860|NCT01656889|452093092|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
125340002|NCT01761240|450879942|FG004|Overall Study|Progressive disease:radiology assessment|0|||
125340003|NCT01761240|450879938|FG000|Overall Study|Progressive disease:clinical assessment|0|||
125340004|NCT01761240|450879939|FG001|Overall Study|Progressive disease:clinical assessment|0|||
125340005|NCT01761240|450879940|FG002|Overall Study|Progressive disease:clinical assessment|3|||
125340006|NCT01761240|450879941|FG003|Overall Study|Progressive disease:clinical assessment|1|||
125340007|NCT01761240|450879942|FG004|Overall Study|Progressive disease:clinical assessment|0|||
125340008|NCT01761240|450879938|FG000|Overall Study|Withdrawal by Subject|0|||
125340009|NCT01761240|450879939|FG001|Overall Study|Withdrawal by Subject|0|||
125340010|NCT01761240|450879940|FG002|Overall Study|Withdrawal by Subject|0|||
125340011|NCT01761240|450879941|FG003|Overall Study|Withdrawal by Subject|3|||
125340012|NCT01761240|450879942|FG004|Overall Study|Withdrawal by Subject|1|||
125340013|NCT01761240|450879938|FG000|Overall Study|Adverse Event|0|||
125340014|NCT01761240|450879939|FG001|Overall Study|Adverse Event|0|||
125340015|NCT01761240|450879940|FG002|Overall Study|Adverse Event|0|||
125340016|NCT01761240|450879941|FG003|Overall Study|Adverse Event|1|||
125340017|NCT01761240|450879942|FG004|Overall Study|Adverse Event|6|||
125340018|NCT01761240|450879938|FG000|Overall Study|Death|0|||
125340019|NCT01761240|450879939|FG001|Overall Study|Death|1|||
125340020|NCT01761240|450879940|FG002|Overall Study|Death|1|||
125340021|NCT01761240|450879941|FG003|Overall Study|Death|2|||
125340022|NCT01761240|450879942|FG004|Overall Study|Death|1|||
125340023|NCT01761240|450879938|FG000|Overall Study|Non-compliance|0|||
125340024|NCT01761240|450879939|FG001|Overall Study|Non-compliance|0|||
125340025|NCT01761240|450879940|FG002|Overall Study|Non-compliance|1|||
125340026|NCT01761240|450879941|FG003|Overall Study|Non-compliance|0|||
125340027|NCT01761240|450879942|FG004|Overall Study|Non-compliance|0|||
125340028|NCT03158285|450879949|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
125340029|NCT03158285|450879950|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
125340030|NCT03158285|450879951|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
125340031|NCT03158285|450879949|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
125340032|NCT03158285|450879950|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
125340033|NCT03158285|450879951|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
125340034|NCT03158285|450879949|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
125340035|NCT03158285|450879950|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
125340036|NCT03158285|450879951|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
125340037|NCT03158285|450879949|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
125340038|NCT03158285|450879950|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
125340039|NCT03158285|450879951|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
125340040|NCT03158285|450879949|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
125340041|NCT03158285|450879950|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
125340042|NCT03158285|450879951|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
125340043|NCT03158285|450879949|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
125340044|NCT03158285|450879950|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
125340045|NCT03158285|450879951|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
125340046|NCT03158285|450879949|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
125340047|NCT03158285|450879950|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
125340048|NCT03158285|450879951|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
125340049|NCT03158285|450879949|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
125340050|NCT03158285|450879950|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
125340051|NCT03158285|450879951|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
125340052|NCT03158285|450879949|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
125340053|NCT03158285|450879950|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
125340054|NCT03158285|450879951|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
125340055|NCT03158285|450879949|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
125340056|NCT03158285|450879950|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
125340057|NCT03158285|450879951|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
125340058|NCT03158285|450879949|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
125340059|NCT03158285|450879950|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
125340060|NCT03158285|450879951|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
125340061|NCT03158285|450879949|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
125340062|NCT03158285|450879950|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
125340063|NCT03158285|450879951|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
125340064|NCT03158285|450879949|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
125340065|NCT03158285|450879950|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
125340066|NCT03158285|450879951|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
125340067|NCT03158285|450879949|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
125340068|NCT03158285|450879950|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
125340069|NCT03158285|450879951|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
125340070|NCT03158285|450879949|FG000|Active Treatment Period: Week 52-100|Death|1|||
125340071|NCT03158285|450879950|FG001|Active Treatment Period: Week 52-100|Death|0|||
125340072|NCT03158285|450879951|FG002|Active Treatment Period: Week 52-100|Death|0|||
125340073|NCT03158285|450879949|FG000|Active Treatment Period: Week 52-100|Other|4|||
125340074|NCT03158285|450879950|FG001|Active Treatment Period: Week 52-100|Other|1|||
125340075|NCT03158285|450879951|FG002|Active Treatment Period: Week 52-100|Other|0|||
125340076|NCT01516034|450879954|FG000|Overall Study|Physician Decision|1|||
125340077|NCT01516034|450879954|FG000|Overall Study|Lack of Efficacy|7|||
125340078|NCT02228980|450879955|FG000|Overall Study|Adverse Event|14|||
125340079|NCT02228980|450879956|FG001|Overall Study|Adverse Event|0|||
125340080|NCT02228980|450879957|FG002|Overall Study|Adverse Event|0|||
125340081|NCT02228980|450879958|FG003|Overall Study|Adverse Event|0|||
125340082|NCT02228980|450879955|FG000|Overall Study|Protocol Violation|7|||
125340083|NCT02228980|450879956|FG001|Overall Study|Protocol Violation|0|||
125340084|NCT02228980|450879957|FG002|Overall Study|Protocol Violation|0|||
125340085|NCT02228980|450879958|FG003|Overall Study|Protocol Violation|0|||
125340086|NCT02228980|450879955|FG000|Overall Study|Withdrawal by Subject|3|||
125340087|NCT02228980|450879956|FG001|Overall Study|Withdrawal by Subject|3|||
125340088|NCT02228980|450879957|FG002|Overall Study|Withdrawal by Subject|2|||
125340089|NCT02228980|450879958|FG003|Overall Study|Withdrawal by Subject|3|||
125340090|NCT03060551|450879959|FG000|Overall Study|Withdrawal by Subject|1|||
125340091|NCT03060551|450879959|FG000|Overall Study|Adverse Event|1|||
125340092|NCT01642615|450879962|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
125340093|NCT01642615|450879963|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
125340094|NCT01642615|450879964|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
125340095|NCT01642615|450879962|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
125340096|NCT01642615|450879963|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
125340097|NCT01642615|450879964|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
125340098|NCT01642615|450879962|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
125340099|NCT01642615|450879963|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
125340100|NCT01642615|450879964|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
125340101|NCT01642615|450879962|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
125340102|NCT01642615|450879963|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
125340103|NCT01642615|450879964|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
125340104|NCT01642615|450879962|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
125340105|NCT01642615|450879963|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
125340106|NCT01642615|450879964|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
125340107|NCT01642615|450879962|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
125340108|NCT01642615|450879963|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
125340109|NCT01642615|450879964|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
125340110|NCT01642615|450879962|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
125340111|NCT01642615|450879963|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
125340112|NCT01642615|450879964|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
125340113|NCT01642615|450879962|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
125340114|NCT01642615|450879963|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
125340115|NCT01642615|450879964|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
125340116|NCT01642615|450879962|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
125340117|NCT01642615|450879963|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
125340118|NCT01642615|450879964|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
125340119|NCT01699867|450879965|FG000|Overall Study|Screening Failure|3|||
125340120|NCT04002908|450879968|FG000|Overall Study|Death|41|||
125340121|NCT04002908|450879969|FG001|Overall Study|Death|0|||
125340122|NCT04002908|450879970|FG002|Overall Study|Death|0|||
125340123|NCT04002908|450879971|FG003|Overall Study|Death|0|||
125340124|NCT04002908|450879968|FG000|Overall Study|Withdrawal by Subject|112|||
125340125|NCT04002908|450879969|FG001|Overall Study|Withdrawal by Subject|0|||
125340126|NCT04002908|450879970|FG002|Overall Study|Withdrawal by Subject|0|||
125340127|NCT04002908|450879971|FG003|Overall Study|Withdrawal by Subject|0|||
125340128|NCT04002908|450879968|FG000|Overall Study|Lost to Follow-up|72|||
125340129|NCT04002908|450879969|FG001|Overall Study|Lost to Follow-up|0|||
125340130|NCT04002908|450879970|FG002|Overall Study|Lost to Follow-up|0|||
125340131|NCT04002908|450879971|FG003|Overall Study|Lost to Follow-up|0|||
125340132|NCT04002908|450879968|FG000|Overall Study|Infant died, so mother withdrawn|34|||
125340133|NCT04002908|450879969|FG001|Overall Study|Infant died, so mother withdrawn|0|||
125340134|NCT04002908|450879970|FG002|Overall Study|Infant died, so mother withdrawn|0|||
125340135|NCT04002908|450879971|FG003|Overall Study|Infant died, so mother withdrawn|0|||
125340136|NCT00006289|450879974|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
125340137|NCT00006289|450879975|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
125340138|NCT00006289|450879974|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
125340139|NCT00006289|450879975|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
125378908|NCT00589914|451019207|FG001|Overall Study|Adverse Event|10|||
125340140|NCT04359901|450879985|FG000|Overall Study|Withdrawal by Subject|0|||
125340141|NCT04359901|450879986|FG001|Overall Study|Withdrawal by Subject|1|||
125340142|NCT04359901|450879985|FG000|Overall Study|Death|6|||
125340143|NCT04359901|450879986|FG001|Overall Study|Death|2|||
125340144|NCT01888432|450881238|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
125340145|NCT01888432|450881239|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
125340146|NCT01888432|450881238|FG000|12-month Analysis (FAS)|Physician Decision|1|||
125340147|NCT01888432|450881239|FG001|12-month Analysis (FAS)|Physician Decision|1|||
125340148|NCT01888432|450881238|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
125340149|NCT01888432|450881239|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
125340150|NCT01888432|450881238|FG000|12-month Analysis (FAS)|Death|4|||
125340151|NCT01888432|450881239|FG001|12-month Analysis (FAS)|Death|3|||
125340152|NCT01888432|450881238|FG000|24-month Analysis (FAS)|Graft loss|0|||
125340153|NCT01888432|450881239|FG001|24-month Analysis (FAS)|Graft loss|1|||
125340154|NCT01888432|450881238|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
125340155|NCT01888432|450881239|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
125340156|NCT01888432|450881238|FG000|24-month Analysis (FAS)|Physician Decision|2|||
125340157|NCT01888432|450881239|FG001|24-month Analysis (FAS)|Physician Decision|4|||
125340158|NCT01888432|450881238|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
125340159|NCT01888432|450881239|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
125340160|NCT01888432|450881238|FG000|24-month Analysis (FAS)|Death|8|||
125340161|NCT01888432|450881239|FG001|24-month Analysis (FAS)|Death|4|||
125340162|NCT01888432|450881238|FG000|36-month Analysis (Extension)|Death|1|||
125340163|NCT01888432|450881239|FG001|36-month Analysis (Extension)|Death|0|||
125340164|NCT00130247|450881242|FG000|Overall Study|Pregnancy|1|||
125340165|NCT00130247|450881243|FG001|Overall Study|Pregnancy|0|||
125340166|NCT00130247|450881242|FG000|Overall Study|Post-randomization exclusion|1|||
125340167|NCT00130247|450881243|FG001|Overall Study|Post-randomization exclusion|2|||
125340168|NCT00130247|450881242|FG000|Overall Study|Not compliant with DOT|0|||
125340169|NCT00130247|450881243|FG001|Overall Study|Not compliant with DOT|2|||
125340170|NCT02848729|450881244|FG000|Overall Study|Withdrawal by Subject|1|||
125340171|NCT02848729|450881245|FG001|Overall Study|Withdrawal by Subject|0|||
125340172|NCT02848729|450881244|FG000|Overall Study|Emesis|15|||
125340173|NCT02848729|450881245|FG001|Overall Study|Emesis|11|||
125340174|NCT01904773|450881246|FG000|Screen|Screen failure|3|||
125340175|NCT01904773|450881247|FG001|Screen|Screen failure|0|||
125340176|NCT01904773|450881248|FG002|Screen|Screen failure|0|||
125340177|NCT01904773|450881249|FG003|Screen|Screen failure|0|||
125340178|NCT01904773|450881250|FG004|Screen|Screen failure|0|||
125340179|NCT01904773|450881251|FG005|Screen|Screen failure|0|||
125340180|NCT01904773|450881252|FG006|Screen|Screen failure|0|||
125340181|NCT01904773|450881253|FG007|Screen|Screen failure|0|||
125340182|NCT01904773|450881254|FG008|Screen|Screen failure|0|||
125340183|NCT01904773|450881246|FG000|Screen|Withdrawal by Subject|1|||
125340184|NCT01904773|450881247|FG001|Screen|Withdrawal by Subject|0|||
125340185|NCT01904773|450881248|FG002|Screen|Withdrawal by Subject|0|||
125340186|NCT01904773|450881249|FG003|Screen|Withdrawal by Subject|0|||
125340187|NCT01904773|450881250|FG004|Screen|Withdrawal by Subject|0|||
125340188|NCT01904773|450881251|FG005|Screen|Withdrawal by Subject|0|||
125340189|NCT01904773|450881252|FG006|Screen|Withdrawal by Subject|0|||
125340190|NCT01904773|450881253|FG007|Screen|Withdrawal by Subject|0|||
125340191|NCT01904773|450881254|FG008|Screen|Withdrawal by Subject|0|||
125340192|NCT01904773|450881246|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
125340193|NCT01904773|450881247|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125340194|NCT01904773|450881248|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125340195|NCT01904773|450881249|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125340196|NCT01904773|450881250|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125673861|NCT01656889|452093091|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
125673862|NCT01656889|452093092|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
125673863|NCT01656889|452093091|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
125673864|NCT01656889|452093092|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
125673865|NCT01656889|452093091|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
125673866|NCT01656889|452093092|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
125673867|NCT00423800|452093093|FG000|Overall Study|Protocol Violation|0|||
125673868|NCT00423800|452093094|FG001|Overall Study|Protocol Violation|1|||
125340197|NCT01904773|450881251|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125340198|NCT01904773|450881252|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125340199|NCT01904773|450881253|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125340200|NCT01904773|450881254|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
125340201|NCT01904773|450881246|FG000|First Intervention|Adverse Event|0|||
125673869|NCT00458302|452094716|FG000|Overall Study|Adverse Event|4|||
125673870|NCT00458302|452094717|FG001|Overall Study|Adverse Event|14|||
125673871|NCT00458302|452094716|FG000|Overall Study|Pregnancy|2|||
125340202|NCT01904773|450881247|FG001|First Intervention|Adverse Event|0|||
125340203|NCT01904773|450881248|FG002|First Intervention|Adverse Event|0|||
125340204|NCT01904773|450881249|FG003|First Intervention|Adverse Event|0|||
125340205|NCT01904773|450881250|FG004|First Intervention|Adverse Event|0|||
125340206|NCT01904773|450881251|FG005|First Intervention|Adverse Event|0|||
125340207|NCT01904773|450881252|FG006|First Intervention|Adverse Event|1|||
125673872|NCT00458302|452094717|FG001|Overall Study|Pregnancy|1|||
125673873|NCT00458302|452094716|FG000|Overall Study|Protocol Violation|0|||
125673874|NCT00458302|452094717|FG001|Overall Study|Protocol Violation|2|||
125673875|NCT00458302|452094716|FG000|Overall Study|Withdrawal by Subject|6|||
125673876|NCT00458302|452094717|FG001|Overall Study|Withdrawal by Subject|4|||
125673877|NCT00458302|452094716|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
125673878|NCT00458302|452094717|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
125673879|NCT00458302|452094716|FG000|Overall Study|Study Termination By Sponsor|1|||
125673880|NCT00458302|452094717|FG001|Overall Study|Study Termination By Sponsor|0|||
125673881|NCT00458302|452094716|FG000|Overall Study|Lost to Follow-up|2|||
125673882|NCT00458302|452094717|FG001|Overall Study|Lost to Follow-up|0|||
125673883|NCT00458302|452094716|FG000|Overall Study|Other|4|||
125673884|NCT00458302|452094717|FG001|Overall Study|Other|2|||
125673885|NCT02178709|452094718|FG000|Overall Study|Adverse Event|5|||
125673886|NCT02178709|452094718|FG000|Overall Study|Death|2|||
125673887|NCT02178709|452094718|FG000|Overall Study|Withdrawal by Subject|2|||
125673888|NCT02178709|452094718|FG000|Overall Study|Physician Decision|2|||
125673889|NCT02178709|452094718|FG000|Overall Study|Disease Progression|5|||
125673890|NCT01241461|452094719|FG000|Overall Study|Progressive Disease|3|||
125673891|NCT01241461|452094720|FG001|Overall Study|Progressive Disease|6|||
125673892|NCT01379781|452094724|FG000|Overall Study|Lost to Follow-up|11|||
125673893|NCT01379781|452094725|FG001|Overall Study|Lost to Follow-up|8|||
125673894|NCT03329027|452094728|FG000|Overall Study|Lost to Follow-up|1|||
125673895|NCT03329027|452094729|FG001|Overall Study|Lost to Follow-up|0|||
125673896|NCT03329027|452094730|FG002|Overall Study|Lost to Follow-up|1|||
125673897|NCT03329027|452094728|FG000|Overall Study|Protocol Violation|9|||
125673898|NCT03329027|452094729|FG001|Overall Study|Protocol Violation|5|||
125673899|NCT03329027|452094730|FG002|Overall Study|Protocol Violation|7|||
125673900|NCT04849988|452094735|FG000|Overall Study|Lack of Efficacy|3|||
125673901|NCT04849988|452094736|FG001|Overall Study|Lack of Efficacy|4|||
125673902|NCT04849988|452094737|FG002|Overall Study|Lack of Efficacy|1|||
125673903|NCT04849988|452094738|FG003|Overall Study|Lack of Efficacy|4|||
125673904|NCT04849988|452094735|FG000|Overall Study|Other reasons|1|||
125673905|NCT04849988|452094736|FG001|Overall Study|Other reasons|2|||
125673906|NCT04849988|452094737|FG002|Overall Study|Other reasons|2|||
125673907|NCT04849988|452094738|FG003|Overall Study|Other reasons|1|||
125673908|NCT01052116|452094748|FG000|Overall Study|Lost to Follow-up|11|||
125673909|NCT01052116|452094749|FG001|Overall Study|Lost to Follow-up|17|||
125673910|NCT01052116|452094748|FG000|Overall Study|Withdrawal by Subject|3|||
125673911|NCT01052116|452094749|FG001|Overall Study|Withdrawal by Subject|6|||
125673912|NCT01052116|452094748|FG000|Overall Study|Spirometry not performed|0|||
125673913|NCT01052116|452094749|FG001|Overall Study|Spirometry not performed|4|||
125673914|NCT00836927|452094752|FG000|Overall Study|Progressive disease|2|||
125673915|NCT00836927|452094753|FG001|Overall Study|Progressive disease|0|||
125673916|NCT00836927|452094754|FG002|Overall Study|Progressive disease|0|||
125340208|NCT01904773|450881253|FG007|First Intervention|Adverse Event|0|||
125340209|NCT01904773|450881254|FG008|First Intervention|Adverse Event|0|||
125340210|NCT01904773|450881246|FG000|Placebo Washout First Intervention|Condition worsened|0|||
125340211|NCT01904773|450881247|FG001|Placebo Washout First Intervention|Condition worsened|1|||
125340212|NCT01904773|450881248|FG002|Placebo Washout First Intervention|Condition worsened|0|||
125340213|NCT01904773|450881249|FG003|Placebo Washout First Intervention|Condition worsened|0|||
125673917|NCT00836927|452094755|FG003|Overall Study|Progressive disease|1|||
125673918|NCT00836927|452094756|FG004|Overall Study|Progressive disease|1|||
125673919|NCT00836927|452094752|FG000|Overall Study|Withdrawal by Subject|1|||
125673920|NCT00836927|452094753|FG001|Overall Study|Withdrawal by Subject|0|||
125673921|NCT00836927|452094754|FG002|Overall Study|Withdrawal by Subject|0|||
125673922|NCT00836927|452094755|FG003|Overall Study|Withdrawal by Subject|0|||
125673923|NCT00836927|452094756|FG004|Overall Study|Withdrawal by Subject|0|||
125673924|NCT00614055|452094762|FG000|Overall Study|Adverse Event|1|||
125673925|NCT00614055|452094763|FG001|Overall Study|Adverse Event|0|||
125673926|NCT00614055|452094764|FG002|Overall Study|Adverse Event|0|||
125673927|NCT00614055|452094762|FG000|Overall Study|Protocol Violation|2|||
125673928|NCT00614055|452094763|FG001|Overall Study|Protocol Violation|2|||
125673929|NCT00614055|452094764|FG002|Overall Study|Protocol Violation|1|||
125673930|NCT00614055|452094762|FG000|Overall Study|Lack of Efficacy|0|||
125673931|NCT00614055|452094763|FG001|Overall Study|Lack of Efficacy|0|||
125673932|NCT00614055|452094764|FG002|Overall Study|Lack of Efficacy|2|||
125673933|NCT00614055|452094762|FG000|Overall Study|Unclassified|1|||
125673934|NCT00614055|452094763|FG001|Overall Study|Unclassified|4|||
125673935|NCT00614055|452094764|FG002|Overall Study|Unclassified|2|||
125673936|NCT03036579|452094773|FG000|2 Years|Lost to Follow-up|1|||
125673937|NCT03036579|452094774|FG001|2 Years|Lost to Follow-up|0|||
125673938|NCT03036579|452094773|FG000|3 Years|Lost to Follow-up|0|||
125673939|NCT03036579|452094774|FG001|3 Years|Lost to Follow-up|1|||
125673940|NCT02848599|452094775|FG000|Overall Study|Protocol Violation|7|||
125673941|NCT02848599|452094776|FG001|Overall Study|Protocol Violation|9|||
125673942|NCT02352337|452094777|FG000|Overall Study|Patients never treated|4|||
125673943|NCT02352337|452094778|FG001|Overall Study|Patients never treated|1|||
125673944|NCT02352337|452094779|FG002|Overall Study|Patients never treated|2|||
125673945|NCT00992407|452094782|FG000|Overall Study|Protocol Violation|2|||
125673946|NCT00992407|452094783|FG001|Overall Study|Protocol Violation|1|||
125673947|NCT00992407|452094782|FG000|Overall Study|Lost to Follow-up|3|||
125673948|NCT00992407|452094783|FG001|Overall Study|Lost to Follow-up|3|||
125673949|NCT00992407|452094782|FG000|Overall Study|Adverse Event|3|||
125673950|NCT00992407|452094783|FG001|Overall Study|Adverse Event|2|||
125673951|NCT00992407|452094782|FG000|Overall Study|protocol Violation & Adverse events|2|||
125673952|NCT00992407|452094783|FG001|Overall Study|protocol Violation & Adverse events|4|||
125673953|NCT00992407|452094782|FG000|Overall Study|Other|2|||
125673954|NCT00992407|452094783|FG001|Overall Study|Other|0|||
125673955|NCT00992407|452094782|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
125673956|NCT00992407|452094783|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
125673957|NCT00992407|452094782|FG000|Overall Study|Study medication not administered|17|||
125673958|NCT00992407|452094783|FG001|Overall Study|Study medication not administered|13|||
125673959|NCT02918162|452094785|FG000|Overall Study|Withdrawal by Subject|1|||
125673960|NCT02918162|452094785|FG000|Overall Study|Omental Disease|1|||
125673961|NCT00395226|452094786|FG000|Overall Study|Adverse Event|4|||
125673962|NCT00395226|452094787|FG001|Overall Study|Adverse Event|3|||
125673963|NCT00395226|452094786|FG000|Overall Study|Withdrawal by Subject|0|||
125673964|NCT00395226|452094787|FG001|Overall Study|Withdrawal by Subject|1|||
125673965|NCT00395226|452094786|FG000|Overall Study|Lost to Follow-up|0|||
125673966|NCT00395226|452094787|FG001|Overall Study|Lost to Follow-up|1|||
125673967|NCT02374918|452094788|FG000|Overall Study|Protocol Violation|2|||
125673968|NCT02374918|452094789|FG001|Overall Study|Protocol Violation|0|||
125673969|NCT02374918|452094790|FG002|Overall Study|Protocol Violation|2|||
125673970|NCT02374918|452094791|FG003|Overall Study|Protocol Violation|1|||
125673971|NCT02374918|452094788|FG000|Overall Study|Withdrawal by Subject|1|||
125673972|NCT02374918|452094789|FG001|Overall Study|Withdrawal by Subject|1|||
125673973|NCT02374918|452094790|FG002|Overall Study|Withdrawal by Subject|1|||
125673974|NCT02374918|452094791|FG003|Overall Study|Withdrawal by Subject|0|||
125673975|NCT02374918|452094788|FG000|Overall Study|Lack of Efficacy|0|||
125673976|NCT02374918|452094789|FG001|Overall Study|Lack of Efficacy|0|||
125673977|NCT02374918|452094790|FG002|Overall Study|Lack of Efficacy|1|||
125673978|NCT02374918|452094791|FG003|Overall Study|Lack of Efficacy|1|||
125673979|NCT02907203|452094792|FG000|Overall Study|Death|1|||
125673980|NCT02907203|452094792|FG000|Overall Study|Lost to Follow-up|3|||
125673981|NCT02907203|452094792|FG000|Overall Study|Withdrawal by Subject|3|||
125673982|NCT02907203|452094792|FG000|Overall Study|Surgical bypass|1|||
125673983|NCT04956666|452094793|FG000|Overall Study|Adverse Event|18|||
125673984|NCT04956666|452094793|FG000|Overall Study|Physician Decision|5|||
125673985|NCT00760383|452094794|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
125673986|NCT00760383|452094795|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
125673987|NCT00783796|452094796|FG000|Overall Study|Did not receive any stent|4|||
125673988|NCT00783796|452094796|FG000|Overall Study|Received non-XIENCE V stent|1|||
125673989|NCT00783796|452094796|FG000|Overall Study|Received commercial XIENCE V stent|1|||
125340214|NCT01904773|450881250|FG004|Placebo Washout First Intervention|Condition worsened|0|||
125340215|NCT01904773|450881251|FG005|Placebo Washout First Intervention|Condition worsened|0|||
125340216|NCT01904773|450881252|FG006|Placebo Washout First Intervention|Condition worsened|0|||
125340217|NCT01904773|450881253|FG007|Placebo Washout First Intervention|Condition worsened|0|||
125340218|NCT01904773|450881254|FG008|Placebo Washout First Intervention|Condition worsened|0|||
125340219|NCT01904773|450881246|FG000|Fifth Intervention|Adverse Event|0|||
125340220|NCT01904773|450881247|FG001|Fifth Intervention|Adverse Event|0|||
125340221|NCT01904773|450881248|FG002|Fifth Intervention|Adverse Event|0|||
125340222|NCT01904773|450881249|FG003|Fifth Intervention|Adverse Event|0|||
125340223|NCT01904773|450881250|FG004|Fifth Intervention|Adverse Event|0|||
125340224|NCT01904773|450881251|FG005|Fifth Intervention|Adverse Event|0|||
125340225|NCT01904773|450881252|FG006|Fifth Intervention|Adverse Event|0|||
125340226|NCT01904773|450881253|FG007|Fifth Intervention|Adverse Event|1|||
125340227|NCT01904773|450881254|FG008|Fifth Intervention|Adverse Event|0|||
125340228|NCT01904773|450881246|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125340229|NCT01904773|450881247|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
125340230|NCT01904773|450881248|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125340231|NCT01904773|450881249|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125340232|NCT01904773|450881250|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125340233|NCT01904773|450881251|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125340234|NCT01904773|450881252|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125340235|NCT01904773|450881253|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125340236|NCT01904773|450881254|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
125340237|NCT00791076|450881255|FG000|Overall Study|Study was terminated,PI left institution|8|||
125340238|NCT00606905|450881258|FG000|Overall Study|No Pregnancy|9|||
125340239|NCT00606905|450881259|FG001|Overall Study|No Pregnancy|6|||
125340240|NCT00606905|450881258|FG000|Overall Study|Non-Index Pregnancy|1|||
125340241|NCT00606905|450881259|FG001|Overall Study|Non-Index Pregnancy|4|||
125340242|NCT00606905|450881258|FG000|Overall Study|Withdrew|5|||
125340243|NCT00606905|450881259|FG001|Overall Study|Withdrew|5|||
125673990|NCT01816477|452094797|FG000|Overall Study|Withdrawal by Subject|13|||
125673991|NCT01816477|452094798|FG001|Overall Study|Withdrawal by Subject|1|||
125673992|NCT01816477|452094797|FG000|Overall Study|Unable to tolerate catheter placement|3|||
125673993|NCT01816477|452094798|FG001|Overall Study|Unable to tolerate catheter placement|0|||
125673994|NCT01766921|452094799|FG000|Overall Study|Administrative Reason|5|||
125673995|NCT01766921|452094800|FG001|Overall Study|Administrative Reason|5|||
125673996|NCT01766921|452094799|FG000|Overall Study|Death|1|||
125673997|NCT01766921|452094800|FG001|Overall Study|Death|1|||
125673998|NCT01766921|452094799|FG000|Overall Study|Lost to Follow-up|1|||
125673999|NCT01766921|452094800|FG001|Overall Study|Lost to Follow-up|3|||
125674000|NCT01766921|452094799|FG000|Overall Study|Unclassified|2|||
125674001|NCT01766921|452094800|FG001|Overall Study|Unclassified|2|||
125674002|NCT01766921|452094799|FG000|Overall Study|Protocol Violation|1|||
125674003|NCT01766921|452094800|FG001|Overall Study|Protocol Violation|1|||
125674004|NCT01766921|452094799|FG000|Overall Study|Withdrawal by Subject|14|||
125674005|NCT01766921|452094800|FG001|Overall Study|Withdrawal by Subject|5|||
125674006|NCT00282256|452094803|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
125674007|NCT00282256|452094803|FG000|Extension Treatment Period|Adverse Event|2|||
125674008|NCT00698685|452094804|FG000|Overall Study|Sister withdrew as donor|1|||
125674009|NCT00698685|452094804|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
125674010|NCT01513148|452094812|FG000|Overall Study|Protocol Violation|2|||
125674011|NCT01513148|452094813|FG001|Overall Study|Protocol Violation|2|||
125674012|NCT04652453|452094814|FG000|Overall Study|Death|8|||
125674013|NCT04652453|452094815|FG001|Overall Study|Death|2|||
125674014|NCT04652453|452094816|FG002|Overall Study|Death|0|||
125674015|NCT04652453|452094814|FG000|Overall Study|Hospice|5|||
125674016|NCT04652453|452094815|FG001|Overall Study|Hospice|5|||
125674017|NCT04652453|452094816|FG002|Overall Study|Hospice|0|||
125674018|NCT04652453|452094814|FG000|Overall Study|Withdrawal by Subject|2|||
125674019|NCT04652453|452094815|FG001|Overall Study|Withdrawal by Subject|0|||
125674020|NCT04652453|452094816|FG002|Overall Study|Withdrawal by Subject|0|||
125674021|NCT00936975|452094820|FG000|Overall Study|Withdrawal by Subject|1|||
125674022|NCT00936975|452094820|FG000|Overall Study|Disease progression|3|||
125674023|NCT00936975|452094820|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
125674024|NCT00619385|452094821|FG000|Overall Study|Adverse Event|0|||
125674025|NCT00619385|452094822|FG001|Overall Study|Adverse Event|0|||
125674026|NCT00619385|452094823|FG002|Overall Study|Adverse Event|3|||
125674027|NCT00619385|452094821|FG000|Overall Study|Other|1|||
125674028|NCT00619385|452094822|FG001|Overall Study|Other|2|||
125674029|NCT00619385|452094823|FG002|Overall Study|Other|1|||
125674030|NCT02041702|452094826|FG000|Overall Study|Lost to Follow-up|1|||
125674031|NCT02041702|452094827|FG001|Overall Study|Lost to Follow-up|6|||
125674032|NCT02041702|452094826|FG000|Overall Study|Death|4|||
125674033|NCT02041702|452094827|FG001|Overall Study|Death|0|||
125340244|NCT03700684|450881267|FG000|Overall Study|COVID-19|0|||
125340245|NCT03700684|450881268|FG001|Overall Study|COVID-19|0|||
125340246|NCT03700684|450881269|FG002|Overall Study|COVID-19|2|||
125340247|NCT03319745|450881270|FG000|Overall Study|Death|1|||
125340248|NCT03319745|450881270|FG000|Overall Study|Toxicity Precluding Surgery|1|||
125340249|NCT00870103|450881271|FG000|Overall Study|Physician Decision|2|||
125340250|NCT00870103|450881271|FG000|Overall Study|Lost to Follow-up|2|||
125340251|NCT01317550|450881272|FG000|Overall Study|Withdrawal by Subject|1|||
125340252|NCT01317550|450881273|FG001|Overall Study|Withdrawal by Subject|0|||
125340253|NCT01317550|450881274|FG002|Overall Study|Withdrawal by Subject|0|||
125340254|NCT01317550|450881275|FG003|Overall Study|Withdrawal by Subject|0|||
125340255|NCT01317550|450881272|FG000|Overall Study|Lack of compliance study med|1|||
125340256|NCT01317550|450881273|FG001|Overall Study|Lack of compliance study med|0|||
125340257|NCT01317550|450881274|FG002|Overall Study|Lack of compliance study med|0|||
125340258|NCT01317550|450881275|FG003|Overall Study|Lack of compliance study med|0|||
125340259|NCT03179202|450881276|FG000|Overall Study|Screen Failure|67|||
125340260|NCT03179202|450881276|FG000|Overall Study|Subject Lost to Follow Up|12|||
125340261|NCT03179202|450881276|FG000|Overall Study|Withdrawal by Subject|7|||
125340262|NCT03179202|450881276|FG000|Overall Study|Adverse Event|3|||
125340263|NCT03179202|450881276|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
125340264|NCT03179202|450881276|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
125340265|NCT01120782|450881277|FG000|Overall Study|Test article shipping error|11|||
125340266|NCT03255629|450881278|FG000|Overall Study|Adverse Event|1|||
125340267|NCT03255629|450881279|FG001|Overall Study|Adverse Event|0|||
125340268|NCT03255629|450881278|FG000|Overall Study|did not experience hypoglycemia|2|||
125340269|NCT03255629|450881279|FG001|Overall Study|did not experience hypoglycemia|1|||
125340270|NCT00859638|450881280|FG000|Overall Study|Lost to Follow-up|6|||
125340271|NCT00859638|450881281|FG001|Overall Study|Lost to Follow-up|1|||
125340272|NCT00859638|450881280|FG000|Overall Study|Withdrawal by Subject|3|||
125340273|NCT00859638|450881281|FG001|Overall Study|Withdrawal by Subject|2|||
125340274|NCT00859638|450881280|FG000|Overall Study|Ill health|1|||
125340275|NCT00859638|450881281|FG001|Overall Study|Ill health|1|||
125340276|NCT02969408|450881283|FG000|Overall Study|Adverse Event|2|||
125340277|NCT02969408|450881283|FG000|Overall Study|Withdrawal by Subject|8|||
125340278|NCT02969408|450881283|FG000|Overall Study|Lost to Follow-up|4|||
125340279|NCT02969408|450881283|FG000|Overall Study|Protocol Violation|1|||
125340280|NCT02969408|450881283|FG000|Overall Study|Other than specified|1|||
125340281|NCT01767142|450881289|FG000|Overall Study|Lost to Follow-up|3|||
125340282|NCT04075734|450881290|FG000|Overall Study|Lost to Follow-up|1|||
125340283|NCT04075734|450881291|FG001|Overall Study|Lost to Follow-up|1|||
125340284|NCT04075734|450881292|FG002|Overall Study|Lost to Follow-up|0|||
125340285|NCT04075734|450881290|FG000|Overall Study|Withdrawal by Subject|3|||
125340286|NCT04075734|450881291|FG001|Overall Study|Withdrawal by Subject|0|||
125340287|NCT04075734|450881292|FG002|Overall Study|Withdrawal by Subject|0|||
125340288|NCT03615040|450881295|FG000|Overall Study|Withdrawal by Subject|2|||
125340289|NCT03615040|450881296|FG001|Overall Study|Withdrawal by Subject|1|||
125340290|NCT03615040|450881295|FG000|Overall Study|Physician Decision|2|||
125340291|NCT03615040|450881296|FG001|Overall Study|Physician Decision|2|||
125340292|NCT03615040|450881295|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
125340293|NCT03615040|450881296|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
125340294|NCT03615040|450881295|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
125340295|NCT03615040|450881296|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
125340296|NCT03615040|450881295|FG000|Overall Study|Death|0|||
125340297|NCT03615040|450881296|FG001|Overall Study|Death|2|||
125340298|NCT01776307|450881299|FG000|Overall Study|Not dosed|0|||
125340299|NCT01776307|450881300|FG001|Overall Study|Not dosed|0|||
125340300|NCT01776307|450881301|FG002|Overall Study|Not dosed|1|||
125340301|NCT05194579|450881304|FG000|Overall Study|Lost to Follow-up|2|||
125340302|NCT05194579|450881305|FG001|Overall Study|Lost to Follow-up|3|||
125340303|NCT05194579|450881304|FG000|Overall Study|Withdrawal by Subject|3|||
125340304|NCT05194579|450881305|FG001|Overall Study|Withdrawal by Subject|4|||
125340305|NCT05194579|450881304|FG000|Overall Study|Refused further study procedures|0|||
125340306|NCT05194579|450881305|FG001|Overall Study|Refused further study procedures|1|||
125340307|NCT05194579|450881304|FG000|Overall Study|Protocol deviation|1|||
125340308|NCT05194579|450881305|FG001|Overall Study|Protocol deviation|0|||
125340309|NCT04145219|450881306|FG000|Overall Study|Adverse Event|18|||
125340310|NCT04145219|450881307|FG001|Overall Study|Adverse Event|6|||
125340311|NCT04145219|450881306|FG000|Overall Study|Lost to Follow-up|2|||
125340312|NCT04145219|450881307|FG001|Overall Study|Lost to Follow-up|3|||
125340313|NCT04145219|450881306|FG000|Overall Study|Physician Decision|0|||
125340314|NCT04145219|450881307|FG001|Overall Study|Physician Decision|2|||
125340315|NCT04145219|450881306|FG000|Overall Study|Withdrawal by Subject|12|||
125340316|NCT04145219|450881307|FG001|Overall Study|Withdrawal by Subject|8|||
125340317|NCT04145219|450881306|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
125340318|NCT04145219|450881307|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
125340319|NCT01788215|450881311|FG000|Overall Study|Withdrawal by Subject|0|||
125340320|NCT01788215|450881312|FG001|Overall Study|Withdrawal by Subject|1|||
125340321|NCT01788215|450881311|FG000|Overall Study|Lost to Follow-up|2|||
125340322|NCT01788215|450881312|FG001|Overall Study|Lost to Follow-up|0|||
125340323|NCT01950013|450881315|FG000|Overall Study|Withdrawal by Subject|0|||
125340324|NCT01950013|450881316|FG001|Overall Study|Withdrawal by Subject|2|||
125340325|NCT01950013|450881317|FG002|Overall Study|Withdrawal by Subject|0|||
125340326|NCT00612105|450881326|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
125340327|NCT00612105|450881327|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
125340328|NCT00612105|450881326|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
125340329|NCT00612105|450881327|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
125340330|NCT00612105|450881326|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
125340331|NCT00612105|450881327|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
125340332|NCT00612105|450881326|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
125340333|NCT00612105|450881327|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
125340334|NCT00612105|450881326|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
125340335|NCT00612105|450881327|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
125340336|NCT00612105|450881326|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
125340337|NCT00612105|450881327|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
125340338|NCT00612105|450881326|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
125340339|NCT00612105|450881327|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
125340340|NCT00612105|450881326|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
125340341|NCT00612105|450881327|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
125340342|NCT00612105|450881326|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
125340343|NCT00612105|450881327|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
125340344|NCT00612105|450881326|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
125674034|NCT02041702|452094826|FG000|Overall Study|Withdrawal by Subject|4|||
125674035|NCT02041702|452094827|FG001|Overall Study|Withdrawal by Subject|3|||
125674036|NCT02041702|452094826|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
125674037|NCT02041702|452094827|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
125674038|NCT02041702|452094826|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
125674039|NCT02041702|452094827|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
125674040|NCT00203307|452094828|FG000|First Intervention|Adverse Event|2|||
125674041|NCT00203307|452094829|FG001|First Intervention|Adverse Event|0|||
125674042|NCT03730103|452094830|FG000|Overall Study|Did not meet inclusion criteria|0|||
125674043|NCT03730103|452094831|FG001|Overall Study|Did not meet inclusion criteria|5|||
125674044|NCT01488578|452094832|FG000|Overall Study|Protocol Violation|1836|||
125674045|NCT02308111|452094833|FG000|Overall Study|Adverse Event|31|||
125674046|NCT02308111|452094834|FG001|Overall Study|Adverse Event|19|||
125674047|NCT02308111|452094833|FG000|Overall Study|Death|9|||
125674048|NCT02308111|452094834|FG001|Overall Study|Death|6|||
125674049|NCT02308111|452094833|FG000|Overall Study|Lost to Follow-up|2|||
125674050|NCT02308111|452094834|FG001|Overall Study|Lost to Follow-up|7|||
125674051|NCT02308111|452094833|FG000|Overall Study|Physician Decision|6|||
125674052|NCT02308111|452094834|FG001|Overall Study|Physician Decision|17|||
125674053|NCT02308111|452094833|FG000|Overall Study|Protocol Violation|0|||
125674054|NCT02308111|452094834|FG001|Overall Study|Protocol Violation|1|||
125674055|NCT02308111|452094833|FG000|Overall Study|Withdrawal by Subject|28|||
125674056|NCT02308111|452094834|FG001|Overall Study|Withdrawal by Subject|38|||
125674057|NCT02308111|452094833|FG000|Overall Study|Study Terminated by Sponsor|72|||
125674058|NCT02308111|452094834|FG001|Overall Study|Study Terminated by Sponsor|61|||
125674059|NCT02308111|452094833|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
125674060|NCT02308111|452094834|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
125674061|NCT02308111|452094833|FG000|Overall Study|Site Closure|3|||
125674062|NCT02308111|452094834|FG001|Overall Study|Site Closure|3|||
125674063|NCT02308111|452094833|FG000|Overall Study|Non-compliance with Study Drug|3|||
125674064|NCT02308111|452094834|FG001|Overall Study|Non-compliance with Study Drug|1|||
125674065|NCT02308111|452094833|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
125674066|NCT02308111|452094834|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
125674067|NCT02308111|452094833|FG000|Overall Study|Liver Transplant|3|||
125674068|NCT02308111|452094834|FG001|Overall Study|Liver Transplant|3|||
125674069|NCT02308111|452094833|FG000|Overall Study|Liver Transplant Waitlist|2|||
125674070|NCT02308111|452094834|FG001|Overall Study|Liver Transplant Waitlist|2|||
125674071|NCT02308111|452094833|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
125674072|NCT02308111|452094834|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
125674073|NCT03271528|452094835|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
125674074|NCT03271528|452094836|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
125674075|NCT03271528|452094835|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
125674076|NCT03271528|452094836|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
125674077|NCT03271528|452094835|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
125674078|NCT03271528|452094836|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
125674079|NCT03271528|452094835|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
125674080|NCT03271528|452094836|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
125674081|NCT03271528|452094835|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
125674082|NCT03271528|452094836|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
125674083|NCT03271528|452094835|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
125674084|NCT03271528|452094836|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
125674085|NCT03271528|452094835|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
125674086|NCT03271528|452094836|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
125674087|NCT00717756|452094840|FG000|Overall Study|Withdrawal by Subject|1|||
125674088|NCT01873859|452094843|FG000|Overall Study|Withdrawal by Subject|0|||
125674089|NCT01873859|452094844|FG001|Overall Study|Withdrawal by Subject|4|||
125674090|NCT03977584|452094845|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
125674091|NCT03977584|452094846|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
125674092|NCT03977584|452094847|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
125674093|NCT01066052|452094851|FG000|Overall Study|Enrolled But Not Treated|3|||
125674094|NCT01066052|452094852|FG001|Overall Study|Enrolled But Not Treated|0|||
125674095|NCT02729896|452094855|FG000|Overall Study|Death|0|||
125674096|NCT02729896|452094856|FG001|Overall Study|Death|2|||
125674097|NCT02729896|452094857|FG002|Overall Study|Death|13|||
125674098|NCT02729896|452094855|FG000|Overall Study|Lost to Follow-up|0|||
125674099|NCT02729896|452094856|FG001|Overall Study|Lost to Follow-up|2|||
125674100|NCT02729896|452094857|FG002|Overall Study|Lost to Follow-up|3|||
125674101|NCT02729896|452094855|FG000|Overall Study|Other|0|||
125674102|NCT02729896|452094856|FG001|Overall Study|Other|2|||
125674103|NCT02729896|452094857|FG002|Overall Study|Other|0|||
125340345|NCT00612105|450881327|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
125340346|NCT00612105|450881326|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
125340347|NCT00612105|450881327|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
125340348|NCT00612105|450881326|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
125340349|NCT00612105|450881327|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
125340350|NCT00271505|450881329|FG000|Overall Study|Screen Failure|3|||
125340351|NCT00271505|450881329|FG000|Overall Study|Adverse Event|1|||
125340352|NCT00271505|450881329|FG000|Overall Study|Death|1|||
125340353|NCT04556383|450881330|FG000|PCP|Lack of Efficacy|28|||
125340354|NCT04556383|450881331|FG001|PCP|Lack of Efficacy|23|||
125340355|NCT04556383|450881332|FG002|PCP|Lack of Efficacy|23|||
125340356|NCT04556383|450881333|FG003|PCP|Lack of Efficacy|0|||
125340357|NCT04556383|450881330|FG000|PCP|Study terminated by sponsor|15|||
125340358|NCT04556383|450881331|FG001|PCP|Study terminated by sponsor|13|||
125340359|NCT04556383|450881332|FG002|PCP|Study terminated by sponsor|16|||
125340360|NCT04556383|450881333|FG003|PCP|Study terminated by sponsor|0|||
125340361|NCT04556383|450881330|FG000|PCP|Withdrawal by Subject|8|||
125340362|NCT04556383|450881331|FG001|PCP|Withdrawal by Subject|6|||
125340363|NCT04556383|450881332|FG002|PCP|Withdrawal by Subject|6|||
125340364|NCT04556383|450881333|FG003|PCP|Withdrawal by Subject|0|||
125340365|NCT04556383|450881330|FG000|PCP|Adverse Event|1|||
125340366|NCT04556383|450881331|FG001|PCP|Adverse Event|7|||
125340367|NCT04556383|450881332|FG002|PCP|Adverse Event|7|||
125340368|NCT04556383|450881333|FG003|PCP|Adverse Event|0|||
125340369|NCT04556383|450881330|FG000|PCP|Other, Not Specified|1|||
125340370|NCT04556383|450881331|FG001|PCP|Other, Not Specified|2|||
125340371|NCT04556383|450881332|FG002|PCP|Other, Not Specified|1|||
125340372|NCT04556383|450881333|FG003|PCP|Other, Not Specified|0|||
125340373|NCT04556383|450881330|FG000|PCP|Protocol Violation|1|||
125340374|NCT04556383|450881331|FG001|PCP|Protocol Violation|0|||
125340375|NCT04556383|450881332|FG002|PCP|Protocol Violation|1|||
125340376|NCT04556383|450881333|FG003|PCP|Protocol Violation|0|||
125340377|NCT04556383|450881330|FG000|PCP|Lost to Follow-up|1|||
125340378|NCT04556383|450881331|FG001|PCP|Lost to Follow-up|0|||
125674104|NCT02729896|452094855|FG000|Overall Study|Physician Decision|1|||
125674105|NCT02729896|452094856|FG001|Overall Study|Physician Decision|2|||
125674106|NCT02729896|452094857|FG002|Overall Study|Physician Decision|3|||
125674107|NCT02729896|452094855|FG000|Overall Study|Progressive Disease|0|||
125425613|NCT01735201|451182284|FG005|Overall Study|Other Miscellaneous Reasons|2|||
125425614|NCT01735201|451182285|FG006|Overall Study|Other Miscellaneous Reasons|1|||
125425615|NCT01735201|451182286|FG007|Overall Study|Other Miscellaneous Reasons|1|||
125425616|NCT01553318|451182287|FG000|Overall Study|Protocol Violation|3|||
125674108|NCT02729896|452094856|FG001|Overall Study|Progressive Disease|1|||
125674109|NCT02729896|452094857|FG002|Overall Study|Progressive Disease|0|||
125674110|NCT02729896|452094855|FG000|Overall Study|Withdrawal by Subject|1|||
125674111|NCT02729896|452094856|FG001|Overall Study|Withdrawal by Subject|0|||
125674112|NCT02729896|452094857|FG002|Overall Study|Withdrawal by Subject|3|||
125674113|NCT01835145|452094858|FG000|Overall Study|Ineligible prior to treatment|1|||
125674114|NCT01835145|452094859|FG001|Overall Study|Ineligible prior to treatment|0|||
125674115|NCT01309919|452094878|FG000|Overall Study|Did not receive a postpartum IUD|17|||
125674116|NCT01309919|452094879|FG001|Overall Study|Did not receive a postpartum IUD|48|||
125674117|NCT00319449|452094880|FG000|Overall Study|Subject did not wish to continue|1|||
125674118|NCT00319449|452094881|FG001|Overall Study|Subject did not wish to continue|0|||
125674119|NCT00319449|452094880|FG000|Overall Study|Noncompliance with the protocol|1|||
125340379|NCT04556383|450881332|FG002|PCP|Lost to Follow-up|0|||
125340380|NCT04556383|450881333|FG003|PCP|Lost to Follow-up|0|||
125340381|NCT04556383|450881330|FG000|PCP|Physician Decision|0|||
125340382|NCT04556383|450881331|FG001|PCP|Physician Decision|1|||
125340383|NCT04556383|450881332|FG002|PCP|Physician Decision|0|||
125340384|NCT04556383|450881333|FG003|PCP|Physician Decision|0|||
125340385|NCT04556383|450881330|FG000|PCP|Site terminated by sponsor|0|||
125340386|NCT04556383|450881331|FG001|PCP|Site terminated by sponsor|1|||
125340387|NCT04556383|450881332|FG002|PCP|Site terminated by sponsor|0|||
125340388|NCT04556383|450881333|FG003|PCP|Site terminated by sponsor|0|||
125340389|NCT04556383|450881330|FG000|OLE|Study terminated by sponsor|0|||
125340390|NCT04556383|450881331|FG001|OLE|Study terminated by sponsor|0|||
125340391|NCT04556383|450881332|FG002|OLE|Study terminated by sponsor|0|||
125340392|NCT04556383|450881333|FG003|OLE|Study terminated by sponsor|68|||
125340393|NCT04556383|450881330|FG000|OLE|Withdrawal by Subject|0|||
125340394|NCT04556383|450881331|FG001|OLE|Withdrawal by Subject|0|||
125340395|NCT04556383|450881332|FG002|OLE|Withdrawal by Subject|0|||
125340396|NCT04556383|450881333|FG003|OLE|Withdrawal by Subject|10|||
125340397|NCT04556383|450881330|FG000|OLE|Lack of Efficacy|0|||
125340398|NCT04556383|450881331|FG001|OLE|Lack of Efficacy|0|||
125340399|NCT04556383|450881332|FG002|OLE|Lack of Efficacy|0|||
125340400|NCT04556383|450881333|FG003|OLE|Lack of Efficacy|7|||
125340401|NCT04556383|450881330|FG000|OLE|Adverse Event|0|||
125340402|NCT04556383|450881331|FG001|OLE|Adverse Event|0|||
125340403|NCT04556383|450881332|FG002|OLE|Adverse Event|0|||
125340404|NCT04556383|450881333|FG003|OLE|Adverse Event|2|||
125340405|NCT04556383|450881330|FG000|OLE|Other, Not Specified|0|||
125674120|NCT00319449|452094881|FG001|Overall Study|Noncompliance with the protocol|0|||
125674121|NCT02102490|452094882|FG000|Overall Study|Death|6|||
125674122|NCT02102490|452094882|FG000|Overall Study|Lost to Follow-up|1|||
125674123|NCT01346410|452094883|FG000|Overall Study|Death|1|||
125674124|NCT00979628|452094884|FG000|Overall Study|received regimen < 24 hours|7|||
125674125|NCT00979628|452094885|FG001|Overall Study|received regimen < 24 hours|6|||
125674126|NCT00979628|452094886|FG002|Overall Study|received regimen < 24 hours|5|||
125674127|NCT00979628|452094884|FG000|Overall Study|received steroids|1|||
125674128|NCT00979628|452094885|FG001|Overall Study|received steroids|1|||
125674129|NCT00979628|452094886|FG002|Overall Study|received steroids|0|||
125674130|NCT00979628|452094884|FG000|Overall Study|transferred to ICU|1|||
125674131|NCT00979628|452094885|FG001|Overall Study|transferred to ICU|2|||
125674132|NCT00979628|452094886|FG002|Overall Study|transferred to ICU|1|||
125674133|NCT02146430|452096607|FG000|Overall Study|Protocol Violation|5|||
125674134|NCT02146430|452096608|FG001|Overall Study|Protocol Violation|4|||
125674135|NCT02146430|452096609|FG002|Overall Study|Protocol Violation|8|||
125674136|NCT02146430|452096610|FG003|Overall Study|Protocol Violation|6|||
125674137|NCT02146430|452096607|FG000|Overall Study|Lack of Efficacy|13|||
125674138|NCT02146430|452096608|FG001|Overall Study|Lack of Efficacy|11|||
125674139|NCT02146430|452096609|FG002|Overall Study|Lack of Efficacy|8|||
125674140|NCT02146430|452096610|FG003|Overall Study|Lack of Efficacy|5|||
125674141|NCT02146430|452096607|FG000|Overall Study|Adverse Event|20|||
125674142|NCT02146430|452096608|FG001|Overall Study|Adverse Event|40|||
125674143|NCT02146430|452096609|FG002|Overall Study|Adverse Event|32|||
125674144|NCT02146430|452096610|FG003|Overall Study|Adverse Event|49|||
125674145|NCT02146430|452096607|FG000|Overall Study|Reason missing or not reported|2|||
125674146|NCT02146430|452096608|FG001|Overall Study|Reason missing or not reported|3|||
125674147|NCT02146430|452096609|FG002|Overall Study|Reason missing or not reported|4|||
125674148|NCT02146430|452096610|FG003|Overall Study|Reason missing or not reported|5|||
125674149|NCT02146430|452096607|FG000|Overall Study|Withdrawal by Subject|27|||
125674150|NCT02146430|452096608|FG001|Overall Study|Withdrawal by Subject|29|||
125674151|NCT02146430|452096609|FG002|Overall Study|Withdrawal by Subject|30|||
125674152|NCT02146430|452096610|FG003|Overall Study|Withdrawal by Subject|34|||
125674153|NCT01893905|452096611|FG000|Overall Study|Withdrawal by Subject|1|||
125674154|NCT01893905|452096612|FG001|Overall Study|Withdrawal by Subject|0|||
125674155|NCT01893905|452096611|FG000|Overall Study|Adverse Event|9|||
125674156|NCT01893905|452096612|FG001|Overall Study|Adverse Event|3|||
125674157|NCT01893905|452096611|FG000|Overall Study|Lack of Efficacy|5|||
125674158|NCT01893905|452096612|FG001|Overall Study|Lack of Efficacy|7|||
125674159|NCT01893905|452096611|FG000|Overall Study|Lost to Follow-up|1|||
125674160|NCT01893905|452096612|FG001|Overall Study|Lost to Follow-up|0|||
125674161|NCT01893905|452096611|FG000|Overall Study|Protocol Violation|6|||
125674162|NCT01893905|452096612|FG001|Overall Study|Protocol Violation|1|||
125340406|NCT04556383|450881331|FG001|OLE|Other, Not Specified|0|||
125340407|NCT04556383|450881332|FG002|OLE|Other, Not Specified|0|||
125340408|NCT04556383|450881333|FG003|OLE|Other, Not Specified|2|||
125340409|NCT04556383|450881330|FG000|OLE|Death|0|||
125340410|NCT04556383|450881331|FG001|OLE|Death|0|||
125674163|NCT01893905|452096611|FG000|Overall Study|Lack of adherence to treatment|2|||
125674164|NCT01893905|452096612|FG001|Overall Study|Lack of adherence to treatment|0|||
125674165|NCT01893905|452096611|FG000|Overall Study|Other reason|1|||
125674166|NCT01893905|452096612|FG001|Overall Study|Other reason|3|||
125674167|NCT01768858|452096613|FG000|Overall Study|Lost to Follow-up|9|||
125674168|NCT01768858|452096613|FG000|Overall Study|Lack of Efficacy|8|||
125674169|NCT01768858|452096613|FG000|Overall Study|Serious Adverse Event|1|||
125674170|NCT01768858|452096613|FG000|Overall Study|Participant moved to Germany|1|||
125674171|NCT01768858|452096613|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
125674172|NCT01768858|452096613|FG000|Overall Study|Exanthema|1|||
125674173|NCT01768858|452096613|FG000|Overall Study|Withdrawal by Subject|1|||
125674174|NCT03312530|452096614|FG000|Overall Study|Death|5|||
125340411|NCT04556383|450881332|FG002|OLE|Death|0|||
125340412|NCT04556383|450881333|FG003|OLE|Death|1|||
125340413|NCT04556383|450881330|FG000|OLE|Lost to Follow-up|0|||
125340414|NCT04556383|450881331|FG001|OLE|Lost to Follow-up|0|||
125340415|NCT04556383|450881332|FG002|OLE|Lost to Follow-up|0|||
125340416|NCT04556383|450881333|FG003|OLE|Lost to Follow-up|1|||
125340417|NCT00509145|450881334|FG000|Overall Study|Death|0|||
125674175|NCT03312530|452096615|FG001|Overall Study|Death|5|||
125674176|NCT03312530|452096616|FG002|Overall Study|Death|4|||
125340418|NCT00509145|450881335|FG001|Overall Study|Death|2|||
125340419|NCT00509145|450881334|FG000|Overall Study|Adverse Event|42|||
125340420|NCT00509145|450881335|FG001|Overall Study|Adverse Event|28|||
125340421|NCT00509145|450881334|FG000|Overall Study|Withdrawal by Subject|32|||
125340422|NCT00509145|450881335|FG001|Overall Study|Withdrawal by Subject|38|||
125340423|NCT00509145|450881334|FG000|Overall Study|Physician Decision|11|||
125340424|NCT00509145|450881335|FG001|Overall Study|Physician Decision|14|||
125340425|NCT00509145|450881334|FG000|Overall Study|Protocol Violation|1|||
125340426|NCT00509145|450881335|FG001|Overall Study|Protocol Violation|6|||
125340427|NCT00509145|450881334|FG000|Overall Study|Pregnancy|3|||
125340428|NCT00509145|450881335|FG001|Overall Study|Pregnancy|8|||
125340429|NCT00509145|450881334|FG000|Overall Study|Lost to Follow-up|6|||
125340430|NCT00509145|450881335|FG001|Overall Study|Lost to Follow-up|5|||
125340431|NCT00509145|450881334|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
125340432|NCT00509145|450881335|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
125340433|NCT00509145|450881334|FG000|Overall Study|Other|6|||
125340434|NCT00509145|450881335|FG001|Overall Study|Other|6|||
125340435|NCT01994889|450881336|FG000|Overall Study|Adverse Event|5|||
125340436|NCT01994889|450881337|FG001|Overall Study|Adverse Event|12|||
125340437|NCT01994889|450881338|FG002|Overall Study|Adverse Event|11|||
125340438|NCT01994889|450881336|FG000|Overall Study|Cardiac Device Implantation|0|||
125340439|NCT01994889|450881337|FG001|Overall Study|Cardiac Device Implantation|2|||
125340440|NCT01994889|450881338|FG002|Overall Study|Cardiac Device Implantation|0|||
125340441|NCT01994889|450881336|FG000|Overall Study|Organ Transplantation|1|||
125340442|NCT01994889|450881337|FG001|Overall Study|Organ Transplantation|5|||
125340443|NCT01994889|450881338|FG002|Overall Study|Organ Transplantation|5|||
125340444|NCT01994889|450881336|FG000|Overall Study|No longer willing to participate|8|||
125340445|NCT01994889|450881337|FG001|Overall Study|No longer willing to participate|17|||
125340446|NCT01994889|450881338|FG002|Overall Study|No longer willing to participate|37|||
125340447|NCT01994889|450881336|FG000|Overall Study|Lost to Follow-up|0|||
125340448|NCT01994889|450881337|FG001|Overall Study|Lost to Follow-up|1|||
125340449|NCT01994889|450881338|FG002|Overall Study|Lost to Follow-up|0|||
125340450|NCT01994889|450881336|FG000|Overall Study|Protocol Violation|0|||
125340451|NCT01994889|450881337|FG001|Overall Study|Protocol Violation|1|||
125340452|NCT01994889|450881338|FG002|Overall Study|Protocol Violation|1|||
125340453|NCT01994889|450881336|FG000|Overall Study|Death|14|||
125340454|NCT01994889|450881337|FG001|Overall Study|Death|25|||
125340455|NCT01994889|450881338|FG002|Overall Study|Death|38|||
125340456|NCT02969655|450881340|FG000|Overall Study|Withdrawal by Subject|3|||
125340457|NCT02969655|450881341|FG001|Overall Study|Withdrawal by Subject|2|||
125340458|NCT02969655|450881340|FG000|Overall Study|Physician Decision|4|||
125340459|NCT02969655|450881341|FG001|Overall Study|Physician Decision|3|||
125340460|NCT02969655|450881340|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
125340461|NCT02969655|450881341|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
125340462|NCT02969655|450881340|FG000|Overall Study|Adverse Event|10|||
125340463|NCT02969655|450881341|FG001|Overall Study|Adverse Event|8|||
125340464|NCT02674204|450881342|FG000|Overall Study|Adverse Event|1|||
125340465|NCT02674204|450881343|FG001|Overall Study|Adverse Event|0|||
125340466|NCT01525225|450881347|FG000|Enrollment|No longer met study criteria|1|||
125340467|NCT01525225|450881347|FG000|Enrollment|Other|1|||
125340468|NCT00363545|450881348|FG000|Overall Study|Serious Adverse Event|0|||
125340469|NCT00363545|450881349|FG001|Overall Study|Serious Adverse Event|1|||
125340470|NCT00363545|450881348|FG000|Overall Study|Withdrawal by Subject|12|||
125340471|NCT00363545|450881349|FG001|Overall Study|Withdrawal by Subject|15|||
125340472|NCT00363545|450881348|FG000|Overall Study|Migrated/moved from study area|3|||
125340473|NCT00363545|450881349|FG001|Overall Study|Migrated/moved from study area|6|||
125340474|NCT00363545|450881348|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
125340475|NCT00363545|450881349|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
125340476|NCT00363545|450881348|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
125340477|NCT00363545|450881349|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
125340478|NCT00363545|450881348|FG000|Overall Study|Others|1|||
125340479|NCT00363545|450881349|FG001|Overall Study|Others|0|||
125340480|NCT01379508|450881350|FG000|Treatment to Week 104|Adverse Event|2|||
125540916|NCT01237587|451609479|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
125340481|NCT01379508|450881351|FG001|Treatment to Week 104|Adverse Event|0|||
125340482|NCT01379508|450881352|FG002|Treatment to Week 104|Adverse Event|5|||
125340483|NCT01379508|450881353|FG003|Treatment to Week 104|Adverse Event|0|||
125340484|NCT01379508|450881350|FG000|Treatment to Week 104|Abnormal lab value|1|||
125340485|NCT01379508|450881351|FG001|Treatment to Week 104|Abnormal lab value|0|||
125340486|NCT01379508|450881352|FG002|Treatment to Week 104|Abnormal lab value|0|||
125340487|NCT01379508|450881353|FG003|Treatment to Week 104|Abnormal lab value|0|||
125340488|NCT01379508|450881350|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
125340489|NCT01379508|450881351|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
125340490|NCT01379508|450881352|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
125340491|NCT01379508|450881353|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
125340492|NCT01379508|450881350|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
125340493|NCT01379508|450881351|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
125340494|NCT01379508|450881352|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
125340495|NCT01379508|450881353|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
125340496|NCT01379508|450881350|FG000|Treatment to Week 104|Lost to Follow-up|5|||
125340497|NCT01379508|450881351|FG001|Treatment to Week 104|Lost to Follow-up|0|||
125340498|NCT01379508|450881352|FG002|Treatment to Week 104|Lost to Follow-up|3|||
125340499|NCT01379508|450881353|FG003|Treatment to Week 104|Lost to Follow-up|0|||
125340500|NCT01379508|450881350|FG000|Treatment to Week 104|Administrative problems|3|||
125340501|NCT01379508|450881351|FG001|Treatment to Week 104|Administrative problems|1|||
125340502|NCT01379508|450881352|FG002|Treatment to Week 104|Administrative problems|0|||
125340503|NCT01379508|450881353|FG003|Treatment to Week 104|Administrative problems|0|||
125340504|NCT01379508|450881350|FG000|Treatment to Week 104|Protocol Violation|1|||
125340505|NCT01379508|450881351|FG001|Treatment to Week 104|Protocol Violation|1|||
125340506|NCT01379508|450881352|FG002|Treatment to Week 104|Protocol Violation|1|||
125340507|NCT01379508|450881353|FG003|Treatment to Week 104|Protocol Violation|0|||
125340508|NCT01379508|450881350|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
125340509|NCT01379508|450881351|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
125340510|NCT01379508|450881352|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
125340511|NCT01379508|450881353|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
125340512|NCT01379508|450881350|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
125340513|NCT01379508|450881351|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
125340514|NCT01379508|450881352|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
125340515|NCT01379508|450881353|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
125340516|NCT01379508|450881350|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
125340517|NCT01379508|450881351|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
125340518|NCT01379508|450881352|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
125340519|NCT01379508|450881353|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
125340520|NCT01379508|450881350|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
125340521|NCT01379508|450881351|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
125340522|NCT01379508|450881352|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
125340523|NCT01379508|450881353|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
125340524|NCT01457352|450881354|FG000|Period 1|Adverse Event|2|||
125340525|NCT01457352|450881355|FG001|Period 1|Adverse Event|0|||
125340526|NCT01457352|450881354|FG000|Period 1|Withdrawal by Subject|2|||
125340527|NCT01457352|450881355|FG001|Period 1|Withdrawal by Subject|0|||
125340528|NCT01457352|450881354|FG000|Period 1|Physician Decision|2|||
125340529|NCT01457352|450881355|FG001|Period 1|Physician Decision|0|||
125340530|NCT01457352|450881354|FG000|Period 1|MS related disease progression|1|||
125340531|NCT01457352|450881355|FG001|Period 1|MS related disease progression|0|||
125340532|NCT01457352|450881354|FG000|Period 1|Withdrawn|1|||
125340533|NCT01457352|450881355|FG001|Period 1|Withdrawn|0|||
125340534|NCT01457352|450881354|FG000|Period 1|withdrew per sponsor|1|||
125340535|NCT01457352|450881355|FG001|Period 1|withdrew per sponsor|0|||
125340536|NCT01457352|450881354|FG000|Period 1|Protocol Violation|4|||
125340537|NCT01457352|450881355|FG001|Period 1|Protocol Violation|0|||
125340538|NCT01457352|450881354|FG000|Period 1|Did not meet eligibility criteria|3|||
125340539|NCT01457352|450881355|FG001|Period 1|Did not meet eligibility criteria|0|||
125340540|NCT01457352|450881354|FG000|Period 2|Withdrawal by Subject|23|||
125340541|NCT01457352|450881355|FG001|Period 2|Withdrawal by Subject|0|||
125340542|NCT01457352|450881354|FG000|Period 2|Adverse Event|22|||
125340543|NCT01457352|450881355|FG001|Period 2|Adverse Event|0|||
125340544|NCT01457352|450881354|FG000|Period 2|no analysis|10|||
125340545|NCT01457352|450881355|FG001|Period 2|no analysis|0|||
125340546|NCT01457352|450881354|FG000|Period 2|Lack of Efficacy|8|||
125340547|NCT01457352|450881355|FG001|Period 2|Lack of Efficacy|0|||
125340548|NCT01457352|450881354|FG000|Period 2|Protocol Violation|4|||
125340549|NCT01457352|450881355|FG001|Period 2|Protocol Violation|0|||
125340550|NCT01457352|450881354|FG000|Period 2|Sponsor's withdrawal|7|||
125340551|NCT01457352|450881355|FG001|Period 2|Sponsor's withdrawal|0|||
125340552|NCT01457352|450881354|FG000|Period 2|Lost to Follow-up|1|||
125340553|NCT01457352|450881355|FG001|Period 2|Lost to Follow-up|0|||
125340554|NCT01457352|450881354|FG000|Period 2|dose change|1|||
125340555|NCT01457352|450881355|FG001|Period 2|dose change|0|||
125340556|NCT01457352|450881354|FG000|Period 2|Physician Decision|1|||
125340557|NCT01457352|450881355|FG001|Period 2|Physician Decision|0|||
125340558|NCT01457352|450881354|FG000|Period 2|Did not meet eligibility criteria|3|||
125340559|NCT01457352|450881355|FG001|Period 2|Did not meet eligibility criteria|0|||
125340560|NCT01457352|450881354|FG000|Period 3|Adverse Event|1|||
125340561|NCT01457352|450881355|FG001|Period 3|Adverse Event|1|||
125340562|NCT01457352|450881354|FG000|Period 3|Withdrawal by Subject|0|||
125340563|NCT01457352|450881355|FG001|Period 3|Withdrawal by Subject|2|||
125340564|NCT01457352|450881354|FG000|Period 3|incorrect treatment|0|||
125340565|NCT01457352|450881355|FG001|Period 3|incorrect treatment|1|||
125340566|NCT01457352|450881354|FG000|Period 3|Sponsor's withdrawal|0|||
125340567|NCT01457352|450881355|FG001|Period 3|Sponsor's withdrawal|1|||
125340568|NCT02537015|450881356|FG000|Overall Study|Adverse Event|3|||
125340569|NCT02537015|450881356|FG000|Overall Study|Withdrawal by Subject|2|||
125340570|NCT02537015|450881356|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125340571|NCT04174365|450881357|FG000|Overall Study|Lost to Follow-up|1|||
125340572|NCT04174365|450881358|FG001|Overall Study|Lost to Follow-up|2|||
125340573|NCT04174365|450881357|FG000|Overall Study|Adverse Event|2|||
125340574|NCT04174365|450881358|FG001|Overall Study|Adverse Event|1|||
125340575|NCT04174365|450881357|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
125340576|NCT04174365|450881358|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
125340577|NCT04174365|450881357|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
125340578|NCT04174365|450881358|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
125340579|NCT04174365|450881357|FG000|Overall Study|Protocol Deviation|1|||
125340580|NCT04174365|450881358|FG001|Overall Study|Protocol Deviation|0|||
125340581|NCT04174365|450881357|FG000|Overall Study|Lack of Efficacy|0|||
125340582|NCT04174365|450881358|FG001|Overall Study|Lack of Efficacy|2|||
125340583|NCT04174365|450881357|FG000|Overall Study|Disease Relapse|1|||
125340584|NCT04174365|450881358|FG001|Overall Study|Disease Relapse|0|||
125340585|NCT04174365|450881357|FG000|Overall Study|Reason Not Specified|0|||
125340586|NCT04174365|450881358|FG001|Overall Study|Reason Not Specified|1|||
125340587|NCT02156271|450884149|FG000|Overall Study|Physician Decision|4|||
125340588|NCT02156271|450884150|FG001|Overall Study|Physician Decision|3|||
125340589|NCT00109590|450884151|FG000|Overall Study|Lost to Follow-up|1|||
125340590|NCT00109590|450884152|FG001|Overall Study|Lost to Follow-up|0|||
125340591|NCT00109590|450884153|FG002|Overall Study|Lost to Follow-up|1|||
125340592|NCT00109590|450884151|FG000|Overall Study|Never Started Treatment|1|||
125340593|NCT00109590|450884152|FG001|Overall Study|Never Started Treatment|2|||
125340594|NCT00109590|450884153|FG002|Overall Study|Never Started Treatment|3|||
125340595|NCT02617485|450884166|FG000|Treatment and Observation Period|Adverse Event|9|||
125340596|NCT02617485|450884167|FG001|Treatment and Observation Period|Adverse Event|1|||
125340597|NCT02617485|450884166|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
125340598|NCT02617485|450884167|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
125378909|NCT00589914|451019206|FG000|Overall Study|Death|2|||
125340599|NCT02617485|450884166|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
125340600|NCT02617485|450884167|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
125340601|NCT02617485|450884166|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
125340602|NCT02617485|450884167|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
125340603|NCT02617485|450884166|FG000|Treatment and Observation Period|Physician Decision|0|||
125340604|NCT02617485|450884167|FG001|Treatment and Observation Period|Physician Decision|1|||
125340605|NCT02617485|450884166|FG000|Follow-up Period|Adverse Event|1|||
125340606|NCT02617485|450884167|FG001|Follow-up Period|Adverse Event|0|||
125340607|NCT02617485|450884166|FG000|Follow-up Period|Withdrawal by Subject|1|||
125340608|NCT02617485|450884167|FG001|Follow-up Period|Withdrawal by Subject|0|||
125340609|NCT02617485|450884166|FG000|Follow-up Period|Disease progression|2|||
125340610|NCT02617485|450884167|FG001|Follow-up Period|Disease progression|1|||
125340611|NCT02617485|450884166|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
125340612|NCT02617485|450884167|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
125340613|NCT02617485|450884166|FG000|Follow-up Period|Patient needed radiotherapy|9|||
125340614|NCT02617485|450884167|FG001|Follow-up Period|Patient needed radiotherapy|5|||
125340615|NCT02617485|450884166|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
125340616|NCT02617485|450884167|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
125340617|NCT00409331|450884168|FG000|Overall Study|Physician Decision|1|||
125340618|NCT01511055|450884173|FG000|Overall Study|Withdrawal by Subject|6|||
125340619|NCT04590248|450884175|FG000|Overall Study|Lost to Follow-up|1|||
125340620|NCT04590248|450884175|FG000|Overall Study|Withdrawal by Subject|16|||
125340621|NCT04590248|450884175|FG000|Overall Study|Other|2|||
125340622|NCT02052414|450884178|FG000|Overall Study|Adverse Event|12|||
125340623|NCT02052414|450884178|FG000|Overall Study|Lack of Efficacy|2|||
125340624|NCT02052414|450884178|FG000|Overall Study|Withdrawal by Subject|3|||
125340625|NCT03263702|450884182|FG000|Overall Study|Lost to Follow-up|2|||
125340626|NCT03263702|450884183|FG001|Overall Study|Lost to Follow-up|2|||
125340627|NCT03263702|450884182|FG000|Overall Study|Withdrawal by Subject|1|||
125340628|NCT03263702|450884183|FG001|Overall Study|Withdrawal by Subject|2|||
125340629|NCT02527200|450884184|FG000|Overall Study|Withdrawal by Subject|3|||
125340630|NCT02527200|450884185|FG001|Overall Study|Withdrawal by Subject|2|||
125340631|NCT02527200|450884186|FG002|Overall Study|Withdrawal by Subject|1|||
125340632|NCT02527200|450884187|FG003|Overall Study|Withdrawal by Subject|0|||
125340633|NCT02527200|450884184|FG000|Overall Study|Unclassified|0|||
125340634|NCT02527200|450884185|FG001|Overall Study|Unclassified|1|||
125340635|NCT02527200|450884186|FG002|Overall Study|Unclassified|0|||
125540917|NCT01237587|451609478|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
125340636|NCT02527200|450884187|FG003|Overall Study|Unclassified|0|||
125340637|NCT02527200|450884184|FG000|Overall Study|Lost to Follow-up|0|||
125340638|NCT02527200|450884185|FG001|Overall Study|Lost to Follow-up|0|||
125340639|NCT02527200|450884186|FG002|Overall Study|Lost to Follow-up|1|||
125340640|NCT02527200|450884187|FG003|Overall Study|Lost to Follow-up|0|||
125340641|NCT00966875|450884189|FG000|Part A|Adverse Event|2|||
125340642|NCT00966875|450884190|FG001|Part A|Adverse Event|1|||
125340643|NCT00966875|450884191|FG002|Part A|Adverse Event|0|||
125340644|NCT00966875|450884192|FG003|Part A|Adverse Event|1|||
125340645|NCT00966875|450884193|FG004|Part A|Adverse Event|0|||
125340646|NCT00966875|450884194|FG005|Part A|Adverse Event|1|||
125340647|NCT00966875|450884195|FG006|Part A|Adverse Event|0|||
125340648|NCT00966875|450884196|FG007|Part A|Adverse Event|3|||
125340649|NCT00966875|450884197|FG008|Part A|Adverse Event|3|||
125340650|NCT00966875|450884189|FG000|Part A|Entry Criteria|0|||
125340651|NCT00966875|450884190|FG001|Part A|Entry Criteria|0|||
125340652|NCT00966875|450884191|FG002|Part A|Entry Criteria|0|||
125340653|NCT00966875|450884192|FG003|Part A|Entry Criteria|0|||
125340654|NCT00966875|450884193|FG004|Part A|Entry Criteria|0|||
125340655|NCT00966875|450884194|FG005|Part A|Entry Criteria|2|||
125340656|NCT00966875|450884195|FG006|Part A|Entry Criteria|0|||
125340657|NCT00966875|450884196|FG007|Part A|Entry Criteria|0|||
125340658|NCT00966875|450884197|FG008|Part A|Entry Criteria|0|||
125340659|NCT00966875|450884189|FG000|Part A|Lack of Efficacy|0|||
125340660|NCT00966875|450884190|FG001|Part A|Lack of Efficacy|1|||
125340661|NCT00966875|450884191|FG002|Part A|Lack of Efficacy|0|||
125340662|NCT00966875|450884192|FG003|Part A|Lack of Efficacy|0|||
125340663|NCT00966875|450884193|FG004|Part A|Lack of Efficacy|0|||
125340664|NCT00966875|450884194|FG005|Part A|Lack of Efficacy|0|||
125340665|NCT00966875|450884195|FG006|Part A|Lack of Efficacy|4|||
125340666|NCT00966875|450884196|FG007|Part A|Lack of Efficacy|0|||
125340667|NCT00966875|450884197|FG008|Part A|Lack of Efficacy|0|||
125340668|NCT00966875|450884189|FG000|Part A|Lost to Follow-up|2|||
125340669|NCT00966875|450884190|FG001|Part A|Lost to Follow-up|0|||
125340670|NCT00966875|450884191|FG002|Part A|Lost to Follow-up|0|||
125340671|NCT00966875|450884192|FG003|Part A|Lost to Follow-up|0|||
125340672|NCT00966875|450884193|FG004|Part A|Lost to Follow-up|0|||
125340673|NCT00966875|450884194|FG005|Part A|Lost to Follow-up|1|||
125340674|NCT00966875|450884195|FG006|Part A|Lost to Follow-up|0|||
125340675|NCT00966875|450884196|FG007|Part A|Lost to Follow-up|0|||
125340676|NCT00966875|450884197|FG008|Part A|Lost to Follow-up|0|||
125340677|NCT00966875|450884189|FG000|Part A|Parent/Caregiver Decision|0|||
125340678|NCT00966875|450884190|FG001|Part A|Parent/Caregiver Decision|0|||
125340679|NCT00966875|450884191|FG002|Part A|Parent/Caregiver Decision|0|||
125340680|NCT00966875|450884192|FG003|Part A|Parent/Caregiver Decision|1|||
125340681|NCT00966875|450884193|FG004|Part A|Parent/Caregiver Decision|0|||
125340682|NCT00966875|450884194|FG005|Part A|Parent/Caregiver Decision|0|||
125340683|NCT00966875|450884195|FG006|Part A|Parent/Caregiver Decision|0|||
125340684|NCT00966875|450884196|FG007|Part A|Parent/Caregiver Decision|0|||
125340685|NCT00966875|450884197|FG008|Part A|Parent/Caregiver Decision|0|||
125340686|NCT00966875|450884189|FG000|Part A|Physician Decision|0|||
125340687|NCT00966875|450884190|FG001|Part A|Physician Decision|0|||
125340688|NCT00966875|450884191|FG002|Part A|Physician Decision|0|||
125340689|NCT00966875|450884192|FG003|Part A|Physician Decision|0|||
125340690|NCT00966875|450884193|FG004|Part A|Physician Decision|1|||
125340691|NCT00966875|450884194|FG005|Part A|Physician Decision|0|||
125340692|NCT00966875|450884195|FG006|Part A|Physician Decision|1|||
125340693|NCT00966875|450884196|FG007|Part A|Physician Decision|0|||
125340694|NCT00966875|450884197|FG008|Part A|Physician Decision|2|||
125340695|NCT00966875|450884189|FG000|Part A|Sponsor Decision|0|||
125340696|NCT00966875|450884190|FG001|Part A|Sponsor Decision|0|||
125340697|NCT00966875|450884191|FG002|Part A|Sponsor Decision|1|||
125340698|NCT00966875|450884192|FG003|Part A|Sponsor Decision|0|||
125340699|NCT00966875|450884193|FG004|Part A|Sponsor Decision|1|||
125340700|NCT00966875|450884194|FG005|Part A|Sponsor Decision|0|||
125340701|NCT00966875|450884195|FG006|Part A|Sponsor Decision|0|||
125340702|NCT00966875|450884196|FG007|Part A|Sponsor Decision|2|||
125340703|NCT00966875|450884197|FG008|Part A|Sponsor Decision|1|||
125340704|NCT00966875|450884189|FG000|Part A|Withdrawal by Subject|2|||
125340705|NCT00966875|450884190|FG001|Part A|Withdrawal by Subject|2|||
125340706|NCT00966875|450884191|FG002|Part A|Withdrawal by Subject|1|||
125340707|NCT00966875|450884192|FG003|Part A|Withdrawal by Subject|1|||
125340708|NCT00966875|450884193|FG004|Part A|Withdrawal by Subject|3|||
125340709|NCT00966875|450884194|FG005|Part A|Withdrawal by Subject|0|||
125340710|NCT00966875|450884195|FG006|Part A|Withdrawal by Subject|5|||
125340711|NCT00966875|450884196|FG007|Part A|Withdrawal by Subject|1|||
125340712|NCT00966875|450884197|FG008|Part A|Withdrawal by Subject|1|||
125340713|NCT00966875|450884189|FG000|Part A|Protocol Violation|0|||
125340714|NCT00966875|450884190|FG001|Part A|Protocol Violation|0|||
125340715|NCT00966875|450884191|FG002|Part A|Protocol Violation|0|||
125340716|NCT00966875|450884192|FG003|Part A|Protocol Violation|0|||
125340717|NCT00966875|450884193|FG004|Part A|Protocol Violation|0|||
125340718|NCT00966875|450884194|FG005|Part A|Protocol Violation|0|||
125340719|NCT00966875|450884195|FG006|Part A|Protocol Violation|2|||
125340720|NCT00966875|450884196|FG007|Part A|Protocol Violation|1|||
125340721|NCT00966875|450884197|FG008|Part A|Protocol Violation|1|||
125340722|NCT00966875|450884189|FG000|Part B|Adverse Event|0|||
125340723|NCT00966875|450884190|FG001|Part B|Adverse Event|1|||
125340724|NCT00966875|450884191|FG002|Part B|Adverse Event|1|||
125340725|NCT00966875|450884192|FG003|Part B|Adverse Event|0|||
125340726|NCT00966875|450884193|FG004|Part B|Adverse Event|1|||
125340727|NCT00966875|450884194|FG005|Part B|Adverse Event|0|||
125340728|NCT00966875|450884195|FG006|Part B|Adverse Event|5|||
125340729|NCT00966875|450884196|FG007|Part B|Adverse Event|2|||
125340730|NCT00966875|450884197|FG008|Part B|Adverse Event|2|||
125340731|NCT00966875|450884189|FG000|Part B|Death|0|||
125340732|NCT00966875|450884190|FG001|Part B|Death|0|||
125340733|NCT00966875|450884191|FG002|Part B|Death|1|||
125340734|NCT00966875|450884192|FG003|Part B|Death|0|||
125340735|NCT00966875|450884193|FG004|Part B|Death|0|||
125340736|NCT00966875|450884194|FG005|Part B|Death|0|||
125340737|NCT00966875|450884195|FG006|Part B|Death|0|||
125340738|NCT00966875|450884196|FG007|Part B|Death|1|||
125340739|NCT00966875|450884197|FG008|Part B|Death|0|||
125340740|NCT00966875|450884189|FG000|Part B|Lack of Efficacy|2|||
125340741|NCT00966875|450884190|FG001|Part B|Lack of Efficacy|1|||
125340742|NCT00966875|450884191|FG002|Part B|Lack of Efficacy|1|||
125340743|NCT00966875|450884192|FG003|Part B|Lack of Efficacy|1|||
125340744|NCT00966875|450884193|FG004|Part B|Lack of Efficacy|2|||
125340745|NCT00966875|450884194|FG005|Part B|Lack of Efficacy|3|||
125340746|NCT00966875|450884195|FG006|Part B|Lack of Efficacy|12|||
125340747|NCT00966875|450884196|FG007|Part B|Lack of Efficacy|9|||
125340748|NCT00966875|450884197|FG008|Part B|Lack of Efficacy|6|||
125340749|NCT00966875|450884189|FG000|Part B|Lost to Follow-up|0|||
125340750|NCT00966875|450884190|FG001|Part B|Lost to Follow-up|0|||
125340751|NCT00966875|450884191|FG002|Part B|Lost to Follow-up|0|||
125340752|NCT00966875|450884192|FG003|Part B|Lost to Follow-up|1|||
125340753|NCT00966875|450884193|FG004|Part B|Lost to Follow-up|0|||
125340754|NCT00966875|450884194|FG005|Part B|Lost to Follow-up|0|||
125340755|NCT00966875|450884195|FG006|Part B|Lost to Follow-up|0|||
125340756|NCT00966875|450884196|FG007|Part B|Lost to Follow-up|0|||
125340757|NCT00966875|450884197|FG008|Part B|Lost to Follow-up|1|||
125340758|NCT00966875|450884189|FG000|Part B|Physician Decision|0|||
125340759|NCT00966875|450884190|FG001|Part B|Physician Decision|0|||
125340760|NCT00966875|450884191|FG002|Part B|Physician Decision|1|||
125340761|NCT00966875|450884192|FG003|Part B|Physician Decision|0|||
125340762|NCT00966875|450884193|FG004|Part B|Physician Decision|2|||
125340763|NCT00966875|450884194|FG005|Part B|Physician Decision|1|||
125340764|NCT00966875|450884195|FG006|Part B|Physician Decision|0|||
125340765|NCT00966875|450884196|FG007|Part B|Physician Decision|0|||
125340766|NCT00966875|450884197|FG008|Part B|Physician Decision|2|||
125340767|NCT00966875|450884189|FG000|Part B|Sponsor Decision|1|||
125340768|NCT00966875|450884190|FG001|Part B|Sponsor Decision|0|||
125340769|NCT00966875|450884191|FG002|Part B|Sponsor Decision|0|||
125340770|NCT00966875|450884192|FG003|Part B|Sponsor Decision|0|||
125340771|NCT00966875|450884193|FG004|Part B|Sponsor Decision|0|||
125340772|NCT00966875|450884194|FG005|Part B|Sponsor Decision|1|||
125340773|NCT00966875|450884195|FG006|Part B|Sponsor Decision|0|||
125340774|NCT00966875|450884196|FG007|Part B|Sponsor Decision|2|||
125340775|NCT00966875|450884197|FG008|Part B|Sponsor Decision|1|||
125340776|NCT00966875|450884189|FG000|Part B|Withdrawal by Subject|2|||
125340777|NCT00966875|450884190|FG001|Part B|Withdrawal by Subject|1|||
125340778|NCT00966875|450884191|FG002|Part B|Withdrawal by Subject|2|||
125340779|NCT00966875|450884192|FG003|Part B|Withdrawal by Subject|1|||
125340780|NCT00966875|450884193|FG004|Part B|Withdrawal by Subject|2|||
125340781|NCT00966875|450884194|FG005|Part B|Withdrawal by Subject|1|||
125340782|NCT00966875|450884195|FG006|Part B|Withdrawal by Subject|4|||
125340783|NCT00966875|450884196|FG007|Part B|Withdrawal by Subject|5|||
125340784|NCT00966875|450884197|FG008|Part B|Withdrawal by Subject|5|||
125340785|NCT00966875|450884189|FG000|Part B|Entry Criteria|0|||
125340786|NCT00966875|450884190|FG001|Part B|Entry Criteria|0|||
125340787|NCT00966875|450884191|FG002|Part B|Entry Criteria|0|||
125340788|NCT00966875|450884192|FG003|Part B|Entry Criteria|0|||
125340789|NCT00966875|450884193|FG004|Part B|Entry Criteria|0|||
125340790|NCT00966875|450884194|FG005|Part B|Entry Criteria|0|||
125340791|NCT00966875|450884195|FG006|Part B|Entry Criteria|1|||
125340792|NCT00966875|450884196|FG007|Part B|Entry Criteria|0|||
125340793|NCT00966875|450884197|FG008|Part B|Entry Criteria|1|||
125340794|NCT02386189|450884200|FG000|Overall Study|Lost to Follow-up|2|||
125340795|NCT02386189|450884201|FG001|Overall Study|Lost to Follow-up|3|||
125340796|NCT02386189|450884200|FG000|Overall Study|Withdrawal by Subject|1|||
125340797|NCT02386189|450884201|FG001|Overall Study|Withdrawal by Subject|0|||
125340798|NCT02386189|450884200|FG000|Overall Study|Death|1|||
125340799|NCT02386189|450884201|FG001|Overall Study|Death|0|||
125340800|NCT04657666|450884202|FG000|Period 1|Withdrawal of participant consent|2|||
125340801|NCT04657666|450884203|FG001|Period 1|Withdrawal of participant consent|1|||
125340802|NCT04657666|450884202|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
125340803|NCT04657666|450884203|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
125340804|NCT04657666|450884202|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
125340805|NCT04657666|450884203|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
125340806|NCT04657666|450884202|FG000|Period 2|Other|2|||
125340807|NCT04657666|450884203|FG001|Period 2|Other|0|||
125340808|NCT04657666|450884202|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
125340809|NCT04657666|450884203|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
125340810|NCT01659554|450884204|FG000|Overall Study|Study Termination|4|||
125340811|NCT01022398|450884205|FG000|Overall Study|Study terminated|2|||
125340812|NCT01022398|450884206|FG001|Overall Study|Study terminated|2|||
125340813|NCT00640224|450884207|FG000|Overall Study|Lost to Follow-up|5|||
125340814|NCT00640224|450884208|FG001|Overall Study|Lost to Follow-up|2|||
125340815|NCT00640224|450884209|FG002|Overall Study|Lost to Follow-up|0|||
125340816|NCT00640224|450884210|FG003|Overall Study|Lost to Follow-up|0|||
125340817|NCT00640224|450884207|FG000|Overall Study|Withdrawal by Subject|1|||
125340818|NCT00640224|450884208|FG001|Overall Study|Withdrawal by Subject|0|||
125340819|NCT00640224|450884209|FG002|Overall Study|Withdrawal by Subject|0|||
125340820|NCT00640224|450884210|FG003|Overall Study|Withdrawal by Subject|0|||
125340821|NCT00640224|450884207|FG000|Overall Study|Headaches|0|||
125340822|NCT00640224|450884208|FG001|Overall Study|Headaches|1|||
125340823|NCT00640224|450884209|FG002|Overall Study|Headaches|0|||
125340824|NCT00640224|450884210|FG003|Overall Study|Headaches|0|||
125340825|NCT04224688|450884214|FG000|Overall Study|Withdrawal by Subject|1|||
125340826|NCT04224688|450884215|FG001|Overall Study|Withdrawal by Subject|3|||
125340827|NCT04224688|450884214|FG000|Overall Study|Lack of Efficacy|1|||
125340828|NCT04224688|450884215|FG001|Overall Study|Lack of Efficacy|1|||
125340829|NCT04224688|450884214|FG000|Overall Study|Adverse event, not fatal|0|||
125340830|NCT04224688|450884215|FG001|Overall Study|Adverse event, not fatal|2|||
125340831|NCT04224688|450884214|FG000|Overall Study|COVID-19|0|||
125340832|NCT04224688|450884215|FG001|Overall Study|COVID-19|1|||
125340833|NCT01024309|450884221|FG000|Overall Study|Physician Decision|4|||
125340834|NCT01024309|450884222|FG001|Overall Study|Physician Decision|0|||
125340835|NCT01024309|450884221|FG000|Overall Study|Withdrawal by Subject|4|||
125540918|NCT01237587|451609479|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
125340836|NCT01024309|450884222|FG001|Overall Study|Withdrawal by Subject|4|||
125340837|NCT03232333|450884228|FG000|Overall Study|Infection or Osteomyelitis|9|||
125340838|NCT03232333|450884228|FG000|Overall Study|Lost to Follow-up|4|||
125340839|NCT03232333|450884228|FG000|Overall Study|Withdrawal by Subject|2|||
125340840|NCT00653432|450884232|FG000|Overall Study|Adverse Event|4|||
125340841|NCT00653432|450884233|FG001|Overall Study|Adverse Event|1|||
125340842|NCT00653432|450884232|FG000|Overall Study|Withdrawal by Subject|4|||
125340843|NCT00653432|450884233|FG001|Overall Study|Withdrawal by Subject|5|||
125340844|NCT00653432|450884232|FG000|Overall Study|Lost to Follow-up|7|||
125674177|NCT03312530|452096617|FG003|Overall Study|Death|10|||
125674178|NCT03312530|452096618|FG004|Overall Study|Death|8|||
125674179|NCT03312530|452096614|FG000|Overall Study|Lost to Follow-up|0|||
125674180|NCT03312530|452096615|FG001|Overall Study|Lost to Follow-up|0|||
125674181|NCT03312530|452096616|FG002|Overall Study|Lost to Follow-up|0|||
125674182|NCT03312530|452096617|FG003|Overall Study|Lost to Follow-up|1|||
125674183|NCT03312530|452096618|FG004|Overall Study|Lost to Follow-up|0|||
125674184|NCT03312530|452096614|FG000|Overall Study|Participant in another sponsor study.|0|||
125674185|NCT03312530|452096615|FG001|Overall Study|Participant in another sponsor study.|0|||
125674186|NCT03312530|452096616|FG002|Overall Study|Participant in another sponsor study.|0|||
125674187|NCT03312530|452096617|FG003|Overall Study|Participant in another sponsor study.|1|||
125674188|NCT03312530|452096618|FG004|Overall Study|Participant in another sponsor study.|0|||
125674189|NCT03312530|452096614|FG000|Overall Study|Study terminated by sponsor|1|||
125674190|NCT03312530|452096615|FG001|Overall Study|Study terminated by sponsor|0|||
125674191|NCT03312530|452096616|FG002|Overall Study|Study terminated by sponsor|2|||
125674192|NCT03312530|452096617|FG003|Overall Study|Study terminated by sponsor|3|||
125674193|NCT03312530|452096618|FG004|Overall Study|Study terminated by sponsor|7|||
125674194|NCT03312530|452096614|FG000|Overall Study|Withdrawal by Subject|0|||
125674195|NCT03312530|452096615|FG001|Overall Study|Withdrawal by Subject|1|||
125674196|NCT03312530|452096616|FG002|Overall Study|Withdrawal by Subject|0|||
125674197|NCT03312530|452096617|FG003|Overall Study|Withdrawal by Subject|0|||
125674198|NCT03312530|452096618|FG004|Overall Study|Withdrawal by Subject|0|||
125674199|NCT03312530|452096614|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
125674200|NCT03312530|452096615|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
125674201|NCT03312530|452096616|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
125674202|NCT03312530|452096617|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
125674203|NCT03312530|452096618|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
125674204|NCT01691859|452096621|FG000|Overall Study|Adverse Event|19|||
125674205|NCT01691859|452096621|FG000|Overall Study|Lack of Efficacy|11|||
125674206|NCT01691859|452096621|FG000|Overall Study|Protocol Violation|4|||
125674207|NCT01691859|452096621|FG000|Overall Study|Product commercially available|221|||
125674208|NCT01691859|452096621|FG000|Overall Study|Study closed/terminated|50|||
125674209|NCT01691859|452096621|FG000|Overall Study|Lost to Follow-up|5|||
125674210|NCT01691859|452096621|FG000|Overall Study|Physician Decision|6|||
125674211|NCT01691859|452096621|FG000|Overall Study|Withdrawal by Subject|31|||
125674212|NCT04820842|452096622|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
125674213|NCT04820842|452096623|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
125674214|NCT04820842|452096624|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
125674215|NCT04820842|452096625|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
125674216|NCT04820842|452096626|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
125674217|NCT04820842|452096627|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
125674218|NCT04820842|452096628|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
125674219|NCT04820842|452096622|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
125674220|NCT04820842|452096623|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
125674221|NCT04820842|452096624|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
125674222|NCT04820842|452096625|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125674223|NCT04820842|452096626|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125674224|NCT04820842|452096627|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125674225|NCT04820842|452096628|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125674226|NCT04820842|452096622|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125674227|NCT04820842|452096623|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
125674228|NCT04820842|452096624|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125674229|NCT04820842|452096625|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125674230|NCT04820842|452096626|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125674231|NCT04820842|452096627|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125674232|NCT04820842|452096628|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125674233|NCT04820842|452096622|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125674234|NCT04820842|452096623|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125340845|NCT00653432|450884233|FG001|Overall Study|Lost to Follow-up|6|||
125340846|NCT00653432|450884232|FG000|Overall Study|Use/Need of Con Therapy|2|||
125340847|NCT00653432|450884233|FG001|Overall Study|Use/Need of Con Therapy|1|||
125340848|NCT00653432|450884232|FG000|Overall Study|Other - Reason Not Provided|5|||
125340849|NCT00653432|450884233|FG001|Overall Study|Other - Reason Not Provided|3|||
125340850|NCT00567255|450884234|FG000|Overall Study|Adverse Event|241|||
125340851|NCT00567255|450884235|FG001|Overall Study|Adverse Event|68|||
125340852|NCT00567255|450884234|FG000|Overall Study|Lost to Follow-up|77|||
125340853|NCT00567255|450884235|FG001|Overall Study|Lost to Follow-up|48|||
125340854|NCT00567255|450884234|FG000|Overall Study|Withdrawal by Subject|75|||
125674235|NCT04820842|452096624|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125674236|NCT04820842|452096625|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
125674237|NCT04820842|452096626|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125674238|NCT04820842|452096627|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
125674239|NCT04820842|452096628|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
125340855|NCT00567255|450884235|FG001|Overall Study|Withdrawal by Subject|56|||
125340856|NCT00567255|450884234|FG000|Overall Study|Lack of Efficacy|19|||
125340857|NCT00567255|450884235|FG001|Overall Study|Lack of Efficacy|33|||
125340858|NCT00567255|450884234|FG000|Overall Study|Protocol Violation|20|||
125340859|NCT00567255|450884235|FG001|Overall Study|Protocol Violation|8|||
125340860|NCT00567255|450884234|FG000|Overall Study|Pregnancy|6|||
125340861|NCT00567255|450884235|FG001|Overall Study|Pregnancy|0|||
125340862|NCT00567255|450884234|FG000|Overall Study|Drug noncompliance,moved,other|25|||
125340863|NCT00567255|450884235|FG001|Overall Study|Drug noncompliance,moved,other|15|||
125340864|NCT01290796|450884240|FG000|Overall Study|Lost to Follow-up|21|||
125340865|NCT01290796|450884240|FG000|Overall Study|Withdrawal by Subject|4|||
125340866|NCT01290796|450884240|FG000|Overall Study|Physician Decision|2|||
125340867|NCT01290796|450884240|FG000|Overall Study|Secondary Surgical Intervention|2|||
125340868|NCT01290796|450884240|FG000|Overall Study|Withdrawal by Sponsor|1|||
125340869|NCT02343549|450884241|FG000|Overall Study|Death|11|||
125340870|NCT02343549|450884241|FG000|Overall Study|Withdrawal by Subject|2|||
125340871|NCT03087617|450884242|FG000|Overall Study|Lost to Follow-up|32|||
125340872|NCT03087617|450884243|FG001|Overall Study|Lost to Follow-up|30|||
125340873|NCT03087617|450884244|FG002|Overall Study|Lost to Follow-up|30|||
125340874|NCT03087617|450884245|FG003|Overall Study|Lost to Follow-up|39|||
125340875|NCT01090323|450884247|FG000|Overall Study|Adverse Event|12|||
125340876|NCT01090323|450884248|FG001|Overall Study|Adverse Event|2|||
125340877|NCT01090323|450884247|FG000|Overall Study|Abnormal Lab Values|3|||
125340878|NCT01090323|450884248|FG001|Overall Study|Abnormal Lab Values|1|||
125340879|NCT01090323|450884247|FG000|Overall Study|Abnormal Test Procedure Results|2|||
125340880|NCT01090323|450884248|FG001|Overall Study|Abnormal Test Procedure Results|0|||
125340881|NCT01090323|450884247|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125340882|NCT01090323|450884248|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125340883|NCT01090323|450884247|FG000|Overall Study|Condition no longer requires drug|5|||
125340884|NCT01090323|450884248|FG001|Overall Study|Condition no longer requires drug|4|||
125340885|NCT01090323|450884247|FG000|Overall Study|Protocol Violation|2|||
125340886|NCT01090323|450884248|FG001|Overall Study|Protocol Violation|1|||
125340887|NCT01090323|450884247|FG000|Overall Study|Withdrew consent|33|||
125340888|NCT01090323|450884248|FG001|Overall Study|Withdrew consent|11|||
125340889|NCT01090323|450884247|FG000|Overall Study|Lost to Follow-up|11|||
125340890|NCT01090323|450884248|FG001|Overall Study|Lost to Follow-up|6|||
125340891|NCT01090323|450884247|FG000|Overall Study|Administrative problems|6|||
125340892|NCT01090323|450884248|FG001|Overall Study|Administrative problems|4|||
125340893|NCT01090323|450884247|FG000|Overall Study|Death|1|||
125340894|NCT01090323|450884248|FG001|Overall Study|Death|2|||
125340895|NCT01090323|450884247|FG000|Overall Study|Stopped end of core|7|||
125340896|NCT01090323|450884248|FG001|Overall Study|Stopped end of core|0|||
125340897|NCT01090323|450884247|FG000|Overall Study|Stopped end of extension 1#|3|||
125340898|NCT01090323|450884248|FG001|Overall Study|Stopped end of extension 1#|1|||
125340899|NCT01864005|450884249|FG000|Overall Study|Protocol Violation|0|||
125340900|NCT01864005|450884250|FG001|Overall Study|Protocol Violation|1|||
125340901|NCT01864005|450884249|FG000|Overall Study|Withdrawal by Subject|0|||
125340902|NCT01864005|450884250|FG001|Overall Study|Withdrawal by Subject|1|||
125340903|NCT01864005|450884249|FG000|Overall Study|Incorrect enrolment|1|||
125340904|NCT01864005|450884250|FG001|Overall Study|Incorrect enrolment|0|||
125340905|NCT01864005|450884249|FG000|Overall Study|Disease need|1|||
125340906|NCT01864005|450884250|FG001|Overall Study|Disease need|1|||
125340907|NCT01864005|450884249|FG000|Overall Study|Need GP IIb/IIIa|1|||
125340908|NCT01864005|450884250|FG001|Overall Study|Need GP IIb/IIIa|3|||
125340909|NCT00763698|450884251|FG000|Overall Study|Unsuccessful Implant|5|||
125340910|NCT00763698|450884251|FG000|Overall Study|Death|4|||
125340911|NCT00763698|450884251|FG000|Overall Study|Withdrawal by Subject|1|||
125340912|NCT02059291|450884252|FG000|Epoch 2|Lack of Efficacy|0|||
125340913|NCT02059291|450884253|FG001|Epoch 2|Lack of Efficacy|0|||
125340914|NCT02059291|450884254|FG002|Epoch 2|Lack of Efficacy|0|||
125340915|NCT02059291|450884255|FG003|Epoch 2|Lack of Efficacy|1|||
125340916|NCT02059291|450884256|FG004|Epoch 2|Lack of Efficacy|0|||
125340917|NCT02059291|450884257|FG005|Epoch 2|Lack of Efficacy|1|||
125340918|NCT02059291|450884258|FG006|Epoch 2|Lack of Efficacy|0|||
125340919|NCT02059291|450884259|FG007|Epoch 2|Lack of Efficacy|0|||
125340920|NCT02059291|450884260|FG008|Epoch 2|Lack of Efficacy|0|||
125340921|NCT02059291|450884261|FG009|Epoch 2|Lack of Efficacy|0|||
125340922|NCT02059291|450884262|FG010|Epoch 2|Lack of Efficacy|0|||
125340923|NCT02059291|450884263|FG011|Epoch 2|Lack of Efficacy|0|||
125340924|NCT02059291|450884264|FG012|Epoch 2|Lack of Efficacy|0|||
125340925|NCT02059291|450884265|FG013|Epoch 2|Lack of Efficacy|0|||
125340926|NCT02059291|450884266|FG014|Epoch 2|Lack of Efficacy|0|||
125340927|NCT02059291|450884267|FG015|Epoch 2|Lack of Efficacy|0|||
125340928|NCT02059291|450884268|FG016|Epoch 2|Lack of Efficacy|0|||
125340929|NCT02059291|450884269|FG017|Epoch 2|Lack of Efficacy|0|||
125340930|NCT02059291|450884270|FG018|Epoch 2|Lack of Efficacy|0|||
125340931|NCT02059291|450884271|FG019|Epoch 2|Lack of Efficacy|0|||
125340932|NCT02059291|450884272|FG020|Epoch 2|Lack of Efficacy|0|||
125340933|NCT02059291|450884273|FG021|Epoch 2|Lack of Efficacy|0|||
125340934|NCT02059291|450884274|FG022|Epoch 2|Lack of Efficacy|0|||
125340935|NCT02059291|450884275|FG023|Epoch 2|Lack of Efficacy|0|||
125340936|NCT02059291|450884276|FG024|Epoch 2|Lack of Efficacy|0|||
125340937|NCT02059291|450884252|FG000|Epoch 2|Adverse Event|0|||
125340938|NCT02059291|450884253|FG001|Epoch 2|Adverse Event|0|||
125340939|NCT02059291|450884254|FG002|Epoch 2|Adverse Event|1|||
125340940|NCT02059291|450884255|FG003|Epoch 2|Adverse Event|1|||
125340941|NCT02059291|450884256|FG004|Epoch 2|Adverse Event|0|||
125340942|NCT02059291|450884257|FG005|Epoch 2|Adverse Event|0|||
125340943|NCT02059291|450884258|FG006|Epoch 2|Adverse Event|0|||
125340944|NCT02059291|450884259|FG007|Epoch 2|Adverse Event|1|||
125340945|NCT02059291|450884260|FG008|Epoch 2|Adverse Event|1|||
125340946|NCT02059291|450884261|FG009|Epoch 2|Adverse Event|0|||
125340947|NCT02059291|450884262|FG010|Epoch 2|Adverse Event|0|||
125340948|NCT02059291|450884263|FG011|Epoch 2|Adverse Event|0|||
125340949|NCT02059291|450884264|FG012|Epoch 2|Adverse Event|0|||
125340950|NCT02059291|450884265|FG013|Epoch 2|Adverse Event|0|||
125340951|NCT02059291|450884266|FG014|Epoch 2|Adverse Event|0|||
125340952|NCT02059291|450884267|FG015|Epoch 2|Adverse Event|0|||
125340953|NCT02059291|450884268|FG016|Epoch 2|Adverse Event|0|||
125340954|NCT02059291|450884269|FG017|Epoch 2|Adverse Event|0|||
125340955|NCT02059291|450884270|FG018|Epoch 2|Adverse Event|0|||
125340956|NCT02059291|450884271|FG019|Epoch 2|Adverse Event|0|||
125340957|NCT02059291|450884272|FG020|Epoch 2|Adverse Event|0|||
125340958|NCT02059291|450884273|FG021|Epoch 2|Adverse Event|0|||
125340959|NCT02059291|450884274|FG022|Epoch 2|Adverse Event|0|||
125340960|NCT02059291|450884275|FG023|Epoch 2|Adverse Event|0|||
125340961|NCT02059291|450884276|FG024|Epoch 2|Adverse Event|0|||
125340962|NCT02059291|450884252|FG000|Epoch 2|Withdrawal by Subject|0|||
125340963|NCT02059291|450884253|FG001|Epoch 2|Withdrawal by Subject|1|||
125340964|NCT02059291|450884254|FG002|Epoch 2|Withdrawal by Subject|0|||
125340965|NCT02059291|450884255|FG003|Epoch 2|Withdrawal by Subject|0|||
125340966|NCT02059291|450884256|FG004|Epoch 2|Withdrawal by Subject|0|||
125340967|NCT02059291|450884257|FG005|Epoch 2|Withdrawal by Subject|1|||
125340968|NCT02059291|450884258|FG006|Epoch 2|Withdrawal by Subject|0|||
125340969|NCT02059291|450884259|FG007|Epoch 2|Withdrawal by Subject|0|||
125340970|NCT02059291|450884260|FG008|Epoch 2|Withdrawal by Subject|1|||
125340971|NCT02059291|450884261|FG009|Epoch 2|Withdrawal by Subject|0|||
125340972|NCT02059291|450884262|FG010|Epoch 2|Withdrawal by Subject|0|||
125340973|NCT02059291|450884263|FG011|Epoch 2|Withdrawal by Subject|0|||
125340974|NCT02059291|450884264|FG012|Epoch 2|Withdrawal by Subject|0|||
125340975|NCT02059291|450884265|FG013|Epoch 2|Withdrawal by Subject|0|||
125340976|NCT02059291|450884266|FG014|Epoch 2|Withdrawal by Subject|0|||
125340977|NCT02059291|450884267|FG015|Epoch 2|Withdrawal by Subject|0|||
125340978|NCT02059291|450884268|FG016|Epoch 2|Withdrawal by Subject|0|||
125340979|NCT02059291|450884269|FG017|Epoch 2|Withdrawal by Subject|0|||
125340980|NCT02059291|450884270|FG018|Epoch 2|Withdrawal by Subject|0|||
125340981|NCT02059291|450884271|FG019|Epoch 2|Withdrawal by Subject|0|||
125340982|NCT02059291|450884272|FG020|Epoch 2|Withdrawal by Subject|0|||
125340983|NCT02059291|450884273|FG021|Epoch 2|Withdrawal by Subject|0|||
125340984|NCT02059291|450884274|FG022|Epoch 2|Withdrawal by Subject|0|||
125340985|NCT02059291|450884275|FG023|Epoch 2|Withdrawal by Subject|0|||
125340986|NCT02059291|450884276|FG024|Epoch 2|Withdrawal by Subject|0|||
125340987|NCT02059291|450884252|FG000|Epoch 3|Physician Decision|0|||
125340988|NCT02059291|450884253|FG001|Epoch 3|Physician Decision|0|||
125340989|NCT02059291|450884254|FG002|Epoch 3|Physician Decision|0|||
125340990|NCT02059291|450884255|FG003|Epoch 3|Physician Decision|0|||
125340991|NCT02059291|450884256|FG004|Epoch 3|Physician Decision|0|||
125340992|NCT02059291|450884257|FG005|Epoch 3|Physician Decision|0|||
125340993|NCT02059291|450884258|FG006|Epoch 3|Physician Decision|0|||
125340994|NCT02059291|450884259|FG007|Epoch 3|Physician Decision|0|||
125340995|NCT02059291|450884260|FG008|Epoch 3|Physician Decision|0|||
125340996|NCT02059291|450884261|FG009|Epoch 3|Physician Decision|0|||
125340997|NCT02059291|450884262|FG010|Epoch 3|Physician Decision|0|||
125340998|NCT02059291|450884263|FG011|Epoch 3|Physician Decision|0|||
125340999|NCT02059291|450884264|FG012|Epoch 3|Physician Decision|0|||
125341000|NCT02059291|450884265|FG013|Epoch 3|Physician Decision|1|||
125341001|NCT02059291|450884266|FG014|Epoch 3|Physician Decision|0|||
125341002|NCT02059291|450884267|FG015|Epoch 3|Physician Decision|1|||
125341003|NCT02059291|450884268|FG016|Epoch 3|Physician Decision|0|||
125341004|NCT02059291|450884269|FG017|Epoch 3|Physician Decision|0|||
125341005|NCT02059291|450884270|FG018|Epoch 3|Physician Decision|0|||
125341006|NCT02059291|450884271|FG019|Epoch 3|Physician Decision|0|||
125341007|NCT02059291|450884272|FG020|Epoch 3|Physician Decision|0|||
125341008|NCT02059291|450884273|FG021|Epoch 3|Physician Decision|0|||
125341009|NCT02059291|450884274|FG022|Epoch 3|Physician Decision|0|||
125341010|NCT02059291|450884275|FG023|Epoch 3|Physician Decision|0|||
125341011|NCT02059291|450884276|FG024|Epoch 3|Physician Decision|0|||
125341012|NCT02059291|450884252|FG000|Epoch 3|Adverse Event|0|||
125341013|NCT02059291|450884253|FG001|Epoch 3|Adverse Event|0|||
125341014|NCT02059291|450884254|FG002|Epoch 3|Adverse Event|0|||
125341015|NCT02059291|450884255|FG003|Epoch 3|Adverse Event|0|||
125341016|NCT02059291|450884256|FG004|Epoch 3|Adverse Event|0|||
125341017|NCT02059291|450884257|FG005|Epoch 3|Adverse Event|0|||
125341018|NCT02059291|450884258|FG006|Epoch 3|Adverse Event|0|||
125341019|NCT02059291|450884259|FG007|Epoch 3|Adverse Event|0|||
125341020|NCT02059291|450884260|FG008|Epoch 3|Adverse Event|0|||
125341021|NCT02059291|450884261|FG009|Epoch 3|Adverse Event|0|||
125341022|NCT02059291|450884262|FG010|Epoch 3|Adverse Event|0|||
125341023|NCT02059291|450884263|FG011|Epoch 3|Adverse Event|0|||
125341024|NCT02059291|450884264|FG012|Epoch 3|Adverse Event|0|||
125341025|NCT02059291|450884265|FG013|Epoch 3|Adverse Event|0|||
125341026|NCT02059291|450884266|FG014|Epoch 3|Adverse Event|0|||
125341027|NCT02059291|450884267|FG015|Epoch 3|Adverse Event|1|||
125341028|NCT02059291|450884268|FG016|Epoch 3|Adverse Event|0|||
125341029|NCT02059291|450884269|FG017|Epoch 3|Adverse Event|0|||
125341030|NCT02059291|450884270|FG018|Epoch 3|Adverse Event|0|||
125341031|NCT02059291|450884271|FG019|Epoch 3|Adverse Event|0|||
125341032|NCT02059291|450884272|FG020|Epoch 3|Adverse Event|0|||
125341033|NCT02059291|450884273|FG021|Epoch 3|Adverse Event|0|||
125341034|NCT02059291|450884274|FG022|Epoch 3|Adverse Event|0|||
125341035|NCT02059291|450884275|FG023|Epoch 3|Adverse Event|0|||
125341036|NCT02059291|450884276|FG024|Epoch 3|Adverse Event|0|||
125341037|NCT02059291|450884252|FG000|Epoch 3|Lack of Efficacy|0|||
125341038|NCT02059291|450884253|FG001|Epoch 3|Lack of Efficacy|0|||
125341039|NCT02059291|450884254|FG002|Epoch 3|Lack of Efficacy|0|||
125341040|NCT02059291|450884255|FG003|Epoch 3|Lack of Efficacy|0|||
125341041|NCT02059291|450884256|FG004|Epoch 3|Lack of Efficacy|0|||
125341042|NCT02059291|450884257|FG005|Epoch 3|Lack of Efficacy|0|||
125341043|NCT02059291|450884258|FG006|Epoch 3|Lack of Efficacy|0|||
125341044|NCT02059291|450884259|FG007|Epoch 3|Lack of Efficacy|0|||
125341045|NCT02059291|450884260|FG008|Epoch 3|Lack of Efficacy|0|||
125341046|NCT02059291|450884261|FG009|Epoch 3|Lack of Efficacy|0|||
125341047|NCT02059291|450884262|FG010|Epoch 3|Lack of Efficacy|0|||
125341048|NCT02059291|450884263|FG011|Epoch 3|Lack of Efficacy|0|||
125341049|NCT02059291|450884264|FG012|Epoch 3|Lack of Efficacy|0|||
125341050|NCT02059291|450884265|FG013|Epoch 3|Lack of Efficacy|0|||
125341051|NCT02059291|450884266|FG014|Epoch 3|Lack of Efficacy|0|||
125341052|NCT02059291|450884267|FG015|Epoch 3|Lack of Efficacy|3|||
125674240|NCT01090765|452096631|FG000|Overall Study|Patient withdrew consent|0|||
125674241|NCT01090765|452096632|FG001|Overall Study|Patient withdrew consent|0|||
125674242|NCT01090765|452096633|FG002|Overall Study|Patient withdrew consent|0|||
125674243|NCT01090765|452096634|FG003|Overall Study|Patient withdrew consent|0|||
125674244|NCT01090765|452096635|FG004|Overall Study|Patient withdrew consent|1|||
125674245|NCT01090765|452096636|FG005|Overall Study|Patient withdrew consent|1|||
125674246|NCT01090765|452096631|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
125674247|NCT01090765|452096632|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
125341053|NCT02059291|450884268|FG016|Epoch 3|Lack of Efficacy|0|||
125341054|NCT02059291|450884269|FG017|Epoch 3|Lack of Efficacy|0|||
125341055|NCT02059291|450884270|FG018|Epoch 3|Lack of Efficacy|0|||
125341056|NCT02059291|450884271|FG019|Epoch 3|Lack of Efficacy|0|||
125341057|NCT02059291|450884272|FG020|Epoch 3|Lack of Efficacy|0|||
125341058|NCT02059291|450884273|FG021|Epoch 3|Lack of Efficacy|0|||
125341059|NCT02059291|450884274|FG022|Epoch 3|Lack of Efficacy|0|||
125341060|NCT02059291|450884275|FG023|Epoch 3|Lack of Efficacy|0|||
125341061|NCT02059291|450884276|FG024|Epoch 3|Lack of Efficacy|0|||
125341062|NCT02059291|450884252|FG000|Epoch 3|Withdrawal by Subject|0|||
125341063|NCT02059291|450884253|FG001|Epoch 3|Withdrawal by Subject|0|||
125341064|NCT02059291|450884254|FG002|Epoch 3|Withdrawal by Subject|0|||
125341065|NCT02059291|450884255|FG003|Epoch 3|Withdrawal by Subject|0|||
125341066|NCT02059291|450884256|FG004|Epoch 3|Withdrawal by Subject|0|||
125341067|NCT02059291|450884257|FG005|Epoch 3|Withdrawal by Subject|0|||
125341068|NCT02059291|450884258|FG006|Epoch 3|Withdrawal by Subject|0|||
125341069|NCT02059291|450884259|FG007|Epoch 3|Withdrawal by Subject|0|||
125341070|NCT02059291|450884260|FG008|Epoch 3|Withdrawal by Subject|0|||
125341071|NCT02059291|450884261|FG009|Epoch 3|Withdrawal by Subject|0|||
125341072|NCT02059291|450884262|FG010|Epoch 3|Withdrawal by Subject|0|||
125341073|NCT02059291|450884263|FG011|Epoch 3|Withdrawal by Subject|0|||
125341074|NCT02059291|450884264|FG012|Epoch 3|Withdrawal by Subject|0|||
125341075|NCT02059291|450884265|FG013|Epoch 3|Withdrawal by Subject|0|||
125341076|NCT02059291|450884266|FG014|Epoch 3|Withdrawal by Subject|0|||
125341077|NCT02059291|450884267|FG015|Epoch 3|Withdrawal by Subject|1|||
125341078|NCT02059291|450884268|FG016|Epoch 3|Withdrawal by Subject|0|||
125341079|NCT02059291|450884269|FG017|Epoch 3|Withdrawal by Subject|0|||
125341080|NCT02059291|450884270|FG018|Epoch 3|Withdrawal by Subject|0|||
125341081|NCT02059291|450884271|FG019|Epoch 3|Withdrawal by Subject|0|||
125341082|NCT02059291|450884272|FG020|Epoch 3|Withdrawal by Subject|0|||
125341083|NCT02059291|450884273|FG021|Epoch 3|Withdrawal by Subject|0|||
125341084|NCT02059291|450884274|FG022|Epoch 3|Withdrawal by Subject|0|||
125341085|NCT02059291|450884275|FG023|Epoch 3|Withdrawal by Subject|0|||
125341086|NCT02059291|450884276|FG024|Epoch 3|Withdrawal by Subject|0|||
125341087|NCT02059291|450884252|FG000|Epoch 4|Adverse Event|0|||
125341088|NCT02059291|450884253|FG001|Epoch 4|Adverse Event|0|||
125341089|NCT02059291|450884254|FG002|Epoch 4|Adverse Event|0|||
125341090|NCT02059291|450884255|FG003|Epoch 4|Adverse Event|0|||
125341091|NCT02059291|450884256|FG004|Epoch 4|Adverse Event|0|||
125341092|NCT02059291|450884257|FG005|Epoch 4|Adverse Event|0|||
125341093|NCT02059291|450884258|FG006|Epoch 4|Adverse Event|0|||
125341094|NCT02059291|450884259|FG007|Epoch 4|Adverse Event|0|||
125341095|NCT02059291|450884260|FG008|Epoch 4|Adverse Event|0|||
125341096|NCT02059291|450884261|FG009|Epoch 4|Adverse Event|0|||
125341097|NCT02059291|450884262|FG010|Epoch 4|Adverse Event|0|||
125341098|NCT02059291|450884263|FG011|Epoch 4|Adverse Event|0|||
125341099|NCT02059291|450884264|FG012|Epoch 4|Adverse Event|0|||
125341100|NCT02059291|450884265|FG013|Epoch 4|Adverse Event|0|||
125341101|NCT02059291|450884266|FG014|Epoch 4|Adverse Event|0|||
125341102|NCT02059291|450884267|FG015|Epoch 4|Adverse Event|0|||
125341103|NCT02059291|450884268|FG016|Epoch 4|Adverse Event|1|||
125341104|NCT02059291|450884269|FG017|Epoch 4|Adverse Event|0|||
125341105|NCT02059291|450884270|FG018|Epoch 4|Adverse Event|0|||
125341106|NCT02059291|450884271|FG019|Epoch 4|Adverse Event|0|||
125341107|NCT02059291|450884272|FG020|Epoch 4|Adverse Event|0|||
125341108|NCT02059291|450884273|FG021|Epoch 4|Adverse Event|0|||
125341109|NCT02059291|450884274|FG022|Epoch 4|Adverse Event|1|||
125341110|NCT02059291|450884275|FG023|Epoch 4|Adverse Event|0|||
125341111|NCT02059291|450884276|FG024|Epoch 4|Adverse Event|0|||
125341112|NCT02059291|450884252|FG000|Epoch 4|Pregnancy|0|||
125341113|NCT02059291|450884253|FG001|Epoch 4|Pregnancy|0|||
125341114|NCT02059291|450884254|FG002|Epoch 4|Pregnancy|0|||
125341115|NCT02059291|450884255|FG003|Epoch 4|Pregnancy|0|||
125341116|NCT02059291|450884256|FG004|Epoch 4|Pregnancy|0|||
125341117|NCT02059291|450884257|FG005|Epoch 4|Pregnancy|0|||
125341118|NCT02059291|450884258|FG006|Epoch 4|Pregnancy|0|||
125341119|NCT02059291|450884259|FG007|Epoch 4|Pregnancy|0|||
125341120|NCT02059291|450884260|FG008|Epoch 4|Pregnancy|0|||
125341121|NCT02059291|450884261|FG009|Epoch 4|Pregnancy|0|||
125341122|NCT02059291|450884262|FG010|Epoch 4|Pregnancy|0|||
125341123|NCT02059291|450884263|FG011|Epoch 4|Pregnancy|0|||
125341124|NCT02059291|450884264|FG012|Epoch 4|Pregnancy|0|||
125341125|NCT02059291|450884265|FG013|Epoch 4|Pregnancy|0|||
125341126|NCT02059291|450884266|FG014|Epoch 4|Pregnancy|0|||
125341127|NCT02059291|450884267|FG015|Epoch 4|Pregnancy|0|||
125341128|NCT02059291|450884268|FG016|Epoch 4|Pregnancy|1|||
125341129|NCT02059291|450884269|FG017|Epoch 4|Pregnancy|0|||
125341130|NCT02059291|450884270|FG018|Epoch 4|Pregnancy|0|||
125341131|NCT02059291|450884271|FG019|Epoch 4|Pregnancy|0|||
125341132|NCT02059291|450884272|FG020|Epoch 4|Pregnancy|0|||
125341133|NCT02059291|450884273|FG021|Epoch 4|Pregnancy|0|||
125341134|NCT02059291|450884274|FG022|Epoch 4|Pregnancy|0|||
125341135|NCT02059291|450884275|FG023|Epoch 4|Pregnancy|0|||
125341136|NCT02059291|450884276|FG024|Epoch 4|Pregnancy|0|||
125341137|NCT02059291|450884252|FG000|Epoch 4|Withdrawal by Subject|0|||
125341138|NCT02059291|450884253|FG001|Epoch 4|Withdrawal by Subject|0|||
125341139|NCT02059291|450884254|FG002|Epoch 4|Withdrawal by Subject|0|||
125341140|NCT02059291|450884255|FG003|Epoch 4|Withdrawal by Subject|0|||
125341141|NCT02059291|450884256|FG004|Epoch 4|Withdrawal by Subject|0|||
125341142|NCT02059291|450884257|FG005|Epoch 4|Withdrawal by Subject|0|||
125341143|NCT02059291|450884258|FG006|Epoch 4|Withdrawal by Subject|0|||
125341144|NCT02059291|450884259|FG007|Epoch 4|Withdrawal by Subject|0|||
125341145|NCT02059291|450884260|FG008|Epoch 4|Withdrawal by Subject|0|||
125341146|NCT02059291|450884261|FG009|Epoch 4|Withdrawal by Subject|0|||
125341147|NCT02059291|450884262|FG010|Epoch 4|Withdrawal by Subject|0|||
125341148|NCT02059291|450884263|FG011|Epoch 4|Withdrawal by Subject|0|||
125341149|NCT02059291|450884264|FG012|Epoch 4|Withdrawal by Subject|0|||
125341150|NCT02059291|450884265|FG013|Epoch 4|Withdrawal by Subject|0|||
125341151|NCT02059291|450884266|FG014|Epoch 4|Withdrawal by Subject|0|||
125341152|NCT02059291|450884267|FG015|Epoch 4|Withdrawal by Subject|0|||
125341153|NCT02059291|450884268|FG016|Epoch 4|Withdrawal by Subject|0|||
125341154|NCT02059291|450884269|FG017|Epoch 4|Withdrawal by Subject|0|||
125341155|NCT02059291|450884270|FG018|Epoch 4|Withdrawal by Subject|0|||
125341156|NCT02059291|450884271|FG019|Epoch 4|Withdrawal by Subject|0|||
125341157|NCT02059291|450884272|FG020|Epoch 4|Withdrawal by Subject|1|||
125341158|NCT02059291|450884273|FG021|Epoch 4|Withdrawal by Subject|0|||
125341159|NCT02059291|450884274|FG022|Epoch 4|Withdrawal by Subject|0|||
125341160|NCT02059291|450884275|FG023|Epoch 4|Withdrawal by Subject|0|||
125341161|NCT02059291|450884276|FG024|Epoch 4|Withdrawal by Subject|0|||
125341162|NCT02059291|450884252|FG000|Epoch 4|Lack of Efficacy|0|||
125341163|NCT02059291|450884253|FG001|Epoch 4|Lack of Efficacy|0|||
125341164|NCT02059291|450884254|FG002|Epoch 4|Lack of Efficacy|0|||
125341165|NCT02059291|450884255|FG003|Epoch 4|Lack of Efficacy|0|||
125341166|NCT02059291|450884256|FG004|Epoch 4|Lack of Efficacy|0|||
125341167|NCT02059291|450884257|FG005|Epoch 4|Lack of Efficacy|0|||
125341168|NCT02059291|450884258|FG006|Epoch 4|Lack of Efficacy|0|||
125341169|NCT02059291|450884259|FG007|Epoch 4|Lack of Efficacy|0|||
125341170|NCT02059291|450884260|FG008|Epoch 4|Lack of Efficacy|0|||
125341171|NCT02059291|450884261|FG009|Epoch 4|Lack of Efficacy|0|||
125341172|NCT02059291|450884262|FG010|Epoch 4|Lack of Efficacy|0|||
125341173|NCT02059291|450884263|FG011|Epoch 4|Lack of Efficacy|0|||
125341174|NCT02059291|450884264|FG012|Epoch 4|Lack of Efficacy|0|||
125341175|NCT02059291|450884265|FG013|Epoch 4|Lack of Efficacy|0|||
125341176|NCT02059291|450884266|FG014|Epoch 4|Lack of Efficacy|0|||
125341177|NCT02059291|450884267|FG015|Epoch 4|Lack of Efficacy|0|||
125341178|NCT02059291|450884268|FG016|Epoch 4|Lack of Efficacy|0|||
125341179|NCT02059291|450884269|FG017|Epoch 4|Lack of Efficacy|0|||
125341180|NCT02059291|450884270|FG018|Epoch 4|Lack of Efficacy|0|||
125341181|NCT02059291|450884271|FG019|Epoch 4|Lack of Efficacy|0|||
125341182|NCT02059291|450884272|FG020|Epoch 4|Lack of Efficacy|0|||
125341183|NCT02059291|450884273|FG021|Epoch 4|Lack of Efficacy|0|||
125341184|NCT02059291|450884274|FG022|Epoch 4|Lack of Efficacy|0|||
125341185|NCT02059291|450884275|FG023|Epoch 4|Lack of Efficacy|1|||
125341186|NCT02059291|450884276|FG024|Epoch 4|Lack of Efficacy|0|||
125341187|NCT01433289|450884277|FG000|Overall Study|Pregnancy|0|||
125341188|NCT01433289|450884278|FG001|Overall Study|Pregnancy|1|||
125341189|NCT01433289|450884279|FG002|Overall Study|Pregnancy|0|||
125341190|NCT01433289|450884280|FG003|Overall Study|Pregnancy|0|||
125341191|NCT03241368|450884281|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
125341192|NCT03241368|450884281|FG000|Overall Study|Lost to Follow-up|1|||
125341193|NCT03241368|450884281|FG000|Overall Study|Physician Decision|6|||
125341194|NCT03241368|450884281|FG000|Overall Study|Withdrawal by Subject|6|||
125341195|NCT03241368|450884281|FG000|Overall Study|Protocol Violation|1|||
125341196|NCT00080899|450884284|FG000|Overall Study|Adverse Event|1|||
125341197|NCT04343235|450884286|FG000|Overall Study|Lost to Follow-up|3|||
125341198|NCT04343235|450884287|FG001|Overall Study|Lost to Follow-up|2|||
125341199|NCT00787267|450884288|FG000|Overall Study|Screen failure/Ineligible|10|||
125341200|NCT00787267|450884288|FG000|Overall Study|No Reason Provided|1|||
125341201|NCT00787267|450884288|FG000|Overall Study|Withdrawal by Subject|1|||
125341202|NCT00865280|450884289|FG000|Overall Study|Withdrawal by Subject|4|||
125341203|NCT00865280|450884290|FG001|Overall Study|Withdrawal by Subject|1|||
125341204|NCT00865280|450884289|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
125341205|NCT00865280|450884290|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
125341206|NCT00865280|450884289|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
125341207|NCT00865280|450884290|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
125341208|NCT00865280|450884289|FG000|Overall Study|Exclusion Condition|1|||
125341209|NCT00865280|450884290|FG001|Overall Study|Exclusion Condition|0|||
125341210|NCT00865280|450884289|FG000|Overall Study|Adverse Event|0|||
125341211|NCT00865280|450884290|FG001|Overall Study|Adverse Event|1|||
125341212|NCT01616693|450884291|FG000|Evaluated for Safety|Physician Decision|1|||
125341213|NCT01616693|450884292|FG001|Evaluated for Safety|Physician Decision|0|||
125341214|NCT01616693|450884293|FG002|Evaluated for Safety|Physician Decision|1|||
125341215|NCT01616693|450884294|FG003|Evaluated for Safety|Physician Decision|0|||
125341216|NCT01616693|450884291|FG000|Received Both Vaccines|Adverse Event|2|||
125341217|NCT01616693|450884292|FG001|Received Both Vaccines|Adverse Event|0|||
125341218|NCT01616693|450884293|FG002|Received Both Vaccines|Adverse Event|0|||
125341219|NCT01616693|450884294|FG003|Received Both Vaccines|Adverse Event|0|||
125341220|NCT01616693|450884291|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
125341221|NCT01616693|450884292|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
125341222|NCT01616693|450884293|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
125341223|NCT01616693|450884294|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
125341224|NCT01616693|450884291|FG000|Received Both Vaccines|Lost to Follow-up|4|||
125341225|NCT01616693|450884292|FG001|Received Both Vaccines|Lost to Follow-up|3|||
125341226|NCT01616693|450884293|FG002|Received Both Vaccines|Lost to Follow-up|4|||
125341227|NCT01616693|450884294|FG003|Received Both Vaccines|Lost to Follow-up|4|||
125341228|NCT01616693|450884291|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
125341229|NCT01616693|450884292|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
125341230|NCT01616693|450884293|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
125341231|NCT01616693|450884294|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
125341232|NCT00653939|450884295|FG000|Overall Study|Adverse Event|1|||
125341233|NCT00653939|450884296|FG001|Overall Study|Adverse Event|3|||
125341234|NCT00653939|450884295|FG000|Overall Study|Withdrawal by Subject|3|||
125341235|NCT00653939|450884296|FG001|Overall Study|Withdrawal by Subject|3|||
125341236|NCT00653939|450884295|FG000|Overall Study|Physician Decision|4|||
125341237|NCT00653939|450884296|FG001|Overall Study|Physician Decision|0|||
125341238|NCT00653939|450884295|FG000|Overall Study|Disease Progression|2|||
125341239|NCT00653939|450884296|FG001|Overall Study|Disease Progression|3|||
125341240|NCT00653939|450884295|FG000|Overall Study|Other|2|||
125341241|NCT00653939|450884296|FG001|Overall Study|Other|6|||
125341242|NCT01105767|450884297|FG000|Overall Study|Lost to Follow-up|1160|||
125341243|NCT01105767|450884298|FG001|Overall Study|Lost to Follow-up|1614|||
125341244|NCT01105767|450884299|FG002|Overall Study|Lost to Follow-up|1184|||
125341245|NCT00743106|450884300|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
125341246|NCT00743106|450884301|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
125341247|NCT02874144|450884306|FG000|Overall Study|Lost to Follow-up|3|||
125341248|NCT02874144|450884307|FG001|Overall Study|Lost to Follow-up|5|||
125341249|NCT00486811|450884310|FG000|Overall Study|Adverse Event|28|||
125341250|NCT00486811|450884311|FG001|Overall Study|Adverse Event|60|||
125341251|NCT00486811|450884312|FG002|Overall Study|Adverse Event|135|||
125341252|NCT00486811|450884310|FG000|Overall Study|Lack of Efficacy|34|||
125341253|NCT00486811|450884311|FG001|Overall Study|Lack of Efficacy|14|||
125341254|NCT00486811|450884312|FG002|Overall Study|Lack of Efficacy|7|||
125341255|NCT00486811|450884310|FG000|Overall Study|Lost to Follow-up|4|||
125341256|NCT00486811|450884311|FG001|Overall Study|Lost to Follow-up|6|||
125341257|NCT00486811|450884312|FG002|Overall Study|Lost to Follow-up|4|||
125341258|NCT00486811|450884310|FG000|Overall Study|Withdrawal by Subject|33|||
125341259|NCT00486811|450884311|FG001|Overall Study|Withdrawal by Subject|44|||
125341260|NCT00486811|450884312|FG002|Overall Study|Withdrawal by Subject|58|||
125341261|NCT00486811|450884310|FG000|Overall Study|Study drug non-compliant|5|||
125341262|NCT00486811|450884311|FG001|Overall Study|Study drug non-compliant|6|||
125341263|NCT00486811|450884312|FG002|Overall Study|Study drug non-compliant|3|||
125341264|NCT00486811|450884310|FG000|Overall Study|All other|18|||
125341265|NCT00486811|450884311|FG001|Overall Study|All other|11|||
125341266|NCT00486811|450884312|FG002|Overall Study|All other|7|||
125341267|NCT03753789|450884313|FG000|Overall Study|Withdrawal by Subject|2|||
125341268|NCT01711216|450884320|FG000|Overall Study|Adverse Event|4|||
125341269|NCT01711216|450884320|FG000|Overall Study|Pregnancy|56|||
125341270|NCT01711216|450884320|FG000|Overall Study|Withdrawal by Subject|6|||
125341271|NCT01711216|450884320|FG000|Overall Study|Lost to Follow-up|46|||
125341272|NCT01711216|450884320|FG000|Overall Study|variety of other minor reasons|83|||
125341273|NCT01711216|450884320|FG000|Overall Study|no reason specified|22|||
125341274|NCT00946153|450884322|FG000|Phase 2|Adverse Event|0|||
125341275|NCT00946153|450884323|FG001|Phase 2|Adverse Event|0|||
125341276|NCT00946153|450884324|FG002|Phase 2|Adverse Event|0|||
125341277|NCT00946153|450884325|FG003|Phase 2|Adverse Event|0|||
125341278|NCT00946153|450884326|FG004|Phase 2|Adverse Event|6|||
125341279|NCT00946153|450884322|FG000|Phase 2|Need more reduction of dose|0|||
125341280|NCT00946153|450884323|FG001|Phase 2|Need more reduction of dose|0|||
125341281|NCT00946153|450884324|FG002|Phase 2|Need more reduction of dose|0|||
125341282|NCT00946153|450884325|FG003|Phase 2|Need more reduction of dose|0|||
125341283|NCT00946153|450884326|FG004|Phase 2|Need more reduction of dose|2|||
125341284|NCT00946153|450884322|FG000|Phase 2|Physician Decision|0|||
125341285|NCT00946153|450884323|FG001|Phase 2|Physician Decision|0|||
125341286|NCT00946153|450884324|FG002|Phase 2|Physician Decision|0|||
125341287|NCT00946153|450884325|FG003|Phase 2|Physician Decision|0|||
125341288|NCT00946153|450884326|FG004|Phase 2|Physician Decision|1|||
125341289|NCT00946153|450884322|FG000|Phase 2|14 days washout for recovery due to AE|0|||
125341290|NCT00946153|450884323|FG001|Phase 2|14 days washout for recovery due to AE|0|||
125341291|NCT00946153|450884324|FG002|Phase 2|14 days washout for recovery due to AE|0|||
125341292|NCT00946153|450884325|FG003|Phase 2|14 days washout for recovery due to AE|0|||
125341293|NCT00946153|450884326|FG004|Phase 2|14 days washout for recovery due to AE|4|||
125341294|NCT01030666|450884327|FG000|Overall Study|Lost to Follow-up|3|||
125341295|NCT01030666|450884328|FG001|Overall Study|Lost to Follow-up|2|||
125341296|NCT01144299|450884329|FG000|Overall Study|Lost to Follow-up|1|||
125341297|NCT01144299|450884330|FG001|Overall Study|Lost to Follow-up|0|||
125341298|NCT01144299|450884329|FG000|Overall Study|Withdrawal by Subject|1|||
125341299|NCT01144299|450884330|FG001|Overall Study|Withdrawal by Subject|0|||
125341300|NCT03698591|450884336|FG000|Overall Study|Withdrawal by Subject|2|||
125341301|NCT03698591|450884337|FG001|Overall Study|Withdrawal by Subject|2|||
125341302|NCT03698591|450884336|FG000|Overall Study|Failed drug screen|1|||
125341303|NCT03698591|450884337|FG001|Overall Study|Failed drug screen|1|||
125341304|NCT03698591|450884336|FG000|Overall Study|Failed health screen|0|||
125341305|NCT03698591|450884337|FG001|Overall Study|Failed health screen|1|||
125341306|NCT03698591|450884336|FG000|Overall Study|Ineligible for financial compensation|1|||
125341307|NCT03698591|450884337|FG001|Overall Study|Ineligible for financial compensation|0|||
125341308|NCT03698591|450884336|FG000|Overall Study|Equipment Error|1|||
125341309|NCT03698591|450884337|FG001|Overall Study|Equipment Error|0|||
125341310|NCT03698591|450884336|FG000|Overall Study|Could not establish TMS dosage|0|||
125341311|NCT03698591|450884337|FG001|Overall Study|Could not establish TMS dosage|1|||
125341312|NCT00831493|450884341|FG000|Overall Study|Intractable nausea and vomiting|1|||
125341313|NCT00557856|450884348|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
125341314|NCT00557856|450884349|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
125341315|NCT00557856|450884350|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
125341316|NCT00557856|450884351|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
125341317|NCT00557856|450884352|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
125341318|NCT00557856|450884353|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
125341319|NCT00557856|450884354|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
125341320|NCT00557856|450884355|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
125341321|NCT00557856|450884356|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
125341322|NCT00557856|450884348|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
125341323|NCT00557856|450884349|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125341324|NCT00557856|450884350|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
125341325|NCT00557856|450884351|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125674248|NCT01090765|452096633|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
125674249|NCT01090765|452096634|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
125674250|NCT01090765|452096635|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
125674251|NCT01090765|452096636|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
125674252|NCT01090765|452096631|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
125674253|NCT01090765|452096632|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
125674254|NCT01090765|452096633|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
125674255|NCT01090765|452096634|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
125674256|NCT01090765|452096635|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
125674257|NCT01090765|452096636|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
125674258|NCT02623959|452096640|FG000|Overall Study|Progression|0|||
125674259|NCT02623959|452096641|FG001|Overall Study|Progression|1|||
125674260|NCT02336737|452096644|FG000|Overall Study|Withdrawal by Subject|5|||
125674261|NCT02336737|452096644|FG000|Overall Study|Physician Decision|8|||
125674262|NCT02396381|452096645|FG000|Overall Study|Adverse Event|3|||
125674263|NCT02396381|452096646|FG001|Overall Study|Adverse Event|2|||
125674264|NCT02396381|452096645|FG000|Overall Study|Withdrawal by Subject|33|||
125674265|NCT02396381|452096646|FG001|Overall Study|Withdrawal by Subject|24|||
125674266|NCT02396381|452096645|FG000|Overall Study|Lost to Follow-up|49|||
125674267|NCT02396381|452096646|FG001|Overall Study|Lost to Follow-up|31|||
125674268|NCT02396381|452096645|FG000|Overall Study|Protocol Violation|1|||
125674269|NCT02396381|452096646|FG001|Overall Study|Protocol Violation|0|||
125674270|NCT02396381|452096645|FG000|Overall Study|Site terminated by sponsor|7|||
125674271|NCT02396381|452096646|FG001|Overall Study|Site terminated by sponsor|8|||
125674272|NCT02396381|452096645|FG000|Overall Study|Physician Decision|5|||
125674273|NCT02396381|452096646|FG001|Overall Study|Physician Decision|5|||
125674274|NCT02396381|452096645|FG000|Overall Study|Pregnancy|2|||
125674275|NCT02396381|452096646|FG001|Overall Study|Pregnancy|0|||
125674276|NCT02396381|452096645|FG000|Overall Study|Non-compliance with study procedures|1|||
125674277|NCT02396381|452096646|FG001|Overall Study|Non-compliance with study procedures|0|||
125674278|NCT02396381|452096645|FG000|Overall Study|Moved out of town/state|1|||
125674279|NCT02396381|452096646|FG001|Overall Study|Moved out of town/state|3|||
125674280|NCT02396381|452096645|FG000|Overall Study|Could not complete visit|1|||
125674281|NCT02396381|452096646|FG001|Overall Study|Could not complete visit|0|||
125674282|NCT02396381|452096645|FG000|Overall Study|Possible conflict of interest|1|||
125674283|NCT02396381|452096646|FG001|Overall Study|Possible conflict of interest|0|||
125674284|NCT02396381|452096645|FG000|Overall Study|Randomization/Screening Error|3|||
125674285|NCT02396381|452096646|FG001|Overall Study|Randomization/Screening Error|1|||
125674286|NCT00635778|452096648|FG000|Overall Study|Adverse Event|1|||
125341326|NCT00557856|450884352|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125341327|NCT00557856|450884353|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125341328|NCT00557856|450884354|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125341329|NCT00557856|450884355|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125341330|NCT00557856|450884356|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
125341331|NCT00557856|450884348|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
125341332|NCT00557856|450884349|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
125341333|NCT00557856|450884350|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
125341334|NCT00557856|450884351|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
125341335|NCT00557856|450884352|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
125341336|NCT00557856|450884353|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
125341337|NCT00557856|450884354|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
125341338|NCT00557856|450884355|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
125341339|NCT00557856|450884356|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
125341340|NCT00557856|450884348|FG000|Part 1: Dose Escalation Phase|Other|0|||
125341341|NCT00557856|450884349|FG001|Part 1: Dose Escalation Phase|Other|0|||
125341342|NCT00557856|450884350|FG002|Part 1: Dose Escalation Phase|Other|1|||
125341343|NCT00557856|450884351|FG003|Part 1: Dose Escalation Phase|Other|1|||
125341344|NCT00557856|450884352|FG004|Part 1: Dose Escalation Phase|Other|0|||
125341345|NCT00557856|450884353|FG005|Part 1: Dose Escalation Phase|Other|0|||
125341346|NCT00557856|450884354|FG006|Part 1: Dose Escalation Phase|Other|0|||
125341347|NCT00557856|450884355|FG007|Part 1: Dose Escalation Phase|Other|1|||
125341348|NCT00557856|450884356|FG008|Part 1: Dose Escalation Phase|Other|0|||
125341349|NCT00557856|450884348|FG000|Part 1: Dose Escalation Phase|Death|0|||
125341350|NCT00557856|450884349|FG001|Part 1: Dose Escalation Phase|Death|0|||
125341351|NCT00557856|450884350|FG002|Part 1: Dose Escalation Phase|Death|0|||
125341352|NCT00557856|450884351|FG003|Part 1: Dose Escalation Phase|Death|0|||
125341353|NCT00557856|450884352|FG004|Part 1: Dose Escalation Phase|Death|0|||
125341354|NCT00557856|450884353|FG005|Part 1: Dose Escalation Phase|Death|1|||
125341355|NCT00557856|450884354|FG006|Part 1: Dose Escalation Phase|Death|0|||
125341356|NCT00557856|450884355|FG007|Part 1: Dose Escalation Phase|Death|0|||
125341357|NCT00557856|450884356|FG008|Part 1: Dose Escalation Phase|Death|0|||
125341358|NCT00557856|450884348|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125341359|NCT00557856|450884349|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125341360|NCT00557856|450884350|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125341361|NCT00557856|450884351|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125341362|NCT00557856|450884352|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125341363|NCT00557856|450884353|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
125341364|NCT00557856|450884354|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
125341365|NCT00557856|450884355|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125341366|NCT00557856|450884356|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
125341367|NCT00557856|450884348|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
125341368|NCT00557856|450884349|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125341369|NCT00557856|450884350|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125341370|NCT00557856|450884351|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125341371|NCT00557856|450884352|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125341372|NCT00557856|450884353|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125341373|NCT00557856|450884354|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125341374|NCT00557856|450884355|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125341375|NCT00557856|450884356|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
125341376|NCT00557856|450884348|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
125341377|NCT00557856|450884349|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
125341378|NCT00557856|450884350|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
125341379|NCT00557856|450884351|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
125341380|NCT00557856|450884352|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
125341381|NCT00557856|450884353|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
125341382|NCT00557856|450884354|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
125341383|NCT00557856|450884355|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
125341384|NCT00557856|450884356|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
125341385|NCT00557856|450884348|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125341386|NCT00557856|450884349|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125341387|NCT00557856|450884350|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125341388|NCT00557856|450884351|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125341389|NCT00557856|450884352|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125341390|NCT00557856|450884353|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125341391|NCT00557856|450884354|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125341392|NCT00557856|450884355|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
125341393|NCT00557856|450884356|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
125341394|NCT00557856|450884348|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
125341395|NCT00557856|450884349|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
125341396|NCT00557856|450884350|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
125341397|NCT00557856|450884351|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
125341398|NCT00557856|450884352|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
125341399|NCT00557856|450884353|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
125341400|NCT00557856|450884354|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
125341401|NCT00557856|450884355|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
125341402|NCT00557856|450884356|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
125341403|NCT00557856|450884348|FG000|Part 2: Exploratory Phase|Other|0|||
125341404|NCT00557856|450884349|FG001|Part 2: Exploratory Phase|Other|0|||
125341405|NCT00557856|450884350|FG002|Part 2: Exploratory Phase|Other|0|||
125341406|NCT00557856|450884351|FG003|Part 2: Exploratory Phase|Other|0|||
125341407|NCT00557856|450884352|FG004|Part 2: Exploratory Phase|Other|0|||
125341408|NCT00557856|450884353|FG005|Part 2: Exploratory Phase|Other|0|||
125341409|NCT00557856|450884354|FG006|Part 2: Exploratory Phase|Other|0|||
125341410|NCT00557856|450884355|FG007|Part 2: Exploratory Phase|Other|0|||
125341411|NCT00557856|450884356|FG008|Part 2: Exploratory Phase|Other|1|||
125341412|NCT00557856|450884348|FG000|Part 2: Exploratory Phase|Death|0|||
125341413|NCT00557856|450884349|FG001|Part 2: Exploratory Phase|Death|0|||
125341414|NCT00557856|450884350|FG002|Part 2: Exploratory Phase|Death|0|||
125341415|NCT00557856|450884351|FG003|Part 2: Exploratory Phase|Death|0|||
125341416|NCT00557856|450884352|FG004|Part 2: Exploratory Phase|Death|0|||
125341417|NCT00557856|450884353|FG005|Part 2: Exploratory Phase|Death|0|||
125341418|NCT00557856|450884354|FG006|Part 2: Exploratory Phase|Death|0|||
125341419|NCT00557856|450884355|FG007|Part 2: Exploratory Phase|Death|0|||
125341420|NCT00557856|450884356|FG008|Part 2: Exploratory Phase|Death|2|||
125341421|NCT00557856|450884348|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
125341422|NCT00557856|450884349|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
125341423|NCT00557856|450884350|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
125341424|NCT00557856|450884351|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
125341425|NCT00557856|450884352|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
125341426|NCT00557856|450884353|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
125341427|NCT00557856|450884354|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
125341428|NCT00557856|450884355|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
125341429|NCT00557856|450884356|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
125674287|NCT00635778|452096649|FG001|Overall Study|Adverse Event|0|||
125674288|NCT00635778|452096650|FG002|Overall Study|Adverse Event|0|||
125674289|NCT00635778|452096651|FG003|Overall Study|Adverse Event|3|||
125674290|NCT00635778|452096652|FG004|Overall Study|Adverse Event|3|||
125674291|NCT00635778|452096653|FG005|Overall Study|Adverse Event|6|||
125674292|NCT00635778|452096654|FG006|Overall Study|Adverse Event|1|||
125674293|NCT00635778|452096648|FG000|Overall Study|Withdrawal by Subject|0|||
125674294|NCT00635778|452096649|FG001|Overall Study|Withdrawal by Subject|0|||
125674295|NCT00635778|452096650|FG002|Overall Study|Withdrawal by Subject|0|||
125674296|NCT00635778|452096651|FG003|Overall Study|Withdrawal by Subject|1|||
125674297|NCT00635778|452096652|FG004|Overall Study|Withdrawal by Subject|0|||
125674298|NCT00635778|452096653|FG005|Overall Study|Withdrawal by Subject|1|||
125674299|NCT00635778|452096654|FG006|Overall Study|Withdrawal by Subject|1|||
125674300|NCT00635778|452096648|FG000|Overall Study|Progressive disease|0|||
125674301|NCT00635778|452096649|FG001|Overall Study|Progressive disease|3|||
125674302|NCT00635778|452096650|FG002|Overall Study|Progressive disease|3|||
125674303|NCT00635778|452096651|FG003|Overall Study|Progressive disease|4|||
125674304|NCT00635778|452096652|FG004|Overall Study|Progressive disease|5|||
125674305|NCT00635778|452096653|FG005|Overall Study|Progressive disease|14|||
125674306|NCT00635778|452096654|FG006|Overall Study|Progressive disease|4|||
125674307|NCT01884025|452096655|FG000|Overall Study|Lost to Follow-up|3|||
125674308|NCT01884025|452096656|FG001|Overall Study|Lost to Follow-up|4|||
125674309|NCT02324465|452096657|FG000|Overall Study|device failure|0|||
125674310|NCT02324465|452096658|FG001|Overall Study|device failure|1|||
125674311|NCT02655237|452096661|FG000|Overall Study|Adverse Event|10|||
125674312|NCT02655237|452096662|FG001|Overall Study|Adverse Event|7|||
125674313|NCT02655237|452096661|FG000|Overall Study|Protocol Deviation|2|||
125674314|NCT02655237|452096662|FG001|Overall Study|Protocol Deviation|0|||
125674315|NCT02655237|452096661|FG000|Overall Study|Withdrawal by Participant|1|||
125674316|NCT02655237|452096662|FG001|Overall Study|Withdrawal by Participant|2|||
125674317|NCT02655237|452096661|FG000|Overall Study|Lack of Efficacy|0|||
125674318|NCT02655237|452096662|FG001|Overall Study|Lack of Efficacy|1|||
125674319|NCT02655237|452096661|FG000|Overall Study|Recovery Leading to Surgery|2|||
125674320|NCT02655237|452096662|FG001|Overall Study|Recovery Leading to Surgery|1|||
125674321|NCT02655237|452096661|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
125674322|NCT02655237|452096662|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
125674323|NCT02655237|452096661|FG000|Overall Study|Randomized but Not Treated|1|||
125341430|NCT01675167|450884357|FG000|Open-label Titration Phase|Adverse Event|81|||
125341431|NCT01675167|450884358|FG001|Open-label Titration Phase|Adverse Event|0|||
125341432|NCT01675167|450884359|FG002|Open-label Titration Phase|Adverse Event|0|||
125341433|NCT01675167|450884357|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
125341434|NCT01675167|450884358|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
125341435|NCT01675167|450884359|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
125341436|NCT01675167|450884357|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
125341437|NCT01675167|450884358|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
125341438|NCT01675167|450884359|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
125341439|NCT01675167|450884357|FG000|Open-label Titration Phase|Protocol Violation|43|||
125341440|NCT01675167|450884358|FG001|Open-label Titration Phase|Protocol Violation|0|||
125341441|NCT01675167|450884359|FG002|Open-label Titration Phase|Protocol Violation|0|||
125341442|NCT01675167|450884357|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
125341443|NCT01675167|450884358|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
125341444|NCT01675167|450884359|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
125341445|NCT01675167|450884357|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
125341446|NCT01675167|450884358|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
125341447|NCT01675167|450884359|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
125341448|NCT01675167|450884357|FG000|Open-label Titration Phase|Other|55|||
125341449|NCT01675167|450884358|FG001|Open-label Titration Phase|Other|0|||
125341450|NCT01675167|450884359|FG002|Open-label Titration Phase|Other|0|||
125341451|NCT01675167|450884357|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
125341452|NCT01675167|450884358|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
125341453|NCT01675167|450884359|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
125341454|NCT01675167|450884357|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125341455|NCT01675167|450884358|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
125341456|NCT01675167|450884359|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
125341457|NCT01675167|450884357|FG000|Double-blind Treatment Phase|Adverse Event|0|||
125341458|NCT01675167|450884358|FG001|Double-blind Treatment Phase|Adverse Event|5|||
125341459|NCT01675167|450884359|FG002|Double-blind Treatment Phase|Adverse Event|13|||
125341460|NCT01675167|450884357|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
125341461|NCT01675167|450884358|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
125341462|NCT01675167|450884359|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
125341463|NCT01675167|450884357|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
125341464|NCT01675167|450884358|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
125341465|NCT01675167|450884359|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
125341466|NCT01675167|450884357|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
125341467|NCT01675167|450884358|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
125341468|NCT01675167|450884359|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
125341469|NCT01675167|450884357|FG000|Double-blind Treatment Phase|Other|0|||
125341470|NCT01675167|450884358|FG001|Double-blind Treatment Phase|Other|7|||
125341471|NCT01675167|450884359|FG002|Double-blind Treatment Phase|Other|5|||
125341472|NCT03976648|450884360|FG000|Overall Study|Adverse Event|0|||
125341473|NCT03976648|450884361|FG001|Overall Study|Adverse Event|2|||
125341474|NCT03976648|450884360|FG000|Overall Study|Study terminated by sponsor|21|||
125341475|NCT03976648|450884361|FG001|Overall Study|Study terminated by sponsor|8|||
125341476|NCT00243841|450884364|FG000|Overall Study|Physician Decision|0|||
125341477|NCT00243841|450884365|FG001|Overall Study|Physician Decision|0|||
125341478|NCT00243841|450884366|FG002|Overall Study|Physician Decision|1|||
125341479|NCT00243841|450884367|FG003|Overall Study|Physician Decision|0|||
125341480|NCT00243841|450884368|FG004|Overall Study|Physician Decision|0|||
125341481|NCT00243841|450884369|FG005|Overall Study|Physician Decision|2|||
125341482|NCT00881868|450884370|FG000|Overall Study|Adverse Event|0|||
125341483|NCT00881868|450884371|FG001|Overall Study|Adverse Event|1|||
125341484|NCT00881868|450884370|FG000|Overall Study|Lost to Follow-up|2|||
125341485|NCT00881868|450884371|FG001|Overall Study|Lost to Follow-up|1|||
125341486|NCT00881868|450884370|FG000|Overall Study|Physician Decision|4|||
125341487|NCT00881868|450884371|FG001|Overall Study|Physician Decision|0|||
125341488|NCT00881868|450884370|FG000|Overall Study|Protocol Violation|2|||
125341489|NCT00881868|450884371|FG001|Overall Study|Protocol Violation|0|||
125341490|NCT01981551|450884372|FG000|Overall Study|Refused further treatment|8|||
125341491|NCT01981551|450884372|FG000|Overall Study|Adverse Event|1|||
125341492|NCT03255083|450884373|FG000|Overall Study|Clinical progression|1|||
125341493|NCT03255083|450884374|FG001|Overall Study|Clinical progression|0|||
125341494|NCT03255083|450884375|FG002|Overall Study|Clinical progression|0|||
125341495|NCT03255083|450884376|FG003|Overall Study|Clinical progression|0|||
125341496|NCT03255083|450884373|FG000|Overall Study|Adverse Event|0|||
125341497|NCT03255083|450884374|FG001|Overall Study|Adverse Event|1|||
125341498|NCT03255083|450884375|FG002|Overall Study|Adverse Event|0|||
125341499|NCT03255083|450884376|FG003|Overall Study|Adverse Event|0|||
125341500|NCT03255083|450884373|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
125341501|NCT03255083|450884374|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
125341502|NCT03255083|450884375|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
125378910|NCT00589914|451019207|FG001|Overall Study|Death|0|||
125341503|NCT03255083|450884376|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
125341504|NCT03255083|450884373|FG000|Overall Study|Withdrawal by Subject|1|||
125341505|NCT03255083|450884374|FG001|Overall Study|Withdrawal by Subject|1|||
125341506|NCT03255083|450884375|FG002|Overall Study|Withdrawal by Subject|1|||
125341507|NCT03255083|450884376|FG003|Overall Study|Withdrawal by Subject|0|||
125341508|NCT01182844|450884377|FG000|Overall Study|Withdrawal by Subject|0|||
125341509|NCT01182844|450884378|FG001|Overall Study|Withdrawal by Subject|2|||
125341510|NCT01925131|450886330|FG000|Overall Study|Death|0|||
125341511|NCT01925131|450886331|FG001|Overall Study|Death|0|||
125341512|NCT01925131|450886332|FG002|Overall Study|Death|1|||
125341513|NCT01925131|450886333|FG003|Overall Study|Death|0|||
125341514|NCT01925131|450886334|FG004|Overall Study|Death|0|||
125341515|NCT01925131|450886335|FG005|Overall Study|Death|0|||
125341516|NCT01925131|450886330|FG000|Overall Study|Progression/Relapse|1|||
125341517|NCT01925131|450886331|FG001|Overall Study|Progression/Relapse|1|||
125341518|NCT01925131|450886332|FG002|Overall Study|Progression/Relapse|4|||
125341519|NCT01925131|450886333|FG003|Overall Study|Progression/Relapse|0|||
125341520|NCT01925131|450886334|FG004|Overall Study|Progression/Relapse|0|||
125341521|NCT01925131|450886335|FG005|Overall Study|Progression/Relapse|1|||
125341522|NCT01925131|450886330|FG000|Overall Study|Patient Refusal|1|||
125341523|NCT01925131|450886331|FG001|Overall Study|Patient Refusal|0|||
125341524|NCT01925131|450886332|FG002|Overall Study|Patient Refusal|0|||
125341525|NCT01925131|450886333|FG003|Overall Study|Patient Refusal|0|||
125341526|NCT01925131|450886334|FG004|Overall Study|Patient Refusal|0|||
125341527|NCT01925131|450886335|FG005|Overall Study|Patient Refusal|0|||
125341528|NCT01925131|450886330|FG000|Overall Study|Adverse Event|0|||
125341529|NCT01925131|450886331|FG001|Overall Study|Adverse Event|0|||
125341530|NCT01925131|450886332|FG002|Overall Study|Adverse Event|2|||
125341531|NCT01925131|450886333|FG003|Overall Study|Adverse Event|0|||
125341532|NCT01925131|450886334|FG004|Overall Study|Adverse Event|1|||
125341533|NCT01925131|450886335|FG005|Overall Study|Adverse Event|3|||
125341534|NCT01925131|450886330|FG000|Overall Study|Other - Not Protocol Specified|3|||
125341535|NCT01925131|450886331|FG001|Overall Study|Other - Not Protocol Specified|1|||
125341536|NCT01925131|450886332|FG002|Overall Study|Other - Not Protocol Specified|2|||
125341537|NCT01925131|450886333|FG003|Overall Study|Other - Not Protocol Specified|5|||
125341538|NCT01925131|450886334|FG004|Overall Study|Other - Not Protocol Specified|10|||
125341539|NCT01925131|450886335|FG005|Overall Study|Other - Not Protocol Specified|6|||
125341540|NCT01696929|450886339|FG000|Overall Study|Physician Decision|1|||
125341541|NCT01794338|450886340|FG000|Overall Study|Death|2|||
125341542|NCT01794338|450886341|FG001|Overall Study|Death|0|||
125341543|NCT01794338|450886340|FG000|Overall Study|Lost to Follow-up|6|||
125341544|NCT01794338|450886341|FG001|Overall Study|Lost to Follow-up|9|||
125341545|NCT02522624|450886342|FG000|Overall Study|Technical failure|1|||
125341546|NCT02522624|450886343|FG001|Overall Study|Technical failure|0|||
125341547|NCT02123251|450886344|FG000|Overall Study|Death|1|||
125341548|NCT02123251|450886345|FG001|Overall Study|Death|1|||
125341549|NCT02123251|450886344|FG000|Overall Study|Withdrawal by Subject|0|||
125341550|NCT02123251|450886345|FG001|Overall Study|Withdrawal by Subject|3|||
125341551|NCT02123251|450886344|FG000|Overall Study|Lost Medicaid eligibility|29|||
125341552|NCT02123251|450886345|FG001|Overall Study|Lost Medicaid eligibility|22|||
125341553|NCT02123251|450886344|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
125341554|NCT02123251|450886345|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
125341555|NCT00617669|450886352|FG000|Overall Study|Withdrawal by Subject|71|||
125341556|NCT00617669|450886353|FG001|Overall Study|Withdrawal by Subject|77|||
125341557|NCT00617669|450886352|FG000|Overall Study|Lost to Follow-up|3|||
125341558|NCT00617669|450886353|FG001|Overall Study|Lost to Follow-up|2|||
125341559|NCT00617669|450886352|FG000|Overall Study|Adverse Event|87|||
125341560|NCT00617669|450886353|FG001|Overall Study|Adverse Event|76|||
125341561|NCT00617669|450886352|FG000|Overall Study|Protocol Violation|2|||
125341562|NCT00617669|450886353|FG001|Overall Study|Protocol Violation|3|||
125341563|NCT00617669|450886352|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
125341564|NCT00617669|450886353|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
125341565|NCT00617669|450886352|FG000|Overall Study|Patients randomized but not treated|2|||
125341566|NCT00617669|450886353|FG001|Overall Study|Patients randomized but not treated|3|||
125341567|NCT03680742|450886354|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
125341568|NCT02894502|450886357|FG000|Baseline|Withdrawal by Subject|24|||
125341569|NCT02894502|450886358|FG001|Baseline|Withdrawal by Subject|31|||
125341570|NCT02894502|450886359|FG002|Baseline|Withdrawal by Subject|36|||
125341571|NCT02894502|450886357|FG000|Baseline|Death|3|||
125341572|NCT02894502|450886358|FG001|Baseline|Death|1|||
125341573|NCT02894502|450886359|FG002|Baseline|Death|9|||
125341574|NCT02894502|450886357|FG000|First Follow up|Withdrawal by Subject|32|||
125341575|NCT02894502|450886358|FG001|First Follow up|Withdrawal by Subject|29|||
125341576|NCT02894502|450886359|FG002|First Follow up|Withdrawal by Subject|37|||
125341577|NCT02894502|450886357|FG000|First Follow up|Death|2|||
125341578|NCT02894502|450886358|FG001|First Follow up|Death|2|||
125341579|NCT02894502|450886359|FG002|First Follow up|Death|3|||
125341580|NCT02894502|450886357|FG000|Second Follow up|Withdrawal by Subject|13|||
125341581|NCT02894502|450886358|FG001|Second Follow up|Withdrawal by Subject|15|||
125341582|NCT02894502|450886359|FG002|Second Follow up|Withdrawal by Subject|13|||
125341583|NCT02894502|450886357|FG000|Second Follow up|Death|2|||
125341584|NCT02894502|450886358|FG001|Second Follow up|Death|3|||
125341585|NCT02894502|450886359|FG002|Second Follow up|Death|1|||
125341586|NCT02894502|450886357|FG000|Third Follow up|Withdrawal by Subject|5|||
125341587|NCT02894502|450886358|FG001|Third Follow up|Withdrawal by Subject|6|||
125341588|NCT02894502|450886359|FG002|Third Follow up|Withdrawal by Subject|3|||
125341589|NCT02894502|450886357|FG000|Third Follow up|Death|1|||
125341590|NCT02894502|450886358|FG001|Third Follow up|Death|1|||
125341591|NCT02894502|450886359|FG002|Third Follow up|Death|0|||
125341592|NCT04605991|450886360|FG000|Overall Study|Adverse Event|5|||
125341593|NCT04605991|450886360|FG000|Overall Study|Lack of Efficacy|1|||
125341594|NCT04605991|450886360|FG000|Overall Study|Lost to Follow-up|8|||
125341595|NCT04605991|450886360|FG000|Overall Study|Physician Decision|4|||
125341596|NCT04605991|450886360|FG000|Overall Study|Withdrawal by Subject|14|||
125341597|NCT04605991|450886360|FG000|Overall Study|Non-compliance with study|1|||
125341598|NCT01410357|450886361|FG000|Overall Study|Death|2|||
125341599|NCT01410357|450886362|FG001|Overall Study|Death|1|||
125341600|NCT01410357|450886361|FG000|Overall Study|Withdrawal by Subject|1|||
125341601|NCT01410357|450886362|FG001|Overall Study|Withdrawal by Subject|2|||
125341602|NCT01410357|450886361|FG000|Overall Study|Lost to Follow-up|23|||
125341603|NCT01410357|450886362|FG001|Overall Study|Lost to Follow-up|21|||
125341604|NCT00615901|450886363|FG000|Overall Study|Withdrawal by Subject|2|||
125341605|NCT00615901|450886363|FG000|Overall Study|Adverse Event|7|||
125341606|NCT03598114|450886364|FG000|Overall Study|Staff turnover/left the program|3|||
125341607|NCT03598114|450886365|FG001|Overall Study|Staff turnover/left the program|39|||
125341608|NCT01589653|450886366|FG000|Overall Study|Protocol Violation|3|||
125341609|NCT01589653|450886367|FG001|Overall Study|Protocol Violation|1|||
125341610|NCT01589653|450886366|FG000|Overall Study|Withdrawal criteria|4|||
125341611|NCT01589653|450886367|FG001|Overall Study|Withdrawal criteria|7|||
125341612|NCT01589653|450886366|FG000|Overall Study|Unclassified|0|||
125341613|NCT01589653|450886367|FG001|Overall Study|Unclassified|3|||
125341614|NCT00361634|450886369|FG000|Overall Study|Lost to Follow-up|1|||
125341615|NCT00361634|450886369|FG000|Overall Study|Withdrawal by Subject|1|||
125341616|NCT00833417|450886370|FG000|Overall Study|Adverse Event|5|||
125341617|NCT00833417|450886371|FG001|Overall Study|Adverse Event|16|||
125341618|NCT00833417|450886370|FG000|Overall Study|Death|1|||
125341619|NCT00833417|450886371|FG001|Overall Study|Death|3|||
125341620|NCT00833417|450886370|FG000|Overall Study|Lost to Follow-up|1|||
125341621|NCT00833417|450886371|FG001|Overall Study|Lost to Follow-up|2|||
125341622|NCT00833417|450886370|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
125341623|NCT00833417|450886371|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
125341624|NCT00833417|450886370|FG000|Overall Study|Patient Decision to Withdraw|4|||
125341625|NCT00833417|450886371|FG001|Overall Study|Patient Decision to Withdraw|23|||
125341626|NCT00833417|450886370|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
125341627|NCT00833417|450886371|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
125341628|NCT00833417|450886370|FG000|Overall Study|Disease Progression|18|||
125341629|NCT00833417|450886371|FG001|Overall Study|Disease Progression|17|||
125341630|NCT00833417|450886370|FG000|Overall Study|Reason Not Specified|0|||
125341631|NCT00833417|450886371|FG001|Overall Study|Reason Not Specified|1|||
125341632|NCT03330002|450886372|FG000|Overall Study|Lost to Follow-up|15|||
125341633|NCT03330002|450886372|FG000|Overall Study|Death|7|||
125341634|NCT01883453|450886373|FG000|Overall Study|No episode of common cold|25|||
125341635|NCT01883453|450886374|FG001|Overall Study|No episode of common cold|23|||
125341636|NCT00505076|450886375|FG000|Overall Study|Adverse Event|1|||
125341637|NCT00505076|450886376|FG001|Overall Study|Adverse Event|0|||
125341638|NCT00505076|450886377|FG002|Overall Study|Adverse Event|1|||
125674324|NCT02655237|452096662|FG001|Overall Study|Randomized but Not Treated|0|||
125674325|NCT01860976|452096665|FG000|Blinded Treatment|Adverse Event|1|||
125674326|NCT01860976|452096666|FG001|Blinded Treatment|Adverse Event|3|||
125674327|NCT01860976|452096665|FG000|Blinded Treatment|Lack of Efficacy|5|||
125674328|NCT01860976|452096666|FG001|Blinded Treatment|Lack of Efficacy|12|||
125674329|NCT01860976|452096665|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
125674330|NCT01860976|452096666|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
125674331|NCT01860976|452096665|FG000|Blinded Treatment|Withdrawal by Subject|3|||
125674332|NCT01860976|452096666|FG001|Blinded Treatment|Withdrawal by Subject|5|||
125674333|NCT01860976|452096665|FG000|Blinded Treatment|Subject no longer met criteria|1|||
125674334|NCT01860976|452096666|FG001|Blinded Treatment|Subject no longer met criteria|0|||
125674335|NCT01860976|452096665|FG000|Blinded Treatment|Entered Open-Label in error|0|||
125674336|NCT01860976|452096666|FG001|Blinded Treatment|Entered Open-Label in error|1|||
125674337|NCT01860976|452096665|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
125674338|NCT01860976|452096666|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
125674339|NCT01860976|452096665|FG000|Open-Label|Adverse Event|2|||
125674340|NCT01860976|452096666|FG001|Open-Label|Adverse Event|4|||
125674341|NCT01860976|452096665|FG000|Open-Label|Lack of Efficacy|16|||
125674342|NCT01860976|452096666|FG001|Open-Label|Lack of Efficacy|8|||
125674343|NCT01860976|452096665|FG000|Open-Label|Lost to Follow-up|1|||
125674344|NCT01860976|452096666|FG001|Open-Label|Lost to Follow-up|2|||
125674345|NCT01860976|452096665|FG000|Open-Label|Subject request discontinue treatment|4|||
125674346|NCT01860976|452096666|FG001|Open-Label|Subject request discontinue treatment|3|||
125674347|NCT01860976|452096665|FG000|Open-Label|Withdrawal by Subject|4|||
125674348|NCT01860976|452096666|FG001|Open-Label|Withdrawal by Subject|1|||
125674349|NCT01860976|452096665|FG000|Open-Label|Other Reasons|1|||
125674350|NCT01860976|452096666|FG001|Open-Label|Other Reasons|1|||
125674351|NCT01860976|452096665|FG000|Long Term Extension|Adverse Event|4|||
125674352|NCT01860976|452096666|FG001|Long Term Extension|Adverse Event|0|||
125674353|NCT01860976|452096665|FG000|Long Term Extension|Lack of Efficacy|2|||
125341639|NCT00505076|450886375|FG000|Overall Study|Protocol Violation|2|||
125341640|NCT00505076|450886376|FG001|Overall Study|Protocol Violation|1|||
125341641|NCT00505076|450886377|FG002|Overall Study|Protocol Violation|2|||
125341642|NCT00505076|450886375|FG000|Overall Study|Withdrawal by Subject|0|||
125341643|NCT00505076|450886376|FG001|Overall Study|Withdrawal by Subject|1|||
125341644|NCT00505076|450886377|FG002|Overall Study|Withdrawal by Subject|2|||
125341645|NCT00647270|450886378|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
125341646|NCT00647270|450886379|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
125341647|NCT00647270|450886380|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
125341648|NCT00647270|450886378|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
125341649|NCT00647270|450886379|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
125341650|NCT00647270|450886380|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
125341651|NCT00647270|450886378|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
125341652|NCT00647270|450886379|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
125341653|NCT00647270|450886380|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
125341654|NCT00647270|450886378|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
125341655|NCT00647270|450886379|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
125341656|NCT00647270|450886380|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
125341657|NCT00647270|450886378|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
125341658|NCT00647270|450886379|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
125341659|NCT00647270|450886380|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
125341660|NCT00647270|450886378|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
125341661|NCT00647270|450886379|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
125341662|NCT00647270|450886380|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
125341663|NCT00647270|450886378|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
125341664|NCT00647270|450886379|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
125341665|NCT00647270|450886380|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
125341666|NCT03337490|450886381|FG000|Overall Study|Withdrawal by Subject|1|||
125341667|NCT03337490|450886382|FG001|Overall Study|Withdrawal by Subject|0|||
125341668|NCT03337490|450886383|FG002|Overall Study|Withdrawal by Subject|0|||
125341669|NCT03337490|450886381|FG000|Overall Study|Lack of Efficacy|10|||
125341670|NCT03337490|450886382|FG001|Overall Study|Lack of Efficacy|12|||
125341671|NCT03337490|450886383|FG002|Overall Study|Lack of Efficacy|35|||
125341672|NCT03337490|450886381|FG000|Overall Study|Physician Decision|0|||
125341673|NCT03337490|450886382|FG001|Overall Study|Physician Decision|1|||
125341674|NCT03337490|450886383|FG002|Overall Study|Physician Decision|0|||
125341675|NCT03337490|450886381|FG000|Overall Study|Lost to Follow-up|0|||
125341676|NCT03337490|450886382|FG001|Overall Study|Lost to Follow-up|1|||
125341677|NCT03337490|450886383|FG002|Overall Study|Lost to Follow-up|0|||
125341678|NCT00233454|450886384|FG000|Overall Study|Death|6|||
125341679|NCT02745145|450886385|FG000|Overall Study|Adverse Event|1|||
125341680|NCT02745145|450886386|FG001|Overall Study|Adverse Event|0|||
125341681|NCT02745145|450886387|FG002|Overall Study|Adverse Event|0|||
125341682|NCT02745145|450886385|FG000|Overall Study|Death|0|||
125341683|NCT02745145|450886386|FG001|Overall Study|Death|1|||
125341684|NCT02745145|450886387|FG002|Overall Study|Death|0|||
125341685|NCT02745145|450886385|FG000|Overall Study|Progressive disease|0|||
125341686|NCT02745145|450886386|FG001|Overall Study|Progressive disease|0|||
125341687|NCT02745145|450886387|FG002|Overall Study|Progressive disease|1|||
125341688|NCT02745145|450886385|FG000|Overall Study|Withdrew consent|1|||
125341689|NCT02745145|450886386|FG001|Overall Study|Withdrew consent|1|||
125341690|NCT02745145|450886387|FG002|Overall Study|Withdrew consent|1|||
125341691|NCT02745145|450886385|FG000|Overall Study|Study Termination|8|||
125341692|NCT02745145|450886386|FG001|Overall Study|Study Termination|3|||
125341693|NCT02745145|450886387|FG002|Overall Study|Study Termination|7|||
125341694|NCT00388583|450886388|FG000|Overall Study|Protocol Violation|1|||
125341695|NCT00388583|450886389|FG001|Overall Study|Protocol Violation|0|||
125341696|NCT00388583|450886388|FG000|Overall Study|Withdrawal by Subject|3|||
125341697|NCT00388583|450886389|FG001|Overall Study|Withdrawal by Subject|3|||
125341698|NCT00388583|450886388|FG000|Overall Study|Serious Adverse Event|2|||
125341699|NCT00388583|450886389|FG001|Overall Study|Serious Adverse Event|0|||
125341700|NCT00388583|450886388|FG000|Overall Study|Did not receive vaccine|0|||
125341701|NCT00388583|450886389|FG001|Overall Study|Did not receive vaccine|1|||
125341702|NCT02366091|450886390|FG000|Overall Study|Withdrawal by Subject|3|||
125341703|NCT02366091|450886391|FG001|Overall Study|Withdrawal by Subject|7|||
125341704|NCT02366091|450886392|FG002|Overall Study|Withdrawal by Subject|3|||
125341705|NCT02366091|450886393|FG003|Overall Study|Withdrawal by Subject|1|||
125341706|NCT00322621|450886394|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
125378911|NCT00589914|451019206|FG000|Overall Study|Lack of Efficacy|40|||
125341707|NCT00322621|450886395|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
125341708|NCT00322621|450886396|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
125341709|NCT00322621|450886394|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
125341710|NCT00322621|450886395|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
125341711|NCT00322621|450886396|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
125341712|NCT00322621|450886394|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
125341713|NCT00322621|450886395|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
125341714|NCT00322621|450886396|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
125341715|NCT00322621|450886394|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
125341716|NCT00322621|450886395|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
125341717|NCT00322621|450886396|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
125341718|NCT00322621|450886394|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
125341719|NCT00322621|450886395|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
125341720|NCT00322621|450886396|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
125341721|NCT00322621|450886394|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
125341722|NCT00322621|450886395|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
125341723|NCT00322621|450886396|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
125341724|NCT00322621|450886394|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
125341725|NCT00322621|450886395|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
125341726|NCT00322621|450886396|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
125341727|NCT00322621|450886394|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
125341728|NCT00322621|450886395|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
125341729|NCT00322621|450886396|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
125341730|NCT00322621|450886394|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
125341731|NCT00322621|450886395|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
125341732|NCT00322621|450886396|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
125341733|NCT00322621|450886394|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
125341734|NCT00322621|450886395|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
125341735|NCT00322621|450886396|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
125341736|NCT00322621|450886394|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
125341737|NCT00322621|450886395|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
125341738|NCT00322621|450886396|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
125341739|NCT01743001|450886397|FG000|Overall Study|Physician Decision|1|||
125341740|NCT01743001|450886398|FG001|Overall Study|Physician Decision|0|||
125341741|NCT01743001|450886397|FG000|Overall Study|Pregnancy|1|||
125674354|NCT01860976|452096666|FG001|Long Term Extension|Lack of Efficacy|0|||
125674355|NCT01860976|452096665|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
125674356|NCT01860976|452096666|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
125674357|NCT01860976|452096665|FG000|Long Term Extension|Lost to Follow-up|2|||
125674358|NCT01860976|452096666|FG001|Long Term Extension|Lost to Follow-up|0|||
125674359|NCT01860976|452096665|FG000|Long Term Extension|subject withdrew consent|7|||
125674360|NCT01860976|452096666|FG001|Long Term Extension|subject withdrew consent|0|||
125341742|NCT01743001|450886398|FG001|Overall Study|Pregnancy|0|||
125674361|NCT02227862|452096667|FG000|Overall Study|Protocol Violation|7|||
125674362|NCT02227862|452096668|FG001|Overall Study|Protocol Violation|9|||
125341743|NCT01743001|450886397|FG000|Overall Study|Death|1|||
125341744|NCT01743001|450886398|FG001|Overall Study|Death|0|||
125674363|NCT02227862|452096667|FG000|Overall Study|Other|0|||
125674364|NCT02227862|452096668|FG001|Overall Study|Other|2|||
125674365|NCT02227862|452096667|FG000|Overall Study|Adverse Event|4|||
125674366|NCT02227862|452096668|FG001|Overall Study|Adverse Event|3|||
125674367|NCT02227862|452096667|FG000|Overall Study|Withdrawal by Subject|7|||
125674368|NCT02227862|452096668|FG001|Overall Study|Withdrawal by Subject|6|||
125674369|NCT02227862|452096667|FG000|Overall Study|Lost to Follow-up|1|||
125674370|NCT02227862|452096668|FG001|Overall Study|Lost to Follow-up|2|||
125674371|NCT02419313|452096674|FG000|First Intervention|Lost to Follow-up|2|||
125674372|NCT02419313|452096675|FG001|First Intervention|Lost to Follow-up|0|||
125674373|NCT02419313|452096674|FG000|Second Intervention|Lost to Follow-up|1|||
125674374|NCT02419313|452096675|FG001|Second Intervention|Lost to Follow-up|0|||
125674375|NCT00620763|452096676|FG000|Period: First Intervention|Withdrawal by Subject|0|||
125674376|NCT00620763|452096677|FG001|Period: First Intervention|Withdrawal by Subject|2|||
125674377|NCT00620763|452096676|FG000|Period: First Intervention|Protocol Violation|0|||
125674378|NCT00620763|452096677|FG001|Period: First Intervention|Protocol Violation|3|||
125674379|NCT00620763|452096676|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
125674380|NCT00620763|452096677|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
125674381|NCT00819247|452096687|FG000|Overall Study|Adverse Event|0|||
125674382|NCT00819247|452096688|FG001|Overall Study|Adverse Event|5|||
125674383|NCT00819247|452096689|FG002|Overall Study|Adverse Event|3|||
125674384|NCT00819247|452096687|FG000|Overall Study|Insufficient testosterone response|5|||
125674385|NCT00819247|452096688|FG001|Overall Study|Insufficient testosterone response|8|||
125674386|NCT00819247|452096689|FG002|Overall Study|Insufficient testosterone response|10|||
125674387|NCT00819247|452096687|FG000|Overall Study|Withdrawal by Subject|1|||
125674388|NCT00819247|452096688|FG001|Overall Study|Withdrawal by Subject|0|||
125674389|NCT00819247|452096689|FG002|Overall Study|Withdrawal by Subject|0|||
125674390|NCT00819247|452096687|FG000|Overall Study|Protocol Violation|1|||
125674391|NCT00819247|452096688|FG001|Overall Study|Protocol Violation|0|||
125674392|NCT00819247|452096689|FG002|Overall Study|Protocol Violation|1|||
125674393|NCT00819247|452096687|FG000|Overall Study|Mistakenly withdrawn|0|||
125674394|NCT00819247|452096688|FG001|Overall Study|Mistakenly withdrawn|1|||
125674395|NCT00819247|452096689|FG002|Overall Study|Mistakenly withdrawn|0|||
125674396|NCT00819247|452096687|FG000|Overall Study|Bad prostate-specific antigen response|3|||
125674397|NCT00819247|452096688|FG001|Overall Study|Bad prostate-specific antigen response|2|||
125674398|NCT00819247|452096689|FG002|Overall Study|Bad prostate-specific antigen response|0|||
125674399|NCT00819247|452096687|FG000|Overall Study|Other|1|||
125674400|NCT00819247|452096688|FG001|Overall Study|Other|0|||
125674401|NCT00819247|452096689|FG002|Overall Study|Other|0|||
125674402|NCT02540356|452096690|FG000|Overall Study|Terminated due to disease progression|1|||
125674403|NCT02540356|452096691|FG001|Overall Study|Terminated due to disease progression|0|||
125674404|NCT02978326|452096697|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
125674405|NCT02978326|452096698|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
125674406|NCT02978326|452096699|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
125674407|NCT02978326|452096697|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
125674408|NCT02978326|452096698|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
125674409|NCT02978326|452096699|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
125674410|NCT02978326|452096697|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
125674411|NCT02978326|452096698|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
125674412|NCT02978326|452096699|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
125674413|NCT02978326|452096697|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
125674414|NCT02978326|452096698|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
125674415|NCT02978326|452096699|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
125674416|NCT00947427|452096703|FG000|Overall Study|Withdrawal by Subject|1|||
125674417|NCT00947427|452096704|FG001|Overall Study|Withdrawal by Subject|3|||
125674418|NCT00947427|452096703|FG000|Overall Study|Protocol Violation|0|||
125674419|NCT00947427|452096704|FG001|Overall Study|Protocol Violation|1|||
125674420|NCT01411995|452096707|FG000|Overall Study|Failed IUD insertion|0|||
125674421|NCT01411995|452096708|FG001|Overall Study|Failed IUD insertion|1|||
125674422|NCT01937364|452096709|FG000|Overall Study|Adverse Event|2|||
125674423|NCT01937364|452096710|FG001|Overall Study|Adverse Event|1|||
125341745|NCT02709538|450886403|FG000|Overall Study|Adverse Event|13|||
125674424|NCT04104646|452096711|FG000|Overall Study|Withdrawal by Subject|1|||
125674425|NCT04104646|452096712|FG001|Overall Study|Withdrawal by Subject|1|||
125674426|NCT04104646|452096711|FG000|Overall Study|Lost to Follow-up|1|||
125674427|NCT04104646|452096712|FG001|Overall Study|Lost to Follow-up|0|||
125674428|NCT04104646|452096711|FG000|Overall Study|Physician Decision|2|||
125674429|NCT04104646|452096712|FG001|Overall Study|Physician Decision|0|||
125341746|NCT02709538|450886404|FG001|Overall Study|Adverse Event|2|||
125341747|NCT02709538|450886405|FG002|Overall Study|Adverse Event|3|||
125674430|NCT02974153|452096713|FG000|Overall Study|Adverse Event|6|||
125674431|NCT02974153|452096714|FG001|Overall Study|Adverse Event|0|||
125674432|NCT02974153|452096715|FG002|Overall Study|Adverse Event|1|||
125674433|NCT02974153|452096713|FG000|Overall Study|Lack of Efficacy|6|||
125341748|NCT02709538|450886403|FG000|Overall Study|Lack of Efficacy|1|||
125341749|NCT02709538|450886404|FG001|Overall Study|Lack of Efficacy|0|||
125341750|NCT02709538|450886405|FG002|Overall Study|Lack of Efficacy|0|||
125341751|NCT02709538|450886403|FG000|Overall Study|Lost to Follow-up|24|||
125341752|NCT02709538|450886404|FG001|Overall Study|Lost to Follow-up|8|||
125341753|NCT02709538|450886405|FG002|Overall Study|Lost to Follow-up|4|||
125341754|NCT02709538|450886403|FG000|Overall Study|Physician Decision|1|||
125341755|NCT02709538|450886404|FG001|Overall Study|Physician Decision|0|||
125341756|NCT02709538|450886405|FG002|Overall Study|Physician Decision|0|||
125341757|NCT02709538|450886403|FG000|Overall Study|Withdrawal by Subject|40|||
125341758|NCT02709538|450886404|FG001|Overall Study|Withdrawal by Subject|7|||
125341759|NCT02709538|450886405|FG002|Overall Study|Withdrawal by Subject|4|||
125341760|NCT02709538|450886403|FG000|Overall Study|Non-compliance with study procedures|5|||
125341761|NCT02709538|450886404|FG001|Overall Study|Non-compliance with study procedures|0|||
125341762|NCT02709538|450886405|FG002|Overall Study|Non-compliance with study procedures|0|||
125341763|NCT02709538|450886403|FG000|Overall Study|Non-compliance with study drug|2|||
125341764|NCT02709538|450886404|FG001|Overall Study|Non-compliance with study drug|0|||
125341765|NCT02709538|450886405|FG002|Overall Study|Non-compliance with study drug|0|||
125341766|NCT02709538|450886403|FG000|Overall Study|Protocol deviation|10|||
125341767|NCT02709538|450886404|FG001|Overall Study|Protocol deviation|4|||
125341768|NCT02709538|450886405|FG002|Overall Study|Protocol deviation|4|||
125341769|NCT02709538|450886403|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
125341770|NCT02709538|450886404|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
125341771|NCT02709538|450886405|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
125341772|NCT02709538|450886403|FG000|Overall Study|Other|16|||
125341773|NCT02709538|450886404|FG001|Overall Study|Other|7|||
125341774|NCT02709538|450886405|FG002|Overall Study|Other|5|||
125341775|NCT00835211|450886406|FG000|First Intervention|Withdrawal by Subject|0|||
125341776|NCT00835211|450886407|FG001|First Intervention|Withdrawal by Subject|1|||
125341777|NCT00835211|450886406|FG000|Washout: 7 Days|Adverse Event|2|||
125674434|NCT02974153|452096714|FG001|Overall Study|Lack of Efficacy|5|||
125674435|NCT02974153|452096715|FG002|Overall Study|Lack of Efficacy|10|||
125674436|NCT02974153|452096713|FG000|Overall Study|Lost to Follow-up|9|||
125674437|NCT02974153|452096714|FG001|Overall Study|Lost to Follow-up|10|||
125674438|NCT02974153|452096715|FG002|Overall Study|Lost to Follow-up|17|||
125674439|NCT02974153|452096713|FG000|Overall Study|Physician Decision|0|||
125674440|NCT02974153|452096714|FG001|Overall Study|Physician Decision|2|||
125674441|NCT02974153|452096715|FG002|Overall Study|Physician Decision|1|||
125674442|NCT02974153|452096713|FG000|Overall Study|Withdrawal by Subject|9|||
125674443|NCT02974153|452096714|FG001|Overall Study|Withdrawal by Subject|16|||
125674444|NCT02974153|452096715|FG002|Overall Study|Withdrawal by Subject|11|||
125674445|NCT02974153|452096713|FG000|Overall Study|Study Burden|8|||
125674446|NCT02974153|452096714|FG001|Overall Study|Study Burden|7|||
125674447|NCT02974153|452096715|FG002|Overall Study|Study Burden|3|||
125674448|NCT02974153|452096713|FG000|Overall Study|Other|14|||
125674449|NCT02974153|452096714|FG001|Overall Study|Other|8|||
125674450|NCT02974153|452096715|FG002|Overall Study|Other|7|||
125674451|NCT02277769|452096716|FG000|Overall Study|Protocol Violation|3|||
125674452|NCT02277769|452096717|FG001|Overall Study|Protocol Violation|3|||
125674453|NCT02277769|452096718|FG002|Overall Study|Protocol Violation|5|||
125674454|NCT02277769|452096716|FG000|Overall Study|Lack of Efficacy|17|||
125674455|NCT02277769|452096717|FG001|Overall Study|Lack of Efficacy|0|||
125674456|NCT02277769|452096718|FG002|Overall Study|Lack of Efficacy|4|||
125674457|NCT02277769|452096716|FG000|Overall Study|Adverse Event|14|||
125674458|NCT02277769|452096717|FG001|Overall Study|Adverse Event|2|||
125674459|NCT02277769|452096718|FG002|Overall Study|Adverse Event|4|||
125674460|NCT02277769|452096716|FG000|Overall Study|Other than specified above|12|||
125674461|NCT02277769|452096717|FG001|Overall Study|Other than specified above|8|||
125674462|NCT02277769|452096718|FG002|Overall Study|Other than specified above|5|||
125674463|NCT03504852|452096719|FG000|Overall Study|Withdrawal of informed consent|2|||
125674464|NCT03504852|452096720|FG001|Overall Study|Withdrawal of informed consent|1|||
125674465|NCT03504852|452096721|FG002|Overall Study|Withdrawal of informed consent|0|||
125674466|NCT03504852|452096719|FG000|Overall Study|Withdrawal by Subject|5|||
125674467|NCT03504852|452096720|FG001|Overall Study|Withdrawal by Subject|5|||
125674468|NCT03504852|452096721|FG002|Overall Study|Withdrawal by Subject|1|||
125674469|NCT03504852|452096719|FG000|Overall Study|Lost to Follow-up|4|||
125674470|NCT03504852|452096720|FG001|Overall Study|Lost to Follow-up|1|||
125674471|NCT03504852|452096721|FG002|Overall Study|Lost to Follow-up|0|||
125674472|NCT03504852|452096719|FG000|Overall Study|New therapy for study indication|1|||
125674473|NCT03504852|452096720|FG001|Overall Study|New therapy for study indication|0|||
125674474|NCT03504852|452096721|FG002|Overall Study|New therapy for study indication|0|||
125674475|NCT03504852|452096719|FG000|Overall Study|Lack of Efficacy|1|||
125674476|NCT03504852|452096720|FG001|Overall Study|Lack of Efficacy|2|||
125674477|NCT03504852|452096721|FG002|Overall Study|Lack of Efficacy|0|||
125674478|NCT03504852|452096719|FG000|Overall Study|Death|0|||
125674479|NCT03504852|452096720|FG001|Overall Study|Death|1|||
125674480|NCT03504852|452096721|FG002|Overall Study|Death|0|||
125674481|NCT03504852|452096719|FG000|Overall Study|Adverse Event|4|||
125674482|NCT03504852|452096720|FG001|Overall Study|Adverse Event|8|||
125674483|NCT03504852|452096721|FG002|Overall Study|Adverse Event|2|||
125674484|NCT02928848|452096722|FG000|Arm 2|Withdrawal by Subject|1|||
125674485|NCT02928848|452096723|FG001|Arm 2|Withdrawal by Subject|0|||
125674486|NCT03850509|452096724|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
125674487|NCT03850509|452096725|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
125674488|NCT00969332|452096726|FG000|Overall Study|Physician Decision|8|||
125674489|NCT00969332|452096726|FG000|Overall Study|Withdrawal by Subject|3|||
125674490|NCT00582309|452096727|FG000|Overall Study|Protocol Violation|0|||
125674491|NCT00582309|452096728|FG001|Overall Study|Protocol Violation|0|||
125674492|NCT00582309|452096729|FG002|Overall Study|Protocol Violation|2|||
125674493|NCT01565083|452096730|FG000|Overall Study|Withdrawal by Subject|6|||
125674494|NCT01565083|452096731|FG001|Overall Study|Withdrawal by Subject|4|||
125674495|NCT01565083|452096730|FG000|Overall Study|Lost to Follow-up|2|||
125674496|NCT01565083|452096731|FG001|Overall Study|Lost to Follow-up|7|||
125674497|NCT01565083|452096730|FG000|Overall Study|Death|22|||
125674498|NCT01565083|452096731|FG001|Overall Study|Death|23|||
125674499|NCT01565083|452096730|FG000|Overall Study|Other|3|||
125674500|NCT01565083|452096731|FG001|Overall Study|Other|5|||
125674501|NCT01058421|452096732|FG000|1 Month Outcomes|Death|10|||
125674502|NCT01058421|452096733|FG001|1 Month Outcomes|Death|6|||
125674503|NCT01058421|452096732|FG000|1 Month Outcomes|Lost to Follow-up|8|||
125674504|NCT01058421|452096733|FG001|1 Month Outcomes|Lost to Follow-up|7|||
125674505|NCT01058421|452096732|FG000|1 Month Outcomes|Remained in Hospital|5|||
125674506|NCT01058421|452096733|FG001|1 Month Outcomes|Remained in Hospital|12|||
125674507|NCT01058421|452096732|FG000|1 Month Outcomes|Remained in Other Facility|16|||
125674508|NCT01058421|452096733|FG001|1 Month Outcomes|Remained in Other Facility|17|||
125674509|NCT01058421|452096732|FG000|3 Month Outcomes|Death|3|||
125674510|NCT01058421|452096733|FG001|3 Month Outcomes|Death|5|||
125674511|NCT01058421|452096732|FG000|3 Month Outcomes|Lost to Follow-up|12|||
125674512|NCT01058421|452096733|FG001|3 Month Outcomes|Lost to Follow-up|11|||
125341778|NCT00835211|450886407|FG001|Washout: 7 Days|Adverse Event|1|||
125341779|NCT00835211|450886406|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
125341780|NCT00835211|450886407|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
125341781|NCT02160041|450886408|FG000|Overall Study|Adverse Event|11|||
125341782|NCT02160041|450886408|FG000|Overall Study|Death|2|||
125341783|NCT02160041|450886408|FG000|Overall Study|disease progression|57|||
125341784|NCT02160041|450886408|FG000|Overall Study|Protocol Violation|1|||
125378912|NCT00589914|451019207|FG001|Overall Study|Lack of Efficacy|43|||
125341785|NCT02160041|450886408|FG000|Overall Study|non-compliance with study|1|||
125341786|NCT02160041|450886408|FG000|Overall Study|Physician Decision|3|||
125341787|NCT02160041|450886408|FG000|Overall Study|Withdrawal by Subject|8|||
125341788|NCT02160041|450886408|FG000|Overall Study|study terminated by by sponsor|1|||
125341789|NCT01403948|450886409|FG000|Overall Study|Progressive disease|0|||
125341790|NCT01403948|450886410|FG001|Overall Study|Progressive disease|2|||
125341791|NCT01403948|450886411|FG002|Overall Study|Progressive disease|2|||
125341792|NCT01403948|450886412|FG003|Overall Study|Progressive disease|4|||
125341793|NCT01403948|450886413|FG004|Overall Study|Progressive disease|2|||
125341794|NCT01403948|450886414|FG005|Overall Study|Progressive disease|6|||
125341795|NCT01403948|450886415|FG006|Overall Study|Progressive disease|2|||
125674513|NCT01058421|452096732|FG000|3 Month Outcomes|Remained in Hospital|0|||
125674514|NCT01058421|452096733|FG001|3 Month Outcomes|Remained in Hospital|2|||
125674515|NCT01058421|452096732|FG000|3 Month Outcomes|Remained in Other Facility|5|||
125674516|NCT01058421|452096733|FG001|3 Month Outcomes|Remained in Other Facility|8|||
125674517|NCT01058421|452096732|FG000|6 Month Outcomes|Death|2|||
125674518|NCT01058421|452096733|FG001|6 Month Outcomes|Death|2|||
125674519|NCT01058421|452096732|FG000|6 Month Outcomes|Lost to Follow-up|16|||
125674520|NCT01058421|452096733|FG001|6 Month Outcomes|Lost to Follow-up|21|||
125674521|NCT01058421|452096732|FG000|6 Month Outcomes|Remained in Other Facility|1|||
125674522|NCT01058421|452096733|FG001|6 Month Outcomes|Remained in Other Facility|3|||
125674523|NCT00455533|452096736|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
125674524|NCT00455533|452096737|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
125674525|NCT00455533|452096738|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
125674526|NCT00455533|452096736|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
125674527|NCT00455533|452096737|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
125674528|NCT00455533|452096738|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
125674529|NCT00455533|452096736|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
125674530|NCT00455533|452096737|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
125674531|NCT00455533|452096738|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
125674532|NCT00455533|452096736|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
125674533|NCT00455533|452096737|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
125674534|NCT00455533|452096738|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
125674535|NCT00455533|452096736|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
125674536|NCT00455533|452096737|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
125674537|NCT00455533|452096738|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
125674538|NCT00455533|452096736|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
125674539|NCT00455533|452096737|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
125674540|NCT00455533|452096738|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
125674541|NCT00455533|452096736|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
125674542|NCT00455533|452096737|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
125674543|NCT00455533|452096738|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
125674544|NCT00455533|452096736|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
125674545|NCT00455533|452096737|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
125674546|NCT00455533|452096738|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
125674547|NCT00455533|452096736|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
125674548|NCT00455533|452096737|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
125674549|NCT00455533|452096738|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
125674550|NCT00455533|452096736|FG000|Period Two: Randomized Period|Death|0|||
125674551|NCT00455533|452096737|FG001|Period Two: Randomized Period|Death|0|||
125674552|NCT00455533|452096738|FG002|Period Two: Randomized Period|Death|3|||
125674553|NCT00455533|452096736|FG000|Period Two: Randomized Period|Disease Progression|0|||
125674554|NCT00455533|452096737|FG001|Period Two: Randomized Period|Disease Progression|1|||
125674555|NCT00455533|452096738|FG002|Period Two: Randomized Period|Disease Progression|1|||
125674556|NCT00455533|452096736|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
125674557|NCT00455533|452096737|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
125674558|NCT00455533|452096738|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
125674559|NCT00455533|452096736|FG000|Period Two: Randomized Period|Other - need reasons|0|||
125674560|NCT00455533|452096737|FG001|Period Two: Randomized Period|Other - need reasons|1|||
125674561|NCT00455533|452096738|FG002|Period Two: Randomized Period|Other - need reasons|0|||
125674562|NCT00455533|452096736|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
125674563|NCT00455533|452096737|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
125341796|NCT01403948|450886416|FG007|Overall Study|Progressive disease|4|||
125674564|NCT00455533|452096738|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
125674565|NCT00455533|452096736|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
125674566|NCT00455533|452096737|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
125341797|NCT01403948|450886417|FG008|Overall Study|Progressive disease|5|||
125341798|NCT01403948|450886418|FG009|Overall Study|Progressive disease|5|||
125378913|NCT00589914|451019206|FG000|Overall Study|Lost to Follow-up|11|||
125341799|NCT01403948|450886409|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
125341800|NCT01403948|450886410|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
125341801|NCT01403948|450886411|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
125341802|NCT01403948|450886412|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
125341803|NCT01403948|450886413|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
125341804|NCT01403948|450886414|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
125341805|NCT01403948|450886415|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
125341806|NCT01403948|450886416|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
125341807|NCT01403948|450886417|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
125341808|NCT01403948|450886418|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
125341809|NCT01403948|450886409|FG000|Overall Study|Lost to Follow-up|0|||
125341810|NCT01403948|450886410|FG001|Overall Study|Lost to Follow-up|0|||
125341811|NCT01403948|450886411|FG002|Overall Study|Lost to Follow-up|0|||
125341812|NCT01403948|450886412|FG003|Overall Study|Lost to Follow-up|0|||
125341813|NCT01403948|450886413|FG004|Overall Study|Lost to Follow-up|0|||
125341814|NCT01403948|450886414|FG005|Overall Study|Lost to Follow-up|0|||
125341815|NCT01403948|450886415|FG006|Overall Study|Lost to Follow-up|0|||
125341816|NCT01403948|450886416|FG007|Overall Study|Lost to Follow-up|0|||
125341817|NCT01403948|450886417|FG008|Overall Study|Lost to Follow-up|0|||
125341818|NCT01403948|450886418|FG009|Overall Study|Lost to Follow-up|1|||
125341819|NCT01403948|450886409|FG000|Overall Study|Refused cont. medication|0|||
125341820|NCT01403948|450886410|FG001|Overall Study|Refused cont. medication|0|||
125341821|NCT01403948|450886411|FG002|Overall Study|Refused cont. medication|0|||
125341822|NCT01403948|450886412|FG003|Overall Study|Refused cont. medication|0|||
125341823|NCT01403948|450886413|FG004|Overall Study|Refused cont. medication|1|||
125341824|NCT01403948|450886414|FG005|Overall Study|Refused cont. medication|0|||
125341825|NCT01403948|450886415|FG006|Overall Study|Refused cont. medication|0|||
125341826|NCT01403948|450886416|FG007|Overall Study|Refused cont. medication|0|||
125341827|NCT01403948|450886417|FG008|Overall Study|Refused cont. medication|0|||
125341828|NCT01403948|450886418|FG009|Overall Study|Refused cont. medication|1|||
125341829|NCT01403948|450886409|FG000|Overall Study|other than above|1|||
125341830|NCT01403948|450886410|FG001|Overall Study|other than above|2|||
125341831|NCT01403948|450886411|FG002|Overall Study|other than above|1|||
125341832|NCT01403948|450886412|FG003|Overall Study|other than above|0|||
125341833|NCT01403948|450886413|FG004|Overall Study|other than above|1|||
125341834|NCT01403948|450886414|FG005|Overall Study|other than above|1|||
125341835|NCT01403948|450886415|FG006|Overall Study|other than above|2|||
125341836|NCT01403948|450886416|FG007|Overall Study|other than above|0|||
125341837|NCT01403948|450886417|FG008|Overall Study|other than above|0|||
125341838|NCT01403948|450886418|FG009|Overall Study|other than above|0|||
125341839|NCT05498701|450886419|FG000|Period 3|Adverse Event|1|||
125341840|NCT05498701|450886420|FG001|Period 3|Adverse Event|0|||
125341841|NCT00638183|450886424|FG000|Overall Study|Adverse Event|23|||
125341842|NCT00638183|450886424|FG000|Overall Study|Lack of Efficacy|14|||
125341843|NCT00638183|450886424|FG000|Overall Study|Physician Decision|9|||
125341844|NCT00638183|450886424|FG000|Overall Study|Lost to Follow-up|46|||
125341845|NCT00638183|450886424|FG000|Overall Study|Other reason not defined above|27|||
125341846|NCT00006409|450886425|FG000|Baseline|Protocol Violation|48|||
125341847|NCT00006409|450886426|FG001|Baseline|Protocol Violation|70|||
125341848|NCT00006409|450886427|FG002|Baseline|Protocol Violation|0|||
125341849|NCT00006409|450886428|FG003|Baseline|Protocol Violation|0|||
125341850|NCT00006409|450886429|FG004|Baseline|Protocol Violation|0|||
125341851|NCT00006409|450886430|FG005|Baseline|Protocol Violation|0|||
125341852|NCT00006409|450886425|FG000|Post-2 Year Intervention|Protocol Violation|0|||
125341853|NCT00006409|450886426|FG001|Post-2 Year Intervention|Protocol Violation|0|||
125341854|NCT00006409|450886427|FG002|Post-2 Year Intervention|Protocol Violation|251|||
125341855|NCT00006409|450886428|FG003|Post-2 Year Intervention|Protocol Violation|168|||
125341856|NCT00006409|450886429|FG004|Post-2 Year Intervention|Protocol Violation|0|||
125341857|NCT00006409|450886430|FG005|Post-2 Year Intervention|Protocol Violation|0|||
125341858|NCT00006409|450886425|FG000|Post-3 Year Intervention|Protocol Violation|0|||
125341859|NCT00006409|450886426|FG001|Post-3 Year Intervention|Protocol Violation|0|||
125341860|NCT00006409|450886427|FG002|Post-3 Year Intervention|Protocol Violation|0|||
125341861|NCT00006409|450886428|FG003|Post-3 Year Intervention|Protocol Violation|0|||
125341862|NCT00006409|450886429|FG004|Post-3 Year Intervention|Protocol Violation|62|||
125341863|NCT00006409|450886430|FG005|Post-3 Year Intervention|Protocol Violation|62|||
125341864|NCT01763996|450886433|FG000|Treatment Period 2|Adverse Event|0|||
125341865|NCT01763996|450886434|FG001|Treatment Period 2|Adverse Event|1|||
125341866|NCT03704636|450886438|FG000|Overall Study|Inadequate Venous Flow|3|||
125341867|NCT00539188|450886441|FG000|Overall Study|Withdrawal by Subject|1|||
125341868|NCT00539188|450886442|FG001|Overall Study|Withdrawal by Subject|0|||
125341869|NCT00539188|450886441|FG000|Overall Study|Lost to Follow-up|2|||
125341870|NCT00539188|450886442|FG001|Overall Study|Lost to Follow-up|1|||
125341871|NCT01546623|450886443|FG000|Overall Study|Adverse Event|2|||
125341872|NCT01546623|450886444|FG001|Overall Study|Adverse Event|3|||
125341873|NCT01546623|450886443|FG000|Overall Study|Major Protocol Deviation|1|||
125341874|NCT01546623|450886444|FG001|Overall Study|Major Protocol Deviation|1|||
125341875|NCT01546623|450886443|FG000|Overall Study|High Prostate specific antigen|2|||
125341876|NCT01546623|450886444|FG001|Overall Study|High Prostate specific antigen|1|||
125341877|NCT01546623|450886443|FG000|Overall Study|Did Not Receive Study Drug|1|||
125674567|NCT00455533|452096738|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
125674568|NCT02576990|452096743|FG000|Overall Study|Death|29|||
125674569|NCT02576990|452096744|FG001|Overall Study|Death|18|||
125674570|NCT02576990|452096743|FG000|Overall Study|Physician Decision|1|||
125674571|NCT02576990|452096744|FG001|Overall Study|Physician Decision|0|||
125674572|NCT02576990|452096743|FG000|Overall Study|Screen failure|2|||
125674573|NCT02576990|452096744|FG001|Overall Study|Screen failure|0|||
125674574|NCT02576990|452096743|FG000|Overall Study|Sponsor's decision|24|||
125674575|NCT02576990|452096744|FG001|Overall Study|Sponsor's decision|4|||
125674576|NCT02576990|452096743|FG000|Overall Study|Withdrawal by Subject|0|||
125674577|NCT02576990|452096744|FG001|Overall Study|Withdrawal by Subject|2|||
125674578|NCT01736553|452096749|FG000|Overall Study|Death|12|||
125674579|NCT01736553|452096750|FG001|Overall Study|Death|0|||
125674580|NCT01736553|452096749|FG000|Overall Study|Withdrawal by Subject|5|||
125674581|NCT01736553|452096750|FG001|Overall Study|Withdrawal by Subject|2|||
125674582|NCT01736553|452096749|FG000|Overall Study|Lost to Follow-up|2|||
125674583|NCT01736553|452096750|FG001|Overall Study|Lost to Follow-up|2|||
125674584|NCT02415959|452096751|FG000|Overall Study|Adverse Event|0|||
125674585|NCT02415959|452096752|FG001|Overall Study|Adverse Event|1|||
125674586|NCT02415959|452096753|FG002|Overall Study|Adverse Event|0|||
125674587|NCT02415959|452096754|FG003|Overall Study|Adverse Event|0|||
125674588|NCT02415959|452096755|FG004|Overall Study|Adverse Event|0|||
125674589|NCT02415959|452096751|FG000|Overall Study|Protocol Violation|0|||
125674590|NCT02415959|452096752|FG001|Overall Study|Protocol Violation|0|||
125674591|NCT02415959|452096753|FG002|Overall Study|Protocol Violation|0|||
125674592|NCT02415959|452096754|FG003|Overall Study|Protocol Violation|1|||
125674593|NCT02415959|452096755|FG004|Overall Study|Protocol Violation|0|||
125674594|NCT00911859|452096756|FG000|Treatment Period|Adverse Event|3|||
125674595|NCT00911859|452096757|FG001|Treatment Period|Adverse Event|3|||
125674596|NCT00911859|452096758|FG002|Treatment Period|Adverse Event|7|||
125674597|NCT00911859|452096756|FG000|Treatment Period|Death|1|||
125674598|NCT00911859|452096757|FG001|Treatment Period|Death|3|||
125674599|NCT00911859|452096758|FG002|Treatment Period|Death|5|||
125674600|NCT00911859|452096756|FG000|Treatment Period|Lack of Efficacy|1|||
125674601|NCT00911859|452096757|FG001|Treatment Period|Lack of Efficacy|7|||
125674602|NCT00911859|452096758|FG002|Treatment Period|Lack of Efficacy|5|||
125674603|NCT00911859|452096756|FG000|Treatment Period|Physician Decision|3|||
125674604|NCT00911859|452096757|FG001|Treatment Period|Physician Decision|3|||
125674605|NCT00911859|452096758|FG002|Treatment Period|Physician Decision|3|||
125674606|NCT00911859|452096756|FG000|Treatment Period|Withdrawal by Subject|0|||
125674607|NCT00911859|452096757|FG001|Treatment Period|Withdrawal by Subject|4|||
125674608|NCT00911859|452096758|FG002|Treatment Period|Withdrawal by Subject|5|||
125674609|NCT00911859|452096756|FG000|Treatment Period|Did not receive study treatment|0|||
125674610|NCT00911859|452096757|FG001|Treatment Period|Did not receive study treatment|1|||
125674611|NCT00911859|452096758|FG002|Treatment Period|Did not receive study treatment|0|||
125674612|NCT00911859|452096756|FG000|Maintainance Period|Lack of Efficacy|0|||
125674613|NCT00911859|452096757|FG001|Maintainance Period|Lack of Efficacy|0|||
125341878|NCT01546623|450886444|FG001|Overall Study|Did Not Receive Study Drug|1|||
125674614|NCT00911859|452096758|FG002|Maintainance Period|Lack of Efficacy|9|||
125674615|NCT00911859|452096756|FG000|Maintainance Period|Physician Decision|0|||
125674616|NCT00911859|452096757|FG001|Maintainance Period|Physician Decision|0|||
125674617|NCT00911859|452096758|FG002|Maintainance Period|Physician Decision|9|||
125674618|NCT00911859|452096756|FG000|Maintainance Period|Withdrawal by Subject|0|||
125674619|NCT00911859|452096757|FG001|Maintainance Period|Withdrawal by Subject|0|||
125674620|NCT00911859|452096758|FG002|Maintainance Period|Withdrawal by Subject|3|||
125674621|NCT00911859|452096756|FG000|Follow-up Period|Death|5|||
125341879|NCT01134705|450886445|FG000|Overall Study|Adverse Event|1|||
125674622|NCT00911859|452096757|FG001|Follow-up Period|Death|8|||
125674623|NCT00911859|452096758|FG002|Follow-up Period|Death|10|||
125674624|NCT00911859|452096756|FG000|Follow-up Period|Lost to Follow-up|1|||
125341880|NCT01134705|450886446|FG001|Overall Study|Adverse Event|7|||
125341881|NCT01134705|450886445|FG000|Overall Study|Withdrawal by Subject|6|||
125341882|NCT01134705|450886446|FG001|Overall Study|Withdrawal by Subject|6|||
125341883|NCT01134705|450886445|FG000|Overall Study|Pregnancy|1|||
125341884|NCT01134705|450886446|FG001|Overall Study|Pregnancy|0|||
125341885|NCT01134705|450886445|FG000|Overall Study|Lost to Follow-up|5|||
125341886|NCT01134705|450886446|FG001|Overall Study|Lost to Follow-up|2|||
125341887|NCT01134705|450886445|FG000|Overall Study|Protocol Violation|1|||
125341888|NCT01134705|450886446|FG001|Overall Study|Protocol Violation|1|||
125341889|NCT01134705|450886445|FG000|Overall Study|Other|1|||
125341890|NCT01134705|450886446|FG001|Overall Study|Other|6|||
125341891|NCT04784442|450886447|FG000|Overall Study|Adverse Event|1|||
125341892|NCT04784442|450886448|FG001|Overall Study|Adverse Event|0|||
125341893|NCT04784442|450886449|FG002|Overall Study|Adverse Event|2|||
125341894|NCT04784442|450886450|FG003|Overall Study|Adverse Event|1|||
125341895|NCT04784442|450886447|FG000|Overall Study|Protocol Violation|1|||
125341896|NCT04784442|450886448|FG001|Overall Study|Protocol Violation|0|||
125341897|NCT04784442|450886449|FG002|Overall Study|Protocol Violation|0|||
125341898|NCT04784442|450886450|FG003|Overall Study|Protocol Violation|0|||
125341899|NCT04784442|450886447|FG000|Overall Study|Non-compliance with study drug|1|||
125341900|NCT04784442|450886448|FG001|Overall Study|Non-compliance with study drug|0|||
125341901|NCT04784442|450886449|FG002|Overall Study|Non-compliance with study drug|0|||
125341902|NCT04784442|450886450|FG003|Overall Study|Non-compliance with study drug|0|||
125341903|NCT01578850|450886453|FG000|Period 1|Insufficient Clinical Response|1|||
125341904|NCT01578850|450886454|FG001|Period 1|Insufficient Clinical Response|0|||
125341905|NCT01578850|450886455|FG002|Period 1|Insufficient Clinical Response|0|||
125341906|NCT01578850|450886453|FG000|Period 1|Adverse Event|11|||
125341907|NCT01578850|450886454|FG001|Period 1|Adverse Event|0|||
125341908|NCT01578850|450886455|FG002|Period 1|Adverse Event|0|||
125341909|NCT01578850|450886453|FG000|Period 1|Death|1|||
125341910|NCT01578850|450886454|FG001|Period 1|Death|0|||
125341911|NCT01578850|450886455|FG002|Period 1|Death|0|||
125341912|NCT01578850|450886453|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
125341913|NCT01578850|450886454|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
125341914|NCT01578850|450886455|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
125341915|NCT01578850|450886453|FG000|Period 1|Withdrawal by Subject|9|||
125341916|NCT01578850|450886454|FG001|Period 1|Withdrawal by Subject|0|||
125341917|NCT01578850|450886455|FG002|Period 1|Withdrawal by Subject|0|||
125341918|NCT01578850|450886453|FG000|Period 1|Study Terminated by Sponsor|3|||
125341919|NCT01578850|450886454|FG001|Period 1|Study Terminated by Sponsor|0|||
125341920|NCT01578850|450886455|FG002|Period 1|Study Terminated by Sponsor|0|||
125341921|NCT01578850|450886453|FG000|Period 2|Insufficient Clinical Response|0|||
125341922|NCT01578850|450886454|FG001|Period 2|Insufficient Clinical Response|1|||
125341923|NCT01578850|450886455|FG002|Period 2|Insufficient Clinical Response|0|||
125341924|NCT01578850|450886453|FG000|Period 2|Adverse Event|0|||
125341925|NCT01578850|450886454|FG001|Period 2|Adverse Event|3|||
125341926|NCT01578850|450886455|FG002|Period 2|Adverse Event|6|||
125341927|NCT01578850|450886453|FG000|Period 2|Lost to Follow-up|0|||
125341928|NCT01578850|450886454|FG001|Period 2|Lost to Follow-up|1|||
125341929|NCT01578850|450886455|FG002|Period 2|Lost to Follow-up|2|||
125341930|NCT01578850|450886453|FG000|Period 2|Withdrawal by Subject|0|||
125341931|NCT01578850|450886454|FG001|Period 2|Withdrawal by Subject|2|||
125341932|NCT01578850|450886455|FG002|Period 2|Withdrawal by Subject|2|||
125341933|NCT01578850|450886453|FG000|Period 2|Study Terminated by Sponsor|0|||
125341934|NCT01578850|450886454|FG001|Period 2|Study Terminated by Sponsor|5|||
125341935|NCT01578850|450886455|FG002|Period 2|Study Terminated by Sponsor|4|||
125341936|NCT01578850|450886453|FG000|Period 2|Unspecified Reasons|0|||
125341937|NCT01578850|450886454|FG001|Period 2|Unspecified Reasons|1|||
125341938|NCT01578850|450886455|FG002|Period 2|Unspecified Reasons|0|||
125341939|NCT01590758|450886456|FG000|Overall Study|Withdrawal by Subject|0|||
125341940|NCT01590758|450886457|FG001|Overall Study|Withdrawal by Subject|3|||
125341941|NCT01590758|450886456|FG000|Overall Study|Physician Decision|1|||
125341942|NCT01590758|450886457|FG001|Overall Study|Physician Decision|2|||
125341943|NCT01590758|450886456|FG000|Overall Study|Lost to Follow-up|4|||
125674625|NCT00911859|452096757|FG001|Follow-up Period|Lost to Follow-up|1|||
125674626|NCT00911859|452096758|FG002|Follow-up Period|Lost to Follow-up|0|||
125674627|NCT00911859|452096756|FG000|Follow-up Period|Withdrawal by Subject|0|||
125674628|NCT00911859|452096757|FG001|Follow-up Period|Withdrawal by Subject|4|||
125674629|NCT00911859|452096758|FG002|Follow-up Period|Withdrawal by Subject|4|||
125674630|NCT00911859|452096756|FG000|Follow-up Period|Study terminated by sponsor|5|||
125674631|NCT00911859|452096757|FG001|Follow-up Period|Study terminated by sponsor|33|||
125674632|NCT00911859|452096758|FG002|Follow-up Period|Study terminated by sponsor|27|||
125674633|NCT01048333|452096759|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
125674634|NCT01048333|452096760|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
125674635|NCT01048333|452096761|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
125674636|NCT01048333|452096762|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
125674637|NCT01048333|452096763|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
125674638|NCT01048333|452096764|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
125674639|NCT00634179|452096772|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
125674640|NCT00767325|452096775|FG000|Overall Study|Lack of Efficacy|2|||
125674641|NCT00767325|452096775|FG000|Overall Study|Adverse Event|7|||
125674642|NCT00767325|452096775|FG000|Overall Study|Lost to Follow-up|3|||
125674643|NCT00767325|452096775|FG000|Overall Study|No longer met study criteria|2|||
125674644|NCT00767325|452096775|FG000|Overall Study|Missed visit due to family reasons|1|||
125674645|NCT03538756|452096776|FG000|Long-Term Follow-up|Adverse Event|0|||
125674646|NCT03538756|452096777|FG001|Long-Term Follow-up|Adverse Event|0|||
125674647|NCT03538756|452096778|FG002|Long-Term Follow-up|Adverse Event|6|||
125674648|NCT03538756|452096776|FG000|Long-Term Follow-up|Death|0|||
125674649|NCT03538756|452096777|FG001|Long-Term Follow-up|Death|0|||
125674650|NCT03538756|452096778|FG002|Long-Term Follow-up|Death|1|||
125674651|NCT03538756|452096776|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
125674652|NCT03538756|452096777|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
125674653|NCT03538756|452096778|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
125674654|NCT03538756|452096776|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
125674655|NCT03538756|452096777|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
125674656|NCT03538756|452096778|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
125674657|NCT03538756|452096776|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
125674658|NCT03538756|452096777|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
125674659|NCT03538756|452096778|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
125674660|NCT00752856|452096779|FG000|Overall Study|randomized but did not do viral kinetics|0|||
125674661|NCT00752856|452096780|FG001|Overall Study|randomized but did not do viral kinetics|1|||
125674662|NCT02260492|452096781|FG000|Overall Study|Adverse Event|6|||
125674663|NCT02260492|452096782|FG001|Overall Study|Adverse Event|1|||
125674664|NCT02260492|452096783|FG002|Overall Study|Adverse Event|2|||
125674665|NCT02260492|452096781|FG000|Overall Study|Death|0|||
125674666|NCT02260492|452096782|FG001|Overall Study|Death|1|||
125674667|NCT02260492|452096783|FG002|Overall Study|Death|0|||
125674668|NCT02260492|452096781|FG000|Overall Study|Lost to Follow-up|12|||
125674669|NCT02260492|452096782|FG001|Overall Study|Lost to Follow-up|9|||
125674670|NCT02260492|452096783|FG002|Overall Study|Lost to Follow-up|0|||
125674671|NCT02260492|452096781|FG000|Overall Study|Physician Decision|2|||
125674672|NCT02260492|452096782|FG001|Overall Study|Physician Decision|0|||
125674673|NCT02260492|452096783|FG002|Overall Study|Physician Decision|1|||
125674674|NCT02260492|452096781|FG000|Overall Study|Withdrawal by Subject|3|||
125674675|NCT02260492|452096782|FG001|Overall Study|Withdrawal by Subject|2|||
125674676|NCT02260492|452096783|FG002|Overall Study|Withdrawal by Subject|2|||
125674677|NCT03131999|452096784|FG000|Overall Study|Withdrawal by Subject|0|||
125674678|NCT03131999|452096785|FG001|Overall Study|Withdrawal by Subject|1|||
125341944|NCT01590758|450886457|FG001|Overall Study|Lost to Follow-up|2|||
125341945|NCT02756806|450886458|FG000|Overall Study|Study terminated early|5|||
125674679|NCT00996736|452096791|FG000|Overall Study|Death|1|||
125674680|NCT00996736|452096792|FG001|Overall Study|Death|1|||
125341946|NCT02717832|450886459|FG000|Overall Study|Inability to place IV|3|||
125341947|NCT02929498|450886460|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
125341948|NCT02929498|450886461|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
125341949|NCT02929498|450886462|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
125341950|NCT02929498|450886460|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
125341951|NCT02929498|450886461|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
125341952|NCT02929498|450886462|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
125341953|NCT02744040|450886463|FG000|Overall Study|Withdrawal by Subject|3|||
125674681|NCT00996736|452096791|FG000|Overall Study|Lost to Follow-up|15|||
125674682|NCT00996736|452096792|FG001|Overall Study|Lost to Follow-up|14|||
125674683|NCT00996736|452096791|FG000|Overall Study|Visit not within 3-month window|5|||
125674684|NCT00996736|452096792|FG001|Overall Study|Visit not within 3-month window|3|||
125674685|NCT02688608|452096793|FG000|Overall Study|Lost to Follow-up|1|||
125674686|NCT02456909|452096794|FG000|Overall Study|Did not receive allocated intervention|24|||
125674687|NCT02456909|452096795|FG001|Overall Study|Did not receive allocated intervention|26|||
125674688|NCT02456909|452096794|FG000|Overall Study|Did not complete the primary outcome|0|||
125674689|NCT02456909|452096795|FG001|Overall Study|Did not complete the primary outcome|1|||
125674690|NCT01497938|452096796|FG000|Overall Study|Adverse Event|0|||
125674691|NCT01497938|452096797|FG001|Overall Study|Adverse Event|1|||
125674692|NCT01497938|452096796|FG000|Overall Study|Physician Decision|0|||
125674693|NCT01497938|452096797|FG001|Overall Study|Physician Decision|1|||
125674694|NCT01497938|452096796|FG000|Overall Study|Withdrawal by Subject|4|||
125674695|NCT01497938|452096797|FG001|Overall Study|Withdrawal by Subject|0|||
125674696|NCT01497938|452096796|FG000|Overall Study|Device Violation|1|||
125674697|NCT01497938|452096797|FG001|Overall Study|Device Violation|0|||
125674698|NCT00365352|452096798|FG000|Overall Study|Adverse Event|6|||
125674699|NCT00365352|452096799|FG001|Overall Study|Adverse Event|7|||
125674700|NCT00365352|452096800|FG002|Overall Study|Adverse Event|8|||
125674701|NCT00365352|452096798|FG000|Overall Study|Participant Withdrew Consent|8|||
125674702|NCT00365352|452096799|FG001|Overall Study|Participant Withdrew Consent|3|||
125674703|NCT00365352|452096800|FG002|Overall Study|Participant Withdrew Consent|4|||
125674704|NCT00365352|452096798|FG000|Overall Study|Lack of Efficacy|3|||
125674705|NCT00365352|452096799|FG001|Overall Study|Lack of Efficacy|0|||
125674706|NCT00365352|452096800|FG002|Overall Study|Lack of Efficacy|0|||
125674707|NCT00365352|452096798|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
125674708|NCT00365352|452096799|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
125674709|NCT00365352|452096800|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
125674710|NCT00365352|452096798|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
125674711|NCT00365352|452096799|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
125674712|NCT00365352|452096800|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
125674713|NCT00365352|452096798|FG000|Overall Study|Lost to Follow-up|1|||
125674714|NCT00365352|452096799|FG001|Overall Study|Lost to Follow-up|1|||
125674715|NCT00365352|452096800|FG002|Overall Study|Lost to Follow-up|0|||
125674716|NCT00365352|452096798|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
125674717|NCT00365352|452096799|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
125674718|NCT00365352|452096800|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
125674719|NCT02224456|452098564|FG000|Overall Study|Lack of Efficacy|1|||
125674720|NCT02224456|452098564|FG000|Overall Study|Lost to Follow-up|15|||
125674721|NCT02224456|452098564|FG000|Overall Study|Withdrawal by Subject|9|||
125674722|NCT02224456|452098564|FG000|Overall Study|Physician Decision|3|||
125674723|NCT02224456|452098564|FG000|Overall Study|Death|2|||
125674724|NCT02224456|452098564|FG000|Overall Study|Pregnancy|4|||
125674725|NCT02224456|452098564|FG000|Overall Study|Protocol Violation|1|||
125674726|NCT02224456|452098564|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
125674727|NCT01644890|452098565|FG000|Overall Study|Adverse Event|7|||
125674728|NCT01644890|452098566|FG001|Overall Study|Adverse Event|20|||
125674729|NCT01644890|452098565|FG000|Overall Study|Death|1|||
125674730|NCT01644890|452098566|FG001|Overall Study|Death|3|||
125674731|NCT01644890|452098565|FG000|Overall Study|Physician Decision|3|||
125674732|NCT01644890|452098566|FG001|Overall Study|Physician Decision|9|||
125674733|NCT01644890|452098565|FG000|Overall Study|Protocol Violation|6|||
125674734|NCT01644890|452098566|FG001|Overall Study|Protocol Violation|7|||
125674735|NCT01644890|452098565|FG000|Overall Study|Withdrawal by Subject|19|||
125674736|NCT01644890|452098566|FG001|Overall Study|Withdrawal by Subject|27|||
125674737|NCT01644890|452098565|FG000|Overall Study|Progression Disease|160|||
125674738|NCT01644890|452098566|FG001|Overall Study|Progression Disease|131|||
125674739|NCT01644890|452098565|FG000|Overall Study|Clinical Progression|6|||
125674740|NCT01644890|452098566|FG001|Overall Study|Clinical Progression|6|||
125674741|NCT01644890|452098565|FG000|Overall Study|> 28 days since last dose of study drug|6|||
125674742|NCT01644890|452098566|FG001|Overall Study|> 28 days since last dose of study drug|3|||
125674743|NCT01644890|452098565|FG000|Overall Study|Other|8|||
125674744|NCT01644890|452098566|FG001|Overall Study|Other|9|||
125341954|NCT02744040|450886464|FG001|Overall Study|Withdrawal by Subject|2|||
125341955|NCT02744040|450886465|FG002|Overall Study|Withdrawal by Subject|2|||
125341956|NCT02744040|450886463|FG000|Overall Study|Physician Decision|0|||
125674745|NCT02761980|452098569|FG000|Overall Study|Adverse Event|4|||
125674746|NCT02761980|452098570|FG001|Overall Study|Adverse Event|6|||
125674747|NCT02761980|452098571|FG002|Overall Study|Adverse Event|5|||
125341957|NCT02744040|450886464|FG001|Overall Study|Physician Decision|8|||
125341958|NCT02744040|450886465|FG002|Overall Study|Physician Decision|13|||
125674748|NCT02761980|452098572|FG003|Overall Study|Adverse Event|6|||
125674749|NCT02761980|452098569|FG000|Overall Study|Withdrawal by Subject|0|||
125674750|NCT02761980|452098570|FG001|Overall Study|Withdrawal by Subject|1|||
125674751|NCT02761980|452098571|FG002|Overall Study|Withdrawal by Subject|0|||
125341959|NCT02744040|450886463|FG000|Overall Study|Lost to Follow-up|3|||
125341960|NCT02744040|450886464|FG001|Overall Study|Lost to Follow-up|1|||
125341961|NCT02744040|450886465|FG002|Overall Study|Lost to Follow-up|7|||
125341962|NCT00096356|450886466|FG000|Overall Study|Adverse Event|11|||
125341963|NCT00096356|450886467|FG001|Overall Study|Adverse Event|9|||
125341964|NCT00096356|450886466|FG000|Overall Study|Physician Decision|5|||
125341965|NCT00096356|450886467|FG001|Overall Study|Physician Decision|3|||
125341966|NCT00096356|450886466|FG000|Overall Study|Withdrawal by Subject|17|||
125341967|NCT00096356|450886467|FG001|Overall Study|Withdrawal by Subject|23|||
125341968|NCT00096356|450886466|FG000|Overall Study|Lack of Efficacy|1|||
125341969|NCT00096356|450886467|FG001|Overall Study|Lack of Efficacy|0|||
125341970|NCT00096356|450886466|FG000|Overall Study|multiple reasons|10|||
125341971|NCT00096356|450886467|FG001|Overall Study|multiple reasons|18|||
125341972|NCT01008423|450886468|FG000|Overall Study|Adverse Event|13|||
125341973|NCT01008423|450886469|FG001|Overall Study|Adverse Event|6|||
125341974|NCT01008423|450886468|FG000|Overall Study|Withdrawal by Subject|4|||
125341975|NCT01008423|450886469|FG001|Overall Study|Withdrawal by Subject|7|||
125341976|NCT01008423|450886468|FG000|Overall Study|Lost to Follow-up|0|||
125674752|NCT02761980|452098572|FG003|Overall Study|Withdrawal by Subject|0|||
125674753|NCT02761980|452098569|FG000|Overall Study|Other|0|||
125674754|NCT02761980|452098570|FG001|Overall Study|Other|0|||
125674755|NCT02761980|452098571|FG002|Overall Study|Other|1|||
125674756|NCT02761980|452098572|FG003|Overall Study|Other|0|||
125674757|NCT00101582|452098573|FG000|Overall Study|Ineligibility determined|0|||
125674758|NCT00101582|452098574|FG001|Overall Study|Ineligibility determined|1|||
125674759|NCT00101582|452098573|FG000|Overall Study|Adverse Event|1|||
125674760|NCT00101582|452098574|FG001|Overall Study|Adverse Event|4|||
125674761|NCT00101582|452098573|FG000|Overall Study|Withdrawal by Subject|6|||
125674762|NCT00101582|452098574|FG001|Overall Study|Withdrawal by Subject|4|||
125674763|NCT00101582|452098573|FG000|Overall Study|Physician Decision|1|||
125674764|NCT00101582|452098574|FG001|Overall Study|Physician Decision|0|||
125674765|NCT00101582|452098573|FG000|Overall Study|Death|3|||
125674766|NCT00101582|452098574|FG001|Overall Study|Death|5|||
125674767|NCT00101582|452098573|FG000|Overall Study|Other|0|||
125674768|NCT00101582|452098574|FG001|Overall Study|Other|1|||
125674769|NCT00056160|452098575|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
125674770|NCT00056160|452098576|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
125674771|NCT00056160|452098575|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
125674772|NCT00056160|452098576|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
125674773|NCT00056160|452098575|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
125674774|NCT00056160|452098576|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
125674775|NCT00056160|452098575|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
125674776|NCT00056160|452098576|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
125674777|NCT00056160|452098575|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
125674778|NCT00056160|452098576|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
125674779|NCT00056160|452098575|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
125674780|NCT00056160|452098576|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
125674781|NCT00056160|452098575|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
125674782|NCT00056160|452098576|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
125674783|NCT00056160|452098575|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
125674784|NCT00056160|452098576|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
125674785|NCT00056160|452098575|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
125674786|NCT00056160|452098576|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
125674787|NCT00056160|452098575|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
125674788|NCT00056160|452098576|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
125674789|NCT00056160|452098575|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
125674790|NCT00056160|452098576|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
125674791|NCT00056160|452098575|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
125674792|NCT00056160|452098576|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
125674793|NCT00056160|452098575|FG000|Final Follow-up|Transferred into expanded access study.|3|||
125674794|NCT00056160|452098576|FG001|Final Follow-up|Transferred into expanded access study.|0|||
125674795|NCT00056160|452098575|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
125674796|NCT00056160|452098576|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
125674797|NCT00056160|452098575|FG000|Final Follow-up|Adverse Event|1|||
125674798|NCT00056160|452098576|FG001|Final Follow-up|Adverse Event|0|||
125674799|NCT03093324|452098578|FG000|Overall Study|Adverse Event|4|||
125674800|NCT03093324|452098579|FG001|Overall Study|Adverse Event|15|||
125674801|NCT03093324|452098578|FG000|Overall Study|Lost to Follow-up|1|||
125674802|NCT03093324|452098579|FG001|Overall Study|Lost to Follow-up|0|||
125341977|NCT01008423|450886469|FG001|Overall Study|Lost to Follow-up|2|||
125341978|NCT01008423|450886468|FG000|Overall Study|Low Cortisol|0|||
125674803|NCT03093324|452098578|FG000|Overall Study|Protocol Deviation|2|||
125674804|NCT03093324|452098579|FG001|Overall Study|Protocol Deviation|2|||
125674805|NCT03093324|452098578|FG000|Overall Study|Withdrawal by Subject|2|||
125674806|NCT03093324|452098579|FG001|Overall Study|Withdrawal by Subject|2|||
125674807|NCT04583579|452098580|FG000|Overall Study|Lost to Follow-up|4|||
125674808|NCT00278200|452098581|FG000|Overall Study|Death|1|||
125674809|NCT00278200|452098582|FG001|Overall Study|Death|3|||
125674810|NCT00278200|452098581|FG000|Overall Study|Physician Decision|0|||
125341979|NCT01008423|450886469|FG001|Overall Study|Low Cortisol|1|||
125341980|NCT01008423|450886468|FG000|Overall Study|Lack of Efficacy|0|||
125341981|NCT01008423|450886469|FG001|Overall Study|Lack of Efficacy|5|||
125341982|NCT01008423|450886468|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
125341983|NCT01008423|450886469|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
125341984|NCT01008423|450886468|FG000|Overall Study|Personal Conflict|1|||
125341985|NCT01008423|450886469|FG001|Overall Study|Personal Conflict|0|||
125341986|NCT01008423|450886468|FG000|Overall Study|Other|0|||
125341987|NCT01008423|450886469|FG001|Overall Study|Other|1|||
125341988|NCT03288142|450886471|FG000|Overall Study|Lost to Follow-up|22|||
125341989|NCT03288142|450886472|FG001|Overall Study|Lost to Follow-up|15|||
125341990|NCT00934843|450886473|FG000|Overall Study|Protocol Violation|0|||
125341991|NCT00934843|450886474|FG001|Overall Study|Protocol Violation|1|||
125341992|NCT00960570|450886479|FG000|21 Day Washout Period|Adverse Event|1|||
125378914|NCT00589914|451019207|FG001|Overall Study|Lost to Follow-up|18|||
125341993|NCT00960570|450886479|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
125341994|NCT00960570|450886479|FG000|1 Day Period Between Dosing|Adverse Event|2|||
125341995|NCT00960570|450886479|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
125341996|NCT01451437|450886480|FG000|Overall Study|Adverse Event|0|||
125341997|NCT01451437|450886481|FG001|Overall Study|Adverse Event|0|||
125341998|NCT01451437|450886482|FG002|Overall Study|Adverse Event|0|||
125341999|NCT01451437|450886483|FG003|Overall Study|Adverse Event|0|||
125342000|NCT01451437|450886484|FG004|Overall Study|Adverse Event|0|||
125342001|NCT01451437|450886485|FG005|Overall Study|Adverse Event|1|||
125342002|NCT01451437|450886486|FG006|Overall Study|Adverse Event|1|||
125342003|NCT01451437|450886487|FG007|Overall Study|Adverse Event|2|||
125342004|NCT01451437|450886488|FG008|Overall Study|Adverse Event|1|||
125342005|NCT01451437|450886480|FG000|Overall Study|Physician Decision|1|||
125342006|NCT01451437|450886481|FG001|Overall Study|Physician Decision|1|||
125342007|NCT01451437|450886482|FG002|Overall Study|Physician Decision|2|||
125342008|NCT01451437|450886483|FG003|Overall Study|Physician Decision|0|||
125342009|NCT01451437|450886484|FG004|Overall Study|Physician Decision|0|||
125342010|NCT01451437|450886485|FG005|Overall Study|Physician Decision|0|||
125342011|NCT01451437|450886486|FG006|Overall Study|Physician Decision|0|||
125342012|NCT01451437|450886487|FG007|Overall Study|Physician Decision|0|||
125342013|NCT01451437|450886488|FG008|Overall Study|Physician Decision|0|||
125342014|NCT01451437|450886480|FG000|Overall Study|Disease Progression|0|||
125342015|NCT01451437|450886481|FG001|Overall Study|Disease Progression|0|||
125342016|NCT01451437|450886482|FG002|Overall Study|Disease Progression|1|||
125342017|NCT01451437|450886483|FG003|Overall Study|Disease Progression|1|||
125342018|NCT01451437|450886484|FG004|Overall Study|Disease Progression|3|||
125342019|NCT01451437|450886485|FG005|Overall Study|Disease Progression|2|||
125342020|NCT01451437|450886486|FG006|Overall Study|Disease Progression|3|||
125342021|NCT01451437|450886487|FG007|Overall Study|Disease Progression|1|||
125342022|NCT01451437|450886488|FG008|Overall Study|Disease Progression|3|||
125342023|NCT01451437|450886480|FG000|Overall Study|Protocol Violation|0|||
125342024|NCT01451437|450886481|FG001|Overall Study|Protocol Violation|0|||
125342025|NCT01451437|450886482|FG002|Overall Study|Protocol Violation|0|||
125342026|NCT01451437|450886483|FG003|Overall Study|Protocol Violation|0|||
125342027|NCT01451437|450886484|FG004|Overall Study|Protocol Violation|0|||
125342028|NCT01451437|450886485|FG005|Overall Study|Protocol Violation|0|||
125342029|NCT01451437|450886486|FG006|Overall Study|Protocol Violation|1|||
125342030|NCT01451437|450886487|FG007|Overall Study|Protocol Violation|0|||
125342031|NCT01451437|450886488|FG008|Overall Study|Protocol Violation|0|||
125342032|NCT01451437|450886480|FG000|Overall Study|Withdrawal by Subject|0|||
125342033|NCT01451437|450886481|FG001|Overall Study|Withdrawal by Subject|0|||
125674811|NCT00278200|452098582|FG001|Overall Study|Physician Decision|1|||
125674812|NCT00135707|452098585|FG000|Overall Study|Lost to Follow-up|94|||
125674813|NCT00135707|452098586|FG001|Overall Study|Lost to Follow-up|89|||
125674814|NCT00135707|452098585|FG000|Overall Study|Withdrawal by Subject|0|||
125674815|NCT00135707|452098586|FG001|Overall Study|Withdrawal by Subject|1|||
125674816|NCT00135707|452098585|FG000|Overall Study|Institutional review board request|1|||
125674817|NCT00135707|452098586|FG001|Overall Study|Institutional review board request|0|||
125674818|NCT00421174|452098590|FG000|Overall Study|Withdrawal by Subject|0|||
125674819|NCT00421174|452098591|FG001|Overall Study|Withdrawal by Subject|1|||
125674820|NCT00421174|452098590|FG000|Overall Study|Ineligible due to infection|2|||
125674821|NCT00421174|452098591|FG001|Overall Study|Ineligible due to infection|0|||
125674822|NCT02524379|452098592|FG000|Overall Study|Death|1|||
125674823|NCT01829464|452098593|FG000|Overall Study|Adverse Event|1|||
125674824|NCT01829464|452098594|FG001|Overall Study|Adverse Event|0|||
125674825|NCT01829464|452098595|FG002|Overall Study|Adverse Event|0|||
125674826|NCT01829464|452098593|FG000|Overall Study|Lost to Follow-up|0|||
125674827|NCT01829464|452098594|FG001|Overall Study|Lost to Follow-up|0|||
125674828|NCT01829464|452098595|FG002|Overall Study|Lost to Follow-up|1|||
125674829|NCT01829464|452098593|FG000|Overall Study|Withdrawal by Subject|2|||
125674830|NCT01829464|452098594|FG001|Overall Study|Withdrawal by Subject|0|||
125674831|NCT01829464|452098595|FG002|Overall Study|Withdrawal by Subject|0|||
125674832|NCT01829464|452098593|FG000|Overall Study|Study terminated by sponsor|25|||
125674833|NCT01829464|452098594|FG001|Overall Study|Study terminated by sponsor|28|||
125674834|NCT01829464|452098595|FG002|Overall Study|Study terminated by sponsor|25|||
125342034|NCT01451437|450886482|FG002|Overall Study|Withdrawal by Subject|0|||
125342035|NCT01451437|450886483|FG003|Overall Study|Withdrawal by Subject|0|||
125342036|NCT01451437|450886484|FG004|Overall Study|Withdrawal by Subject|1|||
125342037|NCT01451437|450886485|FG005|Overall Study|Withdrawal by Subject|0|||
125342038|NCT01451437|450886486|FG006|Overall Study|Withdrawal by Subject|1|||
125342039|NCT01451437|450886487|FG007|Overall Study|Withdrawal by Subject|0|||
125342040|NCT01451437|450886488|FG008|Overall Study|Withdrawal by Subject|0|||
125342041|NCT03254108|450888665|FG000|Overall Study|Adverse Event|0|||
125342042|NCT03254108|450888666|FG001|Overall Study|Adverse Event|2|||
125342043|NCT03254108|450888667|FG002|Overall Study|Adverse Event|0|||
125674835|NCT01829464|452098593|FG000|Overall Study|Lack of Efficacy|0|||
125674836|NCT01829464|452098594|FG001|Overall Study|Lack of Efficacy|1|||
125674837|NCT01829464|452098595|FG002|Overall Study|Lack of Efficacy|0|||
125674838|NCT02228382|452098600|FG000|Overall Study|Death|5|||
125342044|NCT03254108|450888668|FG003|Overall Study|Adverse Event|1|||
125342045|NCT03254108|450888669|FG004|Overall Study|Adverse Event|1|||
125342046|NCT03254108|450888665|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
125342047|NCT03254108|450888666|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
125342048|NCT03254108|450888667|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
125342049|NCT03254108|450888668|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
125342050|NCT03254108|450888669|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
125342051|NCT00490529|450888671|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
125342052|NCT00490529|450888671|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
125342053|NCT00490529|450888671|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
125342054|NCT00490529|450888671|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
125342055|NCT00490529|450888671|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
125342056|NCT00490529|450888671|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
125342057|NCT03254459|450888672|FG000|Overall Study|Adverse Event|7|||
125342058|NCT03254459|450888673|FG001|Overall Study|Adverse Event|20|||
125342059|NCT03254459|450888672|FG000|Overall Study|Withdrawal by Subject Consent|3|||
125342060|NCT03254459|450888673|FG001|Overall Study|Withdrawal by Subject Consent|1|||
125342061|NCT03254459|450888672|FG000|Overall Study|Lost to Follow-up|0|||
125342062|NCT03254459|450888673|FG001|Overall Study|Lost to Follow-up|1|||
125342063|NCT03254459|450888672|FG000|Overall Study|Miscellaneous|0|||
125342064|NCT03254459|450888673|FG001|Overall Study|Miscellaneous|1|||
125342065|NCT00727441|450888674|FG000|Overall Study|Disease Progression|11|||
125342066|NCT00727441|450888675|FG001|Overall Study|Disease Progression|14|||
125342067|NCT00727441|450888676|FG002|Overall Study|Disease Progression|17|||
125342068|NCT00727441|450888674|FG000|Overall Study|Eligibility|7|||
125342069|NCT00727441|450888675|FG001|Overall Study|Eligibility|5|||
125342070|NCT00727441|450888676|FG002|Overall Study|Eligibility|7|||
125342071|NCT00727441|450888674|FG000|Overall Study|Death|0|||
125342072|NCT00727441|450888675|FG001|Overall Study|Death|1|||
125342073|NCT00727441|450888676|FG002|Overall Study|Death|1|||
125342074|NCT00727441|450888674|FG000|Overall Study|Physician Decision|0|||
125674839|NCT02228382|452098601|FG001|Overall Study|Death|7|||
125674840|NCT02228382|452098602|FG002|Overall Study|Death|5|||
125674841|NCT02228382|452098603|FG003|Overall Study|Death|0|||
125674842|NCT02228382|452098604|FG004|Overall Study|Death|2|||
125674843|NCT02228382|452098600|FG000|Overall Study|Participant refused further follow-up|0|||
125674844|NCT02228382|452098601|FG001|Overall Study|Participant refused further follow-up|0|||
125674845|NCT02228382|452098602|FG002|Overall Study|Participant refused further follow-up|1|||
125674846|NCT02228382|452098603|FG003|Overall Study|Participant refused further follow-up|0|||
125674847|NCT02228382|452098604|FG004|Overall Study|Participant refused further follow-up|0|||
125674848|NCT02228382|452098600|FG000|Overall Study|Study terminated by sponsor|3|||
125674849|NCT02228382|452098601|FG001|Overall Study|Study terminated by sponsor|5|||
125674850|NCT02228382|452098602|FG002|Overall Study|Study terminated by sponsor|7|||
125674851|NCT02228382|452098603|FG003|Overall Study|Study terminated by sponsor|0|||
125674852|NCT02228382|452098604|FG004|Overall Study|Study terminated by sponsor|0|||
125674853|NCT02228382|452098600|FG000|Overall Study|Lost to Follow-up|0|||
125674854|NCT02228382|452098601|FG001|Overall Study|Lost to Follow-up|0|||
125674855|NCT02228382|452098602|FG002|Overall Study|Lost to Follow-up|3|||
125674856|NCT02228382|452098603|FG003|Overall Study|Lost to Follow-up|1|||
125674857|NCT02228382|452098604|FG004|Overall Study|Lost to Follow-up|0|||
125674858|NCT02228382|452098600|FG000|Overall Study|Withdrawal by Subject|0|||
125674859|NCT02228382|452098601|FG001|Overall Study|Withdrawal by Subject|3|||
125674860|NCT02228382|452098602|FG002|Overall Study|Withdrawal by Subject|2|||
125674861|NCT02228382|452098603|FG003|Overall Study|Withdrawal by Subject|1|||
125674862|NCT02228382|452098604|FG004|Overall Study|Withdrawal by Subject|0|||
125674863|NCT02228382|452098600|FG000|Overall Study|Other|2|||
125674864|NCT02228382|452098601|FG001|Overall Study|Other|3|||
125674865|NCT02228382|452098602|FG002|Overall Study|Other|3|||
125674866|NCT02228382|452098603|FG003|Overall Study|Other|0|||
125674867|NCT02228382|452098604|FG004|Overall Study|Other|0|||
125674868|NCT00356200|452098606|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
125674869|NCT00356200|452098607|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
125674870|NCT00356200|452098606|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
125674871|NCT00356200|452098607|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
125674872|NCT00812253|452098608|FG000|Overall Study|Withdrawal by Subject|3|||
125674873|NCT00812253|452098609|FG001|Overall Study|Withdrawal by Subject|2|||
125674874|NCT00812253|452098608|FG000|Overall Study|Protocol Violation|1|||
125674875|NCT00812253|452098609|FG001|Overall Study|Protocol Violation|1|||
125674876|NCT00812253|452098608|FG000|Overall Study|Lost to Follow-up|2|||
125674877|NCT00812253|452098609|FG001|Overall Study|Lost to Follow-up|0|||
125674878|NCT03679741|452098610|FG000|Period 1|No longer meet eligibility criteria|1|||
125674879|NCT03679741|452098611|FG001|Period 1|No longer meet eligibility criteria|0|||
125674880|NCT03679741|452098610|FG000|Period 1|Lost to Follow-up|0|||
125674881|NCT03679741|452098611|FG001|Period 1|Lost to Follow-up|1|||
125674882|NCT03679741|452098610|FG000|Period 1|Adverse Event|1|||
125674883|NCT03679741|452098611|FG001|Period 1|Adverse Event|1|||
125674884|NCT03679741|452098610|FG000|Period 1|Withdrawal by Subject|0|||
125674885|NCT03679741|452098611|FG001|Period 1|Withdrawal by Subject|1|||
125674886|NCT03679741|452098610|FG000|Period 2|Adverse Event|2|||
125342075|NCT00727441|450888675|FG001|Overall Study|Physician Decision|1|||
125342076|NCT00727441|450888676|FG002|Overall Study|Physician Decision|0|||
125342077|NCT00727441|450888674|FG000|Overall Study|Withdrawal by Subject|0|||
125674887|NCT03679741|452098611|FG001|Period 2|Adverse Event|1|||
125674888|NCT03679741|452098610|FG000|Period 2|Withdrawal by Subject|1|||
125674889|NCT03679741|452098611|FG001|Period 2|Withdrawal by Subject|1|||
125674890|NCT02204371|452098621|FG000|Overall Study|Adverse Event|1|||
125674891|NCT00368966|452098624|FG000|Infant Series|Withdrawal by Subject|11|||
125674892|NCT00368966|452098625|FG001|Infant Series|Withdrawal by Subject|6|||
125342078|NCT00727441|450888675|FG001|Overall Study|Withdrawal by Subject|1|||
125342079|NCT00727441|450888676|FG002|Overall Study|Withdrawal by Subject|0|||
125342080|NCT00535288|450888677|FG000|Overall Study|Adverse Event|20|||
125342081|NCT00535288|450888678|FG001|Overall Study|Adverse Event|19|||
125674893|NCT00368966|452098624|FG000|Infant Series|Protocol Violation|2|||
125674894|NCT00368966|452098625|FG001|Infant Series|Protocol Violation|1|||
125674895|NCT00368966|452098624|FG000|Infant Series|Lost to Follow-up|2|||
125674896|NCT00368966|452098625|FG001|Infant Series|Lost to Follow-up|0|||
125674897|NCT00368966|452098624|FG000|Infant Series|Randomization error|0|||
125674898|NCT00368966|452098625|FG001|Infant Series|Randomization error|1|||
125674899|NCT00368966|452098624|FG000|Infant Series|Failed to meet eligibility criteria|0|||
125674900|NCT00368966|452098625|FG001|Infant Series|Failed to meet eligibility criteria|1|||
125674901|NCT00368966|452098624|FG000|Infant Series|Adverse Event|0|||
125674902|NCT00368966|452098625|FG001|Infant Series|Adverse Event|1|||
125674903|NCT00368966|452098624|FG000|Infant Series|Failed to return|1|||
125674904|NCT00368966|452098625|FG001|Infant Series|Failed to return|0|||
125674905|NCT00368966|452098624|FG000|After Infant|Failed to return|3|||
125674906|NCT00368966|452098625|FG001|After Infant|Failed to return|1|||
125674907|NCT00368966|452098624|FG000|After Infant|Adverse Event|1|||
125674908|NCT00368966|452098625|FG001|After Infant|Adverse Event|2|||
125674909|NCT00368966|452098624|FG000|After Infant|Withdrawal by Subject|1|||
125674910|NCT00368966|452098625|FG001|After Infant|Withdrawal by Subject|1|||
125674911|NCT00368966|452098624|FG000|After Infant|Death|1|||
125674912|NCT00368966|452098625|FG001|After Infant|Death|0|||
125674913|NCT00368966|452098624|FG000|After Infant|Lost to Follow-up|0|||
125674914|NCT00368966|452098625|FG001|After Infant|Lost to Follow-up|1|||
125674915|NCT00368966|452098624|FG000|Toddler Dose|Withdrawal by Subject|1|||
125674916|NCT00368966|452098625|FG001|Toddler Dose|Withdrawal by Subject|1|||
125674917|NCT00368966|452098624|FG000|Toddler Dose|Lost to Follow-up|0|||
125674918|NCT00368966|452098625|FG001|Toddler Dose|Lost to Follow-up|2|||
125674919|NCT02866175|452098626|FG000|Overall Study|Adverse Event|56|||
125674920|NCT02866175|452098627|FG001|Overall Study|Adverse Event|54|||
125342082|NCT00535288|450888679|FG002|Overall Study|Adverse Event|25|||
125342083|NCT00535288|450888680|FG003|Overall Study|Adverse Event|20|||
125342084|NCT00535288|450888681|FG004|Overall Study|Adverse Event|30|||
125342085|NCT00535288|450888677|FG000|Overall Study|Lost to Follow-up|0|||
125342086|NCT00535288|450888678|FG001|Overall Study|Lost to Follow-up|3|||
125342087|NCT00535288|450888679|FG002|Overall Study|Lost to Follow-up|0|||
125342088|NCT00535288|450888680|FG003|Overall Study|Lost to Follow-up|0|||
125342089|NCT00535288|450888681|FG004|Overall Study|Lost to Follow-up|0|||
125342090|NCT00535288|450888677|FG000|Overall Study|Lack of Efficacy|26|||
125342091|NCT00535288|450888678|FG001|Overall Study|Lack of Efficacy|3|||
125342092|NCT00535288|450888679|FG002|Overall Study|Lack of Efficacy|4|||
125342093|NCT00535288|450888680|FG003|Overall Study|Lack of Efficacy|4|||
125342094|NCT00535288|450888681|FG004|Overall Study|Lack of Efficacy|7|||
125342095|NCT00535288|450888677|FG000|Overall Study|Unwilling to cooperate|6|||
125342096|NCT00535288|450888678|FG001|Overall Study|Unwilling to cooperate|6|||
125342097|NCT00535288|450888679|FG002|Overall Study|Unwilling to cooperate|3|||
125342098|NCT00535288|450888680|FG003|Overall Study|Unwilling to cooperate|3|||
125342099|NCT00535288|450888681|FG004|Overall Study|Unwilling to cooperate|4|||
125342100|NCT00535288|450888677|FG000|Overall Study|Other|2|||
125342101|NCT00535288|450888678|FG001|Overall Study|Other|1|||
125342102|NCT00535288|450888679|FG002|Overall Study|Other|1|||
125342103|NCT00535288|450888680|FG003|Overall Study|Other|2|||
125342104|NCT00535288|450888681|FG004|Overall Study|Other|1|||
125342105|NCT00745849|450888682|FG000|First Intervention|Withdrawal by Subject|0|||
125342106|NCT00745849|450888683|FG001|First Intervention|Withdrawal by Subject|1|||
125342107|NCT00745849|450888682|FG000|First Intervention|Lost to Follow-up|1|||
125342108|NCT00745849|450888683|FG001|First Intervention|Lost to Follow-up|1|||
125342109|NCT00745849|450888682|FG000|Second Intervention|Lost to Follow-up|2|||
125342110|NCT00745849|450888683|FG001|Second Intervention|Lost to Follow-up|1|||
125342111|NCT01129583|450888684|FG000|Overall Study|Death|1|||
125342112|NCT01129583|450888685|FG001|Overall Study|Death|0|||
125342113|NCT01129583|450888684|FG000|Overall Study|Lost to Follow-up|1|||
125342114|NCT01129583|450888685|FG001|Overall Study|Lost to Follow-up|1|||
125342115|NCT01129583|450888684|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
125342116|NCT01129583|450888685|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
125342117|NCT02600871|450888686|FG000|Overall Study|Lost to Follow-up|13|||
125342118|NCT02600871|450888687|FG001|Overall Study|Lost to Follow-up|10|||
125342119|NCT00830869|450888690|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
125674921|NCT02866175|452098626|FG000|Overall Study|Withdrawal by Subject|31|||
125674922|NCT02866175|452098627|FG001|Overall Study|Withdrawal by Subject|52|||
125674923|NCT02866175|452098626|FG000|Overall Study|Death|30|||
125674924|NCT02866175|452098627|FG001|Overall Study|Death|23|||
125342120|NCT00830869|450888691|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
125342121|NCT00830869|450888692|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
125342122|NCT00830869|450888693|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
125342123|NCT00830869|450888694|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
125342124|NCT00830869|450888695|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
125342125|NCT00830869|450888696|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
125342126|NCT00830869|450888697|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
125674925|NCT02866175|452098626|FG000|Overall Study|Other|7|||
125674926|NCT02866175|452098627|FG001|Overall Study|Other|14|||
125342127|NCT00830869|450888698|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
125342128|NCT00830869|450888699|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
125342129|NCT00830869|450888700|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
125342130|NCT00830869|450888701|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
125342131|NCT00830869|450888690|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
125674927|NCT02866175|452098626|FG000|Overall Study|Progressive disease|1|||
125674928|NCT02866175|452098627|FG001|Overall Study|Progressive disease|1|||
125674929|NCT02866175|452098626|FG000|Overall Study|Lost to Follow-up|2|||
125674930|NCT02866175|452098627|FG001|Overall Study|Lost to Follow-up|0|||
125674931|NCT02866175|452098626|FG000|Overall Study|Lack of Efficacy|0|||
125674932|NCT02866175|452098627|FG001|Overall Study|Lack of Efficacy|1|||
125674933|NCT02866175|452098626|FG000|Overall Study|Physician Decision|3|||
125674934|NCT02866175|452098627|FG001|Overall Study|Physician Decision|15|||
125674935|NCT02866175|452098626|FG000|Overall Study|Did not receive treatment|5|||
125674936|NCT02866175|452098627|FG001|Overall Study|Did not receive treatment|15|||
125674937|NCT01694485|452098628|FG000|Overall Study|Withdrawal by Subject|20|||
125674938|NCT01694485|452098629|FG001|Overall Study|Withdrawal by Subject|6|||
125674939|NCT01694485|452098630|FG002|Overall Study|Withdrawal by Subject|7|||
125674940|NCT01694485|452098631|FG003|Overall Study|Withdrawal by Subject|25|||
125674941|NCT01694485|452098632|FG004|Overall Study|Withdrawal by Subject|18|||
125674942|NCT01694485|452098628|FG000|Overall Study|Sponsor Decision|3|||
125674943|NCT01694485|452098629|FG001|Overall Study|Sponsor Decision|0|||
125674944|NCT01694485|452098630|FG002|Overall Study|Sponsor Decision|0|||
125674945|NCT01694485|452098631|FG003|Overall Study|Sponsor Decision|2|||
125674946|NCT01694485|452098632|FG004|Overall Study|Sponsor Decision|0|||
125674947|NCT01694485|452098628|FG000|Overall Study|Lost to Follow-up|9|||
125674948|NCT01694485|452098629|FG001|Overall Study|Lost to Follow-up|1|||
125674949|NCT01694485|452098630|FG002|Overall Study|Lost to Follow-up|6|||
125674950|NCT01694485|452098631|FG003|Overall Study|Lost to Follow-up|10|||
125674951|NCT01694485|452098632|FG004|Overall Study|Lost to Follow-up|7|||
125674952|NCT01694485|452098628|FG000|Overall Study|Death|1|||
125674953|NCT01694485|452098629|FG001|Overall Study|Death|0|||
125674954|NCT01694485|452098630|FG002|Overall Study|Death|0|||
125674955|NCT01694485|452098631|FG003|Overall Study|Death|1|||
125674956|NCT01694485|452098632|FG004|Overall Study|Death|0|||
125674957|NCT01595009|452098633|FG000|Core|Patients completed per protocol|85|||
125674958|NCT01595009|452098634|FG001|Core|Patients completed per protocol|44|||
125674959|NCT01595009|452098635|FG002|Core|Patients completed per protocol|0|||
125674960|NCT01595009|452098636|FG003|Core|Patients completed per protocol|0|||
125674961|NCT01595009|452098633|FG000|Core|Adverse Event|19|||
125674962|NCT01595009|452098634|FG001|Core|Adverse Event|23|||
125674963|NCT01595009|452098635|FG002|Core|Adverse Event|0|||
125674964|NCT01595009|452098636|FG003|Core|Adverse Event|0|||
125674965|NCT01595009|452098633|FG000|Core|Disease progression|14|||
125674966|NCT01595009|452098634|FG001|Core|Disease progression|26|||
125674967|NCT01595009|452098635|FG002|Core|Disease progression|0|||
125674968|NCT01595009|452098636|FG003|Core|Disease progression|0|||
125674969|NCT01595009|452098633|FG000|Core|Withdrawal by Subject|4|||
125674970|NCT01595009|452098634|FG001|Core|Withdrawal by Subject|17|||
125674971|NCT01595009|452098635|FG002|Core|Withdrawal by Subject|0|||
125674972|NCT01595009|452098636|FG003|Core|Withdrawal by Subject|0|||
125342132|NCT00830869|450888691|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
125342133|NCT00830869|450888692|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
125342134|NCT00830869|450888693|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
125342135|NCT00830869|450888694|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
125342136|NCT00830869|450888695|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
125674973|NCT01595009|452098633|FG000|Core|Death|3|||
125674974|NCT01595009|452098634|FG001|Core|Death|6|||
125674975|NCT01595009|452098635|FG002|Core|Death|0|||
125674976|NCT01595009|452098636|FG003|Core|Death|0|||
125674977|NCT01595009|452098633|FG000|Core|Lost to Follow-up|1|||
125674978|NCT01595009|452098634|FG001|Core|Lost to Follow-up|2|||
125674979|NCT01595009|452098635|FG002|Core|Lost to Follow-up|0|||
125674980|NCT01595009|452098636|FG003|Core|Lost to Follow-up|0|||
125674981|NCT01595009|452098633|FG000|Core|Protocol deviation|0|||
125674982|NCT01595009|452098634|FG001|Core|Protocol deviation|1|||
125342137|NCT00830869|450888696|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
125342138|NCT00830869|450888697|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
125342139|NCT00830869|450888698|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
125342140|NCT00830869|450888699|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
125342141|NCT00830869|450888700|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
125342142|NCT00830869|450888701|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
125674983|NCT01595009|452098635|FG002|Core|Protocol deviation|0|||
125674984|NCT01595009|452098636|FG003|Core|Protocol deviation|0|||
125674985|NCT01595009|452098633|FG000|Core|Administrative problems|0|||
125674986|NCT01595009|452098634|FG001|Core|Administrative problems|1|||
125674987|NCT01595009|452098635|FG002|Core|Administrative problems|0|||
125674988|NCT01595009|452098636|FG003|Core|Administrative problems|0|||
125674989|NCT01595009|452098633|FG000|Extension|Administrative problems|0|||
125674990|NCT01595009|452098634|FG001|Extension|Administrative problems|0|||
125674991|NCT01595009|452098635|FG002|Extension|Administrative problems|0|||
125674992|NCT01595009|452098636|FG003|Extension|Administrative problems|1|||
125674993|NCT01595009|452098633|FG000|Extension|Patients completed per protocol|0|||
125674994|NCT01595009|452098634|FG001|Extension|Patients completed per protocol|0|||
125674995|NCT01595009|452098635|FG002|Extension|Patients completed per protocol|0|||
125674996|NCT01595009|452098636|FG003|Extension|Patients completed per protocol|2|||
125674997|NCT01595009|452098633|FG000|Extension|Disease progression|0|||
125674998|NCT01595009|452098634|FG001|Extension|Disease progression|0|||
125674999|NCT01595009|452098635|FG002|Extension|Disease progression|4|||
125675000|NCT01595009|452098636|FG003|Extension|Disease progression|7|||
125675001|NCT01595009|452098633|FG000|Extension|Adverse Event|0|||
125675002|NCT01595009|452098634|FG001|Extension|Adverse Event|0|||
125675003|NCT01595009|452098635|FG002|Extension|Adverse Event|0|||
125675004|NCT01595009|452098636|FG003|Extension|Adverse Event|1|||
125675005|NCT00662025|452098638|FG000|Overall Study|Objective progression or relapse|51|||
125675006|NCT00662025|452098638|FG000|Overall Study|Adverse Event|7|||
125675007|NCT00662025|452098638|FG000|Overall Study|Withdrawal by Subject|1|||
125675008|NCT00662025|452098638|FG000|Overall Study|Results of other clinical study|2|||
125675009|NCT00662025|452098638|FG000|Overall Study|Target lesion cannot be evaluated|1|||
125675010|NCT00662025|452098638|FG000|Overall Study|Domestic circumstances|1|||
125675011|NCT00626925|452098647|FG000|Overall Study|Lost to Follow-up|1|||
125675012|NCT00626925|452098648|FG001|Overall Study|Lost to Follow-up|2|||
125675013|NCT00626925|452098647|FG000|Overall Study|relapse|1|||
125675014|NCT00626925|452098648|FG001|Overall Study|relapse|0|||
125675015|NCT00626925|452098647|FG000|Overall Study|Adverse effect|6|||
125675016|NCT00626925|452098648|FG001|Overall Study|Adverse effect|2|||
125675017|NCT00626925|452098647|FG000|Overall Study|Lack of Efficacy|1|||
125675018|NCT00626925|452098648|FG001|Overall Study|Lack of Efficacy|4|||
125675019|NCT00626925|452098647|FG000|Overall Study|Time constraints|3|||
125675020|NCT00626925|452098648|FG001|Overall Study|Time constraints|1|||
125675021|NCT01215942|452098652|FG000|Treatment Period|Adverse Event|15|||
125675022|NCT01215942|452098653|FG001|Treatment Period|Adverse Event|26|||
125675023|NCT01215942|452098652|FG000|Treatment Period|Death|2|||
125675024|NCT01215942|452098653|FG001|Treatment Period|Death|4|||
125675025|NCT01215942|452098652|FG000|Treatment Period|Lack of Efficacy|23|||
125675026|NCT01215942|452098653|FG001|Treatment Period|Lack of Efficacy|62|||
125675027|NCT01215942|452098652|FG000|Treatment Period|Lost to Follow-up|3|||
125675028|NCT01215942|452098653|FG001|Treatment Period|Lost to Follow-up|4|||
125675029|NCT01215942|452098652|FG000|Treatment Period|Withdrawal by Subject|17|||
125675030|NCT01215942|452098653|FG001|Treatment Period|Withdrawal by Subject|40|||
125675031|NCT01215942|452098652|FG000|Treatment Period|Physician Decision|5|||
125675032|NCT01215942|452098653|FG001|Treatment Period|Physician Decision|5|||
125675033|NCT01215942|452098652|FG000|Treatment Period|Protocol Violation|0|||
125675034|NCT01215942|452098653|FG001|Treatment Period|Protocol Violation|1|||
125675035|NCT01215942|452098652|FG000|Treatment Period|Sponsor Decision|349|||
125675036|NCT01215942|452098653|FG001|Treatment Period|Sponsor Decision|530|||
125675037|NCT01215942|452098652|FG000|Post-Treatment Follow-Up Period|Death|0|||
125675038|NCT01215942|452098653|FG001|Post-Treatment Follow-Up Period|Death|1|||
125675039|NCT01215942|452098652|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
125675040|NCT01215942|452098653|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
125675041|NCT01215942|452098652|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
125675042|NCT01215942|452098653|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
125675043|NCT01215942|452098652|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
125675044|NCT01215942|452098653|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
125675045|NCT01215942|452098652|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
125675046|NCT01215942|452098653|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
125675047|NCT01966042|452098654|FG000|Overall Study|Death|2|||
125675048|NCT03522948|452098655|FG000|Overall Study|Lost to Follow-up|1|||
125675049|NCT03305055|452098656|FG000|Overall Study|Withdrawal by Subject|0|||
125675050|NCT03305055|452098657|FG001|Overall Study|Withdrawal by Subject|1|||
125675051|NCT03305055|452098656|FG000|Overall Study|Adverse Event|1|||
125675052|NCT03305055|452098657|FG001|Overall Study|Adverse Event|1|||
125675053|NCT01802879|452098658|FG000|Overall Study|Administrative problems|2|||
125675054|NCT01802879|452098658|FG000|Overall Study|Disease progression|6|||
125675055|NCT01047345|452098665|FG000|Base Study|Adverse Event|3|||
125675056|NCT01047345|452098666|FG001|Base Study|Adverse Event|0|||
125675057|NCT01047345|452098667|FG002|Base Study|Adverse Event|0|||
125675058|NCT01047345|452098665|FG000|Base Study|Lost to Follow-up|4|||
125675059|NCT01047345|452098666|FG001|Base Study|Lost to Follow-up|1|||
125675060|NCT01047345|452098667|FG002|Base Study|Lost to Follow-up|0|||
125675061|NCT01047345|452098665|FG000|Base Study|Protocol Violation|3|||
125342143|NCT00830869|450888690|FG000|Period 1: Part 1|Adverse Event|0|||
125342144|NCT00830869|450888691|FG001|Period 1: Part 1|Adverse Event|0|||
125342145|NCT00830869|450888692|FG002|Period 1: Part 1|Adverse Event|0|||
125342146|NCT00830869|450888693|FG003|Period 1: Part 1|Adverse Event|0|||
125342147|NCT00830869|450888694|FG004|Period 1: Part 1|Adverse Event|0|||
125342148|NCT00830869|450888695|FG005|Period 1: Part 1|Adverse Event|1|||
125342149|NCT00830869|450888696|FG006|Period 1: Part 1|Adverse Event|1|||
125342150|NCT00830869|450888697|FG007|Period 1: Part 1|Adverse Event|0|||
125342151|NCT00830869|450888698|FG008|Period 1: Part 1|Adverse Event|0|||
125342152|NCT00830869|450888699|FG009|Period 1: Part 1|Adverse Event|0|||
125342153|NCT00830869|450888700|FG010|Period 1: Part 1|Adverse Event|0|||
125342154|NCT00830869|450888701|FG011|Period 1: Part 1|Adverse Event|0|||
125342155|NCT00830869|450888690|FG000|Period 1: Part 1|Progressive disease|1|||
125342156|NCT00830869|450888691|FG001|Period 1: Part 1|Progressive disease|0|||
125342157|NCT00830869|450888692|FG002|Period 1: Part 1|Progressive disease|1|||
125342158|NCT00830869|450888693|FG003|Period 1: Part 1|Progressive disease|6|||
125342159|NCT00830869|450888694|FG004|Period 1: Part 1|Progressive disease|4|||
125342160|NCT00830869|450888695|FG005|Period 1: Part 1|Progressive disease|4|||
125342161|NCT00830869|450888696|FG006|Period 1: Part 1|Progressive disease|1|||
125675062|NCT01047345|452098666|FG001|Base Study|Protocol Violation|1|||
125675063|NCT01047345|452098667|FG002|Base Study|Protocol Violation|0|||
125675064|NCT01047345|452098665|FG000|Base Study|Withdrawal by Subject|12|||
125675065|NCT01047345|452098666|FG001|Base Study|Withdrawal by Subject|4|||
125675066|NCT01047345|452098667|FG002|Base Study|Withdrawal by Subject|0|||
125675067|NCT01047345|452098665|FG000|Extension|Withdrawal by Subject|0|||
125675068|NCT01047345|452098666|FG001|Extension|Withdrawal by Subject|0|||
125675069|NCT01047345|452098667|FG002|Extension|Withdrawal by Subject|1|||
125675070|NCT01047345|452098665|FG000|Extension|Lost to Follow-up|0|||
125675071|NCT01047345|452098666|FG001|Extension|Lost to Follow-up|0|||
125675072|NCT01047345|452098667|FG002|Extension|Lost to Follow-up|5|||
125675073|NCT02116803|452098668|FG000|Overall Study|Adverse Event|2|||
125675074|NCT02116803|452098669|FG001|Overall Study|Adverse Event|1|||
125675075|NCT02116803|452098668|FG000|Overall Study|Physician Decision|1|||
125675076|NCT02116803|452098669|FG001|Overall Study|Physician Decision|0|||
125675077|NCT02116803|452098668|FG000|Overall Study|Progressive disease|4|||
125675078|NCT02116803|452098669|FG001|Overall Study|Progressive disease|0|||
125675079|NCT02116803|452098668|FG000|Overall Study|Study terminated by sponsor|2|||
125675080|NCT02116803|452098669|FG001|Overall Study|Study terminated by sponsor|1|||
125675081|NCT02116803|452098668|FG000|Overall Study|Death|1|||
125675082|NCT02116803|452098669|FG001|Overall Study|Death|0|||
125675083|NCT01974895|452098672|FG000|Overall Study|Protocol Violation|1|||
125675084|NCT01974895|452098673|FG001|Overall Study|Protocol Violation|0|||
125675085|NCT01974895|452098672|FG000|Overall Study|Lost to Follow-up|4|||
125675086|NCT01974895|452098673|FG001|Overall Study|Lost to Follow-up|6|||
125675087|NCT01974895|452098672|FG000|Overall Study|Withdrawal by Subject|0|||
125675088|NCT01974895|452098673|FG001|Overall Study|Withdrawal by Subject|1|||
125675089|NCT01974895|452098672|FG000|Overall Study|Other (Missed Visit)|1|||
125675090|NCT01974895|452098673|FG001|Overall Study|Other (Missed Visit)|0|||
125675091|NCT01974895|452098672|FG000|Overall Study|Other (Reason unknown)|9|||
125675092|NCT01974895|452098673|FG001|Overall Study|Other (Reason unknown)|8|||
125675093|NCT01984242|452098674|FG000|Overall Study|Death|52|||
125675094|NCT01984242|452098675|FG001|Overall Study|Death|50|||
125675095|NCT01984242|452098676|FG002|Overall Study|Death|52|||
125675096|NCT01984242|452098674|FG000|Overall Study|Withdrawal by Subject|5|||
125675097|NCT01984242|452098675|FG001|Overall Study|Withdrawal by Subject|3|||
125675098|NCT01984242|452098676|FG002|Overall Study|Withdrawal by Subject|10|||
125675099|NCT01984242|452098674|FG000|Overall Study|Physician Decision|0|||
125675100|NCT01984242|452098675|FG001|Overall Study|Physician Decision|0|||
125675101|NCT01984242|452098676|FG002|Overall Study|Physician Decision|1|||
125675102|NCT01984242|452098674|FG000|Overall Study|Lost to Follow-up|4|||
125675103|NCT01984242|452098675|FG001|Overall Study|Lost to Follow-up|0|||
125675104|NCT01984242|452098676|FG002|Overall Study|Lost to Follow-up|3|||
125675105|NCT01984242|452098674|FG000|Overall Study|Sponsor Decision|1|||
125675106|NCT01984242|452098675|FG001|Overall Study|Sponsor Decision|0|||
125675107|NCT01984242|452098676|FG002|Overall Study|Sponsor Decision|0|||
125675108|NCT01984242|452098674|FG000|Overall Study|Non-Compliance|1|||
125675109|NCT01984242|452098675|FG001|Overall Study|Non-Compliance|0|||
125675110|NCT01984242|452098676|FG002|Overall Study|Non-Compliance|0|||
125675111|NCT01984242|452098674|FG000|Overall Study|Study terminated by Sponsor|38|||
125675112|NCT01984242|452098675|FG001|Overall Study|Study terminated by Sponsor|50|||
125675113|NCT01984242|452098676|FG002|Overall Study|Study terminated by Sponsor|34|||
125675114|NCT01984242|452098674|FG000|Overall Study|Disease Progression|0|||
125675115|NCT01984242|452098675|FG001|Overall Study|Disease Progression|0|||
125675116|NCT01984242|452098676|FG002|Overall Study|Disease Progression|1|||
125675117|NCT04543136|452098679|FG000|Overall Study|Withdrawal by Subject|0|||
125675118|NCT04543136|452098680|FG001|Overall Study|Withdrawal by Subject|1|||
125342162|NCT00830869|450888697|FG007|Period 1: Part 1|Progressive disease|0|||
125675119|NCT04543136|452098681|FG002|Overall Study|Withdrawal by Subject|0|||
125675120|NCT04543136|452098682|FG003|Overall Study|Withdrawal by Subject|1|||
125675121|NCT04543136|452098683|FG004|Overall Study|Withdrawal by Subject|0|||
125675122|NCT04543136|452098684|FG005|Overall Study|Withdrawal by Subject|0|||
125675123|NCT00865709|452098685|FG000|Treatment|Adverse Event|9|||
125675124|NCT00865709|452098686|FG001|Treatment|Adverse Event|6|||
125675125|NCT00865709|452098685|FG000|Treatment|Withdrawal by Subject|10|||
125675126|NCT00865709|452098686|FG001|Treatment|Withdrawal by Subject|7|||
125675127|NCT00865709|452098685|FG000|Treatment|Physician Decision|3|||
125675128|NCT00865709|452098686|FG001|Treatment|Physician Decision|2|||
125378915|NCT00589914|451019206|FG000|Overall Study|Pregnancy|1|||
125675129|NCT00865709|452098685|FG000|Treatment|Surgery|8|||
125675130|NCT00865709|452098686|FG001|Treatment|Surgery|3|||
125378916|NCT00589914|451019207|FG001|Overall Study|Pregnancy|0|||
125342163|NCT00830869|450888698|FG008|Period 1: Part 1|Progressive disease|0|||
125342164|NCT00830869|450888699|FG009|Period 1: Part 1|Progressive disease|0|||
125342165|NCT00830869|450888700|FG010|Period 1: Part 1|Progressive disease|0|||
125342166|NCT00830869|450888701|FG011|Period 1: Part 1|Progressive disease|0|||
125342167|NCT00830869|450888690|FG000|Period 2: Part 2|Protocol Violation|0|||
125342168|NCT00830869|450888691|FG001|Period 2: Part 2|Protocol Violation|0|||
125342169|NCT00830869|450888692|FG002|Period 2: Part 2|Protocol Violation|0|||
125342170|NCT00830869|450888693|FG003|Period 2: Part 2|Protocol Violation|0|||
125342171|NCT00830869|450888694|FG004|Period 2: Part 2|Protocol Violation|0|||
125342172|NCT00830869|450888695|FG005|Period 2: Part 2|Protocol Violation|0|||
125342173|NCT00830869|450888696|FG006|Period 2: Part 2|Protocol Violation|0|||
125342174|NCT00830869|450888697|FG007|Period 2: Part 2|Protocol Violation|1|||
125342175|NCT00830869|450888698|FG008|Period 2: Part 2|Protocol Violation|0|||
125342176|NCT00830869|450888699|FG009|Period 2: Part 2|Protocol Violation|1|||
125342177|NCT00830869|450888700|FG010|Period 2: Part 2|Protocol Violation|0|||
125342178|NCT00830869|450888701|FG011|Period 2: Part 2|Protocol Violation|0|||
125342179|NCT00830869|450888690|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
125342180|NCT00830869|450888691|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
125342181|NCT00830869|450888692|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
125342182|NCT00830869|450888693|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
125342183|NCT00830869|450888694|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
125342184|NCT00830869|450888695|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
125342185|NCT00830869|450888696|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
125342186|NCT00830869|450888697|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
125342187|NCT00830869|450888698|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
125342188|NCT00830869|450888699|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
125342189|NCT00830869|450888700|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
125342190|NCT00830869|450888701|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
125342191|NCT00830869|450888690|FG000|Period 2: Part 2|Adverse Event|0|||
125342192|NCT00830869|450888691|FG001|Period 2: Part 2|Adverse Event|0|||
125342193|NCT00830869|450888692|FG002|Period 2: Part 2|Adverse Event|0|||
125342194|NCT00830869|450888693|FG003|Period 2: Part 2|Adverse Event|0|||
125342195|NCT00830869|450888694|FG004|Period 2: Part 2|Adverse Event|0|||
125342196|NCT00830869|450888695|FG005|Period 2: Part 2|Adverse Event|0|||
125342197|NCT00830869|450888696|FG006|Period 2: Part 2|Adverse Event|0|||
125342198|NCT00830869|450888697|FG007|Period 2: Part 2|Adverse Event|4|||
125342199|NCT00830869|450888698|FG008|Period 2: Part 2|Adverse Event|3|||
125342200|NCT00830869|450888699|FG009|Period 2: Part 2|Adverse Event|2|||
125342201|NCT00830869|450888700|FG010|Period 2: Part 2|Adverse Event|2|||
125342202|NCT00830869|450888701|FG011|Period 2: Part 2|Adverse Event|0|||
125342203|NCT00830869|450888690|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
125342204|NCT00830869|450888691|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
125342205|NCT00830869|450888692|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
125342206|NCT00830869|450888693|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
125342207|NCT00830869|450888694|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
125342208|NCT00830869|450888695|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
125342209|NCT00830869|450888696|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
125342210|NCT00830869|450888697|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
125342211|NCT00830869|450888698|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
125342212|NCT00830869|450888699|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
125342213|NCT00830869|450888700|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
125342214|NCT00830869|450888701|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
125342215|NCT00830869|450888690|FG000|Period 2: Part 2|Progressive disease|0|||
125342216|NCT00830869|450888691|FG001|Period 2: Part 2|Progressive disease|0|||
125342217|NCT00830869|450888692|FG002|Period 2: Part 2|Progressive disease|0|||
125342218|NCT00830869|450888693|FG003|Period 2: Part 2|Progressive disease|0|||
125342219|NCT00830869|450888694|FG004|Period 2: Part 2|Progressive disease|0|||
125342220|NCT00830869|450888695|FG005|Period 2: Part 2|Progressive disease|0|||
125342221|NCT00830869|450888696|FG006|Period 2: Part 2|Progressive disease|0|||
125342222|NCT00830869|450888697|FG007|Period 2: Part 2|Progressive disease|14|||
125342223|NCT00830869|450888698|FG008|Period 2: Part 2|Progressive disease|11|||
125342224|NCT00830869|450888699|FG009|Period 2: Part 2|Progressive disease|12|||
125342225|NCT00830869|450888700|FG010|Period 2: Part 2|Progressive disease|8|||
125342226|NCT00830869|450888701|FG011|Period 2: Part 2|Progressive disease|15|||
125342227|NCT00830869|450888690|FG000|Period 2: Part 2|Other|0|||
125342228|NCT00830869|450888691|FG001|Period 2: Part 2|Other|0|||
125342229|NCT00830869|450888692|FG002|Period 2: Part 2|Other|0|||
125342230|NCT00830869|450888693|FG003|Period 2: Part 2|Other|0|||
125342231|NCT00830869|450888694|FG004|Period 2: Part 2|Other|0|||
125342232|NCT00830869|450888695|FG005|Period 2: Part 2|Other|0|||
125342233|NCT00830869|450888696|FG006|Period 2: Part 2|Other|0|||
125342234|NCT00830869|450888697|FG007|Period 2: Part 2|Other|0|||
125342235|NCT00830869|450888698|FG008|Period 2: Part 2|Other|0|||
125342236|NCT00830869|450888699|FG009|Period 2: Part 2|Other|1|||
125342237|NCT00830869|450888700|FG010|Period 2: Part 2|Other|0|||
125342238|NCT00830869|450888701|FG011|Period 2: Part 2|Other|0|||
125342239|NCT03745820|450888702|FG000|Overall Study|Adverse Event|0|||
125675131|NCT00429923|452098687|FG000|Overall Study|Adverse Event|0|||
125675132|NCT00429923|452098688|FG001|Overall Study|Adverse Event|2|||
125675133|NCT00429923|452098689|FG002|Overall Study|Adverse Event|3|||
125675134|NCT00429923|452098687|FG000|Overall Study|Lack of Efficacy|4|||
125675135|NCT00429923|452098688|FG001|Overall Study|Lack of Efficacy|1|||
125675136|NCT00429923|452098689|FG002|Overall Study|Lack of Efficacy|33|||
125675137|NCT00429923|452098687|FG000|Overall Study|Lost to Follow-up|0|||
125675138|NCT00429923|452098688|FG001|Overall Study|Lost to Follow-up|0|||
125675139|NCT00429923|452098689|FG002|Overall Study|Lost to Follow-up|2|||
125675140|NCT00429923|452098687|FG000|Overall Study|Withdrew Consent|1|||
125675141|NCT00429923|452098688|FG001|Overall Study|Withdrew Consent|0|||
125675142|NCT00429923|452098689|FG002|Overall Study|Withdrew Consent|1|||
125675143|NCT00429923|452098687|FG000|Overall Study|Early Termination|0|||
125675144|NCT00429923|452098688|FG001|Overall Study|Early Termination|1|||
125675145|NCT00429923|452098689|FG002|Overall Study|Early Termination|0|||
125675146|NCT00662129|452098694|FG000|Overall Study|Protocol Violation|1|||
125675147|NCT00662129|452098694|FG000|Overall Study|Cancel prior to beginning treatment|1|||
125675148|NCT00662129|452098694|FG000|Overall Study|Ineligible|1|||
125675149|NCT02153736|452098695|FG000|Overall Study|Lost to Follow-up|1|||
125675150|NCT02153736|452098696|FG001|Overall Study|Lost to Follow-up|0|||
125675151|NCT02153736|452098695|FG000|Overall Study|Medical status change made ineligible|1|||
125675152|NCT02153736|452098696|FG001|Overall Study|Medical status change made ineligible|0|||
125675153|NCT02153736|452098695|FG000|Overall Study|Death|0|||
125675154|NCT02153736|452098696|FG001|Overall Study|Death|1|||
125675155|NCT02153736|452098695|FG000|Overall Study|Withdrawal by Subject|0|||
125675156|NCT02153736|452098696|FG001|Overall Study|Withdrawal by Subject|1|||
125675157|NCT00720122|452098709|FG000|Overall Study|Lost to Follow-up|1|||
125675158|NCT00720122|452098709|FG000|Overall Study|Physician Decision|1|||
125675159|NCT00720122|452098709|FG000|Overall Study|Withdrawal by Subject|7|||
125675160|NCT02579096|452098710|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
125675161|NCT02579096|452098711|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
125675162|NCT02579096|452098710|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
125675163|NCT02579096|452098711|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
125675164|NCT02579096|452098710|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
125675165|NCT02579096|452098711|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
125675166|NCT02579096|452098710|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
125675167|NCT02579096|452098711|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
125675168|NCT02579096|452098710|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
125675169|NCT02579096|452098711|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
125675170|NCT02579096|452098710|FG000|Phase 2, Weeks 25 - 48|Death|2|||
125675171|NCT02579096|452098711|FG001|Phase 2, Weeks 25 - 48|Death|4|||
125675172|NCT02579096|452098710|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
125675173|NCT02579096|452098711|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
125675174|NCT02579096|452098710|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
125675175|NCT02579096|452098711|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
125675176|NCT02579096|452098710|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
125675177|NCT02579096|452098711|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
125675178|NCT02579096|452098710|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
125675179|NCT02579096|452098711|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
125675180|NCT02579096|452098710|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
125675181|NCT02579096|452098711|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
125675182|NCT02579096|452098710|FG000|Phase 3, Weeks 49 - 72|Death|3|||
125675183|NCT02579096|452098711|FG001|Phase 3, Weeks 49 - 72|Death|2|||
125675184|NCT02579096|452098710|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
125675185|NCT02579096|452098711|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
125675186|NCT02579096|452098710|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
125675187|NCT02579096|452098711|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
125675188|NCT02579096|452098710|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
125675189|NCT02579096|452098711|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
125675190|NCT02579096|452098710|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
125675191|NCT02579096|452098711|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
125675192|NCT02579096|452098710|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
125675193|NCT02579096|452098711|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
125675194|NCT02579096|452098710|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
125675195|NCT02579096|452098711|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
125675196|NCT01361126|452098712|FG000|Overall Study|Sponsor decision|0|||
125675197|NCT01361126|452098713|FG001|Overall Study|Sponsor decision|2|||
125675198|NCT00663871|452098715|FG000|Overall Study|Lost to Follow-up|5|||
125675199|NCT00663871|452098716|FG001|Overall Study|Lost to Follow-up|5|||
125342240|NCT03745820|450888703|FG001|Overall Study|Adverse Event|3|||
125342241|NCT03745820|450888704|FG002|Overall Study|Adverse Event|2|||
125342242|NCT03745820|450888702|FG000|Overall Study|Non-Compliance with Study Drug|4|||
125342243|NCT03745820|450888703|FG001|Overall Study|Non-Compliance with Study Drug|3|||
125342244|NCT03745820|450888704|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125342245|NCT03745820|450888702|FG000|Overall Study|Withdrawal by Subject|4|||
125342246|NCT03745820|450888703|FG001|Overall Study|Withdrawal by Subject|4|||
125342247|NCT03745820|450888704|FG002|Overall Study|Withdrawal by Subject|4|||
125675200|NCT00663871|452098715|FG000|Overall Study|Withdrawal by Subject|5|||
125675201|NCT00663871|452098716|FG001|Overall Study|Withdrawal by Subject|2|||
125675202|NCT04094870|452098717|FG000|Overall Study|Lost to Follow-up|1|||
125675203|NCT04094870|452098718|FG001|Overall Study|Lost to Follow-up|1|||
125675204|NCT03384745|452098719|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
125675205|NCT03384745|452098720|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
125675206|NCT03384745|452098721|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
125675207|NCT03384745|452098722|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
125675208|NCT03384745|452098723|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
125675209|NCT03384745|452098724|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
125675210|NCT03384745|452098719|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
125675211|NCT03384745|452098720|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
125675212|NCT03384745|452098721|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
125675213|NCT03384745|452098722|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
125675214|NCT03384745|452098723|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
125675215|NCT03384745|452098724|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
125675216|NCT03384745|452098719|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
125675217|NCT03384745|452098720|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
125675218|NCT03384745|452098721|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
125675219|NCT03384745|452098722|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
125675220|NCT03384745|452098723|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
125675221|NCT03384745|452098724|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
125675222|NCT03384745|452098719|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
125675223|NCT03384745|452098720|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
125675224|NCT03384745|452098721|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
125675225|NCT03384745|452098722|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
125675226|NCT03384745|452098723|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
125675227|NCT03384745|452098724|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
125675228|NCT03384745|452098719|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
125675229|NCT03384745|452098720|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
125675230|NCT03384745|452098721|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
125675231|NCT03384745|452098722|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
125675232|NCT03384745|452098723|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
125675233|NCT03384745|452098724|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
125675234|NCT03384745|452098719|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
125675235|NCT03384745|452098720|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
125675236|NCT03384745|452098721|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
125675237|NCT03384745|452098722|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
125675238|NCT03384745|452098723|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
125675239|NCT03384745|452098724|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
125675240|NCT03384745|452098719|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
125675241|NCT03384745|452098720|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
125675242|NCT03384745|452098721|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
125675243|NCT03384745|452098722|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
125675244|NCT03384745|452098723|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
125675245|NCT03384745|452098724|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
125675246|NCT03384745|452098719|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
125342248|NCT03745820|450888702|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
125342249|NCT03745820|450888703|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
125342250|NCT03745820|450888704|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
125342251|NCT03745820|450888702|FG000|Overall Study|Lost to Follow-up|2|||
125342252|NCT03745820|450888703|FG001|Overall Study|Lost to Follow-up|0|||
125342253|NCT03745820|450888704|FG002|Overall Study|Lost to Follow-up|3|||
125342254|NCT03745820|450888702|FG000|Overall Study|Reason not Specified|2|||
125342255|NCT03745820|450888703|FG001|Overall Study|Reason not Specified|4|||
125342256|NCT03745820|450888704|FG002|Overall Study|Reason not Specified|1|||
125342257|NCT00668733|450888708|FG000|Overall Study|Lost to Follow-up|2|||
125342258|NCT00668733|450888709|FG001|Overall Study|Lost to Follow-up|3|||
125342259|NCT00668733|450888708|FG000|Overall Study|Withdrawal by Subject|0|||
125342260|NCT00668733|450888709|FG001|Overall Study|Withdrawal by Subject|4|||
125342261|NCT00945906|450888712|FG000|Overall Study|Withdrawal by Subject|1|||
125342262|NCT00945906|450888712|FG000|Overall Study|Did not want to return for last visit|2|||
125342263|NCT00945906|450888712|FG000|Overall Study|Unable to return for last visit|2|||
125342264|NCT00945906|450888712|FG000|Overall Study|Moved to another country|2|||
125342265|NCT04250077|450888714|FG000|Overall Study|Withdrawal by Subject|0|||
125342266|NCT04250077|450888715|FG001|Overall Study|Withdrawal by Subject|1|||
125342267|NCT04250077|450888716|FG002|Overall Study|Withdrawal by Subject|0|||
125342268|NCT04250077|450888714|FG000|Overall Study|Lost to Follow-up|2|||
125342269|NCT04250077|450888715|FG001|Overall Study|Lost to Follow-up|3|||
125342270|NCT04250077|450888716|FG002|Overall Study|Lost to Follow-up|0|||
125342271|NCT04022733|450888717|FG000|Overall Study|conversion to open surgery|3|||
125342272|NCT04022733|450888718|FG001|Overall Study|conversion to open surgery|2|||
125342273|NCT04022733|450888717|FG000|Overall Study|bradycardia|0|||
125342274|NCT04022733|450888718|FG001|Overall Study|bradycardia|1|||
125342275|NCT00797966|450888719|FG000|Phase A|Lost to Follow-up|0|||
125342276|NCT00797966|450888720|FG001|Phase A|Lost to Follow-up|0|||
125342277|NCT00797966|450888721|FG002|Phase A|Lost to Follow-up|0|||
125342278|NCT00797966|450888722|FG003|Phase A|Lost to Follow-up|0|||
125342279|NCT00797966|450888723|FG004|Phase A|Lost to Follow-up|33|||
125342280|NCT00797966|450888724|FG005|Phase A|Lost to Follow-up|0|||
125342281|NCT00797966|450888719|FG000|Phase A|Adverse Event|0|||
125342282|NCT00797966|450888720|FG001|Phase A|Adverse Event|0|||
125342283|NCT00797966|450888721|FG002|Phase A|Adverse Event|0|||
125342284|NCT00797966|450888722|FG003|Phase A|Adverse Event|0|||
125342285|NCT00797966|450888723|FG004|Phase A|Adverse Event|46|||
125675247|NCT03384745|452098720|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
125675248|NCT03384745|452098721|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
125675249|NCT03384745|452098722|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
125675250|NCT03384745|452098723|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
125675251|NCT03384745|452098724|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
125675252|NCT03384745|452098719|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
125675253|NCT03384745|452098720|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
125675254|NCT03384745|452098721|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
125675255|NCT03384745|452098722|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
125675256|NCT03384745|452098723|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
125675257|NCT03384745|452098724|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
125675258|NCT03384745|452098719|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
125675259|NCT03384745|452098720|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
125675260|NCT03384745|452098721|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
125675261|NCT03384745|452098722|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
125675262|NCT03384745|452098723|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
125675263|NCT03384745|452098724|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
125675264|NCT03384745|452098719|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
125675265|NCT03384745|452098720|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
125675266|NCT03384745|452098721|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
125675267|NCT03384745|452098722|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
125675268|NCT03384745|452098723|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
125675269|NCT03384745|452098724|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
125675270|NCT02984683|452098725|FG000|Overall Study|Adverse Event|3|||
125675271|NCT02984683|452098726|FG001|Overall Study|Adverse Event|3|||
125675272|NCT02984683|452098725|FG000|Overall Study|Withdrawal by Subject|1|||
125342286|NCT00797966|450888724|FG005|Phase A|Adverse Event|0|||
125342287|NCT00797966|450888719|FG000|Phase A|Met withdrawal criteria|0|||
125342288|NCT00797966|450888720|FG001|Phase A|Met withdrawal criteria|0|||
125342289|NCT00797966|450888721|FG002|Phase A|Met withdrawal criteria|0|||
125342290|NCT00797966|450888722|FG003|Phase A|Met withdrawal criteria|0|||
125342291|NCT00797966|450888723|FG004|Phase A|Met withdrawal criteria|4|||
125342292|NCT00797966|450888724|FG005|Phase A|Met withdrawal criteria|0|||
125342293|NCT00797966|450888719|FG000|Phase A|Physician Decision|0|||
125342294|NCT00797966|450888720|FG001|Phase A|Physician Decision|0|||
125342295|NCT00797966|450888721|FG002|Phase A|Physician Decision|0|||
125342296|NCT00797966|450888722|FG003|Phase A|Physician Decision|0|||
125342297|NCT00797966|450888723|FG004|Phase A|Physician Decision|13|||
125342298|NCT00797966|450888724|FG005|Phase A|Physician Decision|0|||
125342299|NCT00797966|450888719|FG000|Phase A|Withdrawal by Subject|0|||
125342300|NCT00797966|450888720|FG001|Phase A|Withdrawal by Subject|0|||
125342301|NCT00797966|450888721|FG002|Phase A|Withdrawal by Subject|0|||
125342302|NCT00797966|450888722|FG003|Phase A|Withdrawal by Subject|0|||
125342303|NCT00797966|450888723|FG004|Phase A|Withdrawal by Subject|33|||
125342304|NCT00797966|450888724|FG005|Phase A|Withdrawal by Subject|0|||
125342305|NCT00797966|450888719|FG000|Phase A|Protocol deviation|0|||
125342306|NCT00797966|450888720|FG001|Phase A|Protocol deviation|0|||
125342307|NCT00797966|450888721|FG002|Phase A|Protocol deviation|0|||
125342308|NCT00797966|450888722|FG003|Phase A|Protocol deviation|0|||
125342309|NCT00797966|450888723|FG004|Phase A|Protocol deviation|56|||
125675273|NCT02984683|452098726|FG001|Overall Study|Withdrawal by Subject|0|||
125675274|NCT02984683|452098725|FG000|Overall Study|Disease progression|7|||
125675275|NCT02984683|452098726|FG001|Overall Study|Disease progression|9|||
125675276|NCT02742181|452098727|FG000|Overall Study|Physician Decision|1|||
125675277|NCT02742181|452098728|FG001|Overall Study|Physician Decision|0|||
125675278|NCT02739984|452098729|FG000|Overall Study|Sponsor Decision|1|||
125675279|NCT02739984|452098730|FG001|Overall Study|Sponsor Decision|0|||
125675280|NCT02739984|452098729|FG000|Overall Study|Withdrawal by Subject|1|||
125675281|NCT02739984|452098730|FG001|Overall Study|Withdrawal by Subject|1|||
125675282|NCT02739984|452098729|FG000|Overall Study|Death|0|||
125675283|NCT02739984|452098730|FG001|Overall Study|Death|1|||
125675284|NCT02739984|452098729|FG000|Overall Study|Lost to Follow-up|3|||
125675285|NCT02739984|452098730|FG001|Overall Study|Lost to Follow-up|0|||
125675286|NCT02946385|452100463|FG000|Overall Study|Lost to Follow-up|0|||
125675287|NCT02946385|452100464|FG001|Overall Study|Lost to Follow-up|0|||
125675288|NCT02946385|452100465|FG002|Overall Study|Lost to Follow-up|3|||
125675289|NCT02946385|452100466|FG003|Overall Study|Lost to Follow-up|0|||
125675290|NCT02946385|452100467|FG004|Overall Study|Lost to Follow-up|2|||
125675291|NCT02946385|452100468|FG005|Overall Study|Lost to Follow-up|1|||
125675292|NCT00313703|452100469|FG000|Overall Study|Lost to Follow-up|11|||
125675293|NCT00313703|452100470|FG001|Overall Study|Lost to Follow-up|2|||
125675294|NCT00313703|452100471|FG002|Overall Study|Lost to Follow-up|5|||
125675295|NCT00313703|452100472|FG003|Overall Study|Lost to Follow-up|12|||
125675296|NCT01060670|452100473|FG000|Run In|screen failure|0|||
125675297|NCT01060670|452100474|FG001|Run In|screen failure|238|||
125675298|NCT03519256|452100479|FG000|Overall Study|Disease recurrence|4|||
125675299|NCT03519256|452100480|FG001|Overall Study|Disease recurrence|4|||
125675300|NCT03519256|452100481|FG002|Overall Study|Disease recurrence|5|||
125675301|NCT03519256|452100482|FG003|Overall Study|Disease recurrence|2|||
125675302|NCT03519256|452100479|FG000|Overall Study|Study drug toxicity|0|||
125675303|NCT03519256|452100480|FG001|Overall Study|Study drug toxicity|2|||
125675304|NCT03519256|452100481|FG002|Overall Study|Study drug toxicity|5|||
125675305|NCT03519256|452100482|FG003|Overall Study|Study drug toxicity|2|||
125675306|NCT03519256|452100479|FG000|Overall Study|Adverse event unrelated to study drug|0|||
125675307|NCT03519256|452100480|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125675308|NCT03519256|452100481|FG002|Overall Study|Adverse event unrelated to study drug|1|||
125675309|NCT03519256|452100482|FG003|Overall Study|Adverse event unrelated to study drug|0|||
125675310|NCT03519256|452100479|FG000|Overall Study|Participant request to discontinue study treatment|0|||
125675311|NCT03519256|452100480|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125675312|NCT03519256|452100481|FG002|Overall Study|Participant request to discontinue study treatment|0|||
125675313|NCT03519256|452100482|FG003|Overall Study|Participant request to discontinue study treatment|2|||
125675314|NCT03519256|452100479|FG000|Overall Study|Other reasons|0|||
125675315|NCT03519256|452100480|FG001|Overall Study|Other reasons|0|||
125675316|NCT03519256|452100481|FG002|Overall Study|Other reasons|2|||
125675317|NCT03519256|452100482|FG003|Overall Study|Other reasons|0|||
125675318|NCT03519256|452100479|FG000|Overall Study|Disease progression|6|||
125675319|NCT03519256|452100480|FG001|Overall Study|Disease progression|3|||
125675320|NCT03519256|452100481|FG002|Overall Study|Disease progression|2|||
125675321|NCT03519256|452100482|FG003|Overall Study|Disease progression|1|||
125675322|NCT03519256|452100479|FG000|Overall Study|Lost to Follow-up|0|||
125675323|NCT03519256|452100480|FG001|Overall Study|Lost to Follow-up|1|||
125675324|NCT03519256|452100481|FG002|Overall Study|Lost to Follow-up|0|||
125675325|NCT03519256|452100482|FG003|Overall Study|Lost to Follow-up|0|||
125675326|NCT05431153|452100483|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125675327|NCT05431153|452100484|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125675328|NCT05431153|452100485|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125675329|NCT05431153|452100486|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125675330|NCT05431153|452100487|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
125675331|NCT05431153|452100488|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125675332|NCT04828161|452100489|FG000|Overall Study|Withdrawal by Subject|0|||
125675333|NCT04828161|452100490|FG001|Overall Study|Withdrawal by Subject|3|||
125675334|NCT04828161|452100491|FG002|Overall Study|Withdrawal by Subject|3|||
125675335|NCT04828161|452100492|FG003|Overall Study|Withdrawal by Subject|4|||
125675336|NCT04828161|452100489|FG000|Overall Study|Lost to Follow-up|1|||
125342310|NCT00797966|450888724|FG005|Phase A|Protocol deviation|0|||
125342311|NCT00797966|450888719|FG000|Phase B|Lost to Follow-up|0|||
125342312|NCT00797966|450888720|FG001|Phase B|Lost to Follow-up|1|||
125342313|NCT00797966|450888721|FG002|Phase B|Lost to Follow-up|3|||
125342314|NCT00797966|450888722|FG003|Phase B|Lost to Follow-up|0|||
125342315|NCT00797966|450888723|FG004|Phase B|Lost to Follow-up|0|||
125342316|NCT00797966|450888724|FG005|Phase B|Lost to Follow-up|0|||
125342317|NCT00797966|450888719|FG000|Phase B|Adverse Event|2|||
125342318|NCT00797966|450888720|FG001|Phase B|Adverse Event|1|||
125342319|NCT00797966|450888721|FG002|Phase B|Adverse Event|3|||
125342320|NCT00797966|450888722|FG003|Phase B|Adverse Event|1|||
125342321|NCT00797966|450888723|FG004|Phase B|Adverse Event|0|||
125342322|NCT00797966|450888724|FG005|Phase B|Adverse Event|0|||
125342323|NCT00797966|450888719|FG000|Phase B|Met Withdrawal Criteria|3|||
125342324|NCT00797966|450888720|FG001|Phase B|Met Withdrawal Criteria|3|||
125342325|NCT00797966|450888721|FG002|Phase B|Met Withdrawal Criteria|6|||
125342326|NCT00797966|450888722|FG003|Phase B|Met Withdrawal Criteria|1|||
125342327|NCT00797966|450888723|FG004|Phase B|Met Withdrawal Criteria|0|||
125342328|NCT00797966|450888724|FG005|Phase B|Met Withdrawal Criteria|0|||
125342329|NCT00797966|450888719|FG000|Phase B|Physician Decision|1|||
125342330|NCT00797966|450888720|FG001|Phase B|Physician Decision|0|||
125342331|NCT00797966|450888721|FG002|Phase B|Physician Decision|3|||
125342332|NCT00797966|450888722|FG003|Phase B|Physician Decision|1|||
125342333|NCT00797966|450888723|FG004|Phase B|Physician Decision|0|||
125342334|NCT00797966|450888724|FG005|Phase B|Physician Decision|0|||
125342335|NCT00797966|450888719|FG000|Phase B|Withdrawal by Subject|1|||
125675337|NCT04828161|452100490|FG001|Overall Study|Lost to Follow-up|4|||
125675338|NCT04828161|452100491|FG002|Overall Study|Lost to Follow-up|2|||
125675339|NCT04828161|452100492|FG003|Overall Study|Lost to Follow-up|2|||
125675340|NCT04828161|452100489|FG000|Overall Study|Other|2|||
125675341|NCT04828161|452100490|FG001|Overall Study|Other|0|||
125675342|NCT04828161|452100491|FG002|Overall Study|Other|2|||
125675343|NCT04828161|452100492|FG003|Overall Study|Other|0|||
125675344|NCT04828161|452100489|FG000|Overall Study|Death|0|||
125675345|NCT04828161|452100490|FG001|Overall Study|Death|0|||
125675346|NCT04828161|452100491|FG002|Overall Study|Death|0|||
125675347|NCT04828161|452100492|FG003|Overall Study|Death|2|||
125675348|NCT02458638|452100495|FG000|Overall Study|Death|309|||
125675349|NCT02458638|452100495|FG000|Overall Study|End of Cohort/End of Study|67|||
125675350|NCT02458638|452100495|FG000|Overall Study|Lost to Follow-up|31|||
125675351|NCT02458638|452100495|FG000|Overall Study|Other Reasons|4|||
125675352|NCT02458638|452100495|FG000|Overall Study|Physician Decision|1|||
125675353|NCT02458638|452100495|FG000|Overall Study|Withdrawal by Subject|47|||
125675354|NCT03093454|452100504|FG000|Overall Study|Withdrawal by Subject|1|||
125675355|NCT03093454|452100505|FG001|Overall Study|Withdrawal by Subject|1|||
125675356|NCT03093454|452100504|FG000|Overall Study|Scheduling conflict|3|||
125675357|NCT03093454|452100505|FG001|Overall Study|Scheduling conflict|1|||
125675358|NCT03093454|452100504|FG000|Overall Study|Physician Decision|2|||
125675359|NCT03093454|452100505|FG001|Overall Study|Physician Decision|1|||
125675360|NCT04540497|452100506|FG000|Overall Study|Adverse Event|0|||
125675361|NCT04540497|452100507|FG001|Overall Study|Adverse Event|2|||
125675362|NCT04540497|452100506|FG000|Overall Study|Lost to Follow-up|1|||
125675363|NCT04540497|452100507|FG001|Overall Study|Lost to Follow-up|0|||
125675364|NCT04540497|452100506|FG000|Overall Study|Withdrawal by Subject|1|||
125675365|NCT04540497|452100507|FG001|Overall Study|Withdrawal by Subject|1|||
125675366|NCT04540497|452100506|FG000|Overall Study|Miscellaneous|2|||
125675367|NCT04540497|452100507|FG001|Overall Study|Miscellaneous|1|||
125675368|NCT01290263|452100514|FG000|Overall Study|Adverse Event|0|||
125675369|NCT01290263|452100515|FG001|Overall Study|Adverse Event|0|||
125675370|NCT01290263|452100516|FG002|Overall Study|Adverse Event|0|||
125675371|NCT01290263|452100517|FG003|Overall Study|Adverse Event|1|||
125675372|NCT01290263|452100518|FG004|Overall Study|Adverse Event|1|||
125675373|NCT01290263|452100514|FG000|Overall Study|Lack of Efficacy|8|||
125675374|NCT01290263|452100515|FG001|Overall Study|Lack of Efficacy|2|||
125675375|NCT01290263|452100516|FG002|Overall Study|Lack of Efficacy|7|||
125675376|NCT01290263|452100517|FG003|Overall Study|Lack of Efficacy|24|||
125675377|NCT01290263|452100518|FG004|Overall Study|Lack of Efficacy|33|||
125675378|NCT01290263|452100514|FG000|Overall Study|Withdrawal by Subject|3|||
125675379|NCT01290263|452100515|FG001|Overall Study|Withdrawal by Subject|1|||
125675380|NCT01290263|452100516|FG002|Overall Study|Withdrawal by Subject|0|||
125675381|NCT01290263|452100517|FG003|Overall Study|Withdrawal by Subject|1|||
125675382|NCT01290263|452100518|FG004|Overall Study|Withdrawal by Subject|2|||
125675383|NCT01290263|452100514|FG000|Overall Study|Participant Non-Compliance|0|||
125342336|NCT00797966|450888720|FG001|Phase B|Withdrawal by Subject|4|||
125342337|NCT00797966|450888721|FG002|Phase B|Withdrawal by Subject|3|||
125342338|NCT00797966|450888722|FG003|Phase B|Withdrawal by Subject|3|||
125342339|NCT00797966|450888723|FG004|Phase B|Withdrawal by Subject|0|||
125342340|NCT00797966|450888724|FG005|Phase B|Withdrawal by Subject|0|||
125675384|NCT01290263|452100515|FG001|Overall Study|Participant Non-Compliance|0|||
125675385|NCT01290263|452100516|FG002|Overall Study|Participant Non-Compliance|0|||
125342341|NCT00797966|450888719|FG000|Phase B|Protocol Deviation|4|||
125342342|NCT00797966|450888720|FG001|Phase B|Protocol Deviation|8|||
125675386|NCT01290263|452100517|FG003|Overall Study|Participant Non-Compliance|1|||
125675387|NCT01290263|452100518|FG004|Overall Study|Participant Non-Compliance|1|||
125675388|NCT03738332|452100519|FG000|Overall Study|Withdrawal by Subject|1|||
125675389|NCT04700449|452100520|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
125675390|NCT04700449|452100521|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
125675391|NCT04700449|452100522|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
125675392|NCT04700449|452100523|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
125675393|NCT04700449|452100520|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
125675394|NCT04700449|452100521|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
125675395|NCT04700449|452100522|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
125675396|NCT04700449|452100523|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
125675397|NCT04700449|452100520|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
125675398|NCT04700449|452100521|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
125675399|NCT04700449|452100522|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
125675400|NCT04700449|452100523|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
125675401|NCT04700449|452100520|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
125675402|NCT04700449|452100521|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
125675403|NCT04700449|452100522|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
125675404|NCT04700449|452100523|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
125675405|NCT04700449|452100520|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
125675406|NCT04700449|452100521|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
125675407|NCT04700449|452100522|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
125675408|NCT04700449|452100523|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
125675409|NCT04700449|452100520|FG000|Stage 1: Double-Blind Period|Other|0|||
125675410|NCT04700449|452100521|FG001|Stage 1: Double-Blind Period|Other|0|||
125675411|NCT04700449|452100522|FG002|Stage 1: Double-Blind Period|Other|1|||
125342343|NCT00797966|450888721|FG002|Phase B|Protocol Deviation|2|||
125675412|NCT04700449|452100523|FG003|Stage 1: Double-Blind Period|Other|0|||
125342344|NCT00797966|450888722|FG003|Phase B|Protocol Deviation|6|||
125342345|NCT00797966|450888723|FG004|Phase B|Protocol Deviation|0|||
125342346|NCT00797966|450888724|FG005|Phase B|Protocol Deviation|0|||
125342347|NCT00797966|450888719|FG000|Phase B|Lack of Efficacy|0|||
125342348|NCT00797966|450888720|FG001|Phase B|Lack of Efficacy|1|||
125342349|NCT00797966|450888721|FG002|Phase B|Lack of Efficacy|1|||
125342350|NCT00797966|450888722|FG003|Phase B|Lack of Efficacy|4|||
125342351|NCT00797966|450888723|FG004|Phase B|Lack of Efficacy|0|||
125342352|NCT00797966|450888724|FG005|Phase B|Lack of Efficacy|0|||
125342353|NCT00797966|450888719|FG000|Phase A+|Lost to Follow-up|0|||
125342354|NCT00797966|450888720|FG001|Phase A+|Lost to Follow-up|0|||
125342355|NCT00797966|450888721|FG002|Phase A+|Lost to Follow-up|0|||
125342356|NCT00797966|450888722|FG003|Phase A+|Lost to Follow-up|0|||
125342357|NCT00797966|450888723|FG004|Phase A+|Lost to Follow-up|0|||
125342358|NCT00797966|450888724|FG005|Phase A+|Lost to Follow-up|9|||
125342359|NCT00797966|450888719|FG000|Phase A+|Met withdrawal criteria|0|||
125342360|NCT00797966|450888720|FG001|Phase A+|Met withdrawal criteria|0|||
125342361|NCT00797966|450888721|FG002|Phase A+|Met withdrawal criteria|0|||
125342362|NCT00797966|450888722|FG003|Phase A+|Met withdrawal criteria|0|||
125342363|NCT00797966|450888723|FG004|Phase A+|Met withdrawal criteria|0|||
125342364|NCT00797966|450888724|FG005|Phase A+|Met withdrawal criteria|5|||
125342365|NCT00797966|450888719|FG000|Phase A+|Withdrawal by Subject|0|||
125342366|NCT00797966|450888720|FG001|Phase A+|Withdrawal by Subject|0|||
125342367|NCT00797966|450888721|FG002|Phase A+|Withdrawal by Subject|0|||
125342368|NCT00797966|450888722|FG003|Phase A+|Withdrawal by Subject|0|||
125342369|NCT00797966|450888723|FG004|Phase A+|Withdrawal by Subject|0|||
125342370|NCT00797966|450888724|FG005|Phase A+|Withdrawal by Subject|6|||
125342371|NCT00797966|450888719|FG000|Phase A+|Adverse Event|0|||
125675413|NCT04700449|452100520|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
125675414|NCT04700449|452100521|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
125675415|NCT04700449|452100522|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
125675416|NCT04700449|452100523|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
125675417|NCT04700449|452100520|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
125675418|NCT04700449|452100521|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
125675419|NCT04700449|452100522|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
125675420|NCT04700449|452100523|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
125675421|NCT04700449|452100520|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
125675422|NCT04700449|452100521|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
125675423|NCT04700449|452100522|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
125675424|NCT04700449|452100523|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
125675425|NCT04700449|452100520|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
125675426|NCT04700449|452100521|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
125675427|NCT04700449|452100522|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
125675428|NCT04700449|452100523|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
125675429|NCT04700449|452100520|FG000|Stage 2 Sub-study 1|Other|1|||
125675430|NCT04700449|452100521|FG001|Stage 2 Sub-study 1|Other|2|||
125675431|NCT04700449|452100522|FG002|Stage 2 Sub-study 1|Other|0|||
125675432|NCT04700449|452100523|FG003|Stage 2 Sub-study 1|Other|0|||
125675433|NCT04700449|452100520|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
125675434|NCT04700449|452100521|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
125675435|NCT04700449|452100522|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
125675436|NCT04700449|452100523|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
125675437|NCT04700449|452100520|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
125675438|NCT04700449|452100521|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
125675439|NCT04700449|452100522|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
125675440|NCT04700449|452100523|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
125675441|NCT04700449|452100520|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
125675442|NCT04700449|452100521|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
125675443|NCT04700449|452100522|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
125675444|NCT04700449|452100523|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
125675445|NCT04700449|452100520|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
125675446|NCT04700449|452100521|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
125675447|NCT04700449|452100522|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
125675448|NCT04700449|452100523|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
125675449|NCT04700449|452100520|FG000|Stage 2 Sub-study 2|Other|0|||
125675450|NCT04700449|452100521|FG001|Stage 2 Sub-study 2|Other|0|||
125675451|NCT04700449|452100522|FG002|Stage 2 Sub-study 2|Other|0|||
125342372|NCT00797966|450888720|FG001|Phase A+|Adverse Event|0|||
125342373|NCT00797966|450888721|FG002|Phase A+|Adverse Event|0|||
125342374|NCT00797966|450888722|FG003|Phase A+|Adverse Event|0|||
125342375|NCT00797966|450888723|FG004|Phase A+|Adverse Event|0|||
125342376|NCT00797966|450888724|FG005|Phase A+|Adverse Event|4|||
125342377|NCT00797966|450888719|FG000|Phase A+|Protocol deviation|0|||
125342378|NCT00797966|450888720|FG001|Phase A+|Protocol deviation|0|||
125342379|NCT00797966|450888721|FG002|Phase A+|Protocol deviation|0|||
125675452|NCT04700449|452100523|FG003|Stage 2 Sub-study 2|Other|5|||
125675453|NCT01521559|452100524|FG000|Overall Study|Adverse Event|0|||
125675454|NCT01521559|452100525|FG001|Overall Study|Adverse Event|4|||
125675455|NCT01521559|452100524|FG000|Overall Study|Death|1|||
125675456|NCT01521559|452100525|FG001|Overall Study|Death|0|||
125675457|NCT01521559|452100524|FG000|Overall Study|Withdrawal by Subject|9|||
125675458|NCT01521559|452100525|FG001|Overall Study|Withdrawal by Subject|11|||
125342380|NCT00797966|450888722|FG003|Phase A+|Protocol deviation|0|||
125342381|NCT00797966|450888723|FG004|Phase A+|Protocol deviation|0|||
125342382|NCT00797966|450888724|FG005|Phase A+|Protocol deviation|4|||
125342383|NCT03859973|450888725|FG000|Overall Study|Other reason than listed|3|||
125342384|NCT03859973|450888726|FG001|Overall Study|Other reason than listed|2|||
125342385|NCT03859973|450888725|FG000|Overall Study|COVID-19 related, not due to AE|3|||
125342386|NCT03859973|450888726|FG001|Overall Study|COVID-19 related, not due to AE|4|||
125342387|NCT03859973|450888725|FG000|Overall Study|Withdrawal by Subject|8|||
125342388|NCT03859973|450888726|FG001|Overall Study|Withdrawal by Subject|9|||
125342389|NCT03859973|450888725|FG000|Overall Study|Lost to Follow-up|2|||
125342390|NCT03859973|450888726|FG001|Overall Study|Lost to Follow-up|3|||
125342391|NCT03859973|450888725|FG000|Overall Study|Protocol Violation|1|||
125342392|NCT03859973|450888726|FG001|Overall Study|Protocol Violation|3|||
125675459|NCT01521559|452100524|FG000|Overall Study|Lost to Follow-up|3|||
125675460|NCT01521559|452100525|FG001|Overall Study|Lost to Follow-up|1|||
125675461|NCT01521559|452100524|FG000|Overall Study|Protocol Violation|1|||
125675462|NCT01521559|452100525|FG001|Overall Study|Protocol Violation|0|||
125675463|NCT01521559|452100524|FG000|Overall Study|Other|1|||
125675464|NCT01521559|452100525|FG001|Overall Study|Other|2|||
125675465|NCT00275002|452100526|FG000|Overall Study|Death|1|||
125675466|NCT00275002|452100527|FG001|Overall Study|Death|0|||
125675467|NCT00275002|452100526|FG000|Overall Study|Disease progression|21|||
125675468|NCT00275002|452100527|FG001|Overall Study|Disease progression|15|||
125675469|NCT00275002|452100526|FG000|Overall Study|Adverse Event|0|||
125675470|NCT00275002|452100527|FG001|Overall Study|Adverse Event|1|||
125675471|NCT00576381|452100537|FG000|Overall Study|Reoperation|3|||
125675472|NCT00576381|452100537|FG000|Overall Study|Adverse Event|4|||
125675473|NCT01031537|452100538|FG000|Overall Study|medical reasons not related to study|3|||
125675474|NCT01031537|452100538|FG000|Overall Study|Lack of Efficacy|1|||
125675475|NCT01031537|452100538|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
125675476|NCT01031537|452100538|FG000|Overall Study|moved, met exclusion criteria|10|||
125675477|NCT01031537|452100538|FG000|Overall Study|Withdrawal by Subject|5|||
125675478|NCT01031537|452100538|FG000|Overall Study|PI removal, no longer met eligibility|12|||
125675479|NCT02132247|452100539|FG000|Overall Study|Protocol Violation|1|||
125675480|NCT02132247|452100540|FG001|Overall Study|Protocol Violation|0|||
125675481|NCT00520741|452100541|FG000|Overall Study|Adverse Event|16|||
125675482|NCT00520741|452100542|FG001|Overall Study|Adverse Event|56|||
125675483|NCT00520741|452100541|FG000|Overall Study|Lack of Efficacy|11|||
125675484|NCT00520741|452100542|FG001|Overall Study|Lack of Efficacy|30|||
125675485|NCT00520741|452100541|FG000|Overall Study|Withdrawal by Subject|0|||
125675486|NCT00520741|452100542|FG001|Overall Study|Withdrawal by Subject|11|||
125675487|NCT00520741|452100541|FG000|Overall Study|Protocol Violation|2|||
125675488|NCT00520741|452100542|FG001|Overall Study|Protocol Violation|15|||
125675489|NCT00520741|452100541|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
125675490|NCT00520741|452100542|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
125675491|NCT00520741|452100541|FG000|Overall Study|Lost to Follow-up|4|||
125675492|NCT00520741|452100542|FG001|Overall Study|Lost to Follow-up|4|||
125675493|NCT00520741|452100541|FG000|Overall Study|Other reasons for premature termination|0|||
125675494|NCT00520741|452100542|FG001|Overall Study|Other reasons for premature termination|6|||
125675495|NCT02750761|452100543|FG000|Overall Study|Lost to Follow-up|0|||
125675496|NCT02750761|452100544|FG001|Overall Study|Lost to Follow-up|0|||
125675497|NCT02750761|452100545|FG002|Overall Study|Lost to Follow-up|1|||
125675498|NCT02750761|452100546|FG003|Overall Study|Lost to Follow-up|0|||
125675499|NCT02750761|452100547|FG004|Overall Study|Lost to Follow-up|0|||
125675500|NCT02750761|452100548|FG005|Overall Study|Lost to Follow-up|0|||
125675501|NCT02354586|452100551|FG000|Overall Study|Death|230|||
125675502|NCT02354586|452100551|FG000|Overall Study|Withdrawal by Subject|59|||
125675503|NCT02354586|452100551|FG000|Overall Study|Lost to Follow-up|11|||
125675504|NCT02354586|452100551|FG000|Overall Study|Sponsor decision|51|||
125675505|NCT02354586|452100551|FG000|Overall Study|Site closure|2|||
125675506|NCT02354586|452100551|FG000|Overall Study|Intercurrent illness|1|||
125675507|NCT02354586|452100551|FG000|Overall Study|Protocol Violation|3|||
125675508|NCT02354586|452100551|FG000|Overall Study|Physician Decision|13|||
125675509|NCT02354586|452100551|FG000|Overall Study|Lack of Efficacy|86|||
125675510|NCT02354586|452100551|FG000|Overall Study|Adverse Event|7|||
125675511|NCT00634907|452100552|FG000|Overall Study|Withdrawal by Subject|3|||
125675512|NCT00634907|452100553|FG001|Overall Study|Withdrawal by Subject|0|||
125675513|NCT00634907|452100552|FG000|Overall Study|Physician Decision|3|||
125675514|NCT00634907|452100553|FG001|Overall Study|Physician Decision|9|||
125675515|NCT00634907|452100552|FG000|Overall Study|Withdrawal by Subject|11|||
125675516|NCT00634907|452100553|FG001|Overall Study|Withdrawal by Subject|8|||
125675517|NCT02720510|452100554|FG000|Overall Study|Study Terminated by the sponsor|2|||
125675518|NCT02720510|452100555|FG001|Overall Study|Study Terminated by the sponsor|0|||
125675519|NCT02720510|452100554|FG000|Overall Study|Adverse Event|0|||
125675520|NCT02720510|452100555|FG001|Overall Study|Adverse Event|1|||
125675521|NCT02720510|452100554|FG000|Overall Study|Physician Decision|1|||
125675522|NCT02720510|452100555|FG001|Overall Study|Physician Decision|2|||
125675523|NCT02985151|452100559|FG000|Original Randomization|Withdrawal by Subject|0|||
125342393|NCT03859973|450888725|FG000|Overall Study|Adverse Event|3|||
125342394|NCT03859973|450888726|FG001|Overall Study|Adverse Event|5|||
125342395|NCT01478048|450888727|FG000|Overall Study|Disease Progression|52|||
125342396|NCT01478048|450888728|FG001|Overall Study|Disease Progression|35|||
125342397|NCT01478048|450888727|FG000|Overall Study|study drug toxicity|11|||
125342398|NCT01478048|450888728|FG001|Overall Study|study drug toxicity|14|||
125342399|NCT01478048|450888727|FG000|Overall Study|Adverse Event|2|||
125342400|NCT01478048|450888728|FG001|Overall Study|Adverse Event|11|||
125342401|NCT01478048|450888727|FG000|Overall Study|subject request to discontinue treatment|3|||
125342402|NCT01478048|450888728|FG001|Overall Study|subject request to discontinue treatment|5|||
125342403|NCT01478048|450888727|FG000|Overall Study|Withdrawal by Subject|2|||
125342404|NCT01478048|450888728|FG001|Overall Study|Withdrawal by Subject|5|||
125342405|NCT01478048|450888727|FG000|Overall Study|non-specified|6|||
125342406|NCT01478048|450888728|FG001|Overall Study|non-specified|4|||
125675524|NCT02985151|452100560|FG001|Original Randomization|Withdrawal by Subject|1|||
125675525|NCT00625807|452100563|FG000|Overall Study|schedule conflict|2|||
125675526|NCT00625807|452100564|FG001|Overall Study|schedule conflict|8|||
125675527|NCT02224391|452100565|FG000|Overall Study|Lost to Follow-up|26|||
125675528|NCT02224391|452100566|FG001|Overall Study|Lost to Follow-up|19|||
125675529|NCT02224391|452100565|FG000|Overall Study|Withdrawal by Subject|6|||
125675530|NCT02224391|452100566|FG001|Overall Study|Withdrawal by Subject|5|||
125675531|NCT00084084|452100568|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
125675532|NCT00084084|452100568|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
125675533|NCT00108732|452100572|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
125675534|NCT00108732|452100572|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
125675535|NCT00108732|452100572|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
125675536|NCT00108732|452100572|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
125675537|NCT00108732|452100572|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
125675538|NCT00108732|452100572|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
125675539|NCT00108732|452100572|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
125675540|NCT03922477|452100577|FG000|Overall Study|Death|9|||
125675541|NCT03922477|452100577|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
125675542|NCT03922477|452100577|FG000|Overall Study|Physician Decision|1|||
125675543|NCT03922477|452100577|FG000|Overall Study|Withdrawal by Subject|2|||
125675544|NCT01485536|452100585|FG000|Overall Study|Withdrawal by Subject|3|||
125675545|NCT01485536|452100585|FG000|Overall Study|Adverse Event|1|||
125675546|NCT02626949|452100586|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
125675547|NCT02626949|452100587|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
125675548|NCT02626949|452100586|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
125675549|NCT02626949|452100587|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
125675550|NCT02626949|452100586|FG000|Enrolled|Lost to Follow-up|7|||
125675551|NCT02626949|452100587|FG001|Enrolled|Lost to Follow-up|6|||
125675552|NCT02626949|452100586|FG000|Enrolled|Withdrawal by Subject|3|||
125675553|NCT02626949|452100587|FG001|Enrolled|Withdrawal by Subject|2|||
125675554|NCT03072459|452100588|FG000|Overall Study|Device revised/removed|1|||
125675555|NCT03072459|452100588|FG000|Overall Study|Subject not able to return|1|||
125675556|NCT02275364|452100589|FG000|Period 1|Withdrawal by Subject|1|||
125675557|NCT02275364|452100590|FG001|Period 1|Withdrawal by Subject|0|||
125675558|NCT02275364|452100589|FG000|Period 1|Other reason|1|||
125675559|NCT02275364|452100590|FG001|Period 1|Other reason|0|||
125675560|NCT03008460|452100599|FG000|Overall Study|Protocol deviation|0|||
125675561|NCT03008460|452100600|FG001|Overall Study|Protocol deviation|2|||
125675562|NCT03008460|452100599|FG000|Overall Study|Study drug not dispensed|0|||
125675563|NCT03008460|452100600|FG001|Overall Study|Study drug not dispensed|1|||
125675564|NCT03008460|452100599|FG000|Overall Study|Adverse Event|0|||
125675565|NCT03008460|452100600|FG001|Overall Study|Adverse Event|1|||
125675566|NCT03008460|452100599|FG000|Overall Study|Withdrawal by Subject|5|||
125675567|NCT03008460|452100600|FG001|Overall Study|Withdrawal by Subject|6|||
125675568|NCT03008460|452100599|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
125675569|NCT03008460|452100600|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
125675570|NCT03008460|452100599|FG000|Overall Study|End of study visit outside permitted time window|0|||
125675571|NCT03008460|452100600|FG001|Overall Study|End of study visit outside permitted time window|1|||
125675572|NCT03008460|452100599|FG000|Overall Study|Lost to Follow-up|1|||
125675573|NCT03008460|452100600|FG001|Overall Study|Lost to Follow-up|3|||
125675574|NCT04947579|452100603|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
125675575|NCT04947579|452100604|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
125675576|NCT04947579|452100605|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
125342407|NCT01478048|450888727|FG000|Overall Study|poor/non-compliance|0|||
125675577|NCT04947579|452100606|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
125342408|NCT01478048|450888728|FG001|Overall Study|poor/non-compliance|1|||
125342409|NCT01478048|450888727|FG000|Overall Study|no longer meets study criteria|1|||
125342410|NCT01478048|450888728|FG001|Overall Study|no longer meets study criteria|0|||
125342411|NCT03032380|450888737|FG000|Overall Study|Adverse Event|0|||
125342412|NCT03032380|450888738|FG001|Overall Study|Adverse Event|1|||
125342413|NCT03032380|450888737|FG000|Overall Study|Lack of Efficacy|1|||
125342414|NCT03032380|450888738|FG001|Overall Study|Lack of Efficacy|0|||
125342415|NCT03032380|450888737|FG000|Overall Study|Withdrawal by Subject|2|||
125342416|NCT03032380|450888738|FG001|Overall Study|Withdrawal by Subject|3|||
125342417|NCT03032380|450888737|FG000|Overall Study|Recovery|0|||
125342418|NCT03032380|450888738|FG001|Overall Study|Recovery|1|||
125342419|NCT03032380|450888737|FG000|Overall Study|Death|39|||
125342420|NCT03032380|450888738|FG001|Overall Study|Death|34|||
125342421|NCT03032380|450888737|FG000|Overall Study|Other - Miscellaneous|0|||
125342422|NCT03032380|450888738|FG001|Overall Study|Other - Miscellaneous|1|||
125342423|NCT01561898|450888739|FG000|Overall Study|Withdrawal by Subject|0|||
125342424|NCT01561898|450888740|FG001|Overall Study|Withdrawal by Subject|8|||
125675578|NCT04947579|452100607|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
125675579|NCT04947579|452100608|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
125675580|NCT04947579|452100603|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
125675581|NCT04947579|452100604|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
125675582|NCT04947579|452100605|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
125675583|NCT04947579|452100606|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
125675584|NCT04947579|452100607|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
125675585|NCT04947579|452100608|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
125675586|NCT04947579|452100603|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
125675587|NCT04947579|452100604|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
125675588|NCT04947579|452100605|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
125675589|NCT04947579|452100606|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
125675590|NCT04947579|452100607|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
125675591|NCT04947579|452100608|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
125675592|NCT04947579|452100603|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
125675593|NCT04947579|452100604|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
125675594|NCT04947579|452100605|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
125675595|NCT04947579|452100606|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
125675596|NCT04947579|452100607|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
125675597|NCT04947579|452100608|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
125675598|NCT04947579|452100603|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
125675599|NCT04947579|452100604|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
125675600|NCT04947579|452100605|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
125675601|NCT04947579|452100606|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
125675602|NCT04947579|452100607|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
125675603|NCT04947579|452100608|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
125675604|NCT04947579|452100603|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
125675605|NCT04947579|452100604|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
125675606|NCT04947579|452100605|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
125675607|NCT04947579|452100606|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
125675608|NCT04947579|452100607|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
125675609|NCT04947579|452100608|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
125675610|NCT04947579|452100603|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
125675611|NCT04947579|452100604|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
125675612|NCT04947579|452100605|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
125675613|NCT04947579|452100606|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
125675614|NCT04947579|452100607|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
125675615|NCT04947579|452100608|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
125675616|NCT04947579|452100603|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
125675617|NCT04947579|452100604|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
125675618|NCT04947579|452100605|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
125675619|NCT04947579|452100606|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
125675620|NCT04947579|452100607|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
125342425|NCT01561898|450888741|FG002|Overall Study|Withdrawal by Subject|12|||
125342426|NCT01561898|450888742|FG003|Overall Study|Withdrawal by Subject|5|||
125342427|NCT01561898|450888739|FG000|Overall Study|Lack of Efficacy|0|||
125342428|NCT01561898|450888740|FG001|Overall Study|Lack of Efficacy|8|||
125675621|NCT04947579|452100608|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
125675622|NCT04947579|452100603|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
125675623|NCT04947579|452100604|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
125675624|NCT04947579|452100605|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
125675625|NCT04947579|452100606|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
125675626|NCT04947579|452100607|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
125675627|NCT04947579|452100608|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
125675628|NCT04947579|452100603|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
125675629|NCT04947579|452100604|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
125675630|NCT04947579|452100605|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
125675631|NCT04947579|452100606|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
125675632|NCT04947579|452100607|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
125675633|NCT04947579|452100608|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
125675634|NCT04947579|452100603|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
125675635|NCT04947579|452100604|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
125675636|NCT04947579|452100605|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
125675637|NCT04947579|452100606|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
125675638|NCT04947579|452100607|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
125675639|NCT04947579|452100608|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
125675640|NCT01575054|452100609|FG000|Overall Study|Other Reasons|5|||
125675641|NCT01575054|452100610|FG001|Overall Study|Other Reasons|3|||
125675642|NCT01575054|452100609|FG000|Overall Study|Protocol Violation|2|||
125675643|NCT01575054|452100610|FG001|Overall Study|Protocol Violation|1|||
125675644|NCT01575054|452100609|FG000|Overall Study|Personal Reasons|10|||
125675645|NCT01575054|452100610|FG001|Overall Study|Personal Reasons|11|||
125675646|NCT01575054|452100609|FG000|Overall Study|Lost to Follow-up|3|||
125675647|NCT01575054|452100610|FG001|Overall Study|Lost to Follow-up|3|||
125675648|NCT01575054|452100609|FG000|Overall Study|Adverse Event|9|||
125675649|NCT01575054|452100610|FG001|Overall Study|Adverse Event|8|||
125675650|NCT05200858|452100621|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
125675651|NCT05200858|452100622|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
125675652|NCT05200858|452100623|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
125675653|NCT05200858|452100624|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
125675654|NCT01691508|452102799|FG000|Overall Study|Adverse Event|3|||
125675655|NCT01691508|452102800|FG001|Overall Study|Adverse Event|3|||
125675656|NCT01691508|452102799|FG000|Overall Study|Withdrawal by Subject|1|||
125675657|NCT01691508|452102800|FG001|Overall Study|Withdrawal by Subject|0|||
125675658|NCT02322047|452102801|FG000|Overall Study|Physician Decision|1|||
125675659|NCT02322047|452102802|FG001|Overall Study|Physician Decision|0|||
125675660|NCT02322047|452102803|FG002|Overall Study|Physician Decision|0|||
125675661|NCT02322047|452102804|FG003|Overall Study|Physician Decision|0|||
125675662|NCT02322047|452102801|FG000|Overall Study|Withdrawal by Subject|1|||
125675663|NCT02322047|452102802|FG001|Overall Study|Withdrawal by Subject|0|||
125675664|NCT02322047|452102803|FG002|Overall Study|Withdrawal by Subject|0|||
125675665|NCT02322047|452102804|FG003|Overall Study|Withdrawal by Subject|1|||
125675666|NCT02322047|452102801|FG000|Overall Study|Adverse Event|0|||
125675667|NCT02322047|452102802|FG001|Overall Study|Adverse Event|1|||
125675668|NCT02322047|452102803|FG002|Overall Study|Adverse Event|0|||
125342429|NCT01561898|450888741|FG002|Overall Study|Lack of Efficacy|10|||
125342430|NCT01561898|450888742|FG003|Overall Study|Lack of Efficacy|5|||
125342431|NCT01561898|450888739|FG000|Overall Study|Worsening of complications|0|||
125342432|NCT01561898|450888740|FG001|Overall Study|Worsening of complications|1|||
125342433|NCT01561898|450888741|FG002|Overall Study|Worsening of complications|0|||
125342434|NCT01561898|450888742|FG003|Overall Study|Worsening of complications|0|||
125342435|NCT01561898|450888739|FG000|Overall Study|Lost to Follow-up|0|||
125342436|NCT01561898|450888740|FG001|Overall Study|Lost to Follow-up|0|||
125342437|NCT01561898|450888741|FG002|Overall Study|Lost to Follow-up|1|||
125342438|NCT01561898|450888742|FG003|Overall Study|Lost to Follow-up|0|||
125342439|NCT01561898|450888739|FG000|Overall Study|Adverse Event|1|||
125342440|NCT01561898|450888740|FG001|Overall Study|Adverse Event|19|||
125342441|NCT01561898|450888741|FG002|Overall Study|Adverse Event|14|||
125342442|NCT01561898|450888742|FG003|Overall Study|Adverse Event|9|||
125342443|NCT01561898|450888739|FG000|Overall Study|Physician Decision|1|||
125342444|NCT01561898|450888740|FG001|Overall Study|Physician Decision|5|||
125342445|NCT01561898|450888741|FG002|Overall Study|Physician Decision|7|||
125342446|NCT01561898|450888742|FG003|Overall Study|Physician Decision|1|||
125342447|NCT00294762|450888743|FG000|Overall Study|Did not receive study treatment|3|||
125342448|NCT00294762|450888744|FG001|Overall Study|Did not receive study treatment|3|||
125342449|NCT02238080|450888745|FG000|Overall Study|Death|13|||
125342450|NCT02238080|450888745|FG000|Overall Study|Treatment interrupted|6|||
125342451|NCT02238080|450888745|FG000|Overall Study|Withdrawal by Subject|2|||
125342452|NCT02238080|450888745|FG000|Overall Study|Other|4|||
125342453|NCT01738646|450888746|FG000|Overall Study|Still Receiving Treatment|2|||
125675669|NCT02322047|452102804|FG003|Overall Study|Adverse Event|0|||
125675670|NCT02322047|452102801|FG000|Overall Study|Lost to Follow-up|0|||
125675671|NCT02322047|452102802|FG001|Overall Study|Lost to Follow-up|0|||
125675672|NCT02322047|452102803|FG002|Overall Study|Lost to Follow-up|1|||
125675673|NCT02322047|452102804|FG003|Overall Study|Lost to Follow-up|1|||
125675674|NCT02207231|452102805|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
125675675|NCT02207231|452102806|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
125675676|NCT02207231|452102807|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
125675677|NCT02207231|452102808|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
125675678|NCT02207231|452102805|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
125675679|NCT02207231|452102806|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
125342454|NCT04093024|450888749|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
125342455|NCT04093024|450888750|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
125675680|NCT02207231|452102807|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
125342456|NCT04093024|450888749|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
125342457|NCT04093024|450888750|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
125342458|NCT04093024|450888749|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
125342459|NCT04093024|450888750|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
125342460|NCT04093024|450888749|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
125342461|NCT04093024|450888750|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
125342462|NCT02267317|450888755|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
125342463|NCT02267317|450888756|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
125342464|NCT02267317|450888757|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
125342465|NCT02267317|450888758|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
125342466|NCT02267317|450888759|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
125342467|NCT02267317|450888760|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
125342468|NCT02267317|450888755|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
125342469|NCT02267317|450888756|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
125342470|NCT02267317|450888757|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
125342471|NCT02267317|450888758|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
125675681|NCT02207231|452102808|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
125675682|NCT02207231|452102805|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
125675683|NCT02207231|452102806|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
125675684|NCT02207231|452102807|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
125675685|NCT02207231|452102808|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
125675686|NCT02207231|452102805|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
125675687|NCT02207231|452102806|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
125675688|NCT02207231|452102807|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
125675689|NCT02207231|452102808|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
125675690|NCT02207231|452102805|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
125675691|NCT02207231|452102806|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
125675692|NCT02207231|452102807|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
125675693|NCT02207231|452102808|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
125675694|NCT02207231|452102805|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
125675695|NCT02207231|452102806|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
125342472|NCT02267317|450888759|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
125342473|NCT02267317|450888760|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
125342474|NCT00796445|450888761|FG000|Overall Study|Protocol Violation|5|||
125342475|NCT00796445|450888762|FG001|Overall Study|Protocol Violation|3|||
125342476|NCT00796445|450888761|FG000|Overall Study|Adverse event, serious fatal|10|||
125342477|NCT00796445|450888762|FG001|Overall Study|Adverse event, serious fatal|5|||
125342478|NCT00796445|450888761|FG000|Overall Study|Adverse event, non-fatal|4|||
125342479|NCT00796445|450888762|FG001|Overall Study|Adverse event, non-fatal|0|||
125342480|NCT00796445|450888761|FG000|Overall Study|Disease progression/recurrence|537|||
125342481|NCT00796445|450888762|FG001|Overall Study|Disease progression/recurrence|268|||
125342482|NCT00796445|450888761|FG000|Overall Study|Other|10|||
125342483|NCT00796445|450888762|FG001|Overall Study|Other|7|||
125342484|NCT00796445|450888761|FG000|Overall Study|Withdrawal by Subject|18|||
125342485|NCT00796445|450888762|FG001|Overall Study|Withdrawal by Subject|9|||
125342486|NCT00796445|450888761|FG000|Overall Study|Invalid Informed Consent Form|1|||
125342487|NCT00796445|450888762|FG001|Overall Study|Invalid Informed Consent Form|0|||
125342488|NCT01155011|450888763|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
125342489|NCT01155011|450888764|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
125342490|NCT01155011|450888763|FG000|Baseline to 6 Months|investigator decision, moved|4|||
125342491|NCT01155011|450888764|FG001|Baseline to 6 Months|investigator decision, moved|5|||
125342492|NCT01155011|450888763|FG000|Baseline to 6 Months|Death|0|||
125342493|NCT01155011|450888764|FG001|Baseline to 6 Months|Death|1|||
125342494|NCT01155011|450888763|FG000|6 to 12 Months|Withdrawal by Subject|8|||
125342495|NCT01155011|450888764|FG001|6 to 12 Months|Withdrawal by Subject|5|||
125342496|NCT01155011|450888763|FG000|6 to 12 Months|Death|1|||
125342497|NCT01155011|450888764|FG001|6 to 12 Months|Death|5|||
125342498|NCT03774823|450888767|FG000|Overall Study|Withdrawal by Subject|1|||
125342499|NCT03774823|450888768|FG001|Overall Study|Withdrawal by Subject|1|||
125342500|NCT00759564|450888769|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
125342501|NCT00759564|450888770|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
125342502|NCT00759564|450888771|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
125342503|NCT00759564|450888772|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
125342504|NCT00759564|450888773|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
125342505|NCT00958438|450888774|FG000|Overall Study|Protocol Violation|3|||
125342506|NCT00958438|450888775|FG001|Overall Study|Protocol Violation|2|||
125342507|NCT00958438|450888776|FG002|Overall Study|Protocol Violation|2|||
125342508|NCT00958438|450888774|FG000|Overall Study|Withdrawal by Subject|4|||
125342509|NCT00958438|450888775|FG001|Overall Study|Withdrawal by Subject|2|||
125342510|NCT00958438|450888776|FG002|Overall Study|Withdrawal by Subject|1|||
125342511|NCT00958438|450888774|FG000|Overall Study|Adverse Event|0|||
125342512|NCT00958438|450888775|FG001|Overall Study|Adverse Event|3|||
125342513|NCT00958438|450888776|FG002|Overall Study|Adverse Event|0|||
125342514|NCT00958438|450888774|FG000|Overall Study|Physician Decision|1|||
125342515|NCT00958438|450888775|FG001|Overall Study|Physician Decision|0|||
125342516|NCT00958438|450888776|FG002|Overall Study|Physician Decision|1|||
125342517|NCT00958438|450888774|FG000|Overall Study|Other than specified above|2|||
125342518|NCT00958438|450888775|FG001|Overall Study|Other than specified above|3|||
125342519|NCT00958438|450888776|FG002|Overall Study|Other than specified above|2|||
125342520|NCT01565343|450888778|FG000|Overall Study|Administrative decision/technical issues|1|||
125342521|NCT01565343|450888779|FG001|Overall Study|Administrative decision/technical issues|0|||
125342522|NCT01565343|450888780|FG002|Overall Study|Administrative decision/technical issues|0|||
125342523|NCT01853839|450888782|FG000|Overall Study|Violated inclusion criteria|2|||
125342524|NCT01853839|450888782|FG000|Overall Study|Not meet ITT population definition|58|||
125342525|NCT01853839|450888782|FG000|Overall Study|End of treatment visit too early|33|||
125342526|NCT01853839|450888782|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
125342527|NCT02350764|450888783|FG000|Overall Study|Adverse Event|4|||
125342528|NCT02350764|450888783|FG000|Overall Study|Death|3|||
125342529|NCT02350764|450888783|FG000|Overall Study|Physician Decision|2|||
125342530|NCT02350764|450888783|FG000|Overall Study|Withdrawal by Subject|2|||
125342531|NCT03531632|450888784|FG000|Overall Study|Adverse Event|0|||
125342532|NCT03531632|450888785|FG001|Overall Study|Adverse Event|0|||
125342533|NCT03531632|450888786|FG002|Overall Study|Adverse Event|1|||
125342534|NCT03531632|450888784|FG000|Overall Study|Death|4|||
125342535|NCT03531632|450888785|FG001|Overall Study|Death|0|||
125342536|NCT03531632|450888786|FG002|Overall Study|Death|14|||
125342537|NCT03531632|450888784|FG000|Overall Study|Study Terminated|1|||
125342538|NCT03531632|450888785|FG001|Overall Study|Study Terminated|3|||
125342539|NCT03531632|450888786|FG002|Overall Study|Study Terminated|11|||
125342540|NCT00600119|450888787|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
125342541|NCT00600119|450888788|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
125342542|NCT00600119|450888789|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
125342543|NCT00600119|450888790|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
125342544|NCT00600119|450888791|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
125342545|NCT00600119|450888792|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
125342546|NCT00600119|450888787|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125342547|NCT00600119|450888788|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
125342548|NCT00600119|450888789|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
125342549|NCT00600119|450888790|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125342550|NCT00600119|450888791|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125342551|NCT00600119|450888792|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125342552|NCT00600119|450888787|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
125342553|NCT00600119|450888788|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
125342554|NCT00600119|450888789|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
125342555|NCT00600119|450888790|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
125342556|NCT00600119|450888791|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
125342557|NCT00600119|450888792|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
125342558|NCT00600119|450888787|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
125342559|NCT00600119|450888788|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
125342560|NCT00600119|450888789|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
125342561|NCT00600119|450888790|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
125342562|NCT00600119|450888791|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
125342563|NCT00600119|450888792|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
125342564|NCT00600119|450888787|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
125342565|NCT00600119|450888788|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
125342566|NCT00600119|450888789|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
125342567|NCT00600119|450888790|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
125342568|NCT00600119|450888791|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
125342569|NCT00600119|450888792|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
125342570|NCT00600119|450888787|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
125342571|NCT00600119|450888788|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
125342572|NCT00600119|450888789|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
125342573|NCT00600119|450888790|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
125342574|NCT00600119|450888791|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
125342575|NCT00600119|450888792|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
125342576|NCT00600119|450888787|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
125342577|NCT00600119|450888788|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
125342578|NCT00600119|450888789|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125342579|NCT00600119|450888790|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
125342580|NCT00600119|450888791|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
125342581|NCT00600119|450888792|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
125342582|NCT00600119|450888787|FG000|Double-blind Treatment Period|Other|0|||
125342583|NCT00600119|450888788|FG001|Double-blind Treatment Period|Other|0|||
125342584|NCT00600119|450888789|FG002|Double-blind Treatment Period|Other|0|||
125342585|NCT00600119|450888790|FG003|Double-blind Treatment Period|Other|0|||
125675696|NCT02207231|452102807|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
125675697|NCT02207231|452102808|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
125675698|NCT02207231|452102805|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
125675699|NCT02207231|452102806|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
125675700|NCT02207231|452102807|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
125675701|NCT02207231|452102808|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
125342586|NCT00600119|450888791|FG004|Double-blind Treatment Period|Other|2|||
125675702|NCT02207231|452102805|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
125675703|NCT02207231|452102806|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
125675704|NCT02207231|452102807|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
125675705|NCT02207231|452102808|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
125675706|NCT02207231|452102805|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
125675707|NCT02207231|452102806|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
125675708|NCT02207231|452102807|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
125342587|NCT00600119|450888792|FG005|Double-blind Treatment Period|Other|1|||
125342588|NCT00600119|450888787|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
125342589|NCT00600119|450888788|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
125675709|NCT02207231|452102808|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
125342590|NCT00600119|450888789|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
125342591|NCT00600119|450888790|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
125342592|NCT00600119|450888791|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
125342593|NCT00600119|450888792|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
125342594|NCT00600119|450888787|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
125342595|NCT00600119|450888788|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
125342596|NCT00600119|450888789|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
125342597|NCT00600119|450888790|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
125342598|NCT00600119|450888791|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
125342599|NCT00600119|450888792|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
125342600|NCT00600119|450888787|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
125342601|NCT00600119|450888788|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
125342602|NCT00600119|450888789|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
125342603|NCT00600119|450888790|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
125342604|NCT00600119|450888791|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
125342605|NCT00600119|450888792|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
125342606|NCT00600119|450888787|FG000|Double-blind Treatment Period|Physician Decision|2|||
125342607|NCT00600119|450888788|FG001|Double-blind Treatment Period|Physician Decision|0|||
125342608|NCT00600119|450888789|FG002|Double-blind Treatment Period|Physician Decision|0|||
125342609|NCT00600119|450888790|FG003|Double-blind Treatment Period|Physician Decision|0|||
125342610|NCT00600119|450888791|FG004|Double-blind Treatment Period|Physician Decision|0|||
125342611|NCT00600119|450888792|FG005|Double-blind Treatment Period|Physician Decision|0|||
125342612|NCT00600119|450888787|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
125342613|NCT00600119|450888788|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
125342614|NCT00600119|450888789|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
125342615|NCT00600119|450888790|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
125342616|NCT00600119|450888791|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
125342617|NCT00600119|450888792|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
125342618|NCT00600119|450888787|FG000|Double-blind Treatment Period|Adverse Event|1|||
125342619|NCT00600119|450888788|FG001|Double-blind Treatment Period|Adverse Event|1|||
125342620|NCT00600119|450888789|FG002|Double-blind Treatment Period|Adverse Event|0|||
125342621|NCT00600119|450888790|FG003|Double-blind Treatment Period|Adverse Event|1|||
125342622|NCT00600119|450888791|FG004|Double-blind Treatment Period|Adverse Event|2|||
125342623|NCT00600119|450888792|FG005|Double-blind Treatment Period|Adverse Event|10|||
125342624|NCT00600119|450888787|FG000|Follow-up Period|Adverse Event|0|||
125342625|NCT00600119|450888788|FG001|Follow-up Period|Adverse Event|0|||
125342626|NCT00600119|450888789|FG002|Follow-up Period|Adverse Event|0|||
125342627|NCT00600119|450888790|FG003|Follow-up Period|Adverse Event|0|||
125342628|NCT00600119|450888791|FG004|Follow-up Period|Adverse Event|0|||
125342629|NCT00600119|450888792|FG005|Follow-up Period|Adverse Event|1|||
125342630|NCT00600119|450888787|FG000|Follow-up Period|Other|1|||
125342631|NCT00600119|450888788|FG001|Follow-up Period|Other|0|||
125342632|NCT00600119|450888789|FG002|Follow-up Period|Other|0|||
125342633|NCT00600119|450888790|FG003|Follow-up Period|Other|0|||
125342634|NCT00600119|450888791|FG004|Follow-up Period|Other|0|||
125342635|NCT00600119|450888792|FG005|Follow-up Period|Other|0|||
125342636|NCT00729469|450888793|FG000|Overall Study|Adverse Event|14|||
125342637|NCT00729469|450888794|FG001|Overall Study|Adverse Event|25|||
125342638|NCT00729469|450888793|FG000|Overall Study|Lost to Follow-up|9|||
125342639|NCT00729469|450888794|FG001|Overall Study|Lost to Follow-up|9|||
125342640|NCT00729469|450888793|FG000|Overall Study|Protocol Violation|2|||
125342641|NCT00729469|450888794|FG001|Overall Study|Protocol Violation|1|||
125342642|NCT00729469|450888793|FG000|Overall Study|Withdrawal by Subject|19|||
125342643|NCT00729469|450888794|FG001|Overall Study|Withdrawal by Subject|8|||
125342644|NCT00729469|450888793|FG000|Overall Study|Other-Not mentioned|9|||
125342645|NCT00729469|450888794|FG001|Overall Study|Other-Not mentioned|4|||
125342646|NCT01270802|450888797|FG000|Overall Study|Withdrawal by Subject|1|||
125342647|NCT01270802|450888798|FG001|Overall Study|Withdrawal by Subject|0|||
125342648|NCT01270802|450888797|FG000|Overall Study|Adverse Event|1|||
125342649|NCT01270802|450888798|FG001|Overall Study|Adverse Event|0|||
125342650|NCT01270802|450888797|FG000|Overall Study|Lost to Follow-up|0|||
125342651|NCT01270802|450888798|FG001|Overall Study|Lost to Follow-up|1|||
125342652|NCT04620798|450888801|FG000|Overall Study|Lost to Follow-up|126|||
125342653|NCT04620798|450888802|FG001|Overall Study|Lost to Follow-up|138|||
125342654|NCT01960907|450888805|FG000|Overall Study|Death|4|||
125342655|NCT01960907|450888806|FG001|Overall Study|Death|3|||
125342656|NCT01960907|450888805|FG000|Overall Study|Withdrawal by Subject|32|||
125342657|NCT01960907|450888806|FG001|Overall Study|Withdrawal by Subject|42|||
125342658|NCT00439738|450888812|FG000|Overall Study|Withdrawal by Subject|16|||
125342659|NCT00439738|450888813|FG001|Overall Study|Withdrawal by Subject|13|||
125342660|NCT00439738|450888812|FG000|Overall Study|Adverse Event|6|||
125342661|NCT00439738|450888813|FG001|Overall Study|Adverse Event|4|||
125342662|NCT00439738|450888812|FG000|Overall Study|Lost to Follow-up|5|||
125342663|NCT00439738|450888813|FG001|Overall Study|Lost to Follow-up|6|||
125342664|NCT00439738|450888812|FG000|Overall Study|Protocol Violation|6|||
125342665|NCT00439738|450888813|FG001|Overall Study|Protocol Violation|3|||
125342666|NCT00439738|450888812|FG000|Overall Study|Lack of Efficacy|2|||
125342667|NCT00439738|450888813|FG001|Overall Study|Lack of Efficacy|2|||
125342668|NCT00439738|450888812|FG000|Overall Study|Abnormal Lab Values|1|||
125342669|NCT00439738|450888813|FG001|Overall Study|Abnormal Lab Values|0|||
125342670|NCT00402740|450888817|FG000|Overall Study|Withdrawal by Subject|18|||
125342671|NCT00402740|450888817|FG000|Overall Study|Death|50|||
125342672|NCT00402740|450888817|FG000|Overall Study|Lost to Follow-up|6|||
125342673|NCT00402740|450888817|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
125342674|NCT00402740|450888817|FG000|Overall Study|Subject disposition unknown.|1|||
125342675|NCT01185353|450888819|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
125342676|NCT01185353|450888820|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
125342677|NCT01185353|450888821|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
125342678|NCT01185353|450888822|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
125342679|NCT01185353|450888823|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
125342680|NCT01185353|450888824|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
125342681|NCT01185353|450888825|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
125342682|NCT01185353|450888826|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
125342683|NCT01185353|450888827|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
125342684|NCT01185353|450888828|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
125342685|NCT01185353|450888819|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125342686|NCT01185353|450888820|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125342687|NCT01185353|450888821|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125342688|NCT01185353|450888822|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125342689|NCT01185353|450888823|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
125342690|NCT01185353|450888824|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125342691|NCT01185353|450888825|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125342692|NCT01185353|450888826|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125342693|NCT01185353|450888827|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125342694|NCT01185353|450888828|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
125342695|NCT01185353|450888819|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
125342696|NCT01185353|450888820|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125342697|NCT01185353|450888821|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125342698|NCT01185353|450888822|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125342699|NCT01185353|450888823|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
125342700|NCT01185353|450888824|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125342701|NCT01185353|450888825|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125342702|NCT01185353|450888826|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125342703|NCT01185353|450888827|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125342704|NCT01185353|450888828|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
125342705|NCT01185353|450888819|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125342706|NCT01185353|450888820|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125342707|NCT01185353|450888821|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
125342708|NCT01185353|450888822|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125342709|NCT01185353|450888823|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
125342710|NCT01185353|450888824|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125342711|NCT01185353|450888825|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125342712|NCT01185353|450888826|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125342713|NCT01185353|450888827|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125342714|NCT01185353|450888828|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
125342715|NCT01185353|450888819|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125342716|NCT01185353|450888820|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125342717|NCT01185353|450888821|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125342718|NCT01185353|450888822|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125342719|NCT01185353|450888823|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
125342720|NCT01185353|450888824|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125342721|NCT01185353|450888825|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125342722|NCT01185353|450888826|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125342723|NCT01185353|450888827|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125342724|NCT01185353|450888828|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
125342725|NCT01185353|450888819|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
125342726|NCT01185353|450888820|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125342727|NCT01185353|450888821|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125342728|NCT01185353|450888822|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125342729|NCT01185353|450888823|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
125342730|NCT01185353|450888824|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125342731|NCT01185353|450888825|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125342732|NCT01185353|450888826|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125342733|NCT01185353|450888827|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125342734|NCT01185353|450888828|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
125342735|NCT01185353|450888819|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125342736|NCT01185353|450888820|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125342737|NCT01185353|450888821|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
125342738|NCT01185353|450888822|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125342739|NCT01185353|450888823|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125342740|NCT01185353|450888824|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
125342741|NCT01185353|450888825|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125342742|NCT01185353|450888826|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125342743|NCT01185353|450888827|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125342744|NCT01185353|450888828|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
125342745|NCT01185353|450888819|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125342746|NCT01185353|450888820|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
125342747|NCT01185353|450888821|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125342748|NCT01185353|450888822|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
125342749|NCT01185353|450888823|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125342750|NCT01185353|450888824|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125342751|NCT01185353|450888825|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125342752|NCT01185353|450888826|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125342753|NCT01185353|450888827|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125342754|NCT01185353|450888828|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
125342755|NCT01185353|450888819|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125342756|NCT01185353|450888820|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125342757|NCT01185353|450888821|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125342758|NCT01185353|450888822|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
125342759|NCT01185353|450888823|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125342760|NCT01185353|450888824|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125342761|NCT01185353|450888825|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
125342762|NCT01185353|450888826|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125342763|NCT01185353|450888827|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125342764|NCT01185353|450888828|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
125342765|NCT01185353|450888819|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
125342766|NCT01185353|450888820|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
125342767|NCT01185353|450888821|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
125342768|NCT01185353|450888822|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
125342769|NCT01185353|450888823|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
125342770|NCT01185353|450888824|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
125342771|NCT01185353|450888825|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
125342772|NCT01185353|450888826|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
125342773|NCT01185353|450888827|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
125342774|NCT01185353|450888828|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
125342775|NCT01185353|450888819|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125342776|NCT01185353|450888820|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125342777|NCT01185353|450888821|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125342778|NCT01185353|450888822|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125342779|NCT01185353|450888823|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125342780|NCT01185353|450888824|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125342781|NCT01185353|450888825|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
125342782|NCT01185353|450888826|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125342783|NCT01185353|450888827|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125342784|NCT01185353|450888828|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
125342785|NCT01185353|450888819|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125342786|NCT01185353|450888820|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125342787|NCT01185353|450888821|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125342788|NCT01185353|450888822|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125342789|NCT01185353|450888823|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125342790|NCT01185353|450888824|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125342791|NCT01185353|450888825|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
125342792|NCT01185353|450888826|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
125342793|NCT01185353|450888827|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
125342794|NCT01185353|450888828|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
125342795|NCT01185353|450888819|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125342796|NCT01185353|450888820|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125342797|NCT01185353|450888821|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125675710|NCT02207231|452102805|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
125675711|NCT02207231|452102806|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
125675712|NCT02207231|452102807|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
125675713|NCT02207231|452102808|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
125675714|NCT02207231|452102805|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
125675715|NCT02207231|452102806|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
125675716|NCT02207231|452102807|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
125675717|NCT02207231|452102808|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
125675718|NCT02207231|452102805|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
125675719|NCT02207231|452102806|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
125342798|NCT01185353|450888822|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125425617|NCT01553318|451182288|FG001|Overall Study|Protocol Violation|2|||
125675720|NCT02207231|452102807|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
125675721|NCT02207231|452102808|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
125675722|NCT02207231|452102805|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
125675723|NCT02207231|452102806|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
125675724|NCT02207231|452102807|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
125675725|NCT02207231|452102808|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
125675726|NCT02207231|452102805|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
125675727|NCT02207231|452102806|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
125675728|NCT02207231|452102807|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
125675729|NCT02207231|452102808|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
125675730|NCT02207231|452102805|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
125675731|NCT02207231|452102806|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
125675732|NCT02207231|452102807|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
125675733|NCT02207231|452102808|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
125675734|NCT02207231|452102805|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
125342799|NCT01185353|450888823|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125342800|NCT01185353|450888824|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125342801|NCT01185353|450888825|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
125342802|NCT01185353|450888826|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
125342803|NCT01185353|450888827|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
125342804|NCT01185353|450888828|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
125342805|NCT01185353|450888819|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125342806|NCT01185353|450888820|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125342807|NCT01185353|450888821|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125342808|NCT01185353|450888822|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125342809|NCT01185353|450888823|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125342810|NCT01185353|450888824|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125342811|NCT01185353|450888825|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
125342812|NCT01185353|450888826|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
125342813|NCT01185353|450888827|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
125675735|NCT02207231|452102806|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
125675736|NCT02207231|452102807|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
125675737|NCT02207231|452102808|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
125675738|NCT02207231|452102805|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
125675739|NCT02207231|452102806|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
125675740|NCT02207231|452102807|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
125675741|NCT02207231|452102808|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
125675742|NCT02207231|452102805|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
125675743|NCT02207231|452102806|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
125675744|NCT02207231|452102807|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
125675745|NCT02207231|452102808|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
125675746|NCT02207231|452102805|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
125675747|NCT02207231|452102806|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
125675748|NCT02207231|452102807|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
125675749|NCT02207231|452102808|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
125675750|NCT02207231|452102805|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
125675751|NCT02207231|452102806|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
125675752|NCT02207231|452102807|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
125675753|NCT02207231|452102808|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
125675754|NCT02207231|452102805|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
125675755|NCT02207231|452102806|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
125675756|NCT02207231|452102807|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
125675757|NCT02207231|452102808|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
125675758|NCT02016300|452102817|FG000|Overall Study|Lost to Follow-up|0|||
125675759|NCT02016300|452102818|FG001|Overall Study|Lost to Follow-up|3|||
125675760|NCT02309099|452102819|FG000|Overall Study|Adverse Event|2|||
125675761|NCT02309099|452102820|FG001|Overall Study|Adverse Event|0|||
125675762|NCT06165744|452102821|FG000|Overall Study|Non device-related adverse event|1|||
125675763|NCT05456529|452102822|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
125675764|NCT05456529|452102822|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
125675765|NCT05456529|452102822|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
125675766|NCT05456529|452102822|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
125675767|NCT05456529|452102822|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
125675768|NCT05456529|452102822|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
125675769|NCT05456529|452102822|FG000|44-week Long-term Safety Period|Physician Decision|2|||
125675770|NCT05456529|452102822|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
125675771|NCT05456529|452102822|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
125675772|NCT05456529|452102822|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
125675773|NCT05456529|452102822|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
125675774|NCT01631864|452102823|FG000|Overall Study|Withdrawal by Subject|0|||
125675775|NCT01631864|452102824|FG001|Overall Study|Withdrawal by Subject|1|||
125675776|NCT01631864|452102823|FG000|Overall Study|Adverse Event|2|||
125675777|NCT01631864|452102824|FG001|Overall Study|Adverse Event|3|||
125675778|NCT00527423|452102851|FG000|Overall Study|Protocol Violation|1|||
125675779|NCT00527423|452102851|FG000|Overall Study|Adverse Event|5|||
125675780|NCT00527423|452102851|FG000|Overall Study|Physician Decision|4|||
125675781|NCT00527423|452102851|FG000|Overall Study|Withdrawal by Subject|10|||
125675782|NCT00527423|452102851|FG000|Overall Study|Lost to Follow-up|4|||
125675783|NCT00527423|452102851|FG000|Overall Study|OTHER|4|||
125675784|NCT00527423|452102851|FG000|Overall Study|Death|9|||
125675785|NCT01957488|452102852|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
125675786|NCT01957488|452102853|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
125342814|NCT01185353|450888828|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
125675787|NCT01957488|452102854|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
125675788|NCT01957488|452102855|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
125675789|NCT01957488|452102856|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
125675790|NCT01957488|452102857|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
125342815|NCT01185353|450888819|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125342816|NCT01185353|450888820|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125342817|NCT01185353|450888821|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125342818|NCT01185353|450888822|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125342819|NCT01185353|450888823|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125342820|NCT01185353|450888824|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125342821|NCT01185353|450888825|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125342822|NCT01185353|450888826|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125342823|NCT01185353|450888827|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
125342824|NCT01185353|450888828|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
125342825|NCT01185353|450888819|FG000|Part C (Weeks 24 Through 76)|Death|0|||
125342826|NCT01185353|450888820|FG001|Part C (Weeks 24 Through 76)|Death|0|||
125342827|NCT01185353|450888821|FG002|Part C (Weeks 24 Through 76)|Death|0|||
125342828|NCT01185353|450888822|FG003|Part C (Weeks 24 Through 76)|Death|0|||
125342829|NCT01185353|450888823|FG004|Part C (Weeks 24 Through 76)|Death|0|||
125342830|NCT01185353|450888824|FG005|Part C (Weeks 24 Through 76)|Death|0|||
125342831|NCT01185353|450888825|FG006|Part C (Weeks 24 Through 76)|Death|0|||
125342832|NCT01185353|450888826|FG007|Part C (Weeks 24 Through 76)|Death|0|||
125342833|NCT01185353|450888827|FG008|Part C (Weeks 24 Through 76)|Death|0|||
125342834|NCT01185353|450888828|FG009|Part C (Weeks 24 Through 76)|Death|1|||
125342835|NCT01185353|450888819|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125342836|NCT01185353|450888820|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125342837|NCT01185353|450888821|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125342838|NCT01185353|450888822|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125342839|NCT01185353|450888823|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125342840|NCT01185353|450888824|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125342841|NCT01185353|450888825|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125342842|NCT01185353|450888826|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125342843|NCT01185353|450888827|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
125342844|NCT01185353|450888828|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
125342845|NCT01185353|450888819|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125342846|NCT01185353|450888820|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125342847|NCT01185353|450888821|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125342848|NCT01185353|450888822|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125342849|NCT01185353|450888823|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125342850|NCT01185353|450888824|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125342851|NCT01185353|450888825|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125342852|NCT01185353|450888826|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125342853|NCT01185353|450888827|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
125342854|NCT01185353|450888828|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
125342855|NCT01185353|450888819|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
125342856|NCT01185353|450888820|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
125342857|NCT01185353|450888821|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
125342858|NCT01185353|450888822|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
125342859|NCT01185353|450888823|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
125342860|NCT01185353|450888824|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
125342861|NCT01185353|450888825|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
125342862|NCT01185353|450888826|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
125342863|NCT01185353|450888827|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
125342864|NCT01185353|450888828|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
125342865|NCT01185353|450888819|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125675791|NCT01957488|452102852|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
125675792|NCT01957488|452102853|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
125675793|NCT01957488|452102854|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
125675794|NCT01957488|452102855|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
125675795|NCT01957488|452102856|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
125675796|NCT01957488|452102857|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
125675797|NCT01957488|452102852|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
125675798|NCT01957488|452102853|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
125675799|NCT01957488|452102854|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
125675800|NCT01957488|452102855|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
125675801|NCT01957488|452102856|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
125675802|NCT01957488|452102857|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
125675803|NCT01957488|452102852|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
125675804|NCT01957488|452102853|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
125675805|NCT01957488|452102854|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
125675806|NCT01957488|452102855|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
125675807|NCT01957488|452102856|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
125342866|NCT01185353|450888820|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125342867|NCT01185353|450888821|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125675808|NCT01957488|452102857|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
125342868|NCT01185353|450888822|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125342869|NCT01185353|450888823|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125342870|NCT01185353|450888824|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125342871|NCT01185353|450888825|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125342872|NCT01185353|450888826|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
125342873|NCT01185353|450888827|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
125675809|NCT01957488|452102852|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
125675810|NCT01957488|452102853|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
125675811|NCT01957488|452102854|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
125675812|NCT01957488|452102855|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
125675813|NCT01957488|452102856|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
125675814|NCT01957488|452102857|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
125675815|NCT01957488|452102852|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
125675816|NCT01957488|452102853|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
125675817|NCT01957488|452102854|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
125675818|NCT01957488|452102855|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
125675819|NCT01957488|452102856|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
125675820|NCT01957488|452102857|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
125675821|NCT01957488|452102852|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
125675822|NCT01957488|452102853|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
125675823|NCT01957488|452102854|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
125675824|NCT01957488|452102855|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
125675825|NCT01957488|452102856|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
125675826|NCT01957488|452102857|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
125675827|NCT01957488|452102852|FG000|Test Period 2 (2 Weeks)|Other|1|||
125675828|NCT01957488|452102853|FG001|Test Period 2 (2 Weeks)|Other|0|||
125675829|NCT01957488|452102854|FG002|Test Period 2 (2 Weeks)|Other|0|||
125675830|NCT01957488|452102855|FG003|Test Period 2 (2 Weeks)|Other|0|||
125675831|NCT01957488|452102856|FG004|Test Period 2 (2 Weeks)|Other|0|||
125675832|NCT01957488|452102857|FG005|Test Period 2 (2 Weeks)|Other|0|||
125675833|NCT01957488|452102852|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
125675834|NCT01957488|452102853|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
125675835|NCT01957488|452102854|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
125675836|NCT01957488|452102855|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
125675837|NCT01957488|452102856|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
125675838|NCT01957488|452102857|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
125675839|NCT01957488|452102852|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
125675840|NCT01957488|452102853|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
125675841|NCT01957488|452102854|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
125675842|NCT01957488|452102855|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
125675843|NCT01957488|452102856|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
125675844|NCT01957488|452102857|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
125675845|NCT01957488|452102852|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
125675846|NCT01957488|452102853|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
125675847|NCT01957488|452102854|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
125675848|NCT01957488|452102855|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
125675849|NCT01957488|452102856|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
125675850|NCT01957488|452102857|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
125675851|NCT01957488|452102852|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
125675852|NCT01957488|452102853|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
125675853|NCT01957488|452102854|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
125675854|NCT01957488|452102855|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
125675855|NCT01957488|452102856|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
125675856|NCT01957488|452102857|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
125675857|NCT01957488|452102852|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
125675858|NCT01957488|452102853|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
125675859|NCT01957488|452102854|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
125675860|NCT01957488|452102855|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
125342874|NCT01185353|450888828|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
125342875|NCT01185353|450888819|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125342876|NCT01185353|450888820|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125675861|NCT01957488|452102856|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
125675862|NCT01957488|452102857|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
125675863|NCT01439165|452102859|FG000|Overall Study|Protocol Violation|3|||
125675864|NCT01439165|452102860|FG001|Overall Study|Protocol Violation|0|||
125675865|NCT01439165|452102859|FG000|Overall Study|Lost to Follow-up|11|||
125675866|NCT01439165|452102860|FG001|Overall Study|Lost to Follow-up|1|||
125342877|NCT01185353|450888821|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125342878|NCT01185353|450888822|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125342879|NCT01185353|450888823|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125342880|NCT01185353|450888824|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125342881|NCT01185353|450888825|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
125342882|NCT01185353|450888826|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
125342883|NCT01185353|450888827|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
125342884|NCT01185353|450888828|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
125342885|NCT01185353|450888819|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125342886|NCT01185353|450888820|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125342887|NCT01185353|450888821|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125342888|NCT01185353|450888822|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125342889|NCT01185353|450888823|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125342890|NCT01185353|450888824|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125342891|NCT01185353|450888825|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125342892|NCT01185353|450888826|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
125342893|NCT01185353|450888827|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
125342894|NCT01185353|450888828|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
125342895|NCT02270944|450888829|FG000|Overall Study|Lost to Follow-up|9|||
125342896|NCT02270944|450888830|FG001|Overall Study|Lost to Follow-up|4|||
125342897|NCT02270944|450888829|FG000|Overall Study|Withdrawal by Subject|2|||
125342898|NCT02270944|450888830|FG001|Overall Study|Withdrawal by Subject|1|||
125342899|NCT00095147|450888831|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
125342900|NCT00095147|450888832|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
125342901|NCT00095147|450888833|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
125342902|NCT00095147|450888834|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
125342903|NCT00095147|450888835|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
125342904|NCT00095147|450888831|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
125342905|NCT00095147|450888832|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
125342906|NCT00095147|450888833|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
125675867|NCT01439165|452102859|FG000|Overall Study|Withdrawal by Subject|7|||
125675868|NCT01439165|452102860|FG001|Overall Study|Withdrawal by Subject|1|||
125675869|NCT00623103|452102861|FG000|Overall Study|Adverse Event|70|||
125675870|NCT00623103|452102862|FG001|Overall Study|Adverse Event|60|||
125675871|NCT00623103|452102861|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125675872|NCT00623103|452102862|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
125675873|NCT00623103|452102861|FG000|Overall Study|Withdrawal by Subject|18|||
125675874|NCT00623103|452102862|FG001|Overall Study|Withdrawal by Subject|24|||
125675875|NCT00623103|452102861|FG000|Overall Study|Lost to Follow-up|4|||
125675876|NCT00623103|452102862|FG001|Overall Study|Lost to Follow-up|1|||
125675877|NCT00623103|452102861|FG000|Overall Study|Administrative problems|2|||
125675878|NCT00623103|452102862|FG001|Overall Study|Administrative problems|4|||
125675879|NCT00623103|452102861|FG000|Overall Study|Death|11|||
125675880|NCT00623103|452102862|FG001|Overall Study|Death|11|||
125675881|NCT00623103|452102861|FG000|Overall Study|Protocol deviation|2|||
125675882|NCT00623103|452102862|FG001|Overall Study|Protocol deviation|1|||
125675883|NCT00688064|452102864|FG000|Overall Study|Protocol Violation|0|||
125675884|NCT00688064|452102865|FG001|Overall Study|Protocol Violation|1|||
125675885|NCT00688064|452102864|FG000|Overall Study|Adverse Event|2|||
125675886|NCT00688064|452102865|FG001|Overall Study|Adverse Event|4|||
125675887|NCT00688064|452102864|FG000|Overall Study|Withdrawal by Subject|7|||
125675888|NCT00688064|452102865|FG001|Overall Study|Withdrawal by Subject|7|||
125675889|NCT00688064|452102864|FG000|Overall Study|Lost to Follow-up|10|||
125675890|NCT00688064|452102865|FG001|Overall Study|Lost to Follow-up|10|||
125342907|NCT00095147|450888834|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
125342908|NCT00095147|450888835|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
125342909|NCT00095147|450888831|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
125342910|NCT00095147|450888832|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
125342911|NCT00095147|450888833|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
125342912|NCT00095147|450888834|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
125342913|NCT00095147|450888835|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
125342914|NCT00095147|450888831|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
125342915|NCT00095147|450888832|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
125342916|NCT00095147|450888833|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
125342917|NCT00095147|450888834|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
125342918|NCT00095147|450888835|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
125342919|NCT00095147|450888831|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
125342920|NCT00095147|450888832|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
125342921|NCT00095147|450888833|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
125342922|NCT00095147|450888834|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
125342923|NCT00095147|450888835|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
125342924|NCT00095147|450888831|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
125342925|NCT00095147|450888832|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
125342926|NCT00095147|450888833|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
125342927|NCT00095147|450888834|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
125342928|NCT00095147|450888835|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
125342929|NCT00095147|450888831|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
125342930|NCT00095147|450888832|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
125342931|NCT00095147|450888833|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
125342932|NCT00095147|450888834|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
125342933|NCT00095147|450888835|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
125342934|NCT00095147|450888831|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
125342935|NCT00095147|450888832|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
125342936|NCT00095147|450888833|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
125342937|NCT00095147|450888834|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
125342938|NCT00095147|450888835|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
125342939|NCT00095147|450888831|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
125342940|NCT00095147|450888832|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
125342941|NCT00095147|450888833|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
125342942|NCT00095147|450888834|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
125342943|NCT00095147|450888835|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
125342944|NCT00095147|450888831|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
125342945|NCT00095147|450888832|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
125342946|NCT00095147|450888833|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
125342947|NCT00095147|450888834|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
125342948|NCT00095147|450888835|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
125675891|NCT00688064|452102864|FG000|Overall Study|Lack of Efficacy|0|||
125675892|NCT00688064|452102865|FG001|Overall Study|Lack of Efficacy|1|||
125675893|NCT00688064|452102864|FG000|Overall Study|Pregnancy|1|||
125675894|NCT00688064|452102865|FG001|Overall Study|Pregnancy|0|||
125675895|NCT00688064|452102864|FG000|Overall Study|Any other reasons|1|||
125675896|NCT00688064|452102865|FG001|Overall Study|Any other reasons|3|||
125675897|NCT00001849|452102866|FG000|Overall Study|Death|4|||
125675898|NCT00001849|452102866|FG000|Overall Study|Lost to Follow-up|2|||
125675899|NCT00001849|452102866|FG000|Overall Study|Withdrawal by Subject|2|||
125675900|NCT00001849|452102866|FG000|Overall Study|tumor remained occult|6|||
125675901|NCT00442936|452102867|FG000|Overall Study|Protocol Violation|1|||
125675902|NCT00442936|452102868|FG001|Overall Study|Protocol Violation|0|||
125675903|NCT00442936|452102869|FG002|Overall Study|Protocol Violation|1|||
125675904|NCT00442936|452102870|FG003|Overall Study|Protocol Violation|1|||
125675905|NCT02433678|452102872|FG000|Overall Study|Lost to Follow-up|1|||
125675906|NCT02433678|452102873|FG001|Overall Study|Lost to Follow-up|2|||
125675907|NCT01506947|452102877|FG000|Overall Study|Lost to Follow-up|7|||
125675908|NCT01506947|452102877|FG000|Overall Study|Adverse Event|5|||
125675909|NCT01506947|452102877|FG000|Overall Study|Death|1|||
125675910|NCT01506947|452102877|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
125675911|NCT01700621|452102878|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
125675912|NCT01700621|452102879|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
125675913|NCT01700621|452102878|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
125675914|NCT01700621|452102879|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
125675915|NCT01700621|452102878|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
125675916|NCT01700621|452102879|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
125675917|NCT02166697|452102880|FG000|Overall Study|Protocol Violation|347|||
125675918|NCT01618266|452102886|FG000|Overall Study|Lost to Follow-up|9|||
125675919|NCT01618266|452102886|FG000|Overall Study|Treatment satisfaction|10|||
125675920|NCT01618266|452102886|FG000|Overall Study|Other reasons|11|||
125675921|NCT01618266|452102886|FG000|Overall Study|Lack of Efficacy|23|||
125675922|NCT01618266|452102886|FG000|Overall Study|Protocol Violation|43|||
125675923|NCT02187042|452102887|FG000|Overall Study|Death|1|||
125675924|NCT02187042|452102888|FG001|Overall Study|Death|1|||
125675925|NCT02187042|452102887|FG000|Overall Study|Toxicity|6|||
125675926|NCT02187042|452102888|FG001|Overall Study|Toxicity|5|||
125675927|NCT02187042|452102887|FG000|Overall Study|Participant choice|1|||
125675928|NCT02187042|452102888|FG001|Overall Study|Participant choice|0|||
125675929|NCT02187042|452102887|FG000|Overall Study|Doctor choice|1|||
125675930|NCT02187042|452102888|FG001|Overall Study|Doctor choice|0|||
125675931|NCT02187042|452102887|FG000|Overall Study|Progressive disease|4|||
125675932|NCT02187042|452102888|FG001|Overall Study|Progressive disease|8|||
125342949|NCT00095147|450888831|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
125675933|NCT00536575|452102890|FG000|Overall Study|Withdrawal by Subject|1|||
125675934|NCT00536575|452102890|FG000|Overall Study|Death|1|||
125675935|NCT01626079|452102891|FG000|Overall Study|Death|167|||
125675936|NCT01626079|452102892|FG001|Overall Study|Death|192|||
125675937|NCT01626079|452102893|FG002|Overall Study|Death|39|||
125675938|NCT01626079|452102891|FG000|Overall Study|Withdrawal by Subject|23|||
125675939|NCT01626079|452102892|FG001|Overall Study|Withdrawal by Subject|37|||
125675940|NCT01626079|452102893|FG002|Overall Study|Withdrawal by Subject|5|||
125675941|NCT01626079|452102891|FG000|Overall Study|Lost to Follow-up|7|||
125675942|NCT01626079|452102892|FG001|Overall Study|Lost to Follow-up|4|||
125342950|NCT00095147|450888832|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
125675943|NCT01626079|452102893|FG002|Overall Study|Lost to Follow-up|2|||
125675944|NCT01626079|452102891|FG000|Overall Study|Missed Visits|1|||
125675945|NCT01626079|452102892|FG001|Overall Study|Missed Visits|4|||
125675946|NCT01626079|452102893|FG002|Overall Study|Missed Visits|6|||
125675947|NCT01457053|452102895|FG000|Overall Study|Unable to undergo selected treatment|1|||
125675948|NCT01457053|452102896|FG001|Overall Study|Unable to undergo selected treatment|1|||
125675949|NCT00788957|452102899|FG000|Part 1|Death|8|||
125675950|NCT00788957|452102900|FG001|Part 1|Death|0|||
125675951|NCT00788957|452102901|FG002|Part 1|Death|0|||
125675952|NCT00788957|452102902|FG003|Part 1|Death|0|||
125675953|NCT00788957|452102903|FG004|Part 1|Death|0|||
125675954|NCT00788957|452102904|FG005|Part 1|Death|0|||
125675955|NCT00788957|452102899|FG000|Part 1|Lost to Follow-up|1|||
125675956|NCT00788957|452102900|FG001|Part 1|Lost to Follow-up|0|||
125675957|NCT00788957|452102901|FG002|Part 1|Lost to Follow-up|0|||
125675958|NCT00788957|452102902|FG003|Part 1|Lost to Follow-up|0|||
125675959|NCT00788957|452102903|FG004|Part 1|Lost to Follow-up|0|||
125675960|NCT00788957|452102904|FG005|Part 1|Lost to Follow-up|0|||
125675961|NCT00788957|452102899|FG000|Part 2|Withdrawal by Subject|0|||
125675962|NCT00788957|452102900|FG001|Part 2|Withdrawal by Subject|9|||
125675963|NCT00788957|452102901|FG002|Part 2|Withdrawal by Subject|5|||
125675964|NCT00788957|452102902|FG003|Part 2|Withdrawal by Subject|3|||
125675965|NCT00788957|452102903|FG004|Part 2|Withdrawal by Subject|0|||
125675966|NCT00788957|452102904|FG005|Part 2|Withdrawal by Subject|0|||
125675967|NCT00788957|452102899|FG000|Part 2|Death|0|||
125675968|NCT00788957|452102900|FG001|Part 2|Death|32|||
125675969|NCT00788957|452102901|FG002|Part 2|Death|35|||
125675970|NCT00788957|452102902|FG003|Part 2|Death|37|||
125675971|NCT00788957|452102903|FG004|Part 2|Death|0|||
125675972|NCT00788957|452102904|FG005|Part 2|Death|0|||
125675973|NCT00788957|452102899|FG000|Part 2|Lost to Follow-up|0|||
125675974|NCT00788957|452102900|FG001|Part 2|Lost to Follow-up|0|||
125675975|NCT00788957|452102901|FG002|Part 2|Lost to Follow-up|3|||
125675976|NCT00788957|452102902|FG003|Part 2|Lost to Follow-up|0|||
125675977|NCT00788957|452102903|FG004|Part 2|Lost to Follow-up|0|||
125675978|NCT00788957|452102904|FG005|Part 2|Lost to Follow-up|0|||
125675979|NCT00788957|452102899|FG000|Part 2|On-study at time of data cut-off|0|||
125675980|NCT00788957|452102900|FG001|Part 2|On-study at time of data cut-off|1|||
125675981|NCT00788957|452102901|FG002|Part 2|On-study at time of data cut-off|1|||
125675982|NCT00788957|452102902|FG003|Part 2|On-study at time of data cut-off|1|||
125675983|NCT00788957|452102903|FG004|Part 2|On-study at time of data cut-off|0|||
125675984|NCT00788957|452102904|FG005|Part 2|On-study at time of data cut-off|0|||
125675985|NCT00788957|452102899|FG000|Part 3|Withdrawal by Subject|0|||
125675986|NCT00788957|452102900|FG001|Part 3|Withdrawal by Subject|0|||
125675987|NCT00788957|452102901|FG002|Part 3|Withdrawal by Subject|0|||
125675988|NCT00788957|452102902|FG003|Part 3|Withdrawal by Subject|0|||
125675989|NCT00788957|452102903|FG004|Part 3|Withdrawal by Subject|0|||
125675990|NCT00788957|452102904|FG005|Part 3|Withdrawal by Subject|2|||
125675991|NCT00788957|452102899|FG000|Part 3|Death|0|||
125675992|NCT00788957|452102900|FG001|Part 3|Death|0|||
125675993|NCT00788957|452102901|FG002|Part 3|Death|0|||
125675994|NCT00788957|452102902|FG003|Part 3|Death|0|||
125675995|NCT00788957|452102903|FG004|Part 3|Death|8|||
125675996|NCT00788957|452102904|FG005|Part 3|Death|8|||
125675997|NCT00788957|452102899|FG000|Part 3|On-study at time of data cut-off|0|||
125675998|NCT00788957|452102900|FG001|Part 3|On-study at time of data cut-off|0|||
125675999|NCT00788957|452102901|FG002|Part 3|On-study at time of data cut-off|0|||
125676000|NCT00788957|452102902|FG003|Part 3|On-study at time of data cut-off|0|||
125676001|NCT00788957|452102903|FG004|Part 3|On-study at time of data cut-off|1|||
125676002|NCT00788957|452102904|FG005|Part 3|On-study at time of data cut-off|0|||
125676003|NCT03387098|452102905|FG000|Overall Study|progressive disease|1|||
125676004|NCT03387098|452102905|FG000|Overall Study|Withdrawal by Subject|2|||
125676005|NCT03387098|452102905|FG000|Overall Study|study terminated by sponsor|1|||
125676006|NCT03276975|452102906|FG000|Overall Study|Withdrawal by Subject|1|||
125676007|NCT03276975|452102907|FG001|Overall Study|Withdrawal by Subject|0|||
125676008|NCT00918567|452102908|FG000|Overall Study|Lack of Efficacy|3|||
125676009|NCT00918567|452102909|FG001|Overall Study|Lack of Efficacy|1|||
125676010|NCT00918567|452102908|FG000|Overall Study|Withdrawal by Subject|1|||
125676011|NCT00918567|452102909|FG001|Overall Study|Withdrawal by Subject|1|||
125676012|NCT00918567|452102908|FG000|Overall Study|Adverse Event|1|||
125676013|NCT00918567|452102909|FG001|Overall Study|Adverse Event|0|||
125676014|NCT02568384|452102910|FG000|Overall Study|Mobile devices incompatible with App|2|||
125676015|NCT03283709|452102921|FG000|Overall Study|trial terminated|0|||
125676016|NCT03283709|452102922|FG001|Overall Study|trial terminated|1|||
125676017|NCT00796510|452102923|FG000|Overall Study|Death|1|||
125676018|NCT00796510|452102924|FG001|Overall Study|Death|0|||
125676019|NCT00796510|452102923|FG000|Overall Study|Study Terminated|2|||
125676020|NCT00796510|452102924|FG001|Overall Study|Study Terminated|0|||
125676021|NCT02799602|452102925|FG000|Overall Study|Protocol Violation|1|||
125676022|NCT02799602|452102926|FG001|Overall Study|Protocol Violation|0|||
125676023|NCT02799602|452102925|FG000|Overall Study|Physician Decision|5|||
125676024|NCT02799602|452102926|FG001|Overall Study|Physician Decision|6|||
125676025|NCT02799602|452102925|FG000|Overall Study|Lost to Follow-up|4|||
125676026|NCT02799602|452102926|FG001|Overall Study|Lost to Follow-up|2|||
125676027|NCT02799602|452102925|FG000|Overall Study|Additional primary malignancy|11|||
125676028|NCT02799602|452102926|FG001|Overall Study|Additional primary malignancy|6|||
125676029|NCT02799602|452102925|FG000|Overall Study|Non-compliance with study drug|14|||
125676030|NCT02799602|452102926|FG001|Overall Study|Non-compliance with study drug|12|||
125676031|NCT02799602|452102925|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
125676032|NCT02799602|452102926|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
125676033|NCT02799602|452102925|FG000|Overall Study|Withdrawal by Subject|26|||
125676034|NCT02799602|452102926|FG001|Overall Study|Withdrawal by Subject|40|||
125676035|NCT02799602|452102925|FG000|Overall Study|Progressive disease - clinical progression|131|||
125676036|NCT02799602|452102926|FG001|Overall Study|Progressive disease - clinical progression|276|||
125676037|NCT02799602|452102925|FG000|Overall Study|Progressive disease - radiological progression|90|||
125676038|NCT02799602|452102926|FG001|Overall Study|Progressive disease - radiological progression|133|||
125676039|NCT02799602|452102925|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
125676040|NCT02799602|452102926|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
125676041|NCT02799602|452102925|FG000|Overall Study|Death|9|||
125676042|NCT02799602|452102926|FG001|Overall Study|Death|5|||
125676043|NCT02799602|452102925|FG000|Overall Study|Other|287|||
125676044|NCT02799602|452102926|FG001|Overall Study|Other|118|||
125676045|NCT02799602|452102925|FG000|Overall Study|Study drug never administered|0|||
125676046|NCT02799602|452102926|FG001|Overall Study|Study drug never administered|3|||
125676047|NCT01734772|452102927|FG000|Overall Study|Adverse Event|1|||
125676048|NCT01734772|452102928|FG001|Overall Study|Adverse Event|2|||
125676049|NCT01734772|452102927|FG000|Overall Study|Withdrawal by Subject|0|||
125676050|NCT01734772|452102928|FG001|Overall Study|Withdrawal by Subject|1|||
125676051|NCT00329602|452102929|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
125676052|NCT00329602|452102930|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
125676053|NCT00329602|452102931|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
125676054|NCT00329602|452102929|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
125676055|NCT00329602|452102930|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
125676056|NCT00329602|452102931|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
125676057|NCT00329602|452102929|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
125676058|NCT00329602|452102930|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
125676059|NCT00329602|452102931|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
125676060|NCT00329602|452102929|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
125676061|NCT00329602|452102930|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
125676062|NCT00329602|452102931|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
125676063|NCT00329602|452102929|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
125676064|NCT00329602|452102930|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
125676065|NCT00329602|452102931|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
125676066|NCT00329602|452102929|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
125676067|NCT00329602|452102930|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
125676068|NCT00329602|452102931|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
125676069|NCT02097121|452102934|FG000|Overall Study|Other, not specified|4|||
125676070|NCT02097121|452102935|FG001|Overall Study|Other, not specified|2|||
125676071|NCT02097121|452102936|FG002|Overall Study|Other, not specified|3|||
125676072|NCT02097121|452102934|FG000|Overall Study|Lack of Efficacy|2|||
125676073|NCT02097121|452102935|FG001|Overall Study|Lack of Efficacy|1|||
125676074|NCT02097121|452102936|FG002|Overall Study|Lack of Efficacy|3|||
125676075|NCT02097121|452102934|FG000|Overall Study|Withdrawal by Subject|0|||
125676076|NCT02097121|452102935|FG001|Overall Study|Withdrawal by Subject|1|||
125676077|NCT02097121|452102936|FG002|Overall Study|Withdrawal by Subject|2|||
125676078|NCT02097121|452102934|FG000|Overall Study|Adverse Event|0|||
125676079|NCT02097121|452102935|FG001|Overall Study|Adverse Event|1|||
125676080|NCT02097121|452102936|FG002|Overall Study|Adverse Event|0|||
125676081|NCT02097121|452102934|FG000|Overall Study|Lost to Follow-up|1|||
125676082|NCT02097121|452102935|FG001|Overall Study|Lost to Follow-up|1|||
125676083|NCT02097121|452102936|FG002|Overall Study|Lost to Follow-up|2|||
125676084|NCT03066999|452102937|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
125676085|NCT03066999|452102938|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
125676086|NCT00661999|452102939|FG000|Overall Study|Adverse Event|11|||
125676087|NCT00661999|452102940|FG001|Overall Study|Adverse Event|5|||
125676088|NCT00661999|452102941|FG002|Overall Study|Adverse Event|8|||
125676089|NCT00661999|452102939|FG000|Overall Study|Death|8|||
125676090|NCT00661999|452102940|FG001|Overall Study|Death|6|||
125676091|NCT00661999|452102941|FG002|Overall Study|Death|3|||
125676092|NCT00661999|452102939|FG000|Overall Study|Other Reasons|5|||
125676093|NCT00661999|452102940|FG001|Overall Study|Other Reasons|12|||
125676094|NCT00661999|452102941|FG002|Overall Study|Other Reasons|23|||
125676095|NCT00661999|452102939|FG000|Overall Study|Withdrawal by Subject|30|||
125342951|NCT00095147|450888833|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
125342952|NCT00095147|450888834|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
125342953|NCT00095147|450888835|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
125342954|NCT00095147|450888831|FG000|Long-term Extension Period|Death|0|||
125342955|NCT00095147|450888832|FG001|Long-term Extension Period|Death|0|||
125342956|NCT00095147|450888833|FG002|Long-term Extension Period|Death|0|||
125342957|NCT00095147|450888834|FG003|Long-term Extension Period|Death|0|||
125342958|NCT00095147|450888835|FG004|Long-term Extension Period|Death|3|||
125676096|NCT00661999|452102940|FG001|Overall Study|Withdrawal by Subject|23|||
125676097|NCT00661999|452102941|FG002|Overall Study|Withdrawal by Subject|14|||
125676098|NCT00661999|452102939|FG000|Overall Study|Alternative Treatment|1|||
125676099|NCT00661999|452102940|FG001|Overall Study|Alternative Treatment|0|||
125676100|NCT00661999|452102941|FG002|Overall Study|Alternative Treatment|0|||
125676101|NCT00661999|452102939|FG000|Overall Study|Other Medical Problems|4|||
125676102|NCT00661999|452102940|FG001|Overall Study|Other Medical Problems|4|||
125676103|NCT00661999|452102941|FG002|Overall Study|Other Medical Problems|9|||
125676104|NCT00510510|452102942|FG000|Overall Study|Adverse Event|4|||
125676105|NCT00510510|452102943|FG001|Overall Study|Adverse Event|3|||
125676106|NCT00510510|452102944|FG002|Overall Study|Adverse Event|6|||
125676107|NCT00510510|452102942|FG000|Overall Study|Lack of Efficacy|0|||
125676108|NCT00510510|452102943|FG001|Overall Study|Lack of Efficacy|1|||
125676109|NCT00510510|452102944|FG002|Overall Study|Lack of Efficacy|1|||
125676110|NCT00510510|452102942|FG000|Overall Study|Subjects no longer requires study drug|0|||
125676111|NCT00510510|452102943|FG001|Overall Study|Subjects no longer requires study drug|0|||
125676112|NCT00510510|452102944|FG002|Overall Study|Subjects no longer requires study drug|2|||
125676113|NCT00510510|452102942|FG000|Overall Study|Withdrawal by Subject|1|||
125676114|NCT00510510|452102943|FG001|Overall Study|Withdrawal by Subject|2|||
125676115|NCT00510510|452102944|FG002|Overall Study|Withdrawal by Subject|3|||
125676116|NCT00510510|452102942|FG000|Overall Study|Lost to Follow-up|0|||
125676117|NCT00510510|452102943|FG001|Overall Study|Lost to Follow-up|0|||
125676118|NCT00510510|452102944|FG002|Overall Study|Lost to Follow-up|1|||
125676119|NCT00510510|452102942|FG000|Overall Study|Protocol Violation|0|||
125676120|NCT00510510|452102943|FG001|Overall Study|Protocol Violation|3|||
125676121|NCT00510510|452102944|FG002|Overall Study|Protocol Violation|4|||
125676122|NCT03595657|452102945|FG000|Overall Study|Adverse Event|14|||
125676123|NCT03595657|452102945|FG000|Overall Study|Death|1|||
125676124|NCT03595657|452102945|FG000|Overall Study|Lack of Efficacy|40|||
125676125|NCT03595657|452102945|FG000|Overall Study|Withdrawal by Subject|10|||
125676126|NCT03595657|452102945|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
125676127|NCT03595657|452102945|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
125676128|NCT03481309|452102949|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
125676129|NCT03481309|452102950|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
125676130|NCT03481309|452102951|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
125676131|NCT03481309|452102952|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
125676132|NCT03481309|452102953|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
125676133|NCT03481309|452102954|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
125676134|NCT03495869|452102955|FG000|Overall Study|Lost to Follow-up|4|||
125676135|NCT03495869|452102956|FG001|Overall Study|Lost to Follow-up|17|||
125676136|NCT03495869|452102957|FG002|Overall Study|Lost to Follow-up|8|||
125676137|NCT03495869|452102958|FG003|Overall Study|Lost to Follow-up|14|||
125676138|NCT03495869|452102955|FG000|Overall Study|Withdrawal by Subject|0|||
125676139|NCT03495869|452102956|FG001|Overall Study|Withdrawal by Subject|3|||
125676140|NCT03495869|452102957|FG002|Overall Study|Withdrawal by Subject|0|||
125676141|NCT03495869|452102958|FG003|Overall Study|Withdrawal by Subject|3|||
125676142|NCT03495869|452102955|FG000|Overall Study|Dropped from study|0|||
125676143|NCT03495869|452102956|FG001|Overall Study|Dropped from study|7|||
125676144|NCT03495869|452102957|FG002|Overall Study|Dropped from study|2|||
125676145|NCT03495869|452102958|FG003|Overall Study|Dropped from study|4|||
125676146|NCT02346201|452102959|FG000|Overall Study|Adverse Event|3|||
125676147|NCT02346201|452102960|FG001|Overall Study|Adverse Event|2|||
125676148|NCT02346201|452102959|FG000|Overall Study|Lost to Follow-up|1|||
125676149|NCT02346201|452102960|FG001|Overall Study|Lost to Follow-up|0|||
125676150|NCT02346201|452102959|FG000|Overall Study|Withdrawal by Subject|6|||
125676151|NCT02346201|452102960|FG001|Overall Study|Withdrawal by Subject|3|||
125676152|NCT02346201|452102959|FG000|Overall Study|Unavailable for future follow-up|0|||
125676153|NCT02346201|452102960|FG001|Overall Study|Unavailable for future follow-up|1|||
125676154|NCT02346201|452102959|FG000|Overall Study|Physician Decision|0|||
125676155|NCT02346201|452102960|FG001|Overall Study|Physician Decision|1|||
125676156|NCT02346201|452102959|FG000|Overall Study|Missed final visit|0|||
125676157|NCT02346201|452102960|FG001|Overall Study|Missed final visit|2|||
125676158|NCT03708211|452102961|FG000|Overall Study|Progressive Disease|10|||
125676159|NCT03708211|452102962|FG001|Overall Study|Progressive Disease|7|||
125676160|NCT03708211|452102961|FG000|Overall Study|Withdrawal by Subject|0|||
125676161|NCT03708211|452102962|FG001|Overall Study|Withdrawal by Subject|1|||
125676162|NCT03708211|452102961|FG000|Overall Study|Other|2|||
125676163|NCT03708211|452102962|FG001|Overall Study|Other|0|||
125342959|NCT00095147|450888831|FG000|Long-term Extension Period|Adverse Event|0|||
125342960|NCT00095147|450888832|FG001|Long-term Extension Period|Adverse Event|0|||
125342961|NCT00095147|450888833|FG002|Long-term Extension Period|Adverse Event|0|||
125342962|NCT00095147|450888834|FG003|Long-term Extension Period|Adverse Event|0|||
125342963|NCT00095147|450888835|FG004|Long-term Extension Period|Adverse Event|11|||
125342964|NCT00095147|450888831|FG000|Long-term Extension Period|Lack of Efficacy|0|||
125342965|NCT00095147|450888832|FG001|Long-term Extension Period|Lack of Efficacy|0|||
125342966|NCT00095147|450888833|FG002|Long-term Extension Period|Lack of Efficacy|0|||
125342967|NCT00095147|450888834|FG003|Long-term Extension Period|Lack of Efficacy|0|||
125342968|NCT00095147|450888835|FG004|Long-term Extension Period|Lack of Efficacy|9|||
125342969|NCT00095147|450888831|FG000|Long-term Extension Period|Lost to Follow-up|0|||
125342970|NCT00095147|450888832|FG001|Long-term Extension Period|Lost to Follow-up|0|||
125342971|NCT00095147|450888833|FG002|Long-term Extension Period|Lost to Follow-up|0|||
125342972|NCT00095147|450888834|FG003|Long-term Extension Period|Lost to Follow-up|0|||
125342973|NCT00095147|450888835|FG004|Long-term Extension Period|Lost to Follow-up|6|||
125342974|NCT00095147|450888831|FG000|Long-term Extension Period|Withdrawal of consent|0|||
125342975|NCT00095147|450888832|FG001|Long-term Extension Period|Withdrawal of consent|0|||
125342976|NCT00095147|450888833|FG002|Long-term Extension Period|Withdrawal of consent|0|||
125342977|NCT00095147|450888834|FG003|Long-term Extension Period|Withdrawal of consent|0|||
125342978|NCT00095147|450888835|FG004|Long-term Extension Period|Withdrawal of consent|12|||
125342979|NCT00095147|450888831|FG000|Long-term Extension Period|Pregnancy|0|||
125342980|NCT00095147|450888832|FG001|Long-term Extension Period|Pregnancy|0|||
125342981|NCT00095147|450888833|FG002|Long-term Extension Period|Pregnancy|0|||
125342982|NCT00095147|450888834|FG003|Long-term Extension Period|Pregnancy|0|||
125342983|NCT00095147|450888835|FG004|Long-term Extension Period|Pregnancy|1|||
125342984|NCT00095147|450888831|FG000|Long-term Extension Period|No longer meets study criteria|0|||
125342985|NCT00095147|450888832|FG001|Long-term Extension Period|No longer meets study criteria|0|||
125342986|NCT00095147|450888833|FG002|Long-term Extension Period|No longer meets study criteria|0|||
125342987|NCT00095147|450888834|FG003|Long-term Extension Period|No longer meets study criteria|0|||
125342988|NCT00095147|450888835|FG004|Long-term Extension Period|No longer meets study criteria|1|||
125342989|NCT00095147|450888831|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
125342990|NCT00095147|450888832|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
125342991|NCT00095147|450888833|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
125342992|NCT00095147|450888834|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
125342993|NCT00095147|450888835|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
125342994|NCT00095147|450888831|FG000|Long-term Extension Period|Leaving country|0|||
125342995|NCT00095147|450888832|FG001|Long-term Extension Period|Leaving country|0|||
125342996|NCT00095147|450888833|FG002|Long-term Extension Period|Leaving country|0|||
125342997|NCT00095147|450888834|FG003|Long-term Extension Period|Leaving country|0|||
125342998|NCT00095147|450888835|FG004|Long-term Extension Period|Leaving country|1|||
125342999|NCT01375075|450888838|FG000|Overall Study|Adverse Event|0|||
125343000|NCT01375075|450888839|FG001|Overall Study|Adverse Event|0|||
125343001|NCT01375075|450888840|FG002|Overall Study|Adverse Event|3|||
125343002|NCT01375075|450888841|FG003|Overall Study|Adverse Event|1|||
125676164|NCT01508936|452102963|FG000|Overall Study|Adverse Event|11|||
125676165|NCT01508936|452102964|FG001|Overall Study|Adverse Event|32|||
125676166|NCT01508936|452102963|FG000|Overall Study|Lack of Efficacy|0|||
125676167|NCT01508936|452102964|FG001|Overall Study|Lack of Efficacy|1|||
125676168|NCT01508936|452102963|FG000|Overall Study|Withdrawal by Subject|4|||
125676169|NCT01508936|452102964|FG001|Overall Study|Withdrawal by Subject|18|||
125676170|NCT01508936|452102963|FG000|Overall Study|Protocol Violation|2|||
125676171|NCT01508936|452102964|FG001|Overall Study|Protocol Violation|3|||
125676172|NCT01508936|452102963|FG000|Overall Study|Lost to Follow-up|2|||
125676173|NCT01508936|452102964|FG001|Overall Study|Lost to Follow-up|9|||
125676174|NCT01508936|452102963|FG000|Overall Study|Other|0|||
125676175|NCT01508936|452102964|FG001|Overall Study|Other|5|||
125676176|NCT01508936|452102963|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
125676177|NCT01508936|452102964|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
125676178|NCT00462982|452102965|FG000|Overall Study|Adverse Event|1|||
125676179|NCT00462982|452102965|FG000|Overall Study|Patient Not Treated|2|||
125676180|NCT00679367|452102966|FG000|Overall Study|Adverse Event|7|||
125676181|NCT00679367|452102966|FG000|Overall Study|inability to swallow oral drugs|1|||
125676182|NCT00679367|452102966|FG000|Overall Study|Lack of Efficacy|3|||
125676183|NCT00679367|452102966|FG000|Overall Study|Withdrawal by Subject|1|||
125343003|NCT01375075|450888842|FG004|Overall Study|Adverse Event|0|||
125343004|NCT01375075|450888843|FG005|Overall Study|Adverse Event|1|||
125343005|NCT01375075|450888838|FG000|Overall Study|Entry Criterion Not Met|1|||
125676184|NCT02109133|452102967|FG000|Overall Study|Lost to Follow-up|1|||
125676185|NCT02109133|452102968|FG001|Overall Study|Lost to Follow-up|0|||
125676186|NCT00409578|452102969|FG000|Overall Study|Adverse Event|27|||
125676187|NCT00409578|452102970|FG001|Overall Study|Adverse Event|37|||
125676188|NCT00409578|452102971|FG002|Overall Study|Adverse Event|25|||
125676189|NCT00409578|452102972|FG003|Overall Study|Adverse Event|33|||
125676190|NCT00409578|452102969|FG000|Overall Study|Abnormal laboratory value(s)|2|||
125343006|NCT01375075|450888839|FG001|Overall Study|Entry Criterion Not Met|0|||
125343007|NCT01375075|450888840|FG002|Overall Study|Entry Criterion Not Met|0|||
125343008|NCT01375075|450888841|FG003|Overall Study|Entry Criterion Not Met|0|||
125343009|NCT01375075|450888842|FG004|Overall Study|Entry Criterion Not Met|0|||
125343010|NCT01375075|450888843|FG005|Overall Study|Entry Criterion Not Met|1|||
125343011|NCT01375075|450888838|FG000|Overall Study|Withdrawal by Subject|0|||
125343012|NCT01375075|450888839|FG001|Overall Study|Withdrawal by Subject|1|||
125343013|NCT01375075|450888840|FG002|Overall Study|Withdrawal by Subject|0|||
125343014|NCT01375075|450888841|FG003|Overall Study|Withdrawal by Subject|0|||
125343015|NCT01375075|450888842|FG004|Overall Study|Withdrawal by Subject|0|||
125343016|NCT01375075|450888843|FG005|Overall Study|Withdrawal by Subject|1|||
125343017|NCT01011309|450888844|FG000|Overall Study|Adverse Event|2|||
125343018|NCT01011309|450888845|FG001|Overall Study|Adverse Event|1|||
125343019|NCT01011309|450888846|FG002|Overall Study|Adverse Event|2|||
125343020|NCT01011309|450888844|FG000|Overall Study|Lack of Efficacy|0|||
125343021|NCT01011309|450888845|FG001|Overall Study|Lack of Efficacy|1|||
125343022|NCT01011309|450888846|FG002|Overall Study|Lack of Efficacy|0|||
125343023|NCT01011309|450888844|FG000|Overall Study|Protocol Violation|0|||
125343024|NCT01011309|450888845|FG001|Overall Study|Protocol Violation|1|||
125343025|NCT01011309|450888846|FG002|Overall Study|Protocol Violation|3|||
125343026|NCT03472547|450888855|FG000|Overall Study|Withdrawal by Subject|30|||
125343027|NCT04236141|450890437|FG000|Overall Study|Death|18|||
125343028|NCT04236141|450890438|FG001|Overall Study|Death|10|||
125343029|NCT04236141|450890437|FG000|Overall Study|Withdrawal by Participant|1|||
125343030|NCT04236141|450890438|FG001|Overall Study|Withdrawal by Participant|0|||
125343031|NCT04236141|450890437|FG000|Overall Study|Reason not Specified|1|||
125343032|NCT04236141|450890438|FG001|Overall Study|Reason not Specified|0|||
125343033|NCT04236141|450890437|FG000|Overall Study|Study terminated by Sponsor|8|||
125343034|NCT04236141|450890438|FG001|Overall Study|Study terminated by Sponsor|4|||
125343035|NCT01031836|450890439|FG000|Stage I|Adverse Event|1|||
125343036|NCT01031836|450890440|FG001|Stage I|Adverse Event|1|||
125343037|NCT01031836|450890441|FG002|Stage I|Adverse Event|0|||
125343038|NCT01031836|450890442|FG003|Stage I|Adverse Event|0|||
125343039|NCT01031836|450890443|FG004|Stage I|Adverse Event|0|||
125343040|NCT01031836|450890444|FG005|Stage I|Adverse Event|0|||
125343041|NCT01031836|450890439|FG000|Stage I|Other|0|||
125343042|NCT01031836|450890440|FG001|Stage I|Other|1|||
125343043|NCT01031836|450890441|FG002|Stage I|Other|0|||
125343044|NCT01031836|450890442|FG003|Stage I|Other|0|||
125343045|NCT01031836|450890443|FG004|Stage I|Other|0|||
125676191|NCT00409578|452102970|FG001|Overall Study|Abnormal laboratory value(s)|2|||
125676192|NCT00409578|452102971|FG002|Overall Study|Abnormal laboratory value(s)|2|||
125676193|NCT00409578|452102972|FG003|Overall Study|Abnormal laboratory value(s)|4|||
125343046|NCT01031836|450890444|FG005|Stage I|Other|1|||
125343047|NCT01031836|450890439|FG000|Stage II|Adverse Event|0|||
125343048|NCT01031836|450890440|FG001|Stage II|Adverse Event|0|||
125343049|NCT01031836|450890441|FG002|Stage II|Adverse Event|2|||
125343050|NCT01031836|450890442|FG003|Stage II|Adverse Event|2|||
125343051|NCT01031836|450890443|FG004|Stage II|Adverse Event|1|||
125343052|NCT01031836|450890444|FG005|Stage II|Adverse Event|1|||
125343053|NCT01031836|450890439|FG000|Stage II|Other|2|||
125343054|NCT01031836|450890440|FG001|Stage II|Other|0|||
125343055|NCT01031836|450890441|FG002|Stage II|Other|0|||
125343056|NCT01031836|450890442|FG003|Stage II|Other|1|||
125343057|NCT01031836|450890443|FG004|Stage II|Other|1|||
125343058|NCT01031836|450890444|FG005|Stage II|Other|0|||
125343059|NCT01948193|450890445|FG000|Overall Study|Serious event|2|||
125343060|NCT01948193|450890445|FG000|Overall Study|Lost to Follow-up|7|||
125343061|NCT03137069|450890447|FG000|Overall Study|Withdrawal by Subject|1|||
125343062|NCT03137069|450890448|FG001|Overall Study|Withdrawal by Subject|2|||
125343063|NCT03137069|450890449|FG002|Overall Study|Withdrawal by Subject|2|||
125676194|NCT00409578|452102969|FG000|Overall Study|Lack of Efficacy|0|||
125676195|NCT00409578|452102970|FG001|Overall Study|Lack of Efficacy|0|||
125676196|NCT00409578|452102971|FG002|Overall Study|Lack of Efficacy|0|||
125676197|NCT00409578|452102972|FG003|Overall Study|Lack of Efficacy|2|||
125676198|NCT00409578|452102969|FG000|Overall Study|Subject no longer requires study drug|0|||
125676199|NCT00409578|452102970|FG001|Overall Study|Subject no longer requires study drug|0|||
125676200|NCT00409578|452102971|FG002|Overall Study|Subject no longer requires study drug|0|||
125676201|NCT00409578|452102972|FG003|Overall Study|Subject no longer requires study drug|1|||
125676202|NCT00409578|452102969|FG000|Overall Study|Withdrawal by Subject|8|||
125676203|NCT00409578|452102970|FG001|Overall Study|Withdrawal by Subject|15|||
125676204|NCT00409578|452102971|FG002|Overall Study|Withdrawal by Subject|16|||
125676205|NCT00409578|452102972|FG003|Overall Study|Withdrawal by Subject|17|||
125676206|NCT00409578|452102969|FG000|Overall Study|Lost to Follow-up|2|||
125676207|NCT00409578|452102970|FG001|Overall Study|Lost to Follow-up|0|||
125676208|NCT00409578|452102971|FG002|Overall Study|Lost to Follow-up|2|||
125676209|NCT00409578|452102972|FG003|Overall Study|Lost to Follow-up|2|||
125676210|NCT00409578|452102969|FG000|Overall Study|Administrative problems|8|||
125676211|NCT00409578|452102970|FG001|Overall Study|Administrative problems|9|||
125676212|NCT00409578|452102971|FG002|Overall Study|Administrative problems|2|||
125676213|NCT00409578|452102972|FG003|Overall Study|Administrative problems|4|||
125676214|NCT00409578|452102969|FG000|Overall Study|Death|2|||
125676215|NCT00409578|452102970|FG001|Overall Study|Death|4|||
125676216|NCT00409578|452102971|FG002|Overall Study|Death|4|||
125676217|NCT00409578|452102972|FG003|Overall Study|Death|2|||
125676218|NCT00409578|452102969|FG000|Overall Study|Protocol Violation|3|||
125676219|NCT00409578|452102970|FG001|Overall Study|Protocol Violation|2|||
125676220|NCT00409578|452102971|FG002|Overall Study|Protocol Violation|3|||
125676221|NCT00409578|452102972|FG003|Overall Study|Protocol Violation|1|||
125676222|NCT00409578|452102969|FG000|Overall Study|Missing|0|||
125676223|NCT00409578|452102970|FG001|Overall Study|Missing|1|||
125676224|NCT00409578|452102971|FG002|Overall Study|Missing|0|||
125676225|NCT00409578|452102972|FG003|Overall Study|Missing|1|||
125676226|NCT00922779|452102973|FG000|Overall Study|Adverse Event|67|||
125676227|NCT00922779|452102973|FG000|Overall Study|Pregnancy|7|||
125676228|NCT00922779|452102973|FG000|Overall Study|Withdrawal by Subject|308|||
125676229|NCT00922779|452102973|FG000|Overall Study|Lost to Follow-up|44|||
125676230|NCT00922779|452102973|FG000|Overall Study|Other|27|||
125676231|NCT00922779|452102973|FG000|Overall Study|Missing|1874|||
125676232|NCT02448771|452102974|FG000|Overall Study|Disease Progression|30|||
125676233|NCT02448771|452102974|FG000|Overall Study|Unacceptable Toxicity|1|||
125676234|NCT02448771|452102974|FG000|Overall Study|Physician Decision|3|||
125676235|NCT02448771|452102974|FG000|Overall Study|Started new therapy|2|||
125676236|NCT02683187|452102975|FG000|Overall Study|Failed IV access|3|||
125676237|NCT02683187|452102975|FG000|Overall Study|Withdrawal by Subject|5|||
125343064|NCT03137069|450890450|FG003|Overall Study|Withdrawal by Subject|2|||
125343065|NCT03137069|450890451|FG004|Overall Study|Withdrawal by Subject|0|||
125343066|NCT03137069|450890452|FG005|Overall Study|Withdrawal by Subject|0|||
125343067|NCT03137069|450890447|FG000|Overall Study|Adverse Event|0|||
125343068|NCT03137069|450890448|FG001|Overall Study|Adverse Event|3|||
125343069|NCT03137069|450890449|FG002|Overall Study|Adverse Event|1|||
125343070|NCT03137069|450890450|FG003|Overall Study|Adverse Event|1|||
125676238|NCT00770315|452102976|FG000|Overall Study|Adverse Event|11|||
125676239|NCT00770315|452102977|FG001|Overall Study|Adverse Event|17|||
125676240|NCT00770315|452102978|FG002|Overall Study|Adverse Event|16|||
125676241|NCT00770315|452102979|FG003|Overall Study|Adverse Event|6|||
125676242|NCT00770315|452102976|FG000|Overall Study|Lost to Follow-up|9|||
125676243|NCT00770315|452102977|FG001|Overall Study|Lost to Follow-up|5|||
125676244|NCT00770315|452102978|FG002|Overall Study|Lost to Follow-up|10|||
125676245|NCT00770315|452102979|FG003|Overall Study|Lost to Follow-up|3|||
125676246|NCT00770315|452102976|FG000|Overall Study|Withdrawal by Subject|13|||
125676247|NCT00770315|452102977|FG001|Overall Study|Withdrawal by Subject|17|||
125676248|NCT00770315|452102978|FG002|Overall Study|Withdrawal by Subject|24|||
125676249|NCT00770315|452102979|FG003|Overall Study|Withdrawal by Subject|20|||
125676250|NCT00770315|452102976|FG000|Overall Study|Noncompliance with Protocol|7|||
125676251|NCT00770315|452102977|FG001|Overall Study|Noncompliance with Protocol|4|||
125676252|NCT00770315|452102978|FG002|Overall Study|Noncompliance with Protocol|7|||
125676253|NCT00770315|452102979|FG003|Overall Study|Noncompliance with Protocol|9|||
125676254|NCT02585258|452102980|FG000|Overall Study|Adverse Event|28|||
125676255|NCT02585258|452102981|FG001|Overall Study|Adverse Event|29|||
125676256|NCT02585258|452102980|FG000|Overall Study|Death|3|||
125676257|NCT02585258|452102981|FG001|Overall Study|Death|2|||
125676258|NCT02585258|452102980|FG000|Overall Study|Lack of Efficacy|7|||
125676259|NCT02585258|452102981|FG001|Overall Study|Lack of Efficacy|9|||
125676260|NCT02585258|452102980|FG000|Overall Study|includes covid-related access problems|42|||
125676261|NCT02585258|452102981|FG001|Overall Study|includes covid-related access problems|46|||
125676262|NCT02585258|452102980|FG000|Overall Study|Lost to Follow-up|5|||
125676263|NCT02585258|452102981|FG001|Overall Study|Lost to Follow-up|2|||
125676264|NCT03702621|452104911|FG000|Overall Study|Physician Decision|6|||
125676265|NCT03702621|452104912|FG001|Overall Study|Physician Decision|6|||
125676266|NCT03194464|452104914|FG000|Overall Study|data not usable|2|||
125676267|NCT03103100|452104915|FG000|Overall Study|Adverse Event|1|||
125676268|NCT03103100|452104916|FG001|Overall Study|Adverse Event|0|||
125676269|NCT03103100|452104917|FG002|Overall Study|Adverse Event|0|||
125676270|NCT03103100|452104915|FG000|Overall Study|Physician Decision|1|||
125676271|NCT03103100|452104916|FG001|Overall Study|Physician Decision|0|||
125676272|NCT03103100|452104917|FG002|Overall Study|Physician Decision|2|||
125676273|NCT00436007|452104920|FG000|Overall Study|Withdrawal by Subject|5|||
125676274|NCT00436007|452104921|FG001|Overall Study|Withdrawal by Subject|3|||
125676275|NCT00436007|452104922|FG002|Overall Study|Withdrawal by Subject|4|||
125343071|NCT03137069|450890451|FG004|Overall Study|Adverse Event|0|||
125343072|NCT03137069|450890452|FG005|Overall Study|Adverse Event|1|||
125676276|NCT00436007|452104920|FG000|Overall Study|Lost to Follow-up|14|||
125676277|NCT00436007|452104921|FG001|Overall Study|Lost to Follow-up|10|||
125676278|NCT00436007|452104922|FG002|Overall Study|Lost to Follow-up|13|||
125676279|NCT00436007|452104920|FG000|Overall Study|Physician Decision|0|||
125343073|NCT03137069|450890447|FG000|Overall Study|Protocol Violation|0|||
125343074|NCT03137069|450890448|FG001|Overall Study|Protocol Violation|1|||
125343075|NCT03137069|450890449|FG002|Overall Study|Protocol Violation|0|||
125343076|NCT03137069|450890450|FG003|Overall Study|Protocol Violation|1|||
125343077|NCT03137069|450890451|FG004|Overall Study|Protocol Violation|1|||
125343078|NCT03137069|450890452|FG005|Overall Study|Protocol Violation|1|||
125343079|NCT03137069|450890447|FG000|Overall Study|Physician Decision|0|||
125343080|NCT03137069|450890448|FG001|Overall Study|Physician Decision|0|||
125343081|NCT03137069|450890449|FG002|Overall Study|Physician Decision|0|||
125343082|NCT03137069|450890450|FG003|Overall Study|Physician Decision|1|||
125343083|NCT03137069|450890451|FG004|Overall Study|Physician Decision|0|||
125343084|NCT03137069|450890452|FG005|Overall Study|Physician Decision|0|||
125343085|NCT03137069|450890447|FG000|Overall Study|Study Terminated by Sponsor|0|||
125343086|NCT03137069|450890448|FG001|Overall Study|Study Terminated by Sponsor|0|||
125343087|NCT03137069|450890449|FG002|Overall Study|Study Terminated by Sponsor|0|||
125343088|NCT03137069|450890450|FG003|Overall Study|Study Terminated by Sponsor|0|||
125343089|NCT03137069|450890451|FG004|Overall Study|Study Terminated by Sponsor|1|||
125343090|NCT03137069|450890452|FG005|Overall Study|Study Terminated by Sponsor|0|||
125343091|NCT03137069|450890447|FG000|Overall Study|Data Entry Error|0|||
125343092|NCT03137069|450890448|FG001|Overall Study|Data Entry Error|0|||
125343093|NCT03137069|450890449|FG002|Overall Study|Data Entry Error|0|||
125343094|NCT03137069|450890450|FG003|Overall Study|Data Entry Error|1|||
125343095|NCT03137069|450890451|FG004|Overall Study|Data Entry Error|0|||
125343096|NCT03137069|450890452|FG005|Overall Study|Data Entry Error|0|||
125343097|NCT02043899|450890454|FG000|Overall Study|Adverse Event|3|||
125343098|NCT02043899|450890454|FG000|Overall Study|Physician Decision|1|||
125343099|NCT02043899|450890454|FG000|Overall Study|Withdrawal by Subject|2|||
125343100|NCT02043899|450890454|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
125343101|NCT02043899|450890454|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
125343102|NCT02043899|450890454|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
125343103|NCT02043899|450890454|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
125676280|NCT00436007|452104921|FG001|Overall Study|Physician Decision|0|||
125676281|NCT00436007|452104922|FG002|Overall Study|Physician Decision|2|||
125676282|NCT00436007|452104920|FG000|Overall Study|Death|0|||
125343104|NCT02043899|450890454|FG000|Overall Study|Treatment delayed|1|||
125343105|NCT01954927|450890456|FG000|Overall Study|Withdrawal by Subject|3|||
125676283|NCT00436007|452104921|FG001|Overall Study|Death|1|||
125676284|NCT00436007|452104922|FG002|Overall Study|Death|3|||
125676285|NCT00436007|452104920|FG000|Overall Study|Other|0|||
125676286|NCT00436007|452104921|FG001|Overall Study|Other|0|||
125676287|NCT00436007|452104922|FG002|Overall Study|Other|1|||
125343106|NCT01954927|450890457|FG001|Overall Study|Withdrawal by Subject|1|||
125343107|NCT03320824|450890458|FG000|Overall Study|Withdrawal by Subject|8|||
125343108|NCT03320824|450890459|FG001|Overall Study|Withdrawal by Subject|1|||
125343109|NCT03320824|450890458|FG000|Overall Study|Lost to Follow-up|10|||
125343110|NCT03320824|450890459|FG001|Overall Study|Lost to Follow-up|1|||
125343111|NCT03320824|450890458|FG000|Overall Study|moved out of state|0|||
125343112|NCT03320824|450890459|FG001|Overall Study|moved out of state|1|||
125343113|NCT03320824|450890458|FG000|Overall Study|could not complete final visit|0|||
125343114|NCT03320824|450890459|FG001|Overall Study|could not complete final visit|1|||
125343115|NCT00955305|450890460|FG000|Overall Study|Disease progression|39|||
125343116|NCT00955305|450890461|FG001|Overall Study|Disease progression|41|||
125343117|NCT00955305|450890460|FG000|Overall Study|Adverse Event|22|||
125676288|NCT00810368|452104923|FG000|Overall Study|Lost to Follow-up|4|||
125676289|NCT00810368|452104924|FG001|Overall Study|Lost to Follow-up|2|||
125676290|NCT00810368|452104923|FG000|Overall Study|Lack of Efficacy|2|||
125343118|NCT00955305|450890461|FG001|Overall Study|Adverse Event|22|||
125343119|NCT00955305|450890460|FG000|Overall Study|Death|2|||
125343120|NCT00955305|450890461|FG001|Overall Study|Death|1|||
125343121|NCT00955305|450890460|FG000|Overall Study|Withdrawal by Subject|5|||
125343122|NCT00955305|450890461|FG001|Overall Study|Withdrawal by Subject|4|||
125343123|NCT00955305|450890460|FG000|Overall Study|Alternative therapy|4|||
125343124|NCT00955305|450890461|FG001|Overall Study|Alternative therapy|0|||
125343125|NCT00955305|450890460|FG000|Overall Study|Other complicating disease|2|||
125343126|NCT00955305|450890461|FG001|Overall Study|Other complicating disease|4|||
125343127|NCT00955305|450890460|FG000|Overall Study|Physician Decision|1|||
125343128|NCT00955305|450890461|FG001|Overall Study|Physician Decision|0|||
125343129|NCT00955305|450890460|FG000|Overall Study|Continued presence of residual disease|0|||
125343130|NCT00955305|450890461|FG001|Overall Study|Continued presence of residual disease|1|||
125676291|NCT00810368|452104924|FG001|Overall Study|Lack of Efficacy|0|||
125343131|NCT00955305|450890460|FG000|Overall Study|Functional decline|2|||
125343132|NCT00955305|450890461|FG001|Overall Study|Functional decline|0|||
125343133|NCT00955305|450890460|FG000|Overall Study|Maximum response achieved|0|||
125343134|NCT00955305|450890461|FG001|Overall Study|Maximum response achieved|1|||
125343135|NCT00955305|450890460|FG000|Overall Study|Lost to Follow-up|0|||
125343136|NCT00955305|450890461|FG001|Overall Study|Lost to Follow-up|1|||
125343137|NCT00955305|450890460|FG000|Overall Study|No off-treatment reason submitted|1|||
125343138|NCT00955305|450890461|FG001|Overall Study|No off-treatment reason submitted|0|||
125343139|NCT00955305|450890460|FG000|Overall Study|Never started protocol treatment|5|||
125343140|NCT00955305|450890461|FG001|Overall Study|Never started protocol treatment|5|||
125343141|NCT00955305|450890460|FG000|Overall Study|Ineligible|5|||
125343142|NCT00955305|450890461|FG001|Overall Study|Ineligible|7|||
125343143|NCT03387111|450890462|FG000|Overall Study|Progressive Disease|3|||
125676292|NCT03331042|452104925|FG000|Overall Study|Protocol Violation|1|||
125676293|NCT03331042|452104926|FG001|Overall Study|Protocol Violation|0|||
125676294|NCT03331042|452104927|FG002|Overall Study|Protocol Violation|0|||
125676295|NCT03331042|452104928|FG003|Overall Study|Protocol Violation|0|||
125676296|NCT03331042|452104925|FG000|Overall Study|Physician Decision|0|||
125676297|NCT03331042|452104926|FG001|Overall Study|Physician Decision|0|||
125676298|NCT03331042|452104927|FG002|Overall Study|Physician Decision|1|||
125676299|NCT03331042|452104928|FG003|Overall Study|Physician Decision|0|||
125676300|NCT03331042|452104925|FG000|Overall Study|Lost to Follow-up|0|||
125676301|NCT03331042|452104926|FG001|Overall Study|Lost to Follow-up|0|||
125676302|NCT03331042|452104927|FG002|Overall Study|Lost to Follow-up|0|||
125676303|NCT03331042|452104928|FG003|Overall Study|Lost to Follow-up|1|||
125676304|NCT00720096|452104933|FG000|Overall Study|Withdrawal by Subject|0|||
125676305|NCT00720096|452104934|FG001|Overall Study|Withdrawal by Subject|2|||
125676306|NCT00524459|452104935|FG000|Overall Study|Withdrawal by Subject|1|||
125676307|NCT00524459|452104935|FG000|Overall Study|Other|1|||
125343144|NCT03387111|450890462|FG000|Overall Study|Other|1|||
125343145|NCT00507728|450890478|FG000|Randomization to Month 3|Lost to Follow-up|15|||
125343146|NCT00507728|450890479|FG001|Randomization to Month 3|Lost to Follow-up|14|||
125676308|NCT02428699|452104936|FG000|Washout Period 1|Screen Failure|1|||
125676309|NCT02428699|452104937|FG001|Washout Period 1|Screen Failure|2|||
125676310|NCT01574248|452104940|FG000|Overall Study|Withdrawal by Subject|2|||
125343147|NCT00507728|450890480|FG002|Randomization to Month 3|Lost to Follow-up|20|||
125343148|NCT00507728|450890478|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
125343149|NCT00507728|450890479|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
125343150|NCT00507728|450890480|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
125343151|NCT01964755|450890481|FG000|Overall Study|Death|2|||
125343152|NCT01332799|450890485|FG000|Overall Study|Insufficient funding|10|||
125343153|NCT01332799|450890486|FG001|Overall Study|Insufficient funding|10|||
125343154|NCT01909791|450890487|FG000|Overall Study|Death|9|||
125343155|NCT01909791|450890488|FG001|Overall Study|Death|8|||
125343156|NCT01909791|450890489|FG002|Overall Study|Death|4|||
125676311|NCT01574248|452104941|FG001|Overall Study|Withdrawal by Subject|0|||
125676312|NCT01574248|452104940|FG000|Overall Study|Missing primary endpoint data|1|||
125676313|NCT01574248|452104941|FG001|Overall Study|Missing primary endpoint data|0|||
125676314|NCT01781286|452104944|FG000|Overall Study|Lost to Follow-up|0|||
125676315|NCT01781286|452104945|FG001|Overall Study|Lost to Follow-up|0|||
125676316|NCT01781286|452104946|FG002|Overall Study|Lost to Follow-up|0|||
125676317|NCT01781286|452104947|FG003|Overall Study|Lost to Follow-up|0|||
125676318|NCT01781286|452104948|FG004|Overall Study|Lost to Follow-up|0|||
125676319|NCT01781286|452104949|FG005|Overall Study|Lost to Follow-up|1|||
125676320|NCT01781286|452104944|FG000|Overall Study|Time Constraints|2|||
125676321|NCT01781286|452104945|FG001|Overall Study|Time Constraints|0|||
125676322|NCT01781286|452104946|FG002|Overall Study|Time Constraints|2|||
125676323|NCT01781286|452104947|FG003|Overall Study|Time Constraints|0|||
125676324|NCT01781286|452104948|FG004|Overall Study|Time Constraints|0|||
125676325|NCT01781286|452104949|FG005|Overall Study|Time Constraints|0|||
125676326|NCT01781286|452104944|FG000|Overall Study|Noncompliance|0|||
125676327|NCT01781286|452104945|FG001|Overall Study|Noncompliance|0|||
125676328|NCT01781286|452104946|FG002|Overall Study|Noncompliance|0|||
125676329|NCT01781286|452104947|FG003|Overall Study|Noncompliance|1|||
125676330|NCT01781286|452104948|FG004|Overall Study|Noncompliance|0|||
125676331|NCT01781286|452104949|FG005|Overall Study|Noncompliance|0|||
125676332|NCT00995410|452104950|FG000|Overall Study|Adverse Event|51|||
125676333|NCT00995410|452104950|FG000|Overall Study|Withdrawal by Subject|7|||
125676334|NCT00995410|452104950|FG000|Overall Study|Lost to Follow-up|2|||
125676335|NCT00995410|452104950|FG000|Overall Study|Misc|28|||
125676336|NCT03594123|452104951|FG000|Overall Study|Lost to Follow-up|0|||
125676337|NCT03594123|452104952|FG001|Overall Study|Lost to Follow-up|1|||
125676338|NCT03594123|452104951|FG000|Overall Study|Adverse Event|8|||
125676339|NCT03594123|452104952|FG001|Overall Study|Adverse Event|5|||
125676340|NCT03594123|452104951|FG000|Overall Study|Site Terminated by Sponsor|4|||
125676341|NCT03594123|452104952|FG001|Overall Study|Site Terminated by Sponsor|1|||
125676342|NCT03594123|452104951|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
125676343|NCT03594123|452104952|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
125676344|NCT03594123|452104951|FG000|Overall Study|Lack of Efficacy|1|||
125676345|NCT03594123|452104952|FG001|Overall Study|Lack of Efficacy|0|||
125676346|NCT03594123|452104951|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
125676347|NCT03594123|452104952|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
125676348|NCT03365375|452104953|FG000|Overall Study|Withdrawal by Subject|0|||
125676349|NCT03365375|452104954|FG001|Overall Study|Withdrawal by Subject|1|||
125676350|NCT03365375|452104953|FG000|Overall Study|Lost to Follow-up|0|||
125676351|NCT03365375|452104954|FG001|Overall Study|Lost to Follow-up|4|||
125676352|NCT02483975|452104955|FG000|Overall Study|Adverse Event|0|||
125676353|NCT02483975|452104956|FG001|Overall Study|Adverse Event|1|||
125676354|NCT02483975|452104955|FG000|Overall Study|Lost to Follow-up|0|||
125676355|NCT02483975|452104956|FG001|Overall Study|Lost to Follow-up|1|||
125676356|NCT02483975|452104955|FG000|Overall Study|Physician Decision|2|||
125676357|NCT02483975|452104956|FG001|Overall Study|Physician Decision|0|||
125676358|NCT03992196|452104957|FG000|Enrollment|lost to follow-up prior dosing|1|||
125676359|NCT03992196|452104958|FG001|Enrollment|lost to follow-up prior dosing|0|||
125676360|NCT03992196|452104959|FG002|Enrollment|lost to follow-up prior dosing|0|||
125676361|NCT03992196|452104957|FG000|Treatment|Protocol Violation|0|||
125676362|NCT03992196|452104958|FG001|Treatment|Protocol Violation|0|||
125676363|NCT03992196|452104959|FG002|Treatment|Protocol Violation|1|||
125676364|NCT03992196|452104957|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
125676365|NCT03992196|452104958|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
125676366|NCT03992196|452104959|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
125676367|NCT03992196|452104957|FG000|Treatment|Withdrawal due to non-compliance|0|||
125676368|NCT03992196|452104958|FG001|Treatment|Withdrawal due to non-compliance|0|||
125676369|NCT03992196|452104959|FG002|Treatment|Withdrawal due to non-compliance|1|||
125676370|NCT03992196|452104957|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
125676371|NCT03992196|452104958|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
125676372|NCT03992196|452104959|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
125676373|NCT03992196|452104957|FG000|Treatment|Withdrawal by parent/guardian|0|||
125676374|NCT03992196|452104958|FG001|Treatment|Withdrawal by parent/guardian|0|||
125676375|NCT03992196|452104959|FG002|Treatment|Withdrawal by parent/guardian|2|||
125676376|NCT02684578|452104960|FG000|Overall Study|Withdrawal by Subject|10|||
125676377|NCT02684578|452104961|FG001|Overall Study|Withdrawal by Subject|7|||
125676378|NCT02684578|452104960|FG000|Overall Study|Lost to Follow-up|0|||
125676379|NCT02684578|452104961|FG001|Overall Study|Lost to Follow-up|3|||
125676380|NCT02684578|452104960|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
125676381|NCT02684578|452104961|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
125676382|NCT02684578|452104960|FG000|Overall Study|Missing follow-up data|0|||
125676383|NCT02684578|452104961|FG001|Overall Study|Missing follow-up data|1|||
125676384|NCT01505530|452104962|FG000|Overall Study|Progressive Disease|19|||
125676385|NCT01505530|452104963|FG001|Overall Study|Progressive Disease|17|||
125676386|NCT01505530|452104964|FG002|Overall Study|Progressive Disease|18|||
125676387|NCT01505530|452104962|FG000|Overall Study|Adverse Event|1|||
125676388|NCT01505530|452104963|FG001|Overall Study|Adverse Event|1|||
125676389|NCT01505530|452104964|FG002|Overall Study|Adverse Event|0|||
125676390|NCT01505530|452104962|FG000|Overall Study|Withdrawal by Subject|7|||
125343157|NCT01909791|450890487|FG000|Overall Study|Withdrawal by Subject|5|||
125343158|NCT01909791|450890488|FG001|Overall Study|Withdrawal by Subject|9|||
125343159|NCT01909791|450890489|FG002|Overall Study|Withdrawal by Subject|13|||
125343160|NCT01909791|450890487|FG000|Overall Study|Lost to Follow-up|5|||
125343161|NCT01909791|450890488|FG001|Overall Study|Lost to Follow-up|11|||
125343162|NCT01909791|450890489|FG002|Overall Study|Lost to Follow-up|10|||
125343163|NCT01909791|450890487|FG000|Overall Study|Missed Visit|2|||
125343164|NCT01909791|450890488|FG001|Overall Study|Missed Visit|0|||
125343165|NCT01909791|450890489|FG002|Overall Study|Missed Visit|1|||
125343166|NCT02168387|450890492|FG000|Overall Study|Planned exubation|6|||
125343167|NCT02168387|450890493|FG001|Overall Study|Planned exubation|3|||
125343168|NCT02168387|450890492|FG000|Overall Study|Death|1|||
125343169|NCT02168387|450890493|FG001|Overall Study|Death|0|||
125343170|NCT03467152|450890494|FG000|Overall Study|Adverse Event|4|||
125343171|NCT03467152|450890495|FG001|Overall Study|Adverse Event|5|||
125343172|NCT03467152|450890496|FG002|Overall Study|Adverse Event|0|||
125343173|NCT03467152|450890494|FG000|Overall Study|Subject Choice|1|||
125343174|NCT03467152|450890495|FG001|Overall Study|Subject Choice|3|||
125343175|NCT03467152|450890496|FG002|Overall Study|Subject Choice|0|||
125343176|NCT03467152|450890494|FG000|Overall Study|Lost to Follow-up|1|||
125343177|NCT03467152|450890495|FG001|Overall Study|Lost to Follow-up|0|||
125343178|NCT03467152|450890496|FG002|Overall Study|Lost to Follow-up|0|||
125343179|NCT03467152|450890494|FG000|Overall Study|Withdrawal by Subject|4|||
125343180|NCT03467152|450890495|FG001|Overall Study|Withdrawal by Subject|2|||
125343181|NCT03467152|450890496|FG002|Overall Study|Withdrawal by Subject|0|||
125343182|NCT03467152|450890494|FG000|Overall Study|Others|3|||
125343183|NCT03467152|450890495|FG001|Overall Study|Others|0|||
125343184|NCT03467152|450890496|FG002|Overall Study|Others|0|||
125343185|NCT03467152|450890494|FG000|Overall Study|Not treated|3|||
125343186|NCT03467152|450890495|FG001|Overall Study|Not treated|1|||
125343187|NCT03467152|450890496|FG002|Overall Study|Not treated|6|||
125343188|NCT01236547|450890497|FG000|Overall Study|Protocol Violation|0|||
125343189|NCT01236547|450890498|FG001|Overall Study|Protocol Violation|1|||
125343190|NCT01236547|450890499|FG002|Overall Study|Protocol Violation|1|||
125343191|NCT01236547|450890500|FG003|Overall Study|Protocol Violation|6|||
125343192|NCT01236547|450890501|FG004|Overall Study|Protocol Violation|12|||
125343193|NCT00910624|450890502|FG000|Treatment Phase|Adverse Event|2|||
125343194|NCT00910624|450890503|FG001|Treatment Phase|Adverse Event|6|||
125343195|NCT00910624|450890504|FG002|Treatment Phase|Adverse Event|6|||
125343196|NCT00910624|450890505|FG003|Treatment Phase|Adverse Event|0|||
125343197|NCT00910624|450890502|FG000|Treatment Phase|Treatment Failure|23|||
125343198|NCT00910624|450890503|FG001|Treatment Phase|Treatment Failure|10|||
125343199|NCT00910624|450890504|FG002|Treatment Phase|Treatment Failure|0|||
125343200|NCT00910624|450890505|FG003|Treatment Phase|Treatment Failure|0|||
125343201|NCT00910624|450890502|FG000|Treatment Phase|Lost to Follow-up|0|||
125343202|NCT00910624|450890503|FG001|Treatment Phase|Lost to Follow-up|0|||
125343203|NCT00910624|450890504|FG002|Treatment Phase|Lost to Follow-up|1|||
125343204|NCT00910624|450890505|FG003|Treatment Phase|Lost to Follow-up|0|||
125343205|NCT00910624|450890502|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
125343206|NCT00910624|450890503|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
125343207|NCT00910624|450890504|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
125343208|NCT00910624|450890505|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
125343209|NCT00910624|450890502|FG000|Treatment Phase|Withdrawal by Subject|2|||
125343210|NCT00910624|450890503|FG001|Treatment Phase|Withdrawal by Subject|1|||
125343211|NCT00910624|450890504|FG002|Treatment Phase|Withdrawal by Subject|0|||
125343212|NCT00910624|450890505|FG003|Treatment Phase|Withdrawal by Subject|0|||
125343213|NCT00910624|450890502|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
125343214|NCT00910624|450890503|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
125343215|NCT00910624|450890504|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
125343216|NCT00910624|450890505|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
125343217|NCT00910624|450890502|FG000|Follow-Up Phase|Adverse Event|0|||
125343218|NCT00910624|450890503|FG001|Follow-Up Phase|Adverse Event|0|||
125343219|NCT00910624|450890504|FG002|Follow-Up Phase|Adverse Event|1|||
125343220|NCT00910624|450890505|FG003|Follow-Up Phase|Adverse Event|0|||
125343221|NCT00910624|450890502|FG000|Follow-Up Phase|Lost to Follow-up|3|||
125343222|NCT00910624|450890503|FG001|Follow-Up Phase|Lost to Follow-up|1|||
125343223|NCT00910624|450890504|FG002|Follow-Up Phase|Lost to Follow-up|2|||
125343224|NCT00910624|450890505|FG003|Follow-Up Phase|Lost to Follow-up|0|||
125343225|NCT00910624|450890502|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
125343226|NCT00910624|450890503|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
125343227|NCT00910624|450890504|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
125343228|NCT00910624|450890505|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
125343229|NCT00910624|450890502|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
125343230|NCT00910624|450890503|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
125343231|NCT00910624|450890504|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
125343232|NCT00910624|450890505|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
125343233|NCT00910624|450890502|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
125343234|NCT00910624|450890503|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
125343235|NCT00910624|450890504|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
125343236|NCT00910624|450890505|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
125343237|NCT00910624|450890502|FG000|Follow-Up Phase|Administrative|0|||
125343238|NCT00910624|450890503|FG001|Follow-Up Phase|Administrative|1|||
125343239|NCT00910624|450890504|FG002|Follow-Up Phase|Administrative|1|||
125343240|NCT00910624|450890505|FG003|Follow-Up Phase|Administrative|0|||
125343241|NCT04140227|450890506|FG000|Overall Study|Withdrawal by Subject|26|||
125343242|NCT04140227|450890506|FG000|Overall Study|Lost to Follow-up|8|||
125343243|NCT04140227|450890506|FG000|Overall Study|Adverse Event|8|||
125343244|NCT04140227|450890506|FG000|Overall Study|Death|1|||
125343245|NCT04140227|450890506|FG000|Overall Study|Other|3|||
125343246|NCT04140227|450890506|FG000|Overall Study|Protocol Violation|2|||
125343247|NCT01713933|450890507|FG000|Overall Study|Lost to Follow-up|2|||
125343248|NCT01713933|450890507|FG000|Overall Study|Withdrawal by Subject|3|||
125343249|NCT01713933|450890507|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
125343250|NCT00412373|450890508|FG000|Overall Study|Adverse Event|8|||
125343251|NCT00412373|450890509|FG001|Overall Study|Adverse Event|13|||
125343252|NCT00412373|450890508|FG000|Overall Study|Lack of Efficacy|16|||
125343253|NCT00412373|450890509|FG001|Overall Study|Lack of Efficacy|22|||
125343254|NCT00412373|450890508|FG000|Overall Study|Lost to Follow-up|7|||
125343255|NCT00412373|450890509|FG001|Overall Study|Lost to Follow-up|13|||
125343256|NCT00412373|450890508|FG000|Overall Study|Withdrawal by Subject|8|||
125343257|NCT00412373|450890509|FG001|Overall Study|Withdrawal by Subject|27|||
125343258|NCT00412373|450890508|FG000|Overall Study|Other|2|||
125343259|NCT00412373|450890509|FG001|Overall Study|Other|2|||
125343260|NCT02855541|450890514|FG000|Overall Study|Change in health status|2|||
125343261|NCT02855541|450890514|FG000|Overall Study|Withdrawal by Subject|2|||
125343262|NCT00422513|450890515|FG000|Overall Study|Lack of Efficacy|4|||
125343263|NCT00422513|450890516|FG001|Overall Study|Lack of Efficacy|5|||
125343264|NCT00422513|450890515|FG000|Overall Study|Protocol Violation|23|||
125343265|NCT00422513|450890516|FG001|Overall Study|Protocol Violation|7|||
125343266|NCT00422513|450890515|FG000|Overall Study|Refused Treatment|4|||
125343267|NCT00422513|450890516|FG001|Overall Study|Refused Treatment|2|||
125343268|NCT00422513|450890515|FG000|Overall Study|Withdrawal by Subject|2|||
125343269|NCT00422513|450890516|FG001|Overall Study|Withdrawal by Subject|1|||
125343270|NCT00422513|450890515|FG000|Overall Study|early termination of the study|67|||
125343271|NCT00422513|450890516|FG001|Overall Study|early termination of the study|80|||
125343272|NCT00422513|450890515|FG000|Overall Study|Adverse Event|4|||
125343273|NCT00422513|450890516|FG001|Overall Study|Adverse Event|4|||
125343274|NCT00422513|450890515|FG000|Overall Study|Death|3|||
125343275|NCT00422513|450890516|FG001|Overall Study|Death|7|||
125343276|NCT03135119|450890517|FG000|Overall Study|Lost to Follow-up|2|||
125343277|NCT03135119|450890518|FG001|Overall Study|Lost to Follow-up|0|||
125343278|NCT03135119|450890517|FG000|Overall Study|Physician Decision|1|||
125343279|NCT03135119|450890518|FG001|Overall Study|Physician Decision|1|||
125343280|NCT03135119|450890517|FG000|Overall Study|COVID-19 Shutdown|2|||
125343281|NCT03135119|450890518|FG001|Overall Study|COVID-19 Shutdown|2|||
125343282|NCT01541397|450890519|FG000|Overall Study|Study ended prior to data collection|4|||
125343283|NCT01541397|450890520|FG001|Overall Study|Study ended prior to data collection|2|||
125343284|NCT01689532|450890521|FG000|Overall Study|Adverse Event|9|||
125343285|NCT01689532|450890522|FG001|Overall Study|Adverse Event|5|||
125343286|NCT01689532|450890521|FG000|Overall Study|Lack of Efficacy|2|||
125343287|NCT01689532|450890522|FG001|Overall Study|Lack of Efficacy|2|||
125343288|NCT01689532|450890521|FG000|Overall Study|Withdrawal by Subject|1|||
125343289|NCT01689532|450890522|FG001|Overall Study|Withdrawal by Subject|2|||
125343290|NCT01689532|450890521|FG000|Overall Study|Physician Decision|2|||
125343291|NCT01689532|450890522|FG001|Overall Study|Physician Decision|0|||
125343292|NCT01363349|450890523|FG000|Overall Study|Adverse Event|6|||
125343293|NCT01363349|450890524|FG001|Overall Study|Adverse Event|7|||
125343294|NCT01363349|450890523|FG000|Overall Study|Lack of Efficacy|3|||
125343295|NCT01363349|450890524|FG001|Overall Study|Lack of Efficacy|10|||
125343296|NCT01363349|450890523|FG000|Overall Study|Non compliance/Protocol deviations|2|||
125343297|NCT01363349|450890524|FG001|Overall Study|Non compliance/Protocol deviations|2|||
125343298|NCT01363349|450890523|FG000|Overall Study|Withdrawal by Subject|14|||
125343299|NCT01363349|450890524|FG001|Overall Study|Withdrawal by Subject|6|||
125343300|NCT01363349|450890523|FG000|Overall Study|Lost to Follow-up|5|||
125343301|NCT01363349|450890524|FG001|Overall Study|Lost to Follow-up|6|||
125343302|NCT01363349|450890523|FG000|Overall Study|Not reported|36|||
125343303|NCT01363349|450890524|FG001|Overall Study|Not reported|37|||
125343304|NCT01363349|450890523|FG000|Overall Study|missing|1|||
125343305|NCT01363349|450890524|FG001|Overall Study|missing|2|||
125343306|NCT02208063|450890525|FG000|Overall Study|Death|3|||
125343307|NCT02208063|450890526|FG001|Overall Study|Death|5|||
125343308|NCT02208063|450890525|FG000|Overall Study|Not Specified in report|3|||
125343309|NCT02208063|450890526|FG001|Overall Study|Not Specified in report|4|||
125676391|NCT01505530|452104963|FG001|Overall Study|Withdrawal by Subject|8|||
125676392|NCT01505530|452104964|FG002|Overall Study|Withdrawal by Subject|6|||
125676393|NCT01505530|452104962|FG000|Overall Study|Physician Decision|6|||
125676394|NCT01505530|452104963|FG001|Overall Study|Physician Decision|2|||
125676395|NCT01505530|452104964|FG002|Overall Study|Physician Decision|5|||
125676396|NCT01505530|452104962|FG000|Overall Study|Sponsor Decision|1|||
125676397|NCT01505530|452104963|FG001|Overall Study|Sponsor Decision|8|||
125676398|NCT01505530|452104964|FG002|Overall Study|Sponsor Decision|7|||
125676399|NCT01505530|452104962|FG000|Overall Study|Death|7|||
125676400|NCT01505530|452104963|FG001|Overall Study|Death|6|||
125676401|NCT01505530|452104964|FG002|Overall Study|Death|5|||
125676402|NCT01505530|452104962|FG000|Overall Study|entry criteria not met|0|||
125676403|NCT01505530|452104963|FG001|Overall Study|entry criteria not met|1|||
125676404|NCT01505530|452104964|FG002|Overall Study|entry criteria not met|0|||
125676405|NCT02492958|452104968|FG000|Overall Study|Withdrawal by Subject|0|||
125676406|NCT02492958|452104969|FG001|Overall Study|Withdrawal by Subject|0|||
125676407|NCT02492958|452104970|FG002|Overall Study|Withdrawal by Subject|1|||
125676408|NCT02492958|452104971|FG003|Overall Study|Withdrawal by Subject|0|||
125676409|NCT02492958|452104968|FG000|Overall Study|Adverse Event|1|||
125676410|NCT02492958|452104969|FG001|Overall Study|Adverse Event|0|||
125676411|NCT02492958|452104970|FG002|Overall Study|Adverse Event|1|||
125676412|NCT02492958|452104971|FG003|Overall Study|Adverse Event|0|||
125676413|NCT01193608|452104972|FG000|Overall Study|Other|0|||
125676414|NCT01193608|452104973|FG001|Overall Study|Other|1|||
125676415|NCT01193608|452104974|FG002|Overall Study|Other|0|||
125676416|NCT01193608|452104975|FG003|Overall Study|Other|0|||
125676417|NCT01193608|452104976|FG004|Overall Study|Other|0|||
125676418|NCT01193608|452104977|FG005|Overall Study|Other|0|||
125676419|NCT01193608|452104972|FG000|Overall Study|Withdrawal by Subject|0|||
125676420|NCT01193608|452104973|FG001|Overall Study|Withdrawal by Subject|1|||
125676421|NCT01193608|452104974|FG002|Overall Study|Withdrawal by Subject|2|||
125676422|NCT01193608|452104975|FG003|Overall Study|Withdrawal by Subject|3|||
125676423|NCT01193608|452104976|FG004|Overall Study|Withdrawal by Subject|3|||
125676424|NCT01193608|452104977|FG005|Overall Study|Withdrawal by Subject|0|||
125676425|NCT01193608|452104972|FG000|Overall Study|Lost to Follow-up|0|||
125676426|NCT01193608|452104973|FG001|Overall Study|Lost to Follow-up|0|||
125676427|NCT01193608|452104974|FG002|Overall Study|Lost to Follow-up|0|||
125343310|NCT02208063|450890525|FG000|Overall Study|Withdrawal by Subject|5|||
125343311|NCT02208063|450890526|FG001|Overall Study|Withdrawal by Subject|2|||
125343312|NCT02208063|450890525|FG000|Overall Study|Lost to Follow-up|1|||
125343313|NCT02208063|450890526|FG001|Overall Study|Lost to Follow-up|0|||
125343314|NCT00913458|450890527|FG000|Phase 1|Non-Responder|54|||
125343315|NCT00913458|450890528|FG001|Phase 1|Non-Responder|0|||
125343316|NCT00913458|450890529|FG002|Phase 1|Non-Responder|0|||
125343317|NCT00913458|450890530|FG003|Phase 1|Non-Responder|0|||
125343318|NCT00913458|450890531|FG004|Phase 1|Non-Responder|0|||
125343319|NCT00913458|450890532|FG005|Phase 1|Non-Responder|0|||
125343320|NCT00913458|450890533|FG006|Phase 1|Non-Responder|0|||
125343321|NCT00913458|450890527|FG000|Phase 1|Subject Request|17|||
125343322|NCT00913458|450890528|FG001|Phase 1|Subject Request|0|||
125676428|NCT01193608|452104975|FG003|Overall Study|Lost to Follow-up|0|||
125676429|NCT01193608|452104976|FG004|Overall Study|Lost to Follow-up|1|||
125676430|NCT01193608|452104977|FG005|Overall Study|Lost to Follow-up|2|||
125343323|NCT00913458|450890529|FG002|Phase 1|Subject Request|0|||
125343324|NCT00913458|450890530|FG003|Phase 1|Subject Request|0|||
125343325|NCT00913458|450890531|FG004|Phase 1|Subject Request|0|||
125676431|NCT01193608|452104972|FG000|Overall Study|Adverse Event|0|||
125343326|NCT00913458|450890532|FG005|Phase 1|Subject Request|0|||
125343327|NCT00913458|450890533|FG006|Phase 1|Subject Request|0|||
125343328|NCT00913458|450890527|FG000|Phase 1|Adverse Event|20|||
125343329|NCT00913458|450890528|FG001|Phase 1|Adverse Event|0|||
125343330|NCT00913458|450890529|FG002|Phase 1|Adverse Event|0|||
125343331|NCT00913458|450890530|FG003|Phase 1|Adverse Event|0|||
125343332|NCT00913458|450890531|FG004|Phase 1|Adverse Event|0|||
125343333|NCT00913458|450890532|FG005|Phase 1|Adverse Event|0|||
125343334|NCT00913458|450890533|FG006|Phase 1|Adverse Event|0|||
125343335|NCT00913458|450890527|FG000|Phase 1|Lost to Follow-up|2|||
125343336|NCT00913458|450890528|FG001|Phase 1|Lost to Follow-up|0|||
125343337|NCT00913458|450890529|FG002|Phase 1|Lost to Follow-up|0|||
125343338|NCT00913458|450890530|FG003|Phase 1|Lost to Follow-up|0|||
125343339|NCT00913458|450890531|FG004|Phase 1|Lost to Follow-up|0|||
125343340|NCT00913458|450890532|FG005|Phase 1|Lost to Follow-up|0|||
125343341|NCT00913458|450890533|FG006|Phase 1|Lost to Follow-up|0|||
125343342|NCT00913458|450890527|FG000|Phase 1|Protocol Violation|10|||
125343343|NCT00913458|450890528|FG001|Phase 1|Protocol Violation|0|||
125343344|NCT00913458|450890529|FG002|Phase 1|Protocol Violation|0|||
125343345|NCT00913458|450890530|FG003|Phase 1|Protocol Violation|0|||
125343346|NCT00913458|450890531|FG004|Phase 1|Protocol Violation|0|||
125343347|NCT00913458|450890532|FG005|Phase 1|Protocol Violation|0|||
125343348|NCT00913458|450890533|FG006|Phase 1|Protocol Violation|0|||
125343349|NCT00913458|450890527|FG000|Phase 1|Sponsor|2|||
125343350|NCT00913458|450890528|FG001|Phase 1|Sponsor|0|||
125343351|NCT00913458|450890529|FG002|Phase 1|Sponsor|0|||
125343352|NCT00913458|450890530|FG003|Phase 1|Sponsor|0|||
125343353|NCT00913458|450890531|FG004|Phase 1|Sponsor|0|||
125343354|NCT00913458|450890532|FG005|Phase 1|Sponsor|0|||
125343355|NCT00913458|450890533|FG006|Phase 1|Sponsor|0|||
125343356|NCT00913458|450890527|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
125343357|NCT00913458|450890528|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
125343358|NCT00913458|450890529|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
125343359|NCT00913458|450890530|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
125343360|NCT00913458|450890531|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
125343361|NCT00913458|450890532|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
125343362|NCT00913458|450890533|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
125343363|NCT00913458|450890527|FG000|Phase 2|Non-Responder|0|||
125343364|NCT00913458|450890528|FG001|Phase 2|Non-Responder|5|||
125343365|NCT00913458|450890529|FG002|Phase 2|Non-Responder|7|||
125343366|NCT00913458|450890530|FG003|Phase 2|Non-Responder|12|||
125343367|NCT00913458|450890531|FG004|Phase 2|Non-Responder|0|||
125343368|NCT00913458|450890532|FG005|Phase 2|Non-Responder|0|||
125343369|NCT00913458|450890533|FG006|Phase 2|Non-Responder|0|||
125343370|NCT00913458|450890527|FG000|Phase 2|Subject Request|0|||
125343371|NCT00913458|450890528|FG001|Phase 2|Subject Request|0|||
125343372|NCT00913458|450890529|FG002|Phase 2|Subject Request|1|||
125343373|NCT00913458|450890530|FG003|Phase 2|Subject Request|2|||
125343374|NCT00913458|450890531|FG004|Phase 2|Subject Request|0|||
125343375|NCT00913458|450890532|FG005|Phase 2|Subject Request|0|||
125343376|NCT00913458|450890533|FG006|Phase 2|Subject Request|0|||
125343377|NCT00913458|450890527|FG000|Phase 2|Adverse Event|0|||
125343378|NCT00913458|450890528|FG001|Phase 2|Adverse Event|3|||
125343379|NCT00913458|450890529|FG002|Phase 2|Adverse Event|0|||
125343380|NCT00913458|450890530|FG003|Phase 2|Adverse Event|1|||
125343381|NCT00913458|450890531|FG004|Phase 2|Adverse Event|0|||
125343382|NCT00913458|450890532|FG005|Phase 2|Adverse Event|0|||
125343383|NCT00913458|450890533|FG006|Phase 2|Adverse Event|0|||
125343384|NCT00913458|450890527|FG000|Phase 2|Lost to Follow-up|0|||
125343385|NCT00913458|450890528|FG001|Phase 2|Lost to Follow-up|0|||
125343386|NCT00913458|450890529|FG002|Phase 2|Lost to Follow-up|0|||
125343387|NCT00913458|450890530|FG003|Phase 2|Lost to Follow-up|1|||
125343388|NCT00913458|450890531|FG004|Phase 2|Lost to Follow-up|0|||
125343389|NCT00913458|450890532|FG005|Phase 2|Lost to Follow-up|0|||
125343390|NCT00913458|450890533|FG006|Phase 2|Lost to Follow-up|0|||
125343391|NCT00913458|450890527|FG000|Phase 2|Protocol Violation|0|||
125676432|NCT01193608|452104973|FG001|Overall Study|Adverse Event|0|||
125676433|NCT01193608|452104974|FG002|Overall Study|Adverse Event|0|||
125676434|NCT01193608|452104975|FG003|Overall Study|Adverse Event|0|||
125676435|NCT01193608|452104976|FG004|Overall Study|Adverse Event|1|||
125676436|NCT01193608|452104977|FG005|Overall Study|Adverse Event|0|||
125676437|NCT00266409|452104978|FG000|Overall Study|Lack of Efficacy|2|||
125676438|NCT00266409|452104979|FG001|Overall Study|Lack of Efficacy|6|||
125676439|NCT00266409|452104980|FG002|Overall Study|Lack of Efficacy|1|||
125676440|NCT00266409|452104981|FG003|Overall Study|Lack of Efficacy|2|||
125676441|NCT00266409|452104978|FG000|Overall Study|Adverse Event|7|||
125676442|NCT00266409|452104979|FG001|Overall Study|Adverse Event|2|||
125676443|NCT00266409|452104980|FG002|Overall Study|Adverse Event|1|||
125676444|NCT00266409|452104981|FG003|Overall Study|Adverse Event|1|||
125676445|NCT00266409|452104978|FG000|Overall Study|Lost to Follow-up|18|||
125676446|NCT00266409|452104979|FG001|Overall Study|Lost to Follow-up|21|||
125676447|NCT00266409|452104980|FG002|Overall Study|Lost to Follow-up|6|||
125676448|NCT00266409|452104981|FG003|Overall Study|Lost to Follow-up|8|||
125676449|NCT00266409|452104978|FG000|Overall Study|Withdrawal by Subject|6|||
125676450|NCT00266409|452104979|FG001|Overall Study|Withdrawal by Subject|10|||
125676451|NCT00266409|452104980|FG002|Overall Study|Withdrawal by Subject|3|||
125676452|NCT00266409|452104981|FG003|Overall Study|Withdrawal by Subject|9|||
125676453|NCT00266409|452104978|FG000|Overall Study|Protocol Violation|5|||
125676454|NCT00266409|452104979|FG001|Overall Study|Protocol Violation|3|||
125676455|NCT00266409|452104980|FG002|Overall Study|Protocol Violation|4|||
125676456|NCT00266409|452104981|FG003|Overall Study|Protocol Violation|2|||
125676457|NCT00266409|452104978|FG000|Overall Study|Other|7|||
125676458|NCT00266409|452104979|FG001|Overall Study|Other|4|||
125343392|NCT00913458|450890528|FG001|Phase 2|Protocol Violation|2|||
125343393|NCT00913458|450890529|FG002|Phase 2|Protocol Violation|0|||
125343394|NCT00913458|450890530|FG003|Phase 2|Protocol Violation|0|||
125676459|NCT00266409|452104980|FG002|Overall Study|Other|2|||
125676460|NCT00266409|452104981|FG003|Overall Study|Other|0|||
125676461|NCT00712010|452104982|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
125676462|NCT00635154|452104985|FG000|Overall Study|Alternative Treatment|8|||
125676463|NCT00635154|452104985|FG000|Overall Study|Other|4|||
125676464|NCT00635154|452104985|FG000|Overall Study|Still on treatment|21|||
125676465|NCT01399736|452104986|FG000|Overall Study|Withdrawal by Subject|4|||
125676466|NCT01399736|452104987|FG001|Overall Study|Withdrawal by Subject|2|||
125676467|NCT01399736|452104986|FG000|Overall Study|Lost to Follow-up|0|||
125676468|NCT01399736|452104987|FG001|Overall Study|Lost to Follow-up|2|||
125676469|NCT03500484|452104988|FG000|Overall Study|Adverse Event|2|||
125676470|NCT03500484|452104989|FG001|Overall Study|Adverse Event|0|||
125676471|NCT03500484|452104988|FG000|Overall Study|Physician Decision|1|||
125676472|NCT03500484|452104989|FG001|Overall Study|Physician Decision|0|||
125676473|NCT03500484|452104988|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
125676474|NCT03500484|452104989|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
125676475|NCT02795104|452104990|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
125676476|NCT02795104|452104991|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
125676477|NCT02795104|452104992|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
125676478|NCT02795104|452104990|FG000|Overall Study|Withdrawal by Subject|0|||
125676479|NCT02795104|452104991|FG001|Overall Study|Withdrawal by Subject|2|||
125676480|NCT02795104|452104992|FG002|Overall Study|Withdrawal by Subject|0|||
125676481|NCT02795104|452104990|FG000|Overall Study|Lost to Follow-up|0|||
125676482|NCT02795104|452104991|FG001|Overall Study|Lost to Follow-up|0|||
125676483|NCT02795104|452104992|FG002|Overall Study|Lost to Follow-up|1|||
125676484|NCT00770510|452104993|FG000|Overall Study|Lost to Follow-up|2|||
125676485|NCT00770510|452104993|FG000|Overall Study|Pregnancy|1|||
125676486|NCT00770510|452104993|FG000|Overall Study|Withdrawal by Subject|2|||
125676487|NCT01089647|452104997|FG000|Overall Study|Lost to Follow-up|2|||
125676488|NCT01089647|452104998|FG001|Overall Study|Lost to Follow-up|2|||
125676489|NCT01089647|452104997|FG000|Overall Study|Withdrawal by Subject|2|||
125676490|NCT01089647|452104998|FG001|Overall Study|Withdrawal by Subject|1|||
125676491|NCT01089647|452104997|FG000|Overall Study|Adverse Event|0|||
125676492|NCT01089647|452104998|FG001|Overall Study|Adverse Event|1|||
125676493|NCT00995553|452104999|FG000|Overall Study|Withdrawal by Subject|2|||
125676494|NCT00995553|452105000|FG001|Overall Study|Withdrawal by Subject|6|||
125676495|NCT00927810|452105001|FG000|Overall Study|Withdrawal by Subject|0|||
125676496|NCT00927810|452105002|FG001|Overall Study|Withdrawal by Subject|3|||
125676497|NCT00927810|452105003|FG002|Overall Study|Withdrawal by Subject|0|||
125676498|NCT00927810|452105004|FG003|Overall Study|Withdrawal by Subject|1|||
125676499|NCT00927810|452105001|FG000|Overall Study|Lost to Follow-up|0|||
125676500|NCT00927810|452105002|FG001|Overall Study|Lost to Follow-up|2|||
125676501|NCT00927810|452105003|FG002|Overall Study|Lost to Follow-up|1|||
125676502|NCT00927810|452105004|FG003|Overall Study|Lost to Follow-up|1|||
125676503|NCT00927810|452105001|FG000|Overall Study|Death|0|||
125676504|NCT00927810|452105002|FG001|Overall Study|Death|2|||
125676505|NCT00927810|452105003|FG002|Overall Study|Death|0|||
125676506|NCT00927810|452105004|FG003|Overall Study|Death|0|||
125676507|NCT00927810|452105001|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125676508|NCT00927810|452105002|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125676509|NCT00927810|452105003|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125676510|NCT00927810|452105004|FG003|Overall Study|Abnormal laboratory value(s)|0|||
125676511|NCT00198029|452105010|FG000|Overall Study|Withdrawal by Subject|4|||
125676512|NCT00814463|452105013|FG000|Overall Study|Lost to Follow-up|1|||
125676513|NCT03982433|452105014|FG000|Overall Study|Lost to Follow-up|1|||
125676514|NCT00368277|452105015|FG000|Overall Study|Adverse Event|33|||
125676515|NCT00368277|452105016|FG001|Overall Study|Adverse Event|49|||
125676516|NCT00368277|452105015|FG000|Overall Study|Death|2|||
125676517|NCT00368277|452105016|FG001|Overall Study|Death|1|||
125676518|NCT00368277|452105015|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
125676519|NCT00368277|452105016|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
125676520|NCT00368277|452105015|FG000|Overall Study|Protocol deviation|7|||
125676521|NCT00368277|452105016|FG001|Overall Study|Protocol deviation|0|||
125676522|NCT00368277|452105015|FG000|Overall Study|Patient withdrew consent|32|||
125676523|NCT00368277|452105016|FG001|Overall Study|Patient withdrew consent|28|||
125676524|NCT00368277|452105015|FG000|Overall Study|Lost to Follow-up|8|||
125676525|NCT00368277|452105016|FG001|Overall Study|Lost to Follow-up|6|||
125676526|NCT00984295|452105017|FG000|Overall Study|Lost to Follow-up|31|||
125676527|NCT00984295|452105018|FG001|Overall Study|Lost to Follow-up|12|||
125676528|NCT00984295|452105019|FG002|Overall Study|Lost to Follow-up|13|||
125676529|NCT00984295|452105017|FG000|Overall Study|Protocol Violation|2|||
125676530|NCT00984295|452105018|FG001|Overall Study|Protocol Violation|1|||
125676531|NCT00984295|452105019|FG002|Overall Study|Protocol Violation|4|||
125676532|NCT00984295|452105017|FG000|Overall Study|Withdrawal by Subject|18|||
125676533|NCT00984295|452105018|FG001|Overall Study|Withdrawal by Subject|9|||
125676534|NCT00984295|452105019|FG002|Overall Study|Withdrawal by Subject|12|||
125676535|NCT00984295|452105017|FG000|Overall Study|CAE - discontinued test vaccine|0|||
125343395|NCT00913458|450890531|FG004|Phase 2|Protocol Violation|0|||
125343396|NCT00913458|450890532|FG005|Phase 2|Protocol Violation|0|||
125343397|NCT00913458|450890533|FG006|Phase 2|Protocol Violation|0|||
125676536|NCT00984295|452105018|FG001|Overall Study|CAE - discontinued test vaccine|1|||
125676537|NCT00984295|452105019|FG002|Overall Study|CAE - discontinued test vaccine|3|||
125676538|NCT00984295|452105017|FG000|Overall Study|Missed one or more blood samplings|3|||
125676539|NCT00984295|452105018|FG001|Overall Study|Missed one or more blood samplings|7|||
125676540|NCT00984295|452105019|FG002|Overall Study|Missed one or more blood samplings|2|||
125676541|NCT00984295|452105017|FG000|Overall Study|Incomplete safety follow-up|11|||
125676542|NCT00984295|452105018|FG001|Overall Study|Incomplete safety follow-up|2|||
125676543|NCT00984295|452105019|FG002|Overall Study|Incomplete safety follow-up|3|||
125676544|NCT04799158|452105020|FG000|Run-In Period|Adverse Event|6|||
125676545|NCT04799158|452105021|FG001|Run-In Period|Adverse Event|0|||
125676546|NCT04799158|452105022|FG002|Run-In Period|Adverse Event|0|||
125676547|NCT04799158|452105023|FG003|Run-In Period|Adverse Event|0|||
125676548|NCT04799158|452105024|FG004|Run-In Period|Adverse Event|0|||
125676549|NCT04799158|452105020|FG000|Run-In Period|Lost to Follow-up|4|||
125676550|NCT04799158|452105021|FG001|Run-In Period|Lost to Follow-up|0|||
125676551|NCT04799158|452105022|FG002|Run-In Period|Lost to Follow-up|0|||
125676552|NCT04799158|452105023|FG003|Run-In Period|Lost to Follow-up|0|||
125676553|NCT04799158|452105024|FG004|Run-In Period|Lost to Follow-up|0|||
125676554|NCT04799158|452105020|FG000|Run-In Period|Significant Protocol Deviation|1|||
125676555|NCT04799158|452105021|FG001|Run-In Period|Significant Protocol Deviation|0|||
125676556|NCT04799158|452105022|FG002|Run-In Period|Significant Protocol Deviation|0|||
125676557|NCT04799158|452105023|FG003|Run-In Period|Significant Protocol Deviation|0|||
125676558|NCT04799158|452105024|FG004|Run-In Period|Significant Protocol Deviation|0|||
125676559|NCT04799158|452105020|FG000|Run-In Period|Withdrawal by Subject|11|||
125676560|NCT04799158|452105021|FG001|Run-In Period|Withdrawal by Subject|0|||
125676561|NCT04799158|452105022|FG002|Run-In Period|Withdrawal by Subject|0|||
125676562|NCT04799158|452105023|FG003|Run-In Period|Withdrawal by Subject|0|||
125676563|NCT04799158|452105024|FG004|Run-In Period|Withdrawal by Subject|0|||
125676564|NCT04799158|452105020|FG000|Run-In Period|Miscellaneous|3|||
125676565|NCT04799158|452105021|FG001|Run-In Period|Miscellaneous|0|||
125676566|NCT04799158|452105022|FG002|Run-In Period|Miscellaneous|0|||
125676567|NCT04799158|452105023|FG003|Run-In Period|Miscellaneous|0|||
125676568|NCT04799158|452105024|FG004|Run-In Period|Miscellaneous|0|||
125676569|NCT04799158|452105020|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
125676570|NCT04799158|452105021|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
125676571|NCT04799158|452105022|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
125676572|NCT04799158|452105023|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
125676573|NCT04799158|452105024|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
125676574|NCT04799158|452105020|FG000|On-Demand Treatment Period|Adverse Event|0|||
125676575|NCT04799158|452105021|FG001|On-Demand Treatment Period|Adverse Event|1|||
125676576|NCT04799158|452105022|FG002|On-Demand Treatment Period|Adverse Event|0|||
125676577|NCT04799158|452105023|FG003|On-Demand Treatment Period|Adverse Event|0|||
125676578|NCT04799158|452105024|FG004|On-Demand Treatment Period|Adverse Event|1|||
125676579|NCT04799158|452105020|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
125676580|NCT04799158|452105021|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
125676581|NCT04799158|452105022|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
125676582|NCT04799158|452105023|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
125676583|NCT04799158|452105024|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
125676584|NCT04799158|452105020|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
125676585|NCT04799158|452105021|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
125676586|NCT04799158|452105022|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
125676587|NCT04799158|452105023|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
125676588|NCT04799158|452105024|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
125676589|NCT04799158|452105020|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
125676590|NCT04799158|452105021|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
125676591|NCT04799158|452105022|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
125676592|NCT04799158|452105023|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
125676593|NCT04799158|452105024|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
125676594|NCT04799158|452105020|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
125676595|NCT04799158|452105021|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
125676596|NCT04799158|452105022|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
125676597|NCT04799158|452105023|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
125676598|NCT04799158|452105024|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
125676599|NCT04799158|452105020|FG000|On-Demand Treatment Period|Miscellaneous|0|||
125676600|NCT04799158|452105021|FG001|On-Demand Treatment Period|Miscellaneous|0|||
125676601|NCT04799158|452105022|FG002|On-Demand Treatment Period|Miscellaneous|0|||
125676602|NCT04799158|452105023|FG003|On-Demand Treatment Period|Miscellaneous|0|||
125676603|NCT04799158|452105024|FG004|On-Demand Treatment Period|Miscellaneous|1|||
125676604|NCT01790568|452105031|FG000|Overall Study|Progression prior to transplant|0|||
125676605|NCT01790568|452105032|FG001|Overall Study|Progression prior to transplant|1|||
125676606|NCT02994056|452105033|FG000|Overall Study|Death|8|||
125676607|NCT02994056|452105033|FG000|Overall Study|Withdrew Consent|1|||
125676608|NCT02199509|452105036|FG000|Overall Study|Suicidal Ideation|0|||
125343398|NCT00913458|450890527|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
125343399|NCT00913458|450890528|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
125343400|NCT00913458|450890529|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
125343401|NCT00913458|450890530|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
125343402|NCT00913458|450890531|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
125343403|NCT00913458|450890532|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
125343404|NCT00913458|450890533|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
125343405|NCT00913458|450890527|FG000|Phase 3|Adverse Event|0|||
125343406|NCT00913458|450890528|FG001|Phase 3|Adverse Event|0|||
125343407|NCT00913458|450890529|FG002|Phase 3|Adverse Event|0|||
125343408|NCT00913458|450890530|FG003|Phase 3|Adverse Event|0|||
125343409|NCT00913458|450890531|FG004|Phase 3|Adverse Event|5|||
125343410|NCT00913458|450890532|FG005|Phase 3|Adverse Event|4|||
125343411|NCT00913458|450890533|FG006|Phase 3|Adverse Event|1|||
125343412|NCT00913458|450890527|FG000|Phase 3|Lost to Follow-up|0|||
125343413|NCT00913458|450890528|FG001|Phase 3|Lost to Follow-up|0|||
125343414|NCT00913458|450890529|FG002|Phase 3|Lost to Follow-up|0|||
125343415|NCT00913458|450890530|FG003|Phase 3|Lost to Follow-up|0|||
125343416|NCT00913458|450890531|FG004|Phase 3|Lost to Follow-up|2|||
125343417|NCT00913458|450890532|FG005|Phase 3|Lost to Follow-up|0|||
125343418|NCT00913458|450890533|FG006|Phase 3|Lost to Follow-up|0|||
125343419|NCT00913458|450890527|FG000|Phase 3|Non-Responder|0|||
125343420|NCT00913458|450890528|FG001|Phase 3|Non-Responder|0|||
125343421|NCT00913458|450890529|FG002|Phase 3|Non-Responder|0|||
125343422|NCT00913458|450890530|FG003|Phase 3|Non-Responder|0|||
125343423|NCT00913458|450890531|FG004|Phase 3|Non-Responder|0|||
125343424|NCT00913458|450890532|FG005|Phase 3|Non-Responder|1|||
125343425|NCT00913458|450890533|FG006|Phase 3|Non-Responder|3|||
125343426|NCT00913458|450890527|FG000|Phase 3|Withdrawal by Subject|0|||
125343427|NCT00913458|450890528|FG001|Phase 3|Withdrawal by Subject|0|||
125343428|NCT00913458|450890529|FG002|Phase 3|Withdrawal by Subject|0|||
125343429|NCT00913458|450890530|FG003|Phase 3|Withdrawal by Subject|0|||
125343430|NCT00913458|450890531|FG004|Phase 3|Withdrawal by Subject|1|||
125343431|NCT00913458|450890532|FG005|Phase 3|Withdrawal by Subject|2|||
125343432|NCT00913458|450890533|FG006|Phase 3|Withdrawal by Subject|0|||
125343433|NCT00913458|450890527|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
125343434|NCT00913458|450890528|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
125343435|NCT00913458|450890529|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
125343436|NCT00913458|450890530|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
125343437|NCT00913458|450890531|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
125343438|NCT00913458|450890532|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
125343439|NCT00913458|450890533|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
125343440|NCT02279407|450890534|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
125343441|NCT02279407|450890535|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
125343442|NCT02279407|450890536|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
125343443|NCT02279407|450890537|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
125343444|NCT02279407|450890534|FG000|Overall Study|Withdrawal by Subject|1|||
125343445|NCT02279407|450890535|FG001|Overall Study|Withdrawal by Subject|0|||
125343446|NCT02279407|450890536|FG002|Overall Study|Withdrawal by Subject|1|||
125343447|NCT02279407|450890537|FG003|Overall Study|Withdrawal by Subject|1|||
125343448|NCT02279407|450890534|FG000|Overall Study|Adverse Event|1|||
125343449|NCT02279407|450890535|FG001|Overall Study|Adverse Event|1|||
125343450|NCT02279407|450890536|FG002|Overall Study|Adverse Event|2|||
125343451|NCT02279407|450890537|FG003|Overall Study|Adverse Event|0|||
125343452|NCT00422084|450890542|FG000|Overall Study|Adverse Event|21|||
125343453|NCT00422084|450890543|FG001|Overall Study|Adverse Event|7|||
125343454|NCT00422084|450890542|FG000|Overall Study|Withdrawal by Subject|12|||
125676609|NCT02199509|452105037|FG001|Overall Study|Suicidal Ideation|1|||
125676610|NCT02199509|452105036|FG000|Overall Study|Misunderstood titration schedule|1|||
125676611|NCT02199509|452105037|FG001|Overall Study|Misunderstood titration schedule|0|||
125676612|NCT03309956|452105038|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
125676613|NCT02768298|452105039|FG000|Overall Study|Adverse Event|1|||
125676614|NCT02768298|452105040|FG001|Overall Study|Adverse Event|4|||
125676615|NCT02768298|452105039|FG000|Overall Study|Death|2|||
125676616|NCT02768298|452105040|FG001|Overall Study|Death|1|||
125676617|NCT02768298|452105039|FG000|Overall Study|Non-compliance with study treatment|0|||
125676618|NCT02768298|452105040|FG001|Overall Study|Non-compliance with study treatment|1|||
125676619|NCT02768298|452105039|FG000|Overall Study|Subject/guardian decision|1|||
125676620|NCT02768298|452105040|FG001|Overall Study|Subject/guardian decision|0|||
125676621|NCT02768298|452105039|FG000|Overall Study|Withdrawal of informed consent|0|||
125676622|NCT02768298|452105040|FG001|Overall Study|Withdrawal of informed consent|1|||
125676623|NCT04603937|452105044|FG000|Overall Study|Adverse Event|9|||
125676624|NCT04603937|452105045|FG001|Overall Study|Adverse Event|10|||
125676625|NCT04603937|452105044|FG000|Overall Study|Withdrawal by Subject|7|||
125676626|NCT04603937|452105045|FG001|Overall Study|Withdrawal by Subject|6|||
125676627|NCT04603937|452105044|FG000|Overall Study|Lost to Follow-up|5|||
125676628|NCT04603937|452105045|FG001|Overall Study|Lost to Follow-up|6|||
125676629|NCT04603937|452105044|FG000|Overall Study|Physician Decision|0|||
125676630|NCT04603937|452105045|FG001|Overall Study|Physician Decision|1|||
125676631|NCT04603937|452105044|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
125676632|NCT04603937|452105045|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
125676633|NCT02518685|452105046|FG000|Overall Study|Adverse Event|29|||
125676634|NCT02518685|452105047|FG001|Overall Study|Adverse Event|1|||
125676635|NCT02518685|452105046|FG000|Overall Study|Withdrawal by Subject|10|||
125676636|NCT02518685|452105047|FG001|Overall Study|Withdrawal by Subject|3|||
125676637|NCT02518685|452105046|FG000|Overall Study|relocation, study fatigue|7|||
125676638|NCT02518685|452105047|FG001|Overall Study|relocation, study fatigue|2|||
125676639|NCT02518685|452105046|FG000|Overall Study|Pregnancy|1|||
125676640|NCT02518685|452105047|FG001|Overall Study|Pregnancy|0|||
125676641|NCT02518685|452105046|FG000|Overall Study|Physician Decision|1|||
125676642|NCT02518685|452105047|FG001|Overall Study|Physician Decision|0|||
125676643|NCT02518685|452105046|FG000|Overall Study|Lost to Follow-up|1|||
125676644|NCT02518685|452105047|FG001|Overall Study|Lost to Follow-up|4|||
125676645|NCT01922349|452105048|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
125676646|NCT01922349|452105049|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
125676647|NCT01922349|452105050|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
125676648|NCT01922349|452105051|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
125676649|NCT01611090|452105052|FG000|Randomized Period|Lost to Follow-up|8|||
125676650|NCT01611090|452105053|FG001|Randomized Period|Lost to Follow-up|3|||
125676651|NCT01611090|452105054|FG002|Randomized Period|Lost to Follow-up|0|||
125676652|NCT01611090|452105052|FG000|Randomized Period|Withdrawal by Subject|22|||
125676653|NCT01611090|452105053|FG001|Randomized Period|Withdrawal by Subject|26|||
125676654|NCT01611090|452105054|FG002|Randomized Period|Withdrawal by Subject|0|||
125676655|NCT01611090|452105052|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
125676656|NCT01611090|452105053|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
125676657|NCT01611090|452105054|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
125676658|NCT01611090|452105052|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
125676659|NCT01611090|452105053|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
125676660|NCT01611090|452105054|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
125676661|NCT01919190|452107501|FG000|Overall Study|Intra-op findings, etc.|3|||
125676662|NCT01919190|452107502|FG001|Overall Study|Intra-op findings, etc.|0|||
125676663|NCT01545076|452107507|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
125676664|NCT01545076|452107508|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
125676665|NCT01545076|452107509|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
125676666|NCT01545076|452107510|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
125676667|NCT01545076|452107511|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
125676668|NCT01545076|452107507|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
125676669|NCT01545076|452107508|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
125676670|NCT01545076|452107509|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
125676671|NCT01545076|452107510|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
125676672|NCT01545076|452107511|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
125676673|NCT01545076|452107507|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
125676674|NCT01545076|452107508|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
125676675|NCT01545076|452107509|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
125676676|NCT01545076|452107510|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
125676677|NCT01545076|452107511|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
125676678|NCT01545076|452107507|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
125676679|NCT01545076|452107508|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
125676680|NCT01545076|452107509|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
125343455|NCT00422084|450890543|FG001|Overall Study|Withdrawal by Subject|9|||
125343456|NCT00422084|450890542|FG000|Overall Study|Lost to Follow-up|14|||
125343457|NCT00422084|450890543|FG001|Overall Study|Lost to Follow-up|9|||
125343458|NCT00422084|450890542|FG000|Overall Study|Protocol Violation|4|||
125343459|NCT00422084|450890543|FG001|Overall Study|Protocol Violation|1|||
125343460|NCT00422084|450890542|FG000|Overall Study|Lack of Efficacy|40|||
125343461|NCT00422084|450890543|FG001|Overall Study|Lack of Efficacy|42|||
125343462|NCT00422084|450890542|FG000|Overall Study|P. vivax infection|3|||
125343463|NCT00422084|450890543|FG001|Overall Study|P. vivax infection|6|||
125343464|NCT00422084|450890542|FG000|Overall Study|Cyesis|1|||
125676681|NCT01545076|452107510|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
125676682|NCT01545076|452107511|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
125676683|NCT01545076|452107507|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
125676684|NCT01545076|452107508|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
125676685|NCT01545076|452107509|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
125676686|NCT01545076|452107510|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
125676687|NCT01545076|452107511|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
125676688|NCT01545076|452107507|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
125676689|NCT01545076|452107508|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
125676690|NCT01545076|452107509|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
125676691|NCT01545076|452107510|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
125676692|NCT01545076|452107511|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
125676693|NCT01545076|452107507|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
125676694|NCT01545076|452107508|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
125676695|NCT01545076|452107509|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
125676696|NCT01545076|452107510|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
125676697|NCT01545076|452107511|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
125676698|NCT01545076|452107507|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
125676699|NCT01545076|452107508|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
125676700|NCT01545076|452107509|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
125676701|NCT01545076|452107510|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
125676702|NCT01545076|452107511|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
125676703|NCT01545076|452107507|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
125676704|NCT01545076|452107508|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
125676705|NCT01545076|452107509|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
125676706|NCT01545076|452107510|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
125343465|NCT00422084|450890543|FG001|Overall Study|Cyesis|0|||
125343466|NCT00422084|450890542|FG000|Overall Study|Withdrawn from study accidentally|1|||
125343467|NCT00422084|450890543|FG001|Overall Study|Withdrawn from study accidentally|0|||
125343468|NCT00422084|450890542|FG000|Overall Study|Non-compliance|1|||
125343469|NCT00422084|450890543|FG001|Overall Study|Non-compliance|0|||
125343470|NCT00422084|450890542|FG000|Overall Study|Re-location|0|||
125343471|NCT00422084|450890543|FG001|Overall Study|Re-location|1|||
125343472|NCT00422084|450890542|FG000|Overall Study|Not defined|1|||
125343473|NCT00422084|450890543|FG001|Overall Study|Not defined|1|||
125343474|NCT02788279|450890544|FG000|Overall Study|Death|62|||
125343475|NCT02788279|450890545|FG001|Overall Study|Death|136|||
125343476|NCT02788279|450890546|FG002|Overall Study|Death|72|||
125343477|NCT02788279|450890544|FG000|Overall Study|Withdrawal by Subject|10|||
125343478|NCT02788279|450890545|FG001|Overall Study|Withdrawal by Subject|15|||
125343479|NCT02788279|450890546|FG002|Overall Study|Withdrawal by Subject|5|||
125343480|NCT02788279|450890544|FG000|Overall Study|Lost to Follow-up|0|||
125343481|NCT02788279|450890545|FG001|Overall Study|Lost to Follow-up|3|||
125343482|NCT02788279|450890546|FG002|Overall Study|Lost to Follow-up|2|||
125343483|NCT02788279|450890544|FG000|Overall Study|Sponsor decision|18|||
125343484|NCT02788279|450890545|FG001|Overall Study|Sponsor decision|29|||
125343485|NCT02788279|450890546|FG002|Overall Study|Sponsor decision|11|||
125343486|NCT03996369|450890547|FG000|Overall Study|Protocol deviation|1|||
125343487|NCT03996369|450890548|FG001|Overall Study|Protocol deviation|1|||
125676707|NCT01545076|452107511|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
125676708|NCT02518113|452107512|FG000|Overall Study|Adverse Event|1|||
125676709|NCT02518113|452107513|FG001|Overall Study|Adverse Event|0|||
125676710|NCT02518113|452107514|FG002|Overall Study|Adverse Event|1|||
125676711|NCT02518113|452107515|FG003|Overall Study|Adverse Event|0|||
125676712|NCT02518113|452107512|FG000|Overall Study|Death|1|||
125676713|NCT02518113|452107513|FG001|Overall Study|Death|2|||
125676714|NCT02518113|452107514|FG002|Overall Study|Death|0|||
125676715|NCT02518113|452107515|FG003|Overall Study|Death|0|||
125676716|NCT02518113|452107512|FG000|Overall Study|Physician Decision|0|||
125676717|NCT02518113|452107513|FG001|Overall Study|Physician Decision|1|||
125343488|NCT03996369|450890547|FG000|Overall Study|Physician Decision|4|||
125676718|NCT02518113|452107514|FG002|Overall Study|Physician Decision|0|||
125343489|NCT03996369|450890548|FG001|Overall Study|Physician Decision|2|||
125343490|NCT03996369|450890547|FG000|Overall Study|Participant decision|0|||
125343491|NCT03996369|450890548|FG001|Overall Study|Participant decision|1|||
125676719|NCT02518113|452107515|FG003|Overall Study|Physician Decision|0|||
125676720|NCT02518113|452107512|FG000|Overall Study|Progressive Disease|1|||
125676721|NCT02518113|452107513|FG001|Overall Study|Progressive Disease|2|||
125343492|NCT03996369|450890547|FG000|Overall Study|Lack of Efficacy|4|||
125676722|NCT02518113|452107514|FG002|Overall Study|Progressive Disease|3|||
125676723|NCT02518113|452107515|FG003|Overall Study|Progressive Disease|0|||
125676724|NCT00797108|452107516|FG000|Overall Study|Adverse Event|1|||
125676725|NCT00797108|452107517|FG001|Overall Study|Adverse Event|0|||
125676726|NCT00797108|452107518|FG002|Overall Study|Adverse Event|3|||
125676727|NCT00797108|452107516|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
125676728|NCT00797108|452107517|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
125676729|NCT00797108|452107518|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
125676730|NCT00797108|452107516|FG000|Overall Study|Global Deterioration of Health Status|0|||
125676731|NCT00797108|452107517|FG001|Overall Study|Global Deterioration of Health Status|1|||
125676732|NCT00797108|452107518|FG002|Overall Study|Global Deterioration of Health Status|0|||
125676733|NCT00797108|452107516|FG000|Overall Study|Lack of Efficacy|1|||
125676734|NCT00797108|452107517|FG001|Overall Study|Lack of Efficacy|0|||
125676735|NCT00797108|452107518|FG002|Overall Study|Lack of Efficacy|1|||
125676736|NCT00797108|452107516|FG000|Overall Study|Other|0|||
125676737|NCT00797108|452107517|FG001|Overall Study|Other|0|||
125676738|NCT00797108|452107518|FG002|Overall Study|Other|2|||
125676739|NCT00797108|452107516|FG000|Overall Study|Randomized but not Treated|2|||
125676740|NCT00797108|452107517|FG001|Overall Study|Randomized but not Treated|0|||
125676741|NCT00797108|452107518|FG002|Overall Study|Randomized but not Treated|0|||
125676742|NCT02270736|452107519|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
125676743|NCT02270736|452107520|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
125676744|NCT02270736|452107521|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
125676745|NCT02270736|452107522|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
125676746|NCT02270736|452107523|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
125676747|NCT02270736|452107519|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
125676748|NCT02270736|452107520|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
125676749|NCT02270736|452107521|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
125676750|NCT02270736|452107522|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
125676751|NCT02270736|452107523|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
125676752|NCT02270736|452107519|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
125676753|NCT02270736|452107520|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
125676754|NCT02270736|452107521|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
125676755|NCT02270736|452107522|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
125343493|NCT03996369|450890548|FG001|Overall Study|Lack of Efficacy|0|||
125343494|NCT03996369|450890547|FG000|Overall Study|Adverse Event|9|||
125343495|NCT03996369|450890548|FG001|Overall Study|Adverse Event|0|||
125343496|NCT03996369|450890547|FG000|Overall Study|Withdrawal by Subject|6|||
125343497|NCT03996369|450890548|FG001|Overall Study|Withdrawal by Subject|8|||
125343498|NCT03996369|450890547|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
125676756|NCT02270736|452107523|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
125676757|NCT02270736|452107519|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
125676758|NCT02270736|452107520|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
125676759|NCT02270736|452107521|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
125676760|NCT02270736|452107522|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
125676761|NCT02270736|452107523|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
125676762|NCT02270736|452107519|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
125676763|NCT02270736|452107520|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
125676764|NCT02270736|452107521|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
125676765|NCT02270736|452107522|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
125676766|NCT02270736|452107523|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
125676767|NCT02270736|452107519|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
125676768|NCT02270736|452107520|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
125676769|NCT02270736|452107521|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
125676770|NCT02270736|452107522|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
125676771|NCT02270736|452107523|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
125676772|NCT02270736|452107519|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
125676773|NCT02270736|452107520|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
125676774|NCT02270736|452107521|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
125676775|NCT02270736|452107522|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
125676776|NCT02270736|452107523|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
125676777|NCT02270736|452107519|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
125676778|NCT02270736|452107520|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
125676779|NCT02270736|452107521|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
125676780|NCT02270736|452107522|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
125676781|NCT02270736|452107523|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
125676782|NCT02270736|452107519|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
125676783|NCT02270736|452107520|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
125676784|NCT02270736|452107521|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
125676785|NCT02270736|452107522|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
125676786|NCT02270736|452107523|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
125676787|NCT04471207|452107526|FG000|Overall Study|Lost to Follow-up|4|||
125676788|NCT04471207|452107527|FG001|Overall Study|Lost to Follow-up|1|||
125676789|NCT04471207|452107526|FG000|Overall Study|Medication Contraindication|0|||
125676790|NCT04471207|452107527|FG001|Overall Study|Medication Contraindication|1|||
125676791|NCT04471207|452107526|FG000|Overall Study|Loss of Interest|2|||
125676792|NCT04471207|452107527|FG001|Overall Study|Loss of Interest|1|||
125676793|NCT04471207|452107526|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
125676794|NCT04471207|452107527|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
125676795|NCT04471207|452107526|FG000|Overall Study|Scheduling Conflicts|3|||
125676796|NCT04471207|452107527|FG001|Overall Study|Scheduling Conflicts|1|||
125676797|NCT04471207|452107526|FG000|Overall Study|Physician Decision|1|||
125676798|NCT04471207|452107527|FG001|Overall Study|Physician Decision|0|||
125676799|NCT04471207|452107526|FG000|Overall Study|Unwilling to Use System|0|||
125676800|NCT04471207|452107527|FG001|Overall Study|Unwilling to Use System|1|||
125676801|NCT00561730|452107528|FG000|Overall Study|Adverse Event|2|||
125676802|NCT00561730|452107528|FG000|Overall Study|Handling of the drug|1|||
125676803|NCT00561730|452107528|FG000|Overall Study|Lost to Follow-up|5|||
125676804|NCT00561730|452107528|FG000|Overall Study|Not specified reasons|1|||
125676805|NCT00376220|452107529|FG000|Overall Study|Lost to Follow-up|7|||
125676806|NCT00376220|452107530|FG001|Overall Study|Lost to Follow-up|10|||
125676807|NCT00376220|452107529|FG000|Overall Study|Withdrawal by Subject|3|||
125676808|NCT00376220|452107530|FG001|Overall Study|Withdrawal by Subject|2|||
125676809|NCT00531206|452107535|FG000|Overall Study|Adverse Event related|5|||
125676810|NCT00531206|452107535|FG000|Overall Study|Lack of Efficacy|2|||
125676811|NCT00531206|452107535|FG000|Overall Study|Lost to Follow-up|5|||
125676812|NCT00531206|452107535|FG000|Overall Study|including non-related adverse events|8|||
125676813|NCT00920140|452107536|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
125676814|NCT00920140|452107537|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
125676815|NCT00920140|452107538|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
125676816|NCT00920140|452107539|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
125676817|NCT00920140|452107540|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
125676818|NCT00920140|452107536|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
125676819|NCT00920140|452107537|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
125676820|NCT00920140|452107538|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
125676821|NCT00920140|452107539|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
125676822|NCT00920140|452107540|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
125343499|NCT03996369|450890548|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
125676823|NCT00920140|452107536|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125676824|NCT00920140|452107537|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
125676825|NCT00920140|452107538|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125676826|NCT00920140|452107539|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125676827|NCT00920140|452107540|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125676828|NCT00920140|452107536|FG000|Phase 2|Adverse Event|0|||
125676829|NCT00920140|452107537|FG001|Phase 2|Adverse Event|0|||
125676830|NCT00920140|452107538|FG002|Phase 2|Adverse Event|14|||
125676831|NCT00920140|452107539|FG003|Phase 2|Adverse Event|2|||
125676832|NCT00920140|452107540|FG004|Phase 2|Adverse Event|3|||
125676833|NCT00920140|452107536|FG000|Phase 2|Lack of Efficacy|0|||
125676834|NCT00920140|452107537|FG001|Phase 2|Lack of Efficacy|0|||
125676835|NCT00920140|452107538|FG002|Phase 2|Lack of Efficacy|29|||
125676836|NCT00920140|452107539|FG003|Phase 2|Lack of Efficacy|14|||
125676837|NCT00920140|452107540|FG004|Phase 2|Lack of Efficacy|5|||
125676838|NCT00920140|452107536|FG000|Phase 2|Lost to Follow-up|0|||
125676839|NCT00920140|452107537|FG001|Phase 2|Lost to Follow-up|0|||
125343500|NCT03996369|450890547|FG000|Overall Study|Lost to Follow-up|0|||
125343501|NCT03996369|450890548|FG001|Overall Study|Lost to Follow-up|1|||
125343502|NCT00329849|450890549|FG000|Overall Study|Withdrawal by Subject|6|||
125343503|NCT00329849|450890550|FG001|Overall Study|Withdrawal by Subject|4|||
125343504|NCT02238067|450890551|FG000|Overall Study|Not completed survey at Month 6|45|||
125343505|NCT01566214|450890553|FG000|Overall Study|Lost to Follow-up|3|||
125343506|NCT01566214|450890554|FG001|Overall Study|Lost to Follow-up|0|||
125343507|NCT00832624|450890558|FG000|Overall Study|Study Terminated|10|||
125343508|NCT02395172|450890559|FG000|Overall Study|Participants randomized but not treated|3|||
125343509|NCT02395172|450890560|FG001|Overall Study|Participants randomized but not treated|31|||
125343510|NCT00717236|450890561|FG000|Double-Blind Period|Adverse Event|33|||
125343511|NCT00717236|450890562|FG001|Double-Blind Period|Adverse Event|6|||
125343512|NCT00717236|450890561|FG000|Double-Blind Period|Lack of Efficacy|6|||
125343513|NCT00717236|450890562|FG001|Double-Blind Period|Lack of Efficacy|6|||
125343514|NCT00717236|450890561|FG000|Double-Blind Period|Lost to Follow-up|3|||
125343515|NCT00717236|450890562|FG001|Double-Blind Period|Lost to Follow-up|5|||
125343516|NCT00717236|450890561|FG000|Double-Blind Period|Withdrawal by Subject|10|||
125343517|NCT00717236|450890562|FG001|Double-Blind Period|Withdrawal by Subject|2|||
125343518|NCT00717236|450890561|FG000|Double-Blind Period|Loss of efficacy|3|||
125343519|NCT00717236|450890562|FG001|Double-Blind Period|Loss of efficacy|0|||
125343520|NCT00717236|450890561|FG000|Double-Blind Period|Other: Death|1|||
125343521|NCT00717236|450890562|FG001|Double-Blind Period|Other: Death|0|||
125343522|NCT00717236|450890561|FG000|Double-Blind Period|Other: Pregnancy|1|||
125343523|NCT00717236|450890562|FG001|Double-Blind Period|Other: Pregnancy|0|||
125343524|NCT00717236|450890561|FG000|Double-Blind Period|Other: Protocol Violation|2|||
125343525|NCT00717236|450890562|FG001|Double-Blind Period|Other: Protocol Violation|0|||
125343526|NCT00717236|450890561|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
125343527|NCT00717236|450890562|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
125343528|NCT00717236|450890561|FG000|Double-Blind Period|Other: Site withdrew|2|||
125343529|NCT00717236|450890562|FG001|Double-Blind Period|Other: Site withdrew|0|||
125343530|NCT00717236|450890561|FG000|Double-Blind Period|Other: Screening failure|1|||
125676840|NCT00920140|452107538|FG002|Phase 2|Lost to Follow-up|0|||
125676841|NCT00920140|452107539|FG003|Phase 2|Lost to Follow-up|1|||
125676842|NCT00920140|452107540|FG004|Phase 2|Lost to Follow-up|0|||
125676843|NCT00920140|452107536|FG000|Phase 2|Physician Decision|0|||
125676844|NCT00920140|452107537|FG001|Phase 2|Physician Decision|0|||
125676845|NCT00920140|452107538|FG002|Phase 2|Physician Decision|3|||
125676846|NCT00920140|452107539|FG003|Phase 2|Physician Decision|3|||
125676847|NCT00920140|452107540|FG004|Phase 2|Physician Decision|2|||
125676848|NCT00920140|452107536|FG000|Phase 2|Withdrawal by Subject|0|||
125676849|NCT00920140|452107537|FG001|Phase 2|Withdrawal by Subject|0|||
125676850|NCT00920140|452107538|FG002|Phase 2|Withdrawal by Subject|4|||
125676851|NCT00920140|452107539|FG003|Phase 2|Withdrawal by Subject|2|||
125676852|NCT00920140|452107540|FG004|Phase 2|Withdrawal by Subject|1|||
125676853|NCT01124149|452107541|FG000|Acute Phase|Withdrawal by Subject|22|||
125676854|NCT01124149|452107541|FG000|Acute Phase|Adverse Event|21|||
125676855|NCT01124149|452107541|FG000|Acute Phase|Lack of Efficacy|17|||
125676856|NCT01124149|452107541|FG000|Acute Phase|Protocol Violation|14|||
125676857|NCT01124149|452107541|FG000|Acute Phase|Lost to Follow-up|2|||
125676858|NCT01124149|452107541|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
125676859|NCT01124149|452107541|FG000|Acute Phase|Sponsor request|1|||
125676860|NCT01124149|452107541|FG000|Acute Phase|UC symptoms not ameliorated|1|||
125676861|NCT01124149|452107541|FG000|Acute Phase|Non-compliance|1|||
125676862|NCT01124149|452107541|FG000|Acute Phase|Low hemoglobin|1|||
125676863|NCT01124149|452107541|FG000|Acute Phase|Travelling to another country|1|||
125676864|NCT01124149|452107541|FG000|Acute Phase|Sponsor decision|1|||
125676865|NCT01124149|452107541|FG000|Maintenance Phase|Lack of Efficacy|40|||
125676866|NCT01124149|452107541|FG000|Maintenance Phase|Adverse Event|24|||
125676867|NCT01124149|452107541|FG000|Maintenance Phase|Lost to Follow-up|15|||
125676868|NCT01124149|452107541|FG000|Maintenance Phase|Withdrawal by Subject|10|||
125676869|NCT01124149|452107541|FG000|Maintenance Phase|Protocol Violation|5|||
125676870|NCT01124149|452107541|FG000|Maintenance Phase|Coordinator error|1|||
125676871|NCT01124149|452107541|FG000|Maintenance Phase|Non-compliance|1|||
125676872|NCT01644500|452107542|FG000|Overall Study|Adverse Event|6|||
125676873|NCT01644500|452107543|FG001|Overall Study|Adverse Event|1|||
125676874|NCT01644500|452107544|FG002|Overall Study|Adverse Event|2|||
125343531|NCT00717236|450890562|FG001|Double-Blind Period|Other: Screening failure|0|||
125343532|NCT00717236|450890561|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
125343533|NCT00717236|450890562|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
125343534|NCT00717236|450890561|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
125676875|NCT01644500|452107542|FG000|Overall Study|Death|0|||
125676876|NCT01644500|452107543|FG001|Overall Study|Death|1|||
125676877|NCT01644500|452107544|FG002|Overall Study|Death|0|||
125676878|NCT01644500|452107542|FG000|Overall Study|Lost to Follow-up|3|||
125676879|NCT01644500|452107543|FG001|Overall Study|Lost to Follow-up|8|||
125676880|NCT01644500|452107544|FG002|Overall Study|Lost to Follow-up|0|||
125343535|NCT00717236|450890562|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
125343536|NCT00717236|450890561|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
125343537|NCT00717236|450890562|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
125343538|NCT00717236|450890561|FG000|Double-Blind Period|Other: History of cancer|1|||
125343539|NCT00717236|450890562|FG001|Double-Blind Period|Other: History of cancer|0|||
125343540|NCT00717236|450890561|FG000|Double-Blind Period|Other: Sponsor request|1|||
125343541|NCT00717236|450890562|FG001|Double-Blind Period|Other: Sponsor request|0|||
125343542|NCT00717236|450890561|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
125343543|NCT00717236|450890562|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
125343544|NCT00717236|450890561|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
125343545|NCT00717236|450890562|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
125343546|NCT00717236|450890561|FG000|Double-Blind Period|Other: Subject moved|1|||
125343547|NCT00717236|450890562|FG001|Double-Blind Period|Other: Subject moved|1|||
125343548|NCT00717236|450890561|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
125343549|NCT00717236|450890562|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
125343550|NCT00717236|450890561|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
125343551|NCT00717236|450890562|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
125343552|NCT00717236|450890561|FG000|Double-Blind Period|Other: Transportation problems|0|||
125343553|NCT00717236|450890562|FG001|Double-Blind Period|Other: Transportation problems|1|||
125343554|NCT00717236|450890561|FG000|Double-Blind Period|Other: Investigator Decision|0|||
125343555|NCT00717236|450890562|FG001|Double-Blind Period|Other: Investigator Decision|1|||
125343556|NCT00717236|450890561|FG000|Open-Label Period|Adverse Event|29|||
125343557|NCT00717236|450890562|FG001|Open-Label Period|Adverse Event|4|||
125343558|NCT00717236|450890561|FG000|Open-Label Period|Lack of Efficacy|30|||
125343559|NCT00717236|450890562|FG001|Open-Label Period|Lack of Efficacy|8|||
125343560|NCT00717236|450890561|FG000|Open-Label Period|Lost to Follow-up|28|||
125343561|NCT00717236|450890562|FG001|Open-Label Period|Lost to Follow-up|4|||
125343562|NCT00717236|450890561|FG000|Open-Label Period|Withdrawal by Subject|20|||
125343563|NCT00717236|450890562|FG001|Open-Label Period|Withdrawal by Subject|2|||
125343564|NCT00717236|450890561|FG000|Open-Label Period|Loss of Efficacy|6|||
125343565|NCT00717236|450890562|FG001|Open-Label Period|Loss of Efficacy|1|||
125343566|NCT00717236|450890561|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
125343567|NCT00717236|450890562|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
125343568|NCT00717236|450890561|FG000|Open-Label Period|Other: Lack of Compliance|1|||
125343569|NCT00717236|450890562|FG001|Open-Label Period|Other: Lack of Compliance|1|||
125343570|NCT00717236|450890561|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
125343571|NCT00717236|450890562|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
125343572|NCT00717236|450890561|FG000|Open-Label Period|Other: Moved|1|||
125343573|NCT00717236|450890562|FG001|Open-Label Period|Other: Moved|0|||
125343574|NCT00717236|450890561|FG000|Open-Label Period|Other: Investigator Decision|1|||
125343575|NCT00717236|450890562|FG001|Open-Label Period|Other: Investigator Decision|0|||
125343576|NCT00717236|450890561|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
125343577|NCT00717236|450890562|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
125343578|NCT00717236|450890561|FG000|Open-Label Period|Other: Sponsor Request|3|||
125343579|NCT00717236|450890562|FG001|Open-Label Period|Other: Sponsor Request|0|||
125343580|NCT00717236|450890561|FG000|Open-Label Period|Other: Cataract Surgery|1|||
125343581|NCT00717236|450890562|FG001|Open-Label Period|Other: Cataract Surgery|0|||
125343582|NCT00717236|450890561|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
125343583|NCT00717236|450890562|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
125343584|NCT00717236|450890561|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
125343585|NCT00717236|450890562|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
125343586|NCT00717236|450890561|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
125343587|NCT00717236|450890562|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
125343588|NCT00475982|450890563|FG000|Overall Study|surgery rescheduled|7|||
125343589|NCT00475982|450890564|FG001|Overall Study|surgery rescheduled|3|||
125343590|NCT00783198|450890569|FG000|Overall Study|Adverse Event|15|||
125343591|NCT00783198|450890570|FG001|Overall Study|Adverse Event|19|||
125343592|NCT00783198|450890571|FG002|Overall Study|Adverse Event|3|||
125343593|NCT00783198|450890569|FG000|Overall Study|Lost to Follow-up|11|||
125343594|NCT00783198|450890570|FG001|Overall Study|Lost to Follow-up|1|||
125343595|NCT00783198|450890571|FG002|Overall Study|Lost to Follow-up|7|||
125343596|NCT00783198|450890569|FG000|Overall Study|Withdrawal by Subject|22|||
125343597|NCT00783198|450890570|FG001|Overall Study|Withdrawal by Subject|14|||
125343598|NCT00783198|450890571|FG002|Overall Study|Withdrawal by Subject|20|||
125343599|NCT00783198|450890569|FG000|Overall Study|Noncompliance with protocol|7|||
125343600|NCT00783198|450890570|FG001|Overall Study|Noncompliance with protocol|7|||
125343601|NCT00783198|450890571|FG002|Overall Study|Noncompliance with protocol|10|||
125343602|NCT00783198|450890569|FG000|Overall Study|Did not meet protocol eligibility|0|||
125343603|NCT00783198|450890570|FG001|Overall Study|Did not meet protocol eligibility|1|||
125343604|NCT00783198|450890571|FG002|Overall Study|Did not meet protocol eligibility|0|||
125343605|NCT00783198|450890569|FG000|Overall Study|Administrative|2|||
125343606|NCT00783198|450890570|FG001|Overall Study|Administrative|1|||
125343607|NCT00783198|450890571|FG002|Overall Study|Administrative|2|||
125343608|NCT00946985|450890572|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
125343609|NCT00946985|450890572|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
125343610|NCT00946985|450890572|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
125343611|NCT00946985|450890572|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
125343612|NCT00946985|450890572|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
125343613|NCT00946985|450890572|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
125343614|NCT00946985|450890572|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
125343615|NCT00946985|450890572|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
125343616|NCT00946985|450890572|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
125343617|NCT04345367|450890573|FG000|Overall Study|Other|3|||
125343618|NCT04345367|450890574|FG001|Overall Study|Other|4|||
125343619|NCT04345367|450890573|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
125343620|NCT04345367|450890574|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
125343621|NCT04345367|450890573|FG000|Overall Study|Withdrawal by Subject|11|||
125343622|NCT04345367|450890574|FG001|Overall Study|Withdrawal by Subject|11|||
125343623|NCT04345367|450890573|FG000|Overall Study|Protocol Violation|4|||
125343624|NCT04345367|450890574|FG001|Overall Study|Protocol Violation|3|||
125343625|NCT04345367|450890573|FG000|Overall Study|Lost to Follow-up|2|||
125343626|NCT04345367|450890574|FG001|Overall Study|Lost to Follow-up|4|||
125343627|NCT04345367|450890573|FG000|Overall Study|Lack of Efficacy|2|||
125343628|NCT04345367|450890574|FG001|Overall Study|Lack of Efficacy|0|||
125343629|NCT04345367|450890573|FG000|Overall Study|Death|2|||
125343630|NCT04345367|450890574|FG001|Overall Study|Death|0|||
125343631|NCT04345367|450890573|FG000|Overall Study|Adverse Event|10|||
125343632|NCT04345367|450890574|FG001|Overall Study|Adverse Event|9|||
125425618|NCT04128293|451182292|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
125425619|NCT04128293|451182293|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
125425620|NCT04128293|451182294|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
125425621|NCT04128293|451182295|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
125425622|NCT02127372|451182300|FG000|Overall Study|Withdrawal by Subject|1|||
125425623|NCT02127372|451182301|FG001|Overall Study|Withdrawal by Subject|0|||
125425624|NCT03597568|451182302|FG000|Overall Study|Withdrawal by Subject|1|||
125425625|NCT03597568|451182303|FG001|Overall Study|Withdrawal by Subject|1|||
125425626|NCT03597568|451182302|FG000|Overall Study|Unable to analyze vascular data|1|||
125425627|NCT03597568|451182303|FG001|Overall Study|Unable to analyze vascular data|1|||
125425628|NCT01357616|451182307|FG000|Overall Study|Adverse Event|1|||
125425629|NCT01357616|451182308|FG001|Overall Study|Adverse Event|1|||
125425630|NCT01357616|451182307|FG000|Overall Study|Lost to Follow-up|4|||
125425631|NCT01357616|451182308|FG001|Overall Study|Lost to Follow-up|3|||
125425632|NCT01357616|451182307|FG000|Overall Study|Protocol Violation|0|||
125425633|NCT01357616|451182308|FG001|Overall Study|Protocol Violation|2|||
125676881|NCT01644500|452107542|FG000|Overall Study|Protocol Violation|1|||
125676882|NCT01644500|452107543|FG001|Overall Study|Protocol Violation|1|||
125676883|NCT01644500|452107544|FG002|Overall Study|Protocol Violation|0|||
125676884|NCT01644500|452107542|FG000|Overall Study|Withdrawal by Subject|11|||
125676885|NCT01644500|452107543|FG001|Overall Study|Withdrawal by Subject|12|||
125676886|NCT01644500|452107544|FG002|Overall Study|Withdrawal by Subject|12|||
125676887|NCT01644500|452107542|FG000|Overall Study|Physician Decision|1|||
125343633|NCT00852371|450890575|FG000|Overall Study|Lost to Follow-up|2|||
125343634|NCT00852371|450890576|FG001|Overall Study|Lost to Follow-up|3|||
125343635|NCT00852371|450890577|FG002|Overall Study|Lost to Follow-up|4|||
125343636|NCT00852371|450890578|FG003|Overall Study|Lost to Follow-up|2|||
125343637|NCT00796523|450890579|FG000|Overall Study|Lost to Follow-up|9|||
125343638|NCT00796523|450890580|FG001|Overall Study|Lost to Follow-up|7|||
125343639|NCT04525885|450890581|FG000|Overall Study|Screen Failure|1|||
125343640|NCT04525885|450890582|FG001|Overall Study|Screen Failure|0|||
125343641|NCT04525885|450890583|FG002|Overall Study|Screen Failure|0|||
125343642|NCT04525885|450890581|FG000|Overall Study|Withdrawal by Subject|14|||
125343643|NCT04525885|450890582|FG001|Overall Study|Withdrawal by Subject|6|||
125343644|NCT04525885|450890583|FG002|Overall Study|Withdrawal by Subject|20|||
125343645|NCT04525885|450890581|FG000|Overall Study|Physician Decision|1|||
125343646|NCT04525885|450890582|FG001|Overall Study|Physician Decision|0|||
125343647|NCT04525885|450890583|FG002|Overall Study|Physician Decision|1|||
125343648|NCT00978757|450890592|FG000|Overall Study|Physician Decision|1|||
125343649|NCT00978757|450890593|FG001|Overall Study|Physician Decision|3|||
125343650|NCT01700387|450890594|FG000|Overall Study|Withdrawal by Subject|1|||
125343651|NCT01700387|450890595|FG001|Overall Study|Withdrawal by Subject|2|||
125343652|NCT01700387|450890594|FG000|Overall Study|Adverse Event|1|||
125343653|NCT01700387|450890595|FG001|Overall Study|Adverse Event|1|||
125343654|NCT01700387|450890594|FG000|Overall Study|Lost to Follow-up|2|||
125343655|NCT01700387|450890595|FG001|Overall Study|Lost to Follow-up|1|||
125343656|NCT01325337|450892236|FG000|Overall Study|Adverse Event|0|||
125343657|NCT01325337|450892237|FG001|Overall Study|Adverse Event|2|||
125343658|NCT01325337|450892238|FG002|Overall Study|Adverse Event|2|||
125343659|NCT01325337|450892239|FG003|Overall Study|Adverse Event|1|||
125343660|NCT01325337|450892240|FG004|Overall Study|Adverse Event|2|||
125343661|NCT01325337|450892236|FG000|Overall Study|Lost to Follow-up|2|||
125343662|NCT01325337|450892237|FG001|Overall Study|Lost to Follow-up|2|||
125343663|NCT01325337|450892238|FG002|Overall Study|Lost to Follow-up|2|||
125343664|NCT01325337|450892239|FG003|Overall Study|Lost to Follow-up|1|||
125343665|NCT01325337|450892240|FG004|Overall Study|Lost to Follow-up|2|||
125343666|NCT01325337|450892236|FG000|Overall Study|Personal Reasons|2|||
125343667|NCT01325337|450892237|FG001|Overall Study|Personal Reasons|5|||
125343668|NCT01325337|450892238|FG002|Overall Study|Personal Reasons|4|||
125343669|NCT01325337|450892239|FG003|Overall Study|Personal Reasons|8|||
125676888|NCT01644500|452107543|FG001|Overall Study|Physician Decision|1|||
125676889|NCT01644500|452107544|FG002|Overall Study|Physician Decision|1|||
125343670|NCT01325337|450892240|FG004|Overall Study|Personal Reasons|3|||
125343671|NCT01325337|450892236|FG000|Overall Study|Withdrawal by Subject|1|||
125343672|NCT01325337|450892237|FG001|Overall Study|Withdrawal by Subject|0|||
125343673|NCT01325337|450892238|FG002|Overall Study|Withdrawal by Subject|1|||
125676890|NCT02153398|452107551|FG000|Overall Study|Withdrawal by Subject|1|||
125676891|NCT02153398|452107552|FG001|Overall Study|Withdrawal by Subject|0|||
125676892|NCT02153398|452107553|FG002|Overall Study|Withdrawal by Subject|0|||
125676893|NCT02153398|452107554|FG003|Overall Study|Withdrawal by Subject|0|||
125676894|NCT02153398|452107555|FG004|Overall Study|Withdrawal by Subject|0|||
125676895|NCT02153398|452107551|FG000|Overall Study|Adverse Event|0|||
125676896|NCT02153398|452107552|FG001|Overall Study|Adverse Event|0|||
125676897|NCT02153398|452107553|FG002|Overall Study|Adverse Event|1|||
125676898|NCT02153398|452107554|FG003|Overall Study|Adverse Event|1|||
125676899|NCT02153398|452107555|FG004|Overall Study|Adverse Event|0|||
125676900|NCT00721409|452107556|FG000|Overall Study|Global deterioration of health status|2|||
125676901|NCT00721409|452107557|FG001|Overall Study|Global deterioration of health status|6|||
125676902|NCT00721409|452107558|FG002|Overall Study|Global deterioration of health status|3|||
125676903|NCT00721409|452107556|FG000|Overall Study|Death|0|||
125676904|NCT00721409|452107557|FG001|Overall Study|Death|1|||
125676905|NCT00721409|452107558|FG002|Overall Study|Death|0|||
125676906|NCT00721409|452107556|FG000|Overall Study|Randomized not Treated|0|||
125676907|NCT00721409|452107557|FG001|Overall Study|Randomized not Treated|1|||
125343674|NCT01325337|450892239|FG003|Overall Study|Withdrawal by Subject|0|||
125343675|NCT01325337|450892240|FG004|Overall Study|Withdrawal by Subject|1|||
125343676|NCT00362180|450892241|FG000|Treated Period|Withdrawal by Subject|1|||
125676908|NCT00721409|452107558|FG002|Overall Study|Randomized not Treated|4|||
125676909|NCT00721409|452107556|FG000|Overall Study|Reason not specified|1|||
125676910|NCT00721409|452107557|FG001|Overall Study|Reason not specified|0|||
125676911|NCT00721409|452107558|FG002|Overall Study|Reason not specified|2|||
125676912|NCT00721409|452107556|FG000|Overall Study|Adverse Event|0|||
125676913|NCT00721409|452107557|FG001|Overall Study|Adverse Event|13|||
125343677|NCT00362180|450892242|FG001|Treated Period|Withdrawal by Subject|0|||
125676914|NCT00721409|452107558|FG002|Overall Study|Adverse Event|2|||
125676915|NCT00721409|452107556|FG000|Overall Study|Lost to Follow-up|0|||
125676916|NCT00721409|452107557|FG001|Overall Study|Lost to Follow-up|0|||
125676917|NCT00721409|452107558|FG002|Overall Study|Lost to Follow-up|1|||
125676918|NCT00721409|452107556|FG000|Overall Study|Withdrawal by Subject|1|||
125676919|NCT00721409|452107557|FG001|Overall Study|Withdrawal by Subject|6|||
125676920|NCT00721409|452107558|FG002|Overall Study|Withdrawal by Subject|5|||
125343678|NCT00362180|450892243|FG002|Treated Period|Withdrawal by Subject|0|||
125343679|NCT00362180|450892244|FG003|Treated Period|Withdrawal by Subject|0|||
125343680|NCT00362180|450892245|FG004|Treated Period|Withdrawal by Subject|0|||
125343681|NCT00362180|450892246|FG005|Treated Period|Withdrawal by Subject|0|||
125343682|NCT00362180|450892247|FG006|Treated Period|Withdrawal by Subject|0|||
125343683|NCT00362180|450892248|FG007|Treated Period|Withdrawal by Subject|0|||
125676921|NCT00721409|452107556|FG000|Overall Study|Objective progression or relapse|8|||
125676922|NCT00721409|452107557|FG001|Overall Study|Objective progression or relapse|55|||
125676923|NCT00721409|452107558|FG002|Overall Study|Objective progression or relapse|62|||
125676924|NCT02402166|452107559|FG000|Overall Study|Adverse Event|2|||
125343684|NCT00362180|450892249|FG008|Treated Period|Withdrawal by Subject|0|||
125343685|NCT00362180|450892241|FG000|Treated Period|Adverse Event|0|||
125343686|NCT00362180|450892242|FG001|Treated Period|Adverse Event|0|||
125343687|NCT00362180|450892243|FG002|Treated Period|Adverse Event|0|||
125676925|NCT02402166|452107559|FG000|Overall Study|Withdrawal by Subject|2|||
125676926|NCT02402166|452107559|FG000|Overall Study|Lost to Follow-up|1|||
125676927|NCT00322491|452107563|FG000|Overall Study|Adverse Event|1|||
125343688|NCT00362180|450892244|FG003|Treated Period|Adverse Event|0|||
125343689|NCT00362180|450892245|FG004|Treated Period|Adverse Event|0|||
125343690|NCT00362180|450892246|FG005|Treated Period|Adverse Event|1|||
125343691|NCT00362180|450892247|FG006|Treated Period|Adverse Event|0|||
125343692|NCT00362180|450892248|FG007|Treated Period|Adverse Event|1|||
125343693|NCT00362180|450892249|FG008|Treated Period|Adverse Event|0|||
125343694|NCT02434471|450892259|FG000|Overall Study|Physician Decision|9|||
125343695|NCT00369629|450892260|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
125343696|NCT00369629|450892261|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
125343697|NCT00369629|450892262|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
125343698|NCT00369629|450892263|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
125343699|NCT00369629|450892260|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
125343700|NCT00369629|450892261|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
125343701|NCT00369629|450892262|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
125343702|NCT00369629|450892263|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
125343703|NCT00369629|450892260|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
125343704|NCT00369629|450892261|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
125343705|NCT00369629|450892262|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
125343706|NCT00369629|450892263|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
125343707|NCT00369629|450892260|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
125343708|NCT00369629|450892261|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
125343709|NCT00369629|450892262|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
125343710|NCT00369629|450892263|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
125343711|NCT00369629|450892260|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
125343712|NCT00369629|450892261|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
125343713|NCT00369629|450892262|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
125343714|NCT00369629|450892263|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
125343715|NCT00369629|450892260|FG000|Completed 4 More Cycles|Progressive disease|2|||
125343716|NCT00369629|450892261|FG001|Completed 4 More Cycles|Progressive disease|1|||
125343717|NCT00369629|450892262|FG002|Completed 4 More Cycles|Progressive disease|2|||
125343718|NCT00369629|450892263|FG003|Completed 4 More Cycles|Progressive disease|0|||
125343719|NCT00369629|450892260|FG000|Follow up for 1 Year|Death|2|||
125343720|NCT00369629|450892261|FG001|Follow up for 1 Year|Death|1|||
125343721|NCT00369629|450892262|FG002|Follow up for 1 Year|Death|1|||
125343722|NCT00369629|450892263|FG003|Follow up for 1 Year|Death|0|||
125343723|NCT00369629|450892260|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
125343724|NCT00369629|450892261|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
125343725|NCT00369629|450892262|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
125343726|NCT00369629|450892263|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
125343727|NCT00369629|450892260|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
125343728|NCT00369629|450892261|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
125676928|NCT00322491|452107564|FG001|Overall Study|Adverse Event|0|||
125676929|NCT00322491|452107563|FG000|Overall Study|Death|1|||
125676930|NCT00322491|452107564|FG001|Overall Study|Death|2|||
125676931|NCT01400425|452107566|FG000|Overall Study|Withdrawal by Subject|10|||
125676932|NCT01424722|452107567|FG000|Overall Study|Sponsor terminated investigation|2258|||
125676933|NCT00818883|452107568|FG000|Overall Study|Adverse Event|28|||
125676934|NCT00818883|452107569|FG001|Overall Study|Adverse Event|19|||
125676935|NCT00818883|452107568|FG000|Overall Study|Protocol Violation|2|||
125676936|NCT00818883|452107569|FG001|Overall Study|Protocol Violation|2|||
125676937|NCT00818883|452107568|FG000|Overall Study|Lost to Follow-up|3|||
125676938|NCT00818883|452107569|FG001|Overall Study|Lost to Follow-up|2|||
125676939|NCT00818883|452107568|FG000|Overall Study|Withdrawal by Subject|16|||
125676940|NCT00818883|452107569|FG001|Overall Study|Withdrawal by Subject|14|||
125676941|NCT00818883|452107568|FG000|Overall Study|Lack of Efficacy|0|||
125676942|NCT00818883|452107569|FG001|Overall Study|Lack of Efficacy|2|||
125676943|NCT00818883|452107568|FG000|Overall Study|Other|2|||
125676944|NCT00818883|452107569|FG001|Overall Study|Other|7|||
125676945|NCT00048048|452107570|FG000|Core Treatment|Withdrawal by Subject|0|||
125676946|NCT00048048|452107571|FG001|Core Treatment|Withdrawal by Subject|0|||
125676947|NCT00048048|452107572|FG002|Core Treatment|Withdrawal by Subject|1|||
125676948|NCT00048048|452107573|FG003|Core Treatment|Withdrawal by Subject|0|||
125676949|NCT00048048|452107574|FG004|Core Treatment|Withdrawal by Subject|0|||
125676950|NCT00048048|452107575|FG005|Core Treatment|Withdrawal by Subject|0|||
125676951|NCT00048048|452107576|FG006|Core Treatment|Withdrawal by Subject|0|||
125676952|NCT00048048|452107577|FG007|Core Treatment|Withdrawal by Subject|0|||
125676953|NCT00048048|452107578|FG008|Core Treatment|Withdrawal by Subject|0|||
125676954|NCT00048048|452107579|FG009|Core Treatment|Withdrawal by Subject|0|||
125676955|NCT00048048|452107580|FG010|Core Treatment|Withdrawal by Subject|0|||
125676956|NCT00048048|452107581|FG011|Core Treatment|Withdrawal by Subject|0|||
125676957|NCT00048048|452107570|FG000|Core Treatment|Adverse Event|0|||
125676958|NCT00048048|452107571|FG001|Core Treatment|Adverse Event|0|||
125676959|NCT00048048|452107572|FG002|Core Treatment|Adverse Event|0|||
125676960|NCT00048048|452107573|FG003|Core Treatment|Adverse Event|0|||
125676961|NCT00048048|452107574|FG004|Core Treatment|Adverse Event|0|||
125676962|NCT00048048|452107575|FG005|Core Treatment|Adverse Event|0|||
125676963|NCT00048048|452107576|FG006|Core Treatment|Adverse Event|0|||
125676964|NCT00048048|452107577|FG007|Core Treatment|Adverse Event|1|||
125676965|NCT00048048|452107578|FG008|Core Treatment|Adverse Event|0|||
125676966|NCT00048048|452107579|FG009|Core Treatment|Adverse Event|0|||
125676967|NCT00048048|452107580|FG010|Core Treatment|Adverse Event|0|||
125676968|NCT00048048|452107581|FG011|Core Treatment|Adverse Event|0|||
125676969|NCT00048048|452107570|FG000|Extension Year 1|Early withdrawals|0|||
125676970|NCT00048048|452107571|FG001|Extension Year 1|Early withdrawals|0|||
125343729|NCT00369629|450892262|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
125343730|NCT00369629|450892263|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
125343731|NCT00874939|450892264|FG000|Overall Study|Study terminated|4|||
125343732|NCT01250496|450892267|FG000|Overall Study|Study terminated|124|||
125343733|NCT01250496|450892268|FG001|Overall Study|Study terminated|124|||
125343734|NCT00883688|450892271|FG000|Overall Study|Ineligible|2|||
125343735|NCT01104376|450892277|FG000|Overall Study|Withdrawal by Subject|15|||
125676971|NCT00048048|452107572|FG002|Extension Year 1|Early withdrawals|0|||
125676972|NCT00048048|452107573|FG003|Extension Year 1|Early withdrawals|0|||
125676973|NCT00048048|452107574|FG004|Extension Year 1|Early withdrawals|0|||
125676974|NCT00048048|452107575|FG005|Extension Year 1|Early withdrawals|0|||
125676975|NCT00048048|452107576|FG006|Extension Year 1|Early withdrawals|0|||
125676976|NCT00048048|452107577|FG007|Extension Year 1|Early withdrawals|0|||
125676977|NCT00048048|452107578|FG008|Extension Year 1|Early withdrawals|0|||
125676978|NCT00048048|452107579|FG009|Extension Year 1|Early withdrawals|2|||
125676979|NCT00048048|452107580|FG010|Extension Year 1|Early withdrawals|2|||
125676980|NCT00048048|452107581|FG011|Extension Year 1|Early withdrawals|4|||
125676981|NCT00048048|452107570|FG000|Extension Year 2|Early withdrawals|0|||
125676982|NCT00048048|452107571|FG001|Extension Year 2|Early withdrawals|0|||
125676983|NCT00048048|452107572|FG002|Extension Year 2|Early withdrawals|0|||
125676984|NCT00048048|452107573|FG003|Extension Year 2|Early withdrawals|0|||
125676985|NCT00048048|452107574|FG004|Extension Year 2|Early withdrawals|0|||
125676986|NCT00048048|452107575|FG005|Extension Year 2|Early withdrawals|0|||
125676987|NCT00048048|452107576|FG006|Extension Year 2|Early withdrawals|0|||
125676988|NCT00048048|452107577|FG007|Extension Year 2|Early withdrawals|0|||
125676989|NCT00048048|452107578|FG008|Extension Year 2|Early withdrawals|0|||
125676990|NCT00048048|452107579|FG009|Extension Year 2|Early withdrawals|0|||
125676991|NCT00048048|452107580|FG010|Extension Year 2|Early withdrawals|4|||
125676992|NCT00048048|452107581|FG011|Extension Year 2|Early withdrawals|2|||
125676993|NCT00973700|452107584|FG000|Overall Study|Withdrawal by Subject|2|||
125676994|NCT00973700|452107585|FG001|Overall Study|Withdrawal by Subject|2|||
125676995|NCT00973700|452107586|FG002|Overall Study|Withdrawal by Subject|8|||
125676996|NCT00973700|452107587|FG003|Overall Study|Withdrawal by Subject|4|||
125676997|NCT00973700|452107588|FG004|Overall Study|Withdrawal by Subject|4|||
125676998|NCT00973700|452107584|FG000|Overall Study|Lost to Follow-up|5|||
125676999|NCT00973700|452107585|FG001|Overall Study|Lost to Follow-up|0|||
125677000|NCT00973700|452107586|FG002|Overall Study|Lost to Follow-up|1|||
125677001|NCT00973700|452107587|FG003|Overall Study|Lost to Follow-up|8|||
125677002|NCT00973700|452107588|FG004|Overall Study|Lost to Follow-up|5|||
125677003|NCT00973700|452107584|FG000|Overall Study|Inappropriate enrolment|0|||
125677004|NCT00973700|452107585|FG001|Overall Study|Inappropriate enrolment|0|||
125677005|NCT00973700|452107586|FG002|Overall Study|Inappropriate enrolment|0|||
125677006|NCT00973700|452107587|FG003|Overall Study|Inappropriate enrolment|4|||
125677007|NCT00973700|452107588|FG004|Overall Study|Inappropriate enrolment|0|||
125677008|NCT00973700|452107584|FG000|Overall Study|Unable to Classify|0|||
125677009|NCT00973700|452107585|FG001|Overall Study|Unable to Classify|0|||
125677010|NCT00973700|452107586|FG002|Overall Study|Unable to Classify|1|||
125677011|NCT00973700|452107587|FG003|Overall Study|Unable to Classify|2|||
125677012|NCT00973700|452107588|FG004|Overall Study|Unable to Classify|1|||
125677013|NCT01901055|452107589|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
125677014|NCT01901055|452107590|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
125677015|NCT01901055|452107589|FG000|Randomization But Not Titrated|Physician Decision|0|||
125677016|NCT01901055|452107590|FG001|Randomization But Not Titrated|Physician Decision|1|||
125677017|NCT01901055|452107589|FG000|Started Protocol to Week 6|Physician Decision|2|||
125677018|NCT01901055|452107590|FG001|Started Protocol to Week 6|Physician Decision|1|||
125677019|NCT01901055|452107589|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
125677020|NCT01901055|452107590|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
125677021|NCT01901055|452107589|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
125677022|NCT01901055|452107590|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
125677023|NCT01901055|452107589|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
125677024|NCT01901055|452107590|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
125677025|NCT01901055|452107589|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
125677026|NCT01901055|452107590|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
125677027|NCT01901055|452107589|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
125677028|NCT01901055|452107590|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
125343736|NCT01104376|450892277|FG000|Overall Study|Consented but excluded after labs|13|||
125343737|NCT03085914|450892285|FG000|Overall Study|Death|6|||
125677029|NCT01901055|452107589|FG000|Week 24|Withdrawal by Subject|13|||
125677030|NCT01901055|452107590|FG001|Week 24|Withdrawal by Subject|19|||
125677031|NCT01901055|452107589|FG000|Week 24|Physician Decision|1|||
125677032|NCT01901055|452107590|FG001|Week 24|Physician Decision|0|||
125677033|NCT01901055|452107589|FG000|Week 36|Withdrawal by Subject|0|||
125677034|NCT01901055|452107590|FG001|Week 36|Withdrawal by Subject|5|||
125343738|NCT03085914|450892286|FG001|Overall Study|Death|6|||
125343739|NCT03085914|450892287|FG002|Overall Study|Death|4|||
125343740|NCT03085914|450892288|FG003|Overall Study|Death|1|||
125343741|NCT03085914|450892289|FG004|Overall Study|Death|5|||
125343742|NCT03085914|450892290|FG005|Overall Study|Death|2|||
125343743|NCT03085914|450892291|FG006|Overall Study|Death|2|||
125343744|NCT03085914|450892285|FG000|Overall Study|Withdrawal by Subject|1|||
125343745|NCT03085914|450892286|FG001|Overall Study|Withdrawal by Subject|1|||
125343746|NCT03085914|450892287|FG002|Overall Study|Withdrawal by Subject|2|||
125343747|NCT03085914|450892288|FG003|Overall Study|Withdrawal by Subject|2|||
125343748|NCT03085914|450892289|FG004|Overall Study|Withdrawal by Subject|2|||
125343749|NCT03085914|450892290|FG005|Overall Study|Withdrawal by Subject|0|||
125343750|NCT03085914|450892291|FG006|Overall Study|Withdrawal by Subject|1|||
125343751|NCT03085914|450892285|FG000|Overall Study|Lost to Follow-up|0|||
125343752|NCT03085914|450892286|FG001|Overall Study|Lost to Follow-up|0|||
125343753|NCT03085914|450892287|FG002|Overall Study|Lost to Follow-up|1|||
125343754|NCT03085914|450892288|FG003|Overall Study|Lost to Follow-up|0|||
125343755|NCT03085914|450892289|FG004|Overall Study|Lost to Follow-up|0|||
125343756|NCT03085914|450892290|FG005|Overall Study|Lost to Follow-up|1|||
125343757|NCT03085914|450892291|FG006|Overall Study|Lost to Follow-up|1|||
125343758|NCT03085914|450892285|FG000|Overall Study|Reason was not specified,|2|||
125343759|NCT03085914|450892286|FG001|Overall Study|Reason was not specified,|2|||
125343760|NCT03085914|450892287|FG002|Overall Study|Reason was not specified,|2|||
125343761|NCT03085914|450892288|FG003|Overall Study|Reason was not specified,|3|||
125343762|NCT03085914|450892289|FG004|Overall Study|Reason was not specified,|3|||
125343763|NCT03085914|450892290|FG005|Overall Study|Reason was not specified,|3|||
125343764|NCT03085914|450892291|FG006|Overall Study|Reason was not specified,|6|||
125343765|NCT03085914|450892285|FG000|Overall Study|Progressive Disease|0|||
125343766|NCT03085914|450892286|FG001|Overall Study|Progressive Disease|0|||
125343767|NCT03085914|450892287|FG002|Overall Study|Progressive Disease|2|||
125343768|NCT03085914|450892288|FG003|Overall Study|Progressive Disease|2|||
125343769|NCT03085914|450892289|FG004|Overall Study|Progressive Disease|1|||
125343770|NCT03085914|450892290|FG005|Overall Study|Progressive Disease|1|||
125343771|NCT03085914|450892291|FG006|Overall Study|Progressive Disease|1|||
125343772|NCT03085914|450892285|FG000|Overall Study|Study Terminated by the Sponsor|0|||
125343773|NCT03085914|450892286|FG001|Overall Study|Study Terminated by the Sponsor|0|||
125343774|NCT03085914|450892287|FG002|Overall Study|Study Terminated by the Sponsor|0|||
125343775|NCT03085914|450892288|FG003|Overall Study|Study Terminated by the Sponsor|1|||
125343776|NCT03085914|450892289|FG004|Overall Study|Study Terminated by the Sponsor|2|||
125343777|NCT03085914|450892290|FG005|Overall Study|Study Terminated by the Sponsor|1|||
125343778|NCT03085914|450892291|FG006|Overall Study|Study Terminated by the Sponsor|0|||
125677035|NCT00525590|452107594|FG000|Overall Study|Adverse Event|3|||
125677036|NCT00525590|452107594|FG000|Overall Study|Physician Decision|3|||
125677037|NCT00525590|452107594|FG000|Overall Study|Withdrawal by Subject|16|||
125677038|NCT00525590|452107594|FG000|Overall Study|Lost to Follow-up|1|||
125343779|NCT04644315|450892292|FG000|Overall Study|Subject withdrawal of consent|1|||
125343780|NCT05315908|450892293|FG000|Overall Study|Lost to Follow-up|4477|||
125343781|NCT05315908|450892294|FG001|Overall Study|Lost to Follow-up|4606|||
125343782|NCT01445548|450892295|FG000|Overall Study|Adverse Event|1|||
125343783|NCT03642132|450892297|FG000|Chemotherapy Period|Adverse Event|1|||
125343784|NCT03642132|450892298|FG001|Chemotherapy Period|Adverse Event|1|||
125343785|NCT03642132|450892299|FG002|Chemotherapy Period|Adverse Event|0|||
125343786|NCT03642132|450892297|FG000|Chemotherapy Period|Physician's decision|4|||
125343787|NCT03642132|450892298|FG001|Chemotherapy Period|Physician's decision|1|||
125677039|NCT00525590|452107594|FG000|Overall Study|Death|9|||
125677040|NCT00525590|452107594|FG000|Overall Study|Other|13|||
125677041|NCT00948675|452107595|FG000|Overall Study|Lost to Follow-up|1|||
125677042|NCT00948675|452107596|FG001|Overall Study|Lost to Follow-up|0|||
125677043|NCT03830164|452107605|FG000|Overall Study|Adverse Event|0|||
125677044|NCT03830164|452107606|FG001|Overall Study|Adverse Event|2|||
125677045|NCT03830164|452107607|FG002|Overall Study|Adverse Event|0|||
125343788|NCT03642132|450892299|FG002|Chemotherapy Period|Physician's decision|0|||
125343789|NCT03642132|450892297|FG000|Chemotherapy Period|Progressive disease|0|||
125677046|NCT03830164|452107605|FG000|Overall Study|Lack of Efficacy|1|||
125677047|NCT03830164|452107606|FG001|Overall Study|Lack of Efficacy|5|||
125343790|NCT03642132|450892298|FG001|Chemotherapy Period|Progressive disease|0|||
125343791|NCT03642132|450892299|FG002|Chemotherapy Period|Progressive disease|1|||
125343792|NCT03642132|450892297|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
125343793|NCT03642132|450892298|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
125343794|NCT03642132|450892299|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
125343795|NCT03642132|450892297|FG000|Chemotherapy Period|Other|1|||
125343796|NCT03642132|450892298|FG001|Chemotherapy Period|Other|0|||
125343797|NCT03642132|450892299|FG002|Chemotherapy Period|Other|2|||
125343798|NCT03642132|450892297|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
125343799|NCT03642132|450892298|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
125677048|NCT03830164|452107607|FG002|Overall Study|Lack of Efficacy|0|||
125677049|NCT03830164|452107605|FG000|Overall Study|Lost to Follow-up|0|||
125343800|NCT03642132|450892299|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
125343801|NCT03642132|450892297|FG000|Maintenance Period|Adverse Event|1|||
125343802|NCT03642132|450892298|FG001|Maintenance Period|Adverse Event|2|||
125677050|NCT03830164|452107606|FG001|Overall Study|Lost to Follow-up|1|||
125677051|NCT03830164|452107607|FG002|Overall Study|Lost to Follow-up|0|||
125677052|NCT03830164|452107605|FG000|Overall Study|Withdrawal by Subject|1|||
125677053|NCT03830164|452107606|FG001|Overall Study|Withdrawal by Subject|0|||
125677054|NCT03830164|452107607|FG002|Overall Study|Withdrawal by Subject|0|||
125677055|NCT02192099|452107608|FG000|Overall Study|Adverse Event|1|||
125677056|NCT02192099|452107608|FG000|Overall Study|Lost to Follow-up|2|||
125677057|NCT02192099|452107608|FG000|Overall Study|Physician Decision|1|||
125677058|NCT02192099|452107608|FG000|Overall Study|Pregnancy|1|||
125677059|NCT02192099|452107608|FG000|Overall Study|Protocol Violation|8|||
125677060|NCT02192099|452107608|FG000|Overall Study|Study Terminated by Sponsor|32|||
125677061|NCT02192099|452107608|FG000|Overall Study|Withdrawal by Subject|11|||
125677062|NCT02192099|452107608|FG000|Overall Study|Miscellaneous Reasons|5|||
125677063|NCT02796664|452107611|FG000|Overall Study|Withdrawal by Subject|0|||
125677064|NCT02796664|452107612|FG001|Overall Study|Withdrawal by Subject|3|||
125677065|NCT02796664|452107611|FG000|Overall Study|Noncompliance|1|||
125677066|NCT02796664|452107612|FG001|Overall Study|Noncompliance|1|||
125677067|NCT02796664|452107611|FG000|Overall Study|Death|0|||
125677068|NCT02796664|452107612|FG001|Overall Study|Death|1|||
125677069|NCT02246478|452107613|FG000|Multiple-dose Phase|Protocol Violation|1|||
125677070|NCT02246478|452107614|FG001|Multiple-dose Phase|Protocol Violation|0|||
125677071|NCT02246478|452107615|FG002|Multiple-dose Phase|Protocol Violation|0|||
125677072|NCT02246478|452107616|FG003|Multiple-dose Phase|Protocol Violation|1|||
125677073|NCT01531205|452107621|FG000|Overall Study|Did not proceed to surgery|1|||
125677074|NCT02001558|452107622|FG000|Overall Study|Lost to Follow-up|8|||
125677075|NCT02001558|452107623|FG001|Overall Study|Lost to Follow-up|14|||
125677076|NCT04128007|452107624|FG000|Overall Study|Withdrawal by Subject|9|||
125677077|NCT04128007|452107625|FG001|Overall Study|Withdrawal by Subject|6|||
125677078|NCT04128007|452107624|FG000|Overall Study|Protocol Violation|1|||
125677079|NCT04128007|452107625|FG001|Overall Study|Protocol Violation|0|||
125677080|NCT04128007|452107624|FG000|Overall Study|Lost to Follow-up|8|||
125677081|NCT04128007|452107625|FG001|Overall Study|Lost to Follow-up|7|||
125677082|NCT04128007|452107624|FG000|Overall Study|Adverse Event|5|||
125677083|NCT04128007|452107625|FG001|Overall Study|Adverse Event|2|||
125677084|NCT04128007|452107624|FG000|Overall Study|Not reported|0|||
125677085|NCT04128007|452107625|FG001|Overall Study|Not reported|2|||
125677086|NCT04117607|452107626|FG000|Overall Study|Early Termination|0|||
125677087|NCT04117607|452107627|FG001|Overall Study|Early Termination|1|||
125677088|NCT04117607|452107628|FG002|Overall Study|Early Termination|0|||
125677089|NCT04117607|452107629|FG003|Overall Study|Early Termination|0|||
125677090|NCT04117607|452107630|FG004|Overall Study|Early Termination|0|||
125677091|NCT04117607|452107631|FG005|Overall Study|Early Termination|0|||
125677092|NCT04117607|452107632|FG006|Overall Study|Early Termination|1|||
125677093|NCT04117607|452107633|FG007|Overall Study|Early Termination|0|||
125677094|NCT04117607|452107634|FG008|Overall Study|Early Termination|0|||
125677095|NCT04117607|452107635|FG009|Overall Study|Early Termination|0|||
125677096|NCT04117607|452107636|FG010|Overall Study|Early Termination|0|||
125677097|NCT04117607|452107637|FG011|Overall Study|Early Termination|0|||
125677098|NCT04117607|452107638|FG012|Overall Study|Early Termination|0|||
125677099|NCT04117607|452107639|FG013|Overall Study|Early Termination|0|||
125677100|NCT00950807|452107643|FG000|Treatment Period 1|Lack of Efficacy|1|||
125677101|NCT00950807|452107644|FG001|Treatment Period 1|Lack of Efficacy|0|||
125677102|NCT00950807|452107645|FG002|Treatment Period 1|Lack of Efficacy|0|||
125677103|NCT00950807|452107646|FG003|Treatment Period 1|Lack of Efficacy|0|||
125677104|NCT00950807|452107647|FG004|Treatment Period 1|Lack of Efficacy|0|||
125677105|NCT00950807|452107648|FG005|Treatment Period 1|Lack of Efficacy|1|||
125677106|NCT00950807|452107649|FG006|Treatment Period 1|Lack of Efficacy|0|||
125677107|NCT00950807|452107650|FG007|Treatment Period 1|Lack of Efficacy|0|||
125677108|NCT00950807|452107651|FG008|Treatment Period 1|Lack of Efficacy|0|||
125677109|NCT00950807|452107652|FG009|Treatment Period 1|Lack of Efficacy|0|||
125677110|NCT00950807|452107643|FG000|Treatment Period 1|Protocol Violation|1|||
125677111|NCT00950807|452107644|FG001|Treatment Period 1|Protocol Violation|0|||
125677112|NCT00950807|452107645|FG002|Treatment Period 1|Protocol Violation|0|||
125677113|NCT00950807|452107646|FG003|Treatment Period 1|Protocol Violation|0|||
125677114|NCT00950807|452107647|FG004|Treatment Period 1|Protocol Violation|0|||
125343803|NCT03642132|450892299|FG002|Maintenance Period|Adverse Event|0|||
125677115|NCT00950807|452107648|FG005|Treatment Period 1|Protocol Violation|0|||
125677116|NCT00950807|452107649|FG006|Treatment Period 1|Protocol Violation|0|||
125677117|NCT00950807|452107650|FG007|Treatment Period 1|Protocol Violation|0|||
125677118|NCT00950807|452107651|FG008|Treatment Period 1|Protocol Violation|0|||
125677119|NCT00950807|452107652|FG009|Treatment Period 1|Protocol Violation|0|||
125677120|NCT00950807|452107643|FG000|Treatment Period 1|Lost to Follow-up|0|||
125677121|NCT00950807|452107644|FG001|Treatment Period 1|Lost to Follow-up|0|||
125343804|NCT03642132|450892297|FG000|Maintenance Period|Non-compliance with study drug|0|||
125343805|NCT03642132|450892298|FG001|Maintenance Period|Non-compliance with study drug|0|||
125343806|NCT03642132|450892299|FG002|Maintenance Period|Non-compliance with study drug|1|||
125343807|NCT03642132|450892297|FG000|Maintenance Period|Physician's decision|2|||
125343808|NCT03642132|450892298|FG001|Maintenance Period|Physician's decision|2|||
125343809|NCT03642132|450892299|FG002|Maintenance Period|Physician's decision|2|||
125343810|NCT03642132|450892297|FG000|Maintenance Period|Progressive disease|9|||
125343811|NCT03642132|450892298|FG001|Maintenance Period|Progressive disease|3|||
125343812|NCT03642132|450892299|FG002|Maintenance Period|Progressive disease|6|||
125343813|NCT03642132|450892297|FG000|Maintenance Period|Other|0|||
125343814|NCT03642132|450892298|FG001|Maintenance Period|Other|0|||
125343815|NCT03642132|450892299|FG002|Maintenance Period|Other|3|||
125343816|NCT03642132|450892297|FG000|Maintenance Period|Withdrawal by Subject|1|||
125343817|NCT03642132|450892298|FG001|Maintenance Period|Withdrawal by Subject|1|||
125343818|NCT03642132|450892299|FG002|Maintenance Period|Withdrawal by Subject|2|||
125343819|NCT03642132|450892297|FG000|Follow-up Period|Other|0|||
125343820|NCT03642132|450892298|FG001|Follow-up Period|Other|0|||
125343821|NCT03642132|450892299|FG002|Follow-up Period|Other|1|||
125343822|NCT03642132|450892297|FG000|Follow-up Period|Withdrawal by Subject|1|||
125343823|NCT03642132|450892298|FG001|Follow-up Period|Withdrawal by Subject|2|||
125343824|NCT03642132|450892299|FG002|Follow-up Period|Withdrawal by Subject|0|||
125343825|NCT03642132|450892297|FG000|Follow-up Period|Study terminated by sponsor|1|||
125343826|NCT03642132|450892298|FG001|Follow-up Period|Study terminated by sponsor|0|||
125343827|NCT03642132|450892299|FG002|Follow-up Period|Study terminated by sponsor|1|||
125343828|NCT03642132|450892297|FG000|Follow-up Period|Lack of Efficacy|1|||
125343829|NCT03642132|450892298|FG001|Follow-up Period|Lack of Efficacy|0|||
125343830|NCT03642132|450892299|FG002|Follow-up Period|Lack of Efficacy|0|||
125343831|NCT03642132|450892297|FG000|Follow-up Period|Death|1|||
125343832|NCT03642132|450892298|FG001|Follow-up Period|Death|0|||
125343833|NCT03642132|450892299|FG002|Follow-up Period|Death|2|||
125343834|NCT03642132|450892297|FG000|Follow-up Period|Adverse Event|1|||
125343835|NCT03642132|450892298|FG001|Follow-up Period|Adverse Event|0|||
125343836|NCT03642132|450892299|FG002|Follow-up Period|Adverse Event|0|||
125343837|NCT04493892|450892310|FG000|Overall Study|Withdrawal by Subject|15|||
125343838|NCT01128621|450892311|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
125677122|NCT00950807|452107645|FG002|Treatment Period 1|Lost to Follow-up|1|||
125677123|NCT00950807|452107646|FG003|Treatment Period 1|Lost to Follow-up|0|||
125677124|NCT00950807|452107647|FG004|Treatment Period 1|Lost to Follow-up|0|||
125677125|NCT00950807|452107648|FG005|Treatment Period 1|Lost to Follow-up|0|||
125677126|NCT00950807|452107649|FG006|Treatment Period 1|Lost to Follow-up|0|||
125677127|NCT00950807|452107650|FG007|Treatment Period 1|Lost to Follow-up|0|||
125677128|NCT00950807|452107651|FG008|Treatment Period 1|Lost to Follow-up|0|||
125677129|NCT00950807|452107652|FG009|Treatment Period 1|Lost to Follow-up|0|||
125677130|NCT00950807|452107643|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125677131|NCT00950807|452107644|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125677132|NCT00950807|452107645|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125677133|NCT00950807|452107646|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125677134|NCT00950807|452107647|FG004|Treatment Period 1|Withdrawal by Subject|1|||
125677135|NCT00950807|452107648|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125677136|NCT00950807|452107649|FG006|Treatment Period 1|Withdrawal by Subject|0|||
125677137|NCT00950807|452107650|FG007|Treatment Period 1|Withdrawal by Subject|0|||
125677138|NCT00950807|452107651|FG008|Treatment Period 1|Withdrawal by Subject|1|||
125677139|NCT00950807|452107652|FG009|Treatment Period 1|Withdrawal by Subject|0|||
125677140|NCT00950807|452107643|FG000|Treatment Period 1|Adverse Event|0|||
125677141|NCT00950807|452107644|FG001|Treatment Period 1|Adverse Event|0|||
125677142|NCT00950807|452107645|FG002|Treatment Period 1|Adverse Event|0|||
125677143|NCT00950807|452107646|FG003|Treatment Period 1|Adverse Event|0|||
125677144|NCT00950807|452107647|FG004|Treatment Period 1|Adverse Event|0|||
125677145|NCT00950807|452107648|FG005|Treatment Period 1|Adverse Event|1|||
125677146|NCT00950807|452107649|FG006|Treatment Period 1|Adverse Event|0|||
125677147|NCT00950807|452107650|FG007|Treatment Period 1|Adverse Event|0|||
125677148|NCT00950807|452107651|FG008|Treatment Period 1|Adverse Event|0|||
125677149|NCT00950807|452107652|FG009|Treatment Period 1|Adverse Event|0|||
125677150|NCT00950807|452107643|FG000|Washout Period 1|Lack of Efficacy|0|||
125677151|NCT00950807|452107644|FG001|Washout Period 1|Lack of Efficacy|0|||
125677152|NCT00950807|452107645|FG002|Washout Period 1|Lack of Efficacy|0|||
125677153|NCT00950807|452107646|FG003|Washout Period 1|Lack of Efficacy|0|||
125677154|NCT00950807|452107647|FG004|Washout Period 1|Lack of Efficacy|0|||
125677155|NCT00950807|452107648|FG005|Washout Period 1|Lack of Efficacy|0|||
125677156|NCT00950807|452107649|FG006|Washout Period 1|Lack of Efficacy|1|||
125677157|NCT00950807|452107650|FG007|Washout Period 1|Lack of Efficacy|0|||
125343839|NCT01128621|450892312|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
125343840|NCT03595618|450892313|FG000|Overall Study|Adverse Event|16|||
125343841|NCT03595618|450892314|FG001|Overall Study|Adverse Event|17|||
125343842|NCT03595618|450892315|FG002|Overall Study|Adverse Event|20|||
125343843|NCT03595618|450892316|FG003|Overall Study|Adverse Event|8|||
125343844|NCT03595618|450892313|FG000|Overall Study|Withdrawal by Subject|12|||
125343845|NCT03595618|450892314|FG001|Overall Study|Withdrawal by Subject|14|||
125343846|NCT03595618|450892315|FG002|Overall Study|Withdrawal by Subject|14|||
125343847|NCT03595618|450892316|FG003|Overall Study|Withdrawal by Subject|10|||
125343848|NCT03595618|450892313|FG000|Overall Study|Lost to Follow-up|6|||
125343849|NCT03595618|450892314|FG001|Overall Study|Lost to Follow-up|4|||
125343850|NCT03595618|450892315|FG002|Overall Study|Lost to Follow-up|5|||
125343851|NCT03595618|450892316|FG003|Overall Study|Lost to Follow-up|6|||
125343852|NCT03595618|450892313|FG000|Overall Study|Protocol Violation|2|||
125343853|NCT03595618|450892314|FG001|Overall Study|Protocol Violation|0|||
125343854|NCT03595618|450892315|FG002|Overall Study|Protocol Violation|6|||
125343855|NCT03595618|450892316|FG003|Overall Study|Protocol Violation|2|||
125343856|NCT03595618|450892313|FG000|Overall Study|Physician Decision|0|||
125343857|NCT03595618|450892314|FG001|Overall Study|Physician Decision|0|||
125343858|NCT03595618|450892315|FG002|Overall Study|Physician Decision|1|||
125343859|NCT03595618|450892316|FG003|Overall Study|Physician Decision|2|||
125343860|NCT03595618|450892313|FG000|Overall Study|Miscellaneous|7|||
125343861|NCT03595618|450892314|FG001|Overall Study|Miscellaneous|5|||
125343862|NCT03595618|450892315|FG002|Overall Study|Miscellaneous|10|||
125343863|NCT03595618|450892316|FG003|Overall Study|Miscellaneous|6|||
125343864|NCT01253811|450892317|FG000|Overall Study|Withdrawal criteria|1|||
125343865|NCT01782469|450892320|FG000|Overall Study|Lost to Follow-up|1|||
125677158|NCT00950807|452107651|FG008|Washout Period 1|Lack of Efficacy|0|||
125677159|NCT00950807|452107652|FG009|Washout Period 1|Lack of Efficacy|0|||
125677160|NCT00950807|452107643|FG000|Washout Period 1|Withdrawal by Subject|0|||
125343866|NCT00357760|450892327|FG000|Overall Study|Disease progression|44|||
125343867|NCT00357760|450892328|FG001|Overall Study|Disease progression|17|||
125343868|NCT00357760|450892327|FG000|Overall Study|Adverse Event|10|||
125343869|NCT00357760|450892328|FG001|Overall Study|Adverse Event|7|||
125677161|NCT00950807|452107644|FG001|Washout Period 1|Withdrawal by Subject|0|||
125677162|NCT00950807|452107645|FG002|Washout Period 1|Withdrawal by Subject|0|||
125677163|NCT00950807|452107646|FG003|Washout Period 1|Withdrawal by Subject|0|||
125677164|NCT00950807|452107647|FG004|Washout Period 1|Withdrawal by Subject|0|||
125677165|NCT00950807|452107648|FG005|Washout Period 1|Withdrawal by Subject|0|||
125677166|NCT00950807|452107649|FG006|Washout Period 1|Withdrawal by Subject|0|||
125677167|NCT00950807|452107650|FG007|Washout Period 1|Withdrawal by Subject|0|||
125677168|NCT00950807|452107651|FG008|Washout Period 1|Withdrawal by Subject|1|||
125677169|NCT00950807|452107652|FG009|Washout Period 1|Withdrawal by Subject|0|||
125677170|NCT00950807|452107643|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
125677171|NCT00950807|452107644|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125677172|NCT00950807|452107645|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125677173|NCT00950807|452107646|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125677174|NCT00950807|452107647|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125677175|NCT00950807|452107648|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125677176|NCT00950807|452107649|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
125677177|NCT00950807|452107650|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
125677178|NCT00950807|452107651|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125677179|NCT00950807|452107652|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
125677180|NCT00950807|452107643|FG000|Washout Period 1|Adverse Event|2|||
125677181|NCT00950807|452107644|FG001|Washout Period 1|Adverse Event|0|||
125677182|NCT00950807|452107645|FG002|Washout Period 1|Adverse Event|0|||
125677183|NCT00950807|452107646|FG003|Washout Period 1|Adverse Event|1|||
125677184|NCT00950807|452107647|FG004|Washout Period 1|Adverse Event|1|||
125677185|NCT00950807|452107648|FG005|Washout Period 1|Adverse Event|0|||
125677186|NCT00950807|452107649|FG006|Washout Period 1|Adverse Event|0|||
125677187|NCT00950807|452107650|FG007|Washout Period 1|Adverse Event|0|||
125677188|NCT00950807|452107651|FG008|Washout Period 1|Adverse Event|0|||
125677189|NCT00950807|452107652|FG009|Washout Period 1|Adverse Event|0|||
125677190|NCT00950807|452107643|FG000|Treatment Period 2|Lack of Efficacy|1|||
125677191|NCT00950807|452107644|FG001|Treatment Period 2|Lack of Efficacy|0|||
125677192|NCT00950807|452107645|FG002|Treatment Period 2|Lack of Efficacy|0|||
125677193|NCT00950807|452107646|FG003|Treatment Period 2|Lack of Efficacy|0|||
125677194|NCT00950807|452107647|FG004|Treatment Period 2|Lack of Efficacy|0|||
125677195|NCT00950807|452107648|FG005|Treatment Period 2|Lack of Efficacy|0|||
125677196|NCT00950807|452107649|FG006|Treatment Period 2|Lack of Efficacy|0|||
125677197|NCT00950807|452107650|FG007|Treatment Period 2|Lack of Efficacy|0|||
125677198|NCT00950807|452107651|FG008|Treatment Period 2|Lack of Efficacy|0|||
125677199|NCT00950807|452107652|FG009|Treatment Period 2|Lack of Efficacy|0|||
125677200|NCT00950807|452107643|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125677201|NCT00950807|452107644|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125677202|NCT00950807|452107645|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125677203|NCT00950807|452107646|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125677204|NCT00950807|452107647|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125677205|NCT00950807|452107648|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125677206|NCT00950807|452107649|FG006|Treatment Period 2|Withdrawal by Subject|1|||
125677207|NCT00950807|452107650|FG007|Treatment Period 2|Withdrawal by Subject|2|||
125677208|NCT00950807|452107651|FG008|Treatment Period 2|Withdrawal by Subject|0|||
125677209|NCT00950807|452107652|FG009|Treatment Period 2|Withdrawal by Subject|0|||
125677210|NCT00950807|452107643|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
125677211|NCT00950807|452107644|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125677212|NCT00950807|452107645|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125677213|NCT00950807|452107646|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125677214|NCT00950807|452107647|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125677215|NCT00950807|452107648|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125677216|NCT00950807|452107649|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125677217|NCT00950807|452107650|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125677218|NCT00950807|452107651|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125677219|NCT00950807|452107652|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125677220|NCT00950807|452107643|FG000|Treatment Period 2|Adverse Event|0|||
125677221|NCT00950807|452107644|FG001|Treatment Period 2|Adverse Event|1|||
125677222|NCT00950807|452107645|FG002|Treatment Period 2|Adverse Event|0|||
125677223|NCT00950807|452107646|FG003|Treatment Period 2|Adverse Event|1|||
125677224|NCT00950807|452107647|FG004|Treatment Period 2|Adverse Event|0|||
125677225|NCT00950807|452107648|FG005|Treatment Period 2|Adverse Event|1|||
125677226|NCT00950807|452107649|FG006|Treatment Period 2|Adverse Event|0|||
125677227|NCT00950807|452107650|FG007|Treatment Period 2|Adverse Event|1|||
125677228|NCT00950807|452107651|FG008|Treatment Period 2|Adverse Event|0|||
125677229|NCT00950807|452107652|FG009|Treatment Period 2|Adverse Event|0|||
125677230|NCT00950807|452107643|FG000|Washout Period 2|Lack of Efficacy|1|||
125343870|NCT00357760|450892327|FG000|Overall Study|Death|0|||
125677231|NCT00950807|452107644|FG001|Washout Period 2|Lack of Efficacy|0|||
125677232|NCT00950807|452107645|FG002|Washout Period 2|Lack of Efficacy|0|||
125677233|NCT00950807|452107646|FG003|Washout Period 2|Lack of Efficacy|0|||
125677234|NCT00950807|452107647|FG004|Washout Period 2|Lack of Efficacy|0|||
125677235|NCT00950807|452107648|FG005|Washout Period 2|Lack of Efficacy|0|||
125677236|NCT00950807|452107649|FG006|Washout Period 2|Lack of Efficacy|0|||
125343871|NCT00357760|450892328|FG001|Overall Study|Death|3|||
125343872|NCT00357760|450892327|FG000|Overall Study|Alternative therapy|1|||
125343873|NCT00357760|450892328|FG001|Overall Study|Alternative therapy|0|||
125343874|NCT00357760|450892327|FG000|Overall Study|Withdrawal by Subject|0|||
125343875|NCT00357760|450892328|FG001|Overall Study|Withdrawal by Subject|2|||
125343876|NCT00357760|450892327|FG000|Overall Study|Never started treatment|2|||
125343877|NCT00357760|450892328|FG001|Overall Study|Never started treatment|1|||
125343878|NCT00357760|450892327|FG000|Overall Study|Ineligible|0|||
125343879|NCT00357760|450892328|FG001|Overall Study|Ineligible|2|||
125343880|NCT00357760|450892327|FG000|Overall Study|Physician Decision|2|||
125343881|NCT00357760|450892328|FG001|Overall Study|Physician Decision|1|||
125343882|NCT00357760|450892327|FG000|Overall Study|Protocol Violation|0|||
125343883|NCT00357760|450892328|FG001|Overall Study|Protocol Violation|1|||
125343884|NCT00357760|450892327|FG000|Overall Study|To receive hospice care|0|||
125343885|NCT00357760|450892328|FG001|Overall Study|To receive hospice care|1|||
125343886|NCT04136444|450892329|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
125343887|NCT04136444|450892330|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
125343888|NCT02184572|450892336|FG000|Overall Study|Lost to Follow-up|29|||
125343889|NCT02184572|450892337|FG001|Overall Study|Lost to Follow-up|21|||
125343890|NCT02184572|450892336|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
125343891|NCT02184572|450892337|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
125343892|NCT02184572|450892336|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
125343893|NCT02184572|450892337|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
125343894|NCT02184572|450892336|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
125343895|NCT02184572|450892337|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
125343896|NCT02184572|450892336|FG000|Overall Study|Traveling Outside The Country|1|||
125343897|NCT02184572|450892337|FG001|Overall Study|Traveling Outside The Country|0|||
125343898|NCT02184572|450892336|FG000|Overall Study|Withdrawal by Subject|14|||
125343899|NCT02184572|450892337|FG001|Overall Study|Withdrawal by Subject|9|||
125343900|NCT03726996|450892338|FG000|Overall Study|Parent's decision|2|||
125343901|NCT03726996|450892338|FG000|Overall Study|Study early termination|2|||
125343902|NCT01328444|450892339|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
125343903|NCT01328444|450892340|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
125343904|NCT01328444|450892341|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
125343905|NCT01328444|450892342|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
125343906|NCT01328444|450892343|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
125343907|NCT01328444|450892344|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
125343908|NCT01328444|450892339|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
125343909|NCT01328444|450892340|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
125343910|NCT01328444|450892341|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
125343911|NCT01328444|450892342|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
125343912|NCT01328444|450892343|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
125343913|NCT01328444|450892344|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
125343914|NCT01328444|450892339|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
125343915|NCT01328444|450892340|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
125343916|NCT01328444|450892341|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
125343917|NCT01328444|450892342|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
125343918|NCT01328444|450892343|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
125343919|NCT01328444|450892344|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
125343920|NCT01328444|450892339|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
125343921|NCT01328444|450892340|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
125343922|NCT01328444|450892341|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
125343923|NCT01328444|450892342|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
125343924|NCT01328444|450892343|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
125343925|NCT01328444|450892344|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
125343926|NCT01328444|450892339|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
125343927|NCT01328444|450892340|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125343928|NCT01328444|450892341|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125343929|NCT01328444|450892342|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
125343930|NCT01328444|450892343|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125343931|NCT01328444|450892344|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
125343932|NCT01328444|450892339|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125343933|NCT01328444|450892340|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
125343934|NCT01328444|450892341|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
125343935|NCT01328444|450892342|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
125343936|NCT01328444|450892343|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
125343937|NCT01328444|450892344|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125343938|NCT01328444|450892339|FG000|Washout Period (14 Days)|Adverse Event|1|||
125343939|NCT01328444|450892340|FG001|Washout Period (14 Days)|Adverse Event|1|||
125343940|NCT01328444|450892341|FG002|Washout Period (14 Days)|Adverse Event|0|||
125343941|NCT01328444|450892342|FG003|Washout Period (14 Days)|Adverse Event|1|||
125343942|NCT01328444|450892343|FG004|Washout Period (14 Days)|Adverse Event|1|||
125343943|NCT01328444|450892344|FG005|Washout Period (14 Days)|Adverse Event|2|||
125343944|NCT01328444|450892339|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
125343945|NCT01328444|450892340|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
125343946|NCT01328444|450892341|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
125343947|NCT01328444|450892342|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
125343948|NCT01328444|450892343|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
125343949|NCT01328444|450892344|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
125343950|NCT01328444|450892339|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
125343951|NCT01328444|450892340|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
125343952|NCT01328444|450892341|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
125343953|NCT01328444|450892342|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
125343954|NCT01328444|450892343|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
125343955|NCT01328444|450892344|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
125343956|NCT01328444|450892339|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
125343957|NCT01328444|450892340|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
125343958|NCT01328444|450892341|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
125343959|NCT01328444|450892342|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
125343960|NCT01328444|450892343|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
125343961|NCT01328444|450892344|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
125343962|NCT01328444|450892339|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
125343963|NCT01328444|450892340|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
125343964|NCT01328444|450892341|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
125343965|NCT01328444|450892342|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
125343966|NCT01328444|450892343|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
125343967|NCT01328444|450892344|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
125343968|NCT01328444|450892339|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
125343969|NCT01328444|450892340|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
125343970|NCT01328444|450892341|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
125343971|NCT01328444|450892342|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
125343972|NCT01328444|450892343|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
125343973|NCT01328444|450892344|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
125343974|NCT01328444|450892339|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
125343975|NCT01328444|450892340|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
125343976|NCT01328444|450892341|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
125343977|NCT01328444|450892342|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
125343978|NCT01328444|450892343|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
125343979|NCT01328444|450892344|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
125343980|NCT01328444|450892339|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
125343981|NCT01328444|450892340|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
125343982|NCT01328444|450892341|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
125343983|NCT01328444|450892342|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
125343984|NCT01328444|450892343|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
125343985|NCT01328444|450892344|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
125343986|NCT01328444|450892339|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125343987|NCT01328444|450892340|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125343988|NCT01328444|450892341|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125343989|NCT01328444|450892342|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125343990|NCT01328444|450892343|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
125343991|NCT01328444|450892344|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
125343992|NCT03180619|450892345|FG000|Overall Study|Withdrew Consent|5|||
125343993|NCT03180619|450892346|FG001|Overall Study|Withdrew Consent|0|||
125343994|NCT03180619|450892347|FG002|Overall Study|Withdrew Consent|2|||
125343995|NCT03180619|450892345|FG000|Overall Study|Death|2|||
125343996|NCT03180619|450892346|FG001|Overall Study|Death|1|||
125343997|NCT03180619|450892347|FG002|Overall Study|Death|2|||
125343998|NCT03180619|450892345|FG000|Overall Study|Adverse Event|2|||
125343999|NCT03180619|450892346|FG001|Overall Study|Adverse Event|0|||
125344000|NCT03180619|450892347|FG002|Overall Study|Adverse Event|1|||
125344001|NCT03180619|450892345|FG000|Overall Study|Investigator's discretion|2|||
125344002|NCT03180619|450892346|FG001|Overall Study|Investigator's discretion|0|||
125344003|NCT03180619|450892347|FG002|Overall Study|Investigator's discretion|1|||
125677237|NCT00950807|452107650|FG007|Washout Period 2|Lack of Efficacy|0|||
125677238|NCT00950807|452107651|FG008|Washout Period 2|Lack of Efficacy|0|||
125344004|NCT02743611|450892348|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
125344005|NCT02743611|450892349|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
125344006|NCT02743611|450892350|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
125677239|NCT00950807|452107652|FG009|Washout Period 2|Lack of Efficacy|0|||
125677240|NCT00950807|452107643|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
125677241|NCT00950807|452107644|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
125677242|NCT00950807|452107645|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
125677243|NCT00950807|452107646|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
125677244|NCT00950807|452107647|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
125677245|NCT00950807|452107648|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
125677246|NCT00950807|452107649|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
125677247|NCT00950807|452107650|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
125677248|NCT00950807|452107651|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
125677249|NCT00950807|452107652|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
125677250|NCT00950807|452107643|FG000|Washout Period 2|Adverse Event|3|||
125677251|NCT00950807|452107644|FG001|Washout Period 2|Adverse Event|0|||
125677252|NCT00950807|452107645|FG002|Washout Period 2|Adverse Event|0|||
125677253|NCT00950807|452107646|FG003|Washout Period 2|Adverse Event|1|||
125677254|NCT00950807|452107647|FG004|Washout Period 2|Adverse Event|0|||
125677255|NCT00950807|452107648|FG005|Washout Period 2|Adverse Event|0|||
125677256|NCT00950807|452107649|FG006|Washout Period 2|Adverse Event|0|||
125677257|NCT00950807|452107650|FG007|Washout Period 2|Adverse Event|0|||
125677258|NCT00950807|452107651|FG008|Washout Period 2|Adverse Event|0|||
125677259|NCT00950807|452107652|FG009|Washout Period 2|Adverse Event|0|||
125344007|NCT02743611|450892351|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
125344008|NCT00561977|450892352|FG000|Overall Study|Withdrawal by Subject|0|||
125344009|NCT00561977|450892353|FG001|Overall Study|Withdrawal by Subject|2|||
125344010|NCT00561977|450892354|FG002|Overall Study|Withdrawal by Subject|1|||
125344011|NCT00561977|450892352|FG000|Overall Study|Pregnancy|0|||
125344012|NCT00561977|450892353|FG001|Overall Study|Pregnancy|1|||
125344013|NCT00561977|450892354|FG002|Overall Study|Pregnancy|1|||
125344014|NCT00781885|450892355|FG000|Overall Study|Physician Decision|1|||
125344015|NCT01755026|450892356|FG000|Overall Study|Adverse Event|1|||
125344016|NCT01755026|450892357|FG001|Overall Study|Adverse Event|0|||
125344017|NCT01755026|450892356|FG000|Overall Study|Withdrawal by Subject|1|||
125344018|NCT01755026|450892357|FG001|Overall Study|Withdrawal by Subject|1|||
125344019|NCT00392379|450892358|FG000|Overall Study|Withdrawal by Subject|17|||
125677260|NCT00950807|452107643|FG000|Treatment Period 3|Withdrawal by Subject|0|||
125677261|NCT00950807|452107644|FG001|Treatment Period 3|Withdrawal by Subject|0|||
125677262|NCT00950807|452107645|FG002|Treatment Period 3|Withdrawal by Subject|0|||
125677263|NCT00950807|452107646|FG003|Treatment Period 3|Withdrawal by Subject|0|||
125677264|NCT00950807|452107647|FG004|Treatment Period 3|Withdrawal by Subject|0|||
125677265|NCT00950807|452107648|FG005|Treatment Period 3|Withdrawal by Subject|0|||
125677266|NCT00950807|452107649|FG006|Treatment Period 3|Withdrawal by Subject|0|||
125677267|NCT00950807|452107650|FG007|Treatment Period 3|Withdrawal by Subject|0|||
125677268|NCT00950807|452107651|FG008|Treatment Period 3|Withdrawal by Subject|0|||
125677269|NCT00950807|452107652|FG009|Treatment Period 3|Withdrawal by Subject|1|||
125677270|NCT00950807|452107643|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
125344020|NCT00392379|450892359|FG001|Overall Study|Withdrawal by Subject|28|||
125344021|NCT00392379|450892358|FG000|Overall Study|Lost to Follow-up|4|||
125344022|NCT00392379|450892359|FG001|Overall Study|Lost to Follow-up|9|||
125344023|NCT00392379|450892358|FG000|Overall Study|Adverse Event|1|||
125344024|NCT00392379|450892359|FG001|Overall Study|Adverse Event|1|||
125344025|NCT02285062|450892360|FG000|Pre-Treatment Period|Protocol Violation|0|||
125344026|NCT02285062|450892361|FG001|Pre-Treatment Period|Protocol Violation|2|||
125677271|NCT00950807|452107644|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125677272|NCT00950807|452107645|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125677273|NCT00950807|452107646|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125677274|NCT00950807|452107647|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125677275|NCT00950807|452107648|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125677276|NCT00950807|452107649|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125677277|NCT00950807|452107650|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
125677278|NCT00950807|452107651|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125677279|NCT00950807|452107652|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125677280|NCT00950807|452107643|FG000|Treatment Period 3|Adverse Event|0|||
125677281|NCT00950807|452107644|FG001|Treatment Period 3|Adverse Event|0|||
125677282|NCT00950807|452107645|FG002|Treatment Period 3|Adverse Event|0|||
125677283|NCT00950807|452107646|FG003|Treatment Period 3|Adverse Event|0|||
125677284|NCT00950807|452107647|FG004|Treatment Period 3|Adverse Event|0|||
125677285|NCT00950807|452107648|FG005|Treatment Period 3|Adverse Event|0|||
125677286|NCT00950807|452107649|FG006|Treatment Period 3|Adverse Event|1|||
125677287|NCT00950807|452107650|FG007|Treatment Period 3|Adverse Event|0|||
125677288|NCT00950807|452107651|FG008|Treatment Period 3|Adverse Event|0|||
125677289|NCT00950807|452107652|FG009|Treatment Period 3|Adverse Event|0|||
125677290|NCT00337077|452107653|FG000|Overall Study|Progressive disease|25|||
125677291|NCT00337077|452107654|FG001|Overall Study|Progressive disease|37|||
125677292|NCT00337077|452107655|FG002|Overall Study|Progressive disease|19|||
125677293|NCT00337077|452107653|FG000|Overall Study|Adverse Event|7|||
125677294|NCT00337077|452107654|FG001|Overall Study|Adverse Event|7|||
125677295|NCT00337077|452107655|FG002|Overall Study|Adverse Event|1|||
125677296|NCT00337077|452107653|FG000|Overall Study|Death|0|||
125677297|NCT00337077|452107654|FG001|Overall Study|Death|1|||
125677298|NCT00337077|452107655|FG002|Overall Study|Death|0|||
125677299|NCT00337077|452107653|FG000|Overall Study|Withdrawal by Subject|7|||
125677300|NCT00337077|452107654|FG001|Overall Study|Withdrawal by Subject|2|||
125677301|NCT00337077|452107655|FG002|Overall Study|Withdrawal by Subject|2|||
125677302|NCT00337077|452107653|FG000|Overall Study|Alternative therapy|1|||
125677303|NCT00337077|452107654|FG001|Overall Study|Alternative therapy|0|||
125677304|NCT00337077|452107655|FG002|Overall Study|Alternative therapy|0|||
125677305|NCT00337077|452107653|FG000|Overall Study|Physician Decision|1|||
125677306|NCT00337077|452107654|FG001|Overall Study|Physician Decision|4|||
125677307|NCT00337077|452107655|FG002|Overall Study|Physician Decision|2|||
125677308|NCT00337077|452107653|FG000|Overall Study|Never started treatment|1|||
125677309|NCT00337077|452107654|FG001|Overall Study|Never started treatment|1|||
125677310|NCT00337077|452107655|FG002|Overall Study|Never started treatment|0|||
125677311|NCT00337077|452107653|FG000|Overall Study|Ineligible|1|||
125677312|NCT00337077|452107654|FG001|Overall Study|Ineligible|1|||
125677313|NCT00337077|452107655|FG002|Overall Study|Ineligible|1|||
125677314|NCT02430870|452107668|FG000|Part 2|Voluntary Withdrawal|0|||
125677315|NCT02430870|452107669|FG001|Part 2|Voluntary Withdrawal|0|||
125677316|NCT02430870|452107670|FG002|Part 2|Voluntary Withdrawal|0|||
125677317|NCT02430870|452107671|FG003|Part 2|Voluntary Withdrawal|0|||
125677318|NCT02430870|452107672|FG004|Part 2|Voluntary Withdrawal|0|||
125677319|NCT02430870|452107673|FG005|Part 2|Voluntary Withdrawal|0|||
125677320|NCT02430870|452107674|FG006|Part 2|Voluntary Withdrawal|1|||
125677321|NCT02430870|452107675|FG007|Part 2|Voluntary Withdrawal|0|||
125677322|NCT02430870|452107668|FG000|Part 2|Other Reason Not Specified|0|||
125677323|NCT02430870|452107669|FG001|Part 2|Other Reason Not Specified|0|||
125677324|NCT02430870|452107670|FG002|Part 2|Other Reason Not Specified|0|||
125677325|NCT02430870|452107671|FG003|Part 2|Other Reason Not Specified|0|||
125677326|NCT02430870|452107672|FG004|Part 2|Other Reason Not Specified|0|||
125677327|NCT02430870|452107673|FG005|Part 2|Other Reason Not Specified|0|||
125677328|NCT02430870|452107674|FG006|Part 2|Other Reason Not Specified|0|||
125677329|NCT02430870|452107675|FG007|Part 2|Other Reason Not Specified|1|||
125677330|NCT01265784|452107676|FG000|Overall Study|Lost to Follow-up|5|||
125677331|NCT01265784|452107677|FG001|Overall Study|Lost to Follow-up|3|||
125677332|NCT01265784|452107678|FG002|Overall Study|Lost to Follow-up|2|||
125677333|NCT01265784|452107676|FG000|Overall Study|Withdrawal by Subject|0|||
125677334|NCT01265784|452107677|FG001|Overall Study|Withdrawal by Subject|5|||
125677335|NCT01265784|452107678|FG002|Overall Study|Withdrawal by Subject|0|||
125677336|NCT01265784|452107676|FG000|Overall Study|Physician Decision|1|||
125344027|NCT02285062|450892360|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
125344028|NCT02285062|450892361|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
125677337|NCT01265784|452107677|FG001|Overall Study|Physician Decision|0|||
125677338|NCT01265784|452107678|FG002|Overall Study|Physician Decision|1|||
125677339|NCT01265784|452107676|FG000|Overall Study|Adverse Event|1|||
125677340|NCT01265784|452107677|FG001|Overall Study|Adverse Event|0|||
125677341|NCT01265784|452107678|FG002|Overall Study|Adverse Event|0|||
125677342|NCT01265784|452107676|FG000|Overall Study|Death|3|||
125677343|NCT01265784|452107677|FG001|Overall Study|Death|0|||
125677344|NCT01265784|452107678|FG002|Overall Study|Death|0|||
125344029|NCT03041129|450892362|FG000|Overall Study|Withdrawal by Subject|2|||
125344030|NCT03041129|450892363|FG001|Overall Study|Withdrawal by Subject|0|||
125344031|NCT03041129|450892364|FG002|Overall Study|Withdrawal by Subject|0|||
125344032|NCT03041129|450892365|FG003|Overall Study|Withdrawal by Subject|0|||
125344033|NCT00821509|450892366|FG000|Overall Study|Withdrawal by Subject|12|||
125344034|NCT00821509|450892367|FG001|Overall Study|Withdrawal by Subject|11|||
125344035|NCT00821509|450892368|FG002|Overall Study|Withdrawal by Subject|34|||
125344036|NCT03678870|450892369|FG000|Overall Study|prescribed non- protocol medications|10|||
125344037|NCT03678870|450892370|FG001|Overall Study|prescribed non- protocol medications|6|||
125344038|NCT03678870|450892369|FG000|Overall Study|Lost to Follow-up|3|||
125344039|NCT03678870|450892370|FG001|Overall Study|Lost to Follow-up|2|||
125344040|NCT03104816|450892372|FG000|Overall Study|Lack of Efficacy|0|||
125344041|NCT03104816|450892373|FG001|Overall Study|Lack of Efficacy|2|||
125344042|NCT03104816|450892374|FG002|Overall Study|Lack of Efficacy|0|||
125344043|NCT03104816|450892372|FG000|Overall Study|Protocol Violation|2|||
125344044|NCT03104816|450892373|FG001|Overall Study|Protocol Violation|0|||
125344045|NCT03104816|450892374|FG002|Overall Study|Protocol Violation|2|||
125344046|NCT01159431|450892376|FG000|Overall Study|Adverse Event|1|||
125344047|NCT01159431|450892377|FG001|Overall Study|Adverse Event|2|||
125344048|NCT01159431|450892376|FG000|Overall Study|non-compliance|1|||
125344049|NCT01159431|450892377|FG001|Overall Study|non-compliance|1|||
125344050|NCT01159431|450892376|FG000|Overall Study|Lack of Efficacy|0|||
125344051|NCT01159431|450892377|FG001|Overall Study|Lack of Efficacy|3|||
125344052|NCT01227629|450892378|FG000|Overall Study|Adverse Event|2|||
125344053|NCT01227629|450892379|FG001|Overall Study|Adverse Event|2|||
125344054|NCT01227629|450892380|FG002|Overall Study|Adverse Event|1|||
125344055|NCT01227629|450892381|FG003|Overall Study|Adverse Event|6|||
125344056|NCT01227629|450892382|FG004|Overall Study|Adverse Event|1|||
125344057|NCT01227629|450892383|FG005|Overall Study|Adverse Event|1|||
125344058|NCT01227629|450892384|FG006|Overall Study|Adverse Event|6|||
125344059|NCT01227629|450892385|FG007|Overall Study|Adverse Event|6|||
125344060|NCT01227629|450892386|FG008|Overall Study|Adverse Event|4|||
125344061|NCT01227629|450892387|FG009|Overall Study|Adverse Event|0|||
125344062|NCT01227629|450892378|FG000|Overall Study|Protocol Violation|0|||
125344063|NCT01227629|450892379|FG001|Overall Study|Protocol Violation|0|||
125344064|NCT01227629|450892380|FG002|Overall Study|Protocol Violation|0|||
125344065|NCT01227629|450892381|FG003|Overall Study|Protocol Violation|1|||
125344066|NCT01227629|450892382|FG004|Overall Study|Protocol Violation|0|||
125344067|NCT01227629|450892383|FG005|Overall Study|Protocol Violation|0|||
125344068|NCT01227629|450892384|FG006|Overall Study|Protocol Violation|0|||
125344069|NCT01227629|450892385|FG007|Overall Study|Protocol Violation|0|||
125344070|NCT01227629|450892386|FG008|Overall Study|Protocol Violation|0|||
125344071|NCT01227629|450892387|FG009|Overall Study|Protocol Violation|0|||
125344072|NCT01227629|450892378|FG000|Overall Study|Lost to Follow-up|0|||
125344073|NCT01227629|450892379|FG001|Overall Study|Lost to Follow-up|0|||
125344074|NCT01227629|450892380|FG002|Overall Study|Lost to Follow-up|0|||
125344075|NCT01227629|450892381|FG003|Overall Study|Lost to Follow-up|0|||
125344076|NCT01227629|450892382|FG004|Overall Study|Lost to Follow-up|1|||
125344077|NCT01227629|450892383|FG005|Overall Study|Lost to Follow-up|0|||
125344078|NCT01227629|450892384|FG006|Overall Study|Lost to Follow-up|0|||
125344079|NCT01227629|450892385|FG007|Overall Study|Lost to Follow-up|0|||
125344080|NCT01227629|450892386|FG008|Overall Study|Lost to Follow-up|0|||
125344081|NCT01227629|450892387|FG009|Overall Study|Lost to Follow-up|0|||
125677345|NCT01265784|452107676|FG000|Overall Study|Protocol Violation|2|||
125677346|NCT01265784|452107677|FG001|Overall Study|Protocol Violation|0|||
125677347|NCT01265784|452107678|FG002|Overall Study|Protocol Violation|0|||
125677348|NCT01265784|452107676|FG000|Overall Study|Incorrectly Randomized|0|||
125677349|NCT01265784|452107677|FG001|Overall Study|Incorrectly Randomized|0|||
125677350|NCT01265784|452107678|FG002|Overall Study|Incorrectly Randomized|1|||
125677351|NCT00796822|452107679|FG000|Overall Study|Lost to Follow-up|2|||
125677352|NCT00796822|452107680|FG001|Overall Study|Lost to Follow-up|0|||
125677353|NCT00796822|452107679|FG000|Overall Study|Adverse Event|1|||
125677354|NCT00796822|452107680|FG001|Overall Study|Adverse Event|0|||
125677355|NCT02603952|452107681|FG000|Overall Study|Withdrawal by Subject|1|||
125677356|NCT02603952|452107682|FG001|Overall Study|Withdrawal by Subject|0|||
125677357|NCT02603952|452107683|FG002|Overall Study|Withdrawal by Subject|0|||
125677358|NCT02603952|452107684|FG003|Overall Study|Withdrawal by Subject|0|||
125677359|NCT02603952|452107681|FG000|Overall Study|Received oseltamivir by error|0|||
125677360|NCT02603952|452107682|FG001|Overall Study|Received oseltamivir by error|0|||
125677361|NCT02603952|452107683|FG002|Overall Study|Received oseltamivir by error|0|||
125677362|NCT02603952|452107684|FG003|Overall Study|Received oseltamivir by error|1|||
125677363|NCT04646109|452107687|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
125677364|NCT04646109|452107688|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
125677365|NCT00577460|452107689|FG000|Overall Study|Adverse Event|11|||
125677366|NCT00577460|452107690|FG001|Overall Study|Adverse Event|7|||
125677367|NCT00577460|452107691|FG002|Overall Study|Adverse Event|14|||
125677368|NCT00577460|452107689|FG000|Overall Study|Protocol Violation|0|||
125677369|NCT00577460|452107690|FG001|Overall Study|Protocol Violation|1|||
125677370|NCT00577460|452107691|FG002|Overall Study|Protocol Violation|1|||
125677371|NCT00577460|452107689|FG000|Overall Study|Lost to Follow-up|0|||
125677372|NCT00577460|452107690|FG001|Overall Study|Lost to Follow-up|3|||
125677373|NCT00577460|452107691|FG002|Overall Study|Lost to Follow-up|4|||
125677374|NCT00577460|452107689|FG000|Overall Study|Withdrawal by Subject|5|||
125677375|NCT00577460|452107690|FG001|Overall Study|Withdrawal by Subject|5|||
125677376|NCT00577460|452107691|FG002|Overall Study|Withdrawal by Subject|6|||
125677377|NCT00577460|452107689|FG000|Overall Study|Other|0|||
125677378|NCT00577460|452107690|FG001|Overall Study|Other|3|||
125677379|NCT00577460|452107691|FG002|Overall Study|Other|2|||
125677380|NCT01867242|452107694|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
125677381|NCT01867242|452107695|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
125677382|NCT01867242|452107696|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
125677383|NCT03184441|452107704|FG000|Overall Study|Withdrawal by Subject|1|||
125677384|NCT00264810|452107705|FG000|Baseline|Withdrawal by Subject|10|||
125677385|NCT00264810|452107706|FG001|Baseline|Withdrawal by Subject|10|||
125677386|NCT00264810|452107705|FG000|Baseline|Physician Decision|7|||
125677387|NCT00264810|452107706|FG001|Baseline|Physician Decision|8|||
125677388|NCT00264810|452107705|FG000|Baseline|Subject Compliance Failure|3|||
125677389|NCT00264810|452107706|FG001|Baseline|Subject Compliance Failure|3|||
125677390|NCT00264810|452107705|FG000|Baseline|Insufficient Seizure Frequency|2|||
125677391|NCT00264810|452107706|FG001|Baseline|Insufficient Seizure Frequency|2|||
125677392|NCT00264810|452107705|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
125677393|NCT00264810|452107706|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
125677394|NCT00264810|452107705|FG000|Baseline|Other|0|||
125677395|NCT00264810|452107706|FG001|Baseline|Other|1|||
125677396|NCT00264810|452107705|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
125344082|NCT01227629|450892378|FG000|Overall Study|Withdrawal by Subject|0|||
125344083|NCT01227629|450892379|FG001|Overall Study|Withdrawal by Subject|0|||
125344084|NCT01227629|450892380|FG002|Overall Study|Withdrawal by Subject|0|||
125344085|NCT01227629|450892381|FG003|Overall Study|Withdrawal by Subject|0|||
125344086|NCT01227629|450892382|FG004|Overall Study|Withdrawal by Subject|0|||
125344087|NCT01227629|450892383|FG005|Overall Study|Withdrawal by Subject|0|||
125344088|NCT01227629|450892384|FG006|Overall Study|Withdrawal by Subject|2|||
125344089|NCT01227629|450892385|FG007|Overall Study|Withdrawal by Subject|0|||
125677397|NCT00264810|452107706|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
125677398|NCT00264810|452107705|FG000|Stimulation Optimization Period|Death|0|||
125677399|NCT00264810|452107706|FG001|Stimulation Optimization Period|Death|1|||
125344090|NCT01227629|450892386|FG008|Overall Study|Withdrawal by Subject|0|||
125344091|NCT01227629|450892387|FG009|Overall Study|Withdrawal by Subject|1|||
125344092|NCT01227629|450892378|FG000|Overall Study|Other|0|||
125344093|NCT01227629|450892379|FG001|Overall Study|Other|0|||
125344094|NCT01227629|450892380|FG002|Overall Study|Other|0|||
125344095|NCT01227629|450892381|FG003|Overall Study|Other|1|||
125344096|NCT01227629|450892382|FG004|Overall Study|Other|0|||
125344097|NCT01227629|450892383|FG005|Overall Study|Other|0|||
125344098|NCT01227629|450892384|FG006|Overall Study|Other|0|||
125344099|NCT01227629|450892385|FG007|Overall Study|Other|0|||
125344100|NCT01227629|450892386|FG008|Overall Study|Other|2|||
125344101|NCT01227629|450892387|FG009|Overall Study|Other|1|||
125344102|NCT00534599|450892393|FG000|Overall Study|Adverse Event|25|||
125344103|NCT00534599|450892394|FG001|Overall Study|Adverse Event|4|||
125344104|NCT00534599|450892393|FG000|Overall Study|Incorrect enrollment|2|||
125344105|NCT00534599|450892394|FG001|Overall Study|Incorrect enrollment|1|||
125344106|NCT00534599|450892393|FG000|Overall Study|Mis-randomization|2|||
125344107|NCT00534599|450892394|FG001|Overall Study|Mis-randomization|2|||
125344108|NCT00534599|450892393|FG000|Overall Study|Developed study-specific d/c criteria|5|||
125344109|NCT00534599|450892394|FG001|Overall Study|Developed study-specific d/c criteria|0|||
125344110|NCT00534599|450892393|FG000|Overall Study|Lack of Efficacy|0|||
125344111|NCT00534599|450892394|FG001|Overall Study|Lack of Efficacy|1|||
125344112|NCT00534599|450892393|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
125344113|NCT00534599|450892394|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
125344114|NCT00534599|450892393|FG000|Overall Study|Protocol Violation|1|||
125344115|NCT00534599|450892394|FG001|Overall Study|Protocol Violation|3|||
125344116|NCT00534599|450892393|FG000|Overall Study|Lost to Follow-up|11|||
125344117|NCT00534599|450892394|FG001|Overall Study|Lost to Follow-up|14|||
125344118|NCT00534599|450892393|FG000|Overall Study|Withdrawal by Subject|4|||
125344119|NCT00534599|450892394|FG001|Overall Study|Withdrawal by Subject|6|||
125344120|NCT00534599|450892393|FG000|Overall Study|Other|7|||
125344121|NCT00534599|450892394|FG001|Overall Study|Other|0|||
125344122|NCT03645434|450892398|FG000|Period 1|Adverse Event|0|||
125344123|NCT03645434|450892399|FG001|Period 1|Adverse Event|0|||
125344124|NCT03645434|450892400|FG002|Period 1|Adverse Event|0|||
125344125|NCT03645434|450892401|FG003|Period 1|Adverse Event|1|||
125344126|NCT03645434|450892402|FG004|Period 1|Adverse Event|0|||
125344127|NCT03645434|450892403|FG005|Period 1|Adverse Event|0|||
125344128|NCT03645434|450892398|FG000|Period 1|COPD exacerbation|0|||
125344129|NCT03645434|450892399|FG001|Period 1|COPD exacerbation|0|||
125344130|NCT03645434|450892400|FG002|Period 1|COPD exacerbation|0|||
125344131|NCT03645434|450892401|FG003|Period 1|COPD exacerbation|0|||
125344132|NCT03645434|450892402|FG004|Period 1|COPD exacerbation|1|||
125344133|NCT03645434|450892403|FG005|Period 1|COPD exacerbation|0|||
125344134|NCT03865316|450893938|FG000|Overall Study|Procedure Cancelled|4|||
125344135|NCT03865316|450893938|FG000|Overall Study|Equipment failure|4|||
125344136|NCT03658876|450893940|FG000|Overall Study|Protocol Violation|3|||
125344137|NCT03658876|450893941|FG001|Overall Study|Protocol Violation|2|||
125344138|NCT03658876|450893940|FG000|Overall Study|Withdrawal by Subject|2|||
125344139|NCT03658876|450893941|FG001|Overall Study|Withdrawal by Subject|0|||
125677400|NCT00264810|452107705|FG000|Blinded Evaluation Period|Explant due to infection|1|||
125677401|NCT00264810|452107706|FG001|Blinded Evaluation Period|Explant due to infection|1|||
125677402|NCT00264810|452107705|FG000|Open Label Evaluation Period|Explant due to infection|1|||
125677403|NCT00264810|452107706|FG001|Open Label Evaluation Period|Explant due to infection|1|||
125677404|NCT00264810|452107705|FG000|Open Label Evaluation Period|Death|3|||
125677405|NCT00264810|452107706|FG001|Open Label Evaluation Period|Death|2|||
125677406|NCT00264810|452107705|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
125677407|NCT00264810|452107706|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
125677408|NCT02093689|452107710|FG000|Overall Study|Physician Decision|4|||
125677409|NCT02093689|452107711|FG001|Overall Study|Physician Decision|0|||
125677410|NCT02093689|452107712|FG002|Overall Study|Physician Decision|0|||
125677411|NCT04634409|452107713|FG000|Overall Study|Death|0|||
125344140|NCT03658876|450893940|FG000|Overall Study|Death|0|||
125344141|NCT03658876|450893941|FG001|Overall Study|Death|1|||
125344142|NCT03658876|450893940|FG000|Overall Study|Intercurrent illness|6|||
125344143|NCT03658876|450893941|FG001|Overall Study|Intercurrent illness|4|||
125344144|NCT03658876|450893940|FG000|Overall Study|Transplantation/other operation|1|||
125344145|NCT03658876|450893941|FG001|Overall Study|Transplantation/other operation|5|||
125344146|NCT01330017|450893942|FG000|Overall Study|Adverse Event|0|||
125344147|NCT01330017|450893943|FG001|Overall Study|Adverse Event|1|||
125344148|NCT01330017|450893944|FG002|Overall Study|Adverse Event|1|||
125344149|NCT01330017|450893945|FG003|Overall Study|Adverse Event|4|||
125344150|NCT01330017|450893946|FG004|Overall Study|Adverse Event|0|||
125344151|NCT01330017|450893942|FG000|Overall Study|Withdrawal by Subject|0|||
125344152|NCT01330017|450893943|FG001|Overall Study|Withdrawal by Subject|0|||
125344153|NCT01330017|450893944|FG002|Overall Study|Withdrawal by Subject|1|||
125344154|NCT01330017|450893945|FG003|Overall Study|Withdrawal by Subject|0|||
125677412|NCT04634409|452107714|FG001|Overall Study|Death|0|||
125677413|NCT04634409|452107715|FG002|Overall Study|Death|0|||
125344155|NCT01330017|450893946|FG004|Overall Study|Withdrawal by Subject|1|||
125344156|NCT01330017|450893942|FG000|Overall Study|Lost to Follow-up|0|||
125344157|NCT01330017|450893943|FG001|Overall Study|Lost to Follow-up|0|||
125344158|NCT01330017|450893944|FG002|Overall Study|Lost to Follow-up|1|||
125344159|NCT01330017|450893945|FG003|Overall Study|Lost to Follow-up|0|||
125344160|NCT01330017|450893946|FG004|Overall Study|Lost to Follow-up|0|||
125344161|NCT01330017|450893942|FG000|Overall Study|Protocol Violation|0|||
125344162|NCT01330017|450893943|FG001|Overall Study|Protocol Violation|0|||
125344163|NCT01330017|450893944|FG002|Overall Study|Protocol Violation|0|||
125344164|NCT01330017|450893945|FG003|Overall Study|Protocol Violation|1|||
125344165|NCT01330017|450893946|FG004|Overall Study|Protocol Violation|0|||
125344166|NCT01330017|450893942|FG000|Overall Study|Unknown Reason|5|||
125344167|NCT01330017|450893943|FG001|Overall Study|Unknown Reason|3|||
125344168|NCT01330017|450893944|FG002|Overall Study|Unknown Reason|5|||
125344169|NCT01330017|450893945|FG003|Overall Study|Unknown Reason|7|||
125344170|NCT01330017|450893946|FG004|Overall Study|Unknown Reason|2|||
125344171|NCT02616146|450893947|FG000|Overall Study|Adverse Event|64|||
125344172|NCT02616146|450893948|FG001|Overall Study|Adverse Event|24|||
125344173|NCT02616146|450893947|FG000|Overall Study|Lost to Follow-up|23|||
125344174|NCT02616146|450893948|FG001|Overall Study|Lost to Follow-up|13|||
125344175|NCT02616146|450893947|FG000|Overall Study|Non-compliance with study protocol|2|||
125344176|NCT02616146|450893948|FG001|Overall Study|Non-compliance with study protocol|0|||
125344177|NCT02616146|450893947|FG000|Overall Study|Non-compliance with study drug|4|||
125344178|NCT02616146|450893948|FG001|Overall Study|Non-compliance with study drug|2|||
125344179|NCT02616146|450893947|FG000|Overall Study|Pregnancy|2|||
125344180|NCT02616146|450893948|FG001|Overall Study|Pregnancy|2|||
125344181|NCT02616146|450893947|FG000|Overall Study|Pregnancy wish|3|||
125344182|NCT02616146|450893948|FG001|Overall Study|Pregnancy wish|0|||
125344183|NCT02616146|450893947|FG000|Overall Study|Protocol Violation|6|||
125344184|NCT02616146|450893948|FG001|Overall Study|Protocol Violation|3|||
125344185|NCT02616146|450893947|FG000|Overall Study|Study terminated by sponsor|1372|||
125344186|NCT02616146|450893948|FG001|Overall Study|Study terminated by sponsor|432|||
125344187|NCT02616146|450893947|FG000|Overall Study|Participant moved|4|||
125344188|NCT02616146|450893948|FG001|Overall Study|Participant moved|3|||
125344189|NCT02616146|450893947|FG000|Overall Study|Withdrawal by Subject|30|||
125344190|NCT02616146|450893948|FG001|Overall Study|Withdrawal by Subject|24|||
125344191|NCT02616146|450893947|FG000|Overall Study|Physician Decision|2|||
125344192|NCT02616146|450893948|FG001|Overall Study|Physician Decision|1|||
125344193|NCT00336856|450893949|FG000|Overall Study|Withdrawal by Subject|3|||
125344194|NCT00336856|450893949|FG000|Overall Study|Found ineligible at time of analysis|1|||
125344195|NCT01106092|450893950|FG000|Overall Study|Withdrawal by Subject|0|||
125344196|NCT01106092|450893951|FG001|Overall Study|Withdrawal by Subject|0|||
125344197|NCT01106092|450893952|FG002|Overall Study|Withdrawal by Subject|0|||
125344198|NCT01106092|450893953|FG003|Overall Study|Withdrawal by Subject|1|||
125344199|NCT00843778|450893954|FG000|Overall Study|Adverse Event|15|||
125344200|NCT00843778|450893954|FG000|Overall Study|Lack of Efficacy|14|||
125344201|NCT00843778|450893954|FG000|Overall Study|Loss of efficacy|2|||
125344202|NCT00843778|450893954|FG000|Overall Study|Withdrawal by Subject|4|||
125344203|NCT03338959|450893959|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
125344204|NCT03338959|450893959|FG000|Overall Study|Physician Decision|1|||
125344205|NCT01604278|450893960|FG000|Overall Study|Lack of Efficacy|0|||
125344206|NCT01604278|450893961|FG001|Overall Study|Lack of Efficacy|1|||
125344207|NCT01604278|450893960|FG000|Overall Study|Lost to Follow-up|1|||
125344208|NCT01604278|450893961|FG001|Overall Study|Lost to Follow-up|0|||
125344209|NCT01604278|450893960|FG000|Overall Study|Administrative problems|2|||
125344210|NCT01604278|450893961|FG001|Overall Study|Administrative problems|1|||
125344211|NCT01604278|450893960|FG000|Overall Study|Withdrawal by Subject|3|||
125344212|NCT01604278|450893961|FG001|Overall Study|Withdrawal by Subject|3|||
125344213|NCT01604278|450893960|FG000|Overall Study|Adverse Event|3|||
125344214|NCT01604278|450893961|FG001|Overall Study|Adverse Event|5|||
125344215|NCT01604278|450893960|FG000|Overall Study|Protocol Deviation|5|||
125677414|NCT04634409|452107716|FG003|Overall Study|Death|0|||
125677415|NCT04634409|452107717|FG004|Overall Study|Death|0|||
125677416|NCT04634409|452107718|FG005|Overall Study|Death|0|||
125677417|NCT04634409|452107719|FG006|Overall Study|Death|0|||
125677418|NCT04634409|452107720|FG007|Overall Study|Death|0|||
125677419|NCT04634409|452107721|FG008|Overall Study|Death|0|||
125677420|NCT04634409|452107722|FG009|Overall Study|Death|0|||
125677421|NCT04634409|452107723|FG010|Overall Study|Death|1|||
125677422|NCT04634409|452107724|FG011|Overall Study|Death|0|||
125677423|NCT04634409|452107725|FG012|Overall Study|Death|1|||
125677424|NCT04634409|452107726|FG013|Overall Study|Death|0|||
125677425|NCT04634409|452107727|FG014|Overall Study|Death|0|||
125677426|NCT04634409|452107728|FG015|Overall Study|Death|0|||
125677427|NCT04634409|452107729|FG016|Overall Study|Death|0|||
125677428|NCT04634409|452107730|FG017|Overall Study|Death|0|||
125677429|NCT04634409|452107731|FG018|Overall Study|Death|0|||
125677430|NCT04634409|452107732|FG019|Overall Study|Death|0|||
125677431|NCT04634409|452107733|FG020|Overall Study|Death|0|||
125677432|NCT04634409|452107734|FG021|Overall Study|Death|0|||
125677433|NCT04634409|452107735|FG022|Overall Study|Death|0|||
125677434|NCT04634409|452107736|FG023|Overall Study|Death|0|||
125677435|NCT04634409|452107737|FG024|Overall Study|Death|0|||
125677436|NCT04634409|452107738|FG025|Overall Study|Death|0|||
125677437|NCT04634409|452107739|FG026|Overall Study|Death|0|||
125677438|NCT04634409|452107713|FG000|Overall Study|Adverse Event|0|||
125677439|NCT04634409|452107714|FG001|Overall Study|Adverse Event|0|||
125677440|NCT04634409|452107715|FG002|Overall Study|Adverse Event|1|||
125677441|NCT04634409|452107716|FG003|Overall Study|Adverse Event|0|||
125677442|NCT04634409|452107717|FG004|Overall Study|Adverse Event|0|||
125677443|NCT04634409|452107718|FG005|Overall Study|Adverse Event|1|||
125677444|NCT04634409|452107719|FG006|Overall Study|Adverse Event|0|||
125677445|NCT04634409|452107720|FG007|Overall Study|Adverse Event|0|||
125677446|NCT04634409|452107721|FG008|Overall Study|Adverse Event|0|||
125677447|NCT04634409|452107722|FG009|Overall Study|Adverse Event|0|||
125677448|NCT04634409|452107723|FG010|Overall Study|Adverse Event|0|||
125677449|NCT04634409|452107724|FG011|Overall Study|Adverse Event|0|||
125677450|NCT04634409|452107725|FG012|Overall Study|Adverse Event|0|||
125677451|NCT04634409|452107726|FG013|Overall Study|Adverse Event|0|||
125677452|NCT04634409|452107727|FG014|Overall Study|Adverse Event|0|||
125677453|NCT04634409|452107728|FG015|Overall Study|Adverse Event|0|||
125677454|NCT04634409|452107729|FG016|Overall Study|Adverse Event|0|||
125677455|NCT04634409|452107730|FG017|Overall Study|Adverse Event|0|||
125677456|NCT04634409|452107731|FG018|Overall Study|Adverse Event|0|||
125677457|NCT04634409|452107732|FG019|Overall Study|Adverse Event|0|||
125677458|NCT04634409|452107733|FG020|Overall Study|Adverse Event|0|||
125677459|NCT04634409|452107734|FG021|Overall Study|Adverse Event|0|||
125677460|NCT04634409|452107735|FG022|Overall Study|Adverse Event|0|||
125677461|NCT04634409|452107736|FG023|Overall Study|Adverse Event|0|||
125677462|NCT04634409|452107737|FG024|Overall Study|Adverse Event|0|||
125677463|NCT04634409|452107738|FG025|Overall Study|Adverse Event|0|||
125344216|NCT01604278|450893961|FG001|Overall Study|Protocol Deviation|3|||
125344217|NCT02184455|450893962|FG000|Overall Study|Lost to Follow-up|1|||
125344218|NCT03328182|450893965|FG000|Overall Study|Withdrawal by Subject|1|||
125344219|NCT03328182|450893965|FG000|Overall Study|Protocol Violation|2|||
125344220|NCT03328182|450893965|FG000|Overall Study|No Product Evaluated|1|||
125677464|NCT04634409|452107739|FG026|Overall Study|Adverse Event|0|||
125677465|NCT04634409|452107713|FG000|Overall Study|Lost to Follow-up|3|||
125677466|NCT04634409|452107714|FG001|Overall Study|Lost to Follow-up|1|||
125677467|NCT04634409|452107715|FG002|Overall Study|Lost to Follow-up|1|||
125677468|NCT04634409|452107716|FG003|Overall Study|Lost to Follow-up|3|||
125677469|NCT04634409|452107717|FG004|Overall Study|Lost to Follow-up|1|||
125677470|NCT04634409|452107718|FG005|Overall Study|Lost to Follow-up|1|||
125677471|NCT04634409|452107719|FG006|Overall Study|Lost to Follow-up|1|||
125677472|NCT04634409|452107720|FG007|Overall Study|Lost to Follow-up|3|||
125344221|NCT01347580|450893969|FG000|Overall Study|Withdrawal by Subject|13|||
125344222|NCT01347580|450893970|FG001|Overall Study|Withdrawal by Subject|23|||
125344223|NCT01347580|450893969|FG000|Overall Study|Death|30|||
125344224|NCT01347580|450893970|FG001|Overall Study|Death|19|||
125344225|NCT01347580|450893969|FG000|Overall Study|Protocol Violation|10|||
125344226|NCT01347580|450893970|FG001|Overall Study|Protocol Violation|7|||
125344227|NCT01347580|450893969|FG000|Overall Study|Lost to Follow-up|3|||
125344228|NCT01347580|450893970|FG001|Overall Study|Lost to Follow-up|1|||
125344229|NCT01347580|450893969|FG000|Overall Study|Had other reason|9|||
125344230|NCT01347580|450893970|FG001|Overall Study|Had other reason|6|||
125344231|NCT02870933|450893971|FG000|Overall Study|Death|2|||
125344232|NCT02870933|450893972|FG001|Overall Study|Death|1|||
125344233|NCT02870933|450893971|FG000|Overall Study|Withdrawal by Subject|0|||
125344234|NCT02870933|450893972|FG001|Overall Study|Withdrawal by Subject|1|||
125344235|NCT00003590|450893973|FG000|Overall Study|Ineligible Patient|1|||
125344236|NCT00003590|450893973|FG000|Overall Study|Adverse Event|7|||
125344237|NCT00003590|450893973|FG000|Overall Study|Withdrawal by Subject|1|||
125344238|NCT00003590|450893973|FG000|Overall Study|Lack of Efficacy|11|||
125344239|NCT00003590|450893973|FG000|Overall Study|Death|1|||
125344240|NCT00003590|450893973|FG000|Overall Study|Physician Decision|1|||
125344241|NCT01425463|450893974|FG000|Overall Study|Adverse Event|5|||
125344242|NCT01425463|450893975|FG001|Overall Study|Adverse Event|7|||
125344243|NCT01425463|450893974|FG000|Overall Study|Lack of Efficacy|1|||
125344244|NCT01425463|450893975|FG001|Overall Study|Lack of Efficacy|1|||
125344245|NCT01425463|450893974|FG000|Overall Study|Protocol Violation|2|||
125344246|NCT01425463|450893975|FG001|Overall Study|Protocol Violation|2|||
125344247|NCT01425463|450893974|FG000|Overall Study|Lost to Follow-up|5|||
125344248|NCT01425463|450893975|FG001|Overall Study|Lost to Follow-up|2|||
125344249|NCT01425463|450893974|FG000|Overall Study|Withdrawal by Subject|7|||
125344250|NCT01425463|450893975|FG001|Overall Study|Withdrawal by Subject|5|||
125344251|NCT01425463|450893974|FG000|Overall Study|Unknown Reason|4|||
125344252|NCT01425463|450893975|FG001|Overall Study|Unknown Reason|7|||
125344253|NCT01009840|450893976|FG000|Overall Study|Lost to Follow-up|1|||
125344254|NCT01009840|450893976|FG000|Overall Study|Adverse Event|4|||
125344255|NCT01009840|450893976|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
125677473|NCT04634409|452107721|FG008|Overall Study|Lost to Follow-up|3|||
125677474|NCT04634409|452107722|FG009|Overall Study|Lost to Follow-up|11|||
125677475|NCT04634409|452107723|FG010|Overall Study|Lost to Follow-up|8|||
125677476|NCT04634409|452107724|FG011|Overall Study|Lost to Follow-up|15|||
125344256|NCT01009840|450893976|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
125344257|NCT01009840|450893976|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
125344258|NCT01958489|450893987|FG000|Period 2|Adverse Event|0|||
125677477|NCT04634409|452107725|FG012|Overall Study|Lost to Follow-up|3|||
125677478|NCT04634409|452107726|FG013|Overall Study|Lost to Follow-up|2|||
125677479|NCT04634409|452107727|FG014|Overall Study|Lost to Follow-up|7|||
125677480|NCT04634409|452107728|FG015|Overall Study|Lost to Follow-up|0|||
125677481|NCT04634409|452107729|FG016|Overall Study|Lost to Follow-up|0|||
125677482|NCT04634409|452107730|FG017|Overall Study|Lost to Follow-up|0|||
125677483|NCT04634409|452107731|FG018|Overall Study|Lost to Follow-up|0|||
125677484|NCT04634409|452107732|FG019|Overall Study|Lost to Follow-up|0|||
125677485|NCT04634409|452107733|FG020|Overall Study|Lost to Follow-up|0|||
125677486|NCT04634409|452107734|FG021|Overall Study|Lost to Follow-up|0|||
125677487|NCT04634409|452107735|FG022|Overall Study|Lost to Follow-up|0|||
125677488|NCT04634409|452107736|FG023|Overall Study|Lost to Follow-up|0|||
125677489|NCT04634409|452107737|FG024|Overall Study|Lost to Follow-up|0|||
125677490|NCT04634409|452107738|FG025|Overall Study|Lost to Follow-up|0|||
125677491|NCT04634409|452107739|FG026|Overall Study|Lost to Follow-up|0|||
125677492|NCT04634409|452107713|FG000|Overall Study|Withdrawal by Subject|3|||
125677493|NCT04634409|452107714|FG001|Overall Study|Withdrawal by Subject|1|||
125677494|NCT04634409|452107715|FG002|Overall Study|Withdrawal by Subject|6|||
125677495|NCT04634409|452107716|FG003|Overall Study|Withdrawal by Subject|4|||
125344259|NCT01958489|450893988|FG001|Period 2|Adverse Event|1|||
125344260|NCT00917644|450893989|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
125677496|NCT04634409|452107717|FG004|Overall Study|Withdrawal by Subject|2|||
125344261|NCT00917644|450893990|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
125344262|NCT00917644|450893989|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
125344263|NCT00917644|450893990|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
125344264|NCT00917644|450893989|FG000|Period 2: Second Intervention|family emergency|1|||
125344265|NCT00917644|450893990|FG001|Period 2: Second Intervention|family emergency|0|||
125344266|NCT02338232|450893991|FG000|Overall Study|Screen Failure|3|||
125344267|NCT02338232|450893991|FG000|Overall Study|Withdrawal by Subject|6|||
125344268|NCT02338232|450893991|FG000|Overall Study|Adverse Event|2|||
125344269|NCT02500056|450893992|FG000|Overall Study|Lost to Follow-up|3|||
125344270|NCT02500056|450893993|FG001|Overall Study|Lost to Follow-up|7|||
125677497|NCT04634409|452107718|FG005|Overall Study|Withdrawal by Subject|0|||
125344271|NCT02500056|450893992|FG000|Overall Study|Recurrence|1|||
125344272|NCT02500056|450893993|FG001|Overall Study|Recurrence|0|||
125344273|NCT02500056|450893992|FG000|Overall Study|Death|3|||
125677498|NCT04634409|452107719|FG006|Overall Study|Withdrawal by Subject|0|||
125344274|NCT02500056|450893993|FG001|Overall Study|Death|1|||
125344275|NCT00864916|450893994|FG000|Overall Study|Lost to Follow-up|4|||
125344276|NCT00864916|450893995|FG001|Overall Study|Lost to Follow-up|4|||
125344277|NCT00864916|450893994|FG000|Overall Study|Protocol Violation|1|||
125344278|NCT00864916|450893995|FG001|Overall Study|Protocol Violation|0|||
125344279|NCT00864916|450893994|FG000|Overall Study|Withdrawal by Subject|1|||
125344280|NCT00864916|450893995|FG001|Overall Study|Withdrawal by Subject|0|||
125344281|NCT01087736|450893998|FG000|Overall Study|Lost to Follow-up|1|||
125344282|NCT01087736|450893999|FG001|Overall Study|Lost to Follow-up|0|||
125344283|NCT01087736|450893998|FG000|Overall Study|Death|0|||
125344284|NCT01087736|450893999|FG001|Overall Study|Death|1|||
125344285|NCT01087736|450893998|FG000|Overall Study|Withdrawal by Subject|0|||
125344286|NCT01087736|450893999|FG001|Overall Study|Withdrawal by Subject|1|||
125344287|NCT02122783|450894008|FG000|Overall Study|Adverse Event|0|||
125344288|NCT02122783|450894009|FG001|Overall Study|Adverse Event|1|||
125344289|NCT01579812|450894012|FG000|Overall Study|Ineligible after treatment start|40|||
125344290|NCT01579812|450894012|FG000|Overall Study|Patient choice|3|||
125344291|NCT01579812|450894012|FG000|Overall Study|Noncompliance|3|||
125344292|NCT01579812|450894012|FG000|Overall Study|Withdrawal by Subject|6|||
125344293|NCT01101308|450894013|FG000|Period 1|Adverse Event|2|||
125344294|NCT01101308|450894014|FG001|Period 1|Adverse Event|1|||
125344295|NCT01101308|450894013|FG000|Period 1|Positive for cotinine|1|||
125344296|NCT01101308|450894014|FG001|Period 1|Positive for cotinine|0|||
125344297|NCT04905498|450894019|FG000|Overall Study|Lost to Follow-up|0|||
125344298|NCT04905498|450894020|FG001|Overall Study|Lost to Follow-up|2|||
125344299|NCT04905498|450894019|FG000|Overall Study|COVID lockdown|1|||
125344300|NCT04905498|450894020|FG001|Overall Study|COVID lockdown|0|||
125344301|NCT00869778|450894023|FG000|Overall Study|Adverse Event|2|||
125344302|NCT00869778|450894024|FG001|Overall Study|Adverse Event|0|||
125344303|NCT00869778|450894025|FG002|Overall Study|Adverse Event|0|||
125344304|NCT00869778|450894023|FG000|Overall Study|Withdrawal by Subject|3|||
125344305|NCT00869778|450894024|FG001|Overall Study|Withdrawal by Subject|4|||
125344306|NCT00869778|450894025|FG002|Overall Study|Withdrawal by Subject|5|||
125344307|NCT00869778|450894023|FG000|Overall Study|Pregnancy|1|||
125344308|NCT00869778|450894024|FG001|Overall Study|Pregnancy|0|||
125344309|NCT00869778|450894025|FG002|Overall Study|Pregnancy|0|||
125344310|NCT00869778|450894023|FG000|Overall Study|Protocol Violation|5|||
125344311|NCT00869778|450894024|FG001|Overall Study|Protocol Violation|3|||
125344312|NCT00869778|450894025|FG002|Overall Study|Protocol Violation|5|||
125344313|NCT00869778|450894023|FG000|Overall Study|Unblinding|1|||
125344314|NCT00869778|450894024|FG001|Overall Study|Unblinding|0|||
125344315|NCT00869778|450894025|FG002|Overall Study|Unblinding|0|||
125344316|NCT03339297|450894026|FG000|Overall Study|Relapse of Hematologic Disease|1|||
125344317|NCT03339297|450894027|FG001|Overall Study|Relapse of Hematologic Disease|0|||
125344318|NCT03339297|450894026|FG000|Overall Study|Death|10|||
125344319|NCT03339297|450894027|FG001|Overall Study|Death|7|||
125344320|NCT03339297|450894026|FG000|Overall Study|Hepatic Candidosis|1|||
125344321|NCT03339297|450894027|FG001|Overall Study|Hepatic Candidosis|0|||
125344322|NCT03339297|450894026|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
125344323|NCT03339297|450894027|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
125344324|NCT03339297|450894026|FG000|Overall Study|Consent Withdrawn by Participant|3|||
125344325|NCT03339297|450894027|FG001|Overall Study|Consent Withdrawn by Participant|3|||
125344326|NCT03339297|450894026|FG000|Overall Study|Disease Relapse|2|||
125344327|NCT03339297|450894027|FG001|Overall Study|Disease Relapse|0|||
125344328|NCT03339297|450894026|FG000|Overall Study|Physician Decision|1|||
125677499|NCT04634409|452107720|FG007|Overall Study|Withdrawal by Subject|2|||
125677500|NCT04634409|452107721|FG008|Overall Study|Withdrawal by Subject|3|||
125677501|NCT04634409|452107722|FG009|Overall Study|Withdrawal by Subject|2|||
125677502|NCT04634409|452107723|FG010|Overall Study|Withdrawal by Subject|3|||
125677503|NCT04634409|452107724|FG011|Overall Study|Withdrawal by Subject|2|||
125677504|NCT04634409|452107725|FG012|Overall Study|Withdrawal by Subject|2|||
125677505|NCT04634409|452107726|FG013|Overall Study|Withdrawal by Subject|1|||
125677506|NCT04634409|452107727|FG014|Overall Study|Withdrawal by Subject|5|||
125344329|NCT03339297|450894027|FG001|Overall Study|Physician Decision|1|||
125344330|NCT03339297|450894026|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
125344331|NCT03339297|450894027|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
125344332|NCT03339297|450894026|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
125344333|NCT03339297|450894027|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
125344334|NCT03339297|450894026|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
125344335|NCT03339297|450894027|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
125344336|NCT03339297|450894026|FG000|Overall Study|Adverse Event, Non-fatal|1|||
125677507|NCT04634409|452107728|FG015|Overall Study|Withdrawal by Subject|0|||
125344337|NCT03339297|450894027|FG001|Overall Study|Adverse Event, Non-fatal|0|||
125344338|NCT03339297|450894026|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
125344339|NCT03339297|450894027|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
125344340|NCT03339297|450894026|FG000|Overall Study|Patient Was Not Eligible|1|||
125344341|NCT03339297|450894027|FG001|Overall Study|Patient Was Not Eligible|0|||
125344342|NCT03051620|450894028|FG000|Overall Study|Lost to Follow-up|6|||
125344343|NCT03051620|450894028|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
125344344|NCT00393510|450894029|FG000|Overall Study|Physician Decision|3|||
125344345|NCT00393510|450894030|FG001|Overall Study|Physician Decision|9|||
125344346|NCT03077087|450894031|FG000|Overall Study|Physician Decision|2|||
125344347|NCT02112045|450894034|FG000|Overall Study|Withdrawal by Subject|1|||
125344348|NCT02112045|450894035|FG001|Overall Study|Withdrawal by Subject|0|||
125344349|NCT00977080|450894037|FG000|Overall Study|Adverse Event|2|||
125344350|NCT00977080|450894038|FG001|Overall Study|Adverse Event|7|||
125344351|NCT00977080|450894039|FG002|Overall Study|Adverse Event|7|||
125344352|NCT00977080|450894040|FG003|Overall Study|Adverse Event|7|||
125344353|NCT00977080|450894037|FG000|Overall Study|Withdrawal by Subject|1|||
125344354|NCT00977080|450894038|FG001|Overall Study|Withdrawal by Subject|5|||
125344355|NCT00977080|450894039|FG002|Overall Study|Withdrawal by Subject|1|||
125344356|NCT00977080|450894040|FG003|Overall Study|Withdrawal by Subject|5|||
125344357|NCT00977080|450894037|FG000|Overall Study|Protocol Violation|7|||
125344358|NCT00977080|450894038|FG001|Overall Study|Protocol Violation|3|||
125344359|NCT00977080|450894039|FG002|Overall Study|Protocol Violation|4|||
125344360|NCT00977080|450894040|FG003|Overall Study|Protocol Violation|3|||
125344361|NCT00977080|450894037|FG000|Overall Study|Noncompliance|0|||
125344362|NCT00977080|450894038|FG001|Overall Study|Noncompliance|2|||
125344363|NCT00977080|450894039|FG002|Overall Study|Noncompliance|1|||
125344364|NCT00977080|450894040|FG003|Overall Study|Noncompliance|0|||
125344365|NCT00977080|450894037|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
125344366|NCT00977080|450894038|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
125344367|NCT00977080|450894039|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
125344368|NCT00977080|450894040|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
125344369|NCT00977080|450894037|FG000|Overall Study|Required kidney transplantation|1|||
125344370|NCT00977080|450894038|FG001|Overall Study|Required kidney transplantation|3|||
125344371|NCT00977080|450894039|FG002|Overall Study|Required kidney transplantation|3|||
125344372|NCT00977080|450894040|FG003|Overall Study|Required kidney transplantation|1|||
125344373|NCT00977080|450894037|FG000|Overall Study|Travel for family reasons|1|||
125344374|NCT00977080|450894038|FG001|Overall Study|Travel for family reasons|0|||
125344375|NCT00977080|450894039|FG002|Overall Study|Travel for family reasons|0|||
125344376|NCT00977080|450894040|FG003|Overall Study|Travel for family reasons|0|||
125344377|NCT00441116|450894043|FG000|Overall Study|Adverse Event|1|||
125344378|NCT00441116|450894044|FG001|Overall Study|Adverse Event|1|||
125344379|NCT00441116|450894043|FG000|Overall Study|Withdrawal by Subject|1|||
125344380|NCT00441116|450894044|FG001|Overall Study|Withdrawal by Subject|0|||
125344381|NCT00441116|450894043|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
125344382|NCT00441116|450894044|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
125344383|NCT00796991|450894056|FG000|Overall Study|Adverse Event|0|||
125344384|NCT00796991|450894057|FG001|Overall Study|Adverse Event|0|||
125344385|NCT00796991|450894058|FG002|Overall Study|Adverse Event|1|||
125344386|NCT00796991|450894056|FG000|Overall Study|Death|2|||
125344387|NCT00796991|450894057|FG001|Overall Study|Death|0|||
125344388|NCT00796991|450894058|FG002|Overall Study|Death|0|||
125344389|NCT00796991|450894056|FG000|Overall Study|Disease Progression|10|||
125344390|NCT00796991|450894057|FG001|Overall Study|Disease Progression|9|||
125344391|NCT00796991|450894058|FG002|Overall Study|Disease Progression|7|||
125344392|NCT00796991|450894056|FG000|Overall Study|Study Drug Toxicity|3|||
125344393|NCT00796991|450894057|FG001|Overall Study|Study Drug Toxicity|3|||
125344394|NCT00796991|450894058|FG002|Overall Study|Study Drug Toxicity|5|||
125344395|NCT00796991|450894056|FG000|Overall Study|Withdrawal by Subject|0|||
125344396|NCT00796991|450894057|FG001|Overall Study|Withdrawal by Subject|0|||
125344397|NCT00796991|450894058|FG002|Overall Study|Withdrawal by Subject|1|||
125344398|NCT01765218|450894059|FG000|Overall Study|Protocol Violation|1|||
125344399|NCT01765218|450894060|FG001|Overall Study|Protocol Violation|2|||
125677508|NCT04634409|452107729|FG016|Overall Study|Withdrawal by Subject|0|||
125677509|NCT04634409|452107730|FG017|Overall Study|Withdrawal by Subject|1|||
125344400|NCT03148691|450894061|FG000|Overall Study|Protocol Violation|1|||
125344401|NCT03148691|450894062|FG001|Overall Study|Protocol Violation|2|||
125344402|NCT03148691|450894063|FG002|Overall Study|Protocol Violation|7|||
125344403|NCT03148691|450894061|FG000|Overall Study|Lost to Follow-up|0|||
125344404|NCT03148691|450894062|FG001|Overall Study|Lost to Follow-up|0|||
125344405|NCT03148691|450894063|FG002|Overall Study|Lost to Follow-up|1|||
125344406|NCT03148691|450894061|FG000|Overall Study|Other|1|||
125344407|NCT03148691|450894062|FG001|Overall Study|Other|0|||
125677510|NCT04634409|452107731|FG018|Overall Study|Withdrawal by Subject|0|||
125677511|NCT04634409|452107732|FG019|Overall Study|Withdrawal by Subject|0|||
125677512|NCT04634409|452107733|FG020|Overall Study|Withdrawal by Subject|0|||
125344408|NCT03148691|450894063|FG002|Overall Study|Other|0|||
125344409|NCT03148691|450894061|FG000|Overall Study|Withdrawal by Subject|1|||
125344410|NCT03148691|450894062|FG001|Overall Study|Withdrawal by Subject|0|||
125344411|NCT03148691|450894063|FG002|Overall Study|Withdrawal by Subject|0|||
125344412|NCT00171834|450894064|FG000|Overall Study|Adverse Event|2|||
125344413|NCT00171834|450894065|FG001|Overall Study|Adverse Event|1|||
125344414|NCT00171834|450894066|FG002|Overall Study|Adverse Event|3|||
125344415|NCT00171834|450894067|FG003|Overall Study|Adverse Event|2|||
125344416|NCT00171834|450894068|FG004|Overall Study|Adverse Event|2|||
125344417|NCT00171834|450894069|FG005|Overall Study|Adverse Event|15|||
125344418|NCT00171834|450894070|FG006|Overall Study|Adverse Event|1|||
125344419|NCT00171834|450894064|FG000|Overall Study|Withdrawal by Subject|0|||
125344420|NCT00171834|450894065|FG001|Overall Study|Withdrawal by Subject|2|||
125344421|NCT00171834|450894066|FG002|Overall Study|Withdrawal by Subject|0|||
125344422|NCT00171834|450894067|FG003|Overall Study|Withdrawal by Subject|1|||
125344423|NCT00171834|450894068|FG004|Overall Study|Withdrawal by Subject|1|||
125344424|NCT00171834|450894069|FG005|Overall Study|Withdrawal by Subject|1|||
125344425|NCT00171834|450894070|FG006|Overall Study|Withdrawal by Subject|0|||
125344426|NCT00171834|450894064|FG000|Overall Study|Death from study indication|0|||
125344427|NCT00171834|450894065|FG001|Overall Study|Death from study indication|1|||
125344428|NCT00171834|450894066|FG002|Overall Study|Death from study indication|0|||
125344429|NCT00171834|450894067|FG003|Overall Study|Death from study indication|0|||
125344430|NCT00171834|450894068|FG004|Overall Study|Death from study indication|1|||
125344431|NCT00171834|450894069|FG005|Overall Study|Death from study indication|0|||
125344432|NCT00171834|450894070|FG006|Overall Study|Death from study indication|0|||
125344433|NCT00171834|450894064|FG000|Overall Study|Disease Progression|4|||
125344434|NCT00171834|450894065|FG001|Overall Study|Disease Progression|8|||
125344435|NCT00171834|450894066|FG002|Overall Study|Disease Progression|8|||
125344436|NCT00171834|450894067|FG003|Overall Study|Disease Progression|9|||
125344437|NCT00171834|450894068|FG004|Overall Study|Disease Progression|2|||
125344438|NCT00171834|450894069|FG005|Overall Study|Disease Progression|18|||
125344439|NCT00171834|450894070|FG006|Overall Study|Disease Progression|3|||
125344440|NCT00171834|450894064|FG000|Overall Study|Treatment Duration Completed|0|||
125344441|NCT00171834|450894065|FG001|Overall Study|Treatment Duration Completed|0|||
125344442|NCT00171834|450894066|FG002|Overall Study|Treatment Duration Completed|1|||
125344443|NCT00171834|450894067|FG003|Overall Study|Treatment Duration Completed|0|||
125344444|NCT00171834|450894068|FG004|Overall Study|Treatment Duration Completed|2|||
125344445|NCT00171834|450894069|FG005|Overall Study|Treatment Duration Completed|1|||
125344446|NCT00171834|450894070|FG006|Overall Study|Treatment Duration Completed|0|||
125344447|NCT02365233|450894080|FG000|Overall Study|IRB withheld the data|1|||
125344448|NCT02365233|450894081|FG001|Overall Study|IRB withheld the data|2|||
125344449|NCT02365233|450894082|FG002|Overall Study|IRB withheld the data|2|||
125344450|NCT01978938|450894083|FG000|Overall Study|Lost to Follow-up|12|||
125344451|NCT01978938|450894084|FG001|Overall Study|Lost to Follow-up|6|||
125344452|NCT01978938|450894083|FG000|Overall Study|Withdrawal by Subject|8|||
125344453|NCT01978938|450894084|FG001|Overall Study|Withdrawal by Subject|4|||
125344454|NCT01978938|450894083|FG000|Overall Study|Adverse Event, non-fatal|2|||
125344455|NCT01978938|450894084|FG001|Overall Study|Adverse Event, non-fatal|1|||
125344456|NCT01978938|450894083|FG000|Overall Study|Participant noncompliance|1|||
125344457|NCT01978938|450894084|FG001|Overall Study|Participant noncompliance|1|||
125344458|NCT01978938|450894083|FG000|Overall Study|Did not meet inclusion criteria|0|||
125344459|NCT01978938|450894084|FG001|Overall Study|Did not meet inclusion criteria|1|||
125344460|NCT01978938|450894083|FG000|Overall Study|Previously scheduled procedure|0|||
125344461|NCT01978938|450894084|FG001|Overall Study|Previously scheduled procedure|1|||
125344462|NCT02342418|450894085|FG000|Overall Study|Adverse Event|0|||
125344463|NCT02342418|450894086|FG001|Overall Study|Adverse Event|1|||
125344464|NCT04255394|450894087|FG000|Overall Study|Death|35|||
125344465|NCT04255394|450894088|FG001|Overall Study|Death|25|||
125344466|NCT04255394|450894087|FG000|Overall Study|Device removed|2|||
125344467|NCT04255394|450894088|FG001|Overall Study|Device removed|10|||
125344468|NCT04255394|450894087|FG000|Overall Study|Withdrawal by Subject|9|||
125344469|NCT04255394|450894088|FG001|Overall Study|Withdrawal by Subject|8|||
125344470|NCT04255394|450894087|FG000|Overall Study|Screen Failure/Not treated|12|||
125344471|NCT04255394|450894088|FG001|Overall Study|Screen Failure/Not treated|8|||
125344472|NCT04255394|450894087|FG000|Overall Study|Lost to Follow-up|123|||
125344473|NCT04255394|450894088|FG001|Overall Study|Lost to Follow-up|265|||
125344474|NCT04255394|450894087|FG000|Overall Study|Adverse Event|1|||
125344475|NCT04255394|450894088|FG001|Overall Study|Adverse Event|3|||
125344476|NCT01246466|450896302|FG000|Overall Study|Death|1|||
125344477|NCT01246466|450896302|FG000|Overall Study|Withdrawal by Subject|1|||
125344478|NCT01012219|450896305|FG000|Period 1|Withdrawal by Subject|1|||
125344479|NCT01012219|450896305|FG000|Period 2|Withdrawal by Subject|1|||
125344480|NCT01350544|450896314|FG000|Overall Study|Administrative Withdrawal|0|||
125344481|NCT01350544|450896315|FG001|Overall Study|Administrative Withdrawal|1|||
125344482|NCT01350544|450896314|FG000|Overall Study|Death|1|||
125344483|NCT01350544|450896315|FG001|Overall Study|Death|2|||
125344484|NCT01350544|450896314|FG000|Overall Study|Moved out of LA County|2|||
125344485|NCT01350544|450896315|FG001|Overall Study|Moved out of LA County|2|||
125344486|NCT01350544|450896314|FG000|Overall Study|Medical Issues|1|||
125677513|NCT04634409|452107734|FG021|Overall Study|Withdrawal by Subject|0|||
125677514|NCT04634409|452107735|FG022|Overall Study|Withdrawal by Subject|0|||
125344487|NCT01350544|450896315|FG001|Overall Study|Medical Issues|1|||
125344488|NCT01350544|450896314|FG000|Overall Study|Withdrawal by Subject|0|||
125344489|NCT01350544|450896315|FG001|Overall Study|Withdrawal by Subject|1|||
125344490|NCT01350544|450896314|FG000|Overall Study|Incarceration|1|||
125344491|NCT01350544|450896315|FG001|Overall Study|Incarceration|0|||
125344492|NCT01350544|450896314|FG000|Overall Study|Lost to Follow-up|18|||
125344493|NCT01350544|450896315|FG001|Overall Study|Lost to Follow-up|15|||
125344494|NCT01444092|450896318|FG000|Overall Study|Adverse Event|8|||
125344495|NCT01444092|450896318|FG000|Overall Study|Protocol Violation|1|||
125344496|NCT01444092|450896318|FG000|Overall Study|Withdrawal by Subject|1|||
125344497|NCT01444092|450896318|FG000|Overall Study|Other Eligibility criteria|7|||
125344498|NCT01328366|450896319|FG000|Overall Study|Death|1|||
125344499|NCT01328366|450896319|FG000|Overall Study|Withdrawal by Subject|2|||
125344500|NCT01328366|450896319|FG000|Overall Study|Lost to Follow-up|7|||
125344501|NCT01122264|450896323|FG000|Overall Study|Adverse Event|6|||
125344502|NCT01122264|450896324|FG001|Overall Study|Adverse Event|5|||
125344503|NCT01122264|450896325|FG002|Overall Study|Adverse Event|7|||
125344504|NCT01122264|450896323|FG000|Overall Study|Death|1|||
125344505|NCT01122264|450896324|FG001|Overall Study|Death|0|||
125344506|NCT01122264|450896325|FG002|Overall Study|Death|0|||
125344507|NCT01122264|450896323|FG000|Overall Study|Lost to Follow-up|5|||
125344508|NCT01122264|450896324|FG001|Overall Study|Lost to Follow-up|9|||
125344509|NCT01122264|450896325|FG002|Overall Study|Lost to Follow-up|13|||
125344510|NCT01122264|450896323|FG000|Overall Study|Entry Criteria Not Met|1|||
125344511|NCT01122264|450896324|FG001|Overall Study|Entry Criteria Not Met|0|||
125344512|NCT01122264|450896325|FG002|Overall Study|Entry Criteria Not Met|0|||
125344513|NCT01122264|450896323|FG000|Overall Study|Protocol Violation|7|||
125344514|NCT01122264|450896324|FG001|Overall Study|Protocol Violation|7|||
125344515|NCT01122264|450896325|FG002|Overall Study|Protocol Violation|9|||
125344516|NCT01122264|450896323|FG000|Overall Study|Withdrawal by Subject|6|||
125344517|NCT01122264|450896324|FG001|Overall Study|Withdrawal by Subject|6|||
125344518|NCT01122264|450896325|FG002|Overall Study|Withdrawal by Subject|16|||
125344519|NCT01122264|450896323|FG000|Overall Study|Physician Decision|3|||
125344520|NCT01122264|450896324|FG001|Overall Study|Physician Decision|1|||
125344521|NCT01122264|450896325|FG002|Overall Study|Physician Decision|1|||
125344522|NCT01122264|450896323|FG000|Overall Study|Lack of Efficacy|3|||
125344523|NCT01122264|450896324|FG001|Overall Study|Lack of Efficacy|1|||
125344524|NCT01122264|450896325|FG002|Overall Study|Lack of Efficacy|1|||
125344525|NCT03005873|450896326|FG000|Overall Study|Prohibited medication use post radnomization|1|||
125344526|NCT03005873|450896327|FG001|Overall Study|Prohibited medication use post radnomization|1|||
125344527|NCT03005873|450896328|FG002|Overall Study|Prohibited medication use post radnomization|1|||
125344528|NCT03005873|450896326|FG000|Overall Study|Withdrew consent|0|||
125344529|NCT03005873|450896327|FG001|Overall Study|Withdrew consent|1|||
125344530|NCT03005873|450896328|FG002|Overall Study|Withdrew consent|2|||
125344531|NCT03005873|450896326|FG000|Overall Study|Lost to Follow-up|0|||
125344532|NCT03005873|450896327|FG001|Overall Study|Lost to Follow-up|1|||
125344533|NCT03005873|450896328|FG002|Overall Study|Lost to Follow-up|0|||
125344534|NCT03005873|450896326|FG000|Overall Study|Ineligible post randomization|0|||
125344535|NCT03005873|450896327|FG001|Overall Study|Ineligible post randomization|0|||
125344536|NCT03005873|450896328|FG002|Overall Study|Ineligible post randomization|1|||
125344537|NCT04585009|450896329|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
125344538|NCT04585009|450896330|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125344539|NCT04585009|450896331|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125344540|NCT04585009|450896332|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125344541|NCT04585009|450896333|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125344542|NCT04585009|450896334|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125344543|NCT04585009|450896335|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125344544|NCT04585009|450896336|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125344545|NCT04585009|450896337|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125344546|NCT04585009|450896338|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125344547|NCT04585009|450896339|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125344548|NCT04585009|450896340|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
125344549|NCT04585009|450896329|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
125344550|NCT04585009|450896330|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125344551|NCT04585009|450896331|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125344552|NCT04585009|450896332|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125344553|NCT04585009|450896333|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125344554|NCT04585009|450896334|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125677515|NCT04634409|452107736|FG023|Overall Study|Withdrawal by Subject|1|||
125677516|NCT04634409|452107737|FG024|Overall Study|Withdrawal by Subject|0|||
125677517|NCT04634409|452107738|FG025|Overall Study|Withdrawal by Subject|0|||
125540919|NCT01237587|451609478|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
125540920|NCT01237587|451609479|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
125540921|NCT01237587|451609478|FG000|Taper Phase|Adverse Event|0|||
125540922|NCT01237587|451609479|FG001|Taper Phase|Adverse Event|2|||
125540923|NCT01237587|451609478|FG000|Taper Phase|Protocol Violation|2|||
125540924|NCT01237587|451609479|FG001|Taper Phase|Protocol Violation|0|||
125540925|NCT01237587|451609478|FG000|Taper Phase|Lack of Efficacy|2|||
125540926|NCT01237587|451609479|FG001|Taper Phase|Lack of Efficacy|5|||
125540927|NCT01237587|451609478|FG000|Taper Phase|Parent/Guardian Decision|0|||
125540928|NCT01237587|451609479|FG001|Taper Phase|Parent/Guardian Decision|2|||
125540929|NCT01237587|451609478|FG000|Taper Phase|Sponsor Decision|1|||
125540930|NCT01237587|451609479|FG001|Taper Phase|Sponsor Decision|0|||
125540931|NCT01237587|451609478|FG000|Taper Phase|Withdrawal by Subject|0|||
125540932|NCT01237587|451609479|FG001|Taper Phase|Withdrawal by Subject|1|||
125540933|NCT02656329|451609480|FG000|Overall Study|Lost to Follow-up|2|||
125540934|NCT02656329|451609481|FG001|Overall Study|Lost to Follow-up|3|||
125540935|NCT02656329|451609480|FG000|Overall Study|Withdrawal by Subject|7|||
125540936|NCT02656329|451609481|FG001|Overall Study|Withdrawal by Subject|6|||
125540937|NCT02656329|451609480|FG000|Overall Study|Study termination by Sponsor|150|||
125540938|NCT02656329|451609481|FG001|Overall Study|Study termination by Sponsor|142|||
125540939|NCT02656329|451609480|FG000|Overall Study|Other than specified above|5|||
125540940|NCT02656329|451609481|FG001|Overall Study|Other than specified above|6|||
125540941|NCT01139580|451609482|FG000|Overall Study|Adverse Event|5|||
125540942|NCT01139580|451609483|FG001|Overall Study|Adverse Event|4|||
125540943|NCT01139580|451609482|FG000|Overall Study|Lost to Follow-up|9|||
125540944|NCT01139580|451609483|FG001|Overall Study|Lost to Follow-up|1|||
125540945|NCT01139580|451609482|FG000|Overall Study|Lack of Efficacy|0|||
125540946|NCT01139580|451609483|FG001|Overall Study|Lack of Efficacy|2|||
125677518|NCT04634409|452107739|FG026|Overall Study|Withdrawal by Subject|0|||
125677519|NCT04634409|452107713|FG000|Overall Study|Other - As reported by Investigator|1|||
125677520|NCT04634409|452107714|FG001|Overall Study|Other - As reported by Investigator|0|||
125677521|NCT04634409|452107715|FG002|Overall Study|Other - As reported by Investigator|0|||
125677522|NCT04634409|452107716|FG003|Overall Study|Other - As reported by Investigator|0|||
125677523|NCT04634409|452107717|FG004|Overall Study|Other - As reported by Investigator|0|||
125677524|NCT04634409|452107718|FG005|Overall Study|Other - As reported by Investigator|0|||
125677525|NCT04634409|452107719|FG006|Overall Study|Other - As reported by Investigator|0|||
125677526|NCT04634409|452107720|FG007|Overall Study|Other - As reported by Investigator|6|||
125677527|NCT04634409|452107721|FG008|Overall Study|Other - As reported by Investigator|4|||
125677528|NCT04634409|452107722|FG009|Overall Study|Other - As reported by Investigator|0|||
125677529|NCT04634409|452107723|FG010|Overall Study|Other - As reported by Investigator|1|||
125677530|NCT04634409|452107724|FG011|Overall Study|Other - As reported by Investigator|2|||
125677531|NCT04634409|452107725|FG012|Overall Study|Other - As reported by Investigator|2|||
125677532|NCT04634409|452107726|FG013|Overall Study|Other - As reported by Investigator|1|||
125677533|NCT04634409|452107727|FG014|Overall Study|Other - As reported by Investigator|0|||
125677534|NCT04634409|452107728|FG015|Overall Study|Other - As reported by Investigator|0|||
125677535|NCT04634409|452107729|FG016|Overall Study|Other - As reported by Investigator|0|||
125677536|NCT04634409|452107730|FG017|Overall Study|Other - As reported by Investigator|0|||
125677537|NCT04634409|452107731|FG018|Overall Study|Other - As reported by Investigator|0|||
125677538|NCT04634409|452107732|FG019|Overall Study|Other - As reported by Investigator|0|||
125677539|NCT04634409|452107733|FG020|Overall Study|Other - As reported by Investigator|0|||
125677540|NCT04634409|452107734|FG021|Overall Study|Other - As reported by Investigator|0|||
125677541|NCT04634409|452107735|FG022|Overall Study|Other - As reported by Investigator|0|||
125677542|NCT04634409|452107736|FG023|Overall Study|Other - As reported by Investigator|0|||
125677543|NCT04634409|452107737|FG024|Overall Study|Other - As reported by Investigator|0|||
125677544|NCT04634409|452107738|FG025|Overall Study|Other - As reported by Investigator|0|||
125677545|NCT04634409|452107739|FG026|Overall Study|Other - As reported by Investigator|0|||
125677546|NCT03815942|452109318|FG000|Overall Study|Withdrawal by Subject|0|||
125677547|NCT03815942|452109319|FG001|Overall Study|Withdrawal by Subject|17|||
125677548|NCT03717064|452109320|FG000|Period 2|Adverse Event|1|||
125677549|NCT01298570|452109321|FG000|Overall Study|Disease progression, relapse during acti|64|||
125677550|NCT01298570|452109322|FG001|Overall Study|Disease progression, relapse during acti|40|||
125677551|NCT01298570|452109321|FG000|Overall Study|Adverse Event|20|||
125677552|NCT01298570|452109322|FG001|Overall Study|Adverse Event|2|||
125677553|NCT01298570|452109321|FG000|Overall Study|Withdrawal by Subject|21|||
125677554|NCT01298570|452109322|FG001|Overall Study|Withdrawal by Subject|6|||
125677555|NCT01298570|452109321|FG000|Overall Study|Treatment delay > 4 weeks|4|||
125677556|NCT01298570|452109322|FG001|Overall Study|Treatment delay > 4 weeks|5|||
125677557|NCT01298570|452109321|FG000|Overall Study|Physician Decision|4|||
125677558|NCT01298570|452109322|FG001|Overall Study|Physician Decision|2|||
125677559|NCT01298570|452109321|FG000|Overall Study|Other complicating disease|2|||
125677560|NCT01298570|452109322|FG001|Overall Study|Other complicating disease|1|||
125677561|NCT01298570|452109321|FG000|Overall Study|Surgery|2|||
125677562|NCT01298570|452109322|FG001|Overall Study|Surgery|1|||
125677563|NCT01298570|452109321|FG000|Overall Study|Symptomatic progression/deterioration|3|||
125677564|NCT01298570|452109322|FG001|Overall Study|Symptomatic progression/deterioration|2|||
125677565|NCT01298570|452109321|FG000|Overall Study|Death|0|||
125677566|NCT01298570|452109322|FG001|Overall Study|Death|1|||
125677567|NCT01298570|452109321|FG000|Overall Study|Ineligibility|0|||
125677568|NCT01298570|452109322|FG001|Overall Study|Ineligibility|1|||
125677569|NCT01929109|452109323|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
125677570|NCT01929109|452109324|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
125677571|NCT01929109|452109325|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
125677572|NCT01929109|452109326|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
125677573|NCT01929109|452109327|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
125677574|NCT00076102|452109328|FG000|Overall Study|Clinical progression|1|||
125677575|NCT00076102|452109328|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
125677576|NCT00076102|452109328|FG000|Overall Study|plexiform neurofibroma surgery|1|||
125677577|NCT00076102|452109328|FG000|Overall Study|refusal of further therapy|2|||
125677578|NCT01402908|452109329|FG000|Overall Study|Withdrawal by Subject|30|||
125677579|NCT01402908|452109330|FG001|Overall Study|Withdrawal by Subject|17|||
125677580|NCT01402908|452109329|FG000|Overall Study|Lost to Follow-up|3|||
125677581|NCT01402908|452109330|FG001|Overall Study|Lost to Follow-up|1|||
125677582|NCT01402908|452109329|FG000|Overall Study|Physician Decision|1|||
125677583|NCT01402908|452109330|FG001|Overall Study|Physician Decision|0|||
125677584|NCT01739790|452109332|FG000|Overall Study|Early Trial Termination|2|||
125677585|NCT01739790|452109333|FG001|Overall Study|Early Trial Termination|4|||
125677586|NCT02581345|452109334|FG000|Part 1: up to Week 16|Adverse Event|3|||
125540947|NCT01139580|451609482|FG000|Overall Study|Withdrawal by Subject|6|||
125344555|NCT04585009|450896335|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125344556|NCT04585009|450896336|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125344557|NCT04585009|450896337|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125344558|NCT04585009|450896338|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125344559|NCT04585009|450896339|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125344560|NCT04585009|450896340|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
125344561|NCT04585009|450896329|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125344562|NCT04585009|450896330|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125344563|NCT04585009|450896331|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125344564|NCT04585009|450896332|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125344565|NCT04585009|450896333|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125344566|NCT04585009|450896334|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125344567|NCT04585009|450896335|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125344568|NCT04585009|450896336|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
125344569|NCT04585009|450896337|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125344570|NCT04585009|450896338|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125344571|NCT04585009|450896339|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125344572|NCT04585009|450896340|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
125344573|NCT04585009|450896329|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125344574|NCT04585009|450896330|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125344575|NCT04585009|450896331|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125344576|NCT04585009|450896332|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125344577|NCT04585009|450896333|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
125344578|NCT04585009|450896334|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125344579|NCT04585009|450896335|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125344580|NCT04585009|450896336|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125344581|NCT04585009|450896337|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125344582|NCT04585009|450896338|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125344583|NCT04585009|450896339|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125344584|NCT04585009|450896340|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
125344585|NCT04585009|450896329|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125344586|NCT04585009|450896330|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125344587|NCT04585009|450896331|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125344588|NCT04585009|450896332|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125344589|NCT04585009|450896333|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125344590|NCT04585009|450896334|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125344591|NCT04585009|450896335|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125344592|NCT04585009|450896336|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125344593|NCT04585009|450896337|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125677587|NCT02581345|452109335|FG001|Part 1: up to Week 16|Adverse Event|8|||
125677588|NCT02581345|452109336|FG002|Part 1: up to Week 16|Adverse Event|0|||
125677589|NCT02581345|452109337|FG003|Part 1: up to Week 16|Adverse Event|0|||
125677590|NCT02581345|452109334|FG000|Part 1: up to Week 16|Physician Decision|2|||
125677591|NCT02581345|452109335|FG001|Part 1: up to Week 16|Physician Decision|4|||
125677592|NCT02581345|452109336|FG002|Part 1: up to Week 16|Physician Decision|0|||
125677593|NCT02581345|452109337|FG003|Part 1: up to Week 16|Physician Decision|0|||
125677594|NCT02581345|452109334|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
125677595|NCT02581345|452109335|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
125677596|NCT02581345|452109336|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
125677597|NCT02581345|452109337|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
125677598|NCT02581345|452109334|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
125677599|NCT02581345|452109335|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
125677600|NCT02581345|452109336|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
125677601|NCT02581345|452109337|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
125677602|NCT02581345|452109334|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
125677603|NCT02581345|452109335|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
125677604|NCT02581345|452109336|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
125677605|NCT02581345|452109337|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
125677606|NCT02581345|452109334|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
125677607|NCT02581345|452109335|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
125677608|NCT02581345|452109336|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
125677609|NCT02581345|452109337|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
125677610|NCT02581345|452109334|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
125677611|NCT02581345|452109335|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
125677612|NCT02581345|452109336|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
125677613|NCT02581345|452109337|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
125344594|NCT04585009|450896338|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
125344595|NCT04585009|450896339|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125344596|NCT04585009|450896340|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
125344597|NCT04585009|450896329|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125344598|NCT04585009|450896330|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125344599|NCT04585009|450896331|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125344600|NCT04585009|450896332|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125344601|NCT04585009|450896333|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125344602|NCT04585009|450896334|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125344603|NCT04585009|450896335|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125344604|NCT04585009|450896336|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125344605|NCT04585009|450896337|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125344606|NCT04585009|450896338|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125344607|NCT04585009|450896339|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
125344608|NCT04585009|450896340|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
125344609|NCT00097981|450896349|FG000|Overall Study|Adverse Event|31|||
125344610|NCT00097981|450896350|FG001|Overall Study|Adverse Event|44|||
125344611|NCT00097981|450896349|FG000|Overall Study|Withdrawal by Subject|10|||
125344612|NCT00097981|450896350|FG001|Overall Study|Withdrawal by Subject|8|||
125344613|NCT00097981|450896349|FG000|Overall Study|Protocol Violation|1|||
125344614|NCT00097981|450896350|FG001|Overall Study|Protocol Violation|1|||
125344615|NCT00097981|450896349|FG000|Overall Study|Death|2|||
125344616|NCT00097981|450896350|FG001|Overall Study|Death|4|||
125344617|NCT00097981|450896349|FG000|Overall Study|Physician Decision|7|||
125344618|NCT00097981|450896350|FG001|Overall Study|Physician Decision|1|||
125540948|NCT01139580|451609483|FG001|Overall Study|Withdrawal by Subject|9|||
125540949|NCT01139580|451609482|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
125540950|NCT01139580|451609483|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
125540951|NCT01139580|451609482|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
125540952|NCT01139580|451609483|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
125540953|NCT01139580|451609482|FG000|Overall Study|Misrandomized|1|||
125540954|NCT01139580|451609483|FG001|Overall Study|Misrandomized|0|||
125540955|NCT01139580|451609482|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
125540956|NCT01139580|451609483|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
125540957|NCT01139580|451609482|FG000|Overall Study|Participant Randomization in Error|0|||
125540958|NCT01139580|451609483|FG001|Overall Study|Participant Randomization in Error|1|||
125540959|NCT00633880|451609488|FG000|Open Label Titration|Lack of Efficacy|1|||
125540960|NCT00633880|451609489|FG001|Open Label Titration|Lack of Efficacy|0|||
125540961|NCT00633880|451609490|FG002|Open Label Titration|Lack of Efficacy|0|||
125540962|NCT00633880|451609488|FG000|Open Label Titration|Adverse Event|13|||
125540963|NCT00633880|451609489|FG001|Open Label Titration|Adverse Event|0|||
125540964|NCT00633880|451609490|FG002|Open Label Titration|Adverse Event|0|||
125540965|NCT00633880|451609488|FG000|Open Label Titration|Treatment Failure|55|||
125540966|NCT00633880|451609489|FG001|Open Label Titration|Treatment Failure|0|||
125540967|NCT00633880|451609490|FG002|Open Label Titration|Treatment Failure|0|||
125540968|NCT00633880|451609488|FG000|Open Label Titration|Protocol Violation|6|||
125540969|NCT00633880|451609489|FG001|Open Label Titration|Protocol Violation|0|||
125540970|NCT00633880|451609490|FG002|Open Label Titration|Protocol Violation|0|||
125540971|NCT00633880|451609488|FG000|Open Label Titration|Physician Decision|1|||
125540972|NCT00633880|451609489|FG001|Open Label Titration|Physician Decision|0|||
125540973|NCT00633880|451609490|FG002|Open Label Titration|Physician Decision|0|||
125540974|NCT00633880|451609488|FG000|Open Label Titration|Withdrawal by Subject|4|||
125540975|NCT00633880|451609489|FG001|Open Label Titration|Withdrawal by Subject|0|||
125540976|NCT00633880|451609490|FG002|Open Label Titration|Withdrawal by Subject|0|||
125540977|NCT00847808|451609497|FG000|Overall Study|Adverse Event|7|||
125540978|NCT00847808|451609497|FG000|Overall Study|Protocol Violation|1|||
125540979|NCT00847808|451609497|FG000|Overall Study|Lost to Follow-up|1|||
125540980|NCT00847808|451609497|FG000|Overall Study|Withdrawal by Subject|4|||
125540981|NCT00847808|451609497|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
125540982|NCT00847808|451609497|FG000|Overall Study|Participant Took Excluded Medication|1|||
125540983|NCT05172050|451609504|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
125540984|NCT05172050|451609505|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
125540985|NCT05172050|451609506|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
125540986|NCT05172050|451609504|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
125540987|NCT05172050|451609505|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
125540988|NCT05172050|451609506|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
125540989|NCT05172050|451609504|FG000|Overall Study|Other|2|||
125540990|NCT05172050|451609505|FG001|Overall Study|Other|2|||
125540991|NCT05172050|451609506|FG002|Overall Study|Other|1|||
125540992|NCT02980731|451611296|FG000|Overall Study|Death|63|||
125677614|NCT02581345|452109334|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
125677615|NCT02581345|452109335|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
125677616|NCT02581345|452109336|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
125677617|NCT02581345|452109337|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
125344619|NCT00097981|450896349|FG000|Overall Study|Disease Progression|8|||
125344620|NCT00097981|450896350|FG001|Overall Study|Disease Progression|2|||
125344621|NCT00097981|450896349|FG000|Overall Study|Transplant planned|28|||
125344622|NCT00097981|450896350|FG001|Overall Study|Transplant planned|27|||
125344623|NCT00097981|450896349|FG000|Overall Study|Other|19|||
125344624|NCT00097981|450896350|FG001|Overall Study|Other|13|||
125344625|NCT00538785|450896351|FG000|Overall Study|Death|9|||
125344626|NCT00538785|450896352|FG001|Overall Study|Death|10|||
125344627|NCT00538785|450896351|FG000|Overall Study|Withdrawal of consent|9|||
125344628|NCT00538785|450896352|FG001|Overall Study|Withdrawal of consent|7|||
125344629|NCT00538785|450896351|FG000|Overall Study|Lost to Follow-up|1|||
125344630|NCT00538785|450896352|FG001|Overall Study|Lost to Follow-up|0|||
125344631|NCT01002820|450896353|FG000|Overall Study|Adverse Event|1|||
125344632|NCT01002820|450896353|FG000|Overall Study|Withdrawal by Subject|2|||
125344633|NCT01002820|450896353|FG000|Overall Study|Lack of Efficacy|1|||
125344634|NCT00895011|450896355|FG000|Overall Study|Withdrawal by Subject|14|||
125344635|NCT00895011|450896356|FG001|Overall Study|Withdrawal by Subject|7|||
125344636|NCT00895011|450896357|FG002|Overall Study|Withdrawal by Subject|2|||
125344637|NCT00895011|450896355|FG000|Overall Study|Lost to Follow-up|5|||
125344638|NCT00895011|450896356|FG001|Overall Study|Lost to Follow-up|4|||
125540993|NCT02980731|451611296|FG000|Overall Study|Withdrawal by Subject|6|||
125540994|NCT02980731|451611296|FG000|Overall Study|Lost to Follow-up|5|||
125344639|NCT00895011|450896357|FG002|Overall Study|Lost to Follow-up|1|||
125540995|NCT02980731|451611296|FG000|Overall Study|Study terminated by Sponsor|4|||
125540996|NCT02980731|451611296|FG000|Overall Study|Completed survival follow-up period|65|||
125540997|NCT02980731|451611296|FG000|Overall Study|COVID-19 infection|1|||
125540998|NCT02980731|451611296|FG000|Overall Study|Other, not specified|66|||
125540999|NCT01342341|451611297|FG000|Overall Study|Lost to Follow-up|4|||
125541000|NCT01342341|451611298|FG001|Overall Study|Lost to Follow-up|4|||
125541001|NCT03725085|451611299|FG000|Overall Study|Lost to Follow-up|2|||
125541002|NCT01775475|451611300|FG000|Overall Study|Death|3|||
125541003|NCT01775475|451611301|FG001|Overall Study|Death|3|||
125541004|NCT02245737|451611307|FG000|Overall Study|Adverse Event|23|||
125541005|NCT02245737|451611308|FG001|Overall Study|Adverse Event|26|||
125541006|NCT02245737|451611309|FG002|Overall Study|Adverse Event|33|||
125541007|NCT02245737|451611307|FG000|Overall Study|Condition Worsened|9|||
125541008|NCT02245737|451611308|FG001|Overall Study|Condition Worsened|10|||
125541009|NCT02245737|451611309|FG002|Overall Study|Condition Worsened|9|||
125541010|NCT02245737|451611307|FG000|Overall Study|Death|2|||
125541011|NCT02245737|451611308|FG001|Overall Study|Death|4|||
125541012|NCT02245737|451611309|FG002|Overall Study|Death|4|||
125541013|NCT02245737|451611307|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
125541014|NCT02245737|451611308|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
125541015|NCT02245737|451611309|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
125541016|NCT02245737|451611307|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
125541017|NCT02245737|451611308|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
125541018|NCT02245737|451611309|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
125541019|NCT02245737|451611307|FG000|Overall Study|Lost to Follow-up|2|||
125541020|NCT02245737|451611308|FG001|Overall Study|Lost to Follow-up|5|||
125541021|NCT02245737|451611309|FG002|Overall Study|Lost to Follow-up|4|||
125541022|NCT02245737|451611307|FG000|Overall Study|Other-determined by Investigator|9|||
125541023|NCT02245737|451611308|FG001|Overall Study|Other-determined by Investigator|10|||
125541024|NCT02245737|451611309|FG002|Overall Study|Other-determined by Investigator|10|||
125541025|NCT02245737|451611307|FG000|Overall Study|Physician Decision|6|||
125541026|NCT02245737|451611308|FG001|Overall Study|Physician Decision|3|||
125541027|NCT02245737|451611309|FG002|Overall Study|Physician Decision|6|||
125541028|NCT02245737|451611307|FG000|Overall Study|Protocol Violation|3|||
125541029|NCT02245737|451611308|FG001|Overall Study|Protocol Violation|2|||
125541030|NCT02245737|451611309|FG002|Overall Study|Protocol Violation|3|||
125541031|NCT02245737|451611307|FG000|Overall Study|Withdrawal by Subject|40|||
125541032|NCT02245737|451611308|FG001|Overall Study|Withdrawal by Subject|41|||
125541033|NCT02245737|451611309|FG002|Overall Study|Withdrawal by Subject|44|||
125541034|NCT02245737|451611307|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
125541035|NCT02245737|451611308|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
125541036|NCT02245737|451611309|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
125541037|NCT02245737|451611307|FG000|Overall Study|Sponsor Decision|445|||
125541038|NCT02245737|451611308|FG001|Overall Study|Sponsor Decision|430|||
125541039|NCT02245737|451611309|FG002|Overall Study|Sponsor Decision|432|||
125541040|NCT00618618|451611310|FG000|Overall Study|Patient Request|0|||
125541041|NCT00618618|451611311|FG001|Overall Study|Patient Request|0|||
125344640|NCT00895011|450896355|FG000|Overall Study|Protocol Violation|3|||
125344641|NCT00895011|450896356|FG001|Overall Study|Protocol Violation|1|||
125344642|NCT00895011|450896357|FG002|Overall Study|Protocol Violation|3|||
125344643|NCT00895011|450896355|FG000|Overall Study|Adverse Event|1|||
125344644|NCT00895011|450896356|FG001|Overall Study|Adverse Event|2|||
125344645|NCT00895011|450896357|FG002|Overall Study|Adverse Event|2|||
125344646|NCT00895011|450896355|FG000|Overall Study|schedule conflict|1|||
125344647|NCT00895011|450896356|FG001|Overall Study|schedule conflict|0|||
125344648|NCT00895011|450896357|FG002|Overall Study|schedule conflict|0|||
125344649|NCT02230527|450896360|FG000|Overall Study|Withdrawal by Subject|1|||
125344650|NCT02230527|450896361|FG001|Overall Study|Withdrawal by Subject|1|||
125344651|NCT02230527|450896360|FG000|Overall Study|Death|1|||
125344652|NCT02230527|450896361|FG001|Overall Study|Death|0|||
125344653|NCT02230527|450896360|FG000|Overall Study|Lost to Follow-up|2|||
125344654|NCT02230527|450896361|FG001|Overall Study|Lost to Follow-up|1|||
125344655|NCT02230527|450896360|FG000|Overall Study|Other|1|||
125344656|NCT02230527|450896361|FG001|Overall Study|Other|0|||
125344657|NCT02661178|450896362|FG000|Part 1|Protocol Violation|1|||
125344658|NCT02661178|450896363|FG001|Part 1|Protocol Violation|0|||
125344659|NCT02661178|450896364|FG002|Part 1|Protocol Violation|0|||
125344660|NCT02661178|450896365|FG003|Part 1|Protocol Violation|0|||
125344661|NCT02661178|450896366|FG004|Part 1|Protocol Violation|0|||
125344662|NCT02661178|450896367|FG005|Part 1|Protocol Violation|0|||
125344663|NCT02661178|450896368|FG006|Part 1|Protocol Violation|0|||
125344664|NCT02661178|450896369|FG007|Part 1|Protocol Violation|0|||
125344665|NCT02661178|450896370|FG008|Part 1|Protocol Violation|0|||
125541042|NCT00618618|451611312|FG002|Overall Study|Patient Request|2|||
125541043|NCT00618618|451611313|FG003|Overall Study|Patient Request|0|||
125541044|NCT00618618|451611310|FG000|Overall Study|Inability to Complete Study Procedures|0|||
125541045|NCT00618618|451611311|FG001|Overall Study|Inability to Complete Study Procedures|1|||
125541046|NCT00618618|451611312|FG002|Overall Study|Inability to Complete Study Procedures|0|||
125541047|NCT00618618|451611313|FG003|Overall Study|Inability to Complete Study Procedures|0|||
125344666|NCT02661178|450896371|FG009|Part 1|Protocol Violation|0|||
125344667|NCT02661178|450896372|FG010|Part 1|Protocol Violation|0|||
125344668|NCT02661178|450896373|FG011|Part 1|Protocol Violation|0|||
125677618|NCT02581345|452109334|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
125677619|NCT02581345|452109335|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
125677620|NCT02581345|452109336|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
125677621|NCT02581345|452109337|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
125677622|NCT02581345|452109334|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
125677623|NCT02581345|452109335|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
125677624|NCT02581345|452109336|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
125677625|NCT02581345|452109337|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
125677626|NCT02581345|452109334|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
125677627|NCT02581345|452109335|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
125677628|NCT02581345|452109336|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
125677629|NCT02581345|452109337|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
125677630|NCT02581345|452109334|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
125677631|NCT02581345|452109335|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
125677632|NCT02581345|452109336|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
125677633|NCT02581345|452109337|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
125677634|NCT01244126|452109343|FG000|Overall Study|Protocol Violation|3|||
125677635|NCT01244126|452109344|FG001|Overall Study|Protocol Violation|3|||
125677636|NCT01244126|452109345|FG002|Overall Study|Protocol Violation|9|||
125677637|NCT01451762|452109346|FG000|Overall Study|Lost to Follow-up|3|||
125677638|NCT01451762|452109347|FG001|Overall Study|Lost to Follow-up|6|||
125677639|NCT01451762|452109348|FG002|Overall Study|Lost to Follow-up|6|||
125677640|NCT00863746|452109353|FG000|Treatment|Not treated|4|||
125677641|NCT00863746|452109354|FG001|Treatment|Not treated|2|||
125344669|NCT02661178|450896374|FG012|Part 1|Protocol Violation|0|||
125344670|NCT02661178|450896375|FG013|Part 1|Protocol Violation|0|||
125344671|NCT02661178|450896376|FG014|Part 1|Protocol Violation|0|||
125344672|NCT04461600|450896378|FG000|Overall Study|Death|6|||
125344673|NCT04461600|450896379|FG001|Overall Study|Death|5|||
125344674|NCT04461600|450896378|FG000|Overall Study|Withdrawal by Subject|0|||
125344675|NCT04461600|450896379|FG001|Overall Study|Withdrawal by Subject|1|||
125344676|NCT01242813|450896380|FG000|Overall Study|Lost to Follow-up|2|||
125344677|NCT01369329|450896383|FG000|Overall Study|Withdrawal by Subject|8|||
125344678|NCT01369329|450896384|FG001|Overall Study|Withdrawal by Subject|6|||
125344679|NCT01369329|450896385|FG002|Overall Study|Withdrawal by Subject|10|||
125344680|NCT01369329|450896383|FG000|Overall Study|Lost to Follow-up|2|||
125344681|NCT01369329|450896384|FG001|Overall Study|Lost to Follow-up|2|||
125344682|NCT01369329|450896385|FG002|Overall Study|Lost to Follow-up|2|||
125344683|NCT01369329|450896383|FG000|Overall Study|Other|2|||
125344684|NCT01369329|450896384|FG001|Overall Study|Other|3|||
125344685|NCT01369329|450896385|FG002|Overall Study|Other|2|||
125344686|NCT01252667|450896386|FG000|Overall Study|Transplant aborted post-conditioning|0|||
125344687|NCT01252667|450896387|FG001|Overall Study|Transplant aborted post-conditioning|0|||
125344688|NCT01252667|450896388|FG002|Overall Study|Transplant aborted post-conditioning|0|||
125344689|NCT01252667|450896389|FG003|Overall Study|Transplant aborted post-conditioning|0|||
125344690|NCT01252667|450896390|FG004|Overall Study|Transplant aborted post-conditioning|0|||
125344691|NCT01252667|450896391|FG005|Overall Study|Transplant aborted post-conditioning|1|||
125344692|NCT01836276|450896392|FG000|Overall Study|Lost to Follow-up|28|||
125344693|NCT01836276|450896393|FG001|Overall Study|Lost to Follow-up|51|||
125344694|NCT00331552|450896396|FG000|Period 3: Phase II|Neurological Symptoms|1|||
125344695|NCT00331552|450896397|FG001|Period 3: Phase II|Neurological Symptoms|0|||
125344696|NCT00331552|450896396|FG000|Period 3: Phase II|Severe Nausea|1|||
125344697|NCT00331552|450896397|FG001|Period 3: Phase II|Severe Nausea|0|||
125344698|NCT02577887|450896399|FG000|Overall Study|Death|93|||
125344699|NCT02577887|450896399|FG000|Overall Study|Protocol Violation|125|||
125344700|NCT02577887|450896399|FG000|Overall Study|Withdrawal by Subject|80|||
125344701|NCT03560518|450896400|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
125344702|NCT03560518|450896401|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
125344703|NCT03560518|450896402|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
125344704|NCT03560518|450896400|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
125344705|NCT03560518|450896401|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
125344706|NCT03560518|450896402|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
125344707|NCT03560518|450896400|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125344708|NCT03560518|450896401|FG001|Double Blind Treatment Period|Protocol Violation|2|||
125344709|NCT03560518|450896402|FG002|Double Blind Treatment Period|Protocol Violation|0|||
125344710|NCT03560518|450896400|FG000|Double Blind Treatment Period|Pregnancy|0|||
125344711|NCT03560518|450896401|FG001|Double Blind Treatment Period|Pregnancy|2|||
125344712|NCT03560518|450896402|FG002|Double Blind Treatment Period|Pregnancy|0|||
125344713|NCT03560518|450896400|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
125344714|NCT03560518|450896401|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
125677642|NCT00863746|452109353|FG000|Treatment|Adverse Event|41|||
125677643|NCT00863746|452109354|FG001|Treatment|Adverse Event|16|||
125677644|NCT00863746|452109353|FG000|Treatment|non-compliant with study medication|4|||
125677645|NCT00863746|452109354|FG001|Treatment|non-compliant with study medication|0|||
125344715|NCT03560518|450896402|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
125344716|NCT03560518|450896400|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
125344717|NCT03560518|450896401|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
125344718|NCT03560518|450896402|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
125344719|NCT03560518|450896400|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
125344720|NCT03560518|450896401|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
125541048|NCT00618618|451611310|FG000|Overall Study|Lost to Follow-up|3|||
125541049|NCT00618618|451611311|FG001|Overall Study|Lost to Follow-up|0|||
125541050|NCT00618618|451611312|FG002|Overall Study|Lost to Follow-up|0|||
125541051|NCT00618618|451611313|FG003|Overall Study|Lost to Follow-up|1|||
125541052|NCT00618618|451611310|FG000|Overall Study|Non-compliance|1|||
125541053|NCT00618618|451611311|FG001|Overall Study|Non-compliance|1|||
125541054|NCT00618618|451611312|FG002|Overall Study|Non-compliance|0|||
125541055|NCT00618618|451611313|FG003|Overall Study|Non-compliance|0|||
125541056|NCT00618618|451611310|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
125344721|NCT03560518|450896402|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
125541057|NCT00618618|451611311|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
125541058|NCT00618618|451611312|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
125541059|NCT00618618|451611313|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
125541060|NCT00618618|451611310|FG000|Overall Study|Death|0|||
125541061|NCT00618618|451611311|FG001|Overall Study|Death|1|||
125541062|NCT00618618|451611312|FG002|Overall Study|Death|0|||
125541063|NCT00618618|451611313|FG003|Overall Study|Death|0|||
125541064|NCT02929329|451611316|FG000|Overall Study|Withdrawal by Subject|24|||
125541065|NCT02929329|451611317|FG001|Overall Study|Withdrawal by Subject|21|||
125677646|NCT00863746|452109353|FG000|Treatment|Consent withdrawn|15|||
125677647|NCT00863746|452109354|FG001|Treatment|Consent withdrawn|14|||
125677648|NCT00863746|452109353|FG000|Treatment|Lost to Follow-up|1|||
125677649|NCT00863746|452109354|FG001|Treatment|Lost to Follow-up|0|||
125677650|NCT00863746|452109353|FG000|Treatment|Protocol Violation|5|||
125677651|NCT00863746|452109354|FG001|Treatment|Protocol Violation|3|||
125677652|NCT00863746|452109353|FG000|Treatment|Other|1|||
125677653|NCT00863746|452109354|FG001|Treatment|Other|0|||
125677654|NCT00863746|452109353|FG000|Survival Follow up|Death|244|||
125677655|NCT00863746|452109354|FG001|Survival Follow up|Death|271|||
125677656|NCT00863746|452109353|FG000|Survival Follow up|Lost to Follow-up|2|||
125677657|NCT00863746|452109354|FG001|Survival Follow up|Lost to Follow-up|1|||
125677658|NCT00863746|452109353|FG000|Survival Follow up|Consent Withdrawn|7|||
125677659|NCT00863746|452109354|FG001|Survival Follow up|Consent Withdrawn|8|||
125677660|NCT00862979|452109360|FG000|Overall Study|Adverse Event|6|||
125677661|NCT00862979|452109361|FG001|Overall Study|Adverse Event|3|||
125677662|NCT00862979|452109360|FG000|Overall Study|Protocol Violation|0|||
125677663|NCT00862979|452109361|FG001|Overall Study|Protocol Violation|1|||
125677664|NCT00862979|452109360|FG000|Overall Study|Patient withdrew consent|2|||
125677665|NCT00862979|452109361|FG001|Overall Study|Patient withdrew consent|1|||
125677666|NCT00862979|452109360|FG000|Overall Study|Administrative problems|0|||
125677667|NCT00862979|452109361|FG001|Overall Study|Administrative problems|1|||
125677668|NCT00862979|452109360|FG000|Overall Study|Death|0|||
125677669|NCT00862979|452109361|FG001|Overall Study|Death|1|||
125677670|NCT01367275|452109364|FG000|Overall Study|Ineligible|1|||
125677671|NCT01367275|452109364|FG000|Overall Study|Disease Progression|2|||
125677672|NCT00502775|452109367|FG000|Overall Study|Adverse Event|1|||
125677673|NCT00502775|452109368|FG001|Overall Study|Adverse Event|2|||
125677674|NCT00502775|452109369|FG002|Overall Study|Adverse Event|1|||
125677675|NCT00502775|452109367|FG000|Overall Study|Protocol Violation|1|||
125677676|NCT00502775|452109368|FG001|Overall Study|Protocol Violation|5|||
125677677|NCT00502775|452109369|FG002|Overall Study|Protocol Violation|2|||
125677678|NCT00502775|452109367|FG000|Overall Study|Withdrawal by Subject|1|||
125677679|NCT00502775|452109368|FG001|Overall Study|Withdrawal by Subject|1|||
125677680|NCT00502775|452109369|FG002|Overall Study|Withdrawal by Subject|2|||
125677681|NCT00502775|452109367|FG000|Overall Study|Sponsor Terminated Study|1|||
125677682|NCT00502775|452109368|FG001|Overall Study|Sponsor Terminated Study|0|||
125677683|NCT00502775|452109369|FG002|Overall Study|Sponsor Terminated Study|1|||
125677684|NCT00502775|452109367|FG000|Overall Study|Non-compliance with eDiary|4|||
125677685|NCT00502775|452109368|FG001|Overall Study|Non-compliance with eDiary|1|||
125677686|NCT00502775|452109369|FG002|Overall Study|Non-compliance with eDiary|1|||
125677687|NCT00502775|452109367|FG000|Overall Study|Subject unable to swallow capsule|1|||
125677688|NCT00502775|452109368|FG001|Overall Study|Subject unable to swallow capsule|0|||
125677689|NCT00502775|452109369|FG002|Overall Study|Subject unable to swallow capsule|1|||
125677690|NCT00502775|452109367|FG000|Overall Study|Logpad compliance <80%|1|||
125677691|NCT00502775|452109368|FG001|Overall Study|Logpad compliance <80%|0|||
125677692|NCT00502775|452109369|FG002|Overall Study|Logpad compliance <80%|0|||
125677693|NCT00502775|452109367|FG000|Overall Study|Randomized in error|0|||
125677694|NCT00502775|452109368|FG001|Overall Study|Randomized in error|1|||
125677695|NCT00502775|452109369|FG002|Overall Study|Randomized in error|1|||
125677696|NCT00502775|452109367|FG000|Overall Study|Non-compliance|0|||
125677697|NCT00502775|452109368|FG001|Overall Study|Non-compliance|2|||
125677698|NCT00502775|452109369|FG002|Overall Study|Non-compliance|2|||
125677699|NCT00502775|452109367|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
125541066|NCT02929329|451611316|FG000|Overall Study|Lost to Follow-up|26|||
125541067|NCT02929329|451611317|FG001|Overall Study|Lost to Follow-up|20|||
125677700|NCT00502775|452109368|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
125677701|NCT00502775|452109369|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
125677702|NCT00502775|452109367|FG000|Overall Study|Declining pollen counts|0|||
125677703|NCT00502775|452109368|FG001|Overall Study|Declining pollen counts|1|||
125677704|NCT00502775|452109369|FG002|Overall Study|Declining pollen counts|1|||
125677705|NCT00502775|452109367|FG000|Overall Study|Subject in jail|0|||
125677706|NCT00502775|452109368|FG001|Overall Study|Subject in jail|1|||
125677707|NCT00502775|452109369|FG002|Overall Study|Subject in jail|0|||
125677708|NCT00502775|452109367|FG000|Overall Study|Subject took disallowed drug|0|||
125677709|NCT00502775|452109368|FG001|Overall Study|Subject took disallowed drug|0|||
125677710|NCT00502775|452109369|FG002|Overall Study|Subject took disallowed drug|1|||
125677711|NCT00287118|452109371|FG000|Overall Study|Adverse Event|30|||
125677712|NCT00287118|452109371|FG000|Overall Study|Death|1|||
125677713|NCT00287118|452109371|FG000|Overall Study|Lack of Efficacy|11|||
125677714|NCT00287118|452109371|FG000|Overall Study|Lost to Follow-up|1|||
125677715|NCT00287118|452109371|FG000|Overall Study|Protocol Violation|2|||
125677716|NCT00287118|452109371|FG000|Overall Study|Other|7|||
125541068|NCT02929329|451611316|FG000|Overall Study|Death|1054|||
125541069|NCT02929329|451611317|FG001|Overall Study|Death|1051|||
125541070|NCT00309959|451611324|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
125541071|NCT03836716|451611328|FG000|Overall Study|Adverse Event|3|||
125541072|NCT03836716|451611328|FG000|Overall Study|Death|22|||
125541073|NCT03836716|451611328|FG000|Overall Study|Withdrawal by Subject|8|||
125541074|NCT03836716|451611328|FG000|Overall Study|Study terminated by sponsor|87|||
125541075|NCT01983254|451611329|FG000|Overall Study|Death|6|||
125541076|NCT01983254|451611330|FG001|Overall Study|Death|6|||
125541077|NCT01983254|451611329|FG000|Overall Study|Lost to Follow-up|17|||
125541078|NCT01983254|451611330|FG001|Overall Study|Lost to Follow-up|16|||
125541079|NCT01983254|451611329|FG000|Overall Study|too ill|11|||
125541080|NCT01983254|451611330|FG001|Overall Study|too ill|8|||
125541081|NCT00434213|451611331|FG000|Overall Study|Adverse Event|12|||
125541082|NCT00434213|451611331|FG000|Overall Study|Lack of Efficacy|9|||
125344722|NCT03560518|450896400|FG000|Double Blind Treatment Period|Adverse Event|0|||
125344723|NCT03560518|450896401|FG001|Double Blind Treatment Period|Adverse Event|3|||
125344724|NCT03560518|450896402|FG002|Double Blind Treatment Period|Adverse Event|1|||
125344725|NCT02984943|450896404|FG000|Overall Study|Withdrawal by Subject|3|||
125344726|NCT02984943|450896404|FG000|Overall Study|Physician Decision|1|||
125344727|NCT01133990|450896405|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
125344728|NCT01133990|450896406|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125344729|NCT01133990|450896407|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125344730|NCT01133990|450896408|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125344731|NCT01133990|450896409|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125344732|NCT01133990|450896410|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125344733|NCT01133990|450896405|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
125344734|NCT01133990|450896406|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
125344735|NCT01133990|450896407|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
125344736|NCT01133990|450896408|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
125344737|NCT01133990|450896409|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
125344738|NCT01133990|450896410|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
125344739|NCT01133990|450896405|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
125344740|NCT01133990|450896406|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125344741|NCT01133990|450896407|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125344742|NCT01133990|450896408|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125344743|NCT01133990|450896409|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125344744|NCT01133990|450896410|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125541083|NCT00434213|451611331|FG000|Overall Study|Lost to Follow-up|14|||
125541084|NCT00434213|451611331|FG000|Overall Study|Withdrawal by Subject|7|||
125541085|NCT00434213|451611331|FG000|Overall Study|Protocol Violation|3|||
125541086|NCT00434213|451611331|FG000|Overall Study|Unable to comply with study visit window|2|||
125541087|NCT00434213|451611331|FG000|Overall Study|Application site reaction|1|||
125541088|NCT00434213|451611331|FG000|Overall Study|Non-compliant to study schedule|1|||
125541089|NCT01253304|451611332|FG000|Overall Study|Adverse Event|0|||
125541090|NCT01253304|451611333|FG001|Overall Study|Adverse Event|0|||
125541091|NCT01253304|451611334|FG002|Overall Study|Adverse Event|0|||
125541092|NCT01253304|451611335|FG003|Overall Study|Adverse Event|1|||
125541093|NCT00768079|451611338|FG000|Overall Study|Lost to Follow-up|2|||
125541094|NCT00768079|451611339|FG001|Overall Study|Lost to Follow-up|0|||
125541095|NCT00768079|451611340|FG002|Overall Study|Lost to Follow-up|4|||
125541096|NCT00768079|451611338|FG000|Overall Study|Participant incarcerated|0|||
125541097|NCT00768079|451611339|FG001|Overall Study|Participant incarcerated|1|||
125541098|NCT00768079|451611340|FG002|Overall Study|Participant incarcerated|0|||
125541099|NCT02207569|451611344|FG000|1-Month|Death|6|||
125541100|NCT02207569|451611344|FG000|1-Month|Withdrawal by Subject|2|||
125541101|NCT02207569|451611344|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
125541102|NCT02207569|451611344|FG000|6-Month|Death|8|||
125541103|NCT02207569|451611344|FG000|6-Month|Withdrawal by Subject|2|||
125541104|NCT02207569|451611344|FG000|12-Month|Death|14|||
125541105|NCT02207569|451611344|FG000|12-Month|Withdrawal by Subject|2|||
125541106|NCT02207569|451611344|FG000|24-Month|Death|23|||
125677717|NCT00262600|452109372|FG000|Overall Study|Lost to Follow-up|17|||
125677718|NCT00262600|452109373|FG001|Overall Study|Lost to Follow-up|31|||
125677719|NCT00262600|452109374|FG002|Overall Study|Lost to Follow-up|41|||
125677720|NCT00262600|452109372|FG000|Overall Study|Withdrawal by Subject|128|||
125677721|NCT00262600|452109373|FG001|Overall Study|Withdrawal by Subject|145|||
125541107|NCT02207569|451611344|FG000|24-Month|Withdrawal by Subject|3|||
125541108|NCT02207569|451611344|FG000|36-Month|Death|23|||
125541109|NCT02207569|451611344|FG000|36-Month|Withdrawal by Subject|4|||
125541110|NCT02207569|451611344|FG000|48-Month|Death|25|||
125541111|NCT02207569|451611344|FG000|48-Month|Withdrawal by Subject|2|||
125677722|NCT00262600|452109374|FG002|Overall Study|Withdrawal by Subject|139|||
125677723|NCT00262600|452109372|FG000|Overall Study|Not Treated|32|||
125677724|NCT00262600|452109373|FG001|Overall Study|Not Treated|17|||
125677725|NCT00262600|452109374|FG002|Overall Study|Not Treated|24|||
125344745|NCT01133990|450896405|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
125344746|NCT01133990|450896406|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
125344747|NCT01133990|450896407|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
125344748|NCT01133990|450896408|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
125344749|NCT01133990|450896409|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
125344750|NCT01133990|450896410|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
125344751|NCT05277337|450896411|FG000|Overall Study|Lost to Follow-up|2|||
125344752|NCT05277337|450896412|FG001|Overall Study|Lost to Follow-up|0|||
125344753|NCT05277337|450896411|FG000|Overall Study|Withdrawal by Subject|1|||
125344754|NCT05277337|450896412|FG001|Overall Study|Withdrawal by Subject|0|||
125344755|NCT02282345|450896414|FG000|Overall Study|Progression|0|||
125344756|NCT02282345|450896415|FG001|Overall Study|Progression|1|||
125344757|NCT01185301|450896416|FG000|Overall Study|Adverse Event|3|||
125344758|NCT01185301|450896417|FG001|Overall Study|Adverse Event|0|||
125344759|NCT01185301|450896418|FG002|Overall Study|Adverse Event|2|||
125344760|NCT01185301|450896419|FG003|Overall Study|Adverse Event|3|||
125344761|NCT01185301|450896416|FG000|Overall Study|Withdrawal by Subject|7|||
125344762|NCT01185301|450896417|FG001|Overall Study|Withdrawal by Subject|5|||
125344763|NCT01185301|450896418|FG002|Overall Study|Withdrawal by Subject|2|||
125344764|NCT01185301|450896419|FG003|Overall Study|Withdrawal by Subject|3|||
125344765|NCT01185301|450896416|FG000|Overall Study|Lost to Follow-up|2|||
125344766|NCT01185301|450896417|FG001|Overall Study|Lost to Follow-up|0|||
125344767|NCT01185301|450896418|FG002|Overall Study|Lost to Follow-up|0|||
125344768|NCT01185301|450896419|FG003|Overall Study|Lost to Follow-up|1|||
125344769|NCT01185301|450896416|FG000|Overall Study|Other Reason|3|||
125344770|NCT01185301|450896417|FG001|Overall Study|Other Reason|2|||
125344771|NCT01185301|450896418|FG002|Overall Study|Other Reason|2|||
125344772|NCT01185301|450896419|FG003|Overall Study|Other Reason|2|||
125344773|NCT02683746|450896420|FG000|Overall Study|Adverse Event|3|||
125344774|NCT02683746|450896421|FG001|Overall Study|Adverse Event|2|||
125344775|NCT02683746|450896420|FG000|Overall Study|Lost to Follow-up|5|||
125344776|NCT02683746|450896421|FG001|Overall Study|Lost to Follow-up|6|||
125344777|NCT02683746|450896420|FG000|Overall Study|Withdrawal by Subject|6|||
125344778|NCT02683746|450896421|FG001|Overall Study|Withdrawal by Subject|5|||
125344779|NCT02683746|450896420|FG000|Overall Study|Physician Decision|2|||
125344780|NCT02683746|450896421|FG001|Overall Study|Physician Decision|1|||
125344781|NCT04987944|450896422|FG000|Overall Study|Adverse Event|0|||
125344782|NCT04987944|450896423|FG001|Overall Study|Adverse Event|1|||
125344783|NCT04987944|450896422|FG000|Overall Study|Withdrawal by Subject|0|||
125344784|NCT04987944|450896423|FG001|Overall Study|Withdrawal by Subject|1|||
125344785|NCT02353143|450896428|FG000|Overall Study|Withdrawal by Subject|1|||
125344786|NCT02353143|450896429|FG001|Overall Study|Withdrawal by Subject|0|||
125344787|NCT02353143|450896430|FG002|Overall Study|Withdrawal by Subject|0|||
125344788|NCT02353143|450896431|FG003|Overall Study|Withdrawal by Subject|0|||
125344789|NCT02353143|450896432|FG004|Overall Study|Withdrawal by Subject|1|||
125344790|NCT02353143|450896433|FG005|Overall Study|Withdrawal by Subject|0|||
125344791|NCT02353143|450896434|FG006|Overall Study|Withdrawal by Subject|0|||
125344792|NCT02353143|450896435|FG007|Overall Study|Withdrawal by Subject|1|||
125344793|NCT02353143|450896436|FG008|Overall Study|Withdrawal by Subject|1|||
125344794|NCT02353143|450896428|FG000|Overall Study|Lack of Efficacy|2|||
125344795|NCT02353143|450896429|FG001|Overall Study|Lack of Efficacy|1|||
125344796|NCT02353143|450896430|FG002|Overall Study|Lack of Efficacy|2|||
125344797|NCT02353143|450896431|FG003|Overall Study|Lack of Efficacy|4|||
125344798|NCT02353143|450896432|FG004|Overall Study|Lack of Efficacy|13|||
125344799|NCT02353143|450896433|FG005|Overall Study|Lack of Efficacy|2|||
125344800|NCT02353143|450896434|FG006|Overall Study|Lack of Efficacy|2|||
125344801|NCT02353143|450896435|FG007|Overall Study|Lack of Efficacy|2|||
125344802|NCT02353143|450896436|FG008|Overall Study|Lack of Efficacy|1|||
125344803|NCT02353143|450896428|FG000|Overall Study|reason not specified|1|||
125344804|NCT02353143|450896429|FG001|Overall Study|reason not specified|2|||
125344805|NCT02353143|450896430|FG002|Overall Study|reason not specified|0|||
125344806|NCT02353143|450896431|FG003|Overall Study|reason not specified|0|||
125344807|NCT02353143|450896432|FG004|Overall Study|reason not specified|6|||
125344808|NCT02353143|450896433|FG005|Overall Study|reason not specified|1|||
125344809|NCT02353143|450896434|FG006|Overall Study|reason not specified|0|||
125344810|NCT02353143|450896435|FG007|Overall Study|reason not specified|3|||
125344811|NCT02353143|450896436|FG008|Overall Study|reason not specified|1|||
125344812|NCT02353143|450896428|FG000|Overall Study|Physician Decision|0|||
125344813|NCT02353143|450896429|FG001|Overall Study|Physician Decision|4|||
125344814|NCT02353143|450896430|FG002|Overall Study|Physician Decision|2|||
125344815|NCT02353143|450896431|FG003|Overall Study|Physician Decision|3|||
125344816|NCT02353143|450896432|FG004|Overall Study|Physician Decision|4|||
125344817|NCT02353143|450896433|FG005|Overall Study|Physician Decision|0|||
125344818|NCT02353143|450896434|FG006|Overall Study|Physician Decision|1|||
125344819|NCT02353143|450896435|FG007|Overall Study|Physician Decision|2|||
125344820|NCT02353143|450896436|FG008|Overall Study|Physician Decision|0|||
125344821|NCT02353143|450896428|FG000|Overall Study|Adverse Event|0|||
125344822|NCT02353143|450896429|FG001|Overall Study|Adverse Event|0|||
125344823|NCT02353143|450896430|FG002|Overall Study|Adverse Event|1|||
125344824|NCT02353143|450896431|FG003|Overall Study|Adverse Event|0|||
125344825|NCT02353143|450896432|FG004|Overall Study|Adverse Event|1|||
125344826|NCT02353143|450896433|FG005|Overall Study|Adverse Event|1|||
125344827|NCT02353143|450896434|FG006|Overall Study|Adverse Event|0|||
125344828|NCT02353143|450896435|FG007|Overall Study|Adverse Event|0|||
125344829|NCT02353143|450896436|FG008|Overall Study|Adverse Event|0|||
125344830|NCT02353143|450896428|FG000|Overall Study|patient receiving other treatment for AML|0|||
125344831|NCT02353143|450896429|FG001|Overall Study|patient receiving other treatment for AML|0|||
125344832|NCT02353143|450896430|FG002|Overall Study|patient receiving other treatment for AML|1|||
125344833|NCT02353143|450896431|FG003|Overall Study|patient receiving other treatment for AML|0|||
125344834|NCT02353143|450896432|FG004|Overall Study|patient receiving other treatment for AML|0|||
125344835|NCT02353143|450896433|FG005|Overall Study|patient receiving other treatment for AML|0|||
125344836|NCT02353143|450896434|FG006|Overall Study|patient receiving other treatment for AML|0|||
125344837|NCT02353143|450896435|FG007|Overall Study|patient receiving other treatment for AML|0|||
125344838|NCT02353143|450896436|FG008|Overall Study|patient receiving other treatment for AML|0|||
125344839|NCT02353143|450896428|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
125344840|NCT02353143|450896429|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
125344841|NCT02353143|450896430|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
125344842|NCT02353143|450896431|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
125344843|NCT02353143|450896432|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
125344844|NCT02353143|450896433|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
125344845|NCT02353143|450896434|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
125344846|NCT02353143|450896435|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
125344847|NCT02353143|450896436|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
125344848|NCT02946931|450896439|FG000|Overall Study|Did not require collection of CRFs|588|||
125344849|NCT02946931|450896439|FG000|Overall Study|Other than listed|37|||
125344850|NCT02946931|450896439|FG000|Overall Study|Discharge from hospital|118|||
125344851|NCT02946931|450896439|FG000|Overall Study|Adverse Event|81|||
125344852|NCT02946931|450896439|FG000|Overall Study|CRFs not valid|1|||
125344853|NCT02946931|450896439|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
125344854|NCT02213133|450896440|FG000|Overall Study|Participant discontinued study therapy|2|||
125344855|NCT02213133|450896441|FG001|Overall Study|Participant discontinued study therapy|0|||
125344856|NCT02213133|450896442|FG002|Overall Study|Participant discontinued study therapy|0|||
125344857|NCT02213133|450896440|FG000|Overall Study|Participant withdrew informed consent|2|||
125344858|NCT02213133|450896441|FG001|Overall Study|Participant withdrew informed consent|1|||
125344859|NCT02213133|450896442|FG002|Overall Study|Participant withdrew informed consent|2|||
125344860|NCT02213133|450896440|FG000|Overall Study|Disease progression|11|||
125344861|NCT02213133|450896441|FG001|Overall Study|Disease progression|2|||
125344862|NCT02213133|450896442|FG002|Overall Study|Disease progression|0|||
125344863|NCT02213133|450896440|FG000|Overall Study|Adverse Event (AE)|1|||
125344864|NCT02213133|450896441|FG001|Overall Study|Adverse Event (AE)|0|||
125344865|NCT02213133|450896442|FG002|Overall Study|Adverse Event (AE)|0|||
125344866|NCT02213133|450896440|FG000|Overall Study|Death|16|||
125344867|NCT02213133|450896441|FG001|Overall Study|Death|2|||
125344868|NCT02213133|450896442|FG002|Overall Study|Death|1|||
125344869|NCT02213133|450896440|FG000|Overall Study|Other|5|||
125344870|NCT02213133|450896441|FG001|Overall Study|Other|0|||
125541112|NCT02207569|451611344|FG000|48-Month|Lost to Follow-up|4|||
125541113|NCT02207569|451611344|FG000|60-Month|Death|1|||
125541114|NCT02207569|451611344|FG000|60-Month|Lost to Follow-up|1|||
125541115|NCT02207569|451611344|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
125541116|NCT02207569|451611344|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
125541117|NCT01844687|451611346|FG000|Visit 1|Protocol Violation|3|||
125541118|NCT01844687|451611346|FG000|Visit 1|Lost to Follow-up|5|||
125541119|NCT01844687|451611346|FG000|Visit 2|Withdrawal by Subject|1|||
125541120|NCT01844687|451611346|FG000|Visit 2|Protocol Violation|1|||
125541121|NCT01844687|451611346|FG000|Visit 3|Lost to Follow-up|1|||
125541122|NCT01844687|451611346|FG000|Visit 3|Withdrawal by Subject|3|||
125541123|NCT01844687|451611346|FG000|Visit 3|child care problems|1|||
125541124|NCT01844687|451611346|FG000|Visit 4|Pregnancy|1|||
125541125|NCT01844687|451611346|FG000|Visit 4|Lost to Follow-up|1|||
125541126|NCT01844687|451611346|FG000|Visit 4|Withdrawal by Subject|2|||
125541127|NCT05383508|451611355|FG000|Overall Study|Withdrawal by Subject|1|||
125541128|NCT05383508|451611356|FG001|Overall Study|Withdrawal by Subject|0|||
125541129|NCT05383508|451611357|FG002|Overall Study|Withdrawal by Subject|1|||
125541130|NCT05383508|451611358|FG003|Overall Study|Withdrawal by Subject|1|||
125541131|NCT05383508|451611359|FG004|Overall Study|Withdrawal by Subject|2|||
125541132|NCT05383508|451611360|FG005|Overall Study|Withdrawal by Subject|0|||
125541133|NCT03047395|451611361|FG000|Overall Study|Adverse Event|142|||
125541134|NCT03047395|451611361|FG000|Overall Study|Withdrawal by Subject|155|||
125541135|NCT03047395|451611361|FG000|Overall Study|Lost to Follow-up|144|||
125541136|NCT03047395|451611361|FG000|Overall Study|COVID-19 Infection|2|||
125541137|NCT03047395|451611361|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
125541138|NCT03047395|451611361|FG000|Overall Study|Other, Not Specified|117|||
125541139|NCT01859988|451611362|FG000|Overall Study|Withdrawal by Subject|6|||
125541140|NCT01859988|451611363|FG001|Overall Study|Withdrawal by Subject|3|||
125541141|NCT01859988|451611364|FG002|Overall Study|Withdrawal by Subject|4|||
125541142|NCT01859988|451611365|FG003|Overall Study|Withdrawal by Subject|3|||
125541143|NCT01859988|451611366|FG004|Overall Study|Withdrawal by Subject|2|||
125541144|NCT01859988|451611367|FG005|Overall Study|Withdrawal by Subject|2|||
125541145|NCT01859988|451611362|FG000|Overall Study|Lack of Efficacy|1|||
125541146|NCT01859988|451611363|FG001|Overall Study|Lack of Efficacy|1|||
125541147|NCT01859988|451611364|FG002|Overall Study|Lack of Efficacy|5|||
125541148|NCT01859988|451611365|FG003|Overall Study|Lack of Efficacy|0|||
125541149|NCT01859988|451611366|FG004|Overall Study|Lack of Efficacy|7|||
125541150|NCT01859988|451611367|FG005|Overall Study|Lack of Efficacy|9|||
125541151|NCT01859988|451611362|FG000|Overall Study|Physician Decision|1|||
125541152|NCT01859988|451611363|FG001|Overall Study|Physician Decision|3|||
125541153|NCT01859988|451611364|FG002|Overall Study|Physician Decision|1|||
125541154|NCT01859988|451611365|FG003|Overall Study|Physician Decision|3|||
125541155|NCT01859988|451611366|FG004|Overall Study|Physician Decision|4|||
125541156|NCT01859988|451611367|FG005|Overall Study|Physician Decision|1|||
125541157|NCT01859988|451611362|FG000|Overall Study|Adverse Event|2|||
125541158|NCT01859988|451611363|FG001|Overall Study|Adverse Event|1|||
125541159|NCT01859988|451611364|FG002|Overall Study|Adverse Event|3|||
125541160|NCT01859988|451611365|FG003|Overall Study|Adverse Event|1|||
125541161|NCT01859988|451611366|FG004|Overall Study|Adverse Event|2|||
125541162|NCT01859988|451611367|FG005|Overall Study|Adverse Event|2|||
125541163|NCT01859988|451611362|FG000|Overall Study|Lost to Follow-up|1|||
125541164|NCT01859988|451611363|FG001|Overall Study|Lost to Follow-up|2|||
125541165|NCT01859988|451611364|FG002|Overall Study|Lost to Follow-up|3|||
125541166|NCT01859988|451611365|FG003|Overall Study|Lost to Follow-up|0|||
125541167|NCT01859988|451611366|FG004|Overall Study|Lost to Follow-up|3|||
125541168|NCT01859988|451611367|FG005|Overall Study|Lost to Follow-up|2|||
125541169|NCT01859988|451611362|FG000|Overall Study|Protocol Violation|0|||
125541170|NCT01859988|451611363|FG001|Overall Study|Protocol Violation|0|||
125541171|NCT01859988|451611364|FG002|Overall Study|Protocol Violation|1|||
125541172|NCT01859988|451611365|FG003|Overall Study|Protocol Violation|0|||
125541173|NCT01859988|451611366|FG004|Overall Study|Protocol Violation|0|||
125541174|NCT01859988|451611367|FG005|Overall Study|Protocol Violation|0|||
125541175|NCT01859988|451611362|FG000|Overall Study|Other than specified above|0|||
125541176|NCT01859988|451611363|FG001|Overall Study|Other than specified above|2|||
125541177|NCT01859988|451611364|FG002|Overall Study|Other than specified above|11|||
125541178|NCT01859988|451611365|FG003|Overall Study|Other than specified above|3|||
125541179|NCT01859988|451611366|FG004|Overall Study|Other than specified above|5|||
125541180|NCT01859988|451611367|FG005|Overall Study|Other than specified above|3|||
125541181|NCT02081417|451611372|FG000|Overall Study|Lost to Follow-up|26|||
125541182|NCT02081417|451611373|FG001|Overall Study|Lost to Follow-up|23|||
125541183|NCT02081417|451611372|FG000|Overall Study|Moved Away|1|||
125541184|NCT02081417|451611373|FG001|Overall Study|Moved Away|2|||
125541185|NCT02081417|451611372|FG000|Overall Study|Incarcerated|2|||
125541186|NCT02081417|451611373|FG001|Overall Study|Incarcerated|2|||
125541187|NCT02081417|451611372|FG000|Overall Study|Death|4|||
125541188|NCT02081417|451611373|FG001|Overall Study|Death|3|||
125541189|NCT02081417|451611372|FG000|Overall Study|Withdrawal by Subject|4|||
125541190|NCT02081417|451611373|FG001|Overall Study|Withdrawal by Subject|0|||
125541191|NCT02081417|451611372|FG000|Overall Study|Admitted to Residential Treatment|2|||
125541192|NCT02081417|451611373|FG001|Overall Study|Admitted to Residential Treatment|0|||
125541193|NCT02081417|451611372|FG000|Overall Study|Did not start treatment|17|||
125541194|NCT02081417|451611373|FG001|Overall Study|Did not start treatment|21|||
125541195|NCT01263665|451611379|FG000|Overall Study|Withdrew Consent|1|||
125541196|NCT01263665|451611379|FG000|Overall Study|Lost to Follow-up|3|||
125541197|NCT01263665|451611379|FG000|Overall Study|Death|2|||
125541198|NCT01263665|451611379|FG000|Overall Study|Amputation above the ankle|1|||
125541199|NCT01263665|451611379|FG000|Overall Study|Surgical Bypass|2|||
125541200|NCT00324675|451611383|FG000|Overall Study|Adverse Event|1|||
125541201|NCT00324675|451611384|FG001|Overall Study|Adverse Event|0|||
125541202|NCT04860297|451611385|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
125541203|NCT04860297|451611386|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
125541204|NCT04860297|451611387|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
125541205|NCT04860297|451611388|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
125541206|NCT04860297|451611389|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
125541207|NCT04860297|451611390|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
125541208|NCT04860297|451611391|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
125541209|NCT04860297|451611392|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
125541210|NCT04860297|451611385|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
125541211|NCT04860297|451611386|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
125541212|NCT04860297|451611387|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
125541213|NCT04860297|451611388|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
125541214|NCT04860297|451611389|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
125541215|NCT04860297|451611390|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
125541216|NCT04860297|451611391|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
125541217|NCT04860297|451611392|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
125541218|NCT04860297|451611385|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
125541219|NCT04860297|451611386|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
125541220|NCT04860297|451611387|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
125541221|NCT04860297|451611388|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
125541222|NCT04860297|451611389|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
125541223|NCT04860297|451611390|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
125541224|NCT04860297|451611391|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
125541225|NCT04860297|451611392|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
125541226|NCT04860297|451611385|FG000|Part B (Booster Dose)|Other Than Specified|0|||
125541227|NCT04860297|451611386|FG001|Part B (Booster Dose)|Other Than Specified|0|||
125541228|NCT04860297|451611387|FG002|Part B (Booster Dose)|Other Than Specified|0|||
125541229|NCT04860297|451611388|FG003|Part B (Booster Dose)|Other Than Specified|0|||
125541230|NCT04860297|451611389|FG004|Part B (Booster Dose)|Other Than Specified|0|||
125541231|NCT04860297|451611390|FG005|Part B (Booster Dose)|Other Than Specified|1|||
125541232|NCT04860297|451611391|FG006|Part B (Booster Dose)|Other Than Specified|1|||
125541233|NCT04860297|451611392|FG007|Part B (Booster Dose)|Other Than Specified|0|||
125541234|NCT04860297|451611385|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
125541235|NCT04860297|451611386|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
125541236|NCT04860297|451611387|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
125541237|NCT04860297|451611388|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
125541238|NCT04860297|451611389|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
125541239|NCT04860297|451611390|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
125541240|NCT04860297|451611391|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
125541241|NCT04860297|451611392|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
125541242|NCT04860297|451611385|FG000|Part B (Booster Dose)|Death|0|||
125541243|NCT04860297|451611386|FG001|Part B (Booster Dose)|Death|0|||
125541244|NCT04860297|451611387|FG002|Part B (Booster Dose)|Death|0|||
125541245|NCT04860297|451611388|FG003|Part B (Booster Dose)|Death|0|||
125541246|NCT04860297|451611389|FG004|Part B (Booster Dose)|Death|1|||
125541247|NCT04860297|451611390|FG005|Part B (Booster Dose)|Death|2|||
125541248|NCT04860297|451611391|FG006|Part B (Booster Dose)|Death|1|||
125541249|NCT04860297|451611392|FG007|Part B (Booster Dose)|Death|0|||
125541250|NCT04860297|451611385|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
125541251|NCT04860297|451611386|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
125541252|NCT04860297|451611387|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
125541253|NCT04860297|451611388|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
125541254|NCT04860297|451611389|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
125541255|NCT04860297|451611390|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
125541256|NCT04860297|451611391|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
125541257|NCT04860297|451611392|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
125541258|NCT04811131|451611396|FG000|Overall Study|Adverse Event|0|||
125541259|NCT04811131|451611397|FG001|Overall Study|Adverse Event|0|||
125541260|NCT04811131|451611398|FG002|Overall Study|Adverse Event|1|||
125541261|NCT04811131|451611399|FG003|Overall Study|Adverse Event|0|||
125541262|NCT04811131|451611396|FG000|Overall Study|Lack of Efficacy|0|||
125541263|NCT04811131|451611397|FG001|Overall Study|Lack of Efficacy|0|||
125541264|NCT04811131|451611398|FG002|Overall Study|Lack of Efficacy|0|||
125541265|NCT04811131|451611399|FG003|Overall Study|Lack of Efficacy|1|||
125541266|NCT04811131|451611396|FG000|Overall Study|Lost to Follow-up|0|||
125541267|NCT04811131|451611397|FG001|Overall Study|Lost to Follow-up|1|||
125541268|NCT04811131|451611398|FG002|Overall Study|Lost to Follow-up|0|||
125541269|NCT04811131|451611399|FG003|Overall Study|Lost to Follow-up|0|||
125541270|NCT04811131|451611396|FG000|Overall Study|Sponsor request|31|||
125541271|NCT04811131|451611397|FG001|Overall Study|Sponsor request|35|||
125541272|NCT04811131|451611398|FG002|Overall Study|Sponsor request|27|||
125541273|NCT04811131|451611399|FG003|Overall Study|Sponsor request|10|||
125541274|NCT04811131|451611396|FG000|Overall Study|Withdrawal by Subject|3|||
125541275|NCT04811131|451611397|FG001|Overall Study|Withdrawal by Subject|1|||
125541276|NCT04811131|451611398|FG002|Overall Study|Withdrawal by Subject|3|||
125344871|NCT02213133|450896442|FG002|Overall Study|Other|0|||
125541277|NCT04811131|451611399|FG003|Overall Study|Withdrawal by Subject|1|||
125541278|NCT01528345|451611401|FG000|Overall Study|Adverse Event|10|||
125541279|NCT01528345|451611402|FG001|Overall Study|Adverse Event|1|||
125541280|NCT01528345|451611401|FG000|Overall Study|Death|1|||
125541281|NCT01528345|451611402|FG001|Overall Study|Death|1|||
125541282|NCT01528345|451611401|FG000|Overall Study|Non-compliance with study treatment|1|||
125541283|NCT01528345|451611402|FG001|Overall Study|Non-compliance with study treatment|0|||
125541284|NCT01528345|451611401|FG000|Overall Study|Progressive Disease|26|||
125541285|NCT01528345|451611402|FG001|Overall Study|Progressive Disease|40|||
125541286|NCT01528345|451611401|FG000|Overall Study|Study Terminated by Sponsor|4|||
125541287|NCT01528345|451611402|FG001|Overall Study|Study Terminated by Sponsor|8|||
125541288|NCT01528345|451611401|FG000|Overall Study|Subject/Guardian Decision|5|||
125541289|NCT01528345|451611402|FG001|Overall Study|Subject/Guardian Decision|0|||
125541290|NCT00371683|451611403|FG000|DB Treatment Period-Randomized Patients|Death|1|||
125541291|NCT00371683|451611404|FG001|DB Treatment Period-Randomized Patients|Death|1|||
125541292|NCT00371683|451611403|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
125541293|NCT00371683|451611404|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
125541294|NCT00371683|451611403|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
125541295|NCT00371683|451611404|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
125541296|NCT00371683|451611403|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
125541297|NCT00371683|451611404|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
125541298|NCT00371683|451611403|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
125541299|NCT00371683|451611404|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
125541300|NCT00371683|451611403|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
125541301|NCT00371683|451611404|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
125541302|NCT00371683|451611403|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
125541303|NCT00371683|451611404|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
125541304|NCT00371683|451611403|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
125541305|NCT00371683|451611404|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
125541306|NCT00371683|451611403|FG000|Follow-Up Period - Randomized Patients|Death|0|||
125541307|NCT00371683|451611404|FG001|Follow-Up Period - Randomized Patients|Death|2|||
125541308|NCT00371683|451611403|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
125541309|NCT00371683|451611404|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
125541310|NCT00371683|451611403|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
125541311|NCT00371683|451611404|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
125541312|NCT03181789|451611406|FG000|Overall Study|Withdrawal by Subject|0|||
125541313|NCT03181789|451611407|FG001|Overall Study|Withdrawal by Subject|1|||
125541314|NCT03181789|451611408|FG002|Overall Study|Withdrawal by Subject|1|||
125541315|NCT03181789|451611409|FG003|Overall Study|Withdrawal by Subject|0|||
125541316|NCT03181789|451611406|FG000|Overall Study|Lost to Follow-up|7|||
125541317|NCT03181789|451611407|FG001|Overall Study|Lost to Follow-up|1|||
125541318|NCT03181789|451611408|FG002|Overall Study|Lost to Follow-up|0|||
125541319|NCT03181789|451611409|FG003|Overall Study|Lost to Follow-up|0|||
125541320|NCT03181789|451611406|FG000|Overall Study|Participant unable to adhere to visit|0|||
125541321|NCT03181789|451611407|FG001|Overall Study|Participant unable to adhere to visit|1|||
125541322|NCT03181789|451611408|FG002|Overall Study|Participant unable to adhere to visit|0|||
125541323|NCT03181789|451611409|FG003|Overall Study|Participant unable to adhere to visit|0|||
125541324|NCT02624791|451611410|FG000|Overall Study|Withdrawal by Subject|2|||
125541325|NCT02624791|451611411|FG001|Overall Study|Withdrawal by Subject|0|||
125541326|NCT02624791|451611412|FG002|Overall Study|Withdrawal by Subject|0|||
125541327|NCT02624791|451611413|FG003|Overall Study|Withdrawal by Subject|0|||
125541328|NCT02624791|451611414|FG004|Overall Study|Withdrawal by Subject|0|||
125541329|NCT02624791|451611415|FG005|Overall Study|Withdrawal by Subject|0|||
125541330|NCT01131182|451611416|FG000|Overall Study|Withdrawal by Subject|1|||
125541331|NCT01131182|451611417|FG001|Overall Study|Withdrawal by Subject|1|||
125541332|NCT01131182|451611416|FG000|Overall Study|Lost to Follow-up|14|||
125541333|NCT01131182|451611417|FG001|Overall Study|Lost to Follow-up|15|||
125541334|NCT01131182|451611416|FG000|Overall Study|Other Reason|1|||
125541335|NCT01131182|451611417|FG001|Overall Study|Other Reason|0|||
125541336|NCT00735475|451611418|FG000|Overall Study|Adverse Event|0|||
125541337|NCT00735475|451611419|FG001|Overall Study|Adverse Event|1|||
125541338|NCT00735475|451611418|FG000|Overall Study|Death|1|||
125541339|NCT00735475|451611419|FG001|Overall Study|Death|1|||
125541340|NCT00735475|451611418|FG000|Overall Study|Lost to Follow-up|3|||
125541341|NCT00735475|451611419|FG001|Overall Study|Lost to Follow-up|3|||
125541342|NCT00735475|451611418|FG000|Overall Study|Physician Decision|0|||
125541343|NCT00735475|451611419|FG001|Overall Study|Physician Decision|1|||
125541344|NCT00735475|451611418|FG000|Overall Study|Withdrawal by Subject|4|||
125541345|NCT00735475|451611419|FG001|Overall Study|Withdrawal by Subject|5|||
125541346|NCT04602221|451611422|FG000|Overall Study|Discontinuation of trial treatment|0|||
125541347|NCT04602221|451611423|FG001|Overall Study|Discontinuation of trial treatment|0|||
125541348|NCT04602221|451611424|FG002|Overall Study|Discontinuation of trial treatment|1|||
125541349|NCT04602221|451611425|FG003|Overall Study|Discontinuation of trial treatment|0|||
125541350|NCT04602221|451611426|FG004|Overall Study|Discontinuation of trial treatment|0|||
125541351|NCT04602221|451611427|FG005|Overall Study|Discontinuation of trial treatment|0|||
125541352|NCT04602221|451611428|FG006|Overall Study|Discontinuation of trial treatment|0|||
125541353|NCT04602221|451611429|FG007|Overall Study|Discontinuation of trial treatment|0|||
125541354|NCT04602221|451611430|FG008|Overall Study|Discontinuation of trial treatment|0|||
125541355|NCT04602221|451611431|FG009|Overall Study|Discontinuation of trial treatment|0|||
125541356|NCT04602221|451611432|FG010|Overall Study|Discontinuation of trial treatment|0|||
125541357|NCT04602221|451611433|FG011|Overall Study|Discontinuation of trial treatment|0|||
125541358|NCT04602221|451611434|FG012|Overall Study|Discontinuation of trial treatment|0|||
125541359|NCT04602221|451611435|FG013|Overall Study|Discontinuation of trial treatment|0|||
125541360|NCT04602221|451611436|FG014|Overall Study|Discontinuation of trial treatment|0|||
125541361|NCT04602221|451611437|FG015|Overall Study|Discontinuation of trial treatment|0|||
125541362|NCT04602221|451611438|FG016|Overall Study|Discontinuation of trial treatment|0|||
125541363|NCT04602221|451611439|FG017|Overall Study|Discontinuation of trial treatment|0|||
125541364|NCT04602221|451611422|FG000|Overall Study|Other than listed|0|||
125541365|NCT04602221|451611423|FG001|Overall Study|Other than listed|0|||
125541366|NCT04602221|451611424|FG002|Overall Study|Other than listed|0|||
125541367|NCT04602221|451611425|FG003|Overall Study|Other than listed|0|||
125541368|NCT04602221|451611426|FG004|Overall Study|Other than listed|0|||
125541369|NCT04602221|451611427|FG005|Overall Study|Other than listed|0|||
125541370|NCT04602221|451611428|FG006|Overall Study|Other than listed|0|||
125541371|NCT04602221|451611429|FG007|Overall Study|Other than listed|0|||
125677726|NCT00262600|452109372|FG000|Overall Study|Other|58|||
125677727|NCT00262600|452109373|FG001|Overall Study|Other|59|||
125677728|NCT00262600|452109374|FG002|Overall Study|Other|62|||
125677729|NCT02906709|452109381|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
125677730|NCT02906709|452109382|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
125677731|NCT02906709|452109381|FG000|Phase A (Week 0 to Week 16)|Death|0|||
125344872|NCT04740905|450896451|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
125344873|NCT04740905|450896452|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
125541372|NCT04602221|451611430|FG008|Overall Study|Other than listed|0|||
125344874|NCT04740905|450896451|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
125541373|NCT04602221|451611431|FG009|Overall Study|Other than listed|0|||
125541374|NCT04602221|451611432|FG010|Overall Study|Other than listed|0|||
125541375|NCT04602221|451611433|FG011|Overall Study|Other than listed|0|||
125541376|NCT04602221|451611434|FG012|Overall Study|Other than listed|0|||
125541377|NCT04602221|451611435|FG013|Overall Study|Other than listed|0|||
125541378|NCT04602221|451611436|FG014|Overall Study|Other than listed|0|||
125541379|NCT04602221|451611437|FG015|Overall Study|Other than listed|1|||
125541380|NCT04602221|451611438|FG016|Overall Study|Other than listed|0|||
125677732|NCT02906709|452109382|FG001|Phase A (Week 0 to Week 16)|Death|1|||
125541381|NCT04602221|451611439|FG017|Overall Study|Other than listed|1|||
125541382|NCT04602221|451611422|FG000|Overall Study|Withdrawal by Subject|0|||
125541383|NCT04602221|451611423|FG001|Overall Study|Withdrawal by Subject|0|||
125541384|NCT04602221|451611424|FG002|Overall Study|Withdrawal by Subject|0|||
125541385|NCT04602221|451611425|FG003|Overall Study|Withdrawal by Subject|0|||
125541386|NCT04602221|451611426|FG004|Overall Study|Withdrawal by Subject|0|||
125541387|NCT04602221|451611427|FG005|Overall Study|Withdrawal by Subject|0|||
125541388|NCT04602221|451611428|FG006|Overall Study|Withdrawal by Subject|0|||
125541389|NCT04602221|451611429|FG007|Overall Study|Withdrawal by Subject|0|||
125541390|NCT04602221|451611430|FG008|Overall Study|Withdrawal by Subject|0|||
125541391|NCT04602221|451611431|FG009|Overall Study|Withdrawal by Subject|0|||
125541392|NCT04602221|451611432|FG010|Overall Study|Withdrawal by Subject|0|||
125541393|NCT04602221|451611433|FG011|Overall Study|Withdrawal by Subject|0|||
125541394|NCT04602221|451611434|FG012|Overall Study|Withdrawal by Subject|1|||
125541395|NCT04602221|451611435|FG013|Overall Study|Withdrawal by Subject|0|||
125541396|NCT04602221|451611436|FG014|Overall Study|Withdrawal by Subject|0|||
125541397|NCT04602221|451611437|FG015|Overall Study|Withdrawal by Subject|0|||
125541398|NCT04602221|451611438|FG016|Overall Study|Withdrawal by Subject|0|||
125541399|NCT04602221|451611439|FG017|Overall Study|Withdrawal by Subject|0|||
125541400|NCT04602221|451611422|FG000|Overall Study|Lost to Follow-up|0|||
125541401|NCT04602221|451611423|FG001|Overall Study|Lost to Follow-up|0|||
125541402|NCT04602221|451611424|FG002|Overall Study|Lost to Follow-up|0|||
125541403|NCT04602221|451611425|FG003|Overall Study|Lost to Follow-up|0|||
125541404|NCT04602221|451611426|FG004|Overall Study|Lost to Follow-up|0|||
125541405|NCT04602221|451611427|FG005|Overall Study|Lost to Follow-up|1|||
125541406|NCT04602221|451611428|FG006|Overall Study|Lost to Follow-up|0|||
125541407|NCT04602221|451611429|FG007|Overall Study|Lost to Follow-up|0|||
125541408|NCT04602221|451611430|FG008|Overall Study|Lost to Follow-up|0|||
125541409|NCT04602221|451611431|FG009|Overall Study|Lost to Follow-up|0|||
125541410|NCT04602221|451611432|FG010|Overall Study|Lost to Follow-up|0|||
125541411|NCT04602221|451611433|FG011|Overall Study|Lost to Follow-up|0|||
125541412|NCT04602221|451611434|FG012|Overall Study|Lost to Follow-up|0|||
125541413|NCT04602221|451611435|FG013|Overall Study|Lost to Follow-up|0|||
125541414|NCT04602221|451611436|FG014|Overall Study|Lost to Follow-up|0|||
125541415|NCT04602221|451611437|FG015|Overall Study|Lost to Follow-up|0|||
125541416|NCT04602221|451611438|FG016|Overall Study|Lost to Follow-up|0|||
125541417|NCT04602221|451611439|FG017|Overall Study|Lost to Follow-up|0|||
125541418|NCT01146782|451611440|FG000|Screening Cohort|Screen Failure|187|||
125541419|NCT01146782|451611440|FG000|Screening Cohort|Lost to Follow-up|4|||
125541420|NCT01146782|451611440|FG000|Screening Cohort|Physician Decision|1|||
125541421|NCT01146782|451611440|FG000|Screening Cohort|Withdrawal by Subject|29|||
125541422|NCT01146782|451611440|FG000|Safety Cohort|Screen Failure|61|||
125541423|NCT01146782|451611440|FG000|Safety Cohort|Withdrawal by Subject|4|||
125541424|NCT01146782|451611440|FG000|Safety Cohort|Control AHI <5|4|||
125541425|NCT01146782|451611440|FG000|Safety Cohort|TST <4 hrs|14|||
125541426|NCT01146782|451611440|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
125541427|NCT01146782|451611440|FG000|Primary Endpoint Cohort|Physician Decision|1|||
125541428|NCT02270515|451611441|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
125541429|NCT02270515|451611441|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
125541430|NCT02270515|451611441|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
125541431|NCT02270515|451611441|FG000|Intervention Period 1: 0-6 Months|Death|7|||
125541432|NCT02270515|451611441|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
125677733|NCT02906709|452109381|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
125677734|NCT02906709|452109382|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
125677735|NCT02906709|452109381|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
125677736|NCT02906709|452109382|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
125677737|NCT00977106|452109384|FG000|Overall Study|Adverse Event|5|||
125677738|NCT00977106|452109385|FG001|Overall Study|Adverse Event|6|||
125541433|NCT02270515|451611441|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
125541434|NCT02270515|451611441|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
125541435|NCT02270515|451611441|FG000|Intervention Period 2: 6-12 Months|Death|5|||
125541436|NCT02270515|451611441|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
125541437|NCT02270515|451611441|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
125541438|NCT02270515|451611441|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
125541439|NCT02270515|451611441|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
125541440|NCT02270515|451611441|FG000|Intervention Period 3: 12-18 Months|Death|3|||
125541441|NCT02270515|451611441|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
125541442|NCT01370590|451611442|FG000|Period 1|Adverse Event|8|||
125541443|NCT01370590|451611443|FG001|Period 1|Adverse Event|4|||
125541444|NCT01370590|451611442|FG000|Period 1|Lost to Follow-up|2|||
125541445|NCT01370590|451611443|FG001|Period 1|Lost to Follow-up|2|||
125541446|NCT01370590|451611442|FG000|Period 1|Protocol Violation|2|||
125541447|NCT01370590|451611443|FG001|Period 1|Protocol Violation|2|||
125541448|NCT01370590|451611442|FG000|Period 1|Withdrawal by Subject|4|||
125677739|NCT00977106|452109384|FG000|Overall Study|Withdrawal by Subject|2|||
125541449|NCT01370590|451611443|FG001|Period 1|Withdrawal by Subject|2|||
125541450|NCT01370590|451611442|FG000|Period 1|Could not access randomization system|0|||
125541451|NCT01370590|451611443|FG001|Period 1|Could not access randomization system|1|||
125541452|NCT01370590|451611442|FG000|Crossover Washout Period|Adverse Event|1|||
125541453|NCT01370590|451611443|FG001|Crossover Washout Period|Adverse Event|4|||
125541454|NCT01370590|451611442|FG000|Crossover Washout Period|Lost to Follow-up|2|||
125541455|NCT01370590|451611443|FG001|Crossover Washout Period|Lost to Follow-up|0|||
125541456|NCT01370590|451611442|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
125541457|NCT01370590|451611443|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
125541458|NCT01370590|451611442|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
125541459|NCT01370590|451611443|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
125541460|NCT01370590|451611442|FG000|Period 2|Adverse Event|0|||
125541461|NCT01370590|451611443|FG001|Period 2|Adverse Event|1|||
125541462|NCT01370590|451611442|FG000|Period 2|Withdrawal by Subject|1|||
125541463|NCT01370590|451611443|FG001|Period 2|Withdrawal by Subject|1|||
125541464|NCT00604825|451611444|FG000|Overall Study|Adverse Event|2|||
125541465|NCT00604825|451611445|FG001|Overall Study|Adverse Event|6|||
125541466|NCT00604825|451611446|FG002|Overall Study|Adverse Event|7|||
125541467|NCT00604825|451611447|FG003|Overall Study|Adverse Event|4|||
125541468|NCT00604825|451611444|FG000|Overall Study|Lost to Follow-up|0|||
125541469|NCT00604825|451611445|FG001|Overall Study|Lost to Follow-up|3|||
125541470|NCT00604825|451611446|FG002|Overall Study|Lost to Follow-up|1|||
125541471|NCT00604825|451611447|FG003|Overall Study|Lost to Follow-up|0|||
125541472|NCT00604825|451611444|FG000|Overall Study|Protocol Violation|0|||
125541473|NCT00604825|451611445|FG001|Overall Study|Protocol Violation|1|||
125541474|NCT00604825|451611446|FG002|Overall Study|Protocol Violation|0|||
125541475|NCT00604825|451611447|FG003|Overall Study|Protocol Violation|0|||
125541476|NCT00604825|451611444|FG000|Overall Study|Withdrawal by Subject|4|||
125541477|NCT00604825|451611445|FG001|Overall Study|Withdrawal by Subject|3|||
125541478|NCT00604825|451611446|FG002|Overall Study|Withdrawal by Subject|5|||
125541479|NCT00604825|451611447|FG003|Overall Study|Withdrawal by Subject|5|||
125541480|NCT00604825|451611444|FG000|Overall Study|Lack of Efficacy|3|||
125541481|NCT00604825|451611445|FG001|Overall Study|Lack of Efficacy|2|||
125541482|NCT00604825|451611446|FG002|Overall Study|Lack of Efficacy|1|||
125541483|NCT00604825|451611447|FG003|Overall Study|Lack of Efficacy|0|||
125541484|NCT00604825|451611444|FG000|Overall Study|Did not meet eligibility criteria|0|||
125541485|NCT00604825|451611445|FG001|Overall Study|Did not meet eligibility criteria|0|||
125541486|NCT00604825|451611446|FG002|Overall Study|Did not meet eligibility criteria|2|||
125541487|NCT00604825|451611447|FG003|Overall Study|Did not meet eligibility criteria|0|||
125677740|NCT00977106|452109385|FG001|Overall Study|Withdrawal by Subject|2|||
125677741|NCT00977106|452109384|FG000|Overall Study|Lack of Efficacy|2|||
125677742|NCT00977106|452109385|FG001|Overall Study|Lack of Efficacy|2|||
125677743|NCT00977106|452109384|FG000|Overall Study|Protocol Violation|0|||
125677744|NCT00977106|452109385|FG001|Overall Study|Protocol Violation|1|||
125677745|NCT00977106|452109384|FG000|Overall Study|Other|1|||
125677746|NCT00977106|452109385|FG001|Overall Study|Other|0|||
125677747|NCT05518487|452109387|FG000|Overall Study|Withdrawal by Subject|3|||
125677748|NCT02752776|452109391|FG000|Overall Study|Adverse Event|15|||
125677749|NCT02752776|452109392|FG001|Overall Study|Adverse Event|23|||
125677750|NCT02752776|452109393|FG002|Overall Study|Adverse Event|11|||
125677751|NCT02752776|452109391|FG000|Overall Study|Lack of Efficacy|2|||
125677752|NCT02752776|452109392|FG001|Overall Study|Lack of Efficacy|6|||
125677753|NCT02752776|452109393|FG002|Overall Study|Lack of Efficacy|14|||
125541488|NCT00604825|451611444|FG000|Overall Study|Physician Decision|0|||
125541489|NCT00604825|451611445|FG001|Overall Study|Physician Decision|0|||
125541490|NCT00604825|451611446|FG002|Overall Study|Physician Decision|0|||
125541491|NCT00604825|451611447|FG003|Overall Study|Physician Decision|1|||
125541492|NCT00604825|451611444|FG000|Overall Study|Exclusion criterion met|0|||
125541493|NCT00604825|451611445|FG001|Overall Study|Exclusion criterion met|0|||
125541494|NCT00604825|451611446|FG002|Overall Study|Exclusion criterion met|0|||
125541495|NCT00604825|451611447|FG003|Overall Study|Exclusion criterion met|1|||
125677754|NCT02752776|452109391|FG000|Overall Study|Lost to Follow-up|11|||
125677755|NCT02752776|452109392|FG001|Overall Study|Lost to Follow-up|12|||
125677756|NCT02752776|452109393|FG002|Overall Study|Lost to Follow-up|4|||
125541496|NCT04617275|451611448|FG000|Treatment Period|Adverse Event|1|||
125541497|NCT04617275|451611449|FG001|Treatment Period|Adverse Event|6|||
125541498|NCT04617275|451611450|FG002|Treatment Period|Adverse Event|4|||
125541499|NCT04617275|451611451|FG003|Treatment Period|Adverse Event|6|||
125541500|NCT04617275|451611452|FG004|Treatment Period|Adverse Event|7|||
125541501|NCT04617275|451611453|FG005|Treatment Period|Adverse Event|8|||
125541502|NCT04617275|451611454|FG006|Treatment Period|Adverse Event|0|||
125541503|NCT04617275|451611455|FG007|Treatment Period|Adverse Event|12|||
125541504|NCT04617275|451611448|FG000|Treatment Period|Lost to Follow-up|0|||
125677757|NCT02752776|452109391|FG000|Overall Study|Non-compliance with study treatment|0|||
125677758|NCT02752776|452109392|FG001|Overall Study|Non-compliance with study treatment|0|||
125677759|NCT02752776|452109393|FG002|Overall Study|Non-compliance with study treatment|1|||
125677760|NCT02752776|452109391|FG000|Overall Study|Physician Decision|2|||
125677761|NCT02752776|452109392|FG001|Overall Study|Physician Decision|6|||
125541505|NCT04617275|451611449|FG001|Treatment Period|Lost to Follow-up|0|||
125541506|NCT04617275|451611450|FG002|Treatment Period|Lost to Follow-up|2|||
125541507|NCT04617275|451611451|FG003|Treatment Period|Lost to Follow-up|0|||
125541508|NCT04617275|451611452|FG004|Treatment Period|Lost to Follow-up|0|||
125541509|NCT04617275|451611453|FG005|Treatment Period|Lost to Follow-up|3|||
125541510|NCT04617275|451611454|FG006|Treatment Period|Lost to Follow-up|0|||
125541511|NCT04617275|451611455|FG007|Treatment Period|Lost to Follow-up|2|||
125541512|NCT04617275|451611448|FG000|Treatment Period|No longer meets eligibility criteria|0|||
125541513|NCT04617275|451611449|FG001|Treatment Period|No longer meets eligibility criteria|0|||
125541514|NCT04617275|451611450|FG002|Treatment Period|No longer meets eligibility criteria|0|||
125541515|NCT04617275|451611451|FG003|Treatment Period|No longer meets eligibility criteria|1|||
125541516|NCT04617275|451611452|FG004|Treatment Period|No longer meets eligibility criteria|0|||
125541517|NCT04617275|451611453|FG005|Treatment Period|No longer meets eligibility criteria|0|||
125541518|NCT04617275|451611454|FG006|Treatment Period|No longer meets eligibility criteria|0|||
125541519|NCT04617275|451611455|FG007|Treatment Period|No longer meets eligibility criteria|0|||
125541520|NCT04617275|451611448|FG000|Treatment Period|Other|0|||
125541521|NCT04617275|451611449|FG001|Treatment Period|Other|1|||
125541522|NCT04617275|451611450|FG002|Treatment Period|Other|0|||
125541523|NCT04617275|451611451|FG003|Treatment Period|Other|0|||
125541524|NCT04617275|451611452|FG004|Treatment Period|Other|0|||
125541525|NCT04617275|451611453|FG005|Treatment Period|Other|0|||
125541526|NCT04617275|451611454|FG006|Treatment Period|Other|0|||
125541527|NCT04617275|451611455|FG007|Treatment Period|Other|0|||
125541528|NCT04617275|451611448|FG000|Treatment Period|Withdrawal by Subject|2|||
125541529|NCT04617275|451611449|FG001|Treatment Period|Withdrawal by Subject|0|||
125541530|NCT04617275|451611450|FG002|Treatment Period|Withdrawal by Subject|0|||
125541531|NCT04617275|451611451|FG003|Treatment Period|Withdrawal by Subject|2|||
125541532|NCT04617275|451611452|FG004|Treatment Period|Withdrawal by Subject|2|||
125541533|NCT04617275|451611453|FG005|Treatment Period|Withdrawal by Subject|0|||
125541534|NCT04617275|451611454|FG006|Treatment Period|Withdrawal by Subject|1|||
125541535|NCT04617275|451611455|FG007|Treatment Period|Withdrawal by Subject|2|||
125541536|NCT04617275|451611448|FG000|Follow-up Period|Adverse Event|1|||
125541537|NCT04617275|451611449|FG001|Follow-up Period|Adverse Event|1|||
125541538|NCT04617275|451611450|FG002|Follow-up Period|Adverse Event|2|||
125541539|NCT04617275|451611451|FG003|Follow-up Period|Adverse Event|3|||
125541540|NCT04617275|451611452|FG004|Follow-up Period|Adverse Event|4|||
125541541|NCT04617275|451611453|FG005|Follow-up Period|Adverse Event|3|||
125541542|NCT04617275|451611454|FG006|Follow-up Period|Adverse Event|0|||
125541543|NCT04617275|451611455|FG007|Follow-up Period|Adverse Event|3|||
125541544|NCT04617275|451611448|FG000|Follow-up Period|Lost to Follow-up|0|||
125541545|NCT04617275|451611449|FG001|Follow-up Period|Lost to Follow-up|1|||
125541546|NCT04617275|451611450|FG002|Follow-up Period|Lost to Follow-up|2|||
125541547|NCT04617275|451611451|FG003|Follow-up Period|Lost to Follow-up|0|||
125541548|NCT04617275|451611452|FG004|Follow-up Period|Lost to Follow-up|0|||
125541549|NCT04617275|451611453|FG005|Follow-up Period|Lost to Follow-up|4|||
125541550|NCT04617275|451611454|FG006|Follow-up Period|Lost to Follow-up|0|||
125541551|NCT04617275|451611455|FG007|Follow-up Period|Lost to Follow-up|3|||
125541552|NCT04617275|451611448|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
125541553|NCT04617275|451611449|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
125541554|NCT04617275|451611450|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
125541555|NCT04617275|451611451|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
125541556|NCT04617275|451611452|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
125541557|NCT04617275|451611453|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
125541558|NCT04617275|451611454|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
125677762|NCT02752776|452109393|FG002|Overall Study|Physician Decision|2|||
125677763|NCT02752776|452109391|FG000|Overall Study|Pregnancy|1|||
125677764|NCT02752776|452109392|FG001|Overall Study|Pregnancy|6|||
125677765|NCT02752776|452109393|FG002|Overall Study|Pregnancy|3|||
125677766|NCT02752776|452109391|FG000|Overall Study|Protocol Violation|10|||
125677767|NCT02752776|452109392|FG001|Overall Study|Protocol Violation|13|||
125677768|NCT02752776|452109393|FG002|Overall Study|Protocol Violation|6|||
125677769|NCT02752776|452109391|FG000|Overall Study|Subject/guardian decision|8|||
125344875|NCT04740905|450896452|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
125344876|NCT04740905|450896451|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
125541559|NCT04617275|451611455|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
125541560|NCT04617275|451611448|FG000|Follow-up Period|Other|0|||
125541561|NCT04617275|451611449|FG001|Follow-up Period|Other|1|||
125541562|NCT04617275|451611450|FG002|Follow-up Period|Other|0|||
125541563|NCT04617275|451611451|FG003|Follow-up Period|Other|0|||
125541564|NCT04617275|451611452|FG004|Follow-up Period|Other|0|||
125541565|NCT04617275|451611453|FG005|Follow-up Period|Other|0|||
125541566|NCT04617275|451611454|FG006|Follow-up Period|Other|0|||
125541567|NCT04617275|451611455|FG007|Follow-up Period|Other|0|||
125677770|NCT02752776|452109392|FG001|Overall Study|Subject/guardian decision|6|||
125677771|NCT02752776|452109393|FG002|Overall Study|Subject/guardian decision|4|||
125677772|NCT02752776|452109391|FG000|Overall Study|Death|0|||
125677773|NCT02752776|452109392|FG001|Overall Study|Death|0|||
125541568|NCT04617275|451611448|FG000|Follow-up Period|Withdrawal by Subject|2|||
125541569|NCT04617275|451611449|FG001|Follow-up Period|Withdrawal by Subject|0|||
125541570|NCT04617275|451611450|FG002|Follow-up Period|Withdrawal by Subject|0|||
125541571|NCT04617275|451611451|FG003|Follow-up Period|Withdrawal by Subject|2|||
125541572|NCT04617275|451611452|FG004|Follow-up Period|Withdrawal by Subject|2|||
125541573|NCT04617275|451611453|FG005|Follow-up Period|Withdrawal by Subject|0|||
125541574|NCT04617275|451611454|FG006|Follow-up Period|Withdrawal by Subject|1|||
125541575|NCT04617275|451611455|FG007|Follow-up Period|Withdrawal by Subject|2|||
125541576|NCT04927884|451611462|FG000|Overall Study|Progressive Disease|2|||
125541577|NCT05593445|451611463|FG000|12-Week DBVC Period|Adverse Event|1|||
125541578|NCT05593445|451611464|FG001|12-Week DBVC Period|Adverse Event|0|||
125541579|NCT05593445|451611465|FG002|12-Week DBVC Period|Adverse Event|0|||
125541580|NCT05593445|451611466|FG003|12-Week DBVC Period|Adverse Event|0|||
125541581|NCT05593445|451611463|FG000|12-Week DBVC Period|Physician Decision|0|||
125541582|NCT05593445|451611464|FG001|12-Week DBVC Period|Physician Decision|1|||
125541583|NCT05593445|451611465|FG002|12-Week DBVC Period|Physician Decision|0|||
125541584|NCT05593445|451611466|FG003|12-Week DBVC Period|Physician Decision|0|||
125541585|NCT05593445|451611463|FG000|12-Week DBVC Period|Protocol Violation|0|||
125541586|NCT05593445|451611464|FG001|12-Week DBVC Period|Protocol Violation|1|||
125541587|NCT05593445|451611465|FG002|12-Week DBVC Period|Protocol Violation|0|||
125541588|NCT05593445|451611466|FG003|12-Week DBVC Period|Protocol Violation|0|||
125541589|NCT05593445|451611463|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
125541590|NCT05593445|451611464|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
125541591|NCT05593445|451611465|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
125541592|NCT05593445|451611466|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
125541593|NCT05593445|451611463|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
125541594|NCT05593445|451611464|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
125541595|NCT05593445|451611465|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
125541596|NCT05593445|451611466|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
125541597|NCT05593445|451611463|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
125541598|NCT05593445|451611464|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
125541599|NCT05593445|451611465|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
125541600|NCT05593445|451611466|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
125541601|NCT05593445|451611463|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
125541602|NCT05593445|451611464|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
125541603|NCT05593445|451611465|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
125541604|NCT05593445|451611466|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
125541605|NCT05593445|451611463|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125541606|NCT05593445|451611464|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125541607|NCT05593445|451611465|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
125541608|NCT05593445|451611466|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125541609|NCT05559476|451611467|FG000|Overall Study|Adverse Event|2|||
125541610|NCT05559476|451611468|FG001|Overall Study|Adverse Event|0|||
125541611|NCT05559476|451611467|FG000|Overall Study|Lost to Follow-up|13|||
125541612|NCT05559476|451611468|FG001|Overall Study|Lost to Follow-up|12|||
125541613|NCT05559476|451611467|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
125541614|NCT05559476|451611468|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
125541615|NCT05559476|451611467|FG000|Overall Study|Other|0|||
125541616|NCT05559476|451611468|FG001|Overall Study|Other|2|||
125677774|NCT02752776|452109393|FG002|Overall Study|Death|1|||
125677775|NCT02752776|452109391|FG000|Overall Study|Withdrawal by Subject|3|||
125677776|NCT02752776|452109392|FG001|Overall Study|Withdrawal by Subject|4|||
125677777|NCT02752776|452109393|FG002|Overall Study|Withdrawal by Subject|2|||
125677778|NCT01946165|452109394|FG000|Overall Study|Physician Decision|2|||
125677779|NCT01946165|452109395|FG001|Overall Study|Physician Decision|0|||
125677780|NCT01946165|452109394|FG000|Overall Study|Withdrawal by Subject|0|||
125677781|NCT01946165|452109395|FG001|Overall Study|Withdrawal by Subject|2|||
125677782|NCT01179919|452109396|FG000|Overall Study|Protocol Violation|1|||
125677783|NCT01179919|452109396|FG000|Overall Study|Adverse Event|1|||
125677784|NCT00806156|452109397|FG000|Overall Study|Death|35|||
125677785|NCT00806156|452109398|FG001|Overall Study|Death|95|||
125677786|NCT00806156|452109397|FG000|Overall Study|Did not meet eligibility criteria|1|||
125677787|NCT00806156|452109398|FG001|Overall Study|Did not meet eligibility criteria|0|||
125541617|NCT00727311|451611469|FG000|Overall Study|Did not receive drug|316|||
125541618|NCT00727311|451611469|FG000|Overall Study|Missing end of therapy data|205|||
125541619|NCT00727311|451611469|FG000|Overall Study|Adverse Event|58|||
125541620|NCT00727311|451611469|FG000|Overall Study|Lack of Efficacy|242|||
125541621|NCT00727311|451611469|FG000|Overall Study|Lost to Follow-up|73|||
125541622|NCT00727311|451611469|FG000|Overall Study|Withdrawal by Subject|77|||
125541623|NCT00727311|451611469|FG000|Overall Study|Other|97|||
125677788|NCT00806156|452109397|FG000|Overall Study|Study terminated by Sponsor|2|||
125677789|NCT00806156|452109398|FG001|Overall Study|Study terminated by Sponsor|40|||
125677790|NCT00806156|452109397|FG000|Overall Study|Consent withdrawn by subject|1|||
125677791|NCT00806156|452109398|FG001|Overall Study|Consent withdrawn by subject|3|||
125677792|NCT00806156|452109397|FG000|Overall Study|Lost to Follow-up|0|||
125541624|NCT00727311|451611469|FG000|Overall Study|Multiple reasons|39|||
125541625|NCT00969709|451612549|FG000|Overall Study|Adverse Event|3|||
125541626|NCT00969709|451612550|FG001|Overall Study|Adverse Event|13|||
125541627|NCT00969709|451612551|FG002|Overall Study|Adverse Event|26|||
125541628|NCT00969709|451612552|FG003|Overall Study|Adverse Event|12|||
125541629|NCT00969709|451612549|FG000|Overall Study|Lack of Efficacy|7|||
125541630|NCT00969709|451612550|FG001|Overall Study|Lack of Efficacy|4|||
125541631|NCT00969709|451612551|FG002|Overall Study|Lack of Efficacy|1|||
125541632|NCT00969709|451612552|FG003|Overall Study|Lack of Efficacy|3|||
125541633|NCT00969709|451612549|FG000|Overall Study|Protocol Violation|9|||
125541634|NCT00969709|451612550|FG001|Overall Study|Protocol Violation|5|||
125541635|NCT00969709|451612551|FG002|Overall Study|Protocol Violation|9|||
125541636|NCT00969709|451612552|FG003|Overall Study|Protocol Violation|10|||
125541637|NCT00969709|451612549|FG000|Overall Study|Withdrawal by Subject|9|||
125541638|NCT00969709|451612550|FG001|Overall Study|Withdrawal by Subject|12|||
125541639|NCT00969709|451612551|FG002|Overall Study|Withdrawal by Subject|11|||
125541640|NCT00969709|451612552|FG003|Overall Study|Withdrawal by Subject|23|||
125541641|NCT00969709|451612549|FG000|Overall Study|Lost to Follow-up|10|||
125541642|NCT00969709|451612550|FG001|Overall Study|Lost to Follow-up|14|||
125541643|NCT00969709|451612551|FG002|Overall Study|Lost to Follow-up|8|||
125541644|NCT00969709|451612552|FG003|Overall Study|Lost to Follow-up|15|||
125541645|NCT00969709|451612549|FG000|Overall Study|Other reasons|0|||
125541646|NCT00969709|451612550|FG001|Overall Study|Other reasons|0|||
125541647|NCT00969709|451612551|FG002|Overall Study|Other reasons|3|||
125541648|NCT00969709|451612552|FG003|Overall Study|Other reasons|0|||
125541649|NCT01238900|451612553|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
125541650|NCT01238900|451612553|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
125541651|NCT00616902|451612554|FG000|Overall Study|Termination of study|6|||
125541652|NCT00616902|451612555|FG001|Overall Study|Termination of study|6|||
125541653|NCT01119105|451612560|FG000|Overall Study|Withdrawal by Subject|1|||
125541654|NCT01119105|451612561|FG001|Overall Study|Withdrawal by Subject|1|||
125541655|NCT01119105|451612562|FG002|Overall Study|Withdrawal by Subject|1|||
125541656|NCT01119105|451612560|FG000|Overall Study|Lost to Follow-up|0|||
125541657|NCT01119105|451612561|FG001|Overall Study|Lost to Follow-up|2|||
125541658|NCT01119105|451612562|FG002|Overall Study|Lost to Follow-up|5|||
125541659|NCT01119105|451612560|FG000|Overall Study|Adverse Event|1|||
125541660|NCT01119105|451612561|FG001|Overall Study|Adverse Event|0|||
125541661|NCT01119105|451612562|FG002|Overall Study|Adverse Event|1|||
125541662|NCT01119105|451612560|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
125541663|NCT01119105|451612561|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
125541664|NCT01119105|451612562|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
125541665|NCT01119105|451612560|FG000|Overall Study|Other|1|||
125541666|NCT01119105|451612561|FG001|Overall Study|Other|1|||
125541667|NCT01119105|451612562|FG002|Overall Study|Other|0|||
125541668|NCT04988867|451612566|FG000|Overall Study|Study terminated by Sponsor|12|||
125541669|NCT04988867|451612566|FG000|Overall Study|Adverse Event|2|||
125541670|NCT04988867|451612566|FG000|Overall Study|Study drug noncompliance|1|||
125541671|NCT01699503|451612567|FG000|Overall Study|Death|31|||
125541672|NCT01699503|451612568|FG001|Overall Study|Death|40|||
125541673|NCT01699503|451612567|FG000|Overall Study|Withdrawal by Subject|65|||
125541674|NCT01699503|451612568|FG001|Overall Study|Withdrawal by Subject|57|||
125541675|NCT01699503|451612567|FG000|Overall Study|Lost to Follow-up|121|||
125541676|NCT01699503|451612568|FG001|Overall Study|Lost to Follow-up|117|||
125541677|NCT01699503|451612567|FG000|Overall Study|Excluded due to quality|783|||
125541678|NCT01699503|451612568|FG001|Overall Study|Excluded due to quality|791|||
125541679|NCT01236534|451612571|FG000|Overall Study|Adverse Event|3|||
125541680|NCT01236534|451612572|FG001|Overall Study|Adverse Event|0|||
125541681|NCT01014143|451612573|FG000|Second Intervention|Lost to Follow-up|2|||
125541682|NCT01014143|451612574|FG001|Second Intervention|Lost to Follow-up|0|||
125541683|NCT01014143|451612575|FG002|Second Intervention|Lost to Follow-up|0|||
125541684|NCT04638920|451612580|FG000|Overall Study|Withdrawal by Subject|5|||
125541685|NCT03775434|451612581|FG000|Overall Study|Adverse Event|2|||
125541686|NCT03775434|451612581|FG000|Overall Study|Withdrawal by Subject|1|||
125541687|NCT01871805|451612584|FG000|Phase I|Death|7|||
125541688|NCT01871805|451612585|FG001|Phase I|Death|4|||
125541689|NCT01871805|451612586|FG002|Phase I|Death|6|||
125541690|NCT01871805|451612587|FG003|Phase I|Death|2|||
125541691|NCT01871805|451612588|FG004|Phase I|Death|9|||
125541692|NCT01871805|451612589|FG005|Phase I|Death|0|||
125541693|NCT01871805|451612584|FG000|Phase I|Alive in Survival Follow-up|0|||
125541694|NCT01871805|451612585|FG001|Phase I|Alive in Survival Follow-up|2|||
125541695|NCT01871805|451612586|FG002|Phase I|Alive in Survival Follow-up|4|||
125541696|NCT01871805|451612587|FG003|Phase I|Alive in Survival Follow-up|5|||
125541697|NCT01871805|451612588|FG004|Phase I|Alive in Survival Follow-up|4|||
125541698|NCT01871805|451612589|FG005|Phase I|Alive in Survival Follow-up|0|||
125541699|NCT01871805|451612584|FG000|Phase I|Lost to Follow-up|0|||
125541700|NCT01871805|451612585|FG001|Phase I|Lost to Follow-up|1|||
125541701|NCT01871805|451612586|FG002|Phase I|Lost to Follow-up|3|||
125541702|NCT01871805|451612587|FG003|Phase I|Lost to Follow-up|0|||
125541703|NCT01871805|451612588|FG004|Phase I|Lost to Follow-up|0|||
125541704|NCT01871805|451612589|FG005|Phase I|Lost to Follow-up|0|||
125541705|NCT01871805|451612584|FG000|Phase II|Death|0|||
125541706|NCT01871805|451612585|FG001|Phase II|Death|0|||
125541707|NCT01871805|451612586|FG002|Phase II|Death|0|||
125541708|NCT01871805|451612587|FG003|Phase II|Death|0|||
125541709|NCT01871805|451612588|FG004|Phase II|Death|0|||
125541710|NCT01871805|451612589|FG005|Phase II|Death|45|||
125541711|NCT01871805|451612584|FG000|Phase II|Alive in Survival Follow-up|0|||
125541712|NCT01871805|451612585|FG001|Phase II|Alive in Survival Follow-up|0|||
125677793|NCT00806156|452109398|FG001|Overall Study|Lost to Follow-up|1|||
125677794|NCT00337571|452109402|FG000|Overall Study|Lack of Efficacy|3|||
125677795|NCT00337571|452109403|FG001|Overall Study|Lack of Efficacy|0|||
125677796|NCT00337571|452109404|FG002|Overall Study|Lack of Efficacy|0|||
125677797|NCT00337571|452109405|FG003|Overall Study|Lack of Efficacy|0|||
125677798|NCT00337571|452109402|FG000|Overall Study|Adverse Event|4|||
125677799|NCT00337571|452109403|FG001|Overall Study|Adverse Event|5|||
125677800|NCT00337571|452109404|FG002|Overall Study|Adverse Event|8|||
125677801|NCT00337571|452109405|FG003|Overall Study|Adverse Event|4|||
125677802|NCT00337571|452109402|FG000|Overall Study|Withdrawal by Subject|2|||
125677803|NCT00337571|452109403|FG001|Overall Study|Withdrawal by Subject|2|||
125677804|NCT00337571|452109404|FG002|Overall Study|Withdrawal by Subject|1|||
125677805|NCT00337571|452109405|FG003|Overall Study|Withdrawal by Subject|0|||
125677806|NCT00337571|452109402|FG000|Overall Study|Lost to Follow-up|3|||
125677807|NCT00337571|452109403|FG001|Overall Study|Lost to Follow-up|1|||
125677808|NCT00337571|452109404|FG002|Overall Study|Lost to Follow-up|0|||
125677809|NCT00337571|452109405|FG003|Overall Study|Lost to Follow-up|1|||
125677810|NCT00337571|452109402|FG000|Overall Study|Poor/noncompliance|1|||
125677811|NCT00337571|452109403|FG001|Overall Study|Poor/noncompliance|1|||
125677812|NCT00337571|452109404|FG002|Overall Study|Poor/noncompliance|1|||
125677813|NCT00337571|452109405|FG003|Overall Study|Poor/noncompliance|1|||
125677814|NCT00337571|452109402|FG000|Overall Study|No longer met study criteria|1|||
125677815|NCT00337571|452109403|FG001|Overall Study|No longer met study criteria|0|||
125677816|NCT00337571|452109404|FG002|Overall Study|No longer met study criteria|0|||
125677817|NCT00337571|452109405|FG003|Overall Study|No longer met study criteria|0|||
125677818|NCT00337571|452109402|FG000|Overall Study|High Potassium level|0|||
125677819|NCT00337571|452109403|FG001|Overall Study|High Potassium level|0|||
125677820|NCT00337571|452109404|FG002|Overall Study|High Potassium level|0|||
125677821|NCT00337571|452109405|FG003|Overall Study|High Potassium level|1|||
125677822|NCT02674334|452109408|FG000|Overall Study|Lost to Follow-up|5|||
125677823|NCT02674334|452109409|FG001|Overall Study|Lost to Follow-up|3|||
125677824|NCT02674334|452109408|FG000|Overall Study|participant difficulty breathing|1|||
125677825|NCT02674334|452109409|FG001|Overall Study|participant difficulty breathing|0|||
125677826|NCT02674334|452109408|FG000|Overall Study|NIRS not recording|1|||
125677827|NCT02674334|452109409|FG001|Overall Study|NIRS not recording|0|||
125677828|NCT00449150|452109410|FG000|Overall Study|Adverse Event|11|||
125677829|NCT00449150|452109411|FG001|Overall Study|Adverse Event|18|||
125677830|NCT00449150|452109412|FG002|Overall Study|Adverse Event|9|||
125677831|NCT00449150|452109410|FG000|Overall Study|Lack of Efficacy|1|||
125677832|NCT00449150|452109411|FG001|Overall Study|Lack of Efficacy|2|||
125677833|NCT00449150|452109412|FG002|Overall Study|Lack of Efficacy|2|||
125677834|NCT00449150|452109410|FG000|Overall Study|Other|16|||
125677835|NCT00449150|452109411|FG001|Overall Study|Other|13|||
125677836|NCT00449150|452109412|FG002|Overall Study|Other|14|||
125677837|NCT00449150|452109410|FG000|Overall Study|Withdrawal by Subject|17|||
125677838|NCT00449150|452109411|FG001|Overall Study|Withdrawal by Subject|18|||
125677839|NCT00449150|452109412|FG002|Overall Study|Withdrawal by Subject|21|||
125677840|NCT00449150|452109410|FG000|Overall Study|Protocol Violation|1|||
125677841|NCT00449150|452109411|FG001|Overall Study|Protocol Violation|2|||
125677842|NCT00449150|452109412|FG002|Overall Study|Protocol Violation|1|||
125677843|NCT03552757|452109414|FG000|Overall Study|Withdrawal by Subject|10|||
125677844|NCT03552757|452109415|FG001|Overall Study|Withdrawal by Subject|5|||
125541713|NCT01871805|451612586|FG002|Phase II|Alive in Survival Follow-up|0|||
125541714|NCT01871805|451612587|FG003|Phase II|Alive in Survival Follow-up|0|||
125541715|NCT01871805|451612588|FG004|Phase II|Alive in Survival Follow-up|0|||
125541716|NCT01871805|451612589|FG005|Phase II|Alive in Survival Follow-up|29|||
125677845|NCT03552757|452109416|FG002|Overall Study|Withdrawal by Subject|12|||
125677846|NCT03552757|452109414|FG000|Overall Study|Lost to Follow-up|2|||
125677847|NCT03552757|452109415|FG001|Overall Study|Lost to Follow-up|7|||
125677848|NCT03552757|452109416|FG002|Overall Study|Lost to Follow-up|7|||
125677849|NCT03552757|452109414|FG000|Overall Study|Death|1|||
125677850|NCT03552757|452109415|FG001|Overall Study|Death|1|||
125677851|NCT03552757|452109416|FG002|Overall Study|Death|1|||
125677852|NCT02660242|452109420|FG000|Glucose Tabs|Lost to Follow-up|1|||
125677853|NCT02660242|452109420|FG000|Glucagon Injection|Lost to Follow-up|1|||
125541717|NCT01871805|451612584|FG000|Phase II|Lost to Follow-up|0|||
125677854|NCT01345019|452109422|FG000|Blinded Treatment Phase|Death|147|||
125677855|NCT01345019|452109423|FG001|Blinded Treatment Phase|Death|137|||
125677856|NCT01345019|452109422|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
125677857|NCT01345019|452109423|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
125677858|NCT01345019|452109422|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
125344877|NCT04740905|450896452|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
125344878|NCT04740905|450896451|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
125344879|NCT04740905|450896452|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
125344880|NCT04740905|450896451|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
125344881|NCT04740905|450896452|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
125344882|NCT04740905|450896451|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
125344883|NCT04740905|450896452|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
125677859|NCT01345019|452109423|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
125677860|NCT01345019|452109422|FG000|Blinded Treatment Phase|Disease Progression|12|||
125677861|NCT01345019|452109423|FG001|Blinded Treatment Phase|Disease Progression|10|||
125677862|NCT01345019|452109422|FG000|Blinded Treatment Phase|Adverse Event|6|||
125677863|NCT01345019|452109423|FG001|Blinded Treatment Phase|Adverse Event|13|||
125677864|NCT01345019|452109422|FG000|Blinded Treatment Phase|Administrative Decision|10|||
125677865|NCT01345019|452109423|FG001|Blinded Treatment Phase|Administrative Decision|8|||
125677866|NCT01345019|452109422|FG000|Blinded Treatment Phase|Noncompliance|5|||
125677867|NCT01345019|452109423|FG001|Blinded Treatment Phase|Noncompliance|3|||
125677868|NCT01345019|452109422|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
125677869|NCT01345019|452109423|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
125677870|NCT01345019|452109422|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
125677871|NCT01345019|452109423|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
125677872|NCT01345019|452109422|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
125677873|NCT01345019|452109423|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
125677874|NCT01345019|452109422|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
125677875|NCT01345019|452109423|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
125677876|NCT01345019|452109422|FG000|Open Label Treatment Phase|Death|49|||
125677877|NCT01345019|452109423|FG001|Open Label Treatment Phase|Death|48|||
125541718|NCT01871805|451612585|FG001|Phase II|Lost to Follow-up|0|||
125541719|NCT01871805|451612586|FG002|Phase II|Lost to Follow-up|0|||
125541720|NCT01871805|451612587|FG003|Phase II|Lost to Follow-up|0|||
125541721|NCT01871805|451612588|FG004|Phase II|Lost to Follow-up|0|||
125541722|NCT01871805|451612589|FG005|Phase II|Lost to Follow-up|13|||
125541723|NCT03412747|451612592|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
125541724|NCT03412747|451612593|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
125344884|NCT04740905|450896451|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
125344885|NCT04740905|450896452|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
125344886|NCT04740905|450896451|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
125344887|NCT04740905|450896452|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
125344888|NCT04740905|450896451|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
125344889|NCT04740905|450896452|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
125344890|NCT04740905|450896451|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
125344891|NCT04740905|450896452|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
125344892|NCT04740905|450896451|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
125344893|NCT04740905|450896452|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
125344894|NCT04740905|450896451|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
125344895|NCT04740905|450896452|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
125344896|NCT04740905|450896451|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
125344897|NCT04740905|450896452|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
125344898|NCT04740905|450896451|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
125344899|NCT04740905|450896452|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
125344900|NCT02412488|450896457|FG000|Overall Study|Lost to Follow-up|10|||
125344901|NCT02412488|450896457|FG000|Overall Study|Withdrawal by Subject|5|||
125344902|NCT02412488|450896457|FG000|Overall Study|Physician Decision|1|||
125344903|NCT02412488|450896457|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
125344904|NCT02412488|450896457|FG000|Overall Study|Reveal LINQ explant|1|||
125344905|NCT01989468|450896458|FG000|Overall Study|Adverse Event|10|||
125344906|NCT01989468|450896459|FG001|Overall Study|Adverse Event|15|||
125344907|NCT01989468|450896460|FG002|Overall Study|Adverse Event|4|||
125344908|NCT01989468|450896461|FG003|Overall Study|Adverse Event|5|||
125344909|NCT01989468|450896462|FG004|Overall Study|Adverse Event|4|||
125344910|NCT01989468|450896458|FG000|Overall Study|Lack of Efficacy|11|||
125344911|NCT01989468|450896459|FG001|Overall Study|Lack of Efficacy|11|||
125344912|NCT01989468|450896460|FG002|Overall Study|Lack of Efficacy|7|||
125344913|NCT01989468|450896461|FG003|Overall Study|Lack of Efficacy|4|||
125344914|NCT01989468|450896462|FG004|Overall Study|Lack of Efficacy|2|||
125344915|NCT01989468|450896458|FG000|Overall Study|Lost to Follow-up|5|||
125344916|NCT01989468|450896459|FG001|Overall Study|Lost to Follow-up|2|||
125344917|NCT01989468|450896460|FG002|Overall Study|Lost to Follow-up|0|||
125541725|NCT03412747|451612594|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
125541726|NCT03412747|451612592|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
125541727|NCT03412747|451612593|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
125541728|NCT03412747|451612594|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
125677878|NCT01345019|452109422|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
125677879|NCT01345019|452109423|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
125677880|NCT01345019|452109422|FG000|Open Label Treatment Phase|Adverse Event|30|||
125677881|NCT01345019|452109423|FG001|Open Label Treatment Phase|Adverse Event|51|||
125677882|NCT01345019|452109422|FG000|Open Label Treatment Phase|Administrative Decision|30|||
125677883|NCT01345019|452109423|FG001|Open Label Treatment Phase|Administrative Decision|15|||
125677884|NCT01345019|452109422|FG000|Open Label Treatment Phase|Disease Progression|17|||
125677885|NCT01345019|452109423|FG001|Open Label Treatment Phase|Disease Progression|18|||
125677886|NCT01345019|452109422|FG000|Open Label Treatment Phase|Noncompliance|5|||
125677887|NCT01345019|452109423|FG001|Open Label Treatment Phase|Noncompliance|4|||
125677888|NCT01345019|452109422|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
125677889|NCT01345019|452109423|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
125677890|NCT01345019|452109422|FG000|Open Label Treatment Phase|Pregnancy|1|||
125677891|NCT01345019|452109423|FG001|Open Label Treatment Phase|Pregnancy|0|||
125677892|NCT01345019|452109422|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
125677893|NCT01345019|452109423|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
125677894|NCT01345019|452109422|FG000|Open Label Treatment Phase|Protocol Violation|0|||
125677895|NCT01345019|452109423|FG001|Open Label Treatment Phase|Protocol Violation|1|||
125677896|NCT00386009|452109426|FG000|Overall Study|Adverse Event|0|||
125677897|NCT00386009|452109427|FG001|Overall Study|Adverse Event|2|||
125344918|NCT01989468|450896461|FG003|Overall Study|Lost to Follow-up|1|||
125344919|NCT01989468|450896462|FG004|Overall Study|Lost to Follow-up|1|||
125344920|NCT01989468|450896458|FG000|Overall Study|Physician Decision|4|||
125677898|NCT00386009|452109426|FG000|Overall Study|Death|1|||
125677899|NCT00386009|452109427|FG001|Overall Study|Death|0|||
125344921|NCT01989468|450896459|FG001|Overall Study|Physician Decision|1|||
125344922|NCT01989468|450896460|FG002|Overall Study|Physician Decision|0|||
125541729|NCT03412747|451612592|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
125541730|NCT03412747|451612593|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
125541731|NCT03412747|451612594|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
125541732|NCT03412747|451612592|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
125541733|NCT03412747|451612593|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
125541734|NCT03412747|451612594|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
125541735|NCT03412747|451612592|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
125541736|NCT03412747|451612593|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
125541737|NCT03412747|451612594|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
125541738|NCT03412747|451612592|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
125541739|NCT03412747|451612593|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
125541740|NCT03412747|451612594|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
125344923|NCT01989468|450896461|FG003|Overall Study|Physician Decision|1|||
125344924|NCT01989468|450896462|FG004|Overall Study|Physician Decision|0|||
125541741|NCT03412747|451612592|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
125541742|NCT03412747|451612593|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
125541743|NCT03412747|451612594|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
125541744|NCT03412747|451612592|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
125541745|NCT03412747|451612593|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
125541746|NCT03412747|451612594|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
125541747|NCT03412747|451612592|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
125541748|NCT03412747|451612593|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
125541749|NCT03412747|451612594|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
125541750|NCT03412747|451612592|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
125541751|NCT03412747|451612593|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
125541752|NCT03412747|451612594|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
125541753|NCT03412747|451612592|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
125541754|NCT03412747|451612593|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
125541755|NCT03412747|451612594|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
125541756|NCT03412747|451612592|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
125541757|NCT03412747|451612593|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
125541758|NCT03412747|451612594|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
125541759|NCT03412747|451612592|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
125541760|NCT03412747|451612593|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
125541761|NCT03412747|451612594|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
125541762|NCT03412747|451612592|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
125541763|NCT03412747|451612593|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
125541764|NCT03412747|451612594|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
125541765|NCT03412747|451612592|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
125541766|NCT03412747|451612593|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
125541767|NCT03412747|451612594|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
125541768|NCT03412747|451612592|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
125541769|NCT03412747|451612593|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
125541770|NCT03412747|451612594|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
125541771|NCT00468104|451612595|FG000|First Intervention|Protocol Violation|2|||
125541772|NCT00468104|451612596|FG001|First Intervention|Protocol Violation|1|||
125541773|NCT00468104|451612595|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
125541774|NCT00468104|451612596|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
125541775|NCT00468104|451612595|FG000|First Intervention|died within 3 weeks|1|||
125677900|NCT00386009|452109426|FG000|Overall Study|Entry Criteria Not Met|0|||
125677901|NCT00386009|452109427|FG001|Overall Study|Entry Criteria Not Met|2|||
125677902|NCT00386009|452109426|FG000|Overall Study|Lost to Follow-up|1|||
125677903|NCT00386009|452109427|FG001|Overall Study|Lost to Follow-up|1|||
125677904|NCT00386009|452109426|FG000|Overall Study|Protocol Violation|1|||
125677905|NCT00386009|452109427|FG001|Overall Study|Protocol Violation|0|||
125677906|NCT00386009|452109426|FG000|Overall Study|Sponsor Decision|1|||
125677907|NCT00386009|452109427|FG001|Overall Study|Sponsor Decision|1|||
125677908|NCT00386009|452109426|FG000|Overall Study|Withdrawal by Subject|5|||
125677909|NCT00386009|452109427|FG001|Overall Study|Withdrawal by Subject|4|||
125677910|NCT01492400|452109429|FG000|Overall Study|Miscellaneous Reasons|2|||
125677911|NCT01492400|452109430|FG001|Overall Study|Miscellaneous Reasons|3|||
125677912|NCT01492400|452109429|FG000|Overall Study|Personal Reasons|0|||
125677913|NCT01492400|452109430|FG001|Overall Study|Personal Reasons|5|||
125677914|NCT01492400|452109429|FG000|Overall Study|Lost to Follow-up|3|||
125677915|NCT01492400|452109430|FG001|Overall Study|Lost to Follow-up|1|||
125677916|NCT01492400|452109429|FG000|Overall Study|Pregnancy|0|||
125677917|NCT01492400|452109430|FG001|Overall Study|Pregnancy|1|||
125677918|NCT01492400|452109429|FG000|Overall Study|Lack of Efficacy|1|||
125677919|NCT01492400|452109430|FG001|Overall Study|Lack of Efficacy|1|||
125677920|NCT01492400|452109429|FG000|Overall Study|Adverse Event|10|||
125677921|NCT01492400|452109430|FG001|Overall Study|Adverse Event|5|||
125677922|NCT00604500|452109431|FG000|Overall Study|Adverse Event|2|||
125677923|NCT00604500|452109431|FG000|Overall Study|Protocol Violation|2|||
125677924|NCT00604500|452109431|FG000|Overall Study|Treatment Failure|1|||
125677925|NCT00604500|452109431|FG000|Overall Study|Withdrawal by Subject|4|||
125677926|NCT00604500|452109431|FG000|Overall Study|Administrative|1|||
125677927|NCT00604500|452109431|FG000|Overall Study|Did not meet protocol eligibility|1|||
125677928|NCT00320112|452109433|FG000|Overall Study|Lost to Follow-up|3|||
125677929|NCT00320112|452109434|FG001|Overall Study|Lost to Follow-up|4|||
125677930|NCT00320112|452109433|FG000|Overall Study|Withdrawal by Subject|3|||
125677931|NCT00320112|452109434|FG001|Overall Study|Withdrawal by Subject|0|||
125677932|NCT00320112|452109433|FG000|Overall Study|Death|2|||
125677933|NCT00320112|452109434|FG001|Overall Study|Death|1|||
125677934|NCT02899338|452109435|FG000|Overall Study|Adverse Event|1|||
125677935|NCT02899338|452109436|FG001|Overall Study|Adverse Event|2|||
125541776|NCT00468104|451612596|FG001|First Intervention|died within 3 weeks|0|||
125541777|NCT00468104|451612595|FG000|First Intervention|malposition/blocked chest tube tube|2|||
125541778|NCT00468104|451612596|FG001|First Intervention|malposition/blocked chest tube tube|0|||
125541779|NCT00468104|451612595|FG000|First Intervention|large lung mass with minimal effusion|1|||
125541780|NCT00468104|451612596|FG001|First Intervention|large lung mass with minimal effusion|0|||
125541781|NCT00468104|451612595|FG000|First Intervention|associated prolonged pneumothorax|1|||
125541782|NCT00468104|451612596|FG001|First Intervention|associated prolonged pneumothorax|0|||
125541783|NCT00468104|451612595|FG000|First Intervention|trapped lung|1|||
125541784|NCT00468104|451612596|FG001|First Intervention|trapped lung|0|||
125541785|NCT00468104|451612595|FG000|Second Intervention|Withdrawal by Subject|5|||
125541786|NCT00468104|451612596|FG001|Second Intervention|Withdrawal by Subject|2|||
125541787|NCT00468104|451612595|FG000|Second Intervention|discarded for malposition of chest tube|0|||
125541788|NCT00468104|451612596|FG001|Second Intervention|discarded for malposition of chest tube|2|||
125541789|NCT00381615|451612599|FG000|Overall Study|Withdrawal by Subject|1|||
125541790|NCT00381615|451612600|FG001|Overall Study|Withdrawal by Subject|3|||
125541791|NCT00381615|451612601|FG002|Overall Study|Withdrawal by Subject|0|||
125541792|NCT00381615|451612602|FG003|Overall Study|Withdrawal by Subject|1|||
125541793|NCT00381615|451612599|FG000|Overall Study|Lost to Follow-up|3|||
125541794|NCT00381615|451612600|FG001|Overall Study|Lost to Follow-up|2|||
125541795|NCT00381615|451612601|FG002|Overall Study|Lost to Follow-up|0|||
125541796|NCT00381615|451612602|FG003|Overall Study|Lost to Follow-up|1|||
125541797|NCT00381615|451612599|FG000|Overall Study|Protocol Violation|0|||
125541798|NCT00381615|451612600|FG001|Overall Study|Protocol Violation|0|||
125541799|NCT00381615|451612601|FG002|Overall Study|Protocol Violation|1|||
125541800|NCT00381615|451612602|FG003|Overall Study|Protocol Violation|0|||
125541801|NCT00468559|451612608|FG000|Open-label Treatment Phase|Adverse Event|5|||
125541802|NCT00468559|451612609|FG001|Open-label Treatment Phase|Adverse Event|0|||
125541803|NCT00468559|451612610|FG002|Open-label Treatment Phase|Adverse Event|0|||
125541804|NCT00468559|451612608|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
125541805|NCT00468559|451612609|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
125541806|NCT00468559|451612610|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
125541807|NCT00468559|451612608|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
125541808|NCT00468559|451612609|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
125541809|NCT00468559|451612610|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
125541810|NCT00468559|451612608|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
125541811|NCT00468559|451612609|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
125541812|NCT00468559|451612610|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
125541813|NCT00468559|451612608|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
125541814|NCT00468559|451612609|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
125541815|NCT00468559|451612610|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
125541816|NCT00911768|451612612|FG000|Overall Study|Protocol Violation|5|||
125541817|NCT00911768|451612613|FG001|Overall Study|Protocol Violation|4|||
125541818|NCT00911768|451612612|FG000|Overall Study|Withdrawal by Subject|1|||
125541819|NCT00911768|451612613|FG001|Overall Study|Withdrawal by Subject|0|||
125541820|NCT03538301|451612616|FG000|Overall Study|Adverse Event|1|||
125541821|NCT03538301|451612617|FG001|Overall Study|Adverse Event|4|||
125541822|NCT03538301|451612618|FG002|Overall Study|Adverse Event|4|||
125541823|NCT03538301|451612616|FG000|Overall Study|Death|1|||
125541824|NCT03538301|451612617|FG001|Overall Study|Death|1|||
125541825|NCT03538301|451612618|FG002|Overall Study|Death|0|||
125541826|NCT03538301|451612616|FG000|Overall Study|Physician Decision|0|||
125541827|NCT03538301|451612617|FG001|Overall Study|Physician Decision|1|||
125541828|NCT03538301|451612618|FG002|Overall Study|Physician Decision|0|||
125541829|NCT03538301|451612616|FG000|Overall Study|Protocol Violation|0|||
125541830|NCT03538301|451612617|FG001|Overall Study|Protocol Violation|0|||
125541831|NCT03538301|451612618|FG002|Overall Study|Protocol Violation|1|||
125541832|NCT03538301|451612616|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
125677936|NCT02899338|452109435|FG000|Overall Study|Withdrawal by Subject|2|||
125677937|NCT02899338|452109436|FG001|Overall Study|Withdrawal by Subject|0|||
125677938|NCT02353169|452109437|FG000|Overall Study|QTc > 450 msec|1|||
125677939|NCT02353169|452109438|FG001|Overall Study|QTc > 450 msec|1|||
125677940|NCT02353169|452109439|FG002|Overall Study|QTc > 450 msec|1|||
125677941|NCT02353169|452109440|FG003|Overall Study|QTc > 450 msec|1|||
125677942|NCT02353169|452109437|FG000|Overall Study|OR team declined|2|||
125541833|NCT03538301|451612617|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
125541834|NCT03538301|451612618|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
125677943|NCT02353169|452109438|FG001|Overall Study|OR team declined|0|||
125677944|NCT02353169|452109439|FG002|Overall Study|OR team declined|0|||
125677945|NCT02353169|452109440|FG003|Overall Study|OR team declined|0|||
125541835|NCT02842151|451612621|FG000|Overall Study|Adverse Event|1|||
125541836|NCT02842151|451612621|FG000|Overall Study|Subject moved too far away|1|||
125541837|NCT01879553|451612622|FG000|Overall Study|Withdrawal by Subject|1|||
125541838|NCT01879553|451612623|FG001|Overall Study|Withdrawal by Subject|0|||
125541839|NCT02559895|451612625|FG000|Overall Study|Adverse Event|3|||
125541840|NCT02559895|451612626|FG001|Overall Study|Adverse Event|3|||
125541841|NCT02559895|451612627|FG002|Overall Study|Adverse Event|2|||
125541842|NCT02559895|451612628|FG003|Overall Study|Adverse Event|1|||
125541843|NCT02559895|451612625|FG000|Overall Study|Lack of Efficacy|2|||
125541844|NCT02559895|451612626|FG001|Overall Study|Lack of Efficacy|3|||
125541845|NCT02559895|451612627|FG002|Overall Study|Lack of Efficacy|2|||
125541846|NCT02559895|451612628|FG003|Overall Study|Lack of Efficacy|8|||
125541847|NCT02559895|451612625|FG000|Overall Study|Lost to Follow-up|22|||
125541848|NCT02559895|451612626|FG001|Overall Study|Lost to Follow-up|16|||
125541849|NCT02559895|451612627|FG002|Overall Study|Lost to Follow-up|12|||
125541850|NCT02559895|451612628|FG003|Overall Study|Lost to Follow-up|17|||
125541851|NCT02559895|451612625|FG000|Overall Study|Physician Decision|1|||
125541852|NCT02559895|451612626|FG001|Overall Study|Physician Decision|1|||
125541853|NCT02559895|451612627|FG002|Overall Study|Physician Decision|3|||
125541854|NCT02559895|451612628|FG003|Overall Study|Physician Decision|0|||
125541855|NCT02559895|451612625|FG000|Overall Study|Withdrawal by Subject|16|||
125541856|NCT02559895|451612626|FG001|Overall Study|Withdrawal by Subject|9|||
125541857|NCT02559895|451612627|FG002|Overall Study|Withdrawal by Subject|20|||
125541858|NCT02559895|451612628|FG003|Overall Study|Withdrawal by Subject|9|||
125541859|NCT02559895|451612625|FG000|Overall Study|Study Burden|10|||
125541860|NCT02559895|451612626|FG001|Overall Study|Study Burden|16|||
125541861|NCT02559895|451612627|FG002|Overall Study|Study Burden|12|||
125541862|NCT02559895|451612628|FG003|Overall Study|Study Burden|22|||
125541863|NCT02559895|451612625|FG000|Overall Study|Other|1|||
125541864|NCT02559895|451612626|FG001|Overall Study|Other|5|||
125541865|NCT02559895|451612627|FG002|Overall Study|Other|3|||
125541866|NCT02559895|451612628|FG003|Overall Study|Other|3|||
125541867|NCT04540887|451612634|FG000|Overall Study|Withdrawal by Subject|2|||
125541868|NCT01262027|451612635|FG000|Overall Study|Adverse Event|1|||
125541869|NCT01262027|451612635|FG000|Overall Study|Withdrawal by Subject|3|||
125541870|NCT01262027|451612635|FG000|Overall Study|Protocol Violation|1|||
125541871|NCT02665338|451612638|FG000|Overall Study|Withdrawal by Subject|0|||
125541872|NCT02665338|451612639|FG001|Overall Study|Withdrawal by Subject|1|||
125541873|NCT00589121|451612642|FG000|Overall Study|Protocol Violation|2|||
125541874|NCT00589121|451612643|FG001|Overall Study|Protocol Violation|6|||
125541875|NCT00589121|451612642|FG000|Overall Study|No protocol treatment received|0|||
125541876|NCT00589121|451612643|FG001|Overall Study|No protocol treatment received|1|||
125541877|NCT01758900|451612644|FG000|Overall Study|difficulty for further intubation|7|||
125541878|NCT01758900|451612645|FG001|Overall Study|difficulty for further intubation|8|||
125541879|NCT00935818|451612647|FG000|Overall Study|Withdrawal by Subject|45|||
125541880|NCT00935818|451612648|FG001|Overall Study|Withdrawal by Subject|50|||
125541881|NCT00935818|451612647|FG000|Overall Study|Lost to Follow-up|40|||
125541882|NCT00935818|451612648|FG001|Overall Study|Lost to Follow-up|42|||
125541883|NCT00935818|451612647|FG000|Overall Study|Adverse Event|6|||
125541884|NCT00935818|451612648|FG001|Overall Study|Adverse Event|7|||
125541885|NCT00935818|451612647|FG000|Overall Study|Physician Decision|0|||
125541886|NCT00935818|451612648|FG001|Overall Study|Physician Decision|1|||
125541887|NCT01892540|451612649|FG000|Overall Study|Did not complete PET/MRI|0|||
125541888|NCT01892540|451612650|FG001|Overall Study|Did not complete PET/MRI|0|||
125541889|NCT01892540|451612651|FG002|Overall Study|Did not complete PET/MRI|2|||
125541890|NCT01892540|451612649|FG000|Overall Study|Did not fit in scanner|0|||
125541891|NCT01892540|451612650|FG001|Overall Study|Did not fit in scanner|0|||
125541892|NCT01892540|451612651|FG002|Overall Study|Did not fit in scanner|1|||
125541893|NCT02317432|451612653|FG000|Overall Study|Death|4|||
125541894|NCT02317432|451612654|FG001|Overall Study|Death|1|||
125541895|NCT02317432|451612653|FG000|Overall Study|Lost to Follow-up|0|||
125541896|NCT02317432|451612654|FG001|Overall Study|Lost to Follow-up|5|||
125541897|NCT02317432|451612653|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
125541898|NCT02317432|451612654|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
125541899|NCT03992846|451612659|FG000|Overall Study|Adverse Event|8|||
125541900|NCT03992846|451612660|FG001|Overall Study|Adverse Event|6|||
125541901|NCT03992846|451612661|FG002|Overall Study|Adverse Event|3|||
125541902|NCT03992846|451612659|FG000|Overall Study|Lost to Follow-up|0|||
125541903|NCT03992846|451612660|FG001|Overall Study|Lost to Follow-up|1|||
125541904|NCT03992846|451612661|FG002|Overall Study|Lost to Follow-up|1|||
125541905|NCT03992846|451612659|FG000|Overall Study|Pregnancy|2|||
125541906|NCT03992846|451612660|FG001|Overall Study|Pregnancy|0|||
125541907|NCT03992846|451612661|FG002|Overall Study|Pregnancy|1|||
125541908|NCT03992846|451612659|FG000|Overall Study|Protocol Violation|1|||
125541909|NCT03992846|451612660|FG001|Overall Study|Protocol Violation|2|||
125541910|NCT03992846|451612661|FG002|Overall Study|Protocol Violation|0|||
125541911|NCT03992846|451612659|FG000|Overall Study|Withdrawal by Subject|8|||
125541912|NCT03992846|451612660|FG001|Overall Study|Withdrawal by Subject|10|||
125541913|NCT03992846|451612661|FG002|Overall Study|Withdrawal by Subject|20|||
125541914|NCT03992846|451612659|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
125541915|NCT03992846|451612660|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
125541916|NCT03992846|451612661|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
125541917|NCT00565851|451614131|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
125541918|NCT00565851|451614132|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
125541919|NCT00565851|451614133|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
125541920|NCT00565851|451614134|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
125541921|NCT00565851|451614135|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
125541922|NCT00565851|451614136|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
125541923|NCT00565851|451614137|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
125541924|NCT00565851|451614138|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
125541925|NCT00565851|451614131|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
125541926|NCT00565851|451614132|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
125541927|NCT00565851|451614133|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
125541928|NCT00565851|451614134|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
125541929|NCT00565851|451614135|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
125541930|NCT00565851|451614136|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
125541931|NCT00565851|451614137|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
125541932|NCT00565851|451614138|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
125541933|NCT00775463|451614139|FG000|Overall Study|Withdrawal by Subject|0|||
125541934|NCT00775463|451614140|FG001|Overall Study|Withdrawal by Subject|1|||
125541935|NCT00775463|451614139|FG000|Overall Study|Adverse Event|7|||
125541936|NCT00775463|451614140|FG001|Overall Study|Adverse Event|9|||
125541937|NCT00775463|451614139|FG000|Overall Study|Protocol Violation|2|||
125541938|NCT00775463|451614140|FG001|Overall Study|Protocol Violation|2|||
125541939|NCT00775463|451614139|FG000|Overall Study|Lost to Follow-up|1|||
125541940|NCT00775463|451614140|FG001|Overall Study|Lost to Follow-up|0|||
125541941|NCT00775463|451614139|FG000|Overall Study|Lack of Efficacy|1|||
125541942|NCT00775463|451614140|FG001|Overall Study|Lack of Efficacy|1|||
125541943|NCT03695237|451614141|FG000|Overall Study|Withdrawal by Subject|1|||
125541944|NCT03695237|451614142|FG001|Overall Study|Withdrawal by Subject|3|||
125541945|NCT03695237|451614141|FG000|Overall Study|Lost to Follow-up|1|||
125677946|NCT02353169|452109437|FG000|Overall Study|Inhalational induction|0|||
125677947|NCT02353169|452109438|FG001|Overall Study|Inhalational induction|2|||
125677948|NCT02353169|452109439|FG002|Overall Study|Inhalational induction|0|||
125677949|NCT02353169|452109440|FG003|Overall Study|Inhalational induction|0|||
125677950|NCT02353169|452109437|FG000|Overall Study|ECG data error|0|||
125677951|NCT02353169|452109438|FG001|Overall Study|ECG data error|3|||
125677952|NCT02353169|452109439|FG002|Overall Study|ECG data error|2|||
125677953|NCT02353169|452109440|FG003|Overall Study|ECG data error|2|||
125677954|NCT02353169|452109437|FG000|Overall Study|Pre-op medication|0|||
125677955|NCT02353169|452109438|FG001|Overall Study|Pre-op medication|0|||
125677956|NCT02353169|452109439|FG002|Overall Study|Pre-op medication|1|||
125677957|NCT02353169|452109440|FG003|Overall Study|Pre-op medication|0|||
125677958|NCT00906347|452109441|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
125677959|NCT00906347|452109442|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
125677960|NCT00906347|452109441|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
125677961|NCT00906347|452109442|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
125677962|NCT00906347|452109441|FG000|Received Study Drug|Refused study drug|1|||
125677963|NCT00906347|452109442|FG001|Received Study Drug|Refused study drug|0|||
125677964|NCT00906347|452109441|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
125677965|NCT00906347|452109442|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
125677966|NCT04591626|452109445|FG000|Overall Study|Adverse Event|4|||
125677967|NCT04591626|452109446|FG001|Overall Study|Adverse Event|0|||
125677968|NCT04591626|452109445|FG000|Overall Study|Withdrawal by Subject|5|||
125677969|NCT04591626|452109446|FG001|Overall Study|Withdrawal by Subject|3|||
125677970|NCT04591626|452109445|FG000|Overall Study|Physician Decision|0|||
125677971|NCT04591626|452109446|FG001|Overall Study|Physician Decision|1|||
125677972|NCT04591626|452109445|FG000|Overall Study|Death|0|||
125677973|NCT04591626|452109446|FG001|Overall Study|Death|1|||
125541946|NCT03695237|451614142|FG001|Overall Study|Lost to Follow-up|2|||
125541947|NCT03695237|451614141|FG000|Overall Study|Other, Not Specified|8|||
125541948|NCT03695237|451614142|FG001|Overall Study|Other, Not Specified|2|||
125541949|NCT01789567|451614145|FG000|Overall Study|Death|6|||
125677974|NCT04591626|452109445|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125677975|NCT04591626|452109446|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125677976|NCT02672553|452109447|FG000|Overall Study|Death|3|||
125677977|NCT02672553|452109448|FG001|Overall Study|Death|5|||
125677978|NCT02672553|452109447|FG000|Overall Study|Valve Explant|1|||
125677979|NCT02672553|452109448|FG001|Overall Study|Valve Explant|0|||
125677980|NCT02672553|452109447|FG000|Overall Study|Conversion to Commercial Valve|3|||
125677981|NCT02672553|452109448|FG001|Overall Study|Conversion to Commercial Valve|0|||
125677982|NCT02672553|452109447|FG000|Overall Study|Withdrawal by Subject|3|||
125677983|NCT02672553|452109448|FG001|Overall Study|Withdrawal by Subject|3|||
125541950|NCT00091169|451614146|FG000|Overall Study|Disease progression|3|||
125677984|NCT02672553|452109447|FG000|Overall Study|Intraoperative screen failure|2|||
125541951|NCT00091169|451614147|FG001|Overall Study|Disease progression|1|||
125541952|NCT00091169|451614146|FG000|Overall Study|Adverse Event|11|||
125541953|NCT00091169|451614147|FG001|Overall Study|Adverse Event|17|||
125541954|NCT00091169|451614146|FG000|Overall Study|Death|4|||
125541955|NCT00091169|451614147|FG001|Overall Study|Death|1|||
125541956|NCT00091169|451614146|FG000|Overall Study|Withdrawal by Subject|10|||
125541957|NCT00091169|451614147|FG001|Overall Study|Withdrawal by Subject|13|||
125541958|NCT00091169|451614146|FG000|Overall Study|Other|3|||
125541959|NCT00091169|451614147|FG001|Overall Study|Other|4|||
125541960|NCT00091169|451614146|FG000|Overall Study|Not start protocol therapy|26|||
125541961|NCT00091169|451614147|FG001|Overall Study|Not start protocol therapy|17|||
125541962|NCT00872989|451614148|FG000|Overall Study|Adverse Event|7|||
125541963|NCT00872989|451614149|FG001|Overall Study|Adverse Event|15|||
125541964|NCT00872989|451614148|FG000|Overall Study|Withdrawal by Subject|8|||
125541965|NCT00872989|451614149|FG001|Overall Study|Withdrawal by Subject|5|||
125541966|NCT00872989|451614148|FG000|Overall Study|Progression/relapse|47|||
125541967|NCT00872989|451614149|FG001|Overall Study|Progression/relapse|35|||
125541968|NCT00872989|451614148|FG000|Overall Study|Not protocol specified|3|||
125541969|NCT00872989|451614149|FG001|Overall Study|Not protocol specified|8|||
125541970|NCT02407990|451614150|FG000|Overall Study|Death|2|||
125541971|NCT02407990|451614151|FG001|Overall Study|Death|22|||
125541972|NCT02407990|451614152|FG002|Overall Study|Death|23|||
125541973|NCT02407990|451614153|FG003|Overall Study|Death|7|||
125541974|NCT02407990|451614154|FG004|Overall Study|Death|17|||
125541975|NCT02407990|451614155|FG005|Overall Study|Death|16|||
125541976|NCT02407990|451614156|FG006|Overall Study|Death|10|||
125541977|NCT02407990|451614157|FG007|Overall Study|Death|248|||
125541978|NCT02407990|451614150|FG000|Overall Study|Lost to Follow-up|0|||
125541979|NCT02407990|451614151|FG001|Overall Study|Lost to Follow-up|1|||
125541980|NCT02407990|451614152|FG002|Overall Study|Lost to Follow-up|0|||
125541981|NCT02407990|451614153|FG003|Overall Study|Lost to Follow-up|0|||
125541982|NCT02407990|451614154|FG004|Overall Study|Lost to Follow-up|0|||
125541983|NCT02407990|451614155|FG005|Overall Study|Lost to Follow-up|0|||
125541984|NCT02407990|451614156|FG006|Overall Study|Lost to Follow-up|0|||
125541985|NCT02407990|451614157|FG007|Overall Study|Lost to Follow-up|17|||
125541986|NCT02407990|451614150|FG000|Overall Study|Progressive Disease|0|||
125541987|NCT02407990|451614151|FG001|Overall Study|Progressive Disease|0|||
125541988|NCT02407990|451614152|FG002|Overall Study|Progressive Disease|0|||
125541989|NCT02407990|451614153|FG003|Overall Study|Progressive Disease|0|||
125541990|NCT02407990|451614154|FG004|Overall Study|Progressive Disease|0|||
125541991|NCT02407990|451614155|FG005|Overall Study|Progressive Disease|0|||
125541992|NCT02407990|451614156|FG006|Overall Study|Progressive Disease|0|||
125541993|NCT02407990|451614157|FG007|Overall Study|Progressive Disease|1|||
125541994|NCT02407990|451614150|FG000|Overall Study|Withdrawal by Subject|0|||
125541995|NCT02407990|451614151|FG001|Overall Study|Withdrawal by Subject|0|||
125541996|NCT02407990|451614152|FG002|Overall Study|Withdrawal by Subject|0|||
125541997|NCT02407990|451614153|FG003|Overall Study|Withdrawal by Subject|0|||
125541998|NCT02407990|451614154|FG004|Overall Study|Withdrawal by Subject|1|||
125541999|NCT02407990|451614155|FG005|Overall Study|Withdrawal by Subject|0|||
125542000|NCT02407990|451614156|FG006|Overall Study|Withdrawal by Subject|0|||
125542001|NCT02407990|451614157|FG007|Overall Study|Withdrawal by Subject|30|||
125542002|NCT02407990|451614150|FG000|Overall Study|Study Terminated by Sponsor|1|||
125542003|NCT02407990|451614151|FG001|Overall Study|Study Terminated by Sponsor|3|||
125542004|NCT02407990|451614152|FG002|Overall Study|Study Terminated by Sponsor|3|||
125542005|NCT02407990|451614153|FG003|Overall Study|Study Terminated by Sponsor|0|||
125542006|NCT02407990|451614154|FG004|Overall Study|Study Terminated by Sponsor|3|||
125542007|NCT02407990|451614155|FG005|Overall Study|Study Terminated by Sponsor|4|||
125542008|NCT02407990|451614156|FG006|Overall Study|Study Terminated by Sponsor|3|||
125542009|NCT02407990|451614157|FG007|Overall Study|Study Terminated by Sponsor|37|||
125677985|NCT02672553|452109448|FG001|Overall Study|Intraoperative screen failure|0|||
125677986|NCT00182091|452109451|FG000|Overall Study|Withdrawal by Subject|1|||
125677987|NCT00182091|452109452|FG001|Overall Study|Withdrawal by Subject|0|||
125677988|NCT00182091|452109453|FG002|Overall Study|Withdrawal by Subject|0|||
125677989|NCT00182091|452109454|FG003|Overall Study|Withdrawal by Subject|0|||
125677990|NCT00522457|452109458|FG000|Overall Study|Due to disease progression|16|||
125677991|NCT00522457|452109458|FG000|Overall Study|Adverse Event|2|||
125677992|NCT01691248|452109459|FG000|Overall Study|Protocol Violation|43|||
125677993|NCT01691248|452109460|FG001|Overall Study|Protocol Violation|27|||
125677994|NCT01691248|452109459|FG000|Overall Study|Adverse Event|24|||
125542010|NCT02407990|451614150|FG000|Overall Study|Logistics|0|||
125542011|NCT02407990|451614151|FG001|Overall Study|Logistics|0|||
125542012|NCT02407990|451614152|FG002|Overall Study|Logistics|0|||
125542013|NCT02407990|451614153|FG003|Overall Study|Logistics|0|||
125542014|NCT02407990|451614154|FG004|Overall Study|Logistics|0|||
125542015|NCT02407990|451614155|FG005|Overall Study|Logistics|0|||
125542016|NCT02407990|451614156|FG006|Overall Study|Logistics|0|||
125542017|NCT02407990|451614157|FG007|Overall Study|Logistics|1|||
125542018|NCT02407990|451614150|FG000|Overall Study|Rolled into long-term extension study|0|||
125542019|NCT02407990|451614151|FG001|Overall Study|Rolled into long-term extension study|0|||
125542020|NCT02407990|451614152|FG002|Overall Study|Rolled into long-term extension study|0|||
125677995|NCT01691248|452109460|FG001|Overall Study|Adverse Event|22|||
125677996|NCT01691248|452109459|FG000|Overall Study|Withdrawal by Subject|20|||
125542021|NCT02407990|451614153|FG003|Overall Study|Rolled into long-term extension study|0|||
125542022|NCT02407990|451614154|FG004|Overall Study|Rolled into long-term extension study|0|||
125542023|NCT02407990|451614155|FG005|Overall Study|Rolled into long-term extension study|0|||
125542024|NCT02407990|451614156|FG006|Overall Study|Rolled into long-term extension study|0|||
125542025|NCT02407990|451614157|FG007|Overall Study|Rolled into long-term extension study|1|||
125542026|NCT00734097|451614158|FG000|Screening|Protocol Violation|12|||
125542027|NCT00734097|451614158|FG000|Screening|Withdrawal by Subject|5|||
125542028|NCT00734097|451614158|FG000|Screening|Lost to Follow-up|2|||
125542029|NCT00734097|451614158|FG000|Screening|Unconfirmed pregnancy|1|||
125542030|NCT00734097|451614158|FG000|Open Label|Lost to Follow-up|7|||
125542031|NCT00734097|451614158|FG000|Open Label|Withdrawal by Subject|5|||
125542032|NCT00734097|451614158|FG000|Open Label|Protocol Violation|4|||
125542033|NCT02233543|451614165|FG000|Period 1|Withdrawal by Subject|1|||
125542034|NCT02233543|451614166|FG001|Period 1|Withdrawal by Subject|0|||
125542035|NCT02233543|451614165|FG000|Period 1|Participants required other treatment.|2|||
125542036|NCT02233543|451614166|FG001|Period 1|Participants required other treatment.|3|||
125542037|NCT02233543|451614165|FG000|Period 2|Adverse Event|1|||
125542038|NCT02233543|451614166|FG001|Period 2|Adverse Event|0|||
125542039|NCT02233543|451614165|FG000|Period 2|Participant required other treatment.|0|||
125542040|NCT02233543|451614166|FG001|Period 2|Participant required other treatment.|1|||
125542041|NCT02233543|451614165|FG000|Period 2|COPD exacerbation|1|||
125542042|NCT02233543|451614166|FG001|Period 2|COPD exacerbation|0|||
125542043|NCT00266227|451614167|FG000|Initial Treatment|Adverse Event|0|||
125542044|NCT00266227|451614168|FG001|Initial Treatment|Adverse Event|0|||
125542045|NCT00266227|451614169|FG002|Initial Treatment|Adverse Event|13|||
125542046|NCT00266227|451614167|FG000|Initial Treatment|Lost to Follow-up|0|||
125542047|NCT00266227|451614168|FG001|Initial Treatment|Lost to Follow-up|0|||
125542048|NCT00266227|451614169|FG002|Initial Treatment|Lost to Follow-up|6|||
125542049|NCT00266227|451614167|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
125542050|NCT00266227|451614168|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
125542051|NCT00266227|451614169|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
125542052|NCT00266227|451614167|FG000|Initial Treatment|Physician decision to withdraw|0|||
125542053|NCT00266227|451614168|FG001|Initial Treatment|Physician decision to withdraw|0|||
125542054|NCT00266227|451614169|FG002|Initial Treatment|Physician decision to withdraw|12|||
125542055|NCT00266227|451614167|FG000|Initial Treatment|Pregnancy|0|||
125542056|NCT00266227|451614168|FG001|Initial Treatment|Pregnancy|0|||
125542057|NCT00266227|451614169|FG002|Initial Treatment|Pregnancy|1|||
125542058|NCT00266227|451614167|FG000|Retreatment: Up to Week 48|Death|1|||
125677997|NCT01691248|452109460|FG001|Overall Study|Withdrawal by Subject|18|||
125542059|NCT00266227|451614168|FG001|Retreatment: Up to Week 48|Death|0|||
125677998|NCT01691248|452109459|FG000|Overall Study|Confirmed CDAD|14|||
125677999|NCT01691248|452109460|FG001|Overall Study|Confirmed CDAD|31|||
125678000|NCT01691248|452109459|FG000|Overall Study|Lost to Follow-up|2|||
125678001|NCT01691248|452109460|FG001|Overall Study|Lost to Follow-up|5|||
125678002|NCT01691248|452109459|FG000|Overall Study|Reason not provided|4|||
125678003|NCT01691248|452109460|FG001|Overall Study|Reason not provided|4|||
125678004|NCT01691248|452109459|FG000|Overall Study|Not Treated|4|||
125678005|NCT01691248|452109460|FG001|Overall Study|Not Treated|7|||
125678006|NCT02863575|452109461|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
125678007|NCT02863575|452109462|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
125678008|NCT02863575|452109463|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
125678009|NCT02863575|452109461|FG000|Overall Study|Withdrawal by Subject|0|||
125678010|NCT02863575|452109462|FG001|Overall Study|Withdrawal by Subject|1|||
125678011|NCT02863575|452109463|FG002|Overall Study|Withdrawal by Subject|1|||
125678012|NCT02863575|452109461|FG000|Overall Study|Adverse Event|0|||
125678013|NCT02863575|452109462|FG001|Overall Study|Adverse Event|1|||
125678014|NCT02863575|452109463|FG002|Overall Study|Adverse Event|0|||
125678015|NCT00993616|452109464|FG000|Overall Study|No tumor at entry|1|||
125678016|NCT00993616|452109464|FG000|Overall Study|Never treated|1|||
125678017|NCT02785913|452110715|FG000|Overall Study|Adverse Event|5|||
125678018|NCT02785913|452110715|FG000|Overall Study|Death|2|||
125542060|NCT00266227|451614169|FG002|Retreatment: Up to Week 48|Death|0|||
125542061|NCT00266227|451614167|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
125542062|NCT00266227|451614168|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
125542063|NCT00266227|451614169|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
125678019|NCT02785913|452110715|FG000|Overall Study|Progression|18|||
125678020|NCT02785913|452110715|FG000|Overall Study|Not protocol specified|1|||
125678021|NCT02841709|452110716|FG000|5th Intervention|Adverse Event|2|||
125542064|NCT00266227|451614167|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
125542065|NCT00266227|451614168|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
125542066|NCT00266227|451614169|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
125678022|NCT02841709|452110717|FG001|5th Intervention|Adverse Event|0|||
125678023|NCT02841709|452110718|FG002|5th Intervention|Adverse Event|0|||
125678024|NCT02841709|452110719|FG003|5th Intervention|Adverse Event|0|||
125678025|NCT02841709|452110720|FG004|5th Intervention|Adverse Event|2|||
125678026|NCT01210001|452110721|FG000|Overall Study|Not treated|1|||
125344925|NCT01989468|450896458|FG000|Overall Study|Pregnancy|0|||
125344926|NCT01989468|450896459|FG001|Overall Study|Pregnancy|1|||
125344927|NCT01989468|450896460|FG002|Overall Study|Pregnancy|0|||
125344928|NCT01989468|450896461|FG003|Overall Study|Pregnancy|0|||
125344929|NCT01989468|450896462|FG004|Overall Study|Pregnancy|0|||
125344930|NCT01989468|450896458|FG000|Overall Study|Technical Problems|3|||
125344931|NCT01989468|450896459|FG001|Overall Study|Technical Problems|1|||
125344932|NCT01989468|450896460|FG002|Overall Study|Technical Problems|3|||
125344933|NCT01989468|450896461|FG003|Overall Study|Technical Problems|1|||
125542067|NCT00266227|451614167|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
125542068|NCT00266227|451614168|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
125542069|NCT00266227|451614169|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
125542070|NCT00266227|451614167|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
125542071|NCT00266227|451614168|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
125542072|NCT00266227|451614169|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
125542073|NCT00266227|451614167|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
125542074|NCT00266227|451614168|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
125542075|NCT00266227|451614169|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
125542076|NCT00266227|451614167|FG000|Retreatment: Week 48 to Week 72|Death|1|||
125542077|NCT00266227|451614168|FG001|Retreatment: Week 48 to Week 72|Death|1|||
125542078|NCT00266227|451614169|FG002|Retreatment: Week 48 to Week 72|Death|0|||
125542079|NCT00266227|451614167|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
125542080|NCT00266227|451614168|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
125542081|NCT00266227|451614169|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
125542082|NCT00266227|451614167|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
125542083|NCT00266227|451614168|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
125542084|NCT00266227|451614169|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
125542085|NCT00266227|451614167|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
125542086|NCT00266227|451614168|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
125542087|NCT00266227|451614169|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
125542088|NCT00266227|451614167|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
125542089|NCT00266227|451614168|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
125542090|NCT00266227|451614169|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
125542091|NCT03573583|451614170|FG000|Overall Study|Lost to Follow-up|1|||
125542092|NCT03573583|451614171|FG001|Overall Study|Lost to Follow-up|0|||
125542093|NCT03573583|451614170|FG000|Overall Study|Withdrawal by Subject|1|||
125542094|NCT03573583|451614171|FG001|Overall Study|Withdrawal by Subject|1|||
125542095|NCT03730480|451614176|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
125542096|NCT01227577|451614177|FG000|Overall Study|Protocol deviation|3|||
125542097|NCT01227577|451614177|FG000|Overall Study|Death|3|||
125542098|NCT01227577|451614177|FG000|Overall Study|Administrative problems|2|||
125542099|NCT01227577|451614177|FG000|Overall Study|Lost to Follow-up|1|||
125542100|NCT01227577|451614177|FG000|Overall Study|Withdrawal by Subject|4|||
125542101|NCT01227577|451614177|FG000|Overall Study|Lack of Efficacy|5|||
125542102|NCT01227577|451614177|FG000|Overall Study|Adverse Event|17|||
125542103|NCT00852540|451614178|FG000|Overall Study|Adverse Event|10|||
125542104|NCT00852540|451614179|FG001|Overall Study|Adverse Event|3|||
125542105|NCT00852540|451614178|FG000|Overall Study|Lack of Efficacy|15|||
125542106|NCT00852540|451614179|FG001|Overall Study|Lack of Efficacy|3|||
125542107|NCT00852540|451614178|FG000|Overall Study|Protocol Violation|1|||
125542108|NCT00852540|451614179|FG001|Overall Study|Protocol Violation|2|||
125542109|NCT00852540|451614178|FG000|Overall Study|Lost to Follow-up|2|||
125542110|NCT00852540|451614179|FG001|Overall Study|Lost to Follow-up|3|||
125542111|NCT00852540|451614178|FG000|Overall Study|Investigator Discretion|2|||
125542112|NCT00852540|451614179|FG001|Overall Study|Investigator Discretion|3|||
125542113|NCT00852540|451614178|FG000|Overall Study|Withdrawal by Subject|3|||
125542114|NCT00852540|451614179|FG001|Overall Study|Withdrawal by Subject|1|||
125542115|NCT00852540|451614178|FG000|Overall Study|Did Not Receive Study Drug|3|||
125542116|NCT00852540|451614179|FG001|Overall Study|Did Not Receive Study Drug|3|||
125542117|NCT01639495|451614180|FG000|Overall Study|Lost to Follow-up|6|||
125542118|NCT01639495|451614180|FG000|Overall Study|Consented but didn't have study catheter|4|||
125542119|NCT01639495|451614180|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
125542120|NCT01639495|451614180|FG000|Overall Study|No radiofrequency energy applied|2|||
125542121|NCT01183234|451614181|FG000|First Intervention|Adverse Event|1|||
125542122|NCT01183234|451614182|FG001|First Intervention|Adverse Event|0|||
125542123|NCT00037830|451614185|FG000|Overall Study|Adverse Event|2|||
125542124|NCT00037830|451614186|FG001|Overall Study|Adverse Event|0|||
125542125|NCT00037830|451614187|FG002|Overall Study|Adverse Event|0|||
125542126|NCT00037830|451614185|FG000|Overall Study|Withdrawal by Subject|4|||
125542127|NCT00037830|451614186|FG001|Overall Study|Withdrawal by Subject|5|||
125542128|NCT00037830|451614187|FG002|Overall Study|Withdrawal by Subject|1|||
125542129|NCT00037830|451614185|FG000|Overall Study|Protocol Violation|2|||
125542130|NCT00037830|451614186|FG001|Overall Study|Protocol Violation|2|||
125542131|NCT00037830|451614187|FG002|Overall Study|Protocol Violation|0|||
125542132|NCT00037830|451614185|FG000|Overall Study|Unrelated Medical Problem|2|||
125542133|NCT00037830|451614186|FG001|Overall Study|Unrelated Medical Problem|0|||
125542134|NCT00037830|451614187|FG002|Overall Study|Unrelated Medical Problem|0|||
125542135|NCT01639560|451614191|FG000|Overall Study|Withdrawal by Subject|9|||
125542136|NCT01639560|451614192|FG001|Overall Study|Withdrawal by Subject|14|||
125344934|NCT01989468|450896462|FG004|Overall Study|Technical Problems|0|||
125542137|NCT01639560|451614191|FG000|Overall Study|Lack of Efficacy|1|||
125542138|NCT01639560|451614192|FG001|Overall Study|Lack of Efficacy|2|||
125542139|NCT01639560|451614191|FG000|Overall Study|Lost to Follow-up|9|||
125542140|NCT01639560|451614192|FG001|Overall Study|Lost to Follow-up|11|||
125542141|NCT01639560|451614191|FG000|Overall Study|Adverse Event|0|||
125542142|NCT01639560|451614192|FG001|Overall Study|Adverse Event|2|||
125542143|NCT01004848|451614193|FG000|Overall Study|Lost to Follow-up|55|||
125542144|NCT01004848|451614194|FG001|Overall Study|Lost to Follow-up|45|||
125542145|NCT01160289|451614195|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
125542146|NCT01160289|451614196|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
125542147|NCT01160289|451614197|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
125542148|NCT01160289|451614198|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
125542149|NCT01160289|451614199|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
125542150|NCT01160289|451614200|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
125542151|NCT01160289|451614195|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
125542152|NCT01160289|451614196|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
125542153|NCT01160289|451614197|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
125542154|NCT01160289|451614198|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
125542155|NCT01160289|451614199|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
125542156|NCT01160289|451614200|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
125542157|NCT01160289|451614195|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
125542158|NCT01160289|451614196|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
125542159|NCT01160289|451614197|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
125542160|NCT01160289|451614198|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
125542161|NCT01160289|451614199|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
125542162|NCT01160289|451614200|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
125542163|NCT01160289|451614195|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
125542164|NCT01160289|451614196|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
125542165|NCT01160289|451614197|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
125542166|NCT01160289|451614198|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
125542167|NCT01160289|451614199|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
125542168|NCT01160289|451614200|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
125542169|NCT01160289|451614195|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
125542170|NCT01160289|451614196|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
125344935|NCT01989468|450896458|FG000|Overall Study|Subject Guardian Decision|11|||
125344936|NCT01989468|450896459|FG001|Overall Study|Subject Guardian Decision|6|||
125344937|NCT01989468|450896460|FG002|Overall Study|Subject Guardian Decision|4|||
125542171|NCT01160289|451614197|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
125542172|NCT01160289|451614198|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
125542173|NCT01160289|451614199|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
125542174|NCT01160289|451614200|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
125542175|NCT01160289|451614195|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
125542176|NCT01160289|451614196|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
125542177|NCT01160289|451614197|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
125542178|NCT01160289|451614198|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
125542179|NCT01160289|451614199|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
125542180|NCT01160289|451614200|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
125678027|NCT01210001|452110722|FG001|Overall Study|Not treated|0|||
125678028|NCT01210001|452110723|FG002|Overall Study|Not treated|0|||
125678029|NCT01210001|452110721|FG000|Overall Study|Adverse Event|4|||
125678030|NCT01210001|452110722|FG001|Overall Study|Adverse Event|2|||
125678031|NCT01210001|452110723|FG002|Overall Study|Adverse Event|5|||
125678032|NCT01210001|452110721|FG000|Overall Study|Non compliant with protocol|2|||
125678033|NCT01210001|452110722|FG001|Overall Study|Non compliant with protocol|2|||
125678034|NCT01210001|452110723|FG002|Overall Study|Non compliant with protocol|3|||
125678035|NCT01210001|452110721|FG000|Overall Study|Lost to Follow-up|4|||
125678036|NCT01210001|452110722|FG001|Overall Study|Lost to Follow-up|3|||
125678037|NCT01210001|452110723|FG002|Overall Study|Lost to Follow-up|2|||
125678038|NCT01210001|452110721|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
125678039|NCT01210001|452110722|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
125678040|NCT01210001|452110723|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
125678041|NCT01210001|452110721|FG000|Overall Study|Other reason not defined above|2|||
125678042|NCT01210001|452110722|FG001|Overall Study|Other reason not defined above|2|||
125678043|NCT01210001|452110723|FG002|Overall Study|Other reason not defined above|1|||
125678044|NCT00788125|452110724|FG000|Overall Study|Death|6|||
125678045|NCT05346055|452110734|FG000|Overall Study|Withdrawal by Subject|1|||
125678046|NCT05346055|452110734|FG000|Overall Study|Protocol Violation|1|||
125678047|NCT05346055|452110734|FG000|Overall Study|Therapist decision|1|||
125678048|NCT02319148|452110742|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
125678049|NCT02319148|452110743|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
125678050|NCT02319148|452110744|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
125678051|NCT02319148|452110745|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
125678052|NCT02319148|452110742|FG000|Second Intervention Period|No longer willing to participate|0|||
125678053|NCT02319148|452110743|FG001|Second Intervention Period|No longer willing to participate|1|||
125678054|NCT02319148|452110744|FG002|Second Intervention Period|No longer willing to participate|0|||
125678055|NCT02319148|452110745|FG003|Second Intervention Period|No longer willing to participate|0|||
125678056|NCT02319148|452110742|FG000|Second Intervention Period|Other|0|||
125678057|NCT02319148|452110743|FG001|Second Intervention Period|Other|0|||
125678058|NCT02319148|452110744|FG002|Second Intervention Period|Other|0|||
125678059|NCT02319148|452110745|FG003|Second Intervention Period|Other|1|||
125678060|NCT02388763|452110748|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
125678061|NCT02388763|452110749|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
125678062|NCT02388763|452110748|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
125678063|NCT02388763|452110749|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
125678064|NCT01153984|452110750|FG000|Overall Study|Withdrawal by Subject|1|||
125678065|NCT01153984|452110750|FG000|Overall Study|Adverse Event|1|||
125678066|NCT02460159|452110751|FG000|Overall Study|Adverse Event|4|||
125678067|NCT02460159|452110752|FG001|Overall Study|Adverse Event|1|||
125678068|NCT02460159|452110751|FG000|Overall Study|Withdrawal by Subject|2|||
125678069|NCT02460159|452110752|FG001|Overall Study|Withdrawal by Subject|0|||
125678070|NCT02194998|452110759|FG000|On-HCV Treatment|Did not pick up study medication|0|||
125678071|NCT02194998|452110760|FG001|On-HCV Treatment|Did not pick up study medication|1|||
125678072|NCT02194998|452110761|FG002|On-HCV Treatment|Did not pick up study medication|0|||
125678073|NCT02194998|452110762|FG003|On-HCV Treatment|Did not pick up study medication|0|||
125678074|NCT02194998|452110759|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
125678075|NCT02194998|452110760|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
125678076|NCT02194998|452110761|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
125678077|NCT02194998|452110762|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
125678078|NCT01458405|452110765|FG000|Phase 1 (up to 12 Months)|Other|0|||
125678079|NCT01458405|452110766|FG001|Phase 1 (up to 12 Months)|Other|1|||
125678080|NCT01458405|452110767|FG002|Phase 1 (up to 12 Months)|Other|0|||
125678081|NCT01458405|452110768|FG003|Phase 1 (up to 12 Months)|Other|0|||
125678082|NCT01458405|452110765|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
125678083|NCT01458405|452110766|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
125678084|NCT01458405|452110767|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
125678085|NCT01458405|452110768|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
125678086|NCT01458405|452110765|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
125678087|NCT01458405|452110766|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
125678088|NCT01458405|452110767|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
125678089|NCT01458405|452110768|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
125678090|NCT01458405|452110765|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
125678091|NCT01458405|452110766|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
125678092|NCT01458405|452110767|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
125678093|NCT01458405|452110768|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
125678094|NCT02497781|452110769|FG000|Overall Study|Withdrawal by Subject|2|||
125678095|NCT02497781|452110770|FG001|Overall Study|Withdrawal by Subject|0|||
125678096|NCT02497781|452110769|FG000|Overall Study|Lack of Efficacy|0|||
125678097|NCT02497781|452110770|FG001|Overall Study|Lack of Efficacy|1|||
125678098|NCT02497781|452110769|FG000|Overall Study|Randomised but not treated|1|||
125678099|NCT02497781|452110770|FG001|Overall Study|Randomised but not treated|1|||
125678100|NCT02497781|452110769|FG000|Overall Study|Lost to Follow-up|1|||
125678101|NCT02497781|452110770|FG001|Overall Study|Lost to Follow-up|1|||
125678102|NCT02236130|452110771|FG000|Overall Study|Lost to Follow-up|7|||
125678103|NCT02236130|452110772|FG001|Overall Study|Lost to Follow-up|12|||
125678104|NCT00454636|452110773|FG000|Overall Study|Adverse Event|10|||
125678105|NCT00454636|452110774|FG001|Overall Study|Adverse Event|6|||
125678106|NCT00454636|452110775|FG002|Overall Study|Adverse Event|9|||
125678107|NCT00454636|452110776|FG003|Overall Study|Adverse Event|15|||
125678108|NCT00454636|452110773|FG000|Overall Study|Disease Progression|11|||
125678109|NCT00454636|452110774|FG001|Overall Study|Disease Progression|12|||
125678110|NCT00454636|452110775|FG002|Overall Study|Disease Progression|4|||
125678111|NCT00454636|452110776|FG003|Overall Study|Disease Progression|11|||
125678112|NCT00454636|452110773|FG000|Overall Study|Protocol Violation|3|||
125678113|NCT00454636|452110774|FG001|Overall Study|Protocol Violation|2|||
125678114|NCT00454636|452110775|FG002|Overall Study|Protocol Violation|3|||
125678115|NCT00454636|452110776|FG003|Overall Study|Protocol Violation|3|||
125678116|NCT00454636|452110773|FG000|Overall Study|Death|6|||
125678117|NCT00454636|452110774|FG001|Overall Study|Death|1|||
125678118|NCT00454636|452110775|FG002|Overall Study|Death|1|||
125678119|NCT00454636|452110776|FG003|Overall Study|Death|1|||
125678120|NCT00454636|452110773|FG000|Overall Study|Patient refusal|1|||
125678121|NCT00454636|452110774|FG001|Overall Study|Patient refusal|1|||
125344938|NCT01989468|450896461|FG003|Overall Study|Subject Guardian Decision|4|||
125542181|NCT01160289|451614195|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
125542182|NCT01160289|451614196|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
125542183|NCT01160289|451614197|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
125542184|NCT01160289|451614198|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
125542185|NCT01160289|451614199|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
125542186|NCT01160289|451614200|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
125542187|NCT01160289|451614195|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
125542188|NCT01160289|451614196|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
125678122|NCT00454636|452110775|FG002|Overall Study|Patient refusal|3|||
125678123|NCT00454636|452110776|FG003|Overall Study|Patient refusal|2|||
125678124|NCT00454636|452110773|FG000|Overall Study|Lost to Follow-up|0|||
125678125|NCT00454636|452110774|FG001|Overall Study|Lost to Follow-up|1|||
125678126|NCT00454636|452110775|FG002|Overall Study|Lost to Follow-up|0|||
125678127|NCT00454636|452110776|FG003|Overall Study|Lost to Follow-up|0|||
125678128|NCT01400113|452110777|FG000|Overall Study|Withdrawal by Subject|1|||
125678129|NCT01400113|452110778|FG001|Overall Study|Withdrawal by Subject|1|||
125678130|NCT01025037|452110783|FG000|Overall Study|Adverse Event|3|||
125678131|NCT01025037|452110783|FG000|Overall Study|Lost to Follow-up|7|||
125678132|NCT01025037|452110783|FG000|Overall Study|Withdrawal by Subject|1|||
125678133|NCT01890915|452110785|FG000|Overall Study|Adverse Event|1|||
125678134|NCT01890915|452110786|FG001|Overall Study|Adverse Event|0|||
125678135|NCT01890915|452110785|FG000|Overall Study|Protocol Violation|2|||
125678136|NCT01890915|452110786|FG001|Overall Study|Protocol Violation|0|||
125678137|NCT01890915|452110785|FG000|Overall Study|Equipment Malfunction|0|||
125678138|NCT01890915|452110786|FG001|Overall Study|Equipment Malfunction|1|||
125678139|NCT02114697|452110787|FG000|Overall Study|Study terminated|5|||
125678140|NCT02114697|452110788|FG001|Overall Study|Study terminated|4|||
125678141|NCT00424489|452110789|FG000|Overall Study|Death|3|||
125678142|NCT00860405|452110802|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
125678143|NCT00860405|452110803|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
125678144|NCT02465567|452110804|FG000|Overall Study|Adverse Event|118|||
125678145|NCT02465567|452110805|FG001|Overall Study|Adverse Event|113|||
125678146|NCT02465567|452110806|FG002|Overall Study|Adverse Event|147|||
125678147|NCT02465567|452110807|FG003|Overall Study|Adverse Event|138|||
125678148|NCT02465567|452110804|FG000|Overall Study|Lack of Efficacy|103|||
125678149|NCT02465567|452110805|FG001|Overall Study|Lack of Efficacy|102|||
125678150|NCT02465567|452110806|FG002|Overall Study|Lack of Efficacy|171|||
125678151|NCT02465567|452110807|FG003|Overall Study|Lack of Efficacy|135|||
125678152|NCT02465567|452110804|FG000|Overall Study|Withdrawal by Subject|104|||
125678153|NCT02465567|452110805|FG001|Overall Study|Withdrawal by Subject|94|||
125678154|NCT02465567|452110806|FG002|Overall Study|Withdrawal by Subject|123|||
125678155|NCT02465567|452110807|FG003|Overall Study|Withdrawal by Subject|130|||
125678156|NCT02465567|452110804|FG000|Overall Study|Physician Decision|23|||
125678157|NCT02465567|452110805|FG001|Overall Study|Physician Decision|33|||
125678158|NCT02465567|452110806|FG002|Overall Study|Physician Decision|38|||
125678159|NCT02465567|452110807|FG003|Overall Study|Physician Decision|28|||
125678160|NCT02465567|452110804|FG000|Overall Study|Major Protocol Deviation|24|||
125678161|NCT02465567|452110805|FG001|Overall Study|Major Protocol Deviation|26|||
125678162|NCT02465567|452110806|FG002|Overall Study|Major Protocol Deviation|22|||
125678163|NCT02465567|452110807|FG003|Overall Study|Major Protocol Deviation|25|||
125678164|NCT02465567|452110804|FG000|Overall Study|Lost to Follow-up|25|||
125678165|NCT02465567|452110805|FG001|Overall Study|Lost to Follow-up|21|||
125678166|NCT02465567|452110806|FG002|Overall Study|Lost to Follow-up|19|||
125678167|NCT02465567|452110807|FG003|Overall Study|Lost to Follow-up|15|||
125678168|NCT02465567|452110804|FG000|Overall Study|Protocol Specified Criteria|20|||
125678169|NCT02465567|452110805|FG001|Overall Study|Protocol Specified Criteria|10|||
125678170|NCT02465567|452110806|FG002|Overall Study|Protocol Specified Criteria|9|||
125678171|NCT02465567|452110807|FG003|Overall Study|Protocol Specified Criteria|12|||
125678172|NCT02465567|452110804|FG000|Overall Study|Administrative Reasons|12|||
125678173|NCT02465567|452110805|FG001|Overall Study|Administrative Reasons|9|||
125678174|NCT02465567|452110806|FG002|Overall Study|Administrative Reasons|11|||
125678175|NCT02465567|452110807|FG003|Overall Study|Administrative Reasons|5|||
125678176|NCT02465567|452110804|FG000|Overall Study|Randomized but not treated|1|||
125678177|NCT02465567|452110805|FG001|Overall Study|Randomized but not treated|5|||
125678178|NCT02465567|452110806|FG002|Overall Study|Randomized but not treated|4|||
125678179|NCT02465567|452110807|FG003|Overall Study|Randomized but not treated|5|||
125678180|NCT02465567|452110804|FG000|Overall Study|enrolled in >1 studies|18|||
125678181|NCT02465567|452110805|FG001|Overall Study|enrolled in >1 studies|11|||
125678182|NCT02465567|452110806|FG002|Overall Study|enrolled in >1 studies|19|||
125678183|NCT02465567|452110807|FG003|Overall Study|enrolled in >1 studies|15|||
125678184|NCT02465567|452110804|FG000|Overall Study|missing PI Signature|1|||
125678185|NCT02465567|452110805|FG001|Overall Study|missing PI Signature|0|||
125678186|NCT02465567|452110806|FG002|Overall Study|missing PI Signature|0|||
125678187|NCT02465567|452110807|FG003|Overall Study|missing PI Signature|0|||
125678188|NCT00497796|452110810|FG000|Overall Study|Adverse event (not related)|9|||
125542189|NCT01160289|451614197|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
125542190|NCT01160289|451614198|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
125542191|NCT01160289|451614199|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
125542192|NCT01160289|451614200|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
125542193|NCT01160289|451614195|FG000|Post-Randomization Period|Adverse Event|0|||
125542194|NCT01160289|451614196|FG001|Post-Randomization Period|Adverse Event|4|||
125542195|NCT01160289|451614197|FG002|Post-Randomization Period|Adverse Event|4|||
125542196|NCT01160289|451614198|FG003|Post-Randomization Period|Adverse Event|2|||
125542197|NCT01160289|451614199|FG004|Post-Randomization Period|Adverse Event|0|||
125542198|NCT01160289|451614200|FG005|Post-Randomization Period|Adverse Event|0|||
125542199|NCT01160289|451614195|FG000|Post-Randomization Period|Death|0|||
125542200|NCT01160289|451614196|FG001|Post-Randomization Period|Death|0|||
125542201|NCT01160289|451614197|FG002|Post-Randomization Period|Death|0|||
125542202|NCT01160289|451614198|FG003|Post-Randomization Period|Death|1|||
125542203|NCT01160289|451614199|FG004|Post-Randomization Period|Death|0|||
125542204|NCT01160289|451614200|FG005|Post-Randomization Period|Death|0|||
125542205|NCT01160289|451614195|FG000|Post-Randomization Period|Lack of Efficacy|0|||
125542206|NCT01160289|451614196|FG001|Post-Randomization Period|Lack of Efficacy|1|||
125542207|NCT01160289|451614197|FG002|Post-Randomization Period|Lack of Efficacy|0|||
125542208|NCT01160289|451614198|FG003|Post-Randomization Period|Lack of Efficacy|3|||
125542209|NCT01160289|451614199|FG004|Post-Randomization Period|Lack of Efficacy|0|||
125542210|NCT01160289|451614200|FG005|Post-Randomization Period|Lack of Efficacy|0|||
125542211|NCT01160289|451614195|FG000|Post-Randomization Period|Lost to Follow-up|0|||
125542212|NCT01160289|451614196|FG001|Post-Randomization Period|Lost to Follow-up|3|||
125542213|NCT01160289|451614197|FG002|Post-Randomization Period|Lost to Follow-up|2|||
125542214|NCT01160289|451614198|FG003|Post-Randomization Period|Lost to Follow-up|5|||
125542215|NCT01160289|451614199|FG004|Post-Randomization Period|Lost to Follow-up|3|||
125542216|NCT01160289|451614200|FG005|Post-Randomization Period|Lost to Follow-up|4|||
125542217|NCT01160289|451614195|FG000|Post-Randomization Period|Physician Decision|0|||
125542218|NCT01160289|451614196|FG001|Post-Randomization Period|Physician Decision|0|||
125542219|NCT01160289|451614197|FG002|Post-Randomization Period|Physician Decision|1|||
125542220|NCT01160289|451614198|FG003|Post-Randomization Period|Physician Decision|0|||
125542221|NCT01160289|451614199|FG004|Post-Randomization Period|Physician Decision|0|||
125542222|NCT01160289|451614200|FG005|Post-Randomization Period|Physician Decision|0|||
125542223|NCT01160289|451614195|FG000|Post-Randomization Period|Protocol Violation|0|||
125542224|NCT01160289|451614196|FG001|Post-Randomization Period|Protocol Violation|4|||
125542225|NCT01160289|451614197|FG002|Post-Randomization Period|Protocol Violation|2|||
125542226|NCT01160289|451614198|FG003|Post-Randomization Period|Protocol Violation|0|||
125542227|NCT01160289|451614199|FG004|Post-Randomization Period|Protocol Violation|1|||
125542228|NCT01160289|451614200|FG005|Post-Randomization Period|Protocol Violation|3|||
125542229|NCT01160289|451614195|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
125542230|NCT01160289|451614196|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
125542231|NCT01160289|451614197|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
125542232|NCT01160289|451614198|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
125542233|NCT01160289|451614199|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
125542234|NCT01160289|451614200|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
125542235|NCT01160289|451614195|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
125542236|NCT01160289|451614196|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
125542237|NCT01160289|451614197|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
125542238|NCT01160289|451614198|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
125542239|NCT01160289|451614199|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
125542240|NCT01160289|451614200|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
125542241|NCT01160289|451614195|FG000|Post-Randomization Period|Sponsor Decision|0|||
125542242|NCT01160289|451614196|FG001|Post-Randomization Period|Sponsor Decision|1|||
125542243|NCT01160289|451614197|FG002|Post-Randomization Period|Sponsor Decision|0|||
125542244|NCT01160289|451614198|FG003|Post-Randomization Period|Sponsor Decision|0|||
125542245|NCT01160289|451614199|FG004|Post-Randomization Period|Sponsor Decision|0|||
125542246|NCT01160289|451614200|FG005|Post-Randomization Period|Sponsor Decision|0|||
125678189|NCT00497796|452110811|FG001|Overall Study|Adverse event (not related)|9|||
125678190|NCT00497796|452110810|FG000|Overall Study|Adverse event (related)|5|||
125542247|NCT03292432|451614204|FG000|Overall Study|Lost to Follow-up|11|||
125542248|NCT03292432|451614205|FG001|Overall Study|Lost to Follow-up|8|||
125542249|NCT03292432|451614204|FG000|Overall Study|Death|2|||
125542250|NCT03292432|451614205|FG001|Overall Study|Death|1|||
125542251|NCT03292432|451614204|FG000|Overall Study|Withdrawal by Subject|1|||
125542252|NCT03292432|451614205|FG001|Overall Study|Withdrawal by Subject|2|||
125542253|NCT03292432|451614204|FG000|Overall Study|Site closed before any data collected|1|||
125542254|NCT03292432|451614205|FG001|Overall Study|Site closed before any data collected|0|||
125542255|NCT01156792|451614210|FG000|Overall Study|Adverse Event|1|||
125542256|NCT01156792|451614210|FG000|Overall Study|Lack of Efficacy|36|||
125542257|NCT01156792|451614210|FG000|Overall Study|Protocol Violation|6|||
125542258|NCT01156792|451614210|FG000|Overall Study|Lost to Follow-up|3|||
125542259|NCT01156792|451614210|FG000|Overall Study|Physician Decision|3|||
125542260|NCT01156792|451614210|FG000|Overall Study|Withdrawal by Subject|9|||
125542261|NCT01156792|451614210|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
125542262|NCT01474434|451614211|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
125542263|NCT01474434|451614212|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
125542264|NCT01474434|451614213|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
125542265|NCT01474434|451614214|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
125542266|NCT01474434|451614211|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
125542267|NCT01474434|451614212|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
125542268|NCT01474434|451614213|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
125542269|NCT01474434|451614214|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
125542270|NCT01474434|451614211|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
125542271|NCT01474434|451614212|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
125542272|NCT01474434|451614213|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
125542273|NCT01474434|451614214|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
125542274|NCT00495586|451614220|FG000|Overall Study|Withdrawal by Subject|4|||
125542275|NCT00495586|451614221|FG001|Overall Study|Withdrawal by Subject|4|||
125542276|NCT02038543|451614222|FG000|Overall Study|Screen Failure|0|||
125542277|NCT02038543|451614223|FG001|Overall Study|Screen Failure|0|||
125542278|NCT02038543|451614224|FG002|Overall Study|Screen Failure|0|||
125542279|NCT02038543|451614225|FG003|Overall Study|Screen Failure|1|||
125542280|NCT02038543|451614222|FG000|Overall Study|Withdrawal by Subject|0|||
125542281|NCT02038543|451614223|FG001|Overall Study|Withdrawal by Subject|0|||
125542282|NCT02038543|451614224|FG002|Overall Study|Withdrawal by Subject|0|||
125542283|NCT02038543|451614225|FG003|Overall Study|Withdrawal by Subject|1|||
125542284|NCT00158860|451614226|FG000|Overall Study|Adverse Event|3|||
125542285|NCT00158860|451614227|FG001|Overall Study|Adverse Event|6|||
125678191|NCT00497796|452110811|FG001|Overall Study|Adverse event (related)|4|||
125678192|NCT00497796|452110810|FG000|Overall Study|CMV infection or disease treatment|30|||
125678193|NCT00497796|452110811|FG001|Overall Study|CMV infection or disease treatment|4|||
125678194|NCT00497796|452110810|FG000|Overall Study|Consent withdrawn|10|||
125678195|NCT00497796|452110811|FG001|Overall Study|Consent withdrawn|3|||
125678196|NCT00497796|452110810|FG000|Overall Study|Investigator/sponsor discretion|31|||
125678197|NCT00497796|452110811|FG001|Overall Study|Investigator/sponsor discretion|34|||
125678198|NCT00497796|452110810|FG000|Overall Study|Lost to Follow-up|0|||
125678199|NCT00497796|452110811|FG001|Overall Study|Lost to Follow-up|1|||
125678200|NCT00497796|452110810|FG000|Overall Study|Not applicable (randomized not treated)|0|||
125678201|NCT00497796|452110811|FG001|Overall Study|Not applicable (randomized not treated)|4|||
125678202|NCT01074554|452110812|FG000|Overall Study|Adverse Event|3|||
125678203|NCT01074554|452110813|FG001|Overall Study|Adverse Event|3|||
125678204|NCT01074554|452110812|FG000|Overall Study|Lost to Follow-up|0|||
125678205|NCT01074554|452110813|FG001|Overall Study|Lost to Follow-up|1|||
125678206|NCT04276883|452110816|FG000|Overall Study|Withdrawal by Subject|2|||
125678207|NCT04276883|452110817|FG001|Overall Study|Withdrawal by Subject|3|||
125678208|NCT04276883|452110818|FG002|Overall Study|Withdrawal by Subject|6|||
125678209|NCT04276883|452110816|FG000|Overall Study|Lost to Follow-up|1|||
125678210|NCT04276883|452110817|FG001|Overall Study|Lost to Follow-up|3|||
125678211|NCT04276883|452110818|FG002|Overall Study|Lost to Follow-up|0|||
125678212|NCT04276883|452110816|FG000|Overall Study|Adverse Event|0|||
125678213|NCT04276883|452110817|FG001|Overall Study|Adverse Event|1|||
125678214|NCT04276883|452110818|FG002|Overall Study|Adverse Event|0|||
125678215|NCT04276883|452110816|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
125678216|NCT04276883|452110817|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
125542286|NCT00158860|451614226|FG000|Overall Study|Lost to Follow-up|11|||
125542287|NCT00158860|451614227|FG001|Overall Study|Lost to Follow-up|17|||
125542288|NCT00158860|451614226|FG000|Overall Study|Protocol Violation|8|||
125542289|NCT00158860|451614227|FG001|Overall Study|Protocol Violation|23|||
125678217|NCT04276883|452110818|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
125678218|NCT01876706|452110819|FG000|Overall Study|BPH Intervention|9|||
125678219|NCT01876706|452110819|FG000|Overall Study|Lost to Follow-up|7|||
125542290|NCT00158860|451614226|FG000|Overall Study|Withdrawal by Subject|7|||
125542291|NCT00158860|451614227|FG001|Overall Study|Withdrawal by Subject|17|||
125542292|NCT00158860|451614226|FG000|Overall Study|MOVING OUT OF STATE|1|||
125542293|NCT00158860|451614227|FG001|Overall Study|MOVING OUT OF STATE|0|||
125542294|NCT00158860|451614226|FG000|Overall Study|Pregnancy|3|||
125542295|NCT00158860|451614227|FG001|Overall Study|Pregnancy|3|||
125542296|NCT00158860|451614226|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
125542297|NCT00158860|451614227|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
125542298|NCT00158860|451614226|FG000|Overall Study|SPONSOR REQUEST|0|||
125542299|NCT00158860|451614227|FG001|Overall Study|SPONSOR REQUEST|1|||
125542300|NCT00158860|451614226|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
125542301|NCT00158860|451614227|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
125542302|NCT00158860|451614226|FG000|Overall Study|Closed per sponsor|0|||
125542303|NCT00158860|451614227|FG001|Overall Study|Closed per sponsor|1|||
125542304|NCT01029652|451614228|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
125542305|NCT01029652|451614229|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
125542306|NCT01029652|451614228|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
125542307|NCT01029652|451614229|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
125542308|NCT01029652|451614228|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
125542309|NCT01029652|451614229|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
125542310|NCT01029652|451614228|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
125542311|NCT01029652|451614229|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
125542312|NCT01029652|451614228|FG000|Core Study (0-12 Weeks)|Death|0|||
125542313|NCT01029652|451614229|FG001|Core Study (0-12 Weeks)|Death|1|||
125542314|NCT01029652|451614228|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
125542315|NCT01029652|451614229|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
125542316|NCT01029652|451614228|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
125542317|NCT01029652|451614229|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
125542318|NCT01029652|451614228|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
125542319|NCT01029652|451614229|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
125542320|NCT01029652|451614228|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
125542321|NCT01029652|451614229|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
125542322|NCT01029652|451614228|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
125542323|NCT01029652|451614229|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
125542324|NCT01029652|451614228|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
125542325|NCT01029652|451614229|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
125542326|NCT01029652|451614228|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
125542327|NCT01029652|451614229|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
125542328|NCT02095951|451614230|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
125542329|NCT02095951|451614231|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
125542330|NCT00964886|451614232|FG000|Overall Study|Lost to Follow-up|2|||
125542331|NCT00964886|451614233|FG001|Overall Study|Lost to Follow-up|2|||
125542332|NCT00964886|451614234|FG002|Overall Study|Lost to Follow-up|6|||
125542333|NCT00964886|451614235|FG003|Overall Study|Lost to Follow-up|4|||
125542334|NCT00964886|451614232|FG000|Overall Study|Withdrawal by Subject|6|||
125542335|NCT00964886|451614233|FG001|Overall Study|Withdrawal by Subject|2|||
125542336|NCT00964886|451614234|FG002|Overall Study|Withdrawal by Subject|5|||
125542337|NCT00964886|451614235|FG003|Overall Study|Withdrawal by Subject|3|||
125542338|NCT00964886|451614232|FG000|Overall Study|Adverse Event|3|||
125542339|NCT00964886|451614233|FG001|Overall Study|Adverse Event|1|||
125542340|NCT00964886|451614234|FG002|Overall Study|Adverse Event|5|||
125542341|NCT00964886|451614235|FG003|Overall Study|Adverse Event|2|||
125542342|NCT00964886|451614232|FG000|Overall Study|Protocol Violation|0|||
125542343|NCT00964886|451614233|FG001|Overall Study|Protocol Violation|2|||
125542344|NCT00964886|451614234|FG002|Overall Study|Protocol Violation|0|||
125542345|NCT00964886|451614235|FG003|Overall Study|Protocol Violation|0|||
125542346|NCT01621568|451614238|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
125542347|NCT01621568|451614239|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
125542348|NCT01621568|451614238|FG000|Week 5-6 No Treatment|Death|1|||
125542349|NCT01621568|451614239|FG001|Week 5-6 No Treatment|Death|0|||
125542350|NCT02334423|451614240|FG000|Overall Study|Protocol Violation|10|||
125542351|NCT02334423|451614241|FG001|Overall Study|Protocol Violation|3|||
125542352|NCT02930226|451614242|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
125678220|NCT01876706|452110819|FG000|Overall Study|Withdrawals|6|||
125678221|NCT01876706|452110819|FG000|Overall Study|Death|3|||
125678222|NCT01370408|452110824|FG000|Overall Study|treatment failure|9|||
125344939|NCT01989468|450896462|FG004|Overall Study|Subject Guardian Decision|1|||
125344940|NCT01989468|450896458|FG000|Overall Study|Death|3|||
125542353|NCT02930226|451614243|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
125678223|NCT02073643|452110826|FG000|Overall Study|Lost to Follow-up|24|||
125344941|NCT01989468|450896459|FG001|Overall Study|Death|0|||
125344942|NCT01989468|450896460|FG002|Overall Study|Death|1|||
125542354|NCT02930226|451614244|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
125678224|NCT02780687|452110827|FG000|Overall Study|Adverse Event|1|||
125542355|NCT02930226|451614245|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
125542356|NCT02930226|451614246|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
125542357|NCT02930226|451614247|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
125542358|NCT00652327|451614248|FG000|Overall Study|Adverse Event|0|||
125542359|NCT00652327|451614249|FG001|Overall Study|Adverse Event|2|||
125542360|NCT00652327|451614248|FG000|Overall Study|Lost to Follow-up|0|||
125542361|NCT00652327|451614249|FG001|Overall Study|Lost to Follow-up|3|||
125542362|NCT01076647|451614250|FG000|Overall Study|Adverse Event|4|||
125542363|NCT01076647|451614251|FG001|Overall Study|Adverse Event|1|||
125542364|NCT01076647|451614250|FG000|Overall Study|Lack of Efficacy|0|||
125542365|NCT01076647|451614251|FG001|Overall Study|Lack of Efficacy|1|||
125542366|NCT01076647|451614250|FG000|Overall Study|Protocol Violation|7|||
125542367|NCT01076647|451614251|FG001|Overall Study|Protocol Violation|9|||
125542368|NCT01076647|451614250|FG000|Overall Study|Withdrawal criteria|2|||
125542369|NCT01076647|451614251|FG001|Overall Study|Withdrawal criteria|2|||
125542370|NCT01076647|451614250|FG000|Overall Study|Unclassified|12|||
125542371|NCT01076647|451614251|FG001|Overall Study|Unclassified|12|||
125542372|NCT02224690|451614263|FG000|Overall Study|Adverse Event|8|||
125542373|NCT02224690|451614264|FG001|Overall Study|Adverse Event|1|||
125542374|NCT02224690|451614263|FG000|Overall Study|Met Withdrawal Criteria|4|||
125542375|NCT02224690|451614264|FG001|Overall Study|Met Withdrawal Criteria|0|||
125542376|NCT02224690|451614263|FG000|Overall Study|Use of G-tube|1|||
125542377|NCT02224690|451614264|FG001|Overall Study|Use of G-tube|0|||
125542378|NCT02224690|451614263|FG000|Overall Study|Did not meet eligibility criteria|1|||
125542379|NCT02224690|451614264|FG001|Overall Study|Did not meet eligibility criteria|0|||
125542380|NCT00141219|451614265|FG000|Overall Study|Protocol violations|5|||
125542381|NCT00141219|451614266|FG001|Overall Study|Protocol violations|4|||
125542382|NCT00141219|451614265|FG000|Overall Study|Adverse Event|8|||
125542383|NCT00141219|451614266|FG001|Overall Study|Adverse Event|6|||
125542384|NCT00141219|451614265|FG000|Overall Study|Lack of Efficacy|5|||
125542385|NCT00141219|451614266|FG001|Overall Study|Lack of Efficacy|4|||
125542386|NCT00141219|451614265|FG000|Overall Study|Withdrawal by Subject|6|||
125542387|NCT00141219|451614266|FG001|Overall Study|Withdrawal by Subject|2|||
125542388|NCT01506609|451614268|FG000|Overall Study|Adverse Event Related to Progression|0|||
125542389|NCT01506609|451614269|FG001|Overall Study|Adverse Event Related to Progression|0|||
125542390|NCT01506609|451614270|FG002|Overall Study|Adverse Event Related to Progression|0|||
125542391|NCT01506609|451614271|FG003|Overall Study|Adverse Event Related to Progression|3|||
125542392|NCT01506609|451614272|FG004|Overall Study|Adverse Event Related to Progression|7|||
125542393|NCT01506609|451614273|FG005|Overall Study|Adverse Event Related to Progression|3|||
125542394|NCT01506609|451614268|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
125542395|NCT01506609|451614269|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
125542396|NCT01506609|451614270|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
125542397|NCT01506609|451614271|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
125542398|NCT01506609|451614272|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
125542399|NCT01506609|451614273|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
125542400|NCT01506609|451614268|FG000|Overall Study|Withdrawal by Subject|0|||
125542401|NCT01506609|451614269|FG001|Overall Study|Withdrawal by Subject|0|||
125542402|NCT01506609|451614270|FG002|Overall Study|Withdrawal by Subject|0|||
125542403|NCT01506609|451614271|FG003|Overall Study|Withdrawal by Subject|9|||
125542404|NCT01506609|451614272|FG004|Overall Study|Withdrawal by Subject|7|||
125542405|NCT01506609|451614273|FG005|Overall Study|Withdrawal by Subject|7|||
125542406|NCT01506609|451614268|FG000|Overall Study|Lost to Follow-up|0|||
125542407|NCT01506609|451614269|FG001|Overall Study|Lost to Follow-up|0|||
125542408|NCT01506609|451614270|FG002|Overall Study|Lost to Follow-up|0|||
125542409|NCT01506609|451614271|FG003|Overall Study|Lost to Follow-up|1|||
125542410|NCT01506609|451614272|FG004|Overall Study|Lost to Follow-up|2|||
125542411|NCT01506609|451614273|FG005|Overall Study|Lost to Follow-up|0|||
125542412|NCT01506609|451614268|FG000|Overall Study|Sponsor Discontinued Study|0|||
125542413|NCT01506609|451614269|FG001|Overall Study|Sponsor Discontinued Study|0|||
125542414|NCT01506609|451614270|FG002|Overall Study|Sponsor Discontinued Study|0|||
125542415|NCT01506609|451614271|FG003|Overall Study|Sponsor Discontinued Study|2|||
125542416|NCT01506609|451614272|FG004|Overall Study|Sponsor Discontinued Study|2|||
125542417|NCT01506609|451614273|FG005|Overall Study|Sponsor Discontinued Study|0|||
125542418|NCT01506609|451614268|FG000|Overall Study|Progressive Disease per Protocol|1|||
125542419|NCT01506609|451614269|FG001|Overall Study|Progressive Disease per Protocol|0|||
125542420|NCT01506609|451614270|FG002|Overall Study|Progressive Disease per Protocol|0|||
125678225|NCT02780687|452110828|FG001|Overall Study|Adverse Event|1|||
125344943|NCT01989468|450896461|FG003|Overall Study|Death|0|||
125542421|NCT01506609|451614271|FG003|Overall Study|Progressive Disease per Protocol|64|||
125678226|NCT02780687|452110827|FG000|Overall Study|Withdrawal by Subject|2|||
125542422|NCT01506609|451614272|FG004|Overall Study|Progressive Disease per Protocol|57|||
125542423|NCT01506609|451614273|FG005|Overall Study|Progressive Disease per Protocol|74|||
125542424|NCT01506609|451614268|FG000|Overall Study|Other, Not Specified|0|||
125542425|NCT01506609|451614269|FG001|Overall Study|Other, Not Specified|0|||
125542426|NCT01506609|451614270|FG002|Overall Study|Other, Not Specified|0|||
125542427|NCT01506609|451614271|FG003|Overall Study|Other, Not Specified|10|||
125542428|NCT01506609|451614272|FG004|Overall Study|Other, Not Specified|7|||
125542429|NCT01506609|451614273|FG005|Overall Study|Other, Not Specified|3|||
125542430|NCT01506609|451614268|FG000|Overall Study|Missing / Unknown Reason|1|||
125542431|NCT01506609|451614269|FG001|Overall Study|Missing / Unknown Reason|0|||
125542432|NCT01506609|451614270|FG002|Overall Study|Missing / Unknown Reason|1|||
125542433|NCT01506609|451614271|FG003|Overall Study|Missing / Unknown Reason|4|||
125542434|NCT01506609|451614272|FG004|Overall Study|Missing / Unknown Reason|4|||
125542435|NCT01506609|451614273|FG005|Overall Study|Missing / Unknown Reason|2|||
125542436|NCT00122460|451614274|FG000|Overall Study|investigational study phase ongoing|7|||
125542437|NCT00122460|451614275|FG001|Overall Study|investigational study phase ongoing|1|||
125542438|NCT02595073|451614276|FG000|Overall Study|Progressive Disease|0|||
125542439|NCT02595073|451614277|FG001|Overall Study|Progressive Disease|1|||
125542440|NCT02595073|451614276|FG000|Overall Study|Protocol Violation|2|||
125542441|NCT02595073|451614277|FG001|Overall Study|Protocol Violation|0|||
125542442|NCT02962960|451614278|FG000|Overall Study|Withdrawal by Subject|1|||
125542443|NCT02962960|451614279|FG001|Overall Study|Withdrawal by Subject|1|||
125542444|NCT02962960|451614280|FG002|Overall Study|Withdrawal by Subject|0|||
125542445|NCT02962960|451614278|FG000|Overall Study|Adverse Event|1|||
125542446|NCT02962960|451614279|FG001|Overall Study|Adverse Event|1|||
125542447|NCT02962960|451614280|FG002|Overall Study|Adverse Event|0|||
125542448|NCT02962960|451614278|FG000|Overall Study|Protocol Violation|1|||
125542449|NCT02962960|451614279|FG001|Overall Study|Protocol Violation|0|||
125542450|NCT02962960|451614280|FG002|Overall Study|Protocol Violation|0|||
125542451|NCT02971761|451614281|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
125542452|NCT02549196|451614282|FG000|Overall Study|Protocol Violation|0|||
125542453|NCT02549196|451614283|FG001|Overall Study|Protocol Violation|0|||
125542454|NCT02549196|451614284|FG002|Overall Study|Protocol Violation|0|||
125542455|NCT02549196|451614285|FG003|Overall Study|Protocol Violation|1|||
125542456|NCT02549196|451614282|FG000|Overall Study|Withdrawal by Subject|1|||
125542457|NCT02549196|451614283|FG001|Overall Study|Withdrawal by Subject|0|||
125542458|NCT02549196|451614284|FG002|Overall Study|Withdrawal by Subject|1|||
125542459|NCT02549196|451614285|FG003|Overall Study|Withdrawal by Subject|0|||
125542460|NCT01103362|451614286|FG000|Overall Study|study terminated|596|||
125542461|NCT02679508|451614287|FG000|Healing Phase|Protocol Violation|1|||
125542462|NCT02679508|451614288|FG001|Healing Phase|Protocol Violation|1|||
125542463|NCT02679508|451614287|FG000|Healing Phase|Lost to Follow-up|1|||
125542464|NCT02679508|451614288|FG001|Healing Phase|Lost to Follow-up|0|||
125542465|NCT02679508|451614287|FG000|Maintenance Phase|Adverse Event|12|||
125542466|NCT02679508|451614288|FG001|Maintenance Phase|Adverse Event|2|||
125542467|NCT02679508|451614287|FG000|Maintenance Phase|Lost to Follow-up|0|||
125542468|NCT02679508|451614288|FG001|Maintenance Phase|Lost to Follow-up|1|||
125542469|NCT02679508|451614287|FG000|Maintenance Phase|Withdrawal by Subject|15|||
125542470|NCT02679508|451614288|FG001|Maintenance Phase|Withdrawal by Subject|8|||
125542471|NCT02679508|451614287|FG000|Maintenance Phase|Other|5|||
125542472|NCT02679508|451614288|FG001|Maintenance Phase|Other|4|||
125542473|NCT03143166|451614289|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
125542474|NCT03562975|451614290|FG000|Overall Study|Death|1|||
125542475|NCT03562975|451614290|FG000|Overall Study|Lost to Follow-up|1|||
125542476|NCT03562975|451614290|FG000|Overall Study|Withdrawal by Subject|1|||
125542477|NCT05180500|451614291|FG000|Overall Study|Adverse Event|1|||
125542478|NCT05180500|451614292|FG001|Overall Study|Adverse Event|0|||
125542479|NCT05180500|451614291|FG000|Overall Study|Withdrawal by Subject|2|||
125542480|NCT05180500|451614292|FG001|Overall Study|Withdrawal by Subject|0|||
125542481|NCT00867308|451614293|FG000|Overall Study|Death|1|||
125542482|NCT00867308|451614294|FG001|Overall Study|Death|0|||
125542483|NCT00867308|451614293|FG000|Overall Study|Adverse Event|1|||
125542484|NCT00867308|451614294|FG001|Overall Study|Adverse Event|4|||
125542485|NCT00867308|451614293|FG000|Overall Study|Lack of Efficacy|6|||
125678227|NCT02780687|452110828|FG001|Overall Study|Withdrawal by Subject|1|||
125678228|NCT02780687|452110827|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
125678229|NCT02780687|452110828|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
125678230|NCT02780687|452110827|FG000|Overall Study|progressive disease|29|||
125678231|NCT02780687|452110828|FG001|Overall Study|progressive disease|6|||
125678232|NCT01062256|452110831|FG000|Overall Study|Adverse Event|1|||
125344944|NCT01989468|450896462|FG004|Overall Study|Death|0|||
125344945|NCT03222492|450896465|FG000|Overall Study|Withdrawal by Subject|0|||
125542486|NCT00867308|451614294|FG001|Overall Study|Lack of Efficacy|12|||
125542487|NCT00867308|451614293|FG000|Overall Study|Withdrawal by Subject|1|||
125542488|NCT00867308|451614294|FG001|Overall Study|Withdrawal by Subject|2|||
125542489|NCT05917470|451614300|FG000|Overall Study|Progressive Disease|1|||
125542490|NCT05917470|451614301|FG001|Overall Study|Progressive Disease|1|||
125542491|NCT05917470|451614302|FG002|Overall Study|Progressive Disease|2|||
125542492|NCT05917470|451614303|FG003|Overall Study|Progressive Disease|3|||
125542493|NCT05917470|451614304|FG004|Overall Study|Progressive Disease|1|||
125542494|NCT05917470|451614305|FG005|Overall Study|Progressive Disease|1|||
125542495|NCT05917470|451614306|FG006|Overall Study|Progressive Disease|0|||
125542496|NCT05917470|451614307|FG007|Overall Study|Progressive Disease|0|||
125542497|NCT05917470|451614300|FG000|Overall Study|Withdrawal by Subject|0|||
125542498|NCT05917470|451614301|FG001|Overall Study|Withdrawal by Subject|0|||
125542499|NCT05917470|451614302|FG002|Overall Study|Withdrawal by Subject|1|||
125542500|NCT05917470|451614303|FG003|Overall Study|Withdrawal by Subject|0|||
125542501|NCT05917470|451614304|FG004|Overall Study|Withdrawal by Subject|0|||
125542502|NCT05917470|451614305|FG005|Overall Study|Withdrawal by Subject|0|||
125542503|NCT05917470|451614306|FG006|Overall Study|Withdrawal by Subject|0|||
125542504|NCT05917470|451614307|FG007|Overall Study|Withdrawal by Subject|0|||
125542505|NCT05917470|451614300|FG000|Overall Study|Sponsor Decision|0|||
125542506|NCT05917470|451614301|FG001|Overall Study|Sponsor Decision|0|||
125542507|NCT05917470|451614302|FG002|Overall Study|Sponsor Decision|1|||
125542508|NCT05917470|451614303|FG003|Overall Study|Sponsor Decision|0|||
125542509|NCT05917470|451614304|FG004|Overall Study|Sponsor Decision|2|||
125542510|NCT05917470|451614305|FG005|Overall Study|Sponsor Decision|1|||
125542511|NCT05917470|451614306|FG006|Overall Study|Sponsor Decision|3|||
125542512|NCT05917470|451614307|FG007|Overall Study|Sponsor Decision|3|||
125542513|NCT05917470|451614300|FG000|Overall Study|Adverse Event|0|||
125542514|NCT05917470|451614301|FG001|Overall Study|Adverse Event|0|||
125542515|NCT05917470|451614302|FG002|Overall Study|Adverse Event|0|||
125542516|NCT05917470|451614303|FG003|Overall Study|Adverse Event|0|||
125542517|NCT05917470|451614304|FG004|Overall Study|Adverse Event|0|||
125542518|NCT05917470|451614305|FG005|Overall Study|Adverse Event|1|||
125542519|NCT05917470|451614306|FG006|Overall Study|Adverse Event|0|||
125542520|NCT05917470|451614307|FG007|Overall Study|Adverse Event|0|||
125542521|NCT03647488|451616756|FG000|Overall Study|Progressive disease|10|||
125542522|NCT03647488|451616757|FG001|Overall Study|Progressive disease|0|||
125542523|NCT03647488|451616758|FG002|Overall Study|Progressive disease|0|||
125542524|NCT03647488|451616756|FG000|Overall Study|Adverse Event|5|||
125542525|NCT03647488|451616757|FG001|Overall Study|Adverse Event|0|||
125542526|NCT03647488|451616758|FG002|Overall Study|Adverse Event|0|||
125542527|NCT03647488|451616756|FG000|Overall Study|Clinical progression|2|||
125542528|NCT03647488|451616757|FG001|Overall Study|Clinical progression|0|||
125542529|NCT03647488|451616758|FG002|Overall Study|Clinical progression|0|||
125542530|NCT03647488|451616756|FG000|Overall Study|Participant refused to take investigational product|1|||
125542531|NCT03647488|451616757|FG001|Overall Study|Participant refused to take investigational product|0|||
125542532|NCT03647488|451616758|FG002|Overall Study|Participant refused to take investigational product|0|||
125542533|NCT03694275|451616759|FG000|Overall Study|Adverse Event|0|||
125542534|NCT03694275|451616760|FG001|Overall Study|Adverse Event|1|||
125542535|NCT03694275|451616759|FG000|Overall Study|Reason not Specified|0|||
125542536|NCT03694275|451616760|FG001|Overall Study|Reason not Specified|1|||
125542537|NCT03541174|451616761|FG000|Part 1 Double-Blind|Adverse Event|6|||
125542538|NCT03541174|451616762|FG001|Part 1 Double-Blind|Adverse Event|5|||
125542539|NCT03541174|451616763|FG002|Part 1 Double-Blind|Adverse Event|2|||
125542540|NCT03541174|451616764|FG003|Part 1 Double-Blind|Adverse Event|0|||
125542541|NCT03541174|451616765|FG004|Part 1 Double-Blind|Adverse Event|0|||
125542542|NCT03541174|451616766|FG005|Part 1 Double-Blind|Adverse Event|0|||
125542543|NCT03541174|451616761|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
125542544|NCT03541174|451616762|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
125542545|NCT03541174|451616763|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
125542546|NCT03541174|451616764|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
125542547|NCT03541174|451616765|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
125542548|NCT03541174|451616766|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
125542549|NCT03541174|451616761|FG000|Part 1 Double-Blind|Other reasons|3|||
125542550|NCT03541174|451616762|FG001|Part 1 Double-Blind|Other reasons|2|||
125542551|NCT03541174|451616763|FG002|Part 1 Double-Blind|Other reasons|3|||
125678233|NCT01062256|452110832|FG001|Overall Study|Adverse Event|0|||
125678234|NCT01062256|452110833|FG002|Overall Study|Adverse Event|0|||
125678235|NCT01062256|452110831|FG000|Overall Study|Withdrawal by Subject|1|||
125678236|NCT01062256|452110832|FG001|Overall Study|Withdrawal by Subject|1|||
125678237|NCT01062256|452110833|FG002|Overall Study|Withdrawal by Subject|1|||
125678238|NCT01062256|452110831|FG000|Overall Study|Ineligible|1|||
125678239|NCT01062256|452110832|FG001|Overall Study|Ineligible|4|||
125678240|NCT01062256|452110833|FG002|Overall Study|Ineligible|3|||
125678241|NCT01062256|452110831|FG000|Overall Study|Administrative|0|||
125678242|NCT01062256|452110832|FG001|Overall Study|Administrative|2|||
125678243|NCT01062256|452110833|FG002|Overall Study|Administrative|0|||
125678244|NCT03049488|452110834|FG000|Overall Study|Lost to Follow-up|1|||
125678245|NCT03049488|452110835|FG001|Overall Study|Lost to Follow-up|1|||
125678246|NCT03049488|452110836|FG002|Overall Study|Lost to Follow-up|0|||
125542552|NCT03541174|451616764|FG003|Part 1 Double-Blind|Other reasons|0|||
125542553|NCT03541174|451616765|FG004|Part 1 Double-Blind|Other reasons|0|||
125542554|NCT03541174|451616766|FG005|Part 1 Double-Blind|Other reasons|0|||
125542555|NCT03541174|451616761|FG000|Part 2 Single-Blind|Adverse Event|0|||
125542556|NCT03541174|451616762|FG001|Part 2 Single-Blind|Adverse Event|0|||
125542557|NCT03541174|451616763|FG002|Part 2 Single-Blind|Adverse Event|0|||
125542558|NCT03541174|451616764|FG003|Part 2 Single-Blind|Adverse Event|25|||
125542559|NCT03541174|451616765|FG004|Part 2 Single-Blind|Adverse Event|0|||
125542560|NCT03541174|451616766|FG005|Part 2 Single-Blind|Adverse Event|0|||
125678247|NCT03049488|452110837|FG003|Overall Study|Lost to Follow-up|0|||
125542561|NCT03541174|451616761|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
125542562|NCT03541174|451616762|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
125542563|NCT03541174|451616763|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
125542564|NCT03541174|451616764|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
125542565|NCT03541174|451616765|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
125542566|NCT03541174|451616766|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
125542567|NCT03541174|451616761|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
125542568|NCT03541174|451616762|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
125542569|NCT03541174|451616763|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
125542570|NCT03541174|451616764|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
125542571|NCT03541174|451616765|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
125542572|NCT03541174|451616766|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
125542573|NCT03541174|451616761|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
125542574|NCT03541174|451616762|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
125542575|NCT03541174|451616763|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
125542576|NCT03541174|451616764|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
125542577|NCT03541174|451616765|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
125542578|NCT03541174|451616766|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
125542579|NCT03541174|451616761|FG000|Part 2 Single-Blind|Death|0|||
125542580|NCT03541174|451616762|FG001|Part 2 Single-Blind|Death|0|||
125542581|NCT03541174|451616763|FG002|Part 2 Single-Blind|Death|0|||
125542582|NCT03541174|451616764|FG003|Part 2 Single-Blind|Death|5|||
125542583|NCT03541174|451616765|FG004|Part 2 Single-Blind|Death|0|||
125542584|NCT03541174|451616766|FG005|Part 2 Single-Blind|Death|0|||
125542585|NCT03541174|451616761|FG000|Part 2 Single-Blind|Pregnancy|0|||
125542586|NCT03541174|451616762|FG001|Part 2 Single-Blind|Pregnancy|0|||
125542587|NCT03541174|451616763|FG002|Part 2 Single-Blind|Pregnancy|0|||
125542588|NCT03541174|451616764|FG003|Part 2 Single-Blind|Pregnancy|1|||
125542589|NCT03541174|451616765|FG004|Part 2 Single-Blind|Pregnancy|0|||
125542590|NCT03541174|451616766|FG005|Part 2 Single-Blind|Pregnancy|0|||
125542591|NCT03541174|451616761|FG000|Part 2 Single-Blind|Other reasons|0|||
125542592|NCT03541174|451616762|FG001|Part 2 Single-Blind|Other reasons|0|||
125542593|NCT03541174|451616763|FG002|Part 2 Single-Blind|Other reasons|0|||
125542594|NCT03541174|451616764|FG003|Part 2 Single-Blind|Other reasons|32|||
125542595|NCT03541174|451616765|FG004|Part 2 Single-Blind|Other reasons|0|||
125542596|NCT03541174|451616766|FG005|Part 2 Single-Blind|Other reasons|0|||
125542597|NCT03541174|451616761|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
125542598|NCT03541174|451616762|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
125542599|NCT03541174|451616763|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
125542600|NCT03541174|451616764|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
125542601|NCT03541174|451616765|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
125542602|NCT03541174|451616766|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
125542603|NCT03541174|451616761|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
125542604|NCT03541174|451616762|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
125542605|NCT03541174|451616763|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
125542606|NCT03541174|451616764|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
125542607|NCT03541174|451616765|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
125542608|NCT03541174|451616766|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
125542609|NCT03541174|451616761|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
125542610|NCT03541174|451616762|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
125542611|NCT03541174|451616763|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
125542612|NCT03541174|451616764|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
125542613|NCT03541174|451616765|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
125542614|NCT03541174|451616766|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
125542615|NCT03541174|451616761|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
125542616|NCT03541174|451616762|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
125542617|NCT03541174|451616763|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
125542618|NCT03541174|451616764|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
125542619|NCT03541174|451616765|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
125542620|NCT03541174|451616766|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
125542621|NCT03541174|451616761|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
125542622|NCT03541174|451616762|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
125542623|NCT03541174|451616763|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
125542624|NCT03541174|451616764|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
125542625|NCT03541174|451616765|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
125542626|NCT03541174|451616766|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
125542627|NCT02217332|451616769|FG000|Overall Study|Adverse Event|3|||
125542628|NCT02217332|451616769|FG000|Overall Study|Dose interruption >1 month|1|||
125542629|NCT02217332|451616769|FG000|Overall Study|Protocol Violation (eligibility)|1|||
125542630|NCT02217332|451616769|FG000|Overall Study|Withdrawal by Subject|1|||
125542631|NCT02217332|451616769|FG000|Overall Study|Lost to Follow-up|1|||
125542632|NCT04058366|451616770|FG000|Overall Study|Adverse Event|14|||
125678248|NCT03049488|452110838|FG004|Overall Study|Lost to Follow-up|0|||
125678249|NCT03049488|452110839|FG005|Overall Study|Lost to Follow-up|0|||
125678250|NCT03049488|452110834|FG000|Overall Study|Moved from Area|1|||
125678251|NCT03049488|452110835|FG001|Overall Study|Moved from Area|0|||
125678252|NCT03049488|452110836|FG002|Overall Study|Moved from Area|0|||
125678253|NCT03049488|452110837|FG003|Overall Study|Moved from Area|1|||
125678254|NCT03049488|452110838|FG004|Overall Study|Moved from Area|1|||
125678255|NCT03049488|452110839|FG005|Overall Study|Moved from Area|0|||
125678256|NCT03049488|452110834|FG000|Overall Study|Physician Decision|0|||
125678257|NCT03049488|452110835|FG001|Overall Study|Physician Decision|1|||
125678258|NCT03049488|452110836|FG002|Overall Study|Physician Decision|0|||
125678259|NCT03049488|452110837|FG003|Overall Study|Physician Decision|0|||
125678260|NCT03049488|452110838|FG004|Overall Study|Physician Decision|0|||
125678261|NCT03049488|452110839|FG005|Overall Study|Physician Decision|0|||
125678262|NCT03049488|452110834|FG000|Overall Study|Withdrawal by Subject|0|||
125678263|NCT03049488|452110835|FG001|Overall Study|Withdrawal by Subject|0|||
125678264|NCT03049488|452110836|FG002|Overall Study|Withdrawal by Subject|0|||
125678265|NCT03049488|452110837|FG003|Overall Study|Withdrawal by Subject|1|||
125678266|NCT03049488|452110838|FG004|Overall Study|Withdrawal by Subject|1|||
125678267|NCT03049488|452110839|FG005|Overall Study|Withdrawal by Subject|0|||
125678268|NCT00891293|452110842|FG000|Overall Study|Adverse Event|2|||
125678269|NCT00891293|452110842|FG000|Overall Study|Protocol Violation|2|||
125678270|NCT00891293|452110842|FG000|Overall Study|Laboratory abnormality|4|||
125678271|NCT00891293|452110842|FG000|Overall Study|Lost to Follow-up|7|||
125678272|NCT00891293|452110842|FG000|Overall Study|Subject withdrew consent|7|||
125678273|NCT00891293|452110842|FG000|Overall Study|Sponsor termination|62|||
125678274|NCT01448057|452110843|FG000|Overall Study|Protocol Violation|3|||
125678275|NCT01448057|452110844|FG001|Overall Study|Protocol Violation|2|||
125678276|NCT01448057|452110843|FG000|Overall Study|Lost to Follow-up|3|||
125678277|NCT01448057|452110844|FG001|Overall Study|Lost to Follow-up|0|||
125678278|NCT01448057|452110843|FG000|Overall Study|Adverse Event|0|||
125678279|NCT01448057|452110844|FG001|Overall Study|Adverse Event|2|||
125678280|NCT01448057|452110843|FG000|Overall Study|Withdrawal by Subject|2|||
125678281|NCT01448057|452110844|FG001|Overall Study|Withdrawal by Subject|0|||
125678282|NCT02507375|452110847|FG000|Overall Study|Progressive Disease|4|||
125678283|NCT02507375|452110848|FG001|Overall Study|Progressive Disease|5|||
125678284|NCT02507375|452110847|FG000|Overall Study|Death|0|||
125678285|NCT02507375|452110848|FG001|Overall Study|Death|1|||
125678286|NCT02507375|452110847|FG000|Overall Study|Refused treatment|0|||
125678287|NCT02507375|452110848|FG001|Overall Study|Refused treatment|1|||
125678288|NCT02507375|452110847|FG000|Overall Study|Adverse Event|0|||
125678289|NCT02507375|452110848|FG001|Overall Study|Adverse Event|1|||
125678290|NCT02777528|452112071|FG000|Overall Study|Still in study|24|||
125678291|NCT02777528|452112072|FG001|Overall Study|Still in study|10|||
125678292|NCT02777528|452112073|FG002|Overall Study|Still in study|1|||
125678293|NCT02777528|452112071|FG000|Overall Study|Study Device Explanted|1|||
125678294|NCT02777528|452112072|FG001|Overall Study|Study Device Explanted|0|||
125678295|NCT02777528|452112073|FG002|Overall Study|Study Device Explanted|0|||
125678296|NCT02777528|452112071|FG000|Overall Study|Death|14|||
125678297|NCT02777528|452112072|FG001|Overall Study|Death|7|||
125678298|NCT02777528|452112073|FG002|Overall Study|Death|1|||
125678299|NCT02777528|452112071|FG000|Overall Study|Withdrawal by Subject|2|||
125678300|NCT02777528|452112072|FG001|Overall Study|Withdrawal by Subject|2|||
125678301|NCT02777528|452112073|FG002|Overall Study|Withdrawal by Subject|1|||
125678302|NCT02777528|452112071|FG000|Overall Study|Physician Decision|2|||
125678303|NCT02777528|452112072|FG001|Overall Study|Physician Decision|1|||
125678304|NCT02777528|452112073|FG002|Overall Study|Physician Decision|0|||
125678305|NCT02777528|452112071|FG000|Overall Study|Lost to Follow-up|2|||
125678306|NCT02777528|452112072|FG001|Overall Study|Lost to Follow-up|0|||
125678307|NCT02777528|452112073|FG002|Overall Study|Lost to Follow-up|0|||
125678308|NCT02777528|452112071|FG000|Overall Study|Discontinued due to Other|1|||
125678309|NCT02777528|452112072|FG001|Overall Study|Discontinued due to Other|0|||
125678310|NCT02777528|452112073|FG002|Overall Study|Discontinued due to Other|0|||
125678311|NCT00453362|452112074|FG000|Overall Study|Adverse Event|5|||
125678312|NCT00453362|452112074|FG000|Overall Study|Death|7|||
125678313|NCT00453362|452112074|FG000|Overall Study|Physician Decision|2|||
125678314|NCT00453362|452112074|FG000|Overall Study|Withdrawal by Subject|3|||
125678315|NCT00453362|452112074|FG000|Overall Study|Progression of disease|56|||
125678316|NCT00453362|452112074|FG000|Overall Study|Screening Failure|14|||
125678317|NCT04885296|452112075|FG000|Period 1|Covid-19 Related|1|||
125678318|NCT04885296|452112076|FG001|Period 1|Covid-19 Related|0|||
125678319|NCT04885296|452112075|FG000|Period 1|Adverse Event|0|||
125678320|NCT04885296|452112076|FG001|Period 1|Adverse Event|1|||
125678321|NCT04885296|452112075|FG000|Period 1|Withdrawal by Subject|1|||
125678322|NCT04885296|452112076|FG001|Period 1|Withdrawal by Subject|1|||
125678323|NCT04885296|452112075|FG000|Period 1|Test Article No Longer Available|1|||
125678324|NCT04885296|452112076|FG001|Period 1|Test Article No Longer Available|0|||
125678325|NCT04885296|452112075|FG000|Period 1|Dispensed Study lens in Error|1|||
125678326|NCT04885296|452112076|FG001|Period 1|Dispensed Study lens in Error|0|||
125678327|NCT04885296|452112075|FG000|Period 1|Lost to Follow-up|1|||
125678328|NCT04885296|452112076|FG001|Period 1|Lost to Follow-up|0|||
125678329|NCT04885296|452112075|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
125678330|NCT04885296|452112076|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
125678331|NCT01027143|452112078|FG000|Overall Study|Lost to Follow-up|9|||
125678332|NCT01027143|452112079|FG001|Overall Study|Lost to Follow-up|4|||
125678333|NCT02564263|452112080|FG000|Overall Study|Adverse Event|31|||
125678334|NCT02564263|452112081|FG001|Overall Study|Adverse Event|29|||
125678335|NCT02564263|452112080|FG000|Overall Study|Death|270|||
125678336|NCT02564263|452112081|FG001|Overall Study|Death|262|||
125678337|NCT02564263|452112080|FG000|Overall Study|Withdrawal by Subject|4|||
125678338|NCT02564263|452112081|FG001|Overall Study|Withdrawal by Subject|19|||
125678339|NCT02564263|452112080|FG000|Overall Study|Sponsor's decision|9|||
125678340|NCT02564263|452112081|FG001|Overall Study|Sponsor's decision|4|||
125678341|NCT01087970|452112083|FG000|Overall Study|Protocol Violation|2|||
125678342|NCT00264797|452112084|FG000|Overall Study|Withdrawal by Subject|11|||
125678343|NCT00264797|452112085|FG001|Overall Study|Withdrawal by Subject|11|||
125678344|NCT00264797|452112084|FG000|Overall Study|Lost to Follow-up|9|||
125678345|NCT00264797|452112085|FG001|Overall Study|Lost to Follow-up|17|||
125678346|NCT00264797|452112084|FG000|Overall Study|Moved from area|3|||
125678347|NCT00264797|452112085|FG001|Overall Study|Moved from area|1|||
125678348|NCT00264797|452112084|FG000|Overall Study|Practical Problems|2|||
125678349|NCT00264797|452112085|FG001|Overall Study|Practical Problems|3|||
125678350|NCT00264797|452112084|FG000|Overall Study|Incarceration|4|||
125678351|NCT00264797|452112085|FG001|Overall Study|Incarceration|5|||
125542633|NCT04058366|451616770|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
125542634|NCT04058366|451616770|FG000|Overall Study|Commercial drug is available for participants|6|||
125542635|NCT04058366|451616770|FG000|Overall Study|Death|1|||
125542636|NCT04058366|451616770|FG000|Overall Study|Other non-compliance|2|||
125542637|NCT04058366|451616770|FG000|Overall Study|Other|6|||
125542638|NCT00603304|451616771|FG000|Overall Study|Lost to Follow-up|5|||
125542639|NCT00603304|451616772|FG001|Overall Study|Lost to Follow-up|7|||
125542640|NCT00603304|451616771|FG000|Overall Study|Withdrawal by Subject|8|||
125542641|NCT00603304|451616772|FG001|Overall Study|Withdrawal by Subject|5|||
125542642|NCT00603304|451616771|FG000|Overall Study|Protocol Violation|1|||
125542643|NCT00603304|451616772|FG001|Overall Study|Protocol Violation|0|||
125542644|NCT00603304|451616771|FG000|Overall Study|Adverse Event|4|||
125542645|NCT00603304|451616772|FG001|Overall Study|Adverse Event|2|||
125542646|NCT00603304|451616771|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
125542647|NCT00603304|451616772|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
125542648|NCT00603304|451616771|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
125542649|NCT00603304|451616772|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
125542650|NCT00603304|451616771|FG000|Overall Study|Exclusionary Medication|2|||
125542651|NCT00603304|451616772|FG001|Overall Study|Exclusionary Medication|3|||
125542652|NCT00603304|451616771|FG000|Overall Study|Non-Compliant|0|||
125542653|NCT00603304|451616772|FG001|Overall Study|Non-Compliant|1|||
125542654|NCT00603304|451616771|FG000|Overall Study|Moved Away|0|||
125542655|NCT00603304|451616772|FG001|Overall Study|Moved Away|2|||
125542656|NCT00603304|451616771|FG000|Overall Study|Other|2|||
125542657|NCT00603304|451616772|FG001|Overall Study|Other|0|||
125542658|NCT00603304|451616771|FG000|Overall Study|Patient Decision|2|||
125542659|NCT00603304|451616772|FG001|Overall Study|Patient Decision|0|||
125542660|NCT02480153|451616773|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
125542661|NCT02480153|451616774|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
125542662|NCT02480153|451616775|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
125542663|NCT02480153|451616773|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
125542664|NCT02480153|451616774|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
125542665|NCT02480153|451616775|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
125542666|NCT02480153|451616773|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
125542667|NCT02480153|451616774|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
125542668|NCT02480153|451616775|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
125542669|NCT02480153|451616773|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
125542670|NCT02480153|451616774|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
125542671|NCT02480153|451616775|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
125542672|NCT02480153|451616773|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
125542673|NCT02480153|451616774|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
125542674|NCT02480153|451616775|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
125542675|NCT02480153|451616773|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
125542676|NCT02480153|451616774|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
125542677|NCT02480153|451616775|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
125542678|NCT02480153|451616773|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
125542679|NCT02480153|451616774|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
125542680|NCT02480153|451616775|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
125542681|NCT02480153|451616773|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
125542682|NCT02480153|451616774|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
125542683|NCT02480153|451616775|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
125542684|NCT02480153|451616773|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
125542685|NCT02480153|451616774|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
125542686|NCT02480153|451616775|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
125542687|NCT02480153|451616773|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
125542688|NCT02480153|451616774|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
125542689|NCT02480153|451616775|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
125542690|NCT02480153|451616773|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
125542691|NCT02480153|451616774|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
125542692|NCT02480153|451616775|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
125542693|NCT02480153|451616773|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
125678352|NCT00264797|452112084|FG000|Overall Study|Pressure/advice from Outsiders|1|||
125678353|NCT00264797|452112085|FG001|Overall Study|Pressure/advice from Outsiders|1|||
125678354|NCT00264797|452112084|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
125678355|NCT00264797|452112085|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
125542694|NCT02480153|451616774|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
125542695|NCT02480153|451616775|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
125678356|NCT00264797|452112084|FG000|Overall Study|Other|3|||
125678357|NCT00264797|452112085|FG001|Overall Study|Other|4|||
125542696|NCT02480153|451616773|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
125542697|NCT02480153|451616774|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
125542698|NCT02480153|451616775|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
125542699|NCT02480153|451616773|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
125542700|NCT02480153|451616774|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
125542701|NCT02480153|451616775|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
125542702|NCT02480153|451616773|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
125542703|NCT02480153|451616774|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
125542704|NCT02480153|451616775|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
125542705|NCT02480153|451616773|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
125542706|NCT02480153|451616774|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
125542707|NCT02480153|451616775|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
125542708|NCT02480153|451616773|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
125542709|NCT02480153|451616774|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
125542710|NCT02480153|451616775|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
125542711|NCT02480153|451616773|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
125542712|NCT02480153|451616774|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
125542713|NCT02480153|451616775|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
125542714|NCT00512317|451616776|FG000|Overall Study|Insufficient clinical response|36|||
125542715|NCT00512317|451616776|FG000|Overall Study|Withdrawal by Subject|23|||
125542716|NCT00512317|451616776|FG000|Overall Study|Sponsor closure of study|21|||
125542717|NCT00512317|451616776|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
125542718|NCT00512317|451616776|FG000|Overall Study|Adverse Event|13|||
125542719|NCT00512317|451616776|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
125542720|NCT00512317|451616776|FG000|Overall Study|Lost to Follow-up|2|||
125542721|NCT00512317|451616776|FG000|Overall Study|Other|2|||
125542722|NCT04433585|451616777|FG000|Overall Study|Withdrawal by Subject|15|||
125542723|NCT04433585|451616778|FG001|Overall Study|Withdrawal by Subject|3|||
125542724|NCT04433585|451616779|FG002|Overall Study|Withdrawal by Subject|15|||
125542725|NCT04433585|451616780|FG003|Overall Study|Withdrawal by Subject|6|||
125542726|NCT04433585|451616777|FG000|Overall Study|Adverse Event|10|||
125542727|NCT04433585|451616778|FG001|Overall Study|Adverse Event|4|||
125542728|NCT04433585|451616779|FG002|Overall Study|Adverse Event|1|||
125542729|NCT04433585|451616780|FG003|Overall Study|Adverse Event|0|||
125542730|NCT04433585|451616777|FG000|Overall Study|Due to the conflict in Ukraine|2|||
125542731|NCT04433585|451616778|FG001|Overall Study|Due to the conflict in Ukraine|1|||
125678358|NCT02636907|452112088|FG000|Autoinjector Assessment Period|Adverse Event|2|||
125678359|NCT02636907|452112088|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
125678360|NCT02636907|452112088|FG000|Extension Phase|Adverse Event|2|||
125678361|NCT02636907|452112088|FG000|Extension Phase|Withdrawal by Subject|4|||
125678362|NCT02636907|452112088|FG000|Extension Phase|Physician Decision|1|||
125678363|NCT02636907|452112088|FG000|Extension Phase|Lost to Follow-up|2|||
125678364|NCT02636907|452112088|FG000|Extension Phase|Lack of Efficacy|1|||
125678365|NCT00762086|452112089|FG000|Overall Study|Adverse Event|2|||
125678366|NCT00762086|452112090|FG001|Overall Study|Adverse Event|0|||
125678367|NCT00762086|452112089|FG000|Overall Study|Lost to Follow-up|0|||
125678368|NCT00762086|452112090|FG001|Overall Study|Lost to Follow-up|2|||
125678369|NCT00762086|452112089|FG000|Overall Study|Non compliance|1|||
125678370|NCT00762086|452112090|FG001|Overall Study|Non compliance|0|||
125678371|NCT00762086|452112089|FG000|Overall Study|Withdrawal by Subject|2|||
125678372|NCT00762086|452112090|FG001|Overall Study|Withdrawal by Subject|2|||
125678373|NCT00762086|452112089|FG000|Overall Study|Ineligible to participate in the study|1|||
125678374|NCT00762086|452112090|FG001|Overall Study|Ineligible to participate in the study|0|||
125678375|NCT03883906|452112098|FG000|Overall Study|Withdrawal by Subject|2|||
125678376|NCT03883906|452112098|FG000|Overall Study|Physician Decision|5|||
125678377|NCT00486837|452112099|FG000|Overall Study|Withdrawal by Subject|1|||
125678378|NCT00486837|452112100|FG001|Overall Study|Withdrawal by Subject|0|||
125678379|NCT00486837|452112099|FG000|Overall Study|Adverse Event|1|||
125678380|NCT00486837|452112100|FG001|Overall Study|Adverse Event|1|||
125678381|NCT00486837|452112099|FG000|Overall Study|Protocol Violation|4|||
125542732|NCT04433585|451616779|FG002|Overall Study|Due to the conflict in Ukraine|1|||
125542733|NCT04433585|451616780|FG003|Overall Study|Due to the conflict in Ukraine|2|||
125542734|NCT04433585|451616777|FG000|Overall Study|Physician Decision|1|||
125542735|NCT04433585|451616778|FG001|Overall Study|Physician Decision|2|||
125542736|NCT04433585|451616779|FG002|Overall Study|Physician Decision|0|||
125542737|NCT04433585|451616780|FG003|Overall Study|Physician Decision|0|||
125542738|NCT04433585|451616777|FG000|Overall Study|Lost to Follow-up|1|||
125678382|NCT00486837|452112100|FG001|Overall Study|Protocol Violation|2|||
125678383|NCT00486837|452112099|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
125678384|NCT00486837|452112100|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
125678385|NCT02468778|452112101|FG000|Overall Study|Death|2|||
125678386|NCT02468778|452112102|FG001|Overall Study|Death|1|||
125678387|NCT02468778|452112103|FG002|Overall Study|Death|0|||
125542739|NCT04433585|451616778|FG001|Overall Study|Lost to Follow-up|1|||
125678388|NCT02468778|452112101|FG000|Overall Study|Lost to Follow-up|1|||
125542740|NCT04433585|451616779|FG002|Overall Study|Lost to Follow-up|1|||
125542741|NCT04433585|451616780|FG003|Overall Study|Lost to Follow-up|0|||
125542742|NCT04433585|451616777|FG000|Overall Study|Lack of Efficacy|0|||
125542743|NCT04433585|451616778|FG001|Overall Study|Lack of Efficacy|1|||
125542744|NCT04433585|451616779|FG002|Overall Study|Lack of Efficacy|1|||
125542745|NCT04433585|451616780|FG003|Overall Study|Lack of Efficacy|1|||
125542746|NCT04433585|451616777|FG000|Overall Study|Death|0|||
125542747|NCT04433585|451616778|FG001|Overall Study|Death|1|||
125542748|NCT04433585|451616779|FG002|Overall Study|Death|0|||
125542749|NCT04433585|451616780|FG003|Overall Study|Death|0|||
125542750|NCT02630693|451616783|FG000|Overall Study|No receive treatment|0|||
125542751|NCT02630693|451616784|FG001|Overall Study|No receive treatment|1|||
125542752|NCT00993668|451616785|FG000|Single-Blind Period|Adverse Event|1|||
125542753|NCT00993668|451616786|FG001|Single-Blind Period|Adverse Event|1|||
125542754|NCT00993668|451616785|FG000|Single-Blind Period|Lack of Efficacy|0|||
125542755|NCT00993668|451616786|FG001|Single-Blind Period|Lack of Efficacy|1|||
125542756|NCT00993668|451616785|FG000|Single-Blind Period|Lost to Follow-up|3|||
125542757|NCT00993668|451616786|FG001|Single-Blind Period|Lost to Follow-up|1|||
125542758|NCT00993668|451616785|FG000|Open-Label Period|Adverse Event|9|||
125542759|NCT00993668|451616786|FG001|Open-Label Period|Adverse Event|8|||
125542760|NCT00993668|451616785|FG000|Open-Label Period|Lack of Efficacy|4|||
125542761|NCT00993668|451616786|FG001|Open-Label Period|Lack of Efficacy|3|||
125542762|NCT00993668|451616785|FG000|Open-Label Period|Withdrawal by Subject|4|||
125542763|NCT00993668|451616786|FG001|Open-Label Period|Withdrawal by Subject|3|||
125542764|NCT00993668|451616785|FG000|Open-Label Period|Lost to Follow-up|6|||
125542765|NCT00993668|451616786|FG001|Open-Label Period|Lost to Follow-up|1|||
125542766|NCT03606668|451616789|FG000|Overall Study|Screen Failure|1|||
125542767|NCT03606668|451616789|FG000|Overall Study|Lost to Follow-up|1|||
125542768|NCT02057523|451616793|FG000|Overall Study|Withdrawal by Subject|1|||
125542769|NCT02057523|451616793|FG000|Overall Study|Lack of Efficacy|1|||
125542770|NCT03618823|451616797|FG000|Overall Study|Lost to Follow-up|63|||
125542771|NCT03618823|451616798|FG001|Overall Study|Lost to Follow-up|61|||
125542772|NCT00523640|451616799|FG000|Overall Study|Death|1|||
125542773|NCT02399254|451616801|FG000|Overall Study|Physician Decision|2|||
125542774|NCT00564889|451616802|FG000|Overall Study|Death|7|||
125542775|NCT00564889|451616802|FG000|Overall Study|Adverse Event|12|||
125542776|NCT00564889|451616802|FG000|Overall Study|Alternative treatment|3|||
125542777|NCT00564889|451616802|FG000|Overall Study|Disease progression|3|||
125542778|NCT00564889|451616802|FG000|Overall Study|Other, not specified|4|||
125542779|NCT03500159|451616803|FG000|Overall Study|Study Terminated|2|||
125542780|NCT03500159|451616804|FG001|Overall Study|Study Terminated|1|||
125542781|NCT02292927|451616805|FG000|Overall Study|Protocol Violation|13|||
125542782|NCT02292927|451616806|FG001|Overall Study|Protocol Violation|7|||
125542783|NCT01605916|451616808|FG000|Overall Study|Adverse Event|1|||
125542784|NCT01605916|451616809|FG001|Overall Study|Adverse Event|0|||
125542785|NCT01605916|451616810|FG002|Overall Study|Adverse Event|0|||
125542786|NCT01605916|451616811|FG003|Overall Study|Adverse Event|1|||
125542787|NCT01605916|451616812|FG004|Overall Study|Adverse Event|0|||
125542788|NCT01605916|451616808|FG000|Overall Study|Lack of Efficacy|2|||
125542789|NCT01605916|451616809|FG001|Overall Study|Lack of Efficacy|3|||
125542790|NCT01605916|451616810|FG002|Overall Study|Lack of Efficacy|3|||
125542791|NCT01605916|451616811|FG003|Overall Study|Lack of Efficacy|5|||
125542792|NCT01605916|451616812|FG004|Overall Study|Lack of Efficacy|4|||
125542793|NCT01605916|451616808|FG000|Overall Study|Withdrawal by Subject|1|||
125542794|NCT01605916|451616809|FG001|Overall Study|Withdrawal by Subject|1|||
125542795|NCT01605916|451616810|FG002|Overall Study|Withdrawal by Subject|0|||
125542796|NCT01605916|451616811|FG003|Overall Study|Withdrawal by Subject|0|||
125542797|NCT01605916|451616812|FG004|Overall Study|Withdrawal by Subject|2|||
125542798|NCT01021215|451616822|FG000|Overall Study|Lost to Follow-up|3|||
125542799|NCT01021215|451616823|FG001|Overall Study|Lost to Follow-up|0|||
125542800|NCT01011387|451616829|FG000|Overall Study|Withdrawal by Subject|3|||
125542801|NCT01011387|451616829|FG000|Overall Study|Adverse Event|2|||
125678389|NCT02468778|452112102|FG001|Overall Study|Lost to Follow-up|2|||
125678390|NCT02468778|452112103|FG002|Overall Study|Lost to Follow-up|2|||
125678391|NCT02468778|452112101|FG000|Overall Study|Withdrawal by Subject|0|||
125678392|NCT02468778|452112102|FG001|Overall Study|Withdrawal by Subject|1|||
125678393|NCT02468778|452112103|FG002|Overall Study|Withdrawal by Subject|1|||
125678394|NCT03130699|452112111|FG000|Overall Study|Lost to Follow-up|34|||
125542802|NCT01011387|451616829|FG000|Overall Study|Protocol Violation|1|||
125542803|NCT02433340|451616830|FG000|Overall Study|Adverse Event|0|||
125542804|NCT02433340|451616831|FG001|Overall Study|Adverse Event|0|||
125542805|NCT02433340|451616832|FG002|Overall Study|Adverse Event|1|||
125542806|NCT02433340|451616833|FG003|Overall Study|Adverse Event|0|||
125542807|NCT02433340|451616830|FG000|Overall Study|Withdrawal by Subject|1|||
125678395|NCT03130699|452112112|FG001|Overall Study|Lost to Follow-up|37|||
125542808|NCT02433340|451616831|FG001|Overall Study|Withdrawal by Subject|0|||
125542809|NCT02433340|451616832|FG002|Overall Study|Withdrawal by Subject|1|||
125542810|NCT02433340|451616833|FG003|Overall Study|Withdrawal by Subject|2|||
125542811|NCT02433340|451616830|FG000|Overall Study|Lost to Follow-up|0|||
125542812|NCT02433340|451616831|FG001|Overall Study|Lost to Follow-up|1|||
125542813|NCT02433340|451616832|FG002|Overall Study|Lost to Follow-up|0|||
125542814|NCT02433340|451616833|FG003|Overall Study|Lost to Follow-up|0|||
125542815|NCT02433340|451616830|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
125542816|NCT02433340|451616831|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
125542817|NCT02433340|451616832|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
125542818|NCT02433340|451616833|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
125542819|NCT02433340|451616830|FG000|Overall Study|Other|0|||
125542820|NCT02433340|451616831|FG001|Overall Study|Other|1|||
125542821|NCT02433340|451616832|FG002|Overall Study|Other|0|||
125542822|NCT02433340|451616833|FG003|Overall Study|Other|0|||
125542823|NCT01178385|451616834|FG000|Overall Study|Withdrawal by Subject|2|||
125542824|NCT01178385|451616835|FG001|Overall Study|Withdrawal by Subject|0|||
125542825|NCT01226095|451616836|FG000|Overall Study|Poor compliance|1|||
125542826|NCT01688830|451616839|FG000|Overall Study|Lost to Follow-up|0|||
125542827|NCT01688830|451616840|FG001|Overall Study|Lost to Follow-up|0|||
125542828|NCT01688830|451616841|FG002|Overall Study|Lost to Follow-up|0|||
125542829|NCT01688830|451616842|FG003|Overall Study|Lost to Follow-up|0|||
125542830|NCT01688830|451616843|FG004|Overall Study|Lost to Follow-up|0|||
125542831|NCT01688830|451616844|FG005|Overall Study|Lost to Follow-up|0|||
125542832|NCT01688830|451616845|FG006|Overall Study|Lost to Follow-up|0|||
125542833|NCT01688830|451616846|FG007|Overall Study|Lost to Follow-up|0|||
125542834|NCT01688830|451616847|FG008|Overall Study|Lost to Follow-up|0|||
125542835|NCT01688830|451616848|FG009|Overall Study|Lost to Follow-up|0|||
125542836|NCT01688830|451616849|FG010|Overall Study|Lost to Follow-up|1|||
125542837|NCT01688830|451616850|FG011|Overall Study|Lost to Follow-up|0|||
125542838|NCT01688830|451616851|FG012|Overall Study|Lost to Follow-up|0|||
125542839|NCT01688830|451616852|FG013|Overall Study|Lost to Follow-up|0|||
125542840|NCT01688830|451616853|FG014|Overall Study|Lost to Follow-up|0|||
125542841|NCT01688830|451616854|FG015|Overall Study|Lost to Follow-up|0|||
125542842|NCT01688830|451616855|FG016|Overall Study|Lost to Follow-up|0|||
125542843|NCT01688830|451616856|FG017|Overall Study|Lost to Follow-up|0|||
125542844|NCT01688830|451616857|FG018|Overall Study|Lost to Follow-up|0|||
125542845|NCT01688830|451616858|FG019|Overall Study|Lost to Follow-up|0|||
125542846|NCT01688830|451616859|FG020|Overall Study|Lost to Follow-up|0|||
125542847|NCT04822597|451616860|FG000|Overall Study|Withdrawal by Subject|0|||
125542848|NCT04822597|451616861|FG001|Overall Study|Withdrawal by Subject|1|||
125542849|NCT04822597|451616862|FG002|Overall Study|Withdrawal by Subject|1|||
125542850|NCT04822597|451616863|FG003|Overall Study|Withdrawal by Subject|0|||
125542851|NCT04822597|451616860|FG000|Overall Study|Physician Decision|0|||
125542852|NCT04822597|451616861|FG001|Overall Study|Physician Decision|0|||
125542853|NCT04822597|451616862|FG002|Overall Study|Physician Decision|1|||
125542854|NCT04822597|451616863|FG003|Overall Study|Physician Decision|1|||
125542855|NCT04822597|451616860|FG000|Overall Study|Subject withdrawn after enrollment|0|||
125542856|NCT04822597|451616861|FG001|Overall Study|Subject withdrawn after enrollment|1|||
125542857|NCT04822597|451616862|FG002|Overall Study|Subject withdrawn after enrollment|0|||
125542858|NCT04822597|451616863|FG003|Overall Study|Subject withdrawn after enrollment|1|||
125542859|NCT04822597|451616860|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
125542860|NCT04822597|451616861|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
125542861|NCT04822597|451616862|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
125542862|NCT04822597|451616863|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
125542863|NCT01285609|451616864|FG000|Randomized|Progressive Disease|41|||
125542864|NCT01285609|451616865|FG001|Randomized|Progressive Disease|61|||
125542865|NCT01285609|451616864|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
125678396|NCT03130699|452112113|FG002|Overall Study|Lost to Follow-up|26|||
125678397|NCT03130699|452112111|FG000|Overall Study|Withdrawal by Subject|5|||
125678398|NCT03130699|452112112|FG001|Overall Study|Withdrawal by Subject|1|||
125678399|NCT03130699|452112113|FG002|Overall Study|Withdrawal by Subject|0|||
125542866|NCT01285609|451616865|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
125542867|NCT01285609|451616864|FG000|Randomized|Study Drug Toxicity|13|||
125542868|NCT01285609|451616865|FG001|Randomized|Study Drug Toxicity|14|||
125542869|NCT01285609|451616864|FG000|Randomized|Death|5|||
125542870|NCT01285609|451616865|FG001|Randomized|Death|7|||
125542871|NCT01285609|451616864|FG000|Randomized|Withdrawal by Subject|8|||
125678400|NCT03130699|452112111|FG000|Overall Study|Withdrawal by PI|1|||
125678401|NCT03130699|452112112|FG001|Overall Study|Withdrawal by PI|2|||
125678402|NCT03130699|452112113|FG002|Overall Study|Withdrawal by PI|5|||
125678403|NCT03130699|452112111|FG000|Overall Study|Death|0|||
125678404|NCT03130699|452112112|FG001|Overall Study|Death|0|||
125542872|NCT01285609|451616865|FG001|Randomized|Withdrawal by Subject|11|||
125542873|NCT01285609|451616864|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
125542874|NCT01285609|451616865|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
125542875|NCT01285609|451616864|FG000|Randomized|Undisclosed Reasons|1|||
125542876|NCT01285609|451616865|FG001|Randomized|Undisclosed Reasons|0|||
125542877|NCT01285609|451616864|FG000|Randomized|Randomized but not Treated|4|||
125542878|NCT01285609|451616865|FG001|Randomized|Randomized but not Treated|4|||
125542879|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
125678405|NCT03130699|452112113|FG002|Overall Study|Death|1|||
125542880|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
125542881|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
125542882|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
125542883|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
125542884|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
125542885|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
125542886|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
125542887|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Death|11|||
125542888|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Death|3|||
125542889|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
125542890|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
125542891|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Not Reported|0|||
125542892|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Not Reported|2|||
125542893|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
125542894|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
125542895|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
125542896|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
125542897|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
125542898|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
125542899|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
125542900|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
125542901|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
125542902|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
125542903|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
125542904|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
125542905|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
125542906|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
125542907|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
125542908|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
125542909|NCT01285609|451616864|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
125542910|NCT01285609|451616865|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
125542911|NCT01285609|451616864|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
125542912|NCT01285609|451616865|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
125542913|NCT03265938|451616875|FG000|Overall Study|Withdrawal by Subject|1|||
125542914|NCT03265938|451616875|FG000|Overall Study|Physician Decision|1|||
125542915|NCT03265938|451616875|FG000|Overall Study|friable mass|6|||
125542916|NCT02412371|451616878|FG000|Overall Study|Withdrawal by Subject|0|||
125542917|NCT02412371|451616879|FG001|Overall Study|Withdrawal by Subject|2|||
125542918|NCT02412371|451616880|FG002|Overall Study|Withdrawal by Subject|0|||
125542919|NCT02412371|451616881|FG003|Overall Study|Withdrawal by Subject|1|||
125542920|NCT02412371|451616882|FG004|Overall Study|Withdrawal by Subject|1|||
125542921|NCT02412371|451616883|FG005|Overall Study|Withdrawal by Subject|0|||
125542922|NCT02412371|451616878|FG000|Overall Study|Sponsor Discontinued Study|1|||
125542923|NCT02412371|451616879|FG001|Overall Study|Sponsor Discontinued Study|4|||
125542924|NCT02412371|451616880|FG002|Overall Study|Sponsor Discontinued Study|6|||
125542925|NCT02412371|451616881|FG003|Overall Study|Sponsor Discontinued Study|4|||
125542926|NCT02412371|451616882|FG004|Overall Study|Sponsor Discontinued Study|5|||
125542927|NCT02412371|451616883|FG005|Overall Study|Sponsor Discontinued Study|0|||
125542928|NCT02412371|451616878|FG000|Overall Study|Death|4|||
125542929|NCT02412371|451616879|FG001|Overall Study|Death|2|||
125542930|NCT02412371|451616880|FG002|Overall Study|Death|1|||
125678406|NCT01199861|452112114|FG000|Overall Study|Administrative problems|1|||
125678407|NCT01199861|452112115|FG001|Overall Study|Administrative problems|0|||
125678408|NCT01199861|452112114|FG000|Overall Study|Adverse Event|1|||
125678409|NCT01199861|452112115|FG001|Overall Study|Adverse Event|0|||
125678410|NCT00669864|452112118|FG000|Overall Study|Lost to Follow-up|2|||
125542931|NCT02412371|451616881|FG003|Overall Study|Death|3|||
125542932|NCT02412371|451616882|FG004|Overall Study|Death|5|||
125542933|NCT02412371|451616883|FG005|Overall Study|Death|2|||
125542934|NCT02412371|451616878|FG000|Overall Study|Other|2|||
125678411|NCT00669864|452112118|FG000|Overall Study|Protocol Violation|2|||
125678412|NCT00669864|452112118|FG000|Overall Study|Withdrawal by Subject|3|||
125678413|NCT00669864|452112118|FG000|Overall Study|Other|2|||
125678414|NCT00680121|452112122|FG000|Overall Study|Lost to Follow-up|27|||
125678415|NCT00680121|452112123|FG001|Overall Study|Lost to Follow-up|23|||
125678416|NCT02545998|452112134|FG000|Overall Study|Lost to Follow-up|12|||
125678417|NCT02545998|452112135|FG001|Overall Study|Lost to Follow-up|3|||
125542935|NCT02412371|451616879|FG001|Overall Study|Other|1|||
125678418|NCT02545998|452112134|FG000|Overall Study|Withdrawal by Subject|3|||
125678419|NCT02545998|452112135|FG001|Overall Study|Withdrawal by Subject|2|||
125678420|NCT00117949|452112157|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
125542936|NCT02412371|451616880|FG002|Overall Study|Other|0|||
125542937|NCT02412371|451616881|FG003|Overall Study|Other|0|||
125542938|NCT02412371|451616882|FG004|Overall Study|Other|1|||
125542939|NCT02412371|451616883|FG005|Overall Study|Other|3|||
125542940|NCT02053792|451616884|FG000|Overall Study|Physician Decision|0|||
125542941|NCT02053792|451616885|FG001|Overall Study|Physician Decision|1|||
125542942|NCT02053792|451616884|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
125542943|NCT02053792|451616885|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
125542944|NCT02053792|451616884|FG000|Overall Study|Lack of Efficacy|1|||
125542945|NCT02053792|451616885|FG001|Overall Study|Lack of Efficacy|0|||
125542946|NCT02053792|451616884|FG000|Overall Study|Adverse Event|1|||
125542947|NCT02053792|451616885|FG001|Overall Study|Adverse Event|0|||
125542948|NCT02053792|451616884|FG000|Overall Study|Withdrawal by Subject|2|||
125542949|NCT02053792|451616885|FG001|Overall Study|Withdrawal by Subject|2|||
125542950|NCT02053792|451616884|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
125542951|NCT02053792|451616885|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
125542952|NCT02053792|451616884|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
125542953|NCT02053792|451616885|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
125542954|NCT01028027|451616886|FG000|Overall Study|Lost to Follow-up|4|||
125542955|NCT01028027|451616887|FG001|Overall Study|Lost to Follow-up|1|||
125542956|NCT01028027|451616886|FG000|Overall Study|Withdrawal by Subject|5|||
125542957|NCT01028027|451616887|FG001|Overall Study|Withdrawal by Subject|3|||
125542958|NCT01028027|451616886|FG000|Overall Study|Adverse Event|4|||
125542959|NCT01028027|451616887|FG001|Overall Study|Adverse Event|7|||
125542960|NCT01028027|451616886|FG000|Overall Study|Protocol Violation|3|||
125542961|NCT01028027|451616887|FG001|Overall Study|Protocol Violation|1|||
125542962|NCT01028027|451616886|FG000|Overall Study|Lack of Efficacy|0|||
125542963|NCT01028027|451616887|FG001|Overall Study|Lack of Efficacy|1|||
125542964|NCT05000931|451616897|FG000|Overall Study|Lost to Follow-up|1|||
125542965|NCT05326815|451616898|FG000|Overall Study|Withdrawal by Subject|3|||
125542966|NCT05326815|451616898|FG000|Overall Study|Did not complete required labs|6|||
125542967|NCT05326815|451616898|FG000|Overall Study|Screen fail- abnormal labs|5|||
125542968|NCT00925132|451616899|FG000|Overall Study|Withdrawal by Subject|2|||
125542969|NCT00925132|451616900|FG001|Overall Study|Withdrawal by Subject|0|||
125542970|NCT00925132|451616901|FG002|Overall Study|Withdrawal by Subject|0|||
125542971|NCT00925132|451616902|FG003|Overall Study|Withdrawal by Subject|0|||
125542972|NCT00925132|451616903|FG004|Overall Study|Withdrawal by Subject|1|||
125542973|NCT00925132|451616899|FG000|Overall Study|Removed due to disease progression|0|||
125542974|NCT00925132|451616900|FG001|Overall Study|Removed due to disease progression|0|||
125542975|NCT00925132|451616901|FG002|Overall Study|Removed due to disease progression|0|||
125542976|NCT00925132|451616902|FG003|Overall Study|Removed due to disease progression|0|||
125542977|NCT00925132|451616903|FG004|Overall Study|Removed due to disease progression|4|||
125542978|NCT02545933|451616904|FG000|Overall Study|Adverse Event|3|||
125542979|NCT02545933|451616905|FG001|Overall Study|Adverse Event|0|||
125542980|NCT02545933|451616906|FG002|Overall Study|Adverse Event|0|||
125542981|NCT02545933|451616904|FG000|Overall Study|Withdrawal by Subject|2|||
125542982|NCT02545933|451616905|FG001|Overall Study|Withdrawal by Subject|3|||
125542983|NCT02545933|451616906|FG002|Overall Study|Withdrawal by Subject|3|||
125542984|NCT02545933|451616904|FG000|Overall Study|Protocol Violation|1|||
125542985|NCT02545933|451616905|FG001|Overall Study|Protocol Violation|0|||
125542986|NCT02545933|451616906|FG002|Overall Study|Protocol Violation|1|||
125542987|NCT03149549|451616907|FG000|Study Discontinuation--Treatment Period|Death|0|||
125542988|NCT03149549|451616908|FG001|Study Discontinuation--Treatment Period|Death|0|||
125542989|NCT03149549|451616909|FG002|Study Discontinuation--Treatment Period|Death|0|||
125542990|NCT03149549|451616910|FG003|Study Discontinuation--Treatment Period|Death|1|||
125542991|NCT03149549|451616911|FG004|Study Discontinuation--Treatment Period|Death|2|||
125542992|NCT03149549|451616912|FG005|Study Discontinuation--Treatment Period|Death|1|||
125542993|NCT03149549|451616913|FG006|Study Discontinuation--Treatment Period|Death|1|||
125542994|NCT03149549|451616914|FG007|Study Discontinuation--Treatment Period|Death|2|||
125542995|NCT03149549|451616915|FG008|Study Discontinuation--Treatment Period|Death|4|||
125542996|NCT03149549|451616916|FG009|Study Discontinuation--Treatment Period|Death|1|||
125542997|NCT03149549|451616917|FG010|Study Discontinuation--Treatment Period|Death|0|||
125542998|NCT03149549|451616918|FG011|Study Discontinuation--Treatment Period|Death|0|||
125542999|NCT03149549|451616919|FG012|Study Discontinuation--Treatment Period|Death|1|||
125543000|NCT03149549|451616907|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
125543001|NCT03149549|451616908|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
125543002|NCT03149549|451616909|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
125543003|NCT03149549|451616910|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
125543004|NCT03149549|451616911|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
125543005|NCT03149549|451616912|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
125543006|NCT03149549|451616913|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
125543007|NCT03149549|451616914|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
125543008|NCT03149549|451616915|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
125543009|NCT03149549|451616916|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
125543010|NCT03149549|451616917|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
125543011|NCT03149549|451616918|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
125543012|NCT03149549|451616919|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
125543013|NCT03149549|451616907|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
125543014|NCT03149549|451616908|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
125543015|NCT03149549|451616909|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
125543016|NCT03149549|451616910|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
125543017|NCT03149549|451616911|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
125543018|NCT03149549|451616912|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
125543019|NCT03149549|451616913|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
125543020|NCT03149549|451616914|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
125543021|NCT03149549|451616915|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
125543022|NCT03149549|451616916|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
125543023|NCT03149549|451616917|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
125543024|NCT03149549|451616918|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
125543025|NCT03149549|451616919|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
125543026|NCT03149549|451616907|FG000|Study Discontinuation--Treatment Period|Other|0|||
125543027|NCT03149549|451616908|FG001|Study Discontinuation--Treatment Period|Other|0|||
125543028|NCT03149549|451616909|FG002|Study Discontinuation--Treatment Period|Other|0|||
125543029|NCT03149549|451616910|FG003|Study Discontinuation--Treatment Period|Other|0|||
125543030|NCT03149549|451616911|FG004|Study Discontinuation--Treatment Period|Other|0|||
125543031|NCT03149549|451616912|FG005|Study Discontinuation--Treatment Period|Other|0|||
125543032|NCT03149549|451616913|FG006|Study Discontinuation--Treatment Period|Other|0|||
125543033|NCT03149549|451616914|FG007|Study Discontinuation--Treatment Period|Other|1|||
125543034|NCT03149549|451616915|FG008|Study Discontinuation--Treatment Period|Other|0|||
125543035|NCT03149549|451616916|FG009|Study Discontinuation--Treatment Period|Other|1|||
125543036|NCT03149549|451616917|FG010|Study Discontinuation--Treatment Period|Other|0|||
125543037|NCT03149549|451616918|FG011|Study Discontinuation--Treatment Period|Other|0|||
125543038|NCT03149549|451616919|FG012|Study Discontinuation--Treatment Period|Other|0|||
125543039|NCT03149549|451616907|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125543040|NCT03149549|451616908|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125543041|NCT03149549|451616909|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125543042|NCT03149549|451616910|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125543043|NCT03149549|451616911|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125543044|NCT03149549|451616912|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
125543045|NCT03149549|451616913|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
125678421|NCT00117949|452112158|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
125678422|NCT00117949|452112159|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
125678423|NCT00117949|452112160|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
125678424|NCT00117949|452112157|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
125678425|NCT00117949|452112158|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
125678426|NCT00117949|452112159|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
125678427|NCT00117949|452112160|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
125678428|NCT00117949|452112157|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
125678429|NCT00117949|452112158|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
125678430|NCT00117949|452112159|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
125678431|NCT00117949|452112160|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
125678432|NCT00117949|452112157|FG000|Overall Study|PSA increase >=10ng/mL|0|||
125678433|NCT00117949|452112158|FG001|Overall Study|PSA increase >=10ng/mL|1|||
125678434|NCT00117949|452112159|FG002|Overall Study|PSA increase >=10ng/mL|1|||
125678435|NCT00117949|452112160|FG003|Overall Study|PSA increase >=10ng/mL|0|||
125678436|NCT00117949|452112157|FG000|Overall Study|PSA reduction <=50%|0|||
125678437|NCT00117949|452112158|FG001|Overall Study|PSA reduction <=50%|2|||
125678438|NCT00117949|452112159|FG002|Overall Study|PSA reduction <=50%|2|||
125678439|NCT00117949|452112160|FG003|Overall Study|PSA reduction <=50%|4|||
125678440|NCT00117949|452112157|FG000|Overall Study|Hepatic abnormalities|0|||
125678441|NCT00117949|452112158|FG001|Overall Study|Hepatic abnormalities|1|||
125678442|NCT00117949|452112159|FG002|Overall Study|Hepatic abnormalities|0|||
125678443|NCT00117949|452112160|FG003|Overall Study|Hepatic abnormalities|1|||
125678444|NCT01226797|452112161|FG000|Overall Study|Adverse Event|1|||
125678445|NCT01226797|452112162|FG001|Overall Study|Adverse Event|0|||
125678446|NCT01226797|452112161|FG000|Overall Study|No longer willing to participate|1|||
125678447|NCT01226797|452112162|FG001|Overall Study|No longer willing to participate|0|||
125344946|NCT03222492|450896466|FG001|Overall Study|Withdrawal by Subject|0|||
125543046|NCT03149549|451616914|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125543047|NCT03149549|451616915|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
125543048|NCT03149549|451616916|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125543049|NCT03149549|451616917|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125543050|NCT03149549|451616918|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125543051|NCT03149549|451616919|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
125543052|NCT03149549|451616907|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
125543053|NCT03149549|451616908|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
125543054|NCT03149549|451616909|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
125543055|NCT03149549|451616910|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
125543056|NCT03149549|451616911|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
125543057|NCT03149549|451616912|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
125543058|NCT03149549|451616913|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
125543059|NCT03149549|451616914|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
125543060|NCT03149549|451616915|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
125543061|NCT03149549|451616916|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
125543062|NCT03149549|451616917|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
125543063|NCT03149549|451616918|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
125543064|NCT03149549|451616919|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
125543065|NCT03149549|451616907|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
125543066|NCT03149549|451616908|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
125543067|NCT03149549|451616909|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
125543068|NCT03149549|451616910|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
125543069|NCT03149549|451616911|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
125543070|NCT03149549|451616912|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
125543071|NCT03149549|451616913|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
125543072|NCT03149549|451616914|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
125543073|NCT03149549|451616915|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
125543074|NCT03149549|451616916|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
125543075|NCT03149549|451616917|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
125543076|NCT03149549|451616918|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
125543077|NCT03149549|451616919|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
125543078|NCT03149549|451616907|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
125543079|NCT03149549|451616908|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
125543080|NCT03149549|451616909|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
125543081|NCT03149549|451616910|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
125543082|NCT03149549|451616911|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
125543083|NCT03149549|451616912|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
125543084|NCT03149549|451616913|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
125543085|NCT03149549|451616914|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
125543086|NCT03149549|451616915|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
125543087|NCT03149549|451616916|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
125543088|NCT03149549|451616917|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
125543089|NCT03149549|451616918|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
125543090|NCT03149549|451616919|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
125543091|NCT03149549|451616907|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
125543092|NCT03149549|451616908|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
125543093|NCT03149549|451616909|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
125543094|NCT03149549|451616910|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
125543095|NCT03149549|451616911|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
125543096|NCT03149549|451616912|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
125543097|NCT03149549|451616913|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
125543098|NCT03149549|451616914|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
125543099|NCT03149549|451616915|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
125543100|NCT03149549|451616916|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
125543101|NCT03149549|451616917|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
125543102|NCT03149549|451616918|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
125543103|NCT03149549|451616919|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
125543104|NCT00979134|451616922|FG000|Overall Study|Disease progression|18|||
125543105|NCT00979134|451616923|FG001|Overall Study|Disease progression|2|||
125543106|NCT00979134|451616924|FG002|Overall Study|Disease progression|5|||
125543107|NCT00979134|451616922|FG000|Overall Study|Adverse Event|0|||
125678448|NCT01226797|452112161|FG000|Overall Study|Protocol Violation|0|||
125678449|NCT01226797|452112162|FG001|Overall Study|Protocol Violation|1|||
125678450|NCT01606306|452112164|FG000|Overall Study|Lack of Efficacy|2|||
125678451|NCT01606306|452112165|FG001|Overall Study|Lack of Efficacy|1|||
125543108|NCT00979134|451616923|FG001|Overall Study|Adverse Event|0|||
125543109|NCT00979134|451616924|FG002|Overall Study|Adverse Event|2|||
125543110|NCT00979134|451616922|FG000|Overall Study|Withdrawal by Subject|1|||
125543111|NCT00979134|451616923|FG001|Overall Study|Withdrawal by Subject|1|||
125543112|NCT00979134|451616924|FG002|Overall Study|Withdrawal by Subject|2|||
125543113|NCT00979134|451616922|FG000|Overall Study|Lost to Follow-up|2|||
125543114|NCT00979134|451616923|FG001|Overall Study|Lost to Follow-up|2|||
125543115|NCT00979134|451616924|FG002|Overall Study|Lost to Follow-up|0|||
125543116|NCT00979134|451616922|FG000|Overall Study|Death|4|||
125543117|NCT00979134|451616923|FG001|Overall Study|Death|0|||
125543118|NCT00979134|451616924|FG002|Overall Study|Death|26|||
125543119|NCT00979134|451616922|FG000|Overall Study|Other|8|||
125543120|NCT00979134|451616923|FG001|Overall Study|Other|1|||
125543121|NCT00979134|451616924|FG002|Overall Study|Other|5|||
125543122|NCT01034176|451618797|FG000|Overall Study|Physician Decision|2|||
125543123|NCT01034176|451618798|FG001|Overall Study|Physician Decision|0|||
125543124|NCT01034176|451618797|FG000|Overall Study|Withdrawal by Subject|0|||
125543125|NCT01034176|451618798|FG001|Overall Study|Withdrawal by Subject|1|||
125678452|NCT01606306|452112166|FG002|Overall Study|Lack of Efficacy|4|||
125678453|NCT01606306|452112167|FG003|Overall Study|Lack of Efficacy|4|||
125678454|NCT01606306|452112168|FG004|Overall Study|Lack of Efficacy|1|||
125678455|NCT01606306|452112169|FG005|Overall Study|Lack of Efficacy|2|||
125678456|NCT01606306|452112164|FG000|Overall Study|Adverse Event|1|||
125678457|NCT01606306|452112165|FG001|Overall Study|Adverse Event|0|||
125678458|NCT01606306|452112166|FG002|Overall Study|Adverse Event|1|||
125678459|NCT01606306|452112167|FG003|Overall Study|Adverse Event|1|||
125678460|NCT01606306|452112168|FG004|Overall Study|Adverse Event|2|||
125678461|NCT01606306|452112169|FG005|Overall Study|Adverse Event|0|||
125678462|NCT01606306|452112164|FG000|Overall Study|Lost to Follow-up|7|||
125678463|NCT01606306|452112165|FG001|Overall Study|Lost to Follow-up|4|||
125678464|NCT01606306|452112166|FG002|Overall Study|Lost to Follow-up|5|||
125678465|NCT01606306|452112167|FG003|Overall Study|Lost to Follow-up|4|||
125678466|NCT01606306|452112168|FG004|Overall Study|Lost to Follow-up|3|||
125678467|NCT01606306|452112169|FG005|Overall Study|Lost to Follow-up|5|||
125678468|NCT01606306|452112164|FG000|Overall Study|Withdrawal by Subject|4|||
125678469|NCT01606306|452112165|FG001|Overall Study|Withdrawal by Subject|3|||
125678470|NCT01606306|452112166|FG002|Overall Study|Withdrawal by Subject|4|||
125678471|NCT01606306|452112167|FG003|Overall Study|Withdrawal by Subject|4|||
125678472|NCT01606306|452112168|FG004|Overall Study|Withdrawal by Subject|5|||
125678473|NCT01606306|452112169|FG005|Overall Study|Withdrawal by Subject|4|||
125678474|NCT01606306|452112164|FG000|Overall Study|Physician Decision|1|||
125678475|NCT01606306|452112165|FG001|Overall Study|Physician Decision|2|||
125678476|NCT01606306|452112166|FG002|Overall Study|Physician Decision|0|||
125678477|NCT01606306|452112167|FG003|Overall Study|Physician Decision|0|||
125678478|NCT01606306|452112168|FG004|Overall Study|Physician Decision|0|||
125678479|NCT01606306|452112169|FG005|Overall Study|Physician Decision|0|||
125678480|NCT00841100|452112172|FG000|Phase 1 (28 Days)|Adverse Event|1|||
125678481|NCT00841100|452112172|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
125678482|NCT01355081|452112173|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
125678483|NCT01355081|452112174|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
125678484|NCT01355081|452112175|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
125678485|NCT01355081|452112173|FG000|Overall Study|Major Protocol Deviation|0|||
125678486|NCT01355081|452112174|FG001|Overall Study|Major Protocol Deviation|1|||
125678487|NCT01355081|452112175|FG002|Overall Study|Major Protocol Deviation|0|||
125678488|NCT01355081|452112173|FG000|Overall Study|Lost to Follow-up|0|||
125678489|NCT01355081|452112174|FG001|Overall Study|Lost to Follow-up|0|||
125678490|NCT01355081|452112175|FG002|Overall Study|Lost to Follow-up|1|||
125678491|NCT01355081|452112173|FG000|Overall Study|Withdrawal of Consent|2|||
125678492|NCT01355081|452112174|FG001|Overall Study|Withdrawal of Consent|3|||
125678493|NCT01355081|452112175|FG002|Overall Study|Withdrawal of Consent|3|||
125678494|NCT01355081|452112173|FG000|Overall Study|Lack of Efficacy|2|||
125678495|NCT01355081|452112174|FG001|Overall Study|Lack of Efficacy|1|||
125678496|NCT01355081|452112175|FG002|Overall Study|Lack of Efficacy|1|||
125678497|NCT01355081|452112173|FG000|Overall Study|Non Compliance with Study Medication|0|||
125678498|NCT01355081|452112174|FG001|Overall Study|Non Compliance with Study Medication|1|||
125543126|NCT01034176|451618797|FG000|Overall Study|Lost to Follow-up|0|||
125543127|NCT01034176|451618798|FG001|Overall Study|Lost to Follow-up|1|||
125543128|NCT03207009|451618801|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
125543129|NCT04343872|451618802|FG000|Overall Study|Lost to Follow-up|6|||
125543130|NCT04343872|451618803|FG001|Overall Study|Lost to Follow-up|3|||
125543131|NCT03241225|451618804|FG000|Overall Study|Lost to Follow-up|2|||
125543132|NCT03241225|451618805|FG001|Overall Study|Lost to Follow-up|1|||
125543133|NCT03241225|451618804|FG000|Overall Study|Protocol Violation|4|||
125678499|NCT01355081|452112175|FG002|Overall Study|Non Compliance with Study Medication|0|||
125678500|NCT01475474|452112176|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
125678501|NCT01475474|452112176|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
125543134|NCT03241225|451618805|FG001|Overall Study|Protocol Violation|1|||
125543135|NCT03241225|451618804|FG000|Overall Study|Withdrawal by Subject|1|||
125543136|NCT03241225|451618805|FG001|Overall Study|Withdrawal by Subject|0|||
125543137|NCT01635920|451618810|FG000|Overall Study|Adverse Event|1|||
125543138|NCT01635920|451618811|FG001|Overall Study|Adverse Event|0|||
125543139|NCT01635920|451618810|FG000|Overall Study|Lost to Follow-up|0|||
125543140|NCT01635920|451618811|FG001|Overall Study|Lost to Follow-up|1|||
125543141|NCT01635920|451618810|FG000|Overall Study|Subject decision|2|||
125543142|NCT01635920|451618811|FG001|Overall Study|Subject decision|0|||
125543143|NCT00007345|451618812|FG000|Overall Study|Refused further treatment|0|||
125543144|NCT00007345|451618813|FG001|Overall Study|Refused further treatment|7|||
125543145|NCT00007345|451618812|FG000|Overall Study|Switched to alternative treatment|0|||
125543146|NCT00007345|451618813|FG001|Overall Study|Switched to alternative treatment|3|||
125543147|NCT00007345|451618812|FG000|Overall Study|Intercurrent illness|1|||
125543148|NCT00007345|451618813|FG001|Overall Study|Intercurrent illness|0|||
125543149|NCT00007345|451618812|FG000|Overall Study|Death on study|1|||
125543150|NCT00007345|451618813|FG001|Overall Study|Death on study|1|||
125543151|NCT02074553|451618814|FG000|Intervention Period 1|Family Emergency|0|||
125543152|NCT02074553|451618815|FG001|Intervention Period 1|Family Emergency|0|||
125543153|NCT02074553|451618816|FG002|Intervention Period 1|Family Emergency|0|||
125543154|NCT02074553|451618817|FG003|Intervention Period 1|Family Emergency|1|||
125543155|NCT02074553|451618818|FG004|Intervention Period 1|Family Emergency|0|||
125543156|NCT02074553|451618819|FG005|Intervention Period 1|Family Emergency|0|||
125543157|NCT02074553|451618820|FG006|Intervention Period 1|Family Emergency|0|||
125543158|NCT02074553|451618821|FG007|Intervention Period 1|Family Emergency|0|||
125543159|NCT02074553|451618814|FG000|Washout Period 1|Adverse Event|1|||
125543160|NCT02074553|451618815|FG001|Washout Period 1|Adverse Event|0|||
125543161|NCT02074553|451618816|FG002|Washout Period 1|Adverse Event|0|||
125543162|NCT02074553|451618817|FG003|Washout Period 1|Adverse Event|0|||
125543163|NCT02074553|451618818|FG004|Washout Period 1|Adverse Event|0|||
125543164|NCT02074553|451618819|FG005|Washout Period 1|Adverse Event|0|||
125543165|NCT02074553|451618820|FG006|Washout Period 1|Adverse Event|0|||
125543166|NCT02074553|451618821|FG007|Washout Period 1|Adverse Event|0|||
125543167|NCT02074553|451618814|FG000|Washout Period 1|Physician Decision|0|||
125543168|NCT02074553|451618815|FG001|Washout Period 1|Physician Decision|0|||
125543169|NCT02074553|451618816|FG002|Washout Period 1|Physician Decision|0|||
125543170|NCT02074553|451618817|FG003|Washout Period 1|Physician Decision|1|||
125543171|NCT02074553|451618818|FG004|Washout Period 1|Physician Decision|0|||
125543172|NCT02074553|451618819|FG005|Washout Period 1|Physician Decision|0|||
125543173|NCT02074553|451618820|FG006|Washout Period 1|Physician Decision|0|||
125543174|NCT02074553|451618821|FG007|Washout Period 1|Physician Decision|0|||
125543175|NCT02074553|451618814|FG000|Washout Period 1|Other|0|||
125543176|NCT02074553|451618815|FG001|Washout Period 1|Other|0|||
125543177|NCT02074553|451618816|FG002|Washout Period 1|Other|0|||
125678502|NCT01868009|452112179|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
125678503|NCT01868009|452112180|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
125678504|NCT01868009|452112179|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
125678505|NCT01868009|452112180|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
125678506|NCT01868009|452112179|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
125678507|NCT01868009|452112180|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
125678508|NCT04803357|452112185|FG000|Overall Study|Withdrawal by Subject|31|||
125678509|NCT04803357|452112186|FG001|Overall Study|Withdrawal by Subject|5|||
125678510|NCT01046253|452112187|FG000|Second Intervention|Adverse Event|0|||
125678511|NCT01046253|452112188|FG001|Second Intervention|Adverse Event|1|||
125678512|NCT01046253|452112187|FG000|Second Intervention|Protocol Violation|0|||
125678513|NCT01046253|452112188|FG001|Second Intervention|Protocol Violation|1|||
125678514|NCT02339909|452112191|FG000|Overall Study|Became ineligible after randomisation|89|||
125678515|NCT02339909|452112192|FG001|Overall Study|Became ineligible after randomisation|63|||
125678516|NCT02339909|452112193|FG002|Overall Study|Became ineligible after randomisation|71|||
125678517|NCT00860028|452112196|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
125678518|NCT00860028|452112197|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
125678519|NCT01658943|452112199|FG000|Overall Study|Adverse Event|6|||
125678520|NCT01658943|452112200|FG001|Overall Study|Adverse Event|13|||
125678521|NCT01658943|452112199|FG000|Overall Study|Withdrawal by Subject|9|||
125543178|NCT02074553|451618817|FG003|Washout Period 1|Other|0|||
125543179|NCT02074553|451618818|FG004|Washout Period 1|Other|0|||
125543180|NCT02074553|451618819|FG005|Washout Period 1|Other|1|||
125543181|NCT02074553|451618820|FG006|Washout Period 1|Other|0|||
125543182|NCT02074553|451618821|FG007|Washout Period 1|Other|0|||
125543183|NCT02074553|451618814|FG000|Washout Period 2|Adverse Event|0|||
125543184|NCT02074553|451618815|FG001|Washout Period 2|Adverse Event|0|||
125543185|NCT02074553|451618816|FG002|Washout Period 2|Adverse Event|0|||
125678522|NCT01658943|452112200|FG001|Overall Study|Withdrawal by Subject|2|||
125678523|NCT01658943|452112199|FG000|Overall Study|Progression/Relapse|39|||
125543186|NCT02074553|451618817|FG003|Washout Period 2|Adverse Event|0|||
125543187|NCT02074553|451618818|FG004|Washout Period 2|Adverse Event|0|||
125543188|NCT02074553|451618819|FG005|Washout Period 2|Adverse Event|0|||
125543189|NCT02074553|451618820|FG006|Washout Period 2|Adverse Event|1|||
125543190|NCT02074553|451618821|FG007|Washout Period 2|Adverse Event|0|||
125543191|NCT02074553|451618814|FG000|Washout Period 2|Physician Decision|0|||
125543192|NCT02074553|451618815|FG001|Washout Period 2|Physician Decision|0|||
125543193|NCT02074553|451618816|FG002|Washout Period 2|Physician Decision|0|||
125543194|NCT02074553|451618817|FG003|Washout Period 2|Physician Decision|0|||
125543195|NCT02074553|451618818|FG004|Washout Period 2|Physician Decision|0|||
125543196|NCT02074553|451618819|FG005|Washout Period 2|Physician Decision|1|||
125543197|NCT02074553|451618820|FG006|Washout Period 2|Physician Decision|0|||
125543198|NCT02074553|451618821|FG007|Washout Period 2|Physician Decision|0|||
125543199|NCT02074553|451618814|FG000|Washout Period 2|Lost to Follow-up|0|||
125543200|NCT02074553|451618815|FG001|Washout Period 2|Lost to Follow-up|0|||
125543201|NCT02074553|451618816|FG002|Washout Period 2|Lost to Follow-up|1|||
125543202|NCT02074553|451618817|FG003|Washout Period 2|Lost to Follow-up|0|||
125543203|NCT02074553|451618818|FG004|Washout Period 2|Lost to Follow-up|0|||
125543204|NCT02074553|451618819|FG005|Washout Period 2|Lost to Follow-up|0|||
125543205|NCT02074553|451618820|FG006|Washout Period 2|Lost to Follow-up|0|||
125543206|NCT02074553|451618821|FG007|Washout Period 2|Lost to Follow-up|0|||
125543207|NCT02074553|451618814|FG000|Washout Period 3|Physician Decision|0|||
125543208|NCT02074553|451618815|FG001|Washout Period 3|Physician Decision|0|||
125543209|NCT02074553|451618816|FG002|Washout Period 3|Physician Decision|0|||
125543210|NCT02074553|451618817|FG003|Washout Period 3|Physician Decision|0|||
125543211|NCT02074553|451618818|FG004|Washout Period 3|Physician Decision|0|||
125543212|NCT02074553|451618819|FG005|Washout Period 3|Physician Decision|0|||
125543213|NCT02074553|451618820|FG006|Washout Period 3|Physician Decision|0|||
125543214|NCT02074553|451618821|FG007|Washout Period 3|Physician Decision|1|||
125543215|NCT00194987|451618822|FG000|Overall Study|Withdrawal by Subject|0|||
125543216|NCT00194987|451618823|FG001|Overall Study|Withdrawal by Subject|3|||
125543217|NCT01664598|451618824|FG000|Overall Study|Sponsor Decision|1|||
125543218|NCT01664598|451618824|FG000|Overall Study|Withdrawal of Informed Consent|4|||
125543219|NCT01664598|451618824|FG000|Overall Study|Adverse Event|1|||
125543220|NCT01658150|451618825|FG000|Overall Study|Withdrawal by Subject|1|||
125543221|NCT02342743|451618826|FG000|Baseline Period|Withdrawal by Subject|3|||
125543222|NCT02342743|451618826|FG000|Baseline Period|Lost to Follow-up|2|||
125543223|NCT02342743|451618826|FG000|Baseline Period|Change in prophylactic medication|3|||
125543224|NCT02342743|451618826|FG000|Baseline Period|Screening failure regarding baseline|7|||
125543225|NCT02342743|451618826|FG000|Treatment Period|Withdrawal by Subject|2|||
125543226|NCT02342743|451618826|FG000|Treatment Period|Lost to Follow-up|8|||
125543227|NCT02342743|451618826|FG000|Treatment Period|Change in prophylactic medication|1|||
125543228|NCT04875676|451618827|FG000|Overall Study|Lost to Follow-up|1|||
125543229|NCT04875676|451618828|FG001|Overall Study|Lost to Follow-up|0|||
125543230|NCT04875676|451618829|FG002|Overall Study|Lost to Follow-up|0|||
125543231|NCT04187989|451618830|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
125543232|NCT04187989|451618831|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
125543233|NCT04187989|451618830|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
125543234|NCT04187989|451618831|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
125543235|NCT03646656|451618832|FG000|Overall Study|Lost to Follow-up|1|||
125543236|NCT03646656|451618833|FG001|Overall Study|Lost to Follow-up|0|||
125543237|NCT03646656|451618832|FG000|Overall Study|Withdrawal by Subject|2|||
125543238|NCT03646656|451618833|FG001|Overall Study|Withdrawal by Subject|0|||
125543239|NCT03602066|451618834|FG000|Overall Study|Withdrawal by Subject|2|||
125543240|NCT03602066|451618835|FG001|Overall Study|Withdrawal by Subject|0|||
125543241|NCT03602066|451618834|FG000|Overall Study|Physician Decision|1|||
125344947|NCT03222492|450896467|FG002|Overall Study|Withdrawal by Subject|1|||
125678524|NCT01658943|452112200|FG001|Overall Study|Progression/Relapse|40|||
125678525|NCT01658943|452112199|FG000|Overall Study|Death|4|||
125678526|NCT01658943|452112200|FG001|Overall Study|Death|2|||
125678527|NCT01658943|452112199|FG000|Overall Study|not protocol specified|4|||
125678528|NCT01658943|452112200|FG001|Overall Study|not protocol specified|1|||
125678529|NCT01658943|452112199|FG000|Overall Study|Not eligible|7|||
125678530|NCT01658943|452112200|FG001|Overall Study|Not eligible|9|||
125678531|NCT01658943|452112199|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
125678532|NCT01658943|452112200|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
125678533|NCT03144687|452112202|FG000|Overall Study|Death|0|||
125678534|NCT03144687|452112203|FG001|Overall Study|Death|2|||
125678535|NCT03144687|452112202|FG000|Overall Study|Lost to Follow-up|0|||
125678536|NCT03144687|452112203|FG001|Overall Study|Lost to Follow-up|1|||
125678537|NCT03144687|452112202|FG000|Overall Study|Physician Decision|0|||
125678538|NCT03144687|452112203|FG001|Overall Study|Physician Decision|1|||
125678539|NCT03144687|452112202|FG000|Overall Study|Withdrawal by Subject|1|||
125678540|NCT03144687|452112203|FG001|Overall Study|Withdrawal by Subject|3|||
125678541|NCT03144687|452112202|FG000|Overall Study|Not Reported|2|||
125678542|NCT03144687|452112203|FG001|Overall Study|Not Reported|0|||
125678543|NCT01054599|452112204|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
125678544|NCT01054599|452112205|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
125678545|NCT01054599|452112204|FG000|Overall Study|Protocol Violation|1|||
125678546|NCT01054599|452112205|FG001|Overall Study|Protocol Violation|0|||
125678547|NCT01054599|452112204|FG000|Overall Study|Spells/seizure-like episodes|1|||
125678548|NCT01054599|452112205|FG001|Overall Study|Spells/seizure-like episodes|1|||
125678549|NCT01054599|452112204|FG000|Overall Study|Timing/scheduling difficulties|1|||
125678550|NCT01054599|452112205|FG001|Overall Study|Timing/scheduling difficulties|1|||
125678551|NCT01054599|452112204|FG000|Overall Study|Visual impairment, WTAR <80|0|||
125678552|NCT01054599|452112205|FG001|Overall Study|Visual impairment, WTAR <80|1|||
125678553|NCT01054599|452112204|FG000|Overall Study|Lost to Follow-up|0|||
125678554|NCT01054599|452112205|FG001|Overall Study|Lost to Follow-up|2|||
125678555|NCT01054599|452112204|FG000|Overall Study|Adverse Event|0|||
125678556|NCT01054599|452112205|FG001|Overall Study|Adverse Event|1|||
125678557|NCT01054599|452112204|FG000|Overall Study|Withdrawal by Subject|0|||
125678558|NCT01054599|452112205|FG001|Overall Study|Withdrawal by Subject|1|||
125678559|NCT01478620|452112206|FG000|Overall Study|Lost to Follow-up|6|||
125678560|NCT00475020|452112207|FG000|Overall Study|Physician Decision|3|||
125678561|NCT00475020|452112207|FG000|Overall Study|Insurance Denial|1|||
125678562|NCT00475020|452112207|FG000|Overall Study|Donor not able to donate the last minute|1|||
125678563|NCT02514174|452112211|FG000|Overall Study|Patient refused to continue medication|1|||
125678564|NCT02514174|452112211|FG000|Overall Study|Adverse Event|2|||
125678565|NCT02514174|452112211|FG000|Overall Study|Study closed by sponsor|9|||
125678566|NCT02514174|452112211|FG000|Overall Study|Progressive disease|11|||
125678567|NCT02514174|452112211|FG000|Overall Study|Treatment change|1|||
125678568|NCT02514174|452112211|FG000|Overall Study|Treated off study with Afatinib.|1|||
125678569|NCT02170688|452112214|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
125678570|NCT02170688|452112215|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
125678571|NCT02170688|452112216|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
125678572|NCT02170688|452112217|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
125678573|NCT02170688|452112218|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
125678574|NCT02170688|452112214|FG000|Overall Study|Full dose not received|0|||
125678575|NCT02170688|452112215|FG001|Overall Study|Full dose not received|1|||
125678576|NCT02170688|452112216|FG002|Overall Study|Full dose not received|0|||
125678577|NCT02170688|452112217|FG003|Overall Study|Full dose not received|0|||
125678578|NCT02170688|452112218|FG004|Overall Study|Full dose not received|0|||
125678579|NCT02170688|452112214|FG000|Overall Study|Physician Decision|0|||
125678580|NCT02170688|452112215|FG001|Overall Study|Physician Decision|0|||
125678581|NCT02170688|452112216|FG002|Overall Study|Physician Decision|1|||
125678582|NCT02170688|452112217|FG003|Overall Study|Physician Decision|0|||
125678583|NCT02170688|452112218|FG004|Overall Study|Physician Decision|0|||
125678584|NCT01494506|452114162|FG000|Overall Study|Lack of Efficacy|77|||
125678585|NCT01494506|452114163|FG001|Overall Study|Lack of Efficacy|83|||
125678586|NCT01494506|452114164|FG002|Overall Study|Lack of Efficacy|57|||
125344948|NCT03222492|450896468|FG003|Overall Study|Withdrawal by Subject|0|||
125678587|NCT01494506|452114162|FG000|Overall Study|Adverse Event|17|||
125678588|NCT01494506|452114163|FG001|Overall Study|Adverse Event|10|||
125678589|NCT01494506|452114164|FG002|Overall Study|Adverse Event|11|||
125678590|NCT01494506|452114162|FG000|Overall Study|Death|9|||
125678591|NCT01494506|452114163|FG001|Overall Study|Death|5|||
125678592|NCT01494506|452114164|FG002|Overall Study|Death|2|||
125678593|NCT01494506|452114162|FG000|Overall Study|Physician Decision|7|||
125678594|NCT01494506|452114163|FG001|Overall Study|Physician Decision|5|||
125678595|NCT01494506|452114164|FG002|Overall Study|Physician Decision|4|||
125678596|NCT01494506|452114162|FG000|Overall Study|Withdrawal by Subject|17|||
125678597|NCT01494506|452114163|FG001|Overall Study|Withdrawal by Subject|20|||
125678598|NCT01494506|452114164|FG002|Overall Study|Withdrawal by Subject|14|||
125344949|NCT03222492|450896465|FG000|Overall Study|COVID-19 related|0|||
125344950|NCT03222492|450896466|FG001|Overall Study|COVID-19 related|0|||
125344951|NCT03222492|450896467|FG002|Overall Study|COVID-19 related|1|||
125678599|NCT01494506|452114162|FG000|Overall Study|Clinical Deterioration|21|||
125678600|NCT01494506|452114163|FG001|Overall Study|Clinical Deterioration|17|||
125678601|NCT01494506|452114164|FG002|Overall Study|Clinical Deterioration|13|||
125678602|NCT01494506|452114162|FG000|Overall Study|Sponsor Decision|0|||
125678603|NCT01494506|452114163|FG001|Overall Study|Sponsor Decision|0|||
125678604|NCT01494506|452114164|FG002|Overall Study|Sponsor Decision|1|||
125678605|NCT01494506|452114162|FG000|Overall Study|Other|0|||
125678606|NCT01494506|452114163|FG001|Overall Study|Other|3|||
125678607|NCT01494506|452114164|FG002|Overall Study|Other|1|||
125678608|NCT01492361|452114165|FG000|Overall Study|Withdrawal by Subject|281|||
125678609|NCT01492361|452114166|FG001|Overall Study|Withdrawal by Subject|297|||
125678610|NCT01492361|452114165|FG000|Overall Study|Physician Decision|12|||
125678611|NCT01492361|452114166|FG001|Overall Study|Physician Decision|12|||
125678612|NCT01492361|452114165|FG000|Overall Study|Lost to Follow-up|6|||
125678613|NCT01492361|452114166|FG001|Overall Study|Lost to Follow-up|13|||
125678614|NCT01492361|452114165|FG000|Overall Study|Other than specified above|106|||
125678615|NCT01492361|452114166|FG001|Overall Study|Other than specified above|138|||
125678616|NCT03444038|452114167|FG000|Overall Study|Adverse Event|12|||
125678617|NCT03444038|452114167|FG000|Overall Study|Withdrawal by Subject|7|||
125678618|NCT03444038|452114167|FG000|Overall Study|Lost to Follow-up|1|||
125678619|NCT03444038|452114167|FG000|Overall Study|Physician Decision|2|||
125678620|NCT03444038|452114167|FG000|Overall Study|Lack of Efficacy|7|||
125678621|NCT00543309|452114168|FG000|Overall Study|Physician Decision|0|||
125678622|NCT00543309|452114169|FG001|Overall Study|Physician Decision|1|||
125678623|NCT00543309|452114170|FG002|Overall Study|Physician Decision|0|||
125678624|NCT02143102|452114173|FG000|Overall Study|Lost to Follow-up|11|||
125678625|NCT02143102|452114174|FG001|Overall Study|Lost to Follow-up|0|||
125678626|NCT03247556|452114179|FG000|Overall Study|Adverse Event|1|||
125678627|NCT03247556|452114180|FG001|Overall Study|Adverse Event|4|||
125678628|NCT03247556|452114181|FG002|Overall Study|Adverse Event|5|||
125678629|NCT03247556|452114179|FG000|Overall Study|Lost to Follow-up|5|||
125678630|NCT03247556|452114180|FG001|Overall Study|Lost to Follow-up|5|||
125678631|NCT03247556|452114181|FG002|Overall Study|Lost to Follow-up|4|||
125678632|NCT03247556|452114179|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
125678633|NCT03247556|452114180|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
125678634|NCT03247556|452114181|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
125678635|NCT03247556|452114179|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
125678636|NCT03247556|452114180|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
125678637|NCT03247556|452114181|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
125678638|NCT03247556|452114179|FG000|Overall Study|Protocol Violation|2|||
125678639|NCT03247556|452114180|FG001|Overall Study|Protocol Violation|0|||
125678640|NCT03247556|452114181|FG002|Overall Study|Protocol Violation|1|||
125678641|NCT03247556|452114179|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
125678642|NCT03247556|452114180|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
125678643|NCT03247556|452114181|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
125678644|NCT01203878|452114182|FG000|Overall Study|Withdrawal by Subject|0|||
125678645|NCT01203878|452114183|FG001|Overall Study|Withdrawal by Subject|0|||
125678646|NCT01203878|452114184|FG002|Overall Study|Withdrawal by Subject|1|||
125678647|NCT01203878|452114182|FG000|Overall Study|Adverse Event|0|||
125678648|NCT01203878|452114183|FG001|Overall Study|Adverse Event|0|||
125678649|NCT01203878|452114184|FG002|Overall Study|Adverse Event|2|||
125678650|NCT01682083|452114185|FG000|Overall Study|Lost to Follow-up|11|||
125678651|NCT01682083|452114186|FG001|Overall Study|Lost to Follow-up|18|||
125678652|NCT01682083|452114185|FG000|Overall Study|Withdrawal by Subject|31|||
125678653|NCT01682083|452114186|FG001|Overall Study|Withdrawal by Subject|40|||
125678654|NCT01682083|452114185|FG000|Overall Study|Death|60|||
125678655|NCT01682083|452114186|FG001|Overall Study|Death|93|||
125678656|NCT01682083|452114185|FG000|Overall Study|Physician Decision|5|||
125678657|NCT01682083|452114186|FG001|Overall Study|Physician Decision|4|||
125678658|NCT03952143|452114187|FG000|Lead-In Period|Adverse Event|2|||
125678659|NCT03952143|452114188|FG001|Lead-In Period|Adverse Event|0|||
125678660|NCT03952143|452114189|FG002|Lead-In Period|Adverse Event|0|||
125678661|NCT03952143|452114187|FG000|Lead-In Period|Lack of Efficacy|2|||
125678662|NCT03952143|452114188|FG001|Lead-In Period|Lack of Efficacy|0|||
125344952|NCT03222492|450896468|FG003|Overall Study|COVID-19 related|0|||
125678663|NCT03952143|452114189|FG002|Lead-In Period|Lack of Efficacy|0|||
125678664|NCT03952143|452114187|FG000|Lead-In Period|Physician Decision|5|||
125678665|NCT03952143|452114188|FG001|Lead-In Period|Physician Decision|0|||
125678666|NCT03952143|452114189|FG002|Lead-In Period|Physician Decision|0|||
125678667|NCT03952143|452114187|FG000|Lead-In Period|Protocol Violation|5|||
125678668|NCT03952143|452114188|FG001|Lead-In Period|Protocol Violation|0|||
125678669|NCT03952143|452114189|FG002|Lead-In Period|Protocol Violation|0|||
125678670|NCT03952143|452114187|FG000|Lead-In Period|Withdrawal by Subject|19|||
125678671|NCT03952143|452114188|FG001|Lead-In Period|Withdrawal by Subject|0|||
125678672|NCT03952143|452114189|FG002|Lead-In Period|Withdrawal by Subject|0|||
125678673|NCT03952143|452114187|FG000|Treatment Period|Adverse Event|0|||
125678674|NCT03952143|452114188|FG001|Treatment Period|Adverse Event|0|||
125678675|NCT03952143|452114189|FG002|Treatment Period|Adverse Event|1|||
125678676|NCT03952143|452114187|FG000|Treatment Period|Lost to Follow-up|0|||
125678677|NCT03952143|452114188|FG001|Treatment Period|Lost to Follow-up|2|||
125678678|NCT03952143|452114189|FG002|Treatment Period|Lost to Follow-up|0|||
125678679|NCT03952143|452114187|FG000|Treatment Period|Physician Decision|0|||
125678680|NCT03952143|452114188|FG001|Treatment Period|Physician Decision|0|||
125678681|NCT03952143|452114189|FG002|Treatment Period|Physician Decision|2|||
125678682|NCT03952143|452114187|FG000|Treatment Period|Protocol Violation|0|||
125678683|NCT03952143|452114188|FG001|Treatment Period|Protocol Violation|0|||
125678684|NCT03952143|452114189|FG002|Treatment Period|Protocol Violation|1|||
125678685|NCT03952143|452114187|FG000|Treatment Period|Withdrawal by Subject|0|||
125678686|NCT03952143|452114188|FG001|Treatment Period|Withdrawal by Subject|5|||
125678687|NCT03952143|452114189|FG002|Treatment Period|Withdrawal by Subject|26|||
125678688|NCT03952143|452114187|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
125678689|NCT03952143|452114188|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
125678690|NCT03952143|452114189|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
125678691|NCT03952143|452114187|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
125678692|NCT03952143|452114188|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
125678693|NCT03952143|452114189|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
125678694|NCT01866319|452114190|FG000|Overall Study|Adverse Event|12|||
125678695|NCT01866319|452114191|FG001|Overall Study|Adverse Event|5|||
125678696|NCT01866319|452114192|FG002|Overall Study|Adverse Event|9|||
125678697|NCT01866319|452114190|FG000|Overall Study|Clinical progression|3|||
125678698|NCT01866319|452114191|FG001|Overall Study|Clinical progression|2|||
125678699|NCT01866319|452114192|FG002|Overall Study|Clinical progression|2|||
125678700|NCT01866319|452114190|FG000|Overall Study|Death|153|||
125678701|NCT01866319|452114191|FG001|Overall Study|Death|154|||
125678702|NCT01866319|452114192|FG002|Overall Study|Death|147|||
125678703|NCT01866319|452114190|FG000|Overall Study|Lost to Follow-up|6|||
125678704|NCT01866319|452114191|FG001|Overall Study|Lost to Follow-up|3|||
125678705|NCT01866319|452114192|FG002|Overall Study|Lost to Follow-up|8|||
125678706|NCT01866319|452114190|FG000|Overall Study|Physician Decision|1|||
125678707|NCT01866319|452114191|FG001|Overall Study|Physician Decision|0|||
125678708|NCT01866319|452114192|FG002|Overall Study|Physician Decision|1|||
125678709|NCT01866319|452114190|FG000|Overall Study|Protocol Violation|0|||
125678710|NCT01866319|452114191|FG001|Overall Study|Protocol Violation|0|||
125678711|NCT01866319|452114192|FG002|Overall Study|Protocol Violation|1|||
125678712|NCT01866319|452114190|FG000|Overall Study|Withdrawal by Subject|32|||
125678713|NCT01866319|452114191|FG001|Overall Study|Withdrawal by Subject|14|||
125678714|NCT01866319|452114192|FG002|Overall Study|Withdrawal by Subject|12|||
125678715|NCT03980483|452114196|FG000|Overall Study|Adverse Event|13|||
125678716|NCT03980483|452114197|FG001|Overall Study|Adverse Event|29|||
125678717|NCT03980483|452114198|FG002|Overall Study|Adverse Event|11|||
125678718|NCT03980483|452114199|FG003|Overall Study|Adverse Event|2|||
125678719|NCT03980483|452114200|FG004|Overall Study|Adverse Event|2|||
125678720|NCT03980483|452114201|FG005|Overall Study|Adverse Event|2|||
125678721|NCT03980483|452114196|FG000|Overall Study|Lack of Efficacy|7|||
125678722|NCT03980483|452114197|FG001|Overall Study|Lack of Efficacy|6|||
125678723|NCT03980483|452114198|FG002|Overall Study|Lack of Efficacy|0|||
125678724|NCT03980483|452114199|FG003|Overall Study|Lack of Efficacy|3|||
125678725|NCT03980483|452114200|FG004|Overall Study|Lack of Efficacy|1|||
125678726|NCT03980483|452114201|FG005|Overall Study|Lack of Efficacy|1|||
125678727|NCT03980483|452114196|FG000|Overall Study|Lost to Follow-up|2|||
125678728|NCT03980483|452114197|FG001|Overall Study|Lost to Follow-up|4|||
125678729|NCT03980483|452114198|FG002|Overall Study|Lost to Follow-up|2|||
125678730|NCT03980483|452114199|FG003|Overall Study|Lost to Follow-up|1|||
125678731|NCT03980483|452114200|FG004|Overall Study|Lost to Follow-up|2|||
125678732|NCT03980483|452114201|FG005|Overall Study|Lost to Follow-up|0|||
125678733|NCT03980483|452114196|FG000|Overall Study|Protocol Violation|4|||
125678734|NCT03980483|452114197|FG001|Overall Study|Protocol Violation|2|||
125678735|NCT03980483|452114198|FG002|Overall Study|Protocol Violation|1|||
125678736|NCT03980483|452114199|FG003|Overall Study|Protocol Violation|1|||
125678737|NCT03980483|452114200|FG004|Overall Study|Protocol Violation|0|||
125543242|NCT03602066|451618835|FG001|Overall Study|Physician Decision|0|||
125678738|NCT03980483|452114201|FG005|Overall Study|Protocol Violation|0|||
125678739|NCT03980483|452114196|FG000|Overall Study|Physician Decision|14|||
125678740|NCT03980483|452114197|FG001|Overall Study|Physician Decision|10|||
125678741|NCT03980483|452114198|FG002|Overall Study|Physician Decision|7|||
125678742|NCT03980483|452114199|FG003|Overall Study|Physician Decision|4|||
125678743|NCT03980483|452114200|FG004|Overall Study|Physician Decision|4|||
125678744|NCT03980483|452114201|FG005|Overall Study|Physician Decision|2|||
125678745|NCT03980483|452114196|FG000|Overall Study|Withdrawal by Subject|38|||
125678746|NCT03980483|452114197|FG001|Overall Study|Withdrawal by Subject|21|||
125678747|NCT03980483|452114198|FG002|Overall Study|Withdrawal by Subject|15|||
125678748|NCT03980483|452114199|FG003|Overall Study|Withdrawal by Subject|5|||
125678749|NCT03980483|452114200|FG004|Overall Study|Withdrawal by Subject|3|||
125678750|NCT03980483|452114201|FG005|Overall Study|Withdrawal by Subject|4|||
125678751|NCT03980483|452114196|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
125678752|NCT03980483|452114197|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
125678753|NCT03980483|452114198|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
125678754|NCT03980483|452114199|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
125678755|NCT03980483|452114200|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
125678756|NCT03980483|452114201|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
125678757|NCT03980483|452114196|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
125678758|NCT03980483|452114197|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
125678759|NCT03980483|452114198|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
125678760|NCT03980483|452114199|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
125678761|NCT03980483|452114200|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
125678762|NCT03980483|452114201|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
125678763|NCT03980483|452114196|FG000|Overall Study|Other|0|||
125678764|NCT03980483|452114197|FG001|Overall Study|Other|1|||
125678765|NCT03980483|452114198|FG002|Overall Study|Other|0|||
125678766|NCT03980483|452114199|FG003|Overall Study|Other|0|||
125678767|NCT03980483|452114200|FG004|Overall Study|Other|0|||
125678768|NCT03980483|452114201|FG005|Overall Study|Other|0|||
125678769|NCT00760266|452114204|FG000|Overall Study|Adverse Event|13|||
125678770|NCT00760266|452114205|FG001|Overall Study|Adverse Event|7|||
125678771|NCT00760266|452114204|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125678772|NCT00760266|452114205|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125678773|NCT00760266|452114204|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125678774|NCT00760266|452114205|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125678775|NCT00760266|452114204|FG000|Overall Study|Lack of Efficacy|2|||
125678776|NCT00760266|452114205|FG001|Overall Study|Lack of Efficacy|2|||
125678777|NCT00760266|452114204|FG000|Overall Study|Protocol deviation|2|||
125678778|NCT00760266|452114205|FG001|Overall Study|Protocol deviation|4|||
125678779|NCT00760266|452114204|FG000|Overall Study|Patient withdrew consent|3|||
125678780|NCT00760266|452114205|FG001|Overall Study|Patient withdrew consent|3|||
125678781|NCT00760266|452114204|FG000|Overall Study|Lost to Follow-up|2|||
125678782|NCT00760266|452114205|FG001|Overall Study|Lost to Follow-up|1|||
125678783|NCT00760266|452114204|FG000|Overall Study|Administrative Problems|0|||
125678784|NCT00760266|452114205|FG001|Overall Study|Administrative Problems|1|||
125678785|NCT01225146|452114206|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
125678786|NCT01225146|452114207|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
125678787|NCT00659607|452114210|FG000|Overall Study|No blood pressure recorded|147|||
125678788|NCT00659607|452114210|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
125678789|NCT00659607|452114210|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
125678790|NCT00659607|452114210|FG000|Overall Study|No recorded efficacy data|15|||
125678791|NCT00659607|452114210|FG000|Overall Study|Inconsistent BP measuring date|2|||
125678792|NCT02191891|452114211|FG000|Overall Study|Withdrawal by Subject|0|||
125678793|NCT02191891|452114212|FG001|Overall Study|Withdrawal by Subject|1|||
125678794|NCT02191891|452114213|FG002|Overall Study|Withdrawal by Subject|0|||
125678795|NCT02191891|452114214|FG003|Overall Study|Withdrawal by Subject|0|||
125678796|NCT02191891|452114215|FG004|Overall Study|Withdrawal by Subject|1|||
125678797|NCT02191891|452114211|FG000|Overall Study|Adverse Event|0|||
125678798|NCT02191891|452114212|FG001|Overall Study|Adverse Event|1|||
125678799|NCT02191891|452114213|FG002|Overall Study|Adverse Event|0|||
125678800|NCT02191891|452114214|FG003|Overall Study|Adverse Event|0|||
125678801|NCT02191891|452114215|FG004|Overall Study|Adverse Event|2|||
125678802|NCT02191891|452114211|FG000|Overall Study|Disease Progression|4|||
125678803|NCT02191891|452114212|FG001|Overall Study|Disease Progression|10|||
125678804|NCT02191891|452114213|FG002|Overall Study|Disease Progression|4|||
125678805|NCT02191891|452114214|FG003|Overall Study|Disease Progression|2|||
125678806|NCT02191891|452114215|FG004|Overall Study|Disease Progression|7|||
125678807|NCT00874237|452114221|FG000|Overall Study|Physician Decision|0|||
125678808|NCT00874237|452114222|FG001|Overall Study|Physician Decision|1|||
125678809|NCT00874237|452114223|FG002|Overall Study|Physician Decision|0|||
125678810|NCT00874237|452114224|FG003|Overall Study|Physician Decision|0|||
125678811|NCT00874237|452114225|FG004|Overall Study|Physician Decision|0|||
125678812|NCT00874237|452114226|FG005|Overall Study|Physician Decision|0|||
125678813|NCT00874237|452114221|FG000|Overall Study|Withdrawal by Subject|0|||
125344953|NCT01224782|450896474|FG000|Overall Study|Lost to Follow-up|177|||
125543243|NCT00092495|451618836|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
125543244|NCT00092495|451618837|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
125543245|NCT00092495|451618838|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
125543246|NCT00092495|451618839|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
125678814|NCT00874237|452114222|FG001|Overall Study|Withdrawal by Subject|0|||
125678815|NCT00874237|452114223|FG002|Overall Study|Withdrawal by Subject|1|||
125678816|NCT00874237|452114224|FG003|Overall Study|Withdrawal by Subject|0|||
125678817|NCT00874237|452114225|FG004|Overall Study|Withdrawal by Subject|0|||
125678818|NCT00874237|452114226|FG005|Overall Study|Withdrawal by Subject|0|||
125678819|NCT03912337|452114229|FG000|Overall Study|Withdrawal of Consent From Study|1|||
125678820|NCT03912337|452114230|FG001|Overall Study|Withdrawal of Consent From Study|0|||
125678821|NCT03912337|452114229|FG000|Overall Study|Lost to Follow-up|1|||
125678822|NCT03912337|452114230|FG001|Overall Study|Lost to Follow-up|1|||
125678823|NCT03752528|452114231|FG000|Part A|Lost to Follow-up|1|||
125678824|NCT03752528|452114231|FG000|Part A|Protocol Violation|1|||
125678825|NCT03752528|452114231|FG000|Part B|Protocol Violation|1|||
125678826|NCT03752528|452114231|FG000|Part B|Study terminated by sponsor|3|||
125678827|NCT00414765|452114232|FG000|Overall Study|Adverse Event|5|||
125678828|NCT00414765|452114233|FG001|Overall Study|Adverse Event|9|||
125678829|NCT00414765|452114232|FG000|Overall Study|Withdrawal by Subject|1|||
125678830|NCT00414765|452114233|FG001|Overall Study|Withdrawal by Subject|1|||
125678831|NCT00414765|452114232|FG000|Overall Study|Disease Progression|0|||
125678832|NCT00414765|452114233|FG001|Overall Study|Disease Progression|1|||
125678833|NCT02458469|452114234|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125678834|NCT02458469|452114235|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125678835|NCT02458469|452114236|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
125678836|NCT02458469|452114237|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125678837|NCT02458469|452114238|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125678838|NCT02458469|452114239|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125678839|NCT02458469|452114234|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
125678840|NCT02458469|452114235|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
125678841|NCT02458469|452114236|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
125678842|NCT02458469|452114237|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
125678843|NCT02458469|452114238|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
125678844|NCT02458469|452114239|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
125678845|NCT02458469|452114234|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
125678846|NCT02458469|452114235|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
125678847|NCT02458469|452114236|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
125678848|NCT02458469|452114237|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
125678849|NCT02458469|452114238|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
125678850|NCT02458469|452114239|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
125678851|NCT04534283|452114240|FG000|Overall Study|Physician Decision|2|||
125678852|NCT04534283|452114240|FG000|Overall Study|Withdrawal by Subject|1|||
125678853|NCT04534283|452114240|FG000|Overall Study|Disease Progression|12|||
125678854|NCT04534283|452114240|FG000|Overall Study|Adverse Event|1|||
125678855|NCT00661505|452114241|FG000|Overall Study|Adverse Event|3|||
125678856|NCT00661505|452114241|FG000|Overall Study|Protocol Violation|14|||
125678857|NCT00661505|452114241|FG000|Overall Study|Withdrawal by Subject|8|||
125678858|NCT00661505|452114241|FG000|Overall Study|Lost to Follow-up|3|||
125678859|NCT00661505|452114241|FG000|Overall Study|Other|2|||
125678860|NCT03561883|452114242|FG000|Overall Study|Adverse Event|10|||
125678861|NCT03561883|452114243|FG001|Overall Study|Adverse Event|13|||
125678862|NCT03561883|452114242|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125678863|NCT03561883|452114243|FG001|Overall Study|Non-Compliance With Study Drug|2|||
125678864|NCT03561883|452114242|FG000|Overall Study|Protocol Violation|2|||
125678865|NCT03561883|452114243|FG001|Overall Study|Protocol Violation|3|||
125678866|NCT03561883|452114242|FG000|Overall Study|Withdrawal by Subject|14|||
125678867|NCT03561883|452114243|FG001|Overall Study|Withdrawal by Subject|6|||
125678868|NCT03561883|452114242|FG000|Overall Study|Lost to Follow-up|2|||
125678869|NCT03561883|452114243|FG001|Overall Study|Lost to Follow-up|6|||
125678870|NCT03561883|452114242|FG000|Overall Study|Study Terminated by Sponsor|12|||
125678871|NCT03561883|452114243|FG001|Overall Study|Study Terminated by Sponsor|11|||
125678872|NCT03561883|452114242|FG000|Overall Study|Physician Decision|1|||
125678873|NCT03561883|452114243|FG001|Overall Study|Physician Decision|0|||
125678874|NCT03561883|452114242|FG000|Overall Study|Randomized by Mistake|1|||
125678875|NCT03561883|452114243|FG001|Overall Study|Randomized by Mistake|0|||
125678876|NCT03561883|452114242|FG000|Overall Study|Other, Not Specified|3|||
125678877|NCT03561883|452114243|FG001|Overall Study|Other, Not Specified|2|||
125678878|NCT01318499|452114244|FG000|Overall Study|Adverse Event|16|||
125678879|NCT01318499|452114245|FG001|Overall Study|Adverse Event|11|||
125678880|NCT01318499|452114246|FG002|Overall Study|Adverse Event|6|||
125678881|NCT01318499|452114244|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
125678882|NCT01318499|452114245|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
125678883|NCT01318499|452114246|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
125678884|NCT01318499|452114244|FG000|Overall Study|Noncompliance|2|||
125678885|NCT01318499|452114245|FG001|Overall Study|Noncompliance|3|||
125344954|NCT01224782|450896474|FG000|Overall Study|Withdrawal by Subject|16|||
125344955|NCT01224782|450896474|FG000|Overall Study|Death|14|||
125344956|NCT01224782|450896474|FG000|Overall Study|Improvement|13|||
125543247|NCT00092495|451618840|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
125678886|NCT01318499|452114246|FG002|Overall Study|Noncompliance|0|||
125678887|NCT01318499|452114244|FG000|Overall Study|Treatment Failure|19|||
125678888|NCT01318499|452114245|FG001|Overall Study|Treatment Failure|19|||
125678889|NCT01318499|452114246|FG002|Overall Study|Treatment Failure|101|||
125678890|NCT01318499|452114244|FG000|Overall Study|Protocol Violation|2|||
125678891|NCT01318499|452114245|FG001|Overall Study|Protocol Violation|4|||
125678892|NCT01318499|452114246|FG002|Overall Study|Protocol Violation|2|||
125678893|NCT01318499|452114244|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
125678894|NCT01318499|452114245|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
125678895|NCT01318499|452114246|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
125678896|NCT01318499|452114244|FG000|Overall Study|Other|7|||
125678897|NCT01318499|452114245|FG001|Overall Study|Other|10|||
125678898|NCT01318499|452114246|FG002|Overall Study|Other|22|||
125678899|NCT01974141|452114252|FG000|Overall Study|Other Reasons|28|||
125678900|NCT01974141|452114253|FG001|Overall Study|Other Reasons|18|||
125678901|NCT01974141|452114252|FG000|Overall Study|Protocol Violation|2|||
125678902|NCT01974141|452114253|FG001|Overall Study|Protocol Violation|6|||
125678903|NCT01974141|452114252|FG000|Overall Study|Personal Reasons|21|||
125678904|NCT01974141|452114253|FG001|Overall Study|Personal Reasons|20|||
125678905|NCT01974141|452114252|FG000|Overall Study|Lost to Follow-up|38|||
125678906|NCT01974141|452114253|FG001|Overall Study|Lost to Follow-up|29|||
125344957|NCT01224782|450896474|FG000|Overall Study|Adverse Event|12|||
125344958|NCT01224782|450896474|FG000|Overall Study|Adverse Reaction|11|||
125344959|NCT01224782|450896474|FG000|Overall Study|Noncompliance|10|||
125344960|NCT01224782|450896474|FG000|Overall Study|Other|4|||
125344961|NCT01224782|450896474|FG000|Overall Study|Start of Dialysis|3|||
125344962|NCT01224782|450896474|FG000|Overall Study|Change of Treatment|1|||
125344963|NCT01224782|450896474|FG000|Overall Study|Financial Reasons|1|||
125344964|NCT01224782|450896474|FG000|Overall Study|Deterioration|1|||
125344965|NCT01224782|450896474|FG000|Overall Study|Transplantation|1|||
125344966|NCT00065429|450896477|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
125344967|NCT00065429|450896478|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
125344968|NCT00065429|450896479|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
125344969|NCT00065429|450896480|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
125344970|NCT00065429|450896481|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
125344971|NCT00065429|450896482|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
125344972|NCT00065429|450896483|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
125344973|NCT00065429|450896477|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
125344974|NCT00065429|450896478|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
125344975|NCT00065429|450896479|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
125344976|NCT00065429|450896480|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
125678907|NCT01974141|452114252|FG000|Overall Study|Pregnancy|3|||
125678908|NCT01974141|452114253|FG001|Overall Study|Pregnancy|3|||
125678909|NCT01974141|452114252|FG000|Overall Study|Lack of Efficacy|0|||
125678910|NCT01974141|452114253|FG001|Overall Study|Lack of Efficacy|1|||
125678911|NCT01974141|452114252|FG000|Overall Study|Adverse Event|4|||
125678912|NCT01974141|452114253|FG001|Overall Study|Adverse Event|5|||
125678913|NCT04977336|452114254|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
125678914|NCT04977336|452114255|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
125678915|NCT04977336|452114256|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
125678916|NCT04977336|452114257|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
125678917|NCT04977336|452114258|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
125678918|NCT04977336|452114254|FG000|Overall Study|Lost to Follow-up|0|||
125678919|NCT04977336|452114255|FG001|Overall Study|Lost to Follow-up|0|||
125678920|NCT04977336|452114256|FG002|Overall Study|Lost to Follow-up|1|||
125678921|NCT04977336|452114257|FG003|Overall Study|Lost to Follow-up|0|||
125678922|NCT04977336|452114258|FG004|Overall Study|Lost to Follow-up|0|||
125678923|NCT01347710|452114259|FG000|Overall Study|Withdrawal by Subject|2|||
125678924|NCT01347710|452114259|FG000|Overall Study|Adverse Event|4|||
125678925|NCT01347710|452114259|FG000|Overall Study|Angio or SPECT not completed|18|||
125678926|NCT01347710|452114259|FG000|Overall Study|issue with vitals prior to dosing|1|||
125678927|NCT01347710|452114259|FG000|Overall Study|Lost to Follow-up|1|||
125678928|NCT01347710|452114259|FG000|Overall Study|Physician Decision|2|||
125678929|NCT01347710|452114259|FG000|Overall Study|Other|3|||
125344977|NCT00065429|450896481|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
125344978|NCT00065429|450896482|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
125344979|NCT00065429|450896483|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
125678930|NCT01004172|452114263|FG000|Overall Study|Progressive Disease in CNS Only|16|||
125678931|NCT01004172|452114263|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
125678932|NCT01004172|452114263|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
125678933|NCT01004172|452114263|FG000|Overall Study|Adverse Event|1|||
125678934|NCT01004172|452114263|FG000|Overall Study|Physician Decision|1|||
125678935|NCT01004172|452114263|FG000|Overall Study|Symptomatic Deterioration|2|||
125678936|NCT00950872|452114264|FG000|Overall Study|Withdrawal by Subject|1|||
125543248|NCT00092495|451618836|FG000|Base Study Vaccination Period|Extended|0|||
125543249|NCT00092495|451618837|FG001|Base Study Vaccination Period|Extended|0|||
125543250|NCT00092495|451618838|FG002|Base Study Vaccination Period|Extended|0|||
125344980|NCT00065429|450896477|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
125543251|NCT00092495|451618839|FG003|Base Study Vaccination Period|Extended|1|||
125543252|NCT00092495|451618840|FG004|Base Study Vaccination Period|Extended|0|||
125678937|NCT00950872|452114264|FG000|Overall Study|Did not have surgery|2|||
125678938|NCT00408902|452114267|FG000|Overall Study|Lack of Efficacy|7|||
125678939|NCT00408902|452114267|FG000|Overall Study|Adverse Event|3|||
125678940|NCT00970281|452114268|FG000|Overall Study|Lack of Efficacy|1|||
125678941|NCT00970281|452114269|FG001|Overall Study|Lack of Efficacy|14|||
125678942|NCT00970281|452114268|FG000|Overall Study|Withdrawal by Subject|0|||
125678943|NCT00970281|452114269|FG001|Overall Study|Withdrawal by Subject|1|||
125678944|NCT00970281|452114268|FG000|Overall Study|Physician Decision|1|||
125678945|NCT00970281|452114269|FG001|Overall Study|Physician Decision|1|||
125678946|NCT02003183|452114271|FG000|Overall Study|Lost to Follow-up|0|||
125678947|NCT02003183|452114272|FG001|Overall Study|Lost to Follow-up|2|||
125678948|NCT01139164|452114273|FG000|Overall Study|Withdrawn prior to study start|0|||
125678949|NCT01139164|452114274|FG001|Overall Study|Withdrawn prior to study start|2|||
125678950|NCT01139164|452114275|FG002|Overall Study|Withdrawn prior to study start|0|||
125678951|NCT00878995|452114276|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
125678952|NCT00878995|452114277|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
125678953|NCT01759290|452114280|FG000|Overall Study|Subjects withdrawn consent|5|||
125678954|NCT01759290|452114280|FG000|Overall Study|Physician Decision|2|||
125678955|NCT01759290|452114280|FG000|Overall Study|Death|17|||
125678956|NCT01759290|452114280|FG000|Overall Study|Lost to Follow-up|53|||
125678957|NCT01759290|452114280|FG000|Overall Study|Unknown reason|4|||
125678958|NCT03338972|452114283|FG000|Overall Study|Death|1|||
125678959|NCT03338972|452114284|FG001|Overall Study|Death|1|||
125678960|NCT03338972|452114285|FG002|Overall Study|Death|0|||
125678961|NCT03338972|452114286|FG003|Overall Study|Death|0|||
125678962|NCT03338972|452114283|FG000|Overall Study|Withdrawal by Subject|1|||
125678963|NCT03338972|452114284|FG001|Overall Study|Withdrawal by Subject|0|||
125678964|NCT03338972|452114285|FG002|Overall Study|Withdrawal by Subject|0|||
125678965|NCT03338972|452114286|FG003|Overall Study|Withdrawal by Subject|0|||
125678966|NCT02480764|452114287|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
125678967|NCT02480764|452114288|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
125678968|NCT02480764|452114289|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
125678969|NCT02480764|452114287|FG000|Overall Study|Major Protocol Deviation|1|||
125678970|NCT02480764|452114288|FG001|Overall Study|Major Protocol Deviation|4|||
125678971|NCT02480764|452114289|FG002|Overall Study|Major Protocol Deviation|3|||
125678972|NCT02480764|452114287|FG000|Overall Study|Lost to Follow-up|0|||
125678973|NCT02480764|452114288|FG001|Overall Study|Lost to Follow-up|1|||
125678974|NCT02480764|452114289|FG002|Overall Study|Lost to Follow-up|2|||
125678975|NCT02480764|452114287|FG000|Overall Study|Voluntary Withdrawal|6|||
125678976|NCT02480764|452114288|FG001|Overall Study|Voluntary Withdrawal|5|||
125678977|NCT02480764|452114289|FG002|Overall Study|Voluntary Withdrawal|10|||
125678978|NCT02480764|452114287|FG000|Overall Study|Lack of Efficacy|0|||
125678979|NCT02480764|452114288|FG001|Overall Study|Lack of Efficacy|3|||
125678980|NCT02480764|452114289|FG002|Overall Study|Lack of Efficacy|3|||
125678981|NCT02480764|452114287|FG000|Overall Study|Reason not Specified|0|||
125678982|NCT02480764|452114288|FG001|Overall Study|Reason not Specified|1|||
125678983|NCT02480764|452114289|FG002|Overall Study|Reason not Specified|0|||
125678984|NCT03629249|452114290|FG000|Overall Study|Study terminated by sponsor|197|||
125678985|NCT03629249|452114291|FG001|Overall Study|Study terminated by sponsor|197|||
125678986|NCT03629249|452114292|FG002|Overall Study|Study terminated by sponsor|194|||
125678987|NCT03629249|452114290|FG000|Overall Study|Protocol deviation|0|||
125678988|NCT03629249|452114291|FG001|Overall Study|Protocol deviation|2|||
125678989|NCT03629249|452114292|FG002|Overall Study|Protocol deviation|5|||
125678990|NCT03629249|452114290|FG000|Overall Study|Subject decision|1|||
125678991|NCT03629249|452114291|FG001|Overall Study|Subject decision|1|||
125678992|NCT03629249|452114292|FG002|Overall Study|Subject decision|3|||
125678993|NCT03629249|452114290|FG000|Overall Study|Adverse Event|1|||
125678994|NCT03629249|452114291|FG001|Overall Study|Adverse Event|1|||
125678995|NCT03629249|452114292|FG002|Overall Study|Adverse Event|0|||
125678996|NCT03629249|452114290|FG000|Overall Study|Death|1|||
125678997|NCT03629249|452114291|FG001|Overall Study|Death|0|||
125678998|NCT03629249|452114292|FG002|Overall Study|Death|0|||
125678999|NCT03629249|452114290|FG000|Overall Study|Physician Decision|1|||
125679000|NCT03629249|452114291|FG001|Overall Study|Physician Decision|0|||
125679001|NCT03629249|452114292|FG002|Overall Study|Physician Decision|0|||
125679002|NCT01030965|452114295|FG000|Overall Study|Lack of Efficacy|3|||
125679003|NCT01030965|452114296|FG001|Overall Study|Lack of Efficacy|2|||
125679004|NCT01030965|452114297|FG002|Overall Study|Lack of Efficacy|0|||
125679005|NCT01030965|452114298|FG003|Overall Study|Lack of Efficacy|3|||
125679006|NCT01030965|452114295|FG000|Overall Study|Protocol Violation|1|||
125679007|NCT01030965|452114296|FG001|Overall Study|Protocol Violation|1|||
125344981|NCT00065429|450896478|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
125679008|NCT01030965|452114297|FG002|Overall Study|Protocol Violation|1|||
125679009|NCT01030965|452114298|FG003|Overall Study|Protocol Violation|1|||
125679010|NCT01030965|452114295|FG000|Overall Study|Adverse Event|0|||
125679011|NCT01030965|452114296|FG001|Overall Study|Adverse Event|1|||
125679012|NCT01030965|452114297|FG002|Overall Study|Adverse Event|2|||
125679013|NCT01030965|452114298|FG003|Overall Study|Adverse Event|1|||
125679014|NCT01030965|452114295|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
125679015|NCT01030965|452114296|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
125679016|NCT01030965|452114297|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
125679017|NCT01030965|452114298|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
125679018|NCT01030965|452114295|FG000|Overall Study|Withdrawal by Subject|0|||
125679019|NCT01030965|452114296|FG001|Overall Study|Withdrawal by Subject|1|||
125679020|NCT01030965|452114297|FG002|Overall Study|Withdrawal by Subject|0|||
125679021|NCT01030965|452114298|FG003|Overall Study|Withdrawal by Subject|2|||
125679022|NCT02097290|452114299|FG000|Overall Study|Death|6|||
125679023|NCT02097290|452114299|FG000|Overall Study|Total Withdrawals|3|||
125679024|NCT02097290|452114299|FG000|Overall Study|Attempt|8|||
125679025|NCT05277389|452114300|FG000|Overall Study|Lost to Follow-up|1|||
125679026|NCT05277389|452114301|FG001|Overall Study|Lost to Follow-up|4|||
125679027|NCT06096168|452114302|FG000|Overall Study|Death|30|||
125679028|NCT06096168|452114302|FG000|Overall Study|Revision|2|||
125679029|NCT00743197|452114303|FG000|Overall Study|Study terminated due to departure of PI.|1|||
125679030|NCT00743197|452114304|FG001|Overall Study|Study terminated due to departure of PI.|2|||
125679031|NCT02130466|452114307|FG000|Overall Study|Death|4|||
125679032|NCT02130466|452114308|FG001|Overall Study|Death|1|||
125679033|NCT02130466|452114309|FG002|Overall Study|Death|1|||
125679034|NCT02130466|452114310|FG003|Overall Study|Death|3|||
125679035|NCT02130466|452114311|FG004|Overall Study|Death|2|||
125679036|NCT02130466|452114312|FG005|Overall Study|Death|30|||
125679037|NCT02130466|452114313|FG006|Overall Study|Death|45|||
125679038|NCT02130466|452114314|FG007|Overall Study|Death|2|||
125679039|NCT02130466|452114315|FG008|Overall Study|Death|3|||
125679040|NCT02130466|452114316|FG009|Overall Study|Death|4|||
125679041|NCT02130466|452114317|FG010|Overall Study|Death|5|||
125344982|NCT00065429|450896479|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
125344983|NCT00065429|450896480|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
125344984|NCT00065429|450896481|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
125344985|NCT00065429|450896482|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
125344986|NCT00065429|450896483|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
125344987|NCT00065429|450896477|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
125344988|NCT00065429|450896478|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
125344989|NCT00065429|450896479|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
125344990|NCT00065429|450896480|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
125344991|NCT00065429|450896481|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
125344992|NCT00065429|450896482|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
125344993|NCT00065429|450896483|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
125344994|NCT00065429|450896477|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
125344995|NCT00065429|450896478|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
125344996|NCT00065429|450896479|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
125344997|NCT00065429|450896480|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
125344998|NCT00065429|450896481|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
125344999|NCT00065429|450896482|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
125345000|NCT00065429|450896483|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
125345001|NCT00065429|450896477|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
125345002|NCT00065429|450896478|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
125345003|NCT00065429|450896479|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
125345004|NCT00065429|450896480|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
125345005|NCT00065429|450896481|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
125345006|NCT00065429|450896482|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
125679042|NCT02130466|452114318|FG011|Overall Study|Death|3|||
125679043|NCT02130466|452114319|FG012|Overall Study|Death|11|||
125679044|NCT02130466|452114320|FG013|Overall Study|Death|7|||
125679045|NCT02130466|452114307|FG000|Overall Study|Lost to Follow-up|1|||
125679046|NCT02130466|452114308|FG001|Overall Study|Lost to Follow-up|0|||
125679047|NCT02130466|452114309|FG002|Overall Study|Lost to Follow-up|0|||
125679048|NCT02130466|452114310|FG003|Overall Study|Lost to Follow-up|0|||
125679049|NCT02130466|452114311|FG004|Overall Study|Lost to Follow-up|0|||
125679050|NCT02130466|452114312|FG005|Overall Study|Lost to Follow-up|1|||
125679051|NCT02130466|452114313|FG006|Overall Study|Lost to Follow-up|0|||
125679052|NCT02130466|452114314|FG007|Overall Study|Lost to Follow-up|0|||
125679053|NCT02130466|452114315|FG008|Overall Study|Lost to Follow-up|0|||
125679054|NCT02130466|452114316|FG009|Overall Study|Lost to Follow-up|0|||
125679055|NCT02130466|452114317|FG010|Overall Study|Lost to Follow-up|0|||
125679056|NCT02130466|452114318|FG011|Overall Study|Lost to Follow-up|0|||
125679057|NCT02130466|452114319|FG012|Overall Study|Lost to Follow-up|1|||
125679058|NCT02130466|452114320|FG013|Overall Study|Lost to Follow-up|0|||
125679059|NCT02130466|452114307|FG000|Overall Study|Physician Decision|0|||
125345007|NCT00065429|450896483|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
125345008|NCT00065429|450896477|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
125679060|NCT02130466|452114308|FG001|Overall Study|Physician Decision|0|||
125679061|NCT02130466|452114309|FG002|Overall Study|Physician Decision|0|||
125679062|NCT02130466|452114310|FG003|Overall Study|Physician Decision|0|||
125679063|NCT02130466|452114311|FG004|Overall Study|Physician Decision|0|||
125679064|NCT02130466|452114312|FG005|Overall Study|Physician Decision|1|||
125679065|NCT02130466|452114313|FG006|Overall Study|Physician Decision|1|||
125679066|NCT02130466|452114314|FG007|Overall Study|Physician Decision|0|||
125679067|NCT02130466|452114315|FG008|Overall Study|Physician Decision|0|||
125679068|NCT02130466|452114316|FG009|Overall Study|Physician Decision|0|||
125679069|NCT02130466|452114317|FG010|Overall Study|Physician Decision|0|||
125679070|NCT02130466|452114318|FG011|Overall Study|Physician Decision|0|||
125679071|NCT02130466|452114319|FG012|Overall Study|Physician Decision|0|||
125679072|NCT02130466|452114320|FG013|Overall Study|Physician Decision|0|||
125679073|NCT02130466|452114307|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
125679074|NCT02130466|452114308|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
125679075|NCT02130466|452114309|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
125679076|NCT02130466|452114310|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
125679077|NCT02130466|452114311|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
125679078|NCT02130466|452114312|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
125679079|NCT02130466|452114313|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
125679080|NCT02130466|452114314|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
125679081|NCT02130466|452114315|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
125679082|NCT02130466|452114316|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
125679083|NCT02130466|452114317|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
125679084|NCT02130466|452114318|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
125679085|NCT02130466|452114319|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
125679086|NCT02130466|452114320|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
125679087|NCT02130466|452114307|FG000|Overall Study|Withdrawal by Subject|1|||
125679088|NCT02130466|452114308|FG001|Overall Study|Withdrawal by Subject|0|||
125679089|NCT02130466|452114309|FG002|Overall Study|Withdrawal by Subject|0|||
125679090|NCT02130466|452114310|FG003|Overall Study|Withdrawal by Subject|0|||
125679091|NCT02130466|452114311|FG004|Overall Study|Withdrawal by Subject|0|||
125679092|NCT02130466|452114312|FG005|Overall Study|Withdrawal by Subject|1|||
125679093|NCT02130466|452114313|FG006|Overall Study|Withdrawal by Subject|0|||
125679094|NCT02130466|452114314|FG007|Overall Study|Withdrawal by Subject|0|||
125679095|NCT02130466|452114315|FG008|Overall Study|Withdrawal by Subject|1|||
125679096|NCT02130466|452114316|FG009|Overall Study|Withdrawal by Subject|0|||
125679097|NCT02130466|452114317|FG010|Overall Study|Withdrawal by Subject|0|||
125679098|NCT02130466|452114318|FG011|Overall Study|Withdrawal by Subject|0|||
125679099|NCT02130466|452114319|FG012|Overall Study|Withdrawal by Subject|0|||
125679100|NCT02130466|452114320|FG013|Overall Study|Withdrawal by Subject|0|||
125679101|NCT04529109|452114321|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
125679102|NCT04529109|452114322|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
125679103|NCT01411332|452114323|FG000|Enrollment|Protocol Violation|0|||
125679104|NCT01411332|452114324|FG001|Enrollment|Protocol Violation|1|||
125679105|NCT01411332|452114323|FG000|Enrollment|Withdrawal by Subject|0|||
125679106|NCT01411332|452114324|FG001|Enrollment|Withdrawal by Subject|1|||
125679107|NCT01411332|452114323|FG000|Treatment|Lost to Follow-up|1|||
125679108|NCT01411332|452114324|FG001|Treatment|Lost to Follow-up|0|||
125679109|NCT01471522|452114326|FG000|Overall Study|Withdrawal by Subject|28|||
125679110|NCT01471522|452114327|FG001|Overall Study|Withdrawal by Subject|22|||
125679111|NCT01471522|452114326|FG000|Overall Study|Lost to Follow-up|36|||
125679112|NCT01471522|452114327|FG001|Overall Study|Lost to Follow-up|26|||
125679113|NCT00444145|452115837|FG000|Overall Study|Withdrawal by Subject|2|||
125679114|NCT00444145|452115837|FG000|Overall Study|Lost to Follow-up|1|||
125679115|NCT00444145|452115837|FG000|Overall Study|non-compliant|11|||
125679116|NCT00444145|452115837|FG000|Overall Study|Screen Failures|5|||
125679117|NCT03805438|452115838|FG000|Overall Study|Lack of Efficacy|1|||
125679118|NCT03805438|452115838|FG000|Overall Study|Protocol Violation|1|||
125679119|NCT01374919|452115839|FG000|Overall Study|Withdrawal by Subject|2|||
125679120|NCT00419770|452115840|FG000|Overall Study|Withdrawal by Subject|5|||
125679121|NCT00419770|452115841|FG001|Overall Study|Withdrawal by Subject|1|||
125679122|NCT02848326|452115842|FG000|Treatment Period|Adverse Event|5|||
125679123|NCT02848326|452115843|FG001|Treatment Period|Adverse Event|4|||
125679124|NCT02848326|452115844|FG002|Treatment Period|Adverse Event|11|||
125679125|NCT02848326|452115845|FG003|Treatment Period|Adverse Event|6|||
125679126|NCT02848326|452115846|FG004|Treatment Period|Adverse Event|5|||
125679127|NCT02848326|452115847|FG005|Treatment Period|Adverse Event|7|||
125679128|NCT02848326|452115842|FG000|Treatment Period|Withdrawal of Consent|20|||
125679129|NCT02848326|452115843|FG001|Treatment Period|Withdrawal of Consent|6|||
125679130|NCT02848326|452115844|FG002|Treatment Period|Withdrawal of Consent|9|||
125679131|NCT02848326|452115845|FG003|Treatment Period|Withdrawal of Consent|6|||
125679132|NCT02848326|452115846|FG004|Treatment Period|Withdrawal of Consent|9|||
125679133|NCT02848326|452115847|FG005|Treatment Period|Withdrawal of Consent|6|||
125679134|NCT02848326|452115842|FG000|Treatment Period|Lost to Follow-up|5|||
125679135|NCT02848326|452115843|FG001|Treatment Period|Lost to Follow-up|1|||
125679136|NCT02848326|452115844|FG002|Treatment Period|Lost to Follow-up|11|||
125679137|NCT02848326|452115845|FG003|Treatment Period|Lost to Follow-up|7|||
125679138|NCT02848326|452115846|FG004|Treatment Period|Lost to Follow-up|2|||
125679139|NCT02848326|452115847|FG005|Treatment Period|Lost to Follow-up|3|||
125679140|NCT02848326|452115842|FG000|Treatment Period|Pregnancy|0|||
125679141|NCT02848326|452115843|FG001|Treatment Period|Pregnancy|0|||
125679142|NCT02848326|452115844|FG002|Treatment Period|Pregnancy|1|||
125679143|NCT02848326|452115845|FG003|Treatment Period|Pregnancy|1|||
125679144|NCT02848326|452115846|FG004|Treatment Period|Pregnancy|0|||
125679145|NCT02848326|452115847|FG005|Treatment Period|Pregnancy|1|||
125679146|NCT02848326|452115842|FG000|Treatment Period|Protocol Violation|4|||
125679147|NCT02848326|452115843|FG001|Treatment Period|Protocol Violation|3|||
125679148|NCT02848326|452115844|FG002|Treatment Period|Protocol Violation|4|||
125679149|NCT02848326|452115845|FG003|Treatment Period|Protocol Violation|2|||
125679150|NCT02848326|452115846|FG004|Treatment Period|Protocol Violation|3|||
125679151|NCT02848326|452115847|FG005|Treatment Period|Protocol Violation|3|||
125679152|NCT02848326|452115842|FG000|Treatment Period|Non-compliance with Study Drug|4|||
125679153|NCT02848326|452115843|FG001|Treatment Period|Non-compliance with Study Drug|0|||
125679154|NCT02848326|452115844|FG002|Treatment Period|Non-compliance with Study Drug|0|||
125679155|NCT02848326|452115845|FG003|Treatment Period|Non-compliance with Study Drug|1|||
125679156|NCT02848326|452115846|FG004|Treatment Period|Non-compliance with Study Drug|0|||
125679157|NCT02848326|452115847|FG005|Treatment Period|Non-compliance with Study Drug|0|||
125679158|NCT02848326|452115842|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
125679159|NCT02848326|452115843|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
125679160|NCT02848326|452115844|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
125679161|NCT02848326|452115845|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
125679162|NCT02848326|452115846|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
125679163|NCT02848326|452115847|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
125679164|NCT02848326|452115842|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
125679165|NCT02848326|452115843|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
125679166|NCT02848326|452115844|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
125679167|NCT02848326|452115845|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
125679168|NCT02848326|452115846|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
125679169|NCT02848326|452115847|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
125679170|NCT00090857|452115849|FG000|Overall Study|Lost to Follow-up|0|||
125679171|NCT00090857|452115850|FG001|Overall Study|Lost to Follow-up|1|||
125679172|NCT00090857|452115849|FG000|Overall Study|Withdrawal by Subject|2|||
125679173|NCT00090857|452115850|FG001|Overall Study|Withdrawal by Subject|0|||
125679174|NCT00090857|452115849|FG000|Overall Study|Adverse Event|2|||
125679175|NCT00090857|452115850|FG001|Overall Study|Adverse Event|2|||
125679176|NCT05097326|452115851|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
125679177|NCT05097326|452115852|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
125679178|NCT02684344|452115853|FG000|Overall Study|Withdrawal by Subject|0|||
125679179|NCT02684344|452115854|FG001|Overall Study|Withdrawal by Subject|1|||
125679180|NCT03480425|452115855|FG000|Overall Study|Force transducer technical failure|1|||
125679181|NCT02424188|452115856|FG000|Overall Study|Death|2|||
125679182|NCT02424188|452115857|FG001|Overall Study|Death|2|||
125679183|NCT02424188|452115856|FG000|Overall Study|Lost to Follow-up|1|||
125679184|NCT02424188|452115857|FG001|Overall Study|Lost to Follow-up|3|||
125679185|NCT02424188|452115856|FG000|Overall Study|Incarceration|1|||
125679186|NCT02424188|452115857|FG001|Overall Study|Incarceration|0|||
125679187|NCT00630305|452115858|FG000|Overall Study|Withdrawal by Subject|1|||
125679188|NCT00630305|452115858|FG000|Overall Study|Inability to insert contact lens|1|||
125679189|NCT03100903|452115870|FG000|Overall Study|Withdrawal by Subject|0|||
125679190|NCT03100903|452115871|FG001|Overall Study|Withdrawal by Subject|0|||
125679191|NCT03100903|452115872|FG002|Overall Study|Withdrawal by Subject|1|||
125679192|NCT00433147|452115873|FG000|Overall Study|Adverse Event|0|||
125679193|NCT00433147|452115874|FG001|Overall Study|Adverse Event|1|||
125679194|NCT00433147|452115875|FG002|Overall Study|Adverse Event|0|||
125679195|NCT00433147|452115876|FG003|Overall Study|Adverse Event|0|||
125679196|NCT01882647|452115877|FG000|Overall Study|Lost to Follow-up|2|||
125679197|NCT01882647|452115878|FG001|Overall Study|Lost to Follow-up|2|||
125679198|NCT01882647|452115877|FG000|Overall Study|Withdrawal by Subject|0|||
125679199|NCT01882647|452115878|FG001|Overall Study|Withdrawal by Subject|4|||
125679200|NCT03311646|452115881|FG000|Overall Study|Physician Decision|1|||
125679201|NCT03311646|452115881|FG000|Overall Study|Withdrawal by Subject|5|||
125679202|NCT03311646|452115881|FG000|Overall Study|Lost to Follow-up|5|||
125679203|NCT03311646|452115881|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
125679204|NCT00728949|452115892|FG000|Overall Study|Adverse Event|8|||
125679205|NCT00728949|452115893|FG001|Overall Study|Adverse Event|0|||
125679206|NCT00728949|452115892|FG000|Overall Study|Withdrawal by Subject|2|||
125679207|NCT00728949|452115893|FG001|Overall Study|Withdrawal by Subject|2|||
125679208|NCT00728949|452115892|FG000|Overall Study|Abnormal Lab Results|0|||
125679209|NCT00728949|452115893|FG001|Overall Study|Abnormal Lab Results|2|||
125679210|NCT00728949|452115892|FG000|Overall Study|On treatment at cutoff date|1|||
125679211|NCT00728949|452115893|FG001|Overall Study|On treatment at cutoff date|0|||
125679212|NCT03127137|452115895|FG000|Overall Study|Requested sedation after consent|1|||
125679213|NCT03127137|452115896|FG001|Overall Study|Requested sedation after consent|0|||
125679214|NCT03127137|452115895|FG000|Overall Study|Malfunction in electronic data collection|1|||
125679215|NCT03127137|452115896|FG001|Overall Study|Malfunction in electronic data collection|0|||
125679216|NCT03127137|452115895|FG000|Overall Study|Post procedure testing could not be obtained|0|||
125679217|NCT03127137|452115896|FG001|Overall Study|Post procedure testing could not be obtained|1|||
125679218|NCT01996033|452115897|FG000|Overall Study|Death|1|||
125679219|NCT01996033|452115897|FG000|Overall Study|Physician Decision|1|||
125679220|NCT01996033|452115897|FG000|Overall Study|Withdrawal by Subject|4|||
125679221|NCT01996033|452115897|FG000|Overall Study|Lost to Follow-up|3|||
125679222|NCT01249664|452115898|FG000|Overall Study|Withdrawal by Subject|5|||
125679223|NCT01249664|452115899|FG001|Overall Study|Withdrawal by Subject|0|||
125679224|NCT01249664|452115898|FG000|Overall Study|Adverse Event|1|||
125679225|NCT01249664|452115899|FG001|Overall Study|Adverse Event|0|||
125679226|NCT01239121|452115901|FG000|Overall Study|Withdrawal by Subject|2|||
125679227|NCT01239121|452115902|FG001|Overall Study|Withdrawal by Subject|4|||
125679228|NCT01239121|452115903|FG002|Overall Study|Withdrawal by Subject|0|||
125679229|NCT01856309|452115906|FG000|Overall Study|Death|4|||
125679230|NCT01856309|452115907|FG001|Overall Study|Death|6|||
125679231|NCT01856309|452115908|FG002|Overall Study|Death|11|||
125679232|NCT01856309|452115909|FG003|Overall Study|Death|6|||
125679233|NCT01856309|452115906|FG000|Overall Study|Lost to Follow-up|6|||
125679234|NCT01856309|452115907|FG001|Overall Study|Lost to Follow-up|2|||
125679235|NCT01856309|452115908|FG002|Overall Study|Lost to Follow-up|4|||
125679236|NCT01856309|452115909|FG003|Overall Study|Lost to Follow-up|8|||
125679237|NCT01856309|452115906|FG000|Overall Study|Withdrawal by Subject|11|||
125679238|NCT01856309|452115907|FG001|Overall Study|Withdrawal by Subject|13|||
125679239|NCT01856309|452115908|FG002|Overall Study|Withdrawal by Subject|28|||
125679240|NCT01856309|452115909|FG003|Overall Study|Withdrawal by Subject|26|||
125679241|NCT01856309|452115906|FG000|Overall Study|Other|227|||
125679242|NCT01856309|452115907|FG001|Overall Study|Other|225|||
125679243|NCT01856309|452115908|FG002|Overall Study|Other|447|||
125679244|NCT01856309|452115909|FG003|Overall Study|Other|469|||
125679245|NCT01856309|452115906|FG000|Overall Study|Lack of Efficacy|14|||
125679246|NCT01856309|452115907|FG001|Overall Study|Lack of Efficacy|9|||
125679247|NCT01856309|452115908|FG002|Overall Study|Lack of Efficacy|40|||
125679248|NCT01856309|452115909|FG003|Overall Study|Lack of Efficacy|25|||
125679249|NCT01856309|452115906|FG000|Overall Study|Adverse Event|31|||
125679250|NCT01856309|452115907|FG001|Overall Study|Adverse Event|31|||
125679251|NCT01856309|452115908|FG002|Overall Study|Adverse Event|55|||
125679252|NCT01856309|452115909|FG003|Overall Study|Adverse Event|65|||
125679253|NCT01856309|452115906|FG000|Overall Study|Pregnancy|0|||
125679254|NCT01856309|452115907|FG001|Overall Study|Pregnancy|0|||
125679255|NCT01856309|452115908|FG002|Overall Study|Pregnancy|0|||
125679256|NCT01856309|452115909|FG003|Overall Study|Pregnancy|1|||
125679257|NCT01856309|452115906|FG000|Overall Study|Physician Decision|6|||
125679258|NCT01856309|452115907|FG001|Overall Study|Physician Decision|1|||
125679259|NCT01856309|452115908|FG002|Overall Study|Physician Decision|6|||
125679260|NCT01856309|452115909|FG003|Overall Study|Physician Decision|8|||
125679261|NCT01856309|452115906|FG000|Overall Study|Noncompliance With Study Drug|0|||
125679262|NCT01856309|452115907|FG001|Overall Study|Noncompliance With Study Drug|1|||
125679263|NCT01856309|452115908|FG002|Overall Study|Noncompliance With Study Drug|4|||
125679264|NCT01856309|452115909|FG003|Overall Study|Noncompliance With Study Drug|1|||
125679265|NCT00220337|452115912|FG000|Overall Study|Adverse Event|70|||
125679266|NCT00220337|452115912|FG000|Overall Study|Lack of Efficacy|17|||
125679267|NCT00220337|452115912|FG000|Overall Study|Withdrawal by Subject|68|||
125679268|NCT00220337|452115912|FG000|Overall Study|Protocol Violation|2|||
125679269|NCT00220337|452115912|FG000|Overall Study|Lost to Follow-up|5|||
125679270|NCT00220337|452115912|FG000|Overall Study|Other|12|||
125679271|NCT00220337|452115912|FG000|Overall Study|Unsatisfactory compliance|5|||
125543253|NCT00092495|451618836|FG000|Base Study Vaccination Period|*Clinical AE|1|||
125543254|NCT00092495|451618837|FG001|Base Study Vaccination Period|*Clinical AE|0|||
125345009|NCT00065429|450896478|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
125543255|NCT00092495|451618838|FG002|Base Study Vaccination Period|*Clinical AE|1|||
125543256|NCT00092495|451618839|FG003|Base Study Vaccination Period|*Clinical AE|2|||
125679272|NCT00944697|452115913|FG000|Overall Study|Withdrawal by Subject|1|||
125679273|NCT00944697|452115914|FG001|Overall Study|Withdrawal by Subject|1|||
125679274|NCT00944697|452115913|FG000|Overall Study|Adverse Event|0|||
125679275|NCT00944697|452115914|FG001|Overall Study|Adverse Event|3|||
125679276|NCT00944697|452115913|FG000|Overall Study|Administrative|1|||
125679277|NCT00944697|452115914|FG001|Overall Study|Administrative|1|||
125679278|NCT01273181|452115915|FG000|Phase I, Dose 1|Study termination|1|||
125679279|NCT01273181|452115916|FG001|Phase I, Dose 1|Study termination|0|||
125679280|NCT01273181|452115917|FG002|Phase I, Dose 1|Study termination|0|||
125679281|NCT01273181|452115918|FG003|Phase I, Dose 1|Study termination|0|||
125679282|NCT01273181|452115915|FG000|Phase I, Dose 2|Death during treatment|0|||
125679283|NCT01273181|452115916|FG001|Phase I, Dose 2|Death during treatment|1|||
125679284|NCT01273181|452115917|FG002|Phase I, Dose 2|Death during treatment|0|||
125679285|NCT01273181|452115918|FG003|Phase I, Dose 2|Death during treatment|0|||
125679286|NCT01273181|452115915|FG000|Phase 2, Dose 1|Study termination|0|||
125679287|NCT01273181|452115916|FG001|Phase 2, Dose 1|Study termination|0|||
125679288|NCT01273181|452115917|FG002|Phase 2, Dose 1|Study termination|1|||
125679289|NCT01273181|452115918|FG003|Phase 2, Dose 1|Study termination|0|||
125679290|NCT01273181|452115915|FG000|Phase 2, Dose 2|Death during treatment|0|||
125679291|NCT01273181|452115916|FG001|Phase 2, Dose 2|Death during treatment|0|||
125679292|NCT01273181|452115917|FG002|Phase 2, Dose 2|Death during treatment|0|||
125679293|NCT01273181|452115918|FG003|Phase 2, Dose 2|Death during treatment|1|||
125679294|NCT03657160|452115919|FG000|Overall Study|Adverse Event|5|||
125679295|NCT03657160|452115920|FG001|Overall Study|Adverse Event|6|||
125679296|NCT03657160|452115919|FG000|Overall Study|Protocol Deviation|3|||
125679297|NCT03657160|452115920|FG001|Overall Study|Protocol Deviation|0|||
125679298|NCT03657160|452115919|FG000|Overall Study|Withdrawal by Subject|18|||
125679299|NCT03657160|452115920|FG001|Overall Study|Withdrawal by Subject|16|||
125679300|NCT03657160|452115919|FG000|Overall Study|Site Termination|1|||
125679301|NCT03657160|452115920|FG001|Overall Study|Site Termination|0|||
125679302|NCT03657160|452115919|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
125679303|NCT03657160|452115920|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
125679304|NCT03657160|452115919|FG000|Overall Study|Death|33|||
125679305|NCT03657160|452115920|FG001|Overall Study|Death|26|||
125679306|NCT03657160|452115919|FG000|Overall Study|Death (COVID-19-Related)|1|||
125679307|NCT03657160|452115920|FG001|Overall Study|Death (COVID-19-Related)|0|||
125679308|NCT03657160|452115919|FG000|Overall Study|Reason Not Specified|5|||
125679309|NCT03657160|452115920|FG001|Overall Study|Reason Not Specified|5|||
125679310|NCT03657160|452115919|FG000|Overall Study|Other (COVID-19-Related)|0|||
125679311|NCT03657160|452115920|FG001|Overall Study|Other (COVID-19-Related)|1|||
125679312|NCT02732210|452115922|FG000|Overall Study|Site Closed|0|||
125679313|NCT02732210|452115923|FG001|Overall Study|Site Closed|11|||
125679314|NCT02732210|452115922|FG000|Overall Study|Study Ended|13|||
125679315|NCT02732210|452115923|FG001|Overall Study|Study Ended|13|||
125679316|NCT02732210|452115922|FG000|Overall Study|Withdrawal by Subject|28|||
125679317|NCT02732210|452115923|FG001|Overall Study|Withdrawal by Subject|87|||
125679318|NCT02732210|452115922|FG000|Overall Study|Lost to Follow-up|5|||
125679319|NCT02732210|452115923|FG001|Overall Study|Lost to Follow-up|57|||
125679320|NCT02732210|452115922|FG000|Overall Study|Death|4|||
125679321|NCT02732210|452115923|FG001|Overall Study|Death|15|||
125679322|NCT02732210|452115922|FG000|Overall Study|Other|35|||
125679323|NCT02732210|452115923|FG001|Overall Study|Other|103|||
125679324|NCT02732210|452115922|FG000|Overall Study|Missing|0|||
125679325|NCT02732210|452115923|FG001|Overall Study|Missing|8|||
125679326|NCT04638153|452115924|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125679327|NCT04638153|452115925|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125679328|NCT04638153|452115926|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125679329|NCT04638153|452115924|FG000|Overall Study|Study terminated by sponsor|4|||
125679330|NCT04638153|452115925|FG001|Overall Study|Study terminated by sponsor|2|||
125679331|NCT04638153|452115926|FG002|Overall Study|Study terminated by sponsor|14|||
125679332|NCT04006171|452115927|FG000|Overall Study|Withdrawal by Subject|8|||
125679333|NCT04006171|452115928|FG001|Overall Study|Withdrawal by Subject|7|||
125679334|NCT04006171|452115927|FG000|Overall Study|missing serum samples|2|||
125679335|NCT04006171|452115928|FG001|Overall Study|missing serum samples|2|||
125679336|NCT04006171|452115927|FG000|Overall Study|insufficient sample volume|2|||
125679337|NCT04006171|452115928|FG001|Overall Study|insufficient sample volume|3|||
125679338|NCT01440283|452115929|FG000|Overall Study|Death|3|||
125679339|NCT01440283|452115929|FG000|Overall Study|Withdrawal by Subject|4|||
125679340|NCT01440283|452115929|FG000|Overall Study|Physician Decision|3|||
125679341|NCT00537030|452115930|FG000|Overall Study|Physician Decision|2|||
125679342|NCT00537030|452115930|FG000|Overall Study|Withdrawal by Subject|2|||
125679343|NCT00537030|452115930|FG000|Overall Study|≥ Grade 2 allergy|7|||
125679344|NCT00537030|452115930|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
125679345|NCT00537030|452115930|FG000|Overall Study|Ineligible|2|||
125679346|NCT00537030|452115930|FG000|Overall Study|Inevaluable|2|||
125679347|NCT06354270|452115931|FG000|Overall Study|Withdrawal by Subject|1|||
125679348|NCT06354270|452115932|FG001|Overall Study|Withdrawal by Subject|0|||
125679349|NCT01939197|452115933|FG000|Overall Study|Withdrawal by Subject|1|||
125679350|NCT01939197|452115934|FG001|Overall Study|Withdrawal by Subject|0|||
125345010|NCT00065429|450896479|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
125345011|NCT00065429|450896480|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
125345012|NCT00065429|450896481|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
125679351|NCT01939197|452115935|FG002|Overall Study|Withdrawal by Subject|0|||
125679352|NCT01939197|452115936|FG003|Overall Study|Withdrawal by Subject|0|||
125679353|NCT01939197|452115937|FG004|Overall Study|Withdrawal by Subject|1|||
125679354|NCT01939197|452115938|FG005|Overall Study|Withdrawal by Subject|0|||
125679355|NCT01939197|452115939|FG006|Overall Study|Withdrawal by Subject|0|||
125679356|NCT01939197|452115933|FG000|Overall Study|Lost to Follow-up|0|||
125679357|NCT01939197|452115934|FG001|Overall Study|Lost to Follow-up|1|||
125679358|NCT01939197|452115935|FG002|Overall Study|Lost to Follow-up|0|||
125679359|NCT01939197|452115936|FG003|Overall Study|Lost to Follow-up|1|||
125679360|NCT01939197|452115937|FG004|Overall Study|Lost to Follow-up|3|||
125679361|NCT01939197|452115938|FG005|Overall Study|Lost to Follow-up|1|||
125679362|NCT01939197|452115939|FG006|Overall Study|Lost to Follow-up|2|||
125679363|NCT00745095|452115940|FG000|Overall Study|Declined to participate|1|||
125679364|NCT00745095|452115941|FG001|Overall Study|Declined to participate|0|||
125679365|NCT00745095|452115942|FG002|Overall Study|Declined to participate|0|||
125679366|NCT00745095|452115943|FG003|Overall Study|Declined to participate|0|||
125679367|NCT00745095|452115944|FG004|Overall Study|Declined to participate|92|||
125679368|NCT00745095|452115945|FG005|Overall Study|Declined to participate|95|||
125679369|NCT00745095|452115940|FG000|Overall Study|Ineligible due to GFR criteria|0|||
125679370|NCT00745095|452115941|FG001|Overall Study|Ineligible due to GFR criteria|2|||
125679371|NCT00745095|452115942|FG002|Overall Study|Ineligible due to GFR criteria|3|||
125679372|NCT00745095|452115943|FG003|Overall Study|Ineligible due to GFR criteria|3|||
125543257|NCT00092495|451618840|FG004|Base Study Vaccination Period|*Clinical AE|0|||
125679373|NCT00745095|452115944|FG004|Overall Study|Ineligible due to GFR criteria|30|||
125679374|NCT00745095|452115945|FG005|Overall Study|Ineligible due to GFR criteria|28|||
125679375|NCT00958243|452115946|FG000|Overall Study|Withdrawal by Subject|0|||
125679376|NCT00958243|452115947|FG001|Overall Study|Withdrawal by Subject|1|||
125679377|NCT00958243|452115948|FG002|Overall Study|Withdrawal by Subject|3|||
125679378|NCT00958243|452115949|FG003|Overall Study|Withdrawal by Subject|1|||
125679379|NCT00958243|452115950|FG004|Overall Study|Withdrawal by Subject|1|||
125679380|NCT00958243|452115951|FG005|Overall Study|Withdrawal by Subject|5|||
125543258|NCT00092495|451618836|FG000|Base Study Vaccination Period|*Other reasons|1|||
125679381|NCT00958243|452115946|FG000|Overall Study|Lost to Follow-up|2|||
125679382|NCT00958243|452115947|FG001|Overall Study|Lost to Follow-up|5|||
125679383|NCT00958243|452115948|FG002|Overall Study|Lost to Follow-up|11|||
125679384|NCT00958243|452115949|FG003|Overall Study|Lost to Follow-up|2|||
125679385|NCT00958243|452115950|FG004|Overall Study|Lost to Follow-up|8|||
125679386|NCT00958243|452115951|FG005|Overall Study|Lost to Follow-up|5|||
125679387|NCT00162123|452115954|FG000|Overall Study|Disease progression|27|||
125679388|NCT00162123|452115955|FG001|Overall Study|Disease progression|19|||
125679389|NCT00162123|452115956|FG002|Overall Study|Disease progression|10|||
125679390|NCT00162123|452115957|FG003|Overall Study|Disease progression|4|||
125679391|NCT00162123|452115958|FG004|Overall Study|Disease progression|8|||
125679392|NCT00162123|452115959|FG005|Overall Study|Disease progression|3|||
125679393|NCT00162123|452115960|FG006|Overall Study|Disease progression|1|||
125679394|NCT00162123|452115961|FG007|Overall Study|Disease progression|0|||
125679395|NCT00162123|452115954|FG000|Overall Study|Study drug toxicity|6|||
125679396|NCT00162123|452115955|FG001|Overall Study|Study drug toxicity|1|||
125679397|NCT00162123|452115956|FG002|Overall Study|Study drug toxicity|5|||
125679398|NCT00162123|452115957|FG003|Overall Study|Study drug toxicity|0|||
125679399|NCT00162123|452115958|FG004|Overall Study|Study drug toxicity|4|||
125679400|NCT00162123|452115959|FG005|Overall Study|Study drug toxicity|1|||
125679401|NCT00162123|452115960|FG006|Overall Study|Study drug toxicity|1|||
125679402|NCT00162123|452115961|FG007|Overall Study|Study drug toxicity|0|||
125679403|NCT00162123|452115954|FG000|Overall Study|Death|3|||
125679404|NCT00162123|452115955|FG001|Overall Study|Death|3|||
125679405|NCT00162123|452115956|FG002|Overall Study|Death|1|||
125679406|NCT00162123|452115957|FG003|Overall Study|Death|1|||
125679407|NCT00162123|452115958|FG004|Overall Study|Death|1|||
125679408|NCT00162123|452115959|FG005|Overall Study|Death|1|||
125679409|NCT00162123|452115960|FG006|Overall Study|Death|0|||
125679410|NCT00162123|452115961|FG007|Overall Study|Death|0|||
125679411|NCT00162123|452115954|FG000|Overall Study|Withdrawal by Subject|2|||
125679412|NCT00162123|452115955|FG001|Overall Study|Withdrawal by Subject|0|||
125679413|NCT00162123|452115956|FG002|Overall Study|Withdrawal by Subject|2|||
125679414|NCT00162123|452115957|FG003|Overall Study|Withdrawal by Subject|1|||
125679415|NCT00162123|452115958|FG004|Overall Study|Withdrawal by Subject|1|||
125679416|NCT00162123|452115959|FG005|Overall Study|Withdrawal by Subject|2|||
125679417|NCT00162123|452115960|FG006|Overall Study|Withdrawal by Subject|1|||
125679418|NCT00162123|452115961|FG007|Overall Study|Withdrawal by Subject|0|||
125679419|NCT00162123|452115954|FG000|Overall Study|Deterioration without progression|2|||
125679420|NCT00162123|452115955|FG001|Overall Study|Deterioration without progression|2|||
125679421|NCT00162123|452115956|FG002|Overall Study|Deterioration without progression|3|||
125679422|NCT00162123|452115957|FG003|Overall Study|Deterioration without progression|0|||
125679423|NCT00162123|452115958|FG004|Overall Study|Deterioration without progression|1|||
125679424|NCT00162123|452115959|FG005|Overall Study|Deterioration without progression|0|||
125679425|NCT00162123|452115960|FG006|Overall Study|Deterioration without progression|0|||
125679426|NCT00162123|452115961|FG007|Overall Study|Deterioration without progression|0|||
125679427|NCT00162123|452115954|FG000|Overall Study|Adverse Event|1|||
125679428|NCT00162123|452115955|FG001|Overall Study|Adverse Event|2|||
125679429|NCT00162123|452115956|FG002|Overall Study|Adverse Event|0|||
125679430|NCT00162123|452115957|FG003|Overall Study|Adverse Event|2|||
125679431|NCT00162123|452115958|FG004|Overall Study|Adverse Event|1|||
125679432|NCT00162123|452115959|FG005|Overall Study|Adverse Event|0|||
125679433|NCT00162123|452115960|FG006|Overall Study|Adverse Event|0|||
125679434|NCT00162123|452115961|FG007|Overall Study|Adverse Event|0|||
125679435|NCT00162123|452115954|FG000|Overall Study|Not specified (before treatment)|2|||
125679436|NCT00162123|452115955|FG001|Overall Study|Not specified (before treatment)|0|||
125679437|NCT00162123|452115956|FG002|Overall Study|Not specified (before treatment)|0|||
125679438|NCT00162123|452115957|FG003|Overall Study|Not specified (before treatment)|0|||
125679439|NCT00162123|452115958|FG004|Overall Study|Not specified (before treatment)|12|||
125679440|NCT00162123|452115959|FG005|Overall Study|Not specified (before treatment)|1|||
125679441|NCT00162123|452115960|FG006|Overall Study|Not specified (before treatment)|0|||
125679442|NCT00162123|452115961|FG007|Overall Study|Not specified (before treatment)|0|||
125679443|NCT00162123|452115954|FG000|Overall Study|Not specified (after start of treatment)|0|||
125679444|NCT00162123|452115955|FG001|Overall Study|Not specified (after start of treatment)|0|||
125679445|NCT00162123|452115956|FG002|Overall Study|Not specified (after start of treatment)|0|||
125679446|NCT00162123|452115957|FG003|Overall Study|Not specified (after start of treatment)|0|||
125679447|NCT00162123|452115958|FG004|Overall Study|Not specified (after start of treatment)|3|||
125679448|NCT00162123|452115959|FG005|Overall Study|Not specified (after start of treatment)|0|||
125679449|NCT00162123|452115960|FG006|Overall Study|Not specified (after start of treatment)|0|||
125679450|NCT00162123|452115961|FG007|Overall Study|Not specified (after start of treatment)|0|||
125679451|NCT00162123|452115954|FG000|Overall Study|Physician Decision|1|||
125679452|NCT00162123|452115955|FG001|Overall Study|Physician Decision|2|||
125679453|NCT00162123|452115956|FG002|Overall Study|Physician Decision|0|||
125679454|NCT00162123|452115957|FG003|Overall Study|Physician Decision|0|||
125679455|NCT00162123|452115958|FG004|Overall Study|Physician Decision|0|||
125679456|NCT00162123|452115959|FG005|Overall Study|Physician Decision|1|||
125679457|NCT00162123|452115960|FG006|Overall Study|Physician Decision|1|||
125543259|NCT00092495|451618837|FG001|Base Study Vaccination Period|*Other reasons|0|||
125543260|NCT00092495|451618838|FG002|Base Study Vaccination Period|*Other reasons|0|||
125543261|NCT00092495|451618839|FG003|Base Study Vaccination Period|*Other reasons|1|||
125543262|NCT00092495|451618840|FG004|Base Study Vaccination Period|*Other reasons|0|||
125543263|NCT00092495|451618836|FG000|Base Study Vaccination Period|*Pregnancy|0|||
125543264|NCT00092495|451618837|FG001|Base Study Vaccination Period|*Pregnancy|2|||
125543265|NCT00092495|451618838|FG002|Base Study Vaccination Period|*Pregnancy|5|||
125543266|NCT00092495|451618839|FG003|Base Study Vaccination Period|*Pregnancy|7|||
125543267|NCT00092495|451618840|FG004|Base Study Vaccination Period|*Pregnancy|0|||
125543268|NCT00092495|451618836|FG000|Base Study Vaccination Period|Adverse Event|1|||
125679458|NCT00162123|452115961|FG007|Overall Study|Physician Decision|0|||
125679459|NCT00162123|452115954|FG000|Overall Study|Tumor assessment only (not treated)|0|||
125679460|NCT00162123|452115955|FG001|Overall Study|Tumor assessment only (not treated)|0|||
125679461|NCT00162123|452115956|FG002|Overall Study|Tumor assessment only (not treated)|0|||
125679462|NCT00162123|452115957|FG003|Overall Study|Tumor assessment only (not treated)|0|||
125679463|NCT00162123|452115958|FG004|Overall Study|Tumor assessment only (not treated)|0|||
125679464|NCT00162123|452115959|FG005|Overall Study|Tumor assessment only (not treated)|0|||
125679465|NCT00162123|452115960|FG006|Overall Study|Tumor assessment only (not treated)|0|||
125679466|NCT00162123|452115961|FG007|Overall Study|Tumor assessment only (not treated)|1|||
125679467|NCT00162123|452115954|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
125679468|NCT00162123|452115955|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
125679469|NCT00162123|452115956|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
125679470|NCT00162123|452115957|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
125679471|NCT00162123|452115958|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
125679472|NCT00162123|452115959|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
125679473|NCT00162123|452115960|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
125679474|NCT00162123|452115961|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
125679475|NCT01936948|452115965|FG000|Overall Study|no 30-day follow-up data|0|||
125679476|NCT01936948|452115966|FG001|Overall Study|no 30-day follow-up data|3|||
125679477|NCT01936948|452115967|FG002|Overall Study|no 30-day follow-up data|3|||
125679478|NCT01936948|452115968|FG003|Overall Study|no 30-day follow-up data|3|||
125679479|NCT02781727|452115969|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
125679480|NCT02781727|452115970|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
125679481|NCT02781727|452115969|FG000|Treatment Period|Withdrawal by Subject|1|||
125679482|NCT02781727|452115970|FG001|Treatment Period|Withdrawal by Subject|0|||
125679483|NCT02781727|452115969|FG000|Treatment Period|Lost to Follow-up|0|||
125679484|NCT02781727|452115970|FG001|Treatment Period|Lost to Follow-up|1|||
125679485|NCT02327130|452115971|FG000|Overall Study|Discharged in less than 5 days|5|||
125679486|NCT02327130|452115971|FG000|Overall Study|Physician Decision|2|||
125679487|NCT02327130|452115971|FG000|Overall Study|Unable to provide breath sample|1|||
125679488|NCT02327130|452115971|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
125679489|NCT02327130|452115971|FG000|Overall Study|Met exclusion criteria|3|||
125679490|NCT00406848|452115972|FG000|Overall Study|Withdrawal by Subject|27|||
125679491|NCT00406848|452115973|FG001|Overall Study|Withdrawal by Subject|22|||
125679492|NCT00406848|452115972|FG000|Overall Study|Adverse Event|38|||
125679493|NCT00406848|452115973|FG001|Overall Study|Adverse Event|7|||
125679494|NCT00406848|452115972|FG000|Overall Study|Lack of Efficacy|9|||
125679495|NCT00406848|452115973|FG001|Overall Study|Lack of Efficacy|14|||
125679496|NCT00406848|452115972|FG000|Overall Study|Protocol Violation|10|||
125679497|NCT00406848|452115973|FG001|Overall Study|Protocol Violation|6|||
125679498|NCT00406848|452115972|FG000|Overall Study|Lost to Follow-up|6|||
125679499|NCT00406848|452115973|FG001|Overall Study|Lost to Follow-up|2|||
125679500|NCT00406848|452115972|FG000|Overall Study|Physician Decision|2|||
125679501|NCT00406848|452115973|FG001|Overall Study|Physician Decision|2|||
125679502|NCT00406848|452115972|FG000|Overall Study|Sponsor Decision|1|||
125679503|NCT00406848|452115973|FG001|Overall Study|Sponsor Decision|1|||
125679504|NCT00352690|452115974|FG000|Overall Study|Determined to be ineligible|2|||
125679505|NCT00352690|452115975|FG001|Overall Study|Determined to be ineligible|0|||
125679506|NCT02719522|452115980|FG000|Overall Study|Implant Failure|4|||
125679507|NCT02719522|452115980|FG000|Overall Study|Death|2|||
125679508|NCT02719522|452115980|FG000|Overall Study|Lost to Follow-up|5|||
125679509|NCT04025879|452115984|FG000|Randomization|Participant withdrew consent|0|||
125679510|NCT04025879|452115985|FG001|Randomization|Participant withdrew consent|1|||
125679511|NCT04025879|452115984|FG000|Randomization|Participant no longer met study criteria|1|||
125679512|NCT04025879|452115985|FG001|Randomization|Participant no longer met study criteria|1|||
125679513|NCT04025879|452115984|FG000|Treatment|Ongoing treatment|10|||
125679514|NCT04025879|452115985|FG001|Treatment|Ongoing treatment|8|||
125679515|NCT04025879|452115984|FG000|Treatment|Disease progression/recurrence|36|||
125679516|NCT04025879|452115985|FG001|Treatment|Disease progression/recurrence|72|||
125543269|NCT00092495|451618837|FG001|Base Study Vaccination Period|Adverse Event|0|||
125543270|NCT00092495|451618838|FG002|Base Study Vaccination Period|Adverse Event|0|||
125679517|NCT04025879|452115984|FG000|Treatment|Study drug toxicity|36|||
125679518|NCT04025879|452115985|FG001|Treatment|Study drug toxicity|13|||
125679519|NCT04025879|452115984|FG000|Treatment|Death|2|||
125543271|NCT00092495|451618839|FG003|Base Study Vaccination Period|Adverse Event|3|||
125543272|NCT00092495|451618840|FG004|Base Study Vaccination Period|Adverse Event|0|||
125543273|NCT00092495|451618836|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
125543274|NCT00092495|451618837|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
125543275|NCT00092495|451618838|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
125543276|NCT00092495|451618839|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
125543277|NCT00092495|451618840|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
125543278|NCT00092495|451618836|FG000|Base Study Vaccination Period|Moved|3|||
125543279|NCT00092495|451618837|FG001|Base Study Vaccination Period|Moved|1|||
125543280|NCT00092495|451618838|FG002|Base Study Vaccination Period|Moved|2|||
125543281|NCT00092495|451618839|FG003|Base Study Vaccination Period|Moved|2|||
125543282|NCT00092495|451618840|FG004|Base Study Vaccination Period|Moved|0|||
125543283|NCT00092495|451618836|FG000|Base Study Vaccination Period|Other|1|||
125543284|NCT00092495|451618837|FG001|Base Study Vaccination Period|Other|1|||
125543285|NCT00092495|451618838|FG002|Base Study Vaccination Period|Other|0|||
125543286|NCT00092495|451618839|FG003|Base Study Vaccination Period|Other|2|||
125679520|NCT04025879|452115985|FG001|Treatment|Death|0|||
125679521|NCT04025879|452115984|FG000|Treatment|Adverse event unrelated to study drug|21|||
125679522|NCT04025879|452115985|FG001|Treatment|Adverse event unrelated to study drug|14|||
125679523|NCT04025879|452115984|FG000|Treatment|Participant request to discontinue study treatment|16|||
125679524|NCT04025879|452115985|FG001|Treatment|Participant request to discontinue study treatment|8|||
125679525|NCT04025879|452115984|FG000|Treatment|Participant withdrew consent|1|||
125679526|NCT04025879|452115985|FG001|Treatment|Participant withdrew consent|3|||
125679527|NCT04025879|452115984|FG000|Treatment|Participant no longer meets study criteria|3|||
125679528|NCT04025879|452115985|FG001|Treatment|Participant no longer meets study criteria|2|||
125679529|NCT04025879|452115984|FG000|Treatment|Lost to Follow-up|1|||
125679530|NCT04025879|452115985|FG001|Treatment|Lost to Follow-up|0|||
125679531|NCT04025879|452115984|FG000|Treatment|Other reasons|15|||
125679532|NCT04025879|452115985|FG001|Treatment|Other reasons|17|||
125679533|NCT04025879|452115984|FG000|Treatment|Administrative reason by sponsor|0|||
125679534|NCT04025879|452115985|FG001|Treatment|Administrative reason by sponsor|1|||
125679535|NCT04025879|452115984|FG000|Treatment|Not reported|2|||
125679536|NCT04025879|452115985|FG001|Treatment|Not reported|0|||
125679537|NCT02888171|452115986|FG000|Overall Study|Lost to Follow-up|2|||
125679538|NCT02888171|452115987|FG001|Overall Study|Lost to Follow-up|1|||
125679539|NCT02888171|452115986|FG000|Overall Study|Withdrawal by Subject|3|||
125679540|NCT02888171|452115987|FG001|Overall Study|Withdrawal by Subject|2|||
125679541|NCT02888171|452115986|FG000|Overall Study|Adverse Event|0|||
125679542|NCT02888171|452115987|FG001|Overall Study|Adverse Event|1|||
125679543|NCT00366899|452117530|FG000|Infant Series|Withdrawal by Subject|4|||
125679544|NCT00366899|452117531|FG001|Infant Series|Withdrawal by Subject|7|||
125679545|NCT00366899|452117530|FG000|Infant Series|Protocol Violation|2|||
125679546|NCT00366899|452117531|FG001|Infant Series|Protocol Violation|1|||
125679547|NCT00366899|452117530|FG000|Infant Series|Failed to return|1|||
125679548|NCT00366899|452117531|FG001|Infant Series|Failed to return|1|||
125679549|NCT00366899|452117530|FG000|Infant Series|Lost to Follow-up|0|||
125679550|NCT00366899|452117531|FG001|Infant Series|Lost to Follow-up|2|||
125679551|NCT00366899|452117530|FG000|Infant Series|Adverse Event|0|||
125679552|NCT00366899|452117531|FG001|Infant Series|Adverse Event|1|||
125679553|NCT00366899|452117530|FG000|Infant Series|Physician Decision|1|||
125679554|NCT00366899|452117531|FG001|Infant Series|Physician Decision|0|||
125679555|NCT00366899|452117530|FG000|Infant Series|Randomized but not consented|1|||
125679556|NCT00366899|452117531|FG001|Infant Series|Randomized but not consented|0|||
125679557|NCT00366899|452117530|FG000|After Infant Series|Lost to Follow-up|4|||
125679558|NCT00366899|452117531|FG001|After Infant Series|Lost to Follow-up|3|||
125679559|NCT00366899|452117530|FG000|After Infant Series|Withdrawal by Subject|1|||
125679560|NCT00366899|452117531|FG001|After Infant Series|Withdrawal by Subject|4|||
125679561|NCT00366899|452117530|FG000|After Infant Series|Adverse Event|1|||
125679562|NCT00366899|452117531|FG001|After Infant Series|Adverse Event|2|||
125679563|NCT00366899|452117530|FG000|After Infant Series|Protocol Violation|1|||
125679564|NCT00366899|452117531|FG001|After Infant Series|Protocol Violation|0|||
125679565|NCT00366899|452117530|FG000|Toddler Dose|Withdrawal by Subject|1|||
125679566|NCT00366899|452117531|FG001|Toddler Dose|Withdrawal by Subject|1|||
125679567|NCT00366899|452117530|FG000|Toddler Dose|Protocol Violation|1|||
125679568|NCT00366899|452117531|FG001|Toddler Dose|Protocol Violation|0|||
125543287|NCT00092495|451618840|FG004|Base Study Vaccination Period|Other|0|||
125543288|NCT00092495|451618836|FG000|Base Study Vaccination Period|Pregnancy|2|||
125543289|NCT00092495|451618837|FG001|Base Study Vaccination Period|Pregnancy|0|||
125543290|NCT00092495|451618838|FG002|Base Study Vaccination Period|Pregnancy|0|||
125679569|NCT01619800|452117532|FG000|Overall Study|study terminated|2|||
125679570|NCT01619800|452117533|FG001|Overall Study|study terminated|0|||
125679571|NCT00414466|452117540|FG000|Overall Study|Adverse Event|0|||
125679572|NCT00414466|452117541|FG001|Overall Study|Adverse Event|0|||
125679573|NCT00414466|452117542|FG002|Overall Study|Adverse Event|1|||
125679574|NCT00414466|452117543|FG003|Overall Study|Adverse Event|1|||
125679575|NCT00414466|452117540|FG000|Overall Study|Lack of Efficacy|1|||
125679576|NCT00414466|452117541|FG001|Overall Study|Lack of Efficacy|0|||
125679577|NCT00414466|452117542|FG002|Overall Study|Lack of Efficacy|0|||
125679578|NCT00414466|452117543|FG003|Overall Study|Lack of Efficacy|0|||
125679579|NCT00414466|452117540|FG000|Overall Study|Withdrawn by Sponsor|1|||
125679580|NCT00414466|452117541|FG001|Overall Study|Withdrawn by Sponsor|0|||
125679581|NCT00414466|452117542|FG002|Overall Study|Withdrawn by Sponsor|0|||
125679582|NCT00414466|452117543|FG003|Overall Study|Withdrawn by Sponsor|0|||
125679583|NCT04526210|452117544|FG000|Overall Study|Sponsor decision|7|||
125679584|NCT04526210|452117545|FG001|Overall Study|Sponsor decision|5|||
125679585|NCT04526210|452117544|FG000|Overall Study|Withdrawal by Subject|3|||
125679586|NCT04526210|452117545|FG001|Overall Study|Withdrawal by Subject|2|||
125679587|NCT02637232|452117546|FG000|Overall Study|Lost to Follow-up|42|||
125345013|NCT00065429|450896482|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
125345014|NCT00065429|450896483|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
125345015|NCT02015221|450896486|FG000|Overall Study|Withdrawal by Subject|8|||
125345016|NCT02015221|450896487|FG001|Overall Study|Withdrawal by Subject|6|||
125679588|NCT02637232|452117546|FG000|Overall Study|Adverse Event|11|||
125543291|NCT00092495|451618839|FG003|Base Study Vaccination Period|Pregnancy|0|||
125543292|NCT00092495|451618840|FG004|Base Study Vaccination Period|Pregnancy|0|||
125679589|NCT02637232|452117546|FG000|Overall Study|patient 's decision|2|||
125679590|NCT01781637|452117547|FG000|Overall Study|Adverse Event|1|||
125679591|NCT01781637|452117548|FG001|Overall Study|Adverse Event|0|||
125679592|NCT01781637|452117547|FG000|Overall Study|Lack of Efficacy|2|||
125679593|NCT01781637|452117548|FG001|Overall Study|Lack of Efficacy|6|||
125679594|NCT01781637|452117547|FG000|Overall Study|Withdrawal by Subject|1|||
125679595|NCT01781637|452117548|FG001|Overall Study|Withdrawal by Subject|0|||
125679596|NCT02999178|452117549|FG000|Overall Study|Adverse Event|85|||
125679597|NCT02999178|452117550|FG001|Overall Study|Adverse Event|62|||
125679598|NCT02999178|452117549|FG000|Overall Study|Protocol Violation|1|||
125679599|NCT02999178|452117550|FG001|Overall Study|Protocol Violation|2|||
125679600|NCT02999178|452117549|FG000|Overall Study|Lost to Follow-up|0|||
125679601|NCT02999178|452117550|FG001|Overall Study|Lost to Follow-up|2|||
125679602|NCT02999178|452117549|FG000|Overall Study|Withdrawal by Subject|21|||
125679603|NCT02999178|452117550|FG001|Overall Study|Withdrawal by Subject|21|||
125679604|NCT02999178|452117549|FG000|Overall Study|Other reason not defined above|7|||
125679605|NCT02999178|452117550|FG001|Overall Study|Other reason not defined above|13|||
125679606|NCT03471078|452117558|FG000|Overall Study|Withdrawal by Subject|9|||
125679607|NCT03471078|452117559|FG001|Overall Study|Withdrawal by Subject|1|||
125679608|NCT03471078|452117558|FG000|Overall Study|Adverse Event|4|||
125679609|NCT03471078|452117559|FG001|Overall Study|Adverse Event|1|||
125679610|NCT03471078|452117558|FG000|Overall Study|Physician Decision|3|||
125679611|NCT03471078|452117559|FG001|Overall Study|Physician Decision|2|||
125679612|NCT03471078|452117558|FG000|Overall Study|Death|2|||
125679613|NCT03471078|452117559|FG001|Overall Study|Death|0|||
125679614|NCT03471078|452117558|FG000|Overall Study|Other|3|||
125679615|NCT03471078|452117559|FG001|Overall Study|Other|2|||
125679616|NCT02473640|452117563|FG000|Treatment Period 1|Adverse Event|1|||
125679617|NCT02395822|452117564|FG000|Overall Study|Withdrawal by Subject|1|||
125679618|NCT02395822|452117564|FG000|Overall Study|Death|1|||
125679619|NCT02127281|452117565|FG000|Overall Study|Lost to Follow-up|1|||
125679620|NCT02127281|452117566|FG001|Overall Study|Lost to Follow-up|0|||
125679621|NCT02937701|452117569|FG000|Day 1 to Week 22|Adverse Event|11|||
125679622|NCT02937701|452117570|FG001|Day 1 to Week 22|Adverse Event|14|||
125679623|NCT02937701|452117571|FG002|Day 1 to Week 22|Adverse Event|0|||
125679624|NCT02937701|452117572|FG003|Day 1 to Week 22|Adverse Event|0|||
125679625|NCT02937701|452117573|FG004|Day 1 to Week 22|Adverse Event|0|||
125679626|NCT02937701|452117569|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
125679627|NCT02937701|452117570|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
125679628|NCT02937701|452117571|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
125679629|NCT02937701|452117572|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
125679630|NCT02937701|452117573|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
125679631|NCT02937701|452117569|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
125679632|NCT02937701|452117570|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
125679633|NCT02937701|452117571|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
125679634|NCT02937701|452117572|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
125679635|NCT02937701|452117573|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
125679636|NCT02937701|452117569|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
125679637|NCT02937701|452117570|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
125679638|NCT02937701|452117571|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
125679639|NCT02937701|452117572|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
125679640|NCT02937701|452117573|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
125679641|NCT02937701|452117569|FG000|Day 1 to Week 22|Death|1|||
125679642|NCT02937701|452117570|FG001|Day 1 to Week 22|Death|1|||
125679643|NCT02937701|452117571|FG002|Day 1 to Week 22|Death|0|||
125679644|NCT02937701|452117572|FG003|Day 1 to Week 22|Death|0|||
125679645|NCT02937701|452117573|FG004|Day 1 to Week 22|Death|0|||
125679646|NCT02937701|452117569|FG000|Day 1 to Week 22|Protocol Violation|1|||
125679647|NCT02937701|452117570|FG001|Day 1 to Week 22|Protocol Violation|1|||
125679648|NCT02937701|452117571|FG002|Day 1 to Week 22|Protocol Violation|0|||
125679649|NCT02937701|452117572|FG003|Day 1 to Week 22|Protocol Violation|0|||
125679650|NCT02937701|452117573|FG004|Day 1 to Week 22|Protocol Violation|0|||
125679651|NCT02937701|452117569|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
125679652|NCT02937701|452117570|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
125679653|NCT02937701|452117571|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
125679654|NCT02937701|452117572|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
125679655|NCT02937701|452117573|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
125543293|NCT00092495|451618836|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
125679656|NCT02937701|452117569|FG000|Day 1 to Week 22|Physician Decision|2|||
125679657|NCT02937701|452117570|FG001|Day 1 to Week 22|Physician Decision|0|||
125679658|NCT02937701|452117571|FG002|Day 1 to Week 22|Physician Decision|0|||
125679659|NCT02937701|452117572|FG003|Day 1 to Week 22|Physician Decision|0|||
125679660|NCT02937701|452117573|FG004|Day 1 to Week 22|Physician Decision|0|||
125679661|NCT02937701|452117569|FG000|Day 1 to Week 22|Other|1|||
125679662|NCT02937701|452117570|FG001|Day 1 to Week 22|Other|0|||
125543294|NCT00092495|451618837|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
125543295|NCT00092495|451618838|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
125543296|NCT00092495|451618839|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
125543297|NCT00092495|451618840|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
125679663|NCT02937701|452117571|FG002|Day 1 to Week 22|Other|0|||
125679664|NCT02937701|452117572|FG003|Day 1 to Week 22|Other|0|||
125679665|NCT02937701|452117573|FG004|Day 1 to Week 22|Other|0|||
125679666|NCT02937701|452117569|FG000|Week 22 to Week 50|Adverse Event|0|||
125679667|NCT02937701|452117570|FG001|Week 22 to Week 50|Adverse Event|0|||
125679668|NCT02937701|452117571|FG002|Week 22 to Week 50|Adverse Event|10|||
125679669|NCT02937701|452117572|FG003|Week 22 to Week 50|Adverse Event|3|||
125679670|NCT02937701|452117573|FG004|Week 22 to Week 50|Adverse Event|3|||
125679671|NCT02937701|452117569|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
125679672|NCT02937701|452117570|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
125679673|NCT02937701|452117571|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
125679674|NCT02937701|452117572|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
125679675|NCT02937701|452117573|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
125679676|NCT02937701|452117569|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
125679677|NCT02937701|452117570|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
125679678|NCT02937701|452117571|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
125679679|NCT02937701|452117572|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
125679680|NCT02937701|452117573|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
125679681|NCT02937701|452117569|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
125679682|NCT02937701|452117570|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
125679683|NCT02937701|452117571|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
125679684|NCT02937701|452117572|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
125679685|NCT02937701|452117573|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
125679686|NCT02937701|452117569|FG000|Week 22 to Week 50|Physician Decision|0|||
125679687|NCT02937701|452117570|FG001|Week 22 to Week 50|Physician Decision|0|||
125679688|NCT02937701|452117571|FG002|Week 22 to Week 50|Physician Decision|2|||
125679689|NCT02937701|452117572|FG003|Week 22 to Week 50|Physician Decision|0|||
125679690|NCT02937701|452117573|FG004|Week 22 to Week 50|Physician Decision|1|||
125679691|NCT02937701|452117569|FG000|Week 22 to Week 50|Other|0|||
125679692|NCT02937701|452117570|FG001|Week 22 to Week 50|Other|0|||
125679693|NCT02937701|452117571|FG002|Week 22 to Week 50|Other|0|||
125679694|NCT02937701|452117572|FG003|Week 22 to Week 50|Other|0|||
125679695|NCT02937701|452117573|FG004|Week 22 to Week 50|Other|1|||
125679696|NCT03292653|452117575|FG000|Overall Study|Adverse Event|0|||
125679697|NCT03292653|452117576|FG001|Overall Study|Adverse Event|0|||
125679698|NCT03292653|452117577|FG002|Overall Study|Adverse Event|1|||
125679699|NCT03292653|452117575|FG000|Overall Study|Did not Receive Treatment|1|||
125679700|NCT03292653|452117576|FG001|Overall Study|Did not Receive Treatment|0|||
125679701|NCT03292653|452117577|FG002|Overall Study|Did not Receive Treatment|0|||
125679702|NCT04720664|452117578|FG000|Overall Study|Adverse Event|2|||
125679703|NCT04720664|452117578|FG000|Overall Study|Lack of Efficacy|9|||
125679704|NCT05628675|452117579|FG000|Overall Study|Lost to Follow-up|2|||
125679705|NCT05628675|452117579|FG000|Overall Study|Withdrawal by Subject|1|||
125679706|NCT05818137|452117583|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
125679707|NCT05818137|452117583|FG000|Extension Treatment Period|Ongoing participants|44|||
125679708|NCT01648166|452117586|FG000|Overall Study|inadequate toenail samples|53|||
125679709|NCT01648166|452117587|FG001|Overall Study|inadequate toenail samples|100|||
125679710|NCT00883090|452117588|FG000|Overall Study|Sponsor's decision|1|||
125679711|NCT00883090|452117588|FG000|Overall Study|Withdrawal by Subject|1|||
125679712|NCT01475838|452117591|FG000|Randomized Phase|Randomized but Not Treated|0|||
125679713|NCT01475838|452117592|FG001|Randomized Phase|Randomized but Not Treated|5|||
125679714|NCT01475838|452117591|FG000|Randomized Phase|Adverse Event|6|||
125679715|NCT01475838|452117592|FG001|Randomized Phase|Adverse Event|1|||
125679716|NCT01475838|452117591|FG000|Randomized Phase|Pregnancy|0|||
125679717|NCT01475838|452117592|FG001|Randomized Phase|Pregnancy|1|||
125679718|NCT01475838|452117591|FG000|Randomized Phase|Investigators Discretion|1|||
125543298|NCT00092495|451618836|FG000|Base Study Vaccination Period|Protocol Violation|1|||
125543299|NCT00092495|451618837|FG001|Base Study Vaccination Period|Protocol Violation|0|||
125543300|NCT00092495|451618838|FG002|Base Study Vaccination Period|Protocol Violation|0|||
125543301|NCT00092495|451618839|FG003|Base Study Vaccination Period|Protocol Violation|0|||
125543302|NCT00092495|451618840|FG004|Base Study Vaccination Period|Protocol Violation|0|||
125543303|NCT00092495|451618836|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
125543304|NCT00092495|451618837|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
125543305|NCT00092495|451618838|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
125543306|NCT00092495|451618839|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
125543307|NCT00092495|451618840|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
125543308|NCT00092495|451618836|FG000|Base Study Follow-up Period|Extended|0|||
125543309|NCT00092495|451618837|FG001|Base Study Follow-up Period|Extended|0|||
125543310|NCT00092495|451618838|FG002|Base Study Follow-up Period|Extended|1|||
125543311|NCT00092495|451618839|FG003|Base Study Follow-up Period|Extended|2|||
125543312|NCT00092495|451618840|FG004|Base Study Follow-up Period|Extended|0|||
125543313|NCT00092495|451618836|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
125543314|NCT00092495|451618837|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
125543315|NCT00092495|451618838|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
125543316|NCT00092495|451618839|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
125543317|NCT00092495|451618840|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
125543318|NCT00092495|451618836|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
125543319|NCT00092495|451618837|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
125543320|NCT00092495|451618838|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
125543321|NCT00092495|451618839|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
125543322|NCT00092495|451618840|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
125543323|NCT02937454|451618843|FG000|Overall Study|Adverse Event|0|||
125543324|NCT02937454|451618844|FG001|Overall Study|Adverse Event|1|||
125543325|NCT02937454|451618843|FG000|Overall Study|Death|98|||
125543326|NCT02937454|451618844|FG001|Overall Study|Death|95|||
125543327|NCT02937454|451618843|FG000|Overall Study|Lost to Follow-up|1|||
125543328|NCT02937454|451618844|FG001|Overall Study|Lost to Follow-up|1|||
125543329|NCT02937454|451618843|FG000|Overall Study|Physician Decision|0|||
125543330|NCT02937454|451618844|FG001|Overall Study|Physician Decision|1|||
125543331|NCT02937454|451618843|FG000|Overall Study|Protocol Violation|6|||
125543332|NCT02937454|451618844|FG001|Overall Study|Protocol Violation|10|||
125543333|NCT02937454|451618843|FG000|Overall Study|Withdrawal by Subject|27|||
125543334|NCT02937454|451618844|FG001|Overall Study|Withdrawal by Subject|15|||
125543335|NCT02937454|451618843|FG000|Overall Study|Other|8|||
125543336|NCT02937454|451618844|FG001|Overall Study|Other|5|||
125543337|NCT01888900|451618850|FG000|Overall Study|failed treatment|0|||
125543338|NCT01888900|451618851|FG001|Overall Study|failed treatment|2|||
125543339|NCT03932812|451618852|FG000|Overall Study|Lost to Follow-up|12|||
125543340|NCT03932812|451618853|FG001|Overall Study|Lost to Follow-up|14|||
125543341|NCT03932812|451618852|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
125543342|NCT03932812|451618853|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
125543343|NCT02585232|451618854|FG000|Overall Study|Lost to Follow-up|8|||
125543344|NCT02585232|451618855|FG001|Overall Study|Lost to Follow-up|8|||
125543345|NCT02585232|451618854|FG000|Overall Study|Withdrawal by Subject|4|||
125543346|NCT02585232|451618855|FG001|Overall Study|Withdrawal by Subject|8|||
125543347|NCT02313233|451618856|FG000|Overall Study|Withdrawal by Subject|1|||
125543348|NCT02313233|451618857|FG001|Overall Study|Withdrawal by Subject|2|||
125543349|NCT02313233|451618856|FG000|Overall Study|Administrative reason|1|||
125543350|NCT02313233|451618857|FG001|Overall Study|Administrative reason|1|||
125543351|NCT02679573|451618869|FG000|Overall Study|Adverse Event|13|||
125543352|NCT02679573|451618870|FG001|Overall Study|Adverse Event|6|||
125543353|NCT02679573|451618869|FG000|Overall Study|Lack of Efficacy|12|||
125543354|NCT02679573|451618870|FG001|Overall Study|Lack of Efficacy|15|||
125543355|NCT02679573|451618869|FG000|Overall Study|Could not complete required study visits|6|||
125543356|NCT02679573|451618870|FG001|Overall Study|Could not complete required study visits|2|||
125543357|NCT02679573|451618869|FG000|Overall Study|Withdrawal by Subject|2|||
125543358|NCT02679573|451618870|FG001|Overall Study|Withdrawal by Subject|9|||
125543359|NCT02679573|451618869|FG000|Overall Study|Death|2|||
125543360|NCT02679573|451618870|FG001|Overall Study|Death|0|||
125543361|NCT02679573|451618869|FG000|Overall Study|Physician Decision|2|||
125543362|NCT02679573|451618870|FG001|Overall Study|Physician Decision|4|||
125543363|NCT02679573|451618869|FG000|Overall Study|Lost to Follow-up|0|||
125543364|NCT02679573|451618870|FG001|Overall Study|Lost to Follow-up|3|||
125543365|NCT03545503|451618871|FG000|Overall Study|Protocol Violation|14|||
125543366|NCT03545503|451618872|FG001|Overall Study|Protocol Violation|16|||
125543367|NCT00682890|451618873|FG000|Overall Study|Lost to Follow-up|1|||
125543368|NCT00682890|451618874|FG001|Overall Study|Lost to Follow-up|1|||
125543369|NCT00682890|451618873|FG000|Overall Study|subject moved away|0|||
125543370|NCT00682890|451618874|FG001|Overall Study|subject moved away|1|||
125543371|NCT00682890|451618873|FG000|Overall Study|heavy menstrual bleeding|1|||
125543372|NCT00682890|451618874|FG001|Overall Study|heavy menstrual bleeding|0|||
125543373|NCT02884908|451618877|FG000|Overall Study|Lost to Follow-up|13|||
125543374|NCT02884908|451618878|FG001|Overall Study|Lost to Follow-up|18|||
125543375|NCT01605019|451618881|FG000|Overall Study|pt did not meet transplant endpoint|3|||
125543376|NCT01605019|451618882|FG001|Overall Study|pt did not meet transplant endpoint|0|||
125543377|NCT00862719|451618883|FG000|Overall Study|Disease Progression|5|||
125543378|NCT00862719|451618884|FG001|Overall Study|Disease Progression|0|||
125543379|NCT00862719|451618885|FG002|Overall Study|Disease Progression|1|||
125543380|NCT00862719|451618886|FG003|Overall Study|Disease Progression|0|||
125543381|NCT00862719|451618883|FG000|Overall Study|Death|5|||
125543382|NCT00862719|451618884|FG001|Overall Study|Death|6|||
125543383|NCT00862719|451618885|FG002|Overall Study|Death|1|||
125543384|NCT00862719|451618886|FG003|Overall Study|Death|1|||
125543385|NCT00862719|451618883|FG000|Overall Study|Engraftment failure|0|||
125543386|NCT00862719|451618884|FG001|Overall Study|Engraftment failure|0|||
125543387|NCT00862719|451618885|FG002|Overall Study|Engraftment failure|1|||
125543388|NCT00862719|451618886|FG003|Overall Study|Engraftment failure|0|||
125543389|NCT00862719|451618883|FG000|Overall Study|Veno-Occlusive Disease|0|||
125543390|NCT00862719|451618884|FG001|Overall Study|Veno-Occlusive Disease|0|||
125543391|NCT00862719|451618885|FG002|Overall Study|Veno-Occlusive Disease|1|||
125543392|NCT00862719|451618886|FG003|Overall Study|Veno-Occlusive Disease|0|||
125543393|NCT00324116|451618887|FG000|Overall Study|Adverse Event|5|||
125543394|NCT00324116|451618887|FG000|Overall Study|Lack of Efficacy|17|||
125543395|NCT00324116|451618887|FG000|Overall Study|Withdrawal by Subject|5|||
125543396|NCT00324116|451618887|FG000|Overall Study|Other|5|||
125543397|NCT01806623|451618888|FG000|Overall Study|Withdrawal by Subject|1|||
125543398|NCT01806623|451618888|FG000|Overall Study|Adverse Event|1|||
125543399|NCT01806623|451618888|FG000|Overall Study|Did not meet the inclusion criteria|56|||
125543400|NCT01737827|451618889|FG000|Overall Study|Adverse Event|3|||
125543401|NCT01737827|451618890|FG001|Overall Study|Adverse Event|6|||
125543402|NCT01737827|451618891|FG002|Overall Study|Adverse Event|0|||
125543403|NCT01737827|451618889|FG000|Overall Study|Lost to Follow-up|0|||
125543404|NCT01737827|451618890|FG001|Overall Study|Lost to Follow-up|1|||
125543405|NCT01737827|451618891|FG002|Overall Study|Lost to Follow-up|0|||
125543406|NCT01737827|451618889|FG000|Overall Study|Physician Decision|0|||
125543407|NCT01737827|451618890|FG001|Overall Study|Physician Decision|2|||
125543408|NCT01737827|451618891|FG002|Overall Study|Physician Decision|0|||
125543409|NCT01737827|451618889|FG000|Overall Study|Progressive Disease|5|||
125543410|NCT01737827|451618890|FG001|Overall Study|Progressive Disease|16|||
125543411|NCT01737827|451618891|FG002|Overall Study|Progressive Disease|2|||
125543412|NCT01737827|451618889|FG000|Overall Study|Study Terminated by Sponsor|0|||
125543413|NCT01737827|451618890|FG001|Overall Study|Study Terminated by Sponsor|1|||
125543414|NCT01737827|451618891|FG002|Overall Study|Study Terminated by Sponsor|0|||
125543415|NCT01737827|451618889|FG000|Overall Study|Subject/Guardian Decision|0|||
125543416|NCT01737827|451618890|FG001|Overall Study|Subject/Guardian Decision|2|||
125543417|NCT01737827|451618891|FG002|Overall Study|Subject/Guardian Decision|0|||
125543418|NCT01451827|451618892|FG000|Overall Study|Adverse Event|2|||
125543419|NCT01451827|451618893|FG001|Overall Study|Adverse Event|0|||
125543420|NCT01451827|451618894|FG002|Overall Study|Adverse Event|1|||
125543421|NCT01451827|451618895|FG003|Overall Study|Adverse Event|1|||
125543422|NCT01451827|451618892|FG000|Overall Study|Protocol deviation|1|||
125543423|NCT01451827|451618893|FG001|Overall Study|Protocol deviation|0|||
125543424|NCT01451827|451618894|FG002|Overall Study|Protocol deviation|0|||
125543425|NCT01451827|451618895|FG003|Overall Study|Protocol deviation|0|||
125543426|NCT01451827|451618892|FG000|Overall Study|Lost to Follow-up|0|||
125543427|NCT01451827|451618893|FG001|Overall Study|Lost to Follow-up|3|||
125543428|NCT01451827|451618894|FG002|Overall Study|Lost to Follow-up|0|||
125543429|NCT01451827|451618895|FG003|Overall Study|Lost to Follow-up|2|||
125543430|NCT01451827|451618892|FG000|Overall Study|Participant met withdrawal criteria|0|||
125543431|NCT01451827|451618893|FG001|Overall Study|Participant met withdrawal criteria|2|||
125543432|NCT01451827|451618894|FG002|Overall Study|Participant met withdrawal criteria|0|||
125543433|NCT01451827|451618895|FG003|Overall Study|Participant met withdrawal criteria|0|||
125543434|NCT01451827|451618892|FG000|Overall Study|Withdrawal by Subject|0|||
125543435|NCT01451827|451618893|FG001|Overall Study|Withdrawal by Subject|0|||
125543436|NCT01451827|451618894|FG002|Overall Study|Withdrawal by Subject|1|||
125543437|NCT01451827|451618895|FG003|Overall Study|Withdrawal by Subject|1|||
125543438|NCT01034163|451618898|FG000|Overall Study|Treatment completed as per protocol|8|||
125543439|NCT01034163|451618899|FG001|Overall Study|Treatment completed as per protocol|7|||
125543440|NCT01034163|451618898|FG000|Overall Study|Withdrawal by Subject|8|||
125543441|NCT01034163|451618899|FG001|Overall Study|Withdrawal by Subject|2|||
125543442|NCT01034163|451618898|FG000|Overall Study|Protocol deviation|1|||
125543443|NCT01034163|451618899|FG001|Overall Study|Protocol deviation|0|||
125543444|NCT01034163|451618898|FG000|Overall Study|Disease progression|3|||
125543445|NCT01034163|451618899|FG001|Overall Study|Disease progression|4|||
125543446|NCT01034163|451618898|FG000|Overall Study|Adverse Event|6|||
125543447|NCT01034163|451618899|FG001|Overall Study|Adverse Event|0|||
125543448|NCT01034163|451618898|FG000|Overall Study|Administrative problems|0|||
125543449|NCT01034163|451618899|FG001|Overall Study|Administrative problems|1|||
125543450|NCT01034163|451618898|FG000|Overall Study|Abnormal laboratory value|1|||
125543451|NCT01034163|451618899|FG001|Overall Study|Abnormal laboratory value|0|||
125543452|NCT02424734|451618900|FG000|Overall Study|Treatment stopped to be discharged home|2|||
125543453|NCT02424734|451618901|FG001|Overall Study|Treatment stopped to be discharged home|2|||
125543454|NCT02424734|451618902|FG002|Overall Study|Treatment stopped to be discharged home|0|||
125543455|NCT00528645|451618903|FG000|Overall Study|Adverse Event|3|||
125543456|NCT00116753|451618904|FG000|Overall Study|Adverse Event|16|||
125543457|NCT00116753|451618905|FG001|Overall Study|Adverse Event|10|||
125543458|NCT00116753|451618906|FG002|Overall Study|Adverse Event|7|||
125543459|NCT00116753|451618904|FG000|Overall Study|Withdrawal by Subject|11|||
125543460|NCT00116753|451618905|FG001|Overall Study|Withdrawal by Subject|12|||
125543461|NCT00116753|451618906|FG002|Overall Study|Withdrawal by Subject|8|||
125543462|NCT00116753|451618904|FG000|Overall Study|Lost to Follow-up|0|||
125543463|NCT00116753|451618905|FG001|Overall Study|Lost to Follow-up|2|||
125543464|NCT00116753|451618906|FG002|Overall Study|Lost to Follow-up|1|||
125543465|NCT00116753|451618904|FG000|Overall Study|Protocol Violation|0|||
125543466|NCT00116753|451618905|FG001|Overall Study|Protocol Violation|0|||
125543467|NCT00116753|451618906|FG002|Overall Study|Protocol Violation|1|||
125543468|NCT00116753|451618904|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
125543469|NCT00116753|451618905|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
125543470|NCT00116753|451618906|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
125543471|NCT00116753|451618904|FG000|Overall Study|Disease Progression|3|||
125543472|NCT00116753|451618905|FG001|Overall Study|Disease Progression|4|||
125543473|NCT00116753|451618906|FG002|Overall Study|Disease Progression|3|||
125543474|NCT00116753|451618904|FG000|Overall Study|Abnormal Echocardiogram|0|||
125543475|NCT00116753|451618905|FG001|Overall Study|Abnormal Echocardiogram|0|||
125543476|NCT00116753|451618906|FG002|Overall Study|Abnormal Echocardiogram|1|||
125543477|NCT00116753|451618904|FG000|Overall Study|Progressive Parkinson's Disease|1|||
125543478|NCT00116753|451618905|FG001|Overall Study|Progressive Parkinson's Disease|0|||
125543479|NCT00116753|451618906|FG002|Overall Study|Progressive Parkinson's Disease|0|||
125543480|NCT00116753|451618904|FG000|Overall Study|Dosing Error|0|||
125543481|NCT00116753|451618905|FG001|Overall Study|Dosing Error|1|||
125543482|NCT00116753|451618906|FG002|Overall Study|Dosing Error|0|||
125543483|NCT01642251|451618907|FG000|Overall Study|Progressive disease|0|||
125543484|NCT01642251|451618908|FG001|Overall Study|Progressive disease|0|||
125543485|NCT01642251|451618909|FG002|Overall Study|Progressive disease|3|||
125543486|NCT01642251|451618910|FG003|Overall Study|Progressive disease|3|||
125543487|NCT01642251|451618907|FG000|Overall Study|Adverse Event|0|||
125543488|NCT01642251|451618908|FG001|Overall Study|Adverse Event|0|||
125543489|NCT01642251|451618909|FG002|Overall Study|Adverse Event|5|||
125543490|NCT01642251|451618910|FG003|Overall Study|Adverse Event|4|||
125543491|NCT01642251|451618907|FG000|Overall Study|Death|0|||
125543492|NCT01642251|451618908|FG001|Overall Study|Death|0|||
125543493|NCT01642251|451618909|FG002|Overall Study|Death|1|||
125543494|NCT01642251|451618910|FG003|Overall Study|Death|3|||
125543495|NCT01642251|451618907|FG000|Overall Study|Withdrawal by Subject|0|||
125543496|NCT01642251|451618908|FG001|Overall Study|Withdrawal by Subject|0|||
125543497|NCT01642251|451618909|FG002|Overall Study|Withdrawal by Subject|1|||
125543498|NCT01642251|451618910|FG003|Overall Study|Withdrawal by Subject|3|||
125543499|NCT01642251|451618907|FG000|Overall Study|Alternative therapy|0|||
125543500|NCT01642251|451618908|FG001|Overall Study|Alternative therapy|0|||
125543501|NCT01642251|451618909|FG002|Overall Study|Alternative therapy|0|||
125543502|NCT01642251|451618910|FG003|Overall Study|Alternative therapy|2|||
125543503|NCT01642251|451618907|FG000|Overall Study|Other complicating disease|0|||
125543504|NCT01642251|451618908|FG001|Overall Study|Other complicating disease|0|||
125543505|NCT01642251|451618909|FG002|Overall Study|Other complicating disease|1|||
125543506|NCT01642251|451618910|FG003|Overall Study|Other complicating disease|0|||
125543507|NCT01642251|451618907|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
125543508|NCT01642251|451618908|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
125543509|NCT01642251|451618909|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
125543510|NCT01642251|451618910|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
125543511|NCT01445301|451618911|FG000|Overall Study|Adverse Event|15|||
125543512|NCT01445301|451618912|FG001|Overall Study|Adverse Event|25|||
125543513|NCT01445301|451618913|FG002|Overall Study|Adverse Event|4|||
125543514|NCT01445301|451618911|FG000|Overall Study|Lack of Efficacy|0|||
125543515|NCT01445301|451618912|FG001|Overall Study|Lack of Efficacy|1|||
125543516|NCT01445301|451618913|FG002|Overall Study|Lack of Efficacy|0|||
125543517|NCT01445301|451618911|FG000|Overall Study|Protocol Violation|1|||
125543518|NCT01445301|451618912|FG001|Overall Study|Protocol Violation|0|||
125543519|NCT01445301|451618913|FG002|Overall Study|Protocol Violation|0|||
125679719|NCT01475838|452117592|FG001|Randomized Phase|Investigators Discretion|2|||
125679720|NCT01475838|452117591|FG000|Randomized Phase|Withdrew Consent|10|||
125543520|NCT01445301|451618911|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
125543521|NCT01445301|451618912|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
125679721|NCT01475838|452117592|FG001|Randomized Phase|Withdrew Consent|14|||
125679722|NCT01475838|452117591|FG000|Randomized Phase|Lost to Follow-up|3|||
125679723|NCT01475838|452117592|FG001|Randomized Phase|Lost to Follow-up|4|||
125679724|NCT01475838|452117591|FG000|Randomized Phase|Participant Noncompliance|1|||
125679725|NCT01475838|452117592|FG001|Randomized Phase|Participant Noncompliance|5|||
125679726|NCT01475838|452117591|FG000|Randomized Phase|Protocol Violation|9|||
125679727|NCT01475838|452117592|FG001|Randomized Phase|Protocol Violation|4|||
125679728|NCT01475838|452117591|FG000|Extension Phase|Participant Noncompliance|1|||
125679729|NCT01475838|452117592|FG001|Extension Phase|Participant Noncompliance|0|||
125679730|NCT00048568|452117593|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
125679731|NCT00048568|452117594|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
125679732|NCT00048568|452117595|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
125679733|NCT00048568|452117593|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
125679734|NCT00048568|452117594|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
125679735|NCT00048568|452117595|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
125679736|NCT00048568|452117593|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
125679737|NCT00048568|452117594|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
125679738|NCT00048568|452117595|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
125679739|NCT00048568|452117593|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
125679740|NCT00048568|452117594|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
125679741|NCT00048568|452117595|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
125679742|NCT00048568|452117593|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
125679743|NCT00048568|452117594|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
125679744|NCT00048568|452117595|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
125679745|NCT00048568|452117593|FG000|Double-Blind Period Days 170 to 365|Death|1|||
125679746|NCT00048568|452117594|FG001|Double-Blind Period Days 170 to 365|Death|1|||
125679747|NCT00048568|452117595|FG002|Double-Blind Period Days 170 to 365|Death|0|||
125679748|NCT00048568|452117593|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
125679749|NCT00048568|452117594|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
125679750|NCT00048568|452117595|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
125679751|NCT00048568|452117593|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
125679752|NCT00048568|452117594|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
125679753|NCT00048568|452117595|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
125679754|NCT00048568|452117593|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
125679755|NCT00048568|452117594|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
125679756|NCT00048568|452117595|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
125679757|NCT00048568|452117593|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
125679758|NCT00048568|452117594|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
125679759|NCT00048568|452117595|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
125679760|NCT00048568|452117593|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
125679761|NCT00048568|452117594|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
125679762|NCT00048568|452117595|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
125679763|NCT00048568|452117593|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
125679764|NCT00048568|452117594|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
125679765|NCT00048568|452117595|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
125679766|NCT00048568|452117593|FG000|Open-Label Period|Death|0|||
125679767|NCT00048568|452117594|FG001|Open-Label Period|Death|0|||
125679768|NCT00048568|452117595|FG002|Open-Label Period|Death|13|||
125679769|NCT00048568|452117593|FG000|Open-Label Period|Adverse Event|0|||
125679770|NCT00048568|452117594|FG001|Open-Label Period|Adverse Event|0|||
125679771|NCT00048568|452117595|FG002|Open-Label Period|Adverse Event|49|||
125679772|NCT00048568|452117593|FG000|Open-Label Period|Lack of Efficacy|0|||
125679773|NCT00048568|452117594|FG001|Open-Label Period|Lack of Efficacy|0|||
125679774|NCT00048568|452117595|FG002|Open-Label Period|Lack of Efficacy|32|||
125679775|NCT00048568|452117593|FG000|Open-Label Period|Withdrawal by Subject|0|||
125679776|NCT00048568|452117594|FG001|Open-Label Period|Withdrawal by Subject|0|||
125679777|NCT00048568|452117595|FG002|Open-Label Period|Withdrawal by Subject|26|||
125679778|NCT00048568|452117593|FG000|Open-Label Period|Pregnancy|0|||
125679779|NCT00048568|452117594|FG001|Open-Label Period|Pregnancy|0|||
125679780|NCT00048568|452117595|FG002|Open-Label Period|Pregnancy|5|||
125679781|NCT00048568|452117593|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
125345017|NCT02015221|450896486|FG000|Overall Study|Lost to Follow-up|1|||
125345018|NCT02015221|450896487|FG001|Overall Study|Lost to Follow-up|0|||
125345019|NCT00995566|450896488|FG000|Overall Study|Adverse Event|2|||
125345020|NCT00995566|450896488|FG000|Overall Study|Early study termination|52|||
125345021|NCT01576159|450896489|FG000|Overall Study|Withdrawal by Subject|0|||
125345022|NCT01576159|450896490|FG001|Overall Study|Withdrawal by Subject|1|||
125345023|NCT01576159|450896491|FG002|Overall Study|Withdrawal by Subject|0|||
125345024|NCT01576159|450896492|FG003|Overall Study|Withdrawal by Subject|0|||
125345025|NCT01576159|450896489|FG000|Overall Study|Physician Decision|0|||
125345026|NCT01576159|450896490|FG001|Overall Study|Physician Decision|0|||
125679782|NCT00048568|452117594|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
125679783|NCT00048568|452117595|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
125679784|NCT00048568|452117593|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
125679785|NCT00048568|452117594|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
125679786|NCT00048568|452117595|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
125679787|NCT00048568|452117593|FG000|Open-Label Period|Unknown Reasons|0|||
125679788|NCT00048568|452117594|FG001|Open-Label Period|Unknown Reasons|0|||
125679789|NCT00048568|452117595|FG002|Open-Label Period|Unknown Reasons|25|||
125679790|NCT00048568|452117593|FG000|Open-Label Period|Lost to Follow-up|0|||
125679791|NCT00048568|452117594|FG001|Open-Label Period|Lost to Follow-up|0|||
125679792|NCT00048568|452117595|FG002|Open-Label Period|Lost to Follow-up|7|||
125679793|NCT03831048|452117596|FG000|Overall Study|Protocol Violation|9|||
125679794|NCT03831048|452117597|FG001|Overall Study|Protocol Violation|3|||
125679795|NCT03831048|452117596|FG000|Overall Study|Death|4|||
125679796|NCT03831048|452117597|FG001|Overall Study|Death|9|||
125679797|NCT03831048|452117596|FG000|Overall Study|Re-transplant|0|||
125679798|NCT03831048|452117597|FG001|Overall Study|Re-transplant|2|||
125679799|NCT03831048|452117596|FG000|Overall Study|Protocol violation and death|1|||
125679800|NCT03831048|452117597|FG001|Overall Study|Protocol violation and death|1|||
125679801|NCT00560235|452117601|FG000|Phase 1|Discontinued|8|||
125679802|NCT00560235|452117602|FG001|Phase 1|Discontinued|0|||
125679803|NCT00560235|452117603|FG002|Phase 1|Discontinued|0|||
125679804|NCT00560235|452117601|FG000|Phase 1B|Discontinued|0|||
125679805|NCT00560235|452117602|FG001|Phase 1B|Discontinued|19|||
125679806|NCT00560235|452117603|FG002|Phase 1B|Discontinued|0|||
125679807|NCT00560235|452117601|FG000|Phase 2|Discontinued|0|||
125679808|NCT00560235|452117602|FG001|Phase 2|Discontinued|0|||
125679809|NCT00560235|452117603|FG002|Phase 2|Discontinued|96|||
125679810|NCT00560235|452117601|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
125679811|NCT00560235|452117602|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
125679812|NCT00560235|452117603|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
125679813|NCT01315249|452117606|FG000|Overall Study|Adverse Event|22|||
125679814|NCT01315249|452117607|FG001|Overall Study|Adverse Event|26|||
125679815|NCT01315249|452117606|FG000|Overall Study|Withdrawal by Subject|11|||
125679816|NCT01315249|452117607|FG001|Overall Study|Withdrawal by Subject|10|||
125679817|NCT01315249|452117606|FG000|Overall Study|Protocol Violation|8|||
125679818|NCT01315249|452117607|FG001|Overall Study|Protocol Violation|5|||
125679819|NCT01315249|452117606|FG000|Overall Study|Abnormal test results|1|||
125679820|NCT01315249|452117607|FG001|Overall Study|Abnormal test results|2|||
125679821|NCT01315249|452117606|FG000|Overall Study|Administrative problems|1|||
125679822|NCT01315249|452117607|FG001|Overall Study|Administrative problems|0|||
125679823|NCT01315249|452117606|FG000|Overall Study|inability to use device|1|||
125679824|NCT01315249|452117607|FG001|Overall Study|inability to use device|0|||
125679825|NCT01315249|452117606|FG000|Overall Study|Lack of Efficacy|0|||
125679826|NCT01315249|452117607|FG001|Overall Study|Lack of Efficacy|1|||
125679827|NCT01315249|452117606|FG000|Overall Study|Lost to Follow-up|0|||
125679828|NCT01315249|452117607|FG001|Overall Study|Lost to Follow-up|2|||
125679829|NCT01315249|452117606|FG000|Overall Study|Death|0|||
125679830|NCT01315249|452117607|FG001|Overall Study|Death|1|||
125679831|NCT03227445|452117612|FG000|Period 1 (28 Days)|Adverse Event|1|||
125679832|NCT03227445|452117613|FG001|Period 1 (28 Days)|Adverse Event|2|||
125679833|NCT03227445|452117614|FG002|Period 1 (28 Days)|Adverse Event|0|||
125679834|NCT03227445|452117615|FG003|Period 1 (28 Days)|Adverse Event|1|||
125679835|NCT03227445|452117612|FG000|Period 1 (28 Days)|Protocol Violation|1|||
125679836|NCT03227445|452117613|FG001|Period 1 (28 Days)|Protocol Violation|0|||
125679837|NCT03227445|452117614|FG002|Period 1 (28 Days)|Protocol Violation|0|||
125679838|NCT03227445|452117615|FG003|Period 1 (28 Days)|Protocol Violation|0|||
125679839|NCT03227445|452117612|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
125679840|NCT03227445|452117613|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
125679841|NCT03227445|452117614|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
125345027|NCT01576159|450896491|FG002|Overall Study|Physician Decision|1|||
125345028|NCT01576159|450896492|FG003|Overall Study|Physician Decision|0|||
125679842|NCT03227445|452117615|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
125679843|NCT03227445|452117612|FG000|Period 2 (28 Days)|Adverse Event|1|||
125679844|NCT03227445|452117613|FG001|Period 2 (28 Days)|Adverse Event|0|||
125679845|NCT03227445|452117614|FG002|Period 2 (28 Days)|Adverse Event|2|||
125679846|NCT03227445|452117615|FG003|Period 2 (28 Days)|Adverse Event|1|||
125679847|NCT03227445|452117612|FG000|Period 2 (28 Days)|Protocol Violation|0|||
125679848|NCT03227445|452117613|FG001|Period 2 (28 Days)|Protocol Violation|0|||
125543522|NCT01445301|451618913|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
125543523|NCT01445301|451618911|FG000|Overall Study|Physician Decision|0|||
125543524|NCT01445301|451618912|FG001|Overall Study|Physician Decision|2|||
125543525|NCT01445301|451618913|FG002|Overall Study|Physician Decision|0|||
125543526|NCT01445301|451618911|FG000|Overall Study|Withdrawal by Subject|5|||
125543527|NCT01445301|451618912|FG001|Overall Study|Withdrawal by Subject|6|||
125543528|NCT01445301|451618913|FG002|Overall Study|Withdrawal by Subject|4|||
125543529|NCT00752557|451618914|FG000|Overall Study|Withdrawal by Subject|4|||
125543530|NCT00752557|451618915|FG001|Overall Study|Withdrawal by Subject|3|||
125543531|NCT00752557|451618916|FG002|Overall Study|Withdrawal by Subject|3|||
125543532|NCT00752557|451618914|FG000|Overall Study|Unspecified resaons|0|||
125543533|NCT00752557|451618915|FG001|Overall Study|Unspecified resaons|2|||
125543534|NCT00752557|451618916|FG002|Overall Study|Unspecified resaons|2|||
125543535|NCT00752557|451618914|FG000|Overall Study|Lost to Follow-up|1|||
125543536|NCT00752557|451618915|FG001|Overall Study|Lost to Follow-up|0|||
125543537|NCT00752557|451618916|FG002|Overall Study|Lost to Follow-up|1|||
125543538|NCT02413333|451618917|FG000|Period 1|Adverse Event|1|||
125543539|NCT02413333|451618918|FG001|Period 1|Adverse Event|0|||
125543540|NCT02413333|451618917|FG000|Period 1|Reason Not Specified|0|||
125543541|NCT02413333|451618918|FG001|Period 1|Reason Not Specified|1|||
125543542|NCT02413333|451618917|FG000|Period 2|Protocol Deviation|1|||
125543543|NCT02413333|451618918|FG001|Period 2|Protocol Deviation|0|||
125543544|NCT00470366|451618919|FG000|Overall Study|Adverse Event|3|||
125543545|NCT00470366|451618919|FG000|Overall Study|Poor compliance|1|||
125543546|NCT02996474|451618920|FG000|Overall Study|Physician Decision|5|||
125543547|NCT04493502|451618921|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
125543548|NCT04493502|451618922|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
125543549|NCT04493502|451618921|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
125543550|NCT04493502|451618922|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
125679849|NCT03227445|452117614|FG002|Period 2 (28 Days)|Protocol Violation|0|||
125679850|NCT03227445|452117615|FG003|Period 2 (28 Days)|Protocol Violation|1|||
125679851|NCT03227445|452117612|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
125679852|NCT03227445|452117613|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
125679853|NCT03227445|452117614|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
125679854|NCT03227445|452117615|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
125679855|NCT00755196|452117617|FG000|Overall Study|Lost to Follow-up|1|||
125679856|NCT00755196|452117617|FG000|Overall Study|Lack of Efficiency|1|||
125679857|NCT01703832|452117618|FG000|Overall Study|Withdrawal by Subject|1|||
125679858|NCT01703832|452117619|FG001|Overall Study|Withdrawal by Subject|0|||
125679859|NCT01991470|452117620|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
125679860|NCT01991470|452117620|FG000|Enlite 1 Period|Adverse Event|1|||
125679861|NCT01991470|452117620|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
125679862|NCT01991470|452117620|FG000|Enlite 3 Period|Lost to Follow-up|1|||
125679863|NCT01991470|452117620|FG000|Enlite 3 Period|Physician Decision|2|||
125679864|NCT01991470|452117620|FG000|Enlite 3 Period|Physician Decision|8|||
125679865|NCT01991470|452117620|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
125679866|NCT00623779|452117638|FG000|Overall Study|Adverse Event|1|||
125679867|NCT00623779|452117639|FG001|Overall Study|Adverse Event|3|||
125679868|NCT00623779|452117640|FG002|Overall Study|Adverse Event|0|||
125679869|NCT00623779|452117638|FG000|Overall Study|Criteria from CSR|2|||
125679870|NCT00623779|452117639|FG001|Overall Study|Criteria from CSR|0|||
125679871|NCT00623779|452117640|FG002|Overall Study|Criteria from CSR|1|||
125679872|NCT01434693|452117643|FG000|Overall Study|Adverse Event|1|||
125679873|NCT01434693|452117644|FG001|Overall Study|Adverse Event|0|||
125679874|NCT01434693|452117645|FG002|Overall Study|Adverse Event|0|||
125679875|NCT01434693|452117646|FG003|Overall Study|Adverse Event|0|||
125679876|NCT01434693|452117643|FG000|Overall Study|Withdrawal by Subject|1|||
125679877|NCT01434693|452117644|FG001|Overall Study|Withdrawal by Subject|0|||
125679878|NCT01434693|452117645|FG002|Overall Study|Withdrawal by Subject|1|||
125679879|NCT01434693|452117646|FG003|Overall Study|Withdrawal by Subject|1|||
125679880|NCT01434693|452117643|FG000|Overall Study|Lost to Follow-up|1|||
125679881|NCT01434693|452117644|FG001|Overall Study|Lost to Follow-up|0|||
125679882|NCT01434693|452117645|FG002|Overall Study|Lost to Follow-up|0|||
125679883|NCT01434693|452117646|FG003|Overall Study|Lost to Follow-up|0|||
125679884|NCT00440557|452117648|FG000|Overall Study|Withdrawal by Subject|10|||
125679885|NCT00440557|452117649|FG001|Overall Study|Withdrawal by Subject|5|||
125679886|NCT00440557|452117650|FG002|Overall Study|Withdrawal by Subject|11|||
125679887|NCT00440557|452117648|FG000|Overall Study|Lost to Follow-up|1|||
125679888|NCT00440557|452117649|FG001|Overall Study|Lost to Follow-up|2|||
125679889|NCT00440557|452117650|FG002|Overall Study|Lost to Follow-up|6|||
125679890|NCT00440557|452117648|FG000|Overall Study|Adverse Event|3|||
125543551|NCT04493502|451618921|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
125543552|NCT04493502|451618922|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
125543553|NCT04493502|451618921|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
125543554|NCT04493502|451618922|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
125679891|NCT00440557|452117649|FG001|Overall Study|Adverse Event|3|||
125679892|NCT00440557|452117650|FG002|Overall Study|Adverse Event|5|||
125345029|NCT01576159|450896489|FG000|Overall Study|Lost to Follow-up|0|||
125345030|NCT01576159|450896490|FG001|Overall Study|Lost to Follow-up|0|||
125543555|NCT04493502|451618921|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
125543556|NCT04493502|451618922|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
125543557|NCT04493502|451618921|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
125543558|NCT04493502|451618922|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
125543559|NCT04493502|451618921|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
125543560|NCT04493502|451618922|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
125543561|NCT04493502|451618921|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
125543562|NCT04493502|451618922|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
125345031|NCT01576159|450896491|FG002|Overall Study|Lost to Follow-up|0|||
125345032|NCT01576159|450896492|FG003|Overall Study|Lost to Follow-up|1|||
125345033|NCT01576159|450896489|FG000|Overall Study|Protocol Violation|1|||
125345034|NCT01576159|450896490|FG001|Overall Study|Protocol Violation|0|||
125345035|NCT01576159|450896491|FG002|Overall Study|Protocol Violation|0|||
125345036|NCT01576159|450896492|FG003|Overall Study|Protocol Violation|0|||
125345037|NCT01181986|450896495|FG000|Phase 1|Lost to Follow-up|0|||
125345038|NCT01181986|450896496|FG001|Phase 1|Lost to Follow-up|1|||
125345039|NCT01181986|450896497|FG002|Phase 1|Lost to Follow-up|1|||
125345040|NCT01181986|450896495|FG000|Phase 1|Adverse Event|0|||
125543563|NCT04493502|451618921|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
125543564|NCT04493502|451618922|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
125543565|NCT04493502|451618921|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
125543566|NCT04493502|451618922|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
125543567|NCT04493502|451618921|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
125543568|NCT04493502|451618922|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
125543569|NCT04493502|451618921|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
125543570|NCT04493502|451618922|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
125543571|NCT04493502|451618921|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
125543572|NCT04493502|451618922|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
125543573|NCT00540046|451618923|FG000|Overall Study|Lost to Follow-up|33|||
125543574|NCT00540046|451618924|FG001|Overall Study|Lost to Follow-up|23|||
125543575|NCT02891837|451618925|FG000|Overall Study|Lost to Follow-up|2|||
125543576|NCT02891837|451618926|FG001|Overall Study|Lost to Follow-up|0|||
125679893|NCT00440557|452117648|FG000|Overall Study|Death|2|||
125679894|NCT00440557|452117649|FG001|Overall Study|Death|6|||
125679895|NCT00440557|452117650|FG002|Overall Study|Death|3|||
125679896|NCT00440557|452117648|FG000|Overall Study|Began Dialysis|4|||
125679897|NCT00440557|452117649|FG001|Overall Study|Began Dialysis|1|||
125679898|NCT00440557|452117650|FG002|Overall Study|Began Dialysis|4|||
125679899|NCT00440557|452117648|FG000|Overall Study|Principal Investigator decision|0|||
125679900|NCT00440557|452117649|FG001|Overall Study|Principal Investigator decision|3|||
125679901|NCT00440557|452117650|FG002|Overall Study|Principal Investigator decision|1|||
125679902|NCT00440557|452117648|FG000|Overall Study|Patient moved|1|||
125679903|NCT00440557|452117649|FG001|Overall Study|Patient moved|2|||
125679904|NCT00440557|452117650|FG002|Overall Study|Patient moved|1|||
125679905|NCT00440557|452117648|FG000|Overall Study|Principal Investigator's office closed|3|||
125679906|NCT00440557|452117649|FG001|Overall Study|Principal Investigator's office closed|6|||
125679907|NCT00440557|452117650|FG002|Overall Study|Principal Investigator's office closed|4|||
125679908|NCT00440557|452117648|FG000|Overall Study|Patient transferred to nursing home|0|||
125679909|NCT00440557|452117649|FG001|Overall Study|Patient transferred to nursing home|1|||
125679910|NCT00440557|452117650|FG002|Overall Study|Patient transferred to nursing home|0|||
125679911|NCT00440557|452117648|FG000|Overall Study|Patient had surgery|1|||
125679912|NCT00440557|452117649|FG001|Overall Study|Patient had surgery|0|||
125679913|NCT00440557|452117650|FG002|Overall Study|Patient had surgery|0|||
125679914|NCT01378975|452117653|FG000|Overall Study|Death|77|||
125679915|NCT01378975|452117654|FG001|Overall Study|Death|46|||
125679916|NCT01378975|452117653|FG000|Overall Study|Investigator Request|1|||
125679917|NCT01378975|452117654|FG001|Overall Study|Investigator Request|0|||
125679918|NCT01378975|452117653|FG000|Overall Study|Lost to Follow-up|4|||
125679919|NCT01378975|452117654|FG001|Overall Study|Lost to Follow-up|1|||
125679920|NCT01378975|452117653|FG000|Overall Study|Withdrew Consent|4|||
125679921|NCT01378975|452117654|FG001|Overall Study|Withdrew Consent|3|||
125679922|NCT02343120|452117658|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
125679923|NCT02343120|452117659|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
125679924|NCT02343120|452117660|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
125679925|NCT02343120|452117661|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
125679926|NCT02343120|452117662|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
125679927|NCT02343120|452117658|FG000|Part 1: Dose Escalation|Death|1|||
125679928|NCT02343120|452117659|FG001|Part 1: Dose Escalation|Death|2|||
125679929|NCT02343120|452117660|FG002|Part 1: Dose Escalation|Death|2|||
125679930|NCT02343120|452117661|FG003|Part 1: Dose Escalation|Death|2|||
125345041|NCT01181986|450896496|FG001|Phase 1|Adverse Event|0|||
125345042|NCT01181986|450896497|FG002|Phase 1|Adverse Event|1|||
125345043|NCT01181986|450896495|FG000|Phase 1|Protocol Violation|1|||
125679931|NCT02343120|452117662|FG004|Part 1: Dose Escalation|Death|1|||
125679932|NCT02343120|452117658|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
125679933|NCT02343120|452117659|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
125679934|NCT02343120|452117660|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
125679935|NCT02343120|452117661|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
125679936|NCT02343120|452117662|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
125679937|NCT02343120|452117658|FG000|Part 2: Expansion|Sponsor decision|0|||
125679938|NCT02343120|452117659|FG001|Part 2: Expansion|Sponsor decision|0|||
125679939|NCT02343120|452117660|FG002|Part 2: Expansion|Sponsor decision|0|||
125679940|NCT02343120|452117661|FG003|Part 2: Expansion|Sponsor decision|165|||
125679941|NCT02343120|452117662|FG004|Part 2: Expansion|Sponsor decision|67|||
125679942|NCT02343120|452117658|FG000|Part 2: Expansion|Death|0|||
125679943|NCT02343120|452117659|FG001|Part 2: Expansion|Death|0|||
125679944|NCT02343120|452117660|FG002|Part 2: Expansion|Death|0|||
125679945|NCT02343120|452117661|FG003|Part 2: Expansion|Death|74|||
125679946|NCT02343120|452117662|FG004|Part 2: Expansion|Death|17|||
125679947|NCT02343120|452117658|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
125679948|NCT02343120|452117659|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
125679949|NCT02343120|452117660|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
125679950|NCT02343120|452117661|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
125679951|NCT02343120|452117662|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
125679952|NCT02343120|452117658|FG000|Part 2: Expansion|Lost to Follow-up|0|||
125679953|NCT02343120|452117659|FG001|Part 2: Expansion|Lost to Follow-up|0|||
125679954|NCT02343120|452117660|FG002|Part 2: Expansion|Lost to Follow-up|0|||
125679955|NCT02343120|452117661|FG003|Part 2: Expansion|Lost to Follow-up|5|||
125679956|NCT02343120|452117662|FG004|Part 2: Expansion|Lost to Follow-up|2|||
125679957|NCT02343120|452117658|FG000|Part 2: Expansion|Other|0|||
125679958|NCT02343120|452117659|FG001|Part 2: Expansion|Other|0|||
125679959|NCT02343120|452117660|FG002|Part 2: Expansion|Other|0|||
125679960|NCT02343120|452117661|FG003|Part 2: Expansion|Other|1|||
125679961|NCT02343120|452117662|FG004|Part 2: Expansion|Other|5|||
125679962|NCT02343120|452117658|FG000|Part 2: Expansion|Adverse Event|0|||
125679963|NCT02343120|452117659|FG001|Part 2: Expansion|Adverse Event|0|||
125679964|NCT02343120|452117660|FG002|Part 2: Expansion|Adverse Event|0|||
125679965|NCT02343120|452117661|FG003|Part 2: Expansion|Adverse Event|1|||
125679966|NCT02343120|452117662|FG004|Part 2: Expansion|Adverse Event|1|||
125679967|NCT03544138|452117665|FG000|Overall Study|Lost to Follow-up|29|||
125679968|NCT01766778|452117666|FG000|Overall Study|Adverse Event|4|||
125679969|NCT01766778|452117667|FG001|Overall Study|Adverse Event|4|||
125679970|NCT01766778|452117666|FG000|Overall Study|Withdrawal by Subject|1|||
125679971|NCT01766778|452117667|FG001|Overall Study|Withdrawal by Subject|0|||
125679972|NCT01104662|452117668|FG000|Overall Study|Adverse Event|2|||
125679973|NCT01104662|452117669|FG001|Overall Study|Adverse Event|2|||
125679974|NCT01104662|452117670|FG002|Overall Study|Adverse Event|0|||
125679975|NCT01104662|452117671|FG003|Overall Study|Adverse Event|1|||
125679976|NCT01104662|452117672|FG004|Overall Study|Adverse Event|1|||
125679977|NCT01104662|452117673|FG005|Overall Study|Adverse Event|1|||
125679978|NCT01104662|452117674|FG006|Overall Study|Adverse Event|0|||
125679979|NCT01104662|452117675|FG007|Overall Study|Adverse Event|0|||
125679980|NCT01104662|452117668|FG000|Overall Study|Clinical Failure|1|||
125679981|NCT01104662|452117669|FG001|Overall Study|Clinical Failure|0|||
125679982|NCT01104662|452117670|FG002|Overall Study|Clinical Failure|0|||
125679983|NCT01104662|452117671|FG003|Overall Study|Clinical Failure|0|||
125679984|NCT01104662|452117672|FG004|Overall Study|Clinical Failure|0|||
125679985|NCT01104662|452117673|FG005|Overall Study|Clinical Failure|1|||
125679986|NCT01104662|452117674|FG006|Overall Study|Clinical Failure|0|||
125679987|NCT01104662|452117675|FG007|Overall Study|Clinical Failure|0|||
125679988|NCT01104662|452117668|FG000|Overall Study|Participant left investigator's care|1|||
125679989|NCT01104662|452117669|FG001|Overall Study|Participant left investigator's care|1|||
125679990|NCT01104662|452117670|FG002|Overall Study|Participant left investigator's care|0|||
125679991|NCT01104662|452117671|FG003|Overall Study|Participant left investigator's care|0|||
125679992|NCT01104662|452117672|FG004|Overall Study|Participant left investigator's care|0|||
125679993|NCT01104662|452117673|FG005|Overall Study|Participant left investigator's care|0|||
125679994|NCT01104662|452117674|FG006|Overall Study|Participant left investigator's care|0|||
125679995|NCT01104662|452117675|FG007|Overall Study|Participant left investigator's care|0|||
125679996|NCT01104662|452117668|FG000|Overall Study|Reason not specified|3|||
125679997|NCT01104662|452117669|FG001|Overall Study|Reason not specified|3|||
125679998|NCT01104662|452117670|FG002|Overall Study|Reason not specified|0|||
125679999|NCT01104662|452117671|FG003|Overall Study|Reason not specified|0|||
125680000|NCT01104662|452117672|FG004|Overall Study|Reason not specified|0|||
125680001|NCT01104662|452117673|FG005|Overall Study|Reason not specified|1|||
125680002|NCT01104662|452117674|FG006|Overall Study|Reason not specified|0|||
125680003|NCT01104662|452117675|FG007|Overall Study|Reason not specified|0|||
125680004|NCT01104662|452117668|FG000|Overall Study|Randomized but not treated|3|||
125680005|NCT01104662|452117669|FG001|Overall Study|Randomized but not treated|4|||
125680006|NCT01104662|452117670|FG002|Overall Study|Randomized but not treated|1|||
125345044|NCT01181986|450896496|FG001|Phase 1|Protocol Violation|0|||
125543577|NCT02891837|451618925|FG000|Overall Study|Withdrawal by Subject|1|||
125543578|NCT02891837|451618926|FG001|Overall Study|Withdrawal by Subject|0|||
125543579|NCT02751320|451618927|FG000|Overall Study|Adverse Event|2|||
125543580|NCT02751320|451618927|FG000|Overall Study|Withdrawal by Subject|1|||
125543581|NCT00185965|451618928|FG000|Overall Study|Adverse Event|0|||
125543582|NCT00185965|451618929|FG001|Overall Study|Adverse Event|1|||
125543583|NCT02533531|451618930|FG000|Overall Study|Device did not turn on|1|||
125543584|NCT02047903|451618931|FG000|Overall Study|Adverse Event|14|||
125543585|NCT02047903|451618931|FG000|Overall Study|Serious adverse event|10|||
125543586|NCT02047903|451618931|FG000|Overall Study|Withdrawal by Subject|16|||
125543587|NCT02047903|451618931|FG000|Overall Study|Lost to Follow-up|4|||
125543588|NCT02047903|451618931|FG000|Overall Study|Reason not listed|6|||
125543589|NCT02047903|451618931|FG000|Overall Study|Not Treated|9|||
125543590|NCT00296400|451618935|FG000|Overall Study|Adverse Event|7|||
125543591|NCT00296400|451618936|FG001|Overall Study|Adverse Event|7|||
125543592|NCT00296400|451618937|FG002|Overall Study|Adverse Event|7|||
125543593|NCT00296400|451618935|FG000|Overall Study|Withdrawal by Subject|5|||
125543594|NCT00296400|451618936|FG001|Overall Study|Withdrawal by Subject|6|||
125543595|NCT00296400|451618937|FG002|Overall Study|Withdrawal by Subject|2|||
125543596|NCT00296400|451618935|FG000|Overall Study|Incorrect enrollment|2|||
125543597|NCT00296400|451618936|FG001|Overall Study|Incorrect enrollment|0|||
125543598|NCT00296400|451618937|FG002|Overall Study|Incorrect enrollment|0|||
125543599|NCT00296400|451618935|FG000|Overall Study|Protocol Violation|1|||
125543600|NCT00296400|451618936|FG001|Overall Study|Protocol Violation|1|||
125543601|NCT00296400|451618937|FG002|Overall Study|Protocol Violation|1|||
125543602|NCT00296400|451618935|FG000|Overall Study|Lost to Follow-up|1|||
125543603|NCT00296400|451618936|FG001|Overall Study|Lost to Follow-up|1|||
125543604|NCT00296400|451618937|FG002|Overall Study|Lost to Follow-up|2|||
125543605|NCT00296400|451618935|FG000|Overall Study|Study specific discontinuation criteria|0|||
125543606|NCT00296400|451618936|FG001|Overall Study|Study specific discontinuation criteria|0|||
125543607|NCT00296400|451618937|FG002|Overall Study|Study specific discontinuation criteria|1|||
125543608|NCT00296400|451618935|FG000|Overall Study|Visit 10 was performed earlier|0|||
125543609|NCT00296400|451618936|FG001|Overall Study|Visit 10 was performed earlier|1|||
125543610|NCT00296400|451618937|FG002|Overall Study|Visit 10 was performed earlier|0|||
125543611|NCT00296400|451618935|FG000|Overall Study|Pregnancy|1|||
125543612|NCT00296400|451618936|FG001|Overall Study|Pregnancy|2|||
125543613|NCT00296400|451618937|FG002|Overall Study|Pregnancy|0|||
125543614|NCT01014533|451618938|FG000|Overall Study|Protocol Violation|3|||
125543615|NCT01014533|451618939|FG001|Overall Study|Protocol Violation|2|||
125543616|NCT01014533|451618938|FG000|Overall Study|Withdrawal by Subject|2|||
125543617|NCT01014533|451618939|FG001|Overall Study|Withdrawal by Subject|0|||
125543618|NCT01014533|451618938|FG000|Overall Study|unable to come to appointment|0|||
125543619|NCT01014533|451618939|FG001|Overall Study|unable to come to appointment|3|||
125543620|NCT00412061|451618940|FG000|Double Blind Phase|Disease Progression|101|||
125543621|NCT00412061|451618941|FG001|Double Blind Phase|Disease Progression|154|||
125543622|NCT00412061|451618940|FG000|Double Blind Phase|Adverse Event|61|||
125543623|NCT00412061|451618941|FG001|Double Blind Phase|Adverse Event|16|||
125543624|NCT00412061|451618940|FG000|Double Blind Phase|Final Primary Analysis|26|||
125543625|NCT00412061|451618941|FG001|Double Blind Phase|Final Primary Analysis|14|||
125543626|NCT00412061|451618940|FG000|Double Blind Phase|Withdrawal by Subject|18|||
125543627|NCT00412061|451618941|FG001|Double Blind Phase|Withdrawal by Subject|20|||
125543628|NCT00412061|451618940|FG000|Double Blind Phase|Death|6|||
125543629|NCT00412061|451618941|FG001|Double Blind Phase|Death|3|||
125543630|NCT00412061|451618940|FG000|Double Blind Phase|Protocol Violation|3|||
125543631|NCT00412061|451618941|FG001|Double Blind Phase|Protocol Violation|4|||
125543632|NCT00412061|451618940|FG000|Double Blind Phase|New Cander Therapy|1|||
125543633|NCT00412061|451618941|FG001|Double Blind Phase|New Cander Therapy|1|||
125543634|NCT00412061|451618940|FG000|Double Blind Phase|Lost to Follow-up|0|||
125543635|NCT00412061|451618941|FG001|Double Blind Phase|Lost to Follow-up|1|||
125543636|NCT00412061|451618940|FG000|Open Label Phase|Disease Progression|0|||
125543637|NCT00412061|451618941|FG001|Open Label Phase|Disease Progression|86|||
125543638|NCT00412061|451618940|FG000|Open Label Phase|Adverse Event|0|||
125543639|NCT00412061|451618941|FG001|Open Label Phase|Adverse Event|46|||
125543640|NCT00412061|451618940|FG000|Open Label Phase|Withdrawal by Subject|0|||
125543641|NCT00412061|451618941|FG001|Open Label Phase|Withdrawal by Subject|15|||
125543642|NCT00412061|451618940|FG000|Open Label Phase|Administrative Problems|0|||
125543643|NCT00412061|451618941|FG001|Open Label Phase|Administrative Problems|13|||
125543644|NCT00412061|451618940|FG000|Open Label Phase|Death|0|||
125543645|NCT00412061|451618941|FG001|Open Label Phase|Death|7|||
125543646|NCT00412061|451618940|FG000|Open Label Phase|Lost to Follow-up|0|||
125543647|NCT00412061|451618941|FG001|Open Label Phase|Lost to Follow-up|2|||
125543648|NCT00412061|451618940|FG000|Open Label Phase|New Cancer Therapy|0|||
125543649|NCT00412061|451618941|FG001|Open Label Phase|New Cancer Therapy|1|||
125543650|NCT01942590|451618943|FG000|Overall Study|Withdrawal by Subject|0|||
125543651|NCT01942590|451618944|FG001|Overall Study|Withdrawal by Subject|1|||
125543652|NCT01942590|451618943|FG000|Overall Study|Adverse Event|1|||
125543653|NCT01942590|451618944|FG001|Overall Study|Adverse Event|0|||
125680007|NCT01104662|452117671|FG003|Overall Study|Randomized but not treated|0|||
125680008|NCT01104662|452117672|FG004|Overall Study|Randomized but not treated|0|||
125680009|NCT01104662|452117673|FG005|Overall Study|Randomized but not treated|1|||
125680010|NCT01104662|452117674|FG006|Overall Study|Randomized but not treated|0|||
125680011|NCT01104662|452117675|FG007|Overall Study|Randomized but not treated|0|||
125680012|NCT02158936|452117676|FG000|Overall Study|Study closed/ terminated|57|||
125680013|NCT02158936|452117677|FG001|Overall Study|Study closed/ terminated|77|||
125680014|NCT02158936|452117676|FG000|Overall Study|Azacitidine tx discontinued|53|||
125680015|NCT02158936|452117677|FG001|Overall Study|Azacitidine tx discontinued|46|||
125680016|NCT02158936|452117676|FG000|Overall Study|Adverse Event|39|||
125680017|NCT02158936|452117677|FG001|Overall Study|Adverse Event|24|||
125680018|NCT02158936|452117676|FG000|Overall Study|Withdrawal by Subject|15|||
125680019|NCT02158936|452117677|FG001|Overall Study|Withdrawal by Subject|16|||
125680020|NCT02158936|452117676|FG000|Overall Study|Physician Decision|15|||
125680021|NCT02158936|452117677|FG001|Overall Study|Physician Decision|13|||
125680022|NCT02158936|452117676|FG000|Overall Study|Lost to Follow-up|0|||
125680023|NCT02158936|452117677|FG001|Overall Study|Lost to Follow-up|1|||
125680024|NCT01706926|452117678|FG000|Overall Study|Lost to Follow-up|0|||
125680025|NCT01706926|452117679|FG001|Overall Study|Lost to Follow-up|0|||
125680026|NCT01706926|452117680|FG002|Overall Study|Lost to Follow-up|1|||
125680027|NCT01706926|452117681|FG003|Overall Study|Lost to Follow-up|0|||
125680028|NCT01706926|452117678|FG000|Overall Study|Withdrawal by Subject|2|||
125680029|NCT01706926|452117679|FG001|Overall Study|Withdrawal by Subject|0|||
125680030|NCT01706926|452117680|FG002|Overall Study|Withdrawal by Subject|1|||
125680031|NCT01706926|452117681|FG003|Overall Study|Withdrawal by Subject|2|||
125680032|NCT01706926|452117678|FG000|Overall Study|Other|4|||
125680033|NCT01706926|452117679|FG001|Overall Study|Other|4|||
125680034|NCT01706926|452117680|FG002|Overall Study|Other|4|||
125680035|NCT01706926|452117681|FG003|Overall Study|Other|3|||
125680036|NCT01101022|452119154|FG000|Overall Study|Adverse Event|6|||
125680037|NCT01101022|452119155|FG001|Overall Study|Adverse Event|2|||
125680038|NCT01101022|452119154|FG000|Overall Study|Protocol Violation|4|||
125680039|NCT01101022|452119155|FG001|Overall Study|Protocol Violation|3|||
125680040|NCT01101022|452119154|FG000|Overall Study|Withdrawal by Subject|3|||
125680041|NCT01101022|452119155|FG001|Overall Study|Withdrawal by Subject|8|||
125680042|NCT01101022|452119154|FG000|Overall Study|Lost to Follow-up|1|||
125680043|NCT01101022|452119155|FG001|Overall Study|Lost to Follow-up|4|||
125680044|NCT01101022|452119154|FG000|Overall Study|Lack of Efficacy|0|||
125680045|NCT01101022|452119155|FG001|Overall Study|Lack of Efficacy|7|||
125680046|NCT01101022|452119154|FG000|Overall Study|Sponsor decision|1|||
125680047|NCT01101022|452119155|FG001|Overall Study|Sponsor decision|1|||
125680048|NCT01101022|452119154|FG000|Overall Study|Non-compliance|1|||
125680049|NCT01101022|452119155|FG001|Overall Study|Non-compliance|0|||
125680050|NCT01101022|452119154|FG000|Overall Study|Work schedule|1|||
125680051|NCT01101022|452119155|FG001|Overall Study|Work schedule|1|||
125680052|NCT01101022|452119154|FG000|Overall Study|Vacation|0|||
125680053|NCT01101022|452119155|FG001|Overall Study|Vacation|1|||
125680054|NCT01519661|452119156|FG000|Overall Study|Protocol deviation|6|||
125680055|NCT01519661|452119156|FG000|Overall Study|Lost to Follow-up|3|||
125680056|NCT01519661|452119156|FG000|Overall Study|Withdrawal by Subject|17|||
125680057|NCT01519661|452119156|FG000|Overall Study|Lack of Efficacy|6|||
125680058|NCT01519661|452119156|FG000|Overall Study|Adverse Event|29|||
125680059|NCT01139047|452119157|FG000|Overall Study|Withdrawal by Subject|1|||
125680060|NCT01941095|452119158|FG000|Overall Study|Insufficient therapeutic response|13|||
125680061|NCT01941095|452119158|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
125680062|NCT01941095|452119158|FG000|Overall Study|Adverse Event|11|||
125680063|NCT01941095|452119158|FG000|Overall Study|Physician Decision|3|||
125680064|NCT01941095|452119158|FG000|Overall Study|Withdrawal by Subject|17|||
125680065|NCT01941095|452119158|FG000|Overall Study|Lost to Follow-up|10|||
125680066|NCT02918877|452119161|FG000|Overall Study|Withdrawal by Subject|2|||
125680067|NCT02918877|452119162|FG001|Overall Study|Withdrawal by Subject|2|||
125680068|NCT02918877|452119161|FG000|Overall Study|Surgery cancelled|1|||
125680069|NCT02918877|452119162|FG001|Overall Study|Surgery cancelled|0|||
125680070|NCT02918877|452119161|FG000|Overall Study|Physician Decision|1|||
125680071|NCT02918877|452119162|FG001|Overall Study|Physician Decision|0|||
125680072|NCT02918877|452119161|FG000|Overall Study|Received intraoperative steroids|1|||
125680073|NCT02918877|452119162|FG001|Overall Study|Received intraoperative steroids|0|||
125680074|NCT02918877|452119161|FG000|Overall Study|Unable to obtain lab samples|1|||
125680075|NCT02918877|452119162|FG001|Overall Study|Unable to obtain lab samples|0|||
125680076|NCT02918877|452119161|FG000|Overall Study|Unsafe to perform BAL|0|||
125680077|NCT02918877|452119162|FG001|Overall Study|Unsafe to perform BAL|1|||
125680078|NCT03527745|452119163|FG000|Overall Study|Lost to Follow-up|3|||
125680079|NCT03527745|452119164|FG001|Overall Study|Lost to Follow-up|6|||
125680080|NCT03527745|452119165|FG002|Overall Study|Lost to Follow-up|7|||
125680081|NCT03527745|452119166|FG003|Overall Study|Lost to Follow-up|9|||
125680082|NCT03527745|452119167|FG004|Overall Study|Lost to Follow-up|0|||
125680083|NCT03527745|452119168|FG005|Overall Study|Lost to Follow-up|2|||
125680084|NCT03527745|452119169|FG006|Overall Study|Lost to Follow-up|3|||
125680085|NCT03527745|452119170|FG007|Overall Study|Lost to Follow-up|2|||
125543654|NCT03616977|451618946|FG000|Period 1|Physician Decision|0|||
125543655|NCT03616977|451618947|FG001|Period 1|Physician Decision|1|||
125543656|NCT03616977|451618946|FG000|Period 3|Adverse Event|1|||
125543657|NCT03616977|451618947|FG001|Period 3|Adverse Event|1|||
125543658|NCT01323972|451618949|FG000|Overall Study|Withdrawal by Subject|1|||
125543659|NCT01323972|451618950|FG001|Overall Study|Withdrawal by Subject|0|||
125543660|NCT01323972|451618951|FG002|Overall Study|Withdrawal by Subject|1|||
125543661|NCT01323972|451618952|FG003|Overall Study|Withdrawal by Subject|0|||
125543662|NCT01323972|451618949|FG000|Overall Study|Migrated/moved from study area|1|||
125543663|NCT01323972|451618950|FG001|Overall Study|Migrated/moved from study area|2|||
125543664|NCT01323972|451618951|FG002|Overall Study|Migrated/moved from study area|0|||
125543665|NCT01323972|451618952|FG003|Overall Study|Migrated/moved from study area|0|||
125543666|NCT01323972|451618949|FG000|Overall Study|Lost to Follow-up|0|||
125543667|NCT01323972|451618950|FG001|Overall Study|Lost to Follow-up|1|||
125543668|NCT01323972|451618951|FG002|Overall Study|Lost to Follow-up|1|||
125543669|NCT01323972|451618952|FG003|Overall Study|Lost to Follow-up|1|||
125543670|NCT02008877|451618953|FG000|Overall Study|Inevaluable|0|||
125543671|NCT02008877|451618954|FG001|Overall Study|Inevaluable|1|||
125543672|NCT02008877|451618955|FG002|Overall Study|Inevaluable|0|||
125543673|NCT01049217|451618956|FG000|Overall Study|Adverse Event|2|||
125543674|NCT01049217|451618957|FG001|Overall Study|Adverse Event|1|||
125543675|NCT01049217|451618956|FG000|Overall Study|Lack of Efficacy|1|||
125543676|NCT01049217|451618957|FG001|Overall Study|Lack of Efficacy|1|||
125543677|NCT01049217|451618956|FG000|Overall Study|Lost to Follow-up|3|||
125543678|NCT01049217|451618957|FG001|Overall Study|Lost to Follow-up|8|||
125543679|NCT01049217|451618956|FG000|Overall Study|Withdrawal by Subject|4|||
125543680|NCT01049217|451618957|FG001|Overall Study|Withdrawal by Subject|3|||
125543681|NCT01049217|451618956|FG000|Overall Study|Protocol Violation|1|||
125543682|NCT01049217|451618957|FG001|Overall Study|Protocol Violation|3|||
125543683|NCT01049217|451618956|FG000|Overall Study|Pregnancy|1|||
125543684|NCT01049217|451618957|FG001|Overall Study|Pregnancy|0|||
125543685|NCT01049217|451618956|FG000|Overall Study|Study Terminated by Sponsor|43|||
125543686|NCT01049217|451618957|FG001|Overall Study|Study Terminated by Sponsor|43|||
125543687|NCT01049217|451618956|FG000|Overall Study|Other|1|||
125543688|NCT01049217|451618957|FG001|Overall Study|Other|2|||
125543689|NCT01049217|451618956|FG000|Overall Study|Randomized but not Treated|0|||
125543690|NCT01049217|451618957|FG001|Overall Study|Randomized but not Treated|2|||
125543691|NCT00903682|451618958|FG000|Overall Study|Adverse Event|6|||
125543692|NCT00903682|451618959|FG001|Overall Study|Adverse Event|13|||
125543693|NCT00903682|451618958|FG000|Overall Study|Lost to Follow-up|1|||
125543694|NCT00903682|451618959|FG001|Overall Study|Lost to Follow-up|0|||
125543695|NCT00903682|451618958|FG000|Overall Study|Withdrawal by Subject|5|||
125543696|NCT00903682|451618959|FG001|Overall Study|Withdrawal by Subject|0|||
125543697|NCT00903682|451618958|FG000|Overall Study|Pregnancy|0|||
125543698|NCT00903682|451618959|FG001|Overall Study|Pregnancy|1|||
125543699|NCT00903682|451618958|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
125543700|NCT00903682|451618959|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
125543701|NCT00903682|451618958|FG000|Overall Study|Subject Non-Compliant|1|||
125543702|NCT00903682|451618959|FG001|Overall Study|Subject Non-Compliant|0|||
125543703|NCT00903682|451618958|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
125543704|NCT00903682|451618959|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
125543705|NCT00903682|451618958|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
125543706|NCT00903682|451618959|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
125543707|NCT02495792|451618960|FG000|Overall Study|Lost to Follow-up|5|||
125543708|NCT02495792|451618961|FG001|Overall Study|Lost to Follow-up|9|||
125543709|NCT02495792|451618960|FG000|Overall Study|Protocol Violation|32|||
125543710|NCT02495792|451618961|FG001|Overall Study|Protocol Violation|31|||
125543711|NCT03141905|451618964|FG000|Overall Study|Death|3|||
125543712|NCT03141905|451618965|FG001|Overall Study|Death|2|||
125543713|NCT03141905|451618964|FG000|Overall Study|Withdrawal by Subject|1|||
125543714|NCT03141905|451618965|FG001|Overall Study|Withdrawal by Subject|0|||
125543715|NCT03141905|451618964|FG000|Overall Study|Lost to Follow-up|3|||
125543716|NCT03141905|451618965|FG001|Overall Study|Lost to Follow-up|7|||
125543717|NCT03141905|451618964|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
125543718|NCT03141905|451618965|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
125543719|NCT02502799|451620928|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
125543720|NCT02502799|451620929|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
125543721|NCT02502799|451620930|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
125543722|NCT02502799|451620931|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
125543723|NCT02502799|451620928|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
125543724|NCT02502799|451620929|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
125543725|NCT02502799|451620930|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
125543726|NCT02502799|451620931|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
125543727|NCT02502799|451620928|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
125543728|NCT02502799|451620929|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
125543729|NCT02502799|451620930|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
125543730|NCT02502799|451620931|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
125543731|NCT02502799|451620928|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
125543732|NCT02502799|451620929|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
125543733|NCT02502799|451620930|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
125543734|NCT02502799|451620931|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
125543735|NCT02502799|451620928|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
125543736|NCT02502799|451620929|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
125543737|NCT02502799|451620930|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
125543738|NCT02502799|451620931|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
125543739|NCT01076192|451620945|FG000|Overall Study|Other|197|||
125543740|NCT05087979|451620946|FG000|Overall Study|Converted to general anesthesia|1|||
125543741|NCT05087979|451620947|FG001|Overall Study|Converted to general anesthesia|0|||
125543742|NCT02924428|451620948|FG000|Overall Study|Adverse Event|1|||
125543743|NCT02924428|451620949|FG001|Overall Study|Adverse Event|0|||
125543744|NCT02924428|451620948|FG000|Overall Study|Physician Decision|1|||
125543745|NCT02924428|451620949|FG001|Overall Study|Physician Decision|0|||
125543746|NCT02924428|451620948|FG000|Overall Study|Lost to Follow-up|2|||
125543747|NCT02924428|451620949|FG001|Overall Study|Lost to Follow-up|4|||
125543748|NCT02924428|451620948|FG000|Overall Study|Pregnancy|0|||
125543749|NCT02924428|451620949|FG001|Overall Study|Pregnancy|1|||
125543750|NCT01850446|451620950|FG000|Overall Study|Lack of Efficacy|1|||
125543751|NCT01850446|451620951|FG001|Overall Study|Lack of Efficacy|0|||
125543752|NCT01850446|451620950|FG000|Overall Study|Withdrawal by Subject|4|||
125543753|NCT01850446|451620951|FG001|Overall Study|Withdrawal by Subject|0|||
125543754|NCT01850446|451620950|FG000|Overall Study|Protocol Violation|0|||
125543755|NCT01850446|451620951|FG001|Overall Study|Protocol Violation|2|||
125543756|NCT02680002|451620952|FG000|Overall Study|Lost to Follow-up|5|||
125543757|NCT02680002|451620953|FG001|Overall Study|Lost to Follow-up|1|||
125543758|NCT02680002|451620954|FG002|Overall Study|Lost to Follow-up|4|||
125543759|NCT02680002|451620955|FG003|Overall Study|Lost to Follow-up|2|||
125543760|NCT02680002|451620956|FG004|Overall Study|Lost to Follow-up|0|||
125543761|NCT02680002|451620957|FG005|Overall Study|Lost to Follow-up|2|||
125543762|NCT02680002|451620952|FG000|Overall Study|Physician Decision|5|||
125543763|NCT02680002|451620953|FG001|Overall Study|Physician Decision|1|||
125543764|NCT02680002|451620954|FG002|Overall Study|Physician Decision|1|||
125543765|NCT02680002|451620955|FG003|Overall Study|Physician Decision|1|||
125543766|NCT02680002|451620956|FG004|Overall Study|Physician Decision|1|||
125543767|NCT02680002|451620957|FG005|Overall Study|Physician Decision|1|||
125543768|NCT02680002|451620952|FG000|Overall Study|Protocol Violation|1|||
125543769|NCT02680002|451620953|FG001|Overall Study|Protocol Violation|0|||
125543770|NCT02680002|451620954|FG002|Overall Study|Protocol Violation|1|||
125543771|NCT02680002|451620955|FG003|Overall Study|Protocol Violation|0|||
125543772|NCT02680002|451620956|FG004|Overall Study|Protocol Violation|1|||
125543773|NCT02680002|451620957|FG005|Overall Study|Protocol Violation|2|||
125543774|NCT02680002|451620952|FG000|Overall Study|Withdrawal by Subject|0|||
125543775|NCT02680002|451620953|FG001|Overall Study|Withdrawal by Subject|0|||
125543776|NCT02680002|451620954|FG002|Overall Study|Withdrawal by Subject|1|||
125543777|NCT02680002|451620955|FG003|Overall Study|Withdrawal by Subject|0|||
125543778|NCT02680002|451620956|FG004|Overall Study|Withdrawal by Subject|2|||
125543779|NCT02680002|451620957|FG005|Overall Study|Withdrawal by Subject|2|||
125543780|NCT02680002|451620952|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
125543781|NCT02680002|451620953|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
125543782|NCT02680002|451620954|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
125543783|NCT02680002|451620955|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
125543784|NCT02680002|451620956|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
125543785|NCT02680002|451620957|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
125543786|NCT02680002|451620952|FG000|Overall Study|Other|0|||
125543787|NCT02680002|451620953|FG001|Overall Study|Other|1|||
125543788|NCT02680002|451620954|FG002|Overall Study|Other|0|||
125543789|NCT02680002|451620955|FG003|Overall Study|Other|0|||
125543790|NCT02680002|451620956|FG004|Overall Study|Other|1|||
125543791|NCT02680002|451620957|FG005|Overall Study|Other|0|||
125543792|NCT02680002|451620952|FG000|Overall Study|Adverse Event|0|||
125543793|NCT02680002|451620953|FG001|Overall Study|Adverse Event|0|||
125543794|NCT02680002|451620954|FG002|Overall Study|Adverse Event|0|||
125543795|NCT02680002|451620955|FG003|Overall Study|Adverse Event|0|||
125543796|NCT02680002|451620956|FG004|Overall Study|Adverse Event|1|||
125543797|NCT02680002|451620957|FG005|Overall Study|Adverse Event|2|||
125543798|NCT00759915|451620958|FG000|Overall Study|Withdrawal by Subject|1|||
125543799|NCT00759915|451620959|FG001|Overall Study|Withdrawal by Subject|0|||
125543800|NCT00759915|451620958|FG000|Overall Study|Adverse Event|0|||
125543801|NCT00759915|451620959|FG001|Overall Study|Adverse Event|1|||
125543802|NCT03527173|451620962|FG000|Overall Study|Lost to Follow-up|4|||
125543803|NCT03527173|451620963|FG001|Overall Study|Lost to Follow-up|2|||
125543804|NCT03527173|451620962|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
125543805|NCT03527173|451620963|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
125543806|NCT03527173|451620962|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
125543807|NCT03527173|451620963|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
125543808|NCT03527173|451620962|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
125543809|NCT03527173|451620963|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125543810|NCT01248780|451620968|FG000|Overall Study|Lack of Efficacy|2|||
125543811|NCT01248780|451620969|FG001|Overall Study|Lack of Efficacy|0|||
125543812|NCT01248780|451620968|FG000|Overall Study|Lost to Follow-up|0|||
125543813|NCT01248780|451620969|FG001|Overall Study|Lost to Follow-up|1|||
125543814|NCT01248780|451620968|FG000|Overall Study|Death|0|||
125543815|NCT01248780|451620969|FG001|Overall Study|Death|1|||
125543816|NCT01248780|451620968|FG000|Overall Study|Adverse Event|2|||
125543817|NCT01248780|451620969|FG001|Overall Study|Adverse Event|7|||
125543818|NCT01248780|451620968|FG000|Overall Study|Protocol Violation|1|||
125680086|NCT03527745|452119171|FG008|Overall Study|Lost to Follow-up|3|||
125680087|NCT03527745|452119172|FG009|Overall Study|Lost to Follow-up|2|||
125543819|NCT01248780|451620969|FG001|Overall Study|Protocol Violation|1|||
125543820|NCT01248780|451620968|FG000|Overall Study|Withdrawal by Subject|4|||
125543821|NCT01248780|451620969|FG001|Overall Study|Withdrawal by Subject|4|||
125543822|NCT01248780|451620968|FG000|Overall Study|Not treated|0|||
125543823|NCT01248780|451620969|FG001|Overall Study|Not treated|1|||
125543824|NCT04097301|451620970|FG000|Overall Study|Death|1|||
125543825|NCT04097301|451620970|FG000|Overall Study|Withdrawal by Subject|1|||
125543826|NCT04097301|451620970|FG000|Overall Study|Screening Failure|5|||
125543827|NCT00203476|451620971|FG000|Overall Study|Lost to Follow-up|1|||
125543828|NCT00203476|451620972|FG001|Overall Study|Lost to Follow-up|0|||
125543829|NCT00203476|451620973|FG002|Overall Study|Lost to Follow-up|0|||
125543830|NCT00203476|451620971|FG000|Overall Study|Withdrawal by Subject|0|||
125543831|NCT00203476|451620972|FG001|Overall Study|Withdrawal by Subject|1|||
125543832|NCT00203476|451620973|FG002|Overall Study|Withdrawal by Subject|0|||
125543833|NCT01190514|451620974|FG000|First Intervention (Period 1)|Adverse Event|1|||
125543834|NCT01190514|451620975|FG001|First Intervention (Period 1)|Adverse Event|0|||
125543835|NCT01190514|451620976|FG002|First Intervention (Period 1)|Adverse Event|0|||
125543836|NCT01190514|451620977|FG003|First Intervention (Period 1)|Adverse Event|0|||
125543837|NCT01190514|451620974|FG000|Third Intervention (Period 3)|Adverse Event|1|||
125543838|NCT01190514|451620975|FG001|Third Intervention (Period 3)|Adverse Event|0|||
125543839|NCT01190514|451620976|FG002|Third Intervention (Period 3)|Adverse Event|0|||
125543840|NCT01190514|451620977|FG003|Third Intervention (Period 3)|Adverse Event|0|||
125543841|NCT01813929|451620978|FG000|Overall Study|Withdrawal by Subject|0|||
125543842|NCT01813929|451620979|FG001|Overall Study|Withdrawal by Subject|1|||
125543843|NCT00938470|451620982|FG000|Overall Study|Disease Progression|3|||
125543844|NCT00938470|451620983|FG001|Overall Study|Disease Progression|0|||
125543845|NCT00938470|451620982|FG000|Overall Study|Alternate Treatment|1|||
125543846|NCT00938470|451620983|FG001|Overall Study|Alternate Treatment|0|||
125543847|NCT00938470|451620982|FG000|Overall Study|Death|3|||
125543848|NCT00938470|451620983|FG001|Overall Study|Death|2|||
125543849|NCT00938470|451620982|FG000|Overall Study|Other Reason|0|||
125543850|NCT00938470|451620983|FG001|Overall Study|Other Reason|1|||
125543851|NCT04279392|451620987|FG000|Overall Study|Physician Decision|1|||
125543852|NCT04279392|451620988|FG001|Overall Study|Physician Decision|0|||
125543853|NCT01171807|451620989|FG000|Overall Study|Treatment failure|2|||
125543854|NCT01171807|451620990|FG001|Overall Study|Treatment failure|4|||
125543855|NCT01171807|451620989|FG000|Overall Study|Non compliance|1|||
125543856|NCT01171807|451620990|FG001|Overall Study|Non compliance|0|||
125543857|NCT01171807|451620989|FG000|Overall Study|Lost to Follow-up|3|||
125543858|NCT01171807|451620990|FG001|Overall Study|Lost to Follow-up|0|||
125543859|NCT04101318|451620995|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
125543860|NCT04101318|451620996|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
125543861|NCT04101318|451620995|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
125543862|NCT04101318|451620996|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
125543863|NCT04101318|451620995|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
125543864|NCT04101318|451620996|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
125543865|NCT04289051|451620997|FG000|Overall Study|Lost to Follow-up|0|||
125543866|NCT04289051|451620998|FG001|Overall Study|Lost to Follow-up|0|||
125543867|NCT04289051|451620999|FG002|Overall Study|Lost to Follow-up|2|||
125543868|NCT01901341|451621000|FG000|Overall Study|Adverse Event|4|||
125543869|NCT01901341|451621001|FG001|Overall Study|Adverse Event|2|||
125543870|NCT01901341|451621000|FG000|Overall Study|Lack of Efficacy|0|||
125543871|NCT01901341|451621001|FG001|Overall Study|Lack of Efficacy|2|||
125543872|NCT01901341|451621000|FG000|Overall Study|Lost to Follow-up|0|||
125543873|NCT01901341|451621001|FG001|Overall Study|Lost to Follow-up|1|||
125543874|NCT01901341|451621000|FG000|Overall Study|Protocol Violation|2|||
125543875|NCT01901341|451621001|FG001|Overall Study|Protocol Violation|0|||
125543876|NCT01901341|451621000|FG000|Overall Study|Study Terminated by Sponsor|13|||
125543877|NCT01901341|451621001|FG001|Overall Study|Study Terminated by Sponsor|15|||
125543878|NCT01901341|451621000|FG000|Overall Study|Withdrawal by Subject|1|||
125543879|NCT01901341|451621001|FG001|Overall Study|Withdrawal by Subject|1|||
125543880|NCT00822172|451621005|FG000|Overall Study|Adverse Event|10|||
125543881|NCT00822172|451621006|FG001|Overall Study|Adverse Event|12|||
125543882|NCT00822172|451621005|FG000|Overall Study|Death|1|||
125543883|NCT00822172|451621006|FG001|Overall Study|Death|0|||
125543884|NCT00822172|451621005|FG000|Overall Study|Lost to Follow-up|3|||
125543885|NCT00822172|451621006|FG001|Overall Study|Lost to Follow-up|1|||
125543886|NCT00822172|451621005|FG000|Overall Study|Withdrawal by Subject|1|||
125543887|NCT00822172|451621006|FG001|Overall Study|Withdrawal by Subject|4|||
125543888|NCT00822172|451621005|FG000|Overall Study|site closed|0|||
125543889|NCT00822172|451621006|FG001|Overall Study|site closed|1|||
125543890|NCT00822172|451621005|FG000|Overall Study|Other|0|||
125543891|NCT00822172|451621006|FG001|Overall Study|Other|1|||
125543892|NCT01981473|451621007|FG000|Overall Study|Incorrect diagnosis of RA|0|||
125543893|NCT01981473|451621008|FG001|Overall Study|Incorrect diagnosis of RA|0|||
125543894|NCT01981473|451621009|FG002|Overall Study|Incorrect diagnosis of RA|1|||
125543895|NCT01981473|451621007|FG000|Overall Study|Received treatment for < 6 months|0|||
125543896|NCT01981473|451621008|FG001|Overall Study|Received treatment for < 6 months|0|||
125543897|NCT01981473|451621009|FG002|Overall Study|Received treatment for < 6 months|1|||
125543898|NCT01981473|451621007|FG000|Overall Study|Received treatment for >24 months|2|||
125543899|NCT01981473|451621008|FG001|Overall Study|Received treatment for >24 months|0|||
125543900|NCT01981473|451621009|FG002|Overall Study|Received treatment for >24 months|6|||
125345045|NCT01181986|450896497|FG002|Phase 1|Protocol Violation|0|||
125345046|NCT01181986|450896495|FG000|Phase 2|Adverse Event|0|||
125345047|NCT01181986|450896496|FG001|Phase 2|Adverse Event|3|||
125345048|NCT01181986|450896497|FG002|Phase 2|Adverse Event|0|||
125345049|NCT01181986|450896495|FG000|Phase 2|Medical condition|0|||
125345050|NCT01181986|450896496|FG001|Phase 2|Medical condition|1|||
125345051|NCT01181986|450896497|FG002|Phase 2|Medical condition|0|||
125345052|NCT03720652|450896498|FG000|Overall Study|Withdrawal by Subject|2|||
125345053|NCT03720652|450896499|FG001|Overall Study|Withdrawal by Subject|7|||
125345054|NCT03720652|450896498|FG000|Overall Study|Lost to Follow-up|0|||
125345055|NCT03720652|450896499|FG001|Overall Study|Lost to Follow-up|4|||
125345056|NCT03073733|450896500|FG000|Overall Study|Lost to Follow-up|1|||
125345057|NCT03073733|450896501|FG001|Overall Study|Lost to Follow-up|0|||
125345058|NCT03073733|450896502|FG002|Overall Study|Lost to Follow-up|0|||
125345059|NCT03073733|450896500|FG000|Overall Study|Physician Decision|0|||
125345060|NCT03073733|450896501|FG001|Overall Study|Physician Decision|1|||
125345061|NCT03073733|450896502|FG002|Overall Study|Physician Decision|0|||
125345062|NCT03073733|450896500|FG000|Overall Study|Withdrawal by Subject|0|||
125345063|NCT03073733|450896501|FG001|Overall Study|Withdrawal by Subject|0|||
125345064|NCT03073733|450896502|FG002|Overall Study|Withdrawal by Subject|1|||
125345065|NCT01454778|450896503|FG000|Overall Study|Lost to Follow-up|2|||
125345066|NCT01454778|450896503|FG000|Overall Study|Death|1|||
125345067|NCT00835731|450896504|FG000|Overall Study|Withdrawal by Subject|1|||
125345068|NCT00835731|450896505|FG001|Overall Study|Withdrawal by Subject|0|||
125345069|NCT00835731|450896504|FG000|Overall Study|Physician Decision|1|||
125345070|NCT00835731|450896505|FG001|Overall Study|Physician Decision|1|||
125345071|NCT00348881|450896506|FG000|Overall Study|Lost to Follow-up|12|||
125345072|NCT00348881|450896507|FG001|Overall Study|Lost to Follow-up|6|||
125543901|NCT02257567|451621014|FG000|Overall Study|Adverse Event|0|||
125543902|NCT02257567|451621015|FG001|Overall Study|Adverse Event|0|||
125543903|NCT02257567|451621016|FG002|Overall Study|Adverse Event|0|||
125543904|NCT02257567|451621017|FG003|Overall Study|Adverse Event|1|||
125345073|NCT00348881|450896506|FG000|Overall Study|Withdrawal by Subject|3|||
125345074|NCT00348881|450896507|FG001|Overall Study|Withdrawal by Subject|4|||
125345075|NCT00348881|450896506|FG000|Overall Study|Adverse Event|2|||
125345076|NCT00348881|450896507|FG001|Overall Study|Adverse Event|0|||
125345077|NCT00348881|450896506|FG000|Overall Study|Serious Adverse Event|0|||
125543905|NCT02257567|451621018|FG004|Overall Study|Adverse Event|1|||
125345078|NCT00348881|450896507|FG001|Overall Study|Serious Adverse Event|2|||
125345079|NCT01221272|450898170|FG000|Period 1|Adverse Event|2|||
125345080|NCT01221272|450898171|FG001|Period 1|Adverse Event|0|||
125345081|NCT01221272|450898170|FG000|Period 1|Consent Withdrawal|0|||
125543906|NCT02257567|451621019|FG005|Overall Study|Adverse Event|0|||
125543907|NCT02257567|451621020|FG006|Overall Study|Adverse Event|0|||
125543908|NCT02257567|451621021|FG007|Overall Study|Adverse Event|0|||
125543909|NCT02257567|451621022|FG008|Overall Study|Adverse Event|1|||
125543910|NCT02257567|451621023|FG009|Overall Study|Adverse Event|0|||
125543911|NCT02257567|451621024|FG010|Overall Study|Adverse Event|0|||
125543912|NCT02257567|451621014|FG000|Overall Study|Death|2|||
125543913|NCT02257567|451621015|FG001|Overall Study|Death|2|||
125543914|NCT02257567|451621016|FG002|Overall Study|Death|2|||
125543915|NCT02257567|451621017|FG003|Overall Study|Death|4|||
125543916|NCT02257567|451621018|FG004|Overall Study|Death|15|||
125543917|NCT02257567|451621019|FG005|Overall Study|Death|11|||
125543918|NCT02257567|451621020|FG006|Overall Study|Death|26|||
125543919|NCT02257567|451621021|FG007|Overall Study|Death|30|||
125543920|NCT02257567|451621022|FG008|Overall Study|Death|2|||
125543921|NCT02257567|451621023|FG009|Overall Study|Death|18|||
125543922|NCT02257567|451621024|FG010|Overall Study|Death|65|||
125543923|NCT02257567|451621014|FG000|Overall Study|Lost to Follow-up|0|||
125543924|NCT02257567|451621015|FG001|Overall Study|Lost to Follow-up|0|||
125543925|NCT02257567|451621016|FG002|Overall Study|Lost to Follow-up|0|||
125543926|NCT02257567|451621017|FG003|Overall Study|Lost to Follow-up|0|||
125543927|NCT02257567|451621018|FG004|Overall Study|Lost to Follow-up|2|||
125543928|NCT02257567|451621019|FG005|Overall Study|Lost to Follow-up|2|||
125543929|NCT02257567|451621020|FG006|Overall Study|Lost to Follow-up|0|||
125543930|NCT02257567|451621021|FG007|Overall Study|Lost to Follow-up|0|||
125543931|NCT02257567|451621022|FG008|Overall Study|Lost to Follow-up|0|||
125543932|NCT02257567|451621023|FG009|Overall Study|Lost to Follow-up|1|||
125543933|NCT02257567|451621024|FG010|Overall Study|Lost to Follow-up|1|||
125543934|NCT02257567|451621014|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
125543935|NCT02257567|451621015|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
125543936|NCT02257567|451621016|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
125543937|NCT02257567|451621017|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
125543938|NCT02257567|451621018|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
125543939|NCT02257567|451621019|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
125543940|NCT02257567|451621020|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
125543941|NCT02257567|451621021|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
125543942|NCT02257567|451621022|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
125543943|NCT02257567|451621023|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
125543944|NCT02257567|451621024|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
125543945|NCT02257567|451621014|FG000|Overall Study|Physician Decision|0|||
125543946|NCT02257567|451621015|FG001|Overall Study|Physician Decision|0|||
125543947|NCT02257567|451621016|FG002|Overall Study|Physician Decision|0|||
125543948|NCT02257567|451621017|FG003|Overall Study|Physician Decision|0|||
125543949|NCT02257567|451621018|FG004|Overall Study|Physician Decision|0|||
125543950|NCT02257567|451621019|FG005|Overall Study|Physician Decision|0|||
125543951|NCT02257567|451621020|FG006|Overall Study|Physician Decision|0|||
125543952|NCT02257567|451621021|FG007|Overall Study|Physician Decision|2|||
125543953|NCT02257567|451621022|FG008|Overall Study|Physician Decision|0|||
125543954|NCT02257567|451621023|FG009|Overall Study|Physician Decision|1|||
125543955|NCT02257567|451621024|FG010|Overall Study|Physician Decision|0|||
125543956|NCT02257567|451621014|FG000|Overall Study|Withdrawal by Subject|0|||
125543957|NCT02257567|451621015|FG001|Overall Study|Withdrawal by Subject|0|||
125543958|NCT02257567|451621016|FG002|Overall Study|Withdrawal by Subject|2|||
125543959|NCT02257567|451621017|FG003|Overall Study|Withdrawal by Subject|0|||
125543960|NCT02257567|451621018|FG004|Overall Study|Withdrawal by Subject|0|||
125543961|NCT02257567|451621019|FG005|Overall Study|Withdrawal by Subject|6|||
125543962|NCT02257567|451621020|FG006|Overall Study|Withdrawal by Subject|6|||
125543963|NCT02257567|451621021|FG007|Overall Study|Withdrawal by Subject|6|||
125543964|NCT02257567|451621022|FG008|Overall Study|Withdrawal by Subject|1|||
125543965|NCT02257567|451621023|FG009|Overall Study|Withdrawal by Subject|1|||
125543966|NCT02257567|451621024|FG010|Overall Study|Withdrawal by Subject|10|||
125543967|NCT03215810|451621025|FG000|Overall Study|Still responding to nivolumab|1|||
125543968|NCT03215810|451621025|FG000|Overall Study|Insufficient TIL growth|1|||
125543969|NCT03215810|451621025|FG000|Overall Study|Decline in performance status|1|||
125543970|NCT03215810|451621025|FG000|Overall Study|Withdrawal by Subject|1|||
125543971|NCT01502631|451621028|FG000|Overall Study|Adverse Event|5|||
125543972|NCT01502631|451621029|FG001|Overall Study|Adverse Event|8|||
125543973|NCT01502631|451621028|FG000|Overall Study|Lost to Follow-up|2|||
125543974|NCT01502631|451621029|FG001|Overall Study|Lost to Follow-up|2|||
125543975|NCT01502631|451621028|FG000|Overall Study|Participant withdrew consent|2|||
125543976|NCT01502631|451621029|FG001|Overall Study|Participant withdrew consent|4|||
125543977|NCT01502631|451621028|FG000|Overall Study|Participant non-compliant|1|||
125543978|NCT01502631|451621029|FG001|Overall Study|Participant non-compliant|0|||
125543979|NCT01502631|451621028|FG000|Overall Study|Investigator's decision|0|||
125543980|NCT01502631|451621029|FG001|Overall Study|Investigator's decision|1|||
125543981|NCT01502631|451621028|FG000|Overall Study|Other|10|||
125543982|NCT01502631|451621029|FG001|Overall Study|Other|5|||
125543983|NCT02084056|451621030|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
125543984|NCT02084056|451621031|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
125543985|NCT02084056|451621032|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
125543986|NCT02084056|451621033|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
125543987|NCT02084056|451621030|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
125543988|NCT02084056|451621031|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
125543989|NCT02084056|451621032|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
125543990|NCT02084056|451621033|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
125543991|NCT01293487|451621035|FG000|Overall Study|Lost to Follow-up|0|||
125543992|NCT01293487|451621036|FG001|Overall Study|Lost to Follow-up|0|||
125543993|NCT01293487|451621037|FG002|Overall Study|Lost to Follow-up|0|||
125543994|NCT01293487|451621038|FG003|Overall Study|Lost to Follow-up|1|||
125543995|NCT01293487|451621039|FG004|Overall Study|Lost to Follow-up|0|||
125543996|NCT01293487|451621040|FG005|Overall Study|Lost to Follow-up|0|||
125543997|NCT01293487|451621041|FG006|Overall Study|Lost to Follow-up|0|||
125543998|NCT01293487|451621042|FG007|Overall Study|Lost to Follow-up|0|||
125543999|NCT01293487|451621035|FG000|Overall Study|Withdrawal by Subject|0|||
125544000|NCT01293487|451621036|FG001|Overall Study|Withdrawal by Subject|0|||
125544001|NCT01293487|451621037|FG002|Overall Study|Withdrawal by Subject|0|||
125544002|NCT01293487|451621038|FG003|Overall Study|Withdrawal by Subject|0|||
125544003|NCT01293487|451621039|FG004|Overall Study|Withdrawal by Subject|0|||
125544004|NCT01293487|451621040|FG005|Overall Study|Withdrawal by Subject|0|||
125544005|NCT01293487|451621041|FG006|Overall Study|Withdrawal by Subject|0|||
125544006|NCT01293487|451621042|FG007|Overall Study|Withdrawal by Subject|2|||
125544007|NCT00395460|451621043|FG000|Overall Study|Withdrawal by Subject|1|||
125544008|NCT00395460|451621044|FG001|Overall Study|Withdrawal by Subject|0|||
125544009|NCT04223830|451621051|FG000|Overall Study|Lost to Follow-up|9|||
125544010|NCT04223830|451621051|FG000|Overall Study|Adverse Event|1|||
125544011|NCT01964924|451621052|FG000|Trametinib Monotherapy|Progression|19|||
125544012|NCT01964924|451621053|FG001|Trametinib Monotherapy|Progression|0|||
125544013|NCT00577577|451621055|FG000|Overall Study|Adverse Event|3|||
125544014|NCT00577577|451621056|FG001|Overall Study|Adverse Event|2|||
125544015|NCT00577577|451621055|FG000|Overall Study|Lost to Follow-up|1|||
125544016|NCT00577577|451621056|FG001|Overall Study|Lost to Follow-up|0|||
125544017|NCT00577577|451621055|FG000|Overall Study|Protocol Violation|0|||
125544018|NCT00577577|451621056|FG001|Overall Study|Protocol Violation|3|||
125544019|NCT00577577|451621055|FG000|Overall Study|Transportation|1|||
125544020|NCT00577577|451621056|FG001|Overall Study|Transportation|0|||
125544021|NCT01153958|451621057|FG000|Overall Study|Study Terminated|36|||
125544022|NCT01153958|451621058|FG001|Overall Study|Study Terminated|32|||
125544023|NCT02150343|451621065|FG000|Overall Study|Adverse Event|2|||
125544024|NCT02150343|451621066|FG001|Overall Study|Adverse Event|0|||
125544025|NCT02150343|451621067|FG002|Overall Study|Adverse Event|1|||
125544026|NCT02150343|451621068|FG003|Overall Study|Adverse Event|1|||
125544027|NCT02150343|451621065|FG000|Overall Study|Withdrawal by Subject|13|||
125544028|NCT02150343|451621066|FG001|Overall Study|Withdrawal by Subject|10|||
125544029|NCT02150343|451621067|FG002|Overall Study|Withdrawal by Subject|9|||
125544030|NCT02150343|451621068|FG003|Overall Study|Withdrawal by Subject|4|||
125544031|NCT02150343|451621065|FG000|Overall Study|Lost to Follow-up|4|||
125544032|NCT02150343|451621066|FG001|Overall Study|Lost to Follow-up|4|||
125544033|NCT02150343|451621067|FG002|Overall Study|Lost to Follow-up|2|||
125544034|NCT02150343|451621068|FG003|Overall Study|Lost to Follow-up|3|||
125544035|NCT02150343|451621065|FG000|Overall Study|Other|2|||
125345082|NCT01221272|450898171|FG001|Period 1|Consent Withdrawal|1|||
125544036|NCT02150343|451621066|FG001|Overall Study|Other|6|||
125544037|NCT02150343|451621067|FG002|Overall Study|Other|0|||
125544038|NCT02150343|451621068|FG003|Overall Study|Other|2|||
125544039|NCT00190749|451621069|FG000|Overall Study|Lost to Follow-up|8|||
125544040|NCT00190749|451621070|FG001|Overall Study|Lost to Follow-up|11|||
125544041|NCT00190749|451621069|FG000|Overall Study|Withdrawal by Subject|10|||
125544042|NCT00190749|451621070|FG001|Overall Study|Withdrawal by Subject|6|||
125544043|NCT00190749|451621069|FG000|Overall Study|Protocol Violation|5|||
125544044|NCT00190749|451621070|FG001|Overall Study|Protocol Violation|4|||
125544045|NCT00190749|451621069|FG000|Overall Study|Adverse Event|0|||
125544046|NCT00190749|451621070|FG001|Overall Study|Adverse Event|5|||
125544047|NCT00190749|451621069|FG000|Overall Study|Lack of Efficacy|2|||
125544048|NCT00190749|451621070|FG001|Overall Study|Lack of Efficacy|3|||
125544049|NCT00190749|451621069|FG000|Overall Study|Reason Not Specified|0|||
125544050|NCT00190749|451621070|FG001|Overall Study|Reason Not Specified|2|||
125544051|NCT00190749|451621069|FG000|Overall Study|Sponsor Decision|1|||
125544052|NCT00190749|451621070|FG001|Overall Study|Sponsor Decision|0|||
125544053|NCT02729753|451621071|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
125544054|NCT02729753|451621072|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
125544055|NCT01090427|451621073|FG000|After Controlled Period|Death|0|||
125544056|NCT01090427|451621074|FG001|After Controlled Period|Death|0|||
125544057|NCT01090427|451621075|FG002|After Controlled Period|Death|0|||
125544058|NCT01090427|451621076|FG003|After Controlled Period|Death|0|||
125544059|NCT01090427|451621077|FG004|After Controlled Period|Death|0|||
125544060|NCT01090427|451621078|FG005|After Controlled Period|Death|1|||
125544061|NCT01090427|451621079|FG006|After Controlled Period|Death|0|||
125544062|NCT01090427|451621073|FG000|After Controlled Period|Lack of Efficacy|0|||
125544063|NCT01090427|451621074|FG001|After Controlled Period|Lack of Efficacy|0|||
125544064|NCT01090427|451621075|FG002|After Controlled Period|Lack of Efficacy|0|||
125544065|NCT01090427|451621076|FG003|After Controlled Period|Lack of Efficacy|0|||
125544066|NCT01090427|451621077|FG004|After Controlled Period|Lack of Efficacy|0|||
125544067|NCT01090427|451621078|FG005|After Controlled Period|Lack of Efficacy|3|||
125544068|NCT01090427|451621079|FG006|After Controlled Period|Lack of Efficacy|2|||
125544069|NCT01090427|451621073|FG000|After Controlled Period|Adverse Event|0|||
125544070|NCT01090427|451621074|FG001|After Controlled Period|Adverse Event|0|||
125544071|NCT01090427|451621075|FG002|After Controlled Period|Adverse Event|0|||
125544072|NCT01090427|451621076|FG003|After Controlled Period|Adverse Event|2|||
125544073|NCT01090427|451621077|FG004|After Controlled Period|Adverse Event|0|||
125544074|NCT01090427|451621078|FG005|After Controlled Period|Adverse Event|1|||
125544075|NCT01090427|451621079|FG006|After Controlled Period|Adverse Event|0|||
125544076|NCT01200589|451621080|FG000|Overall Study|Withdrawal by Subject|13|||
125544077|NCT01200589|451621081|FG001|Overall Study|Withdrawal by Subject|11|||
125544078|NCT01200589|451621080|FG000|Overall Study|Physician Decision|2|||
125544079|NCT01200589|451621081|FG001|Overall Study|Physician Decision|2|||
125544080|NCT01200589|451621080|FG000|Overall Study|Lost to Follow-up|5|||
125544081|NCT01200589|451621081|FG001|Overall Study|Lost to Follow-up|4|||
125544082|NCT01200589|451621080|FG000|Overall Study|Study terminated|170|||
125544083|NCT01200589|451621081|FG001|Overall Study|Study terminated|172|||
125544084|NCT01154010|451621082|FG000|Overall Study|Lost to Follow-up|0|||
125544085|NCT01154010|451621083|FG001|Overall Study|Lost to Follow-up|1|||
125544086|NCT00439231|451621084|FG000|Overall Study|Lack of Efficacy|28|||
125544087|NCT03683823|451621088|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
125544088|NCT03683823|451621089|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
125544089|NCT03683823|451621088|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
125544090|NCT03683823|451621089|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
125544091|NCT03683823|451621088|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
125544092|NCT03683823|451621089|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
125544093|NCT02134977|451623419|FG000|Overall Study|Protocol Deviation|102|||
125544094|NCT01773291|451623420|FG000|Overall Study|Protocol Violation|1|||
125544095|NCT01773291|451623421|FG001|Overall Study|Protocol Violation|0|||
125544096|NCT01773291|451623422|FG002|Overall Study|Protocol Violation|0|||
125680088|NCT03527745|452119173|FG010|Overall Study|Lost to Follow-up|1|||
125680089|NCT03527745|452119174|FG011|Overall Study|Lost to Follow-up|1|||
125680090|NCT03527745|452119175|FG012|Overall Study|Lost to Follow-up|0|||
125680091|NCT03527745|452119176|FG013|Overall Study|Lost to Follow-up|0|||
125680092|NCT03527745|452119177|FG014|Overall Study|Lost to Follow-up|0|||
125680093|NCT03527745|452119178|FG015|Overall Study|Lost to Follow-up|0|||
125680094|NCT03527745|452119179|FG016|Overall Study|Lost to Follow-up|1|||
125680095|NCT03527745|452119180|FG017|Overall Study|Lost to Follow-up|0|||
125680096|NCT03527745|452119181|FG018|Overall Study|Lost to Follow-up|0|||
125680097|NCT03527745|452119182|FG019|Overall Study|Lost to Follow-up|1|||
125680098|NCT03527745|452119183|FG020|Overall Study|Lost to Follow-up|1|||
125544097|NCT01773291|451623420|FG000|Overall Study|Withdrawal by Subject|0|||
125544098|NCT01773291|451623421|FG001|Overall Study|Withdrawal by Subject|0|||
125544099|NCT01773291|451623422|FG002|Overall Study|Withdrawal by Subject|1|||
125680099|NCT03527745|452119184|FG021|Overall Study|Lost to Follow-up|5|||
125345083|NCT01221272|450898170|FG000|Period 1|Significant Dosing Noncompliance|0|||
125345084|NCT01221272|450898171|FG001|Period 1|Significant Dosing Noncompliance|1|||
125345085|NCT01221272|450898170|FG000|Period 2|Adverse Event|0|||
125345086|NCT01221272|450898171|FG001|Period 2|Adverse Event|2|||
125345087|NCT04839562|450898174|FG000|Overall Study|Withdrawal by Subject|0|||
125345088|NCT04839562|450898175|FG001|Overall Study|Withdrawal by Subject|1|||
125345089|NCT04839562|450898174|FG000|Overall Study|Physician Decision|0|||
125345090|NCT04839562|450898175|FG001|Overall Study|Physician Decision|1|||
125345091|NCT00877773|450898176|FG000|Overall Study|Disease Progression|44|||
125345092|NCT00003472|450898179|FG000|Overall Study|Not evaluable|3|||
125345093|NCT01673347|450898180|FG000|Overall Study|failure of allograft|7|||
125345094|NCT03086967|450898181|FG000|Overall Study|Screen Failure|2|||
125345095|NCT03086967|450898182|FG001|Overall Study|Screen Failure|2|||
125345096|NCT00704522|450898188|FG000|Overall Study|Lack of Efficacy|65|||
125345097|NCT00704522|450898189|FG001|Overall Study|Lack of Efficacy|17|||
125345098|NCT00704522|450898188|FG000|Overall Study|Failure to appear again at hospital|56|||
125345099|NCT00704522|450898189|FG001|Overall Study|Failure to appear again at hospital|10|||
125345100|NCT00704522|450898188|FG000|Overall Study|Withdrawal by Subject|17|||
125345101|NCT00704522|450898189|FG001|Overall Study|Withdrawal by Subject|8|||
125345102|NCT00704522|450898188|FG000|Overall Study|Adverse Event|9|||
125345103|NCT00704522|450898189|FG001|Overall Study|Adverse Event|1|||
125345104|NCT00704522|450898188|FG000|Overall Study|Undefined causes|9|||
125345105|NCT00704522|450898189|FG001|Overall Study|Undefined causes|7|||
125345106|NCT00704522|450898188|FG000|Overall Study|No information on therapy end|27|||
125345107|NCT00704522|450898189|FG001|Overall Study|No information on therapy end|2|||
125345108|NCT00775203|450898190|FG000|Overall Study|Adverse Event|25|||
125345109|NCT00775203|450898191|FG001|Overall Study|Adverse Event|6|||
125345110|NCT00775203|450898190|FG000|Overall Study|Lack of Efficacy|8|||
125345111|NCT00775203|450898191|FG001|Overall Study|Lack of Efficacy|9|||
125345112|NCT00775203|450898190|FG000|Overall Study|Withdrawal by Subject|11|||
125345113|NCT00775203|450898191|FG001|Overall Study|Withdrawal by Subject|9|||
125345114|NCT00775203|450898190|FG000|Overall Study|Lost to Follow-up|11|||
125345115|NCT00775203|450898191|FG001|Overall Study|Lost to Follow-up|15|||
125345116|NCT00775203|450898190|FG000|Overall Study|Administrative reason|2|||
125544100|NCT00107120|451623424|FG000|Overall Study|Adverse Event|4|||
125544101|NCT00107120|451623425|FG001|Overall Study|Adverse Event|1|||
125345117|NCT00775203|450898191|FG001|Overall Study|Administrative reason|0|||
125345118|NCT00775203|450898190|FG000|Overall Study|Noncompliance|4|||
125345119|NCT00775203|450898191|FG001|Overall Study|Noncompliance|2|||
125345120|NCT00775203|450898190|FG000|Overall Study|Protocol Violation|0|||
125345121|NCT00775203|450898191|FG001|Overall Study|Protocol Violation|1|||
125345122|NCT00775203|450898190|FG000|Overall Study|Entered other study|1|||
125345123|NCT00775203|450898191|FG001|Overall Study|Entered other study|0|||
125345124|NCT00775203|450898190|FG000|Overall Study|Physician Decision|0|||
125345125|NCT00775203|450898191|FG001|Overall Study|Physician Decision|1|||
125345126|NCT01525901|450898197|FG000|Period 2: 12 Weeks|Adverse Event|0|||
125345127|NCT01525901|450898198|FG001|Period 2: 12 Weeks|Adverse Event|1|||
125345128|NCT01525901|450898199|FG002|Period 2: 12 Weeks|Adverse Event|0|||
125345129|NCT01525901|450898200|FG003|Period 2: 12 Weeks|Adverse Event|0|||
125345130|NCT02486627|450898205|FG000|Overall Study|Death|1|||
125544102|NCT00107120|451623424|FG000|Overall Study|Lack of Efficacy|5|||
125544103|NCT00107120|451623425|FG001|Overall Study|Lack of Efficacy|5|||
125544104|NCT00107120|451623424|FG000|Overall Study|Protocol Violation|3|||
125544105|NCT00107120|451623425|FG001|Overall Study|Protocol Violation|0|||
125544106|NCT00107120|451623424|FG000|Overall Study|Withdrawal by Subject|8|||
125544107|NCT00107120|451623425|FG001|Overall Study|Withdrawal by Subject|9|||
125544108|NCT00107120|451623424|FG000|Overall Study|Lost to Follow-up|8|||
125544109|NCT00107120|451623425|FG001|Overall Study|Lost to Follow-up|6|||
125544110|NCT00107120|451623424|FG000|Overall Study|Pregnancy|0|||
125544111|NCT00107120|451623425|FG001|Overall Study|Pregnancy|1|||
125544112|NCT00107120|451623424|FG000|Overall Study|moving away from site|1|||
125544113|NCT00107120|451623425|FG001|Overall Study|moving away from site|1|||
125544114|NCT00107120|451623424|FG000|Overall Study|death of parent|0|||
125544115|NCT00107120|451623425|FG001|Overall Study|death of parent|1|||
125544116|NCT00896051|451623429|FG000|Overall Study|Adverse Event|2|||
125544117|NCT00896051|451623430|FG001|Overall Study|Adverse Event|1|||
125544118|NCT00896051|451623429|FG000|Overall Study|Lost to Follow-up|3|||
125544119|NCT00896051|451623430|FG001|Overall Study|Lost to Follow-up|2|||
125680100|NCT03527745|452119185|FG022|Overall Study|Lost to Follow-up|6|||
125680101|NCT03527745|452119186|FG023|Overall Study|Lost to Follow-up|8|||
125544120|NCT00896051|451623429|FG000|Overall Study|Withdrawal by Subject|3|||
125544121|NCT00896051|451623430|FG001|Overall Study|Withdrawal by Subject|2|||
125680102|NCT03527745|452119187|FG024|Overall Study|Lost to Follow-up|1|||
125680103|NCT03527745|452119188|FG025|Overall Study|Lost to Follow-up|3|||
125680104|NCT01604850|452119189|FG000|Overall Study|Enrolled but never treated|0|||
125680105|NCT01604850|452119190|FG001|Overall Study|Enrolled but never treated|1|||
125680106|NCT01604850|452119189|FG000|Overall Study|Efficacy Failure|50|||
125680107|NCT01604850|452119190|FG001|Overall Study|Efficacy Failure|29|||
125680108|NCT01604850|452119189|FG000|Overall Study|Lost to Follow-up|1|||
125680109|NCT01604850|452119190|FG001|Overall Study|Lost to Follow-up|0|||
125544122|NCT00896051|451623429|FG000|Overall Study|Subject noncompliant|1|||
125680110|NCT01604850|452119189|FG000|Overall Study|Subject withdrew consent|1|||
125544123|NCT00896051|451623430|FG001|Overall Study|Subject noncompliant|3|||
125544124|NCT00896051|451623429|FG000|Overall Study|Other|1|||
125544125|NCT00896051|451623430|FG001|Overall Study|Other|1|||
125680111|NCT01604850|452119190|FG001|Overall Study|Subject withdrew consent|0|||
125544126|NCT02935452|451623431|FG000|Overall Study|work and life commintment|3|||
125544127|NCT02935452|451623432|FG001|Overall Study|work and life commintment|1|||
125544128|NCT01346475|451623435|FG000|First Intervention|Lost to Follow-up|4|||
125544129|NCT01346475|451623436|FG001|First Intervention|Lost to Follow-up|3|||
125544130|NCT02029846|451623439|FG000|Overall Study|n=1 each arm|1|||
125544131|NCT02029846|451623440|FG001|Overall Study|n=1 each arm|1|||
125544132|NCT02966301|451623441|FG000|Overall Study|Death|2|||
125544133|NCT02966301|451623441|FG000|Overall Study|Withdrawal by Subject|1|||
125544134|NCT00700258|451623442|FG000|Overall Study|Premature discontinuation of documentation|136|||
125544135|NCT00700258|451623442|FG000|Overall Study|Type of study end not documented|1|||
125544136|NCT00700258|451623442|FG000|Overall Study|Lost to Follow-up|81|||
125544137|NCT00700258|451623442|FG000|Overall Study|Premature discontinuation of therapy|1013|||
125544138|NCT00370331|451623444|FG000|Overall Study|Adverse Event|4|||
125544139|NCT00370331|451623445|FG001|Overall Study|Adverse Event|13|||
125544140|NCT00370331|451623444|FG000|Overall Study|Withdrawal by Subject|2|||
125544141|NCT00370331|451623445|FG001|Overall Study|Withdrawal by Subject|4|||
125544142|NCT00370331|451623444|FG000|Overall Study|Lost to Follow-up|0|||
125544143|NCT00370331|451623445|FG001|Overall Study|Lost to Follow-up|3|||
125544144|NCT00370331|451623444|FG000|Overall Study|Lack of Efficacy|0|||
125544145|NCT00370331|451623445|FG001|Overall Study|Lack of Efficacy|1|||
125544146|NCT00370331|451623444|FG000|Overall Study|Non-compliance|0|||
125544147|NCT00370331|451623445|FG001|Overall Study|Non-compliance|1|||
125544148|NCT00370331|451623444|FG000|Overall Study|Protocol Violation|1|||
125544149|NCT00370331|451623445|FG001|Overall Study|Protocol Violation|1|||
125544150|NCT01874431|451623446|FG000|Overall Study|Physician Decision|0|||
125544151|NCT01874431|451623447|FG001|Overall Study|Physician Decision|0|||
125544152|NCT01874431|451623448|FG002|Overall Study|Physician Decision|1|||
125544153|NCT01874431|451623449|FG003|Overall Study|Physician Decision|0|||
125544154|NCT01874431|451623450|FG004|Overall Study|Physician Decision|0|||
125544155|NCT01874431|451623451|FG005|Overall Study|Physician Decision|0|||
125544156|NCT01874431|451623452|FG006|Overall Study|Physician Decision|0|||
125544157|NCT01874431|451623453|FG007|Overall Study|Physician Decision|0|||
125544158|NCT01874431|451623446|FG000|Overall Study|Adverse Event|5|||
125544159|NCT01874431|451623447|FG001|Overall Study|Adverse Event|4|||
125544160|NCT01874431|451623448|FG002|Overall Study|Adverse Event|6|||
125544161|NCT01874431|451623449|FG003|Overall Study|Adverse Event|5|||
125544162|NCT01874431|451623450|FG004|Overall Study|Adverse Event|2|||
125544163|NCT01874431|451623451|FG005|Overall Study|Adverse Event|8|||
125544164|NCT01874431|451623452|FG006|Overall Study|Adverse Event|2|||
125544165|NCT01874431|451623453|FG007|Overall Study|Adverse Event|3|||
125544166|NCT01874431|451623446|FG000|Overall Study|Protocol Violation|1|||
125544167|NCT01874431|451623447|FG001|Overall Study|Protocol Violation|1|||
125544168|NCT01874431|451623448|FG002|Overall Study|Protocol Violation|1|||
125544169|NCT01874431|451623449|FG003|Overall Study|Protocol Violation|0|||
125544170|NCT01874431|451623450|FG004|Overall Study|Protocol Violation|3|||
125544171|NCT01874431|451623451|FG005|Overall Study|Protocol Violation|2|||
125544172|NCT01874431|451623452|FG006|Overall Study|Protocol Violation|1|||
125544173|NCT01874431|451623453|FG007|Overall Study|Protocol Violation|1|||
125544174|NCT01874431|451623446|FG000|Overall Study|Non-compliance|0|||
125544175|NCT01874431|451623447|FG001|Overall Study|Non-compliance|0|||
125544176|NCT01874431|451623448|FG002|Overall Study|Non-compliance|0|||
125544177|NCT01874431|451623449|FG003|Overall Study|Non-compliance|0|||
125544178|NCT01874431|451623450|FG004|Overall Study|Non-compliance|1|||
125544179|NCT01874431|451623451|FG005|Overall Study|Non-compliance|0|||
125544180|NCT01874431|451623452|FG006|Overall Study|Non-compliance|1|||
125544181|NCT01874431|451623453|FG007|Overall Study|Non-compliance|0|||
125544182|NCT01874431|451623446|FG000|Overall Study|Logistical difficulties|0|||
125544183|NCT01874431|451623447|FG001|Overall Study|Logistical difficulties|0|||
125544184|NCT01874431|451623448|FG002|Overall Study|Logistical difficulties|0|||
125544185|NCT01874431|451623449|FG003|Overall Study|Logistical difficulties|0|||
125680112|NCT00243932|452119191|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
125680113|NCT00243932|452119192|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
125680114|NCT00243932|452119193|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
125680115|NCT00880568|452119195|FG000|Overall Study|Disease progression|3|||
125680116|NCT00880568|452119196|FG001|Overall Study|Disease progression|3|||
125680117|NCT00880568|452119197|FG002|Overall Study|Disease progression|3|||
125680118|NCT00880568|452119198|FG003|Overall Study|Disease progression|1|||
125544186|NCT01874431|451623450|FG004|Overall Study|Logistical difficulties|0|||
125544187|NCT01874431|451623451|FG005|Overall Study|Logistical difficulties|0|||
125544188|NCT01874431|451623452|FG006|Overall Study|Logistical difficulties|1|||
125544189|NCT01874431|451623453|FG007|Overall Study|Logistical difficulties|0|||
125544190|NCT01874431|451623446|FG000|Overall Study|Withdrawal by Subject|0|||
125680119|NCT00880568|452119199|FG004|Overall Study|Disease progression|3|||
125544191|NCT01874431|451623447|FG001|Overall Study|Withdrawal by Subject|0|||
125544192|NCT01874431|451623448|FG002|Overall Study|Withdrawal by Subject|1|||
125680120|NCT00880568|452119200|FG005|Overall Study|Disease progression|3|||
125544193|NCT01874431|451623449|FG003|Overall Study|Withdrawal by Subject|2|||
125544194|NCT01874431|451623450|FG004|Overall Study|Withdrawal by Subject|1|||
125544195|NCT01874431|451623451|FG005|Overall Study|Withdrawal by Subject|1|||
125680121|NCT00880568|452119201|FG006|Overall Study|Disease progression|5|||
125544196|NCT01874431|451623452|FG006|Overall Study|Withdrawal by Subject|3|||
125544197|NCT01874431|451623453|FG007|Overall Study|Withdrawal by Subject|0|||
125544198|NCT01874431|451623446|FG000|Overall Study|Sponsor decision|0|||
125544199|NCT01874431|451623447|FG001|Overall Study|Sponsor decision|0|||
125544200|NCT01874431|451623448|FG002|Overall Study|Sponsor decision|0|||
125544201|NCT01874431|451623449|FG003|Overall Study|Sponsor decision|0|||
125544202|NCT01874431|451623450|FG004|Overall Study|Sponsor decision|1|||
125544203|NCT01874431|451623451|FG005|Overall Study|Sponsor decision|0|||
125544204|NCT01874431|451623452|FG006|Overall Study|Sponsor decision|0|||
125544205|NCT01874431|451623453|FG007|Overall Study|Sponsor decision|0|||
125544206|NCT01874431|451623446|FG000|Overall Study|Lost to Follow-up|0|||
125544207|NCT01874431|451623447|FG001|Overall Study|Lost to Follow-up|0|||
125544208|NCT01874431|451623448|FG002|Overall Study|Lost to Follow-up|1|||
125544209|NCT01874431|451623449|FG003|Overall Study|Lost to Follow-up|0|||
125544210|NCT01874431|451623450|FG004|Overall Study|Lost to Follow-up|0|||
125544211|NCT01874431|451623451|FG005|Overall Study|Lost to Follow-up|0|||
125544212|NCT01874431|451623452|FG006|Overall Study|Lost to Follow-up|0|||
125544213|NCT01874431|451623453|FG007|Overall Study|Lost to Follow-up|0|||
125544214|NCT00738582|451623456|FG000|Combination Therapy|Completed Combination Therapy|1|||
125544215|NCT00738582|451623457|FG001|Combination Therapy|Completed Combination Therapy|0|||
125544216|NCT00738582|451623456|FG000|Combination Therapy|Physician Decision|1|||
125544217|NCT00738582|451623457|FG001|Combination Therapy|Physician Decision|0|||
125544218|NCT00738582|451623456|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
125544219|NCT00738582|451623457|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
125544220|NCT00738582|451623456|FG000|Combination Therapy|Other|5|||
125544221|NCT00738582|451623457|FG001|Combination Therapy|Other|0|||
125544222|NCT00738582|451623456|FG000|Combination Therapy|Adverse Event|16|||
125544223|NCT00738582|451623457|FG001|Combination Therapy|Adverse Event|0|||
125544224|NCT00738582|451623456|FG000|Combination Therapy|Progressive Disease|9|||
125544225|NCT00738582|451623457|FG001|Combination Therapy|Progressive Disease|0|||
125680122|NCT00880568|452119202|FG007|Overall Study|Disease progression|0|||
125680123|NCT00880568|452119203|FG008|Overall Study|Disease progression|3|||
125680124|NCT00880568|452119195|FG000|Overall Study|Adverse Event|0|||
125680125|NCT00880568|452119196|FG001|Overall Study|Adverse Event|0|||
125680126|NCT00880568|452119197|FG002|Overall Study|Adverse Event|0|||
125680127|NCT00880568|452119198|FG003|Overall Study|Adverse Event|0|||
125680128|NCT00880568|452119199|FG004|Overall Study|Adverse Event|0|||
125680129|NCT00880568|452119200|FG005|Overall Study|Adverse Event|0|||
125680130|NCT00880568|452119201|FG006|Overall Study|Adverse Event|1|||
125680131|NCT00880568|452119202|FG007|Overall Study|Adverse Event|1|||
125680132|NCT00880568|452119203|FG008|Overall Study|Adverse Event|0|||
125680133|NCT00880568|452119195|FG000|Overall Study|Withdrawal by Subject|0|||
125680134|NCT00880568|452119196|FG001|Overall Study|Withdrawal by Subject|0|||
125680135|NCT00880568|452119197|FG002|Overall Study|Withdrawal by Subject|0|||
125680136|NCT00880568|452119198|FG003|Overall Study|Withdrawal by Subject|0|||
125680137|NCT00880568|452119199|FG004|Overall Study|Withdrawal by Subject|0|||
125680138|NCT00880568|452119200|FG005|Overall Study|Withdrawal by Subject|0|||
125680139|NCT00880568|452119201|FG006|Overall Study|Withdrawal by Subject|0|||
125680140|NCT00880568|452119202|FG007|Overall Study|Withdrawal by Subject|1|||
125680141|NCT00880568|452119203|FG008|Overall Study|Withdrawal by Subject|0|||
125680142|NCT00849901|452119204|FG000|Acute Treatment Phase|Adverse Event|9|||
125680143|NCT00849901|452119205|FG001|Acute Treatment Phase|Adverse Event|1|||
125680144|NCT00849901|452119206|FG002|Acute Treatment Phase|Adverse Event|3|||
125680145|NCT00849901|452119204|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
125680146|NCT00849901|452119205|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
125680147|NCT00849901|452119206|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
125680148|NCT00849901|452119204|FG000|Acute Treatment Phase|Protocol Violation|0|||
125680149|NCT00849901|452119205|FG001|Acute Treatment Phase|Protocol Violation|2|||
125680150|NCT00849901|452119206|FG002|Acute Treatment Phase|Protocol Violation|1|||
125680151|NCT00849901|452119204|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
125680152|NCT00849901|452119205|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
125680153|NCT00849901|452119206|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
125680154|NCT00849901|452119204|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
125680155|NCT00849901|452119205|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
125680156|NCT00849901|452119206|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
125680157|NCT00849901|452119204|FG000|Acute Treatment Phase|Physician Decision|1|||
125680158|NCT00849901|452119205|FG001|Acute Treatment Phase|Physician Decision|1|||
125680159|NCT00849901|452119206|FG002|Acute Treatment Phase|Physician Decision|1|||
125680160|NCT00849901|452119204|FG000|Acute Treatment Phase|Sponsor Decision|1|||
125680161|NCT00849901|452119205|FG001|Acute Treatment Phase|Sponsor Decision|0|||
125680162|NCT00849901|452119206|FG002|Acute Treatment Phase|Sponsor Decision|0|||
125544226|NCT00738582|451623456|FG000|Maintenance Therapy|Other|0|||
125544227|NCT00738582|451623457|FG001|Maintenance Therapy|Other|2|||
125544228|NCT00738582|451623456|FG000|Maintenance Therapy|Adverse Event|0|||
125544229|NCT00738582|451623457|FG001|Maintenance Therapy|Adverse Event|6|||
125544230|NCT00738582|451623456|FG000|Maintenance Therapy|Progressive Disease|0|||
125544231|NCT00738582|451623457|FG001|Maintenance Therapy|Progressive Disease|47|||
125544232|NCT00738582|451623456|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
125544233|NCT00738582|451623457|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
125544234|NCT00642772|451623458|FG000|Overall Study|Lost to Follow-up|3|||
125544235|NCT00642772|451623458|FG000|Overall Study|Withdrawal by Subject|7|||
125544236|NCT00757588|451623459|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
125544237|NCT00757588|451623460|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
125544238|NCT00757588|451623459|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
125544239|NCT00757588|451623460|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
125544240|NCT00757588|451623459|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
125544241|NCT00757588|451623460|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
125544242|NCT00757588|451623459|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
125544243|NCT00757588|451623460|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
125544244|NCT00757588|451623459|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
125544245|NCT00757588|451623460|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
125544246|NCT00757588|451623459|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
125544247|NCT00757588|451623460|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
125544248|NCT00757588|451623459|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
125544249|NCT00757588|451623460|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
125544250|NCT00757588|451623459|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
125544251|NCT00757588|451623460|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
125544252|NCT00757588|451623459|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
125544253|NCT00757588|451623460|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
125544254|NCT00757588|451623459|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
125544255|NCT00757588|451623460|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
125544256|NCT00757588|451623459|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
125544257|NCT00757588|451623460|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
125544258|NCT00757588|451623459|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
125544259|NCT00757588|451623460|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
125544260|NCT00757588|451623459|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
125544261|NCT00757588|451623460|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
125544262|NCT00757588|451623459|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
125544263|NCT00757588|451623460|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
125544264|NCT00757588|451623459|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
125544265|NCT00757588|451623460|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
125544266|NCT00757588|451623459|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
125544267|NCT00757588|451623460|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
125544268|NCT01052103|451623461|FG000|Overall Study|Adverse Event|10|||
125544269|NCT01052103|451623462|FG001|Overall Study|Adverse Event|6|||
125544270|NCT01052103|451623461|FG000|Overall Study|Entry Criteria Not Met|3|||
125544271|NCT01052103|451623462|FG001|Overall Study|Entry Criteria Not Met|1|||
125544272|NCT01052103|451623461|FG000|Overall Study|Lost to Follow-up|3|||
125544273|NCT01052103|451623462|FG001|Overall Study|Lost to Follow-up|5|||
125544274|NCT01052103|451623461|FG000|Overall Study|Protocol Violation|10|||
125544275|NCT01052103|451623462|FG001|Overall Study|Protocol Violation|4|||
125544276|NCT01052103|451623461|FG000|Overall Study|Scheduling conflict|2|||
125544277|NCT01052103|451623462|FG001|Overall Study|Scheduling conflict|1|||
125544278|NCT01052103|451623461|FG000|Overall Study|Sponsor Decision|2|||
125544279|NCT01052103|451623462|FG001|Overall Study|Sponsor Decision|0|||
125544280|NCT01052103|451623461|FG000|Overall Study|Withdrawal by Subject|3|||
125544281|NCT01052103|451623462|FG001|Overall Study|Withdrawal by Subject|6|||
125680163|NCT00849901|452119204|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
125680164|NCT00849901|452119205|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
125680165|NCT00849901|452119206|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
125680166|NCT00849901|452119204|FG000|Extension Phase|Adverse Event|2|||
125680167|NCT00849901|452119205|FG001|Extension Phase|Adverse Event|8|||
125680168|NCT00849901|452119206|FG002|Extension Phase|Adverse Event|4|||
125680169|NCT00849901|452119204|FG000|Extension Phase|Lost to Follow-up|3|||
125680170|NCT00849901|452119205|FG001|Extension Phase|Lost to Follow-up|0|||
125680171|NCT00849901|452119206|FG002|Extension Phase|Lost to Follow-up|1|||
125680172|NCT00849901|452119204|FG000|Extension Phase|Protocol Violation|2|||
125680173|NCT00849901|452119205|FG001|Extension Phase|Protocol Violation|2|||
125544282|NCT01052103|451623461|FG000|Overall Study|Perceived Lack of Efficacy|1|||
125544283|NCT01052103|451623462|FG001|Overall Study|Perceived Lack of Efficacy|0|||
125544284|NCT00545051|451623466|FG000|Overall Study|Adverse Event|7|||
125544285|NCT00545051|451623467|FG001|Overall Study|Adverse Event|3|||
125544286|NCT00545051|451623466|FG000|Overall Study|Death|1|||
125544287|NCT00545051|451623467|FG001|Overall Study|Death|0|||
125544288|NCT00545051|451623466|FG000|Overall Study|Violation of inclusion/exclusion|0|||
125544289|NCT00545051|451623467|FG001|Overall Study|Violation of inclusion/exclusion|2|||
125680174|NCT00849901|452119206|FG002|Extension Phase|Protocol Violation|4|||
125544290|NCT00545051|451623466|FG000|Overall Study|Protocol Violation|1|||
125544291|NCT00545051|451623467|FG001|Overall Study|Protocol Violation|0|||
125544292|NCT00545051|451623466|FG000|Overall Study|Withdrawal by Subject|0|||
125544293|NCT00545051|451623467|FG001|Overall Study|Withdrawal by Subject|1|||
125544294|NCT00545051|451623466|FG000|Overall Study|Administrative reasons|0|||
125544295|NCT00545051|451623467|FG001|Overall Study|Administrative reasons|1|||
125544296|NCT05398237|451623468|FG000|Overall Study|Withdrawal by Subject|1|||
125544297|NCT00903006|451623471|FG000|Overall Study|Withdrawal by Subject|2|||
125544298|NCT00903006|451623472|FG001|Overall Study|Withdrawal by Subject|0|||
125544299|NCT00903006|451623473|FG002|Overall Study|Withdrawal by Subject|0|||
125544300|NCT00903006|451623474|FG003|Overall Study|Withdrawal by Subject|0|||
125544301|NCT00903006|451623471|FG000|Overall Study|Progressive Disease|0|||
125544302|NCT00903006|451623472|FG001|Overall Study|Progressive Disease|3|||
125544303|NCT00903006|451623473|FG002|Overall Study|Progressive Disease|1|||
125544304|NCT00903006|451623474|FG003|Overall Study|Progressive Disease|0|||
125544305|NCT03271021|451623478|FG000|Overall Study|Adverse Event|3|||
125544306|NCT03271021|451623479|FG001|Overall Study|Adverse Event|2|||
125544307|NCT03271021|451623478|FG000|Overall Study|Withdrawal by Subject|36|||
125544308|NCT03271021|451623479|FG001|Overall Study|Withdrawal by Subject|53|||
125544309|NCT03271021|451623478|FG000|Overall Study|Lost to Follow-up|34|||
125544310|NCT03271021|451623479|FG001|Overall Study|Lost to Follow-up|39|||
125544311|NCT03271021|451623478|FG000|Overall Study|Protocol Violation|6|||
125544312|NCT03271021|451623479|FG001|Overall Study|Protocol Violation|4|||
125544313|NCT03271021|451623478|FG000|Overall Study|Abnormal Lab Results|1|||
125544314|NCT03271021|451623479|FG001|Overall Study|Abnormal Lab Results|0|||
125544315|NCT03271021|451623478|FG000|Overall Study|Miscellaneous|9|||
125544316|NCT03271021|451623479|FG001|Overall Study|Miscellaneous|8|||
125544317|NCT01383499|451623480|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
125544318|NCT01383499|451623481|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
125544319|NCT01383499|451623482|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
125544320|NCT01383499|451623483|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
125680175|NCT00849901|452119204|FG000|Extension Phase|Withdrawal by Subject|7|||
125680176|NCT00849901|452119205|FG001|Extension Phase|Withdrawal by Subject|6|||
125680177|NCT00849901|452119206|FG002|Extension Phase|Withdrawal by Subject|3|||
125680178|NCT00849901|452119204|FG000|Extension Phase|Parent or Caregiver Decision|10|||
125680179|NCT00849901|452119205|FG001|Extension Phase|Parent or Caregiver Decision|4|||
125680180|NCT00849901|452119206|FG002|Extension Phase|Parent or Caregiver Decision|4|||
125680181|NCT00849901|452119204|FG000|Extension Phase|Physician Decision|1|||
125680182|NCT00849901|452119205|FG001|Extension Phase|Physician Decision|2|||
125680183|NCT00849901|452119206|FG002|Extension Phase|Physician Decision|0|||
125680184|NCT00849901|452119204|FG000|Extension Phase|Lack of Efficacy|2|||
125680185|NCT00849901|452119205|FG001|Extension Phase|Lack of Efficacy|4|||
125680186|NCT00849901|452119206|FG002|Extension Phase|Lack of Efficacy|1|||
125680187|NCT00437658|452119207|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
125680188|NCT00437658|452119208|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
125680189|NCT00437658|452119209|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
125680190|NCT00437658|452119207|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
125680191|NCT00437658|452119208|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
125680192|NCT00437658|452119209|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
125680193|NCT00437658|452119207|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
125680194|NCT00437658|452119208|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
125680195|NCT00437658|452119209|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
125680196|NCT00437658|452119207|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
125680197|NCT00437658|452119208|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
125680198|NCT00437658|452119209|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
125680199|NCT00437658|452119207|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
125680200|NCT00437658|452119208|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
125680201|NCT00437658|452119209|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
125680202|NCT00437658|452119207|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
125680203|NCT00437658|452119208|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
125680204|NCT00437658|452119209|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
125680205|NCT00437658|452119207|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
125680206|NCT00437658|452119208|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
125680207|NCT00437658|452119209|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
125680208|NCT00437658|452119207|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
125544321|NCT04275089|451623484|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
125544322|NCT01079663|451623487|FG000|Overall Study|Adverse Event|0|||
125544323|NCT01079663|451623488|FG001|Overall Study|Adverse Event|2|||
125544324|NCT01079663|451623487|FG000|Overall Study|Protocol Violation|0|||
125544325|NCT01079663|451623488|FG001|Overall Study|Protocol Violation|2|||
125544326|NCT00297232|451623492|FG000|Overall Study|Lack of Efficacy|7|||
125544327|NCT00297232|451623492|FG000|Overall Study|Lost to Follow-up|10|||
125544328|NCT00297232|451623492|FG000|Overall Study|Adverse Event|63|||
125345131|NCT02486627|450898206|FG001|Overall Study|Death|0|||
125680209|NCT00437658|452119208|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
125680210|NCT00437658|452119209|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
125680211|NCT00437658|452119207|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
125680212|NCT00437658|452119208|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
125680213|NCT00437658|452119209|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
125680214|NCT00437658|452119207|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
125680215|NCT00437658|452119208|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
125680216|NCT00437658|452119209|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
125680217|NCT00437658|452119207|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
125680218|NCT00437658|452119208|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
125680219|NCT00437658|452119209|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
125680220|NCT00437658|452119207|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
125680221|NCT00437658|452119208|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
125680222|NCT00437658|452119209|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
125680223|NCT04407806|452119211|FG000|Overall Study|Withdrawal by Subject|1|||
125680224|NCT04407806|452119212|FG001|Overall Study|Withdrawal by Subject|2|||
125680225|NCT02731157|452119213|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
125680226|NCT00832377|452119214|FG000|Overall Study|Protocol Violation|1|||
125680227|NCT01449630|452119215|FG000|Period 1|Physician Decision|1|||
125680228|NCT01449630|452119216|FG001|Period 1|Physician Decision|0|||
125680229|NCT01449630|452119217|FG002|Period 1|Physician Decision|0|||
125680230|NCT01449630|452119218|FG003|Period 1|Physician Decision|1|||
125680231|NCT01449630|452119219|FG004|Period 1|Physician Decision|0|||
125680232|NCT01449630|452119220|FG005|Period 1|Physician Decision|0|||
125680233|NCT01449630|452119221|FG006|Period 1|Physician Decision|0|||
125680234|NCT01449630|452119222|FG007|Period 1|Physician Decision|0|||
125680235|NCT01449630|452119223|FG008|Period 1|Physician Decision|0|||
125680236|NCT01449630|452119215|FG000|Period 1|Sponsor Decision|0|||
125680237|NCT01449630|452119216|FG001|Period 1|Sponsor Decision|0|||
125680238|NCT01449630|452119217|FG002|Period 1|Sponsor Decision|0|||
125680239|NCT01449630|452119218|FG003|Period 1|Sponsor Decision|0|||
125680240|NCT01449630|452119219|FG004|Period 1|Sponsor Decision|0|||
125680241|NCT01449630|452119220|FG005|Period 1|Sponsor Decision|1|||
125680242|NCT01449630|452119221|FG006|Period 1|Sponsor Decision|0|||
125680243|NCT01449630|452119222|FG007|Period 1|Sponsor Decision|0|||
125680244|NCT01449630|452119223|FG008|Period 1|Sponsor Decision|0|||
125680245|NCT01449630|452119215|FG000|Period 2|Sponsor Decision|0|||
125680246|NCT01449630|452119216|FG001|Period 2|Sponsor Decision|0|||
125680247|NCT01449630|452119217|FG002|Period 2|Sponsor Decision|0|||
125680248|NCT01449630|452119218|FG003|Period 2|Sponsor Decision|0|||
125680249|NCT01449630|452119219|FG004|Period 2|Sponsor Decision|0|||
125680250|NCT01449630|452119220|FG005|Period 2|Sponsor Decision|0|||
125680251|NCT01449630|452119221|FG006|Period 2|Sponsor Decision|1|||
125680252|NCT01449630|452119222|FG007|Period 2|Sponsor Decision|0|||
125680253|NCT01449630|452119223|FG008|Period 2|Sponsor Decision|0|||
125680254|NCT01735630|452119228|FG000|Overall Study|Adverse Event|8|||
125680255|NCT01735630|452119229|FG001|Overall Study|Adverse Event|7|||
125680256|NCT01735630|452119228|FG000|Overall Study|Lost to Follow-up|1|||
125680257|NCT01735630|452119229|FG001|Overall Study|Lost to Follow-up|0|||
125680258|NCT01735630|452119228|FG000|Overall Study|Physician Decision|0|||
125680259|NCT01735630|452119229|FG001|Overall Study|Physician Decision|1|||
125680260|NCT01735630|452119228|FG000|Overall Study|Sponsor Decision|2|||
125680261|NCT01735630|452119229|FG001|Overall Study|Sponsor Decision|1|||
125680262|NCT01735630|452119228|FG000|Overall Study|Withdrawal by Subject|7|||
125680263|NCT01735630|452119229|FG001|Overall Study|Withdrawal by Subject|9|||
125680264|NCT03099538|452119230|FG000|Overall Study|Lack of Efficacy|3|||
125680265|NCT01941030|452119243|FG000|Overall Study|Death|3|||
125680266|NCT01941030|452119244|FG001|Overall Study|Death|2|||
125680267|NCT01941030|452119243|FG000|Overall Study|Lost to Follow-up|6|||
125680268|NCT01941030|452119244|FG001|Overall Study|Lost to Follow-up|5|||
125680269|NCT01941030|452119243|FG000|Overall Study|Withdrawal by Subject|4|||
125680270|NCT01941030|452119244|FG001|Overall Study|Withdrawal by Subject|6|||
125680271|NCT02930005|452119245|FG000|Overall Study|Lost to Follow-up|1|||
125680272|NCT02930005|452119246|FG001|Overall Study|Lost to Follow-up|5|||
125680273|NCT00822926|452119249|FG000|Second Injection Visit|Lost to Follow-up|1|||
125680274|NCT00822926|452119250|FG001|Second Injection Visit|Lost to Follow-up|0|||
125680275|NCT00822926|452119249|FG000|Second Injection Visit|Withdrawal by Subject|0|||
125680276|NCT00822926|452119250|FG001|Second Injection Visit|Withdrawal by Subject|1|||
125680277|NCT02534493|452119264|FG000|Overall Study|Lost to Follow-up|1|||
125680278|NCT02534493|452119264|FG000|Overall Study|Withdrawal by Subject|1|||
125680279|NCT03125200|452119265|FG000|Overall Study|Study Termination|0|||
125680280|NCT03125200|452119266|FG001|Overall Study|Study Termination|0|||
125680281|NCT03125200|452119267|FG002|Overall Study|Study Termination|0|||
125680282|NCT03125200|452119268|FG003|Overall Study|Study Termination|1|||
125680283|NCT03125200|452119269|FG004|Overall Study|Study Termination|1|||
125680284|NCT03125200|452119270|FG005|Overall Study|Study Termination|2|||
125680285|NCT03125200|452119271|FG006|Overall Study|Study Termination|1|||
125345132|NCT02486627|450898205|FG000|Overall Study|Other Unspecified|0|||
125345133|NCT02486627|450898206|FG001|Overall Study|Other Unspecified|2|||
125345134|NCT02486627|450898205|FG000|Overall Study|Consent Withdrawn by Participant|4|||
125345135|NCT02486627|450898206|FG001|Overall Study|Consent Withdrawn by Participant|3|||
125345136|NCT02486627|450898205|FG000|Overall Study|Significant Participant Noncompliance|1|||
125345137|NCT02486627|450898206|FG001|Overall Study|Significant Participant Noncompliance|1|||
125345138|NCT02486627|450898205|FG000|Overall Study|Lost to Follow-up|1|||
125345139|NCT02486627|450898206|FG001|Overall Study|Lost to Follow-up|3|||
125345140|NCT01073462|450898207|FG000|Overall Study|Death|14|||
125345141|NCT01073462|450898207|FG000|Overall Study|Kidney transplant|10|||
125345142|NCT01073462|450898207|FG000|Overall Study|Low parathyroid hormone levels|8|||
125345143|NCT01073462|450898207|FG000|Overall Study|Serious adverse event|2|||
125345144|NCT01073462|450898207|FG000|Overall Study|Lost to Follow-up|7|||
125345145|NCT03554486|450898211|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
125345146|NCT03554486|450898212|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
125345147|NCT03554486|450898213|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
125345148|NCT03554486|450898211|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
125345149|NCT03554486|450898212|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
125345150|NCT03554486|450898213|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
125345151|NCT03554486|450898211|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
125345152|NCT03554486|450898212|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
125345153|NCT03554486|450898213|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
125345154|NCT01509053|450898214|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
125345155|NCT01509053|450898214|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
125345156|NCT01509053|450898214|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
125345157|NCT01509053|450898214|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
125345158|NCT01509053|450898214|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
125345159|NCT01509053|450898214|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
125345160|NCT01738477|450898216|FG000|Overall Study|Lost to Follow-up|1|||
125345161|NCT01738477|450898217|FG001|Overall Study|Lost to Follow-up|4|||
125544329|NCT00297232|451623492|FG000|Overall Study|Voluntary Withdrawal|120|||
125544330|NCT00297232|451623492|FG000|Overall Study|Subject was Noncompliant|9|||
125544331|NCT00297232|451623492|FG000|Overall Study|Death|9|||
125544332|NCT00297232|451623492|FG000|Overall Study|Anti-natalizumab Positive|8|||
125544333|NCT00297232|451623492|FG000|Overall Study|Switched to Commercial Tysabri|22|||
125544334|NCT00297232|451623492|FG000|Overall Study|Disease Progression|8|||
125544335|NCT00297232|451623492|FG000|Overall Study|Fear of PML|10|||
125544336|NCT00297232|451623492|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
125544337|NCT00297232|451623492|FG000|Overall Study|Miscellaneous|5|||
125544338|NCT00297232|451623492|FG000|Overall Study|Sponsor Decision|34|||
125544339|NCT00297232|451623492|FG000|Overall Study|Subject Relocated|7|||
125544340|NCT00297232|451623492|FG000|Overall Study|Subject Withdrew Consent|37|||
125544341|NCT00297232|451623492|FG000|Overall Study|Persistently Positive Antibodies|11|||
125544342|NCT00297232|451623492|FG000|Overall Study|Investigator Withdrew From Program|19|||
125544343|NCT00297232|451623492|FG000|Overall Study|Did Not Enroll to Week 264|34|||
125544344|NCT00297232|451623492|FG000|Overall Study|Did Not Enroll to Week 480|17|||
125544345|NCT00297232|451623492|FG000|Overall Study|No data available after Week 264|161|||
125544346|NCT00297232|451623492|FG000|Overall Study|Other|1|||
125544347|NCT03038438|451623495|FG000|Overall Study|Death|3|||
125544348|NCT03038438|451623495|FG000|Overall Study|Lost to Follow-up|8|||
125544349|NCT03038438|451623495|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
125544350|NCT03038438|451623495|FG000|Overall Study|Withdrawal by Subject|5|||
125544351|NCT03038438|451623495|FG000|Overall Study|No 36-Month Follow-Up|18|||
125544352|NCT01656733|451623498|FG000|Overall Study|No permission to collect birth outcomes|0|||
125544353|NCT01656733|451623499|FG001|Overall Study|No permission to collect birth outcomes|1|||
125544354|NCT01656733|451623498|FG000|Overall Study|Delivery at another hospital|0|||
125544355|NCT01656733|451623499|FG001|Overall Study|Delivery at another hospital|2|||
125544356|NCT01656733|451623498|FG000|Overall Study|Spontaneous abortion|0|||
125544357|NCT01656733|451623499|FG001|Overall Study|Spontaneous abortion|1|||
125544358|NCT03625895|451623500|FG000|Overall Study|Protocol Violation|585|||
125544359|NCT01065844|451623501|FG000|Overall Study|Adverse Event|5|||
125544360|NCT02476279|451623502|FG000|Overall Study|Lost to Follow-up|1|||
125544361|NCT02476279|451623503|FG001|Overall Study|Lost to Follow-up|1|||
125544362|NCT00577473|451623506|FG000|Overall Study|Protocol Violation|1|||
125544363|NCT00577473|451623507|FG001|Overall Study|Protocol Violation|4|||
125544364|NCT00577473|451623506|FG000|Overall Study|Adverse Event|8|||
125544365|NCT00577473|451623507|FG001|Overall Study|Adverse Event|5|||
125544366|NCT00577473|451623506|FG000|Overall Study|Withdrawal by Subject|2|||
125544367|NCT00577473|451623507|FG001|Overall Study|Withdrawal by Subject|6|||
125544368|NCT00577473|451623506|FG000|Overall Study|Physician Decision|2|||
125544369|NCT00577473|451623507|FG001|Overall Study|Physician Decision|2|||
125544370|NCT00577473|451623506|FG000|Overall Study|Lack of Efficacy|8|||
125544371|NCT00577473|451623507|FG001|Overall Study|Lack of Efficacy|7|||
125544372|NCT01465347|451623510|FG000|Overall Study|Withdrawal by Subject|1|||
125544373|NCT01465347|451623511|FG001|Overall Study|Withdrawal by Subject|1|||
125544374|NCT01465347|451623510|FG000|Overall Study|Physician Decision|0|||
125544375|NCT01465347|451623511|FG001|Overall Study|Physician Decision|1|||
125544376|NCT01465347|451623510|FG000|Overall Study|Admitted to hospice|0|||
125544377|NCT01465347|451623511|FG001|Overall Study|Admitted to hospice|1|||
125544378|NCT01590082|451623512|FG000|Overall Study|Withdrawal by Subject|1|||
125544379|NCT01590082|451623513|FG001|Overall Study|Withdrawal by Subject|0|||
125544380|NCT01590082|451623512|FG000|Overall Study|Ineligible|1|||
125544381|NCT01590082|451623513|FG001|Overall Study|Ineligible|0|||
125544382|NCT02414932|451623514|FG000|Overall Study|Withdrawal by Subject|2|||
125544383|NCT02414932|451623515|FG001|Overall Study|Withdrawal by Subject|3|||
125544384|NCT02414932|451623514|FG000|Overall Study|Adverse Event|1|||
125544385|NCT02414932|451623515|FG001|Overall Study|Adverse Event|0|||
125544386|NCT00906945|451623516|FG000|Overall Study|Found to be not eligible|0|||
125544387|NCT00906945|451623517|FG001|Overall Study|Found to be not eligible|0|||
125544388|NCT00906945|451623518|FG002|Overall Study|Found to be not eligible|0|||
125544389|NCT00906945|451623519|FG003|Overall Study|Found to be not eligible|1|||
125544390|NCT00906945|451623520|FG004|Overall Study|Found to be not eligible|1|||
125544391|NCT00906945|451623521|FG005|Overall Study|Found to be not eligible|1|||
125544392|NCT00906945|451623516|FG000|Overall Study|Physician Decision|0|||
125544393|NCT00906945|451623517|FG001|Overall Study|Physician Decision|0|||
125544394|NCT00906945|451623518|FG002|Overall Study|Physician Decision|0|||
125544395|NCT00906945|451623519|FG003|Overall Study|Physician Decision|0|||
125544396|NCT00906945|451623520|FG004|Overall Study|Physician Decision|0|||
125544397|NCT00906945|451623521|FG005|Overall Study|Physician Decision|1|||
125544398|NCT01210664|451623523|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
125544399|NCT01210664|451623524|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
125544400|NCT01210664|451623525|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
125544401|NCT01210664|451623526|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
125544402|NCT01210664|451623523|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
125544403|NCT01210664|451623524|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
125544404|NCT01210664|451623525|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
125544405|NCT01210664|451623526|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
125544406|NCT01210664|451623523|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
125544407|NCT01210664|451623524|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
125544408|NCT01210664|451623525|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
125544409|NCT01210664|451623526|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
125544410|NCT01853644|451623527|FG000|Registration and Treatment Start|Did not start treatment|1|||
125544411|NCT01853644|451623527|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
125544412|NCT01853644|451623527|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
125544413|NCT01853644|451623527|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
125544414|NCT01853644|451623527|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
125544415|NCT01853644|451623527|FG000|Continued Treatment After First Response|Adverse Event|2|||
125544416|NCT01853644|451623527|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
125544417|NCT02891408|451623528|FG000|Overall Study|Lost to Follow-up|0|||
125544418|NCT02891408|451623529|FG001|Overall Study|Lost to Follow-up|0|||
125544419|NCT02891408|451623530|FG002|Overall Study|Lost to Follow-up|1|||
125544420|NCT02891408|451623531|FG003|Overall Study|Lost to Follow-up|0|||
125544421|NCT02891408|451623532|FG004|Overall Study|Lost to Follow-up|0|||
125544422|NCT02891408|451623533|FG005|Overall Study|Lost to Follow-up|0|||
125544423|NCT02891408|451623534|FG006|Overall Study|Lost to Follow-up|0|||
125544424|NCT01054170|451623535|FG000|Overall Study|Protocol Violation|1|||
125544425|NCT01054170|451623536|FG001|Overall Study|Protocol Violation|0|||
125544426|NCT01054170|451623535|FG000|Overall Study|Withdrawal by Subject|3|||
125544427|NCT01054170|451623536|FG001|Overall Study|Withdrawal by Subject|2|||
125544428|NCT01054170|451623535|FG000|Overall Study|Adverse Event|0|||
125544429|NCT01054170|451623536|FG001|Overall Study|Adverse Event|4|||
125680286|NCT03125200|452119265|FG000|Overall Study|Clinical Progression|0|||
125680287|NCT03125200|452119266|FG001|Overall Study|Clinical Progression|0|||
125680288|NCT03125200|452119267|FG002|Overall Study|Clinical Progression|0|||
125680289|NCT03125200|452119268|FG003|Overall Study|Clinical Progression|1|||
125544430|NCT02951767|451623537|FG000|Overall Study|Study Terminated By Sponsor|9|||
125680290|NCT03125200|452119269|FG004|Overall Study|Clinical Progression|0|||
125680291|NCT03125200|452119270|FG005|Overall Study|Clinical Progression|1|||
125680292|NCT03125200|452119271|FG006|Overall Study|Clinical Progression|0|||
125680293|NCT03125200|452119265|FG000|Overall Study|Progressive Disease|2|||
125680294|NCT03125200|452119266|FG001|Overall Study|Progressive Disease|1|||
125680295|NCT03125200|452119267|FG002|Overall Study|Progressive Disease|2|||
125544431|NCT02951767|451623537|FG000|Overall Study|Withdrawal by Subject|11|||
125680296|NCT03125200|452119268|FG003|Overall Study|Progressive Disease|1|||
125544432|NCT02951767|451623537|FG000|Overall Study|Death|96|||
125544433|NCT02951767|451623537|FG000|Overall Study|Lost to Follow-up|2|||
125544434|NCT02951767|451623537|FG000|Overall Study|Physician Decision|1|||
125544435|NCT00709852|451623538|FG000|Period 1|Adverse Event|2|||
125544436|NCT00709852|451623539|FG001|Period 1|Adverse Event|0|||
125544437|NCT00709852|451623538|FG000|Period 1|Withdrawal by Subject|4|||
125544438|NCT00709852|451623539|FG001|Period 1|Withdrawal by Subject|2|||
125680297|NCT03125200|452119269|FG004|Overall Study|Progressive Disease|2|||
125544439|NCT00709852|451623538|FG000|Period 1|Protocol Violation|1|||
125544440|NCT00709852|451623539|FG001|Period 1|Protocol Violation|0|||
125544441|NCT00709852|451623538|FG000|Period 1|Defective scanner|0|||
125544442|NCT00709852|451623539|FG001|Period 1|Defective scanner|1|||
125544443|NCT00709852|451623538|FG000|Period 1|Lost to Follow-up|1|||
125544444|NCT00709852|451623539|FG001|Period 1|Lost to Follow-up|0|||
125544445|NCT00709852|451623538|FG000|Period 2|Protocol Violation|4|||
125680298|NCT03125200|452119270|FG005|Overall Study|Progressive Disease|0|||
125680299|NCT03125200|452119271|FG006|Overall Study|Progressive Disease|1|||
125680300|NCT03125200|452119265|FG000|Overall Study|Lack of Efficacy|0|||
125680301|NCT03125200|452119266|FG001|Overall Study|Lack of Efficacy|0|||
125680302|NCT03125200|452119267|FG002|Overall Study|Lack of Efficacy|0|||
125680303|NCT03125200|452119268|FG003|Overall Study|Lack of Efficacy|1|||
125680304|NCT03125200|452119269|FG004|Overall Study|Lack of Efficacy|0|||
125680305|NCT03125200|452119270|FG005|Overall Study|Lack of Efficacy|0|||
125680306|NCT03125200|452119271|FG006|Overall Study|Lack of Efficacy|0|||
125680307|NCT03125200|452119265|FG000|Overall Study|Toxicity|0|||
125680308|NCT03125200|452119266|FG001|Overall Study|Toxicity|0|||
125680309|NCT03125200|452119267|FG002|Overall Study|Toxicity|0|||
125680310|NCT03125200|452119268|FG003|Overall Study|Toxicity|1|||
125680311|NCT03125200|452119269|FG004|Overall Study|Toxicity|0|||
125680312|NCT03125200|452119270|FG005|Overall Study|Toxicity|0|||
125680313|NCT03125200|452119271|FG006|Overall Study|Toxicity|0|||
125680314|NCT03125200|452119265|FG000|Overall Study|Consent Withdrawn by Subject|0|||
125680315|NCT03125200|452119266|FG001|Overall Study|Consent Withdrawn by Subject|1|||
125680316|NCT03125200|452119267|FG002|Overall Study|Consent Withdrawn by Subject|0|||
125680317|NCT03125200|452119268|FG003|Overall Study|Consent Withdrawn by Subject|0|||
125680318|NCT03125200|452119269|FG004|Overall Study|Consent Withdrawn by Subject|1|||
125680319|NCT03125200|452119270|FG005|Overall Study|Consent Withdrawn by Subject|0|||
125680320|NCT03125200|452119271|FG006|Overall Study|Consent Withdrawn by Subject|1|||
125680321|NCT00119379|452119275|FG000|Overall Study|Adverse Event|4|||
125680322|NCT00119379|452119276|FG001|Overall Study|Adverse Event|1|||
125680323|NCT01706536|452119282|FG000|Overall Study|Withdrawal by Subject|1|||
125680324|NCT01706536|452119283|FG001|Overall Study|Withdrawal by Subject|0|||
125680325|NCT01706536|452119284|FG002|Overall Study|Withdrawal by Subject|1|||
125680326|NCT01706536|452119285|FG003|Overall Study|Withdrawal by Subject|0|||
125680327|NCT01706536|452119286|FG004|Overall Study|Withdrawal by Subject|0|||
125680328|NCT01706536|452119282|FG000|Overall Study|Adverse Event|2|||
125680329|NCT01706536|452119283|FG001|Overall Study|Adverse Event|3|||
125680330|NCT01706536|452119284|FG002|Overall Study|Adverse Event|4|||
125680331|NCT01706536|452119285|FG003|Overall Study|Adverse Event|3|||
125680332|NCT01706536|452119286|FG004|Overall Study|Adverse Event|2|||
125680333|NCT01706536|452119282|FG000|Overall Study|Lack of Efficacy|1|||
125680334|NCT01706536|452119283|FG001|Overall Study|Lack of Efficacy|0|||
125680335|NCT01706536|452119284|FG002|Overall Study|Lack of Efficacy|0|||
125680336|NCT01706536|452119285|FG003|Overall Study|Lack of Efficacy|1|||
125680337|NCT01706536|452119286|FG004|Overall Study|Lack of Efficacy|0|||
125680338|NCT01706536|452119282|FG000|Overall Study|non compliance|0|||
125680339|NCT01706536|452119283|FG001|Overall Study|non compliance|1|||
125680340|NCT01706536|452119284|FG002|Overall Study|non compliance|0|||
125680341|NCT01706536|452119285|FG003|Overall Study|non compliance|0|||
125680342|NCT01706536|452119286|FG004|Overall Study|non compliance|0|||
125680343|NCT00683293|452119295|FG000|Overall Study|Withdrawal by Subject|2|||
125680344|NCT00683293|452119296|FG001|Overall Study|Withdrawal by Subject|3|||
125680345|NCT03262012|452119297|FG000|Overall Study|Withdrawal by Subject|15|||
125680346|NCT03262012|452119298|FG001|Overall Study|Withdrawal by Subject|13|||
125680347|NCT03262012|452119299|FG002|Overall Study|Withdrawal by Subject|8|||
125680348|NCT03262012|452119300|FG003|Overall Study|Withdrawal by Subject|7|||
125680349|NCT03262012|452119297|FG000|Overall Study|Adverse Event|10|||
125680350|NCT03262012|452119298|FG001|Overall Study|Adverse Event|12|||
125680351|NCT03262012|452119299|FG002|Overall Study|Adverse Event|4|||
125680352|NCT03262012|452119300|FG003|Overall Study|Adverse Event|6|||
125680353|NCT03262012|452119297|FG000|Overall Study|Physician Decision|2|||
125680354|NCT03262012|452119298|FG001|Overall Study|Physician Decision|5|||
125680355|NCT03262012|452119299|FG002|Overall Study|Physician Decision|1|||
125680356|NCT03262012|452119300|FG003|Overall Study|Physician Decision|0|||
125680357|NCT03262012|452119297|FG000|Overall Study|Lack of Efficacy|0|||
125680358|NCT03262012|452119298|FG001|Overall Study|Lack of Efficacy|5|||
125680359|NCT03262012|452119299|FG002|Overall Study|Lack of Efficacy|1|||
125680360|NCT03262012|452119300|FG003|Overall Study|Lack of Efficacy|2|||
125544446|NCT00709852|451623539|FG001|Period 2|Protocol Violation|1|||
125544447|NCT00709852|451623538|FG000|Period 2|Adverse Event|1|||
125544448|NCT00709852|451623539|FG001|Period 2|Adverse Event|1|||
125680361|NCT03262012|452119297|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
125680362|NCT03262012|452119298|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
125680363|NCT03262012|452119299|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
125680364|NCT03262012|452119300|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
125680365|NCT01469546|452119301|FG000|Received 5 mg Dose|Adverse Event|13|||
125680366|NCT01469546|452119301|FG000|Received 5 mg Dose|Death|2|||
125544449|NCT00709852|451623538|FG000|Period 2|Lost to Follow-up|1|||
125544450|NCT00709852|451623539|FG001|Period 2|Lost to Follow-up|0|||
125544451|NCT00709852|451623538|FG000|Period 2|No 72-hour follow-up|3|||
125544452|NCT00709852|451623539|FG001|Period 2|No 72-hour follow-up|0|||
125544453|NCT01442779|451623540|FG000|Overall Study|Withdrawal by Subject|3|||
125544454|NCT01442779|451623540|FG000|Overall Study|Death|3|||
125544455|NCT01442779|451623540|FG000|Overall Study|Non-compliance|1|||
125544456|NCT01048671|451623541|FG000|Overall Study|Protocol Violation|0|||
125544457|NCT01048671|451623542|FG001|Overall Study|Protocol Violation|1|||
125544458|NCT01048671|451623543|FG002|Overall Study|Protocol Violation|1|||
125544459|NCT03814187|451623544|FG000|Overall Study|Sponsor's Administrative Decision|0|||
125544460|NCT03814187|451623545|FG001|Overall Study|Sponsor's Administrative Decision|0|||
125544461|NCT03814187|451623546|FG002|Overall Study|Sponsor's Administrative Decision|272|||
125544462|NCT03814187|451623544|FG000|Overall Study|Death|80|||
125544463|NCT03814187|451623545|FG001|Overall Study|Death|81|||
125544464|NCT03814187|451623546|FG002|Overall Study|Death|4|||
125544465|NCT03814187|451623544|FG000|Overall Study|Withdrew Consent|77|||
125544466|NCT03814187|451623545|FG001|Overall Study|Withdrew Consent|78|||
125544467|NCT03814187|451623546|FG002|Overall Study|Withdrew Consent|2|||
125544468|NCT03814187|451623544|FG000|Overall Study|Lost to Follow-up|47|||
125544469|NCT03814187|451623545|FG001|Overall Study|Lost to Follow-up|52|||
125544470|NCT03814187|451623546|FG002|Overall Study|Lost to Follow-up|1|||
125544471|NCT03814187|451623544|FG000|Overall Study|Adverse Event|22|||
125544472|NCT03814187|451623545|FG001|Overall Study|Adverse Event|23|||
125544473|NCT03814187|451623546|FG002|Overall Study|Adverse Event|0|||
125544474|NCT03814187|451623544|FG000|Overall Study|Physician Decision|7|||
125544475|NCT03814187|451623545|FG001|Overall Study|Physician Decision|4|||
125544476|NCT03814187|451623546|FG002|Overall Study|Physician Decision|2|||
125544477|NCT03814187|451623544|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
125544478|NCT03814187|451623545|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
125544479|NCT03814187|451623546|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
125544480|NCT03814187|451623544|FG000|Overall Study|Other reasons|34|||
125544481|NCT03814187|451623545|FG001|Overall Study|Other reasons|40|||
125544482|NCT03814187|451623546|FG002|Overall Study|Other reasons|2|||
125544483|NCT00513604|451623547|FG000|Overall Study|Not treated|2|||
125544484|NCT00513604|451623548|FG001|Overall Study|Not treated|0|||
125544485|NCT00513604|451623549|FG002|Overall Study|Not treated|1|||
125544486|NCT00513604|451623550|FG003|Overall Study|Not treated|0|||
125544487|NCT00513604|451623551|FG004|Overall Study|Not treated|0|||
125544488|NCT00513604|451623547|FG000|Overall Study|Death during treatment|0|||
125544489|NCT00513604|451623548|FG001|Overall Study|Death during treatment|3|||
125544490|NCT00513604|451623549|FG002|Overall Study|Death during treatment|2|||
125544491|NCT00513604|451623550|FG003|Overall Study|Death during treatment|0|||
125544492|NCT00513604|451623551|FG004|Overall Study|Death during treatment|0|||
125544493|NCT00196976|451623552|FG000|Primary Study|Migrated from study area|0|||
125544494|NCT00196976|451623553|FG001|Primary Study|Migrated from study area|0|||
125544495|NCT00196976|451623554|FG002|Primary Study|Migrated from study area|0|||
125544496|NCT00196976|451623555|FG003|Primary Study|Migrated from study area|0|||
125680367|NCT01469546|452119301|FG000|Received 5 mg Dose|Protocol Violation|2|||
125680368|NCT01469546|452119301|FG000|Received 5 mg Dose|Progressive Disease|3|||
125680369|NCT01469546|452119301|FG000|Received 5 mg Dose|Physician Decision|3|||
125680370|NCT02079532|452119304|FG000|Overall Study|Adverse Event|7|||
125680371|NCT02079532|452119304|FG000|Overall Study|Additional or changed therapy|2|||
125680372|NCT02079532|452119304|FG000|Overall Study|Lack of Efficacy|9|||
125680373|NCT02079532|452119304|FG000|Overall Study|Protocol Violation|3|||
125680374|NCT02079532|452119304|FG000|Overall Study|Withdrawal by Subject|1|||
125680375|NCT02079532|452119304|FG000|Overall Study|Administrative problems|1|||
125680376|NCT02079532|452119304|FG000|Overall Study|Inclusion into ReFIRST|3|||
125680377|NCT02079532|452119304|FG000|Overall Study|Other|3|||
125680378|NCT01432171|452119305|FG000|Overall Study|Death|1|||
125680379|NCT01432171|452119306|FG001|Overall Study|Death|2|||
125680380|NCT01432171|452119305|FG000|Overall Study|Lost to Follow-up|6|||
125680381|NCT01432171|452119306|FG001|Overall Study|Lost to Follow-up|5|||
125680382|NCT01432171|452119305|FG000|Overall Study|Withdrawal by Subject|3|||
125680383|NCT01432171|452119306|FG001|Overall Study|Withdrawal by Subject|1|||
125544497|NCT00196976|451623556|FG004|Primary Study|Migrated from study area|0|||
125544498|NCT00196976|451623557|FG005|Primary Study|Migrated from study area|0|||
125544499|NCT00196976|451623558|FG006|Primary Study|Migrated from study area|0|||
125544500|NCT00196976|451623559|FG007|Primary Study|Migrated from study area|1|||
125544501|NCT00196976|451623560|FG008|Primary Study|Migrated from study area|0|||
125544502|NCT00196976|451623561|FG009|Primary Study|Migrated from study area|0|||
125544503|NCT00196976|451623562|FG010|Primary Study|Migrated from study area|0|||
125544504|NCT00196976|451623563|FG011|Primary Study|Migrated from study area|0|||
125544505|NCT00196976|451623564|FG012|Primary Study|Migrated from study area|0|||
125544506|NCT00196976|451623565|FG013|Primary Study|Migrated from study area|0|||
125544507|NCT00196976|451623552|FG000|Primary Study|Protocol Violation|0|||
125544508|NCT00196976|451623553|FG001|Primary Study|Protocol Violation|1|||
125680384|NCT01432171|452119305|FG000|Overall Study|Noncompliance|2|||
125544509|NCT00196976|451623554|FG002|Primary Study|Protocol Violation|1|||
125544510|NCT00196976|451623555|FG003|Primary Study|Protocol Violation|0|||
125544511|NCT00196976|451623556|FG004|Primary Study|Protocol Violation|0|||
125544512|NCT00196976|451623557|FG005|Primary Study|Protocol Violation|0|||
125544513|NCT00196976|451623558|FG006|Primary Study|Protocol Violation|0|||
125544514|NCT00196976|451623559|FG007|Primary Study|Protocol Violation|0|||
125544515|NCT00196976|451623560|FG008|Primary Study|Protocol Violation|0|||
125544516|NCT00196976|451623561|FG009|Primary Study|Protocol Violation|0|||
125544517|NCT00196976|451623562|FG010|Primary Study|Protocol Violation|0|||
125544518|NCT00196976|451623563|FG011|Primary Study|Protocol Violation|0|||
125544519|NCT00196976|451623564|FG012|Primary Study|Protocol Violation|0|||
125544520|NCT00196976|451623565|FG013|Primary Study|Protocol Violation|0|||
125544521|NCT00196976|451623552|FG000|Primary Study|Withdrawal by Subject|1|||
125544522|NCT00196976|451623553|FG001|Primary Study|Withdrawal by Subject|0|||
125544523|NCT00196976|451623554|FG002|Primary Study|Withdrawal by Subject|1|||
125544524|NCT00196976|451623555|FG003|Primary Study|Withdrawal by Subject|1|||
125544525|NCT00196976|451623556|FG004|Primary Study|Withdrawal by Subject|2|||
125544526|NCT00196976|451623557|FG005|Primary Study|Withdrawal by Subject|1|||
125544527|NCT00196976|451623558|FG006|Primary Study|Withdrawal by Subject|0|||
125544528|NCT00196976|451623559|FG007|Primary Study|Withdrawal by Subject|0|||
125544529|NCT00196976|451623560|FG008|Primary Study|Withdrawal by Subject|0|||
125544530|NCT00196976|451623561|FG009|Primary Study|Withdrawal by Subject|1|||
125544531|NCT00196976|451623562|FG010|Primary Study|Withdrawal by Subject|0|||
125544532|NCT00196976|451623563|FG011|Primary Study|Withdrawal by Subject|0|||
125544533|NCT00196976|451623564|FG012|Primary Study|Withdrawal by Subject|0|||
125544534|NCT00196976|451623565|FG013|Primary Study|Withdrawal by Subject|0|||
125544535|NCT00196976|451623552|FG000|Primary Study|Lost to Follow-up|0|||
125544536|NCT00196976|451623553|FG001|Primary Study|Lost to Follow-up|0|||
125544537|NCT00196976|451623554|FG002|Primary Study|Lost to Follow-up|0|||
125544538|NCT00196976|451623555|FG003|Primary Study|Lost to Follow-up|0|||
125544539|NCT00196976|451623556|FG004|Primary Study|Lost to Follow-up|1|||
125544540|NCT00196976|451623557|FG005|Primary Study|Lost to Follow-up|1|||
125544541|NCT00196976|451623558|FG006|Primary Study|Lost to Follow-up|0|||
125544542|NCT00196976|451623559|FG007|Primary Study|Lost to Follow-up|2|||
125544543|NCT00196976|451623560|FG008|Primary Study|Lost to Follow-up|0|||
125544544|NCT00196976|451623561|FG009|Primary Study|Lost to Follow-up|0|||
125544545|NCT00196976|451623562|FG010|Primary Study|Lost to Follow-up|0|||
125544546|NCT00196976|451623563|FG011|Primary Study|Lost to Follow-up|0|||
125544547|NCT00196976|451623564|FG012|Primary Study|Lost to Follow-up|0|||
125544548|NCT00196976|451623565|FG013|Primary Study|Lost to Follow-up|0|||
125544549|NCT00196976|451623552|FG000|Primary Study|Other|0|||
125544550|NCT00196976|451623553|FG001|Primary Study|Other|0|||
125680385|NCT01432171|452119306|FG001|Overall Study|Noncompliance|3|||
125680386|NCT01432171|452119305|FG000|Overall Study|Insurance denial trial coverage|1|||
125680387|NCT01432171|452119306|FG001|Overall Study|Insurance denial trial coverage|0|||
125680388|NCT01432171|452119305|FG000|Overall Study|Patient moved to palliative care|1|||
125680389|NCT01432171|452119306|FG001|Overall Study|Patient moved to palliative care|0|||
125680390|NCT01085045|452120618|FG000|Part A|Withdrawal by Subject|4|||
125680391|NCT01085045|452120618|FG000|Part A|Adverse Event|6|||
125680392|NCT01085045|452120618|FG000|Part A|Protocol Violation|1|||
125680393|NCT01085045|452120618|FG000|Part A|Protocol Specified Criteria|7|||
125680394|NCT01085045|452120618|FG000|Part B|Withdrawal by Subject|2|||
125680395|NCT01085045|452120618|FG000|Part B|Protocol Specified Criteria|6|||
125680396|NCT01085045|452120618|FG000|Part B|Lost to Follow-up|1|||
125680397|NCT01085045|452120618|FG000|Part B|Adverse Event|6|||
125680398|NCT00416520|452120623|FG000|Open-label Period|Adverse Event|28|||
125680399|NCT00416520|452120624|FG001|Open-label Period|Adverse Event|10|||
125680400|NCT00416520|452120625|FG002|Open-label Period|Adverse Event|0|||
125680401|NCT00416520|452120626|FG003|Open-label Period|Adverse Event|0|||
125680402|NCT00416520|452120623|FG000|Open-label Period|Death|2|||
125680403|NCT00416520|452120624|FG001|Open-label Period|Death|1|||
125680404|NCT00416520|452120625|FG002|Open-label Period|Death|0|||
125680405|NCT00416520|452120626|FG003|Open-label Period|Death|0|||
125345162|NCT01915303|450898218|FG000|Core Phase|Adverse Event|7|||
125544551|NCT00196976|451623554|FG002|Primary Study|Other|2|||
125544552|NCT00196976|451623555|FG003|Primary Study|Other|0|||
125544553|NCT00196976|451623556|FG004|Primary Study|Other|0|||
125544554|NCT00196976|451623557|FG005|Primary Study|Other|0|||
125544555|NCT00196976|451623558|FG006|Primary Study|Other|0|||
125544556|NCT00196976|451623559|FG007|Primary Study|Other|0|||
125680406|NCT00416520|452120623|FG000|Open-label Period|Lack of Efficacy|8|||
125544557|NCT00196976|451623560|FG008|Primary Study|Other|0|||
125544558|NCT00196976|451623561|FG009|Primary Study|Other|0|||
125544559|NCT00196976|451623562|FG010|Primary Study|Other|0|||
125544560|NCT00196976|451623563|FG011|Primary Study|Other|0|||
125680407|NCT00416520|452120624|FG001|Open-label Period|Lack of Efficacy|1|||
125544561|NCT00196976|451623564|FG012|Primary Study|Other|0|||
125544562|NCT00196976|451623565|FG013|Primary Study|Other|0|||
125544563|NCT00196976|451623552|FG000|Booster Study|Withdrawal by Subject|0|||
125544564|NCT00196976|451623553|FG001|Booster Study|Withdrawal by Subject|0|||
125544565|NCT00196976|451623554|FG002|Booster Study|Withdrawal by Subject|0|||
125544566|NCT00196976|451623555|FG003|Booster Study|Withdrawal by Subject|0|||
125544567|NCT00196976|451623556|FG004|Booster Study|Withdrawal by Subject|0|||
125544568|NCT00196976|451623557|FG005|Booster Study|Withdrawal by Subject|0|||
125544569|NCT00196976|451623558|FG006|Booster Study|Withdrawal by Subject|0|||
125345163|NCT01915303|450898218|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
125345164|NCT01915303|450898218|FG000|Core Phase|Death|2|||
125345165|NCT01915303|450898218|FG000|Core Phase|Protocol Violation|2|||
125345166|NCT01915303|450898218|FG000|Core Phase|Abnormal lab value|1|||
125345167|NCT01915303|450898218|FG000|Core Phase|Withdrawal by Subject|1|||
125345168|NCT01915303|450898218|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
125345169|NCT01915303|450898218|FG000|Extension Phase|Withdrawal by Subject|4|||
125345170|NCT01915303|450898218|FG000|Extension Phase|Adverse Event|3|||
125345171|NCT01915303|450898218|FG000|Extension Phase|Death|1|||
125345172|NCT01915303|450898218|FG000|Extension Phase|Protocol Violation|1|||
125345173|NCT02925338|450898219|FG000|Overall Study|Death|0|||
125345174|NCT02925338|450898220|FG001|Overall Study|Death|2|||
125345175|NCT02925338|450898221|FG002|Overall Study|Death|1|||
125345176|NCT02925338|450898222|FG003|Overall Study|Death|0|||
125345177|NCT02925338|450898223|FG004|Overall Study|Death|0|||
125345178|NCT02925338|450898219|FG000|Overall Study|Lost to Follow-up|30|||
125345179|NCT02925338|450898220|FG001|Overall Study|Lost to Follow-up|10|||
125345180|NCT02925338|450898221|FG002|Overall Study|Lost to Follow-up|1|||
125345181|NCT02925338|450898222|FG003|Overall Study|Lost to Follow-up|16|||
125345182|NCT02925338|450898223|FG004|Overall Study|Lost to Follow-up|3|||
125345183|NCT02925338|450898219|FG000|Overall Study|Withdrawal by Subject|3|||
125345184|NCT02925338|450898220|FG001|Overall Study|Withdrawal by Subject|0|||
125345185|NCT02925338|450898221|FG002|Overall Study|Withdrawal by Subject|3|||
125345186|NCT02925338|450898222|FG003|Overall Study|Withdrawal by Subject|2|||
125345187|NCT02925338|450898223|FG004|Overall Study|Withdrawal by Subject|2|||
125345188|NCT02925338|450898219|FG000|Overall Study|Missing|38|||
125345189|NCT02925338|450898220|FG001|Overall Study|Missing|27|||
125345190|NCT02925338|450898221|FG002|Overall Study|Missing|0|||
125345191|NCT02925338|450898222|FG003|Overall Study|Missing|3|||
125345192|NCT02925338|450898223|FG004|Overall Study|Missing|2|||
125345193|NCT02925338|450898219|FG000|Overall Study|Participant's Decision|11|||
125345194|NCT02925338|450898220|FG001|Overall Study|Participant's Decision|7|||
125345195|NCT02925338|450898221|FG002|Overall Study|Participant's Decision|3|||
125680408|NCT00416520|452120625|FG002|Open-label Period|Lack of Efficacy|0|||
125680409|NCT00416520|452120626|FG003|Open-label Period|Lack of Efficacy|0|||
125680410|NCT00416520|452120623|FG000|Open-label Period|Protocol Violation|3|||
125680411|NCT00416520|452120624|FG001|Open-label Period|Protocol Violation|3|||
125680412|NCT00416520|452120625|FG002|Open-label Period|Protocol Violation|0|||
125680413|NCT00416520|452120626|FG003|Open-label Period|Protocol Violation|0|||
125680414|NCT00416520|452120623|FG000|Open-label Period|Withdrawal by Subject|16|||
125680415|NCT00416520|452120624|FG001|Open-label Period|Withdrawal by Subject|5|||
125680416|NCT00416520|452120625|FG002|Open-label Period|Withdrawal by Subject|0|||
125680417|NCT00416520|452120626|FG003|Open-label Period|Withdrawal by Subject|0|||
125680418|NCT00416520|452120623|FG000|Open-label Period|Other Reasons|3|||
125680419|NCT00416520|452120624|FG001|Open-label Period|Other Reasons|12|||
125680420|NCT00416520|452120625|FG002|Open-label Period|Other Reasons|0|||
125680421|NCT00416520|452120626|FG003|Open-label Period|Other Reasons|0|||
125680422|NCT00416520|452120623|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
125680423|NCT00416520|452120624|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
125680424|NCT00416520|452120625|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
125680425|NCT00416520|452120626|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
125680426|NCT00416520|452120623|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
125680427|NCT00416520|452120624|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
125680428|NCT00416520|452120625|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
125680429|NCT00416520|452120626|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
125680430|NCT00416520|452120623|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
125680431|NCT00416520|452120624|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
125680432|NCT00416520|452120625|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
125680433|NCT00416520|452120626|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
125680434|NCT04455633|452120633|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
125345196|NCT02925338|450898222|FG003|Overall Study|Participant's Decision|8|||
125345197|NCT02925338|450898223|FG004|Overall Study|Participant's Decision|1|||
125345198|NCT02925338|450898219|FG000|Overall Study|Treatment Discontinuation|144|||
125345199|NCT02925338|450898220|FG001|Overall Study|Treatment Discontinuation|65|||
125345200|NCT02925338|450898221|FG002|Overall Study|Treatment Discontinuation|56|||
125345201|NCT02925338|450898222|FG003|Overall Study|Treatment Discontinuation|131|||
125345202|NCT02925338|450898223|FG004|Overall Study|Treatment Discontinuation|22|||
125345203|NCT02509117|450898224|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125345204|NCT02509117|450898225|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
125345205|NCT02509117|450898226|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125345206|NCT02509117|450898227|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125345207|NCT02509117|450898228|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125345208|NCT02509117|450898229|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125345209|NCT02509117|450898230|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125345210|NCT02509117|450898231|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125345211|NCT02509117|450898232|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125345212|NCT02509117|450898233|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
125345213|NCT02509117|450898224|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125345214|NCT02509117|450898225|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125345215|NCT02509117|450898226|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125345216|NCT02509117|450898227|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125345217|NCT02509117|450898228|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125345218|NCT02509117|450898229|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125345219|NCT02509117|450898230|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125345220|NCT02509117|450898231|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125345221|NCT02509117|450898232|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
125345222|NCT02509117|450898233|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
125345223|NCT02509117|450898224|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125345224|NCT02509117|450898225|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125345225|NCT02509117|450898226|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125345226|NCT02509117|450898227|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125345227|NCT02509117|450898228|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125345228|NCT02509117|450898229|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125345229|NCT02509117|450898230|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125345230|NCT02509117|450898231|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125345231|NCT02509117|450898232|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
125345232|NCT02509117|450898233|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
125345233|NCT00548184|450898236|FG000|Overall Study|Adverse Event|3|||
125345234|NCT00548184|450898236|FG000|Overall Study|took other drug|1|||
125345235|NCT00548184|450898236|FG000|Overall Study|Found Her2 negative|1|||
125345236|NCT00636363|450898237|FG000|Overall Study|Conjunctivitis|0|||
125345237|NCT00636363|450898238|FG001|Overall Study|Conjunctivitis|0|||
125345238|NCT00636363|450898239|FG002|Overall Study|Conjunctivitis|1|||
125345239|NCT00636363|450898237|FG000|Overall Study|Adverse Event|0|||
125544570|NCT00196976|451623559|FG007|Booster Study|Withdrawal by Subject|0|||
125544571|NCT00196976|451623560|FG008|Booster Study|Withdrawal by Subject|0|||
125544572|NCT00196976|451623561|FG009|Booster Study|Withdrawal by Subject|0|||
125345240|NCT00636363|450898238|FG001|Overall Study|Adverse Event|0|||
125544573|NCT00196976|451623562|FG010|Booster Study|Withdrawal by Subject|1|||
125544574|NCT00196976|451623563|FG011|Booster Study|Withdrawal by Subject|0|||
125544575|NCT00196976|451623564|FG012|Booster Study|Withdrawal by Subject|0|||
125544576|NCT00196976|451623565|FG013|Booster Study|Withdrawal by Subject|0|||
125544577|NCT00196976|451623552|FG000|Booster Study|Lost to Follow-up|0|||
125544578|NCT00196976|451623553|FG001|Booster Study|Lost to Follow-up|0|||
125544579|NCT00196976|451623554|FG002|Booster Study|Lost to Follow-up|0|||
125544580|NCT00196976|451623555|FG003|Booster Study|Lost to Follow-up|0|||
125544581|NCT00196976|451623556|FG004|Booster Study|Lost to Follow-up|0|||
125544582|NCT00196976|451623557|FG005|Booster Study|Lost to Follow-up|0|||
125544583|NCT00196976|451623558|FG006|Booster Study|Lost to Follow-up|0|||
125544584|NCT00196976|451623559|FG007|Booster Study|Lost to Follow-up|0|||
125544585|NCT00196976|451623560|FG008|Booster Study|Lost to Follow-up|0|||
125544586|NCT00196976|451623561|FG009|Booster Study|Lost to Follow-up|0|||
125544587|NCT00196976|451623562|FG010|Booster Study|Lost to Follow-up|1|||
125544588|NCT00196976|451623563|FG011|Booster Study|Lost to Follow-up|2|||
125544589|NCT00196976|451623564|FG012|Booster Study|Lost to Follow-up|0|||
125544590|NCT00196976|451623565|FG013|Booster Study|Lost to Follow-up|0|||
125544591|NCT02689518|451623566|FG000|Overall Study|Withdrawal by Subject|3|||
125544592|NCT00825825|451623567|FG000|First Medication Period (14 Days)|Adverse Event|1|||
125345241|NCT00636363|450898239|FG002|Overall Study|Adverse Event|1|||
125345242|NCT00636363|450898237|FG000|Overall Study|Positive slit lamp finding|0|||
125345243|NCT00636363|450898238|FG001|Overall Study|Positive slit lamp finding|2|||
125345244|NCT00636363|450898239|FG002|Overall Study|Positive slit lamp finding|1|||
125345245|NCT00636363|450898237|FG000|Overall Study|Study related symptoms/complaints|8|||
125345246|NCT00636363|450898238|FG001|Overall Study|Study related symptoms/complaints|7|||
125345247|NCT00636363|450898239|FG002|Overall Study|Study related symptoms/complaints|4|||
125345248|NCT00636363|450898237|FG000|Overall Study|Met ineligibility criteria|0|||
125345249|NCT00636363|450898238|FG001|Overall Study|Met ineligibility criteria|0|||
125345250|NCT00636363|450898239|FG002|Overall Study|Met ineligibility criteria|3|||
125345251|NCT00636363|450898237|FG000|Overall Study|Missed > 1 visit|0|||
125345252|NCT00636363|450898238|FG001|Overall Study|Missed > 1 visit|1|||
125345253|NCT00636363|450898239|FG002|Overall Study|Missed > 1 visit|3|||
125345254|NCT00636363|450898237|FG000|Overall Study|Lack of motivation|1|||
125345255|NCT00636363|450898238|FG001|Overall Study|Lack of motivation|0|||
125345256|NCT00636363|450898239|FG002|Overall Study|Lack of motivation|1|||
125345257|NCT00636363|450898237|FG000|Overall Study|Protocol Violation|0|||
125345258|NCT00636363|450898238|FG001|Overall Study|Protocol Violation|3|||
125345259|NCT00636363|450898239|FG002|Overall Study|Protocol Violation|0|||
125345260|NCT00636363|450898237|FG000|Overall Study|Lost to Follow-up|3|||
125345261|NCT00636363|450898238|FG001|Overall Study|Lost to Follow-up|4|||
125345262|NCT00636363|450898239|FG002|Overall Study|Lost to Follow-up|2|||
125345263|NCT00636363|450898237|FG000|Overall Study|Withdrawal by Subject|1|||
125345264|NCT00636363|450898238|FG001|Overall Study|Withdrawal by Subject|3|||
125345265|NCT00636363|450898239|FG002|Overall Study|Withdrawal by Subject|2|||
125345266|NCT00280748|450898241|FG000|Overall Study|Decline in performance|3|||
125544593|NCT00825825|451623568|FG001|First Medication Period (14 Days)|Adverse Event|0|||
125544594|NCT00825825|451623569|FG002|First Medication Period (14 Days)|Adverse Event|0|||
125544595|NCT00825825|451623570|FG003|First Medication Period (14 Days)|Adverse Event|0|||
125544596|NCT00825825|451623571|FG004|First Medication Period (14 Days)|Adverse Event|0|||
125345267|NCT00280748|450898241|FG000|Overall Study|Extra-cranial disease progression|1|||
125345268|NCT00029146|450898242|FG000|Overall Study|Lost to Follow-up|2|||
125345269|NCT00029146|450898243|FG001|Overall Study|Lost to Follow-up|1|||
125345270|NCT03567343|450898245|FG000|Overall Study|Lost to Follow-up|2|||
125345271|NCT03567343|450898246|FG001|Overall Study|Lost to Follow-up|1|||
125345272|NCT03567343|450898245|FG000|Overall Study|No longer eligible|2|||
125345273|NCT03567343|450898246|FG001|Overall Study|No longer eligible|1|||
125345274|NCT03567343|450898245|FG000|Overall Study|Adverse Event|1|||
125345275|NCT03567343|450898246|FG001|Overall Study|Adverse Event|0|||
125345276|NCT03567343|450898245|FG000|Overall Study|Protocol Violation|1|||
125345277|NCT03567343|450898246|FG001|Overall Study|Protocol Violation|1|||
125345278|NCT03007888|450898250|FG000|First Intervention (14 Days)|Adverse Event|1|||
125345279|NCT03007888|450898251|FG001|First Intervention (14 Days)|Adverse Event|0|||
125345280|NCT01806662|450898252|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
125345281|NCT01806662|450898253|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
125345282|NCT01806662|450898252|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
125345283|NCT01806662|450898253|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
125345284|NCT01806662|450898252|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
125345285|NCT01806662|450898253|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
125345286|NCT01806662|450898252|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
125345287|NCT01806662|450898253|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
125345288|NCT00043550|450898257|FG000|Overall Study|Withdrawal by Subject|22|||
125345289|NCT00043550|450898258|FG001|Overall Study|Withdrawal by Subject|12|||
125345290|NCT00043550|450898259|FG002|Overall Study|Withdrawal by Subject|20|||
125345291|NCT00827931|450898262|FG000|Overall Study|Death|3|||
125345292|NCT00827931|450898263|FG001|Overall Study|Death|5|||
125345293|NCT00827931|450898262|FG000|Overall Study|Adverse Event|1|||
125345294|NCT00827931|450898263|FG001|Overall Study|Adverse Event|0|||
125345295|NCT00827931|450898262|FG000|Overall Study|Lost to Follow-up|1|||
125345296|NCT00827931|450898263|FG001|Overall Study|Lost to Follow-up|0|||
125345297|NCT00827931|450898262|FG000|Overall Study|Withdrawal by Subject|0|||
125345298|NCT00827931|450898263|FG001|Overall Study|Withdrawal by Subject|1|||
125345299|NCT00827931|450898262|FG000|Overall Study|Other|1|||
125345300|NCT00827931|450898263|FG001|Overall Study|Other|0|||
125345301|NCT01917656|450898267|FG000|Overall Study|Adverse Event|11|||
125345302|NCT01917656|450898268|FG001|Overall Study|Adverse Event|0|||
125345303|NCT01917656|450898267|FG000|Overall Study|Withdrawal criteria|8|||
125345304|NCT01917656|450898268|FG001|Overall Study|Withdrawal criteria|14|||
125345305|NCT01917656|450898267|FG000|Overall Study|Unclassified|0|||
125345306|NCT01917656|450898268|FG001|Overall Study|Unclassified|3|||
125345307|NCT01917656|450898267|FG000|Overall Study|Withdrawal by Subject|4|||
125345308|NCT01917656|450898268|FG001|Overall Study|Withdrawal by Subject|3|||
125345309|NCT01917656|450898267|FG000|Overall Study|Lost to Follow-up|3|||
125345310|NCT01917656|450898268|FG001|Overall Study|Lost to Follow-up|4|||
125345311|NCT02081859|450898269|FG000|Overall Study|No fertilization|2|||
125345312|NCT02081859|450898270|FG001|Overall Study|No fertilization|2|||
125345313|NCT02081859|450898269|FG000|Overall Study|No sperm|1|||
125345314|NCT02081859|450898270|FG001|Overall Study|No sperm|0|||
125345315|NCT02081859|450898269|FG000|Overall Study|Unanticipated freeze all cycle|2|||
125345316|NCT02081859|450898270|FG001|Overall Study|Unanticipated freeze all cycle|6|||
125345317|NCT02081859|450898269|FG000|Overall Study|< 4 embryos|27|||
125345318|NCT02081859|450898270|FG001|Overall Study|< 4 embryos|23|||
125345319|NCT02081859|450898269|FG000|Overall Study|Other reasons|2|||
125345320|NCT02081859|450898270|FG001|Overall Study|Other reasons|0|||
125345321|NCT00492063|450898271|FG000|Overall Study|Death|0|||
125544597|NCT00825825|451623572|FG005|First Medication Period (14 Days)|Adverse Event|1|||
125544598|NCT00825825|451623567|FG000|First Medication Period (14 Days)|Physician Decision|2|||
125544599|NCT00825825|451623568|FG001|First Medication Period (14 Days)|Physician Decision|0|||
125544600|NCT00825825|451623569|FG002|First Medication Period (14 Days)|Physician Decision|1|||
125544601|NCT00825825|451623570|FG003|First Medication Period (14 Days)|Physician Decision|0|||
125544602|NCT00825825|451623571|FG004|First Medication Period (14 Days)|Physician Decision|0|||
125544603|NCT00825825|451623572|FG005|First Medication Period (14 Days)|Physician Decision|1|||
125544604|NCT00825825|451623567|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
125544605|NCT00825825|451623568|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
125544606|NCT00825825|451623569|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
125544607|NCT00825825|451623570|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
125544608|NCT00825825|451623571|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
125544609|NCT00825825|451623572|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
125544610|NCT00825825|451623567|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
125544611|NCT00825825|451623568|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
125544612|NCT00825825|451623569|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
125544613|NCT00825825|451623570|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
125544614|NCT00825825|451623571|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
125544615|NCT00825825|451623572|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
125544616|NCT00825825|451623567|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
125544617|NCT00825825|451623568|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
125544618|NCT00825825|451623569|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
125544619|NCT00825825|451623570|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
125544620|NCT00825825|451623571|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
125544621|NCT00825825|451623572|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
125544622|NCT00825825|451623567|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
125544623|NCT00825825|451623568|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
125544624|NCT00825825|451623569|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
125544625|NCT00825825|451623570|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
125544626|NCT00825825|451623571|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
125544627|NCT00825825|451623572|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
125544628|NCT00825825|451623567|FG000|Third Medication Period (14 Days)|poor data quality|0|||
125544629|NCT00825825|451623568|FG001|Third Medication Period (14 Days)|poor data quality|1|||
125544630|NCT00825825|451623569|FG002|Third Medication Period (14 Days)|poor data quality|0|||
125345322|NCT00492063|450898272|FG001|Overall Study|Death|0|||
125345323|NCT00492063|450898273|FG002|Overall Study|Death|1|||
125345324|NCT00492063|450898274|FG003|Overall Study|Death|2|||
125345325|NCT00492063|450898271|FG000|Overall Study|Withdrawal by Subject|4|||
125345326|NCT00492063|450898272|FG001|Overall Study|Withdrawal by Subject|3|||
125345327|NCT00492063|450898273|FG002|Overall Study|Withdrawal by Subject|5|||
125345328|NCT00492063|450898274|FG003|Overall Study|Withdrawal by Subject|4|||
125345329|NCT00492063|450898271|FG000|Overall Study|Lost to Follow-up|6|||
125345330|NCT00492063|450898272|FG001|Overall Study|Lost to Follow-up|11|||
125345331|NCT00492063|450898273|FG002|Overall Study|Lost to Follow-up|5|||
125345332|NCT00492063|450898274|FG003|Overall Study|Lost to Follow-up|3|||
125345333|NCT00492063|450898271|FG000|Overall Study|Protocol Violation|0|||
125345334|NCT00492063|450898272|FG001|Overall Study|Protocol Violation|0|||
125345335|NCT00492063|450898273|FG002|Overall Study|Protocol Violation|0|||
125345336|NCT00492063|450898274|FG003|Overall Study|Protocol Violation|1|||
125345337|NCT01870076|450898281|FG000|Overall Study|Withdrawal by Subject|1|||
125345338|NCT01870076|450898282|FG001|Overall Study|Withdrawal by Subject|0|||
125345339|NCT01870076|450898283|FG002|Overall Study|Withdrawal by Subject|1|||
125345340|NCT01870076|450898284|FG003|Overall Study|Withdrawal by Subject|0|||
125345341|NCT00510653|450898289|FG000|Overall Study|Withdrawal by Subject|8|||
125345342|NCT00510653|450898289|FG000|Overall Study|Monetary|3|||
125345343|NCT01947855|450898290|FG000|Overall Study|Withdrawal by Subject|1|||
125544631|NCT00825825|451623570|FG003|Third Medication Period (14 Days)|poor data quality|0|||
125544632|NCT00825825|451623571|FG004|Third Medication Period (14 Days)|poor data quality|0|||
125680435|NCT04455633|452120634|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
125680436|NCT04455633|452120635|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
125680437|NCT04455633|452120633|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
125680438|NCT04455633|452120634|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
125345344|NCT01947855|450898291|FG001|Overall Study|Withdrawal by Subject|0|||
125345345|NCT01947855|450898292|FG002|Overall Study|Withdrawal by Subject|0|||
125544633|NCT00825825|451623572|FG005|Third Medication Period (14 Days)|poor data quality|0|||
125680439|NCT04455633|452120635|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
125345346|NCT00436501|450898293|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
125345347|NCT00436501|450898294|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
125345348|NCT00436501|450898293|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
125544634|NCT01920854|451623573|FG000|Overall Study|Withdrawal by Subject|1|||
125544635|NCT01920854|451623574|FG001|Overall Study|Withdrawal by Subject|0|||
125544636|NCT01920854|451623575|FG002|Overall Study|Withdrawal by Subject|0|||
125544637|NCT01920854|451623576|FG003|Overall Study|Withdrawal by Subject|0|||
125544638|NCT01920854|451623577|FG004|Overall Study|Withdrawal by Subject|1|||
125544639|NCT01920854|451623578|FG005|Overall Study|Withdrawal by Subject|0|||
125544640|NCT01920854|451623579|FG006|Overall Study|Withdrawal by Subject|1|||
125544641|NCT00757783|451623580|FG000|Overall Study|Adverse Event|0|||
125544642|NCT00757783|451623581|FG001|Overall Study|Adverse Event|2|||
125544643|NCT00757783|451623580|FG000|Overall Study|Lost to Follow-up|1|||
125544644|NCT00757783|451623581|FG001|Overall Study|Lost to Follow-up|1|||
125544645|NCT00757783|451623580|FG000|Overall Study|Protocol Violation|1|||
125544646|NCT00757783|451623581|FG001|Overall Study|Protocol Violation|0|||
125544647|NCT00757783|451623580|FG000|Overall Study|Withdrawal by Subject|2|||
125544648|NCT00757783|451623581|FG001|Overall Study|Withdrawal by Subject|1|||
125544649|NCT00757783|451623580|FG000|Overall Study|Other|1|||
125544650|NCT00757783|451623581|FG001|Overall Study|Other|2|||
125544651|NCT02054520|451623582|FG000|Overall Study|Adverse Event|1|||
125544652|NCT02054520|451623583|FG001|Overall Study|Adverse Event|4|||
125544653|NCT02054520|451623584|FG002|Overall Study|Adverse Event|2|||
125544654|NCT02054520|451623585|FG003|Overall Study|Adverse Event|1|||
125544655|NCT02054520|451623586|FG004|Overall Study|Adverse Event|1|||
125544656|NCT02054520|451623587|FG005|Overall Study|Adverse Event|0|||
125544657|NCT02054520|451623582|FG000|Overall Study|Lack of Efficacy|7|||
125544658|NCT02054520|451623583|FG001|Overall Study|Lack of Efficacy|0|||
125544659|NCT02054520|451623584|FG002|Overall Study|Lack of Efficacy|2|||
125544660|NCT02054520|451623585|FG003|Overall Study|Lack of Efficacy|1|||
125544661|NCT02054520|451623586|FG004|Overall Study|Lack of Efficacy|3|||
125544662|NCT02054520|451623587|FG005|Overall Study|Lack of Efficacy|2|||
125544663|NCT02054520|451623582|FG000|Overall Study|Withdrawal by Subject|1|||
125544664|NCT02054520|451623583|FG001|Overall Study|Withdrawal by Subject|0|||
125544665|NCT02054520|451623584|FG002|Overall Study|Withdrawal by Subject|0|||
125544666|NCT02054520|451623585|FG003|Overall Study|Withdrawal by Subject|2|||
125544667|NCT02054520|451623586|FG004|Overall Study|Withdrawal by Subject|1|||
125544668|NCT02054520|451623587|FG005|Overall Study|Withdrawal by Subject|0|||
125544669|NCT02054520|451623582|FG000|Overall Study|Physician Decision|0|||
125544670|NCT02054520|451623583|FG001|Overall Study|Physician Decision|1|||
125544671|NCT02054520|451623584|FG002|Overall Study|Physician Decision|0|||
125544672|NCT02054520|451623585|FG003|Overall Study|Physician Decision|1|||
125544673|NCT02054520|451623586|FG004|Overall Study|Physician Decision|0|||
125544674|NCT02054520|451623587|FG005|Overall Study|Physician Decision|1|||
125544675|NCT02054520|451623582|FG000|Overall Study|Study terminated by Sponsor|0|||
125544676|NCT02054520|451623583|FG001|Overall Study|Study terminated by Sponsor|0|||
125544677|NCT02054520|451623584|FG002|Overall Study|Study terminated by Sponsor|2|||
125544678|NCT02054520|451623585|FG003|Overall Study|Study terminated by Sponsor|1|||
125544679|NCT02054520|451623586|FG004|Overall Study|Study terminated by Sponsor|0|||
125544680|NCT02054520|451623587|FG005|Overall Study|Study terminated by Sponsor|0|||
125544681|NCT02372136|451623592|FG000|Overall Study|Death|3|||
125544682|NCT02372136|451623593|FG001|Overall Study|Death|1|||
125544683|NCT00985946|451623594|FG000|Overall Study|Lost to Follow-up|6|||
125544684|NCT00985946|451623594|FG000|Overall Study|Withdrawal by Subject|1|||
125544685|NCT02471833|451623595|FG000|Overall Study|Lost to Follow-up|1|||
125544686|NCT02471833|451623596|FG001|Overall Study|Lost to Follow-up|0|||
125544687|NCT02471833|451623597|FG002|Overall Study|Lost to Follow-up|0|||
125544688|NCT02471833|451623595|FG000|Overall Study|Withdrawal by Subject|2|||
125544689|NCT02471833|451623596|FG001|Overall Study|Withdrawal by Subject|1|||
125544690|NCT02471833|451623597|FG002|Overall Study|Withdrawal by Subject|5|||
125544691|NCT03965351|451623599|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
125544692|NCT03965351|451623600|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
125544693|NCT03965351|451623599|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
125544694|NCT03965351|451623600|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
125544695|NCT00490724|451623601|FG000|Period I|Physician Decision|0|||
125544696|NCT00490724|451623602|FG001|Period I|Physician Decision|0|||
125544697|NCT00490724|451623603|FG002|Period I|Physician Decision|1|||
125544698|NCT00490724|451623601|FG000|Period II|Treatment Discontinuation|3|||
125544699|NCT00490724|451623602|FG001|Period II|Treatment Discontinuation|1|||
125544700|NCT00490724|451623603|FG002|Period II|Treatment Discontinuation|3|||
125544701|NCT00994682|451623604|FG000|Double Bilnd|Withdrawal by Subject|5|||
125544702|NCT00994682|451623605|FG001|Double Bilnd|Withdrawal by Subject|6|||
125544703|NCT00994682|451623604|FG000|Double Bilnd|Lost to Follow-up|3|||
125544704|NCT00994682|451623605|FG001|Double Bilnd|Lost to Follow-up|3|||
125544705|NCT00994682|451623604|FG000|Double Bilnd|Adverse Event|1|||
125544706|NCT00994682|451623605|FG001|Double Bilnd|Adverse Event|0|||
125544707|NCT00994682|451623604|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
125544708|NCT00994682|451623605|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
125544709|NCT00994682|451623604|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
125544710|NCT00994682|451623605|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
125544711|NCT00994682|451623604|FG000|Pioglitazone Open Label|Physician Decision|6|||
125544712|NCT00994682|451623605|FG001|Pioglitazone Open Label|Physician Decision|1|||
125544713|NCT02859324|451623608|FG000|Overall Study|Death|4|||
125544714|NCT02859324|451623609|FG001|Overall Study|Death|6|||
125544715|NCT02859324|451623610|FG002|Overall Study|Death|5|||
125544716|NCT02859324|451623608|FG000|Overall Study|Other reasons|3|||
125544717|NCT02859324|451623609|FG001|Overall Study|Other reasons|3|||
125544718|NCT02859324|451623610|FG002|Overall Study|Other reasons|0|||
125544719|NCT00112047|451623613|FG000|Randomized Phase|Lost to Follow-up|26|||
125544720|NCT00112047|451623614|FG001|Randomized Phase|Lost to Follow-up|33|||
125544721|NCT00112047|451623613|FG000|Randomized Phase|Adverse Event|10|||
125544722|NCT00112047|451623614|FG001|Randomized Phase|Adverse Event|10|||
125544723|NCT00112047|451623613|FG000|Randomized Phase|Withrawal of consent|10|||
125544724|NCT00112047|451623614|FG001|Randomized Phase|Withrawal of consent|18|||
125544725|NCT00112047|451623613|FG000|Randomized Phase|Sub-optimal virological response|3|||
125544726|NCT00112047|451623614|FG001|Randomized Phase|Sub-optimal virological response|13|||
125544727|NCT00112047|451623613|FG000|Randomized Phase|Noncompliance|8|||
125544728|NCT00112047|451623614|FG001|Randomized Phase|Noncompliance|4|||
125544729|NCT00112047|451623613|FG000|Randomized Phase|Protocol Violation|2|||
125544730|NCT00112047|451623614|FG001|Randomized Phase|Protocol Violation|0|||
125544731|NCT00112047|451623613|FG000|Randomized Phase|Pregnancy|3|||
125544732|NCT00112047|451623614|FG001|Randomized Phase|Pregnancy|1|||
125544733|NCT00112047|451623613|FG000|Randomized Phase|Death|1|||
125544734|NCT00112047|451623614|FG001|Randomized Phase|Death|3|||
125544735|NCT00112047|451623613|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
125544736|NCT00112047|451623614|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
125544737|NCT00112047|451623613|FG000|Randomized Phase|Inability to swallow pills|0|||
125544738|NCT00112047|451623614|FG001|Randomized Phase|Inability to swallow pills|1|||
125544739|NCT00112047|451623613|FG000|Randomized Phase|Incarceration|3|||
125544740|NCT00112047|451623614|FG001|Randomized Phase|Incarceration|2|||
125544741|NCT00112047|451623613|FG000|Randomized Phase|Moved out of State|0|||
125544742|NCT00112047|451623614|FG001|Randomized Phase|Moved out of State|1|||
125544743|NCT00112047|451623613|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
125544744|NCT00112047|451623614|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
125544745|NCT00112047|451623613|FG000|Randomized Phase|High Hepatitis B DNA|0|||
125544746|NCT00112047|451623614|FG001|Randomized Phase|High Hepatitis B DNA|1|||
125544747|NCT00112047|451623613|FG000|Atripla Phase|Adverse Event|2|||
125544748|NCT00112047|451623614|FG001|Atripla Phase|Adverse Event|1|||
125544749|NCT00112047|451623613|FG000|Atripla Phase|Lost to Follow-up|5|||
125544750|NCT00112047|451623614|FG001|Atripla Phase|Lost to Follow-up|7|||
125544751|NCT00112047|451623613|FG000|Atripla Phase|Pregnancy|0|||
125544752|NCT00112047|451623614|FG001|Atripla Phase|Pregnancy|1|||
125544753|NCT00112047|451623613|FG000|Atripla Phase|Death|0|||
125544754|NCT00112047|451623614|FG001|Atripla Phase|Death|2|||
125544755|NCT00112047|451623613|FG000|Atripla Phase|Withdrew consent|7|||
125544756|NCT00112047|451623614|FG001|Atripla Phase|Withdrew consent|7|||
125544757|NCT00112047|451623613|FG000|Atripla Phase|Sub-optimal virological response|0|||
125544758|NCT00112047|451623614|FG001|Atripla Phase|Sub-optimal virological response|1|||
125544759|NCT00112047|451623613|FG000|Atripla Phase|Non-compliance|1|||
125345349|NCT00436501|450898294|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
125345350|NCT03011892|450898296|FG000|Double Blind (DB) Period|Adverse Event|0|||
125544760|NCT00112047|451623614|FG001|Atripla Phase|Non-compliance|0|||
125544761|NCT00112047|451623613|FG000|Atripla Phase|Other|3|||
125544762|NCT00112047|451623614|FG001|Atripla Phase|Other|1|||
125544763|NCT01307579|451623615|FG000|Overall Study|Death|3|||
125544764|NCT01307579|451623616|FG001|Overall Study|Death|6|||
125544765|NCT01307579|451623615|FG000|Overall Study|Physician Decision|26|||
125544766|NCT01307579|451623616|FG001|Overall Study|Physician Decision|29|||
125544767|NCT01307579|451623615|FG000|Overall Study|Withdrawal by Subject|7|||
125544768|NCT01307579|451623616|FG001|Overall Study|Withdrawal by Subject|3|||
125544769|NCT01307579|451623615|FG000|Overall Study|Institutional diagnosis of IFD|21|||
125544770|NCT01307579|451623616|FG001|Overall Study|Institutional diagnosis of IFD|36|||
125544771|NCT01307579|451623615|FG000|Overall Study|Begin conditioning for HSCT|42|||
125544772|NCT01307579|451623616|FG001|Overall Study|Begin conditioning for HSCT|44|||
125210689|NCT04299048|450395637|FG000|Overall Study|Global deterioration of health status|2|||
125210690|NCT04299048|450395637|FG000|Overall Study|Enrolled and not treated|1|||
125210691|NCT01706575|450395638|FG000|Overall Study|Participant Withdrew Consent|4|||
125210692|NCT01706575|450395638|FG000|Overall Study|Lost to Follow-up|2|||
125210693|NCT01706575|450395638|FG000|Overall Study|Started but not Treated|6|||
125345351|NCT03011892|450898297|FG001|Double Blind (DB) Period|Adverse Event|1|||
125345352|NCT03011892|450898298|FG002|Double Blind (DB) Period|Adverse Event|1|||
125345353|NCT03011892|450898299|FG003|Double Blind (DB) Period|Adverse Event|0|||
125345354|NCT03011892|450898300|FG004|Double Blind (DB) Period|Adverse Event|0|||
125345355|NCT03011892|450898301|FG005|Double Blind (DB) Period|Adverse Event|0|||
125345356|NCT03011892|450898302|FG006|Double Blind (DB) Period|Adverse Event|0|||
125345357|NCT03011892|450898303|FG007|Double Blind (DB) Period|Adverse Event|0|||
125345358|NCT03011892|450898304|FG008|Double Blind (DB) Period|Adverse Event|0|||
125345359|NCT03011892|450898305|FG009|Double Blind (DB) Period|Adverse Event|0|||
125345360|NCT03011892|450898306|FG010|Double Blind (DB) Period|Adverse Event|0|||
125345361|NCT03011892|450898307|FG011|Double Blind (DB) Period|Adverse Event|0|||
125345362|NCT03011892|450898296|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
125345363|NCT03011892|450898297|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
125345364|NCT03011892|450898298|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
125345365|NCT03011892|450898299|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
125345366|NCT03011892|450898300|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
125345367|NCT03011892|450898301|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
125345368|NCT03011892|450898302|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
125345369|NCT03011892|450898303|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
125345370|NCT03011892|450898304|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
125345371|NCT03011892|450898305|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
125345372|NCT03011892|450898306|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
125345373|NCT03011892|450898307|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
125345374|NCT03011892|450898296|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
125345375|NCT03011892|450898297|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
125345376|NCT03011892|450898298|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
125345377|NCT03011892|450898299|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
125345378|NCT03011892|450898300|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
125345379|NCT03011892|450898301|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
125345380|NCT03011892|450898302|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
125345381|NCT03011892|450898303|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
125345382|NCT03011892|450898304|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
125345383|NCT03011892|450898305|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
125345384|NCT03011892|450898306|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
125345385|NCT03011892|450898307|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
125345386|NCT03011892|450898296|FG000|Double Blind (DB) Period|Other|1|||
125345387|NCT03011892|450898297|FG001|Double Blind (DB) Period|Other|1|||
125345388|NCT03011892|450898298|FG002|Double Blind (DB) Period|Other|1|||
125345389|NCT03011892|450898299|FG003|Double Blind (DB) Period|Other|0|||
125345390|NCT03011892|450898300|FG004|Double Blind (DB) Period|Other|1|||
125345391|NCT03011892|450898301|FG005|Double Blind (DB) Period|Other|0|||
125345392|NCT03011892|450898302|FG006|Double Blind (DB) Period|Other|0|||
125345393|NCT03011892|450898303|FG007|Double Blind (DB) Period|Other|0|||
125345394|NCT03011892|450898304|FG008|Double Blind (DB) Period|Other|0|||
125345395|NCT03011892|450898305|FG009|Double Blind (DB) Period|Other|0|||
125345396|NCT03011892|450898306|FG010|Double Blind (DB) Period|Other|0|||
125345397|NCT03011892|450898307|FG011|Double Blind (DB) Period|Other|0|||
125345398|NCT03011892|450898296|FG000|Double Blind (DB) Period|Physician Decision|1|||
125345399|NCT03011892|450898297|FG001|Double Blind (DB) Period|Physician Decision|0|||
125345400|NCT03011892|450898298|FG002|Double Blind (DB) Period|Physician Decision|1|||
125345401|NCT03011892|450898299|FG003|Double Blind (DB) Period|Physician Decision|0|||
125345402|NCT03011892|450898300|FG004|Double Blind (DB) Period|Physician Decision|0|||
125345403|NCT03011892|450898301|FG005|Double Blind (DB) Period|Physician Decision|0|||
125345404|NCT03011892|450898302|FG006|Double Blind (DB) Period|Physician Decision|0|||
125345405|NCT03011892|450898303|FG007|Double Blind (DB) Period|Physician Decision|0|||
125345406|NCT03011892|450898304|FG008|Double Blind (DB) Period|Physician Decision|0|||
125210694|NCT02536781|450395655|FG000|Overall Study|Lost to Follow-up|2|||
125210695|NCT02536781|450395656|FG001|Overall Study|Lost to Follow-up|0|||
125345407|NCT03011892|450898305|FG009|Double Blind (DB) Period|Physician Decision|0|||
125345408|NCT03011892|450898306|FG010|Double Blind (DB) Period|Physician Decision|0|||
125345409|NCT03011892|450898307|FG011|Double Blind (DB) Period|Physician Decision|0|||
125345410|NCT03011892|450898296|FG000|Double Blind (DB) Period|Pregnancy|0|||
125210696|NCT03423147|450395657|FG000|Overall Study|Lost to Follow-up|5|||
125210697|NCT03423147|450395658|FG001|Overall Study|Lost to Follow-up|8|||
125345411|NCT03011892|450898297|FG001|Double Blind (DB) Period|Pregnancy|0|||
125345412|NCT03011892|450898298|FG002|Double Blind (DB) Period|Pregnancy|0|||
125345413|NCT03011892|450898299|FG003|Double Blind (DB) Period|Pregnancy|0|||
125544773|NCT01307579|451623615|FG000|Overall Study|Refractory or relapsed AML|38|||
125210698|NCT03423147|450395657|FG000|Overall Study|Withdrawal by Subject|1|||
125345414|NCT03011892|450898300|FG004|Double Blind (DB) Period|Pregnancy|1|||
125345415|NCT03011892|450898301|FG005|Double Blind (DB) Period|Pregnancy|0|||
125345416|NCT03011892|450898302|FG006|Double Blind (DB) Period|Pregnancy|0|||
125345417|NCT03011892|450898303|FG007|Double Blind (DB) Period|Pregnancy|0|||
125345418|NCT03011892|450898304|FG008|Double Blind (DB) Period|Pregnancy|0|||
125345419|NCT03011892|450898305|FG009|Double Blind (DB) Period|Pregnancy|0|||
125345420|NCT03011892|450898306|FG010|Double Blind (DB) Period|Pregnancy|0|||
125345421|NCT03011892|450898307|FG011|Double Blind (DB) Period|Pregnancy|0|||
125345422|NCT03011892|450898296|FG000|Double Blind (DB) Period|Protocol Violation|1|||
125345423|NCT03011892|450898297|FG001|Double Blind (DB) Period|Protocol Violation|0|||
125345424|NCT03011892|450898298|FG002|Double Blind (DB) Period|Protocol Violation|0|||
125345425|NCT03011892|450898299|FG003|Double Blind (DB) Period|Protocol Violation|0|||
125345426|NCT03011892|450898300|FG004|Double Blind (DB) Period|Protocol Violation|0|||
125345427|NCT03011892|450898301|FG005|Double Blind (DB) Period|Protocol Violation|0|||
125544774|NCT01307579|451623616|FG001|Overall Study|Refractory or relapsed AML|23|||
125544775|NCT01307579|451623615|FG000|Overall Study|Ineligible|3|||
125544776|NCT01307579|451623616|FG001|Overall Study|Ineligible|4|||
125544777|NCT00812331|451625337|FG000|Overall Study|Adverse Event|1|||
125544778|NCT00812331|451625338|FG001|Overall Study|Adverse Event|0|||
125544779|NCT00812331|451625339|FG002|Overall Study|Adverse Event|0|||
125544780|NCT00812331|451625340|FG003|Overall Study|Adverse Event|0|||
125544781|NCT00812331|451625341|FG004|Overall Study|Adverse Event|0|||
125544782|NCT01506453|451625342|FG000|Overall Study|Withdrawal prior to treatment|0|||
125544783|NCT01506453|451625343|FG001|Overall Study|Withdrawal prior to treatment|2|||
125544784|NCT00055601|451625344|FG000|Overall Study|Protocol Violation|1|||
125544785|NCT00055601|451625345|FG001|Overall Study|Protocol Violation|1|||
125544786|NCT00055601|451625344|FG000|Overall Study|No protocol treatment received|1|||
125544787|NCT00055601|451625345|FG001|Overall Study|No protocol treatment received|1|||
125544788|NCT00117845|451625346|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
125544789|NCT00484289|451625347|FG000|Long Term Phase|Adverse Event|1|||
125544790|NCT00484289|451625348|FG001|Long Term Phase|Adverse Event|17|||
125544791|NCT00484289|451625349|FG002|Long Term Phase|Adverse Event|5|||
125544792|NCT00484289|451625347|FG000|Long Term Phase|Withdrawal by Subject|0|||
125544793|NCT00484289|451625348|FG001|Long Term Phase|Withdrawal by Subject|7|||
125544794|NCT00484289|451625349|FG002|Long Term Phase|Withdrawal by Subject|6|||
125544795|NCT00484289|451625347|FG000|Long Term Phase|Inadequate response|2|||
125544796|NCT00484289|451625348|FG001|Long Term Phase|Inadequate response|7|||
125544797|NCT00484289|451625349|FG002|Long Term Phase|Inadequate response|4|||
125544798|NCT00484289|451625347|FG000|Long Term Phase|Other Reason|0|||
125544799|NCT00484289|451625348|FG001|Long Term Phase|Other Reason|5|||
125544800|NCT00484289|451625349|FG002|Long Term Phase|Other Reason|1|||
125544801|NCT00484289|451625347|FG000|Post Marketing Phase|Adverse Event|0|||
125544802|NCT00484289|451625348|FG001|Post Marketing Phase|Adverse Event|1|||
125544803|NCT00484289|451625349|FG002|Post Marketing Phase|Adverse Event|0|||
125544804|NCT02349425|451625350|FG000|Period 1|Adverse Event|1|||
125544805|NCT02349425|451625351|FG001|Period 1|Adverse Event|1|||
125544806|NCT02349425|451625352|FG002|Period 1|Adverse Event|0|||
125544807|NCT02349425|451625353|FG003|Period 1|Adverse Event|0|||
125544808|NCT02349425|451625350|FG000|Period 2|Adverse Event|0|||
125544809|NCT02349425|451625351|FG001|Period 2|Adverse Event|1|||
125544810|NCT02349425|451625352|FG002|Period 2|Adverse Event|1|||
125544811|NCT02349425|451625353|FG003|Period 2|Adverse Event|0|||
125544812|NCT01403610|451625354|FG000|Overall Study|Withdrawal by Subject|2|||
125544813|NCT01403610|451625355|FG001|Overall Study|Withdrawal by Subject|0|||
125544814|NCT01403610|451625356|FG002|Overall Study|Withdrawal by Subject|0|||
125544815|NCT01403610|451625357|FG003|Overall Study|Withdrawal by Subject|0|||
125544816|NCT01403610|451625354|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
125544817|NCT01403610|451625355|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
125544818|NCT01403610|451625356|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
125345428|NCT03011892|450898302|FG006|Double Blind (DB) Period|Protocol Violation|0|||
125544819|NCT01403610|451625357|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
125544820|NCT00876928|451625358|FG000|Overall Study|Lost to Follow-up|2|||
125544821|NCT00876928|451625359|FG001|Overall Study|Lost to Follow-up|5|||
125544822|NCT00876928|451625358|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
125544823|NCT00876928|451625359|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
125544824|NCT00686725|451625362|FG000|Overall Study|Adverse Event|1|||
125544825|NCT00686725|451625363|FG001|Overall Study|Adverse Event|1|||
125544826|NCT00686725|451625362|FG000|Overall Study|Progressive Disease|17|||
125544827|NCT00686725|451625363|FG001|Overall Study|Progressive Disease|23|||
125544828|NCT00686725|451625362|FG000|Overall Study|Lost to Follow-up|7|||
125544829|NCT00686725|451625363|FG001|Overall Study|Lost to Follow-up|5|||
125544830|NCT00686725|451625362|FG000|Overall Study|Death|6|||
125544831|NCT00686725|451625363|FG001|Overall Study|Death|3|||
125544832|NCT00686725|451625362|FG000|Overall Study|Withdrawal by Subject|13|||
125345429|NCT03011892|450898303|FG007|Double Blind (DB) Period|Protocol Violation|0|||
125544833|NCT00686725|451625363|FG001|Overall Study|Withdrawal by Subject|4|||
125210699|NCT03423147|450395658|FG001|Overall Study|Withdrawal by Subject|0|||
125210700|NCT03423147|450395657|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
125210701|NCT03423147|450395658|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
125210702|NCT03423147|450395657|FG000|Overall Study|Age < 18|1|||
125210703|NCT03423147|450395658|FG001|Overall Study|Age < 18|0|||
125210704|NCT03423147|450395657|FG000|Overall Study|No Trial of Labor|0|||
125210705|NCT03423147|450395658|FG001|Overall Study|No Trial of Labor|1|||
125210706|NCT02069093|450395659|FG000|Overall Study|Disease progression|14|||
125210707|NCT02069093|450395659|FG000|Overall Study|New cancer therapy|1|||
125345430|NCT03011892|450898304|FG008|Double Blind (DB) Period|Protocol Violation|0|||
125345431|NCT03011892|450898305|FG009|Double Blind (DB) Period|Protocol Violation|0|||
125345432|NCT03011892|450898306|FG010|Double Blind (DB) Period|Protocol Violation|0|||
125345433|NCT03011892|450898307|FG011|Double Blind (DB) Period|Protocol Violation|0|||
125345434|NCT03011892|450898296|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
125345435|NCT03011892|450898297|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
125345436|NCT03011892|450898298|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
125345437|NCT03011892|450898299|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
125345438|NCT03011892|450898300|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
125345439|NCT03011892|450898301|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
125345440|NCT03011892|450898302|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
125345441|NCT03011892|450898303|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
125345442|NCT03011892|450898304|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
125345443|NCT03011892|450898305|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
125345444|NCT03011892|450898306|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
125345445|NCT03011892|450898307|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
125345446|NCT03011892|450898296|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
125345447|NCT03011892|450898297|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
125345448|NCT03011892|450898298|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
125345449|NCT03011892|450898299|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
125345450|NCT03011892|450898300|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
125345451|NCT03011892|450898301|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
125680440|NCT04455633|452120633|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
125680441|NCT04455633|452120634|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
125680442|NCT04455633|452120635|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
125680443|NCT04455633|452120633|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
125680444|NCT04455633|452120634|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
125680445|NCT04455633|452120635|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
125680446|NCT02532764|452120636|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
125680447|NCT02532764|452120637|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
125680448|NCT02532764|452120638|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
125680449|NCT02532764|452120639|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
125680450|NCT02532764|452120640|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
125680451|NCT02532764|452120641|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
125680452|NCT02532764|452120642|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
125680453|NCT02532764|452120643|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
125680454|NCT02532764|452120644|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
125680455|NCT02532764|452120645|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
125680456|NCT01717976|452120646|FG000|Overall Study|Protocol Violation|0|||
125680457|NCT01717976|452120647|FG001|Overall Study|Protocol Violation|1|||
125680458|NCT00727571|452120652|FG000|Overall Study|Ineligibility determined|1|||
125680459|NCT00727571|452120653|FG001|Overall Study|Ineligibility determined|1|||
125680460|NCT00727571|452120654|FG002|Overall Study|Ineligibility determined|1|||
125680461|NCT00727571|452120655|FG003|Overall Study|Ineligibility determined|0|||
125210708|NCT02069093|450395659|FG000|Overall Study|Death|1|||
125210709|NCT02069093|450395659|FG000|Overall Study|Administrative problems|1|||
125544834|NCT00686725|451625362|FG000|Overall Study|Protocol Violation|1|||
125544835|NCT00686725|451625363|FG001|Overall Study|Protocol Violation|3|||
125544836|NCT00686725|451625362|FG000|Overall Study|Other|1|||
125544837|NCT00686725|451625363|FG001|Overall Study|Other|3|||
125544838|NCT03064035|451625366|FG000|Overall Study|Did not receive allocated intervention|4|||
125544839|NCT03064035|451625367|FG001|Overall Study|Did not receive allocated intervention|2|||
125544840|NCT03064035|451625366|FG000|Overall Study|Lost to Follow-up|1|||
125544841|NCT03064035|451625367|FG001|Overall Study|Lost to Follow-up|1|||
125544842|NCT03103763|451625368|FG000|Overall Study|Death|15|||
125544843|NCT03103763|451625369|FG001|Overall Study|Death|5|||
125544844|NCT03103763|451625370|FG002|Overall Study|Death|5|||
125544845|NCT03103763|451625368|FG000|Overall Study|Withdrawal by Subject|0|||
125544846|NCT03103763|451625369|FG001|Overall Study|Withdrawal by Subject|3|||
125544847|NCT03103763|451625370|FG002|Overall Study|Withdrawal by Subject|2|||
125544848|NCT01143038|451625371|FG000|Overall Study|Withdrawal by Subject|4|||
125544849|NCT01143038|451625371|FG000|Overall Study|Requirement for alternative therapy|5|||
125544850|NCT01143038|451625371|FG000|Overall Study|Adverse Event|3|||
125544851|NCT01143038|451625371|FG000|Overall Study|Lost to Follow-up|2|||
125544852|NCT01143038|451625371|FG000|Overall Study|Protocol Deviation|1|||
125544853|NCT01143038|451625371|FG000|Overall Study|Death|1|||
125544854|NCT01970345|451625372|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
125544855|NCT01970345|451625373|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
125544856|NCT01970345|451625372|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
125544857|NCT01970345|451625373|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
125544858|NCT00558259|451625378|FG000|Overall Study|Adverse Event|50|||
125544859|NCT00558259|451625379|FG001|Overall Study|Adverse Event|81|||
125544860|NCT00558259|451625378|FG000|Overall Study|Protocol Violation|9|||
125544861|NCT00558259|451625379|FG001|Overall Study|Protocol Violation|5|||
125544862|NCT00558259|451625378|FG000|Overall Study|Withdrawal by Subject|12|||
125544863|NCT00558259|451625379|FG001|Overall Study|Withdrawal by Subject|13|||
125544864|NCT02874924|451625380|FG000|Overall Study|Adverse Event|2|||
125544865|NCT02874924|451625381|FG001|Overall Study|Adverse Event|0|||
125544866|NCT02874924|451625382|FG002|Overall Study|Adverse Event|0|||
125544867|NCT02874924|451625380|FG000|Overall Study|Withdrawal by Subject|1|||
125544868|NCT02874924|451625381|FG001|Overall Study|Withdrawal by Subject|0|||
125544869|NCT02874924|451625382|FG002|Overall Study|Withdrawal by Subject|0|||
125544870|NCT00321373|451625387|FG000|Overall Study|Adverse Event|0|||
125544871|NCT00321373|451625388|FG001|Overall Study|Adverse Event|0|||
125544872|NCT00321373|451625389|FG002|Overall Study|Adverse Event|1|||
125544873|NCT00321373|451625387|FG000|Overall Study|Lost to Follow-up|1|||
125544874|NCT00321373|451625388|FG001|Overall Study|Lost to Follow-up|0|||
125544875|NCT00321373|451625389|FG002|Overall Study|Lost to Follow-up|1|||
125544876|NCT00321373|451625387|FG000|Overall Study|Withdrawal by Subject|1|||
125544877|NCT00321373|451625388|FG001|Overall Study|Withdrawal by Subject|0|||
125544878|NCT00321373|451625389|FG002|Overall Study|Withdrawal by Subject|0|||
125680462|NCT00727571|452120652|FG000|Overall Study|Death|0|||
125680463|NCT00727571|452120653|FG001|Overall Study|Death|19|||
125680464|NCT00727571|452120654|FG002|Overall Study|Death|5|||
125680465|NCT00727571|452120655|FG003|Overall Study|Death|1|||
125680466|NCT00727571|452120652|FG000|Overall Study|Physician Decision|0|||
125680467|NCT00727571|452120653|FG001|Overall Study|Physician Decision|5|||
125680468|NCT00727571|452120654|FG002|Overall Study|Physician Decision|0|||
125680469|NCT00727571|452120655|FG003|Overall Study|Physician Decision|0|||
125680470|NCT00727571|452120652|FG000|Overall Study|Withdrawal by Subject|0|||
125680471|NCT00727571|452120653|FG001|Overall Study|Withdrawal by Subject|10|||
125680472|NCT00727571|452120654|FG002|Overall Study|Withdrawal by Subject|11|||
125680473|NCT00727571|452120655|FG003|Overall Study|Withdrawal by Subject|0|||
125680474|NCT00727571|452120652|FG000|Overall Study|Subject Non Compliance|0|||
125680475|NCT00727571|452120653|FG001|Overall Study|Subject Non Compliance|6|||
125680476|NCT00727571|452120654|FG002|Overall Study|Subject Non Compliance|0|||
125680477|NCT00727571|452120655|FG003|Overall Study|Subject Non Compliance|4|||
125680478|NCT00727571|452120652|FG000|Overall Study|Dismissed from nursing home|0|||
125680479|NCT00727571|452120653|FG001|Overall Study|Dismissed from nursing home|9|||
125680480|NCT00727571|452120654|FG002|Overall Study|Dismissed from nursing home|5|||
125680481|NCT00727571|452120655|FG003|Overall Study|Dismissed from nursing home|0|||
125680482|NCT00727571|452120652|FG000|Overall Study|Hospitalization|0|||
125680483|NCT00727571|452120653|FG001|Overall Study|Hospitalization|1|||
125544879|NCT00321373|451625387|FG000|Overall Study|Other|0|||
125544880|NCT00321373|451625388|FG001|Overall Study|Other|0|||
125544881|NCT00321373|451625389|FG002|Overall Study|Other|1|||
125544882|NCT00552240|451625393|FG000|Overall Study|Adverse Event|9|||
125544883|NCT00552240|451625394|FG001|Overall Study|Adverse Event|9|||
125544884|NCT00552240|451625393|FG000|Overall Study|Protocol Violation|1|||
125544885|NCT00552240|451625394|FG001|Overall Study|Protocol Violation|1|||
125544886|NCT00552240|451625393|FG000|Overall Study|Lost to Follow-up|5|||
125544887|NCT00552240|451625394|FG001|Overall Study|Lost to Follow-up|6|||
125544888|NCT00552240|451625393|FG000|Overall Study|Withdrawal by Subject|2|||
125544889|NCT00552240|451625394|FG001|Overall Study|Withdrawal by Subject|2|||
125544890|NCT00552240|451625393|FG000|Overall Study|Lack of Efficacy|6|||
125544891|NCT00552240|451625394|FG001|Overall Study|Lack of Efficacy|0|||
125544892|NCT00552240|451625393|FG000|Overall Study|Other|1|||
125544893|NCT00552240|451625394|FG001|Overall Study|Other|0|||
125544894|NCT02783768|451625395|FG000|Overall Study|Lost to Follow-up|1|||
125544895|NCT02783768|451625396|FG001|Overall Study|Lost to Follow-up|0|||
125544896|NCT01323647|451625397|FG000|Overall Study|Migrated/moved from study area|2|||
125544897|NCT01323647|451625398|FG001|Overall Study|Migrated/moved from study area|0|||
125544898|NCT01323647|451625397|FG000|Overall Study|Withdrawal by Subject|5|||
125544899|NCT01323647|451625398|FG001|Overall Study|Withdrawal by Subject|0|||
125544900|NCT01323647|451625397|FG000|Overall Study|Lost to Follow-up|2|||
125544901|NCT01323647|451625398|FG001|Overall Study|Lost to Follow-up|0|||
125544902|NCT01236339|451625406|FG000|Overall Study|Termination of study by sponsor|11|||
125544903|NCT01236339|451625407|FG001|Overall Study|Termination of study by sponsor|13|||
125544904|NCT02054741|451625408|FG000|Overall Study|Protocol Violation|13|||
125544905|NCT02054741|451625409|FG001|Overall Study|Protocol Violation|2|||
125544906|NCT02054741|451625408|FG000|Overall Study|Withdrawal by Subject|10|||
125544907|NCT02054741|451625409|FG001|Overall Study|Withdrawal by Subject|5|||
125544908|NCT02054741|451625408|FG000|Overall Study|Death|94|||
125544909|NCT02054741|451625409|FG001|Overall Study|Death|90|||
125544910|NCT02054741|451625408|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
125544911|NCT02054741|451625409|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
125544912|NCT01945060|451625413|FG000|Overall Study|Lost to follow up|1|||
125544913|NCT01945060|451625414|FG001|Overall Study|Lost to follow up|0|||
125544914|NCT01945060|451625413|FG000|Overall Study|Distress related to IV access|0|||
125544915|NCT01945060|451625414|FG001|Overall Study|Distress related to IV access|1|||
125544916|NCT00402597|451625415|FG000|Overall Study|Death|15|||
125544917|NCT00402597|451625416|FG001|Overall Study|Death|7|||
125544918|NCT00402597|451625417|FG002|Overall Study|Death|6|||
125544919|NCT00402597|451625418|FG003|Overall Study|Death|4|||
125544920|NCT00402597|451625419|FG004|Overall Study|Death|6|||
125544921|NCT00402597|451625415|FG000|Overall Study|Adverse Event|81|||
125544922|NCT00402597|451625416|FG001|Overall Study|Adverse Event|18|||
125544923|NCT00402597|451625417|FG002|Overall Study|Adverse Event|106|||
125544924|NCT00402597|451625418|FG003|Overall Study|Adverse Event|39|||
125544925|NCT00402597|451625419|FG004|Overall Study|Adverse Event|71|||
125544926|NCT00402597|451625415|FG000|Overall Study|Lost to Follow-up|8|||
125544927|NCT00402597|451625416|FG001|Overall Study|Lost to Follow-up|1|||
125544928|NCT00402597|451625417|FG002|Overall Study|Lost to Follow-up|8|||
125544929|NCT00402597|451625418|FG003|Overall Study|Lost to Follow-up|2|||
125544930|NCT00402597|451625419|FG004|Overall Study|Lost to Follow-up|3|||
125544931|NCT00402597|451625415|FG000|Overall Study|Withdrawal by Subject|57|||
125544932|NCT00402597|451625416|FG001|Overall Study|Withdrawal by Subject|16|||
125544933|NCT00402597|451625417|FG002|Overall Study|Withdrawal by Subject|65|||
125544934|NCT00402597|451625418|FG003|Overall Study|Withdrawal by Subject|15|||
125544935|NCT00402597|451625419|FG004|Overall Study|Withdrawal by Subject|24|||
125544936|NCT00402597|451625415|FG000|Overall Study|reason not specified|30|||
125544937|NCT00402597|451625416|FG001|Overall Study|reason not specified|4|||
125544938|NCT00402597|451625417|FG002|Overall Study|reason not specified|27|||
125544939|NCT00402597|451625418|FG003|Overall Study|reason not specified|14|||
125544940|NCT00402597|451625419|FG004|Overall Study|reason not specified|20|||
125544941|NCT02319525|451625421|FG000|Overall Study|Withdrawal by Subject|2|||
125544942|NCT02319525|451625422|FG001|Overall Study|Withdrawal by Subject|1|||
125544943|NCT00938860|451625423|FG000|Overall Study|Adverse Event|2|||
125544944|NCT00938860|451625424|FG001|Overall Study|Adverse Event|1|||
125544945|NCT00938860|451625423|FG000|Overall Study|Abnormal laboratory values|2|||
125544946|NCT00938860|451625424|FG001|Overall Study|Abnormal laboratory values|2|||
125544947|NCT00938860|451625423|FG000|Overall Study|Withdrawal by Subject|11|||
125544948|NCT00938860|451625424|FG001|Overall Study|Withdrawal by Subject|8|||
125544949|NCT00938860|451625423|FG000|Overall Study|Lost to Follow-up|4|||
125544950|NCT00938860|451625424|FG001|Overall Study|Lost to Follow-up|4|||
125544951|NCT00938860|451625423|FG000|Overall Study|Administration problems|2|||
125544952|NCT00938860|451625424|FG001|Overall Study|Administration problems|0|||
125544953|NCT00938860|451625423|FG000|Overall Study|Death|1|||
125544954|NCT00938860|451625424|FG001|Overall Study|Death|1|||
125544955|NCT00938860|451625423|FG000|Overall Study|Protocol Violation|3|||
125544956|NCT00938860|451625424|FG001|Overall Study|Protocol Violation|1|||
125544957|NCT00232544|451625425|FG000|Overall Study|Lost to Follow-up|20|||
125544958|NCT00232544|451625426|FG001|Overall Study|Lost to Follow-up|15|||
125544959|NCT00336895|451625427|FG000|Overall Study|diarrhea|1|||
125544960|NCT00336895|451625427|FG000|Overall Study|nausea and upset stomach|1|||
125544961|NCT00336895|451625427|FG000|Overall Study|Physician Decision|1|||
125544962|NCT00336895|451625427|FG000|Overall Study|screen failed|1|||
125544963|NCT00986973|451625431|FG000|Overall Study|Withdrawn by study team|1|||
125544964|NCT00598273|451625432|FG000|Overall Study|Adverse Event|4|||
125544965|NCT00598273|451625433|FG001|Overall Study|Adverse Event|5|||
125544966|NCT00598273|451625434|FG002|Overall Study|Adverse Event|2|||
125544967|NCT00598273|451625432|FG000|Overall Study|Death|6|||
125544968|NCT00598273|451625433|FG001|Overall Study|Death|12|||
125544969|NCT00598273|451625434|FG002|Overall Study|Death|8|||
125544970|NCT00598273|451625432|FG000|Overall Study|Lost to Follow-up|8|||
125544971|NCT00598273|451625433|FG001|Overall Study|Lost to Follow-up|3|||
125544972|NCT00598273|451625434|FG002|Overall Study|Lost to Follow-up|5|||
125544973|NCT00598273|451625432|FG000|Overall Study|Physician Decision|0|||
125544974|NCT00598273|451625433|FG001|Overall Study|Physician Decision|0|||
125544975|NCT00598273|451625434|FG002|Overall Study|Physician Decision|1|||
125544976|NCT00598273|451625432|FG000|Overall Study|Withdrawal by Subject|12|||
125345452|NCT03011892|450898302|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
125345453|NCT03011892|450898303|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
125345454|NCT03011892|450898304|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
125345455|NCT03011892|450898305|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
125345456|NCT03011892|450898306|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
125345457|NCT03011892|450898307|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
125345458|NCT03011892|450898296|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
125345459|NCT03011892|450898297|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
125345460|NCT03011892|450898298|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
125345461|NCT03011892|450898299|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
125345462|NCT03011892|450898300|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
125345463|NCT03011892|450898301|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
125345464|NCT03011892|450898302|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
125345465|NCT03011892|450898303|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
125345466|NCT03011892|450898304|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
125345467|NCT03011892|450898305|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
125345468|NCT03011892|450898306|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
125345469|NCT03011892|450898307|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
125345470|NCT03011892|450898296|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
125345471|NCT03011892|450898297|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
125544977|NCT00598273|451625433|FG001|Overall Study|Withdrawal by Subject|10|||
125544978|NCT00598273|451625434|FG002|Overall Study|Withdrawal by Subject|10|||
125544979|NCT00598273|451625432|FG000|Overall Study|Noncompliance|3|||
125345472|NCT03011892|450898298|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
125345473|NCT03011892|450898299|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
125345474|NCT03011892|450898300|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
125345475|NCT03011892|450898301|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
125345476|NCT03011892|450898302|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
125345477|NCT03011892|450898303|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
125345478|NCT03011892|450898304|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
125345479|NCT03011892|450898305|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
125345480|NCT03011892|450898306|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
125345481|NCT03011892|450898307|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
125345482|NCT03011892|450898296|FG000|Open Label (OL) Period|Reason not specified|0|||
125345483|NCT03011892|450898297|FG001|Open Label (OL) Period|Reason not specified|0|||
125345484|NCT03011892|450898298|FG002|Open Label (OL) Period|Reason not specified|0|||
125345485|NCT03011892|450898299|FG003|Open Label (OL) Period|Reason not specified|0|||
125345486|NCT03011892|450898300|FG004|Open Label (OL) Period|Reason not specified|0|||
125345487|NCT03011892|450898301|FG005|Open Label (OL) Period|Reason not specified|0|||
125345488|NCT03011892|450898302|FG006|Open Label (OL) Period|Reason not specified|0|||
125345489|NCT03011892|450898303|FG007|Open Label (OL) Period|Reason not specified|1|||
125345490|NCT03011892|450898304|FG008|Open Label (OL) Period|Reason not specified|0|||
125345491|NCT03011892|450898305|FG009|Open Label (OL) Period|Reason not specified|0|||
125345492|NCT03011892|450898306|FG010|Open Label (OL) Period|Reason not specified|0|||
125345493|NCT03011892|450898307|FG011|Open Label (OL) Period|Reason not specified|0|||
125345494|NCT02312687|450898308|FG000|Overall Study|Other, Not Specified|1|||
125345495|NCT00217464|450898311|FG000|Overall Study|Progression|15|||
125345496|NCT00217464|450898311|FG000|Overall Study|Other|2|||
125345497|NCT00169442|450898312|FG000|Overall Study|Withdrawal by Subject|0|||
125345498|NCT00169442|450898313|FG001|Overall Study|Withdrawal by Subject|0|||
125345499|NCT00169442|450898314|FG002|Overall Study|Withdrawal by Subject|1|||
125345500|NCT00169442|450898315|FG003|Overall Study|Withdrawal by Subject|0|||
125345501|NCT00169442|450898316|FG004|Overall Study|Withdrawal by Subject|0|||
125345502|NCT00169442|450898317|FG005|Overall Study|Withdrawal by Subject|0|||
125345503|NCT00169442|450898312|FG000|Overall Study|Migrated/moved from study area|0|||
125345504|NCT00169442|450898313|FG001|Overall Study|Migrated/moved from study area|0|||
125345505|NCT00169442|450898314|FG002|Overall Study|Migrated/moved from study area|0|||
125345506|NCT00169442|450898315|FG003|Overall Study|Migrated/moved from study area|0|||
125345507|NCT00169442|450898316|FG004|Overall Study|Migrated/moved from study area|0|||
125345508|NCT00169442|450898317|FG005|Overall Study|Migrated/moved from study area|2|||
125345509|NCT00169442|450898312|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
125345510|NCT00169442|450898313|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
125345511|NCT00169442|450898314|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
125345512|NCT00169442|450898315|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
125345513|NCT00169442|450898316|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
125345514|NCT00169442|450898317|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
125345515|NCT00169442|450898312|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
125210710|NCT02069093|450395659|FG000|Overall Study|Withdrawal by Subject|2|||
125345516|NCT00169442|450898313|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
125345517|NCT00169442|450898314|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
125345518|NCT00169442|450898315|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
125345519|NCT00169442|450898316|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
125345520|NCT00169442|450898317|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
125345521|NCT01426789|450898318|FG000|Part 1|Protocol deviation|0|||
125345522|NCT01426789|450898319|FG001|Part 1|Protocol deviation|1|||
125345523|NCT01426789|450898320|FG002|Part 1|Protocol deviation|0|||
125345524|NCT01426789|450898321|FG003|Part 1|Protocol deviation|0|||
125345525|NCT01426789|450898322|FG004|Part 1|Protocol deviation|0|||
125345526|NCT01426789|450898323|FG005|Part 1|Protocol deviation|0|||
125345527|NCT01426789|450898318|FG000|Part 1|Lost to Follow-up|1|||
125544980|NCT00598273|451625433|FG001|Overall Study|Noncompliance|2|||
125544981|NCT00598273|451625434|FG002|Overall Study|Noncompliance|3|||
125544982|NCT00598273|451625432|FG000|Overall Study|Relocation|0|||
125544983|NCT00598273|451625433|FG001|Overall Study|Relocation|2|||
125544984|NCT00598273|451625434|FG002|Overall Study|Relocation|4|||
125544985|NCT00598273|451625432|FG000|Overall Study|Renal transplant|1|||
125544986|NCT00598273|451625433|FG001|Overall Study|Renal transplant|0|||
125544987|NCT00598273|451625434|FG002|Overall Study|Renal transplant|1|||
125544988|NCT00598273|451625432|FG000|Overall Study|Site elected to close|1|||
125544989|NCT00598273|451625433|FG001|Overall Study|Site elected to close|0|||
125544990|NCT00598273|451625434|FG002|Overall Study|Site elected to close|0|||
125544991|NCT00598273|451625432|FG000|Overall Study|Started dialysis|6|||
125544992|NCT00598273|451625433|FG001|Overall Study|Started dialysis|4|||
125544993|NCT00598273|451625434|FG002|Overall Study|Started dialysis|5|||
125544994|NCT03426605|451625435|FG000|Overall Study|AML relapse or progression|2|||
125544995|NCT03426605|451625436|FG001|Overall Study|AML relapse or progression|1|||
125544996|NCT03426605|451625437|FG002|Overall Study|AML relapse or progression|2|||
125544997|NCT03426605|451625438|FG003|Overall Study|AML relapse or progression|2|||
125544998|NCT03426605|451625435|FG000|Overall Study|Treatment failure|3|||
125544999|NCT03426605|451625436|FG001|Overall Study|Treatment failure|2|||
125545000|NCT03426605|451625437|FG002|Overall Study|Treatment failure|0|||
125545001|NCT03426605|451625438|FG003|Overall Study|Treatment failure|0|||
125545002|NCT03426605|451625435|FG000|Overall Study|Adverse Event|1|||
125545003|NCT03426605|451625436|FG001|Overall Study|Adverse Event|0|||
125545004|NCT03426605|451625437|FG002|Overall Study|Adverse Event|1|||
125545005|NCT03426605|451625438|FG003|Overall Study|Adverse Event|1|||
125545006|NCT03426605|451625435|FG000|Overall Study|Withdrawal by Subject|0|||
125545007|NCT03426605|451625436|FG001|Overall Study|Withdrawal by Subject|0|||
125545008|NCT03426605|451625437|FG002|Overall Study|Withdrawal by Subject|1|||
125545009|NCT03426605|451625438|FG003|Overall Study|Withdrawal by Subject|1|||
125545010|NCT01535560|451625442|FG000|Overall Study|Adverse Event|12|||
125545011|NCT01535560|451625443|FG001|Overall Study|Adverse Event|7|||
125545012|NCT01535560|451625442|FG000|Overall Study|Lost to Follow-up|1|||
125545013|NCT01535560|451625443|FG001|Overall Study|Lost to Follow-up|3|||
125545014|NCT01535560|451625442|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
125545015|NCT01535560|451625443|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
125545016|NCT01535560|451625442|FG000|Overall Study|Treatment Failure|21|||
125545017|NCT01535560|451625443|FG001|Overall Study|Treatment Failure|83|||
125545018|NCT01535560|451625442|FG000|Overall Study|Other|0|||
125545019|NCT01535560|451625443|FG001|Overall Study|Other|1|||
125545020|NCT01535560|451625442|FG000|Overall Study|Randomized in Error|0|||
125545021|NCT01535560|451625443|FG001|Overall Study|Randomized in Error|1|||
125545022|NCT02009761|451625444|FG000|Overall Study|Adverse Event|4|||
125545023|NCT02673515|451625452|FG000|Overall Study|Lack of motivation|2|||
125545024|NCT02673515|451625453|FG001|Overall Study|Lack of motivation|1|||
125545025|NCT04227704|451625457|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
125545026|NCT04227704|451625458|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
125545027|NCT04227704|451625459|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
125545028|NCT04227704|451625457|FG000|Overall Study|due to C/S being cancelled|1|||
125545029|NCT04227704|451625458|FG001|Overall Study|due to C/S being cancelled|0|||
125345528|NCT01426789|450898319|FG001|Part 1|Lost to Follow-up|2|||
125345529|NCT01426789|450898320|FG002|Part 1|Lost to Follow-up|0|||
125545030|NCT04227704|451625459|FG002|Overall Study|due to C/S being cancelled|0|||
125545031|NCT03432260|451625470|FG000|Overall Study|Lost to Follow-up|1|||
125545032|NCT03432260|451625471|FG001|Overall Study|Lost to Follow-up|1|||
125545033|NCT03432260|451625472|FG002|Overall Study|Lost to Follow-up|0|||
125545034|NCT03432260|451625473|FG003|Overall Study|Lost to Follow-up|0|||
125345530|NCT01426789|450898321|FG003|Part 1|Lost to Follow-up|0|||
125345531|NCT01426789|450898322|FG004|Part 1|Lost to Follow-up|0|||
125545035|NCT03432260|451625474|FG004|Overall Study|Lost to Follow-up|1|||
125545036|NCT01775124|451625476|FG000|Core Period|Disease Progression|0|||
125545037|NCT01775124|451625477|FG001|Core Period|Disease Progression|1|||
125545038|NCT01775124|451625476|FG000|Core Period|Physician Decision|1|||
125545039|NCT01775124|451625477|FG001|Core Period|Physician Decision|1|||
125345532|NCT01426789|450898323|FG005|Part 1|Lost to Follow-up|0|||
125545040|NCT01775124|451625476|FG000|Core Period|Death|0|||
125545041|NCT01775124|451625477|FG001|Core Period|Death|1|||
125545042|NCT01775124|451625476|FG000|Core Period|Administrative problems|1|||
125545043|NCT01775124|451625477|FG001|Core Period|Administrative problems|0|||
125545044|NCT01775124|451625476|FG000|Core Period|Withdrawal by Subject|4|||
125545045|NCT01775124|451625477|FG001|Core Period|Withdrawal by Subject|2|||
125545046|NCT01775124|451625476|FG000|Core Period|Adverse Event|5|||
125545047|NCT01775124|451625477|FG001|Core Period|Adverse Event|5|||
125545048|NCT01775124|451625476|FG000|Extension Period|Adverse Event|3|||
125545049|NCT01775124|451625477|FG001|Extension Period|Adverse Event|2|||
125545050|NCT01775124|451625476|FG000|Extension Period|Physician Decision|0|||
125545051|NCT01775124|451625477|FG001|Extension Period|Physician Decision|2|||
125545052|NCT01775124|451625476|FG000|Extension Period|Administrative problems|0|||
125545053|NCT01775124|451625477|FG001|Extension Period|Administrative problems|1|||
125545054|NCT01775124|451625476|FG000|Extension Period|Lost to Follow-up|0|||
125545055|NCT01775124|451625477|FG001|Extension Period|Lost to Follow-up|1|||
125545056|NCT01775124|451625476|FG000|Extension Period|Withdrawal by Subject|9|||
125545057|NCT01775124|451625477|FG001|Extension Period|Withdrawal by Subject|12|||
125545058|NCT01022268|451627252|FG000|Overall Study|Withdrawal by Subject|1|||
125545059|NCT01022268|451627253|FG001|Overall Study|Withdrawal by Subject|0|||
125545060|NCT01022268|451627252|FG000|Overall Study|Withdrawal by Subject|1|||
125545061|NCT01022268|451627253|FG001|Overall Study|Withdrawal by Subject|0|||
125545062|NCT00910689|451627254|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
125545063|NCT00910689|451627255|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
125545064|NCT00910689|451627256|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
125545065|NCT00910689|451627257|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
125545066|NCT00910689|451627254|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
125545067|NCT00910689|451627255|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
125545068|NCT00910689|451627256|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
125545069|NCT00910689|451627257|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
125545070|NCT00910689|451627254|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
125545071|NCT00910689|451627255|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
125545072|NCT00910689|451627256|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
125545073|NCT00910689|451627257|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
125545074|NCT00910689|451627254|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
125545075|NCT00910689|451627255|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
125545076|NCT00910689|451627256|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
125545077|NCT00910689|451627257|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
125545078|NCT00910689|451627254|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
125545079|NCT00910689|451627255|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
125545080|NCT00910689|451627256|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
125545081|NCT00910689|451627257|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
125545082|NCT00910689|451627254|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
125545083|NCT00910689|451627255|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
125545084|NCT00910689|451627256|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
125545085|NCT00910689|451627257|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
125545086|NCT00910689|451627254|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
125545087|NCT00910689|451627255|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
125545088|NCT00910689|451627256|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
125545089|NCT00910689|451627257|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
125545090|NCT00910689|451627254|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
125545091|NCT00910689|451627255|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
125545092|NCT00910689|451627256|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
125545093|NCT00910689|451627257|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
125545094|NCT00910689|451627254|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
125545095|NCT00910689|451627255|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
125545096|NCT00910689|451627256|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
125545097|NCT00910689|451627257|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
125545098|NCT00910689|451627254|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
125545099|NCT00910689|451627255|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
125545100|NCT00910689|451627256|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
125545101|NCT00910689|451627257|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
125545102|NCT00910689|451627254|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
125680484|NCT00727571|452120654|FG002|Overall Study|Hospitalization|0|||
125680485|NCT00727571|452120655|FG003|Overall Study|Hospitalization|1|||
125680486|NCT00727571|452120652|FG000|Overall Study|AE not leading to hospitalization|0|||
125680487|NCT00727571|452120653|FG001|Overall Study|AE not leading to hospitalization|0|||
125680488|NCT00727571|452120654|FG002|Overall Study|AE not leading to hospitalization|2|||
125680489|NCT00727571|452120655|FG003|Overall Study|AE not leading to hospitalization|0|||
125680490|NCT00727571|452120652|FG000|Overall Study|Other|0|||
125680491|NCT00727571|452120653|FG001|Overall Study|Other|4|||
125680492|NCT00727571|452120654|FG002|Overall Study|Other|6|||
125680493|NCT00727571|452120655|FG003|Overall Study|Other|0|||
125545103|NCT00910689|451627255|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
125545104|NCT00910689|451627256|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
125545105|NCT00910689|451627257|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
125545106|NCT00910689|451627254|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
125545107|NCT00910689|451627255|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
125545108|NCT00910689|451627256|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
125545109|NCT00910689|451627257|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
125545110|NCT00910689|451627254|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
125545111|NCT00910689|451627255|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
125545112|NCT00910689|451627256|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
125545113|NCT00910689|451627257|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
125545114|NCT00910689|451627254|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
125545115|NCT00910689|451627255|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
125545116|NCT00910689|451627256|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
125545117|NCT00910689|451627257|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
125545118|NCT00910689|451627254|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
125545119|NCT00910689|451627255|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
125545120|NCT00910689|451627256|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
125545121|NCT00910689|451627257|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
125545122|NCT00910689|451627254|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
125545123|NCT00910689|451627255|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
125545124|NCT00910689|451627256|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
125545125|NCT00910689|451627257|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
125545126|NCT00910689|451627254|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
125545127|NCT00910689|451627255|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
125545128|NCT00910689|451627256|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
125545129|NCT00910689|451627257|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
125545130|NCT00910689|451627254|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
125545131|NCT00910689|451627255|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
125545132|NCT00910689|451627256|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
125545133|NCT00910689|451627257|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
125545134|NCT00910689|451627254|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
125545135|NCT00910689|451627255|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
125545136|NCT00910689|451627256|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
125545137|NCT00910689|451627257|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
125545138|NCT00910689|451627254|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
125545139|NCT00910689|451627255|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
125545140|NCT00910689|451627256|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
125545141|NCT00910689|451627257|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
125545142|NCT00910689|451627254|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
125545143|NCT00910689|451627255|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
125545144|NCT00910689|451627256|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
125545145|NCT00910689|451627257|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
125545146|NCT00189488|451627258|FG000|Overall Study|Ineligibility determined|1|||
125545147|NCT00189488|451627259|FG001|Overall Study|Ineligibility determined|0|||
125545148|NCT00189488|451627258|FG000|Overall Study|Protocol deviation|2|||
125545149|NCT00189488|451627259|FG001|Overall Study|Protocol deviation|1|||
125545150|NCT00189488|451627258|FG000|Overall Study|Adverse Event|2|||
125545151|NCT00189488|451627259|FG001|Overall Study|Adverse Event|1|||
125545152|NCT00189488|451627258|FG000|Overall Study|Withdrawal by Subject|2|||
125545153|NCT00189488|451627259|FG001|Overall Study|Withdrawal by Subject|6|||
125545154|NCT00189488|451627258|FG000|Overall Study|Disease progression|2|||
125545155|NCT00189488|451627259|FG001|Overall Study|Disease progression|4|||
125545156|NCT00189488|451627258|FG000|Overall Study|Administrative Decision|0|||
125545157|NCT00189488|451627259|FG001|Overall Study|Administrative Decision|2|||
125545158|NCT00189488|451627258|FG000|Overall Study|Death|5|||
125545159|NCT00189488|451627259|FG001|Overall Study|Death|8|||
125545160|NCT00189488|451627258|FG000|Overall Study|Other|1|||
125545161|NCT00189488|451627259|FG001|Overall Study|Other|0|||
125545162|NCT00192647|451627265|FG000|Overall Study|Death|1|||
125545163|NCT00192647|451627266|FG001|Overall Study|Death|1|||
125545164|NCT00192647|451627265|FG000|Overall Study|Adverse Event|35|||
125545165|NCT00192647|451627266|FG001|Overall Study|Adverse Event|29|||
125545166|NCT00192647|451627265|FG000|Overall Study|Laboratory Test Abnormality|4|||
125545167|NCT00192647|451627266|FG001|Overall Study|Laboratory Test Abnormality|2|||
125545168|NCT00192647|451627265|FG000|Overall Study|Insufficient Therapeutic Response|53|||
125545169|NCT00192647|451627266|FG001|Overall Study|Insufficient Therapeutic Response|83|||
125545170|NCT00192647|451627265|FG000|Overall Study|Entry Criteria Violation|6|||
125545171|NCT00192647|451627266|FG001|Overall Study|Entry Criteria Violation|6|||
125545172|NCT00192647|451627265|FG000|Overall Study|Protocol Violation|3|||
125345533|NCT01426789|450898318|FG000|Part 1|Lack of Efficacy|2|||
125545173|NCT00192647|451627266|FG001|Overall Study|Protocol Violation|1|||
125545174|NCT00192647|451627265|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
125545175|NCT00192647|451627266|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
125545176|NCT00192647|451627265|FG000|Overall Study|Failure to Return|11|||
125545177|NCT00192647|451627266|FG001|Overall Study|Failure to Return|13|||
125545178|NCT00192647|451627265|FG000|Overall Study|Other/Administrative|5|||
125545179|NCT00192647|451627266|FG001|Overall Study|Other/Administrative|3|||
125545180|NCT01828073|451627267|FG000|Overall Study|Lost to Follow-up|1|||
125545181|NCT01828073|451627268|FG001|Overall Study|Lost to Follow-up|2|||
125545182|NCT02915302|451627269|FG000|Overall Study|Adverse Event|3|||
125545183|NCT02915302|451627270|FG001|Overall Study|Adverse Event|0|||
125545184|NCT02915302|451627269|FG000|Overall Study|Protocol Violation|20|||
125545185|NCT02915302|451627270|FG001|Overall Study|Protocol Violation|27|||
125545186|NCT02915302|451627269|FG000|Overall Study|Lost to Follow-up|19|||
125545187|NCT02915302|451627270|FG001|Overall Study|Lost to Follow-up|22|||
125545188|NCT02915302|451627269|FG000|Overall Study|Withdrawal by Subject|22|||
125545189|NCT02915302|451627270|FG001|Overall Study|Withdrawal by Subject|29|||
125545190|NCT02915302|451627269|FG000|Overall Study|Other|1|||
125545191|NCT02915302|451627270|FG001|Overall Study|Other|0|||
125545192|NCT00690443|451627271|FG000|Overall Study|Adverse Event|1|||
125545193|NCT00690443|451627272|FG001|Overall Study|Adverse Event|2|||
125545194|NCT01877837|451627273|FG000|Overall Study|Lost to Follow-up|1|||
125545195|NCT01877837|451627273|FG000|Overall Study|Ineligible|4|||
125545196|NCT00645801|451627275|FG000|Overall Study|unclear if patient took all the medication.|1|||
125545197|NCT00645801|451627276|FG001|Overall Study|unclear if patient took all the medication.|0|||
125545198|NCT00645801|451627275|FG000|Overall Study|Lost to Follow-up|19|||
125545199|NCT00645801|451627276|FG001|Overall Study|Lost to Follow-up|15|||
125545200|NCT00705679|451627277|FG000|Overall Study|Adverse Event|1|||
125545201|NCT00705679|451627278|FG001|Overall Study|Adverse Event|1|||
125545202|NCT00705679|451627279|FG002|Overall Study|Adverse Event|0|||
125545203|NCT00705679|451627280|FG003|Overall Study|Adverse Event|0|||
125545204|NCT00705679|451627281|FG004|Overall Study|Adverse Event|0|||
125545205|NCT00705679|451627277|FG000|Overall Study|Death|0|||
125545206|NCT00705679|451627278|FG001|Overall Study|Death|0|||
125680494|NCT03164772|452120657|FG000|Overall Study|Death|4|||
125680495|NCT03164772|452120658|FG001|Overall Study|Death|2|||
125680496|NCT03164772|452120657|FG000|Overall Study|Adverse Event|1|||
125680497|NCT03164772|452120658|FG001|Overall Study|Adverse Event|4|||
125680498|NCT03164772|452120657|FG000|Overall Study|Progressive Disease|11|||
125680499|NCT03164772|452120658|FG001|Overall Study|Progressive Disease|21|||
125680500|NCT03164772|452120657|FG000|Overall Study|Physician Decision|2|||
125680501|NCT03164772|452120658|FG001|Overall Study|Physician Decision|0|||
125680502|NCT03164772|452120657|FG000|Overall Study|Withdrawal by Subject|0|||
125680503|NCT03164772|452120658|FG001|Overall Study|Withdrawal by Subject|4|||
125680504|NCT04099888|452120661|FG000|Overall Study|Study terminated by sponsor|9|||
125680505|NCT04099888|452120662|FG001|Overall Study|Study terminated by sponsor|11|||
125680506|NCT04099888|452120661|FG000|Overall Study|Lost to Follow-up|1|||
125680507|NCT04099888|452120662|FG001|Overall Study|Lost to Follow-up|1|||
125680508|NCT04099888|452120661|FG000|Overall Study|Withdrawal by Subject|5|||
125680509|NCT04099888|452120662|FG001|Overall Study|Withdrawal by Subject|6|||
125680510|NCT04099888|452120661|FG000|Overall Study|Death|5|||
125680511|NCT04099888|452120662|FG001|Overall Study|Death|2|||
125680512|NCT04099888|452120661|FG000|Overall Study|Other|1|||
125680513|NCT04099888|452120662|FG001|Overall Study|Other|0|||
125680514|NCT04538170|452120663|FG000|Overall Study|Withdrawal by Subject|104|||
125680515|NCT04538170|452120664|FG001|Overall Study|Withdrawal by Subject|210|||
125680516|NCT00051025|452120668|FG000|Overall Study|Progressive Disease|1|||
125680517|NCT00051025|452120669|FG001|Overall Study|Progressive Disease|1|||
125680518|NCT00051025|452120668|FG000|Overall Study|Adverse Event|1|||
125680519|NCT00051025|452120669|FG001|Overall Study|Adverse Event|1|||
125680520|NCT00051025|452120668|FG000|Overall Study|Withdrawal by Subject|0|||
125680521|NCT00051025|452120669|FG001|Overall Study|Withdrawal by Subject|1|||
125680522|NCT00051025|452120668|FG000|Overall Study|Death|0|||
125680523|NCT00051025|452120669|FG001|Overall Study|Death|1|||
125680524|NCT00274937|452120670|FG000|Overall Study|Physician Decision|10|||
125680525|NCT00274937|452120670|FG000|Overall Study|Withdrawal by Subject|6|||
125680526|NCT00274937|452120670|FG000|Overall Study|Progressive Disease|4|||
125345534|NCT01426789|450898319|FG001|Part 1|Lack of Efficacy|1|||
125545207|NCT00705679|451627279|FG002|Overall Study|Death|3|||
125545208|NCT00705679|451627280|FG003|Overall Study|Death|2|||
125545209|NCT00705679|451627281|FG004|Overall Study|Death|1|||
125545210|NCT00705679|451627277|FG000|Overall Study|Lost to Follow-up|32|||
125545211|NCT00705679|451627278|FG001|Overall Study|Lost to Follow-up|60|||
125680527|NCT02189941|452120671|FG000|Overall Study|Non-compliance|0|||
125680528|NCT02189941|452120672|FG001|Overall Study|Non-compliance|0|||
125680529|NCT02189941|452120673|FG002|Overall Study|Non-compliance|1|||
125680530|NCT00445003|452120674|FG000|Overall Study|Death|1|||
125545212|NCT00705679|451627279|FG002|Overall Study|Lost to Follow-up|44|||
125680531|NCT00445003|452120675|FG001|Overall Study|Death|2|||
125680532|NCT00445003|452120676|FG002|Overall Study|Death|1|||
125545213|NCT00705679|451627280|FG003|Overall Study|Lost to Follow-up|30|||
125545214|NCT00705679|451627281|FG004|Overall Study|Lost to Follow-up|35|||
125545215|NCT00705679|451627277|FG000|Overall Study|Physician Decision|0|||
125545216|NCT00705679|451627278|FG001|Overall Study|Physician Decision|1|||
125545217|NCT00705679|451627279|FG002|Overall Study|Physician Decision|0|||
125545218|NCT00705679|451627280|FG003|Overall Study|Physician Decision|1|||
125545219|NCT00705679|451627281|FG004|Overall Study|Physician Decision|0|||
125545220|NCT00705679|451627277|FG000|Overall Study|Withdrawal by Subject|32|||
125545221|NCT00705679|451627278|FG001|Overall Study|Withdrawal by Subject|77|||
125545222|NCT00705679|451627279|FG002|Overall Study|Withdrawal by Subject|68|||
125545223|NCT00705679|451627280|FG003|Overall Study|Withdrawal by Subject|47|||
125545224|NCT00705679|451627281|FG004|Overall Study|Withdrawal by Subject|33|||
125545225|NCT00932113|451627282|FG000|Overall Study|Lost to Follow-up|1|||
125545226|NCT00932113|451627283|FG001|Overall Study|Lost to Follow-up|0|||
125545227|NCT01776541|451627287|FG000|Overall Study|Administrative Reason|6|||
125545228|NCT01776541|451627288|FG001|Overall Study|Administrative Reason|2|||
125545229|NCT01776541|451627287|FG000|Overall Study|Death|4|||
125545230|NCT01776541|451627288|FG001|Overall Study|Death|0|||
125545231|NCT01776541|451627287|FG000|Overall Study|Lost to Follow-up|27|||
125545232|NCT01776541|451627288|FG001|Overall Study|Lost to Follow-up|48|||
125545233|NCT01776541|451627287|FG000|Overall Study|Unclassified|5|||
125545234|NCT01776541|451627288|FG001|Overall Study|Unclassified|4|||
125545235|NCT01776541|451627287|FG000|Overall Study|Protocol Violation|2|||
125545236|NCT01776541|451627288|FG001|Overall Study|Protocol Violation|1|||
125545237|NCT01776541|451627287|FG000|Overall Study|Withdrawal by Subject|12|||
125545238|NCT01776541|451627288|FG001|Overall Study|Withdrawal by Subject|20|||
125545239|NCT02090959|451627289|FG000|Overall Study|Withdrawal by Subject|10|||
125545240|NCT02090959|451627289|FG000|Overall Study|Adverse Event|1|||
125545241|NCT02090959|451627289|FG000|Overall Study|Investigator decision|2|||
125545242|NCT02090959|451627289|FG000|Overall Study|Study termination|6|||
125545243|NCT02090959|451627289|FG000|Overall Study|Enrolled but not treated|1|||
125545244|NCT02090959|451627289|FG000|Overall Study|Transfer for compassionate use medicine|4|||
125545245|NCT02090959|451627289|FG000|Overall Study|Move to medical need program|3|||
125545246|NCT02090959|451627289|FG000|Overall Study|Entered in to other study|34|||
125545247|NCT02090959|451627289|FG000|Overall Study|Switched to commercial supply|88|||
125545248|NCT02090959|451627289|FG000|Overall Study|Other than specified|2|||
125545249|NCT00522873|451627292|FG000|Overall Study|Adverse Event|41|||
125545250|NCT00522873|451627293|FG001|Overall Study|Adverse Event|26|||
125545251|NCT00522873|451627292|FG000|Overall Study|Withdrawal by Subject|20|||
125545252|NCT00522873|451627293|FG001|Overall Study|Withdrawal by Subject|9|||
125545253|NCT00522873|451627292|FG000|Overall Study|Protocol Violation|14|||
125545254|NCT00522873|451627293|FG001|Overall Study|Protocol Violation|4|||
125545255|NCT00522873|451627292|FG000|Overall Study|Lost to Follow-up|11|||
125545256|NCT00522873|451627293|FG001|Overall Study|Lost to Follow-up|3|||
125545257|NCT00522873|451627292|FG000|Overall Study|Personal Reasons|8|||
125545258|NCT00522873|451627293|FG001|Overall Study|Personal Reasons|1|||
125545259|NCT00522873|451627292|FG000|Overall Study|Medication Errors|1|||
125545260|NCT00522873|451627293|FG001|Overall Study|Medication Errors|1|||
125545261|NCT00522873|451627292|FG000|Overall Study|Never Received Medication|1|||
125545262|NCT00522873|451627293|FG001|Overall Study|Never Received Medication|0|||
125545263|NCT01248065|451627296|FG000|Overall Study|Lost to Follow-up|3|||
125545264|NCT01248065|451627297|FG001|Overall Study|Lost to Follow-up|5|||
125545265|NCT01248065|451627296|FG000|Overall Study|Withdrawal by Subject|14|||
125680533|NCT00445003|452120674|FG000|Overall Study|Missed Visit|3|||
125680534|NCT00445003|452120675|FG001|Overall Study|Missed Visit|5|||
125680535|NCT00445003|452120676|FG002|Overall Study|Missed Visit|1|||
125345535|NCT01426789|450898320|FG002|Part 1|Lack of Efficacy|0|||
125345536|NCT01426789|450898321|FG003|Part 1|Lack of Efficacy|0|||
125345537|NCT01426789|450898322|FG004|Part 1|Lack of Efficacy|0|||
125345538|NCT01426789|450898323|FG005|Part 1|Lack of Efficacy|0|||
125345539|NCT01426789|450898318|FG000|Part 1|Adverse Event|3|||
125345540|NCT01426789|450898319|FG001|Part 1|Adverse Event|0|||
125345541|NCT01426789|450898320|FG002|Part 1|Adverse Event|0|||
125680536|NCT00445003|452120674|FG000|Overall Study|Dropped|1|||
125680537|NCT00445003|452120675|FG001|Overall Study|Dropped|3|||
125545266|NCT01248065|451627297|FG001|Overall Study|Withdrawal by Subject|11|||
125545267|NCT01248065|451627296|FG000|Overall Study|Adverse Event|3|||
125545268|NCT01248065|451627297|FG001|Overall Study|Adverse Event|0|||
125545269|NCT01248065|451627296|FG000|Overall Study|Third treatment failure event|3|||
125545270|NCT01248065|451627297|FG001|Overall Study|Third treatment failure event|1|||
125545271|NCT01248065|451627296|FG000|Overall Study|Other|3|||
125680538|NCT00445003|452120676|FG002|Overall Study|Dropped|2|||
125345542|NCT01426789|450898321|FG003|Part 1|Adverse Event|0|||
125345543|NCT01426789|450898322|FG004|Part 1|Adverse Event|0|||
125545272|NCT01248065|451627297|FG001|Overall Study|Other|5|||
125545273|NCT03010176|451627301|FG000|Overall Study|Death|21|||
125545274|NCT03010176|451627302|FG001|Overall Study|Death|35|||
125545275|NCT03010176|451627303|FG002|Overall Study|Death|19|||
125545276|NCT03010176|451627304|FG003|Overall Study|Death|19|||
125545277|NCT03010176|451627305|FG004|Overall Study|Death|14|||
125345544|NCT01426789|450898323|FG005|Part 1|Adverse Event|0|||
125345545|NCT01426789|450898318|FG000|Part 2|Protocol deviation|0|||
125345546|NCT01426789|450898319|FG001|Part 2|Protocol deviation|0|||
125345547|NCT01426789|450898320|FG002|Part 2|Protocol deviation|1|||
125345548|NCT01426789|450898321|FG003|Part 2|Protocol deviation|0|||
125345549|NCT01426789|450898322|FG004|Part 2|Protocol deviation|0|||
125345550|NCT01426789|450898323|FG005|Part 2|Protocol deviation|0|||
125345551|NCT01426789|450898318|FG000|Part 2|Death|0|||
125345552|NCT01426789|450898319|FG001|Part 2|Death|0|||
125345553|NCT01426789|450898320|FG002|Part 2|Death|1|||
125345554|NCT01426789|450898321|FG003|Part 2|Death|0|||
125345555|NCT01426789|450898322|FG004|Part 2|Death|1|||
125345556|NCT01426789|450898323|FG005|Part 2|Death|0|||
125345557|NCT01426789|450898318|FG000|Part 2|Administrative problems|0|||
125345558|NCT01426789|450898319|FG001|Part 2|Administrative problems|0|||
125345559|NCT01426789|450898320|FG002|Part 2|Administrative problems|2|||
125345560|NCT01426789|450898321|FG003|Part 2|Administrative problems|0|||
125345561|NCT01426789|450898322|FG004|Part 2|Administrative problems|1|||
125345562|NCT01426789|450898323|FG005|Part 2|Administrative problems|0|||
125345563|NCT01426789|450898318|FG000|Part 2|Lost to Follow-up|0|||
125345564|NCT01426789|450898319|FG001|Part 2|Lost to Follow-up|0|||
125545278|NCT03010176|451627306|FG005|Overall Study|Death|0|||
125545279|NCT03010176|451627301|FG000|Overall Study|Lost to Follow-up|0|||
125545280|NCT03010176|451627302|FG001|Overall Study|Lost to Follow-up|0|||
125545281|NCT03010176|451627303|FG002|Overall Study|Lost to Follow-up|0|||
125545282|NCT03010176|451627304|FG003|Overall Study|Lost to Follow-up|0|||
125545283|NCT03010176|451627305|FG004|Overall Study|Lost to Follow-up|1|||
125545284|NCT03010176|451627306|FG005|Overall Study|Lost to Follow-up|0|||
125545285|NCT03010176|451627301|FG000|Overall Study|Physician Decision|0|||
125545286|NCT03010176|451627302|FG001|Overall Study|Physician Decision|4|||
125545287|NCT03010176|451627303|FG002|Overall Study|Physician Decision|0|||
125545288|NCT03010176|451627304|FG003|Overall Study|Physician Decision|1|||
125545289|NCT03010176|451627305|FG004|Overall Study|Physician Decision|0|||
125545290|NCT03010176|451627306|FG005|Overall Study|Physician Decision|0|||
125545291|NCT03010176|451627301|FG000|Overall Study|Sponsor Decision|0|||
125545292|NCT03010176|451627302|FG001|Overall Study|Sponsor Decision|4|||
125545293|NCT03010176|451627303|FG002|Overall Study|Sponsor Decision|4|||
125545294|NCT03010176|451627304|FG003|Overall Study|Sponsor Decision|1|||
125545295|NCT03010176|451627305|FG004|Overall Study|Sponsor Decision|6|||
125545296|NCT03010176|451627306|FG005|Overall Study|Sponsor Decision|0|||
125545297|NCT03010176|451627301|FG000|Overall Study|Withdrawal by Subject|11|||
125545298|NCT03010176|451627302|FG001|Overall Study|Withdrawal by Subject|9|||
125545299|NCT03010176|451627303|FG002|Overall Study|Withdrawal by Subject|3|||
125545300|NCT03010176|451627304|FG003|Overall Study|Withdrawal by Subject|0|||
125545301|NCT03010176|451627305|FG004|Overall Study|Withdrawal by Subject|4|||
125545302|NCT03010176|451627306|FG005|Overall Study|Withdrawal by Subject|0|||
125545303|NCT01774487|451627307|FG000|Overall Study|Did not tolerate taste|4|||
125545304|NCT01774487|451627308|FG001|Overall Study|Did not tolerate taste|4|||
125545305|NCT00461032|451627309|FG000|Overall Study|Adverse Event|5|||
125545306|NCT00461032|451627310|FG001|Overall Study|Adverse Event|6|||
125545307|NCT00461032|451627309|FG000|Overall Study|Lack of Efficacy|5|||
125545308|NCT00461032|451627310|FG001|Overall Study|Lack of Efficacy|1|||
125545309|NCT00461032|451627309|FG000|Overall Study|Lost to Follow-up|7|||
125545310|NCT00461032|451627310|FG001|Overall Study|Lost to Follow-up|12|||
125545311|NCT00461032|451627309|FG000|Overall Study|Protocol Violation|4|||
125545312|NCT00461032|451627310|FG001|Overall Study|Protocol Violation|4|||
125545313|NCT00461032|451627309|FG000|Overall Study|Withdrawal by Subject|7|||
125545314|NCT00461032|451627310|FG001|Overall Study|Withdrawal by Subject|15|||
125545315|NCT00461032|451627309|FG000|Overall Study|Patient Moved or Relocated|2|||
125545316|NCT00461032|451627310|FG001|Overall Study|Patient Moved or Relocated|1|||
125545317|NCT00461032|451627309|FG000|Overall Study|Other|7|||
125545318|NCT00461032|451627310|FG001|Overall Study|Other|5|||
125545319|NCT04447846|451627311|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
125545320|NCT01878214|451627312|FG000|Overall Study|Withdrawal by Subject|18|||
125545321|NCT01878214|451627313|FG001|Overall Study|Withdrawal by Subject|7|||
125545322|NCT01878214|451627312|FG000|Overall Study|Death|0|||
125545323|NCT01878214|451627313|FG001|Overall Study|Death|1|||
125545324|NCT01878214|451627312|FG000|Overall Study|Lost to Follow-up|35|||
125545325|NCT01878214|451627313|FG001|Overall Study|Lost to Follow-up|36|||
125545326|NCT00946101|451627314|FG000|Overall Study|Lost to Follow-up|2|||
125545327|NCT00946101|451627315|FG001|Overall Study|Lost to Follow-up|1|||
125545328|NCT00946101|451627314|FG000|Overall Study|Withdrawal of consent|2|||
125545329|NCT00946101|451627315|FG001|Overall Study|Withdrawal of consent|0|||
125545330|NCT00946101|451627314|FG000|Overall Study|Physician Decision|0|||
125545331|NCT00946101|451627315|FG001|Overall Study|Physician Decision|1|||
125545332|NCT02647866|451627318|FG000|Overall Study|Adverse Event|0|||
125545333|NCT02647866|451627319|FG001|Overall Study|Adverse Event|0|||
125545334|NCT02647866|451627320|FG002|Overall Study|Adverse Event|2|||
125545335|NCT02647866|451627321|FG003|Overall Study|Adverse Event|2|||
125545336|NCT02647866|451627322|FG004|Overall Study|Adverse Event|1|||
125545337|NCT02647866|451627318|FG000|Overall Study|Disease Worsening|3|||
125545338|NCT02647866|451627319|FG001|Overall Study|Disease Worsening|1|||
125545339|NCT02647866|451627320|FG002|Overall Study|Disease Worsening|0|||
125545340|NCT02647866|451627321|FG003|Overall Study|Disease Worsening|0|||
125545341|NCT02647866|451627322|FG004|Overall Study|Disease Worsening|1|||
125545342|NCT02647866|451627318|FG000|Overall Study|Withdrawal by Subject|1|||
125545343|NCT02647866|451627319|FG001|Overall Study|Withdrawal by Subject|1|||
125345565|NCT01426789|450898320|FG002|Part 2|Lost to Follow-up|4|||
125545344|NCT02647866|451627320|FG002|Overall Study|Withdrawal by Subject|2|||
125545345|NCT02647866|451627321|FG003|Overall Study|Withdrawal by Subject|4|||
125545346|NCT02647866|451627322|FG004|Overall Study|Withdrawal by Subject|4|||
125545347|NCT02647866|451627318|FG000|Overall Study|Physician Decision|0|||
125545348|NCT02647866|451627319|FG001|Overall Study|Physician Decision|1|||
125545349|NCT02647866|451627320|FG002|Overall Study|Physician Decision|1|||
125545350|NCT02647866|451627321|FG003|Overall Study|Physician Decision|0|||
125545351|NCT02647866|451627322|FG004|Overall Study|Physician Decision|2|||
125545352|NCT02647866|451627318|FG000|Overall Study|Death|0|||
125545353|NCT02647866|451627319|FG001|Overall Study|Death|1|||
125545354|NCT02647866|451627320|FG002|Overall Study|Death|0|||
125545355|NCT02647866|451627321|FG003|Overall Study|Death|0|||
125545356|NCT02647866|451627322|FG004|Overall Study|Death|0|||
125545357|NCT02647866|451627318|FG000|Overall Study|Subject moved to different country|1|||
125545358|NCT02647866|451627319|FG001|Overall Study|Subject moved to different country|0|||
125545359|NCT02647866|451627320|FG002|Overall Study|Subject moved to different country|0|||
125545360|NCT02647866|451627321|FG003|Overall Study|Subject moved to different country|0|||
125545361|NCT02647866|451627322|FG004|Overall Study|Subject moved to different country|0|||
125545362|NCT00069108|451627326|FG000|Overall Study|Withdrawal by Subject|5|||
125545363|NCT00069108|451627327|FG001|Overall Study|Withdrawal by Subject|9|||
125545364|NCT00069108|451627326|FG000|Overall Study|Adverse Event|64|||
125545365|NCT00069108|451627327|FG001|Overall Study|Adverse Event|42|||
125545366|NCT00069108|451627326|FG000|Overall Study|Death|6|||
125545367|NCT00069108|451627327|FG001|Overall Study|Death|6|||
125545368|NCT00069108|451627326|FG000|Overall Study|Administration|15|||
125545369|NCT00069108|451627327|FG001|Overall Study|Administration|4|||
125545370|NCT00069108|451627326|FG000|Overall Study|Insufficient therapy|117|||
125545371|NCT00069108|451627327|FG001|Overall Study|Insufficient therapy|144|||
125545372|NCT00069108|451627326|FG000|Overall Study|Violation criteria|1|||
125545373|NCT00069108|451627327|FG001|Overall Study|Violation criteria|4|||
125545374|NCT00069108|451627326|FG000|Overall Study|Refused treatment|5|||
125545375|NCT00069108|451627327|FG001|Overall Study|Refused treatment|10|||
125545376|NCT01415531|451627329|FG000|Overall Study|Adverse Event|7|||
125545377|NCT01415531|451627330|FG001|Overall Study|Adverse Event|10|||
125545378|NCT01415531|451627329|FG000|Overall Study|Lack of Efficacy|3|||
125545379|NCT01415531|451627330|FG001|Overall Study|Lack of Efficacy|2|||
125545380|NCT01415531|451627329|FG000|Overall Study|Protocol Violation|0|||
125545381|NCT01415531|451627330|FG001|Overall Study|Protocol Violation|1|||
125545382|NCT01415531|451627329|FG000|Overall Study|Withdrawal by Subject|5|||
125545383|NCT01415531|451627330|FG001|Overall Study|Withdrawal by Subject|4|||
125545384|NCT01415531|451627329|FG000|Overall Study|Lost to Follow-up|6|||
125545385|NCT01415531|451627330|FG001|Overall Study|Lost to Follow-up|14|||
125545386|NCT01415531|451627329|FG000|Overall Study|Lack of Compliance|1|||
125545387|NCT01415531|451627330|FG001|Overall Study|Lack of Compliance|4|||
125345566|NCT01426789|450898321|FG003|Part 2|Lost to Follow-up|0|||
125345567|NCT01426789|450898322|FG004|Part 2|Lost to Follow-up|1|||
125345568|NCT01426789|450898323|FG005|Part 2|Lost to Follow-up|0|||
125345569|NCT01426789|450898318|FG000|Part 2|Withdrawal by Subject|0|||
125345570|NCT01426789|450898319|FG001|Part 2|Withdrawal by Subject|0|||
125345571|NCT01426789|450898320|FG002|Part 2|Withdrawal by Subject|0|||
125345572|NCT01426789|450898321|FG003|Part 2|Withdrawal by Subject|1|||
125345573|NCT01426789|450898322|FG004|Part 2|Withdrawal by Subject|2|||
125345574|NCT01426789|450898323|FG005|Part 2|Withdrawal by Subject|0|||
125345575|NCT01426789|450898318|FG000|Part 2|Lack of Efficacy|0|||
125680539|NCT01471093|452120677|FG000|Overall Study|Adverse Event|1|||
125680540|NCT01471093|452120678|FG001|Overall Study|Adverse Event|0|||
125680541|NCT01471093|452120679|FG002|Overall Study|Adverse Event|0|||
125680542|NCT01471093|452120680|FG003|Overall Study|Adverse Event|0|||
125680543|NCT02475954|452120681|FG000|Overall Study|Withdrawal by Subject|2|||
125680544|NCT02475954|452120682|FG001|Overall Study|Withdrawal by Subject|2|||
125680545|NCT02475954|452120681|FG000|Overall Study|Lost to Follow-up|11|||
125680546|NCT02475954|452120682|FG001|Overall Study|Lost to Follow-up|9|||
125680547|NCT02475954|452120681|FG000|Overall Study|Death|1|||
125680548|NCT02475954|452120682|FG001|Overall Study|Death|1|||
125680549|NCT02932878|452120684|FG000|Overall Study|Due to Lab Results|2|||
125680550|NCT02932878|452120685|FG001|Overall Study|Due to Lab Results|1|||
125680551|NCT00864097|452120687|FG000|Overall Study|Death|0|||
125680552|NCT00864097|452120688|FG001|Overall Study|Death|1|||
125680553|NCT00864097|452120689|FG002|Overall Study|Death|0|||
125680554|NCT00864097|452120690|FG003|Overall Study|Death|0|||
125680555|NCT00864097|452120687|FG000|Overall Study|Adverse Event|6|||
125680556|NCT00864097|452120688|FG001|Overall Study|Adverse Event|8|||
125680557|NCT00864097|452120689|FG002|Overall Study|Adverse Event|11|||
125680558|NCT00864097|452120690|FG003|Overall Study|Adverse Event|9|||
125680559|NCT00864097|452120687|FG000|Overall Study|Lack of Efficacy|9|||
125680560|NCT00864097|452120688|FG001|Overall Study|Lack of Efficacy|3|||
125680561|NCT00864097|452120689|FG002|Overall Study|Lack of Efficacy|7|||
125680562|NCT00864097|452120690|FG003|Overall Study|Lack of Efficacy|2|||
125680563|NCT00864097|452120687|FG000|Overall Study|Lost to Follow-up|0|||
125680564|NCT00864097|452120688|FG001|Overall Study|Lost to Follow-up|1|||
125680565|NCT00864097|452120689|FG002|Overall Study|Lost to Follow-up|0|||
125680566|NCT00864097|452120690|FG003|Overall Study|Lost to Follow-up|1|||
125680567|NCT00864097|452120687|FG000|Overall Study|Withdrawal by Subject|15|||
125680568|NCT00864097|452120688|FG001|Overall Study|Withdrawal by Subject|11|||
125680569|NCT00864097|452120689|FG002|Overall Study|Withdrawal by Subject|11|||
125680570|NCT00864097|452120690|FG003|Overall Study|Withdrawal by Subject|12|||
125680571|NCT00864097|452120687|FG000|Overall Study|Protocol Violation|2|||
125680572|NCT00864097|452120688|FG001|Overall Study|Protocol Violation|1|||
125680573|NCT00864097|452120689|FG002|Overall Study|Protocol Violation|0|||
125680574|NCT00864097|452120690|FG003|Overall Study|Protocol Violation|1|||
125680575|NCT00864097|452120687|FG000|Overall Study|Terminated by sponsor|105|||
125680576|NCT00864097|452120688|FG001|Overall Study|Terminated by sponsor|112|||
125680577|NCT00864097|452120689|FG002|Overall Study|Terminated by sponsor|102|||
125680578|NCT00864097|452120690|FG003|Overall Study|Terminated by sponsor|99|||
125680579|NCT00864097|452120687|FG000|Overall Study|Randomized but not treated|2|||
125680580|NCT00864097|452120688|FG001|Overall Study|Randomized but not treated|0|||
125680581|NCT00864097|452120689|FG002|Overall Study|Randomized but not treated|1|||
125680582|NCT00864097|452120690|FG003|Overall Study|Randomized but not treated|0|||
125680583|NCT00864097|452120687|FG000|Overall Study|Other|0|||
125680584|NCT00864097|452120688|FG001|Overall Study|Other|0|||
125680585|NCT00864097|452120689|FG002|Overall Study|Other|0|||
125680586|NCT00864097|452120690|FG003|Overall Study|Other|1|||
125680587|NCT01918397|452120691|FG000|Overall Study|Never started treatment|2|||
125680588|NCT01918397|452120692|FG001|Overall Study|Never started treatment|1|||
125680589|NCT01918397|452120693|FG002|Overall Study|Never started treatment|0|||
125680590|NCT01918397|452120694|FG003|Overall Study|Never started treatment|0|||
125680591|NCT01918397|452120691|FG000|Overall Study|Adverse Event|1|||
125680592|NCT01918397|452120692|FG001|Overall Study|Adverse Event|1|||
125680593|NCT01918397|452120693|FG002|Overall Study|Adverse Event|1|||
125680594|NCT01918397|452120694|FG003|Overall Study|Adverse Event|0|||
125680595|NCT01918397|452120691|FG000|Overall Study|Lack of compliance|2|||
125680596|NCT01918397|452120692|FG001|Overall Study|Lack of compliance|2|||
125680597|NCT01918397|452120693|FG002|Overall Study|Lack of compliance|3|||
125680598|NCT01918397|452120694|FG003|Overall Study|Lack of compliance|0|||
125680599|NCT01918397|452120691|FG000|Overall Study|Pregnancy|0|||
125680600|NCT01918397|452120692|FG001|Overall Study|Pregnancy|1|||
125680601|NCT01918397|452120693|FG002|Overall Study|Pregnancy|0|||
125680602|NCT01918397|452120694|FG003|Overall Study|Pregnancy|0|||
125680603|NCT01918397|452120691|FG000|Overall Study|Rifampin susceptible|0|||
125680604|NCT01918397|452120692|FG001|Overall Study|Rifampin susceptible|0|||
125680605|NCT01918397|452120693|FG002|Overall Study|Rifampin susceptible|0|||
125680606|NCT01918397|452120694|FG003|Overall Study|Rifampin susceptible|2|||
125680607|NCT01918397|452120691|FG000|Overall Study|Treatment failure|0|||
125680608|NCT01918397|452120692|FG001|Overall Study|Treatment failure|0|||
125680609|NCT01918397|452120693|FG002|Overall Study|Treatment failure|0|||
125345576|NCT01426789|450898319|FG001|Part 2|Lack of Efficacy|0|||
125345577|NCT01426789|450898320|FG002|Part 2|Lack of Efficacy|5|||
125545388|NCT01415531|451627329|FG000|Overall Study|Other Reasons|3|||
125545389|NCT01415531|451627330|FG001|Overall Study|Other Reasons|2|||
125545390|NCT00394082|451627333|FG000|Overall Study|Unacceptable toxicity|15|||
125545391|NCT00394082|451627333|FG000|Overall Study|Adverse Event|4|||
125545392|NCT00394082|451627333|FG000|Overall Study|Physician Decision|4|||
125545393|NCT00394082|451627333|FG000|Overall Study|Withdrawal by Subject|2|||
125545394|NCT00394082|451627333|FG000|Overall Study|Other|1|||
125545395|NCT02344004|451627335|FG000|Overall Study|Adverse Event|11|||
125545396|NCT02344004|451627336|FG001|Overall Study|Adverse Event|1|||
125545397|NCT02344004|451627335|FG000|Overall Study|Death|9|||
125545398|NCT02344004|451627336|FG001|Overall Study|Death|7|||
125545399|NCT02344004|451627335|FG000|Overall Study|Physician Decision|4|||
125545400|NCT02344004|451627336|FG001|Overall Study|Physician Decision|1|||
125545401|NCT02344004|451627335|FG000|Overall Study|Withdrawal by Subject|22|||
125545402|NCT02344004|451627336|FG001|Overall Study|Withdrawal by Subject|5|||
125545403|NCT02344004|451627335|FG000|Overall Study|Rescue Medication|2|||
125545404|NCT02344004|451627336|FG001|Overall Study|Rescue Medication|0|||
125545405|NCT02344004|451627335|FG000|Overall Study|Other Not Specified|12|||
125545406|NCT02344004|451627336|FG001|Overall Study|Other Not Specified|0|||
125545407|NCT02344004|451627335|FG000|Overall Study|Protocol Violation|1|||
125545408|NCT02344004|451627336|FG001|Overall Study|Protocol Violation|0|||
125545409|NCT02481947|451627337|FG000|Overall Study|Withdrawal by Subject|24|||
125545410|NCT02481947|451627338|FG001|Overall Study|Withdrawal by Subject|10|||
125545411|NCT02481947|451627337|FG000|Overall Study|Lost to Follow-up|11|||
125545412|NCT02481947|451627338|FG001|Overall Study|Lost to Follow-up|5|||
125545413|NCT02481947|451627337|FG000|Overall Study|Adverse Event|6|||
125545414|NCT02481947|451627338|FG001|Overall Study|Adverse Event|11|||
125545415|NCT02481947|451627337|FG000|Overall Study|Physician Decision|4|||
125545416|NCT02481947|451627338|FG001|Overall Study|Physician Decision|5|||
125545417|NCT02481947|451627337|FG000|Overall Study|Protocol Violation|1|||
125545418|NCT02481947|451627338|FG001|Overall Study|Protocol Violation|5|||
125545419|NCT05249829|451627339|FG000|Overall Study|Participant Relocation|0|||
125545420|NCT05249829|451627340|FG001|Overall Study|Participant Relocation|1|||
125545421|NCT05249829|451627341|FG002|Overall Study|Participant Relocation|2|||
125545422|NCT05249829|451627342|FG003|Overall Study|Participant Relocation|2|||
125545423|NCT05249829|451627339|FG000|Overall Study|Withdrawal by Subject|9|||
125545424|NCT05249829|451627340|FG001|Overall Study|Withdrawal by Subject|17|||
125545425|NCT05249829|451627341|FG002|Overall Study|Withdrawal by Subject|40|||
125545426|NCT05249829|451627342|FG003|Overall Study|Withdrawal by Subject|35|||
125545427|NCT05249829|451627339|FG000|Overall Study|Physician Decision|1|||
125545428|NCT05249829|451627340|FG001|Overall Study|Physician Decision|0|||
125545429|NCT05249829|451627341|FG002|Overall Study|Physician Decision|0|||
125545430|NCT05249829|451627342|FG003|Overall Study|Physician Decision|0|||
125545431|NCT05249829|451627339|FG000|Overall Study|Lost to Follow-up|16|||
125545432|NCT05249829|451627340|FG001|Overall Study|Lost to Follow-up|16|||
125545433|NCT05249829|451627341|FG002|Overall Study|Lost to Follow-up|57|||
125545434|NCT05249829|451627342|FG003|Overall Study|Lost to Follow-up|60|||
125545435|NCT05249829|451627339|FG000|Overall Study|Adverse Event|2|||
125545436|NCT05249829|451627340|FG001|Overall Study|Adverse Event|2|||
125545437|NCT05249829|451627341|FG002|Overall Study|Adverse Event|2|||
125545438|NCT05249829|451627342|FG003|Overall Study|Adverse Event|2|||
125545439|NCT05249829|451627339|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
125545440|NCT05249829|451627340|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
125345578|NCT01426789|450898321|FG003|Part 2|Lack of Efficacy|0|||
125345579|NCT01426789|450898322|FG004|Part 2|Lack of Efficacy|2|||
125345580|NCT01426789|450898323|FG005|Part 2|Lack of Efficacy|0|||
125545441|NCT05249829|451627341|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
125545442|NCT05249829|451627342|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
125545443|NCT05249829|451627339|FG000|Overall Study|Protocol Violation|2|||
125545444|NCT05249829|451627340|FG001|Overall Study|Protocol Violation|0|||
125545445|NCT05249829|451627341|FG002|Overall Study|Protocol Violation|5|||
125545446|NCT05249829|451627342|FG003|Overall Study|Protocol Violation|3|||
125545447|NCT05249829|451627339|FG000|Overall Study|Death|0|||
125545448|NCT05249829|451627340|FG001|Overall Study|Death|1|||
125545449|NCT05249829|451627341|FG002|Overall Study|Death|2|||
125545450|NCT05249829|451627342|FG003|Overall Study|Death|4|||
125545451|NCT02842827|451627344|FG000|Overall Study|Adverse Event|0|||
125545452|NCT02842827|451627345|FG001|Overall Study|Adverse Event|1|||
125545453|NCT02842827|451627346|FG002|Overall Study|Adverse Event|0|||
125545454|NCT02842827|451627347|FG003|Overall Study|Adverse Event|1|||
125545455|NCT02842827|451627348|FG004|Overall Study|Adverse Event|0|||
125545456|NCT02842827|451627349|FG005|Overall Study|Adverse Event|1|||
125545457|NCT02842827|451627350|FG006|Overall Study|Adverse Event|0|||
125545458|NCT02842827|451627351|FG007|Overall Study|Adverse Event|0|||
125545459|NCT02842827|451627344|FG000|Overall Study|Death|1|||
125545460|NCT02842827|451627345|FG001|Overall Study|Death|0|||
125545461|NCT02842827|451627346|FG002|Overall Study|Death|2|||
125545462|NCT02842827|451627347|FG003|Overall Study|Death|3|||
125545463|NCT02842827|451627348|FG004|Overall Study|Death|2|||
125545464|NCT02842827|451627349|FG005|Overall Study|Death|1|||
125545465|NCT02842827|451627350|FG006|Overall Study|Death|0|||
125545466|NCT02842827|451627351|FG007|Overall Study|Death|4|||
125545467|NCT02842827|451627344|FG000|Overall Study|Physician Decision|1|||
125545468|NCT02842827|451627345|FG001|Overall Study|Physician Decision|3|||
125545469|NCT02842827|451627346|FG002|Overall Study|Physician Decision|0|||
125545470|NCT02842827|451627347|FG003|Overall Study|Physician Decision|0|||
125545471|NCT02842827|451627348|FG004|Overall Study|Physician Decision|1|||
125545472|NCT02842827|451627349|FG005|Overall Study|Physician Decision|4|||
125545473|NCT02842827|451627350|FG006|Overall Study|Physician Decision|2|||
125545474|NCT02842827|451627351|FG007|Overall Study|Physician Decision|1|||
125545475|NCT02842827|451627344|FG000|Overall Study|Protocol Defined Disease Progression|0|||
125545476|NCT02842827|451627345|FG001|Overall Study|Protocol Defined Disease Progression|0|||
125545477|NCT02842827|451627346|FG002|Overall Study|Protocol Defined Disease Progression|0|||
125545478|NCT02842827|451627347|FG003|Overall Study|Protocol Defined Disease Progression|0|||
125545479|NCT02842827|451627348|FG004|Overall Study|Protocol Defined Disease Progression|0|||
125545480|NCT02842827|451627349|FG005|Overall Study|Protocol Defined Disease Progression|1|||
125545481|NCT02842827|451627350|FG006|Overall Study|Protocol Defined Disease Progression|0|||
125545482|NCT02842827|451627351|FG007|Overall Study|Protocol Defined Disease Progression|0|||
125545483|NCT02842827|451627344|FG000|Overall Study|Participant Withdrawal of Consent|1|||
125545484|NCT02842827|451627345|FG001|Overall Study|Participant Withdrawal of Consent|2|||
125545485|NCT02842827|451627346|FG002|Overall Study|Participant Withdrawal of Consent|2|||
125545486|NCT02842827|451627347|FG003|Overall Study|Participant Withdrawal of Consent|2|||
125545487|NCT02842827|451627348|FG004|Overall Study|Participant Withdrawal of Consent|2|||
125545488|NCT02842827|451627349|FG005|Overall Study|Participant Withdrawal of Consent|1|||
125545489|NCT02842827|451627350|FG006|Overall Study|Participant Withdrawal of Consent|2|||
125680610|NCT01918397|452120694|FG003|Overall Study|Treatment failure|1|||
125680611|NCT01918397|452120691|FG000|Overall Study|Withdrawal by Subject|3|||
125680612|NCT01918397|452120692|FG001|Overall Study|Withdrawal by Subject|2|||
125680613|NCT01918397|452120693|FG002|Overall Study|Withdrawal by Subject|1|||
125680614|NCT01918397|452120694|FG003|Overall Study|Withdrawal by Subject|1|||
125680615|NCT01918397|452120691|FG000|Overall Study|XDR at baseline|0|||
125680616|NCT01918397|452120692|FG001|Overall Study|XDR at baseline|0|||
125680617|NCT01918397|452120693|FG002|Overall Study|XDR at baseline|1|||
125680618|NCT01918397|452120694|FG003|Overall Study|XDR at baseline|0|||
125680619|NCT01918397|452120691|FG000|Overall Study|Lost to Follow-up|2|||
125680620|NCT01918397|452120692|FG001|Overall Study|Lost to Follow-up|1|||
125680621|NCT01918397|452120693|FG002|Overall Study|Lost to Follow-up|1|||
125680622|NCT01918397|452120694|FG003|Overall Study|Lost to Follow-up|1|||
125680623|NCT01918397|452120691|FG000|Overall Study|Increased QTc|1|||
125680624|NCT01918397|452120692|FG001|Overall Study|Increased QTc|0|||
125680625|NCT01918397|452120693|FG002|Overall Study|Increased QTc|0|||
125680626|NCT01918397|452120694|FG003|Overall Study|Increased QTc|1|||
125680627|NCT01918397|452120691|FG000|Overall Study|Death|0|||
125680628|NCT01918397|452120692|FG001|Overall Study|Death|0|||
125680629|NCT01918397|452120693|FG002|Overall Study|Death|1|||
125680630|NCT01918397|452120694|FG003|Overall Study|Death|0|||
125680631|NCT01918397|452120691|FG000|Overall Study|Involved in another investigative trial|0|||
125680632|NCT01918397|452120692|FG001|Overall Study|Involved in another investigative trial|0|||
125680633|NCT01918397|452120693|FG002|Overall Study|Involved in another investigative trial|0|||
125680634|NCT01918397|452120694|FG003|Overall Study|Involved in another investigative trial|1|||
125680635|NCT00620022|452120698|FG000|Treatment Period 1|Adverse Event|4|||
125680636|NCT00620022|452120699|FG001|Treatment Period 1|Adverse Event|6|||
125680637|NCT00620022|452120698|FG000|Treatment Period 1|Subject withdrew consent|1|||
125680638|NCT00620022|452120699|FG001|Treatment Period 1|Subject withdrew consent|0|||
125680639|NCT00620022|452120698|FG000|Treatment Period 2|Adverse Event|2|||
125680640|NCT00620022|452120699|FG001|Treatment Period 2|Adverse Event|2|||
125680641|NCT00262223|452120700|FG000|Treatment Phase|Withdrawal by Subject|3|||
125545490|NCT02842827|451627351|FG007|Overall Study|Participant Withdrawal of Consent|1|||
125545491|NCT01815138|451627354|FG000|Overall Study|Withdrawal by Subject|0|||
125545492|NCT01815138|451627355|FG001|Overall Study|Withdrawal by Subject|1|||
125545493|NCT01815138|451627354|FG000|Overall Study|Physician Decision|8|||
125680642|NCT00262223|452120701|FG001|Treatment Phase|Withdrawal by Subject|6|||
125680643|NCT00262223|452120700|FG000|Treatment Phase|Adverse Event|1|||
125680644|NCT00262223|452120701|FG001|Treatment Phase|Adverse Event|2|||
125680645|NCT00262223|452120700|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
125680646|NCT00262223|452120701|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
125545494|NCT01815138|451627355|FG001|Overall Study|Physician Decision|5|||
125545495|NCT03426267|451627356|FG000|Overall Study|Physician Decision|1|||
125545496|NCT03426267|451627357|FG001|Overall Study|Physician Decision|4|||
125345581|NCT01426789|450898318|FG000|Part 2|Adverse Event|0|||
125345582|NCT01426789|450898319|FG001|Part 2|Adverse Event|0|||
125345583|NCT01426789|450898320|FG002|Part 2|Adverse Event|2|||
125345584|NCT01426789|450898321|FG003|Part 2|Adverse Event|0|||
125345585|NCT01426789|450898322|FG004|Part 2|Adverse Event|1|||
125345586|NCT01426789|450898323|FG005|Part 2|Adverse Event|0|||
125345587|NCT00311584|450898326|FG000|Overall Study|Death|1|||
125345588|NCT00311584|450898327|FG001|Overall Study|Death|0|||
125345589|NCT00311584|450898326|FG000|Overall Study|Lack of Efficacy|12|||
125345590|NCT00311584|450898327|FG001|Overall Study|Lack of Efficacy|15|||
125345591|NCT00311584|450898326|FG000|Overall Study|Physician Decision|4|||
125345592|NCT00311584|450898327|FG001|Overall Study|Physician Decision|5|||
125345593|NCT00311584|450898326|FG000|Overall Study|Withdrawal by Subject|1|||
125345594|NCT00311584|450898327|FG001|Overall Study|Withdrawal by Subject|1|||
125345595|NCT00311584|450898326|FG000|Overall Study|ineligible|2|||
125345596|NCT00311584|450898327|FG001|Overall Study|ineligible|2|||
125345597|NCT00167778|450898332|FG000|Overall Study|Withdrawal by Subject|1|||
125345598|NCT02654717|450898333|FG000|Overall Study|Adverse Event|2|||
125345599|NCT02654717|450898334|FG001|Overall Study|Adverse Event|2|||
125345600|NCT02654717|450898333|FG000|Overall Study|Protocol Violation|1|||
125345601|NCT02654717|450898334|FG001|Overall Study|Protocol Violation|2|||
125345602|NCT02654717|450898333|FG000|Overall Study|Withdrawal by Subject|0|||
125345603|NCT02654717|450898334|FG001|Overall Study|Withdrawal by Subject|1|||
125345604|NCT02654717|450898333|FG000|Overall Study|Non-permitted medication|3|||
125345605|NCT02654717|450898334|FG001|Overall Study|Non-permitted medication|0|||
125345606|NCT00528970|450899773|FG000|Overall Study|Adverse Event|6|||
125345607|NCT00528970|450899774|FG001|Overall Study|Adverse Event|8|||
125345608|NCT00528970|450899775|FG002|Overall Study|Adverse Event|5|||
125345609|NCT00528970|450899773|FG000|Overall Study|Lost to Follow-up|0|||
125345610|NCT00528970|450899774|FG001|Overall Study|Lost to Follow-up|0|||
125345611|NCT00528970|450899775|FG002|Overall Study|Lost to Follow-up|1|||
125345612|NCT00528970|450899773|FG000|Overall Study|Other than specified|2|||
125345613|NCT00528970|450899774|FG001|Overall Study|Other than specified|3|||
125345614|NCT00528970|450899775|FG002|Overall Study|Other than specified|3|||
125345615|NCT00528970|450899773|FG000|Overall Study|Protocol Violation|2|||
125345616|NCT00528970|450899774|FG001|Overall Study|Protocol Violation|1|||
125345617|NCT00528970|450899775|FG002|Overall Study|Protocol Violation|4|||
125345618|NCT00528970|450899773|FG000|Overall Study|Lack of Efficacy|0|||
125345619|NCT00528970|450899774|FG001|Overall Study|Lack of Efficacy|0|||
125345620|NCT00528970|450899775|FG002|Overall Study|Lack of Efficacy|1|||
125345621|NCT00528970|450899773|FG000|Overall Study|Withdrawal by Subject|4|||
125345622|NCT00528970|450899774|FG001|Overall Study|Withdrawal by Subject|3|||
125545497|NCT03426267|451627356|FG000|Overall Study|Lost to Follow-up|1|||
125545498|NCT03426267|451627357|FG001|Overall Study|Lost to Follow-up|0|||
125545499|NCT03426267|451627356|FG000|Overall Study|Withdrawal by Subject|4|||
125345623|NCT00528970|450899775|FG002|Overall Study|Withdrawal by Subject|5|||
125545500|NCT03426267|451627357|FG001|Overall Study|Withdrawal by Subject|10|||
125345624|NCT00528970|450899773|FG000|Overall Study|Randomized but not treated|0|||
125345625|NCT00528970|450899774|FG001|Overall Study|Randomized but not treated|0|||
125345626|NCT00528970|450899775|FG002|Overall Study|Randomized but not treated|1|||
125345627|NCT00770146|450899786|FG000|Treatment Period|Withdrawal by Subject|6|||
125345628|NCT00770146|450899787|FG001|Treatment Period|Withdrawal by Subject|13|||
125345629|NCT00770146|450899786|FG000|Treatment Period|Adverse Event|2|||
125345630|NCT00770146|450899787|FG001|Treatment Period|Adverse Event|26|||
125545501|NCT03426267|451627356|FG000|Overall Study|Protocol Violation|1|||
125545502|NCT03426267|451627357|FG001|Overall Study|Protocol Violation|3|||
125545503|NCT03426267|451627356|FG000|Overall Study|Adverse Event|9|||
125545504|NCT03426267|451627357|FG001|Overall Study|Adverse Event|27|||
125545505|NCT03426267|451627356|FG000|Overall Study|Prohibited Treatment Intake|2|||
125545506|NCT03426267|451627357|FG001|Overall Study|Prohibited Treatment Intake|3|||
125545507|NCT03426267|451627356|FG000|Overall Study|Lack of Efficacy|0|||
125545508|NCT03426267|451627357|FG001|Overall Study|Lack of Efficacy|25|||
125545509|NCT03426267|451627356|FG000|Overall Study|other|3|||
125545510|NCT03426267|451627357|FG001|Overall Study|other|0|||
125545511|NCT00609765|451627360|FG000|Overall Study|Study ended prior to 12 months|1|||
125545512|NCT02649946|451627367|FG000|Overall Study|Withdrawal by Subject|1|||
125545513|NCT02649946|451627368|FG001|Overall Study|Withdrawal by Subject|1|||
125545514|NCT02649946|451627367|FG000|Overall Study|Death|7|||
125545515|NCT02649946|451627368|FG001|Overall Study|Death|9|||
125545516|NCT02649946|451627367|FG000|Overall Study|Physician Decision|1|||
125545517|NCT02649946|451627368|FG001|Overall Study|Physician Decision|0|||
125545518|NCT02649946|451627367|FG000|Overall Study|Lost to Follow-up|2|||
125545519|NCT02649946|451627368|FG001|Overall Study|Lost to Follow-up|1|||
125545520|NCT02649946|451627367|FG000|Overall Study|Erroneously enrolled|1|||
125545521|NCT02649946|451627368|FG001|Overall Study|Erroneously enrolled|0|||
125545522|NCT02649946|451627367|FG000|Overall Study|Missed 6-month follow-up visit|0|||
125545523|NCT02649946|451627368|FG001|Overall Study|Missed 6-month follow-up visit|4|||
125545524|NCT00950950|451627369|FG000|Overall Study|Adverse Event|1|||
125545525|NCT00950950|451627370|FG001|Overall Study|Adverse Event|0|||
125545526|NCT00950950|451627369|FG000|Overall Study|Withdrawal by Subject|0|||
125545527|NCT00950950|451627370|FG001|Overall Study|Withdrawal by Subject|1|||
125545528|NCT01047293|451627374|FG000|Overall Study|DLT criteria not fulfilled|1|||
125545529|NCT01047293|451627375|FG001|Overall Study|DLT criteria not fulfilled|1|||
125545530|NCT01047293|451627376|FG002|Overall Study|DLT criteria not fulfilled|0|||
125545531|NCT01047293|451627377|FG003|Overall Study|DLT criteria not fulfilled|0|||
125545532|NCT01272804|451627380|FG000|Overall Study|Adverse Event|1|||
125545533|NCT01272804|451627381|FG001|Overall Study|Adverse Event|0|||
125545534|NCT01272804|451627382|FG002|Overall Study|Adverse Event|0|||
125545535|NCT01272804|451627383|FG003|Overall Study|Adverse Event|0|||
125545536|NCT01272804|451627384|FG004|Overall Study|Adverse Event|2|||
125680647|NCT00262223|452120700|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
125680648|NCT00262223|452120701|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
125680649|NCT00262223|452120700|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
125680650|NCT00262223|452120701|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
125680651|NCT01804270|452120704|FG000|Overall Study|Withdrawal by Subject|1|||
125680652|NCT01804270|452120705|FG001|Overall Study|Withdrawal by Subject|1|||
125680653|NCT01328093|452120709|FG000|Double-Blind Phase|Adverse Event|78|||
125680654|NCT01328093|452120710|FG001|Double-Blind Phase|Adverse Event|15|||
125680655|NCT01328093|452120709|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
125680656|NCT01328093|452120710|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
125680657|NCT01328093|452120709|FG000|Double-Blind Phase|Lost to Follow-up|39|||
125680658|NCT01328093|452120710|FG001|Double-Blind Phase|Lost to Follow-up|14|||
125680659|NCT01328093|452120709|FG000|Double-Blind Phase|Protocol Violation|30|||
125680660|NCT01328093|452120710|FG001|Double-Blind Phase|Protocol Violation|10|||
125680661|NCT01328093|452120709|FG000|Double-Blind Phase|Lack of Efficacy|55|||
125680662|NCT01328093|452120710|FG001|Double-Blind Phase|Lack of Efficacy|13|||
125680663|NCT01328093|452120709|FG000|Double-Blind Phase|Sponsor Decision|17|||
125680664|NCT01328093|452120710|FG001|Double-Blind Phase|Sponsor Decision|3|||
125680665|NCT01328093|452120709|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
125680666|NCT01328093|452120710|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
125680667|NCT01328093|452120709|FG000|Double-Blind Phase|Scheduling conflict|8|||
125680668|NCT01328093|452120710|FG001|Double-Blind Phase|Scheduling conflict|3|||
125680669|NCT01328093|452120709|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
125680670|NCT01328093|452120710|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
125680671|NCT01328093|452120709|FG000|Double-Blind Phase|Death|1|||
125680672|NCT01328093|452120710|FG001|Double-Blind Phase|Death|0|||
125680673|NCT01328093|452120709|FG000|Open-Label Phase|Sponsor Decision|98|||
125680674|NCT01328093|452120710|FG001|Open-Label Phase|Sponsor Decision|34|||
125680675|NCT01328093|452120709|FG000|Open-Label Phase|Protocol Violation|8|||
125680676|NCT01328093|452120710|FG001|Open-Label Phase|Protocol Violation|3|||
125680677|NCT01328093|452120709|FG000|Open-Label Phase|Lost to Follow-up|10|||
125680678|NCT01328093|452120710|FG001|Open-Label Phase|Lost to Follow-up|1|||
125545537|NCT01272804|451627385|FG005|Overall Study|Adverse Event|1|||
125545538|NCT02318797|451627386|FG000|Overall Study|Death|3|||
125545539|NCT02318797|451627387|FG001|Overall Study|Death|6|||
125545540|NCT02318797|451627386|FG000|Overall Study|Lost to Follow-up|85|||
125545541|NCT02318797|451627387|FG001|Overall Study|Lost to Follow-up|96|||
125545542|NCT02112708|451627390|FG000|Baseline|Physician Decision|16|||
125680679|NCT01328093|452120709|FG000|Open-Label Phase|Adverse Event|10|||
125680680|NCT01328093|452120710|FG001|Open-Label Phase|Adverse Event|4|||
125680681|NCT01328093|452120709|FG000|Open-Label Phase|Lack of Efficacy|5|||
125680682|NCT01328093|452120710|FG001|Open-Label Phase|Lack of Efficacy|6|||
125545543|NCT02112708|451627391|FG001|Baseline|Physician Decision|11|||
125545544|NCT02112708|451627390|FG000|Baseline|Lost to Follow-up|12|||
125545545|NCT02112708|451627391|FG001|Baseline|Lost to Follow-up|0|||
125545546|NCT02112708|451627390|FG000|4 Month|Death|0|||
125545547|NCT02112708|451627391|FG001|4 Month|Death|1|||
125545548|NCT02112708|451627390|FG000|4 Month|Withdrawal by Subject|12|||
125545549|NCT02112708|451627391|FG001|4 Month|Withdrawal by Subject|0|||
125545550|NCT02232243|451627396|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
125545551|NCT02232243|451627397|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
125545552|NCT02232243|451627398|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
125545553|NCT00704405|451627399|FG000|Overall Study (NC Population)|Adverse Event|1|||
125545554|NCT00704405|451627400|FG001|Overall Study (NC Population)|Adverse Event|0|||
125545555|NCT00704405|451627401|FG002|Overall Study (NC Population)|Adverse Event|0|||
125545556|NCT00704405|451627402|FG003|Overall Study (NC Population)|Adverse Event|0|||
125545557|NCT00704405|451627403|FG004|Overall Study (NC Population)|Adverse Event|0|||
125545558|NCT00704405|451627399|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
125545559|NCT00704405|451627400|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
125545560|NCT00704405|451627401|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
125545561|NCT00704405|451627402|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
125545562|NCT00704405|451627403|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
125545563|NCT00704405|451627399|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
125545564|NCT00704405|451627400|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
125545565|NCT00704405|451627401|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
125545566|NCT00704405|451627402|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
125345631|NCT00770146|450899786|FG000|Treatment Period|Other|1|||
125345632|NCT00770146|450899787|FG001|Treatment Period|Other|5|||
125545567|NCT00704405|451627403|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
125545568|NCT00704405|451627399|FG000|Overall Study (NC Population)|Other|0|||
125545569|NCT00704405|451627400|FG001|Overall Study (NC Population)|Other|0|||
125545570|NCT00704405|451627401|FG002|Overall Study (NC Population)|Other|0|||
125545571|NCT00704405|451627402|FG003|Overall Study (NC Population)|Other|0|||
125545572|NCT00704405|451627403|FG004|Overall Study (NC Population)|Other|1|||
125345633|NCT00770146|450899786|FG000|Treatment Period|Protocol non-compliance|0|||
125545573|NCT00704405|451627399|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
125545574|NCT00704405|451627400|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
125545575|NCT00704405|451627401|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
125545576|NCT00704405|451627402|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
125545577|NCT00704405|451627403|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
125545578|NCT00704405|451627399|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
125545579|NCT00704405|451627400|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
125545580|NCT00704405|451627401|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
125545581|NCT00704405|451627402|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
125545582|NCT00704405|451627403|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
125545583|NCT00928018|451627404|FG000|Overall Study|Withdrawal by Subject|1|||
125545584|NCT00928018|451627405|FG001|Overall Study|Withdrawal by Subject|0|||
125545585|NCT03218397|451627406|FG000|Overall Study|Prior positive blood culture|8|||
125545586|NCT03218397|451627407|FG001|Overall Study|Prior positive blood culture|13|||
125545587|NCT03218397|451627406|FG000|Overall Study|Comfort care|8|||
125545588|NCT03218397|451627407|FG001|Overall Study|Comfort care|5|||
125545589|NCT03218397|451627406|FG000|Overall Study|Comfort care and positive blood culture|1|||
125545590|NCT03218397|451627407|FG001|Overall Study|Comfort care and positive blood culture|0|||
125545591|NCT03218397|451627406|FG000|Overall Study|Comfort care and mixed culture|0|||
125545592|NCT03218397|451627407|FG001|Overall Study|Comfort care and mixed culture|1|||
125545593|NCT03218397|451627406|FG000|Overall Study|Mixed culture|2|||
125545594|NCT03218397|451627407|FG001|Overall Study|Mixed culture|2|||
125545595|NCT03218397|451627406|FG000|Overall Study|Inaccessible hospital records|2|||
125545596|NCT03218397|451627407|FG001|Overall Study|Inaccessible hospital records|5|||
125545597|NCT03218397|451627406|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
125545598|NCT03218397|451627407|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
125545599|NCT03218397|451627406|FG000|Overall Study|Randomized during laboratory off hours|2|||
125545600|NCT03218397|451627407|FG001|Overall Study|Randomized during laboratory off hours|1|||
125345634|NCT00770146|450899787|FG001|Treatment Period|Protocol non-compliance|1|||
125345635|NCT00770146|450899786|FG000|Follow-up Period|Withdrawal by Subject|7|||
125345636|NCT00770146|450899787|FG001|Follow-up Period|Withdrawal by Subject|13|||
125345637|NCT00770146|450899786|FG000|Follow-up Period|Adverse Event|0|||
125345638|NCT00770146|450899787|FG001|Follow-up Period|Adverse Event|2|||
125345639|NCT00770146|450899786|FG000|Follow-up Period|Other|4|||
125345640|NCT00770146|450899787|FG001|Follow-up Period|Other|5|||
125345641|NCT00816023|450899789|FG000|Overall Study|Lost to Follow-up|1|||
125345642|NCT00816023|450899790|FG001|Overall Study|Lost to Follow-up|1|||
125345643|NCT00816023|450899791|FG002|Overall Study|Lost to Follow-up|0|||
125345644|NCT00816023|450899792|FG003|Overall Study|Lost to Follow-up|0|||
125345645|NCT00816023|450899789|FG000|Overall Study|Withdrawal by Subject|1|||
125345646|NCT00816023|450899790|FG001|Overall Study|Withdrawal by Subject|0|||
125345647|NCT00816023|450899791|FG002|Overall Study|Withdrawal by Subject|0|||
125345648|NCT00816023|450899792|FG003|Overall Study|Withdrawal by Subject|0|||
125345649|NCT00816023|450899789|FG000|Overall Study|Physician Decision|0|||
125345650|NCT00816023|450899790|FG001|Overall Study|Physician Decision|0|||
125345651|NCT00816023|450899791|FG002|Overall Study|Physician Decision|1|||
125345652|NCT00816023|450899792|FG003|Overall Study|Physician Decision|0|||
125345653|NCT00816023|450899789|FG000|Overall Study|assessments complete prior to window|1|||
125345654|NCT00816023|450899790|FG001|Overall Study|assessments complete prior to window|1|||
125345655|NCT00816023|450899791|FG002|Overall Study|assessments complete prior to window|2|||
125345656|NCT00816023|450899792|FG003|Overall Study|assessments complete prior to window|1|||
125345657|NCT00816023|450899789|FG000|Overall Study|Randomized Not Treated|6|||
125345658|NCT00816023|450899790|FG001|Overall Study|Randomized Not Treated|4|||
125345659|NCT00816023|450899791|FG002|Overall Study|Randomized Not Treated|6|||
125345660|NCT00816023|450899792|FG003|Overall Study|Randomized Not Treated|11|||
125345661|NCT05027971|450899793|FG000|Overall Study|Physician Decision|7|||
125345662|NCT05027971|450899794|FG001|Overall Study|Physician Decision|3|||
125345663|NCT05027971|450899793|FG000|Overall Study|Lost to Follow-up|1|||
125345664|NCT05027971|450899794|FG001|Overall Study|Lost to Follow-up|1|||
125345665|NCT05027971|450899793|FG000|Overall Study|Withdrawal by Subject|0|||
125345666|NCT05027971|450899794|FG001|Overall Study|Withdrawal by Subject|2|||
125345667|NCT05027971|450899793|FG000|Overall Study|Non-study fiber used.|0|||
125545601|NCT00943111|451627408|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
125345668|NCT05027971|450899794|FG001|Overall Study|Non-study fiber used.|1|||
125345669|NCT05027971|450899793|FG000|Overall Study|Protocol Violation|0|||
125345670|NCT05027971|450899794|FG001|Overall Study|Protocol Violation|2|||
125345671|NCT05395091|450899795|FG000|Baseline to Month 12|Adverse Event|7|||
125345672|NCT05395091|450899796|FG001|Baseline to Month 12|Adverse Event|2|||
125545602|NCT00943111|451627409|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
125545603|NCT00943111|451627410|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
125545604|NCT00943111|451627408|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
125545605|NCT00943111|451627409|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
125545606|NCT00943111|451627410|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
125545607|NCT00943111|451627408|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
125545608|NCT00943111|451627409|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
125545609|NCT00943111|451627410|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
125545610|NCT00943111|451627408|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
125545611|NCT00943111|451627409|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
125545612|NCT00943111|451627410|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
125545613|NCT00943111|451627408|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
125545614|NCT00943111|451627409|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
125545615|NCT00943111|451627410|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
125545616|NCT00943111|451627408|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
125545617|NCT00943111|451627409|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
125545618|NCT00943111|451627410|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
125545619|NCT00943111|451627408|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
125545620|NCT00943111|451627409|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
125545621|NCT00943111|451627410|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
125545622|NCT00943111|451627408|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
125545623|NCT00943111|451627409|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
125545624|NCT00943111|451627410|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
125545625|NCT01796548|451627411|FG000|Overall Study|Lost to Follow-up|1|||
125545626|NCT01796548|451627411|FG000|Overall Study|Other|2|||
125545627|NCT01946438|451627412|FG000|Overall Study|Adverse Event|0|||
125545628|NCT01946438|451627413|FG001|Overall Study|Adverse Event|0|||
125545629|NCT01946438|451627414|FG002|Overall Study|Adverse Event|0|||
125545630|NCT01946438|451627415|FG003|Overall Study|Adverse Event|1|||
125545631|NCT01946438|451627412|FG000|Overall Study|Serious Adverse event|1|||
125545632|NCT01946438|451627413|FG001|Overall Study|Serious Adverse event|0|||
125545633|NCT01946438|451627414|FG002|Overall Study|Serious Adverse event|0|||
125545634|NCT01946438|451627415|FG003|Overall Study|Serious Adverse event|0|||
125545635|NCT01946438|451627412|FG000|Overall Study|Protocol Violation|0|||
125545636|NCT01946438|451627413|FG001|Overall Study|Protocol Violation|0|||
125545637|NCT01946438|451627414|FG002|Overall Study|Protocol Violation|1|||
125545638|NCT01946438|451627415|FG003|Overall Study|Protocol Violation|0|||
125545639|NCT01946438|451627412|FG000|Overall Study|Withdrawal by Subject|1|||
125545640|NCT01946438|451627413|FG001|Overall Study|Withdrawal by Subject|0|||
125545641|NCT01946438|451627414|FG002|Overall Study|Withdrawal by Subject|0|||
125545642|NCT01946438|451627415|FG003|Overall Study|Withdrawal by Subject|0|||
125545643|NCT02457559|451627416|FG000|Overall Study|Progressive Disease|1|||
125545644|NCT02457559|451627417|FG001|Overall Study|Progressive Disease|2|||
125545645|NCT02457559|451627418|FG002|Overall Study|Progressive Disease|3|||
125545646|NCT02457559|451627419|FG003|Overall Study|Progressive Disease|0|||
125545647|NCT02457559|451627420|FG004|Overall Study|Progressive Disease|0|||
125545648|NCT02457559|451627421|FG005|Overall Study|Progressive Disease|2|||
125545649|NCT02457559|451627422|FG006|Overall Study|Progressive Disease|1|||
125545650|NCT02457559|451627423|FG007|Overall Study|Progressive Disease|0|||
125545651|NCT02457559|451627424|FG008|Overall Study|Progressive Disease|1|||
125545652|NCT02457559|451627425|FG009|Overall Study|Progressive Disease|1|||
125545653|NCT02457559|451627426|FG010|Overall Study|Progressive Disease|1|||
125545654|NCT02457559|451627416|FG000|Overall Study|Investigator's Discretion|0|||
125545655|NCT02457559|451627417|FG001|Overall Study|Investigator's Discretion|0|||
125680683|NCT01328093|452120709|FG000|Open-Label Phase|Withdrawal by Subject|4|||
125680684|NCT01328093|452120710|FG001|Open-Label Phase|Withdrawal by Subject|1|||
125680685|NCT01328093|452120709|FG000|Open-Label Phase|Scheduling conflict|2|||
125680686|NCT01328093|452120710|FG001|Open-Label Phase|Scheduling conflict|1|||
125680687|NCT01328093|452120709|FG000|Open-Label Phase|Subject is moving or has moved|2|||
125680688|NCT01328093|452120710|FG001|Open-Label Phase|Subject is moving or has moved|0|||
125680689|NCT01328093|452120709|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
125545656|NCT02457559|451627418|FG002|Overall Study|Investigator's Discretion|2|||
125545657|NCT02457559|451627419|FG003|Overall Study|Investigator's Discretion|0|||
125545658|NCT02457559|451627420|FG004|Overall Study|Investigator's Discretion|1|||
125545659|NCT02457559|451627421|FG005|Overall Study|Investigator's Discretion|0|||
125545660|NCT02457559|451627422|FG006|Overall Study|Investigator's Discretion|1|||
125545661|NCT02457559|451627423|FG007|Overall Study|Investigator's Discretion|0|||
125545662|NCT02457559|451627424|FG008|Overall Study|Investigator's Discretion|1|||
125545663|NCT02457559|451627425|FG009|Overall Study|Investigator's Discretion|0|||
125545664|NCT02457559|451627426|FG010|Overall Study|Investigator's Discretion|1|||
125680690|NCT01328093|452120710|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
125680691|NCT05150964|452120713|FG000|Overall Study|Lost to Follow-up|2|||
125680692|NCT03661528|452120714|FG000|Overall Study|Death|1|||
125545665|NCT02457559|451627416|FG000|Overall Study|Adverse Event|0|||
125545666|NCT02457559|451627417|FG001|Overall Study|Adverse Event|1|||
125545667|NCT02457559|451627418|FG002|Overall Study|Adverse Event|2|||
125545668|NCT02457559|451627419|FG003|Overall Study|Adverse Event|0|||
125345673|NCT05395091|450899797|FG002|Baseline to Month 12|Adverse Event|0|||
125545669|NCT02457559|451627420|FG004|Overall Study|Adverse Event|0|||
125545670|NCT02457559|451627421|FG005|Overall Study|Adverse Event|0|||
125545671|NCT02457559|451627422|FG006|Overall Study|Adverse Event|0|||
125545672|NCT02457559|451627423|FG007|Overall Study|Adverse Event|0|||
125545673|NCT02457559|451627424|FG008|Overall Study|Adverse Event|0|||
125545674|NCT02457559|451627425|FG009|Overall Study|Adverse Event|0|||
125545675|NCT02457559|451627426|FG010|Overall Study|Adverse Event|0|||
125345674|NCT05395091|450899795|FG000|Baseline to Month 12|Death|3|||
125345675|NCT05395091|450899796|FG001|Baseline to Month 12|Death|1|||
125345676|NCT05395091|450899797|FG002|Baseline to Month 12|Death|0|||
125345677|NCT05395091|450899795|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
125345678|NCT05395091|450899796|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
125345679|NCT05395091|450899797|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
125345680|NCT05395091|450899795|FG000|Baseline to Month 12|Protocol Violation|2|||
125345681|NCT05395091|450899796|FG001|Baseline to Month 12|Protocol Violation|3|||
125345682|NCT05395091|450899797|FG002|Baseline to Month 12|Protocol Violation|0|||
125345683|NCT05395091|450899795|FG000|Baseline to Month 12|Physician Decision|1|||
125345684|NCT05395091|450899796|FG001|Baseline to Month 12|Physician Decision|0|||
125345685|NCT05395091|450899797|FG002|Baseline to Month 12|Physician Decision|0|||
125345686|NCT05395091|450899795|FG000|Month 12 to Month 18|Death|1|||
125345687|NCT05395091|450899796|FG001|Month 12 to Month 18|Death|0|||
125345688|NCT05395091|450899797|FG002|Month 12 to Month 18|Death|0|||
125345689|NCT05395091|450899795|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
125345690|NCT05395091|450899796|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
125345691|NCT05395091|450899797|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
125345692|NCT05395091|450899795|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
125345693|NCT05395091|450899796|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
125345694|NCT05395091|450899797|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
125345695|NCT05395091|450899795|FG000|Month 12 to Month 18|Other reasons|0|||
125345696|NCT05395091|450899796|FG001|Month 12 to Month 18|Other reasons|0|||
125345697|NCT05395091|450899797|FG002|Month 12 to Month 18|Other reasons|1|||
125345698|NCT00313781|450899800|FG000|Before Crossover|Death|22|||
125345699|NCT00313781|450899801|FG001|Before Crossover|Death|8|||
125345700|NCT00313781|450899802|FG002|Before Crossover|Death|0|||
125345701|NCT00313781|450899800|FG000|Before Crossover|Lost to Follow-up|0|||
125345702|NCT00313781|450899801|FG001|Before Crossover|Lost to Follow-up|3|||
125345703|NCT00313781|450899802|FG002|Before Crossover|Lost to Follow-up|0|||
125345704|NCT00313781|450899800|FG000|Before Crossover|Withdrawal by Subject|3|||
125345705|NCT00313781|450899801|FG001|Before Crossover|Withdrawal by Subject|1|||
125345706|NCT00313781|450899802|FG002|Before Crossover|Withdrawal by Subject|0|||
125345707|NCT00313781|450899800|FG000|Before Crossover|Other|45|||
125345708|NCT00313781|450899801|FG001|Before Crossover|Other|30|||
125345709|NCT00313781|450899802|FG002|Before Crossover|Other|0|||
125345710|NCT00313781|450899800|FG000|Before Crossover|Crossover|0|||
125345711|NCT00313781|450899801|FG001|Before Crossover|Crossover|37|||
125345712|NCT00313781|450899802|FG002|Before Crossover|Crossover|0|||
125345713|NCT00313781|450899800|FG000|Before Crossover|Randomized, not treated|5|||
125345714|NCT00313781|450899801|FG001|Before Crossover|Randomized, not treated|0|||
125345715|NCT00313781|450899802|FG002|Before Crossover|Randomized, not treated|0|||
125345716|NCT00313781|450899800|FG000|After Crossover|Death|0|||
125345717|NCT00313781|450899801|FG001|After Crossover|Death|0|||
125345718|NCT00313781|450899802|FG002|After Crossover|Death|6|||
125345719|NCT00313781|450899800|FG000|After Crossover|Withdrawal by Subject|0|||
125345720|NCT00313781|450899801|FG001|After Crossover|Withdrawal by Subject|0|||
125345721|NCT00313781|450899802|FG002|After Crossover|Withdrawal by Subject|3|||
125345722|NCT00313781|450899800|FG000|After Crossover|Other|0|||
125345723|NCT00313781|450899801|FG001|After Crossover|Other|0|||
125345724|NCT00313781|450899802|FG002|After Crossover|Other|18|||
125345725|NCT01433250|450899803|FG000|Overall Study|Protocol Violation|0|||
125345726|NCT01433250|450899804|FG001|Overall Study|Protocol Violation|1|||
125345727|NCT01433250|450899803|FG000|Overall Study|Withdrawal by Subject|3|||
125345728|NCT01433250|450899804|FG001|Overall Study|Withdrawal by Subject|2|||
125345729|NCT00834080|450899805|FG000|Overall Study|Adverse Event|7|||
125345730|NCT00834080|450899805|FG000|Overall Study|Lost to Follow-up|7|||
125345731|NCT00834080|450899805|FG000|Overall Study|Withdrawal by Subject|5|||
125345732|NCT00834080|450899805|FG000|Overall Study|Other - Pregnancy|1|||
125545676|NCT02457559|451627416|FG000|Overall Study|Reason not Specified|1|||
125545677|NCT02457559|451627417|FG001|Overall Study|Reason not Specified|0|||
125345733|NCT00834080|450899805|FG000|Overall Study|Other - False positive tests of the UDS|1|||
125545678|NCT02457559|451627418|FG002|Overall Study|Reason not Specified|0|||
125345734|NCT00834080|450899805|FG000|Overall Study|Physician Decision|1|||
125345735|NCT00834080|450899805|FG000|Overall Study|Subject Relocated|1|||
125345736|NCT02431260|450899806|FG000|Overall Study|Subject Decision|0|||
125545679|NCT02457559|451627419|FG003|Overall Study|Reason not Specified|0|||
125545680|NCT02457559|451627420|FG004|Overall Study|Reason not Specified|0|||
125545681|NCT02457559|451627421|FG005|Overall Study|Reason not Specified|0|||
125545682|NCT02457559|451627422|FG006|Overall Study|Reason not Specified|0|||
125545683|NCT02457559|451627423|FG007|Overall Study|Reason not Specified|0|||
125545684|NCT02457559|451627424|FG008|Overall Study|Reason not Specified|0|||
125545685|NCT02457559|451627425|FG009|Overall Study|Reason not Specified|2|||
125545686|NCT02457559|451627426|FG010|Overall Study|Reason not Specified|0|||
125545687|NCT02457559|451627416|FG000|Overall Study|Death|0|||
125545688|NCT02457559|451627417|FG001|Overall Study|Death|0|||
125545689|NCT02457559|451627418|FG002|Overall Study|Death|0|||
125545690|NCT02457559|451627419|FG003|Overall Study|Death|0|||
125545691|NCT02457559|451627420|FG004|Overall Study|Death|0|||
125545692|NCT02457559|451627421|FG005|Overall Study|Death|0|||
125545693|NCT02457559|451627422|FG006|Overall Study|Death|0|||
125545694|NCT02457559|451627423|FG007|Overall Study|Death|0|||
125545695|NCT02457559|451627424|FG008|Overall Study|Death|1|||
125545696|NCT02457559|451627425|FG009|Overall Study|Death|1|||
125545697|NCT02457559|451627426|FG010|Overall Study|Death|0|||
125545698|NCT00031551|451629244|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
125545699|NCT00031551|451629245|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
125545700|NCT00409773|451629246|FG000|Overall Study|Adverse Event|3|||
125545701|NCT00409773|451629247|FG001|Overall Study|Adverse Event|4|||
125545702|NCT00409773|451629248|FG002|Overall Study|Adverse Event|4|||
125545703|NCT00409773|451629249|FG003|Overall Study|Adverse Event|2|||
125545704|NCT00409773|451629250|FG004|Overall Study|Adverse Event|6|||
125545705|NCT00409773|451629246|FG000|Overall Study|Lost to Follow-up|6|||
125545706|NCT00409773|451629247|FG001|Overall Study|Lost to Follow-up|1|||
125545707|NCT00409773|451629248|FG002|Overall Study|Lost to Follow-up|2|||
125545708|NCT00409773|451629249|FG003|Overall Study|Lost to Follow-up|3|||
125545709|NCT00409773|451629250|FG004|Overall Study|Lost to Follow-up|1|||
125545710|NCT00409773|451629246|FG000|Overall Study|Physician Decision|0|||
125545711|NCT00409773|451629247|FG001|Overall Study|Physician Decision|0|||
125545712|NCT00409773|451629248|FG002|Overall Study|Physician Decision|0|||
125545713|NCT00409773|451629249|FG003|Overall Study|Physician Decision|2|||
125545714|NCT00409773|451629250|FG004|Overall Study|Physician Decision|0|||
125545715|NCT00409773|451629246|FG000|Overall Study|Protocol Violation|0|||
125545716|NCT00409773|451629247|FG001|Overall Study|Protocol Violation|2|||
125545717|NCT00409773|451629248|FG002|Overall Study|Protocol Violation|3|||
125545718|NCT00409773|451629249|FG003|Overall Study|Protocol Violation|3|||
125545719|NCT00409773|451629250|FG004|Overall Study|Protocol Violation|1|||
125545720|NCT00409773|451629246|FG000|Overall Study|Withdrawal by Subject|0|||
125545721|NCT00409773|451629247|FG001|Overall Study|Withdrawal by Subject|0|||
125545722|NCT00409773|451629248|FG002|Overall Study|Withdrawal by Subject|0|||
125545723|NCT00409773|451629249|FG003|Overall Study|Withdrawal by Subject|2|||
125545724|NCT00409773|451629250|FG004|Overall Study|Withdrawal by Subject|1|||
125545725|NCT00409773|451629246|FG000|Overall Study|Lack of Eligibility|0|||
125545726|NCT00409773|451629247|FG001|Overall Study|Lack of Eligibility|0|||
125545727|NCT00409773|451629248|FG002|Overall Study|Lack of Eligibility|0|||
125545728|NCT00409773|451629249|FG003|Overall Study|Lack of Eligibility|0|||
125545729|NCT00409773|451629250|FG004|Overall Study|Lack of Eligibility|1|||
125545730|NCT00153062|451629251|FG000|Overall Study|Death|360|||
125545731|NCT00153062|451629252|FG001|Overall Study|Death|352|||
125545732|NCT00153062|451629253|FG002|Overall Study|Death|369|||
125545733|NCT00153062|451629254|FG003|Overall Study|Death|365|||
125545734|NCT00153062|451629251|FG000|Overall Study|Withdrawal by Subject|14|||
125545735|NCT00153062|451629252|FG001|Overall Study|Withdrawal by Subject|30|||
125545736|NCT00153062|451629253|FG002|Overall Study|Withdrawal by Subject|27|||
125545737|NCT00153062|451629254|FG003|Overall Study|Withdrawal by Subject|28|||
125545738|NCT00153062|451629251|FG000|Overall Study|Lost to Follow-up|12|||
125545739|NCT00153062|451629252|FG001|Overall Study|Lost to Follow-up|20|||
125545740|NCT00153062|451629253|FG002|Overall Study|Lost to Follow-up|15|||
125545741|NCT00153062|451629254|FG003|Overall Study|Lost to Follow-up|16|||
125545742|NCT00153062|451629251|FG000|Overall Study|Adverse Event|0|||
125545743|NCT00153062|451629252|FG001|Overall Study|Adverse Event|1|||
125545744|NCT00153062|451629253|FG002|Overall Study|Adverse Event|1|||
125545745|NCT00153062|451629254|FG003|Overall Study|Adverse Event|0|||
125545746|NCT00153062|451629251|FG000|Overall Study|Protocol Violation|0|||
125545747|NCT00153062|451629252|FG001|Overall Study|Protocol Violation|2|||
125545748|NCT00153062|451629253|FG002|Overall Study|Protocol Violation|1|||
125545749|NCT00153062|451629254|FG003|Overall Study|Protocol Violation|1|||
125545750|NCT00153062|451629251|FG000|Overall Study|No disposition data available|1|||
125545751|NCT00153062|451629252|FG001|Overall Study|No disposition data available|1|||
125545752|NCT00153062|451629253|FG002|Overall Study|No disposition data available|1|||
125545753|NCT00153062|451629254|FG003|Overall Study|No disposition data available|1|||
125545754|NCT00153062|451629251|FG000|Overall Study|Other|0|||
125545755|NCT00153062|451629252|FG001|Overall Study|Other|0|||
125545756|NCT00153062|451629253|FG002|Overall Study|Other|1|||
125545757|NCT00153062|451629254|FG003|Overall Study|Other|0|||
125545758|NCT02359877|451629255|FG000|Overall Study|Withdrawal by Subject|1|||
125545759|NCT02359877|451629256|FG001|Overall Study|Withdrawal by Subject|0|||
125545760|NCT02359877|451629257|FG002|Overall Study|Withdrawal by Subject|0|||
125545761|NCT02359877|451629258|FG003|Overall Study|Withdrawal by Subject|2|||
125545762|NCT02359877|451629255|FG000|Overall Study|Adverse Event|0|||
125545763|NCT02359877|451629256|FG001|Overall Study|Adverse Event|0|||
125545764|NCT02359877|451629257|FG002|Overall Study|Adverse Event|0|||
125545765|NCT02359877|451629258|FG003|Overall Study|Adverse Event|1|||
125545766|NCT01919814|451629265|FG000|Overall Study|Adverse Event|1|||
125545767|NCT01919814|451629266|FG001|Overall Study|Adverse Event|0|||
125545768|NCT01919814|451629265|FG000|Overall Study|Protocol Violation|1|||
125545769|NCT01919814|451629266|FG001|Overall Study|Protocol Violation|0|||
125545770|NCT01919814|451629265|FG000|Overall Study|Withdrawal by Subject|1|||
125545771|NCT01919814|451629266|FG001|Overall Study|Withdrawal by Subject|0|||
125545772|NCT00275262|451629267|FG000|Overall Study|Adverse Event|2|||
125545773|NCT00275262|451629268|FG001|Overall Study|Adverse Event|0|||
125545774|NCT00275262|451629267|FG000|Overall Study|Disease progression|2|||
125545775|NCT00275262|451629268|FG001|Overall Study|Disease progression|5|||
125545776|NCT00275262|451629267|FG000|Overall Study|Lost to Follow-up|0|||
125545777|NCT00275262|451629268|FG001|Overall Study|Lost to Follow-up|2|||
125545778|NCT00275262|451629267|FG000|Overall Study|Protocol Violation|0|||
125545779|NCT00275262|451629268|FG001|Overall Study|Protocol Violation|2|||
125545780|NCT00275262|451629267|FG000|Overall Study|Death|1|||
125545781|NCT00275262|451629268|FG001|Overall Study|Death|0|||
125545782|NCT00275262|451629267|FG000|Overall Study|Started Chemotherapy|1|||
125545783|NCT00275262|451629268|FG001|Overall Study|Started Chemotherapy|0|||
125545784|NCT02164383|451629271|FG000|Overall Study|Lost to Follow-up|1|||
125545785|NCT02164383|451629272|FG001|Overall Study|Lost to Follow-up|0|||
125545786|NCT01589237|451629283|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
125545787|NCT01589237|451629284|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
125545788|NCT01589237|451629285|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
125545789|NCT01589237|451629286|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
125545790|NCT01589237|451629283|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
125545791|NCT01589237|451629284|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
125545792|NCT01589237|451629285|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
125545793|NCT01589237|451629286|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
125545794|NCT01589237|451629283|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
125545795|NCT01589237|451629284|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
125545796|NCT01589237|451629285|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
125545797|NCT01589237|451629286|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
125545798|NCT01589237|451629283|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
125545799|NCT01589237|451629284|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
125545800|NCT01589237|451629285|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
125545801|NCT01589237|451629286|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
125545802|NCT02594163|451629287|FG000|Treatment Period|Progressive disease|2|||
125545803|NCT02594163|451629288|FG001|Treatment Period|Progressive disease|3|||
125545804|NCT02594163|451629287|FG000|Treatment Period|Adverse Event|1|||
125545805|NCT02594163|451629288|FG001|Treatment Period|Adverse Event|5|||
125545806|NCT02594163|451629287|FG000|Treatment Period|Physician Decision|1|||
125545807|NCT02594163|451629288|FG001|Treatment Period|Physician Decision|3|||
125545808|NCT02594163|451629287|FG000|Treatment Period|Study termination by sponsor|2|||
125545809|NCT02594163|451629288|FG001|Treatment Period|Study termination by sponsor|1|||
125545810|NCT02594163|451629287|FG000|Treatment Period|Other, Non-AE|1|||
125545811|NCT02594163|451629288|FG001|Treatment Period|Other, Non-AE|0|||
125545812|NCT02594163|451629287|FG000|Follow-up Period|Withdrawal by Subject|0|||
125545813|NCT02594163|451629288|FG001|Follow-up Period|Withdrawal by Subject|1|||
125545814|NCT02594163|451629287|FG000|Follow-up Period|Study Termination by Sponsor|6|||
125545815|NCT02594163|451629288|FG001|Follow-up Period|Study Termination by Sponsor|4|||
125545816|NCT02594163|451629287|FG000|Follow-up Period|Lost to Follow-up|1|||
125545817|NCT02594163|451629288|FG001|Follow-up Period|Lost to Follow-up|0|||
125545818|NCT02594163|451629287|FG000|Follow-up Period|Death|2|||
125545819|NCT02594163|451629288|FG001|Follow-up Period|Death|5|||
125545820|NCT02594163|451629287|FG000|Follow-up Period|Adverse Event|0|||
125545821|NCT02594163|451629288|FG001|Follow-up Period|Adverse Event|1|||
125545822|NCT02594163|451629287|FG000|Follow-up Period|Progressive Disease|2|||
125545823|NCT02594163|451629288|FG001|Follow-up Period|Progressive Disease|0|||
125545824|NCT02594163|451629287|FG000|Follow-up Period|Physician Decision|0|||
125545825|NCT02594163|451629288|FG001|Follow-up Period|Physician Decision|1|||
125545826|NCT01290029|451629291|FG000|Overall Study|Other|2|||
125545827|NCT02831387|451629292|FG000|Overall Study|Withdrawal by Subject|1|||
125545828|NCT02831387|451629293|FG001|Overall Study|Withdrawal by Subject|1|||
125545829|NCT02831387|451629292|FG000|Overall Study|Discontinued due to stock recovery|0|||
125545830|NCT02831387|451629293|FG001|Overall Study|Discontinued due to stock recovery|1|||
125545831|NCT02336178|451629297|FG000|Overall Study|Lost to Follow-up|1|||
125345737|NCT02431260|450899807|FG001|Overall Study|Subject Decision|1|||
125345738|NCT02431260|450899808|FG002|Overall Study|Subject Decision|1|||
125345739|NCT02431260|450899809|FG003|Overall Study|Subject Decision|0|||
125345740|NCT02431260|450899810|FG004|Overall Study|Subject Decision|0|||
125210711|NCT02069093|450395659|FG000|Overall Study|Abnormal laboratory values|1|||
125345741|NCT02431260|450899811|FG005|Overall Study|Subject Decision|0|||
125345742|NCT02431260|450899812|FG006|Overall Study|Subject Decision|0|||
125345743|NCT02431260|450899813|FG007|Overall Study|Subject Decision|0|||
125545832|NCT02336178|451629297|FG000|Overall Study|Protocol Violation|1|||
125545833|NCT02336178|451629297|FG000|Overall Study|Withdrawal by Subject|1|||
125545834|NCT02336178|451629297|FG000|Overall Study|Other|1|||
125545835|NCT00618982|451629298|FG000|Overall Study|Adverse Event|23|||
125545836|NCT00618982|451629298|FG000|Overall Study|Withdrawal by Subject|1|||
125545837|NCT00618982|451629298|FG000|Overall Study|Protocol Violation|1|||
125545838|NCT00618982|451629298|FG000|Overall Study|ongoing, still treated with study med.|25|||
125545839|NCT00156819|451629301|FG000|Overall Study|Lost to Follow-up|1|||
125545840|NCT00156819|451629302|FG001|Overall Study|Lost to Follow-up|1|||
125545841|NCT00156819|451629303|FG002|Overall Study|Lost to Follow-up|3|||
125545842|NCT00799513|451629306|FG000|Overall Study|Physician Decision|1|||
125545843|NCT00799513|451629306|FG000|Overall Study|Adverse Event|1|||
125545844|NCT00666679|451629307|FG000|First Intervention|Lost to Follow-up|1|||
125545845|NCT00666679|451629308|FG001|First Intervention|Lost to Follow-up|0|||
125545846|NCT00666679|451629307|FG000|First Intervention|Protocol Violation|1|||
125545847|NCT00666679|451629308|FG001|First Intervention|Protocol Violation|0|||
125545848|NCT00666679|451629307|FG000|First Intervention|Withdrawal by Subject|1|||
125545849|NCT00666679|451629308|FG001|First Intervention|Withdrawal by Subject|0|||
125545850|NCT00666679|451629307|FG000|First Intervention|Randomized did not start treatment|1|||
125545851|NCT00666679|451629308|FG001|First Intervention|Randomized did not start treatment|1|||
125545852|NCT00666679|451629307|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
125545853|NCT00666679|451629308|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
125545854|NCT00666679|451629307|FG000|Washout Period of 1 Week|Protocol Violation|0|||
125545855|NCT00666679|451629308|FG001|Washout Period of 1 Week|Protocol Violation|1|||
125545856|NCT00666679|451629307|FG000|Second Intervention|Adverse Event|1|||
125545857|NCT00666679|451629308|FG001|Second Intervention|Adverse Event|0|||
125545858|NCT00666679|451629307|FG000|Second Intervention|Death|0|||
125545859|NCT00666679|451629308|FG001|Second Intervention|Death|1|||
125545860|NCT05062759|451629311|FG000|Overall Study|Death|0|||
125545861|NCT05062759|451629312|FG001|Overall Study|Death|1|||
125545862|NCT05062759|451629311|FG000|Overall Study|Lost to Follow-up|1|||
125545863|NCT05062759|451629312|FG001|Overall Study|Lost to Follow-up|0|||
125545864|NCT02781844|451629313|FG000|Treatment Period 1|Adverse Event|0|||
125545865|NCT02781844|451629314|FG001|Treatment Period 1|Adverse Event|0|||
125545866|NCT02781844|451629315|FG002|Treatment Period 1|Adverse Event|0|||
125545867|NCT02781844|451629316|FG003|Treatment Period 1|Adverse Event|0|||
125545868|NCT02781844|451629317|FG004|Treatment Period 1|Adverse Event|0|||
125545869|NCT02781844|451629318|FG005|Treatment Period 1|Adverse Event|1|||
125545870|NCT02781844|451629319|FG006|Treatment Period 1|Adverse Event|0|||
125545871|NCT02781844|451629320|FG007|Treatment Period 1|Adverse Event|0|||
125545872|NCT02518490|451629323|FG000|Overall Study|Withdrawal by Subject|1|||
125545873|NCT02518490|451629324|FG001|Overall Study|Withdrawal by Subject|1|||
125545874|NCT04256629|451629325|FG000|Overall Study|Adverse Event|0|||
125545875|NCT04256629|451629326|FG001|Overall Study|Adverse Event|0|||
125545876|NCT04256629|451629327|FG002|Overall Study|Adverse Event|0|||
125545877|NCT04256629|451629328|FG003|Overall Study|Adverse Event|0|||
125545878|NCT04256629|451629329|FG004|Overall Study|Adverse Event|0|||
125545879|NCT04256629|451629330|FG005|Overall Study|Adverse Event|1|||
125545880|NCT04256629|451629325|FG000|Overall Study|Protocol Violation|0|||
125545881|NCT04256629|451629326|FG001|Overall Study|Protocol Violation|1|||
125545882|NCT04256629|451629327|FG002|Overall Study|Protocol Violation|0|||
125545883|NCT04256629|451629328|FG003|Overall Study|Protocol Violation|0|||
125545884|NCT04256629|451629329|FG004|Overall Study|Protocol Violation|0|||
125545885|NCT04256629|451629330|FG005|Overall Study|Protocol Violation|0|||
125345744|NCT02431260|450899814|FG008|Overall Study|Subject Decision|1|||
125545886|NCT00346632|451629331|FG000|Overall Study|Progressive Disease|2|||
125545887|NCT00346632|451629332|FG001|Overall Study|Progressive Disease|2|||
125545888|NCT00346632|451629333|FG002|Overall Study|Progressive Disease|4|||
125545889|NCT00346632|451629334|FG003|Overall Study|Progressive Disease|3|||
125545890|NCT00346632|451629335|FG004|Overall Study|Progressive Disease|3|||
125545891|NCT00346632|451629336|FG005|Overall Study|Progressive Disease|1|||
125545892|NCT00346632|451629337|FG006|Overall Study|Progressive Disease|2|||
125545893|NCT00346632|451629338|FG007|Overall Study|Progressive Disease|2|||
125545894|NCT00346632|451629339|FG008|Overall Study|Progressive Disease|2|||
125545895|NCT00346632|451629340|FG009|Overall Study|Progressive Disease|2|||
125545896|NCT00346632|451629331|FG000|Overall Study|Adverse Event|0|||
125210712|NCT02069093|450395659|FG000|Overall Study|Adverse Event|10|||
125545897|NCT00346632|451629332|FG001|Overall Study|Adverse Event|0|||
125545898|NCT00346632|451629333|FG002|Overall Study|Adverse Event|0|||
125545899|NCT00346632|451629334|FG003|Overall Study|Adverse Event|0|||
125545900|NCT00346632|451629335|FG004|Overall Study|Adverse Event|1|||
125545901|NCT00346632|451629336|FG005|Overall Study|Adverse Event|1|||
125545902|NCT00346632|451629337|FG006|Overall Study|Adverse Event|1|||
125545903|NCT00346632|451629338|FG007|Overall Study|Adverse Event|0|||
125545904|NCT00346632|451629339|FG008|Overall Study|Adverse Event|0|||
125545905|NCT00346632|451629340|FG009|Overall Study|Adverse Event|0|||
125545906|NCT00346632|451629331|FG000|Overall Study|Death|0|||
125545907|NCT00346632|451629332|FG001|Overall Study|Death|0|||
125545908|NCT00346632|451629333|FG002|Overall Study|Death|1|||
125545909|NCT00346632|451629334|FG003|Overall Study|Death|0|||
125545910|NCT00346632|451629335|FG004|Overall Study|Death|0|||
125545911|NCT00346632|451629336|FG005|Overall Study|Death|0|||
125545912|NCT00346632|451629337|FG006|Overall Study|Death|0|||
125545913|NCT00346632|451629338|FG007|Overall Study|Death|0|||
125545914|NCT00346632|451629339|FG008|Overall Study|Death|0|||
125545915|NCT00346632|451629340|FG009|Overall Study|Death|0|||
125545916|NCT00346632|451629331|FG000|Overall Study|Protocol Violation|0|||
125545917|NCT00346632|451629332|FG001|Overall Study|Protocol Violation|0|||
125545918|NCT00346632|451629333|FG002|Overall Study|Protocol Violation|0|||
125545919|NCT00346632|451629334|FG003|Overall Study|Protocol Violation|0|||
125545920|NCT00346632|451629335|FG004|Overall Study|Protocol Violation|0|||
125545921|NCT00346632|451629336|FG005|Overall Study|Protocol Violation|0|||
125545922|NCT00346632|451629337|FG006|Overall Study|Protocol Violation|1|||
125545923|NCT00346632|451629338|FG007|Overall Study|Protocol Violation|0|||
125545924|NCT00346632|451629339|FG008|Overall Study|Protocol Violation|0|||
125545925|NCT00346632|451629340|FG009|Overall Study|Protocol Violation|0|||
125545926|NCT00346632|451629331|FG000|Overall Study|Withdrawal by Subject|0|||
125545927|NCT00346632|451629332|FG001|Overall Study|Withdrawal by Subject|0|||
125545928|NCT00346632|451629333|FG002|Overall Study|Withdrawal by Subject|0|||
125545929|NCT00346632|451629334|FG003|Overall Study|Withdrawal by Subject|0|||
125545930|NCT00346632|451629335|FG004|Overall Study|Withdrawal by Subject|0|||
125545931|NCT00346632|451629336|FG005|Overall Study|Withdrawal by Subject|0|||
125545932|NCT00346632|451629337|FG006|Overall Study|Withdrawal by Subject|1|||
125545933|NCT00346632|451629338|FG007|Overall Study|Withdrawal by Subject|0|||
125545934|NCT00346632|451629339|FG008|Overall Study|Withdrawal by Subject|0|||
125680693|NCT03661528|452120715|FG001|Overall Study|Death|0|||
125545935|NCT00346632|451629340|FG009|Overall Study|Withdrawal by Subject|0|||
125680694|NCT03661528|452120714|FG000|Overall Study|Physician Decision|3|||
125680695|NCT03661528|452120715|FG001|Overall Study|Physician Decision|1|||
125680696|NCT03661528|452120714|FG000|Overall Study|Other than Specified|5|||
125680697|NCT03661528|452120715|FG001|Overall Study|Other than Specified|2|||
125680698|NCT03661528|452120714|FG000|Overall Study|Withdrawal by Subject|5|||
125680699|NCT03661528|452120715|FG001|Overall Study|Withdrawal by Subject|3|||
125680700|NCT03661528|452120714|FG000|Overall Study|Disease Progression|8|||
125680701|NCT03661528|452120715|FG001|Overall Study|Disease Progression|13|||
125680702|NCT03661528|452120714|FG000|Overall Study|Adverse Event|61|||
125680703|NCT03661528|452120715|FG001|Overall Study|Adverse Event|55|||
125680704|NCT02178722|452120716|FG000|Overall Study|Withdrawal by Subject|0|||
125680705|NCT02178722|452120717|FG001|Overall Study|Withdrawal by Subject|0|||
125680706|NCT02178722|452120718|FG002|Overall Study|Withdrawal by Subject|0|||
125680707|NCT02178722|452120719|FG003|Overall Study|Withdrawal by Subject|2|||
125680708|NCT02178722|452120720|FG004|Overall Study|Withdrawal by Subject|33|||
125680709|NCT02178722|452120716|FG000|Overall Study|Death|2|||
125680710|NCT02178722|452120717|FG001|Overall Study|Death|13|||
125680711|NCT02178722|452120718|FG002|Overall Study|Death|12|||
125680712|NCT02178722|452120719|FG003|Overall Study|Death|12|||
125680713|NCT02178722|452120720|FG004|Overall Study|Death|205|||
125680714|NCT02178722|452120716|FG000|Overall Study|Lost to Follow-up|0|||
125680715|NCT02178722|452120717|FG001|Overall Study|Lost to Follow-up|0|||
125680716|NCT02178722|452120718|FG002|Overall Study|Lost to Follow-up|0|||
125680717|NCT02178722|452120719|FG003|Overall Study|Lost to Follow-up|2|||
125680718|NCT02178722|452120720|FG004|Overall Study|Lost to Follow-up|11|||
125680719|NCT02178722|452120716|FG000|Overall Study|Study terminated by Sponsor|2|||
125680720|NCT02178722|452120717|FG001|Overall Study|Study terminated by Sponsor|7|||
125210713|NCT02028169|450395660|FG000|Overall Study|Lost to Follow-up|21|||
125545936|NCT00346632|451629331|FG000|Overall Study|Switched to alternative treatment|0|||
125545937|NCT00346632|451629332|FG001|Overall Study|Switched to alternative treatment|0|||
125545938|NCT00346632|451629333|FG002|Overall Study|Switched to alternative treatment|1|||
125545939|NCT00346632|451629334|FG003|Overall Study|Switched to alternative treatment|0|||
125545940|NCT00346632|451629335|FG004|Overall Study|Switched to alternative treatment|0|||
125545941|NCT00346632|451629336|FG005|Overall Study|Switched to alternative treatment|0|||
125680721|NCT02178722|452120718|FG002|Overall Study|Study terminated by Sponsor|6|||
125680722|NCT02178722|452120719|FG003|Overall Study|Study terminated by Sponsor|4|||
125545942|NCT00346632|451629337|FG006|Overall Study|Switched to alternative treatment|0|||
125545943|NCT00346632|451629338|FG007|Overall Study|Switched to alternative treatment|0|||
125680723|NCT02178722|452120720|FG004|Overall Study|Study terminated by Sponsor|128|||
125545944|NCT00346632|451629339|FG008|Overall Study|Switched to alternative treatment|0|||
125545945|NCT00346632|451629340|FG009|Overall Study|Switched to alternative treatment|0|||
125545946|NCT00346632|451629331|FG000|Overall Study|Not Stated|1|||
125545947|NCT00346632|451629332|FG001|Overall Study|Not Stated|1|||
125545948|NCT00346632|451629333|FG002|Overall Study|Not Stated|0|||
125545949|NCT00346632|451629334|FG003|Overall Study|Not Stated|0|||
125545950|NCT00346632|451629335|FG004|Overall Study|Not Stated|0|||
125545951|NCT00346632|451629336|FG005|Overall Study|Not Stated|0|||
125545952|NCT00346632|451629337|FG006|Overall Study|Not Stated|0|||
125545953|NCT00346632|451629338|FG007|Overall Study|Not Stated|2|||
125545954|NCT00346632|451629339|FG008|Overall Study|Not Stated|2|||
125545955|NCT00346632|451629340|FG009|Overall Study|Not Stated|1|||
125545956|NCT00918580|451629341|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
125545957|NCT00918580|451629341|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
125545958|NCT00918580|451629341|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
125545959|NCT00918580|451629341|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
125545960|NCT00918580|451629341|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
125545961|NCT00918580|451629341|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
125545962|NCT00918580|451629341|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
125545963|NCT03486457|451629345|FG000|Up to Month 3|Adverse Event|2|||
125545964|NCT03486457|451629346|FG001|Up to Month 3|Adverse Event|5|||
125545965|NCT03486457|451629345|FG000|Up to Month 3|Lack of Efficacy|1|||
125545966|NCT03486457|451629346|FG001|Up to Month 3|Lack of Efficacy|0|||
125545967|NCT03486457|451629345|FG000|Up to Month 3|Withdrawal by Subject|1|||
125545968|NCT03486457|451629346|FG001|Up to Month 3|Withdrawal by Subject|0|||
125545969|NCT03486457|451629345|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
125545970|NCT03486457|451629346|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
125545971|NCT03486457|451629345|FG000|Up to Month 3|Other|1|||
125545972|NCT03486457|451629346|FG001|Up to Month 3|Other|0|||
125545973|NCT03486457|451629345|FG000|Month 3 to Month 6|Adverse Event|2|||
125545974|NCT03486457|451629346|FG001|Month 3 to Month 6|Adverse Event|0|||
125545975|NCT03486457|451629345|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
125545976|NCT03486457|451629346|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
125545977|NCT03486457|451629345|FG000|Month 3 to Month 6|Pregnancy|0|||
125545978|NCT03486457|451629346|FG001|Month 3 to Month 6|Pregnancy|1|||
125545979|NCT03486457|451629345|FG000|Month 3 to Month 6|Other|1|||
125545980|NCT03486457|451629346|FG001|Month 3 to Month 6|Other|0|||
125545981|NCT00262951|451629349|FG000|Overall Study|Progressive disease/relapse|3|||
125545982|NCT00262951|451629349|FG000|Overall Study|Adverse Event|7|||
125545983|NCT00262951|451629349|FG000|Overall Study|Death|1|||
125545984|NCT00262951|451629349|FG000|Overall Study|Withdrawal by Subject|1|||
125545985|NCT00262951|451629349|FG000|Overall Study|Alternative treatment|3|||
125545986|NCT00262951|451629349|FG000|Overall Study|Off treatment for other disease|1|||
125545987|NCT01602562|451629355|FG000|Overall Study|Adverse Event|3|||
125545988|NCT01602562|451629356|FG001|Overall Study|Adverse Event|1|||
125545989|NCT01602562|451629355|FG000|Overall Study|Physician Decision|1|||
125545990|NCT01602562|451629356|FG001|Overall Study|Physician Decision|1|||
125545991|NCT01602562|451629355|FG000|Overall Study|Withdrawal by Subject|1|||
125545992|NCT01602562|451629356|FG001|Overall Study|Withdrawal by Subject|1|||
125545993|NCT03881553|451629357|FG000|Overall Study|Discharged prior to participation|1|||
125545994|NCT03881553|451629358|FG001|Overall Study|Discharged prior to participation|1|||
125545995|NCT03881553|451629359|FG002|Overall Study|Discharged prior to participation|0|||
125545996|NCT03881553|451629357|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
125545997|NCT03881553|451629358|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
125545998|NCT03881553|451629359|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
125545999|NCT01959516|451629360|FG000|Epoch 1|Adverse Event|4|||
125546000|NCT01959516|451629361|FG001|Epoch 1|Adverse Event|1|||
125546001|NCT01959516|451629360|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
125546002|NCT01959516|451629361|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
125546003|NCT01959516|451629360|FG000|Epoch 1|Subject withdrew consent|3|||
125546004|NCT01959516|451629361|FG001|Epoch 1|Subject withdrew consent|2|||
125345745|NCT02431260|450899815|FG009|Overall Study|Subject Decision|1|||
125546005|NCT01959516|451629360|FG000|Epoch 1|Administrative problems|1|||
125546006|NCT01959516|451629361|FG001|Epoch 1|Administrative problems|0|||
125546007|NCT01959516|451629360|FG000|Epoch 1|Use of prohibited treatment|1|||
125345746|NCT02431260|450899816|FG010|Overall Study|Subject Decision|0|||
125546008|NCT01959516|451629361|FG001|Epoch 1|Use of prohibited treatment|0|||
125680724|NCT02178722|452120716|FG000|Overall Study|Physician Decision|0|||
125680725|NCT02178722|452120717|FG001|Overall Study|Physician Decision|0|||
125680726|NCT02178722|452120718|FG002|Overall Study|Physician Decision|0|||
125680727|NCT02178722|452120719|FG003|Overall Study|Physician Decision|0|||
125680728|NCT02178722|452120720|FG004|Overall Study|Physician Decision|3|||
125680729|NCT02178722|452120716|FG000|Overall Study|Other|0|||
125680730|NCT02178722|452120717|FG001|Overall Study|Other|0|||
125680731|NCT02178722|452120718|FG002|Overall Study|Other|0|||
125680732|NCT02178722|452120719|FG003|Overall Study|Other|0|||
125680733|NCT02178722|452120720|FG004|Overall Study|Other|2|||
125546009|NCT01959516|451629360|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
125546010|NCT01959516|451629361|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
125546011|NCT01959516|451629360|FG000|Epoch 1|Protocol deviation|0|||
125546012|NCT01959516|451629361|FG001|Epoch 1|Protocol deviation|1|||
125546013|NCT01959516|451629360|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
125546014|NCT01959516|451629361|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
125546015|NCT01959516|451629360|FG000|Epoch 2|Subject withdrew consent|1|||
125546016|NCT01959516|451629361|FG001|Epoch 2|Subject withdrew consent|0|||
125546017|NCT01959516|451629360|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
125546018|NCT01959516|451629361|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
125546019|NCT01477333|451629362|FG000|Overall Study|Adverse Event|1|||
125546020|NCT01477333|451629362|FG000|Overall Study|Withdrawal by Subject|1|||
125546021|NCT01477333|451629362|FG000|Overall Study|Clinical Deterioration|1|||
125546022|NCT03801915|451629367|FG000|Overall Study|Screen failure|0|||
125546023|NCT03801915|451629368|FG001|Overall Study|Screen failure|0|||
125546024|NCT03801915|451629369|FG002|Overall Study|Screen failure|1|||
125546025|NCT03801915|451629367|FG000|Overall Study|Ineligible|1|||
125546026|NCT03801915|451629368|FG001|Overall Study|Ineligible|0|||
125546027|NCT03801915|451629369|FG002|Overall Study|Ineligible|0|||
125546028|NCT03801915|451629367|FG000|Overall Study|Physician Decision|2|||
125546029|NCT03801915|451629368|FG001|Overall Study|Physician Decision|1|||
125546030|NCT03801915|451629369|FG002|Overall Study|Physician Decision|0|||
125546031|NCT02308020|451629372|FG000|Overall Study|Lost to Follow-up|1|||
125546032|NCT02308020|451629373|FG001|Overall Study|Lost to Follow-up|7|||
125546033|NCT02308020|451629374|FG002|Overall Study|Lost to Follow-up|0|||
125546034|NCT02308020|451629375|FG003|Overall Study|Lost to Follow-up|0|||
125546035|NCT02308020|451629376|FG004|Overall Study|Lost to Follow-up|1|||
125546036|NCT02308020|451629377|FG005|Overall Study|Lost to Follow-up|2|||
125546037|NCT02308020|451629372|FG000|Overall Study|Sponsor Decision|0|||
125546038|NCT02308020|451629373|FG001|Overall Study|Sponsor Decision|8|||
125546039|NCT02308020|451629374|FG002|Overall Study|Sponsor Decision|0|||
125546040|NCT02308020|451629375|FG003|Overall Study|Sponsor Decision|2|||
125546041|NCT02308020|451629376|FG004|Overall Study|Sponsor Decision|2|||
125546042|NCT02308020|451629377|FG005|Overall Study|Sponsor Decision|1|||
125546043|NCT02308020|451629372|FG000|Overall Study|Withdrawal by Subject|3|||
125546044|NCT02308020|451629373|FG001|Overall Study|Withdrawal by Subject|5|||
125546045|NCT02308020|451629374|FG002|Overall Study|Withdrawal by Subject|3|||
125345747|NCT02431260|450899817|FG011|Overall Study|Subject Decision|1|||
125345748|NCT02431260|450899818|FG012|Overall Study|Subject Decision|0|||
125345749|NCT02431260|450899819|FG013|Overall Study|Subject Decision|0|||
125345750|NCT02431260|450899806|FG000|Overall Study|Death|4|||
125345751|NCT02431260|450899807|FG001|Overall Study|Death|4|||
125345752|NCT02431260|450899808|FG002|Overall Study|Death|3|||
125546046|NCT02308020|451629375|FG003|Overall Study|Withdrawal by Subject|2|||
125546047|NCT02308020|451629376|FG004|Overall Study|Withdrawal by Subject|1|||
125546048|NCT02308020|451629377|FG005|Overall Study|Withdrawal by Subject|2|||
125546049|NCT01211288|451629378|FG000|Overall Study|Lost to Follow-up|1|||
125546050|NCT01211288|451629379|FG001|Overall Study|Lost to Follow-up|1|||
125546051|NCT04217590|451629380|FG000|Overall Study|Other|1|||
125680734|NCT03340727|452120721|FG000|Overall Study|Death|1|||
125680735|NCT03340727|452120722|FG001|Overall Study|Death|0|||
125546052|NCT04217590|451629381|FG001|Overall Study|Other|1|||
125546053|NCT04217590|451629380|FG000|Overall Study|Withdrawal by Subject|3|||
125546054|NCT04217590|451629381|FG001|Overall Study|Withdrawal by Subject|1|||
125546055|NCT04217590|451629380|FG000|Overall Study|Death|0|||
125680736|NCT03340727|452120721|FG000|Overall Study|Lost to Follow-up|31|||
125680737|NCT03340727|452120722|FG001|Overall Study|Lost to Follow-up|35|||
125680738|NCT03340727|452120721|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
125680739|NCT03340727|452120722|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
125680740|NCT03340727|452120721|FG000|Overall Study|Transferred to another facility|10|||
125680741|NCT03340727|452120722|FG001|Overall Study|Transferred to another facility|7|||
125680742|NCT03340727|452120721|FG000|Overall Study|Withdrawal by Subject|28|||
125680743|NCT03340727|452120722|FG001|Overall Study|Withdrawal by Subject|17|||
125680744|NCT03553823|452120723|FG000|Overall Study|Physician Decision|0|||
125680745|NCT03553823|452120724|FG001|Overall Study|Physician Decision|1|||
125680746|NCT03991494|452120731|FG000|Overall Study|Progressive Disease|4|||
125680747|NCT01937390|452120737|FG000|Overall Study|Death|2|||
125680748|NCT01937390|452120737|FG000|Overall Study|Lost to Follow-up|7|||
125680749|NCT01937390|452120737|FG000|Overall Study|Withdrawal by Subject|5|||
125680750|NCT01937390|452120737|FG000|Overall Study|Fail to return|21|||
125680751|NCT01569152|452120738|FG000|Phase IIa, Period 1|Early Escape|5|||
125680752|NCT01569152|452120739|FG001|Phase IIa, Period 1|Early Escape|22|||
125680753|NCT01569152|452120740|FG002|Phase IIa, Period 1|Early Escape|0|||
125345753|NCT02431260|450899809|FG003|Overall Study|Death|4|||
125546056|NCT04217590|451629381|FG001|Overall Study|Death|1|||
125546057|NCT02003573|451629393|FG000|Overall Study|Progressive disease|2|||
125546058|NCT02003573|451629394|FG001|Overall Study|Progressive disease|0|||
125546059|NCT02003573|451629395|FG002|Overall Study|Progressive disease|1|||
125546060|NCT02003573|451629393|FG000|Overall Study|Other Adverse event|0|||
125345754|NCT02431260|450899810|FG004|Overall Study|Death|2|||
125345755|NCT02431260|450899811|FG005|Overall Study|Death|2|||
125345756|NCT02431260|450899812|FG006|Overall Study|Death|3|||
125345757|NCT02431260|450899813|FG007|Overall Study|Death|1|||
125345758|NCT02431260|450899814|FG008|Overall Study|Death|6|||
125345759|NCT02431260|450899815|FG009|Overall Study|Death|6|||
125345760|NCT02431260|450899816|FG010|Overall Study|Death|3|||
125345761|NCT02431260|450899817|FG011|Overall Study|Death|2|||
125345762|NCT02431260|450899818|FG012|Overall Study|Death|5|||
125345763|NCT02431260|450899819|FG013|Overall Study|Death|1|||
125345764|NCT02431260|450899806|FG000|Overall Study|Lost to Follow-up|0|||
125345765|NCT02431260|450899807|FG001|Overall Study|Lost to Follow-up|0|||
125345766|NCT02431260|450899808|FG002|Overall Study|Lost to Follow-up|0|||
125345767|NCT02431260|450899809|FG003|Overall Study|Lost to Follow-up|0|||
125345768|NCT02431260|450899810|FG004|Overall Study|Lost to Follow-up|0|||
125345769|NCT02431260|450899811|FG005|Overall Study|Lost to Follow-up|1|||
125345770|NCT02431260|450899812|FG006|Overall Study|Lost to Follow-up|0|||
125345771|NCT02431260|450899813|FG007|Overall Study|Lost to Follow-up|0|||
125345772|NCT02431260|450899814|FG008|Overall Study|Lost to Follow-up|0|||
125345773|NCT02431260|450899815|FG009|Overall Study|Lost to Follow-up|0|||
125345774|NCT02431260|450899816|FG010|Overall Study|Lost to Follow-up|0|||
125345775|NCT02431260|450899817|FG011|Overall Study|Lost to Follow-up|0|||
125345776|NCT02431260|450899818|FG012|Overall Study|Lost to Follow-up|0|||
125345777|NCT02431260|450899819|FG013|Overall Study|Lost to Follow-up|0|||
125345778|NCT02431260|450899806|FG000|Overall Study|Study Terminated by the Sponsor|0|||
125345779|NCT02431260|450899807|FG001|Overall Study|Study Terminated by the Sponsor|0|||
125345780|NCT02431260|450899808|FG002|Overall Study|Study Terminated by the Sponsor|2|||
125345781|NCT02431260|450899809|FG003|Overall Study|Study Terminated by the Sponsor|1|||
125345782|NCT02431260|450899810|FG004|Overall Study|Study Terminated by the Sponsor|1|||
125345783|NCT02431260|450899811|FG005|Overall Study|Study Terminated by the Sponsor|0|||
125345784|NCT02431260|450899812|FG006|Overall Study|Study Terminated by the Sponsor|1|||
125345785|NCT02431260|450899813|FG007|Overall Study|Study Terminated by the Sponsor|2|||
125345786|NCT02431260|450899814|FG008|Overall Study|Study Terminated by the Sponsor|1|||
125345787|NCT02431260|450899815|FG009|Overall Study|Study Terminated by the Sponsor|1|||
125345788|NCT02431260|450899816|FG010|Overall Study|Study Terminated by the Sponsor|1|||
125345789|NCT02431260|450899817|FG011|Overall Study|Study Terminated by the Sponsor|0|||
125345790|NCT02431260|450899818|FG012|Overall Study|Study Terminated by the Sponsor|4|||
125345791|NCT02431260|450899819|FG013|Overall Study|Study Terminated by the Sponsor|0|||
125345792|NCT02431260|450899806|FG000|Overall Study|Physician Decision|0|||
125345793|NCT02431260|450899807|FG001|Overall Study|Physician Decision|0|||
125345794|NCT02431260|450899808|FG002|Overall Study|Physician Decision|0|||
125345795|NCT02431260|450899809|FG003|Overall Study|Physician Decision|0|||
125345796|NCT02431260|450899810|FG004|Overall Study|Physician Decision|0|||
125345797|NCT02431260|450899811|FG005|Overall Study|Physician Decision|1|||
125345798|NCT02431260|450899812|FG006|Overall Study|Physician Decision|0|||
125345799|NCT02431260|450899813|FG007|Overall Study|Physician Decision|0|||
125345800|NCT02431260|450899814|FG008|Overall Study|Physician Decision|0|||
125345801|NCT02431260|450899815|FG009|Overall Study|Physician Decision|0|||
125345802|NCT02431260|450899816|FG010|Overall Study|Physician Decision|0|||
125345803|NCT02431260|450899817|FG011|Overall Study|Physician Decision|0|||
125345804|NCT02431260|450899818|FG012|Overall Study|Physician Decision|0|||
125345805|NCT02431260|450899819|FG013|Overall Study|Physician Decision|0|||
125345806|NCT02431260|450899806|FG000|Overall Study|Other Unspecified|0|||
125345807|NCT02431260|450899807|FG001|Overall Study|Other Unspecified|0|||
125345808|NCT02431260|450899808|FG002|Overall Study|Other Unspecified|0|||
125345809|NCT02431260|450899809|FG003|Overall Study|Other Unspecified|0|||
125345810|NCT02431260|450899810|FG004|Overall Study|Other Unspecified|0|||
125345811|NCT02431260|450899811|FG005|Overall Study|Other Unspecified|0|||
125345812|NCT02431260|450899812|FG006|Overall Study|Other Unspecified|0|||
125345813|NCT02431260|450899813|FG007|Overall Study|Other Unspecified|0|||
125546061|NCT02003573|451629394|FG001|Overall Study|Other Adverse event|1|||
125546062|NCT02003573|451629395|FG002|Overall Study|Other Adverse event|1|||
125546063|NCT02003573|451629393|FG000|Overall Study|Refuse to take trial medication|0|||
125546064|NCT02003573|451629394|FG001|Overall Study|Refuse to take trial medication|1|||
125546065|NCT02003573|451629395|FG002|Overall Study|Refuse to take trial medication|1|||
125546066|NCT02003573|451629393|FG000|Overall Study|Other than specified|1|||
125546067|NCT02003573|451629394|FG001|Overall Study|Other than specified|2|||
125546068|NCT02003573|451629395|FG002|Overall Study|Other than specified|3|||
125546069|NCT01242800|451629398|FG000|Overall Study|Patient refusal|0|||
125546070|NCT01242800|451629399|FG001|Overall Study|Patient refusal|10|||
125546071|NCT01242800|451629398|FG000|Overall Study|Physician Decision|0|||
125546072|NCT01242800|451629399|FG001|Overall Study|Physician Decision|1|||
125546073|NCT01242800|451629398|FG000|Overall Study|Disease progression|0|||
125546074|NCT01242800|451629399|FG001|Overall Study|Disease progression|3|||
125546075|NCT01242800|451629398|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
125546076|NCT01242800|451629399|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
125546077|NCT01242800|451629398|FG000|Overall Study|Reasons not reported|0|||
125546078|NCT01242800|451629399|FG001|Overall Study|Reasons not reported|4|||
125546079|NCT01395888|451629400|FG000|2-week Run-in Period|Adverse Event|2|||
125546080|NCT01395888|451629401|FG001|2-week Run-in Period|Adverse Event|0|||
125546081|NCT01395888|451629402|FG002|2-week Run-in Period|Adverse Event|0|||
125546082|NCT01395888|451629400|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
125546083|NCT01395888|451629401|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
125546084|NCT01395888|451629402|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
125546085|NCT01395888|451629400|FG000|2-week Run-in Period|Lost to Follow-up|1|||
125546086|NCT01395888|451629401|FG001|2-week Run-in Period|Lost to Follow-up|0|||
125546087|NCT01395888|451629402|FG002|2-week Run-in Period|Lost to Follow-up|0|||
125546088|NCT01395888|451629400|FG000|2-week Run-in Period|Protocol Violation|2|||
125546089|NCT01395888|451629401|FG001|2-week Run-in Period|Protocol Violation|0|||
125546090|NCT01395888|451629402|FG002|2-week Run-in Period|Protocol Violation|0|||
125546091|NCT01395888|451629400|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
125546092|NCT01395888|451629401|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
125546093|NCT01395888|451629402|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
125546094|NCT01395888|451629400|FG000|Treatment Period (TP)|Adverse Event|0|||
125546095|NCT01395888|451629401|FG001|Treatment Period (TP)|Adverse Event|7|||
125546096|NCT01395888|451629402|FG002|Treatment Period (TP)|Adverse Event|6|||
125546097|NCT01395888|451629400|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
125546098|NCT01395888|451629401|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
125546099|NCT01395888|451629402|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
125546100|NCT01395888|451629400|FG000|Treatment Period (TP)|Protocol Violation|0|||
125546101|NCT01395888|451629401|FG001|Treatment Period (TP)|Protocol Violation|1|||
125546102|NCT01395888|451629402|FG002|Treatment Period (TP)|Protocol Violation|5|||
125546103|NCT01395888|451629400|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
125546104|NCT01395888|451629401|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
125546105|NCT01395888|451629402|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
125546106|NCT01395888|451629400|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
125546107|NCT01395888|451629401|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
125546108|NCT01395888|451629402|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
125546109|NCT00126503|451629405|FG000|Overall Study|disease progression|23|||
125546110|NCT00126503|451629406|FG001|Overall Study|disease progression|14|||
125546111|NCT00126503|451629405|FG000|Overall Study|Withdrawal by Subject|0|||
125546112|NCT00126503|451629406|FG001|Overall Study|Withdrawal by Subject|1|||
125546113|NCT00126503|451629405|FG000|Overall Study|alternative therapy|1|||
125546114|NCT00126503|451629406|FG001|Overall Study|alternative therapy|1|||
125546115|NCT00126503|451629405|FG000|Overall Study|other complicating disease|4|||
125546116|NCT00126503|451629406|FG001|Overall Study|other complicating disease|1|||
125546117|NCT00126503|451629405|FG000|Overall Study|Death|3|||
125546118|NCT00126503|451629406|FG001|Overall Study|Death|0|||
125680754|NCT01569152|452120738|FG000|Phase IIa, Period 1|Adverse Event|4|||
125680755|NCT01569152|452120739|FG001|Phase IIa, Period 1|Adverse Event|0|||
125680756|NCT01569152|452120740|FG002|Phase IIa, Period 1|Adverse Event|0|||
125680757|NCT01569152|452120738|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
125680758|NCT01569152|452120739|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
125680759|NCT01569152|452120740|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
125680760|NCT01569152|452120738|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
125680761|NCT01569152|452120739|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
125680762|NCT01569152|452120740|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
125680763|NCT01569152|452120738|FG000|Phase IIa, Period 1|Protocol Violation|0|||
125680764|NCT01569152|452120739|FG001|Phase IIa, Period 1|Protocol Violation|1|||
125546119|NCT00126503|451629405|FG000|Overall Study|Adverse Event|13|||
125680765|NCT01569152|452120740|FG002|Phase IIa, Period 1|Protocol Violation|0|||
125680766|NCT01569152|452120738|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
125210714|NCT02028169|450395660|FG000|Overall Study|Lack of Efficacy|2|||
125546120|NCT00126503|451629406|FG001|Overall Study|Adverse Event|3|||
125546121|NCT00126503|451629405|FG000|Overall Study|non-compliant|1|||
125345814|NCT02431260|450899814|FG008|Overall Study|Other Unspecified|0|||
125345815|NCT02431260|450899815|FG009|Overall Study|Other Unspecified|0|||
125345816|NCT02431260|450899816|FG010|Overall Study|Other Unspecified|0|||
125345817|NCT02431260|450899817|FG011|Overall Study|Other Unspecified|1|||
125345818|NCT02431260|450899818|FG012|Overall Study|Other Unspecified|1|||
125345819|NCT02431260|450899819|FG013|Overall Study|Other Unspecified|0|||
125345820|NCT00321646|450899820|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
125345821|NCT00321646|450899820|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
125345822|NCT00321646|450899820|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
125345823|NCT02576145|450899823|FG000|Overall Study|Adverse Event|1|||
125345824|NCT02576145|450899824|FG001|Overall Study|Adverse Event|0|||
125345825|NCT02576145|450899823|FG000|Overall Study|Withdrawal by Subject|1|||
125345826|NCT02576145|450899824|FG001|Overall Study|Withdrawal by Subject|0|||
125345827|NCT02576145|450899823|FG000|Overall Study|Acute rejection|1|||
125345828|NCT02576145|450899824|FG001|Overall Study|Acute rejection|0|||
125345829|NCT02576145|450899823|FG000|Overall Study|Tetanus Titers Decreased|0|||
125345830|NCT02576145|450899824|FG001|Overall Study|Tetanus Titers Decreased|1|||
125345831|NCT02660138|450899825|FG000|Overall Study|Adverse Event|0|||
125345832|NCT02660138|450899826|FG001|Overall Study|Adverse Event|3|||
125345833|NCT02660138|450899827|FG002|Overall Study|Adverse Event|2|||
125345834|NCT02660138|450899825|FG000|Overall Study|Lack of Efficacy|1|||
125345835|NCT02660138|450899826|FG001|Overall Study|Lack of Efficacy|2|||
125345836|NCT02660138|450899827|FG002|Overall Study|Lack of Efficacy|1|||
125345837|NCT02660138|450899825|FG000|Overall Study|Withdrawal by Subject|7|||
125345838|NCT02660138|450899826|FG001|Overall Study|Withdrawal by Subject|6|||
125345839|NCT02660138|450899827|FG002|Overall Study|Withdrawal by Subject|6|||
125345840|NCT02660138|450899825|FG000|Overall Study|Lost to Follow-up|4|||
125345841|NCT02660138|450899826|FG001|Overall Study|Lost to Follow-up|4|||
125345842|NCT02660138|450899827|FG002|Overall Study|Lost to Follow-up|1|||
125345843|NCT02660138|450899825|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
125345844|NCT02660138|450899826|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
125345845|NCT02660138|450899827|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
125345846|NCT02660138|450899825|FG000|Overall Study|Other|1|||
125345847|NCT02660138|450899826|FG001|Overall Study|Other|1|||
125345848|NCT02660138|450899827|FG002|Overall Study|Other|0|||
125345849|NCT02660138|450899825|FG000|Overall Study|Not treated|0|||
125345850|NCT02660138|450899826|FG001|Overall Study|Not treated|1|||
125345851|NCT02660138|450899827|FG002|Overall Study|Not treated|0|||
125345852|NCT00308581|450899828|FG000|Induction Phase|Adverse Event|0|||
125345853|NCT00308581|450899829|FG001|Induction Phase|Adverse Event|0|||
125345854|NCT00308581|450899830|FG002|Induction Phase|Adverse Event|37|||
125345855|NCT00308581|450899828|FG000|Induction Phase|Lack of Efficacy|0|||
125345856|NCT00308581|450899829|FG001|Induction Phase|Lack of Efficacy|0|||
125345857|NCT00308581|450899830|FG002|Induction Phase|Lack of Efficacy|121|||
125345858|NCT00308581|450899828|FG000|Induction Phase|Withdrawal by Subject|0|||
125345859|NCT00308581|450899829|FG001|Induction Phase|Withdrawal by Subject|0|||
125345860|NCT00308581|450899830|FG002|Induction Phase|Withdrawal by Subject|5|||
125345861|NCT00308581|450899828|FG000|Induction Phase|Unknown reason|0|||
125345862|NCT00308581|450899829|FG001|Induction Phase|Unknown reason|0|||
125345863|NCT00308581|450899830|FG002|Induction Phase|Unknown reason|3|||
125345864|NCT00308581|450899828|FG000|Randomized Maintenance Phase|Adverse Event|10|||
125345865|NCT00308581|450899829|FG001|Randomized Maintenance Phase|Adverse Event|17|||
125345866|NCT00308581|450899830|FG002|Randomized Maintenance Phase|Adverse Event|0|||
125345867|NCT00308581|450899828|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
125345868|NCT00308581|450899829|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
125345869|NCT00308581|450899830|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
125345870|NCT00308581|450899828|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
125680767|NCT01569152|452120739|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
125680768|NCT01569152|452120740|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
125680769|NCT01569152|452120738|FG000|Safety Extension, Period 3|Adverse Event|0|||
125680770|NCT01569152|452120739|FG001|Safety Extension, Period 3|Adverse Event|0|||
125680771|NCT01569152|452120740|FG002|Safety Extension, Period 3|Adverse Event|4|||
125680772|NCT01569152|452120738|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
125680773|NCT01569152|452120739|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
125345871|NCT00308581|450899829|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
125345872|NCT00308581|450899830|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
125345873|NCT00308581|450899828|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
125345874|NCT00308581|450899829|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
125345875|NCT00308581|450899830|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
125345876|NCT00308581|450899828|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
125345877|NCT00308581|450899829|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
125345878|NCT00308581|450899830|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
125345879|NCT00308581|450899828|FG000|Randomized Maintenance Phase|Unknown reason|3|||
125345880|NCT00308581|450899829|FG001|Randomized Maintenance Phase|Unknown reason|0|||
125345881|NCT00308581|450899830|FG002|Randomized Maintenance Phase|Unknown reason|0|||
125546122|NCT00126503|451629406|FG001|Overall Study|non-compliant|0|||
125546123|NCT00126503|451629405|FG000|Overall Study|Physician Decision|2|||
125546124|NCT00126503|451629406|FG001|Overall Study|Physician Decision|1|||
125546125|NCT04677179|451629407|FG000|Induction Treatment Period|Adverse Event|1|||
125546126|NCT04677179|451629408|FG001|Induction Treatment Period|Adverse Event|0|||
125546127|NCT04677179|451629409|FG002|Induction Treatment Period|Adverse Event|0|||
125546128|NCT04677179|451629410|FG003|Induction Treatment Period|Adverse Event|0|||
125546129|NCT04677179|451629411|FG004|Induction Treatment Period|Adverse Event|0|||
125546130|NCT04677179|451629412|FG005|Induction Treatment Period|Adverse Event|0|||
125546131|NCT04677179|451629413|FG006|Induction Treatment Period|Adverse Event|0|||
125546132|NCT04677179|451629414|FG007|Induction Treatment Period|Adverse Event|0|||
125546133|NCT04677179|451629415|FG008|Induction Treatment Period|Adverse Event|0|||
125546134|NCT04677179|451629416|FG009|Induction Treatment Period|Adverse Event|0|||
125546135|NCT04677179|451629407|FG000|Induction Treatment Period|Physician Decision|1|||
125546136|NCT04677179|451629408|FG001|Induction Treatment Period|Physician Decision|0|||
125546137|NCT04677179|451629409|FG002|Induction Treatment Period|Physician Decision|1|||
125546138|NCT04677179|451629410|FG003|Induction Treatment Period|Physician Decision|0|||
125546139|NCT04677179|451629411|FG004|Induction Treatment Period|Physician Decision|0|||
125546140|NCT04677179|451629412|FG005|Induction Treatment Period|Physician Decision|0|||
125546141|NCT04677179|451629413|FG006|Induction Treatment Period|Physician Decision|0|||
125546142|NCT04677179|451629414|FG007|Induction Treatment Period|Physician Decision|0|||
125546143|NCT04677179|451629415|FG008|Induction Treatment Period|Physician Decision|0|||
125546144|NCT04677179|451629416|FG009|Induction Treatment Period|Physician Decision|0|||
125546145|NCT04677179|451629407|FG000|Induction Treatment Period|Protocol Violation|0|||
125546146|NCT04677179|451629408|FG001|Induction Treatment Period|Protocol Violation|1|||
125546147|NCT04677179|451629409|FG002|Induction Treatment Period|Protocol Violation|0|||
125546148|NCT04677179|451629410|FG003|Induction Treatment Period|Protocol Violation|0|||
125546149|NCT04677179|451629411|FG004|Induction Treatment Period|Protocol Violation|0|||
125546150|NCT04677179|451629412|FG005|Induction Treatment Period|Protocol Violation|0|||
125546151|NCT04677179|451629413|FG006|Induction Treatment Period|Protocol Violation|0|||
125546152|NCT04677179|451629414|FG007|Induction Treatment Period|Protocol Violation|0|||
125546153|NCT04677179|451629415|FG008|Induction Treatment Period|Protocol Violation|0|||
125546154|NCT04677179|451629416|FG009|Induction Treatment Period|Protocol Violation|0|||
125546155|NCT04677179|451629407|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
125546156|NCT04677179|451629408|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
125546157|NCT04677179|451629409|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
125546158|NCT04677179|451629410|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
125546159|NCT04677179|451629411|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
125546160|NCT04677179|451629412|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
125546161|NCT04677179|451629413|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
125546162|NCT04677179|451629414|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
125546163|NCT04677179|451629415|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
125546164|NCT04677179|451629416|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
125546165|NCT04677179|451629407|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
125546166|NCT04677179|451629408|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
125546167|NCT04677179|451629409|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
125546168|NCT04677179|451629410|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
125546169|NCT04677179|451629411|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
125546170|NCT04677179|451629412|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
125546171|NCT04677179|451629413|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
125546172|NCT04677179|451629414|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
125546173|NCT04677179|451629415|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
125546174|NCT04677179|451629416|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
125546175|NCT04677179|451629407|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
125546176|NCT04677179|451629408|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
125546177|NCT04677179|451629409|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
125546178|NCT04677179|451629410|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
125546179|NCT04677179|451629411|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
125546180|NCT04677179|451629412|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
125546181|NCT04677179|451629413|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
125546182|NCT04677179|451629414|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
125546183|NCT04677179|451629415|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
125546184|NCT04677179|451629416|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
125546185|NCT04677179|451629407|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
125546186|NCT04677179|451629408|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
125546187|NCT04677179|451629409|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
125546188|NCT04677179|451629410|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
125546189|NCT04677179|451629411|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
125546190|NCT04677179|451629412|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
125546191|NCT04677179|451629413|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
125546192|NCT04677179|451629414|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
125546193|NCT04677179|451629415|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
125546194|NCT04677179|451629416|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
125546195|NCT04677179|451629407|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
125546196|NCT04677179|451629408|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
125546197|NCT04677179|451629409|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
125546198|NCT04677179|451629410|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
125546199|NCT04677179|451629411|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
125546200|NCT04677179|451629412|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
125546201|NCT04677179|451629413|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
125546202|NCT04677179|451629414|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
125546203|NCT04677179|451629415|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
125546204|NCT04677179|451629416|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
125546205|NCT04677179|451629407|FG000|Extension Treatment Period|Lack of Efficacy|0|||
125546206|NCT04677179|451629408|FG001|Extension Treatment Period|Lack of Efficacy|0|||
125546207|NCT04677179|451629409|FG002|Extension Treatment Period|Lack of Efficacy|0|||
125546208|NCT04677179|451629410|FG003|Extension Treatment Period|Lack of Efficacy|0|||
125546209|NCT04677179|451629411|FG004|Extension Treatment Period|Lack of Efficacy|0|||
125546210|NCT04677179|451629412|FG005|Extension Treatment Period|Lack of Efficacy|0|||
125546211|NCT04677179|451629413|FG006|Extension Treatment Period|Lack of Efficacy|6|||
125546212|NCT04677179|451629414|FG007|Extension Treatment Period|Lack of Efficacy|0|||
125546213|NCT04677179|451629415|FG008|Extension Treatment Period|Lack of Efficacy|0|||
125546214|NCT04677179|451629416|FG009|Extension Treatment Period|Lack of Efficacy|0|||
125546215|NCT04677179|451629407|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
125546216|NCT04677179|451629408|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
125546217|NCT04677179|451629409|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
125546218|NCT04677179|451629410|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
125546219|NCT04677179|451629411|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
125546220|NCT04677179|451629412|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
125546221|NCT04677179|451629413|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
125546222|NCT04677179|451629414|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
125546223|NCT04677179|451629415|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
125546224|NCT04677179|451629416|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
125546225|NCT04677179|451629407|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
125546226|NCT04677179|451629408|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
125546227|NCT04677179|451629409|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
125546228|NCT04677179|451629410|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
125546229|NCT04677179|451629411|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
125546230|NCT04677179|451629412|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
125546231|NCT04677179|451629413|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
125546232|NCT04677179|451629414|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
125546233|NCT04677179|451629415|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
125546234|NCT04677179|451629416|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
125546235|NCT04677179|451629407|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
125546236|NCT04677179|451629408|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
125546237|NCT04677179|451629409|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
125546238|NCT04677179|451629410|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
125546239|NCT04677179|451629411|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
125546240|NCT04677179|451629412|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
125546241|NCT04677179|451629413|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
125546242|NCT04677179|451629414|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
125546243|NCT04677179|451629415|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
125546244|NCT04677179|451629416|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
125546245|NCT04677179|451629407|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
125546246|NCT04677179|451629408|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
125546247|NCT04677179|451629409|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
125546248|NCT04677179|451629410|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
125546249|NCT04677179|451629411|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
125546250|NCT04677179|451629412|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
125546251|NCT04677179|451629413|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
125546252|NCT04677179|451629414|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
125546253|NCT04677179|451629415|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
125546254|NCT04677179|451629416|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
125546255|NCT04677179|451629407|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125546256|NCT04677179|451629408|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125546257|NCT04677179|451629409|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125345882|NCT01087788|450899832|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
125345883|NCT01087788|450899833|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
125345884|NCT01087788|450899834|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
125345885|NCT01087788|450899832|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
125546258|NCT04677179|451629410|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125546259|NCT04677179|451629411|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125546260|NCT04677179|451629412|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125546261|NCT04677179|451629413|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125546262|NCT04677179|451629414|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
125546263|NCT04677179|451629415|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125546264|NCT04677179|451629416|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125546265|NCT04677179|451629407|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125546266|NCT04677179|451629408|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125546267|NCT04677179|451629409|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125546268|NCT04677179|451629410|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125546269|NCT04677179|451629411|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125546270|NCT04677179|451629412|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125546271|NCT04677179|451629413|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125546272|NCT04677179|451629414|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
125546273|NCT04677179|451629415|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
125546274|NCT04677179|451629416|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125546275|NCT04677179|451629407|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
125546276|NCT04677179|451629408|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
125546277|NCT04677179|451629409|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
125546278|NCT04677179|451629410|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
125546279|NCT04677179|451629411|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
125546280|NCT04677179|451629412|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
125546281|NCT04677179|451629413|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
125546282|NCT04677179|451629414|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
125546283|NCT04677179|451629415|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
125546284|NCT04677179|451629416|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
125546285|NCT00998335|451629418|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
125546286|NCT00998335|451629419|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
125546287|NCT03169101|451629421|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
125546288|NCT03169101|451629422|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
125546289|NCT03169101|451629423|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
125546290|NCT03169101|451629424|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
125546291|NCT00790751|451629430|FG000|Overall Study|Protocol non-compliance|16|||
125546292|NCT00790751|451629431|FG001|Overall Study|Protocol non-compliance|16|||
125546293|NCT00790751|451629432|FG002|Overall Study|Protocol non-compliance|10|||
125546294|NCT00790751|451629433|FG003|Overall Study|Protocol non-compliance|11|||
125546295|NCT00790751|451629430|FG000|Overall Study|Lost to Follow-up|4|||
125546296|NCT00790751|451629431|FG001|Overall Study|Lost to Follow-up|9|||
125546297|NCT00790751|451629432|FG002|Overall Study|Lost to Follow-up|4|||
125546298|NCT00790751|451629433|FG003|Overall Study|Lost to Follow-up|5|||
125546299|NCT00790751|451629430|FG000|Overall Study|Adverse Event|5|||
125546300|NCT00790751|451629431|FG001|Overall Study|Adverse Event|3|||
125546301|NCT00790751|451629432|FG002|Overall Study|Adverse Event|5|||
125680774|NCT01569152|452120740|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
125680775|NCT01569152|452120738|FG000|Safety Extension, Period 3|Physician Decision|0|||
125680776|NCT01569152|452120739|FG001|Safety Extension, Period 3|Physician Decision|0|||
125680777|NCT01569152|452120740|FG002|Safety Extension, Period 3|Physician Decision|2|||
125680778|NCT01569152|452120738|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
125680779|NCT01569152|452120739|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
125680780|NCT01569152|452120740|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
125680781|NCT02920996|452120745|FG000|Overall Study|Adverse Event|8|||
125680782|NCT02920996|452120746|FG001|Overall Study|Adverse Event|0|||
125680783|NCT02920996|452120745|FG000|Overall Study|Physician Decision|1|||
125680784|NCT02920996|452120746|FG001|Overall Study|Physician Decision|0|||
125680785|NCT02920996|452120745|FG000|Overall Study|Death|1|||
125680786|NCT02920996|452120746|FG001|Overall Study|Death|0|||
125680787|NCT02920996|452120745|FG000|Overall Study|Missing|1|||
125680788|NCT02920996|452120746|FG001|Overall Study|Missing|0|||
125680789|NCT02920996|452120745|FG000|Overall Study|Subject Non-Compliance|1|||
125680790|NCT02920996|452120746|FG001|Overall Study|Subject Non-Compliance|0|||
125680791|NCT00154102|452120747|FG000|Overall Study|investigational study phase ongoing|7|||
125680792|NCT00154102|452120748|FG001|Overall Study|investigational study phase ongoing|2|||
125680793|NCT00463606|452120749|FG000|Overall Study|Adverse Event|21|||
125680794|NCT00463606|452120750|FG001|Overall Study|Adverse Event|18|||
125680795|NCT00463606|452120751|FG002|Overall Study|Adverse Event|11|||
125680796|NCT00463606|452120749|FG000|Overall Study|Withdrawal by Subject|11|||
125680797|NCT00463606|452120750|FG001|Overall Study|Withdrawal by Subject|11|||
125680798|NCT00463606|452120751|FG002|Overall Study|Withdrawal by Subject|5|||
125680799|NCT00463606|452120749|FG000|Overall Study|Lost to Follow-up|2|||
125546302|NCT00790751|451629433|FG003|Overall Study|Adverse Event|4|||
125546303|NCT00790751|451629430|FG000|Overall Study|Requirement for restricted medication|0|||
125345886|NCT01087788|450899833|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
125345887|NCT01087788|450899834|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
125345888|NCT01087788|450899832|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
125345889|NCT01087788|450899833|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
125345890|NCT01087788|450899834|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
125345891|NCT01087788|450899832|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
125345892|NCT01087788|450899833|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
125345893|NCT01087788|450899834|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
125345894|NCT01087788|450899832|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
125345895|NCT01087788|450899833|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
125345896|NCT01087788|450899834|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
125345897|NCT01087788|450899832|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
125345898|NCT01087788|450899833|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
125345899|NCT01087788|450899834|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
125345900|NCT01087788|450899832|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
125345901|NCT01087788|450899833|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
125345902|NCT01087788|450899834|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
125345903|NCT01087788|450899832|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
125345904|NCT01087788|450899833|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
125345905|NCT01087788|450899834|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
125345906|NCT01087788|450899832|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
125546304|NCT00790751|451629431|FG001|Overall Study|Requirement for restricted medication|2|||
125546305|NCT00790751|451629432|FG002|Overall Study|Requirement for restricted medication|0|||
125546306|NCT00790751|451629433|FG003|Overall Study|Requirement for restricted medication|0|||
125680800|NCT00463606|452120750|FG001|Overall Study|Lost to Follow-up|2|||
125680801|NCT00463606|452120751|FG002|Overall Study|Lost to Follow-up|3|||
125680802|NCT00463606|452120749|FG000|Overall Study|Subject noncompliance|1|||
125680803|NCT00463606|452120750|FG001|Overall Study|Subject noncompliance|1|||
125680804|NCT00463606|452120751|FG002|Overall Study|Subject noncompliance|0|||
125680805|NCT00463606|452120749|FG000|Overall Study|Subject moved out of town|1|||
125680806|NCT00463606|452120750|FG001|Overall Study|Subject moved out of town|0|||
125680807|NCT00463606|452120751|FG002|Overall Study|Subject moved out of town|0|||
125680808|NCT00463606|452120749|FG000|Overall Study|Physician Decision|0|||
125680809|NCT00463606|452120750|FG001|Overall Study|Physician Decision|1|||
125680810|NCT00463606|452120751|FG002|Overall Study|Physician Decision|0|||
125680811|NCT00463606|452120749|FG000|Overall Study|Sponsor request|0|||
125680812|NCT00463606|452120750|FG001|Overall Study|Sponsor request|1|||
125680813|NCT00463606|452120751|FG002|Overall Study|Sponsor request|0|||
125680814|NCT00463606|452120749|FG000|Overall Study|Exclusion criteria violation|2|||
125680815|NCT00463606|452120750|FG001|Overall Study|Exclusion criteria violation|0|||
125680816|NCT00463606|452120751|FG002|Overall Study|Exclusion criteria violation|0|||
125680817|NCT00463606|452120749|FG000|Overall Study|Coordinator error|1|||
125680818|NCT00463606|452120750|FG001|Overall Study|Coordinator error|0|||
125680819|NCT00463606|452120751|FG002|Overall Study|Coordinator error|0|||
125680820|NCT00463606|452120749|FG000|Overall Study|Patient randomized in error|1|||
125680821|NCT00463606|452120750|FG001|Overall Study|Patient randomized in error|0|||
125680822|NCT00463606|452120751|FG002|Overall Study|Patient randomized in error|0|||
125680823|NCT00463606|452120749|FG000|Overall Study|Participation in another ABT-335 trial|1|||
125680824|NCT00463606|452120750|FG001|Overall Study|Participation in another ABT-335 trial|0|||
125680825|NCT00463606|452120751|FG002|Overall Study|Participation in another ABT-335 trial|0|||
125680826|NCT00463606|452120749|FG000|Overall Study|Protocol Violation|0|||
125680827|NCT00463606|452120750|FG001|Overall Study|Protocol Violation|0|||
125680828|NCT00463606|452120751|FG002|Overall Study|Protocol Violation|1|||
125680829|NCT02682602|452120753|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
125680830|NCT02682602|452120754|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
125680831|NCT02682602|452120753|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
125680832|NCT02682602|452120754|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
125680833|NCT04015232|452122004|FG000|Overall Study|Withdrawal by Subject|7|||
125680834|NCT04015232|452122005|FG001|Overall Study|Withdrawal by Subject|4|||
125680835|NCT04015232|452122004|FG000|Overall Study|Protocol Violation|1|||
125680836|NCT04015232|452122005|FG001|Overall Study|Protocol Violation|0|||
125680837|NCT04015232|452122004|FG000|Overall Study|Medical Grounds|3|||
125680838|NCT04015232|452122005|FG001|Overall Study|Medical Grounds|3|||
125680839|NCT02152566|452122006|FG000|Overall Study|Lost to Follow-up|1|||
125680840|NCT02152566|452122006|FG000|Overall Study|Withdrawal by Subject|2|||
125680841|NCT02334722|452122011|FG000|Overall Study|Lost to Follow-up|4|||
125680842|NCT02334722|452122012|FG001|Overall Study|Lost to Follow-up|0|||
125680843|NCT02334722|452122011|FG000|Overall Study|6 week questionnaire not completed|2|||
125680844|NCT02334722|452122012|FG001|Overall Study|6 week questionnaire not completed|0|||
125680845|NCT02334722|452122011|FG000|Overall Study|Unable to obtain medication|1|||
125680846|NCT02334722|452122012|FG001|Overall Study|Unable to obtain medication|1|||
125680847|NCT02334722|452122011|FG000|Overall Study|Withdrawal by Subject|0|||
125546307|NCT00790751|451629430|FG000|Overall Study|Death|0|||
125546308|NCT00790751|451629431|FG001|Overall Study|Death|0|||
125546309|NCT00790751|451629432|FG002|Overall Study|Death|1|||
125546310|NCT00790751|451629433|FG003|Overall Study|Death|0|||
125546311|NCT00790751|451629430|FG000|Overall Study|Physician Decision|0|||
125546312|NCT00790751|451629431|FG001|Overall Study|Physician Decision|0|||
125546313|NCT00790751|451629432|FG002|Overall Study|Physician Decision|0|||
125546314|NCT00790751|451629433|FG003|Overall Study|Physician Decision|1|||
125546315|NCT01078454|451629436|FG000|Overall Study|Adverse Event|1|||
125546316|NCT01078454|451629437|FG001|Overall Study|Adverse Event|1|||
125546317|NCT01078454|451629436|FG000|Overall Study|Death|0|||
125345907|NCT01087788|450899833|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
125345908|NCT01087788|450899834|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
125345909|NCT01087788|450899832|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
125345910|NCT01087788|450899833|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
125345911|NCT01087788|450899834|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
125345912|NCT01087788|450899832|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
125345913|NCT01087788|450899833|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
125345914|NCT01087788|450899834|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
125378917|NCT00589914|451019206|FG000|Overall Study|Withdrawal by Subject|55|||
125546318|NCT01078454|451629437|FG001|Overall Study|Death|1|||
125680848|NCT02334722|452122012|FG001|Overall Study|Withdrawal by Subject|3|||
125680849|NCT02334722|452122011|FG000|Overall Study|Adverse Event|0|||
125680850|NCT02334722|452122012|FG001|Overall Study|Adverse Event|2|||
125680851|NCT02334722|452122011|FG000|Overall Study|Physician Decision|0|||
125680852|NCT02334722|452122012|FG001|Overall Study|Physician Decision|1|||
125680853|NCT00856388|452122013|FG000|Overall Study|Other|1|||
125680854|NCT01617668|452122016|FG000|Overall Study|Adverse Event|7|||
125680855|NCT01617668|452122017|FG001|Overall Study|Adverse Event|0|||
125680856|NCT01617668|452122018|FG002|Overall Study|Adverse Event|12|||
125680857|NCT01617668|452122019|FG003|Overall Study|Adverse Event|5|||
125680858|NCT01617668|452122016|FG000|Overall Study|Physician Decision|1|||
125680859|NCT01617668|452122017|FG001|Overall Study|Physician Decision|2|||
125680860|NCT01617668|452122018|FG002|Overall Study|Physician Decision|3|||
125680861|NCT01617668|452122019|FG003|Overall Study|Physician Decision|0|||
125680862|NCT01617668|452122016|FG000|Overall Study|Progressive Disease|4|||
125680863|NCT01617668|452122017|FG001|Overall Study|Progressive Disease|4|||
125680864|NCT01617668|452122018|FG002|Overall Study|Progressive Disease|6|||
125680865|NCT01617668|452122019|FG003|Overall Study|Progressive Disease|9|||
125680866|NCT01617668|452122016|FG000|Overall Study|Subject/guardian decision|1|||
125680867|NCT01617668|452122017|FG001|Overall Study|Subject/guardian decision|3|||
125680868|NCT01617668|452122018|FG002|Overall Study|Subject/guardian decision|2|||
125680869|NCT01617668|452122019|FG003|Overall Study|Subject/guardian decision|1|||
125680870|NCT02017964|452122020|FG000|Overall Study|Patient deemed ineligible|1|||
125680871|NCT00925769|452122021|FG000|Overall Study|Major toxicity|1|||
125680872|NCT00925769|452122022|FG001|Overall Study|Major toxicity|0|||
125680873|NCT00925769|452122023|FG002|Overall Study|Major toxicity|1|||
125680874|NCT00925769|452122024|FG003|Overall Study|Major toxicity|1|||
125680875|NCT00925769|452122025|FG004|Overall Study|Major toxicity|0|||
125680876|NCT00925769|452122026|FG005|Overall Study|Major toxicity|0|||
125680877|NCT00925769|452122021|FG000|Overall Study|Disease progression|4|||
125680878|NCT00925769|452122022|FG001|Overall Study|Disease progression|5|||
125680879|NCT00925769|452122023|FG002|Overall Study|Disease progression|3|||
125680880|NCT00925769|452122024|FG003|Overall Study|Disease progression|4|||
125680881|NCT00925769|452122025|FG004|Overall Study|Disease progression|2|||
125680882|NCT00925769|452122026|FG005|Overall Study|Disease progression|3|||
125680883|NCT00925769|452122021|FG000|Overall Study|Death|0|||
125680884|NCT00925769|452122022|FG001|Overall Study|Death|0|||
125680885|NCT00925769|452122023|FG002|Overall Study|Death|1|||
125680886|NCT00925769|452122024|FG003|Overall Study|Death|0|||
125680887|NCT00925769|452122025|FG004|Overall Study|Death|0|||
125680888|NCT00925769|452122026|FG005|Overall Study|Death|0|||
125680889|NCT00925769|452122021|FG000|Overall Study|Physician Decision|1|||
125680890|NCT00925769|452122022|FG001|Overall Study|Physician Decision|0|||
125680891|NCT00925769|452122023|FG002|Overall Study|Physician Decision|0|||
125680892|NCT00925769|452122024|FG003|Overall Study|Physician Decision|0|||
125680893|NCT00925769|452122025|FG004|Overall Study|Physician Decision|0|||
125680894|NCT00925769|452122026|FG005|Overall Study|Physician Decision|0|||
125680895|NCT00925769|452122021|FG000|Overall Study|Missing documentation|0|||
125680896|NCT00925769|452122022|FG001|Overall Study|Missing documentation|1|||
125546319|NCT00346268|451631361|FG000|Overall Study|Adverse Event|1|||
125680897|NCT00925769|452122023|FG002|Overall Study|Missing documentation|0|||
125680898|NCT00925769|452122024|FG003|Overall Study|Missing documentation|0|||
125680899|NCT00925769|452122025|FG004|Overall Study|Missing documentation|0|||
125680900|NCT00925769|452122026|FG005|Overall Study|Missing documentation|0|||
125680901|NCT00925769|452122021|FG000|Overall Study|End of study visit not done|0|||
125680902|NCT00925769|452122022|FG001|Overall Study|End of study visit not done|0|||
125680903|NCT00925769|452122023|FG002|Overall Study|End of study visit not done|1|||
125546320|NCT00346268|451631362|FG001|Overall Study|Adverse Event|0|||
125546321|NCT00346268|451631361|FG000|Overall Study|Protocol Violation|1|||
125546322|NCT00346268|451631362|FG001|Overall Study|Protocol Violation|0|||
125546323|NCT00346268|451631361|FG000|Overall Study|Participant refused|0|||
125546324|NCT00346268|451631362|FG001|Overall Study|Participant refused|3|||
125546325|NCT02186223|451631366|FG000|Overall Study|Not eligible for device placement|6|||
125546326|NCT02186223|451631366|FG000|Overall Study|Unable to obtain femoral access|3|||
125546327|NCT02186223|451631366|FG000|Overall Study|Death|3|||
125546328|NCT02186223|451631366|FG000|Overall Study|Device in place less than 48 hours|9|||
125546329|NCT02079610|451631367|FG000|Overall Study|Withdrawal by Subject|1|||
125546330|NCT02079610|451631368|FG001|Overall Study|Withdrawal by Subject|1|||
125546331|NCT01111474|451631369|FG000|Overall Study|Lost to Follow-up|12|||
125546332|NCT01016977|451631370|FG000|Overall Study|Lost to Follow-up|1|||
125546333|NCT01016977|451631371|FG001|Overall Study|Lost to Follow-up|0|||
125546334|NCT01016977|451631370|FG000|Overall Study|Withdrawal by Subject|2|||
125546335|NCT01016977|451631371|FG001|Overall Study|Withdrawal by Subject|2|||
125546336|NCT00824161|451631372|FG000|Overall Study|Withdrawal by Subject|1|||
125546337|NCT00824161|451631372|FG000|Overall Study|Screen Failure|1|||
125546338|NCT04882995|451631373|FG000|Overall Study|Withdrawal by Subject|1|||
125546339|NCT04882995|451631374|FG001|Overall Study|Withdrawal by Subject|2|||
125546340|NCT04882995|451631373|FG000|Overall Study|Protocol Violation|4|||
125546341|NCT04882995|451631374|FG001|Overall Study|Protocol Violation|4|||
125546342|NCT04882995|451631373|FG000|Overall Study|Surgery postponed due to COVID|1|||
125546343|NCT04882995|451631374|FG001|Overall Study|Surgery postponed due to COVID|1|||
125546344|NCT00477334|451631375|FG000|Overall Study|Discontinued prior to taking study drug|106|||
125546345|NCT00477334|451631376|FG001|Overall Study|Discontinued prior to taking study drug|53|||
125546346|NCT00477334|451631375|FG000|Overall Study|Adverse Event|1|||
125546347|NCT00477334|451631376|FG001|Overall Study|Adverse Event|2|||
125546348|NCT00477334|451631375|FG000|Overall Study|Withdrawal by Subject|2|||
125546349|NCT00477334|451631376|FG001|Overall Study|Withdrawal by Subject|1|||
125546350|NCT00477334|451631375|FG000|Overall Study|Lost to Follow-up|15|||
125546351|NCT00477334|451631376|FG001|Overall Study|Lost to Follow-up|4|||
125546352|NCT00477334|451631375|FG000|Overall Study|Administrative Problems|39|||
125546353|NCT00477334|451631376|FG001|Overall Study|Administrative Problems|15|||
125546354|NCT00477334|451631375|FG000|Overall Study|Protocol Violation|7|||
125546355|NCT00477334|451631376|FG001|Overall Study|Protocol Violation|1|||
125546356|NCT02354508|451631380|FG000|Period 1: Core Phase|Adverse Event|1|||
125546357|NCT02354508|451631381|FG001|Period 1: Core Phase|Adverse Event|1|||
125546358|NCT02354508|451631382|FG002|Period 1: Core Phase|Adverse Event|2|||
125546359|NCT02354508|451631380|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
125546360|NCT02354508|451631381|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
125546361|NCT02354508|451631382|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
125546362|NCT02354508|451631380|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
125546363|NCT02354508|451631381|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
125546364|NCT02354508|451631382|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
125546365|NCT02354508|451631380|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
125546366|NCT02354508|451631381|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
125546367|NCT02354508|451631382|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
125546368|NCT02354508|451631380|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
125546369|NCT02354508|451631381|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
125546370|NCT02354508|451631382|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
125546371|NCT02354508|451631380|FG000|Period 2: Extension Phase|Physician Decision|5|||
125546372|NCT02354508|451631381|FG001|Period 2: Extension Phase|Physician Decision|0|||
125345915|NCT01087788|450899832|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
125546373|NCT02354508|451631382|FG002|Period 2: Extension Phase|Physician Decision|1|||
125546374|NCT02354508|451631380|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
125546375|NCT02354508|451631381|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
125546376|NCT02354508|451631382|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
125546377|NCT02354508|451631380|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
125546378|NCT02354508|451631381|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
125546379|NCT02354508|451631382|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
125546380|NCT02354508|451631380|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
125546381|NCT02354508|451631381|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
125546382|NCT02354508|451631382|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
125546383|NCT03587974|451631383|FG000|Overall Study|caregiver demented, care recipient died|3|||
125546384|NCT03587974|451631384|FG001|Overall Study|caregiver demented, care recipient died|3|||
125546385|NCT03587974|451631383|FG000|Overall Study|Withdrawal by Subject|2|||
125546386|NCT03587974|451631384|FG001|Overall Study|Withdrawal by Subject|1|||
125546387|NCT04371198|451631385|FG000|Overall Study|inadequate sample|4|||
125546388|NCT00372229|451631386|FG000|Study Phase|Graft loss|0|||
125546389|NCT00372229|451631387|FG001|Study Phase|Graft loss|3|||
125546390|NCT00372229|451631386|FG000|Study Phase|Protocol Violation|3|||
125546391|NCT00372229|451631387|FG001|Study Phase|Protocol Violation|4|||
125546392|NCT00372229|451631386|FG000|Study Phase|Consent withdrawn|16|||
125546393|NCT00372229|451631387|FG001|Study Phase|Consent withdrawn|14|||
125546394|NCT00372229|451631386|FG000|Study Phase|Refused treatment/did not cooperate|3|||
125546395|NCT00372229|451631387|FG001|Study Phase|Refused treatment/did not cooperate|1|||
125546396|NCT00372229|451631386|FG000|Study Phase|Death|3|||
125546397|NCT00372229|451631387|FG001|Study Phase|Death|2|||
125546398|NCT00372229|451631386|FG000|Study Phase|Reason not specified|3|||
125546399|NCT00372229|451631387|FG001|Study Phase|Reason not specified|2|||
125546400|NCT00372229|451631386|FG000|Study Phase|Lost to Follow-up|3|||
125546401|NCT00372229|451631387|FG001|Study Phase|Lost to Follow-up|3|||
125546402|NCT00372229|451631386|FG000|Follow-Up Phase|Graft loss|8|||
125546403|NCT00372229|451631387|FG001|Follow-Up Phase|Graft loss|7|||
125546404|NCT00372229|451631386|FG000|Follow-Up Phase|Consent withdrawn|13|||
125546405|NCT00372229|451631387|FG001|Follow-Up Phase|Consent withdrawn|19|||
125546406|NCT00372229|451631386|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
125546407|NCT00372229|451631387|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
125546408|NCT00372229|451631386|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
125546409|NCT00372229|451631387|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
125546410|NCT00372229|451631386|FG000|Follow-Up Phase|Death|9|||
125546411|NCT00372229|451631387|FG001|Follow-Up Phase|Death|12|||
125546412|NCT00372229|451631386|FG000|Follow-Up Phase|Administrative|1|||
125546413|NCT00372229|451631387|FG001|Follow-Up Phase|Administrative|0|||
125546414|NCT00372229|451631386|FG000|Follow-Up Phase|Reason not specified|2|||
125546415|NCT00372229|451631387|FG001|Follow-Up Phase|Reason not specified|3|||
125546416|NCT00372229|451631386|FG000|Follow-Up Phase|Lost to Follow-up|12|||
125546417|NCT00372229|451631387|FG001|Follow-Up Phase|Lost to Follow-up|10|||
125546418|NCT03536143|451631388|FG000|Overall Study|Early termination, Sponsor decision|1|||
125546419|NCT04754477|451631389|FG000|Overall Study|Withdrawal by Subject|1|||
125546420|NCT01347762|451631390|FG000|Overall Study|Lost to Follow-up|0|||
125546421|NCT01347762|451631391|FG001|Overall Study|Lost to Follow-up|1|||
125546422|NCT01347762|451631392|FG002|Overall Study|Lost to Follow-up|6|||
125546423|NCT01347762|451631393|FG003|Overall Study|Lost to Follow-up|5|||
125546424|NCT01347762|451631390|FG000|Overall Study|Withdrawal by Subject|4|||
125546425|NCT01347762|451631391|FG001|Overall Study|Withdrawal by Subject|1|||
125546426|NCT01347762|451631392|FG002|Overall Study|Withdrawal by Subject|3|||
125546427|NCT01347762|451631393|FG003|Overall Study|Withdrawal by Subject|3|||
125546428|NCT00093808|451631394|FG000|Overall Study|Cancel participation before receiving tx|1|||
125546429|NCT00093808|451631394|FG000|Overall Study|Protocol Violation|1|||
125546430|NCT00871780|451631395|FG000|Overall Study|Enrolled But Not Treated|6|||
125546431|NCT00871780|451631395|FG000|Overall Study|Withdrawal by Subject|9|||
125546432|NCT00871780|451631395|FG000|Overall Study|Adverse Event|6|||
125546433|NCT00871780|451631395|FG000|Overall Study|Voluntary Discontinuation|4|||
125546434|NCT00871780|451631395|FG000|Overall Study|Death|1|||
125546435|NCT00871780|451631395|FG000|Overall Study|Physician Decision|1|||
125546436|NCT03406260|451631396|FG000|Period 1|Adverse Event|0|||
125546437|NCT03406260|451631397|FG001|Period 1|Adverse Event|0|||
125546438|NCT03406260|451631398|FG002|Period 1|Adverse Event|0|||
125546439|NCT03406260|451631399|FG003|Period 1|Adverse Event|0|||
125546440|NCT03406260|451631400|FG004|Period 1|Adverse Event|1|||
125546441|NCT03406260|451631401|FG005|Period 1|Adverse Event|0|||
125546442|NCT02527343|451631402|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
125345916|NCT01087788|450899833|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
125546443|NCT02527343|451631403|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
125546444|NCT02527343|451631404|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
125345917|NCT01087788|450899834|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
125546445|NCT02527343|451631405|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
125546446|NCT02527343|451631406|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
125546447|NCT02527343|451631407|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
125546448|NCT02527343|451631402|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
125546449|NCT02527343|451631403|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
125546450|NCT02527343|451631404|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
125546451|NCT02527343|451631405|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
125546452|NCT02527343|451631406|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
125546453|NCT02527343|451631407|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
125637197|NCT03073200|451952833|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
125680904|NCT00925769|452122024|FG003|Overall Study|End of study visit not done|0|||
125680905|NCT00925769|452122025|FG004|Overall Study|End of study visit not done|0|||
125680906|NCT00925769|452122026|FG005|Overall Study|End of study visit not done|0|||
125680907|NCT00925769|452122021|FG000|Overall Study|Participant is unable to swallow drug|0|||
125680908|NCT00925769|452122022|FG001|Overall Study|Participant is unable to swallow drug|0|||
125680909|NCT00925769|452122023|FG002|Overall Study|Participant is unable to swallow drug|0|||
125680910|NCT00925769|452122024|FG003|Overall Study|Participant is unable to swallow drug|1|||
125680911|NCT00925769|452122025|FG004|Overall Study|Participant is unable to swallow drug|0|||
125680912|NCT00925769|452122026|FG005|Overall Study|Participant is unable to swallow drug|0|||
125546454|NCT02527343|451631402|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
125546455|NCT02527343|451631403|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
125546456|NCT02527343|451631404|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
125546457|NCT02527343|451631405|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
125546458|NCT02527343|451631406|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
125546459|NCT02527343|451631407|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
125546460|NCT02527343|451631402|FG000|RT Period: Weeks 1 to 52|Other|4|||
125546461|NCT02527343|451631403|FG001|RT Period: Weeks 1 to 52|Other|3|||
125546462|NCT02527343|451631404|FG002|RT Period: Weeks 1 to 52|Other|0|||
125546463|NCT02527343|451631405|FG003|RT Period: Weeks 1 to 52|Other|0|||
125546464|NCT02527343|451631406|FG004|RT Period: Weeks 1 to 52|Other|0|||
125546465|NCT02527343|451631407|FG005|RT Period: Weeks 1 to 52|Other|0|||
125546466|NCT02527343|451631402|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
125546467|NCT02527343|451631403|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
125546468|NCT02527343|451631404|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
125546469|NCT02527343|451631405|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
125546470|NCT02527343|451631406|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
125546471|NCT02527343|451631407|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
125546472|NCT02527343|451631402|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
125546473|NCT02527343|451631403|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
125546474|NCT02527343|451631404|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
125546475|NCT02527343|451631405|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
125546476|NCT02527343|451631406|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
125546477|NCT02527343|451631407|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
125546478|NCT02527343|451631402|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
125546479|NCT02527343|451631403|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
125546480|NCT02527343|451631404|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
125546481|NCT02527343|451631405|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
125546482|NCT02527343|451631406|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
125546483|NCT02527343|451631407|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
125546484|NCT02527343|451631402|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
125546485|NCT02527343|451631403|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
125546486|NCT02527343|451631404|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
125546487|NCT02527343|451631405|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
125210715|NCT02028169|450395660|FG000|Overall Study|Withdrawal by Subject|2|||
125210716|NCT02028169|450395660|FG000|Overall Study|Adverse Event|1|||
125210717|NCT02028169|450395660|FG000|Overall Study|Cessation of Drug|1|||
125210718|NCT02028169|450395660|FG000|Overall Study|Concomitant Medication Usage|1|||
125210719|NCT02258334|450395661|FG000|Overall Study|Adverse Event|1|||
125210720|NCT02258334|450395662|FG001|Overall Study|Adverse Event|0|||
125210721|NCT02258334|450395663|FG002|Overall Study|Adverse Event|0|||
125210722|NCT02258334|450395664|FG003|Overall Study|Adverse Event|0|||
125210723|NCT00862459|450395665|FG000|Overall Study|Lost to Follow-up|1|||
125210724|NCT00862459|450395666|FG001|Overall Study|Lost to Follow-up|2|||
125210725|NCT00862459|450395667|FG002|Overall Study|Lost to Follow-up|2|||
125210726|NCT00862459|450395665|FG000|Overall Study|Protocol Violation|1|||
125210727|NCT00862459|450395666|FG001|Overall Study|Protocol Violation|0|||
125210728|NCT00862459|450395667|FG002|Overall Study|Protocol Violation|0|||
125210729|NCT00862459|450395665|FG000|Overall Study|Withdrawal by Subject|1|||
125210730|NCT00862459|450395666|FG001|Overall Study|Withdrawal by Subject|1|||
125210731|NCT00862459|450395667|FG002|Overall Study|Withdrawal by Subject|3|||
125210732|NCT00862459|450395665|FG000|Overall Study|Adverse Event|0|||
125210733|NCT00862459|450395666|FG001|Overall Study|Adverse Event|1|||
125210734|NCT00862459|450395667|FG002|Overall Study|Adverse Event|0|||
125210735|NCT00862459|450395665|FG000|Overall Study|Personal reasons|1|||
125345918|NCT01087788|450899832|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
125345919|NCT01087788|450899833|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
125345920|NCT01087788|450899834|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
125345921|NCT01087788|450899832|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
125345922|NCT01087788|450899833|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
125345923|NCT01087788|450899834|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
125345924|NCT01087788|450899832|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
125345925|NCT01087788|450899833|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
125345926|NCT01087788|450899834|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
125345927|NCT01087788|450899832|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
125345928|NCT01087788|450899833|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
125345929|NCT01087788|450899834|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
125345930|NCT01087788|450899832|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
125345931|NCT01087788|450899833|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
125345932|NCT01087788|450899834|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
125345933|NCT01087788|450899832|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
125345934|NCT01087788|450899833|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
125345935|NCT01087788|450899834|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
125345936|NCT01087788|450899832|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
125345937|NCT01087788|450899833|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
125345938|NCT01087788|450899834|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
125345939|NCT01087788|450899832|FG000|24-weeks Dose-blind Period|Patient moved|0|||
125345940|NCT01087788|450899833|FG001|24-weeks Dose-blind Period|Patient moved|0|||
125345941|NCT01087788|450899834|FG002|24-weeks Dose-blind Period|Patient moved|1|||
125345942|NCT01087788|450899832|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
125345943|NCT01087788|450899833|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
125345944|NCT01087788|450899834|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
125345945|NCT01087788|450899832|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
125345946|NCT01087788|450899833|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
125345947|NCT01087788|450899834|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
125345948|NCT01087788|450899832|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
125345949|NCT01087788|450899833|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
125345950|NCT01087788|450899834|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
125345951|NCT01087788|450899832|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
125345952|NCT01087788|450899833|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
125345953|NCT01087788|450899834|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
125345954|NCT01087788|450899832|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
125345955|NCT01087788|450899833|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
125210736|NCT00862459|450395666|FG001|Overall Study|Personal reasons|0|||
125210737|NCT00862459|450395667|FG002|Overall Study|Personal reasons|0|||
125345956|NCT01087788|450899834|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
125345957|NCT01087788|450899832|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
125345958|NCT01087788|450899833|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
125345959|NCT01087788|450899834|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
125345960|NCT01087788|450899832|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
125345961|NCT01087788|450899833|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
125345962|NCT01087788|450899834|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
125345963|NCT01087788|450899832|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
125345964|NCT01087788|450899833|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
125345965|NCT01087788|450899834|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
125345966|NCT01087788|450899832|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
125345967|NCT01087788|450899833|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
125345968|NCT01087788|450899834|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
125345969|NCT01087788|450899832|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
125210738|NCT00862459|450395665|FG000|Overall Study|Operation|1|||
125210739|NCT00862459|450395666|FG001|Overall Study|Operation|1|||
125345970|NCT01087788|450899833|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
125546488|NCT02527343|451631406|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
125546489|NCT02527343|451631407|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
125546490|NCT02527343|451631402|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
125546491|NCT02527343|451631403|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
125546492|NCT02527343|451631404|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
125546493|NCT02527343|451631405|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
125546494|NCT02527343|451631406|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
125546495|NCT02527343|451631407|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
125546496|NCT02527343|451631402|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
125546497|NCT02527343|451631403|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
125546498|NCT02527343|451631404|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
125546499|NCT02527343|451631405|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
125546500|NCT02527343|451631406|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
125546501|NCT02527343|451631407|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
125546502|NCT02527343|451631402|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
125546503|NCT02527343|451631403|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
125546504|NCT02527343|451631404|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
125546505|NCT02527343|451631405|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
125546506|NCT02527343|451631406|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
125546507|NCT02527343|451631407|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
125546508|NCT02527343|451631402|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
125546509|NCT02527343|451631403|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
125546510|NCT02527343|451631404|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
125546511|NCT02527343|451631405|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
125546512|NCT02527343|451631406|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
125546513|NCT02527343|451631407|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
125546514|NCT02527343|451631402|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
125546515|NCT02527343|451631403|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
125546516|NCT02527343|451631404|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
125546517|NCT02527343|451631405|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
125546518|NCT02527343|451631406|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
125546519|NCT02527343|451631407|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
125546520|NCT00701220|451631408|FG000|Overall Study|Withdrawal by Subject|0|||
125546521|NCT00701220|451631409|FG001|Overall Study|Withdrawal by Subject|2|||
125546522|NCT00701220|451631408|FG000|Overall Study|Protocol Violation|2|||
125546523|NCT00701220|451631409|FG001|Overall Study|Protocol Violation|0|||
125546524|NCT03235284|451631410|FG000|Overall Study|Adverse Event|1|||
125546525|NCT03235284|451631411|FG001|Overall Study|Adverse Event|2|||
125546526|NCT03235284|451631412|FG002|Overall Study|Adverse Event|1|||
125546527|NCT00440999|451631415|FG000|Overall Study|Adverse Event|0|||
125546528|NCT00440999|451631416|FG001|Overall Study|Adverse Event|2|||
125546529|NCT00440999|451631415|FG000|Overall Study|Lack of Efficacy|6|||
125546530|NCT00440999|451631416|FG001|Overall Study|Lack of Efficacy|7|||
125546531|NCT00440999|451631415|FG000|Overall Study|Lost to Follow-up|19|||
125546532|NCT00440999|451631416|FG001|Overall Study|Lost to Follow-up|12|||
125546533|NCT00440999|451631415|FG000|Overall Study|Protocol Violation|1|||
125546534|NCT00440999|451631416|FG001|Overall Study|Protocol Violation|0|||
125546535|NCT00440999|451631415|FG000|Overall Study|Withdrawal by Subject|2|||
125546536|NCT00440999|451631416|FG001|Overall Study|Withdrawal by Subject|5|||
125546537|NCT00440999|451631415|FG000|Overall Study|Subjets missed the visit|1|||
125546538|NCT00440999|451631416|FG001|Overall Study|Subjets missed the visit|0|||
125546539|NCT00440999|451631415|FG000|Overall Study|Mixed infection at entry|1|||
125546540|NCT00440999|451631416|FG001|Overall Study|Mixed infection at entry|0|||
125546541|NCT00440999|451631415|FG000|Overall Study|P. falciparum malaria|5|||
125546542|NCT00440999|451631416|FG001|Overall Study|P. falciparum malaria|14|||
125546543|NCT00440999|451631415|FG000|Overall Study|Subj left hosp without inform staff|0|||
125546544|NCT00440999|451631416|FG001|Overall Study|Subj left hosp without inform staff|1|||
125546545|NCT04745026|451631419|FG000|Overall Study|Physician Decision|1|||
125546546|NCT04745026|451631420|FG001|Overall Study|Physician Decision|0|||
125546547|NCT04745026|451631419|FG000|Overall Study|Adverse Event|2|||
125546548|NCT04745026|451631420|FG001|Overall Study|Adverse Event|2|||
125546549|NCT04745026|451631419|FG000|Overall Study|Protocol Violation|1|||
125546550|NCT04745026|451631420|FG001|Overall Study|Protocol Violation|3|||
125546551|NCT04745026|451631419|FG000|Overall Study|Lost to Follow-up|4|||
125546552|NCT04745026|451631420|FG001|Overall Study|Lost to Follow-up|3|||
125546553|NCT04745026|451631419|FG000|Overall Study|Withdrawal by Subject|5|||
125546554|NCT04745026|451631420|FG001|Overall Study|Withdrawal by Subject|5|||
125680913|NCT00925769|452122021|FG000|Overall Study|Adverse Event|0|||
125680914|NCT00925769|452122022|FG001|Overall Study|Adverse Event|0|||
125680915|NCT00925769|452122023|FG002|Overall Study|Adverse Event|0|||
125680916|NCT00925769|452122024|FG003|Overall Study|Adverse Event|0|||
125680917|NCT00925769|452122025|FG004|Overall Study|Adverse Event|1|||
125680918|NCT00925769|452122026|FG005|Overall Study|Adverse Event|0|||
125680919|NCT00686959|452122028|FG000|Overall Study|Participants censored (no death events)|124|||
125680920|NCT00686959|452122029|FG001|Overall Study|Participants censored (no death events)|117|||
125345971|NCT01087788|450899834|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
125345972|NCT01087788|450899832|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
125345973|NCT01087788|450899833|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
125345974|NCT01087788|450899834|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
125345975|NCT01087788|450899832|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
125345976|NCT01087788|450899833|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
125546555|NCT01205152|451631421|FG000|Overall Study|Death|1|||
125546556|NCT00249002|451631422|FG000|Overall Study|Adverse Event|2|||
125546557|NCT00249002|451631422|FG000|Overall Study|Study cancellation|3|||
125546558|NCT00249002|451631422|FG000|Overall Study|Other|2|||
125546559|NCT03256851|451631423|FG000|Overall Study|Withdrawal by Subject|1|||
125546560|NCT03256851|451631424|FG001|Overall Study|Withdrawal by Subject|0|||
125546561|NCT02208999|451631426|FG000|Overall Study|Lost to Follow-up|1|||
125546562|NCT00319839|451631427|FG000|Overall Study|Adverse Event|5|||
125546563|NCT00319839|451631427|FG000|Overall Study|Withdrawal by Subject|1|||
125546564|NCT01577745|451631428|FG000|Overall Study|Withdrawal by Subject|0|||
125546565|NCT01577745|451631429|FG001|Overall Study|Withdrawal by Subject|1|||
125546566|NCT01577745|451631430|FG002|Overall Study|Withdrawal by Subject|0|||
125546567|NCT01577745|451631431|FG003|Overall Study|Withdrawal by Subject|3|||
125546568|NCT01577745|451631432|FG004|Overall Study|Withdrawal by Subject|2|||
125546569|NCT01577745|451631433|FG005|Overall Study|Withdrawal by Subject|0|||
125546570|NCT01577745|451631428|FG000|Overall Study|Death|3|||
125546571|NCT01577745|451631429|FG001|Overall Study|Death|2|||
125546572|NCT01577745|451631430|FG002|Overall Study|Death|2|||
125546573|NCT01577745|451631431|FG003|Overall Study|Death|1|||
125546574|NCT01577745|451631432|FG004|Overall Study|Death|1|||
125546575|NCT01577745|451631433|FG005|Overall Study|Death|3|||
125546576|NCT01577745|451631428|FG000|Overall Study|Physician Decision|0|||
125546577|NCT01577745|451631429|FG001|Overall Study|Physician Decision|0|||
125680921|NCT00150462|452122030|FG000|Overall Study|Disease Progression or Relapse|3|||
125680922|NCT00150462|452122031|FG001|Overall Study|Disease Progression or Relapse|1|||
125680923|NCT00150462|452122032|FG002|Overall Study|Disease Progression or Relapse|2|||
125680924|NCT00150462|452122033|FG003|Overall Study|Disease Progression or Relapse|1|||
125680925|NCT00150462|452122034|FG004|Overall Study|Disease Progression or Relapse|2|||
125680926|NCT00150462|452122035|FG005|Overall Study|Disease Progression or Relapse|2|||
125680927|NCT00150462|452122036|FG006|Overall Study|Disease Progression or Relapse|3|||
125680928|NCT00150462|452122037|FG007|Overall Study|Disease Progression or Relapse|5|||
125680929|NCT00150462|452122038|FG008|Overall Study|Disease Progression or Relapse|5|||
125680930|NCT00150462|452122039|FG009|Overall Study|Disease Progression or Relapse|3|||
125680931|NCT00150462|452122040|FG010|Overall Study|Disease Progression or Relapse|2|||
125680932|NCT00150462|452122030|FG000|Overall Study|Withdrawal by Subject|0|||
125680933|NCT00150462|452122031|FG001|Overall Study|Withdrawal by Subject|1|||
125680934|NCT00150462|452122032|FG002|Overall Study|Withdrawal by Subject|1|||
125680935|NCT00150462|452122033|FG003|Overall Study|Withdrawal by Subject|0|||
125680936|NCT00150462|452122034|FG004|Overall Study|Withdrawal by Subject|1|||
125680937|NCT00150462|452122035|FG005|Overall Study|Withdrawal by Subject|2|||
125680938|NCT00150462|452122036|FG006|Overall Study|Withdrawal by Subject|0|||
125680939|NCT00150462|452122037|FG007|Overall Study|Withdrawal by Subject|1|||
125680940|NCT00150462|452122038|FG008|Overall Study|Withdrawal by Subject|0|||
125680941|NCT00150462|452122039|FG009|Overall Study|Withdrawal by Subject|1|||
125680942|NCT00150462|452122040|FG010|Overall Study|Withdrawal by Subject|0|||
125680943|NCT00150462|452122030|FG000|Overall Study|Death|0|||
125680944|NCT00150462|452122031|FG001|Overall Study|Death|1|||
125680945|NCT00150462|452122032|FG002|Overall Study|Death|0|||
125680946|NCT00150462|452122033|FG003|Overall Study|Death|0|||
125680947|NCT00150462|452122034|FG004|Overall Study|Death|0|||
125680948|NCT00150462|452122035|FG005|Overall Study|Death|0|||
125680949|NCT00150462|452122036|FG006|Overall Study|Death|0|||
125680950|NCT00150462|452122037|FG007|Overall Study|Death|0|||
125680951|NCT00150462|452122038|FG008|Overall Study|Death|1|||
125680952|NCT00150462|452122039|FG009|Overall Study|Death|0|||
125680953|NCT00150462|452122040|FG010|Overall Study|Death|0|||
125680954|NCT00150462|452122030|FG000|Overall Study|Adverse Event|0|||
125680955|NCT00150462|452122031|FG001|Overall Study|Adverse Event|0|||
125680956|NCT00150462|452122032|FG002|Overall Study|Adverse Event|0|||
125680957|NCT00150462|452122033|FG003|Overall Study|Adverse Event|1|||
125680958|NCT00150462|452122034|FG004|Overall Study|Adverse Event|0|||
125546578|NCT01577745|451631430|FG002|Overall Study|Physician Decision|0|||
125546579|NCT01577745|451631431|FG003|Overall Study|Physician Decision|1|||
125546580|NCT01577745|451631432|FG004|Overall Study|Physician Decision|1|||
125546581|NCT01577745|451631433|FG005|Overall Study|Physician Decision|0|||
125546582|NCT01577745|451631428|FG000|Overall Study|Lost to Follow-up|0|||
125680959|NCT00150462|452122035|FG005|Overall Study|Adverse Event|0|||
125680960|NCT00150462|452122036|FG006|Overall Study|Adverse Event|0|||
125680961|NCT00150462|452122037|FG007|Overall Study|Adverse Event|2|||
125680962|NCT00150462|452122038|FG008|Overall Study|Adverse Event|0|||
125680963|NCT00150462|452122039|FG009|Overall Study|Adverse Event|1|||
125680964|NCT00150462|452122040|FG010|Overall Study|Adverse Event|0|||
125210740|NCT00862459|450395667|FG002|Overall Study|Operation|0|||
125210741|NCT00862459|450395665|FG000|Overall Study|Intravenous (IV) site problems|1|||
125210742|NCT00862459|450395666|FG001|Overall Study|Intravenous (IV) site problems|0|||
125210743|NCT00862459|450395667|FG002|Overall Study|Intravenous (IV) site problems|1|||
125210744|NCT00862459|450395665|FG000|Overall Study|Unable to hold still for imaging|0|||
125210745|NCT00862459|450395666|FG001|Overall Study|Unable to hold still for imaging|1|||
125210746|NCT00862459|450395667|FG002|Overall Study|Unable to hold still for imaging|0|||
125210747|NCT00862459|450395665|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
125210748|NCT00862459|450395666|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
125210749|NCT00862459|450395667|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
125210750|NCT00862459|450395665|FG000|Overall Study|Administrative problems|0|||
125210751|NCT00862459|450395666|FG001|Overall Study|Administrative problems|1|||
125210752|NCT00862459|450395667|FG002|Overall Study|Administrative problems|0|||
125210753|NCT04907227|450395672|FG000|Overall Study|Death|12|||
125210754|NCT04907227|450395673|FG001|Overall Study|Death|8|||
125210755|NCT04907227|450395672|FG000|Overall Study|Withdrawal by Subject|2|||
125210756|NCT04907227|450395673|FG001|Overall Study|Withdrawal by Subject|2|||
125210757|NCT04907227|450395672|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
125210758|NCT04907227|450395673|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
125210759|NCT04907227|450395672|FG000|Overall Study|Sponsor Decision|25|||
125210760|NCT04907227|450395673|FG001|Overall Study|Sponsor Decision|30|||
125210761|NCT04907227|450395672|FG000|Overall Study|Physician Decision|1|||
125210762|NCT04907227|450395673|FG001|Overall Study|Physician Decision|0|||
125210763|NCT02240069|450395674|FG000|Overall Study|Withdrawal by Subject|5|||
125210764|NCT02240069|450395675|FG001|Overall Study|Withdrawal by Subject|5|||
125546583|NCT01577745|451631429|FG001|Overall Study|Lost to Follow-up|0|||
125546584|NCT01577745|451631430|FG002|Overall Study|Lost to Follow-up|0|||
125546585|NCT01577745|451631431|FG003|Overall Study|Lost to Follow-up|0|||
125546586|NCT01577745|451631432|FG004|Overall Study|Lost to Follow-up|0|||
125345977|NCT01087788|450899834|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
125345978|NCT01087788|450899832|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
125345979|NCT01087788|450899833|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
125345980|NCT01087788|450899834|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
125345981|NCT00534313|450899838|FG000|Short-term Period|Adverse Event|1|||
125345982|NCT00534313|450899839|FG001|Short-term Period|Adverse Event|2|||
125345983|NCT00534313|450899840|FG002|Short-term Period|Adverse Event|1|||
125345984|NCT00534313|450899841|FG003|Short-term Period|Adverse Event|3|||
125546587|NCT01577745|451631433|FG005|Overall Study|Lost to Follow-up|1|||
125546588|NCT01577745|451631428|FG000|Overall Study|Alternative Therapy|0|||
125546589|NCT01577745|451631429|FG001|Overall Study|Alternative Therapy|0|||
125546590|NCT01577745|451631430|FG002|Overall Study|Alternative Therapy|0|||
125546591|NCT01577745|451631431|FG003|Overall Study|Alternative Therapy|1|||
125546592|NCT01577745|451631432|FG004|Overall Study|Alternative Therapy|1|||
125546593|NCT01577745|451631433|FG005|Overall Study|Alternative Therapy|0|||
125546594|NCT02483585|451631434|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
125546595|NCT02483585|451631435|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
125546596|NCT02483585|451631434|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
125546597|NCT02483585|451631435|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
125546598|NCT02483585|451631434|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
125546599|NCT02483585|451631435|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
125546600|NCT02483585|451631434|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
125546601|NCT02483585|451631435|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
125546602|NCT02483585|451631434|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
125546603|NCT02483585|451631435|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
125546604|NCT02483585|451631434|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
125546605|NCT02483585|451631435|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
125546606|NCT02483585|451631434|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
125546607|NCT02483585|451631435|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
125546608|NCT01324440|451631440|FG000|Overall Study|Subject moved|0|||
125546609|NCT01324440|451631441|FG001|Overall Study|Subject moved|1|||
125546610|NCT00903630|451631442|FG000|Phase 2|Adverse Event|0|||
125546611|NCT00903630|451631443|FG001|Phase 2|Adverse Event|0|||
125546612|NCT00903630|451631444|FG002|Phase 2|Adverse Event|1|||
125546613|NCT04025580|451631445|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
125546614|NCT04025580|451631446|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
125546615|NCT04025580|451631447|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
125546616|NCT02325557|451631448|FG000|Overall Study|Progressive disease|1|||
125546617|NCT02325557|451631449|FG001|Overall Study|Progressive disease|0|||
125546618|NCT02325557|451631450|FG002|Overall Study|Progressive disease|0|||
125546619|NCT02325557|451631451|FG003|Overall Study|Progressive disease|0|||
125546620|NCT02325557|451631448|FG000|Overall Study|Withdrawal by Subject|4|||
125546621|NCT02325557|451631449|FG001|Overall Study|Withdrawal by Subject|0|||
125546622|NCT02325557|451631450|FG002|Overall Study|Withdrawal by Subject|0|||
125546623|NCT02325557|451631451|FG003|Overall Study|Withdrawal by Subject|15|||
125546624|NCT02325557|451631448|FG000|Overall Study|Death|5|||
125546625|NCT02325557|451631449|FG001|Overall Study|Death|1|||
125546626|NCT02325557|451631450|FG002|Overall Study|Death|1|||
125546627|NCT02325557|451631451|FG003|Overall Study|Death|16|||
125546628|NCT02325557|451631448|FG000|Overall Study|Lost to Follow-up|0|||
125546629|NCT02325557|451631449|FG001|Overall Study|Lost to Follow-up|0|||
125546630|NCT02325557|451631450|FG002|Overall Study|Lost to Follow-up|1|||
125546631|NCT02325557|451631451|FG003|Overall Study|Lost to Follow-up|1|||
125546632|NCT02325557|451631448|FG000|Overall Study|Other|0|||
125546633|NCT02325557|451631449|FG001|Overall Study|Other|0|||
125546634|NCT02325557|451631450|FG002|Overall Study|Other|0|||
125546635|NCT02325557|451631451|FG003|Overall Study|Other|5|||
125546636|NCT00138671|451631452|FG000|Overall Study|Death|0|||
125546637|NCT00138671|451631453|FG001|Overall Study|Death|3|||
125546638|NCT00138671|451631452|FG000|Overall Study|Adverse Event|6|||
125546639|NCT00138671|451631453|FG001|Overall Study|Adverse Event|3|||
125546640|NCT00138671|451631452|FG000|Overall Study|Lost to Follow-up|1|||
125546641|NCT00138671|451631453|FG001|Overall Study|Lost to Follow-up|2|||
125546642|NCT00138671|451631452|FG000|Overall Study|Withdrawal by Subject|3|||
125546643|NCT00138671|451631453|FG001|Overall Study|Withdrawal by Subject|5|||
125546644|NCT00138671|451631452|FG000|Overall Study|Other|3|||
125546645|NCT00138671|451631453|FG001|Overall Study|Other|3|||
125546646|NCT01488487|451631456|FG000|Overall Study|Adverse Event|6|||
125680965|NCT00150462|452122030|FG000|Overall Study|Physician Decision|0|||
125680966|NCT00150462|452122031|FG001|Overall Study|Physician Decision|0|||
125680967|NCT00150462|452122032|FG002|Overall Study|Physician Decision|1|||
125680968|NCT00150462|452122033|FG003|Overall Study|Physician Decision|1|||
125680969|NCT00150462|452122034|FG004|Overall Study|Physician Decision|0|||
125680970|NCT00150462|452122035|FG005|Overall Study|Physician Decision|0|||
125680971|NCT00150462|452122036|FG006|Overall Study|Physician Decision|0|||
125680972|NCT00150462|452122037|FG007|Overall Study|Physician Decision|0|||
125680973|NCT00150462|452122038|FG008|Overall Study|Physician Decision|0|||
125680974|NCT00150462|452122039|FG009|Overall Study|Physician Decision|0|||
125680975|NCT00150462|452122040|FG010|Overall Study|Physician Decision|0|||
125680976|NCT00150462|452122030|FG000|Overall Study|Other|0|||
125546647|NCT01488487|451631456|FG000|Overall Study|Death|1|||
125546648|NCT01488487|451631456|FG000|Overall Study|Withdrawal by Subject|2|||
125546649|NCT01136772|451631457|FG000|Overall Study|Adverse Event|15|||
125546650|NCT01136772|451631458|FG001|Overall Study|Adverse Event|14|||
125546651|NCT01136772|451631457|FG000|Overall Study|Lack of Efficacy|42|||
125680977|NCT00150462|452122031|FG001|Overall Study|Other|0|||
125680978|NCT00150462|452122032|FG002|Overall Study|Other|0|||
125680979|NCT00150462|452122033|FG003|Overall Study|Other|0|||
125345985|NCT00534313|450899838|FG000|Short-term Period|Lack of Efficacy|3|||
125345986|NCT00534313|450899839|FG001|Short-term Period|Lack of Efficacy|4|||
125345987|NCT00534313|450899840|FG002|Short-term Period|Lack of Efficacy|0|||
125345988|NCT00534313|450899841|FG003|Short-term Period|Lack of Efficacy|3|||
125345989|NCT00534313|450899838|FG000|Short-term Period|Participant not meeting study criteria|0|||
125345990|NCT00534313|450899839|FG001|Short-term Period|Participant not meeting study criteria|0|||
125345991|NCT00534313|450899840|FG002|Short-term Period|Participant not meeting study criteria|0|||
125345992|NCT00534313|450899841|FG003|Short-term Period|Participant not meeting study criteria|1|||
125345993|NCT00534313|450899838|FG000|Short-term Period|Participant withdrew consent|2|||
125345994|NCT00534313|450899839|FG001|Short-term Period|Participant withdrew consent|0|||
125345995|NCT00534313|450899840|FG002|Short-term Period|Participant withdrew consent|0|||
125345996|NCT00534313|450899841|FG003|Short-term Period|Participant withdrew consent|2|||
125546652|NCT01136772|451631458|FG001|Overall Study|Lack of Efficacy|39|||
125680980|NCT00150462|452122034|FG004|Overall Study|Other|0|||
125680981|NCT00150462|452122035|FG005|Overall Study|Other|0|||
125680982|NCT00150462|452122036|FG006|Overall Study|Other|0|||
125680983|NCT00150462|452122037|FG007|Overall Study|Other|0|||
125680984|NCT00150462|452122038|FG008|Overall Study|Other|0|||
125680985|NCT00150462|452122039|FG009|Overall Study|Other|1|||
125680986|NCT00150462|452122040|FG010|Overall Study|Other|1|||
125680987|NCT01196052|452122043|FG000|Overall Study|Adverse Event|9|||
125680988|NCT01196052|452122043|FG000|Overall Study|Lost to Follow-up|1|||
125680989|NCT01196052|452122043|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
125345997|NCT00534313|450899838|FG000|Short-term Period|Pregnancy|0|||
125680990|NCT01196052|452122043|FG000|Overall Study|Reason not Specified|5|||
125680991|NCT01196052|452122043|FG000|Overall Study|Withdrawal by Subject|6|||
125546653|NCT01136772|451631457|FG000|Overall Study|Administrative|14|||
125546654|NCT01136772|451631458|FG001|Overall Study|Administrative|12|||
125546655|NCT01136772|451631457|FG000|Overall Study|Withdrawal by Subject|33|||
125546656|NCT01136772|451631458|FG001|Overall Study|Withdrawal by Subject|36|||
125546657|NCT01136772|451631457|FG000|Overall Study|Did not receive injection|10|||
125546658|NCT01136772|451631458|FG001|Overall Study|Did not receive injection|7|||
125546659|NCT01136772|451631457|FG000|Overall Study|Did not follow up after first injection|2|||
125546660|NCT01136772|451631458|FG001|Overall Study|Did not follow up after first injection|2|||
125546661|NCT00928746|451631462|FG000|Overall Study|Adverse Event|2|||
125546662|NCT00928746|451631462|FG000|Overall Study|Protocol Violation|1|||
125546663|NCT00928746|451631462|FG000|Overall Study|Withdrawal by Subject|1|||
125546664|NCT00928746|451631462|FG000|Overall Study|Other|2|||
125546665|NCT02004353|451631468|FG000|Overall Study|Voluntary participation|1334|||
125546666|NCT02581631|451631469|FG000|Overall Study|Disease progression|29|||
125546667|NCT02581631|451631470|FG001|Overall Study|Disease progression|19|||
125546668|NCT02581631|451631471|FG002|Overall Study|Disease progression|13|||
125546669|NCT02581631|451631472|FG003|Overall Study|Disease progression|5|||
125546670|NCT02581631|451631473|FG004|Overall Study|Disease progression|8|||
125546671|NCT02581631|451631469|FG000|Overall Study|Study drug toxicity|4|||
125546672|NCT02581631|451631470|FG001|Overall Study|Study drug toxicity|6|||
125546673|NCT02581631|451631471|FG002|Overall Study|Study drug toxicity|7|||
125546674|NCT02581631|451631472|FG003|Overall Study|Study drug toxicity|0|||
125546675|NCT02581631|451631473|FG004|Overall Study|Study drug toxicity|3|||
125546676|NCT02581631|451631469|FG000|Overall Study|AE unrelated to study drug|3|||
125546677|NCT02581631|451631470|FG001|Overall Study|AE unrelated to study drug|1|||
125546678|NCT02581631|451631471|FG002|Overall Study|AE unrelated to study drug|1|||
125546679|NCT02581631|451631472|FG003|Overall Study|AE unrelated to study drug|0|||
125546680|NCT02581631|451631473|FG004|Overall Study|AE unrelated to study drug|2|||
125546681|NCT02581631|451631469|FG000|Overall Study|Request to discontinue|1|||
125546682|NCT02581631|451631470|FG001|Overall Study|Request to discontinue|0|||
125546683|NCT02581631|451631471|FG002|Overall Study|Request to discontinue|3|||
125546684|NCT02581631|451631472|FG003|Overall Study|Request to discontinue|0|||
125546685|NCT02581631|451631473|FG004|Overall Study|Request to discontinue|1|||
125546686|NCT02581631|451631469|FG000|Overall Study|participant withdrew consent|3|||
125546687|NCT02581631|451631470|FG001|Overall Study|participant withdrew consent|0|||
125546688|NCT02581631|451631471|FG002|Overall Study|participant withdrew consent|1|||
125546689|NCT02581631|451631472|FG003|Overall Study|participant withdrew consent|0|||
125546690|NCT02581631|451631473|FG004|Overall Study|participant withdrew consent|0|||
125546691|NCT02581631|451631469|FG000|Overall Study|Maximum clinical benefit|1|||
125546692|NCT02581631|451631470|FG001|Overall Study|Maximum clinical benefit|7|||
125546693|NCT02581631|451631471|FG002|Overall Study|Maximum clinical benefit|1|||
125546694|NCT02581631|451631472|FG003|Overall Study|Maximum clinical benefit|3|||
125546695|NCT02581631|451631473|FG004|Overall Study|Maximum clinical benefit|13|||
125546696|NCT02581631|451631469|FG000|Overall Study|Other Reasons|1|||
125546697|NCT02581631|451631470|FG001|Overall Study|Other Reasons|0|||
125546698|NCT02581631|451631471|FG002|Overall Study|Other Reasons|2|||
125546699|NCT02581631|451631472|FG003|Overall Study|Other Reasons|2|||
125546700|NCT02581631|451631473|FG004|Overall Study|Other Reasons|3|||
125546701|NCT02581631|451631469|FG000|Overall Study|Poor/Non-Compliance|0|||
125546702|NCT02581631|451631470|FG001|Overall Study|Poor/Non-Compliance|0|||
125546703|NCT02581631|451631471|FG002|Overall Study|Poor/Non-Compliance|1|||
125546704|NCT02581631|451631472|FG003|Overall Study|Poor/Non-Compliance|0|||
125546705|NCT02581631|451631473|FG004|Overall Study|Poor/Non-Compliance|0|||
125546706|NCT00819390|451631474|FG000|Overall Study|Lost to Follow-up|1|||
125546707|NCT00819390|451631475|FG001|Overall Study|Lost to Follow-up|1|||
125546708|NCT00819390|451631476|FG002|Overall Study|Lost to Follow-up|0|||
125546709|NCT00819390|451631477|FG003|Overall Study|Lost to Follow-up|0|||
125546710|NCT00819390|451631474|FG000|Overall Study|Withdrawal by Subject|2|||
125546711|NCT00819390|451631475|FG001|Overall Study|Withdrawal by Subject|0|||
125546712|NCT00819390|451631476|FG002|Overall Study|Withdrawal by Subject|0|||
125546713|NCT00819390|451631477|FG003|Overall Study|Withdrawal by Subject|0|||
125546714|NCT00819390|451631474|FG000|Overall Study|Adverse Event|0|||
125546715|NCT00819390|451631475|FG001|Overall Study|Adverse Event|0|||
125546716|NCT00819390|451631476|FG002|Overall Study|Adverse Event|1|||
125546717|NCT00819390|451631477|FG003|Overall Study|Adverse Event|0|||
125546718|NCT01270971|451631484|FG000|Overall Study|Withdrawal by Subject|24|||
125546719|NCT01270971|451631485|FG001|Overall Study|Withdrawal by Subject|11|||
125546720|NCT01270971|451631484|FG000|Overall Study|Lost to Follow-up|18|||
125546721|NCT01270971|451631485|FG001|Overall Study|Lost to Follow-up|5|||
125546722|NCT01270971|451631484|FG000|Overall Study|Adverse Event|1|||
125546723|NCT01270971|451631485|FG001|Overall Study|Adverse Event|2|||
125546724|NCT01270971|451631484|FG000|Overall Study|Non compliance|2|||
125546725|NCT01270971|451631485|FG001|Overall Study|Non compliance|2|||
125345998|NCT00534313|450899839|FG001|Short-term Period|Pregnancy|0|||
125345999|NCT00534313|450899840|FG002|Short-term Period|Pregnancy|1|||
125346000|NCT00534313|450899841|FG003|Short-term Period|Pregnancy|0|||
125346001|NCT00534313|450899838|FG000|Long-term Period|Adverse Event|2|||
125346002|NCT00534313|450899839|FG001|Long-term Period|Adverse Event|1|||
125346003|NCT00534313|450899840|FG002|Long-term Period|Adverse Event|0|||
125346004|NCT00534313|450899841|FG003|Long-term Period|Adverse Event|1|||
125346005|NCT00534313|450899838|FG000|Long-term Period|Lack of Efficacy|14|||
125346006|NCT00534313|450899839|FG001|Long-term Period|Lack of Efficacy|10|||
125346007|NCT00534313|450899840|FG002|Long-term Period|Lack of Efficacy|14|||
125346008|NCT00534313|450899841|FG003|Long-term Period|Lack of Efficacy|12|||
125346009|NCT00534313|450899838|FG000|Long-term Period|Lost to Follow-up|1|||
125346010|NCT00534313|450899839|FG001|Long-term Period|Lost to Follow-up|2|||
125346011|NCT00534313|450899840|FG002|Long-term Period|Lost to Follow-up|0|||
125346012|NCT00534313|450899841|FG003|Long-term Period|Lost to Follow-up|0|||
125346013|NCT00534313|450899838|FG000|Long-term Period|Withdrawal by Subject|2|||
125346014|NCT00534313|450899839|FG001|Long-term Period|Withdrawal by Subject|2|||
125346015|NCT00534313|450899840|FG002|Long-term Period|Withdrawal by Subject|0|||
125346016|NCT00534313|450899841|FG003|Long-term Period|Withdrawal by Subject|0|||
125346017|NCT00534313|450899838|FG000|Long-term Period|No longer meets study criteria|0|||
125346018|NCT00534313|450899839|FG001|Long-term Period|No longer meets study criteria|1|||
125346019|NCT00534313|450899840|FG002|Long-term Period|No longer meets study criteria|0|||
125346020|NCT00534313|450899841|FG003|Long-term Period|No longer meets study criteria|0|||
125346021|NCT00534313|450899838|FG000|Long-term Period|Poor compliance/noncompliance|0|||
125346022|NCT00534313|450899839|FG001|Long-term Period|Poor compliance/noncompliance|1|||
125346023|NCT00534313|450899840|FG002|Long-term Period|Poor compliance/noncompliance|1|||
125346024|NCT00534313|450899841|FG003|Long-term Period|Poor compliance/noncompliance|0|||
125346025|NCT00534313|450899838|FG000|Long-term Period|Administrative reason by sponsor|17|||
125346026|NCT00534313|450899839|FG001|Long-term Period|Administrative reason by sponsor|15|||
125346027|NCT00534313|450899840|FG002|Long-term Period|Administrative reason by sponsor|26|||
125346028|NCT00534313|450899841|FG003|Long-term Period|Administrative reason by sponsor|18|||
125346029|NCT00534313|450899838|FG000|Long-term Period|Other|1|||
125346030|NCT00534313|450899839|FG001|Long-term Period|Other|2|||
125346031|NCT00534313|450899840|FG002|Long-term Period|Other|2|||
125346032|NCT00534313|450899841|FG003|Long-term Period|Other|2|||
125346033|NCT03709576|450899847|FG000|Overall Study|progression prior to enrollment|1|||
125346034|NCT02282293|450899855|FG000|Overall Study|Lost to Follow-up|2|||
125346035|NCT02282293|450899856|FG001|Overall Study|Lost to Follow-up|2|||
125346036|NCT02282293|450899855|FG000|Overall Study|Unable to comply with study procedures|1|||
125346037|NCT02282293|450899856|FG001|Overall Study|Unable to comply with study procedures|0|||
125346038|NCT02282293|450899855|FG000|Overall Study|Moved out of study area|0|||
125346039|NCT02282293|450899856|FG001|Overall Study|Moved out of study area|1|||
125346040|NCT01924429|450899868|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
125346041|NCT01924429|450899869|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
125346042|NCT00384111|450899870|FG000|Overall Study|Disease Progression|3|||
125346043|NCT00384111|450899870|FG000|Overall Study|Adverse Event|1|||
125346044|NCT00384111|450899870|FG000|Overall Study|Investigator Decision|3|||
125346045|NCT00384111|450899870|FG000|Overall Study|Study Terminated by the Sponsor|19|||
125346046|NCT00807573|450899871|FG000|Overall Study|Withdrawal by Subject|1|||
125680992|NCT01572948|452122044|FG000|Overall Study|Lost to Follow-up|1|||
125680993|NCT01572948|452122045|FG001|Overall Study|Lost to Follow-up|0|||
125680994|NCT01572948|452122044|FG000|Overall Study|unable to contact|0|||
125680995|NCT01572948|452122045|FG001|Overall Study|unable to contact|1|||
125680996|NCT03603314|452122046|FG000|Overall Study|Lost to Follow-up|0|||
125680997|NCT03603314|452122047|FG001|Overall Study|Lost to Follow-up|3|||
125680998|NCT03603314|452122048|FG002|Overall Study|Lost to Follow-up|0|||
125680999|NCT03603314|452122046|FG000|Overall Study|Protocol Violation|0|||
125681000|NCT03603314|452122047|FG001|Overall Study|Protocol Violation|1|||
125681001|NCT03603314|452122048|FG002|Overall Study|Protocol Violation|0|||
125681002|NCT03603314|452122046|FG000|Overall Study|Adverse Event|2|||
125681003|NCT03603314|452122047|FG001|Overall Study|Adverse Event|0|||
125681004|NCT03603314|452122048|FG002|Overall Study|Adverse Event|0|||
125681005|NCT03603314|452122046|FG000|Overall Study|Physician Decision|1|||
125681006|NCT03603314|452122047|FG001|Overall Study|Physician Decision|1|||
125681007|NCT03603314|452122048|FG002|Overall Study|Physician Decision|0|||
125681008|NCT03603314|452122046|FG000|Overall Study|Withdrawal by Subject|4|||
125346047|NCT00807573|450899871|FG000|Overall Study|Adverse Event|1|||
125346048|NCT01089361|450899872|FG000|Overall Study|Death|1|||
125346049|NCT01089361|450899873|FG001|Overall Study|Death|0|||
125346050|NCT03612856|450899874|FG000|Pre-dose Period|Physician Decision|0|||
125346051|NCT03612856|450899875|FG001|Pre-dose Period|Physician Decision|1|||
125346052|NCT03612856|450899876|FG002|Pre-dose Period|Physician Decision|1|||
125346053|NCT03612856|450899874|FG000|Pre-dose Period|Withdrawal by Subject|0|||
125681009|NCT03603314|452122047|FG001|Overall Study|Withdrawal by Subject|5|||
125681010|NCT03603314|452122048|FG002|Overall Study|Withdrawal by Subject|3|||
125681011|NCT03603314|452122046|FG000|Overall Study|Other|0|||
125681012|NCT03603314|452122047|FG001|Overall Study|Other|1|||
125546726|NCT01270971|451631484|FG000|Overall Study|Non-specific|7|||
125546727|NCT01270971|451631485|FG001|Overall Study|Non-specific|3|||
125546728|NCT01588496|451631486|FG000|Overall Study|Withdrawal by Subject|0|||
125546729|NCT01588496|451631487|FG001|Overall Study|Withdrawal by Subject|1|||
125546730|NCT01588496|451631488|FG002|Overall Study|Withdrawal by Subject|0|||
125546731|NCT03333837|451631489|FG000|Overall Study|Adverse Event|2|||
125546732|NCT03333837|451631490|FG001|Overall Study|Adverse Event|1|||
125546733|NCT03333837|451631491|FG002|Overall Study|Adverse Event|1|||
125546734|NCT03333837|451631492|FG003|Overall Study|Adverse Event|1|||
125546735|NCT03333837|451631493|FG004|Overall Study|Adverse Event|0|||
125546736|NCT03333837|451631489|FG000|Overall Study|Caregiver withdrew|0|||
125546737|NCT03333837|451631490|FG001|Overall Study|Caregiver withdrew|2|||
125546738|NCT03333837|451631491|FG002|Overall Study|Caregiver withdrew|1|||
125546739|NCT03333837|451631492|FG003|Overall Study|Caregiver withdrew|0|||
125546740|NCT03333837|451631493|FG004|Overall Study|Caregiver withdrew|0|||
125546741|NCT03333837|451631489|FG000|Overall Study|Withdrawal by Subject|0|||
125546742|NCT03333837|451631490|FG001|Overall Study|Withdrawal by Subject|0|||
125546743|NCT03333837|451631491|FG002|Overall Study|Withdrawal by Subject|1|||
125546744|NCT03333837|451631492|FG003|Overall Study|Withdrawal by Subject|1|||
125546745|NCT03333837|451631493|FG004|Overall Study|Withdrawal by Subject|3|||
125546746|NCT03333837|451631489|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
125546747|NCT03333837|451631490|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
125546748|NCT03333837|451631491|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
125546749|NCT03333837|451631492|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
125546750|NCT03333837|451631493|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
125546751|NCT01013285|451631494|FG000|Overall Study|Death|48|||
125546752|NCT01013285|451631495|FG001|Overall Study|Death|89|||
125546753|NCT00953745|451631498|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
125546754|NCT00953745|451631499|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
125546755|NCT00953745|451631498|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
125546756|NCT00953745|451631499|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
125546757|NCT00953745|451631498|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
125546758|NCT00953745|451631499|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
125546759|NCT00953745|451631498|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
125546760|NCT00953745|451631499|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
125546761|NCT00953745|451631498|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
125546762|NCT00953745|451631499|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
125546763|NCT00953745|451631498|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
125546764|NCT00953745|451631499|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
125546765|NCT02640157|451631502|FG000|Overall Study|Adverse Event|2|||
125546766|NCT02640157|451631503|FG001|Overall Study|Adverse Event|2|||
125546767|NCT02640157|451631504|FG002|Overall Study|Adverse Event|1|||
125546768|NCT02640157|451631502|FG000|Overall Study|Withdrew consent|2|||
125546769|NCT02640157|451631503|FG001|Overall Study|Withdrew consent|0|||
125546770|NCT02640157|451631504|FG002|Overall Study|Withdrew consent|2|||
125546771|NCT02640157|451631502|FG000|Overall Study|Lost to Follow-up|9|||
125546772|NCT02640157|451631503|FG001|Overall Study|Lost to Follow-up|2|||
125546773|NCT02640157|451631504|FG002|Overall Study|Lost to Follow-up|7|||
125546774|NCT02640157|451631502|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
125546775|NCT02640157|451631503|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
125546776|NCT02640157|451631504|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
125546777|NCT01679405|451631505|FG000|Overall Study|Death|2|||
125546778|NCT01679405|451631506|FG001|Overall Study|Death|5|||
125681013|NCT03603314|452122048|FG002|Overall Study|Other|0|||
125681014|NCT03450070|452122049|FG000|Overall Study|Withdrawal by Subject|8|||
125681015|NCT01720264|452122052|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
125681016|NCT01720264|452122052|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
125681017|NCT01720264|452122052|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
125681018|NCT00877032|452122053|FG000|Overall Study|Did not meet entrance criteria|0|||
125681019|NCT00877032|452122054|FG001|Overall Study|Did not meet entrance criteria|0|||
125681020|NCT00877032|452122055|FG002|Overall Study|Did not meet entrance criteria|0|||
125681021|NCT00877032|452122056|FG003|Overall Study|Did not meet entrance criteria|1|||
125681022|NCT00877032|452122057|FG004|Overall Study|Did not meet entrance criteria|0|||
125681023|NCT00877032|452122058|FG005|Overall Study|Did not meet entrance criteria|0|||
125546779|NCT02374671|451631507|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
125681024|NCT00877032|452122059|FG006|Overall Study|Did not meet entrance criteria|2|||
125681025|NCT00615069|452122069|FG000|Overall Study|Death|10|||
125681026|NCT00615069|452122069|FG000|Overall Study|Physician Decision|2|||
125546780|NCT02374671|451631508|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
125546781|NCT02374671|451631509|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
125546782|NCT02374671|451631507|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
125681027|NCT00615069|452122069|FG000|Overall Study|Withdrawal by Subject|4|||
125546783|NCT02374671|451631508|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
125546784|NCT02374671|451631509|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
125546785|NCT02374671|451631507|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
125546786|NCT02374671|451631508|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
125546787|NCT02374671|451631509|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
125546788|NCT02374671|451631507|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
125546789|NCT02374671|451631508|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
125546790|NCT02374671|451631509|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
125546791|NCT02374671|451631507|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
125546792|NCT02374671|451631508|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
125546793|NCT02374671|451631509|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
125546794|NCT03866473|451631512|FG000|Phase 1|Death|1|||
125546795|NCT03866473|451631513|FG001|Phase 1|Death|0|||
125546796|NCT03866473|451631512|FG000|Phase 2|Death|0|||
125546797|NCT03866473|451631513|FG001|Phase 2|Death|2|||
125546798|NCT03866473|451631512|FG000|Phase 2|Dropped|1|||
125546799|NCT03866473|451631513|FG001|Phase 2|Dropped|1|||
125546800|NCT03866473|451631512|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
125546801|NCT03866473|451631513|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
125546802|NCT02641496|451631514|FG000|Overall Study|Lost to Follow-up|13|||
125546803|NCT02641496|451631515|FG001|Overall Study|Lost to Follow-up|12|||
125546804|NCT02641496|451631514|FG000|Overall Study|Withdrawal by Subject|1|||
125546805|NCT02641496|451631515|FG001|Overall Study|Withdrawal by Subject|0|||
125546806|NCT00600886|451631516|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
125546807|NCT00600886|451631517|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
125546808|NCT00600886|451631516|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
125546809|NCT00600886|451631517|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
125546810|NCT00600886|451631516|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
125546811|NCT00600886|451631517|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
125546812|NCT00600886|451631516|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
125546813|NCT00600886|451631517|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
125546814|NCT00600886|451631516|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
125546815|NCT00600886|451631517|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
125546816|NCT00600886|451631516|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
125546817|NCT00600886|451631517|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
125546818|NCT00600886|451631516|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
125546819|NCT00600886|451631517|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
125546820|NCT00600886|451631516|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
125546821|NCT00600886|451631517|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
125546822|NCT00600886|451631516|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
125546823|NCT00600886|451631517|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
125546824|NCT00600886|451631516|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
125546825|NCT00600886|451631517|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
125546826|NCT00600886|451631516|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
125546827|NCT00600886|451631517|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
125546828|NCT00600886|451631516|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
125546829|NCT00600886|451631517|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
125546830|NCT00600886|451631516|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
125546831|NCT00600886|451631517|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
125546832|NCT00600886|451631516|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
125546833|NCT00600886|451631517|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
125546834|NCT00600886|451631516|FG000|Extension - Same Treatment (FAS)|Death|1|||
125546835|NCT00600886|451631517|FG001|Extension - Same Treatment (FAS)|Death|1|||
125546836|NCT00600886|451631516|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
125681028|NCT00669942|452122071|FG000|Parts 2 and 3|Adverse Event|0|||
125681029|NCT00669942|452122072|FG001|Parts 2 and 3|Adverse Event|0|||
125681030|NCT00669942|452122073|FG002|Parts 2 and 3|Adverse Event|0|||
125681031|NCT00669942|452122074|FG003|Parts 2 and 3|Adverse Event|0|||
125681032|NCT00669942|452122075|FG004|Parts 2 and 3|Adverse Event|0|||
125681033|NCT00669942|452122076|FG005|Parts 2 and 3|Adverse Event|0|||
125681034|NCT00669942|452122077|FG006|Parts 2 and 3|Adverse Event|0|||
125681035|NCT00669942|452122078|FG007|Parts 2 and 3|Adverse Event|2|||
125681036|NCT00669942|452122079|FG008|Parts 2 and 3|Adverse Event|1|||
125681037|NCT00669942|452122080|FG009|Parts 2 and 3|Adverse Event|0|||
125681038|NCT00669942|452122081|FG010|Parts 2 and 3|Adverse Event|0|||
125681039|NCT00669942|452122082|FG011|Parts 2 and 3|Adverse Event|0|||
125681040|NCT00669942|452122071|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
125681041|NCT00669942|452122072|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
125681042|NCT00669942|452122073|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
125681043|NCT00669942|452122074|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
125681044|NCT00669942|452122075|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
125681045|NCT00669942|452122076|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
125546837|NCT00600886|451631517|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
125546838|NCT00600886|451631516|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
125546839|NCT00600886|451631517|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
125546840|NCT00600886|451631516|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
125546841|NCT00600886|451631517|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
125546842|NCT00600886|451631516|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
125546843|NCT00600886|451631517|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
125546844|NCT00600886|451631516|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
125546845|NCT00600886|451631517|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
125546846|NCT00600886|451631516|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
125546847|NCT00600886|451631517|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
125546848|NCT00600886|451631516|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
125546849|NCT00600886|451631517|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
125546850|NCT00600886|451631516|FG000|Extension - After Crossover (CAS)|Death|1|||
125546851|NCT00600886|451631517|FG001|Extension - After Crossover (CAS)|Death|0|||
125546852|NCT03075410|451631518|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
125546853|NCT03075410|451631519|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
125546854|NCT03075410|451631520|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
125546855|NCT03075410|451631521|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
125546856|NCT03075410|451631522|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
125546857|NCT03075410|451631523|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
125546858|NCT03075410|451631524|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
125546859|NCT03075410|451631525|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
125546860|NCT03075410|451631526|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
125546861|NCT03075410|451631518|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
125546862|NCT03075410|451631519|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
125546863|NCT03075410|451631520|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
125546864|NCT03075410|451631521|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
125546865|NCT03075410|451631522|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
125546866|NCT03075410|451631523|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
125546867|NCT03075410|451631524|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
125546868|NCT03075410|451631525|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
125546869|NCT03075410|451631526|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
125546870|NCT02523599|451631527|FG000|Overall Study|Adverse Event|1|||
125546871|NCT02523599|451631528|FG001|Overall Study|Adverse Event|0|||
125546872|NCT02523599|451631527|FG000|Overall Study|Physician Decision|1|||
125546873|NCT02523599|451631528|FG001|Overall Study|Physician Decision|0|||
125546874|NCT02523599|451631527|FG000|Overall Study|Lost to Follow-up|4|||
125546875|NCT02523599|451631528|FG001|Overall Study|Lost to Follow-up|1|||
125546876|NCT02523599|451631527|FG000|Overall Study|Did not return for Day 30 visit|2|||
125546877|NCT02523599|451631528|FG001|Overall Study|Did not return for Day 30 visit|0|||
125546878|NCT01427751|451631529|FG000|Overall Study|Adverse Event|18|||
125546879|NCT01427751|451631530|FG001|Overall Study|Adverse Event|2|||
125546880|NCT01427751|451631529|FG000|Overall Study|No further treatment benefit expected|5|||
125546881|NCT01427751|451631530|FG001|Overall Study|No further treatment benefit expected|1|||
125681046|NCT00669942|452122077|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
125681047|NCT00669942|452122078|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
125681048|NCT00669942|452122079|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
125346054|NCT03612856|450899875|FG001|Pre-dose Period|Withdrawal by Subject|1|||
125681049|NCT00669942|452122080|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
125681050|NCT00669942|452122081|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
125681051|NCT00669942|452122082|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
125681052|NCT00669942|452122071|FG000|Parts 2 and 3|Protocol Violation|0|||
125681053|NCT00669942|452122072|FG001|Parts 2 and 3|Protocol Violation|0|||
125681054|NCT00669942|452122073|FG002|Parts 2 and 3|Protocol Violation|0|||
125681055|NCT00669942|452122074|FG003|Parts 2 and 3|Protocol Violation|0|||
125681056|NCT00669942|452122075|FG004|Parts 2 and 3|Protocol Violation|0|||
125681057|NCT00669942|452122076|FG005|Parts 2 and 3|Protocol Violation|1|||
125681058|NCT00669942|452122077|FG006|Parts 2 and 3|Protocol Violation|0|||
125346055|NCT03612856|450899876|FG002|Pre-dose Period|Withdrawal by Subject|0|||
125546882|NCT01427751|451631529|FG000|Overall Study|Lost to Follow-up|3|||
125546883|NCT01427751|451631530|FG001|Overall Study|Lost to Follow-up|1|||
125546884|NCT01427751|451631529|FG000|Overall Study|Withdrawal of consent|2|||
125546885|NCT01427751|451631530|FG001|Overall Study|Withdrawal of consent|2|||
125546886|NCT01427751|451631529|FG000|Overall Study|Protocol Violation|6|||
125681059|NCT00669942|452122078|FG007|Parts 2 and 3|Protocol Violation|0|||
125681060|NCT00669942|452122079|FG008|Parts 2 and 3|Protocol Violation|0|||
125546887|NCT01427751|451631530|FG001|Overall Study|Protocol Violation|4|||
125546888|NCT01427751|451631529|FG000|Overall Study|Death|2|||
125546889|NCT01427751|451631530|FG001|Overall Study|Death|0|||
125546890|NCT01427751|451631529|FG000|Overall Study|Other miscellaneous reasons|6|||
125546891|NCT01427751|451631530|FG001|Overall Study|Other miscellaneous reasons|4|||
125546892|NCT05330312|451631531|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
125546893|NCT05330312|451631532|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
125546894|NCT05330312|451631533|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
125546895|NCT05330312|451631531|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
125546896|NCT05330312|451631532|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
125546897|NCT05330312|451631533|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
125546898|NCT05330312|451631531|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
125546899|NCT05330312|451631532|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
125546900|NCT05330312|451631533|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
125546901|NCT05330312|451631531|FG000|Pivotal Investigation - Part 2|Death|1|||
125546902|NCT05330312|451631532|FG001|Pivotal Investigation - Part 2|Death|4|||
125546903|NCT05330312|451631533|FG002|Pivotal Investigation - Part 2|Death|0|||
125546904|NCT03319849|451631534|FG000|Overall Study|Adverse Event|1|||
125546905|NCT03319849|451631535|FG001|Overall Study|Adverse Event|0|||
125546906|NCT03319849|451631534|FG000|Overall Study|Physician Decision|0|||
125546907|NCT03319849|451631535|FG001|Overall Study|Physician Decision|1|||
125546908|NCT03319849|451631534|FG000|Overall Study|Withdrawal by Subject|0|||
125546909|NCT03319849|451631535|FG001|Overall Study|Withdrawal by Subject|1|||
125546910|NCT03319849|451631534|FG000|Overall Study|COVID-19|0|||
125546911|NCT03319849|451631535|FG001|Overall Study|COVID-19|1|||
125546912|NCT03319849|451631534|FG000|Overall Study|Other|1|||
125546913|NCT03319849|451631535|FG001|Overall Study|Other|2|||
125546914|NCT03319849|451631534|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
125546915|NCT03319849|451631535|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
125546916|NCT03319849|451631534|FG000|Overall Study|Lost to Follow-up|0|||
125546917|NCT03319849|451631535|FG001|Overall Study|Lost to Follow-up|2|||
125546918|NCT00743275|451633318|FG000|Overall Study|Protocol Violation|0|||
125546919|NCT00743275|451633319|FG001|Overall Study|Protocol Violation|1|||
125546920|NCT03938545|451633321|FG000|Overall Study|Lost to Follow-up|0|||
125546921|NCT03938545|451633322|FG001|Overall Study|Lost to Follow-up|0|||
125546922|NCT03938545|451633323|FG002|Overall Study|Lost to Follow-up|0|||
125546923|NCT03938545|451633324|FG003|Overall Study|Lost to Follow-up|1|||
125546924|NCT03938545|451633321|FG000|Overall Study|Non-compliance with study drug|0|||
125546925|NCT03938545|451633322|FG001|Overall Study|Non-compliance with study drug|0|||
125546926|NCT03938545|451633323|FG002|Overall Study|Non-compliance with study drug|1|||
125546927|NCT03938545|451633324|FG003|Overall Study|Non-compliance with study drug|0|||
125546928|NCT03938545|451633321|FG000|Overall Study|Pregnancy|1|||
125546929|NCT03938545|451633322|FG001|Overall Study|Pregnancy|0|||
125546930|NCT03938545|451633323|FG002|Overall Study|Pregnancy|0|||
125210765|NCT02240069|450395676|FG002|Overall Study|Withdrawal by Subject|2|||
125546931|NCT03938545|451633324|FG003|Overall Study|Pregnancy|0|||
125546932|NCT03938545|451633321|FG000|Overall Study|Study terminated by sponsor|6|||
125546933|NCT03938545|451633322|FG001|Overall Study|Study terminated by sponsor|4|||
125546934|NCT03938545|451633323|FG002|Overall Study|Study terminated by sponsor|2|||
125546935|NCT03938545|451633324|FG003|Overall Study|Study terminated by sponsor|4|||
125546936|NCT03938545|451633321|FG000|Overall Study|Withdrawal by Subject|0|||
125546937|NCT03938545|451633322|FG001|Overall Study|Withdrawal by Subject|1|||
125546938|NCT03938545|451633323|FG002|Overall Study|Withdrawal by Subject|0|||
125546939|NCT03938545|451633324|FG003|Overall Study|Withdrawal by Subject|0|||
125546940|NCT03938545|451633321|FG000|Overall Study|Adverse Event|1|||
125546941|NCT03938545|451633322|FG001|Overall Study|Adverse Event|0|||
125546942|NCT03938545|451633323|FG002|Overall Study|Adverse Event|0|||
125546943|NCT03938545|451633324|FG003|Overall Study|Adverse Event|0|||
125546944|NCT01060540|451633325|FG000|Overall Study|Withdrawal by Subject|10|||
125546945|NCT01060540|451633326|FG001|Overall Study|Withdrawal by Subject|20|||
125546946|NCT01060540|451633325|FG000|Overall Study|Lost to Follow-up|52|||
125546947|NCT01060540|451633326|FG001|Overall Study|Lost to Follow-up|43|||
125546948|NCT01060540|451633325|FG000|Overall Study|Death|2|||
125546949|NCT01060540|451633326|FG001|Overall Study|Death|1|||
125546950|NCT01060540|451633325|FG000|Overall Study|Physician Decision|0|||
125546951|NCT01060540|451633326|FG001|Overall Study|Physician Decision|1|||
125546952|NCT02502097|451633331|FG000|Period 1|Adverse Event|0|||
125546953|NCT02502097|451633332|FG001|Period 1|Adverse Event|0|||
125546954|NCT02502097|451633333|FG002|Period 1|Adverse Event|1|||
125546955|NCT02502097|451633334|FG003|Period 1|Adverse Event|0|||
125546956|NCT02502097|451633331|FG000|Wash Out Period|Adverse Event|0|||
125546957|NCT02502097|451633332|FG001|Wash Out Period|Adverse Event|1|||
125546958|NCT02502097|451633333|FG002|Wash Out Period|Adverse Event|1|||
125546959|NCT02502097|451633334|FG003|Wash Out Period|Adverse Event|1|||
125546960|NCT02502097|451633331|FG000|Period 2|Adverse Event|0|||
125546961|NCT02502097|451633332|FG001|Period 2|Adverse Event|0|||
125546962|NCT02502097|451633333|FG002|Period 2|Adverse Event|1|||
125546963|NCT02502097|451633334|FG003|Period 2|Adverse Event|0|||
125546964|NCT01201317|451633335|FG000|Overall Study|Withdrawal by Subject|5|||
125546965|NCT01201317|451633336|FG001|Overall Study|Withdrawal by Subject|0|||
125546966|NCT01201317|451633337|FG002|Overall Study|Withdrawal by Subject|3|||
125546967|NCT01201317|451633335|FG000|Overall Study|Adverse Event|2|||
125546968|NCT01201317|451633336|FG001|Overall Study|Adverse Event|2|||
125546969|NCT01201317|451633337|FG002|Overall Study|Adverse Event|2|||
125546970|NCT01201317|451633335|FG000|Overall Study|Screen failure|1|||
125546971|NCT01201317|451633336|FG001|Overall Study|Screen failure|1|||
125546972|NCT01201317|451633337|FG002|Overall Study|Screen failure|0|||
125546973|NCT01201317|451633335|FG000|Overall Study|Protocol Violation|0|||
125546974|NCT01201317|451633336|FG001|Overall Study|Protocol Violation|1|||
125546975|NCT01201317|451633337|FG002|Overall Study|Protocol Violation|1|||
125546976|NCT01201317|451633335|FG000|Overall Study|Death|0|||
125546977|NCT01201317|451633336|FG001|Overall Study|Death|1|||
125546978|NCT01201317|451633337|FG002|Overall Study|Death|0|||
125546979|NCT01201317|451633335|FG000|Overall Study|Study-specific withdrawal criteria|0|||
125546980|NCT01201317|451633336|FG001|Overall Study|Study-specific withdrawal criteria|0|||
125546981|NCT01201317|451633337|FG002|Overall Study|Study-specific withdrawal criteria|1|||
125546982|NCT01201317|451633335|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
125546983|NCT01201317|451633336|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
125681061|NCT00669942|452122080|FG009|Parts 2 and 3|Protocol Violation|0|||
125681062|NCT00669942|452122081|FG010|Parts 2 and 3|Protocol Violation|0|||
125681063|NCT00669942|452122082|FG011|Parts 2 and 3|Protocol Violation|0|||
125346056|NCT04463069|450899877|FG000|Overall Study|Withdrawal by Subject|2|||
125681064|NCT00259012|452122084|FG000|Overall Study|Adverse Event|0|||
125681065|NCT00259012|452122085|FG001|Overall Study|Adverse Event|1|||
125681066|NCT00259012|452122084|FG000|Overall Study|Withdrawal by Subject|1|||
125346057|NCT04463069|450899878|FG001|Overall Study|Withdrawal by Subject|10|||
125546984|NCT01201317|451633337|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
125546985|NCT01201317|451633335|FG000|Overall Study|Decrease in renal function|0|||
125681067|NCT00259012|452122085|FG001|Overall Study|Withdrawal by Subject|0|||
125681068|NCT00259012|452122084|FG000|Overall Study|Physician Decision|0|||
125681069|NCT00259012|452122085|FG001|Overall Study|Physician Decision|1|||
125681070|NCT00259012|452122084|FG000|Overall Study|Lost to Follow-up|0|||
125346058|NCT04463069|450899877|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
125546986|NCT01201317|451633336|FG001|Overall Study|Decrease in renal function|1|||
125546987|NCT01201317|451633337|FG002|Overall Study|Decrease in renal function|0|||
125546988|NCT01201317|451633335|FG000|Overall Study|Lack of Efficacy|1|||
125546989|NCT01201317|451633336|FG001|Overall Study|Lack of Efficacy|0|||
125546990|NCT01201317|451633337|FG002|Overall Study|Lack of Efficacy|0|||
125546991|NCT01201317|451633335|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
125546992|NCT01201317|451633336|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
125546993|NCT01201317|451633337|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
125546994|NCT00252733|451633338|FG000|Overall Study|Withdrawal by Subject|73|||
125546995|NCT00252733|451633339|FG001|Overall Study|Withdrawal by Subject|67|||
125546996|NCT00252733|451633338|FG000|Overall Study|Death|7|||
125546997|NCT00252733|451633339|FG001|Overall Study|Death|5|||
125546998|NCT00252733|451633338|FG000|Overall Study|Lost to Follow-up|12|||
125546999|NCT00252733|451633339|FG001|Overall Study|Lost to Follow-up|6|||
125547000|NCT00252733|451633338|FG000|Overall Study|Multiple Reasons|14|||
125547001|NCT00252733|451633339|FG001|Overall Study|Multiple Reasons|14|||
125547002|NCT01350336|451633340|FG000|Overall Study|Lost to Follow-up|31|||
125547003|NCT01350336|451633340|FG000|Overall Study|Withdrawal by Subject|14|||
125547004|NCT01350336|451633340|FG000|Overall Study|Physician Decision|8|||
125547005|NCT01350336|451633340|FG000|Overall Study|Death|4|||
125547006|NCT01491672|451633341|FG000|Overall Study|Lost to Follow-up|0|||
125547007|NCT01491672|451633342|FG001|Overall Study|Lost to Follow-up|4|||
125547008|NCT01491672|451633343|FG002|Overall Study|Lost to Follow-up|1|||
125547009|NCT01491672|451633341|FG000|Overall Study|Withdrawal by Subject|6|||
125547010|NCT01491672|451633342|FG001|Overall Study|Withdrawal by Subject|7|||
125547011|NCT01491672|451633343|FG002|Overall Study|Withdrawal by Subject|0|||
125547012|NCT01491672|451633341|FG000|Overall Study|Adverse Event|8|||
125547013|NCT01491672|451633342|FG001|Overall Study|Adverse Event|10|||
125547014|NCT01491672|451633343|FG002|Overall Study|Adverse Event|4|||
125547015|NCT01491672|451633341|FG000|Overall Study|Disease progression|42|||
125547016|NCT01491672|451633342|FG001|Overall Study|Disease progression|34|||
125547017|NCT01491672|451633343|FG002|Overall Study|Disease progression|6|||
125547018|NCT01491672|451633341|FG000|Overall Study|Protocol deviation|0|||
125547019|NCT01491672|451633342|FG001|Overall Study|Protocol deviation|1|||
125547020|NCT01491672|451633343|FG002|Overall Study|Protocol deviation|0|||
125547021|NCT01491672|451633341|FG000|Overall Study|Death|0|||
125547022|NCT01491672|451633342|FG001|Overall Study|Death|4|||
125547023|NCT01491672|451633343|FG002|Overall Study|Death|0|||
125547024|NCT03310268|451633347|FG000|Overall Study|(Not specified)|1|||
125547025|NCT03310268|451633348|FG001|Overall Study|(Not specified)|5|||
125547026|NCT03310268|451633349|FG002|Overall Study|(Not specified)|0|||
125547027|NCT00706433|451633352|FG000|Overall Study|Lost to Follow-up|3|||
125547028|NCT00706433|451633353|FG001|Overall Study|Lost to Follow-up|1|||
125547029|NCT00706433|451633354|FG002|Overall Study|Lost to Follow-up|6|||
125547030|NCT00706433|451633355|FG003|Overall Study|Lost to Follow-up|0|||
125547031|NCT00706433|451633352|FG000|Overall Study|Withdrawal by Subject|1|||
125547032|NCT00706433|451633353|FG001|Overall Study|Withdrawal by Subject|2|||
125547033|NCT00706433|451633354|FG002|Overall Study|Withdrawal by Subject|3|||
125547034|NCT00706433|451633355|FG003|Overall Study|Withdrawal by Subject|1|||
125547035|NCT00706433|451633352|FG000|Overall Study|Adverse Event|0|||
125547036|NCT00706433|451633353|FG001|Overall Study|Adverse Event|0|||
125547037|NCT00706433|451633354|FG002|Overall Study|Adverse Event|1|||
125547038|NCT00706433|451633355|FG003|Overall Study|Adverse Event|0|||
125547039|NCT00706433|451633352|FG000|Overall Study|Protocol Violation|1|||
125547040|NCT00706433|451633353|FG001|Overall Study|Protocol Violation|0|||
125547041|NCT00706433|451633354|FG002|Overall Study|Protocol Violation|0|||
125547042|NCT00706433|451633355|FG003|Overall Study|Protocol Violation|0|||
125547043|NCT00706433|451633352|FG000|Overall Study|new job|0|||
125547044|NCT00706433|451633353|FG001|Overall Study|new job|0|||
125547045|NCT00706433|451633354|FG002|Overall Study|new job|0|||
125547046|NCT00706433|451633355|FG003|Overall Study|new job|1|||
125547047|NCT01236365|451633356|FG000|Overall Study|Lost to Follow-up|0|||
125547048|NCT01236365|451633357|FG001|Overall Study|Lost to Follow-up|2|||
125547049|NCT01236365|451633356|FG000|Overall Study|Moved Out of State|1|||
125547050|NCT01236365|451633357|FG001|Overall Study|Moved Out of State|0|||
125547051|NCT01236365|451633356|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
125547052|NCT01236365|451633357|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
125547053|NCT00717067|451633358|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
125547054|NCT00717067|451633359|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
125547055|NCT00717067|451633360|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
125346059|NCT04463069|450899878|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
125346060|NCT01155167|450899881|FG000|Overall Study|Insufficient ultrasound data|2|||
125346061|NCT01155167|450899882|FG001|Overall Study|Insufficient ultrasound data|0|||
125346062|NCT01155167|450899881|FG000|Overall Study|Access site changed to femoral artery|1|||
125346063|NCT01155167|450899882|FG001|Overall Study|Access site changed to femoral artery|0|||
125346064|NCT02880956|450899888|FG000|Overall Study|Adverse Event|3|||
125346065|NCT02880956|450899889|FG001|Overall Study|Adverse Event|6|||
125346066|NCT02880956|450899890|FG002|Overall Study|Adverse Event|5|||
125346067|NCT02880956|450899891|FG003|Overall Study|Adverse Event|4|||
125346068|NCT02880956|450899888|FG000|Overall Study|Withdrawal by Subject|9|||
125346069|NCT02880956|450899889|FG001|Overall Study|Withdrawal by Subject|4|||
125346070|NCT02880956|450899890|FG002|Overall Study|Withdrawal by Subject|6|||
125346071|NCT02880956|450899891|FG003|Overall Study|Withdrawal by Subject|11|||
125346072|NCT02880956|450899888|FG000|Overall Study|Lost to Follow-up|0|||
125346073|NCT02880956|450899889|FG001|Overall Study|Lost to Follow-up|1|||
125346074|NCT02880956|450899890|FG002|Overall Study|Lost to Follow-up|0|||
125346075|NCT02880956|450899891|FG003|Overall Study|Lost to Follow-up|0|||
125346076|NCT02880956|450899888|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
125346077|NCT02880956|450899889|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
125346078|NCT02880956|450899890|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
125346079|NCT02880956|450899891|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
125346080|NCT02880956|450899888|FG000|Overall Study|Other, Not Specified|4|||
125346081|NCT02880956|450899889|FG001|Overall Study|Other, Not Specified|2|||
125346082|NCT02880956|450899890|FG002|Overall Study|Other, Not Specified|0|||
125346083|NCT02880956|450899891|FG003|Overall Study|Other, Not Specified|3|||
125346084|NCT00853970|450899892|FG000|Overall Study|Withdrawal by Subject|2|||
125346085|NCT00853970|450899893|FG001|Overall Study|Withdrawal by Subject|1|||
125346086|NCT00853970|450899892|FG000|Overall Study|Cancelled surgery|4|||
125547056|NCT00717067|451633361|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
125547057|NCT00717067|451633362|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
125681071|NCT00259012|452122085|FG001|Overall Study|Lost to Follow-up|1|||
125681072|NCT00259012|452122084|FG000|Overall Study|Protocol Violation|1|||
125681073|NCT00259012|452122085|FG001|Overall Study|Protocol Violation|1|||
125681074|NCT01496183|452122092|FG000|Overall Study|Physician Decision|3|||
125681075|NCT01496183|452122093|FG001|Overall Study|Physician Decision|1|||
125681076|NCT01496183|452122092|FG000|Overall Study|Withdrawal by Subject|0|||
125681077|NCT01496183|452122093|FG001|Overall Study|Withdrawal by Subject|1|||
125681078|NCT03002077|452122094|FG000|Overall Study|Non-compliance with Study Drug|4|||
125681079|NCT03002077|452122094|FG000|Overall Study|Non-compliance w/Background ADT|1|||
125681080|NCT03002077|452122094|FG000|Overall Study|Study Terminated by Sponsor|257|||
125681081|NCT03002077|452122094|FG000|Overall Study|Site Terminated by Sponsor|5|||
125681082|NCT03002077|452122094|FG000|Overall Study|Miscellaneous Reasons|10|||
125681083|NCT03002077|452122094|FG000|Overall Study|Adverse Event|23|||
125681084|NCT03002077|452122094|FG000|Overall Study|Lack of Efficacy|20|||
125681085|NCT03002077|452122094|FG000|Overall Study|Withdrawal by Subject|72|||
125681086|NCT03002077|452122094|FG000|Overall Study|Lost to Follow-up|21|||
125681087|NCT03002077|452122094|FG000|Overall Study|Pregnancy|4|||
125681088|NCT03002077|452122094|FG000|Overall Study|Protocol Violation|21|||
125681089|NCT04625114|452122097|FG000|Overall Study|Adverse Event|3|||
125681090|NCT04625114|452122098|FG001|Overall Study|Adverse Event|1|||
125681091|NCT04625114|452122097|FG000|Overall Study|Withdrawal by Subject|2|||
125681092|NCT04625114|452122098|FG001|Overall Study|Withdrawal by Subject|0|||
125681093|NCT00472290|452122099|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
125681094|NCT00472290|452122099|FG000|Overall Study|Protocol Specified Criteria|7|||
125681095|NCT00472290|452122099|FG000|Overall Study|Administrative Decision|37|||
125681096|NCT00472290|452122099|FG000|Overall Study|Death|3|||
125681097|NCT00472290|452122099|FG000|Overall Study|Lost to Follow-up|1|||
125681098|NCT00472290|452122099|FG000|Overall Study|Lack of Efficacy|1|||
125681099|NCT00472290|452122099|FG000|Overall Study|Disease Progression|4|||
125681100|NCT00472290|452122099|FG000|Overall Study|Withdrawal by Subject|5|||
125547058|NCT01689337|451633363|FG000|Overall Study|Study Discontinuation|1|||
125547059|NCT02572882|451633364|FG000|Overall Study|Withdrawal by Subject|1|||
125681101|NCT00472290|452122099|FG000|Overall Study|Adverse Event|6|||
125681102|NCT00472290|452122099|FG000|Overall Study|Requirement for alternative therapy|7|||
125681103|NCT00777829|452122100|FG000|Overall Study|Withdrawal by Subject|0|||
125681104|NCT00777829|452122101|FG001|Overall Study|Withdrawal by Subject|2|||
125681105|NCT02016170|452122114|FG000|Overall Study|Adverse Event|1|||
125681106|NCT02016170|452122115|FG001|Overall Study|Adverse Event|1|||
125681107|NCT02016170|452122116|FG002|Overall Study|Adverse Event|0|||
125681108|NCT02016170|452122114|FG000|Overall Study|Protocol Violation|1|||
125681109|NCT02016170|452122115|FG001|Overall Study|Protocol Violation|0|||
125346087|NCT00853970|450899893|FG001|Overall Study|Cancelled surgery|2|||
125346088|NCT00576420|450901974|FG000|Overall Study|Death|0|||
125346089|NCT00576420|450901975|FG001|Overall Study|Death|0|||
125346090|NCT00576420|450901976|FG002|Overall Study|Death|1|||
125346091|NCT01771809|450901981|FG000|Overall Study|Adverse Event|4|||
125681110|NCT02016170|452122116|FG002|Overall Study|Protocol Violation|0|||
125547060|NCT02572882|451633364|FG000|Overall Study|Participant received kidney transplant|1|||
125547061|NCT01590017|451633365|FG000|Overall Study|Adverse Event|1|||
125547062|NCT01590017|451633365|FG000|Overall Study|Withdrawal by Subject|1|||
125547063|NCT01590017|451633365|FG000|Overall Study|Lack of Efficacy|1|||
125547064|NCT01590017|451633365|FG000|Overall Study|Physician Decision|1|||
125547065|NCT05041101|451633366|FG000|Overall Study|Adverse Event|1|||
125547066|NCT05041101|451633367|FG001|Overall Study|Adverse Event|0|||
125547067|NCT05041101|451633368|FG002|Overall Study|Adverse Event|0|||
125547068|NCT05041101|451633366|FG000|Overall Study|Diease Progression|5|||
125547069|NCT05041101|451633367|FG001|Overall Study|Diease Progression|0|||
125547070|NCT05041101|451633368|FG002|Overall Study|Diease Progression|0|||
125547071|NCT04426851|451633369|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
125547072|NCT04426851|451633370|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
125547073|NCT04426851|451633369|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
125547074|NCT04426851|451633370|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
125547075|NCT00986674|451633371|FG000|Overall Study|Lack of Efficacy|28|||
125547076|NCT00986674|451633372|FG001|Overall Study|Lack of Efficacy|25|||
125547077|NCT00986674|451633373|FG002|Overall Study|Lack of Efficacy|23|||
125547078|NCT00986674|451633371|FG000|Overall Study|Adverse Event|4|||
125547079|NCT00986674|451633372|FG001|Overall Study|Adverse Event|8|||
125547080|NCT00986674|451633373|FG002|Overall Study|Adverse Event|9|||
125547081|NCT00986674|451633371|FG000|Overall Study|Death|5|||
125547082|NCT00986674|451633372|FG001|Overall Study|Death|0|||
125547083|NCT00986674|451633373|FG002|Overall Study|Death|4|||
125547084|NCT00986674|451633371|FG000|Overall Study|Withdrawal by Subject|6|||
125547085|NCT00986674|451633372|FG001|Overall Study|Withdrawal by Subject|2|||
125547086|NCT00986674|451633373|FG002|Overall Study|Withdrawal by Subject|1|||
125547087|NCT00986674|451633371|FG000|Overall Study|alternative therapy|0|||
125547088|NCT00986674|451633372|FG001|Overall Study|alternative therapy|0|||
125547089|NCT00986674|451633373|FG002|Overall Study|alternative therapy|1|||
125547090|NCT00986674|451633371|FG000|Overall Study|not start protocol therapy|4|||
125547091|NCT00986674|451633372|FG001|Overall Study|not start protocol therapy|3|||
125547092|NCT00986674|451633373|FG002|Overall Study|not start protocol therapy|1|||
125547093|NCT00986674|451633371|FG000|Overall Study|unknown/not specify|0|||
125547094|NCT00986674|451633372|FG001|Overall Study|unknown/not specify|7|||
125547095|NCT00986674|451633373|FG002|Overall Study|unknown/not specify|9|||
125547096|NCT02128542|451633374|FG000|Overall Study|Lost to Follow-up|3|||
125547097|NCT02128542|451633375|FG001|Overall Study|Lost to Follow-up|0|||
125547098|NCT02128542|451633374|FG000|Overall Study|Withdrew Consent|1|||
125547099|NCT02128542|451633375|FG001|Overall Study|Withdrew Consent|0|||
125547100|NCT01853137|451633376|FG000|Overall Study|Lost to Follow-up|4|||
125547101|NCT01853137|451633377|FG001|Overall Study|Lost to Follow-up|1|||
125547102|NCT00825916|451633378|FG000|Overall Study|Lost to Follow-up|4|||
125547103|NCT00825916|451633379|FG001|Overall Study|Lost to Follow-up|2|||
125547104|NCT00825916|451633380|FG002|Overall Study|Lost to Follow-up|1|||
125547105|NCT01990560|451633381|FG000|Overall Study|Withdrawal by Subject|1|||
125547106|NCT01778023|451633382|FG000|Overall Study|Withdrawal by Subject|0|||
125547107|NCT01778023|451633383|FG001|Overall Study|Withdrawal by Subject|3|||
125547108|NCT01098097|451633384|FG000|Overall Study|Adverse Event|17|||
125547109|NCT01098097|451633384|FG000|Overall Study|Lost to Follow-up|18|||
125547110|NCT01098097|451633384|FG000|Overall Study|Status unknown|16|||
125547111|NCT01098097|451633384|FG000|Overall Study|No reason reported|31|||
125547112|NCT01411215|451633385|FG000|Overall Study|Adverse Event|1|||
125547113|NCT01411215|451633386|FG001|Overall Study|Adverse Event|2|||
125547114|NCT01411215|451633385|FG000|Overall Study|Lack of Efficacy|2|||
125547115|NCT01411215|451633386|FG001|Overall Study|Lack of Efficacy|4|||
125547116|NCT01411215|451633385|FG000|Overall Study|Lost to Follow-up|12|||
125547117|NCT01411215|451633386|FG001|Overall Study|Lost to Follow-up|18|||
125547118|NCT01411215|451633385|FG000|Overall Study|Did not meet entrance criteria|0|||
125547119|NCT01411215|451633386|FG001|Overall Study|Did not meet entrance criteria|1|||
125547120|NCT01411215|451633385|FG000|Overall Study|Study terminated by sponsor|2|||
125547121|NCT01411215|451633386|FG001|Overall Study|Study terminated by sponsor|15|||
125547122|NCT01411215|451633385|FG000|Overall Study|Protocol Violation|3|||
125547123|NCT01411215|451633386|FG001|Overall Study|Protocol Violation|5|||
125547124|NCT01411215|451633385|FG000|Overall Study|Withdrawal by Subject|34|||
125547125|NCT01411215|451633386|FG001|Overall Study|Withdrawal by Subject|21|||
125547126|NCT01411215|451633385|FG000|Overall Study|Other|12|||
125547127|NCT01411215|451633386|FG001|Overall Study|Other|17|||
125547128|NCT01411215|451633385|FG000|Overall Study|Screen failure|0|||
125547129|NCT01411215|451633386|FG001|Overall Study|Screen failure|1|||
125547130|NCT00848926|451633387|FG000|Treatment Period|Progressive disease|45|||
125547131|NCT00848926|451633387|FG000|Treatment Period|Adverse Event|20|||
125547132|NCT00848926|451633387|FG000|Treatment Period|Physician Decision|12|||
125547133|NCT00848926|451633387|FG000|Treatment Period|Withdrawal by Subject|7|||
125547134|NCT00848926|451633387|FG000|Follow-up Period|Lost to Follow-up|7|||
125547135|NCT00848926|451633387|FG000|Follow-up Period|Withdrawal by Subject|3|||
125547136|NCT00848926|451633387|FG000|Follow-up Period|Other|2|||
125547137|NCT02924064|451633390|FG000|Overall Study|Adverse Event|2|||
125547138|NCT02924064|451633391|FG001|Overall Study|Adverse Event|2|||
125547139|NCT02924064|451633390|FG000|Overall Study|Lost to Follow-up|0|||
125547140|NCT02924064|451633391|FG001|Overall Study|Lost to Follow-up|2|||
125547141|NCT02924064|451633390|FG000|Overall Study|Physician Decision|0|||
125547142|NCT02924064|451633391|FG001|Overall Study|Physician Decision|2|||
125547143|NCT02924064|451633390|FG000|Overall Study|Protocol Violation|1|||
125547144|NCT02924064|451633391|FG001|Overall Study|Protocol Violation|3|||
125547145|NCT02924064|451633390|FG000|Overall Study|Withdrawal by Subject|4|||
125547146|NCT02924064|451633391|FG001|Overall Study|Withdrawal by Subject|5|||
125547147|NCT02924064|451633390|FG000|Overall Study|Other|17|||
125547148|NCT02924064|451633391|FG001|Overall Study|Other|29|||
125547149|NCT04507126|451633392|FG000|Overall Study|Withdrawal by Subject|1|||
125547150|NCT04507126|451633392|FG000|Overall Study|Protocol Violation|2|||
125547151|NCT04507126|451633392|FG000|Overall Study|Physician Decision|1|||
125547152|NCT00966277|451633395|FG000|Overall Study|Withdrawal by Subject|3|||
125547153|NCT00966277|451633396|FG001|Overall Study|Withdrawal by Subject|0|||
125681111|NCT00336479|452122117|FG000|Overall Study|Adverse Event|8|||
125681112|NCT00336479|452122118|FG001|Overall Study|Adverse Event|11|||
125681113|NCT00336479|452122119|FG002|Overall Study|Adverse Event|18|||
125681114|NCT00336479|452122120|FG003|Overall Study|Adverse Event|4|||
125681115|NCT00336479|452122117|FG000|Overall Study|Noncompliant|1|||
125681116|NCT00336479|452122118|FG001|Overall Study|Noncompliant|7|||
125681117|NCT00336479|452122119|FG002|Overall Study|Noncompliant|3|||
125681118|NCT00336479|452122120|FG003|Overall Study|Noncompliant|0|||
125681119|NCT00336479|452122117|FG000|Overall Study|Physician Decision|2|||
125681120|NCT00336479|452122118|FG001|Overall Study|Physician Decision|3|||
125681121|NCT00336479|452122119|FG002|Overall Study|Physician Decision|1|||
125681122|NCT00336479|452122120|FG003|Overall Study|Physician Decision|0|||
125681123|NCT00336479|452122117|FG000|Overall Study|Lost to Follow-up|3|||
125681124|NCT00336479|452122118|FG001|Overall Study|Lost to Follow-up|2|||
125681125|NCT00336479|452122119|FG002|Overall Study|Lost to Follow-up|0|||
125681126|NCT00336479|452122120|FG003|Overall Study|Lost to Follow-up|0|||
125681127|NCT00336479|452122117|FG000|Overall Study|Withdrawal by Subject|3|||
125681128|NCT00336479|452122118|FG001|Overall Study|Withdrawal by Subject|2|||
125681129|NCT00336479|452122119|FG002|Overall Study|Withdrawal by Subject|3|||
125681130|NCT00336479|452122120|FG003|Overall Study|Withdrawal by Subject|0|||
125681131|NCT00336479|452122117|FG000|Overall Study|Other|0|||
125681132|NCT00336479|452122118|FG001|Overall Study|Other|0|||
125681133|NCT00336479|452122119|FG002|Overall Study|Other|1|||
125681134|NCT00336479|452122120|FG003|Overall Study|Other|0|||
125681135|NCT00336479|452122117|FG000|Overall Study|Virologic Stopping Rule|20|||
125681136|NCT00336479|452122118|FG001|Overall Study|Virologic Stopping Rule|0|||
125681137|NCT00336479|452122119|FG002|Overall Study|Virologic Stopping Rule|0|||
125681138|NCT00336479|452122120|FG003|Overall Study|Virologic Stopping Rule|0|||
125681139|NCT01479439|452122121|FG000|Overall Study|Adverse Event|1|||
125346092|NCT01771809|450901982|FG001|Overall Study|Adverse Event|12|||
125346093|NCT01771809|450901981|FG000|Overall Study|Protocol Violation|0|||
125547154|NCT00966277|451633395|FG000|Overall Study|Ineligible|1|||
125547155|NCT00966277|451633396|FG001|Overall Study|Ineligible|3|||
125547156|NCT00966277|451633395|FG000|Overall Study|Treatment Plan Changed|0|||
125681140|NCT01479439|452122122|FG001|Overall Study|Adverse Event|0|||
125681141|NCT01479439|452122123|FG002|Overall Study|Adverse Event|0|||
125681142|NCT01479439|452122121|FG000|Overall Study|Lost to Follow-up|0|||
125210766|NCT03723070|450395677|FG000|Overall Study|Lost to Follow-up|2|||
125547157|NCT00966277|451633396|FG001|Overall Study|Treatment Plan Changed|1|||
125547158|NCT01100034|451633397|FG000|Overall Study|Lost to Follow-up|11|||
125547159|NCT01100034|451633397|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
125547160|NCT01100034|451633397|FG000|Overall Study|Withdrawal by Subject|4|||
125547161|NCT01100034|451633397|FG000|Overall Study|Sponsor decision|21|||
125681143|NCT01479439|452122122|FG001|Overall Study|Lost to Follow-up|1|||
125681144|NCT01479439|452122123|FG002|Overall Study|Lost to Follow-up|0|||
125681145|NCT01479439|452122121|FG000|Overall Study|Protocol Violation|0|||
125681146|NCT01479439|452122122|FG001|Overall Study|Protocol Violation|0|||
125681147|NCT01479439|452122123|FG002|Overall Study|Protocol Violation|2|||
125681148|NCT02365207|452122124|FG000|Overall Study|Withdrawal by Subject|1|||
125681149|NCT02365207|452122124|FG000|Overall Study|Physician Decision|1|||
125681150|NCT01722877|452122125|FG000|Overall Study|Death|1|||
125547162|NCT01100034|451633397|FG000|Overall Study|Participated in another clinical trial|1|||
125547163|NCT01100034|451633397|FG000|Overall Study|Participants moved to another hospital|4|||
125547164|NCT01100034|451633397|FG000|Overall Study|Site closed due to non-responsiveness|1|||
125547165|NCT01831856|451633398|FG000|Overall Study|Adverse Event|5|||
125547166|NCT01831856|451633399|FG001|Overall Study|Adverse Event|8|||
125547167|NCT01831856|451633398|FG000|Overall Study|Lack of Efficacy|13|||
125547168|NCT01831856|451633399|FG001|Overall Study|Lack of Efficacy|11|||
125547169|NCT01831856|451633398|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
125547170|NCT01831856|451633399|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
125547171|NCT00455325|451633400|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
125547172|NCT00455325|451633401|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
125547173|NCT00455325|451633402|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
125547174|NCT00455325|451633403|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
125547175|NCT00455325|451633400|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
125346094|NCT01771809|450901982|FG001|Overall Study|Protocol Violation|1|||
125346095|NCT01771809|450901981|FG000|Overall Study|Withdrawal by Subject|34|||
125547176|NCT00455325|451633401|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
125547177|NCT00455325|451633402|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
125681151|NCT01722877|452122125|FG000|Overall Study|Lost to Follow-up|1|||
125681152|NCT01395030|452122126|FG000|Overall Study|Did not complete FCH PET/CT|7|||
125681153|NCT02079766|452122127|FG000|Overall Study|Physician Decision|1|||
125681154|NCT02079766|452122128|FG001|Overall Study|Physician Decision|0|||
125681155|NCT02079766|452122127|FG000|Overall Study|Withdrawal by Subject|1|||
125681156|NCT02079766|452122128|FG001|Overall Study|Withdrawal by Subject|0|||
125681157|NCT05067647|452122132|FG000|Overall Study|Lost to Follow-up|1|||
125681158|NCT00857623|452122135|FG000|Overall Study|Adverse Event|5|||
125681159|NCT00857623|452122136|FG001|Overall Study|Adverse Event|2|||
125681160|NCT00857623|452122135|FG000|Overall Study|Study-specific discontinuation criteria|5|||
125681161|NCT00857623|452122136|FG001|Overall Study|Study-specific discontinuation criteria|3|||
125681162|NCT00857623|452122135|FG000|Overall Study|Withdrawal by Subject|2|||
125681163|NCT00857623|452122136|FG001|Overall Study|Withdrawal by Subject|1|||
125681164|NCT00857623|452122135|FG000|Overall Study|Lack of Efficacy|1|||
125681165|NCT00857623|452122136|FG001|Overall Study|Lack of Efficacy|1|||
125681166|NCT00857623|452122135|FG000|Overall Study|Severe non-compliance to protocol|1|||
125681167|NCT00857623|452122136|FG001|Overall Study|Severe non-compliance to protocol|1|||
125681168|NCT00857623|452122135|FG000|Overall Study|Intake of prohibited medication|0|||
125681169|NCT00857623|452122136|FG001|Overall Study|Intake of prohibited medication|1|||
125681170|NCT00857623|452122135|FG000|Overall Study|Positive for HEP C|0|||
125681171|NCT00857623|452122136|FG001|Overall Study|Positive for HEP C|1|||
125681172|NCT00870870|452122139|FG000|Overall Study|Withdrawal by Subject|0|||
125681173|NCT00870870|452122140|FG001|Overall Study|Withdrawal by Subject|1|||
125681174|NCT00870870|452122141|FG002|Overall Study|Withdrawal by Subject|1|||
125681175|NCT00870870|452122142|FG003|Overall Study|Withdrawal by Subject|3|||
125681176|NCT00870870|452122139|FG000|Overall Study|Adverse Event|0|||
125681177|NCT00870870|452122140|FG001|Overall Study|Adverse Event|0|||
125681178|NCT00870870|452122141|FG002|Overall Study|Adverse Event|2|||
125681179|NCT00870870|452122142|FG003|Overall Study|Adverse Event|2|||
125681180|NCT00694551|452122145|FG000|Overall Study|Disease Progression|1|||
125681181|NCT00694551|452122146|FG001|Overall Study|Disease Progression|0|||
125681182|NCT00694551|452122147|FG002|Overall Study|Disease Progression|1|||
125681183|NCT00385684|452122152|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
125681184|NCT00385684|452122153|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
125681185|NCT00385684|452122152|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
125681186|NCT00385684|452122153|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
125681187|NCT00385684|452122152|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
125681188|NCT00385684|452122153|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
125681189|NCT02801877|452122154|FG000|Overall Study|Lost to Follow-up|1|||
125681190|NCT02801877|452122155|FG001|Overall Study|Lost to Follow-up|1|||
125681191|NCT02801877|452122156|FG002|Overall Study|Lost to Follow-up|2|||
125681192|NCT02801877|452122157|FG003|Overall Study|Lost to Follow-up|0|||
125681193|NCT02801877|452122154|FG000|Overall Study|Never Started Treatment|2|||
125681194|NCT02801877|452122155|FG001|Overall Study|Never Started Treatment|0|||
125681195|NCT02801877|452122156|FG002|Overall Study|Never Started Treatment|4|||
125681196|NCT02801877|452122157|FG003|Overall Study|Never Started Treatment|0|||
125681197|NCT00591630|452122158|FG000|Overall Study|Death|0|||
125681198|NCT00591630|452122159|FG001|Overall Study|Death|0|||
125681199|NCT00591630|452122160|FG002|Overall Study|Death|1|||
125681200|NCT00591630|452122161|FG003|Overall Study|Death|0|||
125681201|NCT02924038|452123723|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
125681202|NCT02924038|452123724|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
125346096|NCT01771809|450901982|FG001|Overall Study|Withdrawal by Subject|42|||
125547178|NCT00455325|451633403|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
125547179|NCT00455325|451633400|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
125681203|NCT03601637|452123725|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
125547180|NCT00455325|451633401|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
125547181|NCT00455325|451633402|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
125547182|NCT00455325|451633403|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
125547183|NCT00455325|451633400|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
125547184|NCT00455325|451633401|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
125547185|NCT00455325|451633402|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
125547186|NCT00455325|451633403|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
125547187|NCT00455325|451633400|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
125547188|NCT00455325|451633401|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
125547189|NCT00455325|451633402|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
125547190|NCT00455325|451633403|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
125547191|NCT00455325|451633400|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
125547192|NCT00455325|451633401|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
125547193|NCT00455325|451633402|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
125547194|NCT00455325|451633403|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
125547195|NCT00455325|451633400|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
125547196|NCT00455325|451633401|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
125547197|NCT00455325|451633402|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
125547198|NCT00455325|451633403|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
125547199|NCT04620811|451633404|FG000|Overall Study|Withdrawal by Subject|18|||
125547200|NCT04620811|451633405|FG001|Overall Study|Withdrawal by Subject|15|||
125547201|NCT04620811|451633404|FG000|Overall Study|Adverse Event|6|||
125547202|NCT04620811|451633405|FG001|Overall Study|Adverse Event|11|||
125547203|NCT04620811|451633404|FG000|Overall Study|Lost to Follow-up|4|||
125547204|NCT04620811|451633405|FG001|Overall Study|Lost to Follow-up|8|||
125547205|NCT04620811|451633404|FG000|Overall Study|Physician Decision|1|||
125547206|NCT04620811|451633405|FG001|Overall Study|Physician Decision|4|||
125547207|NCT04620811|451633404|FG000|Overall Study|Sponsor Decision|0|||
125547208|NCT04620811|451633405|FG001|Overall Study|Sponsor Decision|1|||
125547209|NCT04620811|451633404|FG000|Overall Study|Elevation of ALT or AST|1|||
125547210|NCT04620811|451633405|FG001|Overall Study|Elevation of ALT or AST|0|||
125547211|NCT04620811|451633404|FG000|Overall Study|Other|3|||
125547212|NCT04620811|451633405|FG001|Overall Study|Other|5|||
125547213|NCT01691768|451633406|FG000|Overall Study|Death|0|||
125547214|NCT01691768|451633407|FG001|Overall Study|Death|2|||
125547215|NCT01691768|451633406|FG000|Overall Study|Lost to Follow-up|4|||
125547216|NCT01691768|451633407|FG001|Overall Study|Lost to Follow-up|3|||
125547217|NCT01691768|451633406|FG000|Overall Study|Withdrawal by Subject|10|||
125547218|NCT01691768|451633407|FG001|Overall Study|Withdrawal by Subject|9|||
125547219|NCT01691768|451633406|FG000|Overall Study|Relocated|0|||
125547220|NCT01691768|451633407|FG001|Overall Study|Relocated|1|||
125547221|NCT01691768|451633406|FG000|Overall Study|Investigator decision|1|||
125547222|NCT01691768|451633407|FG001|Overall Study|Investigator decision|1|||
125547223|NCT01759368|451633408|FG000|Overall Study|Lost to Follow-up|1|||
125547224|NCT01759368|451633409|FG001|Overall Study|Lost to Follow-up|0|||
125547225|NCT01191268|451633410|FG000|Overall Study|Withdrawal by Subject|19|||
125547226|NCT01191268|451633411|FG001|Overall Study|Withdrawal by Subject|25|||
125547227|NCT01191268|451633412|FG002|Overall Study|Withdrawal by Subject|21|||
125547228|NCT01191268|451633410|FG000|Overall Study|Adverse Event|21|||
125547229|NCT01191268|451633411|FG001|Overall Study|Adverse Event|13|||
125547230|NCT01191268|451633412|FG002|Overall Study|Adverse Event|8|||
125547231|NCT01191268|451633410|FG000|Overall Study|Physician Decision|6|||
125547232|NCT01191268|451633411|FG001|Overall Study|Physician Decision|8|||
125547233|NCT01191268|451633412|FG002|Overall Study|Physician Decision|9|||
125547234|NCT01191268|451633410|FG000|Overall Study|Lost to Follow-up|8|||
125547235|NCT01191268|451633411|FG001|Overall Study|Lost to Follow-up|5|||
125547236|NCT01191268|451633412|FG002|Overall Study|Lost to Follow-up|9|||
125547237|NCT01191268|451633410|FG000|Overall Study|Entry Criteria Not Met|3|||
125547238|NCT01191268|451633411|FG001|Overall Study|Entry Criteria Not Met|1|||
125547239|NCT01191268|451633412|FG002|Overall Study|Entry Criteria Not Met|1|||
125681204|NCT03601637|452123726|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
125681205|NCT03601637|452123725|FG000|Overall Study|Adverse Event|1|||
125681206|NCT03601637|452123726|FG001|Overall Study|Adverse Event|1|||
125681207|NCT03601637|452123725|FG000|Overall Study|Other|0|||
125681208|NCT03601637|452123726|FG001|Overall Study|Other|1|||
125681209|NCT01248247|452123727|FG000|Overall Study|Adverse Event|2|||
125681210|NCT01248247|452123728|FG001|Overall Study|Adverse Event|4|||
125681211|NCT01248247|452123729|FG002|Overall Study|Adverse Event|4|||
125681212|NCT01248247|452123730|FG003|Overall Study|Adverse Event|2|||
125681213|NCT01248247|452123727|FG000|Overall Study|Death|0|||
125681214|NCT01248247|452123728|FG001|Overall Study|Death|1|||
125681215|NCT01248247|452123729|FG002|Overall Study|Death|4|||
125681216|NCT01248247|452123730|FG003|Overall Study|Death|7|||
125681217|NCT01248247|452123727|FG000|Overall Study|Lost to Follow-up|0|||
125681218|NCT01248247|452123728|FG001|Overall Study|Lost to Follow-up|1|||
125681219|NCT01248247|452123729|FG002|Overall Study|Lost to Follow-up|1|||
125681220|NCT01248247|452123730|FG003|Overall Study|Lost to Follow-up|0|||
125547240|NCT01191268|451633410|FG000|Overall Study|Death|0|||
125547241|NCT01191268|451633411|FG001|Overall Study|Death|1|||
125547242|NCT01191268|451633412|FG002|Overall Study|Death|3|||
125547243|NCT01191268|451633410|FG000|Overall Study|Protocol Violation|1|||
125547244|NCT01191268|451633411|FG001|Overall Study|Protocol Violation|0|||
125547245|NCT01191268|451633412|FG002|Overall Study|Protocol Violation|1|||
125547246|NCT01191268|451633410|FG000|Overall Study|Sponsor Decision|0|||
125547247|NCT01191268|451633411|FG001|Overall Study|Sponsor Decision|2|||
125547248|NCT01191268|451633412|FG002|Overall Study|Sponsor Decision|0|||
125547249|NCT01959334|451633415|FG000|Second Dose|Adverse Event|1|||
125547250|NCT01959334|451633416|FG001|Second Dose|Adverse Event|0|||
125547251|NCT01959334|451633415|FG000|Third Dose|Adverse Event|0|||
125547252|NCT01959334|451633416|FG001|Third Dose|Adverse Event|1|||
125547253|NCT02294227|451633417|FG000|Overall Study|Death|0|||
125547254|NCT02294227|451633418|FG001|Overall Study|Death|0|||
125547255|NCT02294227|451633419|FG002|Overall Study|Death|1|||
125547256|NCT02294227|451633417|FG000|Overall Study|Subject/Guardian Decision|6|||
125547257|NCT02294227|451633418|FG001|Overall Study|Subject/Guardian Decision|3|||
125547258|NCT02294227|451633419|FG002|Overall Study|Subject/Guardian Decision|7|||
125547259|NCT02294227|451633417|FG000|Overall Study|Physician Decision|1|||
125547260|NCT02294227|451633418|FG001|Overall Study|Physician Decision|2|||
125547261|NCT02294227|451633419|FG002|Overall Study|Physician Decision|1|||
125547262|NCT02294227|451633417|FG000|Overall Study|Lost to Follow-up|1|||
125547263|NCT02294227|451633418|FG001|Overall Study|Lost to Follow-up|0|||
125547264|NCT02294227|451633419|FG002|Overall Study|Lost to Follow-up|0|||
125547265|NCT02294227|451633417|FG000|Overall Study|Lack of Efficacy|11|||
125547266|NCT02294227|451633418|FG001|Overall Study|Lack of Efficacy|12|||
125547267|NCT02294227|451633419|FG002|Overall Study|Lack of Efficacy|8|||
125547268|NCT02294227|451633417|FG000|Overall Study|Adverse Event|6|||
125547269|NCT02294227|451633418|FG001|Overall Study|Adverse Event|8|||
125547270|NCT02294227|451633419|FG002|Overall Study|Adverse Event|2|||
125547271|NCT01768637|451633420|FG000|Overall Study|Lost to Follow-up|2|||
125547272|NCT01768637|451633421|FG001|Overall Study|Lost to Follow-up|7|||
125547273|NCT01768637|451633420|FG000|Overall Study|Difficult blood draw|1|||
125547274|NCT01768637|451633421|FG001|Overall Study|Difficult blood draw|0|||
125547275|NCT00887432|451633422|FG000|Overall Study|Start Excluded Therapy|3|||
125547276|NCT00887432|451633423|FG001|Overall Study|Start Excluded Therapy|0|||
125346097|NCT01771809|450901981|FG000|Overall Study|Lost to Follow-up|1|||
125547277|NCT00887432|451633422|FG000|Overall Study|Did not complete treatment|6|||
125547278|NCT00887432|451633423|FG001|Overall Study|Did not complete treatment|8|||
125547279|NCT00887432|451633422|FG000|Overall Study|Protocol Violation|2|||
125346098|NCT01771809|450901982|FG001|Overall Study|Lost to Follow-up|3|||
125547280|NCT00887432|451633423|FG001|Overall Study|Protocol Violation|3|||
125547281|NCT00887432|451633422|FG000|Overall Study|Withdrawal by Subject|3|||
125547282|NCT00887432|451633423|FG001|Overall Study|Withdrawal by Subject|2|||
125346099|NCT01771809|450901981|FG000|Overall Study|Other (Insufficient clinical response)|22|||
125547283|NCT00887432|451633422|FG000|Overall Study|Lost to Follow-up|1|||
125547284|NCT00887432|451633423|FG001|Overall Study|Lost to Follow-up|0|||
125547285|NCT00887432|451633422|FG000|Overall Study|No reason provided|0|||
125547286|NCT00887432|451633423|FG001|Overall Study|No reason provided|1|||
125547287|NCT01636960|451633424|FG000|Induction Phase|Adverse Event|2|||
125547288|NCT01636960|451633424|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
125547289|NCT01636960|451633424|FG000|Maintenance Phase|Adverse Event|3|||
125547290|NCT01636960|451633424|FG000|Maintenance Phase|Progressive disease|1|||
125547291|NCT01209780|451633427|FG000|Overall Study|Adverse Event|0|||
125547292|NCT01209780|451633428|FG001|Overall Study|Adverse Event|1|||
125547293|NCT01209780|451633429|FG002|Overall Study|Adverse Event|0|||
125547294|NCT01209780|451633430|FG003|Overall Study|Adverse Event|0|||
125547295|NCT01209780|451633431|FG004|Overall Study|Adverse Event|0|||
125547296|NCT01209780|451633427|FG000|Overall Study|Withdrawal by Subject|9|||
125547297|NCT01209780|451633428|FG001|Overall Study|Withdrawal by Subject|2|||
125547298|NCT01209780|451633429|FG002|Overall Study|Withdrawal by Subject|1|||
125547299|NCT01209780|451633430|FG003|Overall Study|Withdrawal by Subject|1|||
125547300|NCT01209780|451633431|FG004|Overall Study|Withdrawal by Subject|0|||
125547301|NCT01209780|451633427|FG000|Overall Study|Lost to Follow-up|17|||
125547302|NCT01209780|451633428|FG001|Overall Study|Lost to Follow-up|12|||
125547303|NCT01209780|451633429|FG002|Overall Study|Lost to Follow-up|3|||
125547304|NCT01209780|451633430|FG003|Overall Study|Lost to Follow-up|9|||
125547305|NCT01209780|451633431|FG004|Overall Study|Lost to Follow-up|4|||
125547306|NCT01209780|451633427|FG000|Overall Study|Protocol Violation|0|||
125547307|NCT01209780|451633428|FG001|Overall Study|Protocol Violation|1|||
125547308|NCT01209780|451633429|FG002|Overall Study|Protocol Violation|0|||
125547309|NCT01209780|451633430|FG003|Overall Study|Protocol Violation|0|||
125547310|NCT01209780|451633431|FG004|Overall Study|Protocol Violation|0|||
125547311|NCT01209780|451633427|FG000|Overall Study|Inappropriate enrollment|0|||
125547312|NCT01209780|451633428|FG001|Overall Study|Inappropriate enrollment|2|||
125547313|NCT01209780|451633429|FG002|Overall Study|Inappropriate enrollment|0|||
125547314|NCT01209780|451633430|FG003|Overall Study|Inappropriate enrollment|0|||
125547315|NCT01209780|451633431|FG004|Overall Study|Inappropriate enrollment|1|||
125547316|NCT01580969|451633432|FG000|Overall Study|Physician Decision|3|||
125547317|NCT01580969|451633433|FG001|Overall Study|Physician Decision|0|||
125547318|NCT01580969|451633434|FG002|Overall Study|Physician Decision|0|||
125547319|NCT00511472|451633440|FG000|Overall Study|Clinical Adverse Event|1|||
125547320|NCT00511472|451633441|FG001|Overall Study|Clinical Adverse Event|2|||
125547321|NCT00511472|451633440|FG000|Overall Study|Laboratory Adverse Event|0|||
125547322|NCT00511472|451633441|FG001|Overall Study|Laboratory Adverse Event|2|||
125547323|NCT00511472|451633440|FG000|Overall Study|Not reported|2|||
125547324|NCT00511472|451633441|FG001|Overall Study|Not reported|2|||
125547325|NCT02709096|451633442|FG000|Overall Study|non-compliance|1|||
125547326|NCT02709096|451633443|FG001|Overall Study|non-compliance|1|||
125547327|NCT00505284|451633444|FG000|Overall Study|Adverse Event|3|||
125547328|NCT00505284|451633445|FG001|Overall Study|Adverse Event|7|||
125547329|NCT00505284|451633446|FG002|Overall Study|Adverse Event|9|||
125210767|NCT03723070|450395677|FG000|Overall Study|Physician Decision|1|||
125346100|NCT01771809|450901982|FG001|Overall Study|Other (Insufficient clinical response)|20|||
125547330|NCT00505284|451633447|FG003|Overall Study|Adverse Event|14|||
125547331|NCT00505284|451633448|FG004|Overall Study|Adverse Event|22|||
125547332|NCT00505284|451633444|FG000|Overall Study|Protocol Violation|0|||
125547333|NCT00505284|451633445|FG001|Overall Study|Protocol Violation|1|||
125547334|NCT00505284|451633446|FG002|Overall Study|Protocol Violation|1|||
125547335|NCT00505284|451633447|FG003|Overall Study|Protocol Violation|0|||
125346101|NCT01771809|450901981|FG000|Overall Study|Death|1|||
125547336|NCT00505284|451633448|FG004|Overall Study|Protocol Violation|0|||
125547337|NCT00505284|451633444|FG000|Overall Study|Withdrawal by Subject|2|||
125547338|NCT00505284|451633445|FG001|Overall Study|Withdrawal by Subject|6|||
125547339|NCT00505284|451633446|FG002|Overall Study|Withdrawal by Subject|1|||
125547340|NCT00505284|451633447|FG003|Overall Study|Withdrawal by Subject|0|||
125547341|NCT00505284|451633448|FG004|Overall Study|Withdrawal by Subject|6|||
125547342|NCT00505284|451633444|FG000|Overall Study|Lack of Efficacy|0|||
125547343|NCT00505284|451633445|FG001|Overall Study|Lack of Efficacy|1|||
125547344|NCT00505284|451633446|FG002|Overall Study|Lack of Efficacy|1|||
125547345|NCT00505284|451633447|FG003|Overall Study|Lack of Efficacy|1|||
125547346|NCT00505284|451633448|FG004|Overall Study|Lack of Efficacy|1|||
125547347|NCT00505284|451633444|FG000|Overall Study|Physician Decision|0|||
125547348|NCT00505284|451633445|FG001|Overall Study|Physician Decision|1|||
125547349|NCT00505284|451633446|FG002|Overall Study|Physician Decision|0|||
125346102|NCT01771809|450901982|FG001|Overall Study|Death|0|||
125346103|NCT01771809|450901981|FG000|Overall Study|Other (other)|9|||
125346104|NCT01771809|450901982|FG001|Overall Study|Other (other)|5|||
125547350|NCT00505284|451633447|FG003|Overall Study|Physician Decision|0|||
125547351|NCT00505284|451633448|FG004|Overall Study|Physician Decision|0|||
125547352|NCT00505284|451633444|FG000|Overall Study|Other|5|||
125346105|NCT02656680|450901983|FG000|Overall Study|Lost to Follow-up|0|||
125547353|NCT00505284|451633445|FG001|Overall Study|Other|0|||
125547354|NCT00505284|451633446|FG002|Overall Study|Other|0|||
125547355|NCT00505284|451633447|FG003|Overall Study|Other|4|||
125547356|NCT00505284|451633448|FG004|Overall Study|Other|4|||
125547357|NCT00731120|451633449|FG000|Overall Study|Adverse Event|7|||
125547358|NCT00731120|451633450|FG001|Overall Study|Adverse Event|6|||
125547359|NCT00731120|451633451|FG002|Overall Study|Adverse Event|8|||
125547360|NCT00731120|451633449|FG000|Overall Study|Lack of Efficacy|4|||
125547361|NCT00731120|451633450|FG001|Overall Study|Lack of Efficacy|5|||
125547362|NCT00731120|451633451|FG002|Overall Study|Lack of Efficacy|4|||
125547363|NCT00731120|451633449|FG000|Overall Study|Noncompliance with Study Drug|3|||
125547364|NCT00731120|451633450|FG001|Overall Study|Noncompliance with Study Drug|3|||
125547365|NCT00731120|451633451|FG002|Overall Study|Noncompliance with Study Drug|1|||
125547366|NCT00731120|451633449|FG000|Overall Study|Protocol Deviations|1|||
125547367|NCT00731120|451633450|FG001|Overall Study|Protocol Deviations|6|||
125547368|NCT00731120|451633451|FG002|Overall Study|Protocol Deviations|1|||
125547369|NCT00731120|451633449|FG000|Overall Study|Withdrawal of Consent|13|||
125547370|NCT00731120|451633450|FG001|Overall Study|Withdrawal of Consent|8|||
125346106|NCT02656680|450901984|FG001|Overall Study|Lost to Follow-up|1|||
125346107|NCT02656680|450901985|FG002|Overall Study|Lost to Follow-up|7|||
125346108|NCT01142089|450901991|FG000|Overall Study|Physician Decision|1|||
125547371|NCT00731120|451633451|FG002|Overall Study|Withdrawal of Consent|4|||
125547372|NCT00731120|451633449|FG000|Overall Study|Lost to Follow-up|10|||
125547373|NCT00731120|451633450|FG001|Overall Study|Lost to Follow-up|15|||
125547374|NCT00731120|451633451|FG002|Overall Study|Lost to Follow-up|17|||
125346109|NCT01142089|450901992|FG001|Overall Study|Physician Decision|0|||
125346110|NCT01142089|450901991|FG000|Overall Study|Withdrawal by Subject|1|||
125346111|NCT01142089|450901992|FG001|Overall Study|Withdrawal by Subject|2|||
125346112|NCT01142089|450901991|FG000|Overall Study|Use of prohibited medications|0|||
125346113|NCT01142089|450901992|FG001|Overall Study|Use of prohibited medications|1|||
125346114|NCT01142089|450901991|FG000|Overall Study|Noncompliance with study procedures|2|||
125346115|NCT01142089|450901992|FG001|Overall Study|Noncompliance with study procedures|1|||
125346116|NCT01142089|450901991|FG000|Overall Study|Patient required rescue medication|8|||
125346117|NCT01142089|450901992|FG001|Overall Study|Patient required rescue medication|17|||
125346118|NCT02907892|450901995|FG000|Overall Study|Lost to Follow-up|27|||
125346119|NCT02907892|450901996|FG001|Overall Study|Lost to Follow-up|40|||
125346120|NCT01974765|450901997|FG000|Overall Study|Withdrawal by Subject|1|||
125346121|NCT01974765|450901997|FG000|Overall Study|Death|1|||
125346122|NCT01974765|450901997|FG000|Overall Study|Adverse Event|2|||
125346123|NCT03860935|450901998|FG000|Overall Study|Withdrawal of Consent|15|||
125346124|NCT03860935|450901999|FG001|Overall Study|Withdrawal of Consent|6|||
125346125|NCT03860935|450901998|FG000|Overall Study|Death|75|||
125346126|NCT03860935|450901999|FG001|Overall Study|Death|51|||
125346127|NCT01430754|450902000|FG000|Run-In Phase|Circadian Period Ineligible|24|||
125346128|NCT01430754|450902001|FG001|Run-In Phase|Circadian Period Ineligible|0|||
125346129|NCT01430754|450902000|FG000|Run-In Phase|Protocol Violation|6|||
125346130|NCT01430754|450902001|FG001|Run-In Phase|Protocol Violation|0|||
125346131|NCT01430754|450902000|FG000|Run-In Phase|Adverse Event|2|||
125346132|NCT01430754|450902001|FG001|Run-In Phase|Adverse Event|0|||
125346133|NCT01430754|450902000|FG000|Run-In Phase|Other|2|||
125346134|NCT01430754|450902001|FG001|Run-In Phase|Other|0|||
125346135|NCT01430754|450902000|FG000|Run-In Phase|Withdrawal by Subject|2|||
125346136|NCT01430754|450902001|FG001|Run-In Phase|Withdrawal by Subject|0|||
125346137|NCT01430754|450902000|FG000|Run-In Phase|Lost to Follow-up|1|||
125346138|NCT01430754|450902001|FG001|Run-In Phase|Lost to Follow-up|0|||
125346139|NCT00701662|450902005|FG000|Overall Study|Lack of Efficacy|1|||
125346140|NCT00635024|450902006|FG000|Overall Study|Adverse Event|1|||
125346141|NCT01105065|450902007|FG000|Overall Study|Adverse Event|5|||
125346142|NCT01105065|450902007|FG000|Overall Study|Technical Problems|1|||
125346143|NCT01038869|450902009|FG000|Overall Study|Withdrawal by Subject|1|||
125346144|NCT01038869|450902009|FG000|Overall Study|Lost to Follow-up|6|||
125346145|NCT04575597|450902010|FG000|Overall Study|Death|0|||
125547375|NCT00731120|451633449|FG000|Overall Study|Other|4|||
125681221|NCT01248247|452123727|FG000|Overall Study|Alternative treatment|0|||
125681222|NCT01248247|452123728|FG001|Overall Study|Alternative treatment|1|||
125681223|NCT01248247|452123729|FG002|Overall Study|Alternative treatment|0|||
125681224|NCT01248247|452123730|FG003|Overall Study|Alternative treatment|0|||
125681225|NCT01248247|452123727|FG000|Overall Study|Other|2|||
125681226|NCT01248247|452123728|FG001|Overall Study|Other|8|||
125681227|NCT01248247|452123729|FG002|Overall Study|Other|8|||
125681228|NCT01248247|452123730|FG003|Overall Study|Other|5|||
125681229|NCT01248247|452123727|FG000|Overall Study|Progression|18|||
125681230|NCT01248247|452123728|FG001|Overall Study|Progression|27|||
125681231|NCT01248247|452123729|FG002|Overall Study|Progression|56|||
125681232|NCT01248247|452123730|FG003|Overall Study|Progression|44|||
125681233|NCT01248247|452123727|FG000|Overall Study|Refuse further treatment|0|||
125681234|NCT01248247|452123728|FG001|Overall Study|Refuse further treatment|0|||
125681235|NCT01248247|452123729|FG002|Overall Study|Refuse further treatment|1|||
125681236|NCT01248247|452123730|FG003|Overall Study|Refuse further treatment|2|||
125681237|NCT01248247|452123727|FG000|Overall Study|Complicating disease|0|||
125681238|NCT01248247|452123728|FG001|Overall Study|Complicating disease|0|||
125681239|NCT01248247|452123729|FG002|Overall Study|Complicating disease|1|||
125681240|NCT01248247|452123730|FG003|Overall Study|Complicating disease|1|||
125681241|NCT01108094|452123733|FG000|Overall Study|Adverse Event|2|||
125681242|NCT01108094|452123734|FG001|Overall Study|Adverse Event|0|||
125681243|NCT01108094|452123735|FG002|Overall Study|Adverse Event|0|||
125681244|NCT01108094|452123736|FG003|Overall Study|Adverse Event|0|||
125681245|NCT01108094|452123733|FG000|Overall Study|Withdrawal by Subject|1|||
125681246|NCT01108094|452123734|FG001|Overall Study|Withdrawal by Subject|0|||
125681247|NCT01108094|452123735|FG002|Overall Study|Withdrawal by Subject|0|||
125346146|NCT04575597|450902011|FG001|Overall Study|Death|0|||
125346147|NCT04575597|450902012|FG002|Overall Study|Death|0|||
125346148|NCT04575597|450902013|FG003|Overall Study|Death|1|||
125346149|NCT04575597|450902014|FG004|Overall Study|Death|3|||
125346150|NCT04575597|450902015|FG005|Overall Study|Death|14|||
125346151|NCT04575597|450902010|FG000|Overall Study|Lost to Follow-up|2|||
125681248|NCT01108094|452123736|FG003|Overall Study|Withdrawal by Subject|0|||
125681249|NCT00420303|452123737|FG000|Overall Study|Serious Adverse Event|1|||
125681250|NCT00420303|452123738|FG001|Overall Study|Serious Adverse Event|0|||
125346152|NCT04575597|450902011|FG001|Overall Study|Lost to Follow-up|1|||
125681251|NCT00420303|452123737|FG000|Overall Study|Lack of Efficacy|0|||
125346153|NCT04575597|450902012|FG002|Overall Study|Lost to Follow-up|1|||
125346154|NCT04575597|450902013|FG003|Overall Study|Lost to Follow-up|2|||
125681252|NCT00420303|452123738|FG001|Overall Study|Lack of Efficacy|3|||
125681253|NCT00420303|452123737|FG000|Overall Study|Physician Decision|0|||
125547376|NCT00731120|451633450|FG001|Overall Study|Other|0|||
125547377|NCT00731120|451633451|FG002|Overall Study|Other|1|||
125547378|NCT01551212|451633457|FG000|Overall Study|Graft loss/Retransplantation|0|||
125547379|NCT01551212|451633458|FG001|Overall Study|Graft loss/Retransplantation|1|||
125547380|NCT01551212|451633457|FG000|Overall Study|Administrative problems|1|||
125547381|NCT01551212|451633458|FG001|Overall Study|Administrative problems|2|||
125547382|NCT01551212|451633457|FG000|Overall Study|Lost to Follow-up|0|||
125547383|NCT01551212|451633458|FG001|Overall Study|Lost to Follow-up|1|||
125547384|NCT01551212|451633457|FG000|Overall Study|Protocol Violation|0|||
125547385|NCT01551212|451633458|FG001|Overall Study|Protocol Violation|1|||
125547386|NCT01551212|451633457|FG000|Overall Study|Withdrawal by Subject|0|||
125547387|NCT01551212|451633458|FG001|Overall Study|Withdrawal by Subject|7|||
125547388|NCT01551212|451633457|FG000|Overall Study|Death|2|||
125547389|NCT01551212|451633458|FG001|Overall Study|Death|4|||
125547390|NCT01551212|451633457|FG000|Overall Study|Never Received Study Treatment|2|||
125547391|NCT01551212|451633458|FG001|Overall Study|Never Received Study Treatment|4|||
125681254|NCT00420303|452123738|FG001|Overall Study|Physician Decision|1|||
125681255|NCT01029353|452123740|FG000|Overall Study|Lost to Follow-up|4|||
125681256|NCT01029353|452123741|FG001|Overall Study|Lost to Follow-up|5|||
125681257|NCT01029353|452123742|FG002|Overall Study|Lost to Follow-up|5|||
125681258|NCT01029353|452123743|FG003|Overall Study|Lost to Follow-up|4|||
125681259|NCT01029353|452123740|FG000|Overall Study|Consent Withdrawn|2|||
125681260|NCT01029353|452123741|FG001|Overall Study|Consent Withdrawn|0|||
125681261|NCT01029353|452123742|FG002|Overall Study|Consent Withdrawn|0|||
125681262|NCT01029353|452123743|FG003|Overall Study|Consent Withdrawn|0|||
125681263|NCT01029353|452123740|FG000|Overall Study|Primary Outcome Indeterminate|1|||
125681264|NCT01029353|452123741|FG001|Overall Study|Primary Outcome Indeterminate|3|||
125681265|NCT01029353|452123742|FG002|Overall Study|Primary Outcome Indeterminate|2|||
125681266|NCT01029353|452123743|FG003|Overall Study|Primary Outcome Indeterminate|0|||
125681267|NCT01900730|452123744|FG000|Overall Study|Withdrawal by Subject|1|||
125681268|NCT01900730|452123745|FG001|Overall Study|Withdrawal by Subject|0|||
125681269|NCT01900730|452123744|FG000|Overall Study|Screen Failure|1|||
125681270|NCT01900730|452123745|FG001|Overall Study|Screen Failure|0|||
125681271|NCT01520909|452123746|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
125681272|NCT01520909|452123747|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
125681273|NCT01520909|452123748|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
125681274|NCT01520909|452123746|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
125681275|NCT01520909|452123747|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
125681276|NCT01520909|452123748|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
125681277|NCT01520909|452123746|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
125681278|NCT01520909|452123747|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
125681279|NCT01520909|452123748|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
125681280|NCT01520909|452123746|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
125681281|NCT01520909|452123747|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
125681282|NCT01520909|452123748|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
125681283|NCT02942264|452123749|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125681284|NCT02942264|452123750|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
125681285|NCT02942264|452123751|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125681286|NCT02942264|452123752|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125681287|NCT02942264|452123753|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125681288|NCT02942264|452123754|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125681289|NCT02942264|452123755|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
125681290|NCT02942264|452123756|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125681291|NCT02942264|452123757|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
125681292|NCT02942264|452123749|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125681293|NCT02942264|452123750|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125681294|NCT02942264|452123751|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125681295|NCT02942264|452123752|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125681296|NCT02942264|452123753|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125681297|NCT02942264|452123754|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125681298|NCT02942264|452123755|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125681299|NCT02942264|452123756|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
125681300|NCT02942264|452123757|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
125681301|NCT00569374|452123760|FG000|Overall Study|Withdrawal by Subject|4|||
125547392|NCT00705523|451633459|FG000|Overall Study|Lost to Follow-up|2|||
125547393|NCT00705523|451633460|FG001|Overall Study|Lost to Follow-up|3|||
125547394|NCT03110185|451633463|FG000|Overall Study|Death|0|||
125547395|NCT03110185|451633464|FG001|Overall Study|Death|1|||
125547396|NCT03110185|451633463|FG000|Overall Study|Withdrawal by Subject|2|||
125681302|NCT00064753|452123761|FG000|Overall Study|Death|251|||
125681303|NCT00064753|452123762|FG001|Overall Study|Death|242|||
125681304|NCT00064753|452123761|FG000|Overall Study|Withdrawal by Subject|198|||
125547397|NCT03110185|451633464|FG001|Overall Study|Withdrawal by Subject|7|||
125346155|NCT04575597|450902014|FG004|Overall Study|Lost to Follow-up|10|||
125346156|NCT04575597|450902015|FG005|Overall Study|Lost to Follow-up|8|||
125346157|NCT04575597|450902010|FG000|Overall Study|Withdrawal by Subject|2|||
125346158|NCT04575597|450902011|FG001|Overall Study|Withdrawal by Subject|2|||
125346159|NCT04575597|450902012|FG002|Overall Study|Withdrawal by Subject|4|||
125346160|NCT04575597|450902013|FG003|Overall Study|Withdrawal by Subject|2|||
125346161|NCT04575597|450902014|FG004|Overall Study|Withdrawal by Subject|25|||
125346162|NCT04575597|450902015|FG005|Overall Study|Withdrawal by Subject|28|||
125346163|NCT04575597|450902010|FG000|Overall Study|Not Recorded|0|||
125346164|NCT04575597|450902011|FG001|Overall Study|Not Recorded|0|||
125346165|NCT04575597|450902012|FG002|Overall Study|Not Recorded|0|||
125346166|NCT04575597|450902013|FG003|Overall Study|Not Recorded|0|||
125346167|NCT04575597|450902014|FG004|Overall Study|Not Recorded|0|||
125346168|NCT04575597|450902015|FG005|Overall Study|Not Recorded|2|||
125346169|NCT04575597|450902010|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125346170|NCT04575597|450902011|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125346171|NCT04575597|450902012|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125346172|NCT04575597|450902013|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125346173|NCT04575597|450902014|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
125346174|NCT04575597|450902015|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
125547398|NCT03110185|451633463|FG000|Overall Study|Time Constraints|0|||
125547399|NCT03110185|451633464|FG001|Overall Study|Time Constraints|6|||
125547400|NCT03110185|451633463|FG000|Overall Study|Conflict with care|5|||
125547401|NCT03110185|451633464|FG001|Overall Study|Conflict with care|12|||
125681305|NCT00064753|452123762|FG001|Overall Study|Withdrawal by Subject|171|||
125681306|NCT00064753|452123761|FG000|Overall Study|Lost to Follow-up|225|||
125681307|NCT00064753|452123762|FG001|Overall Study|Lost to Follow-up|235|||
125681308|NCT01544127|452123768|FG000|Overall Study|Lost to Follow-up|4|||
125681309|NCT01544127|452123769|FG001|Overall Study|Lost to Follow-up|2|||
125681310|NCT01544127|452123770|FG002|Overall Study|Lost to Follow-up|9|||
125681311|NCT01544127|452123768|FG000|Overall Study|Withdrawal by Subject|2|||
125681312|NCT01544127|452123769|FG001|Overall Study|Withdrawal by Subject|2|||
125681313|NCT01544127|452123770|FG002|Overall Study|Withdrawal by Subject|1|||
125681314|NCT01544127|452123768|FG000|Overall Study|Discharged out of catchment area|1|||
125681315|NCT01544127|452123769|FG001|Overall Study|Discharged out of catchment area|1|||
125681316|NCT01544127|452123770|FG002|Overall Study|Discharged out of catchment area|1|||
125681317|NCT01544127|452123768|FG000|Overall Study|Death|1|||
125681318|NCT01544127|452123769|FG001|Overall Study|Death|0|||
125681319|NCT01544127|452123770|FG002|Overall Study|Death|0|||
125681320|NCT01544127|452123768|FG000|Overall Study|Jail or Prison|1|||
125681321|NCT01544127|452123769|FG001|Overall Study|Jail or Prison|1|||
125681322|NCT01544127|452123770|FG002|Overall Study|Jail or Prison|2|||
125681323|NCT01544127|452123768|FG000|Overall Study|Became Psychotic|1|||
125681324|NCT01544127|452123769|FG001|Overall Study|Became Psychotic|0|||
125681325|NCT01544127|452123770|FG002|Overall Study|Became Psychotic|0|||
125681326|NCT01544127|452123768|FG000|Overall Study|Researcher withdrew|1|||
125681327|NCT01544127|452123769|FG001|Overall Study|Researcher withdrew|0|||
125681328|NCT01544127|452123770|FG002|Overall Study|Researcher withdrew|0|||
125681329|NCT01544127|452123768|FG000|Overall Study|Went active duty|0|||
125681330|NCT01544127|452123769|FG001|Overall Study|Went active duty|0|||
125681331|NCT01544127|452123770|FG002|Overall Study|Went active duty|1|||
125681332|NCT00533273|452123771|FG000|Double-blind|Withdrew consent|0|||
125681333|NCT00533273|452123772|FG001|Double-blind|Withdrew consent|2|||
125681334|NCT00533273|452123771|FG000|Open-label|Withdrawal by Subject|6|||
125681335|NCT00533273|452123772|FG001|Open-label|Withdrawal by Subject|0|||
125681336|NCT02914600|452123775|FG000|Overall Study|Adverse Event|298|||
125681337|NCT02914600|452123776|FG001|Overall Study|Adverse Event|35|||
125681338|NCT02914600|452123777|FG002|Overall Study|Adverse Event|25|||
125681339|NCT02914600|452123775|FG000|Overall Study|Sponsors decision|287|||
125681340|NCT02914600|452123776|FG001|Overall Study|Sponsors decision|41|||
125681341|NCT02914600|452123777|FG002|Overall Study|Sponsors decision|12|||
125681342|NCT02914600|452123775|FG000|Overall Study|Withdrawal by Subject|158|||
125681343|NCT02914600|452123776|FG001|Overall Study|Withdrawal by Subject|20|||
125681344|NCT02914600|452123777|FG002|Overall Study|Withdrawal by Subject|18|||
125681345|NCT02914600|452123775|FG000|Overall Study|Investigators discretion|169|||
125681346|NCT02914600|452123776|FG001|Overall Study|Investigators discretion|14|||
125681347|NCT02914600|452123777|FG002|Overall Study|Investigators discretion|13|||
125681348|NCT02914600|452123775|FG000|Overall Study|Lost to Follow-up|10|||
125681349|NCT02914600|452123776|FG001|Overall Study|Lost to Follow-up|4|||
125681350|NCT02914600|452123777|FG002|Overall Study|Lost to Follow-up|0|||
125681351|NCT02914600|452123775|FG000|Overall Study|Pregnancy|8|||
125681352|NCT02914600|452123776|FG001|Overall Study|Pregnancy|0|||
125681353|NCT02914600|452123777|FG002|Overall Study|Pregnancy|0|||
125681354|NCT02914600|452123775|FG000|Overall Study|Protocol Violation|5|||
125681355|NCT02914600|452123776|FG001|Overall Study|Protocol Violation|3|||
125681356|NCT02914600|452123777|FG002|Overall Study|Protocol Violation|0|||
125681357|NCT02914600|452123775|FG000|Overall Study|Non-compliance with study drug|6|||
125681358|NCT02914600|452123776|FG001|Overall Study|Non-compliance with study drug|1|||
125681359|NCT02914600|452123777|FG002|Overall Study|Non-compliance with study drug|0|||
125681360|NCT02914600|452123775|FG000|Overall Study|Death|3|||
125681361|NCT02914600|452123776|FG001|Overall Study|Death|1|||
125681362|NCT02914600|452123777|FG002|Overall Study|Death|1|||
125681363|NCT02914600|452123775|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
125681364|NCT02914600|452123776|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
125681365|NCT02914600|452123777|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
125681366|NCT02914600|452123775|FG000|Overall Study|Enrolled but not treated|1|||
125681367|NCT02914600|452123776|FG001|Overall Study|Enrolled but not treated|0|||
125681368|NCT02914600|452123777|FG002|Overall Study|Enrolled but not treated|0|||
125681369|NCT00454909|452123778|FG000|Overall Study|Withdrawal by Subject|1|||
125681370|NCT00454909|452123779|FG001|Overall Study|Withdrawal by Subject|0|||
125681371|NCT00454909|452123780|FG002|Overall Study|Withdrawal by Subject|0|||
125681372|NCT00454909|452123778|FG000|Overall Study|Migrated/moved from study area|0|||
125681373|NCT00454909|452123779|FG001|Overall Study|Migrated/moved from study area|0|||
125681374|NCT00454909|452123780|FG002|Overall Study|Migrated/moved from study area|1|||
125681375|NCT00454909|452123778|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
125681376|NCT00454909|452123779|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
125681377|NCT00454909|452123780|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
125547402|NCT03110185|451633463|FG000|Overall Study|Protocol Violation|1|||
125547403|NCT03110185|451633464|FG001|Overall Study|Protocol Violation|4|||
125547404|NCT03110185|451633463|FG000|Overall Study|MRI Incompatible|2|||
125547405|NCT03110185|451633464|FG001|Overall Study|MRI Incompatible|0|||
125547406|NCT03110185|451633463|FG000|Overall Study|Patient Refusal|0|||
125547407|NCT03110185|451633464|FG001|Overall Study|Patient Refusal|1|||
125547408|NCT01050790|451633465|FG000|Overall Study|Adverse Event|1|||
125547409|NCT03705832|451633466|FG000|Overall Study|Physician Decision|0|||
125547410|NCT03705832|451633467|FG001|Overall Study|Physician Decision|1|||
125547411|NCT03705832|451633466|FG000|Overall Study|Withdrawal by Subject|1|||
125547412|NCT03705832|451633467|FG001|Overall Study|Withdrawal by Subject|0|||
125547413|NCT01912456|451634989|FG000|Period 1|Physician Decision|0|||
125547414|NCT01912456|451634990|FG001|Period 1|Physician Decision|0|||
125547415|NCT01912456|451634991|FG002|Period 1|Physician Decision|1|||
125547416|NCT01912456|451634992|FG003|Period 1|Physician Decision|0|||
125547417|NCT01912456|451634989|FG000|Period 1|non-compliance|1|||
125547418|NCT01912456|451634990|FG001|Period 1|non-compliance|0|||
125547419|NCT01912456|451634991|FG002|Period 1|non-compliance|0|||
125547420|NCT01912456|451634992|FG003|Period 1|non-compliance|1|||
125547421|NCT01912456|451634989|FG000|Period 1|Adverse Event|1|||
125547422|NCT01912456|451634990|FG001|Period 1|Adverse Event|0|||
125547423|NCT01912456|451634991|FG002|Period 1|Adverse Event|0|||
125547424|NCT01912456|451634992|FG003|Period 1|Adverse Event|1|||
125547425|NCT01912456|451634989|FG000|Period 1|Withdrawal by Subject|0|||
125547426|NCT01912456|451634990|FG001|Period 1|Withdrawal by Subject|1|||
125547427|NCT01912456|451634991|FG002|Period 1|Withdrawal by Subject|1|||
125346175|NCT03316911|450902020|FG000|Overall Study|Lost to Follow-up|33|||
125547428|NCT01912456|451634992|FG003|Period 1|Withdrawal by Subject|1|||
125547429|NCT01912456|451634989|FG000|Period 2|Lack of Efficacy|0|||
125547430|NCT01912456|451634990|FG001|Period 2|Lack of Efficacy|2|||
125547431|NCT01912456|451634991|FG002|Period 2|Lack of Efficacy|0|||
125547432|NCT01912456|451634992|FG003|Period 2|Lack of Efficacy|0|||
125547433|NCT01912456|451634989|FG000|Period 2|Adverse Event|0|||
125547434|NCT01912456|451634990|FG001|Period 2|Adverse Event|0|||
125547435|NCT01912456|451634991|FG002|Period 2|Adverse Event|0|||
125547436|NCT01912456|451634992|FG003|Period 2|Adverse Event|1|||
125547437|NCT01201343|451634993|FG000|Overall Study|Adverse Event|6|||
125346176|NCT03316911|450902021|FG001|Overall Study|Lost to Follow-up|29|||
125346177|NCT01119937|450902022|FG000|Overall Study|Adverse Event|11|||
125346178|NCT01119937|450902023|FG001|Overall Study|Adverse Event|5|||
125346179|NCT01119937|450902022|FG000|Overall Study|Protocol deviation|3|||
125346180|NCT01119937|450902023|FG001|Overall Study|Protocol deviation|1|||
125346181|NCT01119937|450902022|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
125346182|NCT01119937|450902023|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125346183|NCT01119937|450902022|FG000|Overall Study|Withdrawal by Subject|2|||
125547438|NCT01201343|451634993|FG000|Overall Study|Withdrawal by Subject|5|||
125547439|NCT01201343|451634993|FG000|Overall Study|Lost to Follow-up|2|||
125681378|NCT00454909|452123778|FG000|Overall Study|Others|1|||
125681379|NCT00454909|452123779|FG001|Overall Study|Others|0|||
125681380|NCT00454909|452123780|FG002|Overall Study|Others|0|||
125681381|NCT02457520|452123781|FG000|Active Treatment Phase|Adverse Event|10|||
125681382|NCT02457520|452123781|FG000|Active Treatment Phase|Lost to Follow-up|8|||
125681383|NCT02457520|452123781|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
125681384|NCT02457520|452123781|FG000|Active Treatment Phase|other|4|||
125681385|NCT02457520|452123781|FG000|Active Treatment Phase|Physician Decision|1|||
125681386|NCT02457520|452123781|FG000|Active Treatment Phase|Protocol Violation|1|||
125681387|NCT02457520|452123781|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
125681388|NCT02457520|452123781|FG000|Post-treatment Period|Other: Retreatment Required|7|||
125681389|NCT02457520|452123781|FG000|Post-treatment Period|Lost to Follow-up|23|||
125681390|NCT02457520|452123781|FG000|Post-treatment Period|Other|3|||
125681391|NCT02457520|452123781|FG000|Post-treatment Period|Physician Decision|1|||
125681392|NCT02457520|452123781|FG000|Post-treatment Period|Withdrawal by Subject|14|||
125681393|NCT02107092|452123782|FG000|Overall Study|Miscellaneous|3|||
125681394|NCT02107092|452123782|FG000|Overall Study|Subject compliance|3|||
125681395|NCT02107092|452123782|FG000|Overall Study|Hypo-or hyperkalemia|2|||
125681396|NCT02107092|452123782|FG000|Overall Study|Met ECG withdrawal criteria|3|||
125681397|NCT02107092|452123782|FG000|Overall Study|Physician Decision|3|||
125681398|NCT02107092|452123782|FG000|Overall Study|Lost to Follow-up|2|||
125681399|NCT02107092|452123782|FG000|Overall Study|Withdrawal by Subject|9|||
125681400|NCT02107092|452123782|FG000|Overall Study|Adverse Event|7|||
125681401|NCT02107092|452123782|FG000|Overall Study|Expected progression of CKD|12|||
125681402|NCT03522675|452123784|FG000|Overall Study|Screen fail|1|||
125681403|NCT03522675|452123784|FG000|Overall Study|Non-reactive to histamine|1|||
125681404|NCT00707161|452123785|FG000|Overall Study|Physician Decision|6|||
125681405|NCT02076022|452123788|FG000|Overall Study|Withdrawal by Subject|2|||
125681406|NCT02076022|452123789|FG001|Overall Study|Withdrawal by Subject|0|||
125681407|NCT00312663|452123790|FG000|Immunization Phase|Adverse Event|0|||
125681408|NCT00312663|452123791|FG001|Immunization Phase|Adverse Event|1|||
125681409|NCT00312663|452123792|FG002|Immunization Phase|Adverse Event|0|||
125681410|NCT02661295|452123797|FG000|Overall Study|Death|1|||
125681411|NCT02661295|452123797|FG000|Overall Study|Transferred Out|1|||
125681412|NCT02661295|452123797|FG000|Overall Study|Kidney Transplant|1|||
125681413|NCT02661295|452123797|FG000|Overall Study|Withdrawn due to side effects|8|||
125681414|NCT02661295|452123797|FG000|Overall Study|Withdrawn due to access type|1|||
125681415|NCT02661295|452123797|FG000|Overall Study|Withdrawn due to allergies|1|||
125681416|NCT02661295|452123797|FG000|Overall Study|Withdrawn due to non-compliance|1|||
125681417|NCT02661295|452123797|FG000|Overall Study|Withdrawal by Subject|3|||
125681418|NCT02661295|452123797|FG000|Overall Study|Failed screening|2|||
125681419|NCT01376167|452123798|FG000|Overall Study|Lost to Follow-up|2|||
125681420|NCT01376167|452123799|FG001|Overall Study|Lost to Follow-up|4|||
125681421|NCT01376167|452123800|FG002|Overall Study|Lost to Follow-up|2|||
125681422|NCT01376167|452123798|FG000|Overall Study|Physician Decision|1|||
125681423|NCT01376167|452123799|FG001|Overall Study|Physician Decision|1|||
125681424|NCT01376167|452123800|FG002|Overall Study|Physician Decision|0|||
125681425|NCT01376167|452123798|FG000|Overall Study|Withdrawal by Subject|1|||
125681426|NCT01376167|452123799|FG001|Overall Study|Withdrawal by Subject|5|||
125681427|NCT01376167|452123800|FG002|Overall Study|Withdrawal by Subject|4|||
125681428|NCT02849652|452123809|FG000|Overall Study|Lost to Follow-up|104|||
125681429|NCT02849652|452123810|FG001|Overall Study|Lost to Follow-up|35|||
125681430|NCT02849652|452123811|FG002|Overall Study|Lost to Follow-up|116|||
125681431|NCT02849652|452123812|FG003|Overall Study|Lost to Follow-up|22|||
125681432|NCT02849652|452123809|FG000|Overall Study|Withdrawal by Subject|10|||
125681433|NCT02849652|452123810|FG001|Overall Study|Withdrawal by Subject|2|||
125681434|NCT02849652|452123811|FG002|Overall Study|Withdrawal by Subject|8|||
125681435|NCT02849652|452123812|FG003|Overall Study|Withdrawal by Subject|4|||
125681436|NCT00565448|452123813|FG000|Overall Study|Adverse Event|1|||
125681437|NCT00565448|452123814|FG001|Overall Study|Adverse Event|2|||
125681438|NCT00565448|452123813|FG000|Overall Study|Disease progression|1|||
125681439|NCT00565448|452123814|FG001|Overall Study|Disease progression|0|||
125681440|NCT00565448|452123813|FG000|Overall Study|Withdrawal by Subject|1|||
125681441|NCT00565448|452123814|FG001|Overall Study|Withdrawal by Subject|0|||
125346184|NCT01119937|450902023|FG001|Overall Study|Withdrawal by Subject|1|||
125681442|NCT00302952|452123816|FG000|Overall Study|Physician Decision|1|||
125681443|NCT00302952|452123817|FG001|Overall Study|Physician Decision|1|||
125681444|NCT00302952|452123816|FG000|Overall Study|Withdrawal by Subject|2|||
125547440|NCT01201343|451634993|FG000|Overall Study|Lack of Efficacy|2|||
125547441|NCT01201343|451634993|FG000|Overall Study|Participant wrongly included in trial|1|||
125547442|NCT01201343|451634993|FG000|Overall Study|Randomized, not treated|3|||
125547443|NCT01036763|451634997|FG000|Overall Study|Adverse Event|25|||
125547444|NCT01036763|451634997|FG000|Overall Study|Lost to Follow-up|28|||
125547445|NCT01036763|451634997|FG000|Overall Study|Other reason (not specified)|40|||
125547446|NCT01672723|451634998|FG000|First Intervention|Adverse Event|3|||
125547447|NCT01672723|451634999|FG001|First Intervention|Adverse Event|0|||
125547448|NCT02401867|451635007|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
125547449|NCT02401867|451635007|FG000|Analysis|Cervical assay could not be conducted|9|||
125547450|NCT02795429|451635008|FG000|Overall Study|Adverse Event|1|||
125547451|NCT02795429|451635009|FG001|Overall Study|Adverse Event|2|||
125547452|NCT02795429|451635010|FG002|Overall Study|Adverse Event|1|||
125547453|NCT02795429|451635011|FG003|Overall Study|Adverse Event|2|||
125547454|NCT02795429|451635012|FG004|Overall Study|Adverse Event|1|||
125547455|NCT02795429|451635008|FG000|Overall Study|Death|1|||
125547456|NCT02795429|451635009|FG001|Overall Study|Death|0|||
125547457|NCT02795429|451635010|FG002|Overall Study|Death|1|||
125547458|NCT02795429|451635011|FG003|Overall Study|Death|2|||
125547459|NCT02795429|451635012|FG004|Overall Study|Death|1|||
125547460|NCT02795429|451635008|FG000|Overall Study|Physician Decision|0|||
125547461|NCT02795429|451635009|FG001|Overall Study|Physician Decision|0|||
125547462|NCT02795429|451635010|FG002|Overall Study|Physician Decision|2|||
125547463|NCT02795429|451635011|FG003|Overall Study|Physician Decision|1|||
125547464|NCT02795429|451635012|FG004|Overall Study|Physician Decision|5|||
125547465|NCT02795429|451635008|FG000|Overall Study|Progressive disease|3|||
125547466|NCT02795429|451635009|FG001|Overall Study|Progressive disease|7|||
125547467|NCT02795429|451635010|FG002|Overall Study|Progressive disease|6|||
125547468|NCT02795429|451635011|FG003|Overall Study|Progressive disease|26|||
125547469|NCT02795429|451635012|FG004|Overall Study|Progressive disease|20|||
125547470|NCT02795429|451635008|FG000|Overall Study|Subject/guardian decision|1|||
125547471|NCT02795429|451635009|FG001|Overall Study|Subject/guardian decision|1|||
125547472|NCT02795429|451635010|FG002|Overall Study|Subject/guardian decision|1|||
125547473|NCT02795429|451635011|FG003|Overall Study|Subject/guardian decision|1|||
125681445|NCT00302952|452123817|FG001|Overall Study|Withdrawal by Subject|3|||
125681446|NCT00302952|452123816|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
125681447|NCT00302952|452123817|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
125681448|NCT02373098|452123821|FG000|Overall Study|Lost to Follow-up|1|||
125681449|NCT02373098|452123822|FG001|Overall Study|Lost to Follow-up|0|||
125681450|NCT02373098|452123821|FG000|Overall Study|Protocol Violation|3|||
125681451|NCT02373098|452123822|FG001|Overall Study|Protocol Violation|0|||
125681452|NCT02373098|452123821|FG000|Overall Study|Withdrawal by Subject|5|||
125681453|NCT02373098|452123822|FG001|Overall Study|Withdrawal by Subject|0|||
125681454|NCT02373098|452123821|FG000|Overall Study|Adverse Event|3|||
125681455|NCT02373098|452123822|FG001|Overall Study|Adverse Event|0|||
125681456|NCT02008565|452123823|FG000|Overall Study|Protocol Violation|1|||
125681457|NCT02008565|452123824|FG001|Overall Study|Protocol Violation|1|||
125681458|NCT02008565|452123825|FG002|Overall Study|Protocol Violation|2|||
125681459|NCT02008565|452123826|FG003|Overall Study|Protocol Violation|0|||
125681460|NCT02193178|452123827|FG000|Overall Study|Lost to Follow-up|1|||
125681461|NCT02193178|452123827|FG000|Overall Study|Dry eyes|1|||
125681462|NCT03435081|452123828|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
125681463|NCT03435081|452123829|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
125681464|NCT03435081|452123830|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
125681465|NCT03435081|452123828|FG000|Week 0 to Week 16|Adverse Event|2|||
125681466|NCT03435081|452123829|FG001|Week 0 to Week 16|Adverse Event|2|||
125681467|NCT03435081|452123830|FG002|Week 0 to Week 16|Adverse Event|2|||
125681468|NCT03435081|452123828|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
125681469|NCT03435081|452123829|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
125681470|NCT03435081|452123830|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
125681471|NCT03435081|452123828|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
125681472|NCT03435081|452123829|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
125681473|NCT03435081|452123830|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
125681474|NCT03435081|452123828|FG000|Week 0 to Week 16|Pregnancy|1|||
125681475|NCT03435081|452123829|FG001|Week 0 to Week 16|Pregnancy|0|||
125681476|NCT03435081|452123830|FG002|Week 0 to Week 16|Pregnancy|0|||
125681477|NCT03435081|452123828|FG000|Week 0 to Week 16|Non-compliance|1|||
125681478|NCT03435081|452123829|FG001|Week 0 to Week 16|Non-compliance|0|||
125681479|NCT03435081|452123830|FG002|Week 0 to Week 16|Non-compliance|2|||
125681480|NCT03435081|452123828|FG000|Week 0 to Week 16|Inadequate Response|0|||
125681481|NCT03435081|452123829|FG001|Week 0 to Week 16|Inadequate Response|1|||
125681482|NCT03435081|452123830|FG002|Week 0 to Week 16|Inadequate Response|0|||
125681483|NCT03435081|452123828|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
125681484|NCT03435081|452123829|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
125681485|NCT03435081|452123830|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
125681486|NCT03435081|452123828|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
125681487|NCT03435081|452123829|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
125681488|NCT03435081|452123830|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
125681489|NCT03435081|452123828|FG000|Week 16 to Week 104|Adverse Event|1|||
125681490|NCT03435081|452123829|FG001|Week 16 to Week 104|Adverse Event|0|||
125681491|NCT03435081|452123830|FG002|Week 16 to Week 104|Adverse Event|2|||
125681492|NCT03435081|452123828|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
125681493|NCT03435081|452123829|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
125547474|NCT02795429|451635012|FG004|Overall Study|Subject/guardian decision|3|||
125547475|NCT01640054|451635015|FG000|Overall Study|Study-specific disc criteria|1|||
125547476|NCT01640054|451635015|FG000|Overall Study|Lack of Efficacy|3|||
125547477|NCT01640054|451635015|FG000|Overall Study|Adverse Event|2|||
125346185|NCT02536404|450902028|FG000|Overall Study|Adverse Event|5|||
125346186|NCT02536404|450902029|FG001|Overall Study|Adverse Event|0|||
125346187|NCT02536404|450902028|FG000|Overall Study|Withdrawal by Subject|4|||
125346188|NCT02536404|450902029|FG001|Overall Study|Withdrawal by Subject|1|||
125346189|NCT02536404|450902028|FG000|Overall Study|Physician Decision|10|||
125346190|NCT02536404|450902029|FG001|Overall Study|Physician Decision|0|||
125346191|NCT02536404|450902028|FG000|Overall Study|Sponsor decision|1|||
125346192|NCT02536404|450902029|FG001|Overall Study|Sponsor decision|0|||
125346193|NCT01238588|450902036|FG000|Overall Study|Withdrawal by Subject|1|||
125346194|NCT01238588|450902036|FG000|Overall Study|Physician Decision|2|||
125346195|NCT01903252|450902039|FG000|Double-Blind Induction|Adverse Event|20|||
125346196|NCT01903252|450902040|FG001|Double-Blind Induction|Adverse Event|18|||
125346197|NCT01903252|450902041|FG002|Double-Blind Induction|Adverse Event|0|||
125346198|NCT01903252|450902042|FG003|Double-Blind Induction|Adverse Event|0|||
125346199|NCT01903252|450902043|FG004|Double-Blind Induction|Adverse Event|0|||
125346200|NCT01903252|450902044|FG005|Double-Blind Induction|Adverse Event|0|||
125346201|NCT01903252|450902039|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
125346202|NCT01903252|450902040|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
125346203|NCT01903252|450902041|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
125547478|NCT02080221|451635016|FG000|Overall Study|Withdrawal by Subject|1|||
125547479|NCT02080221|451635016|FG000|Overall Study|Clinical Progression of Disease|1|||
125547480|NCT01386788|451635019|FG000|Overall Study|Lost to Follow-up|2|||
125547481|NCT02808143|451635022|FG000|Maintenance Phase|Disease recurrence|1|||
125346204|NCT01903252|450902042|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
125547482|NCT02808143|451635023|FG001|Maintenance Phase|Disease recurrence|3|||
125547483|NCT02808143|451635022|FG000|Maintenance Phase|Disease progression|1|||
125547484|NCT02808143|451635023|FG001|Maintenance Phase|Disease progression|2|||
125547485|NCT02808143|451635022|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
125346205|NCT01903252|450902043|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
125346206|NCT01903252|450902044|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
125346207|NCT01903252|450902039|FG000|Double-Blind Induction|Physician Decision|2|||
125346208|NCT01903252|450902040|FG001|Double-Blind Induction|Physician Decision|3|||
125346209|NCT01903252|450902041|FG002|Double-Blind Induction|Physician Decision|0|||
125346210|NCT01903252|450902042|FG003|Double-Blind Induction|Physician Decision|0|||
125346211|NCT01903252|450902043|FG004|Double-Blind Induction|Physician Decision|0|||
125346212|NCT01903252|450902044|FG005|Double-Blind Induction|Physician Decision|0|||
125346213|NCT01903252|450902039|FG000|Double-Blind Induction|non-compliance,|7|||
125346214|NCT01903252|450902040|FG001|Double-Blind Induction|non-compliance,|7|||
125346215|NCT01903252|450902041|FG002|Double-Blind Induction|non-compliance,|0|||
125346216|NCT01903252|450902042|FG003|Double-Blind Induction|non-compliance,|0|||
125346217|NCT01903252|450902043|FG004|Double-Blind Induction|non-compliance,|0|||
125346218|NCT01903252|450902044|FG005|Double-Blind Induction|non-compliance,|0|||
125346219|NCT01903252|450902039|FG000|Extended Induction, Open-Label|Adverse Event|0|||
125346220|NCT01903252|450902040|FG001|Extended Induction, Open-Label|Adverse Event|0|||
125346221|NCT01903252|450902041|FG002|Extended Induction, Open-Label|Adverse Event|17|||
125346222|NCT01903252|450902042|FG003|Extended Induction, Open-Label|Adverse Event|0|||
125346223|NCT01903252|450902043|FG004|Extended Induction, Open-Label|Adverse Event|0|||
125346224|NCT01903252|450902044|FG005|Extended Induction, Open-Label|Adverse Event|0|||
125346225|NCT01903252|450902039|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
125346226|NCT01903252|450902040|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
125346227|NCT01903252|450902041|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
125346228|NCT01903252|450902042|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
125346229|NCT01903252|450902043|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
125346230|NCT01903252|450902044|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
125346231|NCT01903252|450902039|FG000|Extended Induction, Open-Label|Physician Decision|0|||
125346232|NCT01903252|450902040|FG001|Extended Induction, Open-Label|Physician Decision|0|||
125346233|NCT01903252|450902041|FG002|Extended Induction, Open-Label|Physician Decision|1|||
125346234|NCT01903252|450902042|FG003|Extended Induction, Open-Label|Physician Decision|0|||
125346235|NCT01903252|450902043|FG004|Extended Induction, Open-Label|Physician Decision|0|||
125346236|NCT01903252|450902044|FG005|Extended Induction, Open-Label|Physician Decision|0|||
125346237|NCT01903252|450902039|FG000|Maintenance, Open-Label|Adverse Event|0|||
125346238|NCT01903252|450902040|FG001|Maintenance, Open-Label|Adverse Event|0|||
125346239|NCT01903252|450902041|FG002|Maintenance, Open-Label|Adverse Event|0|||
125346240|NCT01903252|450902042|FG003|Maintenance, Open-Label|Adverse Event|3|||
125346241|NCT01903252|450902043|FG004|Maintenance, Open-Label|Adverse Event|9|||
125346242|NCT01903252|450902044|FG005|Maintenance, Open-Label|Adverse Event|14|||
125346243|NCT01903252|450902039|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
125346244|NCT01903252|450902040|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
125346245|NCT01903252|450902041|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
125346246|NCT01903252|450902042|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
125346247|NCT01903252|450902043|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
125346248|NCT01903252|450902044|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
125547486|NCT02808143|451635023|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
125547487|NCT02808143|451635022|FG000|Survival Follow-Up|Disease recurrence|0|||
125547488|NCT02808143|451635023|FG001|Survival Follow-Up|Disease recurrence|2|||
125681494|NCT03435081|452123830|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
125681495|NCT03435081|452123828|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
125681496|NCT03435081|452123829|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
125681497|NCT03435081|452123830|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
125681498|NCT03435081|452123828|FG000|Week 16 to Week 104|Non--Compliance|0|||
125681499|NCT03435081|452123829|FG001|Week 16 to Week 104|Non--Compliance|0|||
125681500|NCT03435081|452123830|FG002|Week 16 to Week 104|Non--Compliance|1|||
125681501|NCT00420238|452123831|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
125681502|NCT00420238|452123832|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
125681503|NCT00420238|452123831|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
125681504|NCT00420238|452123832|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
125681505|NCT00420238|452123831|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
125681506|NCT00420238|452123832|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
125681507|NCT00420238|452123831|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
125681508|NCT00420238|452123832|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
125681509|NCT00420238|452123831|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
125681510|NCT00420238|452123832|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
125681511|NCT00420238|452123831|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
125681512|NCT00420238|452123832|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
125681513|NCT05214560|452123833|FG000|Overall Study|Screening Failure|1|||
125681514|NCT05214560|452123833|FG000|Overall Study|Physician Decision|4|||
125681515|NCT05214560|452123833|FG000|Overall Study|Withdrawal by Subject|1|||
125681516|NCT05214560|452123833|FG000|Overall Study|Lost to Follow-up|2|||
125681517|NCT05214560|452123833|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
125681518|NCT05214560|452123833|FG000|Overall Study|Study physician not available for the anesthesia|3|||
125681519|NCT05214560|452123833|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
125681520|NCT05214560|452123833|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
125346249|NCT01903252|450902039|FG000|Maintenance, Open-Label|Other|0|||
125346250|NCT01903252|450902040|FG001|Maintenance, Open-Label|Other|0|||
125346251|NCT01903252|450902041|FG002|Maintenance, Open-Label|Other|0|||
125346252|NCT01903252|450902042|FG003|Maintenance, Open-Label|Other|2|||
125547489|NCT02808143|451635022|FG000|Survival Follow-Up|Adverse Event|0|||
125547490|NCT02808143|451635023|FG001|Survival Follow-Up|Adverse Event|1|||
125547491|NCT02808143|451635022|FG000|Survival Follow-Up|Death|1|||
125547492|NCT02808143|451635023|FG001|Survival Follow-Up|Death|0|||
125547493|NCT04964388|451635024|FG000|Overall Study|Lost to Follow-up|3|||
125547494|NCT04964388|451635025|FG001|Overall Study|Lost to Follow-up|2|||
125547495|NCT00448279|451635027|FG000|Overall Study|Lost to Follow-up|2|||
125547496|NCT00448279|451635028|FG001|Overall Study|Lost to Follow-up|2|||
125547497|NCT00448279|451635027|FG000|Overall Study|Adverse Event|1|||
125547498|NCT00448279|451635028|FG001|Overall Study|Adverse Event|1|||
125547499|NCT00448279|451635027|FG000|Overall Study|Disease progression|16|||
125547500|NCT00448279|451635028|FG001|Overall Study|Disease progression|18|||
125547501|NCT00448279|451635027|FG000|Overall Study|Withdrawal by Subject|4|||
125547502|NCT00448279|451635028|FG001|Overall Study|Withdrawal by Subject|3|||
125547503|NCT00448279|451635027|FG000|Overall Study|Other|6|||
125547504|NCT00448279|451635028|FG001|Overall Study|Other|4|||
125547505|NCT00448279|451635027|FG000|Overall Study|Protocol Violation|0|||
125547506|NCT00448279|451635028|FG001|Overall Study|Protocol Violation|1|||
125547507|NCT03907410|451635029|FG000|Overall Study|Lost to Follow-up|4|||
125547508|NCT03907410|451635030|FG001|Overall Study|Lost to Follow-up|1|||
125547509|NCT03907410|451635031|FG002|Overall Study|Lost to Follow-up|1|||
125547510|NCT03907410|451635029|FG000|Overall Study|Lost to follow-up and research burden|0|||
125547511|NCT03907410|451635030|FG001|Overall Study|Lost to follow-up and research burden|0|||
125547512|NCT03907410|451635031|FG002|Overall Study|Lost to follow-up and research burden|1|||
125547513|NCT03718533|451635032|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
125681521|NCT05214560|452123833|FG000|Overall Study|Surgery not performed|3|||
125681522|NCT03639311|452123834|FG000|Maintenance Phase|Lost to Follow-up|1|||
125681523|NCT03639311|452123835|FG001|Maintenance Phase|Lost to Follow-up|0|||
125681524|NCT03639311|452123836|FG002|Maintenance Phase|Lost to Follow-up|0|||
125681525|NCT03639311|452123834|FG000|Maintenance Phase|Adverse Event|1|||
125681526|NCT03639311|452123835|FG001|Maintenance Phase|Adverse Event|0|||
125681527|NCT03639311|452123836|FG002|Maintenance Phase|Adverse Event|0|||
125681528|NCT03639311|452123834|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
125681529|NCT03639311|452123835|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
125681530|NCT03639311|452123836|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
125681531|NCT03639311|452123834|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
125681532|NCT03639311|452123835|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
125681533|NCT03639311|452123836|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
125681534|NCT03639311|452123834|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
125681535|NCT03639311|452123835|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
125681536|NCT03639311|452123836|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
125681537|NCT03639311|452123834|FG000|Maintenance Phase|Lack of Efficacy|1|||
125681538|NCT03639311|452123835|FG001|Maintenance Phase|Lack of Efficacy|0|||
125681539|NCT03639311|452123836|FG002|Maintenance Phase|Lack of Efficacy|0|||
125681540|NCT03018249|452123839|FG000|Overall Study|Withdrawal by Subject|2|||
125681541|NCT03018249|452123840|FG001|Overall Study|Withdrawal by Subject|2|||
125681542|NCT04320849|452123841|FG000|Overall Study|Withdrawal by Subject|4|||
125681543|NCT04320849|452123841|FG000|Overall Study|Imaging data unavailable|2|||
125681544|NCT04320849|452123841|FG000|Overall Study|Incomplete imaging|2|||
125681545|NCT00304083|452123849|FG000|Overall Study|Withdrawal by Subject|4|||
125681546|NCT00304083|452123850|FG001|Overall Study|Withdrawal by Subject|2|||
125681547|NCT00304083|452123849|FG000|Overall Study|Physician Decision|8|||
125681548|NCT00304083|452123850|FG001|Overall Study|Physician Decision|3|||
125681549|NCT00304083|452123849|FG000|Overall Study|Disease Progression|5|||
125681550|NCT00304083|452123850|FG001|Overall Study|Disease Progression|1|||
125681551|NCT00304083|452123849|FG000|Overall Study|Other|5|||
125681552|NCT00304083|452123850|FG001|Overall Study|Other|2|||
125681553|NCT03966365|452123853|FG000|Overall Study|Protocol Violation|1|||
125681554|NCT03966365|452123854|FG001|Overall Study|Protocol Violation|0|||
125681555|NCT01044732|452123855|FG000|Overall Study|Lost to Follow-up|2|||
125681556|NCT01044732|452123856|FG001|Overall Study|Lost to Follow-up|1|||
125681557|NCT01044732|452123855|FG000|Overall Study|Physician Decision|5|||
125681558|NCT01044732|452123856|FG001|Overall Study|Physician Decision|3|||
125681559|NCT01044732|452123855|FG000|Overall Study|Protocol Violation|11|||
125681560|NCT01044732|452123856|FG001|Overall Study|Protocol Violation|12|||
125547514|NCT03718533|451635032|FG000|Overall Study|Protocol deviation|1|||
125547515|NCT03718533|451635032|FG000|Overall Study|Disease progression|1|||
125547516|NCT03718533|451635032|FG000|Overall Study|Relapse|1|||
125547517|NCT03718533|451635032|FG000|Overall Study|Physician Decision|2|||
125681561|NCT01044732|452123855|FG000|Overall Study|Withdrawal by Subject|0|||
125681562|NCT01044732|452123856|FG001|Overall Study|Withdrawal by Subject|1|||
125681563|NCT01044732|452123855|FG000|Overall Study|Inadequate bowel preparation|11|||
125681564|NCT01044732|452123856|FG001|Overall Study|Inadequate bowel preparation|17|||
125547518|NCT03718533|451635032|FG000|Overall Study|Physician Decision and Adverse Event|1|||
125547519|NCT01295034|451635033|FG000|Overall Study|Lost to Follow-up|5|||
125547520|NCT01295034|451635034|FG001|Overall Study|Lost to Follow-up|5|||
125547521|NCT01174160|451635037|FG000|Overall Study|Adverse Event|1|||
125547522|NCT01174160|451635038|FG001|Overall Study|Adverse Event|0|||
125547523|NCT01174160|451635037|FG000|Overall Study|Lost to Follow-up|1|||
125547524|NCT01174160|451635038|FG001|Overall Study|Lost to Follow-up|0|||
125547525|NCT01174160|451635037|FG000|Overall Study|Physician Decision|1|||
125547526|NCT01174160|451635038|FG001|Overall Study|Physician Decision|0|||
125547527|NCT01174160|451635037|FG000|Overall Study|Protocol Violation|4|||
125547528|NCT01174160|451635038|FG001|Overall Study|Protocol Violation|6|||
125547529|NCT01174160|451635037|FG000|Overall Study|Withdrawal by Subject|1|||
125547530|NCT01174160|451635038|FG001|Overall Study|Withdrawal by Subject|0|||
125547531|NCT04218084|451635039|FG000|Overall Study|Adverse Event|7|||
125547532|NCT04218084|451635040|FG001|Overall Study|Adverse Event|2|||
125547533|NCT04218084|451635039|FG000|Overall Study|Withdrawal of Consent|4|||
125547534|NCT04218084|451635040|FG001|Overall Study|Withdrawal of Consent|5|||
125547535|NCT04218084|451635039|FG000|Overall Study|Physician Decision|1|||
125547536|NCT04218084|451635040|FG001|Overall Study|Physician Decision|1|||
125547537|NCT04218084|451635039|FG000|Overall Study|Lost to Follow-up|1|||
125547538|NCT04218084|451635040|FG001|Overall Study|Lost to Follow-up|1|||
125547539|NCT04218084|451635039|FG000|Overall Study|Non-compliance with study drug|1|||
125346253|NCT01903252|450902043|FG004|Maintenance, Open-Label|Other|6|||
125346254|NCT01903252|450902044|FG005|Maintenance, Open-Label|Other|2|||
125346255|NCT02437110|450902045|FG000|Screening|Lost to Follow-up|3|||
125346256|NCT02437110|450902045|FG000|Screening|Physician Decision|1|||
125346257|NCT02437110|450902045|FG000|ART|Adverse Event|3|||
125346258|NCT02437110|450902045|FG000|ART|Protocol Violation|3|||
125346259|NCT02437110|450902045|FG000|ART|Withdrawal by Subject|4|||
125346260|NCT02437110|450902045|FG000|ART|Lost to follow-up prior to start of intervention|1|||
125346261|NCT02437110|450902045|FG000|ART|Physician decision prior to start of intervention|2|||
125346262|NCT02437110|450902045|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
125346263|NCT02437110|450902045|FG000|Post-ART|Lost to Follow-up|3|||
125346264|NCT02437110|450902045|FG000|Post-ART|Protocol Violation|4|||
125547540|NCT04218084|451635040|FG001|Overall Study|Non-compliance with study drug|1|||
125547541|NCT04218084|451635039|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
125547542|NCT04218084|451635040|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
125547543|NCT04218084|451635039|FG000|Overall Study|Other|0|||
125547544|NCT04218084|451635040|FG001|Overall Study|Other|1|||
125547545|NCT04218084|451635039|FG000|Overall Study|Ongoing at data cut-off date|62|||
125547546|NCT04218084|451635040|FG001|Overall Study|Ongoing at data cut-off date|58|||
125547547|NCT05580588|451635041|FG000|Overall Study|Lack of Efficacy|12|||
125547548|NCT00211185|451635044|FG000|Overall Study|Death|2|||
125346265|NCT02437110|450902045|FG000|Post-ART|Withdrawal by Subject|3|||
125346266|NCT03836001|450902048|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
125346267|NCT03836001|450902049|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
125346268|NCT03836001|450902050|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
125346269|NCT03836001|450902048|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
125346270|NCT03836001|450902049|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
125346271|NCT03836001|450902050|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
125346272|NCT03836001|450902048|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
125346273|NCT03836001|450902049|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
125346274|NCT03836001|450902050|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
125346275|NCT03836001|450902048|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
125346276|NCT03836001|450902049|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
125346277|NCT03836001|450902050|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
125346278|NCT01381562|450902051|FG000|Overall Study|Adverse Event|0|||
125346279|NCT01381562|450902052|FG001|Overall Study|Adverse Event|1|||
125346280|NCT01381562|450902053|FG002|Overall Study|Adverse Event|0|||
125346281|NCT01642732|450902058|FG000|Overall Study|Withdrawal by Subject|1|||
125547549|NCT00211185|451635044|FG000|Overall Study|Disease progression|7|||
125547550|NCT00211185|451635044|FG000|Overall Study|Withdrawal by Subject|6|||
125547551|NCT00211185|451635044|FG000|Overall Study|Physician Decision|5|||
125547552|NCT00712673|451635045|FG000|Overall Study|Adverse Event|3|||
125346282|NCT00899353|450902059|FG000|Overall Study|Adverse Event|2|||
125346283|NCT00899353|450902059|FG000|Overall Study|Lost to Follow-up|1|||
125346284|NCT00899353|450902059|FG000|Overall Study|Withdrawal by Subject|2|||
125346285|NCT02730793|450902067|FG000|Overall Study|Physician Decision|0|||
125346286|NCT02730793|450902068|FG001|Overall Study|Physician Decision|1|||
125346287|NCT02730793|450902067|FG000|Overall Study|Withdrawal by Subject|0|||
125346288|NCT02730793|450902068|FG001|Overall Study|Withdrawal by Subject|1|||
125346289|NCT01284491|450902069|FG000|Overall Study|Study termination|13|||
125547553|NCT00712673|451635046|FG001|Overall Study|Adverse Event|3|||
125547554|NCT00712673|451635047|FG002|Overall Study|Adverse Event|21|||
125547555|NCT00712673|451635048|FG003|Overall Study|Adverse Event|26|||
125547556|NCT00712673|451635045|FG000|Overall Study|Lack of Efficacy|2|||
125547557|NCT00712673|451635046|FG001|Overall Study|Lack of Efficacy|8|||
125547558|NCT00712673|451635047|FG002|Overall Study|Lack of Efficacy|8|||
125547559|NCT00712673|451635048|FG003|Overall Study|Lack of Efficacy|6|||
125346290|NCT02694757|450902072|FG000|Overall Study|Lack of Efficacy|3|||
125346291|NCT02650921|450902073|FG000|Overall Study|Withdrawal by Subject|4|||
125346292|NCT02650921|450902073|FG000|Overall Study|Lost to Follow-up|2|||
125346293|NCT02650921|450902073|FG000|Overall Study|Adverse Event|1|||
125346294|NCT02650921|450902073|FG000|Overall Study|Due to Medical Condition|1|||
125346295|NCT00783302|450902074|FG000|Overall Study|Lost to Follow-up|17|||
125346296|NCT00783302|450902074|FG000|Overall Study|Technical Problems|11|||
125346297|NCT00783302|450902074|FG000|Overall Study|Protocol Violation|3|||
125346298|NCT00783302|450902074|FG000|Overall Study|Physician Decision|1|||
125346299|NCT00783302|450902074|FG000|Overall Study|Withdrawal by Subject|3|||
125346300|NCT04604132|450902075|FG000|Overall Study|Adverse Event|2|||
125346301|NCT04604132|450902076|FG001|Overall Study|Adverse Event|0|||
125346302|NCT04604132|450902077|FG002|Overall Study|Adverse Event|0|||
125346303|NCT04604132|450902078|FG003|Overall Study|Adverse Event|1|||
125346304|NCT04604132|450902079|FG004|Overall Study|Adverse Event|2|||
125346305|NCT04604132|450902075|FG000|Overall Study|Study terminated by sponsor|0|||
125346306|NCT04604132|450902076|FG001|Overall Study|Study terminated by sponsor|0|||
125346307|NCT04604132|450902077|FG002|Overall Study|Study terminated by sponsor|0|||
125346308|NCT04604132|450902078|FG003|Overall Study|Study terminated by sponsor|0|||
125346309|NCT04604132|450902079|FG004|Overall Study|Study terminated by sponsor|1|||
125346310|NCT04604132|450902075|FG000|Overall Study|Progressive disease: Clinical progression|0|||
125346311|NCT04604132|450902076|FG001|Overall Study|Progressive disease: Clinical progression|0|||
125346312|NCT04604132|450902077|FG002|Overall Study|Progressive disease: Clinical progression|1|||
125346313|NCT04604132|450902078|FG003|Overall Study|Progressive disease: Clinical progression|0|||
125346314|NCT04604132|450902079|FG004|Overall Study|Progressive disease: Clinical progression|0|||
125346315|NCT04604132|450902075|FG000|Overall Study|Progressive disease: Radiological progression|8|||
125346316|NCT04604132|450902076|FG001|Overall Study|Progressive disease: Radiological progression|7|||
125346317|NCT04604132|450902077|FG002|Overall Study|Progressive disease: Radiological progression|10|||
125346318|NCT04604132|450902078|FG003|Overall Study|Progressive disease: Radiological progression|4|||
125346319|NCT04604132|450902079|FG004|Overall Study|Progressive disease: Radiological progression|3|||
125346320|NCT04604132|450902075|FG000|Overall Study|Death|3|||
125346321|NCT04604132|450902076|FG001|Overall Study|Death|1|||
125346322|NCT04604132|450902077|FG002|Overall Study|Death|2|||
125346323|NCT04604132|450902078|FG003|Overall Study|Death|1|||
125346324|NCT04604132|450902079|FG004|Overall Study|Death|0|||
125346325|NCT00952380|450902080|FG000|Overall Study|Other|0|||
125547560|NCT00712673|451635045|FG000|Overall Study|Poor Compliance to Protocol|3|||
125547561|NCT00712673|451635046|FG001|Overall Study|Poor Compliance to Protocol|3|||
125547562|NCT00712673|451635047|FG002|Overall Study|Poor Compliance to Protocol|4|||
125547563|NCT00712673|451635048|FG003|Overall Study|Poor Compliance to Protocol|16|||
125547564|NCT00712673|451635045|FG000|Overall Study|Lost to Follow-up|1|||
125547565|NCT00712673|451635046|FG001|Overall Study|Lost to Follow-up|0|||
125547566|NCT00712673|451635047|FG002|Overall Study|Lost to Follow-up|2|||
125547567|NCT00712673|451635048|FG003|Overall Study|Lost to Follow-up|0|||
125547568|NCT00712673|451635045|FG000|Overall Study|Withdrawal by Subject|6|||
125547569|NCT00712673|451635046|FG001|Overall Study|Withdrawal by Subject|7|||
125547570|NCT00712673|451635047|FG002|Overall Study|Withdrawal by Subject|15|||
125547571|NCT00712673|451635048|FG003|Overall Study|Withdrawal by Subject|20|||
125547572|NCT00712673|451635045|FG000|Overall Study|Familial and Personal Reasons|5|||
125547573|NCT00712673|451635046|FG001|Overall Study|Familial and Personal Reasons|0|||
125547574|NCT00712673|451635047|FG002|Overall Study|Familial and Personal Reasons|5|||
125547575|NCT00712673|451635048|FG003|Overall Study|Familial and Personal Reasons|2|||
125547576|NCT00712673|451635045|FG000|Overall Study|Investigator's Decision|1|||
125547577|NCT00712673|451635046|FG001|Overall Study|Investigator's Decision|0|||
125547578|NCT00712673|451635047|FG002|Overall Study|Investigator's Decision|0|||
125547579|NCT00712673|451635048|FG003|Overall Study|Investigator's Decision|0|||
125547580|NCT00712673|451635045|FG000|Overall Study|Protocol Violation|0|||
125547581|NCT00712673|451635046|FG001|Overall Study|Protocol Violation|0|||
125547582|NCT00712673|451635047|FG002|Overall Study|Protocol Violation|2|||
125547583|NCT00712673|451635048|FG003|Overall Study|Protocol Violation|0|||
125547584|NCT03658668|451635049|FG000|Overall Study|Time Commitment|1|||
125547585|NCT03658668|451635050|FG001|Overall Study|Time Commitment|1|||
125547586|NCT03305731|451635051|FG000|Overall Study|Protocol Violation|1|||
125547587|NCT01952054|451635052|FG000|Overall Study|Physician Decision|1|||
125547588|NCT05208866|451635053|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
125547589|NCT02070588|451635054|FG000|Overall Study|Withdrawal by Subject|29|||
125547590|NCT02070588|451635055|FG001|Overall Study|Withdrawal by Subject|1|||
125547591|NCT02070588|451635056|FG002|Overall Study|Withdrawal by Subject|0|||
125547592|NCT02070588|451635054|FG000|Overall Study|Writhdrawal due to early termination|9|||
125547593|NCT02070588|451635055|FG001|Overall Study|Writhdrawal due to early termination|0|||
125547594|NCT02070588|451635056|FG002|Overall Study|Writhdrawal due to early termination|0|||
125547595|NCT02070588|451635054|FG000|Overall Study|Adverse Event|1|||
125547596|NCT02070588|451635055|FG001|Overall Study|Adverse Event|0|||
125547597|NCT02070588|451635056|FG002|Overall Study|Adverse Event|0|||
125547598|NCT01718353|451635060|FG000|Overall Study|Lost to Follow-up|0|||
125547599|NCT01718353|451635061|FG001|Overall Study|Lost to Follow-up|1|||
125547600|NCT01718353|451635060|FG000|Overall Study|Principal Investigator's Decision|10|||
125547601|NCT01718353|451635061|FG001|Overall Study|Principal Investigator's Decision|4|||
125547602|NCT01718353|451635060|FG000|Overall Study|Randomized but not treated|2|||
125547603|NCT01718353|451635061|FG001|Overall Study|Randomized but not treated|0|||
125547604|NCT01078675|451635062|FG000|Overall Study|Withdrawal by Subject|7|||
125547605|NCT01078675|451635063|FG001|Overall Study|Withdrawal by Subject|3|||
125547606|NCT01078675|451635062|FG000|Overall Study|Protocol Violation|56|||
125547607|NCT01078675|451635063|FG001|Overall Study|Protocol Violation|0|||
125547608|NCT01078675|451635062|FG000|Overall Study|Provided in CRF for specific reasons|2|||
125547609|NCT01078675|451635063|FG001|Overall Study|Provided in CRF for specific reasons|3|||
125547610|NCT01078675|451635062|FG000|Overall Study|Adverse Event|3|||
125547611|NCT01078675|451635063|FG001|Overall Study|Adverse Event|0|||
125547612|NCT02745392|451635069|FG000|Overall Study|Lost to Follow-up|0|||
125547613|NCT02745392|451635070|FG001|Overall Study|Lost to Follow-up|1|||
125547614|NCT02745392|451635071|FG002|Overall Study|Lost to Follow-up|0|||
125547615|NCT02745392|451635072|FG003|Overall Study|Lost to Follow-up|0|||
125547616|NCT00899548|451635075|FG000|Overall Study|Physician Decision|3|||
125547617|NCT04781387|451635076|FG000|Overall Study|Withdrawal by Subject|1|||
125547618|NCT04781387|451635077|FG001|Overall Study|Withdrawal by Subject|0|||
125547619|NCT04781387|451635078|FG002|Overall Study|Withdrawal by Subject|1|||
125547620|NCT04781387|451635076|FG000|Overall Study|Lost to Follow-up|1|||
125346326|NCT00952380|450902081|FG001|Overall Study|Other|0|||
125346327|NCT00952380|450902082|FG002|Overall Study|Other|0|||
125346328|NCT00952380|450902083|FG003|Overall Study|Other|0|||
125547621|NCT04781387|451635077|FG001|Overall Study|Lost to Follow-up|0|||
125547622|NCT04781387|451635078|FG002|Overall Study|Lost to Follow-up|0|||
125547623|NCT00710021|451635079|FG000|Overall Study|Lost to Follow-up|1|||
125547624|NCT00710021|451635080|FG001|Overall Study|Lost to Follow-up|0|||
125547625|NCT00710021|451635081|FG002|Overall Study|Lost to Follow-up|0|||
125547626|NCT00710021|451635079|FG000|Overall Study|Subject's Decision|0|||
125547627|NCT00710021|451635080|FG001|Overall Study|Subject's Decision|1|||
125547628|NCT00710021|451635081|FG002|Overall Study|Subject's Decision|0|||
125547629|NCT00710021|451635079|FG000|Overall Study|Subject misrandomized|0|||
125547630|NCT00710021|451635080|FG001|Overall Study|Subject misrandomized|1|||
125547631|NCT00710021|451635081|FG002|Overall Study|Subject misrandomized|1|||
125547632|NCT00710021|451635079|FG000|Overall Study|Physician Decision|0|||
125547633|NCT00710021|451635080|FG001|Overall Study|Physician Decision|1|||
125547634|NCT00710021|451635081|FG002|Overall Study|Physician Decision|0|||
125547635|NCT01575028|451635082|FG000|Overall Study|Physician Decision|0|||
125547636|NCT01575028|451635083|FG001|Overall Study|Physician Decision|1|||
125547637|NCT00529958|451635088|FG000|2-Year Follow-up|Lost to Follow-up|1|||
125547638|NCT00529958|451635089|FG001|2-Year Follow-up|Lost to Follow-up|2|||
125547639|NCT00529958|451635090|FG002|2-Year Follow-up|Lost to Follow-up|2|||
125547640|NCT00529958|451635088|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
125547641|NCT00529958|451635089|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
125547642|NCT00529958|451635090|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
125547643|NCT00529958|451635088|FG000|5-Year Follow-up|Lost to Follow-up|2|||
125547644|NCT00529958|451635089|FG001|5-Year Follow-up|Lost to Follow-up|3|||
125547645|NCT00529958|451635090|FG002|5-Year Follow-up|Lost to Follow-up|1|||
125547646|NCT00529958|451635088|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
125547647|NCT00529958|451635089|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
125547648|NCT00529958|451635090|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
125547649|NCT03534284|451635092|FG000|Overall Study|Death|2|||
125547650|NCT03534284|451635093|FG001|Overall Study|Death|3|||
125547651|NCT03534284|451635094|FG002|Overall Study|Death|3|||
125547652|NCT03534284|451635092|FG000|Overall Study|Withdrawal by Subject|5|||
125547653|NCT03534284|451635093|FG001|Overall Study|Withdrawal by Subject|0|||
125547654|NCT03534284|451635094|FG002|Overall Study|Withdrawal by Subject|0|||
125547655|NCT03316300|451635095|FG000|Overall Study|Withdrawal by Subject|3|||
125547656|NCT03316300|451635096|FG001|Overall Study|Withdrawal by Subject|2|||
125547657|NCT03316300|451635095|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
125547658|NCT03316300|451635096|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
125547659|NCT03316300|451635095|FG000|Overall Study|Adverse Event|1|||
125547660|NCT03316300|451635096|FG001|Overall Study|Adverse Event|0|||
125547661|NCT03316300|451635095|FG000|Overall Study|COVID-19|0|||
125547662|NCT03316300|451635096|FG001|Overall Study|COVID-19|1|||
125547663|NCT04737187|451635098|FG000|Overall Study|Switched to marketed drug|32|||
125547664|NCT04737187|451635099|FG001|Overall Study|Switched to marketed drug|4|||
125547665|NCT04737187|451635098|FG000|Overall Study|Radiological Progressive Disease|145|||
125547666|NCT04737187|451635099|FG001|Overall Study|Radiological Progressive Disease|146|||
125547667|NCT04737187|451635098|FG000|Overall Study|Clinical Progressive Disease|20|||
125547668|NCT04737187|451635099|FG001|Overall Study|Clinical Progressive Disease|20|||
125547669|NCT04737187|451635098|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
125547670|NCT04737187|451635099|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
125547671|NCT04737187|451635098|FG000|Overall Study|Adverse Event|16|||
125547672|NCT04737187|451635099|FG001|Overall Study|Adverse Event|16|||
125547673|NCT04737187|451635098|FG000|Overall Study|Physician Decision|2|||
125547674|NCT04737187|451635099|FG001|Overall Study|Physician Decision|0|||
125547675|NCT04737187|451635098|FG000|Overall Study|Withdrawal by Subject|5|||
125547676|NCT04737187|451635099|FG001|Overall Study|Withdrawal by Subject|8|||
125547677|NCT03756129|451635100|FG000|Overall Study|Adverse Event|1|||
125547678|NCT03756129|451635101|FG001|Overall Study|Adverse Event|1|||
125547679|NCT03756129|451635102|FG002|Overall Study|Adverse Event|0|||
125547680|NCT03756129|451635103|FG003|Overall Study|Adverse Event|2|||
125547681|NCT03756129|451635104|FG004|Overall Study|Adverse Event|0|||
125547682|NCT03756129|451635105|FG005|Overall Study|Adverse Event|0|||
125346329|NCT00952380|450902084|FG004|Overall Study|Other|1|||
125346330|NCT00952380|450902080|FG000|Overall Study|Withdrawal by Subject|0|||
125346331|NCT00952380|450902081|FG001|Overall Study|Withdrawal by Subject|0|||
125547683|NCT03756129|451635100|FG000|Overall Study|Withdrawal by Subject|2|||
125346332|NCT00952380|450902082|FG002|Overall Study|Withdrawal by Subject|1|||
125346333|NCT00952380|450902083|FG003|Overall Study|Withdrawal by Subject|0|||
125346334|NCT00952380|450902084|FG004|Overall Study|Withdrawal by Subject|2|||
125346335|NCT00952380|450902080|FG000|Overall Study|Adverse Event|0|||
125547684|NCT03756129|451635101|FG001|Overall Study|Withdrawal by Subject|1|||
125547685|NCT03756129|451635102|FG002|Overall Study|Withdrawal by Subject|3|||
125547686|NCT03756129|451635103|FG003|Overall Study|Withdrawal by Subject|1|||
125547687|NCT03756129|451635104|FG004|Overall Study|Withdrawal by Subject|1|||
125547688|NCT03756129|451635105|FG005|Overall Study|Withdrawal by Subject|3|||
125346336|NCT00952380|450902081|FG001|Overall Study|Adverse Event|1|||
125547689|NCT03756129|451635100|FG000|Overall Study|Lost to Follow-up|0|||
125547690|NCT03756129|451635101|FG001|Overall Study|Lost to Follow-up|0|||
125547691|NCT03756129|451635102|FG002|Overall Study|Lost to Follow-up|0|||
125547692|NCT03756129|451635103|FG003|Overall Study|Lost to Follow-up|0|||
125547693|NCT03756129|451635104|FG004|Overall Study|Lost to Follow-up|0|||
125547694|NCT03756129|451635105|FG005|Overall Study|Lost to Follow-up|1|||
125547695|NCT03756129|451635100|FG000|Overall Study|Physician Decision|0|||
125547696|NCT03756129|451635101|FG001|Overall Study|Physician Decision|0|||
125547697|NCT03756129|451635102|FG002|Overall Study|Physician Decision|0|||
125547698|NCT03756129|451635103|FG003|Overall Study|Physician Decision|0|||
125547699|NCT03756129|451635104|FG004|Overall Study|Physician Decision|0|||
125547700|NCT03756129|451635105|FG005|Overall Study|Physician Decision|1|||
125547701|NCT01315353|451635106|FG000|Overall Study|Death|2|||
125547702|NCT01315353|451635107|FG001|Overall Study|Death|1|||
125547703|NCT01315353|451635108|FG002|Overall Study|Death|0|||
125547704|NCT01315353|451635106|FG000|Overall Study|Withdrawal by Subject|2|||
125547705|NCT01315353|451635107|FG001|Overall Study|Withdrawal by Subject|6|||
125547706|NCT01315353|451635108|FG002|Overall Study|Withdrawal by Subject|1|||
125547707|NCT01315353|451635106|FG000|Overall Study|Lost to Follow-up|13|||
125547708|NCT01315353|451635107|FG001|Overall Study|Lost to Follow-up|6|||
125547709|NCT01315353|451635108|FG002|Overall Study|Lost to Follow-up|6|||
125547710|NCT01315353|451635106|FG000|Overall Study|Unwilling to adhere to requirements|5|||
125547711|NCT01315353|451635107|FG001|Overall Study|Unwilling to adhere to requirements|5|||
125547712|NCT01315353|451635108|FG002|Overall Study|Unwilling to adhere to requirements|4|||
125547713|NCT01315353|451635106|FG000|Overall Study|Site closing|7|||
125547714|NCT01315353|451635107|FG001|Overall Study|Site closing|4|||
125547715|NCT01315353|451635108|FG002|Overall Study|Site closing|0|||
125547716|NCT01315353|451635106|FG000|Overall Study|Taken off study by site in error|0|||
125547717|NCT01315353|451635107|FG001|Overall Study|Taken off study by site in error|1|||
125547718|NCT01315353|451635108|FG002|Overall Study|Taken off study by site in error|0|||
125547719|NCT01315353|451635106|FG000|Overall Study|Inadvertent randomization/assignment|0|||
125547720|NCT01315353|451635107|FG001|Overall Study|Inadvertent randomization/assignment|0|||
125547721|NCT01315353|451635108|FG002|Overall Study|Inadvertent randomization/assignment|2|||
125547722|NCT03567434|451635109|FG000|Overall Study|Lost to Follow-up|1|||
125547723|NCT03567434|451635110|FG001|Overall Study|Lost to Follow-up|3|||
125547724|NCT03035201|451635111|FG000|Overall Study|Death|9|||
125547725|NCT03035201|451635112|FG001|Overall Study|Death|12|||
125547726|NCT03035201|451635113|FG002|Overall Study|Death|9|||
125547727|NCT03035201|451635114|FG003|Overall Study|Death|10|||
125547728|NCT03035201|451635111|FG000|Overall Study|Withdrawal by Subject|51|||
125547729|NCT03035201|451635112|FG001|Overall Study|Withdrawal by Subject|49|||
125547730|NCT03035201|451635113|FG002|Overall Study|Withdrawal by Subject|37|||
125547731|NCT03035201|451635114|FG003|Overall Study|Withdrawal by Subject|46|||
125547732|NCT03035201|451635111|FG000|Overall Study|Lost to Follow-up|67|||
125547733|NCT03035201|451635112|FG001|Overall Study|Lost to Follow-up|51|||
125547734|NCT03035201|451635113|FG002|Overall Study|Lost to Follow-up|64|||
125547735|NCT03035201|451635114|FG003|Overall Study|Lost to Follow-up|69|||
125547736|NCT01880528|451635116|FG000|Overall Study|Other|1|||
125547737|NCT01880528|451635117|FG001|Overall Study|Other|1|||
125547738|NCT01439360|451635118|FG000|Overall Study|Adverse Event|4|||
125547739|NCT01439360|451635119|FG001|Overall Study|Adverse Event|16|||
125547740|NCT01439360|451635118|FG000|Overall Study|Lost to Follow-up|43|||
125547741|NCT01439360|451635119|FG001|Overall Study|Lost to Follow-up|58|||
125547742|NCT01439360|451635118|FG000|Overall Study|Others|10|||
125547743|NCT01439360|451635119|FG001|Overall Study|Others|5|||
125547744|NCT01439360|451635118|FG000|Overall Study|Protocol Violation|1|||
125547745|NCT01439360|451635119|FG001|Overall Study|Protocol Violation|0|||
125547746|NCT01439360|451635118|FG000|Overall Study|Withdrawal by Subject|140|||
125547747|NCT01439360|451635119|FG001|Overall Study|Withdrawal by Subject|129|||
125547748|NCT03727438|451635125|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
125547749|NCT03727438|451635126|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
125547750|NCT03727438|451635125|FG000|Intervention Period|Excluded (health)|1|||
125547751|NCT03727438|451635126|FG001|Intervention Period|Excluded (health)|0|||
125681565|NCT01044732|452123855|FG000|Overall Study|Inability to reach cecum|5|||
125681566|NCT01044732|452123856|FG001|Overall Study|Inability to reach cecum|2|||
125681567|NCT01044732|452123855|FG000|Overall Study|Technical error or malfunction|15|||
125547752|NCT03727438|451635125|FG000|Intervention Period|Withdrawal by Subject|3|||
125547753|NCT03727438|451635126|FG001|Intervention Period|Withdrawal by Subject|1|||
125547754|NCT03727438|451635125|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
125547755|NCT03727438|451635126|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
125547756|NCT03727438|451635125|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
125547757|NCT03727438|451635126|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
125547758|NCT03727438|451635125|FG000|8 Week Assessment|Withdrawal by Subject|6|||
125547759|NCT03727438|451635126|FG001|8 Week Assessment|Withdrawal by Subject|1|||
125547760|NCT03727438|451635125|FG000|6 mo Assessment|did not complete assessment|10|||
125547761|NCT03727438|451635126|FG001|6 mo Assessment|did not complete assessment|11|||
125547762|NCT00001962|451636992|FG000|Overall Study|Lack of Efficacy|18|||
125681568|NCT01044732|452123856|FG001|Overall Study|Technical error or malfunction|14|||
125547763|NCT00001962|451636992|FG000|Overall Study|Lack of Accrual|6|||
125547764|NCT00001962|451636992|FG000|Overall Study|Death|1|||
125547765|NCT00001962|451636992|FG000|Overall Study|Lost to Follow-up|2|||
125547766|NCT00001962|451636992|FG000|Overall Study|Adverse Event|1|||
125547767|NCT01177722|451636993|FG000|Overall Study|Serious Adverse Event|0|||
125547768|NCT01177722|451636994|FG001|Overall Study|Serious Adverse Event|0|||
125547769|NCT01177722|451636995|FG002|Overall Study|Serious Adverse Event|1|||
125547770|NCT01177722|451636996|FG003|Overall Study|Serious Adverse Event|0|||
125547771|NCT01177722|451636993|FG000|Overall Study|Protocol Violation|0|||
125547772|NCT01177722|451636994|FG001|Overall Study|Protocol Violation|0|||
125547773|NCT01177722|451636995|FG002|Overall Study|Protocol Violation|1|||
125547774|NCT01177722|451636996|FG003|Overall Study|Protocol Violation|0|||
125547775|NCT01177722|451636993|FG000|Overall Study|Lost to Follow-up|3|||
125547776|NCT01177722|451636994|FG001|Overall Study|Lost to Follow-up|4|||
125547777|NCT01177722|451636995|FG002|Overall Study|Lost to Follow-up|3|||
125547778|NCT01177722|451636996|FG003|Overall Study|Lost to Follow-up|1|||
125547779|NCT01177722|451636993|FG000|Overall Study|Withdrawal by Subject|10|||
125547780|NCT01177722|451636994|FG001|Overall Study|Withdrawal by Subject|6|||
125547781|NCT01177722|451636995|FG002|Overall Study|Withdrawal by Subject|4|||
125547782|NCT01177722|451636996|FG003|Overall Study|Withdrawal by Subject|6|||
125547783|NCT01222507|451636997|FG000|Overall Study|Physician Decision|1|||
125547784|NCT01222507|451636997|FG000|Overall Study|Withdrawal by Subject|1|||
125547785|NCT02647320|451636998|FG000|Overall Study|Adverse Event|0|||
125547786|NCT02647320|451636999|FG001|Overall Study|Adverse Event|1|||
125547787|NCT02647320|451637000|FG002|Overall Study|Adverse Event|3|||
125547788|NCT02647320|451637001|FG003|Overall Study|Adverse Event|2|||
125547789|NCT02647320|451637002|FG004|Overall Study|Adverse Event|1|||
125547790|NCT02647320|451636998|FG000|Overall Study|Protocol Violation|0|||
125547791|NCT02647320|451636999|FG001|Overall Study|Protocol Violation|0|||
125547792|NCT02647320|451637000|FG002|Overall Study|Protocol Violation|3|||
125547793|NCT02647320|451637001|FG003|Overall Study|Protocol Violation|0|||
125547794|NCT02647320|451637002|FG004|Overall Study|Protocol Violation|0|||
125547795|NCT02647320|451636998|FG000|Overall Study|Withdrawal by Subject|7|||
125547796|NCT02647320|451636999|FG001|Overall Study|Withdrawal by Subject|4|||
125547797|NCT02647320|451637000|FG002|Overall Study|Withdrawal by Subject|2|||
125547798|NCT02647320|451637001|FG003|Overall Study|Withdrawal by Subject|2|||
125547799|NCT02647320|451637002|FG004|Overall Study|Withdrawal by Subject|7|||
125547800|NCT02647320|451636998|FG000|Overall Study|Persistent hyperglycemia|0|||
125547801|NCT02647320|451636999|FG001|Overall Study|Persistent hyperglycemia|1|||
125547802|NCT02647320|451637000|FG002|Overall Study|Persistent hyperglycemia|1|||
125547803|NCT02647320|451637001|FG003|Overall Study|Persistent hyperglycemia|1|||
125547804|NCT02647320|451637002|FG004|Overall Study|Persistent hyperglycemia|1|||
125547805|NCT02647320|451636998|FG000|Overall Study|Study terminated by sponsor|1|||
125547806|NCT02647320|451636999|FG001|Overall Study|Study terminated by sponsor|1|||
125547807|NCT02647320|451637000|FG002|Overall Study|Study terminated by sponsor|1|||
125547808|NCT02647320|451637001|FG003|Overall Study|Study terminated by sponsor|1|||
125547809|NCT02647320|451637002|FG004|Overall Study|Study terminated by sponsor|2|||
125547810|NCT02647320|451636998|FG000|Overall Study|Reason not provided|0|||
125547811|NCT02647320|451636999|FG001|Overall Study|Reason not provided|0|||
125547812|NCT02647320|451637000|FG002|Overall Study|Reason not provided|1|||
125547813|NCT02647320|451637001|FG003|Overall Study|Reason not provided|0|||
125547814|NCT02647320|451637002|FG004|Overall Study|Reason not provided|2|||
125547815|NCT02647320|451636998|FG000|Overall Study|Lost to Follow-up|1|||
125547816|NCT02647320|451636999|FG001|Overall Study|Lost to Follow-up|1|||
125547817|NCT02647320|451637000|FG002|Overall Study|Lost to Follow-up|0|||
125547818|NCT02647320|451637001|FG003|Overall Study|Lost to Follow-up|0|||
125547819|NCT02647320|451637002|FG004|Overall Study|Lost to Follow-up|0|||
125547820|NCT02647320|451636998|FG000|Overall Study|Develop anemia|1|||
125547821|NCT02647320|451636999|FG001|Overall Study|Develop anemia|0|||
125547822|NCT02647320|451637000|FG002|Overall Study|Develop anemia|0|||
125547823|NCT02647320|451637001|FG003|Overall Study|Develop anemia|0|||
125547824|NCT02647320|451637002|FG004|Overall Study|Develop anemia|0|||
125547825|NCT02647320|451636998|FG000|Overall Study|Lack of Efficacy|0|||
125547826|NCT02647320|451636999|FG001|Overall Study|Lack of Efficacy|0|||
125547827|NCT02647320|451637000|FG002|Overall Study|Lack of Efficacy|0|||
125547828|NCT02647320|451637001|FG003|Overall Study|Lack of Efficacy|1|||
125547829|NCT02647320|451637002|FG004|Overall Study|Lack of Efficacy|0|||
125547830|NCT02647320|451636998|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
125681569|NCT00824265|452123859|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
125547831|NCT02647320|451636999|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
125547832|NCT02647320|451637000|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
125547833|NCT02647320|451637001|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
125547834|NCT02647320|451637002|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
125547835|NCT00596427|451637003|FG000|Overall Study|Withdrawal by Subject|2|||
125547836|NCT00596427|451637004|FG001|Overall Study|Withdrawal by Subject|2|||
125547837|NCT00596427|451637003|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
125547838|NCT00596427|451637004|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
125547839|NCT00596427|451637003|FG000|Overall Study|Protocol Violation|1|||
125547840|NCT00596427|451637004|FG001|Overall Study|Protocol Violation|0|||
125547841|NCT00320541|451637005|FG000|Overall Study|Adverse Event|21|||
125547842|NCT00320541|451637006|FG001|Overall Study|Adverse Event|19|||
125547843|NCT00320541|451637005|FG000|Overall Study|Protocol Violation|0|||
125547844|NCT00320541|451637006|FG001|Overall Study|Protocol Violation|1|||
125547845|NCT00320541|451637005|FG000|Overall Study|Withdrawal by Subject|12|||
125547846|NCT00320541|451637006|FG001|Overall Study|Withdrawal by Subject|16|||
125547847|NCT00320541|451637005|FG000|Overall Study|Physician Decision|9|||
125547848|NCT00320541|451637006|FG001|Overall Study|Physician Decision|13|||
125547849|NCT00320541|451637005|FG000|Overall Study|Other|3|||
125547850|NCT00320541|451637006|FG001|Overall Study|Other|4|||
125547851|NCT00320541|451637005|FG000|Overall Study|Sponsor Decision|2|||
125547852|NCT00320541|451637006|FG001|Overall Study|Sponsor Decision|1|||
125547853|NCT00320541|451637005|FG000|Overall Study|Death due to Study Disease|1|||
125547854|NCT00320541|451637006|FG001|Overall Study|Death due to Study Disease|3|||
125547855|NCT00320541|451637005|FG000|Overall Study|Death due to Adverse Event(s)|1|||
125547856|NCT00320541|451637006|FG001|Overall Study|Death due to Adverse Event(s)|0|||
125547857|NCT00320541|451637005|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
125547858|NCT00320541|451637006|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
125547859|NCT03057977|451637007|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
125547860|NCT03057977|451637008|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
125547861|NCT03057977|451637007|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
125547862|NCT03057977|451637008|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
125547863|NCT03057977|451637007|FG000|Discontinuation From Treatment|Protocol Violation|6|||
125547864|NCT03057977|451637008|FG001|Discontinuation From Treatment|Protocol Violation|5|||
125547865|NCT03057977|451637007|FG000|Discontinuation From Treatment|Not treated|4|||
125547866|NCT03057977|451637008|FG001|Discontinuation From Treatment|Not treated|0|||
125547867|NCT03057977|451637007|FG000|Discontinuation From Treatment|Adverse Event|343|||
125547868|NCT03057977|451637008|FG001|Discontinuation From Treatment|Adverse Event|337|||
125547869|NCT03057977|451637007|FG000|Discontinuation From Treatment|Reason Unknown|0|||
125547870|NCT03057977|451637008|FG001|Discontinuation From Treatment|Reason Unknown|1|||
125547871|NCT03057977|451637007|FG000|Discontinuation From Treatment|Personal Reasons|1|||
125547872|NCT03057977|451637008|FG001|Discontinuation From Treatment|Personal Reasons|1|||
125547873|NCT03057977|451637007|FG000|Discontinuation From Treatment|Unblinded medication|1|||
125547874|NCT03057977|451637008|FG001|Discontinuation From Treatment|Unblinded medication|0|||
125547875|NCT03057977|451637007|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
125547876|NCT03057977|451637008|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
125547877|NCT03057977|451637007|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
125547878|NCT03057977|451637008|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
125547879|NCT03057977|451637007|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
125547880|NCT03057977|451637008|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
125547881|NCT03057977|451637007|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
125547882|NCT03057977|451637008|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
125547883|NCT03057977|451637007|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
125547884|NCT03057977|451637008|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
125346337|NCT00952380|450902082|FG002|Overall Study|Adverse Event|0|||
125547885|NCT03057977|451637007|FG000|Discontinuation From Treatment|Not attending study visit|3|||
125547886|NCT03057977|451637008|FG001|Discontinuation From Treatment|Not attending study visit|10|||
125547887|NCT03057977|451637007|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
125547888|NCT03057977|451637008|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
125547889|NCT03057977|451637007|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
125547890|NCT03057977|451637008|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
125547891|NCT03057977|451637007|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
125547892|NCT03057977|451637008|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
125547893|NCT03057977|451637007|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
125547894|NCT03057977|451637008|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
125547895|NCT03057977|451637007|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
125547896|NCT03057977|451637008|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
125547897|NCT01650246|451637011|FG000|Overall Study|Adverse Event|23|||
125547898|NCT01650246|451637011|FG000|Overall Study|Protocol Violation|5|||
125547899|NCT01650246|451637011|FG000|Overall Study|Sponsor terminated study|53|||
125547900|NCT01650246|451637011|FG000|Overall Study|Lost to Follow-up|5|||
125547901|NCT01650246|451637011|FG000|Overall Study|Withdrawal by Subject|26|||
125547902|NCT01650246|451637011|FG000|Overall Study|Death|1|||
125547903|NCT01650246|451637011|FG000|Overall Study|Lack of Efficacy|30|||
125547904|NCT00953407|451637012|FG000|Overall Study|Failed inclusion criteria|1|||
125547905|NCT00953407|451637013|FG001|Overall Study|Failed inclusion criteria|1|||
125547906|NCT00953407|451637014|FG002|Overall Study|Failed inclusion criteria|1|||
125547907|NCT00953407|451637015|FG003|Overall Study|Failed inclusion criteria|1|||
125547908|NCT00953407|451637016|FG004|Overall Study|Failed inclusion criteria|1|||
125547909|NCT00953407|451637012|FG000|Overall Study|Lost to Follow-up|0|||
125547910|NCT00953407|451637013|FG001|Overall Study|Lost to Follow-up|0|||
125547911|NCT00953407|451637014|FG002|Overall Study|Lost to Follow-up|0|||
125547912|NCT00953407|451637015|FG003|Overall Study|Lost to Follow-up|1|||
125547913|NCT00953407|451637016|FG004|Overall Study|Lost to Follow-up|0|||
125547914|NCT03435497|451637018|FG000|Overall Study|Lost to Follow-up|1|||
125547915|NCT03435497|451637019|FG001|Overall Study|Lost to Follow-up|0|||
125547916|NCT03435497|451637018|FG000|Overall Study|Death|1|||
125547917|NCT03435497|451637019|FG001|Overall Study|Death|0|||
125547918|NCT03435497|451637018|FG000|Overall Study|Withdrawal by Subject|0|||
125547919|NCT03435497|451637019|FG001|Overall Study|Withdrawal by Subject|4|||
125547920|NCT03435497|451637018|FG000|Overall Study|Wrong survey administered|0|||
125547921|NCT03435497|451637019|FG001|Overall Study|Wrong survey administered|2|||
125547922|NCT05220254|451637021|FG000|Overall Study|Withdrawal by Subject|4|||
125547923|NCT05220254|451637021|FG000|Overall Study|Removed due to ineligibility|1|||
125547924|NCT05220254|451637021|FG000|Overall Study|Lost to Follow-up|7|||
125547925|NCT01557283|451637022|FG000|Overall Study|Lost to Follow-up|7|||
125547926|NCT01557283|451637022|FG000|Overall Study|Non-responder|19|||
125547927|NCT01557283|451637022|FG000|Overall Study|Adverse Event|7|||
125547928|NCT01557283|451637022|FG000|Overall Study|Lack of Efficacy|1|||
125547929|NCT01557283|451637022|FG000|Overall Study|Non-compliance|1|||
125547930|NCT01557283|451637022|FG000|Overall Study|Withdrawal by Subject|1|||
125547931|NCT01557283|451637022|FG000|Overall Study|Participant's weight too high for dose|1|||
125547932|NCT01557283|451637022|FG000|Overall Study|Worsening of psoriasis|1|||
125547933|NCT01557283|451637022|FG000|Overall Study|Other|6|||
125547934|NCT00120406|451637023|FG000|Overall Study|Death|9|||
125547935|NCT00120406|451637024|FG001|Overall Study|Death|4|||
125547936|NCT00120406|451637023|FG000|Overall Study|Withdrawal by Subject|5|||
125547937|NCT00120406|451637024|FG001|Overall Study|Withdrawal by Subject|7|||
125547938|NCT00120406|451637023|FG000|Overall Study|Lost to Follow-up|5|||
125547939|NCT00120406|451637024|FG001|Overall Study|Lost to Follow-up|2|||
125547940|NCT00120406|451637023|FG000|Overall Study|received non-study stent|0|||
125547941|NCT00120406|451637024|FG001|Overall Study|received non-study stent|2|||
125547942|NCT00120406|451637023|FG000|Overall Study|patient moved but has not withdrawn|0|||
125547943|NCT00120406|451637024|FG001|Overall Study|patient moved but has not withdrawn|1|||
125547944|NCT00250679|451637025|FG000|Overall Study|Adverse Event|12|||
125547945|NCT00250679|451637026|FG001|Overall Study|Adverse Event|15|||
125547946|NCT00250679|451637027|FG002|Overall Study|Adverse Event|16|||
125547947|NCT00250679|451637025|FG000|Overall Study|Protocol Violation|2|||
125547948|NCT00250679|451637026|FG001|Overall Study|Protocol Violation|4|||
125547949|NCT00250679|451637027|FG002|Overall Study|Protocol Violation|3|||
125547950|NCT00250679|451637025|FG000|Overall Study|Withdrawal by Subject|15|||
125547951|NCT00250679|451637026|FG001|Overall Study|Withdrawal by Subject|18|||
125547952|NCT00250679|451637027|FG002|Overall Study|Withdrawal by Subject|15|||
125547953|NCT00250679|451637025|FG000|Overall Study|Lost to Follow-up|3|||
125547954|NCT00250679|451637026|FG001|Overall Study|Lost to Follow-up|4|||
125547955|NCT00250679|451637027|FG002|Overall Study|Lost to Follow-up|2|||
125547956|NCT00250679|451637025|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
125547957|NCT00250679|451637026|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
125547958|NCT00250679|451637027|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
125547959|NCT00250679|451637025|FG000|Overall Study|Lack of Efficacy|0|||
125547960|NCT00250679|451637026|FG001|Overall Study|Lack of Efficacy|1|||
125547961|NCT00250679|451637027|FG002|Overall Study|Lack of Efficacy|3|||
125547962|NCT00250679|451637025|FG000|Overall Study|Technical Holter issues|1|||
125547963|NCT00250679|451637026|FG001|Overall Study|Technical Holter issues|0|||
125547964|NCT00250679|451637027|FG002|Overall Study|Technical Holter issues|2|||
125547965|NCT00250679|451637025|FG000|Overall Study|Moved|1|||
125547966|NCT00250679|451637026|FG001|Overall Study|Moved|1|||
125547967|NCT00250679|451637027|FG002|Overall Study|Moved|0|||
125547968|NCT00250679|451637025|FG000|Overall Study|Non-compliance|1|||
125547969|NCT00250679|451637026|FG001|Overall Study|Non-compliance|1|||
125547970|NCT00250679|451637027|FG002|Overall Study|Non-compliance|0|||
125346338|NCT00952380|450902083|FG003|Overall Study|Adverse Event|0|||
125346339|NCT00952380|450902084|FG004|Overall Study|Adverse Event|3|||
125346340|NCT00952380|450902080|FG000|Overall Study|Physician Decision|0|||
125346341|NCT00952380|450902081|FG001|Overall Study|Physician Decision|0|||
125346342|NCT00952380|450902082|FG002|Overall Study|Physician Decision|1|||
125346343|NCT00952380|450902083|FG003|Overall Study|Physician Decision|2|||
125346344|NCT00952380|450902084|FG004|Overall Study|Physician Decision|0|||
125346345|NCT00952380|450902080|FG000|Overall Study|Non-compliant to protocol|0|||
125346346|NCT00952380|450902081|FG001|Overall Study|Non-compliant to protocol|0|||
125346347|NCT00952380|450902082|FG002|Overall Study|Non-compliant to protocol|0|||
125346348|NCT00952380|450902083|FG003|Overall Study|Non-compliant to protocol|1|||
125346349|NCT00952380|450902084|FG004|Overall Study|Non-compliant to protocol|0|||
125346350|NCT03400956|450902085|FG000|Treatment Period 1|Adverse Event|0|||
125346351|NCT03400956|450902086|FG001|Treatment Period 1|Adverse Event|1|||
125346352|NCT03400956|450902087|FG002|Treatment Period 1|Adverse Event|0|||
125346353|NCT03400956|450902085|FG000|Treatment Period 1|Lost to Follow-up|0|||
125346354|NCT03400956|450902086|FG001|Treatment Period 1|Lost to Follow-up|0|||
125346355|NCT03400956|450902087|FG002|Treatment Period 1|Lost to Follow-up|1|||
125346356|NCT03400956|450902085|FG000|Treatment Period 1|Protocol Violation|0|||
125346357|NCT03400956|450902086|FG001|Treatment Period 1|Protocol Violation|2|||
125346358|NCT03400956|450902087|FG002|Treatment Period 1|Protocol Violation|0|||
125346359|NCT03400956|450902085|FG000|Treatment Period 1|Study terminated by sponsor|3|||
125346360|NCT03400956|450902086|FG001|Treatment Period 1|Study terminated by sponsor|1|||
125346361|NCT03400956|450902087|FG002|Treatment Period 1|Study terminated by sponsor|1|||
125346362|NCT03400956|450902085|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125346363|NCT03400956|450902086|FG001|Treatment Period 1|Withdrawal by Subject|2|||
125346364|NCT03400956|450902087|FG002|Treatment Period 1|Withdrawal by Subject|4|||
125346365|NCT03400956|450902085|FG000|Treatment Period 1|Other|1|||
125346366|NCT03400956|450902086|FG001|Treatment Period 1|Other|2|||
125346367|NCT03400956|450902087|FG002|Treatment Period 1|Other|3|||
125346368|NCT03400956|450902085|FG000|Post-treatment Period 1|Adverse Event|0|||
125346369|NCT03400956|450902086|FG001|Post-treatment Period 1|Adverse Event|0|||
125346370|NCT03400956|450902087|FG002|Post-treatment Period 1|Adverse Event|1|||
125346371|NCT03400956|450902085|FG000|Post-treatment Period 1|Physician Decision|2|||
125346372|NCT03400956|450902086|FG001|Post-treatment Period 1|Physician Decision|3|||
125346373|NCT03400956|450902087|FG002|Post-treatment Period 1|Physician Decision|0|||
125346374|NCT03400956|450902085|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
125346375|NCT03400956|450902086|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
125346376|NCT03400956|450902087|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
125346377|NCT03400956|450902085|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
125346378|NCT03400956|450902086|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
125346379|NCT03400956|450902087|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
125346380|NCT03400956|450902085|FG000|Post-treatment Period 1|Other|4|||
125346381|NCT03400956|450902086|FG001|Post-treatment Period 1|Other|3|||
125346382|NCT03400956|450902087|FG002|Post-treatment Period 1|Other|4|||
125346383|NCT03400956|450902085|FG000|Treatment Period 2|Adverse Event|2|||
125346384|NCT03400956|450902086|FG001|Treatment Period 2|Adverse Event|1|||
125346385|NCT03400956|450902087|FG002|Treatment Period 2|Adverse Event|1|||
125346386|NCT03400956|450902085|FG000|Treatment Period 2|Lost to Follow-up|1|||
125346387|NCT03400956|450902086|FG001|Treatment Period 2|Lost to Follow-up|1|||
125346388|NCT03400956|450902087|FG002|Treatment Period 2|Lost to Follow-up|0|||
125346389|NCT03400956|450902085|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125346390|NCT03400956|450902086|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125346391|NCT03400956|450902087|FG002|Treatment Period 2|Withdrawal by Subject|3|||
125346392|NCT03400956|450902085|FG000|Treatment Period 2|Other|1|||
125346393|NCT03400956|450902086|FG001|Treatment Period 2|Other|1|||
125346394|NCT03400956|450902087|FG002|Treatment Period 2|Other|0|||
125346395|NCT03400956|450902085|FG000|Follow-up Period|Withdrawal by Subject|0|||
125346396|NCT03400956|450902086|FG001|Follow-up Period|Withdrawal by Subject|0|||
125346397|NCT03400956|450902087|FG002|Follow-up Period|Withdrawal by Subject|1|||
125346398|NCT03400956|450902085|FG000|Follow-up Period|Other|0|||
125346399|NCT03400956|450902086|FG001|Follow-up Period|Other|0|||
125346400|NCT03400956|450902087|FG002|Follow-up Period|Other|1|||
125681570|NCT00824265|452123860|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
125681571|NCT00824265|452123859|FG000|Treatment Phase|Protocol Violation|1|||
125346401|NCT00160667|450902088|FG000|Overall Study|Adverse Event|3|||
125346402|NCT00160667|450902089|FG001|Overall Study|Adverse Event|1|||
125346403|NCT00160667|450902090|FG002|Overall Study|Adverse Event|4|||
125346404|NCT00160667|450902088|FG000|Overall Study|Withdrawal by Subject|2|||
125346405|NCT00160667|450902089|FG001|Overall Study|Withdrawal by Subject|0|||
125346406|NCT00160667|450902090|FG002|Overall Study|Withdrawal by Subject|1|||
125346407|NCT00160667|450902088|FG000|Overall Study|Lack of Efficacy|0|||
125346408|NCT00160667|450902089|FG001|Overall Study|Lack of Efficacy|1|||
125346409|NCT00160667|450902090|FG002|Overall Study|Lack of Efficacy|0|||
125346410|NCT00160667|450902088|FG000|Overall Study|Protocol Violation|0|||
125346411|NCT00160667|450902089|FG001|Overall Study|Protocol Violation|1|||
125346412|NCT00160667|450902090|FG002|Overall Study|Protocol Violation|0|||
125547971|NCT00250679|451637025|FG000|Overall Study|various single events: hip surgery,diary|3|||
125547972|NCT00250679|451637026|FG001|Overall Study|various single events: hip surgery,diary|1|||
125547973|NCT00250679|451637027|FG002|Overall Study|various single events: hip surgery,diary|1|||
125547974|NCT03603028|451637028|FG000|Overall Study|Withdrawal by Subject|1|||
125547975|NCT00842985|451637033|FG000|Screening|Did not meet entrance requirements|27|||
125547976|NCT00842985|451637033|FG000|First Intervention|Withdrawal by Subject|3|||
125547977|NCT00842985|451637033|FG000|First Intervention|Protocol Violation|3|||
125547978|NCT00842985|451637033|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
125547979|NCT00842985|451637033|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
125547980|NCT01037244|451637034|FG000|Overall Study|Adverse Event|3|||
125547981|NCT01037244|451637035|FG001|Overall Study|Adverse Event|2|||
125547982|NCT01037244|451637036|FG002|Overall Study|Adverse Event|6|||
125547983|NCT01037244|451637037|FG003|Overall Study|Adverse Event|3|||
125547984|NCT01037244|451637034|FG000|Overall Study|Lack of Efficacy|1|||
125547985|NCT01037244|451637035|FG001|Overall Study|Lack of Efficacy|1|||
125547986|NCT01037244|451637036|FG002|Overall Study|Lack of Efficacy|0|||
125547987|NCT01037244|451637037|FG003|Overall Study|Lack of Efficacy|1|||
125547988|NCT01037244|451637034|FG000|Overall Study|Lost to Follow-up|3|||
125547989|NCT01037244|451637035|FG001|Overall Study|Lost to Follow-up|3|||
125547990|NCT01037244|451637036|FG002|Overall Study|Lost to Follow-up|4|||
125547991|NCT01037244|451637037|FG003|Overall Study|Lost to Follow-up|4|||
125547992|NCT01037244|451637034|FG000|Overall Study|Withdrawal by Subject|1|||
125547993|NCT01037244|451637035|FG001|Overall Study|Withdrawal by Subject|5|||
125547994|NCT01037244|451637036|FG002|Overall Study|Withdrawal by Subject|3|||
125547995|NCT01037244|451637037|FG003|Overall Study|Withdrawal by Subject|5|||
125547996|NCT01037244|451637034|FG000|Overall Study|Partner Withdrew Consent|2|||
125547997|NCT01037244|451637035|FG001|Overall Study|Partner Withdrew Consent|1|||
125547998|NCT01037244|451637036|FG002|Overall Study|Partner Withdrew Consent|0|||
125547999|NCT01037244|451637037|FG003|Overall Study|Partner Withdrew Consent|0|||
125548000|NCT01037244|451637034|FG000|Overall Study|Various|3|||
125548001|NCT01037244|451637035|FG001|Overall Study|Various|2|||
125548002|NCT01037244|451637036|FG002|Overall Study|Various|1|||
125548003|NCT01037244|451637037|FG003|Overall Study|Various|1|||
125548004|NCT00690820|451637038|FG000|Period 1|Withdrawal by Subject|0|||
125548005|NCT00690820|451637039|FG001|Period 1|Withdrawal by Subject|1|||
125548006|NCT01768117|451637041|FG000|Overall Study|Lost to Follow-up|1|||
125548007|NCT01768117|451637041|FG000|Overall Study|Withdrawal by Subject|2|||
125548008|NCT01768117|451637041|FG000|Overall Study|Protocol Violation|3|||
125548009|NCT01249274|451637044|FG000|Overall Study|Lost to Follow-up|3|||
125548010|NCT01249274|451637045|FG001|Overall Study|Lost to Follow-up|4|||
125548011|NCT01249274|451637044|FG000|Overall Study|Received inpatient substance treatment|1|||
125548012|NCT01249274|451637045|FG001|Overall Study|Received inpatient substance treatment|2|||
125548013|NCT01000636|451637046|FG000|Overall Study|Withdrawal by Subject|1|||
125548014|NCT01000636|451637046|FG000|Overall Study|Adverse Event|1|||
125548015|NCT03451162|451637047|FG000|Overall Study|Lost to Follow-up|1|||
125548016|NCT03451162|451637048|FG001|Overall Study|Lost to Follow-up|0|||
125548017|NCT03451162|451637049|FG002|Overall Study|Lost to Follow-up|0|||
125548018|NCT03451162|451637050|FG003|Overall Study|Lost to Follow-up|0|||
125548019|NCT03451162|451637051|FG004|Overall Study|Lost to Follow-up|0|||
125548020|NCT03451162|451637047|FG000|Overall Study|Physician Decision|0|||
125548021|NCT03451162|451637048|FG001|Overall Study|Physician Decision|1|||
125548022|NCT03451162|451637049|FG002|Overall Study|Physician Decision|0|||
125548023|NCT03451162|451637050|FG003|Overall Study|Physician Decision|0|||
125548024|NCT03451162|451637051|FG004|Overall Study|Physician Decision|0|||
125548025|NCT03451162|451637047|FG000|Overall Study|Withdrawal by Subject|1|||
125548026|NCT03451162|451637048|FG001|Overall Study|Withdrawal by Subject|1|||
125548027|NCT03451162|451637049|FG002|Overall Study|Withdrawal by Subject|0|||
125548028|NCT03451162|451637050|FG003|Overall Study|Withdrawal by Subject|0|||
125548029|NCT03451162|451637051|FG004|Overall Study|Withdrawal by Subject|0|||
125548030|NCT01127139|451637052|FG000|Overall Study|Adverse Event|40|||
125681572|NCT00824265|452123860|FG001|Treatment Phase|Protocol Violation|0|||
125548031|NCT01127139|451637052|FG000|Overall Study|Incompliance|12|||
125681573|NCT00824265|452123859|FG000|Treatment Phase|Lost to Follow-up|1|||
125548032|NCT01127139|451637052|FG000|Overall Study|Lack of Efficacy|4|||
125548033|NCT01127139|451637052|FG000|Overall Study|Reason not specified|1|||
125548034|NCT01498653|451637054|FG000|Overall Study|Adverse Event|2|||
125681574|NCT00824265|452123860|FG001|Treatment Phase|Lost to Follow-up|1|||
125681575|NCT00824265|452123859|FG000|Treatment Phase|Physician Decision|6|||
125681576|NCT00824265|452123860|FG001|Treatment Phase|Physician Decision|12|||
125681577|NCT00824265|452123859|FG000|Treatment Phase|Withdrawal by Subject|6|||
125548035|NCT01498653|451637055|FG001|Overall Study|Adverse Event|2|||
125548036|NCT01498653|451637054|FG000|Overall Study|Lack of Efficacy|12|||
125548037|NCT01498653|451637055|FG001|Overall Study|Lack of Efficacy|26|||
125548038|NCT01498653|451637054|FG000|Overall Study|Protocol Violation|0|||
125548039|NCT01498653|451637055|FG001|Overall Study|Protocol Violation|4|||
125548040|NCT01498653|451637054|FG000|Overall Study|Lost to Follow-up|1|||
125548041|NCT01498653|451637055|FG001|Overall Study|Lost to Follow-up|0|||
125548042|NCT01498653|451637054|FG000|Overall Study|Physician Decision|2|||
125548043|NCT01498653|451637055|FG001|Overall Study|Physician Decision|0|||
125548044|NCT01498653|451637054|FG000|Overall Study|Withdrawal by Subject|2|||
125548045|NCT01498653|451637055|FG001|Overall Study|Withdrawal by Subject|3|||
125548046|NCT02216357|451637057|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
125548047|NCT02216357|451637058|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
125548048|NCT00836095|451637059|FG000|Overall Study|Physician Decision|0|||
125548049|NCT00836095|451637060|FG001|Overall Study|Physician Decision|3|||
125548050|NCT04964414|451637062|FG000|Overall Study|Lost to Follow-up|10|||
125548051|NCT04964414|451637063|FG001|Overall Study|Lost to Follow-up|8|||
125548052|NCT04964414|451637062|FG000|Overall Study|Withdrawal by Subject|1|||
125548053|NCT04964414|451637063|FG001|Overall Study|Withdrawal by Subject|1|||
125548054|NCT01079741|451637072|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
125548055|NCT01079741|451637073|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
125548056|NCT01079741|451637074|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
125548057|NCT01079741|451637075|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
125548058|NCT01079741|451637076|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
125548059|NCT01079741|451637072|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
125548060|NCT01079741|451637073|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
125548061|NCT01079741|451637074|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
125548062|NCT01079741|451637075|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
125548063|NCT01079741|451637076|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
125548064|NCT00446992|451637077|FG000|Overall Study|Adverse Event|11|||
125548065|NCT00446992|451637077|FG000|Overall Study|Lost to Follow-up|5|||
125548066|NCT01275131|451637078|FG000|Period 1|Withdrawal by Subject|1|||
125548067|NCT01275131|451637079|FG001|Period 1|Withdrawal by Subject|0|||
125548068|NCT01275131|451637080|FG002|Period 1|Withdrawal by Subject|3|||
125548069|NCT01275131|451637081|FG003|Period 1|Withdrawal by Subject|2|||
125548070|NCT01275131|451637078|FG000|Period 1|Physician Decision|1|||
125548071|NCT01275131|451637079|FG001|Period 1|Physician Decision|0|||
125548072|NCT01275131|451637080|FG002|Period 1|Physician Decision|0|||
125548073|NCT01275131|451637081|FG003|Period 1|Physician Decision|0|||
125548074|NCT01275131|451637078|FG000|Period 2 (Crossover)|Adverse Event|0|||
125548075|NCT01275131|451637079|FG001|Period 2 (Crossover)|Adverse Event|1|||
125548076|NCT01275131|451637080|FG002|Period 2 (Crossover)|Adverse Event|0|||
125548077|NCT01275131|451637081|FG003|Period 2 (Crossover)|Adverse Event|0|||
125548078|NCT01275131|451637078|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
125548079|NCT01275131|451637079|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
125548080|NCT01275131|451637080|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
125548081|NCT01275131|451637081|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
125548082|NCT02076178|451637082|FG000|Oral Phase|Adverse Event|0|||
125548083|NCT02076178|451637083|FG001|Oral Phase|Adverse Event|7|||
125548084|NCT02076178|451637082|FG000|Oral Phase|Withdrawal by Subject|0|||
125548085|NCT02076178|451637083|FG001|Oral Phase|Withdrawal by Subject|4|||
125548086|NCT02076178|451637082|FG000|Oral Phase|Physician Decision|0|||
125548087|NCT02076178|451637083|FG001|Oral Phase|Physician Decision|1|||
125548088|NCT02076178|451637082|FG000|Injection Phase|Protocol defined stopping criteria|1|||
125548089|NCT02076178|451637083|FG001|Injection Phase|Protocol defined stopping criteria|0|||
125548090|NCT02076178|451637082|FG000|Injection Phase|Withdrawal by Subject|0|||
125548091|NCT02076178|451637083|FG001|Injection Phase|Withdrawal by Subject|3|||
125548092|NCT02076178|451637082|FG000|Injection Phase|Physician Decision|0|||
125548093|NCT02076178|451637083|FG001|Injection Phase|Physician Decision|3|||
125548094|NCT02076178|451637082|FG000|Injection Phase|Lost to Follow-up|0|||
125548095|NCT02076178|451637083|FG001|Injection Phase|Lost to Follow-up|1|||
125548096|NCT02434939|451637091|FG000|Overall Study|Lack of Efficacy|34|||
125548097|NCT02434939|451637092|FG001|Overall Study|Lack of Efficacy|48|||
125548098|NCT02434939|451637091|FG000|Overall Study|Withdrawal by Subject|3|||
125548099|NCT02434939|451637092|FG001|Overall Study|Withdrawal by Subject|0|||
125548100|NCT02434939|451637091|FG000|Overall Study|Adverse Event|0|||
125548101|NCT02434939|451637092|FG001|Overall Study|Adverse Event|1|||
125346413|NCT00160667|450902088|FG000|Overall Study|Patient decision|0|||
125346414|NCT00160667|450902089|FG001|Overall Study|Patient decision|0|||
125346415|NCT00160667|450902090|FG002|Overall Study|Patient decision|1|||
125346416|NCT00927940|450902091|FG000|Overall Study|Death|1|||
125548102|NCT00585195|451637106|FG000|Overall Study|Adverse Event|0|||
125548103|NCT00585195|451637107|FG001|Overall Study|Adverse Event|0|||
125548104|NCT00585195|451637108|FG002|Overall Study|Adverse Event|0|||
125548105|NCT00585195|451637109|FG003|Overall Study|Adverse Event|0|||
125548106|NCT00585195|451637110|FG004|Overall Study|Adverse Event|2|||
125548107|NCT00585195|451637111|FG005|Overall Study|Adverse Event|1|||
125548108|NCT00585195|451637112|FG006|Overall Study|Adverse Event|0|||
125548109|NCT00585195|451637113|FG007|Overall Study|Adverse Event|1|||
125548110|NCT00585195|451637114|FG008|Overall Study|Adverse Event|0|||
125548111|NCT00585195|451637115|FG009|Overall Study|Adverse Event|0|||
125548112|NCT00585195|451637116|FG010|Overall Study|Adverse Event|3|||
125346417|NCT03044574|450902095|FG000|Overall Study|Lost to Follow-up|37|||
125548113|NCT00585195|451637117|FG011|Overall Study|Adverse Event|0|||
125548114|NCT00585195|451637118|FG012|Overall Study|Adverse Event|8|||
125548115|NCT00585195|451637119|FG013|Overall Study|Adverse Event|6|||
125548116|NCT00585195|451637120|FG014|Overall Study|Adverse Event|4|||
125548117|NCT00585195|451637121|FG015|Overall Study|Adverse Event|1|||
125548118|NCT00585195|451637122|FG016|Overall Study|Adverse Event|14|||
125548119|NCT00585195|451637123|FG017|Overall Study|Adverse Event|9|||
125548120|NCT00585195|451637124|FG018|Overall Study|Adverse Event|2|||
125548121|NCT00585195|451637125|FG019|Overall Study|Adverse Event|3|||
125548122|NCT00585195|451637126|FG020|Overall Study|Adverse Event|1|||
125548123|NCT00585195|451637106|FG000|Overall Study|Progressive Disease|2|||
125548124|NCT00585195|451637107|FG001|Overall Study|Progressive Disease|2|||
125548125|NCT00585195|451637108|FG002|Overall Study|Progressive Disease|5|||
125548126|NCT00585195|451637109|FG003|Overall Study|Progressive Disease|4|||
125548127|NCT00585195|451637110|FG004|Overall Study|Progressive Disease|6|||
125548128|NCT00585195|451637111|FG005|Overall Study|Progressive Disease|4|||
125548129|NCT00585195|451637112|FG006|Overall Study|Progressive Disease|6|||
125548130|NCT00585195|451637113|FG007|Overall Study|Progressive Disease|3|||
125548131|NCT00585195|451637114|FG008|Overall Study|Progressive Disease|0|||
125548132|NCT00585195|451637115|FG009|Overall Study|Progressive Disease|5|||
125548133|NCT00585195|451637116|FG010|Overall Study|Progressive Disease|2|||
125548134|NCT00585195|451637117|FG011|Overall Study|Progressive Disease|25|||
125548135|NCT00585195|451637118|FG012|Overall Study|Progressive Disease|29|||
125548136|NCT00585195|451637119|FG013|Overall Study|Progressive Disease|26|||
125548137|NCT00585195|451637120|FG014|Overall Study|Progressive Disease|21|||
125548138|NCT00585195|451637121|FG015|Overall Study|Progressive Disease|12|||
125548139|NCT00585195|451637122|FG016|Overall Study|Progressive Disease|94|||
125548140|NCT00585195|451637123|FG017|Overall Study|Progressive Disease|42|||
125548141|NCT00585195|451637124|FG018|Overall Study|Progressive Disease|4|||
125548142|NCT00585195|451637125|FG019|Overall Study|Progressive Disease|9|||
125548143|NCT00585195|451637126|FG020|Overall Study|Progressive Disease|8|||
125548144|NCT00585195|451637106|FG000|Overall Study|Withdrawal by Subject|1|||
125548145|NCT00585195|451637107|FG001|Overall Study|Withdrawal by Subject|1|||
125548146|NCT00585195|451637108|FG002|Overall Study|Withdrawal by Subject|2|||
125548147|NCT00585195|451637109|FG003|Overall Study|Withdrawal by Subject|2|||
125548148|NCT00585195|451637110|FG004|Overall Study|Withdrawal by Subject|0|||
125548149|NCT00585195|451637111|FG005|Overall Study|Withdrawal by Subject|0|||
125548150|NCT00585195|451637112|FG006|Overall Study|Withdrawal by Subject|0|||
125548151|NCT00585195|451637113|FG007|Overall Study|Withdrawal by Subject|1|||
125548152|NCT00585195|451637114|FG008|Overall Study|Withdrawal by Subject|0|||
125548153|NCT00585195|451637115|FG009|Overall Study|Withdrawal by Subject|0|||
125548154|NCT00585195|451637116|FG010|Overall Study|Withdrawal by Subject|3|||
125548155|NCT00585195|451637117|FG011|Overall Study|Withdrawal by Subject|8|||
125548156|NCT00585195|451637118|FG012|Overall Study|Withdrawal by Subject|15|||
125548157|NCT00585195|451637119|FG013|Overall Study|Withdrawal by Subject|0|||
125548158|NCT00585195|451637120|FG014|Overall Study|Withdrawal by Subject|3|||
125548159|NCT00585195|451637121|FG015|Overall Study|Withdrawal by Subject|0|||
125548160|NCT00585195|451637122|FG016|Overall Study|Withdrawal by Subject|7|||
125548161|NCT00585195|451637123|FG017|Overall Study|Withdrawal by Subject|1|||
125548162|NCT00585195|451637124|FG018|Overall Study|Withdrawal by Subject|2|||
125548163|NCT00585195|451637125|FG019|Overall Study|Withdrawal by Subject|2|||
125548164|NCT00585195|451637126|FG020|Overall Study|Withdrawal by Subject|0|||
125548165|NCT00585195|451637106|FG000|Overall Study|Other|0|||
125548166|NCT00585195|451637107|FG001|Overall Study|Other|1|||
125548167|NCT00585195|451637108|FG002|Overall Study|Other|1|||
125548168|NCT00585195|451637109|FG003|Overall Study|Other|1|||
125548169|NCT00585195|451637110|FG004|Overall Study|Other|0|||
125548170|NCT00585195|451637111|FG005|Overall Study|Other|1|||
125548171|NCT00585195|451637112|FG006|Overall Study|Other|0|||
125548172|NCT00585195|451637113|FG007|Overall Study|Other|0|||
125548173|NCT00585195|451637114|FG008|Overall Study|Other|2|||
125548174|NCT00585195|451637115|FG009|Overall Study|Other|1|||
125548175|NCT00585195|451637116|FG010|Overall Study|Other|0|||
125548176|NCT00585195|451637117|FG011|Overall Study|Other|19|||
125548177|NCT00585195|451637118|FG012|Overall Study|Other|24|||
125548178|NCT00585195|451637119|FG013|Overall Study|Other|7|||
125548179|NCT00585195|451637120|FG014|Overall Study|Other|11|||
125548180|NCT00585195|451637121|FG015|Overall Study|Other|3|||
125548181|NCT00585195|451637122|FG016|Overall Study|Other|28|||
125548182|NCT00585195|451637123|FG017|Overall Study|Other|12|||
125548183|NCT00585195|451637124|FG018|Overall Study|Other|10|||
125548184|NCT00585195|451637125|FG019|Overall Study|Other|4|||
125548185|NCT00585195|451637126|FG020|Overall Study|Other|2|||
125548186|NCT00585195|451637106|FG000|Overall Study|Randomized not treated|0|||
125548187|NCT00585195|451637107|FG001|Overall Study|Randomized not treated|0|||
125548188|NCT00585195|451637108|FG002|Overall Study|Randomized not treated|1|||
125548189|NCT00585195|451637109|FG003|Overall Study|Randomized not treated|0|||
125548190|NCT00585195|451637110|FG004|Overall Study|Randomized not treated|1|||
125548191|NCT00585195|451637111|FG005|Overall Study|Randomized not treated|0|||
125346418|NCT03044574|450902096|FG001|Overall Study|Lost to Follow-up|45|||
125346419|NCT00890045|450902097|FG000|Overall Study|Death|0|||
125346420|NCT00890045|450902098|FG001|Overall Study|Death|1|||
125346421|NCT00890045|450902097|FG000|Overall Study|Did not receive HeRO Graft|0|||
125346422|NCT00890045|450902098|FG001|Overall Study|Did not receive HeRO Graft|2|||
125346423|NCT00890045|450902097|FG000|Overall Study|Lost to Follow-up|5|||
125346424|NCT00890045|450902098|FG001|Overall Study|Lost to Follow-up|7|||
125346425|NCT00483756|450902103|FG000|Overall Study|Death|2|||
125346426|NCT00483756|450902104|FG001|Overall Study|Death|0|||
125346427|NCT00483756|450902105|FG002|Overall Study|Death|1|||
125346428|NCT00483756|450902103|FG000|Overall Study|Adverse Event|19|||
125346429|NCT00483756|450902104|FG001|Overall Study|Adverse Event|38|||
125346430|NCT00483756|450902105|FG002|Overall Study|Adverse Event|40|||
125346431|NCT00483756|450902103|FG000|Overall Study|Lack of Efficacy|1|||
125346432|NCT00483756|450902104|FG001|Overall Study|Lack of Efficacy|0|||
125548192|NCT00585195|451637112|FG006|Overall Study|Randomized not treated|1|||
125548193|NCT00585195|451637113|FG007|Overall Study|Randomized not treated|0|||
125548194|NCT00585195|451637114|FG008|Overall Study|Randomized not treated|0|||
125346433|NCT00483756|450902105|FG002|Overall Study|Lack of Efficacy|0|||
125346434|NCT00483756|450902103|FG000|Overall Study|Lost to Follow-up|3|||
125346435|NCT00483756|450902104|FG001|Overall Study|Lost to Follow-up|1|||
125346436|NCT00483756|450902105|FG002|Overall Study|Lost to Follow-up|0|||
125346437|NCT00483756|450902103|FG000|Overall Study|Withdrawal by Subject|5|||
125346438|NCT00483756|450902104|FG001|Overall Study|Withdrawal by Subject|3|||
125346439|NCT00483756|450902105|FG002|Overall Study|Withdrawal by Subject|4|||
125346440|NCT00483756|450902103|FG000|Overall Study|Other|2|||
125346441|NCT00483756|450902104|FG001|Overall Study|Other|4|||
125346442|NCT00483756|450902105|FG002|Overall Study|Other|3|||
125346443|NCT00483756|450902103|FG000|Overall Study|Randomized, Not Treated|1|||
125346444|NCT00483756|450902104|FG001|Overall Study|Randomized, Not Treated|4|||
125346445|NCT00483756|450902105|FG002|Overall Study|Randomized, Not Treated|4|||
125346446|NCT00495040|450902106|FG000|Overall Study|Withdrawal by Subject|3|||
125346447|NCT01892384|450902107|FG000|Overall Study|Withdrawal by Subject|1|||
125346448|NCT01892384|450902108|FG001|Overall Study|Withdrawal by Subject|1|||
125346449|NCT01892384|450902109|FG002|Overall Study|Withdrawal by Subject|0|||
125346450|NCT01892384|450902110|FG003|Overall Study|Withdrawal by Subject|0|||
125346451|NCT00592774|450902111|FG000|Overall Study|Adverse Event|5|||
125346452|NCT00592774|450902112|FG001|Overall Study|Adverse Event|19|||
125346453|NCT00592774|450902113|FG002|Overall Study|Adverse Event|2|||
125346454|NCT00592774|450902114|FG003|Overall Study|Adverse Event|14|||
125346455|NCT00592774|450902115|FG004|Overall Study|Adverse Event|8|||
125346456|NCT00592774|450902111|FG000|Overall Study|Protocol Violation|0|||
125346457|NCT00592774|450902112|FG001|Overall Study|Protocol Violation|1|||
125346458|NCT00592774|450902113|FG002|Overall Study|Protocol Violation|0|||
125346459|NCT00592774|450902114|FG003|Overall Study|Protocol Violation|0|||
125346460|NCT00592774|450902115|FG004|Overall Study|Protocol Violation|1|||
125346461|NCT00592774|450902111|FG000|Overall Study|Withdrawal by Subject|3|||
125346462|NCT00592774|450902112|FG001|Overall Study|Withdrawal by Subject|7|||
125346463|NCT00592774|450902113|FG002|Overall Study|Withdrawal by Subject|0|||
125346464|NCT00592774|450902114|FG003|Overall Study|Withdrawal by Subject|0|||
125346465|NCT00592774|450902115|FG004|Overall Study|Withdrawal by Subject|0|||
125346466|NCT00592774|450902111|FG000|Overall Study|Lack of Efficacy|3|||
125346467|NCT00592774|450902112|FG001|Overall Study|Lack of Efficacy|3|||
125346468|NCT00592774|450902113|FG002|Overall Study|Lack of Efficacy|0|||
125346469|NCT00592774|450902114|FG003|Overall Study|Lack of Efficacy|0|||
125346470|NCT00592774|450902115|FG004|Overall Study|Lack of Efficacy|2|||
125346471|NCT00592774|450902111|FG000|Overall Study|Physician Decision|0|||
125346472|NCT00592774|450902112|FG001|Overall Study|Physician Decision|1|||
125346473|NCT00592774|450902113|FG002|Overall Study|Physician Decision|1|||
125346474|NCT00592774|450902114|FG003|Overall Study|Physician Decision|0|||
125346475|NCT00592774|450902115|FG004|Overall Study|Physician Decision|1|||
125346476|NCT00592774|450902111|FG000|Overall Study|Other|0|||
125681578|NCT00824265|452123860|FG001|Treatment Phase|Withdrawal by Subject|15|||
125681579|NCT00824265|452123859|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
125681580|NCT00824265|452123860|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
125681581|NCT00824265|452123859|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
125681582|NCT00824265|452123860|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
125681583|NCT01402947|452123861|FG000|First Intervention|Adverse Event|0|||
125681584|NCT01402947|452123862|FG001|First Intervention|Adverse Event|1|||
125681585|NCT02079740|452125586|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
125681586|NCT02079740|452125587|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
125681587|NCT02079740|452125588|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
125681588|NCT02079740|452125589|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
125681589|NCT02079740|452125590|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
125681590|NCT02079740|452125591|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
125681591|NCT02079740|452125592|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
125681592|NCT02079740|452125593|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
125681593|NCT02079740|452125594|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
125346477|NCT00592774|450902112|FG001|Overall Study|Other|1|||
125346478|NCT00592774|450902113|FG002|Overall Study|Other|1|||
125346479|NCT00592774|450902114|FG003|Overall Study|Other|0|||
125346480|NCT00592774|450902115|FG004|Overall Study|Other|2|||
125346481|NCT01700439|450902116|FG000|Overall Study|Lost to Follow-up|47|||
125346482|NCT01700439|450902116|FG000|Overall Study|Withdrawal by Subject|183|||
125346483|NCT01700439|450902116|FG000|Overall Study|Death|186|||
125346484|NCT00621621|450902117|FG000|Overall Study|Subjects were exited at EP study|30|||
125346485|NCT00621621|450902118|FG001|Overall Study|Subjects were exited at EP study|0|||
125346486|NCT00906971|450902125|FG000|Overall Study|Withdrawal by Subject|8|||
125346487|NCT00906971|450902126|FG001|Overall Study|Withdrawal by Subject|2|||
125346488|NCT00906971|450902125|FG000|Overall Study|Lost to Follow-up|0|||
125346489|NCT00906971|450902126|FG001|Overall Study|Lost to Follow-up|1|||
125346490|NCT04054947|450902127|FG000|Overall Study|Withdrawal by Subject|1|||
125346491|NCT04054947|450902128|FG001|Overall Study|Withdrawal by Subject|0|||
125346492|NCT04054947|450902127|FG000|Overall Study|Lost to Follow-up|2|||
125346493|NCT04054947|450902128|FG001|Overall Study|Lost to Follow-up|5|||
125346494|NCT01606878|450902129|FG000|Overall Study|Adverse Event|1|||
125346495|NCT01606878|450902130|FG001|Overall Study|Adverse Event|1|||
125346496|NCT01606878|450902131|FG002|Overall Study|Adverse Event|0|||
125346497|NCT01606878|450902132|FG003|Overall Study|Adverse Event|0|||
125346498|NCT01606878|450902133|FG004|Overall Study|Adverse Event|0|||
125346499|NCT01606878|450902134|FG005|Overall Study|Adverse Event|0|||
125346500|NCT01606878|450902135|FG006|Overall Study|Adverse Event|1|||
125346501|NCT01606878|450902136|FG007|Overall Study|Adverse Event|0|||
125346502|NCT01606878|450902137|FG008|Overall Study|Adverse Event|1|||
125346503|NCT01606878|450902138|FG009|Overall Study|Adverse Event|3|||
125346504|NCT01606878|450902139|FG010|Overall Study|Adverse Event|0|||
125346505|NCT01606878|450902129|FG000|Overall Study|Lack of Efficacy|1|||
125346506|NCT01606878|450902130|FG001|Overall Study|Lack of Efficacy|1|||
125346507|NCT01606878|450902131|FG002|Overall Study|Lack of Efficacy|1|||
125346508|NCT01606878|450902132|FG003|Overall Study|Lack of Efficacy|2|||
125346509|NCT01606878|450902133|FG004|Overall Study|Lack of Efficacy|1|||
125346510|NCT01606878|450902134|FG005|Overall Study|Lack of Efficacy|2|||
125346511|NCT01606878|450902135|FG006|Overall Study|Lack of Efficacy|1|||
125346512|NCT01606878|450902136|FG007|Overall Study|Lack of Efficacy|2|||
125346513|NCT01606878|450902137|FG008|Overall Study|Lack of Efficacy|2|||
125346514|NCT01606878|450902138|FG009|Overall Study|Lack of Efficacy|0|||
125346515|NCT01606878|450902139|FG010|Overall Study|Lack of Efficacy|1|||
125346516|NCT01606878|450902129|FG000|Overall Study|Physician Decision|1|||
125346517|NCT01606878|450902130|FG001|Overall Study|Physician Decision|0|||
125346518|NCT01606878|450902131|FG002|Overall Study|Physician Decision|2|||
125346519|NCT01606878|450902132|FG003|Overall Study|Physician Decision|1|||
125346520|NCT01606878|450902133|FG004|Overall Study|Physician Decision|1|||
125346521|NCT01606878|450902134|FG005|Overall Study|Physician Decision|1|||
125346522|NCT01606878|450902135|FG006|Overall Study|Physician Decision|2|||
125346523|NCT01606878|450902136|FG007|Overall Study|Physician Decision|0|||
125346524|NCT01606878|450902137|FG008|Overall Study|Physician Decision|1|||
125346525|NCT01606878|450902138|FG009|Overall Study|Physician Decision|0|||
125346526|NCT01606878|450902139|FG010|Overall Study|Physician Decision|0|||
125346527|NCT01606878|450902129|FG000|Overall Study|Withdrawal by Subject|3|||
125346528|NCT01606878|450902130|FG001|Overall Study|Withdrawal by Subject|2|||
125346529|NCT01606878|450902131|FG002|Overall Study|Withdrawal by Subject|2|||
125346530|NCT01606878|450902132|FG003|Overall Study|Withdrawal by Subject|0|||
125346531|NCT01606878|450902133|FG004|Overall Study|Withdrawal by Subject|1|||
125346532|NCT01606878|450902134|FG005|Overall Study|Withdrawal by Subject|1|||
125346533|NCT01606878|450902135|FG006|Overall Study|Withdrawal by Subject|2|||
125346534|NCT01606878|450902136|FG007|Overall Study|Withdrawal by Subject|1|||
125346535|NCT01606878|450902137|FG008|Overall Study|Withdrawal by Subject|2|||
125346536|NCT01606878|450902138|FG009|Overall Study|Withdrawal by Subject|0|||
125346537|NCT01606878|450902139|FG010|Overall Study|Withdrawal by Subject|2|||
125346538|NCT03473548|450902140|FG000|Overall Study|Did not attempt HST testing|3|||
125346539|NCT03473548|450902141|FG001|Overall Study|Did not attempt HST testing|0|||
125346540|NCT00129311|450902142|FG000|Overall Study|Withdrawal by Subject|12|||
125346541|NCT00129311|450902143|FG001|Overall Study|Withdrawal by Subject|19|||
125346542|NCT01340872|450903645|FG000|Double-blind Phase|Adverse Event|6|||
125346543|NCT01340872|450903646|FG001|Double-blind Phase|Adverse Event|4|||
125346544|NCT01340872|450903647|FG002|Double-blind Phase|Adverse Event|0|||
125346545|NCT01340872|450903648|FG003|Double-blind Phase|Adverse Event|0|||
125346546|NCT01340872|450903645|FG000|Double-blind Phase|Withdrawal by Subject|3|||
125346547|NCT01340872|450903646|FG001|Double-blind Phase|Withdrawal by Subject|5|||
125346548|NCT01340872|450903647|FG002|Double-blind Phase|Withdrawal by Subject|0|||
125346549|NCT01340872|450903648|FG003|Double-blind Phase|Withdrawal by Subject|0|||
125346550|NCT01340872|450903645|FG000|Double-blind Phase|Lost to Follow-up|0|||
125346551|NCT01340872|450903646|FG001|Double-blind Phase|Lost to Follow-up|1|||
125346552|NCT01340872|450903647|FG002|Double-blind Phase|Lost to Follow-up|0|||
125346553|NCT01340872|450903648|FG003|Double-blind Phase|Lost to Follow-up|0|||
125346554|NCT01340872|450903645|FG000|Double-blind Phase|Protocol Violation|0|||
125346555|NCT01340872|450903646|FG001|Double-blind Phase|Protocol Violation|1|||
125346556|NCT01340872|450903647|FG002|Double-blind Phase|Protocol Violation|0|||
125346557|NCT01340872|450903648|FG003|Double-blind Phase|Protocol Violation|0|||
125346558|NCT01340872|450903645|FG000|Open-label Phase|Physician Decision|0|||
125346559|NCT01340872|450903646|FG001|Open-label Phase|Physician Decision|0|||
125346560|NCT01340872|450903647|FG002|Open-label Phase|Physician Decision|2|||
125346561|NCT01340872|450903648|FG003|Open-label Phase|Physician Decision|1|||
125346562|NCT01340872|450903645|FG000|Open-label Phase|Pregnancy|0|||
125346563|NCT01340872|450903646|FG001|Open-label Phase|Pregnancy|0|||
125346564|NCT01340872|450903647|FG002|Open-label Phase|Pregnancy|1|||
125346565|NCT01340872|450903648|FG003|Open-label Phase|Pregnancy|0|||
125346566|NCT01340872|450903645|FG000|Open-label Phase|Adverse Event|0|||
125346567|NCT01340872|450903646|FG001|Open-label Phase|Adverse Event|0|||
125346568|NCT01340872|450903647|FG002|Open-label Phase|Adverse Event|8|||
125346569|NCT01340872|450903648|FG003|Open-label Phase|Adverse Event|4|||
125346570|NCT01340872|450903645|FG000|Open-label Phase|Withdrawal by Subject|0|||
125346571|NCT01340872|450903646|FG001|Open-label Phase|Withdrawal by Subject|0|||
125346572|NCT01340872|450903647|FG002|Open-label Phase|Withdrawal by Subject|1|||
125346573|NCT01340872|450903648|FG003|Open-label Phase|Withdrawal by Subject|6|||
125346574|NCT01340872|450903645|FG000|Open-label Phase|Worsening of IBD|0|||
125346575|NCT01340872|450903646|FG001|Open-label Phase|Worsening of IBD|0|||
125346576|NCT01340872|450903647|FG002|Open-label Phase|Worsening of IBD|1|||
125346577|NCT01340872|450903648|FG003|Open-label Phase|Worsening of IBD|0|||
125346578|NCT03603509|450903649|FG000|Overall Study|Lost to Follow-up|3|||
125346579|NCT03603509|450903650|FG001|Overall Study|Lost to Follow-up|4|||
125346580|NCT01258998|450903653|FG000|Overall Study|Ineligible|1|||
125346581|NCT01143389|450903654|FG000|Overall Study|Lost to Follow-up|26|||
125346582|NCT01143389|450903655|FG001|Overall Study|Lost to Follow-up|25|||
125346583|NCT04966910|450903658|FG000|Baseline|Participant did not complete measure|0|||
125346584|NCT04966910|450903659|FG001|Baseline|Participant did not complete measure|0|||
125346585|NCT04966910|450903660|FG002|Baseline|Participant did not complete measure|1|||
125346586|NCT04966910|450903661|FG003|Baseline|Participant did not complete measure|0|||
125346587|NCT04966910|450903658|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
125346588|NCT04966910|450903659|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
125346589|NCT04966910|450903660|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
125346590|NCT04966910|450903661|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
125346591|NCT04966910|450903658|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
125346592|NCT04966910|450903659|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
125346593|NCT04966910|450903660|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
125346594|NCT04966910|450903661|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
125346595|NCT04966910|450903658|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
125346596|NCT04966910|450903659|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
125346597|NCT04966910|450903660|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
125346598|NCT04966910|450903661|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
125346599|NCT02276027|450903663|FG000|Overall Study|Death|1|||
125346600|NCT02276027|450903664|FG001|Overall Study|Death|0|||
125346601|NCT02276027|450903665|FG002|Overall Study|Death|0|||
125346602|NCT02276027|450903666|FG003|Overall Study|Death|2|||
125346603|NCT02276027|450903663|FG000|Overall Study|Physician Decision|0|||
125346604|NCT02276027|450903664|FG001|Overall Study|Physician Decision|0|||
125346605|NCT02276027|450903665|FG002|Overall Study|Physician Decision|0|||
125346606|NCT02276027|450903666|FG003|Overall Study|Physician Decision|1|||
125346607|NCT02276027|450903663|FG000|Overall Study|Progressive disease|1|||
125346608|NCT02276027|450903664|FG001|Overall Study|Progressive disease|13|||
125346609|NCT02276027|450903665|FG002|Overall Study|Progressive disease|12|||
125346610|NCT02276027|450903666|FG003|Overall Study|Progressive disease|14|||
125346611|NCT02276027|450903663|FG000|Overall Study|Subject/guardian decision|0|||
125346612|NCT02276027|450903664|FG001|Overall Study|Subject/guardian decision|1|||
125346613|NCT02276027|450903665|FG002|Overall Study|Subject/guardian decision|0|||
125548195|NCT00585195|451637115|FG009|Overall Study|Randomized not treated|0|||
125548196|NCT00585195|451637116|FG010|Overall Study|Randomized not treated|2|||
125548197|NCT00585195|451637117|FG011|Overall Study|Randomized not treated|0|||
125346614|NCT02276027|450903666|FG003|Overall Study|Subject/guardian decision|3|||
125346615|NCT02276027|450903663|FG000|Overall Study|Adverse Event|0|||
125346616|NCT02276027|450903664|FG001|Overall Study|Adverse Event|2|||
125346617|NCT02276027|450903665|FG002|Overall Study|Adverse Event|8|||
125346618|NCT02276027|450903666|FG003|Overall Study|Adverse Event|2|||
125346619|NCT03224598|450903667|FG000|Overall Study|Lost to Follow-up|0|||
125346620|NCT03224598|450903668|FG001|Overall Study|Lost to Follow-up|2|||
125346621|NCT03224598|450903669|FG002|Overall Study|Lost to Follow-up|0|||
125346622|NCT03224598|450903667|FG000|Overall Study|Other|0|||
125346623|NCT03224598|450903668|FG001|Overall Study|Other|1|||
125346624|NCT03224598|450903669|FG002|Overall Study|Other|0|||
125346625|NCT01527357|450903679|FG000|Overall Study|Death|8|||
125346626|NCT01527357|450903680|FG001|Overall Study|Death|2|||
125346627|NCT01527357|450903679|FG000|Overall Study|Lost to Follow-up|6|||
125346628|NCT01527357|450903680|FG001|Overall Study|Lost to Follow-up|4|||
125346629|NCT01527357|450903679|FG000|Overall Study|Withdrew Consent|1|||
125346630|NCT01527357|450903680|FG001|Overall Study|Withdrew Consent|1|||
125346631|NCT01527357|450903679|FG000|Overall Study|Non-compliance|0|||
125346632|NCT01527357|450903680|FG001|Overall Study|Non-compliance|1|||
125346633|NCT01527357|450903679|FG000|Overall Study|No Day 29 Visit|0|||
125346634|NCT01527357|450903680|FG001|Overall Study|No Day 29 Visit|1|||
125346635|NCT01527357|450903679|FG000|Overall Study|Did Not Receive Treatment|2|||
125346636|NCT01527357|450903680|FG001|Overall Study|Did Not Receive Treatment|0|||
125346637|NCT02446171|450903681|FG000|Overall Study|Withdrawal by Subject|0|||
125346638|NCT02446171|450903682|FG001|Overall Study|Withdrawal by Subject|0|||
125346639|NCT02446171|450903683|FG002|Overall Study|Withdrawal by Subject|2|||
125346640|NCT02446171|450903684|FG003|Overall Study|Withdrawal by Subject|0|||
125346641|NCT04531462|450903685|FG000|Overall Study|Withdrawal by Subject|3|||
125346642|NCT04531462|450903686|FG001|Overall Study|Withdrawal by Subject|1|||
125346643|NCT04531462|450903685|FG000|Overall Study|Adverse Event|3|||
125346644|NCT04531462|450903686|FG001|Overall Study|Adverse Event|3|||
125346645|NCT00504582|450903687|FG000|Overall Study|Lost to Follow-up|1|||
125346646|NCT00504582|450903688|FG001|Overall Study|Lost to Follow-up|0|||
125346647|NCT00504582|450903689|FG002|Overall Study|Lost to Follow-up|0|||
125346648|NCT02292784|450903692|FG000|Overall Study|Lost to Follow-up|1|||
125346649|NCT02292784|450903693|FG001|Overall Study|Lost to Follow-up|17|||
125346650|NCT02292784|450903694|FG002|Overall Study|Lost to Follow-up|18|||
125346651|NCT02292784|450903692|FG000|Overall Study|Withdrawal by Subject|0|||
125346652|NCT02292784|450903693|FG001|Overall Study|Withdrawal by Subject|3|||
125346653|NCT02292784|450903694|FG002|Overall Study|Withdrawal by Subject|3|||
125346654|NCT00348933|450903695|FG000|Overall Study|Withdrawal by Subject|10|||
125346655|NCT00348933|450903695|FG000|Overall Study|Lost to Follow-up|6|||
125346656|NCT00348933|450903695|FG000|Overall Study|Protocol Violation|2|||
125346657|NCT00348933|450903695|FG000|Overall Study|Adverse Event|7|||
125346658|NCT01264081|450903696|FG000|Participants Screened|Screening failures|30|||
125346659|NCT01264081|450903696|FG000|Started Treatment|Withdrawal by Subject|1|||
125346660|NCT01264081|450903696|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
125346661|NCT01489111|450903697|FG000|Overall Study|Withdrawal criterion|1|||
125346662|NCT00134784|450903698|FG000|Overall Study|Withdrawal by Subject|2|||
125346663|NCT00134784|450903699|FG001|Overall Study|Withdrawal by Subject|2|||
125346664|NCT00134784|450903700|FG002|Overall Study|Withdrawal by Subject|2|||
125346665|NCT00134784|450903701|FG003|Overall Study|Withdrawal by Subject|1|||
125346666|NCT00730028|450903706|FG000|Overall Study|Adverse Event|23|||
125346667|NCT00730028|450903707|FG001|Overall Study|Adverse Event|26|||
125346668|NCT00730028|450903708|FG002|Overall Study|Adverse Event|16|||
125346669|NCT00730028|450903709|FG003|Overall Study|Adverse Event|20|||
125346670|NCT00730028|450903710|FG004|Overall Study|Adverse Event|43|||
125346671|NCT00730028|450903706|FG000|Overall Study|Lost to Follow-up|13|||
125346672|NCT00730028|450903707|FG001|Overall Study|Lost to Follow-up|26|||
125346673|NCT00730028|450903708|FG002|Overall Study|Lost to Follow-up|22|||
125346674|NCT00730028|450903709|FG003|Overall Study|Lost to Follow-up|26|||
125346675|NCT00730028|450903710|FG004|Overall Study|Lost to Follow-up|25|||
125346676|NCT00730028|450903706|FG000|Overall Study|Protocol Violation|6|||
125346677|NCT00730028|450903707|FG001|Overall Study|Protocol Violation|1|||
125346678|NCT00730028|450903708|FG002|Overall Study|Protocol Violation|1|||
125346679|NCT00730028|450903709|FG003|Overall Study|Protocol Violation|2|||
125346680|NCT00730028|450903710|FG004|Overall Study|Protocol Violation|0|||
125346681|NCT00730028|450903706|FG000|Overall Study|Withdrawal by Subject|9|||
125346682|NCT00730028|450903707|FG001|Overall Study|Withdrawal by Subject|5|||
125346683|NCT00730028|450903708|FG002|Overall Study|Withdrawal by Subject|4|||
125346684|NCT00730028|450903709|FG003|Overall Study|Withdrawal by Subject|5|||
125548198|NCT00585195|451637118|FG012|Overall Study|Randomized not treated|0|||
125548199|NCT00585195|451637119|FG013|Overall Study|Randomized not treated|0|||
125346685|NCT00730028|450903710|FG004|Overall Study|Withdrawal by Subject|9|||
125346686|NCT00730028|450903706|FG000|Overall Study|Physician Decision|3|||
125346687|NCT00730028|450903707|FG001|Overall Study|Physician Decision|3|||
125548200|NCT00585195|451637120|FG014|Overall Study|Randomized not treated|0|||
125346688|NCT00730028|450903708|FG002|Overall Study|Physician Decision|2|||
125346689|NCT00730028|450903709|FG003|Overall Study|Physician Decision|3|||
125346690|NCT00730028|450903710|FG004|Overall Study|Physician Decision|2|||
125346691|NCT00730028|450903706|FG000|Overall Study|Treatment Failure|5|||
125346692|NCT00730028|450903707|FG001|Overall Study|Treatment Failure|5|||
125346693|NCT00730028|450903708|FG002|Overall Study|Treatment Failure|0|||
125346694|NCT00730028|450903709|FG003|Overall Study|Treatment Failure|0|||
125346695|NCT00730028|450903710|FG004|Overall Study|Treatment Failure|1|||
125346696|NCT00730028|450903706|FG000|Overall Study|Randomization Error|1|||
125346697|NCT00730028|450903707|FG001|Overall Study|Randomization Error|0|||
125346698|NCT00730028|450903708|FG002|Overall Study|Randomization Error|0|||
125346699|NCT00730028|450903709|FG003|Overall Study|Randomization Error|0|||
125346700|NCT00730028|450903710|FG004|Overall Study|Randomization Error|2|||
125346701|NCT03811093|450903711|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
125346702|NCT03811093|450903712|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
125346703|NCT03811093|450903711|FG000|Overall Study|Unable to measure body fat percentage|2|||
125346704|NCT03811093|450903712|FG001|Overall Study|Unable to measure body fat percentage|0|||
125346705|NCT00464490|450903713|FG000|Overall Study|Physician Decision|11|||
125346706|NCT00464490|450903714|FG001|Overall Study|Physician Decision|11|||
125346707|NCT03188042|450903715|FG000|Overall Study|Withdrawal by Subject|1|||
125346708|NCT03188042|450903716|FG001|Overall Study|Withdrawal by Subject|1|||
125346709|NCT03565367|450903720|FG000|Overall Study|No scan due to technical issues|4|||
125346710|NCT03565367|450903721|FG001|Overall Study|No scan due to technical issues|0|||
125346711|NCT04352127|450903722|FG000|Overall Study|Unable to obtain readings|4|||
125346712|NCT04352127|450903723|FG001|Overall Study|Unable to obtain readings|1|||
125346713|NCT05338671|450903724|FG000|Overall Study|Lost to Follow-up|2|||
125346714|NCT05338671|450903725|FG001|Overall Study|Lost to Follow-up|2|||
125346715|NCT05338671|450903724|FG000|Overall Study|Root canal completed in a single visit|1|||
125346716|NCT05338671|450903725|FG001|Overall Study|Root canal completed in a single visit|0|||
125346717|NCT03874429|450903726|FG000|Overall Study|Adverse Event|2|||
125346718|NCT03874429|450903727|FG001|Overall Study|Adverse Event|2|||
125346719|NCT03874429|450903726|FG000|Overall Study|Lack of Efficacy|0|||
125346720|NCT03874429|450903727|FG001|Overall Study|Lack of Efficacy|1|||
125346721|NCT03874429|450903726|FG000|Overall Study|Covid-19 pandemic|4|||
125346722|NCT03874429|450903727|FG001|Overall Study|Covid-19 pandemic|2|||
125346723|NCT00868517|450903730|FG000|Overall Study|Withdrawal by Subject|3|||
125346724|NCT00868517|450903731|FG001|Overall Study|Withdrawal by Subject|3|||
125346725|NCT00868517|450903732|FG002|Overall Study|Withdrawal by Subject|2|||
125346726|NCT00868517|450903730|FG000|Overall Study|Protocol Violation|1|||
125346727|NCT00868517|450903731|FG001|Overall Study|Protocol Violation|1|||
125346728|NCT00868517|450903732|FG002|Overall Study|Protocol Violation|0|||
125346729|NCT00420641|450903735|FG000|Overall Study|Adverse Event|3|||
125346730|NCT00420641|450903736|FG001|Overall Study|Adverse Event|25|||
125346731|NCT00420641|450903737|FG002|Overall Study|Adverse Event|10|||
125346732|NCT00420641|450903735|FG000|Overall Study|Lost to Follow-up|2|||
125346733|NCT00420641|450903736|FG001|Overall Study|Lost to Follow-up|4|||
125346734|NCT00420641|450903737|FG002|Overall Study|Lost to Follow-up|2|||
125346735|NCT00420641|450903735|FG000|Overall Study|Protocol Violation|8|||
125346736|NCT00420641|450903736|FG001|Overall Study|Protocol Violation|8|||
125346737|NCT00420641|450903737|FG002|Overall Study|Protocol Violation|7|||
125346738|NCT00420641|450903735|FG000|Overall Study|Withdrawal by Subject|15|||
125346739|NCT00420641|450903736|FG001|Overall Study|Withdrawal by Subject|21|||
125346740|NCT00420641|450903737|FG002|Overall Study|Withdrawal by Subject|14|||
125346741|NCT00420641|450903735|FG000|Overall Study|Lack of Efficacy|6|||
125346742|NCT00420641|450903736|FG001|Overall Study|Lack of Efficacy|5|||
125346743|NCT00420641|450903737|FG002|Overall Study|Lack of Efficacy|4|||
125346744|NCT00420641|450903735|FG000|Overall Study|Non-compliance|7|||
125346745|NCT00420641|450903736|FG001|Overall Study|Non-compliance|5|||
125346746|NCT00420641|450903737|FG002|Overall Study|Non-compliance|4|||
125346747|NCT00420641|450903735|FG000|Overall Study|Other|4|||
125346748|NCT00420641|450903736|FG001|Overall Study|Other|4|||
125346749|NCT00420641|450903737|FG002|Overall Study|Other|3|||
125346750|NCT01227824|450903740|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
125346751|NCT01227824|450903741|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
125346752|NCT01227824|450903742|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
125346753|NCT01227824|450903740|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
125346754|NCT01227824|450903741|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
125346755|NCT01227824|450903742|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
125548201|NCT00585195|451637121|FG015|Overall Study|Randomized not treated|1|||
125548202|NCT00585195|451637122|FG016|Overall Study|Randomized not treated|0|||
125346756|NCT01227824|450903740|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
125346757|NCT01227824|450903741|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
125346758|NCT01227824|450903742|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
125346759|NCT01227824|450903740|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
125378918|NCT00589914|451019207|FG001|Overall Study|Withdrawal by Subject|49|||
125346760|NCT01227824|450903741|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
125346761|NCT01227824|450903742|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
125346762|NCT01227824|450903740|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
125346763|NCT01227824|450903741|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
125346764|NCT01227824|450903742|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
125346765|NCT01227824|450903740|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
125346766|NCT01227824|450903741|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
125346767|NCT01227824|450903742|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
125346768|NCT01227824|450903740|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
125346769|NCT01227824|450903741|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
125346770|NCT01227824|450903742|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
125346771|NCT01227824|450903740|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
125346772|NCT01227824|450903741|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
125346773|NCT01227824|450903742|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
125346774|NCT01227824|450903740|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
125346775|NCT01227824|450903741|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
125346776|NCT01227824|450903742|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
125346777|NCT01227824|450903740|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
125346778|NCT01227824|450903741|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
125346779|NCT01227824|450903742|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
125346780|NCT01227824|450903740|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
125346781|NCT01227824|450903741|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
125346782|NCT01227824|450903742|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
125346783|NCT01227824|450903740|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
125346784|NCT01227824|450903741|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
125346785|NCT01227824|450903742|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
125346786|NCT01227824|450903740|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
125346787|NCT01227824|450903741|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
125346788|NCT01227824|450903742|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
125346789|NCT01227824|450903740|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
125346790|NCT01227824|450903741|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
125346791|NCT01227824|450903742|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
125346792|NCT01227824|450903740|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
125346793|NCT01227824|450903741|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
125346794|NCT01227824|450903742|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
125346795|NCT02395302|450903745|FG000|Overall Study|Screen Failure|3|||
125346796|NCT02395302|450903745|FG000|Overall Study|Run In Failure|7|||
125346797|NCT02395302|450903745|FG000|Overall Study|Withdrawal by Subject|2|||
125346798|NCT02395302|450903745|FG000|Overall Study|Physician Decision|2|||
125346799|NCT01306929|450903746|FG000|Overall Study|Withdrawal by Subject|23|||
125346800|NCT01306929|450903746|FG000|Overall Study|Adverse Event|21|||
125346801|NCT01306929|450903746|FG000|Overall Study|Physician Decision|13|||
125346802|NCT01306929|450903746|FG000|Overall Study|Death|8|||
125346803|NCT01306929|450903746|FG000|Overall Study|Withdrawal by parent/guardian|5|||
125346804|NCT01306929|450903746|FG000|Overall Study|Protocol Violation|3|||
125346805|NCT01306929|450903746|FG000|Overall Study|Non-compliance with study drug|2|||
125346806|NCT01306929|450903746|FG000|Overall Study|Lost to Follow-up|2|||
125346807|NCT01306929|450903746|FG000|Overall Study|Various|17|||
125346808|NCT00710762|450903749|FG000|Overall Study|Progressive disease|27|||
125346809|NCT00710762|450903750|FG001|Overall Study|Progressive disease|30|||
125346810|NCT00710762|450903749|FG000|Overall Study|Adverse Event other disease worsening|2|||
125346811|NCT00710762|450903750|FG001|Overall Study|Adverse Event other disease worsening|1|||
125346812|NCT00710762|450903749|FG000|Overall Study|Other Adverse Event|7|||
125346813|NCT00710762|450903750|FG001|Overall Study|Other Adverse Event|7|||
125346814|NCT00710762|450903749|FG000|Overall Study|Lost to Follow-up|1|||
125346815|NCT00710762|450903750|FG001|Overall Study|Lost to Follow-up|0|||
125346816|NCT00710762|450903749|FG000|Overall Study|Reason other than listed above|2|||
125346817|NCT00710762|450903750|FG001|Overall Study|Reason other than listed above|2|||
125346818|NCT00608569|450903763|FG000|Overall Study|Death|4|||
125346819|NCT00608569|450903764|FG001|Overall Study|Death|3|||
125346820|NCT00608569|450903763|FG000|Overall Study|Lost to Follow-up|4|||
125346821|NCT00608569|450903764|FG001|Overall Study|Lost to Follow-up|5|||
125346822|NCT00608569|450903763|FG000|Overall Study|Withdrawal by Subject|1|||
125346823|NCT00608569|450903764|FG001|Overall Study|Withdrawal by Subject|0|||
125346824|NCT00608569|450903763|FG000|Overall Study|Adverse Event|1|||
125346825|NCT00608569|450903764|FG001|Overall Study|Adverse Event|0|||
125346826|NCT00608569|450903763|FG000|Overall Study|Unable to adhere with study requirements|0|||
125346827|NCT00608569|450903764|FG001|Overall Study|Unable to adhere with study requirements|1|||
125346828|NCT00053898|450903765|FG000|Overall Study|No follow-up data from any source|9|||
125346829|NCT00053898|450903766|FG001|Overall Study|No follow-up data from any source|12|||
125346830|NCT00053898|450903765|FG000|Overall Study|Follow-up from telephone contact only|5|||
125346831|NCT00053898|450903766|FG001|Overall Study|Follow-up from telephone contact only|1|||
125346832|NCT00545129|450903769|FG000|Overall Study|Lack of Efficacy|2|||
125346833|NCT00545129|450903770|FG001|Overall Study|Lack of Efficacy|5|||
125346834|NCT00545129|450903769|FG000|Overall Study|Death|2|||
125346835|NCT00545129|450903770|FG001|Overall Study|Death|1|||
125346836|NCT00545129|450903769|FG000|Overall Study|Adverse Event|1|||
125346837|NCT00545129|450903770|FG001|Overall Study|Adverse Event|1|||
125346838|NCT00545129|450903769|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
125346839|NCT00545129|450903770|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
125346840|NCT00545129|450903769|FG000|Overall Study|Other|3|||
125346841|NCT00545129|450903770|FG001|Overall Study|Other|3|||
125346842|NCT01894568|450903771|FG000|Overall Study|Adverse Event|2|||
125346843|NCT01894568|450903772|FG001|Overall Study|Adverse Event|3|||
125346844|NCT01894568|450903771|FG000|Overall Study|Protocol required discontinuation|2|||
125346845|NCT01894568|450903772|FG001|Overall Study|Protocol required discontinuation|1|||
125346846|NCT01894568|450903771|FG000|Overall Study|Withdrawal by Subject|5|||
125548203|NCT00585195|451637123|FG017|Overall Study|Randomized not treated|1|||
125548204|NCT00585195|451637124|FG018|Overall Study|Randomized not treated|3|||
125548205|NCT00585195|451637125|FG019|Overall Study|Randomized not treated|0|||
125548206|NCT00585195|451637126|FG020|Overall Study|Randomized not treated|2|||
125346847|NCT01894568|450903772|FG001|Overall Study|Withdrawal by Subject|5|||
125346848|NCT01894568|450903771|FG000|Overall Study|Physician Decision|1|||
125346849|NCT01894568|450903772|FG001|Overall Study|Physician Decision|0|||
125346850|NCT01894568|450903771|FG000|Overall Study|Lost to Follow-up|0|||
125346851|NCT01894568|450903772|FG001|Overall Study|Lost to Follow-up|1|||
125346852|NCT01514370|450903774|FG000|Overall Study|Protocol Violation|2|||
125346853|NCT01514370|450903775|FG001|Overall Study|Protocol Violation|3|||
125346854|NCT01514370|450903774|FG000|Overall Study|Lost to Follow-up|0|||
125346855|NCT01514370|450903775|FG001|Overall Study|Lost to Follow-up|2|||
125346856|NCT01514370|450903774|FG000|Overall Study|Withdrawal by Subject|2|||
125346857|NCT01514370|450903775|FG001|Overall Study|Withdrawal by Subject|1|||
125346858|NCT01514370|450903774|FG000|Overall Study|Adverse Event|1|||
125346859|NCT01514370|450903775|FG001|Overall Study|Adverse Event|3|||
125346860|NCT01514370|450903774|FG000|Overall Study|Other|6|||
125346861|NCT01514370|450903775|FG001|Overall Study|Other|7|||
125346862|NCT01551420|450903776|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
125346863|NCT01551420|450903777|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
125346864|NCT01551420|450903776|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
125346865|NCT01551420|450903777|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
125346866|NCT01551420|450903776|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
125346867|NCT01551420|450903777|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
125346868|NCT01551420|450903776|FG000|Screened for Part B Eligibility|Declined participation|8|||
125346869|NCT01551420|450903777|FG001|Screened for Part B Eligibility|Declined participation|1|||
125346870|NCT01551420|450903776|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
125346871|NCT01551420|450903777|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
125346872|NCT01551420|450903776|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
125346873|NCT01551420|450903777|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
125346874|NCT01551420|450903776|FG000|Home Use (Part B)|Withdrawal by staff|0|||
125346875|NCT01551420|450903777|FG001|Home Use (Part B)|Withdrawal by staff|1|||
125346876|NCT03353740|450903779|FG000|Overall Study|Images for these participants not viable|52|||
125346877|NCT02232880|450903780|FG000|Overall Study|study stopped prior to randomization|1|||
125346878|NCT02545543|450903781|FG000|Overall Study|Lost to Follow-up|67|||
125346879|NCT02545543|450903782|FG001|Overall Study|Lost to Follow-up|25|||
125346880|NCT02545543|450903781|FG000|Overall Study|Physician Decision|3|||
125346881|NCT02545543|450903782|FG001|Overall Study|Physician Decision|0|||
125346882|NCT02545543|450903781|FG000|Overall Study|Withdrawal by Subject|9|||
125346883|NCT02545543|450903782|FG001|Overall Study|Withdrawal by Subject|8|||
125346884|NCT02545543|450903781|FG000|Overall Study|Noncomplaince|1|||
125346885|NCT02545543|450903782|FG001|Overall Study|Noncomplaince|0|||
125346886|NCT02545543|450903781|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
125681594|NCT02079740|452125595|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
125681595|NCT02079740|452125596|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
125681596|NCT02079740|452125597|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
125681597|NCT02079740|452125598|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
125681598|NCT02079740|452125586|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
125681599|NCT02079740|452125587|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
125681600|NCT02079740|452125588|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
125681601|NCT02079740|452125589|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
125681602|NCT02079740|452125590|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
125681603|NCT02079740|452125591|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
125681604|NCT02079740|452125592|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
125681605|NCT02079740|452125593|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
125681606|NCT02079740|452125594|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
125681607|NCT02079740|452125595|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
125681608|NCT02079740|452125596|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
125681609|NCT02079740|452125597|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
125681610|NCT02079740|452125598|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
125681611|NCT02079740|452125586|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
125681612|NCT02079740|452125587|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
125681613|NCT02079740|452125588|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
125681614|NCT02079740|452125589|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
125681615|NCT02079740|452125590|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
125681616|NCT02079740|452125591|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
125681617|NCT02079740|452125592|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
125681618|NCT02079740|452125593|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
125681619|NCT02079740|452125594|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
125681620|NCT02079740|452125595|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
125681621|NCT02079740|452125596|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
125681622|NCT02079740|452125597|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
125681623|NCT02079740|452125598|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
125681624|NCT02079740|452125586|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125681625|NCT02079740|452125587|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125681626|NCT02079740|452125588|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125681627|NCT02079740|452125589|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125681628|NCT02079740|452125590|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125681629|NCT02079740|452125591|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125681630|NCT02079740|452125592|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125346887|NCT02545543|450903782|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
125346888|NCT02829944|450903783|FG000|Overall Study|Physician Decision|0|||
125346889|NCT02829944|450903784|FG001|Overall Study|Physician Decision|1|||
125346890|NCT02829944|450903783|FG000|Overall Study|Screen Failure|2|||
125346891|NCT02829944|450903784|FG001|Overall Study|Screen Failure|2|||
125346892|NCT02829944|450903783|FG000|Overall Study|Inadequate Neuraxial Block|1|||
125346893|NCT02829944|450903784|FG001|Overall Study|Inadequate Neuraxial Block|1|||
125346894|NCT02829944|450903783|FG000|Overall Study|Withdrawal by Subject|2|||
125346895|NCT02829944|450903784|FG001|Overall Study|Withdrawal by Subject|1|||
125346896|NCT02829944|450903783|FG000|Overall Study|Catheter Displacement|1|||
125346897|NCT02829944|450903784|FG001|Overall Study|Catheter Displacement|0|||
125346898|NCT02829944|450903783|FG000|Overall Study|Catheter broke|0|||
125346899|NCT02829944|450903784|FG001|Overall Study|Catheter broke|1|||
125346900|NCT02829944|450903783|FG000|Overall Study|Staff unavailable|0|||
125346901|NCT02829944|450903784|FG001|Overall Study|Staff unavailable|1|||
125346902|NCT01395784|450903785|FG000|Overall Study|Lost to Follow-up|7|||
125346903|NCT01395784|450903785|FG000|Overall Study|Withdrawal by Subject|3|||
125346904|NCT01395784|450903785|FG000|Overall Study|Physician Decision|5|||
125346905|NCT04268823|450903786|FG000|Overall Study|Adverse Event|1|||
125346906|NCT04268823|450903787|FG001|Overall Study|Adverse Event|0|||
125346907|NCT04268823|450903786|FG000|Overall Study|Participant Decision|1|||
125346908|NCT04268823|450903787|FG001|Overall Study|Participant Decision|0|||
125346909|NCT02055365|450905525|FG000|Overall Study|Prematurely Withdrawn|1|||
125346910|NCT02882152|450905526|FG000|Overall Study|Lost to Follow-up|1|||
125346911|NCT02882152|450905527|FG001|Overall Study|Lost to Follow-up|0|||
125346912|NCT01343823|450905530|FG000|Overall Study|Study Terminated|1|||
125346913|NCT01343823|450905531|FG001|Overall Study|Study Terminated|0|||
125346914|NCT01343823|450905532|FG002|Overall Study|Study Terminated|0|||
125346915|NCT01343823|450905533|FG003|Overall Study|Study Terminated|1|||
125346916|NCT01343823|450905530|FG000|Overall Study|Withdrawal by Subject|1|||
125346917|NCT01343823|450905531|FG001|Overall Study|Withdrawal by Subject|0|||
125346918|NCT01343823|450905532|FG002|Overall Study|Withdrawal by Subject|0|||
125346919|NCT01343823|450905533|FG003|Overall Study|Withdrawal by Subject|0|||
125346920|NCT00923364|450905534|FG000|Overall Study|Death|3|||
125346921|NCT00923364|450905535|FG001|Overall Study|Death|0|||
125548207|NCT00585195|451637106|FG000|Overall Study|Death|0|||
125548208|NCT00585195|451637107|FG001|Overall Study|Death|0|||
125548209|NCT00585195|451637108|FG002|Overall Study|Death|0|||
125548210|NCT00585195|451637109|FG003|Overall Study|Death|0|||
125548211|NCT00585195|451637110|FG004|Overall Study|Death|0|||
125548212|NCT00585195|451637111|FG005|Overall Study|Death|0|||
125548213|NCT00585195|451637112|FG006|Overall Study|Death|0|||
125548214|NCT00585195|451637113|FG007|Overall Study|Death|0|||
125681631|NCT02079740|452125593|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
125681632|NCT02079740|452125594|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125681633|NCT02079740|452125595|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125681634|NCT02079740|452125596|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125681635|NCT02079740|452125597|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125681636|NCT02079740|452125598|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
125681637|NCT02079740|452125586|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125681638|NCT02079740|452125587|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125681639|NCT02079740|452125588|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125681640|NCT02079740|452125589|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125681641|NCT02079740|452125590|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125681642|NCT02079740|452125591|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125681643|NCT02079740|452125592|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125681644|NCT02079740|452125593|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125681645|NCT02079740|452125594|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125681646|NCT02079740|452125595|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
125681647|NCT02079740|452125596|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
125681648|NCT02079740|452125597|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
125681649|NCT02079740|452125598|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
125681650|NCT02328014|452125599|FG000|Overall Study|Adverse Event|1|||
125681651|NCT02328014|452125600|FG001|Overall Study|Adverse Event|0|||
125681652|NCT02328014|452125601|FG002|Overall Study|Adverse Event|0|||
125681653|NCT02328014|452125602|FG003|Overall Study|Adverse Event|1|||
125681654|NCT02328014|452125599|FG000|Overall Study|Death|0|||
125681655|NCT02328014|452125600|FG001|Overall Study|Death|0|||
125681656|NCT02328014|452125601|FG002|Overall Study|Death|0|||
125346922|NCT00923364|450905534|FG000|Overall Study|Did not go to transplant|1|||
125681657|NCT02328014|452125602|FG003|Overall Study|Death|4|||
125346923|NCT00923364|450905535|FG001|Overall Study|Did not go to transplant|0|||
125346924|NCT01752036|450905536|FG000|Overall Study|Death|2|||
125346925|NCT01437995|450905537|FG000|Overall Study|Lost to Follow-up|11|||
125346926|NCT01437995|450905538|FG001|Overall Study|Lost to Follow-up|18|||
125548215|NCT00585195|451637114|FG008|Overall Study|Death|1|||
125548216|NCT00585195|451637115|FG009|Overall Study|Death|0|||
125548217|NCT00585195|451637116|FG010|Overall Study|Death|1|||
125548218|NCT00585195|451637117|FG011|Overall Study|Death|1|||
125548219|NCT00585195|451637118|FG012|Overall Study|Death|7|||
125346927|NCT01437995|450905539|FG002|Overall Study|Lost to Follow-up|20|||
125681658|NCT02328014|452125599|FG000|Overall Study|Physician Decision|0|||
125681659|NCT02328014|452125600|FG001|Overall Study|Physician Decision|0|||
125681660|NCT02328014|452125601|FG002|Overall Study|Physician Decision|0|||
125681661|NCT02328014|452125602|FG003|Overall Study|Physician Decision|1|||
125681662|NCT02328014|452125599|FG000|Overall Study|Disease Progression|1|||
125681663|NCT02328014|452125600|FG001|Overall Study|Disease Progression|0|||
125681664|NCT02328014|452125601|FG002|Overall Study|Disease Progression|1|||
125681665|NCT02328014|452125602|FG003|Overall Study|Disease Progression|3|||
125681666|NCT02328014|452125599|FG000|Overall Study|Study Terminated by Sponsor|4|||
125681667|NCT02328014|452125600|FG001|Overall Study|Study Terminated by Sponsor|1|||
125681668|NCT02328014|452125601|FG002|Overall Study|Study Terminated by Sponsor|1|||
125681669|NCT02328014|452125602|FG003|Overall Study|Study Terminated by Sponsor|0|||
125681670|NCT02328014|452125599|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
125681671|NCT02328014|452125600|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
125681672|NCT02328014|452125601|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
125681673|NCT02328014|452125602|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
125681674|NCT02328014|452125599|FG000|Overall Study|Withdrawal by Subject|0|||
125681675|NCT02328014|452125600|FG001|Overall Study|Withdrawal by Subject|0|||
125681676|NCT02328014|452125601|FG002|Overall Study|Withdrawal by Subject|0|||
125681677|NCT02328014|452125602|FG003|Overall Study|Withdrawal by Subject|1|||
125681678|NCT01274338|452125603|FG000|Overall Study|Lack of Efficacy|72|||
125681679|NCT01274338|452125604|FG001|Overall Study|Lack of Efficacy|108|||
125681680|NCT01274338|452125605|FG002|Overall Study|Lack of Efficacy|116|||
125681681|NCT01274338|452125606|FG003|Overall Study|Lack of Efficacy|0|||
125681682|NCT01274338|452125607|FG004|Overall Study|Lack of Efficacy|0|||
125346928|NCT04456673|450905540|FG000|Overall Study|Adverse Event|7|||
125346929|NCT04456673|450905541|FG001|Overall Study|Adverse Event|14|||
125346930|NCT04456673|450905540|FG000|Overall Study|Poor compliance to protocol|1|||
125346931|NCT04456673|450905541|FG001|Overall Study|Poor compliance to protocol|0|||
125346932|NCT04456673|450905540|FG000|Overall Study|Withdrawal by Subject|31|||
125346933|NCT04456673|450905541|FG001|Overall Study|Withdrawal by Subject|23|||
125346934|NCT04456673|450905540|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
125346935|NCT04456673|450905541|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
125346936|NCT04391049|450905542|FG000|Overall Study|Protocol Violation|1|||
125346937|NCT02160002|450905543|FG000|Overall Study|Withdrawal by Subject|2|||
125346938|NCT02160002|450905544|FG001|Overall Study|Withdrawal by Subject|1|||
125346939|NCT00246571|450905545|FG000|Overall Study|Adverse Event|7|||
125346940|NCT00246571|450905546|FG001|Overall Study|Adverse Event|0|||
125346941|NCT00246571|450905545|FG000|Overall Study|Protocol Violation|0|||
125346942|NCT00246571|450905546|FG001|Overall Study|Protocol Violation|1|||
125346943|NCT00246571|450905545|FG000|Overall Study|Withdrawal by Subject|2|||
125346944|NCT00246571|450905546|FG001|Overall Study|Withdrawal by Subject|3|||
125346945|NCT00246571|450905545|FG000|Overall Study|Lack of Efficacy|84|||
125346946|NCT00246571|450905546|FG001|Overall Study|Lack of Efficacy|21|||
125346947|NCT00246571|450905545|FG000|Overall Study|Death|17|||
125346948|NCT00246571|450905546|FG001|Overall Study|Death|3|||
125346949|NCT00246571|450905545|FG000|Overall Study|Sponsor|0|||
125346950|NCT00246571|450905546|FG001|Overall Study|Sponsor|1|||
125346951|NCT00246571|450905545|FG000|Overall Study|Did not meet entrance criteria|2|||
125346952|NCT00246571|450905546|FG001|Overall Study|Did not meet entrance criteria|1|||
125346953|NCT00246571|450905545|FG000|Overall Study|Laboratory abnormalities|1|||
125346954|NCT00246571|450905546|FG001|Overall Study|Laboratory abnormalities|0|||
125346955|NCT00246571|450905545|FG000|Overall Study|Crossover participants|0|||
125346956|NCT00246571|450905546|FG001|Overall Study|Crossover participants|74|||
125346957|NCT04896229|450905547|FG000|Overall Study|Lost to Follow-up|113|||
125346958|NCT04896229|450905548|FG001|Overall Study|Lost to Follow-up|113|||
125346959|NCT00159822|450905551|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
125346960|NCT00159822|450905551|FG000|Voriconazole Treatment Period|Adverse Event|9|||
125346961|NCT00159822|450905551|FG000|Voriconazole Treatment Period|Death|4|||
125346962|NCT00159822|450905551|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
125346963|NCT00159822|450905551|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
125346964|NCT00159822|450905551|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
125346965|NCT00159822|450905551|FG000|Post-treatment Follow-up Period|Death|1|||
125346966|NCT00159822|450905551|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
125346967|NCT00159822|450905551|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
125346968|NCT00713310|450905552|FG000|Overall Study|Adverse Event|5|||
125346969|NCT00713310|450905553|FG001|Overall Study|Adverse Event|2|||
125346970|NCT00713310|450905552|FG000|Overall Study|Lack of Efficacy|0|||
125346971|NCT00713310|450905553|FG001|Overall Study|Lack of Efficacy|2|||
125346972|NCT00713310|450905552|FG000|Overall Study|Withdrawal by Subject|0|||
125346973|NCT00713310|450905553|FG001|Overall Study|Withdrawal by Subject|2|||
125346974|NCT00275821|450905555|FG000|Overall Study|Adverse Event|4|||
125346975|NCT00275821|450905556|FG001|Overall Study|Adverse Event|12|||
125346976|NCT00275821|450905557|FG002|Overall Study|Adverse Event|5|||
125346977|NCT00275821|450905555|FG000|Overall Study|Administrative problems|3|||
125346978|NCT00275821|450905556|FG001|Overall Study|Administrative problems|4|||
125346979|NCT00275821|450905557|FG002|Overall Study|Administrative problems|4|||
125346980|NCT00275821|450905555|FG000|Overall Study|Withdrawal by Subject|0|||
125346981|NCT00275821|450905556|FG001|Overall Study|Withdrawal by Subject|2|||
125346982|NCT00275821|450905557|FG002|Overall Study|Withdrawal by Subject|1|||
125346983|NCT00275821|450905555|FG000|Overall Study|Lost to Follow-up|0|||
125346984|NCT00275821|450905556|FG001|Overall Study|Lost to Follow-up|1|||
125346985|NCT00275821|450905557|FG002|Overall Study|Lost to Follow-up|1|||
125346986|NCT00275821|450905555|FG000|Overall Study|Death|0|||
125346987|NCT00275821|450905556|FG001|Overall Study|Death|2|||
125346988|NCT00275821|450905557|FG002|Overall Study|Death|1|||
125346989|NCT00275821|450905555|FG000|Overall Study|Lack of Efficacy|2|||
125346990|NCT00275821|450905556|FG001|Overall Study|Lack of Efficacy|1|||
125346991|NCT00275821|450905557|FG002|Overall Study|Lack of Efficacy|0|||
125346992|NCT00275821|450905555|FG000|Overall Study|Protocol Violation|5|||
125346993|NCT00275821|450905556|FG001|Overall Study|Protocol Violation|1|||
125346994|NCT00275821|450905557|FG002|Overall Study|Protocol Violation|0|||
125346995|NCT00329901|450905558|FG000|Overall Study|Withdrawal by Subject|4|||
125346996|NCT00329901|450905559|FG001|Overall Study|Withdrawal by Subject|3|||
125346997|NCT00329901|450905560|FG002|Overall Study|Withdrawal by Subject|2|||
125346998|NCT00329901|450905558|FG000|Overall Study|Lost to Follow-up|2|||
125346999|NCT00329901|450905559|FG001|Overall Study|Lost to Follow-up|0|||
125347000|NCT00329901|450905560|FG002|Overall Study|Lost to Follow-up|1|||
125347001|NCT00329901|450905558|FG000|Overall Study|Protocol Violation|1|||
125347002|NCT00329901|450905559|FG001|Overall Study|Protocol Violation|0|||
125347003|NCT00329901|450905560|FG002|Overall Study|Protocol Violation|1|||
125347004|NCT00329901|450905558|FG000|Overall Study|Unable to classify|2|||
125347005|NCT00329901|450905559|FG001|Overall Study|Unable to classify|2|||
125347006|NCT00329901|450905560|FG002|Overall Study|Unable to classify|0|||
125347007|NCT00992589|450905561|FG000|Open-Label Phase|Adverse Event|4|||
125347008|NCT00992589|450905562|FG001|Open-Label Phase|Adverse Event|0|||
125347009|NCT00992589|450905563|FG002|Open-Label Phase|Adverse Event|0|||
125347010|NCT00992589|450905564|FG003|Open-Label Phase|Adverse Event|0|||
125347011|NCT00992589|450905561|FG000|Open-Label Phase|Withdrawal by Subject|20|||
125347012|NCT00992589|450905562|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125347013|NCT00992589|450905563|FG002|Open-Label Phase|Withdrawal by Subject|0|||
125347014|NCT00992589|450905564|FG003|Open-Label Phase|Withdrawal by Subject|0|||
125347015|NCT00992589|450905561|FG000|Open-Label Phase|Lost to Follow-up|1|||
125347016|NCT00992589|450905562|FG001|Open-Label Phase|Lost to Follow-up|0|||
125548220|NCT00585195|451637119|FG013|Overall Study|Death|2|||
125548221|NCT00585195|451637120|FG014|Overall Study|Death|8|||
125548222|NCT00585195|451637121|FG015|Overall Study|Death|2|||
125548223|NCT00585195|451637122|FG016|Overall Study|Death|11|||
125548224|NCT00585195|451637123|FG017|Overall Study|Death|0|||
125548225|NCT00585195|451637124|FG018|Overall Study|Death|0|||
125347017|NCT00992589|450905563|FG002|Open-Label Phase|Lost to Follow-up|0|||
125347018|NCT00992589|450905564|FG003|Open-Label Phase|Lost to Follow-up|0|||
125347019|NCT00992589|450905561|FG000|Open-Label Phase|Protocol Violation|3|||
125347020|NCT00992589|450905562|FG001|Open-Label Phase|Protocol Violation|0|||
125548226|NCT00585195|451637125|FG019|Overall Study|Death|0|||
125548227|NCT00585195|451637126|FG020|Overall Study|Death|1|||
125548228|NCT00585195|451637106|FG000|Overall Study|Lost to Follow-up|0|||
125347021|NCT00992589|450905563|FG002|Open-Label Phase|Protocol Violation|0|||
125347022|NCT00992589|450905564|FG003|Open-Label Phase|Protocol Violation|0|||
125347023|NCT00992589|450905561|FG000|Open-Label Phase|Physician Decision|4|||
125347024|NCT00992589|450905562|FG001|Open-Label Phase|Physician Decision|0|||
125347025|NCT00992589|450905563|FG002|Open-Label Phase|Physician Decision|0|||
125347026|NCT00992589|450905564|FG003|Open-Label Phase|Physician Decision|0|||
125347027|NCT00992589|450905561|FG000|Open-Label Phase|Other|45|||
125347028|NCT00992589|450905562|FG001|Open-Label Phase|Other|0|||
125347029|NCT00992589|450905563|FG002|Open-Label Phase|Other|0|||
125347030|NCT00992589|450905564|FG003|Open-Label Phase|Other|0|||
125347031|NCT00992589|450905561|FG000|Double-Blind Phase|Adverse Event|0|||
125347032|NCT00992589|450905562|FG001|Double-Blind Phase|Adverse Event|6|||
125347033|NCT00992589|450905563|FG002|Double-Blind Phase|Adverse Event|2|||
125347034|NCT00992589|450905564|FG003|Double-Blind Phase|Adverse Event|3|||
125347035|NCT00992589|450905561|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
125347036|NCT00992589|450905562|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
125347037|NCT00992589|450905563|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
125347038|NCT00992589|450905564|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
125347039|NCT00992589|450905561|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125347040|NCT00992589|450905562|FG001|Double-Blind Phase|Lost to Follow-up|0|||
125347041|NCT00992589|450905563|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125347042|NCT00992589|450905564|FG003|Double-Blind Phase|Lost to Follow-up|2|||
125347043|NCT00992589|450905561|FG000|Double-Blind Phase|Other|0|||
125347044|NCT00992589|450905562|FG001|Double-Blind Phase|Other|1|||
125347045|NCT00992589|450905563|FG002|Double-Blind Phase|Other|6|||
125347046|NCT00992589|450905564|FG003|Double-Blind Phase|Other|3|||
125347047|NCT01215916|450905565|FG000|Overall Study|Progressive Disease|0|||
125347048|NCT01215916|450905566|FG001|Overall Study|Progressive Disease|2|||
125347049|NCT01215916|450905567|FG002|Overall Study|Progressive Disease|1|||
125347050|NCT01215916|450905568|FG003|Overall Study|Progressive Disease|2|||
125347051|NCT01215916|450905569|FG004|Overall Study|Progressive Disease|5|||
125347052|NCT01215916|450905570|FG005|Overall Study|Progressive Disease|4|||
125347053|NCT01215916|450905571|FG006|Overall Study|Progressive Disease|5|||
125347054|NCT01215916|450905572|FG007|Overall Study|Progressive Disease|3|||
125347055|NCT01215916|450905573|FG008|Overall Study|Progressive Disease|1|||
125347056|NCT01215916|450905565|FG000|Overall Study|Adverse Event|1|||
125347057|NCT01215916|450905566|FG001|Overall Study|Adverse Event|1|||
125347058|NCT01215916|450905567|FG002|Overall Study|Adverse Event|0|||
125347059|NCT01215916|450905568|FG003|Overall Study|Adverse Event|1|||
125347060|NCT01215916|450905569|FG004|Overall Study|Adverse Event|0|||
125347061|NCT01215916|450905570|FG005|Overall Study|Adverse Event|0|||
125347062|NCT01215916|450905571|FG006|Overall Study|Adverse Event|3|||
125347063|NCT01215916|450905572|FG007|Overall Study|Adverse Event|0|||
125347064|NCT01215916|450905573|FG008|Overall Study|Adverse Event|0|||
125347065|NCT01215916|450905565|FG000|Overall Study|Withdrawal by Subject|0|||
125347066|NCT01215916|450905566|FG001|Overall Study|Withdrawal by Subject|1|||
125347067|NCT01215916|450905567|FG002|Overall Study|Withdrawal by Subject|1|||
125347068|NCT01215916|450905568|FG003|Overall Study|Withdrawal by Subject|2|||
125347069|NCT01215916|450905569|FG004|Overall Study|Withdrawal by Subject|0|||
125347070|NCT01215916|450905570|FG005|Overall Study|Withdrawal by Subject|0|||
125347071|NCT01215916|450905571|FG006|Overall Study|Withdrawal by Subject|1|||
125347072|NCT01215916|450905572|FG007|Overall Study|Withdrawal by Subject|0|||
125347073|NCT01215916|450905573|FG008|Overall Study|Withdrawal by Subject|0|||
125347074|NCT01215916|450905565|FG000|Overall Study|Death|0|||
125347075|NCT01215916|450905566|FG001|Overall Study|Death|1|||
125347076|NCT01215916|450905567|FG002|Overall Study|Death|0|||
125347077|NCT01215916|450905568|FG003|Overall Study|Death|0|||
125347078|NCT01215916|450905569|FG004|Overall Study|Death|1|||
125347079|NCT01215916|450905570|FG005|Overall Study|Death|0|||
125347080|NCT01215916|450905571|FG006|Overall Study|Death|0|||
125347081|NCT01215916|450905572|FG007|Overall Study|Death|0|||
125347082|NCT01215916|450905573|FG008|Overall Study|Death|1|||
125347083|NCT01215916|450905565|FG000|Overall Study|Physician Decision|0|||
125347084|NCT01215916|450905566|FG001|Overall Study|Physician Decision|0|||
125347085|NCT01215916|450905567|FG002|Overall Study|Physician Decision|1|||
125347086|NCT01215916|450905568|FG003|Overall Study|Physician Decision|1|||
125347087|NCT01215916|450905569|FG004|Overall Study|Physician Decision|0|||
125347088|NCT01215916|450905570|FG005|Overall Study|Physician Decision|0|||
125347089|NCT01215916|450905571|FG006|Overall Study|Physician Decision|0|||
125347090|NCT01215916|450905572|FG007|Overall Study|Physician Decision|0|||
125347091|NCT01215916|450905573|FG008|Overall Study|Physician Decision|0|||
125347092|NCT02142387|450905574|FG000|Overall Study|<19 years old|49|||
125347093|NCT02142387|450905575|FG001|Overall Study|<19 years old|326|||
125347094|NCT02142387|450905574|FG000|Overall Study|non-cardiac etiology|504|||
125347095|NCT02142387|450905575|FG001|Overall Study|non-cardiac etiology|3431|||
125347096|NCT02142387|450905574|FG000|Overall Study|CPR not performed|74|||
125347097|NCT02142387|450905575|FG001|Overall Study|CPR not performed|473|||
125347098|NCT02142387|450905574|FG000|Overall Study|witnessed by paramedic|139|||
125347099|NCT02142387|450905575|FG001|Overall Study|witnessed by paramedic|917|||
125347100|NCT02142387|450905574|FG000|Overall Study|incomplete data|1|||
125347101|NCT02142387|450905575|FG001|Overall Study|incomplete data|9|||
125347102|NCT02142387|450905574|FG000|Overall Study|occurred not at home|298|||
125347103|NCT02142387|450905575|FG001|Overall Study|occurred not at home|2474|||
125347104|NCT05028361|450905576|FG000|Overall Study|Withdrawal by Subject|1|||
125347105|NCT05028361|450905577|FG001|Overall Study|Withdrawal by Subject|0|||
125347106|NCT00779259|450905582|FG000|Quinine Alone|Adverse Event|2|||
125347107|NCT02047318|450905586|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
125347108|NCT02047318|450905586|FG000|Core Study Period|Adverse Event|1|||
125347109|NCT02047318|450905586|FG000|Core Study Period|Withdrawal by caregiver|3|||
125347110|NCT02047318|450905586|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
125347111|NCT02296138|450905587|FG000|Overall Study|Adverse Event|348|||
125347112|NCT02296138|450905588|FG001|Overall Study|Adverse Event|259|||
125347113|NCT02296138|450905587|FG000|Overall Study|Lack of Efficacy|59|||
125347114|NCT02296138|450905588|FG001|Overall Study|Lack of Efficacy|37|||
125347115|NCT02296138|450905587|FG000|Overall Study|Protocol Violation|35|||
125347116|NCT02296138|450905588|FG001|Overall Study|Protocol Violation|36|||
125347117|NCT02296138|450905587|FG000|Overall Study|Lost to Follow-up|9|||
125347118|NCT02296138|450905588|FG001|Overall Study|Lost to Follow-up|12|||
125347119|NCT02296138|450905587|FG000|Overall Study|Withdrawal by Subject|184|||
125347120|NCT02296138|450905588|FG001|Overall Study|Withdrawal by Subject|131|||
125347121|NCT02296138|450905587|FG000|Overall Study|Not Treated|1|||
125347122|NCT02296138|450905588|FG001|Overall Study|Not Treated|1|||
125347123|NCT02296138|450905587|FG000|Overall Study|Patients with data irregularities|10|||
125347124|NCT02296138|450905588|FG001|Overall Study|Patients with data irregularities|11|||
125347125|NCT02296138|450905587|FG000|Overall Study|Other than specified|15|||
125347126|NCT02296138|450905588|FG001|Overall Study|Other than specified|13|||
125347127|NCT00711516|450905589|FG000|Overall Study|Adverse Event|1|||
125347128|NCT00711516|450905590|FG001|Overall Study|Adverse Event|1|||
125347129|NCT00711516|450905589|FG000|Overall Study|Withdrawal by Subject|0|||
125347130|NCT00711516|450905590|FG001|Overall Study|Withdrawal by Subject|1|||
125347131|NCT00711516|450905589|FG000|Overall Study|Protocol Violation|0|||
125347132|NCT00711516|450905590|FG001|Overall Study|Protocol Violation|1|||
125347133|NCT01029405|450905594|FG000|Overall Study|Withdrawal by Subject|0|||
125347134|NCT01029405|450905595|FG001|Overall Study|Withdrawal by Subject|1|||
125347135|NCT01029405|450905596|FG002|Overall Study|Withdrawal by Subject|2|||
125347136|NCT01029405|450905597|FG003|Overall Study|Withdrawal by Subject|0|||
125347137|NCT01029405|450905594|FG000|Overall Study|Protocol Violation|0|||
125347138|NCT01029405|450905595|FG001|Overall Study|Protocol Violation|0|||
125347139|NCT01029405|450905596|FG002|Overall Study|Protocol Violation|0|||
125347140|NCT01029405|450905597|FG003|Overall Study|Protocol Violation|1|||
125347141|NCT01029405|450905594|FG000|Overall Study|Adverse Event|0|||
125347142|NCT01029405|450905595|FG001|Overall Study|Adverse Event|0|||
125347143|NCT01029405|450905596|FG002|Overall Study|Adverse Event|1|||
125347144|NCT01029405|450905597|FG003|Overall Study|Adverse Event|1|||
125347145|NCT01029405|450905594|FG000|Overall Study|Lost to Follow-up|2|||
125347146|NCT01029405|450905595|FG001|Overall Study|Lost to Follow-up|1|||
125347147|NCT01029405|450905596|FG002|Overall Study|Lost to Follow-up|1|||
125347148|NCT01029405|450905597|FG003|Overall Study|Lost to Follow-up|2|||
125347149|NCT01029405|450905594|FG000|Overall Study|Other|0|||
125347150|NCT01029405|450905595|FG001|Overall Study|Other|1|||
125347151|NCT01029405|450905596|FG002|Overall Study|Other|0|||
125347152|NCT01029405|450905597|FG003|Overall Study|Other|1|||
125347153|NCT00409175|450905598|FG000|Overall Study|Adverse Event|4|||
125347154|NCT00409175|450905599|FG001|Overall Study|Adverse Event|3|||
125347155|NCT00409175|450905598|FG000|Overall Study|Withdrawal by Subject|1|||
125347156|NCT00409175|450905599|FG001|Overall Study|Withdrawal by Subject|2|||
125347157|NCT00409175|450905598|FG000|Overall Study|Negative genotype|0|||
125217426|NCT01348100|450423520|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125347158|NCT00409175|450905599|FG001|Overall Study|Negative genotype|1|||
125347159|NCT00409175|450905598|FG000|Overall Study|Liver transplantation|13|||
125347160|NCT00409175|450905599|FG001|Overall Study|Liver transplantation|13|||
125347161|NCT02108262|450905602|FG000|Overall Study|Non-compliance|0|||
125347162|NCT02108262|450905603|FG001|Overall Study|Non-compliance|2|||
125347163|NCT02108262|450905604|FG002|Overall Study|Non-compliance|1|||
125347164|NCT02108262|450905605|FG003|Overall Study|Non-compliance|1|||
125347165|NCT02108262|450905602|FG000|Overall Study|Randomized by error/screen failure|0|||
125347166|NCT02108262|450905603|FG001|Overall Study|Randomized by error/screen failure|0|||
125347167|NCT02108262|450905604|FG002|Overall Study|Randomized by error/screen failure|1|||
125347168|NCT02108262|450905605|FG003|Overall Study|Randomized by error/screen failure|0|||
125347169|NCT02108262|450905602|FG000|Overall Study|Distance to center|0|||
125347170|NCT02108262|450905603|FG001|Overall Study|Distance to center|1|||
125347171|NCT02108262|450905604|FG002|Overall Study|Distance to center|1|||
125347172|NCT02108262|450905605|FG003|Overall Study|Distance to center|0|||
125347173|NCT02108262|450905602|FG000|Overall Study|Adverse Event|0|||
125347174|NCT02108262|450905603|FG001|Overall Study|Adverse Event|11|||
125347175|NCT02108262|450905604|FG002|Overall Study|Adverse Event|6|||
125347176|NCT02108262|450905605|FG003|Overall Study|Adverse Event|12|||
125347177|NCT02108262|450905602|FG000|Overall Study|Death|0|||
125347178|NCT02108262|450905603|FG001|Overall Study|Death|2|||
125347179|NCT02108262|450905604|FG002|Overall Study|Death|2|||
125347180|NCT02108262|450905605|FG003|Overall Study|Death|1|||
125347181|NCT02108262|450905602|FG000|Overall Study|Lost to Follow-up|0|||
125347182|NCT02108262|450905603|FG001|Overall Study|Lost to Follow-up|0|||
125347183|NCT02108262|450905604|FG002|Overall Study|Lost to Follow-up|1|||
125347184|NCT02108262|450905605|FG003|Overall Study|Lost to Follow-up|0|||
125347185|NCT02108262|450905602|FG000|Overall Study|Physician Decision|0|||
125347186|NCT02108262|450905603|FG001|Overall Study|Physician Decision|0|||
125347187|NCT02108262|450905604|FG002|Overall Study|Physician Decision|2|||
125347188|NCT02108262|450905605|FG003|Overall Study|Physician Decision|0|||
125347189|NCT02108262|450905602|FG000|Overall Study|Withdrawal by Subject|0|||
125347190|NCT02108262|450905603|FG001|Overall Study|Withdrawal by Subject|7|||
125347191|NCT02108262|450905604|FG002|Overall Study|Withdrawal by Subject|3|||
125347192|NCT02108262|450905605|FG003|Overall Study|Withdrawal by Subject|4|||
125347193|NCT02108262|450905602|FG000|Overall Study|Due to key hepatic values|0|||
125347194|NCT02108262|450905603|FG001|Overall Study|Due to key hepatic values|1|||
125347195|NCT02108262|450905604|FG002|Overall Study|Due to key hepatic values|0|||
125347196|NCT02108262|450905605|FG003|Overall Study|Due to key hepatic values|0|||
125347197|NCT02108262|450905602|FG000|Overall Study|Unable to contact patient|0|||
125347198|NCT02108262|450905603|FG001|Overall Study|Unable to contact patient|3|||
125347199|NCT02108262|450905604|FG002|Overall Study|Unable to contact patient|1|||
125347200|NCT02108262|450905605|FG003|Overall Study|Unable to contact patient|2|||
125347201|NCT02108262|450905602|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
125347202|NCT02108262|450905603|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
125347203|NCT02108262|450905604|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
125347204|NCT02108262|450905605|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
125347205|NCT02108262|450905602|FG000|Overall Study|Patient did not want another infusion|0|||
125347206|NCT02108262|450905603|FG001|Overall Study|Patient did not want another infusion|3|||
125347207|NCT02108262|450905604|FG002|Overall Study|Patient did not want another infusion|3|||
125681683|NCT01274338|452125608|FG005|Overall Study|Lack of Efficacy|0|||
125347208|NCT02108262|450905605|FG003|Overall Study|Patient did not want another infusion|2|||
125347209|NCT02108262|450905602|FG000|Overall Study|Vacation|0|||
125347210|NCT02108262|450905603|FG001|Overall Study|Vacation|1|||
125681684|NCT01274338|452125603|FG000|Overall Study|Adverse Event|272|||
125681685|NCT01274338|452125604|FG001|Overall Study|Adverse Event|105|||
125681686|NCT01274338|452125605|FG002|Overall Study|Adverse Event|180|||
125681687|NCT01274338|452125606|FG003|Overall Study|Adverse Event|1|||
125681688|NCT01274338|452125607|FG004|Overall Study|Adverse Event|0|||
125681689|NCT01274338|452125608|FG005|Overall Study|Adverse Event|0|||
125681690|NCT01274338|452125603|FG000|Overall Study|Death|8|||
125681691|NCT01274338|452125604|FG001|Overall Study|Death|1|||
125681692|NCT01274338|452125605|FG002|Overall Study|Death|0|||
125681693|NCT01274338|452125606|FG003|Overall Study|Death|0|||
125681694|NCT01274338|452125607|FG004|Overall Study|Death|0|||
125347211|NCT02108262|450905604|FG002|Overall Study|Vacation|0|||
125347212|NCT02108262|450905605|FG003|Overall Study|Vacation|0|||
125347213|NCT02108262|450905602|FG000|Overall Study|Patient decision|0|||
125347214|NCT02108262|450905603|FG001|Overall Study|Patient decision|7|||
125347215|NCT02108262|450905604|FG002|Overall Study|Patient decision|9|||
125347216|NCT02108262|450905605|FG003|Overall Study|Patient decision|14|||
125347217|NCT02108262|450905602|FG000|Overall Study|Missed IV due to pharmacy error|0|||
125347218|NCT02108262|450905603|FG001|Overall Study|Missed IV due to pharmacy error|0|||
125347219|NCT02108262|450905604|FG002|Overall Study|Missed IV due to pharmacy error|1|||
125347220|NCT02108262|450905605|FG003|Overall Study|Missed IV due to pharmacy error|0|||
125681695|NCT01274338|452125608|FG005|Overall Study|Death|0|||
125681696|NCT01274338|452125603|FG000|Overall Study|Withdrawal by Subject|27|||
125347221|NCT00761150|450905606|FG000|Open-label Period|Adverse Event|36|||
125681697|NCT01274338|452125604|FG001|Overall Study|Withdrawal by Subject|99|||
125347222|NCT00761150|450905607|FG001|Open-label Period|Adverse Event|0|||
125347223|NCT00761150|450905608|FG002|Open-label Period|Adverse Event|0|||
125347224|NCT00761150|450905606|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
125347225|NCT00761150|450905607|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
125347226|NCT00761150|450905608|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
125347227|NCT00761150|450905606|FG000|Open-label Period|Lost to Follow-up|7|||
125347228|NCT00761150|450905607|FG001|Open-label Period|Lost to Follow-up|0|||
125347229|NCT00761150|450905608|FG002|Open-label Period|Lost to Follow-up|0|||
125347230|NCT00761150|450905606|FG000|Open-label Period|Lack of Efficacy|4|||
125347231|NCT00761150|450905607|FG001|Open-label Period|Lack of Efficacy|0|||
125347232|NCT00761150|450905608|FG002|Open-label Period|Lack of Efficacy|0|||
125347233|NCT00761150|450905606|FG000|Open-label Period|Withdrawal by Subject|5|||
125347234|NCT00761150|450905607|FG001|Open-label Period|Withdrawal by Subject|0|||
125347235|NCT00761150|450905608|FG002|Open-label Period|Withdrawal by Subject|0|||
125347236|NCT00761150|450905606|FG000|Open-label Period|Noncompliance|2|||
125347237|NCT00761150|450905607|FG001|Open-label Period|Noncompliance|0|||
125347238|NCT00761150|450905608|FG002|Open-label Period|Noncompliance|0|||
125347239|NCT00761150|450905606|FG000|Open-label Period|Other|5|||
125347240|NCT00761150|450905607|FG001|Open-label Period|Other|0|||
125347241|NCT00761150|450905608|FG002|Open-label Period|Other|0|||
125347242|NCT00761150|450905606|FG000|Double-blind Period|Lack of Efficacy|0|||
125347243|NCT00761150|450905607|FG001|Double-blind Period|Lack of Efficacy|2|||
125347244|NCT00761150|450905608|FG002|Double-blind Period|Lack of Efficacy|19|||
125347245|NCT00761150|450905606|FG000|Double-blind Period|Adverse Event|0|||
125347246|NCT00761150|450905607|FG001|Double-blind Period|Adverse Event|3|||
125347247|NCT00761150|450905608|FG002|Double-blind Period|Adverse Event|3|||
125347248|NCT00761150|450905606|FG000|Double-blind Period|Withdrawal by Subject|0|||
125347249|NCT00761150|450905607|FG001|Double-blind Period|Withdrawal by Subject|3|||
125347250|NCT00761150|450905608|FG002|Double-blind Period|Withdrawal by Subject|2|||
125347251|NCT00761150|450905606|FG000|Double-blind Period|Lost to Follow-up|0|||
125347252|NCT00761150|450905607|FG001|Double-blind Period|Lost to Follow-up|2|||
125347253|NCT00761150|450905608|FG002|Double-blind Period|Lost to Follow-up|1|||
125347254|NCT00761150|450905606|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
125347255|NCT00761150|450905607|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
125347256|NCT00761150|450905608|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
125347257|NCT00761150|450905606|FG000|Double-blind Period|Noncompliance|0|||
125347258|NCT00761150|450905607|FG001|Double-blind Period|Noncompliance|1|||
125347259|NCT00761150|450905608|FG002|Double-blind Period|Noncompliance|0|||
125347260|NCT00761150|450905606|FG000|Double-blind Period|Other|0|||
125347261|NCT00761150|450905607|FG001|Double-blind Period|Other|3|||
125347262|NCT00761150|450905608|FG002|Double-blind Period|Other|3|||
125347263|NCT01860846|450905609|FG000|Overall Study|Lost to Follow-up|33|||
125347264|NCT05463198|450905610|FG000|Overall Study|Withdrawal by Subject|19|||
125347265|NCT05463198|450905610|FG000|Overall Study|Procedure Notes Missing|18|||
125347266|NCT00466687|450905613|FG000|Overall Study|Adverse Event|1|||
125347267|NCT00466687|450905613|FG000|Overall Study|Other complicating illness|3|||
125347268|NCT00466687|450905613|FG000|Overall Study|Withdrawal by Subject|1|||
125347269|NCT00466687|450905613|FG000|Overall Study|Disease progression|29|||
125347270|NCT01925989|450905614|FG000|Period 1|Sponsor Decision|1|||
125347271|NCT01925989|450905615|FG001|Period 1|Sponsor Decision|1|||
125347272|NCT01925989|450905616|FG002|Period 1|Sponsor Decision|0|||
125347273|NCT01925989|450905614|FG000|Period 1|Withdrawal by Subject|0|||
125347274|NCT01925989|450905615|FG001|Period 1|Withdrawal by Subject|1|||
125347275|NCT01925989|450905616|FG002|Period 1|Withdrawal by Subject|0|||
125347276|NCT03459690|450905620|FG000|Overall Study|Lost to Follow-up|0|||
125347277|NCT03459690|450905621|FG001|Overall Study|Lost to Follow-up|1|||
125347278|NCT03459690|450905620|FG000|Overall Study|Withdrawal by Subject|1|||
125347279|NCT03459690|450905621|FG001|Overall Study|Withdrawal by Subject|1|||
125347280|NCT02586506|450905622|FG000|Overall Study|Protocol Violation|6|||
125347281|NCT02586506|450905622|FG000|Overall Study|Lost to Follow-up|1|||
125347282|NCT02586506|450905622|FG000|Overall Study|Other Reason|2|||
125347283|NCT02815280|450905628|FG000|Double-Blind Phase|Adverse Event|1|||
125347284|NCT02815280|450905629|FG001|Double-Blind Phase|Adverse Event|1|||
125347285|NCT02815280|450905628|FG000|Double-Blind Phase|Lost to Follow-up|10|||
125347286|NCT02815280|450905629|FG001|Double-Blind Phase|Lost to Follow-up|9|||
125347287|NCT02815280|450905628|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
125347288|NCT02815280|450905629|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
125347289|NCT02815280|450905628|FG000|Double-Blind Phase|Protocol Violation|2|||
125347290|NCT02815280|450905629|FG001|Double-Blind Phase|Protocol Violation|2|||
125347291|NCT02815280|450905628|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
125347292|NCT02815280|450905629|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
125347293|NCT02815280|450905628|FG000|Open-Label Phase|Adverse Event|2|||
125347294|NCT02815280|450905629|FG001|Open-Label Phase|Adverse Event|3|||
125347295|NCT02815280|450905628|FG000|Open-Label Phase|Lost to Follow-up|18|||
125347296|NCT02815280|450905629|FG001|Open-Label Phase|Lost to Follow-up|9|||
125347297|NCT02815280|450905628|FG000|Open-Label Phase|Withdrawal by Subject|33|||
125347298|NCT02815280|450905629|FG001|Open-Label Phase|Withdrawal by Subject|18|||
125347299|NCT02815280|450905628|FG000|Open-Label Phase|Protocol Violation|3|||
125347300|NCT02815280|450905629|FG001|Open-Label Phase|Protocol Violation|0|||
125347301|NCT02815280|450905628|FG000|Open-Label Phase|Administrative|26|||
125347302|NCT02815280|450905629|FG001|Open-Label Phase|Administrative|12|||
125347303|NCT02815280|450905628|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
125347304|NCT02815280|450905629|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
125347305|NCT01534182|450905644|FG000|Overall Study|Administrative problems|1|||
125347306|NCT01534182|450905645|FG001|Overall Study|Administrative problems|0|||
125347307|NCT01534182|450905644|FG000|Overall Study|Withdrawal by Subject|4|||
125347308|NCT01534182|450905645|FG001|Overall Study|Withdrawal by Subject|7|||
125347309|NCT01534182|450905644|FG000|Overall Study|Adverse Event|7|||
125347310|NCT01534182|450905645|FG001|Overall Study|Adverse Event|3|||
125347311|NCT01944839|450905646|FG000|Overall Study|Physician Decision|2|||
125347312|NCT01944839|450905647|FG001|Overall Study|Physician Decision|2|||
125347313|NCT01944839|450905646|FG000|Overall Study|Protocol Violation|0|||
125347314|NCT01944839|450905647|FG001|Overall Study|Protocol Violation|1|||
125347315|NCT01944839|450905646|FG000|Overall Study|Adverse Event|10|||
125347316|NCT01944839|450905647|FG001|Overall Study|Adverse Event|5|||
125347317|NCT01944839|450905646|FG000|Overall Study|Withdrawal by Subject|9|||
125347318|NCT01944839|450905647|FG001|Overall Study|Withdrawal by Subject|17|||
125347319|NCT01944839|450905646|FG000|Overall Study|Lost to Follow-up|1|||
125347320|NCT01944839|450905647|FG001|Overall Study|Lost to Follow-up|0|||
125347321|NCT01944839|450905646|FG000|Overall Study|Subject non-compliance|0|||
125347322|NCT01944839|450905647|FG001|Overall Study|Subject non-compliance|3|||
125347323|NCT05093790|450905651|FG000|Overall Study|Failure to meet continuation criteria|0|||
125347324|NCT05093790|450905652|FG001|Overall Study|Failure to meet continuation criteria|0|||
125347325|NCT05093790|450905653|FG002|Overall Study|Failure to meet continuation criteria|1|||
125347326|NCT05093790|450905654|FG003|Overall Study|Failure to meet continuation criteria|0|||
125347327|NCT05093790|450905651|FG000|Overall Study|Adverse Event|1|||
125347328|NCT05093790|450905652|FG001|Overall Study|Adverse Event|0|||
125347329|NCT05093790|450905653|FG002|Overall Study|Adverse Event|0|||
125347330|NCT05093790|450905654|FG003|Overall Study|Adverse Event|0|||
125347331|NCT00924170|450905655|FG000|Overall Study|Refused further treatment|0|||
125347332|NCT00924170|450905656|FG001|Overall Study|Refused further treatment|1|||
125347333|NCT00924170|450905655|FG000|Overall Study|Physician Decision|0|||
125347334|NCT00924170|450905656|FG001|Overall Study|Physician Decision|1|||
125347335|NCT00924170|450905655|FG000|Overall Study|Progressive disease|3|||
125347336|NCT00924170|450905656|FG001|Overall Study|Progressive disease|6|||
125347337|NCT00924170|450905655|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
125347338|NCT00924170|450905656|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
125347339|NCT00924170|450905655|FG000|Overall Study|Death|1|||
125347340|NCT00924170|450905656|FG001|Overall Study|Death|0|||
125347341|NCT04449029|450905659|FG000|Overall Study|Adverse Event|0|||
125347342|NCT04449029|450905660|FG001|Overall Study|Adverse Event|1|||
125347343|NCT04449029|450905661|FG002|Overall Study|Adverse Event|1|||
125347344|NCT04449029|450905662|FG003|Overall Study|Adverse Event|0|||
125347345|NCT04449029|450905663|FG004|Overall Study|Adverse Event|1|||
125347346|NCT04449029|450905664|FG005|Overall Study|Adverse Event|0|||
125347347|NCT04449029|450905665|FG006|Overall Study|Adverse Event|1|||
125347348|NCT04449029|450905666|FG007|Overall Study|Adverse Event|0|||
125347349|NCT04449029|450905659|FG000|Overall Study|Lost to Follow-up|0|||
125347350|NCT04449029|450905660|FG001|Overall Study|Lost to Follow-up|1|||
125347351|NCT04449029|450905661|FG002|Overall Study|Lost to Follow-up|0|||
125347352|NCT04449029|450905662|FG003|Overall Study|Lost to Follow-up|0|||
125347353|NCT04449029|450905663|FG004|Overall Study|Lost to Follow-up|0|||
125347354|NCT04449029|450905664|FG005|Overall Study|Lost to Follow-up|0|||
125347355|NCT04449029|450905665|FG006|Overall Study|Lost to Follow-up|0|||
125347356|NCT04449029|450905666|FG007|Overall Study|Lost to Follow-up|0|||
125347357|NCT04449029|450905659|FG000|Overall Study|Protocol Violation|0|||
125347358|NCT04449029|450905660|FG001|Overall Study|Protocol Violation|1|||
125347359|NCT04449029|450905661|FG002|Overall Study|Protocol Violation|0|||
125347360|NCT04449029|450905662|FG003|Overall Study|Protocol Violation|0|||
125347361|NCT04449029|450905663|FG004|Overall Study|Protocol Violation|0|||
125347362|NCT04449029|450905664|FG005|Overall Study|Protocol Violation|0|||
125347363|NCT04449029|450905665|FG006|Overall Study|Protocol Violation|0|||
125347364|NCT04449029|450905666|FG007|Overall Study|Protocol Violation|0|||
125347365|NCT04449029|450905659|FG000|Overall Study|Physician Decision|0|||
125347366|NCT04449029|450905660|FG001|Overall Study|Physician Decision|0|||
125347367|NCT04449029|450905661|FG002|Overall Study|Physician Decision|0|||
125347368|NCT04449029|450905662|FG003|Overall Study|Physician Decision|0|||
125347369|NCT04449029|450905663|FG004|Overall Study|Physician Decision|0|||
125347370|NCT04449029|450905664|FG005|Overall Study|Physician Decision|1|||
125347371|NCT04449029|450905665|FG006|Overall Study|Physician Decision|0|||
125347372|NCT04449029|450905666|FG007|Overall Study|Physician Decision|0|||
125347373|NCT04449029|450905659|FG000|Overall Study|Withdrawal by Subject|3|||
125347374|NCT04449029|450905660|FG001|Overall Study|Withdrawal by Subject|0|||
125347375|NCT04449029|450905661|FG002|Overall Study|Withdrawal by Subject|1|||
125347376|NCT04449029|450905662|FG003|Overall Study|Withdrawal by Subject|1|||
125347377|NCT04449029|450905663|FG004|Overall Study|Withdrawal by Subject|5|||
125347378|NCT04449029|450905664|FG005|Overall Study|Withdrawal by Subject|1|||
125347379|NCT04449029|450905665|FG006|Overall Study|Withdrawal by Subject|4|||
125347380|NCT04449029|450905666|FG007|Overall Study|Withdrawal by Subject|0|||
125347381|NCT02025556|450905668|FG000|Overall Study|Adverse Event|0|||
125347382|NCT02025556|450905669|FG001|Overall Study|Adverse Event|4|||
125347383|NCT02025556|450905670|FG002|Overall Study|Adverse Event|2|||
125347384|NCT02025556|450905668|FG000|Overall Study|Lack of Efficacy|2|||
125347385|NCT02025556|450905669|FG001|Overall Study|Lack of Efficacy|1|||
125347386|NCT02025556|450905670|FG002|Overall Study|Lack of Efficacy|0|||
125347387|NCT02025556|450905668|FG000|Overall Study|Protocol Violation|2|||
125347388|NCT02025556|450905669|FG001|Overall Study|Protocol Violation|1|||
125347389|NCT02025556|450905670|FG002|Overall Study|Protocol Violation|0|||
125347390|NCT02025556|450905668|FG000|Overall Study|Withdrawal by Subject|0|||
125347391|NCT02025556|450905669|FG001|Overall Study|Withdrawal by Subject|3|||
125347392|NCT02025556|450905670|FG002|Overall Study|Withdrawal by Subject|6|||
125548229|NCT00585195|451637107|FG001|Overall Study|Lost to Follow-up|0|||
125548230|NCT00585195|451637108|FG002|Overall Study|Lost to Follow-up|0|||
125681698|NCT01274338|452125605|FG002|Overall Study|Withdrawal by Subject|17|||
125681699|NCT01274338|452125606|FG003|Overall Study|Withdrawal by Subject|0|||
125681700|NCT01274338|452125607|FG004|Overall Study|Withdrawal by Subject|0|||
125681701|NCT01274338|452125608|FG005|Overall Study|Withdrawal by Subject|0|||
125681702|NCT01274338|452125603|FG000|Overall Study|Did not start treatment|8|||
125681703|NCT01274338|452125604|FG001|Overall Study|Did not start treatment|116|||
125681704|NCT01274338|452125605|FG002|Overall Study|Did not start treatment|7|||
125681705|NCT01274338|452125606|FG003|Overall Study|Did not start treatment|0|||
125681706|NCT01274338|452125607|FG004|Overall Study|Did not start treatment|0|||
125681707|NCT01274338|452125608|FG005|Overall Study|Did not start treatment|0|||
125681708|NCT01274338|452125603|FG000|Overall Study|Alternative therapy|0|||
125681709|NCT01274338|452125604|FG001|Overall Study|Alternative therapy|1|||
125681710|NCT01274338|452125605|FG002|Overall Study|Alternative therapy|0|||
125681711|NCT01274338|452125606|FG003|Overall Study|Alternative therapy|0|||
125681712|NCT01274338|452125607|FG004|Overall Study|Alternative therapy|0|||
125681713|NCT01274338|452125608|FG005|Overall Study|Alternative therapy|0|||
125681714|NCT01274338|452125603|FG000|Overall Study|Other complicating diseases|0|||
125681715|NCT01274338|452125604|FG001|Overall Study|Other complicating diseases|3|||
125681716|NCT01274338|452125605|FG002|Overall Study|Other complicating diseases|1|||
125681717|NCT01274338|452125606|FG003|Overall Study|Other complicating diseases|0|||
125681718|NCT01274338|452125607|FG004|Overall Study|Other complicating diseases|0|||
125681719|NCT01274338|452125608|FG005|Overall Study|Other complicating diseases|0|||
125681720|NCT01274338|452125603|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
125347393|NCT02025556|450905668|FG000|Overall Study|Lost to Follow-up|2|||
125347394|NCT02025556|450905669|FG001|Overall Study|Lost to Follow-up|4|||
125347395|NCT02025556|450905670|FG002|Overall Study|Lost to Follow-up|0|||
125347396|NCT02025556|450905668|FG000|Overall Study|Reason not reported|0|||
125347397|NCT02025556|450905669|FG001|Overall Study|Reason not reported|0|||
125347398|NCT02025556|450905670|FG002|Overall Study|Reason not reported|1|||
125347399|NCT00627445|450905672|FG000|Overall Study|Adverse Event|3|||
125347400|NCT00627445|450905673|FG001|Overall Study|Adverse Event|3|||
125347401|NCT00627445|450905672|FG000|Overall Study|Lack of Efficacy|0|||
125548231|NCT00585195|451637109|FG003|Overall Study|Lost to Follow-up|0|||
125347402|NCT00627445|450905673|FG001|Overall Study|Lack of Efficacy|1|||
125347403|NCT00627445|450905672|FG000|Overall Study|Other|6|||
125347404|NCT00627445|450905673|FG001|Overall Study|Other|8|||
125347405|NCT04098224|450905674|FG000|Overall Study|Adverse Event|1|||
125347406|NCT04098224|450905675|FG001|Overall Study|Adverse Event|0|||
125347407|NCT04098224|450905674|FG000|Overall Study|Physician Decision|1|||
125347408|NCT04098224|450905675|FG001|Overall Study|Physician Decision|0|||
125347409|NCT04098224|450905674|FG000|Overall Study|Patient not required enteral feeding|1|||
125347410|NCT04098224|450905675|FG001|Overall Study|Patient not required enteral feeding|0|||
125347411|NCT04098224|450905674|FG000|Overall Study|Patient failure nasogastric tube|1|||
125347412|NCT04098224|450905675|FG001|Overall Study|Patient failure nasogastric tube|0|||
125347413|NCT04098224|450905674|FG000|Overall Study|Patient early extubation|1|||
125347414|NCT04098224|450905675|FG001|Overall Study|Patient early extubation|3|||
125347415|NCT02217527|450905676|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
125347416|NCT02217527|450905677|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
125347417|NCT02217527|450905676|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
125347418|NCT02217527|450905677|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
125347419|NCT01203852|450905678|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
125347420|NCT01203852|450905678|FG000|Washout 2 Weeks|Physician Decision|46|||
125347421|NCT00247611|450905682|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
125347422|NCT00247611|450905683|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
125347423|NCT00247611|450905682|FG000|Baselined|Completed baseline only|9|||
125347424|NCT00247611|450905683|FG001|Baselined|Completed baseline only|8|||
125347425|NCT01587898|450905684|FG000|Overall Study|Adverse Event|1|||
125347426|NCT01587898|450905685|FG001|Overall Study|Adverse Event|1|||
125347427|NCT01587898|450905686|FG002|Overall Study|Adverse Event|0|||
125347428|NCT01587898|450905687|FG003|Overall Study|Adverse Event|0|||
125347429|NCT01587898|450905684|FG000|Overall Study|Protocol Violation|0|||
125347430|NCT01587898|450905685|FG001|Overall Study|Protocol Violation|2|||
125347431|NCT01587898|450905686|FG002|Overall Study|Protocol Violation|1|||
125347432|NCT01587898|450905687|FG003|Overall Study|Protocol Violation|1|||
125347433|NCT01587898|450905684|FG000|Overall Study|Lost to Follow-up|0|||
125347434|NCT01587898|450905685|FG001|Overall Study|Lost to Follow-up|0|||
125347435|NCT01587898|450905686|FG002|Overall Study|Lost to Follow-up|0|||
125347436|NCT01587898|450905687|FG003|Overall Study|Lost to Follow-up|1|||
125347437|NCT01587898|450905684|FG000|Overall Study|Withdrawal by Subject|2|||
125347438|NCT01587898|450905685|FG001|Overall Study|Withdrawal by Subject|1|||
125347439|NCT01587898|450905686|FG002|Overall Study|Withdrawal by Subject|0|||
125347440|NCT01587898|450905687|FG003|Overall Study|Withdrawal by Subject|0|||
125347441|NCT01587898|450905684|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
125347442|NCT01587898|450905685|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
125347443|NCT01587898|450905686|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
125347444|NCT01587898|450905687|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
125347445|NCT00502203|450905688|FG000|Overall Study|Inevaluable|1|||
125347446|NCT01829243|450905693|FG000|First Intervention|Screen Failure|4|||
125347447|NCT01829243|450905694|FG001|First Intervention|Screen Failure|2|||
125347448|NCT01077375|450905697|FG000|Overall Study|Adverse Event|2|||
125347449|NCT01077375|450905698|FG001|Overall Study|Adverse Event|15|||
125347450|NCT01077375|450905697|FG000|Overall Study|Lack of Efficacy|6|||
125347451|NCT01077375|450905698|FG001|Overall Study|Lack of Efficacy|8|||
125347452|NCT01077375|450905697|FG000|Overall Study|Withdrawal by Subject|0|||
125347453|NCT01077375|450905698|FG001|Overall Study|Withdrawal by Subject|6|||
125347454|NCT01077375|450905697|FG000|Overall Study|Lost to Follow-up|2|||
125347455|NCT01077375|450905698|FG001|Overall Study|Lost to Follow-up|5|||
125347456|NCT01077375|450905697|FG000|Overall Study|Other Reason|0|||
125347457|NCT01077375|450905698|FG001|Overall Study|Other Reason|1|||
125347458|NCT00336583|450907497|FG000|Overall Study|Lost to Follow-up|1|||
125347459|NCT00336583|450907497|FG000|Overall Study|Death|1|||
125347460|NCT03039621|450907498|FG000|Overall Study|Violation of inclusion criteria|3|||
125347461|NCT03039621|450907499|FG001|Overall Study|Violation of inclusion criteria|2|||
125347462|NCT03039621|450907498|FG000|Overall Study|Non-compliance with protocol requirement|4|||
125347463|NCT03039621|450907499|FG001|Overall Study|Non-compliance with protocol requirement|5|||
125347464|NCT03039621|450907498|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
125347465|NCT03039621|450907499|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
125548232|NCT00585195|451637110|FG004|Overall Study|Lost to Follow-up|0|||
125347466|NCT03039621|450907498|FG000|Overall Study|Violation of non-inclusion criteria|1|||
125347467|NCT03039621|450907499|FG001|Overall Study|Violation of non-inclusion criteria|2|||
125681721|NCT01274338|452125604|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
125347468|NCT00814333|450907502|FG000|Enrollment|Lost to Follow-up|1|||
125681722|NCT01274338|452125605|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
125681723|NCT01274338|452125606|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
125681724|NCT01274338|452125607|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
125681725|NCT01274338|452125608|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
125681726|NCT01274338|452125603|FG000|Overall Study|Pregnancy|0|||
125681727|NCT01274338|452125604|FG001|Overall Study|Pregnancy|0|||
125347469|NCT00814333|450907503|FG001|Enrollment|Lost to Follow-up|0|||
125347470|NCT02927067|450907504|FG000|Overall Study|Withdrawn Consent|20|||
125347471|NCT02927067|450907505|FG001|Overall Study|Withdrawn Consent|12|||
125347472|NCT02927067|450907504|FG000|Overall Study|Death|18|||
125347473|NCT02927067|450907505|FG001|Overall Study|Death|31|||
125347474|NCT02927067|450907504|FG000|Overall Study|Adverse Event|13|||
125347475|NCT02927067|450907505|FG001|Overall Study|Adverse Event|10|||
125347476|NCT02927067|450907504|FG000|Overall Study|Noncompliance|5|||
125347477|NCT02927067|450907505|FG001|Overall Study|Noncompliance|2|||
125347478|NCT02927067|450907504|FG000|Overall Study|Reason not Specified|4|||
125347479|NCT02927067|450907505|FG001|Overall Study|Reason not Specified|6|||
125347480|NCT02716896|450907506|FG000|Overall Study|Physician Decision|0|||
125347481|NCT02716896|450907507|FG001|Overall Study|Physician Decision|1|||
125347482|NCT01727700|450907508|FG000|Overall Study|Adverse Event|0|||
125347483|NCT01727700|450907509|FG001|Overall Study|Adverse Event|7|||
125347484|NCT01727700|450907510|FG002|Overall Study|Adverse Event|1|||
125347485|NCT01727700|450907508|FG000|Overall Study|Particpant withdrew consent|0|||
125347486|NCT01727700|450907509|FG001|Overall Study|Particpant withdrew consent|3|||
125347487|NCT01727700|450907510|FG002|Overall Study|Particpant withdrew consent|1|||
125347488|NCT01727700|450907508|FG000|Overall Study|Protocol Violation|2|||
125347489|NCT01727700|450907509|FG001|Overall Study|Protocol Violation|0|||
125347490|NCT01727700|450907510|FG002|Overall Study|Protocol Violation|0|||
125347491|NCT02519855|450907511|FG000|Overall Study|Adverse Event|0|||
125347492|NCT02519855|450907512|FG001|Overall Study|Adverse Event|1|||
125347493|NCT02519855|450907511|FG000|Overall Study|Lost to Follow-up|3|||
125347494|NCT02519855|450907512|FG001|Overall Study|Lost to Follow-up|3|||
125347495|NCT00003830|450907526|FG000|Overall Study|No follow up data|3|||
125347496|NCT00003830|450907527|FG001|Overall Study|No follow up data|0|||
125347497|NCT00003830|450907526|FG000|Overall Study|Sentinel node positive patients|829|||
125347498|NCT00003830|450907527|FG001|Overall Study|Sentinel node positive patients|793|||
125347499|NCT05347147|450907531|FG000|Overall Study|Lost to Follow-up|0|||
125347500|NCT05347147|450907532|FG001|Overall Study|Lost to Follow-up|1|||
125347501|NCT05347147|450907531|FG000|Overall Study|Sponsor request|3|||
125347502|NCT05347147|450907532|FG001|Overall Study|Sponsor request|3|||
125347503|NCT05347147|450907531|FG000|Overall Study|Study termination|2|||
125347504|NCT05347147|450907532|FG001|Overall Study|Study termination|1|||
125347505|NCT00603590|450907533|FG000|Overall Study|Did not attend study clinic|39|||
125347506|NCT00603590|450907534|FG001|Overall Study|Did not attend study clinic|30|||
125347507|NCT00603590|450907533|FG000|Overall Study|Refused blood test|5|||
125347508|NCT00603590|450907534|FG001|Overall Study|Refused blood test|1|||
125347509|NCT00603590|450907533|FG000|Overall Study|Patient discontinued study drug|22|||
125347510|NCT00603590|450907534|FG001|Overall Study|Patient discontinued study drug|15|||
125347511|NCT00603590|450907533|FG000|Overall Study|Adverse Event|2|||
125347512|NCT00603590|450907534|FG001|Overall Study|Adverse Event|0|||
125347513|NCT00603590|450907533|FG000|Overall Study|Lost to Follow-up|8|||
125347514|NCT00603590|450907534|FG001|Overall Study|Lost to Follow-up|4|||
125347515|NCT00603590|450907533|FG000|Overall Study|Cardiovascular event|0|||
125347516|NCT00603590|450907534|FG001|Overall Study|Cardiovascular event|1|||
125347517|NCT03699475|450907540|FG000|Overall Study|Death|1|||
125347518|NCT00137839|450907541|FG000|Overall Study|Adverse Event|7|||
125347519|NCT00137839|450907541|FG000|Overall Study|Physician Decision|7|||
125347520|NCT00137839|450907541|FG000|Overall Study|Death|8|||
125347521|NCT00137839|450907541|FG000|Overall Study|Disease Progression|60|||
125347522|NCT00137839|450907541|FG000|Overall Study|Not Start Treatment|1|||
125347523|NCT00137839|450907541|FG000|Overall Study|Prolonged Treatment Delay|1|||
125347524|NCT03739242|450907548|FG000|Overall Study|Withdrawal by Subject|1|||
125347525|NCT03739242|450907549|FG001|Overall Study|Withdrawal by Subject|1|||
125347526|NCT03739242|450907548|FG000|Overall Study|Protocol Violation|0|||
125347527|NCT03739242|450907549|FG001|Overall Study|Protocol Violation|1|||
125347528|NCT02446743|450907550|FG000|Overall Study|Withdrawal by Subject|1|||
125347529|NCT02446743|450907551|FG001|Overall Study|Withdrawal by Subject|1|||
125347530|NCT02446743|450907550|FG000|Overall Study|Lost to Follow-up|1|||
125347531|NCT02446743|450907551|FG001|Overall Study|Lost to Follow-up|0|||
125347532|NCT02446743|450907550|FG000|Overall Study|Adverse Event|1|||
125347533|NCT02446743|450907551|FG001|Overall Study|Adverse Event|1|||
125548233|NCT00585195|451637111|FG005|Overall Study|Lost to Follow-up|0|||
125548234|NCT00585195|451637112|FG006|Overall Study|Lost to Follow-up|0|||
125347534|NCT02446743|450907550|FG000|Overall Study|Other|2|||
125347535|NCT02446743|450907551|FG001|Overall Study|Other|3|||
125347536|NCT03718299|450907552|FG000|Overall Study|Adverse Event|1|||
125347537|NCT03718299|450907552|FG000|Overall Study|Withdrawal by Subject|6|||
125347538|NCT03718299|450907552|FG000|Overall Study|Physician Decision|2|||
125347539|NCT03718299|450907552|FG000|Overall Study|Lost to Follow-up|1|||
125347540|NCT01475071|450907557|FG000|Overall Study|Physician Decision|1|||
125347541|NCT01475071|450907557|FG000|Overall Study|Withdrawal by Subject|6|||
125347542|NCT01475071|450907557|FG000|Overall Study|Lost to Follow-up|1|||
125347543|NCT01011478|450907558|FG000|Overall Study|No follow up data|12|||
125347544|NCT01011478|450907559|FG001|Overall Study|No follow up data|7|||
125347545|NCT00978432|450907560|FG000|Overall Study|Withdrawal by Subject|0|||
125378919|NCT00589914|451019206|FG000|Overall Study|Other|22|||
125347546|NCT00978432|450907561|FG001|Overall Study|Withdrawal by Subject|0|||
125347547|NCT00978432|450907562|FG002|Overall Study|Withdrawal by Subject|1|||
125347548|NCT00978432|450907560|FG000|Overall Study|Lack of Efficacy|1|||
125347549|NCT00978432|450907561|FG001|Overall Study|Lack of Efficacy|1|||
125347550|NCT00978432|450907562|FG002|Overall Study|Lack of Efficacy|3|||
125347551|NCT00978432|450907560|FG000|Overall Study|Adverse Event|2|||
125347552|NCT00978432|450907561|FG001|Overall Study|Adverse Event|0|||
125347553|NCT00978432|450907562|FG002|Overall Study|Adverse Event|1|||
125347554|NCT04418661|450907566|FG000|Overall Study|Adverse Event|0|||
125347555|NCT04418661|450907567|FG001|Overall Study|Adverse Event|1|||
125347556|NCT04418661|450907568|FG002|Overall Study|Adverse Event|5|||
125347557|NCT04418661|450907569|FG003|Overall Study|Adverse Event|3|||
125347558|NCT04418661|450907570|FG004|Overall Study|Adverse Event|0|||
125347559|NCT04418661|450907571|FG005|Overall Study|Adverse Event|2|||
125347560|NCT04418661|450907566|FG000|Overall Study|Progressive disease|4|||
125347561|NCT04418661|450907567|FG001|Overall Study|Progressive disease|11|||
125347562|NCT04418661|450907568|FG002|Overall Study|Progressive disease|6|||
125347563|NCT04418661|450907569|FG003|Overall Study|Progressive disease|11|||
125347564|NCT04418661|450907570|FG004|Overall Study|Progressive disease|1|||
125347565|NCT04418661|450907571|FG005|Overall Study|Progressive disease|12|||
125347566|NCT04418661|450907566|FG000|Overall Study|Withdrawal by Subject|0|||
125347567|NCT04418661|450907567|FG001|Overall Study|Withdrawal by Subject|1|||
125347568|NCT04418661|450907568|FG002|Overall Study|Withdrawal by Subject|0|||
125347569|NCT04418661|450907569|FG003|Overall Study|Withdrawal by Subject|1|||
125347570|NCT04418661|450907570|FG004|Overall Study|Withdrawal by Subject|0|||
125347571|NCT04418661|450907571|FG005|Overall Study|Withdrawal by Subject|0|||
125347572|NCT04418661|450907566|FG000|Overall Study|Other|0|||
125347573|NCT04418661|450907567|FG001|Overall Study|Other|0|||
125347574|NCT04418661|450907568|FG002|Overall Study|Other|1|||
125347575|NCT04418661|450907569|FG003|Overall Study|Other|3|||
125347576|NCT04418661|450907570|FG004|Overall Study|Other|0|||
125347577|NCT04418661|450907571|FG005|Overall Study|Other|1|||
125347578|NCT00045942|450907574|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
125347579|NCT00045942|450907575|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125347580|NCT00045942|450907576|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125347581|NCT00045942|450907577|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125347582|NCT00045942|450907578|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125347583|NCT00045942|450907579|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125347584|NCT00045942|450907580|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125347585|NCT00045942|450907581|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125347586|NCT00045942|450907582|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
125347587|NCT00045942|450907574|FG000|PKC412A2104 (Core)|Adverse Event|5|||
125548235|NCT00585195|451637113|FG007|Overall Study|Lost to Follow-up|0|||
125347588|NCT00045942|450907575|FG001|PKC412A2104 (Core)|Adverse Event|0|||
125347589|NCT00045942|450907576|FG002|PKC412A2104 (Core)|Adverse Event|0|||
125347590|NCT00045942|450907577|FG003|PKC412A2104 (Core)|Adverse Event|0|||
125347591|NCT00045942|450907578|FG004|PKC412A2104 (Core)|Adverse Event|0|||
125347592|NCT00045942|450907579|FG005|PKC412A2104 (Core)|Adverse Event|0|||
125347593|NCT00045942|450907580|FG006|PKC412A2104 (Core)|Adverse Event|0|||
125548236|NCT00585195|451637114|FG008|Overall Study|Lost to Follow-up|0|||
125548237|NCT00585195|451637115|FG009|Overall Study|Lost to Follow-up|0|||
125347594|NCT00045942|450907581|FG007|PKC412A2104 (Core)|Adverse Event|0|||
125347595|NCT00045942|450907582|FG008|PKC412A2104 (Core)|Adverse Event|0|||
125548238|NCT00585195|451637116|FG010|Overall Study|Lost to Follow-up|0|||
125347596|NCT00045942|450907574|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
125347597|NCT00045942|450907575|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
125347598|NCT00045942|450907576|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
125548239|NCT00585195|451637117|FG011|Overall Study|Lost to Follow-up|0|||
125347599|NCT00045942|450907577|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
125347600|NCT00045942|450907578|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
125347601|NCT00045942|450907579|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
125347602|NCT00045942|450907580|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
125347603|NCT00045942|450907581|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
125347604|NCT00045942|450907582|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
125347605|NCT00045942|450907574|FG000|PKC412A2104 (Core)|Death|1|||
125347606|NCT00045942|450907575|FG001|PKC412A2104 (Core)|Death|0|||
125347607|NCT00045942|450907576|FG002|PKC412A2104 (Core)|Death|0|||
125347608|NCT00045942|450907577|FG003|PKC412A2104 (Core)|Death|0|||
125347609|NCT00045942|450907578|FG004|PKC412A2104 (Core)|Death|0|||
125347610|NCT00045942|450907579|FG005|PKC412A2104 (Core)|Death|0|||
125347611|NCT00045942|450907580|FG006|PKC412A2104 (Core)|Death|0|||
125347612|NCT00045942|450907581|FG007|PKC412A2104 (Core)|Death|0|||
125548240|NCT00585195|451637118|FG012|Overall Study|Lost to Follow-up|1|||
125548241|NCT00585195|451637119|FG013|Overall Study|Lost to Follow-up|0|||
125548242|NCT00585195|451637120|FG014|Overall Study|Lost to Follow-up|0|||
125548243|NCT00585195|451637121|FG015|Overall Study|Lost to Follow-up|0|||
125548244|NCT00585195|451637122|FG016|Overall Study|Lost to Follow-up|0|||
125347613|NCT00045942|450907582|FG008|PKC412A2104 (Core)|Death|0|||
125347614|NCT00045942|450907574|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
125347615|NCT00045942|450907575|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
125347616|NCT00045942|450907576|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
125347617|NCT00045942|450907577|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
125347618|NCT00045942|450907578|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
125347619|NCT00045942|450907579|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
125347620|NCT00045942|450907580|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
125347621|NCT00045942|450907581|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
125347622|NCT00045942|450907582|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
125347623|NCT00045942|450907574|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
125347624|NCT00045942|450907575|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
125347625|NCT00045942|450907576|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
125347626|NCT00045942|450907577|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
125347627|NCT00045942|450907578|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
125347628|NCT00045942|450907579|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
125347629|NCT00045942|450907580|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
125347630|NCT00045942|450907581|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
125347631|NCT00045942|450907582|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
125347632|NCT00045942|450907574|FG000|PKC412A2104E1|Lack of Efficacy|0|||
125347633|NCT00045942|450907575|FG001|PKC412A2104E1|Lack of Efficacy|11|||
125347634|NCT00045942|450907576|FG002|PKC412A2104E1|Lack of Efficacy|11|||
125347635|NCT00045942|450907577|FG003|PKC412A2104E1|Lack of Efficacy|23|||
125347636|NCT00045942|450907578|FG004|PKC412A2104E1|Lack of Efficacy|17|||
125347637|NCT00045942|450907579|FG005|PKC412A2104E1|Lack of Efficacy|0|||
125347638|NCT00045942|450907580|FG006|PKC412A2104E1|Lack of Efficacy|0|||
125347639|NCT00045942|450907581|FG007|PKC412A2104E1|Lack of Efficacy|0|||
125347640|NCT00045942|450907582|FG008|PKC412A2104E1|Lack of Efficacy|0|||
125347641|NCT00045942|450907574|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
125347642|NCT00045942|450907575|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
125347643|NCT00045942|450907576|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
125347644|NCT00045942|450907577|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
125347645|NCT00045942|450907578|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
125347646|NCT00045942|450907579|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
125347647|NCT00045942|450907580|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
125347648|NCT00045942|450907581|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
125347649|NCT00045942|450907582|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
125347650|NCT00045942|450907574|FG000|PKC412A2104E1|Adverse Event|0|||
125347651|NCT00045942|450907575|FG001|PKC412A2104E1|Adverse Event|1|||
125347652|NCT00045942|450907576|FG002|PKC412A2104E1|Adverse Event|1|||
125347653|NCT00045942|450907577|FG003|PKC412A2104E1|Adverse Event|3|||
125347654|NCT00045942|450907578|FG004|PKC412A2104E1|Adverse Event|6|||
125548245|NCT00585195|451637123|FG017|Overall Study|Lost to Follow-up|2|||
125347655|NCT00045942|450907579|FG005|PKC412A2104E1|Adverse Event|0|||
125347656|NCT00045942|450907580|FG006|PKC412A2104E1|Adverse Event|0|||
125347657|NCT00045942|450907581|FG007|PKC412A2104E1|Adverse Event|0|||
125347658|NCT00045942|450907582|FG008|PKC412A2104E1|Adverse Event|0|||
125347659|NCT00045942|450907574|FG000|PKC412A2104E1|Death|0|||
125347660|NCT00045942|450907575|FG001|PKC412A2104E1|Death|4|||
125347661|NCT00045942|450907576|FG002|PKC412A2104E1|Death|1|||
125347662|NCT00045942|450907577|FG003|PKC412A2104E1|Death|1|||
125347663|NCT00045942|450907578|FG004|PKC412A2104E1|Death|1|||
125347664|NCT00045942|450907579|FG005|PKC412A2104E1|Death|0|||
125347665|NCT00045942|450907580|FG006|PKC412A2104E1|Death|0|||
125347666|NCT00045942|450907581|FG007|PKC412A2104E1|Death|0|||
125347667|NCT00045942|450907582|FG008|PKC412A2104E1|Death|0|||
125347668|NCT00045942|450907574|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125347669|NCT00045942|450907575|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125548246|NCT00585195|451637124|FG018|Overall Study|Lost to Follow-up|0|||
125347670|NCT00045942|450907576|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
125347671|NCT00045942|450907577|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
125347672|NCT00045942|450907578|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125347673|NCT00045942|450907579|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125347674|NCT00045942|450907580|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125347675|NCT00045942|450907581|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125347676|NCT00045942|450907582|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
125347677|NCT00045942|450907574|FG000|PKC412A2104E2|Lost to Follow-up|0|||
125347678|NCT00045942|450907575|FG001|PKC412A2104E2|Lost to Follow-up|0|||
125347679|NCT00045942|450907576|FG002|PKC412A2104E2|Lost to Follow-up|0|||
125347680|NCT00045942|450907577|FG003|PKC412A2104E2|Lost to Follow-up|0|||
125347681|NCT00045942|450907578|FG004|PKC412A2104E2|Lost to Follow-up|0|||
125347682|NCT00045942|450907579|FG005|PKC412A2104E2|Lost to Follow-up|0|||
125347683|NCT00045942|450907580|FG006|PKC412A2104E2|Lost to Follow-up|0|||
125347684|NCT00045942|450907581|FG007|PKC412A2104E2|Lost to Follow-up|3|||
125347685|NCT00045942|450907582|FG008|PKC412A2104E2|Lost to Follow-up|0|||
125347686|NCT00045942|450907574|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
125347687|NCT00045942|450907575|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
125347688|NCT00045942|450907576|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
125347689|NCT00045942|450907577|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
125347690|NCT00045942|450907578|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
125347691|NCT00045942|450907579|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
125347692|NCT00045942|450907580|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
125347693|NCT00045942|450907581|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
125347694|NCT00045942|450907582|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
125347695|NCT00045942|450907574|FG000|PKC412A2104E2|Lack of Efficacy|0|||
125347696|NCT00045942|450907575|FG001|PKC412A2104E2|Lack of Efficacy|0|||
125347697|NCT00045942|450907576|FG002|PKC412A2104E2|Lack of Efficacy|0|||
125347698|NCT00045942|450907577|FG003|PKC412A2104E2|Lack of Efficacy|0|||
125347699|NCT00045942|450907578|FG004|PKC412A2104E2|Lack of Efficacy|0|||
125347700|NCT00045942|450907579|FG005|PKC412A2104E2|Lack of Efficacy|3|||
125347701|NCT00045942|450907580|FG006|PKC412A2104E2|Lack of Efficacy|2|||
125347702|NCT00045942|450907581|FG007|PKC412A2104E2|Lack of Efficacy|2|||
125347703|NCT00045942|450907582|FG008|PKC412A2104E2|Lack of Efficacy|6|||
125347704|NCT00045942|450907574|FG000|PKC412A2104E2|Adverse Event|0|||
125347705|NCT00045942|450907575|FG001|PKC412A2104E2|Adverse Event|0|||
125347706|NCT00045942|450907576|FG002|PKC412A2104E2|Adverse Event|0|||
125347707|NCT00045942|450907577|FG003|PKC412A2104E2|Adverse Event|0|||
125347708|NCT00045942|450907578|FG004|PKC412A2104E2|Adverse Event|0|||
125347709|NCT00045942|450907579|FG005|PKC412A2104E2|Adverse Event|4|||
125347710|NCT00045942|450907580|FG006|PKC412A2104E2|Adverse Event|3|||
125347711|NCT00045942|450907581|FG007|PKC412A2104E2|Adverse Event|1|||
125347712|NCT00045942|450907582|FG008|PKC412A2104E2|Adverse Event|0|||
125347713|NCT00045942|450907574|FG000|PKC412A2104E2|Death|0|||
125347714|NCT00045942|450907575|FG001|PKC412A2104E2|Death|0|||
125347715|NCT00045942|450907576|FG002|PKC412A2104E2|Death|0|||
125347716|NCT00045942|450907577|FG003|PKC412A2104E2|Death|0|||
125347717|NCT00045942|450907578|FG004|PKC412A2104E2|Death|0|||
125347718|NCT00045942|450907579|FG005|PKC412A2104E2|Death|1|||
125347719|NCT00045942|450907580|FG006|PKC412A2104E2|Death|2|||
125347720|NCT00045942|450907581|FG007|PKC412A2104E2|Death|0|||
125347721|NCT00045942|450907582|FG008|PKC412A2104E2|Death|0|||
125347722|NCT02514473|450907584|FG000|Overall Study|Adverse Event|0|||
125347723|NCT02514473|450907585|FG001|Overall Study|Adverse Event|2|||
125347724|NCT02514473|450907584|FG000|Overall Study|Withdrawal by Subject|2|||
125347725|NCT02514473|450907585|FG001|Overall Study|Withdrawal by Subject|1|||
125347726|NCT02514473|450907584|FG000|Overall Study|Lost to Follow-up|0|||
125347727|NCT02514473|450907585|FG001|Overall Study|Lost to Follow-up|1|||
125347728|NCT02514473|450907584|FG000|Overall Study|Other|1|||
125347729|NCT02514473|450907585|FG001|Overall Study|Other|1|||
125347730|NCT02158364|450907586|FG000|Overall Study|Case report forms uncollected|10|||
125347731|NCT02158364|450907586|FG000|Overall Study|Protocol Deviation|50|||
125347732|NCT00674154|450907589|FG000|Overall Study|Withdrawal by Subject|3|||
125681728|NCT01274338|452125605|FG002|Overall Study|Pregnancy|1|||
125347733|NCT00674154|450907590|FG001|Overall Study|Withdrawal by Subject|1|||
125347734|NCT00674154|450907589|FG000|Overall Study|Did not want parathyroidectomy|0|||
125347735|NCT00674154|450907590|FG001|Overall Study|Did not want parathyroidectomy|2|||
125347736|NCT01107379|450907591|FG000|Overall Study|Withdrawal by Subject|18|||
125347737|NCT01107379|450907591|FG000|Overall Study|Lost to Follow-up|3|||
125347738|NCT00609362|450907592|FG000|Overall Study|Withdrawal by Subject|2|||
125347739|NCT00609362|450907593|FG001|Overall Study|Withdrawal by Subject|1|||
125347740|NCT00609362|450907592|FG000|Overall Study|Adverse Event|1|||
125347741|NCT00609362|450907593|FG001|Overall Study|Adverse Event|0|||
125347742|NCT04559529|450907594|FG000|First Intervention (1 Day)|Adverse Event|0|||
125347743|NCT04559529|450907595|FG001|First Intervention (1 Day)|Adverse Event|0|||
125347744|NCT04559529|450907596|FG002|First Intervention (1 Day)|Adverse Event|0|||
125347745|NCT04559529|450907597|FG003|First Intervention (1 Day)|Adverse Event|1|||
125347746|NCT04559529|450907594|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
125347747|NCT04559529|450907595|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
125347748|NCT04559529|450907596|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
125347749|NCT04559529|450907597|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
125347750|NCT04559529|450907594|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
125347751|NCT04559529|450907595|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
125347752|NCT04559529|450907596|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
125347753|NCT04559529|450907597|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
125347754|NCT01009281|450907598|FG000|Overall Study|Administrative problems|7|||
125347755|NCT00548405|450907599|FG000|Overall Study|Adverse Event|6|||
125347756|NCT00548405|450907600|FG001|Overall Study|Adverse Event|2|||
125347757|NCT00548405|450907601|FG002|Overall Study|Adverse Event|0|||
125347758|NCT00548405|450907599|FG000|Overall Study|Lack of Efficacy|6|||
125347759|NCT00548405|450907600|FG001|Overall Study|Lack of Efficacy|0|||
125347760|NCT00548405|450907601|FG002|Overall Study|Lack of Efficacy|0|||
125347761|NCT00548405|450907599|FG000|Overall Study|Physician Decision|3|||
125347762|NCT00548405|450907600|FG001|Overall Study|Physician Decision|4|||
125347763|NCT00548405|450907601|FG002|Overall Study|Physician Decision|1|||
125347764|NCT00548405|450907599|FG000|Overall Study|Pregnancy|1|||
125347765|NCT00548405|450907600|FG001|Overall Study|Pregnancy|0|||
125347766|NCT00548405|450907601|FG002|Overall Study|Pregnancy|0|||
125347767|NCT00548405|450907599|FG000|Overall Study|Protocol Violation|1|||
125347768|NCT00548405|450907600|FG001|Overall Study|Protocol Violation|0|||
125347769|NCT00548405|450907601|FG002|Overall Study|Protocol Violation|0|||
125347770|NCT00548405|450907599|FG000|Overall Study|Withdrawal by Subject|36|||
125347771|NCT00548405|450907600|FG001|Overall Study|Withdrawal by Subject|12|||
125347772|NCT00548405|450907601|FG002|Overall Study|Withdrawal by Subject|5|||
125347773|NCT00548405|450907599|FG000|Overall Study|Lost to Follow-up|1|||
125347774|NCT00548405|450907600|FG001|Overall Study|Lost to Follow-up|1|||
125347775|NCT00548405|450907601|FG002|Overall Study|Lost to Follow-up|2|||
125347776|NCT00548405|450907599|FG000|Overall Study|Death|0|||
125347777|NCT00548405|450907600|FG001|Overall Study|Death|1|||
125347778|NCT00548405|450907601|FG002|Overall Study|Death|1|||
125347779|NCT00548405|450907599|FG000|Overall Study|Sponsor decision|1|||
125347780|NCT00548405|450907600|FG001|Overall Study|Sponsor decision|0|||
125347781|NCT00548405|450907601|FG002|Overall Study|Sponsor decision|0|||
125347782|NCT00548405|450907599|FG000|Overall Study|Randomized but not treated|1|||
125347783|NCT00548405|450907600|FG001|Overall Study|Randomized but not treated|0|||
125347784|NCT00548405|450907601|FG002|Overall Study|Randomized but not treated|0|||
125347785|NCT02582684|450907602|FG000|Overall Study|Unable to contact subject/parent|4|||
125347786|NCT02582684|450907602|FG000|Overall Study|Subject not able to get to clinic|10|||
125548247|NCT00585195|451637125|FG019|Overall Study|Lost to Follow-up|0|||
125347787|NCT02582684|450907602|FG000|Overall Study|Subject withdrew consent|1|||
125347788|NCT02582684|450907602|FG000|Overall Study|Found to be ineligible after enrollment|2|||
125347789|NCT00899392|450907612|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
125347790|NCT00899392|450907613|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
125347791|NCT01261780|450907620|FG000|Overall Study|Withdrawal by Subject|1|||
125347792|NCT01261780|450907621|FG001|Overall Study|Withdrawal by Subject|0|||
125548248|NCT00585195|451637126|FG020|Overall Study|Lost to Follow-up|0|||
125548249|NCT00585195|451637106|FG000|Overall Study|Site Terminated by Sponsor|0|||
125681729|NCT01274338|452125606|FG003|Overall Study|Pregnancy|0|||
125681730|NCT01274338|452125607|FG004|Overall Study|Pregnancy|0|||
125681731|NCT01274338|452125608|FG005|Overall Study|Pregnancy|0|||
125681732|NCT01274338|452125603|FG000|Overall Study|Reason not reported|12|||
125681733|NCT01274338|452125604|FG001|Overall Study|Reason not reported|21|||
125681734|NCT01274338|452125605|FG002|Overall Study|Reason not reported|3|||
125681735|NCT01274338|452125606|FG003|Overall Study|Reason not reported|0|||
125681736|NCT01274338|452125607|FG004|Overall Study|Reason not reported|1|||
125681737|NCT01274338|452125608|FG005|Overall Study|Reason not reported|0|||
125681738|NCT03493945|452125610|FG000|Phase I Dose Escalation|Ineligible|0|||
125681739|NCT03493945|452125611|FG001|Phase I Dose Escalation|Ineligible|0|||
125681740|NCT03493945|452125612|FG002|Phase I Dose Escalation|Ineligible|1|||
125681741|NCT03493945|452125613|FG003|Phase I Dose Escalation|Ineligible|0|||
125681742|NCT03493945|452125614|FG004|Phase I Dose Escalation|Ineligible|0|||
125681743|NCT03493945|452125615|FG005|Phase I Dose Escalation|Ineligible|0|||
125681744|NCT03493945|452125616|FG006|Phase I Dose Escalation|Ineligible|0|||
125681745|NCT03493945|452125610|FG000|Phase I Dose Escalation|New therapy|0|||
125681746|NCT03493945|452125611|FG001|Phase I Dose Escalation|New therapy|1|||
125681747|NCT03493945|452125612|FG002|Phase I Dose Escalation|New therapy|0|||
125681748|NCT03493945|452125613|FG003|Phase I Dose Escalation|New therapy|0|||
125681749|NCT03493945|452125614|FG004|Phase I Dose Escalation|New therapy|0|||
125681750|NCT03493945|452125615|FG005|Phase I Dose Escalation|New therapy|0|||
125681751|NCT03493945|452125616|FG006|Phase I Dose Escalation|New therapy|0|||
125681752|NCT03493945|452125610|FG000|Phase II Dose Expansion|Refused further treatment|0|||
125681753|NCT03493945|452125611|FG001|Phase II Dose Expansion|Refused further treatment|0|||
125681754|NCT03493945|452125612|FG002|Phase II Dose Expansion|Refused further treatment|0|||
125681755|NCT03493945|452125613|FG003|Phase II Dose Expansion|Refused further treatment|0|||
125681756|NCT03493945|452125614|FG004|Phase II Dose Expansion|Refused further treatment|1|||
125681757|NCT03493945|452125615|FG005|Phase II Dose Expansion|Refused further treatment|1|||
125681758|NCT03493945|452125616|FG006|Phase II Dose Expansion|Refused further treatment|0|||
125681759|NCT03493945|452125610|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
125681760|NCT03493945|452125611|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
125681761|NCT03493945|452125612|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
125681762|NCT03493945|452125613|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
125681763|NCT03493945|452125614|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
125681764|NCT03493945|452125615|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
125681765|NCT03493945|452125616|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
125681766|NCT05422339|452125621|FG000|Overall Study|Withdrawal by Subject|17|||
125681767|NCT05422339|452125622|FG001|Overall Study|Withdrawal by Subject|15|||
125681768|NCT04319198|452125623|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
125681769|NCT04319198|452125624|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
125681770|NCT04319198|452125625|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
125681771|NCT04319198|452125623|FG000|Overall Study|Death|0|||
125681772|NCT04319198|452125624|FG001|Overall Study|Death|3|||
125681773|NCT04319198|452125625|FG002|Overall Study|Death|3|||
125681774|NCT04319198|452125623|FG000|Overall Study|Reason Not Specified|0|||
125681775|NCT04319198|452125624|FG001|Overall Study|Reason Not Specified|2|||
125681776|NCT04319198|452125625|FG002|Overall Study|Reason Not Specified|4|||
125681777|NCT04319198|452125623|FG000|Overall Study|Withdrawal of Consent|0|||
125681778|NCT04319198|452125624|FG001|Overall Study|Withdrawal of Consent|0|||
125681779|NCT04319198|452125625|FG002|Overall Study|Withdrawal of Consent|5|||
125681780|NCT04319198|452125623|FG000|Overall Study|Site Terminated by Sponsor|0|||
125681781|NCT04319198|452125624|FG001|Overall Study|Site Terminated by Sponsor|1|||
125681782|NCT04319198|452125625|FG002|Overall Study|Site Terminated by Sponsor|0|||
125681783|NCT05472038|452125626|FG000|Overall Study|Adverse Event|0|||
125681784|NCT05472038|452125627|FG001|Overall Study|Adverse Event|0|||
125681785|NCT05472038|452125628|FG002|Overall Study|Adverse Event|1|||
125681786|NCT05472038|452125629|FG003|Overall Study|Adverse Event|0|||
125681787|NCT05472038|452125630|FG004|Overall Study|Adverse Event|0|||
125681788|NCT05472038|452125631|FG005|Overall Study|Adverse Event|0|||
125681789|NCT05472038|452125632|FG006|Overall Study|Adverse Event|0|||
125681790|NCT05472038|452125633|FG007|Overall Study|Adverse Event|0|||
125681791|NCT05472038|452125634|FG008|Overall Study|Adverse Event|0|||
125681792|NCT05472038|452125635|FG009|Overall Study|Adverse Event|0|||
125681793|NCT05472038|452125636|FG010|Overall Study|Adverse Event|0|||
125681794|NCT05472038|452125637|FG011|Overall Study|Adverse Event|0|||
125681795|NCT05472038|452125626|FG000|Overall Study|Death|0|||
125681796|NCT05472038|452125627|FG001|Overall Study|Death|0|||
125681797|NCT05472038|452125628|FG002|Overall Study|Death|0|||
125681798|NCT05472038|452125629|FG003|Overall Study|Death|0|||
125681799|NCT05472038|452125630|FG004|Overall Study|Death|0|||
125681800|NCT05472038|452125631|FG005|Overall Study|Death|1|||
125681801|NCT05472038|452125632|FG006|Overall Study|Death|0|||
125681802|NCT05472038|452125633|FG007|Overall Study|Death|0|||
125681803|NCT05472038|452125634|FG008|Overall Study|Death|0|||
125347793|NCT01261780|450907620|FG000|Overall Study|Event not related to subject|1|||
125347794|NCT01261780|450907621|FG001|Overall Study|Event not related to subject|2|||
125347795|NCT01239732|450907622|FG000|Overall Study|Termination of study per protocol|667|||
125347796|NCT01239732|450907622|FG000|Overall Study|Death|226|||
125347797|NCT01239732|450907622|FG000|Overall Study|Withdrawal by Subject|87|||
125347798|NCT01239732|450907622|FG000|Overall Study|Adverse Event|6|||
125347799|NCT01239732|450907622|FG000|Overall Study|Protocol Violation|3|||
125347800|NCT01239732|450907622|FG000|Overall Study|Participant non compliance|5|||
125347801|NCT01239732|450907622|FG000|Overall Study|Study termination by sponsor|2|||
125347802|NCT01239732|450907622|FG000|Overall Study|Investigator's decision|4|||
125347803|NCT01239732|450907622|FG000|Overall Study|Treatment failure|2|||
125347804|NCT01239732|450907622|FG000|Overall Study|Other|19|||
125347805|NCT00732940|450907623|FG000|Overall Study|Withdrawal by Subject|1|||
125347806|NCT00732940|450907624|FG001|Overall Study|Withdrawal by Subject|2|||
125347807|NCT00732940|450907623|FG000|Overall Study|Adverse Event|0|||
125347808|NCT00732940|450907624|FG001|Overall Study|Adverse Event|1|||
125347809|NCT00732940|450907623|FG000|Overall Study|Lost to Follow-up|1|||
125347810|NCT00732940|450907624|FG001|Overall Study|Lost to Follow-up|0|||
125347811|NCT02241889|450907625|FG000|Overall Study|device issues|0|||
125347812|NCT02241889|450907626|FG001|Overall Study|device issues|0|||
125347813|NCT02241889|450907627|FG002|Overall Study|device issues|1|||
125347814|NCT02241889|450907628|FG003|Overall Study|device issues|0|||
125347815|NCT02241889|450907629|FG004|Overall Study|device issues|0|||
125347816|NCT02241889|450907630|FG005|Overall Study|device issues|0|||
125347817|NCT02241889|450907625|FG000|Overall Study|Withdrawal by Subject|0|||
125347818|NCT02241889|450907626|FG001|Overall Study|Withdrawal by Subject|0|||
125347819|NCT02241889|450907627|FG002|Overall Study|Withdrawal by Subject|0|||
125347820|NCT02241889|450907628|FG003|Overall Study|Withdrawal by Subject|0|||
125347821|NCT02241889|450907629|FG004|Overall Study|Withdrawal by Subject|0|||
125347822|NCT02241889|450907630|FG005|Overall Study|Withdrawal by Subject|1|||
125347823|NCT00266877|450907631|FG000|Overall Study|Death|1|||
125347824|NCT00266877|450907632|FG001|Overall Study|Death|1|||
125347825|NCT00266877|450907633|FG002|Overall Study|Death|1|||
125347826|NCT00266877|450907631|FG000|Overall Study|Adverse Event|6|||
125347827|NCT00266877|450907632|FG001|Overall Study|Adverse Event|4|||
125347828|NCT00266877|450907633|FG002|Overall Study|Adverse Event|1|||
125347829|NCT00266877|450907631|FG000|Overall Study|Physician Decision|2|||
125347830|NCT00266877|450907632|FG001|Overall Study|Physician Decision|1|||
125347831|NCT00266877|450907633|FG002|Overall Study|Physician Decision|1|||
125347832|NCT00266877|450907631|FG000|Overall Study|Withdrawal by Subject|3|||
125347833|NCT00266877|450907632|FG001|Overall Study|Withdrawal by Subject|1|||
125347834|NCT00266877|450907633|FG002|Overall Study|Withdrawal by Subject|1|||
125347835|NCT00266877|450907631|FG000|Overall Study|Disease Progression|72|||
125347836|NCT00266877|450907632|FG001|Overall Study|Disease Progression|37|||
125347837|NCT00266877|450907633|FG002|Overall Study|Disease Progression|23|||
125347838|NCT00266877|450907631|FG000|Overall Study|Symptomatic Deterioration|6|||
125347839|NCT00266877|450907632|FG001|Overall Study|Symptomatic Deterioration|3|||
125347840|NCT00266877|450907633|FG002|Overall Study|Symptomatic Deterioration|1|||
125548250|NCT00585195|451637107|FG001|Overall Study|Site Terminated by Sponsor|0|||
125548251|NCT00585195|451637108|FG002|Overall Study|Site Terminated by Sponsor|0|||
125548252|NCT00585195|451637109|FG003|Overall Study|Site Terminated by Sponsor|0|||
125548253|NCT00585195|451637110|FG004|Overall Study|Site Terminated by Sponsor|0|||
125548254|NCT00585195|451637111|FG005|Overall Study|Site Terminated by Sponsor|0|||
125548255|NCT00585195|451637112|FG006|Overall Study|Site Terminated by Sponsor|0|||
125347841|NCT00266877|450907631|FG000|Overall Study|Hospitalization|1|||
125347842|NCT00266877|450907632|FG001|Overall Study|Hospitalization|0|||
125347843|NCT00266877|450907633|FG002|Overall Study|Hospitalization|0|||
125347844|NCT00266877|450907631|FG000|Overall Study|Concomitant Radiotherapy|0|||
125347845|NCT00266877|450907632|FG001|Overall Study|Concomitant Radiotherapy|1|||
125347846|NCT00266877|450907633|FG002|Overall Study|Concomitant Radiotherapy|0|||
125347847|NCT03985878|450907642|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
125347848|NCT03985878|450907642|FG000|Overall Study|Study Terminated by Sponsor|12|||
125347849|NCT03985878|450907642|FG000|Overall Study|Withdrawal by Subject|1|||
125347850|NCT00278915|450907646|FG000|Overall Study|Disease progression|1|||
125347851|NCT02520089|450907647|FG000|Overall Study|Lost to Follow-up|3|||
125347852|NCT02520089|450907648|FG001|Overall Study|Lost to Follow-up|4|||
125347853|NCT00002931|450908852|FG000|Overall Study|rapidly progressing disease during|2|||
125347854|NCT00910247|450908854|FG000|Overall Study|Adverse Event|15|||
125347855|NCT00910247|450908854|FG000|Overall Study|Death|2|||
125347856|NCT00910247|450908854|FG000|Overall Study|Lost to Follow-up|10|||
125347857|NCT00910247|450908854|FG000|Overall Study|Physician Decision|3|||
125347858|NCT00910247|450908854|FG000|Overall Study|Protocol Violation|10|||
125347859|NCT00910247|450908854|FG000|Overall Study|Withdrawal by Subject|25|||
125548256|NCT00585195|451637113|FG007|Overall Study|Site Terminated by Sponsor|0|||
125548257|NCT00585195|451637114|FG008|Overall Study|Site Terminated by Sponsor|0|||
125548258|NCT00585195|451637115|FG009|Overall Study|Site Terminated by Sponsor|0|||
125548259|NCT00585195|451637116|FG010|Overall Study|Site Terminated by Sponsor|0|||
125548260|NCT00585195|451637117|FG011|Overall Study|Site Terminated by Sponsor|0|||
125548261|NCT00585195|451637118|FG012|Overall Study|Site Terminated by Sponsor|1|||
125548262|NCT00585195|451637119|FG013|Overall Study|Site Terminated by Sponsor|0|||
125548263|NCT00585195|451637120|FG014|Overall Study|Site Terminated by Sponsor|0|||
125681804|NCT05472038|452125635|FG009|Overall Study|Death|0|||
125681805|NCT05472038|452125636|FG010|Overall Study|Death|0|||
125681806|NCT05472038|452125637|FG011|Overall Study|Death|0|||
125681807|NCT05472038|452125626|FG000|Overall Study|Lost to Follow-up|1|||
125681808|NCT05472038|452125627|FG001|Overall Study|Lost to Follow-up|3|||
125681809|NCT05472038|452125628|FG002|Overall Study|Lost to Follow-up|3|||
125681810|NCT05472038|452125629|FG003|Overall Study|Lost to Follow-up|9|||
125681811|NCT05472038|452125630|FG004|Overall Study|Lost to Follow-up|2|||
125681812|NCT05472038|452125631|FG005|Overall Study|Lost to Follow-up|2|||
125681813|NCT05472038|452125632|FG006|Overall Study|Lost to Follow-up|1|||
125681814|NCT05472038|452125633|FG007|Overall Study|Lost to Follow-up|0|||
125681815|NCT05472038|452125634|FG008|Overall Study|Lost to Follow-up|1|||
125681816|NCT05472038|452125635|FG009|Overall Study|Lost to Follow-up|0|||
125681817|NCT05472038|452125636|FG010|Overall Study|Lost to Follow-up|2|||
125681818|NCT05472038|452125637|FG011|Overall Study|Lost to Follow-up|1|||
125681819|NCT05472038|452125626|FG000|Overall Study|Physician Decision|0|||
125681820|NCT05472038|452125627|FG001|Overall Study|Physician Decision|0|||
125681821|NCT05472038|452125628|FG002|Overall Study|Physician Decision|0|||
125681822|NCT05472038|452125629|FG003|Overall Study|Physician Decision|0|||
125681823|NCT05472038|452125630|FG004|Overall Study|Physician Decision|1|||
125681824|NCT05472038|452125631|FG005|Overall Study|Physician Decision|0|||
125681825|NCT05472038|452125632|FG006|Overall Study|Physician Decision|0|||
125681826|NCT05472038|452125633|FG007|Overall Study|Physician Decision|0|||
125681827|NCT05472038|452125634|FG008|Overall Study|Physician Decision|0|||
125681828|NCT05472038|452125635|FG009|Overall Study|Physician Decision|0|||
125681829|NCT05472038|452125636|FG010|Overall Study|Physician Decision|0|||
125681830|NCT05472038|452125637|FG011|Overall Study|Physician Decision|0|||
125681831|NCT05472038|452125626|FG000|Overall Study|Withdrawal by Subject|1|||
125681832|NCT05472038|452125627|FG001|Overall Study|Withdrawal by Subject|3|||
125681833|NCT05472038|452125628|FG002|Overall Study|Withdrawal by Subject|1|||
125681834|NCT05472038|452125629|FG003|Overall Study|Withdrawal by Subject|6|||
125681835|NCT05472038|452125630|FG004|Overall Study|Withdrawal by Subject|1|||
125681836|NCT05472038|452125631|FG005|Overall Study|Withdrawal by Subject|3|||
125681837|NCT05472038|452125632|FG006|Overall Study|Withdrawal by Subject|0|||
125681838|NCT05472038|452125633|FG007|Overall Study|Withdrawal by Subject|2|||
125681839|NCT05472038|452125634|FG008|Overall Study|Withdrawal by Subject|3|||
125681840|NCT05472038|452125635|FG009|Overall Study|Withdrawal by Subject|1|||
125681841|NCT05472038|452125636|FG010|Overall Study|Withdrawal by Subject|2|||
125681842|NCT05472038|452125637|FG011|Overall Study|Withdrawal by Subject|2|||
125681843|NCT05472038|452125626|FG000|Overall Study|Protocol Violation|0|||
125681844|NCT05472038|452125627|FG001|Overall Study|Protocol Violation|0|||
125681845|NCT05472038|452125628|FG002|Overall Study|Protocol Violation|0|||
125681846|NCT05472038|452125629|FG003|Overall Study|Protocol Violation|0|||
125681847|NCT05472038|452125630|FG004|Overall Study|Protocol Violation|0|||
125681848|NCT05472038|452125631|FG005|Overall Study|Protocol Violation|0|||
125681849|NCT05472038|452125632|FG006|Overall Study|Protocol Violation|0|||
125681850|NCT05472038|452125633|FG007|Overall Study|Protocol Violation|1|||
125347860|NCT00910247|450908854|FG000|Overall Study|Not collected|4|||
125548264|NCT00585195|451637121|FG015|Overall Study|Site Terminated by Sponsor|0|||
125548265|NCT00585195|451637122|FG016|Overall Study|Site Terminated by Sponsor|0|||
125681851|NCT05472038|452125634|FG008|Overall Study|Protocol Violation|1|||
125681852|NCT05472038|452125635|FG009|Overall Study|Protocol Violation|1|||
125681853|NCT05472038|452125636|FG010|Overall Study|Protocol Violation|1|||
125681854|NCT05472038|452125637|FG011|Overall Study|Protocol Violation|1|||
125681855|NCT05472038|452125626|FG000|Overall Study|Not vaccinated|0|||
125681856|NCT05472038|452125627|FG001|Overall Study|Not vaccinated|0|||
125681857|NCT05472038|452125628|FG002|Overall Study|Not vaccinated|0|||
125681858|NCT05472038|452125629|FG003|Overall Study|Not vaccinated|1|||
125548266|NCT00585195|451637123|FG017|Overall Study|Site Terminated by Sponsor|0|||
125681859|NCT05472038|452125630|FG004|Overall Study|Not vaccinated|0|||
125681860|NCT05472038|452125631|FG005|Overall Study|Not vaccinated|0|||
125347861|NCT01879579|450908855|FG000|Overall Study|Phone incompatible with texting platform|3|||
125347862|NCT01879579|450908856|FG001|Overall Study|Phone incompatible with texting platform|0|||
125347863|NCT01879579|450908855|FG000|Overall Study|Did not enroll in texting platform|1|||
125347864|NCT01879579|450908856|FG001|Overall Study|Did not enroll in texting platform|0|||
125347865|NCT01879579|450908855|FG000|Overall Study|Did not initiate insulin treatment|1|||
125347866|NCT01879579|450908856|FG001|Overall Study|Did not initiate insulin treatment|0|||
125548267|NCT00585195|451637124|FG018|Overall Study|Site Terminated by Sponsor|0|||
125548268|NCT00585195|451637125|FG019|Overall Study|Site Terminated by Sponsor|0|||
125548269|NCT00585195|451637126|FG020|Overall Study|Site Terminated by Sponsor|0|||
125347867|NCT01879579|450908855|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
125347868|NCT01879579|450908856|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
125347869|NCT01879579|450908855|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
125347870|NCT01879579|450908856|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
125347871|NCT01757691|450908860|FG000|Overall Study|Administrative problems|2|||
125347872|NCT01757691|450908861|FG001|Overall Study|Administrative problems|0|||
125347873|NCT02919969|450908868|FG000|Overall Study|Lack of Efficacy|22|||
125347874|NCT02919969|450908868|FG000|Overall Study|Death|4|||
125347875|NCT02919969|450908868|FG000|Overall Study|Physician Decision|3|||
125347876|NCT02919969|450908868|FG000|Overall Study|Withdrawal by Subject|2|||
125347877|NCT01842633|450908869|FG000|Overall Study|Screen Failure|1|||
125347878|NCT01842633|450908870|FG001|Overall Study|Screen Failure|0|||
125347879|NCT01842633|450908871|FG002|Overall Study|Screen Failure|0|||
125347880|NCT01842633|450908869|FG000|Overall Study|Adverse Event|1|||
125347881|NCT01842633|450908870|FG001|Overall Study|Adverse Event|1|||
125347882|NCT01842633|450908871|FG002|Overall Study|Adverse Event|0|||
125347883|NCT01842633|450908869|FG000|Overall Study|Withdrawal by Subject|0|||
125347884|NCT01842633|450908870|FG001|Overall Study|Withdrawal by Subject|1|||
125347885|NCT01842633|450908871|FG002|Overall Study|Withdrawal by Subject|0|||
125347886|NCT01842633|450908869|FG000|Overall Study|Technical issues|1|||
125347887|NCT01842633|450908870|FG001|Overall Study|Technical issues|0|||
125347888|NCT01842633|450908871|FG002|Overall Study|Technical issues|0|||
125347889|NCT01122394|450908876|FG000|Overall Study|Withdrawal by Subject|1|||
125347890|NCT01122394|450908877|FG001|Overall Study|Withdrawal by Subject|1|||
125347891|NCT01122394|450908876|FG000|Overall Study|Lost to Follow-up|2|||
125347892|NCT01122394|450908877|FG001|Overall Study|Lost to Follow-up|2|||
125347893|NCT01122394|450908876|FG000|Overall Study|Adverse Event|0|||
125347894|NCT01122394|450908877|FG001|Overall Study|Adverse Event|1|||
125347895|NCT00718081|450908880|FG000|Overall Study|Adverse Event|0|||
125347896|NCT00718081|450908881|FG001|Overall Study|Adverse Event|1|||
125347897|NCT00718081|450908882|FG002|Overall Study|Adverse Event|0|||
125347898|NCT00718081|450908880|FG000|Overall Study|Lack of Efficacy|7|||
125347899|NCT00718081|450908881|FG001|Overall Study|Lack of Efficacy|3|||
125347900|NCT00718081|450908882|FG002|Overall Study|Lack of Efficacy|21|||
125347901|NCT01397825|450908883|FG000|Overall Study|Progressive Disease|10|||
125347902|NCT01397825|450908884|FG001|Overall Study|Progressive Disease|3|||
125347903|NCT01397825|450908885|FG002|Overall Study|Progressive Disease|11|||
125347904|NCT01397825|450908886|FG003|Overall Study|Progressive Disease|1|||
125347905|NCT01397825|450908887|FG004|Overall Study|Progressive Disease|0|||
125347906|NCT01397825|450908883|FG000|Overall Study|Symptomatic Deterioration|2|||
125347907|NCT01397825|450908884|FG001|Overall Study|Symptomatic Deterioration|0|||
125347908|NCT01397825|450908885|FG002|Overall Study|Symptomatic Deterioration|4|||
125347909|NCT01397825|450908886|FG003|Overall Study|Symptomatic Deterioration|0|||
125347910|NCT01397825|450908887|FG004|Overall Study|Symptomatic Deterioration|0|||
125347911|NCT01397825|450908883|FG000|Overall Study|Adverse Event|0|||
125347912|NCT01397825|450908884|FG001|Overall Study|Adverse Event|1|||
125347913|NCT01397825|450908885|FG002|Overall Study|Adverse Event|5|||
125347914|NCT01397825|450908886|FG003|Overall Study|Adverse Event|1|||
125347915|NCT01397825|450908887|FG004|Overall Study|Adverse Event|0|||
125347916|NCT01397825|450908883|FG000|Overall Study|Withdrawal by Subject|1|||
125347917|NCT01397825|450908884|FG001|Overall Study|Withdrawal by Subject|0|||
125548270|NCT00585195|451637106|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
125347918|NCT01397825|450908885|FG002|Overall Study|Withdrawal by Subject|5|||
125347919|NCT01397825|450908886|FG003|Overall Study|Withdrawal by Subject|1|||
125347920|NCT01397825|450908887|FG004|Overall Study|Withdrawal by Subject|0|||
125347921|NCT01931670|450908889|FG000|Treatment Period|Exclusionary Medication Received|1|||
125347922|NCT01931670|450908890|FG001|Treatment Period|Exclusionary Medication Received|1|||
125347923|NCT01931670|450908891|FG002|Treatment Period|Exclusionary Medication Received|1|||
125347924|NCT01931670|450908889|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
125347925|NCT01931670|450908890|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
125347926|NCT01931670|450908891|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
125347927|NCT01931670|450908889|FG000|Treatment Period|Subject Noncompliant|4|||
125347928|NCT01931670|450908890|FG001|Treatment Period|Subject Noncompliant|9|||
125347929|NCT01931670|450908891|FG002|Treatment Period|Subject Noncompliant|5|||
125347930|NCT01931670|450908889|FG000|Treatment Period|Adverse Event|19|||
125347931|NCT01931670|450908890|FG001|Treatment Period|Adverse Event|8|||
125347932|NCT01931670|450908891|FG002|Treatment Period|Adverse Event|21|||
125347933|NCT01931670|450908889|FG000|Treatment Period|Lack of Efficacy|11|||
125347934|NCT01931670|450908890|FG001|Treatment Period|Lack of Efficacy|2|||
125347935|NCT01931670|450908891|FG002|Treatment Period|Lack of Efficacy|2|||
125347936|NCT01931670|450908889|FG000|Treatment Period|Pregnancy|7|||
125347937|NCT01931670|450908890|FG001|Treatment Period|Pregnancy|2|||
125347938|NCT01931670|450908891|FG002|Treatment Period|Pregnancy|0|||
125347939|NCT01931670|450908889|FG000|Treatment Period|Other|8|||
125347940|NCT01931670|450908890|FG001|Treatment Period|Other|7|||
125347941|NCT01931670|450908891|FG002|Treatment Period|Other|2|||
125347942|NCT01931670|450908889|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
125347943|NCT01931670|450908890|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
125347944|NCT01931670|450908891|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
125347945|NCT01931670|450908889|FG000|Treatment Period|Lost to Follow-up|19|||
125347946|NCT01931670|450908890|FG001|Treatment Period|Lost to Follow-up|5|||
125347947|NCT01931670|450908891|FG002|Treatment Period|Lost to Follow-up|7|||
125347948|NCT01931670|450908889|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
125548271|NCT00585195|451637107|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
125548272|NCT00585195|451637108|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
125681861|NCT05472038|452125632|FG006|Overall Study|Not vaccinated|0|||
125347949|NCT01931670|450908890|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
125347950|NCT01931670|450908891|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
125347951|NCT01931670|450908889|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
125347952|NCT01931670|450908890|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
125347953|NCT01931670|450908891|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
125347954|NCT01931670|450908889|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
125347955|NCT01931670|450908890|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
125347956|NCT01931670|450908891|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
125347957|NCT01931670|450908889|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
125347958|NCT01931670|450908890|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
125347959|NCT01931670|450908891|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
125347960|NCT01931670|450908889|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
125347961|NCT01931670|450908890|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
125347962|NCT01931670|450908891|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
125347963|NCT01931670|450908889|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
125347964|NCT01931670|450908890|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
125347965|NCT01931670|450908891|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
125347966|NCT00815516|450908892|FG000|Overall Study|Death|3|||
125347967|NCT00815516|450908893|FG001|Overall Study|Death|1|||
125347968|NCT00815516|450908892|FG000|Overall Study|Physician Decision|1|||
125347969|NCT00815516|450908893|FG001|Overall Study|Physician Decision|0|||
125347970|NCT00976508|450908899|FG000|Overall Study|Death|7|||
125347971|NCT00976508|450908900|FG001|Overall Study|Death|1|||
125347972|NCT00976508|450908899|FG000|Overall Study|Lost to Follow-up|1|||
125347973|NCT00976508|450908900|FG001|Overall Study|Lost to Follow-up|0|||
125347974|NCT00976508|450908899|FG000|Overall Study|Withdrawal by Subject|1|||
125347975|NCT00976508|450908900|FG001|Overall Study|Withdrawal by Subject|0|||
125347976|NCT00976508|450908899|FG000|Overall Study|Disease Progression|4|||
125347977|NCT00976508|450908900|FG001|Overall Study|Disease Progression|4|||
125347978|NCT00976508|450908899|FG000|Overall Study|Subject Enrolled in Hospice|1|||
125347979|NCT00976508|450908900|FG001|Overall Study|Subject Enrolled in Hospice|0|||
125347980|NCT00976508|450908899|FG000|Overall Study|Terminated by the Sponsor|0|||
125347981|NCT00976508|450908900|FG001|Overall Study|Terminated by the Sponsor|1|||
125347982|NCT01205581|450908904|FG000|Overall Study|Withdrawal by Subject|1|||
125347983|NCT01205581|450908905|FG001|Overall Study|Withdrawal by Subject|0|||
125347984|NCT01205581|450908906|FG002|Overall Study|Withdrawal by Subject|0|||
125347985|NCT01205581|450908907|FG003|Overall Study|Withdrawal by Subject|0|||
125347986|NCT01205581|450908908|FG004|Overall Study|Withdrawal by Subject|0|||
125347987|NCT01205581|450908909|FG005|Overall Study|Withdrawal by Subject|0|||
125347988|NCT02278471|450908910|FG000|Overall Study|Lost to Follow-up|6|||
125347989|NCT02278471|450908911|FG001|Overall Study|Lost to Follow-up|15|||
125347990|NCT02278471|450908910|FG000|Overall Study|Death|2|||
125347991|NCT02278471|450908911|FG001|Overall Study|Death|2|||
125347992|NCT02278471|450908910|FG000|Overall Study|Withdrawal by Subject|0|||
125347993|NCT02278471|450908911|FG001|Overall Study|Withdrawal by Subject|3|||
125347994|NCT00640835|450908912|FG000|Overall Study|Adverse Event|5|||
125347995|NCT00640835|450908913|FG001|Overall Study|Adverse Event|3|||
125347996|NCT00640835|450908912|FG000|Overall Study|Withdrawal by Subject|12|||
125347997|NCT00640835|450908913|FG001|Overall Study|Withdrawal by Subject|14|||
125347998|NCT00640835|450908912|FG000|Overall Study|Physician Decision|10|||
125347999|NCT00640835|450908913|FG001|Overall Study|Physician Decision|14|||
125348000|NCT00640835|450908912|FG000|Overall Study|Sponsor's Decision|11|||
125348001|NCT00640835|450908913|FG001|Overall Study|Sponsor's Decision|7|||
125348002|NCT00640835|450908912|FG000|Overall Study|Protocol Violation|2|||
125348003|NCT00640835|450908913|FG001|Overall Study|Protocol Violation|2|||
125348004|NCT00640835|450908912|FG000|Overall Study|Lost to Follow-up|17|||
125348005|NCT00640835|450908913|FG001|Overall Study|Lost to Follow-up|13|||
125348006|NCT00640835|450908912|FG000|Overall Study|Other Reason|19|||
125348007|NCT00640835|450908913|FG001|Overall Study|Other Reason|4|||
125348008|NCT03468543|450908914|FG000|Overall Study|Protocol stopping rules met|3|||
125348009|NCT04618770|450908916|FG000|Overall Study|Censored from Analysis|12|||
125348010|NCT04618770|450908916|FG000|Overall Study|Early Termination|25|||
125348011|NCT02095132|450908919|FG000|Overall Study|Adverse Event|0|||
125348012|NCT02095132|450908920|FG001|Overall Study|Adverse Event|0|||
125348013|NCT02095132|450908921|FG002|Overall Study|Adverse Event|0|||
125348014|NCT02095132|450908922|FG003|Overall Study|Adverse Event|0|||
125348015|NCT02095132|450908923|FG004|Overall Study|Adverse Event|1|||
125348016|NCT02095132|450908924|FG005|Overall Study|Adverse Event|0|||
125348017|NCT02095132|450908925|FG006|Overall Study|Adverse Event|1|||
125348018|NCT02095132|450908926|FG007|Overall Study|Adverse Event|0|||
125348019|NCT02095132|450908927|FG008|Overall Study|Adverse Event|0|||
125348020|NCT02095132|450908919|FG000|Overall Study|Death|0|||
125348021|NCT02095132|450908920|FG001|Overall Study|Death|0|||
125348022|NCT02095132|450908921|FG002|Overall Study|Death|0|||
125348023|NCT02095132|450908922|FG003|Overall Study|Death|0|||
125348024|NCT02095132|450908923|FG004|Overall Study|Death|0|||
125348025|NCT02095132|450908924|FG005|Overall Study|Death|0|||
125348026|NCT02095132|450908925|FG006|Overall Study|Death|1|||
125348027|NCT02095132|450908926|FG007|Overall Study|Death|0|||
125348028|NCT02095132|450908927|FG008|Overall Study|Death|0|||
125348029|NCT02095132|450908919|FG000|Overall Study|Lack of Efficacy|3|||
125348030|NCT02095132|450908920|FG001|Overall Study|Lack of Efficacy|5|||
125348031|NCT02095132|450908921|FG002|Overall Study|Lack of Efficacy|2|||
125348032|NCT02095132|450908922|FG003|Overall Study|Lack of Efficacy|8|||
125348033|NCT02095132|450908923|FG004|Overall Study|Lack of Efficacy|3|||
125348034|NCT02095132|450908924|FG005|Overall Study|Lack of Efficacy|6|||
125348035|NCT02095132|450908925|FG006|Overall Study|Lack of Efficacy|10|||
125348036|NCT02095132|450908926|FG007|Overall Study|Lack of Efficacy|9|||
125348037|NCT02095132|450908927|FG008|Overall Study|Lack of Efficacy|8|||
125348038|NCT02095132|450908919|FG000|Overall Study|Physician Decision|1|||
125348039|NCT02095132|450908920|FG001|Overall Study|Physician Decision|0|||
125348040|NCT02095132|450908921|FG002|Overall Study|Physician Decision|0|||
125348041|NCT02095132|450908922|FG003|Overall Study|Physician Decision|0|||
125348042|NCT02095132|450908923|FG004|Overall Study|Physician Decision|0|||
125348043|NCT02095132|450908924|FG005|Overall Study|Physician Decision|0|||
125348044|NCT02095132|450908925|FG006|Overall Study|Physician Decision|1|||
125348045|NCT02095132|450908926|FG007|Overall Study|Physician Decision|0|||
125348046|NCT02095132|450908927|FG008|Overall Study|Physician Decision|2|||
125348047|NCT02095132|450908919|FG000|Overall Study|Withdrawal by Subject|0|||
125348048|NCT02095132|450908920|FG001|Overall Study|Withdrawal by Subject|0|||
125348049|NCT02095132|450908921|FG002|Overall Study|Withdrawal by Subject|2|||
125348050|NCT02095132|450908922|FG003|Overall Study|Withdrawal by Subject|2|||
125348051|NCT02095132|450908923|FG004|Overall Study|Withdrawal by Subject|3|||
125348052|NCT02095132|450908924|FG005|Overall Study|Withdrawal by Subject|0|||
125348053|NCT02095132|450908925|FG006|Overall Study|Withdrawal by Subject|5|||
125348054|NCT02095132|450908926|FG007|Overall Study|Withdrawal by Subject|0|||
125348055|NCT02095132|450908927|FG008|Overall Study|Withdrawal by Subject|0|||
125348056|NCT01895361|450908931|FG000|Overall Study|Adverse Event|1|||
125348057|NCT01895361|450908932|FG001|Overall Study|Adverse Event|1|||
125348058|NCT01895361|450908933|FG002|Overall Study|Adverse Event|3|||
125348059|NCT01895361|450908931|FG000|Overall Study|Death|2|||
125348060|NCT01895361|450908932|FG001|Overall Study|Death|1|||
125348061|NCT01895361|450908933|FG002|Overall Study|Death|2|||
125348062|NCT01895361|450908931|FG000|Overall Study|Lost to Follow-up|4|||
125348063|NCT01895361|450908932|FG001|Overall Study|Lost to Follow-up|4|||
125348064|NCT01895361|450908933|FG002|Overall Study|Lost to Follow-up|6|||
125348065|NCT01895361|450908931|FG000|Overall Study|Non-compliance with study|1|||
125348066|NCT01895361|450908932|FG001|Overall Study|Non-compliance with study|3|||
125348067|NCT01895361|450908933|FG002|Overall Study|Non-compliance with study|1|||
125348068|NCT01895361|450908931|FG000|Overall Study|Physician Decision|2|||
125348069|NCT01895361|450908932|FG001|Overall Study|Physician Decision|2|||
125348070|NCT01895361|450908933|FG002|Overall Study|Physician Decision|2|||
125348071|NCT01895361|450908931|FG000|Overall Study|Withdrawal by Subject|7|||
125348072|NCT01895361|450908932|FG001|Overall Study|Withdrawal by Subject|6|||
125348073|NCT01895361|450908933|FG002|Overall Study|Withdrawal by Subject|6|||
125348074|NCT01895361|450908931|FG000|Overall Study|Lack of Efficacy|0|||
125348075|NCT01895361|450908932|FG001|Overall Study|Lack of Efficacy|1|||
125348076|NCT01895361|450908933|FG002|Overall Study|Lack of Efficacy|0|||
125348077|NCT01895361|450908931|FG000|Overall Study|Reasons different from categories above|7|||
125348078|NCT01895361|450908932|FG001|Overall Study|Reasons different from categories above|3|||
125348079|NCT01895361|450908933|FG002|Overall Study|Reasons different from categories above|4|||
125348080|NCT00761748|450908937|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
125348081|NCT00761748|450908938|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
125348082|NCT00761748|450908937|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
125348083|NCT00761748|450908938|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
125348084|NCT01209832|450908939|FG000|Period 1|Sponsor Decision and was not dosed|1|||
125348085|NCT01209832|450908939|FG000|Period 2|Sponsor Decision|1|||
125348086|NCT01268579|450908940|FG000|Overall Study|Adverse Event|1|||
125348087|NCT01268579|450908940|FG000|Overall Study|Withdrawal by Subject|2|||
125348088|NCT02692651|450908941|FG000|Study Treatment|Death|7|||
125348089|NCT02692651|450908942|FG001|Study Treatment|Death|3|||
125348090|NCT02692651|450908941|FG000|Study Treatment|comfort care|1|||
125348091|NCT02692651|450908942|FG001|Study Treatment|comfort care|1|||
125348092|NCT02692651|450908941|FG000|Study Treatment|Protocol violation per treating team preference|8|||
125348093|NCT02692651|450908942|FG001|Study Treatment|Protocol violation per treating team preference|6|||
125348094|NCT02692651|450908941|FG000|Post Study Treatment Follow-up|Death|4|||
125348095|NCT02692651|450908942|FG001|Post Study Treatment Follow-up|Death|4|||
125348096|NCT02480712|450908943|FG000|Overall Study|Enrolled but Never Treated|1|||
125348097|NCT02480712|450908943|FG000|Overall Study|Lost to Follow-up|5|||
125348098|NCT02480712|450908943|FG000|Overall Study|Withdrew Consent|3|||
125348099|NCT02480712|450908943|FG000|Overall Study|Death|1|||
125348100|NCT02480712|450908943|FG000|Overall Study|Lack of Efficacy|1|||
125348101|NCT02239120|450908944|FG000|Overall Study|Death|56|||
125348102|NCT02239120|450908945|FG001|Overall Study|Death|58|||
125348103|NCT02239120|450908944|FG000|Overall Study|Lost to Follow-up|19|||
125348104|NCT02239120|450908945|FG001|Overall Study|Lost to Follow-up|14|||
125348105|NCT01878149|450908950|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
125348106|NCT01878149|450908951|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
125348107|NCT02048241|450908952|FG000|Overall Study|Withdrawal by Subject|0|||
125348108|NCT02048241|450908953|FG001|Overall Study|Withdrawal by Subject|1|||
125348109|NCT00402233|450908954|FG000|Overall Study|Adverse Event|1|||
125348110|NCT00402233|450908955|FG001|Overall Study|Adverse Event|7|||
125348111|NCT00402233|450908956|FG002|Overall Study|Adverse Event|9|||
125348112|NCT00402233|450908957|FG003|Overall Study|Adverse Event|9|||
125348113|NCT00402233|450908954|FG000|Overall Study|Protocol Violation|0|||
125348114|NCT00402233|450908955|FG001|Overall Study|Protocol Violation|1|||
125348115|NCT00402233|450908956|FG002|Overall Study|Protocol Violation|0|||
125348116|NCT00402233|450908957|FG003|Overall Study|Protocol Violation|0|||
125348117|NCT00402233|450908954|FG000|Overall Study|Withdrawal by Subject|2|||
125348118|NCT00402233|450908955|FG001|Overall Study|Withdrawal by Subject|1|||
125348119|NCT00402233|450908956|FG002|Overall Study|Withdrawal by Subject|2|||
125348120|NCT00402233|450908957|FG003|Overall Study|Withdrawal by Subject|2|||
125348121|NCT00402233|450908954|FG000|Overall Study|Worsening of disease under study|2|||
125348122|NCT00402233|450908955|FG001|Overall Study|Worsening of disease under study|0|||
125348123|NCT00402233|450908956|FG002|Overall Study|Worsening of disease under study|0|||
125348124|NCT00402233|450908957|FG003|Overall Study|Worsening of disease under study|0|||
125348125|NCT00402233|450908954|FG000|Overall Study|Worsening of other pre-existing disease|0|||
125348126|NCT00402233|450908955|FG001|Overall Study|Worsening of other pre-existing disease|1|||
125348127|NCT00402233|450908956|FG002|Overall Study|Worsening of other pre-existing disease|0|||
125348128|NCT00402233|450908957|FG003|Overall Study|Worsening of other pre-existing disease|0|||
125348129|NCT04658940|450908961|FG000|Overall Study|Withdrawal by Subject|1|||
125348130|NCT03579602|450908962|FG000|Overall Study|Subject unable to receive study drug|0|||
125348131|NCT03579602|450908963|FG001|Overall Study|Subject unable to receive study drug|2|||
125348132|NCT03579602|450908962|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
125348133|NCT03579602|450908963|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
125348134|NCT02518464|450908964|FG000|Overall Study|Adverse Event|2|||
125348135|NCT01120067|450908967|FG000|Overall Study|Lost to Follow-up|3|||
125348136|NCT01120067|450908968|FG001|Overall Study|Lost to Follow-up|1|||
125348137|NCT01120067|450908967|FG000|Overall Study|fail to engage >3 sessions|2|||
125348138|NCT01120067|450908968|FG001|Overall Study|fail to engage >3 sessions|0|||
125348139|NCT00604214|450908988|FG000|Baseline to Day 28|Death|223|||
125348140|NCT00604214|450908989|FG001|Baseline to Day 28|Death|202|||
125348141|NCT00604214|450908988|FG000|Baseline to Day 28|Lost to Follow-up|2|||
125348142|NCT00604214|450908989|FG001|Baseline to Day 28|Lost to Follow-up|4|||
125348143|NCT00604214|450908988|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
125348144|NCT00604214|450908989|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
125348145|NCT00604214|450908988|FG000|Day 29 to Day 90|Death|64|||
125348146|NCT00604214|450908989|FG001|Day 29 to Day 90|Death|67|||
125348147|NCT00604214|450908988|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
125348148|NCT00604214|450908989|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
125348149|NCT00604214|450908988|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
125348150|NCT00604214|450908989|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
125348151|NCT00604214|450908988|FG000|Day 91 to Day 180|Death|19|||
125348152|NCT00604214|450908989|FG001|Day 91 to Day 180|Death|23|||
125348153|NCT00604214|450908988|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
125348154|NCT00604214|450908989|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
125348155|NCT00604214|450908988|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
125348156|NCT00604214|450908989|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
125348157|NCT00686998|450908990|FG000|Overall Study|Adverse Event|3|||
125348158|NCT00686998|450908991|FG001|Overall Study|Adverse Event|2|||
125348159|NCT00686998|450908992|FG002|Overall Study|Adverse Event|1|||
125348160|NCT00686998|450908990|FG000|Overall Study|Withdrawal by Subject|2|||
125348161|NCT00686998|450908991|FG001|Overall Study|Withdrawal by Subject|1|||
125348162|NCT00686998|450908992|FG002|Overall Study|Withdrawal by Subject|2|||
125348163|NCT00686998|450908990|FG000|Overall Study|Lack of Efficacy|7|||
125348164|NCT00686998|450908991|FG001|Overall Study|Lack of Efficacy|5|||
125348165|NCT00686998|450908992|FG002|Overall Study|Lack of Efficacy|0|||
125348166|NCT00686998|450908990|FG000|Overall Study|Other|0|||
125348167|NCT00686998|450908991|FG001|Overall Study|Other|0|||
125348168|NCT00686998|450908992|FG002|Overall Study|Other|1|||
125348169|NCT00686998|450908990|FG000|Overall Study|Safety Reasons|1|||
125348170|NCT00686998|450908991|FG001|Overall Study|Safety Reasons|0|||
125348171|NCT00686998|450908992|FG002|Overall Study|Safety Reasons|0|||
125348172|NCT00130442|450910340|FG000|Overall Study|Withdrawal by Subject|0|||
125348173|NCT00130442|450910341|FG001|Overall Study|Withdrawal by Subject|1|||
125348174|NCT00130442|450910340|FG000|Overall Study|did not meet criteria|1|||
125348175|NCT00130442|450910341|FG001|Overall Study|did not meet criteria|1|||
125348176|NCT02233946|450910342|FG000|Baseline|Withdrawal by Subject|2|||
125348177|NCT02233946|450910343|FG001|Baseline|Withdrawal by Subject|0|||
125348178|NCT02233946|450910342|FG000|3-months Follow-up|Lost to Follow-up|53|||
125348179|NCT02233946|450910343|FG001|3-months Follow-up|Lost to Follow-up|29|||
125348180|NCT02233946|450910342|FG000|6-months Follow-up|Lost to Follow-up|21|||
125348181|NCT02233946|450910343|FG001|6-months Follow-up|Lost to Follow-up|2|||
125348182|NCT02233946|450910342|FG000|9-month Follow-up|Lost to Follow-up|20|||
125348183|NCT02233946|450910343|FG001|9-month Follow-up|Lost to Follow-up|11|||
125348184|NCT02233946|450910342|FG000|12-month Follow-up|Lost to Follow-up|28|||
125348185|NCT02233946|450910343|FG001|12-month Follow-up|Lost to Follow-up|11|||
125348186|NCT02054481|450910344|FG000|Overall Study|Adverse Event|1|||
125348187|NCT02054481|450910345|FG001|Overall Study|Adverse Event|1|||
125348188|NCT02054481|450910346|FG002|Overall Study|Adverse Event|0|||
125348189|NCT02054481|450910347|FG003|Overall Study|Adverse Event|1|||
125348190|NCT02054481|450910344|FG000|Overall Study|Lost to Follow-up|1|||
125348191|NCT02054481|450910345|FG001|Overall Study|Lost to Follow-up|0|||
125348192|NCT02054481|450910346|FG002|Overall Study|Lost to Follow-up|0|||
125348193|NCT02054481|450910347|FG003|Overall Study|Lost to Follow-up|0|||
125348194|NCT02054481|450910344|FG000|Overall Study|Other reason|2|||
125348195|NCT02054481|450910345|FG001|Overall Study|Other reason|1|||
125348196|NCT02054481|450910346|FG002|Overall Study|Other reason|2|||
125348197|NCT02054481|450910347|FG003|Overall Study|Other reason|0|||
125348198|NCT02320903|450910348|FG000|Overall Study|Withdrawal by Subject|0|||
125348199|NCT02320903|450910349|FG001|Overall Study|Withdrawal by Subject|9|||
125348200|NCT02320903|450910350|FG002|Overall Study|Withdrawal by Subject|9|||
125348201|NCT02320903|450910348|FG000|Overall Study|Exited therapy; no longer eligible|8|||
125348202|NCT02320903|450910349|FG001|Overall Study|Exited therapy; no longer eligible|2|||
125348203|NCT02320903|450910350|FG002|Overall Study|Exited therapy; no longer eligible|2|||
125348204|NCT02320903|450910348|FG000|Overall Study|Lost to Follow-up|0|||
125348205|NCT02320903|450910349|FG001|Overall Study|Lost to Follow-up|5|||
125348206|NCT02320903|450910350|FG002|Overall Study|Lost to Follow-up|5|||
125348207|NCT00773383|450910351|FG000|Overall Study|Adverse Event|4|||
125348208|NCT00773383|450910351|FG000|Overall Study|Death|1|||
125348209|NCT00773383|450910351|FG000|Overall Study|Progression of Disease|23|||
125348210|NCT00773383|450910351|FG000|Overall Study|Other|2|||
125348211|NCT00773383|450910351|FG000|Overall Study|No study dose received|1|||
125348212|NCT03384693|450910352|FG000|Overall Study|Adverse Event|3|||
125348213|NCT03621475|450910355|FG000|Overall Study|No longer required restraints at initiation|0|||
125348214|NCT03621475|450910356|FG001|Overall Study|No longer required restraints at initiation|1|||
125348215|NCT01095094|450910358|FG000|Overall Study|Withdrawal by Subject|1|||
125348216|NCT01095094|450910358|FG000|Overall Study|Death|1|||
125348217|NCT01095094|450910358|FG000|Overall Study|Physician Decision|1|||
125348218|NCT02093351|450910359|FG000|Part A|Adverse Event|0|||
125348219|NCT02093351|450910360|FG001|Part A|Adverse Event|1|||
125348220|NCT02093351|450910361|FG002|Part A|Adverse Event|1|||
125348221|NCT02093351|450910362|FG003|Part A|Adverse Event|0|||
125348222|NCT02093351|450910359|FG000|Part A|Condition under investigation worsened|2|||
125348223|NCT02093351|450910360|FG001|Part A|Condition under investigation worsened|0|||
125348224|NCT02093351|450910361|FG002|Part A|Condition under investigation worsened|2|||
125348225|NCT02093351|450910362|FG003|Part A|Condition under investigation worsened|0|||
125348226|NCT02093351|450910359|FG000|Part A|Death|0|||
125348227|NCT02093351|450910360|FG001|Part A|Death|1|||
125348228|NCT02093351|450910361|FG002|Part A|Death|0|||
125348229|NCT02093351|450910362|FG003|Part A|Death|0|||
125348230|NCT02093351|450910359|FG000|Part B|Patient decision|0|||
125348231|NCT02093351|450910360|FG001|Part B|Patient decision|0|||
125348232|NCT02093351|450910361|FG002|Part B|Patient decision|0|||
125348233|NCT02093351|450910362|FG003|Part B|Patient decision|3|||
125348234|NCT02093351|450910359|FG000|Part B|Disease progression|0|||
125348235|NCT02093351|450910360|FG001|Part B|Disease progression|0|||
125348236|NCT02093351|450910361|FG002|Part B|Disease progression|0|||
125348237|NCT02093351|450910362|FG003|Part B|Disease progression|4|||
125348238|NCT02093351|450910359|FG000|Part B|Complete response|0|||
125348239|NCT02093351|450910360|FG001|Part B|Complete response|0|||
125348240|NCT02093351|450910361|FG002|Part B|Complete response|0|||
125348241|NCT02093351|450910362|FG003|Part B|Complete response|1|||
125348242|NCT02093351|450910359|FG000|Part B|Adverse event + disease progression|0|||
125348243|NCT02093351|450910360|FG001|Part B|Adverse event + disease progression|0|||
125348244|NCT02093351|450910361|FG002|Part B|Adverse event + disease progression|0|||
125348245|NCT02093351|450910362|FG003|Part B|Adverse event + disease progression|1|||
125348246|NCT02093351|450910359|FG000|Part B|Lack of therapeutic response|0|||
125348247|NCT02093351|450910360|FG001|Part B|Lack of therapeutic response|0|||
125348248|NCT02093351|450910361|FG002|Part B|Lack of therapeutic response|0|||
125348249|NCT02093351|450910362|FG003|Part B|Lack of therapeutic response|12|||
125348250|NCT02093351|450910359|FG000|Part B|Condition under investigation worsened|0|||
125348251|NCT02093351|450910360|FG001|Part B|Condition under investigation worsened|0|||
125348252|NCT02093351|450910361|FG002|Part B|Condition under investigation worsened|0|||
125348253|NCT02093351|450910362|FG003|Part B|Condition under investigation worsened|39|||
125348254|NCT02093351|450910359|FG000|Part B|Adverse Event|0|||
125348255|NCT02093351|450910360|FG001|Part B|Adverse Event|0|||
125348256|NCT02093351|450910361|FG002|Part B|Adverse Event|0|||
125348257|NCT02093351|450910362|FG003|Part B|Adverse Event|2|||
125348258|NCT02093351|450910359|FG000|Part B|Death|0|||
125348259|NCT02093351|450910360|FG001|Part B|Death|0|||
125348260|NCT02093351|450910361|FG002|Part B|Death|0|||
125348261|NCT02093351|450910362|FG003|Part B|Death|1|||
125348262|NCT01099709|450910363|FG000|Period 1|Withdrawal by Subject|0|||
125348263|NCT01099709|450910364|FG001|Period 1|Withdrawal by Subject|1|||
125348264|NCT01099709|450910363|FG000|Period 1|Positive cotinine test|0|||
125348265|NCT01099709|450910364|FG001|Period 1|Positive cotinine test|1|||
125348266|NCT01099709|450910363|FG000|Period 1|Adverse Event|1|||
125348267|NCT01099709|450910364|FG001|Period 1|Adverse Event|0|||
125348268|NCT00039871|450910368|FG000|Overall Study|Adverse Event|165|||
125348269|NCT00039871|450910368|FG000|Overall Study|Lost to Follow-up|18|||
125348270|NCT00039871|450910368|FG000|Overall Study|Protocol Violation|24|||
125348271|NCT00039871|450910368|FG000|Overall Study|Withdrawal by Subject|97|||
125348272|NCT00039871|450910368|FG000|Overall Study|Did not meet eligibility criteria|11|||
125348273|NCT00039871|450910368|FG000|Overall Study|Administrative|1|||
125348274|NCT00039871|450910368|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
125348275|NCT00039871|450910368|FG000|Overall Study|Never entered follow-up|7|||
125348276|NCT01736657|450910371|FG000|Overall Study|insufficient vascular access|1|||
125348277|NCT01992159|450910384|FG000|Overall Study|Withdrawal by Subject|4|||
125348278|NCT01992159|450910385|FG001|Overall Study|Withdrawal by Subject|7|||
125348279|NCT01992159|450910386|FG002|Overall Study|Withdrawal by Subject|0|||
125348280|NCT01992159|450910387|FG003|Overall Study|Withdrawal by Subject|3|||
125348281|NCT01992159|450910384|FG000|Overall Study|Adverse Event|0|||
125348282|NCT01992159|450910385|FG001|Overall Study|Adverse Event|1|||
125348283|NCT01992159|450910386|FG002|Overall Study|Adverse Event|0|||
125348284|NCT01992159|450910387|FG003|Overall Study|Adverse Event|1|||
125348285|NCT01992159|450910384|FG000|Overall Study|Death|0|||
125348286|NCT01992159|450910385|FG001|Overall Study|Death|0|||
125348287|NCT01992159|450910386|FG002|Overall Study|Death|1|||
125348288|NCT01992159|450910387|FG003|Overall Study|Death|0|||
125348289|NCT03023046|450910388|FG000|Overall Study|Withdrawal by Subject|1|||
125348290|NCT01741012|450910389|FG000|Overall Study|Lost to Follow-up|1|||
125348291|NCT01741012|450910389|FG000|Overall Study|Withdrawal by Subject|2|||
125348292|NCT04393298|450910392|FG000|Overall Study|Adverse Event|0|||
125348293|NCT04393298|450910393|FG001|Overall Study|Adverse Event|0|||
125348294|NCT04393298|450910394|FG002|Overall Study|Adverse Event|0|||
125348295|NCT04393298|450910395|FG003|Overall Study|Adverse Event|0|||
125348296|NCT04393298|450910396|FG004|Overall Study|Adverse Event|1|||
125348297|NCT04393298|450910397|FG005|Overall Study|Adverse Event|0|||
125348298|NCT04393298|450910398|FG006|Overall Study|Adverse Event|0|||
125348299|NCT04393298|450910399|FG007|Overall Study|Adverse Event|0|||
125348300|NCT04393298|450910400|FG008|Overall Study|Adverse Event|2|||
125348301|NCT04393298|450910401|FG009|Overall Study|Adverse Event|0|||
125348302|NCT04393298|450910402|FG010|Overall Study|Adverse Event|0|||
125348303|NCT04393298|450910403|FG011|Overall Study|Adverse Event|0|||
125348304|NCT04393298|450910404|FG012|Overall Study|Adverse Event|1|||
125348305|NCT04393298|450910405|FG013|Overall Study|Adverse Event|1|||
125348306|NCT04393298|450910406|FG014|Overall Study|Adverse Event|0|||
125348307|NCT04393298|450910392|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125348308|NCT04393298|450910393|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125348309|NCT04393298|450910394|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
125348310|NCT04393298|450910395|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125348311|NCT04393298|450910396|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125348312|NCT04393298|450910397|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125348313|NCT04393298|450910398|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125348314|NCT04393298|450910399|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125348315|NCT04393298|450910400|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125348316|NCT04393298|450910401|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125348317|NCT04393298|450910402|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125348318|NCT04393298|450910403|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125348319|NCT04393298|450910404|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125348320|NCT04393298|450910405|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
125348321|NCT04393298|450910406|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
125348322|NCT04393298|450910392|FG000|Overall Study|Lack of Efficacy|0|||
125348323|NCT04393298|450910393|FG001|Overall Study|Lack of Efficacy|0|||
125348324|NCT04393298|450910394|FG002|Overall Study|Lack of Efficacy|0|||
125348325|NCT04393298|450910395|FG003|Overall Study|Lack of Efficacy|0|||
125348326|NCT04393298|450910396|FG004|Overall Study|Lack of Efficacy|0|||
125348327|NCT04393298|450910397|FG005|Overall Study|Lack of Efficacy|0|||
125348328|NCT04393298|450910398|FG006|Overall Study|Lack of Efficacy|0|||
125348329|NCT04393298|450910399|FG007|Overall Study|Lack of Efficacy|0|||
125348330|NCT04393298|450910400|FG008|Overall Study|Lack of Efficacy|0|||
125348331|NCT04393298|450910401|FG009|Overall Study|Lack of Efficacy|0|||
125348332|NCT04393298|450910402|FG010|Overall Study|Lack of Efficacy|0|||
125348333|NCT04393298|450910403|FG011|Overall Study|Lack of Efficacy|0|||
125348334|NCT04393298|450910404|FG012|Overall Study|Lack of Efficacy|0|||
125348335|NCT04393298|450910405|FG013|Overall Study|Lack of Efficacy|0|||
125348336|NCT04393298|450910406|FG014|Overall Study|Lack of Efficacy|1|||
125348337|NCT04393298|450910392|FG000|Overall Study|Progression|1|||
125348338|NCT04393298|450910393|FG001|Overall Study|Progression|0|||
125348339|NCT04393298|450910394|FG002|Overall Study|Progression|0|||
125348340|NCT04393298|450910395|FG003|Overall Study|Progression|0|||
125348341|NCT04393298|450910396|FG004|Overall Study|Progression|0|||
125348342|NCT04393298|450910397|FG005|Overall Study|Progression|0|||
125348343|NCT04393298|450910398|FG006|Overall Study|Progression|0|||
125348344|NCT04393298|450910399|FG007|Overall Study|Progression|0|||
125348345|NCT04393298|450910400|FG008|Overall Study|Progression|0|||
125348346|NCT04393298|450910401|FG009|Overall Study|Progression|0|||
125348347|NCT04393298|450910402|FG010|Overall Study|Progression|1|||
125348348|NCT04393298|450910403|FG011|Overall Study|Progression|1|||
125348349|NCT04393298|450910404|FG012|Overall Study|Progression|0|||
125348350|NCT04393298|450910405|FG013|Overall Study|Progression|0|||
125348351|NCT04393298|450910406|FG014|Overall Study|Progression|0|||
125348352|NCT04393298|450910392|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
125348353|NCT04393298|450910393|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348354|NCT04393298|450910394|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348355|NCT04393298|450910395|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348356|NCT04393298|450910396|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348357|NCT04393298|450910397|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348358|NCT04393298|450910398|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348359|NCT04393298|450910399|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348360|NCT04393298|450910400|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348361|NCT04393298|450910401|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348362|NCT04393298|450910402|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348363|NCT04393298|450910403|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348364|NCT04393298|450910404|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348365|NCT04393298|450910405|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348366|NCT04393298|450910406|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
125348367|NCT04393298|450910392|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348368|NCT04393298|450910393|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
125348369|NCT04393298|450910394|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348370|NCT04393298|450910395|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348371|NCT04393298|450910396|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348372|NCT04393298|450910397|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348373|NCT04393298|450910398|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348374|NCT04393298|450910399|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348375|NCT04393298|450910400|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348376|NCT04393298|450910401|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348377|NCT04393298|450910402|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348378|NCT04393298|450910403|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348379|NCT04393298|450910404|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348380|NCT04393298|450910405|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348381|NCT04393298|450910406|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
125348382|NCT04393298|450910392|FG000|Overall Study|Clinical Progression|0|||
125348383|NCT04393298|450910393|FG001|Overall Study|Clinical Progression|2|||
125348384|NCT04393298|450910394|FG002|Overall Study|Clinical Progression|0|||
125348385|NCT04393298|450910395|FG003|Overall Study|Clinical Progression|0|||
125348386|NCT04393298|450910396|FG004|Overall Study|Clinical Progression|0|||
125348387|NCT04393298|450910397|FG005|Overall Study|Clinical Progression|0|||
125348388|NCT04393298|450910398|FG006|Overall Study|Clinical Progression|0|||
125348389|NCT04393298|450910399|FG007|Overall Study|Clinical Progression|0|||
125348390|NCT04393298|450910400|FG008|Overall Study|Clinical Progression|0|||
125348391|NCT04393298|450910401|FG009|Overall Study|Clinical Progression|0|||
125348392|NCT04393298|450910402|FG010|Overall Study|Clinical Progression|0|||
125348393|NCT04393298|450910403|FG011|Overall Study|Clinical Progression|0|||
125348394|NCT04393298|450910404|FG012|Overall Study|Clinical Progression|0|||
125348395|NCT04393298|450910405|FG013|Overall Study|Clinical Progression|0|||
125348396|NCT04393298|450910406|FG014|Overall Study|Clinical Progression|0|||
125348397|NCT04393298|450910392|FG000|Overall Study|Disease Progression|0|||
125348398|NCT04393298|450910393|FG001|Overall Study|Disease Progression|1|||
125348399|NCT04393298|450910394|FG002|Overall Study|Disease Progression|0|||
125348400|NCT04393298|450910395|FG003|Overall Study|Disease Progression|0|||
125348401|NCT04393298|450910396|FG004|Overall Study|Disease Progression|0|||
125348402|NCT04393298|450910397|FG005|Overall Study|Disease Progression|3|||
125348403|NCT04393298|450910398|FG006|Overall Study|Disease Progression|2|||
125348404|NCT04393298|450910399|FG007|Overall Study|Disease Progression|1|||
125348405|NCT04393298|450910400|FG008|Overall Study|Disease Progression|2|||
125348406|NCT04393298|450910401|FG009|Overall Study|Disease Progression|1|||
125348407|NCT04393298|450910402|FG010|Overall Study|Disease Progression|0|||
125348408|NCT04393298|450910403|FG011|Overall Study|Disease Progression|3|||
125348409|NCT04393298|450910404|FG012|Overall Study|Disease Progression|0|||
125348410|NCT04393298|450910405|FG013|Overall Study|Disease Progression|0|||
125348411|NCT04393298|450910406|FG014|Overall Study|Disease Progression|1|||
125348412|NCT04393298|450910392|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348413|NCT04393298|450910393|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348414|NCT04393298|450910394|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
125348415|NCT04393298|450910395|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348416|NCT04393298|450910396|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348417|NCT04393298|450910397|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348418|NCT04393298|450910398|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348419|NCT04393298|450910399|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348420|NCT04393298|450910400|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348421|NCT04393298|450910401|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348422|NCT04393298|450910402|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348423|NCT04393298|450910403|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348424|NCT04393298|450910404|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348425|NCT04393298|450910405|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348426|NCT04393298|450910406|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
125348427|NCT04393298|450910392|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
125348428|NCT04393298|450910393|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
125348429|NCT04393298|450910394|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
125681862|NCT05472038|452125633|FG007|Overall Study|Not vaccinated|0|||
125681863|NCT05472038|452125634|FG008|Overall Study|Not vaccinated|0|||
125681864|NCT05472038|452125635|FG009|Overall Study|Not vaccinated|0|||
125681865|NCT05472038|452125636|FG010|Overall Study|Not vaccinated|0|||
125681866|NCT05472038|452125637|FG011|Overall Study|Not vaccinated|0|||
125681867|NCT05369208|452125642|FG000|Core Phase|Prohibited Medication Required|2|||
125681868|NCT05369208|452125642|FG000|Core Phase|Adverse Event|1|||
125681869|NCT05369208|452125642|FG000|Core Phase|Lack of Efficacy|1|||
125681870|NCT06056310|452125643|FG000|Overall Study|Other Reasons|2|||
125348430|NCT04393298|450910395|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
125348431|NCT04393298|450910396|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
125348432|NCT04393298|450910397|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
125348433|NCT04393298|450910398|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
125681871|NCT06056310|452125643|FG000|Overall Study|Sponsor Request|16|||
125681872|NCT04914897|452125646|FG000|Overall Study|Withdrawal by Subject|3|||
125681873|NCT04914897|452125647|FG001|Overall Study|Withdrawal by Subject|1|||
125348434|NCT04393298|450910399|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
125348435|NCT04393298|450910400|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
125348436|NCT04393298|450910401|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
125348437|NCT04393298|450910402|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
125348438|NCT04393298|450910403|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
125348439|NCT04393298|450910404|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
125348440|NCT04393298|450910405|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
125348441|NCT04393298|450910406|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
125348442|NCT04393298|450910392|FG000|Overall Study|Progressive Disease (PD)|0|||
125348443|NCT04393298|450910393|FG001|Overall Study|Progressive Disease (PD)|0|||
125348444|NCT04393298|450910394|FG002|Overall Study|Progressive Disease (PD)|0|||
125348445|NCT04393298|450910395|FG003|Overall Study|Progressive Disease (PD)|3|||
125348446|NCT04393298|450910396|FG004|Overall Study|Progressive Disease (PD)|0|||
125348447|NCT04393298|450910397|FG005|Overall Study|Progressive Disease (PD)|0|||
125348448|NCT04393298|450910398|FG006|Overall Study|Progressive Disease (PD)|0|||
125348449|NCT04393298|450910399|FG007|Overall Study|Progressive Disease (PD)|0|||
125348450|NCT04393298|450910400|FG008|Overall Study|Progressive Disease (PD)|0|||
125348451|NCT04393298|450910401|FG009|Overall Study|Progressive Disease (PD)|0|||
125348452|NCT04393298|450910402|FG010|Overall Study|Progressive Disease (PD)|0|||
125348453|NCT04393298|450910403|FG011|Overall Study|Progressive Disease (PD)|0|||
125348454|NCT04393298|450910404|FG012|Overall Study|Progressive Disease (PD)|0|||
125348455|NCT04393298|450910405|FG013|Overall Study|Progressive Disease (PD)|0|||
125348456|NCT04393298|450910406|FG014|Overall Study|Progressive Disease (PD)|0|||
125348457|NCT04393298|450910392|FG000|Overall Study|Started a New Cancer Treatment|0|||
125348458|NCT04393298|450910393|FG001|Overall Study|Started a New Cancer Treatment|0|||
125348459|NCT04393298|450910394|FG002|Overall Study|Started a New Cancer Treatment|0|||
125348460|NCT04393298|450910395|FG003|Overall Study|Started a New Cancer Treatment|0|||
125348461|NCT04393298|450910396|FG004|Overall Study|Started a New Cancer Treatment|1|||
125348462|NCT04393298|450910397|FG005|Overall Study|Started a New Cancer Treatment|0|||
125348463|NCT04393298|450910398|FG006|Overall Study|Started a New Cancer Treatment|0|||
125348464|NCT04393298|450910399|FG007|Overall Study|Started a New Cancer Treatment|0|||
125348465|NCT04393298|450910400|FG008|Overall Study|Started a New Cancer Treatment|0|||
125348466|NCT04393298|450910401|FG009|Overall Study|Started a New Cancer Treatment|0|||
125348467|NCT04393298|450910402|FG010|Overall Study|Started a New Cancer Treatment|0|||
125348468|NCT04393298|450910403|FG011|Overall Study|Started a New Cancer Treatment|0|||
125348469|NCT04393298|450910404|FG012|Overall Study|Started a New Cancer Treatment|0|||
125348470|NCT04393298|450910405|FG013|Overall Study|Started a New Cancer Treatment|0|||
125348471|NCT04393298|450910406|FG014|Overall Study|Started a New Cancer Treatment|0|||
125348472|NCT04393298|450910392|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125348473|NCT04393298|450910393|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125348474|NCT04393298|450910394|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125348475|NCT04393298|450910395|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125348476|NCT04393298|450910396|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
125348477|NCT04393298|450910397|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125348478|NCT04393298|450910398|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125348479|NCT04393298|450910399|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125348480|NCT04393298|450910400|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125348481|NCT04393298|450910401|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125348482|NCT04393298|450910402|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125348483|NCT04393298|450910403|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125348484|NCT04393298|450910404|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125348485|NCT04393298|450910405|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125681874|NCT04914897|452125648|FG002|Overall Study|Withdrawal by Subject|1|||
125681875|NCT04914897|452125649|FG003|Overall Study|Withdrawal by Subject|1|||
125681876|NCT04914897|452125646|FG000|Overall Study|Poor compliance to protocol|0|||
125681877|NCT04914897|452125647|FG001|Overall Study|Poor compliance to protocol|0|||
125681878|NCT04914897|452125648|FG002|Overall Study|Poor compliance to protocol|1|||
125681879|NCT04914897|452125649|FG003|Overall Study|Poor compliance to protocol|0|||
125681880|NCT04914897|452125646|FG000|Overall Study|Progressive disease|5|||
125681881|NCT04914897|452125647|FG001|Overall Study|Progressive disease|14|||
125681882|NCT04914897|452125648|FG002|Overall Study|Progressive disease|30|||
125681883|NCT04914897|452125649|FG003|Overall Study|Progressive disease|21|||
125681884|NCT04914897|452125646|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
125681885|NCT04914897|452125647|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
125348486|NCT04393298|450910406|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
125348487|NCT04393298|450910392|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125348488|NCT04393298|450910393|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125681886|NCT04914897|452125648|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
125681887|NCT04914897|452125649|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
125348489|NCT04393298|450910394|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125348490|NCT04393298|450910395|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125348491|NCT04393298|450910396|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125348492|NCT04393298|450910397|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
125348493|NCT04393298|450910398|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125548273|NCT00585195|451637109|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
125548274|NCT00585195|451637110|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
125348494|NCT04393298|450910399|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125348495|NCT04393298|450910400|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125348496|NCT04393298|450910401|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125348497|NCT04393298|450910402|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125348498|NCT04393298|450910403|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125348499|NCT04393298|450910404|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125348500|NCT04393298|450910405|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125348501|NCT04393298|450910406|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
125348502|NCT04393298|450910392|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125348503|NCT04393298|450910393|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125348504|NCT04393298|450910394|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125348505|NCT04393298|450910395|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125348506|NCT04393298|450910396|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125348507|NCT04393298|450910397|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
125348508|NCT04393298|450910398|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125348509|NCT04393298|450910399|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125348510|NCT04393298|450910400|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125348511|NCT04393298|450910401|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125348512|NCT04393298|450910402|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125348513|NCT04393298|450910403|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125348514|NCT04393298|450910404|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125548275|NCT00585195|451637111|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
125681888|NCT04914897|452125646|FG000|Overall Study|Other|1|||
125681889|NCT04914897|452125647|FG001|Overall Study|Other|0|||
125681890|NCT04914897|452125648|FG002|Overall Study|Other|0|||
125681891|NCT04914897|452125649|FG003|Overall Study|Other|1|||
125681892|NCT02674152|452125650|FG000|Overall Study|Personal Reasons|1|||
125681893|NCT02674152|452125651|FG001|Overall Study|Personal Reasons|0|||
125681894|NCT02674152|452125652|FG002|Overall Study|Personal Reasons|0|||
125681895|NCT02674152|452125653|FG003|Overall Study|Personal Reasons|1|||
125681896|NCT02674152|452125654|FG004|Overall Study|Personal Reasons|1|||
125681897|NCT02674152|452125650|FG000|Overall Study|Other adverse event or clinical progression|0|||
125681898|NCT02674152|452125651|FG001|Overall Study|Other adverse event or clinical progression|1|||
125681899|NCT02674152|452125652|FG002|Overall Study|Other adverse event or clinical progression|0|||
125681900|NCT02674152|452125653|FG003|Overall Study|Other adverse event or clinical progression|3|||
125681901|NCT02674152|452125654|FG004|Overall Study|Other adverse event or clinical progression|0|||
125681902|NCT02674152|452125650|FG000|Overall Study|Dose-limiting toxicity|0|||
125681903|NCT02674152|452125651|FG001|Overall Study|Dose-limiting toxicity|0|||
125681904|NCT02674152|452125652|FG002|Overall Study|Dose-limiting toxicity|0|||
125681905|NCT02674152|452125653|FG003|Overall Study|Dose-limiting toxicity|0|||
125681906|NCT02674152|452125654|FG004|Overall Study|Dose-limiting toxicity|1|||
125681907|NCT02674152|452125650|FG000|Overall Study|Progressive Disease|2|||
125681908|NCT02674152|452125651|FG001|Overall Study|Progressive Disease|1|||
125681909|NCT02674152|452125652|FG002|Overall Study|Progressive Disease|1|||
125681910|NCT02674152|452125653|FG003|Overall Study|Progressive Disease|13|||
125681911|NCT02674152|452125654|FG004|Overall Study|Progressive Disease|2|||
125681912|NCT02674152|452125650|FG000|Overall Study|Adverse Event|0|||
125681913|NCT02674152|452125651|FG001|Overall Study|Adverse Event|0|||
125681914|NCT02674152|452125652|FG002|Overall Study|Adverse Event|1|||
125681915|NCT02674152|452125653|FG003|Overall Study|Adverse Event|0|||
125681916|NCT02674152|452125654|FG004|Overall Study|Adverse Event|1|||
125681917|NCT04934722|452125655|FG000|Overall Study|Death|4|||
125681918|NCT04934722|452125656|FG001|Overall Study|Death|3|||
125681919|NCT04934722|452125655|FG000|Overall Study|Participants Ongoing|88|||
125681920|NCT04934722|452125656|FG001|Overall Study|Participants Ongoing|91|||
125681921|NCT05265624|452125665|FG000|Overall Study|Lost to Follow-up|3|||
125681922|NCT05265624|452125666|FG001|Overall Study|Lost to Follow-up|0|||
125348515|NCT04393298|450910405|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
125348516|NCT04393298|450910406|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
125681923|NCT05265624|452125665|FG000|Overall Study|Withdrawal by Subject|1|||
125681924|NCT05265624|452125666|FG001|Overall Study|Withdrawal by Subject|0|||
125681925|NCT06039579|452125667|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125681926|NCT06039579|452125668|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125681927|NCT06039579|452125669|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125548276|NCT00585195|451637112|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
125348517|NCT04393298|450910392|FG000|Overall Study|Death|0|||
125348518|NCT04393298|450910393|FG001|Overall Study|Death|0|||
125348519|NCT04393298|450910394|FG002|Overall Study|Death|0|||
125348520|NCT04393298|450910395|FG003|Overall Study|Death|0|||
125348521|NCT04393298|450910396|FG004|Overall Study|Death|0|||
125348522|NCT04393298|450910397|FG005|Overall Study|Death|1|||
125348523|NCT04393298|450910398|FG006|Overall Study|Death|1|||
125348524|NCT04393298|450910399|FG007|Overall Study|Death|0|||
125348525|NCT04393298|450910400|FG008|Overall Study|Death|1|||
125348526|NCT04393298|450910401|FG009|Overall Study|Death|1|||
125348527|NCT04393298|450910402|FG010|Overall Study|Death|0|||
125348528|NCT04393298|450910403|FG011|Overall Study|Death|1|||
125348529|NCT04393298|450910404|FG012|Overall Study|Death|1|||
125548277|NCT00585195|451637113|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
125548278|NCT00585195|451637114|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
125348530|NCT04393298|450910405|FG013|Overall Study|Death|0|||
125348531|NCT04393298|450910406|FG014|Overall Study|Death|1|||
125348532|NCT04393298|450910392|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348533|NCT04393298|450910393|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348534|NCT04393298|450910394|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348535|NCT04393298|450910395|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348536|NCT04393298|450910396|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348537|NCT04393298|450910397|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
125348538|NCT04393298|450910398|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348539|NCT04393298|450910399|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348540|NCT04393298|450910400|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348541|NCT04393298|450910401|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348542|NCT04393298|450910402|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348543|NCT04393298|450910403|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348544|NCT04393298|450910404|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348545|NCT04393298|450910405|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348546|NCT04393298|450910406|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
125348547|NCT04393298|450910392|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
125348548|NCT04393298|450910393|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
125348549|NCT04393298|450910394|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
125348550|NCT04393298|450910395|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
125348551|NCT04393298|450910396|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
125348552|NCT04393298|450910397|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
125348553|NCT04393298|450910398|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
125348554|NCT04393298|450910399|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
125348555|NCT04393298|450910400|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
125348556|NCT04393298|450910401|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
125348557|NCT04393298|450910402|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
125348558|NCT04393298|450910403|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
125348559|NCT04393298|450910404|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
125348560|NCT04393298|450910405|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
125348561|NCT04393298|450910406|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
125348562|NCT04393298|450910392|FG000|Overall Study|Patient Passed Away|0|||
125348563|NCT04393298|450910393|FG001|Overall Study|Patient Passed Away|0|||
125348564|NCT04393298|450910394|FG002|Overall Study|Patient Passed Away|0|||
125348565|NCT04393298|450910395|FG003|Overall Study|Patient Passed Away|0|||
125348566|NCT04393298|450910396|FG004|Overall Study|Patient Passed Away|0|||
125348567|NCT04393298|450910397|FG005|Overall Study|Patient Passed Away|0|||
125348568|NCT04393298|450910398|FG006|Overall Study|Patient Passed Away|0|||
125348569|NCT04393298|450910399|FG007|Overall Study|Patient Passed Away|1|||
125348570|NCT04393298|450910400|FG008|Overall Study|Patient Passed Away|0|||
125348571|NCT04393298|450910401|FG009|Overall Study|Patient Passed Away|0|||
125348572|NCT04393298|450910402|FG010|Overall Study|Patient Passed Away|0|||
125348573|NCT04393298|450910403|FG011|Overall Study|Patient Passed Away|0|||
125348574|NCT04393298|450910404|FG012|Overall Study|Patient Passed Away|0|||
125348575|NCT04393298|450910405|FG013|Overall Study|Patient Passed Away|0|||
125348576|NCT04393298|450910406|FG014|Overall Study|Patient Passed Away|0|||
125348577|NCT04393298|450910392|FG000|Overall Study|Patient Deceased|0|||
125348578|NCT04393298|450910393|FG001|Overall Study|Patient Deceased|0|||
125348579|NCT04393298|450910394|FG002|Overall Study|Patient Deceased|0|||
125348580|NCT04393298|450910395|FG003|Overall Study|Patient Deceased|0|||
125348581|NCT04393298|450910396|FG004|Overall Study|Patient Deceased|0|||
125348582|NCT04393298|450910397|FG005|Overall Study|Patient Deceased|0|||
125348583|NCT04393298|450910398|FG006|Overall Study|Patient Deceased|0|||
125348584|NCT04393298|450910399|FG007|Overall Study|Patient Deceased|1|||
125348585|NCT04393298|450910400|FG008|Overall Study|Patient Deceased|0|||
125348586|NCT04393298|450910401|FG009|Overall Study|Patient Deceased|0|||
125348587|NCT04393298|450910402|FG010|Overall Study|Patient Deceased|0|||
125348588|NCT04393298|450910403|FG011|Overall Study|Patient Deceased|0|||
125348589|NCT04393298|450910404|FG012|Overall Study|Patient Deceased|0|||
125348590|NCT04393298|450910405|FG013|Overall Study|Patient Deceased|0|||
125348591|NCT04393298|450910406|FG014|Overall Study|Patient Deceased|0|||
125348592|NCT04393298|450910392|FG000|Overall Study|Patient Discharged to Hospice|0|||
125348593|NCT04393298|450910393|FG001|Overall Study|Patient Discharged to Hospice|0|||
125348594|NCT04393298|450910394|FG002|Overall Study|Patient Discharged to Hospice|0|||
125348595|NCT04393298|450910395|FG003|Overall Study|Patient Discharged to Hospice|0|||
125348596|NCT04393298|450910396|FG004|Overall Study|Patient Discharged to Hospice|0|||
125348597|NCT04393298|450910397|FG005|Overall Study|Patient Discharged to Hospice|0|||
125348598|NCT04393298|450910398|FG006|Overall Study|Patient Discharged to Hospice|0|||
125348599|NCT04393298|450910399|FG007|Overall Study|Patient Discharged to Hospice|0|||
125348600|NCT04393298|450910400|FG008|Overall Study|Patient Discharged to Hospice|1|||
125348601|NCT04393298|450910401|FG009|Overall Study|Patient Discharged to Hospice|0|||
125348602|NCT04393298|450910402|FG010|Overall Study|Patient Discharged to Hospice|0|||
125348603|NCT04393298|450910403|FG011|Overall Study|Patient Discharged to Hospice|0|||
125348604|NCT04393298|450910404|FG012|Overall Study|Patient Discharged to Hospice|0|||
125348605|NCT04393298|450910405|FG013|Overall Study|Patient Discharged to Hospice|0|||
125348606|NCT04393298|450910406|FG014|Overall Study|Patient Discharged to Hospice|0|||
125348607|NCT04393298|450910392|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348608|NCT04393298|450910393|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348609|NCT04393298|450910394|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348610|NCT04393298|450910395|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348611|NCT04393298|450910396|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348612|NCT04393298|450910397|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348613|NCT04393298|450910398|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348614|NCT04393298|450910399|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348615|NCT04393298|450910400|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348616|NCT04393298|450910401|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
125348617|NCT04393298|450910402|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348618|NCT04393298|450910403|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348619|NCT04393298|450910404|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348620|NCT04393298|450910405|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348621|NCT04393298|450910406|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
125348622|NCT04393298|450910392|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
125348623|NCT04393298|450910393|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
125348624|NCT04393298|450910394|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
125348625|NCT04393298|450910395|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
125348626|NCT04393298|450910396|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
125348627|NCT04393298|450910397|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
125348628|NCT04393298|450910398|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
125348629|NCT04393298|450910399|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
125348630|NCT04393298|450910400|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
125348631|NCT04393298|450910401|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
125348632|NCT04393298|450910402|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
125348633|NCT04393298|450910403|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
125348634|NCT04393298|450910404|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
125348635|NCT04393298|450910405|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
125348636|NCT04393298|450910406|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
125348637|NCT02311582|450910407|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
125348638|NCT02311582|450910408|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
125348639|NCT02311582|450910409|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
125348640|NCT02311582|450910410|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
125348641|NCT02311582|450910411|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
125348642|NCT04972630|450910413|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
125348643|NCT04972630|450910414|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
125348644|NCT04972630|450910415|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
125348645|NCT01129024|450910423|FG000|Overall Study|Physician Decision|5|||
125348646|NCT01129024|450910423|FG000|Overall Study|Study Terminated by Sponsor|8|||
125348647|NCT01129024|450910423|FG000|Overall Study|Withdrawal by Subject|2|||
125348648|NCT01129024|450910423|FG000|Overall Study|Lack of Efficacy|3|||
125348649|NCT01129024|450910423|FG000|Overall Study|Needed a Platelet Transfusion|1|||
125348650|NCT00686634|450910429|FG000|Overall Study|Protocol Violation|6|||
125348651|NCT00924781|450910432|FG000|Overall Study|Study terminated by sponsor|12|||
125348652|NCT00924781|450910433|FG001|Overall Study|Study terminated by sponsor|10|||
125348653|NCT01653132|450910434|FG000|First Intervention|Protocol Violation|1|||
125348654|NCT01653132|450910435|FG001|First Intervention|Protocol Violation|0|||
125348655|NCT03828370|450910436|FG000|3 Month Follow-up|Lost to Follow-up|4|||
125348656|NCT03828370|450910437|FG001|3 Month Follow-up|Lost to Follow-up|12|||
125348657|NCT03828370|450910436|FG000|9 Month Follow up|Lost to Follow-up|12|||
125348658|NCT03828370|450910437|FG001|9 Month Follow up|Lost to Follow-up|20|||
125348659|NCT02677324|450910438|FG000|Overall Study|Disease Progression|6|||
125348660|NCT02677324|450910438|FG000|Overall Study|Inability to Swallow pills|1|||
125348661|NCT02677324|450910438|FG000|Overall Study|Non-compliance|1|||
125348662|NCT02677324|450910438|FG000|Overall Study|Lack of Efficacy|1|||
125348663|NCT02677324|450910438|FG000|Overall Study|Medical insurance coverage|1|||
125348664|NCT02677324|450910438|FG000|Overall Study|Adverse Event|1|||
125348665|NCT02677324|450910438|FG000|Overall Study|IgM Myeloma diagnosis|1|||
125348666|NCT03312751|450910441|FG000|Overall Study|Death|7|||
125348667|NCT03312751|450910442|FG001|Overall Study|Death|9|||
125348668|NCT03312751|450910441|FG000|Overall Study|Study discontinuation due to other reason|0|||
125348669|NCT03312751|450910442|FG001|Overall Study|Study discontinuation due to other reason|1|||
125348670|NCT00475423|450910443|FG000|Overall Study|Protocol Violation|5|||
125348671|NCT00475423|450910443|FG000|Overall Study|Adverse Event|4|||
125348672|NCT00475423|450910443|FG000|Overall Study|Withdrawal by Subject|6|||
125348673|NCT00475423|450910443|FG000|Overall Study|Lack of Efficacy|8|||
125348674|NCT00475423|450910443|FG000|Overall Study|Death|1|||
125348675|NCT00475423|450910443|FG000|Overall Study|Reason not specified|1|||
125348676|NCT00475423|450910443|FG000|Overall Study|Lost to Follow-up|7|||
125348677|NCT00046891|450910444|FG000|Overall Study|Cancels|5|||
125348678|NCT00046891|450910445|FG001|Overall Study|Cancels|9|||
125348679|NCT00046891|450910444|FG000|Overall Study|Ineligible|1|||
125348680|NCT00046891|450910445|FG001|Overall Study|Ineligible|1|||
125348681|NCT00046891|450910444|FG000|Overall Study|Withdrawal by Subject|18|||
125348682|NCT00046891|450910445|FG001|Overall Study|Withdrawal by Subject|15|||
125348683|NCT00046891|450910444|FG000|Overall Study|Adverse Event|5|||
125348684|NCT00046891|450910445|FG001|Overall Study|Adverse Event|5|||
125348685|NCT02496676|450910446|FG000|Phase 1 - Period 1|Adverse Event|0|||
125348686|NCT02496676|450910447|FG001|Phase 1 - Period 1|Adverse Event|1|||
125348687|NCT02496676|450910446|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
125348688|NCT02496676|450910447|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
125348689|NCT04381988|450910448|FG000|Overall Study|The study was terminated|4|||
125348690|NCT04381988|450910449|FG001|Overall Study|The study was terminated|0|||
125348691|NCT01624870|450910450|FG000|Overall Study|Death|19|||
125348692|NCT01624870|450910450|FG000|Overall Study|Withdrawal by Subject|1|||
125348693|NCT01624870|450910450|FG000|Overall Study|CoreValve not implanted|6|||
125348694|NCT01624870|450910450|FG000|Overall Study|Lost to follow up|1|||
125348695|NCT04672252|450910454|FG000|Overall Study|Protocol Violation|1|||
125348696|NCT04672252|450910455|FG001|Overall Study|Protocol Violation|0|||
125348697|NCT04391569|450910456|FG000|Overall Study|Death|15|||
125348698|NCT04391569|450910457|FG001|Overall Study|Death|10|||
125348699|NCT04391569|450910456|FG000|Overall Study|Withdrawal by Subject|1|||
125348700|NCT04391569|450910457|FG001|Overall Study|Withdrawal by Subject|0|||
125348701|NCT04391569|450910456|FG000|Overall Study|Lost to Follow-up|3|||
125348702|NCT04391569|450910457|FG001|Overall Study|Lost to Follow-up|2|||
125348703|NCT04391569|450910456|FG000|Overall Study|Lack of Efficacy|0|||
125348704|NCT04391569|450910457|FG001|Overall Study|Lack of Efficacy|1|||
125348705|NCT04391569|450910456|FG000|Overall Study|Participant discharged to hospice facility|0|||
125348706|NCT04391569|450910457|FG001|Overall Study|Participant discharged to hospice facility|1|||
125348707|NCT04391569|450910456|FG000|Overall Study|Participant family decision|1|||
125348708|NCT04391569|450910457|FG001|Overall Study|Participant family decision|0|||
125348709|NCT04391569|450910456|FG000|Overall Study|Participant discharged prematurely|1|||
125348710|NCT04391569|450910457|FG001|Overall Study|Participant discharged prematurely|0|||
125348711|NCT01431638|450910458|FG000|Overall Study|Adverse Event|1|||
125348712|NCT01431638|450910459|FG001|Overall Study|Adverse Event|3|||
125348713|NCT01431638|450910460|FG002|Overall Study|Adverse Event|1|||
125348714|NCT01431638|450910458|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125348715|NCT01431638|450910459|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125348716|NCT01431638|450910460|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
125348717|NCT01431638|450910458|FG000|Overall Study|Participants condition no longer requires study drug|0|||
125348718|NCT01431638|450910459|FG001|Overall Study|Participants condition no longer requires study drug|1|||
125348719|NCT01431638|450910460|FG002|Overall Study|Participants condition no longer requires study drug|0|||
125348720|NCT01431638|450910458|FG000|Overall Study|Participant withdrew consent|14|||
125348721|NCT01431638|450910459|FG001|Overall Study|Participant withdrew consent|5|||
125348722|NCT01431638|450910460|FG002|Overall Study|Participant withdrew consent|8|||
125348723|NCT01431638|450910458|FG000|Overall Study|Lost to Follow-up|7|||
125348724|NCT01431638|450910459|FG001|Overall Study|Lost to Follow-up|9|||
125348725|NCT01431638|450910460|FG002|Overall Study|Lost to Follow-up|7|||
125348726|NCT01431638|450910458|FG000|Overall Study|Administrative problems|1|||
125348727|NCT01431638|450910459|FG001|Overall Study|Administrative problems|4|||
125348728|NCT01431638|450910460|FG002|Overall Study|Administrative problems|6|||
125348729|NCT01431638|450910458|FG000|Overall Study|Death|1|||
125348730|NCT01431638|450910459|FG001|Overall Study|Death|0|||
125348731|NCT01431638|450910460|FG002|Overall Study|Death|0|||
125348732|NCT01431638|450910458|FG000|Overall Study|Protocol deviation|1|||
125348733|NCT01431638|450910459|FG001|Overall Study|Protocol deviation|1|||
125348734|NCT01431638|450910460|FG002|Overall Study|Protocol deviation|4|||
125348735|NCT01431638|450910458|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
125348736|NCT01431638|450910459|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
125348737|NCT01431638|450910460|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
125348738|NCT00773838|450910461|FG000|Overall Study|Adverse Event|29|||
125348739|NCT00773838|450910461|FG000|Overall Study|Lost to Follow-up|1|||
125348740|NCT00773838|450910461|FG000|Overall Study|Physician Decision|8|||
125348741|NCT00773838|450910461|FG000|Overall Study|Progressive Disease|82|||
125348742|NCT00773838|450910461|FG000|Overall Study|Protocol Violation|2|||
125348743|NCT00773838|450910461|FG000|Overall Study|Withdrawal by Subject|21|||
125348744|NCT03562767|450910464|FG000|Overall Study|Physician Decision|2|||
125348745|NCT03562767|450910465|FG001|Overall Study|Physician Decision|0|||
125348746|NCT03562767|450910466|FG002|Overall Study|Physician Decision|0|||
125348747|NCT03562767|450910464|FG000|Overall Study|Logistic Reason|1|||
125348748|NCT03562767|450910465|FG001|Overall Study|Logistic Reason|3|||
125348749|NCT03562767|450910466|FG002|Overall Study|Logistic Reason|0|||
125681928|NCT06039579|452125670|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125681929|NCT06039579|452125671|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125681930|NCT06039579|452125672|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125681931|NCT06039579|452125673|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
125681932|NCT06039579|452125674|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
125681933|NCT05927753|452125680|FG000|Overall Study|Withdrawal by Subject|0|||
125681934|NCT05927753|452125681|FG001|Overall Study|Withdrawal by Subject|2|||
125681935|NCT05927753|452125680|FG000|Overall Study|Physician Decision|0|||
125681936|NCT05927753|452125681|FG001|Overall Study|Physician Decision|1|||
125681937|NCT02356159|452125685|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
125681938|NCT02356159|452125686|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
125681939|NCT02356159|452125687|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
125681940|NCT02356159|452125688|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
125681941|NCT02356159|452125689|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
125681942|NCT02356159|452125690|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
125681943|NCT00861705|452125691|FG000|Overall Study|Never Began Treatment|7|||
125681944|NCT00861705|452125692|FG001|Overall Study|Never Began Treatment|3|||
125681945|NCT00861705|452125693|FG002|Overall Study|Never Began Treatment|0|||
125681946|NCT00861705|452125694|FG003|Overall Study|Never Began Treatment|1|||
125681947|NCT06418152|452125696|FG000|Overall Study|Frequent DBS setting changes|1|||
125681948|NCT06418152|452125696|FG000|Overall Study|Withdrawal by Subject|2|||
125681949|NCT03653507|452125697|FG000|Overall Study|Miscellaneous|28|||
125681950|NCT03653507|452125698|FG001|Overall Study|Miscellaneous|19|||
125681951|NCT03653507|452125697|FG000|Overall Study|Withdrawal by Subject|37|||
125681952|NCT03653507|452125698|FG001|Overall Study|Withdrawal by Subject|22|||
125681953|NCT03653507|452125697|FG000|Overall Study|Protocol Deviation|2|||
125681954|NCT03653507|452125698|FG001|Overall Study|Protocol Deviation|1|||
125681955|NCT03653507|452125697|FG000|Overall Study|Progressive disease|117|||
125681956|NCT03653507|452125698|FG001|Overall Study|Progressive disease|168|||
125681957|NCT03653507|452125697|FG000|Overall Study|Lost to Follow-up|1|||
125681958|NCT03653507|452125698|FG001|Overall Study|Lost to Follow-up|1|||
125681959|NCT03653507|452125697|FG000|Overall Study|Death|25|||
125681960|NCT03653507|452125698|FG001|Overall Study|Death|22|||
125681961|NCT03653507|452125697|FG000|Overall Study|Adverse Event|35|||
125681962|NCT03653507|452125698|FG001|Overall Study|Adverse Event|14|||
125681963|NCT05250115|452125699|FG000|Overall Study|Premature study end|40|||
125681964|NCT05250115|452125699|FG000|Overall Study|Adverse Event|8|||
125681965|NCT05250115|452125699|FG000|Overall Study|Lost to Follow-up|7|||
125681966|NCT05250115|452125699|FG000|Overall Study|Withdrawal by Subject|6|||
125681967|NCT05250115|452125699|FG000|Overall Study|Withdrawal of informed consent|1|||
125681968|NCT05250115|452125699|FG000|Overall Study|Other|7|||
125681969|NCT04401267|452125700|FG000|Overall Study|Death|0|||
125681970|NCT04401267|452125701|FG001|Overall Study|Death|1|||
125681971|NCT04401267|452125700|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
125681972|NCT04401267|452125701|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
125681973|NCT04401267|452125700|FG000|Overall Study|Found to be Ineligible|1|||
125681974|NCT04401267|452125701|FG001|Overall Study|Found to be Ineligible|0|||
125681975|NCT03360682|452125702|FG000|Overall Study|Adverse Event|3|||
125681976|NCT05381948|452125705|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
125348750|NCT02889562|450910467|FG000|Overall Study|Physician Decision|0|||
125348751|NCT02889562|450910468|FG001|Overall Study|Physician Decision|1|||
125348752|NCT02889562|450910467|FG000|Overall Study|Withdrawal by Subject|0|||
125348753|NCT02889562|450910468|FG001|Overall Study|Withdrawal by Subject|1|||
125348754|NCT01470989|450910471|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
125348755|NCT01470989|450910472|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
125348756|NCT01470989|450910471|FG000|Overall Study|Adverse Event|2|||
125348757|NCT01470989|450910472|FG001|Overall Study|Adverse Event|5|||
125348758|NCT01470989|450910471|FG000|Overall Study|Abnormal laboratory value|1|||
125348759|NCT01470989|450910472|FG001|Overall Study|Abnormal laboratory value|1|||
125348760|NCT01470989|450910471|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125348761|NCT01470989|450910472|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
125348762|NCT01470989|450910471|FG000|Overall Study|Withdrawal by Subject|19|||
125348763|NCT01470989|450910472|FG001|Overall Study|Withdrawal by Subject|17|||
125348764|NCT01470989|450910471|FG000|Overall Study|Lost to Follow-up|18|||
125348765|NCT01470989|450910472|FG001|Overall Study|Lost to Follow-up|13|||
125348766|NCT01470989|450910471|FG000|Overall Study|Administrative problems|2|||
125348767|NCT01470989|450910472|FG001|Overall Study|Administrative problems|4|||
125348768|NCT01470989|450910471|FG000|Overall Study|Death|2|||
125348769|NCT01470989|450910472|FG001|Overall Study|Death|2|||
125348770|NCT01470989|450910471|FG000|Overall Study|Protocol deviation|1|||
125348771|NCT01470989|450910472|FG001|Overall Study|Protocol deviation|2|||
125348772|NCT02119676|450910473|FG000|Overall Study|Adverse Event|9|||
125348773|NCT02119676|450910474|FG001|Overall Study|Adverse Event|17|||
125348774|NCT02119676|450910475|FG002|Overall Study|Adverse Event|10|||
125348775|NCT02119676|450910476|FG003|Overall Study|Adverse Event|10|||
125348776|NCT02119676|450910473|FG000|Overall Study|Disease progression|53|||
125348777|NCT02119676|450910474|FG001|Overall Study|Disease progression|55|||
125348778|NCT02119676|450910475|FG002|Overall Study|Disease progression|68|||
125348779|NCT02119676|450910476|FG003|Overall Study|Disease progression|73|||
125348780|NCT02119676|450910473|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
125348781|NCT02119676|450910474|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
125348782|NCT02119676|450910475|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
125348783|NCT02119676|450910476|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
125348784|NCT02119676|450910473|FG000|Overall Study|Physician Decision|4|||
125348785|NCT02119676|450910474|FG001|Overall Study|Physician Decision|2|||
125348786|NCT02119676|450910475|FG002|Overall Study|Physician Decision|3|||
125348787|NCT02119676|450910476|FG003|Overall Study|Physician Decision|2|||
125348788|NCT02119676|450910473|FG000|Overall Study|Death|9|||
125348789|NCT02119676|450910474|FG001|Overall Study|Death|3|||
125348790|NCT02119676|450910475|FG002|Overall Study|Death|2|||
125348791|NCT02119676|450910476|FG003|Overall Study|Death|1|||
125348792|NCT02119676|450910473|FG000|Overall Study|Noncompliance|0|||
125348793|NCT02119676|450910474|FG001|Overall Study|Noncompliance|1|||
125348794|NCT02119676|450910475|FG002|Overall Study|Noncompliance|0|||
125348795|NCT02119676|450910476|FG003|Overall Study|Noncompliance|0|||
125348796|NCT02119676|450910473|FG000|Overall Study|Lost to Follow-up|0|||
125348797|NCT02119676|450910474|FG001|Overall Study|Lost to Follow-up|0|||
125348798|NCT02119676|450910475|FG002|Overall Study|Lost to Follow-up|1|||
125348799|NCT02119676|450910476|FG003|Overall Study|Lost to Follow-up|0|||
125348800|NCT02119676|450910473|FG000|Overall Study|Protocol deviation|0|||
125681977|NCT05381948|452125706|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
125681978|NCT05381948|452125707|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
125681979|NCT05381948|452125705|FG000|Overall Study|Adverse Event: Non-ocular|0|||
125681980|NCT05381948|452125706|FG001|Overall Study|Adverse Event: Non-ocular|1|||
125681981|NCT05381948|452125707|FG002|Overall Study|Adverse Event: Non-ocular|0|||
125681982|NCT05381948|452125705|FG000|Overall Study|Lost to Follow-up|1|||
125681983|NCT05381948|452125706|FG001|Overall Study|Lost to Follow-up|0|||
125681984|NCT05381948|452125707|FG002|Overall Study|Lost to Follow-up|0|||
125681985|NCT05381948|452125705|FG000|Overall Study|Protocol Deviation|0|||
125681986|NCT05381948|452125706|FG001|Overall Study|Protocol Deviation|2|||
125681987|NCT05381948|452125707|FG002|Overall Study|Protocol Deviation|0|||
125681988|NCT05381948|452125705|FG000|Overall Study|Withdrawal by Subject|1|||
125681989|NCT05381948|452125706|FG001|Overall Study|Withdrawal by Subject|0|||
125681990|NCT05381948|452125707|FG002|Overall Study|Withdrawal by Subject|1|||
125681991|NCT05381948|452125705|FG000|Overall Study|Death|0|||
125348801|NCT02119676|450910474|FG001|Overall Study|Protocol deviation|0|||
125348802|NCT02119676|450910475|FG002|Overall Study|Protocol deviation|1|||
125348803|NCT02119676|450910476|FG003|Overall Study|Protocol deviation|0|||
125348804|NCT02119676|450910473|FG000|Overall Study|Other, unspecified|2|||
125348805|NCT02119676|450910474|FG001|Overall Study|Other, unspecified|1|||
125348806|NCT02119676|450910475|FG002|Overall Study|Other, unspecified|3|||
125348807|NCT02119676|450910476|FG003|Overall Study|Other, unspecified|4|||
125348808|NCT02119676|450910473|FG000|Overall Study|Did not receive study med|2|||
125348809|NCT02119676|450910474|FG001|Overall Study|Did not receive study med|2|||
125348810|NCT02119676|450910475|FG002|Overall Study|Did not receive study med|4|||
125348811|NCT02119676|450910476|FG003|Overall Study|Did not receive study med|5|||
125348812|NCT04085367|450911799|FG000|Overall Study|Adverse Event|1|||
125681992|NCT05381948|452125706|FG001|Overall Study|Death|2|||
125681993|NCT05381948|452125707|FG002|Overall Study|Death|0|||
125348813|NCT04085367|450911800|FG001|Overall Study|Adverse Event|1|||
125348814|NCT04085367|450911799|FG000|Overall Study|Withdrawal by Subject|13|||
125348815|NCT04085367|450911800|FG001|Overall Study|Withdrawal by Subject|4|||
125348816|NCT04085367|450911799|FG000|Overall Study|Lost to Follow-up|3|||
125348817|NCT04085367|450911800|FG001|Overall Study|Lost to Follow-up|1|||
125348818|NCT04085367|450911799|FG000|Overall Study|Other unspecified|2|||
125348819|NCT04085367|450911800|FG001|Overall Study|Other unspecified|1|||
125348820|NCT04085367|450911799|FG000|Overall Study|Status Unknown|1|||
125348821|NCT04085367|450911800|FG001|Overall Study|Status Unknown|1|||
125348822|NCT00470158|450911811|FG000|Overall Study|Death|0|||
125348823|NCT00470158|450911812|FG001|Overall Study|Death|0|||
125348824|NCT00470158|450911813|FG002|Overall Study|Death|0|||
125348825|NCT00470158|450911814|FG003|Overall Study|Death|0|||
125348826|NCT00470158|450911815|FG004|Overall Study|Death|2|||
125348827|NCT00470158|450911811|FG000|Overall Study|Lost to Follow-up|7|||
125348828|NCT00470158|450911812|FG001|Overall Study|Lost to Follow-up|8|||
125348829|NCT00470158|450911813|FG002|Overall Study|Lost to Follow-up|8|||
125348830|NCT00470158|450911814|FG003|Overall Study|Lost to Follow-up|5|||
125348831|NCT00470158|450911815|FG004|Overall Study|Lost to Follow-up|4|||
125348832|NCT00470158|450911811|FG000|Overall Study|Protocol Violation|1|||
125348833|NCT00470158|450911812|FG001|Overall Study|Protocol Violation|0|||
125348834|NCT00470158|450911813|FG002|Overall Study|Protocol Violation|0|||
125348835|NCT00470158|450911814|FG003|Overall Study|Protocol Violation|0|||
125348836|NCT00470158|450911815|FG004|Overall Study|Protocol Violation|0|||
125348837|NCT00880685|450911816|FG000|Memantine 10mg|Lost to Follow-up|2|||
125348838|NCT00880685|450911816|FG000|Memantine 20mg|Withdrawal by Subject|1|||
125348839|NCT01249118|450911817|FG000|First Washout Period|Physician Decision|0|||
125348840|NCT01249118|450911818|FG001|First Washout Period|Physician Decision|1|||
125348841|NCT01249118|450911819|FG002|First Washout Period|Physician Decision|0|||
125348842|NCT00997438|450911820|FG000|Overall Study|Blood draw difficulty|2|||
125348843|NCT00997438|450911821|FG001|Overall Study|Blood draw difficulty|0|||
125348844|NCT00997438|450911822|FG002|Overall Study|Blood draw difficulty|1|||
125348845|NCT00997438|450911820|FG000|Overall Study|Withdrawal by Subject|1|||
125348846|NCT00997438|450911821|FG001|Overall Study|Withdrawal by Subject|1|||
125348847|NCT00997438|450911822|FG002|Overall Study|Withdrawal by Subject|0|||
125348848|NCT00997438|450911820|FG000|Overall Study|Exclusion criteria at visit 1|2|||
125348849|NCT00997438|450911821|FG001|Overall Study|Exclusion criteria at visit 1|2|||
125348850|NCT00997438|450911822|FG002|Overall Study|Exclusion criteria at visit 1|3|||
125348851|NCT01236118|450911823|FG000|Overall Study|Adverse Event|2|||
125348852|NCT01236118|450911824|FG001|Overall Study|Adverse Event|0|||
125348853|NCT01236118|450911825|FG002|Overall Study|Adverse Event|2|||
125348854|NCT01236118|450911823|FG000|Overall Study|Physician Decision|0|||
125348855|NCT01236118|450911824|FG001|Overall Study|Physician Decision|1|||
125348856|NCT01236118|450911825|FG002|Overall Study|Physician Decision|0|||
125348857|NCT01236118|450911823|FG000|Overall Study|Withdrawal by Subject|0|||
125348858|NCT01236118|450911824|FG001|Overall Study|Withdrawal by Subject|0|||
125348859|NCT01236118|450911825|FG002|Overall Study|Withdrawal by Subject|1|||
125348860|NCT00095238|450911826|FG000|Overall Study|Lack of Efficacy|9|||
125348861|NCT00095238|450911827|FG001|Overall Study|Lack of Efficacy|9|||
125348862|NCT00095238|450911826|FG000|Overall Study|Adverse Event|331|||
125348863|NCT00095238|450911827|FG001|Overall Study|Adverse Event|287|||
125348864|NCT00095238|450911826|FG000|Overall Study|Subject Withdrew Consent|208|||
125348865|NCT00095238|450911827|FG001|Overall Study|Subject Withdrew Consent|223|||
125348866|NCT00095238|450911826|FG000|Overall Study|Death|154|||
125348867|NCT00095238|450911827|FG001|Overall Study|Death|170|||
125348868|NCT00095238|450911826|FG000|Overall Study|Lost to Follow-up|19|||
125348869|NCT00095238|450911827|FG001|Overall Study|Lost to Follow-up|24|||
125348870|NCT00095238|450911826|FG000|Overall Study|Noncompliance|44|||
125348871|NCT00095238|450911827|FG001|Overall Study|Noncompliance|45|||
125348872|NCT00095238|450911826|FG000|Overall Study|No longer met study criteria|4|||
125681994|NCT05381948|452125705|FG000|Overall Study|Discontinued study without receiving study drug|0|||
125681995|NCT05381948|452125706|FG001|Overall Study|Discontinued study without receiving study drug|0|||
125681996|NCT05381948|452125707|FG002|Overall Study|Discontinued study without receiving study drug|1|||
125681997|NCT04198428|452125708|FG000|Overall Study|Withdrawal by Subject|150|||
125681998|NCT04198428|452125709|FG001|Overall Study|Withdrawal by Subject|156|||
125681999|NCT05815342|452125710|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
125682000|NCT05815342|452125710|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
125348873|NCT00095238|450911827|FG001|Overall Study|No longer met study criteria|5|||
125348874|NCT00095238|450911826|FG000|Overall Study|Study terminated by sponsor|0|||
125348875|NCT00095238|450911827|FG001|Overall Study|Study terminated by sponsor|1|||
125348876|NCT00095238|450911826|FG000|Overall Study|Missing|1|||
125348877|NCT00095238|450911827|FG001|Overall Study|Missing|0|||
125348878|NCT00095238|450911826|FG000|Overall Study|Other Reasons|87|||
125348879|NCT00095238|450911827|FG001|Overall Study|Other Reasons|88|||
125348880|NCT03505671|450911828|FG000|Overall Study|Withdrawal by Subject|2|||
125348881|NCT03505671|450911829|FG001|Overall Study|Withdrawal by Subject|1|||
125348882|NCT03505671|450911828|FG000|Overall Study|Lost to Follow-up|1|||
125348883|NCT03505671|450911829|FG001|Overall Study|Lost to Follow-up|0|||
125348884|NCT04535167|450911832|FG000|Treatment|Adverse Event|0|||
125348885|NCT04535167|450911833|FG001|Treatment|Adverse Event|0|||
125348886|NCT04535167|450911834|FG002|Treatment|Adverse Event|0|||
125348887|NCT04535167|450911835|FG003|Treatment|Adverse Event|0|||
125348888|NCT04535167|450911836|FG004|Treatment|Adverse Event|0|||
125348889|NCT04535167|450911837|FG005|Treatment|Adverse Event|0|||
125348890|NCT04535167|450911838|FG006|Treatment|Adverse Event|1|||
125348891|NCT04535167|450911832|FG000|Follow-Up|Death|0|||
125348892|NCT04535167|450911833|FG001|Follow-Up|Death|0|||
125348893|NCT04535167|450911834|FG002|Follow-Up|Death|0|||
125348894|NCT04535167|450911835|FG003|Follow-Up|Death|0|||
125348895|NCT04535167|450911836|FG004|Follow-Up|Death|0|||
125348896|NCT04535167|450911837|FG005|Follow-Up|Death|0|||
125348897|NCT04535167|450911838|FG006|Follow-Up|Death|1|||
125348898|NCT04535167|450911832|FG000|Follow-Up|Lost to Follow-up|0|||
125348899|NCT04535167|450911833|FG001|Follow-Up|Lost to Follow-up|0|||
125348900|NCT04535167|450911834|FG002|Follow-Up|Lost to Follow-up|0|||
125348901|NCT04535167|450911835|FG003|Follow-Up|Lost to Follow-up|1|||
125348902|NCT04535167|450911836|FG004|Follow-Up|Lost to Follow-up|0|||
125348903|NCT04535167|450911837|FG005|Follow-Up|Lost to Follow-up|0|||
125348904|NCT04535167|450911838|FG006|Follow-Up|Lost to Follow-up|0|||
125348905|NCT02038829|450911839|FG000|Washout Period 1|Death|0|||
125348906|NCT02038829|450911840|FG001|Washout Period 1|Death|0|||
125348907|NCT02038829|450911841|FG002|Washout Period 1|Death|0|||
125348908|NCT02038829|450911842|FG003|Washout Period 1|Death|0|||
125348909|NCT02038829|450911843|FG004|Washout Period 1|Death|1|||
125348910|NCT02038829|450911844|FG005|Washout Period 1|Death|0|||
125348911|NCT02038829|450911845|FG006|Washout Period 1|Death|0|||
125348912|NCT02038829|450911846|FG007|Washout Period 1|Death|0|||
125348913|NCT02038829|450911847|FG008|Washout Period 1|Death|0|||
125348914|NCT02038829|450911848|FG009|Washout Period 1|Death|0|||
125348915|NCT02038829|450911849|FG010|Washout Period 1|Death|0|||
125348916|NCT02038829|450911850|FG011|Washout Period 1|Death|0|||
125348917|NCT02038829|450911839|FG000|Treatment Period 2|Adverse Event|0|||
125348918|NCT02038829|450911840|FG001|Treatment Period 2|Adverse Event|0|||
125348919|NCT02038829|450911841|FG002|Treatment Period 2|Adverse Event|0|||
125348920|NCT02038829|450911842|FG003|Treatment Period 2|Adverse Event|0|||
125348921|NCT02038829|450911843|FG004|Treatment Period 2|Adverse Event|0|||
125348922|NCT02038829|450911844|FG005|Treatment Period 2|Adverse Event|0|||
125348923|NCT02038829|450911845|FG006|Treatment Period 2|Adverse Event|0|||
125348924|NCT02038829|450911846|FG007|Treatment Period 2|Adverse Event|0|||
125348925|NCT02038829|450911847|FG008|Treatment Period 2|Adverse Event|0|||
125348926|NCT02038829|450911848|FG009|Treatment Period 2|Adverse Event|0|||
125348927|NCT02038829|450911849|FG010|Treatment Period 2|Adverse Event|1|||
125348928|NCT02038829|450911850|FG011|Treatment Period 2|Adverse Event|0|||
125348929|NCT02038829|450911839|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125348930|NCT02038829|450911840|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125348931|NCT02038829|450911841|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125348932|NCT02038829|450911842|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125348933|NCT02038829|450911843|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125348934|NCT02038829|450911844|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125348935|NCT02038829|450911845|FG006|Treatment Period 2|Withdrawal by Subject|0|||
125348936|NCT02038829|450911846|FG007|Treatment Period 2|Withdrawal by Subject|0|||
125348937|NCT02038829|450911847|FG008|Treatment Period 2|Withdrawal by Subject|0|||
125348938|NCT02038829|450911848|FG009|Treatment Period 2|Withdrawal by Subject|0|||
125348939|NCT02038829|450911849|FG010|Treatment Period 2|Withdrawal by Subject|0|||
125348940|NCT02038829|450911850|FG011|Treatment Period 2|Withdrawal by Subject|0|||
125348941|NCT02038829|450911839|FG000|Washout Period 2|Adverse Event|0|||
125348942|NCT02038829|450911840|FG001|Washout Period 2|Adverse Event|0|||
125348943|NCT02038829|450911841|FG002|Washout Period 2|Adverse Event|0|||
125348944|NCT02038829|450911842|FG003|Washout Period 2|Adverse Event|0|||
125348945|NCT02038829|450911843|FG004|Washout Period 2|Adverse Event|0|||
125348946|NCT02038829|450911844|FG005|Washout Period 2|Adverse Event|0|||
125348947|NCT02038829|450911845|FG006|Washout Period 2|Adverse Event|0|||
125348948|NCT02038829|450911846|FG007|Washout Period 2|Adverse Event|0|||
125348949|NCT02038829|450911847|FG008|Washout Period 2|Adverse Event|1|||
125348950|NCT02038829|450911848|FG009|Washout Period 2|Adverse Event|0|||
125348951|NCT02038829|450911849|FG010|Washout Period 2|Adverse Event|0|||
125348952|NCT02038829|450911850|FG011|Washout Period 2|Adverse Event|0|||
125348953|NCT02038829|450911839|FG000|Washout Period 2|Withdrawal by Subject|0|||
125348954|NCT02038829|450911840|FG001|Washout Period 2|Withdrawal by Subject|0|||
125348955|NCT02038829|450911841|FG002|Washout Period 2|Withdrawal by Subject|0|||
125348956|NCT02038829|450911842|FG003|Washout Period 2|Withdrawal by Subject|0|||
125348957|NCT02038829|450911843|FG004|Washout Period 2|Withdrawal by Subject|0|||
125348958|NCT02038829|450911844|FG005|Washout Period 2|Withdrawal by Subject|1|||
125348959|NCT02038829|450911845|FG006|Washout Period 2|Withdrawal by Subject|0|||
125348960|NCT02038829|450911846|FG007|Washout Period 2|Withdrawal by Subject|0|||
125348961|NCT02038829|450911847|FG008|Washout Period 2|Withdrawal by Subject|0|||
125348962|NCT02038829|450911848|FG009|Washout Period 2|Withdrawal by Subject|0|||
125348963|NCT02038829|450911849|FG010|Washout Period 2|Withdrawal by Subject|0|||
125348964|NCT02038829|450911850|FG011|Washout Period 2|Withdrawal by Subject|0|||
125348965|NCT02038829|450911839|FG000|Treatment Period 4|Adverse Event|0|||
125348966|NCT02038829|450911840|FG001|Treatment Period 4|Adverse Event|1|||
125348967|NCT02038829|450911841|FG002|Treatment Period 4|Adverse Event|0|||
125348968|NCT02038829|450911842|FG003|Treatment Period 4|Adverse Event|0|||
125348969|NCT02038829|450911843|FG004|Treatment Period 4|Adverse Event|0|||
125348970|NCT02038829|450911844|FG005|Treatment Period 4|Adverse Event|0|||
125348971|NCT02038829|450911845|FG006|Treatment Period 4|Adverse Event|0|||
125348972|NCT02038829|450911846|FG007|Treatment Period 4|Adverse Event|0|||
125348973|NCT02038829|450911847|FG008|Treatment Period 4|Adverse Event|0|||
125348974|NCT02038829|450911848|FG009|Treatment Period 4|Adverse Event|0|||
125348975|NCT02038829|450911849|FG010|Treatment Period 4|Adverse Event|0|||
125348976|NCT02038829|450911850|FG011|Treatment Period 4|Adverse Event|0|||
125348977|NCT02038829|450911839|FG000|Washout Period 4|Adverse Event|0|||
125348978|NCT02038829|450911840|FG001|Washout Period 4|Adverse Event|0|||
125348979|NCT02038829|450911841|FG002|Washout Period 4|Adverse Event|0|||
125348980|NCT02038829|450911842|FG003|Washout Period 4|Adverse Event|0|||
125348981|NCT02038829|450911843|FG004|Washout Period 4|Adverse Event|0|||
125348982|NCT02038829|450911844|FG005|Washout Period 4|Adverse Event|0|||
125348983|NCT02038829|450911845|FG006|Washout Period 4|Adverse Event|1|||
125348984|NCT02038829|450911846|FG007|Washout Period 4|Adverse Event|0|||
125348985|NCT02038829|450911847|FG008|Washout Period 4|Adverse Event|0|||
125348986|NCT02038829|450911848|FG009|Washout Period 4|Adverse Event|0|||
125348987|NCT02038829|450911849|FG010|Washout Period 4|Adverse Event|0|||
125348988|NCT02038829|450911850|FG011|Washout Period 4|Adverse Event|0|||
125348989|NCT02038829|450911839|FG000|Treatment Period 6|Adverse Event|0|||
125348990|NCT02038829|450911840|FG001|Treatment Period 6|Adverse Event|0|||
125348991|NCT02038829|450911841|FG002|Treatment Period 6|Adverse Event|1|||
125348992|NCT02038829|450911842|FG003|Treatment Period 6|Adverse Event|0|||
125348993|NCT02038829|450911843|FG004|Treatment Period 6|Adverse Event|0|||
125348994|NCT02038829|450911844|FG005|Treatment Period 6|Adverse Event|0|||
125348995|NCT02038829|450911845|FG006|Treatment Period 6|Adverse Event|0|||
125348996|NCT02038829|450911846|FG007|Treatment Period 6|Adverse Event|0|||
125348997|NCT02038829|450911847|FG008|Treatment Period 6|Adverse Event|0|||
125348998|NCT02038829|450911848|FG009|Treatment Period 6|Adverse Event|0|||
125548279|NCT00585195|451637115|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
125682001|NCT05815342|452125710|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
125348999|NCT02038829|450911849|FG010|Treatment Period 6|Adverse Event|0|||
125349000|NCT02038829|450911850|FG011|Treatment Period 6|Adverse Event|0|||
125349001|NCT00075270|450911851|FG000|Overall Study|Withdrawal by Subject|28|||
125349002|NCT00075270|450911852|FG001|Overall Study|Withdrawal by Subject|21|||
125349003|NCT00075270|450911851|FG000|Overall Study|Lost to Follow-up|25|||
125349004|NCT00075270|450911852|FG001|Overall Study|Lost to Follow-up|28|||
125349005|NCT00075270|450911851|FG000|Overall Study|Protocol Violation|0|||
125349006|NCT00075270|450911852|FG001|Overall Study|Protocol Violation|2|||
125349007|NCT00075270|450911851|FG000|Overall Study|Death|198|||
125349008|NCT00075270|450911852|FG001|Overall Study|Death|215|||
125349009|NCT00075270|450911851|FG000|Overall Study|Other/Unknown|9|||
125349010|NCT00075270|450911852|FG001|Overall Study|Other/Unknown|5|||
125682002|NCT05815342|452125710|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
125682003|NCT05815342|452125710|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
125682004|NCT04649359|452125714|FG000|Overall Study|Withdrawal by Subject|7|||
125682005|NCT04649359|452125715|FG001|Overall Study|Withdrawal by Subject|7|||
125682006|NCT04649359|452125714|FG000|Overall Study|Death|41|||
125349011|NCT00075270|450911851|FG000|Overall Study|Missing|26|||
125349012|NCT00075270|450911852|FG001|Overall Study|Missing|13|||
125349013|NCT04656275|450911854|FG000|Overall Study|Study terminated by sponsor|2|||
125349014|NCT04656275|450911855|FG001|Overall Study|Study terminated by sponsor|4|||
125349015|NCT02361580|450911857|FG000|Overall Study|Lost to Follow-up|6|||
125349016|NCT02361580|450911858|FG001|Overall Study|Lost to Follow-up|3|||
125349017|NCT03490981|450911859|FG000|Overall Study|Lost to Follow-up|1|||
125349018|NCT03490981|450911860|FG001|Overall Study|Lost to Follow-up|2|||
125349019|NCT00723203|450911869|FG000|Overall Study|Withdrawal by Subject|3|||
125349020|NCT00740051|450911870|FG000|Overall Study|Lack of Efficacy|2|||
125349021|NCT00740051|450911871|FG001|Overall Study|Lack of Efficacy|5|||
125349022|NCT00740051|450911870|FG000|Overall Study|Adverse Event|1|||
125349023|NCT00740051|450911871|FG001|Overall Study|Adverse Event|4|||
125349024|NCT00740051|450911870|FG000|Overall Study|Protocol Violation|2|||
125349025|NCT00740051|450911871|FG001|Overall Study|Protocol Violation|6|||
125349026|NCT00740051|450911870|FG000|Overall Study|Lost to Follow-up|3|||
125349027|NCT00740051|450911871|FG001|Overall Study|Lost to Follow-up|8|||
125349028|NCT00740051|450911870|FG000|Overall Study|Withdrawal by Subject|6|||
125349029|NCT00740051|450911871|FG001|Overall Study|Withdrawal by Subject|8|||
125349030|NCT00740051|450911870|FG000|Overall Study|Other reason (not specified)|4|||
125349031|NCT00740051|450911871|FG001|Overall Study|Other reason (not specified)|1|||
125349032|NCT00274924|450911872|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
125349033|NCT00274924|450911873|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
125349034|NCT00274924|450911874|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
125349035|NCT00274924|450911872|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
125349036|NCT00274924|450911873|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
125349037|NCT00274924|450911874|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
125349038|NCT00274924|450911872|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
125349039|NCT00274924|450911873|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
125349040|NCT00274924|450911874|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
125349041|NCT00274924|450911872|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
125349042|NCT00274924|450911873|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
125349043|NCT00274924|450911874|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
125349044|NCT00274924|450911872|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
125349045|NCT00274924|450911873|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
125349046|NCT00274924|450911874|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
125349047|NCT00274924|450911872|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
125349048|NCT00274924|450911873|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
125349049|NCT00274924|450911874|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
125349050|NCT00274924|450911872|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
125349051|NCT00274924|450911873|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
125349052|NCT00274924|450911874|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
125349053|NCT00274924|450911872|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
125349054|NCT00274924|450911873|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
125349055|NCT00274924|450911874|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
125349056|NCT00274924|450911872|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
125349057|NCT00274924|450911873|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
125349058|NCT00274924|450911874|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
125349059|NCT00274924|450911872|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
125349060|NCT00274924|450911873|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
125349061|NCT00274924|450911874|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
125349062|NCT00274924|450911872|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
125349063|NCT00274924|450911873|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
125349064|NCT00274924|450911874|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
125349065|NCT00274924|450911872|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
125349066|NCT00274924|450911873|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
125349067|NCT00274924|450911874|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
125349068|NCT00274924|450911872|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
125349069|NCT00274924|450911873|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
125349070|NCT00274924|450911874|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
125349071|NCT01903525|450911876|FG000|Overall Study|Lost to Follow-up|5|||
125349072|NCT01903525|450911877|FG001|Overall Study|Lost to Follow-up|9|||
125349073|NCT01903525|450911876|FG000|Overall Study|Adverse Event|0|||
125349074|NCT01903525|450911877|FG001|Overall Study|Adverse Event|1|||
125349075|NCT03485495|450911880|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
125349076|NCT03485495|450911881|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
125349077|NCT02915874|450911882|FG000|Overall Study|Lost to Follow-up|5|||
125349078|NCT02915874|450911883|FG001|Overall Study|Lost to Follow-up|4|||
125349079|NCT02915874|450911882|FG000|Overall Study|Withdrawal by Subject|1|||
125349080|NCT02915874|450911883|FG001|Overall Study|Withdrawal by Subject|1|||
125349081|NCT02915874|450911882|FG000|Overall Study|Started New Anxiety Medication|0|||
125349082|NCT02915874|450911883|FG001|Overall Study|Started New Anxiety Medication|1|||
125349083|NCT01056380|450911885|FG000|Overall Study|Lost to Follow-up|2|||
125349084|NCT01056380|450911886|FG001|Overall Study|Lost to Follow-up|3|||
125349085|NCT03901456|450911887|FG000|Overall Study|Withdrawal by Subject|0|||
125349086|NCT03901456|450911888|FG001|Overall Study|Withdrawal by Subject|0|||
125349087|NCT03901456|450911889|FG002|Overall Study|Withdrawal by Subject|1|||
125349088|NCT03901456|450911887|FG000|Overall Study|Lost to Follow-up|0|||
125349089|NCT03901456|450911888|FG001|Overall Study|Lost to Follow-up|1|||
125349090|NCT03901456|450911889|FG002|Overall Study|Lost to Follow-up|0|||
125548280|NCT00585195|451637116|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
125548281|NCT00585195|451637117|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
125682007|NCT04649359|452125715|FG001|Overall Study|Death|26|||
125682008|NCT04649359|452125714|FG000|Overall Study|Ongoing in the study|75|||
125349091|NCT03025035|450911890|FG000|Overall Study|Death|2|||
125349092|NCT03025035|450911890|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
125349093|NCT01589770|450911896|FG000|Overall Study|EGFR <60ml/min|6|||
125349094|NCT01589770|450911897|FG001|Overall Study|EGFR <60ml/min|4|||
125349095|NCT01589770|450911896|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
125349096|NCT01589770|450911897|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
125349097|NCT00725842|450911898|FG000|Overall Study|Lost to Follow-up|19|||
125349098|NCT00725842|450911898|FG000|Overall Study|Death|1|||
125349099|NCT00725842|450911898|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
125349100|NCT00725842|450911898|FG000|Overall Study|Consent date prior to study start date|5|||
125349101|NCT00725842|450911898|FG000|Overall Study|Inclusion criterion not met|1|||
125349102|NCT00725842|450911898|FG000|Overall Study|No Visit 1 data|1|||
125349103|NCT01853618|450911901|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
125349104|NCT01853618|450911902|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
125349105|NCT01853618|450911903|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
125349106|NCT01853618|450911904|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
125349107|NCT01853618|450911905|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
125349108|NCT01853618|450911901|FG000|Overall Study|Progressive disease|1|||
125349109|NCT01853618|450911902|FG001|Overall Study|Progressive disease|1|||
125349110|NCT01853618|450911903|FG002|Overall Study|Progressive disease|1|||
125349111|NCT01853618|450911904|FG003|Overall Study|Progressive disease|1|||
125349112|NCT01853618|450911905|FG004|Overall Study|Progressive disease|2|||
125349113|NCT01853618|450911901|FG000|Overall Study|Physician Decision|0|||
125349114|NCT01853618|450911902|FG001|Overall Study|Physician Decision|1|||
125682009|NCT04649359|452125715|FG001|Overall Study|Ongoing in the study|31|||
125682010|NCT01701674|452125716|FG000|Overall Study|Unable to safely complete treatment|1|||
125682011|NCT05604170|452125717|FG000|Overall Study|Lack of Efficacy|5|||
125682012|NCT05604170|452125717|FG000|Overall Study|Adverse Event|6|||
125682013|NCT05604170|452125717|FG000|Overall Study|Physician Decision|6|||
125682014|NCT05604170|452125717|FG000|Overall Study|Lost to Follow-up|6|||
125682015|NCT05604170|452125717|FG000|Overall Study|Withdrawal by Subject|11|||
125682016|NCT05604170|452125717|FG000|Overall Study|Early study termination by sponsor|77|||
125349115|NCT01853618|450911903|FG002|Overall Study|Physician Decision|1|||
125349116|NCT01853618|450911904|FG003|Overall Study|Physician Decision|0|||
125349117|NCT01853618|450911905|FG004|Overall Study|Physician Decision|0|||
125349118|NCT01853618|450911901|FG000|Overall Study|Refused further treatment|0|||
125349119|NCT01853618|450911902|FG001|Overall Study|Refused further treatment|0|||
125349120|NCT01853618|450911903|FG002|Overall Study|Refused further treatment|0|||
125349121|NCT01853618|450911904|FG003|Overall Study|Refused further treatment|0|||
125349122|NCT01853618|450911905|FG004|Overall Study|Refused further treatment|1|||
125349123|NCT01658813|450911906|FG000|Overall Study|Disease progression|3|||
125349124|NCT00938886|450911907|FG000|Overall Study|Death|0|||
125349125|NCT00938886|450911908|FG001|Overall Study|Death|1|||
125349126|NCT00938886|450911907|FG000|Overall Study|Withdrawal by Subject|4|||
125349127|NCT00938886|450911908|FG001|Overall Study|Withdrawal by Subject|7|||
125349128|NCT00938886|450911907|FG000|Overall Study|Lost to Follow-up|3|||
125349129|NCT00938886|450911908|FG001|Overall Study|Lost to Follow-up|2|||
125349130|NCT01075191|450911909|FG000|Overall Study|Death|1|||
125349131|NCT01075191|450911909|FG000|Overall Study|Intensification|3|||
125349132|NCT01075191|450911909|FG000|Overall Study|Co-morbidities|1|||
125349133|NCT01075191|450911909|FG000|Overall Study|Adverse Event|4|||
125349134|NCT01075191|450911909|FG000|Overall Study|Noncompliance|3|||
125349135|NCT01075191|450911909|FG000|Overall Study|Therapy Break|3|||
125349136|NCT01075191|450911909|FG000|Overall Study|Patient's Wish|2|||
125349137|NCT01075191|450911909|FG000|Overall Study|Unknown Reasons|1|||
125349138|NCT02068768|450911910|FG000|Overall Study|Lost to Follow-up|5|||
125349139|NCT02068768|450911910|FG000|Overall Study|Early Termination by Sponsor|2|||
125349140|NCT02674854|450911911|FG000|Overall Study|Adverse Event|17|||
125349141|NCT02674854|450911912|FG001|Overall Study|Adverse Event|15|||
125349142|NCT02674854|450911913|FG002|Overall Study|Adverse Event|5|||
125349143|NCT02674854|450911911|FG000|Overall Study|Withdrawal by Subject|1|||
125349144|NCT02674854|450911912|FG001|Overall Study|Withdrawal by Subject|5|||
125349145|NCT02674854|450911913|FG002|Overall Study|Withdrawal by Subject|4|||
125349146|NCT02674854|450911911|FG000|Overall Study|No-compliant subject|1|||
125349147|NCT02674854|450911912|FG001|Overall Study|No-compliant subject|0|||
125349148|NCT02674854|450911913|FG002|Overall Study|No-compliant subject|1|||
125349149|NCT02674854|450911911|FG000|Overall Study|Lost to Follow-up|1|||
125349150|NCT02674854|450911912|FG001|Overall Study|Lost to Follow-up|0|||
125349151|NCT02674854|450911913|FG002|Overall Study|Lost to Follow-up|2|||
125349152|NCT02674854|450911911|FG000|Overall Study|Lack of Efficacy|0|||
125349153|NCT02674854|450911912|FG001|Overall Study|Lack of Efficacy|3|||
125682017|NCT05604170|452125717|FG000|Overall Study|Other|6|||
125682018|NCT05767021|452125718|FG000|Overall Study|Adverse Event|2|||
125548282|NCT00585195|451637118|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
125548283|NCT00585195|451637119|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
125548284|NCT00585195|451637120|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
125548285|NCT00585195|451637121|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
125548286|NCT00585195|451637122|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
125548287|NCT00585195|451637123|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
125548288|NCT00585195|451637124|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
125548289|NCT00585195|451637125|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
125548290|NCT00585195|451637126|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
125548291|NCT02796560|451637127|FG000|Overall Study|Adverse Event|2|||
125548292|NCT02796560|451637128|FG001|Overall Study|Adverse Event|0|||
125548293|NCT02796560|451637127|FG000|Overall Study|Withdrawal by Subject|2|||
125548294|NCT02796560|451637128|FG001|Overall Study|Withdrawal by Subject|2|||
125548295|NCT04002401|451637129|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
125548296|NCT04002401|451637129|FG000|Overall Study|Death|10|||
125548297|NCT04002401|451637129|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
125548298|NCT04002401|451637129|FG000|Overall Study|Enrolled but Never Treated|1|||
125548299|NCT04002401|451637129|FG000|Overall Study|Lost to Follow-up|1|||
125548300|NCT00423930|451637130|FG000|Overall Study|Withdrawal by Subject|2|||
125548301|NCT01009580|451637135|FG000|Overall Study|Adverse Event|4|||
125548302|NCT01009580|451637136|FG001|Overall Study|Adverse Event|4|||
125548303|NCT01009580|451637135|FG000|Overall Study|Lack of Efficacy|0|||
125548304|NCT01009580|451637136|FG001|Overall Study|Lack of Efficacy|1|||
125548305|NCT01009580|451637135|FG000|Overall Study|Protocol Violation|2|||
125548306|NCT01009580|451637136|FG001|Overall Study|Protocol Violation|3|||
125548307|NCT01009580|451637135|FG000|Overall Study|Withdrawal Criteria|4|||
125349154|NCT02674854|450911913|FG002|Overall Study|Lack of Efficacy|0|||
125349155|NCT02674854|450911911|FG000|Overall Study|Disallowed Concurrent Medication|2|||
125349156|NCT02674854|450911912|FG001|Overall Study|Disallowed Concurrent Medication|2|||
125349157|NCT02674854|450911913|FG002|Overall Study|Disallowed Concurrent Medication|0|||
125349158|NCT02674854|450911911|FG000|Overall Study|Protocol Violation|1|||
125548308|NCT01009580|451637136|FG001|Overall Study|Withdrawal Criteria|6|||
125548309|NCT01009580|451637135|FG000|Overall Study|Unclassified|17|||
125548310|NCT01009580|451637136|FG001|Overall Study|Unclassified|21|||
125548311|NCT02390245|451637137|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
125548312|NCT02390245|451637138|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
125548313|NCT02390245|451637139|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
125548314|NCT02390245|451637137|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
125548315|NCT02390245|451637138|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
125548316|NCT02390245|451637139|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
125548317|NCT01440374|451638182|FG000|Part 1: Open-label Phase|Adverse Event|5|||
125548318|NCT01440374|451638183|FG001|Part 1: Open-label Phase|Adverse Event|0|||
125548319|NCT01440374|451638184|FG002|Part 1: Open-label Phase|Adverse Event|0|||
125682019|NCT05767021|452125718|FG000|Overall Study|Protocol Deviation|1|||
125682020|NCT05767021|452125718|FG000|Overall Study|Withdrawal by Subject|1|||
125682021|NCT05767021|452125718|FG000|Overall Study|Physician Decision|1|||
125682022|NCT05767021|452125718|FG000|Overall Study|Lack of Efficacy|11|||
125682023|NCT05767021|452125718|FG000|Overall Study|Assigned Treatment by Mistake|1|||
125682024|NCT03032172|452125719|FG000|Treatment Period|Adverse Event|0|||
125682025|NCT03032172|452125720|FG001|Treatment Period|Adverse Event|1|||
125682026|NCT03032172|452125721|FG002|Treatment Period|Adverse Event|0|||
125682027|NCT03032172|452125722|FG003|Treatment Period|Adverse Event|0|||
125682028|NCT03032172|452125723|FG004|Treatment Period|Adverse Event|0|||
125682029|NCT03032172|452125724|FG005|Treatment Period|Adverse Event|0|||
125682030|NCT03032172|452125725|FG006|Treatment Period|Adverse Event|0|||
125682031|NCT03032172|452125726|FG007|Treatment Period|Adverse Event|0|||
125682032|NCT03032172|452125719|FG000|Treatment Period|Lack of Efficacy|0|||
125682033|NCT03032172|452125720|FG001|Treatment Period|Lack of Efficacy|1|||
125682034|NCT03032172|452125721|FG002|Treatment Period|Lack of Efficacy|0|||
125682035|NCT03032172|452125722|FG003|Treatment Period|Lack of Efficacy|0|||
125682036|NCT03032172|452125723|FG004|Treatment Period|Lack of Efficacy|0|||
125682037|NCT03032172|452125724|FG005|Treatment Period|Lack of Efficacy|0|||
125682038|NCT03032172|452125725|FG006|Treatment Period|Lack of Efficacy|0|||
125349159|NCT02674854|450911912|FG001|Overall Study|Protocol Violation|1|||
125548320|NCT01440374|451638185|FG003|Part 1: Open-label Phase|Adverse Event|0|||
125548321|NCT01440374|451638182|FG000|Part 1: Open-label Phase|Physician Decision|1|||
125548322|NCT01440374|451638183|FG001|Part 1: Open-label Phase|Physician Decision|0|||
125548323|NCT01440374|451638184|FG002|Part 1: Open-label Phase|Physician Decision|0|||
125548324|NCT01440374|451638185|FG003|Part 1: Open-label Phase|Physician Decision|0|||
125548325|NCT01440374|451638182|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
125548326|NCT01440374|451638183|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
125682039|NCT03032172|452125726|FG007|Treatment Period|Lack of Efficacy|0|||
125682040|NCT03032172|452125719|FG000|Treatment Period|Non-compliance With Study Drug|0|||
125682041|NCT03032172|452125720|FG001|Treatment Period|Non-compliance With Study Drug|1|||
125682042|NCT03032172|452125721|FG002|Treatment Period|Non-compliance With Study Drug|0|||
125682043|NCT03032172|452125722|FG003|Treatment Period|Non-compliance With Study Drug|0|||
125548327|NCT01440374|451638184|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
125548328|NCT01440374|451638185|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
125548329|NCT01440374|451638182|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
125548330|NCT01440374|451638183|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
125548331|NCT01440374|451638184|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
125548332|NCT01440374|451638185|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
125548333|NCT01440374|451638182|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
125548334|NCT01440374|451638183|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
125548335|NCT01440374|451638184|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
125548336|NCT01440374|451638185|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
125548337|NCT01440374|451638182|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
125548338|NCT01440374|451638183|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
125548339|NCT01440374|451638184|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
125548340|NCT01440374|451638185|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
125548341|NCT01440374|451638182|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
125548342|NCT01440374|451638183|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
125548343|NCT01440374|451638184|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
125548344|NCT01440374|451638185|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
125548345|NCT01440374|451638182|FG000|Part 2; Double-blind Phase|Not treated|0|||
125548346|NCT01440374|451638183|FG001|Part 2; Double-blind Phase|Not treated|0|||
125548347|NCT01440374|451638184|FG002|Part 2; Double-blind Phase|Not treated|1|||
125548348|NCT01440374|451638185|FG003|Part 2; Double-blind Phase|Not treated|0|||
125548349|NCT01440374|451638182|FG000|Part 3: Extension|Withdrawal by Subject|0|||
125548350|NCT01440374|451638183|FG001|Part 3: Extension|Withdrawal by Subject|0|||
125548351|NCT01440374|451638184|FG002|Part 3: Extension|Withdrawal by Subject|0|||
125548352|NCT01440374|451638185|FG003|Part 3: Extension|Withdrawal by Subject|5|||
125548353|NCT01440374|451638182|FG000|Part 3: Extension|Adverse Event|0|||
125548354|NCT01440374|451638183|FG001|Part 3: Extension|Adverse Event|0|||
125548355|NCT01440374|451638184|FG002|Part 3: Extension|Adverse Event|0|||
125548356|NCT01440374|451638185|FG003|Part 3: Extension|Adverse Event|13|||
125548357|NCT01440374|451638182|FG000|Part 3: Extension|Physician Decision|0|||
125548358|NCT01440374|451638183|FG001|Part 3: Extension|Physician Decision|0|||
125548359|NCT01440374|451638184|FG002|Part 3: Extension|Physician Decision|0|||
125548360|NCT01440374|451638185|FG003|Part 3: Extension|Physician Decision|14|||
125548361|NCT04281004|451638194|FG000|Overall Study|Physician Decision|1|||
125548362|NCT04281004|451638195|FG001|Overall Study|Physician Decision|0|||
125548363|NCT03628898|451638196|FG000|Overall Study|Device deficiency|1|||
125548364|NCT00701779|451638197|FG000|Overall Study|Adverse Event|6|||
125548365|NCT00701779|451638197|FG000|Overall Study|Lost to Follow-up|1|||
125682044|NCT03032172|452125723|FG004|Treatment Period|Non-compliance With Study Drug|0|||
125682045|NCT03032172|452125724|FG005|Treatment Period|Non-compliance With Study Drug|0|||
125682046|NCT03032172|452125725|FG006|Treatment Period|Non-compliance With Study Drug|0|||
125682047|NCT03032172|452125726|FG007|Treatment Period|Non-compliance With Study Drug|0|||
125682048|NCT03032172|452125719|FG000|Treatment Period|Reason Not Specified|0|||
125682049|NCT03032172|452125720|FG001|Treatment Period|Reason Not Specified|4|||
125682050|NCT03032172|452125721|FG002|Treatment Period|Reason Not Specified|1|||
125682051|NCT03032172|452125722|FG003|Treatment Period|Reason Not Specified|0|||
125682052|NCT03032172|452125723|FG004|Treatment Period|Reason Not Specified|0|||
125682053|NCT03032172|452125724|FG005|Treatment Period|Reason Not Specified|0|||
125682054|NCT03032172|452125725|FG006|Treatment Period|Reason Not Specified|0|||
125682055|NCT03032172|452125726|FG007|Treatment Period|Reason Not Specified|0|||
125682056|NCT03032172|452125719|FG000|Treatment Period|Physician Decision|0|||
125682057|NCT03032172|452125720|FG001|Treatment Period|Physician Decision|2|||
125682058|NCT03032172|452125721|FG002|Treatment Period|Physician Decision|1|||
125682059|NCT03032172|452125722|FG003|Treatment Period|Physician Decision|0|||
125682060|NCT03032172|452125723|FG004|Treatment Period|Physician Decision|0|||
125682061|NCT03032172|452125724|FG005|Treatment Period|Physician Decision|0|||
125682062|NCT03032172|452125725|FG006|Treatment Period|Physician Decision|0|||
125682063|NCT03032172|452125726|FG007|Treatment Period|Physician Decision|0|||
125682064|NCT03032172|452125719|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
125682065|NCT03032172|452125720|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
125682066|NCT03032172|452125721|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
125682067|NCT03032172|452125722|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
125682068|NCT03032172|452125723|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
125548366|NCT00701779|451638197|FG000|Overall Study|Withdrawal by Subject|2|||
125548367|NCT01217957|451638198|FG000|Phase 1|Withdrawal by Patient|1|||
125548368|NCT01217957|451638199|FG001|Phase 1|Withdrawal by Patient|0|||
125548369|NCT01217957|451638200|FG002|Phase 1|Withdrawal by Patient|1|||
125548370|NCT01217957|451638201|FG003|Phase 1|Withdrawal by Patient|1|||
125548371|NCT01217957|451638202|FG004|Phase 1|Withdrawal by Patient|0|||
125682069|NCT03032172|452125724|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
125548372|NCT01217957|451638198|FG000|Phase 2|Withdrawal by Patient|0|||
125548373|NCT01217957|451638199|FG001|Phase 2|Withdrawal by Patient|0|||
125548374|NCT01217957|451638200|FG002|Phase 2|Withdrawal by Patient|0|||
125548375|NCT01217957|451638201|FG003|Phase 2|Withdrawal by Patient|0|||
125548376|NCT01217957|451638202|FG004|Phase 2|Withdrawal by Patient|1|||
125548377|NCT01873495|451638205|FG000|Overall Study|Withdrawal by Subject|1|||
125548378|NCT01873495|451638205|FG000|Overall Study|Physician Decision|3|||
125548379|NCT01873495|451638205|FG000|Overall Study|Adverse Event|1|||
125548380|NCT01873495|451638205|FG000|Overall Study|Removed for Transplantation|1|||
125548381|NCT01873495|451638205|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
125548382|NCT01206777|451638206|FG000|Overall Study|Death|1|||
125548383|NCT01206777|451638206|FG000|Overall Study|Adverse Event|1|||
125548384|NCT02986334|451638207|FG000|Overall Study|Withdrawal by Subject|0|||
125548385|NCT02986334|451638208|FG001|Overall Study|Withdrawal by Subject|1|||
125548386|NCT02986334|451638209|FG002|Overall Study|Withdrawal by Subject|2|||
125548387|NCT02986334|451638207|FG000|Overall Study|Lost to Follow-up|1|||
125548388|NCT02986334|451638208|FG001|Overall Study|Lost to Follow-up|2|||
125548389|NCT02986334|451638209|FG002|Overall Study|Lost to Follow-up|1|||
125548390|NCT02986334|451638207|FG000|Overall Study|Adverse Event|0|||
125548391|NCT02986334|451638208|FG001|Overall Study|Adverse Event|2|||
125548392|NCT02986334|451638209|FG002|Overall Study|Adverse Event|1|||
125548393|NCT02986334|451638207|FG000|Overall Study|non compliance in phone ratings|2|||
125548394|NCT02986334|451638208|FG001|Overall Study|non compliance in phone ratings|1|||
125548395|NCT02986334|451638209|FG002|Overall Study|non compliance in phone ratings|2|||
125548396|NCT02986334|451638207|FG000|Overall Study|undisclosed comorbidities|0|||
125548397|NCT02986334|451638208|FG001|Overall Study|undisclosed comorbidities|1|||
125548398|NCT02986334|451638209|FG002|Overall Study|undisclosed comorbidities|1|||
125548399|NCT03864146|451638210|FG000|Overall Study|Lost to Follow-up|14|||
125548400|NCT03864146|451638211|FG001|Overall Study|Lost to Follow-up|23|||
125548401|NCT03864146|451638210|FG000|Overall Study|Withdrawal by Subject|3|||
125349160|NCT02674854|450911913|FG002|Overall Study|Protocol Violation|2|||
125349161|NCT02674854|450911911|FG000|Overall Study|Death|0|||
125349162|NCT02674854|450911912|FG001|Overall Study|Death|1|||
125349163|NCT02674854|450911913|FG002|Overall Study|Death|0|||
125349164|NCT02674854|450911911|FG000|Overall Study|Subject missed V6.2|1|||
125349165|NCT02674854|450911912|FG001|Overall Study|Subject missed V6.2|0|||
125548402|NCT03864146|451638211|FG001|Overall Study|Withdrawal by Subject|2|||
125548403|NCT01313637|451638217|FG000|Overall Study|Adverse Event|17|||
125548404|NCT01313637|451638218|FG001|Overall Study|Adverse Event|24|||
125548405|NCT01313637|451638219|FG002|Overall Study|Adverse Event|25|||
125548406|NCT01313637|451638220|FG003|Overall Study|Adverse Event|18|||
125548407|NCT01313637|451638217|FG000|Overall Study|Lack of Efficacy|44|||
125349166|NCT02674854|450911913|FG002|Overall Study|Subject missed V6.2|0|||
125349167|NCT00913692|450911914|FG000|Screening (4 Months)|Physician Decision|3|||
125349168|NCT00913692|450911914|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
125349169|NCT00913692|450911914|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
125349170|NCT04738318|450911915|FG000|Overall Study|Protocol Violation|1|||
125349171|NCT04738318|450911916|FG001|Overall Study|Protocol Violation|0|||
125548408|NCT01313637|451638218|FG001|Overall Study|Lack of Efficacy|38|||
125548409|NCT01313637|451638219|FG002|Overall Study|Lack of Efficacy|37|||
125548410|NCT01313637|451638220|FG003|Overall Study|Lack of Efficacy|24|||
125548411|NCT01313637|451638217|FG000|Overall Study|Protocol Violation|4|||
125548412|NCT01313637|451638218|FG001|Overall Study|Protocol Violation|3|||
125548413|NCT01313637|451638219|FG002|Overall Study|Protocol Violation|11|||
125349172|NCT01226121|450911917|FG000|Overall Study|Lost to Follow-up|2|||
125548414|NCT01313637|451638220|FG003|Overall Study|Protocol Violation|5|||
125548415|NCT01313637|451638217|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
125548416|NCT01313637|451638218|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
125548417|NCT01313637|451638219|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
125548418|NCT01313637|451638220|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
125548419|NCT01313637|451638217|FG000|Overall Study|Lost to Follow-up|0|||
125548420|NCT01313637|451638218|FG001|Overall Study|Lost to Follow-up|2|||
125548421|NCT01313637|451638219|FG002|Overall Study|Lost to Follow-up|1|||
125548422|NCT01313637|451638220|FG003|Overall Study|Lost to Follow-up|3|||
125548423|NCT01313637|451638217|FG000|Overall Study|Withdrawal by Subject|11|||
125548424|NCT01313637|451638218|FG001|Overall Study|Withdrawal by Subject|13|||
125548425|NCT01313637|451638219|FG002|Overall Study|Withdrawal by Subject|18|||
125548426|NCT01313637|451638220|FG003|Overall Study|Withdrawal by Subject|15|||
125548427|NCT00846391|451638222|FG000|Overall Study|Physician Decision|0|||
125548428|NCT00846391|451638223|FG001|Overall Study|Physician Decision|0|||
125548429|NCT00846391|451638224|FG002|Overall Study|Physician Decision|1|||
125548430|NCT00846391|451638222|FG000|Overall Study|Study Terminated by Sponsor|1|||
125548431|NCT00846391|451638223|FG001|Overall Study|Study Terminated by Sponsor|2|||
125548432|NCT00846391|451638224|FG002|Overall Study|Study Terminated by Sponsor|2|||
125548433|NCT04634825|451638226|FG000|Overall Study|Death|10|||
125548434|NCT04634825|451638227|FG001|Overall Study|Death|3|||
125548435|NCT04634825|451638226|FG000|Overall Study|Lost to Follow-up|1|||
125548436|NCT04634825|451638227|FG001|Overall Study|Lost to Follow-up|0|||
125548437|NCT04634825|451638226|FG000|Overall Study|Study terminated by sponsor|35|||
125548438|NCT04634825|451638227|FG001|Overall Study|Study terminated by sponsor|11|||
125548439|NCT04634825|451638226|FG000|Overall Study|Withdrawal by Subject|2|||
125548440|NCT04634825|451638227|FG001|Overall Study|Withdrawal by Subject|0|||
125548441|NCT05116046|451638235|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125548442|NCT05116046|451638236|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125548443|NCT05116046|451638237|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125548444|NCT05116046|451638235|FG000|Overall Study|Study terminated by sponsor|14|||
125548445|NCT05116046|451638236|FG001|Overall Study|Study terminated by sponsor|16|||
125548446|NCT05116046|451638237|FG002|Overall Study|Study terminated by sponsor|1|||
125548447|NCT01745848|451638243|FG000|Overall Study|Adverse Event|6|||
125548448|NCT00679627|451638244|FG000|Overall Study|Death|41|||
125548449|NCT00679627|451638245|FG001|Overall Study|Death|29|||
125548450|NCT00679627|451638244|FG000|Overall Study|Adverse Event|43|||
125548451|NCT00679627|451638245|FG001|Overall Study|Adverse Event|53|||
125548452|NCT00679627|451638244|FG000|Overall Study|Withdrawal by Subject|168|||
125682070|NCT03032172|452125725|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
125682071|NCT03032172|452125726|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
125682072|NCT03032172|452125719|FG000|Treatment Period|Withdrawal by Subject|2|||
125349173|NCT01226121|450911918|FG001|Overall Study|Lost to Follow-up|0|||
125349174|NCT01226121|450911919|FG002|Overall Study|Lost to Follow-up|1|||
125349175|NCT04231981|450911920|FG000|Overall Study|Adverse Event|1|||
125349176|NCT04231981|450911920|FG000|Overall Study|Death|16|||
125349177|NCT04231981|450911920|FG000|Overall Study|Lost to Follow-up|1|||
125349178|NCT00969280|450911921|FG000|Overall Study|Protocol Violation|2|||
125349179|NCT00969280|450911922|FG001|Overall Study|Protocol Violation|1|||
125682073|NCT03032172|452125720|FG001|Treatment Period|Withdrawal by Subject|0|||
125682074|NCT03032172|452125721|FG002|Treatment Period|Withdrawal by Subject|3|||
125682075|NCT03032172|452125722|FG003|Treatment Period|Withdrawal by Subject|0|||
125682076|NCT03032172|452125723|FG004|Treatment Period|Withdrawal by Subject|0|||
125682077|NCT03032172|452125724|FG005|Treatment Period|Withdrawal by Subject|0|||
125349180|NCT00969280|450911921|FG000|Overall Study|Withdrawal by Subject|0|||
125349181|NCT00969280|450911922|FG001|Overall Study|Withdrawal by Subject|1|||
125349182|NCT00969280|450911921|FG000|Overall Study|infection of influenza A(H1N1)|0|||
125682078|NCT03032172|452125725|FG006|Treatment Period|Withdrawal by Subject|0|||
125682079|NCT03032172|452125726|FG007|Treatment Period|Withdrawal by Subject|0|||
125682080|NCT03032172|452125719|FG000|Open-label Extension Period|Death|0|||
125682081|NCT03032172|452125720|FG001|Open-label Extension Period|Death|0|||
125682082|NCT03032172|452125721|FG002|Open-label Extension Period|Death|0|||
125682083|NCT03032172|452125722|FG003|Open-label Extension Period|Death|0|||
125682084|NCT03032172|452125723|FG004|Open-label Extension Period|Death|0|||
125349183|NCT00969280|450911922|FG001|Overall Study|infection of influenza A(H1N1)|1|||
125548453|NCT00679627|451638245|FG001|Overall Study|Withdrawal by Subject|172|||
125548454|NCT00679627|451638244|FG000|Overall Study|Lost to Follow-up|22|||
125548455|NCT00679627|451638245|FG001|Overall Study|Lost to Follow-up|26|||
125548456|NCT00679627|451638244|FG000|Overall Study|Early Study Closure|425|||
125548457|NCT00679627|451638245|FG001|Overall Study|Early Study Closure|405|||
125548458|NCT01886378|451638246|FG000|Overall Study|Adverse Event|1|||
125548459|NCT01886378|451638246|FG000|Overall Study|Withdrawal by Subject|4|||
125548460|NCT03021954|451638250|FG000|Overall Study|Lost to Follow-up|10|||
125548461|NCT03021954|451638251|FG001|Overall Study|Lost to Follow-up|43|||
125682085|NCT03032172|452125724|FG005|Open-label Extension Period|Death|0|||
125682086|NCT03032172|452125725|FG006|Open-label Extension Period|Death|0|||
125349184|NCT00570232|450911923|FG000|Overall Study|Adverse Event|10|||
125349185|NCT00570232|450911923|FG000|Overall Study|discontinued due to medical condition|3|||
125349186|NCT00570232|450911923|FG000|Overall Study|discontinued due to recurrence|8|||
125349187|NCT00570232|450911923|FG000|Overall Study|discontinued due to noncompliance|2|||
125349188|NCT01037088|450911924|FG000|Overall Study|Withdrawal by Subject|3|||
125349189|NCT02216812|450911925|FG000|Overall Study|Lost to Follow-up|10|||
125349190|NCT02216812|450911926|FG001|Overall Study|Lost to Follow-up|5|||
125349191|NCT01585584|450911927|FG000|Overall Study|Lack of Efficacy|1|||
125349192|NCT01585584|450911927|FG000|Overall Study|Withdrawal by Subject|1|||
125349193|NCT01585584|450911927|FG000|Overall Study|Physician Decision|2|||
125349194|NCT00527488|450911928|FG000|Overall Study|Withdrawn prior to dosing|0|||
125349195|NCT00527488|450911929|FG001|Overall Study|Withdrawn prior to dosing|1|||
125349196|NCT00527488|450911930|FG002|Overall Study|Withdrawn prior to dosing|1|||
125349197|NCT00527488|450911931|FG003|Overall Study|Withdrawn prior to dosing|0|||
125349198|NCT01958827|450911932|FG000|Overall Study|Adverse Event|3|||
125349199|NCT01958827|450911932|FG000|Overall Study|Lack of Efficacy|6|||
125349200|NCT01958827|450911932|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
125349201|NCT00266864|450911933|FG000|Overall Study|Lost to Follow-up|4|||
125349202|NCT00266864|450911934|FG001|Overall Study|Lost to Follow-up|1|||
125349203|NCT00266864|450911933|FG000|Overall Study|Withdrawal by Subject|1|||
125349204|NCT00266864|450911934|FG001|Overall Study|Withdrawal by Subject|1|||
125349205|NCT03036800|450911935|FG000|Overall Study|Protocol Violation|1|||
125349206|NCT03036800|450911936|FG001|Overall Study|Protocol Violation|0|||
125349207|NCT03036800|450911935|FG000|Overall Study|Non-compliance|1|||
125349208|NCT03036800|450911936|FG001|Overall Study|Non-compliance|0|||
125349209|NCT03036800|450911935|FG000|Overall Study|Lost to Follow-up|1|||
125349210|NCT03036800|450911936|FG001|Overall Study|Lost to Follow-up|0|||
125349211|NCT03036800|450911935|FG000|Overall Study|Death|1|||
125349212|NCT03036800|450911936|FG001|Overall Study|Death|0|||
125349213|NCT03036800|450911935|FG000|Overall Study|Tolerance|5|||
125349214|NCT03036800|450911936|FG001|Overall Study|Tolerance|0|||
125349215|NCT03036800|450911935|FG000|Overall Study|Unknown/no reason given|50|||
125349216|NCT03036800|450911936|FG001|Overall Study|Unknown/no reason given|39|||
125349217|NCT01077154|450911937|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
125349218|NCT01077154|450911938|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
125349219|NCT01077154|450911937|FG000|Overall Study|Withdrawal by Subject|369|||
125349220|NCT01077154|450911938|FG001|Overall Study|Withdrawal by Subject|385|||
125349221|NCT01077154|450911937|FG000|Overall Study|Death|215|||
125349222|NCT01077154|450911938|FG001|Overall Study|Death|214|||
125349223|NCT01077154|450911937|FG000|Overall Study|Lost to Follow-up|43|||
125349224|NCT01077154|450911938|FG001|Overall Study|Lost to Follow-up|35|||
125349225|NCT01077154|450911937|FG000|Overall Study|Noncompliance|22|||
125349226|NCT01077154|450911938|FG001|Overall Study|Noncompliance|20|||
125349227|NCT01077154|450911937|FG000|Overall Study|Disease Progression|18|||
125349228|NCT01077154|450911938|FG001|Overall Study|Disease Progression|20|||
125349229|NCT01077154|450911937|FG000|Overall Study|Ineligibility Determined|10|||
125349230|NCT01077154|450911938|FG001|Overall Study|Ineligibility Determined|14|||
125349231|NCT01077154|450911937|FG000|Overall Study|Other|14|||
125349232|NCT01077154|450911938|FG001|Overall Study|Other|11|||
125349233|NCT01077154|450911937|FG000|Overall Study|Adverse Event|9|||
125349234|NCT01077154|450911938|FG001|Overall Study|Adverse Event|9|||
125349235|NCT01077154|450911937|FG000|Overall Study|Administrative Decision|1|||
125349236|NCT01077154|450911938|FG001|Overall Study|Administrative Decision|6|||
125349237|NCT01077154|450911937|FG000|Overall Study|Protocol Deviation|1|||
125349238|NCT01077154|450911938|FG001|Overall Study|Protocol Deviation|0|||
125349239|NCT05985980|450911939|FG000|Overall Study|Withdrawal by Subject|1|||
125349240|NCT05985980|450911939|FG000|Overall Study|Withdrawal by Subject|1|||
125349241|NCT05985980|450911939|FG000|Overall Study|Withdrawal by Subject|1|||
125349242|NCT05985980|450911939|FG000|Overall Study|Withdrawal by Subject|1|||
125349243|NCT02207946|450911940|FG000|Overall Study|Lost to Follow-up|1|||
125349244|NCT02207946|450911941|FG001|Overall Study|Lost to Follow-up|0|||
125349245|NCT02207946|450911940|FG000|Overall Study|Adverse Event|0|||
125349246|NCT02207946|450911941|FG001|Overall Study|Adverse Event|1|||
125349247|NCT00811642|450911942|FG000|Overall Study|Adverse Event|3|||
125349248|NCT00811642|450911942|FG000|Overall Study|Protocol Violation|1|||
125349249|NCT00811642|450911942|FG000|Overall Study|Death|2|||
125349250|NCT00811642|450911942|FG000|Overall Study|Withdrawal by Subject|7|||
125349251|NCT00811642|450911942|FG000|Overall Study|Cumulative use of antifungal agent|2|||
125349252|NCT01163318|450911950|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
125349253|NCT01163318|450911950|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
125349254|NCT01163318|450911950|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
125349255|NCT01163318|450911950|FG000|Overall Study|Participants Without Case Report Form|7|||
125378920|NCT00589914|451019207|FG001|Overall Study|Other|17|||
125548462|NCT03021954|451638250|FG000|Overall Study|Subjects had avulsion trauma|4|||
125548463|NCT03021954|451638251|FG001|Overall Study|Subjects had avulsion trauma|1|||
125548464|NCT00069238|451638252|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
125548465|NCT00069238|451638253|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
125548466|NCT00069238|451638254|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
125548467|NCT00069238|451638252|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
125548468|NCT00069238|451638253|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
125548469|NCT00069238|451638254|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
125548470|NCT00069238|451638252|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
125548471|NCT00069238|451638253|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
125548472|NCT00069238|451638254|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
125548473|NCT01001832|451638255|FG000|Short-term Period|Adverse Event|2|||
125548474|NCT01001832|451638256|FG001|Short-term Period|Adverse Event|3|||
125548475|NCT01001832|451638255|FG000|Long-term Period|Adverse Event|2|||
125682087|NCT03032172|452125726|FG007|Open-label Extension Period|Death|2|||
125682088|NCT03032172|452125719|FG000|Open-label Extension Period|Reason Not Specified|0|||
125682089|NCT03032172|452125720|FG001|Open-label Extension Period|Reason Not Specified|0|||
125682090|NCT03032172|452125721|FG002|Open-label Extension Period|Reason Not Specified|0|||
125682091|NCT03032172|452125722|FG003|Open-label Extension Period|Reason Not Specified|0|||
125682092|NCT03032172|452125723|FG004|Open-label Extension Period|Reason Not Specified|0|||
125682093|NCT03032172|452125724|FG005|Open-label Extension Period|Reason Not Specified|5|||
125682094|NCT03032172|452125725|FG006|Open-label Extension Period|Reason Not Specified|3|||
125682095|NCT03032172|452125726|FG007|Open-label Extension Period|Reason Not Specified|0|||
125682096|NCT03032172|452125719|FG000|Open-label Extension Period|Pregnancy|0|||
125682097|NCT03032172|452125720|FG001|Open-label Extension Period|Pregnancy|0|||
125682098|NCT03032172|452125721|FG002|Open-label Extension Period|Pregnancy|0|||
125682099|NCT03032172|452125722|FG003|Open-label Extension Period|Pregnancy|0|||
125682100|NCT03032172|452125723|FG004|Open-label Extension Period|Pregnancy|0|||
125682101|NCT03032172|452125724|FG005|Open-label Extension Period|Pregnancy|0|||
125682102|NCT03032172|452125725|FG006|Open-label Extension Period|Pregnancy|1|||
125682103|NCT03032172|452125726|FG007|Open-label Extension Period|Pregnancy|0|||
125682104|NCT03032172|452125719|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
125682105|NCT03032172|452125720|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
125682106|NCT03032172|452125721|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
125682107|NCT03032172|452125722|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
125682108|NCT03032172|452125723|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
125682109|NCT03032172|452125724|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
125682110|NCT03032172|452125725|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
125682111|NCT03032172|452125726|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
125682112|NCT04885998|452125728|FG000|Overall Study|Withdrawal by Subject|0|||
125682113|NCT04885998|452125729|FG001|Overall Study|Withdrawal by Subject|2|||
125682114|NCT04885998|452125730|FG002|Overall Study|Withdrawal by Subject|0|||
125682115|NCT04885998|452125731|FG003|Overall Study|Withdrawal by Subject|3|||
125682116|NCT04885998|452125728|FG000|Overall Study|Lost to Follow-up|1|||
125682117|NCT04885998|452125729|FG001|Overall Study|Lost to Follow-up|1|||
125682118|NCT04885998|452125730|FG002|Overall Study|Lost to Follow-up|0|||
125682119|NCT04885998|452125731|FG003|Overall Study|Lost to Follow-up|0|||
125682120|NCT04885998|452125728|FG000|Overall Study|Death|2|||
125682121|NCT04885998|452125729|FG001|Overall Study|Death|1|||
125682122|NCT04885998|452125730|FG002|Overall Study|Death|2|||
125682123|NCT04885998|452125731|FG003|Overall Study|Death|2|||
125682124|NCT04885998|452125728|FG000|Overall Study|Decision by sponsor|1|||
125682125|NCT04885998|452125729|FG001|Overall Study|Decision by sponsor|1|||
125682126|NCT04885998|452125730|FG002|Overall Study|Decision by sponsor|0|||
125682127|NCT04885998|452125731|FG003|Overall Study|Decision by sponsor|0|||
125682128|NCT04751929|452125741|FG000|Overall Study|Withdrawal by Subject|2|||
125682129|NCT04751929|452125742|FG001|Overall Study|Withdrawal by Subject|0|||
125682130|NCT04751929|452125743|FG002|Overall Study|Withdrawal by Subject|0|||
125682131|NCT04751929|452125744|FG003|Overall Study|Withdrawal by Subject|0|||
125682132|NCT04751929|452125741|FG000|Overall Study|Rising PSA|0|||
125682133|NCT04751929|452125742|FG001|Overall Study|Rising PSA|1|||
125682134|NCT04751929|452125743|FG002|Overall Study|Rising PSA|0|||
125682135|NCT04751929|452125744|FG003|Overall Study|Rising PSA|0|||
125682136|NCT04751929|452125741|FG000|Overall Study|Adverse Event|1|||
125217427|NCT01348100|450423521|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125548476|NCT01001832|451638256|FG001|Long-term Period|Adverse Event|1|||
125548477|NCT01001832|451638255|FG000|Long-term Period|Withdrawal by Subject|1|||
125548478|NCT01001832|451638256|FG001|Long-term Period|Withdrawal by Subject|0|||
125682137|NCT04751929|452125742|FG001|Overall Study|Adverse Event|2|||
125682138|NCT04751929|452125743|FG002|Overall Study|Adverse Event|0|||
125682139|NCT04751929|452125744|FG003|Overall Study|Adverse Event|0|||
125682140|NCT04751929|452125741|FG000|Overall Study|Progressive Disease|3|||
125682141|NCT04751929|452125742|FG001|Overall Study|Progressive Disease|4|||
125682142|NCT04751929|452125743|FG002|Overall Study|Progressive Disease|4|||
125682143|NCT04751929|452125744|FG003|Overall Study|Progressive Disease|0|||
125682144|NCT04751929|452125741|FG000|Overall Study|Death|1|||
125548479|NCT01001832|451638255|FG000|Long-term Period|Lack of Efficacy|0|||
125548480|NCT01001832|451638256|FG001|Long-term Period|Lack of Efficacy|2|||
125548481|NCT01001832|451638255|FG000|Long-term Period|Other|1|||
125548482|NCT01001832|451638256|FG001|Long-term Period|Other|2|||
125548483|NCT01001832|451638255|FG000|Follow-up Period|Withdrawal by Subject|1|||
125548484|NCT01001832|451638256|FG001|Follow-up Period|Withdrawal by Subject|0|||
125548485|NCT01001832|451638255|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
125548486|NCT01001832|451638256|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
125548487|NCT01001832|451638255|FG000|Follow-up Period|Other|2|||
125548488|NCT01001832|451638256|FG001|Follow-up Period|Other|1|||
125548489|NCT00807235|451638263|FG000|Overall Study|Adverse Event|1|||
125548490|NCT00807235|451638264|FG001|Overall Study|Adverse Event|0|||
125548491|NCT01765179|451638265|FG000|Overall Study|Adverse Event|3|||
125548492|NCT01765179|451638265|FG000|Overall Study|Lost to Follow-up|5|||
125548493|NCT01765179|451638265|FG000|Overall Study|Non-compliance with study drug|2|||
125548494|NCT01765179|451638265|FG000|Overall Study|Protocol Violation|1|||
125548495|NCT01765179|451638265|FG000|Overall Study|Withdrawal by Subject|8|||
125548496|NCT01765179|451638265|FG000|Overall Study|Hematocrit >54%|3|||
125548497|NCT01765179|451638265|FG000|Overall Study|prohibited med|1|||
125548498|NCT01765179|451638265|FG000|Overall Study|Out of country unable to finish study|1|||
125548499|NCT01765179|451638265|FG000|Overall Study|lack of venous access|1|||
125548500|NCT01765179|451638265|FG000|Overall Study|work conflict|1|||
125548501|NCT01765179|451638265|FG000|Overall Study|Ca elevated 10.6|1|||
125548502|NCT01536015|451638266|FG000|Overall Study|Adverse Event|1|||
125548503|NCT01536015|451638267|FG001|Overall Study|Adverse Event|4|||
125548504|NCT01536015|451638266|FG000|Overall Study|Lost to Follow-up|0|||
125548505|NCT01536015|451638267|FG001|Overall Study|Lost to Follow-up|1|||
125548506|NCT01536015|451638266|FG000|Overall Study|Inclusion Criterion not met|2|||
125548507|NCT01536015|451638267|FG001|Overall Study|Inclusion Criterion not met|0|||
125548508|NCT01536015|451638266|FG000|Overall Study|Study closure|5|||
125548509|NCT01536015|451638267|FG001|Overall Study|Study closure|5|||
125548510|NCT03581825|451638269|FG000|Period 1|Lens Discomfort|1|||
125548511|NCT03581825|451638270|FG001|Period 1|Lens Discomfort|0|||
125548512|NCT03581825|451638269|FG000|Period 2|Unsatisfactory Vision to Test|0|||
125548513|NCT03581825|451638270|FG001|Period 2|Unsatisfactory Vision to Test|1|||
125548514|NCT01668667|451638271|FG000|Overall Study|Adverse Event|3|||
125548515|NCT01668667|451638272|FG001|Overall Study|Adverse Event|6|||
125548516|NCT01668667|451638273|FG002|Overall Study|Adverse Event|4|||
125548517|NCT01668667|451638274|FG003|Overall Study|Adverse Event|4|||
125548518|NCT01668667|451638271|FG000|Overall Study|Lack of Efficacy|3|||
125548519|NCT01668667|451638272|FG001|Overall Study|Lack of Efficacy|2|||
125548520|NCT01668667|451638273|FG002|Overall Study|Lack of Efficacy|2|||
125548521|NCT01668667|451638274|FG003|Overall Study|Lack of Efficacy|3|||
125548522|NCT01668667|451638271|FG000|Overall Study|Protocol Violation|6|||
125548523|NCT01668667|451638272|FG001|Overall Study|Protocol Violation|10|||
125548524|NCT01668667|451638273|FG002|Overall Study|Protocol Violation|12|||
125349256|NCT01163318|450911950|FG000|Overall Study|Multiple Reasons Per Participant|224|||
125548525|NCT01668667|451638274|FG003|Overall Study|Protocol Violation|5|||
125548526|NCT01668667|451638271|FG000|Overall Study|Lost to Follow-up|9|||
125548527|NCT01668667|451638272|FG001|Overall Study|Lost to Follow-up|4|||
125548528|NCT01668667|451638273|FG002|Overall Study|Lost to Follow-up|7|||
125548529|NCT01668667|451638274|FG003|Overall Study|Lost to Follow-up|6|||
125548530|NCT01668667|451638271|FG000|Overall Study|Physician Decision|3|||
125548531|NCT01668667|451638272|FG001|Overall Study|Physician Decision|0|||
125548532|NCT01668667|451638273|FG002|Overall Study|Physician Decision|1|||
125548533|NCT01668667|451638274|FG003|Overall Study|Physician Decision|0|||
125548534|NCT01668667|451638271|FG000|Overall Study|Withdrawal by Subject|7|||
125548535|NCT01668667|451638272|FG001|Overall Study|Withdrawal by Subject|4|||
125548536|NCT01668667|451638273|FG002|Overall Study|Withdrawal by Subject|5|||
125548537|NCT01668667|451638274|FG003|Overall Study|Withdrawal by Subject|5|||
125548538|NCT00511901|451638275|FG000|Overall Study|Withdrawal by Subject|1|||
125548539|NCT00511901|451638276|FG001|Overall Study|Withdrawal by Subject|3|||
125548540|NCT00178126|451638277|FG000|Overall Study|Lost to Follow-up|21|||
125548541|NCT00178126|451638278|FG001|Overall Study|Lost to Follow-up|21|||
125548542|NCT00178126|451638277|FG000|Overall Study|did not receive intervention|4|||
125548543|NCT00178126|451638278|FG001|Overall Study|did not receive intervention|6|||
125548544|NCT02447172|451638279|FG000|Overall Study|Adverse Event|11|||
125548545|NCT02447172|451638280|FG001|Overall Study|Adverse Event|8|||
125548546|NCT02447172|451638281|FG002|Overall Study|Adverse Event|7|||
125548547|NCT02447172|451638279|FG000|Overall Study|Death|3|||
125548548|NCT02447172|451638280|FG001|Overall Study|Death|1|||
125548549|NCT02447172|451638281|FG002|Overall Study|Death|0|||
125548550|NCT02447172|451638279|FG000|Overall Study|Protocol Violation|2|||
125548551|NCT02447172|451638280|FG001|Overall Study|Protocol Violation|1|||
125548552|NCT02447172|451638281|FG002|Overall Study|Protocol Violation|2|||
125548553|NCT02447172|451638279|FG000|Overall Study|Lost to Follow-up|7|||
125548554|NCT02447172|451638280|FG001|Overall Study|Lost to Follow-up|4|||
125349257|NCT01006603|450911952|FG000|Overall Study|Withdrawal by Subject|17|||
125349258|NCT01006603|450911953|FG001|Overall Study|Withdrawal by Subject|19|||
125349259|NCT01006603|450911952|FG000|Overall Study|Lost to Follow-up|0|||
125548555|NCT02447172|451638281|FG002|Overall Study|Lost to Follow-up|4|||
125548556|NCT02447172|451638279|FG000|Overall Study|Withdrawal by Subject|5|||
125548557|NCT02447172|451638280|FG001|Overall Study|Withdrawal by Subject|1|||
125548558|NCT02447172|451638281|FG002|Overall Study|Withdrawal by Subject|3|||
125548559|NCT02447172|451638279|FG000|Overall Study|protocol specific treatment unrelated|3|||
125682145|NCT04751929|452125742|FG001|Overall Study|Death|1|||
125682146|NCT04751929|452125743|FG002|Overall Study|Death|0|||
125682147|NCT04751929|452125744|FG003|Overall Study|Death|0|||
125682148|NCT04154943|452125746|FG000|Overall Study|Study Ongoing|68|||
125682149|NCT04154943|452125746|FG000|Overall Study|Lost to Follow-up|1|||
125682150|NCT04154943|452125746|FG000|Overall Study|Decision by the Investigator|1|||
125682151|NCT04154943|452125746|FG000|Overall Study|Death|5|||
125682152|NCT04154943|452125746|FG000|Overall Study|Withdrawal by Subject|4|||
125682153|NCT02869867|452125747|FG000|Overall Study|Protocol Violation|1|||
125682154|NCT02869867|452125748|FG001|Overall Study|Protocol Violation|0|||
125682155|NCT02869867|452125747|FG000|Overall Study|Lost to Follow-up|5|||
125682156|NCT02869867|452125748|FG001|Overall Study|Lost to Follow-up|5|||
125682157|NCT06284525|452125752|FG000|Overall Study|Withdrawal by Subject|1|||
125682158|NCT02362035|452125753|FG000|Overall Study|Death|67|||
125682159|NCT02362035|452125753|FG000|Overall Study|Lost to Follow-up|3|||
125682160|NCT02362035|452125753|FG000|Overall Study|Adverse Event|1|||
125682161|NCT02362035|452125753|FG000|Overall Study|Physician Decision|1|||
125682162|NCT02362035|452125753|FG000|Overall Study|Subject started another cancer therapy|10|||
125682163|NCT02362035|452125753|FG000|Overall Study|Study terminated by sponsor|45|||
125682164|NCT02362035|452125753|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
125682165|NCT02362035|452125753|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
125682166|NCT02362035|452125753|FG000|Overall Study|Disease progression|11|||
125682167|NCT02362035|452125753|FG000|Overall Study|Withdrawal by Subject|20|||
125682168|NCT02069366|452125754|FG000|Overall Study|Lost to Follow-up|0|||
125682169|NCT02069366|452125755|FG001|Overall Study|Lost to Follow-up|0|||
125682170|NCT02069366|452125756|FG002|Overall Study|Lost to Follow-up|1|||
125682171|NCT02069366|452125757|FG003|Overall Study|Lost to Follow-up|0|||
125682172|NCT02069366|452125758|FG004|Overall Study|Lost to Follow-up|0|||
125682173|NCT02069366|452125759|FG005|Overall Study|Lost to Follow-up|2|||
125682174|NCT02069366|452125754|FG000|Overall Study|Protocol Violation|0|||
125682175|NCT02069366|452125755|FG001|Overall Study|Protocol Violation|0|||
125682176|NCT02069366|452125756|FG002|Overall Study|Protocol Violation|1|||
125682177|NCT02069366|452125757|FG003|Overall Study|Protocol Violation|0|||
125682178|NCT02069366|452125758|FG004|Overall Study|Protocol Violation|0|||
125682179|NCT02069366|452125759|FG005|Overall Study|Protocol Violation|0|||
125349260|NCT01006603|450911953|FG001|Overall Study|Lost to Follow-up|1|||
125349261|NCT01006603|450911952|FG000|Overall Study|Safety reason|1|||
125349262|NCT01006603|450911953|FG001|Overall Study|Safety reason|1|||
125349263|NCT01006603|450911952|FG000|Overall Study|Protocol Violation|1|||
125349264|NCT01006603|450911953|FG001|Overall Study|Protocol Violation|3|||
125349265|NCT01006603|450911952|FG000|Overall Study|Incorrect enrolment|0|||
125349266|NCT01006603|450911953|FG001|Overall Study|Incorrect enrolment|2|||
125349267|NCT01006603|450911952|FG000|Overall Study|Adverse Event|15|||
125349268|NCT01006603|450911953|FG001|Overall Study|Adverse Event|7|||
125349269|NCT01006603|450911952|FG000|Overall Study|Death|1|||
125349270|NCT01006603|450911953|FG001|Overall Study|Death|1|||
125349271|NCT01006603|450911952|FG000|Overall Study|Study specific discontinuation criteria|33|||
125349272|NCT01006603|450911953|FG001|Overall Study|Study specific discontinuation criteria|34|||
125349273|NCT01006603|450911952|FG000|Overall Study|Other|3|||
125349274|NCT01006603|450911953|FG001|Overall Study|Other|7|||
125349275|NCT00706849|450913423|FG000|Treatment Period|Adverse Event|0|||
125349276|NCT00706849|450913424|FG001|Treatment Period|Adverse Event|9|||
125349277|NCT00706849|450913423|FG000|Treatment Period|Other|0|||
125349278|NCT00706849|450913424|FG001|Treatment Period|Other|1|||
125349279|NCT00706849|450913423|FG000|Follow-up Period|Withdrawal by Subject|0|||
125349280|NCT00706849|450913424|FG001|Follow-up Period|Withdrawal by Subject|2|||
125349281|NCT00706849|450913423|FG000|Follow-up Period|Protocol non-compliance|0|||
125349282|NCT00706849|450913424|FG001|Follow-up Period|Protocol non-compliance|1|||
125349283|NCT01611454|450913425|FG000|Overall Study|Lack of Efficacy|18|||
125349284|NCT01611454|450913426|FG001|Overall Study|Lack of Efficacy|10|||
125349285|NCT03269552|450913428|FG000|Overall Study|Adverse Event|2|||
125349286|NCT00920907|450913429|FG000|Induction Period|Adverse Event|0|||
125349287|NCT00920907|450913430|FG001|Induction Period|Adverse Event|2|||
125349288|NCT00920907|450913429|FG000|Induction Period|Death|1|||
125349289|NCT00920907|450913430|FG001|Induction Period|Death|1|||
125349290|NCT00920907|450913429|FG000|Induction Period|Disease Progression|12|||
125349291|NCT00920907|450913430|FG001|Induction Period|Disease Progression|11|||
125349292|NCT00920907|450913429|FG000|Induction Period|Study Drug Toxicity|8|||
125349293|NCT00920907|450913430|FG001|Induction Period|Study Drug Toxicity|6|||
125349294|NCT00920907|450913429|FG000|Induction Period|No longer meets study criteria|0|||
125349295|NCT00920907|450913430|FG001|Induction Period|No longer meets study criteria|1|||
125349296|NCT00920907|450913429|FG000|Induction Period|Withdrawal by Subject|1|||
125349297|NCT00920907|450913430|FG001|Induction Period|Withdrawal by Subject|1|||
125349298|NCT00920907|450913429|FG000|Maintenance Period|Disease Progression|3|||
125349299|NCT00920907|450913430|FG001|Maintenance Period|Disease Progression|7|||
125349300|NCT00920907|450913429|FG000|Maintenance Period|Administrative (study closure)|7|||
125349301|NCT00920907|450913430|FG001|Maintenance Period|Administrative (study closure)|2|||
125349302|NCT00920907|450913429|FG000|Maintenance Period|Study Drug Toxicity|0|||
125349303|NCT00920907|450913430|FG001|Maintenance Period|Study Drug Toxicity|2|||
125349304|NCT00920907|450913429|FG000|Maintenance Period|Death|1|||
125349305|NCT00920907|450913430|FG001|Maintenance Period|Death|1|||
125349306|NCT00920907|450913429|FG000|Maintenance Period|Withdrawal by Subject|1|||
125349307|NCT00920907|450913430|FG001|Maintenance Period|Withdrawal by Subject|0|||
125349308|NCT00920907|450913429|FG000|Maintenance Period|Adverse Event|0|||
125349309|NCT00920907|450913430|FG001|Maintenance Period|Adverse Event|1|||
125349310|NCT02616601|450913431|FG000|Overall Study|Withdrawal by Subject|4|||
125349311|NCT02616601|450913432|FG001|Overall Study|Withdrawal by Subject|4|||
125349312|NCT02616601|450913433|FG002|Overall Study|Withdrawal by Subject|3|||
125349313|NCT02616601|450913431|FG000|Overall Study|Adverse Event|2|||
125349314|NCT02616601|450913432|FG001|Overall Study|Adverse Event|0|||
125349315|NCT02616601|450913433|FG002|Overall Study|Adverse Event|2|||
125349316|NCT02616601|450913431|FG000|Overall Study|Death|1|||
125349317|NCT02616601|450913432|FG001|Overall Study|Death|0|||
125349318|NCT02616601|450913433|FG002|Overall Study|Death|0|||
125548560|NCT02447172|451638280|FG001|Overall Study|protocol specific treatment unrelated|0|||
125548561|NCT02447172|451638281|FG002|Overall Study|protocol specific treatment unrelated|2|||
125548562|NCT00427895|451638284|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
125548563|NCT00427895|451638285|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
125548564|NCT00427895|451638286|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
125548565|NCT00427895|451638287|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
125548566|NCT00427895|451638288|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
125548567|NCT00427895|451638289|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
125548568|NCT00427895|451638290|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
125548569|NCT00427895|451638291|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
125548570|NCT00427895|451638284|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
125548571|NCT00427895|451638285|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
125548572|NCT00427895|451638286|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
125349319|NCT02616601|450913431|FG000|Overall Study|Lost to Follow-up|1|||
125548573|NCT00427895|451638287|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
125548574|NCT00427895|451638288|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
125548575|NCT00427895|451638289|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
125548576|NCT00427895|451638290|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
125548577|NCT00427895|451638291|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
125682180|NCT02069366|452125754|FG000|Overall Study|Withdrawal by Subject|1|||
125682181|NCT02069366|452125755|FG001|Overall Study|Withdrawal by Subject|0|||
125682182|NCT02069366|452125756|FG002|Overall Study|Withdrawal by Subject|1|||
125548578|NCT00427895|451638284|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
125548579|NCT00427895|451638285|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
125548580|NCT00427895|451638286|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
125548581|NCT00427895|451638287|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
125548582|NCT00427895|451638288|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
125682183|NCT02069366|452125757|FG003|Overall Study|Withdrawal by Subject|2|||
125682184|NCT02069366|452125758|FG004|Overall Study|Withdrawal by Subject|0|||
125682185|NCT02069366|452125759|FG005|Overall Study|Withdrawal by Subject|0|||
125682186|NCT04250194|452125762|FG000|Overall Study|Declined to schedule biopsy|6|||
125682187|NCT04250194|452125763|FG001|Overall Study|Declined to schedule biopsy|10|||
125682188|NCT04250194|452125762|FG000|Overall Study|Medically Unfit for Biopsy|2|||
125682189|NCT04250194|452125763|FG001|Overall Study|Medically Unfit for Biopsy|1|||
125682190|NCT04250194|452125762|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
125682191|NCT04250194|452125763|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
125682192|NCT04250194|452125762|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
125682193|NCT04250194|452125763|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
125682194|NCT04250194|452125762|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
125682195|NCT04250194|452125763|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
125682196|NCT04516967|452125764|FG000|Core Phase|Adverse Event|2|||
125682197|NCT04516967|452125765|FG001|Core Phase|Adverse Event|1|||
125548583|NCT00427895|451638289|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
125548584|NCT00427895|451638290|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
125548585|NCT00427895|451638291|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
125548586|NCT00427895|451638284|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
125548587|NCT00427895|451638285|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
125548588|NCT00427895|451638286|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
125548589|NCT00427895|451638287|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
125548590|NCT00427895|451638288|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
125548591|NCT00427895|451638289|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
125548592|NCT00427895|451638290|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
125548593|NCT00427895|451638291|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
125548594|NCT00427895|451638284|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
125548595|NCT00427895|451638285|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
125548596|NCT00427895|451638286|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
125548597|NCT00427895|451638287|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
125548598|NCT00427895|451638288|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
125548599|NCT00427895|451638289|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
125548600|NCT00427895|451638290|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
125548601|NCT00427895|451638291|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
125548602|NCT00427895|451638284|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
125548603|NCT00427895|451638285|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
125548604|NCT00427895|451638286|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
125548605|NCT00427895|451638287|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
125548606|NCT00427895|451638288|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
125548607|NCT00427895|451638289|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
125548608|NCT00427895|451638290|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
125548609|NCT00427895|451638291|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
125548610|NCT00427895|451638284|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
125548611|NCT00427895|451638285|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
125548612|NCT00427895|451638286|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
125548613|NCT00427895|451638287|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
125548614|NCT00427895|451638288|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
125548615|NCT00427895|451638289|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
125548616|NCT00427895|451638290|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
125548617|NCT00427895|451638291|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
125548618|NCT00427895|451638284|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
125548619|NCT00427895|451638285|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
125548620|NCT00427895|451638286|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
125548621|NCT00427895|451638287|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
125548622|NCT00427895|451638288|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
125548623|NCT00427895|451638289|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
125548624|NCT00427895|451638290|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
125548625|NCT00427895|451638291|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
125548626|NCT00427895|451638284|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
125548627|NCT00427895|451638285|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
125548628|NCT00427895|451638286|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
125548629|NCT00427895|451638287|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
125548630|NCT00427895|451638288|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
125349320|NCT02616601|450913432|FG001|Overall Study|Lost to Follow-up|0|||
125349321|NCT02616601|450913433|FG002|Overall Study|Lost to Follow-up|1|||
125349322|NCT02616601|450913431|FG000|Overall Study|Non-Compliance with Test Article|1|||
125349323|NCT02616601|450913432|FG001|Overall Study|Non-Compliance with Test Article|0|||
125349324|NCT02616601|450913433|FG002|Overall Study|Non-Compliance with Test Article|1|||
125349325|NCT04389970|450913435|FG000|Overall Study|Lost to Follow-up|1|||
125349326|NCT04179890|450913436|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
125548631|NCT00427895|451638289|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
125548632|NCT00427895|451638290|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
125349327|NCT04179890|450913437|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
125378921|NCT00531050|451019208|FG000|Part 1: Period 1|Adverse Event|0|||
125349328|NCT04179890|450913436|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
125349329|NCT04179890|450913437|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
125349330|NCT04179890|450913436|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
125349331|NCT04179890|450913437|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
125349332|NCT04179890|450913436|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
125349333|NCT04179890|450913437|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
125349334|NCT04179890|450913436|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
125349335|NCT04179890|450913437|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
125349336|NCT04179890|450913436|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
125349337|NCT04179890|450913437|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
125349338|NCT04179890|450913436|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
125349339|NCT04179890|450913437|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
125349340|NCT04179890|450913436|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
125349341|NCT04179890|450913437|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
125349342|NCT04179890|450913436|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
125349343|NCT04179890|450913437|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
125349344|NCT02579928|450913438|FG000|Overall Study|Withdrawal by Subject|1|||
125349345|NCT02579928|450913439|FG001|Overall Study|Withdrawal by Subject|0|||
125349346|NCT03754972|450913442|FG000|Overall Study|Protocol Violation|25|||
125349347|NCT03422627|450913443|FG000|Overall Study|Protocol-specified Criteria|1|||
125349348|NCT03422627|450913444|FG001|Overall Study|Protocol-specified Criteria|1|||
125349349|NCT03422627|450913445|FG002|Overall Study|Protocol-specified Criteria|0|||
125349350|NCT03422627|450913446|FG003|Overall Study|Protocol-specified Criteria|0|||
125349351|NCT03422627|450913447|FG004|Overall Study|Protocol-specified Criteria|2|||
125349352|NCT03422627|450913443|FG000|Overall Study|Requirement for Alternative Therapy|1|||
125349353|NCT03422627|450913444|FG001|Overall Study|Requirement for Alternative Therapy|1|||
125349354|NCT03422627|450913445|FG002|Overall Study|Requirement for Alternative Therapy|2|||
125349355|NCT03422627|450913446|FG003|Overall Study|Requirement for Alternative Therapy|0|||
125349356|NCT03422627|450913447|FG004|Overall Study|Requirement for Alternative Therapy|0|||
125349357|NCT03422627|450913443|FG000|Overall Study|Disease Progression|1|||
125349358|NCT03422627|450913444|FG001|Overall Study|Disease Progression|0|||
125349359|NCT03422627|450913445|FG002|Overall Study|Disease Progression|1|||
125349360|NCT03422627|450913446|FG003|Overall Study|Disease Progression|2|||
125349361|NCT03422627|450913447|FG004|Overall Study|Disease Progression|0|||
125349362|NCT03422627|450913443|FG000|Overall Study|Adverse Event|2|||
125349363|NCT03422627|450913444|FG001|Overall Study|Adverse Event|1|||
125349364|NCT03422627|450913445|FG002|Overall Study|Adverse Event|0|||
125349365|NCT03422627|450913446|FG003|Overall Study|Adverse Event|0|||
125349366|NCT03422627|450913447|FG004|Overall Study|Adverse Event|2|||
125349367|NCT03422627|450913443|FG000|Overall Study|Ineligibility Determined|0|||
125349368|NCT03422627|450913444|FG001|Overall Study|Ineligibility Determined|1|||
125349369|NCT03422627|450913445|FG002|Overall Study|Ineligibility Determined|0|||
125349370|NCT03422627|450913446|FG003|Overall Study|Ineligibility Determined|0|||
125349371|NCT03422627|450913447|FG004|Overall Study|Ineligibility Determined|0|||
125349372|NCT03422627|450913443|FG000|Overall Study|Death|0|||
125349373|NCT03422627|450913444|FG001|Overall Study|Death|1|||
125349374|NCT03422627|450913445|FG002|Overall Study|Death|1|||
125349375|NCT03422627|450913446|FG003|Overall Study|Death|0|||
125349376|NCT03422627|450913447|FG004|Overall Study|Death|0|||
125349377|NCT03422627|450913443|FG000|Overall Study|Withdrawal by Subject|0|||
125349378|NCT03422627|450913444|FG001|Overall Study|Withdrawal by Subject|0|||
125349379|NCT03422627|450913445|FG002|Overall Study|Withdrawal by Subject|0|||
125349380|NCT03422627|450913446|FG003|Overall Study|Withdrawal by Subject|1|||
125349381|NCT03422627|450913447|FG004|Overall Study|Withdrawal by Subject|0|||
125349382|NCT00934648|450913450|FG000|Overall Study|Failure to return|8|||
125349383|NCT00934648|450913450|FG000|Overall Study|Withdrawal by Subject|1|||
125548633|NCT00427895|451638291|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
125548634|NCT00427895|451638284|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
125548635|NCT00427895|451638285|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
125548636|NCT00427895|451638286|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
125548637|NCT00427895|451638287|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
125548638|NCT00427895|451638288|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
125548639|NCT00427895|451638289|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
125548640|NCT00427895|451638290|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
125548641|NCT00427895|451638291|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
125548642|NCT00427895|451638284|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
125548643|NCT00427895|451638285|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
125548644|NCT00427895|451638286|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
125548645|NCT00427895|451638287|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
125548646|NCT00427895|451638288|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
125548647|NCT00427895|451638289|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
125548648|NCT00427895|451638290|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
125548649|NCT00427895|451638291|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
125548650|NCT00427895|451638284|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
125548651|NCT00427895|451638285|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
125548652|NCT00427895|451638286|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
125548653|NCT00427895|451638287|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
125548654|NCT00427895|451638288|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
125548655|NCT00427895|451638289|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
125548656|NCT00427895|451638290|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
125548657|NCT00427895|451638291|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
125548658|NCT00427895|451638284|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
125548659|NCT00427895|451638285|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
125548660|NCT00427895|451638286|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
125548661|NCT00427895|451638287|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
125548662|NCT00427895|451638288|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
125548663|NCT00427895|451638289|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
125548664|NCT00427895|451638290|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
125548665|NCT00427895|451638291|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
125548666|NCT00427895|451638284|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
125548667|NCT00427895|451638285|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
125548668|NCT00427895|451638286|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
125548669|NCT00427895|451638287|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
125548670|NCT00427895|451638288|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
125548671|NCT00427895|451638289|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
125548672|NCT00427895|451638290|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
125548673|NCT00427895|451638291|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
125548674|NCT00427895|451638284|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
125548675|NCT00427895|451638285|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
125548676|NCT00427895|451638286|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
125548677|NCT00427895|451638287|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
125548678|NCT00427895|451638288|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
125548679|NCT00427895|451638289|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
125548680|NCT00427895|451638290|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
125548681|NCT00427895|451638291|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
125548682|NCT00427895|451638284|FG000|Vax 1/Year 1 Follow-up|Death|1|||
125548683|NCT00427895|451638285|FG001|Vax 1/Year 1 Follow-up|Death|0|||
125548684|NCT00427895|451638286|FG002|Vax 1/Year 1 Follow-up|Death|0|||
125548685|NCT00427895|451638287|FG003|Vax 1/Year 1 Follow-up|Death|0|||
125548686|NCT00427895|451638288|FG004|Vax 1/Year 1 Follow-up|Death|0|||
125548687|NCT00427895|451638289|FG005|Vax 1/Year 1 Follow-up|Death|0|||
125548688|NCT00427895|451638290|FG006|Vax 1/Year 1 Follow-up|Death|0|||
125548689|NCT00427895|451638291|FG007|Vax 1/Year 1 Follow-up|Death|0|||
125548690|NCT00427895|451638284|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
125548691|NCT00427895|451638285|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
125548692|NCT00427895|451638286|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
125548693|NCT00427895|451638287|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
125548694|NCT00427895|451638288|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
125548695|NCT00427895|451638289|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
125548696|NCT00427895|451638290|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
125548697|NCT00427895|451638291|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
125548698|NCT00427895|451638284|FG000|Vax 1/Year 1 Follow-up|Other|0|||
125548699|NCT00427895|451638285|FG001|Vax 1/Year 1 Follow-up|Other|0|||
125548700|NCT00427895|451638286|FG002|Vax 1/Year 1 Follow-up|Other|0|||
125548701|NCT00427895|451638287|FG003|Vax 1/Year 1 Follow-up|Other|2|||
125548702|NCT00427895|451638288|FG004|Vax 1/Year 1 Follow-up|Other|0|||
125548703|NCT00427895|451638289|FG005|Vax 1/Year 1 Follow-up|Other|0|||
125548704|NCT00427895|451638290|FG006|Vax 1/Year 1 Follow-up|Other|0|||
125682198|NCT04516967|452125766|FG002|Core Phase|Adverse Event|0|||
125682199|NCT04516967|452125764|FG000|Core Phase|Physician Decision|1|||
125349384|NCT01993836|450913451|FG000|Overall Study|Surgery Cancelled|3|||
125349385|NCT01993836|450913452|FG001|Overall Study|Surgery Cancelled|0|||
125349386|NCT01993836|450913453|FG002|Overall Study|Surgery Cancelled|0|||
125349387|NCT01993836|450913451|FG000|Overall Study|Physician Decision|2|||
125349388|NCT01993836|450913452|FG001|Overall Study|Physician Decision|1|||
125349389|NCT01993836|450913453|FG002|Overall Study|Physician Decision|0|||
125349390|NCT01993836|450913451|FG000|Overall Study|Death|0|||
125349391|NCT01993836|450913452|FG001|Overall Study|Death|2|||
125349392|NCT01993836|450913453|FG002|Overall Study|Death|0|||
125349393|NCT01993836|450913451|FG000|Overall Study|Withdrawal by Subject|12|||
125349394|NCT01993836|450913452|FG001|Overall Study|Withdrawal by Subject|10|||
125349395|NCT01993836|450913453|FG002|Overall Study|Withdrawal by Subject|5|||
125349396|NCT02195687|450913455|FG000|Overall Study|Personal Reasons|1|||
125349397|NCT02195687|450913456|FG001|Overall Study|Personal Reasons|1|||
125349398|NCT02195687|450913455|FG000|Overall Study|Lost to Follow-up|4|||
125349399|NCT02195687|450913456|FG001|Overall Study|Lost to Follow-up|1|||
125349400|NCT04369924|450913457|FG000|Overall Study|Lost to Follow-up|302|||
125349401|NCT04369924|450913458|FG001|Overall Study|Lost to Follow-up|339|||
125349402|NCT00708201|450913459|FG000|Overall Study|Adverse Event|4|||
125349403|NCT00708201|450913460|FG001|Overall Study|Adverse Event|4|||
125349404|NCT00708201|450913459|FG000|Overall Study|Withdrawal by Subject|1|||
125349405|NCT00708201|450913460|FG001|Overall Study|Withdrawal by Subject|1|||
125349406|NCT00708201|450913459|FG000|Overall Study|Lost to Follow-up|2|||
125349407|NCT00708201|450913460|FG001|Overall Study|Lost to Follow-up|0|||
125349408|NCT00708201|450913459|FG000|Overall Study|Protocol Violation|0|||
125349409|NCT00708201|450913460|FG001|Overall Study|Protocol Violation|1|||
125349410|NCT00282464|450913461|FG000|Overall Study|Adverse Event|26|||
125349411|NCT00282464|450913462|FG001|Overall Study|Adverse Event|20|||
125349412|NCT00282464|450913461|FG000|Overall Study|Lack of Efficacy|8|||
125349413|NCT00282464|450913462|FG001|Overall Study|Lack of Efficacy|8|||
125349414|NCT00282464|450913461|FG000|Overall Study|Lost to Follow-up|10|||
125349415|NCT00282464|450913462|FG001|Overall Study|Lost to Follow-up|10|||
125349416|NCT00282464|450913461|FG000|Overall Study|Withdrawal by Subject|24|||
125349417|NCT00282464|450913462|FG001|Overall Study|Withdrawal by Subject|10|||
125349418|NCT00282464|450913461|FG000|Overall Study|laboratory abnormality|1|||
125349419|NCT00282464|450913462|FG001|Overall Study|laboratory abnormality|2|||
125349420|NCT00282464|450913461|FG000|Overall Study|Protocol Violation|0|||
125349421|NCT00282464|450913462|FG001|Overall Study|Protocol Violation|7|||
125349422|NCT00282464|450913461|FG000|Overall Study|Patient moved|1|||
125349423|NCT00282464|450913462|FG001|Overall Study|Patient moved|0|||
125349424|NCT00282464|450913461|FG000|Overall Study|patient non-compliant|3|||
125349425|NCT00282464|450913462|FG001|Overall Study|patient non-compliant|0|||
125349426|NCT00282464|450913461|FG000|Overall Study|patient no show|0|||
125349427|NCT00282464|450913462|FG001|Overall Study|patient no show|1|||
125349428|NCT00282464|450913461|FG000|Overall Study|patient incarcerated|0|||
125349429|NCT00282464|450913462|FG001|Overall Study|patient incarcerated|1|||
125349430|NCT00282464|450913461|FG000|Overall Study|family crisis|0|||
125349431|NCT00282464|450913462|FG001|Overall Study|family crisis|1|||
125349432|NCT00282464|450913461|FG000|Overall Study|dispensed wrong kit|0|||
125349433|NCT00282464|450913462|FG001|Overall Study|dispensed wrong kit|1|||
125349434|NCT00282464|450913461|FG000|Overall Study|dropped due to missed visits|0|||
125349435|NCT00282464|450913462|FG001|Overall Study|dropped due to missed visits|1|||
125349436|NCT00812487|450913463|FG000|Overall Study|Lost to Follow-up|2|||
125349437|NCT00812487|450913464|FG001|Overall Study|Lost to Follow-up|0|||
125349438|NCT00812487|450913463|FG000|Overall Study|Withdrawal by Subject|3|||
125349439|NCT00812487|450913464|FG001|Overall Study|Withdrawal by Subject|2|||
125349440|NCT00812487|450913463|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
125349441|NCT00812487|450913464|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
125349442|NCT00812487|450913463|FG000|Overall Study|Protocol Violation|0|||
125349443|NCT00812487|450913464|FG001|Overall Study|Protocol Violation|1|||
125682200|NCT04516967|452125765|FG001|Core Phase|Physician Decision|1|||
125682201|NCT04516967|452125766|FG002|Core Phase|Physician Decision|0|||
125682202|NCT04516967|452125764|FG000|Core Phase|Lack of Efficacy|7|||
125682203|NCT04516967|452125765|FG001|Core Phase|Lack of Efficacy|18|||
125682204|NCT04516967|452125766|FG002|Core Phase|Lack of Efficacy|0|||
125682205|NCT03570749|452125767|FG000|Overall Study|Ongoing|26|||
125682206|NCT03570749|452125768|FG001|Overall Study|Ongoing|25|||
125682207|NCT03570749|452125769|FG002|Overall Study|Ongoing|25|||
125682208|NCT03570749|452125770|FG003|Overall Study|Ongoing|26|||
125349444|NCT02360605|450913465|FG000|Overall Study|Withdrawal by Subject|4|||
125349445|NCT02360605|450913466|FG001|Overall Study|Withdrawal by Subject|9|||
125349446|NCT02360605|450913465|FG000|Overall Study|Lost to Follow-up|7|||
125349447|NCT02360605|450913466|FG001|Overall Study|Lost to Follow-up|8|||
125349448|NCT02360605|450913465|FG000|Overall Study|Death|0|||
125349449|NCT02360605|450913466|FG001|Overall Study|Death|1|||
125682209|NCT03570749|452125771|FG004|Overall Study|Ongoing|140|||
125349450|NCT00290407|450913467|FG000|Overall Study|Physician Decision|2|||
125349451|NCT01117792|450913469|FG000|Overall Study|Death|1|||
125349452|NCT01117792|450913469|FG000|Overall Study|Adverse Event|3|||
125682210|NCT03570749|452125772|FG005|Overall Study|Ongoing|142|||
125548705|NCT00427895|451638291|FG007|Vax 1/Year 1 Follow-up|Other|0|||
125548706|NCT00427895|451638284|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
125548707|NCT00427895|451638285|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
125548708|NCT00427895|451638286|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
125548709|NCT00427895|451638287|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
125548710|NCT00427895|451638288|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
125548711|NCT00427895|451638289|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
125548712|NCT00427895|451638290|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
125548713|NCT00427895|451638291|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
125548714|NCT02533570|451638293|FG000|Overall Study|Adverse Event|0|||
125548715|NCT02533570|451638294|FG001|Overall Study|Adverse Event|1|||
125548716|NCT02533570|451638295|FG002|Overall Study|Adverse Event|1|||
125548717|NCT02881957|451638303|FG000|Overall Study|Comfort care|0|||
125548718|NCT02881957|451638304|FG001|Overall Study|Comfort care|1|||
125548719|NCT02881957|451638303|FG000|Overall Study|Concurrent trial enrollment|0|||
125548720|NCT02881957|451638304|FG001|Overall Study|Concurrent trial enrollment|1|||
125548721|NCT02881957|451638303|FG000|Overall Study|Discharged within 48 hours|0|||
125548722|NCT02881957|451638304|FG001|Overall Study|Discharged within 48 hours|1|||
125548723|NCT02881957|451638303|FG000|Overall Study|Withdrawal by Subject|2|||
125548724|NCT02881957|451638304|FG001|Overall Study|Withdrawal by Subject|1|||
125548725|NCT02881957|451638303|FG000|Overall Study|Protocol Violation|1|||
125548726|NCT02881957|451638304|FG001|Overall Study|Protocol Violation|0|||
125548727|NCT00081497|451638305|FG000|Overall Study|Adverse Event|2|||
125548728|NCT00081497|451638306|FG001|Overall Study|Adverse Event|0|||
125548729|NCT00081497|451638305|FG000|Overall Study|Death|0|||
125548730|NCT00081497|451638306|FG001|Overall Study|Death|1|||
125548731|NCT00081497|451638305|FG000|Overall Study|Withdrawal by Subject|1|||
125548732|NCT00081497|451638306|FG001|Overall Study|Withdrawal by Subject|0|||
125548733|NCT00081497|451638305|FG000|Overall Study|Non-compliance|0|||
125548734|NCT00081497|451638306|FG001|Overall Study|Non-compliance|1|||
125548735|NCT00345293|451638307|FG000|Overall Study|Unable to access line for sample|1|||
125548736|NCT00345293|451638308|FG001|Overall Study|Unable to access line for sample|0|||
125548737|NCT00345293|451638307|FG000|Overall Study|Withdrawal by Subject|1|||
125548738|NCT00345293|451638308|FG001|Overall Study|Withdrawal by Subject|0|||
125548739|NCT03442985|451639692|FG000|Overall Study|Sponsor Request|55|||
125548740|NCT03442985|451639693|FG001|Overall Study|Sponsor Request|60|||
125548741|NCT03442985|451639694|FG002|Overall Study|Sponsor Request|54|||
125548742|NCT03442985|451639692|FG000|Overall Study|Lost to Follow-up|5|||
125548743|NCT03442985|451639693|FG001|Overall Study|Lost to Follow-up|2|||
125548744|NCT03442985|451639694|FG002|Overall Study|Lost to Follow-up|7|||
125548745|NCT03442985|451639692|FG000|Overall Study|Withdrawal by Subject|2|||
125548746|NCT03442985|451639693|FG001|Overall Study|Withdrawal by Subject|3|||
125548747|NCT03442985|451639694|FG002|Overall Study|Withdrawal by Subject|4|||
125548748|NCT03442985|451639692|FG000|Overall Study|Adverse Event|0|||
125548749|NCT03442985|451639693|FG001|Overall Study|Adverse Event|1|||
125548750|NCT03442985|451639694|FG002|Overall Study|Adverse Event|0|||
125548751|NCT01716117|451639698|FG000|Overall Study|Death|5|||
125548752|NCT01716117|451639699|FG001|Overall Study|Death|2|||
125548753|NCT01716117|451639698|FG000|Overall Study|Withdrawal by Subject|2|||
125548754|NCT01716117|451639699|FG001|Overall Study|Withdrawal by Subject|0|||
125548755|NCT03645057|451639700|FG000|Randomization to Baseline|Lost to Follow-up|1|||
125548756|NCT03645057|451639701|FG001|Randomization to Baseline|Lost to Follow-up|0|||
125548757|NCT03645057|451639702|FG002|Randomization to Baseline|Lost to Follow-up|1|||
125548758|NCT03645057|451639703|FG003|Randomization to Baseline|Lost to Follow-up|0|||
125548759|NCT03645057|451639700|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
125548760|NCT03645057|451639701|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
125548761|NCT03645057|451639702|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
125548762|NCT03645057|451639703|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
125548763|NCT03645057|451639700|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
125548764|NCT03645057|451639701|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
125548765|NCT03645057|451639702|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
125548766|NCT03645057|451639703|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
125548767|NCT03645057|451639700|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
125349453|NCT01721577|450913470|FG000|Overall Study|Lack of Efficacy|1|||
125349454|NCT01721577|450913471|FG001|Overall Study|Lack of Efficacy|0|||
125349455|NCT01721577|450913470|FG000|Overall Study|Death|1|||
125548768|NCT03645057|451639701|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
125548769|NCT03645057|451639702|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
125349456|NCT01721577|450913471|FG001|Overall Study|Death|0|||
125548770|NCT03645057|451639703|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
125548771|NCT00762970|451639704|FG000|Overall Study|Withdrawal by Subject|7|||
125548772|NCT00762970|451639705|FG001|Overall Study|Withdrawal by Subject|4|||
125548773|NCT00762970|451639706|FG002|Overall Study|Withdrawal by Subject|0|||
125548774|NCT00762970|451639704|FG000|Overall Study|Protocol Violation|3|||
125349457|NCT01721577|450913470|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
125548775|NCT00762970|451639705|FG001|Overall Study|Protocol Violation|1|||
125548776|NCT00762970|451639706|FG002|Overall Study|Protocol Violation|1|||
125548777|NCT00762970|451639704|FG000|Overall Study|Lost to Follow-up|1|||
125548778|NCT00762970|451639705|FG001|Overall Study|Lost to Follow-up|2|||
125548779|NCT00762970|451639706|FG002|Overall Study|Lost to Follow-up|0|||
125548780|NCT00762970|451639704|FG000|Overall Study|Difficulty of handling lens|1|||
125548781|NCT00762970|451639705|FG001|Overall Study|Difficulty of handling lens|2|||
125548782|NCT00762970|451639706|FG002|Overall Study|Difficulty of handling lens|0|||
125548783|NCT01009203|451639707|FG000|Overall Study|Withdrawal by Subject|1|||
125548784|NCT01009203|451639707|FG000|Overall Study|Adverse Event|5|||
125548785|NCT01009203|451639707|FG000|Overall Study|Treatment-unrelated death|1|||
125548786|NCT00892723|451639708|FG000|Overall Study|Lost to Follow-up|1|||
125548787|NCT00892723|451639709|FG001|Overall Study|Lost to Follow-up|3|||
125548788|NCT00892723|451639710|FG002|Overall Study|Lost to Follow-up|1|||
125548789|NCT00892723|451639708|FG000|Overall Study|Withdrawal by Subject|1|||
125548790|NCT00892723|451639709|FG001|Overall Study|Withdrawal by Subject|1|||
125548791|NCT00892723|451639710|FG002|Overall Study|Withdrawal by Subject|1|||
125548792|NCT01007448|451639712|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
125548793|NCT01007448|451639713|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
125548794|NCT01007448|451639712|FG000|Overall Study|Staph Skin Infection Flare|1|||
125548795|NCT01007448|451639713|FG001|Overall Study|Staph Skin Infection Flare|0|||
125548796|NCT01007448|451639712|FG000|Overall Study|Participant Leaving the Country|1|||
125548797|NCT01007448|451639713|FG001|Overall Study|Participant Leaving the Country|0|||
125548798|NCT01007448|451639712|FG000|Overall Study|Participant Given Prohibited Medication|1|||
125548799|NCT01007448|451639713|FG001|Overall Study|Participant Given Prohibited Medication|0|||
125548800|NCT01007448|451639712|FG000|Overall Study|Progressive Disease|1|||
125548801|NCT01007448|451639713|FG001|Overall Study|Progressive Disease|2|||
125349458|NCT01721577|450913471|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
125349459|NCT01721577|450913470|FG000|Overall Study|Adverse Event|0|||
125349460|NCT01721577|450913471|FG001|Overall Study|Adverse Event|2|||
125349461|NCT01055496|450913479|FG000|Overall Study|Withdrawal by Subject|2|||
125349462|NCT01055496|450913480|FG001|Overall Study|Withdrawal by Subject|4|||
125349463|NCT01055496|450913479|FG000|Overall Study|Death|13|||
125349464|NCT01055496|450913480|FG001|Overall Study|Death|23|||
125349465|NCT01055496|450913479|FG000|Overall Study|Lost to Follow-up|0|||
125349466|NCT01055496|450913480|FG001|Overall Study|Lost to Follow-up|2|||
125349467|NCT01055496|450913479|FG000|Overall Study|Other - Unspecified|0|||
125349468|NCT01055496|450913480|FG001|Overall Study|Other - Unspecified|1|||
125349469|NCT01673282|450913486|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
125349470|NCT01673282|450913487|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
125349471|NCT01673282|450913486|FG000|Overall Study|Lack of Efficacy|9|||
125349472|NCT01673282|450913487|FG001|Overall Study|Lack of Efficacy|2|||
125349473|NCT01673282|450913486|FG000|Overall Study|Lost to Follow-up|11|||
125349474|NCT01673282|450913487|FG001|Overall Study|Lost to Follow-up|10|||
125349475|NCT01673282|450913486|FG000|Overall Study|Withdrawal by Subject|3|||
125349476|NCT01673282|450913487|FG001|Overall Study|Withdrawal by Subject|3|||
125349477|NCT01673282|450913486|FG000|Overall Study|Other|1|||
125349478|NCT01673282|450913487|FG001|Overall Study|Other|6|||
125349479|NCT02106923|450913493|FG000|Overall Study|Protocol Violation|0|||
125349480|NCT02106923|450913494|FG001|Overall Study|Protocol Violation|0|||
125349481|NCT02106923|450913495|FG002|Overall Study|Protocol Violation|0|||
125349482|NCT02106923|450913496|FG003|Overall Study|Protocol Violation|0|||
125349483|NCT02106923|450913497|FG004|Overall Study|Protocol Violation|0|||
125349484|NCT02106923|450913498|FG005|Overall Study|Protocol Violation|1|||
125349485|NCT01323920|450913499|FG000|Overall Study|Death|5|||
125349486|NCT01323920|450913499|FG000|Overall Study|Withdrawal by Subject|1|||
125349487|NCT01715129|450913504|FG000|Overall Study|Adverse Event, fatal|1|||
125349488|NCT01715129|450913504|FG000|Overall Study|Lack of Efficacy|3|||
125349489|NCT01715129|450913504|FG000|Overall Study|Protocol Violation|1|||
125349490|NCT01715129|450913504|FG000|Overall Study|Consent Withdrawn|2|||
125349491|NCT01715129|450913504|FG000|Overall Study|Lost to Follow-up|1|||
125548802|NCT01007448|451639712|FG000|Overall Study|Lack of Efficacy|2|||
125548803|NCT01007448|451639713|FG001|Overall Study|Lack of Efficacy|0|||
125548804|NCT01007448|451639712|FG000|Overall Study|Withdrawal by Subject|2|||
125349492|NCT01715129|450913504|FG000|Overall Study|Other|1|||
125349493|NCT00555425|450913509|FG000|Overall Study|Missed Medication > 1 wk|34|||
125349494|NCT00555425|450913510|FG001|Overall Study|Missed Medication > 1 wk|15|||
125349495|NCT00555425|450913509|FG000|Overall Study|Missed 3 physician management visits|1|||
125548805|NCT01007448|451639713|FG001|Overall Study|Withdrawal by Subject|3|||
125548806|NCT01007448|451639712|FG000|Overall Study|Adverse Event|1|||
125548807|NCT01007448|451639713|FG001|Overall Study|Adverse Event|4|||
125349496|NCT00555425|450913510|FG001|Overall Study|Missed 3 physician management visits|0|||
125349497|NCT00555425|450913509|FG000|Overall Study|Met criteria for protective transfer|16|||
125349498|NCT00555425|450913510|FG001|Overall Study|Met criteria for protective transfer|3|||
125548808|NCT01337115|451639714|FG000|Overall Study|Protocol Violation|2|||
125548809|NCT01337115|451639715|FG001|Overall Study|Protocol Violation|0|||
125548810|NCT00448123|451639716|FG000|Overall Study|Lost to Follow-up|9|||
125548811|NCT00448123|451639717|FG001|Overall Study|Lost to Follow-up|6|||
125548812|NCT00448123|451639716|FG000|Overall Study|Physician Decision|6|||
125548813|NCT00448123|451639717|FG001|Overall Study|Physician Decision|6|||
125548814|NCT02027623|451639719|FG000|Overall Study|Lost to Follow-up|3|||
125548815|NCT02027623|451639720|FG001|Overall Study|Lost to Follow-up|3|||
125548816|NCT02027623|451639719|FG000|Overall Study|Withdrawal by Subject|6|||
125548817|NCT02027623|451639720|FG001|Overall Study|Withdrawal by Subject|9|||
125548818|NCT00406653|451639724|FG000|Induction Period|Adverse Event|1|||
125548819|NCT00406653|451639725|FG001|Induction Period|Adverse Event|10|||
125548820|NCT00406653|451639726|FG002|Induction Period|Adverse Event|4|||
125548821|NCT00406653|451639727|FG003|Induction Period|Adverse Event|11|||
125548822|NCT00406653|451639728|FG004|Induction Period|Adverse Event|0|||
125548823|NCT00406653|451639729|FG005|Induction Period|Adverse Event|0|||
125682211|NCT03570749|452125773|FG006|Overall Study|Ongoing|220|||
125682212|NCT03570749|452125767|FG000|Overall Study|Adverse Event|0|||
125682213|NCT03570749|452125768|FG001|Overall Study|Adverse Event|0|||
125682214|NCT03570749|452125769|FG002|Overall Study|Adverse Event|0|||
125682215|NCT03570749|452125770|FG003|Overall Study|Adverse Event|0|||
125682216|NCT03570749|452125771|FG004|Overall Study|Adverse Event|2|||
125682217|NCT03570749|452125772|FG005|Overall Study|Adverse Event|3|||
125682218|NCT03570749|452125773|FG006|Overall Study|Adverse Event|6|||
125682219|NCT03570749|452125767|FG000|Overall Study|Lack of Efficacy|0|||
125682220|NCT03570749|452125768|FG001|Overall Study|Lack of Efficacy|0|||
125682221|NCT03570749|452125769|FG002|Overall Study|Lack of Efficacy|0|||
125682222|NCT03570749|452125770|FG003|Overall Study|Lack of Efficacy|0|||
125682223|NCT03570749|452125771|FG004|Overall Study|Lack of Efficacy|8|||
125682224|NCT03570749|452125772|FG005|Overall Study|Lack of Efficacy|2|||
125682225|NCT03570749|452125773|FG006|Overall Study|Lack of Efficacy|7|||
125682226|NCT03570749|452125767|FG000|Overall Study|Lost to Follow-up|0|||
125682227|NCT03570749|452125768|FG001|Overall Study|Lost to Follow-up|0|||
125682228|NCT03570749|452125769|FG002|Overall Study|Lost to Follow-up|0|||
125682229|NCT03570749|452125770|FG003|Overall Study|Lost to Follow-up|0|||
125682230|NCT03570749|452125771|FG004|Overall Study|Lost to Follow-up|5|||
125682231|NCT03570749|452125772|FG005|Overall Study|Lost to Follow-up|10|||
125682232|NCT03570749|452125773|FG006|Overall Study|Lost to Follow-up|10|||
125682233|NCT03570749|452125767|FG000|Overall Study|Pregnancy|0|||
125682234|NCT03570749|452125768|FG001|Overall Study|Pregnancy|0|||
125682235|NCT03570749|452125769|FG002|Overall Study|Pregnancy|0|||
125682236|NCT03570749|452125770|FG003|Overall Study|Pregnancy|0|||
125682237|NCT03570749|452125771|FG004|Overall Study|Pregnancy|0|||
125682238|NCT03570749|452125772|FG005|Overall Study|Pregnancy|1|||
125682239|NCT03570749|452125773|FG006|Overall Study|Pregnancy|1|||
125682240|NCT03570749|452125767|FG000|Overall Study|Screen Fail|0|||
125682241|NCT03570749|452125768|FG001|Overall Study|Screen Fail|0|||
125682242|NCT03570749|452125769|FG002|Overall Study|Screen Fail|0|||
125682243|NCT03570749|452125770|FG003|Overall Study|Screen Fail|0|||
125682244|NCT03570749|452125771|FG004|Overall Study|Screen Fail|0|||
125682245|NCT03570749|452125772|FG005|Overall Study|Screen Fail|0|||
125682246|NCT03570749|452125773|FG006|Overall Study|Screen Fail|1|||
125682247|NCT03570749|452125767|FG000|Overall Study|Withdrawal by Subject|2|||
125682248|NCT03570749|452125768|FG001|Overall Study|Withdrawal by Subject|3|||
125682249|NCT03570749|452125769|FG002|Overall Study|Withdrawal by Subject|2|||
125682250|NCT03570749|452125770|FG003|Overall Study|Withdrawal by Subject|1|||
125682251|NCT03570749|452125771|FG004|Overall Study|Withdrawal by Subject|17|||
125682252|NCT03570749|452125772|FG005|Overall Study|Withdrawal by Subject|12|||
125682253|NCT03570749|452125773|FG006|Overall Study|Withdrawal by Subject|15|||
125682254|NCT03570749|452125767|FG000|Overall Study|Other|0|||
125682255|NCT03570749|452125768|FG001|Overall Study|Other|0|||
125682256|NCT03570749|452125769|FG002|Overall Study|Other|0|||
125682257|NCT03570749|452125770|FG003|Overall Study|Other|0|||
125682258|NCT03570749|452125771|FG004|Overall Study|Other|17|||
125682259|NCT03570749|452125772|FG005|Overall Study|Other|14|||
125682260|NCT03570749|452125773|FG006|Overall Study|Other|21|||
125682261|NCT01239381|452125774|FG000|Overall Study|Protocol Violation|1|||
125682262|NCT01239381|452125774|FG000|Overall Study|Withdrawal by Subject|1|||
125682263|NCT06237049|452125775|FG000|Overall Study|Death|0|||
125682264|NCT06237049|452125776|FG001|Overall Study|Death|0|||
125682265|NCT06237049|452125777|FG002|Overall Study|Death|0|||
125682266|NCT06237049|452125778|FG003|Overall Study|Death|1|||
125682267|NCT06237049|452125775|FG000|Overall Study|Lost to Follow-up|11|||
125682268|NCT06237049|452125776|FG001|Overall Study|Lost to Follow-up|5|||
125682269|NCT06237049|452125777|FG002|Overall Study|Lost to Follow-up|8|||
125682270|NCT06237049|452125778|FG003|Overall Study|Lost to Follow-up|8|||
125682271|NCT06237049|452125775|FG000|Overall Study|Protocol Violation|0|||
125682272|NCT06237049|452125776|FG001|Overall Study|Protocol Violation|1|||
125682273|NCT06237049|452125777|FG002|Overall Study|Protocol Violation|0|||
125682274|NCT06237049|452125778|FG003|Overall Study|Protocol Violation|1|||
125682275|NCT06237049|452125775|FG000|Overall Study|Withdrawal by Subject|4|||
125682276|NCT06237049|452125776|FG001|Overall Study|Withdrawal by Subject|2|||
125548824|NCT00406653|451639730|FG006|Induction Period|Adverse Event|0|||
125548825|NCT00406653|451639724|FG000|Induction Period|Lack of Efficacy|11|||
125548826|NCT00406653|451639725|FG001|Induction Period|Lack of Efficacy|14|||
125548827|NCT00406653|451639726|FG002|Induction Period|Lack of Efficacy|8|||
125548828|NCT00406653|451639727|FG003|Induction Period|Lack of Efficacy|10|||
125548829|NCT00406653|451639728|FG004|Induction Period|Lack of Efficacy|0|||
125548830|NCT00406653|451639729|FG005|Induction Period|Lack of Efficacy|0|||
125548831|NCT00406653|451639730|FG006|Induction Period|Lack of Efficacy|0|||
125548832|NCT00406653|451639724|FG000|Induction Period|Lost to Follow-up|0|||
125548833|NCT00406653|451639725|FG001|Induction Period|Lost to Follow-up|2|||
125548834|NCT00406653|451639726|FG002|Induction Period|Lost to Follow-up|0|||
125548835|NCT00406653|451639727|FG003|Induction Period|Lost to Follow-up|0|||
125548836|NCT00406653|451639728|FG004|Induction Period|Lost to Follow-up|0|||
125548837|NCT00406653|451639729|FG005|Induction Period|Lost to Follow-up|0|||
125548838|NCT00406653|451639730|FG006|Induction Period|Lost to Follow-up|0|||
125548839|NCT00406653|451639724|FG000|Induction Period|Withdrawal of Consent|2|||
125548840|NCT00406653|451639725|FG001|Induction Period|Withdrawal of Consent|5|||
125548841|NCT00406653|451639726|FG002|Induction Period|Withdrawal of Consent|1|||
125548842|NCT00406653|451639727|FG003|Induction Period|Withdrawal of Consent|2|||
125548843|NCT00406653|451639728|FG004|Induction Period|Withdrawal of Consent|0|||
125548844|NCT00406653|451639729|FG005|Induction Period|Withdrawal of Consent|0|||
125548845|NCT00406653|451639730|FG006|Induction Period|Withdrawal of Consent|0|||
125548846|NCT00406653|451639724|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
125548847|NCT00406653|451639725|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
125548848|NCT00406653|451639726|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
125548849|NCT00406653|451639727|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
125548850|NCT00406653|451639728|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
125548851|NCT00406653|451639729|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
125548852|NCT00406653|451639730|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
125548853|NCT00406653|451639724|FG000|Induction Period|Pregnancy|1|||
125548854|NCT00406653|451639725|FG001|Induction Period|Pregnancy|0|||
125548855|NCT00406653|451639726|FG002|Induction Period|Pregnancy|0|||
125548856|NCT00406653|451639727|FG003|Induction Period|Pregnancy|0|||
125548857|NCT00406653|451639728|FG004|Induction Period|Pregnancy|0|||
125548858|NCT00406653|451639729|FG005|Induction Period|Pregnancy|0|||
125548859|NCT00406653|451639730|FG006|Induction Period|Pregnancy|0|||
125548860|NCT00406653|451639724|FG000|Induction Period|Declined participation but followup done|0|||
125548861|NCT00406653|451639725|FG001|Induction Period|Declined participation but followup done|2|||
125548862|NCT00406653|451639726|FG002|Induction Period|Declined participation but followup done|1|||
125548863|NCT00406653|451639727|FG003|Induction Period|Declined participation but followup done|1|||
125548864|NCT00406653|451639728|FG004|Induction Period|Declined participation but followup done|0|||
125548865|NCT00406653|451639729|FG005|Induction Period|Declined participation but followup done|0|||
125548866|NCT00406653|451639730|FG006|Induction Period|Declined participation but followup done|0|||
125548867|NCT00406653|451639724|FG000|Induction Period|Given prohibited drug|0|||
125548868|NCT00406653|451639725|FG001|Induction Period|Given prohibited drug|1|||
125349499|NCT00555425|450913509|FG000|Overall Study|Became pregnant and transferred care|0|||
125349500|NCT00555425|450913510|FG001|Overall Study|Became pregnant and transferred care|1|||
125349501|NCT00400153|450913518|FG000|Overall Study|AE due to study disease worsening|14|||
125349502|NCT00400153|450913519|FG001|Overall Study|AE due to study disease worsening|19|||
125548869|NCT00406653|451639726|FG002|Induction Period|Given prohibited drug|2|||
125548870|NCT00406653|451639727|FG003|Induction Period|Given prohibited drug|0|||
125548871|NCT00406653|451639728|FG004|Induction Period|Given prohibited drug|0|||
125548872|NCT00406653|451639729|FG005|Induction Period|Given prohibited drug|0|||
125548873|NCT00406653|451639730|FG006|Induction Period|Given prohibited drug|0|||
125548874|NCT00406653|451639724|FG000|Induction Period|Incarcerated|0|||
125349503|NCT00400153|450913520|FG002|Overall Study|AE due to study disease worsening|20|||
125548875|NCT00406653|451639725|FG001|Induction Period|Incarcerated|0|||
125349504|NCT00400153|450913518|FG000|Overall Study|AE due to other disease worsening|2|||
125349505|NCT00400153|450913519|FG001|Overall Study|AE due to other disease worsening|1|||
125349506|NCT00400153|450913520|FG002|Overall Study|AE due to other disease worsening|0|||
125349507|NCT00400153|450913518|FG000|Overall Study|AE due to other condition|3|||
125349508|NCT00400153|450913519|FG001|Overall Study|AE due to other condition|14|||
125349509|NCT00400153|450913520|FG002|Overall Study|AE due to other condition|15|||
125349510|NCT00400153|450913518|FG000|Overall Study|Protocol Violation|7|||
125349511|NCT00400153|450913519|FG001|Overall Study|Protocol Violation|4|||
125349512|NCT00400153|450913520|FG002|Overall Study|Protocol Violation|9|||
125349513|NCT00400153|450913518|FG000|Overall Study|Lost to Follow-up|2|||
125349514|NCT00400153|450913519|FG001|Overall Study|Lost to Follow-up|1|||
125349515|NCT00400153|450913520|FG002|Overall Study|Lost to Follow-up|4|||
125349516|NCT00400153|450913518|FG000|Overall Study|Withdrawal by Subject|12|||
125349517|NCT00400153|450913519|FG001|Overall Study|Withdrawal by Subject|11|||
125349518|NCT00400153|450913520|FG002|Overall Study|Withdrawal by Subject|10|||
125682277|NCT06237049|452125777|FG002|Overall Study|Withdrawal by Subject|1|||
125682278|NCT06237049|452125778|FG003|Overall Study|Withdrawal by Subject|0|||
125682279|NCT05014412|452127088|FG000|Overall Study|Death|11|||
125682280|NCT05014412|452127089|FG001|Overall Study|Death|7|||
125682281|NCT05014412|452127090|FG002|Overall Study|Death|4|||
125682282|NCT05014412|452127091|FG003|Overall Study|Death|7|||
125682283|NCT05014412|452127088|FG000|Overall Study|Withdrawal by Subject|1|||
125682284|NCT05014412|452127089|FG001|Overall Study|Withdrawal by Subject|1|||
125682285|NCT05014412|452127090|FG002|Overall Study|Withdrawal by Subject|1|||
125682286|NCT05014412|452127091|FG003|Overall Study|Withdrawal by Subject|2|||
125682287|NCT05014412|452127088|FG000|Overall Study|Ongoing|21|||
125682288|NCT05014412|452127089|FG001|Overall Study|Ongoing|4|||
125682289|NCT05014412|452127090|FG002|Overall Study|Ongoing|6|||
125682290|NCT05014412|452127091|FG003|Overall Study|Ongoing|20|||
125682291|NCT02101775|452127092|FG000|Overall Study|Adverse Event|4|||
125682292|NCT02101775|452127093|FG001|Overall Study|Adverse Event|0|||
125682293|NCT02101775|452127094|FG002|Overall Study|Adverse Event|0|||
125682294|NCT02101775|452127092|FG000|Overall Study|Admission to Hospital|0|||
125682295|NCT02101775|452127093|FG001|Overall Study|Admission to Hospital|1|||
125682296|NCT02101775|452127094|FG002|Overall Study|Admission to Hospital|0|||
125682297|NCT02469155|452127097|FG000|Overall Study|Adverse Event|6|||
125682298|NCT02469155|452127098|FG001|Overall Study|Adverse Event|0|||
125682299|NCT02469155|452127099|FG002|Overall Study|Adverse Event|1|||
125682300|NCT02469155|452127100|FG003|Overall Study|Adverse Event|10|||
125682301|NCT02469155|452127097|FG000|Overall Study|Lack of Efficacy|13|||
125682302|NCT02469155|452127098|FG001|Overall Study|Lack of Efficacy|10|||
125682303|NCT02469155|452127099|FG002|Overall Study|Lack of Efficacy|10|||
125682304|NCT02469155|452127100|FG003|Overall Study|Lack of Efficacy|8|||
125682305|NCT02469155|452127097|FG000|Overall Study|Death|0|||
125682306|NCT02469155|452127098|FG001|Overall Study|Death|0|||
125682307|NCT02469155|452127099|FG002|Overall Study|Death|0|||
125682308|NCT02469155|452127100|FG003|Overall Study|Death|1|||
125682309|NCT02469155|452127097|FG000|Overall Study|Lost to Follow-up|5|||
125682310|NCT02469155|452127098|FG001|Overall Study|Lost to Follow-up|2|||
125682311|NCT02469155|452127099|FG002|Overall Study|Lost to Follow-up|7|||
125682312|NCT02469155|452127100|FG003|Overall Study|Lost to Follow-up|2|||
125682313|NCT02469155|452127097|FG000|Overall Study|Physician Decision|0|||
125682314|NCT02469155|452127098|FG001|Overall Study|Physician Decision|0|||
125682315|NCT02469155|452127099|FG002|Overall Study|Physician Decision|1|||
125682316|NCT02469155|452127100|FG003|Overall Study|Physician Decision|0|||
125682317|NCT02469155|452127097|FG000|Overall Study|Withdrawal by Subject|34|||
125682318|NCT02469155|452127098|FG001|Overall Study|Withdrawal by Subject|30|||
125682319|NCT02469155|452127099|FG002|Overall Study|Withdrawal by Subject|20|||
125682320|NCT02469155|452127100|FG003|Overall Study|Withdrawal by Subject|37|||
125682321|NCT02469155|452127097|FG000|Overall Study|Other|3|||
125682322|NCT02469155|452127098|FG001|Overall Study|Other|3|||
125682323|NCT02469155|452127099|FG002|Overall Study|Other|2|||
125682324|NCT02469155|452127100|FG003|Overall Study|Other|10|||
125682325|NCT02469155|452127097|FG000|Overall Study|Protocol Violation|0|||
125682326|NCT02469155|452127098|FG001|Overall Study|Protocol Violation|1|||
125682327|NCT02469155|452127099|FG002|Overall Study|Protocol Violation|0|||
125682328|NCT02469155|452127100|FG003|Overall Study|Protocol Violation|1|||
125682329|NCT02062827|452127101|FG000|Overall Study|Death|1|||
125682330|NCT02062827|452127102|FG001|Overall Study|Death|0|||
125682331|NCT02062827|452127103|FG002|Overall Study|Death|0|||
125682332|NCT02062827|452127104|FG003|Overall Study|Death|0|||
125349519|NCT00400153|450913518|FG000|Overall Study|Other reasons - not mentioned above|8|||
125349520|NCT00400153|450913519|FG001|Overall Study|Other reasons - not mentioned above|5|||
125682333|NCT02062827|452127105|FG004|Overall Study|Death|0|||
125682334|NCT02062827|452127106|FG005|Overall Study|Death|0|||
125682335|NCT02062827|452127107|FG006|Overall Study|Death|0|||
125682336|NCT02062827|452127108|FG007|Overall Study|Death|0|||
125682337|NCT02062827|452127101|FG000|Overall Study|Withdrawal by Subject|3|||
125682338|NCT02062827|452127102|FG001|Overall Study|Withdrawal by Subject|1|||
125682339|NCT02062827|452127103|FG002|Overall Study|Withdrawal by Subject|1|||
125682340|NCT02062827|452127104|FG003|Overall Study|Withdrawal by Subject|2|||
125682341|NCT02062827|452127105|FG004|Overall Study|Withdrawal by Subject|6|||
125548876|NCT00406653|451639726|FG002|Induction Period|Incarcerated|1|||
125548877|NCT00406653|451639727|FG003|Induction Period|Incarcerated|0|||
125548878|NCT00406653|451639728|FG004|Induction Period|Incarcerated|0|||
125548879|NCT00406653|451639729|FG005|Induction Period|Incarcerated|0|||
125548880|NCT00406653|451639730|FG006|Induction Period|Incarcerated|0|||
125548881|NCT00406653|451639724|FG000|Induction Period|Patient relocated|0|||
125548882|NCT00406653|451639725|FG001|Induction Period|Patient relocated|0|||
125548883|NCT00406653|451639726|FG002|Induction Period|Patient relocated|1|||
125548884|NCT00406653|451639727|FG003|Induction Period|Patient relocated|0|||
125548885|NCT00406653|451639728|FG004|Induction Period|Patient relocated|0|||
125548886|NCT00406653|451639729|FG005|Induction Period|Patient relocated|0|||
125548887|NCT00406653|451639730|FG006|Induction Period|Patient relocated|0|||
125548888|NCT00406653|451639724|FG000|Maintenance Period|Adverse Event|0|||
125548889|NCT00406653|451639725|FG001|Maintenance Period|Adverse Event|0|||
125548890|NCT00406653|451639726|FG002|Maintenance Period|Adverse Event|0|||
125548891|NCT00406653|451639727|FG003|Maintenance Period|Adverse Event|0|||
125548892|NCT00406653|451639728|FG004|Maintenance Period|Adverse Event|1|||
125548893|NCT00406653|451639729|FG005|Maintenance Period|Adverse Event|1|||
125548894|NCT00406653|451639730|FG006|Maintenance Period|Adverse Event|0|||
125548895|NCT00406653|451639724|FG000|Maintenance Period|Lack of Efficacy|0|||
125548896|NCT00406653|451639725|FG001|Maintenance Period|Lack of Efficacy|0|||
125548897|NCT00406653|451639726|FG002|Maintenance Period|Lack of Efficacy|0|||
125548898|NCT00406653|451639727|FG003|Maintenance Period|Lack of Efficacy|0|||
125548899|NCT00406653|451639728|FG004|Maintenance Period|Lack of Efficacy|20|||
125548900|NCT00406653|451639729|FG005|Maintenance Period|Lack of Efficacy|26|||
125548901|NCT00406653|451639730|FG006|Maintenance Period|Lack of Efficacy|0|||
125548902|NCT00406653|451639724|FG000|Maintenance Period|Lost to Follow-up|0|||
125548903|NCT00406653|451639725|FG001|Maintenance Period|Lost to Follow-up|0|||
125548904|NCT00406653|451639726|FG002|Maintenance Period|Lost to Follow-up|0|||
125548905|NCT00406653|451639727|FG003|Maintenance Period|Lost to Follow-up|0|||
125548906|NCT00406653|451639728|FG004|Maintenance Period|Lost to Follow-up|2|||
125548907|NCT00406653|451639729|FG005|Maintenance Period|Lost to Follow-up|1|||
125548908|NCT00406653|451639730|FG006|Maintenance Period|Lost to Follow-up|0|||
125548909|NCT00406653|451639724|FG000|Maintenance Period|Withdrawal of Consent|0|||
125548910|NCT00406653|451639725|FG001|Maintenance Period|Withdrawal of Consent|0|||
125548911|NCT00406653|451639726|FG002|Maintenance Period|Withdrawal of Consent|0|||
125548912|NCT00406653|451639727|FG003|Maintenance Period|Withdrawal of Consent|0|||
125548913|NCT00406653|451639728|FG004|Maintenance Period|Withdrawal of Consent|2|||
125548914|NCT00406653|451639729|FG005|Maintenance Period|Withdrawal of Consent|0|||
125548915|NCT00406653|451639730|FG006|Maintenance Period|Withdrawal of Consent|0|||
125548916|NCT00406653|451639724|FG000|Maintenance Period|Pregnancy|0|||
125548917|NCT00406653|451639725|FG001|Maintenance Period|Pregnancy|0|||
125548918|NCT00406653|451639726|FG002|Maintenance Period|Pregnancy|0|||
125548919|NCT00406653|451639727|FG003|Maintenance Period|Pregnancy|0|||
125548920|NCT00406653|451639728|FG004|Maintenance Period|Pregnancy|0|||
125548921|NCT00406653|451639729|FG005|Maintenance Period|Pregnancy|1|||
125548922|NCT00406653|451639730|FG006|Maintenance Period|Pregnancy|0|||
125548923|NCT00406653|451639724|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
125548924|NCT00406653|451639725|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
125548925|NCT00406653|451639726|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
125548926|NCT00406653|451639727|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
125548927|NCT00406653|451639728|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
125548928|NCT00406653|451639729|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
125548929|NCT00406653|451639730|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
125548930|NCT00406653|451639724|FG000|Maintenance Period|Error in disease score evaluation|0|||
125349521|NCT00400153|450913520|FG002|Overall Study|Other reasons - not mentioned above|3|||
125349522|NCT00393042|450913521|FG000|First Intervention|Withdrawal by Subject|1|||
125548931|NCT00406653|451639725|FG001|Maintenance Period|Error in disease score evaluation|0|||
125548932|NCT00406653|451639726|FG002|Maintenance Period|Error in disease score evaluation|0|||
125548933|NCT00406653|451639727|FG003|Maintenance Period|Error in disease score evaluation|0|||
125548934|NCT00406653|451639728|FG004|Maintenance Period|Error in disease score evaluation|1|||
125548935|NCT00406653|451639729|FG005|Maintenance Period|Error in disease score evaluation|0|||
125548936|NCT00406653|451639730|FG006|Maintenance Period|Error in disease score evaluation|0|||
125548937|NCT00406653|451639724|FG000|Open-Label Period|Death|0|||
125548938|NCT00406653|451639725|FG001|Open-Label Period|Death|0|||
125548939|NCT00406653|451639726|FG002|Open-Label Period|Death|0|||
125349523|NCT00393042|450913522|FG001|First Intervention|Withdrawal by Subject|2|||
125548940|NCT00406653|451639727|FG003|Open-Label Period|Death|0|||
125548941|NCT00406653|451639728|FG004|Open-Label Period|Death|0|||
125548942|NCT00406653|451639729|FG005|Open-Label Period|Death|0|||
125548943|NCT00406653|451639730|FG006|Open-Label Period|Death|1|||
125548944|NCT00406653|451639724|FG000|Open-Label Period|Adverse Event|0|||
125548945|NCT00406653|451639725|FG001|Open-Label Period|Adverse Event|0|||
125548946|NCT00406653|451639726|FG002|Open-Label Period|Adverse Event|0|||
125548947|NCT00406653|451639727|FG003|Open-Label Period|Adverse Event|0|||
125548948|NCT00406653|451639728|FG004|Open-Label Period|Adverse Event|0|||
125548949|NCT00406653|451639729|FG005|Open-Label Period|Adverse Event|0|||
125548950|NCT00406653|451639730|FG006|Open-Label Period|Adverse Event|18|||
125548951|NCT00406653|451639724|FG000|Open-Label Period|Lack of Efficacy|0|||
125548952|NCT00406653|451639725|FG001|Open-Label Period|Lack of Efficacy|0|||
125548953|NCT00406653|451639726|FG002|Open-Label Period|Lack of Efficacy|0|||
125548954|NCT00406653|451639727|FG003|Open-Label Period|Lack of Efficacy|0|||
125548955|NCT00406653|451639728|FG004|Open-Label Period|Lack of Efficacy|0|||
125548956|NCT00406653|451639729|FG005|Open-Label Period|Lack of Efficacy|0|||
125548957|NCT00406653|451639730|FG006|Open-Label Period|Lack of Efficacy|160|||
125548958|NCT00406653|451639724|FG000|Open-Label Period|Lost to Follow-up|0|||
125548959|NCT00406653|451639725|FG001|Open-Label Period|Lost to Follow-up|0|||
125548960|NCT00406653|451639726|FG002|Open-Label Period|Lost to Follow-up|0|||
125548961|NCT00406653|451639727|FG003|Open-Label Period|Lost to Follow-up|0|||
125548962|NCT00406653|451639728|FG004|Open-Label Period|Lost to Follow-up|0|||
125548963|NCT00406653|451639729|FG005|Open-Label Period|Lost to Follow-up|0|||
125548964|NCT00406653|451639730|FG006|Open-Label Period|Lost to Follow-up|6|||
125548965|NCT00406653|451639724|FG000|Open-Label Period|Withdrawal of Consent|0|||
125548966|NCT00406653|451639725|FG001|Open-Label Period|Withdrawal of Consent|0|||
125548967|NCT00406653|451639726|FG002|Open-Label Period|Withdrawal of Consent|0|||
125548968|NCT00406653|451639727|FG003|Open-Label Period|Withdrawal of Consent|0|||
125548969|NCT00406653|451639728|FG004|Open-Label Period|Withdrawal of Consent|0|||
125548970|NCT00406653|451639729|FG005|Open-Label Period|Withdrawal of Consent|0|||
125548971|NCT00406653|451639730|FG006|Open-Label Period|Withdrawal of Consent|11|||
125548972|NCT00406653|451639724|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
125548973|NCT00406653|451639725|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
125548974|NCT00406653|451639726|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
125548975|NCT00406653|451639727|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
125548976|NCT00406653|451639728|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
125548977|NCT00406653|451639729|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
125548978|NCT00406653|451639730|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
125548979|NCT00406653|451639724|FG000|Open-Label Period|Pregnancy|0|||
125548980|NCT00406653|451639725|FG001|Open-Label Period|Pregnancy|0|||
125548981|NCT00406653|451639726|FG002|Open-Label Period|Pregnancy|0|||
125548982|NCT00406653|451639727|FG003|Open-Label Period|Pregnancy|0|||
125548983|NCT00406653|451639728|FG004|Open-Label Period|Pregnancy|0|||
125548984|NCT00406653|451639729|FG005|Open-Label Period|Pregnancy|0|||
125548985|NCT00406653|451639730|FG006|Open-Label Period|Pregnancy|2|||
125548986|NCT00406653|451639724|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
125548987|NCT00406653|451639725|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
125548988|NCT00406653|451639726|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
125548989|NCT00406653|451639727|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
125548990|NCT00406653|451639728|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
125548991|NCT00406653|451639729|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
125548992|NCT00406653|451639730|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
125548993|NCT00406653|451639724|FG000|Open-Label Period|Declined participation but followup done|0|||
125548994|NCT00406653|451639725|FG001|Open-Label Period|Declined participation but followup done|0|||
125548995|NCT00406653|451639726|FG002|Open-Label Period|Declined participation but followup done|0|||
125548996|NCT00406653|451639727|FG003|Open-Label Period|Declined participation but followup done|0|||
125548997|NCT00406653|451639728|FG004|Open-Label Period|Declined participation but followup done|0|||
125548998|NCT00406653|451639729|FG005|Open-Label Period|Declined participation but followup done|0|||
125682342|NCT02062827|452127106|FG005|Overall Study|Withdrawal by Subject|0|||
125682343|NCT02062827|452127107|FG006|Overall Study|Withdrawal by Subject|5|||
125682344|NCT02062827|452127108|FG007|Overall Study|Withdrawal by Subject|0|||
125682345|NCT02062827|452127101|FG000|Overall Study|Screen Fail|0|||
125682346|NCT02062827|452127102|FG001|Overall Study|Screen Fail|0|||
125682347|NCT02062827|452127103|FG002|Overall Study|Screen Fail|0|||
125682348|NCT02062827|452127104|FG003|Overall Study|Screen Fail|0|||
125682349|NCT02062827|452127105|FG004|Overall Study|Screen Fail|0|||
125682350|NCT02062827|452127106|FG005|Overall Study|Screen Fail|0|||
125548999|NCT00406653|451639730|FG006|Open-Label Period|Declined participation but followup done|8|||
125549000|NCT00406653|451639724|FG000|Open-Label Period|Discontinued by Sponsor|0|||
125549001|NCT00406653|451639725|FG001|Open-Label Period|Discontinued by Sponsor|0|||
125549002|NCT00406653|451639726|FG002|Open-Label Period|Discontinued by Sponsor|0|||
125682351|NCT02062827|452127107|FG006|Overall Study|Screen Fail|0|||
125682352|NCT02062827|452127108|FG007|Overall Study|Screen Fail|8|||
125549003|NCT00406653|451639727|FG003|Open-Label Period|Discontinued by Sponsor|0|||
125549004|NCT00406653|451639728|FG004|Open-Label Period|Discontinued by Sponsor|0|||
125549005|NCT00406653|451639729|FG005|Open-Label Period|Discontinued by Sponsor|0|||
125549006|NCT00406653|451639730|FG006|Open-Label Period|Discontinued by Sponsor|1|||
125549007|NCT00406653|451639724|FG000|Open-Label Period|Refused followup|0|||
125549008|NCT00406653|451639725|FG001|Open-Label Period|Refused followup|0|||
125549009|NCT00406653|451639726|FG002|Open-Label Period|Refused followup|0|||
125549010|NCT00406653|451639727|FG003|Open-Label Period|Refused followup|0|||
125549011|NCT00406653|451639728|FG004|Open-Label Period|Refused followup|0|||
125549012|NCT00406653|451639729|FG005|Open-Label Period|Refused followup|0|||
125549013|NCT00406653|451639730|FG006|Open-Label Period|Refused followup|1|||
125549014|NCT00818649|451639731|FG000|Overall Study|Declining performance status|2|||
125549015|NCT00818649|451639731|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
125549016|NCT00818649|451639731|FG000|Overall Study|Adverse Event|1|||
125549017|NCT03513588|451639732|FG000|Overall Study|Lost to Follow-up|0|||
125549018|NCT03513588|451639733|FG001|Overall Study|Lost to Follow-up|1|||
125549019|NCT03513588|451639734|FG002|Overall Study|Lost to Follow-up|1|||
125549020|NCT03513588|451639732|FG000|Overall Study|Study dosing paused by sponsor|1|||
125549021|NCT03513588|451639733|FG001|Overall Study|Study dosing paused by sponsor|1|||
125549022|NCT03513588|451639734|FG002|Overall Study|Study dosing paused by sponsor|0|||
125549023|NCT03513588|451639732|FG000|Overall Study|Death|0|||
125549024|NCT03513588|451639733|FG001|Overall Study|Death|0|||
125549025|NCT03513588|451639734|FG002|Overall Study|Death|1|||
125549026|NCT00940108|451639738|FG000|Overall Study|Adverse Event|2|||
125549027|NCT00940108|451639739|FG001|Overall Study|Adverse Event|4|||
125549028|NCT00940108|451639740|FG002|Overall Study|Adverse Event|0|||
125549029|NCT00940108|451639741|FG003|Overall Study|Adverse Event|2|||
125549030|NCT00940108|451639738|FG000|Overall Study|Withdrew Consent|2|||
125549031|NCT00940108|451639739|FG001|Overall Study|Withdrew Consent|1|||
125549032|NCT00940108|451639740|FG002|Overall Study|Withdrew Consent|0|||
125549033|NCT00940108|451639741|FG003|Overall Study|Withdrew Consent|1|||
125549034|NCT00940108|451639738|FG000|Overall Study|Dose 2 contraindicated|1|||
125549035|NCT00940108|451639739|FG001|Overall Study|Dose 2 contraindicated|1|||
125349524|NCT00393042|450913521|FG000|First Intervention|Lost to Follow-up|3|||
125349525|NCT00393042|450913522|FG001|First Intervention|Lost to Follow-up|3|||
125349526|NCT00393042|450913521|FG000|First Intervention|Protocol Violation|1|||
125349527|NCT00393042|450913522|FG001|First Intervention|Protocol Violation|0|||
125349528|NCT00393042|450913521|FG000|First Intervention|Adverse Event|0|||
125349529|NCT00393042|450913522|FG001|First Intervention|Adverse Event|1|||
125349530|NCT00393042|450913521|FG000|Second Intervetion|Adverse Event|0|||
125349531|NCT00393042|450913522|FG001|Second Intervetion|Adverse Event|3|||
125349532|NCT00393042|450913521|FG000|Second Intervetion|Withdrawal by Subject|0|||
125349533|NCT00393042|450913522|FG001|Second Intervetion|Withdrawal by Subject|2|||
125349534|NCT00393042|450913521|FG000|Second Intervetion|Lack of Efficacy|1|||
125349535|NCT00393042|450913522|FG001|Second Intervetion|Lack of Efficacy|0|||
125349536|NCT00393042|450913521|FG000|Second Intervetion|Lost to Follow-up|0|||
125349537|NCT00393042|450913522|FG001|Second Intervetion|Lost to Follow-up|2|||
125349538|NCT00393042|450913521|FG000|Second Intervetion|Protocol Violation|1|||
125349539|NCT00393042|450913522|FG001|Second Intervetion|Protocol Violation|1|||
125349540|NCT01150474|450913524|FG000|Overall Study|Withdrawal by Subject|5|||
125549036|NCT00940108|451639740|FG002|Overall Study|Dose 2 contraindicated|0|||
125549037|NCT00940108|451639741|FG003|Overall Study|Dose 2 contraindicated|1|||
125682353|NCT01886872|452127109|FG000|Overall Study|Ineligible|7|||
125349541|NCT01150474|450913525|FG001|Overall Study|Withdrawal by Subject|2|||
125349542|NCT01150474|450913524|FG000|Overall Study|Cancer found|1|||
125349543|NCT01150474|450913525|FG001|Overall Study|Cancer found|0|||
125349544|NCT01150474|450913524|FG000|Overall Study|Multiple Studies|0|||
125349545|NCT01150474|450913525|FG001|Overall Study|Multiple Studies|1|||
125349546|NCT01150474|450913524|FG000|Overall Study|Rectotomy|1|||
125349547|NCT01150474|450913525|FG001|Overall Study|Rectotomy|0|||
125349548|NCT01150474|450913524|FG000|Overall Study|Drug did not arrive in time|1|||
125349549|NCT01150474|450913525|FG001|Overall Study|Drug did not arrive in time|0|||
125682354|NCT01886872|452127110|FG001|Overall Study|Ineligible|4|||
125682355|NCT01886872|452127111|FG002|Overall Study|Ineligible|12|||
125682356|NCT04908397|452127112|FG000|Overall Study|Withdrawal by Subject|2|||
125682357|NCT04264442|452127113|FG000|Overall Study|Lack of Efficacy|6|||
125682358|NCT04264442|452127113|FG000|Overall Study|Lost to Follow-up|2|||
125682359|NCT04264442|452127113|FG000|Overall Study|Sponsor Decision|23|||
125682360|NCT04264442|452127113|FG000|Overall Study|Withdrawal by Subject|11|||
125682361|NCT04264442|452127113|FG000|Overall Study|Study Termination|5|||
125682362|NCT04941482|452127114|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
125682363|NCT04941482|452127115|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
125682364|NCT00288353|452127116|FG000|Overall Study|Lack of Efficacy|2|||
125682365|NCT00288353|452127117|FG001|Overall Study|Lack of Efficacy|2|||
125682366|NCT00288353|452127116|FG000|Overall Study|Withdrawal by Subject|5|||
125682367|NCT00288353|452127117|FG001|Overall Study|Withdrawal by Subject|5|||
125549038|NCT00940108|451639738|FG000|Overall Study|Declined further vaccination|0|||
125549039|NCT00940108|451639739|FG001|Overall Study|Declined further vaccination|1|||
125549040|NCT00940108|451639740|FG002|Overall Study|Declined further vaccination|3|||
125549041|NCT00940108|451639741|FG003|Overall Study|Declined further vaccination|0|||
125549042|NCT00940108|451639738|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
125549043|NCT00940108|451639739|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
125549044|NCT00940108|451639740|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
125549045|NCT00940108|451639741|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
125549046|NCT00940108|451639738|FG000|Overall Study|Viral illness after Dose 1|0|||
125549047|NCT00940108|451639739|FG001|Overall Study|Viral illness after Dose 1|1|||
125549048|NCT00940108|451639740|FG002|Overall Study|Viral illness after Dose 1|0|||
125549049|NCT00940108|451639741|FG003|Overall Study|Viral illness after Dose 1|0|||
125549050|NCT00940108|451639738|FG000|Overall Study|Diagnosed with H1N1|0|||
125549051|NCT00940108|451639739|FG001|Overall Study|Diagnosed with H1N1|0|||
125549052|NCT00940108|451639740|FG002|Overall Study|Diagnosed with H1N1|0|||
125549053|NCT00940108|451639741|FG003|Overall Study|Diagnosed with H1N1|1|||
125549054|NCT02075541|451639742|FG000|Overall Study|Serious Adverse Event|1|||
125549055|NCT02075541|451639743|FG001|Overall Study|Serious Adverse Event|4|||
125549056|NCT02075541|451639742|FG000|Overall Study|Protocol Violation|1|||
125549057|NCT02075541|451639743|FG001|Overall Study|Protocol Violation|0|||
125549058|NCT02075541|451639742|FG000|Overall Study|Withdrawal by Subject|1|||
125549059|NCT02075541|451639743|FG001|Overall Study|Withdrawal by Subject|3|||
125549060|NCT02075541|451639742|FG000|Overall Study|Sponsor study termination|0|||
125549061|NCT02075541|451639743|FG001|Overall Study|Sponsor study termination|1|||
125549062|NCT02075541|451639742|FG000|Overall Study|Other- unable to perform study procedure|1|||
125549063|NCT02075541|451639743|FG001|Overall Study|Other- unable to perform study procedure|0|||
125549064|NCT01142596|451639745|FG000|Overall Study|Withdrawal by Subject|9|||
125549065|NCT01142596|451639746|FG001|Overall Study|Withdrawal by Subject|35|||
125549066|NCT01142596|451639745|FG000|Overall Study|Adverse Event|8|||
125549067|NCT01142596|451639746|FG001|Overall Study|Adverse Event|35|||
125549068|NCT01142596|451639745|FG000|Overall Study|Lack of Efficacy|5|||
125549069|NCT01142596|451639746|FG001|Overall Study|Lack of Efficacy|9|||
125549070|NCT01142596|451639745|FG000|Overall Study|Lost to Follow-up|2|||
125549071|NCT01142596|451639746|FG001|Overall Study|Lost to Follow-up|3|||
125549072|NCT01142596|451639745|FG000|Overall Study|Other reason (not specified)|5|||
125549073|NCT01142596|451639746|FG001|Overall Study|Other reason (not specified)|4|||
125549074|NCT01054846|451639747|FG000|Overall Study|Lost to Follow-up|76|||
125549075|NCT01054846|451639748|FG001|Overall Study|Lost to Follow-up|17|||
125549076|NCT02446886|451639749|FG000|Overall Study|Adverse Event|1|||
125549077|NCT02446886|451639750|FG001|Overall Study|Adverse Event|3|||
125549078|NCT02446886|451639749|FG000|Overall Study|Withdrawal by Subject|1|||
125549079|NCT02446886|451639750|FG001|Overall Study|Withdrawal by Subject|1|||
125549080|NCT00928447|451639751|FG000|Overall Study|Withdrawal by Subject|1|||
125549081|NCT00928447|451639751|FG000|Overall Study|Investigator's decision|1|||
125549082|NCT01259284|451639752|FG000|Overall Study|Study Termination|2|||
125549083|NCT01259284|451639753|FG001|Overall Study|Study Termination|0|||
125549084|NCT01259284|451639754|FG002|Overall Study|Study Termination|0|||
125549085|NCT02988622|451639755|FG000|Overall Study|Lost to Follow-up|17|||
125549086|NCT03562247|451639759|FG000|Overall Study|Lost to Follow-up|3|||
125549087|NCT03562247|451639760|FG001|Overall Study|Lost to Follow-up|1|||
125549088|NCT03562247|451639761|FG002|Overall Study|Lost to Follow-up|1|||
125549089|NCT01204398|451639762|FG000|Overall Study|Adverse Event|1|||
125549090|NCT00983931|451639763|FG000|14 Day Washout Period|Physician Decision|1|||
125549091|NCT01281969|451639766|FG000|Overall Study|not randomized didn't meet criteria|0|||
125549092|NCT01281969|451639767|FG001|Overall Study|not randomized didn't meet criteria|0|||
125549093|NCT01281969|451639768|FG002|Overall Study|not randomized didn't meet criteria|7|||
125549094|NCT01281969|451639766|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
125549095|NCT01281969|451639767|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
125549096|NCT01281969|451639768|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
125549097|NCT01281969|451639766|FG000|Overall Study|not randomized, child consent not given|0|||
125349550|NCT01150474|450913524|FG000|Overall Study|Drug not administered|1|||
125549098|NCT01281969|451639767|FG001|Overall Study|not randomized, child consent not given|0|||
125549099|NCT01281969|451639768|FG002|Overall Study|not randomized, child consent not given|2|||
125549100|NCT01201265|451639773|FG000|Overall Study|Death|14|||
125549101|NCT01201265|451639773|FG000|Overall Study|Insufficient Therapeutic Response|3|||
125549102|NCT01201265|451639773|FG000|Overall Study|Lost to Follow-up|10|||
125349551|NCT01150474|450913525|FG001|Overall Study|Drug not administered|0|||
125549103|NCT01201265|451639773|FG000|Overall Study|Withdrawal by Subject|7|||
125549104|NCT01201265|451639773|FG000|Overall Study|Disease Progression|4|||
125549105|NCT04640077|451639774|FG000|Period 1|Withdrawal by Subject|4|||
125549106|NCT04640077|451639775|FG001|Period 1|Withdrawal by Subject|5|||
125549107|NCT04640077|451639776|FG002|Period 1|Withdrawal by Subject|0|||
125549108|NCT04640077|451639774|FG000|Period 1|Adverse Event|1|||
125549109|NCT04640077|451639775|FG001|Period 1|Adverse Event|1|||
125549110|NCT04640077|451639776|FG002|Period 1|Adverse Event|0|||
125549111|NCT04640077|451639774|FG000|Period 1|Screen Failure|2|||
125549112|NCT04640077|451639775|FG001|Period 1|Screen Failure|0|||
125549113|NCT04640077|451639776|FG002|Period 1|Screen Failure|0|||
125549114|NCT04640077|451639774|FG000|Period 2|Withdrawal by Subject|0|||
125549115|NCT04640077|451639775|FG001|Period 2|Withdrawal by Subject|0|||
125549116|NCT04640077|451639776|FG002|Period 2|Withdrawal by Subject|18|||
125549117|NCT04640077|451639774|FG000|Period 2|Adverse Event|0|||
125549118|NCT04640077|451639775|FG001|Period 2|Adverse Event|0|||
125549119|NCT04640077|451639776|FG002|Period 2|Adverse Event|6|||
125549120|NCT04640077|451639774|FG000|Period 2|Lost to Follow-up|0|||
125549121|NCT04640077|451639775|FG001|Period 2|Lost to Follow-up|0|||
125549122|NCT04640077|451639776|FG002|Period 2|Lost to Follow-up|2|||
125549123|NCT04640077|451639774|FG000|Period 2|Death|0|||
125549124|NCT04640077|451639775|FG001|Period 2|Death|0|||
125549125|NCT04640077|451639776|FG002|Period 2|Death|2|||
125549126|NCT04640077|451639774|FG000|Period 2|Progressive Disease|0|||
125549127|NCT04640077|451639775|FG001|Period 2|Progressive Disease|0|||
125549128|NCT04640077|451639776|FG002|Period 2|Progressive Disease|1|||
125549129|NCT04640077|451639774|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
125549130|NCT04640077|451639775|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
125549131|NCT04640077|451639776|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
125549132|NCT01257425|451639777|FG000|Overall Study|Lack of Efficacy|3|||
125549133|NCT01257425|451639778|FG001|Overall Study|Lack of Efficacy|3|||
125549134|NCT01257425|451639777|FG000|Overall Study|Adverse Event|1|||
125549135|NCT01257425|451639778|FG001|Overall Study|Adverse Event|1|||
125549136|NCT01257425|451639777|FG000|Overall Study|Protocol Violation|1|||
125549137|NCT01257425|451639778|FG001|Overall Study|Protocol Violation|1|||
125549138|NCT01257425|451639777|FG000|Overall Study|Withdrawal by Subject|0|||
125549139|NCT01257425|451639778|FG001|Overall Study|Withdrawal by Subject|1|||
125549140|NCT01257425|451639777|FG000|Overall Study|Death|1|||
125549141|NCT01257425|451639778|FG001|Overall Study|Death|0|||
125549142|NCT01182194|451639779|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
125549143|NCT01182194|451639780|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
125549144|NCT03343301|451639782|FG000|Overall Study|Withdrawal by Subject|1|||
125549145|NCT03343301|451639783|FG001|Overall Study|Withdrawal by Subject|1|||
125549146|NCT03343301|451639782|FG000|Overall Study|Death|0|||
125549147|NCT03343301|451639783|FG001|Overall Study|Death|2|||
125549148|NCT03343301|451639782|FG000|Overall Study|Other|0|||
125549149|NCT03343301|451639783|FG001|Overall Study|Other|6|||
125549150|NCT03343301|451639782|FG000|Overall Study|Missing|2|||
125549151|NCT03343301|451639783|FG001|Overall Study|Missing|0|||
125549152|NCT00368992|451639784|FG000|Overall Study|Ineligible|5|||
125549153|NCT00368992|451639784|FG000|Overall Study|Refused treatment|3|||
125549154|NCT00368992|451639784|FG000|Overall Study|Lack of Efficacy|63|||
125549155|NCT00368992|451639784|FG000|Overall Study|Adverse Event|26|||
125549156|NCT00368992|451639784|FG000|Overall Study|Death|4|||
125549157|NCT00368992|451639784|FG000|Overall Study|Other|9|||
125549158|NCT02668185|451639785|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
125549159|NCT02668185|451639786|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
125549160|NCT02668185|451639785|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
125549161|NCT02668185|451639786|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
125549162|NCT02668185|451639785|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
125549163|NCT02668185|451639786|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
125549164|NCT02668185|451639785|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
125549165|NCT02668185|451639786|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
125549166|NCT01013597|451639787|FG000|Overall Study|Withdrawal by Subject|1|||
125549167|NCT00723021|451639792|FG000|Intervention Period 4|Adverse Event|0|||
125682368|NCT04604275|452127118|FG000|Washout-1 Week|Withdrawal by Subject|1|||
125682369|NCT04604275|452127119|FG001|Washout-1 Week|Withdrawal by Subject|0|||
125682370|NCT05615935|452127122|FG000|Overall Study|Lost to Follow-up|1|||
125682371|NCT05615935|452127123|FG001|Overall Study|Lost to Follow-up|1|||
125549168|NCT00723021|451639793|FG001|Intervention Period 4|Adverse Event|0|||
125549169|NCT00723021|451639794|FG002|Intervention Period 4|Adverse Event|0|||
125549170|NCT00723021|451639795|FG003|Intervention Period 4|Adverse Event|0|||
125549171|NCT00723021|451639796|FG004|Intervention Period 4|Adverse Event|1|||
125549172|NCT00770341|451639797|FG000|Overall Study|Did not meet eligibility criteria|1|||
125549173|NCT00770341|451639798|FG001|Overall Study|Did not meet eligibility criteria|0|||
125549174|NCT00770341|451639799|FG002|Overall Study|Did not meet eligibility criteria|0|||
125549175|NCT00770341|451639797|FG000|Overall Study|Withdrawal by Subject|0|||
125549176|NCT00770341|451639798|FG001|Overall Study|Withdrawal by Subject|1|||
125549177|NCT00770341|451639799|FG002|Overall Study|Withdrawal by Subject|0|||
125549178|NCT00770341|451639797|FG000|Overall Study|Clinical Adverse Event|3|||
125549179|NCT00770341|451639798|FG001|Overall Study|Clinical Adverse Event|1|||
125549180|NCT00770341|451639799|FG002|Overall Study|Clinical Adverse Event|2|||
125682372|NCT04985604|452127125|FG000|Overall Study|Death|4|||
125682373|NCT04985604|452127126|FG001|Overall Study|Death|6|||
125549181|NCT00770341|451639797|FG000|Overall Study|Laboratory adverse event|3|||
125549182|NCT00770341|451639798|FG001|Overall Study|Laboratory adverse event|3|||
125549183|NCT00770341|451639799|FG002|Overall Study|Laboratory adverse event|0|||
125549184|NCT00770341|451639797|FG000|Overall Study|Lack of Efficacy|3|||
125549185|NCT00770341|451639798|FG001|Overall Study|Lack of Efficacy|0|||
125549186|NCT00770341|451639799|FG002|Overall Study|Lack of Efficacy|1|||
125549187|NCT00770341|451639797|FG000|Overall Study|Other|1|||
125549188|NCT00770341|451639798|FG001|Overall Study|Other|0|||
125549189|NCT00770341|451639799|FG002|Overall Study|Other|0|||
125549190|NCT00770341|451639797|FG000|Overall Study|Not treated|1|||
125549191|NCT00770341|451639798|FG001|Overall Study|Not treated|0|||
125549192|NCT00770341|451639799|FG002|Overall Study|Not treated|0|||
125549193|NCT00960531|451639805|FG000|Overall Study|Lack of Efficacy|1|||
125549194|NCT00960531|451639806|FG001|Overall Study|Lack of Efficacy|0|||
125549195|NCT00960531|451639807|FG002|Overall Study|Lack of Efficacy|0|||
125549196|NCT00960531|451639808|FG003|Overall Study|Lack of Efficacy|0|||
125549197|NCT00960531|451639809|FG004|Overall Study|Lack of Efficacy|0|||
125549198|NCT00960531|451639810|FG005|Overall Study|Lack of Efficacy|0|||
125549199|NCT00960531|451639811|FG006|Overall Study|Lack of Efficacy|0|||
125549200|NCT00960531|451639812|FG007|Overall Study|Lack of Efficacy|0|||
125549201|NCT00960531|451639813|FG008|Overall Study|Lack of Efficacy|0|||
125549202|NCT00960531|451639814|FG009|Overall Study|Lack of Efficacy|0|||
125549203|NCT00960531|451639805|FG000|Overall Study|Withdrawal by Subject|1|||
125549204|NCT00960531|451639806|FG001|Overall Study|Withdrawal by Subject|0|||
125549205|NCT00960531|451639807|FG002|Overall Study|Withdrawal by Subject|5|||
125549206|NCT00960531|451639808|FG003|Overall Study|Withdrawal by Subject|2|||
125549207|NCT00960531|451639809|FG004|Overall Study|Withdrawal by Subject|0|||
125549208|NCT00960531|451639810|FG005|Overall Study|Withdrawal by Subject|0|||
125549209|NCT00960531|451639811|FG006|Overall Study|Withdrawal by Subject|2|||
125549210|NCT00960531|451639812|FG007|Overall Study|Withdrawal by Subject|0|||
125549211|NCT00960531|451639813|FG008|Overall Study|Withdrawal by Subject|1|||
125549212|NCT00960531|451639814|FG009|Overall Study|Withdrawal by Subject|0|||
125549213|NCT00960531|451639805|FG000|Overall Study|Caregiver Request|2|||
125549214|NCT00960531|451639806|FG001|Overall Study|Caregiver Request|0|||
125549215|NCT00960531|451639807|FG002|Overall Study|Caregiver Request|6|||
125549216|NCT00960531|451639808|FG003|Overall Study|Caregiver Request|5|||
125549217|NCT00960531|451639809|FG004|Overall Study|Caregiver Request|0|||
125549218|NCT00960531|451639810|FG005|Overall Study|Caregiver Request|2|||
125549219|NCT00960531|451639811|FG006|Overall Study|Caregiver Request|3|||
125549220|NCT00960531|451639812|FG007|Overall Study|Caregiver Request|1|||
125549221|NCT00960531|451639813|FG008|Overall Study|Caregiver Request|3|||
125549222|NCT00960531|451639814|FG009|Overall Study|Caregiver Request|0|||
125549223|NCT00960531|451639805|FG000|Overall Study|Investigator Request|0|||
125549224|NCT00960531|451639806|FG001|Overall Study|Investigator Request|0|||
125549225|NCT00960531|451639807|FG002|Overall Study|Investigator Request|1|||
125549226|NCT00960531|451639808|FG003|Overall Study|Investigator Request|0|||
125549227|NCT00960531|451639809|FG004|Overall Study|Investigator Request|0|||
125549228|NCT00960531|451639810|FG005|Overall Study|Investigator Request|0|||
125549229|NCT00960531|451639811|FG006|Overall Study|Investigator Request|0|||
125549230|NCT00960531|451639812|FG007|Overall Study|Investigator Request|0|||
125549231|NCT00960531|451639813|FG008|Overall Study|Investigator Request|0|||
125549232|NCT00960531|451639814|FG009|Overall Study|Investigator Request|0|||
125549233|NCT00960531|451639805|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
125549234|NCT00960531|451639806|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
125549235|NCT00960531|451639807|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
125549236|NCT00960531|451639808|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
125549237|NCT00960531|451639809|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
125549238|NCT00960531|451639810|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
125549239|NCT00960531|451639811|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
125549240|NCT00960531|451639812|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
125549241|NCT00960531|451639813|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
125549242|NCT00960531|451639814|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
125549243|NCT00960531|451639805|FG000|Overall Study|Lost to Follow-up|0|||
125549244|NCT00960531|451639806|FG001|Overall Study|Lost to Follow-up|0|||
125549245|NCT00960531|451639807|FG002|Overall Study|Lost to Follow-up|1|||
125549246|NCT00960531|451639808|FG003|Overall Study|Lost to Follow-up|0|||
125549247|NCT00960531|451639809|FG004|Overall Study|Lost to Follow-up|0|||
125549248|NCT00960531|451639810|FG005|Overall Study|Lost to Follow-up|0|||
125549249|NCT00960531|451639811|FG006|Overall Study|Lost to Follow-up|1|||
125549250|NCT00960531|451639812|FG007|Overall Study|Lost to Follow-up|0|||
125549251|NCT00960531|451639813|FG008|Overall Study|Lost to Follow-up|0|||
125549252|NCT00960531|451639814|FG009|Overall Study|Lost to Follow-up|0|||
125549253|NCT00960531|451639805|FG000|Overall Study|Failed to Return|2|||
125549254|NCT00960531|451639806|FG001|Overall Study|Failed to Return|0|||
125549255|NCT00960531|451639807|FG002|Overall Study|Failed to Return|0|||
125549256|NCT00960531|451639808|FG003|Overall Study|Failed to Return|0|||
125549257|NCT00960531|451639809|FG004|Overall Study|Failed to Return|0|||
125549258|NCT00960531|451639810|FG005|Overall Study|Failed to Return|0|||
125549259|NCT00960531|451639811|FG006|Overall Study|Failed to Return|0|||
125549260|NCT00960531|451639812|FG007|Overall Study|Failed to Return|2|||
125549261|NCT00960531|451639813|FG008|Overall Study|Failed to Return|0|||
125549262|NCT00960531|451639814|FG009|Overall Study|Failed to Return|0|||
125549263|NCT00960531|451639805|FG000|Overall Study|Adverse Event (AE)|2|||
125549264|NCT00960531|451639806|FG001|Overall Study|Adverse Event (AE)|0|||
125549265|NCT00960531|451639807|FG002|Overall Study|Adverse Event (AE)|0|||
125549266|NCT00960531|451639808|FG003|Overall Study|Adverse Event (AE)|0|||
125549267|NCT00960531|451639809|FG004|Overall Study|Adverse Event (AE)|0|||
125549268|NCT00960531|451639810|FG005|Overall Study|Adverse Event (AE)|1|||
125549269|NCT00960531|451639811|FG006|Overall Study|Adverse Event (AE)|2|||
125549270|NCT00960531|451639812|FG007|Overall Study|Adverse Event (AE)|0|||
125549271|NCT00960531|451639813|FG008|Overall Study|Adverse Event (AE)|2|||
125549272|NCT00960531|451639814|FG009|Overall Study|Adverse Event (AE)|0|||
125549273|NCT00960531|451639805|FG000|Overall Study|Reason not Specified|2|||
125549274|NCT00960531|451639806|FG001|Overall Study|Reason not Specified|1|||
125549275|NCT00960531|451639807|FG002|Overall Study|Reason not Specified|13|||
125549276|NCT00960531|451639808|FG003|Overall Study|Reason not Specified|1|||
125549277|NCT00960531|451639809|FG004|Overall Study|Reason not Specified|2|||
125549278|NCT00960531|451639810|FG005|Overall Study|Reason not Specified|0|||
125549279|NCT00960531|451639811|FG006|Overall Study|Reason not Specified|16|||
125549280|NCT00960531|451639812|FG007|Overall Study|Reason not Specified|0|||
125549281|NCT00960531|451639813|FG008|Overall Study|Reason not Specified|8|||
125549282|NCT00960531|451639814|FG009|Overall Study|Reason not Specified|1|||
125549283|NCT01163916|451639815|FG000|Overall Study|Withdrawal by Subject|2|||
125549284|NCT01163916|451639816|FG001|Overall Study|Withdrawal by Subject|0|||
125549285|NCT01163916|451639817|FG002|Overall Study|Withdrawal by Subject|2|||
125549286|NCT01163916|451639815|FG000|Overall Study|Adverse Event|2|||
125549287|NCT01163916|451639816|FG001|Overall Study|Adverse Event|0|||
125549288|NCT01163916|451639817|FG002|Overall Study|Adverse Event|1|||
125549289|NCT01163916|451639815|FG000|Overall Study|Lack of Efficacy|2|||
125549290|NCT01163916|451639816|FG001|Overall Study|Lack of Efficacy|0|||
125549291|NCT01163916|451639817|FG002|Overall Study|Lack of Efficacy|1|||
125549292|NCT01163916|451639815|FG000|Overall Study|Other|24|||
125549293|NCT01163916|451639816|FG001|Overall Study|Other|4|||
125549294|NCT01163916|451639817|FG002|Overall Study|Other|16|||
125549295|NCT00883051|451639818|FG000|Overall Study|Lost to Follow-up|0|||
125549296|NCT00883051|451639819|FG001|Overall Study|Lost to Follow-up|0|||
125549297|NCT00883051|451639820|FG002|Overall Study|Lost to Follow-up|0|||
125549298|NCT00883051|451639821|FG003|Overall Study|Lost to Follow-up|0|||
125549299|NCT00883051|451639822|FG004|Overall Study|Lost to Follow-up|1|||
125549300|NCT00883051|451639818|FG000|Overall Study|Did not use study medication|24|||
125549301|NCT00883051|451639819|FG001|Overall Study|Did not use study medication|22|||
125549302|NCT00883051|451639820|FG002|Overall Study|Did not use study medication|29|||
125549303|NCT00883051|451639821|FG003|Overall Study|Did not use study medication|29|||
125549304|NCT00883051|451639822|FG004|Overall Study|Did not use study medication|17|||
125549305|NCT02337751|451639823|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
125549306|NCT02337751|451639824|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
125549307|NCT02337751|451639823|FG000|Overall Study|Voluntary Withdrawal|6|||
125549308|NCT02337751|451639824|FG001|Overall Study|Voluntary Withdrawal|8|||
125549309|NCT02337751|451639823|FG000|Overall Study|Lack of Efficacy|2|||
125549310|NCT02337751|451639824|FG001|Overall Study|Lack of Efficacy|5|||
125549311|NCT02337751|451639823|FG000|Overall Study|Investigator's Judgement|1|||
125549312|NCT02337751|451639824|FG001|Overall Study|Investigator's Judgement|0|||
125549313|NCT02656823|451639831|FG000|Overall Study|Adverse Event|3|||
125549314|NCT02656823|451639831|FG000|Overall Study|Lost to Follow-up|2|||
125549315|NCT01910181|451639832|FG000|Overall Study|Death|37|||
125549316|NCT01910181|451639832|FG000|Overall Study|Lost to Follow-up|3|||
125549317|NCT01910181|451639832|FG000|Overall Study|Study Terminated by Sponsor|6|||
125549318|NCT05269355|451639833|FG000|Overall Study|Progressive Disease|104|||
125549319|NCT05269355|451639834|FG001|Overall Study|Progressive Disease|68|||
125549320|NCT05269355|451639833|FG000|Overall Study|Study Terminated by Sponsor|87|||
125549321|NCT05269355|451639834|FG001|Overall Study|Study Terminated by Sponsor|29|||
125549322|NCT05269355|451639833|FG000|Overall Study|Adverse Event|15|||
125549323|NCT05269355|451639834|FG001|Overall Study|Adverse Event|8|||
125549324|NCT05269355|451639833|FG000|Overall Study|Withdrawal by Subject|18|||
125549325|NCT05269355|451639834|FG001|Overall Study|Withdrawal by Subject|5|||
125549326|NCT05269355|451639833|FG000|Overall Study|Physician Decision|6|||
125549327|NCT05269355|451639834|FG001|Overall Study|Physician Decision|4|||
125549328|NCT05269355|451639833|FG000|Overall Study|Death|3|||
125549329|NCT05269355|451639834|FG001|Overall Study|Death|5|||
125549330|NCT05269355|451639833|FG000|Overall Study|Other Than Specified|5|||
125549331|NCT05269355|451639834|FG001|Overall Study|Other Than Specified|1|||
125549332|NCT05269355|451639833|FG000|Overall Study|Randomized But Not Treated|1|||
125549333|NCT05269355|451639834|FG001|Overall Study|Randomized But Not Treated|0|||
125549334|NCT00959647|451639836|FG000|Overall Study|Adverse Event|2|||
125549335|NCT00959647|451639836|FG000|Overall Study|Progressive disease|6|||
125549336|NCT00959647|451639836|FG000|Overall Study|Study terminated by sponsor|4|||
125549337|NCT00959647|451639836|FG000|Overall Study|Withdrawal by Subject|7|||
125549338|NCT01328717|451642267|FG000|Overall Study|Adverse Event|1|||
125549339|NCT03440320|451642268|FG000|Overall Study|Withdrawal by Subject|0|||
125549340|NCT03440320|451642269|FG001|Overall Study|Withdrawal by Subject|1|||
125549341|NCT01786174|451642272|FG000|Overall Study|Discontinued Study Drug|2|||
125549342|NCT01786174|451642273|FG001|Overall Study|Discontinued Study Drug|0|||
125549343|NCT01620255|451642282|FG000|Overall Study|Withdrawal by Subject|4|||
125549344|NCT01620255|451642283|FG001|Overall Study|Withdrawal by Subject|1|||
125549345|NCT01620255|451642284|FG002|Overall Study|Withdrawal by Subject|1|||
125549346|NCT01620255|451642285|FG003|Overall Study|Withdrawal by Subject|2|||
125549347|NCT01620255|451642286|FG004|Overall Study|Withdrawal by Subject|4|||
125549348|NCT01620255|451642282|FG000|Overall Study|Participant underwent fecal transplant|0|||
125549349|NCT01620255|451642283|FG001|Overall Study|Participant underwent fecal transplant|0|||
125549350|NCT01620255|451642284|FG002|Overall Study|Participant underwent fecal transplant|1|||
125549351|NCT01620255|451642285|FG003|Overall Study|Participant underwent fecal transplant|0|||
125549352|NCT01620255|451642286|FG004|Overall Study|Participant underwent fecal transplant|0|||
125549353|NCT01620255|451642282|FG000|Overall Study|Non-compliance|0|||
125549354|NCT01620255|451642283|FG001|Overall Study|Non-compliance|1|||
125549355|NCT01620255|451642284|FG002|Overall Study|Non-compliance|0|||
125549356|NCT01620255|451642285|FG003|Overall Study|Non-compliance|0|||
125549357|NCT01620255|451642286|FG004|Overall Study|Non-compliance|0|||
125549358|NCT01620255|451642282|FG000|Overall Study|Adverse Event|0|||
125549359|NCT01620255|451642283|FG001|Overall Study|Adverse Event|4|||
125549360|NCT01620255|451642284|FG002|Overall Study|Adverse Event|0|||
125549361|NCT01620255|451642285|FG003|Overall Study|Adverse Event|1|||
125549362|NCT01620255|451642286|FG004|Overall Study|Adverse Event|1|||
125549363|NCT01620255|451642282|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
125549364|NCT01620255|451642283|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
125549365|NCT01620255|451642284|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
125549366|NCT01620255|451642285|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
125549367|NCT01620255|451642286|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
125549368|NCT00288509|451642290|FG000|Treatment Cycle 1|Adverse Event|1|||
125549369|NCT00288509|451642290|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
125549370|NCT00288509|451642290|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
125549371|NCT00288509|451642290|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
125549372|NCT00288509|451642290|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
125549373|NCT00288509|451642290|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
125549374|NCT00288509|451642290|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
125549375|NCT00288509|451642290|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
125549376|NCT00288509|451642290|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
125549377|NCT00288509|451642290|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
125549378|NCT00288509|451642290|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
125682374|NCT04985604|452127125|FG000|Overall Study|Withdrawal by Subject|0|||
125349552|NCT01150474|450913524|FG000|Overall Study|Surgery Changed|1|||
125349553|NCT01150474|450913525|FG001|Overall Study|Surgery Changed|0|||
125349554|NCT01423604|450913526|FG000|Safety Run-In|Adverse Event|3|||
125349555|NCT01423604|450913527|FG001|Safety Run-In|Adverse Event|0|||
125349556|NCT01423604|450913526|FG000|Safety Run-In|Death|1|||
125349557|NCT01423604|450913527|FG001|Safety Run-In|Death|0|||
125349558|NCT01423604|450913526|FG000|Safety Run-In|Physician Decision|1|||
125349559|NCT01423604|450913527|FG001|Safety Run-In|Physician Decision|0|||
125549379|NCT00288509|451642290|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
125549380|NCT00288509|451642290|FG000|Treatment Cycle 4|Physician Decision|4|||
125549381|NCT00288509|451642290|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
125549382|NCT01155375|451642298|FG000|Overall Study|Adverse Event|1|||
125549383|NCT01155375|451642299|FG001|Overall Study|Adverse Event|0|||
125549384|NCT01480674|451642303|FG000|Overall Study|Death|23|||
125549385|NCT01480674|451642303|FG000|Overall Study|Lost to Follow-up|2|||
125549386|NCT01480674|451642303|FG000|Overall Study|visit not done|10|||
125549387|NCT03818204|451642304|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549388|NCT03818204|451642305|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549389|NCT03818204|451642306|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549390|NCT03818204|451642307|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549391|NCT03818204|451642308|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
125682375|NCT04985604|452127126|FG001|Overall Study|Withdrawal by Subject|1|||
125549392|NCT03818204|451642309|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549393|NCT03818204|451642310|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549394|NCT03818204|451642311|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549395|NCT03818204|451642312|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549396|NCT03818204|451642313|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549397|NCT03818204|451642314|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549398|NCT03818204|451642315|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549399|NCT03818204|451642316|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549400|NCT03818204|451642317|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
125549401|NCT03818204|451642318|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549402|NCT03818204|451642319|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549403|NCT03818204|451642320|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549404|NCT03818204|451642321|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549405|NCT03818204|451642322|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
125549406|NCT03818204|451642304|FG000|Overall Study|Physician Decision|0|||
125549407|NCT03818204|451642305|FG001|Overall Study|Physician Decision|0|||
125549408|NCT03818204|451642306|FG002|Overall Study|Physician Decision|0|||
125549409|NCT03818204|451642307|FG003|Overall Study|Physician Decision|0|||
125549410|NCT03818204|451642308|FG004|Overall Study|Physician Decision|0|||
125549411|NCT03818204|451642309|FG005|Overall Study|Physician Decision|0|||
125549412|NCT03818204|451642310|FG006|Overall Study|Physician Decision|0|||
125549413|NCT03818204|451642311|FG007|Overall Study|Physician Decision|0|||
125549414|NCT03818204|451642312|FG008|Overall Study|Physician Decision|0|||
125549415|NCT03818204|451642313|FG009|Overall Study|Physician Decision|0|||
125549416|NCT03818204|451642314|FG010|Overall Study|Physician Decision|0|||
125549417|NCT03818204|451642315|FG011|Overall Study|Physician Decision|0|||
125549418|NCT03818204|451642316|FG012|Overall Study|Physician Decision|0|||
125549419|NCT03818204|451642317|FG013|Overall Study|Physician Decision|0|||
125549420|NCT03818204|451642318|FG014|Overall Study|Physician Decision|1|||
125549421|NCT03818204|451642319|FG015|Overall Study|Physician Decision|0|||
125549422|NCT03818204|451642320|FG016|Overall Study|Physician Decision|0|||
125549423|NCT03818204|451642321|FG017|Overall Study|Physician Decision|0|||
125549424|NCT03818204|451642322|FG018|Overall Study|Physician Decision|0|||
125549425|NCT01933113|451642323|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
125549426|NCT04981366|451642324|FG000|Overall Study|Withdrawal by Subject|5|||
125549427|NCT04981366|451642325|FG001|Overall Study|Withdrawal by Subject|4|||
125549428|NCT04981366|451642326|FG002|Overall Study|Withdrawal by Subject|8|||
125549429|NCT04981366|451642324|FG000|Overall Study|Health issues unrelated to the trial|1|||
125549430|NCT04981366|451642325|FG001|Overall Study|Health issues unrelated to the trial|2|||
125549431|NCT04981366|451642326|FG002|Overall Study|Health issues unrelated to the trial|0|||
125549432|NCT00795951|451642327|FG000|Overall Study|Lost to Follow-up|1|||
125549433|NCT00795951|451642327|FG000|Overall Study|Withdrawal by Subject|1|||
125549434|NCT01122862|451642339|FG000|Period 1|Protocol Violation|0|||
125549435|NCT01122862|451642340|FG001|Period 1|Protocol Violation|1|||
125549436|NCT01122862|451642341|FG002|Period 1|Protocol Violation|0|||
125549437|NCT01122862|451642339|FG000|Period 2|Adverse Event|0|||
125549438|NCT01122862|451642340|FG001|Period 2|Adverse Event|0|||
125549439|NCT01122862|451642341|FG002|Period 2|Adverse Event|1|||
125549440|NCT02699983|451642344|FG000|Overall Study|Withdrawal by Subject|1|||
125549441|NCT02699983|451642345|FG001|Overall Study|Withdrawal by Subject|0|||
125549442|NCT03421431|451642346|FG000|Overall Study|Adverse Event|2|||
125549443|NCT03421431|451642347|FG001|Overall Study|Adverse Event|1|||
125549444|NCT03421431|451642348|FG002|Overall Study|Adverse Event|12|||
125549445|NCT03421431|451642346|FG000|Overall Study|Lost to Follow-up|1|||
125549446|NCT03421431|451642347|FG001|Overall Study|Lost to Follow-up|1|||
125549447|NCT03421431|451642348|FG002|Overall Study|Lost to Follow-up|1|||
125549448|NCT03421431|451642346|FG000|Overall Study|Withdrawal by Subject|3|||
125549449|NCT03421431|451642347|FG001|Overall Study|Withdrawal by Subject|2|||
125549450|NCT03421431|451642348|FG002|Overall Study|Withdrawal by Subject|1|||
125549451|NCT03421431|451642346|FG000|Overall Study|Protocol Violation|0|||
125549452|NCT03421431|451642347|FG001|Overall Study|Protocol Violation|1|||
125549453|NCT03421431|451642348|FG002|Overall Study|Protocol Violation|0|||
125549454|NCT03421431|451642346|FG000|Overall Study|Participant met Stopping Rules|0|||
125549455|NCT03421431|451642347|FG001|Overall Study|Participant met Stopping Rules|1|||
125549456|NCT03421431|451642348|FG002|Overall Study|Participant met Stopping Rules|0|||
125682376|NCT02282761|452127129|FG000|Overall Study|Death|0|||
125682377|NCT02282761|452127130|FG001|Overall Study|Death|0|||
125682378|NCT02282761|452127131|FG002|Overall Study|Death|1|||
125682379|NCT02282761|452127129|FG000|Overall Study|Adverse Event|6|||
125682380|NCT02282761|452127130|FG001|Overall Study|Adverse Event|2|||
125549457|NCT00141726|451642352|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
125549458|NCT00235326|451642357|FG000|Overall Study|Lost to Follow-up|746|||
125549459|NCT00235326|451642358|FG001|Overall Study|Lost to Follow-up|1400|||
125682381|NCT02282761|452127131|FG002|Overall Study|Adverse Event|0|||
125682382|NCT02282761|452127129|FG000|Overall Study|Lack of Efficacy|11|||
125549460|NCT01790126|451642359|FG000|Overall Study|PSA Progression|12|||
125549461|NCT01790126|451642360|FG001|Overall Study|PSA Progression|16|||
125549462|NCT01790126|451642361|FG002|Overall Study|PSA Progression|16|||
125549463|NCT01790126|451642359|FG000|Overall Study|Other|5|||
125549464|NCT01790126|451642360|FG001|Overall Study|Other|4|||
125349560|NCT01423604|450913526|FG000|Safety Run-In|Disease progression|3|||
125349561|NCT01423604|450913527|FG001|Safety Run-In|Disease progression|0|||
125349562|NCT01423604|450913526|FG000|Safety Run-In|Patient decision|1|||
125349563|NCT01423604|450913527|FG001|Safety Run-In|Patient decision|0|||
125349564|NCT01423604|450913526|FG000|Randomized|Adverse Event|4|||
125349565|NCT01423604|450913527|FG001|Randomized|Adverse Event|10|||
125349566|NCT01423604|450913526|FG000|Randomized|Death|1|||
125349567|NCT01423604|450913527|FG001|Randomized|Death|0|||
125349568|NCT01423604|450913526|FG000|Randomized|Physician Decision|16|||
125349569|NCT01423604|450913527|FG001|Randomized|Physician Decision|13|||
125349570|NCT01423604|450913526|FG000|Randomized|Other - unspecified|37|||
125549465|NCT01790126|451642361|FG002|Overall Study|Other|8|||
125549466|NCT01790126|451642359|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
125549467|NCT01790126|451642360|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
125549468|NCT01790126|451642361|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
125549469|NCT01790126|451642359|FG000|Overall Study|Withdrawal by Physician|1|||
125549470|NCT01790126|451642360|FG001|Overall Study|Withdrawal by Physician|1|||
125549471|NCT01790126|451642361|FG002|Overall Study|Withdrawal by Physician|2|||
125549472|NCT01790126|451642359|FG000|Overall Study|Withdrawal by Subject|3|||
125549473|NCT01790126|451642360|FG001|Overall Study|Withdrawal by Subject|1|||
125549474|NCT01790126|451642361|FG002|Overall Study|Withdrawal by Subject|2|||
125549475|NCT01790126|451642359|FG000|Overall Study|Lost to Follow-up|1|||
125549476|NCT01790126|451642360|FG001|Overall Study|Lost to Follow-up|0|||
125549477|NCT01790126|451642361|FG002|Overall Study|Lost to Follow-up|1|||
125549478|NCT01790126|451642359|FG000|Overall Study|Adverse Event|0|||
125549479|NCT01790126|451642360|FG001|Overall Study|Adverse Event|2|||
125549480|NCT01790126|451642361|FG002|Overall Study|Adverse Event|0|||
125549481|NCT01790126|451642359|FG000|Overall Study|Death|2|||
125549482|NCT01790126|451642360|FG001|Overall Study|Death|0|||
125549483|NCT01790126|451642361|FG002|Overall Study|Death|0|||
125549484|NCT01790126|451642359|FG000|Overall Study|Radiographic Progression|3|||
125549485|NCT01790126|451642360|FG001|Overall Study|Radiographic Progression|1|||
125549486|NCT01790126|451642361|FG002|Overall Study|Radiographic Progression|0|||
125549487|NCT01128738|451642362|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
125549488|NCT01128738|451642363|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
125549489|NCT01128738|451642362|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
125549490|NCT01128738|451642363|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
125549491|NCT01128738|451642362|FG000|Second TP|Lost to Follow-up|0|||
125549492|NCT01128738|451642363|FG001|Second TP|Lost to Follow-up|1|||
125549493|NCT01128738|451642362|FG000|Second TP|Withdrawal by Subject|0|||
125549494|NCT01128738|451642363|FG001|Second TP|Withdrawal by Subject|2|||
125549495|NCT01178671|451642364|FG000|Overall Study|Adverse Event|4|||
125549496|NCT01178671|451642365|FG001|Overall Study|Adverse Event|6|||
125549497|NCT01178671|451642364|FG000|Overall Study|Protocol Violation|1|||
125549498|NCT01178671|451642365|FG001|Overall Study|Protocol Violation|1|||
125549499|NCT01178671|451642364|FG000|Overall Study|Lack of Efficacy|0|||
125549500|NCT01178671|451642365|FG001|Overall Study|Lack of Efficacy|1|||
125549501|NCT01178671|451642364|FG000|Overall Study|Lost to Follow-up|3|||
125549502|NCT01178671|451642365|FG001|Overall Study|Lost to Follow-up|1|||
125549503|NCT01178671|451642364|FG000|Overall Study|Physician Decision|4|||
125549504|NCT01178671|451642365|FG001|Overall Study|Physician Decision|6|||
125549505|NCT01211197|451642369|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125549506|NCT01211197|451642370|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125549507|NCT01211197|451642371|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
125549508|NCT01211197|451642372|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125549509|NCT01211197|451642373|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125549510|NCT01211197|451642374|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125549511|NCT01211197|451642369|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
125549512|NCT01211197|451642370|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
125549513|NCT01211197|451642371|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
125549514|NCT01211197|451642372|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
125549515|NCT01211197|451642373|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
125549516|NCT01211197|451642374|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
125549517|NCT02349451|451642375|FG000|Overall Study|Withdrawal by Subject|0|||
125549518|NCT02349451|451642376|FG001|Overall Study|Withdrawal by Subject|1|||
125549519|NCT02349451|451642377|FG002|Overall Study|Withdrawal by Subject|2|||
125549520|NCT02349451|451642378|FG003|Overall Study|Withdrawal by Subject|1|||
125349571|NCT01423604|450913527|FG001|Randomized|Other - unspecified|31|||
125349572|NCT01423604|450913526|FG000|Randomized|Patient decision|5|||
125349573|NCT01423604|450913527|FG001|Randomized|Patient decision|9|||
125349574|NCT00424255|450913528|FG000|Overall Study|Death|115|||
125349575|NCT00424255|450913529|FG001|Overall Study|Death|111|||
125349576|NCT00424255|450913528|FG000|Overall Study|Lost to Follow-up|26|||
125349577|NCT00424255|450913529|FG001|Overall Study|Lost to Follow-up|20|||
125549521|NCT02683941|451642379|FG000|Double-blind Phase|Adverse Event|0|||
125549522|NCT02683941|451642380|FG001|Double-blind Phase|Adverse Event|1|||
125549523|NCT02683941|451642379|FG000|Double-blind Phase|Withdrawal by Subject|4|||
125549524|NCT02683941|451642380|FG001|Double-blind Phase|Withdrawal by Subject|2|||
125549525|NCT02683941|451642379|FG000|Double-blind Phase|Lost to Follow-up|1|||
125549526|NCT02683941|451642380|FG001|Double-blind Phase|Lost to Follow-up|0|||
125549527|NCT02683941|451642379|FG000|Double-blind Phase|Disease Progression|5|||
125549528|NCT02683941|451642380|FG001|Double-blind Phase|Disease Progression|2|||
125549529|NCT02683941|451642379|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
125549530|NCT02683941|451642380|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
125549531|NCT02683941|451642379|FG000|Open-label Treatment Phase|Disease Progression|1|||
125549532|NCT02683941|451642380|FG001|Open-label Treatment Phase|Disease Progression|2|||
125549533|NCT02683941|451642379|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
125549534|NCT02683941|451642380|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
125549535|NCT02683941|451642379|FG000|Open-label Treatment Phase|Other|1|||
125549536|NCT02683941|451642380|FG001|Open-label Treatment Phase|Other|0|||
125549537|NCT02683941|451642379|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
125549538|NCT02683941|451642380|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
125549539|NCT02683941|451642379|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
125549540|NCT02683941|451642380|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
125549541|NCT02683941|451642379|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
125549542|NCT02683941|451642380|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
125549543|NCT02683941|451642379|FG000|Open-label Follow-up Phase|Other|8|||
125549544|NCT02683941|451642380|FG001|Open-label Follow-up Phase|Other|1|||
125549545|NCT00261846|451642381|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
125549546|NCT00261846|451642382|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
125549547|NCT00261846|451642383|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
125549548|NCT00261846|451642384|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
125549549|NCT00261846|451642385|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
125549550|NCT00261846|451642386|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
125549551|NCT00261846|451642387|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
125549552|NCT00261846|451642388|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
125549553|NCT00261846|451642389|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
125549554|NCT00261846|451642390|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
125549555|NCT00261846|451642391|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
125549556|NCT00261846|451642392|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
125549557|NCT00261846|451642381|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
125549558|NCT00261846|451642382|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
125549559|NCT00261846|451642383|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
125549560|NCT00261846|451642384|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
125549561|NCT00261846|451642385|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
125549562|NCT00261846|451642386|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
125549563|NCT00261846|451642387|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
125549564|NCT00261846|451642388|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
125549565|NCT00261846|451642389|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
125549566|NCT00261846|451642390|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
125549567|NCT00261846|451642391|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
125549568|NCT00261846|451642392|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
125549569|NCT00261846|451642381|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
125549570|NCT00261846|451642382|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
125549571|NCT00261846|451642383|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
125549572|NCT00261846|451642384|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
125549573|NCT00261846|451642385|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
125549574|NCT00261846|451642386|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
125682383|NCT02282761|452127130|FG001|Overall Study|Lack of Efficacy|6|||
125682384|NCT02282761|452127131|FG002|Overall Study|Lack of Efficacy|17|||
125682385|NCT02282761|452127129|FG000|Overall Study|Lost to Follow-up|2|||
125682386|NCT02282761|452127130|FG001|Overall Study|Lost to Follow-up|2|||
125682387|NCT02282761|452127131|FG002|Overall Study|Lost to Follow-up|1|||
125682388|NCT02282761|452127129|FG000|Overall Study|Physician Decision|0|||
125682389|NCT02282761|452127130|FG001|Overall Study|Physician Decision|0|||
125682390|NCT02282761|452127131|FG002|Overall Study|Physician Decision|2|||
125349578|NCT00424255|450913528|FG000|Overall Study|Protocol Violation|0|||
125549575|NCT00261846|451642387|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
125549576|NCT00261846|451642388|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
125549577|NCT00261846|451642389|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
125549578|NCT00261846|451642390|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
125682391|NCT02282761|452127129|FG000|Overall Study|Withdrawal by Subject|8|||
125682392|NCT02282761|452127130|FG001|Overall Study|Withdrawal by Subject|10|||
125349579|NCT00424255|450913529|FG001|Overall Study|Protocol Violation|1|||
125549579|NCT00261846|451642391|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
125549580|NCT00261846|451642392|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
125549581|NCT00261846|451642381|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
125549582|NCT00261846|451642382|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
125549583|NCT00261846|451642383|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
125549584|NCT00261846|451642384|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
125549585|NCT00261846|451642385|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
125549586|NCT00261846|451642386|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
125549587|NCT00261846|451642387|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
125549588|NCT00261846|451642388|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
125549589|NCT00261846|451642389|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
125549590|NCT00261846|451642390|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
125549591|NCT00261846|451642391|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
125549592|NCT00261846|451642392|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
125549593|NCT00261846|451642381|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
125549594|NCT00261846|451642382|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
125549595|NCT00261846|451642383|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
125549596|NCT00261846|451642384|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
125549597|NCT00261846|451642385|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
125549598|NCT00261846|451642386|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
125549599|NCT00261846|451642387|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
125549600|NCT00261846|451642388|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
125549601|NCT00261846|451642389|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
125549602|NCT00261846|451642390|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
125549603|NCT00261846|451642391|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
125549604|NCT00261846|451642392|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
125549605|NCT00261846|451642381|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
125549606|NCT00261846|451642382|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
125549607|NCT00261846|451642383|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
125549608|NCT00261846|451642384|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
125549609|NCT00261846|451642385|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
125549610|NCT00261846|451642386|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
125549611|NCT00261846|451642387|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
125549612|NCT00261846|451642388|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
125549613|NCT00261846|451642389|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
125549614|NCT00261846|451642390|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
125549615|NCT00261846|451642391|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
125549616|NCT00261846|451642392|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
125549617|NCT00261846|451642381|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
125549618|NCT00261846|451642382|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
125549619|NCT00261846|451642383|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
125549620|NCT00261846|451642384|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
125549621|NCT00261846|451642385|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
125549622|NCT00261846|451642386|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
125549623|NCT00261846|451642387|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
125549624|NCT00261846|451642388|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
125549625|NCT00261846|451642389|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
125549626|NCT00261846|451642390|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
125549627|NCT00261846|451642391|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
125549628|NCT00261846|451642392|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
125549629|NCT00150969|451642393|FG000|24 Month Main Study|Adverse Event|3|||
125549630|NCT00150969|451642394|FG001|24 Month Main Study|Adverse Event|4|||
125549631|NCT00150969|451642393|FG000|24 Month Main Study|Death|1|||
125549632|NCT00150969|451642394|FG001|24 Month Main Study|Death|1|||
125549633|NCT00150969|451642393|FG000|24 Month Main Study|Lack of Efficacy|1|||
125549634|NCT00150969|451642394|FG001|24 Month Main Study|Lack of Efficacy|8|||
125549635|NCT00150969|451642393|FG000|24 Month Main Study|Lost to Follow-up|3|||
125549636|NCT00150969|451642394|FG001|24 Month Main Study|Lost to Follow-up|2|||
125549637|NCT00150969|451642393|FG000|24 Month Main Study|Protocol Violation|4|||
125549638|NCT00150969|451642394|FG001|24 Month Main Study|Protocol Violation|2|||
125549639|NCT00150969|451642393|FG000|24 Month Main Study|Withdrawal by Subject|7|||
125549640|NCT00150969|451642394|FG001|24 Month Main Study|Withdrawal by Subject|4|||
125549641|NCT00150969|451642393|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
125549642|NCT00150969|451642394|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
125549643|NCT00150969|451642393|FG000|24-48 Month Extension|Lack of Efficacy|0|||
125549644|NCT00150969|451642394|FG001|24-48 Month Extension|Lack of Efficacy|1|||
125549645|NCT00150969|451642393|FG000|24-48 Month Extension|Adverse Event|1|||
125549646|NCT00150969|451642394|FG001|24-48 Month Extension|Adverse Event|3|||
125549647|NCT00150969|451642393|FG000|24-48 Month Extension|Other Reason|81|||
125549648|NCT00150969|451642394|FG001|24-48 Month Extension|Other Reason|91|||
125549649|NCT00615836|451642395|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
125549650|NCT00615836|451642396|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
125549651|NCT00615836|451642397|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
125549652|NCT00615836|451642398|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
125549653|NCT00615836|451642399|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
125549654|NCT00615836|451642395|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
125549655|NCT00615836|451642396|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
125549656|NCT00615836|451642397|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
125549657|NCT00615836|451642398|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
125549658|NCT00615836|451642399|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
125549659|NCT00615836|451642395|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
125549660|NCT00615836|451642396|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
125549661|NCT00615836|451642397|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
125549662|NCT00615836|451642398|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
125549663|NCT00615836|451642399|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
125549664|NCT00615836|451642395|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
125549665|NCT00615836|451642396|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
125549666|NCT00615836|451642397|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
125549667|NCT00615836|451642398|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
125549668|NCT00615836|451642399|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
125549669|NCT00615836|451642395|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
125549670|NCT00615836|451642396|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
125549671|NCT00615836|451642397|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
125549672|NCT00615836|451642398|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
125549673|NCT00615836|451642399|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
125549674|NCT00615836|451642395|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
125549675|NCT00615836|451642396|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
125549676|NCT00615836|451642397|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
125549677|NCT00615836|451642398|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
125549678|NCT00615836|451642399|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
125549679|NCT00615836|451642395|FG000|Extension Study (FE992026 CS31)|Other|10|||
125549680|NCT00615836|451642396|FG001|Extension Study (FE992026 CS31)|Other|7|||
125549681|NCT00615836|451642397|FG002|Extension Study (FE992026 CS31)|Other|8|||
125549682|NCT00615836|451642398|FG003|Extension Study (FE992026 CS31)|Other|8|||
125549683|NCT00615836|451642399|FG004|Extension Study (FE992026 CS31)|Other|0|||
125549684|NCT00615836|451642395|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
125549685|NCT00615836|451642396|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
125549686|NCT00615836|451642397|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
125549687|NCT00615836|451642398|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
125549688|NCT00615836|451642399|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
125549689|NCT00615836|451642395|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
125549690|NCT00615836|451642396|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
125549691|NCT00615836|451642397|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
125549692|NCT00615836|451642398|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
125549693|NCT00615836|451642399|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
125549694|NCT01313689|451642400|FG000|24-Week Randomization 1|Adverse Event|10|||
125549695|NCT01313689|451642401|FG001|24-Week Randomization 1|Adverse Event|5|||
125549696|NCT01313689|451642402|FG002|24-Week Randomization 1|Adverse Event|0|||
125549697|NCT01313689|451642403|FG003|24-Week Randomization 1|Adverse Event|0|||
125682393|NCT02282761|452127131|FG002|Overall Study|Withdrawal by Subject|16|||
125682394|NCT02282761|452127129|FG000|Overall Study|Other|3|||
125682395|NCT02282761|452127130|FG001|Overall Study|Other|2|||
125682396|NCT02282761|452127131|FG002|Overall Study|Other|1|||
125682397|NCT02838420|452127132|FG000|Overall Study|Ongoing in Study|113|||
125682398|NCT02838420|452127133|FG001|Overall Study|Ongoing in Study|45|||
125682399|NCT02838420|452127132|FG000|Overall Study|Lost to Follow-up|1|||
125682400|NCT02838420|452127133|FG001|Overall Study|Lost to Follow-up|0|||
125682401|NCT02838420|452127132|FG000|Overall Study|Withdrawal by Subject|3|||
125682402|NCT02838420|452127133|FG001|Overall Study|Withdrawal by Subject|4|||
125682403|NCT02838420|452127132|FG000|Overall Study|Death|8|||
125682404|NCT02838420|452127133|FG001|Overall Study|Death|13|||
125682405|NCT04501614|452127134|FG000|Overall Study|Study Terminated by Sponsor|6|||
125682406|NCT04501614|452127135|FG001|Overall Study|Study Terminated by Sponsor|3|||
125682407|NCT04501614|452127134|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
125682408|NCT04501614|452127135|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
125682409|NCT03745313|452127136|FG000|At 30 Days Follow-up|Death|2|||
125378922|NCT00531050|451019209|FG001|Part 1: Period 1|Adverse Event|1|||
125682410|NCT03745313|452127136|FG000|At 6 Months Follow-up|Death|1|||
125682411|NCT03745313|452127136|FG000|At 6 Months Follow-up|Missed Visit|1|||
125549698|NCT01313689|451642404|FG004|24-Week Randomization 1|Adverse Event|0|||
125549699|NCT01313689|451642400|FG000|24-Week Randomization 1|Physician Decision|4|||
125549700|NCT01313689|451642401|FG001|24-Week Randomization 1|Physician Decision|5|||
125549701|NCT01313689|451642402|FG002|24-Week Randomization 1|Physician Decision|0|||
125549702|NCT01313689|451642403|FG003|24-Week Randomization 1|Physician Decision|0|||
125549703|NCT01313689|451642404|FG004|24-Week Randomization 1|Physician Decision|0|||
125549704|NCT01313689|451642400|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
125549705|NCT01313689|451642401|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
125549706|NCT01313689|451642402|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
125549707|NCT01313689|451642403|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
125549708|NCT01313689|451642404|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
125549709|NCT01313689|451642400|FG000|24-Week Randomization 2|Adverse Event|0|||
125549710|NCT01313689|451642401|FG001|24-Week Randomization 2|Adverse Event|0|||
125549711|NCT01313689|451642402|FG002|24-Week Randomization 2|Adverse Event|2|||
125549712|NCT01313689|451642403|FG003|24-Week Randomization 2|Adverse Event|0|||
125549713|NCT01313689|451642404|FG004|24-Week Randomization 2|Adverse Event|8|||
125549714|NCT01313689|451642400|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
125549715|NCT01313689|451642401|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
125549716|NCT01313689|451642402|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
125549717|NCT01313689|451642403|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
125549718|NCT01313689|451642404|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
125549719|NCT01313689|451642400|FG000|24-Week Randomization 2|Physician Decision|0|||
125549720|NCT01313689|451642401|FG001|24-Week Randomization 2|Physician Decision|0|||
125549721|NCT01313689|451642402|FG002|24-Week Randomization 2|Physician Decision|0|||
125549722|NCT01313689|451642403|FG003|24-Week Randomization 2|Physician Decision|0|||
125349580|NCT00424255|450913528|FG000|Overall Study|Withdrawal by Subject|34|||
125549723|NCT01313689|451642404|FG004|24-Week Randomization 2|Physician Decision|4|||
125349581|NCT00424255|450913529|FG001|Overall Study|Withdrawal by Subject|38|||
125549724|NCT02121834|451642406|FG000|Overall Study|Protocol Violation|0|||
125549725|NCT02121834|451642407|FG001|Overall Study|Protocol Violation|1|||
125549726|NCT02121834|451642408|FG002|Overall Study|Protocol Violation|0|||
125549727|NCT02121834|451642409|FG003|Overall Study|Protocol Violation|0|||
125549728|NCT02121834|451642410|FG004|Overall Study|Protocol Violation|0|||
125549729|NCT02121834|451642411|FG005|Overall Study|Protocol Violation|0|||
125549730|NCT02121834|451642412|FG006|Overall Study|Protocol Violation|0|||
125549731|NCT02121834|451642406|FG000|Overall Study|Withdrawal by Subject|0|||
125549732|NCT02121834|451642407|FG001|Overall Study|Withdrawal by Subject|1|||
125549733|NCT02121834|451642408|FG002|Overall Study|Withdrawal by Subject|1|||
125549734|NCT02121834|451642409|FG003|Overall Study|Withdrawal by Subject|0|||
125549735|NCT02121834|451642410|FG004|Overall Study|Withdrawal by Subject|0|||
125549736|NCT02121834|451642411|FG005|Overall Study|Withdrawal by Subject|0|||
125549737|NCT02121834|451642412|FG006|Overall Study|Withdrawal by Subject|0|||
125549738|NCT02121834|451642406|FG000|Overall Study|Lost to Follow-up|0|||
125549739|NCT02121834|451642407|FG001|Overall Study|Lost to Follow-up|0|||
125549740|NCT02121834|451642408|FG002|Overall Study|Lost to Follow-up|1|||
125549741|NCT02121834|451642409|FG003|Overall Study|Lost to Follow-up|0|||
125549742|NCT02121834|451642410|FG004|Overall Study|Lost to Follow-up|0|||
125549743|NCT02121834|451642411|FG005|Overall Study|Lost to Follow-up|0|||
125549744|NCT02121834|451642412|FG006|Overall Study|Lost to Follow-up|0|||
125549745|NCT00551460|451642413|FG000|Overall Study|Adverse Event|1|||
125549746|NCT00551460|451642413|FG000|Overall Study|Withdrawal by Subject|1|||
125549747|NCT00551460|451642413|FG000|Overall Study|Physician Decision|1|||
125549748|NCT00551460|451642413|FG000|Overall Study|Death|7|||
125549749|NCT00551460|451642413|FG000|Overall Study|Ineligible|4|||
125549750|NCT00551460|451642413|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
125549751|NCT01971203|451642414|FG000|Overall Study|Protocol Violation|3|||
125549752|NCT01971203|451642415|FG001|Overall Study|Protocol Violation|2|||
125549753|NCT01971203|451642414|FG000|Overall Study|Withdrawal by Subject|5|||
125549754|NCT01971203|451642415|FG001|Overall Study|Withdrawal by Subject|6|||
125549755|NCT01971203|451642414|FG000|Overall Study|Adverse Event|1|||
125549756|NCT01971203|451642415|FG001|Overall Study|Adverse Event|0|||
125549757|NCT03353350|451642416|FG000|30-week Core Treatment Period|Protocol Violation|1|||
125549758|NCT03353350|451642417|FG001|30-week Core Treatment Period|Protocol Violation|1|||
125549759|NCT03353350|451642418|FG002|30-week Core Treatment Period|Protocol Violation|1|||
125549760|NCT03353350|451642419|FG003|30-week Core Treatment Period|Protocol Violation|0|||
125549761|NCT03353350|451642416|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
125549762|NCT03353350|451642417|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
125549763|NCT03353350|451642418|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
125549764|NCT03353350|451642419|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
125549765|NCT03353350|451642416|FG000|30-week Core Treatment Period|Adverse Event|0|||
125549766|NCT03353350|451642417|FG001|30-week Core Treatment Period|Adverse Event|4|||
125549767|NCT03353350|451642418|FG002|30-week Core Treatment Period|Adverse Event|2|||
125549768|NCT03353350|451642419|FG003|30-week Core Treatment Period|Adverse Event|3|||
125549769|NCT03353350|451642416|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
125549770|NCT03353350|451642417|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
125549771|NCT03353350|451642418|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
125549772|NCT03353350|451642419|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
125549773|NCT03353350|451642416|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
125549774|NCT03353350|451642417|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
125549775|NCT03353350|451642418|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
125549776|NCT03353350|451642419|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
125549777|NCT03353350|451642416|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
125549778|NCT03353350|451642417|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
125549779|NCT03353350|451642418|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
125549780|NCT03353350|451642419|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
125549781|NCT03353350|451642416|FG000|26-week Treatment Extension Period|Adverse Event|1|||
125549782|NCT03353350|451642417|FG001|26-week Treatment Extension Period|Adverse Event|0|||
125549783|NCT03353350|451642418|FG002|26-week Treatment Extension Period|Adverse Event|0|||
125549784|NCT03353350|451642419|FG003|26-week Treatment Extension Period|Adverse Event|1|||
125549785|NCT03353350|451642416|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
125549786|NCT03353350|451642417|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
125549787|NCT03353350|451642418|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
125549788|NCT03353350|451642419|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
125549789|NCT00147823|451642423|FG000|Overall Study|Lost to Follow-up|6|||
125549790|NCT00147823|451642424|FG001|Overall Study|Lost to Follow-up|12|||
125549791|NCT00147823|451642423|FG000|Overall Study|Physician Decision|1|||
125549792|NCT00147823|451642424|FG001|Overall Study|Physician Decision|0|||
125549793|NCT00147823|451642423|FG000|Overall Study|Withdrawal by Subject|0|||
125549794|NCT00147823|451642424|FG001|Overall Study|Withdrawal by Subject|1|||
125549795|NCT00147823|451642423|FG000|Overall Study|Did not receive vitoss due to infection|6|||
125549796|NCT00147823|451642424|FG001|Overall Study|Did not receive vitoss due to infection|2|||
125549797|NCT01012713|451642427|FG000|Overall Study|Lack of Efficacy|3|||
125349582|NCT00424255|450913528|FG000|Overall Study|Physician Decision|3|||
125349583|NCT00424255|450913529|FG001|Overall Study|Physician Decision|7|||
125349584|NCT00424255|450913528|FG000|Overall Study|Cognitive Disturbance|1|||
125349585|NCT00424255|450913529|FG001|Overall Study|Cognitive Disturbance|0|||
125349586|NCT00424255|450913528|FG000|Overall Study|Non-compliance by Participants|1|||
125349587|NCT00424255|450913529|FG001|Overall Study|Non-compliance by Participants|0|||
125349588|NCT00424255|450913528|FG000|Overall Study|Fatigue|1|||
125349589|NCT00424255|450913529|FG001|Overall Study|Fatigue|0|||
125349590|NCT00424255|450913528|FG000|Overall Study|Disease Progression|0|||
125349591|NCT00424255|450913529|FG001|Overall Study|Disease Progression|2|||
125349592|NCT00424255|450913528|FG000|Overall Study|Sponsor Terminated Study|161|||
125349593|NCT00424255|450913529|FG001|Overall Study|Sponsor Terminated Study|167|||
125349594|NCT02290431|450913530|FG000|Overall Study|Adverse Event|20|||
125349595|NCT02290431|450913530|FG000|Overall Study|Progressive disease|4|||
125349596|NCT02290431|450913530|FG000|Overall Study|Study terminated by Sponsor|1|||
125349597|NCT02290431|450913530|FG000|Overall Study|Physician Decision|2|||
125349598|NCT00821327|450913533|FG000|Overall Study|Adverse Event|13|||
125349599|NCT00821327|450913533|FG000|Overall Study|Patient Request|1|||
125349600|NCT00821327|450913533|FG000|Overall Study|Investigator Request|2|||
125349601|NCT00821327|450913533|FG000|Overall Study|Sponsor Request|1|||
125349602|NCT00821327|450913533|FG000|Overall Study|Disease Progression|13|||
125349603|NCT00821327|450913533|FG000|Overall Study|Other/Unknown|5|||
125349604|NCT00459979|450913536|FG000|Overall Study|Withdrawal by Subject|1|||
125349605|NCT00459979|450913536|FG000|Overall Study|Protocol Violation|1|||
125349606|NCT04030026|450913540|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
125349607|NCT04030026|450913541|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
125349608|NCT04030026|450913540|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
125349609|NCT04030026|450913541|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
125349610|NCT04030026|450913540|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
125349611|NCT04030026|450913541|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
125349612|NCT04030026|450913540|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
125349613|NCT04030026|450913541|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
125349614|NCT04030026|450913540|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
125349615|NCT04030026|450913541|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
125349616|NCT04030026|450913540|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
125349617|NCT04030026|450913541|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
125349618|NCT04030026|450913540|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
125349619|NCT04030026|450913541|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
125349620|NCT00523367|450913546|FG000|Overall Study|19 screen failures|19|||
125349621|NCT00523367|450913546|FG000|Overall Study|4 Withdrawn by PI|4|||
125349622|NCT02186301|450915247|FG000|Overall Study|Progressive Disease|7|||
125349623|NCT02186301|450915248|FG001|Overall Study|Progressive Disease|22|||
125349624|NCT02186301|450915249|FG002|Overall Study|Progressive Disease|27|||
125349625|NCT02186301|450915247|FG000|Overall Study|Adverse Event|5|||
125349626|NCT02186301|450915248|FG001|Overall Study|Adverse Event|5|||
125349627|NCT02186301|450915249|FG002|Overall Study|Adverse Event|5|||
125349628|NCT02186301|450915247|FG000|Overall Study|Death|1|||
125349629|NCT02186301|450915248|FG001|Overall Study|Death|0|||
125349630|NCT02186301|450915249|FG002|Overall Study|Death|0|||
125349631|NCT02186301|450915247|FG000|Overall Study|Withdrawal by Subject|5|||
125349632|NCT02186301|450915248|FG001|Overall Study|Withdrawal by Subject|1|||
125349633|NCT02186301|450915249|FG002|Overall Study|Withdrawal by Subject|3|||
125349634|NCT02186301|450915247|FG000|Overall Study|Physician Decision|1|||
125349635|NCT02186301|450915248|FG001|Overall Study|Physician Decision|0|||
125349636|NCT02186301|450915249|FG002|Overall Study|Physician Decision|1|||
125349637|NCT02186301|450915247|FG000|Overall Study|Study Terminated by Sponsor|1|||
125349638|NCT02186301|450915248|FG001|Overall Study|Study Terminated by Sponsor|0|||
125349639|NCT02186301|450915249|FG002|Overall Study|Study Terminated by Sponsor|11|||
125682412|NCT03745313|452127136|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
125682413|NCT03745313|452127136|FG000|At 1 Year Follow-up|Death|2|||
125682414|NCT03745313|452127136|FG000|At 1 Year Follow-up|Missed Visit|2|||
125349640|NCT02186301|450915247|FG000|Overall Study|Protocol Deviation|0|||
125349641|NCT02186301|450915248|FG001|Overall Study|Protocol Deviation|2|||
125349642|NCT02186301|450915249|FG002|Overall Study|Protocol Deviation|0|||
125349643|NCT02186301|450915247|FG000|Overall Study|Missing|0|||
125349644|NCT02186301|450915248|FG001|Overall Study|Missing|0|||
125349645|NCT02186301|450915249|FG002|Overall Study|Missing|2|||
125349646|NCT02186301|450915247|FG000|Overall Study|Other|0|||
125349647|NCT02186301|450915248|FG001|Overall Study|Other|0|||
125349648|NCT02186301|450915249|FG002|Overall Study|Other|1|||
125349649|NCT00371761|450915250|FG000|Overall Study|Adverse Event|1|||
125349650|NCT00371761|450915251|FG001|Overall Study|Adverse Event|1|||
125349651|NCT00371761|450915250|FG000|Overall Study|Withdrawal by Subject|1|||
125349652|NCT00371761|450915251|FG001|Overall Study|Withdrawal by Subject|3|||
125349653|NCT00371761|450915250|FG000|Overall Study|Investigator Judgment|2|||
125349654|NCT00371761|450915251|FG001|Overall Study|Investigator Judgment|3|||
125349655|NCT00371761|450915250|FG000|Overall Study|Study termination|4|||
125349656|NCT00371761|450915251|FG001|Overall Study|Study termination|3|||
125349657|NCT03560739|450915252|FG000|Overall Study|Adverse Event|0|||
125349658|NCT03560739|450915253|FG001|Overall Study|Adverse Event|1|||
125349659|NCT03560739|450915254|FG002|Overall Study|Adverse Event|0|||
125349660|NCT03560739|450915255|FG003|Overall Study|Adverse Event|0|||
125349661|NCT03361176|450915256|FG000|Overall Study|Lost to Follow-up|1|||
125349662|NCT03361176|450915257|FG001|Overall Study|Lost to Follow-up|2|||
125349663|NCT03361176|450915256|FG000|Overall Study|Adverse Event|0|||
125349664|NCT03361176|450915257|FG001|Overall Study|Adverse Event|2|||
125349665|NCT03361176|450915256|FG000|Overall Study|Withdrawal by Subject|0|||
125349666|NCT03361176|450915257|FG001|Overall Study|Withdrawal by Subject|1|||
125349667|NCT03123185|450915258|FG000|Overall Study|Withdrawal by Subject|0|||
125349668|NCT03123185|450915259|FG001|Overall Study|Withdrawal by Subject|0|||
125349669|NCT03123185|450915260|FG002|Overall Study|Withdrawal by Subject|0|||
125349670|NCT03123185|450915261|FG003|Overall Study|Withdrawal by Subject|0|||
125349671|NCT03123185|450915262|FG004|Overall Study|Withdrawal by Subject|0|||
125349672|NCT03123185|450915263|FG005|Overall Study|Withdrawal by Subject|0|||
125349673|NCT03123185|450915264|FG006|Overall Study|Withdrawal by Subject|0|||
125349674|NCT03123185|450915265|FG007|Overall Study|Withdrawal by Subject|0|||
125349675|NCT03123185|450915266|FG008|Overall Study|Withdrawal by Subject|0|||
125349676|NCT03123185|450915267|FG009|Overall Study|Withdrawal by Subject|0|||
125349677|NCT03123185|450915268|FG010|Overall Study|Withdrawal by Subject|0|||
125349678|NCT03123185|450915269|FG011|Overall Study|Withdrawal by Subject|0|||
125349679|NCT03123185|450915270|FG012|Overall Study|Withdrawal by Subject|1|||
125349680|NCT03123185|450915271|FG013|Overall Study|Withdrawal by Subject|0|||
125349681|NCT01083173|450915275|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
125349682|NCT01083173|450915276|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
125349683|NCT01083173|450915275|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
125349684|NCT01083173|450915276|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
125349685|NCT01083173|450915275|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
125349686|NCT01083173|450915276|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
125349687|NCT01083173|450915275|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
125349688|NCT01083173|450915276|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
125349689|NCT01083173|450915275|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
125349690|NCT01083173|450915276|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
125349691|NCT01083173|450915275|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
125349692|NCT01083173|450915276|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
125349693|NCT01083173|450915275|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
125349694|NCT01083173|450915276|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
125349695|NCT01083173|450915275|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
125349696|NCT01083173|450915276|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
125349697|NCT01083173|450915275|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
125349698|NCT01083173|450915276|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
125349699|NCT01083173|450915275|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
125349700|NCT01083173|450915276|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
125349701|NCT01083173|450915275|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
125349702|NCT01083173|450915276|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
125349703|NCT02554279|450915280|FG000|Overall Study|Adverse Event|2|||
125349704|NCT02554279|450915281|FG001|Overall Study|Adverse Event|5|||
125349705|NCT02554279|450915280|FG000|Overall Study|Lost to Follow-up|3|||
125349706|NCT02554279|450915281|FG001|Overall Study|Lost to Follow-up|2|||
125349707|NCT02554279|450915280|FG000|Overall Study|Withdrawal by Subject|6|||
125549798|NCT02571049|451642428|FG000|Screening|Did not meet entry criteria|2|||
125549799|NCT02571049|451642429|FG001|Screening|Did not meet entry criteria|2|||
125549800|NCT02571049|451642428|FG000|Randomization|No migraine attack|0|||
125549801|NCT02571049|451642429|FG001|Randomization|No migraine attack|1|||
125682415|NCT03745313|452127136|FG000|At 2 Year Follow-up|Missed Visit|1|||
125682416|NCT05263492|452127137|FG000|Overall Study|Adverse Event|1|||
125682417|NCT05263492|452127137|FG000|Overall Study|Disease progression during active treatment|3|||
125349708|NCT02554279|450915281|FG001|Overall Study|Withdrawal by Subject|4|||
125349709|NCT02554279|450915280|FG000|Overall Study|Protocol Violation|2|||
125349710|NCT02554279|450915281|FG001|Overall Study|Protocol Violation|1|||
125349711|NCT02554279|450915280|FG000|Overall Study|Other reason|19|||
125349712|NCT02554279|450915281|FG001|Overall Study|Other reason|6|||
125349713|NCT01933789|450915282|FG000|Overall Study|Death|0|||
125349714|NCT01933789|450915283|FG001|Overall Study|Death|0|||
125349715|NCT01933789|450915284|FG002|Overall Study|Death|0|||
125349716|NCT01933789|450915285|FG003|Overall Study|Death|0|||
125349717|NCT01933789|450915286|FG004|Overall Study|Death|21|||
125349718|NCT01933789|450915287|FG005|Overall Study|Death|32|||
125549802|NCT02571049|451642428|FG000|Randomization|Adverse Event|0|||
125549803|NCT02571049|451642429|FG001|Randomization|Adverse Event|1|||
125549804|NCT01055262|451642430|FG000|Overall Study|Adverse Event|5|||
125549805|NCT01055262|451642430|FG000|Overall Study|Protocol Violation|3|||
125549806|NCT01055262|451642430|FG000|Overall Study|Uncooperativeness|1|||
125549807|NCT03370471|451642431|FG000|Overall Study|Withdrawal by Subject|6|||
125549808|NCT03370471|451642432|FG001|Overall Study|Withdrawal by Subject|1|||
125549809|NCT03370471|451642431|FG000|Overall Study|Unable to access veins for blood draw|0|||
125549810|NCT03370471|451642432|FG001|Overall Study|Unable to access veins for blood draw|1|||
125549811|NCT03370471|451642431|FG000|Overall Study|Screen fail|1|||
125549812|NCT03370471|451642432|FG001|Overall Study|Screen fail|0|||
125549813|NCT00561951|451642433|FG000|Overall Study|Adverse Event|11|||
125549814|NCT00561951|451642434|FG001|Overall Study|Adverse Event|14|||
125549815|NCT00561951|451642435|FG002|Overall Study|Adverse Event|14|||
125549816|NCT00561951|451642433|FG000|Overall Study|Lack of Efficacy|5|||
125549817|NCT00561951|451642434|FG001|Overall Study|Lack of Efficacy|3|||
125549818|NCT00561951|451642435|FG002|Overall Study|Lack of Efficacy|2|||
125549819|NCT00561951|451642433|FG000|Overall Study|Lost to Follow-up|1|||
125549820|NCT00561951|451642434|FG001|Overall Study|Lost to Follow-up|1|||
125549821|NCT00561951|451642435|FG002|Overall Study|Lost to Follow-up|0|||
125549822|NCT00561951|451642433|FG000|Overall Study|Withdrawal by Subject|10|||
125549823|NCT00561951|451642434|FG001|Overall Study|Withdrawal by Subject|9|||
125549824|NCT00561951|451642435|FG002|Overall Study|Withdrawal by Subject|10|||
125549825|NCT00561951|451642433|FG000|Overall Study|Protocol Violation|4|||
125549826|NCT00561951|451642434|FG001|Overall Study|Protocol Violation|3|||
125549827|NCT00561951|451642435|FG002|Overall Study|Protocol Violation|4|||
125549828|NCT00561951|451642433|FG000|Overall Study|Physician Decision|1|||
125549829|NCT00561951|451642434|FG001|Overall Study|Physician Decision|0|||
125549830|NCT00561951|451642435|FG002|Overall Study|Physician Decision|0|||
125549831|NCT00561951|451642433|FG000|Overall Study|Pregnancy|0|||
125549832|NCT00561951|451642434|FG001|Overall Study|Pregnancy|1|||
125549833|NCT00561951|451642435|FG002|Overall Study|Pregnancy|0|||
125549834|NCT00561951|451642433|FG000|Overall Study|Meet Withdrawal Criterion|0|||
125549835|NCT00561951|451642434|FG001|Overall Study|Meet Withdrawal Criterion|1|||
125549836|NCT00561951|451642435|FG002|Overall Study|Meet Withdrawal Criterion|1|||
125549837|NCT00561951|451642433|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
125549838|NCT00561951|451642434|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
125549839|NCT00561951|451642435|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
125549840|NCT00392327|451642447|FG000|Overall Study|Death|1|||
125549841|NCT00392327|451642448|FG001|Overall Study|Death|0|||
125549842|NCT00392327|451642449|FG002|Overall Study|Death|1|||
125549843|NCT00392327|451642450|FG003|Overall Study|Death|0|||
125549844|NCT00392327|451642451|FG004|Overall Study|Death|0|||
125549845|NCT00392327|451642452|FG005|Overall Study|Death|0|||
125549846|NCT00392327|451642453|FG006|Overall Study|Death|0|||
125549847|NCT00392327|451642454|FG007|Overall Study|Death|0|||
125549848|NCT00392327|451642447|FG000|Overall Study|Lack of Efficacy|8|||
125549849|NCT00392327|451642448|FG001|Overall Study|Lack of Efficacy|8|||
125549850|NCT00392327|451642449|FG002|Overall Study|Lack of Efficacy|9|||
125549851|NCT00392327|451642450|FG003|Overall Study|Lack of Efficacy|6|||
125549852|NCT00392327|451642451|FG004|Overall Study|Lack of Efficacy|3|||
125549853|NCT00392327|451642452|FG005|Overall Study|Lack of Efficacy|3|||
125549854|NCT00392327|451642453|FG006|Overall Study|Lack of Efficacy|3|||
125549855|NCT00392327|451642454|FG007|Overall Study|Lack of Efficacy|3|||
125549856|NCT00392327|451642447|FG000|Overall Study|Physician Decision|3|||
125549857|NCT00392327|451642448|FG001|Overall Study|Physician Decision|5|||
125549858|NCT00392327|451642449|FG002|Overall Study|Physician Decision|2|||
125549859|NCT00392327|451642450|FG003|Overall Study|Physician Decision|2|||
125549860|NCT00392327|451642451|FG004|Overall Study|Physician Decision|0|||
125549861|NCT00392327|451642452|FG005|Overall Study|Physician Decision|1|||
125549862|NCT00392327|451642453|FG006|Overall Study|Physician Decision|5|||
125549863|NCT00392327|451642454|FG007|Overall Study|Physician Decision|3|||
125549864|NCT00392327|451642447|FG000|Overall Study|Protocol Violation|0|||
125549865|NCT00392327|451642448|FG001|Overall Study|Protocol Violation|0|||
125549866|NCT00392327|451642449|FG002|Overall Study|Protocol Violation|1|||
125549867|NCT00392327|451642450|FG003|Overall Study|Protocol Violation|0|||
125349719|NCT01933789|450915288|FG006|Overall Study|Death|0|||
125349720|NCT01933789|450915289|FG007|Overall Study|Death|0|||
125549868|NCT00392327|451642451|FG004|Overall Study|Protocol Violation|0|||
125549869|NCT00392327|451642452|FG005|Overall Study|Protocol Violation|0|||
125549870|NCT00392327|451642453|FG006|Overall Study|Protocol Violation|0|||
125549871|NCT00392327|451642454|FG007|Overall Study|Protocol Violation|0|||
125549872|NCT00392327|451642447|FG000|Overall Study|Withdrawal by Subject|3|||
125549873|NCT00392327|451642448|FG001|Overall Study|Withdrawal by Subject|2|||
125549874|NCT00392327|451642449|FG002|Overall Study|Withdrawal by Subject|4|||
125549875|NCT00392327|451642450|FG003|Overall Study|Withdrawal by Subject|6|||
125549876|NCT00392327|451642451|FG004|Overall Study|Withdrawal by Subject|0|||
125549877|NCT00392327|451642452|FG005|Overall Study|Withdrawal by Subject|1|||
125549878|NCT00392327|451642453|FG006|Overall Study|Withdrawal by Subject|1|||
125549879|NCT00392327|451642454|FG007|Overall Study|Withdrawal by Subject|5|||
125549880|NCT00392327|451642447|FG000|Overall Study|Ineligible|0|||
125549881|NCT00392327|451642448|FG001|Overall Study|Ineligible|4|||
125549882|NCT00392327|451642449|FG002|Overall Study|Ineligible|3|||
125549883|NCT00392327|451642450|FG003|Overall Study|Ineligible|2|||
125549884|NCT00392327|451642451|FG004|Overall Study|Ineligible|0|||
125549885|NCT00392327|451642452|FG005|Overall Study|Ineligible|0|||
125549886|NCT00392327|451642453|FG006|Overall Study|Ineligible|0|||
125549887|NCT00392327|451642454|FG007|Overall Study|Ineligible|0|||
125549888|NCT04508023|451642455|FG000|Overall Study|Withdrawal by Subject|1|||
125549889|NCT04508023|451642456|FG001|Overall Study|Withdrawal by Subject|2|||
125549890|NCT00421707|451642463|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
125549891|NCT00421707|451642464|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
125549892|NCT00421707|451642463|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
125549893|NCT00421707|451642464|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
125549894|NCT00421707|451642463|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
125549895|NCT00421707|451642464|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
125549896|NCT00421707|451642463|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
125549897|NCT00421707|451642464|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
125549898|NCT00421707|451642463|FG000|Period 2: Washout|Adverse Event|1|||
125549899|NCT00421707|451642464|FG001|Period 2: Washout|Adverse Event|1|||
125549900|NCT00421707|451642463|FG000|Period 2: Washout|Withdrawal by Subject|0|||
125549901|NCT00421707|451642464|FG001|Period 2: Washout|Withdrawal by Subject|1|||
125549902|NCT00421707|451642463|FG000|Period 2: Washout|Lost to Follow-up|0|||
125549903|NCT00421707|451642464|FG001|Period 2: Washout|Lost to Follow-up|1|||
125549904|NCT00421707|451642463|FG000|Period 2: Washout|Other: Pregnancy|0|||
125549905|NCT00421707|451642464|FG001|Period 2: Washout|Other: Pregnancy|1|||
125549906|NCT00421707|451642463|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
125549907|NCT00421707|451642464|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
125549908|NCT00421707|451642463|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
125549909|NCT00421707|451642464|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
125549910|NCT00421707|451642463|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
125549911|NCT00421707|451642464|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
125549912|NCT03261700|451642465|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
125549913|NCT03261700|451642466|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
125549914|NCT01723254|451642467|FG000|Overall Study|Conflict with work schedule|0|||
125549915|NCT01723254|451642468|FG001|Overall Study|Conflict with work schedule|0|||
125549916|NCT01723254|451642469|FG002|Overall Study|Conflict with work schedule|0|||
125549917|NCT01723254|451642470|FG003|Overall Study|Conflict with work schedule|0|||
125549918|NCT01723254|451642471|FG004|Overall Study|Conflict with work schedule|0|||
125549919|NCT01723254|451642472|FG005|Overall Study|Conflict with work schedule|0|||
125549920|NCT01723254|451642473|FG006|Overall Study|Conflict with work schedule|0|||
125549921|NCT01723254|451642474|FG007|Overall Study|Conflict with work schedule|1|||
125549922|NCT01723254|451642467|FG000|Overall Study|Personal issues|0|||
125549923|NCT01723254|451642468|FG001|Overall Study|Personal issues|0|||
125549924|NCT01723254|451642469|FG002|Overall Study|Personal issues|0|||
125549925|NCT01723254|451642470|FG003|Overall Study|Personal issues|0|||
125549926|NCT01723254|451642471|FG004|Overall Study|Personal issues|0|||
125549927|NCT01723254|451642472|FG005|Overall Study|Personal issues|1|||
125549928|NCT01723254|451642473|FG006|Overall Study|Personal issues|0|||
125549929|NCT01723254|451642474|FG007|Overall Study|Personal issues|0|||
125549930|NCT01723254|451642467|FG000|Overall Study|No longer have time to participate|0|||
125549931|NCT01723254|451642468|FG001|Overall Study|No longer have time to participate|0|||
125549932|NCT01723254|451642469|FG002|Overall Study|No longer have time to participate|0|||
125549933|NCT01723254|451642470|FG003|Overall Study|No longer have time to participate|1|||
125549934|NCT01723254|451642471|FG004|Overall Study|No longer have time to participate|0|||
125549935|NCT01723254|451642472|FG005|Overall Study|No longer have time to participate|0|||
125549936|NCT01723254|451642473|FG006|Overall Study|No longer have time to participate|0|||
125549937|NCT01723254|451642474|FG007|Overall Study|No longer have time to participate|0|||
125549938|NCT01723254|451642467|FG000|Overall Study|Move/Left to another country/city|0|||
125549939|NCT01723254|451642468|FG001|Overall Study|Move/Left to another country/city|0|||
125549940|NCT01723254|451642469|FG002|Overall Study|Move/Left to another country/city|2|||
125549941|NCT01723254|451642470|FG003|Overall Study|Move/Left to another country/city|1|||
125549942|NCT01723254|451642471|FG004|Overall Study|Move/Left to another country/city|1|||
125549943|NCT01723254|451642472|FG005|Overall Study|Move/Left to another country/city|0|||
125549944|NCT01723254|451642473|FG006|Overall Study|Move/Left to another country/city|0|||
125549945|NCT01723254|451642474|FG007|Overall Study|Move/Left to another country/city|0|||
125549946|NCT01723254|451642467|FG000|Overall Study|Protocol Violation|0|||
125549947|NCT01723254|451642468|FG001|Overall Study|Protocol Violation|1|||
125549948|NCT01723254|451642469|FG002|Overall Study|Protocol Violation|0|||
125549949|NCT01723254|451642470|FG003|Overall Study|Protocol Violation|0|||
125549950|NCT01723254|451642471|FG004|Overall Study|Protocol Violation|0|||
125549951|NCT01723254|451642472|FG005|Overall Study|Protocol Violation|0|||
125549952|NCT01723254|451642473|FG006|Overall Study|Protocol Violation|0|||
125549953|NCT01723254|451642474|FG007|Overall Study|Protocol Violation|0|||
125549954|NCT01723254|451642467|FG000|Overall Study|Withdrawal by Subject|1|||
125549955|NCT01723254|451642468|FG001|Overall Study|Withdrawal by Subject|2|||
125549956|NCT01723254|451642469|FG002|Overall Study|Withdrawal by Subject|1|||
125349721|NCT01933789|450915290|FG008|Overall Study|Death|0|||
125349722|NCT01933789|450915282|FG000|Overall Study|Lost to Follow-up|0|||
125549957|NCT01723254|451642470|FG003|Overall Study|Withdrawal by Subject|0|||
125549958|NCT01723254|451642471|FG004|Overall Study|Withdrawal by Subject|1|||
125549959|NCT01723254|451642472|FG005|Overall Study|Withdrawal by Subject|1|||
125549960|NCT01723254|451642473|FG006|Overall Study|Withdrawal by Subject|1|||
125549961|NCT01723254|451642474|FG007|Overall Study|Withdrawal by Subject|2|||
125549962|NCT01340196|451644014|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
125549963|NCT00887250|451644018|FG000|Overall Study|Adverse Event|3|||
125549964|NCT00887250|451644019|FG001|Overall Study|Adverse Event|0|||
125549965|NCT00887250|451644020|FG002|Overall Study|Adverse Event|7|||
125549966|NCT00887250|451644018|FG000|Overall Study|Lack of Efficacy|9|||
125549967|NCT00887250|451644019|FG001|Overall Study|Lack of Efficacy|6|||
125549968|NCT00887250|451644020|FG002|Overall Study|Lack of Efficacy|1|||
125549969|NCT00887250|451644018|FG000|Overall Study|Lost to Follow-up|2|||
125549970|NCT00887250|451644019|FG001|Overall Study|Lost to Follow-up|3|||
125549971|NCT00887250|451644020|FG002|Overall Study|Lost to Follow-up|1|||
125549972|NCT00887250|451644018|FG000|Overall Study|Protocol Violation|2|||
125549973|NCT00887250|451644019|FG001|Overall Study|Protocol Violation|2|||
125549974|NCT00887250|451644020|FG002|Overall Study|Protocol Violation|1|||
125549975|NCT00887250|451644018|FG000|Overall Study|Withdrawal by Subject|2|||
125549976|NCT00887250|451644019|FG001|Overall Study|Withdrawal by Subject|1|||
125549977|NCT00887250|451644020|FG002|Overall Study|Withdrawal by Subject|2|||
125549978|NCT00887250|451644018|FG000|Overall Study|Patient uncooperative|0|||
125549979|NCT00887250|451644019|FG001|Overall Study|Patient uncooperative|0|||
125549980|NCT00887250|451644020|FG002|Overall Study|Patient uncooperative|1|||
125549981|NCT00879762|451644021|FG000|Overall Study|Lost to Follow-up|3|||
125549982|NCT00879762|451644022|FG001|Overall Study|Lost to Follow-up|1|||
125549983|NCT00881608|451644023|FG000|Overall Study|Study prematurely terminated|11|||
125549984|NCT03214094|451644024|FG000|Overall Study|Case Report Forms Uncollected|14|||
125549985|NCT03214094|451644024|FG000|Overall Study|Protocol Deviation|46|||
125549986|NCT00655486|451644034|FG000|Overall Study|Adverse Event|10|||
125549987|NCT00655486|451644034|FG000|Overall Study|Lack of Efficacy|8|||
125549988|NCT00655486|451644034|FG000|Overall Study|Withdrawal by Subject|4|||
125549989|NCT00655486|451644034|FG000|Overall Study|Protocol Violation|1|||
125549990|NCT00655486|451644034|FG000|Overall Study|Unsatisfactory compliance|2|||
125549991|NCT00655486|451644034|FG000|Overall Study|Other: Pregnancy|1|||
125549992|NCT00655486|451644034|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
125549993|NCT00655486|451644034|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
125549994|NCT03840486|451644035|FG000|Overall Study|Withdrawal by Subject|0|||
125549995|NCT03840486|451644036|FG001|Overall Study|Withdrawal by Subject|1|||
125549996|NCT03840486|451644037|FG002|Overall Study|Withdrawal by Subject|0|||
125549997|NCT03840486|451644038|FG003|Overall Study|Withdrawal by Subject|0|||
125549998|NCT03840486|451644039|FG004|Overall Study|Withdrawal by Subject|0|||
125549999|NCT03840486|451644040|FG005|Overall Study|Withdrawal by Subject|0|||
125550000|NCT03840486|451644041|FG006|Overall Study|Withdrawal by Subject|0|||
125550001|NCT03840486|451644042|FG007|Overall Study|Withdrawal by Subject|0|||
125550002|NCT03840486|451644043|FG008|Overall Study|Withdrawal by Subject|0|||
125349723|NCT01933789|450915283|FG001|Overall Study|Lost to Follow-up|0|||
125349724|NCT01933789|450915284|FG002|Overall Study|Lost to Follow-up|0|||
125550003|NCT03840486|451644044|FG009|Overall Study|Withdrawal by Subject|0|||
125550004|NCT03840486|451644045|FG010|Overall Study|Withdrawal by Subject|0|||
125550005|NCT03840486|451644046|FG011|Overall Study|Withdrawal by Subject|0|||
125550006|NCT02768870|451644047|FG000|Overall Study|Death|1|||
125550007|NCT02768870|451644047|FG000|Overall Study|Reoperation|6|||
125550008|NCT02768870|451644047|FG000|Overall Study|Lost to Follow-up|1|||
125550009|NCT02768870|451644047|FG000|Overall Study|Exit|4|||
125550010|NCT03401229|451644048|FG000|Overall Study|Lost to Follow-up|2|||
125550011|NCT03401229|451644049|FG001|Overall Study|Lost to Follow-up|1|||
125550012|NCT03401229|451644048|FG000|Overall Study|Other|1|||
125550013|NCT03401229|451644049|FG001|Overall Study|Other|3|||
125550014|NCT03401229|451644048|FG000|Overall Study|Adverse Event|8|||
125349725|NCT01933789|450915285|FG003|Overall Study|Lost to Follow-up|1|||
125682418|NCT04879628|452127138|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
125682419|NCT04879628|452127139|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
125682420|NCT04879628|452127140|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
125349726|NCT01933789|450915286|FG004|Overall Study|Lost to Follow-up|8|||
125349727|NCT01933789|450915287|FG005|Overall Study|Lost to Follow-up|9|||
125349728|NCT01933789|450915288|FG006|Overall Study|Lost to Follow-up|1|||
125682421|NCT04879628|452127141|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
125682422|NCT04879628|452127138|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
125682423|NCT04879628|452127139|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
125682424|NCT04879628|452127140|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
125682425|NCT04879628|452127141|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
125682426|NCT04879628|452127138|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
125682427|NCT04879628|452127139|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
125682428|NCT04879628|452127140|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
125682429|NCT04879628|452127141|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
125682430|NCT04879628|452127138|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
125682431|NCT04879628|452127139|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
125682432|NCT04879628|452127140|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
125682433|NCT04879628|452127141|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
125682434|NCT05446870|452127144|FG000|Overall Study|Death|6|||
125682435|NCT05446870|452127145|FG001|Overall Study|Death|5|||
125682436|NCT05446870|452127144|FG000|Overall Study|Lost to Follow-up|0|||
125682437|NCT05446870|452127145|FG001|Overall Study|Lost to Follow-up|1|||
125682438|NCT05446870|452127144|FG000|Overall Study|Physician Decision|52|||
125682439|NCT05446870|452127145|FG001|Overall Study|Physician Decision|53|||
125682440|NCT05446870|452127144|FG000|Overall Study|Withdrawal by Subject|3|||
125682441|NCT05446870|452127145|FG001|Overall Study|Withdrawal by Subject|3|||
125682442|NCT03345420|452127146|FG000|Overall Study|Withdrawal by Subject|1|||
125682443|NCT03516812|452127147|FG000|Overall Study|Adverse Event|4|||
125682444|NCT03516812|452127147|FG000|Overall Study|Lack of Efficacy|2|||
125682445|NCT05216835|452127150|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
125682446|NCT05216835|452127151|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
125682447|NCT05216835|452127152|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
125682448|NCT05216835|452127153|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
125682449|NCT05216835|452127154|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
125682450|NCT05216835|452127155|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
125682451|NCT05216835|452127156|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
125682452|NCT05216835|452127157|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
125682453|NCT05216835|452127150|FG000|Overall Study|Death|0|||
125682454|NCT05216835|452127151|FG001|Overall Study|Death|0|||
125682455|NCT05216835|452127152|FG002|Overall Study|Death|0|||
125682456|NCT05216835|452127153|FG003|Overall Study|Death|1|||
125682457|NCT05216835|452127154|FG004|Overall Study|Death|1|||
125682458|NCT05216835|452127155|FG005|Overall Study|Death|1|||
125682459|NCT05216835|452127156|FG006|Overall Study|Death|1|||
125682460|NCT05216835|452127157|FG007|Overall Study|Death|1|||
125682461|NCT05216835|452127150|FG000|Overall Study|Physician Decision|0|||
125682462|NCT05216835|452127151|FG001|Overall Study|Physician Decision|0|||
125682463|NCT05216835|452127152|FG002|Overall Study|Physician Decision|0|||
125682464|NCT05216835|452127153|FG003|Overall Study|Physician Decision|0|||
125682465|NCT05216835|452127154|FG004|Overall Study|Physician Decision|0|||
125682466|NCT05216835|452127155|FG005|Overall Study|Physician Decision|1|||
125682467|NCT05216835|452127156|FG006|Overall Study|Physician Decision|1|||
125682468|NCT05216835|452127157|FG007|Overall Study|Physician Decision|0|||
125682469|NCT05216835|452127150|FG000|Overall Study|Study terminated by Sponsor|0|||
125682470|NCT05216835|452127151|FG001|Overall Study|Study terminated by Sponsor|0|||
125682471|NCT05216835|452127152|FG002|Overall Study|Study terminated by Sponsor|0|||
125682472|NCT05216835|452127153|FG003|Overall Study|Study terminated by Sponsor|0|||
125682473|NCT05216835|452127154|FG004|Overall Study|Study terminated by Sponsor|0|||
125682474|NCT05216835|452127155|FG005|Overall Study|Study terminated by Sponsor|0|||
125682475|NCT05216835|452127156|FG006|Overall Study|Study terminated by Sponsor|0|||
125682476|NCT05216835|452127157|FG007|Overall Study|Study terminated by Sponsor|1|||
125682477|NCT05216835|452127150|FG000|Overall Study|Withdrawal by Subject|1|||
125682478|NCT05216835|452127151|FG001|Overall Study|Withdrawal by Subject|0|||
125682479|NCT05216835|452127152|FG002|Overall Study|Withdrawal by Subject|1|||
125682480|NCT05216835|452127153|FG003|Overall Study|Withdrawal by Subject|0|||
125682481|NCT05216835|452127154|FG004|Overall Study|Withdrawal by Subject|1|||
125682482|NCT05216835|452127155|FG005|Overall Study|Withdrawal by Subject|0|||
125682483|NCT05216835|452127156|FG006|Overall Study|Withdrawal by Subject|0|||
125349729|NCT01933789|450915289|FG007|Overall Study|Lost to Follow-up|4|||
125349730|NCT01933789|450915290|FG008|Overall Study|Lost to Follow-up|0|||
125349731|NCT01933789|450915282|FG000|Overall Study|Withdrawal by Subject|2|||
125349732|NCT01933789|450915283|FG001|Overall Study|Withdrawal by Subject|1|||
125550015|NCT03401229|451644049|FG001|Overall Study|Adverse Event|6|||
125550016|NCT03401229|451644048|FG000|Overall Study|Withdrawal by Subject|29|||
125550017|NCT03401229|451644049|FG001|Overall Study|Withdrawal by Subject|26|||
125550018|NCT03401229|451644048|FG000|Overall Study|COVID-19|0|||
125550019|NCT03401229|451644049|FG001|Overall Study|COVID-19|1|||
125550020|NCT01774110|451644050|FG000|Overall Study|Lost to Follow-up|7|||
125550021|NCT00640016|451644051|FG000|Overall Study|Withdrawal by Subject|0|||
125550022|NCT00640016|451644052|FG001|Overall Study|Withdrawal by Subject|1|||
125550023|NCT00640016|451644053|FG002|Overall Study|Withdrawal by Subject|0|||
125550024|NCT00640016|451644054|FG003|Overall Study|Withdrawal by Subject|0|||
125550025|NCT00640016|451644051|FG000|Overall Study|Study termination|2|||
125550026|NCT00640016|451644052|FG001|Overall Study|Study termination|1|||
125550027|NCT00640016|451644053|FG002|Overall Study|Study termination|3|||
125550028|NCT00640016|451644054|FG003|Overall Study|Study termination|2|||
125550029|NCT00640016|451644051|FG000|Overall Study|Adverse Event|0|||
125550030|NCT00640016|451644052|FG001|Overall Study|Adverse Event|0|||
125550031|NCT00640016|451644053|FG002|Overall Study|Adverse Event|0|||
125550032|NCT00640016|451644054|FG003|Overall Study|Adverse Event|1|||
125550033|NCT03575143|451644055|FG000|Overall Study|Lost to Follow-up|0|||
125550034|NCT03575143|451644056|FG001|Overall Study|Lost to Follow-up|0|||
125550035|NCT03575143|451644057|FG002|Overall Study|Lost to Follow-up|4|||
125550036|NCT03575143|451644055|FG000|Overall Study|Withdrawal by Subject|0|||
125550037|NCT03575143|451644056|FG001|Overall Study|Withdrawal by Subject|0|||
125550038|NCT03575143|451644057|FG002|Overall Study|Withdrawal by Subject|5|||
125550039|NCT03575143|451644055|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
125550040|NCT03575143|451644056|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
125550041|NCT03575143|451644057|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
125550042|NCT01287065|451644058|FG000|Treatment Period 1|Adverse Event|0|||
125550043|NCT01287065|451644059|FG001|Treatment Period 1|Adverse Event|0|||
125550044|NCT01287065|451644060|FG002|Treatment Period 1|Adverse Event|0|||
125550045|NCT01287065|451644061|FG003|Treatment Period 1|Adverse Event|0|||
125550046|NCT01287065|451644062|FG004|Treatment Period 1|Adverse Event|1|||
125550047|NCT01287065|451644063|FG005|Treatment Period 1|Adverse Event|0|||
125550048|NCT01287065|451644058|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125550049|NCT01287065|451644059|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125550050|NCT01287065|451644060|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125550051|NCT01287065|451644061|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125550052|NCT01287065|451644062|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125550053|NCT01287065|451644063|FG005|Treatment Period 1|Withdrawal by Subject|1|||
125550054|NCT02875977|451644064|FG000|Overall Study|Lost to Follow-up|42|||
125550055|NCT02875977|451644065|FG001|Overall Study|Lost to Follow-up|29|||
125550056|NCT01259726|451644066|FG000|Overall Study|Death|1|||
125550057|NCT01259726|451644067|FG001|Overall Study|Death|0|||
125550058|NCT01259726|451644068|FG002|Overall Study|Death|0|||
125550059|NCT01259726|451644069|FG003|Overall Study|Death|0|||
125550060|NCT01259726|451644066|FG000|Overall Study|Physician Decision|2|||
125550061|NCT01259726|451644067|FG001|Overall Study|Physician Decision|0|||
125550062|NCT01259726|451644068|FG002|Overall Study|Physician Decision|1|||
125550063|NCT01259726|451644069|FG003|Overall Study|Physician Decision|1|||
125550064|NCT01259726|451644066|FG000|Overall Study|Withdrawal by Subject|1|||
125550065|NCT01259726|451644067|FG001|Overall Study|Withdrawal by Subject|3|||
125550066|NCT01259726|451644068|FG002|Overall Study|Withdrawal by Subject|2|||
125550067|NCT01259726|451644069|FG003|Overall Study|Withdrawal by Subject|1|||
125349733|NCT01933789|450915284|FG002|Overall Study|Withdrawal by Subject|0|||
125349734|NCT01933789|450915285|FG003|Overall Study|Withdrawal by Subject|0|||
125349735|NCT01933789|450915286|FG004|Overall Study|Withdrawal by Subject|17|||
125550068|NCT01259726|451644066|FG000|Overall Study|Lost to Follow-up|1|||
125550069|NCT01259726|451644067|FG001|Overall Study|Lost to Follow-up|1|||
125550070|NCT01259726|451644068|FG002|Overall Study|Lost to Follow-up|1|||
125550071|NCT01259726|451644069|FG003|Overall Study|Lost to Follow-up|3|||
125550072|NCT01978262|451644070|FG000|Overall Study|Withdrawal by Subject|9|||
125550073|NCT01978262|451644070|FG000|Overall Study|Lost to Follow-up|2|||
125550074|NCT02435966|451644078|FG000|Overall Study|Withdrawal by Subject|0|||
125550075|NCT02435966|451644079|FG001|Overall Study|Withdrawal by Subject|1|||
125550076|NCT02435966|451644080|FG002|Overall Study|Withdrawal by Subject|0|||
125550077|NCT02168842|451644082|FG000|Overall Study|Withdrawal by Subject|5|||
125550078|NCT02168842|451644083|FG001|Overall Study|Withdrawal by Subject|3|||
125550079|NCT02168842|451644082|FG000|Overall Study|Lost to Follow-up|0|||
125550080|NCT02168842|451644083|FG001|Overall Study|Lost to Follow-up|2|||
125550081|NCT02168842|451644082|FG000|Overall Study|Death|2|||
125550082|NCT02168842|451644083|FG001|Overall Study|Death|1|||
125550083|NCT02168842|451644082|FG000|Overall Study|Physician Decision|1|||
125550084|NCT02168842|451644083|FG001|Overall Study|Physician Decision|2|||
125550085|NCT00325039|451644084|FG000|Overall Study|Lost to Follow-up|18|||
125550086|NCT00325039|451644085|FG001|Overall Study|Lost to Follow-up|14|||
125550087|NCT02974088|451644086|FG000|Overall Study|Lost to Follow-up|0|||
125550088|NCT02974088|451644087|FG001|Overall Study|Lost to Follow-up|2|||
125550089|NCT02974088|451644086|FG000|Overall Study|Adverse Event|0|||
125550090|NCT02974088|451644087|FG001|Overall Study|Adverse Event|1|||
125550091|NCT00687973|451644093|FG000|Overall Study|Adverse Event|18|||
125550092|NCT00687973|451644094|FG001|Overall Study|Adverse Event|28|||
125550093|NCT00687973|451644093|FG000|Overall Study|Lack of Efficacy|2|||
125550094|NCT00687973|451644094|FG001|Overall Study|Lack of Efficacy|3|||
125550095|NCT00687973|451644093|FG000|Overall Study|Protocol Violation|1|||
125550096|NCT00687973|451644094|FG001|Overall Study|Protocol Violation|2|||
125550097|NCT00687973|451644093|FG000|Overall Study|Administrative Reasons|0|||
125550098|NCT00687973|451644094|FG001|Overall Study|Administrative Reasons|2|||
125550099|NCT00687973|451644093|FG000|Overall Study|Withdrawal by Subject|3|||
125550100|NCT00687973|451644094|FG001|Overall Study|Withdrawal by Subject|3|||
125550101|NCT00343252|451644095|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
125550102|NCT00343252|451644096|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
125550103|NCT00343252|451644095|FG000|6 Months (All Treated Participants)|Death|0|||
125550104|NCT00343252|451644096|FG001|6 Months (All Treated Participants)|Death|2|||
125550105|NCT00343252|451644095|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
125550106|NCT00343252|451644096|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
125550107|NCT00343252|451644095|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
125550108|NCT00343252|451644096|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
125550109|NCT00343252|451644095|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
125550110|NCT00343252|451644096|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
125550111|NCT00343252|451644095|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
125550112|NCT00343252|451644096|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
125550113|NCT00343252|451644095|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
125550114|NCT00343252|451644096|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
125550115|NCT00343252|451644095|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
125550116|NCT00343252|451644096|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
125550117|NCT00343252|451644095|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
125550118|NCT00343252|451644096|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
125550119|NCT00343252|451644095|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
125550120|NCT00343252|451644096|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
125550121|NCT00343252|451644095|FG000|12 Months (All Treated Participants)|Death|3|||
125550122|NCT00343252|451644096|FG001|12 Months (All Treated Participants)|Death|3|||
125550123|NCT00343252|451644095|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
125550124|NCT00343252|451644096|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
125550125|NCT00343252|451644095|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
125550126|NCT00343252|451644096|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
125550127|NCT00343252|451644095|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
125550128|NCT00343252|451644096|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
125550129|NCT00343252|451644095|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
125550130|NCT00343252|451644096|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
125550131|NCT00343252|451644095|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
125550132|NCT00343252|451644096|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
125550133|NCT00343252|451644095|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
125550134|NCT00343252|451644096|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
125550135|NCT00343252|451644095|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
125550136|NCT00343252|451644096|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
125550137|NCT00343252|451644095|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
125550138|NCT00343252|451644096|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
125550139|NCT00343252|451644095|FG000|18 Months (All Treated Participants)|Death|4|||
125550140|NCT00343252|451644096|FG001|18 Months (All Treated Participants)|Death|5|||
125550141|NCT00343252|451644095|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
125550142|NCT00343252|451644096|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
125550143|NCT00343252|451644095|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
125550144|NCT00343252|451644096|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
125550145|NCT00343252|451644095|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
125550146|NCT00343252|451644096|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
125550147|NCT00343252|451644095|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
125550148|NCT00343252|451644096|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
125550149|NCT00343252|451644095|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
125550150|NCT00343252|451644096|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
125550151|NCT00343252|451644095|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
125550152|NCT00343252|451644096|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
125550153|NCT00343252|451644095|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
125550154|NCT00343252|451644096|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
125550155|NCT01740323|451644097|FG000|Overall Study|Adverse Event|1|||
125550156|NCT01740323|451644098|FG001|Overall Study|Adverse Event|0|||
125550157|NCT01740323|451644097|FG000|Overall Study|Randomized but did not take study drug|1|||
125550158|NCT01740323|451644098|FG001|Overall Study|Randomized but did not take study drug|0|||
125550159|NCT02019927|451644101|FG000|Overall Study|Lost to Follow-up|2|||
125682484|NCT05216835|452127157|FG007|Overall Study|Withdrawal by Subject|1|||
125550160|NCT02019927|451644102|FG001|Overall Study|Lost to Follow-up|4|||
125550161|NCT02019927|451644103|FG002|Overall Study|Lost to Follow-up|1|||
125550162|NCT02019927|451644104|FG003|Overall Study|Lost to Follow-up|2|||
125550163|NCT02019927|451644105|FG004|Overall Study|Lost to Follow-up|3|||
125550164|NCT02019927|451644106|FG005|Overall Study|Lost to Follow-up|1|||
125550165|NCT03945825|451644109|FG000|Overall Study|Enrolled but treatment not administered|0|||
125550166|NCT03945825|451644110|FG001|Overall Study|Enrolled but treatment not administered|0|||
125550167|NCT03945825|451644111|FG002|Overall Study|Enrolled but treatment not administered|0|||
125550168|NCT03945825|451644112|FG003|Overall Study|Enrolled but treatment not administered|0|||
125550169|NCT03945825|451644113|FG004|Overall Study|Enrolled but treatment not administered|1|||
125550170|NCT03945825|451644114|FG005|Overall Study|Enrolled but treatment not administered|0|||
125550171|NCT03945825|451644109|FG000|Overall Study|Lost to Follow-up|1|||
125550172|NCT03945825|451644110|FG001|Overall Study|Lost to Follow-up|5|||
125550173|NCT03945825|451644111|FG002|Overall Study|Lost to Follow-up|0|||
125550174|NCT03945825|451644112|FG003|Overall Study|Lost to Follow-up|1|||
125550175|NCT03945825|451644113|FG004|Overall Study|Lost to Follow-up|2|||
125550176|NCT03945825|451644114|FG005|Overall Study|Lost to Follow-up|2|||
125550177|NCT03945825|451644109|FG000|Overall Study|Withdrawal by Subject|1|||
125550178|NCT03945825|451644110|FG001|Overall Study|Withdrawal by Subject|0|||
125550179|NCT03945825|451644111|FG002|Overall Study|Withdrawal by Subject|1|||
125550180|NCT03945825|451644112|FG003|Overall Study|Withdrawal by Subject|1|||
125550181|NCT03945825|451644113|FG004|Overall Study|Withdrawal by Subject|0|||
125550182|NCT03945825|451644114|FG005|Overall Study|Withdrawal by Subject|1|||
125550183|NCT01423253|451644122|FG000|Overall Study|Adverse Event|2|||
125550184|NCT01423253|451644122|FG000|Overall Study|Lack of Efficacy|2|||
125550185|NCT01423253|451644122|FG000|Overall Study|Lost to Follow-up|1|||
125550186|NCT01423253|451644122|FG000|Overall Study|Protocol Violation|2|||
125550187|NCT01423253|451644122|FG000|Overall Study|Withdrawal by Subject|2|||
125550188|NCT00307125|451644123|FG000|Screening Phase|Adverse Event|1|||
125550189|NCT00307125|451644124|FG001|Screening Phase|Adverse Event|0|||
125550190|NCT00307125|451644125|FG002|Screening Phase|Adverse Event|0|||
125550191|NCT00307125|451644123|FG000|Screening Phase|Protocol Violation|27|||
125550192|NCT00307125|451644124|FG001|Screening Phase|Protocol Violation|0|||
125550193|NCT00307125|451644125|FG002|Screening Phase|Protocol Violation|0|||
125550194|NCT00307125|451644123|FG000|Screening Phase|Lost to Follow-up|87|||
125550195|NCT00307125|451644124|FG001|Screening Phase|Lost to Follow-up|0|||
125550196|NCT00307125|451644125|FG002|Screening Phase|Lost to Follow-up|0|||
125550197|NCT00307125|451644123|FG000|Screening Phase|Death|10|||
125550198|NCT00307125|451644124|FG001|Screening Phase|Death|0|||
125550199|NCT00307125|451644125|FG002|Screening Phase|Death|0|||
125550200|NCT00307125|451644123|FG000|Screening Phase|Withdrawal by Subject|77|||
125210768|NCT03723070|450395677|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
125210769|NCT02208050|450395678|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
125210770|NCT02208050|450395679|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
125349736|NCT01933789|450915287|FG005|Overall Study|Withdrawal by Subject|16|||
125550201|NCT00307125|451644124|FG001|Screening Phase|Withdrawal by Subject|0|||
125550202|NCT00307125|451644125|FG002|Screening Phase|Withdrawal by Subject|0|||
125682485|NCT05216835|452127150|FG000|Overall Study|Other|0|||
125682486|NCT05216835|452127151|FG001|Overall Study|Other|1|||
125682487|NCT05216835|452127152|FG002|Overall Study|Other|0|||
125550203|NCT00307125|451644123|FG000|Screening Phase|Physician Decision|26|||
125550204|NCT00307125|451644124|FG001|Screening Phase|Physician Decision|0|||
125550205|NCT00307125|451644125|FG002|Screening Phase|Physician Decision|0|||
125550206|NCT00307125|451644123|FG000|Screening Phase|Sponsor Decision|4|||
125550207|NCT00307125|451644124|FG001|Screening Phase|Sponsor Decision|0|||
125550208|NCT00307125|451644125|FG002|Screening Phase|Sponsor Decision|0|||
125682488|NCT05216835|452127153|FG003|Overall Study|Other|0|||
125682489|NCT05216835|452127154|FG004|Overall Study|Other|0|||
125682490|NCT05216835|452127155|FG005|Overall Study|Other|0|||
125682491|NCT05216835|452127156|FG006|Overall Study|Other|0|||
125682492|NCT05216835|452127157|FG007|Overall Study|Other|0|||
125682493|NCT05179603|452127158|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
125682494|NCT05179603|452127158|FG000|Overall Study|Withdrawal by Subject|1|||
125550209|NCT00307125|451644123|FG000|Screening Phase|Study Terminated|17|||
125550210|NCT00307125|451644124|FG001|Screening Phase|Study Terminated|0|||
125682495|NCT05179603|452127158|FG000|Overall Study|Progressive disease|4|||
125682496|NCT05179603|452127158|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
125682497|NCT02689505|452127159|FG000|Overall Study|Progressive disease|2|||
125682498|NCT02689505|452127160|FG001|Overall Study|Progressive disease|2|||
125682499|NCT02689505|452127161|FG002|Overall Study|Progressive disease|3|||
125682500|NCT02689505|452127162|FG003|Overall Study|Progressive disease|9|||
125682501|NCT02689505|452127163|FG004|Overall Study|Progressive disease|1|||
125550211|NCT00307125|451644125|FG002|Screening Phase|Study Terminated|0|||
125550212|NCT00307125|451644123|FG000|Screening Phase|Graft Loss|3|||
125550213|NCT00307125|451644124|FG001|Screening Phase|Graft Loss|0|||
125550214|NCT00307125|451644125|FG002|Screening Phase|Graft Loss|0|||
125550215|NCT00307125|451644123|FG000|Screening Phase|Graft Failure|8|||
125550216|NCT00307125|451644124|FG001|Screening Phase|Graft Failure|0|||
125550217|NCT00307125|451644125|FG002|Screening Phase|Graft Failure|0|||
125550218|NCT00307125|451644123|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
125550219|NCT00307125|451644124|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
125550220|NCT00307125|451644125|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
125550221|NCT00307125|451644123|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
125550222|NCT00307125|451644124|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
125550223|NCT00307125|451644125|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
125550224|NCT00307125|451644123|FG000|Screening Phase|Moved or transferred facilities|34|||
125550225|NCT00307125|451644124|FG001|Screening Phase|Moved or transferred facilities|0|||
125550226|NCT00307125|451644125|FG002|Screening Phase|Moved or transferred facilities|0|||
125550227|NCT00307125|451644123|FG000|Screening Phase|Received Pancreas Transplant|8|||
125550228|NCT00307125|451644124|FG001|Screening Phase|Received Pancreas Transplant|0|||
125550229|NCT00307125|451644125|FG002|Screening Phase|Received Pancreas Transplant|0|||
125550230|NCT00307125|451644123|FG000|Screening Phase|Ineligible for pilot|4|||
125550231|NCT00307125|451644124|FG001|Screening Phase|Ineligible for pilot|0|||
125550232|NCT00307125|451644125|FG002|Screening Phase|Ineligible for pilot|0|||
125550233|NCT00307125|451644123|FG000|Screening Phase|Try to get pregnant|1|||
125550234|NCT00307125|451644124|FG001|Screening Phase|Try to get pregnant|0|||
125550235|NCT00307125|451644125|FG002|Screening Phase|Try to get pregnant|0|||
125550236|NCT00307125|451644123|FG000|Screening Phase|Developed acute leukemia|1|||
125550237|NCT00307125|451644124|FG001|Screening Phase|Developed acute leukemia|0|||
125550238|NCT00307125|451644125|FG002|Screening Phase|Developed acute leukemia|0|||
125550239|NCT00307125|451644123|FG000|Screening Phase|Metastatic colon cancer|1|||
125550240|NCT00307125|451644124|FG001|Screening Phase|Metastatic colon cancer|0|||
125550241|NCT00307125|451644125|FG002|Screening Phase|Metastatic colon cancer|0|||
125550242|NCT00307125|451644123|FG000|Screening Phase|Malignancy|1|||
125550243|NCT00307125|451644124|FG001|Screening Phase|Malignancy|0|||
125550244|NCT00307125|451644125|FG002|Screening Phase|Malignancy|0|||
125550245|NCT00307125|451644123|FG000|Screening Phase|PAK|1|||
125550246|NCT00307125|451644124|FG001|Screening Phase|PAK|0|||
125550247|NCT00307125|451644125|FG002|Screening Phase|PAK|0|||
125550248|NCT00307125|451644123|FG000|Screening Phase|Ineligible|1|||
125682502|NCT02689505|452127159|FG000|Overall Study|Dose Limiting Toxicity|0|||
125682503|NCT02689505|452127160|FG001|Overall Study|Dose Limiting Toxicity|1|||
125682504|NCT02689505|452127161|FG002|Overall Study|Dose Limiting Toxicity|0|||
125682505|NCT02689505|452127162|FG003|Overall Study|Dose Limiting Toxicity|0|||
125682506|NCT02689505|452127163|FG004|Overall Study|Dose Limiting Toxicity|2|||
125682507|NCT02689505|452127159|FG000|Overall Study|Other AE or clinical progression|0|||
125682508|NCT02689505|452127160|FG001|Overall Study|Other AE or clinical progression|2|||
125682509|NCT02689505|452127161|FG002|Overall Study|Other AE or clinical progression|0|||
125682510|NCT02689505|452127162|FG003|Overall Study|Other AE or clinical progression|2|||
125682511|NCT02689505|452127163|FG004|Overall Study|Other AE or clinical progression|0|||
125682512|NCT04875195|452127166|FG000|Overall Study|Death|9|||
125682513|NCT04875195|452127167|FG001|Overall Study|Death|3|||
125682514|NCT04875195|452127166|FG000|Overall Study|Withdrawal by Subject|2|||
125682515|NCT04875195|452127167|FG001|Overall Study|Withdrawal by Subject|1|||
125682516|NCT04875195|452127166|FG000|Overall Study|Ongoing in study|49|||
125682517|NCT04875195|452127167|FG001|Overall Study|Ongoing in study|2|||
125682518|NCT03389802|452127168|FG000|Overall Study|Lack of Efficacy|3|||
125682519|NCT03389802|452127169|FG001|Overall Study|Lack of Efficacy|3|||
125682520|NCT03389802|452127170|FG002|Overall Study|Lack of Efficacy|13|||
125682521|NCT03389802|452127171|FG003|Overall Study|Lack of Efficacy|6|||
125682522|NCT03389802|452127172|FG004|Overall Study|Lack of Efficacy|1|||
125682523|NCT03389802|452127168|FG000|Overall Study|Adverse Event|0|||
125682524|NCT03389802|452127169|FG001|Overall Study|Adverse Event|0|||
125682525|NCT03389802|452127170|FG002|Overall Study|Adverse Event|1|||
125682526|NCT03389802|452127171|FG003|Overall Study|Adverse Event|0|||
125682527|NCT03389802|452127172|FG004|Overall Study|Adverse Event|4|||
125550249|NCT00307125|451644124|FG001|Screening Phase|Ineligible|0|||
125550250|NCT00307125|451644125|FG002|Screening Phase|Ineligible|0|||
125550251|NCT00307125|451644123|FG000|Screening Phase|Screen Error|1|||
125682528|NCT03389802|452127168|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
125682529|NCT03389802|452127169|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
125682530|NCT03389802|452127170|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
125682531|NCT03389802|452127171|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
125682532|NCT03389802|452127172|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
125682533|NCT05190120|452127173|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
125682534|NCT05190120|452127174|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
125682535|NCT05190120|452127175|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
125550252|NCT00307125|451644124|FG001|Screening Phase|Screen Error|0|||
125550253|NCT00307125|451644125|FG002|Screening Phase|Screen Error|0|||
125682536|NCT05190120|452127176|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
125550254|NCT00307125|451644123|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
125550255|NCT00307125|451644124|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
125550256|NCT00307125|451644125|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
125550257|NCT00307125|451644123|FG000|Screening Phase|AMR and treated with rituximab|1|||
125550258|NCT00307125|451644124|FG001|Screening Phase|AMR and treated with rituximab|0|||
125550259|NCT00307125|451644125|FG002|Screening Phase|AMR and treated with rituximab|0|||
125550260|NCT00307125|451644123|FG000|Screening Phase|Coronary artery bypass|1|||
125550261|NCT00307125|451644124|FG001|Screening Phase|Coronary artery bypass|0|||
125550262|NCT00307125|451644125|FG002|Screening Phase|Coronary artery bypass|0|||
125550263|NCT00307125|451644123|FG000|Pilot Phase|Lost to Follow-up|0|||
125550264|NCT00307125|451644124|FG001|Pilot Phase|Lost to Follow-up|1|||
125550265|NCT00307125|451644125|FG002|Pilot Phase|Lost to Follow-up|0|||
125550266|NCT00307125|451644123|FG000|Pilot Phase|Withdrawal by Subject|0|||
125550267|NCT00307125|451644124|FG001|Pilot Phase|Withdrawal by Subject|1|||
125550268|NCT00307125|451644125|FG002|Pilot Phase|Withdrawal by Subject|1|||
125550269|NCT00051363|451644126|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
125550270|NCT00051363|451644127|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
125550271|NCT00051363|451644126|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
125550272|NCT00051363|451644127|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
125550273|NCT00051363|451644126|FG000|Overall Study|Death|2|||
125550274|NCT00051363|451644127|FG001|Overall Study|Death|2|||
125550275|NCT00051363|451644126|FG000|Overall Study|Excluded Pre-Randomization|2|||
125550276|NCT00051363|451644127|FG001|Overall Study|Excluded Pre-Randomization|5|||
125550277|NCT00985153|451644128|FG000|Overall Study|Lost to Follow-up|16|||
125550278|NCT00985153|451644129|FG001|Overall Study|Lost to Follow-up|19|||
125349737|NCT01933789|450915288|FG006|Overall Study|Withdrawal by Subject|1|||
125349738|NCT01933789|450915289|FG007|Overall Study|Withdrawal by Subject|4|||
125550279|NCT00985153|451644130|FG002|Overall Study|Lost to Follow-up|17|||
125349739|NCT01933789|450915290|FG008|Overall Study|Withdrawal by Subject|0|||
125550280|NCT00985153|451644131|FG003|Overall Study|Lost to Follow-up|20|||
125550281|NCT00985153|451644128|FG000|Overall Study|Protocol Violation|3|||
125550282|NCT00985153|451644129|FG001|Overall Study|Protocol Violation|2|||
125550283|NCT00985153|451644130|FG002|Overall Study|Protocol Violation|4|||
125550284|NCT00985153|451644131|FG003|Overall Study|Protocol Violation|3|||
125550285|NCT00985153|451644128|FG000|Overall Study|Withdrawal by Subject|6|||
125550286|NCT00985153|451644129|FG001|Overall Study|Withdrawal by Subject|11|||
125550287|NCT00985153|451644130|FG002|Overall Study|Withdrawal by Subject|11|||
125349740|NCT01933789|450915282|FG000|Overall Study|Became Ineligible|4|||
125349741|NCT01933789|450915283|FG001|Overall Study|Became Ineligible|0|||
125349742|NCT01933789|450915284|FG002|Overall Study|Became Ineligible|0|||
125349743|NCT01933789|450915285|FG003|Overall Study|Became Ineligible|0|||
125349744|NCT01933789|450915286|FG004|Overall Study|Became Ineligible|13|||
125349745|NCT01933789|450915287|FG005|Overall Study|Became Ineligible|10|||
125349746|NCT01933789|450915288|FG006|Overall Study|Became Ineligible|13|||
125349747|NCT01933789|450915289|FG007|Overall Study|Became Ineligible|6|||
125349748|NCT01933789|450915290|FG008|Overall Study|Became Ineligible|0|||
125349749|NCT01966432|450915291|FG000|Overall Study|Lost to Follow-up|3|||
125550288|NCT00985153|451644131|FG003|Overall Study|Withdrawal by Subject|10|||
125550289|NCT00985153|451644128|FG000|Overall Study|Missed One or More Bleeds|7|||
125550290|NCT00985153|451644129|FG001|Overall Study|Missed One or More Bleeds|7|||
125550291|NCT00985153|451644130|FG002|Overall Study|Missed One or More Bleeds|8|||
125550292|NCT00985153|451644131|FG003|Overall Study|Missed One or More Bleeds|10|||
125550293|NCT00985153|451644128|FG000|Overall Study|Incomplete Safety Follow-up|3|||
125550294|NCT00985153|451644129|FG001|Overall Study|Incomplete Safety Follow-up|5|||
125550295|NCT00985153|451644130|FG002|Overall Study|Incomplete Safety Follow-up|4|||
125550296|NCT00985153|451644131|FG003|Overall Study|Incomplete Safety Follow-up|4|||
125550297|NCT01596621|451644133|FG000|Overall Study|Death|4|||
125550298|NCT01596621|451644133|FG000|Overall Study|Withdrawal by Subject|9|||
125550299|NCT01596621|451644133|FG000|Overall Study|Disease Progression|49|||
125550300|NCT01596621|451644133|FG000|Overall Study|Lost to Follow-up|3|||
125550301|NCT01596621|451644133|FG000|Overall Study|Other than specified|13|||
125349750|NCT01966432|450915292|FG001|Overall Study|Lost to Follow-up|2|||
125349751|NCT01966432|450915293|FG002|Overall Study|Lost to Follow-up|5|||
125349752|NCT01966432|450915291|FG000|Overall Study|Withdrawal by Subject|1|||
125550302|NCT01074216|451644136|FG000|Overall Study|Physician Decision|1|||
125550303|NCT01074216|451644136|FG000|Overall Study|Not Treated|12|||
125550304|NCT01323634|451644137|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
125550305|NCT01323634|451644138|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
125550306|NCT01323634|451644139|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
125550307|NCT01323634|451644137|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
125550308|NCT01323634|451644138|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
125349753|NCT01966432|450915292|FG001|Overall Study|Withdrawal by Subject|3|||
125349754|NCT01966432|450915293|FG002|Overall Study|Withdrawal by Subject|0|||
125349755|NCT01966432|450915291|FG000|Overall Study|Subject Incarcerated|0|||
125349756|NCT01966432|450915292|FG001|Overall Study|Subject Incarcerated|0|||
125349757|NCT01966432|450915293|FG002|Overall Study|Subject Incarcerated|1|||
125550309|NCT01323634|451644139|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
125550310|NCT01323634|451644137|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
125550311|NCT01323634|451644138|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
125550312|NCT01323634|451644139|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
125550313|NCT01323634|451644137|FG000|2-week Run-in Period|Physician Decision|5|||
125550314|NCT01323634|451644138|FG001|2-week Run-in Period|Physician Decision|0|||
125550315|NCT01323634|451644139|FG002|2-week Run-in Period|Physician Decision|0|||
125550316|NCT01323634|451644137|FG000|2-week Run-in Period|Protocol Violation|1|||
125550317|NCT01323634|451644138|FG001|2-week Run-in Period|Protocol Violation|0|||
125550318|NCT01323634|451644139|FG002|2-week Run-in Period|Protocol Violation|0|||
125550319|NCT01323634|451644137|FG000|2-week Run-in Period|Adverse Event|1|||
125550320|NCT01323634|451644138|FG001|2-week Run-in Period|Adverse Event|0|||
125550321|NCT01323634|451644139|FG002|2-week Run-in Period|Adverse Event|0|||
125550322|NCT01323634|451644137|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125550323|NCT01323634|451644138|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
125550324|NCT01323634|451644139|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
125550325|NCT01323634|451644137|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125550326|NCT01323634|451644138|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125349758|NCT01966432|450915291|FG000|Overall Study|SBIRT program ended|1|||
125349759|NCT01966432|450915292|FG001|Overall Study|SBIRT program ended|8|||
125550327|NCT01323634|451644139|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
125550328|NCT01323634|451644137|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125550329|NCT01323634|451644138|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
125550330|NCT01323634|451644139|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
125550331|NCT01323634|451644137|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125550332|NCT01323634|451644138|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
125550333|NCT01323634|451644139|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
125550334|NCT01323634|451644137|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
125550335|NCT01323634|451644138|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
125550336|NCT01323634|451644139|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
125550337|NCT01323634|451644137|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125550338|NCT01323634|451644138|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
125550339|NCT01323634|451644139|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
125550340|NCT01323634|451644137|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
125550341|NCT01323634|451644138|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
125550342|NCT01323634|451644139|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
125550343|NCT05056987|451644140|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
125550344|NCT05056987|451644141|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
125550345|NCT05056987|451644140|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
125550346|NCT05056987|451644141|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
125550347|NCT02678247|451644144|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
125550348|NCT02678247|451644145|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
125550349|NCT02678247|451644144|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
125550350|NCT02678247|451644145|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
125550351|NCT02678247|451644144|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
125550352|NCT02678247|451644145|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
125550353|NCT02678247|451644144|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
125550354|NCT02678247|451644145|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
125550355|NCT02678247|451644144|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
125682537|NCT05190120|452127173|FG000|Overall Study|Lost to Follow-up|5|||
125682538|NCT05190120|452127174|FG001|Overall Study|Lost to Follow-up|0|||
125682539|NCT05190120|452127175|FG002|Overall Study|Lost to Follow-up|2|||
125682540|NCT05190120|452127176|FG003|Overall Study|Lost to Follow-up|3|||
125682541|NCT02446600|452127177|FG000|Overall Study|Never treated|20|||
125682542|NCT02446600|452127178|FG001|Overall Study|Never treated|2|||
125682543|NCT02446600|452127179|FG002|Overall Study|Never treated|6|||
125682544|NCT02446600|452127180|FG003|Overall Study|Never treated|0|||
125682545|NCT02446600|452127177|FG000|Overall Study|Withdrawal by Subject|19|||
125682546|NCT02446600|452127178|FG001|Overall Study|Withdrawal by Subject|5|||
125682547|NCT02446600|452127179|FG002|Overall Study|Withdrawal by Subject|17|||
125682548|NCT02446600|452127180|FG003|Overall Study|Withdrawal by Subject|0|||
125682549|NCT02446600|452127177|FG000|Overall Study|Ineligible|1|||
125682550|NCT02446600|452127178|FG001|Overall Study|Ineligible|4|||
125682551|NCT02446600|452127179|FG002|Overall Study|Ineligible|4|||
125682552|NCT02446600|452127180|FG003|Overall Study|Ineligible|1|||
125682553|NCT02446600|452127177|FG000|Overall Study|Duplicate Enrollment|0|||
125349760|NCT01966432|450915293|FG002|Overall Study|SBIRT program ended|20|||
125682554|NCT02446600|452127178|FG001|Overall Study|Duplicate Enrollment|1|||
125682555|NCT02446600|452127179|FG002|Overall Study|Duplicate Enrollment|0|||
125349761|NCT00930982|450915294|FG000|Overall Study|Adverse Event|19|||
125349762|NCT00930982|450915295|FG001|Overall Study|Adverse Event|23|||
125550356|NCT02678247|451644145|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
125550357|NCT02678247|451644144|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
125550358|NCT02678247|451644145|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
125550359|NCT00753272|451644149|FG000|Overall Study|Adverse Event|878|||
125550360|NCT00753272|451644150|FG001|Overall Study|Adverse Event|869|||
125550361|NCT00753272|451644149|FG000|Overall Study|Protocol Violation|28|||
125550362|NCT00753272|451644150|FG001|Overall Study|Protocol Violation|46|||
125550363|NCT00753272|451644149|FG000|Overall Study|Withdrawal by Subject|2481|||
125550364|NCT00753272|451644150|FG001|Overall Study|Withdrawal by Subject|2407|||
125550365|NCT00753272|451644149|FG000|Overall Study|Lost to Follow-up|491|||
125550366|NCT00753272|451644150|FG001|Overall Study|Lost to Follow-up|497|||
125550367|NCT00753272|451644149|FG000|Overall Study|Other|1104|||
125550368|NCT00753272|451644150|FG001|Overall Study|Other|1088|||
125550369|NCT00971243|451644151|FG000|Double Blind Period|Adverse Event|2|||
125550370|NCT00971243|451644152|FG001|Double Blind Period|Adverse Event|3|||
125550371|NCT00971243|451644153|FG002|Double Blind Period|Adverse Event|2|||
125550372|NCT00971243|451644154|FG003|Double Blind Period|Adverse Event|2|||
125550373|NCT00971243|451644155|FG004|Double Blind Period|Adverse Event|3|||
125550374|NCT00971243|451644151|FG000|Double Blind Period|Lost to Follow-up|0|||
125550375|NCT00971243|451644152|FG001|Double Blind Period|Lost to Follow-up|1|||
125550376|NCT00971243|451644153|FG002|Double Blind Period|Lost to Follow-up|1|||
125550377|NCT00971243|451644154|FG003|Double Blind Period|Lost to Follow-up|0|||
125550378|NCT00971243|451644155|FG004|Double Blind Period|Lost to Follow-up|1|||
125550379|NCT00971243|451644151|FG000|Double Blind Period|Physician Decision|10|||
125550380|NCT00971243|451644152|FG001|Double Blind Period|Physician Decision|6|||
125550381|NCT00971243|451644153|FG002|Double Blind Period|Physician Decision|7|||
125550382|NCT00971243|451644154|FG003|Double Blind Period|Physician Decision|6|||
125550383|NCT00971243|451644155|FG004|Double Blind Period|Physician Decision|7|||
125550384|NCT00971243|451644151|FG000|Double Blind Period|Protocol Violation|2|||
125550385|NCT00971243|451644152|FG001|Double Blind Period|Protocol Violation|0|||
125550386|NCT00971243|451644153|FG002|Double Blind Period|Protocol Violation|3|||
125550387|NCT00971243|451644154|FG003|Double Blind Period|Protocol Violation|2|||
125550388|NCT00971243|451644155|FG004|Double Blind Period|Protocol Violation|2|||
125550389|NCT00971243|451644151|FG000|Double Blind Period|Withdrawal by Subject|4|||
125550390|NCT00971243|451644152|FG001|Double Blind Period|Withdrawal by Subject|1|||
125550391|NCT00971243|451644153|FG002|Double Blind Period|Withdrawal by Subject|4|||
125550392|NCT00971243|451644154|FG003|Double Blind Period|Withdrawal by Subject|4|||
125550393|NCT00971243|451644155|FG004|Double Blind Period|Withdrawal by Subject|4|||
125550394|NCT00971243|451644151|FG000|Double Blind Period|Other reasons|1|||
125550395|NCT00971243|451644152|FG001|Double Blind Period|Other reasons|0|||
125550396|NCT00971243|451644153|FG002|Double Blind Period|Other reasons|2|||
125550397|NCT00971243|451644154|FG003|Double Blind Period|Other reasons|0|||
125550398|NCT00971243|451644155|FG004|Double Blind Period|Other reasons|1|||
125550399|NCT00971243|451644151|FG000|Open-label Period|Adverse Event|1|||
125550400|NCT00971243|451644152|FG001|Open-label Period|Adverse Event|0|||
125550401|NCT00971243|451644153|FG002|Open-label Period|Adverse Event|1|||
125550402|NCT00971243|451644154|FG003|Open-label Period|Adverse Event|1|||
125550403|NCT00971243|451644155|FG004|Open-label Period|Adverse Event|0|||
125550404|NCT00971243|451644151|FG000|Open-label Period|Physician Decision|5|||
125550405|NCT00971243|451644152|FG001|Open-label Period|Physician Decision|9|||
125550406|NCT00971243|451644153|FG002|Open-label Period|Physician Decision|3|||
125550407|NCT00971243|451644154|FG003|Open-label Period|Physician Decision|7|||
125550408|NCT00971243|451644155|FG004|Open-label Period|Physician Decision|2|||
125550409|NCT00971243|451644151|FG000|Open-label Period|Protocol Violation|1|||
125550410|NCT00971243|451644152|FG001|Open-label Period|Protocol Violation|1|||
125550411|NCT00971243|451644153|FG002|Open-label Period|Protocol Violation|1|||
125550412|NCT00971243|451644154|FG003|Open-label Period|Protocol Violation|0|||
125550413|NCT00971243|451644155|FG004|Open-label Period|Protocol Violation|1|||
125550414|NCT00971243|451644151|FG000|Open-label Period|Withdrawal by Subject|1|||
125550415|NCT00971243|451644152|FG001|Open-label Period|Withdrawal by Subject|0|||
125550416|NCT00971243|451644153|FG002|Open-label Period|Withdrawal by Subject|0|||
125550417|NCT00971243|451644154|FG003|Open-label Period|Withdrawal by Subject|2|||
125550418|NCT00971243|451644155|FG004|Open-label Period|Withdrawal by Subject|1|||
125550419|NCT00971243|451644151|FG000|Open-label Period|Other reason|0|||
125550420|NCT00971243|451644152|FG001|Open-label Period|Other reason|0|||
125550421|NCT00971243|451644153|FG002|Open-label Period|Other reason|0|||
125550422|NCT00971243|451644154|FG003|Open-label Period|Other reason|0|||
125550423|NCT00971243|451644155|FG004|Open-label Period|Other reason|2|||
125550424|NCT03604523|451644158|FG000|Overall Study|Physician Decision|1|||
125550425|NCT03604523|451644159|FG001|Overall Study|Physician Decision|0|||
125550426|NCT01675479|451644163|FG000|Overall Study|Lost to Follow-up|11|||
125550427|NCT04223856|451644167|FG000|Overall Study|Progressive disease|153|||
125682556|NCT02446600|452127180|FG003|Overall Study|Duplicate Enrollment|0|||
125682557|NCT04551053|452127181|FG000|Overall Study|Death|10|||
125682558|NCT04551053|452127182|FG001|Overall Study|Death|9|||
125682559|NCT04551053|452127181|FG000|Overall Study|Lost to Follow-up|0|||
125682560|NCT04551053|452127182|FG001|Overall Study|Lost to Follow-up|2|||
125550428|NCT04223856|451644168|FG001|Overall Study|Progressive disease|73|||
125550429|NCT04223856|451644167|FG000|Overall Study|Adverse Event|97|||
125550430|NCT04223856|451644168|FG001|Overall Study|Adverse Event|62|||
125550431|NCT04223856|451644167|FG000|Overall Study|Physician Decision|9|||
125550432|NCT04223856|451644168|FG001|Overall Study|Physician Decision|28|||
125550433|NCT04223856|451644167|FG000|Overall Study|Withdrawal by Subject|22|||
125550434|NCT04223856|451644168|FG001|Overall Study|Withdrawal by Subject|24|||
125550435|NCT04223856|451644167|FG000|Overall Study|Other|7|||
125550436|NCT04223856|451644168|FG001|Overall Study|Other|2|||
125550437|NCT04223856|451644167|FG000|Overall Study|Randomized but not treated|2|||
125550438|NCT04223856|451644168|FG001|Overall Study|Randomized but not treated|11|||
125550439|NCT04223856|451644167|FG000|Overall Study|On-treatment|144|||
125550440|NCT04223856|451644168|FG001|Overall Study|On-treatment|0|||
125550441|NCT03226275|451644169|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
125550442|NCT03226275|451644170|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
125550443|NCT03226275|451644171|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
125550444|NCT03226275|451644172|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
125550445|NCT03226275|451644169|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
125550446|NCT03226275|451644170|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
125550447|NCT03226275|451644171|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
125550448|NCT03226275|451644172|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
125550449|NCT00171704|451645950|FG000|Overall Study|Adverse Event|24|||
125550450|NCT00171704|451645951|FG001|Overall Study|Adverse Event|33|||
125550451|NCT00171704|451645950|FG000|Overall Study|Disease Progression|14|||
125550452|NCT00171704|451645951|FG001|Overall Study|Disease Progression|9|||
125550453|NCT00171704|451645950|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
125550454|NCT00171704|451645951|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
125550455|NCT00171704|451645950|FG000|Overall Study|Administrative Problems|2|||
125550456|NCT00171704|451645951|FG001|Overall Study|Administrative Problems|1|||
125550457|NCT00171704|451645950|FG000|Overall Study|Death|2|||
125550458|NCT00171704|451645951|FG001|Overall Study|Death|2|||
125550459|NCT00171704|451645950|FG000|Overall Study|Withdrawal by Subject|1|||
125550460|NCT00171704|451645951|FG001|Overall Study|Withdrawal by Subject|3|||
125550461|NCT00171704|451645950|FG000|Overall Study|Protocol Violation|0|||
125550462|NCT00171704|451645951|FG001|Overall Study|Protocol Violation|1|||
125550463|NCT02141984|451645952|FG000|Overall Study|Lack of Efficacy|2|||
125550464|NCT00816400|451645956|FG000|Overall Study|Death|2|||
125550465|NCT00816400|451645957|FG001|Overall Study|Death|3|||
125550466|NCT00816400|451645958|FG002|Overall Study|Death|3|||
125550467|NCT00816400|451645959|FG003|Overall Study|Death|3|||
125550468|NCT00816400|451645960|FG004|Overall Study|Death|2|||
125550469|NCT00816400|451645961|FG005|Overall Study|Death|3|||
125550470|NCT00816400|451645962|FG006|Overall Study|Death|2|||
125550471|NCT00816400|451645963|FG007|Overall Study|Death|5|||
125550472|NCT00816400|451645964|FG008|Overall Study|Death|6|||
125550473|NCT00816400|451645956|FG000|Overall Study|In hospice care at the end of the study|0|||
125550474|NCT00816400|451645957|FG001|Overall Study|In hospice care at the end of the study|0|||
125550475|NCT00816400|451645958|FG002|Overall Study|In hospice care at the end of the study|2|||
125550476|NCT00816400|451645959|FG003|Overall Study|In hospice care at the end of the study|0|||
125550477|NCT00816400|451645960|FG004|Overall Study|In hospice care at the end of the study|0|||
125550478|NCT00816400|451645961|FG005|Overall Study|In hospice care at the end of the study|0|||
125550479|NCT00816400|451645962|FG006|Overall Study|In hospice care at the end of the study|0|||
125550480|NCT00816400|451645963|FG007|Overall Study|In hospice care at the end of the study|0|||
125550481|NCT00816400|451645964|FG008|Overall Study|In hospice care at the end of the study|0|||
125550482|NCT00081770|451645965|FG000|Overall Study|Adverse Event|130|||
125550483|NCT00081770|451645966|FG001|Overall Study|Adverse Event|98|||
125550484|NCT00081770|451645967|FG002|Overall Study|Adverse Event|136|||
125550485|NCT00081770|451645965|FG000|Overall Study|Lack of Efficacy|262|||
125550486|NCT00081770|451645966|FG001|Overall Study|Lack of Efficacy|357|||
125550487|NCT00081770|451645967|FG002|Overall Study|Lack of Efficacy|211|||
125550488|NCT00081770|451645965|FG000|Overall Study|Lost to Follow-up|45|||
125550489|NCT00081770|451645966|FG001|Overall Study|Lost to Follow-up|34|||
125550490|NCT00081770|451645967|FG002|Overall Study|Lost to Follow-up|45|||
125550491|NCT00081770|451645965|FG000|Overall Study|Protocol Violation|15|||
125550492|NCT00081770|451645966|FG001|Overall Study|Protocol Violation|10|||
125550493|NCT00081770|451645967|FG002|Overall Study|Protocol Violation|10|||
125550494|NCT00081770|451645965|FG000|Overall Study|Withdrawal by Subject|45|||
125550495|NCT00081770|451645966|FG001|Overall Study|Withdrawal by Subject|40|||
125550496|NCT00081770|451645967|FG002|Overall Study|Withdrawal by Subject|42|||
125550497|NCT00081770|451645965|FG000|Overall Study|Did not meet protocol eligibility|2|||
125349763|NCT00930982|450915294|FG000|Overall Study|Protocol Violation|1|||
125550498|NCT00081770|451645966|FG001|Overall Study|Did not meet protocol eligibility|0|||
125550499|NCT00081770|451645967|FG002|Overall Study|Did not meet protocol eligibility|3|||
125550500|NCT00081770|451645965|FG000|Overall Study|Administrative|1|||
125550501|NCT00081770|451645966|FG001|Overall Study|Administrative|0|||
125550502|NCT00081770|451645967|FG002|Overall Study|Administrative|1|||
125349764|NCT00930982|450915295|FG001|Overall Study|Protocol Violation|5|||
125349765|NCT00930982|450915294|FG000|Overall Study|Withdrawal by Subject|1|||
125349766|NCT00930982|450915295|FG001|Overall Study|Withdrawal by Subject|1|||
125349767|NCT01609478|450915296|FG000|Overall Study|Adverse Event|3|||
125349768|NCT01609478|450915297|FG001|Overall Study|Adverse Event|1|||
125349769|NCT01609478|450915298|FG002|Overall Study|Adverse Event|5|||
125349770|NCT01609478|450915296|FG000|Overall Study|Protocol Deviation|0|||
125349771|NCT01609478|450915297|FG001|Overall Study|Protocol Deviation|1|||
125349772|NCT01609478|450915298|FG002|Overall Study|Protocol Deviation|1|||
125349773|NCT01609478|450915296|FG000|Overall Study|Non-Compliance with study treatment|1|||
125349774|NCT01609478|450915297|FG001|Overall Study|Non-Compliance with study treatment|0|||
125349775|NCT01609478|450915298|FG002|Overall Study|Non-Compliance with study treatment|0|||
125349776|NCT01609478|450915296|FG000|Overall Study|Physician Decision|1|||
125349777|NCT01609478|450915297|FG001|Overall Study|Physician Decision|0|||
125349778|NCT01609478|450915298|FG002|Overall Study|Physician Decision|1|||
125349779|NCT01609478|450915296|FG000|Overall Study|Withdrawal by Subject|2|||
125349780|NCT01609478|450915297|FG001|Overall Study|Withdrawal by Subject|0|||
125349781|NCT01609478|450915298|FG002|Overall Study|Withdrawal by Subject|2|||
125349782|NCT00768469|450915301|FG000|Overall Study|Adverse Event|0|||
125349783|NCT00768469|450915302|FG001|Overall Study|Adverse Event|2|||
125349784|NCT00768469|450915301|FG000|Overall Study|Disease Progression|3|||
125349785|NCT00768469|450915302|FG001|Overall Study|Disease Progression|4|||
125349786|NCT00768469|450915301|FG000|Overall Study|Withdrawal by Subject|0|||
125349787|NCT00768469|450915302|FG001|Overall Study|Withdrawal by Subject|1|||
125349788|NCT04966741|450915303|FG000|Overall Study|Lost to Follow-up|1|||
125349789|NCT04966741|450915304|FG001|Overall Study|Lost to Follow-up|0|||
125349790|NCT02953509|450915310|FG000|Overall Study|Death|1|||
125349791|NCT02953509|450915311|FG001|Overall Study|Death|3|||
125349792|NCT02953509|450915312|FG002|Overall Study|Death|3|||
125349793|NCT02953509|450915313|FG003|Overall Study|Death|4|||
125349794|NCT02953509|450915314|FG004|Overall Study|Death|12|||
125349795|NCT02953509|450915315|FG005|Overall Study|Death|3|||
125349796|NCT02953509|450915316|FG006|Overall Study|Death|25|||
125349797|NCT02953509|450915317|FG007|Overall Study|Death|10|||
125349798|NCT02953509|450915318|FG008|Overall Study|Death|21|||
125349799|NCT02953509|450915319|FG009|Overall Study|Death|20|||
125349800|NCT02953509|450915310|FG000|Overall Study|Reason Not Specified|0|||
125349801|NCT02953509|450915311|FG001|Overall Study|Reason Not Specified|2|||
125349802|NCT02953509|450915312|FG002|Overall Study|Reason Not Specified|8|||
125349803|NCT02953509|450915313|FG003|Overall Study|Reason Not Specified|2|||
125349804|NCT02953509|450915314|FG004|Overall Study|Reason Not Specified|11|||
125349805|NCT02953509|450915315|FG005|Overall Study|Reason Not Specified|4|||
125349806|NCT02953509|450915316|FG006|Overall Study|Reason Not Specified|12|||
125349807|NCT02953509|450915317|FG007|Overall Study|Reason Not Specified|2|||
125349808|NCT02953509|450915318|FG008|Overall Study|Reason Not Specified|7|||
125349809|NCT02953509|450915319|FG009|Overall Study|Reason Not Specified|2|||
125349810|NCT02953509|450915310|FG000|Overall Study|Consent Withdrawn|1|||
125349811|NCT02953509|450915311|FG001|Overall Study|Consent Withdrawn|1|||
125349812|NCT02953509|450915312|FG002|Overall Study|Consent Withdrawn|2|||
125349813|NCT02953509|450915313|FG003|Overall Study|Consent Withdrawn|1|||
125349814|NCT02953509|450915314|FG004|Overall Study|Consent Withdrawn|3|||
125349815|NCT02953509|450915315|FG005|Overall Study|Consent Withdrawn|0|||
125349816|NCT02953509|450915316|FG006|Overall Study|Consent Withdrawn|4|||
125349817|NCT02953509|450915317|FG007|Overall Study|Consent Withdrawn|1|||
125349818|NCT02953509|450915318|FG008|Overall Study|Consent Withdrawn|1|||
125349819|NCT02953509|450915319|FG009|Overall Study|Consent Withdrawn|4|||
125349820|NCT02953509|450915310|FG000|Overall Study|Lost to Follow-up|0|||
125349821|NCT02953509|450915311|FG001|Overall Study|Lost to Follow-up|0|||
125210771|NCT01810783|450395682|FG000|Overall Study|Adverse Event|32|||
125349822|NCT02953509|450915312|FG002|Overall Study|Lost to Follow-up|0|||
125349823|NCT02953509|450915313|FG003|Overall Study|Lost to Follow-up|0|||
125349824|NCT02953509|450915314|FG004|Overall Study|Lost to Follow-up|0|||
125349825|NCT02953509|450915315|FG005|Overall Study|Lost to Follow-up|0|||
125349826|NCT02953509|450915316|FG006|Overall Study|Lost to Follow-up|1|||
125349827|NCT02953509|450915317|FG007|Overall Study|Lost to Follow-up|1|||
125349828|NCT02953509|450915318|FG008|Overall Study|Lost to Follow-up|1|||
125349829|NCT02953509|450915319|FG009|Overall Study|Lost to Follow-up|1|||
125349830|NCT02953509|450915310|FG000|Overall Study|Study terminated by sponsor|1|||
125349831|NCT02953509|450915311|FG001|Overall Study|Study terminated by sponsor|0|||
125349832|NCT02953509|450915312|FG002|Overall Study|Study terminated by sponsor|0|||
125349833|NCT02953509|450915313|FG003|Overall Study|Study terminated by sponsor|0|||
125550503|NCT00081770|451645965|FG000|Overall Study|Other|2|||
125550504|NCT00081770|451645966|FG001|Overall Study|Other|7|||
125550505|NCT00081770|451645967|FG002|Overall Study|Other|8|||
125550506|NCT00601419|451645968|FG000|Overall Study|Lost to Follow-up|3|||
125550507|NCT00601419|451645968|FG000|Overall Study|Missed Visits|1|||
125550508|NCT01614197|451645969|FG000|Overall Study|Withdrawal by Subject|0|||
125550509|NCT01614197|451645970|FG001|Overall Study|Withdrawal by Subject|1|||
125550510|NCT01614197|451645971|FG002|Overall Study|Withdrawal by Subject|0|||
125550511|NCT01614197|451645972|FG003|Overall Study|Withdrawal by Subject|0|||
125550512|NCT02245672|451645973|FG000|Overall Study|Adverse Event|4|||
125550513|NCT02245672|451645974|FG001|Overall Study|Adverse Event|4|||
125550514|NCT02245672|451645975|FG002|Overall Study|Adverse Event|4|||
125550515|NCT02245672|451645973|FG000|Overall Study|Lost to Follow-up|3|||
125550516|NCT02245672|451645974|FG001|Overall Study|Lost to Follow-up|5|||
125550517|NCT02245672|451645975|FG002|Overall Study|Lost to Follow-up|1|||
125550518|NCT02245672|451645973|FG000|Overall Study|Withdrawal by Subject|6|||
125550519|NCT02245672|451645974|FG001|Overall Study|Withdrawal by Subject|3|||
125550520|NCT02245672|451645975|FG002|Overall Study|Withdrawal by Subject|0|||
125550521|NCT02245672|451645973|FG000|Overall Study|Randomized in error (not treated)|0|||
125550522|NCT02245672|451645974|FG001|Overall Study|Randomized in error (not treated)|1|||
125550523|NCT02245672|451645975|FG002|Overall Study|Randomized in error (not treated)|0|||
125550524|NCT00971932|451645976|FG000|Overall Study|Withdrawal by Subject|1|||
125550525|NCT00971932|451645976|FG000|Overall Study|Investigator's decision|2|||
125550526|NCT00971932|451645976|FG000|Overall Study|Ongoing|4|||
125550527|NCT01765192|451645979|FG000|Treatment Period 1|Adverse Event|0|||
125550528|NCT01765192|451645980|FG001|Treatment Period 1|Adverse Event|1|||
125550529|NCT01765192|451645979|FG000|Washout Period|Voluntary Withdrawal|1|||
125550530|NCT01765192|451645980|FG001|Washout Period|Voluntary Withdrawal|1|||
125550531|NCT01765192|451645979|FG000|Washout Period|Reason not specified|1|||
125550532|NCT01765192|451645980|FG001|Washout Period|Reason not specified|0|||
125550533|NCT01765192|451645979|FG000|Treatment Period 2|Reason not specified|0|||
125550534|NCT01765192|451645980|FG001|Treatment Period 2|Reason not specified|2|||
125550535|NCT01765192|451645979|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
125550536|NCT01765192|451645980|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
125550537|NCT00876694|451645985|FG000|Overall Study|Adverse Event|10|||
125550538|NCT00876694|451645986|FG001|Overall Study|Adverse Event|7|||
125550539|NCT00876694|451645985|FG000|Overall Study|Subject withdrew consent|6|||
125550540|NCT00876694|451645986|FG001|Overall Study|Subject withdrew consent|4|||
125550541|NCT00876694|451645985|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125550542|NCT00876694|451645986|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125550543|NCT00876694|451645985|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125550544|NCT00876694|451645986|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125550545|NCT00876694|451645985|FG000|Overall Study|Administrative problems|1|||
125550546|NCT00876694|451645986|FG001|Overall Study|Administrative problems|1|||
125550547|NCT00876694|451645985|FG000|Overall Study|Death|1|||
125550548|NCT00876694|451645986|FG001|Overall Study|Death|0|||
125550549|NCT01215422|451645991|FG000|Overall Study|Relocation|1|||
125550550|NCT01215422|451645992|FG001|Overall Study|Relocation|0|||
125550551|NCT01215422|451645993|FG002|Overall Study|Relocation|0|||
125550552|NCT01215422|451645994|FG003|Overall Study|Relocation|0|||
125550553|NCT01215422|451645991|FG000|Overall Study|Failed intubations|0|||
125550554|NCT01215422|451645992|FG001|Overall Study|Failed intubations|0|||
125550555|NCT01215422|451645993|FG002|Overall Study|Failed intubations|3|||
125550556|NCT01215422|451645994|FG003|Overall Study|Failed intubations|8|||
125550557|NCT01215422|451645991|FG000|Overall Study|Did not complete all intubations|7|||
125550558|NCT01215422|451645992|FG001|Overall Study|Did not complete all intubations|0|||
125550559|NCT01215422|451645993|FG002|Overall Study|Did not complete all intubations|0|||
125550560|NCT01215422|451645994|FG003|Overall Study|Did not complete all intubations|0|||
125550561|NCT00294554|451645997|FG000|Overall Study|Lack of Efficacy|0|||
125550562|NCT00294554|451645998|FG001|Overall Study|Lack of Efficacy|1|||
125550563|NCT00294554|451645997|FG000|Overall Study|Physician Decision|0|||
125550564|NCT00294554|451645998|FG001|Overall Study|Physician Decision|1|||
125550565|NCT00462865|451645999|FG000|Overall Study|Adverse Event|1|||
125550566|NCT02864381|451646000|FG000|Overall Study|Death|58|||
125550567|NCT02864381|451646001|FG001|Overall Study|Death|61|||
125550568|NCT02864381|451646000|FG000|Overall Study|Withdrew Consent|5|||
125550569|NCT02864381|451646001|FG001|Overall Study|Withdrew Consent|6|||
125550570|NCT02864381|451646000|FG000|Overall Study|Reason Unknown|7|||
125550571|NCT02864381|451646001|FG001|Overall Study|Reason Unknown|3|||
125550572|NCT02864381|451646000|FG000|Overall Study|Lost to Follow-up|1|||
125550573|NCT02864381|451646001|FG001|Overall Study|Lost to Follow-up|1|||
125550574|NCT02864381|451646000|FG000|Overall Study|Investigator's Discretion|1|||
125550575|NCT02864381|451646001|FG001|Overall Study|Investigator's Discretion|0|||
125550576|NCT02864381|451646000|FG000|Overall Study|Protocol Violation|0|||
125550577|NCT02864381|451646001|FG001|Overall Study|Protocol Violation|1|||
125550578|NCT04142450|451646002|FG000|Overall Study|Screen Failure|1|||
125550579|NCT04142450|451646002|FG000|Overall Study|Lost to Follow-up|1|||
125550580|NCT01146054|451646003|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
125550581|NCT01146054|451646003|FG000|Overall Study|Rapid tumor progression|2|||
125550582|NCT01146054|451646003|FG000|Overall Study|Other illness precluded treatment|2|||
125550583|NCT01146054|451646003|FG000|Overall Study|Lost to Follow-up|1|||
125550584|NCT04335812|451646004|FG000|Overall Study|Withdrawal by Subject|1|||
125550585|NCT04335812|451646005|FG001|Overall Study|Withdrawal by Subject|3|||
125550586|NCT04335812|451646004|FG000|Overall Study|Lost to Follow-up|12|||
125550587|NCT04335812|451646005|FG001|Overall Study|Lost to Follow-up|12|||
125550588|NCT04335812|451646004|FG000|Overall Study|Did not engage in the intervention|22|||
125550589|NCT04335812|451646005|FG001|Overall Study|Did not engage in the intervention|18|||
125550590|NCT03249714|451646016|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
125550591|NCT03249714|451646017|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
125550592|NCT03249714|451646016|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
125550593|NCT03249714|451646017|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
125550594|NCT03249714|451646016|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
125550595|NCT03249714|451646017|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
125550596|NCT03249714|451646016|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
125550597|NCT03249714|451646017|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
125550598|NCT01607554|451646025|FG000|Overall Study|Disease progression|2|||
125550599|NCT01139021|451646026|FG000|Overall Study|Adverse Event|0|||
125550600|NCT01139021|451646027|FG001|Overall Study|Adverse Event|0|||
125550601|NCT01139021|451646028|FG002|Overall Study|Adverse Event|0|||
125550602|NCT01139021|451646029|FG003|Overall Study|Adverse Event|0|||
125550603|NCT01139021|451646030|FG004|Overall Study|Adverse Event|1|||
125550604|NCT01139021|451646031|FG005|Overall Study|Adverse Event|0|||
125550605|NCT01139021|451646026|FG000|Overall Study|Lost to Follow-up|0|||
125550606|NCT01139021|451646027|FG001|Overall Study|Lost to Follow-up|0|||
125550607|NCT01139021|451646028|FG002|Overall Study|Lost to Follow-up|0|||
125550608|NCT01139021|451646029|FG003|Overall Study|Lost to Follow-up|0|||
125550609|NCT01139021|451646030|FG004|Overall Study|Lost to Follow-up|2|||
125550610|NCT01139021|451646031|FG005|Overall Study|Lost to Follow-up|0|||
125550611|NCT01139021|451646026|FG000|Overall Study|Protocol Violation|1|||
125550612|NCT01139021|451646027|FG001|Overall Study|Protocol Violation|0|||
125550613|NCT01139021|451646028|FG002|Overall Study|Protocol Violation|0|||
125550614|NCT01139021|451646029|FG003|Overall Study|Protocol Violation|0|||
125550615|NCT01139021|451646030|FG004|Overall Study|Protocol Violation|2|||
125550616|NCT01139021|451646031|FG005|Overall Study|Protocol Violation|0|||
125550617|NCT01139021|451646026|FG000|Overall Study|Withdrawal by Subject|0|||
125550618|NCT01139021|451646027|FG001|Overall Study|Withdrawal by Subject|0|||
125550619|NCT01139021|451646028|FG002|Overall Study|Withdrawal by Subject|0|||
125550620|NCT01139021|451646029|FG003|Overall Study|Withdrawal by Subject|1|||
125550621|NCT01139021|451646030|FG004|Overall Study|Withdrawal by Subject|4|||
125550622|NCT01139021|451646031|FG005|Overall Study|Withdrawal by Subject|0|||
125550623|NCT02963610|451646032|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
125550624|NCT01294683|451646039|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
125550625|NCT01294683|451646040|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
125550626|NCT01294683|451646039|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
125550627|NCT01294683|451646040|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
125550628|NCT01294683|451646039|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
125550629|NCT01294683|451646040|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
125550630|NCT01294683|451646039|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
125550631|NCT01294683|451646040|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
125550632|NCT01294683|451646039|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
125550633|NCT01294683|451646040|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
125550634|NCT01294683|451646039|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
125550635|NCT01294683|451646040|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
125550636|NCT01294683|451646039|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
125550637|NCT01294683|451646040|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
125550638|NCT01294683|451646039|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
125550639|NCT01294683|451646040|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
125550640|NCT01294683|451646039|FG000|Post Crossover (Period III)|Adverse Event|6|||
125550641|NCT01294683|451646040|FG001|Post Crossover (Period III)|Adverse Event|6|||
125550642|NCT01294683|451646039|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
125550643|NCT01294683|451646040|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
125550644|NCT01294683|451646039|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
125550645|NCT01294683|451646040|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
125550646|NCT01294683|451646039|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
125550647|NCT01294683|451646040|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
125550648|NCT01032382|451646041|FG000|Overall Study|Disease dissemination|1|||
125550649|NCT01032382|451646042|FG001|Overall Study|Disease dissemination|1|||
125550650|NCT01032382|451646041|FG000|Overall Study|Treatment failure|3|||
125550651|NCT01032382|451646042|FG001|Overall Study|Treatment failure|1|||
125550652|NCT01032382|451646041|FG000|Overall Study|Index lesion relapse|1|||
125550653|NCT01032382|451646042|FG001|Overall Study|Index lesion relapse|3|||
125550654|NCT00412971|451646043|FG000|Overall Study|Lost to Follow-up|17|||
125550655|NCT00412971|451646044|FG001|Overall Study|Lost to Follow-up|9|||
125550656|NCT00412971|451646043|FG000|Overall Study|Protocol Violation|13|||
125550657|NCT00412971|451646044|FG001|Overall Study|Protocol Violation|1|||
125550658|NCT02409368|451646045|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
125550659|NCT02409368|451646046|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
125550660|NCT02409368|451646047|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
125550661|NCT02409368|451646048|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
125550662|NCT02409368|451646045|FG000|ECOG Reclassification|Death|1|||
125550663|NCT02409368|451646046|FG001|ECOG Reclassification|Death|5|||
125550664|NCT02409368|451646047|FG002|ECOG Reclassification|Death|0|||
125550665|NCT02409368|451646048|FG003|ECOG Reclassification|Death|0|||
125550666|NCT02409368|451646045|FG000|ECOG Reclassification|Disease Progression|113|||
125550667|NCT02409368|451646046|FG001|ECOG Reclassification|Disease Progression|382|||
125550668|NCT02409368|451646047|FG002|ECOG Reclassification|Disease Progression|70|||
125550669|NCT02409368|451646048|FG003|ECOG Reclassification|Disease Progression|1|||
125682561|NCT04551053|452127181|FG000|Overall Study|Study Terminated by Sponsor|57|||
125682562|NCT04551053|452127182|FG001|Overall Study|Study Terminated by Sponsor|65|||
125682563|NCT04551053|452127181|FG000|Overall Study|Withdrawal by Subject|12|||
125682564|NCT04551053|452127182|FG001|Overall Study|Withdrawal by Subject|5|||
125682565|NCT04551053|452127181|FG000|Overall Study|Adverse Event|2|||
125682566|NCT04551053|452127182|FG001|Overall Study|Adverse Event|0|||
125682567|NCT04551053|452127181|FG000|Overall Study|Lack of Efficacy|2|||
125682568|NCT04551053|452127182|FG001|Overall Study|Lack of Efficacy|1|||
125682569|NCT04551053|452127181|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
125682570|NCT04551053|452127182|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
125682571|NCT04551053|452127181|FG000|Overall Study|Splenapendectomi|1|||
125682572|NCT04551053|452127182|FG001|Overall Study|Splenapendectomi|0|||
125550670|NCT02409368|451646045|FG000|ECOG Reclassification|Lost to Follow-up|1|||
125550671|NCT02409368|451646046|FG001|ECOG Reclassification|Lost to Follow-up|5|||
125550672|NCT02409368|451646047|FG002|ECOG Reclassification|Lost to Follow-up|0|||
125550673|NCT02409368|451646048|FG003|ECOG Reclassification|Lost to Follow-up|0|||
125550674|NCT02409368|451646045|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
125550675|NCT02409368|451646046|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
125550676|NCT02409368|451646047|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
125550677|NCT02409368|451646048|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
125550678|NCT02409368|451646045|FG000|ECOG Reclassification|Poor/non-compliance|0|||
125550679|NCT02409368|451646046|FG001|ECOG Reclassification|Poor/non-compliance|3|||
125550680|NCT02409368|451646047|FG002|ECOG Reclassification|Poor/non-compliance|2|||
125550681|NCT02409368|451646048|FG003|ECOG Reclassification|Poor/non-compliance|0|||
125550682|NCT02409368|451646045|FG000|ECOG Reclassification|Study drug toxicity|17|||
125550683|NCT02409368|451646046|FG001|ECOG Reclassification|Study drug toxicity|42|||
125550684|NCT02409368|451646047|FG002|ECOG Reclassification|Study drug toxicity|7|||
125550685|NCT02409368|451646048|FG003|ECOG Reclassification|Study drug toxicity|0|||
125550686|NCT02409368|451646045|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
125550687|NCT02409368|451646046|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
125550688|NCT02409368|451646047|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
125550689|NCT02409368|451646048|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
125550690|NCT02409368|451646045|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
125550691|NCT02409368|451646046|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
125550692|NCT02409368|451646047|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
125550693|NCT02409368|451646048|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
125550694|NCT02409368|451646045|FG000|ECOG Reclassification|Participant withdrew consent|2|||
125550695|NCT02409368|451646046|FG001|ECOG Reclassification|Participant withdrew consent|3|||
125550696|NCT02409368|451646047|FG002|ECOG Reclassification|Participant withdrew consent|4|||
125550697|NCT02409368|451646048|FG003|ECOG Reclassification|Participant withdrew consent|0|||
125550698|NCT02409368|451646045|FG000|ECOG Reclassification|Other Reasons|5|||
125550699|NCT02409368|451646046|FG001|ECOG Reclassification|Other Reasons|26|||
125550700|NCT02409368|451646047|FG002|ECOG Reclassification|Other Reasons|2|||
125550701|NCT02409368|451646048|FG003|ECOG Reclassification|Other Reasons|0|||
125550702|NCT02409368|451646045|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
125550703|NCT02409368|451646046|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
125550704|NCT02409368|451646047|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
125550705|NCT02409368|451646048|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
125550706|NCT01296347|451646049|FG000|Allocation|Withdrawal by Subject|1|||
125550707|NCT01296347|451646050|FG001|Allocation|Withdrawal by Subject|2|||
125550708|NCT01296347|451646049|FG000|Allocation|Lack of Efficacy|1|||
125550709|NCT01296347|451646050|FG001|Allocation|Lack of Efficacy|2|||
125550710|NCT01296347|451646049|FG000|Allocation|not received infusion|1|||
125550711|NCT01296347|451646050|FG001|Allocation|not received infusion|0|||
125550712|NCT01296347|451646049|FG000|6 Week Follow up|Death|0|||
125550713|NCT01296347|451646050|FG001|6 Week Follow up|Death|1|||
125550714|NCT01296347|451646049|FG000|3 Month Follow up|Death|1|||
125550715|NCT01296347|451646050|FG001|3 Month Follow up|Death|0|||
125550716|NCT01296347|451646049|FG000|3 Month Follow up|Lost to Follow-up|0|||
125550717|NCT01296347|451646050|FG001|3 Month Follow up|Lost to Follow-up|1|||
125550718|NCT01296347|451646049|FG000|6 Month Follow up|Death|2|||
125550719|NCT01296347|451646050|FG001|6 Month Follow up|Death|1|||
125550720|NCT01296347|451646049|FG000|6 Month Follow up|Lost to Follow-up|0|||
125550721|NCT01296347|451646050|FG001|6 Month Follow up|Lost to Follow-up|1|||
125550722|NCT01296347|451646049|FG000|12 Month Follow up|Lost to Follow-up|3|||
125550723|NCT01296347|451646050|FG001|12 Month Follow up|Lost to Follow-up|1|||
125550724|NCT01296347|451646049|FG000|12 Month Follow up|Death|1|||
125550725|NCT01296347|451646050|FG001|12 Month Follow up|Death|1|||
125550726|NCT01296347|451646049|FG000|12 Month Follow up|Withdrawal by Subject|0|||
125550727|NCT01296347|451646050|FG001|12 Month Follow up|Withdrawal by Subject|1|||
125550728|NCT01585987|451646051|FG000|Randomized|Withdrawal by Subject|0|||
125550729|NCT01585987|451646052|FG001|Randomized|Withdrawal by Subject|4|||
125550730|NCT01585987|451646051|FG000|Randomized|No longer met criteria|0|||
125550731|NCT01585987|451646052|FG001|Randomized|No longer met criteria|2|||
125550732|NCT01585987|451646051|FG000|Treated|Disease Progression|39|||
125550733|NCT01585987|451646052|FG001|Treated|Disease Progression|36|||
125550734|NCT01585987|451646051|FG000|Treated|Study Drug Toxicity|9|||
125550735|NCT01585987|451646052|FG001|Treated|Study Drug Toxicity|5|||
125682573|NCT04551053|452127181|FG000|Overall Study|Medical Decision|1|||
125682574|NCT04551053|452127182|FG001|Overall Study|Medical Decision|1|||
125682575|NCT04529941|452127183|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
125682576|NCT04529941|452127184|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
125682577|NCT04108858|452127185|FG000|Overall Study|Adverse Event|1|||
125682578|NCT01005745|452127186|FG000|Overall Study|No TIL growth|1|||
125682579|NCT01005745|452127186|FG000|Overall Study|Disease progressed during TIL growth|3|||
125682580|NCT01005745|452127186|FG000|Overall Study|Death prior to treatment|1|||
125550736|NCT01585987|451646051|FG000|Treated|Adverse Event|3|||
125550737|NCT01585987|451646052|FG001|Treated|Adverse Event|0|||
125550738|NCT01585987|451646051|FG000|Treated|Withdrawal by Subject|1|||
125550739|NCT01585987|451646052|FG001|Treated|Withdrawal by Subject|2|||
125550740|NCT01585987|451646051|FG000|Treated|Death|1|||
125550741|NCT01585987|451646052|FG001|Treated|Death|0|||
125550742|NCT01585987|451646051|FG000|Treated|Lost to Follow-up|0|||
125550743|NCT01585987|451646052|FG001|Treated|Lost to Follow-up|1|||
125550744|NCT01585987|451646051|FG000|Treated|Maximum Clinical Benefit|0|||
125550745|NCT01585987|451646052|FG001|Treated|Maximum Clinical Benefit|1|||
125550746|NCT01585987|451646051|FG000|Treated|Non-Specified|1|||
125550747|NCT01585987|451646052|FG001|Treated|Non-Specified|2|||
125550748|NCT01585987|451646051|FG000|Treated|Subject Request|0|||
125550749|NCT01585987|451646052|FG001|Treated|Subject Request|1|||
125550750|NCT01585987|451646051|FG000|Treated|Poor/Non-Compliance|0|||
125550751|NCT01585987|451646052|FG001|Treated|Poor/Non-Compliance|1|||
125550752|NCT02041520|451646053|FG000|Overall Study|Adverse Event|2|||
125550753|NCT02041520|451646054|FG001|Overall Study|Adverse Event|1|||
125550754|NCT02041520|451646053|FG000|Overall Study|Withdrawal by Subject|3|||
125550755|NCT02041520|451646054|FG001|Overall Study|Withdrawal by Subject|4|||
125550756|NCT02041520|451646053|FG000|Overall Study|Protocol Violation|1|||
125550757|NCT02041520|451646054|FG001|Overall Study|Protocol Violation|0|||
125550758|NCT02041520|451646053|FG000|Overall Study|Lost to Follow-up|0|||
125550759|NCT02041520|451646054|FG001|Overall Study|Lost to Follow-up|1|||
125550760|NCT02041520|451646053|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
125550761|NCT02041520|451646054|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
125550762|NCT01759407|451646055|FG000|Overall Study|Protocol Violation|0|||
125550763|NCT01759407|451646056|FG001|Overall Study|Protocol Violation|2|||
125550764|NCT03737474|451646057|FG000|Overall Study|Adverse Event|18|||
125550765|NCT03737474|451646058|FG001|Overall Study|Adverse Event|48|||
125550766|NCT03737474|451646057|FG000|Overall Study|Lack of Efficacy|1|||
125550767|NCT03737474|451646058|FG001|Overall Study|Lack of Efficacy|3|||
125550768|NCT03737474|451646057|FG000|Overall Study|Protocol Violation|0|||
125550769|NCT03737474|451646058|FG001|Overall Study|Protocol Violation|8|||
125550770|NCT03737474|451646057|FG000|Overall Study|Withdrawal by Subject|5|||
125550771|NCT03737474|451646058|FG001|Overall Study|Withdrawal by Subject|20|||
125550772|NCT03737474|451646057|FG000|Overall Study|Non-compliance With Study Drug|0|||
125550773|NCT03737474|451646058|FG001|Overall Study|Non-compliance With Study Drug|1|||
125550774|NCT03737474|451646057|FG000|Overall Study|Physician Decision|1|||
125550775|NCT03737474|451646058|FG001|Overall Study|Physician Decision|4|||
125550776|NCT02513745|451646059|FG000|Overall Study|Criteria at time of surgery not met.|3|||
125550777|NCT02513745|451646060|FG001|Overall Study|Criteria at time of surgery not met.|3|||
125550778|NCT01209143|451646061|FG000|Overall Study|Adverse Event|2|||
125550779|NCT01209143|451646062|FG001|Overall Study|Adverse Event|1|||
125550780|NCT01209143|451646061|FG000|Overall Study|Death|0|||
125550781|NCT01209143|451646062|FG001|Overall Study|Death|1|||
125550782|NCT01209143|451646061|FG000|Overall Study|Physician Decision|3|||
125550783|NCT01209143|451646062|FG001|Overall Study|Physician Decision|1|||
125550784|NCT01209143|451646061|FG000|Overall Study|Lost to Follow-up|1|||
125550785|NCT01209143|451646062|FG001|Overall Study|Lost to Follow-up|0|||
125550786|NCT01209143|451646061|FG000|Overall Study|Withdrawal by Subject|2|||
125550787|NCT01209143|451646062|FG001|Overall Study|Withdrawal by Subject|1|||
125550788|NCT01209143|451646061|FG000|Overall Study|Disease progression|11|||
125550789|NCT01209143|451646062|FG001|Overall Study|Disease progression|16|||
125550790|NCT01145755|451646063|FG000|Overall Study|Adverse Event|2|||
125550791|NCT01145755|451646064|FG001|Overall Study|Adverse Event|4|||
125550792|NCT01145755|451646065|FG002|Overall Study|Adverse Event|2|||
125550793|NCT01145755|451646063|FG000|Overall Study|Withdrawal by Subject|2|||
125550794|NCT01145755|451646064|FG001|Overall Study|Withdrawal by Subject|2|||
125550795|NCT01145755|451646065|FG002|Overall Study|Withdrawal by Subject|2|||
125550796|NCT01145755|451646063|FG000|Overall Study|Lost to Follow-up|2|||
125550797|NCT01145755|451646064|FG001|Overall Study|Lost to Follow-up|3|||
125550798|NCT01145755|451646065|FG002|Overall Study|Lost to Follow-up|1|||
125550799|NCT01145755|451646063|FG000|Overall Study|Protocol Violation|0|||
125550800|NCT01145755|451646064|FG001|Overall Study|Protocol Violation|3|||
125550801|NCT01145755|451646065|FG002|Overall Study|Protocol Violation|1|||
125550802|NCT01145755|451646063|FG000|Overall Study|Study Closure|14|||
125550803|NCT01145755|451646064|FG001|Overall Study|Study Closure|14|||
125682581|NCT01005745|452127186|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
125682582|NCT03069352|452127187|FG000|Overall Study|Ongoing|12|||
125682583|NCT03069352|452127188|FG001|Overall Study|Ongoing|40|||
125682584|NCT02621424|452127189|FG000|Overall Study|Withdrawal by Subject|1|||
125550804|NCT01145755|451646065|FG002|Overall Study|Study Closure|17|||
125550805|NCT01145755|451646063|FG000|Overall Study|Lack of Efficacy|0|||
125550806|NCT01145755|451646064|FG001|Overall Study|Lack of Efficacy|1|||
125550807|NCT01145755|451646065|FG002|Overall Study|Lack of Efficacy|0|||
125550808|NCT01145755|451646063|FG000|Overall Study|Patient could not swollow medication|0|||
125550809|NCT01145755|451646064|FG001|Overall Study|Patient could not swollow medication|0|||
125550810|NCT01145755|451646065|FG002|Overall Study|Patient could not swollow medication|1|||
125550811|NCT01145755|451646063|FG000|Overall Study|Withdrawal by Subject|0|||
125550812|NCT01145755|451646064|FG001|Overall Study|Withdrawal by Subject|0|||
125550813|NCT01145755|451646065|FG002|Overall Study|Withdrawal by Subject|1|||
125550814|NCT01145755|451646063|FG000|Overall Study|Positive urine ethanol|0|||
125550815|NCT01145755|451646064|FG001|Overall Study|Positive urine ethanol|1|||
125550816|NCT01145755|451646065|FG002|Overall Study|Positive urine ethanol|0|||
125550817|NCT02092220|451646071|FG000|Period 1|Unrelated Illness|0|||
125550818|NCT02092220|451646072|FG001|Period 1|Unrelated Illness|2|||
125550819|NCT02092220|451646071|FG000|Period 2|Severe Hypoglycaemia|1|||
125550820|NCT02092220|451646072|FG001|Period 2|Severe Hypoglycaemia|0|||
125550821|NCT02092220|451646071|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
125550822|NCT02092220|451646072|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
125550823|NCT02739360|451646073|FG000|Overall Study|Adverse Event|1|||
125550824|NCT02739360|451646073|FG000|Overall Study|Study terminated by Sponsor|2|||
125550825|NCT01193920|451646074|FG000|Overall Study|Withdrawal by Subject|1|||
125550826|NCT01193920|451646075|FG001|Overall Study|Withdrawal by Subject|0|||
125550827|NCT01193920|451646076|FG002|Overall Study|Withdrawal by Subject|5|||
125550828|NCT01193920|451646077|FG003|Overall Study|Withdrawal by Subject|1|||
125550829|NCT01193920|451646078|FG004|Overall Study|Withdrawal by Subject|3|||
125550830|NCT01193920|451646079|FG005|Overall Study|Withdrawal by Subject|1|||
125550831|NCT01193920|451646080|FG006|Overall Study|Withdrawal by Subject|3|||
125550832|NCT01193920|451646081|FG007|Overall Study|Withdrawal by Subject|0|||
125550833|NCT01193920|451646082|FG008|Overall Study|Withdrawal by Subject|1|||
125550834|NCT01193920|451646083|FG009|Overall Study|Withdrawal by Subject|0|||
125550835|NCT01193920|451646074|FG000|Overall Study|Lost to Follow-up|1|||
125550836|NCT01193920|451646075|FG001|Overall Study|Lost to Follow-up|0|||
125550837|NCT01193920|451646076|FG002|Overall Study|Lost to Follow-up|1|||
125378923|NCT00531050|451019210|FG002|Part 1: Period 1|Adverse Event|0|||
125550838|NCT01193920|451646077|FG003|Overall Study|Lost to Follow-up|1|||
125550839|NCT01193920|451646078|FG004|Overall Study|Lost to Follow-up|3|||
125550840|NCT01193920|451646079|FG005|Overall Study|Lost to Follow-up|3|||
125550841|NCT01193920|451646080|FG006|Overall Study|Lost to Follow-up|1|||
125550842|NCT01193920|451646081|FG007|Overall Study|Lost to Follow-up|0|||
125550843|NCT01193920|451646082|FG008|Overall Study|Lost to Follow-up|2|||
125550844|NCT01193920|451646083|FG009|Overall Study|Lost to Follow-up|3|||
125550845|NCT01193920|451646074|FG000|Overall Study|Protocol Violation|1|||
125349834|NCT02953509|450915314|FG004|Overall Study|Study terminated by sponsor|0|||
125349835|NCT02953509|450915315|FG005|Overall Study|Study terminated by sponsor|0|||
125349836|NCT02953509|450915316|FG006|Overall Study|Study terminated by sponsor|1|||
125349837|NCT02953509|450915317|FG007|Overall Study|Study terminated by sponsor|0|||
125349838|NCT02953509|450915318|FG008|Overall Study|Study terminated by sponsor|1|||
125349839|NCT02953509|450915319|FG009|Overall Study|Study terminated by sponsor|1|||
125349840|NCT00484185|450915320|FG000|Overall Study|Lost to Follow-up|44|||
125349841|NCT00484185|450915320|FG000|Overall Study|Other|20|||
125349842|NCT00484185|450915320|FG000|Overall Study|Randomized but not treated|5|||
125349843|NCT00484185|450915320|FG000|Overall Study|Death|2|||
125349844|NCT00459056|450915321|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
125349845|NCT00459056|450915322|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
125349846|NCT02522871|450915323|FG000|Overall Study|Protocol Violation|1|||
125349847|NCT02522871|450915324|FG001|Overall Study|Protocol Violation|4|||
125349848|NCT02522871|450915323|FG000|Overall Study|Treated without randomization|1|||
125349849|NCT02522871|450915324|FG001|Overall Study|Treated without randomization|0|||
125349850|NCT02522871|450915323|FG000|Overall Study|Death|9|||
125349851|NCT02522871|450915324|FG001|Overall Study|Death|9|||
125349852|NCT02522871|450915323|FG000|Overall Study|Died in operating room prior to transplant|0|||
125349853|NCT02522871|450915324|FG001|Overall Study|Died in operating room prior to transplant|1|||
125349854|NCT00509262|450915325|FG000|Overall Study|Adverse Event|16|||
125349855|NCT00509262|450915326|FG001|Overall Study|Adverse Event|18|||
125349856|NCT00509262|450915325|FG000|Overall Study|Other|2|||
125349857|NCT00509262|450915326|FG001|Overall Study|Other|2|||
125349858|NCT00509262|450915325|FG000|Overall Study|Lack of Efficacy|1|||
125349859|NCT00509262|450915326|FG001|Overall Study|Lack of Efficacy|0|||
125349860|NCT00509262|450915325|FG000|Overall Study|Lost to Follow-up|1|||
125349861|NCT00509262|450915326|FG001|Overall Study|Lost to Follow-up|6|||
125349862|NCT00509262|450915325|FG000|Overall Study|Physician Decision|1|||
125349863|NCT00509262|450915326|FG001|Overall Study|Physician Decision|3|||
125349864|NCT00509262|450915325|FG000|Overall Study|Protocol Violation|2|||
125349865|NCT00509262|450915326|FG001|Overall Study|Protocol Violation|2|||
125349866|NCT00509262|450915325|FG000|Overall Study|Withdrawal by Subject|24|||
125349867|NCT00509262|450915326|FG001|Overall Study|Withdrawal by Subject|11|||
125349868|NCT02793622|450915331|FG000|Overall Study|Lost to Follow-up|31|||
125349869|NCT02793622|450915332|FG001|Overall Study|Lost to Follow-up|19|||
125349870|NCT02793622|450915331|FG000|Overall Study|Withdrawal by Subject|21|||
125349871|NCT02793622|450915332|FG001|Overall Study|Withdrawal by Subject|17|||
125349872|NCT02793622|450915331|FG000|Overall Study|Adverse Event|0|||
125349873|NCT02793622|450915332|FG001|Overall Study|Adverse Event|1|||
125349874|NCT02793622|450915331|FG000|Overall Study|Protocol Violation|1|||
125349875|NCT02793622|450915332|FG001|Overall Study|Protocol Violation|5|||
125349876|NCT01146860|450915333|FG000|Overall Study|Withdrawal by Subject|0|||
125349877|NCT01146860|450915334|FG001|Overall Study|Withdrawal by Subject|1|||
125349878|NCT01092832|450915335|FG000|Overall Study|Other|1|||
125349879|NCT01092832|450915336|FG001|Overall Study|Other|0|||
125349880|NCT00722371|450915337|FG000|Overall Study|Adverse Event|6|||
125349881|NCT00722371|450915338|FG001|Overall Study|Adverse Event|13|||
125349882|NCT00722371|450915339|FG002|Overall Study|Adverse Event|9|||
125349883|NCT00722371|450915340|FG003|Overall Study|Adverse Event|10|||
125349884|NCT00722371|450915341|FG004|Overall Study|Adverse Event|6|||
125349885|NCT00722371|450915342|FG005|Overall Study|Adverse Event|8|||
125682585|NCT02621424|452127190|FG001|Overall Study|Withdrawal by Subject|2|||
125682586|NCT05646251|452127197|FG000|Overall Study|Physician Decision|1|||
125349886|NCT00722371|450915343|FG006|Overall Study|Adverse Event|4|||
125349887|NCT00722371|450915337|FG000|Overall Study|Contraindication|0|||
125349888|NCT00722371|450915338|FG001|Overall Study|Contraindication|0|||
125349889|NCT00722371|450915339|FG002|Overall Study|Contraindication|1|||
125349890|NCT00722371|450915340|FG003|Overall Study|Contraindication|0|||
125349891|NCT00722371|450915341|FG004|Overall Study|Contraindication|0|||
125349892|NCT00722371|450915342|FG005|Overall Study|Contraindication|0|||
125349893|NCT00722371|450915343|FG006|Overall Study|Contraindication|0|||
125682587|NCT05646251|452127198|FG001|Overall Study|Physician Decision|0|||
125682588|NCT05646251|452127199|FG002|Overall Study|Physician Decision|2|||
125682589|NCT04016415|452127200|FG000|Overall Study|Adverse Event|2|||
125682590|NCT04016415|452127201|FG001|Overall Study|Adverse Event|1|||
125682591|NCT04016415|452127200|FG000|Overall Study|Lost to Follow-up|6|||
125682592|NCT04016415|452127201|FG001|Overall Study|Lost to Follow-up|2|||
125682593|NCT04016415|452127200|FG000|Overall Study|Physician Decision|5|||
125349894|NCT00722371|450915337|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
125349895|NCT00722371|450915338|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
125349896|NCT00722371|450915339|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
125349897|NCT00722371|450915340|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
125349898|NCT00722371|450915341|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
125349899|NCT00722371|450915342|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
125682594|NCT04016415|452127201|FG001|Overall Study|Physician Decision|1|||
125682595|NCT04016415|452127200|FG000|Overall Study|Pregnancy|0|||
125550846|NCT01193920|451646075|FG001|Overall Study|Protocol Violation|0|||
125550847|NCT01193920|451646076|FG002|Overall Study|Protocol Violation|0|||
125550848|NCT01193920|451646077|FG003|Overall Study|Protocol Violation|0|||
125550849|NCT01193920|451646078|FG004|Overall Study|Protocol Violation|0|||
125550850|NCT01193920|451646079|FG005|Overall Study|Protocol Violation|0|||
125550851|NCT01193920|451646080|FG006|Overall Study|Protocol Violation|0|||
125550852|NCT01193920|451646081|FG007|Overall Study|Protocol Violation|0|||
125550853|NCT01193920|451646082|FG008|Overall Study|Protocol Violation|0|||
125550854|NCT01193920|451646083|FG009|Overall Study|Protocol Violation|0|||
125550855|NCT01193920|451646074|FG000|Overall Study|Death|0|||
125550856|NCT01193920|451646075|FG001|Overall Study|Death|0|||
125550857|NCT01193920|451646076|FG002|Overall Study|Death|0|||
125550858|NCT01193920|451646077|FG003|Overall Study|Death|1|||
125550859|NCT01193920|451646078|FG004|Overall Study|Death|0|||
125550860|NCT01193920|451646079|FG005|Overall Study|Death|0|||
125550861|NCT01193920|451646080|FG006|Overall Study|Death|2|||
125550862|NCT01193920|451646081|FG007|Overall Study|Death|3|||
125550863|NCT01193920|451646082|FG008|Overall Study|Death|2|||
125550864|NCT01193920|451646083|FG009|Overall Study|Death|4|||
125550865|NCT01193920|451646074|FG000|Overall Study|Unable to classify|0|||
125550866|NCT01193920|451646075|FG001|Overall Study|Unable to classify|0|||
125550867|NCT01193920|451646076|FG002|Overall Study|Unable to classify|0|||
125550868|NCT01193920|451646077|FG003|Overall Study|Unable to classify|1|||
125550869|NCT01193920|451646078|FG004|Overall Study|Unable to classify|0|||
125550870|NCT01193920|451646079|FG005|Overall Study|Unable to classify|0|||
125550871|NCT01193920|451646080|FG006|Overall Study|Unable to classify|0|||
125550872|NCT01193920|451646081|FG007|Overall Study|Unable to classify|1|||
125550873|NCT01193920|451646082|FG008|Overall Study|Unable to classify|0|||
125550874|NCT01193920|451646083|FG009|Overall Study|Unable to classify|0|||
125550875|NCT01231516|451646086|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
125550876|NCT01231516|451646087|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
125550877|NCT01231516|451646086|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
125550878|NCT01231516|451646087|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
125550879|NCT01231516|451646086|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
125550880|NCT01231516|451646087|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
125550881|NCT01231516|451646086|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
125550882|NCT01231516|451646087|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
125550883|NCT01231516|451646086|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
125550884|NCT01231516|451646087|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
125550885|NCT01231516|451646086|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
125550886|NCT01231516|451646087|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
125550887|NCT01231516|451646086|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
125550888|NCT01231516|451646087|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
125550889|NCT01231516|451646086|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
125550890|NCT01231516|451646087|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
125550891|NCT01231516|451646086|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
125550892|NCT01231516|451646087|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
125550893|NCT01231516|451646086|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
125550894|NCT01231516|451646087|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
125550895|NCT01231516|451646086|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
125550896|NCT01231516|451646087|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
125550897|NCT01231516|451646086|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
125550898|NCT01231516|451646087|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
125550899|NCT01231516|451646086|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
125550900|NCT01231516|451646087|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
125550901|NCT01231516|451646086|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
125550902|NCT01231516|451646087|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
125550903|NCT01231516|451646086|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
125550904|NCT01231516|451646087|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
125550905|NCT01231516|451646086|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
125550906|NCT01231516|451646087|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
125682596|NCT04016415|452127201|FG001|Overall Study|Pregnancy|1|||
125682597|NCT04016415|452127200|FG000|Overall Study|Withdrawal by Subject|24|||
125682598|NCT04016415|452127201|FG001|Overall Study|Withdrawal by Subject|27|||
125682599|NCT04016415|452127200|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
125550907|NCT00026208|451646088|FG000|Overall Study|Complications of auto accident|1|||
125550908|NCT00026208|451646089|FG001|Overall Study|Complications of auto accident|0|||
125682600|NCT04016415|452127201|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
125682601|NCT05148234|452127202|FG000|Phase I|Ineligible|0|||
125682602|NCT05148234|452127203|FG001|Phase I|Ineligible|0|||
125550909|NCT03170154|451646090|FG000|Overall Study|Lost to Follow-up|4|||
125550910|NCT03170154|451646090|FG000|Overall Study|Death|2|||
125550911|NCT03170154|451646090|FG000|Overall Study|Withdrawal by Subject|2|||
125550912|NCT05266586|451646091|FG000|Overall Study|Adverse Event|2|||
125550913|NCT05266586|451646092|FG001|Overall Study|Adverse Event|2|||
125550914|NCT05266586|451646093|FG002|Overall Study|Adverse Event|1|||
125550915|NCT05266586|451646091|FG000|Overall Study|Withdrawal by Subject|1|||
125550916|NCT05266586|451646092|FG001|Overall Study|Withdrawal by Subject|0|||
125550917|NCT05266586|451646093|FG002|Overall Study|Withdrawal by Subject|1|||
125550918|NCT05266586|451646091|FG000|Overall Study|Non-compliance with study drug|0|||
125550919|NCT05266586|451646092|FG001|Overall Study|Non-compliance with study drug|1|||
125550920|NCT05266586|451646093|FG002|Overall Study|Non-compliance with study drug|0|||
125550921|NCT05266586|451646091|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
125550922|NCT05266586|451646092|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
125550923|NCT05266586|451646093|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
125550924|NCT02225353|451646094|FG000|Overall Study|Lost to Follow-up|0|||
125550925|NCT02225353|451646095|FG001|Overall Study|Lost to Follow-up|1|||
125550926|NCT02225353|451646096|FG002|Overall Study|Lost to Follow-up|3|||
125550927|NCT02225353|451646094|FG000|Overall Study|Protocol Violation|4|||
125550928|NCT02225353|451646095|FG001|Overall Study|Protocol Violation|5|||
125550929|NCT02225353|451646096|FG002|Overall Study|Protocol Violation|12|||
125550930|NCT01117857|451646097|FG000|Overall Study|Lost to Follow-up|4|||
125550931|NCT01117857|451646097|FG000|Overall Study|Withdrawal by Subject|4|||
125550932|NCT01117857|451646097|FG000|Overall Study|Physician Decision|1|||
125550933|NCT02730598|451646098|FG000|Overall Study|Withdrawal by Subject|3|||
125550934|NCT02730598|451646099|FG001|Overall Study|Withdrawal by Subject|3|||
125550935|NCT02730598|451646098|FG000|Overall Study|Protocol Violation|0|||
125550936|NCT02730598|451646099|FG001|Overall Study|Protocol Violation|1|||
125550937|NCT02730598|451646098|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
125550938|NCT02730598|451646099|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
125550939|NCT03282240|451646100|FG000|Overall Study|Adverse Event|2|||
125550940|NCT03282240|451646101|FG001|Overall Study|Adverse Event|2|||
125550941|NCT03282240|451646102|FG002|Overall Study|Adverse Event|0|||
125550942|NCT03282240|451646100|FG000|Overall Study|Lost to Follow-up|3|||
125550943|NCT03282240|451646101|FG001|Overall Study|Lost to Follow-up|0|||
125550944|NCT03282240|451646102|FG002|Overall Study|Lost to Follow-up|0|||
125550945|NCT03282240|451646100|FG000|Overall Study|Protocol Deviation|4|||
125550946|NCT03282240|451646101|FG001|Overall Study|Protocol Deviation|1|||
125550947|NCT03282240|451646102|FG002|Overall Study|Protocol Deviation|2|||
125550948|NCT03282240|451646100|FG000|Overall Study|Withdrawal by Subject|1|||
125550949|NCT03282240|451646101|FG001|Overall Study|Withdrawal by Subject|0|||
125550950|NCT03282240|451646102|FG002|Overall Study|Withdrawal by Subject|1|||
125550951|NCT02146326|451646103|FG000|Overall Study|Lost to Follow-up|3|||
125550952|NCT02146326|451646104|FG001|Overall Study|Lost to Follow-up|3|||
125550953|NCT02146326|451646105|FG002|Overall Study|Lost to Follow-up|11|||
125550954|NCT02146326|451646106|FG003|Overall Study|Lost to Follow-up|19|||
125550955|NCT02146326|451646103|FG000|Overall Study|Withdrawal by Subject|2|||
125550956|NCT02146326|451646104|FG001|Overall Study|Withdrawal by Subject|1|||
125550957|NCT02146326|451646105|FG002|Overall Study|Withdrawal by Subject|15|||
125550958|NCT02146326|451646106|FG003|Overall Study|Withdrawal by Subject|11|||
125550959|NCT02146326|451646103|FG000|Overall Study|Separated from mental health center|23|||
125550960|NCT02146326|451646104|FG001|Overall Study|Separated from mental health center|33|||
125550961|NCT02146326|451646105|FG002|Overall Study|Separated from mental health center|0|||
125550962|NCT02146326|451646106|FG003|Overall Study|Separated from mental health center|0|||
125550963|NCT02146326|451646103|FG000|Overall Study|Incarcerated|0|||
125550964|NCT02146326|451646104|FG001|Overall Study|Incarcerated|0|||
125550965|NCT02146326|451646105|FG002|Overall Study|Incarcerated|3|||
125349900|NCT00722371|450915343|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
125349901|NCT00722371|450915337|FG000|Overall Study|Excluded medication|0|||
125349902|NCT00722371|450915338|FG001|Overall Study|Excluded medication|1|||
125550966|NCT02146326|451646106|FG003|Overall Study|Incarcerated|8|||
125550967|NCT02146326|451646103|FG000|Overall Study|Death|0|||
125550968|NCT02146326|451646104|FG001|Overall Study|Death|0|||
125550969|NCT02146326|451646105|FG002|Overall Study|Death|4|||
125550970|NCT02146326|451646106|FG003|Overall Study|Death|4|||
125550971|NCT02146326|451646103|FG000|Overall Study|Unable to complete interview|0|||
125550972|NCT02146326|451646104|FG001|Overall Study|Unable to complete interview|0|||
125550973|NCT02146326|451646105|FG002|Overall Study|Unable to complete interview|10|||
125550974|NCT02146326|451646106|FG003|Overall Study|Unable to complete interview|6|||
125550975|NCT02910739|451646107|FG000|Overall Study|Adverse Event|1|||
125550976|NCT02910739|451646108|FG001|Overall Study|Adverse Event|0|||
125550977|NCT02910739|451646109|FG002|Overall Study|Adverse Event|0|||
125550978|NCT02910739|451646110|FG003|Overall Study|Adverse Event|0|||
125550979|NCT01340651|451646111|FG000|Overall Study|Adverse Event|3|||
125550980|NCT01340651|451646111|FG000|Overall Study|Consent Withdrawn|2|||
125550981|NCT01340651|451646111|FG000|Overall Study|Commercial Supply per Sponsor|12|||
125550982|NCT01696942|451646114|FG000|Overall Study|Withdrawal by Subject|1|||
125550983|NCT01696942|451646115|FG001|Overall Study|Withdrawal by Subject|0|||
125550984|NCT01696942|451646114|FG000|Overall Study|Protocol Violation|1|||
125550985|NCT01696942|451646115|FG001|Overall Study|Protocol Violation|2|||
125550986|NCT01696942|451646114|FG000|Overall Study|screen failure|0|||
125550987|NCT01696942|451646115|FG001|Overall Study|screen failure|1|||
125550988|NCT01313117|451646120|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
125550989|NCT01313117|451646120|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
125550990|NCT03442114|451646123|FG000|Overall Study|Lost to Follow-up|13|||
125550991|NCT03442114|451646124|FG001|Overall Study|Lost to Follow-up|13|||
125550992|NCT03442114|451646123|FG000|Overall Study|Physician Decision|2|||
125550993|NCT03442114|451646124|FG001|Overall Study|Physician Decision|2|||
125550994|NCT03442114|451646123|FG000|Overall Study|Protocol Violation|0|||
125550995|NCT03442114|451646124|FG001|Overall Study|Protocol Violation|2|||
125550996|NCT03442114|451646123|FG000|Overall Study|Withdrawal by Subject|1|||
125550997|NCT03442114|451646124|FG001|Overall Study|Withdrawal by Subject|3|||
125550998|NCT03442114|451646123|FG000|Overall Study|Guardianship Change|0|||
125550999|NCT03442114|451646124|FG001|Overall Study|Guardianship Change|1|||
125551000|NCT02903368|451646125|FG000|Part 1|Adverse Event|3|||
125682603|NCT05148234|452127204|FG002|Phase I|Ineligible|0|||
125682604|NCT05148234|452127205|FG003|Phase I|Ineligible|0|||
125682605|NCT05148234|452127206|FG004|Phase I|Ineligible|0|||
125682606|NCT05148234|452127207|FG005|Phase I|Ineligible|0|||
125682607|NCT05148234|452127208|FG006|Phase I|Ineligible|0|||
125682608|NCT05148234|452127209|FG007|Phase I|Ineligible|1|||
125551001|NCT02903368|451646126|FG001|Part 1|Adverse Event|0|||
125551002|NCT02903368|451646127|FG002|Part 1|Adverse Event|0|||
125551003|NCT02903368|451646128|FG003|Part 1|Adverse Event|0|||
125551004|NCT02903368|451646125|FG000|Part 1|Withdrawal by Subject|1|||
125551005|NCT02903368|451646126|FG001|Part 1|Withdrawal by Subject|0|||
125551006|NCT02903368|451646127|FG002|Part 1|Withdrawal by Subject|0|||
125551007|NCT02903368|451646128|FG003|Part 1|Withdrawal by Subject|0|||
125551008|NCT02903368|451646125|FG000|Part 2|Adverse Event|0|||
125551009|NCT02903368|451646126|FG001|Part 2|Adverse Event|0|||
125551010|NCT02903368|451646127|FG002|Part 2|Adverse Event|5|||
125551011|NCT02903368|451646128|FG003|Part 2|Adverse Event|0|||
125551012|NCT02903368|451646125|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
125551013|NCT02903368|451646126|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
125551014|NCT02903368|451646127|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
125551015|NCT02903368|451646128|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
125551016|NCT02903368|451646125|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
125551017|NCT02903368|451646126|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
125551018|NCT02903368|451646127|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
125551019|NCT02903368|451646128|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
125551020|NCT02903368|451646125|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
125551021|NCT02903368|451646126|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
125551022|NCT02903368|451646127|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
125551023|NCT02903368|451646128|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
125551024|NCT01101477|451648413|FG000|Overall Study|Protocol Violation|5|||
125682609|NCT05148234|452127202|FG000|Phase I|Company closed the trial.|0|||
125682610|NCT05148234|452127203|FG001|Phase I|Company closed the trial.|1|||
125682611|NCT05148234|452127204|FG002|Phase I|Company closed the trial.|0|||
125551025|NCT01101477|451648414|FG001|Overall Study|Protocol Violation|3|||
125551026|NCT01101477|451648415|FG002|Overall Study|Protocol Violation|1|||
125551027|NCT02382016|451648416|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
125551028|NCT02382016|451648417|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
125551029|NCT02382016|451648416|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
125682612|NCT05148234|452127205|FG003|Phase I|Company closed the trial.|0|||
125682613|NCT05148234|452127206|FG004|Phase I|Company closed the trial.|0|||
125682614|NCT05148234|452127207|FG005|Phase I|Company closed the trial.|0|||
125682615|NCT05148234|452127208|FG006|Phase I|Company closed the trial.|0|||
125551030|NCT02382016|451648417|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
125551031|NCT02382016|451648416|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
125551032|NCT02382016|451648417|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
125682616|NCT05148234|452127209|FG007|Phase I|Company closed the trial.|0|||
125551033|NCT02382016|451648416|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
125682617|NCT03061201|452127211|FG000|Overall Study|Participants Terminated at Month 36|0|||
125682618|NCT03061201|452127212|FG001|Overall Study|Participants Terminated at Month 36|1|||
125551034|NCT02382016|451648417|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
125551035|NCT02382016|451648416|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
125551036|NCT02382016|451648417|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
125551037|NCT02382016|451648416|FG000|Open-label (OL) Treatment Period|Death|4|||
125551038|NCT02382016|451648417|FG001|Open-label (OL) Treatment Period|Death|0|||
125551039|NCT02382016|451648416|FG000|OL Extension Period|Physician Decision|3|||
125551040|NCT02382016|451648417|FG001|OL Extension Period|Physician Decision|0|||
125551041|NCT02382016|451648416|FG000|OL Extension Period|Death|2|||
125551042|NCT02382016|451648417|FG001|OL Extension Period|Death|0|||
125551043|NCT02382016|451648416|FG000|OL Extension Period|Withdrawal by Subject|1|||
125551044|NCT02382016|451648417|FG001|OL Extension Period|Withdrawal by Subject|0|||
125551045|NCT00084266|451648418|FG000|Overall Study|Death|42|||
125551046|NCT00084266|451648419|FG001|Overall Study|Death|39|||
125551047|NCT00084266|451648418|FG000|Overall Study|Adverse Event|8|||
125551048|NCT00084266|451648419|FG001|Overall Study|Adverse Event|5|||
125551049|NCT00084266|451648418|FG000|Overall Study|Lack of Efficacy|2|||
125551050|NCT00084266|451648419|FG001|Overall Study|Lack of Efficacy|4|||
125551051|NCT00084266|451648418|FG000|Overall Study|Lost to Follow-up|5|||
125551052|NCT00084266|451648419|FG001|Overall Study|Lost to Follow-up|3|||
125551053|NCT00084266|451648418|FG000|Overall Study|Participant not willing to participate|3|||
125551054|NCT00084266|451648419|FG001|Overall Study|Participant not willing to participate|8|||
125551055|NCT00084266|451648418|FG000|Overall Study|Other|360|||
125551056|NCT00084266|451648419|FG001|Overall Study|Other|344|||
125551057|NCT00084266|451648418|FG000|Overall Study|Randomized not treated|21|||
125551058|NCT00084266|451648419|FG001|Overall Study|Randomized not treated|20|||
125551059|NCT00730171|451648420|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
125551060|NCT00730171|451648420|FG000|Overall Study|Adverse Event|193|||
125551061|NCT00730171|451648420|FG000|Overall Study|Protocol Violation|48|||
125551062|NCT00730171|451648420|FG000|Overall Study|Withdrawal by Subject|202|||
125551063|NCT00730171|451648420|FG000|Overall Study|Lost to Follow-up|121|||
125551064|NCT00730171|451648420|FG000|Overall Study|Insufficient Therapeutic Response|141|||
125551065|NCT00730171|451648420|FG000|Overall Study|Other|61|||
125551066|NCT01729156|451648421|FG000|Overall Study|Withdrawal by Subject|1|||
125551067|NCT01729156|451648422|FG001|Overall Study|Withdrawal by Subject|0|||
125551068|NCT01729156|451648423|FG002|Overall Study|Withdrawal by Subject|0|||
125551069|NCT02544217|451648424|FG000|Overall Study|Withdrawal by Subject|1|||
125551070|NCT02544217|451648425|FG001|Overall Study|Withdrawal by Subject|1|||
125551071|NCT02544217|451648426|FG002|Overall Study|Withdrawal by Subject|0|||
125551072|NCT02544217|451648427|FG003|Overall Study|Withdrawal by Subject|0|||
125551073|NCT02544217|451648428|FG004|Overall Study|Withdrawal by Subject|0|||
125551074|NCT02544217|451648429|FG005|Overall Study|Withdrawal by Subject|0|||
125551075|NCT02901041|451648432|FG000|Overall Study|Withdrawal by PI|4|||
125551076|NCT02901041|451648433|FG001|Overall Study|Withdrawal by PI|8|||
125551077|NCT02901041|451648432|FG000|Overall Study|Withdrawal by Subject|7|||
125551078|NCT02901041|451648433|FG001|Overall Study|Withdrawal by Subject|3|||
125551079|NCT00975507|451648434|FG000|Overall Study|Adverse Event|1|||
125551080|NCT00975507|451648435|FG001|Overall Study|Adverse Event|0|||
125551081|NCT00975507|451648434|FG000|Overall Study|Lost to Follow-up|7|||
125551082|NCT00975507|451648435|FG001|Overall Study|Lost to Follow-up|1|||
125551083|NCT00975507|451648434|FG000|Overall Study|Protocol Violation|2|||
125551084|NCT00975507|451648435|FG001|Overall Study|Protocol Violation|0|||
125682619|NCT03061201|452127213|FG002|Overall Study|Participants Terminated at Month 36|0|||
125682620|NCT03061201|452127214|FG003|Overall Study|Participants Terminated at Month 36|1|||
125682621|NCT03061201|452127211|FG000|Overall Study|Lost to Follow-up|1|||
125682622|NCT03061201|452127212|FG001|Overall Study|Lost to Follow-up|0|||
125682623|NCT03061201|452127213|FG002|Overall Study|Lost to Follow-up|0|||
125682624|NCT03061201|452127214|FG003|Overall Study|Lost to Follow-up|0|||
125682625|NCT05615870|452127215|FG000|Overall Study|Lost to Follow-up|10|||
125682626|NCT05615870|452127216|FG001|Overall Study|Lost to Follow-up|13|||
125682627|NCT05615870|452127215|FG000|Overall Study|Physician Decision|2|||
125210772|NCT01810783|450395682|FG000|Overall Study|Withdrawal by Subject|22|||
125551085|NCT00975507|451648434|FG000|Overall Study|Withdrawal by Subject|10|||
125551086|NCT00975507|451648435|FG001|Overall Study|Withdrawal by Subject|3|||
125551087|NCT01112306|451648436|FG000|Overall Study|Death|175|||
125551088|NCT01112306|451648436|FG000|Overall Study|Lost to Follow-up|9|||
125551089|NCT01112306|451648436|FG000|Overall Study|Withdrawal by Subject|31|||
125551090|NCT01112306|451648436|FG000|Overall Study|Other|70|||
125551091|NCT03952806|451648438|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
125682628|NCT05615870|452127216|FG001|Overall Study|Physician Decision|0|||
125682629|NCT05615870|452127215|FG000|Overall Study|Withdrawal by Subject|0|||
125551092|NCT03952806|451648439|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
125682630|NCT05615870|452127216|FG001|Overall Study|Withdrawal by Subject|2|||
125551093|NCT03952806|451648438|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
125551094|NCT03952806|451648439|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
125551095|NCT03952806|451648438|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
125551096|NCT03952806|451648439|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
125551097|NCT03952806|451648438|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
125551098|NCT03952806|451648439|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
125551099|NCT03952806|451648438|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
125551100|NCT03952806|451648439|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
125551101|NCT03952806|451648438|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
125551102|NCT03952806|451648439|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
125551103|NCT03952806|451648438|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
125551104|NCT03952806|451648439|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
125551105|NCT03952806|451648438|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
125551106|NCT03952806|451648439|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
125551107|NCT03952806|451648438|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
125551108|NCT03952806|451648439|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
125551109|NCT03952806|451648438|FG000|OLE Phase (48 Weeks)|Other|16|||
125551110|NCT03952806|451648439|FG001|OLE Phase (48 Weeks)|Other|13|||
125551111|NCT00655863|451648440|FG000|Overall Study|Lost to Follow-up|0|||
125551112|NCT00655863|451648441|FG001|Overall Study|Lost to Follow-up|0|||
125551113|NCT00655863|451648442|FG002|Overall Study|Lost to Follow-up|1|||
125551114|NCT01138007|451648443|FG000|Overall Study|Adverse Event|4|||
125551115|NCT01138007|451648444|FG001|Overall Study|Adverse Event|12|||
125551116|NCT01138007|451648445|FG002|Overall Study|Adverse Event|9|||
125551117|NCT01138007|451648443|FG000|Overall Study|Lack of Efficacy|2|||
125551118|NCT01138007|451648444|FG001|Overall Study|Lack of Efficacy|0|||
125551119|NCT01138007|451648445|FG002|Overall Study|Lack of Efficacy|6|||
125551120|NCT01138007|451648443|FG000|Overall Study|Protocol Violation|2|||
125551121|NCT01138007|451648444|FG001|Overall Study|Protocol Violation|3|||
125551122|NCT01138007|451648445|FG002|Overall Study|Protocol Violation|2|||
125551123|NCT01138007|451648443|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
125551124|NCT01138007|451648444|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
125551125|NCT01138007|451648445|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
125551126|NCT01138007|451648443|FG000|Overall Study|Lost to Follow-up|3|||
125551127|NCT01138007|451648444|FG001|Overall Study|Lost to Follow-up|3|||
125551128|NCT01138007|451648445|FG002|Overall Study|Lost to Follow-up|5|||
125551129|NCT01138007|451648443|FG000|Overall Study|Physician Decision|0|||
125551130|NCT01138007|451648444|FG001|Overall Study|Physician Decision|5|||
125551131|NCT01138007|451648445|FG002|Overall Study|Physician Decision|3|||
125551132|NCT01138007|451648443|FG000|Overall Study|Withdrawal by Subject|5|||
125551133|NCT01138007|451648444|FG001|Overall Study|Withdrawal by Subject|6|||
125551134|NCT01138007|451648445|FG002|Overall Study|Withdrawal by Subject|15|||
125551135|NCT04661878|451648446|FG000|Overall Study|Lost to Follow-up|6|||
125551136|NCT04661878|451648447|FG001|Overall Study|Lost to Follow-up|5|||
125349903|NCT00722371|450915339|FG002|Overall Study|Excluded medication|1|||
125349904|NCT00722371|450915340|FG003|Overall Study|Excluded medication|0|||
125349905|NCT00722371|450915341|FG004|Overall Study|Excluded medication|0|||
125349906|NCT00722371|450915342|FG005|Overall Study|Excluded medication|0|||
125349907|NCT00722371|450915343|FG006|Overall Study|Excluded medication|1|||
125349908|NCT00722371|450915337|FG000|Overall Study|Hyperglycemia|2|||
125349909|NCT00722371|450915338|FG001|Overall Study|Hyperglycemia|6|||
125349910|NCT00722371|450915339|FG002|Overall Study|Hyperglycemia|4|||
125349911|NCT00722371|450915340|FG003|Overall Study|Hyperglycemia|2|||
125349912|NCT00722371|450915341|FG004|Overall Study|Hyperglycemia|5|||
125551137|NCT04442737|451648452|FG000|Overall Study|Lost to Follow-up|1|||
125551138|NCT04442737|451648453|FG001|Overall Study|Lost to Follow-up|3|||
125551139|NCT04442737|451648452|FG000|Overall Study|Withdrawal by Subject|3|||
125682631|NCT05615870|452127215|FG000|Overall Study|Protocol Violation|0|||
125682632|NCT05615870|452127216|FG001|Overall Study|Protocol Violation|3|||
125682633|NCT05615870|452127215|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
125682634|NCT05615870|452127216|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
125682635|NCT05615870|452127215|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
125682636|NCT05615870|452127216|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
125682637|NCT05615870|452127215|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
125682638|NCT05615870|452127216|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
125682639|NCT03062358|452127217|FG000|Overall Study|Death|269|||
125682640|NCT03062358|452127218|FG001|Overall Study|Death|145|||
125682641|NCT03062358|452127217|FG000|Overall Study|Withdrawal by Subject|2|||
125682642|NCT03062358|452127218|FG001|Overall Study|Withdrawal by Subject|1|||
125349913|NCT00722371|450915342|FG005|Overall Study|Hyperglycemia|1|||
125349914|NCT00722371|450915343|FG006|Overall Study|Hyperglycemia|1|||
125551140|NCT04442737|451648453|FG001|Overall Study|Withdrawal by Subject|2|||
125551141|NCT04442737|451648452|FG000|Overall Study|Adverse Event|3|||
125682643|NCT03062358|452127217|FG000|Overall Study|Sponsor Decision|29|||
125551142|NCT04442737|451648453|FG001|Overall Study|Adverse Event|2|||
125551143|NCT04442737|451648452|FG000|Overall Study|Death|0|||
125551144|NCT04442737|451648453|FG001|Overall Study|Death|1|||
125551145|NCT04442737|451648452|FG000|Overall Study|Protocol Violation|0|||
125551146|NCT04442737|451648453|FG001|Overall Study|Protocol Violation|2|||
125551147|NCT04442737|451648452|FG000|Overall Study|Other|1|||
125551148|NCT04442737|451648453|FG001|Overall Study|Other|1|||
125551149|NCT00744523|451648454|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
125551150|NCT00744523|451648455|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
125551151|NCT05333224|451648459|FG000|Overall Study - Infants|Lost to Follow-up|1|||
125551152|NCT05333224|451648460|FG001|Overall Study - Infants|Lost to Follow-up|1|||
125551153|NCT00063154|451648461|FG000|Overall Study|Disease progression|27|||
125551154|NCT00063154|451648461|FG000|Overall Study|Adverse Event|2|||
125551155|NCT00063154|451648461|FG000|Overall Study|Physician Decision|10|||
125551156|NCT00063154|451648461|FG000|Overall Study|Death|3|||
125551157|NCT00063154|451648461|FG000|Overall Study|Reason unspecified|1|||
125551158|NCT00063154|451648461|FG000|Overall Study|Did not receive treatment|8|||
125551159|NCT03588728|451648462|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
125551160|NCT03588728|451648463|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
125551161|NCT03588728|451648464|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
125551162|NCT03588728|451648465|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
125551163|NCT03588728|451648462|FG000|Overall Study|Lab shut down due to COVID-19|0|||
125551164|NCT03588728|451648463|FG001|Overall Study|Lab shut down due to COVID-19|0|||
125551165|NCT03588728|451648464|FG002|Overall Study|Lab shut down due to COVID-19|0|||
125551166|NCT03588728|451648465|FG003|Overall Study|Lab shut down due to COVID-19|1|||
125551167|NCT03588728|451648462|FG000|Overall Study|multiple technical issues|1|||
125551168|NCT03588728|451648463|FG001|Overall Study|multiple technical issues|0|||
125551169|NCT03588728|451648464|FG002|Overall Study|multiple technical issues|0|||
125551170|NCT03588728|451648465|FG003|Overall Study|multiple technical issues|0|||
125551171|NCT03588728|451648462|FG000|Overall Study|Hospitalized for COVID|1|||
125551172|NCT03588728|451648463|FG001|Overall Study|Hospitalized for COVID|0|||
125551173|NCT03588728|451648464|FG002|Overall Study|Hospitalized for COVID|0|||
125551174|NCT03588728|451648465|FG003|Overall Study|Hospitalized for COVID|0|||
125551175|NCT03588728|451648462|FG000|Overall Study|Schedule change unable to attend sessions|1|||
125551176|NCT03588728|451648463|FG001|Overall Study|Schedule change unable to attend sessions|0|||
125551177|NCT03588728|451648464|FG002|Overall Study|Schedule change unable to attend sessions|0|||
125551178|NCT03588728|451648465|FG003|Overall Study|Schedule change unable to attend sessions|0|||
125551179|NCT02027701|451648466|FG000|Overall Study|Adverse Event|3|||
125551180|NCT02027701|451648466|FG000|Overall Study|Lack of Efficacy|8|||
125551181|NCT02027701|451648466|FG000|Overall Study|Physician Decision|2|||
125551182|NCT02027701|451648466|FG000|Overall Study|Withdrawal by Subject|3|||
125551183|NCT03285178|451648467|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
125551184|NCT03285178|451648468|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
125551185|NCT03285178|451648469|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
125551186|NCT03285178|451648470|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
125551187|NCT03285178|451648471|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
125551188|NCT03285178|451648472|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
125551189|NCT03285178|451648473|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
125551190|NCT03285178|451648467|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
125551191|NCT03285178|451648468|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
125551192|NCT03285178|451648469|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
125551193|NCT03285178|451648470|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
125551194|NCT03285178|451648471|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
125551195|NCT03285178|451648472|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
125551196|NCT03285178|451648473|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
125551197|NCT03285178|451648467|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
125551198|NCT03285178|451648468|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
125349915|NCT00722371|450915337|FG000|Overall Study|Hypoglycemia|1|||
125349916|NCT00722371|450915338|FG001|Overall Study|Hypoglycemia|0|||
125349917|NCT00722371|450915339|FG002|Overall Study|Hypoglycemia|0|||
125349918|NCT00722371|450915340|FG003|Overall Study|Hypoglycemia|0|||
125349919|NCT00722371|450915341|FG004|Overall Study|Hypoglycemia|0|||
125349920|NCT00722371|450915342|FG005|Overall Study|Hypoglycemia|0|||
125349921|NCT00722371|450915343|FG006|Overall Study|Hypoglycemia|0|||
125551199|NCT03285178|451648469|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
125551200|NCT03285178|451648470|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
125551201|NCT03285178|451648471|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
125551202|NCT03285178|451648472|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
125349922|NCT00722371|450915337|FG000|Overall Study|Lack of Efficacy|4|||
125551203|NCT03285178|451648473|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
125551204|NCT03285178|451648467|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
125551205|NCT03285178|451648468|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
125551206|NCT03285178|451648469|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
125551207|NCT03285178|451648470|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
125551208|NCT03285178|451648471|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
125551209|NCT03285178|451648472|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
125551210|NCT03285178|451648473|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
125551211|NCT03285178|451648467|FG000|Single-Blind Run-In Period|Physician Decision|2|||
125551212|NCT03285178|451648468|FG001|Single-Blind Run-In Period|Physician Decision|0|||
125551213|NCT03285178|451648469|FG002|Single-Blind Run-In Period|Physician Decision|0|||
125551214|NCT03285178|451648470|FG003|Single-Blind Run-In Period|Physician Decision|0|||
125551215|NCT03285178|451648471|FG004|Single-Blind Run-In Period|Physician Decision|0|||
125551216|NCT03285178|451648472|FG005|Single-Blind Run-In Period|Physician Decision|0|||
125551217|NCT03285178|451648473|FG006|Single-Blind Run-In Period|Physician Decision|0|||
125551218|NCT03285178|451648467|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
125551219|NCT03285178|451648468|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
125551220|NCT03285178|451648469|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
125551221|NCT03285178|451648470|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
125551222|NCT03285178|451648471|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
125551223|NCT03285178|451648472|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
125551224|NCT03285178|451648473|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
125551225|NCT03285178|451648467|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125551226|NCT03285178|451648468|FG001|Double-Blind Treatment Period|Adverse Event|0|||
125551227|NCT03285178|451648469|FG002|Double-Blind Treatment Period|Adverse Event|0|||
125551228|NCT03285178|451648470|FG003|Double-Blind Treatment Period|Adverse Event|0|||
125551229|NCT03285178|451648471|FG004|Double-Blind Treatment Period|Adverse Event|0|||
125551230|NCT03285178|451648472|FG005|Double-Blind Treatment Period|Adverse Event|0|||
125551231|NCT03285178|451648473|FG006|Double-Blind Treatment Period|Adverse Event|2|||
125551232|NCT03285178|451648467|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125551233|NCT03285178|451648468|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
125551234|NCT03285178|451648469|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
125551235|NCT03285178|451648470|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
125551236|NCT03285178|451648471|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
125551237|NCT03285178|451648472|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
125551238|NCT03285178|451648473|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
125551239|NCT03285178|451648467|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125349923|NCT00722371|450915338|FG001|Overall Study|Lack of Efficacy|6|||
125349924|NCT00722371|450915339|FG002|Overall Study|Lack of Efficacy|6|||
125349925|NCT00722371|450915340|FG003|Overall Study|Lack of Efficacy|6|||
125349926|NCT00722371|450915341|FG004|Overall Study|Lack of Efficacy|2|||
125349927|NCT00722371|450915342|FG005|Overall Study|Lack of Efficacy|3|||
125349928|NCT00722371|450915343|FG006|Overall Study|Lack of Efficacy|0|||
125349929|NCT00722371|450915337|FG000|Overall Study|Lost to Follow-up|11|||
125349930|NCT00722371|450915338|FG001|Overall Study|Lost to Follow-up|14|||
125349931|NCT00722371|450915339|FG002|Overall Study|Lost to Follow-up|21|||
125349932|NCT00722371|450915340|FG003|Overall Study|Lost to Follow-up|13|||
125349933|NCT00722371|450915341|FG004|Overall Study|Lost to Follow-up|8|||
125551240|NCT03285178|451648468|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125349934|NCT00722371|450915342|FG005|Overall Study|Lost to Follow-up|16|||
125349935|NCT00722371|450915343|FG006|Overall Study|Lost to Follow-up|13|||
125349936|NCT00722371|450915337|FG000|Overall Study|Physician Decision|5|||
125551241|NCT03285178|451648469|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125682644|NCT03062358|452127218|FG001|Overall Study|Sponsor Decision|7|||
125682645|NCT04745676|452127219|FG000|Overall Study|Death|1|||
125682646|NCT04745676|452127220|FG001|Overall Study|Death|0|||
125682647|NCT04745676|452127221|FG002|Overall Study|Death|0|||
125682648|NCT03861273|452127222|FG000|Screening Phase (3 Weeks)|Other|1|||
125682649|NCT03861273|452127222|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
125682650|NCT03861273|452127222|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
125682651|NCT03861273|452127222|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
125682652|NCT03861273|452127222|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
125682653|NCT04659603|452127223|FG000|Overall Study|Study terminated by sponsor|0|||
125682654|NCT04659603|452127224|FG001|Overall Study|Study terminated by sponsor|0|||
125682655|NCT04659603|452127225|FG002|Overall Study|Study terminated by sponsor|2|||
125682656|NCT04659603|452127223|FG000|Overall Study|Withdrawal by Subject|0|||
125682657|NCT04659603|452127224|FG001|Overall Study|Withdrawal by Subject|5|||
125349937|NCT00722371|450915338|FG001|Overall Study|Physician Decision|2|||
125349938|NCT00722371|450915339|FG002|Overall Study|Physician Decision|2|||
125349939|NCT00722371|450915340|FG003|Overall Study|Physician Decision|5|||
125551242|NCT03285178|451648470|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125551243|NCT03285178|451648471|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125551244|NCT03285178|451648472|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
125551245|NCT03285178|451648473|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125551246|NCT03285178|451648467|FG000|Double-Blind Treatment Period|COVID-19|0|||
125551247|NCT03285178|451648468|FG001|Double-Blind Treatment Period|COVID-19|0|||
125551248|NCT03285178|451648469|FG002|Double-Blind Treatment Period|COVID-19|1|||
125551249|NCT03285178|451648470|FG003|Double-Blind Treatment Period|COVID-19|0|||
125551250|NCT03285178|451648471|FG004|Double-Blind Treatment Period|COVID-19|0|||
125551251|NCT03285178|451648472|FG005|Double-Blind Treatment Period|COVID-19|0|||
125551252|NCT03285178|451648473|FG006|Double-Blind Treatment Period|COVID-19|0|||
125551253|NCT01388790|451648474|FG000|Overall Study|Ongoing at data cut-off date|8|||
125551254|NCT01128894|451648475|FG000|Overall Study|Adverse Event|31|||
125551255|NCT01128894|451648476|FG001|Overall Study|Adverse Event|41|||
125551256|NCT01128894|451648475|FG000|Overall Study|Protocol Violation|2|||
125551257|NCT01128894|451648476|FG001|Overall Study|Protocol Violation|1|||
125551258|NCT01128894|451648475|FG000|Overall Study|Noncompliance|4|||
125551259|NCT01128894|451648476|FG001|Overall Study|Noncompliance|5|||
125551260|NCT01128894|451648475|FG000|Overall Study|Lost to Follow-up|8|||
125551261|NCT01128894|451648476|FG001|Overall Study|Lost to Follow-up|8|||
125551262|NCT01128894|451648475|FG000|Overall Study|Withdrawal by Subject|10|||
125551263|NCT01128894|451648476|FG001|Overall Study|Withdrawal by Subject|12|||
125551264|NCT01128894|451648475|FG000|Overall Study|Physician Decision|2|||
125551265|NCT01128894|451648476|FG001|Overall Study|Physician Decision|1|||
125551266|NCT01128894|451648475|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
125551267|NCT01128894|451648476|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
125551268|NCT00195507|451648477|FG000|Overall Study|Adverse Event|24|||
125551269|NCT00195507|451648478|FG001|Overall Study|Adverse Event|13|||
125551270|NCT00195507|451648477|FG000|Overall Study|Death|0|||
125551271|NCT00195507|451648478|FG001|Overall Study|Death|1|||
125551272|NCT00195507|451648477|FG000|Overall Study|Failed to Return|4|||
125551273|NCT00195507|451648478|FG001|Overall Study|Failed to Return|3|||
125551274|NCT00195507|451648477|FG000|Overall Study|Physician Decision|1|||
125551275|NCT00195507|451648478|FG001|Overall Study|Physician Decision|2|||
125551276|NCT00195507|451648477|FG000|Overall Study|Lost to Follow-up|3|||
125551277|NCT00195507|451648478|FG001|Overall Study|Lost to Follow-up|2|||
125551278|NCT00195507|451648477|FG000|Overall Study|Protocol Violation|5|||
125551279|NCT00195507|451648478|FG001|Overall Study|Protocol Violation|4|||
125551280|NCT00195507|451648477|FG000|Overall Study|Lack of Efficacy|40|||
125551281|NCT00195507|451648478|FG001|Overall Study|Lack of Efficacy|67|||
125551282|NCT00195507|451648477|FG000|Overall Study|Withdrawal by Subject|16|||
125551283|NCT00195507|451648478|FG001|Overall Study|Withdrawal by Subject|23|||
125551284|NCT00195507|451648477|FG000|Overall Study|Protocol Deviation|6|||
125551285|NCT00195507|451648478|FG001|Overall Study|Protocol Deviation|3|||
125551286|NCT00973362|451648479|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
125551287|NCT00973362|451648480|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
125551288|NCT00973362|451648479|FG000|Baseline Evaluation|No colposcopy visit|62|||
125551289|NCT00973362|451648480|FG001|Baseline Evaluation|No colposcopy visit|0|||
125551290|NCT00973362|451648479|FG000|Baseline Evaluation|Inevaluable|686|||
125551291|NCT00973362|451648480|FG001|Baseline Evaluation|Inevaluable|223|||
125551292|NCT00973362|451648479|FG000|3-Year Follow-up|Lost to Follow-up|17|||
125551293|NCT00973362|451648480|FG001|3-Year Follow-up|Lost to Follow-up|0|||
125551294|NCT00887679|451648481|FG000|Overall Study|Withdrawal by Subject|1|||
125551295|NCT00887679|451648481|FG000|Overall Study|Lost to Follow-up|4|||
125551296|NCT00887679|451648481|FG000|Overall Study|Physician Decision|5|||
125551297|NCT01630434|451648488|FG000|Overall Study|Donor lungs turned down|1|||
125551298|NCT01630434|451648489|FG001|Overall Study|Donor lungs turned down|0|||
125551299|NCT01630434|451648488|FG000|Overall Study|Protocol Violation|9|||
125551300|NCT01630434|451648489|FG001|Overall Study|Protocol Violation|4|||
125551301|NCT01630434|451648488|FG000|Overall Study|Death|20|||
125551302|NCT01630434|451648489|FG001|Overall Study|Death|26|||
125682658|NCT04659603|452127225|FG002|Overall Study|Withdrawal by Subject|0|||
125425634|NCT01357616|451182307|FG000|Overall Study|Inadequate Control of IOP|1|||
125551303|NCT02578862|451648490|FG000|Overall Study|Withdrawal by Subject|0|||
125551304|NCT02578862|451648491|FG001|Overall Study|Withdrawal by Subject|1|||
125551305|NCT02578862|451648490|FG000|Overall Study|Unplanned unilateral procedure|0|||
125551306|NCT02578862|451648491|FG001|Overall Study|Unplanned unilateral procedure|1|||
125551307|NCT01026454|451648492|FG000|Second Intervention|Pregnancy|1|||
125551308|NCT01026454|451648493|FG001|Second Intervention|Pregnancy|1|||
125551309|NCT02893930|451648494|FG000|Overall Study|Adverse Event|3|||
125551310|NCT02893930|451648494|FG000|Overall Study|Death|1|||
125551311|NCT02893930|451648494|FG000|Overall Study|Disease progression|5|||
125551312|NCT02893930|451648494|FG000|Overall Study|Withdrawal by Subject|2|||
125551313|NCT02893930|451648494|FG000|Overall Study|Physician Decision|1|||
125551314|NCT02893930|451648494|FG000|Overall Study|Ineligible|1|||
125551315|NCT02349360|451648495|FG000|Overall Study|Withdrawal by Subject|0|||
125425635|NCT01357616|451182308|FG001|Overall Study|Inadequate Control of IOP|2|||
125551316|NCT02349360|451648496|FG001|Overall Study|Withdrawal by Subject|1|||
125551317|NCT00394953|451648497|FG000|First Treatment Period|Adverse Event|1|||
125551318|NCT00394953|451648498|FG001|First Treatment Period|Adverse Event|2|||
125551319|NCT00394953|451648497|FG000|First Treatment Period|Death|6|||
125551320|NCT00394953|451648498|FG001|First Treatment Period|Death|7|||
125551321|NCT00394953|451648497|FG000|First Treatment Period|Lack of Efficacy|1|||
125551322|NCT00394953|451648498|FG001|First Treatment Period|Lack of Efficacy|1|||
125551323|NCT00394953|451648497|FG000|First Treatment Period|Withdrawal by Subject|6|||
125551324|NCT00394953|451648498|FG001|First Treatment Period|Withdrawal by Subject|3|||
125551325|NCT00394953|451648497|FG000|First Treatment Period|Lost to Follow-up|0|||
125551326|NCT00394953|451648498|FG001|First Treatment Period|Lost to Follow-up|1|||
125551327|NCT00394953|451648497|FG000|First Treatment Period|Renal transplant|11|||
125551328|NCT00394953|451648498|FG001|First Treatment Period|Renal transplant|7|||
125551329|NCT00394953|451648497|FG000|First Treatment Period|Not defined|4|||
125551330|NCT00394953|451648498|FG001|First Treatment Period|Not defined|1|||
125551331|NCT00394953|451648497|FG000|Second Treatment Period|Adverse Event|2|||
125551332|NCT00394953|451648498|FG001|Second Treatment Period|Adverse Event|5|||
125551333|NCT00394953|451648497|FG000|Second Treatment Period|Death|8|||
125551334|NCT00394953|451648498|FG001|Second Treatment Period|Death|4|||
125551335|NCT00394953|451648497|FG000|Second Treatment Period|Lack of Efficacy|9|||
125551336|NCT00394953|451648498|FG001|Second Treatment Period|Lack of Efficacy|47|||
125551337|NCT00394953|451648497|FG000|Second Treatment Period|Withdrawal by Subject|3|||
125551338|NCT00394953|451648498|FG001|Second Treatment Period|Withdrawal by Subject|3|||
125551339|NCT00394953|451648497|FG000|Second Treatment Period|Lost to Follow-up|0|||
125551340|NCT00394953|451648498|FG001|Second Treatment Period|Lost to Follow-up|1|||
125551341|NCT00394953|451648497|FG000|Second Treatment Period|Renal transplant|4|||
125551342|NCT00394953|451648498|FG001|Second Treatment Period|Renal transplant|6|||
125551343|NCT00394953|451648497|FG000|Second Treatment Period|Not defined|3|||
125551344|NCT00394953|451648498|FG001|Second Treatment Period|Not defined|8|||
125551345|NCT01176773|451648499|FG000|Overall Study|Screen Failure|2|||
125551346|NCT01176773|451648499|FG000|Overall Study|Withdrew consent|1|||
125551347|NCT02196714|451648509|FG000|Overall Study|Protocol Violation|0|||
125551348|NCT02196714|451648510|FG001|Overall Study|Protocol Violation|0|||
125551349|NCT02196714|451648511|FG002|Overall Study|Protocol Violation|1|||
125551350|NCT02196714|451648512|FG003|Overall Study|Protocol Violation|0|||
125551351|NCT01592864|451648514|FG000|Overall Study|Withdrawal by Subject|0|||
125425636|NCT01357616|451182307|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
125425637|NCT01357616|451182308|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
125551352|NCT01592864|451648515|FG001|Overall Study|Withdrawal by Subject|1|||
125551353|NCT04079803|451648520|FG000|Overall Study|Withdrawal by Subject|0|||
125551354|NCT04079803|451648521|FG001|Overall Study|Withdrawal by Subject|0|||
125551355|NCT04079803|451648522|FG002|Overall Study|Withdrawal by Subject|1|||
125551356|NCT01881750|451648523|FG000|Overall Study|Changes in concomitant therapies|2|||
125551357|NCT01881750|451648524|FG001|Overall Study|Changes in concomitant therapies|3|||
125551358|NCT01881750|451648523|FG000|Overall Study|Lost to Follow-up|0|||
125551359|NCT01881750|451648524|FG001|Overall Study|Lost to Follow-up|1|||
125551360|NCT02804178|451648530|FG000|Overall Study|Adverse Event|1|||
125551361|NCT01290601|451648531|FG000|Overall Study|Adverse Event|0|||
125551362|NCT01290601|451648532|FG001|Overall Study|Adverse Event|2|||
125551363|NCT01290601|451648533|FG002|Overall Study|Adverse Event|0|||
125551364|NCT01290601|451648534|FG003|Overall Study|Adverse Event|0|||
125551365|NCT01290601|451648531|FG000|Overall Study|Lack of Efficacy|2|||
125551366|NCT01290601|451648532|FG001|Overall Study|Lack of Efficacy|1|||
125551367|NCT01290601|451648533|FG002|Overall Study|Lack of Efficacy|0|||
125551368|NCT01290601|451648534|FG003|Overall Study|Lack of Efficacy|0|||
125551369|NCT01290601|451648531|FG000|Overall Study|Lost to Follow-up|7|||
125551370|NCT01290601|451648532|FG001|Overall Study|Lost to Follow-up|2|||
125551371|NCT01290601|451648533|FG002|Overall Study|Lost to Follow-up|0|||
125551372|NCT01290601|451648534|FG003|Overall Study|Lost to Follow-up|0|||
125551373|NCT01290601|451648531|FG000|Overall Study|Other|1|||
125551374|NCT01290601|451648532|FG001|Overall Study|Other|0|||
125551375|NCT01290601|451648533|FG002|Overall Study|Other|0|||
125551376|NCT01290601|451648534|FG003|Overall Study|Other|0|||
125551377|NCT01290601|451648531|FG000|Overall Study|Protocol Violation|1|||
125551378|NCT01290601|451648532|FG001|Overall Study|Protocol Violation|0|||
125551379|NCT01290601|451648533|FG002|Overall Study|Protocol Violation|0|||
125551380|NCT01290601|451648534|FG003|Overall Study|Protocol Violation|0|||
125551381|NCT04675151|451648537|FG000|Overall Study|Protocol Violation|1|||
125551382|NCT04675151|451648538|FG001|Overall Study|Protocol Violation|0|||
125551383|NCT04675151|451648539|FG002|Overall Study|Protocol Violation|0|||
125551384|NCT04675151|451648540|FG003|Overall Study|Protocol Violation|1|||
125551385|NCT00777946|451648541|FG000|Overall Study|Adverse Event|11|||
125551386|NCT00777946|451648542|FG001|Overall Study|Adverse Event|1|||
125551387|NCT00777946|451648543|FG002|Overall Study|Adverse Event|3|||
125551388|NCT00777946|451648541|FG000|Overall Study|Lack of Efficacy|0|||
125551389|NCT00777946|451648542|FG001|Overall Study|Lack of Efficacy|0|||
125551390|NCT00777946|451648543|FG002|Overall Study|Lack of Efficacy|9|||
125551391|NCT00777946|451648541|FG000|Overall Study|Condition no longer required study drug|1|||
125551392|NCT00777946|451648542|FG001|Overall Study|Condition no longer required study drug|0|||
125551393|NCT00777946|451648543|FG002|Overall Study|Condition no longer required study drug|0|||
125551394|NCT00777946|451648541|FG000|Overall Study|Patient withdrew consent|3|||
125551395|NCT00777946|451648542|FG001|Overall Study|Patient withdrew consent|2|||
125551396|NCT00777946|451648543|FG002|Overall Study|Patient withdrew consent|3|||
125551397|NCT00777946|451648541|FG000|Overall Study|Lost to Follow-up|3|||
125551398|NCT00777946|451648542|FG001|Overall Study|Lost to Follow-up|1|||
125551399|NCT00777946|451648543|FG002|Overall Study|Lost to Follow-up|0|||
125551400|NCT00777946|451648541|FG000|Overall Study|Protocol deviation|2|||
125551401|NCT00777946|451648542|FG001|Overall Study|Protocol deviation|1|||
125551402|NCT00777946|451648543|FG002|Overall Study|Protocol deviation|1|||
125551403|NCT00777946|451648541|FG000|Overall Study|Randomized in error|1|||
125551404|NCT00777946|451648542|FG001|Overall Study|Randomized in error|1|||
125551405|NCT00777946|451648543|FG002|Overall Study|Randomized in error|0|||
125551406|NCT00688103|451648545|FG000|Overall Study|Adverse Event|4|||
125551407|NCT00688103|451648546|FG001|Overall Study|Adverse Event|1|||
125551408|NCT00688103|451648545|FG000|Overall Study|Lack of Efficacy|11|||
125551409|NCT00688103|451648546|FG001|Overall Study|Lack of Efficacy|1|||
125551410|NCT00688103|451648545|FG000|Overall Study|Withdrawal by Subject|4|||
125551411|NCT00688103|451648546|FG001|Overall Study|Withdrawal by Subject|2|||
125551412|NCT00688103|451648545|FG000|Overall Study|complex reasons|11|||
125551413|NCT00688103|451648546|FG001|Overall Study|complex reasons|9|||
125551414|NCT03602261|451648547|FG000|Overall Study|Adverse Event|5|||
125551415|NCT03602261|451648548|FG001|Overall Study|Adverse Event|1|||
125551416|NCT03602261|451648547|FG000|Overall Study|Physician Decision|1|||
125551417|NCT03602261|451648548|FG001|Overall Study|Physician Decision|0|||
125551418|NCT03602261|451648547|FG000|Overall Study|Withdrawal by Subject|1|||
125551419|NCT03602261|451648548|FG001|Overall Study|Withdrawal by Subject|1|||
125551420|NCT03602261|451648547|FG000|Overall Study|Lack of Efficacy|0|||
125551421|NCT03602261|451648548|FG001|Overall Study|Lack of Efficacy|1|||
125349940|NCT00722371|450915341|FG004|Overall Study|Physician Decision|2|||
125349941|NCT00722371|450915342|FG005|Overall Study|Physician Decision|3|||
125349942|NCT00722371|450915343|FG006|Overall Study|Physician Decision|4|||
125349943|NCT00722371|450915337|FG000|Overall Study|Pregnancy|1|||
125551422|NCT03602261|451648547|FG000|Overall Study|Subject moving out of state|1|||
125551423|NCT03602261|451648548|FG001|Overall Study|Subject moving out of state|0|||
125551424|NCT01485354|451650576|FG000|Overall Study|Withdrawal by Subject|5|||
125551425|NCT00995020|451650583|FG000|Overall Study|margin analysis not performed|2|||
125551426|NCT00995020|451650584|FG001|Overall Study|margin analysis not performed|5|||
125551427|NCT00995020|451650583|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
125349944|NCT00722371|450915338|FG001|Overall Study|Pregnancy|1|||
125551428|NCT00995020|451650584|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
125551429|NCT00719563|451650592|FG000|Overall Study|Adverse Event|16|||
125551430|NCT00719563|451650593|FG001|Overall Study|Adverse Event|13|||
125551431|NCT00719563|451650592|FG000|Overall Study|Medical condition changed|3|||
125551432|NCT00719563|451650593|FG001|Overall Study|Medical condition changed|5|||
125349945|NCT00722371|450915339|FG002|Overall Study|Pregnancy|0|||
125349946|NCT00722371|450915340|FG003|Overall Study|Pregnancy|0|||
125349947|NCT00722371|450915341|FG004|Overall Study|Pregnancy|0|||
125349948|NCT00722371|450915342|FG005|Overall Study|Pregnancy|1|||
125349949|NCT00722371|450915343|FG006|Overall Study|Pregnancy|0|||
125349950|NCT00722371|450915337|FG000|Overall Study|Protocol Violation|6|||
125349951|NCT00722371|450915338|FG001|Overall Study|Protocol Violation|1|||
125349952|NCT00722371|450915339|FG002|Overall Study|Protocol Violation|0|||
125349953|NCT00722371|450915340|FG003|Overall Study|Protocol Violation|1|||
125349954|NCT00722371|450915341|FG004|Overall Study|Protocol Violation|4|||
125349955|NCT00722371|450915342|FG005|Overall Study|Protocol Violation|2|||
125349956|NCT00722371|450915343|FG006|Overall Study|Protocol Violation|1|||
125349957|NCT00722371|450915337|FG000|Overall Study|Withdrawal by Subject|18|||
125349958|NCT00722371|450915338|FG001|Overall Study|Withdrawal by Subject|27|||
125349959|NCT00722371|450915339|FG002|Overall Study|Withdrawal by Subject|19|||
125349960|NCT00722371|450915340|FG003|Overall Study|Withdrawal by Subject|23|||
125349961|NCT00722371|450915341|FG004|Overall Study|Withdrawal by Subject|19|||
125349962|NCT00722371|450915342|FG005|Overall Study|Withdrawal by Subject|18|||
125349963|NCT00722371|450915343|FG006|Overall Study|Withdrawal by Subject|26|||
125349964|NCT02635646|450915344|FG000|Overall Study|Lost to Follow-up|24|||
125349965|NCT02635646|450915345|FG001|Overall Study|Lost to Follow-up|25|||
125349966|NCT02635646|450915344|FG000|Overall Study|Pregnancy|1|||
125349967|NCT02635646|450915345|FG001|Overall Study|Pregnancy|1|||
125349968|NCT01007253|450915351|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
125349969|NCT01007253|450915352|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
125349970|NCT01007253|450915353|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
125682659|NCT04659603|452127223|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
125349971|NCT01007253|450915354|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
125349972|NCT00814801|450915355|FG000|Overall Study|Adverse Event|15|||
125349973|NCT00814801|450915356|FG001|Overall Study|Adverse Event|16|||
125349974|NCT00814801|450915357|FG002|Overall Study|Adverse Event|19|||
125349975|NCT00814801|450915355|FG000|Overall Study|Withdrawal by Subject|9|||
125349976|NCT00814801|450915356|FG001|Overall Study|Withdrawal by Subject|11|||
125349977|NCT00814801|450915357|FG002|Overall Study|Withdrawal by Subject|14|||
125349978|NCT00814801|450915355|FG000|Overall Study|Inappropriate as a subject|1|||
125349979|NCT00814801|450915356|FG001|Overall Study|Inappropriate as a subject|1|||
125349980|NCT00814801|450915357|FG002|Overall Study|Inappropriate as a subject|1|||
125349981|NCT00814801|450915355|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
125682660|NCT04659603|452127224|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
125682661|NCT04659603|452127225|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
125682662|NCT03799341|452127226|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
125682663|NCT03799341|452127227|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
125682664|NCT03799341|452127228|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
125682665|NCT03799341|452127226|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
125682666|NCT03799341|452127227|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
125682667|NCT03799341|452127228|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
125682668|NCT03799341|452127226|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
125682669|NCT03799341|452127227|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
125682670|NCT03799341|452127228|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
125682671|NCT03799341|452127226|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
125682672|NCT03799341|452127227|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
125682673|NCT03799341|452127228|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
125682674|NCT03799341|452127226|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
125682675|NCT03799341|452127227|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
125682676|NCT03799341|452127228|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
125682677|NCT03799341|452127226|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
125682678|NCT03799341|452127227|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
125682679|NCT03799341|452127228|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
125682680|NCT01231906|452127231|FG000|Overall Study|Lack of Efficacy|75|||
125682681|NCT01231906|452127232|FG001|Overall Study|Lack of Efficacy|68|||
125682682|NCT01231906|452127231|FG000|Overall Study|Lost to Follow-up|1|||
125682683|NCT01231906|452127232|FG001|Overall Study|Lost to Follow-up|0|||
125682684|NCT01231906|452127231|FG000|Overall Study|Physician Decision|34|||
125682685|NCT01231906|452127232|FG001|Overall Study|Physician Decision|24|||
125349982|NCT00814801|450915356|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
125349983|NCT00814801|450915357|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
125349984|NCT00814801|450915355|FG000|Overall Study|Missing or change of caregiver|6|||
125349985|NCT00814801|450915356|FG001|Overall Study|Missing or change of caregiver|2|||
125349986|NCT00814801|450915357|FG002|Overall Study|Missing or change of caregiver|4|||
125682686|NCT01231906|452127231|FG000|Overall Study|Withdrawal by Subject|0|||
125682687|NCT01231906|452127232|FG001|Overall Study|Withdrawal by Subject|4|||
125551433|NCT00719563|451650592|FG000|Overall Study|Lack of Efficacy|3|||
125551434|NCT00719563|451650593|FG001|Overall Study|Lack of Efficacy|7|||
125551435|NCT00719563|451650592|FG000|Overall Study|Personal reasons|6|||
125551436|NCT00719563|451650593|FG001|Overall Study|Personal reasons|7|||
125551437|NCT00719563|451650592|FG000|Overall Study|Unknown reasons|4|||
125551438|NCT00719563|451650593|FG001|Overall Study|Unknown reasons|6|||
125551439|NCT00719563|451650592|FG000|Overall Study|Noncompliant|1|||
125551440|NCT00719563|451650593|FG001|Overall Study|Noncompliant|1|||
125551441|NCT00719563|451650592|FG000|Overall Study|Lost to Follow-up|5|||
125551442|NCT00719563|451650593|FG001|Overall Study|Lost to Follow-up|3|||
125551443|NCT00567268|451650594|FG000|Overall Study|Protocol Violation|7|||
125551444|NCT00567268|451650594|FG000|Overall Study|Lost to Follow-up|36|||
125551445|NCT00567268|451650594|FG000|Overall Study|No Visit After First Day of Treatment|2|||
125551446|NCT00567268|451650594|FG000|Overall Study|No Drug Administration|4|||
125551447|NCT00567268|451650594|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
125551448|NCT00792805|451650595|FG000|Overall Study|Adverse Event|12|||
125551449|NCT00792805|451650596|FG001|Overall Study|Adverse Event|10|||
125551450|NCT00792805|451650597|FG002|Overall Study|Adverse Event|10|||
125551451|NCT00792805|451650595|FG000|Overall Study|Subject withdrew consent|5|||
125551452|NCT00792805|451650596|FG001|Overall Study|Subject withdrew consent|6|||
125551453|NCT00792805|451650597|FG002|Overall Study|Subject withdrew consent|5|||
125551454|NCT00792805|451650595|FG000|Overall Study|Administrative problems|2|||
125551455|NCT00792805|451650596|FG001|Overall Study|Administrative problems|0|||
125551456|NCT00792805|451650597|FG002|Overall Study|Administrative problems|4|||
125551457|NCT00792805|451650595|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125551458|NCT00792805|451650596|FG001|Overall Study|Abnormal test procedure result(s)|2|||
125551459|NCT00792805|451650597|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125551460|NCT00792805|451650595|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125551461|NCT00792805|451650596|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
125551462|NCT00792805|451650597|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
125551463|NCT00792805|451650595|FG000|Overall Study|Lost to Follow-up|1|||
125551464|NCT00792805|451650596|FG001|Overall Study|Lost to Follow-up|1|||
125551465|NCT00792805|451650597|FG002|Overall Study|Lost to Follow-up|6|||
125551466|NCT00792805|451650595|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125551467|NCT00792805|451650596|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125551468|NCT00792805|451650597|FG002|Overall Study|Abnormal laboratory value(s)|1|||
125551469|NCT00792805|451650595|FG000|Overall Study|Protocol deviation|0|||
125551470|NCT00792805|451650596|FG001|Overall Study|Protocol deviation|1|||
125551471|NCT00792805|451650597|FG002|Overall Study|Protocol deviation|1|||
125551472|NCT02952001|451650600|FG000|Overall Study|Adverse Event|3|||
125551473|NCT02952001|451650601|FG001|Overall Study|Adverse Event|0|||
125551474|NCT02952001|451650600|FG000|Overall Study|Prohibited therapy|10|||
125551475|NCT02952001|451650601|FG001|Overall Study|Prohibited therapy|3|||
125551476|NCT02952001|451650600|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
125551477|NCT02952001|451650601|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
125551478|NCT03278106|451650609|FG000|Overall Study|No protocol treatment|1|||
125551479|NCT02982187|451650610|FG000|Overall Study|Withdrawal by Subject|0|||
125551480|NCT02982187|451650611|FG001|Overall Study|Withdrawal by Subject|0|||
125551481|NCT02982187|451650612|FG002|Overall Study|Withdrawal by Subject|0|||
125551482|NCT02982187|451650613|FG003|Overall Study|Withdrawal by Subject|0|||
125551483|NCT02982187|451650614|FG004|Overall Study|Withdrawal by Subject|0|||
125551484|NCT02982187|451650615|FG005|Overall Study|Withdrawal by Subject|0|||
125551485|NCT02982187|451650616|FG006|Overall Study|Withdrawal by Subject|1|||
125551486|NCT02982187|451650617|FG007|Overall Study|Withdrawal by Subject|0|||
125551487|NCT02604433|451650618|FG000|Overall Study|Withdrawal by Subject|37|||
125551488|NCT02604433|451650619|FG001|Overall Study|Withdrawal by Subject|16|||
125682688|NCT01231906|452127231|FG000|Overall Study|Ineligible|10|||
125551489|NCT02604433|451650618|FG000|Overall Study|Adverse Event|4|||
125551490|NCT02604433|451650619|FG001|Overall Study|Adverse Event|0|||
125551491|NCT02604433|451650618|FG000|Overall Study|Other reasons|3|||
125551492|NCT02604433|451650619|FG001|Overall Study|Other reasons|5|||
125551493|NCT02604433|451650618|FG000|Overall Study|Death|4|||
125551494|NCT02604433|451650619|FG001|Overall Study|Death|1|||
125551495|NCT02604433|451650618|FG000|Overall Study|Transition to Rollover Protocol|169|||
125551496|NCT02604433|451650619|FG001|Overall Study|Transition to Rollover Protocol|82|||
125551497|NCT02604433|451650618|FG000|Overall Study|Physician Decision|1|||
125551498|NCT02604433|451650619|FG001|Overall Study|Physician Decision|1|||
125551499|NCT02604433|451650618|FG000|Overall Study|Lack of Efficacy|0|||
125551500|NCT02604433|451650619|FG001|Overall Study|Lack of Efficacy|1|||
125551501|NCT03437278|451650620|FG000|Overall Study|Adverse Event|0|||
125551502|NCT03437278|451650621|FG001|Overall Study|Adverse Event|0|||
125551503|NCT03437278|451650622|FG002|Overall Study|Adverse Event|1|||
125551504|NCT03437278|451650620|FG000|Overall Study|Progressive disease|1|||
125551505|NCT03437278|451650621|FG001|Overall Study|Progressive disease|0|||
125551506|NCT03437278|451650622|FG002|Overall Study|Progressive disease|0|||
125551507|NCT03437278|451650620|FG000|Overall Study|Physician Decision|1|||
125551508|NCT03437278|451650621|FG001|Overall Study|Physician Decision|0|||
125682689|NCT01231906|452127232|FG001|Overall Study|Ineligible|3|||
125551509|NCT03437278|451650622|FG002|Overall Study|Physician Decision|1|||
125551510|NCT02202551|451650623|FG000|Overall Study|Adverse Event|8|||
125551511|NCT02202551|451650624|FG001|Overall Study|Adverse Event|19|||
125551512|NCT02202551|451650625|FG002|Overall Study|Adverse Event|5|||
125551513|NCT02202551|451650626|FG003|Overall Study|Adverse Event|9|||
125551514|NCT02202551|451650623|FG000|Overall Study|Death|3|||
125551515|NCT02202551|451650624|FG001|Overall Study|Death|2|||
125551516|NCT02202551|451650625|FG002|Overall Study|Death|1|||
125551517|NCT02202551|451650626|FG003|Overall Study|Death|1|||
125551518|NCT02202551|451650623|FG000|Overall Study|Lost to Follow-up|0|||
125551519|NCT02202551|451650624|FG001|Overall Study|Lost to Follow-up|1|||
125551520|NCT02202551|451650625|FG002|Overall Study|Lost to Follow-up|0|||
125551521|NCT02202551|451650626|FG003|Overall Study|Lost to Follow-up|1|||
125551522|NCT02202551|451650623|FG000|Overall Study|Needed to take excluded medication|0|||
125551523|NCT02202551|451650624|FG001|Overall Study|Needed to take excluded medication|2|||
125551524|NCT02202551|451650625|FG002|Overall Study|Needed to take excluded medication|0|||
125551525|NCT02202551|451650626|FG003|Overall Study|Needed to take excluded medication|1|||
125551526|NCT02202551|451650623|FG000|Overall Study|Subject moved away|0|||
125551527|NCT02202551|451650624|FG001|Overall Study|Subject moved away|1|||
125551528|NCT02202551|451650625|FG002|Overall Study|Subject moved away|0|||
125551529|NCT02202551|451650626|FG003|Overall Study|Subject moved away|0|||
125551530|NCT02202551|451650623|FG000|Overall Study|DBS surgery|3|||
125551531|NCT02202551|451650624|FG001|Overall Study|DBS surgery|0|||
125551532|NCT02202551|451650625|FG002|Overall Study|DBS surgery|0|||
125551533|NCT02202551|451650626|FG003|Overall Study|DBS surgery|0|||
125349987|NCT00814801|450915355|FG000|Overall Study|Non-compliance|0|||
125349988|NCT00814801|450915356|FG001|Overall Study|Non-compliance|1|||
125551534|NCT02202551|451650623|FG000|Overall Study|Dyskinesia upon taper|1|||
125551535|NCT02202551|451650624|FG001|Overall Study|Dyskinesia upon taper|0|||
125551536|NCT02202551|451650625|FG002|Overall Study|Dyskinesia upon taper|0|||
125551537|NCT02202551|451650626|FG003|Overall Study|Dyskinesia upon taper|0|||
125551538|NCT02202551|451650623|FG000|Overall Study|Lack of Efficacy|0|||
125551539|NCT02202551|451650624|FG001|Overall Study|Lack of Efficacy|1|||
125551540|NCT02202551|451650625|FG002|Overall Study|Lack of Efficacy|0|||
125551541|NCT02202551|451650626|FG003|Overall Study|Lack of Efficacy|0|||
125551542|NCT02202551|451650623|FG000|Overall Study|Physician Decision|1|||
125551543|NCT02202551|451650624|FG001|Overall Study|Physician Decision|0|||
125551544|NCT02202551|451650625|FG002|Overall Study|Physician Decision|0|||
125551545|NCT02202551|451650626|FG003|Overall Study|Physician Decision|0|||
125551546|NCT02202551|451650623|FG000|Overall Study|Site closure|3|||
125551547|NCT02202551|451650624|FG001|Overall Study|Site closure|0|||
125551548|NCT02202551|451650625|FG002|Overall Study|Site closure|0|||
125551549|NCT02202551|451650626|FG003|Overall Study|Site closure|1|||
125551550|NCT02202551|451650623|FG000|Overall Study|Unable to complete visits per protocol|1|||
125551551|NCT02202551|451650624|FG001|Overall Study|Unable to complete visits per protocol|0|||
125551552|NCT02202551|451650625|FG002|Overall Study|Unable to complete visits per protocol|0|||
125551553|NCT02202551|451650626|FG003|Overall Study|Unable to complete visits per protocol|0|||
125551554|NCT02202551|451650623|FG000|Overall Study|Worsening Dyskinesia|0|||
125551555|NCT02202551|451650624|FG001|Overall Study|Worsening Dyskinesia|0|||
125551556|NCT02202551|451650625|FG002|Overall Study|Worsening Dyskinesia|0|||
125551557|NCT02202551|451650626|FG003|Overall Study|Worsening Dyskinesia|1|||
125551558|NCT02202551|451650623|FG000|Overall Study|Protocol Violation|0|||
125551559|NCT02202551|451650624|FG001|Overall Study|Protocol Violation|1|||
125551560|NCT02202551|451650625|FG002|Overall Study|Protocol Violation|0|||
125551561|NCT02202551|451650626|FG003|Overall Study|Protocol Violation|0|||
125551562|NCT02202551|451650623|FG000|Overall Study|Sponsor's decision|2|||
125551563|NCT02202551|451650624|FG001|Overall Study|Sponsor's decision|0|||
125551564|NCT02202551|451650625|FG002|Overall Study|Sponsor's decision|0|||
125551565|NCT02202551|451650626|FG003|Overall Study|Sponsor's decision|0|||
125551566|NCT02202551|451650623|FG000|Overall Study|Subject unwilling to proceed|1|||
125551567|NCT02202551|451650624|FG001|Overall Study|Subject unwilling to proceed|5|||
125551568|NCT02202551|451650625|FG002|Overall Study|Subject unwilling to proceed|3|||
125349989|NCT00814801|450915357|FG002|Overall Study|Non-compliance|1|||
125349990|NCT00814801|450915355|FG000|Overall Study|Other|2|||
125551569|NCT02202551|451650626|FG003|Overall Study|Subject unwilling to proceed|5|||
125551570|NCT02202551|451650623|FG000|Overall Study|Subject consent withdrawn|0|||
125551571|NCT02202551|451650624|FG001|Overall Study|Subject consent withdrawn|3|||
125551572|NCT02202551|451650625|FG002|Overall Study|Subject consent withdrawn|1|||
125551573|NCT02202551|451650626|FG003|Overall Study|Subject consent withdrawn|2|||
125551574|NCT02202551|451650623|FG000|Overall Study|eGFR<50mL/min/m2|2|||
125551575|NCT02202551|451650624|FG001|Overall Study|eGFR<50mL/min/m2|2|||
125551576|NCT02202551|451650625|FG002|Overall Study|eGFR<50mL/min/m2|0|||
125551577|NCT02202551|451650626|FG003|Overall Study|eGFR<50mL/min/m2|1|||
125551578|NCT02147353|451650627|FG000|Overall Study|Lost to Follow-up|2|||
125551579|NCT02147353|451650628|FG001|Overall Study|Lost to Follow-up|0|||
125551580|NCT02147353|451650627|FG000|Overall Study|unable to make visits|4|||
125551581|NCT02147353|451650628|FG001|Overall Study|unable to make visits|0|||
125551582|NCT02147353|451650627|FG000|Overall Study|medication noncompliance|3|||
125551583|NCT02147353|451650628|FG001|Overall Study|medication noncompliance|0|||
125551584|NCT01326533|451650639|FG000|Overall Study|Lost to Follow-up|2|||
125551585|NCT01326533|451650640|FG001|Overall Study|Lost to Follow-up|0|||
125551586|NCT01326533|451650639|FG000|Overall Study|Withdrawal by Subject|1|||
125551587|NCT01326533|451650640|FG001|Overall Study|Withdrawal by Subject|0|||
125551588|NCT01326533|451650639|FG000|Overall Study|Adverse Event|1|||
125551589|NCT01326533|451650640|FG001|Overall Study|Adverse Event|0|||
125551590|NCT00926211|451650641|FG000|Overall Study|Lost to Follow-up|1|||
125551591|NCT01106404|451650645|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
125551592|NCT01106404|451650646|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
125551593|NCT01106404|451650645|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
125551594|NCT01106404|451650646|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
125551595|NCT01106404|451650645|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
125551596|NCT01106404|451650646|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
125551597|NCT01106404|451650645|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
125551598|NCT01106404|451650646|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
125551599|NCT00775450|451650647|FG000|Overall Study|Serious Adverse Event|2|||
125551600|NCT00775450|451650648|FG001|Overall Study|Serious Adverse Event|0|||
125551601|NCT00775450|451650649|FG002|Overall Study|Serious Adverse Event|0|||
125551602|NCT00775450|451650650|FG003|Overall Study|Serious Adverse Event|0|||
125551603|NCT00775450|451650651|FG004|Overall Study|Serious Adverse Event|0|||
125551604|NCT00775450|451650647|FG000|Overall Study|Protocol Violation|0|||
125551605|NCT00775450|451650648|FG001|Overall Study|Protocol Violation|0|||
125551606|NCT00775450|451650649|FG002|Overall Study|Protocol Violation|0|||
125551607|NCT00775450|451650650|FG003|Overall Study|Protocol Violation|0|||
125551608|NCT00775450|451650651|FG004|Overall Study|Protocol Violation|1|||
125551609|NCT00775450|451650647|FG000|Overall Study|Withdrawal by Subject|1|||
125551610|NCT00775450|451650648|FG001|Overall Study|Withdrawal by Subject|0|||
125551611|NCT00775450|451650649|FG002|Overall Study|Withdrawal by Subject|0|||
125551612|NCT00775450|451650650|FG003|Overall Study|Withdrawal by Subject|0|||
125551613|NCT00775450|451650651|FG004|Overall Study|Withdrawal by Subject|1|||
125551614|NCT01749540|451650658|FG000|Overall Study|Protocol Violation|0|||
125551615|NCT01749540|451650659|FG001|Overall Study|Protocol Violation|0|||
125551616|NCT01749540|451650660|FG002|Overall Study|Protocol Violation|0|||
125551617|NCT01749540|451650661|FG003|Overall Study|Protocol Violation|0|||
125551618|NCT01749540|451650662|FG004|Overall Study|Protocol Violation|0|||
125551619|NCT01749540|451650663|FG005|Overall Study|Protocol Violation|1|||
125551620|NCT01749540|451650664|FG006|Overall Study|Protocol Violation|1|||
125551621|NCT01749540|451650658|FG000|Overall Study|Withdrawal by Subject|0|||
125551622|NCT01749540|451650659|FG001|Overall Study|Withdrawal by Subject|0|||
125551623|NCT01749540|451650660|FG002|Overall Study|Withdrawal by Subject|0|||
125551624|NCT01749540|451650661|FG003|Overall Study|Withdrawal by Subject|1|||
125551625|NCT01749540|451650662|FG004|Overall Study|Withdrawal by Subject|0|||
125551626|NCT01749540|451650663|FG005|Overall Study|Withdrawal by Subject|0|||
125551627|NCT01749540|451650664|FG006|Overall Study|Withdrawal by Subject|0|||
125551628|NCT01749540|451650658|FG000|Overall Study|Initiated into extension study A536-06|0|||
125551629|NCT01749540|451650659|FG001|Overall Study|Initiated into extension study A536-06|0|||
125551630|NCT01749540|451650660|FG002|Overall Study|Initiated into extension study A536-06|0|||
125551631|NCT01749540|451650661|FG003|Overall Study|Initiated into extension study A536-06|0|||
125551632|NCT01749540|451650662|FG004|Overall Study|Initiated into extension study A536-06|0|||
125551633|NCT01749540|451650663|FG005|Overall Study|Initiated into extension study A536-06|2|||
125551634|NCT01749540|451650664|FG006|Overall Study|Initiated into extension study A536-06|24|||
125551635|NCT00894686|451650665|FG000|Overall Study|Withdrawal by Subject|50|||
125551636|NCT00894686|451650665|FG000|Overall Study|Physician Decision|1|||
125551637|NCT00894686|451650665|FG000|Overall Study|Other|5|||
125551638|NCT00564018|451650666|FG000|Overall Study|Withdrawal by Subject|2|||
125551639|NCT00564018|451650667|FG001|Overall Study|Withdrawal by Subject|3|||
125551640|NCT00564018|451650668|FG002|Overall Study|Withdrawal by Subject|1|||
125682690|NCT01231906|452127231|FG000|Overall Study|No treatment|1|||
125682691|NCT01231906|452127232|FG001|Overall Study|No treatment|2|||
125682692|NCT01116648|452128049|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
125682693|NCT01116648|452128050|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
125682694|NCT01116648|452128051|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
125682695|NCT01116648|452128052|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
125349991|NCT00814801|450915356|FG001|Overall Study|Other|6|||
125551641|NCT03267940|451650671|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
125551642|NCT03267940|451650672|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
125682696|NCT01116648|452128053|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
125682697|NCT01116648|452128054|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
125551643|NCT03267940|451650673|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
125551644|NCT03267940|451650674|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
125551645|NCT03267940|451650675|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
125551646|NCT03267940|451650676|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
125210773|NCT01810783|450395682|FG000|Overall Study|Lack of Efficacy|12|||
125551647|NCT03267940|451650671|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
125551648|NCT03267940|451650672|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
125551649|NCT03267940|451650673|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
125551650|NCT03267940|451650674|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
125551651|NCT03267940|451650675|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
125551652|NCT03267940|451650676|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
125551653|NCT03267940|451650671|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
125551654|NCT03267940|451650672|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
125551655|NCT03267940|451650673|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
125551656|NCT03267940|451650674|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
125551657|NCT03267940|451650675|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
125551658|NCT03267940|451650676|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
125551659|NCT03267940|451650671|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
125551660|NCT03267940|451650672|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
125551661|NCT03267940|451650673|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
125551662|NCT03267940|451650674|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
125551663|NCT03267940|451650675|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
125551664|NCT03267940|451650676|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
125551665|NCT03267940|451650671|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
125551666|NCT03267940|451650672|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
125551667|NCT03267940|451650673|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
125551668|NCT03267940|451650674|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
125551669|NCT03267940|451650675|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
125551670|NCT03267940|451650676|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
125551671|NCT03267940|451650671|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
125551672|NCT03267940|451650672|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
125551673|NCT03267940|451650673|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
125551674|NCT03267940|451650674|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
125551675|NCT03267940|451650675|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
125551676|NCT03267940|451650676|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
125551677|NCT03267940|451650671|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
125551678|NCT03267940|451650672|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
125551679|NCT03267940|451650673|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
125551680|NCT03267940|451650674|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
125551681|NCT03267940|451650675|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
125551682|NCT03267940|451650676|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
125551683|NCT03267940|451650671|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
125551684|NCT03267940|451650672|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
125551685|NCT03267940|451650673|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
125551686|NCT03267940|451650674|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
125551687|NCT03267940|451650675|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
125551688|NCT03267940|451650676|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
125551689|NCT03267940|451650671|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
125551690|NCT03267940|451650672|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
125551691|NCT03267940|451650673|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
125551692|NCT03267940|451650674|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
125551693|NCT03267940|451650675|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
125551694|NCT03267940|451650676|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
125551695|NCT00388154|451650677|FG000|Overall Study|Withdrawal by Subject|1|||
125551696|NCT01948908|451650686|FG000|Overall Study|Protocol Violation|1|||
125551697|NCT01948908|451650687|FG001|Overall Study|Protocol Violation|0|||
125551698|NCT01948908|451650688|FG002|Overall Study|Protocol Violation|2|||
125551699|NCT02240693|451650689|FG000|Overall Study|Adverse Event|0|||
125551700|NCT02240693|451650690|FG001|Overall Study|Adverse Event|0|||
125551701|NCT02240693|451650691|FG002|Overall Study|Adverse Event|0|||
125551702|NCT02240693|451650692|FG003|Overall Study|Adverse Event|0|||
125551703|NCT02240693|451650693|FG004|Overall Study|Adverse Event|1|||
125551704|NCT02240693|451650689|FG000|Overall Study|Withdrawal by Subject|0|||
125551705|NCT02240693|451650690|FG001|Overall Study|Withdrawal by Subject|0|||
125551706|NCT02240693|451650691|FG002|Overall Study|Withdrawal by Subject|2|||
125551707|NCT02240693|451650692|FG003|Overall Study|Withdrawal by Subject|1|||
125551708|NCT02240693|451650693|FG004|Overall Study|Withdrawal by Subject|0|||
125349992|NCT00814801|450915357|FG002|Overall Study|Other|4|||
125349993|NCT01163032|450915361|FG000|Randomization Phase|Withdrawal by Subject|2|||
125349994|NCT01163032|450915362|FG001|Randomization Phase|Withdrawal by Subject|3|||
125551709|NCT02240693|451650689|FG000|Overall Study|Other than specified|0|||
125551710|NCT02240693|451650690|FG001|Overall Study|Other than specified|0|||
125551711|NCT02240693|451650691|FG002|Overall Study|Other than specified|2|||
125551712|NCT02240693|451650692|FG003|Overall Study|Other than specified|0|||
125682698|NCT01116648|452128055|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
125682699|NCT01116648|452128056|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
125682700|NCT01116648|452128057|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
125682701|NCT01116648|452128058|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
125682702|NCT01116648|452128059|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
125682703|NCT01116648|452128060|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
125682704|NCT01116648|452128061|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
125682705|NCT01116648|452128062|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
125682706|NCT01116648|452128063|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
125682707|NCT04539938|452128064|FG000|Overall Study|Death|30|||
125682708|NCT04539938|452128064|FG000|Overall Study|Withdrawal by Subject|4|||
125682709|NCT03100149|452128070|FG000|Overall Study|Adverse Event|0|||
125682710|NCT03100149|452128071|FG001|Overall Study|Adverse Event|1|||
125682711|NCT03100149|452128072|FG002|Overall Study|Adverse Event|0|||
125682712|NCT03100149|452128070|FG000|Overall Study|Participant Moved out of Country|0|||
125682713|NCT03100149|452128071|FG001|Overall Study|Participant Moved out of Country|0|||
125682714|NCT03100149|452128072|FG002|Overall Study|Participant Moved out of Country|1|||
125682715|NCT03100149|452128070|FG000|Overall Study|Withdrawal by Subject|0|||
125682716|NCT03100149|452128071|FG001|Overall Study|Withdrawal by Subject|3|||
125682717|NCT03100149|452128072|FG002|Overall Study|Withdrawal by Subject|1|||
125682718|NCT04827732|452128078|FG000|Overall Study|Did not start treatment|0|||
125682719|NCT04827732|452128079|FG001|Overall Study|Did not start treatment|1|||
125682720|NCT04827732|452128080|FG002|Overall Study|Did not start treatment|0|||
125682721|NCT04827732|452128081|FG003|Overall Study|Did not start treatment|1|||
125682722|NCT01754597|452128084|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
125682723|NCT01754597|452128085|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
125682724|NCT01588236|452128086|FG000|Overall Study|Adverse Event|5|||
125682725|NCT01588236|452128087|FG001|Overall Study|Adverse Event|4|||
125682726|NCT01588236|452128088|FG002|Overall Study|Adverse Event|1|||
125682727|NCT01588236|452128086|FG000|Overall Study|Lost to Follow-up|8|||
125682728|NCT01588236|452128087|FG001|Overall Study|Lost to Follow-up|13|||
125682729|NCT01588236|452128088|FG002|Overall Study|Lost to Follow-up|6|||
125682730|NCT01588236|452128086|FG000|Overall Study|Physician Decision|1|||
125682731|NCT01588236|452128087|FG001|Overall Study|Physician Decision|2|||
125682732|NCT01588236|452128088|FG002|Overall Study|Physician Decision|0|||
125682733|NCT01588236|452128086|FG000|Overall Study|Protocol Violation|0|||
125682734|NCT01588236|452128087|FG001|Overall Study|Protocol Violation|1|||
125682735|NCT01588236|452128088|FG002|Overall Study|Protocol Violation|1|||
125682736|NCT01588236|452128086|FG000|Overall Study|Withdrawal by Subject|14|||
125682737|NCT01588236|452128087|FG001|Overall Study|Withdrawal by Subject|16|||
125682738|NCT01588236|452128088|FG002|Overall Study|Withdrawal by Subject|18|||
125682739|NCT01588236|452128086|FG000|Overall Study|Exclusion Criteria met during study|2|||
125682740|NCT01588236|452128087|FG001|Overall Study|Exclusion Criteria met during study|1|||
125682741|NCT01588236|452128088|FG002|Overall Study|Exclusion Criteria met during study|0|||
125682742|NCT01588236|452128086|FG000|Overall Study|sponsor decision|1|||
125682743|NCT01588236|452128087|FG001|Overall Study|sponsor decision|6|||
125682744|NCT01588236|452128088|FG002|Overall Study|sponsor decision|2|||
125682745|NCT02819141|452128089|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
125682746|NCT02819141|452128090|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
125682747|NCT04544410|452128093|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
125682748|NCT04544410|452128094|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
125682749|NCT04544410|452128093|FG000|Double-blind Treatment Period|Adverse Event|1|||
125682750|NCT04544410|452128094|FG001|Double-blind Treatment Period|Adverse Event|0|||
125682751|NCT04544410|452128093|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
125682752|NCT04544410|452128094|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
125682753|NCT04544410|452128093|FG000|Double-blind Treatment Period|Protocol Violation|1|||
125682754|NCT04544410|452128094|FG001|Double-blind Treatment Period|Protocol Violation|0|||
125682755|NCT04544410|452128093|FG000|Open-Label Treatment Period|Study Terminated|15|||
125682756|NCT04544410|452128094|FG001|Open-Label Treatment Period|Study Terminated|19|||
125682757|NCT04544410|452128093|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
125682758|NCT04544410|452128094|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
125682759|NCT04544410|452128093|FG000|Open-Label Treatment Period|Adverse Event|0|||
125682760|NCT04544410|452128094|FG001|Open-Label Treatment Period|Adverse Event|1|||
125682761|NCT04544410|452128093|FG000|Open-Label Treatment Period|Physician Decision|1|||
125682762|NCT04544410|452128094|FG001|Open-Label Treatment Period|Physician Decision|0|||
125682763|NCT04544410|452128093|FG000|Open-Label Treatment Period|Other|0|||
125682764|NCT04544410|452128094|FG001|Open-Label Treatment Period|Other|1|||
125551713|NCT02240693|451650693|FG004|Overall Study|Other than specified|0|||
125551714|NCT03291587|451650694|FG000|Overall Study|Lost to Follow-up|62|||
125551715|NCT03291587|451650695|FG001|Overall Study|Lost to Follow-up|43|||
125551716|NCT03291587|451650694|FG000|Overall Study|Refused to Answer|5|||
125551717|NCT03291587|451650695|FG001|Overall Study|Refused to Answer|2|||
125551718|NCT03291587|451650694|FG000|Overall Study|Death|2|||
125551719|NCT03291587|451650695|FG001|Overall Study|Death|4|||
125551720|NCT03291587|451650694|FG000|Overall Study|Not interested in participating|8|||
125551721|NCT03291587|451650695|FG001|Overall Study|Not interested in participating|6|||
125551722|NCT03291587|451650694|FG000|Overall Study|Too busy to participate|4|||
125551723|NCT03291587|451650695|FG001|Overall Study|Too busy to participate|2|||
125551724|NCT00796120|451650696|FG000|Overall Study|Death|3|||
125551725|NCT00796120|451650697|FG001|Overall Study|Death|0|||
125551726|NCT00796120|451650696|FG000|Overall Study|Adverse Event|11|||
125551727|NCT00796120|451650697|FG001|Overall Study|Adverse Event|6|||
125551728|NCT00796120|451650696|FG000|Overall Study|Progressive disease|22|||
125551729|NCT00796120|451650697|FG001|Overall Study|Progressive disease|13|||
125551730|NCT00796120|451650696|FG000|Overall Study|Participant refusal|3|||
125551731|NCT00796120|451650697|FG001|Overall Study|Participant refusal|4|||
125551732|NCT00796120|451650696|FG000|Overall Study|Other|6|||
125551733|NCT00796120|451650697|FG001|Overall Study|Other|17|||
125551734|NCT00796120|451650696|FG000|Overall Study|Physician Decision|16|||
125551735|NCT00796120|451650697|FG001|Overall Study|Physician Decision|17|||
125551736|NCT00796120|451650696|FG000|Overall Study|Randomized but not treated|0|||
125551737|NCT00796120|451650697|FG001|Overall Study|Randomized but not treated|3|||
125551738|NCT00413972|451650702|FG000|Overall Study|Adverse Event|2|||
125551739|NCT00413972|451650703|FG001|Overall Study|Adverse Event|1|||
125551740|NCT00413972|451650704|FG002|Overall Study|Adverse Event|0|||
125551741|NCT00413972|451650705|FG003|Overall Study|Adverse Event|0|||
125551742|NCT00413972|451650702|FG000|Overall Study|Lost to Follow-up|1|||
125551743|NCT00413972|451650703|FG001|Overall Study|Lost to Follow-up|2|||
125551744|NCT00413972|451650704|FG002|Overall Study|Lost to Follow-up|1|||
125551745|NCT00413972|451650705|FG003|Overall Study|Lost to Follow-up|0|||
125551746|NCT00413972|451650702|FG000|Overall Study|Withdrawal by Subject|4|||
125551747|NCT00413972|451650703|FG001|Overall Study|Withdrawal by Subject|5|||
125551748|NCT00413972|451650704|FG002|Overall Study|Withdrawal by Subject|7|||
125551749|NCT00413972|451650705|FG003|Overall Study|Withdrawal by Subject|2|||
125551750|NCT00413972|451650702|FG000|Overall Study|Protocol Violation|0|||
125551751|NCT00413972|451650703|FG001|Overall Study|Protocol Violation|0|||
125551752|NCT00413972|451650704|FG002|Overall Study|Protocol Violation|2|||
125551753|NCT00413972|451650705|FG003|Overall Study|Protocol Violation|0|||
125551754|NCT00413972|451650702|FG000|Overall Study|Other|0|||
125551755|NCT00413972|451650703|FG001|Overall Study|Other|0|||
125551756|NCT00413972|451650704|FG002|Overall Study|Other|0|||
125551757|NCT00413972|451650705|FG003|Overall Study|Other|1|||
125551758|NCT01898923|451650708|FG000|Overall Study|Lack of Efficacy|5|||
125551759|NCT01898923|451650709|FG001|Overall Study|Lack of Efficacy|6|||
125551760|NCT01898923|451650708|FG000|Overall Study|Adverse Event|3|||
125551761|NCT01898923|451650709|FG001|Overall Study|Adverse Event|1|||
125551762|NCT01898923|451650708|FG000|Overall Study|Lost to Follow-up|0|||
125551763|NCT01898923|451650709|FG001|Overall Study|Lost to Follow-up|1|||
125551764|NCT01898923|451650708|FG000|Overall Study|Withdrawal by Subject|4|||
125551765|NCT01898923|451650709|FG001|Overall Study|Withdrawal by Subject|7|||
125551766|NCT01898923|451650708|FG000|Overall Study|Physician Decision|3|||
125551767|NCT01898923|451650709|FG001|Overall Study|Physician Decision|4|||
125551768|NCT01898923|451650708|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
125551769|NCT01898923|451650709|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
125551770|NCT00381303|451650710|FG000|Overall Study|Lost to Follow-up|25|||
125551771|NCT00381303|451650711|FG001|Overall Study|Lost to Follow-up|9|||
125551772|NCT00381303|451650710|FG000|Overall Study|AE/HIV-related event|22|||
125682765|NCT03414684|452128095|FG000|First-course Treatment|Complete response|0|||
125551773|NCT00381303|451650711|FG001|Overall Study|AE/HIV-related event|6|||
125551774|NCT00381303|451650710|FG000|Overall Study|Non-Adherence|13|||
125551775|NCT00381303|451650711|FG001|Overall Study|Non-Adherence|6|||
125682766|NCT03414684|452128096|FG001|First-course Treatment|Complete response|1|||
125425638|NCT01357616|451182307|FG000|Overall Study|Withdrawal by Subject|1|||
125551776|NCT00381303|451650710|FG000|Overall Study|Withdrawal by Subject|13|||
125551777|NCT00381303|451650711|FG001|Overall Study|Withdrawal by Subject|6|||
125551778|NCT00381303|451650710|FG000|Overall Study|Virologic failure|6|||
125551779|NCT00381303|451650711|FG001|Overall Study|Virologic failure|4|||
125551780|NCT00381303|451650710|FG000|Overall Study|Ineligible to continue the trial|2|||
125682767|NCT03414684|452128095|FG000|First-course Treatment|Intercurrent illness|1|||
125551781|NCT00381303|451650711|FG001|Overall Study|Ineligible to continue the trial|1|||
125551782|NCT00381303|451650710|FG000|Overall Study|Pregnancy|2|||
125551783|NCT00381303|451650711|FG001|Overall Study|Pregnancy|0|||
125551784|NCT00381303|451650710|FG000|Overall Study|Physician Decision|1|||
125551785|NCT00381303|451650711|FG001|Overall Study|Physician Decision|0|||
125551786|NCT00381303|451650710|FG000|Overall Study|Physician's decision to close the site|3|||
125349995|NCT01163032|450915363|FG002|Randomization Phase|Withdrawal by Subject|0|||
125349996|NCT01163032|450915361|FG000|Randomization Phase|Adverse Event|3|||
125349997|NCT01163032|450915362|FG001|Randomization Phase|Adverse Event|3|||
125349998|NCT01163032|450915363|FG002|Randomization Phase|Adverse Event|0|||
125349999|NCT01163032|450915361|FG000|Randomization Phase|Protocol Violation|0|||
125350000|NCT01163032|450915362|FG001|Randomization Phase|Protocol Violation|1|||
125350001|NCT01163032|450915363|FG002|Randomization Phase|Protocol Violation|0|||
125350002|NCT01163032|450915361|FG000|Randomization Phase|Various*|5|||
125350003|NCT01163032|450915362|FG001|Randomization Phase|Various*|4|||
125350004|NCT01163032|450915363|FG002|Randomization Phase|Various*|0|||
125210774|NCT01810783|450395682|FG000|Overall Study|Lost to Follow-up|10|||
125350005|NCT01163032|450915361|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
125350006|NCT01163032|450915362|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
125350007|NCT01163032|450915363|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
125350008|NCT01163032|450915361|FG000|Open Label Extension Phase|Adverse Event|0|||
125350009|NCT01163032|450915362|FG001|Open Label Extension Phase|Adverse Event|0|||
125350010|NCT01163032|450915363|FG002|Open Label Extension Phase|Adverse Event|3|||
125350011|NCT01163032|450915361|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
125350012|NCT01163032|450915362|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
125350013|NCT01163032|450915363|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
125350014|NCT01163032|450915361|FG000|Open Label Extension Phase|Protocol Violation|0|||
125350015|NCT01163032|450915362|FG001|Open Label Extension Phase|Protocol Violation|0|||
125350016|NCT01163032|450915363|FG002|Open Label Extension Phase|Protocol Violation|1|||
125350017|NCT01163032|450915361|FG000|Open Label Extension Phase|Study Termination|0|||
125350018|NCT01163032|450915362|FG001|Open Label Extension Phase|Study Termination|0|||
125350019|NCT01163032|450915363|FG002|Open Label Extension Phase|Study Termination|7|||
125350020|NCT01163032|450915361|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
125350021|NCT01163032|450915362|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
125350022|NCT01163032|450915363|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
125350023|NCT02751931|450915364|FG000|Overall Study|Adverse Event|3|||
125350024|NCT02751931|450915365|FG001|Overall Study|Adverse Event|0|||
125350025|NCT02751931|450915364|FG000|Overall Study|Other: Miscelleneous|10|||
125350026|NCT02751931|450915365|FG001|Overall Study|Other: Miscelleneous|8|||
125350027|NCT02380690|450915366|FG000|Overall Study|Lost to Follow-up|14|||
125350028|NCT02380690|450915367|FG001|Overall Study|Lost to Follow-up|4|||
125350029|NCT02380690|450915366|FG000|Overall Study|Withdrawal by Subject|20|||
125350030|NCT02380690|450915367|FG001|Overall Study|Withdrawal by Subject|8|||
125350031|NCT00817479|450915371|FG000|Overall Study|Physician Decision|1|||
125350032|NCT00817479|450915372|FG001|Overall Study|Physician Decision|1|||
125350033|NCT00282347|450915373|FG000|Treatment Period|Death|2|||
125350034|NCT00282347|450915374|FG001|Treatment Period|Death|0|||
125350035|NCT00282347|450915373|FG000|Treatment Period|Lost to Follow-up|2|||
125350036|NCT00282347|450915374|FG001|Treatment Period|Lost to Follow-up|5|||
125350037|NCT00282347|450915373|FG000|Treatment Period|Withdrawal by Subject|1|||
125350038|NCT00282347|450915374|FG001|Treatment Period|Withdrawal by Subject|3|||
125350039|NCT00282347|450915373|FG000|Treatment Period|Physician Decision|0|||
125350040|NCT00282347|450915374|FG001|Treatment Period|Physician Decision|1|||
125350041|NCT00282347|450915373|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
125350042|NCT00282347|450915374|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
125350043|NCT00282347|450915373|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
125350044|NCT00282347|450915374|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
125350045|NCT00282347|450915373|FG000|Safety Follow-up Period|Physician Decision|1|||
125350046|NCT00282347|450915374|FG001|Safety Follow-up Period|Physician Decision|1|||
125350047|NCT00282347|450915373|FG000|Safety Follow-up Period|Protocol Deviation|0|||
125350048|NCT00282347|450915374|FG001|Safety Follow-up Period|Protocol Deviation|2|||
125350049|NCT00282347|450915373|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
125350050|NCT00282347|450915374|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
125350051|NCT00282347|450915373|FG000|B Cell Follow-up Period|Physician Decision|1|||
125350052|NCT00282347|450915374|FG001|B Cell Follow-up Period|Physician Decision|0|||
125350053|NCT00282347|450915373|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
125350054|NCT00282347|450915374|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
125350055|NCT02361346|450915375|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
125350056|NCT02361346|450915376|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
125682768|NCT03414684|452128096|FG001|First-course Treatment|Intercurrent illness|0|||
125682769|NCT03414684|452128095|FG000|First-course Treatment|Progressive Disease|31|||
125682770|NCT03414684|452128096|FG001|First-course Treatment|Progressive Disease|32|||
125682771|NCT03414684|452128095|FG000|First-course Treatment|Adverse Event|1|||
125682772|NCT03414684|452128096|FG001|First-course Treatment|Adverse Event|2|||
125682773|NCT03414684|452128095|FG000|First-course Treatment|Physician Decision|0|||
125682774|NCT03414684|452128096|FG001|First-course Treatment|Physician Decision|1|||
125682775|NCT03414684|452128095|FG000|First-course Treatment|Withdrawal by Subject|0|||
125682776|NCT03414684|452128096|FG001|First-course Treatment|Withdrawal by Subject|1|||
125682777|NCT03414684|452128095|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
125682778|NCT03414684|452128096|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
125682779|NCT03414684|452128095|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
125682780|NCT03414684|452128096|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
125682781|NCT03414684|452128095|FG000|First-course Treatment|Still on treatment|3|||
125682782|NCT03414684|452128096|FG001|First-course Treatment|Still on treatment|0|||
125682783|NCT03414684|452128095|FG000|First-course Treatment|Never started protocol therapy|2|||
125682784|NCT03414684|452128096|FG001|First-course Treatment|Never started protocol therapy|1|||
125210775|NCT01810783|450395682|FG000|Overall Study|Protocol Violation|5|||
125350057|NCT02361346|450915377|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
125350058|NCT02361346|450915378|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
125551787|NCT00381303|451650711|FG001|Overall Study|Physician's decision to close the site|1|||
125551788|NCT00381303|451650710|FG000|Overall Study|Subject moved out of state|2|||
125551789|NCT00381303|451650711|FG001|Overall Study|Subject moved out of state|0|||
125551790|NCT00381303|451650710|FG000|Overall Study|Subject taking too many different meds|1|||
125551791|NCT00381303|451650711|FG001|Overall Study|Subject taking too many different meds|0|||
125551792|NCT00381303|451650710|FG000|Overall Study|No virologic response by week 12|1|||
125551793|NCT00381303|451650711|FG001|Overall Study|No virologic response by week 12|0|||
125551794|NCT00381303|451650710|FG000|Overall Study|Subject was too busy for appointments|1|||
125551795|NCT00381303|451650711|FG001|Overall Study|Subject was too busy for appointments|0|||
125551796|NCT00381303|451650710|FG000|Overall Study|Subject did not continue visits|1|||
125551797|NCT00381303|451650711|FG001|Overall Study|Subject did not continue visits|0|||
125551798|NCT00381303|451650710|FG000|Overall Study|Subject primary physician's decision|1|||
125551799|NCT00381303|451650711|FG001|Overall Study|Subject primary physician's decision|0|||
125551800|NCT01966471|451650714|FG000|Overall Study|Death|44|||
125551801|NCT01966471|451650715|FG001|Overall Study|Death|56|||
125551802|NCT01966471|451650714|FG000|Overall Study|Lost to Follow-up|46|||
125551803|NCT01966471|451650715|FG001|Overall Study|Lost to Follow-up|39|||
125551804|NCT01966471|451650714|FG000|Overall Study|Various reasons|4|||
125551805|NCT01966471|451650715|FG001|Overall Study|Various reasons|4|||
125551806|NCT01966471|451650714|FG000|Overall Study|Physician Decision|7|||
125551807|NCT01966471|451650715|FG001|Overall Study|Physician Decision|5|||
125551808|NCT01966471|451650714|FG000|Overall Study|Study Terminated By Sponsor|758|||
125551809|NCT01966471|451650715|FG001|Overall Study|Study Terminated By Sponsor|773|||
125551810|NCT01966471|451650714|FG000|Overall Study|Withdrawal by Subject|59|||
125551811|NCT01966471|451650715|FG001|Overall Study|Withdrawal by Subject|51|||
125551812|NCT01030198|451650716|FG000|Overall Study|Could not measure efficacy accurately|0|||
125551813|NCT01030198|451650717|FG001|Overall Study|Could not measure efficacy accurately|7|||
125551814|NCT02370043|451650718|FG000|Overall Study|Withdrawal by Subject|0|||
125551815|NCT02370043|451650719|FG001|Overall Study|Withdrawal by Subject|0|||
125551816|NCT02370043|451650720|FG002|Overall Study|Withdrawal by Subject|0|||
125551817|NCT02370043|451650721|FG003|Overall Study|Withdrawal by Subject|0|||
125551818|NCT02370043|451650722|FG004|Overall Study|Withdrawal by Subject|1|||
125350059|NCT02361346|450915379|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
125350060|NCT02361346|450915380|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
125551819|NCT02370043|451650723|FG005|Overall Study|Withdrawal by Subject|1|||
125551820|NCT00688181|451650724|FG000|Overall Study|Lost to Follow-up|17|||
125682785|NCT03414684|452128095|FG000|Crossover Treatment|Progressive disease|0|||
125682786|NCT03414684|452128096|FG001|Crossover Treatment|Progressive disease|12|||
125682787|NCT03414684|452128095|FG000|Crossover Treatment|Adverse Event|0|||
125682788|NCT03414684|452128096|FG001|Crossover Treatment|Adverse Event|3|||
125682789|NCT03414684|452128095|FG000|Crossover Treatment|Physician Decision|0|||
125682790|NCT03414684|452128096|FG001|Crossover Treatment|Physician Decision|1|||
125682791|NCT03414684|452128095|FG000|Crossover Treatment|Still on treatment|0|||
125682792|NCT03414684|452128096|FG001|Crossover Treatment|Still on treatment|2|||
125682793|NCT04038580|452128097|FG000|Washout 1|Death|0|||
125682794|NCT04038580|452128098|FG001|Washout 1|Death|0|||
125682795|NCT04038580|452128099|FG002|Washout 1|Death|0|||
125682796|NCT04038580|452128100|FG003|Washout 1|Death|1|||
125682797|NCT04038580|452128101|FG004|Washout 1|Death|0|||
125682798|NCT04038580|452128102|FG005|Washout 1|Death|0|||
125682799|NCT04038580|452128097|FG000|Washout 1|Withdrawal by Subject|0|||
125682800|NCT04038580|452128098|FG001|Washout 1|Withdrawal by Subject|0|||
125682801|NCT04038580|452128099|FG002|Washout 1|Withdrawal by Subject|0|||
125682802|NCT04038580|452128100|FG003|Washout 1|Withdrawal by Subject|0|||
125682803|NCT04038580|452128101|FG004|Washout 1|Withdrawal by Subject|1|||
125682804|NCT04038580|452128102|FG005|Washout 1|Withdrawal by Subject|0|||
125682805|NCT04038580|452128097|FG000|Wash-out 2|Withdrawal by Subject|1|||
125682806|NCT04038580|452128098|FG001|Wash-out 2|Withdrawal by Subject|0|||
125682807|NCT04038580|452128099|FG002|Wash-out 2|Withdrawal by Subject|0|||
125682808|NCT04038580|452128100|FG003|Wash-out 2|Withdrawal by Subject|2|||
125682809|NCT04038580|452128101|FG004|Wash-out 2|Withdrawal by Subject|0|||
125682810|NCT04038580|452128102|FG005|Wash-out 2|Withdrawal by Subject|1|||
125682811|NCT04038580|452128097|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
125682812|NCT04038580|452128098|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
125682813|NCT04038580|452128099|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
125682814|NCT04038580|452128100|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
125682815|NCT04038580|452128101|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
125682816|NCT04038580|452128102|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
125682817|NCT04038580|452128097|FG000|Wash-out 3|Withdrawal by Subject|1|||
125682818|NCT04038580|452128098|FG001|Wash-out 3|Withdrawal by Subject|0|||
125682819|NCT04038580|452128099|FG002|Wash-out 3|Withdrawal by Subject|2|||
125682820|NCT04038580|452128100|FG003|Wash-out 3|Withdrawal by Subject|0|||
125682821|NCT04038580|452128101|FG004|Wash-out 3|Withdrawal by Subject|0|||
125551821|NCT00688181|451650724|FG000|Overall Study|Unknown Reason|4|||
125682822|NCT04038580|452128102|FG005|Wash-out 3|Withdrawal by Subject|0|||
125682823|NCT04972162|452128109|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
125682824|NCT04972162|452128110|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
125350061|NCT02361346|450915381|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
125350062|NCT02361346|450915382|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
125350063|NCT02361346|450915383|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
125350064|NCT02361346|450915375|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125350065|NCT02361346|450915376|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125350066|NCT02361346|450915377|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125350067|NCT02361346|450915378|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125350068|NCT02361346|450915379|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
125551822|NCT00688181|451650724|FG000|Overall Study|Non-clinical Reason|2|||
125350069|NCT02361346|450915380|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125350070|NCT02361346|450915381|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125551823|NCT01050205|451650725|FG000|Overall Study|Lost to Follow-up|7|||
125551824|NCT01050205|451650726|FG001|Overall Study|Lost to Follow-up|1|||
125551825|NCT01050205|451650725|FG000|Overall Study|Withdrawal by Subject|1|||
125551826|NCT01050205|451650726|FG001|Overall Study|Withdrawal by Subject|1|||
125551827|NCT01050205|451650725|FG000|Overall Study|Relocated from area|1|||
125350071|NCT02361346|450915382|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125350072|NCT02361346|450915383|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
125551828|NCT01050205|451650726|FG001|Overall Study|Relocated from area|2|||
125551829|NCT01050205|451650725|FG000|Overall Study|Discontinued Intervention|2|||
125551830|NCT01050205|451650726|FG001|Overall Study|Discontinued Intervention|0|||
125551831|NCT01119001|451650727|FG000|Overall Study|Withdrawal by Subject|2|||
125551832|NCT00954421|451650728|FG000|Screening|screen failures|3|||
125551833|NCT00954421|451650728|FG000|6 Months of DBS|Withdrawal by Subject|1|||
125551834|NCT00954421|451650728|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
125551835|NCT00633061|451650729|FG000|Overall Study|Study closed|86|||
125551836|NCT00633061|451650730|FG001|Overall Study|Study closed|0|||
125350073|NCT02361346|450915375|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
125350074|NCT02361346|450915376|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
125350075|NCT02361346|450915377|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
125350076|NCT02361346|450915378|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
125350077|NCT02361346|450915379|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
125350078|NCT02361346|450915380|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
125551837|NCT05245097|451650731|FG000|Overall Study|Adverse Event|13|||
125350079|NCT02361346|450915381|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
125425639|NCT01357616|451182308|FG001|Overall Study|Withdrawal by Subject|0|||
125425640|NCT01699022|451182316|FG000|Overall Study|Early discontinuation from the study|3|||
125425641|NCT02052310|451182317|FG000|Overall Study|Death|64|||
125425642|NCT02052310|451182318|FG001|Overall Study|Death|54|||
125425643|NCT02052310|451182317|FG000|Overall Study|Withdrawal by Subject|37|||
125425644|NCT02052310|451182318|FG001|Overall Study|Withdrawal by Subject|49|||
125551838|NCT05245097|451650732|FG001|Overall Study|Adverse Event|2|||
125682825|NCT03761173|452128111|FG000|Overall Study|Lost to Follow-up|93|||
125682826|NCT03761173|452128111|FG000|Overall Study|Withdrawal by Subject|74|||
125682827|NCT03761173|452128111|FG000|Overall Study|Death|45|||
125682828|NCT03761173|452128111|FG000|Overall Study|Withdrawal for Other Reasons|29|||
125682829|NCT03761173|452128111|FG000|Overall Study|Protocol Violation|1|||
125682830|NCT00336024|452128112|FG000|Overall Study|Death|2|||
125682831|NCT00336024|452128113|FG001|Overall Study|Death|1|||
125682832|NCT00336024|452128112|FG000|Overall Study|Physician Decision|4|||
125682833|NCT00336024|452128113|FG001|Overall Study|Physician Decision|1|||
125682834|NCT00336024|452128112|FG000|Overall Study|Protocol Violation|1|||
125682835|NCT00336024|452128113|FG001|Overall Study|Protocol Violation|0|||
125682836|NCT00336024|452128112|FG000|Overall Study|Withdrawal by Subject|1|||
125682837|NCT00336024|452128113|FG001|Overall Study|Withdrawal by Subject|2|||
125682838|NCT00336024|452128112|FG000|Overall Study|Failure to fulfill consolidation|1|||
125682839|NCT00336024|452128113|FG001|Overall Study|Failure to fulfill consolidation|1|||
125682840|NCT00336024|452128112|FG000|Overall Study|Progressive Disease|4|||
125682841|NCT00336024|452128113|FG001|Overall Study|Progressive Disease|7|||
125682842|NCT00336024|452128112|FG000|Overall Study|Ineligible|7|||
125682843|NCT00336024|452128113|FG001|Overall Study|Ineligible|7|||
125350080|NCT02361346|450915382|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
125350081|NCT02361346|450915383|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
125350082|NCT02361346|450915375|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125350083|NCT02361346|450915376|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125350084|NCT02361346|450915377|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125350085|NCT02361346|450915378|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125350086|NCT02361346|450915379|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125350087|NCT02361346|450915380|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125350088|NCT02361346|450915381|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125350089|NCT02361346|450915382|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
125350090|NCT02361346|450915383|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
125350091|NCT02361346|450915375|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125350092|NCT02361346|450915376|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125350093|NCT02361346|450915377|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125350094|NCT02361346|450915378|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125350095|NCT02361346|450915379|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125350096|NCT02361346|450915380|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125350097|NCT02361346|450915381|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125350098|NCT02361346|450915382|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
125350099|NCT02361346|450915383|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
125350100|NCT02361346|450915375|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125350101|NCT02361346|450915376|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125350102|NCT02361346|450915377|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125350103|NCT02361346|450915378|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125350104|NCT02361346|450915379|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125350105|NCT02361346|450915380|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125350106|NCT02361346|450915381|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125350107|NCT02361346|450915382|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
125350108|NCT02361346|450915383|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
125350109|NCT00782795|450915384|FG000|Overall Study|Withdrawal by Subject|1|||
125350110|NCT00782795|450915385|FG001|Overall Study|Withdrawal by Subject|2|||
125350111|NCT04480424|450915386|FG000|Overall Study|Withdrawal by Subject|0|||
125350112|NCT04480424|450915387|FG001|Overall Study|Withdrawal by Subject|2|||
125350113|NCT04480424|450915386|FG000|Overall Study|Lost to Follow-up|3|||
125350114|NCT04480424|450915387|FG001|Overall Study|Lost to Follow-up|3|||
125350115|NCT04480424|450915386|FG000|Overall Study|Death|14|||
125350116|NCT04480424|450915387|FG001|Overall Study|Death|16|||
125350117|NCT04480424|450915386|FG000|Overall Study|Reason not Specified|5|||
125350118|NCT04480424|450915387|FG001|Overall Study|Reason not Specified|5|||
125682844|NCT03147287|452128249|FG000|Overall Study|Randomized Not Treated|2|||
125682845|NCT03147287|452128250|FG001|Overall Study|Randomized Not Treated|1|||
125682846|NCT03147287|452128251|FG002|Overall Study|Randomized Not Treated|1|||
125682847|NCT03147287|452128249|FG000|Overall Study|Progressive Disease RECIST|31|||
125682848|NCT03147287|452128250|FG001|Overall Study|Progressive Disease RECIST|72|||
125682849|NCT03147287|452128251|FG002|Overall Study|Progressive Disease RECIST|32|||
125682850|NCT03147287|452128249|FG000|Overall Study|Progressive Disease not RECIST|13|||
125350119|NCT02782923|450915388|FG000|Overall Study|Lost to Follow-up|15|||
125350120|NCT00993044|450915390|FG000|Irinotecan 50 mg|Physician Decision|1|||
125350121|NCT00734747|450915391|FG000|SRS Procedure|No staples placed|3|||
125350122|NCT00734747|450915391|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
125350123|NCT00884377|450916964|FG000|Overall Study|Withdrawal by Subject|1|||
125350124|NCT00884377|450916965|FG001|Overall Study|Withdrawal by Subject|0|||
125350125|NCT00884377|450916964|FG000|Overall Study|Could not confirm diagnosis|1|||
125350126|NCT00884377|450916965|FG001|Overall Study|Could not confirm diagnosis|0|||
125350127|NCT00884377|450916964|FG000|Overall Study|Physician Decision|0|||
125350128|NCT00884377|450916965|FG001|Overall Study|Physician Decision|1|||
125350129|NCT02003365|450916966|FG000|Overall Study|Lost to Follow-up|0|||
125350130|NCT02003365|450916967|FG001|Overall Study|Lost to Follow-up|0|||
125350131|NCT02003365|450916968|FG002|Overall Study|Lost to Follow-up|1|||
125350132|NCT00622739|450916969|FG000|Overall Study|Physician Decision|1|||
125350133|NCT00622739|450916970|FG001|Overall Study|Physician Decision|0|||
125350134|NCT00622739|450916969|FG000|Overall Study|Adverse Event|1|||
125350135|NCT00622739|450916970|FG001|Overall Study|Adverse Event|2|||
125350136|NCT00622739|450916969|FG000|Overall Study|Lack of Efficacy|0|||
125350137|NCT00622739|450916970|FG001|Overall Study|Lack of Efficacy|2|||
125350138|NCT00622739|450916969|FG000|Overall Study|Withdrawal by Subject|0|||
125350139|NCT00622739|450916970|FG001|Overall Study|Withdrawal by Subject|1|||
125350140|NCT00622739|450916969|FG000|Overall Study|Lost to Follow-up|0|||
125350141|NCT00622739|450916970|FG001|Overall Study|Lost to Follow-up|1|||
125350142|NCT03387150|450916979|FG000|Overall Study|Withdrawal by Subject|3|||
125350143|NCT03387150|450916980|FG001|Overall Study|Withdrawal by Subject|0|||
125682851|NCT03147287|452128250|FG001|Overall Study|Progressive Disease not RECIST|21|||
125350144|NCT03387150|450916981|FG002|Overall Study|Withdrawal by Subject|3|||
125350145|NCT03387150|450916982|FG003|Overall Study|Withdrawal by Subject|4|||
125350146|NCT03387150|450916983|FG004|Overall Study|Withdrawal by Subject|1|||
125350147|NCT03387150|450916984|FG005|Overall Study|Withdrawal by Subject|2|||
125350148|NCT03387150|450916985|FG006|Overall Study|Withdrawal by Subject|0|||
125350149|NCT03387150|450916979|FG000|Overall Study|Lost to Follow-up|3|||
125350150|NCT03387150|450916980|FG001|Overall Study|Lost to Follow-up|2|||
125350151|NCT03387150|450916981|FG002|Overall Study|Lost to Follow-up|2|||
125350152|NCT03387150|450916982|FG003|Overall Study|Lost to Follow-up|3|||
125350153|NCT03387150|450916983|FG004|Overall Study|Lost to Follow-up|3|||
125350154|NCT03387150|450916984|FG005|Overall Study|Lost to Follow-up|3|||
125350155|NCT03387150|450916985|FG006|Overall Study|Lost to Follow-up|0|||
125350156|NCT03387150|450916979|FG000|Overall Study|Participant unable to adhere to visit|0|||
125350157|NCT03387150|450916980|FG001|Overall Study|Participant unable to adhere to visit|1|||
125350158|NCT03387150|450916981|FG002|Overall Study|Participant unable to adhere to visit|0|||
125350159|NCT03387150|450916982|FG003|Overall Study|Participant unable to adhere to visit|0|||
125682852|NCT03147287|452128251|FG002|Overall Study|Progressive Disease not RECIST|13|||
125682853|NCT03147287|452128249|FG000|Overall Study|Physician Decision|1|||
125682854|NCT03147287|452128250|FG001|Overall Study|Physician Decision|2|||
125682855|NCT03147287|452128251|FG002|Overall Study|Physician Decision|1|||
125682856|NCT03147287|452128249|FG000|Overall Study|Intercurrent illness|0|||
125682857|NCT03147287|452128250|FG001|Overall Study|Intercurrent illness|1|||
125682858|NCT03147287|452128251|FG002|Overall Study|Intercurrent illness|0|||
125682859|NCT03147287|452128249|FG000|Overall Study|Withdrawal by Subject|2|||
125682860|NCT03147287|452128250|FG001|Overall Study|Withdrawal by Subject|3|||
125682861|NCT03147287|452128251|FG002|Overall Study|Withdrawal by Subject|2|||
125682862|NCT03147287|452128249|FG000|Overall Study|Patient Non-Compliance|0|||
125682863|NCT03147287|452128250|FG001|Overall Study|Patient Non-Compliance|2|||
125682864|NCT03147287|452128251|FG002|Overall Study|Patient Non-Compliance|0|||
125682865|NCT03147287|452128249|FG000|Overall Study|Patient moved|0|||
125682866|NCT03147287|452128250|FG001|Overall Study|Patient moved|1|||
125682867|NCT03147287|452128251|FG002|Overall Study|Patient moved|0|||
125682868|NCT03147287|452128249|FG000|Overall Study|Arm A crossover without PD|1|||
125682869|NCT03147287|452128250|FG001|Overall Study|Arm A crossover without PD|0|||
125682870|NCT03147287|452128251|FG002|Overall Study|Arm A crossover without PD|0|||
125682871|NCT03147287|452128249|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
125682872|NCT03147287|452128250|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
125682873|NCT03147287|452128251|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
125682874|NCT03556891|452128276|FG000|Initial Pivotal Study|Adverse Event|4|||
125682875|NCT03556891|452128276|FG000|Initial Pivotal Study|MRI Need|3|||
125682876|NCT03556891|452128276|FG000|Initial Pivotal Study|Device Failure|1|||
125682877|NCT03556891|452128276|FG000|Initial Pivotal Study|Death|1|||
125682878|NCT03556891|452128276|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
125682879|NCT03556891|452128276|FG000|Initial Pivotal Study|Missing at random|1|||
125350160|NCT03387150|450916983|FG004|Overall Study|Participant unable to adhere to visit|2|||
125350161|NCT03387150|450916984|FG005|Overall Study|Participant unable to adhere to visit|2|||
125682880|NCT03556891|452128276|FG000|Initial Pivotal Study|Missing due to COVID|1|||
125682881|NCT03556891|452128276|FG000|Initial Pivotal Study|Protocol Violation|1|||
125551839|NCT05245097|451650731|FG000|Overall Study|Protocol Violation|8|||
125551840|NCT05245097|451650732|FG001|Overall Study|Protocol Violation|6|||
125551841|NCT05245097|451650731|FG000|Overall Study|Withdrawal by Subject|18|||
125551842|NCT05245097|451650732|FG001|Overall Study|Withdrawal by Subject|0|||
125551843|NCT05245097|451650731|FG000|Overall Study|Death|6|||
125551844|NCT05245097|451650732|FG001|Overall Study|Death|7|||
125551845|NCT05245097|451650731|FG000|Overall Study|Physician Decision|6|||
125551846|NCT05245097|451650732|FG001|Overall Study|Physician Decision|0|||
125551847|NCT05245097|451650731|FG000|Overall Study|Relocation|4|||
125551848|NCT05245097|451650732|FG001|Overall Study|Relocation|3|||
125551849|NCT00607022|451650740|FG000|Overall Study|Withdrawal by Subject|1|||
125551850|NCT00607022|451650741|FG001|Overall Study|Withdrawal by Subject|0|||
125551851|NCT00607022|451650742|FG002|Overall Study|Withdrawal by Subject|0|||
125551852|NCT00810394|451650743|FG000|Overall Study|Withdrawal by Subject|3|||
125551853|NCT03254485|451650744|FG000|Overall Study|Adverse Event|3|||
125551854|NCT03254485|451650745|FG001|Overall Study|Adverse Event|0|||
125551855|NCT03254485|451650746|FG002|Overall Study|Adverse Event|0|||
125551856|NCT03254485|451650747|FG003|Overall Study|Adverse Event|6|||
125551857|NCT03254485|451650744|FG000|Overall Study|Protocol Violation|6|||
125551858|NCT03254485|451650745|FG001|Overall Study|Protocol Violation|0|||
125551859|NCT03254485|451650746|FG002|Overall Study|Protocol Violation|0|||
125551860|NCT03254485|451650747|FG003|Overall Study|Protocol Violation|2|||
125551861|NCT03254485|451650744|FG000|Overall Study|Withdrawal by Subject|1|||
125551862|NCT03254485|451650745|FG001|Overall Study|Withdrawal by Subject|0|||
125551863|NCT03254485|451650746|FG002|Overall Study|Withdrawal by Subject|0|||
125551864|NCT03254485|451650747|FG003|Overall Study|Withdrawal by Subject|4|||
125551865|NCT03254485|451650744|FG000|Overall Study|Death|0|||
125551866|NCT03254485|451650745|FG001|Overall Study|Death|0|||
125551867|NCT03254485|451650746|FG002|Overall Study|Death|0|||
125551868|NCT03254485|451650747|FG003|Overall Study|Death|1|||
125551869|NCT03254485|451650744|FG000|Overall Study|Lost to Follow-up|1|||
125551870|NCT03254485|451650745|FG001|Overall Study|Lost to Follow-up|0|||
125551871|NCT03254485|451650746|FG002|Overall Study|Lost to Follow-up|0|||
125551872|NCT03254485|451650747|FG003|Overall Study|Lost to Follow-up|0|||
125551873|NCT03254485|451650744|FG000|Overall Study|Other|1|||
125551874|NCT03254485|451650745|FG001|Overall Study|Other|0|||
125551875|NCT03254485|451650746|FG002|Overall Study|Other|0|||
125551876|NCT03254485|451650747|FG003|Overall Study|Other|2|||
125551877|NCT00467285|451650748|FG000|Overall Study|Lost to Follow-up|4|||
125551878|NCT00467285|451650749|FG001|Overall Study|Lost to Follow-up|4|||
125551879|NCT01658826|451650763|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
125551880|NCT01658826|451650764|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
125551881|NCT01658826|451650763|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
125551882|NCT01658826|451650764|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
125551883|NCT01658826|451650763|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
125551884|NCT01658826|451650764|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
125551885|NCT01658826|451650763|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
125551886|NCT01658826|451650764|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
125551887|NCT01658826|451650763|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
125551888|NCT01658826|451650764|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
125551889|NCT01658826|451650763|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
125551890|NCT01658826|451650764|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
125551891|NCT01658826|451650763|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
125551892|NCT01658826|451650764|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
125551893|NCT01658826|451650763|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
125551894|NCT01658826|451650764|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
125551895|NCT01658826|451650763|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
125551896|NCT01658826|451650764|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
125551897|NCT01598311|451650766|FG000|Overall Study|Physician Decision|4|||
125551898|NCT01598311|451650767|FG001|Overall Study|Physician Decision|5|||
125551899|NCT01598311|451650766|FG000|Overall Study|Adverse Event|9|||
125551900|NCT01598311|451650767|FG001|Overall Study|Adverse Event|13|||
125551901|NCT01598311|451650766|FG000|Overall Study|Lost to Follow-up|7|||
125551902|NCT01598311|451650767|FG001|Overall Study|Lost to Follow-up|12|||
125551903|NCT01598311|451650766|FG000|Overall Study|Withdrawal by Subject|9|||
125551904|NCT01598311|451650767|FG001|Overall Study|Withdrawal by Subject|13|||
125551905|NCT01598311|451650766|FG000|Overall Study|No reason provided.|0|||
125551906|NCT01598311|451650767|FG001|Overall Study|No reason provided.|5|||
125551907|NCT01598311|451650766|FG000|Overall Study|Randomized but never treated|8|||
125551908|NCT01598311|451650767|FG001|Overall Study|Randomized but never treated|5|||
125551909|NCT01598311|451650766|FG000|Overall Study|Treated but no confirmed CDAD|9|||
125551910|NCT01598311|451650767|FG001|Overall Study|Treated but no confirmed CDAD|8|||
125551911|NCT01598311|451650766|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
125551912|NCT01598311|451650767|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
125551913|NCT00658684|451650768|FG000|Overall Study|Adverse Event|10|||
125551914|NCT00658684|451650769|FG001|Overall Study|Adverse Event|8|||
125551915|NCT00658684|451650770|FG002|Overall Study|Adverse Event|2|||
125551916|NCT00658684|451650771|FG003|Overall Study|Adverse Event|0|||
125551917|NCT00658684|451650768|FG000|Overall Study|Withdrawal by Subject|6|||
125551918|NCT00658684|451650769|FG001|Overall Study|Withdrawal by Subject|4|||
125551919|NCT00658684|451650770|FG002|Overall Study|Withdrawal by Subject|1|||
125551920|NCT00658684|451650771|FG003|Overall Study|Withdrawal by Subject|1|||
125551921|NCT00658684|451650768|FG000|Overall Study|Lack of Efficacy|1|||
125551922|NCT00658684|451650769|FG001|Overall Study|Lack of Efficacy|1|||
125551923|NCT00658684|451650770|FG002|Overall Study|Lack of Efficacy|0|||
125551924|NCT00658684|451650771|FG003|Overall Study|Lack of Efficacy|0|||
125551925|NCT00658684|451650768|FG000|Overall Study|Protocol Violation|1|||
125551926|NCT00658684|451650769|FG001|Overall Study|Protocol Violation|1|||
125551927|NCT00658684|451650770|FG002|Overall Study|Protocol Violation|0|||
125551928|NCT00658684|451650771|FG003|Overall Study|Protocol Violation|0|||
125551929|NCT00658684|451650768|FG000|Overall Study|Pregnancy|1|||
125551930|NCT00658684|451650769|FG001|Overall Study|Pregnancy|1|||
125551931|NCT00658684|451650770|FG002|Overall Study|Pregnancy|0|||
125551932|NCT00658684|451650771|FG003|Overall Study|Pregnancy|0|||
125551933|NCT06515483|451650774|FG000|Overall Study|Subject withdraw due to family issues|1|||
125551934|NCT06515483|451650775|FG001|Overall Study|Subject withdraw due to family issues|0|||
125551935|NCT05677893|451652227|FG000|Overall Study|Withdrawal by Subject|0|||
125551936|NCT05677893|451652228|FG001|Overall Study|Withdrawal by Subject|0|||
125551937|NCT05677893|451652229|FG002|Overall Study|Withdrawal by Subject|0|||
125551938|NCT05677893|451652230|FG003|Overall Study|Withdrawal by Subject|0|||
125551939|NCT05677893|451652231|FG004|Overall Study|Withdrawal by Subject|1|||
125551940|NCT05677893|451652232|FG005|Overall Study|Withdrawal by Subject|1|||
125551941|NCT05677893|451652233|FG006|Overall Study|Withdrawal by Subject|0|||
125551942|NCT05677893|451652227|FG000|Overall Study|Others|1|||
125551943|NCT05677893|451652228|FG001|Overall Study|Others|0|||
125551944|NCT05677893|451652229|FG002|Overall Study|Others|0|||
125551945|NCT05677893|451652230|FG003|Overall Study|Others|0|||
125551946|NCT05677893|451652231|FG004|Overall Study|Others|0|||
125551947|NCT05677893|451652232|FG005|Overall Study|Others|0|||
125551948|NCT05677893|451652233|FG006|Overall Study|Others|0|||
125551949|NCT02101034|451652234|FG000|Overall Study|Enrolled but did not start treatment|0|||
125551950|NCT02101034|451652235|FG001|Overall Study|Enrolled but did not start treatment|0|||
125551951|NCT02101034|451652236|FG002|Overall Study|Enrolled but did not start treatment|1|||
125551952|NCT02101034|451652237|FG003|Overall Study|Enrolled but did not start treatment|0|||
125551953|NCT02101034|451652238|FG004|Overall Study|Enrolled but did not start treatment|0|||
125551954|NCT01103245|451652243|FG000|Overall Study|Withdrawal by Subject|1|||
125551955|NCT01103245|451652244|FG001|Overall Study|Withdrawal by Subject|0|||
125551956|NCT01103245|451652245|FG002|Overall Study|Withdrawal by Subject|3|||
125551957|NCT01103245|451652246|FG003|Overall Study|Withdrawal by Subject|0|||
125551958|NCT01103245|451652243|FG000|Overall Study|Inadequate IV access|1|||
125551959|NCT01103245|451652244|FG001|Overall Study|Inadequate IV access|0|||
125551960|NCT01103245|451652245|FG002|Overall Study|Inadequate IV access|0|||
125551961|NCT01103245|451652246|FG003|Overall Study|Inadequate IV access|0|||
125551962|NCT01103245|451652243|FG000|Overall Study|Adverse Event|0|||
125551963|NCT01103245|451652244|FG001|Overall Study|Adverse Event|2|||
125551964|NCT01103245|451652245|FG002|Overall Study|Adverse Event|1|||
125551965|NCT01103245|451652246|FG003|Overall Study|Adverse Event|0|||
125551966|NCT01103245|451652243|FG000|Overall Study|Physician Decision|1|||
125551967|NCT01103245|451652244|FG001|Overall Study|Physician Decision|0|||
125551968|NCT01103245|451652245|FG002|Overall Study|Physician Decision|0|||
125551969|NCT01103245|451652246|FG003|Overall Study|Physician Decision|0|||
125551970|NCT00720941|451652247|FG000|Overall Study|Protocol Violation|1|||
125551971|NCT00720941|451652248|FG001|Overall Study|Protocol Violation|2|||
125551972|NCT00720941|451652247|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
125551973|NCT00720941|451652248|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
125551974|NCT00720941|451652247|FG000|Overall Study|Lost to Follow-up|20|||
125551975|NCT00720941|451652248|FG001|Overall Study|Lost to Follow-up|15|||
125551976|NCT00720941|451652247|FG000|Overall Study|Physician Decision|14|||
125551977|NCT00720941|451652248|FG001|Overall Study|Physician Decision|12|||
125551978|NCT00720941|451652247|FG000|Overall Study|Withdrawal by Subject|29|||
125551979|NCT00720941|451652248|FG001|Overall Study|Withdrawal by Subject|36|||
125551980|NCT00604279|451652249|FG000|Overall Study|Lack of Efficacy|22|||
125551981|NCT00604279|451652250|FG001|Overall Study|Lack of Efficacy|9|||
125551982|NCT00604279|451652249|FG000|Overall Study|Lost to Follow-up|9|||
125551983|NCT00604279|451652250|FG001|Overall Study|Lost to Follow-up|14|||
125551984|NCT00604279|451652249|FG000|Overall Study|Pregnancy|2|||
125551985|NCT00604279|451652250|FG001|Overall Study|Pregnancy|0|||
125551986|NCT00604279|451652249|FG000|Overall Study|Protocol Violation|3|||
125551987|NCT00604279|451652250|FG001|Overall Study|Protocol Violation|1|||
125551988|NCT00604279|451652249|FG000|Overall Study|Withdrawal by Subject|16|||
125551989|NCT00604279|451652250|FG001|Overall Study|Withdrawal by Subject|5|||
125551990|NCT00604279|451652249|FG000|Overall Study|Adverse Event|4|||
125551991|NCT00604279|451652250|FG001|Overall Study|Adverse Event|5|||
125551992|NCT00604279|451652249|FG000|Overall Study|Other|8|||
125551993|NCT00604279|451652250|FG001|Overall Study|Other|4|||
125551994|NCT00355056|451652251|FG000|Randomization Period|Early Termination|4|||
125551995|NCT00355056|451652252|FG001|Randomization Period|Early Termination|6|||
125551996|NCT01072877|451652253|FG000|Overall Study|Lost to Follow-up|1|||
125551997|NCT01072877|451652254|FG001|Overall Study|Lost to Follow-up|1|||
125551998|NCT01072877|451652255|FG002|Overall Study|Lost to Follow-up|0|||
125551999|NCT01072877|451652256|FG003|Overall Study|Lost to Follow-up|2|||
125552000|NCT01072877|451652257|FG004|Overall Study|Lost to Follow-up|0|||
125552001|NCT02720536|451652258|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
125552002|NCT02720536|451652258|FG000|Overall Study|PR - pregnancy|2|||
125552003|NCT02720536|451652258|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
125552004|NCT02720536|451652258|FG000|Overall Study|PR - death|1|||
125552005|NCT02720536|451652258|FG000|Overall Study|PR - adverse event|1|||
125552006|NCT02720536|451652258|FG000|Overall Study|PR - abnormal lab value(s)|1|||
125552007|NCT02720536|451652258|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
125552008|NCT01717989|451652261|FG000|Overall Study|Ineligibility determined|6|||
125552009|NCT01717989|451652261|FG000|Overall Study|Protocol deviation|6|||
125552010|NCT01717989|451652261|FG000|Overall Study|Withdrawal by Subject|11|||
125552011|NCT01717989|451652261|FG000|Overall Study|Physician Decision|2|||
125552012|NCT01717989|451652261|FG000|Overall Study|Lost to Follow-up|11|||
125552013|NCT01717989|451652261|FG000|Overall Study|Death|439|||
125552014|NCT01717989|451652261|FG000|Overall Study|Protocol-specified criteria|551|||
125552015|NCT01717989|451652261|FG000|Overall Study|Other|40|||
125552016|NCT03224325|451652262|FG000|Overall Study|Adverse Event|1|||
125552017|NCT03224325|451652263|FG001|Overall Study|Adverse Event|0|||
125552018|NCT03224325|451652264|FG002|Overall Study|Adverse Event|0|||
125552019|NCT03224325|451652265|FG003|Overall Study|Adverse Event|0|||
125552020|NCT03224325|451652266|FG004|Overall Study|Adverse Event|0|||
125552021|NCT03224325|451652267|FG005|Overall Study|Adverse Event|0|||
125552022|NCT03224325|451652268|FG006|Overall Study|Adverse Event|1|||
125552023|NCT03224325|451652262|FG000|Overall Study|Withdrawal by Subject|0|||
125552024|NCT03224325|451652263|FG001|Overall Study|Withdrawal by Subject|0|||
125552025|NCT03224325|451652264|FG002|Overall Study|Withdrawal by Subject|0|||
125552026|NCT03224325|451652265|FG003|Overall Study|Withdrawal by Subject|1|||
125350162|NCT03387150|450916985|FG006|Overall Study|Participant unable to adhere to visit|0|||
125350163|NCT01275339|450916986|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
125350164|NCT01275339|450916987|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
125350165|NCT01275339|450916988|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
125350166|NCT01275339|450916989|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
125350167|NCT01275339|450916986|FG000|Overall Study|Withdrawal by Subject|0|||
125350168|NCT01275339|450916987|FG001|Overall Study|Withdrawal by Subject|0|||
125350169|NCT01275339|450916988|FG002|Overall Study|Withdrawal by Subject|1|||
125552027|NCT03224325|451652266|FG004|Overall Study|Withdrawal by Subject|0|||
125552028|NCT03224325|451652267|FG005|Overall Study|Withdrawal by Subject|0|||
125552029|NCT03224325|451652268|FG006|Overall Study|Withdrawal by Subject|0|||
125552030|NCT02120625|451652270|FG000|Overall Study|Physician Decision|2|||
125552031|NCT00820027|451652271|FG000|Overall Study|Adverse Event|15|||
125552032|NCT00820027|451652272|FG001|Overall Study|Adverse Event|8|||
125552033|NCT00820027|451652273|FG002|Overall Study|Adverse Event|10|||
125552034|NCT00820027|451652274|FG003|Overall Study|Adverse Event|5|||
125552035|NCT00820027|451652271|FG000|Overall Study|Lack of Efficacy|2|||
125552036|NCT00820027|451652272|FG001|Overall Study|Lack of Efficacy|1|||
125552037|NCT00820027|451652273|FG002|Overall Study|Lack of Efficacy|2|||
125552038|NCT00820027|451652274|FG003|Overall Study|Lack of Efficacy|2|||
125552039|NCT00820027|451652271|FG000|Overall Study|Physician Decision|0|||
125552040|NCT00820027|451652272|FG001|Overall Study|Physician Decision|1|||
125552041|NCT00820027|451652273|FG002|Overall Study|Physician Decision|1|||
125552042|NCT00820027|451652274|FG003|Overall Study|Physician Decision|0|||
125552043|NCT00820027|451652271|FG000|Overall Study|Protocol Violation|3|||
125552044|NCT00820027|451652272|FG001|Overall Study|Protocol Violation|0|||
125552045|NCT00820027|451652273|FG002|Overall Study|Protocol Violation|4|||
125552046|NCT00820027|451652274|FG003|Overall Study|Protocol Violation|0|||
125552047|NCT00820027|451652271|FG000|Overall Study|Withdrawal by Subject|6|||
125552048|NCT00820027|451652272|FG001|Overall Study|Withdrawal by Subject|4|||
125552049|NCT00820027|451652273|FG002|Overall Study|Withdrawal by Subject|4|||
125552050|NCT00820027|451652274|FG003|Overall Study|Withdrawal by Subject|6|||
125552051|NCT03181451|451652277|FG000|Overall Study|Adverse Event|0|||
125552052|NCT03181451|451652278|FG001|Overall Study|Adverse Event|1|||
125552053|NCT03181451|451652279|FG002|Overall Study|Adverse Event|0|||
125552054|NCT03181451|451652277|FG000|Overall Study|Withdrawal by Subject|0|||
125552055|NCT03181451|451652278|FG001|Overall Study|Withdrawal by Subject|1|||
125552056|NCT03181451|451652279|FG002|Overall Study|Withdrawal by Subject|0|||
125552057|NCT00752622|451652292|FG000|Induction Phase|Adverse Event|3|||
125552058|NCT00752622|451652292|FG000|Induction Phase|Other|3|||
125552059|NCT00752622|451652292|FG000|Induction Phase|Non-responder|14|||
125552060|NCT00752622|451652292|FG000|Induction Phase|Withdrawal by Subject|1|||
125552061|NCT00752622|451652292|FG000|Induction Phase|Premature study termination|14|||
125552062|NCT00752622|451652292|FG000|Observational Phase|Premature Study Termination|36|||
125552063|NCT00752622|451652292|FG000|Observational Phase|Non-responder|2|||
125552064|NCT00752622|451652292|FG000|Observational Phase|Withdrawal by Subject|2|||
125552065|NCT00752622|451652292|FG000|Observational Phase|Adverse Event|1|||
125552066|NCT00752622|451652292|FG000|Observational Phase|Other|2|||
125552067|NCT00752622|451652292|FG000|Interventional Phase|Non-responder|2|||
125552068|NCT00752622|451652292|FG000|Interventional Phase|Physician Decision|1|||
125552069|NCT00752622|451652292|FG000|Interventional Phase|Premature Study Termination|5|||
125552070|NCT00576836|451652293|FG000|Overall Study|Death|0|||
125552071|NCT00576836|451652294|FG001|Overall Study|Death|1|||
125552072|NCT00576836|451652293|FG000|Overall Study|Physician Decision|0|||
125552073|NCT00576836|451652294|FG001|Overall Study|Physician Decision|1|||
125552074|NCT02520284|451652295|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
125552075|NCT02520284|451652296|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
125552076|NCT02520284|451652297|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
125552077|NCT02520284|451652295|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
125552078|NCT02520284|451652296|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
125552079|NCT02520284|451652297|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
125552080|NCT02520284|451652295|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
125552081|NCT02520284|451652296|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
125425645|NCT02052310|451182317|FG000|Overall Study|Other than specified|32|||
125425646|NCT02052310|451182318|FG001|Overall Study|Other than specified|29|||
125425647|NCT02052310|451182317|FG000|Overall Study|Adverse Event|29|||
125425648|NCT02052310|451182318|FG001|Overall Study|Adverse Event|22|||
125425649|NCT02052310|451182317|FG000|Overall Study|Kidney Transplant|23|||
125425650|NCT02052310|451182318|FG001|Overall Study|Kidney Transplant|29|||
125425651|NCT02052310|451182317|FG000|Overall Study|Physician Decision|14|||
125425652|NCT02052310|451182318|FG001|Overall Study|Physician Decision|7|||
125425653|NCT02052310|451182317|FG000|Overall Study|Lack of Efficacy|6|||
125425654|NCT02052310|451182318|FG001|Overall Study|Lack of Efficacy|1|||
125552082|NCT02520284|451652297|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
125552083|NCT02520284|451652295|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
125552084|NCT02520284|451652296|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
125552085|NCT02520284|451652297|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
125552086|NCT02520284|451652295|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
125552087|NCT02520284|451652296|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
125552088|NCT02520284|451652297|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
125552089|NCT02520284|451652295|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
125425655|NCT02052310|451182317|FG000|Overall Study|Site Terminated by Sponsor|5|||
125425656|NCT02052310|451182318|FG001|Overall Study|Site Terminated by Sponsor|13|||
125425657|NCT02052310|451182317|FG000|Overall Study|Lost to Follow-up|4|||
125552090|NCT02520284|451652296|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
125552091|NCT02520284|451652297|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
125552092|NCT02520284|451652295|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
125552093|NCT02520284|451652296|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
125552094|NCT02520284|451652297|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
125425658|NCT02052310|451182318|FG001|Overall Study|Lost to Follow-up|2|||
125552095|NCT02520284|451652295|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
125552096|NCT02520284|451652296|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
125552097|NCT02520284|451652297|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
125552098|NCT02520284|451652295|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
125552099|NCT02520284|451652296|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
125552100|NCT02520284|451652297|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
125552101|NCT02520284|451652295|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
125552102|NCT02520284|451652296|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
125552103|NCT02520284|451652297|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
125552104|NCT02520284|451652295|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
125552105|NCT02520284|451652296|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
125552106|NCT02520284|451652297|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
125552107|NCT01211522|451652301|FG000|Overall Study|Withdrawal by Subject|3|||
125552108|NCT01211522|451652302|FG001|Overall Study|Withdrawal by Subject|7|||
125552109|NCT01211522|451652303|FG002|Overall Study|Withdrawal by Subject|5|||
125552110|NCT01116882|451652309|FG000|30-day|Lost to Follow-up|50|||
125552111|NCT01116882|451652310|FG001|30-day|Lost to Follow-up|21|||
125552112|NCT01116882|451652309|FG000|30-day|Withdrawal by Subject|2|||
125552113|NCT01116882|451652310|FG001|30-day|Withdrawal by Subject|4|||
125552114|NCT01116882|451652309|FG000|30-day|Other Reasons|16|||
125552115|NCT01116882|451652310|FG001|30-day|Other Reasons|6|||
125552116|NCT01116882|451652309|FG000|12-month|Lost to Follow-up|111|||
125552117|NCT01116882|451652310|FG001|12-month|Lost to Follow-up|42|||
125552118|NCT01116882|451652309|FG000|12-month|Other Reasons|151|||
125552119|NCT01116882|451652310|FG001|12-month|Other Reasons|49|||
125552120|NCT01116882|451652309|FG000|12-month|Withdrawal by Subject|5|||
125552121|NCT01116882|451652310|FG001|12-month|Withdrawal by Subject|8|||
125552122|NCT00547365|451652311|FG000|Overall Study|Physician Decision|1|||
125552123|NCT00547365|451652311|FG000|Overall Study|Lost to Follow-up|1|||
125552124|NCT00547365|451652311|FG000|Overall Study|Protocol Violation|2|||
125552125|NCT00547365|451652311|FG000|Overall Study|death (not related to study)|4|||
125552126|NCT01139658|451652312|FG000|Overall Study|Adverse Event|10|||
125552127|NCT01139658|451652313|FG001|Overall Study|Adverse Event|27|||
125552128|NCT01139658|451652312|FG000|Overall Study|Lack of Efficacy|15|||
125552129|NCT01139658|451652313|FG001|Overall Study|Lack of Efficacy|7|||
125552130|NCT01139658|451652312|FG000|Overall Study|Withdrawal by Subject|2|||
125552131|NCT01139658|451652313|FG001|Overall Study|Withdrawal by Subject|4|||
125552132|NCT01139658|451652312|FG000|Overall Study|No documentation of treatment|1|||
125552133|NCT01139658|451652313|FG001|Overall Study|No documentation of treatment|0|||
125552134|NCT01139658|451652312|FG000|Overall Study|Other|28|||
125552135|NCT01139658|451652313|FG001|Overall Study|Other|75|||
125552136|NCT00504881|451652314|FG000|Overall Study|Lack of Efficacy|1|||
125552137|NCT00504881|451652315|FG001|Overall Study|Lack of Efficacy|5|||
125552138|NCT00504881|451652314|FG000|Overall Study|Lost to Follow-up|0|||
125552139|NCT00504881|451652315|FG001|Overall Study|Lost to Follow-up|2|||
125552140|NCT00504881|451652314|FG000|Overall Study|Withdrawal by Subject|1|||
125552141|NCT00504881|451652315|FG001|Overall Study|Withdrawal by Subject|4|||
125552142|NCT00504881|451652314|FG000|Overall Study|Non-Compliance|1|||
125552143|NCT00504881|451652315|FG001|Overall Study|Non-Compliance|0|||
125552144|NCT00504881|451652314|FG000|Overall Study|No Birth Control|0|||
125552145|NCT00504881|451652315|FG001|Overall Study|No Birth Control|1|||
125552146|NCT00504881|451652314|FG000|Overall Study|Safety Visit not performed|0|||
125552147|NCT00504881|451652315|FG001|Overall Study|Safety Visit not performed|1|||
125552148|NCT00504881|451652314|FG000|Overall Study|AE, serious fatal|0|||
125552149|NCT00504881|451652315|FG001|Overall Study|AE, serious fatal|1|||
125552150|NCT00504881|451652314|FG000|Overall Study|SAE, non-fatal|2|||
125552151|NCT00504881|451652315|FG001|Overall Study|SAE, non-fatal|6|||
125552152|NCT00504881|451652314|FG000|Overall Study|AE, non-serious non-fatal|4|||
125552153|NCT00504881|451652315|FG001|Overall Study|AE, non-serious non-fatal|14|||
125552154|NCT00504881|451652314|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
125552155|NCT00504881|451652315|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
125350170|NCT01275339|450916989|FG003|Overall Study|Withdrawal by Subject|0|||
125350171|NCT02469038|450916990|FG000|Overall Study|Physician Decision|4|||
125552156|NCT00504881|451652314|FG000|Overall Study|AE of unknown type|1|||
125552157|NCT00504881|451652315|FG001|Overall Study|AE of unknown type|0|||
125552158|NCT01777269|451652316|FG000|Overall Study|Adverse Event|24|||
125552159|NCT01777269|451652317|FG001|Overall Study|Adverse Event|33|||
125552160|NCT01777269|451652316|FG000|Overall Study|Lack of Efficacy|8|||
125552161|NCT01777269|451652317|FG001|Overall Study|Lack of Efficacy|10|||
125552162|NCT01777269|451652316|FG000|Overall Study|Protocol Violation|4|||
125552163|NCT01777269|451652317|FG001|Overall Study|Protocol Violation|4|||
125552164|NCT01777269|451652316|FG000|Overall Study|Participants reached stopping criteria|1|||
125552165|NCT01777269|451652317|FG001|Overall Study|Participants reached stopping criteria|1|||
125552166|NCT01777269|451652316|FG000|Overall Study|Lost to Follow-up|4|||
125552167|NCT01777269|451652317|FG001|Overall Study|Lost to Follow-up|0|||
125552168|NCT01777269|451652316|FG000|Overall Study|Physician Decision|5|||
125552169|NCT01777269|451652317|FG001|Overall Study|Physician Decision|2|||
125552170|NCT01777269|451652316|FG000|Overall Study|Withdrawal by Subject|9|||
125552171|NCT01777269|451652317|FG001|Overall Study|Withdrawal by Subject|9|||
125552172|NCT00593957|451652322|FG000|Overall Study|Physician Decision|0|||
125552173|NCT00593957|451652323|FG001|Overall Study|Physician Decision|1|||
125552174|NCT00593957|451652324|FG002|Overall Study|Physician Decision|2|||
125552175|NCT00494481|451652327|FG000|Overall Study|Condition under investigation worsened|11|||
125552176|NCT00494481|451652328|FG001|Overall Study|Condition under investigation worsened|13|||
125552177|NCT00494481|451652327|FG000|Overall Study|Adverse Event|15|||
125552178|NCT00494481|451652328|FG001|Overall Study|Adverse Event|11|||
125552179|NCT00494481|451652327|FG000|Overall Study|Other|1|||
125552180|NCT00494481|451652328|FG001|Overall Study|Other|0|||
125552181|NCT00494481|451652327|FG000|Overall Study|Never received IP|2|||
125552182|NCT00494481|451652328|FG001|Overall Study|Never received IP|0|||
125552183|NCT00332189|451652329|FG000|Overall Study|Adverse Event|3|||
125552184|NCT00332189|451652329|FG000|Overall Study|Uncooperative/Noncompliant|3|||
125552185|NCT00332189|451652329|FG000|Overall Study|Withdrawal by Subject|9|||
125552186|NCT00332189|451652329|FG000|Overall Study|Lack of Efficacy|4|||
125552187|NCT00332189|451652329|FG000|Overall Study|Moved out of country|2|||
125552188|NCT02279862|451652330|FG000|Overall Study|Study drug toxicity|3|||
125552189|NCT02279862|451652331|FG001|Overall Study|Study drug toxicity|6|||
125552190|NCT02279862|451652330|FG000|Overall Study|No longer meets criteria|0|||
125552191|NCT02279862|451652331|FG001|Overall Study|No longer meets criteria|1|||
125552192|NCT02279862|451652330|FG000|Overall Study|Administrative reason by sponsor|0|||
125552193|NCT02279862|451652331|FG001|Overall Study|Administrative reason by sponsor|1|||
125552194|NCT02279862|451652330|FG000|Overall Study|Disease progression|5|||
125552195|NCT02279862|451652331|FG001|Overall Study|Disease progression|2|||
125552196|NCT02279862|451652330|FG000|Overall Study|Study closed by sponsor|16|||
125552197|NCT02279862|451652331|FG001|Overall Study|Study closed by sponsor|13|||
125552198|NCT02279862|451652330|FG000|Overall Study|Other|1|||
125552199|NCT02279862|451652331|FG001|Overall Study|Other|2|||
125552200|NCT02279862|451652330|FG000|Overall Study|Withdrawal by Subject|1|||
125552201|NCT02279862|451652331|FG001|Overall Study|Withdrawal by Subject|0|||
125552202|NCT01163721|451652332|FG000|Overall Study|Adverse Event|5|||
125552203|NCT01163721|451652333|FG001|Overall Study|Adverse Event|6|||
125552204|NCT01163721|451652332|FG000|Overall Study|Withdrawal by Subject|3|||
125552205|NCT01163721|451652333|FG001|Overall Study|Withdrawal by Subject|4|||
125552206|NCT01163721|451652332|FG000|Overall Study|Lost to Follow-up|0|||
125552207|NCT01163721|451652333|FG001|Overall Study|Lost to Follow-up|1|||
125552208|NCT01163721|451652332|FG000|Overall Study|Physician Decision|0|||
125552209|NCT01163721|451652333|FG001|Overall Study|Physician Decision|1|||
125552210|NCT02511678|451652334|FG000|Overall Study|Withdrawal by Subject|2|||
125552211|NCT02511678|451652334|FG000|Overall Study|Lost to Follow-up|4|||
125552212|NCT02511678|451652334|FG000|Overall Study|Death|19|||
125552213|NCT02511678|451652334|FG000|Overall Study|Adverse Event|1|||
125552214|NCT02511678|451652334|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
125552215|NCT02511678|451652334|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
125552216|NCT02511678|451652334|FG000|Overall Study|Required Radiofrequency Ablation|1|||
125552217|NCT02511678|451652334|FG000|Overall Study|Biopsy was Negative|1|||
125552218|NCT02511678|451652334|FG000|Overall Study|Protocol Violation|1|||
125552219|NCT02511678|451652334|FG000|Overall Study|Received Radiation Treatment|1|||
125552220|NCT01295281|451652335|FG000|First Intervention (7 Days)|Death|0|||
125552221|NCT01295281|451652336|FG001|First Intervention (7 Days)|Death|1|||
125552222|NCT01411839|451652338|FG000|Overall Study|Lost to Follow-up|4|||
125552223|NCT01411839|451652339|FG001|Overall Study|Lost to Follow-up|3|||
125552224|NCT05461794|451652342|FG000|Overall Study|Withdrawal by Subject|1|||
125552225|NCT05461794|451652343|FG001|Overall Study|Withdrawal by Subject|1|||
125552226|NCT05461794|451652344|FG002|Overall Study|Withdrawal by Subject|3|||
125552227|NCT05461794|451652342|FG000|Overall Study|Study Terminated By Sponsor|18|||
125552228|NCT05461794|451652343|FG001|Overall Study|Study Terminated By Sponsor|13|||
125552229|NCT05461794|451652344|FG002|Overall Study|Study Terminated By Sponsor|16|||
125552230|NCT05461794|451652342|FG000|Overall Study|Death|20|||
125552231|NCT05461794|451652343|FG001|Overall Study|Death|5|||
125552232|NCT05461794|451652344|FG002|Overall Study|Death|19|||
125552233|NCT02684357|451652345|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
125552234|NCT02684357|451652346|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
125552235|NCT02684357|451652347|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
125552236|NCT02684357|451652348|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
125552237|NCT02684357|451652349|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
125552238|NCT02684357|451652350|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
125552239|NCT02684357|451652345|FG000|Part A|Lost to Follow-up|0|||
125552240|NCT02684357|451652346|FG001|Part A|Lost to Follow-up|2|||
125552241|NCT02684357|451652347|FG002|Part A|Lost to Follow-up|2|||
125552242|NCT02684357|451652348|FG003|Part A|Lost to Follow-up|0|||
125552243|NCT02684357|451652349|FG004|Part A|Lost to Follow-up|0|||
125552244|NCT02684357|451652350|FG005|Part A|Lost to Follow-up|0|||
125552245|NCT02684357|451652345|FG000|Part A|Withdrawal by Subject|3|||
125552246|NCT02684357|451652346|FG001|Part A|Withdrawal by Subject|0|||
125552247|NCT02684357|451652347|FG002|Part A|Withdrawal by Subject|0|||
125552248|NCT02684357|451652348|FG003|Part A|Withdrawal by Subject|0|||
125552249|NCT02684357|451652349|FG004|Part A|Withdrawal by Subject|0|||
125552250|NCT02684357|451652350|FG005|Part A|Withdrawal by Subject|0|||
125552251|NCT02684357|451652345|FG000|Part A|Other|0|||
125552252|NCT02684357|451652346|FG001|Part A|Other|1|||
125552253|NCT02684357|451652347|FG002|Part A|Other|0|||
125552254|NCT02684357|451652348|FG003|Part A|Other|0|||
125552255|NCT02684357|451652349|FG004|Part A|Other|0|||
125552256|NCT02684357|451652350|FG005|Part A|Other|0|||
125552257|NCT02684357|451652345|FG000|Part B|Adverse Event (Other)|0|||
125552258|NCT02684357|451652346|FG001|Part B|Adverse Event (Other)|0|||
125552259|NCT02684357|451652347|FG002|Part B|Adverse Event (Other)|0|||
125350172|NCT02469038|450916991|FG001|Overall Study|Physician Decision|5|||
125350173|NCT01850602|450916997|FG000|Overall Study|Adverse Event|7|||
125350174|NCT01850602|450916998|FG001|Overall Study|Adverse Event|10|||
125350175|NCT01850602|450916997|FG000|Overall Study|Physician Decision|2|||
125350176|NCT01850602|450916998|FG001|Overall Study|Physician Decision|1|||
125350177|NCT01850602|450916997|FG000|Overall Study|Withdrawal by Subject|2|||
125350178|NCT01850602|450916998|FG001|Overall Study|Withdrawal by Subject|4|||
125350179|NCT01850602|450916997|FG000|Overall Study|Decrease in serum calcium|2|||
125350180|NCT01850602|450916998|FG001|Overall Study|Decrease in serum calcium|3|||
125350181|NCT01850602|450916997|FG000|Overall Study|Increase in serum ferritin|1|||
125350182|NCT01850602|450916998|FG001|Overall Study|Increase in serum ferritin|0|||
125350183|NCT01857310|450916999|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
125350184|NCT01857310|450917000|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
125350185|NCT02497976|450917001|FG000|Overall Study|Withdrawal by Subject|2|||
125350186|NCT02497976|450917002|FG001|Overall Study|Withdrawal by Subject|0|||
125350187|NCT02497976|450917001|FG000|Overall Study|Moved out of area|0|||
125350188|NCT02497976|450917002|FG001|Overall Study|Moved out of area|1|||
125350189|NCT00584740|450917003|FG000|Overall Study|Adverse Event|1|||
125350190|NCT00584740|450917004|FG001|Overall Study|Adverse Event|1|||
125350191|NCT00584740|450917003|FG000|Overall Study|Lack of Efficacy|8|||
125350192|NCT00584740|450917004|FG001|Overall Study|Lack of Efficacy|2|||
125350193|NCT00584740|450917003|FG000|Overall Study|Withdrawal by Subject|3|||
125350194|NCT00584740|450917004|FG001|Overall Study|Withdrawal by Subject|2|||
125350195|NCT00584740|450917003|FG000|Overall Study|Lost to Follow-up|0|||
125350196|NCT00584740|450917004|FG001|Overall Study|Lost to Follow-up|1|||
125350197|NCT03915860|450917008|FG000|Overall Study|Adverse Event|3|||
125350198|NCT03915860|450917008|FG000|Overall Study|Withdrawal by Subject|6|||
125350199|NCT03915860|450917008|FG000|Overall Study|Lost to Follow-up|2|||
125350200|NCT03915860|450917008|FG000|Overall Study|Other than specified|3|||
125350201|NCT02195011|450917009|FG000|Overall Study|Adverse Event|4|||
125425659|NCT02052310|451182317|FG000|Overall Study|Protocol Violation|1|||
125552260|NCT02684357|451652348|FG003|Part B|Adverse Event (Other)|1|||
125350202|NCT02195011|450917010|FG001|Overall Study|Adverse Event|0|||
125350203|NCT02195011|450917009|FG000|Overall Study|Progressive Disease|18|||
125350204|NCT02195011|450917010|FG001|Overall Study|Progressive Disease|1|||
125350205|NCT02195011|450917009|FG000|Overall Study|Withdrawal by Subject|3|||
125350206|NCT02195011|450917010|FG001|Overall Study|Withdrawal by Subject|0|||
125552261|NCT02684357|451652349|FG004|Part B|Adverse Event (Other)|1|||
125552262|NCT02684357|451652350|FG005|Part B|Adverse Event (Other)|1|||
125552263|NCT02684357|451652345|FG000|Part B|Lost to Follow-up|0|||
125350207|NCT03189381|450917013|FG000|Overall Study|Death|1|||
125552264|NCT02684357|451652346|FG001|Part B|Lost to Follow-up|0|||
125552265|NCT02684357|451652347|FG002|Part B|Lost to Follow-up|0|||
125552266|NCT02684357|451652348|FG003|Part B|Lost to Follow-up|1|||
125552267|NCT02684357|451652349|FG004|Part B|Lost to Follow-up|1|||
125552268|NCT02684357|451652350|FG005|Part B|Lost to Follow-up|7|||
125552269|NCT02684357|451652345|FG000|Part B|Withdrawal by Subject|0|||
125552270|NCT02684357|451652346|FG001|Part B|Withdrawal by Subject|0|||
125552271|NCT02684357|451652347|FG002|Part B|Withdrawal by Subject|0|||
125552272|NCT02684357|451652348|FG003|Part B|Withdrawal by Subject|0|||
125552273|NCT02684357|451652349|FG004|Part B|Withdrawal by Subject|2|||
125552274|NCT02684357|451652350|FG005|Part B|Withdrawal by Subject|4|||
125552275|NCT02684357|451652345|FG000|Part B|Other|0|||
125552276|NCT02684357|451652346|FG001|Part B|Other|0|||
125552277|NCT02684357|451652347|FG002|Part B|Other|0|||
125552278|NCT02684357|451652348|FG003|Part B|Other|1|||
125552279|NCT02684357|451652349|FG004|Part B|Other|0|||
125552280|NCT02684357|451652350|FG005|Part B|Other|1|||
125552281|NCT01079130|451652351|FG000|Overall Study|Adverse Event|1|||
125552282|NCT01079130|451652352|FG001|Overall Study|Adverse Event|1|||
125552283|NCT01079130|451652353|FG002|Overall Study|Adverse Event|0|||
125552284|NCT01079130|451652354|FG003|Overall Study|Adverse Event|1|||
125552285|NCT01079130|451652355|FG004|Overall Study|Adverse Event|5|||
125552286|NCT01079130|451652356|FG005|Overall Study|Adverse Event|1|||
125552287|NCT01079130|451652351|FG000|Overall Study|Administrative problems|1|||
125552288|NCT01079130|451652352|FG001|Overall Study|Administrative problems|3|||
125552289|NCT01079130|451652353|FG002|Overall Study|Administrative problems|0|||
125552290|NCT01079130|451652354|FG003|Overall Study|Administrative problems|0|||
125552291|NCT01079130|451652355|FG004|Overall Study|Administrative problems|0|||
125552292|NCT01079130|451652356|FG005|Overall Study|Administrative problems|1|||
125552293|NCT01079130|451652351|FG000|Overall Study|Withdrawal by Subject|0|||
125552294|NCT01079130|451652352|FG001|Overall Study|Withdrawal by Subject|1|||
125552295|NCT01079130|451652353|FG002|Overall Study|Withdrawal by Subject|0|||
125552296|NCT01079130|451652354|FG003|Overall Study|Withdrawal by Subject|0|||
125552297|NCT01079130|451652355|FG004|Overall Study|Withdrawal by Subject|1|||
125552298|NCT01079130|451652356|FG005|Overall Study|Withdrawal by Subject|3|||
125552299|NCT01079130|451652351|FG000|Overall Study|Protocol deviation|0|||
125552300|NCT01079130|451652352|FG001|Overall Study|Protocol deviation|2|||
125552301|NCT01079130|451652353|FG002|Overall Study|Protocol deviation|1|||
125552302|NCT01079130|451652354|FG003|Overall Study|Protocol deviation|2|||
125552303|NCT01079130|451652355|FG004|Overall Study|Protocol deviation|0|||
125552304|NCT01079130|451652356|FG005|Overall Study|Protocol deviation|0|||
125552305|NCT01079130|451652351|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125552306|NCT01079130|451652352|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125552307|NCT01079130|451652353|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125552308|NCT01079130|451652354|FG003|Overall Study|Abnormal test procedure result(s)|0|||
125552309|NCT01079130|451652355|FG004|Overall Study|Abnormal test procedure result(s)|1|||
125552310|NCT01079130|451652356|FG005|Overall Study|Abnormal test procedure result(s)|0|||
125552311|NCT01079130|451652351|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125552312|NCT01079130|451652352|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125552313|NCT01079130|451652353|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125552314|NCT01079130|451652354|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
125552315|NCT01079130|451652355|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
125552316|NCT01079130|451652356|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
125552317|NCT01079130|451652351|FG000|Overall Study|Lost to Follow-up|0|||
125552318|NCT01079130|451652352|FG001|Overall Study|Lost to Follow-up|0|||
125552319|NCT01079130|451652353|FG002|Overall Study|Lost to Follow-up|0|||
125552320|NCT01079130|451652354|FG003|Overall Study|Lost to Follow-up|0|||
125552321|NCT01079130|451652355|FG004|Overall Study|Lost to Follow-up|1|||
125552322|NCT01079130|451652356|FG005|Overall Study|Lost to Follow-up|0|||
125552323|NCT04821869|451652362|FG000|Overall Study|Adverse Event|4|||
125552324|NCT04821869|451652362|FG000|Overall Study|Withdrawal by Subject|2|||
125552325|NCT04821869|451652362|FG000|Overall Study|Did not meet FEV1 criteria|1|||
125552326|NCT03444324|451652363|FG000|Overall Study|Withdrawal by Subject|0|||
125552327|NCT03444324|451652364|FG001|Overall Study|Withdrawal by Subject|1|||
125552328|NCT03444324|451652363|FG000|Overall Study|Lost to Follow-up|4|||
125552329|NCT03444324|451652364|FG001|Overall Study|Lost to Follow-up|2|||
125552330|NCT03444324|451652363|FG000|Overall Study|Protocol Violation|0|||
125552331|NCT03444324|451652364|FG001|Overall Study|Protocol Violation|1|||
125552332|NCT03444324|451652363|FG000|Overall Study|Lack of Trial Compliance|1|||
125552333|NCT03444324|451652364|FG001|Overall Study|Lack of Trial Compliance|1|||
125552334|NCT03444324|451652363|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
125552335|NCT03444324|451652364|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
125552336|NCT01390181|451653772|FG000|Overall Study|Lost to Follow-up|1|||
125552337|NCT01390181|451653772|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
125552338|NCT02805725|451653773|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
125552339|NCT02805725|451653774|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
125552340|NCT02805725|451653775|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
125552341|NCT02805725|451653776|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
125552342|NCT02805725|451653777|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
125552343|NCT02805725|451653773|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
125552344|NCT02805725|451653774|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
125552345|NCT02805725|451653775|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
125552346|NCT02805725|451653776|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
125552347|NCT02805725|451653777|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
125552348|NCT02805725|451653773|FG000|Phase II|Protocol Violation|0|||
125552349|NCT02805725|451653774|FG001|Phase II|Protocol Violation|0|||
125552350|NCT02805725|451653775|FG002|Phase II|Protocol Violation|0|||
125552351|NCT02805725|451653776|FG003|Phase II|Protocol Violation|0|||
125552352|NCT02805725|451653777|FG004|Phase II|Protocol Violation|6|||
125552353|NCT01195545|451653778|FG000|Overall Study|Protocol Violation|4|||
125552354|NCT02425644|451653779|FG000|Overall Study|Lost to Follow-up|2|||
125552355|NCT02425644|451653780|FG001|Overall Study|Lost to Follow-up|3|||
125552356|NCT02425644|451653779|FG000|Overall Study|Withdrawal by Subject|41|||
125552357|NCT02425644|451653780|FG001|Overall Study|Withdrawal by Subject|36|||
125552358|NCT02425644|451653779|FG000|Overall Study|Lack of Efficacy|3|||
125552359|NCT02425644|451653780|FG001|Overall Study|Lack of Efficacy|10|||
125552360|NCT02425644|451653779|FG000|Overall Study|Adverse Event|13|||
125552361|NCT02425644|451653780|FG001|Overall Study|Adverse Event|3|||
125552362|NCT02425644|451653779|FG000|Overall Study|Death|0|||
125552363|NCT02425644|451653780|FG001|Overall Study|Death|2|||
125552364|NCT02425644|451653779|FG000|Overall Study|Other|18|||
125552365|NCT02425644|451653780|FG001|Overall Study|Other|17|||
125552366|NCT00909792|451653781|FG000|Period 1|Did not meet inclusion criteria|0|||
125552367|NCT00909792|451653782|FG001|Period 1|Did not meet inclusion criteria|1|||
125552368|NCT00909792|451653781|FG000|Period 2|Biomicroscopy|1|||
125552369|NCT00909792|451653782|FG001|Period 2|Biomicroscopy|0|||
125552370|NCT00909792|451653781|FG000|Period 2|Lost to Follow-up|0|||
125552371|NCT00909792|451653782|FG001|Period 2|Lost to Follow-up|1|||
125552372|NCT00293722|451653785|FG000|Overall Study|Other|427|||
125552373|NCT02824263|451653787|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
125552374|NCT02824263|451653788|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
125552375|NCT02824263|451653787|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
125552376|NCT02824263|451653788|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
125552377|NCT00568321|451653789|FG000|Overall Study|Adverse Event|1|||
125552378|NCT00568321|451653790|FG001|Overall Study|Adverse Event|0|||
125552379|NCT00568321|451653791|FG002|Overall Study|Adverse Event|0|||
125552380|NCT00568321|451653789|FG000|Overall Study|Lack of Efficacy|8|||
125552381|NCT00568321|451653790|FG001|Overall Study|Lack of Efficacy|5|||
125552382|NCT00568321|451653791|FG002|Overall Study|Lack of Efficacy|6|||
125552383|NCT00568321|451653789|FG000|Overall Study|Lost to Follow-up|0|||
125552384|NCT00568321|451653790|FG001|Overall Study|Lost to Follow-up|0|||
125552385|NCT00568321|451653791|FG002|Overall Study|Lost to Follow-up|1|||
125552386|NCT00568321|451653789|FG000|Overall Study|Withdrawal by Subject|2|||
125552387|NCT00568321|451653790|FG001|Overall Study|Withdrawal by Subject|0|||
125552388|NCT00568321|451653791|FG002|Overall Study|Withdrawal by Subject|0|||
125552389|NCT00568321|451653789|FG000|Overall Study|Protocol Violation|0|||
125552390|NCT00568321|451653790|FG001|Overall Study|Protocol Violation|0|||
125552391|NCT00568321|451653791|FG002|Overall Study|Protocol Violation|1|||
125552392|NCT00568321|451653789|FG000|Overall Study|Randomized, not treated|2|||
125552393|NCT00568321|451653790|FG001|Overall Study|Randomized, not treated|0|||
125552394|NCT00568321|451653791|FG002|Overall Study|Randomized, not treated|1|||
125552395|NCT00937833|451653792|FG000|Overall Study|Protocol Violation|1|||
125552396|NCT00937833|451653793|FG001|Overall Study|Protocol Violation|2|||
125552397|NCT00937833|451653792|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
125552398|NCT00937833|451653793|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
125552399|NCT00937833|451653792|FG000|Overall Study|Lost to Follow-up|10|||
125552400|NCT00937833|451653793|FG001|Overall Study|Lost to Follow-up|8|||
125552401|NCT00937833|451653792|FG000|Overall Study|Withdrawal by Subject|4|||
125552402|NCT00937833|451653793|FG001|Overall Study|Withdrawal by Subject|6|||
125552403|NCT00221195|451653795|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
125552404|NCT00221195|451653796|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
125552405|NCT00221195|451653795|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
125552406|NCT00221195|451653796|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
125552407|NCT00221195|451653795|FG000|Washout Period (Months 7-9)|Death|0|||
125552408|NCT00221195|451653796|FG001|Washout Period (Months 7-9)|Death|1|||
125552409|NCT00221195|451653795|FG000|Therapy 2 (Months 10-15)|Death|1|||
125552410|NCT00221195|451653796|FG001|Therapy 2 (Months 10-15)|Death|0|||
125552411|NCT00221195|451653795|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
125552412|NCT00221195|451653796|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
125552413|NCT00818389|451653800|FG000|Overall Study|Death|1|||
125552414|NCT00818389|451653801|FG001|Overall Study|Death|3|||
125552415|NCT00818389|451653800|FG000|Overall Study|ALS Disease Progression|1|||
125552416|NCT00818389|451653801|FG001|Overall Study|ALS Disease Progression|0|||
125552417|NCT00818389|451653800|FG000|Overall Study|Withdrawal by Subject|2|||
125552418|NCT00818389|451653801|FG001|Overall Study|Withdrawal by Subject|2|||
125552419|NCT00818389|451653800|FG000|Overall Study|Adverse Event|0|||
125552420|NCT00818389|451653801|FG001|Overall Study|Adverse Event|1|||
125552421|NCT03548987|451653802|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
125552422|NCT03548987|451653803|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
125552423|NCT03548987|451653802|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
125552424|NCT03548987|451653803|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
125552425|NCT03548987|451653802|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
125552426|NCT03548987|451653803|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
125552427|NCT03548987|451653802|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
125552428|NCT03548987|451653803|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
125552429|NCT03548987|451653802|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
125552430|NCT03548987|451653803|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
125552431|NCT03548987|451653802|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
125552432|NCT03548987|451653803|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
125552433|NCT03548987|451653802|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
125552434|NCT03548987|451653803|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
125552435|NCT03548987|451653802|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
125552436|NCT03548987|451653803|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
125552437|NCT03548987|451653802|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
125552438|NCT03548987|451653803|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
125552439|NCT03548987|451653802|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
125552440|NCT03548987|451653803|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
125552441|NCT03548987|451653802|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
125552442|NCT03548987|451653803|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
125552443|NCT03548987|451653802|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
125552444|NCT03548987|451653803|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
125350208|NCT03189381|450917014|FG001|Overall Study|Death|0|||
125350209|NCT03761797|450917015|FG000|Overall Study|Changing hospital|11|||
125350210|NCT03761797|450917015|FG000|Overall Study|Improvement/remission|6|||
125552445|NCT03548987|451653802|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
125552446|NCT03548987|451653803|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
125552447|NCT03548987|451653802|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
125552448|NCT03548987|451653803|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
125552449|NCT01106014|451653806|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
125552450|NCT01106014|451653807|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
125552451|NCT01106014|451653806|FG000|Overall Study|Adverse Event|78|||
125552452|NCT01106014|451653807|FG001|Overall Study|Adverse Event|42|||
125552453|NCT01106014|451653806|FG000|Overall Study|Withdrawal by Subject|43|||
125552454|NCT01106014|451653807|FG001|Overall Study|Withdrawal by Subject|37|||
125552455|NCT01106014|451653806|FG000|Overall Study|Administrative reason|7|||
125552456|NCT01106014|451653807|FG001|Overall Study|Administrative reason|6|||
125552457|NCT01106014|451653806|FG000|Overall Study|Lost to Follow-up|2|||
125552458|NCT01106014|451653807|FG001|Overall Study|Lost to Follow-up|3|||
125552459|NCT00756470|451653810|FG000|Overall Study|Withdrawal by Subject|1|||
125552460|NCT00756470|451653810|FG000|Overall Study|Adverse Event|4|||
125552461|NCT00908232|451653811|FG000|Cycle 1 to 4|Death|5|||
125552462|NCT00908232|451653812|FG001|Cycle 1 to 4|Death|0|||
125552463|NCT00908232|451653813|FG002|Cycle 1 to 4|Death|0|||
125552464|NCT00908232|451653814|FG003|Cycle 1 to 4|Death|0|||
125552465|NCT00908232|451653811|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
125552466|NCT00908232|451653812|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
125552467|NCT00908232|451653813|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
125552468|NCT00908232|451653814|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
125552469|NCT00908232|451653811|FG000|Cycle 1 to 4|Progressive Disease|6|||
125552470|NCT00908232|451653812|FG001|Cycle 1 to 4|Progressive Disease|0|||
125552471|NCT00908232|451653813|FG002|Cycle 1 to 4|Progressive Disease|0|||
125552472|NCT00908232|451653814|FG003|Cycle 1 to 4|Progressive Disease|0|||
125552473|NCT00908232|451653811|FG000|Cycle 1 to 4|Adverse Event|12|||
125552474|NCT00908232|451653812|FG001|Cycle 1 to 4|Adverse Event|0|||
125552475|NCT00908232|451653813|FG002|Cycle 1 to 4|Adverse Event|0|||
125552476|NCT00908232|451653814|FG003|Cycle 1 to 4|Adverse Event|0|||
125552477|NCT00908232|451653811|FG000|Cycle 1 to 4|Other|1|||
125552478|NCT00908232|451653812|FG001|Cycle 1 to 4|Other|0|||
125552479|NCT00908232|451653813|FG002|Cycle 1 to 4|Other|0|||
125552480|NCT00908232|451653814|FG003|Cycle 1 to 4|Other|0|||
125552481|NCT00908232|451653811|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
125552482|NCT00908232|451653812|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
125552483|NCT00908232|451653813|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
125552484|NCT00908232|451653814|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
125350211|NCT03761797|450917015|FG000|Overall Study|Withdrawal by Subject|19|||
125552485|NCT00908232|451653811|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
125552486|NCT00908232|451653812|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
125552487|NCT00908232|451653813|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
125552488|NCT00908232|451653814|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
125552489|NCT00908232|451653811|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
125350212|NCT03761797|450917015|FG000|Overall Study|Lost to Follow-up|33|||
125350213|NCT03761797|450917015|FG000|Overall Study|Adverse Event|37|||
125350214|NCT03761797|450917015|FG000|Overall Study|Case report form (CRF) not collected|5|||
125350215|NCT03761797|450917015|FG000|Overall Study|No patient visit after entry|13|||
125350216|NCT03761797|450917015|FG000|Overall Study|Switch to other diabetes medication|10|||
125350217|NCT03761797|450917015|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
125350218|NCT03761797|450917015|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
125350219|NCT03761797|450917015|FG000|Overall Study|Insufficient effectives|2|||
125350220|NCT03761797|450917015|FG000|Overall Study|Excessive alcohol intake|1|||
125350221|NCT00251004|450917016|FG000|Overall Study|Withdrawal by Subject|23|||
125350222|NCT00251004|450917017|FG001|Overall Study|Withdrawal by Subject|16|||
125350223|NCT00251004|450917018|FG002|Overall Study|Withdrawal by Subject|14|||
125350224|NCT00251004|450917016|FG000|Overall Study|Death|9|||
125350225|NCT00251004|450917017|FG001|Overall Study|Death|10|||
125350226|NCT00251004|450917018|FG002|Overall Study|Death|8|||
125350227|NCT00251004|450917016|FG000|Overall Study|Lost to Follow-up|1|||
125350228|NCT00251004|450917017|FG001|Overall Study|Lost to Follow-up|2|||
125350229|NCT00251004|450917018|FG002|Overall Study|Lost to Follow-up|1|||
125350230|NCT00251004|450917016|FG000|Overall Study|Graft Loss|12|||
125350231|NCT00251004|450917017|FG001|Overall Study|Graft Loss|13|||
125350232|NCT00251004|450917018|FG002|Overall Study|Graft Loss|8|||
125350233|NCT00645788|450917019|FG000|Overall Study|Did not receive study drug|1|||
125350234|NCT00645788|450917020|FG001|Overall Study|Did not receive study drug|1|||
125350235|NCT00645788|450917021|FG002|Overall Study|Did not receive study drug|0|||
125350236|NCT00645788|450917022|FG003|Overall Study|Did not receive study drug|0|||
125350237|NCT00645788|450917019|FG000|Overall Study|Adverse Event|4|||
125350238|NCT00645788|450917020|FG001|Overall Study|Adverse Event|9|||
125350239|NCT00645788|450917021|FG002|Overall Study|Adverse Event|5|||
125350240|NCT00645788|450917022|FG003|Overall Study|Adverse Event|3|||
125350241|NCT00645788|450917019|FG000|Overall Study|Lost to Follow-up|1|||
125350242|NCT00645788|450917020|FG001|Overall Study|Lost to Follow-up|0|||
125350243|NCT00645788|450917021|FG002|Overall Study|Lost to Follow-up|0|||
125350244|NCT00645788|450917022|FG003|Overall Study|Lost to Follow-up|0|||
125350245|NCT00645788|450917019|FG000|Overall Study|Protocol Violation|1|||
125350246|NCT00645788|450917020|FG001|Overall Study|Protocol Violation|0|||
125350247|NCT00645788|450917021|FG002|Overall Study|Protocol Violation|2|||
125350248|NCT00645788|450917022|FG003|Overall Study|Protocol Violation|0|||
125350249|NCT00645788|450917019|FG000|Overall Study|Withdrawal by Subject|0|||
125350250|NCT00645788|450917020|FG001|Overall Study|Withdrawal by Subject|1|||
125350251|NCT00645788|450917021|FG002|Overall Study|Withdrawal by Subject|0|||
125350252|NCT00645788|450917022|FG003|Overall Study|Withdrawal by Subject|2|||
125350253|NCT00645788|450917019|FG000|Overall Study|Pulmonary exacerbation|13|||
125350254|NCT00645788|450917020|FG001|Overall Study|Pulmonary exacerbation|16|||
125350255|NCT00645788|450917021|FG002|Overall Study|Pulmonary exacerbation|11|||
125350256|NCT00645788|450917022|FG003|Overall Study|Pulmonary exacerbation|9|||
125350257|NCT03149848|450917023|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
125350258|NCT03149848|450917023|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
125350259|NCT01244490|450917025|FG000|Overall Study|Lack of Efficacy|14|||
125350260|NCT01244490|450917026|FG001|Overall Study|Lack of Efficacy|5|||
125350261|NCT01244490|450917027|FG002|Overall Study|Lack of Efficacy|5|||
125350262|NCT01244490|450917025|FG000|Overall Study|Withdrawal by Subject|4|||
125350263|NCT01244490|450917026|FG001|Overall Study|Withdrawal by Subject|4|||
125350264|NCT01244490|450917027|FG002|Overall Study|Withdrawal by Subject|9|||
125350265|NCT01244490|450917025|FG000|Overall Study|Adverse Event|1|||
125350266|NCT01244490|450917026|FG001|Overall Study|Adverse Event|9|||
125350267|NCT01244490|450917027|FG002|Overall Study|Adverse Event|5|||
125350268|NCT01244490|450917025|FG000|Overall Study|Lost to Follow-up|0|||
125350269|NCT01244490|450917026|FG001|Overall Study|Lost to Follow-up|6|||
125350270|NCT01244490|450917027|FG002|Overall Study|Lost to Follow-up|3|||
125350271|NCT01244490|450917025|FG000|Overall Study|Other|0|||
125350272|NCT01244490|450917026|FG001|Overall Study|Other|0|||
125350273|NCT01244490|450917027|FG002|Overall Study|Other|1|||
125425660|NCT02052310|451182318|FG001|Overall Study|Protocol Violation|6|||
125425661|NCT01197508|451182322|FG000|Overall Study|Withdrawal by Subject|8|||
125552490|NCT00908232|451653812|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
125552491|NCT00908232|451653813|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
125552492|NCT00908232|451653814|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
125350274|NCT00256282|450917034|FG000|Overall Study|Disease progression, relapse during acti|12|||
125425662|NCT01197508|451182323|FG001|Overall Study|Withdrawal by Subject|7|||
125552493|NCT00908232|451653811|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
125350275|NCT00256282|450917034|FG000|Overall Study|Adverse Event|3|||
125350276|NCT00256282|450917034|FG000|Overall Study|Physician Decision|1|||
125350277|NCT00327470|450917037|FG000|Overall Study|Randomized, but not treated|0|||
125350278|NCT00327470|450917038|FG001|Overall Study|Randomized, but not treated|2|||
125350279|NCT00327470|450917037|FG000|Overall Study|Adverse Event|9|||
125350280|NCT00327470|450917038|FG001|Overall Study|Adverse Event|14|||
125350281|NCT00327470|450917037|FG000|Overall Study|Lack of Efficacy|7|||
125350282|NCT00327470|450917038|FG001|Overall Study|Lack of Efficacy|19|||
125350283|NCT00327470|450917037|FG000|Overall Study|Other|5|||
125425663|NCT01197508|451182324|FG002|Overall Study|Withdrawal by Subject|15|||
125350284|NCT00327470|450917038|FG001|Overall Study|Other|9|||
125350285|NCT00327470|450917037|FG000|Overall Study|Lost to Follow-up|1|||
125350286|NCT00327470|450917038|FG001|Overall Study|Lost to Follow-up|3|||
125350287|NCT00327470|450917037|FG000|Overall Study|Withdrawal by Subject|6|||
125350288|NCT00327470|450917038|FG001|Overall Study|Withdrawal by Subject|12|||
125350289|NCT00327470|450917037|FG000|Overall Study|Death|1|||
125350290|NCT00327470|450917038|FG001|Overall Study|Death|4|||
125350291|NCT02581943|450917041|FG000|Overall Study|Death|5|||
125350292|NCT02581943|450917042|FG001|Overall Study|Death|2|||
125350293|NCT02581943|450917041|FG000|Overall Study|Disease Progression|12|||
125350294|NCT02581943|450917042|FG001|Overall Study|Disease Progression|15|||
125350295|NCT02581943|450917041|FG000|Overall Study|Withdrawal by Subject|1|||
125350296|NCT02581943|450917042|FG001|Overall Study|Withdrawal by Subject|2|||
125350297|NCT03021564|450917043|FG000|Overall Study|Death|84|||
125350298|NCT03021564|450917044|FG001|Overall Study|Death|466|||
125350299|NCT03021564|450917043|FG000|Overall Study|Lost to Follow-up|0|||
125350300|NCT03021564|450917044|FG001|Overall Study|Lost to Follow-up|2|||
125350301|NCT00219544|450917045|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
125350302|NCT00219544|450917046|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
125350303|NCT00219544|450917045|FG000|Single Blind Treatment Period|Adverse Event|9|||
125350304|NCT00219544|450917046|FG001|Single Blind Treatment Period|Adverse Event|0|||
125350305|NCT00219544|450917045|FG000|Single Blind Treatment Period|Protocol Violation|4|||
125350306|NCT00219544|450917046|FG001|Single Blind Treatment Period|Protocol Violation|0|||
125350307|NCT00219544|450917045|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
125350308|NCT00219544|450917046|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
125350309|NCT00219544|450917045|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
125350310|NCT00219544|450917046|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
125350311|NCT00219544|450917045|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
125350312|NCT00219544|450917046|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
125350313|NCT00745615|450917049|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
125350314|NCT00745615|450917050|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
125350315|NCT00745615|450917051|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
125350316|NCT00745615|450917052|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
125350317|NCT00745615|450917053|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
125350318|NCT00745615|450917054|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
125350319|NCT00745615|450917049|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
125350320|NCT00745615|450917050|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
125350321|NCT00745615|450917051|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
125350322|NCT00745615|450917052|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
125350323|NCT00745615|450917053|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
125350324|NCT00745615|450917054|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
125350325|NCT00745615|450917049|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
125350326|NCT00745615|450917050|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
125350327|NCT00745615|450917051|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
125350328|NCT00745615|450917052|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
125350329|NCT00745615|450917053|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
125350330|NCT00745615|450917054|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
125350331|NCT00745615|450917049|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
125350332|NCT00745615|450917050|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
125350333|NCT00745615|450917051|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
125350334|NCT00745615|450917052|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
125350335|NCT00745615|450917053|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
125350336|NCT00745615|450917054|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
125350337|NCT00745615|450917049|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
125350338|NCT00745615|450917050|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
125350339|NCT00745615|450917051|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
125350340|NCT00745615|450917052|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
125350341|NCT00745615|450917053|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
125350342|NCT00745615|450917054|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
125350343|NCT00745615|450917049|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
125350344|NCT00745615|450917050|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
125350345|NCT00745615|450917051|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
125350346|NCT00745615|450917052|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
125552494|NCT00908232|451653812|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
125552495|NCT00908232|451653813|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
125552496|NCT00908232|451653814|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
125552497|NCT00908232|451653811|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
125552498|NCT00908232|451653812|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
125552499|NCT00908232|451653813|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
125552500|NCT00908232|451653814|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
125552501|NCT00908232|451653811|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
125552502|NCT00908232|451653812|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
125552503|NCT00908232|451653813|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
125552504|NCT00908232|451653814|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
125552505|NCT00908232|451653811|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
125552506|NCT00908232|451653812|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
125552507|NCT00908232|451653813|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
125552508|NCT00908232|451653814|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
125552509|NCT00908232|451653811|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
125552510|NCT00908232|451653812|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
125552511|NCT00908232|451653813|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
125552512|NCT00908232|451653814|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
125552513|NCT02260882|451653815|FG000|Overall Study|Protocol Violation|0|||
125552514|NCT02260882|451653816|FG001|Overall Study|Protocol Violation|1|||
125552515|NCT00954174|451653817|FG000|Overall Study|Adverse Event|28|||
125552516|NCT00954174|451653818|FG001|Overall Study|Adverse Event|23|||
125552517|NCT00954174|451653819|FG002|Overall Study|Adverse Event|4|||
125552518|NCT00954174|451653820|FG003|Overall Study|Adverse Event|9|||
125552519|NCT00954174|451653817|FG000|Overall Study|Death|4|||
125552520|NCT00954174|451653818|FG001|Overall Study|Death|2|||
125552521|NCT00954174|451653819|FG002|Overall Study|Death|0|||
125552522|NCT00954174|451653820|FG003|Overall Study|Death|0|||
125552523|NCT00954174|451653817|FG000|Overall Study|Lack of Efficacy|32|||
125552524|NCT00954174|451653818|FG001|Overall Study|Lack of Efficacy|22|||
125552525|NCT00954174|451653819|FG002|Overall Study|Lack of Efficacy|8|||
125552526|NCT00954174|451653820|FG003|Overall Study|Lack of Efficacy|6|||
125552527|NCT00954174|451653817|FG000|Overall Study|Withdrawal by Subject|14|||
125552528|NCT00954174|451653818|FG001|Overall Study|Withdrawal by Subject|10|||
125552529|NCT00954174|451653819|FG002|Overall Study|Withdrawal by Subject|4|||
125552530|NCT00954174|451653820|FG003|Overall Study|Withdrawal by Subject|3|||
125552531|NCT00954174|451653817|FG000|Overall Study|Medical Reason|4|||
125552532|NCT00954174|451653818|FG001|Overall Study|Medical Reason|2|||
125552533|NCT00954174|451653819|FG002|Overall Study|Medical Reason|1|||
125552534|NCT00954174|451653820|FG003|Overall Study|Medical Reason|0|||
125552535|NCT00954174|451653817|FG000|Overall Study|Ineligible|40|||
125552536|NCT00954174|451653818|FG001|Overall Study|Ineligible|47|||
125552537|NCT00954174|451653819|FG002|Overall Study|Ineligible|7|||
125552538|NCT00954174|451653820|FG003|Overall Study|Ineligible|4|||
125552539|NCT00954174|451653817|FG000|Overall Study|Never Treated|4|||
125552540|NCT00954174|451653818|FG001|Overall Study|Never Treated|17|||
125552541|NCT00954174|451653819|FG002|Overall Study|Never Treated|0|||
125552542|NCT00954174|451653820|FG003|Overall Study|Never Treated|3|||
125552543|NCT01776424|451653825|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
125552544|NCT01776424|451653826|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
125552545|NCT01776424|451653827|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
125552546|NCT01776424|451653825|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
125552547|NCT01776424|451653826|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
125552548|NCT01776424|451653827|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
125552549|NCT01776424|451653825|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
125552550|NCT01776424|451653826|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
125552551|NCT01776424|451653827|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
125552552|NCT01776424|451653825|FG000|LTOLE Part (Open Label)|Refused|5|||
125552553|NCT01776424|451653826|FG001|LTOLE Part (Open Label)|Refused|2|||
125552554|NCT01776424|451653827|FG002|LTOLE Part (Open Label)|Refused|11|||
125552555|NCT01776424|451653825|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
125552556|NCT01776424|451653826|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
125552557|NCT01776424|451653827|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
125552558|NCT00146757|451653828|FG000|Overall Study|Death|1|||
125552559|NCT00146757|451653829|FG001|Overall Study|Death|0|||
125552560|NCT00146757|451653828|FG000|Overall Study|Adverse Event|1|||
125552561|NCT00146757|451653829|FG001|Overall Study|Adverse Event|0|||
125552562|NCT03294109|451653839|FG000|Overall Study|Withdrawal by Subject|6|||
125552563|NCT03294109|451653840|FG001|Overall Study|Withdrawal by Subject|5|||
125350347|NCT00745615|450917053|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
125552564|NCT01794923|451653841|FG000|Overall Study|Adverse Event|0|||
125350348|NCT00745615|450917054|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
125378924|NCT00531050|451019211|FG003|Part 1: Period 1|Adverse Event|0|||
125552565|NCT01794923|451653842|FG001|Overall Study|Adverse Event|0|||
125350349|NCT00745615|450917049|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
125350350|NCT00745615|450917050|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
125350351|NCT00745615|450917051|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
125350352|NCT00745615|450917052|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
125350353|NCT00745615|450917053|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
125350354|NCT00745615|450917054|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
125350355|NCT00745615|450917049|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
125350356|NCT00745615|450917050|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
125350357|NCT00745615|450917051|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
125350358|NCT00745615|450917052|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
125350359|NCT00745615|450917053|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
125350360|NCT00745615|450917054|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
125350361|NCT00745615|450917049|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
125350362|NCT00745615|450917050|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
125350363|NCT00745615|450917051|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
125350364|NCT00745615|450917052|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
125350365|NCT00745615|450917053|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
125350366|NCT00745615|450917054|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
125350367|NCT00745615|450917049|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
125350368|NCT00745615|450917050|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
125350369|NCT00745615|450917051|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
125350370|NCT00745615|450917052|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
125350371|NCT00745615|450917053|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
125350372|NCT00745615|450917054|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
125350373|NCT00745615|450917049|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
125350374|NCT00745615|450917050|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
125350375|NCT00745615|450917051|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
125350376|NCT00745615|450917052|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
125350377|NCT00745615|450917053|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
125350378|NCT00745615|450917054|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
125350379|NCT00745615|450917049|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
125350380|NCT00745615|450917050|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
125350381|NCT00745615|450917051|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
125350382|NCT00745615|450917052|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
125350383|NCT00745615|450917053|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
125350384|NCT00745615|450917054|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
125350385|NCT00745615|450917049|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
125350386|NCT00745615|450917050|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
125350387|NCT00745615|450917051|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
125350388|NCT00745615|450917052|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
125350389|NCT00745615|450917053|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
125350390|NCT00745615|450917054|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
125350391|NCT00745615|450917049|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
125350392|NCT00745615|450917050|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
125350393|NCT00745615|450917051|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
125350394|NCT00745615|450917052|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
125350395|NCT00745615|450917053|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
125350396|NCT00745615|450917054|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
125350397|NCT00586664|450917055|FG000|Overall Study|Withdrawal by Subject|3|||
125350398|NCT00586664|450917056|FG001|Overall Study|Withdrawal by Subject|7|||
125350399|NCT00586664|450917057|FG002|Overall Study|Withdrawal by Subject|1|||
125350400|NCT00586664|450917055|FG000|Overall Study|Exclusion criteria met|2|||
125350401|NCT00586664|450917056|FG001|Overall Study|Exclusion criteria met|0|||
125350402|NCT00586664|450917057|FG002|Overall Study|Exclusion criteria met|0|||
125350403|NCT00727532|450917059|FG000|Overall Study|Adverse Event|1|||
125350404|NCT00727532|450917059|FG000|Overall Study|Withdrawal by Subject|1|||
125350405|NCT00829933|450917060|FG000|Overall Study|Adverse Event|2|||
125350406|NCT00829933|450917061|FG001|Overall Study|Adverse Event|3|||
125552566|NCT01794923|451653843|FG002|Overall Study|Adverse Event|1|||
125552567|NCT04744285|451653850|FG000|Overall Study|Withdrawal by Subject|1|||
125552568|NCT04744285|451653851|FG001|Overall Study|Withdrawal by Subject|1|||
125552569|NCT04744285|451653852|FG002|Overall Study|Withdrawal by Subject|2|||
125552570|NCT04744285|451653853|FG003|Overall Study|Withdrawal by Subject|1|||
125552571|NCT02030405|451653860|FG000|Overall Study|Withdrawal by Subject|1|||
125552572|NCT02030405|451653860|FG000|Overall Study|Lost to Follow-up|1|||
125552573|NCT00986440|451653861|FG000|Overall Study|Progressive disease|27|||
125552574|NCT00986440|451653862|FG001|Overall Study|Progressive disease|37|||
125552575|NCT00986440|451653861|FG000|Overall Study|Serious adverse event or adverse event|9|||
125552576|NCT00986440|451653862|FG001|Overall Study|Serious adverse event or adverse event|2|||
125552577|NCT00986440|451653861|FG000|Overall Study|Withdrawal by Subject|1|||
125552578|NCT00986440|451653862|FG001|Overall Study|Withdrawal by Subject|2|||
125552579|NCT00986440|451653861|FG000|Overall Study|Screen failure (not dosed)|4|||
125552580|NCT00986440|451653862|FG001|Overall Study|Screen failure (not dosed)|2|||
125552581|NCT00803270|451653863|FG000|Overall Study|Lost to Follow-up|1|||
125552582|NCT00803270|451653864|FG001|Overall Study|Lost to Follow-up|2|||
125552583|NCT02973048|451653865|FG000|Overall Study|Epidural catheter insertion failure|1|||
125552584|NCT02973048|451653866|FG001|Overall Study|Epidural catheter insertion failure|0|||
125552585|NCT02973048|451653865|FG000|Overall Study|Withdrawal by Subject|0|||
125552586|NCT02973048|451653866|FG001|Overall Study|Withdrawal by Subject|3|||
125552587|NCT03707925|451653871|FG000|Overall Study|Inevaluable|1|||
125552588|NCT03431857|451653873|FG000|Overall Study|Death|6|||
125552589|NCT03431857|451653873|FG000|Overall Study|Lost to Follow-up|41|||
125552590|NCT03431857|451653873|FG000|Overall Study|Adverse Event|6|||
125552591|NCT03431857|451653873|FG000|Overall Study|Withdrawal by Subject|1|||
125552592|NCT01323621|451653874|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
125552593|NCT01323621|451653875|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
125552594|NCT01323621|451653876|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
125552595|NCT01323621|451653874|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
125552596|NCT01323621|451653875|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
125552597|NCT01323621|451653876|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
125552598|NCT01323621|451653874|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
125552599|NCT01323621|451653875|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
125552600|NCT01323621|451653876|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
125552601|NCT01323621|451653874|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
125552602|NCT01323621|451653875|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
125552603|NCT01323621|451653876|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
125552604|NCT01323621|451653874|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
125552605|NCT01323621|451653875|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
125552606|NCT01323621|451653876|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
125552607|NCT01323621|451653874|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
125552608|NCT01323621|451653875|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
125552609|NCT01323621|451653876|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
125552610|NCT01323621|451653874|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
125552611|NCT01323621|451653875|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
125552612|NCT01323621|451653876|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
125552613|NCT01323621|451653874|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
125552614|NCT01323621|451653875|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
125552615|NCT01323621|451653876|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
125552616|NCT01323621|451653874|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
125552617|NCT01323621|451653875|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
125552618|NCT01323621|451653876|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
125552619|NCT01323621|451653874|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125552620|NCT01323621|451653875|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
125552621|NCT01323621|451653876|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125552622|NCT01323621|451653874|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
125552623|NCT01323621|451653875|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
125552624|NCT01323621|451653876|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
125552625|NCT01323621|451653874|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125552626|NCT01323621|451653875|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
125552627|NCT01323621|451653876|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
125552628|NCT00651157|451653878|FG000|Overall Study|Death|1|||
125552629|NCT00651157|451653878|FG000|Overall Study|Protocol Violation|1|||
125552630|NCT00364156|451653882|FG000|Overall Study|Withdrawal by Subject|73|||
125552631|NCT00364156|451653883|FG001|Overall Study|Withdrawal by Subject|80|||
125552632|NCT00364156|451653882|FG000|Overall Study|Protocol Violation|6|||
125552633|NCT00364156|451653883|FG001|Overall Study|Protocol Violation|1|||
125552634|NCT01472380|451653884|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
125552635|NCT01472380|451653884|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
125552636|NCT00292461|451653885|FG000|Overall Study|Adverse Event|4|||
125552637|NCT00292461|451653886|FG001|Overall Study|Adverse Event|2|||
125552638|NCT00292461|451653885|FG000|Overall Study|Lack of Efficacy|1|||
125552639|NCT00292461|451653886|FG001|Overall Study|Lack of Efficacy|0|||
125552640|NCT00292461|451653885|FG000|Overall Study|Withdrawal by Subject|0|||
125552641|NCT00292461|451653886|FG001|Overall Study|Withdrawal by Subject|1|||
125552642|NCT00292461|451653885|FG000|Overall Study|Protocol Violation|4|||
125552643|NCT00292461|451653886|FG001|Overall Study|Protocol Violation|3|||
125552644|NCT00292461|451653885|FG000|Overall Study|Lost to Follow-up|1|||
125552645|NCT00292461|451653886|FG001|Overall Study|Lost to Follow-up|0|||
125552646|NCT01891721|451653890|FG000|Overall Study|Lost to Follow-up|10|||
125552647|NCT01891721|451653891|FG001|Overall Study|Lost to Follow-up|5|||
125552648|NCT01891721|451653892|FG002|Overall Study|Lost to Follow-up|1|||
125552649|NCT04908189|451653915|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
125552650|NCT04908189|451653916|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
125552651|NCT04908189|451653917|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
125552652|NCT04908189|451653915|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
125552653|NCT04908189|451653916|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
125552654|NCT04908189|451653917|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
125552655|NCT04908189|451653915|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
125552656|NCT04908189|451653916|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
125552657|NCT04908189|451653917|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
125552658|NCT04908189|451653915|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
125552659|NCT04908189|451653916|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
125552660|NCT04908189|451653917|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
125552661|NCT04908189|451653915|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
125552662|NCT04908189|451653916|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
125552663|NCT04908189|451653917|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
125552664|NCT04908189|451653915|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
125552665|NCT04908189|451653916|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
125552666|NCT04908189|451653917|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
125552667|NCT04908189|451653915|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
125552668|NCT04908189|451653916|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
125552669|NCT04908189|451653917|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
125552670|NCT04908189|451653915|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
125552671|NCT04908189|451653916|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
125552672|NCT04908189|451653917|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
125552673|NCT04908189|451653915|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
125552674|NCT04908189|451653916|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
125552675|NCT04908189|451653917|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
125552676|NCT04908189|451653915|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
125552677|NCT04908189|451653916|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
125552678|NCT04908189|451653917|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
125552679|NCT04908189|451653915|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
125552680|NCT04908189|451653916|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
125552681|NCT04908189|451653917|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
125552682|NCT04908189|451653915|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
125552683|NCT04908189|451653916|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
125552684|NCT04908189|451653917|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
125552685|NCT04683731|451653918|FG000|Overall Study|Withdrawal by Subject|1|||
125552686|NCT04683731|451653919|FG001|Overall Study|Withdrawal by Subject|0|||
125552687|NCT04683731|451653920|FG002|Overall Study|Withdrawal by Subject|3|||
125552688|NCT04683731|451653921|FG003|Overall Study|Withdrawal by Subject|2|||
125552689|NCT04683731|451653918|FG000|Overall Study|Determined patient was not eligible|3|||
125552690|NCT04683731|451653919|FG001|Overall Study|Determined patient was not eligible|3|||
125552691|NCT04683731|451653920|FG002|Overall Study|Determined patient was not eligible|12|||
125552692|NCT04683731|451653921|FG003|Overall Study|Determined patient was not eligible|3|||
125552693|NCT02958267|451653924|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
125552694|NCT02958267|451653925|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
125552695|NCT02958267|451653924|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
125552696|NCT02958267|451653925|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
125552697|NCT02958267|451653924|FG000|Follow-up Visits|Additional treatment pursued|2|||
125552698|NCT02958267|451653925|FG001|Follow-up Visits|Additional treatment pursued|1|||
125552699|NCT01210118|451653926|FG000|Overall Study|Lost to Follow-up|1|||
125552700|NCT01210118|451653927|FG001|Overall Study|Lost to Follow-up|1|||
125552701|NCT01210118|451653926|FG000|Overall Study|Protocol Violation|1|||
125552702|NCT01210118|451653927|FG001|Overall Study|Protocol Violation|1|||
125552703|NCT01210118|451653926|FG000|Overall Study|Spontaneous abortion|1|||
125552704|NCT01210118|451653927|FG001|Overall Study|Spontaneous abortion|3|||
125552705|NCT01853982|451653928|FG000|Overall Study|Withdrawal by Subject|1|||
125552706|NCT01853982|451653929|FG001|Overall Study|Withdrawal by Subject|0|||
125552707|NCT01853982|451653928|FG000|Overall Study|Death|1|||
125552708|NCT01853982|451653929|FG001|Overall Study|Death|0|||
125552709|NCT01853982|451653928|FG000|Overall Study|Lost to Follow-up|0|||
125552710|NCT01853982|451653929|FG001|Overall Study|Lost to Follow-up|1|||
125552711|NCT01839487|451653930|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
125552712|NCT01839487|451653931|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
125552713|NCT01839487|451653932|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
125552714|NCT01839487|451653933|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
125552715|NCT01839487|451653934|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
125552716|NCT01839487|451653935|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
125552717|NCT01839487|451653930|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
125552718|NCT01839487|451653931|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
125552719|NCT01839487|451653932|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
125552720|NCT01839487|451653933|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
125552721|NCT01839487|451653934|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
125552722|NCT01839487|451653935|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
125552723|NCT01839487|451653930|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
125552724|NCT01839487|451653931|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
125552725|NCT01839487|451653932|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
125552726|NCT01839487|451653933|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
125552727|NCT01839487|451653934|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
125552728|NCT01839487|451653935|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
125552729|NCT01839487|451653930|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
125552730|NCT01839487|451653931|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
125552731|NCT01839487|451653932|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
125552732|NCT01839487|451653933|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
125552733|NCT01839487|451653934|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
125552734|NCT01839487|451653935|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
125552735|NCT01839487|451653930|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
125552736|NCT01839487|451653931|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
125552737|NCT01839487|451653932|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
125552738|NCT01839487|451653933|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
125552739|NCT01839487|451653934|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
125552740|NCT01839487|451653935|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
125552741|NCT01839487|451653930|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
125552742|NCT01839487|451653931|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
125552743|NCT01839487|451653932|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
125552744|NCT01839487|451653933|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
125552745|NCT01839487|451653934|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
125552746|NCT01839487|451653935|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
125552747|NCT01839487|451653930|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
125552748|NCT01839487|451653931|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
125552749|NCT01839487|451653932|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
125552750|NCT01839487|451653933|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
125552751|NCT01839487|451653934|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
125552752|NCT01839487|451653935|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
125552753|NCT01839487|451653930|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
125552754|NCT01839487|451653931|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
125552755|NCT01839487|451653932|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
125552756|NCT01839487|451653933|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
125552757|NCT01839487|451653934|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
125552758|NCT01839487|451653935|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
125552759|NCT01839487|451653930|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
125552760|NCT01839487|451653931|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
125552761|NCT01839487|451653932|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
125552762|NCT01839487|451653933|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
125552763|NCT01839487|451653934|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
125552764|NCT01839487|451653935|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
125552765|NCT05066724|451653936|FG000|Overall Study|Adverse Event|1|||
125552766|NCT05066724|451653936|FG000|Overall Study|Non-Compliance With Study Drug|5|||
125552767|NCT05066724|451653936|FG000|Overall Study|Withdrawal by Subject|6|||
125552768|NCT05066724|451653936|FG000|Overall Study|Physician Decision|2|||
125552769|NCT00475033|451653938|FG000|Infant Series|Failed to return|3|||
125552770|NCT00475033|451653939|FG001|Infant Series|Failed to return|4|||
125552771|NCT00475033|451653938|FG000|Infant Series|Parent or legal guardian request|1|||
125552772|NCT00475033|451653939|FG001|Infant Series|Parent or legal guardian request|5|||
125552773|NCT00475033|451653938|FG000|Infant Series|Protocol Violation|1|||
125552774|NCT00475033|451653939|FG001|Infant Series|Protocol Violation|2|||
125552775|NCT00475033|451653938|FG000|Infant Series|Lost to Follow-up|2|||
125552776|NCT00475033|451653939|FG001|Infant Series|Lost to Follow-up|0|||
125552777|NCT00475033|451653938|FG000|Infant Series|Adverse Event|0|||
125552778|NCT00475033|451653939|FG001|Infant Series|Adverse Event|2|||
125552779|NCT00475033|451653938|FG000|After the Infant Series|Adverse Event|0|||
125552780|NCT00475033|451653939|FG001|After the Infant Series|Adverse Event|4|||
125552781|NCT00475033|451653938|FG000|After the Infant Series|Parent or legal guardian request|2|||
125552782|NCT00475033|451653939|FG001|After the Infant Series|Parent or legal guardian request|2|||
125552783|NCT00475033|451653938|FG000|After the Infant Series|Failed to return|2|||
125552784|NCT00475033|451653939|FG001|After the Infant Series|Failed to return|1|||
125552785|NCT00475033|451653938|FG000|After the Infant Series|Protocol Violation|1|||
125552786|NCT00475033|451653939|FG001|After the Infant Series|Protocol Violation|0|||
125552787|NCT00475033|451653938|FG000|After the Infant Series|Lost to Follow-up|1|||
125552788|NCT00475033|451653939|FG001|After the Infant Series|Lost to Follow-up|0|||
125552789|NCT00475033|451653938|FG000|After the Infant Series|Other|0|||
125552790|NCT00475033|451653939|FG001|After the Infant Series|Other|1|||
125552791|NCT00475033|451653938|FG000|Toddler Dose|Parent or legal guardian request|2|||
125552792|NCT00475033|451653939|FG001|Toddler Dose|Parent or legal guardian request|0|||
125552793|NCT00475033|451653938|FG000|Toddler Dose|Failed to return|1|||
125552794|NCT00475033|451653939|FG001|Toddler Dose|Failed to return|0|||
125552795|NCT00475033|451653938|FG000|Toddler Dose|Lost to Follow-up|1|||
125552796|NCT00475033|451653939|FG001|Toddler Dose|Lost to Follow-up|0|||
125552797|NCT01177787|451655214|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
125552798|NCT01177787|451655214|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
125552799|NCT01177787|451655214|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
125552800|NCT00402363|451655215|FG000|Overall Study|Adverse Event|9|||
125552801|NCT00402363|451655216|FG001|Overall Study|Adverse Event|14|||
125552802|NCT00402363|451655217|FG002|Overall Study|Adverse Event|2|||
125552803|NCT00402363|451655218|FG003|Overall Study|Adverse Event|2|||
125552804|NCT00402363|451655215|FG000|Overall Study|Withdrew Consent|10|||
125552805|NCT00402363|451655216|FG001|Overall Study|Withdrew Consent|5|||
125552806|NCT00402363|451655217|FG002|Overall Study|Withdrew Consent|2|||
125552807|NCT00402363|451655218|FG003|Overall Study|Withdrew Consent|1|||
125552808|NCT00402363|451655215|FG000|Overall Study|Protocol Violation|3|||
125552809|NCT00402363|451655216|FG001|Overall Study|Protocol Violation|5|||
125552810|NCT00402363|451655217|FG002|Overall Study|Protocol Violation|0|||
125552811|NCT00402363|451655218|FG003|Overall Study|Protocol Violation|3|||
125552812|NCT00402363|451655215|FG000|Overall Study|Lost to Follow-up|5|||
125552813|NCT00402363|451655216|FG001|Overall Study|Lost to Follow-up|4|||
125552814|NCT00402363|451655217|FG002|Overall Study|Lost to Follow-up|0|||
125552815|NCT00402363|451655218|FG003|Overall Study|Lost to Follow-up|2|||
125552816|NCT00402363|451655215|FG000|Overall Study|"Captured as Other"|6|||
125552817|NCT00402363|451655216|FG001|Overall Study|"Captured as Other"|2|||
125552818|NCT00402363|451655217|FG002|Overall Study|"Captured as Other"|2|||
125552819|NCT00402363|451655218|FG003|Overall Study|"Captured as Other"|2|||
125552820|NCT02634346|451655219|FG000|Overall Study|Withdrawal by Subject|8|||
125552821|NCT02634346|451655220|FG001|Overall Study|Withdrawal by Subject|9|||
125552822|NCT02634346|451655221|FG002|Overall Study|Withdrawal by Subject|8|||
125552823|NCT02634346|451655219|FG000|Overall Study|Adverse Event|2|||
125552824|NCT02634346|451655220|FG001|Overall Study|Adverse Event|2|||
125552825|NCT02634346|451655221|FG002|Overall Study|Adverse Event|7|||
125552826|NCT02634346|451655219|FG000|Overall Study|Lack of Efficacy|1|||
125552827|NCT02634346|451655220|FG001|Overall Study|Lack of Efficacy|2|||
125552828|NCT02634346|451655221|FG002|Overall Study|Lack of Efficacy|8|||
125552829|NCT02634346|451655219|FG000|Overall Study|Lost to Follow-up|1|||
125552830|NCT02634346|451655220|FG001|Overall Study|Lost to Follow-up|0|||
125552831|NCT02634346|451655221|FG002|Overall Study|Lost to Follow-up|0|||
125552832|NCT02634346|451655219|FG000|Overall Study|Protocol Violation|0|||
125552833|NCT02634346|451655220|FG001|Overall Study|Protocol Violation|1|||
125552834|NCT02634346|451655221|FG002|Overall Study|Protocol Violation|0|||
125552835|NCT01008696|451655223|FG000|Overall Study|Participant's evasion of hospital visit|5|||
125552836|NCT01008696|451655224|FG001|Overall Study|Participant's evasion of hospital visit|4|||
125552837|NCT01008696|451655223|FG000|Overall Study|Withdrawal by Subject|2|||
125552838|NCT01008696|451655224|FG001|Overall Study|Withdrawal by Subject|4|||
125552839|NCT01008696|451655223|FG000|Overall Study|Physician Decision|5|||
125552840|NCT01008696|451655224|FG001|Overall Study|Physician Decision|1|||
125552841|NCT01008696|451655223|FG000|Overall Study|Adverse Event|1|||
125552842|NCT01008696|451655224|FG001|Overall Study|Adverse Event|0|||
125552843|NCT01008696|451655223|FG000|Overall Study|Participants' non-cooperation|2|||
125552844|NCT01008696|451655224|FG001|Overall Study|Participants' non-cooperation|3|||
125552845|NCT01008696|451655223|FG000|Overall Study|Other|2|||
125552846|NCT01008696|451655224|FG001|Overall Study|Other|3|||
125552847|NCT01008696|451655223|FG000|Overall Study|Other|0|||
125552848|NCT01008696|451655224|FG001|Overall Study|Other|2|||
125552849|NCT01676909|451655225|FG000|Overall Study|Withdrawal by Subject|3|||
125552850|NCT01676909|451655226|FG001|Overall Study|Withdrawal by Subject|5|||
125552851|NCT01676909|451655225|FG000|Overall Study|Lost to Follow-up|15|||
125552852|NCT01676909|451655226|FG001|Overall Study|Lost to Follow-up|9|||
125552853|NCT00823901|451655230|FG000|Overall Study|Adverse Event|1|||
125552854|NCT00823901|451655231|FG001|Overall Study|Adverse Event|1|||
125552855|NCT00823901|451655230|FG000|Overall Study|Lack of Efficacy|1|||
125552856|NCT00823901|451655231|FG001|Overall Study|Lack of Efficacy|0|||
125552857|NCT00823901|451655230|FG000|Overall Study|Lost to Follow-up|2|||
125552858|NCT00823901|451655231|FG001|Overall Study|Lost to Follow-up|1|||
125552859|NCT01369511|451655233|FG000|Overall Study|Adverse Event|1|||
125552860|NCT01369511|451655234|FG001|Overall Study|Adverse Event|1|||
125552861|NCT01369511|451655235|FG002|Overall Study|Adverse Event|5|||
125552862|NCT01369511|451655236|FG003|Overall Study|Adverse Event|0|||
125552863|NCT01369511|451655233|FG000|Overall Study|Entry criteria not met|2|||
125552864|NCT01369511|451655234|FG001|Overall Study|Entry criteria not met|0|||
125552865|NCT01369511|451655235|FG002|Overall Study|Entry criteria not met|0|||
125552866|NCT01369511|451655236|FG003|Overall Study|Entry criteria not met|1|||
125552867|NCT01369511|451655233|FG000|Overall Study|Lost to Follow-up|0|||
125552868|NCT01369511|451655234|FG001|Overall Study|Lost to Follow-up|1|||
125552869|NCT01369511|451655235|FG002|Overall Study|Lost to Follow-up|1|||
125552870|NCT01369511|451655236|FG003|Overall Study|Lost to Follow-up|2|||
125552871|NCT01369511|451655233|FG000|Overall Study|Protocol Violation|0|||
125552872|NCT01369511|451655234|FG001|Overall Study|Protocol Violation|1|||
125552873|NCT01369511|451655235|FG002|Overall Study|Protocol Violation|0|||
125552874|NCT01369511|451655236|FG003|Overall Study|Protocol Violation|2|||
125552875|NCT01369511|451655233|FG000|Overall Study|Physician Decision|3|||
125552876|NCT01369511|451655234|FG001|Overall Study|Physician Decision|4|||
125552877|NCT01369511|451655235|FG002|Overall Study|Physician Decision|0|||
125552878|NCT01369511|451655236|FG003|Overall Study|Physician Decision|0|||
125552879|NCT01369511|451655233|FG000|Overall Study|Sponsor decision|2|||
125552880|NCT01369511|451655234|FG001|Overall Study|Sponsor decision|0|||
125552881|NCT01369511|451655235|FG002|Overall Study|Sponsor decision|1|||
125552882|NCT01369511|451655236|FG003|Overall Study|Sponsor decision|0|||
125552883|NCT01369511|451655233|FG000|Overall Study|Withdrawal by Subject|5|||
125552884|NCT01369511|451655234|FG001|Overall Study|Withdrawal by Subject|6|||
125552885|NCT01369511|451655235|FG002|Overall Study|Withdrawal by Subject|4|||
125552886|NCT01369511|451655236|FG003|Overall Study|Withdrawal by Subject|6|||
125552887|NCT01180998|451655237|FG000|Overall Study|Poor Vision|0|||
125552888|NCT01180998|451655238|FG001|Overall Study|Poor Vision|2|||
125552889|NCT01180998|451655239|FG002|Overall Study|Poor Vision|2|||
125552890|NCT01180998|451655237|FG000|Overall Study|Lost to Follow-up|0|||
125552891|NCT01180998|451655238|FG001|Overall Study|Lost to Follow-up|0|||
125552892|NCT01180998|451655239|FG002|Overall Study|Lost to Follow-up|1|||
125552893|NCT01180998|451655237|FG000|Overall Study|Protocol Violation|1|||
125552894|NCT01180998|451655238|FG001|Overall Study|Protocol Violation|2|||
125552895|NCT01180998|451655239|FG002|Overall Study|Protocol Violation|0|||
125552896|NCT01180998|451655237|FG000|Overall Study|Withdrawal by Subject|0|||
125552897|NCT01180998|451655238|FG001|Overall Study|Withdrawal by Subject|0|||
125552898|NCT01180998|451655239|FG002|Overall Study|Withdrawal by Subject|1|||
125552899|NCT01180998|451655237|FG000|Overall Study|Poor comfort|3|||
125552900|NCT01180998|451655238|FG001|Overall Study|Poor comfort|0|||
125552901|NCT01180998|451655239|FG002|Overall Study|Poor comfort|4|||
125552902|NCT01180998|451655237|FG000|Overall Study|Poor lens handling|0|||
125552903|NCT01180998|451655238|FG001|Overall Study|Poor lens handling|0|||
125552904|NCT01180998|451655239|FG002|Overall Study|Poor lens handling|2|||
125552905|NCT01376349|451655240|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
125552906|NCT01376349|451655241|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
125552907|NCT01376349|451655242|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
125552908|NCT01376349|451655240|FG000|Raondomized Treatment|Adverse Event|13|||
125552909|NCT01376349|451655241|FG001|Raondomized Treatment|Adverse Event|17|||
125552910|NCT01376349|451655242|FG002|Raondomized Treatment|Adverse Event|14|||
125552911|NCT01376349|451655240|FG000|Raondomized Treatment|Unkown|1|||
125552912|NCT01376349|451655241|FG001|Raondomized Treatment|Unkown|2|||
125552913|NCT01376349|451655242|FG002|Raondomized Treatment|Unkown|1|||
125552914|NCT01376349|451655240|FG000|Raondomized Treatment|Alternative Treatment|0|||
125552915|NCT01376349|451655241|FG001|Raondomized Treatment|Alternative Treatment|0|||
125552916|NCT01376349|451655242|FG002|Raondomized Treatment|Alternative Treatment|1|||
125552917|NCT00162032|451655243|FG000|Overall Study|Lost to Follow-up|4|||
125552918|NCT00162032|451655244|FG001|Overall Study|Lost to Follow-up|2|||
125552919|NCT00162032|451655243|FG000|Overall Study|Reason not specified|1|||
125552920|NCT00162032|451655244|FG001|Overall Study|Reason not specified|0|||
125552921|NCT01176968|451655245|FG000|Overall Study|Adverse Event|10|||
125552922|NCT01176968|451655246|FG001|Overall Study|Adverse Event|11|||
125552923|NCT01176968|451655245|FG000|Overall Study|Death|2|||
125552924|NCT01176968|451655246|FG001|Overall Study|Death|3|||
125552925|NCT01176968|451655245|FG000|Overall Study|Lack of Efficacy|0|||
125552926|NCT01176968|451655246|FG001|Overall Study|Lack of Efficacy|1|||
125552927|NCT01176968|451655245|FG000|Overall Study|Lost to Follow-up|16|||
125552928|NCT01176968|451655246|FG001|Overall Study|Lost to Follow-up|14|||
125552929|NCT01176968|451655245|FG000|Overall Study|Withdrawal by Subject|48|||
125552930|NCT01176968|451655246|FG001|Overall Study|Withdrawal by Subject|48|||
125552931|NCT01176968|451655245|FG000|Overall Study|Protocol Violation|2|||
125552932|NCT01176968|451655246|FG001|Overall Study|Protocol Violation|1|||
125552933|NCT01176968|451655245|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
125552934|NCT01176968|451655246|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
125552935|NCT01176968|451655245|FG000|Overall Study|Study terminated by sponsor|0|||
125552936|NCT01176968|451655246|FG001|Overall Study|Study terminated by sponsor|1|||
125552937|NCT01176968|451655245|FG000|Overall Study|Reason not defined|5|||
125552938|NCT01176968|451655246|FG001|Overall Study|Reason not defined|3|||
125552939|NCT00833911|451655247|FG000|Titration|Adverse Event|18|||
125552940|NCT00833911|451655247|FG000|Titration|Withdrawal by Subject|3|||
125552941|NCT00833911|451655247|FG000|Maintenance Phase I|Adverse Event|73|||
125552942|NCT00833911|451655247|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
125552943|NCT00833911|451655247|FG000|Maintenance Phase I|Physician Decision|10|||
125552944|NCT00833911|451655247|FG000|Maintenance Phase I|Lack of Efficacy|4|||
125552945|NCT00833911|451655247|FG000|Maintenance Phase II|Adverse Event|6|||
125552946|NCT00833911|451655247|FG000|Maintenance Phase II|Physician Decision|2|||
125552947|NCT00833911|451655247|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
125552948|NCT00833911|451655247|FG000|Maintenance Phase II|Lack of Efficacy|1|||
125552949|NCT00718640|451655248|FG000|Overall Study|Adverse Event|4|||
125552950|NCT00718640|451655248|FG000|Overall Study|Death|1|||
125552951|NCT00718640|451655248|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
125552952|NCT01137955|451655249|FG000|Overall Study|Withdrawal by Subject|5|||
125552953|NCT01137955|451655250|FG001|Overall Study|Withdrawal by Subject|4|||
125552954|NCT01207596|451655251|FG000|Overall Study|Physician Decision|4|||
125552955|NCT01207596|451655251|FG000|Overall Study|Lack of Efficacy|1|||
125552956|NCT01207596|451655251|FG000|Overall Study|Adverse Event|3|||
125552957|NCT01207596|451655251|FG000|Overall Study|Withdrawal by Subject|1|||
125552958|NCT00068588|451655252|FG000|Overall Study|Adverse Event|0|||
125552959|NCT00068588|451655253|FG001|Overall Study|Adverse Event|0|||
125552960|NCT00068588|451655254|FG002|Overall Study|Adverse Event|2|||
125552961|NCT00068588|451655252|FG000|Overall Study|Withdrawal by Subject|0|||
125552962|NCT00068588|451655253|FG001|Overall Study|Withdrawal by Subject|0|||
125552963|NCT00068588|451655254|FG002|Overall Study|Withdrawal by Subject|1|||
125552964|NCT00068588|451655252|FG000|Overall Study|Poor KPS|0|||
125552965|NCT00068588|451655253|FG001|Overall Study|Poor KPS|0|||
125552966|NCT00068588|451655254|FG002|Overall Study|Poor KPS|1|||
125552967|NCT05193500|451655255|FG000|Overall Study|Withdrawal by Subject|7|||
125552968|NCT05193500|451655256|FG001|Overall Study|Withdrawal by Subject|4|||
125552969|NCT05193500|451655257|FG002|Overall Study|Withdrawal by Subject|3|||
125552970|NCT05193500|451655258|FG003|Overall Study|Withdrawal by Subject|5|||
125552971|NCT04098068|451655259|FG000|Overall Study|Disease Progression|7|||
125552972|NCT04098068|451655259|FG000|Overall Study|Withdrawal by Subject|2|||
125552973|NCT04098068|451655259|FG000|Overall Study|New Cancer Diagnosis|1|||
125552974|NCT03871829|451655260|FG000|Overall Study|Lost to Follow-up|0|||
125552975|NCT03871829|451655261|FG001|Overall Study|Lost to Follow-up|1|||
125552976|NCT03871829|451655260|FG000|Overall Study|Withdrawal by Subject|1|||
125552977|NCT03871829|451655261|FG001|Overall Study|Withdrawal by Subject|1|||
125552978|NCT03871829|451655260|FG000|Overall Study|Death|12|||
125552979|NCT03871829|451655261|FG001|Overall Study|Death|8|||
125552980|NCT03871829|451655260|FG000|Overall Study|Study terminated by sponsor|31|||
125552981|NCT03871829|451655261|FG001|Overall Study|Study terminated by sponsor|34|||
125552982|NCT00784693|451655267|FG000|Overall Study|Lost to Follow-up|0|||
125552983|NCT00784693|451655268|FG001|Overall Study|Lost to Follow-up|1|||
125552984|NCT00784693|451655267|FG000|Overall Study|Lack of Efficacy|1|||
125552985|NCT00784693|451655268|FG001|Overall Study|Lack of Efficacy|1|||
125552986|NCT00784693|451655267|FG000|Overall Study|Withdrawal by Subject|0|||
125552987|NCT00784693|451655268|FG001|Overall Study|Withdrawal by Subject|4|||
125552988|NCT00784693|451655267|FG000|Overall Study|Randomized but not Treated|1|||
125552989|NCT00784693|451655268|FG001|Overall Study|Randomized but not Treated|0|||
125552990|NCT00784693|451655267|FG000|Overall Study|Other|1|||
125552991|NCT00784693|451655268|FG001|Overall Study|Other|0|||
125552992|NCT05458479|451655269|FG000|Overall Study|Lost to Follow-up|1|||
125552993|NCT01324323|451655270|FG000|Overall Study|Withdrawal by Subject|1|||
125552994|NCT00993915|451655277|FG000|Overall Study|Insufficient clinical response|3|||
125552995|NCT00993915|451655277|FG000|Overall Study|Withdrawal by Subject|2|||
125552996|NCT00993915|451655277|FG000|Overall Study|Other|1|||
125552997|NCT00993915|451655277|FG000|Overall Study|Ongoing|3|||
125552998|NCT02119325|451655278|FG000|Washout Period 1|Adverse Event|0|||
125552999|NCT02119325|451655279|FG001|Washout Period 1|Adverse Event|1|||
125553000|NCT01386658|451655280|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
125553001|NCT01386658|451655281|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
125553002|NCT01386658|451655280|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
125553003|NCT01386658|451655281|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
125553004|NCT02465463|451655290|FG000|Overall Study|Lost to Follow-up|2|||
125553005|NCT02465463|451655291|FG001|Overall Study|Lost to Follow-up|1|||
125553006|NCT02465463|451655290|FG000|Overall Study|Death|1|||
125553007|NCT02465463|451655291|FG001|Overall Study|Death|0|||
125553008|NCT02465463|451655290|FG000|Overall Study|Protocol Violation|1|||
125553009|NCT02465463|451655291|FG001|Overall Study|Protocol Violation|0|||
125553010|NCT03037619|451655295|FG000|Overall Study|Lost to Follow-up|0|||
125553011|NCT03037619|451655296|FG001|Overall Study|Lost to Follow-up|1|||
125553012|NCT01498289|451655297|FG000|Overall Study|Adverse Event|16|||
125553013|NCT01498289|451655298|FG001|Overall Study|Adverse Event|18|||
125553014|NCT01498289|451655297|FG000|Overall Study|Death|6|||
125553015|NCT01498289|451655298|FG001|Overall Study|Death|8|||
125553016|NCT01498289|451655297|FG000|Overall Study|Withdrawal unrelated to AE|16|||
125553017|NCT01498289|451655298|FG001|Overall Study|Withdrawal unrelated to AE|16|||
125553018|NCT01498289|451655297|FG000|Overall Study|Progression/relapse|53|||
125553019|NCT01498289|451655298|FG001|Overall Study|Progression/relapse|59|||
125553020|NCT01498289|451655297|FG000|Overall Study|Not protocol specified|7|||
125553021|NCT01498289|451655298|FG001|Overall Study|Not protocol specified|2|||
125553022|NCT01498289|451655297|FG000|Overall Study|Reason under review|0|||
125553023|NCT01498289|451655298|FG001|Overall Study|Reason under review|1|||
125553024|NCT01774084|451655299|FG000|Overall Study|Personal reasons|1|||
125553025|NCT01774084|451655300|FG001|Overall Study|Personal reasons|0|||
125553026|NCT00821431|451655301|FG000|Overall Study|Adverse Event|6|||
125553027|NCT00821431|451655302|FG001|Overall Study|Adverse Event|3|||
125553028|NCT00821431|451655301|FG000|Overall Study|Withdrawal by Subject|5|||
125553029|NCT00821431|451655302|FG001|Overall Study|Withdrawal by Subject|0|||
125553030|NCT00821431|451655301|FG000|Overall Study|Lost to Follow-up|1|||
125553031|NCT00821431|451655302|FG001|Overall Study|Lost to Follow-up|0|||
125553032|NCT00821431|451655301|FG000|Overall Study|Protocol Violation|3|||
125553033|NCT00821431|451655302|FG001|Overall Study|Protocol Violation|1|||
125553034|NCT00821431|451655301|FG000|Overall Study|Physician Decision|0|||
125553035|NCT00821431|451655302|FG001|Overall Study|Physician Decision|1|||
125553036|NCT04526197|451655304|FG000|Period 1|Adverse Event|0|||
125553037|NCT04526197|451655305|FG001|Period 1|Adverse Event|1|||
125553038|NCT04526197|451655304|FG000|Period 1|Withdrawal by Subject|1|||
125553039|NCT04526197|451655305|FG001|Period 1|Withdrawal by Subject|0|||
125553040|NCT04526197|451655304|FG000|Period 2|Adverse Event|0|||
125553041|NCT04526197|451655305|FG001|Period 2|Adverse Event|1|||
125553042|NCT04526197|451655304|FG000|Period 2|Withdrawal by Subject|0|||
125553043|NCT04526197|451655305|FG001|Period 2|Withdrawal by Subject|1|||
125553044|NCT00372385|451655306|FG000|Overall Study|Adverse Event|6|||
125553045|NCT00372385|451655307|FG001|Overall Study|Adverse Event|11|||
125553046|NCT00372385|451655308|FG002|Overall Study|Adverse Event|9|||
125553047|NCT00372385|451655309|FG003|Overall Study|Adverse Event|7|||
125553048|NCT00372385|451655306|FG000|Overall Study|Noncompliance|0|||
125553049|NCT00372385|451655307|FG001|Overall Study|Noncompliance|1|||
125350407|NCT00829933|450917062|FG002|Overall Study|Adverse Event|2|||
125350408|NCT00829933|450917063|FG003|Overall Study|Adverse Event|1|||
125350409|NCT00829933|450917060|FG000|Overall Study|Death|0|||
125553050|NCT00372385|451655308|FG002|Overall Study|Noncompliance|1|||
125350410|NCT00829933|450917061|FG001|Overall Study|Death|0|||
125553051|NCT00372385|451655309|FG003|Overall Study|Noncompliance|1|||
125553052|NCT00372385|451655306|FG000|Overall Study|Physician Decision|1|||
125553053|NCT00372385|451655307|FG001|Overall Study|Physician Decision|0|||
125553054|NCT00372385|451655308|FG002|Overall Study|Physician Decision|0|||
125553055|NCT00372385|451655309|FG003|Overall Study|Physician Decision|0|||
125553056|NCT00372385|451655306|FG000|Overall Study|Lost to Follow-up|2|||
125553057|NCT00372385|451655307|FG001|Overall Study|Lost to Follow-up|0|||
125553058|NCT00372385|451655308|FG002|Overall Study|Lost to Follow-up|0|||
125350411|NCT00829933|450917062|FG002|Overall Study|Death|1|||
125553059|NCT00372385|451655309|FG003|Overall Study|Lost to Follow-up|0|||
125553060|NCT00372385|451655306|FG000|Overall Study|Withdrawal by Subject|2|||
125553061|NCT00372385|451655307|FG001|Overall Study|Withdrawal by Subject|1|||
125553062|NCT00372385|451655308|FG002|Overall Study|Withdrawal by Subject|0|||
125553063|NCT00372385|451655309|FG003|Overall Study|Withdrawal by Subject|0|||
125553064|NCT00372385|451655306|FG000|Overall Study|Refusal of Treatment|3|||
125553065|NCT00372385|451655307|FG001|Overall Study|Refusal of Treatment|6|||
125553066|NCT00372385|451655308|FG002|Overall Study|Refusal of Treatment|0|||
125553067|NCT00372385|451655309|FG003|Overall Study|Refusal of Treatment|0|||
125553068|NCT00372385|451655306|FG000|Overall Study|No Response|1|||
125553069|NCT00372385|451655307|FG001|Overall Study|No Response|1|||
125553070|NCT00372385|451655308|FG002|Overall Study|No Response|0|||
125553071|NCT00372385|451655309|FG003|Overall Study|No Response|0|||
125553072|NCT00372385|451655306|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
125553073|NCT00372385|451655307|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
125553074|NCT00372385|451655308|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
125553075|NCT00372385|451655309|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
125553076|NCT00372385|451655306|FG000|Overall Study|Virologic Stopping Rule|17|||
125553077|NCT00372385|451655307|FG001|Overall Study|Virologic Stopping Rule|0|||
125553078|NCT00372385|451655308|FG002|Overall Study|Virologic Stopping Rule|0|||
125553079|NCT00372385|451655309|FG003|Overall Study|Virologic Stopping Rule|0|||
125553080|NCT01699789|451655310|FG000|Overall Study|Withdrawal by Subject|18|||
125553081|NCT01699789|451655311|FG001|Overall Study|Withdrawal by Subject|23|||
125553082|NCT01699789|451655310|FG000|Overall Study|Death|1|||
125553083|NCT01699789|451655311|FG001|Overall Study|Death|2|||
125553084|NCT01699789|451655310|FG000|Overall Study|Lost to Follow-up|83|||
125553085|NCT01699789|451655311|FG001|Overall Study|Lost to Follow-up|101|||
125553086|NCT02411578|451655314|FG000|Crossover Trial Phase|Pregnancy|0|||
125553087|NCT02411578|451655315|FG001|Crossover Trial Phase|Pregnancy|1|||
125553088|NCT01557348|451655316|FG000|Overall Study|Adverse Event|6|||
125553089|NCT01557348|451655317|FG001|Overall Study|Adverse Event|16|||
125553090|NCT01557348|451655316|FG000|Overall Study|Infusion reaction event|5|||
125553091|NCT01557348|451655317|FG001|Overall Study|Infusion reaction event|5|||
125553092|NCT01557348|451655316|FG000|Overall Study|Death|7|||
125553093|NCT01557348|451655317|FG001|Overall Study|Death|4|||
125553094|NCT01557348|451655316|FG000|Overall Study|Insufficient Therapeutic Response|13|||
125553095|NCT01557348|451655317|FG001|Overall Study|Insufficient Therapeutic Response|28|||
125553096|NCT01557348|451655316|FG000|Overall Study|Withdrawal by Subject|5|||
125553097|NCT01557348|451655317|FG001|Overall Study|Withdrawal by Subject|4|||
125553098|NCT01557348|451655316|FG000|Overall Study|Lost to Follow-up|26|||
125553099|NCT01557348|451655317|FG001|Overall Study|Lost to Follow-up|22|||
125553100|NCT01557348|451655316|FG000|Overall Study|Administrative|18|||
125553101|NCT01557348|451655317|FG001|Overall Study|Administrative|11|||
125553102|NCT05125679|451655318|FG000|Overall Study|Study Terminated by Sponsor|2|||
125553103|NCT05125679|451655319|FG001|Overall Study|Study Terminated by Sponsor|5|||
125553104|NCT04484259|451655320|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
125553105|NCT04484259|451655321|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
125553106|NCT04484259|451655322|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
125553107|NCT04484259|451655323|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
125553108|NCT04484259|451655324|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
125553109|NCT04484259|451655320|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
125553110|NCT04484259|451655321|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
125553111|NCT04484259|451655322|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
125553112|NCT04484259|451655323|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
125553113|NCT04484259|451655324|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
125553114|NCT04484259|451655320|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
125553115|NCT04484259|451655321|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
125553116|NCT04484259|451655322|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
125553117|NCT04484259|451655323|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
125553118|NCT04484259|451655324|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
125553119|NCT04484259|451655320|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
125553120|NCT04484259|451655321|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
125553121|NCT04484259|451655322|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
125553122|NCT04484259|451655323|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
125553123|NCT04484259|451655324|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
125553124|NCT04484259|451655320|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
125553125|NCT04484259|451655321|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
125553126|NCT04484259|451655322|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
125553127|NCT04484259|451655323|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
125553128|NCT04484259|451655324|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
125553129|NCT04484259|451655320|FG000|Randomized Treatment|Withdrawal by Subject|1|||
125553130|NCT04484259|451655321|FG001|Randomized Treatment|Withdrawal by Subject|0|||
125553131|NCT04484259|451655322|FG002|Randomized Treatment|Withdrawal by Subject|0|||
125553132|NCT04484259|451655323|FG003|Randomized Treatment|Withdrawal by Subject|0|||
125553133|NCT04484259|451655324|FG004|Randomized Treatment|Withdrawal by Subject|0|||
125553134|NCT01422850|451655333|FG000|Overall Study|Physician Decision|3|||
125553135|NCT04484831|451655334|FG000|Overall Study|Withdrawal by Subject|1|||
125553136|NCT04484831|451655335|FG001|Overall Study|Withdrawal by Subject|0|||
125553137|NCT02244996|451655336|FG000|Overall Study|Lack of Efficacy|2|||
125553138|NCT02244996|451655337|FG001|Overall Study|Lack of Efficacy|6|||
125553139|NCT01335009|451655338|FG000|Overall Study|Too ill to travel to study sites|1|||
125553140|NCT01335009|451655339|FG001|Overall Study|Too ill to travel to study sites|0|||
125553141|NCT01335009|451655338|FG000|Overall Study|Death|28|||
125553142|NCT01335009|451655339|FG001|Overall Study|Death|32|||
125553143|NCT01335009|451655338|FG000|Overall Study|Withdrawal by Subject|1|||
125553144|NCT01335009|451655339|FG001|Overall Study|Withdrawal by Subject|1|||
125553145|NCT01335009|451655338|FG000|Overall Study|Lost to Follow-up|1|||
125553146|NCT01335009|451655339|FG001|Overall Study|Lost to Follow-up|0|||
125553147|NCT04751656|451656838|FG000|Overall Study|Lost to Follow-up|1|||
125553148|NCT01128361|451656850|FG000|Overall Study|Lost to Follow-up|0|||
125553149|NCT01128361|451656851|FG001|Overall Study|Lost to Follow-up|1|||
125553150|NCT01128361|451656850|FG000|Overall Study|Withdrawal by Subject|5|||
125553151|NCT01128361|451656851|FG001|Overall Study|Withdrawal by Subject|2|||
125553152|NCT00146328|451656852|FG000|Overall Study|Adverse Event|39|||
125553153|NCT00146328|451656853|FG001|Overall Study|Adverse Event|48|||
125553154|NCT00146328|451656854|FG002|Overall Study|Adverse Event|79|||
125553155|NCT00146328|451656852|FG000|Overall Study|Protocol Violation|11|||
125553156|NCT00146328|451656853|FG001|Overall Study|Protocol Violation|6|||
125553157|NCT00146328|451656854|FG002|Overall Study|Protocol Violation|12|||
125553158|NCT00146328|451656852|FG000|Overall Study|Lost to Follow-up|7|||
125553159|NCT00146328|451656853|FG001|Overall Study|Lost to Follow-up|4|||
125553160|NCT00146328|451656854|FG002|Overall Study|Lost to Follow-up|7|||
125553161|NCT00146328|451656852|FG000|Overall Study|Withdrawal by Subject|16|||
125553162|NCT00146328|451656853|FG001|Overall Study|Withdrawal by Subject|16|||
125553163|NCT00146328|451656854|FG002|Overall Study|Withdrawal by Subject|22|||
125553164|NCT00146328|451656852|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
125553165|NCT00146328|451656853|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
125553166|NCT00146328|451656854|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
125553167|NCT00146328|451656852|FG000|Overall Study|Trial ended/site closed|8|||
125553168|NCT00146328|451656853|FG001|Overall Study|Trial ended/site closed|2|||
125553169|NCT00146328|451656854|FG002|Overall Study|Trial ended/site closed|19|||
125553170|NCT00146328|451656852|FG000|Overall Study|Patient decision to end|0|||
125553171|NCT00146328|451656853|FG001|Overall Study|Patient decision to end|1|||
125553172|NCT00146328|451656854|FG002|Overall Study|Patient decision to end|6|||
125553173|NCT00146328|451656852|FG000|Overall Study|Enroll into other trial|2|||
125553174|NCT00146328|451656853|FG001|Overall Study|Enroll into other trial|4|||
125553175|NCT00146328|451656854|FG002|Overall Study|Enroll into other trial|2|||
125553176|NCT00146328|451656852|FG000|Overall Study|Death|0|||
125553177|NCT00146328|451656853|FG001|Overall Study|Death|1|||
125553178|NCT00146328|451656854|FG002|Overall Study|Death|1|||
125553179|NCT00146328|451656852|FG000|Overall Study|Moved|2|||
125553180|NCT00146328|451656853|FG001|Overall Study|Moved|0|||
125553181|NCT00146328|451656854|FG002|Overall Study|Moved|0|||
125553182|NCT00146328|451656852|FG000|Overall Study|Interaction with other medication|2|||
125553183|NCT00146328|451656853|FG001|Overall Study|Interaction with other medication|0|||
125553184|NCT00146328|451656854|FG002|Overall Study|Interaction with other medication|1|||
125553185|NCT01256658|451656855|FG000|Period 1|Lost to Follow-up|837|||
125553186|NCT01256658|451656856|FG001|Period 1|Lost to Follow-up|661|||
125553187|NCT01256658|451656855|FG000|Period 1|Withdrawal by Subject|35|||
125553188|NCT01256658|451656856|FG001|Period 1|Withdrawal by Subject|43|||
125553189|NCT01256658|451656855|FG000|Period 1|Death|48|||
125553190|NCT01256658|451656856|FG001|Period 1|Death|44|||
125553191|NCT00300781|451656857|FG000|Overall Study|Disease Progression|55|||
125553192|NCT00300781|451656858|FG001|Overall Study|Disease Progression|52|||
125553193|NCT00300781|451656857|FG000|Overall Study|Adverse Event|5|||
125553194|NCT00300781|451656858|FG001|Overall Study|Adverse Event|6|||
125553195|NCT00300781|451656857|FG000|Overall Study|Withdrawal by Subject|1|||
125553196|NCT00300781|451656858|FG001|Overall Study|Withdrawal by Subject|2|||
125553197|NCT00300781|451656857|FG000|Overall Study|Physician Decision|1|||
125553198|NCT00300781|451656858|FG001|Overall Study|Physician Decision|0|||
125553199|NCT00300781|451656857|FG000|Overall Study|Not Recorded|0|||
125553200|NCT00300781|451656858|FG001|Overall Study|Not Recorded|1|||
125553201|NCT00300781|451656857|FG000|Overall Study|Symptomatic Deterioration|1|||
125553202|NCT00300781|451656858|FG001|Overall Study|Symptomatic Deterioration|0|||
125553203|NCT00300781|451656857|FG000|Overall Study|Lost to Follow-up|0|||
125553204|NCT00300781|451656858|FG001|Overall Study|Lost to Follow-up|1|||
125553205|NCT02072434|451656862|FG000|Overall Study|Protocol Violation|10|||
125553206|NCT02072434|451656863|FG001|Overall Study|Protocol Violation|9|||
125553207|NCT02072434|451656862|FG000|Overall Study|Physician Decision|5|||
125553208|NCT02072434|451656863|FG001|Overall Study|Physician Decision|10|||
125553209|NCT02072434|451656862|FG000|Overall Study|Adverse event, serious fatal|1|||
125553210|NCT02072434|451656863|FG001|Overall Study|Adverse event, serious fatal|6|||
125553211|NCT02072434|451656862|FG000|Overall Study|Adverse Event|7|||
125553212|NCT02072434|451656863|FG001|Overall Study|Adverse Event|6|||
125553213|NCT02072434|451656862|FG000|Overall Study|Withdrawal by Subject|17|||
125553214|NCT02072434|451656863|FG001|Overall Study|Withdrawal by Subject|29|||
125553215|NCT02072434|451656862|FG000|Overall Study|Other|14|||
125553216|NCT02072434|451656863|FG001|Overall Study|Other|29|||
125553217|NCT02072434|451656862|FG000|Overall Study|Lost to Follow-up|0|||
125553218|NCT02072434|451656863|FG001|Overall Study|Lost to Follow-up|1|||
125553219|NCT02525861|451656866|FG000|Overall Study|Adverse Event|1|||
125553220|NCT02525861|451656867|FG001|Overall Study|Adverse Event|0|||
125553221|NCT02525861|451656866|FG000|Overall Study|Withdrawal by Subject|0|||
125553222|NCT02525861|451656867|FG001|Overall Study|Withdrawal by Subject|1|||
125553223|NCT02525861|451656866|FG000|Overall Study|Physician Decision|0|||
125553224|NCT02525861|451656867|FG001|Overall Study|Physician Decision|1|||
125553225|NCT01117454|451656870|FG000|Overall Study|Pregnancy|0|||
125553226|NCT01117454|451656871|FG001|Overall Study|Pregnancy|1|||
125553227|NCT00888433|451656872|FG000|Overall Study|Withdrawal by Subject|1|||
125553228|NCT00888433|451656873|FG001|Overall Study|Withdrawal by Subject|2|||
125553229|NCT00888433|451656872|FG000|Overall Study|Missed Visit|2|||
125553230|NCT00888433|451656873|FG001|Overall Study|Missed Visit|1|||
125553231|NCT01681628|451656874|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
125553232|NCT01681628|451656875|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
125553233|NCT01681628|451656874|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
125553234|NCT01681628|451656875|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
125553235|NCT01681628|451656874|FG000|19 Months Follow-up|Death|1|||
125553236|NCT01681628|451656875|FG001|19 Months Follow-up|Death|0|||
125553237|NCT01681628|451656874|FG000|19 Months Follow-up|Lost to Follow-up|61|||
125553238|NCT01681628|451656875|FG001|19 Months Follow-up|Lost to Follow-up|43|||
125553239|NCT01794520|451656878|FG000|Overall Study|Adverse events- related to progression|0|||
125553240|NCT01794520|451656879|FG001|Overall Study|Adverse events- related to progression|0|||
125553241|NCT01794520|451656880|FG002|Overall Study|Adverse events- related to progression|1|||
125553242|NCT01794520|451656881|FG003|Overall Study|Adverse events- related to progression|2|||
125553243|NCT01794520|451656882|FG004|Overall Study|Adverse events- related to progression|0|||
125553244|NCT01794520|451656883|FG005|Overall Study|Adverse events- related to progression|1|||
125553245|NCT01794520|451656884|FG006|Overall Study|Adverse events- related to progression|0|||
125553246|NCT01794520|451656878|FG000|Overall Study|Adverse event- not related to progression|1|||
125553247|NCT01794520|451656879|FG001|Overall Study|Adverse event- not related to progression|1|||
125553248|NCT01794520|451656880|FG002|Overall Study|Adverse event- not related to progression|0|||
125553249|NCT01794520|451656881|FG003|Overall Study|Adverse event- not related to progression|0|||
125553250|NCT01794520|451656882|FG004|Overall Study|Adverse event- not related to progression|2|||
125553251|NCT01794520|451656883|FG005|Overall Study|Adverse event- not related to progression|0|||
125553252|NCT01794520|451656884|FG006|Overall Study|Adverse event- not related to progression|0|||
125553253|NCT01794520|451656878|FG000|Overall Study|Progressive disease|5|||
125553254|NCT01794520|451656879|FG001|Overall Study|Progressive disease|6|||
125553255|NCT01794520|451656880|FG002|Overall Study|Progressive disease|2|||
125553256|NCT01794520|451656881|FG003|Overall Study|Progressive disease|5|||
125553257|NCT01794520|451656882|FG004|Overall Study|Progressive disease|27|||
125553258|NCT01794520|451656883|FG005|Overall Study|Progressive disease|18|||
125350412|NCT00829933|450917063|FG003|Overall Study|Death|1|||
125350413|NCT00829933|450917060|FG000|Overall Study|Lack of Efficacy|0|||
125553259|NCT01794520|451656884|FG006|Overall Study|Progressive disease|0|||
125553260|NCT01794520|451656878|FG000|Overall Study|Withdrew consent|0|||
125553261|NCT01794520|451656879|FG001|Overall Study|Withdrew consent|0|||
125553262|NCT01794520|451656880|FG002|Overall Study|Withdrew consent|1|||
125553263|NCT01794520|451656881|FG003|Overall Study|Withdrew consent|1|||
125553264|NCT01794520|451656882|FG004|Overall Study|Withdrew consent|0|||
125553265|NCT01794520|451656883|FG005|Overall Study|Withdrew consent|0|||
125553266|NCT01794520|451656884|FG006|Overall Study|Withdrew consent|0|||
125553267|NCT01794520|451656878|FG000|Overall Study|Lost to Follow-up|0|||
125553268|NCT01794520|451656879|FG001|Overall Study|Lost to Follow-up|0|||
125553269|NCT01794520|451656880|FG002|Overall Study|Lost to Follow-up|0|||
125553270|NCT01794520|451656881|FG003|Overall Study|Lost to Follow-up|0|||
125553271|NCT01794520|451656882|FG004|Overall Study|Lost to Follow-up|1|||
125553272|NCT01794520|451656883|FG005|Overall Study|Lost to Follow-up|0|||
125350414|NCT00829933|450917061|FG001|Overall Study|Lack of Efficacy|1|||
125350415|NCT00829933|450917062|FG002|Overall Study|Lack of Efficacy|0|||
125350416|NCT00829933|450917063|FG003|Overall Study|Lack of Efficacy|0|||
125350417|NCT00829933|450917060|FG000|Overall Study|Physician Decision|5|||
125350418|NCT00829933|450917061|FG001|Overall Study|Physician Decision|7|||
125350419|NCT00829933|450917062|FG002|Overall Study|Physician Decision|8|||
125350420|NCT00829933|450917063|FG003|Overall Study|Physician Decision|1|||
125350421|NCT00829933|450917060|FG000|Overall Study|Pregnancy|0|||
125350422|NCT00829933|450917061|FG001|Overall Study|Pregnancy|0|||
125350423|NCT00829933|450917062|FG002|Overall Study|Pregnancy|0|||
125350424|NCT00829933|450917063|FG003|Overall Study|Pregnancy|2|||
125350425|NCT00829933|450917060|FG000|Overall Study|Protocol Violation|2|||
125350426|NCT00829933|450917061|FG001|Overall Study|Protocol Violation|1|||
125350427|NCT00829933|450917062|FG002|Overall Study|Protocol Violation|0|||
125350428|NCT00829933|450917063|FG003|Overall Study|Protocol Violation|0|||
125350429|NCT00829933|450917060|FG000|Overall Study|withdrew before treatment started|5|||
125553273|NCT01794520|451656884|FG006|Overall Study|Lost to Follow-up|0|||
125553274|NCT01794520|451656878|FG000|Overall Study|Toxicity|0|||
125350430|NCT00829933|450917061|FG001|Overall Study|withdrew before treatment started|1|||
125350431|NCT00829933|450917062|FG002|Overall Study|withdrew before treatment started|2|||
125350432|NCT00829933|450917063|FG003|Overall Study|withdrew before treatment started|9|||
125350433|NCT01986933|450917068|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
125350434|NCT01986933|450917069|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
125350435|NCT01986933|450917070|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
125350436|NCT01986933|450917071|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
125350437|NCT01986933|450917072|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
125350438|NCT01986933|450917068|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
125350439|NCT01986933|450917069|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
125553275|NCT01794520|451656879|FG001|Overall Study|Toxicity|2|||
125553276|NCT01794520|451656880|FG002|Overall Study|Toxicity|0|||
125553277|NCT01794520|451656881|FG003|Overall Study|Toxicity|0|||
125553278|NCT01794520|451656882|FG004|Overall Study|Toxicity|0|||
125553279|NCT01794520|451656883|FG005|Overall Study|Toxicity|0|||
125553280|NCT01794520|451656884|FG006|Overall Study|Toxicity|0|||
125350440|NCT01986933|450917070|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
125350441|NCT01986933|450917071|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
125553281|NCT01794520|451656878|FG000|Overall Study|Study terminated by sponsor|0|||
125553282|NCT01794520|451656879|FG001|Overall Study|Study terminated by sponsor|0|||
125553283|NCT01794520|451656880|FG002|Overall Study|Study terminated by sponsor|1|||
125553284|NCT01794520|451656881|FG003|Overall Study|Study terminated by sponsor|0|||
125553285|NCT01794520|451656882|FG004|Overall Study|Study terminated by sponsor|1|||
125553286|NCT01794520|451656883|FG005|Overall Study|Study terminated by sponsor|0|||
125350442|NCT01986933|450917072|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
125553287|NCT01794520|451656884|FG006|Overall Study|Study terminated by sponsor|7|||
125553288|NCT01794520|451656878|FG000|Overall Study|Death|0|||
125350443|NCT01986933|450917068|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
125350444|NCT01986933|450917069|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
125350445|NCT01986933|450917070|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
125553289|NCT01794520|451656879|FG001|Overall Study|Death|0|||
125553290|NCT01794520|451656880|FG002|Overall Study|Death|0|||
125553291|NCT01794520|451656881|FG003|Overall Study|Death|0|||
125553292|NCT01794520|451656882|FG004|Overall Study|Death|1|||
125553293|NCT01794520|451656883|FG005|Overall Study|Death|0|||
125350446|NCT01986933|450917071|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
125553294|NCT01794520|451656884|FG006|Overall Study|Death|22|||
125350447|NCT01986933|450917072|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
125350448|NCT01986933|450917068|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
125350449|NCT01986933|450917069|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
125350450|NCT01986933|450917070|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
125350451|NCT01986933|450917071|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
125350452|NCT01986933|450917072|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
125350453|NCT01986933|450917068|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
125378925|NCT00531050|451019212|FG004|Part 1: Period 1|Adverse Event|0|||
125553295|NCT01794520|451656878|FG000|Overall Study|Other, not specified|0|||
125553296|NCT01794520|451656879|FG001|Overall Study|Other, not specified|0|||
125553297|NCT01794520|451656880|FG002|Overall Study|Other, not specified|1|||
125553298|NCT01794520|451656881|FG003|Overall Study|Other, not specified|1|||
125553299|NCT01794520|451656882|FG004|Overall Study|Other, not specified|4|||
125553300|NCT01794520|451656883|FG005|Overall Study|Other, not specified|1|||
125553301|NCT01794520|451656884|FG006|Overall Study|Other, not specified|2|||
125553302|NCT04796896|451656888|FG000|Overall Study|Adverse Event|1|||
125553303|NCT04796896|451656889|FG001|Overall Study|Adverse Event|0|||
125553304|NCT04796896|451656890|FG002|Overall Study|Adverse Event|0|||
125553305|NCT04796896|451656891|FG003|Overall Study|Adverse Event|0|||
125553306|NCT04796896|451656892|FG004|Overall Study|Adverse Event|0|||
125553307|NCT04796896|451656893|FG005|Overall Study|Adverse Event|1|||
125553308|NCT04796896|451656894|FG006|Overall Study|Adverse Event|1|||
125553309|NCT04796896|451656895|FG007|Overall Study|Adverse Event|0|||
125553310|NCT04796896|451656896|FG008|Overall Study|Adverse Event|1|||
125553311|NCT04796896|451656897|FG009|Overall Study|Adverse Event|1|||
125553312|NCT04796896|451656898|FG010|Overall Study|Adverse Event|1|||
125553313|NCT04796896|451656899|FG011|Overall Study|Adverse Event|0|||
125553314|NCT04796896|451656888|FG000|Overall Study|Lost to Follow-up|24|||
125553315|NCT04796896|451656889|FG001|Overall Study|Lost to Follow-up|15|||
125553316|NCT04796896|451656890|FG002|Overall Study|Lost to Follow-up|6|||
125553317|NCT04796896|451656891|FG003|Overall Study|Lost to Follow-up|4|||
125553318|NCT04796896|451656892|FG004|Overall Study|Lost to Follow-up|21|||
125553319|NCT04796896|451656893|FG005|Overall Study|Lost to Follow-up|55|||
125553320|NCT04796896|451656894|FG006|Overall Study|Lost to Follow-up|237|||
125553321|NCT04796896|451656895|FG007|Overall Study|Lost to Follow-up|52|||
125553322|NCT04796896|451656896|FG008|Overall Study|Lost to Follow-up|221|||
125553323|NCT04796896|451656897|FG009|Overall Study|Lost to Follow-up|43|||
125553324|NCT04796896|451656898|FG010|Overall Study|Lost to Follow-up|142|||
125553325|NCT04796896|451656899|FG011|Overall Study|Lost to Follow-up|18|||
125553326|NCT04796896|451656888|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
125553327|NCT04796896|451656889|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
125553328|NCT04796896|451656890|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
125553329|NCT04796896|451656891|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
125553330|NCT04796896|451656892|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
125553331|NCT04796896|451656893|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
125553332|NCT04796896|451656894|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
125553333|NCT04796896|451656895|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
125553334|NCT04796896|451656896|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
125553335|NCT04796896|451656897|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
125553336|NCT04796896|451656898|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
125553337|NCT04796896|451656899|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
125553338|NCT04796896|451656888|FG000|Overall Study|Physician Decision|1|||
125553339|NCT04796896|451656889|FG001|Overall Study|Physician Decision|0|||
125553340|NCT04796896|451656890|FG002|Overall Study|Physician Decision|0|||
125553341|NCT04796896|451656891|FG003|Overall Study|Physician Decision|0|||
125553342|NCT04796896|451656892|FG004|Overall Study|Physician Decision|0|||
125553343|NCT04796896|451656893|FG005|Overall Study|Physician Decision|3|||
125553344|NCT04796896|451656894|FG006|Overall Study|Physician Decision|18|||
125553345|NCT04796896|451656895|FG007|Overall Study|Physician Decision|1|||
125553346|NCT04796896|451656896|FG008|Overall Study|Physician Decision|7|||
125553347|NCT04796896|451656897|FG009|Overall Study|Physician Decision|0|||
125553348|NCT04796896|451656898|FG010|Overall Study|Physician Decision|5|||
125553349|NCT04796896|451656899|FG011|Overall Study|Physician Decision|0|||
125553350|NCT04796896|451656888|FG000|Overall Study|Withdrawal by Subject|36|||
125553351|NCT04796896|451656889|FG001|Overall Study|Withdrawal by Subject|31|||
125553352|NCT04796896|451656890|FG002|Overall Study|Withdrawal by Subject|11|||
125553353|NCT04796896|451656891|FG003|Overall Study|Withdrawal by Subject|8|||
125553354|NCT04796896|451656892|FG004|Overall Study|Withdrawal by Subject|16|||
125553355|NCT04796896|451656893|FG005|Overall Study|Withdrawal by Subject|162|||
125553356|NCT04796896|451656894|FG006|Overall Study|Withdrawal by Subject|299|||
125553357|NCT04796896|451656895|FG007|Overall Study|Withdrawal by Subject|149|||
125553358|NCT04796896|451656896|FG008|Overall Study|Withdrawal by Subject|303|||
125553359|NCT04796896|451656897|FG009|Overall Study|Withdrawal by Subject|94|||
125553360|NCT04796896|451656898|FG010|Overall Study|Withdrawal by Subject|192|||
125553361|NCT04796896|451656899|FG011|Overall Study|Withdrawal by Subject|16|||
125553362|NCT04796896|451656888|FG000|Overall Study|Other Than Specified|6|||
125553363|NCT04796896|451656889|FG001|Overall Study|Other Than Specified|5|||
125553364|NCT04796896|451656890|FG002|Overall Study|Other Than Specified|3|||
125553365|NCT04796896|451656891|FG003|Overall Study|Other Than Specified|2|||
125553366|NCT04796896|451656892|FG004|Overall Study|Other Than Specified|6|||
125553367|NCT04796896|451656893|FG005|Overall Study|Other Than Specified|31|||
125553368|NCT04796896|451656894|FG006|Overall Study|Other Than Specified|86|||
125553369|NCT04796896|451656895|FG007|Overall Study|Other Than Specified|66|||
125553370|NCT04796896|451656896|FG008|Overall Study|Other Than Specified|388|||
125553371|NCT04796896|451656897|FG009|Overall Study|Other Than Specified|48|||
125553372|NCT04796896|451656898|FG010|Overall Study|Other Than Specified|258|||
125553373|NCT04796896|451656899|FG011|Overall Study|Other Than Specified|4|||
125553374|NCT04796896|451656888|FG000|Overall Study|Protocol Deviation|0|||
125553375|NCT04796896|451656889|FG001|Overall Study|Protocol Deviation|0|||
125553376|NCT04796896|451656890|FG002|Overall Study|Protocol Deviation|0|||
125553377|NCT04796896|451656891|FG003|Overall Study|Protocol Deviation|1|||
125553378|NCT04796896|451656892|FG004|Overall Study|Protocol Deviation|1|||
125553379|NCT04796896|451656893|FG005|Overall Study|Protocol Deviation|2|||
125553380|NCT04796896|451656894|FG006|Overall Study|Protocol Deviation|2|||
125553381|NCT04796896|451656895|FG007|Overall Study|Protocol Deviation|2|||
125553382|NCT04796896|451656896|FG008|Overall Study|Protocol Deviation|2|||
125553383|NCT04796896|451656897|FG009|Overall Study|Protocol Deviation|1|||
125553384|NCT04796896|451656898|FG010|Overall Study|Protocol Deviation|0|||
125553385|NCT04796896|451656899|FG011|Overall Study|Protocol Deviation|0|||
125553386|NCT04796896|451656888|FG000|Overall Study|Missing|0|||
125553387|NCT04796896|451656889|FG001|Overall Study|Missing|0|||
125553388|NCT04796896|451656890|FG002|Overall Study|Missing|0|||
125553389|NCT04796896|451656891|FG003|Overall Study|Missing|0|||
125553390|NCT04796896|451656892|FG004|Overall Study|Missing|0|||
125553391|NCT04796896|451656893|FG005|Overall Study|Missing|0|||
125553392|NCT04796896|451656894|FG006|Overall Study|Missing|2|||
125553393|NCT04796896|451656895|FG007|Overall Study|Missing|1|||
125553394|NCT04796896|451656896|FG008|Overall Study|Missing|2|||
125553395|NCT04796896|451656897|FG009|Overall Study|Missing|1|||
125553396|NCT04796896|451656898|FG010|Overall Study|Missing|1|||
125553397|NCT04796896|451656899|FG011|Overall Study|Missing|0|||
125553398|NCT04796896|451656888|FG000|Overall Study|Death|0|||
125553399|NCT04796896|451656889|FG001|Overall Study|Death|0|||
125553400|NCT04796896|451656890|FG002|Overall Study|Death|0|||
125553401|NCT04796896|451656891|FG003|Overall Study|Death|0|||
125553402|NCT04796896|451656892|FG004|Overall Study|Death|0|||
125553403|NCT04796896|451656893|FG005|Overall Study|Death|0|||
125553404|NCT04796896|451656894|FG006|Overall Study|Death|0|||
125553405|NCT04796896|451656895|FG007|Overall Study|Death|0|||
125553406|NCT04796896|451656896|FG008|Overall Study|Death|1|||
125553407|NCT04796896|451656897|FG009|Overall Study|Death|0|||
125553408|NCT04796896|451656898|FG010|Overall Study|Death|0|||
125553409|NCT04796896|451656899|FG011|Overall Study|Death|0|||
125553410|NCT04356183|451656900|FG000|Overall Study|Lost to Follow-up|1|||
125553411|NCT04356183|451656901|FG001|Overall Study|Lost to Follow-up|0|||
125553412|NCT04356183|451656900|FG000|Overall Study|Withdrawal by Subject|1|||
125553413|NCT04356183|451656901|FG001|Overall Study|Withdrawal by Subject|1|||
125553414|NCT02170389|451656908|FG000|Overall Study|Study terminated prior to start of treat|1|||
125553415|NCT00667355|451656909|FG000|Overall Study|Adverse Event|5|||
125553416|NCT00667355|451656909|FG000|Overall Study|Lost to Follow-up|1|||
125553417|NCT00667355|451656909|FG000|Overall Study|Other reason was not specified|5|||
125553418|NCT02175004|451656911|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
125553419|NCT02175004|451656912|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
125553420|NCT02175004|451656911|FG000|Overall Study|Investigator Judgment|1|||
125553421|NCT02175004|451656912|FG001|Overall Study|Investigator Judgment|4|||
125553422|NCT02175004|451656911|FG000|Overall Study|Voluntary Withdrawal|6|||
125553423|NCT02175004|451656912|FG001|Overall Study|Voluntary Withdrawal|19|||
125553424|NCT02175004|451656911|FG000|Overall Study|Liver Transplant|1|||
125553425|NCT02175004|451656912|FG001|Overall Study|Liver Transplant|0|||
125553426|NCT02175004|451656911|FG000|Overall Study|Disease Progression|1|||
125553427|NCT02175004|451656912|FG001|Overall Study|Disease Progression|0|||
125553428|NCT02175004|451656911|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
125553429|NCT02175004|451656912|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
125553430|NCT02960854|451656913|FG000|Overall Study|Not Disclosed|2|||
125553431|NCT02960854|451656914|FG001|Overall Study|Not Disclosed|2|||
125553432|NCT02960854|451656913|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
125553433|NCT02960854|451656914|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
125553434|NCT02960854|451656913|FG000|Overall Study|Subject Withdrew Consent|0|||
125553435|NCT02960854|451656914|FG001|Overall Study|Subject Withdrew Consent|1|||
125553436|NCT02960854|451656913|FG000|Overall Study|Death|4|||
125553437|NCT02960854|451656914|FG001|Overall Study|Death|6|||
125553438|NCT01383161|451656915|FG000|Overall Study|Adverse Event|5|||
125553439|NCT01383161|451656916|FG001|Overall Study|Adverse Event|1|||
125553440|NCT01383161|451656915|FG000|Overall Study|Withdrawal by Subject|0|||
125553441|NCT01383161|451656916|FG001|Overall Study|Withdrawal by Subject|2|||
125553442|NCT01383161|451656915|FG000|Overall Study|Lack of Efficacy|0|||
125553443|NCT01383161|451656916|FG001|Overall Study|Lack of Efficacy|1|||
125553444|NCT03942406|451656923|FG000|Overall Study|Lost to Follow-up|4|||
125553445|NCT03942406|451656924|FG001|Overall Study|Lost to Follow-up|5|||
125553446|NCT03942406|451656925|FG002|Overall Study|Lost to Follow-up|3|||
125553447|NCT03942406|451656926|FG003|Overall Study|Lost to Follow-up|7|||
125553448|NCT03942406|451656927|FG004|Overall Study|Lost to Follow-up|1|||
125553449|NCT03942406|451656928|FG005|Overall Study|Lost to Follow-up|0|||
125553450|NCT03942406|451656929|FG006|Overall Study|Lost to Follow-up|0|||
125553451|NCT03942406|451656923|FG000|Overall Study|Withdrawal by Subject|3|||
125553452|NCT03942406|451656924|FG001|Overall Study|Withdrawal by Subject|1|||
125553453|NCT03942406|451656925|FG002|Overall Study|Withdrawal by Subject|1|||
125553454|NCT03942406|451656926|FG003|Overall Study|Withdrawal by Subject|3|||
125553455|NCT03942406|451656927|FG004|Overall Study|Withdrawal by Subject|0|||
125553456|NCT03942406|451656928|FG005|Overall Study|Withdrawal by Subject|0|||
125553457|NCT03942406|451656929|FG006|Overall Study|Withdrawal by Subject|0|||
125553458|NCT03942406|451656923|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
125553459|NCT03942406|451656924|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
125553460|NCT03942406|451656925|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
125553461|NCT03942406|451656926|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
125553462|NCT03942406|451656927|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
125553463|NCT03942406|451656928|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
125553464|NCT03942406|451656929|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
125553465|NCT00216203|451656932|FG000|Overall Study|Withdrawal by Subject|2|||
125553466|NCT04263909|451656933|FG000|Overall Study|Physician Decision|1|||
125553467|NCT04263909|451656934|FG001|Overall Study|Physician Decision|0|||
125553468|NCT04263909|451656935|FG002|Overall Study|Physician Decision|0|||
125553469|NCT04263909|451656933|FG000|Overall Study|Adverse Event|3|||
125553470|NCT04263909|451656934|FG001|Overall Study|Adverse Event|0|||
125553471|NCT04263909|451656935|FG002|Overall Study|Adverse Event|0|||
125553472|NCT04263909|451656933|FG000|Overall Study|Protocol Violation|5|||
125553473|NCT04263909|451656934|FG001|Overall Study|Protocol Violation|0|||
125553474|NCT04263909|451656935|FG002|Overall Study|Protocol Violation|0|||
125553475|NCT02310672|451656936|FG000|Overall Study|Death|1|||
125553476|NCT02310672|451656936|FG000|Overall Study|Lost to Follow-up|1|||
125553477|NCT02310672|451656936|FG000|Overall Study|Withdrawal by Subject|1|||
125553478|NCT02310672|451656936|FG000|Overall Study|Sponsor's decision|12|||
125553479|NCT04288778|451656937|FG000|Overall Study|Withdrawal by Subject|2|||
125553480|NCT04288778|451656937|FG000|Overall Study|Adverse Event|5|||
125553481|NCT04288778|451656937|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125553482|NCT04288778|451656937|FG000|Overall Study|Other|1|||
125553483|NCT04288778|451656937|FG000|Overall Study|Started but not treated|2|||
125553484|NCT03118674|451656942|FG000|Overall Study|Lost to Follow-up|2|||
125553485|NCT03118674|451656942|FG000|Overall Study|Screen Faliure|8|||
125553486|NCT03118674|451656942|FG000|Overall Study|Withdrawal by Subject|5|||
125553487|NCT03153137|451656943|FG000|Overall Study|Lost to Follow-up|1|||
125553488|NCT03153137|451656944|FG001|Overall Study|Lost to Follow-up|0|||
125553489|NCT03153137|451656943|FG000|Overall Study|Withdrawal by Subject|2|||
125553490|NCT03153137|451656944|FG001|Overall Study|Withdrawal by Subject|1|||
125553491|NCT03153137|451656943|FG000|Overall Study|Physician Decision|0|||
125553492|NCT03153137|451656944|FG001|Overall Study|Physician Decision|3|||
125553493|NCT04209621|451656945|FG000|Overall Study|Death|1|||
125553494|NCT04209621|451656945|FG000|Overall Study|Study Terminated Early|2|||
125553495|NCT02249767|451656946|FG000|Overall Study|Did not use medication|8|||
125553496|NCT02249767|451656947|FG001|Overall Study|Did not use medication|9|||
125553497|NCT02249767|451656948|FG002|Overall Study|Did not use medication|8|||
125553498|NCT01372410|451656949|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
125553499|NCT01372410|451656950|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
125553500|NCT01372410|451656951|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
125553501|NCT01372410|451656952|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
125553502|NCT01372410|451656953|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
125553503|NCT01372410|451656954|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
125553504|NCT01372410|451656955|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
125553505|NCT01372410|451656956|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
125553506|NCT01372410|451656949|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
125553507|NCT01372410|451656950|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
125553508|NCT01372410|451656951|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
125553509|NCT01372410|451656952|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
125553510|NCT01372410|451656953|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
125553511|NCT01372410|451656954|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
125553512|NCT01372410|451656955|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
125553513|NCT01372410|451656956|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
125553514|NCT01372410|451656949|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125553515|NCT01372410|451656950|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125553516|NCT01372410|451656951|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125553517|NCT01372410|451656952|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125553518|NCT01372410|451656953|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
125553519|NCT01372410|451656954|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125553520|NCT01372410|451656955|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125553521|NCT01372410|451656956|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125553522|NCT01372410|451656949|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
125553523|NCT01372410|451656950|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
125553524|NCT01372410|451656951|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
125553525|NCT01372410|451656952|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
125553526|NCT01372410|451656953|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
125553527|NCT01372410|451656954|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
125553528|NCT01372410|451656955|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
125553529|NCT01372410|451656956|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
125553530|NCT01372410|451656949|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
125553531|NCT01372410|451656950|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
125553532|NCT01372410|451656951|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
125553533|NCT01372410|451656952|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
125553534|NCT01372410|451656953|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
125553535|NCT01372410|451656954|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
125553536|NCT01372410|451656955|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
125553537|NCT01372410|451656956|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
125553538|NCT01372410|451656949|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
125553539|NCT01372410|451656950|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
125553540|NCT01372410|451656951|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
125553541|NCT01372410|451656952|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
125553542|NCT01372410|451656953|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
125553543|NCT01372410|451656954|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
125553544|NCT01372410|451656955|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
125553545|NCT01372410|451656956|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
125553546|NCT01372410|451656949|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
125553547|NCT01372410|451656950|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
125553548|NCT01372410|451656951|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
125553549|NCT01372410|451656952|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
125553550|NCT01372410|451656953|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
125553551|NCT01372410|451656954|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
125553552|NCT01372410|451656955|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
125553553|NCT01372410|451656956|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
125553554|NCT01372410|451656949|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
125553555|NCT01372410|451656950|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
125553556|NCT01372410|451656951|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
125553557|NCT01372410|451656952|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
125553558|NCT01372410|451656953|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
125553559|NCT01372410|451656954|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
125553560|NCT01372410|451656955|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
125553561|NCT01372410|451656956|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
125553562|NCT01372410|451656949|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
125553563|NCT01372410|451656950|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
125553564|NCT01372410|451656951|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
125553565|NCT01372410|451656952|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
125553566|NCT01372410|451656953|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
125553567|NCT01372410|451656954|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
125553568|NCT01372410|451656955|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
125553569|NCT01372410|451656956|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
125553570|NCT01372410|451656949|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
125553571|NCT01372410|451656950|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
125553572|NCT01372410|451656951|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
125553573|NCT01372410|451656952|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
125553574|NCT01372410|451656953|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
125553575|NCT01372410|451656954|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
125553576|NCT01372410|451656955|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
125553577|NCT01372410|451656956|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
125553578|NCT04585646|451656957|FG000|First Intervention|Physician Decision|1|||
125553579|NCT04585646|451656958|FG001|First Intervention|Physician Decision|0|||
125553580|NCT04585646|451656957|FG000|First Intervention|Lost to Follow-up|0|||
125553581|NCT04585646|451656958|FG001|First Intervention|Lost to Follow-up|3|||
125553582|NCT04585646|451656957|FG000|First Intervention|Withdrawal by Subject|0|||
125553583|NCT04585646|451656958|FG001|First Intervention|Withdrawal by Subject|1|||
125553584|NCT01067326|451656965|FG000|Overall Study|Adverse Event|0|||
125553585|NCT01067326|451656966|FG001|Overall Study|Adverse Event|2|||
125553586|NCT01067326|451656965|FG000|Overall Study|Withdrawal by Subject|1|||
125553587|NCT01067326|451656966|FG001|Overall Study|Withdrawal by Subject|0|||
125553588|NCT01067326|451656965|FG000|Overall Study|Early Study Termination|1|||
125553589|NCT01067326|451656966|FG001|Overall Study|Early Study Termination|1|||
125553590|NCT01230788|451656973|FG000|Overall Study|Prescribed exclusion drug|1|||
125553591|NCT00769860|451656974|FG000|Overall Study|Withdrawal by Subject|2|||
125553592|NCT00769860|451656975|FG001|Overall Study|Withdrawal by Subject|0|||
125553593|NCT01603082|451656976|FG000|Overall Study|Adverse Event|0|||
125553594|NCT01603082|451656977|FG001|Overall Study|Adverse Event|1|||
125553595|NCT01603082|451656976|FG000|Overall Study|Withdrawal by Subject|1|||
125553596|NCT01603082|451656977|FG001|Overall Study|Withdrawal by Subject|0|||
125553597|NCT01603082|451656976|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
125553598|NCT01603082|451656977|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
125553599|NCT01019317|451656981|FG000|Overall Study|Not Eligible|4|||
125553600|NCT02000427|451656984|FG000|Overall Study|Death|22|||
125553601|NCT04343248|451656985|FG000|Overall Study|Withdrawal by Subject|5|||
125553602|NCT04343248|451656986|FG001|Overall Study|Withdrawal by Subject|6|||
125553603|NCT04343248|451656985|FG000|Overall Study|Death|1|||
125553604|NCT04343248|451656986|FG001|Overall Study|Death|2|||
125553605|NCT04343248|451656985|FG000|Overall Study|Lost to Follow-up|9|||
125553606|NCT04343248|451656986|FG001|Overall Study|Lost to Follow-up|6|||
125553607|NCT04343248|451656985|FG000|Overall Study|Physician Decision|0|||
125553608|NCT04343248|451656986|FG001|Overall Study|Physician Decision|1|||
125553609|NCT04343248|451656985|FG000|Overall Study|Adverse Event|1|||
125553610|NCT04343248|451656986|FG001|Overall Study|Adverse Event|0|||
125553611|NCT02708095|451656987|FG000|Overall Study|Adverse Event|4|||
125553612|NCT02708095|451656988|FG001|Overall Study|Adverse Event|10|||
125553613|NCT02708095|451656989|FG002|Overall Study|Adverse Event|11|||
125553614|NCT02708095|451656987|FG000|Overall Study|Lack of Efficacy|9|||
125553615|NCT02708095|451656988|FG001|Overall Study|Lack of Efficacy|3|||
125553616|NCT02708095|451656989|FG002|Overall Study|Lack of Efficacy|0|||
125553617|NCT02708095|451656987|FG000|Overall Study|Lost to Follow-up|2|||
125553618|NCT02708095|451656988|FG001|Overall Study|Lost to Follow-up|0|||
125553619|NCT02708095|451656989|FG002|Overall Study|Lost to Follow-up|0|||
125553620|NCT02708095|451656987|FG000|Overall Study|Physician Decision|2|||
125553621|NCT02708095|451656988|FG001|Overall Study|Physician Decision|3|||
125553622|NCT02708095|451656989|FG002|Overall Study|Physician Decision|2|||
125553623|NCT02708095|451656987|FG000|Overall Study|Protocol Violation|0|||
125553624|NCT02708095|451656988|FG001|Overall Study|Protocol Violation|0|||
125553625|NCT02708095|451656989|FG002|Overall Study|Protocol Violation|1|||
125553626|NCT02708095|451656987|FG000|Overall Study|Withdrawal by Subject|5|||
125553627|NCT02708095|451656988|FG001|Overall Study|Withdrawal by Subject|3|||
125553628|NCT02708095|451656989|FG002|Overall Study|Withdrawal by Subject|4|||
125553629|NCT01313650|451656990|FG000|Overall Study|Adverse Event|9|||
125553630|NCT01313650|451656991|FG001|Overall Study|Adverse Event|34|||
125553631|NCT01313650|451656992|FG002|Overall Study|Adverse Event|24|||
125553632|NCT01313650|451656993|FG003|Overall Study|Adverse Event|23|||
125553633|NCT01313650|451656990|FG000|Overall Study|Lack of Efficacy|37|||
125553634|NCT01313650|451656991|FG001|Overall Study|Lack of Efficacy|20|||
125553635|NCT01313650|451656992|FG002|Overall Study|Lack of Efficacy|32|||
125553636|NCT01313650|451656993|FG003|Overall Study|Lack of Efficacy|20|||
125553637|NCT01313650|451656990|FG000|Overall Study|Lost to Follow-up|1|||
125553638|NCT01313650|451656991|FG001|Overall Study|Lost to Follow-up|0|||
125553639|NCT01313650|451656992|FG002|Overall Study|Lost to Follow-up|3|||
125553640|NCT01313650|451656993|FG003|Overall Study|Lost to Follow-up|2|||
125553641|NCT01313650|451656990|FG000|Overall Study|Withdrawal by Subject|16|||
125553642|NCT01313650|451656991|FG001|Overall Study|Withdrawal by Subject|20|||
125553643|NCT01313650|451656992|FG002|Overall Study|Withdrawal by Subject|15|||
125553644|NCT01313650|451656993|FG003|Overall Study|Withdrawal by Subject|15|||
125553645|NCT01313650|451656990|FG000|Overall Study|Protocol Violation|4|||
125553646|NCT01313650|451656991|FG001|Overall Study|Protocol Violation|7|||
125553647|NCT01313650|451656992|FG002|Overall Study|Protocol Violation|5|||
125553648|NCT01313650|451656993|FG003|Overall Study|Protocol Violation|6|||
125553649|NCT01313650|451656990|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
125553650|NCT01313650|451656991|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
125553651|NCT01313650|451656992|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
125553652|NCT01313650|451656993|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
125553653|NCT05393037|451656994|FG000|Part A|Death|1|||
125553654|NCT05393037|451656995|FG001|Part A|Death|0|||
125553655|NCT05393037|451656994|FG000|Part A|Lost to Follow-up|1|||
125553656|NCT05393037|451656995|FG001|Part A|Lost to Follow-up|1|||
125553657|NCT05393037|451656994|FG000|Part A|Withdrawal by Subject|2|||
125553658|NCT05393037|451656995|FG001|Part A|Withdrawal by Subject|4|||
125553659|NCT05393037|451656994|FG000|Part B|Lost to Follow-up|1|||
125553660|NCT05393037|451656995|FG001|Part B|Lost to Follow-up|0|||
125553661|NCT01012739|451656996|FG000|Treatment Period 1|Adverse Event|0|||
125553662|NCT01012739|451656997|FG001|Treatment Period 1|Adverse Event|0|||
125553663|NCT01012739|451656998|FG002|Treatment Period 1|Adverse Event|0|||
125553664|NCT01012739|451656999|FG003|Treatment Period 1|Adverse Event|1|||
125553665|NCT01012739|451656996|FG000|Treatment Period 2|Abnormal test procedure results|0|||
125553666|NCT01012739|451656997|FG001|Treatment Period 2|Abnormal test procedure results|0|||
125553667|NCT01012739|451656998|FG002|Treatment Period 2|Abnormal test procedure results|0|||
125553668|NCT01012739|451656999|FG003|Treatment Period 2|Abnormal test procedure results|1|||
125553669|NCT04540133|451657000|FG000|Overall Study|Lost to Follow-up|1|||
125553670|NCT04540133|451657001|FG001|Overall Study|Lost to Follow-up|0|||
125553671|NCT00458341|451657002|FG000|Cycle 1|Adverse Event|1|||
125553672|NCT00458341|451657003|FG001|Cycle 1|Adverse Event|0|||
125553673|NCT03769181|451658832|FG000|Overall Study|Adverse Event|1|||
125553674|NCT03769181|451658833|FG001|Overall Study|Adverse Event|0|||
125553675|NCT03769181|451658834|FG002|Overall Study|Adverse Event|2|||
125553676|NCT03769181|451658835|FG003|Overall Study|Adverse Event|4|||
125553677|NCT03769181|451658832|FG000|Overall Study|Withdrawal by Subject|1|||
125553678|NCT03769181|451658833|FG001|Overall Study|Withdrawal by Subject|0|||
125553679|NCT03769181|451658834|FG002|Overall Study|Withdrawal by Subject|2|||
125553680|NCT03769181|451658835|FG003|Overall Study|Withdrawal by Subject|1|||
125553681|NCT03769181|451658832|FG000|Overall Study|Progressive disease|9|||
125553682|NCT03769181|451658833|FG001|Overall Study|Progressive disease|7|||
125553683|NCT03769181|451658834|FG002|Overall Study|Progressive disease|13|||
125553684|NCT03769181|451658835|FG003|Overall Study|Progressive disease|6|||
125553685|NCT03769181|451658832|FG000|Overall Study|Other - Unspecified|2|||
125553686|NCT03769181|451658833|FG001|Overall Study|Other - Unspecified|1|||
125553687|NCT03769181|451658834|FG002|Overall Study|Other - Unspecified|0|||
125553688|NCT03769181|451658835|FG003|Overall Study|Other - Unspecified|0|||
125553689|NCT03971422|451658836|FG000|Overall Study|Lost to Follow-up|0|||
125553690|NCT03971422|451658837|FG001|Overall Study|Lost to Follow-up|1|||
125553691|NCT03971422|451658838|FG002|Overall Study|Lost to Follow-up|0|||
125553692|NCT03971422|451658836|FG000|Overall Study|Lack of Efficacy|5|||
125553693|NCT03971422|451658837|FG001|Overall Study|Lack of Efficacy|1|||
125553694|NCT03971422|451658838|FG002|Overall Study|Lack of Efficacy|1|||
125553695|NCT03971422|451658836|FG000|Overall Study|Adverse event, not fatal|2|||
125553696|NCT03971422|451658837|FG001|Overall Study|Adverse event, not fatal|2|||
125553697|NCT03971422|451658838|FG002|Overall Study|Adverse event, not fatal|5|||
125553698|NCT03971422|451658836|FG000|Overall Study|Worsening of MG Symptoms|1|||
125553699|NCT03971422|451658837|FG001|Overall Study|Worsening of MG Symptoms|4|||
125553700|NCT03971422|451658838|FG002|Overall Study|Worsening of MG Symptoms|2|||
125553701|NCT03971422|451658836|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
125553702|NCT03971422|451658837|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
125553703|NCT03971422|451658838|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
125553704|NCT03971422|451658836|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
125553705|NCT03971422|451658837|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
125553706|NCT03971422|451658838|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
125553707|NCT03971422|451658836|FG000|Overall Study|Due to COVID-19 pandemic|0|||
125553708|NCT03971422|451658837|FG001|Overall Study|Due to COVID-19 pandemic|1|||
125553709|NCT03971422|451658838|FG002|Overall Study|Due to COVID-19 pandemic|1|||
125553710|NCT03566810|451658839|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
125553711|NCT03566810|451658840|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
125553712|NCT03566810|451658841|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
125553713|NCT03566810|451658842|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
125553714|NCT03217266|451658843|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
125553715|NCT03217266|451658844|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
125378926|NCT00531050|451019213|FG005|Part 1: Period 1|Adverse Event|0|||
125350454|NCT01986933|450917069|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
125350455|NCT01986933|450917070|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
125350456|NCT01986933|450917071|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
125350457|NCT01986933|450917072|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
125350458|NCT01986933|450917068|FG000|Active-to-active (Part B)|Adverse Event|0|||
125350459|NCT01986933|450917069|FG001|Active-to-active (Part B)|Adverse Event|2|||
125350460|NCT01986933|450917070|FG002|Active-to-active (Part B)|Adverse Event|0|||
125350461|NCT01986933|450917071|FG003|Active-to-active (Part B)|Adverse Event|1|||
125350462|NCT01986933|450917072|FG004|Active-to-active (Part B)|Adverse Event|3|||
125350463|NCT01986933|450917068|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
125350464|NCT01986933|450917069|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
125350465|NCT01986933|450917070|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
125350466|NCT01986933|450917071|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
125350467|NCT01986933|450917072|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
125350468|NCT01986933|450917068|FG000|Active-to-active (Part B)|Pregnancy|0|||
125350469|NCT01986933|450917069|FG001|Active-to-active (Part B)|Pregnancy|0|||
125350470|NCT01986933|450917070|FG002|Active-to-active (Part B)|Pregnancy|0|||
125350471|NCT01986933|450917071|FG003|Active-to-active (Part B)|Pregnancy|0|||
125350472|NCT01986933|450917072|FG004|Active-to-active (Part B)|Pregnancy|1|||
125350473|NCT01986933|450917068|FG000|Active-to-active (Part B)|Physician Decision|0|||
125350474|NCT01986933|450917069|FG001|Active-to-active (Part B)|Physician Decision|0|||
125350475|NCT01986933|450917070|FG002|Active-to-active (Part B)|Physician Decision|1|||
125350476|NCT01986933|450917071|FG003|Active-to-active (Part B)|Physician Decision|1|||
125350477|NCT01986933|450917072|FG004|Active-to-active (Part B)|Physician Decision|0|||
125350478|NCT01986933|450917068|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
125350479|NCT01986933|450917069|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
125350480|NCT01986933|450917070|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
125350481|NCT01986933|450917071|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
125350482|NCT01986933|450917072|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
125350483|NCT01986933|450917068|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
125350484|NCT01986933|450917069|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
125350485|NCT01986933|450917070|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
125350486|NCT01986933|450917071|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
125350487|NCT01986933|450917072|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
125350488|NCT01986933|450917068|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
125350489|NCT01986933|450917069|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
125350490|NCT01986933|450917070|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
125350491|NCT01986933|450917071|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
125350492|NCT01986933|450917072|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
125350493|NCT01986933|450917068|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
125350494|NCT01986933|450917069|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
125350495|NCT01986933|450917070|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
125350496|NCT01986933|450917071|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
125350497|NCT01986933|450917072|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
125350498|NCT01986933|450917068|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
125350499|NCT01986933|450917069|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
125350500|NCT01986933|450917070|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
125350501|NCT01986933|450917071|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
125350502|NCT01986933|450917072|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
125350503|NCT01986933|450917068|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
125350504|NCT01986933|450917069|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
125350505|NCT01986933|450917070|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
125350506|NCT01986933|450917071|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
125350507|NCT01986933|450917072|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
125350508|NCT01986933|450917068|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
125350509|NCT01986933|450917069|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
125350510|NCT01986933|450917070|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
125350511|NCT01986933|450917071|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
125350512|NCT01986933|450917072|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
125350513|NCT01986933|450917068|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
125350514|NCT01986933|450917069|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
125350515|NCT01986933|450917070|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
125350516|NCT01986933|450917071|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
125350517|NCT01986933|450917072|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
125350518|NCT03119701|450917073|FG000|6-day Dosing|Death|4|||
125350519|NCT03119701|450917074|FG001|6-day Dosing|Death|1|||
125350520|NCT03119701|450917073|FG000|6-day Dosing|Adverse Event|3|||
125350521|NCT03119701|450917074|FG001|6-day Dosing|Adverse Event|0|||
125350522|NCT03119701|450917073|FG000|6-day Dosing|Physician Decision|0|||
125350523|NCT03119701|450917074|FG001|6-day Dosing|Physician Decision|1|||
125350524|NCT03119701|450917073|FG000|6-day Dosing|Withdrawal by Subject|0|||
125553716|NCT03217266|451658845|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
125553717|NCT03217266|451658846|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
125553718|NCT03217266|451658843|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
125553719|NCT03217266|451658844|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
125553720|NCT03217266|451658845|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
125553721|NCT03217266|451658846|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
125553722|NCT03217266|451658843|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
125553723|NCT03217266|451658844|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
125553724|NCT03217266|451658845|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
125553725|NCT03217266|451658846|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
125553726|NCT03078907|451658850|FG000|Overall Study|Adverse Event|2|||
125553727|NCT03078907|451658851|FG001|Overall Study|Adverse Event|0|||
125553728|NCT03078907|451658850|FG000|Overall Study|Other|1|||
125553729|NCT03078907|451658851|FG001|Overall Study|Other|0|||
125553730|NCT03078907|451658850|FG000|Overall Study|Protocol Violation|0|||
125553731|NCT03078907|451658851|FG001|Overall Study|Protocol Violation|1|||
125553732|NCT01955122|451658852|FG000|Overall Study|Physician Decision|5|||
125553733|NCT01955122|451658853|FG001|Overall Study|Physician Decision|5|||
125553734|NCT00826111|451658854|FG000|Overall Study|Lost to Follow-up|0|||
125553735|NCT00826111|451658855|FG001|Overall Study|Lost to Follow-up|1|||
125553736|NCT00826111|451658854|FG000|Overall Study|Protocol Violation|1|||
125553737|NCT00826111|451658855|FG001|Overall Study|Protocol Violation|0|||
125553738|NCT00826111|451658854|FG000|Overall Study|Withdrawal by Subject|5|||
125553739|NCT00826111|451658855|FG001|Overall Study|Withdrawal by Subject|0|||
125553740|NCT00826111|451658854|FG000|Overall Study|Physician Decision|1|||
125553741|NCT00826111|451658855|FG001|Overall Study|Physician Decision|1|||
125553742|NCT01672788|451658856|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
125553743|NCT01672788|451658857|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
125553744|NCT01672788|451658858|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
125553745|NCT01672788|451658859|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
125553746|NCT03511053|451658862|FG000|Overall Study|Withdrawal by Subject|1|||
125553747|NCT01929980|451658863|FG000|Overall Study|Physician Decision|1|||
125553748|NCT00985166|451658864|FG000|Overall Study|Lost to Follow-up|3|||
125553749|NCT00985166|451658865|FG001|Overall Study|Lost to Follow-up|2|||
125553750|NCT00985166|451658866|FG002|Overall Study|Lost to Follow-up|2|||
125553751|NCT00985166|451658864|FG000|Overall Study|Withdrawal by Subject|3|||
125553752|NCT00985166|451658865|FG001|Overall Study|Withdrawal by Subject|2|||
125553753|NCT00985166|451658866|FG002|Overall Study|Withdrawal by Subject|0|||
125553754|NCT00985166|451658864|FG000|Overall Study|Test not done|2|||
125553755|NCT00985166|451658865|FG001|Overall Study|Test not done|0|||
125553756|NCT00985166|451658866|FG002|Overall Study|Test not done|4|||
125553757|NCT00985166|451658864|FG000|Overall Study|Other|1|||
125553758|NCT00985166|451658865|FG001|Overall Study|Other|0|||
125553759|NCT00985166|451658866|FG002|Overall Study|Other|1|||
125553760|NCT01028222|451658867|FG000|Overall Study|Protocol deviation|1|||
125553761|NCT01028222|451658868|FG001|Overall Study|Protocol deviation|0|||
125553762|NCT01028222|451658867|FG000|Overall Study|Disease progression|33|||
125553763|NCT01028222|451658868|FG001|Overall Study|Disease progression|9|||
125553764|NCT01028222|451658867|FG000|Overall Study|Administrative problems|1|||
125553765|NCT01028222|451658868|FG001|Overall Study|Administrative problems|1|||
125553766|NCT01028222|451658867|FG000|Overall Study|Lost to Follow-up|0|||
125553767|NCT01028222|451658868|FG001|Overall Study|Lost to Follow-up|1|||
125553768|NCT01028222|451658867|FG000|Overall Study|Withdrawal by Subject|1|||
125553769|NCT01028222|451658868|FG001|Overall Study|Withdrawal by Subject|0|||
125553770|NCT01028222|451658867|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
125553771|NCT01028222|451658868|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
125553772|NCT01028222|451658867|FG000|Overall Study|Adverse Event|2|||
125553773|NCT01028222|451658868|FG001|Overall Study|Adverse Event|0|||
125350525|NCT03119701|450917074|FG001|6-day Dosing|Withdrawal by Subject|1|||
125350526|NCT03119701|450917073|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
125350527|NCT03119701|450917074|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
125350528|NCT00596362|450917075|FG000|Overall Study|Progressive Disease|1|||
125350529|NCT00356122|450917078|FG000|TREATMENT|Lack of Efficacy|26|||
125350530|NCT00356122|450917078|FG000|TREATMENT|Adverse Event|10|||
125553774|NCT03236246|451658871|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
125553775|NCT03236246|451658872|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
125553776|NCT03236246|451658871|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
125553777|NCT03236246|451658872|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
125553778|NCT03236246|451658871|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
125553779|NCT03236246|451658872|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
125553780|NCT03236246|451658871|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
125553781|NCT03236246|451658872|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
125553782|NCT03236246|451658871|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
125553783|NCT03236246|451658872|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
125553784|NCT03236246|451658871|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
125553785|NCT03236246|451658872|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
125553786|NCT03236246|451658871|FG000|24-Week Dose Titration Period|Death|3|||
125553787|NCT03236246|451658872|FG001|24-Week Dose Titration Period|Death|1|||
125553788|NCT03236246|451658871|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
125553789|NCT03236246|451658872|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
125553790|NCT03236246|451658871|FG000|24-Week Dose Titration Period|Adverse Event|7|||
125553791|NCT03236246|451658872|FG001|24-Week Dose Titration Period|Adverse Event|8|||
125553792|NCT03236246|451658871|FG000|24-Week Dose Titration Period|Captured as Other|1|||
125553793|NCT03236246|451658872|FG001|24-Week Dose Titration Period|Captured as Other|2|||
125553794|NCT03236246|451658871|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
125553795|NCT03236246|451658872|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
125553796|NCT03236246|451658871|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
125553797|NCT03236246|451658872|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
125553798|NCT03236246|451658871|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
125553799|NCT03236246|451658872|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
125553800|NCT03236246|451658871|FG000|24-Week Dose Maintenance Period|Death|0|||
125553801|NCT03236246|451658872|FG001|24-Week Dose Maintenance Period|Death|1|||
125553802|NCT03236246|451658871|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
125553803|NCT03236246|451658872|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
125553804|NCT02598557|451658873|FG000|Overall Study|Withdrawal by Subject|1|||
125553805|NCT02598557|451658874|FG001|Overall Study|Withdrawal by Subject|0|||
125553806|NCT02598557|451658875|FG002|Overall Study|Withdrawal by Subject|1|||
125553807|NCT02598557|451658873|FG000|Overall Study|Participant did not start treatment|2|||
125553808|NCT02598557|451658874|FG001|Overall Study|Participant did not start treatment|1|||
125553809|NCT02598557|451658875|FG002|Overall Study|Participant did not start treatment|1|||
125553810|NCT02598557|451658873|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
125553811|NCT02598557|451658874|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
125553812|NCT02598557|451658875|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
125553813|NCT02598557|451658873|FG000|Overall Study|Adverse Event|1|||
125553814|NCT02598557|451658874|FG001|Overall Study|Adverse Event|1|||
125553815|NCT02598557|451658875|FG002|Overall Study|Adverse Event|0|||
125553816|NCT01637623|451658880|FG000|Overall Study|Lost to Follow-up|0|||
125553817|NCT01637623|451658881|FG001|Overall Study|Lost to Follow-up|0|||
125553818|NCT01637623|451658882|FG002|Overall Study|Lost to Follow-up|2|||
125553819|NCT01637623|451658880|FG000|Overall Study|Physician Decision|1|||
125553820|NCT01637623|451658881|FG001|Overall Study|Physician Decision|0|||
125553821|NCT01637623|451658882|FG002|Overall Study|Physician Decision|1|||
125553822|NCT05628285|451658883|FG000|Overall Study|Lost to Follow-up|1|||
125553823|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
125553824|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
125553825|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
125553826|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
125553827|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
125553828|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
125553829|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
125553830|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
125553831|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Death|1|||
125553832|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Death|1|||
125553833|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
125553834|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
125553835|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
125553836|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
125553837|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
125553838|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
125553839|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
125553840|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
125350531|NCT00356122|450917078|FG000|TREATMENT|Subject's request|4|||
125553841|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
125553842|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
125553843|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
125553844|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
125553845|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
125350532|NCT00356122|450917078|FG000|TREATMENT|Other|4|||
125350533|NCT00356122|450917078|FG000|TREATMENT|Did not receive study medication|1|||
125350534|NCT00356122|450917078|FG000|FOLLOW-UP|Death|37|||
125350535|NCT00356122|450917078|FG000|FOLLOW-UP|Lost to Follow-up|2|||
125350536|NCT00356122|450917078|FG000|FOLLOW-UP|Other|2|||
125350537|NCT00491556|450917079|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
125350538|NCT00491556|450917080|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
125350539|NCT00491556|450917079|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
125350540|NCT00491556|450917080|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
125350541|NCT00491556|450917079|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
125350542|NCT00491556|450917080|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
125350543|NCT00491556|450917079|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
125350544|NCT00491556|450917080|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
125350545|NCT00491556|450917079|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
125350546|NCT00491556|450917080|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
125350547|NCT00491556|450917079|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
125350548|NCT00491556|450917080|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
125350549|NCT00491556|450917079|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
125350550|NCT00491556|450917080|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
125350551|NCT00491556|450917079|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
125350552|NCT00491556|450917080|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
125350553|NCT00491556|450917079|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
125350554|NCT00491556|450917080|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
125350555|NCT00491556|450917079|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
125350556|NCT00491556|450917080|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
125350557|NCT00491556|450917079|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
125350558|NCT00491556|450917080|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
125350559|NCT00491556|450917079|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
125350560|NCT00491556|450917080|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
125350561|NCT00491556|450917079|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
125350562|NCT00491556|450917080|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
125350563|NCT00491556|450917079|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
125350564|NCT00491556|450917080|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
125350565|NCT00491556|450917079|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
125350566|NCT00491556|450917080|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
125350567|NCT00491556|450917079|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
125350568|NCT00491556|450917080|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
125350569|NCT00491556|450917079|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
125350570|NCT00491556|450917080|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
125350571|NCT00491556|450917079|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
125350572|NCT00491556|450917080|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
125350573|NCT00491556|450917079|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
125350574|NCT00491556|450917080|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
125350575|NCT00491556|450917079|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
125350576|NCT00491556|450917080|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
125350577|NCT02418156|450917081|FG000|Overall Study|Lost to Follow-up|12|||
125350578|NCT02418156|450917081|FG000|Overall Study|Death|2|||
125350579|NCT02418156|450917081|FG000|Overall Study|Physician Decision|1|||
125553846|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
125553847|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
125553848|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
125553849|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
125553850|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
125553851|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
125553852|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
125553853|NCT00559585|451658887|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
125553854|NCT00559585|451658888|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
125553855|NCT00559585|451658887|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
125553856|NCT00559585|451658888|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
125553857|NCT00559585|451658887|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
125553858|NCT00559585|451658888|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
125553859|NCT00559585|451658887|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
125553860|NCT00559585|451658888|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
125553861|NCT00559585|451658887|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
125553862|NCT00559585|451658888|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
125553863|NCT00559585|451658887|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
125553864|NCT00559585|451658888|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
125553865|NCT00559585|451658887|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
125553866|NCT00559585|451658888|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
125553867|NCT00559585|451658887|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
125553868|NCT00559585|451658888|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
125553869|NCT00559585|451658887|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
125553870|NCT00559585|451658888|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
125553871|NCT00559585|451658887|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
125553872|NCT00559585|451658888|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
125553873|NCT00559585|451658887|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
125553874|NCT00559585|451658888|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
125553875|NCT00559585|451658887|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
125553876|NCT00559585|451658888|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
125553877|NCT00559585|451658887|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
125553878|NCT00559585|451658888|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
125553879|NCT04195581|451658889|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
125553880|NCT04195581|451658889|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
125553881|NCT04195581|451658889|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
125553882|NCT04195581|451658889|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
125553883|NCT04195581|451658889|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
125553884|NCT04195581|451658889|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
125553885|NCT01237340|451658890|FG000|Overall Study|Adverse Event|3|||
125553886|NCT01237340|451658890|FG000|Overall Study|Withdrawal by Subject|1|||
125553887|NCT01237340|451658890|FG000|Overall Study|Early termination of the trial|36|||
125553888|NCT02876835|451658893|FG000|Treatment Period (51.1 Month)|Other|1|||
125350580|NCT02418156|450917081|FG000|Overall Study|Withdrawal by Subject|1|||
125553889|NCT02876835|451658894|FG001|Treatment Period (51.1 Month)|Other|0|||
125553890|NCT02876835|451658893|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
125553891|NCT02876835|451658894|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
125553892|NCT02876835|451658893|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
125553893|NCT02876835|451658894|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
125553894|NCT02876835|451658893|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
125553895|NCT02876835|451658894|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
125553896|NCT02540538|451658895|FG000|Overall Study|Pregnancy|0|||
125553897|NCT02540538|451658896|FG001|Overall Study|Pregnancy|1|||
125553898|NCT02540538|451658897|FG002|Overall Study|Pregnancy|0|||
125553899|NCT00403754|451658898|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
125553900|NCT00403754|451658899|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
125553901|NCT00403754|451658900|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
125553902|NCT00403754|451658901|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
125553903|NCT00403754|451658898|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
125553904|NCT00403754|451658899|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
125553905|NCT00403754|451658900|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
125553906|NCT00403754|451658901|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
125553907|NCT03049735|451658906|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
125553908|NCT03049735|451658907|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
125553909|NCT03049735|451658908|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
125553910|NCT03049735|451658906|FG000|Overall Study|Other|5|||
125553911|NCT03049735|451658907|FG001|Overall Study|Other|3|||
125553912|NCT03049735|451658908|FG002|Overall Study|Other|1|||
125553913|NCT03049735|451658906|FG000|Overall Study|Lack of Efficacy|4|||
125553914|NCT03049735|451658907|FG001|Overall Study|Lack of Efficacy|0|||
125553915|NCT03049735|451658908|FG002|Overall Study|Lack of Efficacy|3|||
125553916|NCT03049735|451658906|FG000|Overall Study|Protocol deviation|1|||
125553917|NCT03049735|451658907|FG001|Overall Study|Protocol deviation|0|||
125553918|NCT03049735|451658908|FG002|Overall Study|Protocol deviation|0|||
125553919|NCT03049735|451658906|FG000|Overall Study|Pregnancy|0|||
125553920|NCT03049735|451658907|FG001|Overall Study|Pregnancy|0|||
125553921|NCT03049735|451658908|FG002|Overall Study|Pregnancy|1|||
125553922|NCT03049735|451658906|FG000|Overall Study|Adverse Event|7|||
125553923|NCT03049735|451658907|FG001|Overall Study|Adverse Event|18|||
125553924|NCT03049735|451658908|FG002|Overall Study|Adverse Event|5|||
125553925|NCT03049735|451658906|FG000|Overall Study|Withdrawal by Subject|10|||
125553926|NCT03049735|451658907|FG001|Overall Study|Withdrawal by Subject|3|||
125553927|NCT03049735|451658908|FG002|Overall Study|Withdrawal by Subject|7|||
125553928|NCT03049735|451658906|FG000|Overall Study|Lost to Follow-up|1|||
125553929|NCT03049735|451658907|FG001|Overall Study|Lost to Follow-up|5|||
125553930|NCT03049735|451658908|FG002|Overall Study|Lost to Follow-up|5|||
125553931|NCT03153111|451658909|FG000|Overall Study|Death|2|||
125553932|NCT03153111|451658910|FG001|Overall Study|Death|5|||
125553933|NCT03153111|451658909|FG000|Overall Study|Lost to Follow-up|1|||
125553934|NCT03153111|451658910|FG001|Overall Study|Lost to Follow-up|0|||
125553935|NCT03153111|451658909|FG000|Overall Study|Physician Decision|5|||
125553936|NCT03153111|451658910|FG001|Overall Study|Physician Decision|1|||
125553937|NCT03153111|451658909|FG000|Overall Study|Withdrawal by Subject|3|||
125553938|NCT03153111|451658910|FG001|Overall Study|Withdrawal by Subject|3|||
125553939|NCT03891524|451658911|FG000|Overall Study|Death|0|||
125553940|NCT03891524|451658912|FG001|Overall Study|Death|0|||
125553941|NCT03891524|451658913|FG002|Overall Study|Death|0|||
125553942|NCT03891524|451658914|FG003|Overall Study|Death|0|||
125553943|NCT03891524|451658915|FG004|Overall Study|Death|0|||
125553944|NCT03891524|451658916|FG005|Overall Study|Death|0|||
125553945|NCT03891524|451658917|FG006|Overall Study|Death|0|||
125553946|NCT03891524|451658918|FG007|Overall Study|Death|1|||
125553947|NCT03891524|451658911|FG000|Overall Study|Withdrawal by Subject|0|||
125553948|NCT03891524|451658912|FG001|Overall Study|Withdrawal by Subject|1|||
125553949|NCT03891524|451658913|FG002|Overall Study|Withdrawal by Subject|2|||
125553950|NCT03891524|451658914|FG003|Overall Study|Withdrawal by Subject|1|||
125553951|NCT03891524|451658915|FG004|Overall Study|Withdrawal by Subject|2|||
125553952|NCT03891524|451658916|FG005|Overall Study|Withdrawal by Subject|2|||
125553953|NCT03891524|451658917|FG006|Overall Study|Withdrawal by Subject|2|||
125553954|NCT03891524|451658918|FG007|Overall Study|Withdrawal by Subject|1|||
125553955|NCT00390910|451658919|FG000|Overall Study|Adverse Event|1|||
125553956|NCT00390910|451658920|FG001|Overall Study|Adverse Event|0|||
125553957|NCT00390910|451658921|FG002|Overall Study|Adverse Event|0|||
125553958|NCT00390910|451658919|FG000|Overall Study|Lost to Follow-up|0|||
125553959|NCT00390910|451658920|FG001|Overall Study|Lost to Follow-up|1|||
125553960|NCT00390910|451658921|FG002|Overall Study|Lost to Follow-up|5|||
125553961|NCT00390910|451658919|FG000|Overall Study|Withdrawal by Subject|1|||
125553962|NCT00390910|451658920|FG001|Overall Study|Withdrawal by Subject|3|||
125553963|NCT00390910|451658921|FG002|Overall Study|Withdrawal by Subject|2|||
125553964|NCT00390910|451658919|FG000|Overall Study|Migrated/moved from study area|0|||
125553965|NCT00390910|451658920|FG001|Overall Study|Migrated/moved from study area|0|||
125553966|NCT00390910|451658921|FG002|Overall Study|Migrated/moved from study area|3|||
125553967|NCT00174265|451658927|FG000|Overall Study|Adverse Event|7|||
125553968|NCT00174265|451658928|FG001|Overall Study|Adverse Event|4|||
125553969|NCT00174265|451658927|FG000|Overall Study|Lack of Efficacy|2|||
125553970|NCT00174265|451658928|FG001|Overall Study|Lack of Efficacy|2|||
125553971|NCT00174265|451658927|FG000|Overall Study|Withdrawal by Subject|3|||
125553972|NCT00174265|451658928|FG001|Overall Study|Withdrawal by Subject|5|||
125553973|NCT00174265|451658927|FG000|Overall Study|Lost to Follow-up|1|||
125553974|NCT00174265|451658928|FG001|Overall Study|Lost to Follow-up|0|||
125553975|NCT00174265|451658927|FG000|Overall Study|Other (Not specified)|16|||
125553976|NCT00174265|451658928|FG001|Overall Study|Other (Not specified)|10|||
125553977|NCT03471871|451658929|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
125553978|NCT03471871|451658930|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
125553979|NCT03471871|451658931|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
125553980|NCT03471871|451658932|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
125553981|NCT03471871|451658933|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
125553982|NCT03471871|451658929|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
125553983|NCT03471871|451658930|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
125553984|NCT03471871|451658931|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
125553985|NCT03471871|451658932|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
125553986|NCT03471871|451658933|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
125553987|NCT03471871|451658929|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
125553988|NCT03471871|451658930|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
125553989|NCT03471871|451658931|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
125553990|NCT03471871|451658932|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
125553991|NCT03471871|451658933|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
125553992|NCT03471871|451658929|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
125553993|NCT03471871|451658930|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
125553994|NCT03471871|451658931|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
125553995|NCT03471871|451658932|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
125553996|NCT03471871|451658933|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
125553997|NCT03471871|451658929|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
125553998|NCT03471871|451658930|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
125553999|NCT03471871|451658931|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
125554000|NCT03471871|451658932|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
125554001|NCT03471871|451658933|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
125554002|NCT03040622|451658935|FG000|Overall Study|unable to implant device|3|||
125554003|NCT01572922|451658936|FG000|Overall Study|Adverse Event|1|||
125554004|NCT01572922|451658936|FG000|Overall Study|Protocol Violation|1|||
125554005|NCT01572922|451658936|FG000|Overall Study|Death|1|||
125554006|NCT00445068|451658937|FG000|Overall Study|Disease progression|26|||
125554007|NCT00445068|451658937|FG000|Overall Study|Adverse Event|5|||
125350581|NCT02418156|450917081|FG000|Overall Study|Subject refused to return|1|||
125350582|NCT05772702|450917093|FG000|Overall Study|Adverse Event|1|||
125350583|NCT01909453|450917094|FG000|Overall Study|Ongoing|118|||
125350584|NCT01909453|450917095|FG001|Overall Study|Ongoing|103|||
125350585|NCT01909453|450917096|FG002|Overall Study|Ongoing|83|||
125350586|NCT01909453|450917097|FG003|Overall Study|Ongoing|164|||
125350587|NCT01909453|450917098|FG004|Overall Study|Ongoing|50|||
125350588|NCT01909453|450917094|FG000|Overall Study|Death|69|||
125350589|NCT01909453|450917095|FG001|Overall Study|Death|74|||
125350590|NCT01909453|450917096|FG002|Overall Study|Death|88|||
125350591|NCT01909453|450917097|FG003|Overall Study|Death|86|||
125350592|NCT01909453|450917098|FG004|Overall Study|Death|29|||
125554008|NCT00445068|451658937|FG000|Overall Study|Abnormal laboratory value|2|||
125554009|NCT00445068|451658937|FG000|Overall Study|Withdrawal by Subject|2|||
125554010|NCT00445068|451658937|FG000|Overall Study|Death|1|||
125554011|NCT00447382|451658938|FG000|Overall Study|Adverse Event|1|||
125554012|NCT00447382|451658939|FG001|Overall Study|Adverse Event|1|||
125554013|NCT00447382|451658938|FG000|Overall Study|Lack of Efficacy|1|||
125554014|NCT00447382|451658939|FG001|Overall Study|Lack of Efficacy|0|||
125554015|NCT00447382|451658938|FG000|Overall Study|Protocol Violation|2|||
125554016|NCT00447382|451658939|FG001|Overall Study|Protocol Violation|0|||
125554017|NCT00447382|451658938|FG000|Overall Study|Unclassified|2|||
125554018|NCT00447382|451658939|FG001|Overall Study|Unclassified|5|||
125554019|NCT04600336|451658940|FG000|Initial Treatment|Withdrawal by Subject|1|||
125554020|NCT04600336|451658941|FG001|Initial Treatment|Withdrawal by Subject|2|||
125554021|NCT04600336|451658942|FG002|Initial Treatment|Withdrawal by Subject|0|||
125554022|NCT04600336|451658943|FG003|Initial Treatment|Withdrawal by Subject|0|||
125350593|NCT01909453|450917094|FG000|Overall Study|Lost to Follow-up|3|||
125350594|NCT01909453|450917095|FG001|Overall Study|Lost to Follow-up|4|||
125350595|NCT01909453|450917096|FG002|Overall Study|Lost to Follow-up|4|||
125350596|NCT01909453|450917097|FG003|Overall Study|Lost to Follow-up|3|||
125554023|NCT04600336|451658940|FG000|Initial Treatment|Adverse Event|0|||
125554024|NCT04600336|451658941|FG001|Initial Treatment|Adverse Event|2|||
125554025|NCT04600336|451658942|FG002|Initial Treatment|Adverse Event|0|||
125554026|NCT04600336|451658943|FG003|Initial Treatment|Adverse Event|0|||
125554027|NCT04600336|451658940|FG000|Initial Treatment|Other complicating disease|0|||
125554028|NCT04600336|451658941|FG001|Initial Treatment|Other complicating disease|0|||
125554029|NCT04600336|451658942|FG002|Initial Treatment|Other complicating disease|1|||
125554030|NCT04600336|451658943|FG003|Initial Treatment|Other complicating disease|0|||
125554031|NCT04600336|451658940|FG000|Crossover Treatment|Withdrawal by Subject|0|||
125554032|NCT04600336|451658941|FG001|Crossover Treatment|Withdrawal by Subject|0|||
125554033|NCT04600336|451658942|FG002|Crossover Treatment|Withdrawal by Subject|2|||
125554034|NCT04600336|451658943|FG003|Crossover Treatment|Withdrawal by Subject|1|||
125554035|NCT04600336|451658940|FG000|Crossover Treatment|Adverse Event|0|||
125554036|NCT04600336|451658941|FG001|Crossover Treatment|Adverse Event|0|||
125554037|NCT04600336|451658942|FG002|Crossover Treatment|Adverse Event|1|||
125554038|NCT04600336|451658943|FG003|Crossover Treatment|Adverse Event|1|||
125554039|NCT03144804|451658945|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
125554040|NCT04091451|451658948|FG000|Overall Study|Adverse Event|15|||
125554041|NCT04091451|451658949|FG001|Overall Study|Adverse Event|10|||
125554042|NCT04091451|451658948|FG000|Overall Study|Lost to Follow-up|8|||
125554043|NCT04091451|451658949|FG001|Overall Study|Lost to Follow-up|8|||
125554044|NCT04091451|451658948|FG000|Overall Study|Protocol Violation|5|||
125554045|NCT04091451|451658949|FG001|Overall Study|Protocol Violation|4|||
125554046|NCT04091451|451658948|FG000|Overall Study|Withdrawal by Subject|21|||
125554047|NCT04091451|451658949|FG001|Overall Study|Withdrawal by Subject|27|||
125554048|NCT04091451|451658948|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
125554049|NCT04091451|451658949|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
125554050|NCT04091451|451658948|FG000|Overall Study|Migrated/moved from the study area|3|||
125554051|NCT04091451|451658949|FG001|Overall Study|Migrated/moved from the study area|5|||
125554052|NCT04091451|451658948|FG000|Overall Study|Suspected HZ episode|1|||
125554053|NCT04091451|451658949|FG001|Overall Study|Suspected HZ episode|0|||
125554054|NCT04175808|451660548|FG000|Part A|Miscellaneous|2|||
125554055|NCT04175808|451660549|FG001|Part A|Miscellaneous|0|||
125554056|NCT04175808|451660550|FG002|Part A|Miscellaneous|0|||
125554057|NCT04175808|451660551|FG003|Part A|Miscellaneous|0|||
125554058|NCT04175808|451660552|FG004|Part A|Miscellaneous|0|||
125554059|NCT04175808|451660553|FG005|Part A|Miscellaneous|0|||
125554060|NCT04175808|451660554|FG006|Part A|Miscellaneous|0|||
125554061|NCT04615247|451660555|FG000|Overall Study|Adverse Event|0|||
125554062|NCT04615247|451660556|FG001|Overall Study|Adverse Event|2|||
125554063|NCT04615247|451660555|FG000|Overall Study|Withdrawal by Subject|1|||
125554064|NCT04615247|451660556|FG001|Overall Study|Withdrawal by Subject|1|||
125554065|NCT02076113|451660561|FG000|Overall Study|Lost to Follow-up|4|||
125554066|NCT02076113|451660562|FG001|Overall Study|Lost to Follow-up|1|||
125554067|NCT02076113|451660561|FG000|Overall Study|Withdrawal by Subject|2|||
125554068|NCT02076113|451660562|FG001|Overall Study|Withdrawal by Subject|3|||
125554069|NCT02076113|451660561|FG000|Overall Study|Death|1|||
125554070|NCT02076113|451660562|FG001|Overall Study|Death|3|||
125554071|NCT02596620|451660567|FG000|Overall Study|Lost to Follow-up|1|||
125554072|NCT02596620|451660568|FG001|Overall Study|Lost to Follow-up|1|||
125554073|NCT01054144|451660569|FG000|Overall Study|Death|2|||
125554074|NCT03801902|451660570|FG000|Overall Study|Did not receive protocol treatment.|1|||
125554075|NCT03801902|451660571|FG001|Overall Study|Did not receive protocol treatment.|0|||
125554076|NCT03801902|451660572|FG002|Overall Study|Did not receive protocol treatment.|0|||
125554077|NCT03801902|451660573|FG003|Overall Study|Did not receive protocol treatment.|0|||
125554078|NCT00528866|451660577|FG000|Overall Study|Protocol Violation|6|||
125425664|NCT01197508|451182325|FG003|Overall Study|Withdrawal by Subject|4|||
125554079|NCT01601847|451660578|FG000|Overall Study|Death|1|||
125554080|NCT01601847|451660579|FG001|Overall Study|Death|0|||
125554081|NCT01601847|451660578|FG000|Overall Study|Withdrawal by Subject|11|||
125554082|NCT01601847|451660579|FG001|Overall Study|Withdrawal by Subject|7|||
125554083|NCT01601847|451660578|FG000|Overall Study|Lost to Follow-up|1|||
125554084|NCT01601847|451660579|FG001|Overall Study|Lost to Follow-up|3|||
125554085|NCT01284062|451660580|FG000|Overall Study|Adverse Event|4|||
125554086|NCT01284062|451660581|FG001|Overall Study|Adverse Event|5|||
125554087|NCT01284062|451660582|FG002|Overall Study|Adverse Event|0|||
125554088|NCT01284062|451660583|FG003|Overall Study|Adverse Event|5|||
125554089|NCT01284062|451660580|FG000|Overall Study|Lack of Efficacy|3|||
125554090|NCT01284062|451660581|FG001|Overall Study|Lack of Efficacy|2|||
125554091|NCT01284062|451660582|FG002|Overall Study|Lack of Efficacy|2|||
125554092|NCT01284062|451660583|FG003|Overall Study|Lack of Efficacy|1|||
125554093|NCT01284062|451660580|FG000|Overall Study|Medication error without adverse event|0|||
125554094|NCT01284062|451660581|FG001|Overall Study|Medication error without adverse event|0|||
125554095|NCT01284062|451660582|FG002|Overall Study|Medication error without adverse event|1|||
125554096|NCT01284062|451660583|FG003|Overall Study|Medication error without adverse event|0|||
125554097|NCT01284062|451660580|FG000|Overall Study|Protocol Violation|1|||
125554098|NCT01284062|451660581|FG001|Overall Study|Protocol Violation|0|||
125554099|NCT01284062|451660582|FG002|Overall Study|Protocol Violation|0|||
125554100|NCT01284062|451660583|FG003|Overall Study|Protocol Violation|2|||
125554101|NCT01284062|451660580|FG000|Overall Study|Withdrawal by Subject|3|||
125554102|NCT01284062|451660581|FG001|Overall Study|Withdrawal by Subject|1|||
125554103|NCT01284062|451660582|FG002|Overall Study|Withdrawal by Subject|2|||
125554104|NCT01284062|451660583|FG003|Overall Study|Withdrawal by Subject|5|||
125554105|NCT01284062|451660580|FG000|Overall Study|Other|0|||
125554106|NCT01284062|451660581|FG001|Overall Study|Other|0|||
125554107|NCT01284062|451660582|FG002|Overall Study|Other|0|||
125554108|NCT01284062|451660583|FG003|Overall Study|Other|1|||
125554109|NCT01284062|451660580|FG000|Overall Study|Site Closed|0|||
125554110|NCT01284062|451660581|FG001|Overall Study|Site Closed|0|||
125554111|NCT01284062|451660582|FG002|Overall Study|Site Closed|1|||
125554112|NCT01284062|451660583|FG003|Overall Study|Site Closed|0|||
125554113|NCT02234323|451660584|FG000|All Enrolled|Not Treated: Completed study in database|2|||
125554114|NCT02234323|451660584|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
125554115|NCT02234323|451660584|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
125554116|NCT02234323|451660584|FG000|All Treated|Death|1|||
125554117|NCT02234323|451660584|FG000|All Treated|Physician Decision|5|||
125554118|NCT02234323|451660584|FG000|All Treated|Lack of Efficacy|3|||
125554119|NCT02234323|451660584|FG000|All Treated|Exceeded lab value limit|2|||
125554120|NCT02234323|451660584|FG000|All Treated|Other|7|||
125554121|NCT02644941|451660585|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
125554122|NCT02644941|451660586|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
125554123|NCT04614662|451660587|FG000|Overall Study|Withdrawal by Subject|0|||
125554124|NCT04614662|451660588|FG001|Overall Study|Withdrawal by Subject|1|||
125554125|NCT01717768|451660592|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125554126|NCT01717768|451660593|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
125554127|NCT01717768|451660594|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125554128|NCT01717768|451660595|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125554129|NCT01717768|451660596|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125554130|NCT01717768|451660597|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125554131|NCT01717768|451660598|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125554132|NCT01717768|451660599|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125554133|NCT01717768|451660600|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125350597|NCT01909453|450917098|FG004|Overall Study|Lost to Follow-up|3|||
125350598|NCT01909453|450917094|FG000|Overall Study|Withdrawal by Subject|2|||
125350599|NCT01909453|450917095|FG001|Overall Study|Withdrawal by Subject|13|||
125350600|NCT01909453|450917096|FG002|Overall Study|Withdrawal by Subject|16|||
125350601|NCT01909453|450917097|FG003|Overall Study|Withdrawal by Subject|5|||
125350602|NCT01909453|450917098|FG004|Overall Study|Withdrawal by Subject|4|||
125350603|NCT03150485|450918489|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
125350604|NCT03150485|450918490|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
125350605|NCT03150485|450918491|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
125554134|NCT01717768|451660601|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125350606|NCT03150485|450918492|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
125350607|NCT03150485|450918493|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
125350608|NCT03150485|450918494|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
125554135|NCT01717768|451660602|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125554136|NCT01717768|451660603|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
125554137|NCT01717768|451660592|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
125554138|NCT01717768|451660593|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
125554139|NCT01717768|451660594|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
125554140|NCT01717768|451660595|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
125554141|NCT01717768|451660596|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
125554142|NCT01717768|451660597|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
125554143|NCT01717768|451660598|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
125350609|NCT01394718|450918495|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
125350610|NCT01394718|450918496|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
125350611|NCT04617795|450918497|FG000|Main Study|Lost to Follow-up|1|||
125350612|NCT04617795|450918498|FG001|Main Study|Lost to Follow-up|0|||
125350613|NCT03442764|450918499|FG000|Overall Study|Adverse Event|1|||
125350614|NCT03442764|450918500|FG001|Overall Study|Adverse Event|0|||
125350615|NCT03442764|450918501|FG002|Overall Study|Adverse Event|0|||
125350616|NCT04850313|450918502|FG000|Overall Study|Withdrawal by Subject|0|||
125350617|NCT04850313|450918503|FG001|Overall Study|Withdrawal by Subject|1|||
125350618|NCT02395016|450918504|FG000|Overall Study|Adverse Event|4|||
125350619|NCT02395016|450918505|FG001|Overall Study|Adverse Event|3|||
125350620|NCT02395016|450918504|FG000|Overall Study|Withdrawal by Subject|9|||
125350621|NCT02395016|450918505|FG001|Overall Study|Withdrawal by Subject|6|||
125350622|NCT02395016|450918504|FG000|Overall Study|Protocol Violation|2|||
125350623|NCT02395016|450918505|FG001|Overall Study|Protocol Violation|3|||
125350624|NCT01547780|450918506|FG000|Baseline PET Scan|Physician Decision|1|||
125350625|NCT01547780|450918507|FG001|Baseline PET Scan|Physician Decision|0|||
125350626|NCT01547780|450918508|FG002|Baseline PET Scan|Physician Decision|1|||
125554144|NCT01717768|451660599|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
125554145|NCT01717768|451660600|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
125554146|NCT01717768|451660601|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
125554147|NCT01717768|451660602|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
125554148|NCT01717768|451660603|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
125554149|NCT01717768|451660592|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
125350627|NCT01547780|450918509|FG003|Baseline PET Scan|Physician Decision|0|||
125350628|NCT01547780|450918506|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
125350629|NCT01547780|450918507|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
125350630|NCT01547780|450918508|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
125350631|NCT01547780|450918509|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
125350632|NCT00814879|450918511|FG000|By Week 24|Cancer Diagnosis|1|||
125350633|NCT00814879|450918512|FG001|By Week 24|Cancer Diagnosis|0|||
125350634|NCT00814879|450918511|FG000|By Week 24|Incarceration|0|||
125350635|NCT00814879|450918512|FG001|By Week 24|Incarceration|1|||
125554150|NCT01717768|451660593|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
125554151|NCT01717768|451660594|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
125350636|NCT00814879|450918511|FG000|By Week 48|Lost to Follow-up|2|||
125350637|NCT00814879|450918512|FG001|By Week 48|Lost to Follow-up|2|||
125350638|NCT00814879|450918511|FG000|By Week 48|Death|0|||
125350639|NCT00814879|450918512|FG001|By Week 48|Death|1|||
125350640|NCT01461057|450918513|FG000|Overall Study|Death|10|||
125350641|NCT01461057|450918514|FG001|Overall Study|Death|9|||
125350642|NCT01461057|450918513|FG000|Overall Study|Withdrawal by Subject|2|||
125350643|NCT01461057|450918514|FG001|Overall Study|Withdrawal by Subject|3|||
125350644|NCT01461057|450918513|FG000|Overall Study|Physician Decision|0|||
125350645|NCT01461057|450918514|FG001|Overall Study|Physician Decision|2|||
125350646|NCT01461057|450918513|FG000|Overall Study|Adverse Event|0|||
125350647|NCT01461057|450918514|FG001|Overall Study|Adverse Event|1|||
125350648|NCT01461057|450918513|FG000|Overall Study|Progression of Disease|1|||
125350649|NCT01461057|450918514|FG001|Overall Study|Progression of Disease|0|||
125350650|NCT01461057|450918513|FG000|Overall Study|Study Terminated by Sponsor|2|||
125350651|NCT01461057|450918514|FG001|Overall Study|Study Terminated by Sponsor|0|||
125350652|NCT01288976|450918515|FG000|Overall Study|Withdrawal by Subject|58|||
125350653|NCT01288976|450918516|FG001|Overall Study|Withdrawal by Subject|12|||
125350654|NCT01288976|450918517|FG002|Overall Study|Withdrawal by Subject|9|||
125350655|NCT01288976|450918515|FG000|Overall Study|Death|98|||
125350656|NCT01288976|450918516|FG001|Overall Study|Death|6|||
125350657|NCT01288976|450918517|FG002|Overall Study|Death|4|||
125350658|NCT01288976|450918515|FG000|Overall Study|Data unavailable|22|||
125350659|NCT01288976|450918516|FG001|Overall Study|Data unavailable|9|||
125350660|NCT01288976|450918517|FG002|Overall Study|Data unavailable|7|||
125350661|NCT02478398|450918526|FG000|Overall Study|Adverse Event|20|||
125350662|NCT02478398|450918527|FG001|Overall Study|Adverse Event|5|||
125350663|NCT02478398|450918526|FG000|Overall Study|Lost to Follow-up|5|||
125350664|NCT02478398|450918527|FG001|Overall Study|Lost to Follow-up|4|||
125350665|NCT02478398|450918526|FG000|Overall Study|Non-Compliance With Study Drug|5|||
125350666|NCT02478398|450918527|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125350667|NCT02478398|450918526|FG000|Overall Study|Protocol Violation|3|||
125350668|NCT02478398|450918527|FG001|Overall Study|Protocol Violation|1|||
125350669|NCT02478398|450918526|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
125350670|NCT02478398|450918527|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
125350671|NCT02478398|450918526|FG000|Overall Study|Withdrawal By Participant|10|||
125350672|NCT02478398|450918527|FG001|Overall Study|Withdrawal By Participant|4|||
125350673|NCT01362595|450918529|FG000|Overall Study|Screen failure|10|||
125350674|NCT01362595|450918529|FG000|Overall Study|Withdrawal by Subject|2|||
125350675|NCT00959374|450918530|FG000|Overall Study|Withdrawal by Subject|2|||
125350676|NCT00959374|450918530|FG000|Overall Study|Lost to Follow-up|14|||
125350677|NCT00959374|450918530|FG000|Overall Study|Death|1|||
125350678|NCT00959374|450918530|FG000|Overall Study|Protocol Violation|1|||
125350679|NCT00959374|450918530|FG000|Overall Study|Implant Removed/Not Replaced|4|||
125350680|NCT00959374|450918530|FG000|Overall Study|Physician Decision|1|||
125350681|NCT02448680|450918531|FG000|Overall Study|Physician Decision|1|||
125350682|NCT02448680|450918532|FG001|Overall Study|Physician Decision|1|||
125350683|NCT02448680|450918531|FG000|Overall Study|Withdrawal by Subject|0|||
125350684|NCT02448680|450918532|FG001|Overall Study|Withdrawal by Subject|2|||
125350685|NCT00636987|450918533|FG000|Overall Study|Death|44|||
125350686|NCT00636987|450918533|FG000|Overall Study|Explanted|13|||
125350687|NCT00636987|450918533|FG000|Overall Study|Lost to Follow-up|63|||
125350688|NCT00636987|450918533|FG000|Overall Study|5 year visit window not complete|69|||
125350689|NCT01251146|450918534|FG000|Overall Study|Lost to Follow-up|3|||
125350690|NCT01251146|450918535|FG001|Overall Study|Lost to Follow-up|10|||
125350691|NCT01739400|450918538|FG000|Overall Study|Physician Decision|3|||
125350692|NCT01739400|450918539|FG001|Overall Study|Physician Decision|0|||
125350693|NCT01739400|450918538|FG000|Overall Study|Lost to Follow-up|2|||
125350694|NCT01739400|450918539|FG001|Overall Study|Lost to Follow-up|0|||
125554152|NCT01717768|451660595|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
125554153|NCT01717768|451660596|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
125554154|NCT01717768|451660597|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
125554155|NCT01717768|451660598|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
125554156|NCT01717768|451660599|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
125554157|NCT01717768|451660600|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
125554158|NCT01717768|451660601|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
125554159|NCT01717768|451660602|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
125554160|NCT01717768|451660603|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
125554161|NCT01717768|451660592|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
125554162|NCT01717768|451660593|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
125554163|NCT01717768|451660594|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
125554164|NCT01717768|451660595|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
125554165|NCT01717768|451660596|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
125554166|NCT01717768|451660597|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
125554167|NCT01717768|451660598|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
125554168|NCT01717768|451660599|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
125350695|NCT01739400|450918538|FG000|Overall Study|Death|5|||
125350696|NCT01739400|450918539|FG001|Overall Study|Death|2|||
125350697|NCT01739400|450918538|FG000|Overall Study|Withdrawal by Subject|7|||
125350698|NCT01739400|450918539|FG001|Overall Study|Withdrawal by Subject|7|||
125350699|NCT00737464|450918546|FG000|Overall Study|Adverse Event|1|||
125350700|NCT00737464|450918546|FG000|Overall Study|Death|6|||
125350701|NCT00737464|450918546|FG000|Overall Study|Other - Failure to Return|1|||
125350702|NCT00737464|450918546|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
125554169|NCT01717768|451660600|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
125554170|NCT01717768|451660601|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
125554171|NCT01717768|451660602|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
125554172|NCT01717768|451660603|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
125554173|NCT01843218|451660610|FG000|Overall Study|Withdrawal by Subject|5|||
125554174|NCT01906346|451660611|FG000|Overall Study|AEs|1|||
125554175|NCT04226833|451660612|FG000|Overall Study|Death|0|||
125554176|NCT04226833|451660613|FG001|Overall Study|Death|0|||
125554177|NCT04226833|451660614|FG002|Overall Study|Death|1|||
125554178|NCT04226833|451660615|FG003|Overall Study|Death|0|||
125554179|NCT03829319|451660622|FG000|Overall Study|Sponsor's Decision|4|||
125554180|NCT03829319|451660623|FG001|Overall Study|Sponsor's Decision|90|||
125554181|NCT03829319|451660624|FG002|Overall Study|Sponsor's Decision|102|||
125554182|NCT03829319|451660622|FG000|Overall Study|Withdrawal by Subject|1|||
125554183|NCT03829319|451660623|FG001|Overall Study|Withdrawal by Subject|5|||
125554184|NCT03829319|451660624|FG002|Overall Study|Withdrawal by Subject|4|||
125554185|NCT03829319|451660622|FG000|Overall Study|Physician Decision|0|||
125554186|NCT03829319|451660623|FG001|Overall Study|Physician Decision|3|||
125554187|NCT03829319|451660624|FG002|Overall Study|Physician Decision|0|||
125554188|NCT03829319|451660622|FG000|Overall Study|Lost to Follow-up|0|||
125554189|NCT03829319|451660623|FG001|Overall Study|Lost to Follow-up|0|||
125554190|NCT03829319|451660624|FG002|Overall Study|Lost to Follow-up|1|||
125554191|NCT03829319|451660622|FG000|Overall Study|Death|8|||
125554192|NCT03829319|451660623|FG001|Overall Study|Death|277|||
125554193|NCT03829319|451660624|FG002|Overall Study|Death|266|||
125554194|NCT04498832|451660625|FG000|Overall Study|Adverse Event|1|||
125554195|NCT04498832|451660626|FG001|Overall Study|Adverse Event|3|||
125554196|NCT04498832|451660625|FG000|Overall Study|Withdrawal by Subject|0|||
125554197|NCT04498832|451660626|FG001|Overall Study|Withdrawal by Subject|1|||
125554198|NCT05579990|451660632|FG000|Overall Study|Lost to Follow-up|3|||
125554199|NCT03231943|451660636|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
125350703|NCT00737464|450918546|FG000|Overall Study|Other reasons|4|||
125350704|NCT03220438|450918549|FG000|Overall Study|Lost to Follow-up|0|||
125350705|NCT03220438|450918550|FG001|Overall Study|Lost to Follow-up|0|||
125350706|NCT03220438|450918551|FG002|Overall Study|Lost to Follow-up|1|||
125350707|NCT03220438|450918552|FG003|Overall Study|Lost to Follow-up|0|||
125350708|NCT01634178|450918555|FG000|Treatment Period 1|Adverse Event|0|||
125350709|NCT01634178|450918556|FG001|Treatment Period 1|Adverse Event|1|||
125350710|NCT01634178|450918555|FG000|Treatment Period 2|Adverse Event|1|||
125350711|NCT01634178|450918556|FG001|Treatment Period 2|Adverse Event|0|||
125350712|NCT00991952|450918571|FG000|Overall Study|Adverse Event|0|||
125350713|NCT00991952|450918572|FG001|Overall Study|Adverse Event|1|||
125350714|NCT02483533|450918574|FG000|Overall Study|Lack of Efficacy|50|||
125350715|NCT02483533|450918575|FG001|Overall Study|Lack of Efficacy|50|||
125350716|NCT03452527|450918576|FG000|Overall Study|Withdrawal by Subject|1|||
125350717|NCT03452527|450918577|FG001|Overall Study|Withdrawal by Subject|1|||
125350718|NCT03452527|450918576|FG000|Overall Study|Study Terminated|2|||
125350719|NCT03452527|450918577|FG001|Overall Study|Study Terminated|3|||
125350720|NCT00582816|450918578|FG000|Overall Study|Engraftment Failure|3|||
125554200|NCT03231943|451660637|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
125554201|NCT03231943|451660638|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
125554202|NCT03231943|451660639|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
125554203|NCT03231943|451660640|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
125554204|NCT03231943|451660641|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
125554205|NCT03231943|451660642|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
125554206|NCT03231943|451660643|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
125554207|NCT03231943|451660644|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
125554208|NCT03231943|451660645|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
125554209|NCT03231943|451660646|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
125350721|NCT00174291|450918589|FG000|Overall Study|Lost to Follow-up|1|||
125350722|NCT00174291|450918590|FG001|Overall Study|Lost to Follow-up|1|||
125350723|NCT00174291|450918589|FG000|Overall Study|Protocol Violation|0|||
125350724|NCT00174291|450918590|FG001|Overall Study|Protocol Violation|2|||
125350725|NCT00174291|450918589|FG000|Overall Study|Study terminated by sponsor|1|||
125350726|NCT00174291|450918590|FG001|Overall Study|Study terminated by sponsor|0|||
125350727|NCT00174291|450918589|FG000|Overall Study|Withdrawal by Subject|3|||
125350728|NCT00174291|450918590|FG001|Overall Study|Withdrawal by Subject|3|||
125350729|NCT03116347|450918593|FG000|Overall Study|Withdrawal by Subject|1|||
125350730|NCT03116347|450918594|FG001|Overall Study|Withdrawal by Subject|2|||
125350731|NCT03170232|450918595|FG000|Overall Study|Adverse Event|0|||
125350732|NCT03170232|450918596|FG001|Overall Study|Adverse Event|1|||
125350733|NCT03170232|450918595|FG000|Overall Study|Protocol Violation|0|||
125350734|NCT03170232|450918596|FG001|Overall Study|Protocol Violation|1|||
125350735|NCT03170232|450918595|FG000|Overall Study|Lack of Efficacy|0|||
125350736|NCT03170232|450918596|FG001|Overall Study|Lack of Efficacy|1|||
125350737|NCT03170232|450918595|FG000|Overall Study|Study closed/terminated|26|||
125350738|NCT03170232|450918596|FG001|Overall Study|Study closed/terminated|23|||
125350739|NCT03170232|450918595|FG000|Overall Study|Lost to Follow-up|1|||
125554210|NCT03231943|451660647|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
125554211|NCT03231943|451660648|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
125554212|NCT03231943|451660636|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
125350740|NCT03170232|450918596|FG001|Overall Study|Lost to Follow-up|0|||
125350741|NCT03170232|450918595|FG000|Overall Study|Withdrawal by Subject|0|||
125350742|NCT03170232|450918596|FG001|Overall Study|Withdrawal by Subject|1|||
125350743|NCT00586326|450918597|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
125350744|NCT00586326|450918597|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
125350745|NCT00586326|450918597|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
125350746|NCT00586326|450918597|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
125350747|NCT00586326|450918597|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
125350748|NCT00586326|450918597|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
125350749|NCT00586326|450918597|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
125350750|NCT00586326|450918597|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
125554213|NCT03231943|451660637|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
125554214|NCT03231943|451660638|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
125554215|NCT03231943|451660639|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
125554216|NCT03231943|451660640|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
125554217|NCT03231943|451660641|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
125554218|NCT03231943|451660642|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
125554219|NCT03231943|451660643|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
125554220|NCT03231943|451660644|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
125554221|NCT03231943|451660645|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
125554222|NCT03231943|451660646|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
125554223|NCT03231943|451660647|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
125554224|NCT03231943|451660648|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
125554225|NCT03231943|451660636|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
125554226|NCT03231943|451660637|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
125554227|NCT03231943|451660638|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
125554228|NCT03231943|451660639|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
125554229|NCT03231943|451660640|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
125554230|NCT03231943|451660641|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
125554231|NCT03231943|451660642|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
125350751|NCT00586326|450918597|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
125350752|NCT00586326|450918597|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
125350753|NCT00586326|450918597|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
125350754|NCT00586326|450918597|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
125350755|NCT00586326|450918597|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
125554232|NCT03231943|451660643|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
125554233|NCT03231943|451660644|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
125554234|NCT03231943|451660645|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
125554235|NCT03231943|451660646|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
125554236|NCT03231943|451660647|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
125554237|NCT03231943|451660648|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
125554238|NCT03231943|451660636|FG000|Part 2|Adverse Event|0|||
125554239|NCT03231943|451660637|FG001|Part 2|Adverse Event|0|||
125554240|NCT03231943|451660638|FG002|Part 2|Adverse Event|0|||
125554241|NCT03231943|451660639|FG003|Part 2|Adverse Event|0|||
125554242|NCT03231943|451660640|FG004|Part 2|Adverse Event|0|||
125554243|NCT03231943|451660641|FG005|Part 2|Adverse Event|0|||
125554244|NCT03231943|451660642|FG006|Part 2|Adverse Event|0|||
125350756|NCT00586326|450918597|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
125350757|NCT00586326|450918597|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
125350758|NCT00586326|450918597|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
125350759|NCT00586326|450918597|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
125350760|NCT01439347|450918598|FG000|Overall Study|Death|10|||
125350761|NCT01439347|450918599|FG001|Overall Study|Death|9|||
125350762|NCT01439347|450918598|FG000|Overall Study|Withdrawal by Subject|0|||
125350763|NCT01439347|450918599|FG001|Overall Study|Withdrawal by Subject|1|||
125350764|NCT01439347|450918598|FG000|Overall Study|Physician Decision|1|||
125554245|NCT03231943|451660643|FG007|Part 2|Adverse Event|0|||
125554246|NCT03231943|451660644|FG008|Part 2|Adverse Event|0|||
125554247|NCT03231943|451660645|FG009|Part 2|Adverse Event|0|||
125554248|NCT03231943|451660646|FG010|Part 2|Adverse Event|1|||
125350765|NCT01439347|450918599|FG001|Overall Study|Physician Decision|0|||
125554249|NCT03231943|451660647|FG011|Part 2|Adverse Event|0|||
125554250|NCT03231943|451660648|FG012|Part 2|Adverse Event|0|||
125554251|NCT03231943|451660636|FG000|Part 2|Withdrawal by Subject|0|||
125554252|NCT03231943|451660637|FG001|Part 2|Withdrawal by Subject|0|||
125554253|NCT03231943|451660638|FG002|Part 2|Withdrawal by Subject|0|||
125554254|NCT03231943|451660639|FG003|Part 2|Withdrawal by Subject|0|||
125350766|NCT01439347|450918598|FG000|Overall Study|Sponsor Terminated Study|2|||
125350767|NCT01439347|450918599|FG001|Overall Study|Sponsor Terminated Study|3|||
125554255|NCT03231943|451660640|FG004|Part 2|Withdrawal by Subject|0|||
125425665|NCT01197508|451182322|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
125425666|NCT01197508|451182323|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
125425667|NCT01197508|451182324|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
125425668|NCT01197508|451182325|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
125425669|NCT01197508|451182322|FG000|Overall Study|Adverse Event|10|||
125425670|NCT01197508|451182323|FG001|Overall Study|Adverse Event|13|||
125425671|NCT01197508|451182324|FG002|Overall Study|Adverse Event|23|||
125425672|NCT01197508|451182325|FG003|Overall Study|Adverse Event|3|||
125425673|NCT01197508|451182322|FG000|Overall Study|Severe non-compliance to protocol|0|||
125425674|NCT01197508|451182323|FG001|Overall Study|Severe non-compliance to protocol|3|||
125425675|NCT01197508|451182324|FG002|Overall Study|Severe non-compliance to protocol|1|||
125425676|NCT01197508|451182325|FG003|Overall Study|Severe non-compliance to protocol|3|||
125425677|NCT01197508|451182322|FG000|Overall Study|Condition under investigation worsened|1|||
125425678|NCT01197508|451182323|FG001|Overall Study|Condition under investigation worsened|1|||
125425679|NCT01197508|451182324|FG002|Overall Study|Condition under investigation worsened|1|||
125425680|NCT01197508|451182325|FG003|Overall Study|Condition under investigation worsened|1|||
125425681|NCT01197508|451182322|FG000|Overall Study|Lack of Efficacy|1|||
125425682|NCT01197508|451182323|FG001|Overall Study|Lack of Efficacy|2|||
125425683|NCT01197508|451182324|FG002|Overall Study|Lack of Efficacy|2|||
125425684|NCT01197508|451182325|FG003|Overall Study|Lack of Efficacy|1|||
125425685|NCT01197508|451182322|FG000|Overall Study|Study-specific withdrawal criteria|0|||
125425686|NCT01197508|451182323|FG001|Overall Study|Study-specific withdrawal criteria|0|||
125425687|NCT01197508|451182324|FG002|Overall Study|Study-specific withdrawal criteria|1|||
125425688|NCT01197508|451182325|FG003|Overall Study|Study-specific withdrawal criteria|2|||
125425689|NCT01197508|451182322|FG000|Overall Study|Lost to Follow-up|1|||
125425690|NCT01197508|451182323|FG001|Overall Study|Lost to Follow-up|1|||
125425691|NCT01197508|451182324|FG002|Overall Study|Lost to Follow-up|2|||
125425692|NCT01197508|451182325|FG003|Overall Study|Lost to Follow-up|0|||
125425693|NCT01197508|451182322|FG000|Overall Study|Other|2|||
125425694|NCT01197508|451182323|FG001|Overall Study|Other|3|||
125425695|NCT01197508|451182324|FG002|Overall Study|Other|2|||
125425696|NCT01197508|451182325|FG003|Overall Study|Other|2|||
125425697|NCT01301391|451182327|FG000|Overall Study|Death|13|||
125425698|NCT01301391|451182327|FG000|Overall Study|Lost to Follow-up|3|||
125425699|NCT01301391|451182327|FG000|Overall Study|Physician Decision|2|||
125425700|NCT01301391|451182327|FG000|Overall Study|Sponsor's decision|8|||
125425701|NCT02799784|451182328|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
125425702|NCT02799784|451182329|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
125425703|NCT02799784|451182328|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
125425704|NCT02799784|451182329|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
125425705|NCT02799784|451182328|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
125425706|NCT02799784|451182329|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
125425707|NCT02799784|451182328|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
125425708|NCT02799784|451182329|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
125425709|NCT02799784|451182328|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
125425710|NCT02799784|451182329|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
125425711|NCT02799784|451182328|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
125554256|NCT03231943|451660641|FG005|Part 2|Withdrawal by Subject|0|||
125554257|NCT03231943|451660642|FG006|Part 2|Withdrawal by Subject|0|||
125554258|NCT03231943|451660643|FG007|Part 2|Withdrawal by Subject|0|||
125554259|NCT03231943|451660644|FG008|Part 2|Withdrawal by Subject|0|||
125554260|NCT03231943|451660645|FG009|Part 2|Withdrawal by Subject|0|||
125554261|NCT03231943|451660646|FG010|Part 2|Withdrawal by Subject|0|||
125554262|NCT03231943|451660647|FG011|Part 2|Withdrawal by Subject|1|||
125554263|NCT03231943|451660648|FG012|Part 2|Withdrawal by Subject|0|||
125554264|NCT04824521|451660651|FG000|Overall Study|Lost to Follow-up|1|||
125554265|NCT04124614|451660653|FG000|Placebo Run-in Period|Not Randomized|34|||
125554266|NCT04124614|451660654|FG001|Placebo Run-in Period|Not Randomized|0|||
125554267|NCT04124614|451660655|FG002|Placebo Run-in Period|Not Randomized|0|||
125554268|NCT04124614|451660653|FG000|Double Blind Treatment Period|Adverse Event|0|||
125554269|NCT04124614|451660654|FG001|Double Blind Treatment Period|Adverse Event|7|||
125554270|NCT04124614|451660655|FG002|Double Blind Treatment Period|Adverse Event|22|||
125554271|NCT04124614|451660653|FG000|Double Blind Treatment Period|Death|0|||
125554272|NCT04124614|451660654|FG001|Double Blind Treatment Period|Death|0|||
125554273|NCT04124614|451660655|FG002|Double Blind Treatment Period|Death|1|||
125425712|NCT02799784|451182329|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
125425713|NCT01949870|451182332|FG000|Overall Study|Lack of Efficacy|2|||
125425714|NCT01949870|451182332|FG000|Overall Study|Adverse Event|1|||
125425715|NCT01949870|451182332|FG000|Overall Study|Study termination|1|||
125425716|NCT01949870|451182332|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
125554274|NCT04124614|451660653|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
125350768|NCT04068896|450918601|FG000|Overall Study|Adverse Event|2|||
125350769|NCT04068896|450918602|FG001|Overall Study|Adverse Event|0|||
125350770|NCT04068896|450918603|FG002|Overall Study|Adverse Event|1|||
125350771|NCT04068896|450918604|FG003|Overall Study|Adverse Event|0|||
125350772|NCT04068896|450918605|FG004|Overall Study|Adverse Event|0|||
125350773|NCT04068896|450918606|FG005|Overall Study|Adverse Event|0|||
125350774|NCT04068896|450918601|FG000|Overall Study|Death|3|||
125350775|NCT04068896|450918602|FG001|Overall Study|Death|1|||
125350776|NCT04068896|450918603|FG002|Overall Study|Death|3|||
125350777|NCT04068896|450918604|FG003|Overall Study|Death|19|||
125350778|NCT04068896|450918605|FG004|Overall Study|Death|17|||
125350779|NCT04068896|450918606|FG005|Overall Study|Death|0|||
125350780|NCT04068896|450918601|FG000|Overall Study|Physician Decision|0|||
125350781|NCT04068896|450918602|FG001|Overall Study|Physician Decision|0|||
125350782|NCT04068896|450918603|FG002|Overall Study|Physician Decision|0|||
125350783|NCT04068896|450918604|FG003|Overall Study|Physician Decision|1|||
125350784|NCT04068896|450918605|FG004|Overall Study|Physician Decision|0|||
125350785|NCT04068896|450918606|FG005|Overall Study|Physician Decision|0|||
125350786|NCT04068896|450918601|FG000|Overall Study|progressive disease|3|||
125350787|NCT04068896|450918602|FG001|Overall Study|progressive disease|5|||
125350788|NCT04068896|450918603|FG002|Overall Study|progressive disease|3|||
125350789|NCT04068896|450918604|FG003|Overall Study|progressive disease|2|||
125350790|NCT04068896|450918605|FG004|Overall Study|progressive disease|1|||
125350791|NCT04068896|450918606|FG005|Overall Study|progressive disease|2|||
125554275|NCT04124614|451660654|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
125554276|NCT04124614|451660655|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
125554277|NCT04124614|451660653|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
125554278|NCT04124614|451660654|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
125554279|NCT04124614|451660655|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
125554280|NCT04124614|451660653|FG000|Double Blind Treatment Period|Physician Decision|0|||
125554281|NCT04124614|451660654|FG001|Double Blind Treatment Period|Physician Decision|0|||
125554282|NCT04124614|451660655|FG002|Double Blind Treatment Period|Physician Decision|3|||
125554283|NCT04124614|451660653|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
125554284|NCT04124614|451660654|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
125350792|NCT04068896|450918601|FG000|Overall Study|Study terminated by sponsor|0|||
125350793|NCT04068896|450918602|FG001|Overall Study|Study terminated by sponsor|0|||
125350794|NCT04068896|450918603|FG002|Overall Study|Study terminated by sponsor|1|||
125350795|NCT04068896|450918604|FG003|Overall Study|Study terminated by sponsor|2|||
125350796|NCT04068896|450918605|FG004|Overall Study|Study terminated by sponsor|1|||
125425717|NCT02570126|451182333|FG000|Overall Study|Lost to Follow-up|2|||
125425718|NCT02570126|451182334|FG001|Overall Study|Lost to Follow-up|0|||
125554285|NCT04124614|451660655|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
125554286|NCT04124614|451660653|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
125554287|NCT04124614|451660654|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
125554288|NCT04124614|451660655|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
125554289|NCT04124614|451660653|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
125554290|NCT04124614|451660654|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
125554291|NCT04124614|451660655|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
125554292|NCT03338192|451661493|FG000|Year One to Year Two|High Blood Pressure|7|||
125554293|NCT03338192|451661494|FG001|Year One to Year Two|High Blood Pressure|1|||
125554294|NCT03338192|451661493|FG000|Year One to Year Two|HIV +|1|||
125554295|NCT03338192|451661494|FG001|Year One to Year Two|HIV +|0|||
125554296|NCT03338192|451661493|FG000|Year Two to Year Four|High Blood Pressure|1|||
125554297|NCT03338192|451661494|FG001|Year Two to Year Four|High Blood Pressure|0|||
125350797|NCT04068896|450918606|FG005|Overall Study|Study terminated by sponsor|4|||
125425719|NCT02570126|451182333|FG000|Overall Study|Unable To Arrange Visit 3|1|||
125425720|NCT02570126|451182334|FG001|Overall Study|Unable To Arrange Visit 3|0|||
125425721|NCT02570126|451182333|FG000|Overall Study|Violation Of Procedures GSK|0|||
125425722|NCT02570126|451182334|FG001|Overall Study|Violation Of Procedures GSK|1|||
125425723|NCT02570126|451182333|FG000|Overall Study|Protocol Violation|0|||
125350798|NCT04068896|450918601|FG000|Overall Study|Protocol Violation|0|||
125350799|NCT04068896|450918602|FG001|Overall Study|Protocol Violation|0|||
125350800|NCT04068896|450918603|FG002|Overall Study|Protocol Violation|0|||
125425724|NCT02570126|451182334|FG001|Overall Study|Protocol Violation|1|||
125350801|NCT04068896|450918604|FG003|Overall Study|Protocol Violation|1|||
125350802|NCT04068896|450918605|FG004|Overall Study|Protocol Violation|0|||
125425725|NCT02570126|451182333|FG000|Overall Study|Withdrawal by Subject|3|||
125350803|NCT04068896|450918606|FG005|Overall Study|Protocol Violation|0|||
125350804|NCT04068896|450918601|FG000|Overall Study|Withdrawal by Subject|0|||
125350805|NCT04068896|450918602|FG001|Overall Study|Withdrawal by Subject|3|||
125350806|NCT04068896|450918603|FG002|Overall Study|Withdrawal by Subject|0|||
125350807|NCT04068896|450918604|FG003|Overall Study|Withdrawal by Subject|2|||
125350808|NCT04068896|450918605|FG004|Overall Study|Withdrawal by Subject|1|||
125350809|NCT04068896|450918606|FG005|Overall Study|Withdrawal by Subject|0|||
125350810|NCT04068896|450918601|FG000|Overall Study|Symptomatic deterioration|2|||
125350811|NCT04068896|450918602|FG001|Overall Study|Symptomatic deterioration|0|||
125350812|NCT04068896|450918603|FG002|Overall Study|Symptomatic deterioration|0|||
125350813|NCT04068896|450918604|FG003|Overall Study|Symptomatic deterioration|0|||
125350814|NCT04068896|450918605|FG004|Overall Study|Symptomatic deterioration|0|||
125350815|NCT04068896|450918606|FG005|Overall Study|Symptomatic deterioration|0|||
125350816|NCT01101191|450918607|FG000|Period 1|Withdrawal by Subject|1|||
125350817|NCT01101191|450918608|FG001|Period 1|Withdrawal by Subject|0|||
125350818|NCT01101191|450918607|FG000|Period 1|Adverse Event|1|||
125350819|NCT01101191|450918608|FG001|Period 1|Adverse Event|2|||
125350820|NCT02009384|450918609|FG000|Overall Study|Death|2|||
125350821|NCT00718237|450918611|FG000|Overall Study|Adverse Event|1|||
125350822|NCT00718237|450918612|FG001|Overall Study|Adverse Event|3|||
125350823|NCT00718237|450918611|FG000|Overall Study|Lost to Follow-up|2|||
125350824|NCT00718237|450918612|FG001|Overall Study|Lost to Follow-up|2|||
125350825|NCT00718237|450918611|FG000|Overall Study|Physician Decision|1|||
125350826|NCT00718237|450918612|FG001|Overall Study|Physician Decision|0|||
125350827|NCT00718237|450918611|FG000|Overall Study|Withdrawal by Subject|9|||
125350828|NCT00718237|450918612|FG001|Overall Study|Withdrawal by Subject|10|||
125350829|NCT02694718|450918613|FG000|Overall Study|Death|1|||
125350830|NCT02694718|450918613|FG000|Overall Study|Withdrawal by Subject|1|||
125350831|NCT02925793|450918614|FG000|Overall Study|Adverse Event|3|||
125350832|NCT02925793|450918615|FG001|Overall Study|Adverse Event|3|||
125350833|NCT02925793|450918616|FG002|Overall Study|Adverse Event|6|||
125350834|NCT02925793|450918614|FG000|Overall Study|Withdrawal by Subject|16|||
125350835|NCT02925793|450918615|FG001|Overall Study|Withdrawal by Subject|15|||
125350836|NCT02925793|450918616|FG002|Overall Study|Withdrawal by Subject|13|||
125350837|NCT02925793|450918614|FG000|Overall Study|Investigator Discretion|0|||
125350838|NCT02925793|450918615|FG001|Overall Study|Investigator Discretion|1|||
125350839|NCT02925793|450918616|FG002|Overall Study|Investigator Discretion|1|||
125350840|NCT02925793|450918614|FG000|Overall Study|Lost to Follow-up|2|||
125350841|NCT02925793|450918615|FG001|Overall Study|Lost to Follow-up|3|||
125350842|NCT02925793|450918616|FG002|Overall Study|Lost to Follow-up|1|||
125350843|NCT02925793|450918614|FG000|Overall Study|Lack of Efficacy|2|||
125350844|NCT02925793|450918615|FG001|Overall Study|Lack of Efficacy|6|||
125350845|NCT02925793|450918616|FG002|Overall Study|Lack of Efficacy|4|||
125350846|NCT02925793|450918614|FG000|Overall Study|Other:|2|||
125350847|NCT02925793|450918615|FG001|Overall Study|Other:|1|||
125350848|NCT02925793|450918616|FG002|Overall Study|Other:|3|||
125350849|NCT00879879|450918617|FG000|Overall Study|Death|1|||
125350850|NCT00879879|450918617|FG000|Overall Study|Withdrawal by Subject|1|||
125350851|NCT00879879|450918617|FG000|Overall Study|Physician Decision|1|||
125350852|NCT00667446|450918619|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
125350853|NCT00667446|450918620|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
125350854|NCT00667446|450918619|FG000|Treatment Period (36 Months)|Other|2|||
125350855|NCT00667446|450918620|FG001|Treatment Period (36 Months)|Other|2|||
125350856|NCT00667446|450918619|FG000|Treatment Period (36 Months)|Personal reasons|2|||
125350857|NCT00667446|450918620|FG001|Treatment Period (36 Months)|Personal reasons|2|||
125350858|NCT00667446|450918619|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
125350859|NCT00667446|450918620|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
125350860|NCT00667446|450918619|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
125350861|NCT00667446|450918620|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
125350862|NCT00667446|450918619|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
125350863|NCT00667446|450918620|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
125350864|NCT00667446|450918619|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
125350865|NCT00667446|450918620|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
125350866|NCT00667446|450918619|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
125350867|NCT00667446|450918620|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
125350868|NCT00667446|450918619|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
125350869|NCT00667446|450918620|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
125350870|NCT01343901|450918621|FG000|Overall Study|Death|85|||
125350871|NCT01343901|450918621|FG000|Overall Study|Physician Decision|4|||
125350872|NCT01343901|450918621|FG000|Overall Study|Lost to Follow-up|12|||
125350873|NCT01343901|450918621|FG000|Overall Study|Management by another medical team|11|||
125350874|NCT01343901|450918621|FG000|Overall Study|Participant decision|1|||
125425726|NCT02570126|451182334|FG001|Overall Study|Withdrawal by Subject|7|||
125350875|NCT00769483|450918624|FG000|Overall Study|Withdrawal by Subject|0|||
125350876|NCT00769483|450918625|FG001|Overall Study|Withdrawal by Subject|1|||
125350877|NCT00769483|450918626|FG002|Overall Study|Withdrawal by Subject|0|||
125350878|NCT00769483|450918627|FG003|Overall Study|Withdrawal by Subject|0|||
125350879|NCT00769483|450918628|FG004|Overall Study|Withdrawal by Subject|1|||
125350880|NCT00769483|450918629|FG005|Overall Study|Withdrawal by Subject|0|||
125350881|NCT03455764|450918630|FG000|Overall Study|Adverse Event|1|||
125350882|NCT03455764|450918631|FG001|Overall Study|Adverse Event|0|||
125350883|NCT03455764|450918632|FG002|Overall Study|Adverse Event|0|||
125350884|NCT03455764|450918633|FG003|Overall Study|Adverse Event|0|||
125350885|NCT03455764|450918634|FG004|Overall Study|Adverse Event|0|||
125350886|NCT03455764|450918630|FG000|Overall Study|Disease Progression|4|||
125350887|NCT03455764|450918631|FG001|Overall Study|Disease Progression|0|||
125350888|NCT03455764|450918632|FG002|Overall Study|Disease Progression|0|||
125350889|NCT03455764|450918633|FG003|Overall Study|Disease Progression|0|||
125350890|NCT03455764|450918634|FG004|Overall Study|Disease Progression|0|||
125350891|NCT03455764|450918630|FG000|Overall Study|On Treatment|1|||
125350892|NCT03455764|450918631|FG001|Overall Study|On Treatment|0|||
125350893|NCT03455764|450918632|FG002|Overall Study|On Treatment|0|||
125350894|NCT03455764|450918633|FG003|Overall Study|On Treatment|0|||
125350895|NCT03455764|450918634|FG004|Overall Study|On Treatment|0|||
125350896|NCT05080660|450918635|FG000|Overall Study|Adverse Event|4|||
125350897|NCT05080660|450918636|FG001|Overall Study|Adverse Event|0|||
125350898|NCT05080660|450918635|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
125350899|NCT05080660|450918636|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
125350900|NCT05080660|450918635|FG000|Overall Study|Physician Decision|1|||
125350901|NCT05080660|450918636|FG001|Overall Study|Physician Decision|0|||
125350902|NCT05080660|450918635|FG000|Overall Study|Protocol Deviation|2|||
125350903|NCT05080660|450918636|FG001|Overall Study|Protocol Deviation|0|||
125350904|NCT05080660|450918635|FG000|Overall Study|Withdrawal by Subject|5|||
125350905|NCT05080660|450918636|FG001|Overall Study|Withdrawal by Subject|2|||
125350906|NCT04221230|450918646|FG000|Overall Study|Lost to Follow-up|12|||
125350907|NCT04221230|450918647|FG001|Overall Study|Lost to Follow-up|12|||
125350908|NCT04221230|450918646|FG000|Overall Study|Protocol Violation|2|||
125350909|NCT04221230|450918647|FG001|Overall Study|Protocol Violation|2|||
125350910|NCT04221230|450918646|FG000|Overall Study|Adverse Event|0|||
125350911|NCT04221230|450918647|FG001|Overall Study|Adverse Event|8|||
125350912|NCT04221230|450918646|FG000|Overall Study|Physician Decision|1|||
125350913|NCT04221230|450918647|FG001|Overall Study|Physician Decision|0|||
125350914|NCT04221230|450918646|FG000|Overall Study|Withdrawal by Subject|13|||
125350915|NCT04221230|450918647|FG001|Overall Study|Withdrawal by Subject|11|||
125350916|NCT04221230|450918646|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125350917|NCT04221230|450918647|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125350918|NCT04221230|450918646|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125350919|NCT04221230|450918647|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
125350920|NCT04221230|450918646|FG000|Overall Study|Pregnancy|0|||
125350921|NCT04221230|450918647|FG001|Overall Study|Pregnancy|1|||
125350922|NCT04221230|450918646|FG000|Overall Study|Other|1|||
125350923|NCT04221230|450918647|FG001|Overall Study|Other|2|||
125350924|NCT01307020|450918650|FG000|Overall Study|Lost to Follow-up|0|||
125350925|NCT01307020|450918651|FG001|Overall Study|Lost to Follow-up|0|||
125350926|NCT01307020|450918652|FG002|Overall Study|Lost to Follow-up|1|||
125350927|NCT01307020|450918653|FG003|Overall Study|Lost to Follow-up|1|||
125350928|NCT01307020|450918654|FG004|Overall Study|Lost to Follow-up|0|||
125350929|NCT01307020|450918655|FG005|Overall Study|Lost to Follow-up|0|||
125350930|NCT01307020|450918656|FG006|Overall Study|Lost to Follow-up|1|||
125350931|NCT01307020|450918657|FG007|Overall Study|Lost to Follow-up|0|||
125350932|NCT01307020|450918658|FG008|Overall Study|Lost to Follow-up|0|||
125350933|NCT01307020|450918659|FG009|Overall Study|Lost to Follow-up|0|||
125350934|NCT01307020|450918650|FG000|Overall Study|Electronic data capture failure|0|||
125350935|NCT01307020|450918651|FG001|Overall Study|Electronic data capture failure|1|||
125350936|NCT01307020|450918652|FG002|Overall Study|Electronic data capture failure|0|||
125350937|NCT01307020|450918653|FG003|Overall Study|Electronic data capture failure|0|||
125350938|NCT01307020|450918654|FG004|Overall Study|Electronic data capture failure|0|||
125350939|NCT01307020|450918655|FG005|Overall Study|Electronic data capture failure|0|||
125350940|NCT01307020|450918656|FG006|Overall Study|Electronic data capture failure|0|||
125350941|NCT01307020|450918657|FG007|Overall Study|Electronic data capture failure|0|||
125350942|NCT01307020|450918658|FG008|Overall Study|Electronic data capture failure|0|||
125350943|NCT01307020|450918659|FG009|Overall Study|Electronic data capture failure|0|||
125350944|NCT02021656|450918660|FG000|Overall Study|Adverse Event|1|||
125350945|NCT02021656|450918660|FG000|Overall Study|Lack of Efficacy|2|||
125350946|NCT02021656|450918660|FG000|Overall Study|Lost to Follow-up|1|||
125350947|NCT02021656|450918660|FG000|Overall Study|Withdrew Consent|2|||
125350948|NCT00562627|450920047|FG000|Overall Study|Protocol Violation|1|||
125554298|NCT03338192|451661493|FG000|Year Two to Year Four|HIV +|2|||
125350949|NCT00562627|450920048|FG001|Overall Study|Protocol Violation|1|||
125350950|NCT00562627|450920049|FG002|Overall Study|Protocol Violation|1|||
125350951|NCT00625742|450920050|FG000|Overall Study|Disease Progression|2|||
125350952|NCT00625742|450920050|FG000|Overall Study|Withdrawal by Subject|1|||
125350953|NCT00625742|450920050|FG000|Overall Study|Adverse Event|4|||
125350954|NCT00625742|450920050|FG000|Overall Study|Lost to Follow-up|4|||
125350955|NCT00625742|450920050|FG000|Overall Study|Ineligible|1|||
125350956|NCT01709578|450920051|FG000|Overall Study|Rescued and entered in long term safety|63|||
125350957|NCT01709578|450920052|FG001|Overall Study|Rescued and entered in long term safety|25|||
125350958|NCT01709578|450920053|FG002|Overall Study|Rescued and entered in long term safety|26|||
125554299|NCT03338192|451661494|FG001|Year Two to Year Four|HIV +|0|||
125425727|NCT00917579|451182335|FG000|Washout >= 2 Weeks|Adverse Event|1|||
125425728|NCT00917579|451182336|FG001|Washout >= 2 Weeks|Adverse Event|0|||
125425729|NCT00917579|451182335|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
125425730|NCT00917579|451182336|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
125425731|NCT00754338|451182337|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
125425732|NCT00754338|451182338|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
125425733|NCT00754338|451182339|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
125425734|NCT00754338|451182340|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
125350959|NCT01709578|450920051|FG000|Overall Study|Adverse Event|9|||
125425735|NCT00754338|451182337|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
125425736|NCT00754338|451182338|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
125425737|NCT00754338|451182339|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
125425738|NCT00754338|451182340|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
125425739|NCT04020341|451182341|FG000|Overall Study|Adverse Event|8|||
125425740|NCT04020341|451182342|FG001|Overall Study|Adverse Event|6|||
125425741|NCT04020341|451182341|FG000|Overall Study|Lost to Follow-up|8|||
125425742|NCT04020341|451182342|FG001|Overall Study|Lost to Follow-up|2|||
125425743|NCT04020341|451182341|FG000|Overall Study|Withdrawal by Subject|16|||
125425744|NCT04020341|451182342|FG001|Overall Study|Withdrawal by Subject|16|||
125425745|NCT04020341|451182341|FG000|Overall Study|Participant not able to swallow the tablet|1|||
125425746|NCT04020341|451182342|FG001|Overall Study|Participant not able to swallow the tablet|0|||
125425747|NCT04020341|451182341|FG000|Overall Study|Physician Decision|0|||
125425748|NCT04020341|451182342|FG001|Overall Study|Physician Decision|2|||
125425749|NCT04020341|451182341|FG000|Overall Study|Protocol Deviation|0|||
125425750|NCT04020341|451182342|FG001|Overall Study|Protocol Deviation|2|||
125425751|NCT00677352|451182343|FG000|Treatment Phase|Adverse Event|14|||
125425752|NCT00677352|451182344|FG001|Treatment Phase|Adverse Event|22|||
125425753|NCT00677352|451182343|FG000|Treatment Phase|Lack of Efficacy|2|||
125425754|NCT00677352|451182344|FG001|Treatment Phase|Lack of Efficacy|3|||
125425755|NCT00677352|451182343|FG000|Treatment Phase|Lost to Follow-up|0|||
125425756|NCT00677352|451182344|FG001|Treatment Phase|Lost to Follow-up|1|||
125425757|NCT00677352|451182343|FG000|Treatment Phase|Withdrawal by Subject|7|||
125425758|NCT00677352|451182344|FG001|Treatment Phase|Withdrawal by Subject|7|||
125425759|NCT00677352|451182343|FG000|Treatment Phase|Physician Decision|1|||
125425760|NCT00677352|451182344|FG001|Treatment Phase|Physician Decision|0|||
125425761|NCT00677352|451182343|FG000|Treatment Phase|Pregnancy|0|||
125425762|NCT00677352|451182344|FG001|Treatment Phase|Pregnancy|1|||
125425763|NCT00677352|451182343|FG000|Treatment Phase|Protocol Violation|1|||
125425764|NCT00677352|451182344|FG001|Treatment Phase|Protocol Violation|1|||
125554300|NCT03338192|451661493|FG000|Year Four to Year Six|High Blood Pressure|2|||
125554301|NCT03338192|451661494|FG001|Year Four to Year Six|High Blood Pressure|1|||
125554302|NCT03808688|451661495|FG000|Overall Study|Adverse Event|13|||
125350960|NCT01709578|450920052|FG001|Overall Study|Adverse Event|18|||
125350961|NCT01709578|450920053|FG002|Overall Study|Adverse Event|17|||
125350962|NCT01709578|450920051|FG000|Overall Study|Lack of Efficacy|5|||
125350963|NCT01709578|450920052|FG001|Overall Study|Lack of Efficacy|4|||
125350964|NCT01709578|450920053|FG002|Overall Study|Lack of Efficacy|2|||
125350965|NCT01709578|450920051|FG000|Overall Study|Poor compliance to protocol|1|||
125350966|NCT01709578|450920052|FG001|Overall Study|Poor compliance to protocol|2|||
125350967|NCT01709578|450920053|FG002|Overall Study|Poor compliance to protocol|1|||
125350968|NCT01709578|450920051|FG000|Overall Study|Other, not related to safety or efficacy|2|||
125350969|NCT01709578|450920052|FG001|Overall Study|Other, not related to safety or efficacy|7|||
125350970|NCT01709578|450920053|FG002|Overall Study|Other, not related to safety or efficacy|5|||
125350971|NCT04050371|450920054|FG000|Overall Study|Withdrawal by Subject|1|||
125350972|NCT04050371|450920055|FG001|Overall Study|Withdrawal by Subject|0|||
125350973|NCT01314911|450920057|FG000|Overall Study|Lost to Follow-up|3|||
125350974|NCT01314911|450920058|FG001|Overall Study|Lost to Follow-up|2|||
125350975|NCT01314911|450920057|FG000|Overall Study|Withdrawal by Subject|1|||
125350976|NCT01314911|450920058|FG001|Overall Study|Withdrawal by Subject|3|||
125350977|NCT01314911|450920057|FG000|Overall Study|Received Non-randomized Study Drug|0|||
125350978|NCT01314911|450920058|FG001|Overall Study|Received Non-randomized Study Drug|1|||
125554303|NCT03808688|451661496|FG001|Overall Study|Adverse Event|17|||
125554304|NCT03808688|451661495|FG000|Overall Study|Lack of Efficacy|2|||
125554305|NCT03808688|451661496|FG001|Overall Study|Lack of Efficacy|0|||
125554306|NCT03808688|451661495|FG000|Overall Study|Lost to Follow-up|0|||
125554307|NCT03808688|451661496|FG001|Overall Study|Lost to Follow-up|2|||
125350979|NCT01314911|450920057|FG000|Overall Study|Never Started Treatment|1|||
125350980|NCT01314911|450920058|FG001|Overall Study|Never Started Treatment|0|||
125425765|NCT00677352|451182343|FG000|Treatment Phase|Transference or work related matter|0|||
125425766|NCT00677352|451182344|FG001|Treatment Phase|Transference or work related matter|5|||
125425767|NCT00677352|451182343|FG000|Treatment Phase|Not treated|0|||
125554308|NCT03808688|451661495|FG000|Overall Study|Withdrawal by Subject|1|||
125350981|NCT03350984|450920060|FG000|Overall Study|Death|1|||
125350982|NCT03350984|450920061|FG001|Overall Study|Death|0|||
125350983|NCT03350984|450920060|FG000|Overall Study|Lost to Follow-up|5|||
125350984|NCT03350984|450920061|FG001|Overall Study|Lost to Follow-up|6|||
125350985|NCT03350984|450920060|FG000|Overall Study|Protocol Violation|1|||
125350986|NCT03350984|450920061|FG001|Overall Study|Protocol Violation|2|||
125350987|NCT03350984|450920060|FG000|Overall Study|Physician Decision|1|||
125350988|NCT03350984|450920061|FG001|Overall Study|Physician Decision|0|||
125350989|NCT00642473|450920062|FG000|Overall Study|Withdrawal by Subject|0|||
125350990|NCT00642473|450920063|FG001|Overall Study|Withdrawal by Subject|5|||
125350991|NCT00642473|450920062|FG000|Overall Study|Progression or death|2|||
125350992|NCT00642473|450920063|FG001|Overall Study|Progression or death|4|||
125350993|NCT00642473|450920062|FG000|Overall Study|Other|2|||
125350994|NCT00642473|450920063|FG001|Overall Study|Other|2|||
125350995|NCT00478881|450920066|FG000|Overall Study|Adverse Event|31|||
125350996|NCT00478881|450920067|FG001|Overall Study|Adverse Event|12|||
125350997|NCT00478881|450920066|FG000|Overall Study|Lack of Efficacy|0|||
125350998|NCT00478881|450920067|FG001|Overall Study|Lack of Efficacy|3|||
125350999|NCT00478881|450920066|FG000|Overall Study|Lost to Follow-up|0|||
125351000|NCT00478881|450920067|FG001|Overall Study|Lost to Follow-up|1|||
125351001|NCT00478881|450920066|FG000|Overall Study|Protocol Violation|2|||
125351002|NCT00478881|450920067|FG001|Overall Study|Protocol Violation|2|||
125351003|NCT00478881|450920066|FG000|Overall Study|Withdrawal by Subject|6|||
125351004|NCT00478881|450920067|FG001|Overall Study|Withdrawal by Subject|2|||
125351005|NCT00478881|450920066|FG000|Overall Study|Non-Compliance with Study Medication|0|||
125351006|NCT00478881|450920067|FG001|Overall Study|Non-Compliance with Study Medication|2|||
125351007|NCT03410823|450920068|FG000|Overall Study|Death|1|||
125351008|NCT03410823|450920068|FG000|Overall Study|Withdrawal by Subject|2|||
125351009|NCT03410823|450920068|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
125351010|NCT05128929|450920070|FG000|Overall Study|Adverse Event|0|||
125351011|NCT05128929|450920071|FG001|Overall Study|Adverse Event|1|||
125351012|NCT02742246|450920072|FG000|Overall Study|Never initiated treatment|5|||
125351013|NCT02742246|450920073|FG001|Overall Study|Never initiated treatment|3|||
125351014|NCT02742246|450920074|FG002|Overall Study|Never initiated treatment|1|||
125351015|NCT02742246|450920072|FG000|Overall Study|dropped out during treatment|7|||
125351016|NCT02742246|450920073|FG001|Overall Study|dropped out during treatment|13|||
125351017|NCT02742246|450920074|FG002|Overall Study|dropped out during treatment|10|||
125351018|NCT02742246|450920072|FG000|Overall Study|Death|1|||
125351019|NCT02742246|450920073|FG001|Overall Study|Death|0|||
125351020|NCT02742246|450920074|FG002|Overall Study|Death|0|||
125351021|NCT03584373|450920076|FG000|Overall Study|Lost to Follow-up|7|||
125351022|NCT03584373|450920077|FG001|Overall Study|Lost to Follow-up|8|||
125351023|NCT01487577|450920078|FG000|Overall Study|Became ineligible after signing consent|1|||
125351024|NCT00662532|450920081|FG000|Overall Study|Adverse Event|0|||
125351025|NCT00662532|450920082|FG001|Overall Study|Adverse Event|1|||
125351026|NCT00662532|450920081|FG000|Overall Study|Lost to Follow-up|0|||
125351027|NCT00662532|450920082|FG001|Overall Study|Lost to Follow-up|1|||
125351028|NCT00367770|450920083|FG000|Overall Study|Adverse Event|1|||
125351029|NCT00367770|450920083|FG000|Overall Study|Withdrawal by Subject|1|||
125351030|NCT01155479|450920084|FG000|Part I|Adverse Event|13|||
125351031|NCT01155479|450920085|FG001|Part I|Adverse Event|8|||
125351032|NCT01155479|450920086|FG002|Part I|Adverse Event|18|||
125351033|NCT01155479|450920087|FG003|Part I|Adverse Event|7|||
125351034|NCT01155479|450920088|FG004|Part I|Adverse Event|6|||
125351035|NCT01155479|450920084|FG000|Part I|Administrative|2|||
125351036|NCT01155479|450920085|FG001|Part I|Administrative|2|||
125351037|NCT01155479|450920086|FG002|Part I|Administrative|2|||
125351038|NCT01155479|450920087|FG003|Part I|Administrative|0|||
125351039|NCT01155479|450920088|FG004|Part I|Administrative|0|||
125425768|NCT00677352|451182344|FG001|Treatment Phase|Not treated|2|||
125554309|NCT03808688|451661496|FG001|Overall Study|Withdrawal by Subject|0|||
125554310|NCT03808688|451661495|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
125554311|NCT03808688|451661496|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
125554312|NCT03808688|451661495|FG000|Overall Study|IOP Too High|1|||
125554313|NCT03808688|451661496|FG001|Overall Study|IOP Too High|1|||
125351040|NCT01155479|450920084|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
125425769|NCT00677352|451182343|FG000|Tapering Phase|Adverse Event|1|||
125351041|NCT01155479|450920085|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
125425770|NCT00677352|451182344|FG001|Tapering Phase|Adverse Event|5|||
125351042|NCT01155479|450920086|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
125351043|NCT01155479|450920087|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
125351044|NCT01155479|450920088|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
125351045|NCT01155479|450920084|FG000|Part I|Withdrawal by Subject|11|||
125351046|NCT01155479|450920085|FG001|Part I|Withdrawal by Subject|13|||
125351047|NCT01155479|450920086|FG002|Part I|Withdrawal by Subject|8|||
125351048|NCT01155479|450920087|FG003|Part I|Withdrawal by Subject|8|||
125351049|NCT01155479|450920088|FG004|Part I|Withdrawal by Subject|9|||
125425771|NCT00677352|451182343|FG000|Tapering Phase|Withdrawal by Subject|5|||
125425772|NCT00677352|451182344|FG001|Tapering Phase|Withdrawal by Subject|3|||
125425773|NCT00677352|451182343|FG000|Tapering Phase|Pregnancy|0|||
125425774|NCT00677352|451182344|FG001|Tapering Phase|Pregnancy|1|||
125425775|NCT00677352|451182343|FG000|Tapering Phase|Job transfer|0|||
125425776|NCT00677352|451182344|FG001|Tapering Phase|Job transfer|1|||
125425777|NCT05763628|451182345|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
125425778|NCT05763628|451182346|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
125351050|NCT01155479|450920084|FG000|Part I|Lost to Follow-up|0|||
125351051|NCT01155479|450920085|FG001|Part I|Lost to Follow-up|0|||
125351052|NCT01155479|450920086|FG002|Part I|Lost to Follow-up|1|||
125351053|NCT01155479|450920087|FG003|Part I|Lost to Follow-up|1|||
125351054|NCT01155479|450920088|FG004|Part I|Lost to Follow-up|0|||
125351055|NCT01155479|450920084|FG000|Part I|Treatment Failure|3|||
125351056|NCT01155479|450920085|FG001|Part I|Treatment Failure|0|||
125351057|NCT01155479|450920086|FG002|Part I|Treatment Failure|3|||
125351058|NCT01155479|450920087|FG003|Part I|Treatment Failure|1|||
125351059|NCT01155479|450920088|FG004|Part I|Treatment Failure|2|||
125351060|NCT01155479|450920084|FG000|Part I|Did Not Receive Treatment|4|||
125351061|NCT01155479|450920085|FG001|Part I|Did Not Receive Treatment|2|||
125351062|NCT01155479|450920086|FG002|Part I|Did Not Receive Treatment|2|||
125351063|NCT01155479|450920087|FG003|Part I|Did Not Receive Treatment|6|||
125425779|NCT05763628|451182345|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
125425780|NCT05763628|451182346|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
125425781|NCT05763628|451182345|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
125425782|NCT05763628|451182346|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
125425783|NCT04683926|451182347|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
125351064|NCT01155479|450920088|FG004|Part I|Did Not Receive Treatment|1|||
125351065|NCT01155479|450920084|FG000|Part I|Non-Compliance with Protocol|2|||
125425784|NCT04683926|451182348|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
125425785|NCT04683926|451182349|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
125425786|NCT04683926|451182350|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
125425787|NCT04385368|451182351|FG000|Overall Study|Death|5|||
125425788|NCT04385368|451182352|FG001|Overall Study|Death|5|||
125425789|NCT04385368|451182351|FG000|Overall Study|Physician Decision|3|||
125425790|NCT04385368|451182352|FG001|Overall Study|Physician Decision|0|||
125425791|NCT04385368|451182351|FG000|Overall Study|Withdrawal by Subject|4|||
125425792|NCT04385368|451182352|FG001|Overall Study|Withdrawal by Subject|3|||
125425793|NCT02740049|451182353|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
125425794|NCT01256411|451182354|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
125425795|NCT01256411|451182355|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
125425796|NCT01256411|451182356|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
125425797|NCT01256411|451182357|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
125425798|NCT01256411|451182358|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
125425799|NCT01256411|451182359|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
125425800|NCT01256411|451182354|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
125425801|NCT01256411|451182355|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
125425802|NCT01256411|451182356|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
125425803|NCT01256411|451182357|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
125425804|NCT01256411|451182358|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
125425805|NCT01256411|451182359|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
125425806|NCT01256411|451182354|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
125425807|NCT01256411|451182355|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
125210776|NCT01810783|450395682|FG000|Overall Study|Non-compliance with IMP|4|||
125210777|NCT01810783|450395682|FG000|Overall Study|Adminstrative or other reason(s)|23|||
125351066|NCT01155479|450920085|FG001|Part I|Non-Compliance with Protocol|1|||
125351067|NCT01155479|450920086|FG002|Part I|Non-Compliance with Protocol|3|||
125425808|NCT01256411|451182356|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
125425809|NCT01256411|451182357|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
125425810|NCT01256411|451182358|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
125425811|NCT01256411|451182359|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
125425812|NCT01256411|451182354|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
125425813|NCT01256411|451182355|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
125425814|NCT01256411|451182356|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
125425815|NCT01256411|451182357|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
125425816|NCT01256411|451182358|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
125425817|NCT01256411|451182359|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
125425818|NCT01256411|451182354|FG000|Extension by Maximum Treatment|Adverse Event|4|||
125554314|NCT03808688|451661495|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
125554315|NCT03808688|451661496|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
125351068|NCT01155479|450920087|FG003|Part I|Non-Compliance with Protocol|3|||
125351069|NCT01155479|450920088|FG004|Part I|Non-Compliance with Protocol|2|||
125351070|NCT01155479|450920084|FG000|Part II|Adverse Event|7|||
125351071|NCT01155479|450920085|FG001|Part II|Adverse Event|6|||
125351072|NCT01155479|450920086|FG002|Part II|Adverse Event|8|||
125351073|NCT01155479|450920087|FG003|Part II|Adverse Event|3|||
125351074|NCT01155479|450920088|FG004|Part II|Adverse Event|4|||
125351075|NCT01155479|450920084|FG000|Part II|Administrative|43|||
125351076|NCT01155479|450920085|FG001|Part II|Administrative|49|||
125351077|NCT01155479|450920086|FG002|Part II|Administrative|36|||
125351078|NCT01155479|450920087|FG003|Part II|Administrative|38|||
125351079|NCT01155479|450920088|FG004|Part II|Administrative|46|||
125351080|NCT01155479|450920084|FG000|Part II|Withdrawal by Subject|8|||
125351081|NCT01155479|450920085|FG001|Part II|Withdrawal by Subject|4|||
125351082|NCT01155479|450920086|FG002|Part II|Withdrawal by Subject|12|||
125351083|NCT01155479|450920087|FG003|Part II|Withdrawal by Subject|7|||
125351084|NCT01155479|450920088|FG004|Part II|Withdrawal by Subject|3|||
125351085|NCT01155479|450920084|FG000|Part II|Lost to Follow-up|1|||
125351086|NCT01155479|450920085|FG001|Part II|Lost to Follow-up|0|||
125351087|NCT01155479|450920086|FG002|Part II|Lost to Follow-up|0|||
125351088|NCT01155479|450920087|FG003|Part II|Lost to Follow-up|0|||
125351089|NCT01155479|450920088|FG004|Part II|Lost to Follow-up|1|||
125351090|NCT01155479|450920084|FG000|Part II|Treatment Failure|0|||
125351091|NCT01155479|450920085|FG001|Part II|Treatment Failure|1|||
125351092|NCT01155479|450920086|FG002|Part II|Treatment Failure|2|||
125351093|NCT01155479|450920087|FG003|Part II|Treatment Failure|0|||
125351094|NCT01155479|450920088|FG004|Part II|Treatment Failure|1|||
125351095|NCT01155479|450920084|FG000|Part II|Non-Compliance with Protocol|0|||
125351096|NCT01155479|450920085|FG001|Part II|Non-Compliance with Protocol|1|||
125351097|NCT01155479|450920086|FG002|Part II|Non-Compliance with Protocol|0|||
125351098|NCT01155479|450920087|FG003|Part II|Non-Compliance with Protocol|2|||
125351099|NCT01155479|450920088|FG004|Part II|Non-Compliance with Protocol|0|||
125351100|NCT00998764|450920089|FG000|Overall Study|Lack of Efficacy|3|||
125351101|NCT00998764|450920090|FG001|Overall Study|Lack of Efficacy|6|||
125351102|NCT00998764|450920089|FG000|Overall Study|Adverse Event|17|||
125351103|NCT00998764|450920090|FG001|Overall Study|Adverse Event|12|||
125351104|NCT00998764|450920089|FG000|Overall Study|Withdrawal by Subject|19|||
125351105|NCT00998764|450920090|FG001|Overall Study|Withdrawal by Subject|25|||
125351106|NCT00998764|450920089|FG000|Overall Study|Physician Decision|3|||
125351107|NCT00998764|450920090|FG001|Overall Study|Physician Decision|3|||
125351108|NCT00998764|450920089|FG000|Overall Study|Death|3|||
125351109|NCT00998764|450920090|FG001|Overall Study|Death|1|||
125351110|NCT00998764|450920089|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
125351111|NCT00998764|450920090|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
125351112|NCT00998764|450920089|FG000|Overall Study|Protocol Violation|0|||
125351113|NCT00998764|450920090|FG001|Overall Study|Protocol Violation|1|||
125351114|NCT00998764|450920089|FG000|Overall Study|Failed to Return|1|||
125351115|NCT00998764|450920090|FG001|Overall Study|Failed to Return|1|||
125351116|NCT00998764|450920089|FG000|Overall Study|Lost to Follow-up|1|||
125351117|NCT00998764|450920090|FG001|Overall Study|Lost to Follow-up|1|||
125351118|NCT00998764|450920089|FG000|Overall Study|Loss of Caregiver|0|||
125351119|NCT00998764|450920090|FG001|Overall Study|Loss of Caregiver|3|||
125351120|NCT00998764|450920089|FG000|Overall Study|Other|4|||
125351121|NCT00998764|450920090|FG001|Overall Study|Other|4|||
125351122|NCT00998764|450920089|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
125351123|NCT00998764|450920090|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
125351124|NCT04761627|450920091|FG000|Run-in Period|Death|1|||
125351125|NCT04761627|450920092|FG001|Run-in Period|Death|0|||
125351126|NCT04761627|450920093|FG002|Run-in Period|Death|0|||
125351127|NCT04761627|450920091|FG000|Run-in Period|Required alternative therapy|2|||
125351128|NCT04761627|450920092|FG001|Run-in Period|Required alternative therapy|0|||
125351129|NCT04761627|450920093|FG002|Run-in Period|Required alternative therapy|0|||
125351130|NCT04761627|450920091|FG000|Run-in Period|Lost to Follow-up|2|||
125351131|NCT04761627|450920092|FG001|Run-in Period|Lost to Follow-up|0|||
125351132|NCT04761627|450920093|FG002|Run-in Period|Lost to Follow-up|0|||
125351133|NCT04761627|450920091|FG000|Run-in Period|Protocol Violation|3|||
125351134|NCT04761627|450920092|FG001|Run-in Period|Protocol Violation|0|||
125351135|NCT04761627|450920093|FG002|Run-in Period|Protocol Violation|0|||
125351136|NCT04761627|450920091|FG000|Run-in Period|Abnormal liver function|1|||
125351137|NCT04761627|450920092|FG001|Run-in Period|Abnormal liver function|0|||
125351138|NCT04761627|450920093|FG002|Run-in Period|Abnormal liver function|0|||
125351139|NCT04761627|450920091|FG000|Run-in Period|Adverse Event|6|||
125351140|NCT04761627|450920092|FG001|Run-in Period|Adverse Event|0|||
125351141|NCT04761627|450920093|FG002|Run-in Period|Adverse Event|0|||
125351142|NCT04761627|450920091|FG000|Run-in Period|Withdrawal by Subject|7|||
125351143|NCT04761627|450920092|FG001|Run-in Period|Withdrawal by Subject|0|||
125351144|NCT04761627|450920093|FG002|Run-in Period|Withdrawal by Subject|0|||
125351145|NCT04761627|450920091|FG000|Run-in Period|Did not meet PASI 50|15|||
125425819|NCT01256411|451182355|FG001|Extension by Maximum Treatment|Adverse Event|2|||
125425820|NCT01256411|451182356|FG002|Extension by Maximum Treatment|Adverse Event|1|||
125425821|NCT01256411|451182357|FG003|Extension by Maximum Treatment|Adverse Event|0|||
125425822|NCT01256411|451182358|FG004|Extension by Maximum Treatment|Adverse Event|0|||
125425823|NCT01256411|451182359|FG005|Extension by Maximum Treatment|Adverse Event|0|||
125425824|NCT01256411|451182354|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
125425825|NCT01256411|451182355|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
125425826|NCT01256411|451182356|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
125425827|NCT01256411|451182357|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
125425828|NCT01256411|451182358|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
125425829|NCT01256411|451182359|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
125425830|NCT01256411|451182354|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
125425831|NCT01256411|451182355|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
125425832|NCT01256411|451182356|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
125425833|NCT01256411|451182357|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
125425834|NCT01256411|451182358|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
125425835|NCT01256411|451182359|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
125425836|NCT01256411|451182354|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
125425837|NCT01256411|451182355|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
125425838|NCT01256411|451182356|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
125425839|NCT01256411|451182357|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
125425840|NCT01256411|451182358|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
125425841|NCT01256411|451182359|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
125425842|NCT01256411|451182354|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
125425843|NCT01256411|451182355|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
125425844|NCT01256411|451182356|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
125425845|NCT01256411|451182357|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
125425846|NCT01256411|451182358|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
125425847|NCT01256411|451182359|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
125425848|NCT01256411|451182354|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
125425849|NCT01256411|451182355|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
125425850|NCT01256411|451182356|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
125425851|NCT01256411|451182357|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
125425852|NCT01256411|451182358|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
125425853|NCT01256411|451182359|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
125425854|NCT02123108|451182360|FG000|Overall Study|Death|2|||
125425855|NCT02123108|451182361|FG001|Overall Study|Death|3|||
125425856|NCT00716092|451182362|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
125425857|NCT00716092|451182363|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
125425858|NCT00716092|451182364|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
125425859|NCT04721925|451182365|FG000|2-Month Assessment|Lost to Follow-up|5|||
125425860|NCT04721925|451182366|FG001|2-Month Assessment|Lost to Follow-up|3|||
125425861|NCT04721925|451182365|FG000|4-Month Assessment|Lost to Follow-up|3|||
125425862|NCT04721925|451182366|FG001|4-Month Assessment|Lost to Follow-up|6|||
125425863|NCT01132326|451182367|FG000|Overall Study|Lack of Efficacy|25|||
125425864|NCT01132326|451182367|FG000|Overall Study|Adverse Event|37|||
125425865|NCT01132326|451182367|FG000|Overall Study|Protocol Violation|1|||
125425866|NCT01132326|451182367|FG000|Overall Study|Lost to Follow-up|16|||
125425867|NCT01132326|451182367|FG000|Overall Study|Withdrawal by Subject|40|||
125425868|NCT01132326|451182367|FG000|Overall Study|Physician Decision|10|||
125425869|NCT01132326|451182367|FG000|Overall Study|Study Termination|80|||
125425870|NCT01132326|451182367|FG000|Overall Study|Declining Health|1|||
125425871|NCT01132326|451182367|FG000|Overall Study|Pregnancy|1|||
125425872|NCT01132326|451182367|FG000|Overall Study|Caregiver Withdrew Consent|1|||
125425873|NCT01132326|451182367|FG000|Overall Study|Death|5|||
125425874|NCT01132326|451182367|FG000|Overall Study|Subject Unable to Come To Visits|1|||
125425875|NCT00952367|451182368|FG000|Overall Study|Withdrawal by Subject|2|||
125425876|NCT00952367|451182368|FG000|Overall Study|Noncoordination|1|||
125425877|NCT00952367|451182368|FG000|Overall Study|Protocol Violation|3|||
125351146|NCT04761627|450920092|FG001|Run-in Period|Did not meet PASI 50|0|||
125351147|NCT04761627|450920093|FG002|Run-in Period|Did not meet PASI 50|0|||
125351148|NCT04761627|450920091|FG000|Run-in Period|Study site closure|2|||
125351149|NCT04761627|450920092|FG001|Run-in Period|Study site closure|0|||
125351150|NCT04761627|450920093|FG002|Run-in Period|Study site closure|0|||
125351151|NCT04761627|450920091|FG000|Run-in Period|Pregnancy|2|||
125351152|NCT04761627|450920092|FG001|Run-in Period|Pregnancy|0|||
125351153|NCT04761627|450920093|FG002|Run-in Period|Pregnancy|0|||
125351154|NCT04761627|450920091|FG000|Post-randomization Period|Military service|0|||
125351155|NCT04761627|450920092|FG001|Post-randomization Period|Military service|1|||
125351156|NCT04761627|450920093|FG002|Post-randomization Period|Military service|0|||
125351157|NCT04761627|450920091|FG000|Post-randomization Period|Adverse Event|0|||
125351158|NCT04761627|450920092|FG001|Post-randomization Period|Adverse Event|4|||
125351159|NCT04761627|450920093|FG002|Post-randomization Period|Adverse Event|2|||
125351160|NCT04761627|450920091|FG000|Post-randomization Period|Lost to Follow-up|0|||
125351161|NCT04761627|450920092|FG001|Post-randomization Period|Lost to Follow-up|6|||
125351162|NCT04761627|450920093|FG002|Post-randomization Period|Lost to Follow-up|6|||
125351163|NCT04761627|450920091|FG000|Post-randomization Period|Withdrawal by Subject|0|||
125554316|NCT03808688|451661495|FG000|Overall Study|Visit Out of Window|0|||
125554317|NCT03808688|451661496|FG001|Overall Study|Visit Out of Window|1|||
125554318|NCT03808688|451661495|FG000|Overall Study|Medication Non-Compliance|0|||
125554319|NCT03808688|451661496|FG001|Overall Study|Medication Non-Compliance|1|||
125554320|NCT03329196|451661497|FG000|Overall Study|Adverse Event|10|||
125554321|NCT03329196|451661498|FG001|Overall Study|Adverse Event|5|||
125554322|NCT03329196|451661497|FG000|Overall Study|Physician Decision|2|||
125554323|NCT03329196|451661498|FG001|Overall Study|Physician Decision|2|||
125554324|NCT03329196|451661497|FG000|Overall Study|Withdrawal by Subject|11|||
125554325|NCT03329196|451661498|FG001|Overall Study|Withdrawal by Subject|3|||
125554326|NCT03329196|451661497|FG000|Overall Study|Hepatic function abnormalities|0|||
125554327|NCT03329196|451661498|FG001|Overall Study|Hepatic function abnormalities|1|||
125554328|NCT03329196|451661497|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
125554329|NCT03329196|451661498|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
125554330|NCT03329196|451661497|FG000|Overall Study|Difficult to control Hb|2|||
125554331|NCT03329196|451661498|FG001|Overall Study|Difficult to control Hb|3|||
125554332|NCT03329196|451661497|FG000|Overall Study|Dialysis or renal transplant|13|||
125351164|NCT04761627|450920092|FG001|Post-randomization Period|Withdrawal by Subject|7|||
125351165|NCT04761627|450920093|FG002|Post-randomization Period|Withdrawal by Subject|6|||
125351166|NCT04761627|450920091|FG000|Post-randomization Period|Pregnancy|0|||
125351167|NCT04761627|450920092|FG001|Post-randomization Period|Pregnancy|0|||
125351168|NCT04761627|450920093|FG002|Post-randomization Period|Pregnancy|1|||
125351169|NCT04761627|450920091|FG000|Post-randomization Period|Study site closure|0|||
125351170|NCT04761627|450920092|FG001|Post-randomization Period|Study site closure|0|||
125351171|NCT04761627|450920093|FG002|Post-randomization Period|Study site closure|1|||
125351172|NCT04761627|450920091|FG000|Post-randomization Period|Family planning|0|||
125351173|NCT04761627|450920092|FG001|Post-randomization Period|Family planning|1|||
125351174|NCT04761627|450920093|FG002|Post-randomization Period|Family planning|0|||
125351175|NCT01214174|450920094|FG000|Overall Study|Withdrawal by Subject|0|||
125351176|NCT01214174|450920095|FG001|Overall Study|Withdrawal by Subject|0|||
125351177|NCT01214174|450920096|FG002|Overall Study|Withdrawal by Subject|1|||
125351178|NCT03823378|450920099|FG000|Overall Study|Adverse Event|2|||
125351179|NCT03823378|450920100|FG001|Overall Study|Adverse Event|2|||
125351180|NCT03823378|450920101|FG002|Overall Study|Adverse Event|0|||
125554333|NCT03329196|451661498|FG001|Overall Study|Dialysis or renal transplant|15|||
125351181|NCT03823378|450920102|FG003|Overall Study|Adverse Event|0|||
125351182|NCT03823378|450920103|FG004|Overall Study|Adverse Event|0|||
125351183|NCT03823378|450920104|FG005|Overall Study|Adverse Event|0|||
125351184|NCT03823378|450920099|FG000|Overall Study|Lost to Follow-up|0|||
125351185|NCT03823378|450920100|FG001|Overall Study|Lost to Follow-up|1|||
125351186|NCT03823378|450920101|FG002|Overall Study|Lost to Follow-up|0|||
125351187|NCT03823378|450920102|FG003|Overall Study|Lost to Follow-up|0|||
125351188|NCT03823378|450920103|FG004|Overall Study|Lost to Follow-up|1|||
125351189|NCT03823378|450920104|FG005|Overall Study|Lost to Follow-up|0|||
125351190|NCT03823378|450920099|FG000|Overall Study|Withdrawal by Subject|0|||
125351191|NCT03823378|450920100|FG001|Overall Study|Withdrawal by Subject|1|||
125351192|NCT03823378|450920101|FG002|Overall Study|Withdrawal by Subject|4|||
125351193|NCT03823378|450920102|FG003|Overall Study|Withdrawal by Subject|2|||
125351194|NCT03823378|450920103|FG004|Overall Study|Withdrawal by Subject|0|||
125351195|NCT03823378|450920104|FG005|Overall Study|Withdrawal by Subject|1|||
125351196|NCT03823378|450920099|FG000|Overall Study|Other, not specified|19|||
125554334|NCT01831544|451661499|FG000|Overall Study|Death|1|||
125554335|NCT01831544|451661499|FG000|Overall Study|Still on original MVAD device|2|||
125351197|NCT03823378|450920100|FG001|Overall Study|Other, not specified|12|||
125351198|NCT03823378|450920101|FG002|Overall Study|Other, not specified|6|||
125351199|NCT03823378|450920102|FG003|Overall Study|Other, not specified|8|||
125351200|NCT03823378|450920103|FG004|Overall Study|Other, not specified|17|||
125351201|NCT03823378|450920104|FG005|Overall Study|Other, not specified|7|||
125351202|NCT02093026|450920105|FG000|Overall Study|Adverse Event|26|||
125351203|NCT02093026|450920105|FG000|Overall Study|Death|10|||
125351204|NCT02093026|450920105|FG000|Overall Study|Other|157|||
125351205|NCT02376829|450920106|FG000|Overall Study|Withdrawal by Subject|27|||
125351206|NCT02376829|450920107|FG001|Overall Study|Withdrawal by Subject|44|||
125351207|NCT01255787|450920108|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
125351208|NCT01255787|450920109|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
125351209|NCT01255787|450920110|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
125351210|NCT01255787|450920111|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
125351211|NCT01255787|450920108|FG000|Overall Study|Major Protocol Deviation|1|||
125351212|NCT01255787|450920109|FG001|Overall Study|Major Protocol Deviation|1|||
125351213|NCT01255787|450920110|FG002|Overall Study|Major Protocol Deviation|0|||
125351214|NCT01255787|450920111|FG003|Overall Study|Major Protocol Deviation|4|||
125351215|NCT01255787|450920108|FG000|Overall Study|Lost to Follow-up|1|||
125351216|NCT01255787|450920109|FG001|Overall Study|Lost to Follow-up|2|||
125351217|NCT01255787|450920110|FG002|Overall Study|Lost to Follow-up|4|||
125351218|NCT01255787|450920111|FG003|Overall Study|Lost to Follow-up|2|||
125351219|NCT01255787|450920108|FG000|Overall Study|Withdrawal of Consent|3|||
125351220|NCT01255787|450920109|FG001|Overall Study|Withdrawal of Consent|9|||
125351221|NCT01255787|450920110|FG002|Overall Study|Withdrawal of Consent|3|||
125351222|NCT01255787|450920111|FG003|Overall Study|Withdrawal of Consent|4|||
125351223|NCT01255787|450920108|FG000|Overall Study|Pregnancy|0|||
125351224|NCT01255787|450920109|FG001|Overall Study|Pregnancy|0|||
125351225|NCT01255787|450920110|FG002|Overall Study|Pregnancy|0|||
125351226|NCT01255787|450920111|FG003|Overall Study|Pregnancy|1|||
125351227|NCT01255787|450920108|FG000|Overall Study|Lack of Efficacy|2|||
125351228|NCT01255787|450920109|FG001|Overall Study|Lack of Efficacy|2|||
125351229|NCT01255787|450920110|FG002|Overall Study|Lack of Efficacy|2|||
125351230|NCT01255787|450920111|FG003|Overall Study|Lack of Efficacy|2|||
125351231|NCT01255787|450920108|FG000|Overall Study|Noncompliance with Study Drug|3|||
125351232|NCT01255787|450920109|FG001|Overall Study|Noncompliance with Study Drug|1|||
125351233|NCT01255787|450920110|FG002|Overall Study|Noncompliance with Study Drug|0|||
125351234|NCT01255787|450920111|FG003|Overall Study|Noncompliance with Study Drug|0|||
125351235|NCT00476047|450920112|FG000|Overall Study|Lost to Follow-up|1|||
125351236|NCT05153473|450920113|FG000|Overall Study|Death|46|||
125351237|NCT05153473|450920113|FG000|Overall Study|Lost to Follow-up|3|||
125351238|NCT02283177|450920114|FG000|Overall Study|Withdrawal by Subject|1|||
125351239|NCT02283177|450920115|FG001|Overall Study|Withdrawal by Subject|1|||
125351240|NCT02398227|450920116|FG000|Overall Study|Lost to Follow-up|21|||
125351241|NCT02398227|450920117|FG001|Overall Study|Lost to Follow-up|12|||
125351242|NCT02398227|450920116|FG000|Overall Study|Withdrawal by Subject|5|||
125351243|NCT02398227|450920117|FG001|Overall Study|Withdrawal by Subject|6|||
125351244|NCT02398227|450920116|FG000|Overall Study|Removed from treatment and dropped out|1|||
125351245|NCT02398227|450920117|FG001|Overall Study|Removed from treatment and dropped out|0|||
125351246|NCT01185834|450920118|FG000|Overall Study|Lost to Follow-up|2|||
125351247|NCT01185834|450920118|FG000|Overall Study|Discomfort|4|||
125351248|NCT01185834|450920118|FG000|Overall Study|Biomicroscopy|4|||
125351249|NCT01185834|450920118|FG000|Overall Study|Time/Job Conflict|2|||
125351250|NCT01185834|450920118|FG000|Overall Study|Early exit - Site error|2|||
125351251|NCT01975831|450920119|FG000|Overall Study|Adverse Event|1|||
125351252|NCT01975831|450920120|FG001|Overall Study|Adverse Event|2|||
125351253|NCT01975831|450920121|FG002|Overall Study|Adverse Event|2|||
125351254|NCT01975831|450920122|FG003|Overall Study|Adverse Event|0|||
125351255|NCT01975831|450920123|FG004|Overall Study|Adverse Event|1|||
125351256|NCT01975831|450920124|FG005|Overall Study|Adverse Event|1|||
125351257|NCT01975831|450920125|FG006|Overall Study|Adverse Event|3|||
125351258|NCT01975831|450920126|FG007|Overall Study|Adverse Event|4|||
125351259|NCT01975831|450920127|FG008|Overall Study|Adverse Event|1|||
125351260|NCT01975831|450920119|FG000|Overall Study|Death|1|||
125351261|NCT01975831|450920120|FG001|Overall Study|Death|1|||
125351262|NCT01975831|450920121|FG002|Overall Study|Death|0|||
125351263|NCT01975831|450920122|FG003|Overall Study|Death|0|||
125351264|NCT01975831|450920123|FG004|Overall Study|Death|1|||
125351265|NCT01975831|450920124|FG005|Overall Study|Death|0|||
125351266|NCT01975831|450920125|FG006|Overall Study|Death|1|||
125351267|NCT01975831|450920126|FG007|Overall Study|Death|0|||
125351268|NCT01975831|450920127|FG008|Overall Study|Death|0|||
125351269|NCT01975831|450920119|FG000|Overall Study|Progressive Disease|1|||
125351270|NCT01975831|450920120|FG001|Overall Study|Progressive Disease|3|||
125351271|NCT01975831|450920121|FG002|Overall Study|Progressive Disease|2|||
125351272|NCT01975831|450920122|FG003|Overall Study|Progressive Disease|4|||
125351273|NCT01975831|450920123|FG004|Overall Study|Progressive Disease|13|||
125351274|NCT01975831|450920124|FG005|Overall Study|Progressive Disease|9|||
125351275|NCT01975831|450920125|FG006|Overall Study|Progressive Disease|10|||
125351276|NCT01975831|450920126|FG007|Overall Study|Progressive Disease|8|||
125351277|NCT01975831|450920127|FG008|Overall Study|Progressive Disease|10|||
125351278|NCT01975831|450920119|FG000|Overall Study|Withdrawal by Subject|0|||
125351279|NCT01975831|450920120|FG001|Overall Study|Withdrawal by Subject|3|||
125351280|NCT01975831|450920121|FG002|Overall Study|Withdrawal by Subject|0|||
125351281|NCT01975831|450920122|FG003|Overall Study|Withdrawal by Subject|0|||
125351282|NCT01975831|450920123|FG004|Overall Study|Withdrawal by Subject|3|||
125351283|NCT01975831|450920124|FG005|Overall Study|Withdrawal by Subject|1|||
125351284|NCT01975831|450920125|FG006|Overall Study|Withdrawal by Subject|1|||
125351285|NCT01975831|450920126|FG007|Overall Study|Withdrawal by Subject|0|||
125351286|NCT01975831|450920127|FG008|Overall Study|Withdrawal by Subject|0|||
125351287|NCT01975831|450920119|FG000|Overall Study|Physician Decision|0|||
125351288|NCT01975831|450920120|FG001|Overall Study|Physician Decision|0|||
125351289|NCT01975831|450920121|FG002|Overall Study|Physician Decision|0|||
125351290|NCT01975831|450920122|FG003|Overall Study|Physician Decision|0|||
125351291|NCT01975831|450920123|FG004|Overall Study|Physician Decision|0|||
125351292|NCT01975831|450920124|FG005|Overall Study|Physician Decision|1|||
125351293|NCT01975831|450920125|FG006|Overall Study|Physician Decision|0|||
125351294|NCT01975831|450920126|FG007|Overall Study|Physician Decision|1|||
125351295|NCT01975831|450920127|FG008|Overall Study|Physician Decision|0|||
125425878|NCT00781391|451182375|FG000|Overall Study|never received study drug|24|||
125425879|NCT00781391|451182376|FG001|Overall Study|never received study drug|23|||
125425880|NCT00781391|451182377|FG002|Overall Study|never received study drug|32|||
125425881|NCT00781391|451182375|FG000|Overall Study|Protocol Violation|19|||
125425882|NCT00781391|451182376|FG001|Overall Study|Protocol Violation|17|||
125554336|NCT02021292|451661503|FG000|Overall Study|Physician Decision|0|||
125554337|NCT02021292|451661504|FG001|Overall Study|Physician Decision|1|||
125554338|NCT02021292|451661503|FG000|Overall Study|Lost to Follow-up|0|||
125554339|NCT02021292|451661504|FG001|Overall Study|Lost to Follow-up|1|||
125554340|NCT02021292|451661503|FG000|Overall Study|Death|0|||
125554341|NCT02021292|451661504|FG001|Overall Study|Death|1|||
125554342|NCT04147234|451661505|FG000|Overall Study|Clinical deterioration|0|||
125554343|NCT04147234|451661506|FG001|Overall Study|Clinical deterioration|0|||
125554344|NCT04147234|451661507|FG002|Overall Study|Clinical deterioration|1|||
125554345|NCT04147234|451661508|FG003|Overall Study|Clinical deterioration|0|||
125554346|NCT04147234|451661509|FG004|Overall Study|Clinical deterioration|0|||
125554347|NCT04147234|451661510|FG005|Overall Study|Clinical deterioration|0|||
125554348|NCT04147234|451661511|FG006|Overall Study|Clinical deterioration|0|||
125554349|NCT04147234|451661505|FG000|Overall Study|Withdrawal by Subject|0|||
125554350|NCT04147234|451661506|FG001|Overall Study|Withdrawal by Subject|1|||
125554351|NCT04147234|451661507|FG002|Overall Study|Withdrawal by Subject|1|||
125554352|NCT04147234|451661508|FG003|Overall Study|Withdrawal by Subject|0|||
125554353|NCT04147234|451661509|FG004|Overall Study|Withdrawal by Subject|0|||
125554354|NCT04147234|451661510|FG005|Overall Study|Withdrawal by Subject|0|||
125554355|NCT04147234|451661511|FG006|Overall Study|Withdrawal by Subject|0|||
125554356|NCT04147234|451661505|FG000|Overall Study|Clinical disease progression|1|||
125554357|NCT04147234|451661506|FG001|Overall Study|Clinical disease progression|3|||
125554358|NCT04147234|451661507|FG002|Overall Study|Clinical disease progression|1|||
125554359|NCT04147234|451661508|FG003|Overall Study|Clinical disease progression|1|||
125554360|NCT04147234|451661509|FG004|Overall Study|Clinical disease progression|0|||
125554361|NCT04147234|451661510|FG005|Overall Study|Clinical disease progression|1|||
125554362|NCT04147234|451661511|FG006|Overall Study|Clinical disease progression|0|||
125554363|NCT04147234|451661505|FG000|Overall Study|Objective disease progression|6|||
125554364|NCT04147234|451661506|FG001|Overall Study|Objective disease progression|4|||
125554365|NCT04147234|451661507|FG002|Overall Study|Objective disease progression|3|||
125554366|NCT04147234|451661508|FG003|Overall Study|Objective disease progression|3|||
125554367|NCT04147234|451661509|FG004|Overall Study|Objective disease progression|5|||
125554368|NCT04147234|451661510|FG005|Overall Study|Objective disease progression|2|||
125554369|NCT04147234|451661511|FG006|Overall Study|Objective disease progression|3|||
125554370|NCT04147234|451661505|FG000|Overall Study|Adverse Event|0|||
125554371|NCT04147234|451661506|FG001|Overall Study|Adverse Event|0|||
125554372|NCT04147234|451661507|FG002|Overall Study|Adverse Event|0|||
125351296|NCT01975831|450920119|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
125351297|NCT01975831|450920120|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
125351298|NCT01975831|450920121|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
125351299|NCT01975831|450920122|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
125351300|NCT01975831|450920123|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
125351301|NCT01975831|450920124|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
125351302|NCT01975831|450920125|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
125351303|NCT01975831|450920126|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
125351304|NCT01975831|450920127|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
125425883|NCT00781391|451182377|FG002|Overall Study|Protocol Violation|20|||
125554373|NCT04147234|451661508|FG003|Overall Study|Adverse Event|0|||
125554374|NCT04147234|451661509|FG004|Overall Study|Adverse Event|1|||
125425884|NCT00781391|451182375|FG000|Overall Study|Death|789|||
125554375|NCT04147234|451661510|FG005|Overall Study|Adverse Event|0|||
125351305|NCT01975831|450920119|FG000|Overall Study|Entered Hospice|0|||
125351306|NCT01975831|450920120|FG001|Overall Study|Entered Hospice|0|||
125351307|NCT01975831|450920121|FG002|Overall Study|Entered Hospice|0|||
125351308|NCT01975831|450920122|FG003|Overall Study|Entered Hospice|0|||
125351309|NCT01975831|450920123|FG004|Overall Study|Entered Hospice|0|||
125351310|NCT01975831|450920124|FG005|Overall Study|Entered Hospice|1|||
125351311|NCT01975831|450920125|FG006|Overall Study|Entered Hospice|0|||
125351312|NCT01975831|450920126|FG007|Overall Study|Entered Hospice|0|||
125351313|NCT01975831|450920127|FG008|Overall Study|Entered Hospice|0|||
125351314|NCT01975831|450920119|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
125351315|NCT01975831|450920120|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
125351316|NCT01975831|450920121|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
125351317|NCT01975831|450920122|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
125351318|NCT01975831|450920123|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
125351319|NCT01975831|450920124|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
125351320|NCT01975831|450920125|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
125351321|NCT01975831|450920126|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
125351322|NCT01975831|450920127|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
125351323|NCT00887744|450920128|FG000|Overall Study|Adverse Event|3|||
125351324|NCT00887744|450920128|FG000|Overall Study|Death|1|||
125351325|NCT00887744|450920128|FG000|Overall Study|Lost to Follow-up|3|||
125351326|NCT00887744|450920128|FG000|Overall Study|Withdrawal by Subject|18|||
125351327|NCT00887744|450920128|FG000|Overall Study|Various reasons|9|||
125351328|NCT03324581|450920132|FG000|Overall Study|Adverse Event|18|||
125351329|NCT03324581|450920133|FG001|Overall Study|Adverse Event|11|||
125351330|NCT03324581|450920134|FG002|Overall Study|Adverse Event|7|||
125351331|NCT03324581|450920132|FG000|Overall Study|Lack of Efficacy|0|||
125351332|NCT03324581|450920133|FG001|Overall Study|Lack of Efficacy|1|||
125351333|NCT03324581|450920134|FG002|Overall Study|Lack of Efficacy|0|||
125351334|NCT03324581|450920132|FG000|Overall Study|Lost to Follow-up|5|||
125351335|NCT03324581|450920133|FG001|Overall Study|Lost to Follow-up|3|||
125351336|NCT03324581|450920134|FG002|Overall Study|Lost to Follow-up|6|||
125351337|NCT03324581|450920132|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
125351338|NCT03324581|450920133|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
125351339|NCT03324581|450920134|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
125351340|NCT03324581|450920132|FG000|Overall Study|Physician Decision|0|||
125351341|NCT03324581|450920133|FG001|Overall Study|Physician Decision|1|||
125351342|NCT03324581|450920134|FG002|Overall Study|Physician Decision|2|||
125351343|NCT03324581|450920132|FG000|Overall Study|Protocol Deviation|8|||
125351344|NCT03324581|450920133|FG001|Overall Study|Protocol Deviation|9|||
125351345|NCT03324581|450920134|FG002|Overall Study|Protocol Deviation|4|||
125351346|NCT03324581|450920132|FG000|Overall Study|Withdrawal by Subject|6|||
125351347|NCT03324581|450920133|FG001|Overall Study|Withdrawal by Subject|8|||
125351348|NCT03324581|450920134|FG002|Overall Study|Withdrawal by Subject|6|||
125351349|NCT03324581|450920132|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
125351350|NCT03324581|450920133|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
125351351|NCT03324581|450920134|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
125351352|NCT02274038|450920135|FG000|Overall Study|Death|1|||
125351353|NCT03783702|450920136|FG000|Overall Study|Lost to Follow-up|6|||
125351354|NCT03783702|450920137|FG001|Overall Study|Lost to Follow-up|8|||
125351355|NCT03783702|450920136|FG000|Overall Study|Protocol Violation|1|||
125351356|NCT03783702|450920137|FG001|Overall Study|Protocol Violation|3|||
125351357|NCT04473482|450920138|FG000|Overall Study|Death|0|||
125351358|NCT04473482|450920139|FG001|Overall Study|Death|3|||
125351359|NCT04473482|450920138|FG000|Overall Study|Lost to Follow-up|9|||
125351360|NCT04473482|450920139|FG001|Overall Study|Lost to Follow-up|7|||
125351361|NCT04473482|450920138|FG000|Overall Study|Withdrawal by Subject|2|||
125351362|NCT04473482|450920139|FG001|Overall Study|Withdrawal by Subject|1|||
125351363|NCT00321893|450920141|FG000|Overall Study|Non-Compliance/Refusal|16|||
125351364|NCT00321893|450920142|FG001|Overall Study|Non-Compliance/Refusal|10|||
125351365|NCT00321893|450920141|FG000|Overall Study|Lost to Follow-up|2|||
125351366|NCT00321893|450920142|FG001|Overall Study|Lost to Follow-up|1|||
125351367|NCT00321893|450920141|FG000|Overall Study|Adverse Event|6|||
125351368|NCT00321893|450920142|FG001|Overall Study|Adverse Event|3|||
125351369|NCT01306877|450920143|FG000|Overall Study|Lost to Follow-up|3|||
125351370|NCT01306877|450920144|FG001|Overall Study|Lost to Follow-up|3|||
125351371|NCT01306877|450920143|FG000|Overall Study|Physician Decision|0|||
125351372|NCT01306877|450920144|FG001|Overall Study|Physician Decision|1|||
125351373|NCT00999921|450920149|FG000|Overall Study|Lost to Follow-up|10|||
125351374|NCT00999921|450920150|FG001|Overall Study|Lost to Follow-up|19|||
125351375|NCT00989573|450920154|FG000|Overall Study|Adverse Event|8|||
125351376|NCT00989573|450920155|FG001|Overall Study|Adverse Event|12|||
125351377|NCT00989573|450920156|FG002|Overall Study|Adverse Event|4|||
125351378|NCT00989573|450920154|FG000|Overall Study|Physician Decision|0|||
125351379|NCT00989573|450920155|FG001|Overall Study|Physician Decision|2|||
125351380|NCT00989573|450920156|FG002|Overall Study|Physician Decision|0|||
125351381|NCT00989573|450920154|FG000|Overall Study|Protocol Violation|1|||
125554376|NCT04147234|451661511|FG006|Overall Study|Adverse Event|0|||
125554377|NCT05972733|451661512|FG000|Overall Study|Lost to Follow-up|2|||
125351382|NCT00989573|450920155|FG001|Overall Study|Protocol Violation|1|||
125351383|NCT00989573|450920156|FG002|Overall Study|Protocol Violation|1|||
125554378|NCT05972733|451661512|FG000|Overall Study|Withdrawal by Subject|1|||
125554379|NCT04982588|451661515|FG000|Overall Study|Withdrawal by Subject|2|||
125554380|NCT02366728|451661516|FG000|Overall Study|Death|0|||
125351384|NCT00989573|450920154|FG000|Overall Study|Withdrawal by Subject|4|||
125351385|NCT00989573|450920155|FG001|Overall Study|Withdrawal by Subject|7|||
125351386|NCT00989573|450920156|FG002|Overall Study|Withdrawal by Subject|3|||
125351387|NCT01076075|450920158|FG000|Overall Study|Adverse Event|3|||
125351388|NCT01076075|450920159|FG001|Overall Study|Adverse Event|9|||
125351389|NCT01076075|450920158|FG000|Overall Study|Lack of Efficacy|5|||
125351390|NCT01076075|450920159|FG001|Overall Study|Lack of Efficacy|4|||
125351391|NCT01076075|450920158|FG000|Overall Study|Lost to Follow-up|6|||
125351392|NCT01076075|450920159|FG001|Overall Study|Lost to Follow-up|5|||
125351393|NCT01076075|450920158|FG000|Overall Study|other|19|||
125351394|NCT01076075|450920159|FG001|Overall Study|other|9|||
125351395|NCT01076075|450920158|FG000|Overall Study|Protocol Violation|0|||
125351396|NCT01076075|450920159|FG001|Overall Study|Protocol Violation|1|||
125351397|NCT01076075|450920158|FG000|Overall Study|Withdrawal by Subject|8|||
125351398|NCT01076075|450920159|FG001|Overall Study|Withdrawal by Subject|19|||
125351399|NCT00995865|450920162|FG000|Overall Study|Protocol Violation|2|||
125351400|NCT00995865|450920163|FG001|Overall Study|Protocol Violation|0|||
125351401|NCT00995865|450920164|FG002|Overall Study|Protocol Violation|0|||
125351402|NCT00995865|450920162|FG000|Overall Study|Lost to Follow-up|0|||
125351403|NCT00995865|450920163|FG001|Overall Study|Lost to Follow-up|0|||
125351404|NCT00995865|450920164|FG002|Overall Study|Lost to Follow-up|1|||
125351405|NCT03687970|450920166|FG000|Overall Study|visit scheduling conflicts|2|||
125351406|NCT03687970|450920167|FG001|Overall Study|visit scheduling conflicts|0|||
125351407|NCT01888003|450920170|FG000|Overall Study|Study Terminated|5|||
125351408|NCT01888003|450920171|FG001|Overall Study|Study Terminated|6|||
125351409|NCT01888003|450920172|FG002|Overall Study|Study Terminated|40|||
125351410|NCT02359851|450920173|FG000|Overall Study|Death|1|||
125351411|NCT02359851|450920173|FG000|Overall Study|Disease progression|1|||
125351412|NCT00055471|450920174|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
125351413|NCT00055471|450920175|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
125351414|NCT00055471|450920176|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
125351415|NCT00055471|450920174|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
125351416|NCT00055471|450920175|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
125351417|NCT00055471|450920176|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
125351418|NCT00055471|450920174|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
125351419|NCT00055471|450920175|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
125351420|NCT00055471|450920176|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
125351421|NCT01854944|450920177|FG000|Overall Study|Withdrawal by Subject|0|||
125554381|NCT02366728|451661517|FG001|Overall Study|Death|0|||
125554382|NCT02366728|451661518|FG002|Overall Study|Death|1|||
125554383|NCT02366728|451661516|FG000|Overall Study|Adverse Event|1|||
125554384|NCT02366728|451661517|FG001|Overall Study|Adverse Event|0|||
125554385|NCT02366728|451661518|FG002|Overall Study|Adverse Event|0|||
125554386|NCT02366728|451661516|FG000|Overall Study|Screen Failure|2|||
125554387|NCT02366728|451661517|FG001|Overall Study|Screen Failure|1|||
125554388|NCT02366728|451661518|FG002|Overall Study|Screen Failure|0|||
125554389|NCT02366728|451661516|FG000|Overall Study|Only yielded 2 vaccines|1|||
125554390|NCT02366728|451661517|FG001|Overall Study|Only yielded 2 vaccines|0|||
125554391|NCT02366728|451661518|FG002|Overall Study|Only yielded 2 vaccines|0|||
125554392|NCT00992511|451661520|FG000|Overall Study|Migrated/moved from study area|1|||
125554393|NCT00992511|451661521|FG001|Overall Study|Migrated/moved from study area|0|||
125554394|NCT00992511|451661522|FG002|Overall Study|Migrated/moved from study area|1|||
125554395|NCT00992511|451661523|FG003|Overall Study|Migrated/moved from study area|2|||
125351422|NCT01854944|450920178|FG001|Overall Study|Withdrawal by Subject|0|||
125351423|NCT01854944|450920179|FG002|Overall Study|Withdrawal by Subject|1|||
125554396|NCT00992511|451661520|FG000|Overall Study|Lost to Follow-up|1|||
125351424|NCT02101112|450920180|FG000|Overall Study|Adverse Event|0|||
125351425|NCT02101112|450920181|FG001|Overall Study|Adverse Event|0|||
125351426|NCT02101112|450920182|FG002|Overall Study|Adverse Event|1|||
125554397|NCT00992511|451661521|FG001|Overall Study|Lost to Follow-up|0|||
125554398|NCT00992511|451661522|FG002|Overall Study|Lost to Follow-up|0|||
125554399|NCT00992511|451661523|FG003|Overall Study|Lost to Follow-up|2|||
125554400|NCT00992511|451661520|FG000|Overall Study|Withdrawal by Subject|0|||
125351427|NCT02101112|450920183|FG003|Overall Study|Adverse Event|0|||
125351428|NCT02101112|450920184|FG004|Overall Study|Adverse Event|0|||
125351429|NCT02101112|450920185|FG005|Overall Study|Adverse Event|0|||
125351430|NCT02101112|450920180|FG000|Overall Study|Withdrawal by Subject|0|||
125351431|NCT02101112|450920181|FG001|Overall Study|Withdrawal by Subject|0|||
125554401|NCT00992511|451661521|FG001|Overall Study|Withdrawal by Subject|0|||
125351432|NCT02101112|450920182|FG002|Overall Study|Withdrawal by Subject|0|||
125351433|NCT02101112|450920183|FG003|Overall Study|Withdrawal by Subject|0|||
125351434|NCT02101112|450920184|FG004|Overall Study|Withdrawal by Subject|1|||
125351435|NCT02101112|450920185|FG005|Overall Study|Withdrawal by Subject|0|||
125351436|NCT04340063|450920186|FG000|Overall Study|Withdrawal by Subject|1|||
125351437|NCT04340063|450920187|FG001|Overall Study|Withdrawal by Subject|2|||
125351438|NCT04340063|450920186|FG000|Overall Study|Lost to Follow-up|3|||
125351439|NCT04340063|450920187|FG001|Overall Study|Lost to Follow-up|1|||
125351440|NCT04340063|450920186|FG000|Overall Study|Protocol Violation|0|||
125351441|NCT04340063|450920187|FG001|Overall Study|Protocol Violation|1|||
125351442|NCT01857583|450920188|FG000|Overall Study|Adverse Event|0|||
125351443|NCT01857583|450920189|FG001|Overall Study|Adverse Event|0|||
125351444|NCT01857583|450920190|FG002|Overall Study|Adverse Event|1|||
125351445|NCT01857583|450920191|FG003|Overall Study|Adverse Event|1|||
125351446|NCT01857583|450920188|FG000|Overall Study|Death|0|||
125351447|NCT01857583|450920189|FG001|Overall Study|Death|1|||
125351448|NCT01857583|450920190|FG002|Overall Study|Death|1|||
125351449|NCT01857583|450920191|FG003|Overall Study|Death|0|||
125351450|NCT01857583|450920188|FG000|Overall Study|Physician Decision|0|||
125351451|NCT01857583|450920189|FG001|Overall Study|Physician Decision|0|||
125351452|NCT01857583|450920190|FG002|Overall Study|Physician Decision|0|||
125351453|NCT01857583|450920191|FG003|Overall Study|Physician Decision|1|||
125351454|NCT01857583|450920188|FG000|Overall Study|Withdrawal by Subject|1|||
125351455|NCT01857583|450920189|FG001|Overall Study|Withdrawal by Subject|0|||
125351456|NCT01857583|450920190|FG002|Overall Study|Withdrawal by Subject|1|||
125351457|NCT01857583|450920191|FG003|Overall Study|Withdrawal by Subject|2|||
125351458|NCT00458536|450920194|FG000|Overall Study|Disease progression prior to treatment|7|||
125351459|NCT00458536|450920194|FG000|Overall Study|Unable to make vaccine|3|||
125351460|NCT00458536|450920194|FG000|Overall Study|No measurable disease after surgery|2|||
125351461|NCT00458536|450920194|FG000|Overall Study|Did not have renal cell carcinoma|2|||
125351462|NCT00458536|450920194|FG000|Overall Study|Patient did not have surgery|1|||
125554402|NCT00992511|451661522|FG002|Overall Study|Withdrawal by Subject|1|||
125554403|NCT00992511|451661523|FG003|Overall Study|Withdrawal by Subject|1|||
125554404|NCT04498169|451661524|FG000|Study Completion|Adverse Event|1|||
125554405|NCT04498169|451661525|FG001|Study Completion|Adverse Event|1|||
125554406|NCT02993523|451661526|FG000|Overall Study|Withdrew Consent|0|||
125554407|NCT02993523|451661527|FG001|Overall Study|Withdrew Consent|0|||
125554408|NCT02993523|451661528|FG002|Overall Study|Withdrew Consent|2|||
125554409|NCT02993523|451661529|FG003|Overall Study|Withdrew Consent|9|||
125554410|NCT02993523|451661530|FG004|Overall Study|Withdrew Consent|0|||
125554411|NCT02993523|451661526|FG000|Overall Study|Lost to Follow-up|0|||
125554412|NCT02993523|451661527|FG001|Overall Study|Lost to Follow-up|0|||
125554413|NCT02993523|451661528|FG002|Overall Study|Lost to Follow-up|3|||
125554414|NCT02993523|451661529|FG003|Overall Study|Lost to Follow-up|6|||
125554415|NCT02993523|451661530|FG004|Overall Study|Lost to Follow-up|0|||
125554416|NCT02993523|451661526|FG000|Overall Study|Death|1|||
125554417|NCT02993523|451661527|FG001|Overall Study|Death|1|||
125554418|NCT02993523|451661528|FG002|Overall Study|Death|138|||
125554419|NCT02993523|451661529|FG003|Overall Study|Death|222|||
125554420|NCT02993523|451661530|FG004|Overall Study|Death|6|||
125554421|NCT02993523|451661526|FG000|Overall Study|Reason not Specified|0|||
125554422|NCT02993523|451661527|FG001|Overall Study|Reason not Specified|0|||
125554423|NCT02993523|451661528|FG002|Overall Study|Reason not Specified|1|||
125554424|NCT02993523|451661529|FG003|Overall Study|Reason not Specified|1|||
125554425|NCT02993523|451661530|FG004|Overall Study|Reason not Specified|0|||
125554426|NCT03694418|451661531|FG000|Overall Study|Lost to Follow-up|115|||
125554427|NCT03694418|451661532|FG001|Overall Study|Lost to Follow-up|23|||
125554428|NCT03694418|451661533|FG002|Overall Study|Lost to Follow-up|12|||
125554429|NCT03694418|451661534|FG003|Overall Study|Lost to Follow-up|12|||
125554430|NCT03694418|451661535|FG004|Overall Study|Lost to Follow-up|13|||
125351463|NCT00458536|450920194|FG000|Overall Study|Ineligible due to toxicity|1|||
125554431|NCT01136811|451661536|FG000|Overall Study|Physician Decision|11|||
125554432|NCT01009554|451661537|FG000|Overall Study|Adverse Event|1|||
125351464|NCT00458536|450920194|FG000|Overall Study|Withdrawal by Subject|1|||
125351465|NCT00458536|450920194|FG000|Overall Study|Progressive disease during treatment|2|||
125554433|NCT01009554|451661538|FG001|Overall Study|Adverse Event|1|||
125554434|NCT01009554|451661537|FG000|Overall Study|Withdrawal by Subject|1|||
125554435|NCT01009554|451661538|FG001|Overall Study|Withdrawal by Subject|3|||
125554436|NCT01009554|451661537|FG000|Overall Study|Noncompliant with Study Product|0|||
125554437|NCT01009554|451661538|FG001|Overall Study|Noncompliant with Study Product|3|||
125351466|NCT04854642|450922049|FG000|Overall Study|Adverse Event|1|||
125351467|NCT04854642|450922050|FG001|Overall Study|Adverse Event|2|||
125351468|NCT04854642|450922049|FG000|Overall Study|Withdrawal by Subject|0|||
125351469|NCT04854642|450922050|FG001|Overall Study|Withdrawal by Subject|1|||
125351470|NCT00597701|450922051|FG000|Overall Study|Withdrawal by Subject|5|||
125351471|NCT00597701|450922052|FG001|Overall Study|Withdrawal by Subject|5|||
125351472|NCT00597701|450922051|FG000|Overall Study|Death|0|||
125351473|NCT00597701|450922052|FG001|Overall Study|Death|1|||
125554438|NCT01605253|451661539|FG000|Overall Study|Physician Decision|3|||
125554439|NCT01605253|451661540|FG001|Overall Study|Physician Decision|2|||
125554440|NCT01605253|451661539|FG000|Overall Study|Lost to Follow-up|3|||
125554441|NCT01605253|451661540|FG001|Overall Study|Lost to Follow-up|1|||
125554442|NCT05560763|451661548|FG000|Overall Study|Withdrawal by Subject|4|||
125554443|NCT02673619|451661549|FG000|Overall Study|Lost to Follow-up|1|||
125554444|NCT02673619|451661550|FG001|Overall Study|Lost to Follow-up|0|||
125554445|NCT02673619|451661551|FG002|Overall Study|Lost to Follow-up|0|||
125554446|NCT02673619|451661552|FG003|Overall Study|Lost to Follow-up|0|||
125554447|NCT02673619|451661549|FG000|Overall Study|Withdrawal by Subject|1|||
125554448|NCT02673619|451661550|FG001|Overall Study|Withdrawal by Subject|1|||
125554449|NCT02673619|451661551|FG002|Overall Study|Withdrawal by Subject|1|||
125351474|NCT00597701|450922051|FG000|Overall Study|Physician Decision|2|||
125351475|NCT00597701|450922052|FG001|Overall Study|Physician Decision|0|||
125351476|NCT00597701|450922051|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
125351477|NCT00597701|450922052|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
125351478|NCT01107418|450922053|FG000|Overall Study|Disease Progression|45|||
125351479|NCT01107418|450922053|FG000|Overall Study|Adverse Event|3|||
125351480|NCT01107418|450922053|FG000|Overall Study|Withdrawal by Subject|1|||
125351481|NCT01107418|450922053|FG000|Overall Study|Study Closing|1|||
125351482|NCT01107418|450922053|FG000|Overall Study|Started Other Therapy|1|||
125351483|NCT01107418|450922053|FG000|Overall Study|Entered Extension Study|1|||
125351484|NCT00301821|450922057|FG000|Overall Study|Ineligible|25|||
125351485|NCT00301821|450922057|FG000|Overall Study|Cancel|1|||
125351486|NCT04078178|450922062|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
125351487|NCT04078178|450922063|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
125351488|NCT04078178|450922062|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
125351489|NCT04078178|450922063|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
125351490|NCT04078178|450922062|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
125351491|NCT04078178|450922063|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
125351492|NCT04078178|450922062|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
125351493|NCT04078178|450922063|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
125351494|NCT04078178|450922062|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
125351495|NCT04078178|450922063|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
125351496|NCT04006119|450922064|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
125351497|NCT04006119|450922064|FG000|End of Treatment Veledimex|Adverse Event|2|||
125351498|NCT04006119|450922064|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
125351499|NCT04006119|450922064|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
125351500|NCT04006119|450922064|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
125351501|NCT04006119|450922064|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
125351502|NCT00472459|450922065|FG000|Overall Study|Adverse Event|13|||
125351503|NCT00472459|450922066|FG001|Overall Study|Adverse Event|13|||
125351504|NCT00472459|450922065|FG000|Overall Study|Withdrawal by Subject|5|||
125554450|NCT02673619|451661552|FG003|Overall Study|Withdrawal by Subject|0|||
125554451|NCT02673619|451661549|FG000|Overall Study|Adverse Event|0|||
125351505|NCT00472459|450922066|FG001|Overall Study|Withdrawal by Subject|5|||
125351506|NCT00472459|450922065|FG000|Overall Study|Protocol Violation|3|||
125351507|NCT00472459|450922066|FG001|Overall Study|Protocol Violation|3|||
125554452|NCT02673619|451661550|FG001|Overall Study|Adverse Event|0|||
125554453|NCT02673619|451661551|FG002|Overall Study|Adverse Event|1|||
125554454|NCT02673619|451661552|FG003|Overall Study|Adverse Event|0|||
125554455|NCT02673619|451661549|FG000|Overall Study|Lack of Efficacy|0|||
125351508|NCT00472459|450922065|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
125351509|NCT00472459|450922066|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
125351510|NCT00472459|450922065|FG000|Overall Study|Lost to Follow-up|1|||
125351511|NCT00472459|450922066|FG001|Overall Study|Lost to Follow-up|1|||
125351512|NCT01277042|450922067|FG000|Overall Study|Adverse Event|4|||
125351513|NCT01277042|450922068|FG001|Overall Study|Adverse Event|3|||
125351514|NCT01277042|450922067|FG000|Overall Study|Lost to Follow-up|2|||
125351515|NCT01277042|450922068|FG001|Overall Study|Lost to Follow-up|2|||
125351516|NCT01277042|450922067|FG000|Overall Study|Withdrawal by Subject|2|||
125351517|NCT01277042|450922068|FG001|Overall Study|Withdrawal by Subject|0|||
125351518|NCT00588952|450922069|FG000|Overall Study|Adverse Event|0|||
125351519|NCT00588952|450922070|FG001|Overall Study|Adverse Event|2|||
125351520|NCT00588952|450922069|FG000|Overall Study|Withdrawal by Subject|3|||
125351521|NCT00588952|450922070|FG001|Overall Study|Withdrawal by Subject|5|||
125351522|NCT02284178|450922071|FG000|Overall Study|Met exclusion criteria|49|||
125351523|NCT02284178|450922072|FG001|Overall Study|Met exclusion criteria|54|||
125351524|NCT01483690|450922075|FG000|Overall Study|Adverse Event|1|||
125351525|NCT01483690|450922076|FG001|Overall Study|Adverse Event|2|||
125351526|NCT01483690|450922075|FG000|Overall Study|clinical deterioration|1|||
125351527|NCT01483690|450922076|FG001|Overall Study|clinical deterioration|0|||
125351528|NCT01483690|450922075|FG000|Overall Study|Physician Decision|0|||
125351529|NCT01483690|450922076|FG001|Overall Study|Physician Decision|2|||
125351530|NCT01483690|450922075|FG000|Overall Study|exclusionary procedure|0|||
125351531|NCT01483690|450922076|FG001|Overall Study|exclusionary procedure|1|||
125351532|NCT03569293|450922079|FG000|Overall Study|Adverse Event|4|||
125351533|NCT03569293|450922080|FG001|Overall Study|Adverse Event|1|||
125351534|NCT03569293|450922081|FG002|Overall Study|Adverse Event|5|||
125351535|NCT03569293|450922082|FG003|Overall Study|Adverse Event|1|||
125351536|NCT03569293|450922083|FG004|Overall Study|Adverse Event|0|||
125351537|NCT03569293|450922084|FG005|Overall Study|Adverse Event|0|||
125351538|NCT03569293|450922079|FG000|Overall Study|Withdrawal by Subject|16|||
125351539|NCT03569293|450922080|FG001|Overall Study|Withdrawal by Subject|2|||
125351540|NCT03569293|450922081|FG002|Overall Study|Withdrawal by Subject|4|||
125351541|NCT03569293|450922082|FG003|Overall Study|Withdrawal by Subject|1|||
125351542|NCT03569293|450922083|FG004|Overall Study|Withdrawal by Subject|0|||
125351543|NCT03569293|450922084|FG005|Overall Study|Withdrawal by Subject|0|||
125351544|NCT03569293|450922079|FG000|Overall Study|Lost to Follow-up|1|||
125351545|NCT03569293|450922080|FG001|Overall Study|Lost to Follow-up|3|||
125351546|NCT03569293|450922081|FG002|Overall Study|Lost to Follow-up|1|||
125351547|NCT03569293|450922082|FG003|Overall Study|Lost to Follow-up|1|||
125351548|NCT03569293|450922083|FG004|Overall Study|Lost to Follow-up|0|||
125351549|NCT03569293|450922084|FG005|Overall Study|Lost to Follow-up|0|||
125351550|NCT03569293|450922079|FG000|Overall Study|Other|8|||
125351551|NCT03569293|450922080|FG001|Overall Study|Other|2|||
125351552|NCT03569293|450922081|FG002|Overall Study|Other|1|||
125351553|NCT03569293|450922082|FG003|Overall Study|Other|1|||
125351554|NCT03569293|450922083|FG004|Overall Study|Other|0|||
125351555|NCT03569293|450922084|FG005|Overall Study|Other|0|||
125351556|NCT03569293|450922079|FG000|Overall Study|Ongoing at Time of Analysis|8|||
125351557|NCT03569293|450922080|FG001|Overall Study|Ongoing at Time of Analysis|1|||
125351558|NCT03569293|450922081|FG002|Overall Study|Ongoing at Time of Analysis|3|||
125351559|NCT03569293|450922082|FG003|Overall Study|Ongoing at Time of Analysis|0|||
125351560|NCT03569293|450922083|FG004|Overall Study|Ongoing at Time of Analysis|0|||
125351561|NCT03569293|450922084|FG005|Overall Study|Ongoing at Time of Analysis|0|||
125351562|NCT03553836|450922086|FG000|Overall Study|Ongoing in Study|460|||
125351563|NCT03553836|450922087|FG001|Overall Study|Ongoing in Study|459|||
125351564|NCT03553836|450922086|FG000|Overall Study|Withdrawal by Subject|9|||
125351565|NCT03553836|450922087|FG001|Overall Study|Withdrawal by Subject|10|||
125351566|NCT03553836|450922086|FG000|Overall Study|Lost to Follow-up|1|||
125351567|NCT03553836|450922087|FG001|Overall Study|Lost to Follow-up|3|||
125351568|NCT03553836|450922086|FG000|Overall Study|Death|17|||
125351569|NCT03553836|450922087|FG001|Overall Study|Death|17|||
125351570|NCT04062123|450922088|FG000|Overall Study|Withdrawal by Subject|0|||
125351571|NCT04062123|450922089|FG001|Overall Study|Withdrawal by Subject|1|||
125351572|NCT04062123|450922090|FG002|Overall Study|Withdrawal by Subject|0|||
125351573|NCT01041495|450922091|FG000|Overall Study|Withdrawal by Subject|2|||
125351574|NCT01041495|450922092|FG001|Overall Study|Withdrawal by Subject|5|||
125351575|NCT01041495|450922091|FG000|Overall Study|Adverse Event|2|||
125351576|NCT01041495|450922092|FG001|Overall Study|Adverse Event|1|||
125351577|NCT01041495|450922091|FG000|Overall Study|Lost to Follow-up|0|||
125351578|NCT01041495|450922092|FG001|Overall Study|Lost to Follow-up|1|||
125351579|NCT03780400|450922096|FG000|Overall Study|Lost to Follow-up|5|||
125351580|NCT03780400|450922096|FG000|Overall Study|Withdrawal by Subject|2|||
125351581|NCT01479985|450922097|FG000|Overall Study|Tablet malfunction, no data saved|1|||
125351582|NCT01479985|450922098|FG001|Overall Study|Tablet malfunction, no data saved|1|||
125351583|NCT01479985|450922097|FG000|Overall Study|No decisional conflict scale responses|0|||
125351584|NCT01479985|450922098|FG001|Overall Study|No decisional conflict scale responses|2|||
125351585|NCT01479985|450922097|FG000|Overall Study|No post-visit survey|5|||
125351586|NCT01479985|450922098|FG001|Overall Study|No post-visit survey|3|||
125351587|NCT01653782|450922099|FG000|Overall Study|Withdrawal by Subject|9|||
125351588|NCT01653782|450922100|FG001|Overall Study|Withdrawal by Subject|15|||
125351589|NCT01653782|450922101|FG002|Overall Study|Withdrawal by Subject|4|||
125351590|NCT01653782|450922099|FG000|Overall Study|Lost to Follow-up|7|||
125351591|NCT01653782|450922100|FG001|Overall Study|Lost to Follow-up|3|||
125351592|NCT01653782|450922101|FG002|Overall Study|Lost to Follow-up|2|||
125351593|NCT01142128|450922102|FG000|Overall Study|Physician Decision|1|||
125351594|NCT01142128|450922102|FG000|Overall Study|Lost to Follow-up|1|||
125351595|NCT01142128|450922102|FG000|Overall Study|Withdrawal by Subject|2|||
125351596|NCT00442468|450922103|FG000|Overall Study|Adverse Event|4|||
125351597|NCT00442468|450922103|FG000|Overall Study|Withdrawal by Subject|91|||
125351598|NCT00442468|450922103|FG000|Overall Study|Did not complete all study procedures|88|||
125351599|NCT05867342|450922106|FG000|Overall Study|Investigator Decision|3|||
125351600|NCT05867342|450922107|FG001|Overall Study|Investigator Decision|3|||
125351601|NCT00470184|450922108|FG000|Overall Study|Not Treated(became ineligible)|4|||
125351602|NCT00470184|450922108|FG000|Overall Study|Not treated (other)|1|||
125351603|NCT00470184|450922108|FG000|Overall Study|disease Progression|4|||
125351604|NCT00470184|450922108|FG000|Overall Study|Adverse Event|3|||
125351605|NCT00470184|450922108|FG000|Overall Study|Withdrawal by Subject|4|||
125351606|NCT00470184|450922108|FG000|Overall Study|other|5|||
125351607|NCT00470184|450922108|FG000|Overall Study|recurrence|1|||
125351608|NCT05442775|450922109|FG000|Overall Study|Trial terminated|61|||
125351609|NCT05442775|450922109|FG000|Overall Study|Lack of Efficacy|4|||
125351610|NCT05442775|450922109|FG000|Overall Study|Withdrawal by Subject|4|||
125351611|NCT05442775|450922109|FG000|Overall Study|Death|1|||
125351612|NCT05442775|450922109|FG000|Overall Study|Participant removed at Sponsor request|1|||
125351613|NCT00058539|450922111|FG000|Overall Study|Disease progression|24|||
125351614|NCT00058539|450922111|FG000|Overall Study|Adverse Event|3|||
125351615|NCT00058539|450922111|FG000|Overall Study|Withdrawal by Subject|5|||
125351616|NCT00058539|450922111|FG000|Overall Study|Physician Decision|9|||
125351617|NCT00058539|450922111|FG000|Overall Study|Death|1|||
125351618|NCT03190369|450922112|FG000|Overall Study|Poor compliance to protocol|0|||
125351619|NCT03190369|450922113|FG001|Overall Study|Poor compliance to protocol|1|||
125351620|NCT03190369|450922112|FG000|Overall Study|Withdraw before treatment|1|||
125351621|NCT03190369|450922113|FG001|Overall Study|Withdraw before treatment|5|||
125351622|NCT03190369|450922112|FG000|Overall Study|Randomized but not treated|0|||
125351623|NCT03190369|450922113|FG001|Overall Study|Randomized but not treated|2|||
125351624|NCT02963831|450922114|FG000|Overall Study|Progressive Disease|3|||
125351625|NCT02963831|450922115|FG001|Overall Study|Progressive Disease|3|||
125351626|NCT02963831|450922116|FG002|Overall Study|Progressive Disease|16|||
125351627|NCT02963831|450922117|FG003|Overall Study|Progressive Disease|27|||
125351628|NCT02963831|450922114|FG000|Overall Study|Withdrawal by Subject|1|||
125351629|NCT02963831|450922115|FG001|Overall Study|Withdrawal by Subject|0|||
125351630|NCT02963831|450922116|FG002|Overall Study|Withdrawal by Subject|2|||
125351631|NCT02963831|450922117|FG003|Overall Study|Withdrawal by Subject|4|||
125351632|NCT02963831|450922114|FG000|Overall Study|Adverse Event|0|||
125351633|NCT02963831|450922115|FG001|Overall Study|Adverse Event|1|||
125351634|NCT02963831|450922116|FG002|Overall Study|Adverse Event|1|||
125351635|NCT02963831|450922117|FG003|Overall Study|Adverse Event|2|||
125351636|NCT02963831|450922114|FG000|Overall Study|Death|0|||
125351637|NCT02963831|450922115|FG001|Overall Study|Death|0|||
125351638|NCT02963831|450922116|FG002|Overall Study|Death|0|||
125351639|NCT02963831|450922117|FG003|Overall Study|Death|2|||
125351640|NCT04543409|450922118|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125351641|NCT04543409|450922119|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125351642|NCT04543409|450922118|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
125351643|NCT04543409|450922119|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
125351644|NCT04543409|450922118|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
125351645|NCT04543409|450922119|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
125351646|NCT04543409|450922118|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
125351647|NCT04543409|450922119|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
125351648|NCT04543409|450922118|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
125351649|NCT04543409|450922119|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
125351650|NCT04543409|450922118|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
125351651|NCT04543409|450922119|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
125351652|NCT04543409|450922118|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
125351653|NCT04543409|450922119|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
125351654|NCT04543409|450922118|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
125351655|NCT04543409|450922119|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
125351656|NCT04543409|450922118|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
125351657|NCT04543409|450922119|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
125425885|NCT00781391|451182376|FG001|Overall Study|Death|730|||
125351658|NCT04543409|450922118|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
125351659|NCT04543409|450922119|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
125351660|NCT04543409|450922118|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
125351661|NCT04543409|450922119|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
125351662|NCT01923168|450922120|FG000|Overall Study|Protocol Violation|1|||
125351663|NCT01923168|450922121|FG001|Overall Study|Protocol Violation|1|||
125351664|NCT01923168|450922122|FG002|Overall Study|Protocol Violation|0|||
125351665|NCT01923168|450922120|FG000|Overall Study|Subject/guardian decision|14|||
125351666|NCT01923168|450922121|FG001|Overall Study|Subject/guardian decision|14|||
125351667|NCT01923168|450922122|FG002|Overall Study|Subject/guardian decision|4|||
125351668|NCT01923168|450922120|FG000|Overall Study|Adverse Event|12|||
125351669|NCT01923168|450922121|FG001|Overall Study|Adverse Event|12|||
125351670|NCT01923168|450922122|FG002|Overall Study|Adverse Event|0|||
125351671|NCT01923168|450922120|FG000|Overall Study|Physician Decision|6|||
125351672|NCT01923168|450922121|FG001|Overall Study|Physician Decision|9|||
125351673|NCT01923168|450922122|FG002|Overall Study|Physician Decision|5|||
125351674|NCT01923168|450922120|FG000|Overall Study|Progressive disease|4|||
125351675|NCT01923168|450922121|FG001|Overall Study|Progressive disease|3|||
125351676|NCT01923168|450922122|FG002|Overall Study|Progressive disease|7|||
125351677|NCT01923168|450922120|FG000|Overall Study|Death|0|||
125351678|NCT01923168|450922121|FG001|Overall Study|Death|0|||
125351679|NCT01923168|450922122|FG002|Overall Study|Death|1|||
125351680|NCT03418571|450922123|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
125351681|NCT03418571|450922124|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
125351682|NCT03882008|450922125|FG000|Overall Study|Withdrawal by Subject|1|||
125351683|NCT03882008|450922125|FG000|Overall Study|Lost to Follow-up|1|||
125351684|NCT04341662|450922126|FG000|Overall Study|Did not have source-verified blood loss data|423|||
125351685|NCT04341662|450922127|FG001|Overall Study|Did not have source-verified blood loss data|514|||
125351686|NCT03101267|450922128|FG000|Primary Study Period|Withdrawal by Subject|1|||
125351687|NCT03101267|450922129|FG001|Primary Study Period|Withdrawal by Subject|2|||
125351688|NCT03101267|450922130|FG002|Primary Study Period|Withdrawal by Subject|3|||
125351689|NCT03101267|450922128|FG000|Primary Study Period|Miscellaneous|2|||
125351690|NCT03101267|450922129|FG001|Primary Study Period|Miscellaneous|0|||
125351691|NCT03101267|450922130|FG002|Primary Study Period|Miscellaneous|0|||
125351692|NCT01222403|450922131|FG000|Overall Study|Inappropriate enrollment|0|||
125351693|NCT01222403|450922132|FG001|Overall Study|Inappropriate enrollment|2|||
125351694|NCT01262352|450922134|FG000|Period 1|Illness after randomization|1|||
125351695|NCT01262352|450922135|FG001|Period 1|Illness after randomization|0|||
125351696|NCT01262352|450922134|FG000|Washout|Adverse Event|1|||
125351697|NCT01262352|450922135|FG001|Washout|Adverse Event|1|||
125351698|NCT01262352|450922134|FG000|Washout|Extended Washout|0|||
125351699|NCT01262352|450922135|FG001|Washout|Extended Washout|1|||
125351700|NCT02045303|450922136|FG000|Overall Study|Protocol Violation|2|||
125351701|NCT02045303|450922137|FG001|Overall Study|Protocol Violation|1|||
125351702|NCT02045303|450922138|FG002|Overall Study|Protocol Violation|0|||
125351703|NCT02045303|450922136|FG000|Overall Study|Withdrawal by Subject|0|||
125351704|NCT02045303|450922137|FG001|Overall Study|Withdrawal by Subject|2|||
125351705|NCT02045303|450922138|FG002|Overall Study|Withdrawal by Subject|0|||
125351706|NCT01642407|450922139|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
125351707|NCT01642407|450922139|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
125351708|NCT01642407|450922139|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
125351709|NCT03533686|450922142|FG000|Overall Study|Withdrawal by Subject|1|||
125351710|NCT03533686|450922143|FG001|Overall Study|Withdrawal by Subject|0|||
125351711|NCT03533686|450922144|FG002|Overall Study|Withdrawal by Subject|0|||
125351712|NCT03533686|450922145|FG003|Overall Study|Withdrawal by Subject|3|||
125425886|NCT00781391|451182377|FG002|Overall Study|Death|706|||
125425887|NCT00781391|451182375|FG000|Overall Study|Withdrawal by Subject|47|||
125351713|NCT03533686|450922146|FG004|Overall Study|Withdrawal by Subject|5|||
125351714|NCT03533686|450922147|FG005|Overall Study|Withdrawal by Subject|1|||
125351715|NCT03533686|450922142|FG000|Overall Study|Lost to Follow-up|0|||
125351716|NCT03533686|450922143|FG001|Overall Study|Lost to Follow-up|1|||
125351717|NCT03533686|450922144|FG002|Overall Study|Lost to Follow-up|0|||
125351718|NCT03533686|450922145|FG003|Overall Study|Lost to Follow-up|0|||
125351719|NCT03533686|450922146|FG004|Overall Study|Lost to Follow-up|2|||
125351720|NCT03533686|450922147|FG005|Overall Study|Lost to Follow-up|0|||
125351721|NCT03533686|450922142|FG000|Overall Study|Screen Failure|0|||
125351722|NCT03533686|450922143|FG001|Overall Study|Screen Failure|0|||
125351723|NCT03533686|450922144|FG002|Overall Study|Screen Failure|0|||
125351724|NCT03533686|450922145|FG003|Overall Study|Screen Failure|2|||
125554456|NCT02673619|451661550|FG001|Overall Study|Lack of Efficacy|0|||
125554457|NCT02673619|451661551|FG002|Overall Study|Lack of Efficacy|1|||
125351725|NCT03533686|450922146|FG004|Overall Study|Screen Failure|0|||
125351726|NCT03533686|450922147|FG005|Overall Study|Screen Failure|0|||
125351727|NCT00245583|450922148|FG000|Overall Study|Lost to Follow-up|1|||
125351728|NCT00245583|450922149|FG001|Overall Study|Lost to Follow-up|5|||
125351729|NCT00245583|450922148|FG000|Overall Study|Adverse Event|2|||
125351730|NCT00245583|450922149|FG001|Overall Study|Adverse Event|1|||
125351731|NCT00245583|450922148|FG000|Overall Study|Lack of Efficacy|1|||
125351732|NCT00245583|450922149|FG001|Overall Study|Lack of Efficacy|0|||
125351733|NCT00245583|450922148|FG000|Overall Study|Withdrawal by Subject|2|||
125351734|NCT00245583|450922149|FG001|Overall Study|Withdrawal by Subject|3|||
125351735|NCT00829283|450922150|FG000|Overall Study|Lost to Follow-up|7|||
125351736|NCT00829283|450922151|FG001|Overall Study|Lost to Follow-up|25|||
125351737|NCT00591578|450922154|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
125351738|NCT00591578|450922155|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
125351739|NCT00591578|450922156|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
125351740|NCT00591578|450922154|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
125351741|NCT00591578|450922155|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
125351742|NCT00591578|450922156|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
125351743|NCT00591578|450922154|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
125351744|NCT00591578|450922155|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
125351745|NCT00591578|450922156|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
125351746|NCT00591578|450922154|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
125351747|NCT00591578|450922155|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
125351748|NCT00591578|450922156|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
125351749|NCT00591578|450922154|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
125351750|NCT00591578|450922155|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
125351751|NCT00591578|450922156|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
125351752|NCT00591578|450922154|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
125351753|NCT00591578|450922155|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
125351754|NCT00591578|450922156|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
125351755|NCT00591578|450922154|FG000|Double-Blind Treatment Phase|Other|4|||
125351756|NCT00591578|450922155|FG001|Double-Blind Treatment Phase|Other|9|||
125351757|NCT00591578|450922156|FG002|Double-Blind Treatment Phase|Other|4|||
125351758|NCT00591578|450922154|FG000|Open-Label Extension Phase|Adverse Event|3|||
125351759|NCT00591578|450922155|FG001|Open-Label Extension Phase|Adverse Event|5|||
125351760|NCT00591578|450922156|FG002|Open-Label Extension Phase|Adverse Event|0|||
125351761|NCT00591578|450922154|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
125351762|NCT00591578|450922155|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
125351763|NCT00591578|450922156|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
125351764|NCT00591578|450922154|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
125351765|NCT00591578|450922155|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
125351766|NCT00591578|450922156|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
125351767|NCT00591578|450922154|FG000|Open-Label Extension Phase|Other|1|||
125351768|NCT00591578|450922155|FG001|Open-Label Extension Phase|Other|0|||
125351769|NCT00591578|450922156|FG002|Open-Label Extension Phase|Other|0|||
125351770|NCT03945175|450922157|FG000|Overall Study|Did not meet inclusion criteria|31|||
125351771|NCT03945175|450922157|FG000|Overall Study|Withdrew consent|2|||
125351772|NCT03945175|450922157|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
125351773|NCT03945175|450922157|FG000|Overall Study|Early termination during Mydayis treatment|1|||
125351774|NCT00870233|450922158|FG000|Overall Study|Withdrawal by Subject|18|||
125351775|NCT00870233|450922158|FG000|Overall Study|Did not undergo laparotomy|3|||
125351776|NCT00870233|450922158|FG000|Overall Study|Incompatible internet browser|2|||
125351777|NCT00870233|450922158|FG000|Overall Study|Death|1|||
125351778|NCT00378079|450922159|FG000|Overall Study|Lost to Follow-up|6|||
125351779|NCT00378079|450922160|FG001|Overall Study|Lost to Follow-up|1|||
125351780|NCT00378079|450922161|FG002|Overall Study|Lost to Follow-up|0|||
125351781|NCT00006389|450922162|FG000|Overall Study|Adverse Event|1|||
125351782|NCT01445886|450922171|FG000|Overall Study|Lost to Follow-up|2|||
125351783|NCT01445886|450922171|FG000|Overall Study|Protocol Violation|3|||
125351784|NCT03500679|450922172|FG000|Overall Study|Lost to Follow-up|6|||
125351785|NCT03500679|450922173|FG001|Overall Study|Lost to Follow-up|3|||
125351786|NCT03500679|450922172|FG000|Overall Study|Withdrawal by Subject|3|||
125554458|NCT02673619|451661552|FG003|Overall Study|Lack of Efficacy|0|||
125351787|NCT03500679|450922173|FG001|Overall Study|Withdrawal by Subject|0|||
125351788|NCT01962922|450922174|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
125351789|NCT01962922|450922175|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
125351790|NCT01962922|450922174|FG000|PK Portion Day 7|non-compliance|1|||
125351791|NCT01962922|450922175|FG001|PK Portion Day 7|non-compliance|0|||
125351792|NCT01962922|450922174|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
125351793|NCT01962922|450922175|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
125351794|NCT01962922|450922174|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
125351795|NCT01962922|450922175|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
125351796|NCT03224546|450922176|FG000|Overall Study|Lost to Follow-up|9|||
125351797|NCT03224546|450922177|FG001|Overall Study|Lost to Follow-up|8|||
125351798|NCT03224546|450922178|FG002|Overall Study|Lost to Follow-up|3|||
125351799|NCT03224546|450922176|FG000|Overall Study|Withdrawal by Subject|7|||
125351800|NCT03224546|450922177|FG001|Overall Study|Withdrawal by Subject|14|||
125351801|NCT03224546|450922178|FG002|Overall Study|Withdrawal by Subject|12|||
125351802|NCT02730208|450922179|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
125351803|NCT02730208|450922180|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
125351804|NCT00510952|450922186|FG000|Overall Study|Adverse Event|1|||
125351805|NCT00510952|450922187|FG001|Overall Study|Adverse Event|0|||
125351806|NCT00510952|450922186|FG000|Overall Study|Entry Criteria Not Met|3|||
125351807|NCT00510952|450922187|FG001|Overall Study|Entry Criteria Not Met|1|||
125351808|NCT00510952|450922186|FG000|Overall Study|Lost to Follow-up|5|||
125351809|NCT00510952|450922187|FG001|Overall Study|Lost to Follow-up|3|||
125351810|NCT00510952|450922186|FG000|Overall Study|Physician Decision|1|||
125351811|NCT00510952|450922187|FG001|Overall Study|Physician Decision|1|||
125351812|NCT00510952|450922186|FG000|Overall Study|Protocol Violation|7|||
125351813|NCT00510952|450922187|FG001|Overall Study|Protocol Violation|4|||
125351814|NCT00510952|450922186|FG000|Overall Study|Sponsor Decision|1|||
125351815|NCT00510952|450922187|FG001|Overall Study|Sponsor Decision|0|||
125351816|NCT00510952|450922186|FG000|Overall Study|Withdrawal by Subject|6|||
125351817|NCT00510952|450922187|FG001|Overall Study|Withdrawal by Subject|7|||
125351818|NCT00510952|450922186|FG000|Overall Study|Did Not Receive Study Drug|2|||
125351819|NCT00510952|450922187|FG001|Overall Study|Did Not Receive Study Drug|0|||
125351820|NCT02793128|450922195|FG000|Overall Study|Death|4|||
125351821|NCT02793128|450922195|FG000|Overall Study|Withdrawal by Subject|2|||
125351822|NCT02793128|450922195|FG000|Overall Study|Physician Decision|1|||
125351823|NCT02793128|450922195|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
125351824|NCT02793128|450922195|FG000|Overall Study|Patient elected nephroureterectomy|1|||
125351825|NCT03670836|450922196|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
125351826|NCT03670836|450922197|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
125351827|NCT03670836|450922196|FG000|Per Protocol Population (PP)|Physician Decision|9|||
125351828|NCT03670836|450922197|FG001|Per Protocol Population (PP)|Physician Decision|10|||
125351829|NCT03670836|450922196|FG000|Per Protocol Population (PP)|Physician Decision|4|||
125351830|NCT03670836|450922197|FG001|Per Protocol Population (PP)|Physician Decision|6|||
125351831|NCT03670836|450922196|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
125351832|NCT03670836|450922197|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
125351833|NCT03287635|450922198|FG000|Overall Study|Lost to Follow-up|5|||
125351834|NCT03287635|450922198|FG000|Overall Study|Withdrawal by Subject|1|||
125351835|NCT03287635|450922198|FG000|Overall Study|Physician Decision|1|||
125351836|NCT04285580|450924058|FG000|Overall Study|Protocol Violation|0|||
125351837|NCT04285580|450924059|FG001|Overall Study|Protocol Violation|1|||
125351838|NCT02582255|450924060|FG000|Overall Study|Protocol Violation|0|||
125351839|NCT02582255|450924061|FG001|Overall Study|Protocol Violation|3|||
125351840|NCT00076024|450924065|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
125351841|NCT00076024|450924066|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
125351842|NCT00076024|450924067|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
125351843|NCT00076024|450924068|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
125351844|NCT00076024|450924065|FG000|Phase 1, Lead-in|Adverse Event|1|||
125351845|NCT00076024|450924066|FG001|Phase 1, Lead-in|Adverse Event|0|||
125351846|NCT00076024|450924067|FG002|Phase 1, Lead-in|Adverse Event|0|||
125351847|NCT00076024|450924068|FG003|Phase 1, Lead-in|Adverse Event|0|||
125351848|NCT00076024|450924065|FG000|Phase 1, Lead-in|Clinical progression|1|||
125351849|NCT00076024|450924066|FG001|Phase 1, Lead-in|Clinical progression|0|||
125351850|NCT00076024|450924067|FG002|Phase 1, Lead-in|Clinical progression|0|||
125351851|NCT00076024|450924068|FG003|Phase 1, Lead-in|Clinical progression|0|||
125351852|NCT00076024|450924065|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
125351853|NCT00076024|450924066|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
125351854|NCT00076024|450924067|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
125351855|NCT00076024|450924068|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
125351856|NCT00076024|450924065|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
125351857|NCT00076024|450924066|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
125351858|NCT00076024|450924067|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
125351859|NCT00076024|450924068|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
125351860|NCT00076024|450924065|FG000|Phase 2, Double-blind|Adverse Event|0|||
125351861|NCT00076024|450924066|FG001|Phase 2, Double-blind|Adverse Event|25|||
125351862|NCT00076024|450924067|FG002|Phase 2, Double-blind|Adverse Event|6|||
125351863|NCT00076024|450924068|FG003|Phase 2, Double-blind|Adverse Event|0|||
125351864|NCT00076024|450924065|FG000|Phase 2, Double-blind|Un-specified|0|||
125351865|NCT00076024|450924066|FG001|Phase 2, Double-blind|Un-specified|14|||
125351866|NCT00076024|450924067|FG002|Phase 2, Double-blind|Un-specified|6|||
125351867|NCT00076024|450924068|FG003|Phase 2, Double-blind|Un-specified|0|||
125351868|NCT00076024|450924065|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
125351869|NCT00076024|450924066|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
125351870|NCT00076024|450924067|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
125351871|NCT00076024|450924068|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
125351872|NCT00076024|450924065|FG000|Phase 2, Open-label|Adverse Event|0|||
125351873|NCT00076024|450924066|FG001|Phase 2, Open-label|Adverse Event|0|||
125351874|NCT00076024|450924067|FG002|Phase 2, Open-label|Adverse Event|0|||
125351875|NCT00076024|450924068|FG003|Phase 2, Open-label|Adverse Event|2|||
125351876|NCT00076024|450924065|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
125351877|NCT00076024|450924066|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
125351878|NCT00076024|450924067|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
125351879|NCT00076024|450924068|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
125351880|NCT00076024|450924065|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
125351881|NCT00076024|450924066|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
125351882|NCT00076024|450924067|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
125351883|NCT00076024|450924068|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
125351884|NCT00076024|450924065|FG000|Phase 2, Open-label|Other|0|||
125351885|NCT00076024|450924066|FG001|Phase 2, Open-label|Other|0|||
125351886|NCT00076024|450924067|FG002|Phase 2, Open-label|Other|0|||
125351887|NCT00076024|450924068|FG003|Phase 2, Open-label|Other|2|||
125351888|NCT01155219|450924069|FG000|Overall Study|Adverse Event|3|||
125351889|NCT01155219|450924070|FG001|Overall Study|Adverse Event|1|||
125351890|NCT01155219|450924069|FG000|Overall Study|non-medical reason|1|||
125351891|NCT01155219|450924070|FG001|Overall Study|non-medical reason|2|||
125351892|NCT03981822|450924076|FG000|Overall Study|Lost to Follow-up|0|||
125351893|NCT03981822|450924077|FG001|Overall Study|Lost to Follow-up|1|||
125351894|NCT03981822|450924078|FG002|Overall Study|Lost to Follow-up|1|||
125351895|NCT03981822|450924079|FG003|Overall Study|Lost to Follow-up|0|||
125351896|NCT03981822|450924080|FG004|Overall Study|Lost to Follow-up|6|||
125351897|NCT03981822|450924081|FG005|Overall Study|Lost to Follow-up|4|||
125351898|NCT03981822|450924082|FG006|Overall Study|Lost to Follow-up|4|||
125351899|NCT03981822|450924083|FG007|Overall Study|Lost to Follow-up|2|||
125554459|NCT04225806|451661553|FG000|Overall Study|Trial termination|15|||
125351900|NCT03981822|450924076|FG000|Overall Study|Withdrawal by Subject|0|||
125351901|NCT03981822|450924077|FG001|Overall Study|Withdrawal by Subject|1|||
125351902|NCT03981822|450924078|FG002|Overall Study|Withdrawal by Subject|0|||
125351903|NCT03981822|450924079|FG003|Overall Study|Withdrawal by Subject|0|||
125351904|NCT03981822|450924080|FG004|Overall Study|Withdrawal by Subject|0|||
125351905|NCT03981822|450924081|FG005|Overall Study|Withdrawal by Subject|1|||
125351906|NCT03981822|450924082|FG006|Overall Study|Withdrawal by Subject|0|||
125351907|NCT03981822|450924083|FG007|Overall Study|Withdrawal by Subject|2|||
125351908|NCT03981822|450924076|FG000|Overall Study|COVID-19 Related|0|||
125351909|NCT03981822|450924077|FG001|Overall Study|COVID-19 Related|0|||
125351910|NCT03981822|450924078|FG002|Overall Study|COVID-19 Related|0|||
125351911|NCT03981822|450924079|FG003|Overall Study|COVID-19 Related|0|||
125351912|NCT03981822|450924080|FG004|Overall Study|COVID-19 Related|2|||
125554460|NCT02408861|451661556|FG000|Overall Study|Death|0|||
125554461|NCT02408861|451661557|FG001|Overall Study|Death|3|||
125554462|NCT02408861|451661558|FG002|Overall Study|Death|1|||
125554463|NCT02408861|451661559|FG003|Overall Study|Death|2|||
125554464|NCT02408861|451661560|FG004|Overall Study|Death|4|||
125554465|NCT02408861|451661561|FG005|Overall Study|Death|1|||
125351913|NCT03981822|450924081|FG005|Overall Study|COVID-19 Related|1|||
125351914|NCT03981822|450924082|FG006|Overall Study|COVID-19 Related|2|||
125351915|NCT03981822|450924083|FG007|Overall Study|COVID-19 Related|1|||
125351916|NCT06460493|450924084|FG000|Overall Study|Withdrawal by Subject|2|||
125351917|NCT03489551|450924087|FG000|Overall Study|Withdrawal by Subject|2|||
125351918|NCT02987660|450924090|FG000|Overall Study|Study terminated by sponsor|10|||
125351919|NCT02987660|450924091|FG001|Overall Study|Study terminated by sponsor|10|||
125351920|NCT00054717|450924092|FG000|Overall Study|Randomized but not treated|2|||
125351921|NCT00054717|450924093|FG001|Overall Study|Randomized but not treated|8|||
125351922|NCT00054717|450924092|FG000|Overall Study|Adverse Event|70|||
125351923|NCT00054717|450924093|FG001|Overall Study|Adverse Event|22|||
125351924|NCT00054717|450924092|FG000|Overall Study|Protocol Violation|18|||
125351925|NCT00054717|450924093|FG001|Overall Study|Protocol Violation|19|||
125351926|NCT00054717|450924092|FG000|Overall Study|Lost to Follow-up|23|||
125351927|NCT00054717|450924093|FG001|Overall Study|Lost to Follow-up|13|||
125351928|NCT00054717|450924092|FG000|Overall Study|Withdrawal by Subject|32|||
125351929|NCT00054717|450924093|FG001|Overall Study|Withdrawal by Subject|20|||
125351930|NCT00054717|450924092|FG000|Overall Study|Other reason not defined above|117|||
125351931|NCT00054717|450924093|FG001|Overall Study|Other reason not defined above|217|||
125351932|NCT03707184|450924094|FG000|Overall Study|Withdrawal by Subject|2|||
125351933|NCT04704154|450924095|FG000|Overall Study|Adverse Event|3|||
125351934|NCT04704154|450924096|FG001|Overall Study|Adverse Event|2|||
125351935|NCT04704154|450924097|FG002|Overall Study|Adverse Event|4|||
125351936|NCT04704154|450924098|FG003|Overall Study|Adverse Event|2|||
125351937|NCT04704154|450924099|FG004|Overall Study|Adverse Event|3|||
125351938|NCT04704154|450924100|FG005|Overall Study|Adverse Event|0|||
125351939|NCT04704154|450924095|FG000|Overall Study|Death|3|||
125351940|NCT04704154|450924096|FG001|Overall Study|Death|0|||
125351941|NCT04704154|450924097|FG002|Overall Study|Death|0|||
125351942|NCT04704154|450924098|FG003|Overall Study|Death|0|||
125351943|NCT04704154|450924099|FG004|Overall Study|Death|3|||
125351944|NCT04704154|450924100|FG005|Overall Study|Death|0|||
125351945|NCT04704154|450924095|FG000|Overall Study|Physician Decision|1|||
125351946|NCT04704154|450924096|FG001|Overall Study|Physician Decision|0|||
125351947|NCT04704154|450924097|FG002|Overall Study|Physician Decision|1|||
125351948|NCT04704154|450924098|FG003|Overall Study|Physician Decision|0|||
125351949|NCT04704154|450924099|FG004|Overall Study|Physician Decision|2|||
125351950|NCT04704154|450924100|FG005|Overall Study|Physician Decision|0|||
125351951|NCT04704154|450924095|FG000|Overall Study|Participant Decision|1|||
125351952|NCT04704154|450924096|FG001|Overall Study|Participant Decision|1|||
125351953|NCT04704154|450924097|FG002|Overall Study|Participant Decision|0|||
125351954|NCT04704154|450924098|FG003|Overall Study|Participant Decision|0|||
125351955|NCT04704154|450924099|FG004|Overall Study|Participant Decision|0|||
125351956|NCT04704154|450924100|FG005|Overall Study|Participant Decision|0|||
125351957|NCT04704154|450924095|FG000|Overall Study|Progressive Disease|19|||
125351958|NCT04704154|450924096|FG001|Overall Study|Progressive Disease|17|||
125351959|NCT04704154|450924097|FG002|Overall Study|Progressive Disease|20|||
125351960|NCT04704154|450924098|FG003|Overall Study|Progressive Disease|18|||
125351961|NCT04704154|450924099|FG004|Overall Study|Progressive Disease|36|||
125351962|NCT04704154|450924100|FG005|Overall Study|Progressive Disease|30|||
125351963|NCT04704154|450924095|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
125351964|NCT04704154|450924096|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
125351965|NCT04704154|450924097|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
125351966|NCT04704154|450924098|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
125351967|NCT04704154|450924099|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
125351968|NCT04704154|450924100|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
125351969|NCT04704154|450924095|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
125351970|NCT04704154|450924096|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
125351971|NCT04704154|450924097|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
125351972|NCT04704154|450924098|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
125351973|NCT04704154|450924099|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
125351974|NCT04704154|450924100|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
125351975|NCT04251156|450924101|FG000|Overall Study|Lost to Follow-up|1|||
125351976|NCT04251156|450924102|FG001|Overall Study|Lost to Follow-up|1|||
125351977|NCT04251156|450924101|FG000|Overall Study|Withdrawal by Subject|4|||
125351978|NCT04251156|450924102|FG001|Overall Study|Withdrawal by Subject|4|||
125351979|NCT04209426|450924103|FG000|Overall Study|Lost to Follow-up|3|||
125351980|NCT04209426|450924104|FG001|Overall Study|Lost to Follow-up|2|||
125351981|NCT04423939|450924105|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
125351982|NCT04423939|450924106|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
125351983|NCT04423939|450924105|FG000|Overall Study|Death|3|||
125351984|NCT04423939|450924106|FG001|Overall Study|Death|0|||
125351985|NCT04423939|450924105|FG000|Overall Study|Withdrawal by Subject|3|||
125351986|NCT04423939|450924106|FG001|Overall Study|Withdrawal by Subject|0|||
125351987|NCT04423939|450924105|FG000|Overall Study|Caregiver to patient who died|0|||
125351988|NCT04423939|450924106|FG001|Overall Study|Caregiver to patient who died|3|||
125351989|NCT04423939|450924105|FG000|Overall Study|Caregiver to patient who withdrew|0|||
125351990|NCT04423939|450924106|FG001|Overall Study|Caregiver to patient who withdrew|3|||
125351991|NCT04626310|450924109|FG000|Overall Study|4-miss from treatment|6|||
125351992|NCT04626310|450924110|FG001|Overall Study|4-miss from treatment|5|||
125351993|NCT04626310|450924111|FG002|Overall Study|4-miss from treatment|5|||
125351994|NCT04626310|450924109|FG000|Overall Study|Withdrawal by Subject|1|||
125351995|NCT04626310|450924110|FG001|Overall Study|Withdrawal by Subject|0|||
125351996|NCT04626310|450924111|FG002|Overall Study|Withdrawal by Subject|3|||
125351997|NCT02278341|450924112|FG000|Overall Study|Randomized but never received study drug|1|||
125351998|NCT02278341|450924113|FG001|Overall Study|Randomized but never received study drug|1|||
125351999|NCT02278341|450924112|FG000|Overall Study|Adverse Event|3|||
125352000|NCT02278341|450924113|FG001|Overall Study|Adverse Event|0|||
125352001|NCT02278341|450924112|FG000|Overall Study|Death|68|||
125554466|NCT02408861|451661562|FG006|Overall Study|Death|0|||
125554467|NCT02408861|451661556|FG000|Overall Study|Lost to Follow-up|0|||
125554468|NCT02408861|451661557|FG001|Overall Study|Lost to Follow-up|0|||
125554469|NCT02408861|451661558|FG002|Overall Study|Lost to Follow-up|1|||
125554470|NCT02408861|451661559|FG003|Overall Study|Lost to Follow-up|1|||
125554471|NCT02408861|451661560|FG004|Overall Study|Lost to Follow-up|4|||
125554472|NCT02408861|451661561|FG005|Overall Study|Lost to Follow-up|2|||
125554473|NCT02408861|451661562|FG006|Overall Study|Lost to Follow-up|1|||
125554474|NCT02408861|451661556|FG000|Overall Study|Disease Progression|0|||
125554475|NCT02408861|451661557|FG001|Overall Study|Disease Progression|0|||
125554476|NCT02408861|451661558|FG002|Overall Study|Disease Progression|1|||
125554477|NCT02408861|451661559|FG003|Overall Study|Disease Progression|0|||
125554478|NCT02408861|451661560|FG004|Overall Study|Disease Progression|3|||
125554479|NCT02408861|451661561|FG005|Overall Study|Disease Progression|1|||
125554480|NCT02408861|451661562|FG006|Overall Study|Disease Progression|1|||
125554481|NCT02408861|451661556|FG000|Overall Study|Adverse Event|1|||
125554482|NCT02408861|451661557|FG001|Overall Study|Adverse Event|0|||
125554483|NCT02408861|451661558|FG002|Overall Study|Adverse Event|1|||
125554484|NCT02408861|451661559|FG003|Overall Study|Adverse Event|0|||
125554485|NCT02408861|451661560|FG004|Overall Study|Adverse Event|2|||
125554486|NCT02408861|451661561|FG005|Overall Study|Adverse Event|0|||
125554487|NCT02408861|451661562|FG006|Overall Study|Adverse Event|0|||
125554488|NCT02408861|451661556|FG000|Overall Study|Physician Decision|1|||
125554489|NCT02408861|451661557|FG001|Overall Study|Physician Decision|1|||
125352002|NCT02278341|450924113|FG001|Overall Study|Death|56|||
125352003|NCT02278341|450924112|FG000|Overall Study|Withdrawal by Subject|30|||
125352004|NCT02278341|450924113|FG001|Overall Study|Withdrawal by Subject|19|||
125352005|NCT02278341|450924112|FG000|Overall Study|Lost to Follow-up|0|||
125352006|NCT02278341|450924113|FG001|Overall Study|Lost to Follow-up|1|||
125352007|NCT02278341|450924112|FG000|Overall Study|Physician Decision|1|||
125352008|NCT02278341|450924113|FG001|Overall Study|Physician Decision|1|||
125352009|NCT02278341|450924112|FG000|Overall Study|Miscellaneous|15|||
125352010|NCT02278341|450924113|FG001|Overall Study|Miscellaneous|14|||
125352011|NCT02604017|450924114|FG000|Overall Study|Withdrew Consent|0|||
125352012|NCT02604017|450924115|FG001|Overall Study|Withdrew Consent|2|||
125352013|NCT02604017|450924114|FG000|Overall Study|Lost to Follow-up|5|||
125352014|NCT02604017|450924115|FG001|Overall Study|Lost to Follow-up|6|||
125352015|NCT02604017|450924114|FG000|Overall Study|Other|1|||
125352016|NCT02604017|450924115|FG001|Overall Study|Other|0|||
125352017|NCT00740246|450924116|FG000|Overall Study|Received Blood Transfusion|0|||
125352018|NCT00740246|450924117|FG001|Overall Study|Received Blood Transfusion|1|||
125352019|NCT00740246|450924116|FG000|Overall Study|Adverse Event|1|||
125352020|NCT00740246|450924117|FG001|Overall Study|Adverse Event|2|||
125352021|NCT00740246|450924116|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
125352022|NCT00740246|450924117|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
125352023|NCT00740246|450924116|FG000|Overall Study|Lost to Follow-up|2|||
125352024|NCT00740246|450924117|FG001|Overall Study|Lost to Follow-up|2|||
125352025|NCT00740246|450924116|FG000|Overall Study|Withdrawal by Subject|4|||
125352026|NCT00740246|450924117|FG001|Overall Study|Withdrawal by Subject|3|||
125352027|NCT00740246|450924116|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
125352028|NCT00740246|450924117|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
125352029|NCT00740246|450924116|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
125554490|NCT02408861|451661558|FG002|Overall Study|Physician Decision|1|||
125352030|NCT00740246|450924117|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
125352031|NCT00740246|450924116|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
125352032|NCT00740246|450924117|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
125352033|NCT00740246|450924116|FG000|Overall Study|Unable To Comply With Study Visits|2|||
125352034|NCT00740246|450924117|FG001|Overall Study|Unable To Comply With Study Visits|0|||
125554491|NCT02408861|451661559|FG003|Overall Study|Physician Decision|0|||
125554492|NCT02408861|451661560|FG004|Overall Study|Physician Decision|0|||
125554493|NCT02408861|451661561|FG005|Overall Study|Physician Decision|1|||
125554494|NCT02408861|451661562|FG006|Overall Study|Physician Decision|0|||
125554495|NCT02408861|451661556|FG000|Overall Study|Protocol Violation|1|||
125554496|NCT02408861|451661557|FG001|Overall Study|Protocol Violation|0|||
125554497|NCT02408861|451661558|FG002|Overall Study|Protocol Violation|0|||
125554498|NCT02408861|451661559|FG003|Overall Study|Protocol Violation|0|||
125554499|NCT02408861|451661560|FG004|Overall Study|Protocol Violation|0|||
125554500|NCT02408861|451661561|FG005|Overall Study|Protocol Violation|0|||
125554501|NCT02408861|451661562|FG006|Overall Study|Protocol Violation|0|||
125554502|NCT02408861|451661556|FG000|Overall Study|Withdrawal by Subject|0|||
125554503|NCT02408861|451661557|FG001|Overall Study|Withdrawal by Subject|0|||
125554504|NCT02408861|451661558|FG002|Overall Study|Withdrawal by Subject|0|||
125554505|NCT02408861|451661559|FG003|Overall Study|Withdrawal by Subject|0|||
125554506|NCT02408861|451661560|FG004|Overall Study|Withdrawal by Subject|1|||
125554507|NCT02408861|451661561|FG005|Overall Study|Withdrawal by Subject|1|||
125554508|NCT02408861|451661562|FG006|Overall Study|Withdrawal by Subject|0|||
125554509|NCT02408861|451661556|FG000|Overall Study|Other Treatment|0|||
125554510|NCT02408861|451661557|FG001|Overall Study|Other Treatment|0|||
125554511|NCT02408861|451661558|FG002|Overall Study|Other Treatment|0|||
125554512|NCT02408861|451661559|FG003|Overall Study|Other Treatment|0|||
125554513|NCT02408861|451661560|FG004|Overall Study|Other Treatment|0|||
125554514|NCT02408861|451661561|FG005|Overall Study|Other Treatment|1|||
125554515|NCT02408861|451661562|FG006|Overall Study|Other Treatment|1|||
125554516|NCT03756350|451663061|FG000|Overall Study|Lost to Follow-up|1|||
125554517|NCT01096342|451663063|FG000|Overall Study|Protocol Violation|1|||
125554518|NCT03434353|451663064|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
125554519|NCT03434353|451663065|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
125554520|NCT03434353|451663066|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
125554521|NCT03434353|451663067|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
125554522|NCT03434353|451663068|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
125554523|NCT03434353|451663064|FG000|Overall Study|Withdrew consent|1|||
125554524|NCT03434353|451663065|FG001|Overall Study|Withdrew consent|0|||
125554525|NCT03434353|451663066|FG002|Overall Study|Withdrew consent|3|||
125554526|NCT03434353|451663067|FG003|Overall Study|Withdrew consent|0|||
125554527|NCT03434353|451663068|FG004|Overall Study|Withdrew consent|0|||
125554528|NCT03434353|451663064|FG000|Overall Study|Adverse Event|1|||
125554529|NCT03434353|451663065|FG001|Overall Study|Adverse Event|0|||
125554530|NCT03434353|451663066|FG002|Overall Study|Adverse Event|0|||
125554531|NCT03434353|451663067|FG003|Overall Study|Adverse Event|0|||
125554532|NCT03434353|451663068|FG004|Overall Study|Adverse Event|1|||
125554533|NCT03434353|451663064|FG000|Overall Study|Lost to Follow-up|2|||
125554534|NCT03434353|451663065|FG001|Overall Study|Lost to Follow-up|0|||
125554535|NCT03434353|451663066|FG002|Overall Study|Lost to Follow-up|0|||
125554536|NCT03434353|451663067|FG003|Overall Study|Lost to Follow-up|0|||
125554537|NCT03434353|451663068|FG004|Overall Study|Lost to Follow-up|0|||
125554538|NCT04906616|451663069|FG000|Overall Study|Divorce|3|||
125554539|NCT04906616|451663070|FG001|Overall Study|Divorce|2|||
125554540|NCT02464228|451663071|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
125554541|NCT02464228|451663072|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
125554542|NCT02464228|451663073|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
125554543|NCT02464228|451663074|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
125352035|NCT00740246|450924116|FG000|Overall Study|Unable to Access Vein|0|||
125352036|NCT00740246|450924117|FG001|Overall Study|Unable to Access Vein|2|||
125352037|NCT00740246|450924116|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
125554544|NCT02464228|451663071|FG000|Overall Study|Physician Decision|2|||
125554545|NCT02464228|451663072|FG001|Overall Study|Physician Decision|0|||
125554546|NCT02464228|451663073|FG002|Overall Study|Physician Decision|1|||
125554547|NCT02464228|451663074|FG003|Overall Study|Physician Decision|0|||
125554548|NCT02464228|451663071|FG000|Overall Study|Miscellaneous|1|||
125554549|NCT02464228|451663072|FG001|Overall Study|Miscellaneous|0|||
125554550|NCT02464228|451663073|FG002|Overall Study|Miscellaneous|1|||
125554551|NCT02464228|451663074|FG003|Overall Study|Miscellaneous|0|||
125554552|NCT02464228|451663071|FG000|Overall Study|Adverse Event|9|||
125554553|NCT02464228|451663072|FG001|Overall Study|Adverse Event|0|||
125554554|NCT02464228|451663073|FG002|Overall Study|Adverse Event|3|||
125554555|NCT02464228|451663074|FG003|Overall Study|Adverse Event|0|||
125554556|NCT02464228|451663071|FG000|Overall Study|Withdrawal by Subject|1|||
125554557|NCT02464228|451663072|FG001|Overall Study|Withdrawal by Subject|1|||
125554558|NCT02464228|451663073|FG002|Overall Study|Withdrawal by Subject|1|||
125554559|NCT02464228|451663074|FG003|Overall Study|Withdrawal by Subject|0|||
125554560|NCT02464228|451663071|FG000|Overall Study|Disease Progression|22|||
125554561|NCT02464228|451663072|FG001|Overall Study|Disease Progression|12|||
125554562|NCT02464228|451663073|FG002|Overall Study|Disease Progression|5|||
125554563|NCT02464228|451663074|FG003|Overall Study|Disease Progression|2|||
125554564|NCT01990534|451663075|FG000|Overall Study|Death|22|||
125554565|NCT01990534|451663075|FG000|Overall Study|Progressive disease|3|||
125554566|NCT01990534|451663075|FG000|Overall Study|Protocol Violation|1|||
125554567|NCT01990534|451663075|FG000|Overall Study|Withdrawal of Informed Consent|2|||
125554568|NCT01990534|451663075|FG000|Overall Study|Symptomatic Deterioration|1|||
125554569|NCT01990534|451663075|FG000|Overall Study|Withdrawal by Subject|3|||
125554570|NCT01990534|451663075|FG000|Overall Study|Reason not Specified|2|||
125554571|NCT01990534|451663075|FG000|Overall Study|Lost to Follow-up|1|||
125554572|NCT00234494|451663076|FG000|Overall Study|Protocol Violation|2|||
125554573|NCT01521897|451663083|FG000|Overall Study|Protocol Violation|18|||
125554574|NCT01521897|451663083|FG000|Overall Study|Lost to Follow-up|5|||
125554575|NCT03308942|451663090|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
125554576|NCT03308942|451663091|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
125554577|NCT03308942|451663092|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
125554578|NCT03308942|451663093|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
125554579|NCT03308942|451663094|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
125554580|NCT03308942|451663090|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
125554581|NCT03308942|451663091|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
125554582|NCT03308942|451663092|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
125554583|NCT03308942|451663093|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
125352038|NCT00740246|450924117|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
125352039|NCT01282203|450924122|FG000|Overall Study|Adverse Event|1|||
125352040|NCT01606254|450924125|FG000|Overall Study|Withdrawal by Subject|1|||
125352041|NCT01606254|450924126|FG001|Overall Study|Withdrawal by Subject|3|||
125352042|NCT01606254|450924127|FG002|Overall Study|Withdrawal by Subject|0|||
125352043|NCT01606254|450924128|FG003|Overall Study|Withdrawal by Subject|2|||
125352044|NCT01606254|450924125|FG000|Overall Study|Adverse Event|1|||
125352045|NCT01606254|450924126|FG001|Overall Study|Adverse Event|1|||
125352046|NCT01606254|450924127|FG002|Overall Study|Adverse Event|0|||
125352047|NCT01606254|450924128|FG003|Overall Study|Adverse Event|1|||
125352048|NCT02011893|450924130|FG000|Enrollment to Randomization|Adverse Event|2|||
125352049|NCT02011893|450924131|FG001|Enrollment to Randomization|Adverse Event|0|||
125352050|NCT02011893|450924132|FG002|Enrollment to Randomization|Adverse Event|0|||
125352051|NCT02011893|450924130|FG000|Enrollment to Randomization|Physician Decision|10|||
125352052|NCT02011893|450924131|FG001|Enrollment to Randomization|Physician Decision|0|||
125352053|NCT02011893|450924132|FG002|Enrollment to Randomization|Physician Decision|0|||
125352054|NCT02011893|450924130|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
125352055|NCT02011893|450924131|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
125352056|NCT02011893|450924132|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
125352057|NCT02011893|450924130|FG000|Enrollment to Randomization|Screening Failure|29|||
125352058|NCT02011893|450924131|FG001|Enrollment to Randomization|Screening Failure|0|||
125352059|NCT02011893|450924132|FG002|Enrollment to Randomization|Screening Failure|0|||
125352060|NCT02011893|450924130|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
125352061|NCT02011893|450924131|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
125352062|NCT02011893|450924132|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
125352063|NCT02011893|450924130|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
125352064|NCT02011893|450924131|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
125352065|NCT02011893|450924132|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
125352066|NCT02011893|450924130|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
125554584|NCT03308942|451663094|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
125554585|NCT03308942|451663090|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
125554586|NCT03308942|451663091|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
125554587|NCT03308942|451663092|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
125554588|NCT03308942|451663093|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
125554589|NCT03308942|451663094|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
125554590|NCT03308942|451663090|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
125554591|NCT03308942|451663091|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
125554592|NCT03308942|451663092|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
125554593|NCT03308942|451663093|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
125554594|NCT03308942|451663094|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
125554595|NCT03308942|451663090|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
125554596|NCT03308942|451663091|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
125554597|NCT03308942|451663092|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
125554598|NCT03308942|451663093|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
125554599|NCT03308942|451663094|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
125554600|NCT03308942|451663090|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
125554601|NCT03308942|451663091|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
125554602|NCT03308942|451663092|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
125554603|NCT03308942|451663093|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
125554604|NCT03308942|451663094|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
125554605|NCT03308942|451663090|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
125554606|NCT03308942|451663091|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
125554607|NCT03308942|451663092|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
125554608|NCT03308942|451663093|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
125554609|NCT03308942|451663094|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
125554610|NCT02194062|451663095|FG000|Overall Study|Lost to Follow-up|2|||
125554611|NCT02194062|451663096|FG001|Overall Study|Lost to Follow-up|2|||
125554612|NCT02194062|451663097|FG002|Overall Study|Lost to Follow-up|5|||
125554613|NCT02276872|451663098|FG000|Overall Study|Adverse Event|1|||
125554614|NCT02276872|451663099|FG001|Overall Study|Adverse Event|0|||
125554615|NCT02276872|451663100|FG002|Overall Study|Adverse Event|0|||
125554616|NCT00867113|451663104|FG000|Treatment Period|Adverse Event|15|||
125554617|NCT00867113|451663104|FG000|Treatment Period|Death|2|||
125554618|NCT00867113|451663104|FG000|Treatment Period|Withdrawal by Subject|19|||
125554619|NCT00867113|451663104|FG000|Treatment Period|Lost to Follow-up|3|||
125554620|NCT00867113|451663104|FG000|Treatment Period|Administrative problems|1|||
125554621|NCT00867113|451663104|FG000|Treatment Period|Disease progression/relapse|1|||
125554622|NCT00867113|451663104|FG000|Treatment Period|Protocol Violation|4|||
125554623|NCT00867113|451663104|FG000|Post Treatment After Survival Follow-up|Death|1|||
125554624|NCT00867113|451663104|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
125554625|NCT00867113|451663104|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
125554626|NCT00867113|451663104|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
125554627|NCT01387230|451663105|FG000|Overall Study|Adverse Event|0|||
125554628|NCT01387230|451663106|FG001|Overall Study|Adverse Event|1|||
125554629|NCT01387230|451663107|FG002|Overall Study|Adverse Event|3|||
125554630|NCT01387230|451663105|FG000|Overall Study|Lack of Efficacy|8|||
125554631|NCT01387230|451663106|FG001|Overall Study|Lack of Efficacy|5|||
125554632|NCT01387230|451663107|FG002|Overall Study|Lack of Efficacy|4|||
125554633|NCT01387230|451663105|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
125554634|NCT01387230|451663106|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
125554635|NCT01387230|451663107|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
125554636|NCT01387230|451663105|FG000|Overall Study|Lost to Follow-up|0|||
125554637|NCT01387230|451663106|FG001|Overall Study|Lost to Follow-up|0|||
125554638|NCT01387230|451663107|FG002|Overall Study|Lost to Follow-up|1|||
125554639|NCT01387230|451663105|FG000|Overall Study|Withdrawal by Subject|4|||
125554640|NCT01387230|451663106|FG001|Overall Study|Withdrawal by Subject|1|||
125554641|NCT01387230|451663107|FG002|Overall Study|Withdrawal by Subject|0|||
125554642|NCT02066051|451663108|FG000|Overall Study|Subject developed active GVHD|1|||
125554643|NCT03027557|451663114|FG000|Overall Study|Adverse Event|1|||
125554644|NCT03027557|451663115|FG001|Overall Study|Adverse Event|0|||
125554645|NCT03027557|451663116|FG002|Overall Study|Adverse Event|0|||
125554646|NCT01610687|451663117|FG000|Overall Study|Lack of Efficacy|26|||
125554647|NCT01610687|451663117|FG000|Overall Study|Adverse Event|18|||
125554648|NCT01610687|451663117|FG000|Overall Study|Moved out of area|6|||
125554649|NCT01610687|451663117|FG000|Overall Study|Withdrawal by Subject|7|||
125554650|NCT01610687|451663117|FG000|Overall Study|Lost to Follow-up|4|||
125554651|NCT01610687|451663117|FG000|Overall Study|Symptom control without study medication|2|||
125554652|NCT01610687|451663117|FG000|Overall Study|Unable to make journey|1|||
125554653|NCT01610687|451663117|FG000|Overall Study|Death|1|||
125554654|NCT01610687|451663117|FG000|Overall Study|Cannabis affecting job|1|||
125554655|NCT01610687|451663117|FG000|Overall Study|Felt more alter without study medication|1|||
125554656|NCT03836807|451663118|FG000|Overall Study|Physician Decision|1|||
125554657|NCT03836807|451663119|FG001|Overall Study|Physician Decision|0|||
125554658|NCT02430051|451663120|FG000|Overall Study|Withdrawal by Subject|6|||
125425888|NCT00781391|451182376|FG001|Overall Study|Withdrawal by Subject|37|||
125554659|NCT02430051|451663121|FG001|Overall Study|Withdrawal by Subject|3|||
125554660|NCT02430051|451663120|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
125554661|NCT02430051|451663121|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
125554662|NCT02430051|451663120|FG000|Overall Study|Protocol Violation|1|||
125554663|NCT02430051|451663121|FG001|Overall Study|Protocol Violation|0|||
125554664|NCT02019420|451663123|FG000|Overall Study|Did not receive study drug|2|||
125554665|NCT02019420|451663124|FG001|Overall Study|Did not receive study drug|2|||
125554666|NCT02019420|451663123|FG000|Overall Study|Withdrawal by Subject|1|||
125554667|NCT02019420|451663124|FG001|Overall Study|Withdrawal by Subject|3|||
125554668|NCT02019420|451663123|FG000|Overall Study|At request of sponsor or investigator|0|||
125554669|NCT02019420|451663124|FG001|Overall Study|At request of sponsor or investigator|1|||
125554670|NCT02019420|451663123|FG000|Overall Study|Death|104|||
125554671|NCT02019420|451663124|FG001|Overall Study|Death|99|||
125554672|NCT02019420|451663123|FG000|Overall Study|Transferred to other care facility|1|||
125554673|NCT02019420|451663124|FG001|Overall Study|Transferred to other care facility|1|||
125554674|NCT02554903|451663127|FG000|Overall Study|Death|1|||
125554675|NCT02554903|451663128|FG001|Overall Study|Death|1|||
125554676|NCT02554903|451663127|FG000|Overall Study|Physician Decision|2|||
125554677|NCT02554903|451663128|FG001|Overall Study|Physician Decision|2|||
125554678|NCT02554903|451663127|FG000|Overall Study|Heart Transplant|1|||
125554679|NCT02554903|451663128|FG001|Overall Study|Heart Transplant|2|||
125554680|NCT02742766|451663129|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554681|NCT02742766|451663130|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554682|NCT02742766|451663131|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554683|NCT02742766|451663132|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554684|NCT02742766|451663133|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554685|NCT02742766|451663134|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554686|NCT02742766|451663135|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554687|NCT02742766|451663136|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554688|NCT02742766|451663137|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554689|NCT02742766|451663138|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554690|NCT02742766|451663139|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554691|NCT02742766|451663140|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554692|NCT02742766|451663141|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554693|NCT02742766|451663142|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
125554694|NCT02742766|451663143|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554695|NCT02742766|451663144|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554696|NCT02742766|451663145|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554697|NCT02742766|451663146|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554698|NCT02742766|451663147|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
125554699|NCT02742766|451663129|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554700|NCT02742766|451663130|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554701|NCT02742766|451663131|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554702|NCT02742766|451663132|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554703|NCT02742766|451663133|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554704|NCT02742766|451663134|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554705|NCT02742766|451663135|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554706|NCT02742766|451663136|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554707|NCT02742766|451663137|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554708|NCT02742766|451663138|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554709|NCT02742766|451663139|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554710|NCT02742766|451663140|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554711|NCT02742766|451663141|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
125554712|NCT02742766|451663142|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
125554713|NCT02742766|451663143|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554714|NCT02742766|451663144|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
125554715|NCT02742766|451663145|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554716|NCT02742766|451663146|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554717|NCT02742766|451663147|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
125554718|NCT01395316|451663153|FG000|Overall Study|Lost to Follow-up|2|||
125554719|NCT01395316|451663153|FG000|Overall Study|poor MRI quality|1|||
125554720|NCT02846532|451663155|FG000|Overall Study|Lost to Follow-up|0|||
125554721|NCT02846532|451663156|FG001|Overall Study|Lost to Follow-up|1|||
125352067|NCT02011893|450924131|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
125352068|NCT02011893|450924132|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
125554722|NCT02846532|451663157|FG002|Overall Study|Lost to Follow-up|1|||
125554723|NCT02846532|451663155|FG000|Overall Study|Withdrawal by Subject|1|||
125554724|NCT02846532|451663156|FG001|Overall Study|Withdrawal by Subject|2|||
125554725|NCT02846532|451663157|FG002|Overall Study|Withdrawal by Subject|0|||
125352069|NCT02011893|450924130|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
125352070|NCT02011893|450924131|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
125554726|NCT03951220|451663158|FG000|Overall Study|Withdrawal by Subject|9|||
125554727|NCT03951220|451663159|FG001|Overall Study|Withdrawal by Subject|2|||
125554728|NCT03951220|451663160|FG002|Overall Study|Withdrawal by Subject|0|||
125554729|NCT01019980|451663162|FG000|Overall Study|Drug not available.|2|||
125554730|NCT01019980|451663163|FG001|Overall Study|Drug not available.|0|||
125554731|NCT02038920|451663164|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
125554732|NCT02038920|451663165|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
125554733|NCT02038920|451663166|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
125554734|NCT02038920|451663167|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
125554735|NCT02038920|451663168|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
125554736|NCT02038920|451663169|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
125554737|NCT02038920|451663164|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
125554738|NCT02038920|451663165|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
125554739|NCT02038920|451663166|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
125554740|NCT02038920|451663167|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
125554741|NCT02038920|451663168|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
125554742|NCT02038920|451663169|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
125554743|NCT02038920|451663164|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
125554744|NCT02038920|451663165|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
125554745|NCT02038920|451663166|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
125554746|NCT02038920|451663167|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
125554747|NCT02038920|451663168|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
125554748|NCT02038920|451663169|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
125554749|NCT02038920|451663164|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
125554750|NCT02038920|451663165|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
125554751|NCT02038920|451663166|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
125554752|NCT02038920|451663167|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
125554753|NCT02038920|451663168|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
125554754|NCT02038920|451663169|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
125554755|NCT02038920|451663164|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
125554756|NCT02038920|451663165|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
125554757|NCT02038920|451663166|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
125554758|NCT02038920|451663167|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
125554759|NCT02038920|451663168|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
125554760|NCT02038920|451663169|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
125554761|NCT02038920|451663164|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
125554762|NCT02038920|451663165|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
125554763|NCT02038920|451663166|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
125554764|NCT02038920|451663167|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
125554765|NCT02038920|451663168|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
125554766|NCT02038920|451663169|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
125554767|NCT02038920|451663164|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125554768|NCT02038920|451663165|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125554769|NCT02038920|451663166|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125554770|NCT02038920|451663167|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125554771|NCT02038920|451663168|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
125554772|NCT02038920|451663169|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
125554773|NCT02038920|451663164|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
125554774|NCT02038920|451663165|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
125554775|NCT02038920|451663166|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
125554776|NCT02038920|451663167|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
125554777|NCT02038920|451663168|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
125554778|NCT02038920|451663169|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
125554779|NCT02038920|451663164|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
125554780|NCT02038920|451663165|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
125554781|NCT02038920|451663166|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
125554782|NCT02038920|451663167|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
125554783|NCT02038920|451663168|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
125554784|NCT02038920|451663169|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
125554785|NCT02038920|451663164|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
125554786|NCT02038920|451663165|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
125554787|NCT02038920|451663166|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
125554788|NCT02038920|451663167|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
125554789|NCT02038920|451663168|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
125554790|NCT02038920|451663169|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
125554791|NCT02038920|451663164|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
125554792|NCT02038920|451663165|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
125554793|NCT02038920|451663166|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
125554794|NCT02038920|451663167|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
125554795|NCT02038920|451663168|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
125554796|NCT02038920|451663169|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
125554797|NCT02038920|451663164|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
125554798|NCT02038920|451663165|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
125554799|NCT02038920|451663166|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
125554800|NCT02038920|451663167|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
125554801|NCT02038920|451663168|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
125554802|NCT02038920|451663169|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
125554803|NCT00047320|451663170|FG000|Overall Study|Lack of Efficacy|8|||
125554804|NCT00047320|451663170|FG000|Overall Study|Lost to Follow-up|1|||
125554805|NCT00047320|451663170|FG000|Overall Study|Physician Decision|8|||
125554806|NCT00047320|451663170|FG000|Overall Study|Withdrawal by Subject|9|||
125554807|NCT00047320|451663170|FG000|Overall Study|Ineligible|2|||
125554808|NCT02383589|451663171|FG000|Treatment Period|Adverse Event|1|||
125554809|NCT02383589|451663172|FG001|Treatment Period|Adverse Event|3|||
125554810|NCT02383589|451663171|FG000|Treatment Period|Lost to Follow-up|0|||
125554811|NCT02383589|451663172|FG001|Treatment Period|Lost to Follow-up|1|||
125554812|NCT02383589|451663171|FG000|Treatment Period|Withdrawal by Subject|0|||
125554813|NCT02383589|451663172|FG001|Treatment Period|Withdrawal by Subject|5|||
125554814|NCT02383589|451663171|FG000|Treatment Period|Non-compliance with study drug|0|||
125554815|NCT02383589|451663172|FG001|Treatment Period|Non-compliance with study drug|1|||
125554816|NCT02383589|451663171|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
125554817|NCT02383589|451663172|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
125554818|NCT02383589|451663171|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
125554819|NCT02383589|451663172|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
125554820|NCT02383589|451663171|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
125554821|NCT02383589|451663172|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
125554822|NCT04376060|451663173|FG000|Overall Study|Physician Decision|1|||
125554823|NCT02818920|451663174|FG000|Overall Study|Unresectable|4|||
125554824|NCT02818920|451663174|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
125554825|NCT02818920|451663174|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
125554826|NCT02818920|451663174|FG000|Overall Study|Adverse Event|3|||
125554827|NCT02818920|451663174|FG000|Overall Study|Developed Other Disease|1|||
125554828|NCT02818920|451663174|FG000|Overall Study|Refused Further Treatment|1|||
125554829|NCT07052682|451663175|FG000|Overall Study|Withdrawal by Subject|4|||
125554830|NCT05460273|451663176|FG000|Overall Study|Death|43|||
125554831|NCT05460273|451663177|FG001|Overall Study|Death|9|||
125554832|NCT05460273|451663176|FG000|Overall Study|Lost to Follow-up|7|||
125554833|NCT05460273|451663177|FG001|Overall Study|Lost to Follow-up|0|||
125554834|NCT05460273|451663176|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
125554835|NCT05460273|451663177|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
125554836|NCT04890054|451664825|FG000|Overall Study|Lost to Follow-up|202|||
125554837|NCT04890054|451664826|FG001|Overall Study|Lost to Follow-up|219|||
125554838|NCT01940354|451664827|FG000|Overall Study|Withdrawal by Subject|4|||
125554839|NCT01940354|451664828|FG001|Overall Study|Withdrawal by Subject|2|||
125554840|NCT03872453|451664829|FG000|Overall Study|Adverse Event|1|||
125554841|NCT03872453|451664830|FG001|Overall Study|Adverse Event|1|||
125554842|NCT03872453|451664831|FG002|Overall Study|Adverse Event|0|||
125554843|NCT03872453|451664832|FG003|Overall Study|Adverse Event|0|||
125554844|NCT03872453|451664829|FG000|Overall Study|Lost to Follow-up|8|||
125554845|NCT03872453|451664830|FG001|Overall Study|Lost to Follow-up|7|||
125554846|NCT03872453|451664831|FG002|Overall Study|Lost to Follow-up|4|||
125554847|NCT03872453|451664832|FG003|Overall Study|Lost to Follow-up|4|||
125554848|NCT03872453|451664829|FG000|Overall Study|Never Treated Migraine|19|||
125554849|NCT03872453|451664830|FG001|Overall Study|Never Treated Migraine|17|||
125554850|NCT03872453|451664831|FG002|Overall Study|Never Treated Migraine|13|||
125554851|NCT03872453|451664832|FG003|Overall Study|Never Treated Migraine|12|||
125554852|NCT03872453|451664829|FG000|Overall Study|Pregnancy|1|||
125554853|NCT03872453|451664830|FG001|Overall Study|Pregnancy|0|||
125554854|NCT03872453|451664831|FG002|Overall Study|Pregnancy|0|||
125554855|NCT03872453|451664832|FG003|Overall Study|Pregnancy|0|||
125554856|NCT03872453|451664829|FG000|Overall Study|Protocol Deviation|2|||
125554857|NCT03872453|451664830|FG001|Overall Study|Protocol Deviation|0|||
125554858|NCT03872453|451664831|FG002|Overall Study|Protocol Deviation|0|||
125554859|NCT03872453|451664832|FG003|Overall Study|Protocol Deviation|2|||
125554860|NCT03872453|451664829|FG000|Overall Study|Withdrawal by Subject|0|||
125554861|NCT03872453|451664830|FG001|Overall Study|Withdrawal by Subject|1|||
125554862|NCT03872453|451664831|FG002|Overall Study|Withdrawal by Subject|2|||
125554863|NCT03872453|451664832|FG003|Overall Study|Withdrawal by Subject|0|||
125554864|NCT03872453|451664829|FG000|Overall Study|Other Than Specified|1|||
125554865|NCT03872453|451664830|FG001|Overall Study|Other Than Specified|0|||
125554866|NCT03872453|451664831|FG002|Overall Study|Other Than Specified|0|||
125554867|NCT03872453|451664832|FG003|Overall Study|Other Than Specified|0|||
125352071|NCT02011893|450924132|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
125554868|NCT00352885|451664833|FG000|Overall Study|Withdrawal by Subject|0|||
125554869|NCT00352885|451664834|FG001|Overall Study|Withdrawal by Subject|3|||
125554870|NCT00352885|451664833|FG000|Overall Study|Development of major depression|0|||
125554871|NCT00352885|451664834|FG001|Overall Study|Development of major depression|1|||
125554872|NCT00352885|451664833|FG000|Overall Study|Progression of metastatic melanoma|5|||
125554873|NCT00352885|451664834|FG001|Overall Study|Progression of metastatic melanoma|3|||
125554874|NCT00352885|451664833|FG000|Overall Study|Side effects of IL-2 administration|1|||
125554875|NCT00352885|451664834|FG001|Overall Study|Side effects of IL-2 administration|0|||
125554876|NCT03873493|451664835|FG000|Overall Study|Withdrawal by Subject|1|||
125554877|NCT03873493|451664835|FG000|Overall Study|Death|9|||
125554878|NCT03873493|451664835|FG000|Overall Study|Lost to Follow-up|1|||
125554879|NCT03873493|451664835|FG000|Overall Study|Study Terminated by Sponsor|1|||
125554880|NCT03873493|451664835|FG000|Overall Study|Other|2|||
125554881|NCT00440700|451664839|FG000|Overall Study|Withdrawal by Subject|8|||
125554882|NCT00440700|451664840|FG001|Overall Study|Withdrawal by Subject|8|||
125554883|NCT00440700|451664841|FG002|Overall Study|Withdrawal by Subject|4|||
125554884|NCT01423812|451664842|FG000|Overall Study|Lost to Follow-up|2|||
125554885|NCT01423812|451664843|FG001|Overall Study|Lost to Follow-up|2|||
125554886|NCT01423812|451664842|FG000|Overall Study|Withdrawal by Subject|1|||
125554887|NCT01423812|451664843|FG001|Overall Study|Withdrawal by Subject|2|||
125554888|NCT01179672|451664844|FG000|Overall Study|Adverse Event|17|||
125554889|NCT01179672|451664845|FG001|Overall Study|Adverse Event|8|||
125554890|NCT01179672|451664844|FG000|Overall Study|Withdrawal by Subject|10|||
125554891|NCT01179672|451664845|FG001|Overall Study|Withdrawal by Subject|12|||
125554892|NCT01179672|451664844|FG000|Overall Study|Entry Criteria Not Met|0|||
125554893|NCT01179672|451664845|FG001|Overall Study|Entry Criteria Not Met|2|||
125554894|NCT01179672|451664844|FG000|Overall Study|Lost to Follow-up|0|||
125554895|NCT01179672|451664845|FG001|Overall Study|Lost to Follow-up|1|||
125554896|NCT01179672|451664844|FG000|Overall Study|Protocol Violation|2|||
125554897|NCT01179672|451664845|FG001|Overall Study|Protocol Violation|2|||
125554898|NCT01179672|451664844|FG000|Overall Study|Physician Decision|1|||
125554899|NCT01179672|451664845|FG001|Overall Study|Physician Decision|1|||
125554900|NCT02748018|451664848|FG000|Study Period|Adverse Event|1|||
125554901|NCT02748018|451664849|FG001|Study Period|Adverse Event|3|||
125554902|NCT02748018|451664850|FG002|Study Period|Adverse Event|4|||
125554903|NCT02748018|451664851|FG003|Study Period|Adverse Event|0|||
125554904|NCT02748018|451664852|FG004|Study Period|Adverse Event|3|||
125554905|NCT02748018|451664853|FG005|Study Period|Adverse Event|3|||
125352072|NCT02011893|450924130|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
125554906|NCT02748018|451664848|FG000|Study Period|Withdrawal by Subject|7|||
125554907|NCT02748018|451664849|FG001|Study Period|Withdrawal by Subject|4|||
125554908|NCT02748018|451664850|FG002|Study Period|Withdrawal by Subject|4|||
125554909|NCT02748018|451664851|FG003|Study Period|Withdrawal by Subject|11|||
125554910|NCT02748018|451664852|FG004|Study Period|Withdrawal by Subject|12|||
125554911|NCT02748018|451664853|FG005|Study Period|Withdrawal by Subject|10|||
125554912|NCT02748018|451664848|FG000|Study Period|Pregnancy|0|||
125554913|NCT02748018|451664849|FG001|Study Period|Pregnancy|1|||
125554914|NCT02748018|451664850|FG002|Study Period|Pregnancy|0|||
125554915|NCT02748018|451664851|FG003|Study Period|Pregnancy|0|||
125554916|NCT02748018|451664852|FG004|Study Period|Pregnancy|1|||
125554917|NCT02748018|451664853|FG005|Study Period|Pregnancy|0|||
125554918|NCT02748018|451664848|FG000|Study Period|Physician Decision|2|||
125352073|NCT02011893|450924131|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
125352074|NCT02011893|450924132|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
125352075|NCT03977454|450924133|FG000|Overall Study|immediate postoperative revision|2|||
125352076|NCT03977454|450924134|FG001|Overall Study|immediate postoperative revision|2|||
125352077|NCT01289782|450924135|FG000|Overall Study|Lost to Follow-up|14|||
125352078|NCT01289782|450924136|FG001|Overall Study|Lost to Follow-up|7|||
125352079|NCT01289782|450924135|FG000|Overall Study|Protocol Violation|1|||
125352080|NCT01289782|450924136|FG001|Overall Study|Protocol Violation|1|||
125352081|NCT01289782|450924135|FG000|Overall Study|Withdrawal by Subject|8|||
125352082|NCT01289782|450924136|FG001|Overall Study|Withdrawal by Subject|2|||
125352083|NCT01289782|450924135|FG000|Overall Study|Sponsor's Decision|1|||
125352084|NCT01289782|450924136|FG001|Overall Study|Sponsor's Decision|0|||
125352085|NCT01289782|450924135|FG000|Overall Study|Reason not specified|1|||
125352086|NCT01289782|450924136|FG001|Overall Study|Reason not specified|2|||
125352087|NCT01241240|450924137|FG000|Overall Study|Adverse Event|5|||
125352088|NCT01241240|450924138|FG001|Overall Study|Adverse Event|4|||
125352089|NCT01241240|450924137|FG000|Overall Study|Lost to Follow-up|2|||
125352090|NCT01241240|450924138|FG001|Overall Study|Lost to Follow-up|4|||
125352091|NCT01241240|450924137|FG000|Overall Study|Personal Reasons|1|||
125352092|NCT01241240|450924138|FG001|Overall Study|Personal Reasons|1|||
125352093|NCT04365257|450924142|FG000|Overall Study|Physician Decision|1|||
125352094|NCT04365257|450924143|FG001|Overall Study|Physician Decision|0|||
125352095|NCT04365257|450924142|FG000|Overall Study|Patient Noncompliance|1|||
125352096|NCT04365257|450924143|FG001|Overall Study|Patient Noncompliance|0|||
125352097|NCT04365257|450924142|FG000|Overall Study|Withdrawal by Subject|0|||
125352098|NCT04365257|450924143|FG001|Overall Study|Withdrawal by Subject|1|||
125352099|NCT00518973|450924144|FG000|Overall Study|Withdrawal by Subject|3|||
125352100|NCT00518973|450924145|FG001|Overall Study|Withdrawal by Subject|2|||
125352101|NCT01001299|450924148|FG000|Overall Study|Insufficient Therapeutic Response|20|||
125352102|NCT01001299|450924148|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
125352103|NCT01001299|450924148|FG000|Overall Study|Death|1|||
125352104|NCT01001299|450924148|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
125352105|NCT01001299|450924148|FG000|Overall Study|Withdrew Consent|1|||
125352106|NCT01565499|450924153|FG000|Overall Study|Physician Decision|1|||
125352107|NCT01565499|450924153|FG000|Overall Study|Adverse Event|5|||
125352108|NCT01565499|450924153|FG000|Overall Study|Withdrawal by Subject|2|||
125352109|NCT03519386|450924156|FG000|Overall Study|Withdrawal by Subject|4|||
125352110|NCT03519386|450924157|FG001|Overall Study|Withdrawal by Subject|1|||
125352111|NCT03519386|450924158|FG002|Overall Study|Withdrawal by Subject|2|||
125352112|NCT03519386|450924156|FG000|Overall Study|Physician Decision|1|||
125352113|NCT03519386|450924157|FG001|Overall Study|Physician Decision|1|||
125352114|NCT03519386|450924158|FG002|Overall Study|Physician Decision|1|||
125352115|NCT03519386|450924156|FG000|Overall Study|Lost to Follow-up|0|||
125352116|NCT03519386|450924157|FG001|Overall Study|Lost to Follow-up|1|||
125352117|NCT03519386|450924158|FG002|Overall Study|Lost to Follow-up|1|||
125352118|NCT03519386|450924156|FG000|Overall Study|Death|1|||
125352119|NCT03519386|450924157|FG001|Overall Study|Death|0|||
125352120|NCT03519386|450924158|FG002|Overall Study|Death|4|||
125352121|NCT03519386|450924156|FG000|Overall Study|Adverse Event|2|||
125352122|NCT03519386|450924157|FG001|Overall Study|Adverse Event|1|||
125352123|NCT03519386|450924158|FG002|Overall Study|Adverse Event|2|||
125352124|NCT03519386|450924156|FG000|Overall Study|Explanted|2|||
125352125|NCT03519386|450924157|FG001|Overall Study|Explanted|1|||
125352126|NCT03519386|450924158|FG002|Overall Study|Explanted|0|||
125352127|NCT03519386|450924156|FG000|Overall Study|Ongoing in study|190|||
125352128|NCT03519386|450924157|FG001|Overall Study|Ongoing in study|192|||
125352129|NCT03519386|450924158|FG002|Overall Study|Ongoing in study|183|||
125352130|NCT01582854|450924160|FG000|Overall Study|Death|8|||
125352131|NCT01582854|450924161|FG001|Overall Study|Death|5|||
125352132|NCT01582854|450924160|FG000|Overall Study|Adverse Event|2|||
125352133|NCT01582854|450924161|FG001|Overall Study|Adverse Event|3|||
125352134|NCT01582854|450924160|FG000|Overall Study|Withdrawal by Participant|8|||
125352135|NCT01582854|450924161|FG001|Overall Study|Withdrawal by Participant|11|||
125352136|NCT01582854|450924160|FG000|Overall Study|Lost to Follow-up|1|||
125352137|NCT01582854|450924161|FG001|Overall Study|Lost to Follow-up|2|||
125352138|NCT01582854|450924160|FG000|Overall Study|Physician Decision|0|||
125352139|NCT01582854|450924161|FG001|Overall Study|Physician Decision|1|||
125352140|NCT01582854|450924160|FG000|Overall Study|Recurrent Stroke|13|||
125352141|NCT01582854|450924161|FG001|Overall Study|Recurrent Stroke|8|||
125352142|NCT01582854|450924160|FG000|Overall Study|Disallowed Concomitant Medication|3|||
125352143|NCT01582854|450924161|FG001|Overall Study|Disallowed Concomitant Medication|2|||
125352144|NCT01582854|450924160|FG000|Overall Study|Carotid or Neurosurgery|0|||
125425889|NCT00781391|451182377|FG002|Overall Study|Withdrawal by Subject|25|||
125352145|NCT01582854|450924161|FG001|Overall Study|Carotid or Neurosurgery|1|||
125554919|NCT02748018|451664849|FG001|Study Period|Physician Decision|2|||
125554920|NCT02748018|451664850|FG002|Study Period|Physician Decision|1|||
125554921|NCT02748018|451664851|FG003|Study Period|Physician Decision|0|||
125554922|NCT02748018|451664852|FG004|Study Period|Physician Decision|2|||
125554923|NCT02748018|451664853|FG005|Study Period|Physician Decision|0|||
125554924|NCT02748018|451664848|FG000|Study Period|Lost to Follow-up|0|||
125554925|NCT02748018|451664849|FG001|Study Period|Lost to Follow-up|0|||
125554926|NCT02748018|451664850|FG002|Study Period|Lost to Follow-up|0|||
125554927|NCT02748018|451664851|FG003|Study Period|Lost to Follow-up|2|||
125554928|NCT02748018|451664852|FG004|Study Period|Lost to Follow-up|0|||
125554929|NCT02748018|451664853|FG005|Study Period|Lost to Follow-up|1|||
125554930|NCT02748018|451664848|FG000|Continuation Period|Adverse Event|2|||
125554931|NCT02748018|451664849|FG001|Continuation Period|Adverse Event|0|||
125554932|NCT02748018|451664850|FG002|Continuation Period|Adverse Event|1|||
125554933|NCT02748018|451664851|FG003|Continuation Period|Adverse Event|1|||
125554934|NCT02748018|451664852|FG004|Continuation Period|Adverse Event|1|||
125554935|NCT02748018|451664853|FG005|Continuation Period|Adverse Event|4|||
125554936|NCT02748018|451664848|FG000|Continuation Period|Withdrawal by Subject|3|||
125554937|NCT02748018|451664849|FG001|Continuation Period|Withdrawal by Subject|5|||
125554938|NCT02748018|451664850|FG002|Continuation Period|Withdrawal by Subject|3|||
125554939|NCT02748018|451664851|FG003|Continuation Period|Withdrawal by Subject|9|||
125554940|NCT02748018|451664852|FG004|Continuation Period|Withdrawal by Subject|11|||
125554941|NCT02748018|451664853|FG005|Continuation Period|Withdrawal by Subject|1|||
125554942|NCT02748018|451664848|FG000|Continuation Period|Lost to Follow-up|0|||
125554943|NCT02748018|451664849|FG001|Continuation Period|Lost to Follow-up|2|||
125554944|NCT02748018|451664850|FG002|Continuation Period|Lost to Follow-up|1|||
125554945|NCT02748018|451664851|FG003|Continuation Period|Lost to Follow-up|0|||
125554946|NCT02748018|451664852|FG004|Continuation Period|Lost to Follow-up|1|||
125554947|NCT02748018|451664853|FG005|Continuation Period|Lost to Follow-up|0|||
125554948|NCT02748018|451664848|FG000|Continuation Period|Pregnancy|1|||
125554949|NCT02748018|451664849|FG001|Continuation Period|Pregnancy|2|||
125554950|NCT02748018|451664850|FG002|Continuation Period|Pregnancy|0|||
125554951|NCT02748018|451664851|FG003|Continuation Period|Pregnancy|0|||
125554952|NCT02748018|451664852|FG004|Continuation Period|Pregnancy|0|||
125554953|NCT02748018|451664853|FG005|Continuation Period|Pregnancy|0|||
125554954|NCT02748018|451664848|FG000|Continuation Period|Physician Decision|0|||
125554955|NCT02748018|451664849|FG001|Continuation Period|Physician Decision|1|||
125554956|NCT02748018|451664850|FG002|Continuation Period|Physician Decision|2|||
125554957|NCT02748018|451664851|FG003|Continuation Period|Physician Decision|0|||
125554958|NCT02748018|451664852|FG004|Continuation Period|Physician Decision|2|||
125554959|NCT02748018|451664853|FG005|Continuation Period|Physician Decision|1|||
125554960|NCT02748018|451664848|FG000|Continuation Period|Protocol Violation|0|||
125554961|NCT02748018|451664849|FG001|Continuation Period|Protocol Violation|1|||
125554962|NCT02748018|451664850|FG002|Continuation Period|Protocol Violation|0|||
125554963|NCT02748018|451664851|FG003|Continuation Period|Protocol Violation|0|||
125554964|NCT02748018|451664852|FG004|Continuation Period|Protocol Violation|0|||
125554965|NCT02748018|451664853|FG005|Continuation Period|Protocol Violation|0|||
125554966|NCT02315898|451664854|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
125554967|NCT02315898|451664855|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
125554968|NCT02315898|451664856|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
125554969|NCT02315898|451664857|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
125554970|NCT00578786|451664867|FG000|Overall Study|Adverse Event|27|||
125554971|NCT00578786|451664868|FG001|Overall Study|Adverse Event|37|||
125554972|NCT00578786|451664869|FG002|Overall Study|Adverse Event|17|||
125554973|NCT00578786|451664867|FG000|Overall Study|Lack of Efficacy|2|||
125554974|NCT00578786|451664868|FG001|Overall Study|Lack of Efficacy|5|||
125554975|NCT00578786|451664869|FG002|Overall Study|Lack of Efficacy|2|||
125554976|NCT00578786|451664867|FG000|Overall Study|Early Escape from Prior Study|2|||
125554977|NCT00578786|451664868|FG001|Overall Study|Early Escape from Prior Study|1|||
125554978|NCT00578786|451664869|FG002|Overall Study|Early Escape from Prior Study|2|||
125554979|NCT00578786|451664867|FG000|Overall Study|Withdrawal by Subject|7|||
125554980|NCT00578786|451664868|FG001|Overall Study|Withdrawal by Subject|8|||
125554981|NCT00578786|451664869|FG002|Overall Study|Withdrawal by Subject|5|||
125554982|NCT00578786|451664867|FG000|Overall Study|Protocol Violation|0|||
125554983|NCT00578786|451664868|FG001|Overall Study|Protocol Violation|3|||
125554984|NCT00578786|451664869|FG002|Overall Study|Protocol Violation|1|||
125554985|NCT00578786|451664867|FG000|Overall Study|Physician Decision|1|||
125554986|NCT00578786|451664868|FG001|Overall Study|Physician Decision|0|||
125554987|NCT00578786|451664869|FG002|Overall Study|Physician Decision|1|||
125554988|NCT00578786|451664867|FG000|Overall Study|Sponsor Decision|0|||
125554989|NCT00578786|451664868|FG001|Overall Study|Sponsor Decision|0|||
125554990|NCT00578786|451664869|FG002|Overall Study|Sponsor Decision|1|||
125554991|NCT00578786|451664867|FG000|Overall Study|Lost to Follow-up|0|||
125554992|NCT00578786|451664868|FG001|Overall Study|Lost to Follow-up|4|||
125554993|NCT00578786|451664869|FG002|Overall Study|Lost to Follow-up|0|||
125554994|NCT00578786|451664867|FG000|Overall Study|Pregnancy|0|||
125352146|NCT01582854|450924160|FG000|Overall Study|General Anaesthesia|0|||
125352147|NCT01582854|450924161|FG001|Overall Study|General Anaesthesia|1|||
125352148|NCT01582854|450924160|FG000|Overall Study|Other Miscellaneous Reason|1|||
125352149|NCT01582854|450924161|FG001|Overall Study|Other Miscellaneous Reason|0|||
125352150|NCT02652767|450924166|FG000|Overall Study|Death|2|||
125352151|NCT02652767|450924166|FG000|Overall Study|Lost to Follow-up|1|||
125352152|NCT02652767|450924166|FG000|Overall Study|Withdrawal by Subject|1|||
125352153|NCT01028378|450924167|FG000|Overall Study|Lost to Follow-up|12|||
125352154|NCT01028378|450924167|FG000|Overall Study|Withdrawal by Subject|1|||
125352155|NCT01028378|450924167|FG000|Overall Study|Adminstrative Reasons|4|||
125352156|NCT00107952|450924171|FG000|Overall Study|Death|75|||
125352157|NCT00107952|450924172|FG001|Overall Study|Death|61|||
125352158|NCT00107952|450924171|FG000|Overall Study|Lost to Follow-up|0|||
125352159|NCT00107952|450924172|FG001|Overall Study|Lost to Follow-up|3|||
125352160|NCT00107952|450924171|FG000|Overall Study|Withdrawal by Subject|9|||
125352161|NCT00107952|450924172|FG001|Overall Study|Withdrawal by Subject|6|||
125352162|NCT00107952|450924171|FG000|Overall Study|Other|2|||
125352163|NCT00107952|450924172|FG001|Overall Study|Other|5|||
125352164|NCT00107952|450924171|FG000|Overall Study|Never received study treatment|9|||
125352165|NCT00107952|450924172|FG001|Overall Study|Never received study treatment|6|||
125352166|NCT01401959|450924173|FG000|Enrolled|Withdrawal by Subject|1|||
125352167|NCT01401959|450924174|FG001|Enrolled|Withdrawal by Subject|0|||
125352168|NCT01401959|450924175|FG002|Enrolled|Withdrawal by Subject|0|||
125352169|NCT01401959|450924173|FG000|Treated|Disease Progression|2|||
125352170|NCT01401959|450924174|FG001|Treated|Disease Progression|2|||
125352171|NCT01401959|450924175|FG002|Treated|Disease Progression|1|||
125352172|NCT01401959|450924173|FG000|Treated|Adverse Event|4|||
125352173|NCT01401959|450924174|FG001|Treated|Adverse Event|3|||
125352174|NCT01401959|450924175|FG002|Treated|Adverse Event|2|||
125352175|NCT01401959|450924173|FG000|Treated|Withdrawal by Subject|1|||
125352176|NCT01401959|450924174|FG001|Treated|Withdrawal by Subject|2|||
125352177|NCT01401959|450924175|FG002|Treated|Withdrawal by Subject|2|||
125352178|NCT01401959|450924173|FG000|Treated|Protocol Violation|0|||
125352179|NCT01401959|450924174|FG001|Treated|Protocol Violation|1|||
125352180|NCT01401959|450924175|FG002|Treated|Protocol Violation|0|||
125352181|NCT03614975|450924182|FG000|Overall Study|Physician Decision|7|||
125352182|NCT03614975|450924183|FG001|Overall Study|Physician Decision|5|||
125352183|NCT03614975|450924182|FG000|Overall Study|Withdrawal by Subject|2|||
125352184|NCT03614975|450924183|FG001|Overall Study|Withdrawal by Subject|2|||
125352185|NCT03614975|450924182|FG000|Overall Study|Specimens not in lab batch shipment|1|||
125352186|NCT03614975|450924183|FG001|Overall Study|Specimens not in lab batch shipment|1|||
125352187|NCT00450385|450924184|FG000|Overall Study|Death|3|||
125352188|NCT00450385|450924184|FG000|Overall Study|Protocol Violation|1|||
125352189|NCT00450385|450924184|FG000|Overall Study|Withdrawal by Subject|2|||
125352190|NCT00450385|450924184|FG000|Overall Study|Lack of Efficacy|2|||
125352191|NCT00450385|450924184|FG000|Overall Study|Adverse Event|1|||
125352192|NCT00450385|450924184|FG000|Overall Study|Physician Decision|1|||
125352193|NCT00450385|450924184|FG000|Overall Study|Other|3|||
125352194|NCT01569464|450924185|FG000|Overall Study|Adverse Event|4|||
125352195|NCT01569464|450924186|FG001|Overall Study|Adverse Event|0|||
125352196|NCT01569464|450924185|FG000|Overall Study|Lack of Efficacy|1|||
125352197|NCT01569464|450924186|FG001|Overall Study|Lack of Efficacy|0|||
125352198|NCT01569464|450924185|FG000|Overall Study|Protocol Violation|1|||
125352199|NCT01569464|450924186|FG001|Overall Study|Protocol Violation|0|||
125352200|NCT01569464|450924185|FG000|Overall Study|Lost to Follow-up|2|||
125352201|NCT01569464|450924186|FG001|Overall Study|Lost to Follow-up|3|||
125554995|NCT00578786|451664868|FG001|Overall Study|Pregnancy|1|||
125554996|NCT00578786|451664869|FG002|Overall Study|Pregnancy|0|||
125352202|NCT01569464|450924185|FG000|Overall Study|Withdrawal by Subject|1|||
125352203|NCT01569464|450924186|FG001|Overall Study|Withdrawal by Subject|1|||
125352204|NCT01569464|450924185|FG000|Overall Study|Other|1|||
125352205|NCT01569464|450924186|FG001|Overall Study|Other|1|||
125352206|NCT01390220|450924192|FG000|Test Dose Phase|Adverse Event|17|||
125352207|NCT01390220|450924193|FG001|Test Dose Phase|Adverse Event|0|||
125352208|NCT01390220|450924194|FG002|Test Dose Phase|Adverse Event|0|||
125352209|NCT01390220|450924192|FG000|Test Dose Phase|Withdrawal by Subject|8|||
125352210|NCT01390220|450924193|FG001|Test Dose Phase|Withdrawal by Subject|0|||
125554997|NCT00578786|451664867|FG000|Overall Study|Not Otherwise Specified|0|||
125352211|NCT01390220|450924194|FG002|Test Dose Phase|Withdrawal by Subject|0|||
125352212|NCT01390220|450924192|FG000|Test Dose Phase|Lost to Follow-up|2|||
125352213|NCT01390220|450924193|FG001|Test Dose Phase|Lost to Follow-up|0|||
125352214|NCT01390220|450924194|FG002|Test Dose Phase|Lost to Follow-up|0|||
125352215|NCT01390220|450924192|FG000|Test Dose Phase|Protocol Violation|8|||
125425890|NCT00781391|451182375|FG000|Overall Study|Lost to Follow-up|0|||
125554998|NCT00578786|451664868|FG001|Overall Study|Not Otherwise Specified|4|||
125554999|NCT00578786|451664869|FG002|Overall Study|Not Otherwise Specified|1|||
125555000|NCT00578786|451664867|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
125555001|NCT00578786|451664868|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
125555002|NCT00578786|451664869|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
125555003|NCT05105789|451664870|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
125555004|NCT00323297|451664873|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
125555005|NCT00323297|451664874|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
125555006|NCT00323297|451664873|FG000|Part A (Double Blind Randomized)|Death|0|||
125555007|NCT00323297|451664874|FG001|Part A (Double Blind Randomized)|Death|1|||
125555008|NCT00323297|451664873|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
125555009|NCT00323297|451664874|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
125555010|NCT00323297|451664873|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
125555011|NCT00323297|451664874|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
125555012|NCT00323297|451664873|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
125555013|NCT00323297|451664874|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
125555014|NCT00323297|451664873|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
125555015|NCT00323297|451664874|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
125555016|NCT00323297|451664873|FG000|Part B (Open-label)|Death|0|||
125555017|NCT00323297|451664874|FG001|Part B (Open-label)|Death|1|||
125555018|NCT00323297|451664873|FG000|Part B (Open-label)|Reason unspecified|0|||
125555019|NCT00323297|451664874|FG001|Part B (Open-label)|Reason unspecified|1|||
125555020|NCT00323297|451664873|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
125555021|NCT00323297|451664874|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
125555022|NCT00323297|451664873|FG000|Part B (Open-label)|Lack of Efficacy|3|||
125555023|NCT00323297|451664874|FG001|Part B (Open-label)|Lack of Efficacy|1|||
125555024|NCT00323297|451664873|FG000|Part B (Open-label)|Adverse Event|5|||
125555025|NCT00323297|451664874|FG001|Part B (Open-label)|Adverse Event|5|||
125555026|NCT00323297|451664873|FG000|Part B (Open-label)|Protocol Violation|0|||
125555027|NCT00323297|451664874|FG001|Part B (Open-label)|Protocol Violation|1|||
125555028|NCT01003990|451664875|FG000|Overall Study|Adverse Event|8|||
125555029|NCT01003990|451664876|FG001|Overall Study|Adverse Event|5|||
125555030|NCT01003990|451664877|FG002|Overall Study|Adverse Event|11|||
125555031|NCT01003990|451664875|FG000|Overall Study|Death|0|||
125555032|NCT01003990|451664876|FG001|Overall Study|Death|8|||
125555033|NCT01003990|451664877|FG002|Overall Study|Death|1|||
125555034|NCT01003990|451664875|FG000|Overall Study|Lack of Efficacy|10|||
125555035|NCT01003990|451664876|FG001|Overall Study|Lack of Efficacy|2|||
125555036|NCT01003990|451664877|FG002|Overall Study|Lack of Efficacy|3|||
125555037|NCT01003990|451664875|FG000|Overall Study|Lost to Follow-up|30|||
125555038|NCT01003990|451664876|FG001|Overall Study|Lost to Follow-up|12|||
125555039|NCT01003990|451664877|FG002|Overall Study|Lost to Follow-up|7|||
125555040|NCT01003990|451664875|FG000|Overall Study|Reasons Not Identified|14|||
125555041|NCT01003990|451664876|FG001|Overall Study|Reasons Not Identified|13|||
125555042|NCT01003990|451664877|FG002|Overall Study|Reasons Not Identified|8|||
125555043|NCT01003990|451664875|FG000|Overall Study|Poor/Non-compliance|4|||
125555044|NCT01003990|451664876|FG001|Overall Study|Poor/Non-compliance|3|||
125555045|NCT01003990|451664877|FG002|Overall Study|Poor/Non-compliance|2|||
125555046|NCT01003990|451664875|FG000|Overall Study|Pregnancy|10|||
125555047|NCT01003990|451664876|FG001|Overall Study|Pregnancy|2|||
125555048|NCT01003990|451664877|FG002|Overall Study|Pregnancy|4|||
125555049|NCT01003990|451664875|FG000|Overall Study|No Longer Met Study Criteria|4|||
125555050|NCT01003990|451664876|FG001|Overall Study|No Longer Met Study Criteria|1|||
125555051|NCT01003990|451664877|FG002|Overall Study|No Longer Met Study Criteria|0|||
125555052|NCT01003990|451664875|FG000|Overall Study|Subject Withdrew Consent|12|||
125555053|NCT01003990|451664876|FG001|Overall Study|Subject Withdrew Consent|5|||
125555054|NCT01003990|451664877|FG002|Overall Study|Subject Withdrew Consent|7|||
125555055|NCT00634010|451664882|FG000|Overall Study|Adverse Event|2|||
125555056|NCT00634010|451664883|FG001|Overall Study|Adverse Event|5|||
125555057|NCT00634010|451664882|FG000|Overall Study|Withdrawal by Subject|5|||
125555058|NCT00634010|451664883|FG001|Overall Study|Withdrawal by Subject|6|||
125555059|NCT00634010|451664882|FG000|Overall Study|Physician Decision|1|||
125425891|NCT00781391|451182376|FG001|Overall Study|Lost to Follow-up|0|||
125555060|NCT00634010|451664883|FG001|Overall Study|Physician Decision|1|||
125555061|NCT00634010|451664882|FG000|Overall Study|Disease Progression|1|||
125555062|NCT00634010|451664883|FG001|Overall Study|Disease Progression|1|||
125555063|NCT00634010|451664882|FG000|Overall Study|Non-Compliant|1|||
125555064|NCT00634010|451664883|FG001|Overall Study|Non-Compliant|1|||
125555065|NCT00448435|451664889|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
125555066|NCT00448435|451664890|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
125555067|NCT01822522|451664891|FG000|Overall Study|Adverse Event|1|||
125555068|NCT01822522|451664892|FG001|Overall Study|Adverse Event|1|||
125555069|NCT01822522|451664893|FG002|Overall Study|Adverse Event|1|||
125555070|NCT01822522|451664894|FG003|Overall Study|Adverse Event|0|||
125555071|NCT01822522|451664895|FG004|Overall Study|Adverse Event|0|||
125555072|NCT01822522|451664896|FG005|Overall Study|Adverse Event|1|||
125352216|NCT01390220|450924193|FG001|Test Dose Phase|Protocol Violation|0|||
125555073|NCT01822522|451664891|FG000|Overall Study|Death|3|||
125555074|NCT01822522|451664892|FG001|Overall Study|Death|0|||
125555075|NCT01822522|451664893|FG002|Overall Study|Death|2|||
125555076|NCT01822522|451664894|FG003|Overall Study|Death|0|||
125555077|NCT01822522|451664895|FG004|Overall Study|Death|0|||
125555078|NCT01822522|451664896|FG005|Overall Study|Death|0|||
125555079|NCT01822522|451664891|FG000|Overall Study|Lost to Follow-up|0|||
125555080|NCT01822522|451664892|FG001|Overall Study|Lost to Follow-up|0|||
125555081|NCT01822522|451664893|FG002|Overall Study|Lost to Follow-up|1|||
125555082|NCT01822522|451664894|FG003|Overall Study|Lost to Follow-up|1|||
125555083|NCT01822522|451664895|FG004|Overall Study|Lost to Follow-up|0|||
125555084|NCT01822522|451664896|FG005|Overall Study|Lost to Follow-up|1|||
125555085|NCT01822522|451664891|FG000|Overall Study|Withdrawal by Subject|0|||
125555086|NCT01822522|451664892|FG001|Overall Study|Withdrawal by Subject|0|||
125555087|NCT01822522|451664893|FG002|Overall Study|Withdrawal by Subject|0|||
125555088|NCT01822522|451664894|FG003|Overall Study|Withdrawal by Subject|1|||
125555089|NCT01822522|451664895|FG004|Overall Study|Withdrawal by Subject|0|||
125555090|NCT01822522|451664896|FG005|Overall Study|Withdrawal by Subject|0|||
125555091|NCT01822522|451664891|FG000|Overall Study|Lack of Efficacy|0|||
125555092|NCT01822522|451664892|FG001|Overall Study|Lack of Efficacy|0|||
125555093|NCT01822522|451664893|FG002|Overall Study|Lack of Efficacy|0|||
125555094|NCT01822522|451664894|FG003|Overall Study|Lack of Efficacy|0|||
125555095|NCT01822522|451664895|FG004|Overall Study|Lack of Efficacy|0|||
125555096|NCT01822522|451664896|FG005|Overall Study|Lack of Efficacy|2|||
125555097|NCT00890929|451664897|FG000|Overall Study|Death before treatment|2|||
125555098|NCT00890929|451664897|FG000|Overall Study|Withdrawal by Subject|3|||
125555099|NCT00890929|451664897|FG000|Overall Study|Physician Decision|1|||
125555100|NCT01006265|451664900|FG000|Overall Study|Lost to Follow-up|1|||
125555101|NCT01006265|451664901|FG001|Overall Study|Lost to Follow-up|0|||
125555102|NCT01006265|451664902|FG002|Overall Study|Lost to Follow-up|1|||
125555103|NCT01006265|451664903|FG003|Overall Study|Lost to Follow-up|0|||
125555104|NCT01006265|451664900|FG000|Overall Study|Withdrawal by Subject|4|||
125555105|NCT01006265|451664901|FG001|Overall Study|Withdrawal by Subject|7|||
125555106|NCT01006265|451664902|FG002|Overall Study|Withdrawal by Subject|5|||
125555107|NCT01006265|451664903|FG003|Overall Study|Withdrawal by Subject|5|||
125352217|NCT01390220|450924194|FG002|Test Dose Phase|Protocol Violation|0|||
125352218|NCT01390220|450924192|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
125352219|NCT01390220|450924193|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
125352220|NCT01390220|450924194|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
125352221|NCT01390220|450924192|FG000|Test Dose Phase|Study/Site closure|6|||
125352222|NCT01390220|450924193|FG001|Test Dose Phase|Study/Site closure|0|||
125352223|NCT01390220|450924194|FG002|Test Dose Phase|Study/Site closure|0|||
125352224|NCT01390220|450924192|FG000|Test Dose Phase|Caregiver no longer available|5|||
125352225|NCT01390220|450924193|FG001|Test Dose Phase|Caregiver no longer available|0|||
125352226|NCT01390220|450924194|FG002|Test Dose Phase|Caregiver no longer available|0|||
125352227|NCT01390220|450924192|FG000|Test Dose Phase|Noncompliance|2|||
125352228|NCT01390220|450924193|FG001|Test Dose Phase|Noncompliance|0|||
125555108|NCT01006265|451664900|FG000|Overall Study|Administrative reason|1|||
125555109|NCT01006265|451664901|FG001|Overall Study|Administrative reason|2|||
125555110|NCT01006265|451664902|FG002|Overall Study|Administrative reason|3|||
125352229|NCT01390220|450924194|FG002|Test Dose Phase|Noncompliance|0|||
125555111|NCT01006265|451664903|FG003|Overall Study|Administrative reason|0|||
125352230|NCT01390220|450924192|FG000|Test Dose Phase|Logistical|6|||
125352231|NCT01390220|450924193|FG001|Test Dose Phase|Logistical|0|||
125352232|NCT01390220|450924194|FG002|Test Dose Phase|Logistical|0|||
125555112|NCT01272947|451664904|FG000|Overall Study|Abnormal Laboratory Value|2|||
125555113|NCT01272947|451664905|FG001|Overall Study|Abnormal Laboratory Value|2|||
125555114|NCT02510560|451664908|FG000|Overall Study|Discontinued from Treatment|27|||
125555115|NCT02510560|451664909|FG001|Overall Study|Discontinued from Treatment|18|||
125555116|NCT02510560|451664910|FG002|Overall Study|Discontinued from Treatment|19|||
125555117|NCT02510560|451664908|FG000|Overall Study|Other|4|||
125555118|NCT02510560|451664909|FG001|Overall Study|Other|4|||
125555119|NCT02510560|451664910|FG002|Overall Study|Other|3|||
125555120|NCT00132496|451664911|FG000|Overall Study|Withdrawal by Subject|1|||
125555121|NCT00132496|451664912|FG001|Overall Study|Withdrawal by Subject|2|||
125555122|NCT00132496|451664911|FG000|Overall Study|Physician Decision|1|||
125555123|NCT00132496|451664912|FG001|Overall Study|Physician Decision|0|||
125555124|NCT01093625|451664917|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
125555125|NCT01093625|451664918|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
125555126|NCT01093625|451664917|FG000|2-Week Visit|Withdrawal by Subject|1|||
125555127|NCT01093625|451664918|FG001|2-Week Visit|Withdrawal by Subject|0|||
125555128|NCT01093625|451664917|FG000|1-Month Visit|Lost to Follow-up|2|||
125555129|NCT01093625|451664918|FG001|1-Month Visit|Lost to Follow-up|0|||
125555130|NCT01093625|451664917|FG000|3-Month Visit|Lost to Follow-up|2|||
125555131|NCT01093625|451664918|FG001|3-Month Visit|Lost to Follow-up|0|||
125555132|NCT01093625|451664917|FG000|6-Month Visit|Withdrawal by Subject|6|||
125555133|NCT01093625|451664918|FG001|6-Month Visit|Withdrawal by Subject|7|||
125555134|NCT01093625|451664917|FG000|6-Month Visit|Lost to Follow-up|2|||
125555135|NCT01093625|451664918|FG001|6-Month Visit|Lost to Follow-up|2|||
125555136|NCT01093625|451664917|FG000|1-Year Visit|Lost to Follow-up|5|||
125555137|NCT01093625|451664918|FG001|1-Year Visit|Lost to Follow-up|3|||
125555138|NCT02014740|451664919|FG000|Overall Study|Lost to Follow-up|4|||
125555139|NCT02014740|451664920|FG001|Overall Study|Lost to Follow-up|4|||
125555140|NCT02014740|451664919|FG000|Overall Study|Withdrawal by Subject|2|||
125555141|NCT02014740|451664920|FG001|Overall Study|Withdrawal by Subject|1|||
125555142|NCT01431534|451664921|FG000|Treatment Phase|Adverse Event|0|||
125555143|NCT01431534|451664922|FG001|Treatment Phase|Adverse Event|0|||
125555144|NCT01431534|451664923|FG002|Treatment Phase|Adverse Event|1|||
125555145|NCT01431534|451664921|FG000|Treatment Phase|Progressive Disease|4|||
125555146|NCT01431534|451664922|FG001|Treatment Phase|Progressive Disease|3|||
125555147|NCT01431534|451664923|FG002|Treatment Phase|Progressive Disease|10|||
125555148|NCT04427501|451664926|FG000|Overall Study|Death|0|||
125555149|NCT04427501|451664927|FG001|Overall Study|Death|0|||
125555150|NCT04427501|451664928|FG002|Overall Study|Death|0|||
125555151|NCT04427501|451664929|FG003|Overall Study|Death|0|||
125352233|NCT01390220|450924192|FG000|Comparative Phase|Withdrawal by Subject|0|||
125352234|NCT01390220|450924193|FG001|Comparative Phase|Withdrawal by Subject|1|||
125555152|NCT04427501|451664930|FG004|Overall Study|Death|0|||
125555153|NCT04427501|451664931|FG005|Overall Study|Death|15|||
125555154|NCT04427501|451664932|FG006|Overall Study|Death|0|||
125555155|NCT04427501|451664933|FG007|Overall Study|Death|0|||
125555156|NCT04427501|451664934|FG008|Overall Study|Death|0|||
125555157|NCT04427501|451664935|FG009|Overall Study|Death|0|||
125555158|NCT04427501|451664936|FG010|Overall Study|Death|0|||
125555159|NCT04427501|451664937|FG011|Overall Study|Death|0|||
125555160|NCT04427501|451664926|FG000|Overall Study|Lost to Follow-up|5|||
125555161|NCT04427501|451664927|FG001|Overall Study|Lost to Follow-up|1|||
125555162|NCT04427501|451664928|FG002|Overall Study|Lost to Follow-up|2|||
125555163|NCT04427501|451664929|FG003|Overall Study|Lost to Follow-up|0|||
125555164|NCT04427501|451664930|FG004|Overall Study|Lost to Follow-up|2|||
125555165|NCT04427501|451664931|FG005|Overall Study|Lost to Follow-up|11|||
125555166|NCT04427501|451664932|FG006|Overall Study|Lost to Follow-up|10|||
125555167|NCT04427501|451664933|FG007|Overall Study|Lost to Follow-up|10|||
125555168|NCT04427501|451664934|FG008|Overall Study|Lost to Follow-up|2|||
125555169|NCT04427501|451664935|FG009|Overall Study|Lost to Follow-up|5|||
125555170|NCT04427501|451664936|FG010|Overall Study|Lost to Follow-up|2|||
125555171|NCT04427501|451664937|FG011|Overall Study|Lost to Follow-up|0|||
125555172|NCT04427501|451664926|FG000|Overall Study|Physician Decision|0|||
125555173|NCT04427501|451664927|FG001|Overall Study|Physician Decision|3|||
125555174|NCT04427501|451664928|FG002|Overall Study|Physician Decision|0|||
125555175|NCT04427501|451664929|FG003|Overall Study|Physician Decision|0|||
125555176|NCT04427501|451664930|FG004|Overall Study|Physician Decision|0|||
125555177|NCT04427501|451664931|FG005|Overall Study|Physician Decision|0|||
125555178|NCT04427501|451664932|FG006|Overall Study|Physician Decision|2|||
125555179|NCT04427501|451664933|FG007|Overall Study|Physician Decision|0|||
125555180|NCT04427501|451664934|FG008|Overall Study|Physician Decision|0|||
125555181|NCT04427501|451664935|FG009|Overall Study|Physician Decision|0|||
125555182|NCT04427501|451664936|FG010|Overall Study|Physician Decision|0|||
125555183|NCT04427501|451664937|FG011|Overall Study|Physician Decision|0|||
125555184|NCT04427501|451664926|FG000|Overall Study|Withdrawal by Subject|9|||
125555185|NCT04427501|451664927|FG001|Overall Study|Withdrawal by Subject|2|||
125555186|NCT04427501|451664928|FG002|Overall Study|Withdrawal by Subject|2|||
125555187|NCT04427501|451664929|FG003|Overall Study|Withdrawal by Subject|3|||
125555188|NCT04427501|451664930|FG004|Overall Study|Withdrawal by Subject|7|||
125555189|NCT04427501|451664931|FG005|Overall Study|Withdrawal by Subject|25|||
125555190|NCT04427501|451664932|FG006|Overall Study|Withdrawal by Subject|15|||
125555191|NCT04427501|451664933|FG007|Overall Study|Withdrawal by Subject|7|||
125555192|NCT04427501|451664934|FG008|Overall Study|Withdrawal by Subject|4|||
125555193|NCT04427501|451664935|FG009|Overall Study|Withdrawal by Subject|1|||
125555194|NCT04427501|451664936|FG010|Overall Study|Withdrawal by Subject|4|||
125555195|NCT04427501|451664937|FG011|Overall Study|Withdrawal by Subject|0|||
125555196|NCT04427501|451664926|FG000|Overall Study|Other - as reported by the investigator|1|||
125555197|NCT04427501|451664927|FG001|Overall Study|Other - as reported by the investigator|0|||
125555198|NCT04427501|451664928|FG002|Overall Study|Other - as reported by the investigator|0|||
125555199|NCT04427501|451664929|FG003|Overall Study|Other - as reported by the investigator|0|||
125555200|NCT04427501|451664930|FG004|Overall Study|Other - as reported by the investigator|0|||
125555201|NCT04427501|451664931|FG005|Overall Study|Other - as reported by the investigator|6|||
125555202|NCT04427501|451664932|FG006|Overall Study|Other - as reported by the investigator|6|||
125555203|NCT04427501|451664933|FG007|Overall Study|Other - as reported by the investigator|0|||
125555204|NCT04427501|451664934|FG008|Overall Study|Other - as reported by the investigator|0|||
125555205|NCT04427501|451664935|FG009|Overall Study|Other - as reported by the investigator|0|||
125555206|NCT04427501|451664936|FG010|Overall Study|Other - as reported by the investigator|0|||
125555207|NCT04427501|451664937|FG011|Overall Study|Other - as reported by the investigator|0|||
125555208|NCT04427501|451664926|FG000|Overall Study|Other|0|||
125555209|NCT04427501|451664927|FG001|Overall Study|Other|0|||
125555210|NCT04427501|451664928|FG002|Overall Study|Other|0|||
125555211|NCT04427501|451664929|FG003|Overall Study|Other|0|||
125555212|NCT04427501|451664930|FG004|Overall Study|Other|0|||
125555213|NCT04427501|451664931|FG005|Overall Study|Other|0|||
125555214|NCT04427501|451664932|FG006|Overall Study|Other|0|||
125555215|NCT04427501|451664933|FG007|Overall Study|Other|0|||
125555216|NCT04427501|451664934|FG008|Overall Study|Other|0|||
125555217|NCT04427501|451664935|FG009|Overall Study|Other|0|||
125555218|NCT04427501|451664936|FG010|Overall Study|Other|0|||
125555219|NCT04427501|451664937|FG011|Overall Study|Other|1|||
125555220|NCT00999713|451664938|FG000|Overall Study|Physician Decision|2|||
125555221|NCT00999713|451664939|FG001|Overall Study|Physician Decision|0|||
125555222|NCT04936841|451664940|FG000|Overall Study|Death|1|||
125555223|NCT00639223|451664941|FG000|Overall Study|Lost to Follow-up|0|||
125555224|NCT00639223|451664942|FG001|Overall Study|Lost to Follow-up|2|||
125555225|NCT03739437|451664943|FG000|Overall Study|Lost to Follow-up|2|||
125555226|NCT03739437|451664944|FG001|Overall Study|Lost to Follow-up|5|||
125555227|NCT03359590|451664947|FG000|First Intervention|Withdrawal by Subject|1|||
125555228|NCT03359590|451664948|FG001|First Intervention|Withdrawal by Subject|1|||
125555229|NCT03359590|451664947|FG000|First Intervention|Protocol Violation|0|||
125555230|NCT03359590|451664948|FG001|First Intervention|Protocol Violation|1|||
125555231|NCT06132425|451664949|FG000|Overall Study|Withdrawal by Subject|3|||
125555232|NCT06132425|451664950|FG001|Overall Study|Withdrawal by Subject|0|||
125555233|NCT06132425|451664949|FG000|Overall Study|Did not follow study instructions|0|||
125555234|NCT06132425|451664950|FG001|Overall Study|Did not follow study instructions|2|||
125555235|NCT06132425|451664949|FG000|Overall Study|Lost to Follow-up|3|||
125555236|NCT06132425|451664950|FG001|Overall Study|Lost to Follow-up|5|||
125555237|NCT04598477|451664951|FG000|Overall Study|Adverse Event|2|||
125555238|NCT04598477|451664952|FG001|Overall Study|Adverse Event|0|||
125555239|NCT04598477|451664951|FG000|Overall Study|Death|0|||
125555240|NCT04598477|451664952|FG001|Overall Study|Death|1|||
125555241|NCT04598477|451664951|FG000|Overall Study|Lost to Follow-up|1|||
125555242|NCT04598477|451664952|FG001|Overall Study|Lost to Follow-up|0|||
125555243|NCT04598477|451664951|FG000|Overall Study|Physician Decision|7|||
125555244|NCT04598477|451664952|FG001|Overall Study|Physician Decision|2|||
125555245|NCT04598477|451664951|FG000|Overall Study|Pregnancy|0|||
125555246|NCT04598477|451664952|FG001|Overall Study|Pregnancy|1|||
125555247|NCT04598477|451664951|FG000|Overall Study|Requires Prohibited Medication|0|||
125555248|NCT04598477|451664952|FG001|Overall Study|Requires Prohibited Medication|1|||
125555249|NCT04598477|451664951|FG000|Overall Study|Study Terminated by Sponsor|18|||
125555250|NCT04598477|451664952|FG001|Overall Study|Study Terminated by Sponsor|12|||
125555251|NCT04598477|451664951|FG000|Overall Study|Withdrawal by Subject|16|||
125555252|NCT04598477|451664952|FG001|Overall Study|Withdrawal by Subject|12|||
125555253|NCT04598477|451664951|FG000|Overall Study|Other|15|||
125555254|NCT04598477|451664952|FG001|Overall Study|Other|8|||
125555255|NCT02499770|451664958|FG000|Overall Study|Death|17|||
125555256|NCT02499770|451664959|FG001|Overall Study|Death|56|||
125555257|NCT02499770|451664958|FG000|Overall Study|Study completion|1|||
125555258|NCT02499770|451664959|FG001|Overall Study|Study completion|10|||
125555259|NCT02499770|451664958|FG000|Overall Study|Withdrawal by Subject|0|||
125555260|NCT02499770|451664959|FG001|Overall Study|Withdrawal by Subject|7|||
125555261|NCT02499770|451664958|FG000|Overall Study|Lost to Follow-up|0|||
125555262|NCT02499770|451664959|FG001|Overall Study|Lost to Follow-up|2|||
125555263|NCT02499770|451664958|FG000|Overall Study|Subject declined further treatment|1|||
125555264|NCT02499770|451664959|FG001|Overall Study|Subject declined further treatment|0|||
125555265|NCT02499770|451664958|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
125555266|NCT02499770|451664959|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
125555267|NCT02499770|451664958|FG000|Overall Study|Randomized but not enrolled|0|||
125555268|NCT02499770|451664959|FG001|Overall Study|Randomized but not enrolled|1|||
125555269|NCT01298518|451664963|FG000|Overall Study|Withdrawal by Subject|0|||
125555270|NCT01298518|451664964|FG001|Overall Study|Withdrawal by Subject|0|||
125555271|NCT01298518|451664965|FG002|Overall Study|Withdrawal by Subject|1|||
125555272|NCT02273726|451664966|FG000|Overall Study|Death|70|||
125555273|NCT02273726|451664967|FG001|Overall Study|Death|62|||
125555274|NCT02273726|451664966|FG000|Overall Study|Withdrawal by Subject|41|||
125555275|NCT02273726|451664967|FG001|Overall Study|Withdrawal by Subject|29|||
125555276|NCT02273726|451664966|FG000|Overall Study|Kidney transplant|31|||
125555277|NCT02273726|451664967|FG001|Overall Study|Kidney transplant|39|||
125555278|NCT02273726|451664966|FG000|Overall Study|Physician Decision|30|||
125555279|NCT02273726|451664967|FG001|Overall Study|Physician Decision|15|||
125555280|NCT02273726|451664966|FG000|Overall Study|Adverse Event|27|||
125555281|NCT02273726|451664967|FG001|Overall Study|Adverse Event|9|||
125555282|NCT02273726|451664966|FG000|Overall Study|Lost to Follow-up|6|||
125555283|NCT02273726|451664967|FG001|Overall Study|Lost to Follow-up|3|||
125555284|NCT02273726|451664966|FG000|Overall Study|Lack of Efficacy|6|||
125555285|NCT02273726|451664967|FG001|Overall Study|Lack of Efficacy|1|||
125555286|NCT02273726|451664966|FG000|Overall Study|Protocol Violation|4|||
125555287|NCT02273726|451664967|FG001|Overall Study|Protocol Violation|0|||
125555288|NCT02273726|451664966|FG000|Overall Study|Other than specified|28|||
125555289|NCT02273726|451664967|FG001|Overall Study|Other than specified|30|||
125555290|NCT02129205|451664974|FG000|Overall Study|Withdrawal by Subject|0|||
125425892|NCT00781391|451182377|FG002|Overall Study|Lost to Follow-up|1|||
125425893|NCT01822587|451182379|FG000|Overall Study|Lost to Follow-up|7|||
125425894|NCT01822587|451182380|FG001|Overall Study|Lost to Follow-up|9|||
125425895|NCT01822587|451182381|FG002|Overall Study|Lost to Follow-up|12|||
125555291|NCT02129205|451664975|FG001|Overall Study|Withdrawal by Subject|0|||
125555292|NCT02129205|451664976|FG002|Overall Study|Withdrawal by Subject|0|||
125555293|NCT02129205|451664977|FG003|Overall Study|Withdrawal by Subject|0|||
125555294|NCT02129205|451664978|FG004|Overall Study|Withdrawal by Subject|1|||
125555295|NCT02129205|451664979|FG005|Overall Study|Withdrawal by Subject|1|||
125555296|NCT02129205|451664980|FG006|Overall Study|Withdrawal by Subject|1|||
125555297|NCT02129205|451664981|FG007|Overall Study|Withdrawal by Subject|0|||
125555298|NCT02129205|451664982|FG008|Overall Study|Withdrawal by Subject|1|||
125555299|NCT02129205|451664983|FG009|Overall Study|Withdrawal by Subject|0|||
125555300|NCT02129205|451664974|FG000|Overall Study|Other|1|||
125555301|NCT02129205|451664975|FG001|Overall Study|Other|0|||
125425896|NCT01822587|451182379|FG000|Overall Study|Physician Decision|9|||
125555302|NCT02129205|451664976|FG002|Overall Study|Other|0|||
125555303|NCT02129205|451664977|FG003|Overall Study|Other|0|||
125555304|NCT02129205|451664978|FG004|Overall Study|Other|2|||
125425897|NCT01822587|451182380|FG001|Overall Study|Physician Decision|6|||
125425898|NCT01822587|451182381|FG002|Overall Study|Physician Decision|6|||
125425899|NCT00708916|451182382|FG000|Overall Study|Subject Noncompliance|2|||
125425900|NCT00708916|451182382|FG000|Overall Study|Adverse Event|2|||
125425901|NCT01058304|451182391|FG000|Overall Study|Withdrawal by Subject|8|||
125425902|NCT01058304|451182392|FG001|Overall Study|Withdrawal by Subject|5|||
125425903|NCT01058304|451182391|FG000|Overall Study|Lost to Follow-up|13|||
125425904|NCT01058304|451182392|FG001|Overall Study|Lost to Follow-up|16|||
125425905|NCT01058304|451182391|FG000|Overall Study|Developed exclusion criterion|6|||
125425906|NCT01058304|451182392|FG001|Overall Study|Developed exclusion criterion|12|||
125425907|NCT01820559|451182393|FG000|Overall Study|Adverse Event|4|||
125425908|NCT01820559|451182394|FG001|Overall Study|Adverse Event|6|||
125425909|NCT01820559|451182395|FG002|Overall Study|Adverse Event|13|||
125425910|NCT01820559|451182393|FG000|Overall Study|Withdrawal by Subject|1|||
125425911|NCT01820559|451182394|FG001|Overall Study|Withdrawal by Subject|2|||
125425912|NCT01820559|451182395|FG002|Overall Study|Withdrawal by Subject|5|||
125425913|NCT01820559|451182393|FG000|Overall Study|Protocol Violation|2|||
125425914|NCT01820559|451182394|FG001|Overall Study|Protocol Violation|1|||
125425915|NCT01820559|451182395|FG002|Overall Study|Protocol Violation|3|||
125425916|NCT01820559|451182393|FG000|Overall Study|Subject's non-compliance|1|||
125425917|NCT01820559|451182394|FG001|Overall Study|Subject's non-compliance|0|||
125425918|NCT01820559|451182395|FG002|Overall Study|Subject's non-compliance|2|||
125425919|NCT01820559|451182393|FG000|Overall Study|Lost to Follow-up|3|||
125425920|NCT01820559|451182394|FG001|Overall Study|Lost to Follow-up|2|||
125425921|NCT01820559|451182395|FG002|Overall Study|Lost to Follow-up|2|||
125425922|NCT01820559|451182393|FG000|Overall Study|At sponsor request|0|||
125425923|NCT01820559|451182394|FG001|Overall Study|At sponsor request|0|||
125425924|NCT01820559|451182395|FG002|Overall Study|At sponsor request|1|||
125555305|NCT02129205|451664979|FG005|Overall Study|Other|3|||
125555306|NCT02129205|451664980|FG006|Overall Study|Other|3|||
125555307|NCT02129205|451664981|FG007|Overall Study|Other|2|||
125555308|NCT02129205|451664982|FG008|Overall Study|Other|1|||
125555309|NCT02129205|451664983|FG009|Overall Study|Other|0|||
125425925|NCT01820559|451182393|FG000|Overall Study|Lack of Efficacy|3|||
125425926|NCT01820559|451182394|FG001|Overall Study|Lack of Efficacy|2|||
125425927|NCT01820559|451182395|FG002|Overall Study|Lack of Efficacy|3|||
125425928|NCT02954354|451182398|FG000|Overall Study|Adverse Event|2|||
125425929|NCT02954354|451182399|FG001|Overall Study|Adverse Event|2|||
125425930|NCT02954354|451182400|FG002|Overall Study|Adverse Event|4|||
125425931|NCT02954354|451182398|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
125425932|NCT02954354|451182399|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
125425933|NCT02954354|451182400|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
125425934|NCT02954354|451182398|FG000|Overall Study|Lack of Efficacy|0|||
125425935|NCT02954354|451182399|FG001|Overall Study|Lack of Efficacy|2|||
125425936|NCT02954354|451182400|FG002|Overall Study|Lack of Efficacy|0|||
125425937|NCT02954354|451182398|FG000|Overall Study|Withdrawal by Subject|17|||
125425938|NCT02954354|451182399|FG001|Overall Study|Withdrawal by Subject|9|||
125425939|NCT02954354|451182400|FG002|Overall Study|Withdrawal by Subject|11|||
125425940|NCT02954354|451182398|FG000|Overall Study|Lost to Follow-up|12|||
125425941|NCT02954354|451182399|FG001|Overall Study|Lost to Follow-up|5|||
125425942|NCT02954354|451182400|FG002|Overall Study|Lost to Follow-up|0|||
125425943|NCT02954354|451182398|FG000|Overall Study|Miscellaneous|2|||
125425944|NCT02954354|451182399|FG001|Overall Study|Miscellaneous|2|||
125425945|NCT02954354|451182400|FG002|Overall Study|Miscellaneous|1|||
125425946|NCT04495179|451182401|FG000|Overall Study|Lost to Follow-up|0|||
125425947|NCT04495179|451182402|FG001|Overall Study|Lost to Follow-up|1|||
125425948|NCT04495179|451182401|FG000|Overall Study|Withdrawal by Subject|2|||
125425949|NCT04495179|451182402|FG001|Overall Study|Withdrawal by Subject|4|||
125425950|NCT04495179|451182401|FG000|Overall Study|Study terminated by sponsor|0|||
125425951|NCT04495179|451182402|FG001|Overall Study|Study terminated by sponsor|18|||
125425952|NCT04495179|451182401|FG000|Overall Study|Death|0|||
125555310|NCT00866697|451664994|FG000|Overall Study|Study closed/terminated|156|||
125555311|NCT00866697|451664995|FG001|Overall Study|Study closed/terminated|138|||
125555312|NCT00866697|451664994|FG000|Overall Study|Lost to Follow-up|22|||
125425953|NCT04495179|451182402|FG001|Overall Study|Death|4|||
125425954|NCT04495179|451182401|FG000|Overall Study|Adverse Event|0|||
125425955|NCT04495179|451182402|FG001|Overall Study|Adverse Event|1|||
125425956|NCT02618967|451182406|FG000|Overall Study|Lost to Follow-up|0|||
125425957|NCT02618967|451182407|FG001|Overall Study|Lost to Follow-up|0|||
125425958|NCT02618967|451182408|FG002|Overall Study|Lost to Follow-up|1|||
125425959|NCT02618967|451182409|FG003|Overall Study|Lost to Follow-up|0|||
125425960|NCT02618967|451182410|FG004|Overall Study|Lost to Follow-up|2|||
125425961|NCT02618967|451182411|FG005|Overall Study|Lost to Follow-up|0|||
125425962|NCT02618967|451182412|FG006|Overall Study|Lost to Follow-up|0|||
125425963|NCT02618967|451182413|FG007|Overall Study|Lost to Follow-up|0|||
125425964|NCT02618967|451182406|FG000|Overall Study|Withdrawal by Subject|1|||
125555313|NCT00866697|451664995|FG001|Overall Study|Lost to Follow-up|28|||
125555314|NCT00866697|451664994|FG000|Overall Study|Physician Decision|3|||
125555315|NCT00866697|451664995|FG001|Overall Study|Physician Decision|5|||
125352235|NCT01390220|450924194|FG002|Comparative Phase|Withdrawal by Subject|0|||
125352236|NCT03063203|450924195|FG000|Overall Study|Chose alternative therapy|3|||
125352237|NCT03063203|450924195|FG000|Overall Study|Death|2|||
125352238|NCT03063203|450924195|FG000|Overall Study|Disease progression|4|||
125352239|NCT03063203|450924195|FG000|Overall Study|Physician Decision|5|||
125352240|NCT01856023|450924196|FG000|Overall Study|Death|1|||
125352241|NCT01856023|450924197|FG001|Overall Study|Death|2|||
125352242|NCT01856023|450924196|FG000|Overall Study|Adverse Event|2|||
125352243|NCT01856023|450924197|FG001|Overall Study|Adverse Event|1|||
125352244|NCT01856023|450924196|FG000|Overall Study|Lack of Efficacy|5|||
125352245|NCT01856023|450924197|FG001|Overall Study|Lack of Efficacy|5|||
125352246|NCT01856023|450924196|FG000|Overall Study|non compliance, study closure|1|||
125352247|NCT01856023|450924197|FG001|Overall Study|non compliance, study closure|3|||
125352248|NCT01856023|450924196|FG000|Overall Study|Withdrawal by Subject|1|||
125352249|NCT01856023|450924197|FG001|Overall Study|Withdrawal by Subject|1|||
125352250|NCT04718103|450924198|FG000|Overall Study|Adverse Event|1|||
125352251|NCT04718103|450924199|FG001|Overall Study|Adverse Event|1|||
125352252|NCT04718103|450924198|FG000|Overall Study|Lack of Efficacy|4|||
125352253|NCT04718103|450924199|FG001|Overall Study|Lack of Efficacy|1|||
125352254|NCT04718103|450924198|FG000|Overall Study|Lost to Follow-up|2|||
125352255|NCT04718103|450924199|FG001|Overall Study|Lost to Follow-up|2|||
125352256|NCT04718103|450924198|FG000|Overall Study|Physician Decision|2|||
125352257|NCT04718103|450924199|FG001|Overall Study|Physician Decision|0|||
125352258|NCT04718103|450924198|FG000|Overall Study|Pregnancy|0|||
125352259|NCT04718103|450924199|FG001|Overall Study|Pregnancy|1|||
125352260|NCT04718103|450924198|FG000|Overall Study|Withdrawal by Subject|10|||
125352261|NCT04718103|450924199|FG001|Overall Study|Withdrawal by Subject|6|||
125352262|NCT04718103|450924198|FG000|Overall Study|Randomized, not treated|4|||
125352263|NCT04718103|450924199|FG001|Overall Study|Randomized, not treated|1|||
125352264|NCT04718103|450924198|FG000|Overall Study|GCP violations|7|||
125352265|NCT04718103|450924199|FG001|Overall Study|GCP violations|5|||
125352266|NCT00136604|450924202|FG000|Overall Study|Lost to Follow-up|1|||
125352267|NCT00136604|450924203|FG001|Overall Study|Lost to Follow-up|0|||
125352268|NCT00136604|450924204|FG002|Overall Study|Lost to Follow-up|0|||
125352269|NCT00136604|450924205|FG003|Overall Study|Lost to Follow-up|0|||
125352270|NCT00136604|450924206|FG004|Overall Study|Lost to Follow-up|1|||
125352271|NCT00136604|450924202|FG000|Overall Study|Migrated/moved from study area|0|||
125352272|NCT00136604|450924203|FG001|Overall Study|Migrated/moved from study area|1|||
125352273|NCT00136604|450924204|FG002|Overall Study|Migrated/moved from study area|0|||
125352274|NCT00136604|450924205|FG003|Overall Study|Migrated/moved from study area|0|||
125352275|NCT00136604|450924206|FG004|Overall Study|Migrated/moved from study area|0|||
125352276|NCT03631355|450924207|FG000|Overall Study|Lost to Follow-up|1|||
125352277|NCT03631355|450924208|FG001|Overall Study|Lost to Follow-up|2|||
125352278|NCT01233687|450924209|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
125352279|NCT01233687|450924209|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
125352280|NCT01233687|450924209|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
125352281|NCT03640559|450924212|FG000|Overall Study|Physician Decision|1|||
125352282|NCT03640559|450924213|FG001|Overall Study|Physician Decision|1|||
125352283|NCT03640559|450924212|FG000|Overall Study|Withdrawal by Subject|1|||
125352284|NCT03640559|450924213|FG001|Overall Study|Withdrawal by Subject|0|||
125352285|NCT02125604|450924214|FG000|Overall Study|Other|4|||
125352286|NCT02125604|450924214|FG000|Overall Study|Investigator Decision|1|||
125352287|NCT02125604|450924214|FG000|Overall Study|Lost to Follow-up|2|||
125352288|NCT02125604|450924214|FG000|Overall Study|Consent Withdrawn|4|||
125352289|NCT02125604|450924214|FG000|Overall Study|Adverse Event|20|||
125352290|NCT01876810|450924217|FG000|Overall Study|Physician Decision|0|||
125352291|NCT01876810|450924218|FG001|Overall Study|Physician Decision|1|||
125352292|NCT00719264|450925929|FG000|Overall Study|Adverse Event|41|||
125352293|NCT00719264|450925930|FG001|Overall Study|Adverse Event|49|||
125352294|NCT00719264|450925929|FG000|Overall Study|Death|13|||
125352295|NCT00719264|450925930|FG001|Overall Study|Death|10|||
125352296|NCT00719264|450925929|FG000|Overall Study|Administrative Problems|6|||
125352297|NCT00719264|450925930|FG001|Overall Study|Administrative Problems|4|||
125352298|NCT00719264|450925929|FG000|Overall Study|Lost to Follow-up|1|||
125352299|NCT00719264|450925930|FG001|Overall Study|Lost to Follow-up|1|||
125352300|NCT00719264|450925929|FG000|Overall Study|Withdrawal by Subject|12|||
125352301|NCT00719264|450925930|FG001|Overall Study|Withdrawal by Subject|7|||
125352302|NCT00719264|450925929|FG000|Overall Study|Protocol Deviation|1|||
125352303|NCT00719264|450925930|FG001|Overall Study|Protocol Deviation|3|||
125352304|NCT00719264|450925929|FG000|Overall Study|New Cancer Therapy|4|||
125352305|NCT00719264|450925930|FG001|Overall Study|New Cancer Therapy|2|||
125352306|NCT00719264|450925929|FG000|Overall Study|Disease Progression|104|||
125352307|NCT00719264|450925930|FG001|Overall Study|Disease Progression|107|||
125352308|NCT03034200|450925931|FG000|Overall Study|Disease progression|8|||
125352309|NCT03034200|450925932|FG001|Overall Study|Disease progression|10|||
125352310|NCT03034200|450925933|FG002|Overall Study|Disease progression|4|||
125352311|NCT03034200|450925931|FG000|Overall Study|Physician Decision|2|||
125352312|NCT03034200|450925932|FG001|Overall Study|Physician Decision|0|||
125352313|NCT03034200|450925933|FG002|Overall Study|Physician Decision|3|||
125555316|NCT00866697|451664994|FG000|Overall Study|Withdrawal by Subject|33|||
125555317|NCT00866697|451664995|FG001|Overall Study|Withdrawal by Subject|57|||
125555318|NCT02906787|451664998|FG000|Overall Study|Withdrawal by Subject|12|||
125555319|NCT02906787|451664999|FG001|Overall Study|Withdrawal by Subject|10|||
125555320|NCT02906787|451664998|FG000|Overall Study|Missed|24|||
125555321|NCT02906787|451664999|FG001|Overall Study|Missed|22|||
125555322|NCT04275297|451665000|FG000|Overall Study|Lost to Follow-up|1|||
125555323|NCT04275297|451665001|FG001|Overall Study|Lost to Follow-up|1|||
125555324|NCT01310803|451666950|FG000|Overall Study|Subject terminated by Sponsor|1|||
125555325|NCT01310803|451666951|FG001|Overall Study|Subject terminated by Sponsor|0|||
125555326|NCT01306890|451666952|FG000|Overall Study|Adverse Event|2|||
125555327|NCT01306890|451666952|FG000|Overall Study|Death|1223|||
125555328|NCT01306890|451666952|FG000|Overall Study|Lost to Follow-up|58|||
125555329|NCT01306890|451666952|FG000|Overall Study|Withdrawal by Subject|88|||
125555330|NCT01306890|451666952|FG000|Overall Study|Unspecified reasons|104|||
125555331|NCT01306890|451666952|FG000|Overall Study|Study Termination|3|||
125555332|NCT01306890|451666952|FG000|Overall Study|No discontinuation documentation|41|||
125555333|NCT03739762|451666957|FG000|Overall Study|Lost to Follow-up|1|||
125555334|NCT03739762|451666958|FG001|Overall Study|Lost to Follow-up|1|||
125555335|NCT03739762|451666957|FG000|Overall Study|Withdrawal by Subject|2|||
125555336|NCT03739762|451666958|FG001|Overall Study|Withdrawal by Subject|6|||
125555337|NCT01131351|451666960|FG000|Overall Study|Adverse Event|0|||
125555338|NCT01131351|451666961|FG001|Overall Study|Adverse Event|2|||
125555339|NCT01131351|451666960|FG000|Overall Study|Protocol Deviation|0|||
125555340|NCT01131351|451666961|FG001|Overall Study|Protocol Deviation|1|||
125555341|NCT02294682|451666962|FG000|Overall Study|Could not swallow pills|1|||
125555342|NCT02294682|451666963|FG001|Overall Study|Could not swallow pills|0|||
125555343|NCT03422172|451666966|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
125555344|NCT03422172|451666966|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
125555345|NCT03422172|451666966|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
125555346|NCT00059839|451666969|FG000|Overall Study|Death|1|||
125555347|NCT00059839|451666970|FG001|Overall Study|Death|1|||
125555348|NCT00059839|451666969|FG000|Overall Study|Lack of Efficacy|6|||
125555349|NCT00059839|451666970|FG001|Overall Study|Lack of Efficacy|5|||
125555350|NCT00059839|451666969|FG000|Overall Study|Lost to Follow-up|2|||
125555351|NCT00059839|451666970|FG001|Overall Study|Lost to Follow-up|0|||
125555352|NCT00059839|451666969|FG000|Overall Study|Physician Decision|1|||
125555353|NCT00059839|451666970|FG001|Overall Study|Physician Decision|2|||
125555354|NCT00059839|451666969|FG000|Overall Study|Withdrawal by Subject|1|||
125555355|NCT00059839|451666970|FG001|Overall Study|Withdrawal by Subject|6|||
125555356|NCT00059839|451666969|FG000|Overall Study|Ineligible|1|||
125555357|NCT00059839|451666970|FG001|Overall Study|Ineligible|3|||
125555358|NCT00129623|451666971|FG000|Overall Study|Adverse Event|3|||
125555359|NCT00129623|451666972|FG001|Overall Study|Adverse Event|7|||
125555360|NCT00129623|451666971|FG000|Overall Study|Refused Treatment|5|||
125555361|NCT00129623|451666972|FG001|Overall Study|Refused Treatment|3|||
125555362|NCT00129623|451666971|FG000|Overall Study|Failure to Return|1|||
125555363|NCT00129623|451666972|FG001|Overall Study|Failure to Return|1|||
125555364|NCT00129623|451666971|FG000|Overall Study|Relocated job out of state|1|||
125555365|NCT00129623|451666972|FG001|Overall Study|Relocated job out of state|0|||
125555366|NCT00129623|451666971|FG000|Overall Study|Uncertainty to return|0|||
125555367|NCT00129623|451666972|FG001|Overall Study|Uncertainty to return|1|||
125555368|NCT03155373|451666973|FG000|Overall Study|No longer required surgery|1|||
125555369|NCT03155373|451666973|FG000|Overall Study|Protocol Violation|1|||
125555370|NCT03155373|451666973|FG000|Overall Study|Death|2|||
125352314|NCT03034200|450925931|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
125352315|NCT03034200|450925932|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
125555371|NCT03155373|451666973|FG000|Overall Study|Withdrawal by Subject|3|||
125555372|NCT05352048|451666978|FG000|Overall Study|Lost to Follow-up|1|||
125555373|NCT05352048|451666978|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
125555374|NCT01214187|451666979|FG000|Overall Study|Adverse Event|6|||
125555375|NCT01214187|451666980|FG001|Overall Study|Adverse Event|2|||
125555376|NCT01214187|451666979|FG000|Overall Study|Death|1|||
125555377|NCT01214187|451666980|FG001|Overall Study|Death|1|||
125555378|NCT01214187|451666979|FG000|Overall Study|Withdrawal by Subject|0|||
125555379|NCT01214187|451666980|FG001|Overall Study|Withdrawal by Subject|3|||
125555380|NCT01233869|451666988|FG000|Initial Treatment Period (24 Months)|Death|1|||
125555381|NCT01233869|451666989|FG001|Initial Treatment Period (24 Months)|Death|0|||
125555382|NCT01233869|451666990|FG002|Initial Treatment Period (24 Months)|Death|0|||
125555383|NCT01233869|451666991|FG003|Initial Treatment Period (24 Months)|Death|0|||
125555384|NCT01233869|451666988|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
125555385|NCT01233869|451666989|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
125555386|NCT01233869|451666990|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
125555387|NCT01233869|451666991|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
125555388|NCT01233869|451666988|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
125555389|NCT01233869|451666989|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
125555390|NCT01233869|451666990|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
125555391|NCT01233869|451666991|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
125555392|NCT01233869|451666988|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
125555393|NCT01233869|451666989|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
125555394|NCT01233869|451666990|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
125555395|NCT01233869|451666991|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
125555396|NCT01233869|451666988|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
125555397|NCT01233869|451666989|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
125555398|NCT01233869|451666990|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
125555399|NCT01233869|451666991|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
125555400|NCT01233869|451666988|FG000|Extended Treatment Period (46 Months)|Other|3|||
125555401|NCT01233869|451666989|FG001|Extended Treatment Period (46 Months)|Other|0|||
125555402|NCT01233869|451666990|FG002|Extended Treatment Period (46 Months)|Other|0|||
125555403|NCT01233869|451666991|FG003|Extended Treatment Period (46 Months)|Other|3|||
125555404|NCT01233869|451666988|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
125555405|NCT01233869|451666989|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
125555406|NCT01233869|451666990|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
125555407|NCT01233869|451666991|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
125555408|NCT03678103|451666992|FG000|Overall Study|Withdrawn prior to completion|4|||
125555409|NCT00537485|451666993|FG000|Overall Study|Adverse Event|10|||
125555410|NCT00537485|451666994|FG001|Overall Study|Adverse Event|5|||
125555411|NCT00537485|451666993|FG000|Overall Study|Withdrawal by Subject|3|||
125555412|NCT00537485|451666994|FG001|Overall Study|Withdrawal by Subject|2|||
125555413|NCT00537485|451666993|FG000|Overall Study|Withdrawal by Subject|1|||
125555414|NCT00537485|451666994|FG001|Overall Study|Withdrawal by Subject|3|||
125555415|NCT00537485|451666993|FG000|Overall Study|Physician Decision|1|||
125555416|NCT00537485|451666994|FG001|Overall Study|Physician Decision|0|||
125555417|NCT01241552|451667000|FG000|Overall Study|Lack of Efficacy|1|||
125555418|NCT01241552|451667001|FG001|Overall Study|Lack of Efficacy|0|||
125555419|NCT01241552|451667002|FG002|Overall Study|Lack of Efficacy|0|||
125555420|NCT01241552|451667003|FG003|Overall Study|Lack of Efficacy|0|||
125555421|NCT01241552|451667000|FG000|Overall Study|Death|26|||
125555422|NCT01241552|451667001|FG001|Overall Study|Death|30|||
125555423|NCT01241552|451667002|FG002|Overall Study|Death|20|||
125555424|NCT01241552|451667003|FG003|Overall Study|Death|25|||
125555425|NCT01241552|451667000|FG000|Overall Study|Adverse Event|1|||
125555426|NCT01241552|451667001|FG001|Overall Study|Adverse Event|1|||
125555427|NCT01241552|451667002|FG002|Overall Study|Adverse Event|0|||
125555428|NCT01241552|451667003|FG003|Overall Study|Adverse Event|0|||
125555429|NCT01241552|451667000|FG000|Overall Study|Technical Problems|2|||
125555430|NCT01241552|451667001|FG001|Overall Study|Technical Problems|0|||
125555431|NCT01241552|451667002|FG002|Overall Study|Technical Problems|2|||
125555432|NCT01241552|451667003|FG003|Overall Study|Technical Problems|2|||
125555433|NCT01241552|451667000|FG000|Overall Study|Progressive Disease|0|||
125555434|NCT01241552|451667001|FG001|Overall Study|Progressive Disease|0|||
125555435|NCT01241552|451667002|FG002|Overall Study|Progressive Disease|1|||
125555436|NCT01241552|451667003|FG003|Overall Study|Progressive Disease|2|||
125555437|NCT01241552|451667000|FG000|Overall Study|Protocol Violation|0|||
125555438|NCT01241552|451667001|FG001|Overall Study|Protocol Violation|2|||
125555439|NCT01241552|451667002|FG002|Overall Study|Protocol Violation|6|||
125555440|NCT01241552|451667003|FG003|Overall Study|Protocol Violation|1|||
125555441|NCT01241552|451667000|FG000|Overall Study|Withdrawal by Subject|7|||
125555442|NCT01241552|451667001|FG001|Overall Study|Withdrawal by Subject|15|||
125555443|NCT01241552|451667002|FG002|Overall Study|Withdrawal by Subject|14|||
125555444|NCT01241552|451667003|FG003|Overall Study|Withdrawal by Subject|15|||
125555445|NCT01241552|451667000|FG000|Overall Study|Physician Decision|2|||
125555446|NCT01241552|451667001|FG001|Overall Study|Physician Decision|4|||
125555447|NCT01241552|451667002|FG002|Overall Study|Physician Decision|2|||
125555448|NCT01241552|451667003|FG003|Overall Study|Physician Decision|3|||
125555449|NCT01241552|451667000|FG000|Overall Study|Lost to Follow-up|2|||
125555450|NCT01241552|451667001|FG001|Overall Study|Lost to Follow-up|11|||
125555451|NCT01241552|451667002|FG002|Overall Study|Lost to Follow-up|15|||
125555452|NCT01241552|451667003|FG003|Overall Study|Lost to Follow-up|16|||
125555453|NCT01296035|451667005|FG000|Overall Study|Withdrawal by Subject|1|||
125555454|NCT05696236|451667010|FG000|Overall Study|Lost to Follow-up|1|||
125555455|NCT05696236|451667011|FG001|Overall Study|Lost to Follow-up|0|||
125555456|NCT05696236|451667010|FG000|Overall Study|Later determined to not be eligible for participation|0|||
125555457|NCT05696236|451667011|FG001|Overall Study|Later determined to not be eligible for participation|1|||
125555458|NCT05696236|451667010|FG000|Overall Study|Withdrawal by Subject|2|||
125555459|NCT05696236|451667011|FG001|Overall Study|Withdrawal by Subject|2|||
125555460|NCT01829360|451667014|FG000|Overall Study|Protocol Violation|0|||
125555461|NCT01829360|451667015|FG001|Overall Study|Protocol Violation|0|||
125555462|NCT01829360|451667016|FG002|Overall Study|Protocol Violation|1|||
125555463|NCT01829360|451667017|FG003|Overall Study|Protocol Violation|0|||
125555464|NCT01145495|451667020|FG000|Overall Study|Adverse Event|6|||
125555465|NCT01145495|451667020|FG000|Overall Study|Withdrawal by Subject|6|||
125555466|NCT01145495|451667020|FG000|Overall Study|Disease progression after respone|2|||
125555467|NCT01886313|451667023|FG000|Overall Study|Adverse Event|1|||
125555468|NCT01886313|451667024|FG001|Overall Study|Adverse Event|1|||
125555469|NCT03838198|451667025|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
125555470|NCT03838198|451667026|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
125555471|NCT03838198|451667027|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
125555472|NCT03838198|451667028|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
125555473|NCT03838198|451667025|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
125555474|NCT03838198|451667026|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
125555475|NCT03838198|451667027|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
125555476|NCT03838198|451667028|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
125555477|NCT02378220|451667029|FG000|Overall Study|Death|6|||
125555478|NCT02378220|451667030|FG001|Overall Study|Death|1|||
125555479|NCT00312221|451667031|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
125555480|NCT00312221|451667032|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
125555481|NCT00312221|451667033|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
125555482|NCT00312221|451667034|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
125555483|NCT00312221|451667031|FG000|Open-label Run-in Period|Adverse Event|74|||
125555484|NCT00312221|451667032|FG001|Open-label Run-in Period|Adverse Event|0|||
125555485|NCT00312221|451667033|FG002|Open-label Run-in Period|Adverse Event|0|||
125555486|NCT00312221|451667034|FG003|Open-label Run-in Period|Adverse Event|0|||
125555487|NCT00312221|451667031|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
125555488|NCT00312221|451667032|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
125555489|NCT00312221|451667033|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
125555490|NCT00312221|451667034|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
125555491|NCT00312221|451667031|FG000|Open-label Run-in Period|Administrative|42|||
125555492|NCT00312221|451667032|FG001|Open-label Run-in Period|Administrative|0|||
125555493|NCT00312221|451667033|FG002|Open-label Run-in Period|Administrative|0|||
125555494|NCT00312221|451667034|FG003|Open-label Run-in Period|Administrative|0|||
125555495|NCT00312221|451667031|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
125555496|NCT00312221|451667032|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
125555497|NCT00312221|451667033|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
125555498|NCT00312221|451667034|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
125555499|NCT00312221|451667031|FG000|Open-label Run-in Period|Did not qualify|5|||
125555500|NCT00312221|451667032|FG001|Open-label Run-in Period|Did not qualify|0|||
125555501|NCT00312221|451667033|FG002|Open-label Run-in Period|Did not qualify|0|||
125555502|NCT00312221|451667034|FG003|Open-label Run-in Period|Did not qualify|0|||
125555503|NCT00312221|451667031|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125555504|NCT00312221|451667032|FG001|Double-blind Phase|Withdrawal by Subject|6|||
125555505|NCT00312221|451667033|FG002|Double-blind Phase|Withdrawal by Subject|8|||
125555506|NCT00312221|451667034|FG003|Double-blind Phase|Withdrawal by Subject|7|||
125555507|NCT00312221|451667031|FG000|Double-blind Phase|Adverse Event|0|||
125555508|NCT00312221|451667032|FG001|Double-blind Phase|Adverse Event|10|||
125555509|NCT00312221|451667033|FG002|Double-blind Phase|Adverse Event|19|||
125555510|NCT00312221|451667034|FG003|Double-blind Phase|Adverse Event|18|||
125555511|NCT00312221|451667031|FG000|Double-blind Phase|Lost to Follow-up|0|||
125555512|NCT00312221|451667032|FG001|Double-blind Phase|Lost to Follow-up|0|||
125555513|NCT00312221|451667033|FG002|Double-blind Phase|Lost to Follow-up|2|||
125555514|NCT00312221|451667034|FG003|Double-blind Phase|Lost to Follow-up|2|||
125555515|NCT00312221|451667031|FG000|Double-blind Phase|Administrative|0|||
125555516|NCT00312221|451667032|FG001|Double-blind Phase|Administrative|26|||
125555517|NCT00312221|451667033|FG002|Double-blind Phase|Administrative|37|||
125555518|NCT00312221|451667034|FG003|Double-blind Phase|Administrative|33|||
125555519|NCT00312221|451667031|FG000|Double-blind Phase|Lack of Efficacy|0|||
125555520|NCT00312221|451667032|FG001|Double-blind Phase|Lack of Efficacy|17|||
125352316|NCT03034200|450925933|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
125352317|NCT03034200|450925931|FG000|Overall Study|Adjuvant Therapy|0|||
125352318|NCT03034200|450925932|FG001|Overall Study|Adjuvant Therapy|0|||
125555521|NCT00312221|451667033|FG002|Double-blind Phase|Lack of Efficacy|6|||
125555522|NCT00312221|451667034|FG003|Double-blind Phase|Lack of Efficacy|10|||
125352319|NCT03034200|450925933|FG002|Overall Study|Adjuvant Therapy|1|||
125555523|NCT02060721|451667035|FG000|Overall Study|Lost to Follow-up|1|||
125555524|NCT02060721|451667035|FG000|Overall Study|Physician Decision|2|||
125555525|NCT02060721|451667035|FG000|Overall Study|Death|14|||
125555526|NCT02060721|451667035|FG000|Overall Study|Withdrawal by Subject|2|||
125555527|NCT02060721|451667035|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
125555528|NCT00117507|451667036|FG000|Overall Study|Adverse Event|4|||
125555529|NCT00117507|451667036|FG000|Overall Study|Abnormal laboratory values|3|||
125555530|NCT00117507|451667036|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125555531|NCT00117507|451667036|FG000|Overall Study|Patient withdrew consent|4|||
125555532|NCT00117507|451667036|FG000|Overall Study|Death|3|||
125555533|NCT00866723|451667037|FG000|Overall Study|Withdrawal by Subject|1|||
125555534|NCT00866723|451667037|FG000|Overall Study|Disease Progression|4|||
125555535|NCT01271803|451667038|FG000|Overall Study|Progressive disease|0|||
125555536|NCT01271803|451667039|FG001|Overall Study|Progressive disease|0|||
125555537|NCT01271803|451667040|FG002|Overall Study|Progressive disease|2|||
125555538|NCT01271803|451667038|FG000|Overall Study|Death|53|||
125555539|NCT01271803|451667039|FG001|Overall Study|Death|34|||
125555540|NCT01271803|451667040|FG002|Overall Study|Death|0|||
125555541|NCT01271803|451667038|FG000|Overall Study|Withdrawal by Subject|1|||
125555542|NCT01271803|451667039|FG001|Overall Study|Withdrawal by Subject|5|||
125555543|NCT01271803|451667040|FG002|Overall Study|Withdrawal by Subject|0|||
125555544|NCT01271803|451667038|FG000|Overall Study|Lost to Follow-up|1|||
125555545|NCT01271803|451667039|FG001|Overall Study|Lost to Follow-up|0|||
125555546|NCT01271803|451667040|FG002|Overall Study|Lost to Follow-up|0|||
125555547|NCT05211739|451667044|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
125555548|NCT05211739|451667045|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
125555549|NCT05211739|451667044|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
125555550|NCT05211739|451667045|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
125555551|NCT05211739|451667044|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
125555552|NCT05211739|451667045|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
125555553|NCT05211739|451667044|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
125555554|NCT05211739|451667045|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
125555555|NCT01862640|451667046|FG000|Overall Study|Adverse Event|4|||
125555556|NCT01862640|451667047|FG001|Overall Study|Adverse Event|10|||
125555557|NCT01862640|451667048|FG002|Overall Study|Adverse Event|6|||
125555558|NCT01862640|451667049|FG003|Overall Study|Adverse Event|8|||
125555559|NCT01862640|451667046|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
125555560|NCT01862640|451667047|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
125555561|NCT01862640|451667048|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
125555562|NCT01862640|451667049|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
125555563|NCT01862640|451667046|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
125555564|NCT01862640|451667047|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
125555565|NCT01862640|451667048|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
125555566|NCT01862640|451667049|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
125555567|NCT01862640|451667046|FG000|Overall Study|Withdrawal by Subject|2|||
125555568|NCT01862640|451667047|FG001|Overall Study|Withdrawal by Subject|4|||
125555569|NCT01862640|451667048|FG002|Overall Study|Withdrawal by Subject|8|||
125555570|NCT01862640|451667049|FG003|Overall Study|Withdrawal by Subject|5|||
125555571|NCT01862640|451667046|FG000|Overall Study|Protocol Deviation|0|||
125555572|NCT01862640|451667047|FG001|Overall Study|Protocol Deviation|0|||
125555573|NCT01862640|451667048|FG002|Overall Study|Protocol Deviation|1|||
125555574|NCT01862640|451667049|FG003|Overall Study|Protocol Deviation|0|||
125555575|NCT02178553|451667052|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
125555576|NCT02178553|451667053|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
125555577|NCT02178553|451667052|FG000|Overall Study|Physician Decision|0|||
125555578|NCT02178553|451667053|FG001|Overall Study|Physician Decision|4|||
125555579|NCT02178553|451667052|FG000|Overall Study|Technical problem with injection|1|||
125555580|NCT02178553|451667053|FG001|Overall Study|Technical problem with injection|3|||
125555581|NCT01975428|451667054|FG000|Overall Study|Lost to Follow-up|17|||
125555582|NCT01975428|451667055|FG001|Overall Study|Lost to Follow-up|4|||
125555583|NCT01975428|451667054|FG000|Overall Study|Withdrawal by Subject|3|||
125555584|NCT01975428|451667055|FG001|Overall Study|Withdrawal by Subject|10|||
125555585|NCT02187809|451667056|FG000|Overall Study|The study was terminated|3|||
125555586|NCT05085665|451667057|FG000|Overall Study|Physician Decision|2|||
125555587|NCT01641809|451667058|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
125555588|NCT01641809|451667059|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
125555589|NCT01641809|451667060|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
125555590|NCT01641809|451667061|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
125555591|NCT01641809|451667058|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
125555592|NCT01641809|451667059|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
125555593|NCT01641809|451667060|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
125555594|NCT01641809|451667061|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
125555595|NCT01641809|451667058|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
125555596|NCT01641809|451667059|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
125352320|NCT05523323|450925934|FG000|Overall Study|Death|26|||
125352321|NCT05523323|450925935|FG001|Overall Study|Death|21|||
125555597|NCT01641809|451667060|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
125555598|NCT01641809|451667061|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
125555599|NCT01641809|451667058|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
125352322|NCT05523323|450925934|FG000|Overall Study|Ongoing participants|35|||
125352323|NCT05523323|450925935|FG001|Overall Study|Ongoing participants|30|||
125555600|NCT01641809|451667059|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
125555601|NCT01641809|451667060|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
125352324|NCT03435640|450925936|FG000|Overall Study|Withdrawal by Subject|0|||
125352325|NCT03435640|450925937|FG001|Overall Study|Withdrawal by Subject|1|||
125352326|NCT03435640|450925938|FG002|Overall Study|Withdrawal by Subject|0|||
125352327|NCT03435640|450925939|FG003|Overall Study|Withdrawal by Subject|2|||
125352328|NCT03435640|450925940|FG004|Overall Study|Withdrawal by Subject|0|||
125352329|NCT03435640|450925941|FG005|Overall Study|Withdrawal by Subject|0|||
125352330|NCT03435640|450925942|FG006|Overall Study|Withdrawal by Subject|3|||
125352331|NCT03435640|450925943|FG007|Overall Study|Withdrawal by Subject|0|||
125352332|NCT03435640|450925944|FG008|Overall Study|Withdrawal by Subject|0|||
125352333|NCT03435640|450925945|FG009|Overall Study|Withdrawal by Subject|2|||
125352334|NCT03435640|450925946|FG010|Overall Study|Withdrawal by Subject|3|||
125352335|NCT03435640|450925936|FG000|Overall Study|Lost to Follow-up|0|||
125352336|NCT03435640|450925937|FG001|Overall Study|Lost to Follow-up|0|||
125352337|NCT03435640|450925938|FG002|Overall Study|Lost to Follow-up|1|||
125352338|NCT03435640|450925939|FG003|Overall Study|Lost to Follow-up|0|||
125352339|NCT03435640|450925940|FG004|Overall Study|Lost to Follow-up|0|||
125352340|NCT03435640|450925941|FG005|Overall Study|Lost to Follow-up|0|||
125352341|NCT03435640|450925942|FG006|Overall Study|Lost to Follow-up|0|||
125352342|NCT03435640|450925943|FG007|Overall Study|Lost to Follow-up|0|||
125352343|NCT03435640|450925944|FG008|Overall Study|Lost to Follow-up|0|||
125352344|NCT03435640|450925945|FG009|Overall Study|Lost to Follow-up|0|||
125352345|NCT03435640|450925946|FG010|Overall Study|Lost to Follow-up|0|||
125555602|NCT01641809|451667061|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
125555603|NCT01641809|451667058|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
125555604|NCT01641809|451667059|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
125555605|NCT01641809|451667060|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
125555606|NCT01641809|451667061|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
125352346|NCT00920829|450925954|FG000|Allocation|No post randomization data|3|||
125352347|NCT00920829|450925955|FG001|Allocation|No post randomization data|1|||
125555607|NCT01641809|451667058|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
125555608|NCT01641809|451667059|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
125352348|NCT00920829|450925956|FG002|Allocation|No post randomization data|0|||
125352349|NCT00920829|450925957|FG003|Allocation|No post randomization data|2|||
125352350|NCT00920829|450925954|FG000|Available for Analysis|Withdrawal by Subject|6|||
125352351|NCT00920829|450925955|FG001|Available for Analysis|Withdrawal by Subject|6|||
125352352|NCT00920829|450925956|FG002|Available for Analysis|Withdrawal by Subject|6|||
125352353|NCT00920829|450925957|FG003|Available for Analysis|Withdrawal by Subject|10|||
125425965|NCT02618967|451182407|FG001|Overall Study|Withdrawal by Subject|0|||
125555609|NCT01641809|451667060|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
125555610|NCT01641809|451667061|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
125555611|NCT01641809|451667058|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
125555612|NCT01641809|451667059|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
125555613|NCT01641809|451667060|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
125555614|NCT01641809|451667061|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
125555615|NCT01641809|451667058|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
125555616|NCT01641809|451667059|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
125555617|NCT01641809|451667060|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
125555618|NCT01641809|451667061|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
125555619|NCT01641809|451667058|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
125555620|NCT01641809|451667059|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
125555621|NCT01641809|451667060|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
125555622|NCT01641809|451667061|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
125555623|NCT01641809|451667058|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
125352354|NCT00920829|450925954|FG000|Available for Analysis|Required Medical Treatment|0|||
125425966|NCT02618967|451182408|FG002|Overall Study|Withdrawal by Subject|0|||
125425967|NCT02618967|451182409|FG003|Overall Study|Withdrawal by Subject|0|||
125352355|NCT00920829|450925955|FG001|Available for Analysis|Required Medical Treatment|1|||
125352356|NCT00920829|450925956|FG002|Available for Analysis|Required Medical Treatment|2|||
125352357|NCT00920829|450925957|FG003|Available for Analysis|Required Medical Treatment|0|||
125352358|NCT00920829|450925954|FG000|Available for Analysis|Adverse Event|1|||
125352359|NCT00920829|450925955|FG001|Available for Analysis|Adverse Event|2|||
125352360|NCT00920829|450925956|FG002|Available for Analysis|Adverse Event|1|||
125352361|NCT00920829|450925957|FG003|Available for Analysis|Adverse Event|0|||
125555624|NCT01641809|451667059|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
125555625|NCT01641809|451667060|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
125555626|NCT01641809|451667061|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
125555627|NCT01641809|451667058|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
125555628|NCT01641809|451667059|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
125555629|NCT01641809|451667060|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
125555630|NCT01641809|451667061|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
125555631|NCT01641809|451667058|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
125555632|NCT01641809|451667059|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
125352362|NCT00920829|450925954|FG000|Available for Analysis|Death|1|||
125352363|NCT00920829|450925955|FG001|Available for Analysis|Death|0|||
125352364|NCT00920829|450925956|FG002|Available for Analysis|Death|0|||
125352365|NCT00920829|450925957|FG003|Available for Analysis|Death|0|||
125352366|NCT00920829|450925954|FG000|Available for Analysis|Protocol Violation|0|||
125352367|NCT00920829|450925955|FG001|Available for Analysis|Protocol Violation|0|||
125352368|NCT00920829|450925956|FG002|Available for Analysis|Protocol Violation|1|||
125555633|NCT01641809|451667060|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
125555634|NCT01641809|451667061|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
125555635|NCT01641809|451667058|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
125555636|NCT01641809|451667059|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
125555637|NCT01641809|451667060|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
125555638|NCT01641809|451667061|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
125555639|NCT01641809|451667058|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
125555640|NCT01641809|451667059|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
125555641|NCT01641809|451667060|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
125555642|NCT01641809|451667061|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
125555643|NCT01641809|451667058|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
125555644|NCT01641809|451667059|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
125555645|NCT01641809|451667060|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
125555646|NCT01641809|451667061|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
125555647|NCT01641809|451667058|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
125555648|NCT01641809|451667059|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
125555649|NCT01641809|451667060|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
125352369|NCT00920829|450925957|FG003|Available for Analysis|Protocol Violation|0|||
125352370|NCT00920829|450925954|FG000|Available for Analysis|Required more treatment|0|||
125352371|NCT00920829|450925955|FG001|Available for Analysis|Required more treatment|2|||
125352372|NCT00920829|450925956|FG002|Available for Analysis|Required more treatment|0|||
125352373|NCT00920829|450925957|FG003|Available for Analysis|Required more treatment|1|||
125352374|NCT04533880|450925958|FG000|Overall Study|Lost to Follow-up|0|||
125555650|NCT01641809|451667061|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
125555651|NCT01641809|451667058|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
125555652|NCT01641809|451667059|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
125555653|NCT01641809|451667060|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
125555654|NCT01641809|451667061|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
125555655|NCT01641809|451667058|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
125555656|NCT01641809|451667059|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
125352375|NCT04533880|450925959|FG001|Overall Study|Lost to Follow-up|1|||
125352376|NCT04533880|450925960|FG002|Overall Study|Lost to Follow-up|1|||
125352377|NCT01711879|450925965|FG000|Overall Study|Death|1|||
125352378|NCT01711879|450925966|FG001|Overall Study|Death|0|||
125352379|NCT02239224|450925971|FG000|Overall Study|Administrative|0|||
125352380|NCT02239224|450925972|FG001|Overall Study|Administrative|0|||
125352381|NCT02239224|450925973|FG002|Overall Study|Administrative|3|||
125352382|NCT02239224|450925974|FG003|Overall Study|Administrative|1|||
125352383|NCT03183778|450925975|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
125555657|NCT01641809|451667060|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
125555658|NCT01641809|451667061|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
125555659|NCT03690141|451667062|FG000|Overall Study|Adverse Event|5|||
125555660|NCT03690141|451667062|FG000|Overall Study|Withdrawal by Subject|3|||
125555661|NCT03690141|451667062|FG000|Overall Study|Physician Decision|4|||
125555662|NCT03690141|451667062|FG000|Overall Study|Disease progression|4|||
125555663|NCT02558231|451667064|FG000|Overall Study|Death|4|||
125555664|NCT02558231|451667065|FG001|Overall Study|Death|12|||
125555665|NCT02558231|451667064|FG000|Overall Study|Lost to Follow-up|7|||
125555666|NCT02558231|451667065|FG001|Overall Study|Lost to Follow-up|4|||
125555667|NCT02558231|451667064|FG000|Overall Study|Withdrawal by Subject|7|||
125555668|NCT02558231|451667065|FG001|Overall Study|Withdrawal by Subject|4|||
125555669|NCT02558231|451667064|FG000|Overall Study|Physician Decision|7|||
125555670|NCT02558231|451667065|FG001|Overall Study|Physician Decision|5|||
125555671|NCT02558231|451667064|FG000|Overall Study|Sponsor Decision|0|||
125555672|NCT02558231|451667065|FG001|Overall Study|Sponsor Decision|1|||
125555673|NCT03065023|451667067|FG000|Overall Study|Progressive Disease|0|||
125555674|NCT03065023|451667068|FG001|Overall Study|Progressive Disease|1|||
125555675|NCT03065023|451667069|FG002|Overall Study|Progressive Disease|0|||
125555676|NCT03065023|451667070|FG003|Overall Study|Progressive Disease|0|||
125555677|NCT03065023|451667071|FG004|Overall Study|Progressive Disease|0|||
125555678|NCT03065023|451667067|FG000|Overall Study|Death|2|||
125555679|NCT03065023|451667068|FG001|Overall Study|Death|0|||
125555680|NCT03065023|451667069|FG002|Overall Study|Death|1|||
125555681|NCT03065023|451667070|FG003|Overall Study|Death|1|||
125555682|NCT03065023|451667071|FG004|Overall Study|Death|0|||
125555683|NCT03065023|451667067|FG000|Overall Study|Lost to Follow-up|0|||
125555684|NCT03065023|451667068|FG001|Overall Study|Lost to Follow-up|1|||
125555685|NCT03065023|451667069|FG002|Overall Study|Lost to Follow-up|0|||
125555686|NCT03065023|451667070|FG003|Overall Study|Lost to Follow-up|0|||
125555687|NCT03065023|451667071|FG004|Overall Study|Lost to Follow-up|0|||
125555688|NCT03065023|451667067|FG000|Overall Study|Participant Decision|0|||
125555689|NCT03065023|451667068|FG001|Overall Study|Participant Decision|0|||
125555690|NCT03065023|451667069|FG002|Overall Study|Participant Decision|0|||
125555691|NCT03065023|451667070|FG003|Overall Study|Participant Decision|1|||
125555692|NCT03065023|451667071|FG004|Overall Study|Participant Decision|0|||
125555693|NCT03065023|451667067|FG000|Overall Study|Withdrawal by Subject|0|||
125555694|NCT03065023|451667068|FG001|Overall Study|Withdrawal by Subject|0|||
125555695|NCT03065023|451667069|FG002|Overall Study|Withdrawal by Subject|0|||
125555696|NCT03065023|451667070|FG003|Overall Study|Withdrawal by Subject|1|||
125555697|NCT03065023|451667071|FG004|Overall Study|Withdrawal by Subject|0|||
125555698|NCT04029961|451667072|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
125352384|NCT01466179|450925977|FG000|Overall Study|Ongoing in core study|2|||
125352385|NCT01466179|450925977|FG000|Overall Study|Physician Decision|46|||
125352386|NCT01466179|450925977|FG000|Overall Study|Progressive disease|43|||
125352387|NCT01466179|450925977|FG000|Overall Study|Adverse Event|32|||
125352388|NCT01466179|450925977|FG000|Overall Study|Disease relapse|23|||
125352389|NCT01466179|450925977|FG000|Overall Study|Lack of Efficacy|14|||
125352390|NCT01466179|450925977|FG000|Overall Study|Death|7|||
125555699|NCT04029961|451667073|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
125555700|NCT04029961|451667072|FG000|Overall Study|Change in Treatment Course|0|||
125555701|NCT04029961|451667073|FG001|Overall Study|Change in Treatment Course|1|||
125555702|NCT03427125|451667074|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
125555703|NCT03427125|451667075|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
125555704|NCT03427125|451667076|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
125555705|NCT05975840|451667077|FG000|Overall Study|Other|1|||
125555706|NCT05975840|451667078|FG001|Overall Study|Other|0|||
125555707|NCT05975840|451667079|FG002|Overall Study|Other|0|||
125555708|NCT05975840|451667080|FG003|Overall Study|Other|0|||
125352391|NCT01466179|450925977|FG000|Overall Study|Withdrawal by Subject|7|||
125352392|NCT01466179|450925977|FG000|Overall Study|Protocol Violation|2|||
125352393|NCT01466179|450925977|FG000|Overall Study|Other|3|||
125352394|NCT00749580|450925978|FG000|Overall Study|Lost to Follow-up|4|||
125352395|NCT00749580|450925979|FG001|Overall Study|Lost to Follow-up|8|||
125555709|NCT05975840|451667081|FG004|Overall Study|Other|1|||
125352396|NCT00749580|450925978|FG000|Overall Study|Adverse Event|0|||
125555710|NCT05975840|451667082|FG005|Overall Study|Other|0|||
125555711|NCT05975840|451667083|FG006|Overall Study|Other|0|||
125555712|NCT05975840|451667084|FG007|Overall Study|Other|0|||
125555713|NCT05975840|451667077|FG000|Overall Study|Lost to Follow-up|3|||
125555714|NCT05975840|451667078|FG001|Overall Study|Lost to Follow-up|6|||
125555715|NCT05975840|451667079|FG002|Overall Study|Lost to Follow-up|3|||
125555716|NCT05975840|451667080|FG003|Overall Study|Lost to Follow-up|1|||
125555717|NCT05975840|451667081|FG004|Overall Study|Lost to Follow-up|4|||
125555718|NCT05975840|451667082|FG005|Overall Study|Lost to Follow-up|1|||
125555719|NCT05975840|451667083|FG006|Overall Study|Lost to Follow-up|2|||
125555720|NCT05975840|451667084|FG007|Overall Study|Lost to Follow-up|4|||
125555721|NCT05975840|451667077|FG000|Overall Study|Migrated/moved from the study area|1|||
125555722|NCT05975840|451667078|FG001|Overall Study|Migrated/moved from the study area|0|||
125555723|NCT05975840|451667079|FG002|Overall Study|Migrated/moved from the study area|0|||
125555724|NCT05975840|451667080|FG003|Overall Study|Migrated/moved from the study area|0|||
125555725|NCT05975840|451667081|FG004|Overall Study|Migrated/moved from the study area|0|||
125555726|NCT05975840|451667082|FG005|Overall Study|Migrated/moved from the study area|0|||
125555727|NCT05975840|451667083|FG006|Overall Study|Migrated/moved from the study area|0|||
125555728|NCT05975840|451667084|FG007|Overall Study|Migrated/moved from the study area|0|||
125555729|NCT05975840|451667077|FG000|Overall Study|Withdrawal by Subject|0|||
125555730|NCT05975840|451667078|FG001|Overall Study|Withdrawal by Subject|5|||
125555731|NCT05975840|451667079|FG002|Overall Study|Withdrawal by Subject|2|||
125555732|NCT05975840|451667080|FG003|Overall Study|Withdrawal by Subject|2|||
125555733|NCT05975840|451667081|FG004|Overall Study|Withdrawal by Subject|0|||
125555734|NCT05975840|451667082|FG005|Overall Study|Withdrawal by Subject|2|||
125555735|NCT05975840|451667083|FG006|Overall Study|Withdrawal by Subject|2|||
125555736|NCT05975840|451667084|FG007|Overall Study|Withdrawal by Subject|1|||
125555737|NCT05975840|451667077|FG000|Overall Study|Protocol Violation|0|||
125555738|NCT05975840|451667078|FG001|Overall Study|Protocol Violation|1|||
125555739|NCT05975840|451667079|FG002|Overall Study|Protocol Violation|0|||
125555740|NCT05975840|451667080|FG003|Overall Study|Protocol Violation|0|||
125555741|NCT05975840|451667081|FG004|Overall Study|Protocol Violation|0|||
125555742|NCT05975840|451667082|FG005|Overall Study|Protocol Violation|0|||
125555743|NCT05975840|451667083|FG006|Overall Study|Protocol Violation|0|||
125555744|NCT05975840|451667084|FG007|Overall Study|Protocol Violation|0|||
125555745|NCT05975840|451667077|FG000|Overall Study|Adverse Event|0|||
125555746|NCT05975840|451667078|FG001|Overall Study|Adverse Event|0|||
125555747|NCT05975840|451667079|FG002|Overall Study|Adverse Event|0|||
125555748|NCT05975840|451667080|FG003|Overall Study|Adverse Event|1|||
125555749|NCT05975840|451667081|FG004|Overall Study|Adverse Event|0|||
125555750|NCT05975840|451667082|FG005|Overall Study|Adverse Event|0|||
125555751|NCT05975840|451667083|FG006|Overall Study|Adverse Event|0|||
125555752|NCT05975840|451667084|FG007|Overall Study|Adverse Event|0|||
125555753|NCT05975840|451667077|FG000|Overall Study|Death|0|||
125555754|NCT05975840|451667078|FG001|Overall Study|Death|1|||
125555755|NCT05975840|451667079|FG002|Overall Study|Death|0|||
125555756|NCT05975840|451667080|FG003|Overall Study|Death|0|||
125555757|NCT05975840|451667081|FG004|Overall Study|Death|0|||
125555758|NCT05975840|451667082|FG005|Overall Study|Death|0|||
125555759|NCT05975840|451667083|FG006|Overall Study|Death|0|||
125555760|NCT05975840|451667084|FG007|Overall Study|Death|1|||
125555761|NCT02877927|451667087|FG000|Overall Study|Adverse Event|1|||
125425968|NCT02618967|451182410|FG004|Overall Study|Withdrawal by Subject|0|||
125425969|NCT02618967|451182411|FG005|Overall Study|Withdrawal by Subject|0|||
125425970|NCT02618967|451182412|FG006|Overall Study|Withdrawal by Subject|0|||
125425971|NCT02618967|451182413|FG007|Overall Study|Withdrawal by Subject|0|||
125425972|NCT01368965|451182414|FG000|Overall Study|Lost to Follow-up|12|||
125425973|NCT00553696|451182417|FG000|Overall Study|Adverse Event|2|||
125425974|NCT00553696|451182418|FG001|Overall Study|Adverse Event|4|||
125555762|NCT02877927|451667088|FG001|Overall Study|Adverse Event|0|||
125555763|NCT02877927|451667087|FG000|Overall Study|Lost to Follow-up|37|||
125555764|NCT02877927|451667088|FG001|Overall Study|Lost to Follow-up|38|||
125425975|NCT00553696|451182419|FG002|Overall Study|Adverse Event|0|||
125555765|NCT02877927|451667087|FG000|Overall Study|Withdrawal by Subject|11|||
125555766|NCT02877927|451667088|FG001|Overall Study|Withdrawal by Subject|12|||
125555767|NCT02877927|451667087|FG000|Overall Study|Physician Decision|0|||
125555768|NCT02877927|451667088|FG001|Overall Study|Physician Decision|1|||
125555769|NCT02877927|451667087|FG000|Overall Study|Missed EOT/PTE Visit|5|||
125555770|NCT02877927|451667088|FG001|Overall Study|Missed EOT/PTE Visit|6|||
125555771|NCT00708175|451667089|FG000|Overall Study|Adverse Event|4|||
125555772|NCT00708175|451667090|FG001|Overall Study|Adverse Event|5|||
125555773|NCT00708175|451667089|FG000|Overall Study|Protocol Violation|2|||
125555774|NCT00708175|451667090|FG001|Overall Study|Protocol Violation|3|||
125555775|NCT00708175|451667089|FG000|Overall Study|Lost to Follow-up|5|||
125555776|NCT00708175|451667090|FG001|Overall Study|Lost to Follow-up|3|||
125555777|NCT00708175|451667089|FG000|Overall Study|Withdrawal by Subject|5|||
125555778|NCT00708175|451667090|FG001|Overall Study|Withdrawal by Subject|7|||
125555779|NCT00708175|451667089|FG000|Overall Study|BMD loss >7%|2|||
125555780|NCT00708175|451667090|FG001|Overall Study|BMD loss >7%|3|||
125555781|NCT04435782|451667094|FG000|Overall Study|Study terminated by sponsor|4|||
125555782|NCT03672461|451667095|FG000|Overall Study|COVID Related|4|||
125555783|NCT03672461|451667096|FG001|Overall Study|COVID Related|2|||
125555784|NCT03672461|451667095|FG000|Overall Study|Adverse Event|2|||
125555785|NCT03672461|451667096|FG001|Overall Study|Adverse Event|0|||
125555786|NCT03672461|451667095|FG000|Overall Study|Serious Adverse Event|0|||
125555787|NCT03672461|451667096|FG001|Overall Study|Serious Adverse Event|1|||
125555788|NCT03672461|451667095|FG000|Overall Study|Too Busy|3|||
125555789|NCT03672461|451667096|FG001|Overall Study|Too Busy|1|||
125555790|NCT03672461|451667095|FG000|Overall Study|Lost to Follow-up|1|||
125555791|NCT03672461|451667096|FG001|Overall Study|Lost to Follow-up|2|||
125555792|NCT03672461|451667095|FG000|Overall Study|Family|2|||
125555793|NCT03672461|451667096|FG001|Overall Study|Family|2|||
125555794|NCT03672461|451667095|FG000|Overall Study|No remote technology access|0|||
125555795|NCT03672461|451667096|FG001|Overall Study|No remote technology access|1|||
125555796|NCT03672461|451667095|FG000|Overall Study|Withdrawal by Subject|1|||
125555797|NCT03672461|451667096|FG001|Overall Study|Withdrawal by Subject|0|||
125555798|NCT03672461|451667095|FG000|Overall Study|Cannot tolerate intervention|1|||
125555799|NCT03672461|451667096|FG001|Overall Study|Cannot tolerate intervention|0|||
125555800|NCT03672461|451667095|FG000|Overall Study|Incomplete outcome data|6|||
125555801|NCT03672461|451667096|FG001|Overall Study|Incomplete outcome data|1|||
125555802|NCT01444651|451668603|FG000|Overall Study|Adverse Event|3|||
125555803|NCT01444651|451668604|FG001|Overall Study|Adverse Event|2|||
125555804|NCT01444651|451668603|FG000|Overall Study|Lost to Follow-up|5|||
125555805|NCT01444651|451668604|FG001|Overall Study|Lost to Follow-up|5|||
125555806|NCT01444651|451668603|FG000|Overall Study|Non-fasting|2|||
125555807|NCT01444651|451668604|FG001|Overall Study|Non-fasting|1|||
125555808|NCT01444651|451668603|FG000|Overall Study|Missing data|1|||
125555809|NCT01444651|451668604|FG001|Overall Study|Missing data|1|||
125555810|NCT03383289|451668607|FG000|Overall Study|Death|83|||
125555811|NCT03383289|451668608|FG001|Overall Study|Death|78|||
125555812|NCT03383289|451668607|FG000|Overall Study|discharge from facility|84|||
125555813|NCT03383289|451668608|FG001|Overall Study|discharge from facility|84|||
125555814|NCT03383289|451668607|FG000|Overall Study|Withdrawal by Subject|4|||
125555815|NCT03383289|451668608|FG001|Overall Study|Withdrawal by Subject|1|||
125555816|NCT00832117|451668609|FG000|Overall Study|Death|1|||
125555817|NCT00832117|451668609|FG000|Overall Study|Disease Progression|11|||
125555818|NCT00404066|451668610|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
125555819|NCT00404066|451668610|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
125555820|NCT01524133|451668613|FG000|Treatment Phase|Withdrawal by Subject|13|||
125555821|NCT01524133|451668614|FG001|Treatment Phase|Withdrawal by Subject|28|||
125555822|NCT01524133|451668615|FG002|Treatment Phase|Withdrawal by Subject|31|||
125555823|NCT01524133|451668613|FG000|Treatment Phase|Physician Decision|6|||
125555824|NCT01524133|451668614|FG001|Treatment Phase|Physician Decision|3|||
125555825|NCT01524133|451668615|FG002|Treatment Phase|Physician Decision|3|||
125555826|NCT01524133|451668613|FG000|Treatment Phase|Lost to Follow-up|0|||
125555827|NCT01524133|451668614|FG001|Treatment Phase|Lost to Follow-up|1|||
125555828|NCT01524133|451668615|FG002|Treatment Phase|Lost to Follow-up|2|||
125555829|NCT01524133|451668613|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
125555830|NCT01524133|451668614|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
125555831|NCT01524133|451668615|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
125555832|NCT01524133|451668613|FG000|Overall Study 52 Weeks|Physician Decision|1|||
125555833|NCT01524133|451668614|FG001|Overall Study 52 Weeks|Physician Decision|0|||
125555834|NCT01524133|451668615|FG002|Overall Study 52 Weeks|Physician Decision|2|||
125555835|NCT01524133|451668613|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
125555836|NCT01524133|451668614|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
125555837|NCT01524133|451668615|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
125555838|NCT03842163|451668620|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
125555839|NCT03842163|451668620|FG000|Overall Study|Scintigraphy was not performed|44|||
125555840|NCT03829241|451668621|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
125555841|NCT03829241|451668622|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
125555842|NCT03829241|451668621|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
125555843|NCT03829241|451668622|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
125555844|NCT03829241|451668621|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
125555845|NCT03829241|451668622|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
125555846|NCT03829241|451668621|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
125555847|NCT03829241|451668622|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
125555848|NCT03829241|451668621|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
125555849|NCT03829241|451668622|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
125555850|NCT03829241|451668621|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
125555851|NCT03829241|451668622|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
125555852|NCT03829241|451668621|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
125555853|NCT03829241|451668622|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
125555854|NCT03829241|451668621|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
125555855|NCT03829241|451668622|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
125555856|NCT03829241|451668621|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
125555857|NCT03829241|451668622|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
125555858|NCT03829241|451668621|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
125555859|NCT03829241|451668622|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
125555860|NCT03829241|451668621|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
125555861|NCT03829241|451668622|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
125555862|NCT03829241|451668621|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
125555863|NCT03829241|451668622|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
125555864|NCT03829241|451668621|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
125555865|NCT03829241|451668622|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
125555866|NCT03829241|451668621|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
125555867|NCT03829241|451668622|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
125555868|NCT00698451|451668623|FG000|Overall Study|Adverse Event|22|||
125555869|NCT00698451|451668623|FG000|Overall Study|Physician Decision|2|||
125555870|NCT00698451|451668623|FG000|Overall Study|Protocol Violation|6|||
125555871|NCT00698451|451668623|FG000|Overall Study|Withdrawal by Subject|6|||
125555872|NCT00698451|451668623|FG000|Overall Study|Disease progression|3|||
125555873|NCT02224599|451668624|FG000|Overall Study|Physician Decision|1|||
125555874|NCT02224599|451668624|FG000|Overall Study|Progression of Disease|1|||
125555875|NCT01187550|451668625|FG000|Overall Study|Protocol Violation|3|||
125555876|NCT01187550|451668626|FG001|Overall Study|Protocol Violation|1|||
125555877|NCT01187550|451668625|FG000|Overall Study|Other|3|||
125555878|NCT01187550|451668626|FG001|Overall Study|Other|0|||
125555879|NCT01187550|451668625|FG000|Overall Study|Randomized but not treated|8|||
125555880|NCT01187550|451668626|FG001|Overall Study|Randomized but not treated|0|||
125555881|NCT00733304|451668627|FG000|Overall Study|Adverse Event|3|||
125555882|NCT00733304|451668628|FG001|Overall Study|Adverse Event|0|||
125555883|NCT00733304|451668629|FG002|Overall Study|Adverse Event|0|||
125555884|NCT00733304|451668627|FG000|Overall Study|Lack of Efficacy|0|||
125555885|NCT00733304|451668628|FG001|Overall Study|Lack of Efficacy|0|||
125555886|NCT00733304|451668629|FG002|Overall Study|Lack of Efficacy|2|||
125555887|NCT00733304|451668627|FG000|Overall Study|Lost to Follow-up|0|||
125555888|NCT00733304|451668628|FG001|Overall Study|Lost to Follow-up|1|||
125555889|NCT00733304|451668629|FG002|Overall Study|Lost to Follow-up|0|||
125555890|NCT00733304|451668627|FG000|Overall Study|Physician Decision|3|||
125555891|NCT00733304|451668628|FG001|Overall Study|Physician Decision|1|||
125555892|NCT00733304|451668629|FG002|Overall Study|Physician Decision|3|||
125555893|NCT00733304|451668627|FG000|Overall Study|Withdrawal by Subject|1|||
125555894|NCT00733304|451668628|FG001|Overall Study|Withdrawal by Subject|1|||
125555895|NCT00733304|451668629|FG002|Overall Study|Withdrawal by Subject|0|||
125555896|NCT02616614|451668639|FG000|Overall Study|Withdrawal by Subject|10|||
125555897|NCT02616614|451668640|FG001|Overall Study|Withdrawal by Subject|5|||
125555898|NCT02616614|451668641|FG002|Overall Study|Withdrawal by Subject|6|||
125555899|NCT02616614|451668639|FG000|Overall Study|Physician Decision|2|||
125555900|NCT02616614|451668640|FG001|Overall Study|Physician Decision|1|||
125555901|NCT02616614|451668641|FG002|Overall Study|Physician Decision|0|||
125555902|NCT02616614|451668639|FG000|Overall Study|Adverse Event|1|||
125555903|NCT02616614|451668640|FG001|Overall Study|Adverse Event|4|||
125555904|NCT02616614|451668641|FG002|Overall Study|Adverse Event|1|||
125555905|NCT02616614|451668639|FG000|Overall Study|Protocol Violation|0|||
125555906|NCT02616614|451668640|FG001|Overall Study|Protocol Violation|3|||
125555907|NCT02616614|451668641|FG002|Overall Study|Protocol Violation|1|||
125555908|NCT02616614|451668639|FG000|Overall Study|Prohibited Medication|12|||
125555909|NCT02616614|451668640|FG001|Overall Study|Prohibited Medication|9|||
125555910|NCT02616614|451668641|FG002|Overall Study|Prohibited Medication|5|||
125555911|NCT02616614|451668639|FG000|Overall Study|More than 3 applications missed|6|||
125555912|NCT02616614|451668640|FG001|Overall Study|More than 3 applications missed|8|||
125555913|NCT02616614|451668641|FG002|Overall Study|More than 3 applications missed|1|||
125352397|NCT00749580|450925979|FG001|Overall Study|Adverse Event|1|||
125352398|NCT03868124|450925983|FG000|Overall Study|Withdrawal by Subject|4|||
125352399|NCT03868124|450925984|FG001|Overall Study|Withdrawal by Subject|0|||
125555914|NCT02616614|451668639|FG000|Overall Study|Lost to Follow-up|31|||
125555915|NCT02616614|451668640|FG001|Overall Study|Lost to Follow-up|28|||
125555916|NCT02616614|451668641|FG002|Overall Study|Lost to Follow-up|13|||
125555917|NCT02616614|451668639|FG000|Overall Study|Pregnancy|2|||
125555918|NCT02616614|451668640|FG001|Overall Study|Pregnancy|0|||
125555919|NCT02616614|451668641|FG002|Overall Study|Pregnancy|1|||
125555920|NCT02616614|451668639|FG000|Overall Study|Other|1|||
125555921|NCT02616614|451668640|FG001|Overall Study|Other|2|||
125555922|NCT02616614|451668641|FG002|Overall Study|Other|1|||
125555923|NCT00596934|451668642|FG000|Overall Study|Protocol Violation|1|||
125555924|NCT00596934|451668642|FG000|Overall Study|Withdrawal by Subject|1|||
125555925|NCT02445755|451668643|FG000|Overall Study|Withdrawal by Subject|2|||
125555926|NCT02445755|451668643|FG000|Overall Study|Protocol Violation|6|||
125555927|NCT02445755|451668643|FG000|Overall Study|Screen Failure|5|||
125555928|NCT03239483|451668644|FG000|Overall Study|Lost to Follow-up|1|||
125555929|NCT03239483|451668645|FG001|Overall Study|Lost to Follow-up|0|||
125555930|NCT03239483|451668644|FG000|Overall Study|Withdrawal by Subject|1|||
125555931|NCT03239483|451668645|FG001|Overall Study|Withdrawal by Subject|0|||
125555932|NCT00728481|451668646|FG000|Overall Study|Withdrawal by Subject|0|||
125555933|NCT00728481|451668647|FG001|Overall Study|Withdrawal by Subject|1|||
125555934|NCT00728481|451668646|FG000|Overall Study|Adverse Event|0|||
125555935|NCT00728481|451668647|FG001|Overall Study|Adverse Event|1|||
125555936|NCT00728481|451668646|FG000|Overall Study|Study medication non-compliance|0|||
125555937|NCT00728481|451668647|FG001|Overall Study|Study medication non-compliance|2|||
125555938|NCT00728481|451668646|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
125555939|NCT00728481|451668647|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
125352400|NCT03868124|450925985|FG002|Overall Study|Withdrawal by Subject|1|||
125352401|NCT03868124|450925983|FG000|Overall Study|Physician Decision|1|||
125555944|NCT00778622|451668652|FG000|Overall Study|Adverse Event|5|||
125555945|NCT00778622|451668653|FG001|Overall Study|Adverse Event|4|||
125555946|NCT00778622|451668654|FG002|Overall Study|Adverse Event|7|||
125555947|NCT00778622|451668652|FG000|Overall Study|Withdrawal by Subject|4|||
125555948|NCT00778622|451668653|FG001|Overall Study|Withdrawal by Subject|5|||
125555949|NCT00778622|451668654|FG002|Overall Study|Withdrawal by Subject|5|||
125555950|NCT00778622|451668652|FG000|Overall Study|Lost to Follow-up|3|||
125555951|NCT00778622|451668653|FG001|Overall Study|Lost to Follow-up|3|||
125555952|NCT00778622|451668654|FG002|Overall Study|Lost to Follow-up|2|||
125555953|NCT00778622|451668652|FG000|Overall Study|Protocol Violation|0|||
125555954|NCT00778622|451668653|FG001|Overall Study|Protocol Violation|3|||
125555955|NCT00778622|451668654|FG002|Overall Study|Protocol Violation|0|||
125555956|NCT00778622|451668652|FG000|Overall Study|Lack of Efficacy|2|||
125555957|NCT00778622|451668653|FG001|Overall Study|Lack of Efficacy|0|||
125555958|NCT00778622|451668654|FG002|Overall Study|Lack of Efficacy|0|||
125555959|NCT00778622|451668652|FG000|Overall Study|immigration|1|||
125555960|NCT00778622|451668653|FG001|Overall Study|immigration|0|||
125555961|NCT00778622|451668654|FG002|Overall Study|immigration|0|||
125555962|NCT00778622|451668652|FG000|Overall Study|Other|1|||
125555963|NCT00778622|451668653|FG001|Overall Study|Other|0|||
125555964|NCT00778622|451668654|FG002|Overall Study|Other|1|||
125555965|NCT01505010|451668655|FG000|Overall Study|Protocol Violation|0|||
125555966|NCT01505010|451668656|FG001|Overall Study|Protocol Violation|1|||
125555967|NCT01505010|451668655|FG000|Overall Study|Lost to Follow-up|0|||
125555968|NCT01505010|451668656|FG001|Overall Study|Lost to Follow-up|1|||
125555969|NCT01251120|451668660|FG000|Overall Study|Lack of Efficacy|0|||
125555970|NCT01251120|451668661|FG001|Overall Study|Lack of Efficacy|1|||
125555971|NCT01807923|451668666|FG000|Overall Study|Adverse Event|2|||
125555972|NCT01807923|451668667|FG001|Overall Study|Adverse Event|1|||
125555973|NCT01807923|451668668|FG002|Overall Study|Adverse Event|2|||
125555974|NCT01807923|451668666|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
125555975|NCT01807923|451668667|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
125555976|NCT01807923|451668668|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
125555977|NCT01807923|451668666|FG000|Overall Study|Physician Decision|0|||
125555978|NCT01807923|451668667|FG001|Overall Study|Physician Decision|0|||
125555979|NCT01807923|451668668|FG002|Overall Study|Physician Decision|1|||
125555980|NCT01807923|451668666|FG000|Overall Study|Not Eligible (Genotype)|0|||
125555981|NCT01807923|451668667|FG001|Overall Study|Not Eligible (Genotype)|0|||
125555982|NCT01807923|451668668|FG002|Overall Study|Not Eligible (Genotype)|1|||
125555983|NCT01807923|451668666|FG000|Overall Study|Randomized But Not Treated|3|||
125555984|NCT01807923|451668667|FG001|Overall Study|Randomized But Not Treated|2|||
125555985|NCT01807923|451668668|FG002|Overall Study|Randomized But Not Treated|5|||
125555986|NCT00108069|451668669|FG000|Overall Study|Never rec'd study drug|0|||
125555987|NCT00108069|451668670|FG001|Overall Study|Never rec'd study drug|1|||
125555988|NCT00108069|451668669|FG000|Overall Study|Adverse Event|1|||
125555989|NCT00108069|451668670|FG001|Overall Study|Adverse Event|1|||
125555990|NCT00108069|451668669|FG000|Overall Study|Withdrawal by Subject|1|||
125555991|NCT00108069|451668670|FG001|Overall Study|Withdrawal by Subject|0|||
125555992|NCT00108069|451668669|FG000|Overall Study|Death|1|||
125555993|NCT00108069|451668670|FG001|Overall Study|Death|0|||
125555994|NCT00108069|451668669|FG000|Overall Study|Progessive disease|27|||
125555995|NCT00108069|451668670|FG001|Overall Study|Progessive disease|11|||
125555996|NCT01910116|451668672|FG000|Overall Study|Adverse Event|0|||
125555997|NCT01910116|451668673|FG001|Overall Study|Adverse Event|3|||
125555998|NCT01910116|451668672|FG000|Overall Study|Lack of Efficacy|3|||
125555999|NCT01910116|451668673|FG001|Overall Study|Lack of Efficacy|4|||
125556000|NCT01910116|451668672|FG000|Overall Study|Lost to Follow-up|1|||
125556001|NCT01910116|451668673|FG001|Overall Study|Lost to Follow-up|0|||
125556002|NCT01910116|451668672|FG000|Overall Study|Protocol Violation|1|||
125556003|NCT01910116|451668673|FG001|Overall Study|Protocol Violation|2|||
125556004|NCT01910116|451668672|FG000|Overall Study|Withdrawal by Subject|8|||
125556005|NCT01910116|451668673|FG001|Overall Study|Withdrawal by Subject|3|||
125556006|NCT01910116|451668672|FG000|Overall Study|uncertain allocation|1|||
125556007|NCT01910116|451668673|FG001|Overall Study|uncertain allocation|3|||
125352402|NCT03868124|450925984|FG001|Overall Study|Physician Decision|0|||
125352403|NCT03868124|450925985|FG002|Overall Study|Physician Decision|1|||
125352404|NCT03868124|450925983|FG000|Overall Study|Lost to Follow-up|1|||
125352405|NCT03868124|450925984|FG001|Overall Study|Lost to Follow-up|1|||
125352406|NCT03868124|450925985|FG002|Overall Study|Lost to Follow-up|2|||
125556008|NCT01910116|451668672|FG000|Overall Study|incomplete data|0|||
125556009|NCT01910116|451668673|FG001|Overall Study|incomplete data|1|||
125556010|NCT02469896|451668674|FG000|Overall Study|Withdrawal by Subject|2|||
125556011|NCT02469896|451668675|FG001|Overall Study|Withdrawal by Subject|0|||
125352407|NCT03868124|450925983|FG000|Overall Study|Death|1|||
125556012|NCT04233164|451668678|FG000|Overall Study|Unable to obtain specimen|0|||
125352408|NCT03868124|450925984|FG001|Overall Study|Death|1|||
125556013|NCT04233164|451668679|FG001|Overall Study|Unable to obtain specimen|1|||
125556014|NCT01840605|451668680|FG000|Overall Study|Adverse Event|0|||
125556015|NCT01840605|451668681|FG001|Overall Study|Adverse Event|1|||
125556016|NCT01840605|451668680|FG000|Overall Study|Physician Decision|2|||
125556017|NCT01840605|451668681|FG001|Overall Study|Physician Decision|1|||
125556018|NCT01130974|451668682|FG000|Overall Study|Protocol Violation|10|||
125352409|NCT03868124|450925985|FG002|Overall Study|Death|2|||
125352410|NCT03868124|450925983|FG000|Overall Study|Adverse Event|0|||
125352411|NCT03868124|450925984|FG001|Overall Study|Adverse Event|0|||
125352412|NCT03868124|450925985|FG002|Overall Study|Adverse Event|3|||
125352413|NCT03868124|450925983|FG000|Overall Study|Explanted|2|||
125352414|NCT03868124|450925984|FG001|Overall Study|Explanted|1|||
125352415|NCT03868124|450925985|FG002|Overall Study|Explanted|0|||
125352416|NCT03868124|450925983|FG000|Overall Study|Ongoing in study|176|||
125352417|NCT03868124|450925984|FG001|Overall Study|Ongoing in study|180|||
125425976|NCT00553696|451182420|FG003|Overall Study|Adverse Event|1|||
125425977|NCT00553696|451182417|FG000|Overall Study|Global deterioration of health status|0|||
125425978|NCT00553696|451182418|FG001|Overall Study|Global deterioration of health status|2|||
125425979|NCT00553696|451182419|FG002|Overall Study|Global deterioration of health status|0|||
125556019|NCT01130974|451668683|FG001|Overall Study|Protocol Violation|10|||
125556020|NCT01130974|451668682|FG000|Overall Study|Withdrawal by Subject|0|||
125556021|NCT01130974|451668683|FG001|Overall Study|Withdrawal by Subject|1|||
125556022|NCT01130974|451668682|FG000|Overall Study|Ineligibility criteria|5|||
125556023|NCT01130974|451668683|FG001|Overall Study|Ineligibility criteria|2|||
125556024|NCT02536755|451668684|FG000|Overall Study|Adverse Event|4|||
125556025|NCT02301936|451668685|FG000|Overall Study|Lost to Follow-up|1|||
125556026|NCT02301936|451668686|FG001|Overall Study|Lost to Follow-up|0|||
125556027|NCT04014361|451668689|FG000|Period 2|Physician Decision|0|||
125556028|NCT04014361|451668690|FG001|Period 2|Physician Decision|0|||
125556029|NCT04014361|451668691|FG002|Period 2|Physician Decision|0|||
125556030|NCT04014361|451668692|FG003|Period 2|Physician Decision|1|||
125556031|NCT04014361|451668693|FG004|Period 2|Physician Decision|0|||
125556032|NCT04014361|451668694|FG005|Period 2|Physician Decision|0|||
125556033|NCT04014361|451668695|FG006|Period 2|Physician Decision|0|||
125556034|NCT04014361|451668696|FG007|Period 2|Physician Decision|0|||
125556035|NCT01130051|451668698|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
125556036|NCT01130051|451668699|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
125556037|NCT01130051|451668698|FG000|Washout Period of 14 Days|Protocol Violation|1|||
125556038|NCT01130051|451668699|FG001|Washout Period of 14 Days|Protocol Violation|1|||
125556039|NCT04252287|451668702|FG000|Overall Study|Death|5|||
125556040|NCT04252287|451668703|FG001|Overall Study|Death|3|||
125556041|NCT04252287|451668702|FG000|Overall Study|Lost to Follow-up|4|||
125556042|NCT04252287|451668703|FG001|Overall Study|Lost to Follow-up|6|||
125556043|NCT04252287|451668702|FG000|Overall Study|Withdrawal by Subject|19|||
125556044|NCT04252287|451668703|FG001|Overall Study|Withdrawal by Subject|16|||
125556045|NCT04252287|451668702|FG000|Overall Study|Protocol Violation|3|||
125556046|NCT04252287|451668703|FG001|Overall Study|Protocol Violation|4|||
125556047|NCT03610165|451668706|FG000|Overall Study|Device didn't work|0|||
125556048|NCT03610165|451668707|FG001|Overall Study|Device didn't work|1|||
125556049|NCT01810016|451668708|FG000|Overall Study|Progressive disease|1|||
125556050|NCT01810016|451668709|FG001|Overall Study|Progressive disease|1|||
125556051|NCT01810016|451668710|FG002|Overall Study|Progressive disease|0|||
125556052|NCT01810016|451668708|FG000|Overall Study|Death|0|||
125556053|NCT01810016|451668709|FG001|Overall Study|Death|0|||
125556054|NCT01810016|451668710|FG002|Overall Study|Death|1|||
125556055|NCT03828292|451668713|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
125556056|NCT03828292|451668714|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
125556057|NCT03828292|451668715|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
125556058|NCT03828292|451668716|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
125556059|NCT03828292|451668717|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
125556060|NCT03828292|451668718|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
125556061|NCT03828292|451668713|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
125556062|NCT03828292|451668714|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
125556063|NCT03828292|451668715|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
125556064|NCT03828292|451668716|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
125556065|NCT03828292|451668717|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
125556066|NCT03828292|451668718|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
125556067|NCT03828292|451668713|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
125556068|NCT03828292|451668714|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
125352418|NCT03868124|450925985|FG002|Overall Study|Ongoing in study|183|||
125352419|NCT04565236|450925986|FG000|Overall Study|Patient/Guardian Decision|0|||
125556069|NCT03828292|451668715|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
125556070|NCT03828292|451668716|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
125556071|NCT03828292|451668717|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
125556072|NCT03828292|451668718|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
125556073|NCT03828292|451668713|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
125556074|NCT03828292|451668714|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
125556075|NCT03828292|451668715|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
125425980|NCT00553696|451182420|FG003|Overall Study|Global deterioration of health status|0|||
125556076|NCT03828292|451668716|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
125556077|NCT03828292|451668717|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
125352420|NCT04565236|450925987|FG001|Overall Study|Patient/Guardian Decision|0|||
125352421|NCT04565236|450925988|FG002|Overall Study|Patient/Guardian Decision|1|||
125352422|NCT04565236|450925989|FG003|Overall Study|Patient/Guardian Decision|0|||
125352423|NCT01117051|450925990|FG000|Overall Study|Withdrawal by Subject|5|||
125352424|NCT01117051|450925991|FG001|Overall Study|Withdrawal by Subject|3|||
125352425|NCT01117051|450925990|FG000|Overall Study|Adverse Event|4|||
125556078|NCT03828292|451668718|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
125556079|NCT03828292|451668713|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
125556080|NCT03828292|451668714|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
125556081|NCT03828292|451668715|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
125556082|NCT03828292|451668716|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
125556083|NCT03828292|451668717|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
125556084|NCT03828292|451668718|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
125556085|NCT04667247|451668721|FG000|Overall Study|Withdrawal by Subject|0|||
125556086|NCT04667247|451668722|FG001|Overall Study|Withdrawal by Subject|1|||
125556087|NCT06950879|451668723|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
125556088|NCT01436071|451670633|FG000|Overall Study|Adverse Event|1|||
125556089|NCT01436071|451670634|FG001|Overall Study|Adverse Event|0|||
125556090|NCT01436071|451670633|FG000|Overall Study|Lack of Efficacy|16|||
125556091|NCT01436071|451670634|FG001|Overall Study|Lack of Efficacy|7|||
125556092|NCT01436071|451670633|FG000|Overall Study|Protocol Violation|0|||
125556093|NCT01436071|451670634|FG001|Overall Study|Protocol Violation|1|||
125556094|NCT01436071|451670633|FG000|Overall Study|Lost to Follow-up|3|||
125556095|NCT01436071|451670634|FG001|Overall Study|Lost to Follow-up|1|||
125556096|NCT01436071|451670633|FG000|Overall Study|Physician Decision|1|||
125352426|NCT01117051|450925991|FG001|Overall Study|Adverse Event|3|||
125352427|NCT01117051|450925990|FG000|Overall Study|Lost to Follow-up|0|||
125352428|NCT01117051|450925991|FG001|Overall Study|Lost to Follow-up|1|||
125352429|NCT01117051|450925990|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
125352430|NCT01117051|450925991|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
125352431|NCT01117051|450925990|FG000|Overall Study|Sponsor's decision|3|||
125352432|NCT01117051|450925991|FG001|Overall Study|Sponsor's decision|1|||
125352433|NCT01117051|450925990|FG000|Overall Study|Surgical procedure|0|||
125352434|NCT01117051|450925991|FG001|Overall Study|Surgical procedure|1|||
125352435|NCT01117051|450925990|FG000|Overall Study|Randomized by mistake|0|||
125556097|NCT01436071|451670634|FG001|Overall Study|Physician Decision|0|||
125352436|NCT01117051|450925991|FG001|Overall Study|Randomized by mistake|1|||
125556098|NCT01436071|451670633|FG000|Overall Study|Withdrawal by Subject|2|||
125556099|NCT01436071|451670634|FG001|Overall Study|Withdrawal by Subject|2|||
125556100|NCT01436071|451670633|FG000|Overall Study|Did Not Receive Trial Medication|3|||
125556101|NCT01436071|451670634|FG001|Overall Study|Did Not Receive Trial Medication|3|||
125556102|NCT03047551|451670638|FG000|Overall Study|Did not receive TAS|1|||
125352437|NCT01117051|450925990|FG000|Overall Study|Convenience issue|1|||
125352438|NCT01117051|450925991|FG001|Overall Study|Convenience issue|0|||
125352439|NCT00206076|450925993|FG000|Overall Study|Physician Decision|2|||
125352440|NCT00206076|450925994|FG001|Overall Study|Physician Decision|0|||
125352441|NCT00206076|450925993|FG000|Overall Study|Withdrawal by Subject|1|||
125352442|NCT00206076|450925994|FG001|Overall Study|Withdrawal by Subject|1|||
125352443|NCT00366340|450925997|FG000|Infant Series|Protocol Violation|3|||
125352444|NCT00366340|450925998|FG001|Infant Series|Protocol Violation|4|||
125352445|NCT00366340|450925997|FG000|Infant Series|Withdrawal by Subject|3|||
125352446|NCT00366340|450925998|FG001|Infant Series|Withdrawal by Subject|3|||
125352447|NCT00366340|450925997|FG000|Infant Series|Adverse Event|0|||
125352448|NCT00366340|450925998|FG001|Infant Series|Adverse Event|2|||
125352449|NCT00366340|450925997|FG000|Infant Series|Lost to Follow-up|1|||
125352450|NCT00366340|450925998|FG001|Infant Series|Lost to Follow-up|1|||
125352451|NCT00366340|450925997|FG000|Infant Series|Failure to return|1|||
125352452|NCT00366340|450925998|FG001|Infant Series|Failure to return|0|||
125352453|NCT00366340|450925997|FG000|After the Infant Series|Parent/legal guardian request|1|||
125352454|NCT00366340|450925998|FG001|After the Infant Series|Parent/legal guardian request|1|||
125556103|NCT03047551|451670639|FG001|Overall Study|Did not receive TAS|0|||
125556104|NCT03047551|451670638|FG000|Overall Study|Physician Decision|1|||
125556105|NCT03047551|451670639|FG001|Overall Study|Physician Decision|0|||
125556106|NCT03047551|451670638|FG000|Overall Study|Withdrawal by Subject|0|||
125556107|NCT03047551|451670639|FG001|Overall Study|Withdrawal by Subject|1|||
125556108|NCT03047551|451670638|FG000|Overall Study|Probe malfunction|0|||
125556109|NCT03047551|451670639|FG001|Overall Study|Probe malfunction|1|||
125556110|NCT03047551|451670638|FG000|Overall Study|Ineligible|0|||
125556111|NCT03047551|451670639|FG001|Overall Study|Ineligible|1|||
125556112|NCT00726622|451670640|FG000|Overall Study|Withdrawal by Subject|16|||
125556113|NCT00726622|451670641|FG001|Overall Study|Withdrawal by Subject|2|||
125556114|NCT00726622|451670640|FG000|Overall Study|Physician Decision|0|||
125556115|NCT00726622|451670641|FG001|Overall Study|Physician Decision|1|||
125556116|NCT00726622|451670640|FG000|Overall Study|Metastasis|2|||
125556117|NCT00726622|451670641|FG001|Overall Study|Metastasis|0|||
125556118|NCT02462928|451670642|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
125556119|NCT02462928|451670643|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
125556120|NCT02462928|451670644|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
125556121|NCT02462928|451670642|FG000|Overall Study|Adverse Event|47|||
125352455|NCT00366340|450925997|FG000|After the Infant Series|Failed to return|0|||
125352456|NCT00366340|450925998|FG001|After the Infant Series|Failed to return|1|||
125556122|NCT02462928|451670643|FG001|Overall Study|Adverse Event|51|||
125556123|NCT02462928|451670644|FG002|Overall Study|Adverse Event|25|||
125352457|NCT00366340|450925997|FG000|After the Infant Series|Protocol Violation|2|||
125556124|NCT02462928|451670642|FG000|Overall Study|Lack of Efficacy|3|||
125556125|NCT02462928|451670643|FG001|Overall Study|Lack of Efficacy|8|||
125556126|NCT02462928|451670644|FG002|Overall Study|Lack of Efficacy|3|||
125556127|NCT02462928|451670642|FG000|Overall Study|Lost to Follow-up|4|||
125556128|NCT02462928|451670643|FG001|Overall Study|Lost to Follow-up|4|||
125556129|NCT02462928|451670644|FG002|Overall Study|Lost to Follow-up|1|||
125556130|NCT02462928|451670642|FG000|Overall Study|Withdrawal by Patient|31|||
125556131|NCT02462928|451670643|FG001|Overall Study|Withdrawal by Patient|21|||
125556132|NCT02462928|451670644|FG002|Overall Study|Withdrawal by Patient|21|||
125556133|NCT02462928|451670642|FG000|Overall Study|Protocol Violation|0|||
125556134|NCT02462928|451670643|FG001|Overall Study|Protocol Violation|1|||
125556135|NCT02462928|451670644|FG002|Overall Study|Protocol Violation|0|||
125556136|NCT02462928|451670642|FG000|Overall Study|Reason not Specified|4|||
125556137|NCT02462928|451670643|FG001|Overall Study|Reason not Specified|6|||
125556138|NCT02462928|451670644|FG002|Overall Study|Reason not Specified|5|||
125556139|NCT01493557|451670645|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
125556140|NCT01493557|451670646|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
125556141|NCT01493557|451670647|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
125556142|NCT01493557|451670645|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
125556143|NCT01493557|451670646|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
125352458|NCT00366340|450925998|FG001|After the Infant Series|Protocol Violation|2|||
125352459|NCT00366340|450925997|FG000|After the Infant Series|Adverse Event|0|||
125352460|NCT00366340|450925998|FG001|After the Infant Series|Adverse Event|1|||
125352461|NCT00366340|450925997|FG000|After the Infant Series|Lost to Follow-up|0|||
125352462|NCT00366340|450925998|FG001|After the Infant Series|Lost to Follow-up|1|||
125352463|NCT00366340|450925997|FG000|Toddler Dose|Failed to return|1|||
125352464|NCT00366340|450925998|FG001|Toddler Dose|Failed to return|0|||
125352465|NCT00366340|450925997|FG000|Toddler Dose|Parent/legal guardian request|0|||
125352466|NCT00366340|450925998|FG001|Toddler Dose|Parent/legal guardian request|1|||
125352467|NCT03355664|450925999|FG000|Overall Study|Adverse Event|1|||
125352468|NCT03355664|450926000|FG001|Overall Study|Adverse Event|2|||
125352469|NCT03355664|450925999|FG000|Overall Study|Lost to Follow-up|11|||
125352470|NCT03355664|450926000|FG001|Overall Study|Lost to Follow-up|7|||
125352471|NCT03355664|450925999|FG000|Overall Study|Protocol Violation|1|||
125352472|NCT03355664|450926000|FG001|Overall Study|Protocol Violation|2|||
125352473|NCT03355664|450925999|FG000|Overall Study|Withdrawal by Subject|2|||
125352474|NCT03355664|450926000|FG001|Overall Study|Withdrawal by Subject|1|||
125352475|NCT01315236|450926006|FG000|Double-blind Phase|Death|1|||
125352476|NCT01315236|450926007|FG001|Double-blind Phase|Death|0|||
125352477|NCT01315236|450926006|FG000|Double-blind Phase|Adverse Event|1|||
125352478|NCT01315236|450926007|FG001|Double-blind Phase|Adverse Event|0|||
125352479|NCT01315236|450926006|FG000|Double-blind Phase|Withdrawal of Consent|1|||
125352480|NCT01315236|450926007|FG001|Double-blind Phase|Withdrawal of Consent|0|||
125352481|NCT01315236|450926006|FG000|Double-blind Phase|Lost to Follow-up|1|||
125352482|NCT01315236|450926007|FG001|Double-blind Phase|Lost to Follow-up|0|||
125352483|NCT01315236|450926006|FG000|Open-label Phase|Death|1|||
125352484|NCT01315236|450926007|FG001|Open-label Phase|Death|0|||
125352485|NCT01315236|450926006|FG000|Open-label Phase|Adverse Event|0|||
125352486|NCT01315236|450926007|FG001|Open-label Phase|Adverse Event|1|||
125352487|NCT01315236|450926006|FG000|Open-label Phase|Other|0|||
125352488|NCT01315236|450926007|FG001|Open-label Phase|Other|1|||
125352489|NCT01315236|450926006|FG000|12-Month Follow-up Period|Death|0|||
125352490|NCT01315236|450926007|FG001|12-Month Follow-up Period|Death|1|||
125352491|NCT01315236|450926006|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
125352492|NCT01315236|450926007|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
125352493|NCT01751802|450926008|FG000|Overall Study|Adverse Event|4|||
125352494|NCT01751802|450926009|FG001|Overall Study|Adverse Event|2|||
125352495|NCT00589784|450926012|FG000|Overall Study|Withdrawal by Subject|0|||
125352496|NCT00589784|450926013|FG001|Overall Study|Withdrawal by Subject|6|||
125352497|NCT00589784|450926012|FG000|Overall Study|Patient inevaluable|1|||
125352498|NCT00589784|450926013|FG001|Overall Study|Patient inevaluable|0|||
125352499|NCT00589784|450926012|FG000|Overall Study|Adverse Event|0|||
125352500|NCT00589784|450926013|FG001|Overall Study|Adverse Event|4|||
125352501|NCT00521001|450926014|FG000|Overall Study|Ineligible|1|||
125352502|NCT02821910|450926016|FG000|Overall Study|Withdrawal by Subject|0|||
125352503|NCT02821910|450926017|FG001|Overall Study|Withdrawal by Subject|0|||
125352504|NCT02821910|450926018|FG002|Overall Study|Withdrawal by Subject|1|||
125556144|NCT01493557|451670647|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
125556145|NCT01493557|451670645|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
125556146|NCT01493557|451670646|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
125556147|NCT01493557|451670647|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
125556148|NCT01493557|451670645|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
125556149|NCT01493557|451670646|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
125556150|NCT01493557|451670647|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
125556151|NCT01493557|451670645|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
125556152|NCT01493557|451670646|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
125556153|NCT01493557|451670647|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
125352505|NCT02821910|450926019|FG003|Overall Study|Withdrawal by Subject|0|||
125352506|NCT02821910|450926020|FG004|Overall Study|Withdrawal by Subject|0|||
125352507|NCT02821910|450926021|FG005|Overall Study|Withdrawal by Subject|1|||
125352508|NCT02821910|450926016|FG000|Overall Study|Other than specified|1|||
125352509|NCT02821910|450926017|FG001|Overall Study|Other than specified|0|||
125352510|NCT02821910|450926018|FG002|Overall Study|Other than specified|1|||
125352511|NCT02821910|450926019|FG003|Overall Study|Other than specified|0|||
125352512|NCT02821910|450926020|FG004|Overall Study|Other than specified|0|||
125352513|NCT02821910|450926021|FG005|Overall Study|Other than specified|0|||
125352514|NCT00287079|450926022|FG000|Overall Study|Qualifying relapse|12|||
125352515|NCT00287079|450926023|FG001|Overall Study|Qualifying relapse|1|||
125352516|NCT00287079|450926022|FG000|Overall Study|Non-qualifying relapse|1|||
125352517|NCT00287079|450926023|FG001|Overall Study|Non-qualifying relapse|0|||
125352518|NCT00287079|450926022|FG000|Overall Study|Adverse Event|5|||
125556154|NCT01493557|451670645|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
125556155|NCT01493557|451670646|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
125556156|NCT01493557|451670647|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
125556157|NCT01493557|451670645|FG000|Not Randomized to Management Strategies|Early termination|0|||
125556158|NCT01493557|451670646|FG001|Not Randomized to Management Strategies|Early termination|0|||
125556159|NCT01493557|451670647|FG002|Not Randomized to Management Strategies|Early termination|34|||
125352519|NCT00287079|450926023|FG001|Overall Study|Adverse Event|0|||
125352520|NCT00287079|450926022|FG000|Overall Study|Protocol Violation|1|||
125352521|NCT00287079|450926023|FG001|Overall Study|Protocol Violation|0|||
125352522|NCT00287079|450926022|FG000|Overall Study|Other|3|||
125352523|NCT00287079|450926023|FG001|Overall Study|Other|0|||
125352524|NCT01082640|450926026|FG000|Overall Study|Adverse Event|9|||
125352525|NCT01082640|450926027|FG001|Overall Study|Adverse Event|5|||
125352526|NCT01082640|450926028|FG002|Overall Study|Adverse Event|3|||
125352527|NCT01082640|450926026|FG000|Overall Study|Withdrawal by Subject|3|||
125352528|NCT01082640|450926027|FG001|Overall Study|Withdrawal by Subject|3|||
125352529|NCT01082640|450926028|FG002|Overall Study|Withdrawal by Subject|2|||
125352530|NCT01082640|450926026|FG000|Overall Study|Major protocol deviation|3|||
125352531|NCT01082640|450926027|FG001|Overall Study|Major protocol deviation|3|||
125352532|NCT01082640|450926028|FG002|Overall Study|Major protocol deviation|0|||
125352533|NCT01082640|450926026|FG000|Overall Study|Lost to Follow-up|0|||
125352534|NCT01082640|450926027|FG001|Overall Study|Lost to Follow-up|3|||
125352535|NCT01082640|450926028|FG002|Overall Study|Lost to Follow-up|0|||
125352536|NCT01082640|450926026|FG000|Overall Study|Other|2|||
125352537|NCT01082640|450926027|FG001|Overall Study|Other|1|||
125352538|NCT01082640|450926028|FG002|Overall Study|Other|3|||
125352539|NCT02129777|450926031|FG000|Double-Blind Period|Adverse Event|0|||
125352540|NCT02129777|450926032|FG001|Double-Blind Period|Adverse Event|0|||
125352541|NCT02129777|450926033|FG002|Double-Blind Period|Adverse Event|0|||
125352542|NCT02129777|450926034|FG003|Double-Blind Period|Adverse Event|0|||
125352543|NCT02129777|450926035|FG004|Double-Blind Period|Adverse Event|1|||
125352544|NCT02129777|450926036|FG005|Double-Blind Period|Adverse Event|0|||
125352545|NCT02129777|450926037|FG006|Double-Blind Period|Adverse Event|0|||
125352546|NCT02129777|450926031|FG000|Double-Blind Period|Lost to Follow-up|1|||
125352547|NCT02129777|450926032|FG001|Double-Blind Period|Lost to Follow-up|1|||
125352548|NCT02129777|450926033|FG002|Double-Blind Period|Lost to Follow-up|1|||
125352549|NCT02129777|450926034|FG003|Double-Blind Period|Lost to Follow-up|2|||
125352550|NCT02129777|450926035|FG004|Double-Blind Period|Lost to Follow-up|0|||
125352551|NCT02129777|450926036|FG005|Double-Blind Period|Lost to Follow-up|0|||
125352552|NCT02129777|450926037|FG006|Double-Blind Period|Lost to Follow-up|0|||
125352553|NCT02129777|450926031|FG000|Double-Blind Period|Withdrawal by Subject|2|||
125352554|NCT02129777|450926032|FG001|Double-Blind Period|Withdrawal by Subject|4|||
125352555|NCT02129777|450926033|FG002|Double-Blind Period|Withdrawal by Subject|3|||
125352556|NCT02129777|450926034|FG003|Double-Blind Period|Withdrawal by Subject|2|||
125352557|NCT02129777|450926035|FG004|Double-Blind Period|Withdrawal by Subject|3|||
125352558|NCT02129777|450926036|FG005|Double-Blind Period|Withdrawal by Subject|0|||
125352559|NCT02129777|450926037|FG006|Double-Blind Period|Withdrawal by Subject|0|||
125352560|NCT02129777|450926031|FG000|Double-Blind Period|Pregnancy|0|||
125352561|NCT02129777|450926032|FG001|Double-Blind Period|Pregnancy|0|||
125352562|NCT02129777|450926033|FG002|Double-Blind Period|Pregnancy|0|||
125352563|NCT02129777|450926034|FG003|Double-Blind Period|Pregnancy|0|||
125352564|NCT02129777|450926035|FG004|Double-Blind Period|Pregnancy|1|||
125352565|NCT02129777|450926036|FG005|Double-Blind Period|Pregnancy|0|||
125352566|NCT02129777|450926037|FG006|Double-Blind Period|Pregnancy|0|||
125352567|NCT02129777|450926031|FG000|Double-Blind Period|Lack of Efficacy|3|||
125352568|NCT02129777|450926032|FG001|Double-Blind Period|Lack of Efficacy|1|||
125352569|NCT02129777|450926033|FG002|Double-Blind Period|Lack of Efficacy|0|||
125352570|NCT02129777|450926034|FG003|Double-Blind Period|Lack of Efficacy|3|||
125352571|NCT02129777|450926035|FG004|Double-Blind Period|Lack of Efficacy|2|||
125352572|NCT02129777|450926036|FG005|Double-Blind Period|Lack of Efficacy|0|||
125352573|NCT02129777|450926037|FG006|Double-Blind Period|Lack of Efficacy|0|||
125352574|NCT02129777|450926031|FG000|Double-Blind Period|Other|1|||
125352575|NCT02129777|450926032|FG001|Double-Blind Period|Other|2|||
125352576|NCT02129777|450926033|FG002|Double-Blind Period|Other|0|||
125352577|NCT02129777|450926034|FG003|Double-Blind Period|Other|0|||
125556160|NCT01493557|451670645|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
125556161|NCT01493557|451670646|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
125556162|NCT01493557|451670647|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
125556163|NCT01493557|451670645|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
125556164|NCT01493557|451670646|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
125556165|NCT01493557|451670647|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
125556166|NCT01493557|451670645|FG000|Randomized to Management Strategies|Other adverse event|8|||
125556167|NCT01493557|451670646|FG001|Randomized to Management Strategies|Other adverse event|5|||
125556168|NCT01493557|451670647|FG002|Randomized to Management Strategies|Other adverse event|0|||
125556169|NCT01493557|451670645|FG000|Randomized to Management Strategies|Protocol Violation|3|||
125352578|NCT02129777|450926035|FG004|Double-Blind Period|Other|0|||
125352579|NCT02129777|450926036|FG005|Double-Blind Period|Other|0|||
125352580|NCT02129777|450926037|FG006|Double-Blind Period|Other|0|||
125352581|NCT02129777|450926031|FG000|Open-Label Period|Lack of Efficacy|0|||
125352582|NCT02129777|450926032|FG001|Open-Label Period|Lack of Efficacy|0|||
125352583|NCT02129777|450926033|FG002|Open-Label Period|Lack of Efficacy|0|||
125352584|NCT02129777|450926034|FG003|Open-Label Period|Lack of Efficacy|0|||
125352585|NCT02129777|450926035|FG004|Open-Label Period|Lack of Efficacy|0|||
125352586|NCT02129777|450926036|FG005|Open-Label Period|Lack of Efficacy|0|||
125556170|NCT01493557|451670646|FG001|Randomized to Management Strategies|Protocol Violation|0|||
125556171|NCT01493557|451670647|FG002|Randomized to Management Strategies|Protocol Violation|0|||
125556172|NCT01493557|451670645|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
125556173|NCT01493557|451670646|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
125556174|NCT01493557|451670647|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
125556175|NCT01493557|451670645|FG000|Randomized to Management Strategies|Other than stated above|1|||
125556176|NCT01493557|451670646|FG001|Randomized to Management Strategies|Other than stated above|3|||
125556177|NCT01493557|451670647|FG002|Randomized to Management Strategies|Other than stated above|0|||
125556178|NCT01493557|451670645|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
125556179|NCT01493557|451670646|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
125556180|NCT01493557|451670647|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
125556181|NCT01493557|451670645|FG000|Adding the Second Strategy|Other adverse event|1|||
125556182|NCT01493557|451670646|FG001|Adding the Second Strategy|Other adverse event|2|||
125425981|NCT00553696|451182417|FG000|Overall Study|Objective progression or relapse|2|||
125425982|NCT00553696|451182418|FG001|Overall Study|Objective progression or relapse|9|||
125425983|NCT00553696|451182419|FG002|Overall Study|Objective progression or relapse|6|||
125352587|NCT02129777|450926037|FG006|Open-Label Period|Lack of Efficacy|5|||
125352588|NCT02129777|450926031|FG000|Open-Label Period|Lost to Follow-up|0|||
125352589|NCT02129777|450926032|FG001|Open-Label Period|Lost to Follow-up|0|||
125352590|NCT02129777|450926033|FG002|Open-Label Period|Lost to Follow-up|0|||
125352591|NCT02129777|450926034|FG003|Open-Label Period|Lost to Follow-up|0|||
125352592|NCT02129777|450926035|FG004|Open-Label Period|Lost to Follow-up|0|||
125352593|NCT02129777|450926036|FG005|Open-Label Period|Lost to Follow-up|1|||
125352594|NCT02129777|450926037|FG006|Open-Label Period|Lost to Follow-up|1|||
125352595|NCT02129777|450926031|FG000|Open-Label Period|Withdrawal by Subject|0|||
125352596|NCT02129777|450926032|FG001|Open-Label Period|Withdrawal by Subject|0|||
125352597|NCT02129777|450926033|FG002|Open-Label Period|Withdrawal by Subject|0|||
125352598|NCT02129777|450926034|FG003|Open-Label Period|Withdrawal by Subject|0|||
125352599|NCT02129777|450926035|FG004|Open-Label Period|Withdrawal by Subject|0|||
125352600|NCT02129777|450926036|FG005|Open-Label Period|Withdrawal by Subject|1|||
125352601|NCT02129777|450926037|FG006|Open-Label Period|Withdrawal by Subject|3|||
125352602|NCT02129777|450926031|FG000|Open-Label Period|Study Termination|0|||
125556183|NCT01493557|451670647|FG002|Adding the Second Strategy|Other adverse event|0|||
125556184|NCT01493557|451670645|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
125556185|NCT01493557|451670646|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
125556186|NCT01493557|451670647|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
125352603|NCT02129777|450926032|FG001|Open-Label Period|Study Termination|0|||
125352604|NCT02129777|450926033|FG002|Open-Label Period|Study Termination|0|||
125352605|NCT02129777|450926034|FG003|Open-Label Period|Study Termination|0|||
125352606|NCT02129777|450926035|FG004|Open-Label Period|Study Termination|0|||
125352607|NCT02129777|450926036|FG005|Open-Label Period|Study Termination|10|||
125352608|NCT02129777|450926037|FG006|Open-Label Period|Study Termination|39|||
125352609|NCT00542451|450926041|FG000|Overall Study|Adverse Event|31|||
125352610|NCT00542451|450926041|FG000|Overall Study|Withdrawal by Subject|30|||
125352611|NCT00542451|450926041|FG000|Overall Study|Physician Decision|4|||
125352612|NCT00542451|450926041|FG000|Overall Study|Recurrent disease|1|||
125352613|NCT00542451|450926041|FG000|Overall Study|unknown reason|1|||
125352614|NCT00542451|450926041|FG000|Overall Study|Death|2|||
125352615|NCT00542451|450926041|FG000|Overall Study|Lost to Follow-up|10|||
125352616|NCT00064298|450926050|FG000|Overall Study|Withdrawal by Subject|2|||
125352617|NCT00064298|450926051|FG001|Overall Study|Withdrawal by Subject|1|||
125352618|NCT00064298|450926050|FG000|Overall Study|Lost to Follow-up|2|||
125352619|NCT00064298|450926051|FG001|Overall Study|Lost to Follow-up|2|||
125352620|NCT00064298|450926050|FG000|Overall Study|Death|0|||
125352621|NCT00064298|450926051|FG001|Overall Study|Death|1|||
125352622|NCT00064298|450926050|FG000|Overall Study|Disease Progression|2|||
125352623|NCT00064298|450926051|FG001|Overall Study|Disease Progression|1|||
125352624|NCT00322153|450926052|FG000|Overall Study|Adverse Event|21|||
125352625|NCT00322153|450926053|FG001|Overall Study|Adverse Event|34|||
125352626|NCT00322153|450926052|FG000|Overall Study|Protocol Violation|6|||
125352627|NCT00322153|450926053|FG001|Overall Study|Protocol Violation|14|||
125352628|NCT00322153|450926052|FG000|Overall Study|Withdrawal by Subject|18|||
125352629|NCT00322153|450926053|FG001|Overall Study|Withdrawal by Subject|10|||
125352630|NCT00322153|450926052|FG000|Overall Study|Lack of Efficacy|8|||
125352631|NCT00322153|450926053|FG001|Overall Study|Lack of Efficacy|3|||
125352632|NCT00322153|450926052|FG000|Overall Study|Lost to Follow-up|5|||
125352633|NCT00322153|450926053|FG001|Overall Study|Lost to Follow-up|4|||
125352634|NCT00322153|450926052|FG000|Overall Study|Withdrawn for other reasons|5|||
125352635|NCT00322153|450926053|FG001|Overall Study|Withdrawn for other reasons|4|||
125352636|NCT01309893|450926054|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
125352637|NCT01309893|450926055|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
125352638|NCT01309893|450926054|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
125352639|NCT01309893|450926055|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
125352640|NCT02414139|450926056|FG000|Treatment Period|Adverse Event|11|||
125352641|NCT02414139|450926057|FG001|Treatment Period|Adverse Event|6|||
125352642|NCT02414139|450926058|FG002|Treatment Period|Adverse Event|8|||
125556187|NCT01890148|451670662|FG000|Overall Study|Adverse Event|1|||
125556188|NCT01215175|451670663|FG000|Overall Study|Lost to Follow-up|0|||
125352643|NCT02414139|450926059|FG003|Treatment Period|Adverse Event|5|||
125352644|NCT02414139|450926060|FG004|Treatment Period|Adverse Event|14|||
125352645|NCT02414139|450926061|FG005|Treatment Period|Adverse Event|3|||
125352646|NCT02414139|450926062|FG006|Treatment Period|Adverse Event|6|||
125352647|NCT02414139|450926063|FG007|Treatment Period|Adverse Event|1|||
125352648|NCT02414139|450926064|FG008|Treatment Period|Adverse Event|6|||
125352649|NCT02414139|450926065|FG009|Treatment Period|Adverse Event|8|||
125352650|NCT02414139|450926056|FG000|Treatment Period|Death|0|||
125556189|NCT01215175|451670664|FG001|Overall Study|Lost to Follow-up|1|||
125352651|NCT02414139|450926057|FG001|Treatment Period|Death|0|||
125556190|NCT01215175|451670665|FG002|Overall Study|Lost to Follow-up|0|||
125352652|NCT02414139|450926058|FG002|Treatment Period|Death|1|||
125352653|NCT02414139|450926059|FG003|Treatment Period|Death|1|||
125352654|NCT02414139|450926060|FG004|Treatment Period|Death|0|||
125352655|NCT02414139|450926061|FG005|Treatment Period|Death|0|||
125352656|NCT02414139|450926062|FG006|Treatment Period|Death|0|||
125556191|NCT01215175|451670666|FG003|Overall Study|Lost to Follow-up|1|||
125556192|NCT01215175|451670667|FG004|Overall Study|Lost to Follow-up|0|||
125556193|NCT01678209|451670668|FG000|Overall Study|could not scan twice|1|||
125556194|NCT01678209|451670669|FG001|Overall Study|could not scan twice|1|||
125556195|NCT01678209|451670670|FG002|Overall Study|could not scan twice|1|||
125556196|NCT01678209|451670668|FG000|Overall Study|scheduling conflicts|0|||
125556197|NCT01678209|451670669|FG001|Overall Study|scheduling conflicts|0|||
125352657|NCT02414139|450926063|FG007|Treatment Period|Death|0|||
125352658|NCT02414139|450926064|FG008|Treatment Period|Death|0|||
125352659|NCT02414139|450926065|FG009|Treatment Period|Death|1|||
125352660|NCT02414139|450926056|FG000|Treatment Period|Physician Decision|5|||
125352661|NCT02414139|450926057|FG001|Treatment Period|Physician Decision|4|||
125352662|NCT02414139|450926058|FG002|Treatment Period|Physician Decision|6|||
125352663|NCT02414139|450926059|FG003|Treatment Period|Physician Decision|1|||
125352664|NCT02414139|450926060|FG004|Treatment Period|Physician Decision|4|||
125352665|NCT02414139|450926061|FG005|Treatment Period|Physician Decision|0|||
125352666|NCT02414139|450926062|FG006|Treatment Period|Physician Decision|2|||
125352667|NCT02414139|450926063|FG007|Treatment Period|Physician Decision|0|||
125352668|NCT02414139|450926064|FG008|Treatment Period|Physician Decision|1|||
125352669|NCT02414139|450926065|FG009|Treatment Period|Physician Decision|4|||
125352670|NCT02414139|450926056|FG000|Treatment Period|Progressive disease|48|||
125352671|NCT02414139|450926057|FG001|Treatment Period|Progressive disease|31|||
125352672|NCT02414139|450926058|FG002|Treatment Period|Progressive disease|37|||
125352673|NCT02414139|450926059|FG003|Treatment Period|Progressive disease|21|||
125352674|NCT02414139|450926060|FG004|Treatment Period|Progressive disease|43|||
125352675|NCT02414139|450926061|FG005|Treatment Period|Progressive disease|12|||
125352676|NCT02414139|450926062|FG006|Treatment Period|Progressive disease|16|||
125352677|NCT02414139|450926063|FG007|Treatment Period|Progressive disease|2|||
125352678|NCT02414139|450926064|FG008|Treatment Period|Progressive disease|20|||
125352679|NCT02414139|450926065|FG009|Treatment Period|Progressive disease|14|||
125352680|NCT02414139|450926056|FG000|Treatment Period|Protocol deviation|0|||
125352681|NCT02414139|450926057|FG001|Treatment Period|Protocol deviation|0|||
125352682|NCT02414139|450926058|FG002|Treatment Period|Protocol deviation|1|||
125352683|NCT02414139|450926059|FG003|Treatment Period|Protocol deviation|0|||
125352684|NCT02414139|450926060|FG004|Treatment Period|Protocol deviation|0|||
125352685|NCT02414139|450926061|FG005|Treatment Period|Protocol deviation|0|||
125352686|NCT02414139|450926062|FG006|Treatment Period|Protocol deviation|0|||
125352687|NCT02414139|450926063|FG007|Treatment Period|Protocol deviation|0|||
125352688|NCT02414139|450926064|FG008|Treatment Period|Protocol deviation|0|||
125556198|NCT01678209|451670670|FG002|Overall Study|scheduling conflicts|1|||
125352689|NCT02414139|450926065|FG009|Treatment Period|Protocol deviation|0|||
125352690|NCT02414139|450926056|FG000|Treatment Period|Subject/Guardian decision|5|||
125556199|NCT01678209|451670668|FG000|Overall Study|screen fail|16|||
125556200|NCT01678209|451670669|FG001|Overall Study|screen fail|17|||
125556201|NCT01678209|451670670|FG002|Overall Study|screen fail|16|||
125556202|NCT00702845|451670671|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
125556203|NCT00702845|451670672|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
125556204|NCT00702845|451670671|FG000|Overall Study|Too high ovarian response|5|||
125556205|NCT00702845|451670672|FG001|Overall Study|Too high ovarian response|1|||
125556206|NCT00702845|451670671|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
125352691|NCT02414139|450926057|FG001|Treatment Period|Subject/Guardian decision|1|||
125352692|NCT02414139|450926058|FG002|Treatment Period|Subject/Guardian decision|1|||
125352693|NCT02414139|450926059|FG003|Treatment Period|Subject/Guardian decision|2|||
125352694|NCT02414139|450926060|FG004|Treatment Period|Subject/Guardian decision|5|||
125352695|NCT02414139|450926061|FG005|Treatment Period|Subject/Guardian decision|0|||
125556207|NCT00702845|451670672|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
125556208|NCT00702845|451670671|FG000|Overall Study|Insufficient ovarian response|1|||
125556209|NCT00702845|451670672|FG001|Overall Study|Insufficient ovarian response|0|||
125556210|NCT00702845|451670671|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
125556211|NCT00702845|451670672|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
125556212|NCT00702845|451670671|FG000|Overall Study|No or abnormal fertilization|4|||
125556213|NCT00702845|451670672|FG001|Overall Study|No or abnormal fertilization|2|||
125556214|NCT00702845|451670671|FG000|Overall Study|Patient's decision|2|||
125556215|NCT00702845|451670672|FG001|Overall Study|Patient's decision|1|||
125556216|NCT00702845|451670671|FG000|Overall Study|Not randomized|0|||
125556217|NCT00702845|451670672|FG001|Overall Study|Not randomized|1|||
125556218|NCT02973425|451670676|FG000|Overall Study|Lost to Follow-up|49|||
125556219|NCT02973425|451670677|FG001|Overall Study|Lost to Follow-up|53|||
125556220|NCT03876171|451670678|FG000|Overall Study|Withdrawal by Subject|3|||
125352696|NCT02414139|450926062|FG006|Treatment Period|Subject/Guardian decision|2|||
125352697|NCT02414139|450926063|FG007|Treatment Period|Subject/Guardian decision|0|||
125352698|NCT02414139|450926064|FG008|Treatment Period|Subject/Guardian decision|1|||
125352699|NCT02414139|450926065|FG009|Treatment Period|Subject/Guardian decision|1|||
125352700|NCT02414139|450926056|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
125352701|NCT02414139|450926057|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
125352702|NCT02414139|450926058|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
125352703|NCT02414139|450926059|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
125352704|NCT02414139|450926060|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
125352705|NCT02414139|450926061|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
125352706|NCT02414139|450926062|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
125352707|NCT02414139|450926063|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
125352708|NCT02414139|450926064|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
125425984|NCT00553696|451182420|FG003|Overall Study|Objective progression or relapse|0|||
125425985|NCT00553696|451182417|FG000|Overall Study|Withdrawal by Subject|0|||
125556221|NCT03876171|451670679|FG001|Overall Study|Withdrawal by Subject|3|||
125556222|NCT03876171|451670678|FG000|Overall Study|Re-arrest|0|||
125556223|NCT03876171|451670679|FG001|Overall Study|Re-arrest|4|||
125556224|NCT03503513|451670680|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
125556225|NCT03503513|451670680|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
125556226|NCT03503513|451670680|FG000|Overall Study|Physician Decision|3|||
125556227|NCT03503513|451670680|FG000|Overall Study|Withdrawal by Subject|2|||
125352709|NCT02414139|450926065|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
125556228|NCT03503513|451670680|FG000|Overall Study|Lost to Follow-up|1|||
125352710|NCT02414139|450926056|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
125425986|NCT00553696|451182418|FG001|Overall Study|Withdrawal by Subject|1|||
125425987|NCT00553696|451182419|FG002|Overall Study|Withdrawal by Subject|0|||
125425988|NCT00553696|451182420|FG003|Overall Study|Withdrawal by Subject|0|||
125425989|NCT02276222|451182423|FG000|Overall Study|Adverse Event|62|||
125425990|NCT02276222|451182424|FG001|Overall Study|Adverse Event|11|||
125425991|NCT02276222|451182423|FG000|Overall Study|Death|3|||
125425992|NCT02276222|451182424|FG001|Overall Study|Death|4|||
125425993|NCT02276222|451182423|FG000|Overall Study|Lack of Efficacy|13|||
125556229|NCT00929656|451670685|FG000|Overall Study|Lost to Follow-up|0|||
125556230|NCT00929656|451670686|FG001|Overall Study|Lost to Follow-up|1|||
125425994|NCT02276222|451182424|FG001|Overall Study|Lack of Efficacy|3|||
125556231|NCT00607880|451670687|FG000|Overall Study|Unable to place port due to occlusion|1|||
125556232|NCT00607880|451670688|FG001|Overall Study|Unable to place port due to occlusion|0|||
125556233|NCT01170039|451670691|FG000|Overall Study|Withdrawal by Subject|5|||
125556234|NCT01170039|451670692|FG001|Overall Study|Withdrawal by Subject|3|||
125556235|NCT01170039|451670691|FG000|Overall Study|Lack of funding, drug not available|3|||
125556236|NCT01170039|451670692|FG001|Overall Study|Lack of funding, drug not available|3|||
125556237|NCT00908583|451670693|FG000|Phase 1|Withdrawal by Subject|1|||
125556238|NCT00908583|451670693|FG000|Phase 1|Adverse Event|4|||
125556239|NCT00908583|451670693|FG000|Phase 2|Physician Decision|1|||
125556240|NCT00908583|451670693|FG000|Phase 2|Adverse Event|1|||
125556241|NCT00908583|451670693|FG000|Phase 3|Adverse Event|2|||
125556242|NCT00908583|451670693|FG000|Phase 4|Adverse Event|1|||
125556243|NCT00908583|451670693|FG000|Phase 4|Physician Decision|1|||
125556244|NCT00908583|451670693|FG000|Phase 5|Adverse Event|3|||
125556245|NCT00993954|451670694|FG000|Overall Study|Protocol Violation|21|||
125556246|NCT00993954|451670695|FG001|Overall Study|Protocol Violation|2|||
125556247|NCT00860951|451670696|FG000|Overall Study|Withdrawal by Subject|2|||
125556248|NCT00860951|451670696|FG000|Overall Study|Lost to Follow-up|5|||
125556249|NCT00727649|451670697|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
125556250|NCT00727649|451670698|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
125556251|NCT00727649|451670697|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
125556252|NCT00727649|451670698|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
125556253|NCT00727649|451670697|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
125556254|NCT00727649|451670698|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
125556255|NCT00727649|451670697|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
125556256|NCT00727649|451670698|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
125556257|NCT00727649|451670697|FG000|Second Intervention (4-weeks)|Death|1|||
125556258|NCT00727649|451670698|FG001|Second Intervention (4-weeks)|Death|0|||
125556259|NCT00727649|451670697|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
125556260|NCT00727649|451670698|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
125425995|NCT02276222|451182423|FG000|Overall Study|Protocol Violation|3|||
125556261|NCT00727649|451670697|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
125556262|NCT00727649|451670698|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
125425996|NCT02276222|451182424|FG001|Overall Study|Protocol Violation|2|||
125556263|NCT03627767|451670699|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
125556264|NCT03627767|451670700|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
125556265|NCT03627767|451670701|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
125556266|NCT03627767|451670702|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
125556267|NCT03627767|451670703|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
125556268|NCT03627767|451670699|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
125425997|NCT02276222|451182423|FG000|Overall Study|Withdrawal by Subject|79|||
125556269|NCT03627767|451670700|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
125556270|NCT03627767|451670701|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
125556271|NCT03627767|451670702|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
125556272|NCT03627767|451670703|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
125556273|NCT03627767|451670699|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
125352711|NCT02414139|450926057|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125352712|NCT02414139|450926058|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125352713|NCT02414139|450926059|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125352714|NCT02414139|450926060|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
125352715|NCT02414139|450926061|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125352716|NCT02414139|450926062|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125352717|NCT02414139|450926063|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125352718|NCT02414139|450926064|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125352719|NCT02414139|450926065|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125352720|NCT02414139|450926056|FG000|Post-treatment Efficacy Follow-up|Death|0|||
125352721|NCT02414139|450926057|FG001|Post-treatment Efficacy Follow-up|Death|1|||
125352722|NCT02414139|450926058|FG002|Post-treatment Efficacy Follow-up|Death|0|||
125352723|NCT02414139|450926059|FG003|Post-treatment Efficacy Follow-up|Death|0|||
125352724|NCT02414139|450926060|FG004|Post-treatment Efficacy Follow-up|Death|1|||
125352725|NCT02414139|450926061|FG005|Post-treatment Efficacy Follow-up|Death|0|||
125352726|NCT02414139|450926062|FG006|Post-treatment Efficacy Follow-up|Death|0|||
125352727|NCT02414139|450926063|FG007|Post-treatment Efficacy Follow-up|Death|0|||
125352728|NCT02414139|450926064|FG008|Post-treatment Efficacy Follow-up|Death|0|||
125352729|NCT02414139|450926065|FG009|Post-treatment Efficacy Follow-up|Death|1|||
125352730|NCT02414139|450926056|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
125352731|NCT02414139|450926057|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125352732|NCT02414139|450926058|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125352733|NCT02414139|450926059|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125352734|NCT02414139|450926060|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125352735|NCT02414139|450926061|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125352736|NCT02414139|450926062|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125352737|NCT02414139|450926063|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125352738|NCT02414139|450926064|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125352739|NCT02414139|450926065|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125352740|NCT02414139|450926056|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
125352741|NCT02414139|450926057|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
125352742|NCT02414139|450926058|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
125556274|NCT03627767|451670700|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
125556275|NCT03627767|451670701|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
125556276|NCT03627767|451670702|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
125556277|NCT03627767|451670703|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
125556278|NCT03627767|451670699|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
125556279|NCT03627767|451670700|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
125556280|NCT03627767|451670701|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
125352743|NCT02414139|450926059|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
125352744|NCT02414139|450926060|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
125352745|NCT02414139|450926061|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
125352746|NCT02414139|450926062|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125352747|NCT02414139|450926063|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
125352748|NCT02414139|450926064|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
125352749|NCT02414139|450926065|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125352750|NCT02414139|450926056|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
125352751|NCT02414139|450926057|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
125352752|NCT02414139|450926058|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
125352753|NCT02414139|450926059|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
125352754|NCT02414139|450926060|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
125352755|NCT02414139|450926061|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
125352756|NCT02414139|450926062|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
125352757|NCT02414139|450926063|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
125352758|NCT02414139|450926064|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
125352759|NCT02414139|450926065|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
125352760|NCT02414139|450926056|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125352761|NCT02414139|450926057|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
125352762|NCT02414139|450926058|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125352763|NCT02414139|450926059|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125352764|NCT02414139|450926060|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125556281|NCT03627767|451670702|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
125556282|NCT03627767|451670703|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
125556283|NCT03627767|451670699|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
125352765|NCT02414139|450926061|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125352766|NCT02414139|450926062|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125352767|NCT02414139|450926063|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125352768|NCT02414139|450926064|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
125352769|NCT02414139|450926065|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
125352770|NCT02414139|450926056|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
125352771|NCT02414139|450926057|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
125352772|NCT02414139|450926058|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
125352773|NCT02414139|450926059|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
125352774|NCT02414139|450926060|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
125352775|NCT02414139|450926061|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
125352776|NCT02414139|450926062|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
125352777|NCT02414139|450926063|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
125352778|NCT02414139|450926064|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
125352779|NCT02414139|450926065|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
125352780|NCT02632838|450926066|FG000|Overall Study|Withdrawal by Subject|3|||
125352781|NCT02632838|450926067|FG001|Overall Study|Withdrawal by Subject|0|||
125352782|NCT02632838|450926066|FG000|Overall Study|Lost to Follow-up|0|||
125352783|NCT02632838|450926067|FG001|Overall Study|Lost to Follow-up|2|||
125352784|NCT02810340|450926068|FG000|Overall Study|Withdrawal by Subject|1|||
125352785|NCT02810340|450926069|FG001|Overall Study|Withdrawal by Subject|0|||
125352786|NCT02810340|450926070|FG002|Overall Study|Withdrawal by Subject|0|||
125352787|NCT02810340|450926068|FG000|Overall Study|Incarceration|0|||
125556284|NCT03627767|451670700|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
125352788|NCT02810340|450926069|FG001|Overall Study|Incarceration|1|||
125352789|NCT02810340|450926070|FG002|Overall Study|Incarceration|0|||
125352790|NCT02810340|450926068|FG000|Overall Study|Lost to Follow-up|0|||
125352791|NCT02810340|450926069|FG001|Overall Study|Lost to Follow-up|0|||
125352792|NCT02810340|450926070|FG002|Overall Study|Lost to Follow-up|1|||
125352793|NCT01484938|450926076|FG000|Overall Study|Adverse Event|2|||
125352794|NCT01484938|450926076|FG000|Overall Study|Lost to Follow-up|1|||
125352795|NCT01484938|450926076|FG000|Overall Study|Noncompliance|1|||
125352796|NCT02942576|450926077|FG000|Overall Study|Adverse Event|28|||
125352797|NCT02942576|450926078|FG001|Overall Study|Adverse Event|6|||
125352798|NCT02942576|450926077|FG000|Overall Study|Withdrawal by Subject|7|||
125352799|NCT02942576|450926078|FG001|Overall Study|Withdrawal by Subject|5|||
125352800|NCT02942576|450926077|FG000|Overall Study|Physician Decision|1|||
125352801|NCT02942576|450926078|FG001|Overall Study|Physician Decision|4|||
125352802|NCT02942576|450926077|FG000|Overall Study|Other|10|||
125352803|NCT02942576|450926078|FG001|Overall Study|Other|8|||
125352804|NCT00938964|450926079|FG000|Overall Study|Death|3|||
125352805|NCT00938964|450926080|FG001|Overall Study|Death|3|||
125352806|NCT00938964|450926079|FG000|Overall Study|Lost to Follow-up|2|||
125352807|NCT00938964|450926080|FG001|Overall Study|Lost to Follow-up|3|||
125352808|NCT00938964|450926079|FG000|Overall Study|Withdrawal by Subject|22|||
125352809|NCT00938964|450926080|FG001|Overall Study|Withdrawal by Subject|18|||
125352810|NCT00938964|450926079|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
125352811|NCT00938964|450926080|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
125556285|NCT03627767|451670701|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
125352812|NCT02211638|450926081|FG000|Overall Study|Case Report Forms Uncollected|291|||
125352813|NCT02211638|450926081|FG000|Overall Study|Protocol Violation|692|||
125352814|NCT02775903|450926084|FG000|Overall Study|Death|7|||
125352815|NCT02775903|450926085|FG001|Overall Study|Death|11|||
125352816|NCT02775903|450926086|FG002|Overall Study|Death|12|||
125352817|NCT02775903|450926087|FG003|Overall Study|Death|11|||
125556286|NCT03627767|451670702|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
125556287|NCT03627767|451670703|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
125556288|NCT03627767|451670699|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
125556289|NCT03627767|451670700|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
125556290|NCT03627767|451670701|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
125556291|NCT03627767|451670702|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
125556292|NCT03627767|451670703|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
125556293|NCT03627767|451670699|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
125556294|NCT03627767|451670700|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
125556295|NCT03627767|451670701|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
125556296|NCT03627767|451670702|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
125556297|NCT03627767|451670703|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
125556298|NCT03627767|451670699|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
125556299|NCT03627767|451670700|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
125556300|NCT03627767|451670701|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
125352818|NCT02775903|450926084|FG000|Overall Study|Adverse Event|0|||
125352819|NCT02775903|450926085|FG001|Overall Study|Adverse Event|1|||
125352820|NCT02775903|450926086|FG002|Overall Study|Adverse Event|12|||
125352821|NCT02775903|450926087|FG003|Overall Study|Adverse Event|3|||
125556301|NCT03627767|451670702|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
125556302|NCT03627767|451670703|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
125556303|NCT03627767|451670699|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
125556304|NCT03627767|451670700|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
125352822|NCT02775903|450926084|FG000|Overall Study|Progressive disease|15|||
125352823|NCT02775903|450926085|FG001|Overall Study|Progressive disease|14|||
125352824|NCT02775903|450926086|FG002|Overall Study|Progressive disease|30|||
125352825|NCT02775903|450926087|FG003|Overall Study|Progressive disease|20|||
125352826|NCT02775903|450926084|FG000|Overall Study|Lack of Efficacy|2|||
125352827|NCT02775903|450926085|FG001|Overall Study|Lack of Efficacy|2|||
125352828|NCT02775903|450926086|FG002|Overall Study|Lack of Efficacy|2|||
125352829|NCT02775903|450926087|FG003|Overall Study|Lack of Efficacy|6|||
125352830|NCT02775903|450926084|FG000|Overall Study|Withdrawal by Subject|7|||
125352831|NCT02775903|450926085|FG001|Overall Study|Withdrawal by Subject|5|||
125352832|NCT02775903|450926086|FG002|Overall Study|Withdrawal by Subject|5|||
125352833|NCT02775903|450926087|FG003|Overall Study|Withdrawal by Subject|8|||
125352834|NCT02775903|450926084|FG000|Overall Study|Other reasons|7|||
125352835|NCT02775903|450926085|FG001|Overall Study|Other reasons|8|||
125352836|NCT02775903|450926086|FG002|Overall Study|Other reasons|2|||
125352837|NCT02775903|450926087|FG003|Overall Study|Other reasons|12|||
125556305|NCT03627767|451670701|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
125556306|NCT03627767|451670702|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
125556307|NCT03627767|451670703|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
125556308|NCT03627767|451670699|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
125556309|NCT03627767|451670700|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
125556310|NCT03627767|451670701|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
125556311|NCT03627767|451670702|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
125556312|NCT03627767|451670703|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
125556313|NCT03627767|451670699|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
125556314|NCT03627767|451670700|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
125352838|NCT04041700|450926088|FG000|Overall Study|Pregnancy|1|||
125352839|NCT04041700|450926088|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
125352840|NCT04571515|450926091|FG000|Overall Study|Physician Decision|0|||
125352841|NCT04571515|450926092|FG001|Overall Study|Physician Decision|0|||
125352842|NCT04571515|450926093|FG002|Overall Study|Physician Decision|0|||
125352843|NCT04571515|450926094|FG003|Overall Study|Physician Decision|0|||
125352844|NCT04571515|450926095|FG004|Overall Study|Physician Decision|1|||
125352845|NCT04571515|450926091|FG000|Overall Study|Withdrawal by Subject|0|||
125352846|NCT04571515|450926092|FG001|Overall Study|Withdrawal by Subject|0|||
125352847|NCT04571515|450926093|FG002|Overall Study|Withdrawal by Subject|0|||
125352848|NCT04571515|450926094|FG003|Overall Study|Withdrawal by Subject|0|||
125352849|NCT04571515|450926095|FG004|Overall Study|Withdrawal by Subject|1|||
125352850|NCT04571515|450926091|FG000|Overall Study|insufficient pain|1|||
125352851|NCT04571515|450926092|FG001|Overall Study|insufficient pain|0|||
125352852|NCT04571515|450926093|FG002|Overall Study|insufficient pain|0|||
125352853|NCT04571515|450926094|FG003|Overall Study|insufficient pain|0|||
125352854|NCT04571515|450926095|FG004|Overall Study|insufficient pain|1|||
125352855|NCT05140382|450926096|FG000|Overall Study|Death|3|||
125352856|NCT05140382|450926097|FG001|Overall Study|Death|0|||
125352857|NCT05140382|450926098|FG002|Overall Study|Death|0|||
125352858|NCT05140382|450926096|FG000|Overall Study|Investigator decision|1|||
125352859|NCT05140382|450926097|FG001|Overall Study|Investigator decision|0|||
125425998|NCT02276222|451182424|FG001|Overall Study|Withdrawal by Subject|33|||
125425999|NCT02276222|451182423|FG000|Overall Study|non compliance with study medication|6|||
125426000|NCT02276222|451182424|FG001|Overall Study|non compliance with study medication|2|||
125426001|NCT02276222|451182423|FG000|Overall Study|sponsor decision|0|||
125352860|NCT05140382|450926098|FG002|Overall Study|Investigator decision|0|||
125352861|NCT05140382|450926096|FG000|Overall Study|Other|4|||
125352862|NCT05140382|450926097|FG001|Overall Study|Other|0|||
125352863|NCT05140382|450926098|FG002|Overall Study|Other|1|||
125352864|NCT05140382|450926096|FG000|Overall Study|Progressive disease|20|||
125352865|NCT05140382|450926097|FG001|Overall Study|Progressive disease|1|||
125426002|NCT02276222|451182424|FG001|Overall Study|sponsor decision|3|||
125426003|NCT02276222|451182423|FG000|Overall Study|Lost to Follow-up|15|||
125426004|NCT02276222|451182424|FG001|Overall Study|Lost to Follow-up|5|||
125426005|NCT02276222|451182423|FG000|Overall Study|Physician Decision|2|||
125426006|NCT02276222|451182424|FG001|Overall Study|Physician Decision|1|||
125426007|NCT02276222|451182423|FG000|Overall Study|sheduling conflict|1|||
125426008|NCT02276222|451182424|FG001|Overall Study|sheduling conflict|0|||
125426009|NCT02276222|451182423|FG000|Overall Study|subject withdrew after randomization|1|||
125426010|NCT02276222|451182424|FG001|Overall Study|subject withdrew after randomization|0|||
125426011|NCT03645759|451182425|FG000|Overall Study|Lost to Follow-up|3|||
125426012|NCT03645759|451182426|FG001|Overall Study|Lost to Follow-up|2|||
125426013|NCT01648270|451182427|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
125426014|NCT02170025|451182428|FG000|Overall Study|Adverse Event|2|||
125426015|NCT02170025|451182429|FG001|Overall Study|Adverse Event|0|||
125426016|NCT00572195|451182430|FG000|Overall Study|Withdrawal by Subject|50|||
125426017|NCT00572195|451182430|FG000|Overall Study|Death|9|||
125426018|NCT00572195|451182430|FG000|Overall Study|Adverse Event|4|||
125426019|NCT00572195|451182430|FG000|Overall Study|Lost to Follow-up|5|||
125426020|NCT00902694|451182431|FG000|Overall Study|Death|1|||
125426021|NCT00902694|451182432|FG001|Overall Study|Death|3|||
125352866|NCT05140382|450926098|FG002|Overall Study|Progressive disease|12|||
125352867|NCT05140382|450926096|FG000|Overall Study|Subjective disease progression|2|||
125352868|NCT05140382|450926097|FG001|Overall Study|Subjective disease progression|1|||
125352869|NCT05140382|450926098|FG002|Overall Study|Subjective disease progression|0|||
125352870|NCT05140382|450926096|FG000|Overall Study|Unknown at data cut-off|0|||
125352871|NCT05140382|450926097|FG001|Overall Study|Unknown at data cut-off|0|||
125352872|NCT05140382|450926098|FG002|Overall Study|Unknown at data cut-off|1|||
125556315|NCT03627767|451670701|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
125556316|NCT03627767|451670702|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
125352873|NCT05140382|450926096|FG000|Overall Study|Withdrawal by Subject|1|||
125352874|NCT05140382|450926097|FG001|Overall Study|Withdrawal by Subject|0|||
125556317|NCT03627767|451670703|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
125352875|NCT05140382|450926098|FG002|Overall Study|Withdrawal by Subject|4|||
125352876|NCT05140382|450926096|FG000|Overall Study|Withdrawal of consent|0|||
125352877|NCT05140382|450926097|FG001|Overall Study|Withdrawal of consent|0|||
125352878|NCT05140382|450926098|FG002|Overall Study|Withdrawal of consent|1|||
125352879|NCT00323869|450926105|FG000|Overall Study|Death|1|||
125352880|NCT04902326|450927639|FG000|Overall Study|Withdrawal by Subject|1|||
125352881|NCT04902326|450927640|FG001|Overall Study|Withdrawal by Subject|3|||
125352882|NCT04902326|450927641|FG002|Overall Study|Withdrawal by Subject|0|||
125352883|NCT04902326|450927642|FG003|Overall Study|Withdrawal by Subject|1|||
125352884|NCT04902326|450927639|FG000|Overall Study|Lost to Follow-up|14|||
125352885|NCT04902326|450927640|FG001|Overall Study|Lost to Follow-up|14|||
125352886|NCT04902326|450927641|FG002|Overall Study|Lost to Follow-up|14|||
125352887|NCT04902326|450927642|FG003|Overall Study|Lost to Follow-up|6|||
125352888|NCT00427960|450927643|FG000|Overall Study|Adverse Event|2|||
125352889|NCT00427960|450927644|FG001|Overall Study|Adverse Event|0|||
125352890|NCT00427960|450927643|FG000|Overall Study|Withdrawal by Subject|0|||
125556318|NCT03627767|451670699|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
125556319|NCT03627767|451670700|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
125556320|NCT03627767|451670701|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
125556321|NCT03627767|451670702|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
125352891|NCT00427960|450927644|FG001|Overall Study|Withdrawal by Subject|3|||
125352892|NCT00427960|450927643|FG000|Overall Study|Other|0|||
125352893|NCT00427960|450927644|FG001|Overall Study|Other|1|||
125352894|NCT00423670|450927647|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
125352895|NCT00423670|450927648|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
125352896|NCT00423670|450927649|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
125352897|NCT00423670|450927650|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
125352898|NCT00423670|450927651|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
125352899|NCT00423670|450927652|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
125352900|NCT00423670|450927653|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
125352901|NCT00423670|450927654|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
125352902|NCT00423670|450927647|FG000|Treatment Period|Adverse Event|8|||
125352903|NCT00423670|450927648|FG001|Treatment Period|Adverse Event|12|||
125352904|NCT00423670|450927649|FG002|Treatment Period|Adverse Event|15|||
125352905|NCT00423670|450927650|FG003|Treatment Period|Adverse Event|20|||
125352906|NCT00423670|450927651|FG004|Treatment Period|Adverse Event|9|||
125352907|NCT00423670|450927652|FG005|Treatment Period|Adverse Event|4|||
125352908|NCT00423670|450927653|FG006|Treatment Period|Adverse Event|7|||
125352909|NCT00423670|450927654|FG007|Treatment Period|Adverse Event|2|||
125352910|NCT00423670|450927647|FG000|Treatment Period|Protocol-defined clinical event|0|||
125352911|NCT00423670|450927648|FG001|Treatment Period|Protocol-defined clinical event|7|||
125352912|NCT00423670|450927649|FG002|Treatment Period|Protocol-defined clinical event|4|||
125352913|NCT00423670|450927650|FG003|Treatment Period|Protocol-defined clinical event|12|||
125352914|NCT00423670|450927651|FG004|Treatment Period|Protocol-defined clinical event|5|||
125352915|NCT00423670|450927652|FG005|Treatment Period|Protocol-defined clinical event|4|||
125352916|NCT00423670|450927653|FG006|Treatment Period|Protocol-defined clinical event|16|||
125352917|NCT00423670|450927654|FG007|Treatment Period|Protocol-defined clinical event|15|||
125352918|NCT00423670|450927647|FG000|Treatment Period|Lost to Follow-up|2|||
125352919|NCT00423670|450927648|FG001|Treatment Period|Lost to Follow-up|1|||
125352920|NCT00423670|450927649|FG002|Treatment Period|Lost to Follow-up|3|||
125352921|NCT00423670|450927650|FG003|Treatment Period|Lost to Follow-up|1|||
125352922|NCT00423670|450927651|FG004|Treatment Period|Lost to Follow-up|6|||
125352923|NCT00423670|450927652|FG005|Treatment Period|Lost to Follow-up|0|||
125556322|NCT03627767|451670703|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
125556323|NCT03627767|451670699|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
125556324|NCT03627767|451670700|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
125556325|NCT03627767|451670701|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
125556326|NCT03627767|451670702|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
125556327|NCT03627767|451670703|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
125556328|NCT03627767|451670699|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
125556329|NCT03627767|451670700|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
125352924|NCT00423670|450927653|FG006|Treatment Period|Lost to Follow-up|3|||
125352925|NCT00423670|450927654|FG007|Treatment Period|Lost to Follow-up|1|||
125352926|NCT00423670|450927647|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
125556330|NCT03627767|451670701|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
125556331|NCT03627767|451670702|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
125556332|NCT03627767|451670703|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
125352927|NCT00423670|450927648|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
125352928|NCT00423670|450927649|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
125426022|NCT00902694|451182431|FG000|Overall Study|Lost to Follow-up|1|||
125426023|NCT00902694|451182432|FG001|Overall Study|Lost to Follow-up|0|||
125426024|NCT00902694|451182431|FG000|Overall Study|Censored per protocol|3|||
125426025|NCT00902694|451182432|FG001|Overall Study|Censored per protocol|1|||
125426026|NCT00902694|451182431|FG000|Overall Study|Pregnancy|1|||
125426027|NCT00902694|451182432|FG001|Overall Study|Pregnancy|1|||
125426028|NCT00902694|451182431|FG000|Overall Study|Incarceration|1|||
125426029|NCT00902694|451182432|FG001|Overall Study|Incarceration|0|||
125426030|NCT04969263|451182433|FG000|Overall Study|Death|1|||
125426031|NCT04969263|451182433|FG000|Overall Study|Lost to Follow-up|2|||
125426032|NCT04969263|451182433|FG000|Overall Study|Withdrawal by Subject|5|||
125426033|NCT04969263|451182433|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
125426034|NCT02693743|451182434|FG000|Overall Study|Physician Decision|1|||
125426035|NCT02693743|451182435|FG001|Overall Study|Physician Decision|0|||
125426036|NCT01024608|451182436|FG000|Overall Study|Adverse Event|1|||
125426037|NCT01024608|451182437|FG001|Overall Study|Adverse Event|0|||
125426038|NCT01024608|451182436|FG000|Overall Study|Withdrawal by Subject|1|||
125352929|NCT00423670|450927650|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
125352930|NCT00423670|450927651|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
125352931|NCT00423670|450927652|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
125426039|NCT01024608|451182437|FG001|Overall Study|Withdrawal by Subject|0|||
125426040|NCT01024608|451182436|FG000|Overall Study|Lost to Follow-up|0|||
125637198|NCT03073200|451952834|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
125352932|NCT00423670|450927653|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
125352933|NCT00423670|450927654|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
125352934|NCT00423670|450927647|FG000|Treatment Period|Investigator decision|0|||
125352935|NCT00423670|450927648|FG001|Treatment Period|Investigator decision|0|||
125352936|NCT00423670|450927649|FG002|Treatment Period|Investigator decision|0|||
125352937|NCT00423670|450927650|FG003|Treatment Period|Investigator decision|0|||
125352938|NCT00423670|450927651|FG004|Treatment Period|Investigator decision|0|||
125352939|NCT00423670|450927652|FG005|Treatment Period|Investigator decision|0|||
125352940|NCT00423670|450927653|FG006|Treatment Period|Investigator decision|0|||
125352941|NCT00423670|450927654|FG007|Treatment Period|Investigator decision|1|||
125352942|NCT00423670|450927647|FG000|Treatment Period|Non-compliance with protocol|3|||
125352943|NCT00423670|450927648|FG001|Treatment Period|Non-compliance with protocol|1|||
125352944|NCT00423670|450927649|FG002|Treatment Period|Non-compliance with protocol|1|||
125352945|NCT00423670|450927650|FG003|Treatment Period|Non-compliance with protocol|3|||
125352946|NCT00423670|450927651|FG004|Treatment Period|Non-compliance with protocol|2|||
125352947|NCT00423670|450927652|FG005|Treatment Period|Non-compliance with protocol|0|||
125352948|NCT00423670|450927653|FG006|Treatment Period|Non-compliance with protocol|2|||
125352949|NCT00423670|450927654|FG007|Treatment Period|Non-compliance with protocol|2|||
125352950|NCT00423670|450927647|FG000|Follow-up Period|Lost to Follow-up|0|||
125426041|NCT01024608|451182437|FG001|Overall Study|Lost to Follow-up|1|||
125426042|NCT01024608|451182436|FG000|Overall Study|Protocol Violation|0|||
125352951|NCT00423670|450927648|FG001|Follow-up Period|Lost to Follow-up|12|||
125426043|NCT01024608|451182437|FG001|Overall Study|Protocol Violation|3|||
125352952|NCT00423670|450927649|FG002|Follow-up Period|Lost to Follow-up|8|||
125352953|NCT00423670|450927650|FG003|Follow-up Period|Lost to Follow-up|3|||
125352954|NCT00423670|450927651|FG004|Follow-up Period|Lost to Follow-up|1|||
125426044|NCT01024608|451182436|FG000|Overall Study|Never received study treatment|2|||
125426045|NCT01024608|451182437|FG001|Overall Study|Never received study treatment|0|||
125426046|NCT02412137|451182438|FG000|Overall Study|Withdrawal by Subject|2|||
125426047|NCT02412137|451182439|FG001|Overall Study|Withdrawal by Subject|0|||
125426048|NCT02412137|451182438|FG000|Overall Study|Lost to Follow-up|21|||
125426049|NCT02412137|451182439|FG001|Overall Study|Lost to Follow-up|14|||
125426050|NCT02412137|451182438|FG000|Overall Study|Physician Decision|28|||
125426051|NCT02412137|451182439|FG001|Overall Study|Physician Decision|9|||
125426052|NCT04981678|451182446|FG000|Overall Study|Lost to Follow-up|0|||
125426053|NCT04981678|451182447|FG001|Overall Study|Lost to Follow-up|1|||
125426054|NCT04922554|451182448|FG000|Overall Study|Adverse Event|4|||
125426055|NCT04922554|451182449|FG001|Overall Study|Adverse Event|0|||
125426056|NCT04922554|451182448|FG000|Overall Study|Withdrawal by Subject|1|||
125426057|NCT04922554|451182449|FG001|Overall Study|Withdrawal by Subject|0|||
125426058|NCT01323530|451184360|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
125426059|NCT01323530|451184361|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125426060|NCT01323530|451184362|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125426061|NCT01323530|451184363|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125426062|NCT01323530|451184364|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125426063|NCT01323530|451184365|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
125426064|NCT01323530|451184366|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
125426065|NCT01323530|451184360|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
125426066|NCT01323530|451184361|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
125426067|NCT01323530|451184362|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
125426068|NCT01323530|451184363|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125426069|NCT01323530|451184364|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
125426070|NCT01323530|451184365|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125426071|NCT01323530|451184366|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
125426072|NCT01323530|451184360|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
125426073|NCT01323530|451184361|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
125426074|NCT01323530|451184362|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
125426075|NCT01323530|451184363|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
125426076|NCT01323530|451184364|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
125556333|NCT03627767|451670699|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
125556334|NCT03627767|451670700|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
125556335|NCT03627767|451670701|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
125556336|NCT03627767|451670702|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
125556337|NCT03627767|451670703|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
125556338|NCT03627767|451670699|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
125556339|NCT03627767|451670700|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
125556340|NCT03627767|451670701|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
125556341|NCT03627767|451670702|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
125556342|NCT03627767|451670703|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
125556343|NCT03627767|451670699|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
125556344|NCT03627767|451670700|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
125556345|NCT03627767|451670701|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
125556346|NCT03627767|451670702|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
125556347|NCT03627767|451670703|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
125556348|NCT03627767|451670699|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
125556349|NCT03627767|451670700|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
125556350|NCT03627767|451670701|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
125556351|NCT03627767|451670702|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
125556352|NCT03627767|451670703|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
125556353|NCT03627767|451670699|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
125556354|NCT03627767|451670700|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
125556355|NCT03627767|451670701|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
125556356|NCT03627767|451670702|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
125556357|NCT03627767|451670703|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
125556358|NCT03627767|451670699|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
125556359|NCT03627767|451670700|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
125556360|NCT03627767|451670701|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
125556361|NCT03627767|451670702|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
125556362|NCT03627767|451670703|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
125556363|NCT01873417|451670704|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
125426077|NCT01323530|451184365|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
125556364|NCT01873417|451670704|FG000|Overall Study|Adverse Event|24|||
125426078|NCT01323530|451184366|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
125426079|NCT01323530|451184360|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
125426080|NCT01323530|451184361|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
125426081|NCT01323530|451184362|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
125556365|NCT01873417|451670704|FG000|Overall Study|Lost to Follow-up|2|||
125556366|NCT01873417|451670704|FG000|Overall Study|Withdrawal by Subject|2|||
125556367|NCT01873417|451670704|FG000|Overall Study|Physician Decision|3|||
125556368|NCT00785044|451670705|FG000|Overall Study|Dosed at non-participating sites|152|||
125556369|NCT00785044|451670705|FG000|Overall Study|Death|77|||
125556370|NCT00785044|451670705|FG000|Overall Study|Lost to Follow-up|266|||
125352955|NCT00423670|450927652|FG005|Follow-up Period|Lost to Follow-up|0|||
125352956|NCT00423670|450927653|FG006|Follow-up Period|Lost to Follow-up|5|||
125352957|NCT00423670|450927654|FG007|Follow-up Period|Lost to Follow-up|0|||
125352958|NCT00423670|450927647|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
125352959|NCT00423670|450927648|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
125352960|NCT00423670|450927649|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
125556371|NCT00785044|451670705|FG000|Overall Study|Withdrawal by Subject|1|||
125556372|NCT00385203|451670706|FG000|Overall Study|Adverse Event|5|||
125556373|NCT00385203|451670707|FG001|Overall Study|Adverse Event|4|||
125556374|NCT00385203|451670706|FG000|Overall Study|Death|1|||
125556375|NCT00385203|451670707|FG001|Overall Study|Death|0|||
125556376|NCT00385203|451670706|FG000|Overall Study|Condition under investigation worsened|18|||
125556377|NCT00385203|451670707|FG001|Overall Study|Condition under investigation worsened|3|||
125556378|NCT00385203|451670706|FG000|Overall Study|Incorrect enrollment|2|||
125556379|NCT00385203|451670707|FG001|Overall Study|Incorrect enrollment|0|||
125556380|NCT01798992|451670708|FG000|Overall Study|Administrative withdrawal|0|||
125556381|NCT01798992|451670709|FG001|Overall Study|Administrative withdrawal|1|||
125556382|NCT01798992|451670710|FG002|Overall Study|Administrative withdrawal|0|||
125556383|NCT01798992|451670711|FG003|Overall Study|Administrative withdrawal|1|||
125556384|NCT01798992|451670708|FG000|Overall Study|Lost to Follow-up|0|||
125556385|NCT01798992|451670709|FG001|Overall Study|Lost to Follow-up|1|||
125556386|NCT01798992|451670710|FG002|Overall Study|Lost to Follow-up|1|||
125556387|NCT01798992|451670711|FG003|Overall Study|Lost to Follow-up|0|||
125556388|NCT01798992|451670708|FG000|Overall Study|Insufficient biopsy tissue|0|||
125556389|NCT01798992|451670709|FG001|Overall Study|Insufficient biopsy tissue|0|||
125352961|NCT00423670|450927650|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
125352962|NCT00423670|450927651|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
125352963|NCT00423670|450927652|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
125352964|NCT00423670|450927653|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
125352965|NCT00423670|450927654|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
125352966|NCT00423670|450927647|FG000|Follow-up Period|Non-compliance with protocol|2|||
125352967|NCT00423670|450927648|FG001|Follow-up Period|Non-compliance with protocol|0|||
125352968|NCT00423670|450927649|FG002|Follow-up Period|Non-compliance with protocol|1|||
125352969|NCT00423670|450927650|FG003|Follow-up Period|Non-compliance with protocol|1|||
125352970|NCT00423670|450927651|FG004|Follow-up Period|Non-compliance with protocol|0|||
125352971|NCT00423670|450927652|FG005|Follow-up Period|Non-compliance with protocol|0|||
125352972|NCT00423670|450927653|FG006|Follow-up Period|Non-compliance with protocol|3|||
125352973|NCT00423670|450927654|FG007|Follow-up Period|Non-compliance with protocol|2|||
125352974|NCT04163718|450927655|FG000|Overall Study|Study terminated|12|||
125352975|NCT01025154|450927656|FG000|Overall Study|Lost to Follow-up|1|||
125352976|NCT01025154|450927656|FG000|Overall Study|Withdrawal by Subject|1|||
125352977|NCT01858636|450927658|FG000|Overall Study|No Device Deployment Attempted|24|||
125352978|NCT01858636|450927658|FG000|Overall Study|Physician Decision|1|||
125352979|NCT01858636|450927658|FG000|Overall Study|Death|1|||
125352980|NCT01858636|450927658|FG000|Overall Study|Lost to Follow-up|1|||
125556390|NCT01798992|451670710|FG002|Overall Study|Insufficient biopsy tissue|1|||
125556391|NCT01798992|451670711|FG003|Overall Study|Insufficient biopsy tissue|0|||
125556392|NCT03823404|451670712|FG000|Overall Study|Lost to Follow-up|1|||
125556393|NCT03823404|451670713|FG001|Overall Study|Lost to Follow-up|2|||
125556394|NCT03823404|451670714|FG002|Overall Study|Lost to Follow-up|3|||
125352981|NCT01858636|450927658|FG000|Overall Study|Withdrawal by Subject|1|||
125352982|NCT03523000|450927662|FG000|Overall Study|Withdrawal by Subject|3|||
125352983|NCT03523000|450927663|FG001|Overall Study|Withdrawal by Subject|0|||
125352984|NCT03523000|450927662|FG000|Overall Study|Unsuccessful trial|2|||
125352985|NCT03523000|450927663|FG001|Overall Study|Unsuccessful trial|0|||
125352986|NCT01227564|450927666|FG000|Overall Study|No Longer Willing to Participate|4|||
125556395|NCT03823404|451670712|FG000|Overall Study|Protocol Violation|2|||
125556396|NCT03823404|451670713|FG001|Overall Study|Protocol Violation|0|||
125556397|NCT03823404|451670714|FG002|Overall Study|Protocol Violation|2|||
125556398|NCT03823404|451670712|FG000|Overall Study|Adverse Event|35|||
125556399|NCT03823404|451670713|FG001|Overall Study|Adverse Event|38|||
125556400|NCT03823404|451670714|FG002|Overall Study|Adverse Event|8|||
125556401|NCT03823404|451670712|FG000|Overall Study|Withdrawal by Subject|38|||
125556402|NCT03823404|451670713|FG001|Overall Study|Withdrawal by Subject|40|||
125556403|NCT03823404|451670714|FG002|Overall Study|Withdrawal by Subject|35|||
125556404|NCT03823404|451670712|FG000|Overall Study|Death|4|||
125556405|NCT03823404|451670713|FG001|Overall Study|Death|0|||
125556406|NCT03823404|451670714|FG002|Overall Study|Death|0|||
125556407|NCT03823404|451670712|FG000|Overall Study|Other: Various reasons provided|5|||
125556408|NCT03823404|451670713|FG001|Overall Study|Other: Various reasons provided|5|||
125556409|NCT03823404|451670714|FG002|Overall Study|Other: Various reasons provided|6|||
125556410|NCT02308007|451670715|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
125556411|NCT02308007|451670716|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
125556412|NCT02308007|451670717|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
125556413|NCT02308007|451670715|FG000|Overall Study|Positive for STD at Baseline|7|||
125556414|NCT02308007|451670716|FG001|Overall Study|Positive for STD at Baseline|11|||
125556415|NCT02308007|451670717|FG002|Overall Study|Positive for STD at Baseline|7|||
125556416|NCT02308007|451670715|FG000|Overall Study|Lost to Follow-up|3|||
125556417|NCT02308007|451670716|FG001|Overall Study|Lost to Follow-up|0|||
125556418|NCT02308007|451670717|FG002|Overall Study|Lost to Follow-up|1|||
125556419|NCT00528567|451670722|FG000|Overall Study|Death|4|||
125556420|NCT00528567|451670723|FG001|Overall Study|Death|5|||
125556421|NCT00528567|451670722|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
125556422|NCT00528567|451670723|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
125556423|NCT00528567|451670722|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
125556424|NCT00528567|451670723|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
125556425|NCT00528567|451670722|FG000|Overall Study|Violation Criteria at Entry|3|||
125556426|NCT00528567|451670723|FG001|Overall Study|Violation Criteria at Entry|17|||
125556427|NCT00528567|451670722|FG000|Overall Study|Withdrew Consent|59|||
125556428|NCT00528567|451670723|FG001|Overall Study|Withdrew Consent|55|||
125556429|NCT00528567|451670722|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
125352987|NCT01227564|450927667|FG001|Overall Study|No Longer Willing to Participate|2|||
125352988|NCT01227564|450927668|FG002|Overall Study|No Longer Willing to Participate|5|||
125352989|NCT01227564|450927666|FG000|Overall Study|Participant moved to another town|0|||
125352990|NCT01227564|450927667|FG001|Overall Study|Participant moved to another town|0|||
125352991|NCT01227564|450927668|FG002|Overall Study|Participant moved to another town|1|||
125352992|NCT02862600|450927677|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
125352993|NCT02862600|450927677|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
125426082|NCT01323530|451184363|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
125426083|NCT01323530|451184364|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
125426084|NCT01323530|451184365|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
125426085|NCT01323530|451184366|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
125426086|NCT01323530|451184360|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
125426087|NCT01323530|451184361|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
125426088|NCT01323530|451184362|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
125426089|NCT01323530|451184363|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
125426090|NCT01323530|451184364|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
125426091|NCT01323530|451184365|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
125426092|NCT01323530|451184366|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
125426093|NCT01323530|451184360|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
125556430|NCT00528567|451670723|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
125556431|NCT00528567|451670722|FG000|Overall Study|Failure to Return|1|||
125556432|NCT00528567|451670723|FG001|Overall Study|Failure to Return|4|||
125352994|NCT02862600|450927677|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
125352995|NCT02862600|450927677|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
125352996|NCT00772070|450927697|FG000|Overall Study|Lost to Follow-up|0|||
125352997|NCT00772070|450927698|FG001|Overall Study|Lost to Follow-up|8|||
125352998|NCT00772070|450927697|FG000|Overall Study|Withdrawal by Subject|0|||
125352999|NCT00772070|450927698|FG001|Overall Study|Withdrawal by Subject|2|||
125353000|NCT00772070|450927697|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
125353001|NCT00772070|450927698|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
125426094|NCT01323530|451184361|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
125556433|NCT00528567|451670722|FG000|Overall Study|Other Protocol Violation|5|||
125556434|NCT00528567|451670723|FG001|Overall Study|Other Protocol Violation|21|||
125556435|NCT00528567|451670722|FG000|Overall Study|Administrative/Other|22|||
125556436|NCT00528567|451670723|FG001|Overall Study|Administrative/Other|75|||
125556437|NCT03085758|451670726|FG000|Overall Study|Death|26|||
125556438|NCT03085758|451670727|FG001|Overall Study|Death|24|||
125353002|NCT01309308|450927699|FG000|Overall Study|Lost to Follow-up|6|||
125556439|NCT03085758|451670728|FG002|Overall Study|Death|53|||
125556440|NCT03085758|451670726|FG000|Overall Study|Lost to Follow-up|1|||
125426095|NCT01323530|451184362|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
125426096|NCT01323530|451184363|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
125426097|NCT01323530|451184364|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
125426098|NCT01323530|451184365|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
125426099|NCT01323530|451184366|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
125426100|NCT01323530|451184360|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
125426101|NCT01323530|451184361|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
125426102|NCT01323530|451184362|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
125426103|NCT01323530|451184363|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
125426104|NCT01323530|451184364|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
125426105|NCT01323530|451184365|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
125426106|NCT01323530|451184366|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
125556441|NCT03085758|451670727|FG001|Overall Study|Lost to Follow-up|1|||
125556442|NCT03085758|451670728|FG002|Overall Study|Lost to Follow-up|1|||
125556443|NCT03085758|451670726|FG000|Overall Study|Withdrawal by Subject|2|||
125353003|NCT01309308|450927700|FG001|Overall Study|Lost to Follow-up|4|||
125556444|NCT03085758|451670727|FG001|Overall Study|Withdrawal by Subject|2|||
125556445|NCT03085758|451670728|FG002|Overall Study|Withdrawal by Subject|1|||
125556446|NCT03085758|451670726|FG000|Overall Study|Refusal to recall it up to day 90|0|||
125556447|NCT03085758|451670727|FG001|Overall Study|Refusal to recall it up to day 90|0|||
125353004|NCT01017575|450927701|FG000|Overall Study|Lack of Efficacy|0|||
125556448|NCT03085758|451670728|FG002|Overall Study|Refusal to recall it up to day 90|1|||
125426107|NCT01323530|451184360|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
125353005|NCT01017575|450927702|FG001|Overall Study|Lack of Efficacy|1|||
125353006|NCT01017575|450927703|FG002|Overall Study|Lack of Efficacy|0|||
125353007|NCT01017575|450927704|FG003|Overall Study|Lack of Efficacy|1|||
125353008|NCT01017575|450927705|FG004|Overall Study|Lack of Efficacy|1|||
125353009|NCT01017575|450927701|FG000|Overall Study|Adverse Event|0|||
125353010|NCT01017575|450927702|FG001|Overall Study|Adverse Event|1|||
125353011|NCT01017575|450927703|FG002|Overall Study|Adverse Event|0|||
125353012|NCT01017575|450927704|FG003|Overall Study|Adverse Event|0|||
125556449|NCT03085758|451670726|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
125556450|NCT03085758|451670727|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
125556451|NCT03085758|451670728|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
125556452|NCT04004429|451670731|FG000|Overall Study|Protocol Violation|1|||
125556453|NCT04004429|451670732|FG001|Overall Study|Protocol Violation|0|||
125556454|NCT04004429|451670733|FG002|Overall Study|Protocol Violation|0|||
125556455|NCT04004429|451670731|FG000|Overall Study|Physician Decision|0|||
125556456|NCT04004429|451670732|FG001|Overall Study|Physician Decision|1|||
125556457|NCT04004429|451670733|FG002|Overall Study|Physician Decision|1|||
125556458|NCT04004429|451670731|FG000|Overall Study|Withdrawal by Subject|1|||
125556459|NCT04004429|451670732|FG001|Overall Study|Withdrawal by Subject|1|||
125353013|NCT01017575|450927705|FG004|Overall Study|Adverse Event|2|||
125556460|NCT04004429|451670733|FG002|Overall Study|Withdrawal by Subject|1|||
125556461|NCT00631189|451670734|FG000|Initial Phase|Protocol Violation|347|||
125556462|NCT00631189|451670735|FG001|Initial Phase|Protocol Violation|0|||
125353014|NCT01017575|450927701|FG000|Overall Study|Withdrawal by Subject|1|||
125353015|NCT01017575|450927702|FG001|Overall Study|Withdrawal by Subject|0|||
125353016|NCT01017575|450927703|FG002|Overall Study|Withdrawal by Subject|0|||
125353017|NCT01017575|450927704|FG003|Overall Study|Withdrawal by Subject|0|||
125353018|NCT01017575|450927705|FG004|Overall Study|Withdrawal by Subject|0|||
125556463|NCT00631189|451670736|FG002|Initial Phase|Protocol Violation|0|||
125353019|NCT01476644|450927706|FG000|Overall Study|Death|5|||
125353020|NCT01476644|450927706|FG000|Overall Study|moved to another state|2|||
125556464|NCT00631189|451670737|FG003|Initial Phase|Protocol Violation|0|||
125556465|NCT00631189|451670734|FG000|Initial Phase|Withdrawal by Subject|4|||
125353021|NCT01476644|450927706|FG000|Overall Study|Lost to Follow-up|19|||
125426108|NCT01323530|451184361|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
125426109|NCT01323530|451184362|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
125426110|NCT01323530|451184363|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
125426111|NCT01323530|451184364|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
125426112|NCT01323530|451184365|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
125426113|NCT01323530|451184366|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
125426114|NCT01111123|451184367|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
125426115|NCT01111123|451184368|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
125426116|NCT01111123|451184367|FG000|Maintenance Phase|Lost to Follow-up|0|||
125426117|NCT01111123|451184368|FG001|Maintenance Phase|Lost to Follow-up|2|||
125426118|NCT00119405|451184369|FG000|Overall Study|Withdrawal by Subject|1|||
125426119|NCT01332227|451184378|FG000|Overall Study|Adverse Event|4|||
125426120|NCT01332227|451184379|FG001|Overall Study|Adverse Event|1|||
125426121|NCT01332227|451184378|FG000|Overall Study|Withdrawal by Subject|5|||
125426122|NCT01332227|451184379|FG001|Overall Study|Withdrawal by Subject|1|||
125426123|NCT01332227|451184378|FG000|Overall Study|Lost to Follow-up|2|||
125426124|NCT01332227|451184379|FG001|Overall Study|Lost to Follow-up|0|||
125426125|NCT01332227|451184378|FG000|Overall Study|Lack of Efficacy|3|||
125426126|NCT01332227|451184379|FG001|Overall Study|Lack of Efficacy|1|||
125426127|NCT01332227|451184378|FG000|Overall Study|Poor compliance/noncompliance|1|||
125426128|NCT01332227|451184379|FG001|Overall Study|Poor compliance/noncompliance|1|||
125426129|NCT01332227|451184378|FG000|Overall Study|Patient moved from area|1|||
125426130|NCT01332227|451184379|FG001|Overall Study|Patient moved from area|0|||
125426131|NCT01332227|451184378|FG000|Overall Study|Patient began prohibited medication|0|||
125426132|NCT01332227|451184379|FG001|Overall Study|Patient began prohibited medication|1|||
125426133|NCT00514943|451184380|FG000|Stage 1|Progressive disease|4|||
125426134|NCT00514943|451184381|FG001|Stage 1|Progressive disease|8|||
125426135|NCT00514943|451184380|FG000|Stage 1|Other Adverse Event|16|||
125426136|NCT00514943|451184381|FG001|Stage 1|Other Adverse Event|6|||
125426137|NCT00514943|451184380|FG000|Stage 1|Not treated|1|||
125426138|NCT00514943|451184381|FG001|Stage 1|Not treated|2|||
125426139|NCT00514943|451184380|FG000|Stage 1|Patient refused to continue study meds|8|||
125426140|NCT00514943|451184381|FG001|Stage 1|Patient refused to continue study meds|3|||
125426141|NCT00514943|451184380|FG000|Stage 1|Other than stated above|1|||
125426142|NCT00514943|451184381|FG001|Stage 1|Other than stated above|7|||
125426143|NCT00514943|451184380|FG000|Stage 2|Progressive disease|27|||
125426144|NCT00514943|451184381|FG001|Stage 2|Progressive disease|24|||
125426145|NCT00514943|451184380|FG000|Stage 2|Other Adverse Event|3|||
125426146|NCT00514943|451184381|FG001|Stage 2|Other Adverse Event|10|||
125426147|NCT00514943|451184380|FG000|Stage 2|Patient refused to continue study meds|2|||
125353022|NCT01476644|450927706|FG000|Overall Study|Withdrawal by Subject|13|||
125353023|NCT00095628|450927707|FG000|Overall Study|Disease progression prior to treatment|1|||
125353024|NCT04271280|450927708|FG000|Overall Study|Lost to Follow-up|300|||
125353025|NCT04271280|450927708|FG000|Overall Study|Death|153|||
125353026|NCT04271280|450927708|FG000|Overall Study|Withdrawal of consent by patient|59|||
125353027|NCT04271280|450927708|FG000|Overall Study|Other|51|||
125353028|NCT04271280|450927708|FG000|Overall Study|No end of study information|42|||
125353029|NCT00495131|450927709|FG000|Overall Study|Adverse Event|6|||
125353030|NCT00495131|450927710|FG001|Overall Study|Adverse Event|2|||
125353031|NCT00495131|450927709|FG000|Overall Study|Lack of Efficacy|0|||
125353032|NCT00495131|450927710|FG001|Overall Study|Lack of Efficacy|2|||
125353033|NCT00495131|450927709|FG000|Overall Study|Lost to Follow-up|0|||
125353034|NCT00495131|450927710|FG001|Overall Study|Lost to Follow-up|2|||
125353035|NCT00495131|450927709|FG000|Overall Study|Withdrawal by Subject|1|||
125426148|NCT00514943|451184381|FG001|Stage 2|Patient refused to continue study meds|0|||
125426149|NCT00514943|451184380|FG000|Stage 2|Other than stated above|0|||
125426150|NCT00514943|451184381|FG001|Stage 2|Other than stated above|2|||
125426151|NCT02173548|451184386|FG000|Overall Study|Lost to Follow-up|0|||
125426152|NCT02173548|451184387|FG001|Overall Study|Lost to Follow-up|2|||
125426153|NCT02173548|451184386|FG000|Overall Study|Withdrawal by Subject|1|||
125426154|NCT02173548|451184387|FG001|Overall Study|Withdrawal by Subject|0|||
125426155|NCT02066402|451184390|FG000|Overall Study|Adverse Event|1|||
125426156|NCT02066402|451184391|FG001|Overall Study|Adverse Event|2|||
125426157|NCT02066402|451184390|FG000|Overall Study|Lost to Follow-up|11|||
125426158|NCT02066402|451184391|FG001|Overall Study|Lost to Follow-up|8|||
125426159|NCT02066402|451184390|FG000|Overall Study|Withdrawal by Subject|14|||
125426160|NCT02066402|451184391|FG001|Overall Study|Withdrawal by Subject|11|||
125353036|NCT00495131|450927710|FG001|Overall Study|Withdrawal by Subject|0|||
125353037|NCT00744471|450927711|FG000|Overall Study|Randomized but not treated|1|||
125353038|NCT00744471|450927712|FG001|Overall Study|Randomized but not treated|1|||
125426161|NCT02066402|451184390|FG000|Overall Study|Progressive disease-clinical progression|0|||
125426162|NCT02066402|451184391|FG001|Overall Study|Progressive disease-clinical progression|1|||
125426163|NCT02066402|451184390|FG000|Overall Study|Protocol driven decision point|0|||
125353039|NCT00744471|450927713|FG002|Overall Study|Randomized but not treated|4|||
125556466|NCT00631189|451670735|FG001|Initial Phase|Withdrawal by Subject|0|||
125556467|NCT00631189|451670736|FG002|Initial Phase|Withdrawal by Subject|0|||
125556468|NCT00631189|451670737|FG003|Initial Phase|Withdrawal by Subject|0|||
125556469|NCT00631189|451670734|FG000|Treatment Phase|Withdrawal by Subject|0|||
125556470|NCT00631189|451670735|FG001|Treatment Phase|Withdrawal by Subject|2|||
125556471|NCT00631189|451670736|FG002|Treatment Phase|Withdrawal by Subject|1|||
125556472|NCT00631189|451670737|FG003|Treatment Phase|Withdrawal by Subject|1|||
125556473|NCT00631189|451670734|FG000|Treatment Phase|Protocol Violation|0|||
125556474|NCT00631189|451670735|FG001|Treatment Phase|Protocol Violation|1|||
125556475|NCT00631189|451670736|FG002|Treatment Phase|Protocol Violation|6|||
125556476|NCT00631189|451670737|FG003|Treatment Phase|Protocol Violation|2|||
125556477|NCT00631189|451670734|FG000|Treatment Phase|Adverse Event|0|||
125556478|NCT00631189|451670735|FG001|Treatment Phase|Adverse Event|3|||
125556479|NCT00631189|451670736|FG002|Treatment Phase|Adverse Event|2|||
125556480|NCT00631189|451670737|FG003|Treatment Phase|Adverse Event|4|||
125556481|NCT00631189|451670734|FG000|Treatment Phase|Lost to Follow-up|0|||
125556482|NCT00631189|451670735|FG001|Treatment Phase|Lost to Follow-up|1|||
125556483|NCT00631189|451670736|FG002|Treatment Phase|Lost to Follow-up|0|||
125556484|NCT00631189|451670737|FG003|Treatment Phase|Lost to Follow-up|0|||
125556485|NCT00631189|451670734|FG000|Treatment Phase|Pregnancy|0|||
125556486|NCT00631189|451670735|FG001|Treatment Phase|Pregnancy|0|||
125556487|NCT00631189|451670736|FG002|Treatment Phase|Pregnancy|1|||
125426164|NCT02066402|451184391|FG001|Overall Study|Protocol driven decision point|1|||
125426165|NCT01505387|451184392|FG000|Overall Study|Protocol Violation|1|||
125556488|NCT00631189|451670737|FG003|Treatment Phase|Pregnancy|0|||
125556489|NCT00631189|451670734|FG000|Treatment Phase|patient did not take pravastatin|0|||
125556490|NCT00631189|451670735|FG001|Treatment Phase|patient did not take pravastatin|0|||
125556491|NCT00631189|451670736|FG002|Treatment Phase|patient did not take pravastatin|1|||
125556492|NCT00631189|451670737|FG003|Treatment Phase|patient did not take pravastatin|0|||
125556493|NCT04464265|451670738|FG000|Overall Study|Physician Decision|2|||
125556494|NCT00974090|451670743|FG000|Period 1: Double Blind Period|Adverse Event|2|||
125556495|NCT00974090|451670744|FG001|Period 1: Double Blind Period|Adverse Event|1|||
125556496|NCT00974090|451670743|FG000|Period 1: Double Blind Period|Physician Decision|1|||
125556497|NCT00974090|451670744|FG001|Period 1: Double Blind Period|Physician Decision|0|||
125353040|NCT00744471|450927714|FG003|Overall Study|Randomized but not treated|0|||
125353041|NCT00744471|450927711|FG000|Overall Study|Death|0|||
125556498|NCT00974090|451670743|FG000|Period 2: Open-label Period|Adverse Event|4|||
125556499|NCT00974090|451670744|FG001|Period 2: Open-label Period|Adverse Event|6|||
125556500|NCT00974090|451670743|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
125556501|NCT00974090|451670744|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
125556502|NCT00974090|451670743|FG000|Period 2: Open-label Period|Physician Decision|0|||
125556503|NCT00974090|451670744|FG001|Period 2: Open-label Period|Physician Decision|3|||
125556504|NCT00974090|451670743|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
125556505|NCT00974090|451670744|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
125556506|NCT03189862|451670745|FG000|Overall Study|Withdrawal by Subject|1|||
125556507|NCT03189862|451670746|FG001|Overall Study|Withdrawal by Subject|0|||
125556508|NCT03189862|451670745|FG000|Overall Study|Lost to Follow-up|54|||
125556509|NCT03189862|451670746|FG001|Overall Study|Lost to Follow-up|62|||
125353042|NCT00744471|450927712|FG001|Overall Study|Death|0|||
125353043|NCT00744471|450927713|FG002|Overall Study|Death|0|||
125353044|NCT00744471|450927714|FG003|Overall Study|Death|1|||
125353045|NCT00744471|450927711|FG000|Overall Study|Adverse Event|6|||
125353046|NCT00744471|450927712|FG001|Overall Study|Adverse Event|7|||
125353047|NCT00744471|450927713|FG002|Overall Study|Adverse Event|5|||
125353048|NCT00744471|450927714|FG003|Overall Study|Adverse Event|9|||
125353049|NCT00744471|450927711|FG000|Overall Study|Withdrawal by Subject|9|||
125353050|NCT00744471|450927712|FG001|Overall Study|Withdrawal by Subject|9|||
125353051|NCT00744471|450927713|FG002|Overall Study|Withdrawal by Subject|15|||
125353052|NCT00744471|450927714|FG003|Overall Study|Withdrawal by Subject|12|||
125353053|NCT00744471|450927711|FG000|Overall Study|Protocol Violation|1|||
125353054|NCT00744471|450927712|FG001|Overall Study|Protocol Violation|4|||
125353055|NCT00744471|450927713|FG002|Overall Study|Protocol Violation|1|||
125353056|NCT00744471|450927714|FG003|Overall Study|Protocol Violation|2|||
125353057|NCT00744471|450927711|FG000|Overall Study|Entered extension study|41|||
125353058|NCT00744471|450927712|FG001|Overall Study|Entered extension study|84|||
125353059|NCT00744471|450927713|FG002|Overall Study|Entered extension study|100|||
125353060|NCT00744471|450927714|FG003|Overall Study|Entered extension study|91|||
125353061|NCT00744471|450927711|FG000|Overall Study|Other|2|||
125353062|NCT00744471|450927712|FG001|Overall Study|Other|3|||
125353063|NCT00744471|450927713|FG002|Overall Study|Other|6|||
125353064|NCT00744471|450927714|FG003|Overall Study|Other|2|||
125353065|NCT00744471|450927711|FG000|Overall Study|Lack of Efficacy|83|||
125353066|NCT00744471|450927712|FG001|Overall Study|Lack of Efficacy|37|||
125353067|NCT00744471|450927713|FG002|Overall Study|Lack of Efficacy|19|||
125353068|NCT00744471|450927714|FG003|Overall Study|Lack of Efficacy|31|||
125353069|NCT00744471|450927711|FG000|Overall Study|Lost to Follow-up|0|||
125353070|NCT00744471|450927712|FG001|Overall Study|Lost to Follow-up|0|||
125353071|NCT00744471|450927713|FG002|Overall Study|Lost to Follow-up|2|||
125353072|NCT00744471|450927714|FG003|Overall Study|Lost to Follow-up|0|||
125353073|NCT04706416|450927719|FG000|Overall Study|Lost to Follow-up|2|||
125556510|NCT00056862|451670747|FG000|Overall Study|Protocol Violation|1|||
125556511|NCT00056862|451670748|FG001|Overall Study|Protocol Violation|0|||
125556512|NCT01122576|451670749|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
125556513|NCT01122576|451670750|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
125556514|NCT01122576|451670751|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
125556515|NCT01122576|451670749|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
125556516|NCT01122576|451670750|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
125556517|NCT01122576|451670751|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
125556518|NCT01122576|451670749|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
125556519|NCT01122576|451670750|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
125556520|NCT01122576|451670751|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
125353074|NCT04706416|450927720|FG001|Overall Study|Lost to Follow-up|0|||
125353075|NCT01539317|450927724|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
125353076|NCT01539317|450927725|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
125353077|NCT00976573|450927732|FG000|Overall Study|Ineligible|0|||
125353078|NCT00976573|450927733|FG001|Overall Study|Ineligible|1|||
125556521|NCT00381563|451670756|FG000|Overall Study|Withdrawal by Subject|5|||
125353079|NCT00976573|450927732|FG000|Overall Study|Cancel prior to receiving treatment|4|||
125353080|NCT00976573|450927733|FG001|Overall Study|Cancel prior to receiving treatment|2|||
125353081|NCT02117427|450927734|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
125353082|NCT02117427|450927735|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
125353083|NCT02117427|450927736|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
125353084|NCT02117427|450927734|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
125353085|NCT02117427|450927735|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
125353086|NCT02117427|450927736|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
125556522|NCT00381563|451670757|FG001|Overall Study|Withdrawal by Subject|5|||
125556523|NCT00381563|451670756|FG000|Overall Study|Lost to Follow-up|2|||
125556524|NCT00381563|451670757|FG001|Overall Study|Lost to Follow-up|0|||
125556525|NCT00381563|451670756|FG000|Overall Study|Protocol Violation|0|||
125556526|NCT00381563|451670757|FG001|Overall Study|Protocol Violation|1|||
125353087|NCT02117427|450927734|FG000|Overall Study|Physician Decision|0|||
125353088|NCT02117427|450927735|FG001|Overall Study|Physician Decision|2|||
125556527|NCT00931944|451670759|FG000|Overall Study|Adverse Event|4|||
125556528|NCT00931944|451670759|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
125556529|NCT00931944|451670759|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
125556530|NCT00931944|451670759|FG000|Overall Study|Death|28|||
125556531|NCT00931944|451670759|FG000|Overall Study|Other|2|||
125556532|NCT01132612|451670760|FG000|Overall Study|Death|0|||
125556533|NCT01132612|451670761|FG001|Overall Study|Death|0|||
125556534|NCT01132612|451670762|FG002|Overall Study|Death|1|||
125556535|NCT01132612|451670760|FG000|Overall Study|Protocol deviation|0|||
125556536|NCT01132612|451670761|FG001|Overall Study|Protocol deviation|0|||
125556537|NCT01132612|451670762|FG002|Overall Study|Protocol deviation|3|||
125556538|NCT01132612|451670760|FG000|Overall Study|Lost to Follow-up|2|||
125353089|NCT02117427|450927736|FG002|Overall Study|Physician Decision|0|||
125353090|NCT02117427|450927734|FG000|Overall Study|No longer meets inclusion criteria|0|||
125353091|NCT02117427|450927735|FG001|Overall Study|No longer meets inclusion criteria|1|||
125353092|NCT02117427|450927736|FG002|Overall Study|No longer meets inclusion criteria|0|||
125353093|NCT02117427|450927734|FG000|Overall Study|Death|0|||
125353094|NCT02117427|450927735|FG001|Overall Study|Death|1|||
125353095|NCT02117427|450927736|FG002|Overall Study|Death|0|||
125353096|NCT00937391|450927745|FG000|Stage 2|Withdrawal by Subject|1|||
125353097|NCT03194490|450927760|FG000|Overall Study|Lost to Follow-up|1|||
125353098|NCT03194490|450927761|FG001|Overall Study|Lost to Follow-up|3|||
125556539|NCT01132612|451670761|FG001|Overall Study|Lost to Follow-up|2|||
125556540|NCT01132612|451670762|FG002|Overall Study|Lost to Follow-up|7|||
125556541|NCT01132612|451670760|FG000|Overall Study|Adverse Event|5|||
125556542|NCT01132612|451670761|FG001|Overall Study|Adverse Event|2|||
125556543|NCT01132612|451670762|FG002|Overall Study|Adverse Event|15|||
125556544|NCT01132612|451670760|FG000|Overall Study|Withdrawal by Subject|5|||
125556545|NCT01132612|451670761|FG001|Overall Study|Withdrawal by Subject|8|||
125556546|NCT01132612|451670762|FG002|Overall Study|Withdrawal by Subject|19|||
125556547|NCT01132612|451670760|FG000|Overall Study|Administrative problems|5|||
125556548|NCT01132612|451670761|FG001|Overall Study|Administrative problems|1|||
125556549|NCT01132612|451670762|FG002|Overall Study|Administrative problems|52|||
125556550|NCT01132612|451670760|FG000|Overall Study|Lack of Efficacy|23|||
125556551|NCT01132612|451670761|FG001|Overall Study|Lack of Efficacy|22|||
125556552|NCT01132612|451670762|FG002|Overall Study|Lack of Efficacy|73|||
125556553|NCT02252536|451670763|FG000|Overall Study|Lost to Follow-up|5|||
125556554|NCT02252536|451670764|FG001|Overall Study|Lost to Follow-up|3|||
125556555|NCT01438151|451670765|FG000|Overall Study|study terminated|8|||
125556556|NCT00006392|451670774|FG000|Overall Study|Ineligible|11|||
125556557|NCT00006392|451670775|FG001|Overall Study|Ineligible|3|||
125556558|NCT00006392|451670776|FG002|Overall Study|Ineligible|5|||
125556559|NCT00006392|451670777|FG003|Overall Study|Ineligible|5|||
125556560|NCT00006392|451670774|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
125556561|NCT00006392|451670775|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
125556562|NCT00006392|451670776|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
125556563|NCT00006392|451670777|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
125556564|NCT02545322|451670779|FG000|Overall Study|Withdrawal by Subject|3|||
125556565|NCT00995007|451670780|FG000|Overall Study|Withdrew consent|1|||
125556566|NCT00995007|451670781|FG001|Overall Study|Withdrew consent|0|||
125556567|NCT00995007|451670780|FG000|Overall Study|Refused further treatment|8|||
125556568|NCT00995007|451670781|FG001|Overall Study|Refused further treatment|2|||
125556569|NCT00995007|451670780|FG000|Overall Study|Toxicity|8|||
125556570|NCT00995007|451670781|FG001|Overall Study|Toxicity|0|||
125556571|NCT03606980|451670782|FG000|Overall Study|Lost to Follow-up|3|||
125556572|NCT03606980|451670783|FG001|Overall Study|Lost to Follow-up|2|||
125556573|NCT03606980|451670784|FG002|Overall Study|Lost to Follow-up|3|||
125556574|NCT03606980|451670782|FG000|Overall Study|Withdrawal by Subject|1|||
125556575|NCT03606980|451670783|FG001|Overall Study|Withdrawal by Subject|0|||
125556576|NCT03606980|451670784|FG002|Overall Study|Withdrawal by Subject|4|||
125556577|NCT01294150|451670787|FG000|Overall Study|Physician Decision|2|||
125353099|NCT03194490|450927760|FG000|Overall Study|participant developed specific neck pain|1|||
125556578|NCT01294150|451670788|FG001|Overall Study|Physician Decision|2|||
125556579|NCT03675776|451670789|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
125556580|NCT03675776|451670790|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
125556581|NCT03675776|451670791|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
125426166|NCT01505387|451184393|FG001|Overall Study|Protocol Violation|0|||
125556582|NCT03675776|451670789|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
125353100|NCT03194490|450927761|FG001|Overall Study|participant developed specific neck pain|0|||
125353101|NCT01758289|450927762|FG000|Overall Study|Premature Study Termination|44|||
125353102|NCT01758289|450927762|FG000|Overall Study|Adverse Event|9|||
125353103|NCT01574079|450927763|FG000|Overall Study|Physician Decision|0|||
125353104|NCT01574079|450927764|FG001|Overall Study|Physician Decision|2|||
125353105|NCT01574079|450927763|FG000|Overall Study|Lost to Follow-up|1|||
125353106|NCT01574079|450927764|FG001|Overall Study|Lost to Follow-up|0|||
125353107|NCT01436162|450927768|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
125353108|NCT01436162|450927769|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
125353109|NCT01436162|450927770|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
125353110|NCT01436162|450927768|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
125353111|NCT01436162|450927769|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
125353112|NCT01436162|450927770|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
125353113|NCT01436162|450927768|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
125353114|NCT01436162|450927769|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
125353115|NCT01436162|450927770|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
125353116|NCT01436162|450927768|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
125353117|NCT01436162|450927769|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
125353118|NCT01436162|450927770|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
125353119|NCT01436162|450927768|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
125353120|NCT01436162|450927769|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125353121|NCT01436162|450927770|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125353122|NCT01436162|450927768|FG000|Single-blind Lead-in Phase|Other|107|||
125353123|NCT01436162|450927769|FG001|Single-blind Lead-in Phase|Other|0|||
125353124|NCT01436162|450927770|FG002|Single-blind Lead-in Phase|Other|0|||
125353125|NCT01436162|450927768|FG000|Randomized Phase|Adverse Event|1|||
125353126|NCT01436162|450927769|FG001|Randomized Phase|Adverse Event|5|||
125353127|NCT01436162|450927770|FG002|Randomized Phase|Adverse Event|6|||
125353128|NCT01436162|450927768|FG000|Randomized Phase|Protocol Violation|4|||
125353129|NCT01436162|450927769|FG001|Randomized Phase|Protocol Violation|4|||
125353130|NCT01436162|450927770|FG002|Randomized Phase|Protocol Violation|2|||
125353131|NCT01436162|450927768|FG000|Randomized Phase|Withdrawal by Subject|16|||
125353132|NCT01436162|450927769|FG001|Randomized Phase|Withdrawal by Subject|9|||
125353133|NCT01436162|450927770|FG002|Randomized Phase|Withdrawal by Subject|8|||
125353134|NCT01436162|450927768|FG000|Randomized Phase|Lost to Follow-up|17|||
125353135|NCT01436162|450927769|FG001|Randomized Phase|Lost to Follow-up|5|||
125353136|NCT01436162|450927770|FG002|Randomized Phase|Lost to Follow-up|4|||
125353137|NCT01436162|450927768|FG000|Randomized Phase|Lack of Efficacy|0|||
125353138|NCT01436162|450927769|FG001|Randomized Phase|Lack of Efficacy|1|||
125353139|NCT01436162|450927770|FG002|Randomized Phase|Lack of Efficacy|1|||
125353140|NCT01436162|450927768|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
125353141|NCT01436162|450927769|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
125353142|NCT01436162|450927770|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
125353143|NCT01436162|450927768|FG000|Randomized Phase|Other|2|||
125353144|NCT01436162|450927769|FG001|Randomized Phase|Other|5|||
125353145|NCT01436162|450927770|FG002|Randomized Phase|Other|4|||
125353146|NCT01931202|450927774|FG000|Overall Study|Withdrawal by Subject|0|||
125353147|NCT01931202|450927775|FG001|Overall Study|Withdrawal by Subject|0|||
125353148|NCT01931202|450927776|FG002|Overall Study|Withdrawal by Subject|2|||
125353149|NCT01931202|450927774|FG000|Overall Study|Lost to Follow-up|0|||
125353150|NCT01931202|450927775|FG001|Overall Study|Lost to Follow-up|5|||
125353151|NCT01931202|450927776|FG002|Overall Study|Lost to Follow-up|2|||
125353152|NCT04597918|450927779|FG000|Overall Study|Withdrawal by Subject|6|||
125353153|NCT04597918|450927779|FG000|Overall Study|Lost to Follow-up|3|||
125353154|NCT04597918|450927779|FG000|Overall Study|Death|1|||
125353155|NCT00395538|450927780|FG000|Overall Study|Did not re-consent to revised protocol|1|||
125353156|NCT00395538|450927781|FG001|Overall Study|Did not re-consent to revised protocol|10|||
125353157|NCT00395538|450927782|FG002|Overall Study|Did not re-consent to revised protocol|0|||
125426167|NCT01505387|451184392|FG000|Overall Study|Withdrawal by Subject|1|||
125426168|NCT01505387|451184393|FG001|Overall Study|Withdrawal by Subject|1|||
125426169|NCT04493931|451184395|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
125426170|NCT04493931|451184396|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
125426171|NCT04493931|451184397|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
125426172|NCT04493931|451184398|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
125426173|NCT04493931|451184399|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
125353158|NCT00395538|450927780|FG000|Overall Study|FDA partial hold on PTH|0|||
125353159|NCT00395538|450927781|FG001|Overall Study|FDA partial hold on PTH|0|||
125353160|NCT00395538|450927782|FG002|Overall Study|FDA partial hold on PTH|11|||
125353161|NCT00395538|450927780|FG000|Overall Study|Failed screening|0|||
125353162|NCT00395538|450927781|FG001|Overall Study|Failed screening|0|||
125353163|NCT00395538|450927782|FG002|Overall Study|Failed screening|4|||
125353164|NCT00395538|450927780|FG000|Overall Study|Switch to Natpara|0|||
125353165|NCT00395538|450927781|FG001|Overall Study|Switch to Natpara|0|||
125353166|NCT00395538|450927782|FG002|Overall Study|Switch to Natpara|3|||
125353167|NCT00395538|450927780|FG000|Overall Study|Adverse Event|1|||
125353168|NCT00395538|450927781|FG001|Overall Study|Adverse Event|0|||
125426174|NCT04493931|451184400|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
125426175|NCT04493931|451184401|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
125426176|NCT04493931|451184395|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
125426177|NCT04493931|451184396|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
125426178|NCT04493931|451184397|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
125426179|NCT04493931|451184398|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
125426180|NCT04493931|451184399|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
125426181|NCT04493931|451184400|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
125556583|NCT03675776|451670790|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
125556584|NCT03675776|451670791|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
125556585|NCT02401412|451670792|FG000|Overall Study|Lost to Follow-up|1|||
125556586|NCT02401412|451670793|FG001|Overall Study|Lost to Follow-up|0|||
125556587|NCT02401412|451670792|FG000|Overall Study|Discontinued Intervention|15|||
125556588|NCT02401412|451670793|FG001|Overall Study|Discontinued Intervention|21|||
125556589|NCT02401412|451670792|FG000|Overall Study|Withdrawal by Subject|4|||
125556590|NCT02401412|451670793|FG001|Overall Study|Withdrawal by Subject|4|||
125556591|NCT02401412|451670792|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
125556592|NCT02401412|451670793|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
125556593|NCT02401412|451670792|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
125556594|NCT02401412|451670793|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
125426182|NCT04493931|451184401|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
125426183|NCT04493931|451184395|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
125426184|NCT04493931|451184396|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
125556595|NCT01351623|451670795|FG000|Overall Study|Protocol Violation|2|||
125556596|NCT01351623|451670795|FG000|Overall Study|Adverse Event|4|||
125556597|NCT01351623|451670795|FG000|Overall Study|Withdrawal by Subject|1|||
125556598|NCT01351623|451670795|FG000|Overall Study|Death|2|||
125556599|NCT00387764|451670796|FG000|Overall Study|Adverse Event|12|||
125556600|NCT00387764|451670796|FG000|Overall Study|Withdrawal by Subject|8|||
125556601|NCT00387764|451670796|FG000|Overall Study|Sponsor Terminated Study|1|||
125556602|NCT00387764|451670796|FG000|Overall Study|Physician Decision|1|||
125556603|NCT00387764|451670796|FG000|Overall Study|Other|2|||
125556604|NCT00387764|451670796|FG000|Overall Study|Death|7|||
125556605|NCT01184053|451670797|FG000|Overall Study|progression while on treatment|3|||
125353169|NCT00395538|450927782|FG002|Overall Study|Adverse Event|2|||
125353170|NCT00395538|450927780|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
125353171|NCT00395538|450927781|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
125353172|NCT00395538|450927782|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
125556606|NCT04399122|451670798|FG000|Overall Study|Lost to Follow-up|2|||
125556607|NCT04399122|451670799|FG001|Overall Study|Lost to Follow-up|0|||
125556608|NCT04399122|451670798|FG000|Overall Study|Withdrawal by Subject|1|||
125556609|NCT04399122|451670799|FG001|Overall Study|Withdrawal by Subject|0|||
125353173|NCT00395538|450927780|FG000|Overall Study|Non-compliance with study protocol|0|||
125353174|NCT00395538|450927781|FG001|Overall Study|Non-compliance with study protocol|1|||
125353175|NCT00395538|450927782|FG002|Overall Study|Non-compliance with study protocol|0|||
125353176|NCT00395538|450927780|FG000|Overall Study|PTH resistance|0|||
125353177|NCT00395538|450927781|FG001|Overall Study|PTH resistance|0|||
125353178|NCT00395538|450927782|FG002|Overall Study|PTH resistance|1|||
125556610|NCT01174238|451670802|FG000|Overall Study|Lost to Follow-up|2|||
125556611|NCT01102803|451670803|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
125556612|NCT01102803|451670804|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
125556613|NCT01102803|451670803|FG000|Post to Follow-Up|Lost to Follow-up|1|||
125556614|NCT01102803|451670804|FG001|Post to Follow-Up|Lost to Follow-up|3|||
125556615|NCT02684279|451670805|FG000|Overall Study|Adverse Event|87|||
125556616|NCT02684279|451670805|FG000|Overall Study|Lack of Efficacy|4|||
125556617|NCT02684279|451670805|FG000|Overall Study|Lost to Follow-up|61|||
125556618|NCT02684279|451670805|FG000|Overall Study|Protocol Violation|6|||
125556619|NCT02684279|451670805|FG000|Overall Study|Pregnancy|8|||
125556620|NCT02684279|451670805|FG000|Overall Study|Withdrawal by Subject|92|||
125556621|NCT02684279|451670805|FG000|Overall Study|non-compliance with study drug|9|||
125556622|NCT02684279|451670805|FG000|Overall Study|non compliance with study visits|2|||
125556623|NCT02684279|451670805|FG000|Overall Study|subject to have surgery|1|||
125556624|NCT02684279|451670805|FG000|Overall Study|family emergency|1|||
125556625|NCT02684279|451670805|FG000|Overall Study|Site closures|7|||
125556626|NCT02684279|451670805|FG000|Overall Study|Physician Decision|1|||
125556627|NCT02733185|451670806|FG000|Overall Study|Withdrawal by Subject|12|||
125556628|NCT02733185|451670807|FG001|Overall Study|Withdrawal by Subject|10|||
125556629|NCT02733185|451670808|FG002|Overall Study|Withdrawal by Subject|17|||
125556630|NCT02733185|451670809|FG003|Overall Study|Withdrawal by Subject|21|||
125556631|NCT02733185|451670806|FG000|Overall Study|Death|46|||
125556632|NCT02733185|451670807|FG001|Overall Study|Death|34|||
125556633|NCT02733185|451670808|FG002|Overall Study|Death|35|||
125556634|NCT02733185|451670809|FG003|Overall Study|Death|43|||
125556635|NCT02733185|451670806|FG000|Overall Study|Lost to Follow-up|17|||
125556636|NCT02733185|451670807|FG001|Overall Study|Lost to Follow-up|18|||
125556637|NCT02733185|451670808|FG002|Overall Study|Lost to Follow-up|16|||
125556638|NCT02733185|451670809|FG003|Overall Study|Lost to Follow-up|11|||
125556639|NCT02593786|451670810|FG000|Overall Study|Disease progression|12|||
125556640|NCT02593786|451670811|FG001|Overall Study|Disease progression|16|||
125556641|NCT02593786|451670812|FG002|Overall Study|Disease progression|10|||
125556642|NCT02593786|451670813|FG003|Overall Study|Disease progression|7|||
125556643|NCT02593786|451670810|FG000|Overall Study|Study drug toxicity|1|||
125556644|NCT02593786|451670811|FG001|Overall Study|Study drug toxicity|0|||
125556645|NCT02593786|451670812|FG002|Overall Study|Study drug toxicity|0|||
125556646|NCT02593786|451670813|FG003|Overall Study|Study drug toxicity|0|||
125556647|NCT02593786|451670810|FG000|Overall Study|Adverse event unrelated to study drug|1|||
125556648|NCT02593786|451670811|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125556649|NCT02593786|451670812|FG002|Overall Study|Adverse event unrelated to study drug|1|||
125556650|NCT02593786|451670813|FG003|Overall Study|Adverse event unrelated to study drug|0|||
125556651|NCT02593786|451670810|FG000|Overall Study|Participant request to discontinue study therapy|0|||
125556652|NCT02593786|451670811|FG001|Overall Study|Participant request to discontinue study therapy|2|||
125556653|NCT02593786|451670812|FG002|Overall Study|Participant request to discontinue study therapy|0|||
125556654|NCT02593786|451670813|FG003|Overall Study|Participant request to discontinue study therapy|0|||
125556655|NCT02593786|451670810|FG000|Overall Study|Other reasons|1|||
125556656|NCT02593786|451670811|FG001|Overall Study|Other reasons|1|||
125556657|NCT02593786|451670812|FG002|Overall Study|Other reasons|0|||
125556658|NCT02593786|451670813|FG003|Overall Study|Other reasons|5|||
125556659|NCT00671554|451670817|FG000|Overall Study|Disease progression|3|||
125556660|NCT01479829|451670818|FG000|Overall Study|Withdrawal by Subject|8|||
125556661|NCT01479829|451670819|FG001|Overall Study|Withdrawal by Subject|10|||
125556662|NCT00601250|451670820|FG000|Overall Study|Adverse Event|3|||
125556663|NCT00601250|451670821|FG001|Overall Study|Adverse Event|9|||
125556664|NCT00601250|451670820|FG000|Overall Study|Protocol Violation|3|||
125556665|NCT00601250|451670821|FG001|Overall Study|Protocol Violation|2|||
125556666|NCT00601250|451670820|FG000|Overall Study|Lost to Follow-up|2|||
125556667|NCT00601250|451670821|FG001|Overall Study|Lost to Follow-up|6|||
125353179|NCT00395538|450927780|FG000|Overall Study|Pregnancy|1|||
125353180|NCT00395538|450927781|FG001|Overall Study|Pregnancy|0|||
125353181|NCT00395538|450927782|FG002|Overall Study|Pregnancy|0|||
125353182|NCT00395538|450927780|FG000|Overall Study|Partial recovery of parathyroid function|0|||
125353183|NCT00395538|450927781|FG001|Overall Study|Partial recovery of parathyroid function|0|||
125353184|NCT00395538|450927782|FG002|Overall Study|Partial recovery of parathyroid function|1|||
125353185|NCT00395538|450927780|FG000|Overall Study|Participant elected to discontinue|0|||
125556668|NCT00601250|451670820|FG000|Overall Study|Withdrawal by Subject|4|||
125556669|NCT00601250|451670821|FG001|Overall Study|Withdrawal by Subject|13|||
125556670|NCT00601250|451670820|FG000|Overall Study|Other incl. lack of efficacy|2|||
125556671|NCT00601250|451670821|FG001|Overall Study|Other incl. lack of efficacy|9|||
125556672|NCT01791803|451670823|FG000|Overall Study|Withdrawal by Subject|0|||
125556673|NCT01791803|451670824|FG001|Overall Study|Withdrawal by Subject|0|||
125556674|NCT01791803|451670825|FG002|Overall Study|Withdrawal by Subject|0|||
125556675|NCT01791803|451670826|FG003|Overall Study|Withdrawal by Subject|2|||
125556676|NCT01791803|451670823|FG000|Overall Study|Physician Decision|0|||
125556677|NCT01791803|451670824|FG001|Overall Study|Physician Decision|2|||
125556678|NCT01791803|451670825|FG002|Overall Study|Physician Decision|0|||
125556679|NCT01791803|451670826|FG003|Overall Study|Physician Decision|1|||
125556680|NCT01791803|451670823|FG000|Overall Study|Death|0|||
125556681|NCT01791803|451670824|FG001|Overall Study|Death|0|||
125556682|NCT01791803|451670825|FG002|Overall Study|Death|2|||
125556683|NCT01791803|451670826|FG003|Overall Study|Death|2|||
125556684|NCT04752475|451672254|FG000|Overall Study|Withdrawal by Subject|1|||
125556685|NCT04752475|451672255|FG001|Overall Study|Withdrawal by Subject|1|||
125556686|NCT00594516|451672260|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
125556687|NCT00594516|451672261|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
125556688|NCT00594516|451672262|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
125556689|NCT00594516|451672260|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
125556690|NCT00594516|451672261|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
125556691|NCT00594516|451672262|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
125556692|NCT00594516|451672260|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
125556693|NCT00594516|451672261|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
125556694|NCT00594516|451672262|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
125556695|NCT00594516|451672260|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
125556696|NCT00594516|451672261|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
125556697|NCT00594516|451672262|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
125556698|NCT00594516|451672260|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
125556699|NCT00594516|451672261|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
125556700|NCT00594516|451672262|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
125556701|NCT00594516|451672260|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
125556702|NCT00594516|451672261|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
125556703|NCT00594516|451672262|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
125556704|NCT00594516|451672260|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
125556705|NCT00594516|451672261|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
125556706|NCT00594516|451672262|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
125556707|NCT00594516|451672260|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
125556708|NCT00594516|451672261|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
125556709|NCT00594516|451672262|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
125556710|NCT00594516|451672260|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
125556711|NCT00594516|451672261|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
125556712|NCT00594516|451672262|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
125556713|NCT00088907|451672263|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
125556714|NCT00088907|451672264|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
125556715|NCT00088907|451672263|FG000|Randomized Study (Step 1)|Adverse Event|14|||
125556716|NCT00088907|451672264|FG001|Randomized Study (Step 1)|Adverse Event|19|||
125556717|NCT00088907|451672263|FG000|Randomized Study (Step 1)|Death|11|||
125556718|NCT00088907|451672264|FG001|Randomized Study (Step 1)|Death|12|||
125556719|NCT00088907|451672263|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
125556720|NCT00088907|451672264|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
125556721|NCT00088907|451672263|FG000|Randomized Study (Step 1)|complicating disease|3|||
125556722|NCT00088907|451672264|FG001|Randomized Study (Step 1)|complicating disease|1|||
125556723|NCT00088907|451672263|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
125556724|NCT00088907|451672264|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
125556725|NCT00088907|451672263|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
125556726|NCT00088907|451672264|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
125556727|NCT00088907|451672263|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
125556728|NCT00088907|451672264|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
125556729|NCT00088907|451672263|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
125556730|NCT00088907|451672264|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
125556731|NCT00088907|451672263|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
125556732|NCT00088907|451672264|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
125556733|NCT00088907|451672263|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
125556734|NCT00088907|451672264|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
125556735|NCT03426787|451672269|FG000|Overall Study|Withdrawal by Subject|6|||
125556736|NCT03426787|451672269|FG000|Overall Study|Lost to Follow-up|7|||
125556737|NCT03426787|451672269|FG000|Overall Study|Unrelated to intervention death|1|||
125556738|NCT04641299|451672270|FG000|Overall Study|Adverse Event|0|||
125556739|NCT04641299|451672271|FG001|Overall Study|Adverse Event|0|||
125556740|NCT04641299|451672272|FG002|Overall Study|Adverse Event|2|||
125556741|NCT04641299|451672273|FG003|Overall Study|Adverse Event|0|||
125556742|NCT04641299|451672270|FG000|Overall Study|Lost to Follow-up|0|||
125556743|NCT04641299|451672271|FG001|Overall Study|Lost to Follow-up|1|||
125556744|NCT04641299|451672272|FG002|Overall Study|Lost to Follow-up|0|||
125556745|NCT04641299|451672273|FG003|Overall Study|Lost to Follow-up|0|||
125556746|NCT04641299|451672270|FG000|Overall Study|Withdrawal by Subject|1|||
125556747|NCT04641299|451672271|FG001|Overall Study|Withdrawal by Subject|0|||
125556748|NCT04641299|451672272|FG002|Overall Study|Withdrawal by Subject|0|||
125556749|NCT04641299|451672273|FG003|Overall Study|Withdrawal by Subject|0|||
125556750|NCT04641299|451672270|FG000|Overall Study|Reason not given|1|||
125556751|NCT04641299|451672271|FG001|Overall Study|Reason not given|0|||
125556752|NCT04641299|451672272|FG002|Overall Study|Reason not given|0|||
125556753|NCT04641299|451672273|FG003|Overall Study|Reason not given|0|||
125556754|NCT01016964|451672276|FG000|Overall Study|Lost to Follow-up|3|||
125556755|NCT01016964|451672277|FG001|Overall Study|Lost to Follow-up|3|||
125556756|NCT00659529|451672278|FG000|Overall Study|Withdrawal by Subject|4|||
125556757|NCT00659529|451672278|FG000|Overall Study|Protocol Violation|3|||
125556758|NCT00659529|451672278|FG000|Overall Study|Screen failure|9|||
125556759|NCT00763971|451672279|FG000|Overall Study|Adverse Event|5|||
125556760|NCT00763971|451672280|FG001|Overall Study|Adverse Event|2|||
125556761|NCT00763971|451672281|FG002|Overall Study|Adverse Event|4|||
125556762|NCT00763971|451672279|FG000|Overall Study|Protocol Violation|3|||
125556763|NCT00763971|451672280|FG001|Overall Study|Protocol Violation|3|||
125556764|NCT00763971|451672281|FG002|Overall Study|Protocol Violation|2|||
125556765|NCT00763971|451672279|FG000|Overall Study|Withdrawal by Subject|4|||
125556766|NCT00763971|451672280|FG001|Overall Study|Withdrawal by Subject|5|||
125556767|NCT00763971|451672281|FG002|Overall Study|Withdrawal by Subject|5|||
125556768|NCT00763971|451672279|FG000|Overall Study|Lost to Follow-up|0|||
125556769|NCT00763971|451672280|FG001|Overall Study|Lost to Follow-up|1|||
125556770|NCT00763971|451672281|FG002|Overall Study|Lost to Follow-up|0|||
125426185|NCT04493931|451184397|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
125426186|NCT04493931|451184398|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
125556771|NCT00763971|451672279|FG000|Overall Study|Lack of Efficacy|11|||
125556772|NCT00763971|451672280|FG001|Overall Study|Lack of Efficacy|22|||
125556773|NCT00763971|451672281|FG002|Overall Study|Lack of Efficacy|54|||
125556774|NCT00763971|451672279|FG000|Overall Study|Unable to swallow capsule|2|||
125556775|NCT00763971|451672280|FG001|Overall Study|Unable to swallow capsule|1|||
125556776|NCT00763971|451672281|FG002|Overall Study|Unable to swallow capsule|1|||
125556777|NCT00763971|451672279|FG000|Overall Study|Personal reason|3|||
125556778|NCT00763971|451672280|FG001|Overall Study|Personal reason|0|||
125556779|NCT00763971|451672281|FG002|Overall Study|Personal reason|0|||
125556780|NCT00763971|451672279|FG000|Overall Study|Exclusion criteria met|1|||
125556781|NCT00763971|451672280|FG001|Overall Study|Exclusion criteria met|0|||
125556782|NCT00763971|451672281|FG002|Overall Study|Exclusion criteria met|0|||
125556783|NCT00763971|451672279|FG000|Overall Study|Sponsor decision|1|||
125556784|NCT00763971|451672280|FG001|Overall Study|Sponsor decision|0|||
125556785|NCT00763971|451672281|FG002|Overall Study|Sponsor decision|0|||
125556786|NCT00763971|451672279|FG000|Overall Study|Due to holiday season|2|||
125556787|NCT00763971|451672280|FG001|Overall Study|Due to holiday season|0|||
125556788|NCT00763971|451672281|FG002|Overall Study|Due to holiday season|1|||
125556789|NCT00763971|451672279|FG000|Overall Study|Randomization error|0|||
125556790|NCT00763971|451672280|FG001|Overall Study|Randomization error|0|||
125556791|NCT00763971|451672281|FG002|Overall Study|Randomization error|1|||
125556792|NCT00763971|451672279|FG000|Overall Study|Medical monitor decision|0|||
125556793|NCT00763971|451672280|FG001|Overall Study|Medical monitor decision|0|||
125556794|NCT00763971|451672281|FG002|Overall Study|Medical monitor decision|1|||
125556795|NCT00763971|451672279|FG000|Overall Study|Moved to another country|0|||
125556796|NCT00763971|451672280|FG001|Overall Study|Moved to another country|1|||
125556797|NCT00763971|451672281|FG002|Overall Study|Moved to another country|0|||
125556798|NCT00763971|451672279|FG000|Overall Study|Subject wanted dose reduction|0|||
125556799|NCT00763971|451672280|FG001|Overall Study|Subject wanted dose reduction|1|||
125556800|NCT00763971|451672281|FG002|Overall Study|Subject wanted dose reduction|0|||
125556801|NCT00763971|451672279|FG000|Overall Study|Lack of availability|0|||
125556802|NCT00763971|451672280|FG001|Overall Study|Lack of availability|1|||
125556803|NCT00763971|451672281|FG002|Overall Study|Lack of availability|0|||
125556804|NCT00763971|451672279|FG000|Overall Study|Performed final visit on phone|0|||
125556805|NCT00763971|451672280|FG001|Overall Study|Performed final visit on phone|1|||
125556806|NCT00763971|451672281|FG002|Overall Study|Performed final visit on phone|0|||
125556807|NCT00763971|451672279|FG000|Overall Study|Participation in 489-326 required|1|||
125556808|NCT00763971|451672280|FG001|Overall Study|Participation in 489-326 required|0|||
125556809|NCT00763971|451672281|FG002|Overall Study|Participation in 489-326 required|0|||
125556810|NCT04439071|451672283|FG000|Overall Study|Lost to Follow-up|0|||
125556811|NCT04439071|451672284|FG001|Overall Study|Lost to Follow-up|3|||
125556812|NCT04439071|451672283|FG000|Overall Study|Withdrawal by Subject|3|||
125556813|NCT04439071|451672284|FG001|Overall Study|Withdrawal by Subject|8|||
125556814|NCT04439071|451672283|FG000|Overall Study|Death|6|||
125556815|NCT04439071|451672284|FG001|Overall Study|Death|4|||
125556816|NCT04439071|451672283|FG000|Overall Study|Other than specified|3|||
125556817|NCT04439071|451672284|FG001|Overall Study|Other than specified|3|||
125556818|NCT04439071|451672283|FG000|Overall Study|Randomized but not treated|2|||
125556819|NCT04439071|451672284|FG001|Overall Study|Randomized but not treated|0|||
125556820|NCT00024167|451672287|FG000|Overall Study|Death|53|||
125556821|NCT00024167|451672288|FG001|Overall Study|Death|47|||
125556822|NCT01186796|451672296|FG000|Overall Study|Adverse Event|3|||
125556823|NCT01186796|451672297|FG001|Overall Study|Adverse Event|0|||
125556824|NCT01186796|451672296|FG000|Overall Study|Withdrawal by Subject|1|||
125556825|NCT01186796|451672297|FG001|Overall Study|Withdrawal by Subject|1|||
125556826|NCT01186796|451672296|FG000|Overall Study|Protocol Violation|0|||
125556827|NCT01186796|451672297|FG001|Overall Study|Protocol Violation|1|||
125556828|NCT01287364|451672298|FG000|Overall Study|Adverse Event|0|||
125556829|NCT01287364|451672299|FG001|Overall Study|Adverse Event|3|||
125556830|NCT01287364|451672298|FG000|Overall Study|Protocol Violation|5|||
125556831|NCT01287364|451672299|FG001|Overall Study|Protocol Violation|5|||
125556832|NCT01287364|451672298|FG000|Overall Study|Other Reason|4|||
125556833|NCT01287364|451672299|FG001|Overall Study|Other Reason|2|||
125556834|NCT00962390|451672303|FG000|Overall Study|Adverse Event|0|||
125556835|NCT00962390|451672304|FG001|Overall Study|Adverse Event|0|||
125556836|NCT00962390|451672305|FG002|Overall Study|Adverse Event|3|||
125556837|NCT00962390|451672306|FG003|Overall Study|Adverse Event|1|||
125556838|NCT00962390|451672303|FG000|Overall Study|Lost to Follow-up|2|||
125556839|NCT00962390|451672304|FG001|Overall Study|Lost to Follow-up|2|||
125556840|NCT00962390|451672305|FG002|Overall Study|Lost to Follow-up|0|||
125556841|NCT00962390|451672306|FG003|Overall Study|Lost to Follow-up|0|||
125556842|NCT00962390|451672303|FG000|Overall Study|Protocol Violation|1|||
125556843|NCT00962390|451672304|FG001|Overall Study|Protocol Violation|0|||
125556844|NCT00962390|451672305|FG002|Overall Study|Protocol Violation|0|||
125556845|NCT00962390|451672306|FG003|Overall Study|Protocol Violation|0|||
125556846|NCT00962390|451672303|FG000|Overall Study|Withdrawal by Subject|1|||
125556847|NCT00962390|451672304|FG001|Overall Study|Withdrawal by Subject|1|||
125556848|NCT00962390|451672305|FG002|Overall Study|Withdrawal by Subject|1|||
125556849|NCT00962390|451672306|FG003|Overall Study|Withdrawal by Subject|0|||
125556850|NCT03740997|451672314|FG000|Overall Study|Withdrawal by Subject|1|||
125556851|NCT03740997|451672315|FG001|Overall Study|Withdrawal by Subject|0|||
125556852|NCT03740997|451672314|FG000|Overall Study|Participant was unable to complete study procedures|1|||
125556853|NCT03740997|451672315|FG001|Overall Study|Participant was unable to complete study procedures|0|||
125556854|NCT01026142|451672316|FG000|Overall Study|Death|136|||
125556855|NCT01026142|451672317|FG001|Overall Study|Death|134|||
125556856|NCT01026142|451672316|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
125556857|NCT01026142|451672317|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
125556858|NCT01829425|451672318|FG000|Overall Study|Withdrawal by Subject|4|||
125556859|NCT01829425|451672319|FG001|Overall Study|Withdrawal by Subject|3|||
125556860|NCT01829425|451672318|FG000|Overall Study|Lost to Follow-up|2|||
125556861|NCT01829425|451672319|FG001|Overall Study|Lost to Follow-up|1|||
125556862|NCT04178967|451672320|FG000|Induction Period|Adverse Event|4|||
125556863|NCT04178967|451672321|FG001|Induction Period|Adverse Event|6|||
125556864|NCT04178967|451672322|FG002|Induction Period|Adverse Event|0|||
125556865|NCT04178967|451672323|FG003|Induction Period|Adverse Event|0|||
125556866|NCT04178967|451672324|FG004|Induction Period|Adverse Event|0|||
125556867|NCT04178967|451672325|FG005|Induction Period|Adverse Event|0|||
125556868|NCT04178967|451672326|FG006|Induction Period|Adverse Event|0|||
125556869|NCT04178967|451672327|FG007|Induction Period|Adverse Event|0|||
125556870|NCT04178967|451672328|FG008|Induction Period|Adverse Event|0|||
125556871|NCT04178967|451672329|FG009|Induction Period|Adverse Event|0|||
125556872|NCT04178967|451672330|FG010|Induction Period|Adverse Event|0|||
125556873|NCT04178967|451672320|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
125556874|NCT04178967|451672321|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
125556875|NCT04178967|451672322|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
125556876|NCT04178967|451672323|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
125556877|NCT04178967|451672324|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
125556878|NCT04178967|451672325|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
125556879|NCT04178967|451672326|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
125556880|NCT04178967|451672327|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
125556881|NCT04178967|451672328|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
125556882|NCT04178967|451672329|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
125556883|NCT04178967|451672330|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
125556884|NCT04178967|451672320|FG000|Induction Period|Lack of Efficacy|4|||
125556885|NCT04178967|451672321|FG001|Induction Period|Lack of Efficacy|1|||
125556886|NCT04178967|451672322|FG002|Induction Period|Lack of Efficacy|0|||
125556887|NCT04178967|451672323|FG003|Induction Period|Lack of Efficacy|0|||
125556888|NCT04178967|451672324|FG004|Induction Period|Lack of Efficacy|0|||
125556889|NCT04178967|451672325|FG005|Induction Period|Lack of Efficacy|0|||
125556890|NCT04178967|451672326|FG006|Induction Period|Lack of Efficacy|0|||
125556891|NCT04178967|451672327|FG007|Induction Period|Lack of Efficacy|0|||
125556892|NCT04178967|451672328|FG008|Induction Period|Lack of Efficacy|0|||
125556893|NCT04178967|451672329|FG009|Induction Period|Lack of Efficacy|0|||
125556894|NCT04178967|451672330|FG010|Induction Period|Lack of Efficacy|0|||
125556895|NCT04178967|451672320|FG000|Induction Period|Protocol Violation|0|||
125556896|NCT04178967|451672321|FG001|Induction Period|Protocol Violation|6|||
125556897|NCT04178967|451672322|FG002|Induction Period|Protocol Violation|0|||
125556898|NCT04178967|451672323|FG003|Induction Period|Protocol Violation|0|||
125556899|NCT04178967|451672324|FG004|Induction Period|Protocol Violation|0|||
125556900|NCT04178967|451672325|FG005|Induction Period|Protocol Violation|0|||
125556901|NCT04178967|451672326|FG006|Induction Period|Protocol Violation|0|||
125556902|NCT04178967|451672327|FG007|Induction Period|Protocol Violation|0|||
125556903|NCT04178967|451672328|FG008|Induction Period|Protocol Violation|0|||
125556904|NCT04178967|451672329|FG009|Induction Period|Protocol Violation|0|||
125556905|NCT04178967|451672330|FG010|Induction Period|Protocol Violation|0|||
125556906|NCT04178967|451672320|FG000|Induction Period|Withdrawal by Subject|6|||
125556907|NCT04178967|451672321|FG001|Induction Period|Withdrawal by Subject|4|||
125556908|NCT04178967|451672322|FG002|Induction Period|Withdrawal by Subject|0|||
125556909|NCT04178967|451672323|FG003|Induction Period|Withdrawal by Subject|0|||
125556910|NCT04178967|451672324|FG004|Induction Period|Withdrawal by Subject|0|||
125556911|NCT04178967|451672325|FG005|Induction Period|Withdrawal by Subject|0|||
125556912|NCT04178967|451672326|FG006|Induction Period|Withdrawal by Subject|0|||
125556913|NCT04178967|451672327|FG007|Induction Period|Withdrawal by Subject|0|||
125556914|NCT04178967|451672328|FG008|Induction Period|Withdrawal by Subject|0|||
125556915|NCT04178967|451672329|FG009|Induction Period|Withdrawal by Subject|0|||
125556916|NCT04178967|451672330|FG010|Induction Period|Withdrawal by Subject|0|||
125556917|NCT04178967|451672320|FG000|Induction Period|Lost to Follow-up|2|||
125556918|NCT04178967|451672321|FG001|Induction Period|Lost to Follow-up|0|||
125556919|NCT04178967|451672322|FG002|Induction Period|Lost to Follow-up|0|||
125426187|NCT04493931|451184399|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
125426188|NCT04493931|451184400|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
125556920|NCT04178967|451672323|FG003|Induction Period|Lost to Follow-up|0|||
125556921|NCT04178967|451672324|FG004|Induction Period|Lost to Follow-up|0|||
125556922|NCT04178967|451672325|FG005|Induction Period|Lost to Follow-up|0|||
125556923|NCT04178967|451672326|FG006|Induction Period|Lost to Follow-up|0|||
125556924|NCT04178967|451672327|FG007|Induction Period|Lost to Follow-up|0|||
125556925|NCT04178967|451672328|FG008|Induction Period|Lost to Follow-up|0|||
125556926|NCT04178967|451672329|FG009|Induction Period|Lost to Follow-up|0|||
125556927|NCT04178967|451672330|FG010|Induction Period|Lost to Follow-up|0|||
125556928|NCT04178967|451672320|FG000|Induction Period|Participant Missed Study Visits|0|||
125556929|NCT04178967|451672321|FG001|Induction Period|Participant Missed Study Visits|1|||
125556930|NCT04178967|451672322|FG002|Induction Period|Participant Missed Study Visits|0|||
125556931|NCT04178967|451672323|FG003|Induction Period|Participant Missed Study Visits|0|||
125556932|NCT04178967|451672324|FG004|Induction Period|Participant Missed Study Visits|0|||
125556933|NCT04178967|451672325|FG005|Induction Period|Participant Missed Study Visits|0|||
125556934|NCT04178967|451672326|FG006|Induction Period|Participant Missed Study Visits|0|||
125556935|NCT04178967|451672327|FG007|Induction Period|Participant Missed Study Visits|0|||
125556936|NCT04178967|451672328|FG008|Induction Period|Participant Missed Study Visits|0|||
125556937|NCT04178967|451672329|FG009|Induction Period|Participant Missed Study Visits|0|||
125556938|NCT04178967|451672330|FG010|Induction Period|Participant Missed Study Visits|0|||
125556939|NCT04178967|451672320|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
125556940|NCT04178967|451672321|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
125556941|NCT04178967|451672322|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
125556942|NCT04178967|451672323|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
125556943|NCT04178967|451672324|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
125556944|NCT04178967|451672325|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
125556945|NCT04178967|451672326|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
125556946|NCT04178967|451672327|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
125556947|NCT04178967|451672328|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
125556948|NCT04178967|451672329|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
125353186|NCT00395538|450927781|FG001|Overall Study|Participant elected to discontinue|0|||
125353187|NCT00395538|450927782|FG002|Overall Study|Participant elected to discontinue|1|||
125353188|NCT01074047|450927783|FG000|Treatment Phase|Adverse Event|89|||
125353189|NCT01074047|450927784|FG001|Treatment Phase|Adverse Event|66|||
125353190|NCT01074047|450927783|FG000|Treatment Phase|Disease Progression|16|||
125353191|NCT01074047|450927784|FG001|Treatment Phase|Disease Progression|21|||
125353192|NCT01074047|450927783|FG000|Treatment Phase|Withdrawal by Subject|27|||
125353193|NCT01074047|450927784|FG001|Treatment Phase|Withdrawal by Subject|48|||
125353194|NCT01074047|450927783|FG000|Treatment Phase|Death|53|||
125353195|NCT01074047|450927784|FG001|Treatment Phase|Death|58|||
125353196|NCT01074047|450927783|FG000|Treatment Phase|Lost to Follow-up|0|||
125353197|NCT01074047|450927784|FG001|Treatment Phase|Lost to Follow-up|1|||
125353198|NCT01074047|450927783|FG000|Treatment Phase|Protocol Violation|0|||
125353199|NCT01074047|450927784|FG001|Treatment Phase|Protocol Violation|1|||
125353200|NCT01074047|450927783|FG000|Treatment Phase|Miscellaneous|32|||
125353201|NCT01074047|450927784|FG001|Treatment Phase|Miscellaneous|39|||
125353202|NCT01074047|450927783|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
125353203|NCT01074047|450927784|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
125353204|NCT01074047|450927783|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
125353205|NCT01074047|450927784|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
125353206|NCT01074047|450927783|FG000|Survival Follow-Up Phase|Death|116|||
125353207|NCT01074047|450927784|FG001|Survival Follow-Up Phase|Death|124|||
125353208|NCT01074047|450927783|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
125353209|NCT01074047|450927784|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
125353210|NCT01074047|450927783|FG000|Extension Phase|Physician Decision|1|||
125353211|NCT01074047|450927784|FG001|Extension Phase|Physician Decision|0|||
125353212|NCT01074047|450927783|FG000|Extension Phase|Adverse Event|5|||
125353213|NCT01074047|450927784|FG001|Extension Phase|Adverse Event|0|||
125353214|NCT01074047|450927783|FG000|Extension Phase|Disease Progression|9|||
125353215|NCT01074047|450927784|FG001|Extension Phase|Disease Progression|0|||
125353216|NCT01074047|450927783|FG000|Extension Phase|Withdrawal by Subject|2|||
125353217|NCT01074047|450927784|FG001|Extension Phase|Withdrawal by Subject|0|||
125353218|NCT01074047|450927783|FG000|Extension Phase|Death|5|||
125353219|NCT01074047|450927784|FG001|Extension Phase|Death|0|||
125353220|NCT01683019|450929387|FG000|Overall Study|Withdrawal by Subject|2|||
125353221|NCT01683019|450929388|FG001|Overall Study|Withdrawal by Subject|1|||
125353222|NCT01683019|450929389|FG002|Overall Study|Withdrawal by Subject|4|||
125353223|NCT00543855|450929390|FG000|Overall Study|Adverse Event|3|||
125353224|NCT00543855|450929391|FG001|Overall Study|Adverse Event|1|||
125353225|NCT00543855|450929392|FG002|Overall Study|Adverse Event|3|||
125353226|NCT00543855|450929393|FG003|Overall Study|Adverse Event|4|||
125353227|NCT00543855|450929390|FG000|Overall Study|Lost to Follow-up|0|||
125353228|NCT00543855|450929391|FG001|Overall Study|Lost to Follow-up|0|||
125353229|NCT00543855|450929392|FG002|Overall Study|Lost to Follow-up|1|||
125353230|NCT00543855|450929393|FG003|Overall Study|Lost to Follow-up|0|||
125353231|NCT00543855|450929390|FG000|Overall Study|Withdrawal by Subject|0|||
125353232|NCT00543855|450929391|FG001|Overall Study|Withdrawal by Subject|1|||
125353233|NCT00543855|450929392|FG002|Overall Study|Withdrawal by Subject|2|||
125353234|NCT00543855|450929393|FG003|Overall Study|Withdrawal by Subject|0|||
125353235|NCT00543855|450929390|FG000|Overall Study|Protocol Violation|1|||
125353236|NCT00543855|450929391|FG001|Overall Study|Protocol Violation|0|||
125353237|NCT00543855|450929392|FG002|Overall Study|Protocol Violation|0|||
125353238|NCT00543855|450929393|FG003|Overall Study|Protocol Violation|0|||
125353239|NCT04444895|450929395|FG000|Overall Study|Adverse Event|2|||
125353240|NCT04444895|450929395|FG000|Overall Study|Lost to Follow-up|2|||
125556949|NCT04178967|451672330|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
125556950|NCT04178967|451672320|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125556951|NCT04178967|451672321|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125556952|NCT04178967|451672322|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125556953|NCT04178967|451672323|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125556954|NCT04178967|451672324|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125556955|NCT04178967|451672325|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
125556956|NCT04178967|451672326|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125556957|NCT04178967|451672327|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125556958|NCT04178967|451672328|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125556959|NCT04178967|451672329|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125556960|NCT04178967|451672330|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125556961|NCT04178967|451672320|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125556962|NCT04178967|451672321|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125556963|NCT04178967|451672322|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125556964|NCT04178967|451672323|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
125556965|NCT04178967|451672324|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125556966|NCT04178967|451672325|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125556967|NCT04178967|451672326|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125556968|NCT04178967|451672327|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125556969|NCT04178967|451672328|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125556970|NCT04178967|451672329|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125556971|NCT04178967|451672330|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125556972|NCT04178967|451672320|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
125556973|NCT04178967|451672321|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
125556974|NCT04178967|451672322|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
125556975|NCT04178967|451672323|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
125556976|NCT04178967|451672324|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
125556977|NCT04178967|451672325|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
125556978|NCT04178967|451672326|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
125556979|NCT04178967|451672327|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
125556980|NCT04178967|451672328|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
125556981|NCT04178967|451672329|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
125556982|NCT04178967|451672330|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
125556983|NCT04178967|451672320|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125556984|NCT04178967|451672321|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125556985|NCT04178967|451672322|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125556986|NCT04178967|451672323|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125556987|NCT04178967|451672324|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
125556988|NCT04178967|451672325|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
125556989|NCT04178967|451672326|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125556990|NCT04178967|451672327|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
125556991|NCT04178967|451672328|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125556992|NCT04178967|451672329|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125556993|NCT04178967|451672330|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125556994|NCT04178967|451672320|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
125556995|NCT04178967|451672321|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
125556996|NCT04178967|451672322|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
125556997|NCT04178967|451672323|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
125556998|NCT04178967|451672324|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
125556999|NCT04178967|451672325|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
125557000|NCT04178967|451672326|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
125557001|NCT04178967|451672327|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
125557002|NCT04178967|451672328|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
125557003|NCT04178967|451672329|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
125557004|NCT04178967|451672330|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
125557005|NCT04178967|451672320|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125557006|NCT04178967|451672321|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125557007|NCT04178967|451672322|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125557008|NCT04178967|451672323|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
125557009|NCT04178967|451672324|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125557010|NCT04178967|451672325|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
125557011|NCT04178967|451672326|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
125557012|NCT04178967|451672327|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
125353241|NCT04444895|450929395|FG000|Overall Study|Withdrawal by Subject|5|||
125353242|NCT03954041|450929396|FG000|Overall Study|Lost to Follow-up|3|||
125353243|NCT03954041|450929397|FG001|Overall Study|Lost to Follow-up|3|||
125353244|NCT03954041|450929398|FG002|Overall Study|Lost to Follow-up|6|||
125353245|NCT03954041|450929396|FG000|Overall Study|Death|4|||
125353246|NCT03954041|450929397|FG001|Overall Study|Death|0|||
125353247|NCT03954041|450929398|FG002|Overall Study|Death|1|||
125353248|NCT03954041|450929396|FG000|Overall Study|Death by neurologic criteria|0|||
125353249|NCT03954041|450929397|FG001|Overall Study|Death by neurologic criteria|0|||
125353250|NCT03954041|450929398|FG002|Overall Study|Death by neurologic criteria|1|||
125353251|NCT03954041|450929396|FG000|Overall Study|Reason not specified|7|||
125353252|NCT03954041|450929397|FG001|Overall Study|Reason not specified|4|||
125557013|NCT04178967|451672328|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125557014|NCT04178967|451672329|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125557015|NCT04178967|451672330|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125557016|NCT04178967|451672320|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
125557017|NCT04178967|451672321|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
125557018|NCT04178967|451672322|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
125557019|NCT04178967|451672323|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
125557020|NCT04178967|451672324|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
125557021|NCT04178967|451672325|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
125557022|NCT04178967|451672326|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
125557023|NCT04178967|451672327|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
125557024|NCT04178967|451672328|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
125557025|NCT04178967|451672329|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
125557026|NCT04178967|451672330|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
125557027|NCT04178967|451672320|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125557028|NCT04178967|451672321|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125557029|NCT04178967|451672322|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125557030|NCT04178967|451672323|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125557031|NCT04178967|451672324|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125557032|NCT04178967|451672325|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125557033|NCT04178967|451672326|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125557034|NCT04178967|451672327|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125557035|NCT04178967|451672328|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
125557036|NCT04178967|451672329|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
125557037|NCT04178967|451672330|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
125353253|NCT03954041|450929398|FG002|Overall Study|Reason not specified|2|||
125557038|NCT04178967|451672320|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125557039|NCT04178967|451672321|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125557040|NCT04178967|451672322|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125557041|NCT04178967|451672323|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125557042|NCT04178967|451672324|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125557043|NCT04178967|451672325|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125557044|NCT04178967|451672326|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125557045|NCT04178967|451672327|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125557046|NCT04178967|451672328|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125557047|NCT04178967|451672329|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
125557048|NCT04178967|451672330|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125557049|NCT04178967|451672320|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125557050|NCT04178967|451672321|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125557051|NCT04178967|451672322|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125557052|NCT04178967|451672323|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125557053|NCT04178967|451672324|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125557054|NCT04178967|451672325|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125557055|NCT04178967|451672326|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125557056|NCT04178967|451672327|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125557057|NCT04178967|451672328|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
125557058|NCT04178967|451672329|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
125557059|NCT04178967|451672330|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
125557060|NCT04178967|451672320|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125557061|NCT04178967|451672321|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125557062|NCT04178967|451672322|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125557063|NCT04178967|451672323|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125557064|NCT04178967|451672324|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125557065|NCT04178967|451672325|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125557066|NCT04178967|451672326|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125557067|NCT04178967|451672327|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125557068|NCT04178967|451672328|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125557069|NCT04178967|451672329|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
125557070|NCT04178967|451672330|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
125557071|NCT04178967|451672320|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125557072|NCT04178967|451672321|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125557073|NCT04178967|451672322|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125557074|NCT04178967|451672323|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125557075|NCT04178967|451672324|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125557076|NCT04178967|451672325|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125557077|NCT04178967|451672326|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125557078|NCT04178967|451672327|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125557079|NCT04178967|451672328|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125557080|NCT04178967|451672329|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
125557081|NCT04178967|451672330|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
125557082|NCT00628251|451672331|FG000|Randomised Part|Withdrawal by Subject|0|||
125557083|NCT00628251|451672332|FG001|Randomised Part|Withdrawal by Subject|0|||
125557084|NCT00628251|451672333|FG002|Randomised Part|Withdrawal by Subject|1|||
125557085|NCT00628251|451672331|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
125557086|NCT00628251|451672332|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
125557087|NCT00628251|451672333|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
125557088|NCT00628251|451672331|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
125557089|NCT00628251|451672332|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
125557090|NCT00628251|451672333|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
125557091|NCT00628251|451672331|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
125557092|NCT00628251|451672332|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
125557093|NCT00628251|451672333|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
125557094|NCT00628251|451672331|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
125557095|NCT00628251|451672332|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
125557096|NCT00628251|451672333|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
125557097|NCT00628251|451672331|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
125557098|NCT00628251|451672332|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
125557099|NCT00628251|451672333|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
125557100|NCT00041067|451672334|FG000|Overall Study|Adverse Event|20|||
125557101|NCT00041067|451672334|FG000|Overall Study|Progression|19|||
125557102|NCT00041067|451672334|FG000|Overall Study|Patient refusal|12|||
125557103|NCT00041067|451672334|FG000|Overall Study|Other reasons|23|||
125557104|NCT00041067|451672334|FG000|Overall Study|Ineligible|2|||
125557105|NCT01968070|451672336|FG000|Period 1|Withdrawal by Subject|0|||
125557106|NCT01968070|451672337|FG001|Period 1|Withdrawal by Subject|1|||
125557107|NCT01968070|451672338|FG002|Period 1|Withdrawal by Subject|0|||
125557108|NCT01968070|451672339|FG003|Period 1|Withdrawal by Subject|0|||
125557109|NCT01968070|451672340|FG004|Period 1|Withdrawal by Subject|0|||
125557110|NCT01968070|451672341|FG005|Period 1|Withdrawal by Subject|0|||
125557111|NCT01968070|451672342|FG006|Period 1|Withdrawal by Subject|1|||
125557112|NCT01968070|451672343|FG007|Period 1|Withdrawal by Subject|0|||
125557113|NCT01968070|451672344|FG008|Period 1|Withdrawal by Subject|0|||
125557114|NCT01968070|451672345|FG009|Period 1|Withdrawal by Subject|0|||
125557115|NCT01968070|451672346|FG010|Period 1|Withdrawal by Subject|0|||
125557116|NCT01968070|451672347|FG011|Period 1|Withdrawal by Subject|0|||
125557117|NCT01968070|451672348|FG012|Period 1|Withdrawal by Subject|0|||
125557118|NCT01968070|451672349|FG013|Period 1|Withdrawal by Subject|0|||
125557119|NCT01968070|451672350|FG014|Period 1|Withdrawal by Subject|0|||
125557120|NCT01968070|451672351|FG015|Period 1|Withdrawal by Subject|1|||
125557121|NCT01968070|451672352|FG016|Period 1|Withdrawal by Subject|0|||
125557122|NCT01968070|451672353|FG017|Period 1|Withdrawal by Subject|0|||
125557123|NCT01968070|451672336|FG000|Period 1|Protocol Violation|0|||
125557124|NCT01968070|451672337|FG001|Period 1|Protocol Violation|0|||
125557125|NCT01968070|451672338|FG002|Period 1|Protocol Violation|0|||
125557126|NCT01968070|451672339|FG003|Period 1|Protocol Violation|1|||
125557127|NCT01968070|451672340|FG004|Period 1|Protocol Violation|1|||
125557128|NCT01968070|451672341|FG005|Period 1|Protocol Violation|0|||
125557129|NCT01968070|451672342|FG006|Period 1|Protocol Violation|0|||
125557130|NCT01968070|451672343|FG007|Period 1|Protocol Violation|0|||
125557131|NCT01968070|451672344|FG008|Period 1|Protocol Violation|0|||
125557132|NCT01968070|451672345|FG009|Period 1|Protocol Violation|0|||
125557133|NCT01968070|451672346|FG010|Period 1|Protocol Violation|0|||
125557134|NCT01968070|451672347|FG011|Period 1|Protocol Violation|0|||
125557135|NCT01968070|451672348|FG012|Period 1|Protocol Violation|0|||
125557136|NCT01968070|451672349|FG013|Period 1|Protocol Violation|0|||
125557137|NCT01968070|451672350|FG014|Period 1|Protocol Violation|0|||
125557138|NCT01968070|451672351|FG015|Period 1|Protocol Violation|0|||
125557139|NCT01968070|451672352|FG016|Period 1|Protocol Violation|0|||
125557140|NCT01968070|451672353|FG017|Period 1|Protocol Violation|0|||
125557141|NCT01968070|451672336|FG000|Period 1|Lost to Follow-up|0|||
125557142|NCT01968070|451672337|FG001|Period 1|Lost to Follow-up|0|||
125557143|NCT01968070|451672338|FG002|Period 1|Lost to Follow-up|0|||
125557144|NCT01968070|451672339|FG003|Period 1|Lost to Follow-up|1|||
125557145|NCT01968070|451672340|FG004|Period 1|Lost to Follow-up|0|||
125557146|NCT01968070|451672341|FG005|Period 1|Lost to Follow-up|0|||
125557147|NCT01968070|451672342|FG006|Period 1|Lost to Follow-up|0|||
125557148|NCT01968070|451672343|FG007|Period 1|Lost to Follow-up|0|||
125557149|NCT01968070|451672344|FG008|Period 1|Lost to Follow-up|0|||
125557150|NCT01968070|451672345|FG009|Period 1|Lost to Follow-up|0|||
125557151|NCT01968070|451672346|FG010|Period 1|Lost to Follow-up|0|||
125557152|NCT01968070|451672347|FG011|Period 1|Lost to Follow-up|0|||
125557153|NCT01968070|451672348|FG012|Period 1|Lost to Follow-up|0|||
125557154|NCT01968070|451672349|FG013|Period 1|Lost to Follow-up|0|||
125557155|NCT01968070|451672350|FG014|Period 1|Lost to Follow-up|0|||
125557156|NCT01968070|451672351|FG015|Period 1|Lost to Follow-up|0|||
125557157|NCT01968070|451672352|FG016|Period 1|Lost to Follow-up|0|||
125557158|NCT01968070|451672353|FG017|Period 1|Lost to Follow-up|0|||
125557159|NCT01968070|451672336|FG000|Period 1|Adverse Event|0|||
125557160|NCT01968070|451672337|FG001|Period 1|Adverse Event|0|||
125557161|NCT01968070|451672338|FG002|Period 1|Adverse Event|0|||
125557162|NCT01968070|451672339|FG003|Period 1|Adverse Event|0|||
125557163|NCT01968070|451672340|FG004|Period 1|Adverse Event|0|||
125557164|NCT01968070|451672341|FG005|Period 1|Adverse Event|0|||
125557165|NCT01968070|451672342|FG006|Period 1|Adverse Event|1|||
125557166|NCT01968070|451672343|FG007|Period 1|Adverse Event|0|||
125557167|NCT01968070|451672344|FG008|Period 1|Adverse Event|0|||
125557168|NCT01968070|451672345|FG009|Period 1|Adverse Event|0|||
125557169|NCT01968070|451672346|FG010|Period 1|Adverse Event|0|||
125557170|NCT01968070|451672347|FG011|Period 1|Adverse Event|0|||
125557171|NCT01968070|451672348|FG012|Period 1|Adverse Event|0|||
125557172|NCT01968070|451672349|FG013|Period 1|Adverse Event|0|||
125557173|NCT01968070|451672350|FG014|Period 1|Adverse Event|0|||
125557174|NCT01968070|451672351|FG015|Period 1|Adverse Event|0|||
125557175|NCT01968070|451672352|FG016|Period 1|Adverse Event|0|||
125557176|NCT01968070|451672353|FG017|Period 1|Adverse Event|0|||
125557177|NCT01968070|451672336|FG000|Period 1|Physician Decision|0|||
125557178|NCT01968070|451672337|FG001|Period 1|Physician Decision|0|||
125557179|NCT01968070|451672338|FG002|Period 1|Physician Decision|0|||
125557180|NCT01968070|451672339|FG003|Period 1|Physician Decision|0|||
125557181|NCT01968070|451672340|FG004|Period 1|Physician Decision|0|||
125557182|NCT01968070|451672341|FG005|Period 1|Physician Decision|0|||
125557183|NCT01968070|451672342|FG006|Period 1|Physician Decision|0|||
125557184|NCT01968070|451672343|FG007|Period 1|Physician Decision|0|||
125557185|NCT01968070|451672344|FG008|Period 1|Physician Decision|0|||
125557186|NCT01968070|451672345|FG009|Period 1|Physician Decision|0|||
125557187|NCT01968070|451672346|FG010|Period 1|Physician Decision|0|||
125557188|NCT01968070|451672347|FG011|Period 1|Physician Decision|1|||
125557189|NCT01968070|451672348|FG012|Period 1|Physician Decision|0|||
125557190|NCT01968070|451672349|FG013|Period 1|Physician Decision|0|||
125557191|NCT01968070|451672350|FG014|Period 1|Physician Decision|0|||
125557192|NCT01968070|451672351|FG015|Period 1|Physician Decision|0|||
125557193|NCT01968070|451672352|FG016|Period 1|Physician Decision|0|||
125557194|NCT01968070|451672353|FG017|Period 1|Physician Decision|0|||
125557195|NCT01968070|451672336|FG000|Period 2|Withdrawal by Subject|0|||
125557196|NCT01968070|451672337|FG001|Period 2|Withdrawal by Subject|0|||
125557197|NCT01968070|451672338|FG002|Period 2|Withdrawal by Subject|0|||
125557198|NCT01968070|451672339|FG003|Period 2|Withdrawal by Subject|0|||
125557199|NCT01968070|451672340|FG004|Period 2|Withdrawal by Subject|1|||
125557200|NCT01968070|451672341|FG005|Period 2|Withdrawal by Subject|0|||
125557201|NCT01968070|451672342|FG006|Period 2|Withdrawal by Subject|0|||
125557202|NCT01968070|451672343|FG007|Period 2|Withdrawal by Subject|0|||
125557203|NCT01968070|451672344|FG008|Period 2|Withdrawal by Subject|0|||
125557204|NCT01968070|451672345|FG009|Period 2|Withdrawal by Subject|0|||
125557205|NCT01968070|451672346|FG010|Period 2|Withdrawal by Subject|0|||
125557206|NCT01968070|451672347|FG011|Period 2|Withdrawal by Subject|0|||
125557207|NCT01968070|451672348|FG012|Period 2|Withdrawal by Subject|0|||
125557208|NCT01968070|451672349|FG013|Period 2|Withdrawal by Subject|0|||
125557209|NCT01968070|451672350|FG014|Period 2|Withdrawal by Subject|0|||
125557210|NCT01968070|451672351|FG015|Period 2|Withdrawal by Subject|0|||
125557211|NCT01968070|451672352|FG016|Period 2|Withdrawal by Subject|0|||
125557212|NCT01968070|451672353|FG017|Period 2|Withdrawal by Subject|0|||
125557213|NCT00882310|451672357|FG000|Overall Study|Screen Failure|10|||
125557214|NCT00882310|451672357|FG000|Overall Study|Never received treatment|1|||
125557215|NCT00882310|451672357|FG000|Overall Study|Death|6|||
125557216|NCT00882310|451672357|FG000|Overall Study|Progression of disease|4|||
125557217|NCT00882310|451672357|FG000|Overall Study|Adverse Event|1|||
125557218|NCT04246801|451672360|FG000|Overall Study|Adverse Event|1|||
125557219|NCT04246801|451672361|FG001|Overall Study|Adverse Event|1|||
125557220|NCT04246801|451672360|FG000|Overall Study|Protocol Violation|1|||
125557221|NCT04246801|451672361|FG001|Overall Study|Protocol Violation|1|||
125557222|NCT04246801|451672360|FG000|Overall Study|Lack of Efficacy|0|||
125557223|NCT04246801|451672361|FG001|Overall Study|Lack of Efficacy|2|||
125557224|NCT04246801|451672360|FG000|Overall Study|Lost to Follow-up|1|||
125557225|NCT04246801|451672361|FG001|Overall Study|Lost to Follow-up|1|||
125557226|NCT04246801|451672360|FG000|Overall Study|Withdrawal by Subject|2|||
125557227|NCT04246801|451672361|FG001|Overall Study|Withdrawal by Subject|1|||
125557228|NCT03684642|451672362|FG000|Overall Study|Adverse Event|6|||
125557229|NCT03684642|451672363|FG001|Overall Study|Adverse Event|15|||
125557230|NCT03684642|451672364|FG002|Overall Study|Adverse Event|11|||
125557231|NCT03684642|451672362|FG000|Overall Study|Withdrawal by Subject|35|||
125557232|NCT03684642|451672363|FG001|Overall Study|Withdrawal by Subject|53|||
125557233|NCT03684642|451672364|FG002|Overall Study|Withdrawal by Subject|23|||
125557234|NCT03684642|451672362|FG000|Overall Study|Lack of Efficacy|0|||
125557235|NCT03684642|451672363|FG001|Overall Study|Lack of Efficacy|0|||
125557236|NCT03684642|451672364|FG002|Overall Study|Lack of Efficacy|1|||
125557237|NCT03684642|451672362|FG000|Overall Study|Poor compliance to protocol|0|||
125557238|NCT03684642|451672363|FG001|Overall Study|Poor compliance to protocol|4|||
125557239|NCT03684642|451672364|FG002|Overall Study|Poor compliance to protocol|1|||
125557240|NCT03684642|451672362|FG000|Overall Study|Other than specified|62|||
125557241|NCT03684642|451672363|FG001|Overall Study|Other than specified|60|||
125557242|NCT03684642|451672364|FG002|Overall Study|Other than specified|67|||
125557243|NCT03684642|451672362|FG000|Overall Study|Randomized and not treated|0|||
125557244|NCT03684642|451672363|FG001|Overall Study|Randomized and not treated|0|||
125557245|NCT03684642|451672364|FG002|Overall Study|Randomized and not treated|1|||
125557246|NCT03684642|451672362|FG000|Overall Study|Missing completion status but alive at last contact|0|||
125557247|NCT03684642|451672363|FG001|Overall Study|Missing completion status but alive at last contact|1|||
125557248|NCT03684642|451672364|FG002|Overall Study|Missing completion status but alive at last contact|2|||
125557249|NCT04201821|451672373|FG000|Overall Study|Withdrawal by Subject|2|||
125557250|NCT01326728|451672374|FG000|Overall Study|Death|13|||
125557251|NCT01326728|451672375|FG001|Overall Study|Death|0|||
125557252|NCT01326728|451672374|FG000|Overall Study|Early closure of study|34|||
125557253|NCT01326728|451672375|FG001|Overall Study|Early closure of study|9|||
125557254|NCT03785678|451672376|FG000|Overall Study|Death|44|||
125557255|NCT03785678|451672377|FG001|Overall Study|Death|42|||
125557256|NCT03785678|451672376|FG000|Overall Study|Lost to Follow-up|4|||
125557257|NCT03785678|451672377|FG001|Overall Study|Lost to Follow-up|2|||
125557258|NCT03785678|451672376|FG000|Overall Study|Physician Decision|0|||
125557259|NCT03785678|451672377|FG001|Overall Study|Physician Decision|2|||
125557260|NCT03785678|451672376|FG000|Overall Study|Withdrawal by Subject|5|||
125557261|NCT03785678|451672377|FG001|Overall Study|Withdrawal by Subject|3|||
125557262|NCT02374021|451672381|FG000|Overall Study|Adverse Event|1|||
125557263|NCT02374021|451672382|FG001|Overall Study|Adverse Event|0|||
125557264|NCT02374021|451672381|FG000|Overall Study|Lost to Follow-up|3|||
125557265|NCT02374021|451672382|FG001|Overall Study|Lost to Follow-up|2|||
125557266|NCT02374021|451672381|FG000|Overall Study|Physician Decision|0|||
125557267|NCT02374021|451672382|FG001|Overall Study|Physician Decision|3|||
125557268|NCT02374021|451672381|FG000|Overall Study|Withdrawal by Subject|6|||
125557269|NCT02374021|451672382|FG001|Overall Study|Withdrawal by Subject|5|||
125557270|NCT02374021|451672381|FG000|Overall Study|Poor Adherence|0|||
125557271|NCT02374021|451672382|FG001|Overall Study|Poor Adherence|1|||
125557272|NCT02374021|451672381|FG000|Overall Study|Scan protocol not followed|0|||
125557273|NCT02374021|451672382|FG001|Overall Study|Scan protocol not followed|1|||
125557274|NCT02374021|451672381|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
125557275|NCT02374021|451672382|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
125353254|NCT03954041|450929396|FG000|Overall Study|Withdrew prior to dosing|4|||
125557276|NCT01667107|451672383|FG000|Overall Study|Adverse Event|4|||
125557277|NCT01667107|451672384|FG001|Overall Study|Adverse Event|3|||
125557278|NCT01667107|451672383|FG000|Overall Study|Tolerability issues|0|||
125557279|NCT01667107|451672384|FG001|Overall Study|Tolerability issues|2|||
125557280|NCT01667107|451672383|FG000|Overall Study|Protocol Violation|0|||
125557281|NCT01667107|451672384|FG001|Overall Study|Protocol Violation|1|||
125557282|NCT01667107|451672383|FG000|Overall Study|Lack of Efficacy|0|||
125557283|NCT01667107|451672384|FG001|Overall Study|Lack of Efficacy|1|||
125557284|NCT01162239|451672385|FG000|Treatment Phase|Withdrawal by Subject|1|||
125557285|NCT01162239|451672386|FG001|Treatment Phase|Withdrawal by Subject|3|||
125557286|NCT01162239|451672387|FG002|Treatment Phase|Withdrawal by Subject|2|||
125557287|NCT01162239|451672388|FG003|Treatment Phase|Withdrawal by Subject|3|||
125557288|NCT01162239|451672385|FG000|Treatment Phase|Death|0|||
125557289|NCT01162239|451672386|FG001|Treatment Phase|Death|0|||
125557290|NCT01162239|451672387|FG002|Treatment Phase|Death|0|||
125557291|NCT01162239|451672388|FG003|Treatment Phase|Death|1|||
125557292|NCT01162239|451672385|FG000|Treatment Phase|Lost to Follow-up|5|||
125557293|NCT01162239|451672386|FG001|Treatment Phase|Lost to Follow-up|4|||
125557294|NCT01162239|451672387|FG002|Treatment Phase|Lost to Follow-up|2|||
125557295|NCT01162239|451672388|FG003|Treatment Phase|Lost to Follow-up|1|||
125557296|NCT01162239|451672385|FG000|Extended Follow-up|Lost to Follow-up|8|||
125557297|NCT01162239|451672386|FG001|Extended Follow-up|Lost to Follow-up|13|||
125557298|NCT01162239|451672387|FG002|Extended Follow-up|Lost to Follow-up|8|||
125557299|NCT01162239|451672388|FG003|Extended Follow-up|Lost to Follow-up|6|||
125557300|NCT00228566|451672389|FG000|Overall Study|Adverse Event|31|||
125557301|NCT00228566|451672389|FG000|Overall Study|Lack of Efficacy|14|||
125557302|NCT00228566|451672389|FG000|Overall Study|Lost to Follow-up|16|||
125557303|NCT00228566|451672389|FG000|Overall Study|Physician Decision|5|||
125557304|NCT00228566|451672389|FG000|Overall Study|Withdrawal by Subject|4|||
125557305|NCT00228566|451672389|FG000|Overall Study|Miscellaneous|1|||
125557306|NCT04448756|451672390|FG000|Overall Study|Adverse Event|0|||
125557307|NCT04448756|451672391|FG001|Overall Study|Adverse Event|1|||
125557308|NCT04448756|451672392|FG002|Overall Study|Adverse Event|0|||
125557309|NCT04448756|451672390|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
125557310|NCT04448756|451672391|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
125557311|NCT04448756|451672392|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
125557312|NCT04448756|451672390|FG000|Overall Study|Withdrawal by Subject|0|||
125557313|NCT04448756|451672391|FG001|Overall Study|Withdrawal by Subject|3|||
125557314|NCT04448756|451672392|FG002|Overall Study|Withdrawal by Subject|1|||
125557315|NCT04448756|451672390|FG000|Overall Study|Death|2|||
125557316|NCT04448756|451672391|FG001|Overall Study|Death|1|||
125557317|NCT04448756|451672392|FG002|Overall Study|Death|0|||
125557318|NCT00835120|451672393|FG000|Overall Study|Lack of Efficacy|1|||
125557319|NCT00835120|451672393|FG000|Overall Study|Lost to Follow-up|3|||
125557320|NCT00835120|451672393|FG000|Overall Study|Adverse Event|2|||
125557321|NCT00835120|451672393|FG000|Overall Study|Withdrawal by Subject|2|||
125557322|NCT01624259|451672394|FG000|Overall Study|Adverse Event|18|||
125557323|NCT01624259|451672395|FG001|Overall Study|Adverse Event|18|||
125353255|NCT03954041|450929397|FG001|Overall Study|Withdrew prior to dosing|2|||
125353256|NCT03954041|450929398|FG002|Overall Study|Withdrew prior to dosing|0|||
125353257|NCT04177355|450929399|FG000|Overall Study|Lost to Follow-up|0|||
125353258|NCT04177355|450929400|FG001|Overall Study|Lost to Follow-up|2|||
125353259|NCT04177355|450929401|FG002|Overall Study|Lost to Follow-up|0|||
125557324|NCT01624259|451672394|FG000|Overall Study|Protocol Violation|1|||
125557325|NCT01624259|451672395|FG001|Overall Study|Protocol Violation|2|||
125353260|NCT04177355|450929402|FG003|Overall Study|Lost to Follow-up|1|||
125353261|NCT04177355|450929403|FG004|Overall Study|Lost to Follow-up|2|||
125353262|NCT04177355|450929404|FG005|Overall Study|Lost to Follow-up|0|||
125353263|NCT04177355|450929405|FG006|Overall Study|Lost to Follow-up|1|||
125557326|NCT01624259|451672394|FG000|Overall Study|Withdrawal by Subject|5|||
125557327|NCT01624259|451672395|FG001|Overall Study|Withdrawal by Subject|7|||
125557328|NCT01624259|451672394|FG000|Overall Study|Physician Decision|1|||
125557329|NCT01624259|451672395|FG001|Overall Study|Physician Decision|1|||
125557330|NCT01624259|451672394|FG000|Overall Study|Lost to Follow-up|2|||
125557331|NCT01624259|451672395|FG001|Overall Study|Lost to Follow-up|3|||
125557332|NCT01624259|451672394|FG000|Overall Study|Abnormal laboratory measure|3|||
125557333|NCT01624259|451672395|FG001|Overall Study|Abnormal laboratory measure|0|||
125557334|NCT00232141|451672396|FG000|Overall Study|Adverse Event|9|||
125557335|NCT00232141|451672397|FG001|Overall Study|Adverse Event|4|||
125557336|NCT00232141|451672396|FG000|Overall Study|Lack of Efficacy|0|||
125557337|NCT00232141|451672397|FG001|Overall Study|Lack of Efficacy|3|||
125557338|NCT00232141|451672396|FG000|Overall Study|Lost to Follow-up|9|||
125557339|NCT00232141|451672397|FG001|Overall Study|Lost to Follow-up|6|||
125557340|NCT00232141|451672396|FG000|Overall Study|Other|8|||
125557341|NCT00232141|451672397|FG001|Overall Study|Other|10|||
125353264|NCT04177355|450929406|FG007|Overall Study|Lost to Follow-up|0|||
125557342|NCT00232141|451672396|FG000|Overall Study|Withdrawal by Subject|5|||
125557343|NCT00232141|451672397|FG001|Overall Study|Withdrawal by Subject|3|||
125557344|NCT04572854|451672398|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
125557345|NCT04572854|451672399|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
125557346|NCT04572854|451672400|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
125557347|NCT04572854|451672401|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
125557348|NCT04572854|451672398|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
125557349|NCT04572854|451672399|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
125557350|NCT04572854|451672400|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
125557351|NCT04572854|451672401|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
125557352|NCT01093326|451672403|FG000|Overall Study|Death|0|||
125557353|NCT01093326|451672404|FG001|Overall Study|Death|1|||
125557354|NCT01093326|451672405|FG002|Overall Study|Death|0|||
125557355|NCT01093326|451672403|FG000|Overall Study|Lack of Efficacy|7|||
125557356|NCT01093326|451672404|FG001|Overall Study|Lack of Efficacy|6|||
125557357|NCT01093326|451672405|FG002|Overall Study|Lack of Efficacy|3|||
125557358|NCT01093326|451672403|FG000|Overall Study|Lost to Follow-up|2|||
125557359|NCT01093326|451672404|FG001|Overall Study|Lost to Follow-up|5|||
125557360|NCT01093326|451672405|FG002|Overall Study|Lost to Follow-up|4|||
125557361|NCT01093326|451672403|FG000|Overall Study|Physician Decision|3|||
125557362|NCT01093326|451672404|FG001|Overall Study|Physician Decision|1|||
125557363|NCT01093326|451672405|FG002|Overall Study|Physician Decision|3|||
125557364|NCT01093326|451672403|FG000|Overall Study|Withdrawal by Subject|30|||
125557365|NCT01093326|451672404|FG001|Overall Study|Withdrawal by Subject|27|||
125557366|NCT01093326|451672405|FG002|Overall Study|Withdrawal by Subject|26|||
125557367|NCT01093326|451672403|FG000|Overall Study|Adverse Event|2|||
125557368|NCT01093326|451672404|FG001|Overall Study|Adverse Event|1|||
125557369|NCT01093326|451672405|FG002|Overall Study|Adverse Event|4|||
125557370|NCT01093326|451672403|FG000|Overall Study|Other|0|||
125557371|NCT01093326|451672404|FG001|Overall Study|Other|0|||
125557372|NCT01093326|451672405|FG002|Overall Study|Other|1|||
125557373|NCT01444456|451672406|FG000|Overall Study|Withdrawal by Subject|21|||
125557374|NCT01444456|451672406|FG000|Overall Study|Physician Decision|9|||
125557375|NCT01444456|451672406|FG000|Overall Study|Lost to Follow-up|37|||
125557376|NCT01444456|451672406|FG000|Overall Study|Death|73|||
125557377|NCT01444456|451672406|FG000|Overall Study|Ineligibility determined|23|||
125557378|NCT01444456|451672406|FG000|Overall Study|Other|18|||
125557379|NCT01444456|451672406|FG000|Overall Study|Not treated|104|||
125557380|NCT04263896|451672407|FG000|Overall Study|Withdrawal by Subject|2|||
125557381|NCT04263896|451672408|FG001|Overall Study|Withdrawal by Subject|4|||
125557382|NCT04263896|451672407|FG000|Overall Study|converted to open procedure|0|||
125557383|NCT04263896|451672408|FG001|Overall Study|converted to open procedure|1|||
125557384|NCT04263896|451672407|FG000|Overall Study|Lost to Follow-up|9|||
125557385|NCT04263896|451672408|FG001|Overall Study|Lost to Follow-up|11|||
125557386|NCT04263896|451672407|FG000|Overall Study|surveys lost in mail|5|||
125557387|NCT04263896|451672408|FG001|Overall Study|surveys lost in mail|3|||
125557388|NCT04263896|451672407|FG000|Overall Study|excluded from analysis|1|||
125557389|NCT04263896|451672408|FG001|Overall Study|excluded from analysis|0|||
125557390|NCT04313153|451673776|FG000|Overall Study|Adverse Event (includes Death)|14|||
125557391|NCT04313153|451673777|FG001|Overall Study|Adverse Event (includes Death)|19|||
125557392|NCT04313153|451673778|FG002|Overall Study|Adverse Event (includes Death)|10|||
125557393|NCT04313153|451673776|FG000|Overall Study|Physician Decision|4|||
125557394|NCT04313153|451673777|FG001|Overall Study|Physician Decision|2|||
125557395|NCT04313153|451673778|FG002|Overall Study|Physician Decision|1|||
125557396|NCT04313153|451673776|FG000|Overall Study|Withdrawal by Subject|7|||
125557397|NCT04313153|451673777|FG001|Overall Study|Withdrawal by Subject|6|||
125557398|NCT04313153|451673778|FG002|Overall Study|Withdrawal by Subject|2|||
125557399|NCT04313153|451673776|FG000|Overall Study|Lack of Efficacy|3|||
125557400|NCT04313153|451673777|FG001|Overall Study|Lack of Efficacy|3|||
125557401|NCT04313153|451673778|FG002|Overall Study|Lack of Efficacy|0|||
125557402|NCT04313153|451673776|FG000|Overall Study|Lost to Follow-up|1|||
125557403|NCT04313153|451673777|FG001|Overall Study|Lost to Follow-up|0|||
125557404|NCT04313153|451673778|FG002|Overall Study|Lost to Follow-up|2|||
125557405|NCT04313153|451673776|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
125557406|NCT04313153|451673777|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
125557407|NCT04313153|451673778|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
125557408|NCT04313153|451673776|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
125557409|NCT04313153|451673777|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
125557410|NCT04313153|451673778|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
125557411|NCT04313153|451673776|FG000|Overall Study|Change in Dialysis Modality|0|||
125353265|NCT04177355|450929407|FG008|Overall Study|Lost to Follow-up|0|||
125353266|NCT04177355|450929408|FG009|Overall Study|Lost to Follow-up|0|||
125557412|NCT04313153|451673777|FG001|Overall Study|Change in Dialysis Modality|1|||
125557413|NCT04313153|451673778|FG002|Overall Study|Change in Dialysis Modality|2|||
125557414|NCT04313153|451673776|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
125557415|NCT04313153|451673777|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
125557416|NCT04313153|451673778|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
125557417|NCT04313153|451673776|FG000|Overall Study|Other|5|||
125557418|NCT04313153|451673777|FG001|Overall Study|Other|3|||
125557419|NCT04313153|451673778|FG002|Overall Study|Other|2|||
125557420|NCT05586269|451673779|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
125557421|NCT05586269|451673780|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
125557422|NCT05586269|451673781|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
125557423|NCT05586269|451673782|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
125557424|NCT05586269|451673779|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
125557425|NCT05586269|451673780|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
125557426|NCT05586269|451673781|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
125557427|NCT05586269|451673782|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
125557428|NCT02217436|451673783|FG000|Overall Study|Protocol Violation|1|||
125557429|NCT02217436|451673784|FG001|Overall Study|Protocol Violation|1|||
125557430|NCT02217436|451673783|FG000|Overall Study|Incomplete data|0|||
125557431|NCT02217436|451673784|FG001|Overall Study|Incomplete data|1|||
125557432|NCT01920594|451673787|FG000|Overall Study|Adverse Event|4|||
125557433|NCT01920594|451673788|FG001|Overall Study|Adverse Event|2|||
125557434|NCT01920594|451673787|FG000|Overall Study|Lost to Follow-up|1|||
125557435|NCT01920594|451673788|FG001|Overall Study|Lost to Follow-up|0|||
125557436|NCT01920594|451673787|FG000|Overall Study|Recovery|2|||
125557437|NCT01920594|451673788|FG001|Overall Study|Recovery|0|||
125557438|NCT01920594|451673787|FG000|Overall Study|Investigator discretion|0|||
125557439|NCT01920594|451673788|FG001|Overall Study|Investigator discretion|1|||
125557440|NCT00928564|451673789|FG000|Overall Study|Lost to Follow-up|6|||
125557441|NCT00928564|451673790|FG001|Overall Study|Lost to Follow-up|0|||
125557442|NCT02460497|451673794|FG000|Overall Study|Participant Requested Withdrawal|4|||
125557443|NCT02460497|451673794|FG000|Overall Study|Non-Compliance|1|||
125557444|NCT02460497|451673794|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
125557445|NCT02460497|451673794|FG000|Overall Study|Lost to Follow-up|2|||
125557446|NCT02460497|451673794|FG000|Overall Study|Investigator Decision|1|||
125557447|NCT01448213|451673799|FG000|Overall Study|Lost to Follow-up|12|||
125557448|NCT01448213|451673800|FG001|Overall Study|Lost to Follow-up|10|||
125557449|NCT01448213|451673799|FG000|Overall Study|Adverse Event|4|||
125557450|NCT01448213|451673800|FG001|Overall Study|Adverse Event|10|||
125557451|NCT01448213|451673799|FG000|Overall Study|Protocol Violation|1|||
125557452|NCT01448213|451673800|FG001|Overall Study|Protocol Violation|2|||
125557453|NCT02012296|451673801|FG000|Overall Study|Lack of Efficacy|0|||
125557454|NCT02012296|451673802|FG001|Overall Study|Lack of Efficacy|0|||
125557455|NCT02012296|451673803|FG002|Overall Study|Lack of Efficacy|15|||
125557456|NCT02012296|451673801|FG000|Overall Study|Adverse Event|0|||
125557457|NCT02012296|451673802|FG001|Overall Study|Adverse Event|0|||
125557458|NCT02012296|451673803|FG002|Overall Study|Adverse Event|2|||
125353267|NCT04177355|450929409|FG010|Overall Study|Lost to Follow-up|0|||
125353268|NCT04177355|450929399|FG000|Overall Study|Withdrawal by Subject|0|||
125557459|NCT02012296|451673801|FG000|Overall Study|Early study closure|0|||
125557460|NCT02012296|451673802|FG001|Overall Study|Early study closure|0|||
125557461|NCT02012296|451673803|FG002|Overall Study|Early study closure|5|||
125557462|NCT02012296|451673801|FG000|Overall Study|Protocol Violation|0|||
125557463|NCT02012296|451673802|FG001|Overall Study|Protocol Violation|1|||
125557464|NCT02012296|451673803|FG002|Overall Study|Protocol Violation|0|||
125557465|NCT01330914|451673804|FG000|Overall Study|Withdrawal by Subject|4|||
125557466|NCT01330914|451673804|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
125557467|NCT02615470|451673805|FG000|Overall Study|Lost to Follow-up|21|||
125557468|NCT02615470|451673806|FG001|Overall Study|Lost to Follow-up|32|||
125557469|NCT01650285|451673809|FG000|Overall Study|Adverse Event|1|||
125557470|NCT00907257|451673816|FG000|Overall Study|Adverse Event|0|||
125557471|NCT00907257|451673817|FG001|Overall Study|Adverse Event|4|||
125557472|NCT00907257|451673816|FG000|Overall Study|Protocol Violation|1|||
125557473|NCT00907257|451673817|FG001|Overall Study|Protocol Violation|2|||
125557474|NCT00907257|451673816|FG000|Overall Study|Lost to Follow-up|3|||
125557475|NCT00907257|451673817|FG001|Overall Study|Lost to Follow-up|3|||
125557476|NCT00907257|451673816|FG000|Overall Study|Withdrawal by Subject|1|||
125557477|NCT00907257|451673817|FG001|Overall Study|Withdrawal by Subject|2|||
125557478|NCT00907257|451673816|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
125557479|NCT00907257|451673817|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
125557480|NCT00907257|451673816|FG000|Overall Study|Moved|1|||
125557481|NCT00907257|451673817|FG001|Overall Study|Moved|0|||
125557482|NCT00907257|451673816|FG000|Overall Study|Personal Reasons|6|||
125557483|NCT00907257|451673817|FG001|Overall Study|Personal Reasons|1|||
125557484|NCT04163900|451673818|FG000|Overall Study|Radiological disease progression|112|||
125557485|NCT04163900|451673819|FG001|Overall Study|Radiological disease progression|127|||
125557486|NCT04163900|451673818|FG000|Overall Study|Study closure|98|||
125557487|NCT04163900|451673819|FG001|Overall Study|Study closure|133|||
125557488|NCT04163900|451673818|FG000|Overall Study|Adverse Event|78|||
125557489|NCT04163900|451673819|FG001|Overall Study|Adverse Event|32|||
125557490|NCT04163900|451673818|FG000|Overall Study|Withdrawal by Subject|37|||
125557491|NCT04163900|451673819|FG001|Overall Study|Withdrawal by Subject|34|||
125557492|NCT04163900|451673818|FG000|Overall Study|Death|29|||
125557493|NCT04163900|451673819|FG001|Overall Study|Death|16|||
125557494|NCT04163900|451673818|FG000|Overall Study|Physician Decision|17|||
125557495|NCT04163900|451673819|FG001|Overall Study|Physician Decision|25|||
125557496|NCT04163900|451673818|FG000|Overall Study|Clinical disease progression|14|||
125557497|NCT04163900|451673819|FG001|Overall Study|Clinical disease progression|13|||
125557498|NCT04163900|451673818|FG000|Overall Study|Protocol Violation|3|||
125557499|NCT04163900|451673819|FG001|Overall Study|Protocol Violation|4|||
125557500|NCT04163900|451673818|FG000|Overall Study|Lost to Follow-up|0|||
125557501|NCT04163900|451673819|FG001|Overall Study|Lost to Follow-up|1|||
125557502|NCT00283049|451673820|FG000|Overall Study|Adverse Event|6|||
125557503|NCT00283049|451673821|FG001|Overall Study|Adverse Event|1|||
125557504|NCT00283049|451673822|FG002|Overall Study|Adverse Event|4|||
125557505|NCT00283049|451673820|FG000|Overall Study|Protocol Violation|3|||
125557506|NCT00283049|451673821|FG001|Overall Study|Protocol Violation|0|||
125557507|NCT00283049|451673822|FG002|Overall Study|Protocol Violation|3|||
125557508|NCT00283049|451673820|FG000|Overall Study|Death|1|||
125557509|NCT00283049|451673821|FG001|Overall Study|Death|1|||
125557510|NCT00283049|451673822|FG002|Overall Study|Death|1|||
125557511|NCT00283049|451673820|FG000|Overall Study|Lack of Efficacy|0|||
125557512|NCT00283049|451673821|FG001|Overall Study|Lack of Efficacy|1|||
125557513|NCT00283049|451673822|FG002|Overall Study|Lack of Efficacy|1|||
125557514|NCT00283049|451673820|FG000|Overall Study|Lost to Follow-up|4|||
125557515|NCT00283049|451673821|FG001|Overall Study|Lost to Follow-up|2|||
125557516|NCT00283049|451673822|FG002|Overall Study|Lost to Follow-up|5|||
125557517|NCT00283049|451673820|FG000|Overall Study|Withdrawal by Subject|26|||
125557518|NCT00283049|451673821|FG001|Overall Study|Withdrawal by Subject|24|||
125557519|NCT00283049|451673822|FG002|Overall Study|Withdrawal by Subject|19|||
125557520|NCT00283049|451673820|FG000|Overall Study|Discontinuation of Study|18|||
125557521|NCT00283049|451673821|FG001|Overall Study|Discontinuation of Study|16|||
125557522|NCT00283049|451673822|FG002|Overall Study|Discontinuation of Study|20|||
125557523|NCT00283049|451673820|FG000|Overall Study|No longer requires study treatment|0|||
125557524|NCT00283049|451673821|FG001|Overall Study|No longer requires study treatment|0|||
125557525|NCT00283049|451673822|FG002|Overall Study|No longer requires study treatment|1|||
125557526|NCT01830855|451673823|FG000|Overall Study|Other|7|||
125557527|NCT01830855|451673824|FG001|Overall Study|Other|1|||
125557528|NCT01830855|451673825|FG002|Overall Study|Other|4|||
125557529|NCT01830855|451673826|FG003|Overall Study|Other|4|||
125557530|NCT01830855|451673823|FG000|Overall Study|Medication error without associated AE|1|||
125557531|NCT01830855|451673824|FG001|Overall Study|Medication error without associated AE|0|||
125557532|NCT01830855|451673825|FG002|Overall Study|Medication error without associated AE|0|||
125557533|NCT01830855|451673826|FG003|Overall Study|Medication error without associated AE|1|||
125557534|NCT01830855|451673823|FG000|Overall Study|Pregnancy|3|||
125557535|NCT01830855|451673824|FG001|Overall Study|Pregnancy|1|||
125557536|NCT01830855|451673825|FG002|Overall Study|Pregnancy|2|||
125557537|NCT01830855|451673826|FG003|Overall Study|Pregnancy|1|||
125557538|NCT01830855|451673823|FG000|Overall Study|No longer meets eligibility criteria|11|||
125557539|NCT01830855|451673824|FG001|Overall Study|No longer meets eligibility criteria|2|||
125557540|NCT01830855|451673825|FG002|Overall Study|No longer meets eligibility criteria|3|||
125557541|NCT01830855|451673826|FG003|Overall Study|No longer meets eligibility criteria|5|||
125557542|NCT01830855|451673823|FG000|Overall Study|Adverse Event|11|||
125557543|NCT01830855|451673824|FG001|Overall Study|Adverse Event|5|||
125557544|NCT01830855|451673825|FG002|Overall Study|Adverse Event|6|||
125557545|NCT01830855|451673826|FG003|Overall Study|Adverse Event|3|||
125557546|NCT01830855|451673823|FG000|Overall Study|Protocol deviation|10|||
125557547|NCT01830855|451673824|FG001|Overall Study|Protocol deviation|5|||
125557548|NCT01830855|451673825|FG002|Overall Study|Protocol deviation|6|||
125557549|NCT01830855|451673826|FG003|Overall Study|Protocol deviation|6|||
125557550|NCT01830855|451673823|FG000|Overall Study|Withdrawal by Subject|33|||
125557551|NCT01830855|451673824|FG001|Overall Study|Withdrawal by Subject|14|||
125557552|NCT01830855|451673825|FG002|Overall Study|Withdrawal by Subject|10|||
125557553|NCT01830855|451673826|FG003|Overall Study|Withdrawal by Subject|12|||
125557554|NCT01830855|451673823|FG000|Overall Study|No longer willing to participate|32|||
125557555|NCT01830855|451673824|FG001|Overall Study|No longer willing to participate|13|||
125557556|NCT01830855|451673825|FG002|Overall Study|No longer willing to participate|12|||
125557557|NCT01830855|451673826|FG003|Overall Study|No longer willing to participate|17|||
125557558|NCT01830855|451673823|FG000|Overall Study|Lost to Follow-up|47|||
125557559|NCT01830855|451673824|FG001|Overall Study|Lost to Follow-up|20|||
125557560|NCT01830855|451673825|FG002|Overall Study|Lost to Follow-up|23|||
125557561|NCT01830855|451673826|FG003|Overall Study|Lost to Follow-up|33|||
125557562|NCT01667081|451673827|FG000|Overall Study|Death|43|||
125557563|NCT01667081|451673828|FG001|Overall Study|Death|3|||
125557564|NCT01667081|451673827|FG000|Overall Study|Lost to Follow-up|99|||
125557565|NCT01667081|451673828|FG001|Overall Study|Lost to Follow-up|48|||
125557566|NCT01667081|451673827|FG000|Overall Study|Physician Decision|16|||
125557567|NCT01667081|451673828|FG001|Overall Study|Physician Decision|2|||
125557568|NCT01667081|451673827|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
125557569|NCT01667081|451673828|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
125557570|NCT01667081|451673827|FG000|Overall Study|Withdrawal by Subject|90|||
125557571|NCT01667081|451673828|FG001|Overall Study|Withdrawal by Subject|35|||
125557572|NCT00930722|451673829|FG000|Overall Study|Lost to Follow-up|16|||
125557573|NCT00930722|451673829|FG000|Overall Study|No longer willing to participate|9|||
125557574|NCT00930722|451673829|FG000|Overall Study|Study terminated by sponsor|2|||
125557575|NCT03034460|451673830|FG000|Overall Study|Adverse Event|0|||
125557576|NCT03034460|451673831|FG001|Overall Study|Adverse Event|1|||
125557577|NCT03034460|451673830|FG000|Overall Study|Withdrawal by Subject|2|||
125557578|NCT03034460|451673831|FG001|Overall Study|Withdrawal by Subject|2|||
125557579|NCT03034460|451673830|FG000|Overall Study|Personal Reasons|1|||
125557580|NCT03034460|451673831|FG001|Overall Study|Personal Reasons|0|||
125557581|NCT00295633|451673832|FG000|Overall Study|Lack of Efficacy|19|||
125557582|NCT00295633|451673833|FG001|Overall Study|Lack of Efficacy|7|||
125557583|NCT00295633|451673834|FG002|Overall Study|Lack of Efficacy|16|||
125557584|NCT00295633|451673832|FG000|Overall Study|Withdrawal of consent by subject|16|||
125557585|NCT00295633|451673833|FG001|Overall Study|Withdrawal of consent by subject|16|||
125557586|NCT00295633|451673834|FG002|Overall Study|Withdrawal of consent by subject|26|||
125557587|NCT00295633|451673832|FG000|Overall Study|Adverse Event|9|||
125557588|NCT00295633|451673833|FG001|Overall Study|Adverse Event|17|||
125557589|NCT00295633|451673834|FG002|Overall Study|Adverse Event|9|||
125557590|NCT00295633|451673832|FG000|Overall Study|Lost to Follow-up|6|||
125557591|NCT00295633|451673833|FG001|Overall Study|Lost to Follow-up|11|||
125557592|NCT00295633|451673834|FG002|Overall Study|Lost to Follow-up|7|||
125557593|NCT00295633|451673832|FG000|Overall Study|Physician Decision|9|||
125557594|NCT00295633|451673833|FG001|Overall Study|Physician Decision|10|||
125557595|NCT00295633|451673834|FG002|Overall Study|Physician Decision|8|||
125557596|NCT00295633|451673832|FG000|Overall Study|Poor/Noncompliance|2|||
125353269|NCT04177355|450929400|FG001|Overall Study|Withdrawal by Subject|0|||
125557597|NCT00295633|451673833|FG001|Overall Study|Poor/Noncompliance|2|||
125557598|NCT00295633|451673834|FG002|Overall Study|Poor/Noncompliance|6|||
125353270|NCT04177355|450929401|FG002|Overall Study|Withdrawal by Subject|0|||
125353271|NCT04177355|450929402|FG003|Overall Study|Withdrawal by Subject|1|||
125557599|NCT00295633|451673832|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
125557600|NCT00295633|451673833|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
125557601|NCT00295633|451673834|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
125557602|NCT00295633|451673832|FG000|Overall Study|Death|1|||
125557603|NCT00295633|451673833|FG001|Overall Study|Death|1|||
125557604|NCT00295633|451673834|FG002|Overall Study|Death|0|||
125557605|NCT00295633|451673832|FG000|Overall Study|Administrative reason by sponsor|0|||
125557606|NCT00295633|451673833|FG001|Overall Study|Administrative reason by sponsor|0|||
125557607|NCT00295633|451673834|FG002|Overall Study|Administrative reason by sponsor|1|||
125557608|NCT00419120|451673835|FG000|Long Term Follow up Period|study ongoing|10|||
125557609|NCT01754857|451673844|FG000|Overall Study|Adverse Event|7|||
125557610|NCT01754857|451673844|FG000|Overall Study|Disease progression|3|||
125557611|NCT01754857|451673844|FG000|Overall Study|Physician Decision|2|||
125557612|NCT01754857|451673844|FG000|Overall Study|Withdrawal by Subject|3|||
125557613|NCT01754857|451673844|FG000|Overall Study|other complicating disease|1|||
125557614|NCT01754857|451673844|FG000|Overall Study|ineligible to continue onto maintenance|1|||
125557615|NCT01754857|451673844|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
125557616|NCT01754857|451673844|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
125557617|NCT01509079|451673845|FG000|Overall Study|Lack of Efficacy|0|||
125557618|NCT01509079|451673846|FG001|Overall Study|Lack of Efficacy|2|||
125557619|NCT01509079|451673845|FG000|Overall Study|started an excluded medication|0|||
125557620|NCT01509079|451673846|FG001|Overall Study|started an excluded medication|1|||
125557621|NCT01399190|451673849|FG000|Overall Study|Not Eligible for Final Analysis|5|||
125557622|NCT01399190|451673849|FG000|Overall Study|Adverse Event|8|||
125557623|NCT01399190|451673849|FG000|Overall Study|Participant's Request|5|||
125557624|NCT01399190|451673849|FG000|Overall Study|Physician Decision|2|||
125557625|NCT00436618|451673853|FG000|Overall Study|Withdrawal by Subject|5|||
125557626|NCT00436618|451673854|FG001|Overall Study|Withdrawal by Subject|8|||
125557627|NCT00436618|451673855|FG002|Overall Study|Withdrawal by Subject|11|||
125557628|NCT00436618|451673853|FG000|Overall Study|Adverse Event|8|||
125557629|NCT00436618|451673854|FG001|Overall Study|Adverse Event|8|||
125557630|NCT00436618|451673855|FG002|Overall Study|Adverse Event|9|||
125557631|NCT00436618|451673853|FG000|Overall Study|Alternate Treatment|3|||
125557632|NCT00436618|451673854|FG001|Overall Study|Alternate Treatment|4|||
125557633|NCT00436618|451673855|FG002|Overall Study|Alternate Treatment|12|||
125557634|NCT00436618|451673853|FG000|Overall Study|Other Medical Problems|3|||
125557635|NCT00436618|451673854|FG001|Overall Study|Other Medical Problems|1|||
125557636|NCT00436618|451673855|FG002|Overall Study|Other Medical Problems|7|||
125557637|NCT00436618|451673853|FG000|Overall Study|Death|4|||
125557638|NCT00436618|451673854|FG001|Overall Study|Death|2|||
125557639|NCT00436618|451673855|FG002|Overall Study|Death|3|||
125557640|NCT00436618|451673853|FG000|Overall Study|New Primary or Other Reasons|6|||
125557641|NCT00436618|451673854|FG001|Overall Study|New Primary or Other Reasons|2|||
125557642|NCT00436618|451673855|FG002|Overall Study|New Primary or Other Reasons|12|||
125557643|NCT00436618|451673853|FG000|Overall Study|Still on treatment|1|||
125557644|NCT00436618|451673854|FG001|Overall Study|Still on treatment|2|||
125557645|NCT00436618|451673855|FG002|Overall Study|Still on treatment|7|||
125557646|NCT00698204|451673856|FG000|Overall Study|Withdrawal by Subject|1|||
125557647|NCT00698204|451673857|FG001|Overall Study|Withdrawal by Subject|0|||
125557648|NCT01949155|451673858|FG000|Overall Study|Lost to Follow-up|1|||
125557649|NCT01949155|451673859|FG001|Overall Study|Lost to Follow-up|0|||
125557650|NCT01949155|451673858|FG000|Overall Study|Protocol Violation|1|||
125557651|NCT01949155|451673859|FG001|Overall Study|Protocol Violation|0|||
125557652|NCT00314249|451673860|FG000|Overall Study|Adverse Event|73|||
125557653|NCT00314249|451673861|FG001|Overall Study|Adverse Event|94|||
125557654|NCT00314249|451673860|FG000|Overall Study|Lack of Efficacy|33|||
125557655|NCT00314249|451673861|FG001|Overall Study|Lack of Efficacy|24|||
125557656|NCT00314249|451673860|FG000|Overall Study|Withdrawal by Subject|21|||
125557657|NCT00314249|451673861|FG001|Overall Study|Withdrawal by Subject|28|||
125557658|NCT00314249|451673860|FG000|Overall Study|Lost to Follow-up|15|||
125557659|NCT00314249|451673861|FG001|Overall Study|Lost to Follow-up|9|||
125557660|NCT00314249|451673860|FG000|Overall Study|Physician Decision|1|||
125557661|NCT00314249|451673861|FG001|Overall Study|Physician Decision|1|||
125557662|NCT00314249|451673860|FG000|Overall Study|Withdrawn for other reasons|4|||
125557663|NCT00314249|451673861|FG001|Overall Study|Withdrawn for other reasons|1|||
125557664|NCT00314249|451673860|FG000|Overall Study|Non-Compliant|5|||
125557665|NCT00314249|451673861|FG001|Overall Study|Non-Compliant|6|||
125557666|NCT00210184|451673862|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
125557667|NCT01118325|451673865|FG000|Overall Study|Adverse Event|1|||
125557668|NCT01118325|451673866|FG001|Overall Study|Adverse Event|0|||
125557669|NCT01118325|451673867|FG002|Overall Study|Adverse Event|1|||
125557670|NCT03334409|451673868|FG000|Overall Study|Did not meet inclusion criteria|1|||
125557671|NCT03334409|451673869|FG001|Overall Study|Did not meet inclusion criteria|0|||
125557672|NCT00975715|451673870|FG000|Titration Period|Adverse Event|6|||
125557673|NCT00975715|451673871|FG001|Titration Period|Adverse Event|0|||
125557674|NCT00975715|451673870|FG000|Titration Period|Protocol Violation|1|||
125557675|NCT00975715|451673871|FG001|Titration Period|Protocol Violation|0|||
125557676|NCT00975715|451673870|FG000|Maintenance Period|Adverse Event|2|||
125557677|NCT00975715|451673871|FG001|Maintenance Period|Adverse Event|1|||
125557678|NCT01674712|451673873|FG000|Overall Study|Adverse Event|5|||
125557679|NCT01674712|451673874|FG001|Overall Study|Adverse Event|6|||
125557680|NCT01674712|451673875|FG002|Overall Study|Adverse Event|3|||
125557681|NCT01674712|451673876|FG003|Overall Study|Adverse Event|4|||
125557682|NCT01674712|451673877|FG004|Overall Study|Adverse Event|6|||
125557683|NCT01674712|451673873|FG000|Overall Study|Lost to Follow-up|1|||
125557684|NCT01674712|451673874|FG001|Overall Study|Lost to Follow-up|0|||
125557685|NCT01674712|451673875|FG002|Overall Study|Lost to Follow-up|0|||
125557686|NCT01674712|451673876|FG003|Overall Study|Lost to Follow-up|0|||
125557687|NCT01674712|451673877|FG004|Overall Study|Lost to Follow-up|0|||
125557688|NCT01674712|451673873|FG000|Overall Study|Protocol Violation|2|||
125557689|NCT01674712|451673874|FG001|Overall Study|Protocol Violation|0|||
125557690|NCT01674712|451673875|FG002|Overall Study|Protocol Violation|0|||
125557691|NCT01674712|451673876|FG003|Overall Study|Protocol Violation|0|||
125557692|NCT01674712|451673877|FG004|Overall Study|Protocol Violation|0|||
125557693|NCT01674712|451673873|FG000|Overall Study|Withdrawal by Subject|2|||
125557694|NCT01674712|451673874|FG001|Overall Study|Withdrawal by Subject|2|||
125557695|NCT01674712|451673875|FG002|Overall Study|Withdrawal by Subject|5|||
125557696|NCT01674712|451673876|FG003|Overall Study|Withdrawal by Subject|4|||
125557697|NCT01674712|451673877|FG004|Overall Study|Withdrawal by Subject|3|||
125557698|NCT01674712|451673873|FG000|Overall Study|Administrative|0|||
125557699|NCT01674712|451673874|FG001|Overall Study|Administrative|1|||
125557700|NCT01674712|451673875|FG002|Overall Study|Administrative|0|||
125557701|NCT01674712|451673876|FG003|Overall Study|Administrative|0|||
125557702|NCT01674712|451673877|FG004|Overall Study|Administrative|1|||
125557703|NCT01674712|451673873|FG000|Overall Study|Lack of Efficacy|0|||
125557704|NCT01674712|451673874|FG001|Overall Study|Lack of Efficacy|0|||
125557705|NCT01674712|451673875|FG002|Overall Study|Lack of Efficacy|1|||
125557706|NCT01674712|451673876|FG003|Overall Study|Lack of Efficacy|0|||
125557707|NCT01674712|451673877|FG004|Overall Study|Lack of Efficacy|1|||
125557708|NCT01109173|451673878|FG000|Overall Study|Adverse Event|15|||
125557709|NCT01109173|451673879|FG001|Overall Study|Adverse Event|17|||
125557710|NCT01109173|451673880|FG002|Overall Study|Adverse Event|9|||
125557711|NCT01109173|451673881|FG003|Overall Study|Adverse Event|6|||
125557712|NCT01109173|451673878|FG000|Overall Study|Lost to Follow-up|0|||
125557713|NCT01109173|451673879|FG001|Overall Study|Lost to Follow-up|1|||
125557714|NCT01109173|451673880|FG002|Overall Study|Lost to Follow-up|0|||
125557715|NCT01109173|451673881|FG003|Overall Study|Lost to Follow-up|0|||
125557716|NCT01109173|451673878|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
125557717|NCT01109173|451673879|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
125557718|NCT01109173|451673880|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
125557719|NCT01109173|451673881|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
125557720|NCT01109173|451673878|FG000|Overall Study|Noncompliance|0|||
125557721|NCT01109173|451673879|FG001|Overall Study|Noncompliance|1|||
125557722|NCT01109173|451673880|FG002|Overall Study|Noncompliance|0|||
125557723|NCT01109173|451673881|FG003|Overall Study|Noncompliance|0|||
125557724|NCT01109173|451673878|FG000|Overall Study|Treatment Failure|25|||
125557725|NCT01109173|451673879|FG001|Overall Study|Treatment Failure|32|||
125557726|NCT01109173|451673880|FG002|Overall Study|Treatment Failure|69|||
125557727|NCT01109173|451673881|FG003|Overall Study|Treatment Failure|64|||
125557728|NCT01109173|451673878|FG000|Overall Study|Protocol Violation|4|||
125557729|NCT01109173|451673879|FG001|Overall Study|Protocol Violation|5|||
125557730|NCT01109173|451673880|FG002|Overall Study|Protocol Violation|1|||
125557731|NCT01109173|451673881|FG003|Overall Study|Protocol Violation|2|||
125557732|NCT01109173|451673878|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
125557733|NCT01109173|451673879|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
125557734|NCT01109173|451673880|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
125557735|NCT01109173|451673881|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
125557736|NCT01109173|451673878|FG000|Overall Study|Not Specifiied|5|||
125557737|NCT01109173|451673879|FG001|Overall Study|Not Specifiied|4|||
125557738|NCT01109173|451673880|FG002|Overall Study|Not Specifiied|9|||
125557739|NCT01109173|451673881|FG003|Overall Study|Not Specifiied|14|||
125557740|NCT02459769|451673890|FG000|Overall Study|Withdrawal by Subject|7|||
125557741|NCT02459769|451673891|FG001|Overall Study|Withdrawal by Subject|4|||
125557742|NCT02459769|451673892|FG002|Overall Study|Withdrawal by Subject|8|||
125557743|NCT02459769|451673893|FG003|Overall Study|Withdrawal by Subject|5|||
125557744|NCT02459769|451673890|FG000|Overall Study|Lost to Follow-up|1|||
125557745|NCT02459769|451673891|FG001|Overall Study|Lost to Follow-up|0|||
125557746|NCT02459769|451673892|FG002|Overall Study|Lost to Follow-up|1|||
125557747|NCT02459769|451673893|FG003|Overall Study|Lost to Follow-up|0|||
125557748|NCT01379573|451673895|FG000|Overall Study|Lost to Follow-up|1|||
125557749|NCT01379573|451673895|FG000|Overall Study|Screen Failure|10|||
125557750|NCT00770770|451673900|FG000|Overall Study|Lost to Follow-up|1|||
125557751|NCT00770770|451673901|FG001|Overall Study|Lost to Follow-up|0|||
125557752|NCT00770770|451673900|FG000|Overall Study|Withdrawal by Subject|1|||
125557753|NCT00770770|451673901|FG001|Overall Study|Withdrawal by Subject|0|||
125557754|NCT00770770|451673900|FG000|Overall Study|Death|0|||
125557755|NCT00770770|451673901|FG001|Overall Study|Death|1|||
125557756|NCT00770770|451673900|FG000|Overall Study|Study Terminated|8|||
125557757|NCT00770770|451673901|FG001|Overall Study|Study Terminated|0|||
125557758|NCT05372653|451673903|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
125557759|NCT05372653|451673904|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
125557760|NCT05372653|451673903|FG000|Overall Study|Adverse Event|0|||
125557761|NCT05372653|451673904|FG001|Overall Study|Adverse Event|1|||
125557762|NCT00711529|451673911|FG000|Overall Study|Protocol Violation|2|||
125557763|NCT00711529|451673912|FG001|Overall Study|Protocol Violation|0|||
125557764|NCT00711529|451673911|FG000|Overall Study|Withdrawal by Subject|2|||
125557765|NCT00711529|451673912|FG001|Overall Study|Withdrawal by Subject|6|||
125557766|NCT03681951|451673917|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
125557767|NCT03681951|451673918|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125557768|NCT03681951|451673919|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125557769|NCT03681951|451673920|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125557770|NCT03681951|451673921|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125557771|NCT03681951|451673922|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125557772|NCT03681951|451673923|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125557773|NCT03681951|451673924|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
125557774|NCT03681951|451673917|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
125557775|NCT03681951|451673918|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125557776|NCT03681951|451673919|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125557777|NCT03681951|451673920|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125557778|NCT03681951|451673921|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125557779|NCT03681951|451673922|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125557780|NCT03681951|451673923|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125557781|NCT03681951|451673924|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
125557782|NCT03681951|451673917|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
125557783|NCT03681951|451673918|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125557784|NCT03681951|451673919|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125557785|NCT03681951|451673920|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125557786|NCT03681951|451673921|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125557787|NCT03681951|451673922|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125557788|NCT03681951|451673923|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125557789|NCT03681951|451673924|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
125557790|NCT01020448|451673925|FG000|Pre-assignment|Adverse Event|6|||
125557791|NCT01020448|451673925|FG000|Pre-assignment|Withdrawal by Subject|5|||
125557792|NCT01020448|451673925|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
125557793|NCT01020448|451673925|FG000|Treatment|Adverse Event|11|||
125557794|NCT01020448|451673925|FG000|Treatment|Consent Withdrawn|3|||
125557795|NCT01020448|451673925|FG000|Treatment|Disease Progression|2|||
125557796|NCT01020448|451673925|FG000|Treatment|Lack of Efficacy|8|||
125557797|NCT01020448|451673925|FG000|Treatment|Lost to Follow-up|2|||
125557798|NCT01230554|451673926|FG000|Overall Study|Lost to Follow-up|2|||
125557799|NCT01230554|451673926|FG000|Overall Study|Inability to maintain visit schedule|1|||
125557800|NCT00685685|451673927|FG000|Washout Period of 7 Days|Adverse Event|2|||
125557801|NCT00685685|451673928|FG001|Washout Period of 7 Days|Adverse Event|0|||
125557802|NCT00685685|451673927|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
125557803|NCT00685685|451673928|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125557804|NCT01660451|451673931|FG000|Overall Study|Protocol Violation|0|||
125557805|NCT01660451|451673932|FG001|Overall Study|Protocol Violation|1|||
125557806|NCT01660451|451673933|FG002|Overall Study|Protocol Violation|1|||
125557807|NCT01660451|451673931|FG000|Overall Study|AE not associated with clinical disease progression|13|||
125557808|NCT01660451|451673932|FG001|Overall Study|AE not associated with clinical disease progression|10|||
125557809|NCT01660451|451673933|FG002|Overall Study|AE not associated with clinical disease progression|40|||
125557810|NCT01660451|451673931|FG000|Overall Study|AE associated with clinical disease progression|1|||
125557811|NCT01660451|451673932|FG001|Overall Study|AE associated with clinical disease progression|3|||
125557812|NCT01660451|451673933|FG002|Overall Study|AE associated with clinical disease progression|11|||
125557813|NCT01660451|451673931|FG000|Overall Study|Sponsor Decision|0|||
125557814|NCT01660451|451673932|FG001|Overall Study|Sponsor Decision|0|||
125557815|NCT01660451|451673933|FG002|Overall Study|Sponsor Decision|1|||
125557816|NCT01660451|451673931|FG000|Overall Study|Protocol Deviation|0|||
125557817|NCT01660451|451673932|FG001|Overall Study|Protocol Deviation|0|||
125557818|NCT01660451|451673933|FG002|Overall Study|Protocol Deviation|1|||
125557819|NCT01660451|451673931|FG000|Overall Study|Physician Decision|1|||
125557820|NCT01660451|451673932|FG001|Overall Study|Physician Decision|2|||
125557821|NCT01660451|451673933|FG002|Overall Study|Physician Decision|5|||
125557822|NCT01660451|451673931|FG000|Overall Study|Withdrawal by Subject|1|||
125557823|NCT01660451|451673932|FG001|Overall Study|Withdrawal by Subject|1|||
125557824|NCT01660451|451673933|FG002|Overall Study|Withdrawal by Subject|20|||
125557825|NCT01660451|451673931|FG000|Overall Study|Trial closure.|0|||
125557826|NCT01660451|451673932|FG001|Overall Study|Trial closure.|0|||
125557827|NCT01660451|451673933|FG002|Overall Study|Trial closure.|1|||
125557828|NCT01660451|451673931|FG000|Overall Study|Switching to other therapy|0|||
125557829|NCT01660451|451673932|FG001|Overall Study|Switching to other therapy|1|||
125557830|NCT01660451|451673933|FG002|Overall Study|Switching to other therapy|1|||
125557831|NCT01660451|451673931|FG000|Overall Study|Progressive disease - clinical progression|4|||
125557832|NCT01660451|451673932|FG001|Overall Study|Progressive disease - clinical progression|10|||
125557833|NCT01660451|451673933|FG002|Overall Study|Progressive disease - clinical progression|9|||
125557834|NCT01660451|451673931|FG000|Overall Study|Progressive disease - radiological progression|12|||
125557835|NCT01660451|451673932|FG001|Overall Study|Progressive disease - radiological progression|23|||
125557836|NCT01660451|451673933|FG002|Overall Study|Progressive disease - radiological progression|50|||
125557837|NCT01660451|451673931|FG000|Overall Study|Death|1|||
125557838|NCT01660451|451673932|FG001|Overall Study|Death|0|||
125557839|NCT01660451|451673933|FG002|Overall Study|Death|1|||
125557840|NCT01660451|451673931|FG000|Overall Study|Other|0|||
125557841|NCT01660451|451673932|FG001|Overall Study|Other|0|||
125557842|NCT01660451|451673933|FG002|Overall Study|Other|1|||
125557843|NCT00523718|451674944|FG000|Overall Study|Withdrawal by Subject|1|||
125557844|NCT00523718|451674945|FG001|Overall Study|Withdrawal by Subject|0|||
125557845|NCT00523718|451674944|FG000|Overall Study|Protocol Violation|2|||
125557846|NCT00523718|451674945|FG001|Overall Study|Protocol Violation|0|||
125557847|NCT02113579|451674946|FG000|Overall Study|Adverse Event|1|||
125557848|NCT02113579|451674947|FG001|Overall Study|Adverse Event|0|||
125557849|NCT02113579|451674946|FG000|Overall Study|Withdrawal by Subject|3|||
125557850|NCT02113579|451674947|FG001|Overall Study|Withdrawal by Subject|2|||
125557851|NCT02113579|451674946|FG000|Overall Study|Lost to Follow-up|6|||
125557852|NCT02113579|451674947|FG001|Overall Study|Lost to Follow-up|2|||
125557853|NCT02060383|451674948|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
125557854|NCT02060383|451674949|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
125557855|NCT02060383|451674950|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
125557856|NCT02060383|451674951|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
125557857|NCT02060383|451674952|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
125557858|NCT02060383|451674948|FG000|Core Phase|Adverse Event|2|||
125557859|NCT02060383|451674949|FG001|Core Phase|Adverse Event|0|||
125353272|NCT04177355|450929403|FG004|Overall Study|Withdrawal by Subject|1|||
125353273|NCT04177355|450929404|FG005|Overall Study|Withdrawal by Subject|0|||
125557860|NCT02060383|451674950|FG002|Core Phase|Adverse Event|0|||
125557861|NCT02060383|451674951|FG003|Core Phase|Adverse Event|2|||
125557862|NCT02060383|451674952|FG004|Core Phase|Adverse Event|6|||
125557863|NCT02060383|451674948|FG000|Core Phase|Administrative problems|0|||
125557864|NCT02060383|451674949|FG001|Core Phase|Administrative problems|1|||
125557865|NCT02060383|451674950|FG002|Core Phase|Administrative problems|0|||
125557866|NCT02060383|451674951|FG003|Core Phase|Administrative problems|0|||
125557867|NCT02060383|451674952|FG004|Core Phase|Administrative problems|0|||
125557868|NCT02060383|451674948|FG000|Core Phase|Protocol Violation|0|||
125557869|NCT02060383|451674949|FG001|Core Phase|Protocol Violation|0|||
125557870|NCT02060383|451674950|FG002|Core Phase|Protocol Violation|0|||
125557871|NCT02060383|451674951|FG003|Core Phase|Protocol Violation|1|||
125557872|NCT02060383|451674952|FG004|Core Phase|Protocol Violation|0|||
125557873|NCT02060383|451674948|FG000|Core Phase|Withdrawal by Subject|0|||
125557874|NCT02060383|451674949|FG001|Core Phase|Withdrawal by Subject|0|||
125557875|NCT02060383|451674950|FG002|Core Phase|Withdrawal by Subject|0|||
125557876|NCT02060383|451674951|FG003|Core Phase|Withdrawal by Subject|4|||
125557877|NCT02060383|451674952|FG004|Core Phase|Withdrawal by Subject|2|||
125557878|NCT02060383|451674948|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
125557879|NCT02060383|451674949|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
125557880|NCT02060383|451674950|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
125557881|NCT02060383|451674951|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
125557882|NCT02060383|451674952|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
125557883|NCT02060383|451674948|FG000|Extension Phase|Adverse Event|1|||
125557884|NCT02060383|451674949|FG001|Extension Phase|Adverse Event|1|||
125557885|NCT02060383|451674950|FG002|Extension Phase|Adverse Event|2|||
125557886|NCT02060383|451674951|FG003|Extension Phase|Adverse Event|0|||
125557887|NCT02060383|451674952|FG004|Extension Phase|Adverse Event|1|||
125557888|NCT02060383|451674948|FG000|Extension Phase|Withdrawal by Subject|0|||
125557889|NCT02060383|451674949|FG001|Extension Phase|Withdrawal by Subject|1|||
125557890|NCT02060383|451674950|FG002|Extension Phase|Withdrawal by Subject|0|||
125557891|NCT02060383|451674951|FG003|Extension Phase|Withdrawal by Subject|0|||
125557892|NCT02060383|451674952|FG004|Extension Phase|Withdrawal by Subject|2|||
125557893|NCT02060383|451674948|FG000|Extension Phase|Administrative problems|1|||
125557894|NCT02060383|451674949|FG001|Extension Phase|Administrative problems|0|||
125557895|NCT02060383|451674950|FG002|Extension Phase|Administrative problems|0|||
125557896|NCT02060383|451674951|FG003|Extension Phase|Administrative problems|0|||
125557897|NCT02060383|451674952|FG004|Extension Phase|Administrative problems|0|||
125557898|NCT02060383|451674948|FG000|Extension Phase|Death|0|||
125557899|NCT02060383|451674949|FG001|Extension Phase|Death|0|||
125557900|NCT02060383|451674950|FG002|Extension Phase|Death|1|||
125557901|NCT02060383|451674951|FG003|Extension Phase|Death|0|||
125353274|NCT04177355|450929405|FG006|Overall Study|Withdrawal by Subject|0|||
125557902|NCT02060383|451674952|FG004|Extension Phase|Death|1|||
125557903|NCT02060383|451674948|FG000|Extension Phase|Protocol Violation|0|||
125557904|NCT02060383|451674949|FG001|Extension Phase|Protocol Violation|0|||
125557905|NCT02060383|451674950|FG002|Extension Phase|Protocol Violation|0|||
125557906|NCT02060383|451674951|FG003|Extension Phase|Protocol Violation|0|||
125557907|NCT02060383|451674952|FG004|Extension Phase|Protocol Violation|1|||
125557908|NCT00332839|451674953|FG000|Core (Months 0 - 12)|Administrative problems|1|||
125557909|NCT00332839|451674954|FG001|Core (Months 0 - 12)|Administrative problems|1|||
125557910|NCT00332839|451674953|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
125557911|NCT00332839|451674954|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
125557912|NCT00332839|451674953|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
125557913|NCT00332839|451674954|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
125557914|NCT00332839|451674953|FG000|Core (Months 0 - 12)|Adverse Event|5|||
125557915|NCT00332839|451674954|FG001|Core (Months 0 - 12)|Adverse Event|15|||
125557916|NCT00332839|451674953|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
125557917|NCT00332839|451674954|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
125557918|NCT00332839|451674953|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
125557919|NCT00332839|451674954|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
125557920|NCT00332839|451674953|FG000|Follow-up (Months 12 - 60)|Death|1|||
125557921|NCT00332839|451674954|FG001|Follow-up (Months 12 - 60)|Death|1|||
125557922|NCT02020863|451674956|FG000|Overall Study|Discovery of Metastatic disease|4|||
125557923|NCT02020863|451674956|FG000|Overall Study|Team chose not to place an a line|1|||
125557924|NCT03523728|451674961|FG000|Stage 1 (24 Months)|Adverse Event|2|||
125557925|NCT03523728|451674962|FG001|Stage 1 (24 Months)|Adverse Event|2|||
125557926|NCT03523728|451674963|FG002|Stage 1 (24 Months)|Adverse Event|4|||
125557927|NCT03523728|451674964|FG003|Stage 1 (24 Months)|Adverse Event|0|||
125557928|NCT03523728|451674965|FG004|Stage 1 (24 Months)|Adverse Event|0|||
125353275|NCT04177355|450929406|FG007|Overall Study|Withdrawal by Subject|0|||
125557929|NCT03523728|451674961|FG000|Stage 1 (24 Months)|Progressive disease|0|||
125557930|NCT03523728|451674962|FG001|Stage 1 (24 Months)|Progressive disease|0|||
125557931|NCT03523728|451674963|FG002|Stage 1 (24 Months)|Progressive disease|1|||
125557932|NCT03523728|451674964|FG003|Stage 1 (24 Months)|Progressive disease|0|||
125557933|NCT03523728|451674965|FG004|Stage 1 (24 Months)|Progressive disease|0|||
125557934|NCT03523728|451674961|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
125557935|NCT03523728|451674962|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
125557936|NCT03523728|451674963|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
125557937|NCT03523728|451674964|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
125557938|NCT03523728|451674965|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
125557939|NCT03523728|451674961|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
125557940|NCT03523728|451674962|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
125557941|NCT03523728|451674963|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
125557942|NCT03523728|451674964|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
125557943|NCT03523728|451674965|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
125557944|NCT03523728|451674961|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
125557945|NCT03523728|451674962|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
125557946|NCT03523728|451674963|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
125557947|NCT03523728|451674964|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
125557948|NCT03523728|451674965|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
125557949|NCT03523728|451674961|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
125557950|NCT03523728|451674962|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
125557951|NCT03523728|451674963|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
125557952|NCT03523728|451674964|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
125557953|NCT03523728|451674965|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
125557954|NCT03523728|451674961|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
125557955|NCT03523728|451674962|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
125557956|NCT03523728|451674963|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
125557957|NCT03523728|451674964|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
125557958|NCT03523728|451674965|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
125557959|NCT03523728|451674961|FG000|Stage 2 (24 Months)|Adverse Event|0|||
125557960|NCT03523728|451674962|FG001|Stage 2 (24 Months)|Adverse Event|0|||
125557961|NCT03523728|451674963|FG002|Stage 2 (24 Months)|Adverse Event|0|||
125557962|NCT03523728|451674964|FG003|Stage 2 (24 Months)|Adverse Event|1|||
125557963|NCT03523728|451674965|FG004|Stage 2 (24 Months)|Adverse Event|2|||
125557964|NCT03523728|451674961|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
125557965|NCT03523728|451674962|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
125557966|NCT03523728|451674963|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
125557967|NCT03523728|451674964|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
125557968|NCT03523728|451674965|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
125557969|NCT03523728|451674961|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
125557970|NCT03523728|451674962|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
125557971|NCT03523728|451674963|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
125557972|NCT03523728|451674964|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
125557973|NCT03523728|451674965|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
125557974|NCT03523728|451674961|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
125557975|NCT03523728|451674962|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
125557976|NCT03523728|451674963|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
125557977|NCT03523728|451674964|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
125557978|NCT03523728|451674965|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
125557979|NCT03523728|451674961|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
125557980|NCT03523728|451674962|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
125557981|NCT03523728|451674963|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
125557982|NCT03523728|451674964|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
125557983|NCT03523728|451674965|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
125557984|NCT00621751|451674966|FG000|Overall Study|Adverse Event|0|||
125557985|NCT00621751|451674967|FG001|Overall Study|Adverse Event|1|||
125557986|NCT01950247|451674969|FG000|Overall Study|Withdrawal by Subject|28|||
125557987|NCT01950247|451674970|FG001|Overall Study|Withdrawal by Subject|13|||
125557988|NCT01950247|451674969|FG000|Overall Study|Lost to Follow-up|18|||
125557989|NCT01950247|451674970|FG001|Overall Study|Lost to Follow-up|16|||
125557990|NCT01950247|451674969|FG000|Overall Study|Physician Decision|3|||
125557991|NCT01950247|451674970|FG001|Overall Study|Physician Decision|4|||
125557992|NCT01950247|451674969|FG000|Overall Study|Adverse Event|3|||
125557993|NCT01950247|451674970|FG001|Overall Study|Adverse Event|2|||
125557994|NCT01950247|451674969|FG000|Overall Study|Death|1|||
125557995|NCT01950247|451674970|FG001|Overall Study|Death|1|||
125557996|NCT01950247|451674969|FG000|Overall Study|Not Defined|4|||
125557997|NCT01950247|451674970|FG001|Overall Study|Not Defined|10|||
125557998|NCT00434421|451674973|FG000|Overall Study|Withdrawal by Subject|1|||
125557999|NCT00434421|451674973|FG000|Overall Study|Non-compliance with study treatment|1|||
125558000|NCT03631667|451674974|FG000|Overall Study|Withdrawal by Subject|3|||
125558001|NCT01446016|451674975|FG000|Overall Study|Lost to Follow-up|3|||
125558002|NCT01446016|451674975|FG000|Overall Study|Withdrawal by Subject|1|||
125558003|NCT01446016|451674975|FG000|Overall Study|Toxicity|3|||
125558004|NCT01087957|451674985|FG000|Overall Study|Death|2|||
125558005|NCT01087957|451674986|FG001|Overall Study|Death|2|||
125558006|NCT01087957|451674985|FG000|Overall Study|Lost to Follow-up|3|||
125558007|NCT01087957|451674986|FG001|Overall Study|Lost to Follow-up|4|||
125558008|NCT01087957|451674985|FG000|Overall Study|Protocol Violation|13|||
125558009|NCT01087957|451674986|FG001|Overall Study|Protocol Violation|25|||
125558010|NCT01087957|451674985|FG000|Overall Study|Withdrawal by Subject|18|||
125558011|NCT01087957|451674986|FG001|Overall Study|Withdrawal by Subject|15|||
125558012|NCT01087957|451674985|FG000|Overall Study|Physician Decision|5|||
125558013|NCT01087957|451674986|FG001|Overall Study|Physician Decision|9|||
125558014|NCT01186939|451674987|FG000|Overall Study|Death|7|||
125558015|NCT01186939|451674987|FG000|Overall Study|Withdrawal by Subject|2|||
125558016|NCT01186939|451674987|FG000|Overall Study|No longer receiving clinical benefit|17|||
125558017|NCT01186939|451674987|FG000|Overall Study|Program closed|5|||
125558018|NCT01186939|451674987|FG000|Overall Study|Sponsor decision|4|||
125558019|NCT01186939|451674987|FG000|Overall Study|Started additional treatment|1|||
125558020|NCT01186939|451674987|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
125558021|NCT01186939|451674987|FG000|Overall Study|Myocardial infarction|1|||
125558022|NCT01186939|451674987|FG000|Overall Study|Bone marrow transplant|1|||
125558023|NCT01186939|451674987|FG000|Overall Study|Transformation to AML|1|||
125558024|NCT00874770|451674991|FG000|Overall Study|Lack of Efficacy|2|||
125558025|NCT00874770|451674992|FG001|Overall Study|Lack of Efficacy|0|||
125558026|NCT00874770|451674993|FG002|Overall Study|Lack of Efficacy|0|||
125558027|NCT00874770|451674994|FG003|Overall Study|Lack of Efficacy|2|||
125558028|NCT00874770|451674991|FG000|Overall Study|Adverse Event|1|||
125558029|NCT00874770|451674992|FG001|Overall Study|Adverse Event|1|||
125558030|NCT00874770|451674993|FG002|Overall Study|Adverse Event|4|||
125558031|NCT00874770|451674994|FG003|Overall Study|Adverse Event|2|||
125558032|NCT00874770|451674991|FG000|Overall Study|Lost to Follow-up|1|||
125558033|NCT00874770|451674992|FG001|Overall Study|Lost to Follow-up|0|||
125558034|NCT00874770|451674993|FG002|Overall Study|Lost to Follow-up|0|||
125558035|NCT00874770|451674994|FG003|Overall Study|Lost to Follow-up|1|||
125558036|NCT00874770|451674991|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
125558037|NCT00874770|451674992|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
125558038|NCT00874770|451674993|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
125558039|NCT00874770|451674994|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
125558040|NCT05395104|451674995|FG000|Overall Study|Met Liver Stopping Criteria|1|||
125558041|NCT05395104|451674995|FG000|Overall Study|Withdrawal by Subject|1|||
125558042|NCT03974334|451674996|FG000|Overall Study|Lost to Follow-up|1|||
125558043|NCT04029116|451674997|FG000|Overall Study|Adverse Event|0|||
125558044|NCT04029116|451674998|FG001|Overall Study|Adverse Event|2|||
125558045|NCT04029116|451674997|FG000|Overall Study|Lost to Follow-up|3|||
125558046|NCT04029116|451674998|FG001|Overall Study|Lost to Follow-up|5|||
125558047|NCT04029116|451674997|FG000|Overall Study|Physician Decision|2|||
125558048|NCT04029116|451674998|FG001|Overall Study|Physician Decision|0|||
125558049|NCT04029116|451674997|FG000|Overall Study|Pregnancy|1|||
125558050|NCT04029116|451674998|FG001|Overall Study|Pregnancy|2|||
125558051|NCT04029116|451674997|FG000|Overall Study|Withdrawal by Subject|4|||
125558052|NCT04029116|451674998|FG001|Overall Study|Withdrawal by Subject|6|||
125558053|NCT04029116|451674997|FG000|Overall Study|Other|2|||
125558054|NCT04029116|451674998|FG001|Overall Study|Other|1|||
125558055|NCT00307333|451674999|FG000|Overall Study|Lost to Follow-up|11|||
125558056|NCT00307333|451675000|FG001|Overall Study|Lost to Follow-up|3|||
125558057|NCT04513665|451675001|FG000|Overall Study|Adverse Event|2|||
125558058|NCT04513665|451675002|FG001|Overall Study|Adverse Event|0|||
125558059|NCT04513665|451675001|FG000|Overall Study|Lack of Efficacy|14|||
125558060|NCT04513665|451675002|FG001|Overall Study|Lack of Efficacy|0|||
125558061|NCT02608879|451675019|FG000|Overall Study|Lost to Follow-up|1|||
125558062|NCT02608879|451675020|FG001|Overall Study|Lost to Follow-up|0|||
125558063|NCT02608879|451675021|FG002|Overall Study|Lost to Follow-up|0|||
125558064|NCT02608879|451675019|FG000|Overall Study|Did not meet continuation criteria|0|||
125558065|NCT02608879|451675020|FG001|Overall Study|Did not meet continuation criteria|0|||
125558066|NCT02608879|451675021|FG002|Overall Study|Did not meet continuation criteria|3|||
125558067|NCT00760669|451675022|FG000|Overall Study|Not assessed for overall improvement|18|||
125558068|NCT00760669|451675022|FG000|Overall Study|Participants missing efficacy assessment|6|||
125558069|NCT00760669|451675022|FG000|Overall Study|Participants with overlapping cases|1|||
125558070|NCT00760669|451675022|FG000|Overall Study|Took drug before entering in contract|5|||
125558071|NCT01572675|451675023|FG000|Overall Study|End of prescribed treatment|140|||
125558072|NCT01572675|451675024|FG001|Overall Study|End of prescribed treatment|118|||
125558073|NCT01572675|451675023|FG000|Overall Study|Recovery|16|||
125558074|NCT01572675|451675024|FG001|Overall Study|Recovery|23|||
125558075|NCT01572675|451675023|FG000|Overall Study|Lack of Efficacy|31|||
125558076|NCT01572675|451675024|FG001|Overall Study|Lack of Efficacy|31|||
125558077|NCT01572675|451675023|FG000|Overall Study|Intolerance|6|||
125558078|NCT01572675|451675024|FG001|Overall Study|Intolerance|5|||
125558079|NCT01572675|451675023|FG000|Overall Study|Improved symptoms|8|||
125558080|NCT01572675|451675024|FG001|Overall Study|Improved symptoms|2|||
125558081|NCT01572675|451675023|FG000|Overall Study|Surgical intervention|3|||
125558082|NCT01572675|451675024|FG001|Overall Study|Surgical intervention|6|||
125558083|NCT01572675|451675023|FG000|Overall Study|Withdrawal by Subject|5|||
125558084|NCT01572675|451675024|FG001|Overall Study|Withdrawal by Subject|1|||
125558085|NCT01572675|451675023|FG000|Overall Study|Physician Decision|2|||
125558086|NCT01572675|451675024|FG001|Overall Study|Physician Decision|2|||
125558087|NCT01572675|451675023|FG000|Overall Study|Death unrelated to coxibs|1|||
125558088|NCT01572675|451675024|FG001|Overall Study|Death unrelated to coxibs|1|||
125558089|NCT01572675|451675023|FG000|Overall Study|Other disease detected|1|||
125558090|NCT01572675|451675024|FG001|Overall Study|Other disease detected|1|||
125558091|NCT01572675|451675023|FG000|Overall Study|Unknown reason|1|||
125558092|NCT01572675|451675024|FG001|Overall Study|Unknown reason|1|||
125558093|NCT01572675|451675023|FG000|Overall Study|Rheumatologist new evaluation|0|||
125558094|NCT01572675|451675024|FG001|Overall Study|Rheumatologist new evaluation|1|||
125558095|NCT01572675|451675023|FG000|Overall Study|Missing data|1|||
125558096|NCT01572675|451675024|FG001|Overall Study|Missing data|4|||
125558097|NCT01572675|451675023|FG000|Overall Study|Lost to Follow-up|22|||
125558098|NCT01572675|451675024|FG001|Overall Study|Lost to Follow-up|27|||
125558099|NCT03346057|451675028|FG000|Overall Study|Death|1|||
125558100|NCT03346057|451675029|FG001|Overall Study|Death|2|||
125558101|NCT03346057|451675030|FG002|Overall Study|Death|0|||
125558102|NCT03346057|451675031|FG003|Overall Study|Death|0|||
125558103|NCT03346057|451675028|FG000|Overall Study|Lost to Follow-up|0|||
125558104|NCT03346057|451675029|FG001|Overall Study|Lost to Follow-up|2|||
125558105|NCT03346057|451675030|FG002|Overall Study|Lost to Follow-up|1|||
125558106|NCT03346057|451675031|FG003|Overall Study|Lost to Follow-up|0|||
125558107|NCT03346057|451675028|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
125558108|NCT03346057|451675029|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
125558109|NCT03346057|451675030|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
125558110|NCT03346057|451675031|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
125558111|NCT03346057|451675028|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
125558112|NCT03346057|451675029|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
125558113|NCT03346057|451675030|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
125558114|NCT03346057|451675031|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
125558115|NCT03346057|451675028|FG000|Overall Study|Physician Decision|3|||
125558116|NCT03346057|451675029|FG001|Overall Study|Physician Decision|2|||
125558117|NCT03346057|451675030|FG002|Overall Study|Physician Decision|0|||
125558118|NCT03346057|451675031|FG003|Overall Study|Physician Decision|2|||
125558119|NCT03346057|451675028|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
125558120|NCT03346057|451675029|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
125558121|NCT03346057|451675030|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
125558122|NCT03346057|451675031|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
125558123|NCT03346057|451675028|FG000|Overall Study|Withdrawal by Subject|1|||
125558124|NCT03346057|451675029|FG001|Overall Study|Withdrawal by Subject|0|||
125558125|NCT03346057|451675030|FG002|Overall Study|Withdrawal by Subject|0|||
125558126|NCT03346057|451675031|FG003|Overall Study|Withdrawal by Subject|0|||
125558127|NCT02966223|451675032|FG000|Overall Study|Physician Decision|3|||
125558128|NCT02966223|451675032|FG000|Overall Study|Withdrawal by Subject|11|||
125558129|NCT02966223|451675032|FG000|Overall Study|Lost to Follow-up|1|||
125558130|NCT02003014|451675033|FG000|Overall Study|Case report forms uncollected|9|||
125558131|NCT02003014|451675033|FG000|Overall Study|Treatment started after contract period|1|||
125558132|NCT02003014|451675033|FG000|Overall Study|Patient did not visit the study site|5|||
125558133|NCT02003014|451675033|FG000|Overall Study|Investigator's transfer|4|||
125558134|NCT01159912|451675034|FG000|Overall Study|Adverse Event|2|||
125558135|NCT01159912|451675035|FG001|Overall Study|Adverse Event|2|||
125558136|NCT01159912|451675036|FG002|Overall Study|Adverse Event|3|||
125558137|NCT01159912|451675034|FG000|Overall Study|Lack of Efficacy|23|||
125558138|NCT01159912|451675035|FG001|Overall Study|Lack of Efficacy|15|||
125558139|NCT01159912|451675036|FG002|Overall Study|Lack of Efficacy|14|||
125558140|NCT01159912|451675034|FG000|Overall Study|Protocol Violation|1|||
125558141|NCT01159912|451675035|FG001|Overall Study|Protocol Violation|2|||
125558142|NCT01159912|451675036|FG002|Overall Study|Protocol Violation|3|||
125558143|NCT01159912|451675034|FG000|Overall Study|Lost to Follow-up|4|||
125558144|NCT01159912|451675035|FG001|Overall Study|Lost to Follow-up|0|||
125558145|NCT01159912|451675036|FG002|Overall Study|Lost to Follow-up|0|||
125558146|NCT01159912|451675034|FG000|Overall Study|Physician Decision|0|||
125558147|NCT01159912|451675035|FG001|Overall Study|Physician Decision|0|||
125558148|NCT01159912|451675036|FG002|Overall Study|Physician Decision|3|||
125558149|NCT01159912|451675034|FG000|Overall Study|Withdrawal by Subject|10|||
125558150|NCT01159912|451675035|FG001|Overall Study|Withdrawal by Subject|3|||
125558151|NCT01159912|451675036|FG002|Overall Study|Withdrawal by Subject|3|||
125558152|NCT02456662|451675038|FG000|Overall Study|Lost to Follow-up|2|||
125558153|NCT02456662|451675039|FG001|Overall Study|Lost to Follow-up|1|||
125558154|NCT00805025|451675041|FG000|Overall Study|Screened but not enrolled/treated|42|||
125558155|NCT00805025|451675041|FG000|Overall Study|Adverse Event|4|||
125558156|NCT00805025|451675041|FG000|Overall Study|Withdrawal by Subject|2|||
125558157|NCT00805025|451675041|FG000|Overall Study|Physician Decision|1|||
125558158|NCT00375219|451675044|FG000|Overall Study|Failure to achieve a response|16|||
125558159|NCT00375219|451675045|FG001|Overall Study|Failure to achieve a response|2|||
125558160|NCT00375219|451675046|FG002|Overall Study|Failure to achieve a response|0|||
125558161|NCT00375219|451675044|FG000|Overall Study|Adverse Event|8|||
125558162|NCT00375219|451675045|FG001|Overall Study|Adverse Event|2|||
125558163|NCT00375219|451675046|FG002|Overall Study|Adverse Event|1|||
125558164|NCT00375219|451675044|FG000|Overall Study|Protocol Violation|1|||
125558165|NCT00375219|451675045|FG001|Overall Study|Protocol Violation|0|||
125558166|NCT00375219|451675046|FG002|Overall Study|Protocol Violation|1|||
125558167|NCT00375219|451675044|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
125558168|NCT00375219|451675045|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
125558169|NCT00375219|451675046|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
125558170|NCT00375219|451675044|FG000|Overall Study|Lost to Follow-up|1|||
125558171|NCT00375219|451675045|FG001|Overall Study|Lost to Follow-up|1|||
125558172|NCT00375219|451675046|FG002|Overall Study|Lost to Follow-up|0|||
125558173|NCT00375219|451675044|FG000|Overall Study|Disease progression|18|||
125558174|NCT00375219|451675045|FG001|Overall Study|Disease progression|9|||
125558175|NCT00375219|451675046|FG002|Overall Study|Disease progression|12|||
125558176|NCT00375219|451675044|FG000|Overall Study|Death|4|||
125558177|NCT00375219|451675045|FG001|Overall Study|Death|3|||
125558178|NCT00375219|451675046|FG002|Overall Study|Death|7|||
125558179|NCT00375219|451675044|FG000|Overall Study|Hematologic resistance|1|||
125558180|NCT00375219|451675045|FG001|Overall Study|Hematologic resistance|0|||
125558181|NCT00375219|451675046|FG002|Overall Study|Hematologic resistance|0|||
125558182|NCT00375219|451675044|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
125558183|NCT00375219|451675045|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
125558184|NCT00375219|451675046|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
125558185|NCT00375219|451675044|FG000|Overall Study|Allograft|2|||
125558186|NCT00375219|451675045|FG001|Overall Study|Allograft|0|||
125558187|NCT00375219|451675046|FG002|Overall Study|Allograft|0|||
125558188|NCT00375219|451675044|FG000|Overall Study|Cord blood transplantation|1|||
125558189|NCT00375219|451675045|FG001|Overall Study|Cord blood transplantation|0|||
125426189|NCT04493931|451184401|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
125558190|NCT00375219|451675046|FG002|Overall Study|Cord blood transplantation|0|||
125558191|NCT00375219|451675044|FG000|Overall Study|Withdrawal by Subject|1|||
125558192|NCT00375219|451675045|FG001|Overall Study|Withdrawal by Subject|0|||
125558193|NCT00375219|451675046|FG002|Overall Study|Withdrawal by Subject|0|||
125558194|NCT02281357|451675047|FG000|Overall Study|Adverse Event|2|||
125353276|NCT04177355|450929407|FG008|Overall Study|Withdrawal by Subject|1|||
125353277|NCT04177355|450929408|FG009|Overall Study|Withdrawal by Subject|0|||
125353278|NCT04177355|450929409|FG010|Overall Study|Withdrawal by Subject|0|||
125353279|NCT00397943|450929410|FG000|Overall Study|Unspecified reasons|12|||
125353280|NCT00397943|450929411|FG001|Overall Study|Unspecified reasons|9|||
125353281|NCT00397943|450929412|FG002|Overall Study|Unspecified reasons|0|||
125353282|NCT00397943|450929413|FG003|Overall Study|Unspecified reasons|0|||
125353283|NCT00397943|450929414|FG004|Overall Study|Unspecified reasons|0|||
125353284|NCT05007717|450929415|FG000|Overall Study|Death|3|||
125353285|NCT05007717|450929416|FG001|Overall Study|Death|2|||
125353286|NCT02806973|450929418|FG000|Period 1|Withdrawal by Subject|0|||
125353287|NCT02806973|450929419|FG001|Period 1|Withdrawal by Subject|2|||
125353288|NCT02806973|450929420|FG002|Period 1|Withdrawal by Subject|1|||
125353289|NCT02806973|450929421|FG003|Period 1|Withdrawal by Subject|1|||
125353290|NCT02806973|450929418|FG000|Period 1|Adverse Event|0|||
125353291|NCT02806973|450929419|FG001|Period 1|Adverse Event|0|||
125353292|NCT02806973|450929420|FG002|Period 1|Adverse Event|0|||
125353293|NCT02806973|450929421|FG003|Period 1|Adverse Event|1|||
125353294|NCT02806973|450929418|FG000|Period 3|Withdrawal by Subject|0|||
125353295|NCT02806973|450929419|FG001|Period 3|Withdrawal by Subject|0|||
125353296|NCT02806973|450929420|FG002|Period 3|Withdrawal by Subject|0|||
125353297|NCT02806973|450929421|FG003|Period 3|Withdrawal by Subject|3|||
125353298|NCT02806973|450929418|FG000|Period 3|Adverse Event|0|||
125353299|NCT02806973|450929419|FG001|Period 3|Adverse Event|0|||
125353300|NCT02806973|450929420|FG002|Period 3|Adverse Event|1|||
125353301|NCT02806973|450929421|FG003|Period 3|Adverse Event|0|||
125353302|NCT00608543|450929428|FG000|Overall Study|Adverse Event|4|||
125353303|NCT03282565|450929431|FG000|Overall Study|COVID-19 Research Shutdown|0|||
125353304|NCT03282565|450929432|FG001|Overall Study|COVID-19 Research Shutdown|2|||
125353305|NCT03282565|450929433|FG002|Overall Study|COVID-19 Research Shutdown|2|||
125353306|NCT02131532|450929434|FG000|Overall Study|Withdrawal by Subject|1|||
125353307|NCT02131532|450929434|FG000|Overall Study|Physician Decision|1|||
125353308|NCT02131532|450929434|FG000|Overall Study|Other health conditions|2|||
125353309|NCT01466595|450929435|FG000|Overall Study|Withdrawal by Subject|0|||
125353310|NCT01466595|450929436|FG001|Overall Study|Withdrawal by Subject|1|||
125353311|NCT00450112|450929437|FG000|Overall Study|Other Treatment Required|5|||
125353312|NCT00450112|450929438|FG001|Overall Study|Other Treatment Required|1|||
125353313|NCT00450112|450929437|FG000|Overall Study|Withdrawal by Subject|4|||
125353314|NCT00450112|450929438|FG001|Overall Study|Withdrawal by Subject|1|||
125353315|NCT00450112|450929437|FG000|Overall Study|Lost to Follow-up|2|||
125353316|NCT00450112|450929438|FG001|Overall Study|Lost to Follow-up|1|||
125353317|NCT00450112|450929437|FG000|Overall Study|Others|2|||
125353318|NCT00450112|450929438|FG001|Overall Study|Others|3|||
125353319|NCT01264016|450929439|FG000|Overall Study|Withdrawal by Subject|1|||
125353320|NCT01264016|450929439|FG000|Overall Study|Felt faint at sight of blood|1|||
125353321|NCT02147184|450929440|FG000|Overall Study|Lost to Follow-up|28|||
125353322|NCT02147184|450929441|FG001|Overall Study|Lost to Follow-up|15|||
125353323|NCT02147184|450929440|FG000|Overall Study|Study Burden|11|||
125353324|NCT02147184|450929441|FG001|Overall Study|Study Burden|7|||
125353325|NCT02147184|450929440|FG000|Overall Study|Pregnancy|6|||
125353326|NCT02147184|450929441|FG001|Overall Study|Pregnancy|0|||
125353327|NCT02147184|450929440|FG000|Overall Study|Moved out of state|3|||
125353328|NCT02147184|450929441|FG001|Overall Study|Moved out of state|3|||
125353329|NCT02147184|450929440|FG000|Overall Study|Physician Decision|0|||
125353330|NCT02147184|450929441|FG001|Overall Study|Physician Decision|2|||
125353331|NCT02147184|450929440|FG000|Overall Study|Other|1|||
125353332|NCT02147184|450929441|FG001|Overall Study|Other|0|||
125353333|NCT02117414|450929442|FG000|Overall Study|Death|5|||
125353334|NCT02117414|450929443|FG001|Overall Study|Death|2|||
125353335|NCT02117414|450929442|FG000|Overall Study|Withdrawal by Subject|10|||
125353336|NCT02117414|450929443|FG001|Overall Study|Withdrawal by Subject|4|||
125353337|NCT00417482|450929444|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
125353338|NCT00417482|450929445|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
125353339|NCT00417482|450929446|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
125353340|NCT00417482|450929444|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
125353341|NCT00417482|450929445|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
125353342|NCT00417482|450929446|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
125353343|NCT00417482|450929444|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
125353344|NCT00417482|450929445|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
125353345|NCT00417482|450929446|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
125353346|NCT00417482|450929444|FG000|Phase B 1st 16 Weeks|Death|1|||
125353347|NCT00417482|450929445|FG001|Phase B 1st 16 Weeks|Death|0|||
125353348|NCT00417482|450929446|FG002|Phase B 1st 16 Weeks|Death|0|||
125353349|NCT00417482|450929444|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
125353350|NCT00417482|450929445|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
125353351|NCT00417482|450929446|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
125353352|NCT00417482|450929444|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
125353353|NCT00417482|450929445|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
125353354|NCT00417482|450929446|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
125353355|NCT00417482|450929444|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
125353356|NCT00417482|450929445|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
125353357|NCT00417482|450929446|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
125353358|NCT00417482|450929444|FG000|Phase B 2nd 16 Weeks|Death|1|||
125353359|NCT00417482|450929445|FG001|Phase B 2nd 16 Weeks|Death|1|||
125353360|NCT00417482|450929446|FG002|Phase B 2nd 16 Weeks|Death|0|||
125353361|NCT06400979|450929449|FG000|Overall Study|Lost to Follow-up|29|||
125353362|NCT06400979|450929449|FG000|Overall Study|Withdrawal by Subject|1|||
125353363|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
125353364|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
125353365|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
125353366|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
125353367|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
125353368|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
125353369|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
125558195|NCT02281357|451675048|FG001|Overall Study|Adverse Event|1|||
125558196|NCT02281357|451675047|FG000|Overall Study|Lost to Follow-up|1|||
125558197|NCT02281357|451675048|FG001|Overall Study|Lost to Follow-up|0|||
125558198|NCT02281357|451675047|FG000|Overall Study|Withdrawal by Subject|4|||
125558199|NCT02281357|451675048|FG001|Overall Study|Withdrawal by Subject|3|||
125558200|NCT03007979|451675051|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
125558201|NCT00482703|451675052|FG000|Overall Study|Poor compliance|1|||
125558202|NCT00482703|451675053|FG001|Overall Study|Poor compliance|0|||
125558203|NCT01428661|451675060|FG000|Double-Masked Phase|Protocol Violation|9|||
125558204|NCT01428661|451675061|FG001|Double-Masked Phase|Protocol Violation|4|||
125558205|NCT01428661|451675062|FG002|Double-Masked Phase|Protocol Violation|0|||
125558206|NCT01428661|451675060|FG000|Double-Masked Phase|Adverse Event|13|||
125558207|NCT01428661|451675061|FG001|Double-Masked Phase|Adverse Event|4|||
125558208|NCT01428661|451675062|FG002|Double-Masked Phase|Adverse Event|0|||
125558209|NCT01428661|451675060|FG000|Double-Masked Phase|Lost to Follow-up|14|||
125558210|NCT01428661|451675061|FG001|Double-Masked Phase|Lost to Follow-up|14|||
125558211|NCT01428661|451675062|FG002|Double-Masked Phase|Lost to Follow-up|0|||
125558212|NCT01428661|451675060|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
125558213|NCT01428661|451675061|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
125558214|NCT01428661|451675062|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
125558215|NCT01428661|451675060|FG000|Double-Masked Phase|Lack of Efficacy|2|||
125558216|NCT01428661|451675061|FG001|Double-Masked Phase|Lack of Efficacy|1|||
125558217|NCT01428661|451675062|FG002|Double-Masked Phase|Lack of Efficacy|0|||
125558218|NCT01428661|451675060|FG000|Double-Masked Phase|*Various|1|||
125558219|NCT01428661|451675061|FG001|Double-Masked Phase|*Various|6|||
125558220|NCT01428661|451675062|FG002|Double-Masked Phase|*Various|0|||
125558221|NCT01428661|451675060|FG000|Open Label Extension|Protocol Violation|0|||
125558222|NCT01428661|451675061|FG001|Open Label Extension|Protocol Violation|0|||
125558223|NCT01428661|451675062|FG002|Open Label Extension|Protocol Violation|9|||
125558224|NCT01428661|451675060|FG000|Open Label Extension|Adverse Event|0|||
125558225|NCT01428661|451675061|FG001|Open Label Extension|Adverse Event|0|||
125558226|NCT01428661|451675062|FG002|Open Label Extension|Adverse Event|15|||
125558227|NCT01428661|451675060|FG000|Open Label Extension|Lost to Follow-up|0|||
125558228|NCT01428661|451675061|FG001|Open Label Extension|Lost to Follow-up|0|||
125558229|NCT01428661|451675062|FG002|Open Label Extension|Lost to Follow-up|38|||
125558230|NCT01428661|451675060|FG000|Open Label Extension|Withdrawal by Subject|0|||
125558231|NCT01428661|451675061|FG001|Open Label Extension|Withdrawal by Subject|0|||
125558232|NCT01428661|451675062|FG002|Open Label Extension|Withdrawal by Subject|49|||
125558233|NCT01428661|451675060|FG000|Open Label Extension|Lack of Efficacy|0|||
125558234|NCT01428661|451675061|FG001|Open Label Extension|Lack of Efficacy|0|||
125558235|NCT01428661|451675062|FG002|Open Label Extension|Lack of Efficacy|24|||
125558236|NCT01428661|451675060|FG000|Open Label Extension|**Various|0|||
125558237|NCT01428661|451675061|FG001|Open Label Extension|**Various|0|||
125558238|NCT01428661|451675062|FG002|Open Label Extension|**Various|185|||
125558239|NCT00972777|451675063|FG000|Overall Study|Adverse Event|3|||
125558240|NCT00972777|451675064|FG001|Overall Study|Adverse Event|2|||
125558241|NCT00972777|451675063|FG000|Overall Study|Lost to Follow-up|0|||
125558242|NCT00972777|451675064|FG001|Overall Study|Lost to Follow-up|4|||
125558243|NCT00972777|451675063|FG000|Overall Study|Withdrawal by Subject|4|||
125558244|NCT00972777|451675064|FG001|Overall Study|Withdrawal by Subject|5|||
125558245|NCT00972777|451675063|FG000|Overall Study|Physician Decision|4|||
125558246|NCT00972777|451675064|FG001|Overall Study|Physician Decision|0|||
125558247|NCT00972777|451675063|FG000|Overall Study|Protocol Violation|0|||
125558248|NCT00972777|451675064|FG001|Overall Study|Protocol Violation|2|||
125558249|NCT00972777|451675063|FG000|Overall Study|Screening Failure|2|||
125558250|NCT00972777|451675064|FG001|Overall Study|Screening Failure|1|||
125558251|NCT00972777|451675063|FG000|Overall Study|Missed visit|1|||
125558252|NCT00972777|451675064|FG001|Overall Study|Missed visit|0|||
125558253|NCT00729378|451676631|FG000|Baseline|Did not complete study measurements|72|||
125558254|NCT00729378|451676632|FG001|Baseline|Did not complete study measurements|33|||
125558255|NCT00729378|451676631|FG000|Baseline|Withdrawal by Subject|66|||
125558256|NCT00729378|451676632|FG001|Baseline|Withdrawal by Subject|59|||
125558257|NCT00729378|451676631|FG000|12-months|Lost to Follow-up|100|||
125558258|NCT00729378|451676632|FG001|12-months|Lost to Follow-up|65|||
125558259|NCT00729378|451676631|FG000|24-months|Lost to Follow-up|72|||
125558260|NCT00729378|451676632|FG001|24-months|Lost to Follow-up|51|||
125558261|NCT00729378|451676631|FG000|36-months|Lost to Follow-up|15|||
125558262|NCT00729378|451676632|FG001|36-months|Lost to Follow-up|6|||
125558263|NCT02246582|451676635|FG000|Overall Study|Withdrawal by Subject|3|||
125558264|NCT02246582|451676636|FG001|Overall Study|Withdrawal by Subject|4|||
125558265|NCT03441334|451676638|FG000|Overall Study|Withdrawal by Subject|1|||
125558266|NCT03441334|451676639|FG001|Overall Study|Withdrawal by Subject|0|||
125558267|NCT02592551|451676640|FG000|Overall Study|Not evaluable|1|||
125558268|NCT02592551|451676641|FG001|Overall Study|Not evaluable|3|||
125558269|NCT02592551|451676642|FG002|Overall Study|Not evaluable|0|||
125558270|NCT01876251|451676643|FG000|Overall Study|Clinical progression|1|||
125558271|NCT01876251|451676644|FG001|Overall Study|Clinical progression|0|||
125558272|NCT01876251|451676645|FG002|Overall Study|Clinical progression|0|||
125558273|NCT01876251|451676643|FG000|Overall Study|Death|2|||
125558274|NCT01876251|451676644|FG001|Overall Study|Death|0|||
125558275|NCT01876251|451676645|FG002|Overall Study|Death|1|||
125558276|NCT01876251|451676643|FG000|Overall Study|Participant started new treatment|1|||
125558277|NCT01876251|451676644|FG001|Overall Study|Participant started new treatment|0|||
125558278|NCT01876251|451676645|FG002|Overall Study|Participant started new treatment|1|||
125558279|NCT01876251|451676643|FG000|Overall Study|Participant refused further follow-up|0|||
125558280|NCT01876251|451676644|FG001|Overall Study|Participant refused further follow-up|0|||
125558281|NCT01876251|451676645|FG002|Overall Study|Participant refused further follow-up|1|||
125558282|NCT01876251|451676643|FG000|Overall Study|Study terminated|1|||
125558283|NCT01876251|451676644|FG001|Overall Study|Study terminated|0|||
125558284|NCT01876251|451676645|FG002|Overall Study|Study terminated|0|||
125558285|NCT01876251|451676643|FG000|Overall Study|Objective progression or relapse|10|||
125558286|NCT01876251|451676644|FG001|Overall Study|Objective progression or relapse|3|||
125558287|NCT01876251|451676645|FG002|Overall Study|Objective progression or relapse|8|||
125558288|NCT00268437|451676646|FG000|Overall Study|Ineligible|1|||
125558289|NCT01628107|451676650|FG000|Overall Study|Withdrawal by Subject|17|||
125558290|NCT01628107|451676650|FG000|Overall Study|Lost to Follow-up|4|||
125558291|NCT01628107|451676650|FG000|Overall Study|Adverse Event|33|||
125558292|NCT01628107|451676650|FG000|Overall Study|Physician Decision|2|||
125558293|NCT01628107|451676650|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
125558294|NCT01628107|451676650|FG000|Overall Study|Non-compliant with Study Procedures|10|||
125558295|NCT01628107|451676650|FG000|Overall Study|Not Treated|8|||
125558296|NCT01628107|451676650|FG000|Overall Study|Sponsor Decision|11|||
125558297|NCT01628107|451676650|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
125558298|NCT01628107|451676650|FG000|Overall Study|Relocated|8|||
125558299|NCT01628107|451676650|FG000|Overall Study|Kidney Transplant|9|||
125558300|NCT01628107|451676650|FG000|Overall Study|Use of Standard of Care|9|||
125558301|NCT01086410|451676651|FG000|Overall Study|Adverse Event|1|||
125558302|NCT01086410|451676652|FG001|Overall Study|Adverse Event|0|||
125558303|NCT01086410|451676653|FG002|Overall Study|Adverse Event|0|||
125558304|NCT01086410|451676654|FG003|Overall Study|Adverse Event|2|||
125558305|NCT01086410|451676651|FG000|Overall Study|Lack of Efficacy|1|||
125558306|NCT01086410|451676652|FG001|Overall Study|Lack of Efficacy|1|||
125558307|NCT01086410|451676653|FG002|Overall Study|Lack of Efficacy|0|||
125558308|NCT01086410|451676654|FG003|Overall Study|Lack of Efficacy|0|||
125558309|NCT01086410|451676651|FG000|Overall Study|Protocol Violation|1|||
125558310|NCT01086410|451676652|FG001|Overall Study|Protocol Violation|1|||
125558311|NCT01086410|451676653|FG002|Overall Study|Protocol Violation|0|||
125558312|NCT01086410|451676654|FG003|Overall Study|Protocol Violation|0|||
125558313|NCT01086410|451676651|FG000|Overall Study|Lost to Follow-up|0|||
125558314|NCT01086410|451676652|FG001|Overall Study|Lost to Follow-up|0|||
125558315|NCT01086410|451676653|FG002|Overall Study|Lost to Follow-up|1|||
125558316|NCT01086410|451676654|FG003|Overall Study|Lost to Follow-up|0|||
125558317|NCT02953639|451676655|FG000|Overall Study|Adverse Event|2|||
125558318|NCT02953639|451676656|FG001|Overall Study|Adverse Event|0|||
125558319|NCT02953639|451676657|FG002|Overall Study|Adverse Event|1|||
125558320|NCT02953639|451676655|FG000|Overall Study|Lost to Follow-up|8|||
125558321|NCT02953639|451676656|FG001|Overall Study|Lost to Follow-up|4|||
125558322|NCT02953639|451676657|FG002|Overall Study|Lost to Follow-up|3|||
125558323|NCT02953639|451676655|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125558324|NCT02953639|451676656|FG001|Overall Study|Non-Compliance With Study Drug|2|||
125558325|NCT02953639|451676657|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125558326|NCT02953639|451676655|FG000|Overall Study|Multiple Reasons|1|||
125558327|NCT02953639|451676656|FG001|Overall Study|Multiple Reasons|0|||
125558328|NCT02953639|451676657|FG002|Overall Study|Multiple Reasons|1|||
125558329|NCT02953639|451676655|FG000|Overall Study|Physician Decision|1|||
125558330|NCT02953639|451676656|FG001|Overall Study|Physician Decision|0|||
125558331|NCT02953639|451676657|FG002|Overall Study|Physician Decision|0|||
125558332|NCT02953639|451676655|FG000|Overall Study|Withdrawal by Subject|7|||
125558333|NCT02953639|451676656|FG001|Overall Study|Withdrawal by Subject|8|||
125558334|NCT02953639|451676657|FG002|Overall Study|Withdrawal by Subject|10|||
125558335|NCT02953639|451676655|FG000|Overall Study|Completed or Discontinued information is missing|1|||
125558336|NCT02953639|451676656|FG001|Overall Study|Completed or Discontinued information is missing|0|||
125558337|NCT02953639|451676657|FG002|Overall Study|Completed or Discontinued information is missing|0|||
125558338|NCT04196803|451676658|FG000|Overall Study|Withdrawal by Subject|1|||
125558339|NCT04196803|451676659|FG001|Overall Study|Withdrawal by Subject|3|||
125558340|NCT04196803|451676658|FG000|Overall Study|Adverse Event|4|||
125558341|NCT04196803|451676659|FG001|Overall Study|Adverse Event|2|||
125558342|NCT04196803|451676658|FG000|Overall Study|Lost to Follow-up|0|||
125558343|NCT04196803|451676659|FG001|Overall Study|Lost to Follow-up|1|||
125558344|NCT01022996|451676660|FG000|Overall Study|Adverse Event|14|||
125558345|NCT01022996|451676660|FG000|Overall Study|Withdrawal by Subject|3|||
125558346|NCT01022996|451676660|FG000|Overall Study|Lost to Follow-up|1|||
125558347|NCT01022996|451676660|FG000|Overall Study|Administrative problems|6|||
125558348|NCT01022996|451676660|FG000|Overall Study|Disease Progression|32|||
125558349|NCT01022996|451676660|FG000|Overall Study|Protocol Violation|1|||
125558350|NCT00710879|451676661|FG000|Overall Study|Lost to Follow-up|2|||
125558351|NCT00710879|451676662|FG001|Overall Study|Lost to Follow-up|1|||
125558352|NCT00710879|451676661|FG000|Overall Study|Protocol Violation|0|||
125558353|NCT00710879|451676662|FG001|Overall Study|Protocol Violation|3|||
125558354|NCT01809132|451676663|FG000|Overall Study|Withdrawal by Subject|0|||
125558355|NCT01809132|451676664|FG001|Overall Study|Withdrawal by Subject|0|||
125558356|NCT01809132|451676665|FG002|Overall Study|Withdrawal by Subject|1|||
125558357|NCT03349775|451676666|FG000|Overall Study|Side Effects|1|||
125558358|NCT03349775|451676667|FG001|Overall Study|Side Effects|2|||
125558359|NCT03349775|451676666|FG000|Overall Study|Withdrawal by Subject|1|||
125558360|NCT03349775|451676667|FG001|Overall Study|Withdrawal by Subject|1|||
125558361|NCT03349775|451676666|FG000|Overall Study|No primary outcome measurements|0|||
125558362|NCT03349775|451676667|FG001|Overall Study|No primary outcome measurements|1|||
125558363|NCT01516970|451676668|FG000|Overall Study|Lost to Follow-up|7|||
125558364|NCT01516970|451676669|FG001|Overall Study|Lost to Follow-up|8|||
125558365|NCT01516970|451676668|FG000|Overall Study|Adverse Event|1|||
125558366|NCT01516970|451676669|FG001|Overall Study|Adverse Event|5|||
125558367|NCT01516970|451676668|FG000|Overall Study|Withdrawal by Subject|1|||
125558368|NCT01516970|451676669|FG001|Overall Study|Withdrawal by Subject|1|||
125558369|NCT01516970|451676668|FG000|Overall Study|Other|9|||
125558370|NCT01516970|451676669|FG001|Overall Study|Other|7|||
125558371|NCT01756040|451676670|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
125558372|NCT01756040|451676670|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
125558373|NCT01756040|451676670|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
125558374|NCT01688466|451676671|FG000|Overall Study|Withdrawal by Subject|2|||
125558375|NCT01688466|451676672|FG001|Overall Study|Withdrawal by Subject|1|||
125558376|NCT01688466|451676671|FG000|Overall Study|Death|0|||
125558377|NCT01688466|451676672|FG001|Overall Study|Death|1|||
125558378|NCT01688466|451676671|FG000|Overall Study|Adverse Event|0|||
125558379|NCT01688466|451676672|FG001|Overall Study|Adverse Event|4|||
125558380|NCT01688466|451676671|FG000|Overall Study|Not evaluable|0|||
125558381|NCT01688466|451676672|FG001|Overall Study|Not evaluable|1|||
125558382|NCT01205438|451676673|FG000|Overall Study|Adverse Event|19|||
125558383|NCT01205438|451676674|FG001|Overall Study|Adverse Event|17|||
125558384|NCT01205438|451676675|FG002|Overall Study|Adverse Event|24|||
125558385|NCT01205438|451676673|FG000|Overall Study|Death|1|||
125558386|NCT01205438|451676674|FG001|Overall Study|Death|1|||
125558387|NCT01205438|451676675|FG002|Overall Study|Death|3|||
125558388|NCT01205438|451676673|FG000|Overall Study|Entry Criteria Not Met|16|||
125558389|NCT01205438|451676674|FG001|Overall Study|Entry Criteria Not Met|15|||
125558390|NCT01205438|451676675|FG002|Overall Study|Entry Criteria Not Met|13|||
125558391|NCT01205438|451676673|FG000|Overall Study|Lack of Efficacy|14|||
125558392|NCT01205438|451676674|FG001|Overall Study|Lack of Efficacy|11|||
125558393|NCT01205438|451676675|FG002|Overall Study|Lack of Efficacy|14|||
125558394|NCT01205438|451676673|FG000|Overall Study|Lost to Follow-up|6|||
125558395|NCT01205438|451676674|FG001|Overall Study|Lost to Follow-up|7|||
125558396|NCT01205438|451676675|FG002|Overall Study|Lost to Follow-up|8|||
125558397|NCT01205438|451676673|FG000|Overall Study|Withdrawal by Subject|19|||
125558398|NCT01205438|451676674|FG001|Overall Study|Withdrawal by Subject|25|||
125558399|NCT01205438|451676675|FG002|Overall Study|Withdrawal by Subject|19|||
125558400|NCT01205438|451676673|FG000|Overall Study|Physician Decision|0|||
125558401|NCT01205438|451676674|FG001|Overall Study|Physician Decision|3|||
125558402|NCT01205438|451676675|FG002|Overall Study|Physician Decision|2|||
125558403|NCT01205438|451676673|FG000|Overall Study|Protocol Violation|2|||
125558404|NCT01205438|451676674|FG001|Overall Study|Protocol Violation|7|||
125558405|NCT01205438|451676675|FG002|Overall Study|Protocol Violation|4|||
125558406|NCT01205438|451676673|FG000|Overall Study|Sponsor Decision|0|||
125558407|NCT01205438|451676674|FG001|Overall Study|Sponsor Decision|1|||
125558408|NCT01205438|451676675|FG002|Overall Study|Sponsor Decision|1|||
125558409|NCT00884325|451676680|FG000|Overall Study|Lost to Follow-up|1|||
125558410|NCT00884325|451676681|FG001|Overall Study|Lost to Follow-up|2|||
125558411|NCT00884325|451676680|FG000|Overall Study|Lack of Efficacy|0|||
125558412|NCT00884325|451676681|FG001|Overall Study|Lack of Efficacy|1|||
125558413|NCT00884325|451676680|FG000|Overall Study|Withdrawal by Subject|1|||
125558414|NCT00884325|451676681|FG001|Overall Study|Withdrawal by Subject|1|||
125558415|NCT00884325|451676680|FG000|Overall Study|Not provided|1|||
125558416|NCT00884325|451676681|FG001|Overall Study|Not provided|0|||
125558417|NCT00892177|451676698|FG000|Phase II|Ineligible|0|||
125558418|NCT00892177|451676699|FG001|Phase II|Ineligible|0|||
125558419|NCT00892177|451676700|FG002|Phase II|Ineligible|0|||
125558420|NCT00892177|451676701|FG003|Phase II|Ineligible|0|||
125558421|NCT00892177|451676702|FG004|Phase II|Ineligible|1|||
125558422|NCT00892177|451676703|FG005|Phase II|Ineligible|1|||
125558423|NCT00892177|451676698|FG000|Phase II|Withdrawal by Subject|0|||
125558424|NCT00892177|451676699|FG001|Phase II|Withdrawal by Subject|0|||
125558425|NCT00892177|451676700|FG002|Phase II|Withdrawal by Subject|0|||
125558426|NCT00892177|451676701|FG003|Phase II|Withdrawal by Subject|0|||
125558427|NCT00892177|451676702|FG004|Phase II|Withdrawal by Subject|4|||
125558428|NCT00892177|451676703|FG005|Phase II|Withdrawal by Subject|1|||
125558429|NCT00616434|451676707|FG000|Overall Study|Adverse Event|5|||
125558430|NCT00616434|451676708|FG001|Overall Study|Adverse Event|2|||
125558431|NCT00616434|451676707|FG000|Overall Study|Physician Decision|0|||
125558432|NCT00616434|451676708|FG001|Overall Study|Physician Decision|4|||
125558433|NCT00616434|451676707|FG000|Overall Study|Withdrawal by Subject|1|||
125558434|NCT00616434|451676708|FG001|Overall Study|Withdrawal by Subject|1|||
125558435|NCT00616434|451676707|FG000|Overall Study|Protocol deviation|0|||
125558436|NCT00616434|451676708|FG001|Overall Study|Protocol deviation|1|||
125558437|NCT03945591|451676709|FG000|Overall Study|Participant not transplanted|1|||
125558438|NCT03945591|451676709|FG000|Overall Study|Change in treatment plan|3|||
125558439|NCT03945591|451676709|FG000|Overall Study|Adverse Event|1|||
125558440|NCT03083847|451676710|FG000|Main|Physician Decision|0|||
125558441|NCT03083847|451676711|FG001|Main|Physician Decision|0|||
125558442|NCT03083847|451676712|FG002|Main|Physician Decision|0|||
125558443|NCT03083847|451676713|FG003|Main|Physician Decision|0|||
125558444|NCT03083847|451676714|FG004|Main|Physician Decision|0|||
125558445|NCT03083847|451676715|FG005|Main|Physician Decision|1|||
125558446|NCT03083847|451676716|FG006|Main|Physician Decision|0|||
125558447|NCT03083847|451676717|FG007|Main|Physician Decision|0|||
125558448|NCT03083847|451676718|FG008|Main|Physician Decision|0|||
125558449|NCT03083847|451676719|FG009|Main|Physician Decision|0|||
125558450|NCT03083847|451676710|FG000|Main|Pregnancy|0|||
125558451|NCT03083847|451676711|FG001|Main|Pregnancy|0|||
125558452|NCT03083847|451676712|FG002|Main|Pregnancy|0|||
125558453|NCT03083847|451676713|FG003|Main|Pregnancy|0|||
125558454|NCT03083847|451676714|FG004|Main|Pregnancy|0|||
125558455|NCT03083847|451676715|FG005|Main|Pregnancy|0|||
125558456|NCT03083847|451676716|FG006|Main|Pregnancy|0|||
125558457|NCT03083847|451676717|FG007|Main|Pregnancy|1|||
125558458|NCT03083847|451676718|FG008|Main|Pregnancy|0|||
125558459|NCT03083847|451676719|FG009|Main|Pregnancy|0|||
125558460|NCT03083847|451676710|FG000|Main|Adverse Event|0|||
125558461|NCT03083847|451676711|FG001|Main|Adverse Event|0|||
125558462|NCT03083847|451676712|FG002|Main|Adverse Event|0|||
125558463|NCT03083847|451676713|FG003|Main|Adverse Event|0|||
125558464|NCT03083847|451676714|FG004|Main|Adverse Event|0|||
125558465|NCT03083847|451676715|FG005|Main|Adverse Event|0|||
125353370|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
125353371|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
125353372|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
125353373|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
125353374|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
125558466|NCT03083847|451676716|FG006|Main|Adverse Event|0|||
125558467|NCT03083847|451676717|FG007|Main|Adverse Event|2|||
125558468|NCT03083847|451676718|FG008|Main|Adverse Event|0|||
125558469|NCT03083847|451676719|FG009|Main|Adverse Event|0|||
125558470|NCT03083847|451676710|FG000|Main|Withdrawal by Subject|0|||
125558471|NCT03083847|451676711|FG001|Main|Withdrawal by Subject|0|||
125353375|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
125353376|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
125558472|NCT03083847|451676712|FG002|Main|Withdrawal by Subject|0|||
125558473|NCT03083847|451676713|FG003|Main|Withdrawal by Subject|0|||
125558474|NCT03083847|451676714|FG004|Main|Withdrawal by Subject|0|||
125558475|NCT03083847|451676715|FG005|Main|Withdrawal by Subject|0|||
125558476|NCT03083847|451676716|FG006|Main|Withdrawal by Subject|1|||
125558477|NCT03083847|451676717|FG007|Main|Withdrawal by Subject|1|||
125558478|NCT03083847|451676718|FG008|Main|Withdrawal by Subject|0|||
125558479|NCT03083847|451676719|FG009|Main|Withdrawal by Subject|0|||
125558480|NCT00058552|451676721|FG000|Overall Study|Died prior to receiving treatment|4|||
125558481|NCT00058552|451676722|FG001|Overall Study|Died prior to receiving treatment|2|||
125558482|NCT00058552|451676721|FG000|Overall Study|Disease progression|52|||
125558483|NCT00058552|451676722|FG001|Overall Study|Disease progression|44|||
125558484|NCT00058552|451676721|FG000|Overall Study|Adverse Event|4|||
125558485|NCT00058552|451676722|FG001|Overall Study|Adverse Event|2|||
125558486|NCT00058552|451676721|FG000|Overall Study|Withdrawal by Subject|3|||
125558487|NCT00058552|451676722|FG001|Overall Study|Withdrawal by Subject|5|||
125558488|NCT00058552|451676721|FG000|Overall Study|Physician Decision|2|||
125558489|NCT00058552|451676722|FG001|Overall Study|Physician Decision|5|||
125558490|NCT00058552|451676721|FG000|Overall Study|Clinical disease progression|0|||
125558491|NCT00058552|451676722|FG001|Overall Study|Clinical disease progression|4|||
125558492|NCT02319668|451676723|FG000|Overall Study|Other (Not specified)|0|||
125558493|NCT02319668|451676724|FG001|Overall Study|Other (Not specified)|2|||
125558494|NCT02316340|451676727|FG000|First Progression|Clinical progression|2|||
125558495|NCT02316340|451676728|FG001|First Progression|Clinical progression|1|||
125558496|NCT02316340|451676727|FG000|First Progression|Withdrawal by Subject|1|||
125558497|NCT02316340|451676728|FG001|First Progression|Withdrawal by Subject|0|||
125558498|NCT01986920|451676729|FG000|A- 101 25%|Withdrawal by Subject|1|||
125558499|NCT01986920|451676730|FG001|A- 101 25%|Withdrawal by Subject|0|||
125558500|NCT01986920|451676731|FG002|A- 101 25%|Withdrawal by Subject|0|||
125558501|NCT01986920|451676732|FG003|A- 101 25%|Withdrawal by Subject|0|||
125558502|NCT01986920|451676729|FG000|A-101 32.5%|Withdrawal by Subject|0|||
125558503|NCT01986920|451676730|FG001|A-101 32.5%|Withdrawal by Subject|1|||
125558504|NCT01986920|451676731|FG002|A-101 32.5%|Withdrawal by Subject|0|||
125558505|NCT01986920|451676732|FG003|A-101 32.5%|Withdrawal by Subject|0|||
125558506|NCT01986920|451676729|FG000|A-101 40%|Withdrawal by Subject|0|||
125558507|NCT01986920|451676730|FG001|A-101 40%|Withdrawal by Subject|0|||
125558508|NCT01986920|451676731|FG002|A-101 40%|Withdrawal by Subject|1|||
125558509|NCT01986920|451676732|FG003|A-101 40%|Withdrawal by Subject|0|||
125558510|NCT01986920|451676729|FG000|Placebo|Withdrawal by Subject|0|||
125558511|NCT01986920|451676730|FG001|Placebo|Withdrawal by Subject|0|||
125558512|NCT01986920|451676731|FG002|Placebo|Withdrawal by Subject|0|||
125558513|NCT01986920|451676732|FG003|Placebo|Withdrawal by Subject|1|||
125558514|NCT03781323|451676733|FG000|Overall Study|Withdrawal by Subject|1|||
125558515|NCT01338415|451676734|FG000|Core + Extension|Adverse Event|8|||
125558516|NCT01338415|451676735|FG001|Core + Extension|Adverse Event|6|||
125558517|NCT01338415|451676736|FG002|Core + Extension|Adverse Event|0|||
125558518|NCT01338415|451676734|FG000|Core + Extension|Withdrawal by Subject|1|||
125558519|NCT01338415|451676735|FG001|Core + Extension|Withdrawal by Subject|1|||
125558520|NCT01338415|451676736|FG002|Core + Extension|Withdrawal by Subject|0|||
125353377|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
125353378|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
125353379|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Program Termination|3|||
125353380|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Program Termination|0|||
125353381|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Program Termination|1|||
125353382|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Program Termination|1|||
125353383|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
125558521|NCT01338415|451676734|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
125558522|NCT01338415|451676735|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
125558523|NCT01338415|451676736|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
125558524|NCT01338415|451676734|FG000|Core + Extension|Other (administrative reason)|1|||
125558525|NCT01338415|451676735|FG001|Core + Extension|Other (administrative reason)|0|||
125558526|NCT01338415|451676736|FG002|Core + Extension|Other (administrative reason)|0|||
125558527|NCT01338415|451676734|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
125558528|NCT01338415|451676735|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
125558529|NCT01338415|451676736|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
125558530|NCT01338415|451676734|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
125558531|NCT01338415|451676735|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
125558532|NCT01338415|451676736|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
125558533|NCT01338415|451676734|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
125558534|NCT01338415|451676735|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
125558535|NCT01338415|451676736|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
125558536|NCT01338415|451676734|FG000|Exceptional Use Treatment Period|Death|0|||
125558537|NCT01338415|451676735|FG001|Exceptional Use Treatment Period|Death|0|||
125558538|NCT01338415|451676736|FG002|Exceptional Use Treatment Period|Death|1|||
125558539|NCT04880447|451676742|FG000|Overall Study|No vaccination information|1|||
125558540|NCT04880447|451676742|FG000|Overall Study|No adverse event information (missing information)|1|||
125558541|NCT04880447|451676742|FG000|Overall Study|Disease not covered in this study|35|||
125558542|NCT01970488|451676743|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
125558543|NCT01970488|451676744|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
125558544|NCT01970488|451676745|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
125558545|NCT01970488|451676746|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
125558546|NCT01970488|451676747|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
125558547|NCT01970488|451676743|FG000|Part 1: Through Week 16|Protocol Violation|1|||
125558548|NCT01970488|451676744|FG001|Part 1: Through Week 16|Protocol Violation|2|||
125558549|NCT01970488|451676745|FG002|Part 1: Through Week 16|Protocol Violation|0|||
125558550|NCT01970488|451676746|FG003|Part 1: Through Week 16|Protocol Violation|0|||
125558551|NCT01970488|451676747|FG004|Part 1: Through Week 16|Protocol Violation|0|||
125558552|NCT01970488|451676743|FG000|Part 1: Through Week 16|Adverse Event|6|||
125558553|NCT01970488|451676744|FG001|Part 1: Through Week 16|Adverse Event|5|||
125558554|NCT01970488|451676745|FG002|Part 1: Through Week 16|Adverse Event|0|||
125558555|NCT01970488|451676746|FG003|Part 1: Through Week 16|Adverse Event|0|||
125558556|NCT01970488|451676747|FG004|Part 1: Through Week 16|Adverse Event|0|||
125558557|NCT01970488|451676743|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
125558558|NCT01970488|451676744|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
125558559|NCT01970488|451676745|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
125558560|NCT01970488|451676746|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
125558561|NCT01970488|451676747|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
125558562|NCT01970488|451676743|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
125558563|NCT01970488|451676744|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
125558564|NCT01970488|451676745|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
125558565|NCT01970488|451676746|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
125558566|NCT01970488|451676747|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
125558567|NCT01970488|451676743|FG000|Part 2: Post Week 16|Physician Decision|0|||
125558568|NCT01970488|451676744|FG001|Part 2: Post Week 16|Physician Decision|0|||
125558569|NCT01970488|451676745|FG002|Part 2: Post Week 16|Physician Decision|0|||
125558570|NCT01970488|451676746|FG003|Part 2: Post Week 16|Physician Decision|0|||
125558571|NCT01970488|451676747|FG004|Part 2: Post Week 16|Physician Decision|1|||
125558572|NCT01970488|451676743|FG000|Part 2: Post Week 16|Non-compliance|0|||
125558573|NCT01970488|451676744|FG001|Part 2: Post Week 16|Non-compliance|0|||
125558574|NCT01970488|451676745|FG002|Part 2: Post Week 16|Non-compliance|1|||
125558575|NCT01970488|451676746|FG003|Part 2: Post Week 16|Non-compliance|0|||
125558576|NCT01970488|451676747|FG004|Part 2: Post Week 16|Non-compliance|0|||
125558577|NCT01970488|451676743|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
125558578|NCT01970488|451676744|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
125558579|NCT01970488|451676745|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
125558580|NCT01970488|451676746|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
125558581|NCT01970488|451676747|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
125558582|NCT01970488|451676743|FG000|Part 2: Post Week 16|Adverse Event|0|||
125558583|NCT01970488|451676744|FG001|Part 2: Post Week 16|Adverse Event|0|||
125558584|NCT01970488|451676745|FG002|Part 2: Post Week 16|Adverse Event|5|||
125558585|NCT01970488|451676746|FG003|Part 2: Post Week 16|Adverse Event|1|||
125558586|NCT01970488|451676747|FG004|Part 2: Post Week 16|Adverse Event|1|||
125558587|NCT01970488|451676743|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
125558588|NCT01970488|451676744|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
125558589|NCT01970488|451676745|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
125558590|NCT01970488|451676746|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
125558591|NCT01970488|451676747|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
125558592|NCT01970488|451676743|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
125558593|NCT01970488|451676744|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
125558594|NCT01970488|451676745|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
125558595|NCT01970488|451676746|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
125558596|NCT01970488|451676747|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
125558597|NCT04060563|451676748|FG000|Overall Study|Lost to Follow-up|1|||
125558598|NCT04060563|451676749|FG001|Overall Study|Lost to Follow-up|1|||
125558599|NCT04060563|451676748|FG000|Overall Study|Physician Decision|0|||
125558600|NCT04060563|451676749|FG001|Overall Study|Physician Decision|1|||
125558601|NCT02613884|451676756|FG000|Overall Study|Death|1|||
125558602|NCT02613884|451676756|FG000|Overall Study|Lost to Follow-up|1|||
125558603|NCT00433914|451676760|FG000|Overall Study|Withdrawal by Subject|0|||
125558604|NCT00433914|451676761|FG001|Overall Study|Withdrawal by Subject|2|||
125558605|NCT00433914|451676760|FG000|Overall Study|Lost to Follow-up|0|||
125558606|NCT00433914|451676761|FG001|Overall Study|Lost to Follow-up|1|||
125558607|NCT01848353|451676762|FG000|Phase 1|Withdrawal by Subject|3|||
125558608|NCT01848353|451676763|FG001|Phase 1|Withdrawal by Subject|1|||
125558609|NCT01848353|451676764|FG002|Phase 1|Withdrawal by Subject|0|||
125558610|NCT01848353|451676765|FG003|Phase 1|Withdrawal by Subject|0|||
125558611|NCT01848353|451676762|FG000|Phase 2|Withdrawal by Subject|3|||
125558612|NCT01848353|451676763|FG001|Phase 2|Withdrawal by Subject|2|||
125558613|NCT01848353|451676764|FG002|Phase 2|Withdrawal by Subject|0|||
125558614|NCT01848353|451676765|FG003|Phase 2|Withdrawal by Subject|0|||
125558615|NCT01848353|451676762|FG000|Phase 3|Withdrawal by Subject|1|||
125558616|NCT01848353|451676763|FG001|Phase 3|Withdrawal by Subject|1|||
125558617|NCT01848353|451676764|FG002|Phase 3|Withdrawal by Subject|0|||
125558618|NCT01848353|451676765|FG003|Phase 3|Withdrawal by Subject|0|||
125558619|NCT03933397|451676766|FG000|Overall Study|No emergency department visit|65|||
125558620|NCT03933397|451676767|FG001|Overall Study|No emergency department visit|71|||
125558621|NCT03933397|451676766|FG000|Overall Study|Missed emergency department visit|25|||
125558622|NCT03933397|451676767|FG001|Overall Study|Missed emergency department visit|30|||
125558623|NCT03933397|451676766|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
125558624|NCT03933397|451676767|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
125558625|NCT03933397|451676766|FG000|Overall Study|Withdrawal by Subject|1|||
125558626|NCT03933397|451676767|FG001|Overall Study|Withdrawal by Subject|0|||
125558627|NCT03933397|451676766|FG000|Overall Study|Physician Decision|1|||
125558628|NCT03933397|451676767|FG001|Overall Study|Physician Decision|1|||
125558629|NCT03933397|451676766|FG000|Overall Study|missing pain score|1|||
125558630|NCT03933397|451676767|FG001|Overall Study|missing pain score|1|||
125558631|NCT03933397|451676766|FG000|Overall Study|Confirmed COVID-19|1|||
125558632|NCT03933397|451676767|FG001|Overall Study|Confirmed COVID-19|2|||
125558633|NCT01514136|451676771|FG000|Test Period 1; Test A|Protocol Violation|1|||
125558634|NCT01514136|451676772|FG001|Test Period 1; Test A|Protocol Violation|0|||
125558635|NCT01514136|451676773|FG002|Test Period 1; Test A|Protocol Violation|0|||
125558636|NCT01514136|451676774|FG003|Test Period 1; Test A|Protocol Violation|0|||
125558637|NCT01514136|451676775|FG004|Test Period 1; Test A|Protocol Violation|0|||
125558638|NCT01514136|451676776|FG005|Test Period 1; Test A|Protocol Violation|0|||
125558639|NCT01514136|451676777|FG006|Test Period 1; Test A|Protocol Violation|0|||
125558640|NCT01514136|451676778|FG007|Test Period 1; Test A|Protocol Violation|0|||
125558641|NCT01514136|451676771|FG000|Test Period 1; Test A|Break from study holiday|2|||
125558642|NCT01514136|451676772|FG001|Test Period 1; Test A|Break from study holiday|0|||
125558643|NCT01514136|451676773|FG002|Test Period 1; Test A|Break from study holiday|0|||
125558644|NCT01514136|451676774|FG003|Test Period 1; Test A|Break from study holiday|0|||
125558645|NCT01514136|451676775|FG004|Test Period 1; Test A|Break from study holiday|0|||
125558646|NCT01514136|451676776|FG005|Test Period 1; Test A|Break from study holiday|0|||
125558647|NCT01514136|451676777|FG006|Test Period 1; Test A|Break from study holiday|0|||
125558648|NCT01514136|451676778|FG007|Test Period 1; Test A|Break from study holiday|0|||
125558649|NCT01514136|451676771|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
125558650|NCT01514136|451676772|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
125558651|NCT01514136|451676773|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
125558652|NCT01514136|451676774|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
125558653|NCT01514136|451676775|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
125558654|NCT01514136|451676776|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
125558655|NCT01514136|451676777|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
125558656|NCT01514136|451676778|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
125558657|NCT01514136|451676771|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
125558658|NCT01514136|451676772|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
125558659|NCT01514136|451676773|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
125558660|NCT01514136|451676774|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
125558661|NCT01514136|451676775|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
125558662|NCT01514136|451676776|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
125558663|NCT01514136|451676777|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
125558664|NCT01514136|451676778|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
125558665|NCT01514136|451676771|FG000|Test Period 2; Test A*|Adverse Event|0|||
125558666|NCT01514136|451676772|FG001|Test Period 2; Test A*|Adverse Event|0|||
125558667|NCT01514136|451676773|FG002|Test Period 2; Test A*|Adverse Event|0|||
125558668|NCT01514136|451676774|FG003|Test Period 2; Test A*|Adverse Event|0|||
125558669|NCT01514136|451676775|FG004|Test Period 2; Test A*|Adverse Event|1|||
125558670|NCT01514136|451676776|FG005|Test Period 2; Test A*|Adverse Event|0|||
125558671|NCT01514136|451676777|FG006|Test Period 2; Test A*|Adverse Event|0|||
125558672|NCT01514136|451676778|FG007|Test Period 2; Test A*|Adverse Event|0|||
125558673|NCT01514136|451676771|FG000|Test Period 2; Test A*|Holiday|0|||
125558674|NCT01514136|451676772|FG001|Test Period 2; Test A*|Holiday|0|||
125558675|NCT01514136|451676773|FG002|Test Period 2; Test A*|Holiday|0|||
125558676|NCT01514136|451676774|FG003|Test Period 2; Test A*|Holiday|0|||
125558677|NCT01514136|451676775|FG004|Test Period 2; Test A*|Holiday|1|||
125558678|NCT01514136|451676776|FG005|Test Period 2; Test A*|Holiday|0|||
125558679|NCT01514136|451676777|FG006|Test Period 2; Test A*|Holiday|0|||
125558680|NCT01514136|451676778|FG007|Test Period 2; Test A*|Holiday|0|||
125558681|NCT01514136|451676771|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
125558682|NCT01514136|451676772|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
125558683|NCT01514136|451676773|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
125558684|NCT01514136|451676774|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
125558685|NCT01514136|451676775|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
125558686|NCT01514136|451676776|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
125558687|NCT01514136|451676777|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
125558688|NCT01514136|451676778|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
125558689|NCT01514136|451676771|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
125558690|NCT01514136|451676772|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
125558691|NCT01514136|451676773|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
125558692|NCT01514136|451676774|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
125558693|NCT01514136|451676775|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
125558694|NCT01514136|451676776|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
125558695|NCT01514136|451676777|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
125558696|NCT01514136|451676778|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
125558697|NCT01514136|451676771|FG000|Test Period 2; Test C*|holiday|0|||
125558698|NCT01514136|451676772|FG001|Test Period 2; Test C*|holiday|0|||
125558699|NCT01514136|451676773|FG002|Test Period 2; Test C*|holiday|0|||
125558700|NCT01514136|451676774|FG003|Test Period 2; Test C*|holiday|0|||
125558701|NCT01514136|451676775|FG004|Test Period 2; Test C*|holiday|0|||
125558702|NCT01514136|451676776|FG005|Test Period 2; Test C*|holiday|0|||
125558703|NCT01514136|451676777|FG006|Test Period 2; Test C*|holiday|1|||
125558704|NCT01514136|451676778|FG007|Test Period 2; Test C*|holiday|0|||
125558705|NCT01514136|451676771|FG000|Test Period 2; Test C*|Protocol Violation|0|||
125558706|NCT01514136|451676772|FG001|Test Period 2; Test C*|Protocol Violation|0|||
125558707|NCT01514136|451676773|FG002|Test Period 2; Test C*|Protocol Violation|0|||
125558708|NCT01514136|451676774|FG003|Test Period 2; Test C*|Protocol Violation|0|||
125558709|NCT01514136|451676775|FG004|Test Period 2; Test C*|Protocol Violation|0|||
125558710|NCT01514136|451676776|FG005|Test Period 2; Test C*|Protocol Violation|0|||
125558711|NCT01514136|451676777|FG006|Test Period 2; Test C*|Protocol Violation|1|||
125558712|NCT01514136|451676778|FG007|Test Period 2; Test C*|Protocol Violation|0|||
125558713|NCT02941926|451676779|FG000|Core Phase|Progressive disease|1109|||
125558714|NCT02941926|451676779|FG000|Core Phase|Adverse Event|504|||
125558715|NCT02941926|451676779|FG000|Core Phase|Subject/guardian decision|127|||
125558716|NCT02941926|451676779|FG000|Core Phase|Physician Decision|112|||
125558717|NCT02941926|451676779|FG000|Core Phase|Death|46|||
125558718|NCT02941926|451676779|FG000|Core Phase|Protocol deviation|34|||
125558719|NCT02941926|451676779|FG000|Core Phase|Lost to Follow-up|8|||
125558720|NCT02941926|451676779|FG000|Core Phase|Technical problems|5|||
125558721|NCT02941926|451676779|FG000|Extension Phase|Physician Decision|155|||
125558722|NCT02941926|451676779|FG000|Extension Phase|Progressive disease|115|||
125558723|NCT02941926|451676779|FG000|Extension Phase|Adverse Event|13|||
125558724|NCT02941926|451676779|FG000|Extension Phase|Subject/Guardian decision|12|||
125558725|NCT02941926|451676779|FG000|Extension Phase|Death|6|||
125558726|NCT02729740|451676780|FG000|Overall Study|Early Termination|130|||
125558727|NCT02729740|451676780|FG000|Overall Study|Other|1|||
125558728|NCT00601705|451676784|FG000|Overall Study|Withdrawal by Subject|1|||
125558729|NCT04223791|451676785|FG000|Overall Study|Lost to Follow-up|0|||
125558730|NCT04223791|451676786|FG001|Overall Study|Lost to Follow-up|4|||
125558731|NCT04223791|451676785|FG000|Overall Study|Physician Decision|5|||
125558732|NCT04223791|451676786|FG001|Overall Study|Physician Decision|1|||
125558733|NCT04223791|451676785|FG000|Overall Study|Protocol Violation|1|||
125558734|NCT04223791|451676786|FG001|Overall Study|Protocol Violation|1|||
125558735|NCT04223791|451676785|FG000|Overall Study|Withdrawal by Subject|10|||
125558736|NCT04223791|451676786|FG001|Overall Study|Withdrawal by Subject|12|||
125558737|NCT04223791|451676785|FG000|Overall Study|Pregnancy|1|||
125558738|NCT04223791|451676786|FG001|Overall Study|Pregnancy|1|||
125558739|NCT04223791|451676785|FG000|Overall Study|Ongoing in Study|305|||
125558740|NCT04223791|451676786|FG001|Overall Study|Ongoing in Study|302|||
125558741|NCT00395863|451679012|FG000|Overall Study|Patients did not complete both exams|2|||
125558742|NCT00395863|451679013|FG001|Overall Study|Patients did not complete both exams|3|||
125558743|NCT01069120|451679016|FG000|Overall Study|Study prematurely terminated|27|||
125558744|NCT02486653|451679019|FG000|Overall Study|Withdrawal by Subject|1|||
125558745|NCT02486653|451679020|FG001|Overall Study|Withdrawal by Subject|3|||
125558746|NCT02486653|451679019|FG000|Overall Study|Protocol Violation|1|||
125558747|NCT02486653|451679020|FG001|Overall Study|Protocol Violation|0|||
125558748|NCT02486653|451679019|FG000|Overall Study|surgery cancelled|4|||
125558749|NCT02486653|451679020|FG001|Overall Study|surgery cancelled|1|||
125558750|NCT02678416|451679031|FG000|Part 1|Withdrawal by Subject|1|||
125558751|NCT02678416|451679031|FG000|Part 2|Adverse Event|2|||
125558752|NCT02678416|451679031|FG000|Part 2|Withdrawal by Subject|1|||
125558753|NCT00935272|451679032|FG000|Overall Study|Lost to Follow-up|10|||
125558754|NCT00935272|451679033|FG001|Overall Study|Lost to Follow-up|3|||
125558755|NCT00935272|451679032|FG000|Overall Study|Withdrawal by Subject|8|||
125558756|NCT00935272|451679033|FG001|Overall Study|Withdrawal by Subject|2|||
125558757|NCT00935272|451679032|FG000|Overall Study|Physician Decision|1|||
125558758|NCT00935272|451679033|FG001|Overall Study|Physician Decision|0|||
125558759|NCT00935272|451679032|FG000|Overall Study|Protocol Violation|0|||
125558760|NCT00935272|451679033|FG001|Overall Study|Protocol Violation|1|||
125558761|NCT01478360|451679045|FG000|Overall Study|Lost to Follow-up|1|||
125558762|NCT01478360|451679046|FG001|Overall Study|Lost to Follow-up|0|||
125558763|NCT01478360|451679045|FG000|Overall Study|Adverse Event|0|||
125558764|NCT01478360|451679046|FG001|Overall Study|Adverse Event|1|||
125558765|NCT01478360|451679045|FG000|Overall Study|Administrative problems|1|||
125558766|NCT01478360|451679046|FG001|Overall Study|Administrative problems|2|||
125558767|NCT02289352|451679047|FG000|Overall Study|Withdrawal by Subject|1|||
125558768|NCT02289352|451679048|FG001|Overall Study|Withdrawal by Subject|1|||
125558769|NCT02289352|451679049|FG002|Overall Study|Withdrawal by Subject|0|||
125558770|NCT01177384|451679050|FG000|Overall Study|Adverse Event|6|||
125558771|NCT01177384|451679051|FG001|Overall Study|Adverse Event|4|||
125558772|NCT01177384|451679050|FG000|Overall Study|Lack of Efficacy|0|||
125558773|NCT01177384|451679051|FG001|Overall Study|Lack of Efficacy|1|||
125558774|NCT01177384|451679050|FG000|Overall Study|Lost to Follow-up|3|||
125558775|NCT01177384|451679051|FG001|Overall Study|Lost to Follow-up|4|||
125558776|NCT01177384|451679050|FG000|Overall Study|Physician Decision|0|||
125558777|NCT01177384|451679051|FG001|Overall Study|Physician Decision|3|||
125558778|NCT01177384|451679050|FG000|Overall Study|Protocol Violation|0|||
125558779|NCT01177384|451679051|FG001|Overall Study|Protocol Violation|2|||
125558780|NCT01177384|451679050|FG000|Overall Study|Withdrawal by Subject|5|||
125558781|NCT01177384|451679051|FG001|Overall Study|Withdrawal by Subject|12|||
125558782|NCT01849497|451679052|FG000|Overall Study|Withdrawal by Subject|1|||
125558783|NCT01849497|451679053|FG001|Overall Study|Withdrawal by Subject|2|||
125558784|NCT01849497|451679052|FG000|Overall Study|Sponsor Decision|0|||
125558785|NCT01849497|451679053|FG001|Overall Study|Sponsor Decision|1|||
125558786|NCT01849497|451679052|FG000|Overall Study|Lost to Follow-up|0|||
125558787|NCT01849497|451679053|FG001|Overall Study|Lost to Follow-up|1|||
125558788|NCT00529451|451679079|FG000|Overall Study|Subject withdrew consent|16|||
125558789|NCT00529451|451679080|FG001|Overall Study|Subject withdrew consent|21|||
125558790|NCT00529451|451679081|FG002|Overall Study|Subject withdrew consent|13|||
125558791|NCT00529451|451679082|FG003|Overall Study|Subject withdrew consent|12|||
125558792|NCT00529451|451679079|FG000|Overall Study|Adverse Event|9|||
125558793|NCT00529451|451679080|FG001|Overall Study|Adverse Event|16|||
125558794|NCT00529451|451679081|FG002|Overall Study|Adverse Event|14|||
125558795|NCT00529451|451679082|FG003|Overall Study|Adverse Event|8|||
125558796|NCT00529451|451679079|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
125558797|NCT00529451|451679080|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
125558798|NCT00529451|451679081|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
125558799|NCT00529451|451679082|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
125558800|NCT00529451|451679079|FG000|Overall Study|Lost to Follow-up|4|||
125558801|NCT00529451|451679080|FG001|Overall Study|Lost to Follow-up|7|||
125558802|NCT00529451|451679081|FG002|Overall Study|Lost to Follow-up|4|||
125558803|NCT00529451|451679082|FG003|Overall Study|Lost to Follow-up|4|||
125558804|NCT00529451|451679079|FG000|Overall Study|Protocol deviation|1|||
125558805|NCT00529451|451679080|FG001|Overall Study|Protocol deviation|1|||
125558806|NCT00529451|451679081|FG002|Overall Study|Protocol deviation|4|||
125558807|NCT00529451|451679082|FG003|Overall Study|Protocol deviation|1|||
125558808|NCT00529451|451679079|FG000|Overall Study|Administrative problems|1|||
125558809|NCT00529451|451679080|FG001|Overall Study|Administrative problems|1|||
125558810|NCT00529451|451679081|FG002|Overall Study|Administrative problems|0|||
125558811|NCT00529451|451679082|FG003|Overall Study|Administrative problems|2|||
125558812|NCT00911625|451679083|FG000|Overall Study|Lost to Follow-up|7|||
125558813|NCT00911625|451679084|FG001|Overall Study|Lost to Follow-up|0|||
125558814|NCT01010633|451679092|FG000|Overall Study|Adverse Event|1|||
125558815|NCT01010633|451679093|FG001|Overall Study|Adverse Event|1|||
125558816|NCT01010633|451679092|FG000|Overall Study|Protocol Violation|1|||
125558817|NCT01010633|451679093|FG001|Overall Study|Protocol Violation|2|||
125558818|NCT01010633|451679092|FG000|Overall Study|Withdrawal by Subject|2|||
125558819|NCT01010633|451679093|FG001|Overall Study|Withdrawal by Subject|1|||
125558820|NCT01010633|451679092|FG000|Overall Study|Investigator decision|0|||
125558821|NCT01010633|451679093|FG001|Overall Study|Investigator decision|1|||
125558822|NCT00097773|451679095|FG000|Overall Study|Lost to Follow-up|2|||
125558823|NCT00097773|451679096|FG001|Overall Study|Lost to Follow-up|2|||
125558824|NCT00097773|451679097|FG002|Overall Study|Lost to Follow-up|0|||
125558825|NCT00097773|451679098|FG003|Overall Study|Lost to Follow-up|1|||
125558826|NCT00097773|451679095|FG000|Overall Study|Physician Decision|2|||
125558827|NCT00097773|451679096|FG001|Overall Study|Physician Decision|2|||
125558828|NCT00097773|451679097|FG002|Overall Study|Physician Decision|3|||
125558829|NCT00097773|451679098|FG003|Overall Study|Physician Decision|1|||
125558830|NCT00097773|451679095|FG000|Overall Study|Withdrawal by Subject|3|||
125558831|NCT00097773|451679096|FG001|Overall Study|Withdrawal by Subject|3|||
125558832|NCT00097773|451679097|FG002|Overall Study|Withdrawal by Subject|3|||
125558833|NCT00097773|451679098|FG003|Overall Study|Withdrawal by Subject|1|||
125558834|NCT00097773|451679095|FG000|Overall Study|Adverse Event|0|||
125558835|NCT00097773|451679096|FG001|Overall Study|Adverse Event|1|||
125558836|NCT00097773|451679097|FG002|Overall Study|Adverse Event|0|||
125558837|NCT00097773|451679098|FG003|Overall Study|Adverse Event|0|||
125558838|NCT00097773|451679095|FG000|Overall Study|Other|1|||
125558839|NCT00097773|451679096|FG001|Overall Study|Other|0|||
125558840|NCT00097773|451679097|FG002|Overall Study|Other|2|||
125558841|NCT00097773|451679098|FG003|Overall Study|Other|0|||
125558842|NCT00003702|451679099|FG000|Overall Study|Ineligible cell types|2|||
125558843|NCT00003702|451679100|FG001|Overall Study|Ineligible cell types|2|||
125558844|NCT00003702|451679099|FG000|Overall Study|Did not meet criteria for persistence|8|||
125558845|NCT00003702|451679100|FG001|Overall Study|Did not meet criteria for persistence|5|||
125558846|NCT00003702|451679099|FG000|Overall Study|WHO score > 6|2|||
125353384|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
125353385|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
125353386|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
125353387|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
125558847|NCT00003702|451679100|FG001|Overall Study|WHO score > 6|1|||
125558848|NCT00003702|451679099|FG000|Overall Study|Inadequate documentation of disease|1|||
125558849|NCT00003702|451679100|FG001|Overall Study|Inadequate documentation of disease|3|||
125558850|NCT01494350|451679101|FG000|Overall Study|Worsening of lesion|1|||
125353388|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
125558851|NCT00698932|451679102|FG000|Overall Study|Adverse Event|0|||
125558852|NCT00698932|451679103|FG001|Overall Study|Adverse Event|2|||
125558853|NCT00698932|451679102|FG000|Overall Study|Incorrect enrollment|0|||
125558854|NCT00698932|451679103|FG001|Overall Study|Incorrect enrollment|2|||
125558855|NCT00698932|451679102|FG000|Overall Study|Study specific discontinuation criteria|3|||
125558856|NCT00698932|451679103|FG001|Overall Study|Study specific discontinuation criteria|4|||
125558857|NCT00698932|451679102|FG000|Overall Study|Withdrawal by Subject|11|||
125558858|NCT00698932|451679103|FG001|Overall Study|Withdrawal by Subject|23|||
125558859|NCT00698932|451679102|FG000|Overall Study|Lost to Follow-up|6|||
125558860|NCT00698932|451679103|FG001|Overall Study|Lost to Follow-up|1|||
125558861|NCT00698932|451679102|FG000|Overall Study|Severe non-compliance to protocol|1|||
125558862|NCT00698932|451679103|FG001|Overall Study|Severe non-compliance to protocol|2|||
125558863|NCT00698932|451679102|FG000|Overall Study|Safety reasons|0|||
125558864|NCT00698932|451679103|FG001|Overall Study|Safety reasons|2|||
125558865|NCT00698932|451679102|FG000|Overall Study|Death|1|||
125558866|NCT00698932|451679103|FG001|Overall Study|Death|0|||
125558867|NCT01245387|451679104|FG000|Overall Study|Lost to Follow-up|106|||
125558868|NCT01245387|451679104|FG000|Overall Study|Lack of Efficacy|195|||
125558869|NCT01245387|451679104|FG000|Overall Study|Adverse Event|9|||
125558870|NCT01245387|451679104|FG000|Overall Study|Death|3|||
125558871|NCT01245387|451679104|FG000|Overall Study|Other|131|||
125558872|NCT01245387|451679104|FG000|Overall Study|Missing discontinuation status|369|||
125558873|NCT00757003|451679105|FG000|Overall Study|Death|33|||
125558874|NCT00757003|451679105|FG000|Overall Study|Lost to Follow-up|9|||
125558875|NCT00757003|451679105|FG000|Overall Study|Withdrawal by Subject|4|||
125558876|NCT00757003|451679105|FG000|Overall Study|Surgically explanted|2|||
125558877|NCT00757003|451679105|FG000|Overall Study|Not implanted|1|||
125558878|NCT02146599|451679108|FG000|Overall Study|Failed to meet inclusion criteria|5|||
125558879|NCT03061175|451679114|FG000|Baseline|Participant was deemed ineligible|1|||
125558880|NCT03061175|451679115|FG001|Baseline|Participant was deemed ineligible|0|||
125558881|NCT03061175|451679114|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
125558882|NCT03061175|451679115|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
125558883|NCT03061175|451679114|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
125558884|NCT03061175|451679115|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
125558885|NCT03061175|451679114|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
125558886|NCT03061175|451679115|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
125558887|NCT02243865|451679116|FG000|Overall Study|Protocol Violation|1|||
125558888|NCT02243865|451679117|FG001|Overall Study|Protocol Violation|3|||
125558889|NCT02243865|451679116|FG000|Overall Study|Lost to Follow-up|1|||
125558890|NCT02243865|451679117|FG001|Overall Study|Lost to Follow-up|1|||
125558891|NCT02243865|451679116|FG000|Overall Study|Withdrawal by Subject|1|||
125558892|NCT02243865|451679117|FG001|Overall Study|Withdrawal by Subject|0|||
125558893|NCT02243865|451679116|FG000|Overall Study|Adverse Event|1|||
125558894|NCT02243865|451679117|FG001|Overall Study|Adverse Event|1|||
125558895|NCT03044249|451679120|FG000|Overall Study|Adverse Event|4|||
125558896|NCT03044249|451679121|FG001|Overall Study|Adverse Event|9|||
125558897|NCT03044249|451679120|FG000|Overall Study|Lost to Follow-up|1|||
125558898|NCT03044249|451679121|FG001|Overall Study|Lost to Follow-up|0|||
125558899|NCT03044249|451679120|FG000|Overall Study|Non-compliance with Study Drug|1|||
125558900|NCT03044249|451679121|FG001|Overall Study|Non-compliance with Study Drug|0|||
125558901|NCT03044249|451679120|FG000|Overall Study|Study Terminated by Sponsor|2|||
125558902|NCT03044249|451679121|FG001|Overall Study|Study Terminated by Sponsor|0|||
125558903|NCT03044249|451679120|FG000|Overall Study|Withdrawal by Subject|2|||
125558904|NCT03044249|451679121|FG001|Overall Study|Withdrawal by Subject|5|||
125558905|NCT02101021|451679122|FG000|Overall Study|Death|4|||
125558906|NCT02101021|451679123|FG001|Overall Study|Death|3|||
125558907|NCT02101021|451679124|FG002|Overall Study|Death|6|||
125558908|NCT02101021|451679125|FG003|Overall Study|Death|0|||
125558909|NCT02101021|451679126|FG004|Overall Study|Death|3|||
125558910|NCT02101021|451679122|FG000|Overall Study|Withdrew Consent from study|1|||
125558911|NCT02101021|451679123|FG001|Overall Study|Withdrew Consent from study|1|||
125558912|NCT02101021|451679124|FG002|Overall Study|Withdrew Consent from study|0|||
125558913|NCT02101021|451679125|FG003|Overall Study|Withdrew Consent from study|2|||
125558914|NCT02101021|451679126|FG004|Overall Study|Withdrew Consent from study|0|||
125558915|NCT02101021|451679122|FG000|Overall Study|Lost to Follow-up|1|||
125558916|NCT02101021|451679123|FG001|Overall Study|Lost to Follow-up|0|||
125558917|NCT02101021|451679124|FG002|Overall Study|Lost to Follow-up|0|||
125558918|NCT02101021|451679125|FG003|Overall Study|Lost to Follow-up|0|||
125558919|NCT02101021|451679126|FG004|Overall Study|Lost to Follow-up|0|||
125558920|NCT02101021|451679122|FG000|Overall Study|Study Terminated by Sponsor|1|||
125558921|NCT02101021|451679123|FG001|Overall Study|Study Terminated by Sponsor|0|||
125558922|NCT02101021|451679124|FG002|Overall Study|Study Terminated by Sponsor|1|||
125558923|NCT02101021|451679125|FG003|Overall Study|Study Terminated by Sponsor|1|||
125558924|NCT02101021|451679126|FG004|Overall Study|Study Terminated by Sponsor|1|||
125558925|NCT01621542|451679127|FG000|Overall Study|Adverse Event|0|||
125558926|NCT01621542|451679128|FG001|Overall Study|Adverse Event|0|||
125558927|NCT01621542|451679129|FG002|Overall Study|Adverse Event|1|||
125558928|NCT01621542|451679130|FG003|Overall Study|Adverse Event|3|||
125558929|NCT01621542|451679131|FG004|Overall Study|Adverse Event|0|||
125558930|NCT01621542|451679132|FG005|Overall Study|Adverse Event|0|||
125558931|NCT01621542|451679127|FG000|Overall Study|Death|0|||
125558932|NCT01621542|451679128|FG001|Overall Study|Death|1|||
125558933|NCT01621542|451679129|FG002|Overall Study|Death|0|||
125558934|NCT01621542|451679130|FG003|Overall Study|Death|0|||
125558935|NCT01621542|451679131|FG004|Overall Study|Death|0|||
125558936|NCT01621542|451679132|FG005|Overall Study|Death|0|||
125558937|NCT01621542|451679127|FG000|Overall Study|Physician Decision|1|||
125558938|NCT01621542|451679128|FG001|Overall Study|Physician Decision|0|||
125558939|NCT01621542|451679129|FG002|Overall Study|Physician Decision|1|||
125558940|NCT01621542|451679130|FG003|Overall Study|Physician Decision|13|||
125558941|NCT01621542|451679131|FG004|Overall Study|Physician Decision|3|||
125558942|NCT01621542|451679132|FG005|Overall Study|Physician Decision|1|||
125558943|NCT01621542|451679127|FG000|Overall Study|Withdrawal by Subject|2|||
125558944|NCT01621542|451679128|FG001|Overall Study|Withdrawal by Subject|0|||
125558945|NCT01621542|451679129|FG002|Overall Study|Withdrawal by Subject|1|||
125558946|NCT01621542|451679130|FG003|Overall Study|Withdrawal by Subject|3|||
125558947|NCT01621542|451679131|FG004|Overall Study|Withdrawal by Subject|3|||
125558948|NCT01621542|451679132|FG005|Overall Study|Withdrawal by Subject|3|||
125558949|NCT01621542|451679127|FG000|Overall Study|progression/treatment failure|2|||
125558950|NCT01621542|451679128|FG001|Overall Study|progression/treatment failure|4|||
125558951|NCT01621542|451679129|FG002|Overall Study|progression/treatment failure|3|||
125558952|NCT01621542|451679130|FG003|Overall Study|progression/treatment failure|7|||
125558953|NCT01621542|451679131|FG004|Overall Study|progression/treatment failure|3|||
125558954|NCT01621542|451679132|FG005|Overall Study|progression/treatment failure|5|||
125558955|NCT01621542|451679127|FG000|Overall Study|Protocol Violation|0|||
125558956|NCT01621542|451679128|FG001|Overall Study|Protocol Violation|0|||
125558957|NCT01621542|451679129|FG002|Overall Study|Protocol Violation|0|||
125558958|NCT01621542|451679130|FG003|Overall Study|Protocol Violation|1|||
125558959|NCT01621542|451679131|FG004|Overall Study|Protocol Violation|0|||
125558960|NCT01621542|451679132|FG005|Overall Study|Protocol Violation|0|||
125558961|NCT01621542|451679127|FG000|Overall Study|study stopped by sponsor|0|||
125558962|NCT01621542|451679128|FG001|Overall Study|study stopped by sponsor|0|||
125558963|NCT01621542|451679129|FG002|Overall Study|study stopped by sponsor|0|||
125558964|NCT01621542|451679130|FG003|Overall Study|study stopped by sponsor|1|||
125558965|NCT01621542|451679131|FG004|Overall Study|study stopped by sponsor|0|||
125558966|NCT01621542|451679132|FG005|Overall Study|study stopped by sponsor|0|||
125558967|NCT00955279|451679133|FG000|Overall Study|Other|0|||
125558968|NCT00955279|451679134|FG001|Overall Study|Other|0|||
125558969|NCT00955279|451679135|FG002|Overall Study|Other|3|||
125558970|NCT00955279|451679133|FG000|Overall Study|Death|1|||
125558971|NCT00955279|451679134|FG001|Overall Study|Death|1|||
125558972|NCT00955279|451679135|FG002|Overall Study|Death|1|||
125558973|NCT00955279|451679133|FG000|Overall Study|Lost to Follow-up|0|||
125558974|NCT00955279|451679134|FG001|Overall Study|Lost to Follow-up|3|||
125558975|NCT00955279|451679135|FG002|Overall Study|Lost to Follow-up|1|||
125558976|NCT00955279|451679133|FG000|Overall Study|Withdrawal by Subject|2|||
125558977|NCT00955279|451679134|FG001|Overall Study|Withdrawal by Subject|0|||
125558978|NCT00955279|451679135|FG002|Overall Study|Withdrawal by Subject|3|||
125558979|NCT01368042|451679136|FG000|Overall Study|Death|14|||
125558980|NCT01368042|451679136|FG000|Overall Study|Protocol Violation|11|||
125558981|NCT01368042|451679136|FG000|Overall Study|Lost to Follow-up|4|||
125558982|NCT01368042|451679136|FG000|Overall Study|Transplanted|1|||
125558983|NCT02632721|451679140|FG000|Overall Study|Adverse Event|0|||
125558984|NCT02632721|451679141|FG001|Overall Study|Adverse Event|0|||
125558985|NCT02632721|451679142|FG002|Overall Study|Adverse Event|2|||
125558986|NCT02632721|451679143|FG003|Overall Study|Adverse Event|5|||
125558987|NCT02632721|451679144|FG004|Overall Study|Adverse Event|3|||
125558988|NCT02632721|451679140|FG000|Overall Study|Dose limiting toxicity|0|||
125558989|NCT02632721|451679141|FG001|Overall Study|Dose limiting toxicity|0|||
125558990|NCT02632721|451679142|FG002|Overall Study|Dose limiting toxicity|0|||
125558991|NCT02632721|451679143|FG003|Overall Study|Dose limiting toxicity|1|||
125558992|NCT02632721|451679144|FG004|Overall Study|Dose limiting toxicity|0|||
125558993|NCT02632721|451679140|FG000|Overall Study|Progressive disease|3|||
125558994|NCT02632721|451679141|FG001|Overall Study|Progressive disease|0|||
125558995|NCT02632721|451679142|FG002|Overall Study|Progressive disease|4|||
125558996|NCT02632721|451679143|FG003|Overall Study|Progressive disease|6|||
125558997|NCT02632721|451679144|FG004|Overall Study|Progressive disease|5|||
125558998|NCT02632721|451679140|FG000|Overall Study|Refused to continue taking trial medication|0|||
125558999|NCT02632721|451679141|FG001|Overall Study|Refused to continue taking trial medication|1|||
125559000|NCT02632721|451679142|FG002|Overall Study|Refused to continue taking trial medication|1|||
125559001|NCT02632721|451679143|FG003|Overall Study|Refused to continue taking trial medication|1|||
125559002|NCT02632721|451679144|FG004|Overall Study|Refused to continue taking trial medication|2|||
125353389|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
125559003|NCT02632721|451679140|FG000|Overall Study|Inadequate clinical condition|0|||
125559004|NCT02632721|451679141|FG001|Overall Study|Inadequate clinical condition|0|||
125559005|NCT02632721|451679142|FG002|Overall Study|Inadequate clinical condition|0|||
125559006|NCT02632721|451679143|FG003|Overall Study|Inadequate clinical condition|0|||
125559007|NCT02632721|451679144|FG004|Overall Study|Inadequate clinical condition|1|||
125559008|NCT02632721|451679140|FG000|Overall Study|No meet eligibility|0|||
125559009|NCT02632721|451679141|FG001|Overall Study|No meet eligibility|0|||
125559010|NCT02632721|451679142|FG002|Overall Study|No meet eligibility|0|||
125559011|NCT02632721|451679143|FG003|Overall Study|No meet eligibility|0|||
125559012|NCT02632721|451679144|FG004|Overall Study|No meet eligibility|1|||
125559013|NCT02632721|451679140|FG000|Overall Study|Allergic reaction|0|||
125559014|NCT02632721|451679141|FG001|Overall Study|Allergic reaction|0|||
125559015|NCT02632721|451679142|FG002|Overall Study|Allergic reaction|0|||
125559016|NCT02632721|451679143|FG003|Overall Study|Allergic reaction|1|||
125559017|NCT02632721|451679144|FG004|Overall Study|Allergic reaction|0|||
125559018|NCT02632721|451679140|FG000|Overall Study|Receiving Decitabine locally|0|||
125559019|NCT02632721|451679141|FG001|Overall Study|Receiving Decitabine locally|0|||
125559020|NCT02632721|451679142|FG002|Overall Study|Receiving Decitabine locally|1|||
125559021|NCT02632721|451679143|FG003|Overall Study|Receiving Decitabine locally|0|||
125559022|NCT02632721|451679144|FG004|Overall Study|Receiving Decitabine locally|0|||
125559023|NCT02632721|451679140|FG000|Overall Study|No benefit from study treatment|1|||
125559024|NCT02632721|451679141|FG001|Overall Study|No benefit from study treatment|1|||
125559025|NCT02632721|451679142|FG002|Overall Study|No benefit from study treatment|0|||
125559026|NCT02632721|451679143|FG003|Overall Study|No benefit from study treatment|0|||
125559027|NCT02632721|451679144|FG004|Overall Study|No benefit from study treatment|1|||
125559028|NCT02632721|451679140|FG000|Overall Study|Patient wish for other treatment|0|||
125559029|NCT02632721|451679141|FG001|Overall Study|Patient wish for other treatment|1|||
125559030|NCT02632721|451679142|FG002|Overall Study|Patient wish for other treatment|0|||
125559031|NCT02632721|451679143|FG003|Overall Study|Patient wish for other treatment|0|||
125559032|NCT02632721|451679144|FG004|Overall Study|Patient wish for other treatment|0|||
125559033|NCT02632721|451679140|FG000|Overall Study|Relapsed Pneumonia|0|||
125559034|NCT02632721|451679141|FG001|Overall Study|Relapsed Pneumonia|0|||
125559035|NCT02632721|451679142|FG002|Overall Study|Relapsed Pneumonia|0|||
125559036|NCT02632721|451679143|FG003|Overall Study|Relapsed Pneumonia|0|||
125559037|NCT02632721|451679144|FG004|Overall Study|Relapsed Pneumonia|1|||
125559038|NCT02632721|451679140|FG000|Overall Study|Therapy refractory AML|0|||
125559039|NCT02632721|451679141|FG001|Overall Study|Therapy refractory AML|0|||
125559040|NCT02632721|451679142|FG002|Overall Study|Therapy refractory AML|0|||
125559041|NCT02632721|451679143|FG003|Overall Study|Therapy refractory AML|0|||
125559042|NCT02632721|451679144|FG004|Overall Study|Therapy refractory AML|1|||
125559043|NCT02632721|451679140|FG000|Overall Study|Increase of white blood cell count|0|||
125559044|NCT02632721|451679141|FG001|Overall Study|Increase of white blood cell count|0|||
125559045|NCT02632721|451679142|FG002|Overall Study|Increase of white blood cell count|0|||
125559046|NCT02632721|451679143|FG003|Overall Study|Increase of white blood cell count|0|||
125559047|NCT02632721|451679144|FG004|Overall Study|Increase of white blood cell count|1|||
125559048|NCT02632721|451679140|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
125559049|NCT02632721|451679141|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
125559050|NCT02632721|451679142|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
125559051|NCT02632721|451679143|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
125559052|NCT02632721|451679144|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
125559053|NCT00544648|451679148|FG000|Overall Study|Withdrawal by Subject|1|||
125559054|NCT00544648|451679149|FG001|Overall Study|Withdrawal by Subject|0|||
125559055|NCT00544648|451679148|FG000|Overall Study|Adverse Event|1|||
125559056|NCT00544648|451679149|FG001|Overall Study|Adverse Event|1|||
125559057|NCT00544648|451679148|FG000|Overall Study|progression of disease|1|||
125559058|NCT00544648|451679149|FG001|Overall Study|progression of disease|0|||
125559059|NCT02663271|451679150|FG000|Overall Study|Withdrawal by Subject|5|||
125559060|NCT02663271|451679150|FG000|Overall Study|Lack of Efficacy|1|||
125559061|NCT01235793|451679151|FG000|Overall Study|Death|6|||
125559062|NCT04166383|451679157|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
125559063|NCT04166383|451679157|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
125559064|NCT04166383|451679157|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
125559065|NCT03044886|451679159|FG000|Overall Study|Lost to Follow-up|15|||
125559066|NCT03044886|451679160|FG001|Overall Study|Lost to Follow-up|10|||
125353390|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
125353391|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
125353392|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
125559067|NCT03044886|451679161|FG002|Overall Study|Lost to Follow-up|12|||
125559068|NCT02921269|451679162|FG000|Overall Study|Did not complete DLT period|1|||
125559069|NCT02054325|451679173|FG000|Overall Study|Lost to Follow-up|8|||
125559070|NCT02054325|451679174|FG001|Overall Study|Lost to Follow-up|5|||
125559071|NCT00504153|451679181|FG000|Overall Study|Withdrawal by Subject|1|||
125559072|NCT00504153|451679181|FG000|Overall Study|Adverse Event|4|||
125559073|NCT00504153|451679181|FG000|Overall Study|Death|1|||
125559074|NCT00074581|451679183|FG000|Overall Study|Death|15|||
125559075|NCT00074581|451679184|FG001|Overall Study|Death|16|||
125559076|NCT00074581|451679183|FG000|Overall Study|Withdrawal by Subject|50|||
125559077|NCT00074581|451679184|FG001|Overall Study|Withdrawal by Subject|49|||
125559078|NCT00074581|451679183|FG000|Overall Study|Unable to adhere to visit schedule|13|||
125559079|NCT00074581|451679184|FG001|Overall Study|Unable to adhere to visit schedule|14|||
125559080|NCT00074581|451679183|FG000|Overall Study|Relocated|14|||
125559081|NCT00074581|451679184|FG001|Overall Study|Relocated|9|||
125559082|NCT00074581|451679183|FG000|Overall Study|Were withdrawn by investigator|5|||
125559083|NCT00074581|451679184|FG001|Overall Study|Were withdrawn by investigator|2|||
125559084|NCT00074581|451679183|FG000|Overall Study|Lost to Follow-up|16|||
125559085|NCT00074581|451679184|FG001|Overall Study|Lost to Follow-up|11|||
125559086|NCT00074581|451679183|FG000|Overall Study|Ended relationship w. index participant|117|||
125559087|NCT00074581|451679184|FG001|Overall Study|Ended relationship w. index participant|106|||
125559088|NCT00074581|451679183|FG000|Overall Study|Other|14|||
125559089|NCT00074581|451679184|FG001|Overall Study|Other|19|||
125559090|NCT02322229|451679188|FG000|Overall Study|Physician Decision|2|||
125559091|NCT03250832|451679189|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
125559092|NCT03250832|451679190|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
125559093|NCT03250832|451679191|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
125559094|NCT03250832|451679192|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
125559095|NCT03250832|451679193|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
125559096|NCT03250832|451679194|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
125559097|NCT03250832|451679195|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
125559098|NCT03250832|451679196|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
125559099|NCT03250832|451679197|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
125559100|NCT03250832|451679198|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
125559101|NCT03250832|451679199|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
125559102|NCT03250832|451679200|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
125559103|NCT03250832|451679189|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
125559104|NCT03250832|451679190|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
125559105|NCT03250832|451679191|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
125559106|NCT03250832|451679192|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
125559107|NCT03250832|451679193|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
125559108|NCT03250832|451679194|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
125353393|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
125353394|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
125559109|NCT03250832|451679195|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
125559110|NCT03250832|451679196|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
125559111|NCT03250832|451679197|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
125559112|NCT03250832|451679198|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
125559113|NCT03250832|451679199|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
125559114|NCT03250832|451679200|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
125559115|NCT03250832|451679189|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125559116|NCT03250832|451679190|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125559117|NCT03250832|451679191|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
125559118|NCT03250832|451679192|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125559119|NCT03250832|451679193|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125559120|NCT03250832|451679194|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125559121|NCT03250832|451679195|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125559122|NCT03250832|451679196|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125559123|NCT03250832|451679197|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125559124|NCT03250832|451679198|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125559125|NCT03250832|451679199|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125559126|NCT03250832|451679200|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
125559127|NCT03250832|451679189|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
125559128|NCT03250832|451679190|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
125559129|NCT03250832|451679191|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
125559130|NCT03250832|451679192|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
125559131|NCT03250832|451679193|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
125559132|NCT03250832|451679194|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
125559133|NCT03250832|451679195|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
125559134|NCT03250832|451679196|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
125559135|NCT03250832|451679197|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
125559136|NCT03250832|451679198|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
125559137|NCT03250832|451679199|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
125559138|NCT03250832|451679200|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
125559139|NCT03250832|451679189|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125559140|NCT03250832|451679190|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125559141|NCT03250832|451679191|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125559142|NCT03250832|451679192|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125559143|NCT03250832|451679193|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125559144|NCT03250832|451679194|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125559145|NCT03250832|451679195|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125559146|NCT03250832|451679196|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
125559147|NCT03250832|451679197|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125559148|NCT03250832|451679198|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125559149|NCT03250832|451679199|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125559150|NCT03250832|451679200|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
125559151|NCT03250832|451679189|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125559152|NCT03250832|451679190|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125559153|NCT03250832|451679191|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125559154|NCT03250832|451679192|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125559155|NCT03250832|451679193|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125559156|NCT03250832|451679194|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125559157|NCT03250832|451679195|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125559158|NCT03250832|451679196|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
125559159|NCT03250832|451679197|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125559160|NCT03250832|451679198|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125559161|NCT03250832|451679199|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125559162|NCT03250832|451679200|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
125559163|NCT03250832|451679189|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125559164|NCT03250832|451679190|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125559165|NCT03250832|451679191|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125559166|NCT03250832|451679192|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125559167|NCT03250832|451679193|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125559168|NCT03250832|451679194|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125559169|NCT03250832|451679195|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125559170|NCT03250832|451679196|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
125559171|NCT03250832|451679197|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125559172|NCT03250832|451679198|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125559173|NCT03250832|451679199|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125559174|NCT03250832|451679200|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
125559175|NCT03250832|451679189|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
125559176|NCT03250832|451679190|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
125559177|NCT03250832|451679191|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
125559178|NCT03250832|451679192|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
125559179|NCT03250832|451679193|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
125559180|NCT03250832|451679194|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
125559181|NCT03250832|451679195|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
125559182|NCT03250832|451679196|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
125559183|NCT03250832|451679197|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
125559184|NCT03250832|451679198|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
125559185|NCT03250832|451679199|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
125559186|NCT03250832|451679200|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
125559187|NCT03250832|451679189|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
125559188|NCT03250832|451679190|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
125559189|NCT03250832|451679191|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
125559190|NCT03250832|451679192|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
125559191|NCT03250832|451679193|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
125559192|NCT03250832|451679194|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
125559193|NCT03250832|451679195|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
125559194|NCT03250832|451679196|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
125559195|NCT03250832|451679197|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
125559196|NCT03250832|451679198|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
125559197|NCT03250832|451679199|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
125559198|NCT03250832|451679200|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
125559199|NCT03250832|451679189|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125559200|NCT03250832|451679190|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125559201|NCT03250832|451679191|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125559202|NCT03250832|451679192|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125559203|NCT03250832|451679193|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125559204|NCT03250832|451679194|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125559205|NCT03250832|451679195|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125559206|NCT03250832|451679196|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125559207|NCT03250832|451679197|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
125559208|NCT03250832|451679198|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
125559209|NCT03250832|451679199|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125559210|NCT03250832|451679200|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
125559211|NCT03250832|451679189|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125559212|NCT03250832|451679190|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125559213|NCT03250832|451679191|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125559214|NCT03250832|451679192|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125559215|NCT03250832|451679193|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125559216|NCT03250832|451679194|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125559217|NCT03250832|451679195|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125559218|NCT03250832|451679196|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125559219|NCT03250832|451679197|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
125559220|NCT03250832|451679198|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
125559221|NCT03250832|451679199|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125559222|NCT03250832|451679200|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
125559223|NCT03250832|451679189|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125559224|NCT03250832|451679190|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125559225|NCT03250832|451679191|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125559226|NCT03250832|451679192|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125559227|NCT03250832|451679193|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125559228|NCT03250832|451679194|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125559229|NCT03250832|451679195|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125559230|NCT03250832|451679196|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125559231|NCT03250832|451679197|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125559232|NCT03250832|451679198|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125559233|NCT03250832|451679199|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
125559234|NCT03250832|451679200|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
125559235|NCT00617604|451679201|FG000|Overall Study|Death|2|||
125559236|NCT00617604|451679202|FG001|Overall Study|Death|1|||
125559237|NCT00617604|451679201|FG000|Overall Study|Lost to Follow-up|1|||
125559238|NCT00617604|451679202|FG001|Overall Study|Lost to Follow-up|0|||
125559239|NCT00617604|451679201|FG000|Overall Study|Miscellaneous Reasons|8|||
125559240|NCT00617604|451679202|FG001|Overall Study|Miscellaneous Reasons|10|||
125559241|NCT00617604|451679201|FG000|Overall Study|Withdrawal by Subject|4|||
125559242|NCT00617604|451679202|FG001|Overall Study|Withdrawal by Subject|6|||
125559243|NCT00617604|451679201|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
125559244|NCT00617604|451679202|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
125559245|NCT02303704|451679203|FG000|Overall Study|Protocol Violation|5|||
125559246|NCT02303704|451679204|FG001|Overall Study|Protocol Violation|9|||
125559247|NCT00705432|451679207|FG000|Treatment Period|Adverse Event|45|||
125559248|NCT00705432|451679208|FG001|Treatment Period|Adverse Event|37|||
125559249|NCT00705432|451679209|FG002|Treatment Period|Adverse Event|51|||
125559250|NCT00705432|451679210|FG003|Treatment Period|Adverse Event|12|||
125559251|NCT00705432|451679211|FG004|Treatment Period|Adverse Event|8|||
125559252|NCT00705432|451679212|FG005|Treatment Period|Adverse Event|9|||
125559253|NCT00705432|451679207|FG000|Treatment Period|Treatment failure|92|||
125559254|NCT00705432|451679208|FG001|Treatment Period|Treatment failure|42|||
125559255|NCT00705432|451679209|FG002|Treatment Period|Treatment failure|33|||
125559256|NCT00705432|451679210|FG003|Treatment Period|Treatment failure|25|||
125559257|NCT00705432|451679211|FG004|Treatment Period|Treatment failure|13|||
125559258|NCT00705432|451679212|FG005|Treatment Period|Treatment failure|14|||
125559259|NCT00705432|451679207|FG000|Treatment Period|Non medical reason|26|||
125559260|NCT00705432|451679208|FG001|Treatment Period|Non medical reason|32|||
125559261|NCT00705432|451679209|FG002|Treatment Period|Non medical reason|37|||
125559262|NCT00705432|451679210|FG003|Treatment Period|Non medical reason|4|||
125559263|NCT00705432|451679211|FG004|Treatment Period|Non medical reason|7|||
125559264|NCT00705432|451679212|FG005|Treatment Period|Non medical reason|7|||
125559265|NCT00705432|451679207|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
125559266|NCT00705432|451679208|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
125559267|NCT00705432|451679209|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
125559268|NCT00705432|451679210|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
125559269|NCT00705432|451679211|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
125559270|NCT00705432|451679212|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
125559271|NCT00705432|451679207|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
125559272|NCT00705432|451679208|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
125559273|NCT00705432|451679209|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
125559274|NCT00705432|451679210|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
125426190|NCT04493931|451184395|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
125426191|NCT04493931|451184396|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
125426192|NCT04493931|451184397|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
125426193|NCT04493931|451184398|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
125426194|NCT04493931|451184399|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
125426195|NCT04493931|451184400|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
125426196|NCT04493931|451184401|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
125426197|NCT00420199|451184402|FG000|Overall Study|Participant no longer met study criteria|1|||
125426198|NCT00420199|451184403|FG001|Overall Study|Participant no longer met study criteria|0|||
125426199|NCT00266825|451184404|FG000|Completed Follow-Up|Lost to Follow-up|14|||
125426200|NCT00266825|451184405|FG001|Completed Follow-Up|Lost to Follow-up|19|||
125426201|NCT00266825|451184404|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
125426202|NCT00266825|451184405|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
125426203|NCT03466086|451184412|FG000|Period 1|Sponsor decision due to study timeline|1|||
125559275|NCT00705432|451679211|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
125559276|NCT00705432|451679212|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
125559277|NCT04411628|451679213|FG000|Overall Study|Withdrawal by Subject|1|||
125559278|NCT04411628|451679214|FG001|Overall Study|Withdrawal by Subject|1|||
125559279|NCT04411628|451679215|FG002|Overall Study|Withdrawal by Subject|2|||
125559280|NCT04411628|451679216|FG003|Overall Study|Withdrawal by Subject|0|||
125559281|NCT04411628|451679213|FG000|Overall Study|Lost to Follow-up|0|||
125559282|NCT04411628|451679214|FG001|Overall Study|Lost to Follow-up|1|||
125559283|NCT04411628|451679215|FG002|Overall Study|Lost to Follow-up|0|||
125559284|NCT04411628|451679216|FG003|Overall Study|Lost to Follow-up|0|||
125559285|NCT00732251|451679217|FG000|Overall Study|Lost to Follow-up|3|||
125559286|NCT00732251|451679217|FG000|Overall Study|Withdrawal by Subject|3|||
125559287|NCT00732251|451679217|FG000|Overall Study|Early Term due to Site Closure|1|||
125559288|NCT00521053|451679218|FG000|Observation Phase|Disease Progression|55|||
125559289|NCT00521053|451679218|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
125559290|NCT00521053|451679218|FG000|Observation Phase|Death|2|||
125559291|NCT00521053|451679218|FG000|Observation Phase|Adverse Event|1|||
125559292|NCT00521053|451679218|FG000|Observation Phase|Other non-study melanoma treatment|1|||
125559293|NCT00521053|451679218|FG000|Observation Phase|Physician Decision|1|||
125559294|NCT01034540|451679219|FG000|Overall Study|Adverse Event|0|||
125559295|NCT01034540|451679220|FG001|Overall Study|Adverse Event|1|||
125559296|NCT03519867|451679223|FG000|Overall Study|Adverse Event|1|||
125559297|NCT03519867|451679224|FG001|Overall Study|Adverse Event|1|||
125559298|NCT03519867|451679225|FG002|Overall Study|Adverse Event|0|||
125559299|NCT03519867|451679226|FG003|Overall Study|Adverse Event|0|||
125559300|NCT03519867|451679227|FG004|Overall Study|Adverse Event|0|||
125559301|NCT03519867|451679228|FG005|Overall Study|Adverse Event|0|||
125559302|NCT03519867|451679229|FG006|Overall Study|Adverse Event|0|||
125559303|NCT03519867|451679230|FG007|Overall Study|Adverse Event|0|||
125559304|NCT03519867|451679231|FG008|Overall Study|Adverse Event|0|||
125559305|NCT03519867|451679232|FG009|Overall Study|Adverse Event|0|||
125559306|NCT03519867|451679223|FG000|Overall Study|Protocol Violation|0|||
125559307|NCT03519867|451679224|FG001|Overall Study|Protocol Violation|0|||
125559308|NCT03519867|451679225|FG002|Overall Study|Protocol Violation|0|||
125559309|NCT03519867|451679226|FG003|Overall Study|Protocol Violation|0|||
125559310|NCT03519867|451679227|FG004|Overall Study|Protocol Violation|0|||
125559311|NCT03519867|451679228|FG005|Overall Study|Protocol Violation|1|||
125559312|NCT03519867|451679229|FG006|Overall Study|Protocol Violation|0|||
125559313|NCT03519867|451679230|FG007|Overall Study|Protocol Violation|0|||
125559314|NCT03519867|451679231|FG008|Overall Study|Protocol Violation|0|||
125559315|NCT03519867|451679232|FG009|Overall Study|Protocol Violation|0|||
125559316|NCT03519867|451679223|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125559317|NCT03519867|451679224|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125559318|NCT03519867|451679225|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125559319|NCT03519867|451679226|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125559320|NCT03519867|451679227|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125559321|NCT03519867|451679228|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125559322|NCT03519867|451679229|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
125559323|NCT03519867|451679230|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125559324|NCT03519867|451679231|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125559325|NCT03519867|451679232|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
125559326|NCT03519867|451679223|FG000|Overall Study|Admin. of other reversal agent|1|||
125559327|NCT03519867|451679224|FG001|Overall Study|Admin. of other reversal agent|1|||
125559328|NCT03519867|451679225|FG002|Overall Study|Admin. of other reversal agent|0|||
125559329|NCT03519867|451679226|FG003|Overall Study|Admin. of other reversal agent|0|||
125559330|NCT03519867|451679227|FG004|Overall Study|Admin. of other reversal agent|0|||
125559331|NCT03519867|451679228|FG005|Overall Study|Admin. of other reversal agent|1|||
125559332|NCT03519867|451679229|FG006|Overall Study|Admin. of other reversal agent|0|||
125559333|NCT03519867|451679230|FG007|Overall Study|Admin. of other reversal agent|0|||
125559334|NCT03519867|451679231|FG008|Overall Study|Admin. of other reversal agent|0|||
125559335|NCT03519867|451679232|FG009|Overall Study|Admin. of other reversal agent|0|||
125559336|NCT03519867|451679223|FG000|Overall Study|Reason not provided|1|||
125559337|NCT03519867|451679224|FG001|Overall Study|Reason not provided|1|||
125559338|NCT03519867|451679225|FG002|Overall Study|Reason not provided|1|||
125559339|NCT03519867|451679226|FG003|Overall Study|Reason not provided|1|||
125559340|NCT03519867|451679227|FG004|Overall Study|Reason not provided|0|||
125559341|NCT03519867|451679228|FG005|Overall Study|Reason not provided|1|||
125559342|NCT03519867|451679229|FG006|Overall Study|Reason not provided|0|||
125559343|NCT03519867|451679230|FG007|Overall Study|Reason not provided|1|||
125559344|NCT03519867|451679231|FG008|Overall Study|Reason not provided|1|||
125559345|NCT03519867|451679232|FG009|Overall Study|Reason not provided|0|||
125559346|NCT01252810|451679233|FG000|Overall Study|Withdrawal by Subject|4|||
125559347|NCT01252810|451679234|FG001|Overall Study|Withdrawal by Subject|1|||
125559348|NCT01252810|451679233|FG000|Overall Study|Lost to Follow-up|0|||
125559349|NCT01252810|451679234|FG001|Overall Study|Lost to Follow-up|1|||
125559350|NCT01252810|451679233|FG000|Overall Study|Physician Decision|2|||
125559351|NCT01252810|451679234|FG001|Overall Study|Physician Decision|1|||
125559352|NCT01252810|451679233|FG000|Overall Study|Various reasons|8|||
125559353|NCT01252810|451679234|FG001|Overall Study|Various reasons|0|||
125559354|NCT05162027|451680817|FG000|Overall Study|Adverse Event|1|||
125559355|NCT05162027|451680818|FG001|Overall Study|Adverse Event|0|||
125559356|NCT02767323|451680822|FG000|Overall Study|Withdrawal by Subject|17|||
125559357|NCT02767323|451680823|FG001|Overall Study|Withdrawal by Subject|5|||
125559358|NCT02767323|451680824|FG002|Overall Study|Withdrawal by Subject|13|||
125559359|NCT02767323|451680825|FG003|Overall Study|Withdrawal by Subject|0|||
125559360|NCT02767323|451680822|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
125559361|NCT02767323|451680823|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
125559362|NCT02767323|451680824|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
125559363|NCT02767323|451680825|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
125559364|NCT01641237|451680827|FG000|Period II|Withdrawal by Subject|1|||
125559365|NCT01641237|451680828|FG001|Period II|Withdrawal by Subject|0|||
125559366|NCT01641237|451680829|FG002|Period II|Withdrawal by Subject|0|||
125559367|NCT01641237|451680830|FG003|Period II|Withdrawal by Subject|0|||
125559368|NCT01641237|451680827|FG000|Period III|Lost to Follow-up|1|||
125559369|NCT01641237|451680828|FG001|Period III|Lost to Follow-up|0|||
125559370|NCT01641237|451680829|FG002|Period III|Lost to Follow-up|0|||
125559371|NCT01641237|451680830|FG003|Period III|Lost to Follow-up|0|||
125559372|NCT03593850|451680835|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
125559373|NCT03593850|451680836|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
125559374|NCT01735279|451680837|FG000|Overall Study|Lost to Follow-up|11|||
125559375|NCT01735279|451680838|FG001|Overall Study|Lost to Follow-up|8|||
125559376|NCT05097716|451680843|FG000|Period 1|Adverse Event|1|||
125559377|NCT05097716|451680843|FG000|Period 1|Close contact with highly-transmissible infection|1|||
125559378|NCT00922480|451680851|FG000|Main Study|Protocol Violation|3|||
125559379|NCT00922480|451680852|FG001|Main Study|Protocol Violation|6|||
125559380|NCT00922480|451680851|FG000|Main Study|Adverse Event|6|||
125559381|NCT00922480|451680852|FG001|Main Study|Adverse Event|7|||
125559382|NCT00922480|451680851|FG000|Main Study|Lack of Efficacy|3|||
125559383|NCT00922480|451680852|FG001|Main Study|Lack of Efficacy|0|||
125559384|NCT00922480|451680851|FG000|Main Study|Withdrawal by Subject|20|||
125559385|NCT00922480|451680852|FG001|Main Study|Withdrawal by Subject|15|||
125559386|NCT00922480|451680851|FG000|Main Study|Lost to Follow-up|5|||
125559387|NCT00922480|451680852|FG001|Main Study|Lost to Follow-up|0|||
125559388|NCT00922480|451680851|FG000|Main Study|Physician Decision|0|||
125559389|NCT00922480|451680852|FG001|Main Study|Physician Decision|1|||
125559390|NCT00922480|451680851|FG000|Extension Study|Protocol Violation|3|||
125559391|NCT00922480|451680852|FG001|Extension Study|Protocol Violation|0|||
125559392|NCT00922480|451680851|FG000|Extension Study|Adverse Event|1|||
125559393|NCT00922480|451680852|FG001|Extension Study|Adverse Event|1|||
125559394|NCT00922480|451680851|FG000|Extension Study|Withdrawal by Subject|1|||
125559395|NCT00922480|451680852|FG001|Extension Study|Withdrawal by Subject|1|||
125559396|NCT00922480|451680851|FG000|Extension Study|Others|0|||
125559397|NCT00922480|451680852|FG001|Extension Study|Others|1|||
125559398|NCT01011439|451680853|FG000|Overall Study|Death|37|||
125559399|NCT01011439|451680853|FG000|Overall Study|Lost to Follow-up|4|||
125559400|NCT01011439|451680853|FG000|Overall Study|Withdrawal by Subject|1|||
125559401|NCT01011439|451680853|FG000|Overall Study|Sponsor's decision|15|||
125559402|NCT01372150|451680854|FG000|Overall Study|Lack of Efficacy|3|||
125559403|NCT01372150|451680855|FG001|Overall Study|Lack of Efficacy|0|||
125559404|NCT01372150|451680856|FG002|Overall Study|Lack of Efficacy|1|||
125559405|NCT01372150|451680854|FG000|Overall Study|Lost to Follow-up|4|||
125559406|NCT01372150|451680855|FG001|Overall Study|Lost to Follow-up|5|||
125559407|NCT01372150|451680856|FG002|Overall Study|Lost to Follow-up|6|||
125559408|NCT01372150|451680854|FG000|Overall Study|Protocol Violation|1|||
125559409|NCT01372150|451680855|FG001|Overall Study|Protocol Violation|0|||
125559410|NCT01372150|451680856|FG002|Overall Study|Protocol Violation|3|||
125559411|NCT01372150|451680854|FG000|Overall Study|Withdrawal by Subject|2|||
125559412|NCT01372150|451680855|FG001|Overall Study|Withdrawal by Subject|7|||
125559413|NCT01372150|451680856|FG002|Overall Study|Withdrawal by Subject|2|||
125559414|NCT01372150|451680854|FG000|Overall Study|Other|1|||
125559415|NCT01372150|451680855|FG001|Overall Study|Other|0|||
125559416|NCT01372150|451680856|FG002|Overall Study|Other|2|||
125559417|NCT01372150|451680854|FG000|Overall Study|Adverse Event|2|||
125559418|NCT01372150|451680855|FG001|Overall Study|Adverse Event|1|||
125559419|NCT01372150|451680856|FG002|Overall Study|Adverse Event|2|||
125559420|NCT01372150|451680854|FG000|Overall Study|Randomized but not treated|0|||
125559421|NCT01372150|451680855|FG001|Overall Study|Randomized but not treated|1|||
125559422|NCT01372150|451680856|FG002|Overall Study|Randomized but not treated|0|||
125559423|NCT00536809|451680857|FG000|Phase II|Adverse Event|1|||
125559424|NCT00536809|451680857|FG000|Phase II|Referred for surgical resection|1|||
125559425|NCT01526551|451680858|FG000|Overall Study|Lack of returned parental consent form|424|||
125559426|NCT05215262|451680859|FG000|Overall Study|Lost to Follow-up|12|||
125559427|NCT05215262|451680860|FG001|Overall Study|Lost to Follow-up|0|||
125559428|NCT00718549|451680865|FG000|Induction Phase|Disease Progression|1|||
125559429|NCT00718549|451680866|FG001|Induction Phase|Disease Progression|0|||
125559430|NCT00718549|451680867|FG002|Induction Phase|Disease Progression|0|||
125559431|NCT00718549|451680865|FG000|Induction Phase|Eligibility Criteria Violation|2|||
125559432|NCT00718549|451680866|FG001|Induction Phase|Eligibility Criteria Violation|0|||
125559433|NCT00718549|451680867|FG002|Induction Phase|Eligibility Criteria Violation|0|||
125559434|NCT00718549|451680865|FG000|Induction Phase|Early Termination - No Additional Info|59|||
125559435|NCT00718549|451680866|FG001|Induction Phase|Early Termination - No Additional Info|0|||
125559436|NCT00718549|451680867|FG002|Induction Phase|Early Termination - No Additional Info|0|||
125559437|NCT00718549|451680865|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
125559438|NCT00718549|451680866|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
125559439|NCT00718549|451680867|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
125559440|NCT00718549|451680865|FG000|Maintenance/ Observation Phase|Death|0|||
125559441|NCT00718549|451680866|FG001|Maintenance/ Observation Phase|Death|1|||
125559442|NCT00718549|451680867|FG002|Maintenance/ Observation Phase|Death|2|||
125559443|NCT00718549|451680865|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
125559444|NCT00718549|451680866|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
125559445|NCT00718549|451680867|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
125559446|NCT00718549|451680865|FG000|Maintenance/ Observation Phase|Progression|0|||
125559447|NCT00718549|451680866|FG001|Maintenance/ Observation Phase|Progression|5|||
125559448|NCT00718549|451680867|FG002|Maintenance/ Observation Phase|Progression|14|||
125559449|NCT00718549|451680865|FG000|Maintenance/ Observation Phase|Relapse|0|||
125559450|NCT00718549|451680866|FG001|Maintenance/ Observation Phase|Relapse|3|||
125559451|NCT00718549|451680867|FG002|Maintenance/ Observation Phase|Relapse|2|||
125559452|NCT01353508|451680868|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
125559453|NCT01353508|451680869|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
125559454|NCT01353508|451680870|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
125559455|NCT01353508|451680871|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
125559456|NCT01353508|451680868|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
125559457|NCT01353508|451680869|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
125559458|NCT01353508|451680870|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
125559459|NCT01353508|451680871|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
125559460|NCT02606461|451680872|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
125559461|NCT02606461|451680873|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
125559462|NCT02606461|451680874|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
125559463|NCT02606461|451680875|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
125559464|NCT02606461|451680876|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
125559465|NCT02606461|451680877|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
125559466|NCT02092350|451680882|FG000|Overall Study|Adverse Event|0|||
125559467|NCT02092350|451680883|FG001|Overall Study|Adverse Event|3|||
125559468|NCT02092350|451680882|FG000|Overall Study|Death|2|||
125559469|NCT02092350|451680883|FG001|Overall Study|Death|5|||
125559470|NCT02092350|451680882|FG000|Overall Study|Lost to Follow-up|3|||
125559471|NCT02092350|451680883|FG001|Overall Study|Lost to Follow-up|1|||
125559472|NCT02092350|451680882|FG000|Overall Study|Protocol Violation|1|||
125559473|NCT02092350|451680883|FG001|Overall Study|Protocol Violation|0|||
125559474|NCT02092350|451680882|FG000|Overall Study|Physician Decision|1|||
125559475|NCT02092350|451680883|FG001|Overall Study|Physician Decision|1|||
125559476|NCT02092350|451680882|FG000|Overall Study|Screen Failure|1|||
125559477|NCT02092350|451680883|FG001|Overall Study|Screen Failure|0|||
125559478|NCT02092350|451680882|FG000|Overall Study|Withdrawal by Subject|2|||
125559479|NCT02092350|451680883|FG001|Overall Study|Withdrawal by Subject|2|||
125559480|NCT00239226|451680884|FG000|Overall Study|permAF during stabilization period|0|||
125559481|NCT00239226|451680885|FG001|Overall Study|permAF during stabilization period|0|||
125559482|NCT00239226|451680886|FG002|Overall Study|permAF during stabilization period|0|||
125559483|NCT00239226|451680887|FG003|Overall Study|permAF during stabilization period|3|||
125559484|NCT00239226|451680884|FG000|Overall Study|Lost to Follow-up|1|||
125559485|NCT00239226|451680885|FG001|Overall Study|Lost to Follow-up|0|||
125559486|NCT00239226|451680886|FG002|Overall Study|Lost to Follow-up|1|||
125559487|NCT00239226|451680887|FG003|Overall Study|Lost to Follow-up|0|||
125559488|NCT00646906|451680889|FG000|Crossover Period 1|Withdrawal by Subject|1|||
125559489|NCT00646906|451680890|FG001|Crossover Period 1|Withdrawal by Subject|0|||
125559490|NCT00646906|451680891|FG002|Crossover Period 1|Withdrawal by Subject|0|||
125559491|NCT00646906|451680892|FG003|Crossover Period 1|Withdrawal by Subject|0|||
125559492|NCT00646906|451680893|FG004|Crossover Period 1|Withdrawal by Subject|0|||
125559493|NCT00646906|451680894|FG005|Crossover Period 1|Withdrawal by Subject|1|||
125559494|NCT00646906|451680895|FG006|Crossover Period 1|Withdrawal by Subject|0|||
125559495|NCT00646906|451680889|FG000|Crossover Period 2|Withdrawal by Subject|0|||
125559496|NCT00646906|451680890|FG001|Crossover Period 2|Withdrawal by Subject|1|||
125559497|NCT00646906|451680891|FG002|Crossover Period 2|Withdrawal by Subject|2|||
125559498|NCT00646906|451680892|FG003|Crossover Period 2|Withdrawal by Subject|1|||
125559499|NCT00646906|451680893|FG004|Crossover Period 2|Withdrawal by Subject|0|||
125559500|NCT00646906|451680894|FG005|Crossover Period 2|Withdrawal by Subject|0|||
125559501|NCT00646906|451680895|FG006|Crossover Period 2|Withdrawal by Subject|0|||
125559502|NCT00646906|451680889|FG000|Crossover Period 2|Physician Decision|0|||
125559503|NCT00646906|451680890|FG001|Crossover Period 2|Physician Decision|0|||
125559504|NCT00646906|451680891|FG002|Crossover Period 2|Physician Decision|0|||
125559505|NCT00646906|451680892|FG003|Crossover Period 2|Physician Decision|0|||
125559506|NCT00646906|451680893|FG004|Crossover Period 2|Physician Decision|0|||
125559507|NCT00646906|451680894|FG005|Crossover Period 2|Physician Decision|0|||
125559508|NCT00646906|451680895|FG006|Crossover Period 2|Physician Decision|1|||
125559509|NCT01303965|451680897|FG000|Overall Study|Adverse Event|1|||
125559510|NCT01303965|451680898|FG001|Overall Study|Adverse Event|1|||
125559511|NCT01303965|451680897|FG000|Overall Study|Death|0|||
125559512|NCT01303965|451680898|FG001|Overall Study|Death|3|||
125559513|NCT01303965|451680897|FG000|Overall Study|Withdrawal by Subject|1|||
125559514|NCT01303965|451680898|FG001|Overall Study|Withdrawal by Subject|0|||
125559515|NCT01303965|451680897|FG000|Overall Study|Disease Progression|1|||
125559516|NCT01303965|451680898|FG001|Overall Study|Disease Progression|6|||
125559517|NCT02448225|451680901|FG000|Overall Study|Withdrawal by Subject|1|||
125559518|NCT02448225|451680901|FG000|Overall Study|Did not get FSPG scan|18|||
125559519|NCT02448225|451680901|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
125559520|NCT00851682|451680902|FG000|Overall Study|screen failure|5|||
125559521|NCT00851682|451680903|FG001|Overall Study|screen failure|0|||
125559522|NCT02844920|451680906|FG000|Overall Study|Lost to Follow-up|2|||
125559523|NCT00800436|451680911|FG000|Overall Study|Withdrawal by Subject|0|||
125559524|NCT00800436|451680912|FG001|Overall Study|Withdrawal by Subject|0|||
125559525|NCT00800436|451680913|FG002|Overall Study|Withdrawal by Subject|1|||
125559526|NCT00800436|451680914|FG003|Overall Study|Withdrawal by Subject|1|||
125559527|NCT00800436|451680915|FG004|Overall Study|Withdrawal by Subject|0|||
125559528|NCT00800436|451680916|FG005|Overall Study|Withdrawal by Subject|0|||
125559529|NCT00800436|451680917|FG006|Overall Study|Withdrawal by Subject|0|||
125559530|NCT00766090|451680918|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125559531|NCT00766090|451680919|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125559532|NCT00766090|451680920|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125559533|NCT00766090|451680921|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125559534|NCT00766090|451680922|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125559535|NCT00766090|451680923|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125559536|NCT00766090|451680924|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125559537|NCT00766090|451680925|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125559538|NCT00766090|451680926|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
125559539|NCT00766090|451680927|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125559540|NCT00766090|451680928|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125559541|NCT00766090|451680929|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125559542|NCT00766090|451680918|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
125559543|NCT00766090|451680919|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125559544|NCT00766090|451680920|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125559545|NCT00766090|451680921|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125559546|NCT00766090|451680922|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125559547|NCT00766090|451680923|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125559548|NCT00766090|451680924|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125559549|NCT00766090|451680925|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125559550|NCT00766090|451680926|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125559551|NCT00766090|451680927|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125559552|NCT00766090|451680928|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125559553|NCT00766090|451680929|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
125559554|NCT00766090|451680918|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
125559555|NCT00766090|451680919|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125559556|NCT00766090|451680920|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125559557|NCT00766090|451680921|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
125559558|NCT00766090|451680922|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125559559|NCT00766090|451680923|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125559560|NCT00766090|451680924|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125559561|NCT00766090|451680925|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125559562|NCT00766090|451680926|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125559563|NCT00766090|451680927|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125559564|NCT00766090|451680928|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125559565|NCT00766090|451680929|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125559566|NCT00766090|451680918|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
125559567|NCT00766090|451680919|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
125559568|NCT00766090|451680920|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
125559569|NCT00766090|451680921|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
125559570|NCT00766090|451680922|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
125559571|NCT00766090|451680923|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
125559572|NCT00766090|451680924|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
125559573|NCT00766090|451680925|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
125559574|NCT00766090|451680926|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
125559575|NCT00766090|451680927|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
125559576|NCT00766090|451680928|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
125559577|NCT00766090|451680929|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
125559578|NCT00766090|451680918|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125559579|NCT00766090|451680919|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125559580|NCT00766090|451680920|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125559581|NCT00766090|451680921|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125559582|NCT00766090|451680922|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
125559583|NCT00766090|451680923|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125559584|NCT00766090|451680924|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125353395|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
125353396|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
125353397|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
125353398|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
125353399|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
125353400|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
125559585|NCT00766090|451680925|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125559586|NCT00766090|451680926|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125559587|NCT00766090|451680927|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125559588|NCT00766090|451680928|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125559589|NCT00766090|451680929|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125559590|NCT00766090|451680918|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125559591|NCT00766090|451680919|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125559592|NCT00766090|451680920|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
125559593|NCT00766090|451680921|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125559594|NCT00766090|451680922|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125559595|NCT00766090|451680923|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125559596|NCT00766090|451680924|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125559597|NCT00766090|451680925|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125559598|NCT00766090|451680926|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125559599|NCT00766090|451680927|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125559600|NCT00766090|451680928|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125559601|NCT00766090|451680929|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
125559602|NCT00766090|451680918|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
125559603|NCT00766090|451680919|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
125559604|NCT00766090|451680920|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
125559605|NCT00766090|451680921|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
125559606|NCT00766090|451680922|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
125559607|NCT00766090|451680923|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
125559608|NCT00766090|451680924|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
125559609|NCT00766090|451680925|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
125559610|NCT00766090|451680926|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
125559611|NCT00766090|451680927|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
125559612|NCT00766090|451680928|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
125559613|NCT00766090|451680929|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
125559614|NCT00766090|451680918|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125559615|NCT00766090|451680919|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125559616|NCT00766090|451680920|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125559617|NCT00766090|451680921|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125559618|NCT00766090|451680922|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125559619|NCT00766090|451680923|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
125559620|NCT00766090|451680924|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125559621|NCT00766090|451680925|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125559622|NCT00766090|451680926|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125559623|NCT00766090|451680927|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125559624|NCT00766090|451680928|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125559625|NCT00766090|451680929|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
125559626|NCT00766090|451680918|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125559627|NCT00766090|451680919|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
125559628|NCT00766090|451680920|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125559629|NCT00766090|451680921|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
125559630|NCT00766090|451680922|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125559631|NCT00766090|451680923|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125559632|NCT00766090|451680924|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125426204|NCT03466086|451184413|FG001|Period 1|Sponsor decision due to study timeline|0|||
125559633|NCT00766090|451680925|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125559634|NCT00766090|451680926|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125559635|NCT00766090|451680927|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125559636|NCT00766090|451680928|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
125559637|NCT00766090|451680929|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
125426205|NCT03466086|451184412|FG000|Period 1|Withdrawal by Subject|1|||
125559638|NCT00766090|451680918|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125559639|NCT00766090|451680919|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125559640|NCT00766090|451680920|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125559641|NCT00766090|451680921|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125559642|NCT00766090|451680922|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
125559643|NCT00766090|451680923|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125559644|NCT00766090|451680924|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125559645|NCT00766090|451680925|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125559646|NCT00766090|451680926|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125559647|NCT00766090|451680927|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125559648|NCT00766090|451680928|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125559649|NCT00766090|451680929|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
125559650|NCT01106027|451680934|FG000|Overall Study|Lost graft early, discontinued|1|||
125559651|NCT02871778|451680935|FG000|Part A: Treatment Period 1|Adverse Event|1|||
125559652|NCT02871778|451680936|FG001|Part A: Treatment Period 1|Adverse Event|1|||
125559653|NCT02871778|451680937|FG002|Part A: Treatment Period 1|Adverse Event|1|||
125559654|NCT02871778|451680938|FG003|Part A: Treatment Period 1|Adverse Event|0|||
125559655|NCT02871778|451680939|FG004|Part A: Treatment Period 1|Adverse Event|0|||
125559656|NCT02871778|451680940|FG005|Part A: Treatment Period 1|Adverse Event|0|||
125559657|NCT02871778|451680941|FG006|Part A: Treatment Period 1|Adverse Event|0|||
125559658|NCT02871778|451680942|FG007|Part A: Treatment Period 1|Adverse Event|0|||
125559659|NCT02871778|451680935|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
125559660|NCT02871778|451680936|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
125559661|NCT02871778|451680937|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
125559662|NCT02871778|451680938|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
125559663|NCT02871778|451680939|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
125559664|NCT02871778|451680940|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
125559665|NCT02871778|451680941|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
125559666|NCT02871778|451680942|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
125559667|NCT02871778|451680935|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125559668|NCT02871778|451680936|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125559669|NCT02871778|451680937|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
125559670|NCT02871778|451680938|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125559671|NCT02871778|451680939|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125559672|NCT02871778|451680940|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125559673|NCT02871778|451680941|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125559674|NCT02871778|451680942|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
125559675|NCT02871778|451680935|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125559676|NCT02871778|451680936|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125559677|NCT02871778|451680937|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
125559678|NCT02871778|451680938|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125559679|NCT02871778|451680939|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125559680|NCT02871778|451680940|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125559681|NCT02871778|451680941|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125559682|NCT02871778|451680942|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
125559683|NCT02871778|451680935|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
125559684|NCT02871778|451680936|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
125559685|NCT02871778|451680937|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
125559686|NCT02871778|451680938|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
125559687|NCT02871778|451680939|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
125559688|NCT02871778|451680940|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
125559689|NCT02871778|451680941|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
125559690|NCT02871778|451680942|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
125559691|NCT02871778|451680935|FG000|Part A: Treatment Period 2|Adverse Event|2|||
125559692|NCT02871778|451680936|FG001|Part A: Treatment Period 2|Adverse Event|2|||
125559693|NCT02871778|451680937|FG002|Part A: Treatment Period 2|Adverse Event|0|||
125559694|NCT02871778|451680938|FG003|Part A: Treatment Period 2|Adverse Event|0|||
125559695|NCT02871778|451680939|FG004|Part A: Treatment Period 2|Adverse Event|0|||
125559696|NCT02871778|451680940|FG005|Part A: Treatment Period 2|Adverse Event|0|||
125559697|NCT02871778|451680941|FG006|Part A: Treatment Period 2|Adverse Event|0|||
125559698|NCT02871778|451680942|FG007|Part A: Treatment Period 2|Adverse Event|0|||
125559699|NCT02871778|451680935|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
125559700|NCT02871778|451680936|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
125559701|NCT02871778|451680937|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
125559702|NCT02871778|451680938|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
125559703|NCT02871778|451680939|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
125559704|NCT02871778|451680940|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
125559705|NCT02871778|451680941|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
125559706|NCT02871778|451680942|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
125559707|NCT02871778|451680935|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
125559708|NCT02871778|451680936|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
125559709|NCT02871778|451680937|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
125559710|NCT02871778|451680938|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
125559711|NCT02871778|451680939|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
125559712|NCT02871778|451680940|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
125559713|NCT02871778|451680941|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
125559714|NCT02871778|451680942|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
125559715|NCT02871778|451680935|FG000|Part B: Treatment Period 3|Adverse Event|0|||
125559716|NCT02871778|451680936|FG001|Part B: Treatment Period 3|Adverse Event|0|||
125559717|NCT02871778|451680937|FG002|Part B: Treatment Period 3|Adverse Event|0|||
125559718|NCT02871778|451680938|FG003|Part B: Treatment Period 3|Adverse Event|0|||
125559719|NCT02871778|451680939|FG004|Part B: Treatment Period 3|Adverse Event|1|||
125559720|NCT02871778|451680940|FG005|Part B: Treatment Period 3|Adverse Event|1|||
125559721|NCT02871778|451680941|FG006|Part B: Treatment Period 3|Adverse Event|1|||
125559722|NCT02871778|451680942|FG007|Part B: Treatment Period 3|Adverse Event|0|||
125559723|NCT02653300|451680943|FG000|Overall Study|Withdrawal by Subject|2|||
125559724|NCT02170779|451680944|FG000|Overall Study|Withdrawal by Subject|1|||
125559725|NCT02170779|451680945|FG001|Overall Study|Withdrawal by Subject|0|||
125559726|NCT02170779|451680944|FG000|Overall Study|Lost to Follow-up|0|||
125559727|NCT02170779|451680945|FG001|Overall Study|Lost to Follow-up|1|||
125559728|NCT00369785|451680957|FG000|Overall Study|Physician Decision|3|||
125559729|NCT00369785|451680958|FG001|Overall Study|Physician Decision|2|||
125559730|NCT00369785|451680957|FG000|Overall Study|Death|1|||
125559731|NCT00369785|451680958|FG001|Overall Study|Death|2|||
125559732|NCT00369785|451680957|FG000|Overall Study|Withdrawal by Subject|7|||
125559733|NCT00369785|451680958|FG001|Overall Study|Withdrawal by Subject|6|||
125559734|NCT00369785|451680957|FG000|Overall Study|Toxicity|6|||
125559735|NCT00369785|451680958|FG001|Overall Study|Toxicity|4|||
125559736|NCT00369785|451680957|FG000|Overall Study|Never started|0|||
125559737|NCT00369785|451680958|FG001|Overall Study|Never started|2|||
125559738|NCT00369785|451680957|FG000|Overall Study|Progression|4|||
125559739|NCT00369785|451680958|FG001|Overall Study|Progression|4|||
125559740|NCT00369785|451680957|FG000|Overall Study|Multiple reasons|6|||
125559741|NCT00369785|451680958|FG001|Overall Study|Multiple reasons|5|||
125559742|NCT00800683|451680959|FG000|Overall Study|Adverse Event|11|||
125559743|NCT00800683|451680960|FG001|Overall Study|Adverse Event|8|||
125559744|NCT00800683|451680959|FG000|Overall Study|Lost to Follow-up|3|||
125559745|NCT00800683|451680960|FG001|Overall Study|Lost to Follow-up|1|||
125559746|NCT00800683|451680959|FG000|Overall Study|Withdrawal by Subject|1|||
125559747|NCT00800683|451680960|FG001|Overall Study|Withdrawal by Subject|7|||
125559748|NCT00800683|451680959|FG000|Overall Study|Lack of Efficacy|1|||
125559749|NCT00800683|451680960|FG001|Overall Study|Lack of Efficacy|1|||
125559750|NCT00800683|451680959|FG000|Overall Study|Other|1|||
125559751|NCT00800683|451680960|FG001|Overall Study|Other|2|||
125559752|NCT04556136|451680965|FG000|Overall Study|Lost to Follow-up|6|||
125559753|NCT04556136|451680966|FG001|Overall Study|Lost to Follow-up|6|||
125559754|NCT04556136|451680965|FG000|Overall Study|Physician Decision|2|||
125559755|NCT04556136|451680966|FG001|Overall Study|Physician Decision|1|||
125559756|NCT04556136|451680965|FG000|Overall Study|Withdrawal by Subject|2|||
125559757|NCT04556136|451680966|FG001|Overall Study|Withdrawal by Subject|1|||
125559758|NCT03492554|451680967|FG000|Overall Study|Protocol Violation|0|||
125559759|NCT03492554|451680968|FG001|Overall Study|Protocol Violation|14|||
125559760|NCT04340557|451680969|FG000|Overall Study|Transferred to ICU and/or death|1|||
125559761|NCT04340557|451680970|FG001|Overall Study|Transferred to ICU and/or death|2|||
125559762|NCT01289821|451680973|FG000|Treatment Period|Withdrawal by Subject|1|||
125353401|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
125353402|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
125426206|NCT03466086|451184413|FG001|Period 1|Withdrawal by Subject|0|||
125559763|NCT01289821|451680973|FG000|Treatment Period|Physician Decision|3|||
125559764|NCT01289821|451680973|FG000|Treatment Period|Adverse Event|4|||
125559765|NCT01289821|451680973|FG000|Treatment Period|Radiological Progression|43|||
125559766|NCT01289821|451680973|FG000|Treatment Period|Clinical Progression|2|||
125559767|NCT01289821|451680973|FG000|Treatment Period|Therapeutic procedure required|1|||
125559768|NCT01289821|451680973|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
125559769|NCT01289821|451680973|FG000|Safety Follow-up Period|Protocol Violation|3|||
125559770|NCT01289821|451680973|FG000|Safety Follow-up Period|Unspecified reason|1|||
125559771|NCT01289821|451680973|FG000|Survival Follow-up Period|Protocol Violation|1|||
125559772|NCT01289821|451680973|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
125559773|NCT01289821|451680973|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
125559774|NCT00773136|451680976|FG000|Overall Study|Physician Decision|2|||
125559775|NCT02463071|451680978|FG000|Overall Study|Adverse Event|3|||
125559776|NCT02463071|451680979|FG001|Overall Study|Adverse Event|5|||
125559777|NCT02463071|451680980|FG002|Overall Study|Adverse Event|1|||
125559778|NCT02463071|451680978|FG000|Overall Study|Death|1|||
125559779|NCT02463071|451680979|FG001|Overall Study|Death|0|||
125559780|NCT02463071|451680980|FG002|Overall Study|Death|0|||
125559781|NCT02463071|451680978|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
125559782|NCT02463071|451680979|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125559783|NCT02463071|451680980|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
125559784|NCT02463071|451680978|FG000|Overall Study|Reason not specified|7|||
125559785|NCT02463071|451680979|FG001|Overall Study|Reason not specified|9|||
125559786|NCT02463071|451680980|FG002|Overall Study|Reason not specified|4|||
125559787|NCT02463071|451680978|FG000|Overall Study|Protocol Violation|0|||
125559788|NCT02463071|451680979|FG001|Overall Study|Protocol Violation|2|||
125559789|NCT02463071|451680980|FG002|Overall Study|Protocol Violation|0|||
125559790|NCT02463071|451680978|FG000|Overall Study|Lost to Follow-up|0|||
125559791|NCT02463071|451680979|FG001|Overall Study|Lost to Follow-up|0|||
125559792|NCT02463071|451680980|FG002|Overall Study|Lost to Follow-up|1|||
125559793|NCT00888381|451680983|FG000|Overall Study|Lost to Follow-up|0|||
125559794|NCT00888381|451680984|FG001|Overall Study|Lost to Follow-up|1|||
125559795|NCT01009034|451680985|FG000|Overall Study|Lost to Follow-up|2|||
125559796|NCT01009034|451680985|FG000|Overall Study|Withdrawal by Subject|2|||
125559797|NCT00667823|451680986|FG000|Overall Study|Lost to Follow-up|5|||
125559798|NCT00667823|451680986|FG000|Overall Study|Adverse Event|7|||
125559799|NCT00667823|451680986|FG000|Overall Study|Death|182|||
125559800|NCT00667823|451680986|FG000|Overall Study|Withdrawal by Subject|12|||
125559801|NCT00667823|451680986|FG000|Overall Study|Other|8|||
125559802|NCT00667823|451680986|FG000|Overall Study|Missing (completion page missing)|2|||
125559803|NCT04376827|451680987|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
125559804|NCT04376827|451680988|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
125559805|NCT04376827|451680987|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
125559806|NCT04376827|451680988|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
125559807|NCT04376827|451680987|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
125559808|NCT04376827|451680988|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
125559809|NCT04376827|451680987|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
125559810|NCT04376827|451680988|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
125559811|NCT04376827|451680987|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
125559812|NCT04376827|451680988|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
125559813|NCT00761306|451682932|FG000|Overall Study|Adverse Event|5|||
125559814|NCT00761306|451682932|FG000|Overall Study|Lack of Efficacy|4|||
125559815|NCT00761306|451682932|FG000|Overall Study|Protocol Violation|2|||
125559816|NCT00761306|451682932|FG000|Overall Study|Withdrawal of Consent|3|||
125559817|NCT00761306|451682932|FG000|Overall Study|Lost to Follow-up|1|||
125559818|NCT00761306|451682932|FG000|Overall Study|Administrative or Other Reasons|5|||
125559819|NCT04042740|451682933|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
125559820|NCT04042740|451682933|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
125559821|NCT00880555|451682934|FG000|Overall Study|Physician Decision|0|||
125559822|NCT00880555|451682935|FG001|Overall Study|Physician Decision|8|||
125559823|NCT00880555|451682936|FG002|Overall Study|Physician Decision|0|||
125559824|NCT00880555|451682937|FG003|Overall Study|Physician Decision|2|||
125559825|NCT00880555|451682938|FG004|Overall Study|Physician Decision|1|||
125559826|NCT00880555|451682939|FG005|Overall Study|Physician Decision|0|||
125559827|NCT00880555|451682934|FG000|Overall Study|Withdrawal by Subject|1|||
125559828|NCT00880555|451682935|FG001|Overall Study|Withdrawal by Subject|1|||
125559829|NCT00880555|451682936|FG002|Overall Study|Withdrawal by Subject|0|||
125559830|NCT00880555|451682937|FG003|Overall Study|Withdrawal by Subject|0|||
125559831|NCT00880555|451682938|FG004|Overall Study|Withdrawal by Subject|0|||
125559832|NCT00880555|451682939|FG005|Overall Study|Withdrawal by Subject|0|||
125559833|NCT00880555|451682934|FG000|Overall Study|Lack of resources (hired rater)|9|||
125559834|NCT00880555|451682935|FG001|Overall Study|Lack of resources (hired rater)|7|||
125559835|NCT00880555|451682936|FG002|Overall Study|Lack of resources (hired rater)|5|||
125559836|NCT00880555|451682937|FG003|Overall Study|Lack of resources (hired rater)|0|||
125559837|NCT00880555|451682938|FG004|Overall Study|Lack of resources (hired rater)|0|||
125559838|NCT00880555|451682939|FG005|Overall Study|Lack of resources (hired rater)|0|||
125559839|NCT00880555|451682934|FG000|Overall Study|Death|0|||
125559840|NCT00880555|451682935|FG001|Overall Study|Death|0|||
125559841|NCT00880555|451682936|FG002|Overall Study|Death|0|||
125559842|NCT00880555|451682937|FG003|Overall Study|Death|0|||
125559843|NCT00880555|451682938|FG004|Overall Study|Death|0|||
125559844|NCT00880555|451682939|FG005|Overall Study|Death|1|||
125559845|NCT00880555|451682934|FG000|Overall Study|Lost to Follow-up|0|||
125559846|NCT00880555|451682935|FG001|Overall Study|Lost to Follow-up|1|||
125559847|NCT00880555|451682936|FG002|Overall Study|Lost to Follow-up|0|||
125559848|NCT00880555|451682937|FG003|Overall Study|Lost to Follow-up|0|||
125559849|NCT00880555|451682938|FG004|Overall Study|Lost to Follow-up|0|||
125559850|NCT00880555|451682939|FG005|Overall Study|Lost to Follow-up|0|||
125559851|NCT02982590|451682941|FG000|Overall Study|Lost to Follow-up|0|||
125559852|NCT02982590|451682942|FG001|Overall Study|Lost to Follow-up|1|||
125559853|NCT02982590|451682941|FG000|Overall Study|Death|4|||
125559854|NCT02982590|451682942|FG001|Overall Study|Death|0|||
125559855|NCT01168973|451682943|FG000|Overall Study|Progressive Disease|341|||
125559856|NCT01168973|451682944|FG001|Overall Study|Progressive Disease|429|||
125559857|NCT01168973|451682943|FG000|Overall Study|Adverse Event|94|||
125559858|NCT01168973|451682944|FG001|Overall Study|Adverse Event|55|||
125559859|NCT01168973|451682943|FG000|Overall Study|Withdrawal by Subject|90|||
125559860|NCT01168973|451682944|FG001|Overall Study|Withdrawal by Subject|53|||
125559861|NCT01168973|451682943|FG000|Overall Study|Death|42|||
125559862|NCT01168973|451682944|FG001|Overall Study|Death|45|||
125559863|NCT01168973|451682943|FG000|Overall Study|Physician Decision|37|||
125559864|NCT01168973|451682944|FG001|Overall Study|Physician Decision|19|||
125559865|NCT01168973|451682943|FG000|Overall Study|Sponsor Decision|2|||
125559866|NCT01168973|451682944|FG001|Overall Study|Sponsor Decision|1|||
125559867|NCT01168973|451682943|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
125559868|NCT01168973|451682944|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
125559869|NCT00388505|451682947|FG000|Overall Study|Adverse Event or Death|43|||
125559870|NCT00388505|451682948|FG001|Overall Study|Adverse Event or Death|17|||
125559871|NCT00388505|451682947|FG000|Overall Study|Withdrawal by Subject|24|||
125559872|NCT00388505|451682948|FG001|Overall Study|Withdrawal by Subject|9|||
125559873|NCT00388505|451682947|FG000|Overall Study|Lost to Follow-up|5|||
125559874|NCT00388505|451682948|FG001|Overall Study|Lost to Follow-up|3|||
125559875|NCT00388505|451682947|FG000|Overall Study|Inappropriate Enrollment|0|||
125559876|NCT00388505|451682948|FG001|Overall Study|Inappropriate Enrollment|1|||
125559877|NCT00388505|451682947|FG000|Overall Study|Administrative Reason|1|||
125559878|NCT00388505|451682948|FG001|Overall Study|Administrative Reason|0|||
125559879|NCT00388505|451682947|FG000|Overall Study|Protocol Violation|6|||
125559880|NCT00388505|451682948|FG001|Overall Study|Protocol Violation|5|||
125559881|NCT00388505|451682947|FG000|Overall Study|Unable to classify|4|||
125559882|NCT00388505|451682948|FG001|Overall Study|Unable to classify|3|||
125559883|NCT04479436|451682952|FG000|Overall Study|Progressive disease|26|||
125559884|NCT04479436|451682953|FG001|Overall Study|Progressive disease|1|||
125559885|NCT04479436|451682952|FG000|Overall Study|Adverse Event|6|||
125559886|NCT04479436|451682953|FG001|Overall Study|Adverse Event|0|||
125559887|NCT04479436|451682952|FG000|Overall Study|Withdrawal by Subject|5|||
125559888|NCT04479436|451682953|FG001|Overall Study|Withdrawal by Subject|0|||
125559889|NCT04479436|451682952|FG000|Overall Study|Clinical progression|1|||
125559890|NCT04479436|451682953|FG001|Overall Study|Clinical progression|0|||
125559891|NCT04479436|451682952|FG000|Overall Study|Physician Decision|1|||
125559892|NCT04479436|451682953|FG001|Overall Study|Physician Decision|0|||
125559893|NCT01480284|451682956|FG000|Overall Study|Withdrawal by Subject|2|||
125559894|NCT01480284|451682957|FG001|Overall Study|Withdrawal by Subject|0|||
125559895|NCT01480284|451682956|FG000|Overall Study|Adverse Event|1|||
125559896|NCT01480284|451682957|FG001|Overall Study|Adverse Event|0|||
125559897|NCT01480284|451682956|FG000|Overall Study|Study closed/terminated|3|||
125559898|NCT01480284|451682957|FG001|Overall Study|Study closed/terminated|0|||
125559899|NCT01480284|451682956|FG000|Overall Study|Lost to Follow-up|1|||
125559900|NCT01480284|451682957|FG001|Overall Study|Lost to Follow-up|0|||
125559901|NCT01480284|451682956|FG000|Overall Study|Physician Decision|1|||
125559902|NCT01480284|451682957|FG001|Overall Study|Physician Decision|0|||
125559903|NCT02357134|451682958|FG000|Overall Study|Lost to Follow-up|1|||
125559904|NCT02357134|451682959|FG001|Overall Study|Lost to Follow-up|0|||
125559905|NCT02357134|451682960|FG002|Overall Study|Lost to Follow-up|0|||
125559906|NCT02357134|451682961|FG003|Overall Study|Lost to Follow-up|0|||
125559907|NCT02716675|451682962|FG000|Overall Study|Death|2|||
125559908|NCT02716675|451682963|FG001|Overall Study|Death|3|||
125559909|NCT02716675|451682964|FG002|Overall Study|Death|0|||
125559910|NCT02716675|451682962|FG000|Overall Study|Physician Decision|2|||
125559911|NCT02716675|451682963|FG001|Overall Study|Physician Decision|1|||
125559912|NCT02716675|451682964|FG002|Overall Study|Physician Decision|1|||
125559913|NCT02716675|451682962|FG000|Overall Study|Lost to Follow-up|100|||
125559914|NCT02716675|451682963|FG001|Overall Study|Lost to Follow-up|87|||
125559915|NCT02716675|451682964|FG002|Overall Study|Lost to Follow-up|99|||
125559916|NCT02716675|451682962|FG000|Overall Study|Withdrawal by Subject|22|||
125559917|NCT02716675|451682963|FG001|Overall Study|Withdrawal by Subject|25|||
125559918|NCT02716675|451682964|FG002|Overall Study|Withdrawal by Subject|20|||
125559919|NCT02716675|451682962|FG000|Overall Study|Protocol Violation|0|||
125559920|NCT02716675|451682963|FG001|Overall Study|Protocol Violation|3|||
125559921|NCT02716675|451682964|FG002|Overall Study|Protocol Violation|1|||
125559922|NCT02716675|451682962|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
125559923|NCT02716675|451682963|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
125559924|NCT02716675|451682964|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
125559925|NCT02716675|451682962|FG000|Overall Study|Other|38|||
125559926|NCT02716675|451682963|FG001|Overall Study|Other|47|||
125559927|NCT02716675|451682964|FG002|Overall Study|Other|48|||
125559928|NCT00709111|451682965|FG000|Overall Study|Withdrawal by Subject|1|||
125559929|NCT00709111|451682965|FG000|Overall Study|Unable to attend clinic visits|1|||
125559930|NCT01301456|451682966|FG000|Stage 1|Withdrawal by Subject|0|||
125559931|NCT01301456|451682967|FG001|Stage 1|Withdrawal by Subject|0|||
125559932|NCT01301456|451682968|FG002|Stage 1|Withdrawal by Subject|1|||
125559933|NCT01301456|451682969|FG003|Stage 1|Withdrawal by Subject|0|||
125559934|NCT01301456|451682970|FG004|Stage 1|Withdrawal by Subject|1|||
125559935|NCT01301456|451682971|FG005|Stage 1|Withdrawal by Subject|0|||
125559936|NCT01301456|451682972|FG006|Stage 1|Withdrawal by Subject|0|||
125559937|NCT01301456|451682973|FG007|Stage 1|Withdrawal by Subject|0|||
125559938|NCT01301456|451682974|FG008|Stage 1|Withdrawal by Subject|0|||
125559939|NCT01301456|451682975|FG009|Stage 1|Withdrawal by Subject|0|||
125559940|NCT01301456|451682976|FG010|Stage 1|Withdrawal by Subject|0|||
125559941|NCT01301456|451682977|FG011|Stage 1|Withdrawal by Subject|0|||
125559942|NCT01301456|451682966|FG000|Stage 1|Randomized but not treated|0|||
125559943|NCT01301456|451682967|FG001|Stage 1|Randomized but not treated|0|||
125559944|NCT01301456|451682968|FG002|Stage 1|Randomized but not treated|0|||
125559945|NCT01301456|451682969|FG003|Stage 1|Randomized but not treated|0|||
125559946|NCT01301456|451682970|FG004|Stage 1|Randomized but not treated|0|||
125559947|NCT01301456|451682971|FG005|Stage 1|Randomized but not treated|0|||
125559948|NCT01301456|451682972|FG006|Stage 1|Randomized but not treated|1|||
125559949|NCT01301456|451682973|FG007|Stage 1|Randomized but not treated|0|||
125559950|NCT01301456|451682974|FG008|Stage 1|Randomized but not treated|0|||
125559951|NCT01301456|451682975|FG009|Stage 1|Randomized but not treated|0|||
125559952|NCT01301456|451682976|FG010|Stage 1|Randomized but not treated|0|||
125559953|NCT01301456|451682977|FG011|Stage 1|Randomized but not treated|0|||
125559954|NCT01301456|451682966|FG000|Stage 2|Adverse Event|0|||
125559955|NCT01301456|451682967|FG001|Stage 2|Adverse Event|0|||
125559956|NCT01301456|451682968|FG002|Stage 2|Adverse Event|0|||
125559957|NCT01301456|451682969|FG003|Stage 2|Adverse Event|0|||
125559958|NCT01301456|451682970|FG004|Stage 2|Adverse Event|0|||
125559959|NCT01301456|451682971|FG005|Stage 2|Adverse Event|0|||
125559960|NCT01301456|451682972|FG006|Stage 2|Adverse Event|0|||
125559961|NCT01301456|451682973|FG007|Stage 2|Adverse Event|0|||
125559962|NCT01301456|451682974|FG008|Stage 2|Adverse Event|0|||
125559963|NCT01301456|451682975|FG009|Stage 2|Adverse Event|0|||
125559964|NCT01301456|451682976|FG010|Stage 2|Adverse Event|1|||
125559965|NCT01301456|451682977|FG011|Stage 2|Adverse Event|0|||
125559966|NCT00915772|451682978|FG000|Overall Study|Adverse Event|12|||
125559967|NCT00915772|451682979|FG001|Overall Study|Adverse Event|13|||
125559968|NCT00915772|451682980|FG002|Overall Study|Adverse Event|11|||
125559969|NCT00915772|451682978|FG000|Overall Study|Protocol Violation|4|||
125559970|NCT00915772|451682979|FG001|Overall Study|Protocol Violation|1|||
125559971|NCT00915772|451682980|FG002|Overall Study|Protocol Violation|2|||
125559972|NCT00915772|451682978|FG000|Overall Study|Lost to Follow-up|1|||
125559973|NCT00915772|451682979|FG001|Overall Study|Lost to Follow-up|2|||
125559974|NCT00915772|451682980|FG002|Overall Study|Lost to Follow-up|2|||
125559975|NCT00915772|451682978|FG000|Overall Study|Lack of Efficacy|9|||
125559976|NCT00915772|451682979|FG001|Overall Study|Lack of Efficacy|15|||
125559977|NCT00915772|451682980|FG002|Overall Study|Lack of Efficacy|3|||
125559978|NCT00915772|451682978|FG000|Overall Study|Refused to continue trial medication|6|||
125559979|NCT00915772|451682979|FG001|Overall Study|Refused to continue trial medication|8|||
125559980|NCT00915772|451682980|FG002|Overall Study|Refused to continue trial medication|4|||
125559981|NCT00915772|451682978|FG000|Overall Study|Any other reason|4|||
125559982|NCT00915772|451682979|FG001|Overall Study|Any other reason|7|||
125559983|NCT00915772|451682980|FG002|Overall Study|Any other reason|7|||
125559984|NCT03583450|451682981|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
125559985|NCT03583450|451682982|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
125559986|NCT03374995|451682983|FG000|Overall Study|Withdrawal by Subject|0|||
125559987|NCT03374995|451682984|FG001|Overall Study|Withdrawal by Subject|1|||
125559988|NCT01383096|451682985|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
125559989|NCT01383096|451682986|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
125559990|NCT01383096|451682987|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
125559991|NCT01383096|451682985|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
125559992|NCT01383096|451682986|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
125559993|NCT01383096|451682987|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
125559994|NCT01383096|451682985|FG000|Third Intervention (8 Days)|Elevated AST|0|||
125559995|NCT01383096|451682986|FG001|Third Intervention (8 Days)|Elevated AST|1|||
125559996|NCT01383096|451682987|FG002|Third Intervention (8 Days)|Elevated AST|0|||
125559997|NCT01383096|451682985|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
125559998|NCT01383096|451682986|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
125559999|NCT01383096|451682987|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
125560000|NCT01383096|451682985|FG000|Third Intervention (8 Days)|Adverse Event|1|||
125560001|NCT01383096|451682986|FG001|Third Intervention (8 Days)|Adverse Event|0|||
125560002|NCT01383096|451682987|FG002|Third Intervention (8 Days)|Adverse Event|0|||
125560003|NCT01383096|451682985|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
125560004|NCT01383096|451682986|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
125560005|NCT01383096|451682987|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
125560006|NCT01383096|451682985|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
125560007|NCT01383096|451682986|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
125560008|NCT01383096|451682987|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
125560009|NCT01383096|451682985|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
125560010|NCT01383096|451682986|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
125560011|NCT01383096|451682987|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
125560012|NCT01383096|451682985|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
125560013|NCT01383096|451682986|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
125560014|NCT01383096|451682987|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
125560015|NCT01383096|451682985|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
125560016|NCT01383096|451682986|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
125560017|NCT01383096|451682987|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
125560018|NCT01383096|451682985|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
125560019|NCT01383096|451682986|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
125560020|NCT01383096|451682987|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
125560021|NCT01211535|451682988|FG000|Overall Study|Adverse Event|0|||
125560022|NCT01211535|451682989|FG001|Overall Study|Adverse Event|1|||
125560023|NCT01380730|451682990|FG000|Overall Study|Death|0|||
125560024|NCT01380730|451682991|FG001|Overall Study|Death|0|||
125560025|NCT01380730|451682992|FG002|Overall Study|Death|0|||
125560026|NCT01380730|451682993|FG003|Overall Study|Death|0|||
125560027|NCT01380730|451682994|FG004|Overall Study|Death|1|||
125560028|NCT01380730|451682995|FG005|Overall Study|Death|0|||
125560029|NCT01380730|451682996|FG006|Overall Study|Death|0|||
125560030|NCT01380730|451682997|FG007|Overall Study|Death|0|||
125560031|NCT00467779|451682998|FG000|Stage 1|Adverse Event|1|||
125560032|NCT00467779|451682999|FG001|Stage 1|Adverse Event|0|||
125560033|NCT00467779|451683000|FG002|Stage 1|Adverse Event|0|||
125560034|NCT00467779|451683001|FG003|Stage 1|Adverse Event|0|||
125560035|NCT00467779|451683002|FG004|Stage 1|Adverse Event|0|||
125560036|NCT00467779|451683003|FG005|Stage 1|Adverse Event|1|||
125560037|NCT00467779|451683004|FG006|Stage 1|Adverse Event|2|||
125560038|NCT00467779|451683005|FG007|Stage 1|Adverse Event|1|||
125560039|NCT00467779|451683006|FG008|Stage 1|Adverse Event|0|||
125560040|NCT00467779|451683007|FG009|Stage 1|Adverse Event|0|||
125560041|NCT00467779|451683008|FG010|Stage 1|Adverse Event|0|||
125560042|NCT00467779|451683009|FG011|Stage 1|Adverse Event|0|||
125560043|NCT00467779|451683010|FG012|Stage 1|Adverse Event|0|||
125560044|NCT00467779|451683011|FG013|Stage 1|Adverse Event|0|||
125560045|NCT00467779|451683012|FG014|Stage 1|Adverse Event|0|||
125560046|NCT00467779|451682998|FG000|Stage 1|Disease Progression|2|||
125560047|NCT00467779|451682999|FG001|Stage 1|Disease Progression|2|||
125560048|NCT00467779|451683000|FG002|Stage 1|Disease Progression|2|||
125560049|NCT00467779|451683001|FG003|Stage 1|Disease Progression|3|||
125560050|NCT00467779|451683002|FG004|Stage 1|Disease Progression|2|||
125560051|NCT00467779|451683003|FG005|Stage 1|Disease Progression|2|||
125560052|NCT00467779|451683004|FG006|Stage 1|Disease Progression|4|||
125560053|NCT00467779|451683005|FG007|Stage 1|Disease Progression|5|||
125560054|NCT00467779|451683006|FG008|Stage 1|Disease Progression|0|||
125560055|NCT00467779|451683007|FG009|Stage 1|Disease Progression|0|||
125560056|NCT00467779|451683008|FG010|Stage 1|Disease Progression|0|||
125560057|NCT00467779|451683009|FG011|Stage 1|Disease Progression|0|||
125560058|NCT00467779|451683010|FG012|Stage 1|Disease Progression|0|||
125560059|NCT00467779|451683011|FG013|Stage 1|Disease Progression|0|||
125560060|NCT00467779|451683012|FG014|Stage 1|Disease Progression|0|||
125560061|NCT00467779|451682998|FG000|Stage 1|Unspecified Reason|1|||
125560062|NCT00467779|451682999|FG001|Stage 1|Unspecified Reason|0|||
125560063|NCT00467779|451683000|FG002|Stage 1|Unspecified Reason|1|||
125560064|NCT00467779|451683001|FG003|Stage 1|Unspecified Reason|0|||
125560065|NCT00467779|451683002|FG004|Stage 1|Unspecified Reason|1|||
125560066|NCT00467779|451683003|FG005|Stage 1|Unspecified Reason|2|||
125560067|NCT00467779|451683004|FG006|Stage 1|Unspecified Reason|0|||
125560068|NCT00467779|451683005|FG007|Stage 1|Unspecified Reason|0|||
125560069|NCT00467779|451683006|FG008|Stage 1|Unspecified Reason|0|||
125560070|NCT00467779|451683007|FG009|Stage 1|Unspecified Reason|0|||
125560071|NCT00467779|451683008|FG010|Stage 1|Unspecified Reason|0|||
125560072|NCT00467779|451683009|FG011|Stage 1|Unspecified Reason|0|||
125560073|NCT00467779|451683010|FG012|Stage 1|Unspecified Reason|0|||
125560074|NCT00467779|451683011|FG013|Stage 1|Unspecified Reason|0|||
125560075|NCT00467779|451683012|FG014|Stage 1|Unspecified Reason|0|||
125560076|NCT00467779|451682998|FG000|Stage 1|Physician Decision|0|||
125560077|NCT00467779|451682999|FG001|Stage 1|Physician Decision|1|||
125560078|NCT00467779|451683000|FG002|Stage 1|Physician Decision|0|||
125560079|NCT00467779|451683001|FG003|Stage 1|Physician Decision|0|||
125560080|NCT00467779|451683002|FG004|Stage 1|Physician Decision|0|||
125560081|NCT00467779|451683003|FG005|Stage 1|Physician Decision|0|||
125560082|NCT00467779|451683004|FG006|Stage 1|Physician Decision|0|||
125560083|NCT00467779|451683005|FG007|Stage 1|Physician Decision|0|||
125560084|NCT00467779|451683006|FG008|Stage 1|Physician Decision|0|||
125560085|NCT00467779|451683007|FG009|Stage 1|Physician Decision|0|||
125560086|NCT00467779|451683008|FG010|Stage 1|Physician Decision|0|||
125560087|NCT00467779|451683009|FG011|Stage 1|Physician Decision|0|||
125560088|NCT00467779|451683010|FG012|Stage 1|Physician Decision|0|||
125560089|NCT00467779|451683011|FG013|Stage 1|Physician Decision|0|||
125560090|NCT00467779|451683012|FG014|Stage 1|Physician Decision|0|||
125560091|NCT00467779|451682998|FG000|Stage 1|Withdrawal by Subject|0|||
125560092|NCT00467779|451682999|FG001|Stage 1|Withdrawal by Subject|0|||
125560093|NCT00467779|451683000|FG002|Stage 1|Withdrawal by Subject|0|||
125560094|NCT00467779|451683001|FG003|Stage 1|Withdrawal by Subject|0|||
125560095|NCT00467779|451683002|FG004|Stage 1|Withdrawal by Subject|0|||
125560096|NCT00467779|451683003|FG005|Stage 1|Withdrawal by Subject|0|||
125560097|NCT00467779|451683004|FG006|Stage 1|Withdrawal by Subject|1|||
125560098|NCT00467779|451683005|FG007|Stage 1|Withdrawal by Subject|1|||
125560099|NCT00467779|451683006|FG008|Stage 1|Withdrawal by Subject|0|||
125560100|NCT00467779|451683007|FG009|Stage 1|Withdrawal by Subject|0|||
125560101|NCT00467779|451683008|FG010|Stage 1|Withdrawal by Subject|0|||
125560102|NCT00467779|451683009|FG011|Stage 1|Withdrawal by Subject|0|||
125560103|NCT00467779|451683010|FG012|Stage 1|Withdrawal by Subject|0|||
125560104|NCT00467779|451683011|FG013|Stage 1|Withdrawal by Subject|0|||
125560105|NCT00467779|451683012|FG014|Stage 1|Withdrawal by Subject|0|||
125560106|NCT00467779|451682998|FG000|Stage 1A|Adverse Event|0|||
125560107|NCT00467779|451682999|FG001|Stage 1A|Adverse Event|0|||
125560108|NCT00467779|451683000|FG002|Stage 1A|Adverse Event|0|||
125560109|NCT00467779|451683001|FG003|Stage 1A|Adverse Event|0|||
125560110|NCT00467779|451683002|FG004|Stage 1A|Adverse Event|0|||
125560111|NCT00467779|451683003|FG005|Stage 1A|Adverse Event|0|||
125560112|NCT00467779|451683004|FG006|Stage 1A|Adverse Event|0|||
125560113|NCT00467779|451683005|FG007|Stage 1A|Adverse Event|0|||
125560114|NCT00467779|451683006|FG008|Stage 1A|Adverse Event|0|||
125560115|NCT00467779|451683007|FG009|Stage 1A|Adverse Event|0|||
125560116|NCT00467779|451683008|FG010|Stage 1A|Adverse Event|0|||
125353403|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
125353404|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
125353405|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
125353406|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
125353407|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
125353408|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
125353409|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
125560117|NCT00467779|451683009|FG011|Stage 1A|Adverse Event|0|||
125560118|NCT00467779|451683010|FG012|Stage 1A|Adverse Event|1|||
125560119|NCT00467779|451683011|FG013|Stage 1A|Adverse Event|0|||
125560120|NCT00467779|451683012|FG014|Stage 1A|Adverse Event|0|||
125560121|NCT00467779|451682998|FG000|Stage 1A|Death|0|||
125560122|NCT00467779|451682999|FG001|Stage 1A|Death|0|||
125560123|NCT00467779|451683000|FG002|Stage 1A|Death|0|||
125560124|NCT00467779|451683001|FG003|Stage 1A|Death|0|||
125560125|NCT00467779|451683002|FG004|Stage 1A|Death|0|||
125560126|NCT00467779|451683003|FG005|Stage 1A|Death|0|||
125560127|NCT00467779|451683004|FG006|Stage 1A|Death|0|||
125560128|NCT00467779|451683005|FG007|Stage 1A|Death|0|||
125560129|NCT00467779|451683006|FG008|Stage 1A|Death|0|||
125560130|NCT00467779|451683007|FG009|Stage 1A|Death|0|||
125560131|NCT00467779|451683008|FG010|Stage 1A|Death|0|||
125560132|NCT00467779|451683009|FG011|Stage 1A|Death|1|||
125560133|NCT00467779|451683010|FG012|Stage 1A|Death|1|||
125560134|NCT00467779|451683011|FG013|Stage 1A|Death|0|||
125560135|NCT00467779|451683012|FG014|Stage 1A|Death|0|||
125560136|NCT00467779|451682998|FG000|Stage 1A|Disease Progression|0|||
125560137|NCT00467779|451682999|FG001|Stage 1A|Disease Progression|0|||
125560138|NCT00467779|451683000|FG002|Stage 1A|Disease Progression|0|||
125560139|NCT00467779|451683001|FG003|Stage 1A|Disease Progression|0|||
125560140|NCT00467779|451683002|FG004|Stage 1A|Disease Progression|0|||
125560141|NCT00467779|451683003|FG005|Stage 1A|Disease Progression|0|||
125560142|NCT00467779|451683004|FG006|Stage 1A|Disease Progression|0|||
125560143|NCT00467779|451683005|FG007|Stage 1A|Disease Progression|0|||
125560144|NCT00467779|451683006|FG008|Stage 1A|Disease Progression|0|||
125560145|NCT00467779|451683007|FG009|Stage 1A|Disease Progression|2|||
125560146|NCT00467779|451683008|FG010|Stage 1A|Disease Progression|2|||
125560147|NCT00467779|451683009|FG011|Stage 1A|Disease Progression|5|||
125560148|NCT00467779|451683010|FG012|Stage 1A|Disease Progression|2|||
125560149|NCT00467779|451683011|FG013|Stage 1A|Disease Progression|0|||
125560150|NCT00467779|451683012|FG014|Stage 1A|Disease Progression|0|||
125560151|NCT00467779|451682998|FG000|Stage 1A|Physician Decision|0|||
125560152|NCT00467779|451682999|FG001|Stage 1A|Physician Decision|0|||
125560153|NCT00467779|451683000|FG002|Stage 1A|Physician Decision|0|||
125560154|NCT00467779|451683001|FG003|Stage 1A|Physician Decision|0|||
125560155|NCT00467779|451683002|FG004|Stage 1A|Physician Decision|0|||
125560156|NCT00467779|451683003|FG005|Stage 1A|Physician Decision|0|||
125560157|NCT00467779|451683004|FG006|Stage 1A|Physician Decision|0|||
125560158|NCT00467779|451683005|FG007|Stage 1A|Physician Decision|0|||
125560159|NCT00467779|451683006|FG008|Stage 1A|Physician Decision|0|||
125560160|NCT00467779|451683007|FG009|Stage 1A|Physician Decision|1|||
125560161|NCT00467779|451683008|FG010|Stage 1A|Physician Decision|0|||
125560162|NCT00467779|451683009|FG011|Stage 1A|Physician Decision|0|||
125560163|NCT00467779|451683010|FG012|Stage 1A|Physician Decision|0|||
125560164|NCT00467779|451683011|FG013|Stage 1A|Physician Decision|0|||
125560165|NCT00467779|451683012|FG014|Stage 1A|Physician Decision|0|||
125560166|NCT00467779|451682998|FG000|Stage 1A|Withdrawal by Subject|0|||
125560167|NCT00467779|451682999|FG001|Stage 1A|Withdrawal by Subject|0|||
125560168|NCT00467779|451683000|FG002|Stage 1A|Withdrawal by Subject|0|||
125560169|NCT00467779|451683001|FG003|Stage 1A|Withdrawal by Subject|0|||
125560170|NCT00467779|451683002|FG004|Stage 1A|Withdrawal by Subject|0|||
125560171|NCT00467779|451683003|FG005|Stage 1A|Withdrawal by Subject|0|||
125560172|NCT00467779|451683004|FG006|Stage 1A|Withdrawal by Subject|0|||
125560173|NCT00467779|451683005|FG007|Stage 1A|Withdrawal by Subject|0|||
125560174|NCT00467779|451683006|FG008|Stage 1A|Withdrawal by Subject|0|||
125560175|NCT00467779|451683007|FG009|Stage 1A|Withdrawal by Subject|0|||
125560176|NCT00467779|451683008|FG010|Stage 1A|Withdrawal by Subject|1|||
125560177|NCT00467779|451683009|FG011|Stage 1A|Withdrawal by Subject|1|||
125560178|NCT00467779|451683010|FG012|Stage 1A|Withdrawal by Subject|1|||
125560179|NCT00467779|451683011|FG013|Stage 1A|Withdrawal by Subject|0|||
125560180|NCT00467779|451683012|FG014|Stage 1A|Withdrawal by Subject|0|||
125560181|NCT00467779|451682998|FG000|Stage 1A|Unspecified Reason|0|||
125560182|NCT00467779|451682999|FG001|Stage 1A|Unspecified Reason|0|||
125560183|NCT00467779|451683000|FG002|Stage 1A|Unspecified Reason|0|||
125560184|NCT00467779|451683001|FG003|Stage 1A|Unspecified Reason|0|||
125560185|NCT00467779|451683002|FG004|Stage 1A|Unspecified Reason|0|||
125560186|NCT00467779|451683003|FG005|Stage 1A|Unspecified Reason|0|||
125560187|NCT00467779|451683004|FG006|Stage 1A|Unspecified Reason|0|||
125560188|NCT00467779|451683005|FG007|Stage 1A|Unspecified Reason|0|||
125560189|NCT00467779|451683006|FG008|Stage 1A|Unspecified Reason|0|||
125560190|NCT00467779|451683007|FG009|Stage 1A|Unspecified Reason|0|||
125560191|NCT00467779|451683008|FG010|Stage 1A|Unspecified Reason|0|||
125560192|NCT00467779|451683009|FG011|Stage 1A|Unspecified Reason|1|||
125560193|NCT00467779|451683010|FG012|Stage 1A|Unspecified Reason|1|||
125560194|NCT00467779|451683011|FG013|Stage 1A|Unspecified Reason|0|||
125560195|NCT00467779|451683012|FG014|Stage 1A|Unspecified Reason|0|||
125560196|NCT00467779|451682998|FG000|Stage 2|Adverse Event|0|||
125560197|NCT00467779|451682999|FG001|Stage 2|Adverse Event|0|||
125560198|NCT00467779|451683000|FG002|Stage 2|Adverse Event|0|||
125560199|NCT00467779|451683001|FG003|Stage 2|Adverse Event|0|||
125560200|NCT00467779|451683002|FG004|Stage 2|Adverse Event|0|||
125560201|NCT00467779|451683003|FG005|Stage 2|Adverse Event|0|||
125560202|NCT00467779|451683004|FG006|Stage 2|Adverse Event|0|||
125560203|NCT00467779|451683005|FG007|Stage 2|Adverse Event|0|||
125560204|NCT00467779|451683006|FG008|Stage 2|Adverse Event|1|||
125560205|NCT00467779|451683007|FG009|Stage 2|Adverse Event|0|||
125560206|NCT00467779|451683008|FG010|Stage 2|Adverse Event|0|||
125560207|NCT00467779|451683009|FG011|Stage 2|Adverse Event|0|||
125560208|NCT00467779|451683010|FG012|Stage 2|Adverse Event|0|||
125560209|NCT00467779|451683011|FG013|Stage 2|Adverse Event|0|||
125560210|NCT00467779|451683012|FG014|Stage 2|Adverse Event|0|||
125560211|NCT00467779|451682998|FG000|Stage 2|Death|0|||
125560212|NCT00467779|451682999|FG001|Stage 2|Death|0|||
125560213|NCT00467779|451683000|FG002|Stage 2|Death|0|||
125560214|NCT00467779|451683001|FG003|Stage 2|Death|0|||
125560215|NCT00467779|451683002|FG004|Stage 2|Death|0|||
125560216|NCT00467779|451683003|FG005|Stage 2|Death|0|||
125560217|NCT00467779|451683004|FG006|Stage 2|Death|0|||
125560218|NCT00467779|451683005|FG007|Stage 2|Death|0|||
125560219|NCT00467779|451683006|FG008|Stage 2|Death|1|||
125560220|NCT00467779|451683007|FG009|Stage 2|Death|0|||
125560221|NCT00467779|451683008|FG010|Stage 2|Death|0|||
125560222|NCT00467779|451683009|FG011|Stage 2|Death|0|||
125560223|NCT00467779|451683010|FG012|Stage 2|Death|0|||
125560224|NCT00467779|451683011|FG013|Stage 2|Death|0|||
125560225|NCT00467779|451683012|FG014|Stage 2|Death|0|||
125560226|NCT00467779|451682998|FG000|Stage 2|Disease Progression|0|||
125560227|NCT00467779|451682999|FG001|Stage 2|Disease Progression|0|||
125560228|NCT00467779|451683000|FG002|Stage 2|Disease Progression|0|||
125560229|NCT00467779|451683001|FG003|Stage 2|Disease Progression|0|||
125560230|NCT00467779|451683002|FG004|Stage 2|Disease Progression|0|||
125560231|NCT00467779|451683003|FG005|Stage 2|Disease Progression|0|||
125560232|NCT00467779|451683004|FG006|Stage 2|Disease Progression|0|||
125560233|NCT00467779|451683005|FG007|Stage 2|Disease Progression|0|||
125560234|NCT00467779|451683006|FG008|Stage 2|Disease Progression|16|||
125560235|NCT00467779|451683007|FG009|Stage 2|Disease Progression|0|||
125560236|NCT00467779|451683008|FG010|Stage 2|Disease Progression|0|||
125560237|NCT00467779|451683009|FG011|Stage 2|Disease Progression|0|||
125560238|NCT00467779|451683010|FG012|Stage 2|Disease Progression|0|||
125560239|NCT00467779|451683011|FG013|Stage 2|Disease Progression|0|||
125560240|NCT00467779|451683012|FG014|Stage 2|Disease Progression|0|||
125560241|NCT00467779|451682998|FG000|Stage 2|Unspecified Reason|0|||
125560242|NCT00467779|451682999|FG001|Stage 2|Unspecified Reason|0|||
125560243|NCT00467779|451683000|FG002|Stage 2|Unspecified Reason|0|||
125560244|NCT00467779|451683001|FG003|Stage 2|Unspecified Reason|0|||
125560245|NCT00467779|451683002|FG004|Stage 2|Unspecified Reason|0|||
125560246|NCT00467779|451683003|FG005|Stage 2|Unspecified Reason|0|||
125560247|NCT00467779|451683004|FG006|Stage 2|Unspecified Reason|0|||
125560248|NCT00467779|451683005|FG007|Stage 2|Unspecified Reason|0|||
125560249|NCT00467779|451683006|FG008|Stage 2|Unspecified Reason|3|||
125560250|NCT00467779|451683007|FG009|Stage 2|Unspecified Reason|0|||
125560251|NCT00467779|451683008|FG010|Stage 2|Unspecified Reason|0|||
125560252|NCT00467779|451683009|FG011|Stage 2|Unspecified Reason|0|||
125560253|NCT00467779|451683010|FG012|Stage 2|Unspecified Reason|0|||
125560254|NCT00467779|451683011|FG013|Stage 2|Unspecified Reason|0|||
125560255|NCT00467779|451683012|FG014|Stage 2|Unspecified Reason|0|||
125560256|NCT00467779|451682998|FG000|Stage 2A|Adverse Event|0|||
125560257|NCT00467779|451682999|FG001|Stage 2A|Adverse Event|0|||
125560258|NCT00467779|451683000|FG002|Stage 2A|Adverse Event|0|||
125560259|NCT00467779|451683001|FG003|Stage 2A|Adverse Event|0|||
125560260|NCT00467779|451683002|FG004|Stage 2A|Adverse Event|0|||
125560261|NCT00467779|451683003|FG005|Stage 2A|Adverse Event|0|||
125560262|NCT00467779|451683004|FG006|Stage 2A|Adverse Event|0|||
125560263|NCT00467779|451683005|FG007|Stage 2A|Adverse Event|0|||
125560264|NCT00467779|451683006|FG008|Stage 2A|Adverse Event|0|||
125560265|NCT00467779|451683007|FG009|Stage 2A|Adverse Event|0|||
125560266|NCT00467779|451683008|FG010|Stage 2A|Adverse Event|0|||
125560267|NCT00467779|451683009|FG011|Stage 2A|Adverse Event|0|||
125560268|NCT00467779|451683010|FG012|Stage 2A|Adverse Event|0|||
125560269|NCT00467779|451683011|FG013|Stage 2A|Adverse Event|2|||
125560270|NCT00467779|451683012|FG014|Stage 2A|Adverse Event|0|||
125560271|NCT00467779|451682998|FG000|Stage 2A|Death|0|||
125560272|NCT00467779|451682999|FG001|Stage 2A|Death|0|||
125560273|NCT00467779|451683000|FG002|Stage 2A|Death|0|||
125560274|NCT00467779|451683001|FG003|Stage 2A|Death|0|||
125560275|NCT00467779|451683002|FG004|Stage 2A|Death|0|||
125560276|NCT00467779|451683003|FG005|Stage 2A|Death|0|||
125560277|NCT00467779|451683004|FG006|Stage 2A|Death|0|||
125560278|NCT00467779|451683005|FG007|Stage 2A|Death|0|||
125560279|NCT00467779|451683006|FG008|Stage 2A|Death|0|||
125560280|NCT00467779|451683007|FG009|Stage 2A|Death|0|||
125560281|NCT00467779|451683008|FG010|Stage 2A|Death|0|||
125560282|NCT00467779|451683009|FG011|Stage 2A|Death|0|||
125560283|NCT00467779|451683010|FG012|Stage 2A|Death|0|||
125560284|NCT00467779|451683011|FG013|Stage 2A|Death|1|||
125560285|NCT00467779|451683012|FG014|Stage 2A|Death|0|||
125560286|NCT00467779|451682998|FG000|Stage 2A|Disease Progression|0|||
125560287|NCT00467779|451682999|FG001|Stage 2A|Disease Progression|0|||
125560288|NCT00467779|451683000|FG002|Stage 2A|Disease Progression|0|||
125560289|NCT00467779|451683001|FG003|Stage 2A|Disease Progression|0|||
125560290|NCT00467779|451683002|FG004|Stage 2A|Disease Progression|0|||
125560291|NCT00467779|451683003|FG005|Stage 2A|Disease Progression|0|||
125560292|NCT00467779|451683004|FG006|Stage 2A|Disease Progression|0|||
125560293|NCT00467779|451683005|FG007|Stage 2A|Disease Progression|0|||
125560294|NCT00467779|451683006|FG008|Stage 2A|Disease Progression|0|||
125560295|NCT00467779|451683007|FG009|Stage 2A|Disease Progression|0|||
125560296|NCT00467779|451683008|FG010|Stage 2A|Disease Progression|0|||
125560297|NCT00467779|451683009|FG011|Stage 2A|Disease Progression|0|||
125560298|NCT00467779|451683010|FG012|Stage 2A|Disease Progression|0|||
125560299|NCT00467779|451683011|FG013|Stage 2A|Disease Progression|10|||
125560300|NCT00467779|451683012|FG014|Stage 2A|Disease Progression|0|||
125560301|NCT00467779|451682998|FG000|Stage 2A|Unspecified Reason|0|||
125560302|NCT00467779|451682999|FG001|Stage 2A|Unspecified Reason|0|||
125560303|NCT00467779|451683000|FG002|Stage 2A|Unspecified Reason|0|||
125560304|NCT00467779|451683001|FG003|Stage 2A|Unspecified Reason|0|||
125560305|NCT00467779|451683002|FG004|Stage 2A|Unspecified Reason|0|||
125560306|NCT00467779|451683003|FG005|Stage 2A|Unspecified Reason|0|||
125560307|NCT00467779|451683004|FG006|Stage 2A|Unspecified Reason|0|||
125560308|NCT00467779|451683005|FG007|Stage 2A|Unspecified Reason|0|||
125560309|NCT00467779|451683006|FG008|Stage 2A|Unspecified Reason|0|||
125560310|NCT00467779|451683007|FG009|Stage 2A|Unspecified Reason|0|||
125560311|NCT00467779|451683008|FG010|Stage 2A|Unspecified Reason|0|||
125560312|NCT00467779|451683009|FG011|Stage 2A|Unspecified Reason|0|||
125560313|NCT00467779|451683010|FG012|Stage 2A|Unspecified Reason|0|||
125560314|NCT00467779|451683011|FG013|Stage 2A|Unspecified Reason|7|||
125560315|NCT00467779|451683012|FG014|Stage 2A|Unspecified Reason|0|||
125560316|NCT00467779|451682998|FG000|Stage 2A|Withdrawal by Subject|0|||
125560317|NCT00467779|451682999|FG001|Stage 2A|Withdrawal by Subject|0|||
125560318|NCT00467779|451683000|FG002|Stage 2A|Withdrawal by Subject|0|||
125560319|NCT00467779|451683001|FG003|Stage 2A|Withdrawal by Subject|0|||
125560320|NCT00467779|451683002|FG004|Stage 2A|Withdrawal by Subject|0|||
125560321|NCT00467779|451683003|FG005|Stage 2A|Withdrawal by Subject|0|||
125560322|NCT00467779|451683004|FG006|Stage 2A|Withdrawal by Subject|0|||
125560323|NCT00467779|451683005|FG007|Stage 2A|Withdrawal by Subject|0|||
125560324|NCT00467779|451683006|FG008|Stage 2A|Withdrawal by Subject|0|||
125560325|NCT00467779|451683007|FG009|Stage 2A|Withdrawal by Subject|0|||
125560326|NCT00467779|451683008|FG010|Stage 2A|Withdrawal by Subject|0|||
125560327|NCT00467779|451683009|FG011|Stage 2A|Withdrawal by Subject|0|||
125560328|NCT00467779|451683010|FG012|Stage 2A|Withdrawal by Subject|0|||
125560329|NCT00467779|451683011|FG013|Stage 2A|Withdrawal by Subject|1|||
125560330|NCT00467779|451683012|FG014|Stage 2A|Withdrawal by Subject|0|||
125560331|NCT00467779|451682998|FG000|Stage 3|Adverse Event|0|||
125560332|NCT00467779|451682999|FG001|Stage 3|Adverse Event|0|||
125560333|NCT00467779|451683000|FG002|Stage 3|Adverse Event|0|||
125560334|NCT00467779|451683001|FG003|Stage 3|Adverse Event|0|||
125560335|NCT00467779|451683002|FG004|Stage 3|Adverse Event|0|||
125560336|NCT00467779|451683003|FG005|Stage 3|Adverse Event|0|||
125560337|NCT00467779|451683004|FG006|Stage 3|Adverse Event|0|||
125560338|NCT00467779|451683005|FG007|Stage 3|Adverse Event|0|||
125560339|NCT00467779|451683006|FG008|Stage 3|Adverse Event|0|||
125560340|NCT00467779|451683007|FG009|Stage 3|Adverse Event|0|||
125560341|NCT00467779|451683008|FG010|Stage 3|Adverse Event|0|||
125560342|NCT00467779|451683009|FG011|Stage 3|Adverse Event|0|||
125560343|NCT00467779|451683010|FG012|Stage 3|Adverse Event|0|||
125560344|NCT00467779|451683011|FG013|Stage 3|Adverse Event|0|||
125560345|NCT00467779|451683012|FG014|Stage 3|Adverse Event|2|||
125560346|NCT00467779|451682998|FG000|Stage 3|Death|0|||
125560347|NCT00467779|451682999|FG001|Stage 3|Death|0|||
125560348|NCT00467779|451683000|FG002|Stage 3|Death|0|||
125560349|NCT00467779|451683001|FG003|Stage 3|Death|0|||
125560350|NCT00467779|451683002|FG004|Stage 3|Death|0|||
125560351|NCT00467779|451683003|FG005|Stage 3|Death|0|||
125560352|NCT00467779|451683004|FG006|Stage 3|Death|0|||
125560353|NCT00467779|451683005|FG007|Stage 3|Death|0|||
125560354|NCT00467779|451683006|FG008|Stage 3|Death|0|||
125560355|NCT00467779|451683007|FG009|Stage 3|Death|0|||
125560356|NCT00467779|451683008|FG010|Stage 3|Death|0|||
125560357|NCT00467779|451683009|FG011|Stage 3|Death|0|||
125560358|NCT00467779|451683010|FG012|Stage 3|Death|0|||
125560359|NCT00467779|451683011|FG013|Stage 3|Death|0|||
125560360|NCT00467779|451683012|FG014|Stage 3|Death|1|||
125560361|NCT00467779|451682998|FG000|Stage 3|Disease Progression|0|||
125560362|NCT00467779|451682999|FG001|Stage 3|Disease Progression|0|||
125560363|NCT00467779|451683000|FG002|Stage 3|Disease Progression|0|||
125560364|NCT00467779|451683001|FG003|Stage 3|Disease Progression|0|||
125560365|NCT00467779|451683002|FG004|Stage 3|Disease Progression|0|||
125560366|NCT00467779|451683003|FG005|Stage 3|Disease Progression|0|||
125560367|NCT00467779|451683004|FG006|Stage 3|Disease Progression|0|||
125560368|NCT00467779|451683005|FG007|Stage 3|Disease Progression|0|||
125560369|NCT00467779|451683006|FG008|Stage 3|Disease Progression|0|||
125560370|NCT00467779|451683007|FG009|Stage 3|Disease Progression|0|||
125560371|NCT00467779|451683008|FG010|Stage 3|Disease Progression|0|||
125560372|NCT00467779|451683009|FG011|Stage 3|Disease Progression|0|||
125560373|NCT00467779|451683010|FG012|Stage 3|Disease Progression|0|||
125560374|NCT00467779|451683011|FG013|Stage 3|Disease Progression|0|||
125560375|NCT00467779|451683012|FG014|Stage 3|Disease Progression|9|||
125560376|NCT00467779|451682998|FG000|Stage 3|Unspecified Reason|0|||
125560377|NCT00467779|451682999|FG001|Stage 3|Unspecified Reason|0|||
125560378|NCT00467779|451683000|FG002|Stage 3|Unspecified Reason|0|||
125560379|NCT00467779|451683001|FG003|Stage 3|Unspecified Reason|0|||
125560380|NCT00467779|451683002|FG004|Stage 3|Unspecified Reason|0|||
125560381|NCT00467779|451683003|FG005|Stage 3|Unspecified Reason|0|||
125560382|NCT00467779|451683004|FG006|Stage 3|Unspecified Reason|0|||
125560383|NCT00467779|451683005|FG007|Stage 3|Unspecified Reason|0|||
125560384|NCT00467779|451683006|FG008|Stage 3|Unspecified Reason|0|||
125560385|NCT00467779|451683007|FG009|Stage 3|Unspecified Reason|0|||
125560386|NCT00467779|451683008|FG010|Stage 3|Unspecified Reason|0|||
125560387|NCT00467779|451683009|FG011|Stage 3|Unspecified Reason|0|||
125560388|NCT00467779|451683010|FG012|Stage 3|Unspecified Reason|0|||
125560389|NCT00467779|451683011|FG013|Stage 3|Unspecified Reason|0|||
125560390|NCT00467779|451683012|FG014|Stage 3|Unspecified Reason|5|||
125560391|NCT01195090|451683015|FG000|Overall Study|Adverse Event|1|||
125560392|NCT01195090|451683016|FG001|Overall Study|Adverse Event|2|||
125560393|NCT01195090|451683015|FG000|Overall Study|Lost to Follow-up|2|||
125560394|NCT01195090|451683016|FG001|Overall Study|Lost to Follow-up|2|||
125560395|NCT01195090|451683015|FG000|Overall Study|Protocol Violation|3|||
125560396|NCT01195090|451683016|FG001|Overall Study|Protocol Violation|4|||
125560397|NCT05111041|451683017|FG000|Overall Study|Lost to Follow-up|6|||
125560398|NCT05111041|451683018|FG001|Overall Study|Lost to Follow-up|7|||
125560399|NCT05111041|451683017|FG000|Overall Study|Withdrawal by Subject|1|||
125560400|NCT05111041|451683018|FG001|Overall Study|Withdrawal by Subject|0|||
125560401|NCT01205230|451683019|FG000|Overall Study|Adverse Event|4|||
125560402|NCT01205230|451683020|FG001|Overall Study|Adverse Event|0|||
125560403|NCT01205230|451683019|FG000|Overall Study|Physician Decision|1|||
125560404|NCT01205230|451683020|FG001|Overall Study|Physician Decision|0|||
125560405|NCT00791258|451683021|FG000|Overall Study|Adverse Event|87|||
125560406|NCT00791258|451683021|FG000|Overall Study|Lost to Follow-up|18|||
125560407|NCT00791258|451683021|FG000|Overall Study|Protocol Violation|109|||
125560408|NCT00791258|451683021|FG000|Overall Study|Withdrawal by Subject|40|||
125560409|NCT00791258|451683021|FG000|Overall Study|Did not take medication for >3 days|1|||
125560410|NCT00791258|451683021|FG000|Overall Study|subject left area|2|||
125560411|NCT00791258|451683021|FG000|Overall Study|non-compliance|3|||
125353410|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
125353411|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
125353412|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
125353413|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
125560412|NCT00791258|451683021|FG000|Overall Study|Subject incarcerated|1|||
125560413|NCT00791258|451683021|FG000|Overall Study|Subject required restricted medication|1|||
125560414|NCT00791258|451683021|FG000|Overall Study|Lack of Efficacy|1|||
125560415|NCT00041080|451683022|FG000|Overall Study|Adverse Event|21|||
125560416|NCT00041080|451683023|FG001|Overall Study|Adverse Event|1|||
125560417|NCT00041080|451683022|FG000|Overall Study|Withdrawal by Subject|6|||
125560418|NCT00041080|451683023|FG001|Overall Study|Withdrawal by Subject|6|||
125560419|NCT00041080|451683022|FG000|Overall Study|Concommitant Illness/Other|1|||
125560420|NCT00041080|451683023|FG001|Overall Study|Concommitant Illness/Other|2|||
125560421|NCT00041080|451683022|FG000|Overall Study|Did not start therapy|1|||
125560422|NCT00041080|451683023|FG001|Overall Study|Did not start therapy|1|||
125560423|NCT00041080|451683022|FG000|Overall Study|Ineligible|1|||
125560424|NCT00041080|451683023|FG001|Overall Study|Ineligible|0|||
125560425|NCT04784897|451683024|FG000|Overall Study|Death|4|||
125560426|NCT04784897|451683025|FG001|Overall Study|Death|2|||
125560427|NCT04784897|451683026|FG002|Overall Study|Death|1|||
125560428|NCT04784897|451683024|FG000|Overall Study|Withdrawal by Subject|0|||
125560429|NCT04784897|451683025|FG001|Overall Study|Withdrawal by Subject|0|||
125560430|NCT04784897|451683026|FG002|Overall Study|Withdrawal by Subject|1|||
125560431|NCT04667377|451683027|FG000|Dose Escalation Period|Other not specified below|3|||
125560432|NCT04667377|451683028|FG001|Dose Escalation Period|Other not specified below|3|||
125560433|NCT04667377|451683029|FG002|Dose Escalation Period|Other not specified below|2|||
125560434|NCT04667377|451683030|FG003|Dose Escalation Period|Other not specified below|1|||
125560435|NCT04667377|451683031|FG004|Dose Escalation Period|Other not specified below|3|||
125560436|NCT04667377|451683027|FG000|Dose Escalation Period|Protocol Violation|2|||
125560437|NCT04667377|451683028|FG001|Dose Escalation Period|Protocol Violation|2|||
125560438|NCT04667377|451683029|FG002|Dose Escalation Period|Protocol Violation|0|||
125560439|NCT04667377|451683030|FG003|Dose Escalation Period|Protocol Violation|2|||
125560440|NCT04667377|451683031|FG004|Dose Escalation Period|Protocol Violation|1|||
125560441|NCT04667377|451683027|FG000|Dose Escalation Period|Burden of study procedures|2|||
125560442|NCT04667377|451683028|FG001|Dose Escalation Period|Burden of study procedures|1|||
125560443|NCT04667377|451683029|FG002|Dose Escalation Period|Burden of study procedures|1|||
125560444|NCT04667377|451683030|FG003|Dose Escalation Period|Burden of study procedures|1|||
125560445|NCT04667377|451683031|FG004|Dose Escalation Period|Burden of study procedures|5|||
125560446|NCT04667377|451683027|FG000|Dose Escalation Period|Change of residence|0|||
125560447|NCT04667377|451683028|FG001|Dose Escalation Period|Change of residence|0|||
125560448|NCT04667377|451683029|FG002|Dose Escalation Period|Change of residence|1|||
125560449|NCT04667377|451683030|FG003|Dose Escalation Period|Change of residence|0|||
125560450|NCT04667377|451683031|FG004|Dose Escalation Period|Change of residence|0|||
125560451|NCT04667377|451683027|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
125560452|NCT04667377|451683028|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
125560453|NCT04667377|451683029|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
125560454|NCT04667377|451683030|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
125560455|NCT04667377|451683031|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
125560456|NCT04667377|451683027|FG000|Dose Escalation Period|Adverse Event|9|||
125560457|NCT04667377|451683028|FG001|Dose Escalation Period|Adverse Event|10|||
125560458|NCT04667377|451683029|FG002|Dose Escalation Period|Adverse Event|12|||
125560459|NCT04667377|451683030|FG003|Dose Escalation Period|Adverse Event|17|||
125560460|NCT04667377|451683031|FG004|Dose Escalation Period|Adverse Event|3|||
125560461|NCT04667377|451683027|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
125560462|NCT04667377|451683028|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
125560463|NCT04667377|451683029|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
125560464|NCT04667377|451683030|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
125560465|NCT04667377|451683031|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
125560466|NCT04667377|451683027|FG000|Dose Escalation Period|Not treated|1|||
125560467|NCT04667377|451683028|FG001|Dose Escalation Period|Not treated|0|||
125560468|NCT04667377|451683029|FG002|Dose Escalation Period|Not treated|0|||
125560469|NCT04667377|451683030|FG003|Dose Escalation Period|Not treated|0|||
125560470|NCT04667377|451683031|FG004|Dose Escalation Period|Not treated|0|||
125560471|NCT04667377|451683027|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
125560472|NCT04667377|451683028|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
125560473|NCT04667377|451683029|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
125560474|NCT04667377|451683030|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
125560475|NCT04667377|451683031|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
125560476|NCT04667377|451683027|FG000|Dose Escalation Period|Lost to Follow-up|0|||
125560477|NCT04667377|451683028|FG001|Dose Escalation Period|Lost to Follow-up|1|||
125560478|NCT04667377|451683029|FG002|Dose Escalation Period|Lost to Follow-up|0|||
125560479|NCT04667377|451683030|FG003|Dose Escalation Period|Lost to Follow-up|0|||
125560480|NCT04667377|451683031|FG004|Dose Escalation Period|Lost to Follow-up|0|||
125560481|NCT04667377|451683027|FG000|Maintenance Period|Perceived lack of efficacy|0|||
125560482|NCT04667377|451683028|FG001|Maintenance Period|Perceived lack of efficacy|2|||
125560483|NCT04667377|451683029|FG002|Maintenance Period|Perceived lack of efficacy|1|||
125560484|NCT04667377|451683030|FG003|Maintenance Period|Perceived lack of efficacy|0|||
125560485|NCT04667377|451683031|FG004|Maintenance Period|Perceived lack of efficacy|1|||
125560486|NCT04667377|451683027|FG000|Maintenance Period|Adverse Event|2|||
125560487|NCT04667377|451683028|FG001|Maintenance Period|Adverse Event|8|||
125560488|NCT04667377|451683029|FG002|Maintenance Period|Adverse Event|5|||
125560489|NCT04667377|451683030|FG003|Maintenance Period|Adverse Event|4|||
125560490|NCT04667377|451683031|FG004|Maintenance Period|Adverse Event|1|||
125560491|NCT04667377|451683027|FG000|Maintenance Period|Adverse event: COVID infection|0|||
125560492|NCT04667377|451683028|FG001|Maintenance Period|Adverse event: COVID infection|1|||
125560493|NCT04667377|451683029|FG002|Maintenance Period|Adverse event: COVID infection|0|||
125560494|NCT04667377|451683030|FG003|Maintenance Period|Adverse event: COVID infection|0|||
125560495|NCT04667377|451683031|FG004|Maintenance Period|Adverse event: COVID infection|0|||
125560496|NCT04667377|451683027|FG000|Maintenance Period|COVID-related|0|||
125560497|NCT04667377|451683028|FG001|Maintenance Period|COVID-related|0|||
125560498|NCT04667377|451683029|FG002|Maintenance Period|COVID-related|1|||
125560499|NCT04667377|451683030|FG003|Maintenance Period|COVID-related|1|||
125560500|NCT04667377|451683031|FG004|Maintenance Period|COVID-related|0|||
125560501|NCT04667377|451683027|FG000|Maintenance Period|Protocol Violation|1|||
125560502|NCT04667377|451683028|FG001|Maintenance Period|Protocol Violation|0|||
125560503|NCT04667377|451683029|FG002|Maintenance Period|Protocol Violation|0|||
125560504|NCT04667377|451683030|FG003|Maintenance Period|Protocol Violation|0|||
125560505|NCT04667377|451683031|FG004|Maintenance Period|Protocol Violation|1|||
125560506|NCT04667377|451683027|FG000|Maintenance Period|Burden of study procedures|1|||
125560507|NCT04667377|451683028|FG001|Maintenance Period|Burden of study procedures|2|||
125560508|NCT04667377|451683029|FG002|Maintenance Period|Burden of study procedures|0|||
125560509|NCT04667377|451683030|FG003|Maintenance Period|Burden of study procedures|1|||
125560510|NCT04667377|451683031|FG004|Maintenance Period|Burden of study procedures|0|||
125560511|NCT04667377|451683027|FG000|Maintenance Period|Change of residence|0|||
125560512|NCT04667377|451683028|FG001|Maintenance Period|Change of residence|1|||
125560513|NCT04667377|451683029|FG002|Maintenance Period|Change of residence|0|||
125560514|NCT04667377|451683030|FG003|Maintenance Period|Change of residence|0|||
125560515|NCT04667377|451683031|FG004|Maintenance Period|Change of residence|1|||
125560516|NCT04667377|451683027|FG000|Maintenance Period|Missing|1|||
125560517|NCT04667377|451683028|FG001|Maintenance Period|Missing|0|||
125560518|NCT04667377|451683029|FG002|Maintenance Period|Missing|0|||
125560519|NCT04667377|451683030|FG003|Maintenance Period|Missing|0|||
125560520|NCT04667377|451683031|FG004|Maintenance Period|Missing|0|||
125560521|NCT04667377|451683027|FG000|Maintenance Period|Other than listed above|2|||
125560522|NCT04667377|451683028|FG001|Maintenance Period|Other than listed above|0|||
125560523|NCT04667377|451683029|FG002|Maintenance Period|Other than listed above|3|||
125560524|NCT04667377|451683030|FG003|Maintenance Period|Other than listed above|2|||
125560525|NCT04667377|451683031|FG004|Maintenance Period|Other than listed above|6|||
125560526|NCT04667377|451683027|FG000|Maintenance Period|Withdrawal by Subject|0|||
125560527|NCT04667377|451683028|FG001|Maintenance Period|Withdrawal by Subject|1|||
125560528|NCT04667377|451683029|FG002|Maintenance Period|Withdrawal by Subject|0|||
125560529|NCT04667377|451683030|FG003|Maintenance Period|Withdrawal by Subject|0|||
125560530|NCT04667377|451683031|FG004|Maintenance Period|Withdrawal by Subject|0|||
125560531|NCT04667377|451683027|FG000|Maintenance Period|Lost to Follow-up|1|||
125560532|NCT04667377|451683028|FG001|Maintenance Period|Lost to Follow-up|0|||
125560533|NCT04667377|451683029|FG002|Maintenance Period|Lost to Follow-up|1|||
125560534|NCT04667377|451683030|FG003|Maintenance Period|Lost to Follow-up|0|||
125560535|NCT04667377|451683031|FG004|Maintenance Period|Lost to Follow-up|1|||
125560536|NCT02428855|451683032|FG000|Overall Study|Withdrawal by Subject|2|||
125560537|NCT02066311|451683033|FG000|Overall Study|Adverse Event|4|||
125560538|NCT02066311|451683033|FG000|Overall Study|Withdrawal by Subject|1|||
125560539|NCT03198520|451683040|FG000|Overall Study|Physician Decision|2|||
125560540|NCT03198520|451683040|FG000|Overall Study|Protocol Violation|2|||
125560541|NCT03198520|451683040|FG000|Overall Study|Withdrawal by Subject|1|||
125560542|NCT03198520|451683040|FG000|Overall Study|Study Ended|1|||
125560543|NCT01670539|451683041|FG000|Overall Study|Death|3|||
125560544|NCT01670539|451683042|FG001|Overall Study|Death|5|||
125560545|NCT01670539|451683041|FG000|Overall Study|Withdrawal by Subject|3|||
125560546|NCT01670539|451683042|FG001|Overall Study|Withdrawal by Subject|0|||
125560547|NCT04353596|451683043|FG000|Overall Study|Protocol Violation|4|||
125560548|NCT04353596|451683044|FG001|Overall Study|Protocol Violation|4|||
125560549|NCT04353596|451683043|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
125560550|NCT04353596|451683044|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
125560551|NCT00823823|451683045|FG000|Overall Study|Lost to Follow-up|3|||
125560552|NCT00823823|451683046|FG001|Overall Study|Lost to Follow-up|1|||
125560553|NCT00823823|451683045|FG000|Overall Study|Protocol Violation|5|||
125560554|NCT00823823|451683046|FG001|Overall Study|Protocol Violation|5|||
125560555|NCT04422990|451683050|FG000|Overall Study|Withdrawal by Subject|0|||
125560556|NCT04422990|451683051|FG001|Overall Study|Withdrawal by Subject|1|||
125560557|NCT04422990|451683050|FG000|Overall Study|Travel|3|||
125560558|NCT04422990|451683051|FG001|Overall Study|Travel|0|||
125560559|NCT01490814|451683052|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
125560560|NCT01490814|451683053|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
125560561|NCT01490814|451683052|FG000|Overall Study|Physician Decision|1|||
125560562|NCT01490814|451683053|FG001|Overall Study|Physician Decision|0|||
125426207|NCT00595504|451184414|FG000|Overall Study|Withdrawal by Subject|1|||
125560563|NCT01490814|451683052|FG000|Overall Study|Withdrawal by Subject|0|||
125560564|NCT01490814|451683053|FG001|Overall Study|Withdrawal by Subject|5|||
125560565|NCT03024970|451683063|FG000|First Intervention|Adverse Event|1|||
125560566|NCT03024970|451683064|FG001|First Intervention|Adverse Event|0|||
125560567|NCT03024970|451683063|FG000|Second Intervention|Lost to Follow-up|1|||
125353414|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
125353415|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
125353416|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
125353417|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
125353418|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
125560568|NCT03024970|451683064|FG001|Second Intervention|Lost to Follow-up|0|||
125560569|NCT01221727|451683068|FG000|Overall Study|Physician Decision|2|||
125560570|NCT01221727|451683069|FG001|Overall Study|Physician Decision|0|||
125560571|NCT01221727|451683068|FG000|Overall Study|Withdrawal by Subject|1|||
125560572|NCT01221727|451683069|FG001|Overall Study|Withdrawal by Subject|1|||
125560573|NCT02790138|451683070|FG000|Overall Study|Adverse Event|5|||
125560574|NCT02790138|451683071|FG001|Overall Study|Adverse Event|2|||
125560575|NCT02790138|451683070|FG000|Overall Study|Significant Protocol Deviation|0|||
125560576|NCT02790138|451683071|FG001|Overall Study|Significant Protocol Deviation|1|||
125560577|NCT02790138|451683070|FG000|Overall Study|Lost to Follow-up|1|||
125560578|NCT02790138|451683071|FG001|Overall Study|Lost to Follow-up|0|||
125560579|NCT02790138|451683070|FG000|Overall Study|Voluntary Withdrawal|8|||
125560580|NCT02790138|451683071|FG001|Overall Study|Voluntary Withdrawal|9|||
125560581|NCT02790138|451683070|FG000|Overall Study|Lack of Efficacy|6|||
125560582|NCT02790138|451683071|FG001|Overall Study|Lack of Efficacy|7|||
125560583|NCT02790138|451683070|FG000|Overall Study|Reason not Specified|1|||
125560584|NCT02790138|451683071|FG001|Overall Study|Reason not Specified|0|||
125560585|NCT01786603|451683072|FG000|Overall Study|Death|5|||
125560586|NCT01786603|451683073|FG001|Overall Study|Death|1|||
125560587|NCT01786603|451683072|FG000|Overall Study|Adverse Event|6|||
125560588|NCT01786603|451683073|FG001|Overall Study|Adverse Event|2|||
125560589|NCT01786603|451683072|FG000|Overall Study|Physician decision to withdraw|6|||
125560590|NCT01786603|451683073|FG001|Overall Study|Physician decision to withdraw|7|||
125560591|NCT01786603|451683072|FG000|Overall Study|Lost to Follow-up|1|||
125560592|NCT01786603|451683073|FG001|Overall Study|Lost to Follow-up|2|||
125560593|NCT01226459|451683074|FG000|Overall Study|Adverse Event|2|||
125560594|NCT01226459|451683075|FG001|Overall Study|Adverse Event|8|||
125560595|NCT01226459|451683074|FG000|Overall Study|Protocol Violation|4|||
125560596|NCT01226459|451683075|FG001|Overall Study|Protocol Violation|3|||
125560597|NCT01226459|451683074|FG000|Overall Study|Withdrawal by Subject|10|||
125560598|NCT01226459|451683075|FG001|Overall Study|Withdrawal by Subject|13|||
125560599|NCT01226459|451683074|FG000|Overall Study|Lost to Follow-up|4|||
125560600|NCT01226459|451683075|FG001|Overall Study|Lost to Follow-up|8|||
125560601|NCT01226459|451683074|FG000|Overall Study|Pregnancy|1|||
125560602|NCT01226459|451683075|FG001|Overall Study|Pregnancy|0|||
125560603|NCT00474708|451683076|FG000|Overall Study|Lack of Efficacy|11|||
125560604|NCT00474708|451683077|FG001|Overall Study|Lack of Efficacy|5|||
125560605|NCT00474708|451683076|FG000|Overall Study|Suicide ideation/behavior|0|||
125560606|NCT00474708|451683077|FG001|Overall Study|Suicide ideation/behavior|1|||
125560607|NCT00474708|451683076|FG000|Overall Study|Withdrawal by Subject|7|||
125560608|NCT00474708|451683077|FG001|Overall Study|Withdrawal by Subject|0|||
125560609|NCT00474708|451683076|FG000|Overall Study|Lack of compliance|12|||
125560610|NCT00474708|451683077|FG001|Overall Study|Lack of compliance|4|||
125560611|NCT00474708|451683076|FG000|Overall Study|Lost to Follow-up|18|||
125560612|NCT00474708|451683077|FG001|Overall Study|Lost to Follow-up|9|||
125560613|NCT00474708|451683076|FG000|Overall Study|Physician Decision|9|||
125560614|NCT00474708|451683077|FG001|Overall Study|Physician Decision|6|||
125560615|NCT03700320|451683078|FG000|Overall Study|Adverse Event|5|||
125560616|NCT03700320|451683079|FG001|Overall Study|Adverse Event|31|||
125560617|NCT03700320|451683078|FG000|Overall Study|Lack of Efficacy|2|||
125560618|NCT03700320|451683079|FG001|Overall Study|Lack of Efficacy|5|||
125560619|NCT03700320|451683078|FG000|Overall Study|Withdrawal by Subject|29|||
125560620|NCT03700320|451683079|FG001|Overall Study|Withdrawal by Subject|75|||
125560621|NCT03700320|451683078|FG000|Overall Study|Lost to Follow-up|16|||
125560622|NCT03700320|451683079|FG001|Overall Study|Lost to Follow-up|23|||
125560623|NCT03700320|451683078|FG000|Overall Study|Pregnancy|2|||
125560624|NCT03700320|451683079|FG001|Overall Study|Pregnancy|4|||
125560625|NCT03700320|451683078|FG000|Overall Study|Protocol Deviation|7|||
125353419|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
125560626|NCT03700320|451683079|FG001|Overall Study|Protocol Deviation|31|||
125560627|NCT03700320|451683078|FG000|Overall Study|Non-compliance with Study Drug|1|||
125560628|NCT03700320|451683079|FG001|Overall Study|Non-compliance with Study Drug|3|||
125560629|NCT03700320|451683078|FG000|Overall Study|Reason not Specified|0|||
125560630|NCT03700320|451683079|FG001|Overall Study|Reason not Specified|1|||
125560631|NCT00175877|451683083|FG000|Overall Study|Adverse Event|136|||
125560632|NCT00175877|451683083|FG000|Overall Study|Withdrawal by Subject|141|||
125560633|NCT00175877|451683083|FG000|Overall Study|Lost to Follow-up|9|||
125560634|NCT00175877|451683083|FG000|Overall Study|Lack of Efficacy|26|||
125560635|NCT00175877|451683083|FG000|Overall Study|Protocol Violation|15|||
125560636|NCT00175877|451683083|FG000|Overall Study|Other Reason|20|||
125560637|NCT00175877|451683083|FG000|Overall Study|AE & Other|1|||
125560638|NCT00175877|451683083|FG000|Overall Study|Withdrawal by subject & Other|1|||
125560639|NCT01092143|451683086|FG000|Overall Study|Adverse Event|10|||
125560640|NCT01092143|451683087|FG001|Overall Study|Adverse Event|5|||
125560641|NCT01092143|451683088|FG002|Overall Study|Adverse Event|1|||
125560642|NCT01092143|451683089|FG003|Overall Study|Adverse Event|4|||
125560643|NCT01092143|451683090|FG004|Overall Study|Adverse Event|3|||
125560644|NCT01092143|451683086|FG000|Overall Study|Lost to Follow-up|1|||
125560645|NCT01092143|451683087|FG001|Overall Study|Lost to Follow-up|0|||
125560646|NCT01092143|451683088|FG002|Overall Study|Lost to Follow-up|1|||
125560647|NCT01092143|451683089|FG003|Overall Study|Lost to Follow-up|0|||
125560648|NCT01092143|451683090|FG004|Overall Study|Lost to Follow-up|0|||
125560649|NCT01092143|451683086|FG000|Overall Study|Consent withdrawn|2|||
125560650|NCT01092143|451683087|FG001|Overall Study|Consent withdrawn|1|||
125560651|NCT01092143|451683088|FG002|Overall Study|Consent withdrawn|0|||
125560652|NCT01092143|451683089|FG003|Overall Study|Consent withdrawn|1|||
125560653|NCT01092143|451683090|FG004|Overall Study|Consent withdrawn|3|||
125560654|NCT01092143|451683086|FG000|Overall Study|Not treated|0|||
125560655|NCT01092143|451683087|FG001|Overall Study|Not treated|0|||
125560656|NCT01092143|451683088|FG002|Overall Study|Not treated|1|||
125560657|NCT01092143|451683089|FG003|Overall Study|Not treated|0|||
125560658|NCT01092143|451683090|FG004|Overall Study|Not treated|0|||
125426208|NCT00595504|451184415|FG001|Overall Study|Withdrawal by Subject|3|||
125560659|NCT01092143|451683086|FG000|Overall Study|did not reversibility criteria|0|||
125560660|NCT01092143|451683087|FG001|Overall Study|did not reversibility criteria|0|||
125560661|NCT01092143|451683088|FG002|Overall Study|did not reversibility criteria|1|||
125560662|NCT01092143|451683089|FG003|Overall Study|did not reversibility criteria|0|||
125560663|NCT01092143|451683090|FG004|Overall Study|did not reversibility criteria|0|||
125560664|NCT01092143|451683086|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
125426209|NCT00595504|451184414|FG000|Overall Study|Physician Decision|1|||
125426210|NCT00595504|451184415|FG001|Overall Study|Physician Decision|0|||
125353420|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
125353421|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
125353422|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
125353423|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
125353424|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
125353425|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
125353426|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
125353427|NCT03739840|450929450|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
125353428|NCT03739840|450929451|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
125353429|NCT03739840|450929452|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
125353430|NCT03739840|450929453|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
125353431|NCT03739840|450929450|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
125353432|NCT03739840|450929451|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
125353433|NCT03739840|450929452|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
125353434|NCT03739840|450929453|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
125353435|NCT03739840|450929450|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
125353436|NCT03739840|450929451|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
125353437|NCT03739840|450929452|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
125353438|NCT03739840|450929453|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
125353439|NCT03739840|450929450|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
125353440|NCT03739840|450929451|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
125353441|NCT03739840|450929452|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
125353442|NCT03739840|450929453|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
125353443|NCT03739840|450929450|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
125353444|NCT03739840|450929451|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
125353445|NCT03739840|450929452|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
125353446|NCT03739840|450929453|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
125353447|NCT03739840|450929450|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
125353448|NCT03739840|450929451|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
125353449|NCT03739840|450929452|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
125353450|NCT03739840|450929453|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
125353451|NCT03739840|450929450|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
125353452|NCT03739840|450929451|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
125353453|NCT03739840|450929452|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
125353454|NCT03739840|450929453|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
125353455|NCT03739840|450929450|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
125353456|NCT03739840|450929451|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
125353457|NCT03739840|450929452|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
125353458|NCT03739840|450929453|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
125353459|NCT03739840|450929450|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
125353460|NCT03739840|450929451|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
125353461|NCT03739840|450929452|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
125353462|NCT03739840|450929453|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
125353463|NCT01058265|450929456|FG000|Overall Study|Lost to Follow-up|11|||
125353464|NCT01058265|450929457|FG001|Overall Study|Lost to Follow-up|12|||
125353465|NCT02962765|450929458|FG000|Overall Study|Protocol Violation|9|||
125353466|NCT02962765|450929458|FG000|Overall Study|Withdrawal by Subject|3|||
125353467|NCT02962765|450929458|FG000|Overall Study|Lost to Follow-up|1|||
125426211|NCT02182973|451184429|FG000|Overall Study|Withdrawal by Subject|3|||
125426212|NCT02182973|451184430|FG001|Overall Study|Withdrawal by Subject|0|||
125426213|NCT01235546|451184431|FG000|Overall Study|Staff error, medication not administered|1|||
125426214|NCT01235546|451184432|FG001|Overall Study|Staff error, medication not administered|0|||
125426215|NCT01235546|451184431|FG000|Overall Study|Protocol Violation|1|||
125426216|NCT01235546|451184432|FG001|Overall Study|Protocol Violation|1|||
125426217|NCT01123382|451184433|FG000|Overall Study|Withdrawal by Subject|1|||
125426218|NCT01123382|451184434|FG001|Overall Study|Withdrawal by Subject|4|||
125426219|NCT01123382|451184433|FG000|Overall Study|Lost to Follow-up|1|||
125426220|NCT01123382|451184434|FG001|Overall Study|Lost to Follow-up|2|||
125426221|NCT04535947|451184435|FG000|Overall Study|Adverse Event|1|||
125426222|NCT04535947|451184436|FG001|Overall Study|Adverse Event|4|||
125426223|NCT04535947|451184435|FG000|Overall Study|Other reasons not specified|2|||
125426224|NCT04535947|451184436|FG001|Overall Study|Other reasons not specified|0|||
125426225|NCT04535947|451184435|FG000|Overall Study|Withdrawal by Subject|1|||
125426226|NCT04535947|451184436|FG001|Overall Study|Withdrawal by Subject|1|||
125426227|NCT03802123|451184437|FG000|Overall Study|Withdrawal by Subject|3|||
125560665|NCT01092143|451683087|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
125560666|NCT01092143|451683088|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
125560667|NCT01092143|451683089|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
125560668|NCT01092143|451683090|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
125560669|NCT01092143|451683086|FG000|Overall Study|Ineligible patient|1|||
125560670|NCT01092143|451683087|FG001|Overall Study|Ineligible patient|0|||
125353468|NCT02962765|450929458|FG000|Overall Study|Death|1|||
125353469|NCT02962765|450929458|FG000|Overall Study|Limited access to study medication|3|||
125353470|NCT00750880|450929461|FG000|Overall Study|Adverse Event|76|||
125353471|NCT00750880|450929461|FG000|Overall Study|Death|4|||
125353472|NCT00750880|450929461|FG000|Overall Study|Lack of Efficacy|46|||
125353473|NCT00750880|450929461|FG000|Overall Study|Lost to Follow-up|10|||
125353474|NCT00750880|450929461|FG000|Overall Study|Protocol Violation|15|||
125353475|NCT00750880|450929461|FG000|Overall Study|Withdrawal by Subject|33|||
125353476|NCT00750880|450929461|FG000|Overall Study|Physician Decision|20|||
125353477|NCT00750880|450929461|FG000|Overall Study|Administrative|11|||
125353478|NCT00984568|450929465|FG000|Overall Study|Withdrawal by Subject|1|||
125353479|NCT00984568|450929466|FG001|Overall Study|Withdrawal by Subject|2|||
125353480|NCT00984568|450929465|FG000|Overall Study|Lack of Efficacy|2|||
125353481|NCT00984568|450929466|FG001|Overall Study|Lack of Efficacy|0|||
125353482|NCT00984568|450929465|FG000|Overall Study|Adverse Event|2|||
125353483|NCT00984568|450929466|FG001|Overall Study|Adverse Event|0|||
125353484|NCT00984568|450929465|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
125353485|NCT00984568|450929466|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
125353486|NCT00984568|450929465|FG000|Overall Study|Lost to Follow-up|0|||
125353487|NCT00984568|450929466|FG001|Overall Study|Lost to Follow-up|1|||
125353488|NCT00984568|450929465|FG000|Overall Study|Opportunistic Infection|1|||
125353489|NCT00984568|450929466|FG001|Overall Study|Opportunistic Infection|0|||
125353490|NCT00984568|450929465|FG000|Overall Study|Unknown Reason|1|||
125353491|NCT00984568|450929466|FG001|Overall Study|Unknown Reason|3|||
125353492|NCT02964507|450929467|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
125353493|NCT02964507|450929468|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
125353494|NCT02964507|450929469|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
125353495|NCT02964507|450929470|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
125353496|NCT02964507|450929471|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
125353497|NCT02964507|450929472|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
125353498|NCT02964507|450929473|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
125353499|NCT02964507|450929474|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
125353500|NCT02964507|450929467|FG000|Overall Study|Study terminated by Sponsor|9|||
125353501|NCT02964507|450929468|FG001|Overall Study|Study terminated by Sponsor|1|||
125353502|NCT02964507|450929469|FG002|Overall Study|Study terminated by Sponsor|9|||
125353503|NCT02964507|450929470|FG003|Overall Study|Study terminated by Sponsor|3|||
125353504|NCT02964507|450929471|FG004|Overall Study|Study terminated by Sponsor|3|||
125353505|NCT02964507|450929472|FG005|Overall Study|Study terminated by Sponsor|2|||
125353506|NCT02964507|450929473|FG006|Overall Study|Study terminated by Sponsor|0|||
125353507|NCT02964507|450929474|FG007|Overall Study|Study terminated by Sponsor|0|||
125353508|NCT02964507|450929467|FG000|Overall Study|Other|3|||
125353509|NCT02964507|450929468|FG001|Overall Study|Other|0|||
125353510|NCT02964507|450929469|FG002|Overall Study|Other|0|||
125353511|NCT02964507|450929470|FG003|Overall Study|Other|0|||
125353512|NCT02964507|450929471|FG004|Overall Study|Other|1|||
125353513|NCT02964507|450929472|FG005|Overall Study|Other|0|||
125353514|NCT02964507|450929473|FG006|Overall Study|Other|0|||
125353515|NCT02964507|450929474|FG007|Overall Study|Other|0|||
125353516|NCT02964507|450929467|FG000|Overall Study|Death|11|||
125353517|NCT02964507|450929468|FG001|Overall Study|Death|9|||
125353518|NCT02964507|450929469|FG002|Overall Study|Death|12|||
125353519|NCT02964507|450929470|FG003|Overall Study|Death|2|||
125353520|NCT02964507|450929471|FG004|Overall Study|Death|10|||
125353521|NCT02964507|450929472|FG005|Overall Study|Death|5|||
125353522|NCT02964507|450929473|FG006|Overall Study|Death|0|||
125353523|NCT02964507|450929474|FG007|Overall Study|Death|0|||
125353524|NCT02964507|450929467|FG000|Overall Study|Withdrawal by Subject|1|||
125353525|NCT02964507|450929468|FG001|Overall Study|Withdrawal by Subject|0|||
125353526|NCT02964507|450929469|FG002|Overall Study|Withdrawal by Subject|1|||
125353527|NCT02964507|450929470|FG003|Overall Study|Withdrawal by Subject|1|||
125353528|NCT02964507|450929471|FG004|Overall Study|Withdrawal by Subject|0|||
125353529|NCT02964507|450929472|FG005|Overall Study|Withdrawal by Subject|1|||
125353530|NCT02964507|450929473|FG006|Overall Study|Withdrawal by Subject|0|||
125353531|NCT02964507|450929474|FG007|Overall Study|Withdrawal by Subject|0|||
125353532|NCT02964507|450929467|FG000|Overall Study|Physician Decision|2|||
125353533|NCT02964507|450929468|FG001|Overall Study|Physician Decision|0|||
125353534|NCT02964507|450929469|FG002|Overall Study|Physician Decision|3|||
125353535|NCT02964507|450929470|FG003|Overall Study|Physician Decision|0|||
125353536|NCT02964507|450929471|FG004|Overall Study|Physician Decision|1|||
125353537|NCT02964507|450929472|FG005|Overall Study|Physician Decision|0|||
125353538|NCT02964507|450929473|FG006|Overall Study|Physician Decision|0|||
125353539|NCT02964507|450929474|FG007|Overall Study|Physician Decision|0|||
125353540|NCT02675231|450929475|FG000|Overall Study|Withdrawal by Subject|2|||
125353541|NCT02675231|450929476|FG001|Overall Study|Withdrawal by Subject|4|||
125353542|NCT02675231|450929477|FG002|Overall Study|Withdrawal by Subject|2|||
125353543|NCT02675231|450929475|FG000|Overall Study|Lost to Follow-up|3|||
125353544|NCT02675231|450929476|FG001|Overall Study|Lost to Follow-up|4|||
125353545|NCT02675231|450929477|FG002|Overall Study|Lost to Follow-up|3|||
125353546|NCT02495233|450929480|FG000|Overall Study|Miscellaneous|0|||
125353547|NCT02495233|450929481|FG001|Overall Study|Miscellaneous|1|||
125353548|NCT03880461|450929483|FG000|Overall Study|Determined ineligible after enrollment|45|||
125353549|NCT03880461|450929484|FG001|Overall Study|Determined ineligible after enrollment|44|||
125353550|NCT03880461|450929483|FG000|Overall Study|No weight measurement after enrollment|24|||
125426228|NCT03802123|451184437|FG000|Overall Study|Physician Decision|1|||
125353551|NCT03880461|450929484|FG001|Overall Study|No weight measurement after enrollment|17|||
125353552|NCT04025710|450929488|FG000|Overall Study|Death|3|||
125353553|NCT04025710|450929488|FG000|Overall Study|Lost to Follow-up|5|||
125353554|NCT04025710|450929488|FG000|Overall Study|Withdrawal by Subject|1|||
125353555|NCT04025710|450929488|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
125353556|NCT04025710|450929488|FG000|Overall Study|Drop-out according to protocol|34|||
125353557|NCT02431247|450929489|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
125353558|NCT02431247|450929490|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
125353559|NCT02431247|450929491|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
125353560|NCT02431247|450929489|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
125353561|NCT02431247|450929490|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
125353562|NCT02431247|450929491|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
125353563|NCT02431247|450929489|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
125353564|NCT02431247|450929490|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
125353565|NCT02431247|450929491|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
125353566|NCT02431247|450929489|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
125353567|NCT02431247|450929490|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
125353568|NCT02431247|450929491|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
125353569|NCT02431247|450929489|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
125353570|NCT02431247|450929490|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
125353571|NCT02431247|450929491|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
125353572|NCT02431247|450929489|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
125353573|NCT02431247|450929490|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
125353574|NCT02431247|450929491|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
125353575|NCT02431247|450929489|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
125353576|NCT02431247|450929490|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
125353577|NCT02431247|450929491|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
125353578|NCT02431247|450929489|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
125353579|NCT02431247|450929490|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
125353580|NCT02431247|450929491|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
125353581|NCT02431247|450929489|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
125353582|NCT02431247|450929490|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
125353583|NCT02431247|450929491|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
125353584|NCT02431247|450929489|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
125353585|NCT02431247|450929490|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
125353586|NCT02431247|450929491|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
125353587|NCT02431247|450929489|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
125353588|NCT02431247|450929490|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
125353589|NCT02431247|450929491|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
125353590|NCT02431247|450929489|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
125353591|NCT02431247|450929490|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
125353592|NCT02431247|450929491|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
125353593|NCT02431247|450929489|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
125353594|NCT02431247|450929490|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
125353595|NCT02431247|450929491|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
125353596|NCT02431247|450929489|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
125353597|NCT02431247|450929490|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
125353598|NCT02431247|450929491|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
125353599|NCT01562873|450929492|FG000|Overall Study|Disease Progression per RECIST|10|||
125353600|NCT01562873|450929493|FG001|Overall Study|Disease Progression per RECIST|0|||
125353601|NCT01562873|450929492|FG000|Overall Study|Adverse Event|1|||
125353602|NCT01562873|450929493|FG001|Overall Study|Adverse Event|0|||
125353603|NCT01562873|450929492|FG000|Overall Study|Clinical Disease Progression|9|||
125353604|NCT01562873|450929493|FG001|Overall Study|Clinical Disease Progression|0|||
125353605|NCT01562873|450929492|FG000|Overall Study|Clinical PD and adverse event|1|||
125353606|NCT01562873|450929493|FG001|Overall Study|Clinical PD and adverse event|0|||
125353607|NCT01369485|450929494|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
125353608|NCT01369485|450929495|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
125426229|NCT03802123|451184437|FG000|Overall Study|Subject moved to hospice care|1|||
125560671|NCT01092143|451683088|FG002|Overall Study|Ineligible patient|0|||
125560672|NCT01092143|451683089|FG003|Overall Study|Ineligible patient|0|||
125560673|NCT01092143|451683090|FG004|Overall Study|Ineligible patient|0|||
125560674|NCT01092143|451683086|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
125560675|NCT01092143|451683087|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
125560676|NCT01092143|451683088|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
125426230|NCT03802123|451184437|FG000|Overall Study|technician error|1|||
125426231|NCT03802123|451184437|FG000|Overall Study|Death|3|||
125560677|NCT01092143|451683089|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
125353609|NCT01369485|450929494|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
125560678|NCT01092143|451683090|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
125560679|NCT01092143|451683086|FG000|Overall Study|Patient travel|0|||
125560680|NCT01092143|451683087|FG001|Overall Study|Patient travel|0|||
125560681|NCT01092143|451683088|FG002|Overall Study|Patient travel|0|||
125560682|NCT01092143|451683089|FG003|Overall Study|Patient travel|0|||
125560683|NCT01092143|451683090|FG004|Overall Study|Patient travel|1|||
125560684|NCT01092143|451683086|FG000|Overall Study|Non compliance with study medication|0|||
125560685|NCT01092143|451683087|FG001|Overall Study|Non compliance with study medication|0|||
125560686|NCT01092143|451683088|FG002|Overall Study|Non compliance with study medication|0|||
125560687|NCT01092143|451683089|FG003|Overall Study|Non compliance with study medication|0|||
125560688|NCT01092143|451683090|FG004|Overall Study|Non compliance with study medication|1|||
125560689|NCT01092143|451683086|FG000|Overall Study|Randomized by mistake|0|||
125560690|NCT01092143|451683087|FG001|Overall Study|Randomized by mistake|0|||
125560691|NCT01092143|451683088|FG002|Overall Study|Randomized by mistake|0|||
125560692|NCT01092143|451683089|FG003|Overall Study|Randomized by mistake|1|||
125560693|NCT01092143|451683090|FG004|Overall Study|Randomized by mistake|0|||
125560694|NCT01092143|451683086|FG000|Overall Study|Pregnancy|0|||
125560695|NCT01092143|451683087|FG001|Overall Study|Pregnancy|0|||
125560696|NCT01092143|451683088|FG002|Overall Study|Pregnancy|0|||
125560697|NCT01092143|451683089|FG003|Overall Study|Pregnancy|1|||
125560698|NCT01092143|451683090|FG004|Overall Study|Pregnancy|0|||
125426232|NCT00658567|451184440|FG000|Overall Study|Adverse Event|5|||
125560699|NCT03986866|451683091|FG000|Overall Study|Withdrawal by Subject|0|||
125560700|NCT03986866|451683092|FG001|Overall Study|Withdrawal by Subject|3|||
125353610|NCT01369485|450929495|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
125353611|NCT01369485|450929494|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
125353612|NCT01369485|450929495|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
125353613|NCT01369485|450929494|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
125353614|NCT01369485|450929495|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
125353615|NCT01369485|450929494|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
125353616|NCT01369485|450929495|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
125353617|NCT01369485|450929494|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
125353618|NCT01369485|450929495|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
125353619|NCT01369485|450929494|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
125353620|NCT01369485|450929495|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
125353621|NCT01369485|450929494|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
125353622|NCT01369485|450929495|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
125353623|NCT01369485|450929494|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
125353624|NCT01369485|450929495|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
125353625|NCT01369485|450929494|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
125353626|NCT01369485|450929495|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
125353627|NCT00194675|450929506|FG000|Overall Study|Lost to Follow-up|1|||
125353628|NCT00194675|450929507|FG001|Overall Study|Lost to Follow-up|1|||
125560701|NCT03986866|451683091|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
125560702|NCT03986866|451683092|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
125560703|NCT05093322|451683095|FG000|Overall Study|Death|6|||
125560704|NCT05093322|451683096|FG001|Overall Study|Death|2|||
125560705|NCT05093322|451683095|FG000|Overall Study|Other|4|||
125353629|NCT00194675|450929506|FG000|Overall Study|lack of interest|1|||
125353630|NCT00194675|450929507|FG001|Overall Study|lack of interest|1|||
125353631|NCT00194675|450929506|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
125353632|NCT00194675|450929507|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
125353633|NCT00194675|450929506|FG000|Overall Study|Protocol Violation|1|||
125353634|NCT00194675|450929507|FG001|Overall Study|Protocol Violation|0|||
125353635|NCT00194675|450929506|FG000|Overall Study|Death|1|||
125353636|NCT00194675|450929507|FG001|Overall Study|Death|0|||
125353637|NCT01285960|450929508|FG000|Overall Study|Withdrawal by Subject|2|||
125353638|NCT01285960|450929508|FG000|Overall Study|Lost to Follow-up|2|||
125353639|NCT01285960|450929508|FG000|Overall Study|2 subjects received less 10 sonications|2|||
125353640|NCT02280473|450929511|FG000|Overall Study|Adverse Event|1|||
125353641|NCT02280473|450929512|FG001|Overall Study|Adverse Event|1|||
125353642|NCT02280473|450929511|FG000|Overall Study|Lack of Efficacy|0|||
125353643|NCT02280473|450929512|FG001|Overall Study|Lack of Efficacy|1|||
125353644|NCT02280473|450929511|FG000|Overall Study|Lost to Follow-up|0|||
125353645|NCT02280473|450929512|FG001|Overall Study|Lost to Follow-up|1|||
125353646|NCT01484054|450929513|FG000|Period 1|Withdrawal by Subject|0|||
125353647|NCT01484054|450929514|FG001|Period 1|Withdrawal by Subject|1|||
125353648|NCT01610271|450929515|FG000|Overall Study|Surgery not complete|0|||
125353649|NCT01610271|450929516|FG001|Overall Study|Surgery not complete|1|||
125353650|NCT01610271|450929515|FG000|Overall Study|Prosthesis not implanted|2|||
125353651|NCT01610271|450929516|FG001|Overall Study|Prosthesis not implanted|3|||
125353652|NCT00364130|450929517|FG000|Intervention Period|Lost to Follow-up|4|||
125353653|NCT00364130|450929518|FG001|Intervention Period|Lost to Follow-up|3|||
125353654|NCT00364130|450929517|FG000|Intervention Period|Pregnancy|1|||
125353655|NCT00364130|450929518|FG001|Intervention Period|Pregnancy|0|||
125353656|NCT00364130|450929517|FG000|Intervention Period|Withdrawal by Subject|4|||
125353657|NCT00364130|450929518|FG001|Intervention Period|Withdrawal by Subject|5|||
125353658|NCT00364130|450929517|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
125353659|NCT00364130|450929518|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
125353660|NCT00410202|450929519|FG000|On-Treatment|Continuing treatment|69|||
125353661|NCT00410202|450929520|FG001|On-Treatment|Continuing treatment|71|||
125353662|NCT00410202|450929521|FG002|On-Treatment|Continuing treatment|66|||
125353663|NCT00410202|450929519|FG000|On-Treatment|Adverse Event|1|||
125353664|NCT00410202|450929520|FG001|On-Treatment|Adverse Event|3|||
125353665|NCT00410202|450929521|FG002|On-Treatment|Adverse Event|2|||
125560706|NCT05093322|451683096|FG001|Overall Study|Other|1|||
125560707|NCT00397033|451683099|FG000|Overall Study|Adverse Event|7|||
125560708|NCT00397033|451683100|FG001|Overall Study|Adverse Event|10|||
125560709|NCT00397033|451683101|FG002|Overall Study|Adverse Event|4|||
125560710|NCT00397033|451683099|FG000|Overall Study|Lack of Efficacy|22|||
125560711|NCT00397033|451683100|FG001|Overall Study|Lack of Efficacy|12|||
125560712|NCT00397033|451683101|FG002|Overall Study|Lack of Efficacy|9|||
125353666|NCT00410202|450929519|FG000|On-Treatment|Death|1|||
125353667|NCT00410202|450929520|FG001|On-Treatment|Death|0|||
125353668|NCT00410202|450929521|FG002|On-Treatment|Death|0|||
125353669|NCT00410202|450929519|FG000|On-Treatment|Lost to Follow-up|1|||
125353670|NCT00410202|450929520|FG001|On-Treatment|Lost to Follow-up|0|||
125353671|NCT00410202|450929521|FG002|On-Treatment|Lost to Follow-up|1|||
125560713|NCT00397033|451683099|FG000|Overall Study|Lost to Follow-up|3|||
125560714|NCT00397033|451683100|FG001|Overall Study|Lost to Follow-up|3|||
125560715|NCT00397033|451683101|FG002|Overall Study|Lost to Follow-up|3|||
125560716|NCT00397033|451683099|FG000|Overall Study|Withdrawal by Subject|12|||
125560717|NCT00397033|451683100|FG001|Overall Study|Withdrawal by Subject|7|||
125560718|NCT00397033|451683101|FG002|Overall Study|Withdrawal by Subject|5|||
125353672|NCT00410202|450929519|FG000|On-Treatment|Lack of Efficacy|1|||
125353673|NCT00410202|450929520|FG001|On-Treatment|Lack of Efficacy|4|||
125353674|NCT00410202|450929521|FG002|On-Treatment|Lack of Efficacy|0|||
125353675|NCT00410202|450929519|FG000|On-Treatment|Withdrawal by Subject|2|||
125353676|NCT00410202|450929520|FG001|On-Treatment|Withdrawal by Subject|1|||
125353677|NCT00410202|450929521|FG002|On-Treatment|Withdrawal by Subject|1|||
125353678|NCT00410202|450929519|FG000|On-Treatment|Other Reason|0|||
125353679|NCT00410202|450929520|FG001|On-Treatment|Other Reason|0|||
125353680|NCT00410202|450929521|FG002|On-Treatment|Other Reason|1|||
125353681|NCT00410202|450929519|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
125353682|NCT00410202|450929520|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
125353683|NCT00410202|450929521|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
125353684|NCT00410202|450929519|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
125353685|NCT00410202|450929520|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
125353686|NCT00410202|450929521|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
125353687|NCT00410202|450929519|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
125353688|NCT00410202|450929520|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
125353689|NCT00410202|450929521|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
125353690|NCT00144027|450929523|FG000|Overall Study|Lost to Follow-up|1|||
125353691|NCT00144027|450929524|FG001|Overall Study|Lost to Follow-up|3|||
125353692|NCT00144027|450929523|FG000|Overall Study|Withdrawal by Subject|2|||
125353693|NCT00144027|450929524|FG001|Overall Study|Withdrawal by Subject|2|||
125353694|NCT00144027|450929523|FG000|Overall Study|did not complete baseline assessment|0|||
125353695|NCT00144027|450929524|FG001|Overall Study|did not complete baseline assessment|6|||
125353696|NCT00285207|450929531|FG000|Overall Study|Lost to Follow-up|3|||
125353697|NCT00285207|450929532|FG001|Overall Study|Lost to Follow-up|2|||
125353698|NCT00285207|450929531|FG000|Overall Study|Withdrawal by Subject|5|||
125353699|NCT00285207|450929532|FG001|Overall Study|Withdrawal by Subject|2|||
125353700|NCT00285207|450929531|FG000|Overall Study|Pregnancy|1|||
125353701|NCT00285207|450929532|FG001|Overall Study|Pregnancy|1|||
125353702|NCT00285207|450929531|FG000|Overall Study|non-compliance|0|||
125353703|NCT00285207|450929532|FG001|Overall Study|non-compliance|1|||
125353704|NCT02294773|450931161|FG000|Overall Study|Withdrawal by Subject|0|||
125353705|NCT02294773|450931162|FG001|Overall Study|Withdrawal by Subject|2|||
125353706|NCT03052764|450931163|FG000|Double-Blind Treatment Period|Adverse Event|2|||
125560719|NCT00397033|451683099|FG000|Overall Study|Other|0|||
125560720|NCT00397033|451683100|FG001|Overall Study|Other|5|||
125560721|NCT00397033|451683101|FG002|Overall Study|Other|2|||
125560722|NCT01984164|451683102|FG000|Overall Study|Withdrawal by Subject|4|||
125560723|NCT01984164|451683103|FG001|Overall Study|Withdrawal by Subject|3|||
125560724|NCT01984164|451683102|FG000|Overall Study|Adverse Event|5|||
125560725|NCT01984164|451683103|FG001|Overall Study|Adverse Event|19|||
125560726|NCT01984164|451683102|FG000|Overall Study|Lost to Follow-up|1|||
125560727|NCT01984164|451683103|FG001|Overall Study|Lost to Follow-up|3|||
125560728|NCT05293743|451683104|FG000|Overall Study|Withdrawal by Subject|1|||
125560729|NCT05293743|451683105|FG001|Overall Study|Withdrawal by Subject|0|||
125560730|NCT02064920|451683106|FG000|Overall Study|Adverse Event|0|||
125560731|NCT02064920|451683107|FG001|Overall Study|Adverse Event|4|||
125560732|NCT02064920|451683106|FG000|Overall Study|Physician Decision|0|||
125560733|NCT02064920|451683107|FG001|Overall Study|Physician Decision|1|||
125560734|NCT02064920|451683106|FG000|Overall Study|Technical Problems|0|||
125560735|NCT02064920|451683107|FG001|Overall Study|Technical Problems|1|||
125560736|NCT02064920|451683106|FG000|Overall Study|Withdrawal by Subject|1|||
125560737|NCT02064920|451683107|FG001|Overall Study|Withdrawal by Subject|3|||
125560738|NCT01129921|451683110|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
125560739|NCT01129921|451683111|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
125560740|NCT01129921|451683110|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
125560741|NCT01129921|451683111|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
125560742|NCT01129921|451683110|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
125560743|NCT01129921|451683111|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
125560744|NCT01129921|451683110|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
125560745|NCT01129921|451683111|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
125560746|NCT00583024|451683112|FG000|Overall Study|Lost to Follow-up|4|||
125353707|NCT03052764|450931164|FG001|Double-Blind Treatment Period|Adverse Event|0|||
125353708|NCT03052764|450931163|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
125560747|NCT00574145|451684699|FG000|Overall Study|Withdrawal by Subject|2|||
125353709|NCT03052764|450931164|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
125353710|NCT03052764|450931163|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
125353711|NCT03052764|450931164|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
125353712|NCT03052764|450931163|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
125353713|NCT03052764|450931164|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125353714|NCT03052764|450931163|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
125560748|NCT00574145|451684700|FG001|Overall Study|Withdrawal by Subject|1|||
125560749|NCT03227471|451684701|FG000|Overall Study|Withdrawal by Subject|0|||
125353715|NCT03052764|450931164|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
125353716|NCT05828095|450931165|FG000|Overall Study|Lost to Follow-up|1|||
125353717|NCT05828095|450931166|FG001|Overall Study|Lost to Follow-up|0|||
125353718|NCT05828095|450931165|FG000|Overall Study|Reactogenicity symptom|0|||
125353719|NCT05828095|450931166|FG001|Overall Study|Reactogenicity symptom|1|||
125353720|NCT03206073|450931167|FG000|Overall Study|Participant Noncompliance|0|||
125353721|NCT03206073|450931168|FG001|Overall Study|Participant Noncompliance|1|||
125353722|NCT03206073|450931169|FG002|Overall Study|Participant Noncompliance|0|||
125353723|NCT03206073|450931170|FG003|Overall Study|Participant Noncompliance|0|||
125353724|NCT03206073|450931167|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
125353725|NCT03206073|450931168|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
125353726|NCT03206073|450931169|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
125353727|NCT03206073|450931170|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
125353728|NCT03206073|450931167|FG000|Overall Study|Death|0|||
125353729|NCT03206073|450931168|FG001|Overall Study|Death|0|||
125353730|NCT03206073|450931169|FG002|Overall Study|Death|1|||
125353731|NCT03206073|450931170|FG003|Overall Study|Death|0|||
125353732|NCT03206073|450931167|FG000|Overall Study|Taken off active treatment|0|||
125353733|NCT03206073|450931168|FG001|Overall Study|Taken off active treatment|0|||
125353734|NCT03206073|450931169|FG002|Overall Study|Taken off active treatment|3|||
125353735|NCT03206073|450931170|FG003|Overall Study|Taken off active treatment|0|||
125353736|NCT03332771|450931171|FG000|Overall Study|Adverse Event|6|||
125353737|NCT03332771|450931172|FG001|Overall Study|Adverse Event|4|||
125353738|NCT03332771|450931173|FG002|Overall Study|Adverse Event|1|||
125353739|NCT03332771|450931174|FG003|Overall Study|Adverse Event|3|||
125353740|NCT03332771|450931171|FG000|Overall Study|Poor Compliance to Protocol|0|||
125353741|NCT03332771|450931172|FG001|Overall Study|Poor Compliance to Protocol|1|||
125353742|NCT03332771|450931173|FG002|Overall Study|Poor Compliance to Protocol|0|||
125353743|NCT03332771|450931174|FG003|Overall Study|Poor Compliance to Protocol|1|||
125353744|NCT03332771|450931171|FG000|Overall Study|Lost to Follow-up|2|||
125353745|NCT03332771|450931172|FG001|Overall Study|Lost to Follow-up|2|||
125353746|NCT03332771|450931173|FG002|Overall Study|Lost to Follow-up|1|||
125353747|NCT03332771|450931174|FG003|Overall Study|Lost to Follow-up|2|||
125353748|NCT03332771|450931171|FG000|Overall Study|At the Participant's own request|20|||
125353749|NCT03332771|450931172|FG001|Overall Study|At the Participant's own request|26|||
125353750|NCT03332771|450931173|FG002|Overall Study|At the Participant's own request|14|||
125353751|NCT03332771|450931174|FG003|Overall Study|At the Participant's own request|23|||
125353752|NCT03332771|450931171|FG000|Overall Study|Reason Not Specified|6|||
125353753|NCT03332771|450931172|FG001|Overall Study|Reason Not Specified|18|||
125353754|NCT03332771|450931173|FG002|Overall Study|Reason Not Specified|16|||
125353755|NCT03332771|450931174|FG003|Overall Study|Reason Not Specified|19|||
125353756|NCT00096954|450931175|FG000|Overall Study|Adverse Event|3|||
125353757|NCT00096954|450931176|FG001|Overall Study|Adverse Event|1|||
125353758|NCT00096954|450931175|FG000|Overall Study|Withdrawal by Subject|9|||
125353759|NCT00096954|450931176|FG001|Overall Study|Withdrawal by Subject|8|||
125353760|NCT00096954|450931175|FG000|Overall Study|Physician Decision|1|||
125353761|NCT00096954|450931176|FG001|Overall Study|Physician Decision|1|||
125353762|NCT00096954|450931175|FG000|Overall Study|Sponsors Decision|1|||
125353763|NCT00096954|450931176|FG001|Overall Study|Sponsors Decision|1|||
125353764|NCT00096954|450931175|FG000|Overall Study|Pregnancy|1|||
125353765|NCT00096954|450931176|FG001|Overall Study|Pregnancy|1|||
125353766|NCT00096954|450931175|FG000|Overall Study|Initiation of immunotherapy|1|||
125353767|NCT00096954|450931176|FG001|Overall Study|Initiation of immunotherapy|0|||
125353768|NCT00096954|450931175|FG000|Overall Study|Non-compliance|0|||
125353769|NCT00096954|450931176|FG001|Overall Study|Non-compliance|3|||
125353770|NCT00096954|450931175|FG000|Overall Study|Lost to Follow-up|8|||
125353771|NCT00096954|450931176|FG001|Overall Study|Lost to Follow-up|5|||
125353772|NCT04478123|450931178|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
125353773|NCT04478123|450931178|FG000|Overall Study|NE|1|||
125353774|NCT03581786|450931181|FG000|Overall Study|Death|67|||
125353775|NCT03581786|450931182|FG001|Overall Study|Death|47|||
125560750|NCT03227471|451684702|FG001|Overall Study|Withdrawal by Subject|0|||
125353776|NCT03581786|450931181|FG000|Overall Study|Withdrawal by Subject|2|||
125353777|NCT03581786|450931182|FG001|Overall Study|Withdrawal by Subject|5|||
125353778|NCT03581786|450931181|FG000|Overall Study|Lost to Follow-up|7|||
125353779|NCT03581786|450931182|FG001|Overall Study|Lost to Follow-up|4|||
125353780|NCT03581786|450931181|FG000|Overall Study|reason other than specified above|0|||
125353781|NCT03581786|450931182|FG001|Overall Study|reason other than specified above|1|||
125353782|NCT01347307|450931185|FG000|Overall Study|Death|0|||
125353783|NCT01347307|450931186|FG001|Overall Study|Death|4|||
125353784|NCT01347307|450931185|FG000|Overall Study|Physician Decision|0|||
125560751|NCT03227471|451684703|FG002|Overall Study|Withdrawal by Subject|0|||
125353785|NCT01347307|450931186|FG001|Overall Study|Physician Decision|1|||
125353786|NCT04123665|450931191|FG000|Overall Study|Withdrawal by Subject|7|||
125353787|NCT04123665|450931192|FG001|Overall Study|Withdrawal by Subject|0|||
125353788|NCT04123665|450931191|FG000|Overall Study|Lost to Follow-up|1|||
125353789|NCT04123665|450931192|FG001|Overall Study|Lost to Follow-up|0|||
125353790|NCT02237911|450931193|FG000|Overall Study|Withdrawal by Subject|4|||
125353791|NCT02237911|450931194|FG001|Overall Study|Withdrawal by Subject|7|||
125353792|NCT02237911|450931195|FG002|Overall Study|Withdrawal by Subject|2|||
125353793|NCT02237911|450931193|FG000|Overall Study|Lost to Follow-up|3|||
125353794|NCT02237911|450931194|FG001|Overall Study|Lost to Follow-up|1|||
125353795|NCT02237911|450931195|FG002|Overall Study|Lost to Follow-up|1|||
125353796|NCT00053365|450931196|FG000|Overall Study|Incorrect cell type|1|||
125353797|NCT00053365|450931196|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
125353798|NCT00053365|450931196|FG000|Overall Study|Never treated|4|||
125353799|NCT00958789|450931201|FG000|Overall Study|Death|5|||
125353800|NCT00958789|450931201|FG000|Overall Study|Lost to Follow-up|14|||
125353801|NCT00958789|450931201|FG000|Overall Study|Withdrawal by Subject|17|||
125353802|NCT00958789|450931201|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
125353803|NCT00958789|450931201|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
125353804|NCT00958789|450931201|FG000|Overall Study|Subject terminated|2|||
125353805|NCT00958789|450931201|FG000|Overall Study|Revision|7|||
125353806|NCT00721123|450931202|FG000|Overall Study|Adverse Event|96|||
125353807|NCT00721123|450931202|FG000|Overall Study|Death|10|||
125353808|NCT00721123|450931202|FG000|Overall Study|Insufficient Therapeutic Response|21|||
125353809|NCT00721123|450931202|FG000|Overall Study|Protocol Violation|1|||
125353810|NCT00721123|450931202|FG000|Overall Study|Refused Treatment|41|||
125353811|NCT00721123|450931202|FG000|Overall Study|Failure to Return|9|||
125353812|NCT00721123|450931202|FG000|Overall Study|Withdrawal by Subject|5|||
125353813|NCT00433511|450931209|FG000|Step 1|Adverse Event|50|||
125353814|NCT00433511|450931210|FG001|Step 1|Adverse Event|157|||
125353815|NCT00433511|450931211|FG002|Step 1|Adverse Event|153|||
125353816|NCT00433511|450931209|FG000|Step 1|Withdrawal by Subject|45|||
125353817|NCT00433511|450931210|FG001|Step 1|Withdrawal by Subject|143|||
125353818|NCT00433511|450931211|FG002|Step 1|Withdrawal by Subject|154|||
125353819|NCT00433511|450931209|FG000|Step 1|Death|3|||
125353820|NCT00433511|450931210|FG001|Step 1|Death|1|||
125353821|NCT00433511|450931211|FG002|Step 1|Death|1|||
125353822|NCT00433511|450931209|FG000|Step 1|Physician Decision|1|||
125353823|NCT00433511|450931210|FG001|Step 1|Physician Decision|4|||
125353824|NCT00433511|450931211|FG002|Step 1|Physician Decision|3|||
125353825|NCT00433511|450931209|FG000|Step 1|Never started protocol therapy|28|||
125353826|NCT00433511|450931210|FG001|Step 1|Never started protocol therapy|64|||
125353827|NCT00433511|450931211|FG002|Step 1|Never started protocol therapy|66|||
125353828|NCT00433511|450931209|FG000|Step 1|Alternative therapy|2|||
125353829|NCT00433511|450931210|FG001|Step 1|Alternative therapy|1|||
125353830|NCT00433511|450931211|FG002|Step 1|Alternative therapy|3|||
125353831|NCT00433511|450931209|FG000|Step 1|Disease progression, relapse|5|||
125353832|NCT00433511|450931210|FG001|Step 1|Disease progression, relapse|3|||
125353833|NCT00433511|450931211|FG002|Step 1|Disease progression, relapse|3|||
125353834|NCT00433511|450931209|FG000|Step 1|Other complicating disease|2|||
125353835|NCT00433511|450931210|FG001|Step 1|Other complicating disease|6|||
125353836|NCT00433511|450931211|FG002|Step 1|Other complicating disease|3|||
125353837|NCT00433511|450931209|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
125560752|NCT03227471|451684704|FG003|Overall Study|Withdrawal by Subject|0|||
125560753|NCT03227471|451684705|FG004|Overall Study|Withdrawal by Subject|1|||
125560754|NCT03227471|451684706|FG005|Overall Study|Withdrawal by Subject|0|||
125560755|NCT03227471|451684707|FG006|Overall Study|Withdrawal by Subject|0|||
125353838|NCT00433511|450931210|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
125353839|NCT00433511|450931211|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
125353840|NCT00433511|450931209|FG000|Step 1|Suspected recurrence|0|||
125353841|NCT00433511|450931210|FG001|Step 1|Suspected recurrence|1|||
125353842|NCT00433511|450931211|FG002|Step 1|Suspected recurrence|0|||
125353843|NCT00433511|450931209|FG000|Step 1|Insurance/drug distribution issues|0|||
125353844|NCT00433511|450931210|FG001|Step 1|Insurance/drug distribution issues|1|||
125353845|NCT00433511|450931211|FG002|Step 1|Insurance/drug distribution issues|2|||
125353846|NCT00433511|450931209|FG000|Step 1|Patient moved|0|||
125353847|NCT00433511|450931210|FG001|Step 1|Patient moved|0|||
125353848|NCT00433511|450931211|FG002|Step 1|Patient moved|1|||
125353849|NCT00433511|450931209|FG000|Step 2 (Arm D)|Adverse Event|0|||
125560756|NCT03227471|451684708|FG007|Overall Study|Withdrawal by Subject|0|||
125560757|NCT03227471|451684709|FG008|Overall Study|Withdrawal by Subject|0|||
125560758|NCT03227471|451684710|FG009|Overall Study|Withdrawal by Subject|0|||
125560759|NCT03227471|451684711|FG010|Overall Study|Withdrawal by Subject|0|||
125560760|NCT03227471|451684712|FG011|Overall Study|Withdrawal by Subject|0|||
125560761|NCT03227471|451684713|FG012|Overall Study|Withdrawal by Subject|1|||
125560762|NCT03227471|451684714|FG013|Overall Study|Withdrawal by Subject|0|||
125560763|NCT03227471|451684715|FG014|Overall Study|Withdrawal by Subject|0|||
125560764|NCT03227471|451684701|FG000|Overall Study|Randomized, Never Dosed|0|||
125560765|NCT03227471|451684702|FG001|Overall Study|Randomized, Never Dosed|0|||
125560766|NCT03227471|451684703|FG002|Overall Study|Randomized, Never Dosed|0|||
125560767|NCT03227471|451684704|FG003|Overall Study|Randomized, Never Dosed|0|||
125560768|NCT03227471|451684705|FG004|Overall Study|Randomized, Never Dosed|0|||
125560769|NCT03227471|451684706|FG005|Overall Study|Randomized, Never Dosed|0|||
125560770|NCT03227471|451684707|FG006|Overall Study|Randomized, Never Dosed|0|||
125560771|NCT03227471|451684708|FG007|Overall Study|Randomized, Never Dosed|0|||
125560772|NCT03227471|451684709|FG008|Overall Study|Randomized, Never Dosed|0|||
125560773|NCT03227471|451684710|FG009|Overall Study|Randomized, Never Dosed|0|||
125560774|NCT03227471|451684711|FG010|Overall Study|Randomized, Never Dosed|0|||
125560775|NCT03227471|451684712|FG011|Overall Study|Randomized, Never Dosed|0|||
125560776|NCT03227471|451684713|FG012|Overall Study|Randomized, Never Dosed|0|||
125560777|NCT03227471|451684714|FG013|Overall Study|Randomized, Never Dosed|0|||
125560778|NCT03227471|451684715|FG014|Overall Study|Randomized, Never Dosed|1|||
125560779|NCT00682448|451684716|FG000|Overall Study|Adverse Event|1|||
125560780|NCT00682448|451684717|FG001|Overall Study|Adverse Event|2|||
125560781|NCT00682448|451684716|FG000|Overall Study|Lack of Efficacy|1|||
125560782|NCT00682448|451684717|FG001|Overall Study|Lack of Efficacy|0|||
125560783|NCT00682448|451684716|FG000|Overall Study|Lost to Follow-up|1|||
125560784|NCT00682448|451684717|FG001|Overall Study|Lost to Follow-up|3|||
125560785|NCT00682448|451684716|FG000|Overall Study|Pregnancy|0|||
125560786|NCT00682448|451684717|FG001|Overall Study|Pregnancy|1|||
125560787|NCT00682448|451684716|FG000|Overall Study|Withdrawal by Subject|2|||
125560788|NCT00682448|451684717|FG001|Overall Study|Withdrawal by Subject|0|||
125560789|NCT02737852|451684720|FG000|Overall Study|Withdrawal by Subject|2|||
125560790|NCT03335163|451684727|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
125560791|NCT03335163|451684727|FG000|Overall Study|Withdrawal by Subject|18|||
125560792|NCT00525044|451684728|FG000|Overall Study|Lost to Follow-up|0|||
125560793|NCT00525044|451684729|FG001|Overall Study|Lost to Follow-up|1|||
125560794|NCT02553265|451684731|FG000|Enrollment|Death|0|||
125560795|NCT02553265|451684732|FG001|Enrollment|Death|0|||
125560796|NCT02553265|451684733|FG002|Enrollment|Death|1|||
125560797|NCT02553265|451684731|FG000|First Intervention (28 Days)|Adverse Event|1|||
125560798|NCT02553265|451684732|FG001|First Intervention (28 Days)|Adverse Event|0|||
125560799|NCT02553265|451684733|FG002|First Intervention (28 Days)|Adverse Event|0|||
125560800|NCT02553265|451684731|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
125560801|NCT02553265|451684732|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
125560802|NCT02553265|451684733|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
125560803|NCT02553265|451684731|FG000|Second Intervention (28 Days)|Adverse Event|1|||
125560804|NCT02553265|451684732|FG001|Second Intervention (28 Days)|Adverse Event|0|||
125560805|NCT02553265|451684733|FG002|Second Intervention (28 Days)|Adverse Event|0|||
125560806|NCT02553265|451684731|FG000|Third Intervention (28 Days)|Adverse Event|1|||
125560807|NCT02553265|451684732|FG001|Third Intervention (28 Days)|Adverse Event|0|||
125560808|NCT02553265|451684733|FG002|Third Intervention (28 Days)|Adverse Event|0|||
125560809|NCT02553265|451684731|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
125560810|NCT02553265|451684732|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
125560811|NCT02553265|451684733|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
125560812|NCT03713034|451684736|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
125560813|NCT03713034|451684737|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
125560814|NCT02982239|451684740|FG000|Overall Study|Lost to Follow-up|3|||
125560815|NCT02982239|451684741|FG001|Overall Study|Lost to Follow-up|2|||
125560816|NCT02023242|451684750|FG000|Overall Study|Lost to Follow-up|3|||
125560817|NCT02023242|451684751|FG001|Overall Study|Lost to Follow-up|1|||
125560818|NCT02023242|451684750|FG000|Overall Study|Death|0|||
125560819|NCT02023242|451684751|FG001|Overall Study|Death|1|||
125560820|NCT04854434|451684758|FG000|Overall Study|Death|1|||
125560821|NCT04854434|451684759|FG001|Overall Study|Death|3|||
125560822|NCT04854434|451684760|FG002|Overall Study|Death|4|||
125560823|NCT04854434|451684758|FG000|Overall Study|Study Terminated by Sponsor|2|||
125560824|NCT04854434|451684759|FG001|Overall Study|Study Terminated by Sponsor|0|||
125560825|NCT04854434|451684760|FG002|Overall Study|Study Terminated by Sponsor|0|||
125560826|NCT04854434|451684758|FG000|Overall Study|Other|1|||
125560827|NCT04854434|451684759|FG001|Overall Study|Other|1|||
125560828|NCT04854434|451684760|FG002|Overall Study|Other|0|||
125560829|NCT02667275|451684761|FG000|Overall Study|Protocol Violation|11|||
125560830|NCT02667275|451684762|FG001|Overall Study|Protocol Violation|7|||
125560831|NCT02667275|451684761|FG000|Overall Study|Lost to Follow-up|0|||
125560832|NCT02667275|451684762|FG001|Overall Study|Lost to Follow-up|2|||
125560833|NCT02667275|451684761|FG000|Overall Study|Withdrawal by Subject|0|||
125560834|NCT02667275|451684762|FG001|Overall Study|Withdrawal by Subject|5|||
125560835|NCT02667275|451684761|FG000|Overall Study|Discontinued early without completing|0|||
125560836|NCT02667275|451684762|FG001|Overall Study|Discontinued early without completing|1|||
125560837|NCT01274715|451684763|FG000|Overall Study|Lost to Follow-up|1|||
125560838|NCT01274715|451684763|FG000|Overall Study|After consent, met exclusion criteria.|1|||
125560839|NCT01274715|451684763|FG000|Overall Study|After consent, met exclusion criteria.|1|||
125560840|NCT01274715|451684763|FG000|Overall Study|After consent, met exclusion criteria.|1|||
125560841|NCT02285920|451684764|FG000|Overall Study|Kidney transplantation|2|||
125560842|NCT02285920|451684765|FG001|Overall Study|Kidney transplantation|2|||
125560843|NCT02285920|451684766|FG002|Overall Study|Kidney transplantation|2|||
125560844|NCT02285920|451684767|FG003|Overall Study|Kidney transplantation|0|||
125560845|NCT02285920|451684764|FG000|Overall Study|Change to peritoneal dialysis|0|||
125560846|NCT02285920|451684765|FG001|Overall Study|Change to peritoneal dialysis|0|||
125560847|NCT02285920|451684766|FG002|Overall Study|Change to peritoneal dialysis|1|||
125560848|NCT02285920|451684767|FG003|Overall Study|Change to peritoneal dialysis|0|||
125560849|NCT02285920|451684764|FG000|Overall Study|Transfer to non-participating unit|0|||
125560850|NCT02285920|451684765|FG001|Overall Study|Transfer to non-participating unit|1|||
125560851|NCT02285920|451684766|FG002|Overall Study|Transfer to non-participating unit|0|||
125560852|NCT02285920|451684767|FG003|Overall Study|Transfer to non-participating unit|0|||
125560853|NCT02285920|451684764|FG000|Overall Study|Dialysis discontinuation|0|||
125560854|NCT02285920|451684765|FG001|Overall Study|Dialysis discontinuation|1|||
125560855|NCT02285920|451684766|FG002|Overall Study|Dialysis discontinuation|0|||
125560856|NCT02285920|451684767|FG003|Overall Study|Dialysis discontinuation|0|||
125560857|NCT02285920|451684764|FG000|Overall Study|Death|2|||
125560858|NCT02285920|451684765|FG001|Overall Study|Death|0|||
125560859|NCT02285920|451684766|FG002|Overall Study|Death|2|||
125560860|NCT02285920|451684767|FG003|Overall Study|Death|1|||
125560861|NCT05418673|451684768|FG000|Overall Study|Study Terminated by Sponsor|2|||
125560862|NCT05418673|451684769|FG001|Overall Study|Study Terminated by Sponsor|4|||
125560863|NCT05418673|451684768|FG000|Overall Study|Lost to Follow-up|1|||
125560864|NCT05418673|451684769|FG001|Overall Study|Lost to Follow-up|0|||
125560865|NCT02665052|451684772|FG000|Overall Study|Lost to Follow-up|1|||
125560866|NCT02665052|451684773|FG001|Overall Study|Lost to Follow-up|0|||
125560867|NCT02665052|451684774|FG002|Overall Study|Lost to Follow-up|0|||
125560868|NCT02665052|451684775|FG003|Overall Study|Lost to Follow-up|0|||
125560869|NCT02665052|451684772|FG000|Overall Study|Withdrawal by Subject|1|||
125560870|NCT02665052|451684773|FG001|Overall Study|Withdrawal by Subject|1|||
125560871|NCT02665052|451684774|FG002|Overall Study|Withdrawal by Subject|0|||
125560872|NCT02665052|451684775|FG003|Overall Study|Withdrawal by Subject|5|||
125560873|NCT02665052|451684772|FG000|Overall Study|Adverse Event|1|||
125560874|NCT02665052|451684773|FG001|Overall Study|Adverse Event|1|||
125560875|NCT02665052|451684774|FG002|Overall Study|Adverse Event|0|||
125560876|NCT02665052|451684775|FG003|Overall Study|Adverse Event|0|||
125560877|NCT00590044|451684782|FG000|Overall Study|Withdrawal by Subject|2|||
125560878|NCT00590044|451684783|FG001|Overall Study|Withdrawal by Subject|2|||
125560879|NCT00590044|451684782|FG000|Overall Study|wrong insulin arm assigned|1|||
125560880|NCT00590044|451684783|FG001|Overall Study|wrong insulin arm assigned|0|||
125560881|NCT00590044|451684782|FG000|Overall Study|Protocol Violation|1|||
125560882|NCT00590044|451684783|FG001|Overall Study|Protocol Violation|0|||
125560883|NCT03199040|451684784|FG000|Overall Study|Lack of Efficacy|2|||
125560884|NCT03199040|451684785|FG001|Overall Study|Lack of Efficacy|0|||
125560885|NCT03199040|451684784|FG000|Overall Study|Withdrawal by Subject|2|||
125560886|NCT03199040|451684785|FG001|Overall Study|Withdrawal by Subject|0|||
125560887|NCT03199040|451684784|FG000|Overall Study|Adverse Event|0|||
125560888|NCT03199040|451684785|FG001|Overall Study|Adverse Event|1|||
125560889|NCT03199040|451684784|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
125560890|NCT03199040|451684785|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
125560891|NCT00199836|451684788|FG000|Overall Study|Progressive Disease|5|||
125560892|NCT00199836|451684788|FG000|Overall Study|Death|1|||
125560893|NCT01708291|451684789|FG000|Overall Study|fighting|2|||
125560894|NCT01708291|451684790|FG001|Overall Study|fighting|1|||
125560895|NCT01843972|451684791|FG000|Overall Study|Withdrawal by Subject|0|||
125560896|NCT01843972|451684792|FG001|Overall Study|Withdrawal by Subject|0|||
125426233|NCT00658567|451184441|FG001|Overall Study|Adverse Event|2|||
125560897|NCT01843972|451684793|FG002|Overall Study|Withdrawal by Subject|0|||
125560898|NCT01843972|451684794|FG003|Overall Study|Withdrawal by Subject|0|||
125560899|NCT01843972|451684795|FG004|Overall Study|Withdrawal by Subject|1|||
125560900|NCT01843972|451684796|FG005|Overall Study|Withdrawal by Subject|0|||
125560901|NCT01843972|451684797|FG006|Overall Study|Withdrawal by Subject|0|||
125560902|NCT01843972|451684798|FG007|Overall Study|Withdrawal by Subject|0|||
125560903|NCT01843972|451684799|FG008|Overall Study|Withdrawal by Subject|0|||
125560904|NCT01843972|451684800|FG009|Overall Study|Withdrawal by Subject|0|||
125560905|NCT00932425|451684804|FG000|Overall Study|Lost to Follow-up|0|||
125560906|NCT00932425|451684805|FG001|Overall Study|Lost to Follow-up|1|||
125426234|NCT00658567|451184442|FG002|Overall Study|Adverse Event|3|||
125426235|NCT00658567|451184440|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
125426236|NCT00658567|451184441|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
125426237|NCT00658567|451184442|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
125560907|NCT00932425|451684804|FG000|Overall Study|Withdrawal by Subject|0|||
125560908|NCT00932425|451684805|FG001|Overall Study|Withdrawal by Subject|1|||
125426238|NCT00658567|451184440|FG000|Overall Study|Physician Decision|0|||
125560909|NCT01854645|451684808|FG000|Overall Study|Protocol-Specified Criteria|13|||
125560910|NCT01854645|451684809|FG001|Overall Study|Protocol-Specified Criteria|10|||
125426239|NCT00658567|451184441|FG001|Overall Study|Physician Decision|1|||
125426240|NCT00658567|451184442|FG002|Overall Study|Physician Decision|0|||
125560911|NCT01854645|451684810|FG002|Overall Study|Protocol-Specified Criteria|8|||
125560912|NCT01854645|451684811|FG003|Overall Study|Protocol-Specified Criteria|5|||
125353850|NCT00433511|450931210|FG001|Step 2 (Arm D)|Adverse Event|0|||
125353851|NCT00433511|450931211|FG002|Step 2 (Arm D)|Adverse Event|135|||
125353852|NCT00433511|450931209|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
125353853|NCT00433511|450931210|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
125353854|NCT00433511|450931211|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
125353855|NCT00433511|450931209|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
125353856|NCT00433511|450931210|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
125353857|NCT00433511|450931211|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
125353858|NCT00433511|450931209|FG000|Step 2 (Arm D)|Physician Decision|0|||
125353859|NCT00433511|450931210|FG001|Step 2 (Arm D)|Physician Decision|0|||
125353860|NCT00433511|450931211|FG002|Step 2 (Arm D)|Physician Decision|9|||
125353861|NCT00433511|450931209|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
125353862|NCT00433511|450931210|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
125353863|NCT00433511|450931211|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
125353864|NCT00433511|450931209|FG000|Step 2 (Arm D)|Other complicating disease|0|||
125353865|NCT00433511|450931210|FG001|Step 2 (Arm D)|Other complicating disease|0|||
125353866|NCT00433511|450931211|FG002|Step 2 (Arm D)|Other complicating disease|3|||
125353867|NCT00433511|450931209|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
125353868|NCT00433511|450931210|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
125353869|NCT00433511|450931211|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
125353870|NCT00433511|450931209|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
125353871|NCT00433511|450931210|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
125353872|NCT00433511|450931211|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
125353873|NCT00433511|450931209|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
125353874|NCT00433511|450931210|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
125353875|NCT00433511|450931211|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
125353876|NCT00433511|450931209|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
125353877|NCT00433511|450931210|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
125353878|NCT00433511|450931211|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
125353879|NCT03139604|450931212|FG000|Overall Study|Other|7|||
125353880|NCT03139604|450931213|FG001|Overall Study|Other|3|||
125353881|NCT03139604|450931212|FG000|Overall Study|Withdrawal by Subject|16|||
125353882|NCT03139604|450931213|FG001|Overall Study|Withdrawal by Subject|17|||
125353883|NCT03139604|450931212|FG000|Overall Study|Physician Decision|1|||
125353884|NCT03139604|450931213|FG001|Overall Study|Physician Decision|2|||
125353885|NCT03139604|450931212|FG000|Overall Study|Lost to Follow-up|3|||
125353886|NCT03139604|450931213|FG001|Overall Study|Lost to Follow-up|1|||
125353887|NCT03139604|450931212|FG000|Overall Study|Death|65|||
125560913|NCT01854645|451684812|FG004|Overall Study|Protocol-Specified Criteria|7|||
125560914|NCT01854645|451684808|FG000|Overall Study|Administrative Reasons / Missing|0|||
125560915|NCT01854645|451684809|FG001|Overall Study|Administrative Reasons / Missing|0|||
125560916|NCT01854645|451684810|FG002|Overall Study|Administrative Reasons / Missing|0|||
125560917|NCT01854645|451684811|FG003|Overall Study|Administrative Reasons / Missing|1|||
125560918|NCT01854645|451684812|FG004|Overall Study|Administrative Reasons / Missing|1|||
125560919|NCT01854645|451684808|FG000|Overall Study|Protocol Violation|3|||
125560920|NCT01854645|451684809|FG001|Overall Study|Protocol Violation|0|||
125560921|NCT01854645|451684810|FG002|Overall Study|Protocol Violation|5|||
125353888|NCT03139604|450931213|FG001|Overall Study|Death|67|||
125353889|NCT03139604|450931212|FG000|Overall Study|Study Terminated by Sponsor|122|||
125353890|NCT03139604|450931213|FG001|Overall Study|Study Terminated by Sponsor|127|||
125353891|NCT03139604|450931212|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
125353892|NCT03139604|450931213|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
125353893|NCT04950608|450931214|FG000|Overall Study|Withdrawal by Subject|2|||
125353894|NCT04950608|450931214|FG000|Overall Study|Physician Decision|3|||
125353895|NCT02007512|450931218|FG000|Double Blind Treatment Period|Adverse Event|4|||
125353896|NCT02007512|450931219|FG001|Double Blind Treatment Period|Adverse Event|6|||
125353897|NCT02007512|450931220|FG002|Double Blind Treatment Period|Adverse Event|2|||
125353898|NCT02007512|450931221|FG003|Double Blind Treatment Period|Adverse Event|2|||
125353899|NCT02007512|450931218|FG000|Double Blind Treatment Period|Death|1|||
125353900|NCT02007512|450931219|FG001|Double Blind Treatment Period|Death|0|||
125353901|NCT02007512|450931220|FG002|Double Blind Treatment Period|Death|0|||
125353902|NCT02007512|450931221|FG003|Double Blind Treatment Period|Death|0|||
125353903|NCT02007512|450931218|FG000|Double Blind Treatment Period|Disease progression|51|||
125353904|NCT02007512|450931219|FG001|Double Blind Treatment Period|Disease progression|50|||
125353905|NCT02007512|450931220|FG002|Double Blind Treatment Period|Disease progression|57|||
125353906|NCT02007512|450931221|FG003|Double Blind Treatment Period|Disease progression|52|||
125353907|NCT02007512|450931218|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
125353908|NCT02007512|450931219|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
125560922|NCT01854645|451684811|FG003|Overall Study|Protocol Violation|4|||
125560923|NCT01854645|451684812|FG004|Overall Study|Protocol Violation|1|||
125353909|NCT02007512|450931220|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
125353910|NCT02007512|450931221|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
125353911|NCT02007512|450931218|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125353912|NCT02007512|450931219|FG001|Double Blind Treatment Period|Protocol Violation|0|||
125353913|NCT02007512|450931220|FG002|Double Blind Treatment Period|Protocol Violation|0|||
125353914|NCT02007512|450931221|FG003|Double Blind Treatment Period|Protocol Violation|1|||
125353915|NCT02007512|450931218|FG000|Double Blind Treatment Period|Other|2|||
125353916|NCT02007512|450931219|FG001|Double Blind Treatment Period|Other|1|||
125353917|NCT02007512|450931220|FG002|Double Blind Treatment Period|Other|1|||
125353918|NCT02007512|450931221|FG003|Double Blind Treatment Period|Other|2|||
125353919|NCT02007512|450931218|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
125353920|NCT02007512|450931219|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
125353921|NCT02007512|450931220|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
125353922|NCT02007512|450931221|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
125353923|NCT02007512|450931218|FG000|Open Label Treatment Period|Adverse Event|1|||
125353924|NCT02007512|450931219|FG001|Open Label Treatment Period|Adverse Event|0|||
125353925|NCT02007512|450931220|FG002|Open Label Treatment Period|Adverse Event|0|||
125353926|NCT02007512|450931221|FG003|Open Label Treatment Period|Adverse Event|0|||
125560924|NCT01854645|451684808|FG000|Overall Study|Lost to Follow-up|10|||
125560925|NCT01854645|451684809|FG001|Overall Study|Lost to Follow-up|7|||
125560926|NCT01854645|451684810|FG002|Overall Study|Lost to Follow-up|8|||
125560927|NCT01854645|451684811|FG003|Overall Study|Lost to Follow-up|5|||
125560928|NCT01854645|451684812|FG004|Overall Study|Lost to Follow-up|0|||
125560929|NCT01854645|451684808|FG000|Overall Study|Physician Decision|1|||
125560930|NCT01854645|451684809|FG001|Overall Study|Physician Decision|5|||
125560931|NCT01854645|451684810|FG002|Overall Study|Physician Decision|3|||
125560932|NCT01854645|451684811|FG003|Overall Study|Physician Decision|3|||
125560933|NCT01854645|451684812|FG004|Overall Study|Physician Decision|7|||
125560934|NCT01854645|451684808|FG000|Overall Study|Withdrawal by Subject|31|||
125560935|NCT01854645|451684809|FG001|Overall Study|Withdrawal by Subject|41|||
125560936|NCT01854645|451684810|FG002|Overall Study|Withdrawal by Subject|30|||
125560937|NCT01854645|451684811|FG003|Overall Study|Withdrawal by Subject|21|||
125560938|NCT01854645|451684812|FG004|Overall Study|Withdrawal by Subject|24|||
125560939|NCT01854645|451684808|FG000|Overall Study|Lack of Efficacy|7|||
125560940|NCT01854645|451684809|FG001|Overall Study|Lack of Efficacy|12|||
125560941|NCT01854645|451684810|FG002|Overall Study|Lack of Efficacy|9|||
125560942|NCT01854645|451684811|FG003|Overall Study|Lack of Efficacy|3|||
125560943|NCT01854645|451684812|FG004|Overall Study|Lack of Efficacy|9|||
125560944|NCT01854645|451684808|FG000|Overall Study|Adverse Event|33|||
125353927|NCT02007512|450931218|FG000|Open Label Treatment Period|Other|1|||
125560945|NCT01854645|451684809|FG001|Overall Study|Adverse Event|31|||
125560946|NCT01854645|451684810|FG002|Overall Study|Adverse Event|19|||
125560947|NCT01854645|451684811|FG003|Overall Study|Adverse Event|20|||
125560948|NCT01854645|451684812|FG004|Overall Study|Adverse Event|11|||
125353928|NCT02007512|450931219|FG001|Open Label Treatment Period|Other|1|||
125353929|NCT02007512|450931220|FG002|Open Label Treatment Period|Other|0|||
125353930|NCT02007512|450931221|FG003|Open Label Treatment Period|Other|0|||
125353931|NCT02007512|450931218|FG000|Open Label Treatment Period|Disease progression|23|||
125353932|NCT02007512|450931219|FG001|Open Label Treatment Period|Disease progression|11|||
125353933|NCT02007512|450931220|FG002|Open Label Treatment Period|Disease progression|0|||
125353934|NCT02007512|450931221|FG003|Open Label Treatment Period|Disease progression|0|||
125353935|NCT03026088|450931222|FG000|Overall Study|Study termination|20|||
125353936|NCT01143207|450931224|FG000|Overall Study|Lost to Follow-up|2|||
125353937|NCT01869725|450931225|FG000|Overall Study|ineligible after registration|1|||
125353938|NCT01869725|450931225|FG000|Overall Study|Death|1|||
125353939|NCT01869725|450931225|FG000|Overall Study|Lost to Follow-up|2|||
125353940|NCT03416374|450931238|FG000|Between Treatment Period I and II|Other|0|||
125426241|NCT00658567|451184440|FG000|Overall Study|At Discretion of Sponsor|1|||
125426242|NCT00658567|451184441|FG001|Overall Study|At Discretion of Sponsor|1|||
125426243|NCT00658567|451184442|FG002|Overall Study|At Discretion of Sponsor|1|||
125426244|NCT02684006|451184446|FG000|Overall Study|Other|18|||
125426245|NCT02684006|451184447|FG001|Overall Study|Other|6|||
125426246|NCT02684006|451184446|FG000|Overall Study|Protocol Violation|2|||
125426247|NCT02684006|451184447|FG001|Overall Study|Protocol Violation|1|||
125426248|NCT02684006|451184446|FG000|Overall Study|Non-compliance with study drug|1|||
125426249|NCT02684006|451184447|FG001|Overall Study|Non-compliance with study drug|1|||
125426250|NCT02684006|451184446|FG000|Overall Study|No longer met eligibility criteria|6|||
125426251|NCT02684006|451184447|FG001|Overall Study|No longer met eligibility criteria|2|||
125426252|NCT02684006|451184446|FG000|Overall Study|Lost to Follow-up|0|||
125426253|NCT02684006|451184447|FG001|Overall Study|Lost to Follow-up|1|||
125426254|NCT02684006|451184446|FG000|Overall Study|Death|25|||
125426255|NCT02684006|451184447|FG001|Overall Study|Death|22|||
125426256|NCT02684006|451184446|FG000|Overall Study|Global deterioration of health status|18|||
125426257|NCT02684006|451184447|FG001|Overall Study|Global deterioration of health status|20|||
125426258|NCT02684006|451184446|FG000|Overall Study|Physician Decision|15|||
125426259|NCT02684006|451184447|FG001|Overall Study|Physician Decision|8|||
125426260|NCT02684006|451184446|FG000|Overall Study|Adverse Event|86|||
125426261|NCT02684006|451184447|FG001|Overall Study|Adverse Event|65|||
125426262|NCT02684006|451184446|FG000|Overall Study|Withdrawal by Subject|29|||
125426263|NCT02684006|451184447|FG001|Overall Study|Withdrawal by Subject|43|||
125426264|NCT02684006|451184446|FG000|Overall Study|Progressive disease|236|||
125426265|NCT02684006|451184447|FG001|Overall Study|Progressive disease|266|||
125426266|NCT02684006|451184446|FG000|Overall Study|Participation terminated by sponsor|6|||
125426267|NCT02684006|451184447|FG001|Overall Study|Participation terminated by sponsor|9|||
125426268|NCT03804710|451184454|FG000|Overall Study|Adverse Event|0|||
125353941|NCT03416374|450931239|FG001|Between Treatment Period I and II|Other|9|||
125353942|NCT03416374|450931238|FG000|Treatment Period II|Lack of Efficacy|3|||
125426269|NCT03804710|451184455|FG001|Overall Study|Adverse Event|3|||
125426270|NCT03804710|451184454|FG000|Overall Study|Withdrawal by Subject|2|||
125426271|NCT03804710|451184455|FG001|Overall Study|Withdrawal by Subject|1|||
125426272|NCT03804710|451184454|FG000|Overall Study|Other|0|||
125426273|NCT03804710|451184455|FG001|Overall Study|Other|1|||
125353943|NCT03416374|450931239|FG001|Treatment Period II|Lack of Efficacy|11|||
125353944|NCT03416374|450931238|FG000|Treatment Period II|Adverse Event|1|||
125560949|NCT01202279|451684818|FG000|Overall Study|Adverse Event|8|||
125560950|NCT01202279|451684819|FG001|Overall Study|Adverse Event|6|||
125560951|NCT01202279|451684818|FG000|Overall Study|Withdrawal by Subject|13|||
125560952|NCT01202279|451684819|FG001|Overall Study|Withdrawal by Subject|10|||
125560953|NCT01202279|451684818|FG000|Overall Study|Physician Decision|0|||
125560954|NCT01202279|451684819|FG001|Overall Study|Physician Decision|1|||
125560955|NCT01202279|451684818|FG000|Overall Study|Lost to Follow-up|10|||
125560956|NCT01202279|451684819|FG001|Overall Study|Lost to Follow-up|7|||
125560957|NCT01202279|451684818|FG000|Overall Study|Protocol Violation|1|||
125560958|NCT01202279|451684819|FG001|Overall Study|Protocol Violation|1|||
125560959|NCT01202279|451684818|FG000|Overall Study|study compliance|5|||
125560960|NCT01202279|451684819|FG001|Overall Study|study compliance|2|||
125560961|NCT02546765|451684822|FG000|Overall Study|Withdrawal by Subject|0|||
125560962|NCT02546765|451684823|FG001|Overall Study|Withdrawal by Subject|1|||
125560963|NCT02546765|451684824|FG002|Overall Study|Withdrawal by Subject|0|||
125560964|NCT02546765|451684825|FG003|Overall Study|Withdrawal by Subject|0|||
125560965|NCT00475722|451684826|FG000|Overall Study|Withdrawal by Subject|12|||
125560966|NCT00475722|451684827|FG001|Overall Study|Withdrawal by Subject|12|||
125560967|NCT00475722|451684826|FG000|Overall Study|Protocol Violation|3|||
125560968|NCT00475722|451684827|FG001|Overall Study|Protocol Violation|0|||
125560969|NCT00916279|451684828|FG000|Overall Study|Death|2|||
125560970|NCT00916279|451684828|FG000|Overall Study|Lost to Follow-up|2|||
125560971|NCT02109562|451684829|FG000|Overall Study|Insufficient clinical response|2|||
125560972|NCT02109562|451684830|FG001|Overall Study|Insufficient clinical response|0|||
125560973|NCT02109562|451684831|FG002|Overall Study|Insufficient clinical response|4|||
125560974|NCT02109562|451684829|FG000|Overall Study|Adverse Event|0|||
125560975|NCT02109562|451684830|FG001|Overall Study|Adverse Event|2|||
125560976|NCT02109562|451684831|FG002|Overall Study|Adverse Event|3|||
125560977|NCT02109562|451684829|FG000|Overall Study|Lost to Follow-up|1|||
125560978|NCT02109562|451684830|FG001|Overall Study|Lost to Follow-up|0|||
125560979|NCT02109562|451684831|FG002|Overall Study|Lost to Follow-up|1|||
125560980|NCT02109562|451684829|FG000|Overall Study|Protocol Violation|0|||
125560981|NCT02109562|451684830|FG001|Overall Study|Protocol Violation|3|||
125560982|NCT02109562|451684831|FG002|Overall Study|Protocol Violation|1|||
125560983|NCT02109562|451684829|FG000|Overall Study|Withdrawal by Subject|20|||
125560984|NCT02109562|451684830|FG001|Overall Study|Withdrawal by Subject|25|||
125560985|NCT02109562|451684831|FG002|Overall Study|Withdrawal by Subject|21|||
125560986|NCT02109562|451684829|FG000|Overall Study|Physician Decision|3|||
125560987|NCT02109562|451684830|FG001|Overall Study|Physician Decision|4|||
125560988|NCT02109562|451684831|FG002|Overall Study|Physician Decision|5|||
125560989|NCT00310804|451684832|FG000|Overall Study|Lost to Follow-up|2|||
125560990|NCT00310804|451684833|FG001|Overall Study|Lost to Follow-up|0|||
125560991|NCT00310804|451684832|FG000|Overall Study|Withdrawal by Subject|3|||
125560992|NCT00310804|451684833|FG001|Overall Study|Withdrawal by Subject|0|||
125560993|NCT00688155|451684838|FG000|Overall Study|Withdrawal by Subject|2|||
125560994|NCT00688155|451684839|FG001|Overall Study|Withdrawal by Subject|2|||
125560995|NCT00688155|451684840|FG002|Overall Study|Withdrawal by Subject|1|||
125560996|NCT00688155|451684841|FG003|Overall Study|Withdrawal by Subject|1|||
125560997|NCT03318978|451684848|FG000|Overall Study|Withdrawal by Subject|1|||
125560998|NCT01200238|451684850|FG000|Overall Study|Adverse Event|2|||
125560999|NCT01200238|451684851|FG001|Overall Study|Adverse Event|1|||
125353945|NCT03416374|450931239|FG001|Treatment Period II|Adverse Event|4|||
125353946|NCT03416374|450931238|FG000|Treatment Period II|Death|0|||
125561000|NCT01200238|451684850|FG000|Overall Study|Progressive Disease|5|||
125561001|NCT01200238|451684851|FG001|Overall Study|Progressive Disease|8|||
125561002|NCT01200238|451684850|FG000|Overall Study|Withdrawal by Subject|0|||
125353947|NCT03416374|450931239|FG001|Treatment Period II|Death|1|||
125561003|NCT01200238|451684851|FG001|Overall Study|Withdrawal by Subject|1|||
125561004|NCT05050318|451686396|FG000|Overall Study|Protocol Deviation|1|||
125561005|NCT05050318|451686397|FG001|Overall Study|Protocol Deviation|0|||
125561006|NCT05050318|451686398|FG002|Overall Study|Protocol Deviation|0|||
125561007|NCT02229539|451686403|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
125561008|NCT02229539|451686404|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
125561009|NCT02229539|451686405|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
125561010|NCT02229539|451686403|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
125561011|NCT02229539|451686404|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
125561012|NCT02229539|451686405|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
125561013|NCT02229539|451686403|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
125561014|NCT02229539|451686404|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
125561015|NCT02229539|451686405|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
125561016|NCT02229539|451686403|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
125561017|NCT02229539|451686404|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
125561018|NCT02229539|451686405|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
125353948|NCT03416374|450931238|FG000|Treatment Period II|Other|0|||
125353949|NCT03416374|450931239|FG001|Treatment Period II|Other|2|||
125353950|NCT01052844|450931240|FG000|Overall Study|Adverse Event|0|||
125561019|NCT02229539|451686403|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
125561020|NCT02229539|451686404|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
125561021|NCT02229539|451686405|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
125561022|NCT02229539|451686403|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
125561023|NCT02229539|451686404|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
125561024|NCT02229539|451686405|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
125561025|NCT00382720|451686409|FG000|Overall Study|Adverse Event|21|||
125561026|NCT00382720|451686410|FG001|Overall Study|Adverse Event|23|||
125561027|NCT00382720|451686411|FG002|Overall Study|Adverse Event|15|||
125353951|NCT01052844|450931241|FG001|Overall Study|Adverse Event|1|||
125353952|NCT03463031|450931242|FG000|Overall Study|Withdrawal by Subject|4|||
125353953|NCT03463031|450931243|FG001|Overall Study|Withdrawal by Subject|2|||
125353954|NCT03463031|450931242|FG000|Overall Study|Investigator/Sponsor Decision|0|||
125353955|NCT03463031|450931243|FG001|Overall Study|Investigator/Sponsor Decision|1|||
125353956|NCT03463031|450931242|FG000|Overall Study|Lost to Follow-up|1|||
125353957|NCT03463031|450931243|FG001|Overall Study|Lost to Follow-up|1|||
125353958|NCT03463031|450931242|FG000|Overall Study|Adverse Event|4|||
125353959|NCT03463031|450931243|FG001|Overall Study|Adverse Event|1|||
125353960|NCT03463031|450931242|FG000|Overall Study|Use of prohibited medication by subject|1|||
125353961|NCT03463031|450931243|FG001|Overall Study|Use of prohibited medication by subject|0|||
125353962|NCT00214500|450931248|FG000|Treatment Period|Adverse Event|1|||
125353963|NCT00214500|450931248|FG000|Extension Period|Withdrawal by Subject|2|||
125353964|NCT00147251|450931249|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
125353965|NCT00147251|450931250|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
125353966|NCT02537574|450931252|FG000|Overall Study|Adverse Event|1|||
125353967|NCT02537574|450931253|FG001|Overall Study|Adverse Event|3|||
125353968|NCT02537574|450931254|FG002|Overall Study|Adverse Event|2|||
125353969|NCT02537574|450931252|FG000|Overall Study|Lost to Follow-up|40|||
125353970|NCT02537574|450931253|FG001|Overall Study|Lost to Follow-up|51|||
125353971|NCT02537574|450931254|FG002|Overall Study|Lost to Follow-up|55|||
125353972|NCT02537574|450931252|FG000|Overall Study|Noncompliance with study drug|0|||
125353973|NCT02537574|450931253|FG001|Overall Study|Noncompliance with study drug|1|||
125353974|NCT02537574|450931254|FG002|Overall Study|Noncompliance with study drug|1|||
125353975|NCT02537574|450931252|FG000|Overall Study|Physician Decision|2|||
125353976|NCT02537574|450931253|FG001|Overall Study|Physician Decision|0|||
125353977|NCT02537574|450931254|FG002|Overall Study|Physician Decision|0|||
125353978|NCT02537574|450931252|FG000|Overall Study|Protocol Violation|4|||
125353979|NCT02537574|450931253|FG001|Overall Study|Protocol Violation|2|||
125353980|NCT02537574|450931254|FG002|Overall Study|Protocol Violation|3|||
125353981|NCT02537574|450931252|FG000|Overall Study|Withdrawal by Subject|37|||
125353982|NCT02537574|450931253|FG001|Overall Study|Withdrawal by Subject|27|||
125353983|NCT02537574|450931254|FG002|Overall Study|Withdrawal by Subject|29|||
125353984|NCT02537574|450931252|FG000|Overall Study|Lack of Efficacy|14|||
125353985|NCT02537574|450931253|FG001|Overall Study|Lack of Efficacy|16|||
125353986|NCT02537574|450931254|FG002|Overall Study|Lack of Efficacy|15|||
125353987|NCT02537574|450931252|FG000|Overall Study|Duplicate Patient|1|||
125353988|NCT02537574|450931253|FG001|Overall Study|Duplicate Patient|0|||
125353989|NCT02537574|450931254|FG002|Overall Study|Duplicate Patient|0|||
125353990|NCT02537574|450931252|FG000|Overall Study|Patient not Stable|0|||
125353991|NCT02537574|450931253|FG001|Overall Study|Patient not Stable|1|||
125353992|NCT02537574|450931254|FG002|Overall Study|Patient not Stable|0|||
125353993|NCT02537574|450931252|FG000|Overall Study|Incarceration|0|||
125353994|NCT02537574|450931253|FG001|Overall Study|Incarceration|1|||
125353995|NCT02537574|450931254|FG002|Overall Study|Incarceration|0|||
125353996|NCT02537574|450931252|FG000|Overall Study|Failed Naloxone Challenge|0|||
125353997|NCT02537574|450931253|FG001|Overall Study|Failed Naloxone Challenge|1|||
125353998|NCT02537574|450931254|FG002|Overall Study|Failed Naloxone Challenge|0|||
125353999|NCT02537574|450931252|FG000|Overall Study|Transportation Issues|0|||
125354000|NCT02537574|450931253|FG001|Overall Study|Transportation Issues|0|||
125354001|NCT02537574|450931254|FG002|Overall Study|Transportation Issues|1|||
125354002|NCT02537574|450931252|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
125354003|NCT02537574|450931253|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
125354004|NCT02537574|450931254|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
125354005|NCT02537574|450931252|FG000|Overall Study|Noncompliance with Protocol|0|||
125354006|NCT02537574|450931253|FG001|Overall Study|Noncompliance with Protocol|0|||
125354007|NCT02537574|450931254|FG002|Overall Study|Noncompliance with Protocol|1|||
125354008|NCT03595774|450931255|FG000|Overall Study|Adverse Event|1|||
125354009|NCT03595774|450931256|FG001|Overall Study|Adverse Event|0|||
125426274|NCT02660827|451184459|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
125426275|NCT02660827|451184459|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
125426276|NCT02660827|451184459|FG000|From Study to End of Continued Access|Adverse Event|3|||
125426277|NCT02660827|451184459|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
125426278|NCT02660827|451184459|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
125426279|NCT02660827|451184459|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
125561028|NCT00382720|451686409|FG000|Overall Study|Protocol Violation|2|||
125354010|NCT03595774|450931257|FG002|Overall Study|Adverse Event|1|||
125354011|NCT03595774|450931258|FG003|Overall Study|Adverse Event|0|||
125354012|NCT03595774|450931255|FG000|Overall Study|screen failure|0|||
125354013|NCT03595774|450931256|FG001|Overall Study|screen failure|1|||
125354014|NCT03595774|450931257|FG002|Overall Study|screen failure|0|||
125354015|NCT03595774|450931258|FG003|Overall Study|screen failure|1|||
125354016|NCT02788474|450931265|FG000|Double Blind Treatment Period|Not treated|1|||
125354017|NCT02788474|450931266|FG001|Double Blind Treatment Period|Not treated|0|||
125354018|NCT02788474|450931265|FG000|Double Blind Treatment Period|Patient's refusal|3|||
125354019|NCT02788474|450931266|FG001|Double Blind Treatment Period|Patient's refusal|0|||
125354020|NCT02788474|450931265|FG000|Double Blind Treatment Period|Adverse Event|6|||
125426280|NCT02660827|451184459|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
125354021|NCT02788474|450931266|FG001|Double Blind Treatment Period|Adverse Event|4|||
125354022|NCT02788474|450931265|FG000|Open Label Treatment Period|Adverse Event|29|||
125561029|NCT00382720|451686410|FG001|Overall Study|Protocol Violation|5|||
125561030|NCT00382720|451686411|FG002|Overall Study|Protocol Violation|1|||
125561031|NCT00382720|451686409|FG000|Overall Study|Death|0|||
125561032|NCT00382720|451686410|FG001|Overall Study|Death|1|||
125561033|NCT00382720|451686411|FG002|Overall Study|Death|2|||
125561034|NCT00382720|451686409|FG000|Overall Study|Progressive disease|37|||
125561035|NCT00382720|451686410|FG001|Overall Study|Progressive disease|28|||
125561036|NCT00382720|451686411|FG002|Overall Study|Progressive disease|38|||
125561037|NCT00382720|451686409|FG000|Overall Study|Withdrew consent|1|||
125561038|NCT00382720|451686410|FG001|Overall Study|Withdrew consent|1|||
125561039|NCT00382720|451686411|FG002|Overall Study|Withdrew consent|2|||
125561040|NCT00382720|451686409|FG000|Overall Study|Withdrawal by Subject|11|||
125561041|NCT00382720|451686410|FG001|Overall Study|Withdrawal by Subject|20|||
125561042|NCT00382720|451686411|FG002|Overall Study|Withdrawal by Subject|12|||
125561043|NCT00382720|451686409|FG000|Overall Study|Surgery|1|||
125561044|NCT00382720|451686410|FG001|Overall Study|Surgery|1|||
125561045|NCT00382720|451686411|FG002|Overall Study|Surgery|4|||
125561046|NCT00382720|451686409|FG000|Overall Study|Patient did not receive study medication|1|||
125561047|NCT00382720|451686410|FG001|Overall Study|Patient did not receive study medication|1|||
125354023|NCT02788474|450931266|FG001|Open Label Treatment Period|Adverse Event|9|||
125354024|NCT02788474|450931265|FG000|Open Label Treatment Period|Other than reason specified|1|||
125354025|NCT02788474|450931266|FG001|Open Label Treatment Period|Other than reason specified|0|||
125354026|NCT02788474|450931265|FG000|Open Label Treatment Period|Patient's refusal|1|||
125561048|NCT00382720|451686411|FG002|Overall Study|Patient did not receive study medication|4|||
125561049|NCT00382720|451686409|FG000|Overall Study|Clinically progressive disease|0|||
125561050|NCT00382720|451686410|FG001|Overall Study|Clinically progressive disease|1|||
125561051|NCT00382720|451686411|FG002|Overall Study|Clinically progressive disease|0|||
125561052|NCT00382720|451686409|FG000|Overall Study|Good prognosis|0|||
125561053|NCT00382720|451686410|FG001|Overall Study|Good prognosis|1|||
125561054|NCT00382720|451686411|FG002|Overall Study|Good prognosis|0|||
125561055|NCT00382720|451686409|FG000|Overall Study|Investigator/Clinical decision|5|||
125561056|NCT00382720|451686410|FG001|Overall Study|Investigator/Clinical decision|6|||
125561057|NCT00382720|451686411|FG002|Overall Study|Investigator/Clinical decision|6|||
125561058|NCT00382720|451686409|FG000|Overall Study|Discontinued at end of study|0|||
125561059|NCT00382720|451686410|FG001|Overall Study|Discontinued at end of study|1|||
125561060|NCT00382720|451686411|FG002|Overall Study|Discontinued at end of study|2|||
125561061|NCT00257166|451686415|FG000|Overall Study|Adverse Event|18|||
125561062|NCT00257166|451686416|FG001|Overall Study|Adverse Event|13|||
125561063|NCT00257166|451686415|FG000|Overall Study|Laboratory abnormality|1|||
125561064|NCT00257166|451686416|FG001|Overall Study|Laboratory abnormality|0|||
125561065|NCT00257166|451686415|FG000|Overall Study|Lost to Follow-up|8|||
125561066|NCT00257166|451686416|FG001|Overall Study|Lost to Follow-up|1|||
125561067|NCT00257166|451686415|FG000|Overall Study|Withdrawal by Subject|9|||
125561068|NCT00257166|451686416|FG001|Overall Study|Withdrawal by Subject|2|||
125561069|NCT00257166|451686415|FG000|Overall Study|Other|16|||
125561070|NCT00257166|451686416|FG001|Overall Study|Other|21|||
125561071|NCT00257166|451686415|FG000|Overall Study|Randomized, but not treated|1|||
125561072|NCT00257166|451686416|FG001|Overall Study|Randomized, but not treated|0|||
125561073|NCT04050670|451686419|FG000|Period 3|Physician Decision|0|||
125561074|NCT04050670|451686420|FG001|Period 3|Physician Decision|1|||
125561075|NCT04050670|451686421|FG002|Period 3|Physician Decision|0|||
125561076|NCT00514514|451686424|FG000|Pre-phase|Death|10|||
125561077|NCT00514514|451686425|FG001|Pre-phase|Death|0|||
125561078|NCT00514514|451686426|FG002|Pre-phase|Death|0|||
125561079|NCT00514514|451686424|FG000|Pre-phase|administrative problems|2|||
125561080|NCT00514514|451686425|FG001|Pre-phase|administrative problems|0|||
125561081|NCT00514514|451686426|FG002|Pre-phase|administrative problems|0|||
125561082|NCT00514514|451686424|FG000|Pre-phase|Protocol Violation|6|||
125561083|NCT00514514|451686425|FG001|Pre-phase|Protocol Violation|0|||
125561084|NCT00514514|451686426|FG002|Pre-phase|Protocol Violation|0|||
125561085|NCT00514514|451686424|FG000|Pre-phase|condition no longer requires study drug|7|||
125561086|NCT00514514|451686425|FG001|Pre-phase|condition no longer requires study drug|0|||
125561087|NCT00514514|451686426|FG002|Pre-phase|condition no longer requires study drug|0|||
125561088|NCT00514514|451686424|FG000|Pre-phase|abnormal test procedure results|15|||
125561089|NCT00514514|451686425|FG001|Pre-phase|abnormal test procedure results|0|||
125561090|NCT00514514|451686426|FG002|Pre-phase|abnormal test procedure results|0|||
125561091|NCT00514514|451686424|FG000|Pre-phase|Lost to Follow-up|2|||
125561092|NCT00514514|451686425|FG001|Pre-phase|Lost to Follow-up|0|||
125561093|NCT00514514|451686426|FG002|Pre-phase|Lost to Follow-up|0|||
125561094|NCT00514514|451686424|FG000|Pre-phase|abnormal lab values|23|||
125561095|NCT00514514|451686425|FG001|Pre-phase|abnormal lab values|0|||
125561096|NCT00514514|451686426|FG002|Pre-phase|abnormal lab values|0|||
125561097|NCT00514514|451686424|FG000|Pre-phase|Lack of Efficacy|35|||
125561098|NCT00514514|451686425|FG001|Pre-phase|Lack of Efficacy|0|||
125561099|NCT00514514|451686426|FG002|Pre-phase|Lack of Efficacy|0|||
125561100|NCT00514514|451686424|FG000|Pre-phase|Adverse Event|137|||
125561101|NCT00514514|451686425|FG001|Pre-phase|Adverse Event|0|||
125561102|NCT00514514|451686426|FG002|Pre-phase|Adverse Event|0|||
125354027|NCT02788474|450931266|FG001|Open Label Treatment Period|Patient's refusal|3|||
125354028|NCT02788474|450931265|FG000|Open Label Treatment Period|Non-compliance|1|||
125354029|NCT02788474|450931266|FG001|Open Label Treatment Period|Non-compliance|0|||
125561103|NCT00514514|451686424|FG000|Pre-phase|Withdrawal by Subject|66|||
125561104|NCT00514514|451686425|FG001|Pre-phase|Withdrawal by Subject|0|||
125561105|NCT00514514|451686426|FG002|Pre-phase|Withdrawal by Subject|0|||
125561106|NCT00514514|451686424|FG000|Randomized - 9 Month|Death|3|||
125561107|NCT00514514|451686425|FG001|Randomized - 9 Month|Death|2|||
125561108|NCT00514514|451686426|FG002|Randomized - 9 Month|Death|2|||
125354030|NCT00117286|450931268|FG000|Overall Study|Adverse Event|12|||
125354031|NCT00117286|450931269|FG001|Overall Study|Adverse Event|6|||
125354032|NCT00117286|450931268|FG000|Overall Study|Lost to Follow-up|2|||
125354033|NCT00117286|450931269|FG001|Overall Study|Lost to Follow-up|0|||
125561109|NCT00514514|451686424|FG000|Randomized - 9 Month|Administrative problems|1|||
125561110|NCT00514514|451686425|FG001|Randomized - 9 Month|Administrative problems|1|||
125561111|NCT00514514|451686426|FG002|Randomized - 9 Month|Administrative problems|2|||
125561112|NCT00514514|451686424|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
125561113|NCT00514514|451686425|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
125561114|NCT00514514|451686426|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
125561115|NCT00514514|451686424|FG000|Randomized - 9 Month|Protocol Violation|1|||
125561116|NCT00514514|451686425|FG001|Randomized - 9 Month|Protocol Violation|1|||
125561117|NCT00514514|451686426|FG002|Randomized - 9 Month|Protocol Violation|0|||
125561118|NCT00514514|451686424|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
125561119|NCT00514514|451686425|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
125561120|NCT00514514|451686426|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
125561121|NCT00514514|451686424|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
125561122|NCT00514514|451686425|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
125561123|NCT00514514|451686426|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
125561124|NCT00514514|451686424|FG000|Randomized - 9 Month|Adverse Event|25|||
125561125|NCT00514514|451686425|FG001|Randomized - 9 Month|Adverse Event|44|||
125561126|NCT00514514|451686426|FG002|Randomized - 9 Month|Adverse Event|27|||
125561127|NCT00514514|451686424|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
125561128|NCT00514514|451686425|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
125561129|NCT00514514|451686426|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
125561130|NCT00514514|451686424|FG000|Extension - 4 Years|Lost to Follow-up|12|||
125561131|NCT00514514|451686425|FG001|Extension - 4 Years|Lost to Follow-up|10|||
125561132|NCT00514514|451686426|FG002|Extension - 4 Years|Lost to Follow-up|9|||
125561133|NCT00514514|451686424|FG000|Extension - 4 Years|Administrative problems|3|||
125561134|NCT00514514|451686425|FG001|Extension - 4 Years|Administrative problems|1|||
125561135|NCT00514514|451686426|FG002|Extension - 4 Years|Administrative problems|1|||
125561136|NCT00514514|451686424|FG000|Extension - 4 Years|Death|8|||
125561137|NCT00514514|451686425|FG001|Extension - 4 Years|Death|3|||
125561138|NCT00514514|451686426|FG002|Extension - 4 Years|Death|6|||
125561139|NCT00514514|451686424|FG000|Extension - 4 Years|Adverse Event|9|||
125561140|NCT00514514|451686425|FG001|Extension - 4 Years|Adverse Event|6|||
125561141|NCT00514514|451686426|FG002|Extension - 4 Years|Adverse Event|3|||
125561142|NCT01101438|451686429|FG000|Overall Study|Withdrawal by Subject|8|||
125561143|NCT01101438|451686430|FG001|Overall Study|Withdrawal by Subject|9|||
125561144|NCT02713542|451686431|FG000|Overall Study|Use of prohibited medication|14|||
125561145|NCT02713542|451686432|FG001|Overall Study|Use of prohibited medication|5|||
125561146|NCT02713542|451686431|FG000|Overall Study|Withdrawal by Subject|4|||
125561147|NCT02713542|451686432|FG001|Overall Study|Withdrawal by Subject|1|||
125561148|NCT00066742|451686433|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
125561149|NCT00066742|451686433|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
125561150|NCT00066742|451686433|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
125561151|NCT00066742|451686433|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
125561152|NCT00066742|451686433|FG000|Induction Chemoradiotherapy|Ineligible|3|||
125561153|NCT00066742|451686433|FG000|Consolidation Chemotherapy|not protocol specified|1|||
125561154|NCT00066742|451686433|FG000|Consolidation Chemotherapy|Ineligible|2|||
125561155|NCT03794583|451686435|FG000|Overall Study|Death|8|||
125561156|NCT03794583|451686435|FG000|Overall Study|Study Terminated by Sponsor|24|||
125561157|NCT03794583|451686435|FG000|Overall Study|Withdrawal by Subject|9|||
125561158|NCT01994382|451686444|FG000|Overall Study|Informed consent withdrawn|0|||
125561159|NCT01994382|451686445|FG001|Overall Study|Informed consent withdrawn|0|||
125561160|NCT01994382|451686446|FG002|Overall Study|Informed consent withdrawn|0|||
125561161|NCT01994382|451686447|FG003|Overall Study|Informed consent withdrawn|0|||
125561162|NCT01994382|451686448|FG004|Overall Study|Informed consent withdrawn|0|||
125561163|NCT01994382|451686449|FG005|Overall Study|Informed consent withdrawn|0|||
125561164|NCT01994382|451686450|FG006|Overall Study|Informed consent withdrawn|1|||
125561165|NCT01994382|451686451|FG007|Overall Study|Informed consent withdrawn|0|||
125561166|NCT01994382|451686452|FG008|Overall Study|Informed consent withdrawn|0|||
125561167|NCT01994382|451686453|FG009|Overall Study|Informed consent withdrawn|0|||
125561168|NCT01994382|451686454|FG010|Overall Study|Informed consent withdrawn|0|||
125561169|NCT01994382|451686455|FG011|Overall Study|Informed consent withdrawn|0|||
125561170|NCT01994382|451686456|FG012|Overall Study|Informed consent withdrawn|0|||
125561171|NCT01994382|451686457|FG013|Overall Study|Informed consent withdrawn|0|||
125561172|NCT01994382|451686458|FG014|Overall Study|Informed consent withdrawn|0|||
125561173|NCT01994382|451686459|FG015|Overall Study|Informed consent withdrawn|0|||
125561174|NCT01994382|451686460|FG016|Overall Study|Informed consent withdrawn|0|||
125354034|NCT00117286|450931268|FG000|Overall Study|Protocol Violation|3|||
125354035|NCT00117286|450931269|FG001|Overall Study|Protocol Violation|3|||
125561175|NCT01994382|451686444|FG000|Overall Study|Progressive disease|3|||
125561176|NCT01994382|451686445|FG001|Overall Study|Progressive disease|4|||
125561177|NCT01994382|451686446|FG002|Overall Study|Progressive disease|4|||
125561178|NCT01994382|451686447|FG003|Overall Study|Progressive disease|3|||
125561179|NCT01994382|451686448|FG004|Overall Study|Progressive disease|2|||
125561180|NCT01994382|451686449|FG005|Overall Study|Progressive disease|3|||
125561181|NCT01994382|451686450|FG006|Overall Study|Progressive disease|3|||
125561182|NCT01994382|451686451|FG007|Overall Study|Progressive disease|6|||
125561183|NCT01994382|451686452|FG008|Overall Study|Progressive disease|2|||
125561184|NCT01994382|451686453|FG009|Overall Study|Progressive disease|2|||
125561185|NCT01994382|451686454|FG010|Overall Study|Progressive disease|13|||
125561186|NCT01994382|451686455|FG011|Overall Study|Progressive disease|8|||
125561187|NCT01994382|451686456|FG012|Overall Study|Progressive disease|7|||
125561188|NCT01994382|451686457|FG013|Overall Study|Progressive disease|3|||
125561189|NCT01994382|451686458|FG014|Overall Study|Progressive disease|6|||
125561190|NCT01994382|451686459|FG015|Overall Study|Progressive disease|44|||
125561191|NCT01994382|451686460|FG016|Overall Study|Progressive disease|28|||
125561192|NCT01994382|451686444|FG000|Overall Study|Physician Decision|0|||
125561193|NCT01994382|451686445|FG001|Overall Study|Physician Decision|1|||
125561194|NCT01994382|451686446|FG002|Overall Study|Physician Decision|0|||
125561195|NCT01994382|451686447|FG003|Overall Study|Physician Decision|0|||
125561196|NCT01994382|451686448|FG004|Overall Study|Physician Decision|0|||
125561197|NCT01994382|451686449|FG005|Overall Study|Physician Decision|0|||
125561198|NCT01994382|451686450|FG006|Overall Study|Physician Decision|0|||
125561199|NCT01994382|451686451|FG007|Overall Study|Physician Decision|0|||
125561200|NCT01994382|451686452|FG008|Overall Study|Physician Decision|0|||
125561201|NCT01994382|451686453|FG009|Overall Study|Physician Decision|0|||
125561202|NCT01994382|451686454|FG010|Overall Study|Physician Decision|3|||
125561203|NCT01994382|451686455|FG011|Overall Study|Physician Decision|1|||
125561204|NCT01994382|451686456|FG012|Overall Study|Physician Decision|1|||
125561205|NCT01994382|451686457|FG013|Overall Study|Physician Decision|0|||
125561206|NCT01994382|451686458|FG014|Overall Study|Physician Decision|1|||
125561207|NCT01994382|451686459|FG015|Overall Study|Physician Decision|4|||
125561208|NCT01994382|451686460|FG016|Overall Study|Physician Decision|2|||
125561209|NCT01994382|451686444|FG000|Overall Study|Death|0|||
125561210|NCT01994382|451686445|FG001|Overall Study|Death|0|||
125561211|NCT01994382|451686446|FG002|Overall Study|Death|0|||
125561212|NCT01994382|451686447|FG003|Overall Study|Death|0|||
125561213|NCT01994382|451686448|FG004|Overall Study|Death|1|||
125561214|NCT01994382|451686449|FG005|Overall Study|Death|0|||
125561215|NCT01994382|451686450|FG006|Overall Study|Death|0|||
125561216|NCT01994382|451686451|FG007|Overall Study|Death|0|||
125561217|NCT01994382|451686452|FG008|Overall Study|Death|1|||
125561218|NCT01994382|451686453|FG009|Overall Study|Death|1|||
125561219|NCT01994382|451686454|FG010|Overall Study|Death|0|||
125561220|NCT01994382|451686455|FG011|Overall Study|Death|0|||
125561221|NCT01994382|451686456|FG012|Overall Study|Death|0|||
125561222|NCT01994382|451686457|FG013|Overall Study|Death|0|||
125561223|NCT01994382|451686458|FG014|Overall Study|Death|0|||
125561224|NCT01994382|451686459|FG015|Overall Study|Death|1|||
125561225|NCT01994382|451686460|FG016|Overall Study|Death|0|||
125561226|NCT01994382|451686444|FG000|Overall Study|Adverse Event|0|||
125561227|NCT01994382|451686445|FG001|Overall Study|Adverse Event|1|||
125561228|NCT01994382|451686446|FG002|Overall Study|Adverse Event|2|||
125561229|NCT01994382|451686447|FG003|Overall Study|Adverse Event|0|||
125561230|NCT01994382|451686448|FG004|Overall Study|Adverse Event|0|||
125561231|NCT01994382|451686449|FG005|Overall Study|Adverse Event|0|||
125561232|NCT01994382|451686450|FG006|Overall Study|Adverse Event|0|||
125561233|NCT01994382|451686451|FG007|Overall Study|Adverse Event|0|||
125561234|NCT01994382|451686452|FG008|Overall Study|Adverse Event|0|||
125561235|NCT01994382|451686453|FG009|Overall Study|Adverse Event|0|||
125561236|NCT01994382|451686454|FG010|Overall Study|Adverse Event|15|||
125561237|NCT01994382|451686455|FG011|Overall Study|Adverse Event|2|||
125561238|NCT01994382|451686456|FG012|Overall Study|Adverse Event|7|||
125561239|NCT01994382|451686457|FG013|Overall Study|Adverse Event|3|||
125561240|NCT01994382|451686458|FG014|Overall Study|Adverse Event|17|||
125561241|NCT01994382|451686459|FG015|Overall Study|Adverse Event|6|||
125561242|NCT01994382|451686460|FG016|Overall Study|Adverse Event|3|||
125561243|NCT01994382|451686444|FG000|Overall Study|Other than specified|0|||
125561244|NCT01994382|451686445|FG001|Overall Study|Other than specified|0|||
125561245|NCT01994382|451686446|FG002|Overall Study|Other than specified|0|||
125561246|NCT01994382|451686447|FG003|Overall Study|Other than specified|0|||
125561247|NCT01994382|451686448|FG004|Overall Study|Other than specified|0|||
125354036|NCT00117286|450931268|FG000|Overall Study|Withdrawal by Subject|6|||
125354037|NCT00117286|450931269|FG001|Overall Study|Withdrawal by Subject|2|||
125354038|NCT00117286|450931268|FG000|Overall Study|Physician Decision|3|||
125354039|NCT00117286|450931269|FG001|Overall Study|Physician Decision|7|||
125354040|NCT00117286|450931268|FG000|Overall Study|Lack of Efficacy|2|||
125561248|NCT01994382|451686449|FG005|Overall Study|Other than specified|0|||
125561249|NCT01994382|451686450|FG006|Overall Study|Other than specified|0|||
125561250|NCT01994382|451686451|FG007|Overall Study|Other than specified|0|||
125561251|NCT01994382|451686452|FG008|Overall Study|Other than specified|0|||
125561252|NCT01994382|451686453|FG009|Overall Study|Other than specified|0|||
125561253|NCT01994382|451686454|FG010|Overall Study|Other than specified|2|||
125561254|NCT01994382|451686455|FG011|Overall Study|Other than specified|0|||
125561255|NCT01994382|451686456|FG012|Overall Study|Other than specified|2|||
125561256|NCT01994382|451686457|FG013|Overall Study|Other than specified|0|||
125561257|NCT01994382|451686458|FG014|Overall Study|Other than specified|0|||
125354041|NCT00117286|450931269|FG001|Overall Study|Lack of Efficacy|1|||
125354042|NCT00117286|450931268|FG000|Overall Study|Research site closing|0|||
125354043|NCT00117286|450931269|FG001|Overall Study|Research site closing|2|||
125354044|NCT00048061|450931270|FG000|Overall Study|Adverse Event|41|||
125354045|NCT00048061|450931271|FG001|Overall Study|Adverse Event|32|||
125354046|NCT00048061|450931272|FG002|Overall Study|Adverse Event|44|||
125354047|NCT00048061|450931273|FG003|Overall Study|Adverse Event|37|||
125354048|NCT00048061|450931270|FG000|Overall Study|Lost to Follow-up|3|||
125354049|NCT00048061|450931271|FG001|Overall Study|Lost to Follow-up|2|||
125354050|NCT00048061|450931272|FG002|Overall Study|Lost to Follow-up|4|||
125354051|NCT00048061|450931273|FG003|Overall Study|Lost to Follow-up|5|||
125354052|NCT00048061|450931270|FG000|Overall Study|Withdrawal by Subject|20|||
125354053|NCT00048061|450931271|FG001|Overall Study|Withdrawal by Subject|29|||
125354054|NCT00048061|450931272|FG002|Overall Study|Withdrawal by Subject|29|||
125354055|NCT00048061|450931273|FG003|Overall Study|Withdrawal by Subject|32|||
125354056|NCT00048061|450931270|FG000|Overall Study|Did not follow-up|5|||
125354057|NCT00048061|450931271|FG001|Overall Study|Did not follow-up|5|||
125354058|NCT00048061|450931272|FG002|Overall Study|Did not follow-up|4|||
125354059|NCT00048061|450931273|FG003|Overall Study|Did not follow-up|5|||
125354060|NCT00048061|450931270|FG000|Overall Study|Early improvement|6|||
125354061|NCT00048061|450931271|FG001|Overall Study|Early improvement|5|||
125354062|NCT00048061|450931272|FG002|Overall Study|Early improvement|3|||
125354063|NCT00048061|450931273|FG003|Overall Study|Early improvement|0|||
125354064|NCT03555435|450931274|FG000|Overall Study|Lost to Follow-up|17|||
125354065|NCT03555435|450931275|FG001|Overall Study|Lost to Follow-up|19|||
125354066|NCT03555435|450931276|FG002|Overall Study|Lost to Follow-up|8|||
125354067|NCT02220998|450931277|FG000|Overall Study|Randomized but Never Treated|1|||
125354068|NCT02220998|450931278|FG001|Overall Study|Randomized but Never Treated|2|||
125354069|NCT02220998|450931277|FG000|Overall Study|Death|2|||
125354070|NCT02220998|450931278|FG001|Overall Study|Death|0|||
125354071|NCT02220998|450931277|FG000|Overall Study|Lack of Efficacy|0|||
125354072|NCT02220998|450931278|FG001|Overall Study|Lack of Efficacy|5|||
125354073|NCT02220998|450931277|FG000|Overall Study|Lost to Follow-up|4|||
125354074|NCT02220998|450931278|FG001|Overall Study|Lost to Follow-up|4|||
125354075|NCT02314143|450931279|FG000|Overall Study|Adverse Event|0|||
125354076|NCT02314143|450931280|FG001|Overall Study|Adverse Event|6|||
125354077|NCT02314143|450931281|FG002|Overall Study|Adverse Event|4|||
125354078|NCT02314143|450931279|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
125354079|NCT02314143|450931280|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
125354080|NCT02314143|450931281|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
125354081|NCT02314143|450931279|FG000|Overall Study|Physician Decision|2|||
125561258|NCT01994382|451686459|FG015|Overall Study|Other than specified|4|||
125354082|NCT02314143|450931280|FG001|Overall Study|Physician Decision|1|||
125354083|NCT02314143|450931281|FG002|Overall Study|Physician Decision|0|||
125354084|NCT02314143|450931279|FG000|Overall Study|Withdrawal by Subject|1|||
125354085|NCT02314143|450931280|FG001|Overall Study|Withdrawal by Subject|0|||
125354086|NCT02314143|450931281|FG002|Overall Study|Withdrawal by Subject|1|||
125354087|NCT00873860|450931283|FG000|Overall Study|Lost to Follow-up|1|||
125354088|NCT00873860|450931284|FG001|Overall Study|Lost to Follow-up|0|||
125354089|NCT00873860|450931285|FG002|Overall Study|Lost to Follow-up|0|||
125354090|NCT00873860|450931286|FG003|Overall Study|Lost to Follow-up|1|||
125354091|NCT00873860|450931283|FG000|Overall Study|Withdrawal by Subject|1|||
125561259|NCT01994382|451686460|FG016|Overall Study|Other than specified|4|||
125561260|NCT01994382|451686444|FG000|Overall Study|Withdrawal by Subject|0|||
125354092|NCT00873860|450931284|FG001|Overall Study|Withdrawal by Subject|0|||
125354093|NCT00873860|450931285|FG002|Overall Study|Withdrawal by Subject|2|||
125354094|NCT00873860|450931286|FG003|Overall Study|Withdrawal by Subject|0|||
125354095|NCT00873860|450931283|FG000|Overall Study|Death|1|||
125354096|NCT00873860|450931284|FG001|Overall Study|Death|0|||
125354097|NCT00873860|450931285|FG002|Overall Study|Death|0|||
125561261|NCT01994382|451686445|FG001|Overall Study|Withdrawal by Subject|0|||
125561262|NCT01994382|451686446|FG002|Overall Study|Withdrawal by Subject|0|||
125561263|NCT01994382|451686447|FG003|Overall Study|Withdrawal by Subject|0|||
125561264|NCT01994382|451686448|FG004|Overall Study|Withdrawal by Subject|0|||
125561265|NCT01994382|451686449|FG005|Overall Study|Withdrawal by Subject|0|||
125561266|NCT01994382|451686450|FG006|Overall Study|Withdrawal by Subject|0|||
125561267|NCT01994382|451686451|FG007|Overall Study|Withdrawal by Subject|0|||
125561268|NCT01994382|451686452|FG008|Overall Study|Withdrawal by Subject|0|||
125561269|NCT01994382|451686453|FG009|Overall Study|Withdrawal by Subject|0|||
125561270|NCT01994382|451686454|FG010|Overall Study|Withdrawal by Subject|6|||
125561271|NCT01994382|451686455|FG011|Overall Study|Withdrawal by Subject|0|||
125561272|NCT01994382|451686456|FG012|Overall Study|Withdrawal by Subject|2|||
125561273|NCT01994382|451686457|FG013|Overall Study|Withdrawal by Subject|0|||
125561274|NCT01994382|451686458|FG014|Overall Study|Withdrawal by Subject|4|||
125561275|NCT01994382|451686459|FG015|Overall Study|Withdrawal by Subject|3|||
125561276|NCT01994382|451686460|FG016|Overall Study|Withdrawal by Subject|0|||
125561277|NCT01994382|451686444|FG000|Overall Study|Lost to Follow-up|0|||
125561278|NCT01994382|451686445|FG001|Overall Study|Lost to Follow-up|0|||
125561279|NCT01994382|451686446|FG002|Overall Study|Lost to Follow-up|0|||
125561280|NCT01994382|451686447|FG003|Overall Study|Lost to Follow-up|0|||
125561281|NCT01994382|451686448|FG004|Overall Study|Lost to Follow-up|0|||
125561282|NCT01994382|451686449|FG005|Overall Study|Lost to Follow-up|0|||
125561283|NCT01994382|451686450|FG006|Overall Study|Lost to Follow-up|0|||
125561284|NCT01994382|451686451|FG007|Overall Study|Lost to Follow-up|0|||
125561285|NCT01994382|451686452|FG008|Overall Study|Lost to Follow-up|0|||
125561286|NCT01994382|451686453|FG009|Overall Study|Lost to Follow-up|0|||
125561287|NCT01994382|451686454|FG010|Overall Study|Lost to Follow-up|1|||
125561288|NCT01994382|451686455|FG011|Overall Study|Lost to Follow-up|0|||
125561289|NCT01994382|451686456|FG012|Overall Study|Lost to Follow-up|0|||
125561290|NCT01994382|451686457|FG013|Overall Study|Lost to Follow-up|0|||
125354098|NCT00873860|450931286|FG003|Overall Study|Death|0|||
125354099|NCT00873860|450931283|FG000|Overall Study|Other|1|||
125354100|NCT00873860|450931284|FG001|Overall Study|Other|0|||
125561291|NCT01994382|451686458|FG014|Overall Study|Lost to Follow-up|0|||
125561292|NCT01994382|451686459|FG015|Overall Study|Lost to Follow-up|0|||
125561293|NCT01994382|451686460|FG016|Overall Study|Lost to Follow-up|0|||
125561294|NCT01994382|451686444|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125561295|NCT01994382|451686445|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125561296|NCT01994382|451686446|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125354101|NCT00873860|450931285|FG002|Overall Study|Other|1|||
125354102|NCT00873860|450931286|FG003|Overall Study|Other|0|||
125354103|NCT02140775|450931288|FG000|Overall Study|Withdrawal by Subject|30|||
125354104|NCT02140775|450931289|FG001|Overall Study|Withdrawal by Subject|7|||
125354105|NCT04650854|450931292|FG000|Overall Study|Adverse Event|1|||
125561297|NCT01994382|451686447|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125561298|NCT01994382|451686448|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125561299|NCT01994382|451686449|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125561300|NCT01994382|451686450|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125561301|NCT01994382|451686451|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125561302|NCT01994382|451686452|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125561303|NCT01994382|451686453|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125561304|NCT01994382|451686454|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
125561305|NCT01994382|451686455|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125561306|NCT01994382|451686456|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
125561307|NCT01994382|451686457|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125561308|NCT01994382|451686458|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
125561309|NCT01994382|451686459|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
125561310|NCT01994382|451686460|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
125561311|NCT01994382|451686444|FG000|Overall Study|Protocol violation/noncompliance|0|||
125561312|NCT01994382|451686445|FG001|Overall Study|Protocol violation/noncompliance|0|||
125561313|NCT01994382|451686446|FG002|Overall Study|Protocol violation/noncompliance|0|||
125561314|NCT01994382|451686447|FG003|Overall Study|Protocol violation/noncompliance|0|||
125561315|NCT01994382|451686448|FG004|Overall Study|Protocol violation/noncompliance|0|||
125561316|NCT01994382|451686449|FG005|Overall Study|Protocol violation/noncompliance|0|||
125561317|NCT01994382|451686450|FG006|Overall Study|Protocol violation/noncompliance|0|||
125561318|NCT01994382|451686451|FG007|Overall Study|Protocol violation/noncompliance|0|||
125561319|NCT01994382|451686452|FG008|Overall Study|Protocol violation/noncompliance|0|||
125561320|NCT01994382|451686453|FG009|Overall Study|Protocol violation/noncompliance|0|||
125561321|NCT01994382|451686454|FG010|Overall Study|Protocol violation/noncompliance|0|||
125561322|NCT01994382|451686455|FG011|Overall Study|Protocol violation/noncompliance|1|||
125561323|NCT01994382|451686456|FG012|Overall Study|Protocol violation/noncompliance|0|||
125561324|NCT01994382|451686457|FG013|Overall Study|Protocol violation/noncompliance|0|||
125561325|NCT01994382|451686458|FG014|Overall Study|Protocol violation/noncompliance|0|||
125561326|NCT01994382|451686459|FG015|Overall Study|Protocol violation/noncompliance|0|||
125561327|NCT01994382|451686460|FG016|Overall Study|Protocol violation/noncompliance|2|||
125561328|NCT01994382|451686444|FG000|Overall Study|Rolled over to Phase 2a|0|||
125561329|NCT01994382|451686445|FG001|Overall Study|Rolled over to Phase 2a|0|||
125561330|NCT01994382|451686446|FG002|Overall Study|Rolled over to Phase 2a|1|||
125561331|NCT01994382|451686447|FG003|Overall Study|Rolled over to Phase 2a|0|||
125561332|NCT01994382|451686448|FG004|Overall Study|Rolled over to Phase 2a|0|||
125561333|NCT01994382|451686449|FG005|Overall Study|Rolled over to Phase 2a|0|||
125561334|NCT01994382|451686450|FG006|Overall Study|Rolled over to Phase 2a|0|||
125561335|NCT01994382|451686451|FG007|Overall Study|Rolled over to Phase 2a|0|||
125561336|NCT01994382|451686452|FG008|Overall Study|Rolled over to Phase 2a|0|||
125561337|NCT01994382|451686453|FG009|Overall Study|Rolled over to Phase 2a|2|||
125561338|NCT01994382|451686454|FG010|Overall Study|Rolled over to Phase 2a|0|||
125561339|NCT01994382|451686455|FG011|Overall Study|Rolled over to Phase 2a|0|||
125561340|NCT01994382|451686456|FG012|Overall Study|Rolled over to Phase 2a|0|||
125561341|NCT01994382|451686457|FG013|Overall Study|Rolled over to Phase 2a|0|||
125561342|NCT01994382|451686458|FG014|Overall Study|Rolled over to Phase 2a|0|||
125561343|NCT01994382|451686459|FG015|Overall Study|Rolled over to Phase 2a|0|||
125561344|NCT01994382|451686460|FG016|Overall Study|Rolled over to Phase 2a|0|||
125561345|NCT02234284|451686461|FG000|Overall Study|Death|4|||
125561346|NCT02234284|451686462|FG001|Overall Study|Death|2|||
125561347|NCT02234284|451686461|FG000|Overall Study|Withdrawal by Subject|1|||
125561348|NCT02234284|451686462|FG001|Overall Study|Withdrawal by Subject|0|||
125561349|NCT02234284|451686461|FG000|Overall Study|Lost to Follow-up|20|||
125561350|NCT02234284|451686462|FG001|Overall Study|Lost to Follow-up|7|||
125561351|NCT00233363|451686463|FG000|Overall Study|Adverse Event|1|||
125561352|NCT00233363|451686464|FG001|Overall Study|Adverse Event|2|||
125561353|NCT00233363|451686463|FG000|Overall Study|Lack of Efficacy|0|||
125561354|NCT00233363|451686464|FG001|Overall Study|Lack of Efficacy|2|||
125561355|NCT00233363|451686463|FG000|Overall Study|Withdrawal by Subject|1|||
125561356|NCT00233363|451686464|FG001|Overall Study|Withdrawal by Subject|1|||
125561357|NCT00233363|451686463|FG000|Overall Study|Aggravation of complication|1|||
125561358|NCT00233363|451686464|FG001|Overall Study|Aggravation of complication|0|||
125561359|NCT00873366|451686470|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
125561360|NCT00873366|451686470|FG000|Overall Study|Off tamoxifen due to side effects|2|||
125561361|NCT00873366|451686470|FG000|Overall Study|Refused to continue DM-BT testing|3|||
125561362|NCT01576172|451686471|FG000|Overall Study|Ineligible|2|||
125561363|NCT01576172|451686472|FG001|Overall Study|Ineligible|1|||
125354106|NCT04650854|450931293|FG001|Overall Study|Adverse Event|12|||
125354107|NCT04650854|450931294|FG002|Overall Study|Adverse Event|14|||
125354108|NCT04650854|450931292|FG000|Overall Study|Lack of Efficacy|1|||
125354109|NCT04650854|450931293|FG001|Overall Study|Lack of Efficacy|3|||
125354110|NCT04650854|450931294|FG002|Overall Study|Lack of Efficacy|6|||
125354111|NCT04650854|450931292|FG000|Overall Study|Lost to Follow-up|1|||
125354112|NCT04650854|450931293|FG001|Overall Study|Lost to Follow-up|1|||
125354113|NCT04650854|450931294|FG002|Overall Study|Lost to Follow-up|0|||
125354114|NCT04650854|450931292|FG000|Overall Study|Withdrawal by Subject|2|||
125354115|NCT04650854|450931293|FG001|Overall Study|Withdrawal by Subject|17|||
125354116|NCT04650854|450931294|FG002|Overall Study|Withdrawal by Subject|9|||
125354117|NCT04650854|450931292|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
125354118|NCT04650854|450931293|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
125354119|NCT04650854|450931294|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
125354120|NCT04650854|450931292|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
125354121|NCT04650854|450931293|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
125354122|NCT04650854|450931294|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
125354123|NCT04650854|450931292|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
125354124|NCT04650854|450931293|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
125354125|NCT04650854|450931294|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
125354126|NCT04650854|450931292|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
125354127|NCT04650854|450931293|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
125354128|NCT04650854|450931294|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
125354129|NCT04650854|450931292|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
125354130|NCT04650854|450931293|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
125354131|NCT04650854|450931294|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
125354132|NCT04650854|450931292|FG000|Overall Study|Use of Rescue Medication|0|||
125354133|NCT04650854|450931293|FG001|Overall Study|Use of Rescue Medication|0|||
125354134|NCT04650854|450931294|FG002|Overall Study|Use of Rescue Medication|1|||
125354135|NCT04650854|450931292|FG000|Overall Study|Last Treatment Per Sponsor|0|||
125354136|NCT04650854|450931293|FG001|Overall Study|Last Treatment Per Sponsor|0|||
125354137|NCT04650854|450931294|FG002|Overall Study|Last Treatment Per Sponsor|2|||
125354138|NCT04650854|450931292|FG000|Overall Study|Rescue Medication|0|||
125354139|NCT04650854|450931293|FG001|Overall Study|Rescue Medication|0|||
125354140|NCT04650854|450931294|FG002|Overall Study|Rescue Medication|1|||
125354141|NCT04650854|450931292|FG000|Overall Study|Participant Want to Start a Family|0|||
125354142|NCT04650854|450931293|FG001|Overall Study|Participant Want to Start a Family|0|||
125354143|NCT04650854|450931294|FG002|Overall Study|Participant Want to Start a Family|1|||
125354144|NCT04650854|450931292|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
125354145|NCT04650854|450931293|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
125354146|NCT04650854|450931294|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
125354147|NCT04650854|450931292|FG000|Overall Study|Participant Screened For MG0020|0|||
125354148|NCT04650854|450931293|FG001|Overall Study|Participant Screened For MG0020|2|||
125354149|NCT04650854|450931294|FG002|Overall Study|Participant Screened For MG0020|3|||
125354150|NCT04650854|450931292|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
125354151|NCT04650854|450931293|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
125354152|NCT04650854|450931294|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
125354153|NCT04650854|450931292|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
125354154|NCT04650854|450931293|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
125354155|NCT04650854|450931294|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
125354156|NCT04650854|450931292|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
125354157|NCT04650854|450931293|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
125354158|NCT04650854|450931294|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
125354159|NCT04650854|450931292|FG000|Overall Study|End Of Study|0|||
125354160|NCT04650854|450931293|FG001|Overall Study|End Of Study|2|||
125354161|NCT04650854|450931294|FG002|Overall Study|End Of Study|1|||
125354162|NCT04650854|450931292|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
125354163|NCT04650854|450931293|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
125354164|NCT04650854|450931294|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
125354165|NCT04650854|450931292|FG000|Overall Study|Participant Received Rescue Medication|0|||
125354166|NCT04650854|450931293|FG001|Overall Study|Participant Received Rescue Medication|1|||
125354167|NCT04650854|450931294|FG002|Overall Study|Participant Received Rescue Medication|0|||
125354168|NCT04650854|450931292|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
125354169|NCT04650854|450931293|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
125354170|NCT04650854|450931294|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
125354171|NCT04650854|450931292|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
125354172|NCT04650854|450931293|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
125354173|NCT04650854|450931294|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
125354174|NCT04650854|450931292|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
125354175|NCT04650854|450931293|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
125354176|NCT04650854|450931294|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
125354177|NCT04650854|450931292|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
125354178|NCT04650854|450931293|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
125354179|NCT04650854|450931294|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
125354180|NCT04650854|450931292|FG000|Overall Study|Enrollment Cup|0|||
125354181|NCT04650854|450931293|FG001|Overall Study|Enrollment Cup|0|||
125354182|NCT04650854|450931294|FG002|Overall Study|Enrollment Cup|1|||
125354183|NCT00704808|450931295|FG000|Overall Study|Discontinued prior to starting treatment|14|||
125354184|NCT00704808|450931295|FG000|Overall Study|Death|7|||
125354185|NCT00704808|450931295|FG000|Overall Study|Tumor progression|80|||
125354186|NCT00704808|450931295|FG000|Overall Study|Patient's decision|11|||
125354187|NCT00704808|450931295|FG000|Overall Study|Early therapy discontinuation|16|||
125354188|NCT00704808|450931295|FG000|Overall Study|Adverse Event|1|||
125561364|NCT01576172|451686471|FG000|Overall Study|Withdrawal by Subject|2|||
125561365|NCT01576172|451686472|FG001|Overall Study|Withdrawal by Subject|0|||
125561366|NCT01576172|451686471|FG000|Overall Study|Insurance issue|1|||
125561367|NCT01576172|451686472|FG001|Overall Study|Insurance issue|0|||
125561368|NCT01537198|451686481|FG000|Overall Study|RSV infection|2|||
125561369|NCT01537198|451686481|FG000|Overall Study|Adverse Event|4|||
125561370|NCT01537198|451686481|FG000|Overall Study|No Further Visits to the Clinic|37|||
125561371|NCT01537198|451686481|FG000|Overall Study|Other|111|||
125561372|NCT01231659|451686482|FG000|Overall Study|Adverse Event|9|||
125561373|NCT01231659|451686482|FG000|Overall Study|Disease Progression|48|||
125561374|NCT01231659|451686482|FG000|Overall Study|Death|2|||
125561375|NCT01231659|451686482|FG000|Overall Study|Patient refused to complete study visit|1|||
125561376|NCT01231659|451686482|FG000|Overall Study|Other protocol defined criteria|12|||
125561377|NCT01022502|451686483|FG000|Overall Study|Adverse Event|1|||
125561378|NCT01022502|451686483|FG000|Overall Study|employment related reasons|1|||
125561379|NCT01022502|451686483|FG000|Overall Study|Withdrawal by Subject|1|||
125561380|NCT01390272|451686484|FG000|Overall Study|Death|3|||
125561381|NCT01390272|451686485|FG001|Overall Study|Death|2|||
125354189|NCT00704808|450931295|FG000|Overall Study|Lost to Follow-up|1|||
125354190|NCT00704808|450931295|FG000|Overall Study|Treatment change|1|||
125354191|NCT01280955|450931299|FG000|Overall Study|Death|2|||
125561382|NCT01390272|451686484|FG000|Overall Study|Withdrawal by Subject|9|||
125561383|NCT01390272|451686485|FG001|Overall Study|Withdrawal by Subject|5|||
125354192|NCT01280955|450931299|FG000|Overall Study|Withdrawal by Subject|1|||
125354193|NCT04223232|450931300|FG000|Overall Study|Withdrawal by Subject|1|||
125354194|NCT05281601|450931301|FG000|Overall Study|Physician Decision|2|||
125354195|NCT05281601|450931302|FG001|Overall Study|Physician Decision|0|||
125354196|NCT05281601|450931301|FG000|Overall Study|Lost to Follow-up|2|||
125354197|NCT05281601|450931302|FG001|Overall Study|Lost to Follow-up|0|||
125354198|NCT05281601|450931301|FG000|Overall Study|Death|1|||
125354199|NCT05281601|450931302|FG001|Overall Study|Death|0|||
125354200|NCT05281601|450931301|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125354201|NCT05281601|450931302|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125354202|NCT03172910|450932733|FG000|Overall Study|Adverse Event|0|||
125354203|NCT03172910|450932734|FG001|Overall Study|Adverse Event|0|||
125354204|NCT03172910|450932735|FG002|Overall Study|Adverse Event|0|||
125354205|NCT03172910|450932736|FG003|Overall Study|Adverse Event|0|||
125354206|NCT03172910|450932737|FG004|Overall Study|Adverse Event|1|||
125354207|NCT01659658|450932739|FG000|Overall Study|Withdrawal by Patient|18|||
125354208|NCT01659658|450932740|FG001|Overall Study|Withdrawal by Patient|4|||
125354209|NCT01659658|450932741|FG002|Overall Study|Withdrawal by Patient|2|||
125354210|NCT01659658|450932742|FG003|Overall Study|Withdrawal by Patient|0|||
125354211|NCT01659658|450932743|FG004|Overall Study|Withdrawal by Patient|11|||
125354212|NCT01659658|450932739|FG000|Overall Study|Study Terminated by Sponsor|9|||
125354213|NCT01659658|450932740|FG001|Overall Study|Study Terminated by Sponsor|7|||
125354214|NCT01659658|450932741|FG002|Overall Study|Study Terminated by Sponsor|0|||
125354215|NCT01659658|450932742|FG003|Overall Study|Study Terminated by Sponsor|1|||
125354216|NCT01659658|450932743|FG004|Overall Study|Study Terminated by Sponsor|4|||
125426281|NCT02660827|451184459|FG000|Period 2: Continued Access Period|Adverse Event|3|||
125561384|NCT01390272|451686484|FG000|Overall Study|Patient moved, no longer eligible|5|||
125561385|NCT01390272|451686485|FG001|Overall Study|Patient moved, no longer eligible|8|||
125561386|NCT01536951|451686489|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125561387|NCT01536951|451686490|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125561388|NCT01536951|451686491|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
125561389|NCT01536951|451686492|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125561390|NCT01536951|451686493|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125561391|NCT01536951|451686494|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125561392|NCT01536951|451686495|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125561393|NCT01536951|451686496|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125561394|NCT01536951|451686497|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
125561395|NCT01536951|451686489|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
125561396|NCT01536951|451686490|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
125354217|NCT01659658|450932739|FG000|Overall Study|Reason not Specified|61|||
125354218|NCT01659658|450932740|FG001|Overall Study|Reason not Specified|15|||
125354219|NCT01659658|450932741|FG002|Overall Study|Reason not Specified|8|||
125354220|NCT01659658|450932742|FG003|Overall Study|Reason not Specified|1|||
125354221|NCT01659658|450932743|FG004|Overall Study|Reason not Specified|34|||
125561397|NCT01536951|451686491|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
125561398|NCT01536951|451686492|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
125561399|NCT01536951|451686493|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
125561400|NCT01536951|451686494|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
125561401|NCT01536951|451686495|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
125561402|NCT01536951|451686496|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
125561403|NCT01536951|451686497|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
125561404|NCT00430482|451686498|FG000|Completed Treatment|Insufficient Treatment|7|||
125561405|NCT00430482|451686499|FG001|Completed Treatment|Insufficient Treatment|11|||
125561406|NCT00545402|451686500|FG000|Overall Study|Discontinuation of treatment|17|||
125561407|NCT00545402|451686501|FG001|Overall Study|Discontinuation of treatment|9|||
125561408|NCT00545402|451686500|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
125561409|NCT00545402|451686501|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
125561410|NCT00545402|451686500|FG000|Overall Study|Death|5|||
125561411|NCT00545402|451686501|FG001|Overall Study|Death|7|||
125561412|NCT00545402|451686500|FG000|Overall Study|Graft loss|2|||
125561413|NCT00545402|451686501|FG001|Overall Study|Graft loss|4|||
125561414|NCT00545402|451686500|FG000|Overall Study|Withdrawal by Subject|0|||
125561415|NCT00545402|451686501|FG001|Overall Study|Withdrawal by Subject|1|||
125561416|NCT00545402|451686500|FG000|Overall Study|Protocol Violation|1|||
125561417|NCT00545402|451686501|FG001|Overall Study|Protocol Violation|0|||
125561418|NCT00545402|451686500|FG000|Overall Study|Reason not specified|1|||
125561419|NCT00545402|451686501|FG001|Overall Study|Reason not specified|1|||
125561420|NCT00555477|451686502|FG000|Overall Study|Adverse Event|0|||
125561421|NCT00555477|451686503|FG001|Overall Study|Adverse Event|9|||
125561422|NCT00555477|451686502|FG000|Overall Study|Withdrawal by Subject|1|||
125561423|NCT00555477|451686503|FG001|Overall Study|Withdrawal by Subject|2|||
125561424|NCT00555477|451686502|FG000|Overall Study|Physician Decision|1|||
125561425|NCT00555477|451686503|FG001|Overall Study|Physician Decision|2|||
125561426|NCT01721876|451686504|FG000|Overall Study|Not treated|1|||
125561427|NCT01721876|451686505|FG001|Overall Study|Not treated|4|||
125561428|NCT01721876|451686504|FG000|Overall Study|Disease progression / relapse|123|||
125354222|NCT01659658|450932739|FG000|Overall Study|Lost to Follow-up|2|||
125354223|NCT01659658|450932740|FG001|Overall Study|Lost to Follow-up|0|||
125354224|NCT01659658|450932741|FG002|Overall Study|Lost to Follow-up|0|||
125354225|NCT01659658|450932742|FG003|Overall Study|Lost to Follow-up|0|||
125354226|NCT01659658|450932743|FG004|Overall Study|Lost to Follow-up|0|||
125354227|NCT00451451|450932745|FG000|Overall Study|Adverse Event|11|||
125354228|NCT00451451|450932746|FG001|Overall Study|Adverse Event|21|||
125354229|NCT00451451|450932747|FG002|Overall Study|Adverse Event|26|||
125561429|NCT01721876|451686505|FG001|Overall Study|Disease progression / relapse|156|||
125561430|NCT01721876|451686504|FG000|Overall Study|Death|6|||
125561431|NCT01721876|451686505|FG001|Overall Study|Death|13|||
125561432|NCT01721876|451686504|FG000|Overall Study|Adverse Event|41|||
125561433|NCT01721876|451686505|FG001|Overall Study|Adverse Event|165|||
125561434|NCT01721876|451686504|FG000|Overall Study|Protocol Violation|2|||
125561435|NCT01721876|451686505|FG001|Overall Study|Protocol Violation|1|||
125561436|NCT01721876|451686504|FG000|Overall Study|Withdrawal by Subject|15|||
125561437|NCT01721876|451686505|FG001|Overall Study|Withdrawal by Subject|38|||
125561438|NCT01721876|451686504|FG000|Overall Study|Reason not listed|34|||
125561439|NCT01721876|451686505|FG001|Overall Study|Reason not listed|63|||
125561440|NCT01721876|451686504|FG000|Overall Study|Sponsor terminated trial|0|||
125561441|NCT01721876|451686505|FG001|Overall Study|Sponsor terminated trial|4|||
125561442|NCT01721057|451686506|FG000|Treatment Period|Withdrawal by Subject|11|||
125561443|NCT01721057|451686507|FG001|Treatment Period|Withdrawal by Subject|5|||
125561444|NCT01721057|451686508|FG002|Treatment Period|Withdrawal by Subject|8|||
125561445|NCT01721057|451686509|FG003|Treatment Period|Withdrawal by Subject|0|||
125561446|NCT01721057|451686510|FG004|Treatment Period|Withdrawal by Subject|0|||
125561447|NCT01721057|451686511|FG005|Treatment Period|Withdrawal by Subject|0|||
125561448|NCT01721057|451686512|FG006|Treatment Period|Withdrawal by Subject|0|||
125561449|NCT01721057|451686506|FG000|Treatment Period|Adverse Event|7|||
125561450|NCT01721057|451686507|FG001|Treatment Period|Adverse Event|10|||
125561451|NCT01721057|451686508|FG002|Treatment Period|Adverse Event|12|||
125561452|NCT01721057|451686509|FG003|Treatment Period|Adverse Event|0|||
125561453|NCT01721057|451686510|FG004|Treatment Period|Adverse Event|0|||
125561454|NCT01721057|451686511|FG005|Treatment Period|Adverse Event|0|||
125561455|NCT01721057|451686512|FG006|Treatment Period|Adverse Event|0|||
125561456|NCT01721057|451686506|FG000|Treatment Period|Lack of Efficacy|7|||
125561457|NCT01721057|451686507|FG001|Treatment Period|Lack of Efficacy|3|||
125561458|NCT01721057|451686508|FG002|Treatment Period|Lack of Efficacy|0|||
125561459|NCT01721057|451686509|FG003|Treatment Period|Lack of Efficacy|0|||
125561460|NCT01721057|451686510|FG004|Treatment Period|Lack of Efficacy|0|||
125561461|NCT01721057|451686511|FG005|Treatment Period|Lack of Efficacy|0|||
125561462|NCT01721057|451686512|FG006|Treatment Period|Lack of Efficacy|0|||
125561463|NCT01721057|451686506|FG000|Treatment Period|Lost to Follow-up|1|||
125561464|NCT01721057|451686507|FG001|Treatment Period|Lost to Follow-up|0|||
125561465|NCT01721057|451686508|FG002|Treatment Period|Lost to Follow-up|0|||
125561466|NCT01721057|451686509|FG003|Treatment Period|Lost to Follow-up|0|||
125561467|NCT01721057|451686510|FG004|Treatment Period|Lost to Follow-up|0|||
125561468|NCT01721057|451686511|FG005|Treatment Period|Lost to Follow-up|0|||
125561469|NCT01721057|451686512|FG006|Treatment Period|Lost to Follow-up|0|||
125561470|NCT01721057|451686506|FG000|Treatment Period|Physician Decision|0|||
125561471|NCT01721057|451686507|FG001|Treatment Period|Physician Decision|1|||
125561472|NCT01721057|451686508|FG002|Treatment Period|Physician Decision|3|||
125561473|NCT01721057|451686509|FG003|Treatment Period|Physician Decision|0|||
125561474|NCT01721057|451686510|FG004|Treatment Period|Physician Decision|0|||
125561475|NCT01721057|451686511|FG005|Treatment Period|Physician Decision|0|||
125561476|NCT01721057|451686512|FG006|Treatment Period|Physician Decision|0|||
125561477|NCT01721057|451686506|FG000|Treatment Period|Death|2|||
125561478|NCT01721057|451686507|FG001|Treatment Period|Death|0|||
125561479|NCT01721057|451686508|FG002|Treatment Period|Death|0|||
125354230|NCT00451451|450932748|FG003|Overall Study|Adverse Event|10|||
125354231|NCT00451451|450932745|FG000|Overall Study|Lost to Follow-up|11|||
125354232|NCT00451451|450932746|FG001|Overall Study|Lost to Follow-up|9|||
125426282|NCT01428076|451184460|FG000|Overall Study|Adverse Event|0|||
125561480|NCT01721057|451686509|FG003|Treatment Period|Death|0|||
125561481|NCT01721057|451686510|FG004|Treatment Period|Death|0|||
125561482|NCT01721057|451686511|FG005|Treatment Period|Death|0|||
125354233|NCT00451451|450932747|FG002|Overall Study|Lost to Follow-up|8|||
125561483|NCT01721057|451686512|FG006|Treatment Period|Death|0|||
125561484|NCT01721057|451686506|FG000|Rescue Period|Adverse Event|0|||
125561485|NCT01721057|451686507|FG001|Rescue Period|Adverse Event|0|||
125561486|NCT01721057|451686508|FG002|Rescue Period|Adverse Event|0|||
125561487|NCT01721057|451686509|FG003|Rescue Period|Adverse Event|1|||
125561488|NCT01721057|451686510|FG004|Rescue Period|Adverse Event|0|||
125561489|NCT01721057|451686511|FG005|Rescue Period|Adverse Event|0|||
125561490|NCT01721057|451686512|FG006|Rescue Period|Adverse Event|0|||
125561491|NCT01721057|451686506|FG000|Rescue Period|Lack of Efficacy|0|||
125561492|NCT01721057|451686507|FG001|Rescue Period|Lack of Efficacy|0|||
125561493|NCT01721057|451686508|FG002|Rescue Period|Lack of Efficacy|0|||
125561494|NCT01721057|451686509|FG003|Rescue Period|Lack of Efficacy|2|||
125561495|NCT01721057|451686510|FG004|Rescue Period|Lack of Efficacy|0|||
125561496|NCT01721057|451686511|FG005|Rescue Period|Lack of Efficacy|0|||
125561497|NCT01721057|451686512|FG006|Rescue Period|Lack of Efficacy|0|||
125561498|NCT03805750|451686513|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
125561499|NCT03805750|451686514|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
125561500|NCT01177683|451686515|FG000|Study Treatment|Disease Progressions during treatment|2|||
125561501|NCT01177683|451686516|FG001|Study Treatment|Disease Progressions during treatment|0|||
125561502|NCT01177683|451686517|FG002|Study Treatment|Disease Progressions during treatment|3|||
125561503|NCT01177683|451686515|FG000|Study Treatment|Adverse Event|0|||
125561504|NCT01177683|451686516|FG001|Study Treatment|Adverse Event|1|||
125561505|NCT01177683|451686517|FG002|Study Treatment|Adverse Event|12|||
125561506|NCT01177683|451686515|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
125561507|NCT01177683|451686516|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
125561508|NCT01177683|451686517|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
125561509|NCT01177683|451686515|FG000|Study Treatment|Alternative therapy|0|||
125561510|NCT01177683|451686516|FG001|Study Treatment|Alternative therapy|0|||
125561511|NCT01177683|451686517|FG002|Study Treatment|Alternative therapy|4|||
125561512|NCT01177683|451686515|FG000|Study Treatment|Physician Decision|1|||
125561513|NCT01177683|451686516|FG001|Study Treatment|Physician Decision|0|||
125561514|NCT01177683|451686517|FG002|Study Treatment|Physician Decision|1|||
125561515|NCT01177683|451686515|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
125561516|NCT01177683|451686516|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
125561517|NCT01177683|451686517|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
125561518|NCT01177683|451686515|FG000|Study Treatment|Symptomatic Deterioration|0|||
125561519|NCT01177683|451686516|FG001|Study Treatment|Symptomatic Deterioration|0|||
125561520|NCT01177683|451686517|FG002|Study Treatment|Symptomatic Deterioration|1|||
125561521|NCT01177683|451686515|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
125561522|NCT01177683|451686516|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
125561523|NCT01177683|451686517|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
125561524|NCT01177683|451686515|FG000|Follow up|Patient lost to follow up|0|||
125561525|NCT01177683|451686516|FG001|Follow up|Patient lost to follow up|0|||
125561526|NCT01177683|451686517|FG002|Follow up|Patient lost to follow up|2|||
125561527|NCT01177683|451686515|FG000|Follow up|Death|2|||
125561528|NCT01177683|451686516|FG001|Follow up|Death|1|||
125561529|NCT01177683|451686517|FG002|Follow up|Death|7|||
125561530|NCT01177683|451686515|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
125561531|NCT01177683|451686516|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
125561532|NCT01177683|451686517|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
125561533|NCT01889238|451686519|FG000|Overall Study|Death|1|||
125561534|NCT01889238|451686519|FG000|Overall Study|Withdrawal by Subject|1|||
125561535|NCT01889238|451686519|FG000|Overall Study|Adverse Event|6|||
125561536|NCT01889238|451686519|FG000|Overall Study|Disease Progression|104|||
125561537|NCT01889238|451686519|FG000|Overall Study|Other|6|||
125561538|NCT04136184|451686520|FG000|Overall Study|Lost to Follow-up|0|||
125561539|NCT04136184|451686521|FG001|Overall Study|Lost to Follow-up|3|||
125561540|NCT04136184|451686520|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
125561541|NCT04136184|451686521|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
125561542|NCT02844816|451686522|FG000|Overall Study|No protocol treatment received|5|||
125561543|NCT02844816|451686523|FG001|Overall Study|No protocol treatment received|1|||
125561544|NCT02844816|451686522|FG000|Overall Study|Ineligible|22|||
125561545|NCT02844816|451686523|FG001|Overall Study|Ineligible|15|||
125561546|NCT02844816|451686522|FG000|Overall Study|Participant refusal|5|||
125561547|NCT02844816|451686523|FG001|Overall Study|Participant refusal|5|||
125561548|NCT02844816|451686522|FG000|Overall Study|Adverse Event|5|||
125426283|NCT01428076|451184461|FG001|Overall Study|Adverse Event|1|||
125426284|NCT00045305|451184465|FG000|Overall Study|Lack of Efficacy|6|||
125561549|NCT02844816|451686523|FG001|Overall Study|Adverse Event|4|||
125561550|NCT02844816|451686522|FG000|Overall Study|Death|0|||
125561551|NCT02844816|451686523|FG001|Overall Study|Death|1|||
125561552|NCT02844816|451686522|FG000|Overall Study|Disease progression/recurrence|50|||
125561553|NCT02844816|451686523|FG001|Overall Study|Disease progression/recurrence|24|||
125561554|NCT02844816|451686522|FG000|Overall Study|Physician Decision|1|||
125561555|NCT02844816|451686523|FG001|Overall Study|Physician Decision|1|||
125561556|NCT02717754|451686524|FG000|Overall Study|Incorrect Infusion Duration|0|||
125561557|NCT02717754|451686525|FG001|Overall Study|Incorrect Infusion Duration|0|||
125561558|NCT02717754|451686526|FG002|Overall Study|Incorrect Infusion Duration|0|||
125561559|NCT02717754|451686527|FG003|Overall Study|Incorrect Infusion Duration|10|||
125561560|NCT02717754|451686528|FG004|Overall Study|Incorrect Infusion Duration|20|||
125561561|NCT02717754|451686529|FG005|Overall Study|Incorrect Infusion Duration|20|||
125561562|NCT03734016|451686530|FG000|Overall Study|Sponsor Ended Study|225|||
125354234|NCT00451451|450932748|FG003|Overall Study|Lost to Follow-up|11|||
125354235|NCT00451451|450932745|FG000|Overall Study|Consent Withdrawn|14|||
125354236|NCT00451451|450932746|FG001|Overall Study|Consent Withdrawn|9|||
125354237|NCT00451451|450932747|FG002|Overall Study|Consent Withdrawn|17|||
125354238|NCT00451451|450932748|FG003|Overall Study|Consent Withdrawn|17|||
125354239|NCT00451451|450932745|FG000|Overall Study|Investigator Decision|6|||
125354240|NCT00451451|450932746|FG001|Overall Study|Investigator Decision|2|||
125354241|NCT00451451|450932747|FG002|Overall Study|Investigator Decision|1|||
125354242|NCT00451451|450932748|FG003|Overall Study|Investigator Decision|2|||
125354243|NCT00451451|450932745|FG000|Overall Study|Subject Non-Compliance|8|||
125354244|NCT00451451|450932746|FG001|Overall Study|Subject Non-Compliance|4|||
125354245|NCT00451451|450932747|FG002|Overall Study|Subject Non-Compliance|3|||
125354246|NCT00451451|450932748|FG003|Overall Study|Subject Non-Compliance|3|||
125354247|NCT00451451|450932745|FG000|Overall Study|Death|1|||
125354248|NCT00451451|450932746|FG001|Overall Study|Death|0|||
125354249|NCT00451451|450932747|FG002|Overall Study|Death|0|||
125354250|NCT00451451|450932748|FG003|Overall Study|Death|1|||
125354251|NCT00451451|450932745|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
125354252|NCT00451451|450932746|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
125354253|NCT00451451|450932747|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
125354254|NCT00451451|450932748|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
125561563|NCT03734016|451686531|FG001|Overall Study|Sponsor Ended Study|200|||
125561564|NCT03734016|451686530|FG000|Overall Study|Death|69|||
125561565|NCT03734016|451686531|FG001|Overall Study|Death|83|||
125561566|NCT03734016|451686530|FG000|Overall Study|Withdrawal by Subject|21|||
125561567|NCT03734016|451686531|FG001|Overall Study|Withdrawal by Subject|27|||
125561568|NCT03734016|451686530|FG000|Overall Study|Physician Decision|1|||
125561569|NCT03734016|451686531|FG001|Overall Study|Physician Decision|12|||
125561570|NCT03734016|451686530|FG000|Overall Study|Lost to Follow-up|6|||
125561571|NCT03734016|451686531|FG001|Overall Study|Lost to Follow-up|2|||
125561572|NCT03734016|451686530|FG000|Overall Study|Miscellaneous|5|||
125561573|NCT03734016|451686531|FG001|Overall Study|Miscellaneous|1|||
125561574|NCT01979835|451686532|FG000|Primary Outcome SA Measurment|failed insertion|18|||
125561575|NCT01979835|451686532|FG000|Follow-up|Lost to Follow-up|32|||
125561576|NCT02592018|451686535|FG000|Overall Study|Adverse Event|1|||
125561577|NCT02592018|451686535|FG000|Overall Study|Lost to Follow-up|1|||
125561578|NCT02710136|451686538|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
125561579|NCT02710136|451686539|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
125561580|NCT00418665|451686540|FG000|Treatment Period|Ineligibility determined|1|||
125561581|NCT00418665|451686541|FG001|Treatment Period|Ineligibility determined|1|||
125561582|NCT00418665|451686542|FG002|Treatment Period|Ineligibility determined|0|||
125561583|NCT00418665|451686540|FG000|Treatment Period|Adverse Event|2|||
125561584|NCT00418665|451686541|FG001|Treatment Period|Adverse Event|2|||
125561585|NCT00418665|451686542|FG002|Treatment Period|Adverse Event|0|||
125561586|NCT00418665|451686540|FG000|Treatment Period|Withdrawal by Subject|0|||
125561587|NCT00418665|451686541|FG001|Treatment Period|Withdrawal by Subject|3|||
125561588|NCT00418665|451686542|FG002|Treatment Period|Withdrawal by Subject|1|||
125561589|NCT00418665|451686540|FG000|Treatment Period|Requirement for alternative therapy|1|||
125561590|NCT00418665|451686541|FG001|Treatment Period|Requirement for alternative therapy|0|||
125561591|NCT00418665|451686542|FG002|Treatment Period|Requirement for alternative therapy|0|||
125561592|NCT00418665|451686540|FG000|Treatment Period|Physician Decision|1|||
125561593|NCT00418665|451686541|FG001|Treatment Period|Physician Decision|0|||
125561594|NCT00418665|451686542|FG002|Treatment Period|Physician Decision|3|||
125561595|NCT00418665|451686540|FG000|Treatment Extension|Adverse Event|1|||
125561596|NCT00418665|451686541|FG001|Treatment Extension|Adverse Event|0|||
125561597|NCT00418665|451686542|FG002|Treatment Extension|Adverse Event|0|||
125561598|NCT00418665|451686540|FG000|Treatment Extension|Withdrawal by Subject|1|||
125561599|NCT00418665|451686541|FG001|Treatment Extension|Withdrawal by Subject|0|||
125561600|NCT00418665|451686542|FG002|Treatment Extension|Withdrawal by Subject|0|||
125561601|NCT00418665|451686540|FG000|Treatment Extension|Requirement for alternative therapy|2|||
125561602|NCT00418665|451686541|FG001|Treatment Extension|Requirement for alternative therapy|2|||
125561603|NCT00418665|451686542|FG002|Treatment Extension|Requirement for alternative therapy|0|||
125561604|NCT00418665|451686540|FG000|Treatment Extension|Physician Decision|2|||
125561605|NCT00418665|451686541|FG001|Treatment Extension|Physician Decision|2|||
125561606|NCT00418665|451686542|FG002|Treatment Extension|Physician Decision|1|||
125561607|NCT00418665|451686540|FG000|Treatment Extension|Death|0|||
125561608|NCT00418665|451686541|FG001|Treatment Extension|Death|0|||
125561609|NCT00418665|451686542|FG002|Treatment Extension|Death|1|||
125561610|NCT01133379|451686545|FG000|Overall Study|Withdrawal by Subject|0|||
125561611|NCT01133379|451686546|FG001|Overall Study|Withdrawal by Subject|1|||
125561612|NCT01133379|451686547|FG002|Overall Study|Withdrawal by Subject|1|||
125561613|NCT01133379|451686545|FG000|Overall Study|Lost to Follow-up|1|||
125561614|NCT01133379|451686546|FG001|Overall Study|Lost to Follow-up|1|||
125561615|NCT01133379|451686547|FG002|Overall Study|Lost to Follow-up|1|||
125561616|NCT00591214|451686548|FG000|Overall Study|Physician Decision|7|||
125561617|NCT00591214|451686548|FG000|Overall Study|Withdrawal by Subject|1|||
125637199|NCT03073200|451952835|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
125637200|NCT03073200|451952836|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
125637201|NCT03073200|451952837|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
125637202|NCT03073200|451952838|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
125637203|NCT03073200|451952839|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
125637204|NCT03073200|451952840|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
125637205|NCT03073200|451952841|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
125637206|NCT03073200|451952842|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
125637207|NCT03073200|451952843|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
125637208|NCT03073200|451952844|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
125637209|NCT03073200|451952845|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
125637210|NCT03073200|451952846|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
125637211|NCT03073200|451952832|FG000|Extension Period|Withdrawal by Subject|0|||
125637212|NCT03073200|451952833|FG001|Extension Period|Withdrawal by Subject|0|||
125637213|NCT03073200|451952834|FG002|Extension Period|Withdrawal by Subject|0|||
125561618|NCT02142738|451687904|FG000|Overall Study|Adverse Event|13|||
125561619|NCT02142738|451687905|FG001|Overall Study|Adverse Event|9|||
125561620|NCT02142738|451687904|FG000|Overall Study|Death|92|||
125561621|NCT02142738|451687905|FG001|Overall Study|Death|112|||
125561622|NCT02142738|451687904|FG000|Overall Study|Lost to Follow-up|0|||
125561623|NCT02142738|451687905|FG001|Overall Study|Lost to Follow-up|3|||
125561624|NCT02142738|451687904|FG000|Overall Study|Withdrawal by Subject|6|||
125561625|NCT02142738|451687905|FG001|Overall Study|Withdrawal by Subject|7|||
125561626|NCT02142738|451687904|FG000|Overall Study|Follow up ended by sponsor|43|||
125561627|NCT02142738|451687905|FG001|Overall Study|Follow up ended by sponsor|20|||
125561628|NCT03688880|451687906|FG000|Overall Study|Withdrawal by Subject|0|||
125561629|NCT03688880|451687907|FG001|Overall Study|Withdrawal by Subject|2|||
125561630|NCT03688880|451687906|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
125561631|NCT03688880|451687907|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
125561632|NCT03688880|451687906|FG000|Overall Study|Lost to Follow-up|4|||
125561633|NCT03688880|451687907|FG001|Overall Study|Lost to Follow-up|7|||
125561634|NCT03688880|451687906|FG000|Overall Study|Adverse Event|0|||
125561635|NCT03688880|451687907|FG001|Overall Study|Adverse Event|2|||
125561636|NCT03688880|451687906|FG000|Overall Study|Device deficiencies|0|||
125561637|NCT03688880|451687907|FG001|Overall Study|Device deficiencies|2|||
125561638|NCT03688880|451687906|FG000|Overall Study|Other|10|||
125561639|NCT03688880|451687907|FG001|Overall Study|Other|16|||
125561640|NCT04490395|451687908|FG000|Overall Study|Lost to Follow-up|0|||
125561641|NCT04490395|451687909|FG001|Overall Study|Lost to Follow-up|1|||
125561642|NCT02230254|451687910|FG000|Overall Study|Lost to Follow-up|3|||
125561643|NCT01942148|451687911|FG000|Overall Study|Adverse Event|4|||
125561644|NCT01942148|451687911|FG000|Overall Study|Lack of Efficacy|2|||
125561645|NCT01942148|451687911|FG000|Overall Study|Physician Decision|11|||
125561646|NCT01942148|451687911|FG000|Overall Study|Protocol Violation|1|||
125561647|NCT01942148|451687911|FG000|Overall Study|Withdrawal by Subject|8|||
125561648|NCT01942148|451687911|FG000|Overall Study|Use of the prohibition medicine|1|||
125561649|NCT00257725|451687913|FG000|Overall Study|Adverse Event|3|||
125561650|NCT01858532|451687914|FG000|Overall Study|Adverse Event|58|||
125561651|NCT01858532|451687915|FG001|Overall Study|Adverse Event|50|||
125561652|NCT01858532|451687916|FG002|Overall Study|Adverse Event|23|||
125561653|NCT01858532|451687917|FG003|Overall Study|Adverse Event|28|||
125561654|NCT01858532|451687914|FG000|Overall Study|Withdrew consent|71|||
125561655|NCT01858532|451687915|FG001|Overall Study|Withdrew consent|93|||
125561656|NCT01858532|451687916|FG002|Overall Study|Withdrew consent|46|||
125561657|NCT01858532|451687917|FG003|Overall Study|Withdrew consent|27|||
125561658|NCT01858532|451687914|FG000|Overall Study|Lost to Follow-up|17|||
125561659|NCT01858532|451687915|FG001|Overall Study|Lost to Follow-up|26|||
125561660|NCT01858532|451687916|FG002|Overall Study|Lost to Follow-up|11|||
125561661|NCT01858532|451687917|FG003|Overall Study|Lost to Follow-up|14|||
125561662|NCT01858532|451687914|FG000|Overall Study|Deterioration of medical status|3|||
125561663|NCT01858532|451687915|FG001|Overall Study|Deterioration of medical status|4|||
125561664|NCT01858532|451687916|FG002|Overall Study|Deterioration of medical status|3|||
125561665|NCT01858532|451687917|FG003|Overall Study|Deterioration of medical status|7|||
125561666|NCT01858532|451687914|FG000|Overall Study|Investigator request|3|||
125561667|NCT01858532|451687915|FG001|Overall Study|Investigator request|4|||
125561668|NCT01858532|451687916|FG002|Overall Study|Investigator request|2|||
125561669|NCT01858532|451687917|FG003|Overall Study|Investigator request|6|||
125561670|NCT01858532|451687914|FG000|Overall Study|Other, not specified|29|||
125561671|NCT01858532|451687915|FG001|Overall Study|Other, not specified|15|||
125561672|NCT01858532|451687916|FG002|Overall Study|Other, not specified|13|||
125561673|NCT01858532|451687917|FG003|Overall Study|Other, not specified|11|||
125561674|NCT03785925|451687919|FG000|Overall Study|Withdrawal by Subject|15|||
125561675|NCT03785925|451687919|FG000|Overall Study|Lost to Follow-up|1|||
125561676|NCT00806195|451687921|FG000|Overall Study|Death|6|||
125561677|NCT00806195|451687922|FG001|Overall Study|Death|0|||
125561678|NCT00806195|451687923|FG002|Overall Study|Death|1|||
125561679|NCT00806195|451687924|FG003|Overall Study|Death|0|||
125561680|NCT00806195|451687921|FG000|Overall Study|Adverse Event|25|||
125561681|NCT00806195|451687922|FG001|Overall Study|Adverse Event|5|||
125561682|NCT00806195|451687923|FG002|Overall Study|Adverse Event|11|||
125561683|NCT00806195|451687924|FG003|Overall Study|Adverse Event|2|||
125561684|NCT00806195|451687921|FG000|Overall Study|Withdrawal by Subject|119|||
125561685|NCT00806195|451687922|FG001|Overall Study|Withdrawal by Subject|31|||
125561686|NCT00806195|451687923|FG002|Overall Study|Withdrawal by Subject|76|||
125561687|NCT00806195|451687924|FG003|Overall Study|Withdrawal by Subject|35|||
125561688|NCT00806195|451687921|FG000|Overall Study|Lost to Follow-up|217|||
125561689|NCT00806195|451687922|FG001|Overall Study|Lost to Follow-up|66|||
125561690|NCT00806195|451687923|FG002|Overall Study|Lost to Follow-up|90|||
125561691|NCT00806195|451687924|FG003|Overall Study|Lost to Follow-up|34|||
125561692|NCT00806195|451687921|FG000|Overall Study|Inappropriate Enrollment|0|||
125561693|NCT00806195|451687922|FG001|Overall Study|Inappropriate Enrollment|1|||
125561694|NCT00806195|451687923|FG002|Overall Study|Inappropriate Enrollment|0|||
125561695|NCT00806195|451687924|FG003|Overall Study|Inappropriate Enrollment|0|||
125561696|NCT00806195|451687921|FG000|Overall Study|Administrative Reason|113|||
125561697|NCT00806195|451687922|FG001|Overall Study|Administrative Reason|35|||
125561698|NCT00806195|451687923|FG002|Overall Study|Administrative Reason|66|||
125561699|NCT00806195|451687924|FG003|Overall Study|Administrative Reason|26|||
125561700|NCT00806195|451687921|FG000|Overall Study|Protocol Violation|34|||
125561701|NCT00806195|451687922|FG001|Overall Study|Protocol Violation|24|||
125561702|NCT00806195|451687923|FG002|Overall Study|Protocol Violation|26|||
125561703|NCT00806195|451687924|FG003|Overall Study|Protocol Violation|9|||
125561704|NCT02490475|451687925|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
125561705|NCT02490475|451687926|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
125561706|NCT02490475|451687927|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
125561707|NCT02490475|451687928|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
125561708|NCT02490475|451687925|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
125561709|NCT02490475|451687926|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
125561710|NCT02490475|451687927|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
125561711|NCT02490475|451687928|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
125561712|NCT02490475|451687925|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
125561713|NCT02490475|451687926|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
125561714|NCT02490475|451687927|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
125561715|NCT02490475|451687928|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
125561716|NCT02490475|451687925|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
125561717|NCT02490475|451687926|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
125426285|NCT00045305|451184465|FG000|Overall Study|Adverse Event|3|||
125561718|NCT02490475|451687927|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
125561719|NCT02490475|451687928|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
125561720|NCT02490475|451687925|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
125561721|NCT02490475|451687926|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
125561722|NCT02490475|451687927|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
125561723|NCT02490475|451687928|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
125561724|NCT02490475|451687925|FG000|Period 2: Extension Phase|Refused Treatment|0|||
125561725|NCT02490475|451687926|FG001|Period 2: Extension Phase|Refused Treatment|0|||
125561726|NCT02490475|451687927|FG002|Period 2: Extension Phase|Refused Treatment|0|||
125561727|NCT02490475|451687928|FG003|Period 2: Extension Phase|Refused Treatment|1|||
125561728|NCT02490475|451687925|FG000|Period 2: Extension Phase|Adverse Event|0|||
125561729|NCT02490475|451687926|FG001|Period 2: Extension Phase|Adverse Event|0|||
125561730|NCT02490475|451687927|FG002|Period 2: Extension Phase|Adverse Event|1|||
125561731|NCT02490475|451687928|FG003|Period 2: Extension Phase|Adverse Event|0|||
125561732|NCT00139776|451687929|FG000|Period I|Did not enter Period II|575|||
125561733|NCT00139776|451687930|FG001|Period I|Did not enter Period II|0|||
125561734|NCT00139776|451687931|FG002|Period I|Did not enter Period II|0|||
125561735|NCT00139776|451687932|FG003|Period I|Did not enter Period II|0|||
125561736|NCT00139776|451687929|FG000|Period II|Not Randomized into Period III|0|||
125561737|NCT00139776|451687930|FG001|Period II|Not Randomized into Period III|322|||
125561738|NCT00139776|451687931|FG002|Period II|Not Randomized into Period III|0|||
125561739|NCT00139776|451687932|FG003|Period II|Not Randomized into Period III|0|||
125561740|NCT00139776|451687929|FG000|Period III|Adverse Event|0|||
125561741|NCT00139776|451687930|FG001|Period III|Adverse Event|0|||
125561742|NCT00139776|451687931|FG002|Period III|Adverse Event|22|||
125561743|NCT00139776|451687932|FG003|Period III|Adverse Event|23|||
125561744|NCT00139776|451687929|FG000|Period III|Other|0|||
125561745|NCT00139776|451687930|FG001|Period III|Other|0|||
125561746|NCT00139776|451687931|FG002|Period III|Other|23|||
125561747|NCT00139776|451687932|FG003|Period III|Other|34|||
125561748|NCT00139776|451687929|FG000|Period III|Lack of Efficacy|0|||
125561749|NCT00139776|451687930|FG001|Period III|Lack of Efficacy|0|||
125561750|NCT00139776|451687931|FG002|Period III|Lack of Efficacy|10|||
125561751|NCT00139776|451687932|FG003|Period III|Lack of Efficacy|24|||
125561752|NCT00139776|451687929|FG000|Period III|Lost to Follow-up|0|||
125561753|NCT00139776|451687930|FG001|Period III|Lost to Follow-up|0|||
125561754|NCT00139776|451687931|FG002|Period III|Lost to Follow-up|5|||
125561755|NCT00139776|451687932|FG003|Period III|Lost to Follow-up|4|||
125561756|NCT00139776|451687929|FG000|Period III|Withdrawal by Subject|0|||
125561757|NCT00139776|451687930|FG001|Period III|Withdrawal by Subject|0|||
125561758|NCT00139776|451687931|FG002|Period III|Withdrawal by Subject|16|||
125561759|NCT00139776|451687932|FG003|Period III|Withdrawal by Subject|21|||
125561760|NCT01519934|451687937|FG000|Overall Study|Lost to Follow-up|3|||
125561761|NCT01368536|451687940|FG000|Overall Study|Adverse Event|5|||
125561762|NCT01368536|451687941|FG001|Overall Study|Adverse Event|6|||
125561763|NCT01368536|451687942|FG002|Overall Study|Adverse Event|8|||
125561764|NCT01368536|451687940|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125561765|NCT01368536|451687941|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125561766|NCT01368536|451687942|FG002|Overall Study|Abnormal laboratory value(s)|2|||
125561767|NCT01368536|451687940|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125561768|NCT01368536|451687941|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125561769|NCT01368536|451687942|FG002|Overall Study|Abnormal test procedure result(s)|1|||
125561770|NCT01368536|451687940|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
125561771|NCT01368536|451687941|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125561772|NCT01368536|451687942|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
125561773|NCT01368536|451687940|FG000|Overall Study|No longer required study medication|0|||
125561774|NCT01368536|451687941|FG001|Overall Study|No longer required study medication|0|||
125561775|NCT01368536|451687942|FG002|Overall Study|No longer required study medication|1|||
125561776|NCT01368536|451687940|FG000|Overall Study|Withdrawal by Subject|2|||
125561777|NCT01368536|451687941|FG001|Overall Study|Withdrawal by Subject|5|||
125561778|NCT01368536|451687942|FG002|Overall Study|Withdrawal by Subject|4|||
125561779|NCT01368536|451687940|FG000|Overall Study|Lost to Follow-up|3|||
125561780|NCT01368536|451687941|FG001|Overall Study|Lost to Follow-up|3|||
125561781|NCT01368536|451687942|FG002|Overall Study|Lost to Follow-up|5|||
125561782|NCT01368536|451687940|FG000|Overall Study|Administrative problems|34|||
125561783|NCT01368536|451687941|FG001|Overall Study|Administrative problems|39|||
125561784|NCT01368536|451687942|FG002|Overall Study|Administrative problems|35|||
125561785|NCT01368536|451687940|FG000|Overall Study|Protocol deviation|0|||
125561786|NCT01368536|451687941|FG001|Overall Study|Protocol deviation|3|||
125561787|NCT01368536|451687942|FG002|Overall Study|Protocol deviation|1|||
125561788|NCT03861936|451687943|FG000|Overall Study|Withdrawal by Subject|4|||
125561789|NCT03861936|451687944|FG001|Overall Study|Withdrawal by Subject|1|||
125561790|NCT03861936|451687945|FG002|Overall Study|Withdrawal by Subject|3|||
125561791|NCT03861936|451687943|FG000|Overall Study|Lost to Follow-up|5|||
125561792|NCT03861936|451687944|FG001|Overall Study|Lost to Follow-up|3|||
125561793|NCT03861936|451687945|FG002|Overall Study|Lost to Follow-up|3|||
125561794|NCT03861936|451687943|FG000|Overall Study|Physician Decision|0|||
125561795|NCT03861936|451687944|FG001|Overall Study|Physician Decision|1|||
125561796|NCT03861936|451687945|FG002|Overall Study|Physician Decision|0|||
125561797|NCT03861936|451687943|FG000|Overall Study|Protocol Deviation|0|||
125561798|NCT03861936|451687944|FG001|Overall Study|Protocol Deviation|0|||
125561799|NCT03861936|451687945|FG002|Overall Study|Protocol Deviation|1|||
125561800|NCT03861936|451687943|FG000|Overall Study|Reason not Specified|5|||
125561801|NCT03861936|451687944|FG001|Overall Study|Reason not Specified|5|||
125354255|NCT01442038|450932751|FG000|Overall Study|Death|35|||
125561802|NCT03861936|451687945|FG002|Overall Study|Reason not Specified|3|||
125561803|NCT00359021|451687946|FG000|Overall Study|Adverse Event|26|||
125561804|NCT00359021|451687947|FG001|Overall Study|Adverse Event|8|||
125561805|NCT00359021|451687946|FG000|Overall Study|Subject Non-Compliant|1|||
125561806|NCT00359021|451687947|FG001|Overall Study|Subject Non-Compliant|2|||
125561807|NCT00359021|451687946|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
125561808|NCT00359021|451687947|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
125561809|NCT00359021|451687946|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
125561810|NCT00359021|451687947|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
125561811|NCT00359021|451687946|FG000|Overall Study|Withdrawal by Subject|2|||
125561812|NCT00359021|451687947|FG001|Overall Study|Withdrawal by Subject|9|||
125561813|NCT00359021|451687946|FG000|Overall Study|Lost to Follow-up|1|||
125561814|NCT00359021|451687947|FG001|Overall Study|Lost to Follow-up|0|||
125561815|NCT00359021|451687946|FG000|Overall Study|Other|4|||
125561816|NCT00359021|451687947|FG001|Overall Study|Other|1|||
125561817|NCT00359021|451687946|FG000|Overall Study|Pregnancy|1|||
125561818|NCT00359021|451687947|FG001|Overall Study|Pregnancy|0|||
125561819|NCT01835015|451687951|FG000|Overall Study|Adverse Event|0|||
125561820|NCT01835015|451687952|FG001|Overall Study|Adverse Event|0|||
125561821|NCT01835015|451687953|FG002|Overall Study|Adverse Event|1|||
125561822|NCT01835015|451687954|FG003|Overall Study|Adverse Event|0|||
125561823|NCT01835015|451687955|FG004|Overall Study|Adverse Event|0|||
125561824|NCT04569032|451687956|FG000|Overall Study|Death|10|||
125561825|NCT04569032|451687957|FG001|Overall Study|Death|13|||
125561826|NCT04569032|451687956|FG000|Overall Study|Withdrawal by Subject|2|||
125561827|NCT04569032|451687957|FG001|Overall Study|Withdrawal by Subject|0|||
125561828|NCT04569032|451687956|FG000|Overall Study|Lost to Follow-up|0|||
125561829|NCT04569032|451687957|FG001|Overall Study|Lost to Follow-up|1|||
125561830|NCT04569032|451687956|FG000|Overall Study|In long term follow up|22|||
125561831|NCT04569032|451687957|FG001|Overall Study|In long term follow up|34|||
125561832|NCT00701090|451687959|FG000|Overall Study|Adverse Event|11|||
125561833|NCT00701090|451687960|FG001|Overall Study|Adverse Event|2|||
125561834|NCT00701090|451687959|FG000|Overall Study|Death|0|||
125561835|NCT00701090|451687960|FG001|Overall Study|Death|1|||
125561836|NCT00701090|451687959|FG000|Overall Study|Lack of Efficacy|5|||
125561837|NCT00701090|451687960|FG001|Overall Study|Lack of Efficacy|4|||
125561838|NCT00701090|451687959|FG000|Overall Study|Lost to Follow-up|9|||
125561839|NCT00701090|451687960|FG001|Overall Study|Lost to Follow-up|9|||
125561840|NCT00701090|451687959|FG000|Overall Study|Physician Decision|3|||
125561841|NCT00701090|451687960|FG001|Overall Study|Physician Decision|4|||
125561842|NCT00701090|451687959|FG000|Overall Study|Protocol Violation|2|||
125561843|NCT00701090|451687960|FG001|Overall Study|Protocol Violation|3|||
125561844|NCT00701090|451687959|FG000|Overall Study|Withdrawal by Subject|11|||
125561845|NCT00701090|451687960|FG001|Overall Study|Withdrawal by Subject|16|||
125561846|NCT00701090|451687959|FG000|Overall Study|Other|7|||
125561847|NCT00701090|451687960|FG001|Overall Study|Other|12|||
125561848|NCT04534491|451687965|FG000|Overall Study|Not completed end-of-study interview|24|||
125561849|NCT04534491|451687965|FG000|Overall Study|Non-users|70|||
125561850|NCT04534491|451687965|FG000|Overall Study|Non-verifiable users|58|||
125561851|NCT00113074|451687967|FG000|Overall Study|Lost to Follow-up|10|||
125561852|NCT00113074|451687968|FG001|Overall Study|Lost to Follow-up|10|||
125561853|NCT00113074|451687969|FG002|Overall Study|Lost to Follow-up|14|||
125561854|NCT02114268|451687970|FG000|Overall Study|Lost to Follow-up|4|||
125561855|NCT02114268|451687971|FG001|Overall Study|Lost to Follow-up|1|||
125561856|NCT02114268|451687972|FG002|Overall Study|Lost to Follow-up|1|||
125561857|NCT02114268|451687973|FG003|Overall Study|Lost to Follow-up|0|||
125561858|NCT02114268|451687974|FG004|Overall Study|Lost to Follow-up|0|||
125561859|NCT02114268|451687975|FG005|Overall Study|Lost to Follow-up|2|||
125561860|NCT02114268|451687970|FG000|Overall Study|Withdrawal by Subject|1|||
125561861|NCT02114268|451687971|FG001|Overall Study|Withdrawal by Subject|0|||
125561862|NCT02114268|451687972|FG002|Overall Study|Withdrawal by Subject|0|||
125561863|NCT02114268|451687973|FG003|Overall Study|Withdrawal by Subject|0|||
125561864|NCT02114268|451687974|FG004|Overall Study|Withdrawal by Subject|0|||
125561865|NCT02114268|451687975|FG005|Overall Study|Withdrawal by Subject|1|||
125561866|NCT02114268|451687970|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
125561867|NCT02114268|451687971|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
125561868|NCT02114268|451687972|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
125561869|NCT02114268|451687973|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
125561870|NCT02114268|451687974|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
125561871|NCT02114268|451687975|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
125561872|NCT02247960|451687976|FG000|Patient Consent and Randomization|Physician Decision|2|||
125561873|NCT02247960|451687977|FG001|Patient Consent and Randomization|Physician Decision|2|||
125561874|NCT02247960|451687976|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
125561875|NCT02247960|451687977|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
125561876|NCT02247960|451687976|FG000|Catheter Removed|Lost to Follow-up|7|||
125561877|NCT02247960|451687977|FG001|Catheter Removed|Lost to Follow-up|10|||
125561878|NCT00702325|451687978|FG000|Overall Study|Adverse Event|1|||
125561879|NCT00702325|451687979|FG001|Overall Study|Adverse Event|0|||
125561880|NCT00702325|451687978|FG000|Overall Study|Withdrawal by Subject|7|||
125561881|NCT00702325|451687979|FG001|Overall Study|Withdrawal by Subject|7|||
125561882|NCT00702325|451687978|FG000|Overall Study|Lost to Follow-up|3|||
125561883|NCT00702325|451687979|FG001|Overall Study|Lost to Follow-up|4|||
125561884|NCT00702325|451687978|FG000|Overall Study|Incorrect enrollment|5|||
125561885|NCT00702325|451687979|FG001|Overall Study|Incorrect enrollment|7|||
125561886|NCT00702325|451687978|FG000|Overall Study|Developed study discontinuation criteria|18|||
125561887|NCT00702325|451687979|FG001|Overall Study|Developed study discontinuation criteria|28|||
125561888|NCT00702325|451687978|FG000|Overall Study|Severe noncompliance to protocol|3|||
125561889|NCT00702325|451687979|FG001|Overall Study|Severe noncompliance to protocol|3|||
125561890|NCT00702325|451687978|FG000|Overall Study|Termination due to lab results|1|||
125561891|NCT00702325|451687979|FG001|Overall Study|Termination due to lab results|0|||
125561892|NCT00702325|451687978|FG000|Overall Study|Didn't follow study medication dosage|0|||
125561893|NCT00702325|451687979|FG001|Overall Study|Didn't follow study medication dosage|2|||
125561894|NCT00702325|451687978|FG000|Overall Study|Withdrew consent|0|||
125561895|NCT00702325|451687979|FG001|Overall Study|Withdrew consent|1|||
125561896|NCT00702325|451687978|FG000|Overall Study|Incorrectly Discontinued|0|||
125561897|NCT00702325|451687979|FG001|Overall Study|Incorrectly Discontinued|1|||
125561898|NCT00736034|451687980|FG000|Overall Study|Adverse Event|2|||
125561899|NCT03716050|451687984|FG000|Overall Study|Lost to Follow-up|0|||
125561900|NCT03716050|451687985|FG001|Overall Study|Lost to Follow-up|0|||
125561901|NCT03716050|451687986|FG002|Overall Study|Lost to Follow-up|1|||
125561902|NCT03716050|451687987|FG003|Overall Study|Lost to Follow-up|0|||
125561903|NCT03716050|451687988|FG004|Overall Study|Lost to Follow-up|0|||
125561904|NCT03716050|451687989|FG005|Overall Study|Lost to Follow-up|0|||
125561905|NCT03716050|451687990|FG006|Overall Study|Lost to Follow-up|0|||
125561906|NCT03716050|451687991|FG007|Overall Study|Lost to Follow-up|0|||
125561907|NCT03716050|451687984|FG000|Overall Study|Physician Decision|0|||
125561908|NCT03716050|451687985|FG001|Overall Study|Physician Decision|0|||
125561909|NCT03716050|451687986|FG002|Overall Study|Physician Decision|0|||
125561910|NCT03716050|451687987|FG003|Overall Study|Physician Decision|1|||
125561911|NCT03716050|451687988|FG004|Overall Study|Physician Decision|0|||
125561912|NCT03716050|451687989|FG005|Overall Study|Physician Decision|0|||
125561913|NCT03716050|451687990|FG006|Overall Study|Physician Decision|0|||
125561914|NCT03716050|451687991|FG007|Overall Study|Physician Decision|0|||
125561915|NCT03716050|451687984|FG000|Overall Study|Protocol Violation|0|||
125561916|NCT03716050|451687985|FG001|Overall Study|Protocol Violation|0|||
125561917|NCT03716050|451687986|FG002|Overall Study|Protocol Violation|0|||
125561918|NCT03716050|451687987|FG003|Overall Study|Protocol Violation|1|||
125561919|NCT03716050|451687988|FG004|Overall Study|Protocol Violation|0|||
125561920|NCT03716050|451687989|FG005|Overall Study|Protocol Violation|0|||
125561921|NCT03716050|451687990|FG006|Overall Study|Protocol Violation|0|||
125561922|NCT03716050|451687991|FG007|Overall Study|Protocol Violation|2|||
125561923|NCT03123250|451687992|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
125561924|NCT02566577|451687994|FG000|Overall Study|Withdrawal by Subject|1|||
125354256|NCT01442038|450932752|FG001|Overall Study|Death|29|||
125354257|NCT01442038|450932751|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
125354258|NCT01442038|450932752|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
125354259|NCT01442038|450932751|FG000|Overall Study|Participant Withdrew Consent|137|||
125354260|NCT01442038|450932752|FG001|Overall Study|Participant Withdrew Consent|102|||
125561925|NCT02566577|451687995|FG001|Overall Study|Withdrawal by Subject|1|||
125561926|NCT02566577|451687994|FG000|Overall Study|Equipment failure|1|||
125561927|NCT02566577|451687995|FG001|Overall Study|Equipment failure|1|||
125561928|NCT02566577|451687994|FG000|Overall Study|Physical limitation|1|||
125561929|NCT02566577|451687995|FG001|Overall Study|Physical limitation|0|||
125561930|NCT03086057|451688002|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
125561931|NCT03086057|451688003|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
125354261|NCT01442038|450932751|FG000|Overall Study|Lost to Follow-up|37|||
125561932|NCT03086057|451688004|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
125561933|NCT03086057|451688005|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
125561934|NCT03086057|451688002|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
125561935|NCT03086057|451688003|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
125561936|NCT03086057|451688004|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
125354262|NCT01442038|450932752|FG001|Overall Study|Lost to Follow-up|51|||
125354263|NCT01442038|450932751|FG000|Overall Study|Adverse Event|26|||
125354264|NCT01442038|450932752|FG001|Overall Study|Adverse Event|15|||
125354265|NCT01442038|450932751|FG000|Overall Study|Protocol Deviation|9|||
125354266|NCT01442038|450932752|FG001|Overall Study|Protocol Deviation|20|||
125561937|NCT03086057|451688005|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
125426286|NCT00045305|451184465|FG000|Overall Study|Death|3|||
125561938|NCT03086057|451688002|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
125561939|NCT03086057|451688003|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
125561940|NCT03086057|451688004|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
125561941|NCT03086057|451688005|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
125561942|NCT03086057|451688002|FG000|Stage 1: PrEP Uptake|Death|1|||
125561943|NCT03086057|451688003|FG001|Stage 1: PrEP Uptake|Death|0|||
125561944|NCT03086057|451688004|FG002|Stage 1: PrEP Uptake|Death|0|||
125561945|NCT03086057|451688005|FG003|Stage 1: PrEP Uptake|Death|0|||
125561946|NCT03086057|451688002|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
125354267|NCT01442038|450932751|FG000|Overall Study|Investigator's Discretion|13|||
125354268|NCT01442038|450932752|FG001|Overall Study|Investigator's Discretion|16|||
125354269|NCT01442038|450932751|FG000|Overall Study|Study Terminated By Sponsor|2|||
125354270|NCT01442038|450932752|FG001|Overall Study|Study Terminated By Sponsor|3|||
125354271|NCT00089284|450932753|FG000|Overall Study|Adverse event before starting treatment|0|||
125354272|NCT00089284|450932754|FG001|Overall Study|Adverse event before starting treatment|0|||
125354273|NCT00089284|450932755|FG002|Overall Study|Adverse event before starting treatment|0|||
125354274|NCT00089284|450932756|FG003|Overall Study|Adverse event before starting treatment|0|||
125354275|NCT00089284|450932757|FG004|Overall Study|Adverse event before starting treatment|0|||
125354276|NCT00089284|450932758|FG005|Overall Study|Adverse event before starting treatment|0|||
125354277|NCT00089284|450932759|FG006|Overall Study|Adverse event before starting treatment|1|||
125354278|NCT02428608|450932760|FG000|Overall Study|Pregnancy|2|||
125354279|NCT02428608|450932760|FG000|Overall Study|Lost to Follow-up|37|||
125354280|NCT02428608|450932760|FG000|Overall Study|Withdrawal by Subject|2|||
125354281|NCT02428608|450932760|FG000|Overall Study|scheduling conflicts|15|||
125354282|NCT02428608|450932760|FG000|Overall Study|moved away|10|||
125354283|NCT02428608|450932760|FG000|Overall Study|Death|1|||
125354284|NCT02428608|450932760|FG000|Overall Study|various|16|||
125354285|NCT03646643|450932761|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
125354286|NCT03646643|450932762|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
125354287|NCT03646643|450932761|FG000|Overall Study|Lost to Follow-up|0|||
125561947|NCT03086057|451688003|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
125561948|NCT03086057|451688004|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
125561949|NCT03086057|451688005|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
125561950|NCT03086057|451688002|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
125561951|NCT03086057|451688003|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
125561952|NCT03086057|451688004|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
125561953|NCT03086057|451688005|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
125561954|NCT03086057|451688002|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
125561955|NCT03086057|451688003|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
125561956|NCT03086057|451688004|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
125561957|NCT03086057|451688005|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
125561958|NCT04305275|451688006|FG000|Overall Study|Adverse Event|4|||
125561959|NCT04305275|451688007|FG001|Overall Study|Adverse Event|0|||
125561960|NCT04305275|451688006|FG000|Overall Study|Lost to Follow-up|1|||
125561961|NCT04305275|451688007|FG001|Overall Study|Lost to Follow-up|1|||
125561962|NCT04305275|451688006|FG000|Overall Study|Withdrawal by Participant|8|||
125561963|NCT04305275|451688007|FG001|Overall Study|Withdrawal by Participant|1|||
125561964|NCT00117598|451688011|FG000|Prior to Treatment Cross Over|Death|40|||
125561965|NCT00117598|451688012|FG001|Prior to Treatment Cross Over|Death|41|||
125561966|NCT00117598|451688013|FG002|Prior to Treatment Cross Over|Death|37|||
125561967|NCT00117598|451688014|FG003|Prior to Treatment Cross Over|Death|0|||
125354288|NCT03646643|450932762|FG001|Overall Study|Lost to Follow-up|1|||
125561968|NCT00117598|451688015|FG004|Prior to Treatment Cross Over|Death|0|||
125561969|NCT00117598|451688011|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
125561970|NCT00117598|451688012|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
125561971|NCT00117598|451688013|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
125561972|NCT00117598|451688014|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
125561973|NCT00117598|451688015|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
125561974|NCT00117598|451688011|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
125561975|NCT00117598|451688012|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
125561976|NCT00117598|451688013|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
125561977|NCT00117598|451688014|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
125561978|NCT00117598|451688015|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
125354289|NCT04521777|450932763|FG000|Overall Study|Death|2|||
125354290|NCT04521777|450932763|FG000|Overall Study|Withdrawal by Subject|2|||
125561979|NCT00117598|451688011|FG000|Prior to Treatment Cross Over|Other|15|||
125354291|NCT00900601|450932764|FG000|Overall Study|Physician Decision|1|||
125354292|NCT01629706|450932766|FG000|Phase 1 PureVision|Screen Failure|4|||
125561980|NCT00117598|451688012|FG001|Prior to Treatment Cross Over|Other|9|||
125561981|NCT00117598|451688013|FG002|Prior to Treatment Cross Over|Other|9|||
125561982|NCT00117598|451688014|FG003|Prior to Treatment Cross Over|Other|0|||
125561983|NCT00117598|451688015|FG004|Prior to Treatment Cross Over|Other|0|||
125354293|NCT01629706|450932766|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
125561984|NCT00117598|451688011|FG000|After Treament Cross Over|Death|0|||
125561985|NCT00117598|451688012|FG001|After Treament Cross Over|Death|0|||
125561986|NCT00117598|451688013|FG002|After Treament Cross Over|Death|0|||
125561987|NCT00117598|451688014|FG003|After Treament Cross Over|Death|1|||
125561988|NCT00117598|451688015|FG004|After Treament Cross Over|Death|2|||
125561989|NCT00117598|451688011|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
125561990|NCT00117598|451688012|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
125561991|NCT00117598|451688013|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
125561992|NCT00117598|451688014|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
125561993|NCT00117598|451688015|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
125561994|NCT00117598|451688011|FG000|After Treament Cross Over|Other|0|||
125561995|NCT00117598|451688012|FG001|After Treament Cross Over|Other|0|||
125561996|NCT00117598|451688013|FG002|After Treament Cross Over|Other|0|||
125561997|NCT00117598|451688014|FG003|After Treament Cross Over|Other|1|||
125561998|NCT00117598|451688015|FG004|After Treament Cross Over|Other|2|||
125561999|NCT04688775|451688023|FG000|Placebo-controlled Period|Randomized, not treated|1|||
125562000|NCT04688775|451688024|FG001|Placebo-controlled Period|Randomized, not treated|1|||
125562001|NCT04688775|451688025|FG002|Placebo-controlled Period|Randomized, not treated|0|||
125562002|NCT04688775|451688026|FG003|Placebo-controlled Period|Randomized, not treated|0|||
125562003|NCT04688775|451688023|FG000|Placebo-controlled Period|Adverse Event|2|||
125562004|NCT04688775|451688024|FG001|Placebo-controlled Period|Adverse Event|0|||
125562005|NCT04688775|451688025|FG002|Placebo-controlled Period|Adverse Event|0|||
125562006|NCT04688775|451688026|FG003|Placebo-controlled Period|Adverse Event|0|||
125562007|NCT04688775|451688023|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
125562008|NCT04688775|451688024|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
125562009|NCT04688775|451688025|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
125562010|NCT04688775|451688026|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
125562011|NCT04688775|451688023|FG000|Placebo-controlled Period|Protocol Violation|0|||
125562012|NCT04688775|451688024|FG001|Placebo-controlled Period|Protocol Violation|1|||
125562013|NCT04688775|451688025|FG002|Placebo-controlled Period|Protocol Violation|0|||
125562014|NCT04688775|451688026|FG003|Placebo-controlled Period|Protocol Violation|0|||
125562015|NCT04688775|451688023|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
125562016|NCT04688775|451688024|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
125562017|NCT04688775|451688025|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
125562018|NCT04688775|451688026|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
125562019|NCT04688775|451688023|FG000|Placebo-controlled Period|Other reasons|0|||
125562020|NCT04688775|451688024|FG001|Placebo-controlled Period|Other reasons|1|||
125562021|NCT04688775|451688025|FG002|Placebo-controlled Period|Other reasons|0|||
125562022|NCT04688775|451688026|FG003|Placebo-controlled Period|Other reasons|0|||
125562023|NCT04688775|451688023|FG000|Delayed Start Period|Adverse Event|0|||
125562024|NCT04688775|451688024|FG001|Delayed Start Period|Adverse Event|0|||
125562025|NCT04688775|451688025|FG002|Delayed Start Period|Adverse Event|1|||
125562026|NCT04688775|451688026|FG003|Delayed Start Period|Adverse Event|0|||
125562027|NCT04688775|451688023|FG000|Delayed Start Period|Lack of Efficacy|0|||
125562028|NCT04688775|451688024|FG001|Delayed Start Period|Lack of Efficacy|0|||
125562029|NCT04688775|451688025|FG002|Delayed Start Period|Lack of Efficacy|0|||
125562030|NCT04688775|451688026|FG003|Delayed Start Period|Lack of Efficacy|3|||
125562031|NCT04688775|451688023|FG000|Delayed Start Period|Withdrawal by Subject|0|||
125562032|NCT04688775|451688024|FG001|Delayed Start Period|Withdrawal by Subject|0|||
125562033|NCT04688775|451688025|FG002|Delayed Start Period|Withdrawal by Subject|2|||
125562034|NCT04688775|451688026|FG003|Delayed Start Period|Withdrawal by Subject|4|||
125562035|NCT04688775|451688023|FG000|Delayed Start Period|Lost to Follow-up|0|||
125562036|NCT04688775|451688024|FG001|Delayed Start Period|Lost to Follow-up|0|||
125562037|NCT04688775|451688025|FG002|Delayed Start Period|Lost to Follow-up|2|||
125562038|NCT04688775|451688026|FG003|Delayed Start Period|Lost to Follow-up|1|||
125562039|NCT04688775|451688023|FG000|Delayed Start Period|other reasons|0|||
125562040|NCT04688775|451688024|FG001|Delayed Start Period|other reasons|0|||
125562041|NCT04688775|451688025|FG002|Delayed Start Period|other reasons|1|||
125354294|NCT01629706|450932766|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
125354295|NCT01629706|450932766|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
125562042|NCT04688775|451688026|FG003|Delayed Start Period|other reasons|0|||
125562043|NCT01770912|451688027|FG000|Overall Study|Lost to Follow-up|2|||
125562044|NCT01770912|451688028|FG001|Overall Study|Lost to Follow-up|0|||
125562045|NCT01817751|451688033|FG000|Overall Study|Physician Decision|1|||
125562046|NCT00382018|451688034|FG000|Overall Study|Progression|0|||
125562047|NCT00382018|451688035|FG001|Overall Study|Progression|136|||
125354296|NCT01629706|450932766|FG000|Phase 2 Habitual|Screen Failure|6|||
125354297|NCT01629706|450932766|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
125354298|NCT01629706|450932766|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
125562048|NCT00382018|451688036|FG002|Overall Study|Progression|51|||
125562049|NCT00382018|451688037|FG003|Overall Study|Progression|43|||
125562050|NCT00382018|451688034|FG000|Overall Study|Death|0|||
125562051|NCT00382018|451688035|FG001|Overall Study|Death|9|||
125562052|NCT00382018|451688036|FG002|Overall Study|Death|7|||
125354299|NCT01629706|450932766|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
125354300|NCT01629706|450932766|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
125354301|NCT02663687|450932767|FG000|Overall Study|Adverse Event|1|||
125354302|NCT02663687|450932768|FG001|Overall Study|Adverse Event|0|||
125354303|NCT02663687|450932769|FG002|Overall Study|Adverse Event|0|||
125354304|NCT02663687|450932770|FG003|Overall Study|Adverse Event|0|||
125354305|NCT02663687|450932771|FG004|Overall Study|Adverse Event|0|||
125354306|NCT02663687|450932767|FG000|Overall Study|Other|1|||
125354307|NCT02663687|450932768|FG001|Overall Study|Other|0|||
125354308|NCT02663687|450932769|FG002|Overall Study|Other|1|||
125354309|NCT02663687|450932770|FG003|Overall Study|Other|0|||
125354310|NCT02663687|450932771|FG004|Overall Study|Other|0|||
125354311|NCT01151098|450932772|FG000|Overall Study|Adverse Event|82|||
125354312|NCT01151098|450932772|FG000|Overall Study|Lost to Follow-up|6|||
125562053|NCT00382018|451688037|FG003|Overall Study|Death|11|||
125562054|NCT00382018|451688034|FG000|Overall Study|Withdrawal by Subject|0|||
125354313|NCT01151098|450932772|FG000|Overall Study|Lack of Efficacy|15|||
125354314|NCT01151098|450932772|FG000|Overall Study|Protocol Violation|1|||
125354315|NCT01151098|450932772|FG000|Overall Study|Miscellaneous|13|||
125354316|NCT00116168|450932773|FG000|Overall Study|Lost to Follow-up|6|||
125354317|NCT00116168|450932774|FG001|Overall Study|Lost to Follow-up|5|||
125354318|NCT00116168|450932775|FG002|Overall Study|Lost to Follow-up|0|||
125354319|NCT00116168|450932776|FG003|Overall Study|Lost to Follow-up|0|||
125354320|NCT01272661|450932780|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
125354321|NCT01272661|450932781|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
125562055|NCT00382018|451688035|FG001|Overall Study|Withdrawal by Subject|4|||
125562056|NCT00382018|451688036|FG002|Overall Study|Withdrawal by Subject|3|||
125562057|NCT00382018|451688037|FG003|Overall Study|Withdrawal by Subject|4|||
125562058|NCT00382018|451688034|FG000|Overall Study|Other, not protocol specified|0|||
125562059|NCT00382018|451688035|FG001|Overall Study|Other, not protocol specified|16|||
125562060|NCT00382018|451688036|FG002|Overall Study|Other, not protocol specified|3|||
125562061|NCT00382018|451688037|FG003|Overall Study|Other, not protocol specified|1|||
125562062|NCT00789880|451688038|FG000|Overall Study|Adverse Event|0|||
125562063|NCT00789880|451688039|FG001|Overall Study|Adverse Event|0|||
125562064|NCT00789880|451688040|FG002|Overall Study|Adverse Event|0|||
125562065|NCT00789880|451688041|FG003|Overall Study|Adverse Event|0|||
125562066|NCT00789880|451688042|FG004|Overall Study|Adverse Event|1|||
125562067|NCT00789880|451688043|FG005|Overall Study|Adverse Event|0|||
125562068|NCT00789880|451688038|FG000|Overall Study|Protocol Violation|0|||
125562069|NCT00789880|451688039|FG001|Overall Study|Protocol Violation|1|||
125562070|NCT00789880|451688040|FG002|Overall Study|Protocol Violation|0|||
125562071|NCT00789880|451688041|FG003|Overall Study|Protocol Violation|1|||
125562072|NCT00789880|451688042|FG004|Overall Study|Protocol Violation|0|||
125562073|NCT00789880|451688043|FG005|Overall Study|Protocol Violation|0|||
125562074|NCT00789880|451688038|FG000|Overall Study|Withdrawal by Subject|1|||
125562075|NCT00789880|451688039|FG001|Overall Study|Withdrawal by Subject|0|||
125562076|NCT00789880|451688040|FG002|Overall Study|Withdrawal by Subject|0|||
125562077|NCT00789880|451688041|FG003|Overall Study|Withdrawal by Subject|0|||
125562078|NCT00789880|451688042|FG004|Overall Study|Withdrawal by Subject|2|||
125562079|NCT00789880|451688043|FG005|Overall Study|Withdrawal by Subject|0|||
125562080|NCT01977820|451688047|FG000|Overall Study|Sponsor terminated the study|1|||
125562081|NCT01977820|451688048|FG001|Overall Study|Sponsor terminated the study|1|||
125562082|NCT02568475|451688049|FG000|Overall Study|Lost to Follow-up|40|||
125562083|NCT02568475|451688050|FG001|Overall Study|Lost to Follow-up|39|||
125562084|NCT02568475|451688049|FG000|Overall Study|Withdrawal by Subject|2|||
125562085|NCT02568475|451688050|FG001|Overall Study|Withdrawal by Subject|0|||
125562086|NCT02568475|451688049|FG000|Overall Study|Discharged home|4|||
125562087|NCT02568475|451688050|FG001|Overall Study|Discharged home|4|||
125562088|NCT02568475|451688049|FG000|Overall Study|Short-term: Discharge location unknown|4|||
125562089|NCT02568475|451688050|FG001|Overall Study|Short-term: Discharge location unknown|0|||
125562090|NCT02568475|451688049|FG000|Overall Study|Transferred to another facility|1|||
125562091|NCT02568475|451688050|FG001|Overall Study|Transferred to another facility|0|||
125562092|NCT00493220|451688051|FG000|Third Intervention|Withdrawal by Subject|1|||
125354322|NCT01272661|450932782|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
125354323|NCT02869438|450932783|FG000|Overall Study|Lost to Follow-up|1|||
125354324|NCT02869438|450932784|FG001|Overall Study|Lost to Follow-up|0|||
125426287|NCT00045305|451184465|FG000|Overall Study|site error|2|||
125426288|NCT02216773|451184471|FG000|Overall Study|Disease progression|4|||
125562093|NCT00493220|451688052|FG001|Third Intervention|Withdrawal by Subject|0|||
125562094|NCT00493220|451688053|FG002|Third Intervention|Withdrawal by Subject|0|||
125562095|NCT00493220|451688054|FG003|Third Intervention|Withdrawal by Subject|0|||
125562096|NCT00493220|451688055|FG004|Third Intervention|Withdrawal by Subject|0|||
125562097|NCT00493220|451688056|FG005|Third Intervention|Withdrawal by Subject|0|||
125562098|NCT02625233|451688057|FG000|Overall Study|Adverse Event|2|||
125562099|NCT02625233|451688058|FG001|Overall Study|Adverse Event|0|||
125354325|NCT02869438|450932783|FG000|Overall Study|Adverse Event|1|||
125562100|NCT03520959|451688065|FG000|Overall Study|Study terminated by Sponsor|0|||
125562101|NCT03520959|451688066|FG001|Overall Study|Study terminated by Sponsor|1|||
125562102|NCT01449461|451688067|FG000|Overall Study|Adverse Event|0|||
125562103|NCT01449461|451688068|FG001|Overall Study|Adverse Event|3|||
125562104|NCT01449461|451688069|FG002|Overall Study|Adverse Event|2|||
125562105|NCT01449461|451688070|FG003|Overall Study|Adverse Event|3|||
125562106|NCT01449461|451688071|FG004|Overall Study|Adverse Event|4|||
125562107|NCT01449461|451688072|FG005|Overall Study|Adverse Event|4|||
125562108|NCT01449461|451688067|FG000|Overall Study|Death|0|||
125562109|NCT01449461|451688068|FG001|Overall Study|Death|2|||
125562110|NCT01449461|451688069|FG002|Overall Study|Death|0|||
125562111|NCT01449461|451688070|FG003|Overall Study|Death|0|||
125562112|NCT01449461|451688071|FG004|Overall Study|Death|7|||
125562113|NCT01449461|451688072|FG005|Overall Study|Death|1|||
125562114|NCT01449461|451688067|FG000|Overall Study|Physician Decision|0|||
125562115|NCT01449461|451688068|FG001|Overall Study|Physician Decision|1|||
125562116|NCT01449461|451688069|FG002|Overall Study|Physician Decision|0|||
125562117|NCT01449461|451688070|FG003|Overall Study|Physician Decision|4|||
125562118|NCT01449461|451688071|FG004|Overall Study|Physician Decision|1|||
125562119|NCT01449461|451688072|FG005|Overall Study|Physician Decision|0|||
125562120|NCT01449461|451688067|FG000|Overall Study|Documented Progressive Disease|4|||
125562121|NCT01449461|451688068|FG001|Overall Study|Documented Progressive Disease|7|||
125562122|NCT01449461|451688069|FG002|Overall Study|Documented Progressive Disease|14|||
125562123|NCT01449461|451688070|FG003|Overall Study|Documented Progressive Disease|15|||
125562124|NCT01449461|451688071|FG004|Overall Study|Documented Progressive Disease|24|||
125562125|NCT01449461|451688072|FG005|Overall Study|Documented Progressive Disease|5|||
125562126|NCT01449461|451688067|FG000|Overall Study|Clinical Progressive Disease|2|||
125562127|NCT01449461|451688068|FG001|Overall Study|Clinical Progressive Disease|2|||
125562128|NCT01449461|451688069|FG002|Overall Study|Clinical Progressive Disease|0|||
125562129|NCT01449461|451688070|FG003|Overall Study|Clinical Progressive Disease|3|||
125562130|NCT01449461|451688071|FG004|Overall Study|Clinical Progressive Disease|4|||
125562131|NCT01449461|451688072|FG005|Overall Study|Clinical Progressive Disease|2|||
125562132|NCT01449461|451688067|FG000|Overall Study|Protocol Violation|0|||
125562133|NCT01449461|451688068|FG001|Overall Study|Protocol Violation|0|||
125562134|NCT01449461|451688069|FG002|Overall Study|Protocol Violation|0|||
125562135|NCT01449461|451688070|FG003|Overall Study|Protocol Violation|1|||
125562136|NCT01449461|451688071|FG004|Overall Study|Protocol Violation|0|||
125562137|NCT01449461|451688072|FG005|Overall Study|Protocol Violation|0|||
125562138|NCT01449461|451688067|FG000|Overall Study|Site Terminated by Sponsor|0|||
125562139|NCT01449461|451688068|FG001|Overall Study|Site Terminated by Sponsor|1|||
125562140|NCT01449461|451688069|FG002|Overall Study|Site Terminated by Sponsor|2|||
125562141|NCT01449461|451688070|FG003|Overall Study|Site Terminated by Sponsor|3|||
125562142|NCT01449461|451688071|FG004|Overall Study|Site Terminated by Sponsor|4|||
125562143|NCT01449461|451688072|FG005|Overall Study|Site Terminated by Sponsor|1|||
125562144|NCT01449461|451688067|FG000|Overall Study|Withdrawal by Subject|0|||
125562145|NCT01449461|451688068|FG001|Overall Study|Withdrawal by Subject|1|||
125562146|NCT01449461|451688069|FG002|Overall Study|Withdrawal by Subject|0|||
125562147|NCT01449461|451688070|FG003|Overall Study|Withdrawal by Subject|0|||
125562148|NCT01449461|451688071|FG004|Overall Study|Withdrawal by Subject|2|||
125562149|NCT01449461|451688072|FG005|Overall Study|Withdrawal by Subject|1|||
125354326|NCT02869438|450932784|FG001|Overall Study|Adverse Event|0|||
125354327|NCT02869438|450932783|FG000|Overall Study|Withdrawal by Subject|1|||
125354328|NCT02869438|450932784|FG001|Overall Study|Withdrawal by Subject|2|||
125354329|NCT02169284|450932790|FG000|Overall Study|Physician Decision|0|||
125354330|NCT02169284|450932791|FG001|Overall Study|Physician Decision|1|||
125354331|NCT04505540|450932792|FG000|Baseline|Protocol Violation|10|||
125354332|NCT04505540|450932792|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
125354333|NCT04505540|450932792|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
125354334|NCT04505540|450932792|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
125354335|NCT04505540|450932792|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
125354336|NCT04505540|450932792|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
125562150|NCT01449461|451688067|FG000|Overall Study|Reason not Specified|0|||
125354337|NCT04505540|450932792|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
125426289|NCT02216773|451184472|FG001|Overall Study|Disease progression|2|||
125562151|NCT01449461|451688068|FG001|Overall Study|Reason not Specified|1|||
125562152|NCT01449461|451688069|FG002|Overall Study|Reason not Specified|0|||
125562153|NCT01449461|451688070|FG003|Overall Study|Reason not Specified|3|||
125562154|NCT01449461|451688071|FG004|Overall Study|Reason not Specified|2|||
125562155|NCT01449461|451688072|FG005|Overall Study|Reason not Specified|1|||
125354338|NCT04505540|450932792|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
125354339|NCT04505540|450932792|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
125354340|NCT04505540|450932792|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
125354341|NCT04505540|450932792|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
125354342|NCT04505540|450932792|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
125354343|NCT04505540|450932792|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
125354344|NCT03583073|450932793|FG000|Overall Study|Lost to Follow-up|8|||
125354345|NCT03583073|450932794|FG001|Overall Study|Lost to Follow-up|12|||
125354346|NCT01013649|450932795|FG000|First Step|Withdrawal by Subject|36|||
125354347|NCT01013649|450932796|FG001|First Step|Withdrawal by Subject|19|||
125354348|NCT01013649|450932797|FG002|First Step|Withdrawal by Subject|0|||
125354349|NCT01013649|450932798|FG003|First Step|Withdrawal by Subject|0|||
125354350|NCT01013649|450932795|FG000|First Step|Progression|58|||
125354351|NCT01013649|450932796|FG001|First Step|Progression|23|||
125354352|NCT01013649|450932797|FG002|First Step|Progression|0|||
125354353|NCT01013649|450932798|FG003|First Step|Progression|0|||
125354354|NCT01013649|450932795|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
125354355|NCT01013649|450932796|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
125354356|NCT01013649|450932797|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
125354357|NCT01013649|450932798|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
125354358|NCT01013649|450932795|FG000|First Step|Death|3|||
125354359|NCT01013649|450932796|FG001|First Step|Death|4|||
125354360|NCT01013649|450932797|FG002|First Step|Death|0|||
125354361|NCT01013649|450932798|FG003|First Step|Death|0|||
125354362|NCT01013649|450932795|FG000|First Step|Adverse Event|9|||
125354363|NCT01013649|450932796|FG001|First Step|Adverse Event|5|||
125354364|NCT01013649|450932797|FG002|First Step|Adverse Event|0|||
125354365|NCT01013649|450932798|FG003|First Step|Adverse Event|0|||
125354366|NCT01013649|450932795|FG000|First Step|Other|4|||
125354367|NCT01013649|450932796|FG001|First Step|Other|6|||
125354368|NCT01013649|450932797|FG002|First Step|Other|0|||
125354369|NCT01013649|450932798|FG003|First Step|Other|0|||
125354370|NCT01367119|450932799|FG000|Overall Study|Adverse Event|1|||
125354371|NCT01367119|450932800|FG001|Overall Study|Adverse Event|0|||
125354372|NCT01367119|450932799|FG000|Overall Study|Withdrawal by Subject|1|||
125354373|NCT01367119|450932800|FG001|Overall Study|Withdrawal by Subject|1|||
125354374|NCT05342532|450932801|FG000|Overall Study|Adverse Event|5|||
125354375|NCT05342532|450932802|FG001|Overall Study|Adverse Event|20|||
125354376|NCT05342532|450932801|FG000|Overall Study|Lost to Follow-up|10|||
125354377|NCT05342532|450932802|FG001|Overall Study|Lost to Follow-up|15|||
125354378|NCT02057393|450932805|FG000|Overall Study|Withdrawal by Subject|1|||
125354379|NCT02057393|450932805|FG000|Overall Study|Patient did not meet criteria|1|||
125354380|NCT03180684|450932806|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
125354381|NCT03180684|450932807|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
125354382|NCT03180684|450932806|FG000|Overall Study|Physician Decision|1|||
125354383|NCT03180684|450932807|FG001|Overall Study|Physician Decision|0|||
125354384|NCT03180684|450932806|FG000|Overall Study|Lost to Follow-up|1|||
125354385|NCT03180684|450932807|FG001|Overall Study|Lost to Follow-up|0|||
125354386|NCT03180684|450932806|FG000|Overall Study|Progressive Disease|1|||
125354387|NCT03180684|450932807|FG001|Overall Study|Progressive Disease|0|||
125354388|NCT01115803|450932808|FG000|Overall Study|Withdrawal by Subject|0|||
125354389|NCT01115803|450932809|FG001|Overall Study|Withdrawal by Subject|0|||
125354390|NCT01115803|450932810|FG002|Overall Study|Withdrawal by Subject|0|||
125354391|NCT01115803|450932811|FG003|Overall Study|Withdrawal by Subject|0|||
125354392|NCT01115803|450932812|FG004|Overall Study|Withdrawal by Subject|0|||
125354393|NCT01115803|450932813|FG005|Overall Study|Withdrawal by Subject|0|||
125354394|NCT01115803|450932814|FG006|Overall Study|Withdrawal by Subject|1|||
125354395|NCT01115803|450932808|FG000|Overall Study|Lost to Follow-up|0|||
125354396|NCT01115803|450932809|FG001|Overall Study|Lost to Follow-up|0|||
125354397|NCT01115803|450932810|FG002|Overall Study|Lost to Follow-up|1|||
125354398|NCT01115803|450932811|FG003|Overall Study|Lost to Follow-up|0|||
125562156|NCT01704287|451689519|FG000|Initial Treatment Period|Death|139|||
125562157|NCT01704287|451689520|FG001|Initial Treatment Period|Death|129|||
125562158|NCT01704287|451689521|FG002|Initial Treatment Period|Death|71|||
125354399|NCT01115803|450932812|FG004|Overall Study|Lost to Follow-up|0|||
125354400|NCT01115803|450932813|FG005|Overall Study|Lost to Follow-up|0|||
125354401|NCT01115803|450932814|FG006|Overall Study|Lost to Follow-up|0|||
125562159|NCT01704287|451689522|FG003|Initial Treatment Period|Death|0|||
125562160|NCT01704287|451689523|FG004|Initial Treatment Period|Death|0|||
125562161|NCT01704287|451689519|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
125562162|NCT01704287|451689520|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
125354402|NCT01115803|450932808|FG000|Overall Study|Progressive Disease during Cycle1|0|||
125354403|NCT01115803|450932809|FG001|Overall Study|Progressive Disease during Cycle1|0|||
125354404|NCT01115803|450932810|FG002|Overall Study|Progressive Disease during Cycle1|0|||
125354405|NCT01115803|450932811|FG003|Overall Study|Progressive Disease during Cycle1|0|||
125426290|NCT02216773|451184471|FG000|Overall Study|Insufficient FLRV|4|||
125562163|NCT01704287|451689521|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
125562164|NCT01704287|451689522|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
125562165|NCT01704287|451689523|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
125562166|NCT01704287|451689519|FG000|Initial Treatment Period|Lost to Follow-up|5|||
125562167|NCT01704287|451689520|FG001|Initial Treatment Period|Lost to Follow-up|3|||
125562168|NCT01704287|451689521|FG002|Initial Treatment Period|Lost to Follow-up|0|||
125562169|NCT01704287|451689522|FG003|Initial Treatment Period|Lost to Follow-up|0|||
125562170|NCT01704287|451689523|FG004|Initial Treatment Period|Lost to Follow-up|0|||
125562171|NCT01704287|451689519|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
125562172|NCT01704287|451689520|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
125562173|NCT01704287|451689521|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
125562174|NCT01704287|451689522|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
125562175|NCT01704287|451689523|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
125562176|NCT01704287|451689519|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
125562177|NCT01704287|451689520|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
125562178|NCT01704287|451689521|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
125562179|NCT01704287|451689522|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
125562180|NCT01704287|451689523|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
125562181|NCT01704287|451689519|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
125562182|NCT01704287|451689520|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
125562183|NCT01704287|451689521|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
125562184|NCT01704287|451689522|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
125562185|NCT01704287|451689523|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
125562186|NCT01704287|451689519|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
125562187|NCT01704287|451689520|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
125562188|NCT01704287|451689521|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
125562189|NCT01704287|451689522|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
125562190|NCT01704287|451689523|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
125562191|NCT00938717|451689524|FG000|Overall Study|Adverse Event|10|||
125562192|NCT00938717|451689525|FG001|Overall Study|Adverse Event|41|||
125562193|NCT00938717|451689524|FG000|Overall Study|Protocol Violation|11|||
125562194|NCT00938717|451689525|FG001|Overall Study|Protocol Violation|8|||
125562195|NCT00938717|451689524|FG000|Overall Study|Withdrawal by Subject|26|||
125562196|NCT00938717|451689525|FG001|Overall Study|Withdrawal by Subject|24|||
125562197|NCT00938717|451689524|FG000|Overall Study|Lost to Follow-up|13|||
125562198|NCT00938717|451689525|FG001|Overall Study|Lost to Follow-up|18|||
125562199|NCT00938717|451689524|FG000|Overall Study|Lack of Efficacy|33|||
125562200|NCT00938717|451689525|FG001|Overall Study|Lack of Efficacy|15|||
125562201|NCT00938717|451689524|FG000|Overall Study|Other reason|5|||
125562202|NCT00938717|451689525|FG001|Overall Study|Other reason|2|||
125562203|NCT01462435|451689528|FG000|Overall Study|Lack of Efficacy|1|||
125562204|NCT01462435|451689529|FG001|Overall Study|Lack of Efficacy|0|||
125562205|NCT01462435|451689530|FG002|Overall Study|Lack of Efficacy|0|||
125562206|NCT01462435|451689531|FG003|Overall Study|Lack of Efficacy|3|||
125562207|NCT01462435|451689528|FG000|Overall Study|Physician Decision|0|||
125562208|NCT01462435|451689529|FG001|Overall Study|Physician Decision|0|||
125562209|NCT01462435|451689530|FG002|Overall Study|Physician Decision|1|||
125562210|NCT01462435|451689531|FG003|Overall Study|Physician Decision|0|||
125562211|NCT01462435|451689528|FG000|Overall Study|Withdrawal by Subject|0|||
125562212|NCT01462435|451689529|FG001|Overall Study|Withdrawal by Subject|0|||
125562213|NCT01462435|451689530|FG002|Overall Study|Withdrawal by Subject|0|||
125562214|NCT01462435|451689531|FG003|Overall Study|Withdrawal by Subject|1|||
125562215|NCT01462435|451689528|FG000|Overall Study|Lost to Follow-up|0|||
125562216|NCT01462435|451689529|FG001|Overall Study|Lost to Follow-up|0|||
125562217|NCT01462435|451689530|FG002|Overall Study|Lost to Follow-up|0|||
125562218|NCT01462435|451689531|FG003|Overall Study|Lost to Follow-up|1|||
125562219|NCT05092919|451689532|FG000|Overall Study|Lost to Follow-up|7|||
125562220|NCT05092919|451689532|FG000|Overall Study|Withdrawal by Subject|2|||
125562221|NCT02248259|451689534|FG000|Treatment Period 1|Adverse Event|0|||
125562222|NCT02248259|451689535|FG001|Treatment Period 1|Adverse Event|0|||
125562223|NCT02248259|451689536|FG002|Treatment Period 1|Adverse Event|1|||
125562224|NCT02248259|451689537|FG003|Treatment Period 1|Adverse Event|0|||
125562225|NCT02573870|451689538|FG000|Overall Study|Adverse Event|0|||
125562226|NCT02573870|451689539|FG001|Overall Study|Adverse Event|2|||
125562227|NCT02573870|451689538|FG000|Overall Study|Lack of Efficacy|0|||
125562228|NCT02573870|451689539|FG001|Overall Study|Lack of Efficacy|1|||
125562229|NCT02573870|451689538|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
125562230|NCT02573870|451689539|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
125562231|NCT02573870|451689538|FG000|Overall Study|Lost to Follow-up|0|||
125562232|NCT02573870|451689539|FG001|Overall Study|Lost to Follow-up|1|||
125562233|NCT02573870|451689538|FG000|Overall Study|Other: Fail to Meet Visit|0|||
125562234|NCT02573870|451689539|FG001|Overall Study|Other: Fail to Meet Visit|2|||
125562235|NCT01848288|451689543|FG000|Overall Study|Death|1|||
125562236|NCT01848288|451689543|FG000|Overall Study|Protocol Violation|1|||
125562237|NCT01848288|451689543|FG000|Overall Study|Withdrawal by Subject|1|||
125562238|NCT00677820|451689545|FG000|Overall Study|Lost to Follow-up|1|||
125562239|NCT00677820|451689546|FG001|Overall Study|Lost to Follow-up|0|||
125562240|NCT02865018|451689570|FG000|Overall Study|Withdrawal by Subject|1|||
125562241|NCT00290290|451689571|FG000|Overall Study|Death|3|||
125562242|NCT00290290|451689572|FG001|Overall Study|Death|4|||
125562243|NCT00290290|451689571|FG000|Overall Study|Withdrawal by Subject|2|||
125562244|NCT00290290|451689572|FG001|Overall Study|Withdrawal by Subject|2|||
125562245|NCT00290290|451689571|FG000|Overall Study|Underwent clean surgical procedure|13|||
125562246|NCT00290290|451689572|FG001|Overall Study|Underwent clean surgical procedure|12|||
125562247|NCT00549939|451689580|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
125562248|NCT00549939|451689581|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
125562249|NCT00549939|451689582|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
125562250|NCT00549939|451689580|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
125562251|NCT00549939|451689581|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
125562252|NCT00549939|451689582|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
125562253|NCT00549939|451689580|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
125562254|NCT00549939|451689581|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
125562255|NCT00549939|451689582|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
125562256|NCT00549939|451689580|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
125562257|NCT00549939|451689581|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
125562258|NCT00549939|451689582|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
125562259|NCT00549939|451689580|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
125562260|NCT00549939|451689581|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
125562261|NCT00549939|451689582|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
125562262|NCT00549939|451689580|FG000|40-week Open Label Treatment Period|Other|0|||
125562263|NCT00549939|451689581|FG001|40-week Open Label Treatment Period|Other|1|||
125562264|NCT00549939|451689582|FG002|40-week Open Label Treatment Period|Other|4|||
125562265|NCT03677596|451689583|FG000|Overall Study|Adverse Event|0|||
125354406|NCT01115803|450932812|FG004|Overall Study|Progressive Disease during Cycle1|0|||
125562266|NCT03677596|451689584|FG001|Overall Study|Adverse Event|1|||
125562267|NCT03677596|451689583|FG000|Overall Study|Death|10|||
125562268|NCT03677596|451689584|FG001|Overall Study|Death|6|||
125562269|NCT03677596|451689583|FG000|Overall Study|Lost to Follow-up|0|||
125562270|NCT03677596|451689584|FG001|Overall Study|Lost to Follow-up|1|||
125562271|NCT03677596|451689583|FG000|Overall Study|Progressive Disease|8|||
125562272|NCT03677596|451689584|FG001|Overall Study|Progressive Disease|8|||
125562273|NCT03677596|451689583|FG000|Overall Study|Withdrawal by Subject|3|||
125562274|NCT03677596|451689584|FG001|Overall Study|Withdrawal by Subject|0|||
125562275|NCT03677596|451689583|FG000|Overall Study|Disease Relapse|2|||
125562276|NCT03677596|451689584|FG001|Overall Study|Disease Relapse|2|||
125562277|NCT03677596|451689583|FG000|Overall Study|Other|0|||
125354407|NCT01115803|450932813|FG005|Overall Study|Progressive Disease during Cycle1|0|||
125354408|NCT01115803|450932814|FG006|Overall Study|Progressive Disease during Cycle1|1|||
125354409|NCT03475875|450932815|FG000|Period 1|Lost to Follow-up|1|||
125354410|NCT03475875|450932816|FG001|Period 1|Lost to Follow-up|0|||
125354411|NCT03475875|450932815|FG000|Period 1|Adverse Event|2|||
125354412|NCT03475875|450932816|FG001|Period 1|Adverse Event|1|||
125354413|NCT03475875|450932815|FG000|Period 2|Adverse Event|3|||
125354414|NCT03475875|450932816|FG001|Period 2|Adverse Event|0|||
125354415|NCT03475875|450932815|FG000|Period 2|Protocol Violation|0|||
125354416|NCT03475875|450932816|FG001|Period 2|Protocol Violation|1|||
125354417|NCT02017171|450932817|FG000|Overall Study|Death|10|||
125354418|NCT02017171|450932818|FG001|Overall Study|Death|4|||
125354419|NCT02017171|450932817|FG000|Overall Study|Withdrawal by Subject|23|||
125354420|NCT02017171|450932818|FG001|Overall Study|Withdrawal by Subject|17|||
125354421|NCT02017171|450932817|FG000|Overall Study|Lost to Follow-up|21|||
125354422|NCT02017171|450932818|FG001|Overall Study|Lost to Follow-up|20|||
125354423|NCT02017171|450932817|FG000|Overall Study|ESKD|6|||
125354424|NCT02017171|450932818|FG001|Overall Study|ESKD|2|||
125354425|NCT02017171|450932817|FG000|Overall Study|Miscellaneous|2|||
125354426|NCT02017171|450932818|FG001|Overall Study|Miscellaneous|3|||
125354427|NCT03091777|450932820|FG000|Overall Study|Pregnancy|2|||
125354428|NCT03091777|450932821|FG001|Overall Study|Pregnancy|1|||
125354429|NCT03091777|450932822|FG002|Overall Study|Pregnancy|0|||
125354430|NCT03091777|450932820|FG000|Overall Study|Adverse Event|2|||
125354431|NCT03091777|450932821|FG001|Overall Study|Adverse Event|1|||
125354432|NCT03091777|450932822|FG002|Overall Study|Adverse Event|4|||
125354433|NCT03091777|450932820|FG000|Overall Study|Withdrawal by Subject|4|||
125354434|NCT03091777|450932821|FG001|Overall Study|Withdrawal by Subject|2|||
125562278|NCT03677596|451689584|FG001|Overall Study|Other|1|||
125562279|NCT00003895|451689585|FG000|Overall Study|Adverse Event|4|||
125562280|NCT00003895|451689586|FG001|Overall Study|Adverse Event|0|||
125562281|NCT00003895|451689585|FG000|Overall Study|Lack of Efficacy|1|||
125562282|NCT00003895|451689586|FG001|Overall Study|Lack of Efficacy|1|||
125562283|NCT00003895|451689585|FG000|Overall Study|Patient Vacation|2|||
125562284|NCT00003895|451689586|FG001|Overall Study|Patient Vacation|0|||
125562285|NCT00003895|451689585|FG000|Overall Study|Withdrawal by Subject|0|||
125562286|NCT00003895|451689586|FG001|Overall Study|Withdrawal by Subject|3|||
125354435|NCT03091777|450932822|FG002|Overall Study|Withdrawal by Subject|6|||
125354436|NCT03091777|450932820|FG000|Overall Study|Protocol Violation|2|||
125354437|NCT03091777|450932821|FG001|Overall Study|Protocol Violation|1|||
125354438|NCT03091777|450932822|FG002|Overall Study|Protocol Violation|1|||
125562287|NCT04912245|451689589|FG000|Overall Study|Withdrawal by Subject|21|||
125562288|NCT04912245|451689590|FG001|Overall Study|Withdrawal by Subject|4|||
125562289|NCT04912245|451689589|FG000|Overall Study|Lost to Follow-up|5|||
125562290|NCT04912245|451689590|FG001|Overall Study|Lost to Follow-up|11|||
125562291|NCT01134614|451689591|FG000|Overall Study|Still on treatment as of March 2013|21|||
125562292|NCT01134614|451689592|FG001|Overall Study|Still on treatment as of March 2013|13|||
125562293|NCT01134614|451689591|FG000|Overall Study|Progressive disease|60|||
125562294|NCT01134614|451689592|FG001|Overall Study|Progressive disease|54|||
125354439|NCT03091777|450932820|FG000|Overall Study|Lost to Follow-up|12|||
125354440|NCT03091777|450932821|FG001|Overall Study|Lost to Follow-up|14|||
125354441|NCT03091777|450932822|FG002|Overall Study|Lost to Follow-up|7|||
125354442|NCT03091777|450932820|FG000|Overall Study|Lack of Efficacy|0|||
125354443|NCT03091777|450932821|FG001|Overall Study|Lack of Efficacy|0|||
125354444|NCT03091777|450932822|FG002|Overall Study|Lack of Efficacy|5|||
125562295|NCT01134614|451689591|FG000|Overall Study|Adverse Event|26|||
125562296|NCT01134614|451689592|FG001|Overall Study|Adverse Event|39|||
125354445|NCT03091777|450932820|FG000|Overall Study|Noncompliance with study drug|2|||
125562297|NCT01134614|451689591|FG000|Overall Study|Death|5|||
125354446|NCT03091777|450932821|FG001|Overall Study|Noncompliance with study drug|3|||
125354447|NCT03091777|450932822|FG002|Overall Study|Noncompliance with study drug|1|||
125562298|NCT01134614|451689592|FG001|Overall Study|Death|8|||
125562299|NCT01134614|451689591|FG000|Overall Study|Withdrawal by Subject|3|||
125562300|NCT01134614|451689592|FG001|Overall Study|Withdrawal by Subject|2|||
125562301|NCT01134614|451689591|FG000|Overall Study|Alternative therapy|2|||
125562302|NCT01134614|451689592|FG001|Overall Study|Alternative therapy|0|||
125562303|NCT01134614|451689591|FG000|Overall Study|Complicating disease|2|||
125562304|NCT01134614|451689592|FG001|Overall Study|Complicating disease|1|||
125562305|NCT01134614|451689591|FG000|Overall Study|Physician's decision|0|||
125562306|NCT01134614|451689592|FG001|Overall Study|Physician's decision|1|||
125562307|NCT01134614|451689591|FG000|Overall Study|Never started treatment|4|||
125562308|NCT01134614|451689592|FG001|Overall Study|Never started treatment|1|||
125562309|NCT01134614|451689591|FG000|Overall Study|Pt received tx not allowed on study|0|||
125562310|NCT01134614|451689592|FG001|Overall Study|Pt received tx not allowed on study|1|||
125562311|NCT01134614|451689591|FG000|Overall Study|Symptomatic deterioration|0|||
125562312|NCT01134614|451689592|FG001|Overall Study|Symptomatic deterioration|1|||
125562313|NCT01134614|451689591|FG000|Overall Study|Patient in hospice care|0|||
125562314|NCT01134614|451689592|FG001|Overall Study|Patient in hospice care|1|||
125562315|NCT02752035|451689593|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
125562316|NCT02752035|451689594|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
125562317|NCT02752035|451689595|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
125562318|NCT02752035|451689596|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
125562319|NCT02752035|451689593|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
125562320|NCT02752035|451689594|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
125562321|NCT02752035|451689595|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
125562322|NCT02752035|451689596|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
125562323|NCT02752035|451689593|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
125562324|NCT02752035|451689594|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
125562325|NCT02752035|451689595|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
125562326|NCT02752035|451689596|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
125562327|NCT02752035|451689593|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
125562328|NCT02752035|451689594|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
125562329|NCT02752035|451689595|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
125562330|NCT02752035|451689596|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
125562331|NCT02752035|451689593|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
125562332|NCT02752035|451689594|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
125562333|NCT02752035|451689595|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
125562334|NCT02752035|451689596|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
125562335|NCT02752035|451689593|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
125562336|NCT02752035|451689594|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
125562337|NCT02752035|451689595|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
125562338|NCT02752035|451689596|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
125562339|NCT02752035|451689593|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
125562340|NCT02752035|451689594|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
125562341|NCT02752035|451689595|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
125562342|NCT02752035|451689596|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
125562343|NCT02752035|451689593|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
125562344|NCT02752035|451689594|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
125562345|NCT02752035|451689595|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
125562346|NCT02752035|451689596|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
125562347|NCT02752035|451689593|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
125562348|NCT02752035|451689594|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
125562349|NCT02752035|451689595|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
125562350|NCT02752035|451689596|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
125562351|NCT02752035|451689593|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
125562352|NCT02752035|451689594|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
125562353|NCT02752035|451689595|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
125562354|NCT02752035|451689596|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
125562355|NCT02752035|451689593|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
125562356|NCT02752035|451689594|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
125562357|NCT02752035|451689595|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
125562358|NCT02752035|451689596|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
125562359|NCT02752035|451689593|FG000|Randomization: Approximately 3 Years|Death|0|||
125562360|NCT02752035|451689594|FG001|Randomization: Approximately 3 Years|Death|25|||
125562361|NCT02752035|451689595|FG002|Randomization: Approximately 3 Years|Death|13|||
125562362|NCT02752035|451689596|FG003|Randomization: Approximately 3 Years|Death|4|||
125562363|NCT02752035|451689593|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
125562364|NCT02752035|451689594|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
125562365|NCT02752035|451689595|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
125562366|NCT02752035|451689596|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
125562367|NCT02752035|451689593|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
125562368|NCT02752035|451689594|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
125562369|NCT02752035|451689595|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
125562370|NCT02752035|451689596|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
125562371|NCT02752035|451689593|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
125562372|NCT02752035|451689594|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
125562373|NCT02752035|451689595|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
125562374|NCT02752035|451689596|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
125562375|NCT02752035|451689593|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
125562376|NCT02752035|451689594|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
125562377|NCT02752035|451689595|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
125562378|NCT02752035|451689596|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
125562379|NCT02752035|451689593|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
125562380|NCT02752035|451689594|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
125562381|NCT02752035|451689595|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
125562382|NCT02752035|451689596|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
125562383|NCT01161043|451689599|FG000|Overall Study|Withdrawal by Subject|3|||
125562384|NCT01236573|451689600|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125562385|NCT01236573|451689601|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125562386|NCT01236573|451689602|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125562387|NCT01236573|451689603|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125562388|NCT01236573|451689604|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125562389|NCT01236573|451689605|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125562390|NCT01236573|451689606|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
125562391|NCT01236573|451689607|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125562392|NCT01236573|451689608|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
125562393|NCT01236573|451689609|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
125562394|NCT01236573|451689610|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
125562395|NCT01236573|451689600|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125562396|NCT01236573|451689601|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125562397|NCT01236573|451689602|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125562398|NCT01236573|451689603|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125562399|NCT01236573|451689604|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125562400|NCT01236573|451689605|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125562401|NCT01236573|451689606|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125562402|NCT01236573|451689607|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125562403|NCT01236573|451689608|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
125562404|NCT01236573|451689609|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125562405|NCT01236573|451689610|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
125562406|NCT01236573|451689600|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125562407|NCT01236573|451689601|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125562408|NCT01236573|451689602|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125562409|NCT01236573|451689603|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125562410|NCT01236573|451689604|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125562411|NCT01236573|451689605|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125562412|NCT01236573|451689606|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125562413|NCT01236573|451689607|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125562414|NCT01236573|451689608|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125562415|NCT01236573|451689609|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
125562416|NCT01236573|451689610|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
125562417|NCT02164929|451689613|FG000|Overall Study|Converted to open procedure|1|||
125562418|NCT02164929|451689614|FG001|Overall Study|Converted to open procedure|0|||
125562419|NCT02164929|451689615|FG002|Overall Study|Converted to open procedure|0|||
125562420|NCT02164929|451689616|FG003|Overall Study|Converted to open procedure|2|||
125562421|NCT02164929|451689613|FG000|Overall Study|Failed regional block|0|||
125562422|NCT02164929|451689614|FG001|Overall Study|Failed regional block|0|||
125562423|NCT02164929|451689615|FG002|Overall Study|Failed regional block|1|||
125562424|NCT02164929|451689616|FG003|Overall Study|Failed regional block|0|||
125562425|NCT00971178|451689617|FG000|Overall Study|Lost to Follow-up|2|||
125562426|NCT00971178|451689618|FG001|Overall Study|Lost to Follow-up|2|||
125562427|NCT00971178|451689619|FG002|Overall Study|Lost to Follow-up|2|||
125562428|NCT02161575|451689621|FG000|Overall Study|Protocol Violation|8|||
125562429|NCT02161575|451689621|FG000|Overall Study|Lack of Efficacy|1|||
125562430|NCT02161575|451689621|FG000|Overall Study|Adverse Event|2|||
125562431|NCT00424749|451689623|FG000|Overall Study|Withdrawal by Subject|1|||
125354448|NCT03091777|450932820|FG000|Overall Study|Physician Decision|1|||
125354449|NCT03091777|450932821|FG001|Overall Study|Physician Decision|0|||
125354450|NCT03091777|450932822|FG002|Overall Study|Physician Decision|1|||
125354451|NCT03091777|450932820|FG000|Overall Study|Abnormal Laboratory Value|7|||
125562432|NCT04109222|451689628|FG000|Overall Study|Adverse Event|1|||
125562433|NCT04109222|451689629|FG001|Overall Study|Adverse Event|0|||
125562434|NCT04109222|451689630|FG002|Overall Study|Adverse Event|0|||
125562435|NCT03023059|451689631|FG000|Overall Study|Withdrawal by Subject|5|||
125562436|NCT02138617|451689632|FG000|Overall Study|Death|1|||
125562437|NCT02138617|451689633|FG001|Overall Study|Death|2|||
125562438|NCT02138617|451689634|FG002|Overall Study|Death|2|||
125562439|NCT02138617|451689632|FG000|Overall Study|Adverse Event|8|||
125562440|NCT02138617|451689633|FG001|Overall Study|Adverse Event|5|||
125562441|NCT02138617|451689634|FG002|Overall Study|Adverse Event|2|||
125562442|NCT02138617|451689632|FG000|Overall Study|Disease Progression|20|||
125562443|NCT02138617|451689633|FG001|Overall Study|Disease Progression|13|||
125562444|NCT02138617|451689634|FG002|Overall Study|Disease Progression|4|||
125562445|NCT02138617|451689632|FG000|Overall Study|Withdrawal by Subject|7|||
125562446|NCT02138617|451689633|FG001|Overall Study|Withdrawal by Subject|10|||
125562447|NCT02138617|451689634|FG002|Overall Study|Withdrawal by Subject|2|||
125562448|NCT02138617|451689632|FG000|Overall Study|other complicating disease|0|||
125562449|NCT02138617|451689633|FG001|Overall Study|other complicating disease|2|||
125562450|NCT02138617|451689634|FG002|Overall Study|other complicating disease|0|||
125562451|NCT02138617|451689632|FG000|Overall Study|Protocol Violation|1|||
125562452|NCT02138617|451689633|FG001|Overall Study|Protocol Violation|0|||
125562453|NCT02138617|451689634|FG002|Overall Study|Protocol Violation|0|||
125562454|NCT02138617|451689632|FG000|Overall Study|Physician Decision|7|||
125562455|NCT02138617|451689633|FG001|Overall Study|Physician Decision|6|||
125562456|NCT02138617|451689634|FG002|Overall Study|Physician Decision|0|||
125562457|NCT02138617|451689632|FG000|Overall Study|financial reason|0|||
125562458|NCT02138617|451689633|FG001|Overall Study|financial reason|1|||
125562459|NCT02138617|451689634|FG002|Overall Study|financial reason|0|||
125562460|NCT02138617|451689632|FG000|Overall Study|other therapy|3|||
125354452|NCT03091777|450932821|FG001|Overall Study|Abnormal Laboratory Value|11|||
125354453|NCT03091777|450932822|FG002|Overall Study|Abnormal Laboratory Value|12|||
125354454|NCT02536833|450932823|FG000|Overall Study|Discontinued Before Treatment|0|||
125354455|NCT02536833|450932824|FG001|Overall Study|Discontinued Before Treatment|0|||
125354456|NCT02536833|450932825|FG002|Overall Study|Discontinued Before Treatment|1|||
125354457|NCT02536833|450932826|FG003|Overall Study|Discontinued Before Treatment|2|||
125354458|NCT02536833|450932823|FG000|Overall Study|Adverse Event|1|||
125354459|NCT02536833|450932824|FG001|Overall Study|Adverse Event|3|||
125354460|NCT02536833|450932825|FG002|Overall Study|Adverse Event|4|||
125354461|NCT02536833|450932826|FG003|Overall Study|Adverse Event|1|||
125354462|NCT02536833|450932823|FG000|Overall Study|Lost to Follow-up|2|||
125354463|NCT02536833|450932824|FG001|Overall Study|Lost to Follow-up|1|||
125354464|NCT02536833|450932825|FG002|Overall Study|Lost to Follow-up|2|||
125354465|NCT02536833|450932826|FG003|Overall Study|Lost to Follow-up|2|||
125354466|NCT02536833|450932823|FG000|Overall Study|Physician Decision|0|||
125354467|NCT02536833|450932824|FG001|Overall Study|Physician Decision|0|||
125562461|NCT02138617|451689633|FG001|Overall Study|other therapy|4|||
125562462|NCT02138617|451689634|FG002|Overall Study|other therapy|0|||
125562463|NCT00596947|451689639|FG000|Overall Study|study halted due to low enrollment|5|||
125562464|NCT00596947|451689640|FG001|Overall Study|study halted due to low enrollment|3|||
125562465|NCT00596947|451689639|FG000|Overall Study|Lost to Follow-up|1|||
125562466|NCT00596947|451689640|FG001|Overall Study|Lost to Follow-up|0|||
125562467|NCT00496730|451689641|FG000|Overall Study|Lost to Follow-up|4|||
125562468|NCT00496730|451689642|FG001|Overall Study|Lost to Follow-up|3|||
125562469|NCT00496730|451689641|FG000|Overall Study|Withdrawal by Subject|2|||
125562470|NCT00496730|451689642|FG001|Overall Study|Withdrawal by Subject|2|||
125562471|NCT03962738|451689643|FG000|Overall Study|Protocol Deviation|3|||
125562472|NCT03962738|451689644|FG001|Overall Study|Protocol Deviation|0|||
125562473|NCT03962738|451689645|FG002|Overall Study|Protocol Deviation|1|||
125562474|NCT03962738|451689646|FG003|Overall Study|Protocol Deviation|1|||
125562475|NCT03962738|451689643|FG000|Overall Study|Withdrawal by Subject|4|||
125562476|NCT03962738|451689644|FG001|Overall Study|Withdrawal by Subject|0|||
125562477|NCT03962738|451689645|FG002|Overall Study|Withdrawal by Subject|0|||
125562478|NCT03962738|451689646|FG003|Overall Study|Withdrawal by Subject|0|||
125562479|NCT03962738|451689643|FG000|Overall Study|Lost to Follow-up|0|||
125562480|NCT03962738|451689644|FG001|Overall Study|Lost to Follow-up|0|||
125562481|NCT03962738|451689645|FG002|Overall Study|Lost to Follow-up|1|||
125562482|NCT03962738|451689646|FG003|Overall Study|Lost to Follow-up|0|||
125354468|NCT02536833|450932825|FG002|Overall Study|Physician Decision|0|||
125354469|NCT02536833|450932826|FG003|Overall Study|Physician Decision|1|||
125354470|NCT02536833|450932823|FG000|Overall Study|Site Terminated by Sponsor|2|||
125354471|NCT02536833|450932824|FG001|Overall Study|Site Terminated by Sponsor|2|||
125354472|NCT02536833|450932825|FG002|Overall Study|Site Terminated by Sponsor|2|||
125354473|NCT02536833|450932826|FG003|Overall Study|Site Terminated by Sponsor|2|||
125354474|NCT02536833|450932823|FG000|Overall Study|Subject Non-Compliance|0|||
125354475|NCT02536833|450932824|FG001|Overall Study|Subject Non-Compliance|1|||
125354476|NCT02536833|450932825|FG002|Overall Study|Subject Non-Compliance|1|||
125354477|NCT02536833|450932826|FG003|Overall Study|Subject Non-Compliance|0|||
125354478|NCT02536833|450932823|FG000|Overall Study|Withdrawal by Subject|4|||
125354479|NCT02536833|450932824|FG001|Overall Study|Withdrawal by Subject|3|||
125354480|NCT02536833|450932825|FG002|Overall Study|Withdrawal by Subject|5|||
125354481|NCT02536833|450932826|FG003|Overall Study|Withdrawal by Subject|11|||
125354482|NCT03370289|450932827|FG000|Overall Study|Screen Failure|1|||
125562483|NCT00509067|451689647|FG000|Overall Study|Lost to Follow-up|1|||
125562484|NCT00509067|451689648|FG001|Overall Study|Lost to Follow-up|1|||
125562485|NCT00509067|451689647|FG000|Overall Study|Adverse Event|3|||
125562486|NCT00509067|451689648|FG001|Overall Study|Adverse Event|1|||
125562487|NCT00509067|451689647|FG000|Overall Study|Protocol Violation|0|||
125354483|NCT03370289|450932827|FG000|Overall Study|Sample Size Sufficient|4|||
125354484|NCT02764190|450932829|FG000|Overall Study|Lost to Follow-up|17|||
125562488|NCT00509067|451689648|FG001|Overall Study|Protocol Violation|3|||
125562489|NCT00131469|451689649|FG000|Overall Study|Withdrawal by Subject|3|||
125562490|NCT00131469|451689650|FG001|Overall Study|Withdrawal by Subject|4|||
125562491|NCT00131469|451689649|FG000|Overall Study|Protocol Violation|3|||
125562492|NCT00131469|451689650|FG001|Overall Study|Protocol Violation|1|||
125562493|NCT00131469|451689649|FG000|Overall Study|Death|0|||
125562494|NCT00131469|451689650|FG001|Overall Study|Death|1|||
125562495|NCT00131469|451689649|FG000|Overall Study|Lost to Follow-up|0|||
125562496|NCT00131469|451689650|FG001|Overall Study|Lost to Follow-up|1|||
125562497|NCT00131469|451689649|FG000|Overall Study|scan not analyzable|3|||
125562498|NCT00131469|451689650|FG001|Overall Study|scan not analyzable|6|||
125562499|NCT00574288|451689651|FG000|Overall Study|Adverse Event|2|||
125562500|NCT00574288|451689652|FG001|Overall Study|Adverse Event|0|||
125562501|NCT00574288|451689653|FG002|Overall Study|Adverse Event|0|||
125562502|NCT00574288|451689654|FG003|Overall Study|Adverse Event|0|||
125562503|NCT00574288|451689655|FG004|Overall Study|Adverse Event|1|||
125562504|NCT00574288|451689656|FG005|Overall Study|Adverse Event|0|||
125562505|NCT00574288|451689657|FG006|Overall Study|Adverse Event|0|||
125562506|NCT00574288|451689651|FG000|Overall Study|Death|0|||
125562507|NCT00574288|451689652|FG001|Overall Study|Death|0|||
125562508|NCT00574288|451689653|FG002|Overall Study|Death|0|||
125562509|NCT00574288|451689654|FG003|Overall Study|Death|0|||
125562510|NCT00574288|451689655|FG004|Overall Study|Death|0|||
125562511|NCT00574288|451689656|FG005|Overall Study|Death|25|||
125562512|NCT00574288|451689657|FG006|Overall Study|Death|21|||
125562513|NCT00574288|451689651|FG000|Overall Study|Lost to Follow-up|0|||
125562514|NCT00574288|451689652|FG001|Overall Study|Lost to Follow-up|0|||
125562515|NCT00574288|451689653|FG002|Overall Study|Lost to Follow-up|0|||
125562516|NCT00574288|451689654|FG003|Overall Study|Lost to Follow-up|0|||
125562517|NCT00574288|451689655|FG004|Overall Study|Lost to Follow-up|0|||
125562518|NCT00574288|451689656|FG005|Overall Study|Lost to Follow-up|1|||
125562519|NCT00574288|451689657|FG006|Overall Study|Lost to Follow-up|2|||
125562520|NCT00574288|451689651|FG000|Overall Study|Study Terminated By Sponsor|0|||
125562521|NCT00574288|451689652|FG001|Overall Study|Study Terminated By Sponsor|0|||
125562522|NCT00574288|451689653|FG002|Overall Study|Study Terminated By Sponsor|0|||
125562523|NCT00574288|451689654|FG003|Overall Study|Study Terminated By Sponsor|0|||
125562524|NCT00574288|451689655|FG004|Overall Study|Study Terminated By Sponsor|0|||
125562525|NCT00574288|451689656|FG005|Overall Study|Study Terminated By Sponsor|0|||
125562526|NCT00574288|451689657|FG006|Overall Study|Study Terminated By Sponsor|5|||
125562527|NCT00574288|451689651|FG000|Overall Study|Progressive Disease|17|||
125562528|NCT00574288|451689652|FG001|Overall Study|Progressive Disease|2|||
125562529|NCT00574288|451689653|FG002|Overall Study|Progressive Disease|3|||
125354485|NCT02764190|450932830|FG001|Overall Study|Lost to Follow-up|13|||
125562530|NCT00574288|451689654|FG003|Overall Study|Progressive Disease|2|||
125562531|NCT00574288|451689655|FG004|Overall Study|Progressive Disease|1|||
125562532|NCT00574288|451689656|FG005|Overall Study|Progressive Disease|0|||
125562533|NCT00574288|451689657|FG006|Overall Study|Progressive Disease|0|||
125562534|NCT00574288|451689651|FG000|Overall Study|Other|1|||
125562535|NCT00574288|451689652|FG001|Overall Study|Other|1|||
125562536|NCT00574288|451689653|FG002|Overall Study|Other|0|||
125562537|NCT00574288|451689654|FG003|Overall Study|Other|0|||
125562538|NCT00574288|451689655|FG004|Overall Study|Other|0|||
125562539|NCT00574288|451689656|FG005|Overall Study|Other|0|||
125562540|NCT00574288|451689657|FG006|Overall Study|Other|0|||
125562541|NCT00356889|451689659|FG000|Overall Study|Protocol Violation|2|||
125562542|NCT00356889|451689659|FG000|Overall Study|Adverse Event|1|||
125562543|NCT02361944|451689662|FG000|Overall Study|surgery cancellation|0|||
125354486|NCT01172275|450932835|FG000|Overall Study|Lost to Follow-up|1|||
125354487|NCT01172275|450932836|FG001|Overall Study|Lost to Follow-up|0|||
125354488|NCT01172275|450932835|FG000|Overall Study|Protocol Violation|1|||
125354489|NCT01172275|450932836|FG001|Overall Study|Protocol Violation|0|||
125354490|NCT05308290|450932841|FG000|Overall Study|Death|1|||
125354491|NCT05308290|450932842|FG001|Overall Study|Death|0|||
125354492|NCT05308290|450932841|FG000|Overall Study|Lost to Follow-up|2|||
125354493|NCT05308290|450932842|FG001|Overall Study|Lost to Follow-up|1|||
125354494|NCT05308290|450932841|FG000|Overall Study|still in study followup|0|||
125354495|NCT05308290|450932842|FG001|Overall Study|still in study followup|1|||
125354496|NCT04437368|450932843|FG000|Overall Study|Death|3|||
125354497|NCT04437368|450932844|FG001|Overall Study|Death|0|||
125354498|NCT04437368|450932845|FG002|Overall Study|Death|2|||
125354499|NCT04437368|450932843|FG000|Overall Study|Study terminated by sponsor|16|||
125354500|NCT04437368|450932844|FG001|Overall Study|Study terminated by sponsor|1|||
125354501|NCT04437368|450932845|FG002|Overall Study|Study terminated by sponsor|25|||
125354502|NCT04437368|450932843|FG000|Overall Study|Withdrawal by Subject|4|||
125354503|NCT04437368|450932844|FG001|Overall Study|Withdrawal by Subject|0|||
125354504|NCT04437368|450932845|FG002|Overall Study|Withdrawal by Subject|3|||
125354505|NCT04437368|450932843|FG000|Overall Study|Sponsor instructions|23|||
125354506|NCT04437368|450932844|FG001|Overall Study|Sponsor instructions|0|||
125354507|NCT04437368|450932845|FG002|Overall Study|Sponsor instructions|0|||
125354508|NCT01982331|450932846|FG000|Received Vaccination 2|Adverse Event|1|||
125354509|NCT01982331|450932847|FG001|Received Vaccination 2|Adverse Event|2|||
125354510|NCT01982331|450932846|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
125354511|NCT01982331|450932847|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
125562544|NCT02361944|451689663|FG001|Overall Study|surgery cancellation|1|||
125562545|NCT00073528|451689664|FG000|Overall Study|Death|488|||
125562546|NCT00073528|451689665|FG001|Overall Study|Death|473|||
125562547|NCT00073528|451689664|FG000|Overall Study|Lost to Follow-up|52|||
125562548|NCT00073528|451689665|FG001|Overall Study|Lost to Follow-up|45|||
125562549|NCT00073528|451689664|FG000|Overall Study|Withdrawal by Subject|50|||
125562550|NCT00073528|451689665|FG001|Overall Study|Withdrawal by Subject|45|||
125562551|NCT00073528|451689664|FG000|Overall Study|Study terminated by Sponsor|10|||
125562552|NCT00073528|451689665|FG001|Overall Study|Study terminated by Sponsor|29|||
125562553|NCT00073528|451689664|FG000|Overall Study|Other|18|||
125562554|NCT00073528|451689665|FG001|Overall Study|Other|19|||
125562555|NCT00073528|451689664|FG000|Overall Study|Other|9|||
125354512|NCT01982331|450932846|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
125354513|NCT01982331|450932847|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
125354514|NCT02393690|450932857|FG000|Overall Study|Ineligible|0|||
125354515|NCT02393690|450932858|FG001|Overall Study|Ineligible|1|||
125354516|NCT00586846|450932859|FG000|Overall Study|Physician Decision|1|||
125354517|NCT00586846|450932859|FG000|Overall Study|Death|1|||
125562556|NCT00073528|451689665|FG001|Overall Study|Other|12|||
125562557|NCT00073528|451689664|FG000|Overall Study|Protocol Violation|3|||
125354518|NCT00586846|450932859|FG000|Overall Study|Evaluable for Toxicity Only|4|||
125354519|NCT01674634|450932860|FG000|Overall Study|Withdrawal by Subject|3|||
125354520|NCT01674634|450932860|FG000|Overall Study|Lost to Follow-up|3|||
125562558|NCT00073528|451689665|FG001|Overall Study|Protocol Violation|5|||
125354521|NCT01721070|450932861|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
125354522|NCT02204007|450932862|FG000|Overall Study|Surgery Canceled|1|||
125354523|NCT02204007|450932863|FG001|Overall Study|Surgery Canceled|1|||
125354524|NCT02059005|450932864|FG000|Overall Study|Death|1|||
125354525|NCT02059005|450932865|FG001|Overall Study|Death|3|||
125354526|NCT02059005|450932864|FG000|Overall Study|Lost to Follow-up|19|||
125354527|NCT02059005|450932865|FG001|Overall Study|Lost to Follow-up|19|||
125354528|NCT02059005|450932864|FG000|Overall Study|Incarceration|0|||
125354529|NCT02059005|450932865|FG001|Overall Study|Incarceration|1|||
125354530|NCT02059005|450932864|FG000|Overall Study|Inpatient|0|||
125354531|NCT02059005|450932865|FG001|Overall Study|Inpatient|1|||
125354532|NCT02142803|450932866|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
125354533|NCT02142803|450932867|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
125354534|NCT02142803|450932868|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
125354535|NCT02142803|450932869|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
125354536|NCT02718300|450932875|FG000|Overall Study|Death|4|||
125354537|NCT02718300|450932876|FG001|Overall Study|Death|5|||
125354538|NCT02718300|450932877|FG002|Overall Study|Death|17|||
125354539|NCT02718300|450932875|FG000|Overall Study|Lost to Follow-up|1|||
125354540|NCT02718300|450932876|FG001|Overall Study|Lost to Follow-up|0|||
125354541|NCT02718300|450932877|FG002|Overall Study|Lost to Follow-up|2|||
125354542|NCT02718300|450932875|FG000|Overall Study|Physician Decision|1|||
125354543|NCT02718300|450932876|FG001|Overall Study|Physician Decision|0|||
125354544|NCT02718300|450932877|FG002|Overall Study|Physician Decision|2|||
125354545|NCT02718300|450932875|FG000|Overall Study|Study Terminated by Sponsor|6|||
125354546|NCT02718300|450932876|FG001|Overall Study|Study Terminated by Sponsor|3|||
125354547|NCT02718300|450932877|FG002|Overall Study|Study Terminated by Sponsor|4|||
125354548|NCT02718300|450932875|FG000|Overall Study|Withdrawal by Subject|0|||
125354549|NCT02718300|450932876|FG001|Overall Study|Withdrawal by Subject|4|||
125354550|NCT02718300|450932877|FG002|Overall Study|Withdrawal by Subject|3|||
125354551|NCT02718300|450932875|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
125354552|NCT02718300|450932876|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
125354553|NCT02718300|450932877|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
125354554|NCT03120624|450932878|FG000|Overall Study|Withdrawal by Subject|0|||
125354555|NCT03120624|450932879|FG001|Overall Study|Withdrawal by Subject|1|||
125354556|NCT03120624|450932880|FG002|Overall Study|Withdrawal by Subject|0|||
125354557|NCT03120624|450932881|FG003|Overall Study|Withdrawal by Subject|0|||
125354558|NCT03120624|450932882|FG004|Overall Study|Withdrawal by Subject|0|||
125354559|NCT03120624|450932883|FG005|Overall Study|Withdrawal by Subject|0|||
125354560|NCT03120624|450932884|FG006|Overall Study|Withdrawal by Subject|0|||
125354561|NCT03120624|450932885|FG007|Overall Study|Withdrawal by Subject|0|||
125354562|NCT05063318|450932886|FG000|Overall Study|Progressive disease|2|||
125354563|NCT05063318|450932887|FG001|Overall Study|Progressive disease|0|||
125354564|NCT05063318|450932888|FG002|Overall Study|Progressive disease|3|||
125354565|NCT05063318|450932886|FG000|Overall Study|Compassionate use|1|||
125354566|NCT05063318|450932887|FG001|Overall Study|Compassionate use|3|||
125354567|NCT05063318|450932888|FG002|Overall Study|Compassionate use|3|||
125354568|NCT05063318|450932886|FG000|Overall Study|Adverse Event|0|||
125354569|NCT05063318|450932887|FG001|Overall Study|Adverse Event|1|||
125354570|NCT05063318|450932888|FG002|Overall Study|Adverse Event|0|||
125354571|NCT05063318|450932886|FG000|Overall Study|Withdrawal by Subject|0|||
125354572|NCT05063318|450932887|FG001|Overall Study|Withdrawal by Subject|1|||
125354573|NCT05063318|450932888|FG002|Overall Study|Withdrawal by Subject|0|||
125354574|NCT01927341|450934816|FG000|Phase 1b|Lost to Follow-up|1|||
125354575|NCT01927341|450934817|FG001|Phase 1b|Lost to Follow-up|0|||
125354576|NCT01927341|450934818|FG002|Phase 1b|Lost to Follow-up|0|||
125426291|NCT02216773|451184472|FG001|Overall Study|Insufficient FLRV|0|||
125426292|NCT02216773|451184471|FG000|Overall Study|Abandoned|4|||
125426293|NCT02216773|451184472|FG001|Overall Study|Abandoned|3|||
125426294|NCT04274894|451184473|FG000|Overall Study|Adverse Event|7|||
125354577|NCT01927341|450934819|FG003|Phase 1b|Lost to Follow-up|0|||
125354578|NCT01927341|450934820|FG004|Phase 1b|Lost to Follow-up|0|||
125354579|NCT01927341|450934816|FG000|Phase 1b|Death|2|||
125354580|NCT01927341|450934817|FG001|Phase 1b|Death|0|||
125354581|NCT01927341|450934818|FG002|Phase 1b|Death|0|||
125354582|NCT01927341|450934819|FG003|Phase 1b|Death|0|||
125354583|NCT01927341|450934820|FG004|Phase 1b|Death|0|||
125354584|NCT01927341|450934816|FG000|Phase 1b|Follow-up completed|7|||
125354585|NCT01927341|450934817|FG001|Phase 1b|Follow-up completed|0|||
125354586|NCT01927341|450934818|FG002|Phase 1b|Follow-up completed|0|||
125354587|NCT01927341|450934819|FG003|Phase 1b|Follow-up completed|0|||
125354588|NCT01927341|450934820|FG004|Phase 1b|Follow-up completed|0|||
125354589|NCT01927341|450934816|FG000|Phase 2|Lost to Follow-up|0|||
125354590|NCT01927341|450934817|FG001|Phase 2|Lost to Follow-up|1|||
125354591|NCT01927341|450934818|FG002|Phase 2|Lost to Follow-up|0|||
125354592|NCT01927341|450934819|FG003|Phase 2|Lost to Follow-up|0|||
125426295|NCT04274894|451184473|FG000|Overall Study|Withdrew consent|5|||
125354593|NCT01927341|450934820|FG004|Phase 2|Lost to Follow-up|0|||
125354594|NCT01927341|450934816|FG000|Phase 2|Participant withdrew consent|0|||
125354595|NCT01927341|450934817|FG001|Phase 2|Participant withdrew consent|2|||
125354596|NCT01927341|450934818|FG002|Phase 2|Participant withdrew consent|1|||
125354597|NCT01927341|450934819|FG003|Phase 2|Participant withdrew consent|2|||
125354598|NCT01927341|450934820|FG004|Phase 2|Participant withdrew consent|3|||
125354599|NCT01927341|450934816|FG000|Phase 2|Death|0|||
125354600|NCT01927341|450934817|FG001|Phase 2|Death|4|||
125354601|NCT01927341|450934818|FG002|Phase 2|Death|0|||
125354602|NCT01927341|450934819|FG003|Phase 2|Death|3|||
125354603|NCT01927341|450934820|FG004|Phase 2|Death|2|||
125354604|NCT01927341|450934816|FG000|Phase 2|New cancer therapy|0|||
125354605|NCT01927341|450934817|FG001|Phase 2|New cancer therapy|1|||
125354606|NCT01927341|450934818|FG002|Phase 2|New cancer therapy|0|||
125354607|NCT01927341|450934819|FG003|Phase 2|New cancer therapy|4|||
125354608|NCT01927341|450934820|FG004|Phase 2|New cancer therapy|1|||
125354609|NCT01927341|450934816|FG000|Phase 2|Disease progression|0|||
125354610|NCT01927341|450934817|FG001|Phase 2|Disease progression|1|||
125354611|NCT01927341|450934818|FG002|Phase 2|Disease progression|1|||
125354612|NCT01927341|450934819|FG003|Phase 2|Disease progression|1|||
125354613|NCT01927341|450934820|FG004|Phase 2|Disease progression|0|||
125354614|NCT01927341|450934816|FG000|Phase 2|Follow-up completed|0|||
125354615|NCT01927341|450934817|FG001|Phase 2|Follow-up completed|6|||
125354616|NCT01927341|450934818|FG002|Phase 2|Follow-up completed|3|||
125354617|NCT01927341|450934819|FG003|Phase 2|Follow-up completed|5|||
125354618|NCT01927341|450934820|FG004|Phase 2|Follow-up completed|2|||
125354619|NCT01397201|450934821|FG000|Overall Study|Not treated|0|||
125562559|NCT03654976|451689666|FG000|Overall Study|Withdrawal by Subject|12|||
125562560|NCT03654976|451689667|FG001|Overall Study|Withdrawal by Subject|11|||
125562561|NCT03654976|451689666|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
125562562|NCT03654976|451689667|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
125562563|NCT03654976|451689666|FG000|Overall Study|Adverse Event|5|||
125562564|NCT03654976|451689667|FG001|Overall Study|Adverse Event|0|||
125562565|NCT03654976|451689666|FG000|Overall Study|Lost to Follow-up|2|||
125354620|NCT01397201|450934822|FG001|Overall Study|Not treated|0|||
125354621|NCT01397201|450934823|FG002|Overall Study|Not treated|1|||
125354622|NCT01397201|450934824|FG003|Overall Study|Not treated|0|||
125354623|NCT01397201|450934825|FG004|Overall Study|Not treated|0|||
125354624|NCT01397201|450934821|FG000|Overall Study|Not yet defined|3|||
125354625|NCT01397201|450934822|FG001|Overall Study|Not yet defined|6|||
125562566|NCT03654976|451689667|FG001|Overall Study|Lost to Follow-up|0|||
125354626|NCT01397201|450934823|FG002|Overall Study|Not yet defined|5|||
125562567|NCT03654976|451689666|FG000|Overall Study|Lack of Efficacy|0|||
125354627|NCT01397201|450934824|FG003|Overall Study|Not yet defined|5|||
125354628|NCT01397201|450934825|FG004|Overall Study|Not yet defined|4|||
125354629|NCT01397201|450934821|FG000|Overall Study|Adverse Event|2|||
125354630|NCT01397201|450934822|FG001|Overall Study|Adverse Event|0|||
125354631|NCT01397201|450934823|FG002|Overall Study|Adverse Event|0|||
125354632|NCT01397201|450934824|FG003|Overall Study|Adverse Event|0|||
125354633|NCT01397201|450934825|FG004|Overall Study|Adverse Event|0|||
125354634|NCT00215683|450934826|FG000|Overall Study|Adverse Event|15|||
125354635|NCT00215683|450934827|FG001|Overall Study|Adverse Event|16|||
125354636|NCT00215683|450934828|FG002|Overall Study|Adverse Event|15|||
125562568|NCT03654976|451689667|FG001|Overall Study|Lack of Efficacy|1|||
125562569|NCT03098836|451689668|FG000|Overall Study|Adverse Event|1|||
125562570|NCT03098836|451689669|FG001|Overall Study|Adverse Event|3|||
125562571|NCT03098836|451689668|FG000|Overall Study|Lack of Efficacy|30|||
125562572|NCT03098836|451689669|FG001|Overall Study|Lack of Efficacy|15|||
125562573|NCT03098836|451689668|FG000|Overall Study|Physician Decision|2|||
125562574|NCT03098836|451689669|FG001|Overall Study|Physician Decision|1|||
125562575|NCT03098836|451689668|FG000|Overall Study|Withdrawal by Subject|3|||
125562576|NCT03098836|451689669|FG001|Overall Study|Withdrawal by Subject|2|||
125562577|NCT01357577|451689670|FG000|Overall Study|Lost to Follow-up|20|||
125562578|NCT01357577|451689671|FG001|Overall Study|Lost to Follow-up|16|||
125562579|NCT01357577|451689670|FG000|Overall Study|Withdrawal by Subject|16|||
125562580|NCT01357577|451689671|FG001|Overall Study|Withdrawal by Subject|8|||
125562581|NCT01357577|451689670|FG000|Overall Study|look at data in database?|1|||
125562582|NCT01357577|451689671|FG001|Overall Study|look at data in database?|2|||
125562583|NCT00937937|451690771|FG000|Overall Study|Adverse Event|6|||
125562584|NCT00937937|451690771|FG000|Overall Study|Withdrawal by Subject|2|||
125562585|NCT00937937|451690771|FG000|Overall Study|Progression/relapse|61|||
125562586|NCT00937937|451690771|FG000|Overall Study|Death|1|||
125562587|NCT00937937|451690771|FG000|Overall Study|Other|2|||
125562588|NCT04024228|451690773|FG000|Overall Study|Adverse Event|1|||
125562589|NCT04024228|451690774|FG001|Overall Study|Adverse Event|0|||
125562590|NCT04024228|451690773|FG000|Overall Study|Protocol Deviation|0|||
125562591|NCT04024228|451690774|FG001|Overall Study|Protocol Deviation|2|||
125562592|NCT04024228|451690773|FG000|Overall Study|Withdrawal by Subject|3|||
125562593|NCT04024228|451690774|FG001|Overall Study|Withdrawal by Subject|4|||
125562594|NCT02932410|451690775|FG000|Overall Study|Death|7|||
125562595|NCT02932410|451690776|FG001|Overall Study|Death|6|||
125562596|NCT02932410|451690777|FG002|Overall Study|Death|0|||
125562597|NCT02932410|451690778|FG003|Overall Study|Death|0|||
125562598|NCT02932410|451690775|FG000|Overall Study|Lost to Follow-up|1|||
125562599|NCT02932410|451690776|FG001|Overall Study|Lost to Follow-up|2|||
125562600|NCT02932410|451690777|FG002|Overall Study|Lost to Follow-up|0|||
125562601|NCT02932410|451690778|FG003|Overall Study|Lost to Follow-up|0|||
125562602|NCT02932410|451690775|FG000|Overall Study|Parent/Subjects decision|6|||
125562603|NCT02932410|451690776|FG001|Overall Study|Parent/Subjects decision|6|||
125562604|NCT02932410|451690777|FG002|Overall Study|Parent/Subjects decision|1|||
125562605|NCT02932410|451690778|FG003|Overall Study|Parent/Subjects decision|0|||
125562606|NCT02932410|451690775|FG000|Overall Study|Physician Decision|0|||
125562607|NCT02932410|451690776|FG001|Overall Study|Physician Decision|1|||
125562608|NCT02932410|451690777|FG002|Overall Study|Physician Decision|0|||
125562609|NCT02932410|451690778|FG003|Overall Study|Physician Decision|0|||
125562610|NCT01007032|451690784|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
125562611|NCT01007032|451690785|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
125562612|NCT01007032|451690786|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
125562613|NCT01007032|451690787|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
125562614|NCT01007032|451690784|FG000|Overall Study|Withdrawal by Subject|0|||
125354637|NCT00215683|450934826|FG000|Overall Study|Lack of Efficacy|5|||
125562615|NCT01007032|451690785|FG001|Overall Study|Withdrawal by Subject|0|||
125562616|NCT01007032|451690786|FG002|Overall Study|Withdrawal by Subject|0|||
125354638|NCT00215683|450934827|FG001|Overall Study|Lack of Efficacy|1|||
125562617|NCT01007032|451690787|FG003|Overall Study|Withdrawal by Subject|1|||
125562618|NCT01841749|451690788|FG000|Overall Study|Protocol Violation|1|||
125562619|NCT05197049|451690794|FG000|Overall Study|Death|0|||
125562620|NCT05197049|451690795|FG001|Overall Study|Death|1|||
125562621|NCT05197049|451690796|FG002|Overall Study|Death|0|||
125354639|NCT00215683|450934828|FG002|Overall Study|Lack of Efficacy|2|||
125354640|NCT00215683|450934826|FG000|Overall Study|Lost to Follow-up|0|||
125354641|NCT00215683|450934827|FG001|Overall Study|Lost to Follow-up|2|||
125354642|NCT00215683|450934828|FG002|Overall Study|Lost to Follow-up|1|||
125426296|NCT04274894|451184473|FG000|Overall Study|Lost to Follow-up|9|||
125426297|NCT04274894|451184473|FG000|Overall Study|COVID-19 infection|1|||
125426298|NCT04274894|451184473|FG000|Overall Study|Other, not specified|20|||
125354643|NCT00215683|450934826|FG000|Overall Study|Withdrawal by Subject|9|||
125354644|NCT00215683|450934827|FG001|Overall Study|Withdrawal by Subject|4|||
125354645|NCT00215683|450934828|FG002|Overall Study|Withdrawal by Subject|13|||
125354646|NCT00215683|450934826|FG000|Overall Study|Physician Decision|0|||
125354647|NCT00215683|450934827|FG001|Overall Study|Physician Decision|0|||
125354648|NCT00215683|450934828|FG002|Overall Study|Physician Decision|1|||
125354649|NCT00215683|450934826|FG000|Overall Study|Difficult to attend visits|0|||
125354650|NCT00215683|450934827|FG001|Overall Study|Difficult to attend visits|1|||
125354651|NCT00215683|450934828|FG002|Overall Study|Difficult to attend visits|0|||
125354652|NCT00215683|450934826|FG000|Overall Study|No study drug available|0|||
125354653|NCT00215683|450934827|FG001|Overall Study|No study drug available|1|||
125354654|NCT00215683|450934828|FG002|Overall Study|No study drug available|0|||
125354655|NCT00215683|450934826|FG000|Overall Study|Intermittent therapy required|0|||
125354656|NCT00215683|450934827|FG001|Overall Study|Intermittent therapy required|1|||
125354657|NCT00215683|450934828|FG002|Overall Study|Intermittent therapy required|0|||
125354658|NCT01083485|450934829|FG000|Overall Study|Adverse Event|0|||
125354659|NCT01083485|450934830|FG001|Overall Study|Adverse Event|1|||
125354660|NCT01083485|450934829|FG000|Overall Study|Protocol Violation|1|||
125354661|NCT01083485|450934830|FG001|Overall Study|Protocol Violation|0|||
125354662|NCT01083485|450934829|FG000|Overall Study|Withdrawal by Subject|5|||
125354663|NCT01083485|450934830|FG001|Overall Study|Withdrawal by Subject|2|||
125354664|NCT01083485|450934829|FG000|Overall Study|Other|1|||
125354665|NCT01083485|450934830|FG001|Overall Study|Other|0|||
125354666|NCT04493333|450934837|FG000|Overall Study|Withdrawal by Subject|1|||
125354667|NCT04493333|450934838|FG001|Overall Study|Withdrawal by Subject|1|||
125354668|NCT04493333|450934837|FG000|Overall Study|Ineligible|0|||
125354669|NCT04493333|450934838|FG001|Overall Study|Ineligible|1|||
125354670|NCT04493333|450934837|FG000|Overall Study|Noncompliance|2|||
125354671|NCT04493333|450934838|FG001|Overall Study|Noncompliance|1|||
125354672|NCT00084838|450934841|FG000|Overall Study|Death|1|||
125354673|NCT00084838|450934841|FG000|Overall Study|Adverse Event|2|||
125354674|NCT00084838|450934841|FG000|Overall Study|Withdrawal by Subject|1|||
125354675|NCT00084838|450934841|FG000|Overall Study|Progressive Disease|4|||
125354676|NCT00084838|450934841|FG000|Overall Study|Pt Non-Compliance|1|||
125354677|NCT00084838|450934841|FG000|Overall Study|Ineligible|4|||
125354678|NCT00122278|450934842|FG000|Overall Study|Lost to Follow-up|2|||
125562622|NCT05197049|451690794|FG000|Overall Study|Lost to Follow-up|3|||
125562623|NCT05197049|451690795|FG001|Overall Study|Lost to Follow-up|1|||
125354679|NCT00122278|450934843|FG001|Overall Study|Lost to Follow-up|0|||
125354680|NCT01865084|450934844|FG000|Double Blind Period (DB)|Adverse Event|2|||
125354681|NCT01865084|450934845|FG001|Double Blind Period (DB)|Adverse Event|2|||
125562624|NCT05197049|451690796|FG002|Overall Study|Lost to Follow-up|0|||
125354682|NCT01865084|450934846|FG002|Double Blind Period (DB)|Adverse Event|1|||
125354683|NCT01865084|450934844|FG000|Double Blind Period (DB)|Protocol Violation|0|||
125354684|NCT01865084|450934845|FG001|Double Blind Period (DB)|Protocol Violation|0|||
125354685|NCT01865084|450934846|FG002|Double Blind Period (DB)|Protocol Violation|1|||
125354686|NCT01865084|450934844|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
125354687|NCT01865084|450934845|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
125562625|NCT05197049|451690794|FG000|Overall Study|Withdrawal by Subject|15|||
125562626|NCT05197049|451690795|FG001|Overall Study|Withdrawal by Subject|3|||
125354688|NCT01865084|450934846|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
125354689|NCT01865084|450934844|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
125354690|NCT01865084|450934845|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
125354691|NCT01865084|450934846|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
125354692|NCT01865084|450934844|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
125354693|NCT01865084|450934845|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
125354694|NCT01865084|450934846|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
125354695|NCT01865084|450934844|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
125354696|NCT01865084|450934845|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
125354697|NCT01865084|450934846|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
125354698|NCT01865084|450934844|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
125354699|NCT01865084|450934845|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
125354700|NCT01865084|450934846|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
125354701|NCT01865084|450934844|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
125354702|NCT01865084|450934845|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
125354703|NCT01865084|450934846|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
125354704|NCT01865084|450934844|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
125354705|NCT01865084|450934845|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
125354706|NCT01865084|450934846|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
125354707|NCT01994590|450934847|FG000|Overall Study|Adverse Event|1|||
125354708|NCT01994590|450934847|FG000|Overall Study|Trial Terminated|1|||
125354709|NCT03607422|450934848|FG000|Overall Study|Adverse Event|7|||
125354710|NCT03607422|450934849|FG001|Overall Study|Adverse Event|3|||
125354711|NCT03607422|450934850|FG002|Overall Study|Adverse Event|2|||
125354712|NCT03607422|450934851|FG003|Overall Study|Adverse Event|0|||
125354713|NCT03607422|450934852|FG004|Overall Study|Adverse Event|2|||
125354714|NCT03607422|450934853|FG005|Overall Study|Adverse Event|0|||
125354715|NCT03607422|450934848|FG000|Overall Study|Withdrawal by Subject|11|||
125354716|NCT03607422|450934849|FG001|Overall Study|Withdrawal by Subject|3|||
125354717|NCT03607422|450934850|FG002|Overall Study|Withdrawal by Subject|6|||
125354718|NCT03607422|450934851|FG003|Overall Study|Withdrawal by Subject|2|||
125354719|NCT03607422|450934852|FG004|Overall Study|Withdrawal by Subject|0|||
125354720|NCT03607422|450934853|FG005|Overall Study|Withdrawal by Subject|0|||
125354721|NCT03607422|450934848|FG000|Overall Study|Lost to Follow-up|0|||
125354722|NCT03607422|450934849|FG001|Overall Study|Lost to Follow-up|0|||
125354723|NCT03607422|450934850|FG002|Overall Study|Lost to Follow-up|1|||
125354724|NCT03607422|450934851|FG003|Overall Study|Lost to Follow-up|0|||
125354725|NCT03607422|450934852|FG004|Overall Study|Lost to Follow-up|0|||
125354726|NCT03607422|450934853|FG005|Overall Study|Lost to Follow-up|0|||
125354727|NCT03607422|450934848|FG000|Overall Study|Other|12|||
125354728|NCT03607422|450934849|FG001|Overall Study|Other|4|||
125354729|NCT03607422|450934850|FG002|Overall Study|Other|1|||
125354730|NCT03607422|450934851|FG003|Overall Study|Other|2|||
125354731|NCT03607422|450934852|FG004|Overall Study|Other|0|||
125354732|NCT03607422|450934853|FG005|Overall Study|Other|2|||
125354733|NCT03607422|450934848|FG000|Overall Study|Ongoing at Time of Analysis|8|||
125354734|NCT03607422|450934849|FG001|Overall Study|Ongoing at Time of Analysis|0|||
125354735|NCT03607422|450934850|FG002|Overall Study|Ongoing at Time of Analysis|2|||
125354736|NCT03607422|450934851|FG003|Overall Study|Ongoing at Time of Analysis|1|||
125354737|NCT03607422|450934852|FG004|Overall Study|Ongoing at Time of Analysis|1|||
125354738|NCT03607422|450934853|FG005|Overall Study|Ongoing at Time of Analysis|1|||
125354739|NCT03693170|450934854|FG000|Overall Study|Disease Progression|48|||
125354740|NCT03693170|450934854|FG000|Overall Study|Adverse Event|16|||
125354741|NCT03693170|450934854|FG000|Overall Study|Physician Decision|6|||
125354742|NCT03693170|450934854|FG000|Overall Study|Protocol Violation|2|||
125354743|NCT03693170|450934854|FG000|Overall Study|Death|1|||
125354744|NCT03693170|450934854|FG000|Overall Study|Non compliance with study drug|1|||
125354745|NCT03693170|450934854|FG000|Overall Study|Withdrawal by Subject|1|||
125354746|NCT02247531|450934855|FG000|Overall Study|Adverse Event|3|||
125354747|NCT02247531|450934856|FG001|Overall Study|Adverse Event|4|||
125354748|NCT02247531|450934857|FG002|Overall Study|Adverse Event|9|||
125354749|NCT02247531|450934855|FG000|Overall Study|Death|8|||
125354750|NCT02247531|450934856|FG001|Overall Study|Death|9|||
125354751|NCT02247531|450934857|FG002|Overall Study|Death|5|||
125354752|NCT02247531|450934855|FG000|Overall Study|Lost to Follow-up|1|||
125354753|NCT02247531|450934856|FG001|Overall Study|Lost to Follow-up|8|||
125354754|NCT02247531|450934857|FG002|Overall Study|Lost to Follow-up|3|||
125354755|NCT02247531|450934855|FG000|Overall Study|Non-compliance|2|||
125354756|NCT02247531|450934856|FG001|Overall Study|Non-compliance|2|||
125354757|NCT02247531|450934857|FG002|Overall Study|Non-compliance|0|||
125354758|NCT02247531|450934855|FG000|Overall Study|Withdrawal by Subject|26|||
125354759|NCT02247531|450934856|FG001|Overall Study|Withdrawal by Subject|31|||
125354760|NCT02247531|450934857|FG002|Overall Study|Withdrawal by Subject|25|||
125354761|NCT02247531|450934855|FG000|Overall Study|Study Terminated by Sponsor|64|||
125354762|NCT02247531|450934856|FG001|Overall Study|Study Terminated by Sponsor|66|||
125354763|NCT02247531|450934857|FG002|Overall Study|Study Terminated by Sponsor|62|||
125354764|NCT02247531|450934855|FG000|Overall Study|Physician Decision|0|||
125354765|NCT02247531|450934856|FG001|Overall Study|Physician Decision|2|||
125562627|NCT05197049|451690796|FG002|Overall Study|Withdrawal by Subject|1|||
125562628|NCT05197049|451690794|FG000|Overall Study|GCP non-compliance|1|||
125562629|NCT05197049|451690795|FG001|Overall Study|GCP non-compliance|2|||
125562630|NCT05197049|451690796|FG002|Overall Study|GCP non-compliance|0|||
125562631|NCT02577406|451690803|FG000|Randomized Period|Death|1|||
125562632|NCT02577406|451690804|FG001|Randomized Period|Death|0|||
125562633|NCT02577406|451690803|FG000|Randomized Period|Other reasons|0|||
125562634|NCT02577406|451690804|FG001|Randomized Period|Other reasons|20|||
125562635|NCT02577406|451690803|FG000|Treatment Period|Death|38|||
125562636|NCT02577406|451690804|FG001|Treatment Period|Death|23|||
125562637|NCT02577406|451690803|FG000|Treatment Period|Adverse Event|17|||
125562638|NCT02577406|451690804|FG001|Treatment Period|Adverse Event|12|||
125562639|NCT02577406|451690803|FG000|Treatment Period|Progressive Disease|53|||
125562640|NCT02577406|451690804|FG001|Treatment Period|Progressive Disease|37|||
125562641|NCT02577406|451690803|FG000|Treatment Period|Withdrawal by Subject|10|||
125562642|NCT02577406|451690804|FG001|Treatment Period|Withdrawal by Subject|24|||
125562643|NCT02577406|451690803|FG000|Treatment Period|Lost to Follow-up|0|||
125562644|NCT02577406|451690804|FG001|Treatment Period|Lost to Follow-up|1|||
125562645|NCT02577406|451690803|FG000|Treatment Period|Transition to commercially available treatment|1|||
125562646|NCT02577406|451690804|FG001|Treatment Period|Transition to commercially available treatment|1|||
125562647|NCT02577406|451690803|FG000|Treatment Period|Physician Decision|1|||
125562648|NCT02577406|451690804|FG001|Treatment Period|Physician Decision|0|||
125562649|NCT02577406|451690803|FG000|Treatment Period|Disease Relapse|28|||
125562650|NCT02577406|451690804|FG001|Treatment Period|Disease Relapse|1|||
125562651|NCT02577406|451690803|FG000|Treatment Period|Protocol Violation|0|||
125562652|NCT02577406|451690804|FG001|Treatment Period|Protocol Violation|1|||
125562653|NCT02577406|451690803|FG000|Treatment Period|Other Reasons|3|||
125562654|NCT02577406|451690804|FG001|Treatment Period|Other Reasons|39|||
125562655|NCT02577406|451690803|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
125562656|NCT02577406|451690804|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
125562657|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
125562658|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
125562659|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125562660|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125562661|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125562662|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
125562663|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
125562664|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125562665|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125562666|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125562667|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125562668|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125562669|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125562670|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
125562671|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125562672|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125562673|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125354766|NCT02247531|450934857|FG002|Overall Study|Physician Decision|2|||
125354767|NCT02247531|450934855|FG000|Overall Study|Unspecified Reason|2|||
125562674|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125562675|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125562676|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
125562677|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
125562678|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125562679|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125562680|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125562681|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125562682|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125562683|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125562684|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
125562685|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
125562686|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125562687|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125562688|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125562689|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125562690|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125562691|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
125354768|NCT02247531|450934856|FG001|Overall Study|Unspecified Reason|3|||
125354769|NCT02247531|450934857|FG002|Overall Study|Unspecified Reason|4|||
125354770|NCT03875118|450934858|FG000|Overall Study|Withdrawal by Subject|4|||
125354771|NCT03875118|450934859|FG001|Overall Study|Withdrawal by Subject|4|||
125354772|NCT03228420|450934869|FG000|Overall Study|Lost to Follow-up|5|||
125354773|NCT03228420|450934870|FG001|Overall Study|Lost to Follow-up|3|||
125354774|NCT03228420|450934869|FG000|Overall Study|Withdrawal by Subject|10|||
125354775|NCT03228420|450934870|FG001|Overall Study|Withdrawal by Subject|0|||
125354776|NCT03228420|450934869|FG000|Overall Study|Adverse Event|5|||
125354777|NCT03228420|450934870|FG001|Overall Study|Adverse Event|2|||
125354778|NCT01298531|450934871|FG000|Overall Study|Lack of Efficacy|0|||
125354779|NCT01298531|450934872|FG001|Overall Study|Lack of Efficacy|1|||
125354780|NCT01298531|450934871|FG000|Overall Study|Lost to Follow-up|2|||
125354781|NCT01298531|450934872|FG001|Overall Study|Lost to Follow-up|0|||
125354782|NCT01298531|450934871|FG000|Overall Study|Protocol Violation|1|||
125354783|NCT01298531|450934872|FG001|Overall Study|Protocol Violation|1|||
125354784|NCT01298531|450934871|FG000|Overall Study|Adverse Event|4|||
125354785|NCT01298531|450934872|FG001|Overall Study|Adverse Event|3|||
125354786|NCT01298531|450934871|FG000|Overall Study|Does not meet entrance criteria|0|||
125354787|NCT01298531|450934872|FG001|Overall Study|Does not meet entrance criteria|1|||
125354788|NCT01298531|450934871|FG000|Overall Study|Other|2|||
125354789|NCT01298531|450934872|FG001|Overall Study|Other|1|||
125354790|NCT03468985|450934875|FG000|Overall Study|Adverse Event|0|||
125354791|NCT03468985|450934876|FG001|Overall Study|Adverse Event|2|||
125354792|NCT03468985|450934877|FG002|Overall Study|Adverse Event|0|||
125354793|NCT03468985|450934878|FG003|Overall Study|Adverse Event|0|||
125354794|NCT03468985|450934875|FG000|Overall Study|Withdrawal by Subject|0|||
125354795|NCT03468985|450934876|FG001|Overall Study|Withdrawal by Subject|0|||
125354796|NCT03468985|450934877|FG002|Overall Study|Withdrawal by Subject|0|||
125354797|NCT03468985|450934878|FG003|Overall Study|Withdrawal by Subject|1|||
125354798|NCT04131556|450934879|FG000|Overall Study|Adverse Event|1|||
125354799|NCT04131556|450934879|FG000|Overall Study|Withdrawal by Subject|1|||
125354800|NCT01933217|450934880|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
125354801|NCT01933217|450934881|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
125354802|NCT01933217|450934880|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
125354803|NCT01933217|450934881|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
125354804|NCT03923738|450934884|FG000|Period 1|Adverse Event|1|||
125354805|NCT03923738|450934884|FG000|Period 1|Withdrawal by Subject|1|||
125354806|NCT03583164|450934886|FG000|Overall Study|Death in Main Phase|35|||
125354807|NCT03583164|450934886|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
125354808|NCT03583164|450934886|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
125354809|NCT03583164|450934886|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
125354810|NCT03583164|450934886|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
125354811|NCT03583164|450934886|FG000|Overall Study|Physician decision in Main Phase|1|||
125354812|NCT03583164|450934886|FG000|Overall Study|Physician decision in Extended Phase|2|||
125354813|NCT03583164|450934886|FG000|Overall Study|Death in Extended Phase|13|||
125354814|NCT03583164|450934886|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
125354815|NCT03583164|450934886|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
125354816|NCT03583164|450934886|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
125354817|NCT03583164|450934886|FG000|Overall Study|Treatment failure in Main Phase|2|||
125354818|NCT03583164|450934886|FG000|Overall Study|Treatment failure in Extended Phase|4|||
125354819|NCT03583164|450934886|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
125354820|NCT03583164|450934886|FG000|Overall Study|Other not specified reason in Main Phase|2|||
125354821|NCT00735254|450934887|FG000|Overall Study|Protocol Violation|1|||
125354822|NCT00735254|450934888|FG001|Overall Study|Protocol Violation|1|||
125354823|NCT00735254|450934889|FG002|Overall Study|Protocol Violation|1|||
125354824|NCT00735254|450934890|FG003|Overall Study|Protocol Violation|0|||
125354825|NCT00057954|450934894|FG000|Overall Study|Death|1|||
125354826|NCT00057954|450934894|FG000|Overall Study|Disease progression|1|||
125354827|NCT01251744|450934895|FG000|Overall Study|Lost to Follow-up|1|||
125562692|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125562693|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125562694|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125562695|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125562696|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125562697|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125562698|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
125562699|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125562700|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125562701|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125562702|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125562703|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125562704|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
125562705|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
125562706|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125562707|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125562708|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125562709|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125562710|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125562711|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125562712|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
125562713|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125562714|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125562715|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125562716|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125562717|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125562718|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125354828|NCT01251744|450934896|FG001|Overall Study|Lost to Follow-up|0|||
125354829|NCT00559754|450934897|FG000|Overall Study|Disease progression|1|||
125562719|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
125562720|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125562721|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125562722|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125562723|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125562724|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125562725|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125562726|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
125562727|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
125562728|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
125562729|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
125562730|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125562731|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125562732|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
125562733|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
125562734|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125354830|NCT00559754|450934897|FG000|Overall Study|Adverse Event|5|||
125562735|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125562736|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125562737|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125562738|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125562739|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125562740|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
125562741|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125562742|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
125562743|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125562744|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125562745|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125562746|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
125562747|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125562748|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125562749|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125562750|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125562751|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125562752|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125562753|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125562754|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
125562755|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
125562756|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125562757|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125562758|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125562759|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125562760|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
125562761|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125562762|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125562763|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125562764|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125562765|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125562766|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125562767|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125562768|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
125562769|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125562770|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125562771|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125562772|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
125562773|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
125562774|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125562775|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125562776|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
125562777|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
125562778|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125562779|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125562780|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125562781|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125562782|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
125562783|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125562784|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125562785|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125562786|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125562787|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125562788|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125562789|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125562790|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
125562791|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
125562792|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125562793|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125562794|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125562795|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125562796|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
125562797|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125562798|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125562799|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125354831|NCT00559754|450934897|FG000|Overall Study|Protocol Violation|1|||
125354832|NCT00559754|450934897|FG000|Overall Study|Investigator criteria|2|||
125354833|NCT00559754|450934897|FG000|Overall Study|Withdrawal by Subject|2|||
125354834|NCT01068652|450934902|FG000|Overall Study|Adverse Event|4|||
125354835|NCT01068652|450934903|FG001|Overall Study|Adverse Event|0|||
125354836|NCT01068652|450934902|FG000|Overall Study|Lack of Efficacy|0|||
125354837|NCT01068652|450934903|FG001|Overall Study|Lack of Efficacy|2|||
125354838|NCT01068652|450934902|FG000|Overall Study|Lost to Follow-up|2|||
125354839|NCT01068652|450934903|FG001|Overall Study|Lost to Follow-up|1|||
125354840|NCT01068652|450934902|FG000|Overall Study|Protocol Violation|3|||
125354841|NCT01068652|450934903|FG001|Overall Study|Protocol Violation|6|||
125354842|NCT01068652|450934902|FG000|Overall Study|Withdrawal criteria|1|||
125354843|NCT01068652|450934903|FG001|Overall Study|Withdrawal criteria|2|||
125354844|NCT01068652|450934902|FG000|Overall Study|Patient was not eligible|1|||
125354845|NCT01068652|450934903|FG001|Overall Study|Patient was not eligible|0|||
125354846|NCT01068652|450934902|FG000|Overall Study|Unclassified|7|||
125354847|NCT01068652|450934903|FG001|Overall Study|Unclassified|4|||
125354848|NCT00751621|450934904|FG000|Overall Study|Adverse Event|1|||
125354849|NCT00751621|450934904|FG000|Overall Study|Withdrawal by Subject|1|||
125562800|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125354850|NCT00751621|450934904|FG000|Overall Study|Subject moved to another country|1|||
125354851|NCT00751621|450934904|FG000|Overall Study|Poor adherence to asthma treatment|1|||
125354852|NCT03343067|450934905|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
125354853|NCT03343067|450934906|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
125354854|NCT03343067|450934907|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
125354855|NCT01323946|450934908|FG000|Overall Study|Lost to Follow-up|0|||
125354856|NCT01323946|450934909|FG001|Overall Study|Lost to Follow-up|1|||
125354857|NCT01323946|450934910|FG002|Overall Study|Lost to Follow-up|0|||
125354858|NCT01323946|450934908|FG000|Overall Study|Parents refused the last blood draw|1|||
125354859|NCT01323946|450934909|FG001|Overall Study|Parents refused the last blood draw|0|||
125354860|NCT01323946|450934910|FG002|Overall Study|Parents refused the last blood draw|0|||
125354861|NCT01323946|450934908|FG000|Overall Study|Withdrawal by Subject|2|||
125354862|NCT01323946|450934909|FG001|Overall Study|Withdrawal by Subject|2|||
125354863|NCT01323946|450934910|FG002|Overall Study|Withdrawal by Subject|0|||
125354864|NCT01243671|450934911|FG000|Overall Study|Adverse Event|3|||
125354865|NCT01243671|450934911|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
125354866|NCT01243671|450934911|FG000|Overall Study|Other|1|||
125354867|NCT00573248|450934912|FG000|Overall Study|scheduling conflicts|15|||
125354868|NCT00573248|450934913|FG001|Overall Study|scheduling conflicts|11|||
125354869|NCT05323656|450934918|FG000|Overall Study|Still On-Treatment|6|||
125354870|NCT05323656|450934919|FG001|Overall Study|Still On-Treatment|6|||
125354871|NCT05323656|450934918|FG000|Overall Study|Progressive Disease|15|||
125354872|NCT05323656|450934919|FG001|Overall Study|Progressive Disease|14|||
125354873|NCT05323656|450934918|FG000|Overall Study|Adverse Event|2|||
125354874|NCT05323656|450934919|FG001|Overall Study|Adverse Event|3|||
125562801|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125562802|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125562803|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125562804|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125562805|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
125562806|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125562807|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125562808|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125562809|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125562810|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
125562811|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125562812|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125562813|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125562814|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
125562815|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125562816|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125562817|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125562818|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125562819|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125562820|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125354875|NCT05323656|450934918|FG000|Overall Study|Death|1|||
125354876|NCT05323656|450934919|FG001|Overall Study|Death|2|||
125354877|NCT05323656|450934918|FG000|Overall Study|Withdrawal by Subject|1|||
125354878|NCT05323656|450934919|FG001|Overall Study|Withdrawal by Subject|0|||
125562821|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125354879|NCT05323656|450934918|FG000|Overall Study|Clinical disease progression|0|||
125354880|NCT05323656|450934919|FG001|Overall Study|Clinical disease progression|1|||
125562822|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125562823|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125562824|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
125562825|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125562826|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125562827|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125562828|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125562829|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125562830|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125562831|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125562832|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
125562833|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
125562834|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125562835|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125562836|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125562837|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125562838|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
125562839|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125562840|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125562841|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125562842|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125562843|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125562844|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125562845|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125562846|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
125562847|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125562848|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125562849|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125562850|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125562851|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125562852|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
125562853|NCT04033445|451690805|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125562854|NCT04033445|451690806|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125562855|NCT04033445|451690807|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125562856|NCT04033445|451690808|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125562857|NCT04033445|451690809|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125562858|NCT04033445|451690810|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125562859|NCT04033445|451690811|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125562860|NCT04033445|451690812|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
125562861|NCT04033445|451690813|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125562862|NCT04033445|451690814|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125562863|NCT04033445|451690815|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125562864|NCT04033445|451690816|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125562865|NCT04033445|451690817|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125562866|NCT04033445|451690818|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
125562867|NCT04033445|451690805|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125562868|NCT04033445|451690806|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125562869|NCT04033445|451690807|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125562870|NCT04033445|451690808|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125562871|NCT04033445|451690809|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125562872|NCT04033445|451690810|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125562873|NCT04033445|451690811|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125562874|NCT04033445|451690812|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125562875|NCT04033445|451690813|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
125562876|NCT04033445|451690814|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
125562877|NCT04033445|451690815|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
125562878|NCT04033445|451690816|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
125562879|NCT04033445|451690817|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
125562880|NCT04033445|451690818|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
125562881|NCT04033445|451690805|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125562882|NCT04033445|451690806|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125562883|NCT04033445|451690807|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125562884|NCT04033445|451690808|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125562885|NCT04033445|451690809|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125562886|NCT04033445|451690810|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125562887|NCT04033445|451690811|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125562888|NCT04033445|451690812|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125562889|NCT04033445|451690813|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
125562890|NCT04033445|451690814|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
125562891|NCT04033445|451690815|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
125562892|NCT04033445|451690816|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
125562893|NCT04033445|451690817|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
125562894|NCT04033445|451690818|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
125562895|NCT04033445|451690805|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125562896|NCT04033445|451690806|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125562897|NCT04033445|451690807|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125562898|NCT04033445|451690808|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125562899|NCT04033445|451690809|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125562900|NCT04033445|451690810|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125562901|NCT04033445|451690811|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125562902|NCT04033445|451690812|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125562903|NCT04033445|451690813|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125562904|NCT04033445|451690814|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125562905|NCT04033445|451690815|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
125562906|NCT04033445|451690816|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
125562907|NCT04033445|451690817|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
125562908|NCT04033445|451690818|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
125562909|NCT04033445|451690805|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125562910|NCT04033445|451690806|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125562911|NCT04033445|451690807|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125562912|NCT04033445|451690808|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125562913|NCT04033445|451690809|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125562914|NCT04033445|451690810|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125562915|NCT04033445|451690811|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125562916|NCT04033445|451690812|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125562917|NCT04033445|451690813|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125562918|NCT04033445|451690814|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
125562919|NCT04033445|451690815|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
125562920|NCT04033445|451690816|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
125562921|NCT04033445|451690817|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
125562922|NCT04033445|451690818|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
125562923|NCT04033445|451690805|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125562924|NCT04033445|451690806|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125562925|NCT04033445|451690807|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125562926|NCT04033445|451690808|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125562927|NCT04033445|451690809|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125562928|NCT04033445|451690810|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125562929|NCT04033445|451690811|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125562930|NCT04033445|451690812|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125562931|NCT04033445|451690813|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
125562932|NCT04033445|451690814|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
125562933|NCT04033445|451690815|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
125562934|NCT04033445|451690816|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
125562935|NCT04033445|451690817|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
125562936|NCT04033445|451690818|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
125562937|NCT04033445|451690805|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125562938|NCT04033445|451690806|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125562939|NCT04033445|451690807|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125562940|NCT04033445|451690808|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125562941|NCT04033445|451690809|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125562942|NCT04033445|451690810|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125562943|NCT04033445|451690811|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125562944|NCT04033445|451690812|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125562945|NCT04033445|451690813|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125354881|NCT05323656|450934918|FG000|Overall Study|Patient and Investigator decision|1|||
125354882|NCT05323656|450934919|FG001|Overall Study|Patient and Investigator decision|0|||
125354883|NCT05323656|450934918|FG000|Overall Study|Physician Decision|0|||
125354884|NCT05323656|450934919|FG001|Overall Study|Physician Decision|1|||
125354885|NCT03309046|450934922|FG000|Overall Study|Withdrawal by Subject|4|||
125354886|NCT03309046|450934923|FG001|Overall Study|Withdrawal by Subject|17|||
125354887|NCT03963401|450934924|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
125354888|NCT03963401|450934925|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
125354889|NCT03963401|450934926|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
125354890|NCT03963401|450934927|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
125354891|NCT03963401|450934928|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
125354892|NCT03963401|450934929|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
125354893|NCT03963401|450934924|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
125354894|NCT03963401|450934925|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
125354895|NCT03963401|450934926|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
125354896|NCT03963401|450934927|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
125354897|NCT03963401|450934928|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
125354898|NCT03963401|450934929|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
125354899|NCT03963401|450934924|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
125354900|NCT03963401|450934925|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
125562946|NCT04033445|451690814|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125562947|NCT04033445|451690815|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125562948|NCT04033445|451690816|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125562949|NCT04033445|451690817|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
125562950|NCT04033445|451690818|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
125562951|NCT04033445|451690805|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
125562952|NCT04033445|451690806|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
125562953|NCT04033445|451690807|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
125562954|NCT04033445|451690808|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
125562955|NCT04033445|451690809|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
125562956|NCT04033445|451690810|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
125562957|NCT04033445|451690811|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
125562958|NCT04033445|451690812|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
125562959|NCT04033445|451690813|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
125562960|NCT04033445|451690814|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
125562961|NCT04033445|451690815|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
125562962|NCT04033445|451690816|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
125562963|NCT04033445|451690817|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
125562964|NCT04033445|451690818|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
125562965|NCT04033445|451690805|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125562966|NCT04033445|451690806|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125562967|NCT04033445|451690807|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125562968|NCT04033445|451690808|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125562969|NCT04033445|451690809|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125562970|NCT04033445|451690810|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125354901|NCT03963401|450934926|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
125354902|NCT03963401|450934927|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
125354903|NCT03963401|450934928|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
125354904|NCT03963401|450934929|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
125354905|NCT03963401|450934924|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
125426299|NCT01936857|451184474|FG000|Overall Study|Sent to prison or 06 center|11|||
125426300|NCT01936857|451184475|FG001|Overall Study|Sent to prison or 06 center|12|||
125426301|NCT01936857|451184474|FG000|Overall Study|Lost to Follow-up|10|||
125426302|NCT01936857|451184475|FG001|Overall Study|Lost to Follow-up|7|||
125426303|NCT01936857|451184474|FG000|Overall Study|Death|7|||
125562971|NCT04033445|451690811|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125562972|NCT04033445|451690812|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125562973|NCT04033445|451690813|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125426304|NCT01936857|451184475|FG001|Overall Study|Death|3|||
125562974|NCT04033445|451690814|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
125562975|NCT04033445|451690815|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125562976|NCT04033445|451690816|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
125562977|NCT04033445|451690817|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
125562978|NCT04033445|451690818|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
125562979|NCT04754802|451690824|FG000|Overall Study|Lost to Follow-up|0|||
125562980|NCT04754802|451690825|FG001|Overall Study|Lost to Follow-up|2|||
125562981|NCT04754802|451690824|FG000|Overall Study|Withdrawal by Subject|2|||
125562982|NCT04754802|451690825|FG001|Overall Study|Withdrawal by Subject|0|||
125562983|NCT04451161|451690826|FG000|Overall Study|Lost to Follow-up|28|||
125562984|NCT04451161|451690827|FG001|Overall Study|Lost to Follow-up|37|||
125562985|NCT04451161|451690828|FG002|Overall Study|Lost to Follow-up|22|||
125562986|NCT04451161|451690829|FG003|Overall Study|Lost to Follow-up|13|||
125562987|NCT04451161|451690830|FG004|Overall Study|Lost to Follow-up|11|||
125562988|NCT04451161|451690831|FG005|Overall Study|Lost to Follow-up|14|||
125562989|NCT04451161|451690826|FG000|Overall Study|Withdrawal by Subject|3|||
125562990|NCT04451161|451690827|FG001|Overall Study|Withdrawal by Subject|0|||
125562991|NCT04451161|451690828|FG002|Overall Study|Withdrawal by Subject|0|||
125562992|NCT04451161|451690829|FG003|Overall Study|Withdrawal by Subject|0|||
125562993|NCT04451161|451690830|FG004|Overall Study|Withdrawal by Subject|2|||
125562994|NCT04451161|451690831|FG005|Overall Study|Withdrawal by Subject|4|||
125562995|NCT05525689|451690832|FG000|Overall Study|Lost to Follow-up|1|||
125562996|NCT05525689|451690833|FG001|Overall Study|Lost to Follow-up|0|||
125562997|NCT01671111|451690834|FG000|Overall Study|Adverse Event|2|||
125562998|NCT01671111|451690834|FG000|Overall Study|Lack of Efficacy|1|||
125562999|NCT01671111|451690834|FG000|Overall Study|Withdrawal by Subject|2|||
125563000|NCT01671111|451690834|FG000|Overall Study|Physician Decision|1|||
125563001|NCT01671111|451690834|FG000|Overall Study|Other|24|||
125563002|NCT03680911|451690835|FG000|At Home Treatment|Study Termination|3|||
125563003|NCT03680911|451690836|FG001|At Home Treatment|Study Termination|0|||
125563004|NCT03680911|451690835|FG000|At Home Treatment|Lost to Follow-up|0|||
125563005|NCT03680911|451690836|FG001|At Home Treatment|Lost to Follow-up|1|||
125563006|NCT03680911|451690835|FG000|At Home Treatment|Withdrawal by Subject|0|||
125563007|NCT03680911|451690836|FG001|At Home Treatment|Withdrawal by Subject|2|||
125563008|NCT03680911|451690835|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
125563009|NCT03680911|451690836|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
125563010|NCT00898443|451690839|FG000|Overall Study|Withdrawal by Subject|1|||
125563011|NCT00898443|451690840|FG001|Overall Study|Withdrawal by Subject|0|||
125563012|NCT04695392|451690841|FG000|Overall Study|Withdrawn by parent/guardian|0|||
125563013|NCT04695392|451690842|FG001|Overall Study|Withdrawn by parent/guardian|1|||
125563014|NCT04695392|451690841|FG000|Overall Study|Withdrawn by physician|0|||
125563015|NCT04695392|451690842|FG001|Overall Study|Withdrawn by physician|1|||
125563016|NCT04702737|451690849|FG000|Overall Study|Decision by Sponsor|1|||
125563017|NCT04702737|451690849|FG000|Overall Study|Withdrawal of Consent from Study|3|||
125563018|NCT04702737|451690849|FG000|Overall Study|Lost to Follow-up|1|||
125563019|NCT04702737|451690849|FG000|Overall Study|Death|35|||
125563020|NCT02811549|451690850|FG000|Overall Study|Lost to Follow-up|1|||
125563021|NCT02811549|451690850|FG000|Overall Study|Withdrawal by Subject|3|||
125563022|NCT02811549|451690850|FG000|Overall Study|Subject screen failed|4|||
125563023|NCT02811549|451690850|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
125563024|NCT03472924|451690852|FG000|Overall Study|Adverse Event|1|||
125563025|NCT03472924|451690853|FG001|Overall Study|Adverse Event|0|||
125563026|NCT00427349|451690854|FG000|Overall Study|Lack of Efficacy|23|||
125563027|NCT00427349|451690854|FG000|Overall Study|Adverse Event|14|||
125563028|NCT00427349|451690854|FG000|Overall Study|Death|1|||
125563029|NCT00427349|451690854|FG000|Overall Study|Withdrawal by Subject|3|||
125563030|NCT00427349|451690854|FG000|Overall Study|Alternative therapy|1|||
125563031|NCT00427349|451690854|FG000|Overall Study|Other|2|||
125563032|NCT00427349|451690854|FG000|Overall Study|Ineligible|1|||
125563033|NCT00427349|451690854|FG000|Overall Study|Never started therapy|1|||
125563034|NCT00698997|451690857|FG000|Overall Study|Lost to Follow-up|3|||
125354906|NCT03963401|450934925|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
125354907|NCT03963401|450934926|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
125354908|NCT03963401|450934927|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
125563035|NCT00698997|451690858|FG001|Overall Study|Lost to Follow-up|0|||
125563036|NCT00698997|451690857|FG000|Overall Study|Withdrawal by Subject|7|||
125563037|NCT00698997|451690858|FG001|Overall Study|Withdrawal by Subject|27|||
125563038|NCT05082376|451690861|FG000|Overall Study|Lost to Follow-up|2|||
125563039|NCT01436084|451690862|FG000|Overall Study|Disease Progression|2|||
125563040|NCT01436084|451690862|FG000|Overall Study|Withdrawal by Subject|1|||
125563041|NCT01436084|451690862|FG000|Overall Study|Early Closure of Study|1|||
125563042|NCT04425720|451690868|FG000|Overall Study|Withdrawal by Subject|0|||
125563043|NCT04425720|451690869|FG001|Overall Study|Withdrawal by Subject|20|||
125563044|NCT00290186|451690870|FG000|Overall Study|Adverse Event|1|||
125563045|NCT00290186|451690871|FG001|Overall Study|Adverse Event|1|||
125563046|NCT00290186|451690870|FG000|Overall Study|Lost to Follow-up|3|||
125563047|NCT00290186|451690871|FG001|Overall Study|Lost to Follow-up|2|||
125563048|NCT00290186|451690870|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
125563049|NCT00290186|451690871|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
125563050|NCT00290186|451690870|FG000|Overall Study|Withdrawal by Subject|0|||
125563051|NCT00290186|451690871|FG001|Overall Study|Withdrawal by Subject|1|||
125563052|NCT00445224|451690872|FG000|Specific Exercises|Withdrawal by Subject|3|||
125563053|NCT00445224|451690873|FG001|Specific Exercises|Withdrawal by Subject|3|||
125563054|NCT00445224|451690872|FG000|Specific Exercises|Withdrawal by Subject|1|||
125563055|NCT00445224|451690873|FG001|Specific Exercises|Withdrawal by Subject|0|||
125563056|NCT00262522|451690883|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
125563057|NCT00262522|451690884|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
125563058|NCT00262522|451690885|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
125563059|NCT00262522|451690886|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
125563060|NCT00262522|451690883|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
125563061|NCT00262522|451690884|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
125563062|NCT00262522|451690885|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
125563063|NCT00262522|451690886|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
125563064|NCT00262522|451690883|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
125563065|NCT00262522|451690884|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
125354909|NCT03963401|450934928|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
125354910|NCT03963401|450934929|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
125354911|NCT03963401|450934924|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
125563066|NCT00262522|451690885|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
125563067|NCT00262522|451690886|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
125563068|NCT00262522|451690883|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
125563069|NCT00262522|451690884|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
125563070|NCT00262522|451690885|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
125563071|NCT00262522|451690886|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
125563072|NCT00262522|451690883|FG000|Study Start Through 8 Weeks|Death|1|||
125563073|NCT00262522|451690884|FG001|Study Start Through 8 Weeks|Death|0|||
125563074|NCT00262522|451690885|FG002|Study Start Through 8 Weeks|Death|0|||
125563075|NCT00262522|451690886|FG003|Study Start Through 8 Weeks|Death|0|||
125354912|NCT03963401|450934925|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
125354913|NCT03963401|450934926|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
125354914|NCT03963401|450934927|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
125354915|NCT03963401|450934928|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
125354916|NCT03963401|450934929|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
125354917|NCT03963401|450934924|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
125354918|NCT03963401|450934925|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
125354919|NCT03963401|450934926|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
125354920|NCT03963401|450934927|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
125354921|NCT03963401|450934928|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
125354922|NCT03963401|450934929|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
125354923|NCT03963401|450934924|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
125354924|NCT03963401|450934925|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
125354925|NCT03963401|450934926|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
125354926|NCT03963401|450934927|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
125354927|NCT03963401|450934928|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
125354928|NCT03963401|450934929|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
125354929|NCT03963401|450934924|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
125378927|NCT00531050|451019208|FG000|Part 1: Period 1|Protocol Deviation|0|||
125563076|NCT00262522|451690883|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
125354930|NCT03963401|450934925|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
125354931|NCT03963401|450934926|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
125354932|NCT03963401|450934927|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
125354933|NCT03963401|450934928|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
125354934|NCT03963401|450934929|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
125354935|NCT03963401|450934924|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
125354936|NCT03963401|450934925|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
125354937|NCT03963401|450934926|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
125354938|NCT03963401|450934927|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
125354939|NCT03963401|450934928|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
125354940|NCT03963401|450934929|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
125354941|NCT03963401|450934924|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
125354942|NCT03963401|450934925|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
125354943|NCT03963401|450934926|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
125354944|NCT03963401|450934927|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
125354945|NCT03963401|450934928|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
125354946|NCT03963401|450934929|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
125354947|NCT03963401|450934924|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
125354948|NCT03963401|450934925|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
125354949|NCT03963401|450934926|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
125354950|NCT03963401|450934927|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
125354951|NCT03963401|450934928|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
125354952|NCT03963401|450934929|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
125354953|NCT00910988|450934932|FG000|Overall Study|Lost to Follow-up|2|||
125354954|NCT00910988|450934933|FG001|Overall Study|Lost to Follow-up|4|||
125354955|NCT00910988|450934934|FG002|Overall Study|Lost to Follow-up|3|||
125354956|NCT00910988|450934935|FG003|Overall Study|Lost to Follow-up|0|||
125354957|NCT03004443|450934936|FG000|Overall Study|Pregnancy|0|||
125354958|NCT03004443|450934937|FG001|Overall Study|Pregnancy|1|||
125354959|NCT00828854|450934938|FG000|Overall Study|Disease Progression|17|||
125354960|NCT00828854|450934938|FG000|Overall Study|Adverse Event|9|||
125354961|NCT00828854|450934938|FG000|Overall Study|Reason not Specified|1|||
125354962|NCT03911843|450934939|FG000|Overall Study|Adverse Event|2|||
125354963|NCT03911843|450934940|FG001|Overall Study|Adverse Event|0|||
125354964|NCT03911843|450934939|FG000|Overall Study|Protocol Violation|2|||
125354965|NCT03911843|450934940|FG001|Overall Study|Protocol Violation|0|||
125354966|NCT03911843|450934939|FG000|Overall Study|Lost to Follow-up|0|||
125354967|NCT03911843|450934940|FG001|Overall Study|Lost to Follow-up|1|||
125354968|NCT01907100|450934941|FG000|Overall Study|PD based on modified RECIST criteria|31|||
125354969|NCT01907100|450934942|FG001|Overall Study|PD based on modified RECIST criteria|32|||
125354970|NCT01907100|450934943|FG002|Overall Study|PD based on modified RECIST criteria|95|||
125354971|NCT01907100|450934944|FG003|Overall Study|PD based on modified RECIST criteria|92|||
125354972|NCT01907100|450934941|FG000|Overall Study|Withdrawal by Subject|2|||
125563077|NCT00262522|451690884|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
125563078|NCT00262522|451690885|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
125563079|NCT00262522|451690886|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
125563080|NCT00262522|451690883|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
125563081|NCT00262522|451690884|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
125563082|NCT00262522|451690885|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
125563083|NCT00262522|451690886|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
125563084|NCT00262522|451690883|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
125563085|NCT00262522|451690884|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
125563086|NCT00262522|451690885|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
125563087|NCT00262522|451690886|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
125354973|NCT01907100|450934942|FG001|Overall Study|Withdrawal by Subject|5|||
125354974|NCT01907100|450934943|FG002|Overall Study|Withdrawal by Subject|10|||
125354975|NCT01907100|450934944|FG003|Overall Study|Withdrawal by Subject|13|||
125354976|NCT01907100|450934941|FG000|Overall Study|Protocol Violation|0|||
125354977|NCT01907100|450934942|FG001|Overall Study|Protocol Violation|0|||
125563088|NCT00262522|451690883|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
125563089|NCT00262522|451690884|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
125563090|NCT00262522|451690885|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
125563091|NCT00262522|451690886|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
125563092|NCT00262522|451690883|FG000|Study Start Through 48 Weeks|Death|2|||
125563093|NCT00262522|451690884|FG001|Study Start Through 48 Weeks|Death|0|||
125563094|NCT00262522|451690885|FG002|Study Start Through 48 Weeks|Death|1|||
125563095|NCT00262522|451690886|FG003|Study Start Through 48 Weeks|Death|0|||
125563096|NCT00262522|451690883|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
125563097|NCT00262522|451690884|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
125563098|NCT00262522|451690885|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
125563099|NCT00262522|451690886|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
125563100|NCT00262522|451690883|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
125563101|NCT00262522|451690884|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
125563102|NCT00262522|451690885|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
125563103|NCT00262522|451690886|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
125563104|NCT00262522|451690883|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
125563105|NCT00262522|451690884|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
125563106|NCT00262522|451690885|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
125563107|NCT00262522|451690886|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
125563108|NCT00262522|451690883|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
125563109|NCT00262522|451690884|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
125563110|NCT00262522|451690885|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
125563111|NCT00262522|451690886|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
125563112|NCT00262522|451690883|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
125563113|NCT00262522|451690884|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
125563114|NCT00262522|451690885|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
125563115|NCT00262522|451690886|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
125563116|NCT00262522|451690883|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
125563117|NCT00262522|451690884|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
125563118|NCT00262522|451690885|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
125563119|NCT00262522|451690886|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
125563120|NCT00262522|451690883|FG000|Study Start Through 96 Weeks|Death|2|||
125563121|NCT00262522|451690884|FG001|Study Start Through 96 Weeks|Death|0|||
125563122|NCT00262522|451690885|FG002|Study Start Through 96 Weeks|Death|2|||
125563123|NCT00262522|451690886|FG003|Study Start Through 96 Weeks|Death|0|||
125563124|NCT00262522|451690883|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
125563125|NCT00262522|451690884|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
125563126|NCT00262522|451690885|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
125563127|NCT00262522|451690886|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
125563128|NCT00262522|451690883|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
125563129|NCT00262522|451690884|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
125563130|NCT00262522|451690885|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
125563131|NCT00262522|451690886|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
125563132|NCT03159091|451690887|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
125563133|NCT03159091|451690888|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
125563134|NCT03159091|451690887|FG000|Overall Study|Patient has taken no dose of study drug|0|||
125563135|NCT03159091|451690888|FG001|Overall Study|Patient has taken no dose of study drug|1|||
125563136|NCT04814823|451690889|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
125563137|NCT04085523|451690890|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
125563138|NCT04085523|451690891|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
125563139|NCT04085523|451690892|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
125563140|NCT04085523|451690893|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
125563141|NCT04085523|451690894|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
125563142|NCT04085523|451690895|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
125563143|NCT01877915|451690898|FG000|Overall Study|Lost to Follow-up|10|||
125563144|NCT01877915|451690899|FG001|Overall Study|Lost to Follow-up|9|||
125563145|NCT01877915|451690898|FG000|Overall Study|Withdrawal by Subject|42|||
125563146|NCT01877915|451690899|FG001|Overall Study|Withdrawal by Subject|55|||
125563147|NCT01877915|451690898|FG000|Overall Study|Other|2|||
125563148|NCT01877915|451690899|FG001|Overall Study|Other|4|||
125563149|NCT00943579|451690900|FG000|Overall Study|Adverse Event|4|||
125563150|NCT00943579|451690901|FG001|Overall Study|Adverse Event|3|||
125563151|NCT00943579|451690900|FG000|Overall Study|Lack of Efficacy|2|||
125563152|NCT00943579|451690901|FG001|Overall Study|Lack of Efficacy|2|||
125563153|NCT03977974|451690904|FG000|Period 2|Adverse Event|0|||
125563154|NCT03977974|451690905|FG001|Period 2|Adverse Event|0|||
125563155|NCT03977974|451690906|FG002|Period 2|Adverse Event|0|||
125563156|NCT03977974|451690907|FG003|Period 2|Adverse Event|0|||
125563157|NCT03977974|451690908|FG004|Period 2|Adverse Event|1|||
125563158|NCT03977974|451690909|FG005|Period 2|Adverse Event|0|||
125563159|NCT03977974|451690910|FG006|Period 2|Adverse Event|0|||
125563160|NCT03977974|451690911|FG007|Period 2|Adverse Event|0|||
125563161|NCT03977974|451690912|FG008|Period 2|Adverse Event|0|||
125563162|NCT03977974|451690913|FG009|Period 2|Adverse Event|0|||
125563163|NCT03977974|451690914|FG010|Period 2|Adverse Event|0|||
125563164|NCT03977974|451690915|FG011|Period 2|Adverse Event|0|||
125563165|NCT03977974|451690916|FG012|Period 2|Adverse Event|0|||
125563166|NCT03697720|451691665|FG000|Overall Study|Lost to Follow-up|7|||
125563167|NCT01502709|451691671|FG000|Overall Study|Lost to Follow-up|4|||
125563168|NCT01502709|451691672|FG001|Overall Study|Lost to Follow-up|0|||
125563169|NCT03281668|451691675|FG000|Overall Study|Physician Decision|1|||
125563170|NCT03281668|451691675|FG000|Overall Study|scheduling conflict, family circumstance|2|||
125563171|NCT03281668|451691675|FG000|Overall Study|Withdrawal by Subject|4|||
125563172|NCT03281668|451691675|FG000|Overall Study|Lost to Follow-up|1|||
125563173|NCT05500274|451691681|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
125563174|NCT05500274|451691682|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
125563175|NCT05500274|451691681|FG000|Overall Study|Lost to Follow-up|76|||
125563176|NCT05500274|451691682|FG001|Overall Study|Lost to Follow-up|51|||
125563177|NCT05807464|451691683|FG000|Overall Study|Adverse Event|1|||
125563178|NCT01555151|451691684|FG000|Overall Study|Withdrawal by Subject|6|||
125563179|NCT01555151|451691685|FG001|Overall Study|Withdrawal by Subject|2|||
125563180|NCT01555151|451691686|FG002|Overall Study|Withdrawal by Subject|0|||
125563181|NCT01555151|451691687|FG003|Overall Study|Withdrawal by Subject|2|||
125563182|NCT01555151|451691684|FG000|Overall Study|Administrative|3|||
125563183|NCT01555151|451691685|FG001|Overall Study|Administrative|1|||
125354978|NCT01907100|450934943|FG002|Overall Study|Protocol Violation|1|||
125563184|NCT01555151|451691686|FG002|Overall Study|Administrative|2|||
125563185|NCT01555151|451691687|FG003|Overall Study|Administrative|0|||
125563186|NCT01555151|451691684|FG000|Overall Study|Protocol Violation|3|||
125563187|NCT01555151|451691685|FG001|Overall Study|Protocol Violation|3|||
125563188|NCT01555151|451691686|FG002|Overall Study|Protocol Violation|3|||
125563189|NCT01555151|451691687|FG003|Overall Study|Protocol Violation|5|||
125563190|NCT01555151|451691684|FG000|Overall Study|Adverse Event|1|||
125563191|NCT01555151|451691685|FG001|Overall Study|Adverse Event|2|||
125563192|NCT01555151|451691686|FG002|Overall Study|Adverse Event|1|||
125563193|NCT01555151|451691687|FG003|Overall Study|Adverse Event|2|||
125563194|NCT01555151|451691684|FG000|Overall Study|Lost to Follow-up|0|||
125563195|NCT01555151|451691685|FG001|Overall Study|Lost to Follow-up|0|||
125563196|NCT01555151|451691686|FG002|Overall Study|Lost to Follow-up|0|||
125563197|NCT01555151|451691687|FG003|Overall Study|Lost to Follow-up|1|||
125563198|NCT03596866|451691688|FG000|Overall Study|Site terminated by Sponsor|64|||
125354979|NCT01907100|450934944|FG003|Overall Study|Protocol Violation|1|||
125354980|NCT01907100|450934941|FG000|Overall Study|Lost to Follow-up|0|||
125354981|NCT01907100|450934942|FG001|Overall Study|Lost to Follow-up|0|||
125563199|NCT03596866|451691689|FG001|Overall Study|Site terminated by Sponsor|65|||
125354982|NCT01907100|450934943|FG002|Overall Study|Lost to Follow-up|0|||
125354983|NCT01907100|450934944|FG003|Overall Study|Lost to Follow-up|1|||
125354984|NCT01907100|450934941|FG000|Overall Study|Not treated|2|||
125354985|NCT01907100|450934942|FG001|Overall Study|Not treated|0|||
125563200|NCT03596866|451691688|FG000|Overall Study|Death|37|||
125563201|NCT03596866|451691689|FG001|Overall Study|Death|24|||
125563202|NCT03596866|451691688|FG000|Overall Study|Withdrawal by Subject|4|||
125563203|NCT03596866|451691689|FG001|Overall Study|Withdrawal by Subject|6|||
125563204|NCT03596866|451691688|FG000|Overall Study|Missing|0|||
125563205|NCT03596866|451691689|FG001|Overall Study|Missing|6|||
125563206|NCT03596866|451691688|FG000|Overall Study|Lost to Follow-up|2|||
125563207|NCT03596866|451691689|FG001|Overall Study|Lost to Follow-up|3|||
125563208|NCT03596866|451691688|FG000|Overall Study|Protocol Violation|1|||
125563209|NCT03596866|451691689|FG001|Overall Study|Protocol Violation|0|||
125563210|NCT03596866|451691688|FG000|Overall Study|Reason Not Specified|14|||
125563211|NCT03596866|451691689|FG001|Overall Study|Reason Not Specified|13|||
125563212|NCT03740165|451691692|FG000|Overall Study|Death|232|||
125563213|NCT03740165|451691693|FG001|Overall Study|Death|242|||
125563214|NCT03740165|451691694|FG002|Overall Study|Death|229|||
125563215|NCT03740165|451691692|FG000|Overall Study|Lost to Follow-up|0|||
125563216|NCT03740165|451691693|FG001|Overall Study|Lost to Follow-up|0|||
125563217|NCT03740165|451691694|FG002|Overall Study|Lost to Follow-up|1|||
125563218|NCT03740165|451691692|FG000|Overall Study|Withdrawal by Subject|7|||
125563219|NCT03740165|451691693|FG001|Overall Study|Withdrawal by Subject|4|||
125563220|NCT03740165|451691694|FG002|Overall Study|Withdrawal by Subject|3|||
125563221|NCT03740165|451691692|FG000|Overall Study|Ongoing in Study|216|||
125563222|NCT03740165|451691693|FG001|Overall Study|Ongoing in Study|212|||
125563223|NCT03740165|451691694|FG002|Overall Study|Ongoing in Study|221|||
125563224|NCT02044133|451691695|FG000|Overall Study|Lost to Follow-up|1|||
125563225|NCT02044133|451691696|FG001|Overall Study|Lost to Follow-up|1|||
125563226|NCT02044133|451691695|FG000|Overall Study|Death|1|||
125563227|NCT02044133|451691696|FG001|Overall Study|Death|0|||
125563228|NCT02044133|451691695|FG000|Overall Study|Release|3|||
125563229|NCT02044133|451691696|FG001|Overall Study|Release|4|||
125563230|NCT02044133|451691695|FG000|Overall Study|Transfer|1|||
125563231|NCT02044133|451691696|FG001|Overall Study|Transfer|0|||
125563232|NCT02044133|451691695|FG000|Overall Study|refusal of blood sampling|0|||
125563233|NCT02044133|451691696|FG001|Overall Study|refusal of blood sampling|1|||
125563234|NCT05318937|451691697|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125563235|NCT05318937|451691698|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125563236|NCT05318937|451691697|FG000|Overall Study|Lost to Follow-up|0|||
125563237|NCT05318937|451691698|FG001|Overall Study|Lost to Follow-up|1|||
125563238|NCT05318937|451691697|FG000|Overall Study|Withdrawal by Subject|0|||
125563239|NCT05318937|451691698|FG001|Overall Study|Withdrawal by Subject|2|||
125563240|NCT05318937|451691697|FG000|Overall Study|Protocol Violation|0|||
125563241|NCT05318937|451691698|FG001|Overall Study|Protocol Violation|1|||
125563242|NCT05678257|451691706|FG000|Overall Study|Withdrawal by Subject|2|||
125563243|NCT05678257|451691707|FG001|Overall Study|Withdrawal by Subject|0|||
125563244|NCT05678257|451691708|FG002|Overall Study|Withdrawal by Subject|5|||
125563245|NCT05678257|451691706|FG000|Overall Study|Physician Decision|1|||
125563246|NCT05678257|451691707|FG001|Overall Study|Physician Decision|0|||
125563247|NCT05678257|451691708|FG002|Overall Study|Physician Decision|1|||
125563248|NCT05678257|451691706|FG000|Overall Study|Adverse Event|1|||
125563249|NCT05678257|451691707|FG001|Overall Study|Adverse Event|3|||
125563250|NCT05678257|451691708|FG002|Overall Study|Adverse Event|1|||
125563251|NCT05678257|451691706|FG000|Overall Study|Progressive disease|11|||
125563252|NCT05678257|451691707|FG001|Overall Study|Progressive disease|18|||
125563253|NCT05678257|451691708|FG002|Overall Study|Progressive disease|7|||
125563254|NCT05678257|451691706|FG000|Overall Study|No longer clinically benefitting|2|||
125563255|NCT05678257|451691707|FG001|Overall Study|No longer clinically benefitting|1|||
125563256|NCT05678257|451691708|FG002|Overall Study|No longer clinically benefitting|0|||
125563257|NCT05678257|451691706|FG000|Overall Study|Sponsor decision|5|||
125563258|NCT05678257|451691707|FG001|Overall Study|Sponsor decision|9|||
125563259|NCT05678257|451691708|FG002|Overall Study|Sponsor decision|8|||
125563260|NCT05678257|451691706|FG000|Overall Study|Protocol Violation|0|||
125563261|NCT05678257|451691707|FG001|Overall Study|Protocol Violation|0|||
125563262|NCT05678257|451691708|FG002|Overall Study|Protocol Violation|1|||
125563263|NCT05678257|451691706|FG000|Overall Study|Patient non-compliance|0|||
125563264|NCT05678257|451691707|FG001|Overall Study|Patient non-compliance|0|||
125563265|NCT05678257|451691708|FG002|Overall Study|Patient non-compliance|3|||
125563266|NCT05314517|451691709|FG000|Double-blind Period|Adverse Event|4|||
125563267|NCT05314517|451691710|FG001|Double-blind Period|Adverse Event|0|||
125563268|NCT05314517|451691711|FG002|Double-blind Period|Adverse Event|0|||
125563269|NCT05314517|451691712|FG003|Double-blind Period|Adverse Event|0|||
125563270|NCT05314517|451691709|FG000|Double-blind Period|Noncompliance|0|||
125563271|NCT05314517|451691710|FG001|Double-blind Period|Noncompliance|1|||
125563272|NCT05314517|451691711|FG002|Double-blind Period|Noncompliance|0|||
125563273|NCT05314517|451691712|FG003|Double-blind Period|Noncompliance|0|||
125563274|NCT05314517|451691709|FG000|Double-blind Period|Randomized, not treated|1|||
125354986|NCT01907100|450934943|FG002|Overall Study|Not treated|1|||
125354987|NCT01907100|450934944|FG003|Overall Study|Not treated|2|||
125354988|NCT01907100|450934941|FG000|Overall Study|Other than reasons specified|1|||
125563275|NCT05314517|451691710|FG001|Double-blind Period|Randomized, not treated|0|||
125563276|NCT05314517|451691711|FG002|Double-blind Period|Randomized, not treated|0|||
125563277|NCT05314517|451691712|FG003|Double-blind Period|Randomized, not treated|0|||
125563278|NCT05314517|451691709|FG000|Open-label Extension|Adverse Event|0|||
125563279|NCT05314517|451691710|FG001|Open-label Extension|Adverse Event|0|||
125563280|NCT05314517|451691711|FG002|Open-label Extension|Adverse Event|1|||
125563281|NCT05314517|451691712|FG003|Open-label Extension|Adverse Event|2|||
125563282|NCT05314517|451691709|FG000|Open-label Extension|Investigator decision|0|||
125563283|NCT05314517|451691710|FG001|Open-label Extension|Investigator decision|0|||
125563284|NCT05314517|451691711|FG002|Open-label Extension|Investigator decision|1|||
125563285|NCT05314517|451691712|FG003|Open-label Extension|Investigator decision|0|||
125563286|NCT05314517|451691709|FG000|Open-label Extension|Lost to Follow-up|0|||
125563287|NCT05314517|451691710|FG001|Open-label Extension|Lost to Follow-up|0|||
125563288|NCT05314517|451691711|FG002|Open-label Extension|Lost to Follow-up|0|||
125563289|NCT05314517|451691712|FG003|Open-label Extension|Lost to Follow-up|1|||
125563290|NCT05314517|451691709|FG000|Open-label Extension|Withdrawal by Subject|0|||
125563291|NCT05314517|451691710|FG001|Open-label Extension|Withdrawal by Subject|0|||
125563292|NCT05314517|451691711|FG002|Open-label Extension|Withdrawal by Subject|1|||
125563293|NCT05314517|451691712|FG003|Open-label Extension|Withdrawal by Subject|2|||
125563294|NCT05314517|451691709|FG000|Open-label Extension|Use of prohibited medication|0|||
125563295|NCT05314517|451691710|FG001|Open-label Extension|Use of prohibited medication|0|||
125563296|NCT05314517|451691711|FG002|Open-label Extension|Use of prohibited medication|1|||
125563297|NCT05314517|451691712|FG003|Open-label Extension|Use of prohibited medication|0|||
125563298|NCT05314517|451691709|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
125563299|NCT05314517|451691710|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
125563300|NCT05314517|451691711|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
125563301|NCT05314517|451691712|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
125354989|NCT01907100|450934942|FG001|Overall Study|Other than reasons specified|0|||
125354990|NCT01907100|450934943|FG002|Overall Study|Other than reasons specified|10|||
125563302|NCT04969276|451691713|FG000|Overall Study|Protocol Deviation|0|||
125563303|NCT04969276|451691714|FG001|Overall Study|Protocol Deviation|1|||
125563304|NCT04969276|451691715|FG002|Overall Study|Protocol Deviation|0|||
125563305|NCT04969276|451691713|FG000|Overall Study|Withdrawal by Subject|1|||
125563306|NCT04969276|451691714|FG001|Overall Study|Withdrawal by Subject|10|||
125563307|NCT04969276|451691715|FG002|Overall Study|Withdrawal by Subject|0|||
125563308|NCT04969276|451691713|FG000|Overall Study|Lost to Follow-up|0|||
125563309|NCT04969276|451691714|FG001|Overall Study|Lost to Follow-up|1|||
125563310|NCT04969276|451691715|FG002|Overall Study|Lost to Follow-up|0|||
125563311|NCT04655144|451691719|FG000|Overall Study|Consumed THC|1|||
125563312|NCT04655144|451691720|FG001|Overall Study|Consumed THC|0|||
125563313|NCT04655144|451691719|FG000|Overall Study|Unilateral embolization|0|||
125563314|NCT04655144|451691720|FG001|Overall Study|Unilateral embolization|1|||
125563315|NCT04490018|451691721|FG000|Overall Study|Protocol Violation|0|||
125563316|NCT04490018|451691722|FG001|Overall Study|Protocol Violation|2|||
125563317|NCT04490018|451691723|FG002|Overall Study|Protocol Violation|1|||
125563318|NCT04490018|451691721|FG000|Overall Study|Lost to Follow-up|2|||
125563319|NCT04490018|451691722|FG001|Overall Study|Lost to Follow-up|2|||
125563320|NCT04490018|451691723|FG002|Overall Study|Lost to Follow-up|0|||
125563321|NCT04490018|451691721|FG000|Overall Study|Withdrawal by Subject|2|||
125563322|NCT04490018|451691722|FG001|Overall Study|Withdrawal by Subject|1|||
125563323|NCT04490018|451691723|FG002|Overall Study|Withdrawal by Subject|0|||
125563324|NCT04490018|451691721|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125563325|NCT04490018|451691722|FG001|Overall Study|Withdrawal by parent/guardian|3|||
125563326|NCT04490018|451691723|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125563327|NCT00282295|451691725|FG000|Overall Study|Adverse Event|0|||
125563328|NCT00282295|451691726|FG001|Overall Study|Adverse Event|1|||
125563329|NCT00282295|451691727|FG002|Overall Study|Adverse Event|0|||
125563330|NCT00282295|451691725|FG000|Overall Study|Serious Adverse Events|0|||
125563331|NCT00282295|451691726|FG001|Overall Study|Serious Adverse Events|0|||
125563332|NCT00282295|451691727|FG002|Overall Study|Serious Adverse Events|1|||
125563333|NCT00282295|451691725|FG000|Overall Study|Protocol Violation|0|||
125563334|NCT00282295|451691726|FG001|Overall Study|Protocol Violation|2|||
125563335|NCT00282295|451691727|FG002|Overall Study|Protocol Violation|1|||
125563336|NCT00282295|451691725|FG000|Overall Study|Withdrawal by Subject|2|||
125563337|NCT00282295|451691726|FG001|Overall Study|Withdrawal by Subject|6|||
125563338|NCT00282295|451691727|FG002|Overall Study|Withdrawal by Subject|4|||
125563339|NCT00282295|451691725|FG000|Overall Study|Lost to Follow-up|1|||
125563340|NCT00282295|451691726|FG001|Overall Study|Lost to Follow-up|7|||
125563341|NCT00282295|451691727|FG002|Overall Study|Lost to Follow-up|2|||
125563342|NCT00282295|451691725|FG000|Overall Study|Other|0|||
125563343|NCT00282295|451691726|FG001|Overall Study|Other|1|||
125563344|NCT00282295|451691727|FG002|Overall Study|Other|0|||
125563345|NCT01401842|451691728|FG000|Overall Study|Withdrawal by Subject|3|||
125563346|NCT01401842|451691729|FG001|Overall Study|Withdrawal by Subject|2|||
125563347|NCT01401842|451691728|FG000|Overall Study|academic reason|4|||
125563348|NCT01401842|451691729|FG001|Overall Study|academic reason|1|||
125563349|NCT01401842|451691728|FG000|Overall Study|changed companies|20|||
125563350|NCT01401842|451691729|FG001|Overall Study|changed companies|34|||
125563351|NCT01401842|451691728|FG000|Overall Study|discharged from US Army|3|||
125563352|NCT01401842|451691729|FG001|Overall Study|discharged from US Army|4|||
125563353|NCT01401842|451691728|FG000|Overall Study|invalid follow-up strength data|1|||
125563354|NCT01401842|451691729|FG001|Overall Study|invalid follow-up strength data|4|||
125563355|NCT01401842|451691728|FG000|Overall Study|on profile|9|||
125563356|NCT01401842|451691729|FG001|Overall Study|on profile|5|||
125563357|NCT01401842|451691728|FG000|Overall Study|other/unknown|28|||
125563358|NCT01401842|451691729|FG001|Overall Study|other/unknown|17|||
125563359|NCT03337542|451691730|FG000|Overall Study|Withdrew Consent|17|||
125563360|NCT03337542|451691730|FG000|Overall Study|Allergic Adverse Event|1|||
125563361|NCT03337542|451691730|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
125563362|NCT03337542|451691730|FG000|Overall Study|Lost to Follow-up|1|||
125563363|NCT03337542|451691730|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
125563364|NCT00121108|451691733|FG000|Overall Study|Lost to Follow-up|10|||
125563365|NCT00121108|451691734|FG001|Overall Study|Lost to Follow-up|22|||
125563366|NCT00121108|451691733|FG000|Overall Study|Withdrawal by Subject|106|||
125563367|NCT00121108|451691734|FG001|Overall Study|Withdrawal by Subject|195|||
125563368|NCT00121108|451691733|FG000|Overall Study|Death|5|||
125563369|NCT00121108|451691734|FG001|Overall Study|Death|8|||
125563370|NCT01380379|451691735|FG000|Overall Study|Pregnancy|1|||
125563371|NCT03496012|451693283|FG000|Overall Study|Withdrawal by Subject|2|||
125563372|NCT03496012|451693284|FG001|Overall Study|Withdrawal by Subject|0|||
125563373|NCT03496012|451693285|FG002|Overall Study|Withdrawal by Subject|2|||
125563374|NCT03496012|451693283|FG000|Overall Study|Adverse Event|0|||
125563375|NCT03496012|451693284|FG001|Overall Study|Adverse Event|0|||
125563376|NCT03496012|451693285|FG002|Overall Study|Adverse Event|1|||
125563377|NCT03496012|451693283|FG000|Overall Study|Reason Not Specified|2|||
125563378|NCT03496012|451693284|FG001|Overall Study|Reason Not Specified|0|||
125563379|NCT03496012|451693285|FG002|Overall Study|Reason Not Specified|1|||
125563380|NCT02322125|451693286|FG000|Overall Study|Withdrawal by Subject|2|||
125563381|NCT00766038|451693292|FG000|Overall Study|Lost to Follow-up|15|||
125563382|NCT00766038|451693293|FG001|Overall Study|Lost to Follow-up|14|||
125563383|NCT00449670|451693295|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
125563384|NCT00449670|451693296|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
125563385|NCT00449670|451693295|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
125563386|NCT00449670|451693296|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
125563387|NCT00449670|451693295|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
125563388|NCT00449670|451693296|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
125563389|NCT00449670|451693295|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
125563390|NCT00449670|451693296|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
125563391|NCT00449670|451693295|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
125563392|NCT00449670|451693296|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
125563393|NCT00449670|451693295|FG000|Booster Phase (Study no.109873)|Other|0|||
125563394|NCT00449670|451693296|FG001|Booster Phase (Study no.109873)|Other|2|||
125563395|NCT04183790|451693300|FG000|Overall Study|Participants did not rollover to Part B|12|||
125563396|NCT04183790|451693301|FG001|Overall Study|Participants did not rollover to Part B|0|||
125563397|NCT04183790|451693300|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
125563398|NCT04183790|451693301|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
125563399|NCT04183790|451693300|FG000|Overall Study|Commercial drug is available for participant|6|||
125563400|NCT04183790|451693301|FG001|Overall Study|Commercial drug is available for participant|0|||
125563401|NCT04183790|451693300|FG000|Overall Study|Adverse Event|1|||
125563402|NCT04183790|451693301|FG001|Overall Study|Adverse Event|0|||
125563403|NCT04183790|451693300|FG000|Overall Study|Not enrolled in 107 study|0|||
125563404|NCT04183790|451693301|FG001|Overall Study|Not enrolled in 107 study|2|||
125563405|NCT01251653|451693302|FG000|Overall Study|Progressive Disease|1|||
125563406|NCT01251653|451693303|FG001|Overall Study|Progressive Disease|7|||
125563407|NCT01251653|451693304|FG002|Overall Study|Progressive Disease|16|||
125563408|NCT01251653|451693305|FG003|Overall Study|Progressive Disease|4|||
125563409|NCT01251653|451693306|FG004|Overall Study|Progressive Disease|0|||
125563410|NCT01251653|451693307|FG005|Overall Study|Progressive Disease|17|||
125563411|NCT01251653|451693308|FG006|Overall Study|Progressive Disease|14|||
125563412|NCT01251653|451693309|FG007|Overall Study|Progressive Disease|7|||
125563413|NCT01251653|451693310|FG008|Overall Study|Progressive Disease|5|||
125563414|NCT01251653|451693302|FG000|Overall Study|Dose-limiting toxicity|0|||
125563415|NCT01251653|451693303|FG001|Overall Study|Dose-limiting toxicity|1|||
125563416|NCT01251653|451693304|FG002|Overall Study|Dose-limiting toxicity|1|||
125563417|NCT01251653|451693305|FG003|Overall Study|Dose-limiting toxicity|1|||
125563418|NCT01251653|451693306|FG004|Overall Study|Dose-limiting toxicity|0|||
125563419|NCT01251653|451693307|FG005|Overall Study|Dose-limiting toxicity|0|||
125563420|NCT01251653|451693308|FG006|Overall Study|Dose-limiting toxicity|2|||
125563421|NCT01251653|451693309|FG007|Overall Study|Dose-limiting toxicity|0|||
125563422|NCT01251653|451693310|FG008|Overall Study|Dose-limiting toxicity|0|||
125563423|NCT01251653|451693302|FG000|Overall Study|Adverse Event|1|||
125563424|NCT01251653|451693303|FG001|Overall Study|Adverse Event|0|||
125563425|NCT01251653|451693304|FG002|Overall Study|Adverse Event|2|||
125563426|NCT01251653|451693305|FG003|Overall Study|Adverse Event|1|||
125563427|NCT01251653|451693306|FG004|Overall Study|Adverse Event|1|||
125563428|NCT01251653|451693307|FG005|Overall Study|Adverse Event|0|||
125563429|NCT01251653|451693308|FG006|Overall Study|Adverse Event|2|||
125563430|NCT01251653|451693309|FG007|Overall Study|Adverse Event|2|||
125563431|NCT01251653|451693310|FG008|Overall Study|Adverse Event|1|||
125563432|NCT01251653|451693302|FG000|Overall Study|Withdrawal by Subject|1|||
125563433|NCT01251653|451693303|FG001|Overall Study|Withdrawal by Subject|0|||
125563434|NCT01251653|451693304|FG002|Overall Study|Withdrawal by Subject|1|||
125563435|NCT01251653|451693305|FG003|Overall Study|Withdrawal by Subject|0|||
125563436|NCT01251653|451693306|FG004|Overall Study|Withdrawal by Subject|1|||
125563437|NCT01251653|451693307|FG005|Overall Study|Withdrawal by Subject|1|||
125563438|NCT01251653|451693308|FG006|Overall Study|Withdrawal by Subject|0|||
125563439|NCT01251653|451693309|FG007|Overall Study|Withdrawal by Subject|1|||
125563440|NCT01251653|451693310|FG008|Overall Study|Withdrawal by Subject|0|||
125563441|NCT01251653|451693302|FG000|Overall Study|Other reason not mentioned above|0|||
125354991|NCT01907100|450934944|FG003|Overall Study|Other than reasons specified|6|||
125563442|NCT01251653|451693303|FG001|Overall Study|Other reason not mentioned above|0|||
125563443|NCT01251653|451693304|FG002|Overall Study|Other reason not mentioned above|0|||
125563444|NCT01251653|451693305|FG003|Overall Study|Other reason not mentioned above|0|||
125563445|NCT01251653|451693306|FG004|Overall Study|Other reason not mentioned above|0|||
125563446|NCT01251653|451693307|FG005|Overall Study|Other reason not mentioned above|0|||
125563447|NCT01251653|451693308|FG006|Overall Study|Other reason not mentioned above|0|||
125563448|NCT01251653|451693309|FG007|Overall Study|Other reason not mentioned above|2|||
125563449|NCT01251653|451693310|FG008|Overall Study|Other reason not mentioned above|0|||
125563450|NCT00847145|451693311|FG000|Overall Study|AE or Death|0|||
125563451|NCT00847145|451693312|FG001|Overall Study|AE or Death|1|||
125563452|NCT00847145|451693313|FG002|Overall Study|AE or Death|1|||
125563453|NCT00847145|451693314|FG003|Overall Study|AE or Death|0|||
125563454|NCT00847145|451693315|FG004|Overall Study|AE or Death|0|||
125563455|NCT00847145|451693316|FG005|Overall Study|AE or Death|0|||
125563456|NCT00847145|451693317|FG006|Overall Study|AE or Death|0|||
125563457|NCT00847145|451693318|FG007|Overall Study|AE or Death|0|||
125563458|NCT00847145|451693311|FG000|Overall Study|Withdrawal by Subject|3|||
125563459|NCT00847145|451693312|FG001|Overall Study|Withdrawal by Subject|4|||
125354992|NCT01907100|450934941|FG000|Overall Study|Adverse event (AE)|6|||
125563460|NCT00847145|451693313|FG002|Overall Study|Withdrawal by Subject|6|||
125563461|NCT00847145|451693314|FG003|Overall Study|Withdrawal by Subject|1|||
125563462|NCT00847145|451693315|FG004|Overall Study|Withdrawal by Subject|0|||
125563463|NCT00847145|451693316|FG005|Overall Study|Withdrawal by Subject|0|||
125563464|NCT00847145|451693317|FG006|Overall Study|Withdrawal by Subject|1|||
125563465|NCT00847145|451693318|FG007|Overall Study|Withdrawal by Subject|1|||
125563466|NCT00847145|451693311|FG000|Overall Study|Lost to Follow-up|3|||
125563467|NCT00847145|451693312|FG001|Overall Study|Lost to Follow-up|1|||
125563468|NCT00847145|451693313|FG002|Overall Study|Lost to Follow-up|1|||
125563469|NCT00847145|451693314|FG003|Overall Study|Lost to Follow-up|0|||
125354993|NCT01907100|450934942|FG001|Overall Study|Adverse event (AE)|3|||
125563470|NCT00847145|451693315|FG004|Overall Study|Lost to Follow-up|4|||
125563471|NCT00847145|451693316|FG005|Overall Study|Lost to Follow-up|4|||
125563472|NCT00847145|451693317|FG006|Overall Study|Lost to Follow-up|8|||
125563473|NCT00847145|451693318|FG007|Overall Study|Lost to Follow-up|2|||
125563474|NCT00847145|451693311|FG000|Overall Study|Inappropriate enrollment|0|||
125563475|NCT00847145|451693312|FG001|Overall Study|Inappropriate enrollment|0|||
125563476|NCT00847145|451693313|FG002|Overall Study|Inappropriate enrollment|0|||
125563477|NCT00847145|451693314|FG003|Overall Study|Inappropriate enrollment|0|||
125563478|NCT00847145|451693315|FG004|Overall Study|Inappropriate enrollment|1|||
125563479|NCT00847145|451693316|FG005|Overall Study|Inappropriate enrollment|0|||
125563480|NCT00847145|451693317|FG006|Overall Study|Inappropriate enrollment|0|||
125563481|NCT00847145|451693318|FG007|Overall Study|Inappropriate enrollment|0|||
125563482|NCT00847145|451693311|FG000|Overall Study|Protocol Violation|0|||
125563483|NCT00847145|451693312|FG001|Overall Study|Protocol Violation|0|||
125563484|NCT00847145|451693313|FG002|Overall Study|Protocol Violation|3|||
125563485|NCT00847145|451693314|FG003|Overall Study|Protocol Violation|0|||
125563486|NCT00847145|451693315|FG004|Overall Study|Protocol Violation|1|||
125563487|NCT00847145|451693316|FG005|Overall Study|Protocol Violation|0|||
125563488|NCT00847145|451693317|FG006|Overall Study|Protocol Violation|0|||
125563489|NCT00847145|451693318|FG007|Overall Study|Protocol Violation|1|||
125563490|NCT02833974|451693320|FG000|Overall Study|Lost to Follow-up|1|||
125563491|NCT02833974|451693321|FG001|Overall Study|Lost to Follow-up|0|||
125563492|NCT02833974|451693320|FG000|Overall Study|Adverse Event|0|||
125563493|NCT02833974|451693321|FG001|Overall Study|Adverse Event|3|||
125563494|NCT04419610|451693322|FG000|Overall Study|Withdrawal by Subject|3|||
125563495|NCT04419610|451693323|FG001|Overall Study|Withdrawal by Subject|1|||
125563496|NCT04419610|451693322|FG000|Overall Study|Adverse Event|1|||
125563497|NCT04419610|451693323|FG001|Overall Study|Adverse Event|0|||
125563498|NCT04419610|451693322|FG000|Overall Study|discharged early|1|||
125563499|NCT04419610|451693323|FG001|Overall Study|discharged early|1|||
125563500|NCT01524198|451693324|FG000|Overall Study|Protocol Violation|8|||
125563501|NCT01524198|451693325|FG001|Overall Study|Protocol Violation|6|||
125563502|NCT01524198|451693324|FG000|Overall Study|Withdrawal by Subject|15|||
125563503|NCT01524198|451693325|FG001|Overall Study|Withdrawal by Subject|10|||
125563504|NCT01439282|451693326|FG000|Overall Study|Adverse Event|5|||
125563505|NCT01439282|451693327|FG001|Overall Study|Adverse Event|0|||
125563506|NCT01439282|451693326|FG000|Overall Study|Withdrawal by Subject|2|||
125563507|NCT01439282|451693327|FG001|Overall Study|Withdrawal by Subject|0|||
125563508|NCT01439282|451693326|FG000|Overall Study|Other|1|||
125563509|NCT01439282|451693327|FG001|Overall Study|Other|1|||
125563510|NCT02232802|451693328|FG000|Period 1|Sponsor request|1|||
125563511|NCT02232802|451693329|FG001|Period 1|Sponsor request|0|||
125563512|NCT02232802|451693328|FG000|Period 1|Adverse Event|1|||
125563513|NCT02232802|451693329|FG001|Period 1|Adverse Event|1|||
125563514|NCT00885703|451693334|FG000|Overall Study|Death|9|||
125563515|NCT00885703|451693335|FG001|Overall Study|Death|7|||
125563516|NCT00885703|451693336|FG002|Overall Study|Death|8|||
125563517|NCT00885703|451693337|FG003|Overall Study|Death|7|||
125563518|NCT00885703|451693338|FG004|Overall Study|Death|7|||
125563519|NCT00885703|451693339|FG005|Overall Study|Death|8|||
125563520|NCT00885703|451693340|FG006|Overall Study|Death|4|||
125563521|NCT00885703|451693334|FG000|Overall Study|Lost to Follow-up|0|||
125563522|NCT00885703|451693335|FG001|Overall Study|Lost to Follow-up|0|||
125563523|NCT00885703|451693336|FG002|Overall Study|Lost to Follow-up|1|||
125563524|NCT00885703|451693337|FG003|Overall Study|Lost to Follow-up|0|||
125563525|NCT00885703|451693338|FG004|Overall Study|Lost to Follow-up|0|||
125563526|NCT00885703|451693339|FG005|Overall Study|Lost to Follow-up|1|||
125563527|NCT00885703|451693340|FG006|Overall Study|Lost to Follow-up|0|||
125563528|NCT00885703|451693334|FG000|Overall Study|Withdrawal by Subject|0|||
125563529|NCT00885703|451693335|FG001|Overall Study|Withdrawal by Subject|0|||
125563530|NCT00885703|451693336|FG002|Overall Study|Withdrawal by Subject|0|||
125354994|NCT01907100|450934943|FG002|Overall Study|Adverse event (AE)|22|||
125563531|NCT00885703|451693337|FG003|Overall Study|Withdrawal by Subject|1|||
125563532|NCT00885703|451693338|FG004|Overall Study|Withdrawal by Subject|3|||
125563533|NCT00885703|451693339|FG005|Overall Study|Withdrawal by Subject|1|||
125563534|NCT00885703|451693340|FG006|Overall Study|Withdrawal by Subject|1|||
125563535|NCT00885703|451693334|FG000|Overall Study|Ineligible (no CM)|1|||
125563536|NCT00885703|451693335|FG001|Overall Study|Ineligible (no CM)|3|||
125563537|NCT00885703|451693336|FG002|Overall Study|Ineligible (no CM)|2|||
125563538|NCT00885703|451693337|FG003|Overall Study|Ineligible (no CM)|1|||
125563539|NCT00885703|451693338|FG004|Overall Study|Ineligible (no CM)|2|||
125563540|NCT00885703|451693339|FG005|Overall Study|Ineligible (no CM)|3|||
125563541|NCT00885703|451693340|FG006|Overall Study|Ineligible (no CM)|1|||
125563542|NCT01183143|451693342|FG000|Overall Study|Protocol Violation|115|||
125563543|NCT01183143|451693342|FG000|Overall Study|Withdrawal by Subject|19|||
125563544|NCT01183143|451693342|FG000|Overall Study|Subject Questionnaires not returned|5|||
125563545|NCT01183143|451693342|FG000|Overall Study|Subjects enrolled, but not treated|11|||
125563546|NCT04096274|451693344|FG000|Phase I|Lost to Follow-up|5|||
125563547|NCT04096274|451693345|FG001|Phase I|Lost to Follow-up|5|||
125563548|NCT04096274|451693344|FG000|Phase II|Lost to Follow-up|11|||
125563549|NCT04096274|451693345|FG001|Phase II|Lost to Follow-up|11|||
125563550|NCT03197493|451693348|FG000|Overall Study|Withdrawal by Subject|5|||
125563551|NCT00516048|451693351|FG000|Overall Study|Death|0|||
125563552|NCT00516048|451693352|FG001|Overall Study|Death|0|||
125563553|NCT00516048|451693353|FG002|Overall Study|Death|1|||
125563554|NCT00516048|451693351|FG000|Overall Study|Subject Decision|0|||
125563555|NCT00516048|451693352|FG001|Overall Study|Subject Decision|2|||
125563556|NCT00516048|451693353|FG002|Overall Study|Subject Decision|0|||
125563557|NCT02807480|451693356|FG000|Overall Study|Withdrawal by Subject|14|||
125563558|NCT02807480|451693357|FG001|Overall Study|Withdrawal by Subject|10|||
125563559|NCT00054704|451693358|FG000|Overall Study|Lack of Efficacy|2|||
125563560|NCT00054704|451693359|FG001|Overall Study|Lack of Efficacy|3|||
125563561|NCT00054704|451693358|FG000|Overall Study|Adverse Event|3|||
125563562|NCT00054704|451693359|FG001|Overall Study|Adverse Event|1|||
125354995|NCT01907100|450934944|FG003|Overall Study|Adverse event (AE)|23|||
125563563|NCT00054704|451693358|FG000|Overall Study|Lost to Follow-up|0|||
125563564|NCT00054704|451693359|FG001|Overall Study|Lost to Follow-up|1|||
125563565|NCT02163187|451693360|FG000|Overall Study|Device removed|1|||
125563566|NCT02163187|451693361|FG001|Overall Study|Device removed|0|||
125563567|NCT02163187|451693360|FG000|Overall Study|Progressive disease|1|||
125563568|NCT02163187|451693361|FG001|Overall Study|Progressive disease|0|||
125563569|NCT00362414|451693362|FG000|Overall Study|Death|2|||
125563570|NCT00362414|451693362|FG000|Overall Study|Adverse Event|1|||
125563571|NCT02369848|451693363|FG000|Overall Study|Death|1|||
125563572|NCT02369848|451693363|FG000|Overall Study|Withdrawal by Subject|2|||
125563573|NCT02369848|451693363|FG000|Overall Study|Lost to Follow-up|1|||
125563574|NCT01543152|451693364|FG000|Overall Study|Withdrawal by Subject|0|||
125563575|NCT01543152|451693365|FG001|Overall Study|Withdrawal by Subject|2|||
125563576|NCT01543152|451693366|FG002|Overall Study|Withdrawal by Subject|0|||
125563577|NCT01543152|451693367|FG003|Overall Study|Withdrawal by Subject|0|||
125563578|NCT01543152|451693368|FG004|Overall Study|Withdrawal by Subject|0|||
125563579|NCT02053168|451693369|FG000|Overall Study|Withdrawal by Subject|1|||
125563580|NCT02053168|451693369|FG000|Overall Study|Physician Decision|1|||
125563581|NCT02053168|451693369|FG000|Overall Study|Lost to Follow-up|1|||
125563582|NCT00636675|451693370|FG000|Overall Study|Lost to Follow-up|121|||
125563583|NCT00636675|451693371|FG001|Overall Study|Lost to Follow-up|31|||
125563584|NCT00636675|451693370|FG000|Overall Study|Withdrawal by Subject|19|||
125563585|NCT00636675|451693371|FG001|Overall Study|Withdrawal by Subject|10|||
125563586|NCT00096785|451693372|FG000|Overall Study|Lost to Follow-up|1|||
125563587|NCT00096785|451693373|FG001|Overall Study|Lost to Follow-up|0|||
125563588|NCT00096785|451693372|FG000|Overall Study|Withdrawal by Subject|0|||
125563589|NCT00096785|451693373|FG001|Overall Study|Withdrawal by Subject|1|||
125563590|NCT00096785|451693372|FG000|Overall Study|Relocated|1|||
125563591|NCT00096785|451693373|FG001|Overall Study|Relocated|0|||
125563592|NCT04053868|451693374|FG000|Overall Study|Withdrawal by Subject|1|||
125563593|NCT04053868|451693375|FG001|Overall Study|Withdrawal by Subject|0|||
125563594|NCT00833053|451693378|FG000|Overall Study|Adverse Event|4|||
125563595|NCT00833053|451693379|FG001|Overall Study|Adverse Event|0|||
125563596|NCT00833053|451693378|FG000|Overall Study|Treatment Failure|3|||
125563597|NCT00833053|451693379|FG001|Overall Study|Treatment Failure|1|||
125563598|NCT00833053|451693378|FG000|Overall Study|Withdrawal by Subject|0|||
125354996|NCT01907100|450934941|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
125354997|NCT01907100|450934942|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
125354998|NCT01907100|450934943|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
125354999|NCT01907100|450934944|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
125355000|NCT03635788|450934945|FG000|Step 1|Death|1|||
125563599|NCT00833053|451693379|FG001|Overall Study|Withdrawal by Subject|1|||
125563600|NCT00833053|451693378|FG000|Overall Study|Protocol Violation|2|||
125563601|NCT00833053|451693379|FG001|Overall Study|Protocol Violation|1|||
125563602|NCT02187471|451693382|FG000|Overall Study|Protocol Violation|4|||
125563603|NCT02187471|451693383|FG001|Overall Study|Protocol Violation|5|||
125563604|NCT02187471|451693384|FG002|Overall Study|Protocol Violation|4|||
125355001|NCT03635788|450934946|FG001|Step 1|Death|0|||
125355002|NCT03635788|450934947|FG002|Step 1|Death|0|||
125355003|NCT03635788|450934945|FG000|Step 1|Lost to Follow-up|31|||
125563605|NCT02187471|451693385|FG003|Overall Study|Protocol Violation|4|||
125355004|NCT03635788|450934946|FG001|Step 1|Lost to Follow-up|0|||
125355005|NCT03635788|450934947|FG002|Step 1|Lost to Follow-up|0|||
125355006|NCT03635788|450934945|FG000|Step 1|Pregnancy|1|||
125355007|NCT03635788|450934946|FG001|Step 1|Pregnancy|0|||
125355008|NCT03635788|450934947|FG002|Step 1|Pregnancy|0|||
125355009|NCT03635788|450934945|FG000|Step 1|Protocol Violation|8|||
125355010|NCT03635788|450934946|FG001|Step 1|Protocol Violation|0|||
125355011|NCT03635788|450934947|FG002|Step 1|Protocol Violation|0|||
125355012|NCT03635788|450934945|FG000|Step 1|Withdrawal by Subject|13|||
125563606|NCT02187471|451693382|FG000|Overall Study|Missing|0|||
125563607|NCT02187471|451693383|FG001|Overall Study|Missing|0|||
125355013|NCT03635788|450934946|FG001|Step 1|Withdrawal by Subject|0|||
125355014|NCT03635788|450934947|FG002|Step 1|Withdrawal by Subject|0|||
125355015|NCT03635788|450934945|FG000|Step 1|Other reasons|12|||
125563608|NCT02187471|451693384|FG002|Overall Study|Missing|0|||
125355016|NCT03635788|450934946|FG001|Step 1|Other reasons|0|||
125355017|NCT03635788|450934947|FG002|Step 1|Other reasons|0|||
125355018|NCT03635788|450934945|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
125355019|NCT03635788|450934946|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
125563609|NCT02187471|451693385|FG003|Overall Study|Missing|1|||
125563610|NCT02187471|451693382|FG000|Overall Study|Lack of Efficacy|18|||
125563611|NCT02187471|451693383|FG001|Overall Study|Lack of Efficacy|9|||
125355020|NCT03635788|450934947|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
125355021|NCT03635788|450934945|FG000|Step 2|Lost to Follow-up|0|||
125355022|NCT03635788|450934946|FG001|Step 2|Lost to Follow-up|8|||
125355023|NCT03635788|450934947|FG002|Step 2|Lost to Follow-up|15|||
125355024|NCT03635788|450934945|FG000|Step 2|Withdrawal by Subject|0|||
125563612|NCT02187471|451693384|FG002|Overall Study|Lack of Efficacy|13|||
125563613|NCT02187471|451693385|FG003|Overall Study|Lack of Efficacy|11|||
125355025|NCT03635788|450934946|FG001|Step 2|Withdrawal by Subject|6|||
125355026|NCT03635788|450934947|FG002|Step 2|Withdrawal by Subject|6|||
125355027|NCT03635788|450934945|FG000|Step 2|Death|0|||
125355028|NCT03635788|450934946|FG001|Step 2|Death|2|||
125355029|NCT03635788|450934947|FG002|Step 2|Death|0|||
125355030|NCT03635788|450934945|FG000|Step 2|Incarceration|0|||
125355031|NCT03635788|450934946|FG001|Step 2|Incarceration|2|||
125355032|NCT03635788|450934947|FG002|Step 2|Incarceration|0|||
125355033|NCT03635788|450934945|FG000|Step 2|Non-Compliance With Study Requirements|0|||
125355034|NCT03635788|450934946|FG001|Step 2|Non-Compliance With Study Requirements|1|||
125355035|NCT03635788|450934947|FG002|Step 2|Non-Compliance With Study Requirements|1|||
125355036|NCT03635788|450934945|FG000|Step 2|Confounding Medical Condition|0|||
125355037|NCT03635788|450934946|FG001|Step 2|Confounding Medical Condition|0|||
125355038|NCT03635788|450934947|FG002|Step 2|Confounding Medical Condition|1|||
125355039|NCT03635788|450934945|FG000|Step 2|Out Of State With No Plan To Return|0|||
125355040|NCT03635788|450934946|FG001|Step 2|Out Of State With No Plan To Return|1|||
125355041|NCT03635788|450934947|FG002|Step 2|Out Of State With No Plan To Return|0|||
125355042|NCT03635788|450934945|FG000|Step 2|Switched To Injectables|0|||
125355043|NCT03635788|450934946|FG001|Step 2|Switched To Injectables|0|||
125355044|NCT03635788|450934947|FG002|Step 2|Switched To Injectables|1|||
125355045|NCT03635788|450934945|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
125355046|NCT03635788|450934946|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
125563614|NCT02187471|451693382|FG000|Overall Study|Adverse Event|24|||
125563615|NCT02187471|451693383|FG001|Overall Study|Adverse Event|34|||
125563616|NCT02187471|451693384|FG002|Overall Study|Adverse Event|44|||
125563617|NCT02187471|451693385|FG003|Overall Study|Adverse Event|36|||
125563618|NCT02187471|451693382|FG000|Overall Study|Withdrawal by Subject|23|||
125563619|NCT02187471|451693383|FG001|Overall Study|Withdrawal by Subject|29|||
125563620|NCT02187471|451693384|FG002|Overall Study|Withdrawal by Subject|22|||
125563621|NCT02187471|451693385|FG003|Overall Study|Withdrawal by Subject|24|||
125563622|NCT02187471|451693382|FG000|Overall Study|Other|7|||
125563623|NCT02187471|451693383|FG001|Overall Study|Other|5|||
125563624|NCT02187471|451693384|FG002|Overall Study|Other|3|||
125563625|NCT02187471|451693385|FG003|Overall Study|Other|4|||
125563626|NCT02236520|451693386|FG000|Overall Study|Physician Decision|0|||
125563627|NCT02236520|451693387|FG001|Overall Study|Physician Decision|5|||
125563628|NCT02236520|451693388|FG002|Overall Study|Physician Decision|0|||
125563629|NCT02236520|451693389|FG003|Overall Study|Physician Decision|0|||
125563630|NCT02236520|451693386|FG000|Overall Study|Withdrawal by Subject|1|||
125563631|NCT02236520|451693387|FG001|Overall Study|Withdrawal by Subject|0|||
125563632|NCT02236520|451693388|FG002|Overall Study|Withdrawal by Subject|0|||
125563633|NCT02236520|451693389|FG003|Overall Study|Withdrawal by Subject|1|||
125563634|NCT02236520|451693386|FG000|Overall Study|Pregnancy|1|||
125563635|NCT02236520|451693387|FG001|Overall Study|Pregnancy|0|||
125563636|NCT02236520|451693388|FG002|Overall Study|Pregnancy|0|||
125563637|NCT02236520|451693389|FG003|Overall Study|Pregnancy|0|||
125563638|NCT01785160|451693390|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
125563639|NCT01785160|451693390|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
125563640|NCT00957528|451693391|FG000|Overall Study|Protocol Violation|0|||
125563641|NCT00957528|451693392|FG001|Overall Study|Protocol Violation|1|||
125563642|NCT00957528|451693393|FG002|Overall Study|Protocol Violation|0|||
125563643|NCT00957528|451693391|FG000|Overall Study|Withdrawal by Subject|0|||
125563644|NCT00957528|451693392|FG001|Overall Study|Withdrawal by Subject|0|||
125355047|NCT03635788|450934947|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
125355048|NCT04382755|450934948|FG000|Overall Study|Withdrawal by Subject|1|||
125355049|NCT04382755|450934949|FG001|Overall Study|Withdrawal by Subject|0|||
125355050|NCT04382755|450934948|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
125355051|NCT04382755|450934949|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
125355052|NCT04382755|450934948|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
125355053|NCT04382755|450934949|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
125355054|NCT04060862|450936425|FG000|Overall Study|Symptomatic Deterioration|1|||
125355055|NCT04060862|450936425|FG000|Overall Study|Un-specified|6|||
125355056|NCT04060862|450936425|FG000|Overall Study|Progressive disease|12|||
125355057|NCT04060862|450936425|FG000|Overall Study|Physician Decision|1|||
125355058|NCT04629508|450936426|FG000|Overall Study|Adverse Event|1|||
125355059|NCT04629508|450936426|FG000|Overall Study|Death|2|||
125355060|NCT04629508|450936426|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
125355061|NCT00760214|450936434|FG000|Overall Study|Adverse Event|8|||
125355062|NCT00760214|450936435|FG001|Overall Study|Adverse Event|9|||
125355063|NCT00760214|450936436|FG002|Overall Study|Adverse Event|12|||
125355064|NCT00760214|450936434|FG000|Overall Study|Protocol Violation|3|||
125355065|NCT00760214|450936435|FG001|Overall Study|Protocol Violation|0|||
125355066|NCT00760214|450936436|FG002|Overall Study|Protocol Violation|3|||
125355067|NCT00760214|450936434|FG000|Overall Study|Lost to Follow-up|0|||
125355068|NCT00760214|450936435|FG001|Overall Study|Lost to Follow-up|0|||
125355069|NCT00760214|450936436|FG002|Overall Study|Lost to Follow-up|1|||
125355070|NCT00760214|450936434|FG000|Overall Study|Withdrawal by Subject|12|||
125355071|NCT00760214|450936435|FG001|Overall Study|Withdrawal by Subject|14|||
125355072|NCT00760214|450936436|FG002|Overall Study|Withdrawal by Subject|13|||
125355073|NCT00760214|450936434|FG000|Overall Study|Lack of Efficacy|3|||
125355074|NCT00760214|450936435|FG001|Overall Study|Lack of Efficacy|2|||
125355075|NCT00760214|450936436|FG002|Overall Study|Lack of Efficacy|4|||
125355076|NCT00760214|450936434|FG000|Overall Study|Pregnancy|0|||
125355077|NCT00760214|450936435|FG001|Overall Study|Pregnancy|0|||
125355078|NCT00760214|450936436|FG002|Overall Study|Pregnancy|1|||
125355079|NCT00760214|450936434|FG000|Overall Study|Physician Decision|1|||
125563645|NCT00957528|451693393|FG002|Overall Study|Withdrawal by Subject|1|||
125355080|NCT00760214|450936435|FG001|Overall Study|Physician Decision|1|||
125355081|NCT00760214|450936436|FG002|Overall Study|Physician Decision|1|||
125355082|NCT00760214|450936434|FG000|Overall Study|Other|3|||
125355083|NCT00760214|450936435|FG001|Overall Study|Other|4|||
125355084|NCT00760214|450936436|FG002|Overall Study|Other|6|||
125355085|NCT03960554|450936440|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
125355086|NCT03960554|450936441|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
125563646|NCT00762892|451693398|FG000|Overall Study|Lost to Follow-up|2|||
125563647|NCT00762892|451693399|FG001|Overall Study|Lost to Follow-up|5|||
125563648|NCT00762892|451693398|FG000|Overall Study|Withdrawal by Subject|0|||
125563649|NCT00762892|451693399|FG001|Overall Study|Withdrawal by Subject|1|||
125563650|NCT00762892|451693398|FG000|Overall Study|Death|1|||
125563651|NCT00762892|451693399|FG001|Overall Study|Death|0|||
125355087|NCT02545075|450936442|FG000|Randomization|Lost to Follow-up|0|||
125355088|NCT02545075|450936443|FG001|Randomization|Lost to Follow-up|1|||
125355089|NCT02545075|450936442|FG000|Randomization|Withdrawal by Subject|0|||
125355090|NCT02545075|450936443|FG001|Randomization|Withdrawal by Subject|6|||
125355091|NCT02545075|450936442|FG000|Treatment|Disease progression|71|||
125355092|NCT02545075|450936443|FG001|Treatment|Disease progression|32|||
125355093|NCT02545075|450936442|FG000|Treatment|Participant dicontinued study treatment|7|||
125563652|NCT00762892|451693398|FG000|Overall Study|Pregnancy|1|||
125563653|NCT00762892|451693399|FG001|Overall Study|Pregnancy|0|||
125563654|NCT00762892|451693398|FG000|Overall Study|Incarceration|1|||
125355094|NCT02545075|450936443|FG001|Treatment|Participant dicontinued study treatment|9|||
125355095|NCT02545075|450936442|FG000|Treatment|Withdrawal by Subject|1|||
125355096|NCT02545075|450936443|FG001|Treatment|Withdrawal by Subject|0|||
125355097|NCT02545075|450936442|FG000|Treatment|Adverse event not related to study drug|1|||
125355098|NCT02545075|450936443|FG001|Treatment|Adverse event not related to study drug|0|||
125355099|NCT02545075|450936442|FG000|Treatment|Death|1|||
125355100|NCT02545075|450936443|FG001|Treatment|Death|0|||
125355101|NCT02545075|450936442|FG000|Treatment|Participant drug toxicity|1|||
125355102|NCT02545075|450936443|FG001|Treatment|Participant drug toxicity|0|||
125355103|NCT02545075|450936442|FG000|Treatment|Completed treatment|40|||
125355104|NCT02545075|450936443|FG001|Treatment|Completed treatment|12|||
125355105|NCT01810432|450936444|FG000|Washout|Protocol Violation|0|||
125355106|NCT01810432|450936445|FG001|Washout|Protocol Violation|1|||
125355107|NCT01810432|450936444|FG000|Washout|Adverse Event|1|||
125355108|NCT01810432|450936445|FG001|Washout|Adverse Event|0|||
125355109|NCT01810432|450936444|FG000|Period 2|Withdrawal by Subject|2|||
125355110|NCT01810432|450936445|FG001|Period 2|Withdrawal by Subject|1|||
125355111|NCT01810432|450936444|FG000|Period 2|Physician Decision|1|||
125355112|NCT01810432|450936445|FG001|Period 2|Physician Decision|0|||
125355113|NCT01810432|450936444|FG000|Period 2|Lost to Follow-up|1|||
125355114|NCT01810432|450936445|FG001|Period 2|Lost to Follow-up|1|||
125355115|NCT00736879|450936448|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
125355116|NCT00736879|450936449|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
125355117|NCT00736879|450936450|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
125355118|NCT00736879|450936451|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
125355119|NCT00736879|450936448|FG000|Double Blind Treatment Period|Adverse Event|0|||
125355120|NCT00736879|450936449|FG001|Double Blind Treatment Period|Adverse Event|1|||
125355121|NCT00736879|450936450|FG002|Double Blind Treatment Period|Adverse Event|1|||
125355122|NCT00736879|450936451|FG003|Double Blind Treatment Period|Adverse Event|0|||
125355123|NCT00736879|450936448|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
125355124|NCT00736879|450936449|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
125355125|NCT00736879|450936450|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
125355126|NCT00736879|450936451|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
125355127|NCT00736879|450936448|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
125355128|NCT00736879|450936449|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
125355129|NCT00736879|450936450|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
125355130|NCT00736879|450936451|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
125355131|NCT00736879|450936448|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
125355132|NCT00736879|450936449|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
125355133|NCT00736879|450936450|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
125563655|NCT00762892|451693399|FG001|Overall Study|Incarceration|0|||
125563656|NCT02234479|451693400|FG000|Overall Study|Withdrawal by Subject|1|||
125355134|NCT00736879|450936451|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
125355135|NCT00736879|450936448|FG000|Double Blind Treatment Period|No longer met criteria|0|||
125355136|NCT00736879|450936449|FG001|Double Blind Treatment Period|No longer met criteria|1|||
125355137|NCT00736879|450936450|FG002|Double Blind Treatment Period|No longer met criteria|0|||
125355138|NCT00736879|450936451|FG003|Double Blind Treatment Period|No longer met criteria|0|||
125355139|NCT00736879|450936448|FG000|Double Blind Treatment Period|non-specified|0|||
125355140|NCT00736879|450936449|FG001|Double Blind Treatment Period|non-specified|1|||
125355141|NCT00736879|450936450|FG002|Double Blind Treatment Period|non-specified|0|||
125355142|NCT00736879|450936451|FG003|Double Blind Treatment Period|non-specified|0|||
125355143|NCT00736879|450936448|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
125355144|NCT00736879|450936449|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
125355145|NCT00736879|450936450|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
125355146|NCT00736879|450936451|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
125355147|NCT00736879|450936448|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
125355148|NCT00736879|450936449|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
125355149|NCT00736879|450936450|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
125355150|NCT00736879|450936451|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
125355151|NCT02360111|450936452|FG000|Overall Study|Death|2|||
125355152|NCT02310321|450936455|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
125563657|NCT02234479|451693401|FG001|Overall Study|Withdrawal by Subject|3|||
125563658|NCT02318667|451693402|FG000|Overall Study|Adverse Event|1|||
125563659|NCT02318667|451693402|FG000|Overall Study|Lack of Efficacy|6|||
125563660|NCT02318667|451693402|FG000|Overall Study|Protocol Violation|2|||
125563661|NCT02289742|451693403|FG000|First Wear Period|Adverse event prior to treatment|0|||
125563662|NCT02289742|451693404|FG001|First Wear Period|Adverse event prior to treatment|1|||
125563663|NCT02289742|451693405|FG002|First Wear Period|Adverse event prior to treatment|0|||
125563664|NCT02289742|451693406|FG003|First Wear Period|Adverse event prior to treatment|0|||
125563665|NCT02289742|451693403|FG000|First Wear Period|Adverse Event|0|||
125563666|NCT02289742|451693404|FG001|First Wear Period|Adverse Event|0|||
125563667|NCT02289742|451693405|FG002|First Wear Period|Adverse Event|1|||
125563668|NCT02289742|451693406|FG003|First Wear Period|Adverse Event|0|||
125563669|NCT02289742|451693403|FG000|First Wear Period|Other prior to treatment|0|||
125563670|NCT02289742|451693404|FG001|First Wear Period|Other prior to treatment|0|||
125563671|NCT02289742|451693405|FG002|First Wear Period|Other prior to treatment|0|||
125563672|NCT02289742|451693406|FG003|First Wear Period|Other prior to treatment|1|||
125563673|NCT02289742|451693403|FG000|Third Wear Period|Adverse Event|0|||
125563674|NCT02289742|451693404|FG001|Third Wear Period|Adverse Event|1|||
125563675|NCT02289742|451693405|FG002|Third Wear Period|Adverse Event|0|||
125563676|NCT02289742|451693406|FG003|Third Wear Period|Adverse Event|0|||
125563677|NCT02289742|451693403|FG000|Third Wear Period|Reason not given|0|||
125563678|NCT02289742|451693404|FG001|Third Wear Period|Reason not given|0|||
125563679|NCT02289742|451693405|FG002|Third Wear Period|Reason not given|0|||
125563680|NCT02289742|451693406|FG003|Third Wear Period|Reason not given|1|||
125563681|NCT00383084|451693411|FG000|Overall Study|Withdrawal by Subject|12|||
125563682|NCT00383084|451693412|FG001|Overall Study|Withdrawal by Subject|10|||
125563683|NCT02636582|451693413|FG000|Overall Study|Surgical Pathology|1|||
125563684|NCT02636582|451693414|FG001|Overall Study|Surgical Pathology|0|||
125563685|NCT00326209|451693415|FG000|Overall Study|Adverse Event|28|||
125563686|NCT00326209|451693415|FG000|Overall Study|Withdrawal by Subject|22|||
125563687|NCT00326209|451693415|FG000|Overall Study|Lack of Efficacy|31|||
125563688|NCT00326209|451693415|FG000|Overall Study|Lost to Follow-up|18|||
125563689|NCT00326209|451693415|FG000|Overall Study|Participant non-compliant|6|||
125563690|NCT00326209|451693415|FG000|Overall Study|Sponsor closed study|173|||
125563691|NCT00326209|451693415|FG000|Overall Study|Prohibited medication use|1|||
125563692|NCT00326209|451693415|FG000|Overall Study|Violation of entry criteria|1|||
125563693|NCT00326209|451693415|FG000|Overall Study|Withdrawn in error|1|||
125563694|NCT00326209|451693415|FG000|Overall Study|Pregnancy|1|||
125563695|NCT00714285|451693416|FG000|Overall Study|Lost to Follow-up|0|||
125563696|NCT00714285|451693417|FG001|Overall Study|Lost to Follow-up|2|||
125563697|NCT00714285|451693418|FG002|Overall Study|Lost to Follow-up|0|||
125563698|NCT00714285|451693419|FG003|Overall Study|Lost to Follow-up|1|||
125563699|NCT00714285|451693416|FG000|Overall Study|Migrated/moved from study area|0|||
125563700|NCT00714285|451693417|FG001|Overall Study|Migrated/moved from study area|1|||
125563701|NCT00714285|451693418|FG002|Overall Study|Migrated/moved from study area|0|||
125563702|NCT00714285|451693419|FG003|Overall Study|Migrated/moved from study area|0|||
125563703|NCT01372384|451693420|FG000|Overall Study|Progression of disease|3|||
125563704|NCT01131676|451693425|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
125563705|NCT01131676|451693426|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
125563706|NCT01131676|451693427|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
125563707|NCT01131676|451693425|FG000|Discontinuation From Treatment|Not treated|4|||
125563708|NCT01131676|451693426|FG001|Discontinuation From Treatment|Not treated|2|||
125563709|NCT01131676|451693427|FG002|Discontinuation From Treatment|Not treated|2|||
125563710|NCT01131676|451693425|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
125563711|NCT01131676|451693426|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
125563712|NCT01131676|451693427|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
125563713|NCT01131676|451693425|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
125563714|NCT01131676|451693426|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
125355153|NCT02310321|450936456|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
125563715|NCT01131676|451693427|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
125563716|NCT01131676|451693425|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
125563717|NCT01131676|451693426|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
125563718|NCT01131676|451693427|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
125563719|NCT01131676|451693425|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
125563720|NCT01131676|451693426|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
125563721|NCT01131676|451693427|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
125563722|NCT01131676|451693425|FG000|Discontinuation From Treatment|Other than those specified|162|||
125563723|NCT01131676|451693426|FG001|Discontinuation From Treatment|Other than those specified|142|||
125563724|NCT01131676|451693427|FG002|Discontinuation From Treatment|Other than those specified|125|||
125563725|NCT01131676|451693425|FG000|Discontinuation From Treatment|Adverse Event|303|||
125563726|NCT01131676|451693426|FG001|Discontinuation From Treatment|Adverse Event|267|||
125563727|NCT01131676|451693427|FG002|Discontinuation From Treatment|Adverse Event|273|||
125563728|NCT01131676|451693425|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
125563729|NCT01131676|451693426|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
125563730|NCT01131676|451693427|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
125563731|NCT01131676|451693425|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
125563732|NCT01131676|451693426|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
125563733|NCT01131676|451693427|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
125563734|NCT01131676|451693425|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
125563735|NCT01131676|451693426|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
125563736|NCT01131676|451693427|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
125563737|NCT01131676|451693425|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
125563738|NCT01131676|451693426|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
125563739|NCT01131676|451693427|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
125563740|NCT01131676|451693425|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
125563741|NCT01131676|451693426|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
125563742|NCT01131676|451693427|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
125563743|NCT01131676|451693425|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
125563744|NCT01131676|451693426|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
125563745|NCT01131676|451693427|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
125563746|NCT03000179|451693430|FG000|Overall Study|Lost to Follow-up|2|||
125563747|NCT01075412|451693431|FG000|Overall Study|Withdrawal by Subject|0|||
125563748|NCT01075412|451693432|FG001|Overall Study|Withdrawal by Subject|1|||
125563749|NCT00865904|451693433|FG000|Overall Study|Randomized but not Treated|2|||
125563750|NCT00865904|451693434|FG001|Overall Study|Randomized but not Treated|0|||
125563751|NCT00865904|451693435|FG002|Overall Study|Randomized but not Treated|0|||
125563752|NCT00865904|451693436|FG003|Overall Study|Randomized but not Treated|1|||
125563753|NCT00865904|451693437|FG004|Overall Study|Randomized but not Treated|1|||
125563754|NCT03625687|451693438|FG000|Overall Study|Death|1|||
125563755|NCT00916149|451693443|FG000|Overall Study|Lost to Follow-up|3|||
125563756|NCT00916149|451693444|FG001|Overall Study|Lost to Follow-up|2|||
125563757|NCT00916149|451693445|FG002|Overall Study|Lost to Follow-up|0|||
125563758|NCT00916149|451693443|FG000|Overall Study|Unable to place scalp EEG leads|1|||
125563759|NCT00916149|451693444|FG001|Overall Study|Unable to place scalp EEG leads|0|||
125563760|NCT00916149|451693445|FG002|Overall Study|Unable to place scalp EEG leads|0|||
125426305|NCT01936857|451184474|FG000|Overall Study|Moved|2|||
125426306|NCT01936857|451184475|FG001|Overall Study|Moved|1|||
125563761|NCT00589420|451693446|FG000|Overall Study|screen failure|1|||
125563762|NCT01940471|451693447|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
125426307|NCT01936857|451184474|FG000|Overall Study|Withdrawal by Subject|1|||
125426308|NCT01936857|451184475|FG001|Overall Study|Withdrawal by Subject|0|||
125426309|NCT01936857|451184474|FG000|Overall Study|Side effect of medication|1|||
125426310|NCT01936857|451184475|FG001|Overall Study|Side effect of medication|0|||
125563763|NCT01940471|451693448|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
125563764|NCT01940471|451693449|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
125563765|NCT01940471|451693450|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
125563766|NCT01940471|451693447|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
125563767|NCT01940471|451693448|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
125563768|NCT01940471|451693449|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
125563769|NCT01940471|451693450|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
125563770|NCT01940471|451693447|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
125563771|NCT01940471|451693448|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
125563772|NCT01940471|451693449|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
125563773|NCT01940471|451693450|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
125563774|NCT01940471|451693447|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
125563775|NCT01940471|451693448|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
125563776|NCT01940471|451693449|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
125563777|NCT01940471|451693450|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
125563778|NCT01940471|451693447|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
125563779|NCT01940471|451693448|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
125563780|NCT01940471|451693449|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
125563781|NCT01940471|451693450|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
125563782|NCT01940471|451693447|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
125563783|NCT01940471|451693448|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
125563784|NCT01940471|451693449|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
125563785|NCT01940471|451693450|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
125563786|NCT01940471|451693447|FG000|Period 1: Double-blind Phase|Death|2|||
125563787|NCT01940471|451693448|FG001|Period 1: Double-blind Phase|Death|1|||
125563788|NCT01940471|451693449|FG002|Period 1: Double-blind Phase|Death|0|||
125563789|NCT01940471|451693450|FG003|Period 1: Double-blind Phase|Death|0|||
125563790|NCT01940471|451693447|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
125563791|NCT01940471|451693448|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
125563792|NCT01940471|451693449|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
125563793|NCT01940471|451693450|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
125563794|NCT01940471|451693447|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
125563795|NCT01940471|451693448|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
125563796|NCT01940471|451693449|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
125563797|NCT01940471|451693450|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
125563798|NCT01940471|451693447|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
125563799|NCT01940471|451693448|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
125563800|NCT01940471|451693449|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
125563801|NCT01940471|451693450|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
125563802|NCT01940471|451693447|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
125563803|NCT01940471|451693448|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
125355154|NCT02310321|450936457|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
125355155|NCT02310321|450936455|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
125355156|NCT02310321|450936456|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
125563804|NCT01940471|451693449|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
125355157|NCT02310321|450936457|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
125355158|NCT02310321|450936455|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
125355159|NCT02310321|450936456|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
125355160|NCT02310321|450936457|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
125355161|NCT02310321|450936455|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
125355162|NCT02310321|450936456|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
125355163|NCT02310321|450936457|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
125355164|NCT02310321|450936455|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
125355165|NCT02310321|450936456|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
125355166|NCT02310321|450936457|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
125355167|NCT02310321|450936455|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
125355168|NCT02310321|450936456|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
125355169|NCT02310321|450936457|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
125355170|NCT02310321|450936455|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
125355171|NCT02310321|450936456|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
125355172|NCT02310321|450936457|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
125355173|NCT02310321|450936455|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
125355174|NCT02310321|450936456|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
125563805|NCT01940471|451693450|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
125563806|NCT01940471|451693447|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
125563807|NCT01940471|451693448|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
125355175|NCT02310321|450936457|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
125355176|NCT02310321|450936455|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
125355177|NCT02310321|450936456|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
125355178|NCT02310321|450936457|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
125355179|NCT02310321|450936455|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
125355180|NCT02310321|450936456|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
125355181|NCT02310321|450936457|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
125355182|NCT02310321|450936455|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
125355183|NCT02310321|450936456|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
125355184|NCT02310321|450936457|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
125355185|NCT02310321|450936455|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
125355186|NCT02310321|450936456|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
125355187|NCT02310321|450936457|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
125355188|NCT02310321|450936455|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
125355189|NCT02310321|450936456|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
125355190|NCT02310321|450936457|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
125563808|NCT01940471|451693449|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
125563809|NCT01940471|451693450|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
125563810|NCT01940471|451693447|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
125563811|NCT01940471|451693448|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
125563812|NCT01940471|451693449|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
125563813|NCT01940471|451693450|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
125563814|NCT01940471|451693447|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
125563815|NCT01940471|451693448|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
125563816|NCT01940471|451693449|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
125563817|NCT01940471|451693450|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
125563818|NCT01940471|451693447|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
125563819|NCT01940471|451693448|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
125563820|NCT01940471|451693449|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
125563821|NCT01940471|451693450|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
125563822|NCT01940471|451693447|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
125563823|NCT01940471|451693448|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
125563824|NCT01940471|451693449|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
125563825|NCT01940471|451693450|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
125355191|NCT02310321|450936455|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
125355192|NCT02310321|450936456|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
125355193|NCT02310321|450936457|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
125355194|NCT02310321|450936455|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
125355195|NCT02310321|450936456|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
125355196|NCT02310321|450936457|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
125355197|NCT02310321|450936455|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
125355198|NCT02310321|450936456|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
125355199|NCT02310321|450936457|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
125355200|NCT02310321|450936455|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
125355201|NCT02310321|450936456|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
125355202|NCT02310321|450936457|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
125355203|NCT02310321|450936455|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
125355204|NCT02310321|450936456|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
125355205|NCT02310321|450936457|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
125355206|NCT02310321|450936455|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
125355207|NCT02310321|450936456|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
125355208|NCT02310321|450936457|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
125355209|NCT02310321|450936455|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
125355210|NCT02310321|450936456|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
125355211|NCT02310321|450936457|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
125355212|NCT02310321|450936455|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
125355213|NCT02310321|450936456|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
125355214|NCT02310321|450936457|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
125355215|NCT02310321|450936455|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
125355216|NCT02310321|450936456|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
125355217|NCT02310321|450936457|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
125355218|NCT02310321|450936455|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
125355219|NCT02310321|450936456|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
125355220|NCT02310321|450936457|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
125355221|NCT01698905|450936458|FG000|Overall Study|Adverse Event|4|||
125355222|NCT01698905|450936458|FG000|Overall Study|Physician Decision|2|||
125355223|NCT01698905|450936458|FG000|Overall Study|Pregnancy|1|||
125355224|NCT01698905|450936458|FG000|Overall Study|Protocol Violation|1|||
125355225|NCT01698905|450936458|FG000|Overall Study|Subject/guardian decision|2|||
125355226|NCT01698905|450936458|FG000|Overall Study|Death|1|||
125355227|NCT02325791|450936461|FG000|Overall Study|Adverse Event|0|||
125355228|NCT02325791|450936462|FG001|Overall Study|Adverse Event|1|||
125355229|NCT02325791|450936463|FG002|Overall Study|Adverse Event|1|||
125355230|NCT02325791|450936464|FG003|Overall Study|Adverse Event|0|||
125355231|NCT02325791|450936461|FG000|Overall Study|Death|0|||
125355232|NCT02325791|450936462|FG001|Overall Study|Death|3|||
125355233|NCT02325791|450936463|FG002|Overall Study|Death|0|||
125355234|NCT02325791|450936464|FG003|Overall Study|Death|1|||
125355235|NCT02325791|450936461|FG000|Overall Study|Lost to Follow-up|0|||
125355236|NCT02325791|450936462|FG001|Overall Study|Lost to Follow-up|15|||
125355237|NCT02325791|450936463|FG002|Overall Study|Lost to Follow-up|14|||
125355238|NCT02325791|450936464|FG003|Overall Study|Lost to Follow-up|9|||
125355239|NCT02325791|450936461|FG000|Overall Study|Physician Decision|0|||
125355240|NCT02325791|450936462|FG001|Overall Study|Physician Decision|1|||
125355241|NCT02325791|450936463|FG002|Overall Study|Physician Decision|1|||
125355242|NCT02325791|450936464|FG003|Overall Study|Physician Decision|0|||
125355243|NCT02325791|450936461|FG000|Overall Study|Protocol Violation|0|||
125355244|NCT02325791|450936462|FG001|Overall Study|Protocol Violation|0|||
125355245|NCT02325791|450936463|FG002|Overall Study|Protocol Violation|1|||
125355246|NCT02325791|450936464|FG003|Overall Study|Protocol Violation|0|||
125355247|NCT02325791|450936461|FG000|Overall Study|Withdrawal by Subject|0|||
125355248|NCT02325791|450936462|FG001|Overall Study|Withdrawal by Subject|5|||
125355249|NCT02325791|450936463|FG002|Overall Study|Withdrawal by Subject|8|||
125355250|NCT02325791|450936464|FG003|Overall Study|Withdrawal by Subject|16|||
125355251|NCT03953183|450936465|FG000|Overall Study|Physician Decision|0|||
125355252|NCT03953183|450936466|FG001|Overall Study|Physician Decision|1|||
125355253|NCT03953183|450936465|FG000|Overall Study|Withdrawal by Subject|0|||
125355254|NCT03953183|450936466|FG001|Overall Study|Withdrawal by Subject|1|||
125355255|NCT01465191|450936467|FG000|Overall Study|Protocol Violation|6|||
125355256|NCT01465191|450936468|FG001|Overall Study|Protocol Violation|3|||
125355257|NCT01465191|450936469|FG002|Overall Study|Protocol Violation|3|||
125355258|NCT01465191|450936467|FG000|Overall Study|Lost to Follow-up|3|||
125355259|NCT01465191|450936468|FG001|Overall Study|Lost to Follow-up|6|||
125355260|NCT01465191|450936469|FG002|Overall Study|Lost to Follow-up|4|||
125355261|NCT02273739|450936470|FG000|Overall Study|Progression of Disease|3|||
125355262|NCT02273739|450936471|FG001|Overall Study|Progression of Disease|4|||
125355263|NCT02273739|450936472|FG002|Overall Study|Progression of Disease|5|||
125355264|NCT02273739|450936473|FG003|Overall Study|Progression of Disease|2|||
125355265|NCT02273739|450936470|FG000|Overall Study|Death|0|||
125355266|NCT02273739|450936471|FG001|Overall Study|Death|0|||
125355267|NCT02273739|450936472|FG002|Overall Study|Death|0|||
125355268|NCT02273739|450936473|FG003|Overall Study|Death|2|||
125355269|NCT02273739|450936470|FG000|Overall Study|Adverse Event|0|||
125355270|NCT02273739|450936471|FG001|Overall Study|Adverse Event|0|||
125355271|NCT02273739|450936472|FG002|Overall Study|Adverse Event|0|||
125355272|NCT02273739|450936473|FG003|Overall Study|Adverse Event|1|||
125355273|NCT02273739|450936470|FG000|Overall Study|Withdrawal by Subject|0|||
125355274|NCT02273739|450936471|FG001|Overall Study|Withdrawal by Subject|0|||
125355275|NCT02273739|450936472|FG002|Overall Study|Withdrawal by Subject|2|||
125355276|NCT02273739|450936473|FG003|Overall Study|Withdrawal by Subject|1|||
125355277|NCT02273739|450936470|FG000|Overall Study|Physician Decision|0|||
125355278|NCT02273739|450936471|FG001|Overall Study|Physician Decision|0|||
125355279|NCT02273739|450936472|FG002|Overall Study|Physician Decision|0|||
125355280|NCT02273739|450936473|FG003|Overall Study|Physician Decision|1|||
125355281|NCT04795622|450936474|FG000|Overall Study|Adverse Event|1|||
125355282|NCT04795622|450936475|FG001|Overall Study|Adverse Event|0|||
125355283|NCT04795622|450936474|FG000|Overall Study|Withdrawal by Subject|3|||
125355284|NCT04795622|450936475|FG001|Overall Study|Withdrawal by Subject|3|||
125355285|NCT04795622|450936474|FG000|Overall Study|Protocol Violation|0|||
125355286|NCT04795622|450936475|FG001|Overall Study|Protocol Violation|2|||
125355287|NCT04795622|450936474|FG000|Overall Study|Lost to Follow-up|2|||
125355288|NCT04795622|450936475|FG001|Overall Study|Lost to Follow-up|3|||
125355289|NCT04795622|450936474|FG000|Overall Study|Other|7|||
125355290|NCT04795622|450936475|FG001|Overall Study|Other|8|||
125355291|NCT00089674|450936476|FG000|Overall Study|Physician Decision|4|||
125355292|NCT00089674|450936477|FG001|Overall Study|Physician Decision|2|||
125355293|NCT00089674|450936476|FG000|Overall Study|Adverse Event|23|||
125355294|NCT00089674|450936477|FG001|Overall Study|Adverse Event|29|||
125355295|NCT00089674|450936476|FG000|Overall Study|Withdrawal by Subject|143|||
125355296|NCT00089674|450936477|FG001|Overall Study|Withdrawal by Subject|127|||
125355297|NCT00089674|450936476|FG000|Overall Study|Death|43|||
125355298|NCT00089674|450936477|FG001|Overall Study|Death|43|||
125355299|NCT00089674|450936476|FG000|Overall Study|Disease progression|21|||
125355300|NCT00089674|450936477|FG001|Overall Study|Disease progression|23|||
125355301|NCT00089674|450936476|FG000|Overall Study|Ineligibility determined|8|||
125355302|NCT00089674|450936477|FG001|Overall Study|Ineligibility determined|10|||
125355303|NCT00089674|450936476|FG000|Overall Study|Lost to Follow-up|21|||
125355304|NCT00089674|450936477|FG001|Overall Study|Lost to Follow-up|17|||
125355305|NCT00089674|450936476|FG000|Overall Study|Noncompliance|7|||
125355306|NCT00089674|450936477|FG001|Overall Study|Noncompliance|3|||
125355307|NCT00089674|450936476|FG000|Overall Study|Other|5|||
125355308|NCT00089674|450936477|FG001|Overall Study|Other|9|||
125355309|NCT00089674|450936476|FG000|Overall Study|Requirement for alternative therapy|14|||
125355310|NCT00089674|450936477|FG001|Overall Study|Requirement for alternative therapy|4|||
125355311|NCT02961218|450936478|FG000|Overall Study|Lost to Follow-up|0|||
125355312|NCT02961218|450936479|FG001|Overall Study|Lost to Follow-up|2|||
125355313|NCT02961218|450936478|FG000|Overall Study|Physician Decision|0|||
125355314|NCT02961218|450936479|FG001|Overall Study|Physician Decision|2|||
125355315|NCT02961218|450936478|FG000|Overall Study|Subject/Guardian Decision|3|||
125355316|NCT02961218|450936479|FG001|Overall Study|Subject/Guardian Decision|1|||
125355317|NCT00591266|450936480|FG000|Overall Study|Adverse Event|2|||
125563826|NCT01940471|451693447|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
125563827|NCT01940471|451693448|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
125563828|NCT01940471|451693449|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
125563829|NCT01940471|451693450|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
125563830|NCT01940471|451693447|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
125563831|NCT01940471|451693448|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
125563832|NCT01940471|451693449|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
125563833|NCT01940471|451693450|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
125563834|NCT01940471|451693447|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
125563835|NCT01940471|451693448|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
125563836|NCT01940471|451693449|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
125563837|NCT01940471|451693450|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
125563838|NCT01940471|451693447|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
125563839|NCT01940471|451693448|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
125563840|NCT01940471|451693449|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
125563841|NCT01940471|451693450|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
125563842|NCT01940471|451693447|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
125563843|NCT01940471|451693448|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
125563844|NCT01940471|451693449|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
125563845|NCT01940471|451693450|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
125563846|NCT01846624|451693451|FG000|Overall Study|Died during induction, no midostaurin|1|||
125563847|NCT03574753|451693452|FG000|Overall Study|Adverse Event|3|||
125563848|NCT03574753|451693452|FG000|Overall Study|Progression/relapse|19|||
125563849|NCT03574753|451693452|FG000|Overall Study|Death|1|||
125563850|NCT03462719|451693455|FG000|Overall Study|Withdrawal by Subject|4|||
125563851|NCT03462719|451693456|FG001|Overall Study|Withdrawal by Subject|3|||
125563852|NCT03462719|451693455|FG000|Overall Study|Ongoing|87|||
125563853|NCT03462719|451693456|FG001|Overall Study|Ongoing|72|||
125563854|NCT00307151|451694536|FG000|Overall Study|Death|4|||
125563855|NCT00307151|451694537|FG001|Overall Study|Death|3|||
125563856|NCT00307151|451694538|FG002|Overall Study|Death|10|||
125563857|NCT00307151|451694539|FG003|Overall Study|Death|3|||
125563858|NCT00307151|451694536|FG000|Overall Study|Severe debilitation, unable to continue|1|||
125563859|NCT00307151|451694537|FG001|Overall Study|Severe debilitation, unable to continue|0|||
125563860|NCT00307151|451694538|FG002|Overall Study|Severe debilitation, unable to continue|0|||
125563861|NCT00307151|451694539|FG003|Overall Study|Severe debilitation, unable to continue|0|||
125563862|NCT00307151|451694536|FG000|Overall Study|Subject unable to get to clinic|1|||
125563863|NCT00307151|451694537|FG001|Overall Study|Subject unable to get to clinic|0|||
125563864|NCT00307151|451694538|FG002|Overall Study|Subject unable to get to clinic|6|||
125355318|NCT00591266|450936481|FG001|Overall Study|Adverse Event|2|||
125563865|NCT00307151|451694539|FG003|Overall Study|Subject unable to get to clinic|2|||
125563866|NCT00307151|451694536|FG000|Overall Study|Withdrew consent|0|||
125563867|NCT00307151|451694537|FG001|Overall Study|Withdrew consent|1|||
125563868|NCT00307151|451694538|FG002|Overall Study|Withdrew consent|1|||
125563869|NCT00307151|451694539|FG003|Overall Study|Withdrew consent|3|||
125563870|NCT00307151|451694536|FG000|Overall Study|Not willing to adhere to study reqs|2|||
125355319|NCT00591266|450936482|FG002|Overall Study|Adverse Event|3|||
125563871|NCT00307151|451694537|FG001|Overall Study|Not willing to adhere to study reqs|0|||
125563872|NCT00307151|451694538|FG002|Overall Study|Not willing to adhere to study reqs|2|||
125563873|NCT00307151|451694539|FG003|Overall Study|Not willing to adhere to study reqs|2|||
125563874|NCT00307151|451694536|FG000|Overall Study|Clinic unable to contact subject|3|||
125563875|NCT00307151|451694537|FG001|Overall Study|Clinic unable to contact subject|3|||
125563876|NCT00307151|451694538|FG002|Overall Study|Clinic unable to contact subject|1|||
125563877|NCT00307151|451694539|FG003|Overall Study|Clinic unable to contact subject|1|||
125563878|NCT01490450|451694540|FG000|Period 1|Lack of Efficacy|2|||
125563879|NCT01490450|451694541|FG001|Period 1|Lack of Efficacy|0|||
125563880|NCT01490450|451694542|FG002|Period 1|Lack of Efficacy|3|||
125563881|NCT01490450|451694543|FG003|Period 1|Lack of Efficacy|0|||
125563882|NCT01490450|451694540|FG000|Period 1|Adverse Event|0|||
125563883|NCT01490450|451694541|FG001|Period 1|Adverse Event|0|||
125563884|NCT01490450|451694542|FG002|Period 1|Adverse Event|0|||
125563885|NCT01490450|451694543|FG003|Period 1|Adverse Event|5|||
125563886|NCT01490450|451694540|FG000|Period 1|Request to discontinue treatment|1|||
125563887|NCT01490450|451694541|FG001|Period 1|Request to discontinue treatment|0|||
125563888|NCT01490450|451694542|FG002|Period 1|Request to discontinue treatment|0|||
125563889|NCT01490450|451694543|FG003|Period 1|Request to discontinue treatment|0|||
125563890|NCT01490450|451694540|FG000|Period 1|Withdrawal by Subject|0|||
125563891|NCT01490450|451694541|FG001|Period 1|Withdrawal by Subject|0|||
125563892|NCT01490450|451694542|FG002|Period 1|Withdrawal by Subject|0|||
125563893|NCT01490450|451694543|FG003|Period 1|Withdrawal by Subject|3|||
125563894|NCT01490450|451694540|FG000|Period 1|No longer met study criteria|0|||
125563895|NCT01490450|451694541|FG001|Period 1|No longer met study criteria|1|||
125563896|NCT01490450|451694542|FG002|Period 1|No longer met study criteria|1|||
125563897|NCT01490450|451694543|FG003|Period 1|No longer met study criteria|0|||
125563898|NCT01490450|451694540|FG000|Period 2|Lack of Efficacy|0|||
125563899|NCT01490450|451694541|FG001|Period 2|Lack of Efficacy|0|||
125563900|NCT01490450|451694542|FG002|Period 2|Lack of Efficacy|0|||
125563901|NCT01490450|451694543|FG003|Period 2|Lack of Efficacy|1|||
125563902|NCT01490450|451694540|FG000|Period 2|Adverse Event|1|||
125563903|NCT01490450|451694541|FG001|Period 2|Adverse Event|1|||
125563904|NCT01490450|451694542|FG002|Period 2|Adverse Event|0|||
125563905|NCT01490450|451694543|FG003|Period 2|Adverse Event|1|||
125563906|NCT01490450|451694540|FG000|Period 2|Withdrawal by Subject|1|||
125563907|NCT01490450|451694541|FG001|Period 2|Withdrawal by Subject|0|||
125563908|NCT01490450|451694542|FG002|Period 2|Withdrawal by Subject|0|||
125563909|NCT01490450|451694543|FG003|Period 2|Withdrawal by Subject|0|||
125563910|NCT01490450|451694540|FG000|Period 2|Lost to Follow-up|0|||
125563911|NCT01490450|451694541|FG001|Period 2|Lost to Follow-up|0|||
125563912|NCT01490450|451694542|FG002|Period 2|Lost to Follow-up|0|||
125563913|NCT01490450|451694543|FG003|Period 2|Lost to Follow-up|2|||
125563914|NCT02081534|451694544|FG000|Overall Study|Adverse Event|5|||
125563915|NCT02081534|451694545|FG001|Overall Study|Adverse Event|4|||
125563916|NCT02081534|451694546|FG002|Overall Study|Adverse Event|3|||
125563917|NCT02081534|451694547|FG003|Overall Study|Adverse Event|10|||
125563918|NCT02081534|451694548|FG004|Overall Study|Adverse Event|2|||
125563919|NCT02081534|451694549|FG005|Overall Study|Adverse Event|8|||
125563920|NCT02081534|451694550|FG006|Overall Study|Adverse Event|2|||
125563921|NCT02081534|451694544|FG000|Overall Study|Withdrawal by Subject|0|||
125563922|NCT02081534|451694545|FG001|Overall Study|Withdrawal by Subject|1|||
125563923|NCT02081534|451694546|FG002|Overall Study|Withdrawal by Subject|1|||
125563924|NCT02081534|451694547|FG003|Overall Study|Withdrawal by Subject|1|||
125563925|NCT02081534|451694548|FG004|Overall Study|Withdrawal by Subject|1|||
125563926|NCT02081534|451694549|FG005|Overall Study|Withdrawal by Subject|0|||
125563927|NCT02081534|451694550|FG006|Overall Study|Withdrawal by Subject|1|||
125563928|NCT02081534|451694544|FG000|Overall Study|Protocol Violation|0|||
125563929|NCT02081534|451694545|FG001|Overall Study|Protocol Violation|3|||
125563930|NCT02081534|451694546|FG002|Overall Study|Protocol Violation|0|||
125563931|NCT02081534|451694547|FG003|Overall Study|Protocol Violation|0|||
125563932|NCT02081534|451694548|FG004|Overall Study|Protocol Violation|0|||
125563933|NCT02081534|451694549|FG005|Overall Study|Protocol Violation|0|||
125563934|NCT02081534|451694550|FG006|Overall Study|Protocol Violation|1|||
125563935|NCT02081534|451694544|FG000|Overall Study|Lost to Follow-up|0|||
125563936|NCT02081534|451694545|FG001|Overall Study|Lost to Follow-up|0|||
125563937|NCT02081534|451694546|FG002|Overall Study|Lost to Follow-up|0|||
125563938|NCT02081534|451694547|FG003|Overall Study|Lost to Follow-up|2|||
125563939|NCT02081534|451694548|FG004|Overall Study|Lost to Follow-up|1|||
125563940|NCT02081534|451694549|FG005|Overall Study|Lost to Follow-up|1|||
125563941|NCT02081534|451694550|FG006|Overall Study|Lost to Follow-up|0|||
125563942|NCT01365039|451694551|FG000|Overall Study|Study related symptoms and complaints|1|||
125563943|NCT01365039|451694552|FG001|Overall Study|Study related symptoms and complaints|0|||
125563944|NCT00253643|451694555|FG000|Overall Study|Withdrawal by Subject|0|||
125563945|NCT00253643|451694556|FG001|Overall Study|Withdrawal by Subject|0|||
125563946|NCT00253643|451694557|FG002|Overall Study|Withdrawal by Subject|1|||
125563947|NCT00253643|451694558|FG003|Overall Study|Withdrawal by Subject|1|||
125563948|NCT00253643|451694555|FG000|Overall Study|Non-Compliance|0|||
125563949|NCT00253643|451694556|FG001|Overall Study|Non-Compliance|0|||
125563950|NCT00253643|451694557|FG002|Overall Study|Non-Compliance|0|||
125563951|NCT00253643|451694558|FG003|Overall Study|Non-Compliance|2|||
125563952|NCT02159729|451694559|FG000|Overall Study|Adverse Event|0|||
125563953|NCT02159729|451694560|FG001|Overall Study|Adverse Event|1|||
125563954|NCT02159729|451694559|FG000|Overall Study|Subject's Request|13|||
125563955|NCT02159729|451694560|FG001|Overall Study|Subject's Request|10|||
125563956|NCT02159729|451694559|FG000|Overall Study|Lost to Follow-up|24|||
125563957|NCT02159729|451694560|FG001|Overall Study|Lost to Follow-up|9|||
125563958|NCT02159729|451694559|FG000|Overall Study|Non compliance|2|||
125563959|NCT02159729|451694560|FG001|Overall Study|Non compliance|0|||
125563960|NCT02159729|451694559|FG000|Overall Study|Other Unspecified|3|||
125563961|NCT02159729|451694560|FG001|Overall Study|Other Unspecified|1|||
125563962|NCT01263483|451694561|FG000|Overall Study|Adverse Event|4|||
125563963|NCT01263483|451694562|FG001|Overall Study|Adverse Event|0|||
125563964|NCT01263483|451694563|FG002|Overall Study|Adverse Event|3|||
125563965|NCT01263483|451694561|FG000|Overall Study|Withdrawal by Subject|1|||
125563966|NCT01263483|451694562|FG001|Overall Study|Withdrawal by Subject|0|||
125563967|NCT01263483|451694563|FG002|Overall Study|Withdrawal by Subject|0|||
125563968|NCT01263483|451694561|FG000|Overall Study|Lack of Efficacy|2|||
125563969|NCT01263483|451694562|FG001|Overall Study|Lack of Efficacy|0|||
125563970|NCT01263483|451694563|FG002|Overall Study|Lack of Efficacy|0|||
125563971|NCT01263483|451694561|FG000|Overall Study|Protocol Violation|0|||
125563972|NCT01263483|451694562|FG001|Overall Study|Protocol Violation|1|||
125563973|NCT01263483|451694563|FG002|Overall Study|Protocol Violation|1|||
125563974|NCT01263483|451694561|FG000|Overall Study|Participant Unavailability|0|||
125426311|NCT01936857|451184474|FG000|Overall Study|Other|2|||
125563975|NCT01263483|451694562|FG001|Overall Study|Participant Unavailability|1|||
125563976|NCT01263483|451694563|FG002|Overall Study|Participant Unavailability|1|||
125563977|NCT01111851|451694564|FG000|Overall Study|All planned PET scans were not obtained.|2|||
125563978|NCT01111851|451694565|FG001|Overall Study|All planned PET scans were not obtained.|0|||
125563979|NCT01961349|451694566|FG000|Overall Study|Withdrawal by Subject|1|||
125563980|NCT01961349|451694567|FG001|Overall Study|Withdrawal by Subject|4|||
125563981|NCT01961349|451694568|FG002|Overall Study|Withdrawal by Subject|0|||
125563982|NCT01961349|451694566|FG000|Overall Study|Adverse Event|0|||
125563983|NCT01961349|451694567|FG001|Overall Study|Adverse Event|0|||
125563984|NCT01961349|451694568|FG002|Overall Study|Adverse Event|1|||
125563985|NCT01961349|451694566|FG000|Overall Study|registration error, personal reason etc|2|||
125563986|NCT01961349|451694567|FG001|Overall Study|registration error, personal reason etc|2|||
125563987|NCT01961349|451694568|FG002|Overall Study|registration error, personal reason etc|1|||
125563988|NCT00829179|451694570|FG000|Overall Study|Withdrawal by Subject|1|||
125563989|NCT01299376|451694571|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
125563990|NCT01299376|451694572|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
125563991|NCT01299376|451694571|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
125563992|NCT01299376|451694572|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
125563993|NCT01299376|451694571|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
125563994|NCT01299376|451694572|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
125563995|NCT01299376|451694571|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
125563996|NCT01299376|451694572|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
125563997|NCT01299376|451694571|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
125563998|NCT01299376|451694572|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
125563999|NCT01299376|451694571|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
125564000|NCT01299376|451694572|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
125564001|NCT01299376|451694571|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
125564002|NCT01299376|451694572|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
125564003|NCT01299376|451694571|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
125564004|NCT01299376|451694572|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
125355320|NCT00591266|450936480|FG000|Overall Study|Lost to Follow-up|0|||
125564005|NCT01299376|451694571|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
125564006|NCT01299376|451694572|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
125564007|NCT01299376|451694571|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
125564008|NCT01299376|451694572|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
125564009|NCT01299376|451694571|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
125564010|NCT01299376|451694572|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
125564011|NCT01431274|451694578|FG000|Overall Study|Adverse Event|51|||
125564012|NCT01431274|451694579|FG001|Overall Study|Adverse Event|37|||
125564013|NCT01431274|451694580|FG002|Overall Study|Adverse Event|43|||
125564014|NCT01431274|451694581|FG003|Overall Study|Adverse Event|30|||
125564015|NCT01431274|451694582|FG004|Overall Study|Adverse Event|37|||
125564016|NCT01431274|451694578|FG000|Overall Study|Consent withdrawn not due to AE|29|||
125564017|NCT01431274|451694579|FG001|Overall Study|Consent withdrawn not due to AE|20|||
125564018|NCT01431274|451694580|FG002|Overall Study|Consent withdrawn not due to AE|17|||
125564019|NCT01431274|451694581|FG003|Overall Study|Consent withdrawn not due to AE|20|||
125564020|NCT01431274|451694582|FG004|Overall Study|Consent withdrawn not due to AE|11|||
125564021|NCT01431274|451694578|FG000|Overall Study|Non compliant with protocol|5|||
125564022|NCT01431274|451694579|FG001|Overall Study|Non compliant with protocol|8|||
125564023|NCT01431274|451694580|FG002|Overall Study|Non compliant with protocol|4|||
125564024|NCT01431274|451694581|FG003|Overall Study|Non compliant with protocol|4|||
125564025|NCT01431274|451694582|FG004|Overall Study|Non compliant with protocol|4|||
125564026|NCT01431274|451694578|FG000|Overall Study|Lost to Follow-up|6|||
125564027|NCT01431274|451694579|FG001|Overall Study|Lost to Follow-up|7|||
125564028|NCT01431274|451694580|FG002|Overall Study|Lost to Follow-up|1|||
125564029|NCT01431274|451694581|FG003|Overall Study|Lost to Follow-up|4|||
125564030|NCT01431274|451694582|FG004|Overall Study|Lost to Follow-up|0|||
125564031|NCT01431274|451694578|FG000|Overall Study|Other reason not stated above|6|||
125564032|NCT01431274|451694579|FG001|Overall Study|Other reason not stated above|5|||
125564033|NCT01431274|451694580|FG002|Overall Study|Other reason not stated above|7|||
125564034|NCT01431274|451694581|FG003|Overall Study|Other reason not stated above|2|||
125564035|NCT01431274|451694582|FG004|Overall Study|Other reason not stated above|4|||
125564036|NCT00711425|451694583|FG000|Overall Study|Protocol Violation|1|||
125564037|NCT00711425|451694583|FG000|Overall Study|Death|2|||
125564038|NCT00711425|451694583|FG000|Overall Study|Lost to Follow-up|1|||
125564039|NCT04607148|451694586|FG000|Overall Study|Withdrawal by Subject|0|||
125564040|NCT04607148|451694587|FG001|Overall Study|Withdrawal by Subject|4|||
125564041|NCT04607148|451694588|FG002|Overall Study|Withdrawal by Subject|2|||
125564042|NCT04607148|451694589|FG003|Overall Study|Withdrawal by Subject|8|||
125564043|NCT04607148|451694586|FG000|Overall Study|Study Terminated by Sponsor|14|||
125564044|NCT04607148|451694587|FG001|Overall Study|Study Terminated by Sponsor|59|||
125564045|NCT04607148|451694588|FG002|Overall Study|Study Terminated by Sponsor|9|||
125564046|NCT04607148|451694589|FG003|Overall Study|Study Terminated by Sponsor|39|||
125564047|NCT04607148|451694586|FG000|Overall Study|Sponsor Decision|0|||
125564048|NCT04607148|451694587|FG001|Overall Study|Sponsor Decision|0|||
125564049|NCT04607148|451694588|FG002|Overall Study|Sponsor Decision|1|||
125564050|NCT04607148|451694589|FG003|Overall Study|Sponsor Decision|0|||
125564051|NCT04607148|451694586|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125564052|NCT04607148|451694587|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125564053|NCT04607148|451694588|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125426312|NCT01936857|451184475|FG001|Overall Study|Other|2|||
125426313|NCT02279043|451184476|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
125426314|NCT02279043|451184477|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
125426315|NCT02279043|451184478|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
125426316|NCT02279043|451184476|FG000|Overall Study|Lost to Follow-up|46|||
125426317|NCT02279043|451184477|FG001|Overall Study|Lost to Follow-up|88|||
125426318|NCT02279043|451184478|FG002|Overall Study|Lost to Follow-up|0|||
125564054|NCT04607148|451694589|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125564055|NCT04607148|451694586|FG000|Overall Study|Lost to Follow-up|0|||
125564056|NCT04607148|451694587|FG001|Overall Study|Lost to Follow-up|2|||
125564057|NCT04607148|451694588|FG002|Overall Study|Lost to Follow-up|0|||
125564058|NCT04607148|451694589|FG003|Overall Study|Lost to Follow-up|0|||
125564059|NCT04607148|451694586|FG000|Overall Study|Death|0|||
125564060|NCT04607148|451694587|FG001|Overall Study|Death|3|||
125564061|NCT04607148|451694588|FG002|Overall Study|Death|0|||
125564062|NCT04607148|451694589|FG003|Overall Study|Death|1|||
125564063|NCT04607148|451694586|FG000|Overall Study|Adverse Event|0|||
125564064|NCT04607148|451694587|FG001|Overall Study|Adverse Event|1|||
125564065|NCT04607148|451694588|FG002|Overall Study|Adverse Event|0|||
125426319|NCT03848403|451184479|FG000|Period 2 (Day 8)|Adverse Event|1|||
125564066|NCT04607148|451694589|FG003|Overall Study|Adverse Event|0|||
125564067|NCT00912028|451694590|FG000|Overall Study|Lost to Follow-up|2|||
125355321|NCT00591266|450936481|FG001|Overall Study|Lost to Follow-up|1|||
125355322|NCT00591266|450936482|FG002|Overall Study|Lost to Follow-up|0|||
125355323|NCT00591266|450936480|FG000|Overall Study|Protocol Violation|0|||
125355324|NCT00591266|450936481|FG001|Overall Study|Protocol Violation|0|||
125564068|NCT00912028|451694591|FG001|Overall Study|Lost to Follow-up|3|||
125355325|NCT00591266|450936482|FG002|Overall Study|Protocol Violation|1|||
125355326|NCT00591266|450936480|FG000|Overall Study|Withdrawal by Subject|6|||
125564069|NCT00912028|451694592|FG002|Overall Study|Lost to Follow-up|0|||
125564070|NCT00912028|451694593|FG003|Overall Study|Lost to Follow-up|1|||
125564071|NCT00912028|451694594|FG004|Overall Study|Lost to Follow-up|3|||
125564072|NCT00912028|451694590|FG000|Overall Study|Withdrawal by Subject|3|||
125564073|NCT00912028|451694591|FG001|Overall Study|Withdrawal by Subject|0|||
125564074|NCT00912028|451694592|FG002|Overall Study|Withdrawal by Subject|0|||
125564075|NCT00912028|451694593|FG003|Overall Study|Withdrawal by Subject|0|||
125564076|NCT00912028|451694594|FG004|Overall Study|Withdrawal by Subject|0|||
125564077|NCT01744665|451694599|FG000|Monitoring Phase|Adverse Event|4|||
125564078|NCT01744665|451694599|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
125564079|NCT01744665|451694599|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
125564080|NCT01744665|451694599|FG000|Monitoring Phase|Withdrawal by Subject|5|||
125564081|NCT01744665|451694599|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
125564082|NCT01744665|451694599|FG000|Consolidation Phase|Adverse Event|2|||
125564083|NCT01744665|451694599|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
125564084|NCT01744665|451694599|FG000|Consolidation Phase|Withdrawal by Subject|4|||
125564085|NCT01744665|451694599|FG000|Consolidation Phase|Administrative problems|9|||
125564086|NCT01744665|451694599|FG000|Re-initiation Phase|Administrative problems|10|||
125564087|NCT01744665|451694599|FG000|Re-initiation Phase|Adverse Event|1|||
125564088|NCT01744665|451694599|FG000|Re-initiation Phase|No longer required treatment|1|||
125564089|NCT01744665|451694599|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
125564090|NCT03184077|451694600|FG000|Overall Study|Lost to Follow-up|21|||
125564091|NCT03184077|451694601|FG001|Overall Study|Lost to Follow-up|21|||
125564092|NCT02046096|451694610|FG000|Overall Study|Death|28|||
125564093|NCT02046096|451694611|FG001|Overall Study|Death|45|||
125564094|NCT02046096|451694610|FG000|Overall Study|Lost to Follow-up|9|||
125564095|NCT02046096|451694611|FG001|Overall Study|Lost to Follow-up|20|||
125564096|NCT02046096|451694610|FG000|Overall Study|Withdrawal by Subject|5|||
125564097|NCT02046096|451694611|FG001|Overall Study|Withdrawal by Subject|17|||
125564098|NCT02046096|451694610|FG000|Overall Study|Other endpoint|2|||
125564099|NCT02046096|451694611|FG001|Overall Study|Other endpoint|19|||
125564100|NCT02090413|451694612|FG000|Overall Study|Adverse Event|11|||
125564101|NCT02090413|451694613|FG001|Overall Study|Adverse Event|15|||
125564102|NCT02090413|451694614|FG002|Overall Study|Adverse Event|20|||
125564103|NCT02090413|451694612|FG000|Overall Study|Flushing event|2|||
125564104|NCT02090413|451694613|FG001|Overall Study|Flushing event|0|||
125564105|NCT02090413|451694614|FG002|Overall Study|Flushing event|1|||
125564106|NCT02090413|451694612|FG000|Overall Study|Withdrawal by Subject|2|||
125564107|NCT02090413|451694613|FG001|Overall Study|Withdrawal by Subject|2|||
125564108|NCT02090413|451694614|FG002|Overall Study|Withdrawal by Subject|2|||
125564109|NCT02090413|451694612|FG000|Overall Study|Investigator Decision|1|||
125564110|NCT02090413|451694613|FG001|Overall Study|Investigator Decision|1|||
125564111|NCT02090413|451694614|FG002|Overall Study|Investigator Decision|0|||
125564112|NCT02090413|451694612|FG000|Overall Study|Other|2|||
125564113|NCT02090413|451694613|FG001|Overall Study|Other|1|||
125564114|NCT02090413|451694614|FG002|Overall Study|Other|0|||
125564115|NCT02090413|451694612|FG000|Overall Study|Lost to Follow-up|1|||
125564116|NCT02090413|451694613|FG001|Overall Study|Lost to Follow-up|1|||
125564117|NCT02090413|451694614|FG002|Overall Study|Lost to Follow-up|0|||
125355327|NCT00591266|450936481|FG001|Overall Study|Withdrawal by Subject|2|||
125355328|NCT00591266|450936482|FG002|Overall Study|Withdrawal by Subject|5|||
125355329|NCT00591266|450936480|FG000|Overall Study|Lack of Efficacy|0|||
125355330|NCT00591266|450936481|FG001|Overall Study|Lack of Efficacy|2|||
125355331|NCT00591266|450936482|FG002|Overall Study|Lack of Efficacy|0|||
125355332|NCT00591266|450936480|FG000|Overall Study|Other|1|||
125355333|NCT00591266|450936481|FG001|Overall Study|Other|4|||
125564118|NCT01045798|451694615|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
125564119|NCT01045798|451694616|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
125564120|NCT01045798|451694615|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
125564121|NCT01045798|451694616|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
125564122|NCT01045798|451694615|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
125355334|NCT00591266|450936482|FG002|Overall Study|Other|5|||
125564123|NCT01045798|451694616|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
125564124|NCT01045798|451694615|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
125564125|NCT01045798|451694616|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
125564126|NCT05321069|451694621|FG000|Overall Study|Adverse Event|52|||
125564127|NCT05321069|451694622|FG001|Overall Study|Adverse Event|52|||
125564128|NCT05321069|451694623|FG002|Overall Study|Adverse Event|64|||
125564129|NCT05321069|451694621|FG000|Overall Study|Protocol Violation|1|||
125564130|NCT05321069|451694622|FG001|Overall Study|Protocol Violation|1|||
125564131|NCT05321069|451694623|FG002|Overall Study|Protocol Violation|0|||
125564132|NCT05321069|451694621|FG000|Overall Study|Withdrawal by Subject|23|||
125564133|NCT05321069|451694622|FG001|Overall Study|Withdrawal by Subject|18|||
125564134|NCT05321069|451694623|FG002|Overall Study|Withdrawal by Subject|12|||
125564135|NCT05321069|451694621|FG000|Overall Study|Lost to Follow-up|1|||
125564136|NCT05321069|451694622|FG001|Overall Study|Lost to Follow-up|0|||
125564137|NCT05321069|451694623|FG002|Overall Study|Lost to Follow-up|1|||
125564138|NCT05321069|451694621|FG000|Overall Study|No reason stated by the participants|23|||
125564139|NCT05321069|451694622|FG001|Overall Study|No reason stated by the participants|22|||
125355335|NCT03488927|450936483|FG000|Overall Study|Withdrawal by Subject|44|||
125564140|NCT05321069|451694623|FG002|Overall Study|No reason stated by the participants|16|||
125564141|NCT05321069|451694621|FG000|Overall Study|Lack of Efficacy|1|||
125564142|NCT05321069|451694622|FG001|Overall Study|Lack of Efficacy|1|||
125564143|NCT05321069|451694623|FG002|Overall Study|Lack of Efficacy|0|||
125564144|NCT06156215|451694626|FG000|Overall Study|Withdrawal by Subject|2|||
125564145|NCT06156215|451694627|FG001|Overall Study|Withdrawal by Subject|4|||
125564146|NCT06156215|451694628|FG002|Overall Study|Withdrawal by Subject|4|||
125564147|NCT06156215|451694629|FG003|Overall Study|Withdrawal by Subject|0|||
125564148|NCT06156215|451694630|FG004|Overall Study|Withdrawal by Subject|2|||
125564149|NCT06156215|451694631|FG005|Overall Study|Withdrawal by Subject|2|||
125564150|NCT06156215|451694626|FG000|Overall Study|Left ED without completing study|9|||
125564151|NCT06156215|451694627|FG001|Overall Study|Left ED without completing study|3|||
125564152|NCT06156215|451694628|FG002|Overall Study|Left ED without completing study|9|||
125564153|NCT06156215|451694629|FG003|Overall Study|Left ED without completing study|0|||
125564154|NCT06156215|451694630|FG004|Overall Study|Left ED without completing study|8|||
125564155|NCT06156215|451694631|FG005|Overall Study|Left ED without completing study|16|||
125564156|NCT06156215|451694626|FG000|Overall Study|Physician Decision|1|||
125564157|NCT06156215|451694627|FG001|Overall Study|Physician Decision|0|||
125564158|NCT06156215|451694628|FG002|Overall Study|Physician Decision|0|||
125564159|NCT06156215|451694629|FG003|Overall Study|Physician Decision|0|||
125564160|NCT06156215|451694630|FG004|Overall Study|Physician Decision|0|||
125564161|NCT06156215|451694631|FG005|Overall Study|Physician Decision|0|||
125564162|NCT06156215|451694626|FG000|Overall Study|Became or found ineligible|2|||
125564163|NCT06156215|451694627|FG001|Overall Study|Became or found ineligible|0|||
125564164|NCT06156215|451694628|FG002|Overall Study|Became or found ineligible|2|||
125564165|NCT06156215|451694629|FG003|Overall Study|Became or found ineligible|0|||
125564166|NCT06156215|451694630|FG004|Overall Study|Became or found ineligible|1|||
125564167|NCT06156215|451694631|FG005|Overall Study|Became or found ineligible|2|||
125564168|NCT00597753|451694636|FG000|Overall Study|Adverse Event|6|||
125564169|NCT00597753|451694637|FG001|Overall Study|Adverse Event|2|||
125564170|NCT00597753|451694636|FG000|Overall Study|Death|55|||
125564171|NCT00597753|451694637|FG001|Overall Study|Death|29|||
125564172|NCT00597753|451694636|FG000|Overall Study|Lack of Efficacy|2|||
125564173|NCT00597753|451694637|FG001|Overall Study|Lack of Efficacy|0|||
125564174|NCT00597753|451694636|FG000|Overall Study|Lost to Follow-up|10|||
125564175|NCT00597753|451694637|FG001|Overall Study|Lost to Follow-up|3|||
125564176|NCT00597753|451694636|FG000|Overall Study|Physician Decision|5|||
125564177|NCT00597753|451694637|FG001|Overall Study|Physician Decision|1|||
125564178|NCT00597753|451694636|FG000|Overall Study|Pregnancy|1|||
125564179|NCT00597753|451694637|FG001|Overall Study|Pregnancy|0|||
125564180|NCT00597753|451694636|FG000|Overall Study|Withdrawal by Subject|35|||
125564181|NCT00597753|451694637|FG001|Overall Study|Withdrawal by Subject|12|||
125564182|NCT00597753|451694636|FG000|Overall Study|Discontinued Dialysis|0|||
125564183|NCT00597753|451694637|FG001|Overall Study|Discontinued Dialysis|1|||
125564184|NCT00597753|451694636|FG000|Overall Study|Never dosed|2|||
125564185|NCT00597753|451694637|FG001|Overall Study|Never dosed|0|||
125564186|NCT00597753|451694636|FG000|Overall Study|Noncompliance|2|||
125564187|NCT00597753|451694637|FG001|Overall Study|Noncompliance|1|||
125564188|NCT00597753|451694636|FG000|Overall Study|Relocation|17|||
125564189|NCT00597753|451694637|FG001|Overall Study|Relocation|6|||
125564190|NCT00597753|451694636|FG000|Overall Study|Renal transplant|10|||
125564191|NCT00597753|451694637|FG001|Overall Study|Renal transplant|3|||
125564192|NCT00597753|451694636|FG000|Overall Study|Site closed by sponsor|19|||
125564193|NCT00597753|451694637|FG001|Overall Study|Site closed by sponsor|7|||
125564194|NCT00597753|451694636|FG000|Overall Study|Site elected to close|2|||
125564195|NCT00597753|451694637|FG001|Overall Study|Site elected to close|4|||
125564196|NCT03451851|451694638|FG000|PCP: Week 0 -16|Adverse Event|1|||
125564197|NCT03451851|451694639|FG001|PCP: Week 0 -16|Adverse Event|0|||
125564198|NCT03451851|451694640|FG002|PCP: Week 0 -16|Adverse Event|0|||
125564199|NCT03451851|451694641|FG003|PCP: Week 0 -16|Adverse Event|0|||
125564200|NCT03451851|451694642|FG004|PCP: Week 0 -16|Adverse Event|0|||
125564201|NCT03451851|451694643|FG005|PCP: Week 0 -16|Adverse Event|0|||
125564202|NCT03451851|451694644|FG006|PCP: Week 0 -16|Adverse Event|1|||
125564203|NCT03451851|451694645|FG007|PCP: Week 0 -16|Adverse Event|0|||
125564204|NCT03451851|451694638|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
125564205|NCT03451851|451694639|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
125564206|NCT03451851|451694640|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
125564207|NCT03451851|451694641|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
125564208|NCT03451851|451694642|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
125564209|NCT03451851|451694643|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
125564210|NCT03451851|451694644|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
125564211|NCT03451851|451694645|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
125426320|NCT03848403|451184480|FG001|Period 2 (Day 8)|Adverse Event|2|||
125564212|NCT03451851|451694638|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125564213|NCT03451851|451694639|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125564214|NCT03451851|451694640|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
125564215|NCT03451851|451694641|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125564216|NCT03451851|451694642|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125564217|NCT03451851|451694643|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125564218|NCT03451851|451694644|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125564219|NCT03451851|451694645|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
125564220|NCT03451851|451694638|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
125564221|NCT03451851|451694639|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
125564222|NCT03451851|451694640|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
125564223|NCT03451851|451694641|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
125564224|NCT03451851|451694642|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
125564225|NCT03451851|451694643|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
125564226|NCT03451851|451694644|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
125564227|NCT03451851|451694645|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
125564228|NCT03451851|451694638|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125564229|NCT03451851|451694639|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125564230|NCT03451851|451694640|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125564231|NCT03451851|451694641|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125564232|NCT03451851|451694642|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
125564233|NCT03451851|451694643|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125564234|NCT03451851|451694644|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125564235|NCT03451851|451694645|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
125564236|NCT03451851|451694638|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125564237|NCT03451851|451694639|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125564238|NCT03451851|451694640|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125564239|NCT03451851|451694641|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125564240|NCT03451851|451694642|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
125564241|NCT03451851|451694643|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125564242|NCT03451851|451694644|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125564243|NCT03451851|451694645|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
125564244|NCT05885737|451694646|FG000|DB Period|Adverse Event|4|||
125564245|NCT05885737|451694647|FG001|DB Period|Adverse Event|4|||
125564246|NCT05885737|451694646|FG000|DB Period|Lost to Follow-up|0|||
125564247|NCT05885737|451694647|FG001|DB Period|Lost to Follow-up|1|||
125564248|NCT05885737|451694646|FG000|DB Period|Physician Decision|2|||
125564249|NCT05885737|451694647|FG001|DB Period|Physician Decision|0|||
125564250|NCT05885737|451694646|FG000|DB Period|Withdrawal by Subject|12|||
125564251|NCT05885737|451694647|FG001|DB Period|Withdrawal by Subject|6|||
125564252|NCT05885737|451694646|FG000|DB Period|Other: Unspecified|2|||
125564253|NCT05885737|451694647|FG001|DB Period|Other: Unspecified|2|||
125564254|NCT05885737|451694646|FG000|OLE Period|Adverse Event|3|||
125564255|NCT05885737|451694647|FG001|OLE Period|Adverse Event|2|||
125564256|NCT05885737|451694646|FG000|OLE Period|Physician Decision|1|||
125564257|NCT05885737|451694647|FG001|OLE Period|Physician Decision|0|||
125564258|NCT05885737|451694646|FG000|OLE Period|Withdrawal by Subject|5|||
125564259|NCT05885737|451694647|FG001|OLE Period|Withdrawal by Subject|5|||
125564260|NCT05885737|451694646|FG000|OLE Period|Other: Unspecified|2|||
125564261|NCT05885737|451694647|FG001|OLE Period|Other: Unspecified|1|||
125564262|NCT02966509|451696705|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
125564263|NCT02966509|451696706|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
125564264|NCT02966509|451696705|FG000|Baseline Satisfaction Survey|Death|0|||
125564265|NCT02966509|451696706|FG001|Baseline Satisfaction Survey|Death|1|||
125564266|NCT02966509|451696705|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
125564267|NCT02966509|451696706|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
125564268|NCT02966509|451696705|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
125564269|NCT02966509|451696706|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
125564270|NCT02966509|451696705|FG000|6 Month Satisfaction Decision Survey|Death|22|||
125564271|NCT02966509|451696706|FG001|6 Month Satisfaction Decision Survey|Death|25|||
125564272|NCT02966509|451696705|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
125564273|NCT02966509|451696706|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
125564274|NCT02966509|451696705|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
125564275|NCT02966509|451696706|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
125564276|NCT02966509|451696705|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
125564277|NCT02966509|451696706|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
125564278|NCT02966509|451696705|FG000|6 Month Satisfaction Survey|Death|36|||
125564279|NCT02966509|451696706|FG001|6 Month Satisfaction Survey|Death|33|||
125564280|NCT02966509|451696705|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
125564281|NCT02966509|451696706|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
125564282|NCT02966509|451696705|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
125426321|NCT03848403|451184481|FG002|Period 2 (Day 8)|Adverse Event|2|||
125426322|NCT03848403|451184479|FG000|Period 2 (Day 8)|Physician Decision|0|||
125426323|NCT03848403|451184480|FG001|Period 2 (Day 8)|Physician Decision|1|||
125426324|NCT03848403|451184481|FG002|Period 2 (Day 8)|Physician Decision|0|||
125426325|NCT03848403|451184479|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
125426326|NCT03848403|451184480|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
125426327|NCT03848403|451184481|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
125426328|NCT02124265|451184482|FG000|Overall Study|Adverse Event|1|||
125426329|NCT01939548|451184483|FG000|Overall Study|Non compliance|0|||
125426330|NCT01939548|451184484|FG001|Overall Study|Non compliance|2|||
125426331|NCT01939548|451184485|FG002|Overall Study|Non compliance|0|||
125426332|NCT01939548|451184483|FG000|Overall Study|Study Terminated by Sponsor|17|||
125426333|NCT01939548|451184484|FG001|Overall Study|Study Terminated by Sponsor|19|||
125426334|NCT01939548|451184485|FG002|Overall Study|Study Terminated by Sponsor|12|||
125426335|NCT01939548|451184483|FG000|Overall Study|Insufficient Clinical Response|1|||
125426336|NCT01939548|451184484|FG001|Overall Study|Insufficient Clinical Response|0|||
125426337|NCT01939548|451184485|FG002|Overall Study|Insufficient Clinical Response|0|||
125426338|NCT01939548|451184483|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
125426339|NCT01939548|451184484|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
125426340|NCT01939548|451184485|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
125426341|NCT01939548|451184483|FG000|Overall Study|Withdrawal by Subject|4|||
125426342|NCT01939548|451184484|FG001|Overall Study|Withdrawal by Subject|4|||
125426343|NCT01939548|451184485|FG002|Overall Study|Withdrawal by Subject|1|||
125426344|NCT01939548|451184483|FG000|Overall Study|Protocol Violation|7|||
125426345|NCT01939548|451184484|FG001|Overall Study|Protocol Violation|6|||
125426346|NCT01939548|451184485|FG002|Overall Study|Protocol Violation|5|||
125426347|NCT01939548|451184483|FG000|Overall Study|Lost to Follow-up|5|||
125426348|NCT01939548|451184484|FG001|Overall Study|Lost to Follow-up|5|||
125426349|NCT01939548|451184485|FG002|Overall Study|Lost to Follow-up|3|||
125426350|NCT01939548|451184483|FG000|Overall Study|Adverse Event|2|||
125426351|NCT01939548|451184484|FG001|Overall Study|Adverse Event|9|||
125426352|NCT01939548|451184485|FG002|Overall Study|Adverse Event|7|||
125426353|NCT01939548|451184483|FG000|Overall Study|Death|0|||
125426354|NCT01939548|451184484|FG001|Overall Study|Death|0|||
125426355|NCT01939548|451184485|FG002|Overall Study|Death|1|||
125426356|NCT01939548|451184483|FG000|Overall Study|Participant dropped|0|||
125426357|NCT01939548|451184484|FG001|Overall Study|Participant dropped|0|||
125426358|NCT01939548|451184485|FG002|Overall Study|Participant dropped|1|||
125426359|NCT01939548|451184483|FG000|Overall Study|Participant unwilling to continue|0|||
125426360|NCT01939548|451184484|FG001|Overall Study|Participant unwilling to continue|1|||
125426361|NCT01939548|451184485|FG002|Overall Study|Participant unwilling to continue|0|||
125426362|NCT01939548|451184483|FG000|Overall Study|Participant withdrew consent|0|||
125426363|NCT01939548|451184484|FG001|Overall Study|Participant withdrew consent|2|||
125426364|NCT01939548|451184485|FG002|Overall Study|Participant withdrew consent|0|||
125426365|NCT01939548|451184483|FG000|Overall Study|Did not complete follow-up|0|||
125426366|NCT01939548|451184484|FG001|Overall Study|Did not complete follow-up|1|||
125426367|NCT01939548|451184485|FG002|Overall Study|Did not complete follow-up|0|||
125426368|NCT00490282|451184486|FG000|Overall Study|Withdrawal by Subject|3|||
125426369|NCT04510675|451184488|FG000|Overall Study|Withdrawal by Subject|5|||
125426370|NCT04198805|451184491|FG000|Overall Study|Death|0|||
125426371|NCT04198805|451184492|FG001|Overall Study|Death|0|||
125426372|NCT04198805|451184493|FG002|Overall Study|Death|0|||
125426373|NCT04198805|451184494|FG003|Overall Study|Death|1|||
125426374|NCT04198805|451184491|FG000|Overall Study|Early Termination|8|||
125426375|NCT04198805|451184492|FG001|Overall Study|Early Termination|4|||
125426376|NCT04198805|451184493|FG002|Overall Study|Early Termination|6|||
125210778|NCT01810783|450395682|FG000|Overall Study|Enrolled, not treated|1|||
125426377|NCT04198805|451184494|FG003|Overall Study|Early Termination|9|||
125426378|NCT01330433|451184497|FG000|Overall Study|Death|1|||
125426379|NCT01330433|451184498|FG001|Overall Study|Death|3|||
125426380|NCT01330433|451184497|FG000|Overall Study|Lost to Follow-up|1|||
125426381|NCT01330433|451184498|FG001|Overall Study|Lost to Follow-up|0|||
125426382|NCT02114151|451184499|FG000|Overall Study|Death|1|||
125210779|NCT02134353|450395684|FG000|Overall Study|Adverse Event|10|||
125564283|NCT02966509|451696706|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
125564284|NCT02966509|451696705|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
125564285|NCT02966509|451696706|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
125564286|NCT02966509|451696705|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
125564287|NCT02966509|451696706|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
125564288|NCT02966509|451696705|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
125564289|NCT02966509|451696706|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
125564290|NCT01717287|451696707|FG000|Overall Study|Lost to Follow-up|0|||
125564291|NCT01717287|451696708|FG001|Overall Study|Lost to Follow-up|2|||
125564292|NCT01717287|451696707|FG000|Overall Study|Protocol Violation|0|||
125564293|NCT01717287|451696708|FG001|Overall Study|Protocol Violation|1|||
125564294|NCT00404820|451696709|FG000|Overall Study|Adverse Event|4|||
125564295|NCT00404820|451696710|FG001|Overall Study|Adverse Event|16|||
125564296|NCT00404820|451696709|FG000|Overall Study|Withdrawal by Subject|5|||
125564297|NCT00404820|451696710|FG001|Overall Study|Withdrawal by Subject|3|||
125564298|NCT00404820|451696709|FG000|Overall Study|Lost to Follow-up|7|||
125564299|NCT00404820|451696710|FG001|Overall Study|Lost to Follow-up|3|||
125564300|NCT00404820|451696709|FG000|Overall Study|Administrative problems|2|||
125564301|NCT00404820|451696710|FG001|Overall Study|Administrative problems|0|||
125564302|NCT00404820|451696709|FG000|Overall Study|Death|1|||
125564303|NCT00404820|451696710|FG001|Overall Study|Death|0|||
125564304|NCT00404820|451696709|FG000|Overall Study|Other|0|||
125564305|NCT00404820|451696710|FG001|Overall Study|Other|2|||
125564306|NCT01469182|451696715|FG000|Overall Study|Adverse Event|21|||
125564307|NCT01469182|451696716|FG001|Overall Study|Adverse Event|3|||
125564308|NCT01469182|451696715|FG000|Overall Study|Lost to Follow-up|3|||
125564309|NCT01469182|451696716|FG001|Overall Study|Lost to Follow-up|0|||
125564310|NCT01469182|451696715|FG000|Overall Study|Withdrawal by Subject|4|||
125564311|NCT01469182|451696716|FG001|Overall Study|Withdrawal by Subject|1|||
125564312|NCT01469182|451696715|FG000|Overall Study|Protocol Violation|4|||
125564313|NCT01469182|451696716|FG001|Overall Study|Protocol Violation|2|||
125564314|NCT01469182|451696715|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
125564315|NCT01469182|451696716|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
125564316|NCT02687542|451696719|FG000|Overall Study|Medication error without associated AEs|0|||
125564317|NCT02687542|451696720|FG001|Overall Study|Medication error without associated AEs|0|||
125564318|NCT02687542|451696721|FG002|Overall Study|Medication error without associated AEs|0|||
125564319|NCT02687542|451696722|FG003|Overall Study|Medication error without associated AEs|0|||
125564320|NCT02687542|451696723|FG004|Overall Study|Medication error without associated AEs|1|||
125564321|NCT02687542|451696719|FG000|Overall Study|Lost to Follow-up|0|||
125564322|NCT02687542|451696720|FG001|Overall Study|Lost to Follow-up|0|||
125564323|NCT02687542|451696721|FG002|Overall Study|Lost to Follow-up|0|||
125564324|NCT02687542|451696722|FG003|Overall Study|Lost to Follow-up|0|||
125564325|NCT02687542|451696723|FG004|Overall Study|Lost to Follow-up|1|||
125564326|NCT02687542|451696719|FG000|Overall Study|Protocol Violation|0|||
125564327|NCT02687542|451696720|FG001|Overall Study|Protocol Violation|1|||
125564328|NCT02687542|451696721|FG002|Overall Study|Protocol Violation|0|||
125564329|NCT02687542|451696722|FG003|Overall Study|Protocol Violation|0|||
125564330|NCT02687542|451696723|FG004|Overall Study|Protocol Violation|0|||
125564331|NCT02687542|451696719|FG000|Overall Study|Other|5|||
125564332|NCT02687542|451696720|FG001|Overall Study|Other|9|||
125564333|NCT02687542|451696721|FG002|Overall Study|Other|10|||
125564334|NCT02687542|451696722|FG003|Overall Study|Other|6|||
125564335|NCT02687542|451696723|FG004|Overall Study|Other|5|||
125564336|NCT02687542|451696719|FG000|Overall Study|Adverse Event|3|||
125564337|NCT02687542|451696720|FG001|Overall Study|Adverse Event|1|||
125564338|NCT02687542|451696721|FG002|Overall Study|Adverse Event|3|||
125564339|NCT02687542|451696722|FG003|Overall Study|Adverse Event|2|||
125564340|NCT02687542|451696723|FG004|Overall Study|Adverse Event|9|||
125564341|NCT02687542|451696719|FG000|Overall Study|Withdrawal by Subject|0|||
125564342|NCT02687542|451696720|FG001|Overall Study|Withdrawal by Subject|1|||
125564343|NCT02687542|451696721|FG002|Overall Study|Withdrawal by Subject|1|||
125564344|NCT02687542|451696722|FG003|Overall Study|Withdrawal by Subject|2|||
125564345|NCT02687542|451696723|FG004|Overall Study|Withdrawal by Subject|4|||
125564346|NCT01838616|451696724|FG000|Titration Period|Adverse Event|18|||
125564347|NCT01838616|451696725|FG001|Titration Period|Adverse Event|48|||
125564348|NCT01838616|451696724|FG000|Titration Period|Lack of Efficacy|5|||
125564349|NCT01838616|451696725|FG001|Titration Period|Lack of Efficacy|12|||
125564350|NCT01838616|451696724|FG000|Titration Period|Withdrawal by Subject|5|||
125564351|NCT01838616|451696725|FG001|Titration Period|Withdrawal by Subject|5|||
125564352|NCT01838616|451696724|FG000|Titration Period|Technical problems|1|||
125564353|NCT01838616|451696725|FG001|Titration Period|Technical problems|0|||
125564354|NCT01838616|451696724|FG000|Titration Period|Other|1|||
125564355|NCT01838616|451696725|FG001|Titration Period|Other|0|||
125564356|NCT01838616|451696724|FG000|Titration Period|Protocol Violation|0|||
125564357|NCT01838616|451696725|FG001|Titration Period|Protocol Violation|1|||
125564358|NCT01838616|451696724|FG000|Continuation Period|Lack of Efficacy|3|||
125564359|NCT01838616|451696725|FG001|Continuation Period|Lack of Efficacy|5|||
125564360|NCT01838616|451696724|FG000|Continuation Period|Adverse Event|8|||
125564361|NCT01838616|451696725|FG001|Continuation Period|Adverse Event|4|||
125564362|NCT01838616|451696724|FG000|Continuation Period|Protocol Violation|2|||
125564363|NCT01838616|451696725|FG001|Continuation Period|Protocol Violation|0|||
125564364|NCT01838616|451696724|FG000|Continuation Period|Lost to Follow-up|1|||
125564365|NCT01838616|451696725|FG001|Continuation Period|Lost to Follow-up|0|||
125564366|NCT01838616|451696724|FG000|Continuation Period|Withdrawal by Subject|0|||
125564367|NCT01838616|451696725|FG001|Continuation Period|Withdrawal by Subject|4|||
125564368|NCT01838616|451696724|FG000|Continuation Period|Technical problems|0|||
125564369|NCT01838616|451696725|FG001|Continuation Period|Technical problems|1|||
125564370|NCT01838616|451696724|FG000|Pick-up Arm|Lack of Efficacy|4|||
125355336|NCT03488927|450936484|FG001|Overall Study|Withdrawal by Subject|118|||
125564371|NCT01838616|451696725|FG001|Pick-up Arm|Lack of Efficacy|0|||
125564372|NCT01838616|451696724|FG000|Pick-up Arm|Adverse Event|9|||
125355337|NCT03488927|450936485|FG002|Overall Study|Withdrawal by Subject|217|||
125564373|NCT01838616|451696725|FG001|Pick-up Arm|Adverse Event|0|||
125564374|NCT01838616|451696724|FG000|Pick-up Arm|Withdrawal by Subject|1|||
125564375|NCT01838616|451696725|FG001|Pick-up Arm|Withdrawal by Subject|0|||
125564376|NCT01838616|451696724|FG000|Pick-up Arm|Technical problems|1|||
125564377|NCT01838616|451696725|FG001|Pick-up Arm|Technical problems|0|||
125564378|NCT00003535|451696726|FG000|Overall Study|Not evaluable|5|||
125564379|NCT02181816|451696727|FG000|Overall Study|Case Report Forms Uncollected|38|||
125564380|NCT02181816|451696727|FG000|Overall Study|Protocol Deviation|21|||
125564381|NCT03807349|451696730|FG000|Overall Study|Early Study Termination|9|||
125564382|NCT00294060|451696731|FG000|Overall Study|Death|225|||
125564383|NCT00294060|451696731|FG000|Overall Study|Other|59|||
125564384|NCT00294060|451696731|FG000|Overall Study|Lost to Follow-up|55|||
125564385|NCT00294060|451696731|FG000|Overall Study|Withdrawal by Subject|11|||
125564386|NCT00294060|451696731|FG000|Overall Study|Physician Decision|797|||
125564387|NCT00294060|451696731|FG000|Overall Study|Medical condition|3|||
125564388|NCT00294060|451696731|FG000|Overall Study|Device explanted/not replaced|23|||
125564389|NCT01360554|451696732|FG000|Overall Study|Death|359|||
125564390|NCT01360554|451696733|FG001|Overall Study|Death|371|||
125564391|NCT01360554|451696732|FG000|Overall Study|Lost to Follow-up|4|||
125564392|NCT01360554|451696733|FG001|Overall Study|Lost to Follow-up|4|||
125564393|NCT01360554|451696732|FG000|Overall Study|Withdrawal by Subject|23|||
125564394|NCT01360554|451696733|FG001|Overall Study|Withdrawal by Subject|24|||
125564395|NCT01360554|451696732|FG000|Overall Study|Study terminated by sponsor|49|||
125564396|NCT01360554|451696733|FG001|Overall Study|Study terminated by sponsor|37|||
125564397|NCT01360554|451696732|FG000|Overall Study|Other, not specified|1|||
125564398|NCT01360554|451696733|FG001|Overall Study|Other, not specified|0|||
125564399|NCT01360554|451696732|FG000|Overall Study|Randomized but not treated.|3|||
125564400|NCT01360554|451696733|FG001|Overall Study|Randomized but not treated.|3|||
125564401|NCT00187096|451696735|FG000|Overall Study|unacceptable toxicity|0|||
125564402|NCT00187096|451696736|FG001|Overall Study|unacceptable toxicity|0|||
125564403|NCT00187096|451696737|FG002|Overall Study|unacceptable toxicity|1|||
125564404|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
125564405|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
125564406|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
125564407|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
125564408|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
125564409|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
125564410|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
125564411|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
125564412|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
125564413|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
125564414|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
125564415|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
125564416|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
125564417|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
125564418|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
125564419|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
125564420|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
125564421|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
125564422|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
125564423|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
125564424|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
125564425|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
125564426|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
125564427|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
125564428|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
125564429|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
125355338|NCT00901927|450936486|FG000|Overall Study|Lack of Efficacy|1|||
125355339|NCT00901927|450936486|FG000|Overall Study|Protocol Violation|3|||
125564430|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
125564431|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
125564432|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
125564433|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
125564434|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
125564435|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
125564436|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
125564437|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
125564438|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
125564439|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
125564440|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
125564441|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
125564442|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
125564443|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
125564444|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
125564445|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
125564446|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
125355340|NCT00901927|450936486|FG000|Overall Study|Withdrawal by Subject|2|||
125564447|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
125564448|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
125564449|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
125564450|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
125564451|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
125564452|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
125564453|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
125564454|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
125564455|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
125564456|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
125564457|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
125564458|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
125564459|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
125564460|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
125564461|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
125564462|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
125564463|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
125564464|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
125564465|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
125564466|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
125564467|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
125564468|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
125564469|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
125564470|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
125564471|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
125564472|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
125564473|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
125355341|NCT02676466|450936489|FG000|Overall Study|Death|0|||
125355342|NCT02676466|450936490|FG001|Overall Study|Death|2|||
125355343|NCT02676466|450936491|FG002|Overall Study|Death|1|||
125564474|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
125564475|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
125564476|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
125564477|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
125564478|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
125564479|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
125564480|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
125564481|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
125564482|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
125564483|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
125564484|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
125564485|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
125564486|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
125564487|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
125564488|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
125564489|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
125564490|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
125564491|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
125564492|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
125564493|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
125564494|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
125564495|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
125564496|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
125564497|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
125564498|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
125564499|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
125564500|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
125564501|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
125564502|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
125564503|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
125564504|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
125564505|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
125564506|NCT00111800|451696738|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
125564507|NCT00111800|451696739|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
125564508|NCT00111800|451696740|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
125564509|NCT00111800|451696741|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
125564510|NCT00111800|451696742|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
125355344|NCT02676466|450936492|FG003|Overall Study|Death|0|||
125355345|NCT02676466|450936493|FG004|Overall Study|Death|0|||
125355346|NCT02676466|450936494|FG005|Overall Study|Death|0|||
125355347|NCT02676466|450936495|FG006|Overall Study|Death|0|||
125564511|NCT00111800|451696743|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
125564512|NCT00111800|451696738|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
125564513|NCT00111800|451696739|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
125564514|NCT00111800|451696740|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
125564515|NCT00111800|451696741|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
125564516|NCT00111800|451696742|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
125564517|NCT00111800|451696743|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
125564518|NCT00111800|451696738|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
125564519|NCT00111800|451696739|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
125564520|NCT00111800|451696740|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
125564521|NCT00111800|451696741|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
125564522|NCT00111800|451696742|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
125564523|NCT00111800|451696743|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
125564524|NCT00111800|451696738|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
125564525|NCT00111800|451696739|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
125564526|NCT00111800|451696740|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
125564527|NCT00111800|451696741|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
125564528|NCT00111800|451696742|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
125564529|NCT00111800|451696743|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
125564530|NCT00111800|451696738|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
125564531|NCT00111800|451696739|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
125564532|NCT00111800|451696740|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
125564533|NCT00111800|451696741|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
125564534|NCT00111800|451696742|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
125564535|NCT00111800|451696743|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
125564536|NCT00111800|451696738|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
125564537|NCT00111800|451696739|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
125564538|NCT00111800|451696740|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
125355348|NCT02676466|450936496|FG007|Overall Study|Death|0|||
125355349|NCT02676466|450936489|FG000|Overall Study|Withdrawal by Subject|4|||
125355350|NCT02676466|450936490|FG001|Overall Study|Withdrawal by Subject|3|||
125355351|NCT02676466|450936491|FG002|Overall Study|Withdrawal by Subject|1|||
125564539|NCT00111800|451696741|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
125564540|NCT00111800|451696742|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
125564541|NCT00111800|451696743|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
125564542|NCT00111800|451696738|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
125564543|NCT00111800|451696739|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
125564544|NCT00111800|451696740|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
125564545|NCT00111800|451696741|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
125564546|NCT00111800|451696742|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
125564547|NCT00111800|451696743|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
125564548|NCT00111800|451696738|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
125564549|NCT00111800|451696739|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
125564550|NCT00111800|451696740|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
125564551|NCT00111800|451696741|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
125564552|NCT00111800|451696742|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
125564553|NCT00111800|451696743|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
125564554|NCT00111800|451696738|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
125564555|NCT00111800|451696739|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
125564556|NCT00111800|451696740|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
125564557|NCT00111800|451696741|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
125564558|NCT00111800|451696742|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
125564559|NCT00111800|451696743|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
125564560|NCT01549275|451696744|FG000|Overall Study|Lost to Follow-up|1|||
125564561|NCT01549275|451696745|FG001|Overall Study|Lost to Follow-up|0|||
125564562|NCT02113436|451696748|FG000|Period 1: 8 Weeks|Adverse Event|1|||
125564563|NCT02113436|451696749|FG001|Period 1: 8 Weeks|Adverse Event|0|||
125564564|NCT02113436|451696750|FG002|Period 1: 8 Weeks|Adverse Event|0|||
125564565|NCT02113436|451696751|FG003|Period 1: 8 Weeks|Adverse Event|0|||
125564566|NCT02113436|451696748|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
125564567|NCT02113436|451696749|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
125564568|NCT02113436|451696750|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
125564569|NCT02113436|451696751|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
125564570|NCT02113436|451696748|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
125564571|NCT02113436|451696749|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
125564572|NCT02113436|451696750|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
125564573|NCT02113436|451696751|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
125564574|NCT02113436|451696748|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
125564575|NCT02113436|451696749|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
125564576|NCT02113436|451696750|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
125564577|NCT02113436|451696751|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
125564578|NCT02113436|451696748|FG000|Period 2: 16 Weeks|Adverse Event|0|||
125564579|NCT02113436|451696749|FG001|Period 2: 16 Weeks|Adverse Event|0|||
125564580|NCT02113436|451696750|FG002|Period 2: 16 Weeks|Adverse Event|4|||
125564581|NCT02113436|451696751|FG003|Period 2: 16 Weeks|Adverse Event|5|||
125564582|NCT02113436|451696748|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
125564583|NCT02113436|451696749|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
125564584|NCT02113436|451696750|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
125564585|NCT02113436|451696751|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
125564586|NCT02113436|451696748|FG000|Period 2: 16 Weeks|Physician Decision|0|||
125355352|NCT02676466|450936492|FG003|Overall Study|Withdrawal by Subject|0|||
125355353|NCT02676466|450936493|FG004|Overall Study|Withdrawal by Subject|3|||
125355354|NCT02676466|450936494|FG005|Overall Study|Withdrawal by Subject|1|||
125355355|NCT02676466|450936495|FG006|Overall Study|Withdrawal by Subject|1|||
125564587|NCT02113436|451696749|FG001|Period 2: 16 Weeks|Physician Decision|0|||
125564588|NCT02113436|451696750|FG002|Period 2: 16 Weeks|Physician Decision|2|||
125564589|NCT02113436|451696751|FG003|Period 2: 16 Weeks|Physician Decision|0|||
125564590|NCT02113436|451696748|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
125564591|NCT02113436|451696749|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
125564592|NCT02113436|451696750|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
125564593|NCT02113436|451696751|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
125564594|NCT02969187|451696754|FG000|Overall Study|Physician Decision|12|||
125564595|NCT02969187|451696755|FG001|Overall Study|Physician Decision|13|||
125564596|NCT01486927|451696756|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
125564597|NCT01486927|451696756|FG000|Overall Study|Physician Decision|1|||
125564598|NCT01486927|451696756|FG000|Overall Study|50 Exposure days not reached|2|||
125564599|NCT01486927|451696756|FG000|Overall Study|Withdrawal by Subject|8|||
125564600|NCT01486927|451696756|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
125564601|NCT00365456|451696757|FG000|Trial Period I (12 Months)|Adverse Event|84|||
125564602|NCT00365456|451696758|FG001|Trial Period I (12 Months)|Adverse Event|0|||
125564603|NCT00365456|451696757|FG000|Trial Period I (12 Months)|Non-compliance|3|||
125564604|NCT00365456|451696758|FG001|Trial Period I (12 Months)|Non-compliance|0|||
125564605|NCT00365456|451696757|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
125564606|NCT00365456|451696758|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
125564607|NCT00365456|451696757|FG000|Trial Period I (12 Months)|Other|11|||
125564608|NCT00365456|451696758|FG001|Trial Period I (12 Months)|Other|0|||
125564609|NCT00365456|451696757|FG000|Trial Period II (12 Months)|Adverse Event|0|||
125564610|NCT00365456|451696758|FG001|Trial Period II (12 Months)|Adverse Event|6|||
125564611|NCT00365456|451696757|FG000|Trial Period II (12 Months)|Non-compliance|0|||
125564612|NCT00365456|451696758|FG001|Trial Period II (12 Months)|Non-compliance|2|||
125564613|NCT00365456|451696757|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
125564614|NCT00365456|451696758|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
125564615|NCT00365456|451696757|FG000|Trial Period II (12 Months)|Other|0|||
125564616|NCT00365456|451696758|FG001|Trial Period II (12 Months)|Other|1|||
125564617|NCT00365456|451696757|FG000|Trial Period III (12 Months)|Adverse Event|13|||
125564618|NCT00365456|451696758|FG001|Trial Period III (12 Months)|Adverse Event|3|||
125564619|NCT00365456|451696757|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
125564620|NCT00365456|451696758|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
125564621|NCT00365456|451696757|FG000|Trial Period III (12 Months)|Other|1|||
125564622|NCT00365456|451696758|FG001|Trial Period III (12 Months)|Other|1|||
125564623|NCT03668600|451696759|FG000|Overall Study|Study Terminated by the Sponsor|157|||
125564624|NCT03668600|451696759|FG000|Overall Study|Protocol Violation|1|||
125564625|NCT03668600|451696759|FG000|Overall Study|Pregnancy|1|||
125564626|NCT03668600|451696759|FG000|Overall Study|Lost to Follow-up|7|||
125564627|NCT03668600|451696759|FG000|Overall Study|Withdrawal by Subject|56|||
125564628|NCT03668600|451696759|FG000|Overall Study|Lack of Efficacy|7|||
125564629|NCT03668600|451696759|FG000|Overall Study|Adverse Event|1|||
125564630|NCT01476475|451696761|FG000|Overall Study|Adverse Event|6|||
125564631|NCT01476475|451696762|FG001|Overall Study|Adverse Event|0|||
125564632|NCT01476475|451696761|FG000|Overall Study|Poor compliance to protocol|1|||
125564633|NCT01476475|451696762|FG001|Overall Study|Poor compliance to protocol|1|||
125564634|NCT01476475|451696761|FG000|Overall Study|Other reasons|4|||
125564635|NCT01476475|451696762|FG001|Overall Study|Other reasons|2|||
125564636|NCT01278745|451696763|FG000|Overall Study|Death|2|||
125564637|NCT01278745|451696764|FG001|Overall Study|Death|5|||
125564638|NCT01278745|451696765|FG002|Overall Study|Death|7|||
125564639|NCT01278745|451696766|FG003|Overall Study|Death|0|||
125564640|NCT01278745|451696763|FG000|Overall Study|Physician Decision|1|||
125564641|NCT01278745|451696764|FG001|Overall Study|Physician Decision|0|||
125564642|NCT01278745|451696765|FG002|Overall Study|Physician Decision|0|||
125564643|NCT01278745|451696766|FG003|Overall Study|Physician Decision|9|||
125564644|NCT01278745|451696763|FG000|Overall Study|Withdrawal by Subject|1|||
125564645|NCT01278745|451696764|FG001|Overall Study|Withdrawal by Subject|1|||
125564646|NCT01278745|451696765|FG002|Overall Study|Withdrawal by Subject|5|||
125564647|NCT01278745|451696766|FG003|Overall Study|Withdrawal by Subject|1|||
125564648|NCT01278745|451696763|FG000|Overall Study|Sponsor Decision|1|||
125564649|NCT01278745|451696764|FG001|Overall Study|Sponsor Decision|0|||
125564650|NCT01278745|451696765|FG002|Overall Study|Sponsor Decision|62|||
125564651|NCT01278745|451696766|FG003|Overall Study|Sponsor Decision|6|||
125564652|NCT01278745|451696763|FG000|Overall Study|Ineligible|0|||
125564653|NCT01278745|451696764|FG001|Overall Study|Ineligible|0|||
125564654|NCT01278745|451696765|FG002|Overall Study|Ineligible|42|||
125564655|NCT01278745|451696766|FG003|Overall Study|Ineligible|61|||
125564656|NCT01278745|451696763|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
125355356|NCT02676466|450936496|FG007|Overall Study|Withdrawal by Subject|1|||
125355357|NCT01178073|450936498|FG000|Overall Study|Adverse Event|34|||
125355358|NCT01178073|450936499|FG001|Overall Study|Adverse Event|27|||
125355359|NCT01178073|450936500|FG002|Overall Study|Adverse Event|24|||
125355360|NCT01178073|450936498|FG000|Overall Study|Protocol Violation|1|||
125355361|NCT01178073|450936499|FG001|Overall Study|Protocol Violation|1|||
125355362|NCT01178073|450936500|FG002|Overall Study|Protocol Violation|1|||
125355363|NCT01178073|450936498|FG000|Overall Study|Lost to Follow-up|2|||
125355364|NCT01178073|450936499|FG001|Overall Study|Lost to Follow-up|0|||
125355365|NCT01178073|450936500|FG002|Overall Study|Lost to Follow-up|3|||
125355366|NCT01178073|450936498|FG000|Overall Study|Physician Decision|14|||
125355367|NCT01178073|450936499|FG001|Overall Study|Physician Decision|10|||
125355368|NCT01178073|450936500|FG002|Overall Study|Physician Decision|10|||
125355369|NCT01178073|450936498|FG000|Overall Study|Withdrawal by Subject|10|||
125355370|NCT01178073|450936499|FG001|Overall Study|Withdrawal by Subject|6|||
125355371|NCT01178073|450936500|FG002|Overall Study|Withdrawal by Subject|8|||
125355372|NCT01178073|450936498|FG000|Overall Study|Missing Completion Status|1|||
125355373|NCT01178073|450936499|FG001|Overall Study|Missing Completion Status|0|||
125355374|NCT01178073|450936500|FG002|Overall Study|Missing Completion Status|0|||
125355375|NCT03497676|450936503|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
125355376|NCT03497676|450936504|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
125355377|NCT03497676|450936505|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
125355378|NCT03497676|450936506|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
125355379|NCT03497676|450936503|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
125355380|NCT03497676|450936504|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
125355381|NCT03497676|450936505|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
125355382|NCT03497676|450936506|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
125355383|NCT03497676|450936503|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
125355384|NCT03497676|450936504|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
125355385|NCT03497676|450936505|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
125355386|NCT03497676|450936506|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
125355387|NCT03497676|450936503|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
125355388|NCT03497676|450936504|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
125355389|NCT03497676|450936505|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
125355390|NCT03497676|450936506|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
125355391|NCT03497676|450936503|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
125355392|NCT03497676|450936504|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
125355393|NCT03497676|450936505|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
125355394|NCT03497676|450936506|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
125355395|NCT03497676|450936503|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
125355396|NCT03497676|450936504|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
125355397|NCT03497676|450936505|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
125355398|NCT03497676|450936506|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
125355399|NCT03497676|450936503|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
125355400|NCT03497676|450936504|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
125355401|NCT03497676|450936505|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
125355402|NCT03497676|450936506|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
125355403|NCT03497676|450936503|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
125355404|NCT03497676|450936504|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
125355405|NCT03497676|450936505|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
125355406|NCT03497676|450936506|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
125355407|NCT01226043|450936516|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
125355408|NCT01226043|450936517|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
125355409|NCT01226043|450936518|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
125355410|NCT01226043|450936519|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
125355411|NCT01226043|450936516|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
125355412|NCT01226043|450936517|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
125355413|NCT01226043|450936518|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
125564657|NCT01278745|451696764|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
125564658|NCT01278745|451696765|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
125564659|NCT01278745|451696766|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
125564660|NCT01816061|451696769|FG000|Overall Study|Lost to Follow-up|13|||
125564661|NCT01816061|451696770|FG001|Overall Study|Lost to Follow-up|24|||
125564662|NCT01265615|451696771|FG000|Overall Study|Protocol Violation|2|||
125564663|NCT01265615|451696772|FG001|Overall Study|Protocol Violation|2|||
125564664|NCT01265615|451696773|FG002|Overall Study|Protocol Violation|4|||
125564665|NCT01265615|451696774|FG003|Overall Study|Protocol Violation|3|||
125564666|NCT01471015|451696776|FG000|Overall Study|Death|0|||
125564667|NCT01471015|451696777|FG001|Overall Study|Death|1|||
125564668|NCT01471015|451696778|FG002|Overall Study|Death|1|||
125564669|NCT02576444|451696779|FG000|Overall Study|Death|1|||
125564670|NCT02576444|451696780|FG001|Overall Study|Death|1|||
125564671|NCT02576444|451696781|FG002|Overall Study|Death|0|||
125564672|NCT02576444|451696782|FG003|Overall Study|Death|0|||
125564673|NCT02576444|451696779|FG000|Overall Study|Withdrawal by Subject|0|||
125564674|NCT02576444|451696780|FG001|Overall Study|Withdrawal by Subject|0|||
125564675|NCT02576444|451696781|FG002|Overall Study|Withdrawal by Subject|2|||
125564676|NCT02576444|451696782|FG003|Overall Study|Withdrawal by Subject|0|||
125564677|NCT02576444|451696779|FG000|Overall Study|Adverse Event|0|||
125564678|NCT02576444|451696780|FG001|Overall Study|Adverse Event|0|||
125564679|NCT02576444|451696781|FG002|Overall Study|Adverse Event|1|||
125564680|NCT02576444|451696782|FG003|Overall Study|Adverse Event|0|||
125564681|NCT02576444|451696779|FG000|Overall Study|Physician Decision|0|||
125564682|NCT02576444|451696780|FG001|Overall Study|Physician Decision|0|||
125564683|NCT02576444|451696781|FG002|Overall Study|Physician Decision|1|||
125564684|NCT02576444|451696782|FG003|Overall Study|Physician Decision|0|||
125564685|NCT01843842|451696787|FG000|Overall Study|Do not meet inclusion criteria|1|||
125564686|NCT01843842|451696788|FG001|Overall Study|Do not meet inclusion criteria|1|||
125564687|NCT02953340|451696789|FG000|Overall Study|Death|0|||
125564688|NCT02953340|451696790|FG001|Overall Study|Death|1|||
125564689|NCT02953340|451696789|FG000|Overall Study|Investigator Decision|3|||
125564690|NCT02953340|451696790|FG001|Overall Study|Investigator Decision|3|||
125564691|NCT02953340|451696789|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
125564692|NCT02953340|451696790|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
125564693|NCT02953340|451696789|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
125564694|NCT02953340|451696790|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
125564695|NCT02953340|451696789|FG000|Overall Study|Withdrawal by Subject|9|||
125210780|NCT02134353|450395685|FG001|Overall Study|Adverse Event|6|||
125355414|NCT01226043|450936519|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
125564696|NCT02953340|451696790|FG001|Overall Study|Withdrawal by Subject|9|||
125564697|NCT02953340|451696789|FG000|Overall Study|Sponsor decision|0|||
125564698|NCT02953340|451696790|FG001|Overall Study|Sponsor decision|2|||
125564699|NCT02953340|451696789|FG000|Overall Study|Lost to Follow-up|3|||
125564700|NCT02953340|451696790|FG001|Overall Study|Lost to Follow-up|2|||
125564701|NCT02953340|451696789|FG000|Overall Study|Reason not specified|2|||
125355415|NCT01226043|450936516|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
125355416|NCT01226043|450936517|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
125355417|NCT01226043|450936518|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
125355418|NCT01226043|450936519|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
125355419|NCT01226043|450936516|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
125355420|NCT01226043|450936517|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
125355421|NCT01226043|450936518|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
125355422|NCT01226043|450936519|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
125355423|NCT01226043|450936516|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
125355424|NCT01226043|450936517|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
125355425|NCT01226043|450936518|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
125355426|NCT01226043|450936519|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
125564702|NCT02953340|451696790|FG001|Overall Study|Reason not specified|2|||
125564703|NCT01376778|451696791|FG000|Overall Study|Lost to Follow-up|3|||
125564704|NCT01376778|451696792|FG001|Overall Study|Lost to Follow-up|2|||
125564705|NCT00928889|451696793|FG000|Overall Study|Lost to Follow-up|3|||
125564706|NCT00928889|451696794|FG001|Overall Study|Lost to Follow-up|1|||
125564707|NCT00928889|451696793|FG000|Overall Study|Protocol Violation|0|||
125564708|NCT00928889|451696794|FG001|Overall Study|Protocol Violation|1|||
125564709|NCT00928889|451696793|FG000|Overall Study|Adverse Event|1|||
125564710|NCT00928889|451696794|FG001|Overall Study|Adverse Event|0|||
125564711|NCT00928889|451696793|FG000|Overall Study|Other|1|||
125564712|NCT00928889|451696794|FG001|Overall Study|Other|0|||
125564713|NCT02343159|451696800|FG000|Overall Study|Early Study Termination|16|||
125564714|NCT02343159|451696801|FG001|Overall Study|Early Study Termination|19|||
125564715|NCT02343159|451696802|FG002|Overall Study|Early Study Termination|23|||
125564716|NCT02343159|451696800|FG000|Overall Study|Physician Decision|2|||
125564717|NCT02343159|451696801|FG001|Overall Study|Physician Decision|0|||
125564718|NCT02343159|451696802|FG002|Overall Study|Physician Decision|1|||
125564719|NCT02343159|451696800|FG000|Overall Study|Withdrawal by Subject|3|||
125564720|NCT02343159|451696801|FG001|Overall Study|Withdrawal by Subject|0|||
125355427|NCT01226043|450936516|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
125355428|NCT01226043|450936517|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
125355429|NCT01226043|450936518|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
125355430|NCT01226043|450936519|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
125355431|NCT01226043|450936516|FG000|6-week Re-randomization Phase|Adverse Event|0|||
125355432|NCT01226043|450936517|FG001|6-week Re-randomization Phase|Adverse Event|0|||
125564721|NCT02343159|451696802|FG002|Overall Study|Withdrawal by Subject|2|||
125564722|NCT02343159|451696800|FG000|Overall Study|Lost to Follow-up|0|||
125355433|NCT01226043|450936518|FG002|6-week Re-randomization Phase|Adverse Event|1|||
125355434|NCT01226043|450936519|FG003|6-week Re-randomization Phase|Adverse Event|1|||
125564723|NCT02343159|451696801|FG001|Overall Study|Lost to Follow-up|2|||
125564724|NCT02343159|451696802|FG002|Overall Study|Lost to Follow-up|2|||
125564725|NCT02343159|451696800|FG000|Overall Study|Adverse Event|4|||
125564726|NCT02343159|451696801|FG001|Overall Study|Adverse Event|4|||
125564727|NCT02343159|451696802|FG002|Overall Study|Adverse Event|2|||
125564728|NCT02343159|451696800|FG000|Overall Study|Sponsor Decision|0|||
125355435|NCT01226043|450936516|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
125355436|NCT01226043|450936517|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
125564729|NCT02343159|451696801|FG001|Overall Study|Sponsor Decision|1|||
125355437|NCT01226043|450936518|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
125355438|NCT01226043|450936519|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
125355439|NCT01226043|450936516|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
125355440|NCT01226043|450936517|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
125355441|NCT01226043|450936518|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
125355442|NCT01226043|450936519|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
125355443|NCT01226043|450936516|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
125355444|NCT01226043|450936517|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
125355445|NCT01226043|450936518|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
125355446|NCT01226043|450936519|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
125355447|NCT01226043|450936516|FG000|6-week Re-randomization Phase|Physician Decision|0|||
125355448|NCT01226043|450936517|FG001|6-week Re-randomization Phase|Physician Decision|0|||
125355449|NCT01226043|450936518|FG002|6-week Re-randomization Phase|Physician Decision|3|||
125355450|NCT01226043|450936519|FG003|6-week Re-randomization Phase|Physician Decision|2|||
125355451|NCT01226043|450936516|FG000|6-week Re-randomization Phase|completed in error|0|||
125426383|NCT02114151|451184499|FG000|Overall Study|Lost to Follow-up|1|||
125426384|NCT02114151|451184499|FG000|Overall Study|Withdrawal by Subject|5|||
125355452|NCT01226043|450936517|FG001|6-week Re-randomization Phase|completed in error|0|||
125426385|NCT01494584|451184500|FG000|Overall Study|Study Closed/Terminated|1|||
125355453|NCT01226043|450936518|FG002|6-week Re-randomization Phase|completed in error|0|||
125426386|NCT01666808|451184501|FG000|Overall Study|Lost to Follow-up|9|||
125426387|NCT01666808|451184502|FG001|Overall Study|Lost to Follow-up|15|||
125355454|NCT01226043|450936519|FG003|6-week Re-randomization Phase|completed in error|1|||
125355455|NCT01226043|450936516|FG000|30-week Observational Phase|Adverse Event|0|||
125355456|NCT01226043|450936517|FG001|30-week Observational Phase|Adverse Event|0|||
125355457|NCT01226043|450936518|FG002|30-week Observational Phase|Adverse Event|1|||
125355458|NCT01226043|450936519|FG003|30-week Observational Phase|Adverse Event|1|||
125564730|NCT02343159|451696802|FG002|Overall Study|Sponsor Decision|0|||
125564731|NCT02343159|451696800|FG000|Overall Study|Enrollment Error|1|||
125564732|NCT02343159|451696801|FG001|Overall Study|Enrollment Error|0|||
125564733|NCT02343159|451696802|FG002|Overall Study|Enrollment Error|0|||
125564734|NCT02375724|451696805|FG000|Overall Study|Lack of Efficacy|1|||
125564735|NCT02375724|451696806|FG001|Overall Study|Lack of Efficacy|1|||
125564736|NCT02375724|451696805|FG000|Overall Study|Withdrawal by Subject|1|||
125564737|NCT02375724|451696806|FG001|Overall Study|Withdrawal by Subject|1|||
125564738|NCT02375724|451696805|FG000|Overall Study|Lost to Follow-up|1|||
125564739|NCT02375724|451696806|FG001|Overall Study|Lost to Follow-up|0|||
125564740|NCT02375724|451696805|FG000|Overall Study|Protocol Violation|1|||
125564741|NCT02375724|451696806|FG001|Overall Study|Protocol Violation|0|||
125564742|NCT02375724|451696805|FG000|Overall Study|Adverse Event|2|||
125564743|NCT02375724|451696806|FG001|Overall Study|Adverse Event|4|||
125564744|NCT04712110|451696807|FG000|Overall Study|Lost to Follow-up|0|||
125564745|NCT04712110|451696808|FG001|Overall Study|Lost to Follow-up|1|||
125564746|NCT04712110|451696807|FG000|Overall Study|Withdrawal by Subject|0|||
125564747|NCT04712110|451696808|FG001|Overall Study|Withdrawal by Subject|4|||
125564748|NCT04712110|451696807|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
125564749|NCT04712110|451696808|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
125564750|NCT01517893|451696809|FG000|Overall Study|Withdrawal by Subject|3|||
125564751|NCT01517893|451696810|FG001|Overall Study|Withdrawal by Subject|0|||
125564752|NCT01309659|451696811|FG000|Overall Study|Protocol Violation|0|||
125564753|NCT01309659|451696812|FG001|Overall Study|Protocol Violation|1|||
125564754|NCT03462576|451696813|FG000|Overall Study|Protocol Violation|5|||
125564755|NCT03462576|451696814|FG001|Overall Study|Protocol Violation|11|||
125564756|NCT03462576|451696815|FG002|Overall Study|Protocol Violation|7|||
125564757|NCT03462576|451696813|FG000|Overall Study|Device Malfunction|0|||
125564758|NCT03462576|451696814|FG001|Overall Study|Device Malfunction|0|||
125564759|NCT03462576|451696815|FG002|Overall Study|Device Malfunction|1|||
125564760|NCT02285777|451696819|FG000|Overall Study|Withdrawal by Subject|1|||
125564761|NCT02285777|451696820|FG001|Overall Study|Withdrawal by Subject|1|||
125564762|NCT02285777|451696819|FG000|Overall Study|Lost to Follow-up|4|||
125564763|NCT02285777|451696820|FG001|Overall Study|Lost to Follow-up|2|||
125564764|NCT03962101|451696824|FG000|Overall Study|Adverse Event|1|||
125564765|NCT03962101|451696824|FG000|Overall Study|Physician Decision|2|||
125564766|NCT03962101|451696824|FG000|Overall Study|Not related to medical events|1|||
125564767|NCT00271596|451696831|FG000|Overall Study|Protocol Violation|1|||
125564768|NCT00271596|451696832|FG001|Overall Study|Protocol Violation|0|||
125564769|NCT00271596|451696831|FG000|Overall Study|Withdrawal by Subject|0|||
125564770|NCT00271596|451696832|FG001|Overall Study|Withdrawal by Subject|1|||
125564771|NCT01069172|451696837|FG000|Overall Study|Withdrawal by Subject|1|||
125564772|NCT01069172|451696838|FG001|Overall Study|Withdrawal by Subject|0|||
125564773|NCT04206605|451696839|FG000|Overall Study|Adverse Event|0|||
125355459|NCT01226043|450936516|FG000|30-week Observational Phase|Protocol Violation|0|||
125355460|NCT01226043|450936517|FG001|30-week Observational Phase|Protocol Violation|0|||
125355461|NCT01226043|450936518|FG002|30-week Observational Phase|Protocol Violation|0|||
125355462|NCT01226043|450936519|FG003|30-week Observational Phase|Protocol Violation|1|||
125355463|NCT01226043|450936516|FG000|30-week Observational Phase|Lost to Follow-up|0|||
125355464|NCT01226043|450936517|FG001|30-week Observational Phase|Lost to Follow-up|0|||
125355465|NCT01226043|450936518|FG002|30-week Observational Phase|Lost to Follow-up|2|||
125564774|NCT04206605|451696840|FG001|Overall Study|Adverse Event|1|||
125564775|NCT04206605|451696839|FG000|Overall Study|Withdrawal by Subject|1|||
125564776|NCT04206605|451696840|FG001|Overall Study|Withdrawal by Subject|0|||
125564777|NCT04315181|451696841|FG000|Overall Study|Non-responsive to drug conditions.|1|||
125564778|NCT05879107|451696844|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
125564779|NCT05879107|451696845|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
125564780|NCT05879107|451696844|FG000|Overall Study|Migrated / moved from the study area|1|||
125564781|NCT05879107|451696845|FG001|Overall Study|Migrated / moved from the study area|1|||
125564782|NCT05879107|451696844|FG000|Overall Study|Lost to Follow-up|8|||
125564783|NCT05879107|451696845|FG001|Overall Study|Lost to Follow-up|13|||
125564784|NCT05879107|451696844|FG000|Overall Study|Death|0|||
125564785|NCT05879107|451696845|FG001|Overall Study|Death|2|||
125564786|NCT05879107|451696844|FG000|Overall Study|Other|0|||
125564787|NCT05879107|451696845|FG001|Overall Study|Other|3|||
125564788|NCT03901079|451696846|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
125564789|NCT00843518|451696847|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
125564790|NCT00843518|451696848|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
125564791|NCT00843518|451696847|FG000|Period 2 (Double-blind Treatment)|Death|0|||
125564792|NCT00843518|451696848|FG001|Period 2 (Double-blind Treatment)|Death|1|||
125564793|NCT00843518|451696847|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
125564794|NCT00843518|451696848|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
125564795|NCT00843518|451696847|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
125564796|NCT00843518|451696848|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
125564797|NCT00843518|451696847|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
125564798|NCT00843518|451696848|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
125564799|NCT00843518|451696847|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
125564800|NCT00843518|451696848|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
125564801|NCT00843518|451696847|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
125564802|NCT00843518|451696848|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
125564803|NCT00827606|451696849|FG000|Overall Study|Protocol Violation|4|||
125564804|NCT00827606|451696850|FG001|Overall Study|Protocol Violation|3|||
125564805|NCT00827606|451696849|FG000|Overall Study|Lost to Follow-up|3|||
125564806|NCT00827606|451696850|FG001|Overall Study|Lost to Follow-up|1|||
125564807|NCT00827606|451696849|FG000|Overall Study|Withdrawal by Subject|7|||
125564808|NCT00827606|451696850|FG001|Overall Study|Withdrawal by Subject|6|||
125564809|NCT00827606|451696849|FG000|Overall Study|Pregnancy|0|||
125564810|NCT00827606|451696850|FG001|Overall Study|Pregnancy|1|||
125564811|NCT00827606|451696849|FG000|Overall Study|Other|5|||
125564812|NCT00827606|451696850|FG001|Overall Study|Other|13|||
125564813|NCT00827606|451696849|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
125564814|NCT00827606|451696850|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
125564815|NCT00827606|451696849|FG000|Overall Study|Adverse Event|4|||
125564816|NCT00827606|451696850|FG001|Overall Study|Adverse Event|2|||
125564817|NCT04037748|451696855|FG000|Treatment Period 1|Withdrawal by Subject|3|||
125564818|NCT04037748|451696856|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125564819|NCT04037748|451696855|FG000|Treatment Period 1|Adverse Event|1|||
125564820|NCT04037748|451696856|FG001|Treatment Period 1|Adverse Event|1|||
125564821|NCT04037748|451696855|FG000|Treatment Period 1|Protocol Violation|4|||
125564822|NCT04037748|451696856|FG001|Treatment Period 1|Protocol Violation|5|||
125564823|NCT04037748|451696855|FG000|Treatment Period 2|Adverse Event|0|||
125564824|NCT04037748|451696856|FG001|Treatment Period 2|Adverse Event|1|||
125564825|NCT04037748|451696855|FG000|Treatment Period 2|Protocol Violation|2|||
125564826|NCT04037748|451696856|FG001|Treatment Period 2|Protocol Violation|0|||
125564827|NCT04544475|451696861|FG000|Overall Study|Withdrawal by Subject|1|||
125564828|NCT04544475|451696862|FG001|Overall Study|Withdrawal by Subject|3|||
125564829|NCT01378858|451696863|FG000|Overall Study|Withdrawal by Subject|4|||
125564830|NCT01378858|451696864|FG001|Overall Study|Withdrawal by Subject|4|||
125564831|NCT00942175|451696865|FG000|Overall Study|Adverse Event|2|||
125564832|NCT00942175|451696866|FG001|Overall Study|Adverse Event|1|||
125564833|NCT00942175|451696867|FG002|Overall Study|Adverse Event|0|||
125564834|NCT00942175|451696868|FG003|Overall Study|Adverse Event|0|||
125564835|NCT00942175|451696865|FG000|Overall Study|Protocol Violation|0|||
125564836|NCT00942175|451696866|FG001|Overall Study|Protocol Violation|1|||
125564837|NCT00942175|451696867|FG002|Overall Study|Protocol Violation|2|||
125564838|NCT00942175|451696868|FG003|Overall Study|Protocol Violation|0|||
125564839|NCT00942175|451696865|FG000|Overall Study|Pregnancy|0|||
125564840|NCT00942175|451696866|FG001|Overall Study|Pregnancy|0|||
125564841|NCT00942175|451696867|FG002|Overall Study|Pregnancy|0|||
125564842|NCT00942175|451696868|FG003|Overall Study|Pregnancy|1|||
125564843|NCT00942175|451696865|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
125564844|NCT00942175|451696866|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
125564845|NCT00942175|451696867|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
125564846|NCT00942175|451696868|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
125564847|NCT00942175|451696865|FG000|Overall Study|Low Platelet Count|0|||
125564848|NCT00942175|451696866|FG001|Overall Study|Low Platelet Count|2|||
125564849|NCT00942175|451696867|FG002|Overall Study|Low Platelet Count|0|||
125564850|NCT00942175|451696868|FG003|Overall Study|Low Platelet Count|0|||
125564851|NCT02664272|451696869|FG000|Overall Study|Fluoroscopic images not made available|2|||
125564852|NCT02973087|451696870|FG000|Overall Study|Withdrawal by Subject|2|||
125564853|NCT02973087|451696871|FG001|Overall Study|Withdrawal by Subject|1|||
125564854|NCT02973087|451696870|FG000|Overall Study|Adverse Event|1|||
125564855|NCT02973087|451696871|FG001|Overall Study|Adverse Event|0|||
125355466|NCT01226043|450936519|FG003|30-week Observational Phase|Lost to Follow-up|2|||
125564856|NCT02973087|451696870|FG000|Overall Study|other|1|||
125564857|NCT02973087|451696871|FG001|Overall Study|other|1|||
125564858|NCT00932360|451696872|FG000|Washout (One Week)|Withdrawal by Subject|0|||
125564859|NCT00932360|451696873|FG001|Washout (One Week)|Withdrawal by Subject|0|||
125564860|NCT00932360|451696874|FG002|Washout (One Week)|Withdrawal by Subject|0|||
125564861|NCT00932360|451696875|FG003|Washout (One Week)|Withdrawal by Subject|0|||
125564862|NCT00932360|451696876|FG004|Washout (One Week)|Withdrawal by Subject|2|||
125564863|NCT00932360|451696877|FG005|Washout (One Week)|Withdrawal by Subject|0|||
125564864|NCT01924182|451696878|FG000|Overall Study|Withdrawal by Subject|1|||
125564865|NCT01924182|451696879|FG001|Overall Study|Withdrawal by Subject|0|||
125564866|NCT04143009|451696880|FG000|Pilot Trial|Lost to Follow-up|0|||
125564867|NCT04143009|451696881|FG001|Pilot Trial|Lost to Follow-up|1|||
125564868|NCT04143009|451696882|FG002|Pilot Trial|Lost to Follow-up|1|||
125564869|NCT00993265|451696883|FG000|Overall Study|Adverse Event|1|||
125564870|NCT00993265|451696884|FG001|Overall Study|Adverse Event|0|||
125564871|NCT00993265|451696883|FG000|Overall Study|Changed dose of concomitant drug|2|||
125564872|NCT00993265|451696884|FG001|Overall Study|Changed dose of concomitant drug|0|||
125564873|NCT00993265|451696883|FG000|Overall Study|Non-compliant with study medication|1|||
125564874|NCT00993265|451696884|FG001|Overall Study|Non-compliant with study medication|0|||
125564875|NCT01357655|451696885|FG000|Overall Study|Administrative Reason by Sponsor|45|||
125564876|NCT01357655|451696886|FG001|Overall Study|Administrative Reason by Sponsor|0|||
125564877|NCT01357655|451696885|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
125564878|NCT01357655|451696886|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
125564879|NCT01357655|451696885|FG000|Overall Study|Disease Progression|1|||
125564880|NCT01357655|451696886|FG001|Overall Study|Disease Progression|0|||
125564881|NCT01357655|451696885|FG000|Overall Study|Lost to Follow-up|2|||
125564882|NCT01357655|451696886|FG001|Overall Study|Lost to Follow-up|0|||
125564883|NCT01357655|451696885|FG000|Overall Study|Maximum Clinical Benefit|2|||
125564884|NCT01357655|451696886|FG001|Overall Study|Maximum Clinical Benefit|0|||
125426388|NCT01666808|451184501|FG000|Overall Study|Withdrawal by Subject|3|||
125564885|NCT01357655|451696885|FG000|Overall Study|Reason Unspecified|1|||
125564886|NCT01357655|451696886|FG001|Overall Study|Reason Unspecified|0|||
125564887|NCT01357655|451696885|FG000|Overall Study|Study Drug Toxicity|11|||
125564888|NCT01357655|451696886|FG001|Overall Study|Study Drug Toxicity|0|||
125564889|NCT01357655|451696885|FG000|Overall Study|Subject Withdrew Consent|1|||
125564890|NCT01357655|451696886|FG001|Overall Study|Subject Withdrew Consent|0|||
125564891|NCT05003622|451696887|FG000|Overall Study|Progressive disease|2|||
125564892|NCT05003622|451696887|FG000|Overall Study|Withdrawal by Subject|1|||
125564893|NCT00609986|451696888|FG000|Overall Study|Did not receive transplant or treatment|8|||
125564894|NCT00609986|451696889|FG001|Overall Study|Did not receive transplant or treatment|3|||
125564895|NCT00736255|451698231|FG000|Overall Study|Adverse Event|1|||
125564896|NCT00736255|451698232|FG001|Overall Study|Adverse Event|0|||
125564897|NCT00736255|451698231|FG000|Overall Study|Physician Decision|1|||
125564898|NCT00736255|451698232|FG001|Overall Study|Physician Decision|0|||
125564899|NCT00736255|451698231|FG000|Overall Study|Non-compliance|1|||
125564900|NCT00736255|451698232|FG001|Overall Study|Non-compliance|1|||
125564901|NCT00840086|451698237|FG000|Overall Study|Adverse Event|1|||
125564902|NCT00840086|451698237|FG000|Overall Study|Protocol Violation|2|||
125564903|NCT00840086|451698237|FG000|Overall Study|Lost to Follow-up|1|||
125564904|NCT03332498|451698238|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
125564905|NCT03332498|451698239|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
125564906|NCT03332498|451698240|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
125564907|NCT01566773|451698241|FG000|Overall Study|Protocol specified criteria|4|||
125564908|NCT01566773|451698241|FG000|Overall Study|Protocol Violation|4|||
125564909|NCT01566773|451698241|FG000|Overall Study|Withdrawal by Subject|9|||
125564910|NCT01566773|451698241|FG000|Overall Study|Administrative reason|1|||
125564911|NCT01566773|451698241|FG000|Overall Study|Adverse Event|10|||
125564912|NCT01566773|451698241|FG000|Overall Study|Physician Decision|2|||
125426389|NCT01666808|451184502|FG001|Overall Study|Withdrawal by Subject|1|||
125426390|NCT01666808|451184501|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
125564913|NCT04036708|451698242|FG000|Overall Study|Lost to Follow-up|14|||
125564914|NCT04036708|451698243|FG001|Overall Study|Lost to Follow-up|4|||
125564915|NCT04036708|451698244|FG002|Overall Study|Lost to Follow-up|14|||
125564916|NCT04036708|451698245|FG003|Overall Study|Lost to Follow-up|4|||
125564917|NCT01033734|451698246|FG000|Overall Study|Withdrawal by Subject|1|||
125564918|NCT01444742|451698249|FG000|Overall Study|Death|1|||
125564919|NCT02349048|451698251|FG000|Overall Study|Withdrawal by Subject|4|||
125564920|NCT02349048|451698252|FG001|Overall Study|Withdrawal by Subject|0|||
125564921|NCT02349048|451698251|FG000|Overall Study|Lost to Follow-up|1|||
125564922|NCT02349048|451698252|FG001|Overall Study|Lost to Follow-up|0|||
125564923|NCT00094770|451698255|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
125564924|NCT00094770|451698256|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
125564925|NCT00094770|451698255|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
125564926|NCT00094770|451698256|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
125564927|NCT00094770|451698255|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
125564928|NCT00094770|451698256|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
125564929|NCT00094770|451698255|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
125564930|NCT00094770|451698256|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
125564931|NCT00094770|451698255|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
125564932|NCT00094770|451698256|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
125564933|NCT00094770|451698255|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
125564934|NCT00094770|451698256|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
125564935|NCT00094770|451698255|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
125564936|NCT00094770|451698256|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
125564937|NCT00094770|451698255|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
125564938|NCT00094770|451698256|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
125564939|NCT00094770|451698255|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
125564940|NCT00094770|451698256|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
125564941|NCT00094770|451698255|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
125564942|NCT00094770|451698256|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
125564943|NCT00094770|451698255|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
125564944|NCT00094770|451698256|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
125564945|NCT00094770|451698255|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
125564946|NCT00094770|451698256|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
125564947|NCT00094770|451698255|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
125355467|NCT01226043|450936516|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
125355468|NCT01226043|450936517|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
125355469|NCT01226043|450936518|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
125355470|NCT01226043|450936519|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
125355471|NCT01226043|450936516|FG000|30-week Observational Phase|Physician Decision|0|||
125355472|NCT01226043|450936517|FG001|30-week Observational Phase|Physician Decision|0|||
125355473|NCT01226043|450936518|FG002|30-week Observational Phase|Physician Decision|2|||
125355474|NCT01226043|450936519|FG003|30-week Observational Phase|Physician Decision|2|||
125355475|NCT00191646|450936521|FG000|Overall Study|Toxicity|26|||
125355476|NCT00191646|450936522|FG001|Overall Study|Toxicity|37|||
125355477|NCT00191646|450936521|FG000|Overall Study|Disease Progression|5|||
125355478|NCT00191646|450936522|FG001|Overall Study|Disease Progression|6|||
125355479|NCT00191646|450936521|FG000|Overall Study|Physician Decision|20|||
125355480|NCT00191646|450936522|FG001|Overall Study|Physician Decision|11|||
125355481|NCT00191646|450936521|FG000|Overall Study|Withdrawal by Subject|58|||
125355482|NCT00191646|450936522|FG001|Overall Study|Withdrawal by Subject|39|||
125355483|NCT00191646|450936521|FG000|Overall Study|Protocol Violation|5|||
125355484|NCT00191646|450936522|FG001|Overall Study|Protocol Violation|7|||
125355485|NCT00191646|450936521|FG000|Overall Study|Death|6|||
125355486|NCT00191646|450936522|FG001|Overall Study|Death|8|||
125355487|NCT00191646|450936521|FG000|Overall Study|Other|33|||
125355488|NCT00191646|450936522|FG001|Overall Study|Other|34|||
125355489|NCT00191646|450936521|FG000|Overall Study|Missing Data|18|||
125355490|NCT00191646|450936522|FG001|Overall Study|Missing Data|11|||
125355491|NCT05211284|450936527|FG000|Overall Study|Study Terminated|3|||
125355492|NCT05211284|450936528|FG001|Overall Study|Study Terminated|1|||
125355493|NCT00908011|450936529|FG000|Overall Study|Withdrawal by Subject|2|||
125355494|NCT00908011|450936530|FG001|Overall Study|Withdrawal by Subject|2|||
125355495|NCT00739596|450936535|FG000|Overall Study|Adverse Event|12|||
125355496|NCT00739596|450936536|FG001|Overall Study|Adverse Event|6|||
125355497|NCT00739596|450936535|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
125355498|NCT00739596|450936536|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125355499|NCT00739596|450936535|FG000|Overall Study|Patient Withdrew Consent|8|||
125355500|NCT00739596|450936536|FG001|Overall Study|Patient Withdrew Consent|8|||
125355501|NCT00739596|450936535|FG000|Overall Study|Lost to Follow-up|0|||
125355502|NCT00739596|450936536|FG001|Overall Study|Lost to Follow-up|2|||
125355503|NCT00739596|450936535|FG000|Overall Study|Protocol Deviation|1|||
125355504|NCT00739596|450936536|FG001|Overall Study|Protocol Deviation|1|||
125355505|NCT00644228|450936537|FG000|Randomization & Eligibility|Ineligible|31|||
125355506|NCT00644228|450936538|FG001|Randomization & Eligibility|Ineligible|21|||
125355507|NCT00644228|450936537|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
125355508|NCT00644228|450936538|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
125355509|NCT00644228|450936537|FG000|Randomization & Eligibility|Invalid Consent|0|||
125355510|NCT00644228|450936538|FG001|Randomization & Eligibility|Invalid Consent|1|||
125355511|NCT00644228|450936537|FG000|Induction Therapy|Adverse Event|22|||
125564948|NCT00094770|451698256|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
125564949|NCT00094770|451698255|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
125564950|NCT00094770|451698256|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
125564951|NCT00094770|451698255|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
125355512|NCT00644228|450936538|FG001|Induction Therapy|Adverse Event|55|||
125564952|NCT00094770|451698256|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
125355513|NCT00644228|450936537|FG000|Induction Therapy|Withdrawal by Subject|10|||
125355514|NCT00644228|450936538|FG001|Induction Therapy|Withdrawal by Subject|3|||
125564953|NCT00094770|451698255|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
125564954|NCT00094770|451698256|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
125564955|NCT00094770|451698255|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
125355515|NCT00644228|450936537|FG000|Induction Therapy|Progression/Relapse|24|||
125355516|NCT00644228|450936538|FG001|Induction Therapy|Progression/Relapse|12|||
125355517|NCT00644228|450936537|FG000|Induction Therapy|Death|3|||
125355518|NCT00644228|450936538|FG001|Induction Therapy|Death|7|||
125355519|NCT00644228|450936537|FG000|Induction Therapy|Not Protocol-Specified|24|||
125564956|NCT00094770|451698256|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
125564957|NCT00094770|451698255|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
125564958|NCT00094770|451698256|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
125564959|NCT01648790|451698257|FG000|Treatment 3|Withdrawal by Subject|0|||
125564960|NCT01648790|451698258|FG001|Treatment 3|Withdrawal by Subject|0|||
125564961|NCT01648790|451698259|FG002|Treatment 3|Withdrawal by Subject|0|||
125564962|NCT01648790|451698260|FG003|Treatment 3|Withdrawal by Subject|1|||
125564963|NCT01648790|451698261|FG004|Treatment 3|Withdrawal by Subject|0|||
125564964|NCT00454857|451698262|FG000|Overall Study|Withdrawal by Subject|15|||
125564965|NCT00454857|451698262|FG000|Overall Study|Lost to Follow-up|16|||
125564966|NCT00454857|451698262|FG000|Overall Study|Noncompliance|6|||
125564967|NCT00454857|451698262|FG000|Overall Study|Death|5|||
125564968|NCT00454857|451698262|FG000|Overall Study|Other|11|||
125564969|NCT00454857|451698262|FG000|Overall Study|Reason unknown|1|||
125564970|NCT04206020|451698265|FG000|Overall Study|Adverse Event|1|||
125564971|NCT04206020|451698266|FG001|Overall Study|Adverse Event|4|||
125564972|NCT04206020|451698265|FG000|Overall Study|Protocol Violation|2|||
125564973|NCT04206020|451698266|FG001|Overall Study|Protocol Violation|0|||
125564974|NCT04206020|451698265|FG000|Overall Study|Withdrawal by Subject|2|||
125564975|NCT04206020|451698266|FG001|Overall Study|Withdrawal by Subject|0|||
125564976|NCT04206020|451698265|FG000|Overall Study|Lost to Follow-up|2|||
125564977|NCT04206020|451698266|FG001|Overall Study|Lost to Follow-up|0|||
125564978|NCT04206020|451698265|FG000|Overall Study|Pregnancy|0|||
125564979|NCT04206020|451698266|FG001|Overall Study|Pregnancy|1|||
125564980|NCT04206020|451698265|FG000|Overall Study|Unable to attend visits|1|||
125564981|NCT04206020|451698266|FG001|Overall Study|Unable to attend visits|2|||
125564982|NCT01197521|451698269|FG000|Overall Study|Not reported|24|||
125564983|NCT01197521|451698270|FG001|Overall Study|Not reported|25|||
125564984|NCT01197521|451698271|FG002|Overall Study|Not reported|21|||
125564985|NCT01197521|451698269|FG000|Overall Study|Enrolment in long term extension|42|||
125564986|NCT01197521|451698270|FG001|Overall Study|Enrolment in long term extension|36|||
125564987|NCT01197521|451698271|FG002|Overall Study|Enrolment in long term extension|87|||
125564988|NCT01197521|451698269|FG000|Overall Study|Severe non-compliance to protocol|1|||
125564989|NCT01197521|451698270|FG001|Overall Study|Severe non-compliance to protocol|3|||
125564990|NCT01197521|451698271|FG002|Overall Study|Severe non-compliance to protocol|3|||
125564991|NCT01197521|451698269|FG000|Overall Study|Lack of therapeutic response|2|||
125564992|NCT01197521|451698270|FG001|Overall Study|Lack of therapeutic response|3|||
125564993|NCT01197521|451698271|FG002|Overall Study|Lack of therapeutic response|4|||
125564994|NCT01197521|451698269|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
125564995|NCT01197521|451698270|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
125564996|NCT01197521|451698271|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
125564997|NCT01197521|451698269|FG000|Overall Study|Lost to Follow-up|3|||
125564998|NCT01197521|451698270|FG001|Overall Study|Lost to Follow-up|2|||
125564999|NCT01197521|451698271|FG002|Overall Study|Lost to Follow-up|2|||
125565000|NCT01197521|451698269|FG000|Overall Study|Adverse Event|25|||
125565001|NCT01197521|451698270|FG001|Overall Study|Adverse Event|28|||
125565002|NCT01197521|451698271|FG002|Overall Study|Adverse Event|24|||
125565003|NCT03073980|451698274|FG000|Overall Study|Lost to Follow-up|10|||
125565004|NCT03073980|451698275|FG001|Overall Study|Lost to Follow-up|2|||
125565005|NCT03073980|451698276|FG002|Overall Study|Lost to Follow-up|9|||
125565006|NCT03073980|451698274|FG000|Overall Study|No post-procedure data|0|||
125565007|NCT03073980|451698275|FG001|Overall Study|No post-procedure data|0|||
125565008|NCT03073980|451698276|FG002|Overall Study|No post-procedure data|2|||
125565009|NCT00545064|451698277|FG000|Overall Study|Lost to Follow-up|3|||
125565010|NCT00545064|451698277|FG000|Overall Study|Withdrawal by Subject|2|||
125565011|NCT00545064|451698277|FG000|Overall Study|did not complete course of treatment|1|||
125565012|NCT00545064|451698277|FG000|Overall Study|cancel all appointments, no rebooking|1|||
125565013|NCT00545064|451698277|FG000|Overall Study|inclement weather|1|||
125565014|NCT00501007|451698278|FG000|Overall Study|Inclusion criteria not met.|29|||
125565015|NCT00501007|451698279|FG001|Overall Study|Inclusion criteria not met.|25|||
125565016|NCT00258674|451698282|FG000|Overall Study|Death|32|||
125565017|NCT00258674|451698283|FG001|Overall Study|Death|53|||
125565018|NCT00258674|451698284|FG002|Overall Study|Death|34|||
125565019|NCT03715153|451698285|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
125565020|NCT03715153|451698286|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
125565021|NCT03715153|451698285|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
125565022|NCT03715153|451698286|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
125565023|NCT03715153|451698285|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
125565024|NCT03715153|451698286|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
125565025|NCT03715153|451698285|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
125565026|NCT03715153|451698286|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
125565027|NCT03715153|451698285|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
125565028|NCT03715153|451698286|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
125565029|NCT03715153|451698285|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
125565030|NCT03715153|451698286|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
125565031|NCT01358760|451698291|FG000|Overall Study|Adverse Event|3|||
125565032|NCT01358760|451698292|FG001|Overall Study|Adverse Event|4|||
125565033|NCT01358760|451698293|FG002|Overall Study|Adverse Event|3|||
125565034|NCT01358760|451698291|FG000|Overall Study|Lost to Follow-up|1|||
125565035|NCT01358760|451698292|FG001|Overall Study|Lost to Follow-up|1|||
125565036|NCT01358760|451698293|FG002|Overall Study|Lost to Follow-up|3|||
125565037|NCT01358760|451698291|FG000|Overall Study|Withdrawal by Subject|5|||
125565038|NCT01358760|451698292|FG001|Overall Study|Withdrawal by Subject|3|||
125565039|NCT01358760|451698293|FG002|Overall Study|Withdrawal by Subject|2|||
125565040|NCT01358760|451698291|FG000|Overall Study|Physician Decision|1|||
125565041|NCT01358760|451698292|FG001|Overall Study|Physician Decision|0|||
125565042|NCT01358760|451698293|FG002|Overall Study|Physician Decision|1|||
125565043|NCT01358760|451698291|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
125565044|NCT01358760|451698292|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
125565045|NCT01358760|451698293|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
125565046|NCT01506960|451698294|FG000|Overall Study|Did not meet angiographic criteria|47|||
125565047|NCT00450723|451698296|FG000|Overall Study|Physician Decision|5|||
125565048|NCT00078325|451698297|FG000|Overall Study|Adverse Event|15|||
125565049|NCT00078325|451698298|FG001|Overall Study|Adverse Event|10|||
125565050|NCT00078325|451698299|FG002|Overall Study|Adverse Event|5|||
125565051|NCT00078325|451698297|FG000|Overall Study|Protocol Violation|2|||
125565052|NCT00078325|451698298|FG001|Overall Study|Protocol Violation|2|||
125565053|NCT00078325|451698299|FG002|Overall Study|Protocol Violation|0|||
125565054|NCT00078325|451698297|FG000|Overall Study|Withdrawal by Subject|1|||
125565055|NCT00078325|451698298|FG001|Overall Study|Withdrawal by Subject|5|||
125565056|NCT00078325|451698299|FG002|Overall Study|Withdrawal by Subject|3|||
125565057|NCT00078325|451698297|FG000|Overall Study|Lost to Follow-up|0|||
125565058|NCT00078325|451698298|FG001|Overall Study|Lost to Follow-up|1|||
125565059|NCT00078325|451698299|FG002|Overall Study|Lost to Follow-up|1|||
125565060|NCT00078325|451698297|FG000|Overall Study|Physician Decision|2|||
125565061|NCT00078325|451698298|FG001|Overall Study|Physician Decision|0|||
125565062|NCT00078325|451698299|FG002|Overall Study|Physician Decision|1|||
125565063|NCT00078325|451698297|FG000|Overall Study|Miscellaneous|1|||
125565064|NCT00078325|451698298|FG001|Overall Study|Miscellaneous|1|||
125565065|NCT00078325|451698299|FG002|Overall Study|Miscellaneous|1|||
125565066|NCT00578136|451698300|FG000|Overall Study|Not given intervention|1|||
125565067|NCT00578136|451698301|FG001|Overall Study|Not given intervention|1|||
125565068|NCT02047253|451698302|FG000|Overall Study|Lost to Follow-up|8|||
125565069|NCT03710486|451698304|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
125565070|NCT03710486|451698305|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
125565071|NCT03710486|451698304|FG000|Overall Study|Missing|0|||
125565072|NCT03710486|451698305|FG001|Overall Study|Missing|2|||
125565073|NCT01987960|451698306|FG000|Period 1|Adverse Event|24|||
125565074|NCT01987960|451698307|FG001|Period 1|Adverse Event|0|||
125565075|NCT01987960|451698308|FG002|Period 1|Adverse Event|0|||
125565076|NCT01987960|451698309|FG003|Period 1|Adverse Event|0|||
125565077|NCT01987960|451698306|FG000|Period 1|Lack of Efficacy|4|||
125565078|NCT01987960|451698307|FG001|Period 1|Lack of Efficacy|0|||
125565079|NCT01987960|451698308|FG002|Period 1|Lack of Efficacy|0|||
125565080|NCT01987960|451698309|FG003|Period 1|Lack of Efficacy|0|||
125565081|NCT01987960|451698306|FG000|Period 1|Non-compliance with IMP|6|||
125565082|NCT01987960|451698307|FG001|Period 1|Non-compliance with IMP|0|||
125565083|NCT01987960|451698308|FG002|Period 1|Non-compliance with IMP|0|||
125565084|NCT01987960|451698309|FG003|Period 1|Non-compliance with IMP|0|||
125565085|NCT01987960|451698306|FG000|Period 1|Protocol Violation|12|||
125565086|NCT01987960|451698307|FG001|Period 1|Protocol Violation|0|||
125565087|NCT01987960|451698308|FG002|Period 1|Protocol Violation|0|||
125565088|NCT01987960|451698309|FG003|Period 1|Protocol Violation|0|||
125565089|NCT01987960|451698306|FG000|Period 1|Withdrawal by Subject|21|||
125565090|NCT01987960|451698307|FG001|Period 1|Withdrawal by Subject|0|||
125565091|NCT01987960|451698308|FG002|Period 1|Withdrawal by Subject|0|||
125565092|NCT01987960|451698309|FG003|Period 1|Withdrawal by Subject|0|||
125565093|NCT01987960|451698306|FG000|Period 1|Lost to Follow-up|40|||
125565094|NCT01987960|451698307|FG001|Period 1|Lost to Follow-up|0|||
125565095|NCT01987960|451698308|FG002|Period 1|Lost to Follow-up|0|||
125565096|NCT01987960|451698309|FG003|Period 1|Lost to Follow-up|0|||
125565097|NCT01987960|451698306|FG000|Period 1|administrative or other reason|75|||
125565098|NCT01987960|451698307|FG001|Period 1|administrative or other reason|0|||
125565099|NCT01987960|451698308|FG002|Period 1|administrative or other reason|0|||
125565100|NCT01987960|451698309|FG003|Period 1|administrative or other reason|0|||
125565101|NCT01987960|451698306|FG000|Period 1|Withdrawal of consent before treatment|4|||
125565102|NCT01987960|451698307|FG001|Period 1|Withdrawal of consent before treatment|0|||
125565103|NCT01987960|451698308|FG002|Period 1|Withdrawal of consent before treatment|0|||
125565104|NCT01987960|451698309|FG003|Period 1|Withdrawal of consent before treatment|0|||
125565105|NCT01987960|451698306|FG000|Period 2|Adverse Event|0|||
125565106|NCT01987960|451698307|FG001|Period 2|Adverse Event|0|||
125565107|NCT01987960|451698308|FG002|Period 2|Adverse Event|1|||
125565108|NCT01987960|451698309|FG003|Period 2|Adverse Event|0|||
125565109|NCT01987960|451698306|FG000|Period 2|Withdrawal by Subject|0|||
125565110|NCT01987960|451698307|FG001|Period 2|Withdrawal by Subject|0|||
125565111|NCT01987960|451698308|FG002|Period 2|Withdrawal by Subject|1|||
125565112|NCT01987960|451698309|FG003|Period 2|Withdrawal by Subject|0|||
125565113|NCT01987960|451698306|FG000|Period 2|Administrative or other reason|0|||
125565114|NCT01987960|451698307|FG001|Period 2|Administrative or other reason|5|||
125565115|NCT01987960|451698308|FG002|Period 2|Administrative or other reason|7|||
125565116|NCT01987960|451698309|FG003|Period 2|Administrative or other reason|0|||
125565117|NCT01987960|451698306|FG000|Period 3|Adverse Event|0|||
125565118|NCT01987960|451698307|FG001|Period 3|Adverse Event|0|||
125565119|NCT01987960|451698308|FG002|Period 3|Adverse Event|0|||
125565120|NCT01987960|451698309|FG003|Period 3|Adverse Event|7|||
125565121|NCT01987960|451698306|FG000|Period 3|Non-compliance with IMP|0|||
125565122|NCT01987960|451698307|FG001|Period 3|Non-compliance with IMP|0|||
125565123|NCT01987960|451698308|FG002|Period 3|Non-compliance with IMP|0|||
125565124|NCT01987960|451698309|FG003|Period 3|Non-compliance with IMP|1|||
125565125|NCT01987960|451698306|FG000|Period 3|Protocol Violation|0|||
125565126|NCT01987960|451698307|FG001|Period 3|Protocol Violation|0|||
125565127|NCT01987960|451698308|FG002|Period 3|Protocol Violation|0|||
125565128|NCT01987960|451698309|FG003|Period 3|Protocol Violation|6|||
125565129|NCT01987960|451698306|FG000|Period 3|Withdrawal by Subject|0|||
125565130|NCT01987960|451698307|FG001|Period 3|Withdrawal by Subject|0|||
125565131|NCT01987960|451698308|FG002|Period 3|Withdrawal by Subject|0|||
125565132|NCT01987960|451698309|FG003|Period 3|Withdrawal by Subject|9|||
125565133|NCT01987960|451698306|FG000|Period 3|Lost to Follow-up|0|||
125565134|NCT01987960|451698307|FG001|Period 3|Lost to Follow-up|0|||
125565135|NCT01987960|451698308|FG002|Period 3|Lost to Follow-up|0|||
125565136|NCT01987960|451698309|FG003|Period 3|Lost to Follow-up|5|||
125565137|NCT01987960|451698306|FG000|Period 3|Administrative or other reason|0|||
125565138|NCT01987960|451698307|FG001|Period 3|Administrative or other reason|0|||
125565139|NCT01987960|451698308|FG002|Period 3|Administrative or other reason|0|||
125565140|NCT01987960|451698309|FG003|Period 3|Administrative or other reason|43|||
125565141|NCT01892163|451698317|FG000|Overall Study|Death|1|||
125565142|NCT01892163|451698318|FG001|Overall Study|Death|1|||
125565143|NCT01892163|451698317|FG000|Overall Study|Lost to Follow-up|1|||
125565144|NCT01892163|451698318|FG001|Overall Study|Lost to Follow-up|0|||
125565145|NCT03302975|451698320|FG000|Overall Study|Lost to Follow-up|4|||
125565146|NCT00219284|451698323|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
125565147|NCT00219284|451698324|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
125565148|NCT00219284|451698323|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
125565149|NCT00219284|451698324|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
125565150|NCT00219284|451698323|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
125565151|NCT00219284|451698324|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
125565152|NCT00219284|451698323|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
125565153|NCT00219284|451698324|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
125565154|NCT00219284|451698323|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
125565155|NCT00219284|451698324|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
125565156|NCT00219284|451698323|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
125565157|NCT00219284|451698324|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
125565158|NCT00219284|451698323|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
125565159|NCT00219284|451698324|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
125565160|NCT00219284|451698323|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
125565161|NCT00219284|451698324|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
125565162|NCT00219284|451698323|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
125565163|NCT00219284|451698324|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
125565164|NCT04722042|451698325|FG000|Overall Study|Withdrawal by Subject|2|||
125565165|NCT04722042|451698326|FG001|Overall Study|Withdrawal by Subject|1|||
125565166|NCT04722042|451698327|FG002|Overall Study|Withdrawal by Subject|0|||
125565167|NCT02321930|451698336|FG000|Overall Study|Lost to Follow-up|1|||
125565168|NCT01293968|451698337|FG000|Overall Study|non-cooperation|3|||
125565169|NCT01293968|451698338|FG001|Overall Study|non-cooperation|3|||
125565170|NCT00853749|451698339|FG000|Overall Study|Lost to Follow-up|0|||
125565171|NCT00853749|451698340|FG001|Overall Study|Lost to Follow-up|1|||
125565172|NCT02269787|451698343|FG000|Overall Study|Lost to Follow-up|20|||
125565173|NCT02269787|451698344|FG001|Overall Study|Lost to Follow-up|6|||
125565174|NCT02269787|451698343|FG000|Overall Study|Death|2|||
125565175|NCT02269787|451698344|FG001|Overall Study|Death|3|||
125565176|NCT02269787|451698343|FG000|Overall Study|Incapacitated|0|||
125565177|NCT02269787|451698344|FG001|Overall Study|Incapacitated|1|||
125565178|NCT00687440|451698345|FG000|Overall Study|Adverse Event|3|||
125565179|NCT00687440|451698345|FG000|Overall Study|Lost to Follow-up|3|||
125565180|NCT00687440|451698345|FG000|Overall Study|Lack of Efficacy|2|||
125565181|NCT00687440|451698345|FG000|Overall Study|Death|2|||
125565182|NCT00687440|451698345|FG000|Overall Study|Other|1|||
125565183|NCT00687440|451698345|FG000|Overall Study|Missing|1|||
125565184|NCT02228720|451698346|FG000|Open Label - Day 30|Lost to Follow-up|1|||
125565185|NCT01392677|451698351|FG000|Overall Study|Adverse Event|3|||
125565186|NCT01392677|451698352|FG001|Overall Study|Adverse Event|1|||
125565187|NCT01392677|451698351|FG000|Overall Study|Withdrawal by Subject|0|||
125565188|NCT01392677|451698352|FG001|Overall Study|Withdrawal by Subject|2|||
125565189|NCT01392677|451698351|FG000|Overall Study|Incorrect enrollment|2|||
125565190|NCT01392677|451698352|FG001|Overall Study|Incorrect enrollment|3|||
125565191|NCT01392677|451698351|FG000|Overall Study|Other reason|3|||
125565192|NCT01392677|451698352|FG001|Overall Study|Other reason|2|||
125565193|NCT03996876|451698353|FG000|Overall Study|Incomplete Data|2|||
125565194|NCT03996876|451698354|FG001|Overall Study|Incomplete Data|4|||
125565195|NCT05264740|451698359|FG000|Baseline|Withdrawal by Subject|0|||
125565196|NCT05264740|451698360|FG001|Baseline|Withdrawal by Subject|1|||
125565197|NCT05264740|451698359|FG000|Follow Up 1|Lost to Follow-up|1|||
125565198|NCT05264740|451698360|FG001|Follow Up 1|Lost to Follow-up|1|||
125565199|NCT05264740|451698359|FG000|Follow Up 1|Withdrawal by Subject|0|||
125565200|NCT05264740|451698360|FG001|Follow Up 1|Withdrawal by Subject|1|||
125565201|NCT05264740|451698359|FG000|Follow Up 2|Lost to Follow-up|1|||
125565202|NCT05264740|451698360|FG001|Follow Up 2|Lost to Follow-up|4|||
125565203|NCT05264740|451698359|FG000|Follow Up 3|Lost to Follow-up|7|||
125565204|NCT05264740|451698360|FG001|Follow Up 3|Lost to Follow-up|4|||
125565205|NCT01538628|451698361|FG000|Overall Study|Withdrawal by Subject|1|||
125565206|NCT01538628|451698362|FG001|Overall Study|Withdrawal by Subject|1|||
125565207|NCT01538628|451698361|FG000|Overall Study|Lost to Follow-up|0|||
125565208|NCT01538628|451698362|FG001|Overall Study|Lost to Follow-up|1|||
125565209|NCT04360551|451699544|FG000|Overall Study|Withdrawal by Subject|1|||
125565210|NCT04360551|451699545|FG001|Overall Study|Withdrawal by Subject|0|||
125565211|NCT00388973|451699550|FG000|Overall Study|Adverse Event|16|||
125565212|NCT00388973|451699551|FG001|Overall Study|Adverse Event|6|||
125565213|NCT00388973|451699550|FG000|Overall Study|Lack of Efficacy|1|||
125565214|NCT00388973|451699551|FG001|Overall Study|Lack of Efficacy|12|||
125565215|NCT00388973|451699550|FG000|Overall Study|Protocol Violation|3|||
125565216|NCT00388973|451699551|FG001|Overall Study|Protocol Violation|0|||
125565217|NCT00388973|451699550|FG000|Overall Study|Withdrawal by Subject|14|||
125565218|NCT00388973|451699551|FG001|Overall Study|Withdrawal by Subject|17|||
125565219|NCT00388973|451699550|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
125565220|NCT00388973|451699551|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
125565221|NCT00388973|451699550|FG000|Overall Study|Did not complete 61 days of treatment|5|||
125565222|NCT00388973|451699551|FG001|Overall Study|Did not complete 61 days of treatment|4|||
125565223|NCT00388973|451699550|FG000|Overall Study|Left region|0|||
125565224|NCT00388973|451699551|FG001|Overall Study|Left region|1|||
125565225|NCT00388973|451699550|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
125565226|NCT00388973|451699551|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
125565227|NCT02535715|451699566|FG000|Overall Study|Withdrawal by Subject|0|||
125565228|NCT02535715|451699567|FG001|Overall Study|Withdrawal by Subject|0|||
125565229|NCT02535715|451699568|FG002|Overall Study|Withdrawal by Subject|1|||
125565230|NCT00909181|451699569|FG000|Overall Study|Lost to Follow-up|39|||
125565231|NCT00909181|451699570|FG001|Overall Study|Lost to Follow-up|18|||
125565232|NCT00909181|451699571|FG002|Overall Study|Lost to Follow-up|33|||
125565233|NCT00914927|451699573|FG000|Overall Study|Adverse Event|0|||
125565234|NCT00914927|451699574|FG001|Overall Study|Adverse Event|0|||
125565235|NCT00914927|451699575|FG002|Overall Study|Adverse Event|0|||
125565236|NCT00914927|451699576|FG003|Overall Study|Adverse Event|0|||
125565237|NCT00914927|451699577|FG004|Overall Study|Adverse Event|1|||
125565238|NCT00914927|451699578|FG005|Overall Study|Adverse Event|0|||
125565239|NCT00914927|451699579|FG006|Overall Study|Adverse Event|0|||
125565240|NCT00914927|451699573|FG000|Overall Study|Withdrawal by Subject|0|||
125565241|NCT00914927|451699574|FG001|Overall Study|Withdrawal by Subject|1|||
125565242|NCT00914927|451699575|FG002|Overall Study|Withdrawal by Subject|0|||
125565243|NCT00914927|451699576|FG003|Overall Study|Withdrawal by Subject|1|||
125565244|NCT00914927|451699577|FG004|Overall Study|Withdrawal by Subject|0|||
125565245|NCT00914927|451699578|FG005|Overall Study|Withdrawal by Subject|0|||
125565246|NCT00914927|451699579|FG006|Overall Study|Withdrawal by Subject|0|||
125565247|NCT00914927|451699573|FG000|Overall Study|Lost to Follow-up|0|||
125565248|NCT00914927|451699574|FG001|Overall Study|Lost to Follow-up|0|||
125565249|NCT00914927|451699575|FG002|Overall Study|Lost to Follow-up|0|||
125565250|NCT00914927|451699576|FG003|Overall Study|Lost to Follow-up|1|||
125565251|NCT00914927|451699577|FG004|Overall Study|Lost to Follow-up|0|||
125565252|NCT00914927|451699578|FG005|Overall Study|Lost to Follow-up|0|||
125565253|NCT00914927|451699579|FG006|Overall Study|Lost to Follow-up|0|||
125565254|NCT00914927|451699573|FG000|Overall Study|Administrative/Other|2|||
125565255|NCT00914927|451699574|FG001|Overall Study|Administrative/Other|1|||
125565256|NCT00914927|451699575|FG002|Overall Study|Administrative/Other|0|||
125565257|NCT00914927|451699576|FG003|Overall Study|Administrative/Other|0|||
125565258|NCT00914927|451699577|FG004|Overall Study|Administrative/Other|1|||
125565259|NCT00914927|451699578|FG005|Overall Study|Administrative/Other|0|||
125565260|NCT00914927|451699579|FG006|Overall Study|Administrative/Other|0|||
125565261|NCT04773106|451699580|FG000|Overall Study|Withdrawal by Subject|3|||
125565262|NCT04773106|451699580|FG000|Overall Study|Death|1|||
125565263|NCT03370120|451699583|FG000|Overall Study|Adverse event, non-fatal|24|||
125565264|NCT03370120|451699583|FG000|Overall Study|Withdrawal by Subject|6|||
125565265|NCT03370120|451699583|FG000|Overall Study|Lost to Follow-up|1|||
125565266|NCT03370120|451699583|FG000|Overall Study|Lack of Efficacy|37|||
125565267|NCT03370120|451699583|FG000|Overall Study|Per sponsor's instructions|1|||
125565268|NCT03370120|451699583|FG000|Overall Study|Study was terminated by parent company UCB|2|||
125565269|NCT03370120|451699583|FG000|Overall Study|The study was ended by the promoter|3|||
125565270|NCT03370120|451699583|FG000|Overall Study|Discontinuation of drug development|3|||
125565271|NCT03370120|451699583|FG000|Overall Study|End of project|2|||
125565272|NCT03370120|451699583|FG000|Overall Study|Premature study closure|2|||
125565273|NCT03370120|451699583|FG000|Overall Study|Premature program termination|1|||
125565274|NCT03370120|451699583|FG000|Overall Study|Premature study termination|7|||
125565275|NCT03370120|451699583|FG000|Overall Study|Trial terminated by sponsor|2|||
125565276|NCT03370120|451699583|FG000|Overall Study|Trial discontinued by sponsor|2|||
125565277|NCT03370120|451699583|FG000|Overall Study|Study ended|15|||
125565278|NCT03370120|451699583|FG000|Overall Study|Clinical trial has been cancelled|1|||
125565279|NCT03370120|451699583|FG000|Overall Study|End of study per sponsor decision|2|||
125565280|NCT03370120|451699583|FG000|Overall Study|Promoter's decision|2|||
125565281|NCT03370120|451699583|FG000|Overall Study|The trial has been suspended|3|||
125565282|NCT03370120|451699583|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
125565283|NCT03370120|451699583|FG000|Overall Study|Early termination by order of sponsor|2|||
125565284|NCT03370120|451699583|FG000|Overall Study|Discontinuation of the study|5|||
125565285|NCT03370120|451699583|FG000|Overall Study|End of clinical trial discontinuation|1|||
125565286|NCT03370120|451699583|FG000|Overall Study|Because the clinical trial ended halfway|4|||
125565287|NCT03370120|451699583|FG000|Overall Study|Development discontinued|5|||
125565288|NCT03370120|451699583|FG000|Overall Study|Padsenovil program closed|3|||
125565289|NCT03370120|451699583|FG000|Overall Study|End of project|2|||
125565290|NCT03370120|451699583|FG000|Overall Study|Termination of project|1|||
125565291|NCT03370120|451699583|FG000|Overall Study|The study was interrupted by sponsor|4|||
125565292|NCT03370120|451699583|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
125565293|NCT03370120|451699583|FG000|Overall Study|End of sponsor decision|1|||
125565294|NCT03370120|451699583|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
125565295|NCT03370120|451699583|FG000|Overall Study|Early termination of studies|5|||
125565296|NCT03370120|451699583|FG000|Overall Study|This study is ended early|1|||
125565297|NCT03370120|451699583|FG000|Overall Study|End of padsevonil program|2|||
125565298|NCT03370120|451699583|FG000|Overall Study|Decision of sponsor|6|||
125565299|NCT03370120|451699583|FG000|Overall Study|Asked by the sponsor|3|||
125565300|NCT03370120|451699583|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
125565301|NCT03370120|451699583|FG000|Overall Study|PI decision poor compliance from participant|1|||
125565302|NCT03370120|451699583|FG000|Overall Study|Promoter ended the study|3|||
125565303|NCT03370120|451699583|FG000|Overall Study|Premature study close by sponsor's decision|4|||
125565304|NCT03370120|451699583|FG000|Overall Study|Study terminated by sponsor|33|||
125565305|NCT03370120|451699583|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
125565306|NCT03370120|451699583|FG000|Overall Study|Sponsor decision to terminate study|63|||
125565307|NCT03370120|451699583|FG000|Overall Study|Program closure|3|||
125565308|NCT03370120|451699583|FG000|Overall Study|Study ended prematurely|1|||
125565309|NCT03370120|451699583|FG000|Overall Study|Study stopped by sponsor|2|||
125565310|NCT03370120|451699583|FG000|Overall Study|Program termination|55|||
125565311|NCT03370120|451699583|FG000|Overall Study|Sponsor decision|62|||
125565312|NCT03370120|451699583|FG000|Overall Study|Sponsor study closure|10|||
125565313|NCT02700412|451699585|FG000|Overall Study|Adverse Event|6|||
125565314|NCT02700412|451699585|FG000|Overall Study|Death|1|||
125565315|NCT02700412|451699585|FG000|Overall Study|Lack of Efficacy|19|||
125565316|NCT02700412|451699585|FG000|Overall Study|Protocol Violation|5|||
125565317|NCT02700412|451699585|FG000|Overall Study|Withdrawal by Subject|2|||
125565318|NCT03374189|451699586|FG000|Overall Study|Lost to Follow-up|1|||
125565319|NCT03374189|451699587|FG001|Overall Study|Lost to Follow-up|0|||
125565320|NCT00552175|451699590|FG000|Overall Study|Lack of Efficacy|2|||
125565321|NCT00552175|451699591|FG001|Overall Study|Lack of Efficacy|0|||
125565322|NCT00552175|451699592|FG002|Overall Study|Lack of Efficacy|1|||
125565323|NCT00552175|451699590|FG000|Overall Study|Adverse Event|9|||
125565324|NCT00552175|451699591|FG001|Overall Study|Adverse Event|9|||
125565325|NCT00552175|451699592|FG002|Overall Study|Adverse Event|10|||
125565326|NCT00552175|451699590|FG000|Overall Study|Withdrawal by Subject|2|||
125565327|NCT00552175|451699591|FG001|Overall Study|Withdrawal by Subject|2|||
125565328|NCT00552175|451699592|FG002|Overall Study|Withdrawal by Subject|1|||
125565329|NCT00552175|451699590|FG000|Overall Study|Lost to Follow-up|0|||
125565330|NCT00552175|451699591|FG001|Overall Study|Lost to Follow-up|0|||
125565331|NCT00552175|451699592|FG002|Overall Study|Lost to Follow-up|1|||
125565332|NCT00552175|451699590|FG000|Overall Study|Entry Criteria Not Met|1|||
125565333|NCT00552175|451699591|FG001|Overall Study|Entry Criteria Not Met|1|||
125565334|NCT00552175|451699592|FG002|Overall Study|Entry Criteria Not Met|0|||
125565335|NCT00552175|451699590|FG000|Overall Study|Reason Not Specified|3|||
125565336|NCT00552175|451699591|FG001|Overall Study|Reason Not Specified|1|||
125565337|NCT00552175|451699592|FG002|Overall Study|Reason Not Specified|1|||
125565338|NCT03975920|451699593|FG000|Overall Study|Lost to Follow-up|1|||
125565339|NCT03975920|451699594|FG001|Overall Study|Lost to Follow-up|2|||
125565340|NCT03975920|451699593|FG000|Overall Study|Protocol Violation|1|||
125565341|NCT03975920|451699594|FG001|Overall Study|Protocol Violation|1|||
125565342|NCT03975920|451699593|FG000|Overall Study|Did not complete survey|2|||
125565343|NCT03975920|451699594|FG001|Overall Study|Did not complete survey|1|||
125565344|NCT00884273|451699597|FG000|Overall Study|Adverse Event|0|||
125565345|NCT00884273|451699598|FG001|Overall Study|Adverse Event|2|||
125565346|NCT00884273|451699597|FG000|Overall Study|Protocol Violation|1|||
125565347|NCT00884273|451699598|FG001|Overall Study|Protocol Violation|3|||
125565348|NCT00884273|451699597|FG000|Overall Study|Practical reasons|1|||
125565349|NCT00884273|451699598|FG001|Overall Study|Practical reasons|0|||
125565350|NCT01147744|451699604|FG000|Overall Study|Protocol Violation|1|||
125565351|NCT01147744|451699605|FG001|Overall Study|Protocol Violation|0|||
125565352|NCT01147744|451699606|FG002|Overall Study|Protocol Violation|1|||
125565353|NCT01147744|451699607|FG003|Overall Study|Protocol Violation|0|||
125565354|NCT01147744|451699608|FG004|Overall Study|Protocol Violation|1|||
125565355|NCT01147744|451699609|FG005|Overall Study|Protocol Violation|3|||
125565356|NCT01147744|451699610|FG006|Overall Study|Protocol Violation|1|||
125565357|NCT01147744|451699604|FG000|Overall Study|Physician Decision|0|||
125565358|NCT01147744|451699605|FG001|Overall Study|Physician Decision|1|||
125565359|NCT01147744|451699606|FG002|Overall Study|Physician Decision|1|||
125565360|NCT01147744|451699607|FG003|Overall Study|Physician Decision|0|||
125565361|NCT01147744|451699608|FG004|Overall Study|Physician Decision|0|||
125565362|NCT01147744|451699609|FG005|Overall Study|Physician Decision|0|||
125565363|NCT01147744|451699610|FG006|Overall Study|Physician Decision|1|||
125565364|NCT01147744|451699604|FG000|Overall Study|Lack of Efficacy|11|||
125565365|NCT01147744|451699605|FG001|Overall Study|Lack of Efficacy|11|||
125565366|NCT01147744|451699606|FG002|Overall Study|Lack of Efficacy|9|||
125565367|NCT01147744|451699607|FG003|Overall Study|Lack of Efficacy|11|||
125565368|NCT01147744|451699608|FG004|Overall Study|Lack of Efficacy|13|||
125565369|NCT01147744|451699609|FG005|Overall Study|Lack of Efficacy|8|||
125565370|NCT01147744|451699610|FG006|Overall Study|Lack of Efficacy|7|||
125565371|NCT01147744|451699604|FG000|Overall Study|Adverse Event|1|||
125565372|NCT01147744|451699605|FG001|Overall Study|Adverse Event|2|||
125565373|NCT01147744|451699606|FG002|Overall Study|Adverse Event|3|||
125565374|NCT01147744|451699607|FG003|Overall Study|Adverse Event|0|||
125565375|NCT01147744|451699608|FG004|Overall Study|Adverse Event|2|||
125565376|NCT01147744|451699609|FG005|Overall Study|Adverse Event|1|||
125565377|NCT01147744|451699610|FG006|Overall Study|Adverse Event|2|||
125565378|NCT01147744|451699604|FG000|Overall Study|Withdrawal by Subject|8|||
125565379|NCT01147744|451699605|FG001|Overall Study|Withdrawal by Subject|4|||
125565380|NCT01147744|451699606|FG002|Overall Study|Withdrawal by Subject|2|||
125565381|NCT01147744|451699607|FG003|Overall Study|Withdrawal by Subject|2|||
125565382|NCT01147744|451699608|FG004|Overall Study|Withdrawal by Subject|2|||
125565383|NCT01147744|451699609|FG005|Overall Study|Withdrawal by Subject|5|||
125565384|NCT01147744|451699610|FG006|Overall Study|Withdrawal by Subject|2|||
125565385|NCT01147744|451699604|FG000|Overall Study|Lost to Follow-up|0|||
125565386|NCT01147744|451699605|FG001|Overall Study|Lost to Follow-up|1|||
125565387|NCT01147744|451699606|FG002|Overall Study|Lost to Follow-up|0|||
125565388|NCT01147744|451699607|FG003|Overall Study|Lost to Follow-up|0|||
125565389|NCT01147744|451699608|FG004|Overall Study|Lost to Follow-up|0|||
125565390|NCT01147744|451699609|FG005|Overall Study|Lost to Follow-up|0|||
125565391|NCT01147744|451699610|FG006|Overall Study|Lost to Follow-up|0|||
125565392|NCT01147744|451699604|FG000|Overall Study|Sponsor decision to amend protocol|7|||
125565393|NCT01147744|451699605|FG001|Overall Study|Sponsor decision to amend protocol|4|||
125565394|NCT01147744|451699606|FG002|Overall Study|Sponsor decision to amend protocol|2|||
125565395|NCT01147744|451699607|FG003|Overall Study|Sponsor decision to amend protocol|5|||
125565396|NCT01147744|451699608|FG004|Overall Study|Sponsor decision to amend protocol|7|||
125565397|NCT01147744|451699609|FG005|Overall Study|Sponsor decision to amend protocol|2|||
125565398|NCT01147744|451699610|FG006|Overall Study|Sponsor decision to amend protocol|6|||
125565399|NCT01147744|451699604|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125565400|NCT01147744|451699605|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
125565401|NCT01147744|451699606|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
125565402|NCT01147744|451699607|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
125565403|NCT01147744|451699608|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
125565404|NCT01147744|451699609|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125565405|NCT01147744|451699610|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
125565406|NCT02536313|451699615|FG000|Overall Study|Lack of Efficacy|0|||
125565407|NCT02536313|451699616|FG001|Overall Study|Lack of Efficacy|1|||
125565408|NCT02437864|451699622|FG000|Overall Study|Protocol Violation|4|||
125565409|NCT02437864|451699623|FG001|Overall Study|Protocol Violation|0|||
125565410|NCT00807742|451699625|FG000|Overall Study|Death|9|||
125565411|NCT00807742|451699626|FG001|Overall Study|Death|2|||
125565412|NCT00807742|451699625|FG000|Overall Study|Withdrawal by Subject|2|||
125565413|NCT00807742|451699626|FG001|Overall Study|Withdrawal by Subject|1|||
125565414|NCT00807742|451699625|FG000|Overall Study|Lost to Follow-up|35|||
125565415|NCT00807742|451699626|FG001|Overall Study|Lost to Follow-up|51|||
125565416|NCT00492752|451699627|FG000|Double Blind Treatment|Death|13|||
125565417|NCT00492752|451699628|FG001|Double Blind Treatment|Death|0|||
125565418|NCT00492752|451699629|FG002|Double Blind Treatment|Death|2|||
125565419|NCT00492752|451699630|FG003|Double Blind Treatment|Death|0|||
125565420|NCT00492752|451699627|FG000|Double Blind Treatment|Adverse Event|1|||
125565421|NCT00492752|451699628|FG001|Double Blind Treatment|Adverse Event|0|||
125565422|NCT00492752|451699629|FG002|Double Blind Treatment|Adverse Event|0|||
125565423|NCT00492752|451699630|FG003|Double Blind Treatment|Adverse Event|0|||
125565424|NCT00492752|451699627|FG000|Double Blind Treatment|Protocol Violation|0|||
125565425|NCT00492752|451699628|FG001|Double Blind Treatment|Protocol Violation|0|||
125565426|NCT00492752|451699629|FG002|Double Blind Treatment|Protocol Violation|1|||
125565427|NCT00492752|451699630|FG003|Double Blind Treatment|Protocol Violation|0|||
125565428|NCT00492752|451699627|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
125565429|NCT00492752|451699628|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
125565430|NCT00492752|451699629|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
125565431|NCT00492752|451699630|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
125565432|NCT00492752|451699627|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
125565433|NCT00492752|451699628|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
125565434|NCT00492752|451699629|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
125565435|NCT00492752|451699630|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
125565436|NCT00492752|451699627|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
125565437|NCT00492752|451699628|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
125565438|NCT00492752|451699629|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
125565439|NCT00492752|451699630|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
125565440|NCT00492752|451699627|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
125565441|NCT00492752|451699628|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
125565442|NCT00492752|451699629|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
125565443|NCT00492752|451699630|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
125565444|NCT00492752|451699627|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
125565445|NCT00492752|451699628|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
125565446|NCT00492752|451699629|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
125565447|NCT00492752|451699630|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
125565448|NCT00492752|451699627|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
125565449|NCT00492752|451699628|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
125565450|NCT00492752|451699629|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
125565451|NCT00492752|451699630|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
125565452|NCT00492752|451699627|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
125565453|NCT00492752|451699628|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
125565454|NCT00492752|451699629|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
125565455|NCT00492752|451699630|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
125565456|NCT00492752|451699627|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
125565457|NCT00492752|451699628|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
125565458|NCT00492752|451699629|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
125565459|NCT00492752|451699630|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
125565460|NCT02258451|451699631|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
125565461|NCT02258451|451699632|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
125565462|NCT02258451|451699631|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
125565463|NCT02258451|451699632|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
125565464|NCT02258451|451699631|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
125565465|NCT02258451|451699632|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
125565466|NCT02258451|451699631|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
125565467|NCT02258451|451699632|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
125355520|NCT00644228|450936538|FG001|Induction Therapy|Not Protocol-Specified|28|||
125355521|NCT00644228|450936537|FG000|Maintenance|Adverse Event|27|||
125355522|NCT00644228|450936538|FG001|Maintenance|Adverse Event|31|||
125565468|NCT02258451|451699631|FG000|Overall Study|Discontinuation all treatment due to death|4|||
125565469|NCT02258451|451699632|FG001|Overall Study|Discontinuation all treatment due to death|3|||
125565470|NCT02258451|451699631|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
125565471|NCT02258451|451699632|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
125565472|NCT02258451|451699631|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
125565473|NCT02258451|451699632|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
125565474|NCT02258451|451699631|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
125565475|NCT02258451|451699632|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
125565476|NCT02258451|451699631|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
125565477|NCT02258451|451699632|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
125565478|NCT02258451|451699631|FG000|Overall Study|Other reason|1|||
125565479|NCT02258451|451699632|FG001|Overall Study|Other reason|1|||
125565480|NCT02258451|451699631|FG000|Overall Study|Never treated|2|||
125565481|NCT02258451|451699632|FG001|Overall Study|Never treated|3|||
125565482|NCT04066491|451699633|FG000|Overall Study|Randomized, not treated|0|||
125565483|NCT04066491|451699634|FG001|Overall Study|Randomized, not treated|0|||
125565484|NCT04066491|451699635|FG002|Overall Study|Randomized, not treated|2|||
125565485|NCT04506086|451699636|FG000|Overall Study|Withdrawal by Subject|2|||
125565486|NCT00517751|451699637|FG000|Overall Study|Death|3|||
125565487|NCT00517751|451699637|FG000|Overall Study|Withdrawal by Subject|37|||
125565488|NCT00517751|451699637|FG000|Overall Study|Lost to Follow-up|4|||
125565489|NCT00517751|451699637|FG000|Overall Study|patient not over due|6|||
125565490|NCT00517751|451699637|FG000|Overall Study|Patient not due for visit|76|||
125565491|NCT00517751|451699637|FG000|Overall Study|Missing|3|||
125565492|NCT01484977|451699642|FG000|Overall Study|Adverse Event|8|||
125565493|NCT01484977|451699642|FG000|Overall Study|Lack of Efficacy|4|||
125565494|NCT01484977|451699642|FG000|Overall Study|Protocol Violation|6|||
125565495|NCT01484977|451699642|FG000|Overall Study|Lost to Follow-up|1|||
125565496|NCT01484977|451699642|FG000|Overall Study|Withdrawal by Subject|4|||
125565497|NCT01484977|451699642|FG000|Overall Study|Subject Protocol Non-compliant|1|||
125565498|NCT01484977|451699642|FG000|Overall Study|Moving Overseas|1|||
125565499|NCT01484977|451699642|FG000|Overall Study|Low White Blood Cell Count|1|||
125565500|NCT01484977|451699642|FG000|Overall Study|Lack of Compliance|1|||
125565501|NCT04857996|451699643|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
125565502|NCT04857996|451699644|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
125565503|NCT04857996|451699643|FG000|Overall Study|Lost to Follow-up|1|||
125565504|NCT04857996|451699644|FG001|Overall Study|Lost to Follow-up|3|||
125565505|NCT04857996|451699643|FG000|Overall Study|Site Closure|1|||
125565506|NCT04857996|451699644|FG001|Overall Study|Site Closure|0|||
125565507|NCT04857996|451699643|FG000|Overall Study|Withdrawal by Subject|1|||
125565508|NCT04857996|451699644|FG001|Overall Study|Withdrawal by Subject|0|||
125565509|NCT00495820|451699645|FG000|Overall Study|Adverse Event|1|||
125565510|NCT00495820|451699646|FG001|Overall Study|Adverse Event|1|||
125565511|NCT00820950|451699647|FG000|Overall Study|Scheduling Conflict|0|||
125565512|NCT00820950|451699648|FG001|Overall Study|Scheduling Conflict|0|||
125565513|NCT00820950|451699649|FG002|Overall Study|Scheduling Conflict|0|||
125436533|NCT02597933|451224422|FG000|Overall Study|Withdrawal by Subject|7|||
125565514|NCT00820950|451699650|FG003|Overall Study|Scheduling Conflict|0|||
125565515|NCT00820950|451699651|FG004|Overall Study|Scheduling Conflict|0|||
125565516|NCT00820950|451699652|FG005|Overall Study|Scheduling Conflict|0|||
125565517|NCT00820950|451699653|FG006|Overall Study|Scheduling Conflict|1|||
125565518|NCT00820950|451699654|FG007|Overall Study|Scheduling Conflict|1|||
125565519|NCT00820950|451699655|FG008|Overall Study|Scheduling Conflict|0|||
125565520|NCT00820950|451699656|FG009|Overall Study|Scheduling Conflict|0|||
125565521|NCT00820950|451699647|FG000|Overall Study|Protocol Violation|1|||
125565522|NCT00820950|451699648|FG001|Overall Study|Protocol Violation|1|||
125565523|NCT00820950|451699649|FG002|Overall Study|Protocol Violation|0|||
125565524|NCT00820950|451699650|FG003|Overall Study|Protocol Violation|0|||
125565525|NCT00820950|451699651|FG004|Overall Study|Protocol Violation|0|||
125565526|NCT00820950|451699652|FG005|Overall Study|Protocol Violation|0|||
125565527|NCT00820950|451699653|FG006|Overall Study|Protocol Violation|0|||
125565528|NCT00820950|451699654|FG007|Overall Study|Protocol Violation|0|||
125565529|NCT00820950|451699655|FG008|Overall Study|Protocol Violation|0|||
125565530|NCT00820950|451699656|FG009|Overall Study|Protocol Violation|0|||
125565531|NCT00798135|451699657|FG000|Overall Study|Disease progression, relapse|11|||
125565532|NCT00798135|451699657|FG000|Overall Study|Disease progression, refractory|1|||
125565533|NCT00798135|451699657|FG000|Overall Study|Physician Decision|1|||
125565534|NCT01423851|451699661|FG000|Whole Study|Disease progression|2|||
125565535|NCT01423851|451699662|FG001|Whole Study|Disease progression|1|||
125565536|NCT01423851|451699663|FG002|Whole Study|Disease progression|1|||
125565537|NCT01423851|451699664|FG003|Whole Study|Disease progression|4|||
125565538|NCT01423851|451699665|FG004|Whole Study|Disease progression|1|||
125565539|NCT01423851|451699666|FG005|Whole Study|Disease progression|3|||
125565540|NCT01423851|451699667|FG006|Whole Study|Disease progression|1|||
125565541|NCT01423851|451699668|FG007|Whole Study|Disease progression|4|||
125565542|NCT01423851|451699669|FG008|Whole Study|Disease progression|0|||
125565543|NCT01423851|451699670|FG009|Whole Study|Disease progression|2|||
125565544|NCT01423851|451699671|FG010|Whole Study|Disease progression|10|||
125565545|NCT01423851|451699661|FG000|Whole Study|Physician Decision|0|||
125565546|NCT01423851|451699662|FG001|Whole Study|Physician Decision|1|||
125426391|NCT01666808|451184502|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
125426392|NCT01499082|451184503|FG000|Overall Study|Randomized but not Treated|0|||
125426393|NCT01499082|451184504|FG001|Overall Study|Randomized but not Treated|1|||
125426394|NCT01499082|451184503|FG000|Overall Study|Adverse Event|12|||
125426395|NCT01499082|451184504|FG001|Overall Study|Adverse Event|16|||
125426396|NCT01499082|451184503|FG000|Overall Study|Lack of Efficacy|1|||
125426397|NCT01499082|451184504|FG001|Overall Study|Lack of Efficacy|1|||
125426398|NCT01499082|451184503|FG000|Overall Study|Protocol Violation|6|||
125426399|NCT01499082|451184504|FG001|Overall Study|Protocol Violation|8|||
125426400|NCT01499082|451184503|FG000|Overall Study|Diverse Reasons|18|||
125426401|NCT01499082|451184504|FG001|Overall Study|Diverse Reasons|14|||
125426402|NCT01499082|451184503|FG000|Overall Study|Site Closure for Noncompliance|5|||
125426403|NCT01499082|451184504|FG001|Overall Study|Site Closure for Noncompliance|2|||
125426404|NCT01499082|451184503|FG000|Overall Study|Hypoglycemia|2|||
125426405|NCT01499082|451184504|FG001|Overall Study|Hypoglycemia|3|||
125565547|NCT01423851|451699663|FG002|Whole Study|Physician Decision|2|||
125565548|NCT01423851|451699664|FG003|Whole Study|Physician Decision|0|||
125565549|NCT01423851|451699665|FG004|Whole Study|Physician Decision|2|||
125565550|NCT01423851|451699666|FG005|Whole Study|Physician Decision|0|||
125565551|NCT01423851|451699667|FG006|Whole Study|Physician Decision|2|||
125565552|NCT01423851|451699668|FG007|Whole Study|Physician Decision|1|||
125565553|NCT01423851|451699669|FG008|Whole Study|Physician Decision|3|||
125565554|NCT01423851|451699670|FG009|Whole Study|Physician Decision|4|||
125565555|NCT01423851|451699671|FG010|Whole Study|Physician Decision|12|||
125565556|NCT01423851|451699661|FG000|Whole Study|Withdrawal by Subject|1|||
125565557|NCT01423851|451699662|FG001|Whole Study|Withdrawal by Subject|1|||
125565558|NCT01423851|451699663|FG002|Whole Study|Withdrawal by Subject|0|||
125565559|NCT01423851|451699664|FG003|Whole Study|Withdrawal by Subject|0|||
125565560|NCT01423851|451699665|FG004|Whole Study|Withdrawal by Subject|0|||
125565561|NCT01423851|451699666|FG005|Whole Study|Withdrawal by Subject|0|||
125565562|NCT01423851|451699667|FG006|Whole Study|Withdrawal by Subject|0|||
125426406|NCT01499082|451184503|FG000|Overall Study|Lost to Follow-up|1|||
125426407|NCT01499082|451184504|FG001|Overall Study|Lost to Follow-up|3|||
125426408|NCT03599349|451184505|FG000|Overall Study|Lost to Follow-up|1|||
125426409|NCT02638948|451184508|FG000|Overall Study|Withdrawal by Subject|4|||
125426410|NCT02638948|451184509|FG001|Overall Study|Withdrawal by Subject|5|||
125426411|NCT02638948|451184510|FG002|Overall Study|Withdrawal by Subject|3|||
125426412|NCT02638948|451184511|FG003|Overall Study|Withdrawal by Subject|1|||
125426413|NCT02638948|451184508|FG000|Overall Study|Administrative Reason by Sponsor|0|||
125565563|NCT01423851|451699668|FG007|Whole Study|Withdrawal by Subject|0|||
125426414|NCT02638948|451184509|FG001|Overall Study|Administrative Reason by Sponsor|1|||
125426415|NCT02638948|451184510|FG002|Overall Study|Administrative Reason by Sponsor|0|||
125426416|NCT02638948|451184511|FG003|Overall Study|Administrative Reason by Sponsor|4|||
125426417|NCT02638948|451184508|FG000|Overall Study|Adverse Event|0|||
125426418|NCT02638948|451184509|FG001|Overall Study|Adverse Event|0|||
125426419|NCT02638948|451184510|FG002|Overall Study|Adverse Event|1|||
125426420|NCT02638948|451184511|FG003|Overall Study|Adverse Event|1|||
125426421|NCT02638948|451184508|FG000|Overall Study|Lack of Efficacy|1|||
125426422|NCT02638948|451184509|FG001|Overall Study|Lack of Efficacy|1|||
125426423|NCT02638948|451184510|FG002|Overall Study|Lack of Efficacy|0|||
125426424|NCT02638948|451184511|FG003|Overall Study|Lack of Efficacy|0|||
125426425|NCT02638948|451184508|FG000|Overall Study|Lost to Follow-up|0|||
125426426|NCT02638948|451184509|FG001|Overall Study|Lost to Follow-up|0|||
125426427|NCT02638948|451184510|FG002|Overall Study|Lost to Follow-up|1|||
125426428|NCT02638948|451184511|FG003|Overall Study|Lost to Follow-up|1|||
125426429|NCT02638948|451184508|FG000|Overall Study|Poor/Non-Compliance|0|||
125426430|NCT02638948|451184509|FG001|Overall Study|Poor/Non-Compliance|2|||
125426431|NCT02638948|451184510|FG002|Overall Study|Poor/Non-Compliance|1|||
125426432|NCT02638948|451184511|FG003|Overall Study|Poor/Non-Compliance|0|||
125426433|NCT02638948|451184508|FG000|Overall Study|Participant no longer met study criteria|0|||
125426434|NCT02638948|451184509|FG001|Overall Study|Participant no longer met study criteria|1|||
125426435|NCT02638948|451184510|FG002|Overall Study|Participant no longer met study criteria|0|||
125426436|NCT02638948|451184511|FG003|Overall Study|Participant no longer met study criteria|0|||
125426437|NCT02638948|451184508|FG000|Overall Study|Other than specified above|4|||
125565564|NCT01423851|451699669|FG008|Whole Study|Withdrawal by Subject|2|||
125355523|NCT00644228|450936537|FG000|Maintenance|Withdrawal by Subject|6|||
125355524|NCT00644228|450936538|FG001|Maintenance|Withdrawal by Subject|4|||
125355525|NCT00644228|450936537|FG000|Maintenance|Progression/Relapse|67|||
125355526|NCT00644228|450936538|FG001|Maintenance|Progression/Relapse|42|||
125355527|NCT00644228|450936537|FG000|Maintenance|Death|3|||
125355528|NCT00644228|450936538|FG001|Maintenance|Death|3|||
125355529|NCT00644228|450936537|FG000|Maintenance|Not Protocol-Specified|14|||
125355530|NCT00644228|450936538|FG001|Maintenance|Not Protocol-Specified|15|||
125355531|NCT00644228|450936537|FG000|Maintenance|On Treatment|26|||
125355532|NCT00644228|450936538|FG001|Maintenance|On Treatment|40|||
125355533|NCT00760084|450936539|FG000|Overall Study|Physician Decision|5|||
125355534|NCT00760084|450936539|FG000|Overall Study|Withdrawal by Subject|2|||
125355535|NCT00760084|450936539|FG000|Overall Study|Progressive Disease|3|||
125355536|NCT02567552|450936540|FG000|Overall Study|Adverse Event|0|||
125355537|NCT02567552|450936541|FG001|Overall Study|Adverse Event|1|||
125355538|NCT03187756|450936542|FG000|Overall Study|Termination of study|4|||
125355539|NCT04669535|450936546|FG000|Overall Study|Death|1|||
125426438|NCT02638948|451184509|FG001|Overall Study|Other than specified above|1|||
125426439|NCT02638948|451184510|FG002|Overall Study|Other than specified above|1|||
125426440|NCT02638948|451184511|FG003|Overall Study|Other than specified above|1|||
125426441|NCT03221387|451184513|FG000|Overall Study|Lost to Follow-up|1|||
125426442|NCT03221387|451184513|FG000|Overall Study|Lung transplant|1|||
125565565|NCT01423851|451699670|FG009|Whole Study|Withdrawal by Subject|0|||
125355540|NCT04669535|450936547|FG001|Overall Study|Death|1|||
125355541|NCT04669535|450936548|FG002|Overall Study|Death|0|||
125565566|NCT01423851|451699671|FG010|Whole Study|Withdrawal by Subject|4|||
125565567|NCT01423851|451699661|FG000|Whole Study|Adverse Event|0|||
125355542|NCT04669535|450936549|FG003|Overall Study|Death|0|||
125565568|NCT01423851|451699662|FG001|Whole Study|Adverse Event|0|||
125565569|NCT01423851|451699663|FG002|Whole Study|Adverse Event|0|||
125565570|NCT01423851|451699664|FG003|Whole Study|Adverse Event|2|||
125565571|NCT01423851|451699665|FG004|Whole Study|Adverse Event|0|||
125565572|NCT01423851|451699666|FG005|Whole Study|Adverse Event|0|||
125565573|NCT01423851|451699667|FG006|Whole Study|Adverse Event|0|||
125565574|NCT01423851|451699668|FG007|Whole Study|Adverse Event|3|||
125565575|NCT01423851|451699669|FG008|Whole Study|Adverse Event|3|||
125565576|NCT01423851|451699670|FG009|Whole Study|Adverse Event|2|||
125565577|NCT01423851|451699671|FG010|Whole Study|Adverse Event|3|||
125565578|NCT03080883|451699672|FG000|Overall Study|Withdrawal by Subject|11|||
125565579|NCT03080883|451699673|FG001|Overall Study|Withdrawal by Subject|15|||
125565580|NCT03080883|451699672|FG000|Overall Study|Adverse Event|22|||
125355543|NCT02452697|450936551|FG000|Overall Study|Physician Decision|4|||
125565581|NCT03080883|451699673|FG001|Overall Study|Adverse Event|22|||
125565582|NCT03080883|451699672|FG000|Overall Study|Alternative Therapy|0|||
125565583|NCT03080883|451699673|FG001|Overall Study|Alternative Therapy|3|||
125565584|NCT03080883|451699672|FG000|Overall Study|Other Complicating Disease|9|||
125565585|NCT03080883|451699673|FG001|Overall Study|Other Complicating Disease|5|||
125565586|NCT03080883|451699672|FG000|Overall Study|Death|21|||
125565587|NCT03080883|451699673|FG001|Overall Study|Death|16|||
125565588|NCT03080883|451699672|FG000|Overall Study|Physician Decision|2|||
125565589|NCT03080883|451699673|FG001|Overall Study|Physician Decision|2|||
125565590|NCT03080883|451699672|FG000|Overall Study|Disease Progression|2|||
125565591|NCT03080883|451699673|FG001|Overall Study|Disease Progression|8|||
125565592|NCT03080883|451699672|FG000|Overall Study|Lost to Follow-up|1|||
125565593|NCT03080883|451699673|FG001|Overall Study|Lost to Follow-up|1|||
125565594|NCT00346073|451701128|FG000|Overall Study|Serious Adverse Event|2|||
125565595|NCT00346073|451701129|FG001|Overall Study|Serious Adverse Event|0|||
125565596|NCT00346073|451701128|FG000|Overall Study|Lost to Follow-up|39|||
125565597|NCT00346073|451701129|FG001|Overall Study|Lost to Follow-up|24|||
125565598|NCT00075023|451701132|FG000|Pilot Study|Physician Decision|1|||
125565599|NCT00075023|451701133|FG001|Pilot Study|Physician Decision|2|||
125565600|NCT00075023|451701132|FG000|Pilot Study|Withdrawal by Subject|1|||
125565601|NCT00075023|451701133|FG001|Pilot Study|Withdrawal by Subject|0|||
125565602|NCT04342871|451701134|FG000|Overall Study|Death|4|||
125565603|NCT04342871|451701134|FG000|Overall Study|Clinical deterioration/illness progression|2|||
125565604|NCT04342871|451701134|FG000|Overall Study|Did not complete baseline assessments|5|||
125565605|NCT04342871|451701134|FG000|Overall Study|Lost to Follow-up|13|||
125565606|NCT03670953|451701135|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
125565607|NCT03670953|451701136|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
125565608|NCT03670953|451701137|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
125565609|NCT03670953|451701138|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
125565610|NCT03670953|451701135|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
125565611|NCT03670953|451701136|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
125565612|NCT03670953|451701137|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
125565613|NCT03670953|451701138|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
125565614|NCT03670953|451701135|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
125565615|NCT03670953|451701136|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
125565616|NCT03670953|451701137|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
125565617|NCT03670953|451701138|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
125565618|NCT03670953|451701135|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
125565619|NCT03670953|451701136|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
125565620|NCT03670953|451701137|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
125565621|NCT03670953|451701138|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
125565622|NCT03670953|451701135|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
125565623|NCT03670953|451701136|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
125565624|NCT03670953|451701137|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
125565625|NCT03670953|451701138|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
125565626|NCT03670953|451701135|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
125565627|NCT03670953|451701136|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
125565628|NCT03670953|451701137|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
125565629|NCT03670953|451701138|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
125565630|NCT03670953|451701135|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
125565631|NCT03670953|451701136|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
125565632|NCT03670953|451701137|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
125565633|NCT03670953|451701138|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
125565634|NCT03670953|451701135|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
125565635|NCT03670953|451701136|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
125565636|NCT03670953|451701137|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
125565637|NCT03670953|451701138|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
125565638|NCT03670953|451701135|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
125565639|NCT03670953|451701136|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
125565640|NCT03670953|451701137|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
125565641|NCT03670953|451701138|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
125565642|NCT03670953|451701135|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
125355544|NCT02452697|450936552|FG001|Overall Study|Physician Decision|4|||
125355545|NCT02452697|450936553|FG002|Overall Study|Physician Decision|3|||
125565643|NCT03670953|451701136|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
125565644|NCT03670953|451701137|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
125565645|NCT03670953|451701138|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
125565646|NCT03670953|451701135|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
125565647|NCT03670953|451701136|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
125565648|NCT03670953|451701137|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
125565649|NCT03670953|451701138|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
125565650|NCT03670953|451701135|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
125565651|NCT03670953|451701136|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
125565652|NCT03670953|451701137|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
125565653|NCT03670953|451701138|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
125565654|NCT03670953|451701135|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
125565655|NCT03670953|451701136|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
125565656|NCT03670953|451701137|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
125565657|NCT03670953|451701138|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
125565658|NCT03670953|451701135|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
125565659|NCT03670953|451701136|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
125565660|NCT03670953|451701137|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
125565661|NCT03670953|451701138|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
125565662|NCT03670953|451701135|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
125565663|NCT03670953|451701136|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
125565664|NCT03670953|451701137|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
125565665|NCT03670953|451701138|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
125565666|NCT03670953|451701135|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
125565667|NCT03670953|451701136|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
125565668|NCT03670953|451701137|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
125565669|NCT03670953|451701138|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
125565670|NCT03670953|451701135|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
125565671|NCT03670953|451701136|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
125565672|NCT03670953|451701137|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
125565673|NCT03670953|451701138|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
125565674|NCT03670953|451701135|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
125565675|NCT03670953|451701136|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
125565676|NCT03670953|451701137|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
125565677|NCT03670953|451701138|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
125565678|NCT04179734|451701139|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
125565679|NCT04179734|451701140|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
125565680|NCT04179734|451701139|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
125565681|NCT04179734|451701140|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
125565682|NCT02263079|451701142|FG000|Overall Study|Physician Decision|1|||
125565683|NCT02263079|451701143|FG001|Overall Study|Physician Decision|0|||
125355546|NCT02452697|450936554|FG003|Overall Study|Physician Decision|2|||
125565684|NCT02263079|451701144|FG002|Overall Study|Physician Decision|0|||
125565685|NCT02263079|451701142|FG000|Overall Study|Withdrawal by Subject|2|||
125565686|NCT02263079|451701143|FG001|Overall Study|Withdrawal by Subject|8|||
125565687|NCT02263079|451701144|FG002|Overall Study|Withdrawal by Subject|0|||
125565688|NCT01227187|451701145|FG000|Overall Study|Physician Decision|0|||
125565689|NCT01227187|451701146|FG001|Overall Study|Physician Decision|0|||
125565690|NCT01227187|451701147|FG002|Overall Study|Physician Decision|0|||
125565691|NCT01227187|451701148|FG003|Overall Study|Physician Decision|1|||
125565692|NCT01761292|451701149|FG000|Part 1|Adverse Event|1|||
125565693|NCT01761292|451701149|FG000|Part 1|not receiving treatment in Part 1|1|||
125565694|NCT01761292|451701149|FG000|Extension 1|Withdrawal by Subject|1|||
125565695|NCT02463409|451701150|FG000|Overall Study|Withdrawal by Subject|1|||
125565696|NCT02463409|451701150|FG000|Overall Study|Screen failure|1|||
125565697|NCT00880399|451701152|FG000|Overall Study|Adverse Event|4|||
125565698|NCT00880399|451701153|FG001|Overall Study|Adverse Event|6|||
125565699|NCT00880399|451701154|FG002|Overall Study|Adverse Event|5|||
125565700|NCT00880399|451701152|FG000|Overall Study|Lack of Efficacy|1|||
125565701|NCT00880399|451701153|FG001|Overall Study|Lack of Efficacy|4|||
125565702|NCT00880399|451701154|FG002|Overall Study|Lack of Efficacy|2|||
125565703|NCT00880399|451701152|FG000|Overall Study|Protocol Violation|4|||
125565704|NCT00880399|451701153|FG001|Overall Study|Protocol Violation|4|||
125565705|NCT00880399|451701154|FG002|Overall Study|Protocol Violation|6|||
125565706|NCT00880399|451701152|FG000|Overall Study|Study closed/terminated|3|||
125565707|NCT00880399|451701153|FG001|Overall Study|Study closed/terminated|7|||
125565708|NCT00880399|451701154|FG002|Overall Study|Study closed/terminated|4|||
125565709|NCT00880399|451701152|FG000|Overall Study|Lost to Follow-up|8|||
125565710|NCT00880399|451701153|FG001|Overall Study|Lost to Follow-up|5|||
125565711|NCT00880399|451701154|FG002|Overall Study|Lost to Follow-up|3|||
125565712|NCT00880399|451701152|FG000|Overall Study|Physician Decision|5|||
125565713|NCT00880399|451701153|FG001|Overall Study|Physician Decision|0|||
125565714|NCT00880399|451701154|FG002|Overall Study|Physician Decision|3|||
125565715|NCT00880399|451701152|FG000|Overall Study|Withdrawal by Subject|6|||
125565716|NCT00880399|451701153|FG001|Overall Study|Withdrawal by Subject|3|||
125565717|NCT00880399|451701154|FG002|Overall Study|Withdrawal by Subject|3|||
125565718|NCT01911442|451701155|FG000|Overall Study|Adverse Event|2|||
125565719|NCT01911442|451701156|FG001|Overall Study|Adverse Event|2|||
125565720|NCT01911442|451701157|FG002|Overall Study|Adverse Event|4|||
125565721|NCT01911442|451701155|FG000|Overall Study|Lack of Efficacy|1|||
125565722|NCT01911442|451701156|FG001|Overall Study|Lack of Efficacy|1|||
125565723|NCT01911442|451701157|FG002|Overall Study|Lack of Efficacy|1|||
125565724|NCT01911442|451701155|FG000|Overall Study|Lost to Follow-up|2|||
125565725|NCT01911442|451701156|FG001|Overall Study|Lost to Follow-up|0|||
125565726|NCT01911442|451701157|FG002|Overall Study|Lost to Follow-up|1|||
125565727|NCT01911442|451701155|FG000|Overall Study|Withdrawal by Subject|1|||
125565728|NCT01911442|451701156|FG001|Overall Study|Withdrawal by Subject|0|||
125565729|NCT01911442|451701157|FG002|Overall Study|Withdrawal by Subject|6|||
125565730|NCT01911442|451701155|FG000|Overall Study|Mother's Work Schedule|0|||
125565731|NCT01911442|451701156|FG001|Overall Study|Mother's Work Schedule|1|||
125565732|NCT01911442|451701157|FG002|Overall Study|Mother's Work Schedule|0|||
125565733|NCT02819635|451701162|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
125565734|NCT02819635|451701163|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
125565735|NCT02819635|451701164|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
125565736|NCT02819635|451701165|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
125565737|NCT02819635|451701166|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
125565738|NCT02819635|451701167|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
125565739|NCT02819635|451701168|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
125565740|NCT02819635|451701169|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
125565741|NCT02819635|451701170|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
125565742|NCT02819635|451701171|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
125565743|NCT02819635|451701172|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
125565744|NCT02819635|451701173|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
125565745|NCT02819635|451701162|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125565746|NCT02819635|451701163|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125565747|NCT02819635|451701164|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125565748|NCT02819635|451701165|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125565749|NCT02819635|451701166|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
125565750|NCT02819635|451701167|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
125565751|NCT02819635|451701168|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
125565752|NCT02819635|451701169|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125565753|NCT02819635|451701170|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125565754|NCT02819635|451701171|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125565755|NCT02819635|451701172|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125565756|NCT02819635|451701173|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
125565757|NCT02819635|451701162|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125565758|NCT02819635|451701163|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125565759|NCT02819635|451701164|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125565760|NCT02819635|451701165|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125565761|NCT02819635|451701166|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125565762|NCT02819635|451701167|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
125565763|NCT02819635|451701168|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
125565764|NCT02819635|451701169|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125565765|NCT02819635|451701170|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125565766|NCT02819635|451701171|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125565767|NCT02819635|451701172|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125565768|NCT02819635|451701173|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
125565769|NCT02819635|451701162|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125565770|NCT02819635|451701163|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125565771|NCT02819635|451701164|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125565772|NCT02819635|451701165|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125565773|NCT02819635|451701166|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125565774|NCT02819635|451701167|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125565775|NCT02819635|451701168|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
125565776|NCT02819635|451701169|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125565777|NCT02819635|451701170|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125565778|NCT02819635|451701171|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125565779|NCT02819635|451701172|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125565780|NCT02819635|451701173|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
125565781|NCT02819635|451701162|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
125565782|NCT02819635|451701163|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
125565783|NCT02819635|451701164|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
125565784|NCT02819635|451701165|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
125565785|NCT02819635|451701166|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
125565786|NCT02819635|451701167|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
125565787|NCT02819635|451701168|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
125565788|NCT02819635|451701169|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
125565789|NCT02819635|451701170|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
125565790|NCT02819635|451701171|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
125565791|NCT02819635|451701172|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
125565792|NCT02819635|451701173|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
125565793|NCT02819635|451701162|FG000|Substudy 2, Part 2|Adverse Event|0|||
125565794|NCT02819635|451701163|FG001|Substudy 2, Part 2|Adverse Event|0|||
125565795|NCT02819635|451701164|FG002|Substudy 2, Part 2|Adverse Event|0|||
125565796|NCT02819635|451701165|FG003|Substudy 2, Part 2|Adverse Event|0|||
125565797|NCT02819635|451701166|FG004|Substudy 2, Part 2|Adverse Event|0|||
125565798|NCT02819635|451701167|FG005|Substudy 2, Part 2|Adverse Event|4|||
125565799|NCT02819635|451701168|FG006|Substudy 2, Part 2|Adverse Event|0|||
125565800|NCT02819635|451701169|FG007|Substudy 2, Part 2|Adverse Event|0|||
125565801|NCT02819635|451701170|FG008|Substudy 2, Part 2|Adverse Event|0|||
125565802|NCT02819635|451701171|FG009|Substudy 2, Part 2|Adverse Event|0|||
125565803|NCT02819635|451701172|FG010|Substudy 2, Part 2|Adverse Event|0|||
125565804|NCT02819635|451701173|FG011|Substudy 2, Part 2|Adverse Event|0|||
125565805|NCT02819635|451701162|FG000|Substudy 2, Part 2|Withdrew consent|0|||
125565806|NCT02819635|451701163|FG001|Substudy 2, Part 2|Withdrew consent|0|||
125565807|NCT02819635|451701164|FG002|Substudy 2, Part 2|Withdrew consent|0|||
125565808|NCT02819635|451701165|FG003|Substudy 2, Part 2|Withdrew consent|0|||
125565809|NCT02819635|451701166|FG004|Substudy 2, Part 2|Withdrew consent|0|||
125565810|NCT02819635|451701167|FG005|Substudy 2, Part 2|Withdrew consent|3|||
125565811|NCT02819635|451701168|FG006|Substudy 2, Part 2|Withdrew consent|1|||
125565812|NCT02819635|451701169|FG007|Substudy 2, Part 2|Withdrew consent|0|||
125565813|NCT02819635|451701170|FG008|Substudy 2, Part 2|Withdrew consent|0|||
125565814|NCT02819635|451701171|FG009|Substudy 2, Part 2|Withdrew consent|0|||
125565815|NCT02819635|451701172|FG010|Substudy 2, Part 2|Withdrew consent|0|||
125565816|NCT02819635|451701173|FG011|Substudy 2, Part 2|Withdrew consent|0|||
125565817|NCT02819635|451701162|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
125565818|NCT02819635|451701163|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
125565819|NCT02819635|451701164|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
125565820|NCT02819635|451701165|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
125565821|NCT02819635|451701166|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
125565822|NCT02819635|451701167|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
125565823|NCT02819635|451701168|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
125565824|NCT02819635|451701169|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
125565825|NCT02819635|451701170|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
125565826|NCT02819635|451701171|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
125565827|NCT02819635|451701172|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
125565828|NCT02819635|451701173|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
125565829|NCT02819635|451701162|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125565830|NCT02819635|451701163|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125565831|NCT02819635|451701164|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125565832|NCT02819635|451701165|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125565833|NCT02819635|451701166|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125565834|NCT02819635|451701167|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125565835|NCT02819635|451701168|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
125565836|NCT02819635|451701169|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125565837|NCT02819635|451701170|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125565838|NCT02819635|451701171|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125565839|NCT02819635|451701172|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125565840|NCT02819635|451701173|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
125565841|NCT02819635|451701162|FG000|Substudy 2, Part 2|Other, not specified|0|||
125565842|NCT02819635|451701163|FG001|Substudy 2, Part 2|Other, not specified|0|||
125565843|NCT02819635|451701164|FG002|Substudy 2, Part 2|Other, not specified|0|||
125565844|NCT02819635|451701165|FG003|Substudy 2, Part 2|Other, not specified|0|||
125565845|NCT02819635|451701166|FG004|Substudy 2, Part 2|Other, not specified|0|||
125565846|NCT02819635|451701167|FG005|Substudy 2, Part 2|Other, not specified|4|||
125565847|NCT02819635|451701168|FG006|Substudy 2, Part 2|Other, not specified|8|||
125565848|NCT02819635|451701169|FG007|Substudy 2, Part 2|Other, not specified|0|||
125565849|NCT02819635|451701170|FG008|Substudy 2, Part 2|Other, not specified|0|||
125565850|NCT02819635|451701171|FG009|Substudy 2, Part 2|Other, not specified|0|||
125565851|NCT02819635|451701172|FG010|Substudy 2, Part 2|Other, not specified|0|||
125565852|NCT02819635|451701173|FG011|Substudy 2, Part 2|Other, not specified|0|||
125565853|NCT02819635|451701162|FG000|Substudy 3|Adverse Event|0|||
125565854|NCT02819635|451701163|FG001|Substudy 3|Adverse Event|0|||
125565855|NCT02819635|451701164|FG002|Substudy 3|Adverse Event|0|||
125565856|NCT02819635|451701165|FG003|Substudy 3|Adverse Event|0|||
125565857|NCT02819635|451701166|FG004|Substudy 3|Adverse Event|0|||
125565858|NCT02819635|451701167|FG005|Substudy 3|Adverse Event|0|||
125565859|NCT02819635|451701168|FG006|Substudy 3|Adverse Event|0|||
125565860|NCT02819635|451701169|FG007|Substudy 3|Adverse Event|0|||
125565861|NCT02819635|451701170|FG008|Substudy 3|Adverse Event|32|||
125565862|NCT02819635|451701171|FG009|Substudy 3|Adverse Event|3|||
125565863|NCT02819635|451701172|FG010|Substudy 3|Adverse Event|12|||
125565864|NCT02819635|451701173|FG011|Substudy 3|Adverse Event|18|||
125565865|NCT02819635|451701162|FG000|Substudy 3|Withdrew consent|0|||
125565866|NCT02819635|451701163|FG001|Substudy 3|Withdrew consent|0|||
125565867|NCT02819635|451701164|FG002|Substudy 3|Withdrew consent|0|||
125565868|NCT02819635|451701165|FG003|Substudy 3|Withdrew consent|0|||
125565869|NCT02819635|451701166|FG004|Substudy 3|Withdrew consent|0|||
125565870|NCT02819635|451701167|FG005|Substudy 3|Withdrew consent|0|||
125565871|NCT02819635|451701168|FG006|Substudy 3|Withdrew consent|0|||
125565872|NCT02819635|451701169|FG007|Substudy 3|Withdrew consent|0|||
125565873|NCT02819635|451701170|FG008|Substudy 3|Withdrew consent|11|||
125565874|NCT02819635|451701171|FG009|Substudy 3|Withdrew consent|1|||
125565875|NCT02819635|451701172|FG010|Substudy 3|Withdrew consent|4|||
125565876|NCT02819635|451701173|FG011|Substudy 3|Withdrew consent|9|||
125565877|NCT02819635|451701162|FG000|Substudy 3|Lost to Follow-up|0|||
125565878|NCT02819635|451701163|FG001|Substudy 3|Lost to Follow-up|0|||
125565879|NCT02819635|451701164|FG002|Substudy 3|Lost to Follow-up|0|||
125565880|NCT02819635|451701165|FG003|Substudy 3|Lost to Follow-up|0|||
125565881|NCT02819635|451701166|FG004|Substudy 3|Lost to Follow-up|0|||
125565882|NCT02819635|451701167|FG005|Substudy 3|Lost to Follow-up|0|||
125565883|NCT02819635|451701168|FG006|Substudy 3|Lost to Follow-up|0|||
125565884|NCT02819635|451701169|FG007|Substudy 3|Lost to Follow-up|0|||
125565885|NCT02819635|451701170|FG008|Substudy 3|Lost to Follow-up|1|||
125565886|NCT02819635|451701171|FG009|Substudy 3|Lost to Follow-up|0|||
125565887|NCT02819635|451701172|FG010|Substudy 3|Lost to Follow-up|1|||
125565888|NCT02819635|451701173|FG011|Substudy 3|Lost to Follow-up|1|||
125565889|NCT02819635|451701162|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
125565890|NCT02819635|451701163|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
125565891|NCT02819635|451701164|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
125565892|NCT02819635|451701165|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
125565893|NCT02819635|451701166|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
125565894|NCT02819635|451701167|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
125565895|NCT02819635|451701168|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
125565896|NCT02819635|451701169|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
125565897|NCT02819635|451701170|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
125565898|NCT02819635|451701171|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
125565899|NCT02819635|451701172|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
125565900|NCT02819635|451701173|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
125565901|NCT02819635|451701162|FG000|Substudy 3|Other, not specified|0|||
125565902|NCT02819635|451701163|FG001|Substudy 3|Other, not specified|0|||
125565903|NCT02819635|451701164|FG002|Substudy 3|Other, not specified|0|||
125565904|NCT02819635|451701165|FG003|Substudy 3|Other, not specified|0|||
125565905|NCT02819635|451701166|FG004|Substudy 3|Other, not specified|0|||
125565906|NCT02819635|451701167|FG005|Substudy 3|Other, not specified|0|||
125565907|NCT02819635|451701168|FG006|Substudy 3|Other, not specified|0|||
125565908|NCT02819635|451701169|FG007|Substudy 3|Other, not specified|0|||
125565909|NCT02819635|451701170|FG008|Substudy 3|Other, not specified|202|||
125565910|NCT02819635|451701171|FG009|Substudy 3|Other, not specified|5|||
125426443|NCT02543658|451185908|FG000|Overall Study|Lack of Efficacy|0|||
125565911|NCT02819635|451701172|FG010|Substudy 3|Other, not specified|89|||
125565912|NCT02819635|451701173|FG011|Substudy 3|Other, not specified|39|||
125565913|NCT03179891|451701174|FG000|First Intervention|Withdrawal by Subject|1|||
125565914|NCT03179891|451701175|FG001|First Intervention|Withdrawal by Subject|1|||
125565915|NCT03179891|451701174|FG000|First Intervention|Unspecified reason|1|||
125565916|NCT03179891|451701175|FG001|First Intervention|Unspecified reason|0|||
125565917|NCT03179891|451701174|FG000|First Intervention|Protocol Violation|0|||
125565918|NCT03179891|451701175|FG001|First Intervention|Protocol Violation|1|||
125565919|NCT01349465|451701177|FG000|Overall Study|Adverse Event|1|||
125565920|NCT01349465|451701178|FG001|Overall Study|Adverse Event|0|||
125565921|NCT01349465|451701177|FG000|Overall Study|Death|3|||
125565922|NCT01349465|451701178|FG001|Overall Study|Death|0|||
125565923|NCT01349465|451701177|FG000|Overall Study|Lost to Follow-up|10|||
125565924|NCT01349465|451701178|FG001|Overall Study|Lost to Follow-up|1|||
125565925|NCT01349465|451701177|FG000|Overall Study|Withdrawal by Subject|4|||
125565926|NCT01349465|451701178|FG001|Overall Study|Withdrawal by Subject|2|||
125565927|NCT01349465|451701177|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
125565928|NCT01349465|451701178|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
125565929|NCT00632099|451701179|FG000|Overall Study|Lost to Follow-up|3|||
125565930|NCT00632099|451701180|FG001|Overall Study|Lost to Follow-up|3|||
125565931|NCT04416555|451701181|FG000|Overall Study|Withdrawal by Subject|0|||
125565932|NCT04416555|451701182|FG001|Overall Study|Withdrawal by Subject|3|||
125565933|NCT02004262|451701193|FG000|Overall Study|Death|67|||
125565934|NCT02004262|451701194|FG001|Overall Study|Death|64|||
125565935|NCT02004262|451701195|FG002|Overall Study|Death|66|||
125565936|NCT02004262|451701196|FG003|Overall Study|Death|28|||
125565937|NCT02004262|451701197|FG004|Overall Study|Death|29|||
125565938|NCT02004262|451701198|FG005|Overall Study|Death|22|||
125565939|NCT02004262|451701193|FG000|Overall Study|Withdrawal by Subject|1|||
125565940|NCT02004262|451701194|FG001|Overall Study|Withdrawal by Subject|0|||
125565941|NCT02004262|451701195|FG002|Overall Study|Withdrawal by Subject|4|||
125565942|NCT02004262|451701196|FG003|Overall Study|Withdrawal by Subject|0|||
125565943|NCT02004262|451701197|FG004|Overall Study|Withdrawal by Subject|1|||
125565944|NCT02004262|451701198|FG005|Overall Study|Withdrawal by Subject|3|||
125565945|NCT02004262|451701193|FG000|Overall Study|Lost to Follow-up|1|||
125565946|NCT02004262|451701194|FG001|Overall Study|Lost to Follow-up|1|||
125565947|NCT02004262|451701195|FG002|Overall Study|Lost to Follow-up|0|||
125565948|NCT02004262|451701196|FG003|Overall Study|Lost to Follow-up|0|||
125565949|NCT02004262|451701197|FG004|Overall Study|Lost to Follow-up|0|||
125565950|NCT02004262|451701198|FG005|Overall Study|Lost to Follow-up|0|||
125565951|NCT02004262|451701193|FG000|Overall Study|Study Terminated by Sponsor|4|||
125565952|NCT02004262|451701194|FG001|Overall Study|Study Terminated by Sponsor|3|||
125565953|NCT02004262|451701195|FG002|Overall Study|Study Terminated by Sponsor|2|||
125565954|NCT02004262|451701196|FG003|Overall Study|Study Terminated by Sponsor|1|||
125565955|NCT02004262|451701197|FG004|Overall Study|Study Terminated by Sponsor|1|||
125565956|NCT02004262|451701198|FG005|Overall Study|Study Terminated by Sponsor|5|||
125565957|NCT01923285|451701199|FG000|Overall Study|Withdrawal by Subject|7|||
125565958|NCT01923285|451701200|FG001|Overall Study|Withdrawal by Subject|6|||
125565959|NCT03200366|451701205|FG000|Patient Navigation Intervention Given|Death|0|||
125565960|NCT03200366|451701206|FG001|Patient Navigation Intervention Given|Death|2|||
125565961|NCT03200366|451701207|FG002|Patient Navigation Intervention Given|Death|0|||
125565962|NCT03200366|451701205|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
125565963|NCT03200366|451701206|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
125565964|NCT03200366|451701207|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
125565965|NCT03200366|451701205|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
125565966|NCT03200366|451701206|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
125565967|NCT03200366|451701207|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
125565968|NCT03200366|451701205|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
125565969|NCT03200366|451701206|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
125565970|NCT03200366|451701207|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
125565971|NCT03200366|451701205|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
125565972|NCT03200366|451701206|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
125565973|NCT03200366|451701207|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
125565974|NCT03200366|451701205|FG000|6 Month Post-Baseline Interview|Death|1|||
125565975|NCT03200366|451701206|FG001|6 Month Post-Baseline Interview|Death|1|||
125565976|NCT03200366|451701207|FG002|6 Month Post-Baseline Interview|Death|1|||
125565977|NCT03200366|451701205|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
125565978|NCT03200366|451701206|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
125565979|NCT03200366|451701207|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
125355547|NCT02452697|450936551|FG000|Overall Study|Withdrawal by Subject|1|||
125565980|NCT03200366|451701205|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
125565981|NCT03200366|451701206|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
125355548|NCT02452697|450936552|FG001|Overall Study|Withdrawal by Subject|0|||
125565982|NCT03200366|451701207|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
125565983|NCT03200366|451701205|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
125565984|NCT03200366|451701206|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
125565985|NCT03200366|451701207|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
125355549|NCT02452697|450936553|FG002|Overall Study|Withdrawal by Subject|0|||
125355550|NCT02452697|450936554|FG003|Overall Study|Withdrawal by Subject|0|||
125565986|NCT03200366|451701205|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
125565987|NCT03200366|451701206|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
125565988|NCT03200366|451701207|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
125565989|NCT03200366|451701205|FG000|9 Month Post-Baseline Interview|Death|1|||
125565990|NCT03200366|451701206|FG001|9 Month Post-Baseline Interview|Death|1|||
125565991|NCT03200366|451701207|FG002|9 Month Post-Baseline Interview|Death|1|||
125565992|NCT03200366|451701205|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
125565993|NCT03200366|451701206|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
125565994|NCT03200366|451701207|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
125565995|NCT03200366|451701205|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
125565996|NCT03200366|451701206|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
125565997|NCT03200366|451701207|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
125565998|NCT03200366|451701205|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
125565999|NCT03200366|451701206|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
125566000|NCT03200366|451701207|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
125566001|NCT03201458|451701208|FG000|Overall Study|No longer eligible|2|||
125566002|NCT03201458|451701209|FG001|Overall Study|No longer eligible|5|||
125566003|NCT03201458|451701208|FG000|Overall Study|Health event before starting|1|||
125566004|NCT03201458|451701209|FG001|Overall Study|Health event before starting|0|||
125566005|NCT03201458|451701208|FG000|Overall Study|Physician Decision|1|||
125566006|NCT03201458|451701209|FG001|Overall Study|Physician Decision|0|||
125566007|NCT00750737|451701212|FG000|Overall Study|Withdrawal by Subject|3|||
125566008|NCT00750737|451701213|FG001|Overall Study|Withdrawal by Subject|3|||
125566009|NCT04707157|451701215|FG000|Overall Study|Adverse Event|12|||
125566010|NCT04707157|451701216|FG001|Overall Study|Adverse Event|3|||
125566011|NCT04707157|451701215|FG000|Overall Study|Lost to Follow-up|2|||
125566012|NCT04707157|451701216|FG001|Overall Study|Lost to Follow-up|0|||
125566013|NCT04707157|451701215|FG000|Overall Study|Sponsor's decision|1|||
125566014|NCT04707157|451701216|FG001|Overall Study|Sponsor's decision|0|||
125566015|NCT04707157|451701215|FG000|Overall Study|Physician Decision|8|||
125566016|NCT04707157|451701216|FG001|Overall Study|Physician Decision|5|||
125566017|NCT04707157|451701215|FG000|Overall Study|Protocol Deviation|1|||
125566018|NCT04707157|451701216|FG001|Overall Study|Protocol Deviation|0|||
125566019|NCT04707157|451701215|FG000|Overall Study|Withdrawal by Subject|1|||
125566020|NCT04707157|451701216|FG001|Overall Study|Withdrawal by Subject|1|||
125566021|NCT01543828|451701217|FG000|Treatment 2|Lost to Follow-up|1|||
125566022|NCT01543828|451701218|FG001|Treatment 2|Lost to Follow-up|0|||
125566023|NCT00804570|451701219|FG000|Overall Study|Adverse Event|14|||
125566024|NCT00804570|451701220|FG001|Overall Study|Adverse Event|7|||
125566025|NCT00804570|451701219|FG000|Overall Study|Lack of Efficacy|0|||
125566026|NCT00804570|451701220|FG001|Overall Study|Lack of Efficacy|1|||
125566027|NCT00804570|451701219|FG000|Overall Study|Lost to Follow-up|18|||
125566028|NCT00804570|451701220|FG001|Overall Study|Lost to Follow-up|21|||
125566029|NCT00804570|451701219|FG000|Overall Study|Entry criteria not met|5|||
125566030|NCT00804570|451701220|FG001|Overall Study|Entry criteria not met|5|||
125566031|NCT00804570|451701219|FG000|Overall Study|Protocol Violation|12|||
125566032|NCT00804570|451701220|FG001|Overall Study|Protocol Violation|16|||
125566033|NCT00804570|451701219|FG000|Overall Study|Physician Decision|1|||
125566034|NCT00804570|451701220|FG001|Overall Study|Physician Decision|2|||
125566035|NCT00804570|451701219|FG000|Overall Study|Sponsor decision|1|||
125566036|NCT00804570|451701220|FG001|Overall Study|Sponsor decision|4|||
125566037|NCT00804570|451701219|FG000|Overall Study|Withdrawal by Subject|21|||
125566038|NCT00804570|451701220|FG001|Overall Study|Withdrawal by Subject|38|||
125566039|NCT00290342|451701221|FG000|Overall Study|Other|0|||
125566040|NCT00290342|451701222|FG001|Overall Study|Other|1|||
125566041|NCT00290342|451701221|FG000|Overall Study|Withdrawal by Subject|6|||
125566042|NCT00290342|451701222|FG001|Overall Study|Withdrawal by Subject|4|||
125566043|NCT00290342|451701221|FG000|Overall Study|Lost to Follow-up|1|||
125566044|NCT00290342|451701222|FG001|Overall Study|Lost to Follow-up|0|||
125566045|NCT01056510|451701225|FG000|Overall Study|Dropout Before Start of Treatment|1|||
125566046|NCT01056510|451701226|FG001|Overall Study|Dropout Before Start of Treatment|1|||
125566047|NCT01056510|451701225|FG000|Overall Study|Withdrawal by Subject|4|||
125566048|NCT01056510|451701226|FG001|Overall Study|Withdrawal by Subject|2|||
125566049|NCT01056510|451701225|FG000|Overall Study|Death|29|||
125566050|NCT01056510|451701226|FG001|Overall Study|Death|34|||
125566051|NCT01056510|451701225|FG000|Overall Study|Noncompliance|1|||
125566052|NCT01056510|451701226|FG001|Overall Study|Noncompliance|3|||
125566053|NCT01056510|451701225|FG000|Overall Study|Physician Decision|4|||
125566054|NCT01056510|451701226|FG001|Overall Study|Physician Decision|5|||
125566055|NCT01056510|451701225|FG000|Overall Study|Lost to Follow-up|5|||
125566056|NCT01056510|451701226|FG001|Overall Study|Lost to Follow-up|6|||
125566057|NCT01056510|451701225|FG000|Overall Study|Other|10|||
125566058|NCT01056510|451701226|FG001|Overall Study|Other|12|||
125566059|NCT01056510|451701225|FG000|Overall Study|Missing|0|||
125566060|NCT01056510|451701226|FG001|Overall Study|Missing|1|||
125566061|NCT00243386|451701227|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
125566062|NCT00243386|451701228|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
125566063|NCT00243386|451701229|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
125566064|NCT00243386|451701227|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
125566065|NCT00243386|451701228|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
125566066|NCT00243386|451701229|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
125566067|NCT00243386|451701227|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
125566068|NCT00243386|451701228|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
125566069|NCT00243386|451701229|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
125566070|NCT00243386|451701227|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
125566071|NCT00243386|451701228|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
125566072|NCT00243386|451701229|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
125566073|NCT00243386|451701227|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
125566074|NCT00243386|451701228|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
125566075|NCT00243386|451701229|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
125566076|NCT00243386|451701227|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
125566077|NCT00243386|451701228|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
125566078|NCT00243386|451701229|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
125566079|NCT00243386|451701227|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
125566080|NCT00243386|451701228|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
125566081|NCT00243386|451701229|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
125566082|NCT00243386|451701227|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
125566083|NCT00243386|451701228|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
125566084|NCT00243386|451701229|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
125566085|NCT02285998|451701230|FG000|Overall Study|Adverse Event|9|||
125566086|NCT02285998|451701231|FG001|Overall Study|Adverse Event|8|||
125566087|NCT02285998|451701230|FG000|Overall Study|Physician Decision|1|||
125566088|NCT02285998|451701231|FG001|Overall Study|Physician Decision|2|||
125566089|NCT02285998|451701230|FG000|Overall Study|Lost to Follow-up|176|||
125566090|NCT02285998|451701231|FG001|Overall Study|Lost to Follow-up|172|||
125566091|NCT02285998|451701230|FG000|Overall Study|Withdrawal by Subject|53|||
125566092|NCT02285998|451701231|FG001|Overall Study|Withdrawal by Subject|61|||
125566093|NCT02285998|451701230|FG000|Overall Study|Other Reasons|7|||
125566094|NCT02285998|451701231|FG001|Overall Study|Other Reasons|10|||
125566095|NCT00545298|451701232|FG000|Overall Study|Issues with Standard of Care|2|||
125566096|NCT00545298|451701233|FG001|Overall Study|Issues with Standard of Care|0|||
125566097|NCT00545298|451701234|FG002|Overall Study|Issues with Standard of Care|1|||
125566098|NCT01793142|451701238|FG000|Overall Study|Randomized not treated|7|||
125566099|NCT01820364|451701243|FG000|Part I: LGX818|Death|1|||
125566100|NCT01820364|451701244|FG001|Part I: LGX818|Death|0|||
125566101|NCT01820364|451701243|FG000|Part I: LGX818|Administrative Problems|3|||
125566102|NCT01820364|451701244|FG001|Part I: LGX818|Administrative Problems|0|||
125566103|NCT01820364|451701243|FG000|Part I: LGX818|Adverse Event|6|||
125566104|NCT01820364|451701244|FG001|Part I: LGX818|Adverse Event|0|||
125566105|NCT01820364|451701243|FG000|Part I: LGX818|Disease Progression|4|||
125566106|NCT01820364|451701244|FG001|Part I: LGX818|Disease Progression|0|||
125566107|NCT01820364|451701243|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
125566108|NCT01820364|451701244|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
125566109|NCT03451084|451701248|FG000|Overall Study|Withdrawal by Subject|2|||
125566110|NCT03451084|451701249|FG001|Overall Study|Withdrawal by Subject|1|||
125566111|NCT03451084|451701250|FG002|Overall Study|Withdrawal by Subject|2|||
125566112|NCT03451084|451701251|FG003|Overall Study|Withdrawal by Subject|1|||
125566113|NCT03451084|451701248|FG000|Overall Study|Disease recurrence|0|||
125566114|NCT03451084|451701249|FG001|Overall Study|Disease recurrence|2|||
125355551|NCT02452697|450936551|FG000|Overall Study|still in follow-up|2|||
125355552|NCT02452697|450936552|FG001|Overall Study|still in follow-up|2|||
125355553|NCT02452697|450936553|FG002|Overall Study|still in follow-up|1|||
125355554|NCT02452697|450936554|FG003|Overall Study|still in follow-up|3|||
125355555|NCT03552965|450936555|FG000|Overall Study|Death|1|||
125355556|NCT03552965|450936556|FG001|Overall Study|Death|1|||
125355557|NCT03552965|450936555|FG000|Overall Study|Lost to Follow-up|1|||
125355558|NCT03552965|450936556|FG001|Overall Study|Lost to Follow-up|1|||
125566115|NCT03451084|451701250|FG002|Overall Study|Disease recurrence|0|||
125566116|NCT03451084|451701251|FG003|Overall Study|Disease recurrence|0|||
125566117|NCT03451084|451701248|FG000|Overall Study|Lack of Efficacy|0|||
125566118|NCT03451084|451701249|FG001|Overall Study|Lack of Efficacy|3|||
125566119|NCT03451084|451701250|FG002|Overall Study|Lack of Efficacy|0|||
125566120|NCT03451084|451701251|FG003|Overall Study|Lack of Efficacy|1|||
125566121|NCT03451084|451701248|FG000|Overall Study|Death|1|||
125566122|NCT03451084|451701249|FG001|Overall Study|Death|0|||
125566123|NCT03451084|451701250|FG002|Overall Study|Death|2|||
125566124|NCT03451084|451701251|FG003|Overall Study|Death|0|||
125566125|NCT03451084|451701248|FG000|Overall Study|Physician Decision|0|||
125566126|NCT03451084|451701249|FG001|Overall Study|Physician Decision|0|||
125355559|NCT03552965|450936555|FG000|Overall Study|Physician Decision|1|||
125566127|NCT03451084|451701250|FG002|Overall Study|Physician Decision|2|||
125566128|NCT03451084|451701251|FG003|Overall Study|Physician Decision|2|||
125566129|NCT03451084|451701248|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
125566130|NCT03451084|451701249|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
125566131|NCT03451084|451701250|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
125566132|NCT03451084|451701251|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
125566133|NCT04995055|451701252|FG000|Period 1|COVID-19 Related|1|||
125566134|NCT04995055|451701253|FG001|Period 1|COVID-19 Related|0|||
125566135|NCT04995055|451701252|FG000|Period 1|Withdrawal by Subject|0|||
125566136|NCT04995055|451701253|FG001|Period 1|Withdrawal by Subject|1|||
125566137|NCT04995055|451701252|FG000|Period 1|Subject discontinued due to timing|4|||
125566138|NCT04995055|451701253|FG001|Period 1|Subject discontinued due to timing|4|||
125566139|NCT03418129|451701258|FG000|Overall Study|Lost to Follow-up|11|||
125566140|NCT03418129|451701259|FG001|Overall Study|Lost to Follow-up|20|||
125566141|NCT03418129|451701260|FG002|Overall Study|Lost to Follow-up|15|||
125566142|NCT03418129|451701258|FG000|Overall Study|Withdrawal by Subject|3|||
125566143|NCT03418129|451701259|FG001|Overall Study|Withdrawal by Subject|6|||
125566144|NCT03418129|451701260|FG002|Overall Study|Withdrawal by Subject|4|||
125566145|NCT01553188|451701264|FG000|Overall Study|Patient choice|1|||
125566146|NCT01553188|451701265|FG001|Overall Study|Patient choice|0|||
125566147|NCT01553188|451701266|FG002|Overall Study|Patient choice|0|||
125566148|NCT01553188|451701267|FG003|Overall Study|Patient choice|0|||
125566149|NCT01553188|451701264|FG000|Overall Study|Intercurrent illness and adverse event|0|||
125566150|NCT01553188|451701265|FG001|Overall Study|Intercurrent illness and adverse event|1|||
125566151|NCT01553188|451701266|FG002|Overall Study|Intercurrent illness and adverse event|2|||
125566152|NCT01553188|451701267|FG003|Overall Study|Intercurrent illness and adverse event|0|||
125566153|NCT01066585|451701268|FG000|Overall Study|Protocol Violation|1|||
125566154|NCT01066585|451701269|FG001|Overall Study|Protocol Violation|0|||
125566155|NCT01066585|451701268|FG000|Overall Study|Withdrawal by Subject|0|||
125566156|NCT01066585|451701269|FG001|Overall Study|Withdrawal by Subject|3|||
125566157|NCT04126083|451701270|FG000|Overall Study|Withdrawal by Subject|1|||
125566158|NCT01279850|451701271|FG000|Overall Study|Protocol Violation|50|||
125566159|NCT01279850|451701271|FG000|Overall Study|No Drug Administration Information|7|||
125566160|NCT01279850|451701271|FG000|Overall Study|No Visit After Treatment|34|||
125566161|NCT01131520|451701272|FG000|Overall Study|Computer problem|1|||
125566162|NCT01131520|451701273|FG001|Overall Study|Computer problem|0|||
125566163|NCT01131520|451701272|FG000|Overall Study|Counselor not available|0|||
125566164|NCT01131520|451701273|FG001|Overall Study|Counselor not available|3|||
125566165|NCT01131520|451701272|FG000|Overall Study|Subject changed history after enrollment|0|||
125566166|NCT01131520|451701273|FG001|Overall Study|Subject changed history after enrollment|1|||
125566167|NCT05419128|451701274|FG000|Overall Study|Withdrawal by Subject|1|||
125566168|NCT05419128|451701275|FG001|Overall Study|Withdrawal by Subject|1|||
125566169|NCT05419128|451701276|FG002|Overall Study|Withdrawal by Subject|0|||
125566170|NCT05419128|451701277|FG003|Overall Study|Withdrawal by Subject|1|||
125566171|NCT05419128|451701278|FG004|Overall Study|Withdrawal by Subject|1|||
125566172|NCT05419128|451701279|FG005|Overall Study|Withdrawal by Subject|0|||
125566173|NCT05419128|451701274|FG000|Overall Study|Lost to Follow-up|0|||
125566174|NCT05419128|451701275|FG001|Overall Study|Lost to Follow-up|0|||
125566175|NCT05419128|451701276|FG002|Overall Study|Lost to Follow-up|1|||
125566176|NCT05419128|451701277|FG003|Overall Study|Lost to Follow-up|0|||
125566177|NCT05419128|451701278|FG004|Overall Study|Lost to Follow-up|0|||
125566178|NCT05419128|451701279|FG005|Overall Study|Lost to Follow-up|1|||
125566179|NCT03834519|451701280|FG000|Overall Study|Lost to Follow-up|2|||
125566180|NCT03834519|451701281|FG001|Overall Study|Lost to Follow-up|1|||
125566181|NCT03834519|451701280|FG000|Overall Study|Withdrawal by Subject|5|||
125566182|NCT03834519|451701281|FG001|Overall Study|Withdrawal by Subject|8|||
125566183|NCT03834519|451701280|FG000|Overall Study|Death|368|||
125566184|NCT03834519|451701281|FG001|Overall Study|Death|174|||
125566185|NCT03834519|451701280|FG000|Overall Study|Physician Decision|5|||
125566186|NCT03834519|451701281|FG001|Overall Study|Physician Decision|1|||
125566187|NCT03834519|451701280|FG000|Overall Study|Sponsor decision|149|||
125566188|NCT03834519|451701281|FG001|Overall Study|Sponsor decision|80|||
125566189|NCT02186847|451701282|FG000|Overall Study|Protocol Violation|3|||
125566190|NCT02186847|451701283|FG001|Overall Study|Protocol Violation|0|||
125566191|NCT03416153|451701284|FG000|Overall Study|Physician Decision|1|||
125566192|NCT03416153|451701285|FG001|Overall Study|Physician Decision|1|||
125566193|NCT03416153|451701284|FG000|Overall Study|Withdrawal by Subject|1|||
125566194|NCT03416153|451701285|FG001|Overall Study|Withdrawal by Subject|0|||
125566195|NCT01617460|451702897|FG000|Overall Study|Adverse Event|10|||
125566196|NCT01617460|451702897|FG000|Overall Study|Physician Decision|16|||
125566197|NCT01617460|451702897|FG000|Overall Study|Protocol Violation|5|||
125566198|NCT01617460|451702897|FG000|Overall Study|Withdrawal by Subject|9|||
125566199|NCT03703882|451702898|FG000|Overall Study|Adverse Event|1|||
125566200|NCT03703882|451702899|FG001|Overall Study|Adverse Event|0|||
125566201|NCT03703882|451702898|FG000|Overall Study|Lost to Follow-up|0|||
125566202|NCT03703882|451702899|FG001|Overall Study|Lost to Follow-up|2|||
125566203|NCT03703882|451702898|FG000|Overall Study|Non-compliance with study drug|0|||
125566204|NCT03703882|451702899|FG001|Overall Study|Non-compliance with study drug|1|||
125566205|NCT03703882|451702898|FG000|Overall Study|Physician Decision|0|||
125566206|NCT03703882|451702899|FG001|Overall Study|Physician Decision|1|||
125566207|NCT03703882|451702898|FG000|Overall Study|Progressive disease|1|||
125566208|NCT03703882|451702899|FG001|Overall Study|Progressive disease|0|||
125566209|NCT03703882|451702898|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125566210|NCT03703882|451702899|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125566211|NCT03703882|451702898|FG000|Overall Study|Starting another treatment|0|||
125566212|NCT03703882|451702899|FG001|Overall Study|Starting another treatment|1|||
125566213|NCT03703882|451702898|FG000|Overall Study|noncompliance with study procedures|0|||
125566214|NCT03703882|451702899|FG001|Overall Study|noncompliance with study procedures|1|||
125566215|NCT00666458|451702905|FG000|Overall Study|Adverse Event|8|||
125566216|NCT00666458|451702906|FG001|Overall Study|Adverse Event|7|||
125566217|NCT00666458|451702905|FG000|Overall Study|Withdrawal by Subject|5|||
125566218|NCT00666458|451702906|FG001|Overall Study|Withdrawal by Subject|4|||
125566219|NCT00666458|451702905|FG000|Overall Study|Lost to Follow-up|0|||
125566220|NCT00666458|451702906|FG001|Overall Study|Lost to Follow-up|3|||
125566221|NCT00666458|451702905|FG000|Overall Study|Administrative reason by sponsor|1|||
125566222|NCT00666458|451702906|FG001|Overall Study|Administrative reason by sponsor|1|||
125566223|NCT00666458|451702905|FG000|Overall Study|Incorrect enrollment|7|||
125566224|NCT00666458|451702906|FG001|Overall Study|Incorrect enrollment|1|||
125566225|NCT00666458|451702905|FG000|Overall Study|Study specific discontinuation criteria|14|||
125566226|NCT00666458|451702906|FG001|Overall Study|Study specific discontinuation criteria|7|||
125426444|NCT02543658|451185909|FG001|Overall Study|Lack of Efficacy|4|||
125426445|NCT00662857|451185910|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
125566227|NCT00666458|451702905|FG000|Overall Study|Severe non-compliance to the protocol|1|||
125566228|NCT00666458|451702906|FG001|Overall Study|Severe non-compliance to the protocol|1|||
125566229|NCT00666458|451702905|FG000|Overall Study|Safety reasons|1|||
125566230|NCT00666458|451702906|FG001|Overall Study|Safety reasons|0|||
125566231|NCT00666458|451702905|FG000|Overall Study|Medical history of anemia|1|||
125566232|NCT00666458|451702906|FG001|Overall Study|Medical history of anemia|0|||
125566233|NCT02222207|451702907|FG000|Overall Study|Death|1|||
125566234|NCT02222207|451702907|FG000|Overall Study|Other reasons|2|||
125566235|NCT02222207|451702907|FG000|Overall Study|Adverse Event|1|||
125566236|NCT02982954|451702908|FG000|Overall Study|Death|55|||
125210781|NCT02134353|450395684|FG000|Overall Study|Lost to Follow-up|1|||
125566237|NCT02982954|451702909|FG001|Overall Study|Death|29|||
125566238|NCT02982954|451702910|FG002|Overall Study|Death|15|||
125566239|NCT02982954|451702911|FG003|Overall Study|Death|20|||
125566240|NCT02982954|451702908|FG000|Overall Study|Lost to Follow-up|2|||
125566241|NCT02982954|451702909|FG001|Overall Study|Lost to Follow-up|1|||
125566242|NCT02982954|451702910|FG002|Overall Study|Lost to Follow-up|0|||
125566243|NCT02982954|451702911|FG003|Overall Study|Lost to Follow-up|0|||
125566244|NCT02982954|451702908|FG000|Overall Study|Participant withdrew consent|7|||
125566245|NCT02982954|451702909|FG001|Overall Study|Participant withdrew consent|5|||
125566246|NCT02982954|451702910|FG002|Overall Study|Participant withdrew consent|1|||
125566247|NCT02982954|451702911|FG003|Overall Study|Participant withdrew consent|1|||
125566248|NCT02982954|451702908|FG000|Overall Study|Other reasons|42|||
125566249|NCT02982954|451702909|FG001|Overall Study|Other reasons|17|||
125566250|NCT02982954|451702910|FG002|Overall Study|Other reasons|12|||
125566251|NCT02982954|451702911|FG003|Overall Study|Other reasons|3|||
125566252|NCT02982954|451702908|FG000|Overall Study|Premature site closure|0|||
125566253|NCT02982954|451702909|FG001|Overall Study|Premature site closure|0|||
125566254|NCT02982954|451702910|FG002|Overall Study|Premature site closure|0|||
125566255|NCT02982954|451702911|FG003|Overall Study|Premature site closure|1|||
125566256|NCT01429584|451702915|FG000|Overall Study|Withdrawal by Subject|1|||
125566257|NCT01429584|451702916|FG001|Overall Study|Withdrawal by Subject|0|||
125566258|NCT01429584|451702915|FG000|Overall Study|Protocol Violation|0|||
125566259|NCT01429584|451702916|FG001|Overall Study|Protocol Violation|1|||
125566260|NCT00747643|451702917|FG000|Overall Study|Withdrawal by Subject|36|||
125566261|NCT00747643|451702918|FG001|Overall Study|Withdrawal by Subject|27|||
125566262|NCT00750698|451702919|FG000|Overall Study|Withdrawal by Subject|1|||
125566263|NCT00750698|451702920|FG001|Overall Study|Withdrawal by Subject|0|||
125566264|NCT00750698|451702919|FG000|Overall Study|Progressive disease|5|||
125566265|NCT00750698|451702920|FG001|Overall Study|Progressive disease|2|||
125566266|NCT02603120|451702921|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
125566267|NCT02603120|451702922|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
125566268|NCT02603120|451702921|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
125566269|NCT02603120|451702922|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
125566270|NCT02603120|451702921|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
125355560|NCT03552965|450936556|FG001|Overall Study|Physician Decision|1|||
125566271|NCT02603120|451702922|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
125566272|NCT02603120|451702921|FG000|Double-Blind Treatment Phase|Death|2|||
125566273|NCT02603120|451702922|FG001|Double-Blind Treatment Phase|Death|0|||
125566274|NCT02603120|451702921|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
125566275|NCT02603120|451702922|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
125566276|NCT02603120|451702921|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
125566277|NCT02603120|451702922|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
125566278|NCT02603120|451702921|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
125566279|NCT02603120|451702922|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
125566280|NCT02603120|451702921|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
125566281|NCT02603120|451702922|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
125566282|NCT02603120|451702921|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
125566283|NCT02603120|451702922|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
125566284|NCT02603120|451702921|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
125566285|NCT02603120|451702922|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
125566286|NCT02603120|451702921|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
125566287|NCT02603120|451702922|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
125566288|NCT02603120|451702921|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
125566289|NCT02603120|451702922|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
125566290|NCT02603120|451702921|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
125566291|NCT02603120|451702922|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
125355561|NCT03552965|450936555|FG000|Overall Study|Withdrawal by Subject|0|||
125355562|NCT03552965|450936556|FG001|Overall Study|Withdrawal by Subject|2|||
125566292|NCT02603120|451702921|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
125566293|NCT02603120|451702922|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
125566294|NCT01199042|451702925|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
125566295|NCT01199042|451702925|FG000|At Home (3 Months)|Lost to Follow-up|1|||
125566296|NCT00176605|451702928|FG000|Overall Study|Withdrawal by Subject|2|||
125355563|NCT03552965|450936555|FG000|Overall Study|Continuation not in patient best interest|1|||
125566297|NCT01321710|451702931|FG000|Overall Study|Lost to Follow-up|4|||
125566298|NCT01321710|451702932|FG001|Overall Study|Lost to Follow-up|5|||
125566299|NCT01321710|451702933|FG002|Overall Study|Lost to Follow-up|0|||
125566300|NCT02554019|451702934|FG000|Overall Study|Withdrawal by Subject|1|||
125566301|NCT02554019|451702935|FG001|Overall Study|Withdrawal by Subject|0|||
125566302|NCT02554019|451702936|FG002|Overall Study|Withdrawal by Subject|2|||
125566303|NCT02554019|451702934|FG000|Overall Study|Adverse Event|1|||
125566304|NCT02554019|451702935|FG001|Overall Study|Adverse Event|0|||
125566305|NCT02554019|451702936|FG002|Overall Study|Adverse Event|0|||
125566306|NCT00772954|451702937|FG000|Overall Study|Adverse Event|0|||
125566307|NCT00772954|451702938|FG001|Overall Study|Adverse Event|0|||
125566308|NCT00772954|451702939|FG002|Overall Study|Adverse Event|1|||
125566309|NCT02495844|451702940|FG000|Overall Study|Lack of Efficacy|1|||
125566310|NCT02495844|451702941|FG001|Overall Study|Lack of Efficacy|2|||
125566311|NCT02495844|451702940|FG000|Overall Study|AE, non-fatal|0|||
125566312|NCT02495844|451702941|FG001|Overall Study|AE, non-fatal|1|||
125566313|NCT02495844|451702940|FG000|Overall Study|Hepatitis Positivity|0|||
125566314|NCT02495844|451702941|FG001|Overall Study|Hepatitis Positivity|1|||
125566315|NCT02325219|451702942|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
125566316|NCT02325219|451702943|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
125566317|NCT02325219|451702944|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
125566318|NCT02325219|451702945|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
125355564|NCT03552965|450936556|FG001|Overall Study|Continuation not in patient best interest|0|||
125566319|NCT02325219|451702946|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
125566320|NCT02325219|451702942|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
125566321|NCT02325219|451702943|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
125566322|NCT02325219|451702944|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
125566323|NCT02325219|451702945|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
125566324|NCT02325219|451702946|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
125566325|NCT02325219|451702942|FG000|Controlled Period (Week 0 - 16)|Other|0|||
125566326|NCT02325219|451702943|FG001|Controlled Period (Week 0 - 16)|Other|0|||
125566327|NCT02325219|451702944|FG002|Controlled Period (Week 0 - 16)|Other|1|||
125566328|NCT02325219|451702945|FG003|Controlled Period (Week 0 - 16)|Other|0|||
125566329|NCT02325219|451702946|FG004|Controlled Period (Week 0 - 16)|Other|0|||
125566330|NCT02325219|451702942|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
125566331|NCT02325219|451702943|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
125566332|NCT02325219|451702944|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
125566333|NCT02325219|451702945|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
125566334|NCT02325219|451702946|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
125566335|NCT02325219|451702942|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
125566336|NCT02325219|451702943|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
125566337|NCT02325219|451702944|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
125566338|NCT02325219|451702945|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
125566339|NCT02325219|451702946|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
125566340|NCT02325219|451702942|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
125566341|NCT02325219|451702943|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
125566342|NCT02325219|451702944|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
125566343|NCT02325219|451702945|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
125566344|NCT02325219|451702946|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
125566345|NCT03577730|451702947|FG000|Overall Study|Physician Decision|3|||
125355565|NCT03552965|450936555|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
125566346|NCT03577730|451702948|FG001|Overall Study|Physician Decision|1|||
125566347|NCT03577730|451702947|FG000|Overall Study|Did not receive allocated intervention|1|||
125566348|NCT03577730|451702948|FG001|Overall Study|Did not receive allocated intervention|0|||
125566349|NCT02634151|451702949|FG000|Overall Study|Withdrawal by Subject|1|||
125566350|NCT02634151|451702950|FG001|Overall Study|Withdrawal by Subject|0|||
125566351|NCT02634151|451702949|FG000|Overall Study|Non-Compliance|0|||
125566352|NCT02634151|451702950|FG001|Overall Study|Non-Compliance|1|||
125566353|NCT02634151|451702949|FG000|Overall Study|Other|0|||
125566354|NCT02634151|451702950|FG001|Overall Study|Other|1|||
125566355|NCT04640272|451702951|FG000|Overall Study|Subject moved out of area|1|||
125566356|NCT04353284|451702956|FG000|Overall Study|Adverse Event|1|||
125566357|NCT04353284|451702957|FG001|Overall Study|Adverse Event|1|||
125566358|NCT04353284|451702956|FG000|Overall Study|Lost to Follow-up|1|||
125566359|NCT04353284|451702957|FG001|Overall Study|Lost to Follow-up|0|||
125566360|NCT00122681|451702960|FG000|Overall Study|Adverse Event|20|||
125566361|NCT00122681|451702961|FG001|Overall Study|Adverse Event|16|||
125566362|NCT00122681|451702960|FG000|Overall Study|Lost to Follow-up|1080|||
125566363|NCT00122681|451702961|FG001|Overall Study|Lost to Follow-up|1097|||
125566364|NCT00122681|451702960|FG000|Overall Study|Protocol Violation|7|||
125566365|NCT00122681|451702961|FG001|Overall Study|Protocol Violation|10|||
125566366|NCT00122681|451702960|FG000|Overall Study|Withdrawal by Subject|257|||
125566367|NCT00122681|451702961|FG001|Overall Study|Withdrawal by Subject|251|||
125566368|NCT00122681|451702960|FG000|Overall Study|Personal reasons|150|||
125566369|NCT00122681|451702961|FG001|Overall Study|Personal reasons|147|||
125566370|NCT00751400|451702965|FG000|Overall Study|Lost to Follow-up|10|||
125566371|NCT00441974|451702969|FG000|Overall Study|Adverse Event|6|||
125566372|NCT00441974|451702969|FG000|Overall Study|Consent Withdrawn|35|||
125566373|NCT00441974|451702969|FG000|Overall Study|Lost to Follow-up|80|||
125566374|NCT00441974|451702969|FG000|Overall Study|Protocol Violation|7|||
125566375|NCT02770547|451702970|FG000|Overall Study|Patient non-compliant|1|||
125566376|NCT02770547|451702971|FG001|Overall Study|Patient non-compliant|0|||
125566377|NCT02770547|451702970|FG000|Overall Study|Adverse Event|0|||
125566378|NCT02770547|451702971|FG001|Overall Study|Adverse Event|1|||
125566379|NCT01148537|451702972|FG000|Overall Study|Withdrawal by Subject|1|||
125566380|NCT01148537|451702973|FG001|Overall Study|Withdrawal by Subject|0|||
125566381|NCT01148537|451702974|FG002|Overall Study|Withdrawal by Subject|2|||
125566382|NCT01148537|451702972|FG000|Overall Study|Adverse Event|2|||
125566383|NCT01148537|451702973|FG001|Overall Study|Adverse Event|0|||
125566384|NCT01148537|451702974|FG002|Overall Study|Adverse Event|1|||
125566385|NCT00393887|451702975|FG000|Overall Study|Physician Decision|5|||
125566386|NCT00393887|451702976|FG001|Overall Study|Physician Decision|0|||
125566387|NCT00393887|451702975|FG000|Overall Study|Lost to Follow-up|11|||
125566388|NCT00393887|451702976|FG001|Overall Study|Lost to Follow-up|9|||
125566389|NCT02018822|451702980|FG000|Overall Study|filling replaced by crown|0|||
125566390|NCT02018822|451702981|FG001|Overall Study|filling replaced by crown|1|||
125566391|NCT02018822|451702982|FG002|Overall Study|filling replaced by crown|0|||
125566392|NCT02018822|451702980|FG000|Overall Study|Physician Decision|0|||
125566393|NCT02018822|451702981|FG001|Overall Study|Physician Decision|1|||
125566394|NCT02018822|451702982|FG002|Overall Study|Physician Decision|1|||
125566395|NCT02018822|451702980|FG000|Overall Study|Lost to Follow-up|6|||
125566396|NCT02018822|451702981|FG001|Overall Study|Lost to Follow-up|6|||
125566397|NCT02018822|451702982|FG002|Overall Study|Lost to Follow-up|5|||
125566398|NCT00715026|451702983|FG000|Overall Study|Withdrawal by Subject|5|||
125566399|NCT00715026|451702983|FG000|Overall Study|Lost to Follow-up|3|||
125566400|NCT00715026|451702983|FG000|Overall Study|Protocol Violation|1|||
125566401|NCT00715026|451702983|FG000|Overall Study|Surgery done on non-study consented hip|1|||
125566402|NCT04744207|451702985|FG000|Treatment|Withdrawal by Subject|2|||
125566403|NCT04744207|451702986|FG001|Treatment|Withdrawal by Subject|0|||
125566404|NCT04744207|451702985|FG000|Treatment|Adverse Event|1|||
125566405|NCT04744207|451702986|FG001|Treatment|Adverse Event|2|||
125566406|NCT05289570|451702991|FG000|Overall Study|Physician Decision|1|||
125566407|NCT01617070|451702992|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
125566408|NCT02230384|451703000|FG000|Phase 1|Lost to Follow-up|1|||
125566409|NCT02230384|451703001|FG001|Phase 1|Lost to Follow-up|0|||
125566410|NCT02230384|451703000|FG000|Phase 1|Physician Decision|0|||
125566411|NCT02230384|451703001|FG001|Phase 1|Physician Decision|1|||
125566412|NCT02230384|451703000|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
125566413|NCT02230384|451703001|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
125566414|NCT02230384|451703000|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
125566415|NCT02230384|451703001|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
125566416|NCT02230384|451703000|FG000|Phase 2 - Switch|Adverse Event|2|||
125566417|NCT02230384|451703001|FG001|Phase 2 - Switch|Adverse Event|0|||
125566418|NCT00808236|451703002|FG000|Overall Study|Was not resuscitated|50|||
125566419|NCT00808236|451703003|FG001|Overall Study|Was not resuscitated|56|||
125566420|NCT00808236|451703002|FG000|Overall Study|Pre-defined exclusion|13|||
125566421|NCT00808236|451703003|FG001|Overall Study|Pre-defined exclusion|3|||
125566422|NCT00808236|451703002|FG000|Overall Study|Lost to Follow-up|1|||
125566423|NCT00808236|451703003|FG001|Overall Study|Lost to Follow-up|1|||
125566424|NCT00808236|451703002|FG000|Overall Study|Physician Decision|0|||
125566425|NCT00808236|451703003|FG001|Overall Study|Physician Decision|1|||
125566426|NCT00808236|451703002|FG000|Overall Study|Death|18|||
125566427|NCT00808236|451703003|FG001|Overall Study|Death|30|||
125566428|NCT00777101|451703004|FG000|Overall Study|Death|48|||
125566429|NCT00777101|451703005|FG001|Overall Study|Death|43|||
125566430|NCT00777101|451703004|FG000|Overall Study|Withdrawal by Subject|11|||
125566431|NCT00777101|451703005|FG001|Overall Study|Withdrawal by Subject|6|||
125566432|NCT00777101|451703004|FG000|Overall Study|Lost to Follow-up|2|||
125566433|NCT00777101|451703005|FG001|Overall Study|Lost to Follow-up|1|||
125566434|NCT00777101|451703004|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
125566435|NCT00777101|451703005|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
125566436|NCT00777101|451703004|FG000|Overall Study|Failed to Return|0|||
125566437|NCT00777101|451703005|FG001|Overall Study|Failed to Return|1|||
125566438|NCT00961220|451703006|FG000|Overall Study|Adverse Event|3|||
125566439|NCT00961220|451703006|FG000|Overall Study|Lack of Efficacy|1|||
125566440|NCT00961220|451703006|FG000|Overall Study|No IV access for O6BG|1|||
125566441|NCT00961220|451703006|FG000|Overall Study|O6BG no longer supplied|1|||
125566442|NCT00961220|451703006|FG000|Overall Study|Complete Response prior to 12 courses|1|||
125566443|NCT05376215|451703007|FG000|Overall Study|Withdrawal by Subject|2|||
125566444|NCT05376215|451703008|FG001|Overall Study|Withdrawal by Subject|1|||
125566445|NCT05376215|451703007|FG000|Overall Study|Lost to Follow-up|0|||
125566446|NCT05376215|451703008|FG001|Overall Study|Lost to Follow-up|1|||
125566447|NCT01301950|451703015|FG000|Overall Study|Surgery was cancelled by patient|0|||
125566448|NCT01301950|451703016|FG001|Overall Study|Surgery was cancelled by patient|1|||
125566449|NCT00786565|451703026|FG000|Enrollment Prior to Surgery|Site Closed|3|||
125566450|NCT00786565|451703026|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
125566451|NCT00786565|451703026|FG000|Post Surgery|Abnormal macular pucker|1|||
125566452|NCT00786565|451703026|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
125566453|NCT05248295|451703032|FG000|Overall Study|found ineligible|4|||
125566454|NCT05248295|451703033|FG001|Overall Study|found ineligible|1|||
125566455|NCT05248295|451703032|FG000|Overall Study|Withdrawal by Subject|0|||
125566456|NCT05248295|451703033|FG001|Overall Study|Withdrawal by Subject|1|||
125566457|NCT05248295|451703032|FG000|Overall Study|Data loss: audio recording error|1|||
125566458|NCT05248295|451703033|FG001|Overall Study|Data loss: audio recording error|1|||
125566459|NCT03021499|451703034|FG000|Overall Study|Adverse Event|1|||
125566460|NCT03021499|451703035|FG001|Overall Study|Adverse Event|0|||
125566461|NCT03021499|451703034|FG000|Overall Study|Death|1|||
125566462|NCT03021499|451703035|FG001|Overall Study|Death|5|||
125566463|NCT03021499|451703034|FG000|Overall Study|Lack of Efficacy|0|||
125566464|NCT03021499|451703035|FG001|Overall Study|Lack of Efficacy|1|||
125566465|NCT03021499|451703034|FG000|Overall Study|Lost to Follow-up|1|||
125566466|NCT03021499|451703035|FG001|Overall Study|Lost to Follow-up|3|||
125566467|NCT03021499|451703034|FG000|Overall Study|Physician Decision|2|||
125566468|NCT03021499|451703035|FG001|Overall Study|Physician Decision|3|||
125566469|NCT03021499|451703034|FG000|Overall Study|Pregnancy|1|||
125566470|NCT03021499|451703035|FG001|Overall Study|Pregnancy|0|||
125566471|NCT03021499|451703034|FG000|Overall Study|Withdrawal by Subject|7|||
125566472|NCT03021499|451703035|FG001|Overall Study|Withdrawal by Subject|14|||
125566473|NCT03021499|451703034|FG000|Overall Study|Prohibited medication required|1|||
125566474|NCT03021499|451703035|FG001|Overall Study|Prohibited medication required|0|||
125566475|NCT03021499|451703034|FG000|Overall Study|Protocol non-compliance|1|||
125566476|NCT03021499|451703035|FG001|Overall Study|Protocol non-compliance|1|||
125566477|NCT03021499|451703034|FG000|Overall Study|None of the above|0|||
125566478|NCT03021499|451703035|FG001|Overall Study|None of the above|4|||
125566479|NCT03021499|451703034|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
125566480|NCT03021499|451703035|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
125566481|NCT01210690|451703036|FG000|Overall Study|Adverse Event|7|||
125566482|NCT01210690|451703036|FG000|Overall Study|Lack of Efficacy|12|||
125566483|NCT01210690|451703036|FG000|Overall Study|Lost to Follow-up|3|||
125566484|NCT01210690|451703036|FG000|Overall Study|Disease Remission|1|||
125566485|NCT01210690|451703036|FG000|Overall Study|Withdrawal by Subject|1|||
125566486|NCT01210690|451703036|FG000|Overall Study|Patient refused to swallow|1|||
125566487|NCT01210690|451703036|FG000|Overall Study|Patient could not take glucose|1|||
125566488|NCT00470054|451703037|FG000|Overall Study|Ineligible|1|||
125566489|NCT04869345|451703044|FG000|Overall Study|Lost to Follow-up|8|||
125566490|NCT04869345|451703045|FG001|Overall Study|Lost to Follow-up|3|||
125566491|NCT00528021|451703049|FG000|Overall Study|Lack of Efficacy|17|||
125566492|NCT00528021|451703050|FG001|Overall Study|Lack of Efficacy|13|||
125566493|NCT00528021|451703051|FG002|Overall Study|Lack of Efficacy|7|||
125566494|NCT00528021|451703052|FG003|Overall Study|Lack of Efficacy|9|||
125566495|NCT04050982|451703053|FG000|Overall Study|Did not meet eligibility criteria|0|||
125566496|NCT04050982|451703054|FG001|Overall Study|Did not meet eligibility criteria|1|||
125566497|NCT04050982|451703055|FG002|Overall Study|Did not meet eligibility criteria|0|||
125566498|NCT04050982|451703053|FG000|Overall Study|Withdrawal by Subject|1|||
125566499|NCT04050982|451703054|FG001|Overall Study|Withdrawal by Subject|0|||
125566500|NCT04050982|451703055|FG002|Overall Study|Withdrawal by Subject|0|||
125566501|NCT04050982|451703053|FG000|Overall Study|Unable to enroll on platform|1|||
125566502|NCT04050982|451703054|FG001|Overall Study|Unable to enroll on platform|0|||
125566503|NCT04050982|451703055|FG002|Overall Study|Unable to enroll on platform|0|||
125566504|NCT05054114|451703056|FG000|Overall Study|Protocol Violation|13|||
125566505|NCT05054114|451703057|FG001|Overall Study|Protocol Violation|1|||
125566506|NCT05054114|451703056|FG000|Overall Study|Pregnancy|0|||
125566507|NCT05054114|451703057|FG001|Overall Study|Pregnancy|1|||
125566508|NCT00733954|451703058|FG000|Overall Study|Lost to Follow-up|5|||
125566509|NCT00733954|451703059|FG001|Overall Study|Lost to Follow-up|2|||
125566510|NCT00733954|451703058|FG000|Overall Study|Protocol Violation|1|||
125566511|NCT00733954|451703059|FG001|Overall Study|Protocol Violation|0|||
125566512|NCT00733954|451703058|FG000|Overall Study|Withdrawal by Subject|2|||
125566513|NCT00733954|451703059|FG001|Overall Study|Withdrawal by Subject|0|||
125566514|NCT02663453|451703060|FG000|Overall Study|Death|4|||
125566515|NCT02663453|451703061|FG001|Overall Study|Death|4|||
125566516|NCT02663453|451703060|FG000|Overall Study|Withdrawal by Subject|1|||
125566517|NCT02663453|451703061|FG001|Overall Study|Withdrawal by Subject|0|||
125566518|NCT03557281|451704789|FG000|Overall Study|Investigator discretion|0|||
125566519|NCT03557281|451704790|FG001|Overall Study|Investigator discretion|0|||
125566520|NCT03557281|451704791|FG002|Overall Study|Investigator discretion|1|||
125566521|NCT03557281|451704792|FG003|Overall Study|Investigator discretion|0|||
125566522|NCT03557281|451704793|FG004|Overall Study|Investigator discretion|0|||
125566523|NCT03557281|451704789|FG000|Overall Study|Withdrawal by Subject|0|||
125566524|NCT03557281|451704790|FG001|Overall Study|Withdrawal by Subject|1|||
125566525|NCT03557281|451704791|FG002|Overall Study|Withdrawal by Subject|1|||
125566526|NCT03557281|451704792|FG003|Overall Study|Withdrawal by Subject|1|||
125566527|NCT03557281|451704793|FG004|Overall Study|Withdrawal by Subject|2|||
125566528|NCT03557281|451704789|FG000|Overall Study|Randomized, but did not receive treatment|0|||
125566529|NCT03557281|451704790|FG001|Overall Study|Randomized, but did not receive treatment|0|||
125566530|NCT03557281|451704791|FG002|Overall Study|Randomized, but did not receive treatment|0|||
125566531|NCT03557281|451704792|FG003|Overall Study|Randomized, but did not receive treatment|0|||
125566532|NCT03557281|451704793|FG004|Overall Study|Randomized, but did not receive treatment|1|||
125566533|NCT00402649|451704794|FG000|Overall Study|Lost to Follow-up|1|||
125566534|NCT00402649|451704794|FG000|Overall Study|Withdrawal by Subject|1|||
125566535|NCT01308008|451704799|FG000|4 Weeks|Illness, disinterest, time|9|||
125566536|NCT01308008|451704800|FG001|4 Weeks|Illness, disinterest, time|2|||
125566537|NCT03357731|451704801|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
125355566|NCT03552965|450936556|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
125355567|NCT02477696|450936557|FG000|Overall Study|Death|89|||
125355568|NCT02477696|450936558|FG001|Overall Study|Death|106|||
125355569|NCT02477696|450936557|FG000|Overall Study|Lost to Follow-up|7|||
125355570|NCT02477696|450936558|FG001|Overall Study|Lost to Follow-up|5|||
125355571|NCT02477696|450936557|FG000|Overall Study|Withdrawal by Subject|37|||
125355572|NCT02477696|450936558|FG001|Overall Study|Withdrawal by Subject|34|||
125355573|NCT02477696|450936557|FG000|Overall Study|Physician Decision|7|||
125355574|NCT02477696|450936558|FG001|Overall Study|Physician Decision|9|||
125355575|NCT02477696|450936557|FG000|Overall Study|Study terminated by sponsor|103|||
125355576|NCT02477696|450936558|FG001|Overall Study|Study terminated by sponsor|99|||
125566538|NCT03357731|451704802|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
125566539|NCT03357731|451704803|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
125566540|NCT03357731|451704804|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
125566541|NCT03357731|451704805|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
125566542|NCT03357731|451704806|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
125355577|NCT02477696|450936557|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
125566543|NCT03357731|451704801|FG000|Overall Study|Acute bradycardia and hypotension|0|||
125566544|NCT03357731|451704802|FG001|Overall Study|Acute bradycardia and hypotension|0|||
125566545|NCT03357731|451704803|FG002|Overall Study|Acute bradycardia and hypotension|0|||
125566546|NCT03357731|451704804|FG003|Overall Study|Acute bradycardia and hypotension|1|||
125566547|NCT03357731|451704805|FG004|Overall Study|Acute bradycardia and hypotension|0|||
125566548|NCT03357731|451704806|FG005|Overall Study|Acute bradycardia and hypotension|0|||
125566549|NCT03357731|451704801|FG000|Overall Study|Adverse Event|0|||
125566550|NCT03357731|451704802|FG001|Overall Study|Adverse Event|0|||
125566551|NCT03357731|451704803|FG002|Overall Study|Adverse Event|0|||
125566552|NCT03357731|451704804|FG003|Overall Study|Adverse Event|0|||
125566553|NCT03357731|451704805|FG004|Overall Study|Adverse Event|0|||
125566554|NCT03357731|451704806|FG005|Overall Study|Adverse Event|1|||
125566555|NCT03357731|451704801|FG000|Overall Study|Hypotension|0|||
125566556|NCT03357731|451704802|FG001|Overall Study|Hypotension|0|||
125566557|NCT03357731|451704803|FG002|Overall Study|Hypotension|1|||
125566558|NCT03357731|451704804|FG003|Overall Study|Hypotension|1|||
125566559|NCT03357731|451704805|FG004|Overall Study|Hypotension|0|||
125566560|NCT03357731|451704806|FG005|Overall Study|Hypotension|0|||
125566561|NCT03357731|451704801|FG000|Overall Study|Lost to Follow-up|0|||
125566562|NCT03357731|451704802|FG001|Overall Study|Lost to Follow-up|0|||
125566563|NCT03357731|451704803|FG002|Overall Study|Lost to Follow-up|0|||
125566564|NCT03357731|451704804|FG003|Overall Study|Lost to Follow-up|1|||
125566565|NCT03357731|451704805|FG004|Overall Study|Lost to Follow-up|0|||
125566566|NCT03357731|451704806|FG005|Overall Study|Lost to Follow-up|0|||
125566567|NCT01417195|451704807|FG000|Overall Study|Stimulation failure|1|||
125566568|NCT01417195|451704808|FG001|Overall Study|Stimulation failure|0|||
125566569|NCT01417195|451704807|FG000|Overall Study|No embryos for transfer|0|||
125566570|NCT01417195|451704808|FG001|Overall Study|No embryos for transfer|1|||
125566571|NCT01417195|451704807|FG000|Overall Study|No transfer due to risk of OHSS|1|||
125566572|NCT01417195|451704808|FG001|Overall Study|No transfer due to risk of OHSS|0|||
125566573|NCT01417195|451704807|FG000|Overall Study|No transfer due to elevated progesterone|1|||
125566574|NCT01417195|451704808|FG001|Overall Study|No transfer due to elevated progesterone|0|||
125566575|NCT01239342|451704809|FG000|Overall Study|Adverse Event|1|||
125566576|NCT01239342|451704810|FG001|Overall Study|Adverse Event|0|||
125566577|NCT01239342|451704809|FG000|Overall Study|Withdrawal by Subject|1|||
125566578|NCT01239342|451704810|FG001|Overall Study|Withdrawal by Subject|5|||
125566579|NCT01239342|451704809|FG000|Overall Study|Reason Unknown|1|||
125566580|NCT01239342|451704810|FG001|Overall Study|Reason Unknown|1|||
125566581|NCT02918864|451704813|FG000|Overall Study|Withdrawal by Subject|1|||
125566582|NCT02918864|451704814|FG001|Overall Study|Withdrawal by Subject|1|||
125566583|NCT02918864|451704813|FG000|Overall Study|Lost to Follow-up|3|||
125566584|NCT02918864|451704814|FG001|Overall Study|Lost to Follow-up|2|||
125566585|NCT00573430|451704822|FG000|Overall Study|Incorrect enrollment of randomization|0|||
125566586|NCT00573430|451704823|FG001|Overall Study|Incorrect enrollment of randomization|4|||
125566587|NCT00573430|451704824|FG002|Overall Study|Incorrect enrollment of randomization|3|||
125566588|NCT00573430|451704822|FG000|Overall Study|Adverse Event|0|||
125566589|NCT00573430|451704823|FG001|Overall Study|Adverse Event|0|||
125566590|NCT00573430|451704824|FG002|Overall Study|Adverse Event|2|||
125566591|NCT00573430|451704822|FG000|Overall Study|Withdrawal by Subject|1|||
125566592|NCT00573430|451704823|FG001|Overall Study|Withdrawal by Subject|0|||
125566593|NCT00573430|451704824|FG002|Overall Study|Withdrawal by Subject|1|||
125566594|NCT00573430|451704822|FG000|Overall Study|Protocol Violation|0|||
125566595|NCT00573430|451704823|FG001|Overall Study|Protocol Violation|1|||
125566596|NCT00573430|451704824|FG002|Overall Study|Protocol Violation|1|||
125566597|NCT00573430|451704822|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125566598|NCT00573430|451704823|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125566599|NCT00573430|451704824|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
125566600|NCT03134599|451704827|FG000|Week 1|Lost to Follow-up|0|||
125566601|NCT03134599|451704828|FG001|Week 1|Lost to Follow-up|0|||
125566602|NCT03134599|451704829|FG002|Week 1|Lost to Follow-up|0|||
125566603|NCT03134599|451704830|FG003|Week 1|Lost to Follow-up|0|||
125566604|NCT03134599|451704831|FG004|Week 1|Lost to Follow-up|1|||
125566605|NCT03134599|451704832|FG005|Week 1|Lost to Follow-up|0|||
125566606|NCT03134599|451704827|FG000|Week 2|Lost to Follow-up|1|||
125566607|NCT03134599|451704828|FG001|Week 2|Lost to Follow-up|0|||
125566608|NCT03134599|451704829|FG002|Week 2|Lost to Follow-up|0|||
125566609|NCT03134599|451704830|FG003|Week 2|Lost to Follow-up|1|||
125566610|NCT03134599|451704831|FG004|Week 2|Lost to Follow-up|1|||
125566611|NCT03134599|451704832|FG005|Week 2|Lost to Follow-up|0|||
125566612|NCT03134599|451704827|FG000|Week 3|Lost to Follow-up|0|||
125566613|NCT03134599|451704828|FG001|Week 3|Lost to Follow-up|0|||
125566614|NCT03134599|451704829|FG002|Week 3|Lost to Follow-up|0|||
125566615|NCT03134599|451704830|FG003|Week 3|Lost to Follow-up|1|||
125566616|NCT03134599|451704831|FG004|Week 3|Lost to Follow-up|0|||
125566617|NCT03134599|451704832|FG005|Week 3|Lost to Follow-up|1|||
125566618|NCT04962022|451704833|FG000|Period 1|Withdrawal by Subject|1|||
125566619|NCT04962022|451704834|FG001|Period 1|Withdrawal by Subject|0|||
125566620|NCT01146873|451704838|FG000|Overall Study|Transfer out|0|||
125566621|NCT01146873|451704839|FG001|Overall Study|Transfer out|6|||
125566622|NCT01967628|451704840|FG000|Overall Study|Withdrawal by Subject|2|||
125566623|NCT01967628|451704841|FG001|Overall Study|Withdrawal by Subject|0|||
125566624|NCT01967628|451704840|FG000|Overall Study|Unable to complete bronchoscopy|4|||
125566625|NCT01967628|451704841|FG001|Overall Study|Unable to complete bronchoscopy|6|||
125566626|NCT01967628|451704840|FG000|Overall Study|Lost to Follow-up|1|||
125566627|NCT01967628|451704841|FG001|Overall Study|Lost to Follow-up|0|||
125566628|NCT01967628|451704840|FG000|Overall Study|Low protein concentration in sample|20|||
125566629|NCT01967628|451704841|FG001|Overall Study|Low protein concentration in sample|25|||
125566630|NCT01356407|451704842|FG000|Overall Study|Lost to Follow-up|2|||
125566631|NCT01356407|451704843|FG001|Overall Study|Lost to Follow-up|0|||
125566632|NCT01356407|451704842|FG000|Overall Study|Patient Withdrew Consent|2|||
125566633|NCT01356407|451704843|FG001|Overall Study|Patient Withdrew Consent|1|||
125566634|NCT01356407|451704842|FG000|Overall Study|Could not afford IMP administration|0|||
125566635|NCT01356407|451704843|FG001|Overall Study|Could not afford IMP administration|1|||
125566636|NCT01356407|451704842|FG000|Overall Study|Not complete Endoscopy|2|||
125566637|NCT01356407|451704843|FG001|Overall Study|Not complete Endoscopy|2|||
125566638|NCT02055820|451704844|FG000|Phase I: Dose-Finding|Death|1|||
125566639|NCT02055820|451704845|FG001|Phase I: Dose-Finding|Death|0|||
125566640|NCT02055820|451704846|FG002|Phase I: Dose-Finding|Death|1|||
125566641|NCT02055820|451704847|FG003|Phase I: Dose-Finding|Death|2|||
125566642|NCT02055820|451704848|FG004|Phase I: Dose-Finding|Death|0|||
125566643|NCT02055820|451704849|FG005|Phase I: Dose-Finding|Death|1|||
125566644|NCT02055820|451704850|FG006|Phase I: Dose-Finding|Death|1|||
125566645|NCT02055820|451704851|FG007|Phase I: Dose-Finding|Death|0|||
125566646|NCT02055820|451704852|FG008|Phase I: Dose-Finding|Death|0|||
125566647|NCT02055820|451704853|FG009|Phase I: Dose-Finding|Death|0|||
125566648|NCT02055820|451704844|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125566649|NCT02055820|451704845|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125566650|NCT02055820|451704846|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125566651|NCT02055820|451704847|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125566652|NCT02055820|451704848|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125566653|NCT02055820|451704849|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
125566654|NCT02055820|451704850|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125566655|NCT02055820|451704851|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125566656|NCT02055820|451704852|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125566657|NCT02055820|451704853|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
125566658|NCT02055820|451704844|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
125566659|NCT02055820|451704845|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
125566660|NCT02055820|451704846|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
125566661|NCT02055820|451704847|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
125566662|NCT02055820|451704848|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
125566663|NCT02055820|451704849|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
125566664|NCT02055820|451704850|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
125566665|NCT02055820|451704851|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
125566666|NCT02055820|451704852|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
125566667|NCT02055820|451704853|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
125566668|NCT02055820|451704844|FG000|Phase II: Expansion|Death|0|||
125566669|NCT02055820|451704845|FG001|Phase II: Expansion|Death|0|||
125566670|NCT02055820|451704846|FG002|Phase II: Expansion|Death|0|||
125566671|NCT02055820|451704847|FG003|Phase II: Expansion|Death|0|||
125566672|NCT02055820|451704848|FG004|Phase II: Expansion|Death|33|||
125566673|NCT02055820|451704849|FG005|Phase II: Expansion|Death|0|||
125566674|NCT02055820|451704850|FG006|Phase II: Expansion|Death|0|||
125566675|NCT02055820|451704851|FG007|Phase II: Expansion|Death|0|||
125566676|NCT02055820|451704852|FG008|Phase II: Expansion|Death|0|||
125566677|NCT02055820|451704853|FG009|Phase II: Expansion|Death|0|||
125566678|NCT02055820|451704844|FG000|Phase II: Expansion|Lost to Follow-up|0|||
125566679|NCT02055820|451704845|FG001|Phase II: Expansion|Lost to Follow-up|0|||
125566680|NCT02055820|451704846|FG002|Phase II: Expansion|Lost to Follow-up|0|||
125566681|NCT02055820|451704847|FG003|Phase II: Expansion|Lost to Follow-up|0|||
125566682|NCT02055820|451704848|FG004|Phase II: Expansion|Lost to Follow-up|4|||
125566683|NCT02055820|451704849|FG005|Phase II: Expansion|Lost to Follow-up|0|||
125566684|NCT02055820|451704850|FG006|Phase II: Expansion|Lost to Follow-up|0|||
125566685|NCT02055820|451704851|FG007|Phase II: Expansion|Lost to Follow-up|0|||
125566686|NCT02055820|451704852|FG008|Phase II: Expansion|Lost to Follow-up|0|||
125566687|NCT02055820|451704853|FG009|Phase II: Expansion|Lost to Follow-up|0|||
125566688|NCT02055820|451704844|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
125566689|NCT02055820|451704845|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
125566690|NCT02055820|451704846|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
125566691|NCT02055820|451704847|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
125566692|NCT02055820|451704848|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
125566693|NCT02055820|451704849|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
125566694|NCT02055820|451704850|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
125566695|NCT02055820|451704851|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
125566696|NCT02055820|451704852|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
125566697|NCT02055820|451704853|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
125566698|NCT01389752|451704856|FG000|Study Period 1|Sponsor decision|0|||
125566699|NCT01389752|451704857|FG001|Study Period 1|Sponsor decision|2|||
125566700|NCT01389752|451704856|FG000|Study Period 2|Sponsor decision|1|||
125566701|NCT01389752|451704857|FG001|Study Period 2|Sponsor decision|0|||
125566702|NCT01157364|451704862|FG000|Overall Study|Other Reasons|1|||
125566703|NCT01157364|451704863|FG001|Overall Study|Other Reasons|1|||
125566704|NCT01157364|451704864|FG002|Overall Study|Other Reasons|2|||
125566705|NCT01157364|451704865|FG003|Overall Study|Other Reasons|1|||
125566706|NCT01157364|451704866|FG004|Overall Study|Other Reasons|0|||
125566707|NCT01157364|451704867|FG005|Overall Study|Other Reasons|0|||
125566708|NCT01157364|451704862|FG000|Overall Study|Personal Reasons|0|||
125566709|NCT01157364|451704863|FG001|Overall Study|Personal Reasons|2|||
125566710|NCT01157364|451704864|FG002|Overall Study|Personal Reasons|0|||
125566711|NCT01157364|451704865|FG003|Overall Study|Personal Reasons|0|||
125566712|NCT01157364|451704866|FG004|Overall Study|Personal Reasons|1|||
125566713|NCT01157364|451704867|FG005|Overall Study|Personal Reasons|1|||
125566714|NCT01157364|451704862|FG000|Overall Study|Lost to Follow-up|1|||
125566715|NCT01157364|451704863|FG001|Overall Study|Lost to Follow-up|0|||
125566716|NCT01157364|451704864|FG002|Overall Study|Lost to Follow-up|1|||
125566717|NCT01157364|451704865|FG003|Overall Study|Lost to Follow-up|0|||
125566718|NCT01157364|451704866|FG004|Overall Study|Lost to Follow-up|0|||
125566719|NCT01157364|451704867|FG005|Overall Study|Lost to Follow-up|0|||
125566720|NCT01157364|451704862|FG000|Overall Study|Lack of Efficacy|0|||
125566721|NCT01157364|451704863|FG001|Overall Study|Lack of Efficacy|0|||
125566722|NCT01157364|451704864|FG002|Overall Study|Lack of Efficacy|0|||
125566723|NCT01157364|451704865|FG003|Overall Study|Lack of Efficacy|1|||
125566724|NCT01157364|451704866|FG004|Overall Study|Lack of Efficacy|0|||
125566725|NCT01157364|451704867|FG005|Overall Study|Lack of Efficacy|0|||
125566726|NCT01157364|451704862|FG000|Overall Study|Adverse Event|0|||
125566727|NCT01157364|451704863|FG001|Overall Study|Adverse Event|1|||
125566728|NCT01157364|451704864|FG002|Overall Study|Adverse Event|1|||
125566729|NCT01157364|451704865|FG003|Overall Study|Adverse Event|0|||
125566730|NCT01157364|451704866|FG004|Overall Study|Adverse Event|1|||
125566731|NCT01157364|451704867|FG005|Overall Study|Adverse Event|0|||
125566732|NCT04251910|451704881|FG000|Overall Study|Covid 19 lockdown|0|||
125566733|NCT04251910|451704882|FG001|Overall Study|Covid 19 lockdown|5|||
125566734|NCT04251910|451704883|FG002|Overall Study|Covid 19 lockdown|0|||
125566735|NCT04251910|451704884|FG003|Overall Study|Covid 19 lockdown|4|||
125566736|NCT04251910|451704885|FG004|Overall Study|Covid 19 lockdown|0|||
125566737|NCT04251910|451704886|FG005|Overall Study|Covid 19 lockdown|0|||
125566738|NCT04251910|451704881|FG000|Overall Study|Assisted living facility was closed|0|||
125566739|NCT04251910|451704882|FG001|Overall Study|Assisted living facility was closed|0|||
125566740|NCT04251910|451704883|FG002|Overall Study|Assisted living facility was closed|0|||
125566741|NCT04251910|451704884|FG003|Overall Study|Assisted living facility was closed|0|||
125566742|NCT04251910|451704885|FG004|Overall Study|Assisted living facility was closed|1|||
125566743|NCT04251910|451704886|FG005|Overall Study|Assisted living facility was closed|0|||
125566744|NCT00841568|451704889|FG000|Overall Study|Adverse Event|1|||
125566745|NCT00841568|451704889|FG000|Overall Study|Death|1|||
125566746|NCT00841568|451704889|FG000|Overall Study|Withdrawal by Subject|2|||
125566747|NCT00841568|451704889|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
125566748|NCT00133991|451704890|FG000|Overall Study|Death|4|||
125566749|NCT03002155|451704891|FG000|Overall Study|Lost to Follow-up|1|||
125566750|NCT03002155|451704892|FG001|Overall Study|Lost to Follow-up|2|||
125566751|NCT03002155|451704891|FG000|Overall Study|Withdrawal by Subject|1|||
125566752|NCT03002155|451704892|FG001|Overall Study|Withdrawal by Subject|0|||
125566753|NCT03002155|451704891|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
125566754|NCT03002155|451704892|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
125566755|NCT00978029|451704893|FG000|Overall Study|Adverse Event|1|||
125566756|NCT00978029|451704894|FG001|Overall Study|Adverse Event|2|||
125566757|NCT00978029|451704895|FG002|Overall Study|Adverse Event|5|||
125566758|NCT00978029|451704893|FG000|Overall Study|Withdrawal by Subject|0|||
125566759|NCT00978029|451704894|FG001|Overall Study|Withdrawal by Subject|0|||
125566760|NCT00978029|451704895|FG002|Overall Study|Withdrawal by Subject|1|||
125566761|NCT00978029|451704893|FG000|Overall Study|Protocol Violation|0|||
125566762|NCT00978029|451704894|FG001|Overall Study|Protocol Violation|1|||
125566763|NCT00978029|451704895|FG002|Overall Study|Protocol Violation|0|||
125566764|NCT01087775|451704896|FG000|Overall Study|failed inclusion criteria|2|||
125566765|NCT00825162|451704903|FG000|Overall Study|Withdrawal by Subject|11|||
125566766|NCT00825162|451704904|FG001|Overall Study|Withdrawal by Subject|13|||
125566767|NCT00825162|451704905|FG002|Overall Study|Withdrawal by Subject|3|||
125566768|NCT00825162|451704903|FG000|Overall Study|Lost to Follow-up|9|||
125566769|NCT00825162|451704904|FG001|Overall Study|Lost to Follow-up|6|||
125566770|NCT00825162|451704905|FG002|Overall Study|Lost to Follow-up|3|||
125566771|NCT00825162|451704903|FG000|Overall Study|Physician Decision|2|||
125566772|NCT00825162|451704904|FG001|Overall Study|Physician Decision|0|||
125566773|NCT00825162|451704905|FG002|Overall Study|Physician Decision|0|||
125566774|NCT00825162|451704903|FG000|Overall Study|Move away from the study area|1|||
125566775|NCT00825162|451704904|FG001|Overall Study|Move away from the study area|0|||
125566776|NCT00825162|451704905|FG002|Overall Study|Move away from the study area|0|||
125566777|NCT00825162|451704903|FG000|Overall Study|Unable to attend the study visit|5|||
125566778|NCT00825162|451704904|FG001|Overall Study|Unable to attend the study visit|2|||
125566779|NCT00825162|451704905|FG002|Overall Study|Unable to attend the study visit|0|||
125566780|NCT00964743|451704906|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
125566781|NCT00781911|451704907|FG000|Overall Study|Adverse Event|4|||
125566782|NCT00781911|451704908|FG001|Overall Study|Adverse Event|4|||
125566783|NCT00781911|451704907|FG000|Overall Study|Withdrawal by Subject|1|||
125566784|NCT00781911|451704908|FG001|Overall Study|Withdrawal by Subject|2|||
125566785|NCT00781911|451704907|FG000|Overall Study|Physician Decision|0|||
125566786|NCT00781911|451704908|FG001|Overall Study|Physician Decision|2|||
125566787|NCT00781911|451704907|FG000|Overall Study|Sponsor Decision|1|||
125566788|NCT00781911|451704908|FG001|Overall Study|Sponsor Decision|0|||
125566789|NCT03317795|451704909|FG000|Overall Study|IUD Expulsion|1|||
125566790|NCT03317795|451704910|FG001|Overall Study|IUD Expulsion|0|||
125566791|NCT03317795|451704909|FG000|Overall Study|Lost to Follow-up|1|||
125566792|NCT03317795|451704910|FG001|Overall Study|Lost to Follow-up|3|||
125566793|NCT03317795|451704909|FG000|Overall Study|Treatment change|0|||
125566794|NCT03317795|451704910|FG001|Overall Study|Treatment change|3|||
125566795|NCT03317795|451704909|FG000|Overall Study|Intolerance of medication|0|||
125566796|NCT03317795|451704910|FG001|Overall Study|Intolerance of medication|1|||
125566797|NCT01549002|451704915|FG000|Overall Study|Excessive pain|0|||
125566798|NCT01549002|451704916|FG001|Overall Study|Excessive pain|2|||
125566799|NCT01549002|451704915|FG000|Overall Study|Moderate sedation required|0|||
125566800|NCT01549002|451704916|FG001|Overall Study|Moderate sedation required|2|||
125566801|NCT02016820|451704923|FG000|Overall Study|Lost to Follow-up|2|||
125566802|NCT02016820|451704924|FG001|Overall Study|Lost to Follow-up|4|||
125566803|NCT02424253|451704925|FG000|Overall Study|Other, unspecified|1|||
125566804|NCT02424253|451704926|FG001|Overall Study|Other, unspecified|0|||
125566805|NCT02424253|451704925|FG000|Overall Study|Compliance problems|1|||
125566806|NCT02424253|451704926|FG001|Overall Study|Compliance problems|0|||
125566807|NCT02424253|451704925|FG000|Overall Study|Physician Decision|2|||
125566808|NCT02424253|451704926|FG001|Overall Study|Physician Decision|0|||
125566809|NCT02424253|451704925|FG000|Overall Study|Lack of Efficacy|0|||
125566810|NCT02424253|451704926|FG001|Overall Study|Lack of Efficacy|7|||
125566811|NCT02424253|451704925|FG000|Overall Study|Adverse Event|2|||
125566812|NCT02424253|451704926|FG001|Overall Study|Adverse Event|0|||
125566813|NCT02424253|451704925|FG000|Overall Study|Consent withdrawn by subject|4|||
125566814|NCT02424253|451704926|FG001|Overall Study|Consent withdrawn by subject|1|||
125566815|NCT02424253|451704925|FG000|Overall Study|Lost to Follow-up|1|||
125566816|NCT02424253|451704926|FG001|Overall Study|Lost to Follow-up|1|||
125566817|NCT04247061|451704927|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
125566818|NCT04247061|451704927|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
125566819|NCT04247061|451704927|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
125566820|NCT02290873|451704934|FG000|Overall Study|Withdrawal by Subject|0|||
125566821|NCT02290873|451704935|FG001|Overall Study|Withdrawal by Subject|1|||
125566822|NCT02290873|451704936|FG002|Overall Study|Withdrawal by Subject|1|||
125566823|NCT02290873|451704934|FG000|Overall Study|Nellcor device error|1|||
125566824|NCT02290873|451704935|FG001|Overall Study|Nellcor device error|0|||
125566825|NCT02290873|451704936|FG002|Overall Study|Nellcor device error|0|||
125566826|NCT02290873|451704934|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
125566827|NCT02290873|451704935|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
125566828|NCT02290873|451704936|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
125566829|NCT02290873|451704934|FG000|Overall Study|Protocol Violation|0|||
125566830|NCT02290873|451704935|FG001|Overall Study|Protocol Violation|0|||
125566831|NCT02290873|451704936|FG002|Overall Study|Protocol Violation|1|||
125566832|NCT01136655|451704937|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
125355578|NCT02477696|450936558|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
125355579|NCT02477696|450936557|FG000|Overall Study|Missing/Unknown|2|||
125355580|NCT02477696|450936558|FG001|Overall Study|Missing/Unknown|0|||
125355581|NCT05419908|450936560|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
125355582|NCT05419908|450936561|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
125355583|NCT05419908|450936560|FG000|Overall Study|Serious Adverse Event|0|||
125566833|NCT01136655|451704937|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
125355584|NCT05419908|450936561|FG001|Overall Study|Serious Adverse Event|2|||
125355585|NCT05419908|450936560|FG000|Overall Study|Withdrawal by Subject|2|||
125355586|NCT05419908|450936561|FG001|Overall Study|Withdrawal by Subject|0|||
125355587|NCT05419908|450936560|FG000|Overall Study|Miscellaneous|1|||
125566834|NCT01136655|451704937|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
125566835|NCT01136655|451704937|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
125566836|NCT01378104|451704941|FG000|Overall Study|Adverse Event|8|||
125566837|NCT01378104|451704942|FG001|Overall Study|Adverse Event|8|||
125566838|NCT01378104|451704941|FG000|Overall Study|Lack of Efficacy|7|||
125566839|NCT01378104|451704942|FG001|Overall Study|Lack of Efficacy|5|||
125566840|NCT01378104|451704941|FG000|Overall Study|Withdrawal by Subject|12|||
125566841|NCT01378104|451704942|FG001|Overall Study|Withdrawal by Subject|13|||
125566842|NCT02287623|451704943|FG000|Overall Study|Protocol Violation|0|||
125566843|NCT02287623|451704944|FG001|Overall Study|Protocol Violation|1|||
125566844|NCT02700997|451704945|FG000|Overall Study|Did not undergo CT imaging|1|||
125566845|NCT02700997|451704945|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
125566846|NCT01473563|451704946|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
125566847|NCT01519765|451704947|FG000|Overall Study|Adverse Event|0|||
125566848|NCT01519765|451704948|FG001|Overall Study|Adverse Event|1|||
125566849|NCT01519765|451704947|FG000|Overall Study|Lack of Efficacy|2|||
125566850|NCT01519765|451704948|FG001|Overall Study|Lack of Efficacy|0|||
125566851|NCT01519765|451704947|FG000|Overall Study|Protocol Violation|1|||
125566852|NCT01519765|451704948|FG001|Overall Study|Protocol Violation|0|||
125566853|NCT01519765|451704947|FG000|Overall Study|Withdrawal by Subject|0|||
125566854|NCT01519765|451704948|FG001|Overall Study|Withdrawal by Subject|1|||
125355588|NCT05419908|450936561|FG001|Overall Study|Miscellaneous|1|||
125355589|NCT02160782|450937904|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
125355590|NCT02160782|450937905|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
125355591|NCT02160782|450937906|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
125355592|NCT02160782|450937907|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
125355593|NCT02160782|450937908|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
125355594|NCT02160782|450937904|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
125355595|NCT02160782|450937905|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
125355596|NCT02160782|450937906|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
125355597|NCT02160782|450937907|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
125355598|NCT02160782|450937908|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
125355599|NCT02160782|450937904|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
125355600|NCT02160782|450937905|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
125355601|NCT02160782|450937906|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
125355602|NCT02160782|450937907|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
125355603|NCT02160782|450937908|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
125355604|NCT02160782|450937904|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
125566855|NCT03610724|451704949|FG000|Overall Study|Death|17|||
125566856|NCT03610724|451704949|FG000|Overall Study|Lost to Follow-up|1|||
125566857|NCT03610724|451704949|FG000|Overall Study|Physician Decision|1|||
125566858|NCT03610724|451704949|FG000|Overall Study|Died prior to infusion|1|||
125566859|NCT02354222|451704950|FG000|Overall Study|Adverse Event|0|||
125566860|NCT02354222|451704951|FG001|Overall Study|Adverse Event|3|||
125566861|NCT02354222|451704950|FG000|Overall Study|Physician Decision|1|||
125566862|NCT02354222|451704951|FG001|Overall Study|Physician Decision|1|||
125566863|NCT02354222|451704950|FG000|Overall Study|Pregnancy|1|||
125566864|NCT02354222|451704951|FG001|Overall Study|Pregnancy|0|||
125566865|NCT02354222|451704950|FG000|Overall Study|Withdrawal by Subject|2|||
125566866|NCT02354222|451704951|FG001|Overall Study|Withdrawal by Subject|3|||
125566867|NCT02354222|451704950|FG000|Overall Study|Conflict with the stopping criteria|0|||
125566868|NCT02354222|451704951|FG001|Overall Study|Conflict with the stopping criteria|4|||
125566869|NCT01342484|451704956|FG000|Overall Study|Other Reasons|1|||
125566870|NCT01342484|451704957|FG001|Overall Study|Other Reasons|0|||
125566871|NCT01342484|451704958|FG002|Overall Study|Other Reasons|0|||
125566872|NCT01342484|451704956|FG000|Overall Study|Protocol Violation|0|||
125566873|NCT01342484|451704957|FG001|Overall Study|Protocol Violation|0|||
125566874|NCT01342484|451704958|FG002|Overall Study|Protocol Violation|1|||
125566875|NCT01342484|451704956|FG000|Overall Study|Withdrawal by Subject|1|||
125566876|NCT01342484|451704957|FG001|Overall Study|Withdrawal by Subject|0|||
125566877|NCT01342484|451704958|FG002|Overall Study|Withdrawal by Subject|0|||
125566878|NCT01840579|451704959|FG000|Overall Study|Status not recorded|0|||
125566879|NCT01840579|451704960|FG001|Overall Study|Status not recorded|0|||
125566880|NCT01840579|451704961|FG002|Overall Study|Status not recorded|2|||
125566881|NCT01840579|451704962|FG003|Overall Study|Status not recorded|3|||
125566882|NCT01840579|451704963|FG004|Overall Study|Status not recorded|4|||
125566883|NCT01840579|451704964|FG005|Overall Study|Status not recorded|3|||
125566884|NCT01840579|451704965|FG006|Overall Study|Status not recorded|0|||
125566885|NCT01840579|451704966|FG007|Overall Study|Status not recorded|3|||
125566886|NCT01840579|451704967|FG008|Overall Study|Status not recorded|3|||
125566887|NCT01840579|451704968|FG009|Overall Study|Status not recorded|3|||
125566888|NCT01840579|451704959|FG000|Overall Study|Progressive disease|3|||
125566889|NCT01840579|451704960|FG001|Overall Study|Progressive disease|5|||
125566890|NCT01840579|451704961|FG002|Overall Study|Progressive disease|0|||
125566891|NCT01840579|451704962|FG003|Overall Study|Progressive disease|0|||
125566892|NCT01840579|451704963|FG004|Overall Study|Progressive disease|0|||
125566893|NCT01840579|451704964|FG005|Overall Study|Progressive disease|0|||
125566894|NCT01840579|451704965|FG006|Overall Study|Progressive disease|0|||
125566895|NCT01840579|451704966|FG007|Overall Study|Progressive disease|0|||
125566896|NCT01840579|451704967|FG008|Overall Study|Progressive disease|0|||
125566897|NCT01840579|451704968|FG009|Overall Study|Progressive disease|0|||
125566898|NCT01840579|451704959|FG000|Overall Study|Ongoing in study|0|||
125566899|NCT01840579|451704960|FG001|Overall Study|Ongoing in study|1|||
125566900|NCT01840579|451704961|FG002|Overall Study|Ongoing in study|0|||
125566901|NCT01840579|451704962|FG003|Overall Study|Ongoing in study|0|||
125566902|NCT01840579|451704963|FG004|Overall Study|Ongoing in study|0|||
125566903|NCT01840579|451704964|FG005|Overall Study|Ongoing in study|0|||
125566904|NCT01840579|451704965|FG006|Overall Study|Ongoing in study|0|||
125566905|NCT01840579|451704966|FG007|Overall Study|Ongoing in study|0|||
125566906|NCT01840579|451704967|FG008|Overall Study|Ongoing in study|0|||
125566907|NCT01840579|451704968|FG009|Overall Study|Ongoing in study|0|||
125566908|NCT01840579|451704959|FG000|Overall Study|Death|0|||
125566909|NCT01840579|451704960|FG001|Overall Study|Death|0|||
125566910|NCT01840579|451704961|FG002|Overall Study|Death|0|||
125566911|NCT01840579|451704962|FG003|Overall Study|Death|0|||
125426446|NCT00662857|451185911|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
125426447|NCT00662857|451185910|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
125426448|NCT00662857|451185911|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
125426449|NCT00662857|451185910|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
125426450|NCT00662857|451185911|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
125426451|NCT00989092|451185912|FG000|Overall Study|Physician Decision|9|||
125426452|NCT00989092|451185913|FG001|Overall Study|Physician Decision|6|||
125426453|NCT00989092|451185912|FG000|Overall Study|Adverse Event|20|||
125426454|NCT00989092|451185913|FG001|Overall Study|Adverse Event|1|||
125566912|NCT01840579|451704963|FG004|Overall Study|Death|0|||
125566913|NCT01840579|451704964|FG005|Overall Study|Death|1|||
125566914|NCT01840579|451704965|FG006|Overall Study|Death|0|||
125566915|NCT01840579|451704966|FG007|Overall Study|Death|0|||
125426455|NCT00989092|451185912|FG000|Overall Study|Chemotherapy initiated|12|||
125426456|NCT00989092|451185913|FG001|Overall Study|Chemotherapy initiated|4|||
125426457|NCT00989092|451185912|FG000|Overall Study|Withdrawal by Subject|17|||
125426458|NCT00989092|451185913|FG001|Overall Study|Withdrawal by Subject|9|||
125426459|NCT00989092|451185912|FG000|Overall Study|Death|14|||
125426460|NCT00989092|451185913|FG001|Overall Study|Death|2|||
125426461|NCT00989092|451185912|FG000|Overall Study|Ineligibility determined|3|||
125426462|NCT00989092|451185913|FG001|Overall Study|Ineligibility determined|3|||
125426463|NCT00989092|451185912|FG000|Overall Study|Lost to Follow-up|6|||
125426464|NCT00989092|451185913|FG001|Overall Study|Lost to Follow-up|2|||
125426465|NCT00989092|451185912|FG000|Overall Study|Other|3|||
125426466|NCT00989092|451185913|FG001|Overall Study|Other|1|||
125426467|NCT00989092|451185912|FG000|Overall Study|Protocol deviation|2|||
125426468|NCT00989092|451185913|FG001|Overall Study|Protocol deviation|0|||
125426469|NCT00989092|451185912|FG000|Overall Study|Erythropoietin therapy initiated|2|||
125426470|NCT00989092|451185913|FG001|Overall Study|Erythropoietin therapy initiated|0|||
125566916|NCT01840579|451704967|FG008|Overall Study|Death|0|||
125566917|NCT01840579|451704968|FG009|Overall Study|Death|0|||
125566918|NCT01840579|451704959|FG000|Overall Study|Adverse Event|0|||
125426471|NCT00989092|451185912|FG000|Overall Study|Did not receive study drug|2|||
125426472|NCT00989092|451185913|FG001|Overall Study|Did not receive study drug|0|||
125426473|NCT03040713|451185914|FG000|Overall Study|Positive amyloid scan|3|||
125426474|NCT04539821|451185915|FG000|Overall Study|Withdrawal by Subject|2|||
125426475|NCT04539821|451185915|FG000|Overall Study|continued care with their physician|20|||
125426476|NCT04539821|451185915|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
125426477|NCT02691182|451185916|FG000|Overall Study|Withdrawal by Subject|4|||
125426478|NCT02691182|451185917|FG001|Overall Study|Withdrawal by Subject|7|||
125426479|NCT02691182|451185918|FG002|Overall Study|Withdrawal by Subject|6|||
125426480|NCT02691182|451185919|FG003|Overall Study|Withdrawal by Subject|8|||
125426481|NCT02691182|451185916|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
125426482|NCT02691182|451185917|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
125426483|NCT02691182|451185918|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
125426484|NCT02691182|451185919|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
125426485|NCT02691182|451185916|FG000|Overall Study|Lost to Follow-up|8|||
125426486|NCT02691182|451185917|FG001|Overall Study|Lost to Follow-up|33|||
125426487|NCT02691182|451185918|FG002|Overall Study|Lost to Follow-up|19|||
125426488|NCT02691182|451185919|FG003|Overall Study|Lost to Follow-up|22|||
125426489|NCT02691182|451185916|FG000|Overall Study|Adverse Event|3|||
125426490|NCT02691182|451185917|FG001|Overall Study|Adverse Event|10|||
125426491|NCT02691182|451185918|FG002|Overall Study|Adverse Event|10|||
125426492|NCT02691182|451185919|FG003|Overall Study|Adverse Event|11|||
125426493|NCT02691182|451185916|FG000|Overall Study|Physician Decision|3|||
125426494|NCT02691182|451185917|FG001|Overall Study|Physician Decision|7|||
125426495|NCT02691182|451185918|FG002|Overall Study|Physician Decision|14|||
125426496|NCT02691182|451185919|FG003|Overall Study|Physician Decision|8|||
125426497|NCT02691182|451185916|FG000|Overall Study|Lack of Efficacy|0|||
125426498|NCT02691182|451185917|FG001|Overall Study|Lack of Efficacy|0|||
125426499|NCT02691182|451185918|FG002|Overall Study|Lack of Efficacy|0|||
125426500|NCT02691182|451185919|FG003|Overall Study|Lack of Efficacy|4|||
125426501|NCT02691182|451185916|FG000|Overall Study|Protocol Violation|2|||
125426502|NCT02691182|451185917|FG001|Overall Study|Protocol Violation|6|||
125426503|NCT02691182|451185918|FG002|Overall Study|Protocol Violation|6|||
125426504|NCT02691182|451185919|FG003|Overall Study|Protocol Violation|8|||
125426505|NCT02691182|451185916|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
125426506|NCT02691182|451185917|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
125426507|NCT02691182|451185918|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
125426508|NCT02691182|451185919|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
125355605|NCT02160782|450937905|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
125355606|NCT02160782|450937906|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
125355607|NCT02160782|450937907|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
125355608|NCT02160782|450937908|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
125355609|NCT02160782|450937904|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
125355610|NCT02160782|450937905|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
125355611|NCT02160782|450937906|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
125355612|NCT02160782|450937907|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
125355613|NCT02160782|450937908|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
125355614|NCT02160782|450937904|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
125355615|NCT02160782|450937905|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
125355616|NCT02160782|450937906|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
125355617|NCT02160782|450937907|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
125355618|NCT02160782|450937908|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
125355619|NCT02160782|450937904|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
125355620|NCT02160782|450937905|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
125355621|NCT02160782|450937906|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
125355622|NCT02160782|450937907|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
125355623|NCT02160782|450937908|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
125355624|NCT00401531|450937913|FG000|Overall Study|Adverse Event|2|||
125355625|NCT00401531|450937914|FG001|Overall Study|Adverse Event|0|||
125355626|NCT00401531|450937913|FG000|Overall Study|Protocol Violation|3|||
125355627|NCT00401531|450937914|FG001|Overall Study|Protocol Violation|7|||
125355628|NCT00401531|450937913|FG000|Overall Study|Lost to Follow-up|1|||
125355629|NCT00401531|450937914|FG001|Overall Study|Lost to Follow-up|1|||
125355630|NCT00401531|450937913|FG000|Overall Study|Withdrawal by Subject|3|||
125355631|NCT00401531|450937914|FG001|Overall Study|Withdrawal by Subject|2|||
125355632|NCT01801072|450937915|FG000|Overall Study|Lost to Follow-up|17|||
125355633|NCT01801072|450937916|FG001|Overall Study|Lost to Follow-up|14|||
125355634|NCT01801072|450937915|FG000|Overall Study|Physician Decision|2|||
125355635|NCT01801072|450937916|FG001|Overall Study|Physician Decision|3|||
125355636|NCT01801072|450937915|FG000|Overall Study|Withdrawal by Subject|1|||
125355637|NCT01801072|450937916|FG001|Overall Study|Withdrawal by Subject|0|||
125355638|NCT01801072|450937915|FG000|Overall Study|Protocol Violation|2|||
125355639|NCT01801072|450937916|FG001|Overall Study|Protocol Violation|0|||
125355640|NCT01801072|450937915|FG000|Overall Study|Death|7|||
125355641|NCT01801072|450937916|FG001|Overall Study|Death|8|||
125355642|NCT03906461|450937917|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
125355643|NCT03906461|450937917|FG000|Completed 12-month Follow-up|Missed Visit|6|||
125355644|NCT00510874|450937918|FG000|Overall Study|Withdrawal by Subject|1|||
125355645|NCT00510874|450937919|FG001|Overall Study|Withdrawal by Subject|1|||
125355646|NCT00510874|450937920|FG002|Overall Study|Withdrawal by Subject|0|||
125355647|NCT00510874|450937921|FG003|Overall Study|Withdrawal by Subject|0|||
125355648|NCT00510874|450937922|FG004|Overall Study|Withdrawal by Subject|3|||
125355649|NCT00510874|450937923|FG005|Overall Study|Withdrawal by Subject|0|||
125355650|NCT00510874|450937924|FG006|Overall Study|Withdrawal by Subject|0|||
125355651|NCT00510874|450937918|FG000|Overall Study|Lost to Follow-up|2|||
125355652|NCT00510874|450937919|FG001|Overall Study|Lost to Follow-up|3|||
125355653|NCT00510874|450937920|FG002|Overall Study|Lost to Follow-up|1|||
125355654|NCT00510874|450937921|FG003|Overall Study|Lost to Follow-up|3|||
125355655|NCT00510874|450937922|FG004|Overall Study|Lost to Follow-up|4|||
125355656|NCT00510874|450937923|FG005|Overall Study|Lost to Follow-up|0|||
125355657|NCT00510874|450937924|FG006|Overall Study|Lost to Follow-up|1|||
125355658|NCT02423109|450937927|FG000|Lens 1|Adverse Event|1|||
125355659|NCT02423109|450937928|FG001|Lens 1|Adverse Event|0|||
125355660|NCT03956056|450937929|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
125355661|NCT03956056|450937929|FG000|Overall Study|Lack of Efficacy|1|||
125355662|NCT00085709|450937930|FG000|Overall Study|Adverse Event|8|||
125210782|NCT02134353|450395685|FG001|Overall Study|Lost to Follow-up|1|||
125355663|NCT00085709|450937931|FG001|Overall Study|Adverse Event|0|||
125355664|NCT00085709|450937930|FG000|Overall Study|Death|8|||
125355665|NCT00085709|450937931|FG001|Overall Study|Death|2|||
125426509|NCT02691182|451185916|FG000|Overall Study|Missing|0|||
125355666|NCT00085709|450937930|FG000|Overall Study|Refusal unrelated to adverse events|1|||
125355667|NCT00085709|450937931|FG001|Overall Study|Refusal unrelated to adverse events|2|||
125355668|NCT00085709|450937930|FG000|Overall Study|Progression|3|||
125355669|NCT00085709|450937931|FG001|Overall Study|Progression|4|||
125355670|NCT00085709|450937930|FG000|Overall Study|Not protocol specified|12|||
125355671|NCT00085709|450937931|FG001|Overall Study|Not protocol specified|22|||
125566919|NCT01840579|451704960|FG001|Overall Study|Adverse Event|1|||
125566920|NCT01840579|451704961|FG002|Overall Study|Adverse Event|0|||
125566921|NCT01840579|451704962|FG003|Overall Study|Adverse Event|0|||
125426510|NCT02691182|451185917|FG001|Overall Study|Missing|5|||
125566922|NCT01840579|451704963|FG004|Overall Study|Adverse Event|0|||
125426511|NCT02691182|451185918|FG002|Overall Study|Missing|1|||
125566923|NCT01840579|451704964|FG005|Overall Study|Adverse Event|0|||
125566924|NCT01840579|451704965|FG006|Overall Study|Adverse Event|0|||
125355672|NCT00085709|450937930|FG000|Overall Study|Not eligible|19|||
125355673|NCT00085709|450937931|FG001|Overall Study|Not eligible|19|||
125355674|NCT00085709|450937930|FG000|Overall Study|Withdrawal by Subject|2|||
125355675|NCT00085709|450937931|FG001|Overall Study|Withdrawal by Subject|1|||
125355676|NCT00293215|450937932|FG000|Overall Study|Progressive disease|3|||
125355677|NCT00293215|450937933|FG001|Overall Study|Progressive disease|1|||
125355678|NCT00293215|450937932|FG000|Overall Study|Adverse Event|2|||
125355679|NCT00293215|450937933|FG001|Overall Study|Adverse Event|2|||
125355680|NCT01229371|450937936|FG000|Overall Study|Withdrawal by Subject|0|||
125355681|NCT01229371|450937937|FG001|Overall Study|Withdrawal by Subject|1|||
125355682|NCT01229371|450937938|FG002|Overall Study|Withdrawal by Subject|0|||
125355683|NCT01229371|450937939|FG003|Overall Study|Withdrawal by Subject|0|||
125355684|NCT04622735|450937940|FG000|Overall Study|Lost to Follow-up|1|||
125355685|NCT04622735|450937941|FG001|Overall Study|Lost to Follow-up|2|||
125355686|NCT04622735|450937942|FG002|Overall Study|Lost to Follow-up|1|||
125355687|NCT04622735|450937940|FG000|Overall Study|Adverse Event|0|||
125355688|NCT04622735|450937941|FG001|Overall Study|Adverse Event|0|||
125355689|NCT04622735|450937942|FG002|Overall Study|Adverse Event|1|||
125355690|NCT04622735|450937940|FG000|Overall Study|Protocol Violation|1|||
125355691|NCT04622735|450937941|FG001|Overall Study|Protocol Violation|0|||
125566925|NCT01840579|451704966|FG007|Overall Study|Adverse Event|0|||
125566926|NCT01840579|451704967|FG008|Overall Study|Adverse Event|0|||
125566927|NCT01840579|451704968|FG009|Overall Study|Adverse Event|0|||
125566928|NCT01840579|451704959|FG000|Overall Study|Follow-up ended by Sponsor|0|||
125566929|NCT01840579|451704960|FG001|Overall Study|Follow-up ended by Sponsor|0|||
125566930|NCT01840579|451704961|FG002|Overall Study|Follow-up ended by Sponsor|0|||
125566931|NCT01840579|451704962|FG003|Overall Study|Follow-up ended by Sponsor|0|||
125566932|NCT01840579|451704963|FG004|Overall Study|Follow-up ended by Sponsor|0|||
125566933|NCT01840579|451704964|FG005|Overall Study|Follow-up ended by Sponsor|0|||
125566934|NCT01840579|451704965|FG006|Overall Study|Follow-up ended by Sponsor|2|||
125566935|NCT01840579|451704966|FG007|Overall Study|Follow-up ended by Sponsor|0|||
125566936|NCT01840579|451704967|FG008|Overall Study|Follow-up ended by Sponsor|0|||
125566937|NCT01840579|451704968|FG009|Overall Study|Follow-up ended by Sponsor|0|||
125566938|NCT00432042|451704969|FG000|Overall Study|Protocol Violation|2|||
125566939|NCT00432042|451704970|FG001|Overall Study|Protocol Violation|0|||
125566940|NCT00432042|451704971|FG002|Overall Study|Protocol Violation|0|||
125566941|NCT00432042|451704969|FG000|Overall Study|Withdrawal by Subject|0|||
125566942|NCT00432042|451704970|FG001|Overall Study|Withdrawal by Subject|0|||
125566943|NCT00432042|451704971|FG002|Overall Study|Withdrawal by Subject|2|||
125566944|NCT00432042|451704969|FG000|Overall Study|Lost to Follow-up|5|||
125566945|NCT00432042|451704970|FG001|Overall Study|Lost to Follow-up|1|||
125566946|NCT00432042|451704971|FG002|Overall Study|Lost to Follow-up|0|||
125566947|NCT01999465|451706158|FG000|Overall Study|Lost to Follow-up|0|||
125566948|NCT01999465|451706159|FG001|Overall Study|Lost to Follow-up|2|||
125566949|NCT01999465|451706158|FG000|Overall Study|Protocol Violation|0|||
125566950|NCT01999465|451706159|FG001|Overall Study|Protocol Violation|1|||
125566951|NCT01611974|451706164|FG000|Overall Study|Death|10|||
125566952|NCT01611974|451706165|FG001|Overall Study|Death|12|||
125566953|NCT01611974|451706166|FG002|Overall Study|Death|10|||
125566954|NCT01611974|451706164|FG000|Overall Study|Lost to Follow-up|0|||
125566955|NCT01611974|451706165|FG001|Overall Study|Lost to Follow-up|1|||
125566956|NCT01611974|451706166|FG002|Overall Study|Lost to Follow-up|0|||
125566957|NCT01611974|451706164|FG000|Overall Study|Physician Decision|5|||
125566958|NCT01611974|451706165|FG001|Overall Study|Physician Decision|1|||
125566959|NCT01611974|451706166|FG002|Overall Study|Physician Decision|2|||
125566960|NCT01611974|451706164|FG000|Overall Study|Withdrawal by Subject|0|||
125566961|NCT01611974|451706165|FG001|Overall Study|Withdrawal by Subject|1|||
125566962|NCT01611974|451706166|FG002|Overall Study|Withdrawal by Subject|4|||
125566963|NCT00916357|451706167|FG000|Period 1|Withdrawal by Subject|1|||
125566964|NCT00916357|451706168|FG001|Period 1|Withdrawal by Subject|0|||
125566965|NCT00916357|451706169|FG002|Period 1|Withdrawal by Subject|0|||
125566966|NCT00916357|451706170|FG003|Period 1|Withdrawal by Subject|0|||
125566967|NCT00916357|451706171|FG004|Period 1|Withdrawal by Subject|0|||
125566968|NCT00916357|451706172|FG005|Period 1|Withdrawal by Subject|0|||
125566969|NCT00916357|451706167|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
125566970|NCT00916357|451706168|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
125566971|NCT00916357|451706169|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
125566972|NCT00916357|451706170|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
125566973|NCT00916357|451706171|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
125566974|NCT00916357|451706172|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
125566975|NCT01773109|451706173|FG000|Overall Study|Symptomatic Progression|2|||
125566976|NCT01773109|451706173|FG000|Overall Study|Death|1|||
125566977|NCT04766021|451706177|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
125566978|NCT04766021|451706177|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
125566979|NCT00789529|451706178|FG000|Overall Study|Withdrawal by Subject|0|||
125566980|NCT00789529|451706179|FG001|Overall Study|Withdrawal by Subject|1|||
125426512|NCT02691182|451185919|FG003|Overall Study|Missing|5|||
125426513|NCT02563002|451185920|FG000|Overall Study|Death|72|||
125566981|NCT00789529|451706178|FG000|Overall Study|Other Reason|1|||
125566982|NCT00789529|451706179|FG001|Overall Study|Other Reason|0|||
125566983|NCT01230242|451706180|FG000|Overall Study|Physician Decision|2|||
125566984|NCT01230242|451706180|FG000|Overall Study|Withdrawal by Subject|1|||
125566985|NCT04329702|451706184|FG000|Overall Study|illness|3|||
125566986|NCT04329702|451706185|FG001|Overall Study|illness|4|||
125566987|NCT04329702|451706186|FG002|Overall Study|illness|0|||
125566988|NCT04329702|451706184|FG000|Overall Study|Lost to Follow-up|0|||
125566989|NCT04329702|451706185|FG001|Overall Study|Lost to Follow-up|0|||
125566990|NCT04329702|451706186|FG002|Overall Study|Lost to Follow-up|2|||
125566991|NCT04329702|451706184|FG000|Overall Study|Death|0|||
125566992|NCT04329702|451706185|FG001|Overall Study|Death|2|||
125566993|NCT04329702|451706186|FG002|Overall Study|Death|0|||
125566994|NCT01438489|451706187|FG000|Overall Study|Lost to Follow-up|4|||
125566995|NCT01438489|451706188|FG001|Overall Study|Lost to Follow-up|2|||
125566996|NCT01438489|451706189|FG002|Overall Study|Lost to Follow-up|2|||
125566997|NCT01438489|451706187|FG000|Overall Study|Withdrawal by Subject|11|||
125566998|NCT01438489|451706188|FG001|Overall Study|Withdrawal by Subject|3|||
125566999|NCT01438489|451706189|FG002|Overall Study|Withdrawal by Subject|8|||
125567000|NCT01438489|451706187|FG000|Overall Study|Death|0|||
125567001|NCT01438489|451706188|FG001|Overall Study|Death|0|||
125567002|NCT01438489|451706189|FG002|Overall Study|Death|1|||
125567003|NCT01438489|451706187|FG000|Overall Study|Sponsor decision|4|||
125567004|NCT01438489|451706188|FG001|Overall Study|Sponsor decision|1|||
125567005|NCT01438489|451706189|FG002|Overall Study|Sponsor decision|4|||
125567006|NCT01438489|451706187|FG000|Overall Study|Subject choice/Subject moved|2|||
125567007|NCT01438489|451706188|FG001|Overall Study|Subject choice/Subject moved|1|||
125567008|NCT01438489|451706189|FG002|Overall Study|Subject choice/Subject moved|1|||
125567009|NCT01438489|451706187|FG000|Overall Study|Investigator decision|0|||
125567010|NCT01438489|451706188|FG001|Overall Study|Investigator decision|1|||
125567011|NCT01438489|451706189|FG002|Overall Study|Investigator decision|0|||
125567012|NCT01438489|451706187|FG000|Overall Study|AE/SAEs|2|||
125567013|NCT01438489|451706188|FG001|Overall Study|AE/SAEs|1|||
125567014|NCT01438489|451706189|FG002|Overall Study|AE/SAEs|1|||
125567015|NCT01438489|451706187|FG000|Overall Study|Received prohibited medication|1|||
125567016|NCT01438489|451706188|FG001|Overall Study|Received prohibited medication|0|||
125567017|NCT01438489|451706189|FG002|Overall Study|Received prohibited medication|0|||
125567018|NCT01438489|451706187|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
125567019|NCT01438489|451706188|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
125567020|NCT01438489|451706189|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
125567021|NCT01438489|451706187|FG000|Overall Study|Inadequate venous access|0|||
125567022|NCT01438489|451706188|FG001|Overall Study|Inadequate venous access|2|||
125567023|NCT01438489|451706189|FG002|Overall Study|Inadequate venous access|0|||
125567024|NCT00766532|451706190|FG000|Overall Study|Protocol Violation|2|||
125567025|NCT02037295|451706195|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
125426514|NCT02563002|451185921|FG001|Overall Study|Death|87|||
125567026|NCT02037295|451706196|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
125567027|NCT02037295|451706197|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
125567028|NCT02037295|451706198|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
125426515|NCT02563002|451185920|FG000|Overall Study|Lost to Follow-up|5|||
125567029|NCT01140451|451706199|FG000|Overall Study|Withdrawal by Subject|26|||
125567030|NCT01140451|451706200|FG001|Overall Study|Withdrawal by Subject|33|||
125567031|NCT01140451|451706199|FG000|Overall Study|Adverse Event|2|||
125567032|NCT01140451|451706200|FG001|Overall Study|Adverse Event|6|||
125567033|NCT01140451|451706199|FG000|Overall Study|Physician Decision|5|||
125567034|NCT01140451|451706200|FG001|Overall Study|Physician Decision|3|||
125567035|NCT01140451|451706199|FG000|Overall Study|Lost to Follow-up|2|||
125567036|NCT01140451|451706200|FG001|Overall Study|Lost to Follow-up|0|||
125567037|NCT01140451|451706199|FG000|Overall Study|Participants Planning Pregnancy|3|||
125567038|NCT01140451|451706200|FG001|Overall Study|Participants Planning Pregnancy|0|||
125567039|NCT00960661|451706204|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
125567040|NCT00960661|451706205|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
125567041|NCT00960661|451706206|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
125567042|NCT00960661|451706204|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
125567043|NCT00960661|451706205|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
125567044|NCT00960661|451706206|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
125567045|NCT00960661|451706204|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
125567046|NCT00960661|451706205|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
125567047|NCT00960661|451706206|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
125567048|NCT00960661|451706204|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
125567049|NCT00960661|451706205|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
125567050|NCT00960661|451706206|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
125567051|NCT00960661|451706204|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
125567052|NCT00960661|451706205|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
125567053|NCT00960661|451706206|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
125567054|NCT00960661|451706204|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
125567055|NCT00960661|451706205|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
125567056|NCT00960661|451706206|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
125567057|NCT00960661|451706204|FG000|Interventional Phase|Adverse Event|0|||
125567058|NCT00960661|451706205|FG001|Interventional Phase|Adverse Event|17|||
125567059|NCT00960661|451706206|FG002|Interventional Phase|Adverse Event|8|||
125567060|NCT00960661|451706204|FG000|Interventional Phase|Death|0|||
125567061|NCT00960661|451706205|FG001|Interventional Phase|Death|1|||
125567062|NCT00960661|451706206|FG002|Interventional Phase|Death|0|||
125567063|NCT00960661|451706204|FG000|Interventional Phase|Lost to Follow-up|0|||
125567064|NCT00960661|451706205|FG001|Interventional Phase|Lost to Follow-up|0|||
125567065|NCT00960661|451706206|FG002|Interventional Phase|Lost to Follow-up|2|||
125567066|NCT00960661|451706204|FG000|Interventional Phase|entry criteria not met|0|||
125567067|NCT00960661|451706205|FG001|Interventional Phase|entry criteria not met|3|||
125567068|NCT00960661|451706206|FG002|Interventional Phase|entry criteria not met|0|||
125567069|NCT00960661|451706204|FG000|Interventional Phase|Protocol Violation|0|||
125567070|NCT00960661|451706205|FG001|Interventional Phase|Protocol Violation|7|||
125567071|NCT00960661|451706206|FG002|Interventional Phase|Protocol Violation|2|||
125567072|NCT00960661|451706204|FG000|Interventional Phase|Withdrawal by Subject|0|||
125567073|NCT00960661|451706205|FG001|Interventional Phase|Withdrawal by Subject|18|||
125567074|NCT00960661|451706206|FG002|Interventional Phase|Withdrawal by Subject|29|||
125567075|NCT00960661|451706204|FG000|Interventional Phase|Physician Decision|0|||
125567076|NCT00960661|451706205|FG001|Interventional Phase|Physician Decision|3|||
125567077|NCT00960661|451706206|FG002|Interventional Phase|Physician Decision|5|||
125567078|NCT00960661|451706204|FG000|Interventional Phase|sponsor decision|0|||
125567079|NCT00960661|451706205|FG001|Interventional Phase|sponsor decision|1|||
125567080|NCT00960661|451706206|FG002|Interventional Phase|sponsor decision|0|||
125567081|NCT00960661|451706204|FG000|Interventional Phase|Lack of Efficacy|0|||
125567082|NCT00960661|451706205|FG001|Interventional Phase|Lack of Efficacy|2|||
125567083|NCT00960661|451706206|FG002|Interventional Phase|Lack of Efficacy|0|||
125567084|NCT02699892|451706207|FG000|Overall Study|Other|36|||
125567085|NCT01324232|451706214|FG000|Overall Study|Protocol Violation|0|||
125567086|NCT01324232|451706215|FG001|Overall Study|Protocol Violation|0|||
125567087|NCT01324232|451706216|FG002|Overall Study|Protocol Violation|0|||
125567088|NCT01324232|451706217|FG003|Overall Study|Protocol Violation|2|||
125567089|NCT01324232|451706214|FG000|Overall Study|Missing|0|||
125567090|NCT01324232|451706215|FG001|Overall Study|Missing|0|||
125567091|NCT01324232|451706216|FG002|Overall Study|Missing|1|||
125567092|NCT01324232|451706217|FG003|Overall Study|Missing|0|||
125567093|NCT01324232|451706214|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
125567094|NCT01324232|451706215|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
125567095|NCT01324232|451706216|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
125567096|NCT01324232|451706217|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
125567097|NCT01324232|451706214|FG000|Overall Study|Lack of Efficacy|2|||
125567098|NCT01324232|451706215|FG001|Overall Study|Lack of Efficacy|1|||
125567099|NCT01324232|451706216|FG002|Overall Study|Lack of Efficacy|2|||
125567100|NCT01324232|451706217|FG003|Overall Study|Lack of Efficacy|2|||
125567101|NCT01324232|451706214|FG000|Overall Study|Participant Refused Medication|0|||
125567102|NCT01324232|451706215|FG001|Overall Study|Participant Refused Medication|1|||
125567103|NCT01324232|451706216|FG002|Overall Study|Participant Refused Medication|0|||
125567104|NCT01324232|451706217|FG003|Overall Study|Participant Refused Medication|0|||
125567105|NCT01324232|451706214|FG000|Overall Study|Intercurrent illness|0|||
125567106|NCT01324232|451706215|FG001|Overall Study|Intercurrent illness|0|||
125567107|NCT01324232|451706216|FG002|Overall Study|Intercurrent illness|0|||
125567108|NCT01324232|451706217|FG003|Overall Study|Intercurrent illness|1|||
125567109|NCT01324232|451706214|FG000|Overall Study|Adverse Event|2|||
125567110|NCT01324232|451706215|FG001|Overall Study|Adverse Event|5|||
125567111|NCT01324232|451706216|FG002|Overall Study|Adverse Event|6|||
125355692|NCT04622735|450937942|FG002|Overall Study|Protocol Violation|0|||
125355693|NCT05314478|450937943|FG000|Overall Study|Physician Decision|1|||
125355694|NCT02923427|450937944|FG000|Overall Study|convert to laparatomy|2|||
125567112|NCT01324232|451706217|FG003|Overall Study|Adverse Event|6|||
125567113|NCT01324232|451706214|FG000|Overall Study|Withdrawal by Subject|0|||
125567114|NCT01324232|451706215|FG001|Overall Study|Withdrawal by Subject|3|||
125567115|NCT01324232|451706216|FG002|Overall Study|Withdrawal by Subject|4|||
125567116|NCT01324232|451706217|FG003|Overall Study|Withdrawal by Subject|0|||
125567117|NCT01324232|451706214|FG000|Overall Study|Lost to Follow-up|1|||
125567118|NCT01324232|451706215|FG001|Overall Study|Lost to Follow-up|0|||
125567119|NCT01324232|451706216|FG002|Overall Study|Lost to Follow-up|0|||
125567120|NCT01324232|451706217|FG003|Overall Study|Lost to Follow-up|0|||
125567121|NCT00661531|451706218|FG000|Overall Study|Withdrawal by Subject|3|||
125567122|NCT02614859|451706221|FG000|Overall Study|Physician Decision|0|||
125567123|NCT02614859|451706222|FG001|Overall Study|Physician Decision|1|||
125567124|NCT02184195|451706223|FG000|Overall Study|Patient decision|5|||
125567125|NCT02184195|451706224|FG001|Overall Study|Patient decision|2|||
125567126|NCT02184195|451706223|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125567127|NCT02184195|451706224|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125567128|NCT02184195|451706223|FG000|Overall Study|Death|67|||
125567129|NCT02184195|451706224|FG001|Overall Study|Death|44|||
125567130|NCT02184195|451706223|FG000|Overall Study|Lost to Follow-up|1|||
125567131|NCT02184195|451706224|FG001|Overall Study|Lost to Follow-up|5|||
125567132|NCT02184195|451706223|FG000|Overall Study|Other|0|||
125567133|NCT02184195|451706224|FG001|Overall Study|Other|3|||
125567134|NCT00939783|451706228|FG000|Overall Study|Death|6|||
125567135|NCT00939783|451706228|FG000|Overall Study|Adverse Event|39|||
125426516|NCT02563002|451185921|FG001|Overall Study|Lost to Follow-up|0|||
125426517|NCT02563002|451185920|FG000|Overall Study|Physician Decision|0|||
125426518|NCT02563002|451185921|FG001|Overall Study|Physician Decision|2|||
125426519|NCT02563002|451185920|FG000|Overall Study|Withdrawal by Subject|2|||
125567136|NCT00939783|451706228|FG000|Overall Study|Study Terminated by Sponsor|498|||
125567137|NCT00939783|451706228|FG000|Overall Study|Withdrawal by Subject|78|||
125567138|NCT00939783|451706228|FG000|Overall Study|Other|16|||
125567139|NCT00939783|451706228|FG000|Overall Study|Lost to Follow-up|8|||
125567140|NCT00939783|451706228|FG000|Overall Study|Protocol Violation|3|||
125567141|NCT00939783|451706228|FG000|Overall Study|Enrolled but not treated|1|||
125567142|NCT02255409|451706230|FG000|Overall Study|Administrative Reason|3|||
125567143|NCT02255409|451706231|FG001|Overall Study|Administrative Reason|7|||
125567144|NCT02255409|451706230|FG000|Overall Study|Withdrawal by Subject|1|||
125567145|NCT02255409|451706231|FG001|Overall Study|Withdrawal by Subject|5|||
125567146|NCT02255409|451706230|FG000|Overall Study|Lost to Follow-up|10|||
125567147|NCT02255409|451706231|FG001|Overall Study|Lost to Follow-up|19|||
125567148|NCT01251367|451706232|FG000|Overall Study|Protocol Violation|1|||
125567149|NCT01251367|451706232|FG000|Overall Study|Lack of Efficacy|2|||
125567150|NCT01251367|451706232|FG000|Overall Study|Adverse Event|19|||
125567151|NCT01251367|451706232|FG000|Overall Study|Withdrawal by Subject|36|||
125567152|NCT01251367|451706232|FG000|Overall Study|Lost to Follow-up|5|||
125567153|NCT01251367|451706232|FG000|Overall Study|Subject Required Alternative Treatment|7|||
125567154|NCT01251367|451706232|FG000|Overall Study|No Study Drug Available|1|||
125567155|NCT01251367|451706232|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
125567156|NCT01251367|451706232|FG000|Overall Study|End of Study Visit Performed in Error|1|||
125567157|NCT01227044|451706233|FG000|Overall Study|Lost to Follow-up|5|||
125567158|NCT01227044|451706234|FG001|Overall Study|Lost to Follow-up|7|||
125567159|NCT01227044|451706233|FG000|Overall Study|Discontinued Intervention|1|||
125567160|NCT01227044|451706234|FG001|Overall Study|Discontinued Intervention|2|||
125567161|NCT00583362|451706235|FG000|Overall Study|Adverse Event|44|||
125567162|NCT00583362|451706235|FG000|Overall Study|Lack of Efficacy|22|||
125567163|NCT00583362|451706235|FG000|Overall Study|Lost to Follow-up|4|||
125567164|NCT00583362|451706235|FG000|Overall Study|Non-compliance with study drug|28|||
125567165|NCT00583362|451706235|FG000|Overall Study|Pregnancy|7|||
125567166|NCT00583362|451706235|FG000|Overall Study|Miscommunication of visit window|5|||
125567167|NCT00583362|451706235|FG000|Overall Study|Current site closed|7|||
125567168|NCT00583362|451706235|FG000|Overall Study|Subject not dosed in LBSL99|1|||
125567169|NCT00583362|451706235|FG000|Overall Study|Subject moved out of the country/state|2|||
125567170|NCT00583362|451706235|FG000|Overall Study|Missed visits due to staff changes|1|||
125567171|NCT00583362|451706235|FG000|Overall Study|Misunderstanding of protocol|1|||
125567172|NCT00583362|451706235|FG000|Overall Study|Behavioral problems and non-compliance|1|||
125567173|NCT00583362|451706235|FG000|Overall Study|Sponsor request due to missed doses|1|||
125567174|NCT00583362|451706235|FG000|Overall Study|Physician Decision|19|||
125567175|NCT00583362|451706235|FG000|Overall Study|Protocol Violation|2|||
125567176|NCT00583362|451706235|FG000|Overall Study|Withdrawal by Subject|57|||
125567177|NCT00473343|451706236|FG000|Overall Study|Adverse Event|9|||
125567178|NCT00473343|451706236|FG000|Overall Study|Lost to Follow-up|8|||
125567179|NCT00473343|451706236|FG000|Overall Study|Treatment failure|27|||
125567180|NCT00473343|451706236|FG000|Overall Study|Withdrew consent|3|||
125567181|NCT00473343|451706236|FG000|Overall Study|Other un-specified reason|3|||
125567182|NCT02370615|451706237|FG000|Overall Study|Adverse Event|1|||
125567183|NCT02370615|451706238|FG001|Overall Study|Adverse Event|0|||
125567184|NCT00645593|451706239|FG000|Overall Study|Later found to be ineligible|1|||
125567185|NCT00645593|451706240|FG001|Overall Study|Later found to be ineligible|0|||
125567186|NCT01585272|451706241|FG000|Overall Study|Adverse Event|22|||
125567187|NCT01585272|451706241|FG000|Overall Study|Protocol Violation|7|||
125567188|NCT01585272|451706241|FG000|Overall Study|Withdrawal by Subject|10|||
125567189|NCT03765138|451706246|FG000|Overall Study|Lost to Follow-up|1|||
125567190|NCT02577146|451706247|FG000|Overall Study|Lost to Follow-up|8|||
125567191|NCT02577146|451706247|FG000|Overall Study|Physician Decision|3|||
125567192|NCT02577146|451706247|FG000|Overall Study|Screen Failure|17|||
125567193|NCT01970501|451706248|FG000|Overall Study|Discontinuation of study by sponsor|16|||
125567194|NCT01970501|451706249|FG001|Overall Study|Discontinuation of study by sponsor|14|||
125567195|NCT01970501|451706248|FG000|Overall Study|Withdrawal by Subject|6|||
125567196|NCT01970501|451706249|FG001|Overall Study|Withdrawal by Subject|7|||
125567197|NCT01970501|451706248|FG000|Overall Study|Adverse Event|2|||
125567198|NCT01970501|451706249|FG001|Overall Study|Adverse Event|4|||
125567199|NCT01970501|451706248|FG000|Overall Study|Death|1|||
125567200|NCT01970501|451706249|FG001|Overall Study|Death|3|||
125567201|NCT01970501|451706248|FG000|Overall Study|Physician Decision|2|||
125567202|NCT01970501|451706249|FG001|Overall Study|Physician Decision|0|||
125567203|NCT03803059|451706251|FG000|Overall Study|Protocol Violation|2|||
125567204|NCT03803059|451706251|FG000|Overall Study|Lost to Follow-up|1|||
125567205|NCT04013529|451706254|FG000|Overall Study|Withdrawal by Subject|1|||
125567206|NCT04013529|451706255|FG001|Overall Study|Withdrawal by Subject|1|||
125567207|NCT03116698|451706256|FG000|Overall Study|Adverse Event|1|||
125567208|NCT03116698|451706257|FG001|Overall Study|Adverse Event|1|||
125567209|NCT03116698|451706258|FG002|Overall Study|Adverse Event|1|||
125567210|NCT03116698|451706259|FG003|Overall Study|Adverse Event|0|||
125567211|NCT03116698|451706256|FG000|Overall Study|Withdrawal by Subject|1|||
125567212|NCT03116698|451706257|FG001|Overall Study|Withdrawal by Subject|4|||
125567213|NCT03116698|451706258|FG002|Overall Study|Withdrawal by Subject|5|||
125567214|NCT03116698|451706259|FG003|Overall Study|Withdrawal by Subject|2|||
125567215|NCT03116698|451706256|FG000|Overall Study|Lost to Follow-up|2|||
125567216|NCT03116698|451706257|FG001|Overall Study|Lost to Follow-up|0|||
125567217|NCT03116698|451706258|FG002|Overall Study|Lost to Follow-up|0|||
125567218|NCT03116698|451706259|FG003|Overall Study|Lost to Follow-up|0|||
125567219|NCT03116698|451706256|FG000|Overall Study|Physician Decision|1|||
125567220|NCT03116698|451706257|FG001|Overall Study|Physician Decision|1|||
125567221|NCT03116698|451706258|FG002|Overall Study|Physician Decision|0|||
125567222|NCT03116698|451706259|FG003|Overall Study|Physician Decision|0|||
125567223|NCT03116698|451706256|FG000|Overall Study|Protocol Violation|1|||
125567224|NCT03116698|451706257|FG001|Overall Study|Protocol Violation|0|||
125567225|NCT03116698|451706258|FG002|Overall Study|Protocol Violation|0|||
125567226|NCT03116698|451706259|FG003|Overall Study|Protocol Violation|0|||
125567227|NCT03116698|451706256|FG000|Overall Study|Death|0|||
125567228|NCT03116698|451706257|FG001|Overall Study|Death|0|||
125567229|NCT03116698|451706258|FG002|Overall Study|Death|2|||
125567230|NCT03116698|451706259|FG003|Overall Study|Death|0|||
125567231|NCT00788372|451706260|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
125567232|NCT00788372|451706260|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
125567233|NCT00788372|451706260|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
125567234|NCT00788372|451706260|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
125567235|NCT00788372|451706260|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
125567236|NCT00788372|451706260|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
125567237|NCT00788372|451706260|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
125567238|NCT02116777|451706263|FG000|Overall Study|Adverse Event|0|||
125567239|NCT02116777|451706264|FG001|Overall Study|Adverse Event|0|||
125567240|NCT02116777|451706265|FG002|Overall Study|Adverse Event|0|||
125567241|NCT02116777|451706266|FG003|Overall Study|Adverse Event|0|||
125567242|NCT02116777|451706267|FG004|Overall Study|Adverse Event|2|||
125567243|NCT02116777|451706268|FG005|Overall Study|Adverse Event|2|||
125567244|NCT02116777|451706269|FG006|Overall Study|Adverse Event|0|||
125567245|NCT02116777|451706263|FG000|Overall Study|Death|0|||
125567246|NCT02116777|451706264|FG001|Overall Study|Death|0|||
125567247|NCT02116777|451706265|FG002|Overall Study|Death|0|||
125567248|NCT02116777|451706266|FG003|Overall Study|Death|1|||
125567249|NCT02116777|451706267|FG004|Overall Study|Death|0|||
125567250|NCT02116777|451706268|FG005|Overall Study|Death|0|||
125567251|NCT02116777|451706269|FG006|Overall Study|Death|0|||
125567252|NCT02116777|451706263|FG000|Overall Study|Lack of Efficacy|3|||
125567253|NCT02116777|451706264|FG001|Overall Study|Lack of Efficacy|3|||
125567254|NCT02116777|451706265|FG002|Overall Study|Lack of Efficacy|3|||
125567255|NCT02116777|451706266|FG003|Overall Study|Lack of Efficacy|8|||
125567256|NCT02116777|451706267|FG004|Overall Study|Lack of Efficacy|4|||
125567257|NCT02116777|451706268|FG005|Overall Study|Lack of Efficacy|1|||
125567258|NCT02116777|451706269|FG006|Overall Study|Lack of Efficacy|9|||
125567259|NCT02116777|451706263|FG000|Overall Study|Physician Decision|0|||
125567260|NCT02116777|451706264|FG001|Overall Study|Physician Decision|0|||
125567261|NCT02116777|451706265|FG002|Overall Study|Physician Decision|0|||
125567262|NCT02116777|451706266|FG003|Overall Study|Physician Decision|2|||
125567263|NCT02116777|451706267|FG004|Overall Study|Physician Decision|0|||
125567264|NCT02116777|451706268|FG005|Overall Study|Physician Decision|0|||
125567265|NCT02116777|451706269|FG006|Overall Study|Physician Decision|0|||
125567266|NCT02116777|451706263|FG000|Overall Study|Protocol Violation|0|||
125567267|NCT02116777|451706264|FG001|Overall Study|Protocol Violation|0|||
125567268|NCT02116777|451706265|FG002|Overall Study|Protocol Violation|0|||
125567269|NCT02116777|451706266|FG003|Overall Study|Protocol Violation|1|||
125567270|NCT02116777|451706267|FG004|Overall Study|Protocol Violation|0|||
125567271|NCT02116777|451706268|FG005|Overall Study|Protocol Violation|0|||
125567272|NCT02116777|451706269|FG006|Overall Study|Protocol Violation|0|||
125567273|NCT02116777|451706263|FG000|Overall Study|Withdrawal by Subject|0|||
125567274|NCT02116777|451706264|FG001|Overall Study|Withdrawal by Subject|0|||
125567275|NCT02116777|451706265|FG002|Overall Study|Withdrawal by Subject|0|||
125567276|NCT02116777|451706266|FG003|Overall Study|Withdrawal by Subject|1|||
125567277|NCT02116777|451706267|FG004|Overall Study|Withdrawal by Subject|0|||
125567278|NCT02116777|451706268|FG005|Overall Study|Withdrawal by Subject|0|||
125567279|NCT02116777|451706269|FG006|Overall Study|Withdrawal by Subject|0|||
125567280|NCT00102960|451706271|FG000|Overall Study|Death|23|||
125567281|NCT00102960|451706272|FG001|Overall Study|Death|11|||
125567282|NCT00102960|451706273|FG002|Overall Study|Death|11|||
125567283|NCT00102960|451706271|FG000|Overall Study|Lost to Follow-up|6|||
125567284|NCT00102960|451706272|FG001|Overall Study|Lost to Follow-up|12|||
125567285|NCT00102960|451706273|FG002|Overall Study|Lost to Follow-up|16|||
125567286|NCT00102960|451706271|FG000|Overall Study|Withdrawal by Subject|1|||
125567287|NCT00102960|451706272|FG001|Overall Study|Withdrawal by Subject|0|||
125567288|NCT00102960|451706273|FG002|Overall Study|Withdrawal by Subject|1|||
125567289|NCT00980200|451707881|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
125567290|NCT00980200|451707882|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
125567291|NCT00980200|451707883|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
125567292|NCT00980200|451707884|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
125567293|NCT00980200|451707885|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
125567294|NCT00980200|451707881|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
125567295|NCT00980200|451707882|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
125567296|NCT00980200|451707883|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
125567297|NCT00980200|451707884|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
125567298|NCT00980200|451707885|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
125567299|NCT00457015|451707886|FG000|Overall Study|Left study site against medical advice|0|||
125567300|NCT00457015|451707887|FG001|Overall Study|Left study site against medical advice|1|||
125567301|NCT02257372|451707888|FG000|Overall Study|Adverse Event|3|||
125567302|NCT02257372|451707889|FG001|Overall Study|Adverse Event|7|||
125567303|NCT02257372|451707888|FG000|Overall Study|Lack of Efficacy|2|||
125567304|NCT02257372|451707889|FG001|Overall Study|Lack of Efficacy|1|||
125567305|NCT02257372|451707888|FG000|Overall Study|Protocol Violation|1|||
125567306|NCT02257372|451707889|FG001|Overall Study|Protocol Violation|1|||
125567307|NCT02257372|451707888|FG000|Overall Study|Lost to Follow-up|0|||
125567308|NCT02257372|451707889|FG001|Overall Study|Lost to Follow-up|1|||
125567309|NCT02257372|451707888|FG000|Overall Study|Withdrew consent|1|||
125567310|NCT02257372|451707889|FG001|Overall Study|Withdrew consent|0|||
125567311|NCT01849874|451707891|FG000|Overall Study|Death|89|||
125567312|NCT01849874|451707892|FG001|Overall Study|Death|42|||
125567313|NCT01849874|451707891|FG000|Overall Study|Withdrawal by Subject|17|||
125567314|NCT01849874|451707892|FG001|Overall Study|Withdrawal by Subject|16|||
125567315|NCT01849874|451707891|FG000|Overall Study|Lost to Follow-up|3|||
125567316|NCT01849874|451707892|FG001|Overall Study|Lost to Follow-up|2|||
125567317|NCT01849874|451707891|FG000|Overall Study|Study Termination By Sponsor|93|||
125567318|NCT01849874|451707892|FG001|Overall Study|Study Termination By Sponsor|48|||
125567319|NCT01849874|451707891|FG000|Overall Study|Completed as per protocol amendment 6|3|||
125567320|NCT01849874|451707892|FG001|Overall Study|Completed as per protocol amendment 6|0|||
125567321|NCT01849874|451707891|FG000|Overall Study|Physician Decision|7|||
125567322|NCT01849874|451707892|FG001|Overall Study|Physician Decision|1|||
125567323|NCT01849874|451707891|FG000|Overall Study|Other|16|||
125567324|NCT01849874|451707892|FG001|Overall Study|Other|4|||
125567325|NCT02104583|451707893|FG000|Overall Study|New ICD or CRT-D implanted|2|||
125567326|NCT02104583|451707894|FG001|Overall Study|New ICD or CRT-D implanted|0|||
125567327|NCT02104583|451707895|FG002|Overall Study|New ICD or CRT-D implanted|1|||
125567328|NCT02104583|451707896|FG003|Overall Study|New ICD or CRT-D implanted|0|||
125567329|NCT02104583|451707897|FG004|Overall Study|New ICD or CRT-D implanted|0|||
125355695|NCT02923427|450937945|FG001|Overall Study|convert to laparatomy|2|||
125355696|NCT02923427|450937944|FG000|Overall Study|destaturation|1|||
125355697|NCT02923427|450937945|FG001|Overall Study|destaturation|0|||
125355698|NCT02923427|450937944|FG000|Overall Study|can not replace LMA|1|||
125355699|NCT02923427|450937945|FG001|Overall Study|can not replace LMA|0|||
125355700|NCT01325623|450937946|FG000|Overall Study|Withdrawal by Subject|3|||
125355701|NCT01229397|450937947|FG000|Overall Study|Withdrawal by Subject|3|||
125355702|NCT01229397|450937948|FG001|Overall Study|Withdrawal by Subject|3|||
125355703|NCT01229397|450937947|FG000|Overall Study|Lost to Follow-up|7|||
125355704|NCT01229397|450937948|FG001|Overall Study|Lost to Follow-up|6|||
125355705|NCT01229397|450937947|FG000|Overall Study|Migrated/moved from study area|1|||
125355706|NCT01229397|450937948|FG001|Overall Study|Migrated/moved from study area|0|||
125355707|NCT02694523|450937949|FG000|Part A|Adverse Event|7|||
125355708|NCT02694523|450937950|FG001|Part A|Adverse Event|3|||
125355709|NCT02694523|450937951|FG002|Part A|Adverse Event|0|||
125355710|NCT02694523|450937952|FG003|Part A|Adverse Event|0|||
125355711|NCT02694523|450937953|FG004|Part A|Adverse Event|0|||
125355712|NCT02694523|450937954|FG005|Part A|Adverse Event|0|||
125355713|NCT02694523|450937955|FG006|Part A|Adverse Event|0|||
125355714|NCT02694523|450937949|FG000|Part A|Protocol Violation|1|||
125355715|NCT02694523|450937950|FG001|Part A|Protocol Violation|0|||
125355716|NCT02694523|450937951|FG002|Part A|Protocol Violation|0|||
125355717|NCT02694523|450937952|FG003|Part A|Protocol Violation|0|||
125355718|NCT02694523|450937953|FG004|Part A|Protocol Violation|0|||
125567330|NCT02104583|451707893|FG000|Overall Study|Death|2|||
125567331|NCT02104583|451707894|FG001|Overall Study|Death|1|||
125567332|NCT02104583|451707895|FG002|Overall Study|Death|3|||
125567333|NCT02104583|451707896|FG003|Overall Study|Death|3|||
125567334|NCT02104583|451707897|FG004|Overall Study|Death|5|||
125355719|NCT02694523|450937954|FG005|Part A|Protocol Violation|0|||
125355720|NCT02694523|450937955|FG006|Part A|Protocol Violation|0|||
125355721|NCT02694523|450937949|FG000|Part A|Lost to Follow-up|1|||
125355722|NCT02694523|450937950|FG001|Part A|Lost to Follow-up|2|||
125355723|NCT02694523|450937951|FG002|Part A|Lost to Follow-up|0|||
125355724|NCT02694523|450937952|FG003|Part A|Lost to Follow-up|0|||
125567335|NCT02104583|451707893|FG000|Overall Study|Subject required cardiac ablation|6|||
125355725|NCT02694523|450937953|FG004|Part A|Lost to Follow-up|0|||
125355726|NCT02694523|450937954|FG005|Part A|Lost to Follow-up|0|||
125355727|NCT02694523|450937955|FG006|Part A|Lost to Follow-up|0|||
125355728|NCT02694523|450937949|FG000|Part A|Withdrawal by Subject|3|||
125355729|NCT02694523|450937950|FG001|Part A|Withdrawal by Subject|1|||
125355730|NCT02694523|450937951|FG002|Part A|Withdrawal by Subject|0|||
125355731|NCT02694523|450937952|FG003|Part A|Withdrawal by Subject|0|||
125355732|NCT02694523|450937953|FG004|Part A|Withdrawal by Subject|0|||
125355733|NCT02694523|450937954|FG005|Part A|Withdrawal by Subject|0|||
125355734|NCT02694523|450937955|FG006|Part A|Withdrawal by Subject|0|||
125355735|NCT02694523|450937949|FG000|Part A|Other|1|||
125355736|NCT02694523|450937950|FG001|Part A|Other|1|||
125355737|NCT02694523|450937951|FG002|Part A|Other|0|||
125355738|NCT02694523|450937952|FG003|Part A|Other|0|||
125355739|NCT02694523|450937953|FG004|Part A|Other|0|||
125355740|NCT02694523|450937954|FG005|Part A|Other|0|||
125355741|NCT02694523|450937955|FG006|Part A|Other|0|||
125355742|NCT02694523|450937949|FG000|Part B|Adverse Event|0|||
125355743|NCT02694523|450937950|FG001|Part B|Adverse Event|0|||
125355744|NCT02694523|450937951|FG002|Part B|Adverse Event|7|||
125355745|NCT02694523|450937952|FG003|Part B|Adverse Event|1|||
125355746|NCT02694523|450937953|FG004|Part B|Adverse Event|1|||
125355747|NCT02694523|450937954|FG005|Part B|Adverse Event|2|||
125355748|NCT02694523|450937955|FG006|Part B|Adverse Event|0|||
125355749|NCT02694523|450937949|FG000|Part B|Protocol Violation|0|||
125355750|NCT02694523|450937950|FG001|Part B|Protocol Violation|0|||
125355751|NCT02694523|450937951|FG002|Part B|Protocol Violation|1|||
125355752|NCT02694523|450937952|FG003|Part B|Protocol Violation|0|||
125355753|NCT02694523|450937953|FG004|Part B|Protocol Violation|0|||
125355754|NCT02694523|450937954|FG005|Part B|Protocol Violation|0|||
125355755|NCT02694523|450937955|FG006|Part B|Protocol Violation|0|||
125355756|NCT02694523|450937949|FG000|Part B|Lost to Follow-up|0|||
125355757|NCT02694523|450937950|FG001|Part B|Lost to Follow-up|0|||
125355758|NCT02694523|450937951|FG002|Part B|Lost to Follow-up|2|||
125355759|NCT02694523|450937952|FG003|Part B|Lost to Follow-up|3|||
125355760|NCT02694523|450937953|FG004|Part B|Lost to Follow-up|2|||
125355761|NCT02694523|450937954|FG005|Part B|Lost to Follow-up|0|||
125355762|NCT02694523|450937955|FG006|Part B|Lost to Follow-up|1|||
125355763|NCT02694523|450937949|FG000|Part B|Withdrawal by Subject|0|||
125355764|NCT02694523|450937950|FG001|Part B|Withdrawal by Subject|0|||
125355765|NCT02694523|450937951|FG002|Part B|Withdrawal by Subject|9|||
125355766|NCT02694523|450937952|FG003|Part B|Withdrawal by Subject|0|||
125355767|NCT02694523|450937953|FG004|Part B|Withdrawal by Subject|1|||
125355768|NCT02694523|450937954|FG005|Part B|Withdrawal by Subject|3|||
125355769|NCT02694523|450937955|FG006|Part B|Withdrawal by Subject|0|||
125355770|NCT02694523|450937949|FG000|Part B|Other|0|||
125355771|NCT02694523|450937950|FG001|Part B|Other|0|||
125355772|NCT02694523|450937951|FG002|Part B|Other|1|||
125355773|NCT02694523|450937952|FG003|Part B|Other|0|||
125210783|NCT02134353|450395684|FG000|Overall Study|Lack of Efficacy|2|||
125355774|NCT02694523|450937953|FG004|Part B|Other|0|||
125355775|NCT02694523|450937954|FG005|Part B|Other|0|||
125355776|NCT02694523|450937955|FG006|Part B|Other|1|||
125355777|NCT05896748|450937956|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
125355778|NCT05896748|450937956|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
125355779|NCT05896748|450937956|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
125355780|NCT05896748|450937956|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
125355781|NCT05896748|450937956|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
125355782|NCT00764504|450937957|FG000|Overall Study|Death|12|||
125355783|NCT00764504|450937958|FG001|Overall Study|Death|6|||
125355784|NCT00764504|450937959|FG002|Overall Study|Death|13|||
125355785|NCT00764504|450937957|FG000|Overall Study|Revision of Device|12|||
125355786|NCT00764504|450937958|FG001|Overall Study|Revision of Device|23|||
125355787|NCT00764504|450937959|FG002|Overall Study|Revision of Device|14|||
125355788|NCT00764504|450937957|FG000|Overall Study|Physician Decision|1|||
125355789|NCT00764504|450937958|FG001|Overall Study|Physician Decision|0|||
125355790|NCT00764504|450937959|FG002|Overall Study|Physician Decision|0|||
125355791|NCT00764504|450937957|FG000|Overall Study|Withdrawal by Subject|1|||
125355792|NCT00764504|450937958|FG001|Overall Study|Withdrawal by Subject|7|||
125355793|NCT00764504|450937959|FG002|Overall Study|Withdrawal by Subject|4|||
125355794|NCT00764504|450937957|FG000|Overall Study|Lost to Follow-up|40|||
125355795|NCT00764504|450937958|FG001|Overall Study|Lost to Follow-up|34|||
125355796|NCT00764504|450937959|FG002|Overall Study|Lost to Follow-up|72|||
125355797|NCT01298193|450937960|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
125355798|NCT01298193|450937960|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
125355799|NCT01298193|450937960|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
125355800|NCT01298193|450937960|FG000|Efficacy Phase (Second Cycle)|Death|1|||
125355801|NCT04010539|450937961|FG000|Overall Study|Withdrawal by Subject|4|||
125355802|NCT04010539|450937962|FG001|Overall Study|Withdrawal by Subject|1|||
125355803|NCT04010539|450937961|FG000|Overall Study|Physician Decision|0|||
125355804|NCT04010539|450937962|FG001|Overall Study|Physician Decision|2|||
125355805|NCT04010539|450937961|FG000|Overall Study|Lost to Follow-up|10|||
125355806|NCT04010539|450937962|FG001|Overall Study|Lost to Follow-up|14|||
125355807|NCT04010539|450937961|FG000|Overall Study|Adverse Event|3|||
125355808|NCT04010539|450937962|FG001|Overall Study|Adverse Event|0|||
125355809|NCT04010539|450937961|FG000|Overall Study|Participant Did Not Receive IP|0|||
125355810|NCT04010539|450937962|FG001|Overall Study|Participant Did Not Receive IP|1|||
125355811|NCT04010539|450937961|FG000|Overall Study|Protocol Deviation|0|||
125355812|NCT04010539|450937962|FG001|Overall Study|Protocol Deviation|1|||
125355813|NCT04010539|450937961|FG000|Overall Study|Randomized in Error/ Mistake|2|||
125355814|NCT04010539|450937962|FG001|Overall Study|Randomized in Error/ Mistake|0|||
125355815|NCT04010539|450937961|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
125355816|NCT04010539|450937962|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
125355817|NCT00249288|450937963|FG000|Overall Study|Lost to Follow-up|3|||
125567336|NCT02104583|451707894|FG001|Overall Study|Subject required cardiac ablation|4|||
125567337|NCT02104583|451707895|FG002|Overall Study|Subject required cardiac ablation|4|||
125567338|NCT02104583|451707896|FG003|Overall Study|Subject required cardiac ablation|5|||
125567339|NCT02104583|451707897|FG004|Overall Study|Subject required cardiac ablation|4|||
125567340|NCT02104583|451707893|FG000|Overall Study|Subject required prohibited medication|0|||
125355818|NCT00249288|450937964|FG001|Overall Study|Lost to Follow-up|3|||
125355819|NCT00249288|450937963|FG000|Overall Study|Withdrawal by Subject|2|||
125355820|NCT00249288|450937964|FG001|Overall Study|Withdrawal by Subject|2|||
125355821|NCT03059446|450937965|FG000|Overall Study|Adverse Event|11|||
125355822|NCT03059446|450937965|FG000|Overall Study|Withdrawal of Consent|16|||
125355823|NCT03059446|450937965|FG000|Overall Study|Lost to Follow-up|3|||
125567341|NCT02104583|451707894|FG001|Overall Study|Subject required prohibited medication|1|||
125567342|NCT02104583|451707895|FG002|Overall Study|Subject required prohibited medication|1|||
125567343|NCT02104583|451707896|FG003|Overall Study|Subject required prohibited medication|0|||
125567344|NCT02104583|451707897|FG004|Overall Study|Subject required prohibited medication|1|||
125567345|NCT02104583|451707893|FG000|Overall Study|Withdrew Consent|3|||
125567346|NCT02104583|451707894|FG001|Overall Study|Withdrew Consent|2|||
125355824|NCT03059446|450937965|FG000|Overall Study|Protocol Violation|1|||
125355825|NCT03059446|450937965|FG000|Overall Study|Study Terminated by Sponsor|131|||
125355826|NCT03059446|450937965|FG000|Overall Study|Reason not Specified|5|||
125355827|NCT05298306|450937971|FG000|Overall Study|Physician Decision|0|||
125355828|NCT05298306|450937972|FG001|Overall Study|Physician Decision|0|||
125355829|NCT05298306|450937973|FG002|Overall Study|Physician Decision|0|||
125355830|NCT05298306|450937974|FG003|Overall Study|Physician Decision|1|||
125567347|NCT02104583|451707895|FG002|Overall Study|Withdrew Consent|0|||
125567348|NCT02104583|451707896|FG003|Overall Study|Withdrew Consent|2|||
125567349|NCT02104583|451707897|FG004|Overall Study|Withdrew Consent|1|||
125567350|NCT02104583|451707893|FG000|Overall Study|Investigator's Discretion|1|||
125567351|NCT02104583|451707894|FG001|Overall Study|Investigator's Discretion|0|||
125567352|NCT02104583|451707895|FG002|Overall Study|Investigator's Discretion|0|||
125567353|NCT02104583|451707896|FG003|Overall Study|Investigator's Discretion|0|||
125567354|NCT02104583|451707897|FG004|Overall Study|Investigator's Discretion|0|||
125567355|NCT02104583|451707893|FG000|Overall Study|Protocol Violation|0|||
125567356|NCT02104583|451707894|FG001|Overall Study|Protocol Violation|0|||
125567357|NCT02104583|451707895|FG002|Overall Study|Protocol Violation|1|||
125567358|NCT02104583|451707896|FG003|Overall Study|Protocol Violation|0|||
125567359|NCT02104583|451707897|FG004|Overall Study|Protocol Violation|0|||
125567360|NCT02104583|451707893|FG000|Overall Study|Adverse Event|3|||
125567361|NCT02104583|451707894|FG001|Overall Study|Adverse Event|3|||
125567362|NCT02104583|451707895|FG002|Overall Study|Adverse Event|6|||
125567363|NCT02104583|451707896|FG003|Overall Study|Adverse Event|6|||
125567364|NCT02104583|451707897|FG004|Overall Study|Adverse Event|1|||
125567365|NCT02104583|451707893|FG000|Overall Study|Lost to Follow-up|1|||
125567366|NCT02104583|451707894|FG001|Overall Study|Lost to Follow-up|0|||
125567367|NCT02104583|451707895|FG002|Overall Study|Lost to Follow-up|0|||
125567368|NCT02104583|451707896|FG003|Overall Study|Lost to Follow-up|0|||
125567369|NCT02104583|451707897|FG004|Overall Study|Lost to Follow-up|0|||
125567370|NCT02104583|451707893|FG000|Overall Study|Randomized but Never Treated|0|||
125567371|NCT02104583|451707894|FG001|Overall Study|Randomized but Never Treated|0|||
125567372|NCT02104583|451707895|FG002|Overall Study|Randomized but Never Treated|0|||
125567373|NCT02104583|451707896|FG003|Overall Study|Randomized but Never Treated|1|||
125567374|NCT02104583|451707897|FG004|Overall Study|Randomized but Never Treated|0|||
125567375|NCT02347098|451707898|FG000|Overall Study|Death|1|||
125567376|NCT02347098|451707899|FG001|Overall Study|Death|0|||
125567377|NCT02347098|451707898|FG000|Overall Study|Withdrawal by Subject|1|||
125567378|NCT02347098|451707899|FG001|Overall Study|Withdrawal by Subject|0|||
125567379|NCT02347098|451707898|FG000|Overall Study|Lost to Follow-up|2|||
125355831|NCT05298306|450937975|FG004|Overall Study|Physician Decision|0|||
125355832|NCT05298306|450937976|FG005|Overall Study|Physician Decision|0|||
125355833|NCT03538431|450937981|FG000|Overall Study|Physician Decision|0|||
125355834|NCT03538431|450937982|FG001|Overall Study|Physician Decision|1|||
125355835|NCT03538431|450937981|FG000|Overall Study|Withdrawal by Subject|1|||
125355836|NCT03538431|450937982|FG001|Overall Study|Withdrawal by Subject|0|||
125355837|NCT00620464|450937983|FG000|Overall Study|Adverse Event|15|||
125355838|NCT00620464|450937984|FG001|Overall Study|Adverse Event|17|||
125355839|NCT00620464|450937983|FG000|Overall Study|Lost to Follow-up|1|||
125567380|NCT02347098|451707899|FG001|Overall Study|Lost to Follow-up|2|||
125355840|NCT00620464|450937984|FG001|Overall Study|Lost to Follow-up|1|||
125355841|NCT00620464|450937983|FG000|Overall Study|Planning Pregnancy|1|||
125355842|NCT00620464|450937984|FG001|Overall Study|Planning Pregnancy|4|||
125355843|NCT00620464|450937983|FG000|Overall Study|Personal|2|||
125355844|NCT00620464|450937984|FG001|Overall Study|Personal|2|||
125355845|NCT00620464|450937983|FG000|Overall Study|Used prohibited medication|1|||
125355846|NCT00620464|450937984|FG001|Overall Study|Used prohibited medication|0|||
125355847|NCT00986479|450937987|FG000|Period 1|Improved mood|1|||
125355848|NCT00986479|450937988|FG001|Period 1|Improved mood|0|||
125355849|NCT00986479|450937987|FG000|Period 1|Administrative reasons|1|||
125355850|NCT00986479|450937988|FG001|Period 1|Administrative reasons|0|||
125355851|NCT00771316|450937993|FG000|Overall Study|Adverse Event|0|||
125355852|NCT00771316|450937994|FG001|Overall Study|Adverse Event|1|||
125355853|NCT00771316|450937993|FG000|Overall Study|Patient withdrew consent|1|||
125567381|NCT02347098|451707898|FG000|Overall Study|Refuse Follow-up Visit|1|||
125567382|NCT02347098|451707899|FG001|Overall Study|Refuse Follow-up Visit|5|||
125567383|NCT02347098|451707898|FG000|Overall Study|no visit due to illness|2|||
125567384|NCT02347098|451707899|FG001|Overall Study|no visit due to illness|1|||
125355854|NCT00771316|450937994|FG001|Overall Study|Patient withdrew consent|0|||
125355855|NCT00771316|450937993|FG000|Overall Study|Discontinued due to early termination|1|||
125355856|NCT00771316|450937994|FG001|Overall Study|Discontinued due to early termination|0|||
125355857|NCT02027376|450937995|FG000|Overall Study|Death|1|||
125567385|NCT02187172|451707900|FG000|Overall Study|Lost to Follow-up|1|||
125426520|NCT02563002|451185921|FG001|Overall Study|Withdrawal by Subject|10|||
125355858|NCT02027376|450937996|FG001|Overall Study|Death|0|||
125355859|NCT02027376|450937997|FG002|Overall Study|Death|0|||
125355860|NCT00880165|450938006|FG000|Overall Study|Withdrawal by Subject|27|||
125355861|NCT00880165|450938007|FG001|Overall Study|Withdrawal by Subject|23|||
125355862|NCT00880165|450938006|FG000|Overall Study|Not diagnosed with OSA|14|||
125355863|NCT00880165|450938007|FG001|Overall Study|Not diagnosed with OSA|8|||
125355864|NCT00880165|450938006|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
125355865|NCT00880165|450938007|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
125355866|NCT00880165|450938006|FG000|Overall Study|Lost to follow|9|||
125355867|NCT00880165|450938007|FG001|Overall Study|Lost to follow|15|||
125355868|NCT00667602|450938008|FG000|Overall Study|Withdrawal by Subject|4|||
125355869|NCT00667602|450938009|FG001|Overall Study|Withdrawal by Subject|9|||
125426521|NCT02563002|451185920|FG000|Overall Study|Sponsor decision|74|||
125426522|NCT02563002|451185921|FG001|Overall Study|Sponsor decision|55|||
125355870|NCT00667602|450938010|FG002|Overall Study|Withdrawal by Subject|10|||
125355871|NCT00667602|450938008|FG000|Overall Study|Lost to Follow-up|4|||
125355872|NCT00667602|450938009|FG001|Overall Study|Lost to Follow-up|5|||
125355873|NCT00667602|450938010|FG002|Overall Study|Lost to Follow-up|6|||
125355874|NCT00667602|450938008|FG000|Overall Study|Administrative reason|0|||
125355875|NCT00667602|450938009|FG001|Overall Study|Administrative reason|0|||
125355876|NCT00667602|450938010|FG002|Overall Study|Administrative reason|2|||
125355877|NCT00667602|450938008|FG000|Overall Study|Protocol Violation|0|||
125355878|NCT00667602|450938009|FG001|Overall Study|Protocol Violation|1|||
125355879|NCT00667602|450938010|FG002|Overall Study|Protocol Violation|0|||
125355880|NCT00973349|450938015|FG000|Overall Study|Adverse Event|0|||
125355881|NCT00973349|450938016|FG001|Overall Study|Adverse Event|0|||
125355882|NCT00973349|450938017|FG002|Overall Study|Adverse Event|0|||
125355883|NCT00973349|450938018|FG003|Overall Study|Adverse Event|0|||
125355884|NCT00973349|450938019|FG004|Overall Study|Adverse Event|1|||
125355885|NCT00973349|450938020|FG005|Overall Study|Adverse Event|0|||
125355886|NCT00973349|450938021|FG006|Overall Study|Adverse Event|0|||
125355887|NCT00973349|450938022|FG007|Overall Study|Adverse Event|0|||
125355888|NCT00973349|450938023|FG008|Overall Study|Adverse Event|1|||
125355889|NCT00973349|450938024|FG009|Overall Study|Adverse Event|0|||
125355890|NCT00973349|450938025|FG010|Overall Study|Adverse Event|0|||
125355891|NCT00973349|450938026|FG011|Overall Study|Adverse Event|0|||
125426523|NCT02054806|451185922|FG000|Overall Study|Sponsor Decision|31|||
125426524|NCT02054806|451185922|FG000|Overall Study|Withdrawal by Subject|43|||
125426525|NCT02054806|451185922|FG000|Overall Study|Protocol Violation|2|||
125426526|NCT02054806|451185922|FG000|Overall Study|Lost to Follow-up|10|||
125426527|NCT02054806|451185922|FG000|Overall Study|Death|391|||
125426528|NCT00645164|451185927|FG000|Overall Study|Lost to Follow-up|2|||
125426529|NCT00645164|451185927|FG000|Overall Study|Withdrawal by Subject|4|||
125426530|NCT00645164|451185927|FG000|Overall Study|Protocol Violation|1|||
125426531|NCT01362439|451185928|FG000|Overall Study|Adverse Event|1|||
125426532|NCT01362439|451185928|FG000|Overall Study|Lack of Efficacy|3|||
125355892|NCT00973349|450938027|FG012|Overall Study|Adverse Event|0|||
125355893|NCT00973349|450938028|FG013|Overall Study|Adverse Event|0|||
125355894|NCT00973349|450938029|FG014|Overall Study|Adverse Event|1|||
125426533|NCT01362439|451185928|FG000|Overall Study|Lost to Follow-up|2|||
125355895|NCT00973349|450938030|FG015|Overall Study|Adverse Event|0|||
125355896|NCT00973349|450938015|FG000|Overall Study|Withdrawal by Subject|1|||
125355897|NCT00973349|450938016|FG001|Overall Study|Withdrawal by Subject|2|||
125355898|NCT00973349|450938017|FG002|Overall Study|Withdrawal by Subject|2|||
125355899|NCT00973349|450938018|FG003|Overall Study|Withdrawal by Subject|3|||
125355900|NCT00973349|450938019|FG004|Overall Study|Withdrawal by Subject|2|||
125355901|NCT00973349|450938020|FG005|Overall Study|Withdrawal by Subject|0|||
125426534|NCT01362439|451185928|FG000|Overall Study|Study medication non-compliant|1|||
125426535|NCT01362439|451185928|FG000|Overall Study|Participant who withdrew consent|8|||
125355902|NCT00973349|450938021|FG006|Overall Study|Withdrawal by Subject|2|||
125355903|NCT00973349|450938022|FG007|Overall Study|Withdrawal by Subject|2|||
125355904|NCT00973349|450938023|FG008|Overall Study|Withdrawal by Subject|0|||
125355905|NCT00973349|450938024|FG009|Overall Study|Withdrawal by Subject|2|||
125355906|NCT00973349|450938025|FG010|Overall Study|Withdrawal by Subject|0|||
125355907|NCT00973349|450938026|FG011|Overall Study|Withdrawal by Subject|1|||
125355908|NCT00973349|450938027|FG012|Overall Study|Withdrawal by Subject|0|||
125355909|NCT00973349|450938028|FG013|Overall Study|Withdrawal by Subject|0|||
125355910|NCT00973349|450938029|FG014|Overall Study|Withdrawal by Subject|0|||
125355911|NCT00973349|450938030|FG015|Overall Study|Withdrawal by Subject|0|||
125355912|NCT00973349|450938015|FG000|Overall Study|Lost to Follow-up|3|||
125355913|NCT00973349|450938016|FG001|Overall Study|Lost to Follow-up|1|||
125567386|NCT02187172|451707901|FG001|Overall Study|Lost to Follow-up|2|||
125355914|NCT00973349|450938017|FG002|Overall Study|Lost to Follow-up|2|||
125567387|NCT02187172|451707900|FG000|Overall Study|Lack of Efficacy|1|||
125355915|NCT00973349|450938018|FG003|Overall Study|Lost to Follow-up|2|||
125355916|NCT00973349|450938019|FG004|Overall Study|Lost to Follow-up|1|||
125567388|NCT02187172|451707901|FG001|Overall Study|Lack of Efficacy|2|||
125355917|NCT00973349|450938020|FG005|Overall Study|Lost to Follow-up|3|||
125355918|NCT00973349|450938021|FG006|Overall Study|Lost to Follow-up|0|||
125355919|NCT00973349|450938022|FG007|Overall Study|Lost to Follow-up|1|||
125355920|NCT00973349|450938023|FG008|Overall Study|Lost to Follow-up|2|||
125355921|NCT00973349|450938024|FG009|Overall Study|Lost to Follow-up|1|||
125355922|NCT00973349|450938025|FG010|Overall Study|Lost to Follow-up|0|||
125355923|NCT00973349|450938026|FG011|Overall Study|Lost to Follow-up|1|||
125355924|NCT00973349|450938027|FG012|Overall Study|Lost to Follow-up|0|||
125355925|NCT00973349|450938028|FG013|Overall Study|Lost to Follow-up|0|||
125355926|NCT00973349|450938029|FG014|Overall Study|Lost to Follow-up|0|||
125355927|NCT00973349|450938030|FG015|Overall Study|Lost to Follow-up|1|||
125355928|NCT00973349|450938015|FG000|Overall Study|Inappropriate enrolment|0|||
125355929|NCT00973349|450938016|FG001|Overall Study|Inappropriate enrolment|0|||
125355930|NCT00973349|450938017|FG002|Overall Study|Inappropriate enrolment|1|||
125355931|NCT00973349|450938018|FG003|Overall Study|Inappropriate enrolment|0|||
125355932|NCT00973349|450938019|FG004|Overall Study|Inappropriate enrolment|0|||
125355933|NCT00973349|450938020|FG005|Overall Study|Inappropriate enrolment|0|||
125355934|NCT00973349|450938021|FG006|Overall Study|Inappropriate enrolment|0|||
125355935|NCT00973349|450938022|FG007|Overall Study|Inappropriate enrolment|0|||
125355936|NCT00973349|450938023|FG008|Overall Study|Inappropriate enrolment|0|||
125355937|NCT00973349|450938024|FG009|Overall Study|Inappropriate enrolment|2|||
125355938|NCT00973349|450938025|FG010|Overall Study|Inappropriate enrolment|0|||
125355939|NCT00973349|450938026|FG011|Overall Study|Inappropriate enrolment|0|||
125355940|NCT00973349|450938027|FG012|Overall Study|Inappropriate enrolment|1|||
125355941|NCT00973349|450938028|FG013|Overall Study|Inappropriate enrolment|0|||
125355942|NCT00973349|450938029|FG014|Overall Study|Inappropriate enrolment|1|||
125355943|NCT00973349|450938030|FG015|Overall Study|Inappropriate enrolment|1|||
125355944|NCT00973349|450938015|FG000|Overall Study|Protocol Violation|0|||
125355945|NCT00973349|450938016|FG001|Overall Study|Protocol Violation|0|||
125355946|NCT00973349|450938017|FG002|Overall Study|Protocol Violation|0|||
125355947|NCT00973349|450938018|FG003|Overall Study|Protocol Violation|0|||
125355948|NCT00973349|450938019|FG004|Overall Study|Protocol Violation|0|||
125355949|NCT00973349|450938020|FG005|Overall Study|Protocol Violation|0|||
125355950|NCT00973349|450938021|FG006|Overall Study|Protocol Violation|0|||
125355951|NCT00973349|450938022|FG007|Overall Study|Protocol Violation|0|||
125355952|NCT00973349|450938023|FG008|Overall Study|Protocol Violation|1|||
125355953|NCT00973349|450938024|FG009|Overall Study|Protocol Violation|0|||
125355954|NCT00973349|450938025|FG010|Overall Study|Protocol Violation|0|||
125355955|NCT00973349|450938026|FG011|Overall Study|Protocol Violation|0|||
125355956|NCT00973349|450938027|FG012|Overall Study|Protocol Violation|0|||
125355957|NCT00973349|450938028|FG013|Overall Study|Protocol Violation|0|||
125567389|NCT02187172|451707900|FG000|Overall Study|Adverse Event|0|||
125567390|NCT02187172|451707901|FG001|Overall Study|Adverse Event|1|||
125355958|NCT00973349|450938029|FG014|Overall Study|Protocol Violation|0|||
125355959|NCT00973349|450938030|FG015|Overall Study|Protocol Violation|0|||
125355960|NCT00973349|450938015|FG000|Overall Study|Unable to classify|0|||
125355961|NCT00973349|450938016|FG001|Overall Study|Unable to classify|0|||
125355962|NCT00973349|450938017|FG002|Overall Study|Unable to classify|0|||
125355963|NCT00973349|450938018|FG003|Overall Study|Unable to classify|0|||
125355964|NCT00973349|450938019|FG004|Overall Study|Unable to classify|1|||
125355965|NCT00973349|450938020|FG005|Overall Study|Unable to classify|1|||
125355966|NCT00973349|450938021|FG006|Overall Study|Unable to classify|0|||
125355967|NCT00973349|450938022|FG007|Overall Study|Unable to classify|0|||
125355968|NCT00973349|450938023|FG008|Overall Study|Unable to classify|0|||
125355969|NCT00973349|450938024|FG009|Overall Study|Unable to classify|1|||
125355970|NCT00973349|450938025|FG010|Overall Study|Unable to classify|0|||
125355971|NCT00973349|450938026|FG011|Overall Study|Unable to classify|0|||
125355972|NCT00973349|450938027|FG012|Overall Study|Unable to classify|0|||
125355973|NCT00973349|450938028|FG013|Overall Study|Unable to classify|0|||
125355974|NCT00973349|450938029|FG014|Overall Study|Unable to classify|0|||
125355975|NCT00973349|450938030|FG015|Overall Study|Unable to classify|0|||
125355976|NCT02301988|450938031|FG000|Overall Study|Withdrawal by Subject|2|||
125355977|NCT02301988|450938032|FG001|Overall Study|Withdrawal by Subject|1|||
125355978|NCT02301988|450938031|FG000|Overall Study|Physician Decision|2|||
125355979|NCT02301988|450938032|FG001|Overall Study|Physician Decision|2|||
125355980|NCT02301988|450938031|FG000|Overall Study|Unknown Reason|1|||
125355981|NCT02301988|450938032|FG001|Overall Study|Unknown Reason|3|||
125355982|NCT02301988|450938031|FG000|Overall Study|Lack of Efficacy|3|||
125355983|NCT02301988|450938032|FG001|Overall Study|Lack of Efficacy|2|||
125355984|NCT02301988|450938031|FG000|Overall Study|Death|1|||
125355985|NCT02301988|450938032|FG001|Overall Study|Death|0|||
125355986|NCT02301988|450938031|FG000|Overall Study|Adverse Event|1|||
125355987|NCT02301988|450938032|FG001|Overall Study|Adverse Event|1|||
125355988|NCT04755283|450938033|FG000|Overall Study|Withdrawal by Subject|14|||
125355989|NCT04755283|450938034|FG001|Overall Study|Withdrawal by Subject|3|||
125355990|NCT04755283|450938035|FG002|Overall Study|Withdrawal by Subject|6|||
125355991|NCT04755283|450938033|FG000|Overall Study|Lost to Follow-up|0|||
125355992|NCT04755283|450938034|FG001|Overall Study|Lost to Follow-up|0|||
125355993|NCT04755283|450938035|FG002|Overall Study|Lost to Follow-up|1|||
125355994|NCT04755283|450938033|FG000|Overall Study|Death|31|||
125355995|NCT04755283|450938034|FG001|Overall Study|Death|36|||
125355996|NCT04755283|450938035|FG002|Overall Study|Death|34|||
125355997|NCT02750943|450938036|FG000|Overall Study|Lost to Follow-up|1|||
125355998|NCT02750943|450938037|FG001|Overall Study|Lost to Follow-up|2|||
125355999|NCT02750943|450938036|FG000|Overall Study|Withdrawal by Subject|5|||
125356000|NCT02750943|450938037|FG001|Overall Study|Withdrawal by Subject|7|||
125356001|NCT00171054|450938038|FG000|Overall Study|Protocol Violation|1|||
125356002|NCT00171054|450938039|FG001|Overall Study|Protocol Violation|2|||
125356003|NCT00171054|450938038|FG000|Overall Study|Patient withdrew consent|1|||
125356004|NCT00171054|450938039|FG001|Overall Study|Patient withdrew consent|0|||
125356005|NCT00171054|450938038|FG000|Overall Study|Lost to Follow-up|0|||
125356006|NCT00171054|450938039|FG001|Overall Study|Lost to Follow-up|1|||
125356007|NCT00171054|450938038|FG000|Overall Study|Adverse Event|8|||
125356008|NCT00171054|450938039|FG001|Overall Study|Adverse Event|8|||
125356009|NCT00171054|450938038|FG000|Overall Study|Condition no longer required study drug|0|||
125356010|NCT00171054|450938039|FG001|Overall Study|Condition no longer required study drug|1|||
125356011|NCT05098938|450938040|FG000|Overall Study|Adverse Event|4|||
125356012|NCT05098938|450938041|FG001|Overall Study|Adverse Event|3|||
125356013|NCT05098938|450938040|FG000|Overall Study|inclusion/exclusion criteria change|11|||
125356014|NCT05098938|450938041|FG001|Overall Study|inclusion/exclusion criteria change|5|||
125356015|NCT05098938|450938040|FG000|Overall Study|lack of compliance|26|||
125356016|NCT05098938|450938041|FG001|Overall Study|lack of compliance|19|||
125356017|NCT05098938|450938040|FG000|Overall Study|Lost to Follow-up|37|||
125356018|NCT05098938|450938041|FG001|Overall Study|Lost to Follow-up|40|||
125356019|NCT05098938|450938040|FG000|Overall Study|Lost in treatment period|17|||
125356020|NCT05098938|450938041|FG001|Overall Study|Lost in treatment period|13|||
125567391|NCT02187172|451707900|FG000|Overall Study|Physician Decision|1|||
125567392|NCT02187172|451707901|FG001|Overall Study|Physician Decision|1|||
125356021|NCT05098938|450938040|FG000|Overall Study|Met an exclusion criterion|0|||
125356022|NCT05098938|450938041|FG001|Overall Study|Met an exclusion criterion|3|||
125356023|NCT05098938|450938040|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
125356024|NCT05098938|450938041|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
125356025|NCT05098938|450938040|FG000|Overall Study|Physician Decision|25|||
125356026|NCT05098938|450938041|FG001|Overall Study|Physician Decision|32|||
125356027|NCT05098938|450938040|FG000|Overall Study|Run in failure in treatment phase|1|||
125356028|NCT05098938|450938041|FG001|Overall Study|Run in failure in treatment phase|1|||
125356029|NCT05098938|450938040|FG000|Overall Study|Withdrawal by Subject|0|||
125356030|NCT05098938|450938041|FG001|Overall Study|Withdrawal by Subject|3|||
125356031|NCT05098938|450938040|FG000|Overall Study|Run-in Failure in early study|505|||
125356032|NCT05098938|450938041|FG001|Overall Study|Run-in Failure in early study|514|||
125356033|NCT05098938|450938040|FG000|Overall Study|IMP delivery missed|1|||
125356034|NCT05098938|450938041|FG001|Overall Study|IMP delivery missed|5|||
125356035|NCT05098938|450938040|FG000|Overall Study|6 months visit was missed|2|||
125356036|NCT05098938|450938041|FG001|Overall Study|6 months visit was missed|0|||
125567393|NCT02830880|451707909|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
125567394|NCT02830880|451707909|FG000|Overall Study|Death|1|||
125567395|NCT02830880|451707909|FG000|Overall Study|Physician Decision|1|||
125567396|NCT03551509|451707914|FG000|Overall Study|Lost to Follow-up|0|||
125567397|NCT03551509|451707915|FG001|Overall Study|Lost to Follow-up|1|||
125567398|NCT03551509|451707916|FG002|Overall Study|Lost to Follow-up|0|||
125567399|NCT01918007|451707921|FG000|Overall Study|Baseline oximetry not acceptable|11|||
125567400|NCT01918007|451707922|FG001|Overall Study|Baseline oximetry not acceptable|7|||
125356037|NCT05098938|450938040|FG000|Overall Study|fit for use was not completed within window|3|||
125356038|NCT05098938|450938041|FG001|Overall Study|fit for use was not completed within window|0|||
125356039|NCT05098938|450938040|FG000|Overall Study|V2 visit was not completed within window|0|||
125356040|NCT05098938|450938041|FG001|Overall Study|V2 visit was not completed within window|1|||
125356041|NCT05098938|450938040|FG000|Overall Study|exclusionary medication use|1|||
125356042|NCT05098938|450938041|FG001|Overall Study|exclusionary medication use|2|||
125356043|NCT05098938|450938040|FG000|Overall Study|change in medication|1|||
125356044|NCT05098938|450938041|FG001|Overall Study|change in medication|0|||
125356045|NCT05098938|450938040|FG000|Overall Study|treatment failure|2|||
125356046|NCT05098938|450938041|FG001|Overall Study|treatment failure|1|||
125356047|NCT01828320|450938042|FG000|Overall Study|Lost to Follow-up|1|||
125356048|NCT01828320|450938043|FG001|Overall Study|Lost to Follow-up|3|||
125356049|NCT01828320|450938042|FG000|Overall Study|Withdrawal by Subject|7|||
125356050|NCT01828320|450938043|FG001|Overall Study|Withdrawal by Subject|2|||
125356051|NCT01104701|450939102|FG000|Overall Study|Withdrawal by Subject|0|||
125356052|NCT01104701|450939103|FG001|Overall Study|Withdrawal by Subject|1|||
125567401|NCT01918007|451707921|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
125567402|NCT01918007|451707922|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
125567403|NCT01918007|451707921|FG000|Overall Study|Lost to Follow-up|4|||
125567404|NCT01918007|451707922|FG001|Overall Study|Lost to Follow-up|7|||
125567405|NCT01732796|451707923|FG000|Overall Study|Adverse Event|16|||
125567406|NCT01732796|451707924|FG001|Overall Study|Adverse Event|16|||
125356053|NCT01104701|450939104|FG002|Overall Study|Withdrawal by Subject|2|||
125356054|NCT01104701|450939105|FG003|Overall Study|Withdrawal by Subject|1|||
125567407|NCT01732796|451707925|FG002|Overall Study|Adverse Event|4|||
125567408|NCT01732796|451707923|FG000|Overall Study|Lack of Efficacy|21|||
125567409|NCT01732796|451707924|FG001|Overall Study|Lack of Efficacy|18|||
125567410|NCT01732796|451707925|FG002|Overall Study|Lack of Efficacy|5|||
125567411|NCT01732796|451707923|FG000|Overall Study|Lost to Follow-up|2|||
125567412|NCT01732796|451707924|FG001|Overall Study|Lost to Follow-up|0|||
125567413|NCT01732796|451707925|FG002|Overall Study|Lost to Follow-up|0|||
125567414|NCT01732796|451707923|FG000|Overall Study|Withdrawal by Subject|6|||
125567415|NCT01732796|451707924|FG001|Overall Study|Withdrawal by Subject|8|||
125567416|NCT01732796|451707925|FG002|Overall Study|Withdrawal by Subject|2|||
125567417|NCT01732796|451707923|FG000|Overall Study|Other reason not defined above|1|||
125567418|NCT01732796|451707924|FG001|Overall Study|Other reason not defined above|0|||
125567419|NCT01732796|451707925|FG002|Overall Study|Other reason not defined above|2|||
125356055|NCT01104701|450939102|FG000|Overall Study|Adverse Event|0|||
125356056|NCT01104701|450939103|FG001|Overall Study|Adverse Event|0|||
125356057|NCT01104701|450939104|FG002|Overall Study|Adverse Event|0|||
125356058|NCT01104701|450939105|FG003|Overall Study|Adverse Event|1|||
125356059|NCT01104701|450939102|FG000|Overall Study|Physician Decision|0|||
125356060|NCT01104701|450939103|FG001|Overall Study|Physician Decision|2|||
125567420|NCT00530270|451707929|FG000|Overall Study|Protocol Violation|1|||
125567421|NCT00530270|451707930|FG001|Overall Study|Protocol Violation|0|||
125567422|NCT01399788|451707935|FG000|First Intervention Period|Adverse Event|1|||
125567423|NCT01399788|451707936|FG001|First Intervention Period|Adverse Event|0|||
125567424|NCT02919436|451707938|FG000|Overall Study|Did not undergo surgery|16|||
125567425|NCT02919436|451707939|FG001|Overall Study|Did not undergo surgery|20|||
125567426|NCT02919436|451707938|FG000|Overall Study|Enrolled before trial registration|44|||
125356061|NCT01104701|450939104|FG002|Overall Study|Physician Decision|0|||
125356062|NCT01104701|450939105|FG003|Overall Study|Physician Decision|0|||
125356063|NCT03437512|450939106|FG000|Randomized|Withdrawal by Subject|0|||
125356064|NCT03437512|450939107|FG001|Randomized|Withdrawal by Subject|2|||
125356065|NCT03437512|450939106|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
125356066|NCT03437512|450939107|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
125356067|NCT00674973|450939108|FG000|Overall Study|Insufficient Therapeutic Response|77|||
125356068|NCT00674973|450939109|FG001|Overall Study|Insufficient Therapeutic Response|72|||
125356069|NCT00674973|450939108|FG000|Overall Study|Refused Treatment|1|||
125356070|NCT00674973|450939109|FG001|Overall Study|Refused Treatment|5|||
125567427|NCT02919436|451707939|FG001|Overall Study|Enrolled before trial registration|33|||
125567428|NCT03699007|451707940|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
125567429|NCT03699007|451707941|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
125567430|NCT03699007|451707940|FG000|6-month Follow Up|Lost to Follow-up|2|||
125567431|NCT03699007|451707941|FG001|6-month Follow Up|Lost to Follow-up|3|||
125567432|NCT04718974|451707944|FG000|Overall Study|Death|0|||
125567433|NCT04718974|451707945|FG001|Overall Study|Death|2|||
125567434|NCT04718974|451707944|FG000|Overall Study|Lost to Follow-up|10|||
125567435|NCT04718974|451707945|FG001|Overall Study|Lost to Follow-up|20|||
125567436|NCT04718974|451707944|FG000|Overall Study|Transferred out|2|||
125356071|NCT00674973|450939108|FG000|Overall Study|Failure to Return|1|||
125356072|NCT00674973|450939109|FG001|Overall Study|Failure to Return|0|||
125356073|NCT00674973|450939108|FG000|Overall Study|Adverse Event|2|||
125356074|NCT00674973|450939109|FG001|Overall Study|Adverse Event|9|||
125356075|NCT00674973|450939108|FG000|Overall Study|Death|19|||
125356076|NCT00674973|450939109|FG001|Overall Study|Death|15|||
125426536|NCT01281644|451185930|FG000|Overall Study|Lost to Follow-up|3|||
125426537|NCT01281644|451185930|FG000|Overall Study|Withdrawal by Subject|2|||
125426538|NCT01755702|451185931|FG000|Wash Out Period I|Other Reason|3|||
125426539|NCT01755702|451185931|FG000|Washout Period II|Other Reason|5|||
125426540|NCT00691938|451185932|FG000|Overall Study|QTc prolongation|1|||
125426541|NCT00691938|451185933|FG001|Overall Study|QTc prolongation|0|||
125426542|NCT00691938|451185934|FG002|Overall Study|QTc prolongation|0|||
125426543|NCT00691938|451185935|FG003|Overall Study|QTc prolongation|0|||
125426544|NCT00691938|451185936|FG004|Overall Study|QTc prolongation|0|||
125426545|NCT00691938|451185937|FG005|Overall Study|QTc prolongation|0|||
125426546|NCT00691938|451185938|FG006|Overall Study|QTc prolongation|0|||
125426547|NCT04860518|451185939|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
125426548|NCT04860518|451185940|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
125426549|NCT01844284|451185942|FG000|Overall Study|Lost to Follow-up|12|||
125426550|NCT01844284|451185943|FG001|Overall Study|Lost to Follow-up|7|||
125567437|NCT04718974|451707945|FG001|Overall Study|Transferred out|4|||
125567438|NCT03259074|451707946|FG000|Overall Study|Adverse Event|9|||
125567439|NCT03259074|451707947|FG001|Overall Study|Adverse Event|12|||
125567440|NCT03259074|451707948|FG002|Overall Study|Adverse Event|8|||
125356077|NCT00674973|450939108|FG000|Overall Study|Protocol Violation|0|||
125356078|NCT00674973|450939109|FG001|Overall Study|Protocol Violation|1|||
125356079|NCT01002482|450939112|FG000|Overall Study|Withdrawal by Subject|14|||
125356080|NCT01002482|450939113|FG001|Overall Study|Withdrawal by Subject|21|||
125356081|NCT01002482|450939112|FG000|Overall Study|Included twice|1|||
125356082|NCT01002482|450939113|FG001|Overall Study|Included twice|0|||
125356083|NCT05108922|450939117|FG000|Overall Study|Adverse Event|2|||
125426551|NCT00611858|451185944|FG000|Overall Study|Adverse Event|2|||
125426552|NCT00611858|451185944|FG000|Overall Study|Withdrawal by Subject|2|||
125567441|NCT03259074|451707946|FG000|Overall Study|Death|1|||
125426553|NCT02755597|451185945|FG000|Overall Study|Withdrew consent|27|||
125426554|NCT02755597|451185946|FG001|Overall Study|Withdrew consent|11|||
125567442|NCT03259074|451707947|FG001|Overall Study|Death|1|||
125567443|NCT03259074|451707948|FG002|Overall Study|Death|3|||
125567444|NCT03259074|451707946|FG000|Overall Study|Lost to Follow-up|2|||
125567445|NCT03259074|451707947|FG001|Overall Study|Lost to Follow-up|4|||
125567446|NCT03259074|451707948|FG002|Overall Study|Lost to Follow-up|3|||
125567447|NCT03259074|451707946|FG000|Overall Study|New Therapy For Study Indication|1|||
125567448|NCT03259074|451707947|FG001|Overall Study|New Therapy For Study Indication|2|||
125567449|NCT03259074|451707948|FG002|Overall Study|New Therapy For Study Indication|2|||
125567450|NCT03259074|451707946|FG000|Overall Study|Physician Decision|4|||
125567451|NCT03259074|451707947|FG001|Overall Study|Physician Decision|12|||
125426555|NCT02755597|451185945|FG000|Overall Study|Lost to Follow-up|1|||
125426556|NCT02755597|451185946|FG001|Overall Study|Lost to Follow-up|0|||
125567452|NCT03259074|451707948|FG002|Overall Study|Physician Decision|10|||
125567453|NCT03259074|451707946|FG000|Overall Study|Pregnancy|1|||
125567454|NCT03259074|451707947|FG001|Overall Study|Pregnancy|1|||
125426557|NCT02755597|451185945|FG000|Overall Study|Death|78|||
125426558|NCT02755597|451185946|FG001|Overall Study|Death|36|||
125426559|NCT02755597|451185945|FG000|Overall Study|Study terminated by Sponsor|67|||
125426560|NCT02755597|451185946|FG001|Overall Study|Study terminated by Sponsor|47|||
125356084|NCT05108922|450939118|FG001|Overall Study|Adverse Event|3|||
125356085|NCT05108922|450939117|FG000|Overall Study|Lost to Follow-up|2|||
125356086|NCT05108922|450939118|FG001|Overall Study|Lost to Follow-up|1|||
125356087|NCT05108922|450939117|FG000|Overall Study|Inadvertent enrollment|0|||
125356088|NCT05108922|450939118|FG001|Overall Study|Inadvertent enrollment|1|||
125356089|NCT05108922|450939117|FG000|Overall Study|Physician Decision|2|||
125356090|NCT05108922|450939118|FG001|Overall Study|Physician Decision|3|||
125356091|NCT05108922|450939117|FG000|Overall Study|Protocol deviation|1|||
125356092|NCT05108922|450939118|FG001|Overall Study|Protocol deviation|0|||
125356093|NCT05108922|450939117|FG000|Overall Study|Screen failure|1|||
125356094|NCT05108922|450939118|FG001|Overall Study|Screen failure|0|||
125356095|NCT05108922|450939117|FG000|Overall Study|Withdrawal by Subject|11|||
125356096|NCT05108922|450939118|FG001|Overall Study|Withdrawal by Subject|8|||
125356097|NCT05036369|450939119|FG000|Overall Study|Run In non compliance|1|||
125356098|NCT05036369|450939120|FG001|Overall Study|Run In non compliance|2|||
125356099|NCT05036369|450939119|FG000|Overall Study|Change in eligibility criteria|0|||
125356100|NCT05036369|450939120|FG001|Overall Study|Change in eligibility criteria|1|||
125356101|NCT00426231|450939123|FG000|Overall Study|Withdrawal by Subject|9|||
125356102|NCT00426231|450939124|FG001|Overall Study|Withdrawal by Subject|12|||
125356103|NCT01795638|450939125|FG000|Overall Study|Death|0|||
125356104|NCT01795638|450939126|FG001|Overall Study|Death|3|||
125356105|NCT01795638|450939125|FG000|Overall Study|transferred to quaternary hospital|2|||
125356106|NCT01795638|450939126|FG001|Overall Study|transferred to quaternary hospital|3|||
125426561|NCT02755597|451185945|FG000|Overall Study|Other, not specified|20|||
125567455|NCT03259074|451707948|FG002|Overall Study|Pregnancy|0|||
125567456|NCT03259074|451707946|FG000|Overall Study|Progressive Disease|1|||
125356107|NCT01795638|450939125|FG000|Overall Study|Protocol Violation|3|||
125356108|NCT01795638|450939126|FG001|Overall Study|Protocol Violation|0|||
125356109|NCT01795638|450939125|FG000|Overall Study|discharged from hospital|7|||
125356110|NCT01795638|450939126|FG001|Overall Study|discharged from hospital|5|||
125356111|NCT01795638|450939125|FG000|Overall Study|Withdrawal by Subject|1|||
125356112|NCT01795638|450939126|FG001|Overall Study|Withdrawal by Subject|0|||
125356113|NCT03403374|450939127|FG000|Overall Study|Lost to Follow-up|1|||
125356114|NCT00950911|450939128|FG000|Overall Study|Adverse Event|0|||
125356115|NCT00950911|450939129|FG001|Overall Study|Adverse Event|2|||
125356116|NCT00950911|450939128|FG000|Overall Study|Death|4|||
125356117|NCT00950911|450939129|FG001|Overall Study|Death|6|||
125356118|NCT00950911|450939128|FG000|Overall Study|Disease progression|2|||
125356119|NCT00950911|450939129|FG001|Overall Study|Disease progression|2|||
125356120|NCT00950911|450939128|FG000|Overall Study|Consent withdrawn|1|||
125356121|NCT00950911|450939129|FG001|Overall Study|Consent withdrawn|3|||
125356122|NCT00950911|450939128|FG000|Overall Study|Administrative decision|3|||
125356123|NCT00950911|450939129|FG001|Overall Study|Administrative decision|1|||
125356124|NCT00950911|450939128|FG000|Overall Study|Ineligibility determined|1|||
125356125|NCT00950911|450939129|FG001|Overall Study|Ineligibility determined|0|||
125356126|NCT00950911|450939128|FG000|Overall Study|Noncompliance|1|||
125356127|NCT00950911|450939129|FG001|Overall Study|Noncompliance|0|||
125356128|NCT00950911|450939128|FG000|Overall Study|Poor performance status|0|||
125356129|NCT00950911|450939129|FG001|Overall Study|Poor performance status|1|||
125356130|NCT02476422|450939132|FG000|Overall Study|Subject/guardian decision|0|||
125356131|NCT02476422|450939133|FG001|Overall Study|Subject/guardian decision|1|||
125356132|NCT01134315|450939138|FG000|Overall Study|Adverse Event|1|||
125356133|NCT01134315|450939139|FG001|Overall Study|Adverse Event|2|||
125356134|NCT01134315|450939138|FG000|Overall Study|Other Reason|8|||
125356135|NCT01134315|450939139|FG001|Overall Study|Other Reason|17|||
125356136|NCT02180165|450939142|FG000|Overall Study|Not Treated|0|||
125356137|NCT02180165|450939143|FG001|Overall Study|Not Treated|0|||
125356138|NCT02180165|450939144|FG002|Overall Study|Not Treated|1|||
125567457|NCT03259074|451707947|FG001|Overall Study|Progressive Disease|0|||
125356139|NCT02180165|450939145|FG003|Overall Study|Not Treated|0|||
125356140|NCT02180165|450939142|FG000|Overall Study|Adverse Event|7|||
125356141|NCT02180165|450939143|FG001|Overall Study|Adverse Event|0|||
125356142|NCT02180165|450939144|FG002|Overall Study|Adverse Event|18|||
125426562|NCT02755597|451185946|FG001|Overall Study|Other, not specified|3|||
125426563|NCT02755597|451185945|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
125426564|NCT02755597|451185946|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
125426565|NCT00594854|451185948|FG000|Overall Study|Study terminated|7|||
125426566|NCT00594854|451185949|FG001|Overall Study|Study terminated|10|||
125426567|NCT03172702|451185950|FG000|Overall Study|Adverse Event|9|||
125426568|NCT03172702|451185950|FG000|Overall Study|Death|2|||
125426569|NCT03172702|451185950|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
125426570|NCT03172702|451185950|FG000|Overall Study|Withdrawal by Subject|5|||
125426571|NCT03172702|451185950|FG000|Overall Study|Other|2|||
125426572|NCT06134180|451185951|FG000|Overall Study|Lost to Follow-up|4|||
125426573|NCT02152982|451185952|FG000|Overall Study|Ineligible|4|||
125426574|NCT02152982|451185953|FG001|Overall Study|Ineligible|4|||
125567458|NCT03259074|451707948|FG002|Overall Study|Progressive Disease|0|||
125210784|NCT02134353|450395685|FG001|Overall Study|Lack of Efficacy|1|||
125426575|NCT02152982|451185952|FG000|Overall Study|Did not start treatment|12|||
125356143|NCT02180165|450939145|FG003|Overall Study|Adverse Event|3|||
125356144|NCT02180165|450939142|FG000|Overall Study|Lack of Efficacy|0|||
125356145|NCT02180165|450939143|FG001|Overall Study|Lack of Efficacy|1|||
125356146|NCT02180165|450939144|FG002|Overall Study|Lack of Efficacy|3|||
125356147|NCT02180165|450939145|FG003|Overall Study|Lack of Efficacy|2|||
125356148|NCT02180165|450939142|FG000|Overall Study|Physician Decision|1|||
125356149|NCT02180165|450939143|FG001|Overall Study|Physician Decision|0|||
125356150|NCT02180165|450939144|FG002|Overall Study|Physician Decision|5|||
125356151|NCT02180165|450939145|FG003|Overall Study|Physician Decision|0|||
125356152|NCT02180165|450939142|FG000|Overall Study|Withdrawal by Subject|3|||
125356153|NCT02180165|450939143|FG001|Overall Study|Withdrawal by Subject|0|||
125356154|NCT02180165|450939144|FG002|Overall Study|Withdrawal by Subject|2|||
125356155|NCT02180165|450939145|FG003|Overall Study|Withdrawal by Subject|1|||
125356156|NCT03875768|450939146|FG000|Overall Study|Lost to Follow-up|16|||
125356157|NCT03875768|450939147|FG001|Overall Study|Lost to Follow-up|13|||
125356158|NCT03875768|450939146|FG000|Overall Study|Withdrawal by Subject|10|||
125356159|NCT03875768|450939147|FG001|Overall Study|Withdrawal by Subject|21|||
125356160|NCT03875768|450939146|FG000|Overall Study|Did not complete assessment|21|||
125356161|NCT03875768|450939147|FG001|Overall Study|Did not complete assessment|12|||
125356162|NCT03875768|450939146|FG000|Overall Study|Became ineligible|1|||
125356163|NCT03875768|450939147|FG001|Overall Study|Became ineligible|0|||
125356164|NCT00737438|450939148|FG000|Overall Study|Withdrawal by Subject|2|||
125356165|NCT00737438|450939148|FG000|Overall Study|Patient ineligible|1|||
125356166|NCT02791594|450939149|FG000|Overall Study|Physician Decision|2|||
125356167|NCT04950166|450939152|FG000|Overall Study|Withdrawal by Subject|1|||
125356168|NCT00857415|450939153|FG000|Overall Study|Image acquisition failure|2|||
125356169|NCT00857415|450939154|FG001|Overall Study|Image acquisition failure|0|||
125356170|NCT00857415|450939153|FG000|Overall Study|Invalid image or not imaged|3|||
125356171|NCT00857415|450939154|FG001|Overall Study|Invalid image or not imaged|0|||
125356172|NCT00857415|450939153|FG000|Overall Study|Subject still living at end of study|110|||
125356173|NCT00857415|450939154|FG001|Overall Study|Subject still living at end of study|0|||
125356174|NCT00857415|450939153|FG000|Overall Study|Deceased with no autopsy|2|||
125356175|NCT00857415|450939154|FG001|Overall Study|Deceased with no autopsy|0|||
125356176|NCT04508140|450939157|FG000|Overall Study|Adverse Event|2|||
125356177|NCT04508140|450939158|FG001|Overall Study|Adverse Event|2|||
125356178|NCT04508140|450939157|FG000|Overall Study|Withdrawal by Subject|0|||
125356179|NCT04508140|450939158|FG001|Overall Study|Withdrawal by Subject|2|||
125356180|NCT04508140|450939157|FG000|Overall Study|progressive disease|9|||
125356181|NCT04508140|450939158|FG001|Overall Study|progressive disease|3|||
125356182|NCT01130103|450939159|FG000|Randomized Treatment|Adverse Event|1|||
125356183|NCT01130103|450939160|FG001|Randomized Treatment|Adverse Event|1|||
125356184|NCT01130103|450939159|FG000|Randomized Treatment|Lost to Follow-up|1|||
125356185|NCT01130103|450939160|FG001|Randomized Treatment|Lost to Follow-up|0|||
125356186|NCT01130103|450939159|FG000|Randomized Treatment|Protocol Violation|3|||
125356187|NCT01130103|450939160|FG001|Randomized Treatment|Protocol Violation|2|||
125356188|NCT01130103|450939159|FG000|Randomized Treatment|Withdrawal by Subject|1|||
125356189|NCT01130103|450939160|FG001|Randomized Treatment|Withdrawal by Subject|2|||
125356190|NCT01130103|450939159|FG000|Maintenance Treatment|Lack of Efficacy|0|||
125356191|NCT01130103|450939160|FG001|Maintenance Treatment|Lack of Efficacy|1|||
125356192|NCT01130103|450939159|FG000|Maintenance Treatment|Lost to Follow-up|1|||
125356193|NCT01130103|450939160|FG001|Maintenance Treatment|Lost to Follow-up|1|||
125356194|NCT01130103|450939159|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
125356195|NCT01130103|450939160|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
125356196|NCT01199731|450939161|FG000|Overall Study|Adverse Event|0|||
125356197|NCT01199731|450939162|FG001|Overall Study|Adverse Event|1|||
125356198|NCT01199731|450939163|FG002|Overall Study|Adverse Event|0|||
125356199|NCT01199731|450939161|FG000|Overall Study|Study closed/terminated|7|||
125356200|NCT01199731|450939162|FG001|Overall Study|Study closed/terminated|9|||
125356201|NCT01199731|450939163|FG002|Overall Study|Study closed/terminated|7|||
125356202|NCT01199731|450939161|FG000|Overall Study|Lost to Follow-up|0|||
125426576|NCT02152982|451185953|FG001|Overall Study|Did not start treatment|6|||
125567459|NCT03259074|451707946|FG000|Overall Study|Protocol Deviation|1|||
125567460|NCT03259074|451707947|FG001|Overall Study|Protocol Deviation|1|||
125567461|NCT03259074|451707948|FG002|Overall Study|Protocol Deviation|3|||
125567462|NCT03259074|451707946|FG000|Overall Study|Subject/Guardian Decision|13|||
125356203|NCT01199731|450939162|FG001|Overall Study|Lost to Follow-up|0|||
125356204|NCT01199731|450939163|FG002|Overall Study|Lost to Follow-up|2|||
125356205|NCT01199731|450939161|FG000|Overall Study|Physician Decision|0|||
125356206|NCT01199731|450939162|FG001|Overall Study|Physician Decision|1|||
125356207|NCT01199731|450939163|FG002|Overall Study|Physician Decision|1|||
125356208|NCT01199731|450939161|FG000|Overall Study|Withdrawal by Subject|2|||
125356209|NCT01199731|450939162|FG001|Overall Study|Withdrawal by Subject|0|||
125356210|NCT01199731|450939163|FG002|Overall Study|Withdrawal by Subject|0|||
125356211|NCT02992132|450939164|FG000|Overall Study|Adverse Event|4|||
125356212|NCT02992132|450939165|FG001|Overall Study|Adverse Event|1|||
125356213|NCT02992132|450939166|FG002|Overall Study|Adverse Event|3|||
125567463|NCT03259074|451707947|FG001|Overall Study|Subject/Guardian Decision|16|||
125356214|NCT02992132|450939164|FG000|Overall Study|Lack of Efficacy|2|||
125356215|NCT02992132|450939165|FG001|Overall Study|Lack of Efficacy|0|||
125356216|NCT02992132|450939166|FG002|Overall Study|Lack of Efficacy|0|||
125356217|NCT02992132|450939164|FG000|Overall Study|Non-compliance with study drug|2|||
125356218|NCT02992132|450939165|FG001|Overall Study|Non-compliance with study drug|0|||
125356219|NCT02992132|450939166|FG002|Overall Study|Non-compliance with study drug|0|||
125356220|NCT02992132|450939164|FG000|Overall Study|Progressive disease|1|||
125356221|NCT02992132|450939165|FG001|Overall Study|Progressive disease|0|||
125356222|NCT02992132|450939166|FG002|Overall Study|Progressive disease|0|||
125356223|NCT02992132|450939164|FG000|Overall Study|Protocol Violation|2|||
125356224|NCT02992132|450939165|FG001|Overall Study|Protocol Violation|2|||
125356225|NCT02992132|450939166|FG002|Overall Study|Protocol Violation|0|||
125356226|NCT02992132|450939164|FG000|Overall Study|Caregiver withdrew consent|2|||
125356227|NCT02992132|450939165|FG001|Overall Study|Caregiver withdrew consent|3|||
125356228|NCT02992132|450939166|FG002|Overall Study|Caregiver withdrew consent|2|||
125356229|NCT02992132|450939164|FG000|Overall Study|Withdrawal by Subject|0|||
125356230|NCT02992132|450939165|FG001|Overall Study|Withdrawal by Subject|2|||
125356231|NCT02992132|450939166|FG002|Overall Study|Withdrawal by Subject|1|||
125356232|NCT02992132|450939164|FG000|Overall Study|Physician Decision|0|||
125356233|NCT02992132|450939165|FG001|Overall Study|Physician Decision|0|||
125356234|NCT02992132|450939166|FG002|Overall Study|Physician Decision|1|||
125356235|NCT00381381|450939172|FG000|Overall Study|Adverse Event|3|||
125356236|NCT00381381|450939172|FG000|Overall Study|Lost to Follow-up|52|||
125356237|NCT00381381|450939172|FG000|Overall Study|Withdrawal by Subject|9|||
125356238|NCT01437878|450939177|FG000|Overall Study|Withdrawal by Subject|1|||
125567464|NCT03259074|451707948|FG002|Overall Study|Subject/Guardian Decision|14|||
125567465|NCT01780662|451707949|FG000|Overall Study|Adverse Event|1|||
125567466|NCT01780662|451707950|FG001|Overall Study|Adverse Event|0|||
125567467|NCT01780662|451707951|FG002|Overall Study|Adverse Event|2|||
125567468|NCT01780662|451707949|FG000|Overall Study|Physician Decision|0|||
125567469|NCT01780662|451707950|FG001|Overall Study|Physician Decision|5|||
125567470|NCT01780662|451707951|FG002|Overall Study|Physician Decision|7|||
125567471|NCT01780662|451707949|FG000|Overall Study|Protocol Violation|0|||
125567472|NCT01780662|451707950|FG001|Overall Study|Protocol Violation|1|||
125567473|NCT01780662|451707951|FG002|Overall Study|Protocol Violation|0|||
125567474|NCT01780662|451707949|FG000|Overall Study|Ineligible|0|||
125567475|NCT01780662|451707950|FG001|Overall Study|Ineligible|0|||
125567476|NCT01780662|451707951|FG002|Overall Study|Ineligible|1|||
125567477|NCT00183274|451707954|FG000|Phase 1: Open-Label|Adverse Event|31|||
125567478|NCT00183274|451707955|FG001|Phase 1: Open-Label|Adverse Event|0|||
125567479|NCT00183274|451707956|FG002|Phase 1: Open-Label|Adverse Event|0|||
125567480|NCT00183274|451707957|FG003|Phase 1: Open-Label|Adverse Event|0|||
125567481|NCT00183274|451707958|FG004|Phase 1: Open-Label|Adverse Event|0|||
125567482|NCT00183274|451707959|FG005|Phase 1: Open-Label|Adverse Event|0|||
125567483|NCT00183274|451707954|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
125567484|NCT00183274|451707955|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
125567485|NCT00183274|451707956|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
125567486|NCT00183274|451707957|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
125567487|NCT00183274|451707958|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
125567488|NCT00183274|451707959|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
125567489|NCT00183274|451707954|FG000|Phase 1: Open-Label|Protocol Violation|11|||
125567490|NCT00183274|451707955|FG001|Phase 1: Open-Label|Protocol Violation|0|||
125567491|NCT00183274|451707956|FG002|Phase 1: Open-Label|Protocol Violation|0|||
125567492|NCT00183274|451707957|FG003|Phase 1: Open-Label|Protocol Violation|0|||
125567493|NCT00183274|451707958|FG004|Phase 1: Open-Label|Protocol Violation|0|||
125567494|NCT00183274|451707959|FG005|Phase 1: Open-Label|Protocol Violation|0|||
125567495|NCT00183274|451707954|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
125567496|NCT00183274|451707955|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
125567497|NCT00183274|451707956|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
125567498|NCT00183274|451707957|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
125567499|NCT00183274|451707958|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
125567500|NCT00183274|451707959|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
125567501|NCT00183274|451707954|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
125356239|NCT01437878|450939178|FG001|Overall Study|Withdrawal by Subject|0|||
125356240|NCT01070043|450939180|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
125356241|NCT01070043|450939181|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
125567502|NCT00183274|451707955|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
125567503|NCT00183274|451707956|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
125567504|NCT00183274|451707957|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
125567505|NCT00183274|451707958|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
125567506|NCT00183274|451707959|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
125356242|NCT01070043|450939182|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
125356243|NCT01070043|450939180|FG000|Double-Blind Treatment|Adverse Event|0|||
125356244|NCT01070043|450939181|FG001|Double-Blind Treatment|Adverse Event|0|||
125567507|NCT00183274|451707954|FG000|Phase 1: Open-Label|Other|9|||
125567508|NCT00183274|451707955|FG001|Phase 1: Open-Label|Other|0|||
125567509|NCT00183274|451707956|FG002|Phase 1: Open-Label|Other|0|||
125567510|NCT00183274|451707957|FG003|Phase 1: Open-Label|Other|0|||
125567511|NCT00183274|451707958|FG004|Phase 1: Open-Label|Other|0|||
125567512|NCT00183274|451707959|FG005|Phase 1: Open-Label|Other|0|||
125567513|NCT00183274|451707954|FG000|Phase 2: Double-Blind|Relapsed|0|||
125567514|NCT00183274|451707955|FG001|Phase 2: Double-Blind|Relapsed|8|||
125567515|NCT00183274|451707956|FG002|Phase 2: Double-Blind|Relapsed|29|||
125567516|NCT00183274|451707957|FG003|Phase 2: Double-Blind|Relapsed|0|||
125567517|NCT00183274|451707958|FG004|Phase 2: Double-Blind|Relapsed|0|||
125567518|NCT00183274|451707959|FG005|Phase 2: Double-Blind|Relapsed|0|||
125567519|NCT00183274|451707954|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
125567520|NCT00183274|451707955|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
125567521|NCT00183274|451707956|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
125567522|NCT00183274|451707957|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
125567523|NCT00183274|451707958|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
125567524|NCT00183274|451707959|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
125567525|NCT00183274|451707954|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
125567526|NCT00183274|451707955|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
125567527|NCT00183274|451707956|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
125567528|NCT00183274|451707957|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
125567529|NCT00183274|451707958|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
125567530|NCT00183274|451707959|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
125567531|NCT00183274|451707954|FG000|Phase 3: Double-Blind|Relapsed|0|||
125567532|NCT00183274|451707955|FG001|Phase 3: Double-Blind|Relapsed|0|||
125567533|NCT00183274|451707956|FG002|Phase 3: Double-Blind|Relapsed|0|||
125567534|NCT00183274|451707957|FG003|Phase 3: Double-Blind|Relapsed|1|||
125567535|NCT00183274|451707958|FG004|Phase 3: Double-Blind|Relapsed|11|||
125567536|NCT00183274|451707959|FG005|Phase 3: Double-Blind|Relapsed|2|||
125567537|NCT04081363|451707962|FG000|Overall Study|Withdrawal by Subject|1|||
125567538|NCT04081363|451707963|FG001|Overall Study|Withdrawal by Subject|0|||
125567539|NCT02409290|451707964|FG000|Overall Study|Protocol Violation|3|||
125567540|NCT02409290|451707965|FG001|Overall Study|Protocol Violation|6|||
125567541|NCT02409290|451707966|FG002|Overall Study|Protocol Violation|9|||
125567542|NCT02409290|451707967|FG003|Overall Study|Protocol Violation|4|||
125567543|NCT02409290|451707964|FG000|Overall Study|No positive culture/no baseline sample|3|||
125567544|NCT02409290|451707965|FG001|Overall Study|No positive culture/no baseline sample|9|||
125567545|NCT02409290|451707966|FG002|Overall Study|No positive culture/no baseline sample|6|||
125567546|NCT02409290|451707967|FG003|Overall Study|No positive culture/no baseline sample|5|||
125567547|NCT02409290|451707964|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
125567548|NCT02409290|451707965|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
125567549|NCT02409290|451707966|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
125567550|NCT02409290|451707967|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
125567551|NCT00708500|451707968|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
125567552|NCT00708500|451707969|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
125426577|NCT02782169|451185959|FG000|Overall Study|Lost to Follow-up|1|||
125567553|NCT00708500|451707970|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
125567554|NCT00708500|451707968|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
125567555|NCT00708500|451707969|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
125567556|NCT00708500|451707970|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
125567557|NCT00708500|451707968|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
125567558|NCT00708500|451707969|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
125567559|NCT00708500|451707970|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
125567560|NCT00708500|451707968|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
125567561|NCT00708500|451707969|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
125567562|NCT00708500|451707970|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
125567563|NCT00708500|451707968|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
125567564|NCT00708500|451707969|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
125567565|NCT00708500|451707970|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
125567566|NCT00708500|451707968|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
125567567|NCT00708500|451707969|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
125567568|NCT00708500|451707970|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
125567569|NCT00708500|451707968|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
125426578|NCT02782169|451185960|FG001|Overall Study|Lost to Follow-up|2|||
125567570|NCT00708500|451707969|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
125567571|NCT00708500|451707970|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
125567572|NCT00708500|451707968|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
125567573|NCT00708500|451707969|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
125567574|NCT00708500|451707970|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
125567575|NCT00708500|451707968|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
125567576|NCT00708500|451707969|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
125567577|NCT00708500|451707970|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
125567578|NCT00708500|451707968|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
125567579|NCT00708500|451707969|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
125567580|NCT00708500|451707970|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
125567581|NCT00708500|451707968|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
125567582|NCT00708500|451707969|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
125567583|NCT00708500|451707970|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
125567584|NCT00708500|451707968|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
125567585|NCT00708500|451707969|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
125567586|NCT00708500|451707970|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
125356245|NCT01070043|450939182|FG002|Double-Blind Treatment|Adverse Event|2|||
125356246|NCT00473746|450939183|FG000|Period 1 (Phase 1)|Adverse Event|1|||
125356247|NCT00473746|450939184|FG001|Period 1 (Phase 1)|Adverse Event|0|||
125356248|NCT00473746|450939185|FG002|Period 1 (Phase 1)|Adverse Event|0|||
125356249|NCT00473746|450939186|FG003|Period 1 (Phase 1)|Adverse Event|0|||
125356250|NCT00473746|450939187|FG004|Period 1 (Phase 1)|Adverse Event|0|||
125356251|NCT00473746|450939183|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
125356252|NCT00473746|450939184|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
125356253|NCT00473746|450939185|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
125356254|NCT00473746|450939186|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
125356255|NCT00473746|450939187|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
125356256|NCT00473746|450939183|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
125356257|NCT00473746|450939184|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
125356258|NCT00473746|450939185|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
125356259|NCT00473746|450939186|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
125356260|NCT00473746|450939187|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
125567587|NCT00708500|451707968|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
125567588|NCT00708500|451707969|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
125567589|NCT00708500|451707970|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
125567590|NCT00708500|451707968|FG000|FOLLOWUP|Adverse Event|0|||
125567591|NCT00708500|451707969|FG001|FOLLOWUP|Adverse Event|1|||
125567592|NCT00708500|451707970|FG002|FOLLOWUP|Adverse Event|0|||
125356261|NCT00473746|450939183|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
125356262|NCT00473746|450939184|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
125356263|NCT00473746|450939185|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
125356264|NCT00473746|450939186|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
125356265|NCT00473746|450939187|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
125356266|NCT00473746|450939183|FG000|Period 1 (Phase 1)|Reason not specified|0|||
125356267|NCT00473746|450939184|FG001|Period 1 (Phase 1)|Reason not specified|1|||
125356268|NCT00473746|450939185|FG002|Period 1 (Phase 1)|Reason not specified|0|||
125356269|NCT00473746|450939186|FG003|Period 1 (Phase 1)|Reason not specified|0|||
125356270|NCT00473746|450939187|FG004|Period 1 (Phase 1)|Reason not specified|0|||
125356271|NCT00473746|450939183|FG000|Period 2 (Phase 2)|Adverse Event|0|||
125356272|NCT00473746|450939184|FG001|Period 2 (Phase 2)|Adverse Event|0|||
125356273|NCT00473746|450939185|FG002|Period 2 (Phase 2)|Adverse Event|0|||
125356274|NCT00473746|450939186|FG003|Period 2 (Phase 2)|Adverse Event|0|||
125356275|NCT00473746|450939187|FG004|Period 2 (Phase 2)|Adverse Event|3|||
125356276|NCT00473746|450939183|FG000|Period 2 (Phase 2)|Death|0|||
125356277|NCT00473746|450939184|FG001|Period 2 (Phase 2)|Death|0|||
125356278|NCT00473746|450939185|FG002|Period 2 (Phase 2)|Death|0|||
125356279|NCT00473746|450939186|FG003|Period 2 (Phase 2)|Death|0|||
125356280|NCT00473746|450939187|FG004|Period 2 (Phase 2)|Death|1|||
125356281|NCT00473746|450939183|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
125356282|NCT00473746|450939184|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
125356283|NCT00473746|450939185|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
125356284|NCT00473746|450939186|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
125356285|NCT00473746|450939187|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
125567593|NCT00708500|451707968|FG000|FOLLOWUP|Lost to Follow-up|1|||
125567594|NCT00708500|451707969|FG001|FOLLOWUP|Lost to Follow-up|6|||
125356286|NCT00473746|450939183|FG000|Period 2 (Phase 2)|Reason not specified|0|||
125356287|NCT00473746|450939184|FG001|Period 2 (Phase 2)|Reason not specified|0|||
125356288|NCT00473746|450939185|FG002|Period 2 (Phase 2)|Reason not specified|0|||
125356289|NCT00473746|450939186|FG003|Period 2 (Phase 2)|Reason not specified|0|||
125356290|NCT00473746|450939187|FG004|Period 2 (Phase 2)|Reason not specified|3|||
125356291|NCT00667420|450939188|FG000|Overall Study|Adverse Event|2|||
125356292|NCT00667420|450939188|FG000|Overall Study|Lack of Efficacy|5|||
125356293|NCT00667420|450939188|FG000|Overall Study|Physician Decision|1|||
125356294|NCT00667420|450939188|FG000|Overall Study|Withdrawal by Subject|2|||
125356295|NCT01528215|450939192|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
125356296|NCT01528215|450939193|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
125356297|NCT01528215|450939192|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
125356298|NCT01528215|450939193|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
125356299|NCT01528215|450939192|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
125356300|NCT01528215|450939193|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
125356301|NCT01528215|450939192|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
125356302|NCT01528215|450939193|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
125356303|NCT01462227|450939194|FG000|Second Assignment|Lost to Follow-up|1|||
125356304|NCT01462227|450939195|FG001|Second Assignment|Lost to Follow-up|0|||
125356305|NCT01462227|450939196|FG002|Second Assignment|Lost to Follow-up|0|||
125356306|NCT01462227|450939197|FG003|Second Assignment|Lost to Follow-up|0|||
125356307|NCT01462227|450939194|FG000|Second Assignment|Protocol Violation|0|||
125567595|NCT00708500|451707970|FG002|FOLLOWUP|Lost to Follow-up|4|||
125567596|NCT00708500|451707968|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
125567597|NCT00708500|451707969|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
125356308|NCT01462227|450939195|FG001|Second Assignment|Protocol Violation|1|||
125356309|NCT01462227|450939196|FG002|Second Assignment|Protocol Violation|1|||
125356310|NCT01462227|450939197|FG003|Second Assignment|Protocol Violation|0|||
125356311|NCT00586066|450939200|FG000|Overall Study|Lost to Follow-up|6|||
125356312|NCT00586066|450939201|FG001|Overall Study|Lost to Follow-up|3|||
125356313|NCT00586066|450939200|FG000|Overall Study|Lack of Efficacy|5|||
125356314|NCT00586066|450939201|FG001|Overall Study|Lack of Efficacy|3|||
125356315|NCT00586066|450939200|FG000|Overall Study|Adverse Event|2|||
125356316|NCT00586066|450939201|FG001|Overall Study|Adverse Event|2|||
125356317|NCT00586066|450939200|FG000|Overall Study|Physician Decision|1|||
125356318|NCT00586066|450939201|FG001|Overall Study|Physician Decision|0|||
125356319|NCT00586066|450939200|FG000|Overall Study|Withdrawal of consent|4|||
125356320|NCT00586066|450939201|FG001|Overall Study|Withdrawal of consent|2|||
125356321|NCT00467610|450939202|FG000|Overall Study|Withdrawal by Subject|1|||
125356322|NCT01369615|450939203|FG000|Overall Study|Withdrawal by Subject|0|||
125356323|NCT01369615|450939204|FG001|Overall Study|Withdrawal by Subject|1|||
125356324|NCT01369615|450939203|FG000|Overall Study|Lost to Follow-up|0|||
125356325|NCT01369615|450939204|FG001|Overall Study|Lost to Follow-up|1|||
125356326|NCT04263454|450939205|FG000|Overall Study|Adverse Event|0|||
125356327|NCT04263454|450939206|FG001|Overall Study|Adverse Event|2|||
125356328|NCT04263454|450939205|FG000|Overall Study|Physician Decision|3|||
125356329|NCT04263454|450939206|FG001|Overall Study|Physician Decision|5|||
125356330|NCT04263454|450939205|FG000|Overall Study|Poor Data Quality|0|||
125356331|NCT04263454|450939206|FG001|Overall Study|Poor Data Quality|1|||
125356332|NCT03911154|450939207|FG000|Overall Study|Withdrawal by Subject|1|||
125356333|NCT02035475|450939208|FG000|Overall Study|Withdrawal by Subject|4|||
125356334|NCT02035475|450939208|FG000|Overall Study|Physician Decision|1|||
125567598|NCT00708500|451707970|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
125356335|NCT02035475|450939208|FG000|Overall Study|Equipment Error|1|||
125356336|NCT01231347|450939209|FG000|Overall Study|Full Consent withdrawn|19|||
125356337|NCT01231347|450939210|FG001|Overall Study|Full Consent withdrawn|19|||
125356338|NCT01231347|450939211|FG002|Overall Study|Full Consent withdrawn|11|||
125356339|NCT01231347|450939209|FG000|Overall Study|Lost to Follow-up|4|||
125356340|NCT01231347|450939210|FG001|Overall Study|Lost to Follow-up|2|||
125356341|NCT01231347|450939211|FG002|Overall Study|Lost to Follow-up|2|||
125567599|NCT00708500|451707968|FG000|FOLLOWUP|Subject withdrew consent|31|||
125356342|NCT01231347|450939209|FG000|Overall Study|Death|202|||
125356343|NCT01231347|450939210|FG001|Overall Study|Death|210|||
125356344|NCT01231347|450939211|FG002|Overall Study|Death|101|||
125356345|NCT01231347|450939209|FG000|Overall Study|other event|7|||
125356346|NCT01231347|450939210|FG001|Overall Study|other event|9|||
125356347|NCT01231347|450939211|FG002|Overall Study|other event|3|||
125356348|NCT02322021|450939212|FG000|Core Phase|Adverse Event|1|||
125356349|NCT02322021|450939213|FG001|Core Phase|Adverse Event|3|||
125356350|NCT02322021|450939214|FG002|Core Phase|Adverse Event|4|||
125356351|NCT02322021|450939215|FG003|Core Phase|Adverse Event|2|||
125356352|NCT02322021|450939216|FG004|Core Phase|Adverse Event|0|||
125356353|NCT02322021|450939212|FG000|Core Phase|Participant Choice|4|||
125356354|NCT02322021|450939213|FG001|Core Phase|Participant Choice|5|||
125356355|NCT02322021|450939214|FG002|Core Phase|Participant Choice|4|||
125356356|NCT02322021|450939215|FG003|Core Phase|Participant Choice|2|||
125356357|NCT02322021|450939216|FG004|Core Phase|Participant Choice|0|||
125356358|NCT02322021|450939212|FG000|Core Phase|Lost to Follow-up|0|||
125356359|NCT02322021|450939213|FG001|Core Phase|Lost to Follow-up|0|||
125356360|NCT02322021|450939214|FG002|Core Phase|Lost to Follow-up|0|||
125356361|NCT02322021|450939215|FG003|Core Phase|Lost to Follow-up|1|||
125356362|NCT02322021|450939216|FG004|Core Phase|Lost to Follow-up|0|||
125356363|NCT02322021|450939212|FG000|Core Phase|Other|0|||
125356364|NCT02322021|450939213|FG001|Core Phase|Other|0|||
125356365|NCT02322021|450939214|FG002|Core Phase|Other|1|||
125356366|NCT02322021|450939215|FG003|Core Phase|Other|0|||
125356367|NCT02322021|450939216|FG004|Core Phase|Other|0|||
125356368|NCT02322021|450939212|FG000|Extension Phase|Adverse Event|0|||
125356369|NCT02322021|450939213|FG001|Extension Phase|Adverse Event|0|||
125356370|NCT02322021|450939214|FG002|Extension Phase|Adverse Event|0|||
125356371|NCT02322021|450939215|FG003|Extension Phase|Adverse Event|0|||
125356372|NCT02322021|450939216|FG004|Extension Phase|Adverse Event|3|||
125356373|NCT02322021|450939212|FG000|Extension Phase|Participant Choice|0|||
125356374|NCT02322021|450939213|FG001|Extension Phase|Participant Choice|0|||
125356375|NCT02322021|450939214|FG002|Extension Phase|Participant Choice|0|||
125356376|NCT02322021|450939215|FG003|Extension Phase|Participant Choice|0|||
125356377|NCT02322021|450939216|FG004|Extension Phase|Participant Choice|6|||
125356378|NCT02322021|450939212|FG000|Extension Phase|Other|0|||
125356379|NCT02322021|450939213|FG001|Extension Phase|Other|0|||
125356380|NCT02322021|450939214|FG002|Extension Phase|Other|0|||
125356381|NCT02322021|450939215|FG003|Extension Phase|Other|0|||
125356382|NCT02322021|450939216|FG004|Extension Phase|Other|3|||
125356383|NCT02322021|450939212|FG000|Extension Phase|Lost to Follow-up|0|||
125356384|NCT02322021|450939213|FG001|Extension Phase|Lost to Follow-up|0|||
125356385|NCT02322021|450939214|FG002|Extension Phase|Lost to Follow-up|0|||
125356386|NCT02322021|450939215|FG003|Extension Phase|Lost to Follow-up|0|||
125356387|NCT02322021|450939216|FG004|Extension Phase|Lost to Follow-up|1|||
125356388|NCT02322021|450939212|FG000|Extension Phase|Study terminated by sponsor|0|||
125356389|NCT02322021|450939213|FG001|Extension Phase|Study terminated by sponsor|0|||
125356390|NCT02322021|450939214|FG002|Extension Phase|Study terminated by sponsor|0|||
125356391|NCT02322021|450939215|FG003|Extension Phase|Study terminated by sponsor|0|||
125356392|NCT02322021|450939216|FG004|Extension Phase|Study terminated by sponsor|28|||
125356393|NCT02047227|450939217|FG000|Overall Study|Adverse Event|2|||
125356394|NCT02047227|450939218|FG001|Overall Study|Adverse Event|4|||
125356395|NCT02047227|450939217|FG000|Overall Study|Lost to Follow-up|0|||
125356396|NCT02047227|450939218|FG001|Overall Study|Lost to Follow-up|3|||
125356397|NCT02047227|450939217|FG000|Overall Study|Protocol Violation|1|||
125356398|NCT02047227|450939218|FG001|Overall Study|Protocol Violation|0|||
125356399|NCT02047227|450939217|FG000|Overall Study|Spontaneous pregnancy|1|||
125356400|NCT02047227|450939218|FG001|Overall Study|Spontaneous pregnancy|0|||
125356401|NCT02047227|450939217|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
125356402|NCT02047227|450939218|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
125356403|NCT02047227|450939217|FG000|Overall Study|No oocytes retrieved|21|||
125356404|NCT02047227|450939218|FG001|Overall Study|No oocytes retrieved|20|||
125356405|NCT02047227|450939217|FG000|Overall Study|No fertilization|61|||
125356406|NCT02047227|450939218|FG001|Overall Study|No fertilization|51|||
125356407|NCT02047227|450939217|FG000|Overall Study|Intention to freeze all embryos|1|||
125356408|NCT02047227|450939218|FG001|Overall Study|Intention to freeze all embryos|0|||
125356409|NCT02047227|450939217|FG000|Overall Study|All embryos discarded|12|||
125356410|NCT02047227|450939218|FG001|Overall Study|All embryos discarded|11|||
125356411|NCT02047227|450939217|FG000|Overall Study|Other|10|||
125356412|NCT02047227|450939218|FG001|Overall Study|Other|9|||
125356413|NCT00492050|450939224|FG000|Overall Study|Adverse Event|1|||
125356414|NCT00492050|450939224|FG000|Overall Study|Lack of Efficacy|1|||
125356415|NCT00492050|450939224|FG000|Overall Study|Withdrawal by Subject|3|||
125356416|NCT00492050|450939224|FG000|Overall Study|Unable to collect SCT|2|||
125356417|NCT00492050|450939224|FG000|Overall Study|Progressive Disease|2|||
125356418|NCT00423722|450940793|FG000|Overall Study|Death|4|||
125356419|NCT00423722|450940794|FG001|Overall Study|Death|4|||
125356420|NCT00423722|450940793|FG000|Overall Study|Declined to participate|2|||
125356421|NCT00423722|450940794|FG001|Overall Study|Declined to participate|3|||
125356422|NCT00423722|450940793|FG000|Overall Study|Unable to complete questionnaires|4|||
125356423|NCT00423722|450940794|FG001|Overall Study|Unable to complete questionnaires|4|||
125356424|NCT00423722|450940793|FG000|Overall Study|Withdrawal by Subject|4|||
125356425|NCT00423722|450940794|FG001|Overall Study|Withdrawal by Subject|2|||
125356426|NCT00518687|450940795|FG000|Overall Study|Adverse Event|201|||
125356427|NCT00518687|450940796|FG001|Overall Study|Adverse Event|177|||
125356428|NCT00518687|450940795|FG000|Overall Study|Lost to Follow-up|144|||
125356429|NCT00518687|450940796|FG001|Overall Study|Lost to Follow-up|155|||
125356430|NCT00518687|450940795|FG000|Overall Study|Physician Decision|42|||
125356431|NCT00518687|450940796|FG001|Overall Study|Physician Decision|48|||
125356432|NCT00518687|450940795|FG000|Overall Study|Progressive disease|2|||
125356433|NCT00518687|450940796|FG001|Overall Study|Progressive disease|2|||
125356434|NCT00518687|450940795|FG000|Overall Study|Protocol Violation|8|||
125356435|NCT00518687|450940796|FG001|Overall Study|Protocol Violation|10|||
125356436|NCT00518687|450940795|FG000|Overall Study|Study terminated by sponsor|930|||
125356437|NCT00518687|450940796|FG001|Overall Study|Study terminated by sponsor|918|||
125356438|NCT00518687|450940795|FG000|Overall Study|Withdrawal by Subject|110|||
125356439|NCT00518687|450940796|FG001|Overall Study|Withdrawal by Subject|110|||
125356440|NCT01846104|450940797|FG000|Overall Study|Withdrawal by Subject|1|||
125356441|NCT01397162|450940798|FG000|Overall Study|Adverse Event|4|||
125356442|NCT01397162|450940799|FG001|Overall Study|Adverse Event|0|||
125356443|NCT01397162|450940800|FG002|Overall Study|Adverse Event|0|||
125356444|NCT01397162|450940801|FG003|Overall Study|Adverse Event|0|||
125356445|NCT01397162|450940802|FG004|Overall Study|Adverse Event|0|||
125356446|NCT01397162|450940798|FG000|Overall Study|Not yet defined|3|||
125356447|NCT01397162|450940799|FG001|Overall Study|Not yet defined|4|||
125356448|NCT01397162|450940800|FG002|Overall Study|Not yet defined|3|||
125356449|NCT01397162|450940801|FG003|Overall Study|Not yet defined|5|||
125356450|NCT01397162|450940802|FG004|Overall Study|Not yet defined|3|||
125356451|NCT03061097|450940803|FG000|Overall Study|Withdrawal by Subject|0|||
125356452|NCT03061097|450940804|FG001|Overall Study|Withdrawal by Subject|3|||
125356453|NCT03911713|450940805|FG000|Overall Study|Lost to Follow-up|0|||
125356454|NCT03911713|450940806|FG001|Overall Study|Lost to Follow-up|2|||
125356455|NCT03911713|450940807|FG002|Overall Study|Lost to Follow-up|0|||
125356456|NCT03911713|450940808|FG003|Overall Study|Lost to Follow-up|0|||
125356457|NCT03911713|450940809|FG004|Overall Study|Lost to Follow-up|0|||
125356458|NCT03911713|450940805|FG000|Overall Study|Other|0|||
125356459|NCT03911713|450940806|FG001|Overall Study|Other|0|||
125356460|NCT03911713|450940807|FG002|Overall Study|Other|0|||
125356461|NCT03911713|450940808|FG003|Overall Study|Other|1|||
125356462|NCT03911713|450940809|FG004|Overall Study|Other|0|||
125356463|NCT03911713|450940805|FG000|Overall Study|Randomized, Never Dosed|1|||
125356464|NCT03911713|450940806|FG001|Overall Study|Randomized, Never Dosed|0|||
125356465|NCT03911713|450940807|FG002|Overall Study|Randomized, Never Dosed|0|||
125356466|NCT03911713|450940808|FG003|Overall Study|Randomized, Never Dosed|1|||
125356467|NCT03911713|450940809|FG004|Overall Study|Randomized, Never Dosed|0|||
125356468|NCT02437513|450940810|FG000|Overall Study|Withdrawal by Subject|2|||
125356469|NCT01845818|450940811|FG000|Overall Study|Withdrawal by Subject|0|||
125356470|NCT01845818|450940812|FG001|Overall Study|Withdrawal by Subject|1|||
125356471|NCT01845818|450940811|FG000|Overall Study|Lost to Follow-up|7|||
125356472|NCT01845818|450940812|FG001|Overall Study|Lost to Follow-up|5|||
125356473|NCT01845818|450940811|FG000|Overall Study|Administrative Reasons|3|||
125356474|NCT01845818|450940812|FG001|Overall Study|Administrative Reasons|1|||
125356475|NCT01845818|450940811|FG000|Overall Study|Serious Adverse Event|1|||
125356476|NCT01845818|450940812|FG001|Overall Study|Serious Adverse Event|1|||
125356477|NCT01845818|450940811|FG000|Overall Study|Other|25|||
125356478|NCT01845818|450940812|FG001|Overall Study|Other|8|||
125356479|NCT01845818|450940811|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
125356480|NCT01845818|450940812|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
125356481|NCT01845818|450940811|FG000|Overall Study|No Follow-Up Data Available|4|||
125356482|NCT01845818|450940812|FG001|Overall Study|No Follow-Up Data Available|1|||
125356483|NCT00422097|450940813|FG000|Dose Level 2|Still on treatment|0|||
125356484|NCT00422097|450940814|FG001|Dose Level 2|Still on treatment|1|||
125356485|NCT00422097|450940815|FG002|Dose Level 2|Still on treatment|0|||
125356486|NCT00422097|450940816|FG003|Dose Level 2|Still on treatment|0|||
125356487|NCT00422097|450940817|FG004|Dose Level 2|Still on treatment|0|||
125356488|NCT00422097|450940818|FG005|Dose Level 2|Still on treatment|0|||
125356489|NCT00422097|450940819|FG006|Dose Level 2|Still on treatment|0|||
125356490|NCT00422097|450940820|FG007|Dose Level 2|Still on treatment|0|||
125356491|NCT02360995|450940821|FG000|Overall Study|Lost to Follow-up|2|||
125356492|NCT02360995|450940822|FG001|Overall Study|Lost to Follow-up|0|||
125567600|NCT00708500|451707969|FG001|FOLLOWUP|Subject withdrew consent|4|||
125567601|NCT00708500|451707970|FG002|FOLLOWUP|Subject withdrew consent|5|||
125567602|NCT00708500|451707968|FG000|FOLLOWUP|Non-compliance with protocol|5|||
125567603|NCT00708500|451707969|FG001|FOLLOWUP|Non-compliance with protocol|0|||
125567604|NCT00708500|451707970|FG002|FOLLOWUP|Non-compliance with protocol|1|||
125567605|NCT00618410|451707975|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
125567606|NCT00618410|451707976|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
125567607|NCT00705783|451707979|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
125567608|NCT00705783|451707980|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
125567609|NCT00705783|451707981|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
125356493|NCT02360995|450940823|FG002|Overall Study|Lost to Follow-up|2|||
125356494|NCT02360995|450940821|FG000|Overall Study|Withdrawal by Subject|0|||
125356495|NCT02360995|450940822|FG001|Overall Study|Withdrawal by Subject|1|||
125356496|NCT02360995|450940823|FG002|Overall Study|Withdrawal by Subject|0|||
125356497|NCT02395666|450940824|FG000|Overall Study|Physician Decision|3|||
125356498|NCT02395666|450940825|FG001|Overall Study|Physician Decision|0|||
125356499|NCT02395666|450940824|FG000|Overall Study|Lost to Follow-up|1|||
125356500|NCT02395666|450940825|FG001|Overall Study|Lost to Follow-up|0|||
125356501|NCT02395666|450940824|FG000|Overall Study|Withdrawal by Subject|2|||
125356502|NCT02395666|450940825|FG001|Overall Study|Withdrawal by Subject|1|||
125356503|NCT02611960|450940826|FG000|Overall Study|Adverse Event|7|||
125567610|NCT00705783|451707979|FG000|Conversion Phase|Lost to Follow-up|13|||
125356504|NCT02611960|450940827|FG001|Overall Study|Adverse Event|8|||
125356505|NCT02611960|450940826|FG000|Overall Study|Death|98|||
125356506|NCT02611960|450940827|FG001|Overall Study|Death|92|||
125356507|NCT02611960|450940826|FG000|Overall Study|Withdrawal by Subject|1|||
125356508|NCT02611960|450940827|FG001|Overall Study|Withdrawal by Subject|5|||
125356509|NCT02611960|450940826|FG000|Overall Study|Sponsor Decision|11|||
125356510|NCT02611960|450940827|FG001|Overall Study|Sponsor Decision|11|||
125356511|NCT01409434|450940839|FG000|Overall Study|Protocol Violation|4|||
125356512|NCT05061966|450940840|FG000|Overall Study|Lost to Follow-up|13|||
125356513|NCT05061966|450940841|FG001|Overall Study|Lost to Follow-up|13|||
125356514|NCT02213042|450940842|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
125356515|NCT02213042|450940843|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
125356516|NCT02213042|450940844|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
125356517|NCT02213042|450940842|FG000|Overall Study|Adverse Event|2|||
125356518|NCT02213042|450940843|FG001|Overall Study|Adverse Event|1|||
125356519|NCT02213042|450940844|FG002|Overall Study|Adverse Event|0|||
125356520|NCT02213042|450940842|FG000|Overall Study|Withdrawal by Subject|0|||
125356521|NCT02213042|450940843|FG001|Overall Study|Withdrawal by Subject|1|||
125356522|NCT02213042|450940844|FG002|Overall Study|Withdrawal by Subject|1|||
125356523|NCT02213042|450940842|FG000|Overall Study|Protocol Violation|1|||
125356524|NCT02213042|450940843|FG001|Overall Study|Protocol Violation|0|||
125356525|NCT02213042|450940844|FG002|Overall Study|Protocol Violation|0|||
125356526|NCT02213042|450940842|FG000|Overall Study|Investigator discretion|0|||
125356527|NCT02213042|450940843|FG001|Overall Study|Investigator discretion|0|||
125356528|NCT02213042|450940844|FG002|Overall Study|Investigator discretion|1|||
125356529|NCT04073368|450940850|FG000|Overall Study|Adverse Event|2|||
125356530|NCT04073368|450940851|FG001|Overall Study|Adverse Event|0|||
125356531|NCT04073368|450940852|FG002|Overall Study|Adverse Event|1|||
125356532|NCT04073368|450940853|FG003|Overall Study|Adverse Event|1|||
125356533|NCT04073368|450940850|FG000|Overall Study|Withdrawal by Subject|2|||
125356534|NCT04073368|450940851|FG001|Overall Study|Withdrawal by Subject|2|||
125356535|NCT04073368|450940852|FG002|Overall Study|Withdrawal by Subject|1|||
125356536|NCT04073368|450940853|FG003|Overall Study|Withdrawal by Subject|1|||
125356537|NCT04073368|450940850|FG000|Overall Study|Lost to Follow-up|1|||
125356538|NCT04073368|450940851|FG001|Overall Study|Lost to Follow-up|1|||
125356539|NCT04073368|450940852|FG002|Overall Study|Lost to Follow-up|1|||
125356540|NCT04073368|450940853|FG003|Overall Study|Lost to Follow-up|0|||
125356541|NCT04073368|450940850|FG000|Overall Study|Protocol Violation|0|||
125356542|NCT04073368|450940851|FG001|Overall Study|Protocol Violation|1|||
125567611|NCT00705783|451707980|FG001|Conversion Phase|Lost to Follow-up|0|||
125567612|NCT00705783|451707981|FG002|Conversion Phase|Lost to Follow-up|0|||
125567613|NCT00705783|451707979|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
125356543|NCT04073368|450940852|FG002|Overall Study|Protocol Violation|0|||
125356544|NCT04073368|450940853|FG003|Overall Study|Protocol Violation|0|||
125356545|NCT04073368|450940850|FG000|Overall Study|Subject noncompliance|7|||
125356546|NCT04073368|450940851|FG001|Overall Study|Subject noncompliance|4|||
125356547|NCT04073368|450940852|FG002|Overall Study|Subject noncompliance|0|||
125356548|NCT04073368|450940853|FG003|Overall Study|Subject noncompliance|0|||
125356549|NCT00145600|450940854|FG000|Overall Study|Death|1|||
125356550|NCT00145600|450940855|FG001|Overall Study|Death|2|||
125356551|NCT00145600|450940856|FG002|Overall Study|Death|2|||
125356552|NCT00145600|450940857|FG003|Overall Study|Death|6|||
125356553|NCT00145600|450940854|FG000|Overall Study|Ineligible|3|||
125356554|NCT00145600|450940855|FG001|Overall Study|Ineligible|0|||
125356555|NCT00145600|450940856|FG002|Overall Study|Ineligible|1|||
125356556|NCT00145600|450940857|FG003|Overall Study|Ineligible|5|||
125426579|NCT02975973|451185961|FG000|Overall Study|Adverse Event|1|||
125356557|NCT00145600|450940854|FG000|Overall Study|Lost to Follow-up|2|||
125356558|NCT00145600|450940855|FG001|Overall Study|Lost to Follow-up|6|||
125356559|NCT00145600|450940856|FG002|Overall Study|Lost to Follow-up|2|||
125356560|NCT00145600|450940857|FG003|Overall Study|Lost to Follow-up|4|||
125356561|NCT00145600|450940854|FG000|Overall Study|Noncompliance|1|||
125356562|NCT00145600|450940855|FG001|Overall Study|Noncompliance|0|||
125356563|NCT00145600|450940856|FG002|Overall Study|Noncompliance|0|||
125356564|NCT00145600|450940857|FG003|Overall Study|Noncompliance|0|||
125356565|NCT00145600|450940854|FG000|Overall Study|Withdrawal by Subject|1|||
125356566|NCT00145600|450940855|FG001|Overall Study|Withdrawal by Subject|2|||
125356567|NCT00145600|450940856|FG002|Overall Study|Withdrawal by Subject|0|||
125426580|NCT02975973|451185962|FG001|Overall Study|Adverse Event|1|||
125567614|NCT00705783|451707980|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
125356568|NCT00145600|450940857|FG003|Overall Study|Withdrawal by Subject|1|||
125356569|NCT00761579|450940859|FG000|Overall Study|Adverse Event|10|||
125356570|NCT00761579|450940859|FG000|Overall Study|Death|2|||
125356571|NCT00761579|450940859|FG000|Overall Study|Lack of Efficacy|21|||
125356572|NCT00761579|450940859|FG000|Overall Study|Lost to Follow-up|16|||
125567615|NCT00705783|451707981|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
125567616|NCT00705783|451707979|FG000|Conversion Phase|Withdrawn by Investigator|4|||
125567617|NCT00705783|451707980|FG001|Conversion Phase|Withdrawn by Investigator|0|||
125567618|NCT00705783|451707981|FG002|Conversion Phase|Withdrawn by Investigator|0|||
125567619|NCT00705783|451707979|FG000|Conversion Phase|Withdrew Consent|24|||
125567620|NCT00705783|451707980|FG001|Conversion Phase|Withdrew Consent|0|||
125567621|NCT00705783|451707981|FG002|Conversion Phase|Withdrew Consent|0|||
125567622|NCT00705783|451707979|FG000|Conversion Phase|Protocol Deviation|2|||
125567623|NCT00705783|451707980|FG001|Conversion Phase|Protocol Deviation|0|||
125567624|NCT00705783|451707981|FG002|Conversion Phase|Protocol Deviation|0|||
125567625|NCT00705783|451707979|FG000|Conversion Phase|Adverse Event|11|||
125567626|NCT00705783|451707980|FG001|Conversion Phase|Adverse Event|0|||
125567627|NCT00705783|451707981|FG002|Conversion Phase|Adverse Event|0|||
125567628|NCT00705783|451707979|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
125567629|NCT00705783|451707980|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
125567630|NCT00705783|451707981|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
125567631|NCT00705783|451707979|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
125567632|NCT00705783|451707980|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
125567633|NCT00705783|451707981|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
125567634|NCT00705783|451707979|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
125567635|NCT00705783|451707980|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
125567636|NCT00705783|451707981|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
125567637|NCT00705783|451707979|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
125567638|NCT00705783|451707980|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
125356573|NCT00761579|450940859|FG000|Overall Study|Pregnancy|1|||
125356574|NCT00761579|450940859|FG000|Overall Study|Withdrawal by Subject|34|||
125356575|NCT00761579|450940859|FG000|Overall Study|Lack of compliance|2|||
125356576|NCT00761579|450940859|FG000|Overall Study|Protocol deviation|1|||
125356577|NCT00761579|450940859|FG000|Overall Study|Drug overdose|1|||
125356578|NCT00761579|450940859|FG000|Overall Study|Aggravation of depression|1|||
125356579|NCT00761579|450940859|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
125356580|NCT00761579|450940859|FG000|Overall Study|Lost survey form|1|||
125356581|NCT00761579|450940859|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
125356582|NCT02600351|450940860|FG000|Overall Study|Lack of Efficacy|3|||
125356583|NCT02600351|450940861|FG001|Overall Study|Lack of Efficacy|0|||
125356584|NCT02600351|450940862|FG002|Overall Study|Lack of Efficacy|5|||
125356585|NCT02600351|450940863|FG003|Overall Study|Lack of Efficacy|2|||
125356586|NCT02600351|450940860|FG000|Overall Study|Lost to Follow-up|1|||
125356587|NCT02600351|450940861|FG001|Overall Study|Lost to Follow-up|0|||
125356588|NCT02600351|450940862|FG002|Overall Study|Lost to Follow-up|0|||
125356589|NCT02600351|450940863|FG003|Overall Study|Lost to Follow-up|0|||
125356590|NCT02600351|450940860|FG000|Overall Study|Randomized but Not Treated|1|||
125567639|NCT00705783|451707981|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
125567640|NCT00705783|451707979|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
125567641|NCT00705783|451707980|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
125567642|NCT00705783|451707981|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
125567643|NCT00705783|451707979|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
125567644|NCT00705783|451707980|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
125567645|NCT00705783|451707981|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
125567646|NCT00705783|451707979|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
125567647|NCT00705783|451707980|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
125567648|NCT00705783|451707981|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
125567649|NCT00705783|451707979|FG000|Oral Stabilization Phase|Adverse Event|14|||
125567650|NCT00705783|451707980|FG001|Oral Stabilization Phase|Adverse Event|0|||
125567651|NCT00705783|451707981|FG002|Oral Stabilization Phase|Adverse Event|0|||
125567652|NCT00705783|451707979|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
125567653|NCT00705783|451707980|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
125567654|NCT00705783|451707981|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
125567655|NCT00705783|451707979|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
125567656|NCT00705783|451707980|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
125567657|NCT00705783|451707981|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
125356591|NCT02600351|450940861|FG001|Overall Study|Randomized but Not Treated|0|||
125356592|NCT02600351|450940862|FG002|Overall Study|Randomized but Not Treated|1|||
125356593|NCT02600351|450940863|FG003|Overall Study|Randomized but Not Treated|3|||
125356594|NCT04087213|450940864|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
125356595|NCT04087213|450940864|FG000|In-Facility Introduction|Adverse Event|1|||
125356596|NCT04087213|450940864|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
125426581|NCT02975973|451185963|FG002|Overall Study|Adverse Event|1|||
125426582|NCT02975973|451185964|FG003|Overall Study|Adverse Event|0|||
125426583|NCT00771810|451185965|FG000|Overall Study|Adverse Event|3|||
125426584|NCT00771810|451185966|FG001|Overall Study|Adverse Event|0|||
125426585|NCT00771810|451185967|FG002|Overall Study|Adverse Event|2|||
125426586|NCT00771810|451185965|FG000|Overall Study|Lost to Follow-up|0|||
125426587|NCT00771810|451185966|FG001|Overall Study|Lost to Follow-up|0|||
125426588|NCT00771810|451185967|FG002|Overall Study|Lost to Follow-up|1|||
125426589|NCT00771810|451185965|FG000|Overall Study|Physician Decision|1|||
125426590|NCT00771810|451185966|FG001|Overall Study|Physician Decision|2|||
125426591|NCT00771810|451185967|FG002|Overall Study|Physician Decision|2|||
125426592|NCT00771810|451185965|FG000|Overall Study|Protocol Violation|0|||
125426593|NCT00771810|451185966|FG001|Overall Study|Protocol Violation|1|||
125426594|NCT00771810|451185967|FG002|Overall Study|Protocol Violation|1|||
125426595|NCT00771810|451185965|FG000|Overall Study|Withdrawal by Subject|1|||
125426596|NCT00771810|451185966|FG001|Overall Study|Withdrawal by Subject|2|||
125426597|NCT00771810|451185967|FG002|Overall Study|Withdrawal by Subject|0|||
125426598|NCT00771810|451185965|FG000|Overall Study|Other|0|||
125426599|NCT00771810|451185966|FG001|Overall Study|Other|0|||
125426600|NCT00771810|451185967|FG002|Overall Study|Other|1|||
125426601|NCT04542018|451185970|FG000|Overall Study|Withdrawal by Subject|0|||
125426602|NCT04542018|451185971|FG001|Overall Study|Withdrawal by Subject|0|||
125426603|NCT04542018|451185972|FG002|Overall Study|Withdrawal by Subject|4|||
125426604|NCT04542018|451185970|FG000|Overall Study|Protocol Violation|0|||
125426605|NCT04542018|451185971|FG001|Overall Study|Protocol Violation|0|||
125426606|NCT04542018|451185972|FG002|Overall Study|Protocol Violation|2|||
125426607|NCT02953938|451185973|FG000|Overall Study|Adverse Event|0|||
125426608|NCT02953938|451185974|FG001|Overall Study|Adverse Event|1|||
125426609|NCT02953938|451185973|FG000|Overall Study|Withdrawal by Subject|1|||
125426610|NCT02953938|451185974|FG001|Overall Study|Withdrawal by Subject|1|||
125426611|NCT00810264|451185983|FG000|Overall Study|Lost to Follow-up|191|||
125426612|NCT00810264|451185983|FG000|Overall Study|Withdrawal by subject or physician|721|||
125426613|NCT00810264|451185983|FG000|Overall Study|Death|641|||
125426614|NCT01830127|451185984|FG000|Overall Study|Adverse Event|1|||
125426615|NCT01830127|451185985|FG001|Overall Study|Adverse Event|6|||
125426616|NCT01830127|451185984|FG000|Overall Study|Lack of Efficacy|3|||
125426617|NCT01830127|451185985|FG001|Overall Study|Lack of Efficacy|0|||
125426618|NCT01830127|451185984|FG000|Overall Study|Withdrawal by Subject|1|||
125426619|NCT01830127|451185985|FG001|Overall Study|Withdrawal by Subject|1|||
125426620|NCT01830127|451185984|FG000|Overall Study|Other reason not defined above|0|||
125426621|NCT01830127|451185985|FG001|Overall Study|Other reason not defined above|2|||
125426622|NCT06213701|451185986|FG000|Overall Study|Withdrawal by Subject|2|||
125426623|NCT06213701|451185987|FG001|Overall Study|Withdrawal by Subject|1|||
125426624|NCT06213701|451185988|FG002|Overall Study|Withdrawal by Subject|0|||
125426625|NCT00567190|451185989|FG000|Overall Study|Death|235|||
125426626|NCT00567190|451185990|FG001|Overall Study|Death|280|||
125426627|NCT00567190|451185989|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
125426628|NCT00567190|451185990|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
125426629|NCT02495025|451185995|FG000|Overall Study|Lost to Follow-up|21|||
125426630|NCT02495025|451185996|FG001|Overall Study|Lost to Follow-up|14|||
125426631|NCT02495025|451185995|FG000|Overall Study|Withdrawal by Subject|5|||
125426632|NCT02495025|451185996|FG001|Overall Study|Withdrawal by Subject|0|||
125426633|NCT00313820|451185997|FG000|Assigned to Treatment|Other|1|||
125426634|NCT00313820|451185998|FG001|Assigned to Treatment|Other|0|||
125426635|NCT00313820|451185997|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
125426636|NCT00313820|451185998|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
125426637|NCT00313820|451185997|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
125426638|NCT00313820|451185998|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
125567658|NCT00705783|451707979|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
125426639|NCT00313820|451185997|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
125426640|NCT00313820|451185998|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
125426641|NCT00313820|451185997|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
125426642|NCT00313820|451185998|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
125426643|NCT00313820|451185997|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
125426644|NCT00313820|451185998|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
125426645|NCT00265889|451186004|FG000|Overall Study|Physician Decision|1|||
125426646|NCT00265889|451186004|FG000|Overall Study|Protocol Violation|1|||
125426647|NCT00265889|451186004|FG000|Overall Study|Insurance denied the request|3|||
125567659|NCT00705783|451707980|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
125567660|NCT00705783|451707981|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
125567661|NCT00705783|451707979|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
125567662|NCT00705783|451707980|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
125567663|NCT00705783|451707981|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
125567664|NCT00705783|451707979|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
125356597|NCT04087213|450940864|FG000|Assisted Evaluable Period|Personal reasons|3|||
125356598|NCT04087213|450940864|FG000|Transition Period B|Renal Transplantation|1|||
125356599|NCT02556203|450940871|FG000|Overall Study|Withdrawal by Subject|21|||
125356600|NCT02556203|450940872|FG001|Overall Study|Withdrawal by Subject|21|||
125356601|NCT02556203|450940871|FG000|Overall Study|Lost to Follow-up|5|||
125356602|NCT02556203|450940872|FG001|Overall Study|Lost to Follow-up|5|||
125356603|NCT02556203|450940871|FG000|Overall Study|Adverse Event|1|||
125356604|NCT02556203|450940872|FG001|Overall Study|Adverse Event|0|||
125356605|NCT04587271|450940873|FG000|Overall Study|Lost to Follow-up|2|||
125356606|NCT04587271|450940874|FG001|Overall Study|Lost to Follow-up|2|||
125356607|NCT04587271|450940875|FG002|Overall Study|Lost to Follow-up|0|||
125356608|NCT04587271|450940876|FG003|Overall Study|Lost to Follow-up|2|||
125356609|NCT04587271|450940877|FG004|Overall Study|Lost to Follow-up|2|||
125356610|NCT04587271|450940878|FG005|Overall Study|Lost to Follow-up|0|||
125356611|NCT04587271|450940873|FG000|Overall Study|Caregiver brought child to visits|0|||
125356612|NCT04587271|450940874|FG001|Overall Study|Caregiver brought child to visits|0|||
125356613|NCT04587271|450940875|FG002|Overall Study|Caregiver brought child to visits|0|||
125356614|NCT04587271|450940876|FG003|Overall Study|Caregiver brought child to visits|1|||
125356615|NCT04587271|450940877|FG004|Overall Study|Caregiver brought child to visits|0|||
125356616|NCT04587271|450940878|FG005|Overall Study|Caregiver brought child to visits|0|||
125356617|NCT00777205|450940885|FG000|Overall Study|Lost to Follow-up|25|||
125356618|NCT00777205|450940886|FG001|Overall Study|Lost to Follow-up|9|||
125356619|NCT00777205|450940885|FG000|Overall Study|Withdrawal by Subject|6|||
125567665|NCT00705783|451707980|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
125567666|NCT00705783|451707981|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
125356620|NCT00777205|450940886|FG001|Overall Study|Withdrawal by Subject|4|||
125356621|NCT00777205|450940885|FG000|Overall Study|Death|0|||
125356622|NCT00777205|450940886|FG001|Overall Study|Death|2|||
125356623|NCT00777205|450940885|FG000|Overall Study|Protocol Violation|0|||
125356624|NCT00777205|450940886|FG001|Overall Study|Protocol Violation|56|||
125356625|NCT03053271|450940889|FG000|Overall Study|Did not meet randomization criteria|3|||
125356626|NCT03053271|450940889|FG000|Overall Study|Withdrawal by Subject|1|||
125356627|NCT04137224|450940891|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
125356628|NCT04137224|450940892|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
125356629|NCT04137224|450940891|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
125356630|NCT04137224|450940892|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
125356631|NCT04137224|450940891|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
125356632|NCT04137224|450940892|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
125356633|NCT01225887|450940893|FG000|Overall Study|Ineligible:required test not done|2|||
125356634|NCT01225887|450940893|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
125356635|NCT01225887|450940893|FG000|Overall Study|Ineligible:inadequate pathology|2|||
125356636|NCT01669928|450940894|FG000|First Intervention|Withdrawal by Subject|3|||
125356637|NCT01669928|450940895|FG001|First Intervention|Withdrawal by Subject|5|||
125356638|NCT00925990|450940899|FG000|Overall Study|Adverse Event|1|||
125356639|NCT00925990|450940900|FG001|Overall Study|Adverse Event|3|||
125567667|NCT00705783|451707979|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
125356640|NCT00925990|450940899|FG000|Overall Study|Withdrawal by Subject|2|||
125567668|NCT00705783|451707980|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
125356641|NCT00925990|450940900|FG001|Overall Study|Withdrawal by Subject|2|||
125356642|NCT00925990|450940899|FG000|Overall Study|Lost to Follow-up|1|||
125356643|NCT00925990|450940900|FG001|Overall Study|Lost to Follow-up|3|||
125356644|NCT00925990|450940899|FG000|Overall Study|Physician Decision|1|||
125356645|NCT00925990|450940900|FG001|Overall Study|Physician Decision|1|||
125356646|NCT00925990|450940899|FG000|Overall Study|moved out of state, missed medication|0|||
125567669|NCT00705783|451707981|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
125567670|NCT00705783|451707979|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
125567671|NCT00705783|451707980|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
125356647|NCT00925990|450940900|FG001|Overall Study|moved out of state, missed medication|2|||
125356648|NCT00679055|450940901|FG000|Overall Study|Adverse Event|0|||
125567672|NCT00705783|451707981|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
125567673|NCT00705783|451707979|FG000|Depot Stabilization Phase|Adverse Event|17|||
125567674|NCT00705783|451707980|FG001|Depot Stabilization Phase|Adverse Event|0|||
125567675|NCT00705783|451707981|FG002|Depot Stabilization Phase|Adverse Event|0|||
125567676|NCT00705783|451707979|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
125567677|NCT00705783|451707980|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
125567678|NCT00705783|451707981|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
125567679|NCT00705783|451707979|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
125567680|NCT00705783|451707980|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
125567681|NCT00705783|451707981|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
125567682|NCT00705783|451707979|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
125567683|NCT00705783|451707980|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
125356649|NCT00679055|450940902|FG001|Overall Study|Adverse Event|1|||
125356650|NCT00679055|450940901|FG000|Overall Study|Other|0|||
125356651|NCT00679055|450940902|FG001|Overall Study|Other|3|||
125356652|NCT00679055|450940901|FG000|Overall Study|Study Terminated|2|||
125356653|NCT00679055|450940902|FG001|Overall Study|Study Terminated|1|||
125356654|NCT01822678|450940909|FG000|Overall Study|Withdrawal by Subject|5|||
125356655|NCT01822678|450940910|FG001|Overall Study|Withdrawal by Subject|4|||
125356656|NCT01822678|450940911|FG002|Overall Study|Withdrawal by Subject|4|||
125356657|NCT01822678|450940909|FG000|Overall Study|Adverse Event|4|||
125356658|NCT01822678|450940910|FG001|Overall Study|Adverse Event|3|||
125356659|NCT01822678|450940911|FG002|Overall Study|Adverse Event|1|||
125356660|NCT01822678|450940909|FG000|Overall Study|Lack of Efficacy|3|||
125356661|NCT01822678|450940910|FG001|Overall Study|Lack of Efficacy|6|||
125356662|NCT01822678|450940911|FG002|Overall Study|Lack of Efficacy|5|||
125356663|NCT01822678|450940909|FG000|Overall Study|Lost to Follow-up|0|||
125356664|NCT01822678|450940910|FG001|Overall Study|Lost to Follow-up|2|||
125356665|NCT01822678|450940911|FG002|Overall Study|Lost to Follow-up|1|||
125356666|NCT00943124|450940915|FG000|Period 1|Withdrawal by Subject|1|||
125356667|NCT00943124|450940916|FG001|Period 1|Withdrawal by Subject|1|||
125356668|NCT00943124|450940915|FG000|Period 1|Did Not Follow Study Procedures|1|||
125356669|NCT00943124|450940916|FG001|Period 1|Did Not Follow Study Procedures|0|||
125356670|NCT00943124|450940915|FG000|Period 1|Personal Reasons|0|||
125356671|NCT00943124|450940916|FG001|Period 1|Personal Reasons|1|||
125356672|NCT01916967|450940919|FG000|Overall Study|Adverse Event|0|||
125356673|NCT01916967|450940920|FG001|Overall Study|Adverse Event|0|||
125356674|NCT01916967|450940921|FG002|Overall Study|Adverse Event|2|||
125567684|NCT00705783|451707981|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
125356675|NCT01916967|450940919|FG000|Overall Study|Lack of Efficacy|0|||
125356676|NCT01916967|450940920|FG001|Overall Study|Lack of Efficacy|0|||
125356677|NCT01916967|450940921|FG002|Overall Study|Lack of Efficacy|6|||
125356678|NCT01916967|450940919|FG000|Overall Study|Physician Decision|0|||
125356679|NCT01916967|450940920|FG001|Overall Study|Physician Decision|0|||
125356680|NCT01916967|450940921|FG002|Overall Study|Physician Decision|1|||
125356681|NCT01916967|450940919|FG000|Overall Study|Protocol Violation|0|||
125356682|NCT01916967|450940920|FG001|Overall Study|Protocol Violation|1|||
125356683|NCT01916967|450940921|FG002|Overall Study|Protocol Violation|0|||
125356684|NCT01912963|450940922|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
125356685|NCT01912963|450940923|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
125356686|NCT01912963|450940924|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
125356687|NCT01912963|450940922|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
125356688|NCT01912963|450940923|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
125356689|NCT01912963|450940924|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
125356690|NCT01912963|450940922|FG000|Overall Study|Adverse Event|0|||
125356691|NCT01912963|450940923|FG001|Overall Study|Adverse Event|1|||
125356692|NCT01912963|450940924|FG002|Overall Study|Adverse Event|1|||
125356693|NCT01912963|450940922|FG000|Overall Study|Withdrawal by Subject|0|||
125356694|NCT01912963|450940923|FG001|Overall Study|Withdrawal by Subject|1|||
125356695|NCT01912963|450940924|FG002|Overall Study|Withdrawal by Subject|0|||
125356696|NCT01912963|450940922|FG000|Overall Study|Sought treatment locally|0|||
125356697|NCT01912963|450940923|FG001|Overall Study|Sought treatment locally|1|||
125356698|NCT01912963|450940924|FG002|Overall Study|Sought treatment locally|0|||
125356699|NCT01702571|450940927|FG000|Overall Study|Death|1067|||
125356700|NCT01702571|450940928|FG001|Overall Study|Death|76|||
125356701|NCT01702571|450940927|FG000|Overall Study|Lost to Follow-up|144|||
125356702|NCT01702571|450940928|FG001|Overall Study|Lost to Follow-up|10|||
125356703|NCT01702571|450940927|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
125356704|NCT01702571|450940928|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
125356705|NCT01702571|450940927|FG000|Overall Study|Investigator Decision|5|||
125356706|NCT01702571|450940928|FG001|Overall Study|Investigator Decision|0|||
125356707|NCT01702571|450940927|FG000|Overall Study|Not Classifiable|1|||
125356708|NCT01702571|450940928|FG001|Overall Study|Not Classifiable|0|||
125356709|NCT01702571|450940927|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
125356710|NCT01702571|450940928|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
125356711|NCT01702571|450940927|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
125356712|NCT01702571|450940928|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
125356713|NCT01702571|450940927|FG000|Overall Study|Progressive Disease|3|||
125356714|NCT01702571|450940928|FG001|Overall Study|Progressive Disease|0|||
125356715|NCT01702571|450940927|FG000|Overall Study|Protocol Violation|2|||
125356716|NCT01702571|450940928|FG001|Overall Study|Protocol Violation|0|||
125356717|NCT01702571|450940927|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
125356718|NCT01702571|450940928|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
125356719|NCT01702571|450940927|FG000|Overall Study|Termination By Sponsor|4|||
125356720|NCT01702571|450940928|FG001|Overall Study|Termination By Sponsor|0|||
125356721|NCT01702571|450940927|FG000|Overall Study|Withdrawal by Subject|177|||
125356722|NCT01702571|450940928|FG001|Overall Study|Withdrawal by Subject|29|||
125356723|NCT01977937|450940935|FG000|Overall Study|Withdrawal by Subject|2|||
125356724|NCT01977937|450940936|FG001|Overall Study|Withdrawal by Subject|1|||
125356725|NCT01977937|450940935|FG000|Overall Study|Adverse Event|1|||
125356726|NCT01977937|450940936|FG001|Overall Study|Adverse Event|0|||
125356727|NCT01977937|450940935|FG000|Overall Study|Physician Decision|0|||
125356728|NCT01977937|450940936|FG001|Overall Study|Physician Decision|1|||
125356729|NCT00915356|450940937|FG000|Overall Study|Withdrawal by Subject|1|||
125356730|NCT00915356|450940938|FG001|Overall Study|Withdrawal by Subject|0|||
125356731|NCT00915356|450940939|FG002|Overall Study|Withdrawal by Subject|0|||
125356732|NCT00915356|450940940|FG003|Overall Study|Withdrawal by Subject|0|||
125356733|NCT00915356|450940941|FG004|Overall Study|Withdrawal by Subject|0|||
125356734|NCT02001181|450940947|FG000|Overall Study|Adverse Event|0|||
125356735|NCT02001181|450940948|FG001|Overall Study|Adverse Event|2|||
125356736|NCT02001181|450940947|FG000|Overall Study|Lost to Follow-up|1|||
125356737|NCT02001181|450940948|FG001|Overall Study|Lost to Follow-up|0|||
125356738|NCT02001181|450940947|FG000|Overall Study|Withdrawal by Subject|0|||
125356739|NCT02001181|450940948|FG001|Overall Study|Withdrawal by Subject|1|||
125356740|NCT00292318|450940949|FG000|Overall Study|Study terminated by officials|2|||
125356741|NCT00292318|450940950|FG001|Overall Study|Study terminated by officials|1|||
125356742|NCT01278160|450940951|FG000|Overall Study|Adverse Event|1|||
125356743|NCT01278160|450940952|FG001|Overall Study|Adverse Event|1|||
125356744|NCT01278160|450940951|FG000|Overall Study|Lost to Follow-up|0|||
125356745|NCT01278160|450940952|FG001|Overall Study|Lost to Follow-up|1|||
125356746|NCT01278160|450940951|FG000|Overall Study|Withdrawal by Subject|3|||
125356747|NCT01278160|450940952|FG001|Overall Study|Withdrawal by Subject|2|||
125356748|NCT01278160|450940951|FG000|Overall Study|Unclassified|1|||
125356749|NCT01278160|450940952|FG001|Overall Study|Unclassified|2|||
125356750|NCT02819518|450940953|FG000|Overall Study|Death|9|||
125356751|NCT02819518|450940954|FG001|Overall Study|Death|12|||
125356752|NCT02819518|450940955|FG002|Overall Study|Death|9|||
125356753|NCT02819518|450940956|FG003|Overall Study|Death|475|||
125356754|NCT02819518|450940957|FG004|Overall Study|Death|244|||
125356755|NCT02819518|450940953|FG000|Overall Study|Withdrawal by Subject|0|||
125356756|NCT02819518|450940954|FG001|Overall Study|Withdrawal by Subject|0|||
125356757|NCT02819518|450940955|FG002|Overall Study|Withdrawal by Subject|0|||
125356758|NCT02819518|450940956|FG003|Overall Study|Withdrawal by Subject|25|||
125356759|NCT02819518|450940957|FG004|Overall Study|Withdrawal by Subject|8|||
125356760|NCT02819518|450940953|FG000|Overall Study|Lost to Follow-up|0|||
125356761|NCT02819518|450940954|FG001|Overall Study|Lost to Follow-up|0|||
125356762|NCT02819518|450940955|FG002|Overall Study|Lost to Follow-up|0|||
125356763|NCT02819518|450940956|FG003|Overall Study|Lost to Follow-up|0|||
125356764|NCT02819518|450940957|FG004|Overall Study|Lost to Follow-up|1|||
125356765|NCT02819518|450940953|FG000|Overall Study|Sponsor Decision|1|||
125356766|NCT02819518|450940954|FG001|Overall Study|Sponsor Decision|1|||
125356767|NCT02819518|450940955|FG002|Overall Study|Sponsor Decision|0|||
125356768|NCT02819518|450940956|FG003|Overall Study|Sponsor Decision|34|||
125356769|NCT02819518|450940957|FG004|Overall Study|Sponsor Decision|17|||
125356770|NCT02819518|450940953|FG000|Overall Study|Transferred to extension study|1|||
125356771|NCT02819518|450940954|FG001|Overall Study|Transferred to extension study|1|||
125356772|NCT02819518|450940955|FG002|Overall Study|Transferred to extension study|1|||
125356773|NCT02819518|450940956|FG003|Overall Study|Transferred to extension study|32|||
125356774|NCT02819518|450940957|FG004|Overall Study|Transferred to extension study|11|||
125356775|NCT01505647|450940958|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
125356776|NCT01505647|450940959|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
125356777|NCT01505647|450940958|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
125356778|NCT01505647|450940959|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
125356779|NCT01505647|450940958|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
125356780|NCT01505647|450940959|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
125356781|NCT01505647|450940958|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
125356782|NCT01505647|450940959|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
125356783|NCT01505647|450940958|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
125356784|NCT01505647|450940959|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
125356785|NCT03112590|450940960|FG000|Overall Study|Adverse Event|0|||
125356786|NCT03112590|450940961|FG001|Overall Study|Adverse Event|1|||
125356787|NCT03112590|450940962|FG002|Overall Study|Adverse Event|0|||
125356788|NCT00843726|450940963|FG000|Overall Study|Death|1|||
125356789|NCT00843726|450940964|FG001|Overall Study|Death|0|||
125356790|NCT00843726|450940963|FG000|Overall Study|Withdrawal by Subject|0|||
125356791|NCT00843726|450940964|FG001|Overall Study|Withdrawal by Subject|1|||
125356792|NCT00406718|450940965|FG000|Overall Study|Withdrawal by Subject|2|||
125356793|NCT00406718|450940966|FG001|Overall Study|Withdrawal by Subject|9|||
125356794|NCT00406718|450940967|FG002|Overall Study|Withdrawal by Subject|4|||
125356795|NCT00406718|450940965|FG000|Overall Study|Lost to Follow-up|2|||
125356796|NCT00406718|450940966|FG001|Overall Study|Lost to Follow-up|5|||
125356797|NCT00406718|450940967|FG002|Overall Study|Lost to Follow-up|4|||
125356798|NCT02898116|450940971|FG000|Overall Study|Adverse Event|1|||
125356799|NCT02898116|450940971|FG000|Overall Study|Progressive disease|1|||
125356800|NCT05597020|450940978|FG000|Washout|Forbidden medication|2|||
125356801|NCT05597020|450940979|FG001|Washout|Forbidden medication|0|||
125356802|NCT05597020|450940978|FG000|Treatment Period II|Advice from primary care physician|1|||
125356803|NCT05597020|450940979|FG001|Treatment Period II|Advice from primary care physician|0|||
125356804|NCT05597020|450940978|FG000|Treatment Period II|Subject lost investigational product|1|||
125356805|NCT05597020|450940979|FG001|Treatment Period II|Subject lost investigational product|0|||
125356806|NCT05597020|450940978|FG000|Treatment Period II|Private reasons|0|||
125356807|NCT05597020|450940979|FG001|Treatment Period II|Private reasons|1|||
125356808|NCT05169567|450940980|FG000|Overall Study|On study treatment|116|||
125356809|NCT05169567|450940981|FG001|Overall Study|On study treatment|128|||
125356810|NCT05169567|450940980|FG000|Overall Study|Lost to Follow-up|1|||
125356811|NCT05169567|450940981|FG001|Overall Study|Lost to Follow-up|0|||
125356812|NCT05169567|450940980|FG000|Overall Study|Withdrawal by Subject|25|||
125356813|NCT05169567|450940981|FG001|Overall Study|Withdrawal by Subject|21|||
125356814|NCT01015131|450940982|FG000|Overall Study|Physician Decision|1|||
125356815|NCT01015131|450940982|FG000|Overall Study|Protocol Violation|1|||
125356816|NCT01015131|450940982|FG000|Overall Study|Withdrawal by Subject|2|||
125356817|NCT01015131|450940982|FG000|Overall Study|Other Protocol Specified Criteria|4|||
125356818|NCT05430022|450940983|FG000|Overall Study|Withdrawal by Subject|4|||
125356819|NCT05430022|450940984|FG001|Overall Study|Withdrawal by Subject|4|||
125356820|NCT02445391|450940993|FG000|Overall Study|No active protocol treatment|3|||
125356821|NCT02445391|450940994|FG001|Overall Study|No active protocol treatment|0|||
125356822|NCT02445391|450940995|FG002|Overall Study|No active protocol treatment|0|||
125356823|NCT02445391|450940993|FG000|Overall Study|Adverse Event|0|||
125356824|NCT02445391|450940994|FG001|Overall Study|Adverse Event|21|||
125356825|NCT02445391|450940995|FG002|Overall Study|Adverse Event|12|||
125356826|NCT02445391|450940993|FG000|Overall Study|Alternative therapy|0|||
125356827|NCT02445391|450940994|FG001|Overall Study|Alternative therapy|0|||
125356828|NCT02445391|450940995|FG002|Overall Study|Alternative therapy|1|||
125356829|NCT02445391|450940993|FG000|Overall Study|Disease progression|0|||
125356830|NCT02445391|450940994|FG001|Overall Study|Disease progression|7|||
125356831|NCT02445391|450940995|FG002|Overall Study|Disease progression|22|||
125356832|NCT02445391|450940993|FG000|Overall Study|Complicating disease|0|||
125356833|NCT02445391|450940994|FG001|Overall Study|Complicating disease|2|||
125356834|NCT02445391|450940995|FG002|Overall Study|Complicating disease|1|||
125356835|NCT02445391|450940993|FG000|Overall Study|Withdrawal by Subject|0|||
125356836|NCT02445391|450940994|FG001|Overall Study|Withdrawal by Subject|4|||
125356837|NCT02445391|450940995|FG002|Overall Study|Withdrawal by Subject|9|||
125356838|NCT02445391|450940993|FG000|Overall Study|Financial issue|0|||
125356839|NCT02445391|450940994|FG001|Overall Study|Financial issue|0|||
125356840|NCT02445391|450940995|FG002|Overall Study|Financial issue|2|||
125356841|NCT02445391|450940993|FG000|Overall Study|Still on treatment|0|||
125356842|NCT02445391|450940994|FG001|Overall Study|Still on treatment|7|||
125356843|NCT02445391|450940995|FG002|Overall Study|Still on treatment|16|||
125356844|NCT02445391|450940993|FG000|Overall Study|Not start protocol therapy|0|||
125356845|NCT02445391|450940994|FG001|Overall Study|Not start protocol therapy|12|||
125356846|NCT02445391|450940995|FG002|Overall Study|Not start protocol therapy|9|||
125356847|NCT00891462|450942429|FG000|Overall Study|Withdrawal by Subject|9|||
125356848|NCT00891462|450942430|FG001|Overall Study|Withdrawal by Subject|6|||
125356849|NCT00891462|450942431|FG002|Overall Study|Withdrawal by Subject|7|||
125356850|NCT00891462|450942429|FG000|Overall Study|Adverse Event|7|||
125356851|NCT00891462|450942430|FG001|Overall Study|Adverse Event|8|||
125356852|NCT00891462|450942431|FG002|Overall Study|Adverse Event|7|||
125356853|NCT00891462|450942429|FG000|Overall Study|Lack of Efficacy|10|||
125356854|NCT00891462|450942430|FG001|Overall Study|Lack of Efficacy|5|||
125356855|NCT00891462|450942431|FG002|Overall Study|Lack of Efficacy|1|||
125356856|NCT00891462|450942429|FG000|Overall Study|COPD exacerbation|7|||
125356857|NCT00891462|450942430|FG001|Overall Study|COPD exacerbation|4|||
125356858|NCT00891462|450942431|FG002|Overall Study|COPD exacerbation|1|||
125356859|NCT00891462|450942429|FG000|Overall Study|Other Reason|2|||
125356860|NCT00891462|450942430|FG001|Overall Study|Other Reason|5|||
125356861|NCT00891462|450942431|FG002|Overall Study|Other Reason|3|||
125356862|NCT00891462|450942429|FG000|Overall Study|Protocol Violation|2|||
125356863|NCT00891462|450942430|FG001|Overall Study|Protocol Violation|1|||
125356864|NCT00891462|450942431|FG002|Overall Study|Protocol Violation|3|||
125356865|NCT00891462|450942429|FG000|Overall Study|Inclusion/exclusion criteria|0|||
125356866|NCT00891462|450942430|FG001|Overall Study|Inclusion/exclusion criteria|2|||
125356867|NCT00891462|450942431|FG002|Overall Study|Inclusion/exclusion criteria|2|||
125356868|NCT00891462|450942429|FG000|Overall Study|Lost to Follow-up|0|||
125356869|NCT00891462|450942430|FG001|Overall Study|Lost to Follow-up|2|||
125356870|NCT00891462|450942431|FG002|Overall Study|Lost to Follow-up|0|||
125356871|NCT01897714|450942435|FG000|Phase I (Dose Escalation)|Disease progression|3|||
125356872|NCT01897714|450942436|FG001|Phase I (Dose Escalation)|Disease progression|5|||
125356873|NCT01897714|450942437|FG002|Phase I (Dose Escalation)|Disease progression|1|||
125356874|NCT01897714|450942438|FG003|Phase I (Dose Escalation)|Disease progression|3|||
125356875|NCT01897714|450942439|FG004|Phase I (Dose Escalation)|Disease progression|0|||
125356876|NCT01897714|450942440|FG005|Phase I (Dose Escalation)|Disease progression|0|||
125356877|NCT01897714|450942435|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
125356878|NCT01897714|450942436|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
125356879|NCT01897714|450942437|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
125356880|NCT01897714|450942438|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
125356881|NCT01897714|450942439|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
125356882|NCT01897714|450942440|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
125356883|NCT01897714|450942435|FG000|Phase I (Dose Escalation)|Other|0|||
125356884|NCT01897714|450942436|FG001|Phase I (Dose Escalation)|Other|1|||
125356885|NCT01897714|450942437|FG002|Phase I (Dose Escalation)|Other|0|||
125356886|NCT01897714|450942438|FG003|Phase I (Dose Escalation)|Other|0|||
125356887|NCT01897714|450942439|FG004|Phase I (Dose Escalation)|Other|0|||
125356888|NCT01897714|450942440|FG005|Phase I (Dose Escalation)|Other|0|||
125356889|NCT01897714|450942435|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
125356890|NCT01897714|450942436|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
125356891|NCT01897714|450942437|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
125356892|NCT01897714|450942438|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
125356893|NCT01897714|450942439|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
125356894|NCT01897714|450942440|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
125356895|NCT01897714|450942435|FG000|Phase II (MTD)|Lost to Follow-up|0|||
125356896|NCT01897714|450942436|FG001|Phase II (MTD)|Lost to Follow-up|0|||
125356897|NCT01897714|450942437|FG002|Phase II (MTD)|Lost to Follow-up|0|||
125356898|NCT01897714|450942438|FG003|Phase II (MTD)|Lost to Follow-up|0|||
125356899|NCT01897714|450942439|FG004|Phase II (MTD)|Lost to Follow-up|1|||
125356900|NCT01897714|450942440|FG005|Phase II (MTD)|Lost to Follow-up|0|||
125356901|NCT01897714|450942435|FG000|Phase II (MTD)|Death|0|||
125356902|NCT01897714|450942436|FG001|Phase II (MTD)|Death|0|||
125356903|NCT01897714|450942437|FG002|Phase II (MTD)|Death|0|||
125356904|NCT01897714|450942438|FG003|Phase II (MTD)|Death|0|||
125356905|NCT01897714|450942439|FG004|Phase II (MTD)|Death|25|||
125356906|NCT01897714|450942440|FG005|Phase II (MTD)|Death|10|||
125356907|NCT01897714|450942435|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
125356908|NCT01897714|450942436|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
125356909|NCT01897714|450942437|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
125356910|NCT01897714|450942438|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
125356911|NCT01897714|450942439|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
125356912|NCT01897714|450942440|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
125356913|NCT01897714|450942435|FG000|Phase II (MTD)|Other|0|||
125356914|NCT01897714|450942436|FG001|Phase II (MTD)|Other|0|||
125356915|NCT01897714|450942437|FG002|Phase II (MTD)|Other|0|||
125356916|NCT01897714|450942438|FG003|Phase II (MTD)|Other|0|||
125356917|NCT01897714|450942439|FG004|Phase II (MTD)|Other|3|||
125356918|NCT01897714|450942440|FG005|Phase II (MTD)|Other|0|||
125356919|NCT00851630|450942449|FG000|Overall Study|Death|2|||
125356920|NCT00851630|450942450|FG001|Overall Study|Death|1|||
125356921|NCT00851630|450942449|FG000|Overall Study|Clinical failure|0|||
125356922|NCT00851630|450942450|FG001|Overall Study|Clinical failure|1|||
125356923|NCT02349061|450942451|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
125356924|NCT02349061|450942452|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
125356925|NCT02349061|450942453|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
125356926|NCT02349061|450942451|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
125356927|NCT02349061|450942452|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
125356928|NCT02349061|450942453|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
125356929|NCT02349061|450942451|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
125356930|NCT02349061|450942452|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
125356931|NCT02349061|450942453|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
125356932|NCT02349061|450942451|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
125356933|NCT02349061|450942452|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
125356934|NCT02349061|450942453|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
125356935|NCT02349061|450942451|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
125356936|NCT02349061|450942452|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
125356937|NCT02349061|450942453|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
125356938|NCT02349061|450942451|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
125356939|NCT02349061|450942452|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
125356940|NCT02349061|450942453|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
125426648|NCT02134587|451186005|FG000|Overall Study|Did not completed all meetings|30|||
125426649|NCT01515748|451186009|FG000|Overall Study|Withdrawal by Subject|32|||
125426650|NCT01515748|451186010|FG001|Overall Study|Withdrawal by Subject|41|||
125426651|NCT01515748|451186009|FG000|Overall Study|Lost to Follow-up|2|||
125426652|NCT01515748|451186010|FG001|Overall Study|Lost to Follow-up|4|||
125426653|NCT01515748|451186009|FG000|Overall Study|Other than specified above|5|||
125426654|NCT01515748|451186010|FG001|Overall Study|Other than specified above|10|||
125426655|NCT04102579|451186016|FG000|Overall Study|Withdrawal by Subject|3|||
125426656|NCT04102579|451186017|FG001|Overall Study|Withdrawal by Subject|4|||
125426657|NCT04102579|451186016|FG000|Overall Study|Lost to Follow-up|0|||
125426658|NCT04102579|451186017|FG001|Overall Study|Lost to Follow-up|1|||
125426659|NCT04102579|451186016|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
125426660|NCT04102579|451186017|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
125426661|NCT04102579|451186016|FG000|Overall Study|Other than Specified|1|||
125426662|NCT04102579|451186017|FG001|Overall Study|Other than Specified|0|||
125426663|NCT04102579|451186016|FG000|Overall Study|Not Dosed with Study Drug|0|||
125426664|NCT04102579|451186017|FG001|Overall Study|Not Dosed with Study Drug|1|||
125426665|NCT03419364|451186018|FG000|Overall Study|Delivery due to maternal condition|2|||
125426666|NCT03419364|451186019|FG001|Overall Study|Delivery due to maternal condition|0|||
125426667|NCT03419364|451186020|FG002|Overall Study|Delivery due to maternal condition|0|||
125356941|NCT02349061|450942451|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
125356942|NCT02349061|450942452|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
125356943|NCT02349061|450942453|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
125356944|NCT02349061|450942451|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
125356945|NCT02349061|450942452|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
125356946|NCT02349061|450942453|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
125356947|NCT02349061|450942451|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
125356948|NCT02349061|450942452|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
125426668|NCT01525602|451186021|FG000|Overall Study|Adverse Event|1|||
125426669|NCT01525602|451186022|FG001|Overall Study|Adverse Event|0|||
125356949|NCT02349061|450942453|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
125356950|NCT02349061|450942451|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
125356951|NCT02349061|450942452|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
125356952|NCT02349061|450942453|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
125356953|NCT02349061|450942451|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
125356954|NCT02349061|450942452|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
125356955|NCT02349061|450942453|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
125356956|NCT02349061|450942451|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
125356957|NCT02349061|450942452|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
125356958|NCT02349061|450942453|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
125356959|NCT02349061|450942451|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
125356960|NCT02349061|450942452|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
125356961|NCT02349061|450942453|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
125356962|NCT00398411|450942454|FG000|Overall Study|Death|0|||
125356963|NCT00398411|450942455|FG001|Overall Study|Death|1|||
125356964|NCT02095223|450942456|FG000|Overall Study|Withdrawal by Subject|1|||
125356965|NCT02095223|450942457|FG001|Overall Study|Withdrawal by Subject|0|||
125356966|NCT02339285|450942458|FG000|Overall Study|Withdrawal by Subject|0|||
125356967|NCT02339285|450942459|FG001|Overall Study|Withdrawal by Subject|1|||
125356968|NCT02339285|450942460|FG002|Overall Study|Withdrawal by Subject|1|||
125356969|NCT02339285|450942458|FG000|Overall Study|Lost to Follow-up|1|||
125356970|NCT02339285|450942459|FG001|Overall Study|Lost to Follow-up|1|||
125356971|NCT02339285|450942460|FG002|Overall Study|Lost to Follow-up|1|||
125356972|NCT02339285|450942458|FG000|Overall Study|Protocol Deviation|0|||
125356973|NCT02339285|450942459|FG001|Overall Study|Protocol Deviation|1|||
125356974|NCT02339285|450942460|FG002|Overall Study|Protocol Deviation|0|||
125356975|NCT00282412|450942463|FG000|Overall Study|Death|2|||
125356976|NCT00537238|450942464|FG000|Overall Study|Death|1|||
125356977|NCT00537238|450942465|FG001|Overall Study|Death|2|||
125356978|NCT00537238|450942464|FG000|Overall Study|Adverse Event|31|||
125356979|NCT00537238|450942465|FG001|Overall Study|Adverse Event|22|||
125356980|NCT00537238|450942464|FG000|Overall Study|Lack of Efficacy|20|||
125356981|NCT00537238|450942465|FG001|Overall Study|Lack of Efficacy|21|||
125356982|NCT00537238|450942464|FG000|Overall Study|Lost to Follow-up|12|||
125356983|NCT00537238|450942465|FG001|Overall Study|Lost to Follow-up|8|||
125356984|NCT00537238|450942464|FG000|Overall Study|Withdrawal by Subject|51|||
125356985|NCT00537238|450942465|FG001|Overall Study|Withdrawal by Subject|47|||
125356986|NCT00537238|450942464|FG000|Overall Study|Protocol Violation|15|||
125356987|NCT00537238|450942465|FG001|Overall Study|Protocol Violation|19|||
125356988|NCT00537238|450942464|FG000|Overall Study|Does not meet entrance criteria|0|||
125356989|NCT00537238|450942465|FG001|Overall Study|Does not meet entrance criteria|2|||
125356990|NCT00537238|450942464|FG000|Overall Study|Other|44|||
125356991|NCT00537238|450942465|FG001|Overall Study|Other|52|||
125356992|NCT00697073|450942466|FG000|Overall Study|Withdrawal by Subject|2|||
125356993|NCT00697073|450942466|FG000|Overall Study|Pregnancy|1|||
125356994|NCT00697073|450942466|FG000|Overall Study|non compliance and other|6|||
125356995|NCT01193660|450942471|FG000|Overall Study|Withdrawal by Subject|2|||
125356996|NCT01193660|450942472|FG001|Overall Study|Withdrawal by Subject|3|||
125356997|NCT01193660|450942473|FG002|Overall Study|Withdrawal by Subject|1|||
125356998|NCT01193660|450942471|FG000|Overall Study|Death|1|||
125356999|NCT01193660|450942472|FG001|Overall Study|Death|0|||
125357000|NCT01193660|450942473|FG002|Overall Study|Death|0|||
125357001|NCT01193660|450942471|FG000|Overall Study|Physician Decision|1|||
125357002|NCT01193660|450942472|FG001|Overall Study|Physician Decision|0|||
125357003|NCT01193660|450942473|FG002|Overall Study|Physician Decision|1|||
125357004|NCT03347188|450942474|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
125357005|NCT03347188|450942475|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
125357006|NCT03347188|450942474|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
125357007|NCT03347188|450942475|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
125357008|NCT03347188|450942474|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
125357009|NCT03347188|450942475|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
125357010|NCT03347188|450942474|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
125357011|NCT03347188|450942475|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
125357012|NCT03347188|450942474|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
125357013|NCT03347188|450942475|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
125357014|NCT03347188|450942474|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
125357015|NCT03347188|450942475|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
125426670|NCT01525602|451186023|FG002|Overall Study|Adverse Event|1|||
125357016|NCT03347188|450942474|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
125357017|NCT03347188|450942475|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
125357018|NCT03347188|450942474|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
125357019|NCT03347188|450942475|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
125357020|NCT00736957|450942476|FG000|Overall Study|Adverse Event|43|||
125357021|NCT00736957|450942476|FG000|Overall Study|Withdrawal by Subject|49|||
125357022|NCT00736957|450942476|FG000|Overall Study|violation of eligibility criteria|2|||
125357023|NCT00736957|450942476|FG000|Overall Study|did not attend hospital appointments|1|||
125357024|NCT00736957|450942476|FG000|Overall Study|not eligible for Treatment Period I|22|||
125357025|NCT00736957|450942476|FG000|Overall Study|Physician Decision|5|||
125357026|NCT02572388|450942477|FG000|Overall Study|Withdrawal by Subject|1|||
125357027|NCT02572388|450942478|FG001|Overall Study|Withdrawal by Subject|1|||
125357028|NCT02572388|450942479|FG002|Overall Study|Withdrawal by Subject|2|||
125357029|NCT02572388|450942480|FG003|Overall Study|Withdrawal by Subject|2|||
125357030|NCT01051466|450942482|FG000|Overall Study|Adverse Event|1|||
125357031|NCT01051466|450942483|FG001|Overall Study|Adverse Event|0|||
125357032|NCT01051466|450942482|FG000|Overall Study|Lost to Follow-up|1|||
125357033|NCT01051466|450942483|FG001|Overall Study|Lost to Follow-up|1|||
125357034|NCT01051466|450942482|FG000|Overall Study|Withdrawal by Subject|5|||
125357035|NCT01051466|450942483|FG001|Overall Study|Withdrawal by Subject|1|||
125357036|NCT01051466|450942482|FG000|Overall Study|Entry Criteria Not Met|0|||
125357037|NCT01051466|450942483|FG001|Overall Study|Entry Criteria Not Met|3|||
125357038|NCT01051466|450942482|FG000|Overall Study|Physician Decision|1|||
125357039|NCT01051466|450942483|FG001|Overall Study|Physician Decision|0|||
125357040|NCT02231918|450942484|FG000|Overall Study|Withdrawal by Subject|0|||
125357041|NCT02231918|450942485|FG001|Overall Study|Withdrawal by Subject|1|||
125357042|NCT02231918|450942486|FG002|Overall Study|Withdrawal by Subject|0|||
125357043|NCT02231918|450942484|FG000|Overall Study|Adverse Event|0|||
125357044|NCT02231918|450942485|FG001|Overall Study|Adverse Event|0|||
125357045|NCT02231918|450942486|FG002|Overall Study|Adverse Event|1|||
125357046|NCT00331864|450942487|FG000|Overall Study|Adverse Event|30|||
125357047|NCT00331864|450942488|FG001|Overall Study|Adverse Event|1|||
125357048|NCT00331864|450942487|FG000|Overall Study|Lack of Efficacy|4|||
125357049|NCT00331864|450942488|FG001|Overall Study|Lack of Efficacy|0|||
125357050|NCT00331864|450942487|FG000|Overall Study|Protocol Violation|3|||
125357051|NCT00331864|450942488|FG001|Overall Study|Protocol Violation|0|||
125357052|NCT00331864|450942487|FG000|Overall Study|Withdrawal by Subject|10|||
125357053|NCT00331864|450942488|FG001|Overall Study|Withdrawal by Subject|0|||
125357054|NCT00331864|450942487|FG000|Overall Study|Lost to Follow-up|4|||
125357055|NCT00331864|450942488|FG001|Overall Study|Lost to Follow-up|3|||
125357056|NCT00331864|450942487|FG000|Overall Study|Administrative Problems|1|||
125357057|NCT00331864|450942488|FG001|Overall Study|Administrative Problems|0|||
125357058|NCT00331864|450942487|FG000|Overall Study|Death|6|||
125357059|NCT00331864|450942488|FG001|Overall Study|Death|0|||
125357060|NCT01092507|450942489|FG000|Overall Study|Withdrawal by Subject|2|||
125357061|NCT01092507|450942490|FG001|Overall Study|Withdrawal by Subject|0|||
125357062|NCT01539642|450942495|FG000|Overall Study|Lack of Efficacy|20|||
125357063|NCT01539642|450942496|FG001|Overall Study|Lack of Efficacy|18|||
125357064|NCT01539642|450942495|FG000|Overall Study|Patient ready for early discharge|8|||
125357065|NCT01539642|450942496|FG001|Overall Study|Patient ready for early discharge|7|||
125357066|NCT01539642|450942495|FG000|Overall Study|Adverse Event|6|||
125357067|NCT01539642|450942496|FG001|Overall Study|Adverse Event|4|||
125357068|NCT01539642|450942495|FG000|Overall Study|Withdrawal by Subject|2|||
125357069|NCT01539642|450942496|FG001|Overall Study|Withdrawal by Subject|2|||
125357070|NCT03611010|450942497|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
125357071|NCT03611010|450942498|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
125357072|NCT03611010|450942499|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
125357073|NCT03611010|450942500|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
125357074|NCT00598702|450942501|FG000|Overall Study|Other|0|||
125357075|NCT00598702|450942502|FG001|Overall Study|Other|2|||
125357076|NCT00598702|450942503|FG002|Overall Study|Other|0|||
125357077|NCT00598702|450942504|FG003|Overall Study|Other|0|||
125357078|NCT00598702|450942505|FG004|Overall Study|Other|0|||
125357079|NCT00598702|450942506|FG005|Overall Study|Other|1|||
125357080|NCT00598702|450942507|FG006|Overall Study|Other|0|||
125357081|NCT00598702|450942508|FG007|Overall Study|Other|0|||
125357082|NCT00598702|450942501|FG000|Overall Study|Early discharge from hospital|0|||
125357083|NCT00598702|450942502|FG001|Overall Study|Early discharge from hospital|0|||
125357084|NCT00598702|450942503|FG002|Overall Study|Early discharge from hospital|2|||
125357085|NCT00598702|450942504|FG003|Overall Study|Early discharge from hospital|5|||
125357086|NCT00598702|450942505|FG004|Overall Study|Early discharge from hospital|0|||
125357087|NCT00598702|450942506|FG005|Overall Study|Early discharge from hospital|10|||
125567685|NCT00705783|451707979|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
125567686|NCT00705783|451707980|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
125567687|NCT00705783|451707981|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
125567688|NCT00705783|451707979|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
125567689|NCT00705783|451707980|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
125357088|NCT00598702|450942507|FG006|Overall Study|Early discharge from hospital|1|||
125357089|NCT00598702|450942508|FG007|Overall Study|Early discharge from hospital|0|||
125357090|NCT00598702|450942501|FG000|Overall Study|Adverse Event|0|||
125357091|NCT00598702|450942502|FG001|Overall Study|Adverse Event|0|||
125357092|NCT00598702|450942503|FG002|Overall Study|Adverse Event|0|||
125357093|NCT00598702|450942504|FG003|Overall Study|Adverse Event|1|||
125567690|NCT00705783|451707981|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
125567691|NCT00705783|451707979|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
125567692|NCT00705783|451707980|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
125567693|NCT00705783|451707981|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
125567694|NCT00705783|451707979|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
125567695|NCT00705783|451707980|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
125567696|NCT00705783|451707981|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
125357094|NCT00598702|450942505|FG004|Overall Study|Adverse Event|0|||
125357095|NCT00598702|450942506|FG005|Overall Study|Adverse Event|0|||
125357096|NCT00598702|450942507|FG006|Overall Study|Adverse Event|0|||
125357097|NCT00598702|450942508|FG007|Overall Study|Adverse Event|0|||
125357098|NCT00598702|450942501|FG000|Overall Study|Withdrawal by Subject|0|||
125357099|NCT00598702|450942502|FG001|Overall Study|Withdrawal by Subject|0|||
125357100|NCT00598702|450942503|FG002|Overall Study|Withdrawal by Subject|0|||
125357101|NCT00598702|450942504|FG003|Overall Study|Withdrawal by Subject|1|||
125357102|NCT00598702|450942505|FG004|Overall Study|Withdrawal by Subject|1|||
125357103|NCT00598702|450942506|FG005|Overall Study|Withdrawal by Subject|0|||
125357104|NCT00598702|450942507|FG006|Overall Study|Withdrawal by Subject|0|||
125357105|NCT00598702|450942508|FG007|Overall Study|Withdrawal by Subject|0|||
125357106|NCT00598702|450942501|FG000|Overall Study|Physician Decision|0|||
125357107|NCT00598702|450942502|FG001|Overall Study|Physician Decision|0|||
125357108|NCT00598702|450942503|FG002|Overall Study|Physician Decision|0|||
125357109|NCT00598702|450942504|FG003|Overall Study|Physician Decision|0|||
125357110|NCT00598702|450942505|FG004|Overall Study|Physician Decision|1|||
125357111|NCT00598702|450942506|FG005|Overall Study|Physician Decision|0|||
125357112|NCT00598702|450942507|FG006|Overall Study|Physician Decision|0|||
125357113|NCT00598702|450942508|FG007|Overall Study|Physician Decision|0|||
125357114|NCT00598702|450942501|FG000|Overall Study|Dose limiting toxicity|0|||
125357115|NCT00598702|450942502|FG001|Overall Study|Dose limiting toxicity|0|||
125357116|NCT00598702|450942503|FG002|Overall Study|Dose limiting toxicity|0|||
125567697|NCT00705783|451707979|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
125567698|NCT00705783|451707980|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
125567699|NCT00705783|451707981|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
125567700|NCT00705783|451707979|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
125567701|NCT00705783|451707980|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
125567702|NCT00705783|451707981|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
125567703|NCT00705783|451707979|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
125567704|NCT00705783|451707980|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
125567705|NCT00705783|451707981|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
125567706|NCT00705783|451707979|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
125567707|NCT00705783|451707980|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
125567708|NCT00705783|451707981|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
125357117|NCT00598702|450942504|FG003|Overall Study|Dose limiting toxicity|1|||
125357118|NCT00598702|450942505|FG004|Overall Study|Dose limiting toxicity|1|||
125357119|NCT00598702|450942506|FG005|Overall Study|Dose limiting toxicity|1|||
125357120|NCT00598702|450942507|FG006|Overall Study|Dose limiting toxicity|0|||
125357121|NCT00598702|450942508|FG007|Overall Study|Dose limiting toxicity|0|||
125357122|NCT01859143|450942511|FG000|Overall Study|Lost to Follow-up|2|||
125357123|NCT01859143|450942512|FG001|Overall Study|Lost to Follow-up|0|||
125357124|NCT02413372|450942516|FG000|Treatment|Lost to Follow-up|0|||
125357125|NCT02413372|450942517|FG001|Treatment|Lost to Follow-up|2|||
125357126|NCT02413372|450942518|FG002|Treatment|Lost to Follow-up|1|||
125357127|NCT02413372|450942516|FG000|Treatment|Withdrawal by Subject|1|||
125357128|NCT02413372|450942517|FG001|Treatment|Withdrawal by Subject|0|||
125357129|NCT02413372|450942518|FG002|Treatment|Withdrawal by Subject|0|||
125357130|NCT02413372|450942516|FG000|Follow-up|Lost to Follow-up|1|||
125357131|NCT02413372|450942517|FG001|Follow-up|Lost to Follow-up|1|||
125357132|NCT02413372|450942518|FG002|Follow-up|Lost to Follow-up|0|||
125357133|NCT02413372|450942516|FG000|Follow-up|Subject Withdrew Consent|1|||
125357134|NCT02413372|450942517|FG001|Follow-up|Subject Withdrew Consent|0|||
125357135|NCT02413372|450942518|FG002|Follow-up|Subject Withdrew Consent|1|||
125357136|NCT02413372|450942516|FG000|Follow-up|Subject unable to return for visit|0|||
125357137|NCT02413372|450942517|FG001|Follow-up|Subject unable to return for visit|0|||
125357138|NCT02413372|450942518|FG002|Follow-up|Subject unable to return for visit|1|||
125357139|NCT02943460|450942519|FG000|Blinded Study Phase|Adverse Event|3|||
125357140|NCT02943460|450942520|FG001|Blinded Study Phase|Adverse Event|0|||
125357141|NCT02943460|450942521|FG002|Blinded Study Phase|Adverse Event|0|||
125357142|NCT02943460|450942519|FG000|Blinded Study Phase|Withdrew Consent|0|||
125357143|NCT02943460|450942520|FG001|Blinded Study Phase|Withdrew Consent|1|||
125357144|NCT02943460|450942521|FG002|Blinded Study Phase|Withdrew Consent|0|||
125357145|NCT02943460|450942519|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
125357146|NCT02943460|450942520|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
125357147|NCT02943460|450942521|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
125357148|NCT02943460|450942519|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
125357149|NCT02943460|450942520|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
125357150|NCT02943460|450942521|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
125357151|NCT02943460|450942519|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
125357152|NCT02943460|450942520|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
125357153|NCT02943460|450942521|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
125357154|NCT01925274|450942524|FG000|Overall Study|Death|1|||
125357155|NCT01925274|450942525|FG001|Overall Study|Death|0|||
125357156|NCT01925274|450942526|FG002|Overall Study|Death|0|||
125357157|NCT01925274|450942524|FG000|Overall Study|Lost to Follow-up|0|||
125357158|NCT01925274|450942525|FG001|Overall Study|Lost to Follow-up|1|||
125357159|NCT01925274|450942526|FG002|Overall Study|Lost to Follow-up|0|||
125357160|NCT01925274|450942524|FG000|Overall Study|Withdrawal by Subject|1|||
125357161|NCT01925274|450942525|FG001|Overall Study|Withdrawal by Subject|2|||
125357162|NCT01925274|450942526|FG002|Overall Study|Withdrawal by Subject|0|||
125357163|NCT01925274|450942524|FG000|Overall Study|Study terminated by sponsor|4|||
125357164|NCT01925274|450942525|FG001|Overall Study|Study terminated by sponsor|0|||
125357165|NCT01925274|450942526|FG002|Overall Study|Study terminated by sponsor|0|||
125357166|NCT01925274|450942524|FG000|Overall Study|Protocol amendment|1|||
125357167|NCT01925274|450942525|FG001|Overall Study|Protocol amendment|3|||
125357168|NCT01925274|450942526|FG002|Overall Study|Protocol amendment|6|||
125357169|NCT01031381|450942527|FG000|Overall Study|Physician Decision|3|||
125357170|NCT01031381|450942527|FG000|Overall Study|Withdrawal by Subject|6|||
125357171|NCT00723398|450942528|FG000|Overall Study|Withdrawal by Subject|2|||
125357172|NCT00723398|450942529|FG001|Overall Study|Withdrawal by Subject|6|||
125357173|NCT00723398|450942530|FG002|Overall Study|Withdrawal by Subject|4|||
125357174|NCT00723398|450942531|FG003|Overall Study|Withdrawal by Subject|4|||
125357175|NCT00723398|450942532|FG004|Overall Study|Withdrawal by Subject|4|||
125357176|NCT00723398|450942528|FG000|Overall Study|Protocol Violation|2|||
125357177|NCT00723398|450942529|FG001|Overall Study|Protocol Violation|1|||
125357178|NCT00723398|450942530|FG002|Overall Study|Protocol Violation|5|||
125357179|NCT00723398|450942531|FG003|Overall Study|Protocol Violation|0|||
125357180|NCT00723398|450942532|FG004|Overall Study|Protocol Violation|0|||
125357181|NCT00723398|450942528|FG000|Overall Study|Physician Decision|2|||
125357182|NCT00723398|450942529|FG001|Overall Study|Physician Decision|2|||
125357183|NCT00723398|450942530|FG002|Overall Study|Physician Decision|5|||
125357184|NCT00723398|450942531|FG003|Overall Study|Physician Decision|0|||
125357185|NCT00723398|450942532|FG004|Overall Study|Physician Decision|1|||
125357186|NCT00723398|450942528|FG000|Overall Study|Adverse Event|0|||
125357187|NCT00723398|450942529|FG001|Overall Study|Adverse Event|5|||
125357188|NCT00723398|450942530|FG002|Overall Study|Adverse Event|3|||
125357189|NCT00723398|450942531|FG003|Overall Study|Adverse Event|1|||
125357190|NCT00723398|450942532|FG004|Overall Study|Adverse Event|4|||
125357191|NCT00723398|450942528|FG000|Overall Study|Lost to Follow-up|0|||
125357192|NCT00723398|450942529|FG001|Overall Study|Lost to Follow-up|1|||
125357193|NCT00723398|450942530|FG002|Overall Study|Lost to Follow-up|0|||
125357194|NCT00723398|450942531|FG003|Overall Study|Lost to Follow-up|0|||
125357195|NCT00723398|450942532|FG004|Overall Study|Lost to Follow-up|0|||
125357196|NCT00580970|450942535|FG000|Pre-treatment|Non-compliance|1|||
125357197|NCT00580970|450942535|FG000|Treatment (Lovastatin)|Non-compliance|6|||
125357198|NCT00580970|450942535|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
125357199|NCT00580970|450942535|FG000|Treatment (Lovastatin)|Physician Decision|4|||
125357200|NCT00580970|450942535|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
125357201|NCT00580970|450942535|FG000|Treatment (Lovastatin)|Death|1|||
125357202|NCT01086423|450942536|FG000|Overall Study|Protocol Violation|0|||
125357203|NCT01086423|450942537|FG001|Overall Study|Protocol Violation|0|||
125357204|NCT01086423|450942538|FG002|Overall Study|Protocol Violation|1|||
125357205|NCT01086423|450942536|FG000|Overall Study|Migrated/moved from study area|2|||
125357206|NCT01086423|450942537|FG001|Overall Study|Migrated/moved from study area|0|||
125357207|NCT01086423|450942538|FG002|Overall Study|Migrated/moved from study area|4|||
125357208|NCT01086423|450942536|FG000|Overall Study|Adverse event, fatal|1|||
125357209|NCT01086423|450942537|FG001|Overall Study|Adverse event, fatal|1|||
125357210|NCT01086423|450942538|FG002|Overall Study|Adverse event, fatal|0|||
125357211|NCT01086423|450942536|FG000|Overall Study|Adverse event, non-fatal|2|||
125357212|NCT01086423|450942537|FG001|Overall Study|Adverse event, non-fatal|1|||
125357213|NCT01086423|450942538|FG002|Overall Study|Adverse event, non-fatal|0|||
125357214|NCT01086423|450942536|FG000|Overall Study|Withdrawal by Subject|5|||
125357215|NCT01086423|450942537|FG001|Overall Study|Withdrawal by Subject|1|||
125357216|NCT01086423|450942538|FG002|Overall Study|Withdrawal by Subject|3|||
125357217|NCT01086423|450942536|FG000|Overall Study|Lost to Follow-up|0|||
125357218|NCT01086423|450942537|FG001|Overall Study|Lost to Follow-up|0|||
125357219|NCT01086423|450942538|FG002|Overall Study|Lost to Follow-up|1|||
125357220|NCT01008150|450942539|FG000|Overall Study|did not receive study drug|1|||
125357221|NCT01008150|450942540|FG001|Overall Study|did not receive study drug|1|||
125357222|NCT01008150|450942541|FG002|Overall Study|did not receive study drug|1|||
125357223|NCT01008150|450942542|FG003|Overall Study|did not receive study drug|0|||
125357224|NCT01400815|450942543|FG000|Overall Study|Adverse Event|3|||
125357225|NCT01400815|450942544|FG001|Overall Study|Adverse Event|0|||
125357226|NCT01400815|450942543|FG000|Overall Study|Death|0|||
125357227|NCT01400815|450942544|FG001|Overall Study|Death|1|||
125357228|NCT01400815|450942543|FG000|Overall Study|Lost to Follow-up|18|||
125357229|NCT01400815|450942544|FG001|Overall Study|Lost to Follow-up|11|||
125357230|NCT01400815|450942543|FG000|Overall Study|Protocol Violation|0|||
125357231|NCT01400815|450942544|FG001|Overall Study|Protocol Violation|1|||
125357232|NCT01400815|450942543|FG000|Overall Study|Physician Decision|1|||
125357233|NCT01400815|450942544|FG001|Overall Study|Physician Decision|0|||
125357234|NCT01400815|450942543|FG000|Overall Study|Withdrawal by Subject|15|||
125357235|NCT01400815|450942544|FG001|Overall Study|Withdrawal by Subject|8|||
125357236|NCT01400815|450942543|FG000|Overall Study|Subject in jail|1|||
125357237|NCT01400815|450942544|FG001|Overall Study|Subject in jail|0|||
125357238|NCT00568685|450942555|FG000|Overall Study|Adverse Event|2|||
125357239|NCT00568685|450942556|FG001|Overall Study|Adverse Event|3|||
125357240|NCT00568685|450942557|FG002|Overall Study|Adverse Event|3|||
125357241|NCT00568685|450942555|FG000|Overall Study|Withdrawal by Subject|7|||
125357242|NCT00568685|450942556|FG001|Overall Study|Withdrawal by Subject|2|||
125357243|NCT00568685|450942557|FG002|Overall Study|Withdrawal by Subject|2|||
125357244|NCT00568685|450942555|FG000|Overall Study|Protocol Violation|1|||
125357245|NCT00568685|450942556|FG001|Overall Study|Protocol Violation|0|||
125357246|NCT00568685|450942557|FG002|Overall Study|Protocol Violation|0|||
125357247|NCT01147172|450942558|FG000|Overall Study|Withdrawal by Subject|2|||
125357248|NCT01147172|450942558|FG000|Overall Study|Lost to Follow-up|2|||
125357249|NCT02787551|450942559|FG000|Core Period: 26 Weeks|Adverse Event|10|||
125357250|NCT02787551|450942560|FG001|Core Period: 26 Weeks|Adverse Event|0|||
125357251|NCT02787551|450942559|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
125357252|NCT02787551|450942560|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
125357253|NCT02787551|450942559|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
125357254|NCT02787551|450942560|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
125357255|NCT02787551|450942559|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
125357256|NCT02787551|450942560|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
125357257|NCT02787551|450942559|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
125357258|NCT02787551|450942560|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
125357259|NCT02787551|450942559|FG000|Core Period: 26 Weeks|Other than specified|3|||
125357260|NCT02787551|450942560|FG001|Core Period: 26 Weeks|Other than specified|1|||
125357261|NCT02787551|450942559|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
125357262|NCT02787551|450942560|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
125357263|NCT02787551|450942559|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
125357264|NCT02787551|450942560|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
125357265|NCT02787551|450942559|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
125357266|NCT02787551|450942560|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
125357267|NCT01638819|450942561|FG000|Overall Study|Lost to Follow-up|1|||
125357268|NCT01638819|450942562|FG001|Overall Study|Lost to Follow-up|0|||
125357269|NCT00237185|450942563|FG000|Core|Adverse Event|3|||
125357270|NCT00237185|450942564|FG001|Core|Adverse Event|4|||
125357271|NCT00237185|450942563|FG000|Core|Abnormal laboratory value|0|||
125357272|NCT00237185|450942564|FG001|Core|Abnormal laboratory value|4|||
125357273|NCT00237185|450942563|FG000|Core|Abnormal test procedure results|1|||
125357274|NCT00237185|450942564|FG001|Core|Abnormal test procedure results|0|||
125357275|NCT00237185|450942563|FG000|Core|Lack of Efficacy|30|||
125357276|NCT00237185|450942564|FG001|Core|Lack of Efficacy|23|||
125357277|NCT00237185|450942563|FG000|Core|Protocol Violation|1|||
125357278|NCT00237185|450942564|FG001|Core|Protocol Violation|1|||
125357279|NCT00237185|450942563|FG000|Core|Withdrawal by Subject|4|||
125357280|NCT00237185|450942564|FG001|Core|Withdrawal by Subject|4|||
125357281|NCT00237185|450942563|FG000|Core|Administrative problems|0|||
125357282|NCT00237185|450942564|FG001|Core|Administrative problems|1|||
125357283|NCT00237185|450942563|FG000|Core|Death|4|||
125357284|NCT00237185|450942564|FG001|Core|Death|0|||
125357285|NCT00237185|450942563|FG000|Core|Determined ineligible post randomization|1|||
125357286|NCT00237185|450942564|FG001|Core|Determined ineligible post randomization|0|||
125357287|NCT00237185|450942563|FG000|Extension|Adverse Event|1|||
125357288|NCT00237185|450942564|FG001|Extension|Adverse Event|0|||
125357289|NCT00237185|450942563|FG000|Extension|Abnormal laboratory value|0|||
125357290|NCT00237185|450942564|FG001|Extension|Abnormal laboratory value|1|||
125357291|NCT00237185|450942563|FG000|Extension|Lack of Efficacy|9|||
125357292|NCT00237185|450942564|FG001|Extension|Lack of Efficacy|14|||
125357293|NCT00237185|450942563|FG000|Extension|Condition no longer required study drug|0|||
125357294|NCT00237185|450942564|FG001|Extension|Condition no longer required study drug|1|||
125357295|NCT00237185|450942563|FG000|Extension|Withdrawal by Subject|3|||
125357296|NCT00237185|450942564|FG001|Extension|Withdrawal by Subject|2|||
125357297|NCT00237185|450942563|FG000|Extension|Lost to Follow-up|1|||
125357298|NCT00237185|450942564|FG001|Extension|Lost to Follow-up|0|||
125357299|NCT00237185|450942563|FG000|Extension|Administrative problems|1|||
125357300|NCT00237185|450942564|FG001|Extension|Administrative problems|0|||
125357301|NCT00237185|450942563|FG000|Extension|Death|1|||
125357302|NCT00237185|450942564|FG001|Extension|Death|1|||
125357303|NCT05069259|450942565|FG000|Overall Study|Withdrawal by Subject|1|||
125357304|NCT05069259|450942565|FG000|Overall Study|Sponsor decision|1|||
125357305|NCT03148275|450942566|FG000|Overall Study|Death|6|||
125357306|NCT03148275|450942566|FG000|Overall Study|Adverse Event|3|||
125357307|NCT03148275|450942566|FG000|Overall Study|Liver transplant|2|||
125357308|NCT03148275|450942566|FG000|Overall Study|Patient decision|5|||
125357309|NCT03148275|450942566|FG000|Overall Study|transition to commercial drug|1|||
125357310|NCT03148275|450942566|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
125357311|NCT03803683|450942567|FG000|Overall Study|Lost to Follow-up|41|||
125357312|NCT03803683|450942568|FG001|Overall Study|Lost to Follow-up|18|||
125357313|NCT03803683|450942569|FG002|Overall Study|Lost to Follow-up|12|||
125357314|NCT03803683|450942567|FG000|Overall Study|Withdrawal by Subject|9|||
125357315|NCT03803683|450942568|FG001|Overall Study|Withdrawal by Subject|1|||
125357316|NCT03803683|450942569|FG002|Overall Study|Withdrawal by Subject|4|||
125357317|NCT01507298|450943843|FG000|Overall Study|Protocol Violation|0|||
125357318|NCT01507298|450943844|FG001|Overall Study|Protocol Violation|6|||
125357319|NCT01920555|450943845|FG000|Overall Study|Physician Decision|1|||
125357320|NCT01920555|450943846|FG001|Overall Study|Physician Decision|2|||
125357321|NCT01920555|450943847|FG002|Overall Study|Physician Decision|1|||
125357322|NCT01920555|450943848|FG003|Overall Study|Physician Decision|2|||
125357323|NCT01920555|450943849|FG004|Overall Study|Physician Decision|0|||
125357324|NCT01920555|450943845|FG000|Overall Study|Lack of Efficacy|2|||
125357325|NCT01920555|450943846|FG001|Overall Study|Lack of Efficacy|0|||
125357326|NCT01920555|450943847|FG002|Overall Study|Lack of Efficacy|0|||
125357327|NCT01920555|450943848|FG003|Overall Study|Lack of Efficacy|0|||
125357328|NCT01920555|450943849|FG004|Overall Study|Lack of Efficacy|0|||
125357329|NCT01920555|450943845|FG000|Overall Study|Travel Difficulties|1|||
125357330|NCT01920555|450943846|FG001|Overall Study|Travel Difficulties|1|||
125357331|NCT01920555|450943847|FG002|Overall Study|Travel Difficulties|0|||
125357332|NCT01920555|450943848|FG003|Overall Study|Travel Difficulties|0|||
125357333|NCT01920555|450943849|FG004|Overall Study|Travel Difficulties|1|||
125357334|NCT01920555|450943845|FG000|Overall Study|Lost to Follow-up|0|||
125357335|NCT01920555|450943846|FG001|Overall Study|Lost to Follow-up|1|||
125357336|NCT01920555|450943847|FG002|Overall Study|Lost to Follow-up|0|||
125357337|NCT01920555|450943848|FG003|Overall Study|Lost to Follow-up|1|||
125357338|NCT01920555|450943849|FG004|Overall Study|Lost to Follow-up|0|||
125357339|NCT03265665|450943850|FG000|24-week Data Collection|Withdrawal by Subject|2|||
125357340|NCT03265665|450943851|FG001|24-week Data Collection|Withdrawal by Subject|2|||
125357341|NCT03265665|450943850|FG000|24-week Data Collection|Lost to Follow-up|4|||
125357342|NCT03265665|450943851|FG001|24-week Data Collection|Lost to Follow-up|5|||
125357343|NCT03265665|450943850|FG000|36-week Data Collection|Lost to Follow-up|6|||
125357344|NCT03265665|450943851|FG001|36-week Data Collection|Lost to Follow-up|8|||
125357345|NCT01614600|450943852|FG000|Overall Study|Unacceptable fit|1|||
125357346|NCT01614600|450943852|FG000|Overall Study|Discomfort|1|||
125357347|NCT01614600|450943852|FG000|Overall Study|Unable to remove lens at the end of day|1|||
125357348|NCT01614600|450943852|FG000|Overall Study|Protocol deviation|1|||
125357349|NCT00195273|450943853|FG000|Overall Study|Adverse Event|9|||
125357350|NCT00195273|450943854|FG001|Overall Study|Adverse Event|9|||
125357351|NCT00195273|450943853|FG000|Overall Study|Protocol deviation|0|||
125357352|NCT00195273|450943854|FG001|Overall Study|Protocol deviation|1|||
125357353|NCT00195273|450943853|FG000|Overall Study|Lack of Efficacy|3|||
125357354|NCT00195273|450943854|FG001|Overall Study|Lack of Efficacy|1|||
125357355|NCT00195273|450943853|FG000|Overall Study|Procedural complications|9|||
125357356|NCT00195273|450943854|FG001|Overall Study|Procedural complications|3|||
125357357|NCT02186873|450943855|FG000|Overall Study|Adverse Event|1|||
125357358|NCT02186873|450943856|FG001|Overall Study|Adverse Event|3|||
125357359|NCT02186873|450943855|FG000|Overall Study|Lack of Efficacy|0|||
125357360|NCT02186873|450943856|FG001|Overall Study|Lack of Efficacy|1|||
125357361|NCT02186873|450943855|FG000|Overall Study|Lost to Follow-up|1|||
125357362|NCT02186873|450943856|FG001|Overall Study|Lost to Follow-up|2|||
125357363|NCT02186873|450943855|FG000|Overall Study|Withdrawal by Subject|7|||
125357364|NCT02186873|450943856|FG001|Overall Study|Withdrawal by Subject|2|||
125357365|NCT01680965|450943857|FG000|Overall Study|Death|0|||
125357366|NCT01680965|450943858|FG001|Overall Study|Death|0|||
125357367|NCT01680965|450943859|FG002|Overall Study|Death|0|||
125357368|NCT01680965|450943860|FG003|Overall Study|Death|6|||
125357369|NCT00595465|450943861|FG000|Overall Study|Adverse Event|4|||
125357370|NCT00595465|450943862|FG001|Overall Study|Adverse Event|3|||
125357371|NCT00595465|450943863|FG002|Overall Study|Adverse Event|3|||
125357372|NCT00595465|450943861|FG000|Overall Study|Pregnancy|0|||
125357373|NCT00595465|450943862|FG001|Overall Study|Pregnancy|0|||
125357374|NCT00595465|450943863|FG002|Overall Study|Pregnancy|1|||
125357375|NCT00595465|450943861|FG000|Overall Study|Protocol Violation|2|||
125357376|NCT00595465|450943862|FG001|Overall Study|Protocol Violation|1|||
125357377|NCT00595465|450943863|FG002|Overall Study|Protocol Violation|0|||
125357378|NCT00595465|450943861|FG000|Overall Study|Lost to Follow-up|0|||
125357379|NCT00595465|450943862|FG001|Overall Study|Lost to Follow-up|0|||
125357380|NCT00595465|450943863|FG002|Overall Study|Lost to Follow-up|2|||
125357381|NCT00595465|450943861|FG000|Overall Study|administrative reason|0|||
125357382|NCT00595465|450943862|FG001|Overall Study|administrative reason|0|||
125357383|NCT00595465|450943863|FG002|Overall Study|administrative reason|1|||
125357384|NCT02595970|450943864|FG000|Overall Study|Withdrawal by Subject|2|||
125357385|NCT02595970|450943864|FG000|Overall Study|Physician Decision|2|||
125357386|NCT02595970|450943864|FG000|Overall Study|Protocol Violation|4|||
125357387|NCT02595970|450943864|FG000|Overall Study|Adverse Event|5|||
125357388|NCT02595970|450943864|FG000|Overall Study|Lack of Efficacy|7|||
125357389|NCT01886716|450943865|FG000|Week 1|Lost to Follow-up|0|||
125357390|NCT01886716|450943866|FG001|Week 1|Lost to Follow-up|0|||
125357391|NCT01886716|450943867|FG002|Week 1|Lost to Follow-up|2|||
125357392|NCT01886716|450943868|FG003|Week 1|Lost to Follow-up|2|||
125357393|NCT01886716|450943865|FG000|Week 2|Lost to Follow-up|3|||
125357394|NCT01886716|450943866|FG001|Week 2|Lost to Follow-up|2|||
125357395|NCT01886716|450943867|FG002|Week 2|Lost to Follow-up|1|||
125357396|NCT01886716|450943868|FG003|Week 2|Lost to Follow-up|3|||
125357397|NCT01886716|450943865|FG000|Week 3|Lost to Follow-up|1|||
125357398|NCT01886716|450943866|FG001|Week 3|Lost to Follow-up|1|||
125357399|NCT01886716|450943867|FG002|Week 3|Lost to Follow-up|0|||
125357400|NCT01886716|450943868|FG003|Week 3|Lost to Follow-up|1|||
125357401|NCT00107783|450943869|FG000|Overall Study|Adverse Event|0|||
125357402|NCT00107783|450943870|FG001|Overall Study|Adverse Event|2|||
125357403|NCT00107783|450943869|FG000|Overall Study|Death|0|||
125357404|NCT00107783|450943870|FG001|Overall Study|Death|1|||
125357405|NCT00107783|450943869|FG000|Overall Study|Withdrawal by Subject|2|||
125357406|NCT00107783|450943870|FG001|Overall Study|Withdrawal by Subject|0|||
125357407|NCT00107783|450943869|FG000|Overall Study|Second hip replacement|1|||
125357408|NCT00107783|450943870|FG001|Overall Study|Second hip replacement|1|||
125357409|NCT04879225|450943873|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
125357410|NCT04879225|450943873|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
125357411|NCT00810108|450943878|FG000|Overall Study|Withdrawal by Subject|1|||
125357412|NCT00810108|450943879|FG001|Overall Study|Withdrawal by Subject|0|||
125357413|NCT01578330|450943886|FG000|Overall Study|Adverse Event|2|||
125357414|NCT01578330|450943886|FG000|Overall Study|Protocol Violation|5|||
125357415|NCT01676727|450943887|FG000|Overall Study|Death|18|||
125357416|NCT01676727|450943887|FG000|Overall Study|Withdrawal by Subject|6|||
125357417|NCT01676727|450943887|FG000|Overall Study|Screening failure|5|||
125357418|NCT01676727|450943887|FG000|Overall Study|Not willing to attend 1-year visit|2|||
125357419|NCT01676727|450943887|FG000|Overall Study|Valve explanted|1|||
125357420|NCT03114488|450943888|FG000|Time Period 2|Withdrawal by Subject|1|||
125357421|NCT03114488|450943889|FG001|Time Period 2|Withdrawal by Subject|3|||
125357422|NCT00566501|450943890|FG000|Overall Study|Adverse Event|68|||
125357423|NCT00566501|450943891|FG001|Overall Study|Adverse Event|59|||
125357424|NCT00566501|450943890|FG000|Overall Study|Medication Non-compliance|5|||
125357425|NCT00566501|450943891|FG001|Overall Study|Medication Non-compliance|0|||
125357426|NCT00566501|450943890|FG000|Overall Study|Protocol Violation|2|||
125357427|NCT00566501|450943891|FG001|Overall Study|Protocol Violation|2|||
125357428|NCT00566501|450943890|FG000|Overall Study|Request of Investigator or Sponsor|6|||
125357429|NCT00566501|450943891|FG001|Overall Study|Request of Investigator or Sponsor|7|||
125357430|NCT00566501|450943890|FG000|Overall Study|Withdrawal by Subject|33|||
125357431|NCT00566501|450943891|FG001|Overall Study|Withdrawal by Subject|30|||
125357432|NCT00566501|450943890|FG000|Overall Study|Lack of Efficacy|8|||
125357433|NCT00566501|450943891|FG001|Overall Study|Lack of Efficacy|3|||
125357434|NCT00566501|450943890|FG000|Overall Study|Other|25|||
125357435|NCT00566501|450943891|FG001|Overall Study|Other|21|||
125357436|NCT01368432|450943896|FG000|Overall Study|Lost to Follow-up|0|||
125357437|NCT01368432|450943897|FG001|Overall Study|Lost to Follow-up|1|||
125357438|NCT00437320|450943899|FG000|Overall Study|Participant request|2|||
125357439|NCT00437320|450943900|FG001|Overall Study|Participant request|1|||
125357440|NCT00437320|450943901|FG002|Overall Study|Participant request|4|||
125357441|NCT01938573|450943902|FG000|Overall Study|Lack of Efficacy|1|||
125357442|NCT01938573|450943903|FG001|Overall Study|Lack of Efficacy|0|||
125357443|NCT01938573|450943902|FG000|Overall Study|Operation at other hospital|1|||
125357444|NCT01938573|450943903|FG001|Overall Study|Operation at other hospital|0|||
125357445|NCT03845543|450943911|FG000|Overall Study|Death|25|||
125357446|NCT03845543|450943911|FG000|Overall Study|Withdrawal by Subject|2|||
125357447|NCT03845543|450943911|FG000|Overall Study|Lost to Follow-up|12|||
125357448|NCT03845543|450943911|FG000|Overall Study|Adverse Event|17|||
125357449|NCT02456103|450943912|FG000|Overall Study|Study Closure|207|||
125357450|NCT02456103|450943912|FG000|Overall Study|Physician Decision|1|||
125357451|NCT02456103|450943912|FG000|Overall Study|Required prohibited medications|5|||
125357452|NCT02456103|450943912|FG000|Overall Study|Protocol Violation|1|||
125357453|NCT02456103|450943912|FG000|Overall Study|Adverse Event|5|||
125357454|NCT02456103|450943912|FG000|Overall Study|Abnormal Laboratory Value|2|||
125357455|NCT02456103|450943912|FG000|Overall Study|Lost to Follow-up|1|||
125357456|NCT02456103|450943912|FG000|Overall Study|Withdrawal by Subject|24|||
125357457|NCT02448810|450943914|FG000|Overall Study|Adverse Event|0|||
125357458|NCT02448810|450943915|FG001|Overall Study|Adverse Event|0|||
125357459|NCT02448810|450943916|FG002|Overall Study|Adverse Event|1|||
125357460|NCT02448810|450943917|FG003|Overall Study|Adverse Event|0|||
125357461|NCT02448810|450943918|FG004|Overall Study|Adverse Event|0|||
125357462|NCT02448810|450943919|FG005|Overall Study|Adverse Event|0|||
125357463|NCT02448810|450943920|FG006|Overall Study|Adverse Event|0|||
125357464|NCT02448810|450943921|FG007|Overall Study|Adverse Event|0|||
125357465|NCT02448810|450943914|FG000|Overall Study|Withdrawal by Subject|0|||
125357466|NCT02448810|450943915|FG001|Overall Study|Withdrawal by Subject|0|||
125357467|NCT02448810|450943916|FG002|Overall Study|Withdrawal by Subject|1|||
125357468|NCT02448810|450943917|FG003|Overall Study|Withdrawal by Subject|0|||
125357469|NCT02448810|450943918|FG004|Overall Study|Withdrawal by Subject|3|||
125357470|NCT02448810|450943919|FG005|Overall Study|Withdrawal by Subject|5|||
125357471|NCT02448810|450943920|FG006|Overall Study|Withdrawal by Subject|0|||
125357472|NCT02448810|450943921|FG007|Overall Study|Withdrawal by Subject|2|||
125357473|NCT02448810|450943914|FG000|Overall Study|Other (study terminated by sponsor)|0|||
125357474|NCT02448810|450943915|FG001|Overall Study|Other (study terminated by sponsor)|0|||
125357475|NCT02448810|450943916|FG002|Overall Study|Other (study terminated by sponsor)|0|||
125357476|NCT02448810|450943917|FG003|Overall Study|Other (study terminated by sponsor)|0|||
125357477|NCT02448810|450943918|FG004|Overall Study|Other (study terminated by sponsor)|4|||
125357478|NCT02448810|450943919|FG005|Overall Study|Other (study terminated by sponsor)|2|||
125357479|NCT02448810|450943920|FG006|Overall Study|Other (study terminated by sponsor)|2|||
125357480|NCT02448810|450943921|FG007|Overall Study|Other (study terminated by sponsor)|1|||
125357481|NCT02448810|450943914|FG000|Overall Study|Death|1|||
125357482|NCT02448810|450943915|FG001|Overall Study|Death|0|||
125357483|NCT02448810|450943916|FG002|Overall Study|Death|1|||
125357484|NCT02448810|450943917|FG003|Overall Study|Death|0|||
125357485|NCT02448810|450943918|FG004|Overall Study|Death|1|||
125357486|NCT02448810|450943919|FG005|Overall Study|Death|0|||
125357487|NCT02448810|450943920|FG006|Overall Study|Death|0|||
125357488|NCT02448810|450943921|FG007|Overall Study|Death|0|||
125357489|NCT02448810|450943914|FG000|Overall Study|Other (Progressive disease)|2|||
125357490|NCT02448810|450943915|FG001|Overall Study|Other (Progressive disease)|2|||
125357491|NCT02448810|450943916|FG002|Overall Study|Other (Progressive disease)|0|||
125357492|NCT02448810|450943917|FG003|Overall Study|Other (Progressive disease)|3|||
125357493|NCT02448810|450943918|FG004|Overall Study|Other (Progressive disease)|23|||
125357494|NCT02448810|450943919|FG005|Overall Study|Other (Progressive disease)|9|||
125357495|NCT02448810|450943920|FG006|Overall Study|Other (Progressive disease)|14|||
125357496|NCT02448810|450943921|FG007|Overall Study|Other (Progressive disease)|5|||
125357497|NCT02448810|450943914|FG000|Overall Study|Lost to Follow-up|0|||
125357498|NCT02448810|450943915|FG001|Overall Study|Lost to Follow-up|1|||
125357499|NCT02448810|450943916|FG002|Overall Study|Lost to Follow-up|0|||
125357500|NCT02448810|450943917|FG003|Overall Study|Lost to Follow-up|0|||
125357501|NCT02448810|450943918|FG004|Overall Study|Lost to Follow-up|0|||
125357502|NCT02448810|450943919|FG005|Overall Study|Lost to Follow-up|0|||
125357503|NCT02448810|450943920|FG006|Overall Study|Lost to Follow-up|0|||
125357504|NCT02448810|450943921|FG007|Overall Study|Lost to Follow-up|0|||
125357505|NCT02448810|450943914|FG000|Overall Study|Other (unspecified)|0|||
125357506|NCT02448810|450943915|FG001|Overall Study|Other (unspecified)|0|||
125357507|NCT02448810|450943916|FG002|Overall Study|Other (unspecified)|0|||
125357508|NCT02448810|450943917|FG003|Overall Study|Other (unspecified)|0|||
125357509|NCT02448810|450943918|FG004|Overall Study|Other (unspecified)|0|||
125357510|NCT02448810|450943919|FG005|Overall Study|Other (unspecified)|0|||
125357511|NCT02448810|450943920|FG006|Overall Study|Other (unspecified)|2|||
125357512|NCT02448810|450943921|FG007|Overall Study|Other (unspecified)|0|||
125357513|NCT00470847|450943926|FG000|Overall Study|Pt still receiving treatment|1|||
125357514|NCT03139279|450943934|FG000|Overall Study|Physician Decision|2|||
125357515|NCT03139279|450943935|FG001|Overall Study|Physician Decision|0|||
125357516|NCT03139279|450943934|FG000|Overall Study|Protocol Violation|5|||
125357517|NCT03139279|450943935|FG001|Overall Study|Protocol Violation|4|||
125357518|NCT03139279|450943934|FG000|Overall Study|Withdrawal by Subject|0|||
125357519|NCT03139279|450943935|FG001|Overall Study|Withdrawal by Subject|2|||
125426671|NCT01525602|451186024|FG003|Overall Study|Adverse Event|1|||
125426672|NCT01525602|451186025|FG004|Overall Study|Adverse Event|3|||
125426673|NCT01525602|451186026|FG005|Overall Study|Adverse Event|3|||
125426674|NCT01525602|451186027|FG006|Overall Study|Adverse Event|0|||
125426675|NCT01525602|451186028|FG007|Overall Study|Adverse Event|1|||
125426676|NCT01525602|451186021|FG000|Overall Study|Disease progression|6|||
125426677|NCT01525602|451186022|FG001|Overall Study|Disease progression|3|||
125426678|NCT01525602|451186023|FG002|Overall Study|Disease progression|2|||
125426679|NCT01525602|451186024|FG003|Overall Study|Disease progression|5|||
125426680|NCT01525602|451186025|FG004|Overall Study|Disease progression|22|||
125426681|NCT01525602|451186026|FG005|Overall Study|Disease progression|2|||
125426682|NCT01525602|451186027|FG006|Overall Study|Disease progression|3|||
125426683|NCT01525602|451186028|FG007|Overall Study|Disease progression|3|||
125567709|NCT03029143|451707987|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
125426684|NCT01525602|451186021|FG000|Overall Study|Clinical progression|2|||
125426685|NCT01525602|451186022|FG001|Overall Study|Clinical progression|0|||
125426686|NCT01525602|451186023|FG002|Overall Study|Clinical progression|0|||
125357520|NCT01090973|450943936|FG000|Overall Study|Disease progression|1|||
125357521|NCT01626495|450943939|FG000|Overall Study|Adverse Event|3|||
125357522|NCT01626495|450943939|FG000|Overall Study|Disease progression|27|||
125357523|NCT01626495|450943939|FG000|Overall Study|Withdrawal by Subject|1|||
125357524|NCT01626495|450943939|FG000|Overall Study|Administrative problem|1|||
125357525|NCT01626495|450943939|FG000|Overall Study|Death|2|||
125357526|NCT01626495|450943939|FG000|Overall Study|Physician Decision|1|||
125357527|NCT01626495|450943939|FG000|Overall Study|New cancer therapy|16|||
125357528|NCT01626495|450943939|FG000|Overall Study|Manufacturing failure|1|||
125357529|NCT01934972|450943940|FG000|Overall Study|Withdrawal by Subject|9|||
125357530|NCT01934972|450943941|FG001|Overall Study|Withdrawal by Subject|6|||
125357531|NCT03131453|450943942|FG000|Overall Study|Study terminated by Sponsor|424|||
125357532|NCT03131453|450943943|FG001|Overall Study|Study terminated by Sponsor|222|||
125357533|NCT03131453|450943944|FG002|Overall Study|Study terminated by Sponsor|438|||
125357534|NCT03131453|450943942|FG000|Overall Study|Withdrawal by Subject|18|||
125357535|NCT03131453|450943943|FG001|Overall Study|Withdrawal by Subject|7|||
125357536|NCT03131453|450943944|FG002|Overall Study|Withdrawal by Subject|13|||
125357537|NCT03131453|450943942|FG000|Overall Study|Adverse Event|10|||
125357538|NCT03131453|450943943|FG001|Overall Study|Adverse Event|3|||
125357539|NCT03131453|450943944|FG002|Overall Study|Adverse Event|3|||
125357540|NCT03131453|450943942|FG000|Overall Study|Lost to Follow-up|1|||
125357541|NCT03131453|450943943|FG001|Overall Study|Lost to Follow-up|0|||
125357542|NCT03131453|450943944|FG002|Overall Study|Lost to Follow-up|1|||
125357543|NCT03131453|450943942|FG000|Overall Study|Physician Decision|1|||
125357544|NCT03131453|450943943|FG001|Overall Study|Physician Decision|0|||
125357545|NCT03131453|450943944|FG002|Overall Study|Physician Decision|1|||
125357546|NCT03131453|450943942|FG000|Overall Study|Non-compliance with study treatment|1|||
125357547|NCT03131453|450943943|FG001|Overall Study|Non-compliance with study treatment|0|||
125357548|NCT03131453|450943944|FG002|Overall Study|Non-compliance with study treatment|0|||
125357549|NCT03131453|450943942|FG000|Overall Study|Technical problems|1|||
125357550|NCT03131453|450943943|FG001|Overall Study|Technical problems|0|||
125357551|NCT03131453|450943944|FG002|Overall Study|Technical problems|0|||
125357552|NCT03131453|450943942|FG000|Overall Study|Protocol deviation|0|||
125357553|NCT03131453|450943943|FG001|Overall Study|Protocol deviation|1|||
125357554|NCT03131453|450943944|FG002|Overall Study|Protocol deviation|0|||
125357555|NCT03438383|450943947|FG000|Overall Study|Protocol Violation|9|||
125357556|NCT03438383|450943948|FG001|Overall Study|Protocol Violation|3|||
125357557|NCT02766465|450943949|FG000|Overall Study|Withdrawal by Subject|0|||
125357558|NCT02766465|450943950|FG001|Overall Study|Withdrawal by Subject|10|||
125357559|NCT02435069|450943951|FG000|Dose Response - First Intervention|Adverse Event|0|||
125357560|NCT02435069|450943952|FG001|Dose Response - First Intervention|Adverse Event|1|||
125357561|NCT02435069|450943953|FG002|Dose Response - First Intervention|Adverse Event|1|||
125357562|NCT02435069|450943954|FG003|Dose Response - First Intervention|Adverse Event|0|||
125357563|NCT02435069|450943955|FG004|Dose Response - First Intervention|Adverse Event|0|||
125357564|NCT02435069|450943951|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
125357565|NCT02435069|450943952|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
125357566|NCT02435069|450943953|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
125357567|NCT02435069|450943954|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
125357568|NCT02435069|450943955|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
125357569|NCT01528033|450943956|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
125357570|NCT01528033|450943957|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
125357571|NCT01528033|450943956|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
125357572|NCT01528033|450943957|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
125357573|NCT01528033|450943956|FG000|Primary Endpoint Assessment ITT|Death|2|||
125357574|NCT01528033|450943957|FG001|Primary Endpoint Assessment ITT|Death|2|||
125357575|NCT01528033|450943956|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
125357576|NCT01528033|450943957|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
125357577|NCT01528033|450943956|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
125357578|NCT01528033|450943957|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
125357579|NCT01528033|450943956|FG000|Follow Up|No data available|46|||
125357580|NCT01528033|450943957|FG001|Follow Up|No data available|44|||
125357581|NCT02520661|450943958|FG000|Overall Study|Lost to Follow-up|7|||
125357582|NCT02520661|450943959|FG001|Overall Study|Lost to Follow-up|3|||
125357583|NCT02520661|450943958|FG000|Overall Study|Admitted from ED|49|||
125357584|NCT02520661|450943959|FG001|Overall Study|Admitted from ED|48|||
125357585|NCT02520661|450943958|FG000|Overall Study|ED greater than 24 hours|29|||
125357586|NCT02520661|450943959|FG001|Overall Study|ED greater than 24 hours|38|||
125357587|NCT02520661|450943958|FG000|Overall Study|other ineligibility|14|||
125357588|NCT02520661|450943959|FG001|Overall Study|other ineligibility|22|||
125357589|NCT02520661|450943958|FG000|Overall Study|Withdrawal by Subject|7|||
125357590|NCT02520661|450943959|FG001|Overall Study|Withdrawal by Subject|16|||
125357591|NCT05156073|450943962|FG000|Overall Study|Patient canceled appointment with PCP|1|||
125357592|NCT02891161|450943973|FG000|Study Treatment|Disease Progression|2|||
125357593|NCT02891161|450943974|FG001|Study Treatment|Disease Progression|4|||
125357594|NCT02891161|450943973|FG000|Study Treatment|AE/Side Effects/Complications|1|||
125357595|NCT02891161|450943974|FG001|Study Treatment|AE/Side Effects/Complications|5|||
125357596|NCT02891161|450943973|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
125357597|NCT02891161|450943974|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
125357598|NCT02891161|450943973|FG000|Follow up|Death|4|||
125357599|NCT02891161|450943974|FG001|Follow up|Death|8|||
125357600|NCT02891161|450943973|FG000|Follow up|Refused to Follow up|0|||
125357601|NCT02891161|450943974|FG001|Follow up|Refused to Follow up|2|||
125357602|NCT02891161|450943973|FG000|Follow up|Symptomatic deterioration|0|||
125357603|NCT02891161|450943974|FG001|Follow up|Symptomatic deterioration|1|||
125357604|NCT02891161|450943973|FG000|Follow up|Study terminated|0|||
125357605|NCT02891161|450943974|FG001|Follow up|Study terminated|6|||
125357606|NCT02734433|450943977|FG000|Overall Study|Disease progression|1|||
125357607|NCT02734433|450943978|FG001|Overall Study|Disease progression|5|||
125357608|NCT02734433|450943977|FG000|Overall Study|Clinical progression|0|||
125357609|NCT02734433|450943978|FG001|Overall Study|Clinical progression|1|||
125357610|NCT02734433|450943977|FG000|Overall Study|Withdrawal by Subject|1|||
125357611|NCT02734433|450943978|FG001|Overall Study|Withdrawal by Subject|2|||
125426687|NCT01525602|451186024|FG003|Overall Study|Clinical progression|0|||
125357612|NCT02628769|450943979|FG000|First Intervention|Adverse Event|1|||
125357613|NCT02628769|450943980|FG001|First Intervention|Adverse Event|0|||
125357614|NCT02628769|450943979|FG000|First Intervention|Withdrawal by Subject|0|||
125426688|NCT01525602|451186025|FG004|Overall Study|Clinical progression|0|||
125357615|NCT02628769|450943980|FG001|First Intervention|Withdrawal by Subject|1|||
125357616|NCT02628769|450943979|FG000|Second Intervention|Adverse Event|2|||
125357617|NCT02628769|450943980|FG001|Second Intervention|Adverse Event|0|||
125357618|NCT02628769|450943979|FG000|Second Intervention|Physician Decision|0|||
125357619|NCT02628769|450943980|FG001|Second Intervention|Physician Decision|1|||
125357620|NCT05521906|450943987|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
125357621|NCT05521906|450943988|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
125357622|NCT00560885|450943989|FG000|Overall Study|Death|7|||
125357623|NCT00560885|450943989|FG000|Overall Study|Withdrawal by Subject|1|||
125357624|NCT02887859|450943990|FG000|Overall Study|Ongoing|6|||
125357625|NCT02887859|450943990|FG000|Overall Study|Adverse Event|7|||
125357626|NCT02887859|450943990|FG000|Overall Study|Death|1|||
125357627|NCT02887859|450943990|FG000|Overall Study|Physician Decision|1|||
125357628|NCT00257608|450946205|FG000|Chemotherapy Phase|Adverse Event|138|||
125357629|NCT00257608|450946206|FG001|Chemotherapy Phase|Adverse Event|0|||
125357630|NCT00257608|450946207|FG002|Chemotherapy Phase|Adverse Event|0|||
125357631|NCT00257608|450946205|FG000|Chemotherapy Phase|Disease progression|139|||
125357632|NCT00257608|450946206|FG001|Chemotherapy Phase|Disease progression|0|||
125357633|NCT00257608|450946207|FG002|Chemotherapy Phase|Disease progression|0|||
125357634|NCT00257608|450946205|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
125357635|NCT00257608|450946206|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
125357636|NCT00257608|450946207|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
125357637|NCT00257608|450946205|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
125357638|NCT00257608|450946206|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
125357639|NCT00257608|450946207|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
125357640|NCT00257608|450946205|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
125357641|NCT00257608|450946206|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
125357642|NCT00257608|450946207|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
125357643|NCT00257608|450946205|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
125357644|NCT00257608|450946206|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
125357645|NCT00257608|450946207|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
125357646|NCT00257608|450946205|FG000|Chemotherapy Phase|Physician Decision|28|||
125357647|NCT00257608|450946206|FG001|Chemotherapy Phase|Physician Decision|0|||
125357648|NCT00257608|450946207|FG002|Chemotherapy Phase|Physician Decision|0|||
125357649|NCT00257608|450946205|FG000|Post Chemotherapy Phase|Adverse Event|0|||
125357650|NCT00257608|450946206|FG001|Post Chemotherapy Phase|Adverse Event|34|||
125357651|NCT00257608|450946207|FG002|Post Chemotherapy Phase|Adverse Event|38|||
125357652|NCT00257608|450946205|FG000|Post Chemotherapy Phase|Disease progression|0|||
125357653|NCT00257608|450946206|FG001|Post Chemotherapy Phase|Disease progression|204|||
125357654|NCT00257608|450946207|FG002|Post Chemotherapy Phase|Disease progression|168|||
125357655|NCT00257608|450946205|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
125357656|NCT00257608|450946206|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
125357657|NCT00257608|450946207|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
125357658|NCT00257608|450946205|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
125357659|NCT00257608|450946206|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
125357660|NCT00257608|450946207|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
125357661|NCT00257608|450946205|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
125357662|NCT00257608|450946206|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
125357663|NCT00257608|450946207|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
125357664|NCT00257608|450946205|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
125357665|NCT00257608|450946206|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
125357666|NCT00257608|450946207|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
125357667|NCT00257608|450946205|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
125357668|NCT00257608|450946206|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
125357669|NCT00257608|450946207|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
125357670|NCT00257608|450946205|FG000|Post Chemotherapy Phase|Physician Decision|0|||
125357671|NCT00257608|450946206|FG001|Post Chemotherapy Phase|Physician Decision|8|||
125357672|NCT00257608|450946207|FG002|Post Chemotherapy Phase|Physician Decision|11|||
125357673|NCT00257608|450946205|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
125357674|NCT00257608|450946206|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
125357675|NCT00257608|450946207|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
125357676|NCT00257608|450946205|FG000|Post Chemotherapy Phase|Not treated|0|||
125357677|NCT00257608|450946206|FG001|Post Chemotherapy Phase|Not treated|4|||
125357678|NCT00257608|450946207|FG002|Post Chemotherapy Phase|Not treated|7|||
125357679|NCT02171065|450946208|FG000|Overall Study|Withdrawal by Subject|1|||
125357680|NCT02171065|450946209|FG001|Overall Study|Withdrawal by Subject|0|||
125357681|NCT02171065|450946210|FG002|Overall Study|Withdrawal by Subject|0|||
125357682|NCT02171065|450946208|FG000|Overall Study|Lost to Follow-up|0|||
125357683|NCT02171065|450946209|FG001|Overall Study|Lost to Follow-up|0|||
125357684|NCT02171065|450946210|FG002|Overall Study|Lost to Follow-up|1|||
125357685|NCT02203071|450946213|FG000|Overall Study|Lost to Follow-up|3|||
125357686|NCT02203071|450946214|FG001|Overall Study|Lost to Follow-up|1|||
125357687|NCT03894046|450946215|FG000|Overall Study|Protocol Violation|1|||
125357688|NCT03894046|450946216|FG001|Overall Study|Protocol Violation|0|||
125357689|NCT03894046|450946217|FG002|Overall Study|Protocol Violation|0|||
125357690|NCT03894046|450946215|FG000|Overall Study|Adverse Event|0|||
125357691|NCT03894046|450946216|FG001|Overall Study|Adverse Event|1|||
125357692|NCT03894046|450946217|FG002|Overall Study|Adverse Event|0|||
125357693|NCT03894046|450946215|FG000|Overall Study|Withdrawal by Subject|2|||
125357694|NCT03894046|450946216|FG001|Overall Study|Withdrawal by Subject|3|||
125357695|NCT03894046|450946217|FG002|Overall Study|Withdrawal by Subject|1|||
125357696|NCT03894046|450946215|FG000|Overall Study|Death|15|||
125357697|NCT03894046|450946216|FG001|Overall Study|Death|21|||
125357698|NCT03894046|450946217|FG002|Overall Study|Death|4|||
125357699|NCT03894046|450946215|FG000|Overall Study|No growth of ABC|2|||
125357700|NCT03894046|450946216|FG001|Overall Study|No growth of ABC|1|||
125357701|NCT03894046|450946217|FG002|Overall Study|No growth of ABC|0|||
125357702|NCT03894046|450946215|FG000|Overall Study|Physician Decision|1|||
125357703|NCT03894046|450946216|FG001|Overall Study|Physician Decision|1|||
125357704|NCT03894046|450946217|FG002|Overall Study|Physician Decision|1|||
125357705|NCT03894046|450946215|FG000|Overall Study|Prohibited concomitant medication|1|||
125357706|NCT03894046|450946216|FG001|Overall Study|Prohibited concomitant medication|0|||
125357707|NCT03894046|450946217|FG002|Overall Study|Prohibited concomitant medication|0|||
125357708|NCT03894046|450946215|FG000|Overall Study|Transferred to other arm/group|1|||
125357709|NCT03894046|450946216|FG001|Overall Study|Transferred to other arm/group|1|||
125357710|NCT03894046|450946217|FG002|Overall Study|Transferred to other arm/group|0|||
125357711|NCT02367131|450946218|FG000|Overall Study|Adverse Event|64|||
125357712|NCT02367131|450946218|FG000|Overall Study|No visit since the first visit|3|||
125357713|NCT02367131|450946218|FG000|Overall Study|Request by patient|53|||
125357714|NCT02367131|450946218|FG000|Overall Study|Improvement/remission|2|||
125357715|NCT02367131|450946218|FG000|Overall Study|No change/progressive disease|78|||
125357716|NCT02367131|450946218|FG000|Overall Study|Other than stated above|20|||
125357717|NCT02367131|450946218|FG000|Overall Study|Not treated|2|||
125357718|NCT01973569|450946219|FG000|Overall Study|Adverse Event|9|||
125357719|NCT01973569|450946220|FG001|Overall Study|Adverse Event|2|||
125357720|NCT01973569|450946221|FG002|Overall Study|Adverse Event|4|||
125357721|NCT01973569|450946219|FG000|Overall Study|Protocol Violation|2|||
125357722|NCT01973569|450946220|FG001|Overall Study|Protocol Violation|1|||
125357723|NCT01973569|450946221|FG002|Overall Study|Protocol Violation|3|||
125357724|NCT01973569|450946219|FG000|Overall Study|Withdrawal by Subject|7|||
125357725|NCT01973569|450946220|FG001|Overall Study|Withdrawal by Subject|5|||
125357726|NCT01973569|450946221|FG002|Overall Study|Withdrawal by Subject|2|||
125357727|NCT01973569|450946219|FG000|Overall Study|Invasive dental treatment|3|||
125357728|NCT01973569|450946220|FG001|Overall Study|Invasive dental treatment|5|||
125357729|NCT01973569|450946221|FG002|Overall Study|Invasive dental treatment|6|||
125357730|NCT01973569|450946219|FG000|Overall Study|Prohibited concomitant d|1|||
125357731|NCT01973569|450946220|FG001|Overall Study|Prohibited concomitant d|5|||
125357732|NCT01973569|450946221|FG002|Overall Study|Prohibited concomitant d|0|||
125357733|NCT01973569|450946219|FG000|Overall Study|Disease progression|0|||
125357734|NCT01973569|450946220|FG001|Overall Study|Disease progression|3|||
125357735|NCT01973569|450946221|FG002|Overall Study|Disease progression|0|||
125357736|NCT01973569|450946219|FG000|Overall Study|Other|1|||
125357737|NCT01973569|450946220|FG001|Overall Study|Other|1|||
125357738|NCT01973569|450946221|FG002|Overall Study|Other|0|||
125357739|NCT01973569|450946219|FG000|Overall Study|Did not receive study drug|6|||
125357740|NCT01973569|450946220|FG001|Overall Study|Did not receive study drug|3|||
125357741|NCT01973569|450946221|FG002|Overall Study|Did not receive study drug|3|||
125357742|NCT00137631|450946224|FG000|Overall Study|Lost to Follow-up|37|||
125357743|NCT00137631|450946225|FG001|Overall Study|Lost to Follow-up|41|||
125357744|NCT02486302|450946227|FG000|Overall Study|Discontinued prematurely|410|||
125357745|NCT02486302|450946227|FG000|Overall Study|Documentation not completed|255|||
125357746|NCT02486302|450946227|FG000|Overall Study|Excluded due to legal reasons|8|||
125357747|NCT02486302|450946227|FG000|Overall Study|Not treated|3|||
125357748|NCT01871142|450946228|FG000|Overall Study|Adverse Event|1|||
125357749|NCT02063880|450946234|FG000|Overall Study|Death|21|||
125357750|NCT02063880|450946235|FG001|Overall Study|Death|18|||
125357751|NCT02063880|450946234|FG000|Overall Study|Lost to Follow-up|7|||
125357752|NCT02063880|450946235|FG001|Overall Study|Lost to Follow-up|7|||
125357753|NCT02063880|450946234|FG000|Overall Study|Ineligible|0|||
125357754|NCT02063880|450946235|FG001|Overall Study|Ineligible|2|||
125357755|NCT00567593|450946238|FG000|Overall Study|Adverse Event|1|||
125357756|NCT00567593|450946238|FG000|Overall Study|Physician Decision|1|||
125357757|NCT02106910|450946239|FG000|Overall Study|Lost to Follow-up|1|||
125426689|NCT01525602|451186026|FG005|Overall Study|Clinical progression|0|||
125426690|NCT01525602|451186027|FG006|Overall Study|Clinical progression|1|||
125426691|NCT01525602|451186028|FG007|Overall Study|Clinical progression|1|||
125426692|NCT01525602|451186021|FG000|Overall Study|Non-compliance|0|||
125426693|NCT01525602|451186022|FG001|Overall Study|Non-compliance|0|||
125426694|NCT01525602|451186023|FG002|Overall Study|Non-compliance|0|||
125426695|NCT01525602|451186024|FG003|Overall Study|Non-compliance|0|||
125426696|NCT01525602|451186025|FG004|Overall Study|Non-compliance|1|||
125426697|NCT01525602|451186026|FG005|Overall Study|Non-compliance|0|||
125426698|NCT01525602|451186027|FG006|Overall Study|Non-compliance|0|||
125426699|NCT01525602|451186028|FG007|Overall Study|Non-compliance|0|||
125426700|NCT01525602|451186021|FG000|Overall Study|Withdrawal by Subject|0|||
125426701|NCT01525602|451186022|FG001|Overall Study|Withdrawal by Subject|0|||
125426702|NCT01525602|451186023|FG002|Overall Study|Withdrawal by Subject|0|||
125426703|NCT01525602|451186024|FG003|Overall Study|Withdrawal by Subject|0|||
125426704|NCT01525602|451186025|FG004|Overall Study|Withdrawal by Subject|3|||
125426705|NCT01525602|451186026|FG005|Overall Study|Withdrawal by Subject|1|||
125426706|NCT01525602|451186027|FG006|Overall Study|Withdrawal by Subject|0|||
125426707|NCT01525602|451186028|FG007|Overall Study|Withdrawal by Subject|1|||
125426708|NCT01525602|451186021|FG000|Overall Study|Physician Decision|0|||
125426709|NCT01525602|451186022|FG001|Overall Study|Physician Decision|0|||
125426710|NCT01525602|451186023|FG002|Overall Study|Physician Decision|0|||
125426711|NCT01525602|451186024|FG003|Overall Study|Physician Decision|0|||
125426712|NCT01525602|451186025|FG004|Overall Study|Physician Decision|3|||
125426713|NCT01525602|451186026|FG005|Overall Study|Physician Decision|0|||
125426714|NCT01525602|451186027|FG006|Overall Study|Physician Decision|1|||
125426715|NCT01525602|451186028|FG007|Overall Study|Physician Decision|0|||
125426716|NCT01525602|451186021|FG000|Overall Study|Death|0|||
125567710|NCT03029143|451707988|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
125357758|NCT02106910|450946240|FG001|Overall Study|Lost to Follow-up|1|||
125357759|NCT01675427|450946241|FG000|Overall Study|Withdrawal by Subject|7|||
125357760|NCT01675427|450946241|FG000|Overall Study|Participant Refused Sample Collection|18|||
125357761|NCT01675427|450946241|FG000|Overall Study|Sample not Collected by Mistake|2|||
125357762|NCT01675427|450946241|FG000|Overall Study|Lost to Follow-up|5|||
125357763|NCT01675427|450946241|FG000|Overall Study|Other|2|||
125357764|NCT00700570|450946242|FG000|Overall Study|Adverse Event|2|||
125357765|NCT00700570|450946243|FG001|Overall Study|Adverse Event|6|||
125357766|NCT00700570|450946242|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
125357767|NCT00700570|450946243|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
125357768|NCT00700570|450946242|FG000|Overall Study|Disease Progression|8|||
125357769|NCT00700570|450946243|FG001|Overall Study|Disease Progression|11|||
125426717|NCT01525602|451186022|FG001|Overall Study|Death|0|||
125426718|NCT01525602|451186023|FG002|Overall Study|Death|0|||
125426719|NCT01525602|451186024|FG003|Overall Study|Death|0|||
125426720|NCT01525602|451186025|FG004|Overall Study|Death|1|||
125426721|NCT01525602|451186026|FG005|Overall Study|Death|1|||
125426722|NCT01525602|451186027|FG006|Overall Study|Death|0|||
125357770|NCT00700570|450946242|FG000|Overall Study|Withdrawal by Subject|1|||
125357771|NCT00700570|450946243|FG001|Overall Study|Withdrawal by Subject|6|||
125357772|NCT00611533|450946244|FG000|First Intervention (6 Weeks)|Never started study|0|||
125357773|NCT00611533|450946245|FG001|First Intervention (6 Weeks)|Never started study|1|||
125357774|NCT00611533|450946244|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
125357775|NCT00611533|450946245|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
125357776|NCT00611533|450946244|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
125357777|NCT00611533|450946245|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
125357778|NCT05246397|450946248|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
125357779|NCT04327674|450946254|FG000|Overall Study|Protocol Violation|19|||
125357780|NCT01461980|450946255|FG000|Overall Study|Other|9|||
125357781|NCT01461980|450946256|FG001|Overall Study|Other|8|||
125357782|NCT01461980|450946257|FG002|Overall Study|Other|6|||
125357783|NCT01461980|450946255|FG000|Overall Study|Medication error|7|||
125357784|NCT01461980|450946256|FG001|Overall Study|Medication error|5|||
125567711|NCT03029143|451707989|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
125567712|NCT03029143|451707987|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
125567713|NCT03029143|451707988|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
125567714|NCT03029143|451707989|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
125357785|NCT01461980|450946257|FG002|Overall Study|Medication error|6|||
125357786|NCT01461980|450946255|FG000|Overall Study|Adverse Event|12|||
125357787|NCT01461980|450946256|FG001|Overall Study|Adverse Event|5|||
125357788|NCT01461980|450946257|FG002|Overall Study|Adverse Event|6|||
125357789|NCT01461980|450946255|FG000|Overall Study|Protocol Violation|12|||
125357790|NCT01461980|450946256|FG001|Overall Study|Protocol Violation|19|||
125357791|NCT01461980|450946257|FG002|Overall Study|Protocol Violation|16|||
125357792|NCT01461980|450946255|FG000|Overall Study|No longer meets eligibility criteria|18|||
125357793|NCT01461980|450946256|FG001|Overall Study|No longer meets eligibility criteria|9|||
125357794|NCT01461980|450946257|FG002|Overall Study|No longer meets eligibility criteria|19|||
125567715|NCT03029143|451707987|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
125567716|NCT03029143|451707988|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
125567717|NCT03029143|451707989|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
125567718|NCT03029143|451707987|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
125567719|NCT03029143|451707988|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
125567720|NCT03029143|451707989|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
125567721|NCT03029143|451707987|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
125567722|NCT03029143|451707988|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
125567723|NCT03029143|451707989|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
125357795|NCT01461980|450946255|FG000|Overall Study|Lost to Follow-up|52|||
125357796|NCT01461980|450946256|FG001|Overall Study|Lost to Follow-up|53|||
125357797|NCT01461980|450946257|FG002|Overall Study|Lost to Follow-up|51|||
125357798|NCT01461980|450946255|FG000|Overall Study|No longer willing to participate|52|||
125426723|NCT01525602|451186028|FG007|Overall Study|Death|0|||
125426724|NCT01525602|451186021|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
125426725|NCT01525602|451186022|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
125426726|NCT01525602|451186023|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
125426727|NCT01525602|451186024|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
125426728|NCT01525602|451186025|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
125426729|NCT01525602|451186026|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
125426730|NCT01525602|451186027|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
125426731|NCT01525602|451186028|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
125426732|NCT04349280|451186032|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
125426733|NCT04349280|451186033|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
125426734|NCT04349280|451186032|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
125426735|NCT04349280|451186033|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
125426736|NCT04349280|451186032|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
125426737|NCT04349280|451186033|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
125426738|NCT02532179|451187931|FG000|Overall Study|Lost to Follow-up|1|||
125426739|NCT02532179|451187931|FG000|Overall Study|Pregnancy|1|||
125426740|NCT02532179|451187931|FG000|Overall Study|Subject received depot steroid injection|1|||
125426741|NCT03076970|451187935|FG000|Washout Period 2|Adverse Event|0|||
125426742|NCT03076970|451187936|FG001|Washout Period 2|Adverse Event|0|||
125426743|NCT03076970|451187937|FG002|Washout Period 2|Adverse Event|0|||
125426744|NCT03076970|451187938|FG003|Washout Period 2|Adverse Event|0|||
125426745|NCT03076970|451187939|FG004|Washout Period 2|Adverse Event|1|||
125426746|NCT03076970|451187940|FG005|Washout Period 2|Adverse Event|0|||
125426747|NCT03076970|451187935|FG000|Period 3|Withdrawal by Subject|0|||
125426748|NCT03076970|451187936|FG001|Period 3|Withdrawal by Subject|0|||
125426749|NCT03076970|451187937|FG002|Period 3|Withdrawal by Subject|0|||
125426750|NCT03076970|451187938|FG003|Period 3|Withdrawal by Subject|0|||
125426751|NCT03076970|451187939|FG004|Period 3|Withdrawal by Subject|0|||
125426752|NCT03076970|451187940|FG005|Period 3|Withdrawal by Subject|1|||
125426753|NCT03076970|451187935|FG000|Period 3|Failure to meet I/E criteria|0|||
125426754|NCT03076970|451187936|FG001|Period 3|Failure to meet I/E criteria|0|||
125426755|NCT03076970|451187937|FG002|Period 3|Failure to meet I/E criteria|0|||
125426756|NCT03076970|451187938|FG003|Period 3|Failure to meet I/E criteria|0|||
125426757|NCT03076970|451187939|FG004|Period 3|Failure to meet I/E criteria|1|||
125426758|NCT03076970|451187940|FG005|Period 3|Failure to meet I/E criteria|0|||
125426759|NCT00789815|451187941|FG000|Overall Study|Protocol Violation|6|||
125426760|NCT00789815|451187942|FG001|Overall Study|Protocol Violation|1|||
125426761|NCT00789815|451187941|FG000|Overall Study|Intubation due to massive bleeding|1|||
125426762|NCT00789815|451187942|FG001|Overall Study|Intubation due to massive bleeding|0|||
125426763|NCT01203930|451187954|FG000|Overall Study|Disease Progression|0|||
125426764|NCT01203930|451187955|FG001|Overall Study|Disease Progression|4|||
125426765|NCT01203930|451187954|FG000|Overall Study|Death|3|||
125426766|NCT01203930|451187955|FG001|Overall Study|Death|1|||
125426767|NCT01203930|451187954|FG000|Overall Study|Withdrew Consent|1|||
125426768|NCT01203930|451187955|FG001|Overall Study|Withdrew Consent|10|||
125426769|NCT01203930|451187954|FG000|Overall Study|Investigator Request|0|||
125426770|NCT01203930|451187955|FG001|Overall Study|Investigator Request|8|||
125426771|NCT01203930|451187954|FG000|Overall Study|Study Terminated by Sponsor|0|||
125426772|NCT01203930|451187955|FG001|Overall Study|Study Terminated by Sponsor|12|||
125426773|NCT01203930|451187954|FG000|Overall Study|Poor tolerance of study drug|0|||
125426774|NCT01203930|451187955|FG001|Overall Study|Poor tolerance of study drug|1|||
125426775|NCT01203930|451187954|FG000|Overall Study|Adverse Event|17|||
125426776|NCT01203930|451187955|FG001|Overall Study|Adverse Event|5|||
125426777|NCT03966053|451187956|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
125426778|NCT04098406|451187959|FG000|Overall Study|Adverse Event|2|||
125426779|NCT04098406|451187960|FG001|Overall Study|Adverse Event|1|||
125426780|NCT04098406|451187959|FG000|Overall Study|Withdrawal by Subject|1|||
125426781|NCT04098406|451187960|FG001|Overall Study|Withdrawal by Subject|0|||
125426782|NCT01783418|451187964|FG000|Overall Study|Withdrawal by Subject|1|||
125567724|NCT03029143|451707987|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
125567725|NCT03029143|451707988|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
125567726|NCT03029143|451707989|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
125567727|NCT03029143|451707987|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
125567728|NCT03029143|451707988|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
125567729|NCT03029143|451707989|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
125567730|NCT03029143|451707987|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125567731|NCT03029143|451707988|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125567732|NCT03029143|451707989|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
125567733|NCT03029143|451707987|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
125567734|NCT03029143|451707988|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
125567735|NCT03029143|451707989|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
125567736|NCT03029143|451707987|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
125567737|NCT03029143|451707988|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
125567738|NCT03029143|451707989|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
125567739|NCT03029143|451707987|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
125567740|NCT03029143|451707988|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
125567741|NCT03029143|451707989|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
125567742|NCT00974675|451707990|FG000|Overall Study|Adverse Event|2|||
125567743|NCT00974675|451707991|FG001|Overall Study|Adverse Event|1|||
125567744|NCT00974675|451707992|FG002|Overall Study|Adverse Event|1|||
125567745|NCT00974675|451707993|FG003|Overall Study|Adverse Event|1|||
125567746|NCT00974675|451707990|FG000|Overall Study|Physician Decision|0|||
125567747|NCT00974675|451707991|FG001|Overall Study|Physician Decision|0|||
125567748|NCT00974675|451707992|FG002|Overall Study|Physician Decision|1|||
125567749|NCT00974675|451707993|FG003|Overall Study|Physician Decision|0|||
125567750|NCT00974675|451707990|FG000|Overall Study|Participant on holiday; unable to attend|0|||
125567751|NCT00974675|451707991|FG001|Overall Study|Participant on holiday; unable to attend|0|||
125567752|NCT00974675|451707992|FG002|Overall Study|Participant on holiday; unable to attend|0|||
125567753|NCT00974675|451707993|FG003|Overall Study|Participant on holiday; unable to attend|1|||
125567754|NCT02121262|451707996|FG000|Overall Study|Adverse Event|6|||
125567755|NCT02121262|451707997|FG001|Overall Study|Adverse Event|3|||
125567756|NCT02121262|451707996|FG000|Overall Study|Lack of Efficacy|3|||
125567757|NCT02121262|451707997|FG001|Overall Study|Lack of Efficacy|0|||
125567758|NCT02121262|451707996|FG000|Overall Study|Personal Reasons|19|||
125567759|NCT02121262|451707997|FG001|Overall Study|Personal Reasons|5|||
125567760|NCT02121262|451707996|FG000|Overall Study|Protocol Violation|1|||
125567761|NCT02121262|451707997|FG001|Overall Study|Protocol Violation|1|||
125567762|NCT02121262|451707996|FG000|Overall Study|Participant Dropped-out|0|||
125567763|NCT02121262|451707997|FG001|Overall Study|Participant Dropped-out|1|||
125567764|NCT02121262|451707996|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
125567765|NCT02121262|451707997|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
125567766|NCT02121262|451707996|FG000|Overall Study|Consent Withdrawn|1|||
125567767|NCT02121262|451707997|FG001|Overall Study|Consent Withdrawn|0|||
125567768|NCT02025907|451708003|FG000|Overall Study|Lack of Efficacy|1|||
125567769|NCT02025907|451708004|FG001|Overall Study|Lack of Efficacy|0|||
125567770|NCT02025907|451708003|FG000|Overall Study|Withdrawal by Subject|15|||
125567771|NCT02025907|451708004|FG001|Overall Study|Withdrawal by Subject|8|||
125567772|NCT02025907|451708003|FG000|Overall Study|Protocol Violation|2|||
125567773|NCT02025907|451708004|FG001|Overall Study|Protocol Violation|0|||
125567774|NCT02025907|451708003|FG000|Overall Study|Physician Decision|2|||
125567775|NCT02025907|451708004|FG001|Overall Study|Physician Decision|0|||
125567776|NCT02025907|451708003|FG000|Overall Study|Lost to Follow-up|2|||
125567777|NCT02025907|451708004|FG001|Overall Study|Lost to Follow-up|2|||
125567778|NCT02025907|451708003|FG000|Overall Study|Adverse Event|3|||
125567779|NCT02025907|451708004|FG001|Overall Study|Adverse Event|1|||
125567780|NCT02025907|451708003|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
125567781|NCT02025907|451708004|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
125567782|NCT00282334|451708005|FG000|Overall Study|Withdrawal by Subject|8|||
125567783|NCT00282334|451708006|FG001|Overall Study|Withdrawal by Subject|5|||
125567784|NCT02411539|451708007|FG000|Overall Study|Lost to Follow-up|2|||
125567785|NCT02411539|451708008|FG001|Overall Study|Lost to Follow-up|0|||
125567786|NCT02411539|451708007|FG000|Overall Study|Confounding medical condition|0|||
125567787|NCT02411539|451708008|FG001|Overall Study|Confounding medical condition|1|||
125567788|NCT03681119|451708009|FG000|Overall Study|No specific reason|4|||
125567789|NCT03681119|451708010|FG001|Overall Study|No specific reason|0|||
125567790|NCT03681119|451708009|FG000|Overall Study|Sickness|2|||
125567791|NCT03681119|451708010|FG001|Overall Study|Sickness|0|||
125567792|NCT00879645|451708012|FG000|Overall Study|Adverse Event|1|||
125567793|NCT00879645|451708013|FG001|Overall Study|Adverse Event|0|||
125567794|NCT00879645|451708014|FG002|Overall Study|Adverse Event|0|||
125567795|NCT00879645|451708015|FG003|Overall Study|Adverse Event|0|||
125567796|NCT03631732|451708018|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
125567797|NCT03631732|451708019|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
125567798|NCT03631732|451708018|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
125567799|NCT03631732|451708019|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
125567800|NCT03631732|451708018|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
125567801|NCT03631732|451708019|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
125567802|NCT03631732|451708018|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
125567803|NCT03631732|451708019|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
125567804|NCT03631732|451708018|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
125567805|NCT03631732|451708019|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
125567806|NCT03631732|451708018|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
125567807|NCT03631732|451708019|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
125567808|NCT03631732|451708018|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
125567809|NCT03631732|451708019|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
125567810|NCT03631732|451708018|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
125567811|NCT03631732|451708019|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
125567812|NCT03631732|451708018|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
125567813|NCT03631732|451708019|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
125567814|NCT03631732|451708018|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
125567815|NCT03631732|451708019|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
125567816|NCT04288154|451708020|FG000|Overall Study|Withdrawal by Subject|9|||
125567817|NCT04288154|451708021|FG001|Overall Study|Withdrawal by Subject|9|||
125567818|NCT01624662|451708027|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
125567819|NCT01624662|451708028|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
125567820|NCT01624662|451708029|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
125567821|NCT01624662|451708030|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
125567822|NCT01624662|451708027|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
125567823|NCT01624662|451708028|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
125567824|NCT01624662|451708029|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
125567825|NCT01624662|451708030|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
125567826|NCT01624662|451708027|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
125567827|NCT01624662|451708028|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
125567828|NCT01624662|451708029|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
125567829|NCT01624662|451708030|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
125567830|NCT01624662|451708027|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
125567831|NCT01624662|451708028|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
125567832|NCT01624662|451708029|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
125567833|NCT01624662|451708030|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
125567834|NCT01624662|451708027|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
125567835|NCT01624662|451708028|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
125567836|NCT01624662|451708029|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
125567837|NCT01624662|451708030|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
125567838|NCT01624662|451708027|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
125357799|NCT01461980|450946256|FG001|Overall Study|No longer willing to participate|38|||
125357800|NCT01461980|450946257|FG002|Overall Study|No longer willing to participate|54|||
125357801|NCT01461980|450946255|FG000|Overall Study|Randomized but not vaccinated|4|||
125357802|NCT01461980|450946256|FG001|Overall Study|Randomized but not vaccinated|8|||
125357803|NCT01461980|450946257|FG002|Overall Study|Randomized but not vaccinated|7|||
125357804|NCT00122109|450946259|FG000|Overall Study|Did not meet criteria|6|||
125357805|NCT00122109|450946260|FG001|Overall Study|Did not meet criteria|7|||
125357806|NCT00809354|450946265|FG000|Overall Study|Adverse Event|32|||
125357807|NCT00809354|450946266|FG001|Overall Study|Adverse Event|45|||
125357808|NCT00809354|450946267|FG002|Overall Study|Adverse Event|37|||
125357809|NCT00809354|450946268|FG003|Overall Study|Adverse Event|53|||
125357810|NCT00809354|450946269|FG004|Overall Study|Adverse Event|26|||
125357811|NCT00809354|450946270|FG005|Overall Study|Adverse Event|33|||
125357812|NCT00809354|450946271|FG006|Overall Study|Adverse Event|44|||
125357813|NCT00809354|450946272|FG007|Overall Study|Adverse Event|40|||
125357814|NCT00809354|450946273|FG008|Overall Study|Adverse Event|46|||
125357815|NCT00809354|450946274|FG009|Overall Study|Adverse Event|26|||
125357816|NCT00809354|450946265|FG000|Overall Study|Lack of Efficacy|23|||
125357817|NCT00809354|450946266|FG001|Overall Study|Lack of Efficacy|23|||
125357818|NCT00809354|450946267|FG002|Overall Study|Lack of Efficacy|22|||
125357819|NCT00809354|450946268|FG003|Overall Study|Lack of Efficacy|15|||
125357820|NCT00809354|450946269|FG004|Overall Study|Lack of Efficacy|40|||
125357821|NCT00809354|450946270|FG005|Overall Study|Lack of Efficacy|19|||
125357822|NCT00809354|450946271|FG006|Overall Study|Lack of Efficacy|21|||
125357823|NCT00809354|450946272|FG007|Overall Study|Lack of Efficacy|15|||
125357824|NCT00809354|450946273|FG008|Overall Study|Lack of Efficacy|18|||
125357825|NCT00809354|450946274|FG009|Overall Study|Lack of Efficacy|38|||
125357826|NCT00809354|450946265|FG000|Overall Study|Lost to Follow-up|10|||
125357827|NCT00809354|450946266|FG001|Overall Study|Lost to Follow-up|11|||
125357828|NCT00809354|450946267|FG002|Overall Study|Lost to Follow-up|8|||
125357829|NCT00809354|450946268|FG003|Overall Study|Lost to Follow-up|13|||
125357830|NCT00809354|450946269|FG004|Overall Study|Lost to Follow-up|6|||
125357831|NCT00809354|450946270|FG005|Overall Study|Lost to Follow-up|2|||
125357832|NCT00809354|450946271|FG006|Overall Study|Lost to Follow-up|0|||
125357833|NCT00809354|450946272|FG007|Overall Study|Lost to Follow-up|5|||
125357834|NCT00809354|450946273|FG008|Overall Study|Lost to Follow-up|4|||
125357835|NCT00809354|450946274|FG009|Overall Study|Lost to Follow-up|0|||
125357836|NCT00809354|450946265|FG000|Overall Study|Protocol Violation|7|||
125357837|NCT00809354|450946266|FG001|Overall Study|Protocol Violation|14|||
125357838|NCT00809354|450946267|FG002|Overall Study|Protocol Violation|14|||
125357839|NCT00809354|450946268|FG003|Overall Study|Protocol Violation|12|||
125357840|NCT00809354|450946269|FG004|Overall Study|Protocol Violation|14|||
125357841|NCT00809354|450946270|FG005|Overall Study|Protocol Violation|6|||
125357842|NCT00809354|450946271|FG006|Overall Study|Protocol Violation|4|||
125357843|NCT00809354|450946272|FG007|Overall Study|Protocol Violation|6|||
125357844|NCT00809354|450946273|FG008|Overall Study|Protocol Violation|9|||
125357845|NCT00809354|450946274|FG009|Overall Study|Protocol Violation|3|||
125357846|NCT00809354|450946265|FG000|Overall Study|Withdrawal by Subject|32|||
125357847|NCT00809354|450946266|FG001|Overall Study|Withdrawal by Subject|27|||
125357848|NCT00809354|450946267|FG002|Overall Study|Withdrawal by Subject|31|||
125357849|NCT00809354|450946268|FG003|Overall Study|Withdrawal by Subject|33|||
125357850|NCT00809354|450946269|FG004|Overall Study|Withdrawal by Subject|34|||
125357851|NCT00809354|450946270|FG005|Overall Study|Withdrawal by Subject|29|||
125357852|NCT00809354|450946271|FG006|Overall Study|Withdrawal by Subject|27|||
125357853|NCT00809354|450946272|FG007|Overall Study|Withdrawal by Subject|19|||
125357854|NCT00809354|450946273|FG008|Overall Study|Withdrawal by Subject|18|||
125357855|NCT00809354|450946274|FG009|Overall Study|Withdrawal by Subject|20|||
125357856|NCT00809354|450946265|FG000|Overall Study|Other|10|||
125357857|NCT00809354|450946266|FG001|Overall Study|Other|2|||
125357858|NCT00809354|450946267|FG002|Overall Study|Other|7|||
125357859|NCT00809354|450946268|FG003|Overall Study|Other|10|||
125357860|NCT00809354|450946269|FG004|Overall Study|Other|5|||
125357861|NCT00809354|450946270|FG005|Overall Study|Other|3|||
125357862|NCT00809354|450946271|FG006|Overall Study|Other|2|||
125357863|NCT00809354|450946272|FG007|Overall Study|Other|3|||
125357864|NCT00809354|450946273|FG008|Overall Study|Other|4|||
125426783|NCT01783418|451187965|FG001|Overall Study|Withdrawal by Subject|0|||
125357865|NCT00809354|450946274|FG009|Overall Study|Other|3|||
125357866|NCT00809354|450946265|FG000|Overall Study|Study terminated by sponsor|138|||
125357867|NCT00809354|450946266|FG001|Overall Study|Study terminated by sponsor|134|||
125357868|NCT00809354|450946267|FG002|Overall Study|Study terminated by sponsor|129|||
125357869|NCT00809354|450946268|FG003|Overall Study|Study terminated by sponsor|120|||
125357870|NCT00809354|450946269|FG004|Overall Study|Study terminated by sponsor|126|||
125357871|NCT00809354|450946270|FG005|Overall Study|Study terminated by sponsor|133|||
125567839|NCT01624662|451708028|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
125567840|NCT01624662|451708029|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
125567841|NCT01624662|451708030|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
125567842|NCT01624662|451708027|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
125567843|NCT01624662|451708028|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
125567844|NCT01624662|451708029|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
125567845|NCT01624662|451708030|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
125567846|NCT01135498|451709838|FG000|Overall Study|Adverse Event|20|||
125567847|NCT01135498|451709838|FG000|Overall Study|Progressive disease|38|||
125567848|NCT01135498|451709838|FG000|Overall Study|Investigator judgement|25|||
125567849|NCT01135498|451709838|FG000|Overall Study|Withdrawal by Subject|4|||
125567850|NCT01135498|451709838|FG000|Overall Study|Death|1|||
125567851|NCT01135498|451709838|FG000|Overall Study|Ongoing at time of analysis|2|||
125567852|NCT02646982|451709840|FG000|Overall Study|Adverse Event|1|||
125567853|NCT02646982|451709841|FG001|Overall Study|Adverse Event|1|||
125567854|NCT02646982|451709840|FG000|Overall Study|Withdrawal by Subject|2|||
125567855|NCT02646982|451709841|FG001|Overall Study|Withdrawal by Subject|1|||
125567856|NCT01040351|451709842|FG000|Overall Study|poor ovarian response|1|||
125567857|NCT01040351|451709843|FG001|Overall Study|poor ovarian response|2|||
125567858|NCT01230307|451709844|FG000|Overall Study|LVAD Placement|0|||
125567859|NCT01230307|451709845|FG001|Overall Study|LVAD Placement|2|||
125567860|NCT00530894|451709850|FG000|Overall Study|Death|84|||
125567861|NCT00530894|451709851|FG001|Overall Study|Death|89|||
125567862|NCT00530894|451709852|FG002|Overall Study|Death|55|||
125567863|NCT00530894|451709853|FG003|Overall Study|Death|89|||
125567864|NCT00530894|451709850|FG000|Overall Study|Lost to Follow-up|1|||
125567865|NCT00530894|451709851|FG001|Overall Study|Lost to Follow-up|3|||
125567866|NCT00530894|451709852|FG002|Overall Study|Lost to Follow-up|0|||
125567867|NCT00530894|451709853|FG003|Overall Study|Lost to Follow-up|0|||
125567868|NCT00530894|451709850|FG000|Overall Study|Withdrawal by Subject|1|||
125567869|NCT00530894|451709851|FG001|Overall Study|Withdrawal by Subject|23|||
125567870|NCT00530894|451709852|FG002|Overall Study|Withdrawal by Subject|0|||
125567871|NCT00530894|451709853|FG003|Overall Study|Withdrawal by Subject|5|||
125567872|NCT00530894|451709850|FG000|Overall Study|Alive and censored prior to 1 year|2|||
125567873|NCT00530894|451709851|FG001|Overall Study|Alive and censored prior to 1 year|0|||
125567874|NCT00530894|451709852|FG002|Overall Study|Alive and censored prior to 1 year|0|||
125567875|NCT00530894|451709853|FG003|Overall Study|Alive and censored prior to 1 year|0|||
125567876|NCT02256540|451709854|FG000|Overall Study|Withdrawal by Subject|0|||
125567877|NCT02256540|451709855|FG001|Overall Study|Withdrawal by Subject|1|||
125567878|NCT02256540|451709856|FG002|Overall Study|Withdrawal by Subject|1|||
125567879|NCT02256540|451709854|FG000|Overall Study|Back pain preventing exercise|0|||
125567880|NCT02256540|451709855|FG001|Overall Study|Back pain preventing exercise|0|||
125567881|NCT02256540|451709856|FG002|Overall Study|Back pain preventing exercise|1|||
125567882|NCT03923426|451709863|FG000|Overall Study|Other|19|||
125567883|NCT03923426|451709863|FG000|Overall Study|Lost to Follow-up|16|||
125567884|NCT03923426|451709863|FG000|Overall Study|Death|107|||
125567885|NCT03923426|451709863|FG000|Overall Study|Incomplete response to question|13|||
125567886|NCT00769002|451709864|FG000|Overall Study|Study was not completed, no data|9|||
125567887|NCT00769002|451709865|FG001|Overall Study|Study was not completed, no data|9|||
125567888|NCT00838331|451709881|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
125567889|NCT03972969|451709882|FG000|3-month Follow-up|Death|1|||
125567890|NCT03972969|451709883|FG001|3-month Follow-up|Death|1|||
125567891|NCT03972969|451709884|FG002|3-month Follow-up|Death|0|||
125567892|NCT03972969|451709882|FG000|6-month Follow-up|Death|1|||
125567893|NCT03972969|451709883|FG001|6-month Follow-up|Death|1|||
125567894|NCT03972969|451709884|FG002|6-month Follow-up|Death|1|||
125567895|NCT03972969|451709882|FG000|6-month Follow-up|Lost to Follow-up|2|||
125567896|NCT03972969|451709883|FG001|6-month Follow-up|Lost to Follow-up|2|||
125567897|NCT03972969|451709884|FG002|6-month Follow-up|Lost to Follow-up|2|||
125567898|NCT00264875|451709885|FG000|Overall Study|Adverse Event|6|||
125567899|NCT00264875|451709885|FG000|Overall Study|Lost to Follow-up|6|||
125567900|NCT00264875|451709885|FG000|Overall Study|Protocol Violation|11|||
125567901|NCT00264875|451709885|FG000|Overall Study|Withdrawal by Subject|7|||
125567902|NCT01500278|451709886|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
125567903|NCT01500278|451709887|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
125567904|NCT01500278|451709886|FG000|Week 0 - Week 12|Protocol Violation|10|||
125567905|NCT01500278|451709887|FG001|Week 0 - Week 12|Protocol Violation|16|||
125567906|NCT01500278|451709886|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
125567907|NCT01500278|451709887|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
125567908|NCT01500278|451709886|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
125567909|NCT01500278|451709887|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
125567910|NCT01500278|451709886|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
125567911|NCT01500278|451709887|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
125567912|NCT01500278|451709886|FG000|Week 0 - Week 12|Patient decision|1|||
125567913|NCT01500278|451709887|FG001|Week 0 - Week 12|Patient decision|0|||
125567914|NCT01500278|451709886|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
125567915|NCT01500278|451709887|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
125567916|NCT01500278|451709886|FG000|Week 0 - Week 12|Investigator decision|1|||
125567917|NCT01500278|451709887|FG001|Week 0 - Week 12|Investigator decision|0|||
125567918|NCT01500278|451709886|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
125567919|NCT01500278|451709887|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
125567920|NCT01500278|451709886|FG000|Week 0 - Week 12|Sponsor decision|1|||
125567921|NCT01500278|451709887|FG001|Week 0 - Week 12|Sponsor decision|0|||
125567922|NCT01500278|451709886|FG000|Week 0 - Week 12|Personal reason|0|||
125567923|NCT01500278|451709887|FG001|Week 0 - Week 12|Personal reason|1|||
125567924|NCT01500278|451709886|FG000|Week 0 - Week 12|Other serious disease|0|||
125567925|NCT01500278|451709887|FG001|Week 0 - Week 12|Other serious disease|1|||
125567926|NCT01500278|451709886|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
125567927|NCT01500278|451709887|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
125567928|NCT01500278|451709886|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
125567929|NCT01500278|451709887|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
125567930|NCT01500278|451709886|FG000|Week 13 - Week 104|Protocol Violation|6|||
125567931|NCT01500278|451709887|FG001|Week 13 - Week 104|Protocol Violation|6|||
125567932|NCT01500278|451709886|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
125567933|NCT01500278|451709887|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
125567934|NCT01500278|451709886|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
125567935|NCT01500278|451709887|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
125567936|NCT01500278|451709886|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
125567937|NCT01500278|451709887|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
125567938|NCT01500278|451709886|FG000|Week 13 - Week 104|Non/bad compliance|7|||
125567939|NCT01500278|451709887|FG001|Week 13 - Week 104|Non/bad compliance|5|||
125567940|NCT01500278|451709886|FG000|Week 13 - Week 104|Recurrent infections|1|||
125567941|NCT01500278|451709887|FG001|Week 13 - Week 104|Recurrent infections|0|||
125567942|NCT01500278|451709886|FG000|Week 13 - Week 104|False positive test|1|||
125567943|NCT01500278|451709887|FG001|Week 13 - Week 104|False positive test|2|||
125567944|NCT01500278|451709886|FG000|Week 13 - Week 104|Sponsor request|4|||
125567945|NCT01500278|451709887|FG001|Week 13 - Week 104|Sponsor request|0|||
125567946|NCT01500278|451709886|FG000|Week 13 - Week 104|Withdrawn in error|1|||
125567947|NCT01500278|451709887|FG001|Week 13 - Week 104|Withdrawn in error|0|||
125567948|NCT01500278|451709886|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
125567949|NCT01500278|451709887|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
125567950|NCT01500278|451709886|FG000|Week 13 - Week 104|Protocol deviation|1|||
125567951|NCT01500278|451709887|FG001|Week 13 - Week 104|Protocol deviation|0|||
125567952|NCT01500278|451709886|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
125567953|NCT01500278|451709887|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
125567954|NCT01500278|451709886|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
125567955|NCT01500278|451709887|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
125567956|NCT01500278|451709886|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
125567957|NCT01500278|451709887|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
125567958|NCT01500278|451709886|FG000|Week 13 - Week 104|Relocation|0|||
125567959|NCT01500278|451709887|FG001|Week 13 - Week 104|Relocation|1|||
125567960|NCT01500278|451709886|FG000|Week 13 - Week 104|Sponsor decision|0|||
125567961|NCT01500278|451709887|FG001|Week 13 - Week 104|Sponsor decision|2|||
125567962|NCT01500278|451709886|FG000|Week 13 - Week 104|Medical monitor decision|0|||
125567963|NCT01500278|451709887|FG001|Week 13 - Week 104|Medical monitor decision|2|||
125567964|NCT01500278|451709886|FG000|Week 13 - Week 104|Personal reason|0|||
125567965|NCT01500278|451709887|FG001|Week 13 - Week 104|Personal reason|1|||
125567966|NCT01500278|451709886|FG000|Week 13 - Week 104|Not completed|0|||
125567967|NCT01500278|451709887|FG001|Week 13 - Week 104|Not completed|1|||
125567968|NCT01500278|451709886|FG000|Week 13 - Week 104|Death|2|||
125567969|NCT01500278|451709887|FG001|Week 13 - Week 104|Death|4|||
125567970|NCT01500278|451709886|FG000|Week 13 - Week 104|Adverse Event|54|||
125567971|NCT01500278|451709887|FG001|Week 13 - Week 104|Adverse Event|54|||
125567972|NCT01709435|451709891|FG000|Overall Study|Adverse Event|1|||
125567973|NCT01709435|451709892|FG001|Overall Study|Adverse Event|1|||
125567974|NCT01709435|451709893|FG002|Overall Study|Adverse Event|1|||
125567975|NCT01709435|451709894|FG003|Overall Study|Adverse Event|0|||
125567976|NCT01709435|451709895|FG004|Overall Study|Adverse Event|0|||
125567977|NCT01709435|451709896|FG005|Overall Study|Adverse Event|1|||
125567978|NCT01709435|451709891|FG000|Overall Study|Lack of Efficacy|5|||
125567979|NCT01709435|451709892|FG001|Overall Study|Lack of Efficacy|7|||
125567980|NCT01709435|451709893|FG002|Overall Study|Lack of Efficacy|2|||
125567981|NCT01709435|451709894|FG003|Overall Study|Lack of Efficacy|2|||
125567982|NCT01709435|451709895|FG004|Overall Study|Lack of Efficacy|6|||
125567983|NCT01709435|451709896|FG005|Overall Study|Lack of Efficacy|3|||
125567984|NCT01709435|451709891|FG000|Overall Study|Physician Decision|0|||
125567985|NCT01709435|451709892|FG001|Overall Study|Physician Decision|1|||
125567986|NCT01709435|451709893|FG002|Overall Study|Physician Decision|0|||
125567987|NCT01709435|451709894|FG003|Overall Study|Physician Decision|1|||
125426784|NCT04791761|451187966|FG000|Overall Study|Lost to Follow-up|8|||
125567988|NCT01709435|451709895|FG004|Overall Study|Physician Decision|2|||
125567989|NCT01709435|451709896|FG005|Overall Study|Physician Decision|0|||
125567990|NCT01709435|451709891|FG000|Overall Study|Withdrawal by Subject|0|||
125567991|NCT01709435|451709892|FG001|Overall Study|Withdrawal by Subject|0|||
125567992|NCT01709435|451709893|FG002|Overall Study|Withdrawal by Subject|3|||
125567993|NCT01709435|451709894|FG003|Overall Study|Withdrawal by Subject|0|||
125567994|NCT01709435|451709895|FG004|Overall Study|Withdrawal by Subject|2|||
125567995|NCT01709435|451709896|FG005|Overall Study|Withdrawal by Subject|2|||
125567996|NCT00053417|451709897|FG000|Overall Study|Adverse Event|1|||
125567997|NCT00053417|451709898|FG001|Overall Study|Adverse Event|0|||
125567998|NCT00053417|451709899|FG002|Overall Study|Adverse Event|1|||
125567999|NCT00053417|451709900|FG003|Overall Study|Adverse Event|5|||
125568000|NCT00053417|451709897|FG000|Overall Study|Non-Compliance|0|||
125568001|NCT00053417|451709898|FG001|Overall Study|Non-Compliance|0|||
125568002|NCT00053417|451709899|FG002|Overall Study|Non-Compliance|0|||
125568003|NCT00053417|451709900|FG003|Overall Study|Non-Compliance|1|||
125568004|NCT00053417|451709897|FG000|Overall Study|Withdrawal by Subject|0|||
125568005|NCT00053417|451709898|FG001|Overall Study|Withdrawal by Subject|1|||
125568006|NCT00053417|451709899|FG002|Overall Study|Withdrawal by Subject|0|||
125568007|NCT00053417|451709900|FG003|Overall Study|Withdrawal by Subject|0|||
125568008|NCT00053417|451709897|FG000|Overall Study|Lost to Follow-up|1|||
125568009|NCT00053417|451709898|FG001|Overall Study|Lost to Follow-up|1|||
125568010|NCT00053417|451709899|FG002|Overall Study|Lost to Follow-up|0|||
125568011|NCT00053417|451709900|FG003|Overall Study|Lost to Follow-up|0|||
125568012|NCT02182687|451709907|FG000|Overall Study|Withdrawal by Subject|4|||
125568013|NCT02182687|451709908|FG001|Overall Study|Withdrawal by Subject|0|||
125568014|NCT02182687|451709907|FG000|Overall Study|Adverse Event|1|||
125568015|NCT02182687|451709908|FG001|Overall Study|Adverse Event|0|||
125568016|NCT02182687|451709907|FG000|Overall Study|Lost to Follow-up|0|||
125568017|NCT02182687|451709908|FG001|Overall Study|Lost to Follow-up|1|||
125568018|NCT01297270|451709909|FG000|Overall Study|Adverse Event|19|||
125568019|NCT01297270|451709910|FG001|Overall Study|Adverse Event|32|||
125568020|NCT01297270|451709911|FG002|Overall Study|Adverse Event|5|||
125568021|NCT01297270|451709909|FG000|Overall Study|Lack of Efficacy|15|||
125568022|NCT01297270|451709910|FG001|Overall Study|Lack of Efficacy|17|||
125568023|NCT01297270|451709911|FG002|Overall Study|Lack of Efficacy|15|||
125568024|NCT01297270|451709909|FG000|Overall Study|Lost to Follow-up|1|||
125568025|NCT01297270|451709910|FG001|Overall Study|Lost to Follow-up|2|||
125568026|NCT01297270|451709911|FG002|Overall Study|Lost to Follow-up|1|||
125568027|NCT01297270|451709909|FG000|Overall Study|Protocol Violation|0|||
125568028|NCT01297270|451709910|FG001|Overall Study|Protocol Violation|2|||
125568029|NCT01297270|451709911|FG002|Overall Study|Protocol Violation|0|||
125568030|NCT01297270|451709909|FG000|Overall Study|Withdrawal by Subject|7|||
125568031|NCT01297270|451709910|FG001|Overall Study|Withdrawal by Subject|15|||
125568032|NCT01297270|451709911|FG002|Overall Study|Withdrawal by Subject|7|||
125568033|NCT01297270|451709909|FG000|Overall Study|Other reason not defined above|3|||
125568034|NCT01297270|451709910|FG001|Overall Study|Other reason not defined above|3|||
125568035|NCT01297270|451709911|FG002|Overall Study|Other reason not defined above|1|||
125568036|NCT01297270|451709909|FG000|Overall Study|Not treated|0|||
125568037|NCT01297270|451709910|FG001|Overall Study|Not treated|1|||
125568038|NCT01297270|451709911|FG002|Overall Study|Not treated|0|||
125568039|NCT02863809|451709914|FG000|Overall Study|Adverse Event|8|||
125568040|NCT02863809|451709915|FG001|Overall Study|Adverse Event|8|||
125568041|NCT02863809|451709914|FG000|Overall Study|Withdrawal by Subject|0|||
125568042|NCT02863809|451709915|FG001|Overall Study|Withdrawal by Subject|1|||
125568043|NCT02863809|451709914|FG000|Overall Study|Lost to Follow-up|1|||
125568044|NCT02863809|451709915|FG001|Overall Study|Lost to Follow-up|1|||
125568045|NCT02863809|451709914|FG000|Overall Study|Death|1|||
125568046|NCT02863809|451709915|FG001|Overall Study|Death|0|||
125568047|NCT02829138|451709916|FG000|Overall Study|Withdrawal by Subject|1|||
125568048|NCT02829138|451709917|FG001|Overall Study|Withdrawal by Subject|0|||
125568049|NCT01394627|451709918|FG000|First Intervention (1 Day)|poor intravenous access|0|||
125568050|NCT01394627|451709919|FG001|First Intervention (1 Day)|poor intravenous access|1|||
125568051|NCT01394627|451709918|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
125568052|NCT01394627|451709919|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
125568053|NCT01765920|451709920|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
125568054|NCT01765920|451709921|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
125568055|NCT01765920|451709920|FG000|Overall Study|Patient code disclosure|0|||
125568056|NCT01765920|451709921|FG001|Overall Study|Patient code disclosure|1|||
125568057|NCT01081249|451709922|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
125568058|NCT01081249|451709923|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
125568059|NCT04041284|451709926|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
125568060|NCT04041284|451709927|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
125568061|NCT04041284|451709926|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
125568062|NCT04041284|451709927|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
125568063|NCT04041284|451709926|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
125568064|NCT04041284|451709927|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
125568065|NCT04041284|451709926|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
125568066|NCT04041284|451709927|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
125568067|NCT04041284|451709926|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
125568068|NCT04041284|451709927|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
125568069|NCT04041284|451709926|FG000|DB Phase (12 Weeks)|Other than specified|1|||
125568070|NCT04041284|451709927|FG001|DB Phase (12 Weeks)|Other than specified|0|||
125568071|NCT04041284|451709926|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
125568072|NCT04041284|451709927|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
125568073|NCT04041284|451709926|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
125568074|NCT04041284|451709927|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
125568075|NCT04041284|451709926|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
125568076|NCT04041284|451709927|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
125568077|NCT04041284|451709926|FG000|OL Phase (12 Weeks)|Other than specified|6|||
125568078|NCT04041284|451709927|FG001|OL Phase (12 Weeks)|Other than specified|2|||
125568079|NCT00563186|451709928|FG000|Overall Study|LOS<48 hours|97|||
125568080|NCT00563186|451709929|FG001|Overall Study|LOS<48 hours|74|||
125568081|NCT00563186|451709928|FG000|Overall Study|Incomplete data|1|||
125568082|NCT00563186|451709929|FG001|Overall Study|Incomplete data|1|||
125568083|NCT00886600|451709930|FG000|Double-blind Monotherapy|Adverse Event|1|||
125568084|NCT00886600|451709931|FG001|Double-blind Monotherapy|Adverse Event|1|||
125568085|NCT00886600|451709932|FG002|Double-blind Monotherapy|Adverse Event|1|||
125568086|NCT00886600|451709933|FG003|Double-blind Monotherapy|Adverse Event|1|||
125568087|NCT00886600|451709930|FG000|Double-blind Monotherapy|Protocol Violation|0|||
125568088|NCT00886600|451709931|FG001|Double-blind Monotherapy|Protocol Violation|0|||
125568089|NCT00886600|451709932|FG002|Double-blind Monotherapy|Protocol Violation|0|||
125568090|NCT00886600|451709933|FG003|Double-blind Monotherapy|Protocol Violation|1|||
125357872|NCT00809354|450946271|FG006|Overall Study|Study terminated by sponsor|124|||
125357873|NCT00809354|450946272|FG007|Overall Study|Study terminated by sponsor|148|||
125568091|NCT00886600|451709930|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
125568092|NCT00886600|451709931|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
125568093|NCT00886600|451709932|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
125568094|NCT00886600|451709933|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
125568095|NCT00886600|451709930|FG000|Combination Therapy Period|Adverse Event|0|||
125568096|NCT00886600|451709931|FG001|Combination Therapy Period|Adverse Event|0|||
125568097|NCT00886600|451709932|FG002|Combination Therapy Period|Adverse Event|1|||
125568098|NCT00886600|451709933|FG003|Combination Therapy Period|Adverse Event|0|||
125568099|NCT00886600|451709930|FG000|Combination Therapy Period|Protocol Violation|0|||
125568100|NCT00886600|451709931|FG001|Combination Therapy Period|Protocol Violation|0|||
125426785|NCT04791761|451187967|FG001|Overall Study|Lost to Follow-up|6|||
125568101|NCT00886600|451709932|FG002|Combination Therapy Period|Protocol Violation|1|||
125568102|NCT00886600|451709933|FG003|Combination Therapy Period|Protocol Violation|0|||
125568103|NCT01439204|451709934|FG000|Overall Study|Withdrawal by Subject|0|||
125568104|NCT01439204|451709935|FG001|Overall Study|Withdrawal by Subject|1|||
125568105|NCT01439204|451709934|FG000|Overall Study|Lost to Follow-up|0|||
125568106|NCT01439204|451709935|FG001|Overall Study|Lost to Follow-up|2|||
125568107|NCT01439204|451709934|FG000|Overall Study|No longer meets study criteria|1|||
125568108|NCT01439204|451709935|FG001|Overall Study|No longer meets study criteria|0|||
125568109|NCT01439204|451709934|FG000|Overall Study|poor/non-compliance|3|||
125568110|NCT01439204|451709935|FG001|Overall Study|poor/non-compliance|0|||
125568111|NCT03775421|451709938|FG000|Overall Study|Lost to Follow-up|2|||
125568112|NCT03775421|451709938|FG000|Overall Study|Withdrawal by Subject|10|||
125568113|NCT03775421|451709938|FG000|Overall Study|Physician Decision|3|||
125568114|NCT03775421|451709938|FG000|Overall Study|Death|1|||
125568115|NCT03775421|451709938|FG000|Overall Study|Study Terminated by Sponsor|94|||
125568116|NCT03917823|451709939|FG000|Overall Study|Lost to Follow-up|1|||
125568117|NCT03917823|451709940|FG001|Overall Study|Lost to Follow-up|1|||
125568118|NCT03917823|451709939|FG000|Overall Study|Withdrawal by Subject|0|||
125568119|NCT03917823|451709940|FG001|Overall Study|Withdrawal by Subject|1|||
125568120|NCT00135668|451709941|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
125568121|NCT00135668|451709942|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
125568122|NCT00135668|451709943|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
125568123|NCT00135668|451709944|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
125568124|NCT00455013|451709949|FG000|Short Term Period|Adverse Event|2|||
125568125|NCT00455013|451709950|FG001|Short Term Period|Adverse Event|5|||
125568126|NCT00455013|451709951|FG002|Short Term Period|Adverse Event|0|||
125568127|NCT00455013|451709949|FG000|Short Term Period|Withdrawal by Subject|0|||
125568128|NCT00455013|451709950|FG001|Short Term Period|Withdrawal by Subject|0|||
125568129|NCT00455013|451709951|FG002|Short Term Period|Withdrawal by Subject|1|||
125568130|NCT00455013|451709949|FG000|Short Term Period|Lack of Efficacy|4|||
125568131|NCT00455013|451709950|FG001|Short Term Period|Lack of Efficacy|0|||
125568132|NCT00455013|451709951|FG002|Short Term Period|Lack of Efficacy|0|||
125568133|NCT00455013|451709949|FG000|Short Term Period|Other|0|||
125568134|NCT00455013|451709950|FG001|Short Term Period|Other|0|||
125568135|NCT00455013|451709951|FG002|Short Term Period|Other|1|||
125568136|NCT00455013|451709949|FG000|Long Term Extension (LTE)|Adverse Event|0|||
125568137|NCT00455013|451709950|FG001|Long Term Extension (LTE)|Adverse Event|1|||
125568138|NCT00455013|451709951|FG002|Long Term Extension (LTE)|Adverse Event|1|||
125568139|NCT00455013|451709949|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
125568140|NCT00455013|451709950|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
125568141|NCT00455013|451709951|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
125568142|NCT00455013|451709949|FG000|Long Term Extension (LTE)|Death|1|||
125568143|NCT00455013|451709950|FG001|Long Term Extension (LTE)|Death|1|||
125568144|NCT00455013|451709951|FG002|Long Term Extension (LTE)|Death|0|||
125568145|NCT00455013|451709949|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
125568146|NCT00455013|451709950|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
125568147|NCT00455013|451709951|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
125568148|NCT00455013|451709949|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
125568149|NCT00455013|451709950|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
125568150|NCT00455013|451709951|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
125568151|NCT00455013|451709949|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
125568152|NCT00455013|451709950|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
125568153|NCT00455013|451709951|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
125568154|NCT00455013|451709949|FG000|Long Term Extension (LTE)|non-specified|0|||
125568155|NCT00455013|451709950|FG001|Long Term Extension (LTE)|non-specified|0|||
125568156|NCT00455013|451709951|FG002|Long Term Extension (LTE)|non-specified|1|||
125568157|NCT02739620|451709954|FG000|Overall Study|Lost to Follow-up|3|||
125568158|NCT02739620|451709955|FG001|Overall Study|Lost to Follow-up|1|||
125568159|NCT02739620|451709954|FG000|Overall Study|Adverse Event|0|||
125568160|NCT02739620|451709955|FG001|Overall Study|Adverse Event|1|||
125568161|NCT02873936|451709956|FG000|Overall Study|Withdrew Consent|4|||
125568162|NCT02873936|451709957|FG001|Overall Study|Withdrew Consent|11|||
125568163|NCT02873936|451709958|FG002|Overall Study|Withdrew Consent|20|||
125568164|NCT02873936|451709956|FG000|Overall Study|Investigator's Discretion|3|||
125568165|NCT02873936|451709957|FG001|Overall Study|Investigator's Discretion|5|||
125568166|NCT02873936|451709958|FG002|Overall Study|Investigator's Discretion|4|||
125426786|NCT04791761|451187968|FG002|Overall Study|Lost to Follow-up|10|||
125568167|NCT02873936|451709956|FG000|Overall Study|Adverse Event|3|||
125568168|NCT02873936|451709957|FG001|Overall Study|Adverse Event|5|||
125568169|NCT02873936|451709958|FG002|Overall Study|Adverse Event|3|||
125357874|NCT00809354|450946273|FG008|Overall Study|Study terminated by sponsor|127|||
125357875|NCT00809354|450946274|FG009|Overall Study|Study terminated by sponsor|135|||
125357876|NCT00809354|450946265|FG000|Overall Study|Withdrawn due to pregnancy|0|||
125357877|NCT00809354|450946266|FG001|Overall Study|Withdrawn due to pregnancy|1|||
125357878|NCT00809354|450946267|FG002|Overall Study|Withdrawn due to pregnancy|0|||
125357879|NCT00809354|450946268|FG003|Overall Study|Withdrawn due to pregnancy|0|||
125568170|NCT02873936|451709956|FG000|Overall Study|Protocol Violation|0|||
125568171|NCT02873936|451709957|FG001|Overall Study|Protocol Violation|1|||
125568172|NCT02873936|451709958|FG002|Overall Study|Protocol Violation|3|||
125568173|NCT02873936|451709956|FG000|Overall Study|Lost to Follow-up|1|||
125568174|NCT02873936|451709957|FG001|Overall Study|Lost to Follow-up|1|||
125568175|NCT02873936|451709958|FG002|Overall Study|Lost to Follow-up|1|||
125568176|NCT02873936|451709956|FG000|Overall Study|Non-compliance With Study Drug|1|||
125568177|NCT02873936|451709957|FG001|Overall Study|Non-compliance With Study Drug|0|||
125568178|NCT02873936|451709958|FG002|Overall Study|Non-compliance With Study Drug|1|||
125568179|NCT02873936|451709956|FG000|Overall Study|Randomized but not Dosed|1|||
125568180|NCT02873936|451709957|FG001|Overall Study|Randomized but not Dosed|0|||
125568181|NCT02873936|451709958|FG002|Overall Study|Randomized but not Dosed|0|||
125568182|NCT05513625|451709959|FG000|Overall Study|Withdrawal by Subject|1|||
125568183|NCT00754793|451709960|FG000|Overall Study|voluntary withdrawn from study|0|||
125568184|NCT00754793|451709961|FG001|Overall Study|voluntary withdrawn from study|1|||
125568185|NCT00917150|451709967|FG000|Overall Study|Adverse Event|12|||
125568186|NCT00917150|451709968|FG001|Overall Study|Adverse Event|7|||
125568187|NCT00917150|451709969|FG002|Overall Study|Adverse Event|12|||
125568188|NCT00917150|451709970|FG003|Overall Study|Adverse Event|11|||
125568189|NCT00917150|451709967|FG000|Overall Study|Death|1|||
125568190|NCT00917150|451709968|FG001|Overall Study|Death|4|||
125568191|NCT00917150|451709969|FG002|Overall Study|Death|3|||
125568192|NCT00917150|451709970|FG003|Overall Study|Death|2|||
125568193|NCT00917150|451709967|FG000|Overall Study|Lost to Follow-up|1|||
125568194|NCT00917150|451709968|FG001|Overall Study|Lost to Follow-up|0|||
125568195|NCT00917150|451709969|FG002|Overall Study|Lost to Follow-up|4|||
125568196|NCT00917150|451709970|FG003|Overall Study|Lost to Follow-up|2|||
125568197|NCT00917150|451709967|FG000|Overall Study|Physician Decision|0|||
125568198|NCT00917150|451709968|FG001|Overall Study|Physician Decision|2|||
125568199|NCT00917150|451709969|FG002|Overall Study|Physician Decision|0|||
125568200|NCT00917150|451709970|FG003|Overall Study|Physician Decision|1|||
125568201|NCT00917150|451709967|FG000|Overall Study|Protocol Violation|5|||
125568202|NCT00917150|451709968|FG001|Overall Study|Protocol Violation|5|||
125568203|NCT00917150|451709969|FG002|Overall Study|Protocol Violation|3|||
125568204|NCT00917150|451709970|FG003|Overall Study|Protocol Violation|5|||
125568205|NCT00917150|451709967|FG000|Overall Study|Withdrawal by Subject|15|||
125568206|NCT00917150|451709968|FG001|Overall Study|Withdrawal by Subject|16|||
125568207|NCT00917150|451709969|FG002|Overall Study|Withdrawal by Subject|18|||
125568208|NCT00917150|451709970|FG003|Overall Study|Withdrawal by Subject|11|||
125568209|NCT00917150|451709967|FG000|Overall Study|Other than specified|3|||
125568210|NCT00917150|451709968|FG001|Overall Study|Other than specified|3|||
125568211|NCT00917150|451709969|FG002|Overall Study|Other than specified|2|||
125568212|NCT00917150|451709970|FG003|Overall Study|Other than specified|2|||
125568213|NCT03891264|451709971|FG000|Overall Study|Adverse Event|1|||
125568214|NCT03891264|451709971|FG000|Overall Study|Withdrawal by Subject|2|||
125568215|NCT03891264|451709971|FG000|Overall Study|Physician Decision|2|||
125568216|NCT01692275|451709972|FG000|Overall Study|Lost to Follow-up|57|||
125568217|NCT01692275|451709973|FG001|Overall Study|Lost to Follow-up|48|||
125568218|NCT01692275|451709972|FG000|Overall Study|Withdrawal by Subject|9|||
125568219|NCT01692275|451709973|FG001|Overall Study|Withdrawal by Subject|11|||
125568220|NCT01033825|451709974|FG000|Overall Study|Withdrawal by Subject|2|||
125568221|NCT01033825|451709975|FG001|Overall Study|Withdrawal by Subject|3|||
125568222|NCT01033825|451709976|FG002|Overall Study|Withdrawal by Subject|2|||
125568223|NCT01033825|451709977|FG003|Overall Study|Withdrawal by Subject|1|||
125568224|NCT01033825|451709978|FG004|Overall Study|Withdrawal by Subject|1|||
125568225|NCT01033825|451709979|FG005|Overall Study|Withdrawal by Subject|0|||
125568226|NCT01033825|451709980|FG006|Overall Study|Withdrawal by Subject|0|||
125568227|NCT01033825|451709974|FG000|Overall Study|Adverse Event|0|||
125568228|NCT01033825|451709975|FG001|Overall Study|Adverse Event|0|||
125568229|NCT01033825|451709976|FG002|Overall Study|Adverse Event|0|||
125568230|NCT01033825|451709977|FG003|Overall Study|Adverse Event|1|||
125568231|NCT01033825|451709978|FG004|Overall Study|Adverse Event|0|||
125568232|NCT01033825|451709979|FG005|Overall Study|Adverse Event|0|||
125568233|NCT01033825|451709980|FG006|Overall Study|Adverse Event|0|||
125568234|NCT01033825|451709974|FG000|Overall Study|Protocol Violation|1|||
125568235|NCT01033825|451709975|FG001|Overall Study|Protocol Violation|0|||
125568236|NCT01033825|451709976|FG002|Overall Study|Protocol Violation|0|||
125568237|NCT01033825|451709977|FG003|Overall Study|Protocol Violation|0|||
125568238|NCT01033825|451709978|FG004|Overall Study|Protocol Violation|0|||
125568239|NCT01033825|451709979|FG005|Overall Study|Protocol Violation|0|||
125568240|NCT01033825|451709980|FG006|Overall Study|Protocol Violation|0|||
125568241|NCT01033825|451709974|FG000|Overall Study|Other|0|||
125568242|NCT01033825|451709975|FG001|Overall Study|Other|0|||
125568243|NCT01033825|451709976|FG002|Overall Study|Other|0|||
125568244|NCT01033825|451709977|FG003|Overall Study|Other|0|||
125568245|NCT01033825|451709978|FG004|Overall Study|Other|1|||
125568246|NCT01033825|451709979|FG005|Overall Study|Other|0|||
125568247|NCT01033825|451709980|FG006|Overall Study|Other|0|||
125568248|NCT03099187|451709981|FG000|Double-blind Treatment|Adverse Event|19|||
125568249|NCT03099187|451709982|FG001|Double-blind Treatment|Adverse Event|1|||
125568250|NCT03099187|451709983|FG002|Double-blind Treatment|Adverse Event|0|||
125568251|NCT03099187|451709984|FG003|Double-blind Treatment|Adverse Event|0|||
125568252|NCT03099187|451709981|FG000|Double-blind Treatment|Death|1|||
125568253|NCT03099187|451709982|FG001|Double-blind Treatment|Death|3|||
125568254|NCT03099187|451709983|FG002|Double-blind Treatment|Death|0|||
125568255|NCT03099187|451709984|FG003|Double-blind Treatment|Death|0|||
125568256|NCT03099187|451709981|FG000|Double-blind Treatment|Lack of Efficacy|1|||
125568257|NCT03099187|451709982|FG001|Double-blind Treatment|Lack of Efficacy|0|||
125568258|NCT03099187|451709983|FG002|Double-blind Treatment|Lack of Efficacy|0|||
125357880|NCT00809354|450946269|FG004|Overall Study|Withdrawn due to pregnancy|0|||
125568259|NCT03099187|451709984|FG003|Double-blind Treatment|Lack of Efficacy|0|||
125568260|NCT03099187|451709981|FG000|Double-blind Treatment|Physician Decision|2|||
125568261|NCT03099187|451709982|FG001|Double-blind Treatment|Physician Decision|1|||
125568262|NCT03099187|451709983|FG002|Double-blind Treatment|Physician Decision|0|||
125568263|NCT03099187|451709984|FG003|Double-blind Treatment|Physician Decision|0|||
125568264|NCT03099187|451709981|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
125426787|NCT04791761|451187966|FG000|Overall Study|Withdrawal by Subject|0|||
125426788|NCT04791761|451187967|FG001|Overall Study|Withdrawal by Subject|1|||
125426789|NCT04791761|451187968|FG002|Overall Study|Withdrawal by Subject|1|||
125426790|NCT04791761|451187966|FG000|Overall Study|Protocol Violation|0|||
125426791|NCT04791761|451187967|FG001|Overall Study|Protocol Violation|1|||
125426792|NCT04791761|451187968|FG002|Overall Study|Protocol Violation|1|||
125426793|NCT03548207|451187969|FG000|Overall Study|Death|10|||
125426794|NCT03548207|451187970|FG001|Overall Study|Death|23|||
125426795|NCT03548207|451187971|FG002|Overall Study|Death|3|||
125426796|NCT03548207|451187969|FG000|Overall Study|Lost to Follow-up|0|||
125426797|NCT03548207|451187970|FG001|Overall Study|Lost to Follow-up|2|||
125426798|NCT03548207|451187971|FG002|Overall Study|Lost to Follow-up|0|||
125426799|NCT03548207|451187969|FG000|Overall Study|Withdrawal by Subject|0|||
125426800|NCT03548207|451187970|FG001|Overall Study|Withdrawal by Subject|3|||
125426801|NCT03548207|451187971|FG002|Overall Study|Withdrawal by Subject|0|||
125426802|NCT03548207|451187969|FG000|Overall Study|Sponsor decision|19|||
125426803|NCT03548207|451187970|FG001|Overall Study|Sponsor decision|40|||
125426804|NCT03548207|451187971|FG002|Overall Study|Sponsor decision|6|||
125426805|NCT03548207|451187969|FG000|Overall Study|Randomized but not treated|6|||
125426806|NCT03548207|451187970|FG001|Overall Study|Randomized but not treated|10|||
125426807|NCT03548207|451187971|FG002|Overall Study|Randomized but not treated|4|||
125426808|NCT01756352|451187972|FG000|Overall Study|moved away and lost to followup|1|||
125426809|NCT00415610|451187973|FG000|Overall Study|Death|3|||
125426810|NCT00415610|451187974|FG001|Overall Study|Death|2|||
125426811|NCT00415610|451187975|FG002|Overall Study|Death|5|||
125568265|NCT03099187|451709982|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
125568266|NCT03099187|451709983|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
125568267|NCT03099187|451709984|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
125568268|NCT03099187|451709981|FG000|Double-blind Treatment|Lung transplantation|0|||
125568269|NCT03099187|451709982|FG001|Double-blind Treatment|Lung transplantation|1|||
125568270|NCT03099187|451709983|FG002|Double-blind Treatment|Lung transplantation|0|||
125426812|NCT00999466|451187978|FG000|Main Part|Withdrawal by Subject|0|||
125426813|NCT00999466|451187979|FG001|Main Part|Withdrawal by Subject|0|||
125426814|NCT00999466|451187980|FG002|Main Part|Withdrawal by Subject|2|||
125426815|NCT00999466|451187978|FG000|Main Part|Adverse Event|0|||
125426816|NCT00999466|451187979|FG001|Main Part|Adverse Event|4|||
125568271|NCT03099187|451709984|FG003|Double-blind Treatment|Lung transplantation|0|||
125568272|NCT03099187|451709981|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
125568273|NCT03099187|451709982|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
125426817|NCT00999466|451187980|FG002|Main Part|Adverse Event|2|||
125426818|NCT01113502|451187982|FG000|Overall Study|Withdrawal by Subject|1|||
125426819|NCT01113502|451187983|FG001|Overall Study|Withdrawal by Subject|0|||
125568274|NCT03099187|451709983|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
125568275|NCT03099187|451709984|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
125568276|NCT03099187|451709981|FG000|Double-blind Treatment|Disease progression|0|||
125568277|NCT03099187|451709982|FG001|Double-blind Treatment|Disease progression|1|||
125568278|NCT03099187|451709983|FG002|Double-blind Treatment|Disease progression|0|||
125568279|NCT03099187|451709984|FG003|Double-blind Treatment|Disease progression|0|||
125568280|NCT03099187|451709981|FG000|Double-blind Treatment|Randomization error|0|||
125568281|NCT03099187|451709982|FG001|Double-blind Treatment|Randomization error|2|||
125568282|NCT03099187|451709983|FG002|Double-blind Treatment|Randomization error|0|||
125568283|NCT03099187|451709984|FG003|Double-blind Treatment|Randomization error|0|||
125568284|NCT03099187|451709981|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
125568285|NCT03099187|451709982|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
125568286|NCT03099187|451709983|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
125568287|NCT03099187|451709984|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
125568288|NCT03099187|451709981|FG000|12-month Safety Follow-up|Adverse Event|0|||
125568289|NCT03099187|451709982|FG001|12-month Safety Follow-up|Adverse Event|0|||
125568290|NCT03099187|451709983|FG002|12-month Safety Follow-up|Adverse Event|5|||
125568291|NCT03099187|451709984|FG003|12-month Safety Follow-up|Adverse Event|12|||
125568292|NCT03099187|451709981|FG000|12-month Safety Follow-up|Death|0|||
125568293|NCT03099187|451709982|FG001|12-month Safety Follow-up|Death|0|||
125568294|NCT03099187|451709983|FG002|12-month Safety Follow-up|Death|7|||
125568295|NCT03099187|451709984|FG003|12-month Safety Follow-up|Death|9|||
125568296|NCT03099187|451709981|FG000|12-month Safety Follow-up|Lung transplantation|0|||
125568297|NCT03099187|451709982|FG001|12-month Safety Follow-up|Lung transplantation|0|||
125568298|NCT03099187|451709983|FG002|12-month Safety Follow-up|Lung transplantation|2|||
125568299|NCT03099187|451709984|FG003|12-month Safety Follow-up|Lung transplantation|1|||
125568300|NCT03099187|451709981|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
125568301|NCT03099187|451709982|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
125568302|NCT03099187|451709983|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
125568303|NCT03099187|451709984|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
125568304|NCT03099187|451709981|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
125568305|NCT03099187|451709982|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
125568306|NCT03099187|451709983|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
125568307|NCT03099187|451709984|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
125568308|NCT03099187|451709981|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
125568309|NCT03099187|451709982|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
125568310|NCT03099187|451709983|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
125568311|NCT03099187|451709984|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
125568312|NCT03099187|451709981|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
125568313|NCT03099187|451709982|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
125568314|NCT03099187|451709983|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
125568315|NCT03099187|451709984|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
125568316|NCT01439555|451709987|FG000|Overall Study|Protocol Violation|1|||
125568317|NCT03077685|451709988|FG000|Overall Study|Lost to Follow-up|0|||
125568318|NCT03077685|451709989|FG001|Overall Study|Lost to Follow-up|0|||
125568319|NCT03077685|451709990|FG002|Overall Study|Lost to Follow-up|0|||
125568320|NCT03077685|451709991|FG003|Overall Study|Lost to Follow-up|0|||
125568321|NCT03077685|451709992|FG004|Overall Study|Lost to Follow-up|1|||
125568322|NCT03077685|451709988|FG000|Overall Study|Death|0|||
125568323|NCT03077685|451709989|FG001|Overall Study|Death|0|||
125568324|NCT03077685|451709990|FG002|Overall Study|Death|1|||
125568325|NCT03077685|451709991|FG003|Overall Study|Death|1|||
125568326|NCT03077685|451709992|FG004|Overall Study|Death|3|||
125568327|NCT03077685|451709988|FG000|Overall Study|Withdrawal by Subject|0|||
125568328|NCT03077685|451709989|FG001|Overall Study|Withdrawal by Subject|0|||
125568329|NCT03077685|451709990|FG002|Overall Study|Withdrawal by Subject|0|||
125568330|NCT03077685|451709991|FG003|Overall Study|Withdrawal by Subject|2|||
125568331|NCT03077685|451709992|FG004|Overall Study|Withdrawal by Subject|1|||
125568332|NCT03077685|451709988|FG000|Overall Study|Physician Decision|0|||
125568333|NCT03077685|451709989|FG001|Overall Study|Physician Decision|0|||
125568334|NCT03077685|451709990|FG002|Overall Study|Physician Decision|1|||
125568335|NCT03077685|451709991|FG003|Overall Study|Physician Decision|0|||
125568336|NCT03077685|451709992|FG004|Overall Study|Physician Decision|3|||
125568337|NCT03077685|451709988|FG000|Overall Study|Disease Progression|1|||
125568338|NCT03077685|451709989|FG001|Overall Study|Disease Progression|0|||
125568339|NCT03077685|451709990|FG002|Overall Study|Disease Progression|0|||
125568340|NCT03077685|451709991|FG003|Overall Study|Disease Progression|2|||
125568341|NCT03077685|451709992|FG004|Overall Study|Disease Progression|1|||
125568342|NCT03077685|451709988|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
125568343|NCT03077685|451709989|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
125568344|NCT03077685|451709990|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
125568345|NCT03077685|451709991|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
125568346|NCT03077685|451709992|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
125568347|NCT03077685|451709988|FG000|Overall Study|Subject entered hospice care|0|||
125568348|NCT03077685|451709989|FG001|Overall Study|Subject entered hospice care|0|||
125568349|NCT03077685|451709990|FG002|Overall Study|Subject entered hospice care|0|||
125568350|NCT03077685|451709991|FG003|Overall Study|Subject entered hospice care|0|||
125568351|NCT03077685|451709992|FG004|Overall Study|Subject entered hospice care|1|||
125568352|NCT01246583|451709994|FG000|Overall Study|Lost to Follow-up|0|||
125568353|NCT01246583|451709995|FG001|Overall Study|Lost to Follow-up|0|||
125568354|NCT01246583|451709996|FG002|Overall Study|Lost to Follow-up|0|||
125568355|NCT01246583|451709997|FG003|Overall Study|Lost to Follow-up|1|||
125568356|NCT01246583|451709994|FG000|Overall Study|Protocol Violation|0|||
125568357|NCT01246583|451709995|FG001|Overall Study|Protocol Violation|0|||
125568358|NCT01246583|451709996|FG002|Overall Study|Protocol Violation|1|||
125568359|NCT01246583|451709997|FG003|Overall Study|Protocol Violation|0|||
125568360|NCT01246583|451709994|FG000|Overall Study|Withdrawal by Subject|1|||
125568361|NCT01246583|451709995|FG001|Overall Study|Withdrawal by Subject|0|||
125568362|NCT01246583|451709996|FG002|Overall Study|Withdrawal by Subject|0|||
125568363|NCT01246583|451709997|FG003|Overall Study|Withdrawal by Subject|0|||
125568364|NCT01806779|451710001|FG000|Overall Study|Physician Decision|2|||
125568365|NCT01806779|451710002|FG001|Overall Study|Physician Decision|0|||
125568366|NCT01806779|451710003|FG002|Overall Study|Physician Decision|1|||
125568367|NCT01806779|451710001|FG000|Overall Study|Lack of Efficacy|1|||
125357881|NCT00809354|450946270|FG005|Overall Study|Withdrawn due to pregnancy|0|||
125357882|NCT00809354|450946271|FG006|Overall Study|Withdrawn due to pregnancy|0|||
125357883|NCT00809354|450946272|FG007|Overall Study|Withdrawn due to pregnancy|0|||
125357884|NCT00809354|450946273|FG008|Overall Study|Withdrawn due to pregnancy|0|||
125357885|NCT00809354|450946274|FG009|Overall Study|Withdrawn due to pregnancy|0|||
125568368|NCT01806779|451710002|FG001|Overall Study|Lack of Efficacy|1|||
125568369|NCT01806779|451710003|FG002|Overall Study|Lack of Efficacy|0|||
125568370|NCT01806779|451710001|FG000|Overall Study|Lost to Follow-up|19|||
125568371|NCT01806779|451710002|FG001|Overall Study|Lost to Follow-up|20|||
125568372|NCT01806779|451710003|FG002|Overall Study|Lost to Follow-up|0|||
125568373|NCT01806779|451710001|FG000|Overall Study|Withdrawal by Subject|20|||
125568374|NCT01806779|451710002|FG001|Overall Study|Withdrawal by Subject|23|||
125568375|NCT01806779|451710003|FG002|Overall Study|Withdrawal by Subject|22|||
125568376|NCT04294901|451710006|FG000|Overall Study|Death|86|||
125568377|NCT04294901|451710007|FG001|Overall Study|Death|110|||
125568378|NCT04294901|451710006|FG000|Overall Study|Provider did not have historical control patients|581|||
125568379|NCT04294901|451710007|FG001|Overall Study|Provider did not have historical control patients|0|||
125568380|NCT04294901|451710006|FG000|Overall Study|Provider did not have intervention patients|0|||
125568381|NCT04294901|451710007|FG001|Overall Study|Provider did not have intervention patients|98|||
125568382|NCT04218201|451711866|FG000|Overall Study|Death|0|||
125568383|NCT04218201|451711867|FG001|Overall Study|Death|0|||
125357886|NCT00809354|450946265|FG000|Overall Study|Randomized but not Treated|3|||
125568384|NCT04218201|451711868|FG002|Overall Study|Death|2|||
125568385|NCT04218201|451711869|FG003|Overall Study|Death|0|||
125568386|NCT04218201|451711866|FG000|Overall Study|Unable to contact participant|4|||
125568387|NCT04218201|451711867|FG001|Overall Study|Unable to contact participant|0|||
125568388|NCT04218201|451711868|FG002|Overall Study|Unable to contact participant|3|||
125568389|NCT04218201|451711869|FG003|Overall Study|Unable to contact participant|0|||
125568390|NCT04218201|451711866|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
125568391|NCT04218201|451711867|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
125568392|NCT04218201|451711868|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
125568393|NCT04218201|451711869|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
125568394|NCT04218201|451711866|FG000|Overall Study|Withdrawal by Subject|2|||
125568395|NCT04218201|451711867|FG001|Overall Study|Withdrawal by Subject|0|||
125568396|NCT04218201|451711868|FG002|Overall Study|Withdrawal by Subject|0|||
125568397|NCT04218201|451711869|FG003|Overall Study|Withdrawal by Subject|0|||
125426820|NCT01113502|451187984|FG002|Overall Study|Withdrawal by Subject|1|||
125426821|NCT01113502|451187985|FG003|Overall Study|Withdrawal by Subject|1|||
125426822|NCT01113502|451187986|FG004|Overall Study|Withdrawal by Subject|0|||
125568398|NCT04218201|451711866|FG000|Overall Study|PCP plans to leave practice|0|||
125568399|NCT04218201|451711867|FG001|Overall Study|PCP plans to leave practice|8|||
125568400|NCT04218201|451711868|FG002|Overall Study|PCP plans to leave practice|0|||
125568401|NCT04218201|451711869|FG003|Overall Study|PCP plans to leave practice|5|||
125568402|NCT04218201|451711866|FG000|Overall Study|Reduced panel|0|||
125357887|NCT00809354|450946266|FG001|Overall Study|Randomized but not Treated|1|||
125357888|NCT00809354|450946267|FG002|Overall Study|Randomized but not Treated|6|||
125568403|NCT04218201|451711867|FG001|Overall Study|Reduced panel|0|||
125568404|NCT04218201|451711868|FG002|Overall Study|Reduced panel|0|||
125568405|NCT04218201|451711869|FG003|Overall Study|Reduced panel|1|||
125568406|NCT04218201|451711866|FG000|Overall Study|No longer interested in participating|0|||
125568407|NCT04218201|451711867|FG001|Overall Study|No longer interested in participating|1|||
125568408|NCT04218201|451711868|FG002|Overall Study|No longer interested in participating|0|||
125568409|NCT04218201|451711869|FG003|Overall Study|No longer interested in participating|0|||
125568410|NCT03723707|451711876|FG000|Overall Study|Death|32|||
125568411|NCT03723707|451711877|FG001|Overall Study|Death|32|||
125568412|NCT03723707|451711876|FG000|Overall Study|Admitted to long term care|12|||
125568413|NCT03723707|451711877|FG001|Overall Study|Admitted to long term care|12|||
125568414|NCT03723707|451711876|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
125357889|NCT00809354|450946268|FG003|Overall Study|Randomized but not Treated|0|||
125568415|NCT03723707|451711877|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
125568416|NCT03723707|451711876|FG000|Overall Study|Lost to Follow-up|40|||
125568417|NCT03723707|451711877|FG001|Overall Study|Lost to Follow-up|22|||
125568418|NCT03723707|451711876|FG000|Overall Study|Discontinued after study closure|24|||
125568419|NCT03723707|451711877|FG001|Overall Study|Discontinued after study closure|12|||
125568420|NCT05121480|451711878|FG000|Overall Study|Lack of Efficacy|2|||
125568421|NCT05121480|451711879|FG001|Overall Study|Lack of Efficacy|2|||
125568422|NCT05121480|451711880|FG002|Overall Study|Lack of Efficacy|1|||
125568423|NCT05121480|451711881|FG003|Overall Study|Lack of Efficacy|4|||
125568424|NCT05121480|451711882|FG004|Overall Study|Lack of Efficacy|0|||
125568425|NCT05121480|451711883|FG005|Overall Study|Lack of Efficacy|1|||
125568426|NCT05121480|451711884|FG006|Overall Study|Lack of Efficacy|0|||
125568427|NCT05121480|451711885|FG007|Overall Study|Lack of Efficacy|2|||
125568428|NCT05121480|451711878|FG000|Overall Study|Treatment Failure|0|||
125357890|NCT00809354|450946269|FG004|Overall Study|Randomized but not Treated|5|||
125357891|NCT00809354|450946270|FG005|Overall Study|Randomized but not Treated|0|||
125568429|NCT05121480|451711879|FG001|Overall Study|Treatment Failure|2|||
125568430|NCT05121480|451711880|FG002|Overall Study|Treatment Failure|0|||
125568431|NCT05121480|451711881|FG003|Overall Study|Treatment Failure|1|||
125568432|NCT05121480|451711882|FG004|Overall Study|Treatment Failure|0|||
125568433|NCT05121480|451711883|FG005|Overall Study|Treatment Failure|0|||
125568434|NCT05121480|451711884|FG006|Overall Study|Treatment Failure|0|||
125568435|NCT05121480|451711885|FG007|Overall Study|Treatment Failure|0|||
125568436|NCT05121480|451711878|FG000|Overall Study|Adverse Event|0|||
125568437|NCT05121480|451711879|FG001|Overall Study|Adverse Event|1|||
125568438|NCT05121480|451711880|FG002|Overall Study|Adverse Event|0|||
125568439|NCT05121480|451711881|FG003|Overall Study|Adverse Event|5|||
125568440|NCT05121480|451711882|FG004|Overall Study|Adverse Event|3|||
125568441|NCT05121480|451711883|FG005|Overall Study|Adverse Event|2|||
125568442|NCT05121480|451711884|FG006|Overall Study|Adverse Event|0|||
125568443|NCT05121480|451711885|FG007|Overall Study|Adverse Event|4|||
125568444|NCT05121480|451711878|FG000|Overall Study|Withdrawal by Subject|4|||
125568445|NCT05121480|451711879|FG001|Overall Study|Withdrawal by Subject|9|||
125568446|NCT05121480|451711880|FG002|Overall Study|Withdrawal by Subject|1|||
125568447|NCT05121480|451711881|FG003|Overall Study|Withdrawal by Subject|8|||
125568448|NCT05121480|451711882|FG004|Overall Study|Withdrawal by Subject|0|||
125568449|NCT05121480|451711883|FG005|Overall Study|Withdrawal by Subject|9|||
125568450|NCT05121480|451711884|FG006|Overall Study|Withdrawal by Subject|0|||
125568451|NCT05121480|451711885|FG007|Overall Study|Withdrawal by Subject|4|||
125568452|NCT05121480|451711878|FG000|Overall Study|Non-compliance with the protocol|0|||
125568453|NCT05121480|451711879|FG001|Overall Study|Non-compliance with the protocol|0|||
125568454|NCT05121480|451711880|FG002|Overall Study|Non-compliance with the protocol|0|||
125568455|NCT05121480|451711881|FG003|Overall Study|Non-compliance with the protocol|0|||
125568456|NCT05121480|451711882|FG004|Overall Study|Non-compliance with the protocol|1|||
125568457|NCT05121480|451711883|FG005|Overall Study|Non-compliance with the protocol|6|||
125568458|NCT05121480|451711884|FG006|Overall Study|Non-compliance with the protocol|0|||
125568459|NCT05121480|451711885|FG007|Overall Study|Non-compliance with the protocol|1|||
125568460|NCT05121480|451711878|FG000|Overall Study|Lost to Follow-up|0|||
125568461|NCT05121480|451711879|FG001|Overall Study|Lost to Follow-up|4|||
125357892|NCT00809354|450946271|FG006|Overall Study|Randomized but not Treated|1|||
125568462|NCT05121480|451711880|FG002|Overall Study|Lost to Follow-up|1|||
125568463|NCT05121480|451711881|FG003|Overall Study|Lost to Follow-up|3|||
125568464|NCT05121480|451711882|FG004|Overall Study|Lost to Follow-up|1|||
125568465|NCT05121480|451711883|FG005|Overall Study|Lost to Follow-up|1|||
125568466|NCT05121480|451711884|FG006|Overall Study|Lost to Follow-up|1|||
125568467|NCT05121480|451711885|FG007|Overall Study|Lost to Follow-up|4|||
125568468|NCT05121480|451711878|FG000|Overall Study|Physician Decision|0|||
125568469|NCT05121480|451711879|FG001|Overall Study|Physician Decision|0|||
125568470|NCT05121480|451711880|FG002|Overall Study|Physician Decision|0|||
125568471|NCT05121480|451711881|FG003|Overall Study|Physician Decision|0|||
125568472|NCT05121480|451711882|FG004|Overall Study|Physician Decision|0|||
125568473|NCT05121480|451711883|FG005|Overall Study|Physician Decision|1|||
125568474|NCT05121480|451711884|FG006|Overall Study|Physician Decision|0|||
125568475|NCT05121480|451711885|FG007|Overall Study|Physician Decision|1|||
125568476|NCT05121480|451711878|FG000|Overall Study|Other Reason|0|||
125568477|NCT05121480|451711879|FG001|Overall Study|Other Reason|0|||
125568478|NCT05121480|451711880|FG002|Overall Study|Other Reason|0|||
125568479|NCT05121480|451711881|FG003|Overall Study|Other Reason|0|||
125568480|NCT05121480|451711882|FG004|Overall Study|Other Reason|0|||
125568481|NCT05121480|451711883|FG005|Overall Study|Other Reason|1|||
125568482|NCT05121480|451711884|FG006|Overall Study|Other Reason|1|||
125568483|NCT05121480|451711885|FG007|Overall Study|Other Reason|1|||
125568484|NCT02831673|451711888|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
125568485|NCT02831673|451711889|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
125568486|NCT02831673|451711890|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
125568487|NCT02831673|451711891|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
125568488|NCT02831673|451711892|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
125568489|NCT02831673|451711888|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
125568490|NCT02831673|451711889|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
125568491|NCT02831673|451711890|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
125568492|NCT02831673|451711891|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
125568493|NCT02831673|451711892|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
125568494|NCT02831673|451711888|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
125568495|NCT02831673|451711889|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
125568496|NCT02831673|451711890|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
125568497|NCT02831673|451711891|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
125357893|NCT00809354|450946272|FG007|Overall Study|Randomized but not Treated|1|||
125357894|NCT00809354|450946273|FG008|Overall Study|Randomized but not Treated|2|||
125568498|NCT02831673|451711892|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
125568499|NCT02831673|451711888|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
125357895|NCT00809354|450946274|FG009|Overall Study|Randomized but not Treated|1|||
125568500|NCT02831673|451711889|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
125568501|NCT02831673|451711890|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
125568502|NCT02831673|451711891|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
125568503|NCT02831673|451711892|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
125568504|NCT02831673|451711888|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
125568505|NCT02831673|451711889|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
125568506|NCT02831673|451711890|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
125568507|NCT02831673|451711891|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
125568508|NCT02831673|451711892|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
125568509|NCT02831673|451711888|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
125568510|NCT02831673|451711889|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
125568511|NCT02831673|451711890|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
125568512|NCT02831673|451711891|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
125568513|NCT02831673|451711892|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
125568514|NCT02831673|451711888|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
125568515|NCT02831673|451711889|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
125568516|NCT02831673|451711890|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
125568517|NCT02831673|451711891|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
125568518|NCT02831673|451711892|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
125568519|NCT02831673|451711888|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
125568520|NCT02831673|451711889|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
125568521|NCT02831673|451711890|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
125426823|NCT01113502|451187982|FG000|Overall Study|Adverse Event|0|||
125568522|NCT02831673|451711891|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
125568523|NCT02831673|451711892|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
125568524|NCT02831673|451711888|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
125568525|NCT02831673|451711889|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
125568526|NCT02831673|451711890|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
125357896|NCT00809354|450946265|FG000|Overall Study|Death|0|||
125357897|NCT00809354|450946266|FG001|Overall Study|Death|0|||
125357898|NCT00809354|450946267|FG002|Overall Study|Death|0|||
125357899|NCT00809354|450946268|FG003|Overall Study|Death|0|||
125357900|NCT00809354|450946269|FG004|Overall Study|Death|0|||
125357901|NCT00809354|450946270|FG005|Overall Study|Death|0|||
125357902|NCT00809354|450946271|FG006|Overall Study|Death|0|||
125357903|NCT00809354|450946272|FG007|Overall Study|Death|1|||
125357904|NCT00809354|450946273|FG008|Overall Study|Death|0|||
125568527|NCT02831673|451711891|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
125568528|NCT02831673|451711892|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
125568529|NCT02831673|451711888|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125568530|NCT02831673|451711889|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125568531|NCT02831673|451711890|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
125568532|NCT02831673|451711891|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
125568533|NCT02831673|451711892|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
125568534|NCT02831673|451711888|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125568535|NCT02831673|451711889|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125568536|NCT02831673|451711890|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125568537|NCT02831673|451711891|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
125568538|NCT02831673|451711892|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
125568539|NCT02831673|451711888|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
125568540|NCT02831673|451711889|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
125568541|NCT02831673|451711890|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
125568542|NCT02831673|451711891|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
125568543|NCT02831673|451711892|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
125568544|NCT02831673|451711888|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
125568545|NCT02831673|451711889|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
125568546|NCT02831673|451711890|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
125568547|NCT02831673|451711891|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
125568548|NCT02831673|451711892|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
125568549|NCT02831673|451711888|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
125568550|NCT02831673|451711889|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
125568551|NCT02831673|451711890|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
125568552|NCT02831673|451711891|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
125568553|NCT02831673|451711892|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
125568554|NCT02831673|451711888|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
125568555|NCT02831673|451711889|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
125568556|NCT02831673|451711890|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
125568557|NCT02831673|451711891|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
125568558|NCT02831673|451711892|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
125568559|NCT02831673|451711888|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
125568560|NCT02831673|451711889|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
125568561|NCT02831673|451711890|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
125568562|NCT02831673|451711891|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
125568563|NCT02831673|451711892|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
125568564|NCT02831673|451711888|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125568565|NCT02831673|451711889|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125568566|NCT02831673|451711890|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125568567|NCT02831673|451711891|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
125568568|NCT02831673|451711892|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
125568569|NCT02831673|451711888|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125568570|NCT02831673|451711889|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125568571|NCT02831673|451711890|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125568572|NCT02831673|451711891|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
125568573|NCT02831673|451711892|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
125568574|NCT02831673|451711888|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125568575|NCT02831673|451711889|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125568576|NCT02831673|451711890|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125568577|NCT02831673|451711891|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
125568578|NCT02831673|451711892|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
125568579|NCT02831673|451711888|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125568580|NCT02831673|451711889|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125568581|NCT02831673|451711890|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125568582|NCT02831673|451711891|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
125568583|NCT02831673|451711892|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
125568584|NCT02356562|451711893|FG000|Overall Study|Withdrawal by Subject|0|||
125568585|NCT02356562|451711894|FG001|Overall Study|Withdrawal by Subject|1|||
125568586|NCT02356562|451711893|FG000|Overall Study|Re-entered treatment in a previous study|1|||
125568587|NCT02356562|451711894|FG001|Overall Study|Re-entered treatment in a previous study|0|||
125568588|NCT02356562|451711893|FG000|Overall Study|site closure|1|||
125568589|NCT02356562|451711894|FG001|Overall Study|site closure|0|||
125568590|NCT01351389|451711904|FG000|Overall Study|Withdrawal by Subject|7|||
125568591|NCT01351389|451711905|FG001|Overall Study|Withdrawal by Subject|0|||
125568592|NCT01351389|451711904|FG000|Overall Study|did not complete intervention|23|||
125568593|NCT01351389|451711905|FG001|Overall Study|did not complete intervention|15|||
125568594|NCT00713700|451711906|FG000|Overall Study|Lost to Follow-up|3|||
125568595|NCT00713700|451711906|FG000|Overall Study|Withdrawal by Subject|1|||
125568596|NCT03719690|451711907|FG000|Overall Study|Withdrawal by Subject|5|||
125568597|NCT03719690|451711908|FG001|Overall Study|Withdrawal by Subject|10|||
125568598|NCT03719690|451711907|FG000|Overall Study|Death|40|||
125568599|NCT03719690|451711908|FG001|Overall Study|Death|149|||
125568600|NCT03719690|451711907|FG000|Overall Study|Miscellaneous|12|||
125568601|NCT03719690|451711908|FG001|Overall Study|Miscellaneous|56|||
125568602|NCT03719690|451711907|FG000|Overall Study|Lost to Follow-up|2|||
125568603|NCT03719690|451711908|FG001|Overall Study|Lost to Follow-up|18|||
125568604|NCT03719690|451711907|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
125568605|NCT03719690|451711908|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
125568606|NCT00847912|451711909|FG000|Overall Study|Protocol Violation|6|||
125568607|NCT00847912|451711910|FG001|Overall Study|Protocol Violation|7|||
125568608|NCT00847912|451711909|FG000|Overall Study|Withdrawal by Subject|3|||
125568609|NCT00847912|451711910|FG001|Overall Study|Withdrawal by Subject|6|||
125568610|NCT01074190|451711911|FG000|Overall Study|Emergency Cesarean Delivery|1|||
125568611|NCT01074190|451711912|FG001|Overall Study|Emergency Cesarean Delivery|2|||
125568612|NCT01074190|451711913|FG002|Overall Study|Emergency Cesarean Delivery|1|||
125568613|NCT01074190|451711911|FG000|Overall Study|Protocol Violation|2|||
125568614|NCT01074190|451711912|FG001|Overall Study|Protocol Violation|1|||
125357905|NCT00809354|450946274|FG009|Overall Study|Death|0|||
125357906|NCT00267189|450946275|FG000|Overall Study|Patient withdrew consent|1|||
125357907|NCT00267189|450946276|FG001|Overall Study|Patient withdrew consent|1|||
125357908|NCT00267189|450946275|FG000|Overall Study|Death|1|||
125357909|NCT00267189|450946276|FG001|Overall Study|Death|0|||
125357910|NCT00267189|450946275|FG000|Overall Study|Missing|3|||
125357911|NCT00267189|450946276|FG001|Overall Study|Missing|0|||
125357912|NCT00100178|450946277|FG000|Overall Study|Lost to Follow-up|0|||
125357913|NCT00100178|450946278|FG001|Overall Study|Lost to Follow-up|6|||
125357914|NCT00100178|450946279|FG002|Overall Study|Lost to Follow-up|5|||
125357915|NCT00100178|450946277|FG000|Overall Study|Adverse Event|2|||
125357916|NCT00100178|450946278|FG001|Overall Study|Adverse Event|2|||
125357917|NCT00100178|450946279|FG002|Overall Study|Adverse Event|1|||
125357918|NCT00100178|450946277|FG000|Overall Study|Withdrawal by Subject|1|||
125357919|NCT00100178|450946278|FG001|Overall Study|Withdrawal by Subject|1|||
125357920|NCT00100178|450946279|FG002|Overall Study|Withdrawal by Subject|1|||
125568615|NCT01074190|451711913|FG002|Overall Study|Protocol Violation|0|||
125568616|NCT01074190|451711911|FG000|Overall Study|Delivered in under 90 minutes|0|||
125568617|NCT01074190|451711912|FG001|Overall Study|Delivered in under 90 minutes|2|||
125568618|NCT01074190|451711913|FG002|Overall Study|Delivered in under 90 minutes|1|||
125568619|NCT01074190|451711911|FG000|Overall Study|Subject withdrew consent|1|||
125568620|NCT01074190|451711912|FG001|Overall Study|Subject withdrew consent|1|||
125568621|NCT01074190|451711913|FG002|Overall Study|Subject withdrew consent|1|||
125568622|NCT00732303|451711920|FG000|Overall Study|Study Terminated|2|||
125568623|NCT03882970|451711921|FG000|Overall Study|Adverse Event|5|||
125568624|NCT03882970|451711922|FG001|Overall Study|Adverse Event|7|||
125568625|NCT03882970|451711923|FG002|Overall Study|Adverse Event|3|||
125568626|NCT03882970|451711924|FG003|Overall Study|Adverse Event|1|||
125568627|NCT03882970|451711921|FG000|Overall Study|Death|1|||
125568628|NCT03882970|451711922|FG001|Overall Study|Death|2|||
125568629|NCT03882970|451711923|FG002|Overall Study|Death|1|||
125568630|NCT03882970|451711924|FG003|Overall Study|Death|1|||
125568631|NCT03882970|451711921|FG000|Overall Study|Lost to Follow-up|8|||
125568632|NCT03882970|451711922|FG001|Overall Study|Lost to Follow-up|9|||
125568633|NCT03882970|451711923|FG002|Overall Study|Lost to Follow-up|5|||
125568634|NCT03882970|451711924|FG003|Overall Study|Lost to Follow-up|5|||
125568635|NCT03882970|451711921|FG000|Overall Study|Physician Decision|0|||
125568636|NCT03882970|451711922|FG001|Overall Study|Physician Decision|2|||
125568637|NCT03882970|451711923|FG002|Overall Study|Physician Decision|2|||
125568638|NCT03882970|451711924|FG003|Overall Study|Physician Decision|2|||
125568639|NCT03882970|451711921|FG000|Overall Study|Protocol Violation|2|||
125568640|NCT03882970|451711922|FG001|Overall Study|Protocol Violation|0|||
125568641|NCT03882970|451711923|FG002|Overall Study|Protocol Violation|0|||
125568642|NCT03882970|451711924|FG003|Overall Study|Protocol Violation|0|||
125568643|NCT03882970|451711921|FG000|Overall Study|Withdrawal by Subject|8|||
125568644|NCT03882970|451711922|FG001|Overall Study|Withdrawal by Subject|17|||
125568645|NCT03882970|451711923|FG002|Overall Study|Withdrawal by Subject|7|||
125568646|NCT03882970|451711924|FG003|Overall Study|Withdrawal by Subject|22|||
125568647|NCT03882970|451711921|FG000|Overall Study|Personal Reason|2|||
125568648|NCT03882970|451711922|FG001|Overall Study|Personal Reason|3|||
125568649|NCT03882970|451711923|FG002|Overall Study|Personal Reason|1|||
125568650|NCT03882970|451711924|FG003|Overall Study|Personal Reason|3|||
125568651|NCT02830776|451711938|FG000|Overall Study|Lost to Follow-up|1|||
125568652|NCT00607386|451711939|FG000|Overall Study|Physician Decision|1|||
125568653|NCT00440947|451711940|FG000|36-Week Induction Phase|Adverse Event|16|||
125568654|NCT00440947|451711941|FG001|36-Week Induction Phase|Adverse Event|0|||
125568655|NCT00440947|451711942|FG002|36-Week Induction Phase|Adverse Event|0|||
125568656|NCT00440947|451711943|FG003|36-Week Induction Phase|Adverse Event|0|||
125568657|NCT00440947|451711944|FG004|36-Week Induction Phase|Adverse Event|0|||
125568658|NCT00440947|451711940|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
125568659|NCT00440947|451711941|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
125568660|NCT00440947|451711942|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
125568661|NCT00440947|451711943|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
125568662|NCT00440947|451711944|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
125568663|NCT00440947|451711940|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
125357921|NCT00100178|450946277|FG000|Overall Study|Physician Decision|6|||
125568664|NCT00440947|451711941|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
125568665|NCT00440947|451711942|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
125568666|NCT00440947|451711943|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
125357922|NCT00100178|450946278|FG001|Overall Study|Physician Decision|1|||
125357923|NCT00100178|450946279|FG002|Overall Study|Physician Decision|3|||
125357924|NCT03257371|450946280|FG000|Overall Study|Lost to Follow-up|1|||
125357925|NCT02477839|450946283|FG000|Overall Study|Adverse Event|0|||
125357926|NCT02477839|450946284|FG001|Overall Study|Adverse Event|1|||
125568667|NCT00440947|451711944|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
125568668|NCT00440947|451711940|FG000|36-Week Induction Phase|Non-compliance|10|||
125568669|NCT00440947|451711941|FG001|36-Week Induction Phase|Non-compliance|0|||
125568670|NCT00440947|451711942|FG002|36-Week Induction Phase|Non-compliance|0|||
125568671|NCT00440947|451711943|FG003|36-Week Induction Phase|Non-compliance|0|||
125568672|NCT00440947|451711944|FG004|36-Week Induction Phase|Non-compliance|0|||
125568673|NCT00440947|451711940|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
125568674|NCT00440947|451711941|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
125568675|NCT00440947|451711942|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
125568676|NCT00440947|451711943|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
125568677|NCT00440947|451711944|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
125568678|NCT00440947|451711940|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
125568679|NCT00440947|451711941|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
125568680|NCT00440947|451711942|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
125568681|NCT00440947|451711943|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
125568682|NCT00440947|451711944|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
125568683|NCT00440947|451711940|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
125568684|NCT00440947|451711941|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
125568685|NCT00440947|451711942|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
125568686|NCT00440947|451711943|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
125568687|NCT00440947|451711944|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
125568688|NCT00440947|451711940|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
125568689|NCT00440947|451711941|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
125568690|NCT00440947|451711942|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
125568691|NCT00440947|451711943|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
125568692|NCT00440947|451711944|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
125568693|NCT00440947|451711940|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
125568694|NCT00440947|451711941|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
125568695|NCT00440947|451711942|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
125568696|NCT00440947|451711943|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
125568697|NCT00440947|451711944|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
125568698|NCT00440947|451711940|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
125568699|NCT00440947|451711941|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
125568700|NCT00440947|451711942|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
125568701|NCT00440947|451711943|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
125568702|NCT00440947|451711944|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
125568703|NCT00440947|451711940|FG000|36-Week Induction Phase|Incarceration|3|||
125568704|NCT00440947|451711941|FG001|36-Week Induction Phase|Incarceration|0|||
125568705|NCT00440947|451711942|FG002|36-Week Induction Phase|Incarceration|0|||
125568706|NCT00440947|451711943|FG003|36-Week Induction Phase|Incarceration|0|||
125568707|NCT00440947|451711944|FG004|36-Week Induction Phase|Incarceration|0|||
125568708|NCT00440947|451711940|FG000|36-Week Induction Phase|Pregnancy|1|||
125568709|NCT00440947|451711941|FG001|36-Week Induction Phase|Pregnancy|0|||
125568710|NCT00440947|451711942|FG002|36-Week Induction Phase|Pregnancy|0|||
125568711|NCT00440947|451711943|FG003|36-Week Induction Phase|Pregnancy|0|||
125568712|NCT00440947|451711944|FG004|36-Week Induction Phase|Pregnancy|0|||
125568713|NCT00440947|451711940|FG000|48-Week Randomization Phase|Adverse Event|0|||
125568714|NCT00440947|451711941|FG001|48-Week Randomization Phase|Adverse Event|2|||
125568715|NCT00440947|451711942|FG002|48-Week Randomization Phase|Adverse Event|5|||
125568716|NCT00440947|451711943|FG003|48-Week Randomization Phase|Adverse Event|0|||
125568717|NCT00440947|451711944|FG004|48-Week Randomization Phase|Adverse Event|0|||
125568718|NCT00440947|451711940|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
125568719|NCT00440947|451711941|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
125568720|NCT00440947|451711942|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
125568721|NCT00440947|451711943|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
125568722|NCT00440947|451711944|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
125568723|NCT00440947|451711940|FG000|48-Week Randomization Phase|Non-compliance|0|||
125568724|NCT00440947|451711941|FG001|48-Week Randomization Phase|Non-compliance|3|||
125568725|NCT00440947|451711942|FG002|48-Week Randomization Phase|Non-compliance|4|||
125568726|NCT00440947|451711943|FG003|48-Week Randomization Phase|Non-compliance|0|||
125568727|NCT00440947|451711944|FG004|48-Week Randomization Phase|Non-compliance|0|||
125568728|NCT00440947|451711940|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
125568729|NCT00440947|451711941|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
125568730|NCT00440947|451711942|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
125568731|NCT00440947|451711943|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
125568732|NCT00440947|451711944|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
125568733|NCT00440947|451711940|FG000|48-Week Randomization Phase|Protocol Violation|0|||
125357927|NCT02477839|450946283|FG000|Overall Study|Protocol Violation|0|||
125357928|NCT02477839|450946284|FG001|Overall Study|Protocol Violation|2|||
125357929|NCT02477839|450946283|FG000|Overall Study|Withdrawal by Subject|3|||
125568734|NCT00440947|451711941|FG001|48-Week Randomization Phase|Protocol Violation|0|||
125568735|NCT00440947|451711942|FG002|48-Week Randomization Phase|Protocol Violation|1|||
125568736|NCT00440947|451711943|FG003|48-Week Randomization Phase|Protocol Violation|0|||
125568737|NCT00440947|451711944|FG004|48-Week Randomization Phase|Protocol Violation|0|||
125568738|NCT00440947|451711940|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
125568739|NCT00440947|451711941|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
125568740|NCT00440947|451711942|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
125568741|NCT00440947|451711943|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
125568742|NCT00440947|451711944|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
125568743|NCT00440947|451711940|FG000|48-Week Randomization Phase|Pregnancy|0|||
125568744|NCT00440947|451711941|FG001|48-Week Randomization Phase|Pregnancy|0|||
125568745|NCT00440947|451711942|FG002|48-Week Randomization Phase|Pregnancy|1|||
125568746|NCT00440947|451711943|FG003|48-Week Randomization Phase|Pregnancy|0|||
125568747|NCT00440947|451711944|FG004|48-Week Randomization Phase|Pregnancy|0|||
125568748|NCT00440947|451711940|FG000|48-Week Randomization Phase|Incarceration|0|||
125568749|NCT00440947|451711941|FG001|48-Week Randomization Phase|Incarceration|3|||
125568750|NCT00440947|451711942|FG002|48-Week Randomization Phase|Incarceration|0|||
125568751|NCT00440947|451711943|FG003|48-Week Randomization Phase|Incarceration|0|||
125568752|NCT00440947|451711944|FG004|48-Week Randomization Phase|Incarceration|0|||
125568753|NCT00440947|451711940|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
125568754|NCT00440947|451711941|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
125568755|NCT00440947|451711942|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
125568756|NCT00440947|451711943|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
125568757|NCT00440947|451711944|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
125568758|NCT00440947|451711940|FG000|48-Week Randomization Phase|Physician Decision|0|||
125568759|NCT00440947|451711941|FG001|48-Week Randomization Phase|Physician Decision|2|||
125568760|NCT00440947|451711942|FG002|48-Week Randomization Phase|Physician Decision|0|||
125568761|NCT00440947|451711943|FG003|48-Week Randomization Phase|Physician Decision|0|||
125568762|NCT00440947|451711944|FG004|48-Week Randomization Phase|Physician Decision|0|||
125568763|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
125568764|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
125568765|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
125568766|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
125568767|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
125568768|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
125568769|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
125568770|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
125568771|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
125568772|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
125568773|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
125568774|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
125568775|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
125568776|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
125568777|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
125568778|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
125568779|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
125568780|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
125568781|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
125568782|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
125568783|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
125568784|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
125568785|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
125568786|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
125568787|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
125568788|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
125568789|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
125568790|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
125568791|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
125568792|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
125568793|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
125568794|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
125568795|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
125568796|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
125568797|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
125568798|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
125568799|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
125568800|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
125568801|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
125568802|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
125568803|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
125568804|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
125568805|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
125568806|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
125568807|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
125568808|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
125568809|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
125568810|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
125568811|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
125568812|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
125568813|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
125568814|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
125568815|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
125568816|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
125568817|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
125568818|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Other|0|||
125568819|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Other|0|||
125568820|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Other|0|||
125568821|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Other|1|||
125568822|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Other|0|||
125568823|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
125568824|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
125568825|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
125568826|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
125568827|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
125568828|NCT00440947|451711940|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
125568829|NCT00440947|451711941|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
125568830|NCT00440947|451711942|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
125568831|NCT00440947|451711943|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
125568832|NCT00440947|451711944|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
125568833|NCT02716987|451711945|FG000|Overall Study|Ligand synthesis failure|0|||
125568834|NCT02716987|451711946|FG001|Overall Study|Ligand synthesis failure|0|||
125568835|NCT02716987|451711947|FG002|Overall Study|Ligand synthesis failure|1|||
125568836|NCT02716987|451711948|FG003|Overall Study|Ligand synthesis failure|0|||
125568837|NCT02716987|451711949|FG004|Overall Study|Ligand synthesis failure|0|||
125568838|NCT02716987|451711950|FG005|Overall Study|Ligand synthesis failure|0|||
125568839|NCT02716987|451711945|FG000|Overall Study|Withdrawal by Subject|0|||
125568840|NCT02716987|451711946|FG001|Overall Study|Withdrawal by Subject|0|||
125568841|NCT02716987|451711947|FG002|Overall Study|Withdrawal by Subject|0|||
125568842|NCT02716987|451711948|FG003|Overall Study|Withdrawal by Subject|0|||
125568843|NCT02716987|451711949|FG004|Overall Study|Withdrawal by Subject|1|||
125568844|NCT02716987|451711950|FG005|Overall Study|Withdrawal by Subject|1|||
125568845|NCT03223428|451711954|FG000|Overall Study|No longer taking Xermelo|27|||
125568846|NCT03223428|451711954|FG000|Overall Study|Declined Consent|1|||
125568847|NCT03223428|451711954|FG000|Overall Study|Non-responders|56|||
125568848|NCT03223428|451711954|FG000|Overall Study|Withdrawal by Subject|14|||
125568849|NCT01834274|451711955|FG000|Overall Study|Study Termination|41|||
125568850|NCT01834274|451711956|FG001|Overall Study|Study Termination|38|||
125568851|NCT01834274|451711955|FG000|Overall Study|Withdrawal by Subject|1|||
125568852|NCT01834274|451711956|FG001|Overall Study|Withdrawal by Subject|1|||
125568853|NCT01834274|451711955|FG000|Overall Study|Lost to Follow-up|3|||
125568854|NCT01834274|451711956|FG001|Overall Study|Lost to Follow-up|1|||
125568855|NCT01834274|451711955|FG000|Overall Study|Other|2|||
125568856|NCT01834274|451711956|FG001|Overall Study|Other|1|||
125568857|NCT01265797|451711967|FG000|Run-in Month|Withdrawal by Subject|0|||
125568858|NCT01265797|451711968|FG001|Run-in Month|Withdrawal by Subject|4|||
125568859|NCT01265797|451711967|FG000|Run-in Month|1st seizure during run-in month|0|||
125568860|NCT01265797|451711968|FG001|Run-in Month|1st seizure during run-in month|1|||
125568861|NCT01265797|451711967|FG000|Blinded Month|Lack of Efficacy|5|||
125568862|NCT01265797|451711968|FG001|Blinded Month|Lack of Efficacy|0|||
125568863|NCT01265797|451711967|FG000|Blinded Month|Lost to Follow-up|1|||
125568864|NCT01265797|451711968|FG001|Blinded Month|Lost to Follow-up|0|||
125568865|NCT01265797|451711967|FG000|Blinded Month|Protocol Violation|2|||
125568866|NCT01265797|451711968|FG001|Blinded Month|Protocol Violation|1|||
125568867|NCT01265797|451711967|FG000|Blinded Month|Adverse Event|2|||
125568868|NCT01265797|451711968|FG001|Blinded Month|Adverse Event|0|||
125568869|NCT01265797|451711967|FG000|Blinded Month|Diary data incomplete|0|||
125568870|NCT01265797|451711968|FG001|Blinded Month|Diary data incomplete|1|||
125568871|NCT01265797|451711967|FG000|Open Label Month|Lost to Follow-up|0|||
125568872|NCT01265797|451711968|FG001|Open Label Month|Lost to Follow-up|1|||
125568873|NCT02813694|451711969|FG000|Overall Study|Physician Decision|0|||
125357930|NCT02477839|450946284|FG001|Overall Study|Withdrawal by Subject|3|||
125357931|NCT02477839|450946283|FG000|Overall Study|Participant had PGS during V6|0|||
125357932|NCT02477839|450946284|FG001|Overall Study|Participant had PGS during V6|1|||
125568874|NCT02813694|451711970|FG001|Overall Study|Physician Decision|1|||
125568875|NCT02813694|451711969|FG000|Overall Study|Withdrawal by Subject|10|||
125568876|NCT02813694|451711970|FG001|Overall Study|Withdrawal by Subject|9|||
125568877|NCT02813694|451711969|FG000|Overall Study|Lost to Follow-up|1|||
125568878|NCT02813694|451711970|FG001|Overall Study|Lost to Follow-up|1|||
125568879|NCT02813694|451711969|FG000|Overall Study|Death|3|||
125568880|NCT02813694|451711970|FG001|Overall Study|Death|3|||
125568881|NCT02813694|451711969|FG000|Overall Study|Randomized- did not receive study drug|2|||
125568882|NCT02813694|451711970|FG001|Overall Study|Randomized- did not receive study drug|0|||
125568883|NCT02813694|451711969|FG000|Overall Study|Patient hospitalized|1|||
125568884|NCT02813694|451711970|FG001|Overall Study|Patient hospitalized|0|||
125568885|NCT02980224|451711971|FG000|Overall Study|Adverse Event|4|||
125568886|NCT02980224|451711972|FG001|Overall Study|Adverse Event|1|||
125568887|NCT02980224|451711971|FG000|Overall Study|Withdrawal by Subject|0|||
125568888|NCT02980224|451711972|FG001|Overall Study|Withdrawal by Subject|2|||
125568889|NCT00606320|451711973|FG000|Overall Study|Adverse Event|3|||
125568890|NCT00606320|451711973|FG000|Overall Study|Lack of Efficacy|5|||
125568891|NCT00606320|451711973|FG000|Overall Study|Physician Decision|7|||
125568892|NCT00606320|451711973|FG000|Overall Study|Protocol Violation|8|||
125568893|NCT00606320|451711973|FG000|Overall Study|Withdrawal by Subject|10|||
125568894|NCT00606320|451711973|FG000|Overall Study|Progression to depressive phase|4|||
125568895|NCT04839380|451711974|FG000|Overall Study|Withdrawal by Subject|2|||
125568896|NCT04839380|451711974|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
125568897|NCT01087905|451711975|FG000|Overall Study|Lost to Follow-up|24|||
125568898|NCT01087905|451711976|FG001|Overall Study|Lost to Follow-up|28|||
125568899|NCT01087905|451711977|FG002|Overall Study|Lost to Follow-up|18|||
125568900|NCT01087905|451711978|FG003|Overall Study|Lost to Follow-up|31|||
125568901|NCT01087905|451711979|FG004|Overall Study|Lost to Follow-up|27|||
125568902|NCT01087905|451711980|FG005|Overall Study|Lost to Follow-up|25|||
125568903|NCT01087905|451711981|FG006|Overall Study|Lost to Follow-up|20|||
125568904|NCT01087905|451711982|FG007|Overall Study|Lost to Follow-up|24|||
125568905|NCT01087905|451711975|FG000|Overall Study|Withdrawal by Subject|5|||
125568906|NCT01087905|451711976|FG001|Overall Study|Withdrawal by Subject|4|||
125568907|NCT01087905|451711977|FG002|Overall Study|Withdrawal by Subject|4|||
125568908|NCT01087905|451711978|FG003|Overall Study|Withdrawal by Subject|5|||
125568909|NCT01087905|451711979|FG004|Overall Study|Withdrawal by Subject|4|||
125568910|NCT01087905|451711980|FG005|Overall Study|Withdrawal by Subject|3|||
125568911|NCT01087905|451711981|FG006|Overall Study|Withdrawal by Subject|3|||
125568912|NCT01087905|451711982|FG007|Overall Study|Withdrawal by Subject|5|||
125568913|NCT01347554|451711983|FG000|Overall Study|Lack of Efficacy|7|||
125568914|NCT01347554|451711984|FG001|Overall Study|Lack of Efficacy|11|||
125568915|NCT02937818|451711988|FG000|Overall Study|Participants decision|2|||
125357933|NCT02477839|450946283|FG000|Overall Study|Parents decided to stop medication|0|||
125357934|NCT02477839|450946284|FG001|Overall Study|Parents decided to stop medication|1|||
125357935|NCT02477839|450946283|FG000|Overall Study|Lack of tolerability|0|||
125357936|NCT02477839|450946284|FG001|Overall Study|Lack of tolerability|1|||
125357937|NCT02477839|450946283|FG000|Overall Study|Exclusion criterion|0|||
125357938|NCT02477839|450946284|FG001|Overall Study|Exclusion criterion|1|||
125357939|NCT01439568|450946291|FG000|Overall Study|Lost to Follow-up|1|||
125357940|NCT01439568|450946292|FG001|Overall Study|Lost to Follow-up|0|||
125568916|NCT02937818|451711989|FG001|Overall Study|Participants decision|1|||
125568917|NCT02937818|451711990|FG002|Overall Study|Participants decision|1|||
125568918|NCT02937818|451711991|FG003|Overall Study|Participants decision|1|||
125568919|NCT02937818|451711988|FG000|Overall Study|Adverse Event|2|||
125568920|NCT02937818|451711989|FG001|Overall Study|Adverse Event|4|||
125568921|NCT02937818|451711990|FG002|Overall Study|Adverse Event|1|||
125568922|NCT02937818|451711991|FG003|Overall Study|Adverse Event|1|||
125357941|NCT01439568|450946291|FG000|Overall Study|Withdrawal by Subject|2|||
125568923|NCT02937818|451711988|FG000|Overall Study|Disease progression|17|||
125568924|NCT02937818|451711989|FG001|Overall Study|Disease progression|15|||
125568925|NCT02937818|451711990|FG002|Overall Study|Disease progression|7|||
125568926|NCT02937818|451711991|FG003|Overall Study|Disease progression|19|||
125568927|NCT02937818|451711988|FG000|Overall Study|Condition under investigation worsened|0|||
125568928|NCT02937818|451711989|FG001|Overall Study|Condition under investigation worsened|0|||
125568929|NCT02937818|451711990|FG002|Overall Study|Condition under investigation worsened|1|||
125568930|NCT02937818|451711991|FG003|Overall Study|Condition under investigation worsened|0|||
125568931|NCT00205855|451711992|FG000|Overall Study|Only received temporary implants|16|||
125568932|NCT00205855|451711992|FG000|Overall Study|Withdrawal by Subject|5|||
125568933|NCT01015768|451711994|FG000|Overall Study|Some subject data unuseable|4|||
125568934|NCT01015768|451711995|FG001|Overall Study|Some subject data unuseable|4|||
125568935|NCT02943564|451711996|FG000|Overall Study|Miscellaneous Reasons|0|||
125568936|NCT02943564|451711997|FG001|Overall Study|Miscellaneous Reasons|0|||
125568937|NCT02943564|451711998|FG002|Overall Study|Miscellaneous Reasons|3|||
125568938|NCT02943564|451711996|FG000|Overall Study|Site terminated by sponsor|0|||
125568939|NCT02943564|451711997|FG001|Overall Study|Site terminated by sponsor|1|||
125568940|NCT02943564|451711998|FG002|Overall Study|Site terminated by sponsor|0|||
125568941|NCT02943564|451711996|FG000|Overall Study|Non-compliance with study drug|0|||
125568942|NCT02943564|451711997|FG001|Overall Study|Non-compliance with study drug|1|||
125568943|NCT02943564|451711998|FG002|Overall Study|Non-compliance with study drug|0|||
125568944|NCT02943564|451711996|FG000|Overall Study|Pregnancy|0|||
125568945|NCT02943564|451711997|FG001|Overall Study|Pregnancy|1|||
125568946|NCT02943564|451711998|FG002|Overall Study|Pregnancy|1|||
125568947|NCT02943564|451711996|FG000|Overall Study|Protocol Violation|2|||
125568948|NCT02943564|451711997|FG001|Overall Study|Protocol Violation|2|||
125568949|NCT02943564|451711998|FG002|Overall Study|Protocol Violation|2|||
125568950|NCT02943564|451711996|FG000|Overall Study|Lost to Follow-up|1|||
125568951|NCT02943564|451711997|FG001|Overall Study|Lost to Follow-up|0|||
125568952|NCT02943564|451711998|FG002|Overall Study|Lost to Follow-up|0|||
125568953|NCT02943564|451711996|FG000|Overall Study|Withdrawal by Subject|6|||
125568954|NCT02943564|451711997|FG001|Overall Study|Withdrawal by Subject|5|||
125568955|NCT02943564|451711998|FG002|Overall Study|Withdrawal by Subject|2|||
125568956|NCT02943564|451711996|FG000|Overall Study|Adverse Event|1|||
125568957|NCT02943564|451711997|FG001|Overall Study|Adverse Event|2|||
125568958|NCT02943564|451711998|FG002|Overall Study|Adverse Event|1|||
125568959|NCT02943564|451711996|FG000|Overall Study|Lack of Efficacy|0|||
125568960|NCT02943564|451711997|FG001|Overall Study|Lack of Efficacy|1|||
125568961|NCT02943564|451711998|FG002|Overall Study|Lack of Efficacy|0|||
125568962|NCT01225731|451712001|FG000|Part 1|Did not meet eligibility criteria|1|||
125568963|NCT01225731|451712002|FG001|Part 1|Did not meet eligibility criteria|0|||
125568964|NCT01225731|451712003|FG002|Part 1|Did not meet eligibility criteria|0|||
125568965|NCT01225731|451712004|FG003|Part 1|Did not meet eligibility criteria|0|||
125426824|NCT01113502|451187983|FG001|Overall Study|Adverse Event|0|||
125426825|NCT01113502|451187984|FG002|Overall Study|Adverse Event|3|||
125426826|NCT01113502|451187985|FG003|Overall Study|Adverse Event|2|||
125426827|NCT01113502|451187986|FG004|Overall Study|Adverse Event|0|||
125426828|NCT03002610|451187995|FG000|Overall Study|Withdrawal by Subject|6|||
125426829|NCT03002610|451187996|FG001|Overall Study|Withdrawal by Subject|25|||
125426830|NCT03002610|451187997|FG002|Overall Study|Withdrawal by Subject|13|||
125568966|NCT01225731|451712005|FG004|Part 1|Did not meet eligibility criteria|1|||
125568967|NCT01225731|451712006|FG005|Part 1|Did not meet eligibility criteria|0|||
125568968|NCT01225731|451712007|FG006|Part 1|Did not meet eligibility criteria|0|||
125568969|NCT01225731|451712008|FG007|Part 1|Did not meet eligibility criteria|0|||
125568970|NCT01225731|451712009|FG008|Part 1|Did not meet eligibility criteria|0|||
125568971|NCT01225731|451712010|FG009|Part 1|Did not meet eligibility criteria|0|||
125568972|NCT01225731|451712011|FG010|Part 1|Did not meet eligibility criteria|0|||
125568973|NCT01225731|451712012|FG011|Part 1|Did not meet eligibility criteria|0|||
125568974|NCT01225731|451712013|FG012|Part 1|Did not meet eligibility criteria|0|||
125568975|NCT01225731|451712001|FG000|Part 1|Adverse Event|1|||
125568976|NCT01225731|451712002|FG001|Part 1|Adverse Event|2|||
125568977|NCT01225731|451712003|FG002|Part 1|Adverse Event|1|||
125568978|NCT01225731|451712004|FG003|Part 1|Adverse Event|1|||
125426831|NCT03641313|451188010|FG000|Overall Study|Death|1|||
125568979|NCT01225731|451712005|FG004|Part 1|Adverse Event|1|||
125568980|NCT01225731|451712006|FG005|Part 1|Adverse Event|0|||
125568981|NCT01225731|451712007|FG006|Part 1|Adverse Event|0|||
125568982|NCT01225731|451712008|FG007|Part 1|Adverse Event|0|||
125568983|NCT01225731|451712009|FG008|Part 1|Adverse Event|0|||
125568984|NCT01225731|451712010|FG009|Part 1|Adverse Event|0|||
125568985|NCT01225731|451712011|FG010|Part 1|Adverse Event|0|||
125568986|NCT01225731|451712012|FG011|Part 1|Adverse Event|0|||
125568987|NCT01225731|451712013|FG012|Part 1|Adverse Event|0|||
125568988|NCT01225731|451712001|FG000|Part 1|Withdrawal by Subject|0|||
125568989|NCT01225731|451712002|FG001|Part 1|Withdrawal by Subject|3|||
125568990|NCT01225731|451712003|FG002|Part 1|Withdrawal by Subject|0|||
125568991|NCT01225731|451712004|FG003|Part 1|Withdrawal by Subject|0|||
125568992|NCT01225731|451712005|FG004|Part 1|Withdrawal by Subject|4|||
125568993|NCT01225731|451712006|FG005|Part 1|Withdrawal by Subject|0|||
125568994|NCT01225731|451712007|FG006|Part 1|Withdrawal by Subject|0|||
125568995|NCT01225731|451712008|FG007|Part 1|Withdrawal by Subject|0|||
125568996|NCT01225731|451712009|FG008|Part 1|Withdrawal by Subject|0|||
125568997|NCT01225731|451712010|FG009|Part 1|Withdrawal by Subject|0|||
125568998|NCT01225731|451712011|FG010|Part 1|Withdrawal by Subject|0|||
125568999|NCT01225731|451712012|FG011|Part 1|Withdrawal by Subject|0|||
125569000|NCT01225731|451712013|FG012|Part 1|Withdrawal by Subject|0|||
125569001|NCT01225731|451712001|FG000|Part 1|Protocol Violation|0|||
125569002|NCT01225731|451712002|FG001|Part 1|Protocol Violation|0|||
125569003|NCT01225731|451712003|FG002|Part 1|Protocol Violation|0|||
125569004|NCT01225731|451712004|FG003|Part 1|Protocol Violation|1|||
125569005|NCT01225731|451712005|FG004|Part 1|Protocol Violation|0|||
125569006|NCT01225731|451712006|FG005|Part 1|Protocol Violation|0|||
125569007|NCT01225731|451712007|FG006|Part 1|Protocol Violation|0|||
125569008|NCT01225731|451712008|FG007|Part 1|Protocol Violation|0|||
125569009|NCT01225731|451712009|FG008|Part 1|Protocol Violation|0|||
125569010|NCT01225731|451712010|FG009|Part 1|Protocol Violation|0|||
125569011|NCT01225731|451712011|FG010|Part 1|Protocol Violation|0|||
125569012|NCT01225731|451712012|FG011|Part 1|Protocol Violation|0|||
125569013|NCT01225731|451712013|FG012|Part 1|Protocol Violation|0|||
125569014|NCT01225731|451712001|FG000|Part 2|Protocol Violation|0|||
125569015|NCT01225731|451712002|FG001|Part 2|Protocol Violation|0|||
125569016|NCT01225731|451712003|FG002|Part 2|Protocol Violation|0|||
125569017|NCT01225731|451712004|FG003|Part 2|Protocol Violation|0|||
125569018|NCT01225731|451712005|FG004|Part 2|Protocol Violation|0|||
125569019|NCT01225731|451712006|FG005|Part 2|Protocol Violation|1|||
125569020|NCT01225731|451712007|FG006|Part 2|Protocol Violation|0|||
125569021|NCT01225731|451712008|FG007|Part 2|Protocol Violation|0|||
125569022|NCT01225731|451712009|FG008|Part 2|Protocol Violation|1|||
125569023|NCT01225731|451712010|FG009|Part 2|Protocol Violation|0|||
125569024|NCT01225731|451712011|FG010|Part 2|Protocol Violation|0|||
125569025|NCT01225731|451712012|FG011|Part 2|Protocol Violation|0|||
125569026|NCT01225731|451712013|FG012|Part 2|Protocol Violation|0|||
125569027|NCT01225731|451712001|FG000|Part 2|Adverse Event|0|||
125569028|NCT01225731|451712002|FG001|Part 2|Adverse Event|0|||
125569029|NCT01225731|451712003|FG002|Part 2|Adverse Event|0|||
125569030|NCT01225731|451712004|FG003|Part 2|Adverse Event|0|||
125569031|NCT01225731|451712005|FG004|Part 2|Adverse Event|0|||
125569032|NCT01225731|451712006|FG005|Part 2|Adverse Event|0|||
125569033|NCT01225731|451712007|FG006|Part 2|Adverse Event|4|||
125569034|NCT01225731|451712008|FG007|Part 2|Adverse Event|4|||
125569035|NCT01225731|451712009|FG008|Part 2|Adverse Event|2|||
125569036|NCT01225731|451712010|FG009|Part 2|Adverse Event|0|||
125569037|NCT01225731|451712011|FG010|Part 2|Adverse Event|0|||
125569038|NCT01225731|451712012|FG011|Part 2|Adverse Event|0|||
125569039|NCT01225731|451712013|FG012|Part 2|Adverse Event|0|||
125569040|NCT01225731|451712001|FG000|Part 2|Lack of Efficacy|0|||
125569041|NCT01225731|451712002|FG001|Part 2|Lack of Efficacy|0|||
125569042|NCT01225731|451712003|FG002|Part 2|Lack of Efficacy|0|||
125569043|NCT01225731|451712004|FG003|Part 2|Lack of Efficacy|0|||
125569044|NCT01225731|451712005|FG004|Part 2|Lack of Efficacy|0|||
125569045|NCT01225731|451712006|FG005|Part 2|Lack of Efficacy|1|||
125569046|NCT01225731|451712007|FG006|Part 2|Lack of Efficacy|0|||
125569047|NCT01225731|451712008|FG007|Part 2|Lack of Efficacy|12|||
125569048|NCT01225731|451712009|FG008|Part 2|Lack of Efficacy|3|||
125569049|NCT01225731|451712010|FG009|Part 2|Lack of Efficacy|0|||
125569050|NCT01225731|451712011|FG010|Part 2|Lack of Efficacy|0|||
125569051|NCT01225731|451712012|FG011|Part 2|Lack of Efficacy|0|||
125569052|NCT01225731|451712013|FG012|Part 2|Lack of Efficacy|0|||
125569053|NCT01225731|451712001|FG000|Part 2|Pregnancy|0|||
125569054|NCT01225731|451712002|FG001|Part 2|Pregnancy|0|||
125569055|NCT01225731|451712003|FG002|Part 2|Pregnancy|0|||
125569056|NCT01225731|451712004|FG003|Part 2|Pregnancy|0|||
125569057|NCT01225731|451712005|FG004|Part 2|Pregnancy|0|||
125569058|NCT01225731|451712006|FG005|Part 2|Pregnancy|0|||
125569059|NCT01225731|451712007|FG006|Part 2|Pregnancy|1|||
125569060|NCT01225731|451712008|FG007|Part 2|Pregnancy|0|||
125569061|NCT01225731|451712009|FG008|Part 2|Pregnancy|1|||
125569062|NCT01225731|451712010|FG009|Part 2|Pregnancy|0|||
125569063|NCT01225731|451712011|FG010|Part 2|Pregnancy|0|||
125569064|NCT01225731|451712012|FG011|Part 2|Pregnancy|0|||
125569065|NCT01225731|451712013|FG012|Part 2|Pregnancy|0|||
125569066|NCT01225731|451712001|FG000|Part 2|Lost to Follow-up|0|||
125569067|NCT01225731|451712002|FG001|Part 2|Lost to Follow-up|0|||
125569068|NCT01225731|451712003|FG002|Part 2|Lost to Follow-up|0|||
125569069|NCT01225731|451712004|FG003|Part 2|Lost to Follow-up|0|||
125569070|NCT01225731|451712005|FG004|Part 2|Lost to Follow-up|0|||
125569071|NCT01225731|451712006|FG005|Part 2|Lost to Follow-up|0|||
125569072|NCT01225731|451712007|FG006|Part 2|Lost to Follow-up|0|||
125569073|NCT01225731|451712008|FG007|Part 2|Lost to Follow-up|3|||
125569074|NCT01225731|451712009|FG008|Part 2|Lost to Follow-up|1|||
125569075|NCT01225731|451712010|FG009|Part 2|Lost to Follow-up|0|||
125569076|NCT01225731|451712011|FG010|Part 2|Lost to Follow-up|0|||
125569077|NCT01225731|451712012|FG011|Part 2|Lost to Follow-up|0|||
125569078|NCT01225731|451712013|FG012|Part 2|Lost to Follow-up|0|||
125569079|NCT01225731|451712001|FG000|Part 2|Physician Decision|0|||
125569080|NCT01225731|451712002|FG001|Part 2|Physician Decision|0|||
125569081|NCT01225731|451712003|FG002|Part 2|Physician Decision|0|||
125569082|NCT01225731|451712004|FG003|Part 2|Physician Decision|0|||
125569083|NCT01225731|451712005|FG004|Part 2|Physician Decision|0|||
125569084|NCT01225731|451712006|FG005|Part 2|Physician Decision|0|||
125569085|NCT01225731|451712007|FG006|Part 2|Physician Decision|0|||
125569086|NCT01225731|451712008|FG007|Part 2|Physician Decision|2|||
125569087|NCT01225731|451712009|FG008|Part 2|Physician Decision|2|||
125569088|NCT01225731|451712010|FG009|Part 2|Physician Decision|0|||
125569089|NCT01225731|451712011|FG010|Part 2|Physician Decision|0|||
125569090|NCT01225731|451712012|FG011|Part 2|Physician Decision|0|||
125569091|NCT01225731|451712013|FG012|Part 2|Physician Decision|0|||
125569092|NCT01225731|451712001|FG000|Part 2|Withdrawal by Subject|0|||
125569093|NCT01225731|451712002|FG001|Part 2|Withdrawal by Subject|0|||
125569094|NCT01225731|451712003|FG002|Part 2|Withdrawal by Subject|0|||
125569095|NCT01225731|451712004|FG003|Part 2|Withdrawal by Subject|0|||
125569096|NCT01225731|451712005|FG004|Part 2|Withdrawal by Subject|0|||
125569097|NCT01225731|451712006|FG005|Part 2|Withdrawal by Subject|1|||
125569098|NCT01225731|451712007|FG006|Part 2|Withdrawal by Subject|3|||
125569099|NCT01225731|451712008|FG007|Part 2|Withdrawal by Subject|4|||
125569100|NCT01225731|451712009|FG008|Part 2|Withdrawal by Subject|1|||
125569101|NCT01225731|451712010|FG009|Part 2|Withdrawal by Subject|0|||
125569102|NCT01225731|451712011|FG010|Part 2|Withdrawal by Subject|0|||
125569103|NCT01225731|451712012|FG011|Part 2|Withdrawal by Subject|0|||
125569104|NCT01225731|451712013|FG012|Part 2|Withdrawal by Subject|0|||
125569105|NCT01225731|451712001|FG000|Part 3|Adverse Event|0|||
125569106|NCT01225731|451712002|FG001|Part 3|Adverse Event|0|||
125569107|NCT01225731|451712003|FG002|Part 3|Adverse Event|0|||
125569108|NCT01225731|451712004|FG003|Part 3|Adverse Event|0|||
125569109|NCT01225731|451712005|FG004|Part 3|Adverse Event|0|||
125569110|NCT01225731|451712006|FG005|Part 3|Adverse Event|0|||
125569111|NCT01225731|451712007|FG006|Part 3|Adverse Event|0|||
125569112|NCT01225731|451712008|FG007|Part 3|Adverse Event|0|||
125569113|NCT01225731|451712009|FG008|Part 3|Adverse Event|0|||
125569114|NCT01225731|451712010|FG009|Part 3|Adverse Event|0|||
125569115|NCT01225731|451712011|FG010|Part 3|Adverse Event|1|||
125569116|NCT01225731|451712012|FG011|Part 3|Adverse Event|1|||
125569117|NCT01225731|451712013|FG012|Part 3|Adverse Event|0|||
125569118|NCT01225731|451712001|FG000|Part 3|Lost to Follow-up|0|||
125569119|NCT01225731|451712002|FG001|Part 3|Lost to Follow-up|0|||
125569120|NCT01225731|451712003|FG002|Part 3|Lost to Follow-up|0|||
125569121|NCT01225731|451712004|FG003|Part 3|Lost to Follow-up|0|||
125569122|NCT01225731|451712005|FG004|Part 3|Lost to Follow-up|0|||
125569123|NCT01225731|451712006|FG005|Part 3|Lost to Follow-up|0|||
125569124|NCT01225731|451712007|FG006|Part 3|Lost to Follow-up|0|||
125569125|NCT01225731|451712008|FG007|Part 3|Lost to Follow-up|0|||
125569126|NCT01225731|451712009|FG008|Part 3|Lost to Follow-up|0|||
125569127|NCT01225731|451712010|FG009|Part 3|Lost to Follow-up|0|||
125569128|NCT01225731|451712011|FG010|Part 3|Lost to Follow-up|1|||
125569129|NCT01225731|451712012|FG011|Part 3|Lost to Follow-up|2|||
125569130|NCT01225731|451712013|FG012|Part 3|Lost to Follow-up|1|||
125569131|NCT01225731|451712001|FG000|Part 3|Physician Decision|0|||
125569132|NCT01225731|451712002|FG001|Part 3|Physician Decision|0|||
125569133|NCT01225731|451712003|FG002|Part 3|Physician Decision|0|||
125569134|NCT01225731|451712004|FG003|Part 3|Physician Decision|0|||
125569135|NCT01225731|451712005|FG004|Part 3|Physician Decision|0|||
125569136|NCT01225731|451712006|FG005|Part 3|Physician Decision|0|||
125569137|NCT01225731|451712007|FG006|Part 3|Physician Decision|0|||
125569138|NCT01225731|451712008|FG007|Part 3|Physician Decision|0|||
125569139|NCT01225731|451712009|FG008|Part 3|Physician Decision|0|||
125569140|NCT01225731|451712010|FG009|Part 3|Physician Decision|0|||
125569141|NCT01225731|451712011|FG010|Part 3|Physician Decision|0|||
125569142|NCT01225731|451712012|FG011|Part 3|Physician Decision|1|||
125569143|NCT01225731|451712013|FG012|Part 3|Physician Decision|2|||
125569144|NCT01225731|451712001|FG000|Part 3|Withdrawal by Subject|0|||
125569145|NCT01225731|451712002|FG001|Part 3|Withdrawal by Subject|0|||
125569146|NCT01225731|451712003|FG002|Part 3|Withdrawal by Subject|0|||
125569147|NCT01225731|451712004|FG003|Part 3|Withdrawal by Subject|0|||
125569148|NCT01225731|451712005|FG004|Part 3|Withdrawal by Subject|0|||
125569149|NCT01225731|451712006|FG005|Part 3|Withdrawal by Subject|0|||
125569150|NCT01225731|451712007|FG006|Part 3|Withdrawal by Subject|0|||
125569151|NCT01225731|451712008|FG007|Part 3|Withdrawal by Subject|0|||
125569152|NCT01225731|451712009|FG008|Part 3|Withdrawal by Subject|0|||
125569153|NCT01225731|451712010|FG009|Part 3|Withdrawal by Subject|0|||
125569154|NCT01225731|451712011|FG010|Part 3|Withdrawal by Subject|4|||
125569155|NCT01225731|451712012|FG011|Part 3|Withdrawal by Subject|6|||
125569156|NCT01225731|451712013|FG012|Part 3|Withdrawal by Subject|4|||
125569157|NCT01073267|451712014|FG000|Overall Study|Disease Progression|3|||
125569158|NCT00577642|451712015|FG000|Overall Study|Clinical Disease Progression|1|||
125569159|NCT01505634|451712020|FG000|Overall Study|Withdrawal by Subject|2|||
125569160|NCT01505634|451712021|FG001|Overall Study|Withdrawal by Subject|5|||
125569161|NCT01505634|451712022|FG002|Overall Study|Withdrawal by Subject|1|||
125569162|NCT01505634|451712020|FG000|Overall Study|Physician Decision|1|||
125569163|NCT01505634|451712021|FG001|Overall Study|Physician Decision|1|||
125569164|NCT01505634|451712022|FG002|Overall Study|Physician Decision|0|||
125569165|NCT01505634|451712020|FG000|Overall Study|Adverse Event|1|||
125569166|NCT01505634|451712021|FG001|Overall Study|Adverse Event|0|||
125569167|NCT01505634|451712022|FG002|Overall Study|Adverse Event|0|||
125569168|NCT01505634|451712020|FG000|Overall Study|Insufficient supply of drug at site|1|||
125569169|NCT01505634|451712021|FG001|Overall Study|Insufficient supply of drug at site|0|||
125569170|NCT01505634|451712022|FG002|Overall Study|Insufficient supply of drug at site|0|||
125569171|NCT01505634|451712020|FG000|Overall Study|Protocol Violation|2|||
125569172|NCT01505634|451712021|FG001|Overall Study|Protocol Violation|0|||
125569173|NCT01505634|451712022|FG002|Overall Study|Protocol Violation|0|||
125569174|NCT01505634|451712020|FG000|Overall Study|Lost to Follow-up|1|||
125569175|NCT01505634|451712021|FG001|Overall Study|Lost to Follow-up|4|||
125569176|NCT01505634|451712022|FG002|Overall Study|Lost to Follow-up|4|||
125569177|NCT01505634|451712020|FG000|Overall Study|Death|1|||
125569178|NCT01505634|451712021|FG001|Overall Study|Death|0|||
125569179|NCT01505634|451712022|FG002|Overall Study|Death|0|||
125569180|NCT01505634|451712020|FG000|Overall Study|In a conflict zone|0|||
125569181|NCT01505634|451712021|FG001|Overall Study|In a conflict zone|0|||
125569182|NCT01505634|451712022|FG002|Overall Study|In a conflict zone|1|||
125569183|NCT02054897|451712023|FG000|Overall Study|Withdrawal by Subject|2|||
125569184|NCT02054897|451712024|FG001|Overall Study|Withdrawal by Subject|0|||
125569185|NCT02054897|451712025|FG002|Overall Study|Withdrawal by Subject|2|||
125569186|NCT02054897|451712023|FG000|Overall Study|Missing follow-up information|3|||
125569187|NCT02054897|451712024|FG001|Overall Study|Missing follow-up information|5|||
125569188|NCT02054897|451712025|FG002|Overall Study|Missing follow-up information|3|||
125569189|NCT02054897|451712023|FG000|Overall Study|Lost to Follow-up|4|||
125569190|NCT02054897|451712024|FG001|Overall Study|Lost to Follow-up|2|||
125569191|NCT02054897|451712025|FG002|Overall Study|Lost to Follow-up|7|||
125569192|NCT02054897|451712023|FG000|Overall Study|Randomized but not exposed|1|||
125569193|NCT02054897|451712024|FG001|Overall Study|Randomized but not exposed|0|||
125569194|NCT02054897|451712025|FG002|Overall Study|Randomized but not exposed|0|||
125569195|NCT00794157|451712026|FG000|Overall Study|Adverse Event|4|||
125569196|NCT00794157|451712027|FG001|Overall Study|Adverse Event|1|||
125569197|NCT00794157|451712028|FG002|Overall Study|Adverse Event|8|||
125569198|NCT00794157|451712026|FG000|Overall Study|Subject withdrew consent|2|||
125569199|NCT00794157|451712027|FG001|Overall Study|Subject withdrew consent|0|||
125569200|NCT00794157|451712028|FG002|Overall Study|Subject withdrew consent|3|||
125569201|NCT00794157|451712026|FG000|Overall Study|Lost to Follow-up|2|||
125569202|NCT00794157|451712027|FG001|Overall Study|Lost to Follow-up|0|||
125569203|NCT00794157|451712028|FG002|Overall Study|Lost to Follow-up|1|||
125569204|NCT00794157|451712026|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125569205|NCT00794157|451712027|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125569206|NCT00794157|451712028|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
125569207|NCT00794157|451712026|FG000|Overall Study|Administrative problems|1|||
125569208|NCT00794157|451712027|FG001|Overall Study|Administrative problems|7|||
125569209|NCT00794157|451712028|FG002|Overall Study|Administrative problems|4|||
125569210|NCT00794157|451712026|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125569211|NCT00794157|451712027|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125569212|NCT00794157|451712028|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125569213|NCT00794157|451712026|FG000|Overall Study|Protocol deviation|0|||
125569214|NCT00794157|451712027|FG001|Overall Study|Protocol deviation|1|||
125569215|NCT00794157|451712028|FG002|Overall Study|Protocol deviation|1|||
125569216|NCT00677014|451712029|FG000|Overall Study|Lost to Follow-up|20|||
125569217|NCT00677014|451712030|FG001|Overall Study|Lost to Follow-up|12|||
125569218|NCT00677014|451712031|FG002|Overall Study|Lost to Follow-up|24|||
125569219|NCT00677014|451712029|FG000|Overall Study|Death|6|||
125569220|NCT00677014|451712030|FG001|Overall Study|Death|15|||
125569221|NCT00677014|451712031|FG002|Overall Study|Death|7|||
125569222|NCT00677014|451712029|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
125569223|NCT00677014|451712030|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
125569224|NCT00677014|451712031|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
125569225|NCT02374099|451712032|FG000|Overall Study|Adverse Event|1|||
125569226|NCT02374099|451712033|FG001|Overall Study|Adverse Event|0|||
125569227|NCT02374099|451712032|FG000|Overall Study|Progressive Disease|35|||
125569228|NCT02374099|451712033|FG001|Overall Study|Progressive Disease|40|||
125569229|NCT02374099|451712032|FG000|Overall Study|Withdrawal by Subject|5|||
125569230|NCT02374099|451712033|FG001|Overall Study|Withdrawal by Subject|1|||
125569231|NCT02374099|451712032|FG000|Overall Study|Miscellaneous|2|||
125569232|NCT02374099|451712033|FG001|Overall Study|Miscellaneous|3|||
125569233|NCT02374099|451712032|FG000|Overall Study|Randomized, but not treated|2|||
125569234|NCT02374099|451712033|FG001|Overall Study|Randomized, but not treated|1|||
125569235|NCT02374099|451712032|FG000|Overall Study|Study Terminated by Sponsor|3|||
125569236|NCT02374099|451712033|FG001|Overall Study|Study Terminated by Sponsor|4|||
125569237|NCT00081159|451712034|FG000|Overall Study|Withdrawal by Subject|0|||
125569238|NCT00081159|451712035|FG001|Overall Study|Withdrawal by Subject|3|||
125569239|NCT00081159|451712034|FG000|Overall Study|Myelosuppression prior to treatment|0|||
125569240|NCT00081159|451712035|FG001|Overall Study|Myelosuppression prior to treatment|1|||
125569241|NCT00081159|451712034|FG000|Overall Study|Lost to Follow-up|2|||
125569242|NCT00081159|451712035|FG001|Overall Study|Lost to Follow-up|1|||
125569243|NCT01553136|451712036|FG000|Overall Study|Adverse Event|3|||
125569244|NCT01553136|451712037|FG001|Overall Study|Adverse Event|2|||
125569245|NCT01553136|451712036|FG000|Overall Study|Withdrawal by Subject|2|||
125357942|NCT01439568|450946292|FG001|Overall Study|Withdrawal by Subject|2|||
125569246|NCT01553136|451712037|FG001|Overall Study|Withdrawal by Subject|3|||
125357943|NCT02607930|450946293|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
125357944|NCT02607930|450946294|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
125357945|NCT02607930|450946295|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
125357946|NCT02607930|450946296|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
125357947|NCT02607930|450946293|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
125357948|NCT02607930|450946294|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
125569247|NCT01553136|451712036|FG000|Overall Study|Lost to Follow-up|4|||
125569248|NCT01553136|451712037|FG001|Overall Study|Lost to Follow-up|10|||
125569249|NCT01553136|451712036|FG000|Overall Study|Physician Decision|2|||
125569250|NCT01553136|451712037|FG001|Overall Study|Physician Decision|3|||
125357949|NCT02607930|450946295|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
125357950|NCT02607930|450946296|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
125357951|NCT02607930|450946293|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
125357952|NCT02607930|450946294|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
125357953|NCT02607930|450946295|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
125357954|NCT02607930|450946296|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
125357955|NCT02607930|450946293|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
125357956|NCT02607930|450946294|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
125569251|NCT01553136|451712036|FG000|Overall Study|Scheduling Difficulties|5|||
125569252|NCT01553136|451712037|FG001|Overall Study|Scheduling Difficulties|4|||
125569253|NCT01100437|451712038|FG000|Titration/Stabilization|Adverse Event|0|||
125569254|NCT01100437|451712039|FG001|Titration/Stabilization|Adverse Event|0|||
125569255|NCT01100437|451712040|FG002|Titration/Stabilization|Adverse Event|4|||
125569256|NCT01100437|451712038|FG000|Titration/Stabilization|Non-compliance|0|||
125569257|NCT01100437|451712039|FG001|Titration/Stabilization|Non-compliance|0|||
125569258|NCT01100437|451712040|FG002|Titration/Stabilization|Non-compliance|1|||
125569259|NCT01100437|451712038|FG000|Titration/Stabilization|Sponsor canceled study|0|||
125569260|NCT01100437|451712039|FG001|Titration/Stabilization|Sponsor canceled study|0|||
125569261|NCT01100437|451712040|FG002|Titration/Stabilization|Sponsor canceled study|1|||
125569262|NCT01100437|451712038|FG000|Maintenance|Withdrawal by Subject|0|||
125426832|NCT03641313|451188010|FG000|Overall Study|Withdrawal by Subject|2|||
125426833|NCT03641313|451188010|FG000|Overall Study|Declining health|1|||
125426834|NCT03641313|451188010|FG000|Overall Study|Adverse Event|1|||
125426835|NCT04642898|451188011|FG000|Overall Study|Withdrawal by Subject|2|||
125426836|NCT04642898|451188012|FG001|Overall Study|Withdrawal by Subject|4|||
125426837|NCT04642898|451188013|FG002|Overall Study|Withdrawal by Subject|4|||
125426838|NCT04642898|451188014|FG003|Overall Study|Withdrawal by Subject|6|||
125569263|NCT01100437|451712039|FG001|Maintenance|Withdrawal by Subject|0|||
125569264|NCT01100437|451712040|FG002|Maintenance|Withdrawal by Subject|1|||
125357957|NCT02607930|450946295|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
125357958|NCT02607930|450946296|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
125357959|NCT02607930|450946293|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
125357960|NCT02607930|450946294|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
125357961|NCT02607930|450946295|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
125357962|NCT02607930|450946296|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
125357963|NCT02607930|450946293|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
125357964|NCT02607930|450946294|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
125357965|NCT02607930|450946295|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
125357966|NCT02607930|450946296|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
125357967|NCT02607930|450946293|FG000|Double-Blinded Treatment Phase|Death|2|||
125357968|NCT02607930|450946294|FG001|Double-Blinded Treatment Phase|Death|1|||
125357969|NCT02607930|450946295|FG002|Double-Blinded Treatment Phase|Death|0|||
125357970|NCT02607930|450946296|FG003|Double-Blinded Treatment Phase|Death|0|||
125357971|NCT02607930|450946293|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
125357972|NCT02607930|450946294|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
125357973|NCT02607930|450946295|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
125357974|NCT02607930|450946296|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
125357975|NCT02607930|450946293|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
125357976|NCT02607930|450946294|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
125357977|NCT02607930|450946295|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
125357978|NCT02607930|450946296|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
125357979|NCT02607930|450946293|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
125357980|NCT02607930|450946294|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
125357981|NCT02607930|450946295|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
125357982|NCT02607930|450946296|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
125357983|NCT02607930|450946293|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
125357984|NCT02607930|450946294|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
125357985|NCT02607930|450946295|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
125357986|NCT02607930|450946296|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
125357987|NCT02607930|450946293|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
125357988|NCT02607930|450946294|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
125357989|NCT02607930|450946295|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
125357990|NCT02607930|450946296|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
125357991|NCT02607930|450946293|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
125357992|NCT02607930|450946294|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
125357993|NCT02607930|450946295|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
125357994|NCT02607930|450946296|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
125357995|NCT02607930|450946293|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
125357996|NCT02607930|450946294|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
125357997|NCT02607930|450946295|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
125357998|NCT02607930|450946296|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
125357999|NCT02607930|450946293|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
125358000|NCT02607930|450946294|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
125358001|NCT02607930|450946295|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
125358002|NCT02607930|450946296|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
125358003|NCT02607930|450946293|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
125358004|NCT02607930|450946294|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
125426839|NCT04642898|451188015|FG004|Overall Study|Withdrawal by Subject|2|||
125569265|NCT01100437|451712038|FG000|Maintenance|Sponsor termination of study|0|||
125569266|NCT01100437|451712039|FG001|Maintenance|Sponsor termination of study|0|||
125569267|NCT01100437|451712040|FG002|Maintenance|Sponsor termination of study|1|||
125569268|NCT00894556|451712041|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
125569269|NCT00894556|451712042|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
125569270|NCT00894556|451712043|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
125569271|NCT00894556|451712044|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
125569272|NCT00894556|451712041|FG000|Treatment Phase|Lost to Follow-up|2|||
125569273|NCT00894556|451712042|FG001|Treatment Phase|Lost to Follow-up|3|||
125569274|NCT00894556|451712043|FG002|Treatment Phase|Lost to Follow-up|1|||
125569275|NCT00894556|451712044|FG003|Treatment Phase|Lost to Follow-up|0|||
125569276|NCT00894556|451712041|FG000|Treatment Phase|Lack of Qualifying Event|2|||
125569277|NCT00894556|451712042|FG001|Treatment Phase|Lack of Qualifying Event|1|||
125569278|NCT00894556|451712043|FG002|Treatment Phase|Lack of Qualifying Event|0|||
125569279|NCT00894556|451712044|FG003|Treatment Phase|Lack of Qualifying Event|0|||
125569280|NCT03921424|451712058|FG000|Overall Study|Lost to Follow-up|0|||
125569281|NCT03921424|451712059|FG001|Overall Study|Lost to Follow-up|1|||
125569282|NCT03921424|451712058|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
125569283|NCT03921424|451712059|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
125569284|NCT02581202|451712062|FG000|Overall Study|Lack of Efficacy|2|||
125569285|NCT02581202|451712062|FG000|Overall Study|Withdrawal by Subject|4|||
125569286|NCT02581202|451712062|FG000|Overall Study|Lost to Follow-up|5|||
125569287|NCT02581202|451712062|FG000|Overall Study|Pregnancy|3|||
125569288|NCT02595450|451712069|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
125569289|NCT02595450|451712069|FG000|Overall Study|Enrolled, but not treated|8|||
125569290|NCT01934556|451712071|FG000|Overall Study|Withdrawal by Subject|0|||
125569291|NCT01934556|451712072|FG001|Overall Study|Withdrawal by Subject|1|||
125569292|NCT01934556|451712073|FG002|Overall Study|Withdrawal by Subject|1|||
125569293|NCT01934556|451712071|FG000|Overall Study|Lost to Follow-up|4|||
125569294|NCT01934556|451712072|FG001|Overall Study|Lost to Follow-up|10|||
125569295|NCT01934556|451712073|FG002|Overall Study|Lost to Follow-up|7|||
125569296|NCT01934556|451712071|FG000|Overall Study|Death|1|||
125569297|NCT01934556|451712072|FG001|Overall Study|Death|5|||
125569298|NCT01934556|451712073|FG002|Overall Study|Death|2|||
125569299|NCT03770260|451713678|FG000|Overall Study|Disease progression|0|||
125569300|NCT03770260|451713679|FG001|Overall Study|Disease progression|1|||
125569301|NCT03770260|451713680|FG002|Overall Study|Disease progression|0|||
125569302|NCT03770260|451713681|FG003|Overall Study|Disease progression|0|||
125569303|NCT04649255|451713684|FG000|Overall Study|Death|9|||
125569304|NCT04649255|451713684|FG000|Overall Study|Withdrawal by Subject|1|||
125569305|NCT01652885|451713688|FG000|Overall Study|Adverse Event|1|||
125569306|NCT00075400|451713689|FG000|Overall Study|Ineligible: wrong primary|1|||
125569307|NCT00075400|451713689|FG000|Overall Study|Never treated|2|||
125569308|NCT00490568|451713690|FG000|Overall Study|Adverse Event|116|||
125569309|NCT00490568|451713690|FG000|Overall Study|Lost to Follow-up|13|||
125569310|NCT00490568|451713690|FG000|Overall Study|Protocol Violation|45|||
125569311|NCT00490568|451713690|FG000|Overall Study|Withdrawal by Subject|135|||
125569312|NCT00490568|451713690|FG000|Overall Study|Still in the study at termination|974|||
125569313|NCT00490568|451713690|FG000|Overall Study|Other|1|||
125569314|NCT00490568|451713690|FG000|Overall Study|Exclusion criteria met|1|||
125569315|NCT00490568|451713690|FG000|Overall Study|Caregiver related|20|||
125569316|NCT00490568|451713690|FG000|Overall Study|Abnormal ECG|25|||
125569317|NCT00490568|451713690|FG000|Overall Study|Participant refused follow-up|9|||
125569318|NCT00490568|451713690|FG000|Overall Study|Legal representative withdrew consent|1|||
125569319|NCT00490568|451713690|FG000|Overall Study|Disease progression|4|||
125569320|NCT00490568|451713690|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
125358005|NCT02607930|450946295|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
125358006|NCT02607930|450946296|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
125569321|NCT00490568|451713690|FG000|Overall Study|Investigator decision|3|||
125569322|NCT00490568|451713690|FG000|Overall Study|Non-Compliance|7|||
125569323|NCT00490568|451713690|FG000|Overall Study|Efficacy related|3|||
125569324|NCT00490568|451713690|FG000|Overall Study|Participant died|1|||
125569325|NCT00490568|451713690|FG000|Overall Study|Participant withdrawal due to surgery|1|||
125569326|NCT01395394|451713691|FG000|Baseline Study Visit|Protocol Violation|1|||
125569327|NCT01395394|451713692|FG001|Baseline Study Visit|Protocol Violation|0|||
125569328|NCT01395394|451713693|FG002|Baseline Study Visit|Protocol Violation|0|||
125569329|NCT03451773|451713696|FG000|Overall Study|Death on study|1|||
125569330|NCT03451773|451713697|FG001|Overall Study|Death on study|5|||
125358007|NCT03198078|450946297|FG000|Overall Study|Adverse Event|0|||
125358008|NCT03198078|450946298|FG001|Overall Study|Adverse Event|1|||
125569331|NCT03451773|451713696|FG000|Overall Study|Death during follow-up period|0|||
125569332|NCT03451773|451713697|FG001|Overall Study|Death during follow-up period|1|||
125569333|NCT03468855|451713698|FG000|Overall Study|Adverse Event|2|||
125569334|NCT03468855|451713698|FG000|Overall Study|Lost to Follow-up|5|||
125569335|NCT03468855|451713698|FG000|Overall Study|Withdrawal by Subject|3|||
125569336|NCT03468855|451713698|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
125569337|NCT01908101|451713699|FG000|Overall Study|Physician Decision|1|||
125569338|NCT01908101|451713699|FG000|Overall Study|Withdrawal by Subject|1|||
125569339|NCT01908101|451713699|FG000|Overall Study|Incorrect Diagnosis|2|||
125358009|NCT03198078|450946299|FG002|Overall Study|Adverse Event|2|||
125358010|NCT03198078|450946297|FG000|Overall Study|Lack of Efficacy|0|||
125358011|NCT03198078|450946298|FG001|Overall Study|Lack of Efficacy|0|||
125358012|NCT03198078|450946299|FG002|Overall Study|Lack of Efficacy|3|||
125358013|NCT03198078|450946297|FG000|Overall Study|Lost to Follow-up|1|||
125569340|NCT01908101|451713699|FG000|Overall Study|Incorrect Starting Dose|1|||
125569341|NCT01908101|451713699|FG000|Overall Study|Did not complete the first cycle|4|||
125569342|NCT00412750|451713701|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125569343|NCT00412750|451713702|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125569344|NCT00412750|451713703|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125569345|NCT00412750|451713701|FG000|Overall Study|Administrative problems|21|||
125569346|NCT00412750|451713702|FG001|Overall Study|Administrative problems|17|||
125569347|NCT00412750|451713703|FG002|Overall Study|Administrative problems|14|||
125569348|NCT00412750|451713701|FG000|Overall Study|Adverse Event|8|||
125569349|NCT00412750|451713702|FG001|Overall Study|Adverse Event|3|||
125569350|NCT00412750|451713703|FG002|Overall Study|Adverse Event|3|||
125569351|NCT00412750|451713701|FG000|Overall Study|Lost to Follow-up|1|||
125569352|NCT00412750|451713702|FG001|Overall Study|Lost to Follow-up|0|||
125569353|NCT00412750|451713703|FG002|Overall Study|Lost to Follow-up|1|||
125569354|NCT00412750|451713701|FG000|Overall Study|Withdrawal by Subject|0|||
125569355|NCT00412750|451713702|FG001|Overall Study|Withdrawal by Subject|1|||
125569356|NCT00412750|451713703|FG002|Overall Study|Withdrawal by Subject|2|||
125569357|NCT00412750|451713701|FG000|Overall Study|Lack of Efficacy|0|||
125569358|NCT00412750|451713702|FG001|Overall Study|Lack of Efficacy|0|||
125569359|NCT00412750|451713703|FG002|Overall Study|Lack of Efficacy|3|||
125569360|NCT04091087|451713704|FG000|Overall Study|Not treated|1|||
125569361|NCT04091087|451713705|FG001|Overall Study|Not treated|0|||
125569362|NCT04091087|451713704|FG000|Overall Study|Adverse Event|4|||
125569363|NCT04091087|451713705|FG001|Overall Study|Adverse Event|4|||
125569364|NCT04091087|451713704|FG000|Overall Study|Protocol Violation|0|||
125358014|NCT03198078|450946298|FG001|Overall Study|Lost to Follow-up|0|||
125358015|NCT03198078|450946299|FG002|Overall Study|Lost to Follow-up|0|||
125358016|NCT03198078|450946297|FG000|Overall Study|Pregnancy|0|||
125358017|NCT03198078|450946298|FG001|Overall Study|Pregnancy|1|||
125569365|NCT04091087|451713705|FG001|Overall Study|Protocol Violation|1|||
125569366|NCT04091087|451713704|FG000|Overall Study|Withdrawal by Subject|5|||
125569367|NCT04091087|451713705|FG001|Overall Study|Withdrawal by Subject|2|||
125569368|NCT05440539|451713706|FG000|Overall Study|Lost to Follow-up|4|||
125569369|NCT05440539|451713707|FG001|Overall Study|Lost to Follow-up|4|||
125569370|NCT05440539|451713706|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
125569371|NCT05440539|451713707|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
125426840|NCT04642898|451188016|FG005|Overall Study|Withdrawal by Subject|6|||
125569372|NCT03808077|451713708|FG000|Overall Study|Physician Decision|2|||
125569373|NCT03808077|451713709|FG001|Overall Study|Physician Decision|3|||
125569374|NCT03808077|451713708|FG000|Overall Study|Withdrawal by Subject|1|||
125569375|NCT03808077|451713709|FG001|Overall Study|Withdrawal by Subject|0|||
125569376|NCT03808077|451713708|FG000|Overall Study|Equipment Issues|2|||
125569377|NCT03808077|451713709|FG001|Overall Study|Equipment Issues|1|||
125569378|NCT04152161|451713710|FG000|Overall Study|Death|0|||
125569379|NCT04152161|451713711|FG001|Overall Study|Death|1|||
125569380|NCT04152161|451713710|FG000|Overall Study|Physician Decision|0|||
125569381|NCT04152161|451713711|FG001|Overall Study|Physician Decision|1|||
125569382|NCT04152161|451713710|FG000|Overall Study|Lost to Follow-up|9|||
125569383|NCT04152161|451713711|FG001|Overall Study|Lost to Follow-up|3|||
125569384|NCT04152161|451713710|FG000|Overall Study|Protocol Violation|1|||
125569385|NCT04152161|451713711|FG001|Overall Study|Protocol Violation|0|||
125569386|NCT04152161|451713710|FG000|Overall Study|Withdrawal by Subject|29|||
125569387|NCT04152161|451713711|FG001|Overall Study|Withdrawal by Subject|28|||
125569388|NCT04152161|451713710|FG000|Overall Study|Sponsor termination of study|750|||
125569389|NCT04152161|451713711|FG001|Overall Study|Sponsor termination of study|755|||
125426841|NCT04642898|451188011|FG000|Overall Study|Lost to Follow-up|0|||
125569390|NCT04152161|451713710|FG000|Overall Study|Other|20|||
125569391|NCT04152161|451713711|FG001|Overall Study|Other|18|||
125569392|NCT00001379|451713712|FG000|Initial Treatment|Disease progression|21|||
125358018|NCT03198078|450946299|FG002|Overall Study|Pregnancy|0|||
125358019|NCT03198078|450946297|FG000|Overall Study|Withdrawal by Subject|1|||
125569393|NCT00001379|451713713|FG001|Initial Treatment|Disease progression|3|||
125358020|NCT03198078|450946298|FG001|Overall Study|Withdrawal by Subject|0|||
125426842|NCT04642898|451188012|FG001|Overall Study|Lost to Follow-up|0|||
125569394|NCT00001379|451713714|FG002|Initial Treatment|Disease progression|0|||
125569395|NCT00001379|451713715|FG003|Initial Treatment|Disease progression|0|||
125569396|NCT00001379|451713712|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
125569397|NCT00001379|451713713|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
125569398|NCT00001379|451713714|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
125569399|NCT00001379|451713715|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
125569400|NCT00001379|451713712|FG000|Initial Treatment|Received alternative treatment|2|||
125569401|NCT00001379|451713713|FG001|Initial Treatment|Received alternative treatment|1|||
125569402|NCT00001379|451713714|FG002|Initial Treatment|Received alternative treatment|0|||
125569403|NCT00001379|451713715|FG003|Initial Treatment|Received alternative treatment|0|||
125569404|NCT00001379|451713712|FG000|Initial Treatment|Refused further treatment|2|||
125569405|NCT00001379|451713713|FG001|Initial Treatment|Refused further treatment|0|||
125569406|NCT00001379|451713714|FG002|Initial Treatment|Refused further treatment|0|||
125569407|NCT00001379|451713715|FG003|Initial Treatment|Refused further treatment|0|||
125569408|NCT00001379|451713712|FG000|Initial Treatment|Did not receive protocol treatment|0|||
125569409|NCT00001379|451713713|FG001|Initial Treatment|Did not receive protocol treatment|0|||
125569410|NCT00001379|451713714|FG002|Initial Treatment|Did not receive protocol treatment|5|||
125569411|NCT00001379|451713715|FG003|Initial Treatment|Did not receive protocol treatment|0|||
125569412|NCT00001379|451713712|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
125569413|NCT00001379|451713713|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
125569414|NCT00001379|451713714|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
125569415|NCT00001379|451713715|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
125358021|NCT03198078|450946299|FG002|Overall Study|Withdrawal by Subject|2|||
125358022|NCT03198078|450946297|FG000|Overall Study|Withdrawal by Caregiver|1|||
125358023|NCT03198078|450946298|FG001|Overall Study|Withdrawal by Caregiver|3|||
125358024|NCT03198078|450946299|FG002|Overall Study|Withdrawal by Caregiver|5|||
125358025|NCT03711266|450946302|FG000|Overall Study|Lost to Follow-up|10|||
125358026|NCT01646073|450946303|FG000|Period A (12 Weeks)|Adverse Event|0|||
125569416|NCT00001379|451713712|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
125569417|NCT00001379|451713713|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
125569418|NCT00001379|451713714|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
125569419|NCT00001379|451713715|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
125569420|NCT00001379|451713712|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
125569421|NCT00001379|451713713|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
125569422|NCT00001379|451713714|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
125569423|NCT00001379|451713715|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
125569424|NCT00001379|451713712|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
125358027|NCT01646073|450946304|FG001|Period A (12 Weeks)|Adverse Event|2|||
125358028|NCT01646073|450946303|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
125358029|NCT01646073|450946304|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
125358030|NCT01646073|450946303|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
125358031|NCT01646073|450946304|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
125358032|NCT01646073|450946303|FG000|Period A (12 Weeks)|Protocol Violation|0|||
125569425|NCT00001379|451713713|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
125569426|NCT00001379|451713714|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
125569427|NCT00001379|451713715|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
125569428|NCT00001379|451713712|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
125569429|NCT00001379|451713713|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
125569430|NCT00001379|451713714|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
125569431|NCT00001379|451713715|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
125569432|NCT03246958|451713716|FG000|Overall Study|Withdrawal by Subject|0|||
125569433|NCT03246958|451713717|FG001|Overall Study|Withdrawal by Subject|1|||
125569434|NCT03246958|451713718|FG002|Overall Study|Withdrawal by Subject|0|||
125569435|NCT03246958|451713719|FG003|Overall Study|Withdrawal by Subject|0|||
125569436|NCT03246958|451713720|FG004|Overall Study|Withdrawal by Subject|0|||
125569437|NCT03246958|451713721|FG005|Overall Study|Withdrawal by Subject|1|||
125569438|NCT03246958|451713722|FG006|Overall Study|Withdrawal by Subject|0|||
125569439|NCT03246958|451713716|FG000|Overall Study|Progression|13|||
125569440|NCT03246958|451713717|FG001|Overall Study|Progression|9|||
125569441|NCT03246958|451713718|FG002|Overall Study|Progression|3|||
125569442|NCT03246958|451713719|FG003|Overall Study|Progression|2|||
125569443|NCT03246958|451713720|FG004|Overall Study|Progression|1|||
125569444|NCT03246958|451713721|FG005|Overall Study|Progression|2|||
125569445|NCT03246958|451713722|FG006|Overall Study|Progression|1|||
125569446|NCT03246958|451713716|FG000|Overall Study|Adverse Event|2|||
125569447|NCT03246958|451713717|FG001|Overall Study|Adverse Event|2|||
125569448|NCT03246958|451713718|FG002|Overall Study|Adverse Event|0|||
125358033|NCT01646073|450946304|FG001|Period A (12 Weeks)|Protocol Violation|1|||
125569449|NCT03246958|451713719|FG003|Overall Study|Adverse Event|1|||
125569450|NCT03246958|451713720|FG004|Overall Study|Adverse Event|1|||
125569451|NCT03246958|451713721|FG005|Overall Study|Adverse Event|0|||
125358034|NCT01646073|450946303|FG000|Period A (12 Weeks)|Other|0|||
125358035|NCT01646073|450946304|FG001|Period A (12 Weeks)|Other|1|||
125358036|NCT01646073|450946303|FG000|Period B (12 Weeks)|Adverse Event|0|||
125358037|NCT01646073|450946304|FG001|Period B (12 Weeks)|Adverse Event|7|||
125569452|NCT03246958|451713722|FG006|Overall Study|Adverse Event|2|||
125569453|NCT03246958|451713716|FG000|Overall Study|Death|0|||
125569454|NCT03246958|451713717|FG001|Overall Study|Death|1|||
125569455|NCT03246958|451713718|FG002|Overall Study|Death|0|||
125569456|NCT03246958|451713719|FG003|Overall Study|Death|0|||
125569457|NCT03246958|451713720|FG004|Overall Study|Death|0|||
125569458|NCT03246958|451713721|FG005|Overall Study|Death|0|||
125569459|NCT03246958|451713722|FG006|Overall Study|Death|0|||
125569460|NCT03246958|451713716|FG000|Overall Study|Physician Decision|0|||
125569461|NCT03246958|451713717|FG001|Overall Study|Physician Decision|0|||
125569462|NCT03246958|451713718|FG002|Overall Study|Physician Decision|0|||
125569463|NCT03246958|451713719|FG003|Overall Study|Physician Decision|1|||
125569464|NCT03246958|451713720|FG004|Overall Study|Physician Decision|0|||
125569465|NCT03246958|451713721|FG005|Overall Study|Physician Decision|0|||
125569466|NCT03246958|451713722|FG006|Overall Study|Physician Decision|0|||
125569467|NCT03246958|451713716|FG000|Overall Study|Never start treatment|1|||
125569468|NCT03246958|451713717|FG001|Overall Study|Never start treatment|0|||
125569469|NCT03246958|451713718|FG002|Overall Study|Never start treatment|0|||
125569470|NCT03246958|451713719|FG003|Overall Study|Never start treatment|0|||
125569471|NCT03246958|451713720|FG004|Overall Study|Never start treatment|0|||
125569472|NCT03246958|451713721|FG005|Overall Study|Never start treatment|0|||
125569473|NCT03246958|451713722|FG006|Overall Study|Never start treatment|0|||
125569474|NCT03246958|451713716|FG000|Overall Study|Over enrollment|0|||
125569475|NCT03246958|451713717|FG001|Overall Study|Over enrollment|2|||
125569476|NCT03246958|451713718|FG002|Overall Study|Over enrollment|0|||
125569477|NCT03246958|451713719|FG003|Overall Study|Over enrollment|0|||
125569478|NCT03246958|451713720|FG004|Overall Study|Over enrollment|0|||
125569479|NCT03246958|451713721|FG005|Overall Study|Over enrollment|0|||
125569480|NCT03246958|451713722|FG006|Overall Study|Over enrollment|0|||
125569481|NCT03703102|451713723|FG000|Overall Study|Adverse Event|4|||
125569482|NCT03703102|451713724|FG001|Overall Study|Adverse Event|3|||
125569483|NCT03703102|451713725|FG002|Overall Study|Adverse Event|7|||
125569484|NCT03703102|451713726|FG003|Overall Study|Adverse Event|3|||
125569485|NCT03703102|451713727|FG004|Overall Study|Adverse Event|13|||
125569486|NCT03703102|451713723|FG000|Overall Study|Lack of Efficacy|4|||
125358038|NCT01646073|450946303|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
125358039|NCT01646073|450946304|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
125358040|NCT01646073|450946303|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
125358041|NCT01646073|450946304|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
125358042|NCT00057876|450946305|FG000|Overall Study|Adverse Event|8|||
125358043|NCT00057876|450946306|FG001|Overall Study|Adverse Event|8|||
125358044|NCT00057876|450946305|FG000|Overall Study|Death|2|||
125358045|NCT00057876|450946306|FG001|Overall Study|Death|1|||
125358046|NCT00057876|450946305|FG000|Overall Study|Withdrawal by Subject|5|||
125358047|NCT00057876|450946306|FG001|Overall Study|Withdrawal by Subject|6|||
125358048|NCT00057876|450946305|FG000|Overall Study|Lack of Efficacy|10|||
125358049|NCT00057876|450946306|FG001|Overall Study|Lack of Efficacy|8|||
125358050|NCT00057876|450946305|FG000|Overall Study|Ineligible|1|||
125358051|NCT00057876|450946306|FG001|Overall Study|Ineligible|2|||
125358052|NCT00057876|450946305|FG000|Overall Study|other reason|2|||
125358053|NCT00057876|450946306|FG001|Overall Study|other reason|2|||
125358054|NCT00057876|450946305|FG000|Overall Study|other complicating disease|1|||
125358055|NCT00057876|450946306|FG001|Overall Study|other complicating disease|0|||
125358056|NCT03799211|450946316|FG000|Overall Study|Lost to Follow-up|2|||
125358057|NCT03799211|450946317|FG001|Overall Study|Lost to Follow-up|13|||
125358058|NCT03799211|450946316|FG000|Overall Study|Withdrawal by Subject|2|||
125358059|NCT03799211|450946317|FG001|Overall Study|Withdrawal by Subject|0|||
125358060|NCT00764491|450946318|FG000|Overall Study|Lost to Follow-up|35|||
125358061|NCT00764491|450946319|FG001|Overall Study|Lost to Follow-up|17|||
125358062|NCT02927262|450946326|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
125358063|NCT02927262|450946327|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
125358064|NCT02927262|450946326|FG000|Treatment Period (Up to 744 Days)|Death|1|||
125358065|NCT02927262|450946327|FG001|Treatment Period (Up to 744 Days)|Death|0|||
125358066|NCT02927262|450946326|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
125358067|NCT02927262|450946327|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
125358068|NCT02927262|450946326|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
125358069|NCT02927262|450946327|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
125358070|NCT02927262|450946326|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
125358071|NCT02927262|450946327|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
125358072|NCT02927262|450946326|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
125358073|NCT02927262|450946327|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
125358074|NCT02927262|450946326|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
125358075|NCT02927262|450946327|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
125358076|NCT02927262|450946326|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
125569487|NCT03703102|451713724|FG001|Overall Study|Lack of Efficacy|0|||
125569488|NCT03703102|451713725|FG002|Overall Study|Lack of Efficacy|1|||
125569489|NCT03703102|451713726|FG003|Overall Study|Lack of Efficacy|4|||
125569490|NCT03703102|451713727|FG004|Overall Study|Lack of Efficacy|1|||
125569491|NCT03703102|451713723|FG000|Overall Study|Lost to Follow-up|0|||
125569492|NCT03703102|451713724|FG001|Overall Study|Lost to Follow-up|0|||
125569493|NCT03703102|451713725|FG002|Overall Study|Lost to Follow-up|1|||
125569494|NCT03703102|451713726|FG003|Overall Study|Lost to Follow-up|2|||
125569495|NCT03703102|451713727|FG004|Overall Study|Lost to Follow-up|2|||
125569496|NCT03703102|451713723|FG000|Overall Study|Physician Decision|2|||
125569497|NCT03703102|451713724|FG001|Overall Study|Physician Decision|2|||
125569498|NCT03703102|451713725|FG002|Overall Study|Physician Decision|2|||
125569499|NCT03703102|451713726|FG003|Overall Study|Physician Decision|2|||
125569500|NCT03703102|451713727|FG004|Overall Study|Physician Decision|4|||
125569501|NCT03703102|451713723|FG000|Overall Study|Withdrawal by Subject|7|||
125569502|NCT03703102|451713724|FG001|Overall Study|Withdrawal by Subject|5|||
125569503|NCT03703102|451713725|FG002|Overall Study|Withdrawal by Subject|5|||
125569504|NCT03703102|451713726|FG003|Overall Study|Withdrawal by Subject|5|||
125569505|NCT03703102|451713727|FG004|Overall Study|Withdrawal by Subject|9|||
125569506|NCT03703102|451713723|FG000|Overall Study|Ineligibility|0|||
125569507|NCT03703102|451713724|FG001|Overall Study|Ineligibility|0|||
125569508|NCT03703102|451713725|FG002|Overall Study|Ineligibility|1|||
125569509|NCT03703102|451713726|FG003|Overall Study|Ineligibility|0|||
125569510|NCT03703102|451713727|FG004|Overall Study|Ineligibility|0|||
125569511|NCT03703102|451713723|FG000|Overall Study|Protocol Deviation|4|||
125569512|NCT03703102|451713724|FG001|Overall Study|Protocol Deviation|4|||
125569513|NCT03703102|451713725|FG002|Overall Study|Protocol Deviation|3|||
125569514|NCT03703102|451713726|FG003|Overall Study|Protocol Deviation|0|||
125569515|NCT03703102|451713727|FG004|Overall Study|Protocol Deviation|0|||
125569516|NCT03703102|451713723|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125569517|NCT03703102|451713724|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125569518|NCT03703102|451713725|FG002|Overall Study|Non-Compliance with Study Drug|2|||
125569519|NCT03703102|451713726|FG003|Overall Study|Non-Compliance with Study Drug|1|||
125569520|NCT03703102|451713727|FG004|Overall Study|Non-Compliance with Study Drug|4|||
125569521|NCT02311153|451713728|FG000|Overall Study|Lost to Follow-up|5|||
125569522|NCT02311153|451713729|FG001|Overall Study|Lost to Follow-up|7|||
125569523|NCT01379274|451713730|FG000|Overall Study|funding withdrawn|1|||
125569524|NCT03363321|451713732|FG000|Overall Study|Withdrawal by Subject|0|||
125569525|NCT03363321|451713733|FG001|Overall Study|Withdrawal by Subject|1|||
125569526|NCT03363321|451713734|FG002|Overall Study|Withdrawal by Subject|0|||
125569527|NCT03363321|451713735|FG003|Overall Study|Withdrawal by Subject|1|||
125569528|NCT03363321|451713736|FG004|Overall Study|Withdrawal by Subject|0|||
125569529|NCT00631020|451713739|FG000|Overall Study|Lost to Follow-up|7|||
125569530|NCT00631020|451713739|FG000|Overall Study|Incarcerated|1|||
125569531|NCT03221751|451713743|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
125569532|NCT03221751|451713744|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
125569533|NCT03571646|451713745|FG000|Overall Study|Adverse Event|1|||
125569534|NCT03571646|451713746|FG001|Overall Study|Adverse Event|0|||
125569535|NCT03571646|451713745|FG000|Overall Study|Withdrawal by Subject|1|||
125569536|NCT03571646|451713746|FG001|Overall Study|Withdrawal by Subject|1|||
125569537|NCT03548935|451713747|FG000|Overall Study|Withdrawal by Subject|26|||
125569538|NCT03548935|451713748|FG001|Overall Study|Withdrawal by Subject|17|||
125569539|NCT03548935|451713747|FG000|Overall Study|Lost to Follow-up|39|||
125569540|NCT03548935|451713748|FG001|Overall Study|Lost to Follow-up|28|||
125569541|NCT03548935|451713747|FG000|Overall Study|Death|1|||
125569542|NCT03548935|451713748|FG001|Overall Study|Death|1|||
125569543|NCT00763815|451713749|FG000|Overall Study|Adverse Event|14|||
125569544|NCT00763815|451713750|FG001|Overall Study|Adverse Event|29|||
125569545|NCT00763815|451713749|FG000|Overall Study|Lack of Efficacy|10|||
125569546|NCT00763815|451713750|FG001|Overall Study|Lack of Efficacy|11|||
125569547|NCT00763815|451713749|FG000|Overall Study|Poor Compliance to Protocol|6|||
125569548|NCT00763815|451713750|FG001|Overall Study|Poor Compliance to Protocol|6|||
125569549|NCT00763815|451713749|FG000|Overall Study|Lost to Follow-up|2|||
125569550|NCT00763815|451713750|FG001|Overall Study|Lost to Follow-up|4|||
125569551|NCT00763815|451713749|FG000|Overall Study|Early Termination|1|||
125569552|NCT00763815|451713750|FG001|Overall Study|Early Termination|0|||
125569553|NCT00763815|451713749|FG000|Overall Study|Familial and Personal Reasons|9|||
125569554|NCT00763815|451713750|FG001|Overall Study|Familial and Personal Reasons|16|||
125569555|NCT00763815|451713749|FG000|Overall Study|Physician Decision|1|||
125569556|NCT00763815|451713750|FG001|Overall Study|Physician Decision|0|||
125569557|NCT00763815|451713749|FG000|Overall Study|Withdrawal by Subject|7|||
125569558|NCT00763815|451713750|FG001|Overall Study|Withdrawal by Subject|12|||
125569559|NCT00763815|451713749|FG000|Overall Study|Protocol Violation|2|||
125569560|NCT00763815|451713750|FG001|Overall Study|Protocol Violation|5|||
125569561|NCT00763815|451713749|FG000|Overall Study|Sponsor's Decision|0|||
125569562|NCT00763815|451713750|FG001|Overall Study|Sponsor's Decision|1|||
125569563|NCT00283595|451713751|FG000|Overall Study|Withdrawal by Subject|1|||
125569564|NCT00283595|451713752|FG001|Overall Study|Withdrawal by Subject|2|||
125569565|NCT01263639|451713753|FG000|Overall Study|Lost to Follow-up|66|||
125569566|NCT01263639|451713754|FG001|Overall Study|Lost to Follow-up|70|||
125569567|NCT01263639|451713753|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
125569568|NCT01263639|451713754|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
125569569|NCT01576549|451713755|FG000|Overall Study|Sponsor Decision|2|||
125569570|NCT04951037|451713756|FG000|Overall Study|Lost to Follow-up|16|||
125569571|NCT04951037|451713756|FG000|Overall Study|Withdrawal by Subject|5|||
125569572|NCT04951037|451713756|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
125569573|NCT05630937|451713757|FG000|Overall Study|Study terminated by sponsor|1|||
125569574|NCT05630937|451713758|FG001|Overall Study|Study terminated by sponsor|1|||
125569575|NCT05630937|451713759|FG002|Overall Study|Study terminated by sponsor|8|||
125569576|NCT05630937|451713760|FG003|Overall Study|Study terminated by sponsor|0|||
125569577|NCT05630937|451713757|FG000|Overall Study|Lost to Follow-up|0|||
125569578|NCT05630937|451713758|FG001|Overall Study|Lost to Follow-up|0|||
125569579|NCT05630937|451713759|FG002|Overall Study|Lost to Follow-up|1|||
125569580|NCT05630937|451713760|FG003|Overall Study|Lost to Follow-up|0|||
125569581|NCT05630937|451713757|FG000|Overall Study|Enrolled but not treated|0|||
125569582|NCT05630937|451713758|FG001|Overall Study|Enrolled but not treated|0|||
125569583|NCT05630937|451713759|FG002|Overall Study|Enrolled but not treated|0|||
125569584|NCT05630937|451713760|FG003|Overall Study|Enrolled but not treated|1|||
125569585|NCT01604265|451713763|FG000|Overall Study|Adverse Event|1|||
125569586|NCT01604265|451713764|FG001|Overall Study|Adverse Event|0|||
125569587|NCT01604265|451713763|FG000|Overall Study|Withdrawal by Subject|1|||
125569588|NCT01604265|451713764|FG001|Overall Study|Withdrawal by Subject|0|||
125569589|NCT02706873|451713765|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
125569590|NCT02706873|451713766|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
125569591|NCT02706873|451713767|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
125569592|NCT02706873|451713768|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
125569593|NCT02706873|451713765|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
125569594|NCT02706873|451713766|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
125569595|NCT02706873|451713767|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
125569596|NCT02706873|451713768|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
125569597|NCT02706873|451713765|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
125569598|NCT02706873|451713766|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
125569599|NCT02706873|451713767|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
125569600|NCT02706873|451713768|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
125569601|NCT02706873|451713765|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
125569602|NCT02706873|451713766|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
125569603|NCT02706873|451713767|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
125569604|NCT02706873|451713768|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
125569605|NCT02706873|451713765|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
125569606|NCT02706873|451713766|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
125569607|NCT02706873|451713767|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
125569608|NCT02706873|451713768|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
125569609|NCT02706873|451713765|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
125569610|NCT02706873|451713766|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
125569611|NCT02706873|451713767|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
125569612|NCT02706873|451713768|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
125569613|NCT02706873|451713765|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
125569614|NCT02706873|451713766|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
125569615|NCT02706873|451713767|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
125569616|NCT02706873|451713768|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
125569617|NCT02706873|451713765|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
125569618|NCT02706873|451713766|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
125569619|NCT02706873|451713767|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
125569620|NCT02706873|451713768|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
125569621|NCT02706873|451713765|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
125569622|NCT02706873|451713766|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
125569623|NCT02706873|451713767|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
125569624|NCT02706873|451713768|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
125569625|NCT02706873|451713765|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
125569626|NCT02706873|451713766|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
125569627|NCT02706873|451713767|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
125569628|NCT02706873|451713768|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
125569629|NCT02706873|451713765|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
125569630|NCT02706873|451713766|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
125569631|NCT02706873|451713767|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
125569632|NCT02706873|451713768|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
125569633|NCT02706873|451713765|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
125569634|NCT02706873|451713766|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
125569635|NCT02706873|451713767|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
125569636|NCT02706873|451713768|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
125569637|NCT02706873|451713765|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
125569638|NCT02706873|451713766|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
125569639|NCT02706873|451713767|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
125569640|NCT02706873|451713768|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
125569641|NCT00586495|451713769|FG000|Treatment Period|Adverse Event|11|||
125569642|NCT00586495|451713769|FG000|Treatment Period|Death|1|||
125569643|NCT00586495|451713769|FG000|Treatment Period|Protocol Violation|1|||
125569644|NCT00586495|451713769|FG000|Treatment Period|Withdrawal by Subject|1|||
125569645|NCT00586495|451713769|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
125569646|NCT00586495|451713769|FG000|Treatment Period|Switch to commercial drug|10|||
125569647|NCT00586495|451713769|FG000|Follow-up|Death|40|||
125569648|NCT00586495|451713769|FG000|Follow-up|Lost to Follow-up|1|||
125569649|NCT00586495|451713769|FG000|Follow-up|Withdrawal by Subject|4|||
125569650|NCT00586495|451713769|FG000|Follow-up|Protocol driven decision point|37|||
125569651|NCT00586495|451713769|FG000|Follow-up|Switch to commercial drug|10|||
125569652|NCT02595723|451713770|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
125569653|NCT02595723|451713771|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
125569654|NCT02595723|451713772|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
125569655|NCT02595723|451713770|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
125569656|NCT02595723|451713771|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
125569657|NCT02595723|451713772|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
125569658|NCT00004259|451713773|FG000|Overall Study|Protocol Violation|1|||
125569659|NCT00004259|451713774|FG001|Overall Study|Protocol Violation|2|||
125569660|NCT00004259|451713775|FG002|Overall Study|Protocol Violation|0|||
125569661|NCT00004259|451713776|FG003|Overall Study|Protocol Violation|0|||
125569662|NCT00004259|451713773|FG000|Overall Study|Withdrawal by Subject|0|||
125569663|NCT00004259|451713774|FG001|Overall Study|Withdrawal by Subject|2|||
125569664|NCT00004259|451713775|FG002|Overall Study|Withdrawal by Subject|0|||
125569665|NCT00004259|451713776|FG003|Overall Study|Withdrawal by Subject|0|||
125569666|NCT00996944|451713777|FG000|Double-blind Treatment Period|Adverse Event|2|||
125569667|NCT00996944|451713778|FG001|Double-blind Treatment Period|Adverse Event|1|||
125569668|NCT00996944|451713777|FG000|Double-blind Treatment Period|Protocol Violation|1|||
125569669|NCT00996944|451713778|FG001|Double-blind Treatment Period|Protocol Violation|0|||
125569670|NCT00996944|451713777|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
125569671|NCT00996944|451713778|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
125569672|NCT00996944|451713777|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
125569673|NCT00996944|451713778|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
125569674|NCT00996944|451713777|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
125569675|NCT00996944|451713778|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
125569676|NCT00769184|451713779|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
125569677|NCT00769184|451713780|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
125569678|NCT00769184|451713779|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
125569679|NCT00769184|451713780|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
125569680|NCT00769184|451713779|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
125569681|NCT00769184|451713780|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
125569682|NCT00531752|451713782|FG000|First Double-blind Intervention Period|Adverse Event|2|||
125569683|NCT00531752|451713783|FG001|First Double-blind Intervention Period|Adverse Event|0|||
125569684|NCT00531752|451713784|FG002|First Double-blind Intervention Period|Adverse Event|1|||
125569685|NCT00531752|451713785|FG003|First Double-blind Intervention Period|Adverse Event|1|||
125569686|NCT00531752|451713782|FG000|First Double-blind Intervention Period|Other|1|||
125569687|NCT00531752|451713783|FG001|First Double-blind Intervention Period|Other|4|||
125569688|NCT00531752|451713784|FG002|First Double-blind Intervention Period|Other|4|||
125569689|NCT00531752|451713785|FG003|First Double-blind Intervention Period|Other|0|||
125569690|NCT00531752|451713782|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
125569691|NCT00531752|451713783|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
125569692|NCT00531752|451713784|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
125569693|NCT00531752|451713785|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
125569694|NCT00531752|451713782|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
125569695|NCT00531752|451713783|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
125569696|NCT00531752|451713784|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
125569697|NCT00531752|451713785|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
125569698|NCT00531752|451713782|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
125569699|NCT00531752|451713783|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
125569700|NCT00531752|451713784|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
125569701|NCT00531752|451713785|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
125569702|NCT00531752|451713782|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
125569703|NCT00531752|451713783|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
125569704|NCT00531752|451713784|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
125569705|NCT00531752|451713785|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
125569706|NCT00531752|451713782|FG000|Second Double-blind Intervention Period|Other|1|||
125569707|NCT00531752|451713783|FG001|Second Double-blind Intervention Period|Other|1|||
125569708|NCT00531752|451713784|FG002|Second Double-blind Intervention Period|Other|0|||
125569709|NCT00531752|451713785|FG003|Second Double-blind Intervention Period|Other|0|||
125569710|NCT00531752|451713782|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
125569711|NCT00531752|451713783|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
125569712|NCT00531752|451713784|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
125569713|NCT00531752|451713785|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
125569714|NCT00531752|451713782|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
125569715|NCT00531752|451713783|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
125569716|NCT00531752|451713784|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
125569717|NCT00531752|451713785|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
125569718|NCT00401375|451713787|FG000|Overall Study|Protocol Violation|2|||
125569719|NCT00401375|451713788|FG001|Overall Study|Protocol Violation|2|||
125569720|NCT00401375|451713789|FG002|Overall Study|Protocol Violation|1|||
125569721|NCT00401375|451713787|FG000|Overall Study|Adverse Event|6|||
125569722|NCT00401375|451713788|FG001|Overall Study|Adverse Event|11|||
125569723|NCT00401375|451713789|FG002|Overall Study|Adverse Event|10|||
125569724|NCT00401375|451713787|FG000|Overall Study|Withdrawal by Subject|9|||
125569725|NCT00401375|451713788|FG001|Overall Study|Withdrawal by Subject|7|||
125569726|NCT00401375|451713789|FG002|Overall Study|Withdrawal by Subject|7|||
125569727|NCT00401375|451713787|FG000|Overall Study|Lost to Follow-up|0|||
125569728|NCT00401375|451713788|FG001|Overall Study|Lost to Follow-up|1|||
125358077|NCT02927262|450946327|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
125569729|NCT00401375|451713789|FG002|Overall Study|Lost to Follow-up|1|||
125569730|NCT00401375|451713787|FG000|Overall Study|Other than specified|2|||
125569731|NCT00401375|451713788|FG001|Overall Study|Other than specified|1|||
125569732|NCT00401375|451713789|FG002|Overall Study|Other than specified|3|||
125569733|NCT00401375|451713787|FG000|Overall Study|Randomized but not treated|3|||
125569734|NCT00401375|451713788|FG001|Overall Study|Randomized but not treated|3|||
125569735|NCT00401375|451713789|FG002|Overall Study|Randomized but not treated|3|||
125569736|NCT00361270|451713790|FG000|Overall Study|Death|0|||
125569737|NCT00361270|451713791|FG001|Overall Study|Death|0|||
125569738|NCT00361270|451713792|FG002|Overall Study|Death|0|||
125569739|NCT00361270|451713793|FG003|Overall Study|Death|2|||
125569740|NCT00361270|451713790|FG000|Overall Study|Lost to Follow-up|4|||
125569741|NCT00361270|451713791|FG001|Overall Study|Lost to Follow-up|1|||
125569742|NCT00361270|451713792|FG002|Overall Study|Lost to Follow-up|0|||
125569743|NCT00361270|451713793|FG003|Overall Study|Lost to Follow-up|0|||
125569744|NCT00361270|451713790|FG000|Overall Study|Physician Decision|0|||
125569745|NCT00361270|451713791|FG001|Overall Study|Physician Decision|0|||
125569746|NCT00361270|451713792|FG002|Overall Study|Physician Decision|1|||
125569747|NCT00361270|451713793|FG003|Overall Study|Physician Decision|0|||
125569748|NCT00361270|451713790|FG000|Overall Study|Protocol Violation|9|||
125569749|NCT00361270|451713791|FG001|Overall Study|Protocol Violation|4|||
125569750|NCT00361270|451713792|FG002|Overall Study|Protocol Violation|5|||
125569751|NCT00361270|451713793|FG003|Overall Study|Protocol Violation|4|||
125569752|NCT00361270|451713790|FG000|Overall Study|Withdrawal by Subject|6|||
125569753|NCT00361270|451713791|FG001|Overall Study|Withdrawal by Subject|6|||
125569754|NCT00361270|451713792|FG002|Overall Study|Withdrawal by Subject|3|||
125569755|NCT00361270|451713793|FG003|Overall Study|Withdrawal by Subject|7|||
125569756|NCT00361270|451713790|FG000|Overall Study|Afraid of Hypnosis|1|||
125569757|NCT00361270|451713791|FG001|Overall Study|Afraid of Hypnosis|2|||
125569758|NCT00361270|451713792|FG002|Overall Study|Afraid of Hypnosis|0|||
125569759|NCT00361270|451713793|FG003|Overall Study|Afraid of Hypnosis|0|||
125569760|NCT00361270|451713790|FG000|Overall Study|Problems with Transportation|4|||
125569761|NCT00361270|451713791|FG001|Overall Study|Problems with Transportation|0|||
125569762|NCT00361270|451713792|FG002|Overall Study|Problems with Transportation|0|||
125569763|NCT00361270|451713793|FG003|Overall Study|Problems with Transportation|0|||
125569764|NCT00361270|451713790|FG000|Overall Study|Adverse Event|0|||
125569765|NCT00361270|451713791|FG001|Overall Study|Adverse Event|1|||
125569766|NCT00361270|451713792|FG002|Overall Study|Adverse Event|1|||
125569767|NCT00361270|451713793|FG003|Overall Study|Adverse Event|0|||
125569768|NCT00950664|451713794|FG000|First Intervention|Lost to Follow-up|1|||
125569769|NCT00950664|451713795|FG001|First Intervention|Lost to Follow-up|3|||
125569770|NCT00950664|451713794|FG000|First Intervention|Withdrawal by Subject|2|||
125569771|NCT00950664|451713795|FG001|First Intervention|Withdrawal by Subject|2|||
125569772|NCT02821715|451713797|FG000|Overall Study|Protocol Violation|1|||
125569773|NCT02821715|451713798|FG001|Overall Study|Protocol Violation|0|||
125569774|NCT02821715|451713799|FG002|Overall Study|Protocol Violation|0|||
125569775|NCT02821715|451713800|FG003|Overall Study|Protocol Violation|0|||
125569776|NCT02821715|451713801|FG004|Overall Study|Protocol Violation|0|||
125569777|NCT02821715|451713802|FG005|Overall Study|Protocol Violation|0|||
125569778|NCT00640328|451713803|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
125569779|NCT00640328|451713804|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
125569780|NCT00640328|451713805|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
125569781|NCT00640328|451713806|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
125569782|NCT00640328|451713807|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
125569783|NCT00640328|451713808|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
125569784|NCT00640328|451713803|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
125569785|NCT00640328|451713804|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
125569786|NCT00640328|451713805|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
125569787|NCT00640328|451713806|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
125569788|NCT00640328|451713807|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
125569789|NCT00640328|451713808|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
125569790|NCT00640328|451713803|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
125569791|NCT00640328|451713804|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
125569792|NCT00640328|451713805|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
125569793|NCT00640328|451713806|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
125569794|NCT00640328|451713807|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
125569795|NCT00640328|451713808|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
125569796|NCT00640328|451713803|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
125569797|NCT00640328|451713804|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
125569798|NCT00640328|451713805|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
125569799|NCT00640328|451713806|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
125569800|NCT00640328|451713807|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
125569801|NCT00640328|451713808|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
125569802|NCT01326546|451713809|FG000|Overall Study|Lost to Follow-up|8|||
125569803|NCT01326546|451713810|FG001|Overall Study|Lost to Follow-up|7|||
125569804|NCT01326546|451713809|FG000|Overall Study|Protocol Violation|3|||
125569805|NCT01326546|451713810|FG001|Overall Study|Protocol Violation|4|||
125569806|NCT01326546|451713809|FG000|Overall Study|Pregnancy|0|||
125569807|NCT01326546|451713810|FG001|Overall Study|Pregnancy|1|||
125569808|NCT01326546|451713809|FG000|Overall Study|Adverse Event|1|||
125569809|NCT01326546|451713810|FG001|Overall Study|Adverse Event|0|||
125569810|NCT01326546|451713809|FG000|Overall Study|Withdrawal by Subject|5|||
125569811|NCT01326546|451713810|FG001|Overall Study|Withdrawal by Subject|1|||
125569812|NCT04294719|451713811|FG000|Overall Study|Withdrawal by Subject|1|||
125569813|NCT01714687|451713812|FG000|Overall Study|Withdrawal by Subject|1|||
125569814|NCT01714687|451713813|FG001|Overall Study|Withdrawal by Subject|0|||
125569815|NCT01714687|451713812|FG000|Overall Study|Lost to Follow-up|2|||
125569816|NCT01714687|451713813|FG001|Overall Study|Lost to Follow-up|4|||
125569817|NCT01979536|451713819|FG000|Overall Study|Physician Decision|2|||
125569818|NCT01979536|451713820|FG001|Overall Study|Physician Decision|3|||
125569819|NCT01979536|451713819|FG000|Overall Study|Withdrawal by Subject|0|||
125569820|NCT01979536|451713820|FG001|Overall Study|Withdrawal by Subject|1|||
125569821|NCT01979536|451713819|FG000|Overall Study|Refusal|0|||
125569822|NCT01979536|451713820|FG001|Overall Study|Refusal|1|||
125569823|NCT01979536|451713819|FG000|Overall Study|Relapse|0|||
125569824|NCT01979536|451713820|FG001|Overall Study|Relapse|1|||
125569825|NCT01979536|451713819|FG000|Overall Study|Study terminated by Sponsor|0|||
125569826|NCT01979536|451713820|FG001|Overall Study|Study terminated by Sponsor|1|||
125569827|NCT01979536|451713819|FG000|Overall Study|Did not start treatment|0|||
125569828|NCT01979536|451713820|FG001|Overall Study|Did not start treatment|1|||
125569829|NCT05038020|451713821|FG000|Overall Study|Early Termination|3|||
125569830|NCT05038020|451713822|FG001|Overall Study|Early Termination|0|||
125569831|NCT00609791|451715760|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
125569832|NCT02484911|451715761|FG000|Overall Study|Withdrawal by Subject|2|||
125569833|NCT02484911|451715762|FG001|Overall Study|Withdrawal by Subject|1|||
125569834|NCT02484911|451715761|FG000|Overall Study|Protocol Violation|2|||
125569835|NCT02484911|451715762|FG001|Overall Study|Protocol Violation|1|||
125569836|NCT04129528|451715763|FG000|Overall Study|Adverse Event|1|||
125569837|NCT04129528|451715764|FG001|Overall Study|Adverse Event|0|||
125569838|NCT04129528|451715763|FG000|Overall Study|Physician Decision|1|||
125569839|NCT04129528|451715764|FG001|Overall Study|Physician Decision|1|||
125569840|NCT04129528|451715763|FG000|Overall Study|Withdrawal by Subject|1|||
125569841|NCT04129528|451715764|FG001|Overall Study|Withdrawal by Subject|1|||
125569842|NCT01964352|451715769|FG000|Overall Study|Adverse Event|13|||
125569843|NCT01964352|451715770|FG001|Overall Study|Adverse Event|3|||
125569844|NCT01964352|451715771|FG002|Overall Study|Adverse Event|4|||
125569845|NCT01964352|451715772|FG003|Overall Study|Adverse Event|3|||
125569846|NCT01964352|451715769|FG000|Overall Study|Lack of Efficacy|6|||
125569847|NCT01964352|451715770|FG001|Overall Study|Lack of Efficacy|0|||
125569848|NCT01964352|451715771|FG002|Overall Study|Lack of Efficacy|0|||
125569849|NCT01964352|451715772|FG003|Overall Study|Lack of Efficacy|0|||
125569850|NCT01964352|451715769|FG000|Overall Study|Protocol Violation|2|||
125569851|NCT01964352|451715770|FG001|Overall Study|Protocol Violation|4|||
125569852|NCT01964352|451715771|FG002|Overall Study|Protocol Violation|0|||
125569853|NCT01964352|451715772|FG003|Overall Study|Protocol Violation|2|||
125569854|NCT01964352|451715769|FG000|Overall Study|Lost to Follow-up|1|||
125569855|NCT01964352|451715770|FG001|Overall Study|Lost to Follow-up|0|||
125569856|NCT01964352|451715771|FG002|Overall Study|Lost to Follow-up|0|||
125569857|NCT01964352|451715772|FG003|Overall Study|Lost to Follow-up|1|||
125569858|NCT01964352|451715769|FG000|Overall Study|Withdrawal by Subject|4|||
125569859|NCT01964352|451715770|FG001|Overall Study|Withdrawal by Subject|2|||
125569860|NCT01964352|451715771|FG002|Overall Study|Withdrawal by Subject|1|||
125569861|NCT01964352|451715772|FG003|Overall Study|Withdrawal by Subject|0|||
125569862|NCT01964352|451715769|FG000|Overall Study|Other than stated above|0|||
125569863|NCT01964352|451715770|FG001|Overall Study|Other than stated above|2|||
125569864|NCT01964352|451715771|FG002|Overall Study|Other than stated above|1|||
125569865|NCT01964352|451715772|FG003|Overall Study|Other than stated above|2|||
125569866|NCT00477165|451715775|FG000|Overall Study|Adverse Event|7|||
125569867|NCT00477165|451715776|FG001|Overall Study|Adverse Event|2|||
125569868|NCT00105443|451715777|FG000|Double-Blind Treatment|Adverse Event|1|||
125569869|NCT00105443|451715778|FG001|Double-Blind Treatment|Adverse Event|0|||
125569870|NCT00105443|451715779|FG002|Double-Blind Treatment|Adverse Event|0|||
125569871|NCT00105443|451715780|FG003|Double-Blind Treatment|Adverse Event|0|||
125569872|NCT00105443|451715777|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
125569873|NCT00105443|451715778|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
125569874|NCT00105443|451715779|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
125569875|NCT00105443|451715780|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
125569876|NCT00105443|451715777|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
125569877|NCT00105443|451715778|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
125569878|NCT00105443|451715779|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
125569879|NCT00105443|451715780|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
125569880|NCT00105443|451715777|FG000|Double-Blind Treatment|Physician Decision|1|||
125569881|NCT00105443|451715778|FG001|Double-Blind Treatment|Physician Decision|0|||
125569882|NCT00105443|451715779|FG002|Double-Blind Treatment|Physician Decision|2|||
125569883|NCT00105443|451715780|FG003|Double-Blind Treatment|Physician Decision|0|||
125569884|NCT00105443|451715777|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
125569885|NCT00105443|451715778|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
125569886|NCT00105443|451715779|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
125569887|NCT00105443|451715780|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
125569888|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
125569889|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
125569890|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
125569891|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
125569892|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
125569893|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
125569894|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
125569895|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
125569896|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
125569897|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
125569898|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
125569899|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
125569900|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
125569901|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
125569902|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
125569903|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
125569904|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
125569905|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
125569906|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
125569907|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
125569908|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
125569909|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
125569910|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
125569911|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
125569912|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
125569913|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
125569914|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
125569915|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
125569916|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
125569917|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
125569918|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
125569919|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
125569920|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
125569921|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
125569922|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
125569923|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
125569924|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
125569925|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
125569926|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
125569927|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
125569928|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
125569929|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
125569930|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
125569931|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
125569932|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
125569933|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
125569934|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
125569935|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
125569936|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
125569937|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
125569938|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
125569939|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
125569940|NCT00105443|451715777|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
125569941|NCT00105443|451715778|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
125569942|NCT00105443|451715779|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
125569943|NCT00105443|451715780|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
125569944|NCT02135692|451715781|FG000|Overall Study|Adverse Event|3|||
125569945|NCT02135692|451715781|FG000|Overall Study|Lack of Efficacy|2|||
125569946|NCT02135692|451715781|FG000|Overall Study|Protocol Violation|2|||
125569947|NCT02135692|451715781|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
125569948|NCT02135692|451715781|FG000|Overall Study|Product commercially available|159|||
125358078|NCT02927262|450946326|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
125358079|NCT02927262|450946327|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
125569949|NCT02135692|451715781|FG000|Overall Study|Study closed/terminated|153|||
125569950|NCT02135692|451715781|FG000|Overall Study|Lost to Follow-up|4|||
125569951|NCT02135692|451715781|FG000|Overall Study|Withdrawal by Subject|15|||
125569952|NCT01157078|451715782|FG000|Overall Study|Withdrawal by Subject|12|||
125569953|NCT01157078|451715783|FG001|Overall Study|Withdrawal by Subject|14|||
125569954|NCT01157078|451715782|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125569955|NCT01157078|451715783|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125569956|NCT01157078|451715782|FG000|Overall Study|Adverse Event|6|||
125569957|NCT01157078|451715783|FG001|Overall Study|Adverse Event|6|||
125569958|NCT01157078|451715782|FG000|Overall Study|Severe non-compliance to protocol|2|||
125569959|NCT01157078|451715783|FG001|Overall Study|Severe non-compliance to protocol|4|||
125569960|NCT01157078|451715782|FG000|Overall Study|Condition under investigation worsened|0|||
125569961|NCT01157078|451715783|FG001|Overall Study|Condition under investigation worsened|1|||
125569962|NCT01157078|451715782|FG000|Overall Study|Lack of Efficacy|2|||
125569963|NCT01157078|451715783|FG001|Overall Study|Lack of Efficacy|0|||
125569964|NCT01157078|451715782|FG000|Overall Study|Study-specific withdrawal criteria|2|||
125569965|NCT01157078|451715783|FG001|Overall Study|Study-specific withdrawal criteria|2|||
125569966|NCT01157078|451715782|FG000|Overall Study|Lost to Follow-up|7|||
125569967|NCT01157078|451715783|FG001|Overall Study|Lost to Follow-up|5|||
125569968|NCT01157078|451715782|FG000|Overall Study|Other|2|||
125569969|NCT01157078|451715783|FG001|Overall Study|Other|4|||
125569970|NCT04429061|451715786|FG000|Overall Study|Lost to Follow-up|62|||
125569971|NCT04429061|451715787|FG001|Overall Study|Lost to Follow-up|87|||
125569972|NCT04429061|451715786|FG000|Overall Study|Withdrawal by Subject|3|||
125569973|NCT04429061|451715787|FG001|Overall Study|Withdrawal by Subject|4|||
125569974|NCT00879229|451715793|FG000|Overall Study|Study terminated by Sponsor|13|||
125569975|NCT00879229|451715794|FG001|Overall Study|Study terminated by Sponsor|12|||
125569976|NCT00879229|451715793|FG000|Overall Study|Death|4|||
125569977|NCT00879229|451715794|FG001|Overall Study|Death|2|||
125569978|NCT00879229|451715793|FG000|Overall Study|Adverse Event|2|||
125569979|NCT00879229|451715794|FG001|Overall Study|Adverse Event|0|||
125569980|NCT00879229|451715793|FG000|Overall Study|Withdrawal by Subject|1|||
125569981|NCT00879229|451715794|FG001|Overall Study|Withdrawal by Subject|0|||
125569982|NCT00879229|451715793|FG000|Overall Study|Clinical status did not improve|1|||
125569983|NCT00879229|451715794|FG001|Overall Study|Clinical status did not improve|0|||
125569984|NCT00879229|451715793|FG000|Overall Study|Other|1|||
125569985|NCT00879229|451715794|FG001|Overall Study|Other|0|||
125569986|NCT01097746|451715795|FG000|Overall Study|Adverse Event|4|||
125569987|NCT01097746|451715795|FG000|Overall Study|taken off study before any treatment given|1|||
125569988|NCT00390546|451715802|FG000|Overall Study|Renal impairment|1|||
125569989|NCT00390546|451715803|FG001|Overall Study|Renal impairment|0|||
125569990|NCT00390546|451715802|FG000|Overall Study|Physician Decision|5|||
125569991|NCT00390546|451715803|FG001|Overall Study|Physician Decision|5|||
125569992|NCT00631371|451715804|FG000|Overall Study|Lost to Follow-up|24|||
125569993|NCT00631371|451715805|FG001|Overall Study|Lost to Follow-up|19|||
125569994|NCT00631371|451715804|FG000|Overall Study|Other reason|5|||
125569995|NCT00631371|451715805|FG001|Overall Study|Other reason|12|||
125569996|NCT00631371|451715804|FG000|Overall Study|subject request|38|||
125569997|NCT00631371|451715805|FG001|Overall Study|subject request|45|||
125569998|NCT00631371|451715804|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
125569999|NCT00631371|451715805|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
125570000|NCT00631371|451715804|FG000|Overall Study|Death|263|||
125570001|NCT00631371|451715805|FG001|Overall Study|Death|239|||
125570002|NCT00812214|451715814|FG000|Overall Study|Lost to Follow-up|3|||
125570003|NCT00812214|451715815|FG001|Overall Study|Lost to Follow-up|1|||
125570004|NCT02145741|451715817|FG000|Overall Study|Progressive disease|3|||
125570005|NCT02145741|451715818|FG001|Overall Study|Progressive disease|6|||
125570006|NCT02145741|451715819|FG002|Overall Study|Progressive disease|6|||
125570007|NCT02145741|451715817|FG000|Overall Study|quality issue with the administered drug|3|||
125570008|NCT02145741|451715818|FG001|Overall Study|quality issue with the administered drug|0|||
125570009|NCT02145741|451715819|FG002|Overall Study|quality issue with the administered drug|0|||
125570010|NCT01192022|451715820|FG000|Overall Study|Withdrawal of Consent|3|||
125570011|NCT01192022|451715821|FG001|Overall Study|Withdrawal of Consent|1|||
125570012|NCT01192022|451715822|FG002|Overall Study|Withdrawal of Consent|0|||
125570013|NCT01192022|451715823|FG003|Overall Study|Withdrawal of Consent|0|||
125570014|NCT01192022|451715824|FG004|Overall Study|Withdrawal of Consent|0|||
125570015|NCT01192022|451715820|FG000|Overall Study|Lost to Follow-up|4|||
125570016|NCT01192022|451715821|FG001|Overall Study|Lost to Follow-up|2|||
125570017|NCT01192022|451715822|FG002|Overall Study|Lost to Follow-up|1|||
125570018|NCT01192022|451715823|FG003|Overall Study|Lost to Follow-up|1|||
125570019|NCT01192022|451715824|FG004|Overall Study|Lost to Follow-up|0|||
125570020|NCT01192022|451715820|FG000|Overall Study|Adverse Event|1|||
125570021|NCT01192022|451715821|FG001|Overall Study|Adverse Event|0|||
125570022|NCT01192022|451715822|FG002|Overall Study|Adverse Event|0|||
125426843|NCT04642898|451188013|FG002|Overall Study|Lost to Follow-up|0|||
125426844|NCT04642898|451188014|FG003|Overall Study|Lost to Follow-up|2|||
125426845|NCT04642898|451188015|FG004|Overall Study|Lost to Follow-up|0|||
125426846|NCT04642898|451188016|FG005|Overall Study|Lost to Follow-up|1|||
125426847|NCT04642898|451188011|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
125426848|NCT04642898|451188012|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
125426849|NCT04642898|451188013|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
125426850|NCT04642898|451188014|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
125426851|NCT04642898|451188015|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
125426852|NCT04642898|451188016|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
125426853|NCT04642898|451188011|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
125426854|NCT04642898|451188012|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
125426855|NCT04642898|451188013|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
125426856|NCT04642898|451188014|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
125426857|NCT04642898|451188015|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
125426858|NCT04642898|451188016|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
125426859|NCT03574597|451188017|FG000|Overall Study|Withdrawal by Subject|67|||
125426860|NCT03574597|451188018|FG001|Overall Study|Withdrawal by Subject|96|||
125426861|NCT03574597|451188017|FG000|Overall Study|Lost to Follow-up|192|||
125426862|NCT03574597|451188018|FG001|Overall Study|Lost to Follow-up|188|||
125570023|NCT01192022|451715823|FG003|Overall Study|Adverse Event|0|||
125570024|NCT01192022|451715824|FG004|Overall Study|Adverse Event|0|||
125570025|NCT01192022|451715820|FG000|Overall Study|Fatal Adverse Event|4|||
125570026|NCT01192022|451715821|FG001|Overall Study|Fatal Adverse Event|6|||
125570027|NCT01192022|451715822|FG002|Overall Study|Fatal Adverse Event|0|||
125570028|NCT01192022|451715823|FG003|Overall Study|Fatal Adverse Event|0|||
125570029|NCT01192022|451715824|FG004|Overall Study|Fatal Adverse Event|1|||
125570030|NCT01192022|451715820|FG000|Overall Study|Physician withdrew-patient hardship|1|||
125570031|NCT01192022|451715821|FG001|Overall Study|Physician withdrew-patient hardship|0|||
125570032|NCT01192022|451715822|FG002|Overall Study|Physician withdrew-patient hardship|0|||
125570033|NCT01192022|451715823|FG003|Overall Study|Physician withdrew-patient hardship|0|||
125570034|NCT01192022|451715824|FG004|Overall Study|Physician withdrew-patient hardship|0|||
125570035|NCT01192022|451715820|FG000|Overall Study|Patient too sick from chemotherapy|0|||
125570036|NCT01192022|451715821|FG001|Overall Study|Patient too sick from chemotherapy|1|||
125570037|NCT01192022|451715822|FG002|Overall Study|Patient too sick from chemotherapy|0|||
125570038|NCT01192022|451715823|FG003|Overall Study|Patient too sick from chemotherapy|0|||
125570039|NCT01192022|451715824|FG004|Overall Study|Patient too sick from chemotherapy|0|||
125570040|NCT01192022|451715820|FG000|Overall Study|Patient needed surgery|0|||
125570041|NCT01192022|451715821|FG001|Overall Study|Patient needed surgery|1|||
125570042|NCT01192022|451715822|FG002|Overall Study|Patient needed surgery|0|||
125570043|NCT01192022|451715823|FG003|Overall Study|Patient needed surgery|0|||
125570044|NCT01192022|451715824|FG004|Overall Study|Patient needed surgery|0|||
125570045|NCT01192022|451715820|FG000|Overall Study|Parents did not allow all follow up|0|||
125570046|NCT01192022|451715821|FG001|Overall Study|Parents did not allow all follow up|0|||
125570047|NCT01192022|451715822|FG002|Overall Study|Parents did not allow all follow up|0|||
125570048|NCT01192022|451715823|FG003|Overall Study|Parents did not allow all follow up|1|||
125570049|NCT01192022|451715824|FG004|Overall Study|Parents did not allow all follow up|0|||
125570050|NCT00129766|451715826|FG000|Overall Study|Death|3|||
125570051|NCT00129766|451715827|FG001|Overall Study|Death|8|||
125570052|NCT00129766|451715826|FG000|Overall Study|Withdrawal of consent|31|||
125570053|NCT00129766|451715827|FG001|Overall Study|Withdrawal of consent|30|||
125570054|NCT00129766|451715826|FG000|Overall Study|Lost to Follow-up|26|||
125570055|NCT00129766|451715827|FG001|Overall Study|Lost to Follow-up|21|||
125570056|NCT03865706|451715829|FG000|Overall Study|Death|0|||
125570057|NCT03865706|451715830|FG001|Overall Study|Death|3|||
125570058|NCT03865706|451715831|FG002|Overall Study|Death|1|||
125570059|NCT01594853|451715832|FG000|Overall Study|Withdrawal by Subject|1|||
125570060|NCT01594853|451715833|FG001|Overall Study|Withdrawal by Subject|1|||
125570061|NCT01594853|451715832|FG000|Overall Study|Lost to Follow-up|1|||
125570062|NCT01594853|451715833|FG001|Overall Study|Lost to Follow-up|1|||
125570063|NCT01594853|451715832|FG000|Overall Study|noncompliance with exercise|0|||
125570064|NCT01594853|451715833|FG001|Overall Study|noncompliance with exercise|1|||
125570065|NCT03709654|451715834|FG000|Overall Study|Lost to Follow-up|1|||
125570066|NCT03709654|451715835|FG001|Overall Study|Lost to Follow-up|1|||
125570067|NCT03709654|451715834|FG000|Overall Study|Withdrawal by Subject|1|||
125570068|NCT03709654|451715835|FG001|Overall Study|Withdrawal by Subject|1|||
125570069|NCT03709654|451715834|FG000|Overall Study|Adverse Event|1|||
125570070|NCT03709654|451715835|FG001|Overall Study|Adverse Event|0|||
125570071|NCT02631200|451715838|FG000|First Period|Death|1|||
125570072|NCT02631200|451715839|FG001|First Period|Death|2|||
125570073|NCT02631200|451715838|FG000|First Period|Patient ill-health|2|||
125570074|NCT02631200|451715839|FG001|First Period|Patient ill-health|4|||
125570075|NCT02631200|451715838|FG000|First Period|Withdrawal by Subject|4|||
125570076|NCT02631200|451715839|FG001|First Period|Withdrawal by Subject|1|||
125570077|NCT02631200|451715838|FG000|Deferred Period|Death|0|||
125570078|NCT02631200|451715839|FG001|Deferred Period|Death|1|||
125570079|NCT02631200|451715838|FG000|Deferred Period|Received kidney transplant|0|||
125570080|NCT02631200|451715839|FG001|Deferred Period|Received kidney transplant|1|||
125570081|NCT02631200|451715838|FG000|Deferred Period|Withdrawal by Subject|0|||
125570082|NCT02631200|451715839|FG001|Deferred Period|Withdrawal by Subject|2|||
125570083|NCT02631200|451715838|FG000|Deferred Period|Lost to Follow-up|0|||
125570084|NCT02631200|451715839|FG001|Deferred Period|Lost to Follow-up|1|||
125570085|NCT01081912|451715841|FG000|Conversion/Titration|Adverse Event|47|||
125570086|NCT01081912|451715842|FG001|Conversion/Titration|Adverse Event|0|||
125570087|NCT01081912|451715843|FG002|Conversion/Titration|Adverse Event|0|||
125570088|NCT01081912|451715841|FG000|Conversion/Titration|Lack of Efficacy|17|||
125570089|NCT01081912|451715842|FG001|Conversion/Titration|Lack of Efficacy|0|||
125570090|NCT01081912|451715843|FG002|Conversion/Titration|Lack of Efficacy|0|||
125570091|NCT01081912|451715841|FG000|Conversion/Titration|Lost to Follow-up|5|||
125570092|NCT01081912|451715842|FG001|Conversion/Titration|Lost to Follow-up|0|||
125570093|NCT01081912|451715843|FG002|Conversion/Titration|Lost to Follow-up|0|||
125570094|NCT01081912|451715841|FG000|Conversion/Titration|Physician Decision|2|||
125570095|NCT01081912|451715842|FG001|Conversion/Titration|Physician Decision|0|||
125570096|NCT01081912|451715843|FG002|Conversion/Titration|Physician Decision|0|||
125570097|NCT01081912|451715841|FG000|Conversion/Titration|Protocol Violation|67|||
125570098|NCT01081912|451715842|FG001|Conversion/Titration|Protocol Violation|0|||
125570099|NCT01081912|451715843|FG002|Conversion/Titration|Protocol Violation|0|||
125570100|NCT01081912|451715841|FG000|Conversion/Titration|Withdrawal by Subject|23|||
125570101|NCT01081912|451715842|FG001|Conversion/Titration|Withdrawal by Subject|0|||
125570102|NCT01081912|451715843|FG002|Conversion/Titration|Withdrawal by Subject|0|||
125570103|NCT01081912|451715841|FG000|Conversion/Titration|Non-Compliance|47|||
125570104|NCT01081912|451715842|FG001|Conversion/Titration|Non-Compliance|0|||
125570105|NCT01081912|451715843|FG002|Conversion/Titration|Non-Compliance|0|||
125570106|NCT01081912|451715841|FG000|Maintenance Treatment|Adverse Event|0|||
125570107|NCT01081912|451715842|FG001|Maintenance Treatment|Adverse Event|2|||
125570108|NCT01081912|451715843|FG002|Maintenance Treatment|Adverse Event|12|||
125570109|NCT01081912|451715841|FG000|Maintenance Treatment|Lack of Efficacy|0|||
125570110|NCT01081912|451715842|FG001|Maintenance Treatment|Lack of Efficacy|14|||
125570111|NCT01081912|451715843|FG002|Maintenance Treatment|Lack of Efficacy|64|||
125570112|NCT01081912|451715841|FG000|Maintenance Treatment|Lost to Follow-up|0|||
125570113|NCT01081912|451715842|FG001|Maintenance Treatment|Lost to Follow-up|1|||
125570114|NCT01081912|451715843|FG002|Maintenance Treatment|Lost to Follow-up|0|||
125570115|NCT01081912|451715841|FG000|Maintenance Treatment|Physician Decision|0|||
125570116|NCT01081912|451715842|FG001|Maintenance Treatment|Physician Decision|0|||
125570117|NCT01081912|451715843|FG002|Maintenance Treatment|Physician Decision|1|||
125570118|NCT01081912|451715841|FG000|Maintenance Treatment|Protocol Violation|0|||
125570119|NCT01081912|451715842|FG001|Maintenance Treatment|Protocol Violation|1|||
125570120|NCT01081912|451715843|FG002|Maintenance Treatment|Protocol Violation|2|||
125570121|NCT01081912|451715841|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
125570122|NCT01081912|451715842|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
125570123|NCT01081912|451715843|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
125570124|NCT01081912|451715841|FG000|Maintenance Treatment|Non-Compliance|0|||
125570125|NCT01081912|451715842|FG001|Maintenance Treatment|Non-Compliance|4|||
125570126|NCT01081912|451715843|FG002|Maintenance Treatment|Non-Compliance|7|||
125570127|NCT01081912|451715841|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
125570128|NCT01081912|451715842|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
125570129|NCT01081912|451715843|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
125570130|NCT03776175|451715846|FG000|Treatment Period (42 Days)|Adverse Event|0|||
125570131|NCT03776175|451715847|FG001|Treatment Period (42 Days)|Adverse Event|1|||
125570132|NCT03776175|451715848|FG002|Treatment Period (42 Days)|Adverse Event|1|||
125570133|NCT03776175|451715849|FG003|Treatment Period (42 Days)|Adverse Event|0|||
125570134|NCT03776175|451715846|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
125570135|NCT03776175|451715847|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
125570136|NCT03776175|451715848|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
125570137|NCT03776175|451715849|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
125570138|NCT03776175|451715846|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
125570139|NCT03776175|451715847|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
125570140|NCT03776175|451715848|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
125358080|NCT02927262|450946326|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
125570141|NCT03776175|451715849|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
125570142|NCT03776175|451715846|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
125570143|NCT03776175|451715847|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
125570144|NCT03776175|451715848|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
125570145|NCT03776175|451715849|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
125570146|NCT03776175|451715846|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
125570147|NCT03776175|451715847|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
125570148|NCT03776175|451715848|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
125570149|NCT03776175|451715849|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
125570150|NCT03776175|451715846|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
125570151|NCT03776175|451715847|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
125570152|NCT03776175|451715848|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
125570153|NCT03776175|451715849|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
125570154|NCT04677712|451715850|FG000|Overall Study|Lost to Follow-up|0|||
125570155|NCT04677712|451715851|FG001|Overall Study|Lost to Follow-up|1|||
125570156|NCT04677712|451715852|FG002|Overall Study|Lost to Follow-up|0|||
125570157|NCT04677712|451715853|FG003|Overall Study|Lost to Follow-up|0|||
125570158|NCT04677712|451715854|FG004|Overall Study|Lost to Follow-up|0|||
125570159|NCT04677712|451715855|FG005|Overall Study|Lost to Follow-up|0|||
125570160|NCT00711100|451715856|FG000|Overall Study|Lack of Efficacy|5|||
125570161|NCT00711100|451715856|FG000|Overall Study|Withdrawal by Subject|8|||
125570162|NCT02513329|451715857|FG000|Overall Study|Lost to Follow-up|5|||
125570163|NCT02513329|451715858|FG001|Overall Study|Lost to Follow-up|2|||
125570164|NCT01294670|451715859|FG000|Overall Study|Not treated|1|||
125570165|NCT01294670|451715860|FG001|Overall Study|Not treated|0|||
125570166|NCT01294670|451715861|FG002|Overall Study|Not treated|0|||
125570167|NCT01294670|451715862|FG003|Overall Study|Not treated|0|||
125570168|NCT01294670|451715863|FG004|Overall Study|Not treated|0|||
125570169|NCT02083380|451715867|FG000|Overall Study|Lack of Efficacy|68|||
125570170|NCT02083380|451715868|FG001|Overall Study|Lack of Efficacy|79|||
125570171|NCT02083380|451715869|FG002|Overall Study|Lack of Efficacy|64|||
125570172|NCT02083380|451715867|FG000|Overall Study|Withdrawal by Subject|9|||
125570173|NCT02083380|451715868|FG001|Overall Study|Withdrawal by Subject|3|||
125570174|NCT02083380|451715869|FG002|Overall Study|Withdrawal by Subject|7|||
125570175|NCT02083380|451715867|FG000|Overall Study|Physician Decision|1|||
125570176|NCT02083380|451715868|FG001|Overall Study|Physician Decision|6|||
125570177|NCT02083380|451715869|FG002|Overall Study|Physician Decision|3|||
125570178|NCT02083380|451715867|FG000|Overall Study|Adverse Event|0|||
125570179|NCT02083380|451715868|FG001|Overall Study|Adverse Event|0|||
125570180|NCT02083380|451715869|FG002|Overall Study|Adverse Event|1|||
125570181|NCT02083380|451715867|FG000|Overall Study|Lost to Follow-up|5|||
125570182|NCT02083380|451715868|FG001|Overall Study|Lost to Follow-up|3|||
125570183|NCT02083380|451715869|FG002|Overall Study|Lost to Follow-up|3|||
125570184|NCT02083380|451715867|FG000|Overall Study|Other|8|||
125570185|NCT02083380|451715868|FG001|Overall Study|Other|4|||
125570186|NCT02083380|451715869|FG002|Overall Study|Other|6|||
125570187|NCT02412787|451715870|FG000|Overall Study|Withdrawal by Subject|9|||
125358081|NCT02927262|450946327|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
125358082|NCT02927262|450946326|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
125358083|NCT02927262|450946327|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
125358084|NCT02927262|450946326|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
125358085|NCT02927262|450946327|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
125426863|NCT03434678|451188019|FG000|Overall Study|Withdrawal by Subject|13|||
125570188|NCT02412787|451715870|FG000|Overall Study|Participation Terminated by Investigator|1|||
125570189|NCT02412787|451715870|FG000|Overall Study|Site Terminated by Sponsor|21|||
125570190|NCT02412787|451715870|FG000|Overall Study|Technical Problems|1|||
125570191|NCT02412787|451715870|FG000|Overall Study|Reason Not Specified|1|||
125570192|NCT00405067|451715878|FG000|Overall Study|Adverse Event|4|||
125570193|NCT00405067|451715879|FG001|Overall Study|Adverse Event|9|||
125570194|NCT00405067|451715880|FG002|Overall Study|Adverse Event|4|||
125570195|NCT00405067|451715878|FG000|Overall Study|Lost to Follow-up|0|||
125570196|NCT00405067|451715879|FG001|Overall Study|Lost to Follow-up|0|||
125570197|NCT00405067|451715880|FG002|Overall Study|Lost to Follow-up|1|||
125570198|NCT01650636|451715881|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
125570199|NCT01650636|451715882|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
125570200|NCT01650636|451715881|FG000|Washout up to 5 Months|Physician Decision|2|||
125570201|NCT01650636|451715882|FG001|Washout up to 5 Months|Physician Decision|2|||
125570202|NCT01650636|451715881|FG000|Washout up to 5 Months|Death|1|||
125570203|NCT01650636|451715882|FG001|Washout up to 5 Months|Death|0|||
125570204|NCT01650636|451715881|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
125570205|NCT01650636|451715882|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
125570206|NCT01650636|451715881|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
125570207|NCT01650636|451715882|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
125570208|NCT01650636|451715881|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
125570209|NCT01650636|451715882|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
125570210|NCT01560780|451715883|FG000|Overall Study|Death|2|||
125570211|NCT01560780|451715884|FG001|Overall Study|Death|1|||
125570212|NCT01560780|451715883|FG000|Overall Study|Patient Preference|11|||
125570213|NCT01560780|451715884|FG001|Overall Study|Patient Preference|11|||
125570214|NCT01577186|451715885|FG000|Overall Study|Adverse Event|23|||
125570215|NCT01577186|451715885|FG000|Overall Study|Death|1|||
125570216|NCT01577186|451715885|FG000|Overall Study|Lost to Follow-up|28|||
125570217|NCT01577186|451715885|FG000|Overall Study|Withdrawal by Subject|35|||
125570218|NCT01577186|451715885|FG000|Overall Study|Insufficient Response|18|||
125570219|NCT01577186|451715885|FG000|Overall Study|Ineligible to Continue|15|||
125570220|NCT01577186|451715885|FG000|Overall Study|Non-Compliant|8|||
125570221|NCT01577186|451715885|FG000|Overall Study|Other|2|||
125570222|NCT01032915|451715886|FG000|Overall Study|Adverse Event|2|||
125570223|NCT01032915|451715887|FG001|Overall Study|Adverse Event|2|||
125570224|NCT01032915|451715888|FG002|Overall Study|Adverse Event|1|||
125570225|NCT01032915|451715889|FG003|Overall Study|Adverse Event|1|||
125570226|NCT01032915|451715886|FG000|Overall Study|Abnormal test procedure result|0|||
125570227|NCT01032915|451715887|FG001|Overall Study|Abnormal test procedure result|0|||
125570228|NCT01032915|451715888|FG002|Overall Study|Abnormal test procedure result|1|||
125570229|NCT01032915|451715889|FG003|Overall Study|Abnormal test procedure result|0|||
125570230|NCT01032915|451715886|FG000|Overall Study|Withdrawal by Subject|0|||
125570231|NCT01032915|451715887|FG001|Overall Study|Withdrawal by Subject|3|||
125570232|NCT01032915|451715888|FG002|Overall Study|Withdrawal by Subject|1|||
125570233|NCT01032915|451715889|FG003|Overall Study|Withdrawal by Subject|1|||
125570234|NCT01032915|451715886|FG000|Overall Study|Administrative reasons|5|||
125570235|NCT01032915|451715887|FG001|Overall Study|Administrative reasons|6|||
125570236|NCT01032915|451715888|FG002|Overall Study|Administrative reasons|4|||
125570237|NCT01032915|451715889|FG003|Overall Study|Administrative reasons|4|||
125570238|NCT01032915|451715886|FG000|Overall Study|Protocol Violation|1|||
125570239|NCT01032915|451715887|FG001|Overall Study|Protocol Violation|0|||
125570240|NCT01032915|451715888|FG002|Overall Study|Protocol Violation|0|||
125570241|NCT01032915|451715889|FG003|Overall Study|Protocol Violation|1|||
125570242|NCT02915523|451715891|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
125570243|NCT02915523|451715892|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
125570244|NCT02915523|451715893|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
125570245|NCT02915523|451715894|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
125570246|NCT02915523|451715891|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
125570247|NCT02915523|451715892|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
125570248|NCT02915523|451715893|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
125570249|NCT02915523|451715894|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
125570250|NCT02915523|451715891|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
125570251|NCT02915523|451715892|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
125570252|NCT02915523|451715893|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
125570253|NCT02915523|451715894|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
125570254|NCT02915523|451715891|FG000|Expansion Phase (Phase 2)|Death|0|||
125570255|NCT02915523|451715892|FG001|Expansion Phase (Phase 2)|Death|0|||
125570256|NCT02915523|451715893|FG002|Expansion Phase (Phase 2)|Death|26|||
125570257|NCT02915523|451715894|FG003|Expansion Phase (Phase 2)|Death|53|||
125570258|NCT02915523|451715891|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
125570259|NCT02915523|451715892|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
125570260|NCT02915523|451715893|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
125570261|NCT02915523|451715894|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
125570262|NCT02915523|451715891|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
125570263|NCT02915523|451715892|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
125570264|NCT02915523|451715893|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
125570265|NCT02915523|451715894|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
125570266|NCT02915523|451715891|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
125570267|NCT02915523|451715892|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
125570268|NCT02915523|451715893|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
125570269|NCT02915523|451715894|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
125570270|NCT00930761|451715895|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
125570271|NCT00930761|451715896|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
125570272|NCT00930761|451715895|FG000|Overall Study|less than 3 music therapy sessions|0|||
125570273|NCT00930761|451715896|FG001|Overall Study|less than 3 music therapy sessions|3|||
125570274|NCT00915681|451715897|FG000|Overall Study|Screening failures|46|||
125358086|NCT02927262|450946326|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
125358087|NCT02927262|450946327|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
125358088|NCT02927262|450946326|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
125358089|NCT02927262|450946327|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
125358090|NCT02927262|450946326|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
125570275|NCT00957008|451715898|FG000|Overall Study|Withdrawal by Subject|13|||
125570276|NCT00957008|451715899|FG001|Overall Study|Withdrawal by Subject|10|||
125570277|NCT00957008|451715900|FG002|Overall Study|Withdrawal by Subject|12|||
125570278|NCT00957008|451715901|FG003|Overall Study|Withdrawal by Subject|16|||
125570279|NCT00957008|451715898|FG000|Overall Study|Lost to Follow-up|3|||
125570280|NCT00957008|451715899|FG001|Overall Study|Lost to Follow-up|1|||
125570281|NCT00957008|451715900|FG002|Overall Study|Lost to Follow-up|3|||
125570282|NCT00957008|451715901|FG003|Overall Study|Lost to Follow-up|4|||
125570283|NCT00957008|451715898|FG000|Overall Study|Physician Decision|1|||
125570284|NCT00957008|451715899|FG001|Overall Study|Physician Decision|0|||
125570285|NCT00957008|451715900|FG002|Overall Study|Physician Decision|1|||
125570286|NCT00957008|451715901|FG003|Overall Study|Physician Decision|1|||
125570287|NCT00957008|451715898|FG000|Overall Study|Relocated; Family conflict|4|||
125570288|NCT00957008|451715899|FG001|Overall Study|Relocated; Family conflict|1|||
125570289|NCT00957008|451715900|FG002|Overall Study|Relocated; Family conflict|1|||
125570290|NCT00957008|451715901|FG003|Overall Study|Relocated; Family conflict|3|||
125570291|NCT01118351|451715902|FG000|Overall Study|Adverse Event|3|||
125570292|NCT01118351|451715902|FG000|Overall Study|Withdrawal by Subject|1|||
125570293|NCT04677959|451715905|FG000|Overall Study|Adverse Event|1|||
125570294|NCT04677959|451715906|FG001|Overall Study|Adverse Event|9|||
125570295|NCT04677959|451715905|FG000|Overall Study|Withdrawal by Subject|2|||
125570296|NCT04677959|451715906|FG001|Overall Study|Withdrawal by Subject|15|||
125570297|NCT04677959|451715905|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125570298|NCT04677959|451715906|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125570299|NCT04677959|451715905|FG000|Overall Study|Non-compliance with study drug|0|||
125570300|NCT04677959|451715906|FG001|Overall Study|Non-compliance with study drug|2|||
125570301|NCT04677959|451715905|FG000|Overall Study|Protocol deviation|0|||
125570302|NCT04677959|451715906|FG001|Overall Study|Protocol deviation|11|||
125570303|NCT04677959|451715905|FG000|Overall Study|Lost to Follow-up|9|||
125570304|NCT04677959|451715906|FG001|Overall Study|Lost to Follow-up|13|||
125570305|NCT04677959|451715905|FG000|Overall Study|Other than specified|0|||
125570306|NCT04677959|451715906|FG001|Overall Study|Other than specified|8|||
125570307|NCT01970995|451715907|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
125570308|NCT01970995|451715908|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
125570309|NCT01970995|451715909|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
125570310|NCT01970995|451715907|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
125570311|NCT01970995|451715908|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
125570312|NCT01970995|451715909|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
125570313|NCT00845728|451715910|FG000|Overall Study|Abnormal laboratory value (s)|2|||
125570314|NCT00845728|451715911|FG001|Overall Study|Abnormal laboratory value (s)|2|||
125570315|NCT00845728|451715910|FG000|Overall Study|Patient's inability to use the device|4|||
125570316|NCT00845728|451715911|FG001|Overall Study|Patient's inability to use the device|6|||
125570317|NCT00845728|451715910|FG000|Overall Study|Abnormal test procedure result (s)|7|||
125570318|NCT00845728|451715911|FG001|Overall Study|Abnormal test procedure result (s)|2|||
125570319|NCT00845728|451715910|FG000|Overall Study|Lost to Follow-up|22|||
125570320|NCT00845728|451715911|FG001|Overall Study|Lost to Follow-up|13|||
125570321|NCT00845728|451715910|FG000|Overall Study|Death|24|||
125570322|NCT00845728|451715911|FG001|Overall Study|Death|26|||
125570323|NCT00845728|451715910|FG000|Overall Study|Administrative Problems|34|||
125570324|NCT00845728|451715911|FG001|Overall Study|Administrative Problems|26|||
125570325|NCT00845728|451715910|FG000|Overall Study|Protocol Violation|36|||
125570326|NCT00845728|451715911|FG001|Overall Study|Protocol Violation|24|||
125570327|NCT00845728|451715910|FG000|Overall Study|Lack of Efficacy|51|||
125570328|NCT00845728|451715911|FG001|Overall Study|Lack of Efficacy|39|||
125570329|NCT00845728|451715910|FG000|Overall Study|Adverse Event|101|||
125570330|NCT00845728|451715911|FG001|Overall Study|Adverse Event|96|||
125570331|NCT00845728|451715910|FG000|Overall Study|Withdrawal by Subject|105|||
125570332|NCT00845728|451715911|FG001|Overall Study|Withdrawal by Subject|108|||
125570333|NCT02599961|451715918|FG000|Overall Study|Withdrawal by Subject|1|||
125570334|NCT02599961|451715918|FG000|Overall Study|Subject Non-Compliance|2|||
125570335|NCT02599961|451715918|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
125570336|NCT02599961|451715918|FG000|Overall Study|Other, Not Specified|3|||
125570337|NCT00464334|451715921|FG000|Overall Study|Adverse Event|0|||
125570338|NCT00464334|451715922|FG001|Overall Study|Adverse Event|0|||
125570339|NCT00464334|451715923|FG002|Overall Study|Adverse Event|0|||
125570340|NCT00464334|451715924|FG003|Overall Study|Adverse Event|1|||
125570341|NCT00464334|451715925|FG004|Overall Study|Adverse Event|1|||
125570342|NCT00464334|451715926|FG005|Overall Study|Adverse Event|1|||
125570343|NCT00464334|451715927|FG006|Overall Study|Adverse Event|0|||
125570344|NCT00464334|451715928|FG007|Overall Study|Adverse Event|0|||
125570345|NCT00464334|451715929|FG008|Overall Study|Adverse Event|2|||
125570346|NCT00464334|451715930|FG009|Overall Study|Adverse Event|1|||
125570347|NCT00464334|451715931|FG010|Overall Study|Adverse Event|2|||
125570348|NCT00464334|451715921|FG000|Overall Study|Lack of Efficacy|0|||
125570349|NCT00464334|451715922|FG001|Overall Study|Lack of Efficacy|1|||
125570350|NCT00464334|451715923|FG002|Overall Study|Lack of Efficacy|0|||
125570351|NCT00464334|451715924|FG003|Overall Study|Lack of Efficacy|0|||
125570352|NCT00464334|451715925|FG004|Overall Study|Lack of Efficacy|0|||
125570353|NCT00464334|451715926|FG005|Overall Study|Lack of Efficacy|0|||
125570354|NCT00464334|451715927|FG006|Overall Study|Lack of Efficacy|0|||
125570355|NCT00464334|451715928|FG007|Overall Study|Lack of Efficacy|0|||
125570356|NCT00464334|451715929|FG008|Overall Study|Lack of Efficacy|0|||
125570357|NCT00464334|451715930|FG009|Overall Study|Lack of Efficacy|0|||
125570358|NCT00464334|451715931|FG010|Overall Study|Lack of Efficacy|0|||
125570359|NCT00464334|451715921|FG000|Overall Study|Lost to Follow-up|0|||
125570360|NCT00464334|451715922|FG001|Overall Study|Lost to Follow-up|0|||
125570361|NCT00464334|451715923|FG002|Overall Study|Lost to Follow-up|1|||
125570362|NCT00464334|451715924|FG003|Overall Study|Lost to Follow-up|0|||
125570363|NCT00464334|451715925|FG004|Overall Study|Lost to Follow-up|1|||
125570364|NCT00464334|451715926|FG005|Overall Study|Lost to Follow-up|0|||
125570365|NCT00464334|451715927|FG006|Overall Study|Lost to Follow-up|1|||
125570366|NCT00464334|451715928|FG007|Overall Study|Lost to Follow-up|0|||
125570367|NCT00464334|451715929|FG008|Overall Study|Lost to Follow-up|0|||
125570368|NCT00464334|451715930|FG009|Overall Study|Lost to Follow-up|0|||
125570369|NCT00464334|451715931|FG010|Overall Study|Lost to Follow-up|2|||
125570370|NCT00464334|451715921|FG000|Overall Study|Progressive Disease|0|||
125570371|NCT00464334|451715922|FG001|Overall Study|Progressive Disease|0|||
125570372|NCT00464334|451715923|FG002|Overall Study|Progressive Disease|0|||
125570373|NCT00464334|451715924|FG003|Overall Study|Progressive Disease|0|||
125570374|NCT00464334|451715925|FG004|Overall Study|Progressive Disease|0|||
125570375|NCT00464334|451715926|FG005|Overall Study|Progressive Disease|1|||
125570376|NCT00464334|451715927|FG006|Overall Study|Progressive Disease|0|||
125570377|NCT00464334|451715928|FG007|Overall Study|Progressive Disease|0|||
125570378|NCT00464334|451715929|FG008|Overall Study|Progressive Disease|1|||
125570379|NCT00464334|451715930|FG009|Overall Study|Progressive Disease|0|||
125570380|NCT00464334|451715931|FG010|Overall Study|Progressive Disease|0|||
125570381|NCT00464334|451715921|FG000|Overall Study|Study Terminated by Sponsor|0|||
125570382|NCT00464334|451715922|FG001|Overall Study|Study Terminated by Sponsor|0|||
125570383|NCT00464334|451715923|FG002|Overall Study|Study Terminated by Sponsor|0|||
125570384|NCT00464334|451715924|FG003|Overall Study|Study Terminated by Sponsor|1|||
125570385|NCT00464334|451715925|FG004|Overall Study|Study Terminated by Sponsor|0|||
125570386|NCT00464334|451715926|FG005|Overall Study|Study Terminated by Sponsor|0|||
125570387|NCT00464334|451715927|FG006|Overall Study|Study Terminated by Sponsor|0|||
125570388|NCT00464334|451715928|FG007|Overall Study|Study Terminated by Sponsor|0|||
125570389|NCT00464334|451715929|FG008|Overall Study|Study Terminated by Sponsor|0|||
125570390|NCT00464334|451715930|FG009|Overall Study|Study Terminated by Sponsor|0|||
125570391|NCT00464334|451715931|FG010|Overall Study|Study Terminated by Sponsor|0|||
125570392|NCT00464334|451715921|FG000|Overall Study|Withdrawal by Subject|1|||
125570393|NCT00464334|451715922|FG001|Overall Study|Withdrawal by Subject|7|||
125570394|NCT00464334|451715923|FG002|Overall Study|Withdrawal by Subject|4|||
125570395|NCT00464334|451715924|FG003|Overall Study|Withdrawal by Subject|2|||
125570396|NCT00464334|451715925|FG004|Overall Study|Withdrawal by Subject|2|||
125570397|NCT00464334|451715926|FG005|Overall Study|Withdrawal by Subject|2|||
125570398|NCT00464334|451715927|FG006|Overall Study|Withdrawal by Subject|2|||
125570399|NCT00464334|451715928|FG007|Overall Study|Withdrawal by Subject|1|||
125570400|NCT00464334|451715929|FG008|Overall Study|Withdrawal by Subject|3|||
125570401|NCT00464334|451715930|FG009|Overall Study|Withdrawal by Subject|0|||
125570402|NCT00464334|451715931|FG010|Overall Study|Withdrawal by Subject|0|||
125570403|NCT01422915|451715940|FG000|Overall Study|Adverse Event|1|||
125570404|NCT01152021|451715942|FG000|Overall Study|Adverse Event|4|||
125570405|NCT01152021|451715943|FG001|Overall Study|Adverse Event|4|||
125358091|NCT02927262|450946327|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
125358092|NCT02927262|450946326|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
125358093|NCT02927262|450946327|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
125570406|NCT01152021|451715942|FG000|Overall Study|Study drug had expired|1|||
125570407|NCT01152021|451715943|FG001|Overall Study|Study drug had expired|0|||
125358094|NCT00923936|450946328|FG000|Overall Study|progressive disease on study|2|||
125358095|NCT00923936|450946329|FG001|Overall Study|progressive disease on study|1|||
125358096|NCT00923936|450946328|FG000|Overall Study|Adverse Event|2|||
125358097|NCT00923936|450946329|FG001|Overall Study|Adverse Event|1|||
125570408|NCT01152021|451715942|FG000|Overall Study|Physician Decision|1|||
125570409|NCT01152021|451715943|FG001|Overall Study|Physician Decision|1|||
125570410|NCT01152021|451715942|FG000|Overall Study|No access to study drug in Pharmacy|0|||
125570411|NCT01152021|451715943|FG001|Overall Study|No access to study drug in Pharmacy|1|||
125570412|NCT00517829|451715944|FG000|Overall Study|Adverse Event|22|||
125570413|NCT00517829|451715945|FG001|Overall Study|Adverse Event|34|||
125570414|NCT00517829|451715944|FG000|Overall Study|Disease Progression|39|||
125570415|NCT00517829|451715945|FG001|Overall Study|Disease Progression|32|||
125570416|NCT00517829|451715944|FG000|Overall Study|Patient Request|6|||
125570417|NCT00517829|451715945|FG001|Overall Study|Patient Request|5|||
125570418|NCT00517829|451715944|FG000|Overall Study|Investigator Request|5|||
125570419|NCT00517829|451715945|FG001|Overall Study|Investigator Request|3|||
125570420|NCT00517829|451715944|FG000|Overall Study|Other|3|||
125570421|NCT00517829|451715945|FG001|Overall Study|Other|1|||
125570422|NCT00385255|451715946|FG000|Overall Study|Serious Adverse Event|1|||
125570423|NCT00385255|451715947|FG001|Overall Study|Serious Adverse Event|2|||
125570424|NCT00385255|451715946|FG000|Overall Study|Protocol Violation|0|||
125570425|NCT00385255|451715947|FG001|Overall Study|Protocol Violation|4|||
125570426|NCT00385255|451715946|FG000|Overall Study|Withdrawal by Subject|0|||
125570427|NCT00385255|451715947|FG001|Overall Study|Withdrawal by Subject|8|||
125570428|NCT00385255|451715946|FG000|Overall Study|Migrated/moved from study area|0|||
125570429|NCT00385255|451715947|FG001|Overall Study|Migrated/moved from study area|1|||
125570430|NCT00385255|451715946|FG000|Overall Study|Lost to Follow-up|20|||
125570431|NCT00385255|451715947|FG001|Overall Study|Lost to Follow-up|58|||
125570432|NCT02443883|451715948|FG000|Overall Study|Adverse Event|0|||
125570433|NCT02443883|451715949|FG001|Overall Study|Adverse Event|1|||
125570434|NCT02443883|451715950|FG002|Overall Study|Adverse Event|0|||
125570435|NCT02443883|451715951|FG003|Overall Study|Adverse Event|0|||
125570436|NCT02443883|451715948|FG000|Overall Study|Lost to Follow-up|3|||
125570437|NCT02443883|451715949|FG001|Overall Study|Lost to Follow-up|2|||
125358098|NCT00923936|450946328|FG000|Overall Study|Lost to follow up|2|||
125358099|NCT00923936|450946329|FG001|Overall Study|Lost to follow up|0|||
125358100|NCT00923936|450946328|FG000|Overall Study|Continuing in follow up period|2|||
125358101|NCT00923936|450946329|FG001|Overall Study|Continuing in follow up period|1|||
125358102|NCT01697358|450946330|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
125358103|NCT01697358|450946331|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
125570438|NCT02443883|451715950|FG002|Overall Study|Lost to Follow-up|1|||
125570439|NCT02443883|451715951|FG003|Overall Study|Lost to Follow-up|0|||
125570440|NCT02443883|451715948|FG000|Overall Study|Physician Decision|1|||
125570441|NCT02443883|451715949|FG001|Overall Study|Physician Decision|1|||
125570442|NCT02443883|451715950|FG002|Overall Study|Physician Decision|0|||
125570443|NCT02443883|451715951|FG003|Overall Study|Physician Decision|3|||
125570444|NCT02443883|451715948|FG000|Overall Study|Withdrawal by Subject|1|||
125570445|NCT02443883|451715949|FG001|Overall Study|Withdrawal by Subject|0|||
125570446|NCT02443883|451715950|FG002|Overall Study|Withdrawal by Subject|0|||
125570447|NCT02443883|451715951|FG003|Overall Study|Withdrawal by Subject|2|||
125570448|NCT02443883|451715948|FG000|Overall Study|Randomized, but never treated|1|||
125570449|NCT02443883|451715949|FG001|Overall Study|Randomized, but never treated|0|||
125570450|NCT02443883|451715950|FG002|Overall Study|Randomized, but never treated|0|||
125570451|NCT02443883|451715951|FG003|Overall Study|Randomized, but never treated|0|||
125570452|NCT00506883|451715963|FG000|Overall Study|Lost to Follow-up|1|||
125570453|NCT00506883|451715964|FG001|Overall Study|Lost to Follow-up|1|||
125570454|NCT00506883|451715965|FG002|Overall Study|Lost to Follow-up|1|||
125570455|NCT00506883|451715963|FG000|Overall Study|Withdrawal by Subject|1|||
125570456|NCT00506883|451715964|FG001|Overall Study|Withdrawal by Subject|0|||
125570457|NCT00506883|451715965|FG002|Overall Study|Withdrawal by Subject|1|||
125570458|NCT00506883|451715963|FG000|Overall Study|Lack of Efficacy|0|||
125570459|NCT00506883|451715964|FG001|Overall Study|Lack of Efficacy|1|||
125570460|NCT00506883|451715965|FG002|Overall Study|Lack of Efficacy|1|||
125570461|NCT00506883|451715963|FG000|Overall Study|Other|5|||
125570462|NCT00506883|451715964|FG001|Overall Study|Other|1|||
125570463|NCT00506883|451715965|FG002|Overall Study|Other|1|||
125570464|NCT01445951|451715966|FG000|Overall Study|Adverse Event|16|||
125570465|NCT01445951|451715967|FG001|Overall Study|Adverse Event|9|||
125570466|NCT01445951|451715968|FG002|Overall Study|Adverse Event|0|||
125570467|NCT01445951|451715966|FG000|Overall Study|Protocol Violation|2|||
125570468|NCT01445951|451715967|FG001|Overall Study|Protocol Violation|2|||
125570469|NCT01445951|451715968|FG002|Overall Study|Protocol Violation|2|||
125570470|NCT01445951|451715966|FG000|Overall Study|Withdrawal by Subject|21|||
125570471|NCT01445951|451715967|FG001|Overall Study|Withdrawal by Subject|16|||
125570472|NCT01445951|451715968|FG002|Overall Study|Withdrawal by Subject|8|||
125570473|NCT01445951|451715966|FG000|Overall Study|Physician Decision|3|||
125570474|NCT01445951|451715967|FG001|Overall Study|Physician Decision|1|||
125570475|NCT01445951|451715968|FG002|Overall Study|Physician Decision|0|||
125570476|NCT01445951|451715966|FG000|Overall Study|Lost to Follow-up|1|||
125570477|NCT01445951|451715967|FG001|Overall Study|Lost to Follow-up|2|||
125570478|NCT01445951|451715968|FG002|Overall Study|Lost to Follow-up|4|||
125570479|NCT01445951|451715966|FG000|Overall Study|Pregnancy|0|||
125570480|NCT01445951|451715967|FG001|Overall Study|Pregnancy|1|||
125570481|NCT01445951|451715968|FG002|Overall Study|Pregnancy|4|||
125570482|NCT01445951|451715966|FG000|Overall Study|Death|0|||
125570483|NCT01445951|451715967|FG001|Overall Study|Death|0|||
125570484|NCT01445951|451715968|FG002|Overall Study|Death|1|||
125570485|NCT01445951|451715966|FG000|Overall Study|Non-compliance with study drug|1|||
125570486|NCT01445951|451715967|FG001|Overall Study|Non-compliance with study drug|2|||
125570487|NCT01445951|451715968|FG002|Overall Study|Non-compliance with study drug|0|||
125570488|NCT01445951|451715966|FG000|Overall Study|Non-compliance with protocol|0|||
125570489|NCT01445951|451715967|FG001|Overall Study|Non-compliance with protocol|1|||
125570490|NCT01445951|451715968|FG002|Overall Study|Non-compliance with protocol|0|||
125570491|NCT01445951|451715966|FG000|Overall Study|Sponsor decision - subject travel|0|||
125570492|NCT01445951|451715967|FG001|Overall Study|Sponsor decision - subject travel|1|||
125570493|NCT01445951|451715968|FG002|Overall Study|Sponsor decision - subject travel|0|||
125570494|NCT01445951|451715966|FG000|Overall Study|Cough|0|||
125358104|NCT01697358|450946330|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
125570495|NCT01445951|451715967|FG001|Overall Study|Cough|1|||
125570496|NCT01445951|451715968|FG002|Overall Study|Cough|0|||
125570497|NCT03152019|451715973|FG000|Overall Study|Adverse Event|0|||
125570498|NCT03152019|451715974|FG001|Overall Study|Adverse Event|1|||
125570499|NCT00254501|451715980|FG000|Overall Study|Lost to Follow-up|1|||
125570500|NCT00254501|451715981|FG001|Overall Study|Lost to Follow-up|1|||
125570501|NCT00923130|451715982|FG000|Overall Study|Stopped treatment due to progression|17|||
125570502|NCT00923130|451715982|FG000|Overall Study|Death|1|||
125570503|NCT00923130|451715982|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
125570504|NCT00923130|451715982|FG000|Overall Study|Switched to alternative treatment|2|||
125570505|NCT00923130|451715982|FG000|Overall Study|Refused further treatment|2|||
125570506|NCT00513409|451717231|FG000|Overall Study|Adverse Event|0|||
125570507|NCT00513409|451717232|FG001|Overall Study|Adverse Event|1|||
125570508|NCT00513409|451717231|FG000|Overall Study|Withdrawal by Subject|0|||
125570509|NCT00513409|451717232|FG001|Overall Study|Withdrawal by Subject|2|||
125570510|NCT00513409|451717231|FG000|Overall Study|Lost to Follow-up|0|||
125570511|NCT00513409|451717232|FG001|Overall Study|Lost to Follow-up|1|||
125570512|NCT00513409|451717231|FG000|Overall Study|Physician Decision|1|||
125570513|NCT00513409|451717232|FG001|Overall Study|Physician Decision|0|||
125570514|NCT00513409|451717231|FG000|Overall Study|Visit 3 not done|1|||
125570515|NCT00513409|451717232|FG001|Overall Study|Visit 3 not done|2|||
125570516|NCT03189446|451717233|FG000|Overall Study|Adverse Event|2|||
125570517|NCT03189446|451717233|FG000|Overall Study|Withdrawal by Subject|2|||
125570518|NCT03189446|451717233|FG000|Overall Study|Physician Decision|1|||
125570519|NCT05634577|451717234|FG000|Overall Study|Lost to Follow-up|1|||
125570520|NCT05634577|451717234|FG000|Overall Study|Withdrawal by Subject|1|||
125570521|NCT04839978|451717235|FG000|Overall Study|Lost to Follow-up|135|||
125570522|NCT04839978|451717236|FG001|Overall Study|Lost to Follow-up|147|||
125570523|NCT00781456|451717237|FG000|Overall Study|Adverse Event|3|||
125570524|NCT00781456|451717238|FG001|Overall Study|Adverse Event|3|||
125570525|NCT00781456|451717237|FG000|Overall Study|Withdrawal by Subject|3|||
125570526|NCT00781456|451717238|FG001|Overall Study|Withdrawal by Subject|5|||
125570527|NCT00781456|451717237|FG000|Overall Study|Protocol Violation|4|||
125570528|NCT00781456|451717238|FG001|Overall Study|Protocol Violation|1|||
125570529|NCT00781456|451717237|FG000|Overall Study|Noncompliance With Protocol|1|||
125570530|NCT00781456|451717238|FG001|Overall Study|Noncompliance With Protocol|1|||
125570531|NCT00781456|451717237|FG000|Overall Study|Lost to Follow-up|10|||
125570532|NCT00781456|451717238|FG001|Overall Study|Lost to Follow-up|5|||
125570533|NCT00781456|451717237|FG000|Overall Study|Other Reason, Unknown|0|||
125570534|NCT00781456|451717238|FG001|Overall Study|Other Reason, Unknown|1|||
125570535|NCT01902966|451717239|FG000|Overall Study|Death|1|||
125570536|NCT01902966|451717239|FG000|Overall Study|Physician Decision|1|||
125570537|NCT01902966|451717239|FG000|Overall Study|Withdrawal by Subject|1|||
125570538|NCT00783094|451717240|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
125570539|NCT00783094|451717241|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
125570540|NCT00783094|451717242|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
125570541|NCT00783094|451717240|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
125570542|NCT00783094|451717241|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
125570543|NCT00783094|451717242|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
125570544|NCT00783094|451717240|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
125570545|NCT00783094|451717241|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
125570546|NCT00783094|451717242|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
125570547|NCT00783094|451717240|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
125570548|NCT00783094|451717241|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
125570549|NCT00783094|451717242|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
125570550|NCT00783094|451717240|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
125570551|NCT00783094|451717241|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
125570552|NCT00783094|451717242|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
125570553|NCT00783094|451717240|FG000|Open-Label Extension Period|Adverse Event|12|||
125570554|NCT00783094|451717241|FG001|Open-Label Extension Period|Adverse Event|7|||
125570555|NCT00783094|451717242|FG002|Open-Label Extension Period|Adverse Event|16|||
125570556|NCT00783094|451717240|FG000|Open-Label Extension Period|Death|0|||
125570557|NCT00783094|451717241|FG001|Open-Label Extension Period|Death|0|||
125570558|NCT00783094|451717242|FG002|Open-Label Extension Period|Death|1|||
125570559|NCT00783094|451717240|FG000|Open-Label Extension Period|Protocol Violation|4|||
125570560|NCT00783094|451717241|FG001|Open-Label Extension Period|Protocol Violation|5|||
125570561|NCT00783094|451717242|FG002|Open-Label Extension Period|Protocol Violation|7|||
125570562|NCT00783094|451717240|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
125570563|NCT00783094|451717241|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
125570564|NCT00783094|451717242|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
125570565|NCT00783094|451717240|FG000|Open-Label Extension Period|Physician Decision|4|||
125570566|NCT00783094|451717241|FG001|Open-Label Extension Period|Physician Decision|2|||
125570567|NCT00783094|451717242|FG002|Open-Label Extension Period|Physician Decision|3|||
125570568|NCT00783094|451717240|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
125570569|NCT00783094|451717241|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
125570570|NCT00783094|451717242|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
125570571|NCT00876187|451717245|FG000|Overall Study|Adverse Event|14|||
125570572|NCT00876187|451717246|FG001|Overall Study|Adverse Event|12|||
125570573|NCT00876187|451717247|FG002|Overall Study|Adverse Event|19|||
125570574|NCT00876187|451717248|FG003|Overall Study|Adverse Event|29|||
125570575|NCT00876187|451717249|FG004|Overall Study|Adverse Event|10|||
125570576|NCT00876187|451717245|FG000|Overall Study|Lack of Efficacy|59|||
125570577|NCT00876187|451717246|FG001|Overall Study|Lack of Efficacy|34|||
125570578|NCT00876187|451717247|FG002|Overall Study|Lack of Efficacy|45|||
125570579|NCT00876187|451717248|FG003|Overall Study|Lack of Efficacy|34|||
125570580|NCT00876187|451717249|FG004|Overall Study|Lack of Efficacy|59|||
125570581|NCT00876187|451717245|FG000|Overall Study|Lost to Follow-up|9|||
125570582|NCT00876187|451717246|FG001|Overall Study|Lost to Follow-up|10|||
125570583|NCT00876187|451717247|FG002|Overall Study|Lost to Follow-up|8|||
125570584|NCT00876187|451717248|FG003|Overall Study|Lost to Follow-up|8|||
125570585|NCT00876187|451717249|FG004|Overall Study|Lost to Follow-up|11|||
125570586|NCT00876187|451717245|FG000|Overall Study|Protocol Violation|6|||
125570587|NCT00876187|451717246|FG001|Overall Study|Protocol Violation|7|||
125570588|NCT00876187|451717247|FG002|Overall Study|Protocol Violation|7|||
125570589|NCT00876187|451717248|FG003|Overall Study|Protocol Violation|6|||
125570590|NCT00876187|451717249|FG004|Overall Study|Protocol Violation|3|||
125570591|NCT00876187|451717245|FG000|Overall Study|Withdrawal by Subject|16|||
125570592|NCT00876187|451717246|FG001|Overall Study|Withdrawal by Subject|26|||
125570593|NCT00876187|451717247|FG002|Overall Study|Withdrawal by Subject|32|||
125570594|NCT00876187|451717248|FG003|Overall Study|Withdrawal by Subject|38|||
125570595|NCT00876187|451717249|FG004|Overall Study|Withdrawal by Subject|37|||
125570596|NCT00876187|451717245|FG000|Overall Study|Entered extension study|101|||
125570597|NCT00876187|451717246|FG001|Overall Study|Entered extension study|120|||
125570598|NCT00876187|451717247|FG002|Overall Study|Entered extension study|156|||
125570599|NCT00876187|451717248|FG003|Overall Study|Entered extension study|151|||
125570600|NCT00876187|451717249|FG004|Overall Study|Entered extension study|144|||
125570601|NCT00876187|451717245|FG000|Overall Study|Randomized but not treated|3|||
125570602|NCT00876187|451717246|FG001|Overall Study|Randomized but not treated|1|||
125570603|NCT00876187|451717247|FG002|Overall Study|Randomized but not treated|3|||
125570604|NCT00876187|451717248|FG003|Overall Study|Randomized but not treated|2|||
125570605|NCT00876187|451717249|FG004|Overall Study|Randomized but not treated|3|||
125570606|NCT00876187|451717245|FG000|Overall Study|Other|2|||
125570607|NCT00876187|451717246|FG001|Overall Study|Other|5|||
125570608|NCT00876187|451717247|FG002|Overall Study|Other|9|||
125570609|NCT00876187|451717248|FG003|Overall Study|Other|7|||
125570610|NCT00876187|451717249|FG004|Overall Study|Other|4|||
125570611|NCT03287219|451717250|FG000|Overall Study|Protocol Violation|0|||
125570612|NCT03287219|451717251|FG001|Overall Study|Protocol Violation|2|||
125570613|NCT00811135|451717252|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
125570614|NCT00811135|451717252|FG000|Overall Study|Death|3|||
125570615|NCT00811135|451717252|FG000|Overall Study|Protocol Violation|2|||
125570616|NCT00811135|451717252|FG000|Overall Study|Violation of Selection Criteria|1|||
125570617|NCT00811135|451717252|FG000|Overall Study|Refused Treatment|1|||
125570618|NCT00811135|451717252|FG000|Overall Study|Withdrawal by Subject|3|||
125570619|NCT00811135|451717252|FG000|Overall Study|Administrative/Other Unspecified|11|||
125570620|NCT00811135|451717252|FG000|Overall Study|Ongoing|59|||
125570621|NCT03245450|451717264|FG000|Overall Study|Radiological disease progression|3|||
125570622|NCT03245450|451717265|FG001|Overall Study|Radiological disease progression|3|||
125570623|NCT03245450|451717266|FG002|Overall Study|Radiological disease progression|2|||
125570624|NCT03245450|451717267|FG003|Overall Study|Radiological disease progression|2|||
125570625|NCT03245450|451717268|FG004|Overall Study|Radiological disease progression|7|||
125570626|NCT03245450|451717269|FG005|Overall Study|Radiological disease progression|6|||
125570627|NCT03245450|451717270|FG006|Overall Study|Radiological disease progression|6|||
125570628|NCT03245450|451717264|FG000|Overall Study|Clinical disease progression|0|||
125570629|NCT03245450|451717265|FG001|Overall Study|Clinical disease progression|0|||
125570630|NCT03245450|451717266|FG002|Overall Study|Clinical disease progression|1|||
125570631|NCT03245450|451717267|FG003|Overall Study|Clinical disease progression|0|||
125570632|NCT03245450|451717268|FG004|Overall Study|Clinical disease progression|0|||
125570633|NCT03245450|451717269|FG005|Overall Study|Clinical disease progression|2|||
125570634|NCT03245450|451717270|FG006|Overall Study|Clinical disease progression|0|||
125570635|NCT03245450|451717264|FG000|Overall Study|Other|0|||
125570636|NCT03245450|451717265|FG001|Overall Study|Other|0|||
125570637|NCT03245450|451717266|FG002|Overall Study|Other|0|||
125570638|NCT03245450|451717267|FG003|Overall Study|Other|1|||
125570639|NCT03245450|451717268|FG004|Overall Study|Other|1|||
125570640|NCT03245450|451717269|FG005|Overall Study|Other|1|||
125570641|NCT03245450|451717270|FG006|Overall Study|Other|1|||
125570642|NCT03245450|451717264|FG000|Overall Study|Withdrawal by Subject|0|||
125570643|NCT03245450|451717265|FG001|Overall Study|Withdrawal by Subject|1|||
125570644|NCT03245450|451717266|FG002|Overall Study|Withdrawal by Subject|0|||
125570645|NCT03245450|451717267|FG003|Overall Study|Withdrawal by Subject|0|||
125570646|NCT03245450|451717268|FG004|Overall Study|Withdrawal by Subject|0|||
125570647|NCT03245450|451717269|FG005|Overall Study|Withdrawal by Subject|0|||
125570648|NCT03245450|451717270|FG006|Overall Study|Withdrawal by Subject|0|||
125570649|NCT03245450|451717264|FG000|Overall Study|Adverse Event|0|||
125570650|NCT03245450|451717265|FG001|Overall Study|Adverse Event|0|||
125570651|NCT03245450|451717266|FG002|Overall Study|Adverse Event|0|||
125570652|NCT03245450|451717267|FG003|Overall Study|Adverse Event|0|||
125570653|NCT03245450|451717268|FG004|Overall Study|Adverse Event|1|||
125570654|NCT03245450|451717269|FG005|Overall Study|Adverse Event|0|||
125570655|NCT03245450|451717270|FG006|Overall Study|Adverse Event|2|||
125570656|NCT02429414|451717271|FG000|Overall Study|Physician Decision|0|||
125426864|NCT03434678|451188020|FG001|Overall Study|Withdrawal by Subject|13|||
125426865|NCT03434678|451188019|FG000|Overall Study|Found to be ineligible post randomization|2|||
125426866|NCT03434678|451188020|FG001|Overall Study|Found to be ineligible post randomization|1|||
125426867|NCT06060457|451188023|FG000|Overall Study|Adverse Event|1|||
125426868|NCT06060457|451188024|FG001|Overall Study|Adverse Event|1|||
125426869|NCT06060457|451188023|FG000|Overall Study|Death|2|||
125426870|NCT06060457|451188024|FG001|Overall Study|Death|2|||
125426871|NCT06060457|451188023|FG000|Overall Study|Lost to Follow-up|17|||
125426872|NCT06060457|451188024|FG001|Overall Study|Lost to Follow-up|19|||
125426873|NCT06060457|451188023|FG000|Overall Study|Physician Decision|0|||
125426874|NCT06060457|451188024|FG001|Overall Study|Physician Decision|1|||
125426875|NCT06060457|451188023|FG000|Overall Study|Protocol Violation|1|||
125426876|NCT06060457|451188024|FG001|Overall Study|Protocol Violation|1|||
125426877|NCT06060457|451188023|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
125426878|NCT06060457|451188024|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
125426879|NCT06060457|451188023|FG000|Overall Study|Withdrawal by Subject|12|||
125426880|NCT06060457|451188024|FG001|Overall Study|Withdrawal by Subject|15|||
125426881|NCT06060457|451188023|FG000|Overall Study|Other Than Specified|2|||
125426882|NCT06060457|451188024|FG001|Overall Study|Other Than Specified|1|||
125426883|NCT02061202|451188025|FG000|Overall Study|Lost to Follow-up|1|||
125426884|NCT02061202|451188026|FG001|Overall Study|Lost to Follow-up|1|||
125426885|NCT00569582|451188030|FG000|Overall Study|Withdrawal by Subject|5|||
125426886|NCT00569582|451188030|FG000|Overall Study|Death|2|||
125426887|NCT00569582|451188030|FG000|Overall Study|Adverse Event|7|||
125426888|NCT00569582|451188030|FG000|Overall Study|Subject was too ill to travel.|1|||
125426889|NCT00569582|451188030|FG000|Overall Study|Subject was non-compliant.|1|||
125426890|NCT01533493|451188031|FG000|Overall Study|Adverse Event|2|||
125426891|NCT01533493|451188032|FG001|Overall Study|Adverse Event|1|||
125426892|NCT01533493|451188031|FG000|Overall Study|Withdrawal by Subject|1|||
125426893|NCT01533493|451188032|FG001|Overall Study|Withdrawal by Subject|2|||
125426894|NCT01533493|451188031|FG000|Overall Study|Lost to Follow-up|2|||
125426895|NCT01533493|451188032|FG001|Overall Study|Lost to Follow-up|0|||
125570657|NCT02429414|451717272|FG001|Overall Study|Physician Decision|1|||
125570658|NCT01965262|451717285|FG000|Second Intervention (7 Days)|Discontinued|0|||
125570659|NCT01965262|451717286|FG001|Second Intervention (7 Days)|Discontinued|1|||
125358105|NCT01697358|450946331|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
125358106|NCT01697358|450946330|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
125358107|NCT01697358|450946331|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
125358108|NCT01697358|450946330|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
125358109|NCT01697358|450946331|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
125358110|NCT01697358|450946330|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
125358111|NCT01697358|450946331|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
125358112|NCT01697358|450946330|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
125358113|NCT01697358|450946331|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
125358114|NCT01697358|450946330|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
125358115|NCT01697358|450946331|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
125358116|NCT01697358|450946330|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
125358117|NCT01697358|450946331|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
125358118|NCT01697358|450946330|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
125358119|NCT01697358|450946331|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
125358120|NCT01697358|450946330|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
125358121|NCT01697358|450946331|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
125358122|NCT02038452|450946332|FG000|Overall Study|Withdrawal by Subject|7|||
125358123|NCT02038452|450946333|FG001|Overall Study|Withdrawal by Subject|9|||
125358124|NCT02038452|450946332|FG000|Overall Study|Lost to Follow-up|31|||
125358125|NCT02038452|450946333|FG001|Overall Study|Lost to Follow-up|28|||
125358126|NCT01460368|450946336|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
125358127|NCT01460368|450946337|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
125358128|NCT01460368|450946338|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
125358129|NCT01460368|450946339|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
125358130|NCT01460368|450946340|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
125358131|NCT01460368|450946341|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
125358132|NCT01460368|450946342|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
125426896|NCT05163522|451188035|FG000|Overall Study|Withdrawal by Subject|0|||
125570660|NCT01965262|451717285|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
125426897|NCT05163522|451188036|FG001|Overall Study|Withdrawal by Subject|0|||
125426898|NCT05163522|451188037|FG002|Overall Study|Withdrawal by Subject|1|||
125426899|NCT05163522|451188038|FG003|Overall Study|Withdrawal by Subject|0|||
125570661|NCT01965262|451717286|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
125570662|NCT01965262|451717285|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
125570663|NCT01965262|451717286|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
125570664|NCT00143312|451717287|FG000|Overall Study|Death|11|||
125570665|NCT00143312|451717287|FG000|Overall Study|Adverse Event|2|||
125570666|NCT00143312|451717287|FG000|Overall Study|Lost to Follow-up|1|||
125570667|NCT00143312|451717287|FG000|Overall Study|Other|1|||
125570668|NCT00143312|451717287|FG000|Overall Study|Withdrawal by Subject|1|||
125570669|NCT01029366|451717288|FG000|Overall Study|Withdrawal by Subject|1|||
125570670|NCT01029366|451717289|FG001|Overall Study|Withdrawal by Subject|0|||
125570671|NCT01029366|451717288|FG000|Overall Study|Death|1|||
125570672|NCT01029366|451717289|FG001|Overall Study|Death|1|||
125570673|NCT01029366|451717288|FG000|Overall Study|disease progression|2|||
125570674|NCT01029366|451717289|FG001|Overall Study|disease progression|0|||
125570675|NCT01029366|451717288|FG000|Overall Study|manufacturing failure|0|||
125570676|NCT01029366|451717289|FG001|Overall Study|manufacturing failure|1|||
125570677|NCT00796315|451717299|FG000|Overall Study|Protocol Violation|0|||
125570678|NCT00796315|451717300|FG001|Overall Study|Protocol Violation|1|||
125570679|NCT00796315|451717301|FG002|Overall Study|Protocol Violation|0|||
125570680|NCT01627860|451717306|FG000|Overall Study|Adverse Event|9|||
125570681|NCT01627860|451717307|FG001|Overall Study|Adverse Event|4|||
125570682|NCT01627860|451717306|FG000|Overall Study|Withdrawal by Subject|2|||
125570683|NCT01627860|451717307|FG001|Overall Study|Withdrawal by Subject|1|||
125570684|NCT01627860|451717306|FG000|Overall Study|Seizure frequency doubled|0|||
125570685|NCT01627860|451717307|FG001|Overall Study|Seizure frequency doubled|1|||
125570686|NCT01627860|451717306|FG000|Overall Study|Protocol Violation|1|||
125570687|NCT01627860|451717307|FG001|Overall Study|Protocol Violation|0|||
125570688|NCT03215771|451717308|FG000|Overall Study|Withdrawal by Subject|2|||
125570689|NCT03215771|451717308|FG000|Overall Study|Physician Decision|1|||
125570690|NCT02039375|451717309|FG000|Overall Study|Lost to Follow-up|2|||
125570691|NCT04770389|451717310|FG000|Overall Study|Adverse Event|1|||
125570692|NCT04770389|451717311|FG001|Overall Study|Adverse Event|2|||
125570693|NCT04770389|451717312|FG002|Overall Study|Adverse Event|0|||
125570694|NCT04770389|451717313|FG003|Overall Study|Adverse Event|1|||
125570695|NCT04770389|451717310|FG000|Overall Study|Withdrawal by Subject|0|||
125570696|NCT04770389|451717311|FG001|Overall Study|Withdrawal by Subject|2|||
125570697|NCT04770389|451717312|FG002|Overall Study|Withdrawal by Subject|1|||
125570698|NCT04770389|451717313|FG003|Overall Study|Withdrawal by Subject|0|||
125570699|NCT04770389|451717310|FG000|Overall Study|Failed attempt to draw blood|1|||
125570700|NCT04770389|451717311|FG001|Overall Study|Failed attempt to draw blood|0|||
125570701|NCT04770389|451717312|FG002|Overall Study|Failed attempt to draw blood|0|||
125570702|NCT04770389|451717313|FG003|Overall Study|Failed attempt to draw blood|0|||
125570703|NCT04770389|451717310|FG000|Overall Study|Left the country|0|||
125570704|NCT04770389|451717311|FG001|Overall Study|Left the country|0|||
125570705|NCT04770389|451717312|FG002|Overall Study|Left the country|1|||
125570706|NCT04770389|451717313|FG003|Overall Study|Left the country|2|||
125570707|NCT04770389|451717310|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
125570708|NCT04770389|451717311|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
125570709|NCT04770389|451717312|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
125570710|NCT04770389|451717313|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
125570711|NCT04770389|451717310|FG000|Overall Study|Lost to Follow-up|0|||
125570712|NCT04770389|451717311|FG001|Overall Study|Lost to Follow-up|0|||
125570713|NCT04770389|451717312|FG002|Overall Study|Lost to Follow-up|0|||
125570714|NCT04770389|451717313|FG003|Overall Study|Lost to Follow-up|1|||
125570715|NCT04770389|451717310|FG000|Overall Study|Moved away from study site|0|||
125570716|NCT04770389|451717311|FG001|Overall Study|Moved away from study site|1|||
125570717|NCT04770389|451717312|FG002|Overall Study|Moved away from study site|0|||
125570718|NCT04770389|451717313|FG003|Overall Study|Moved away from study site|0|||
125570719|NCT00689871|451717318|FG000|Overall Study|Lost to Follow-up|123|||
125570720|NCT00689871|451717319|FG001|Overall Study|Lost to Follow-up|13|||
125570721|NCT00689871|451717320|FG002|Overall Study|Lost to Follow-up|37|||
125570722|NCT00689871|451717321|FG003|Overall Study|Lost to Follow-up|1|||
125570723|NCT00689871|451717318|FG000|Overall Study|Explanted of All Study Devices|36|||
125570724|NCT00689871|451717319|FG001|Overall Study|Explanted of All Study Devices|25|||
125570725|NCT00689871|451717320|FG002|Overall Study|Explanted of All Study Devices|29|||
125570726|NCT00689871|451717321|FG003|Overall Study|Explanted of All Study Devices|3|||
125570727|NCT00689871|451717318|FG000|Overall Study|Withdrawal by Subject|13|||
125570728|NCT00689871|451717319|FG001|Overall Study|Withdrawal by Subject|3|||
125570729|NCT00689871|451717320|FG002|Overall Study|Withdrawal by Subject|4|||
125570730|NCT00689871|451717321|FG003|Overall Study|Withdrawal by Subject|1|||
125570731|NCT00689871|451717318|FG000|Overall Study|Death|1|||
125570732|NCT00689871|451717319|FG001|Overall Study|Death|10|||
125570733|NCT00689871|451717320|FG002|Overall Study|Death|2|||
125570734|NCT00689871|451717321|FG003|Overall Study|Death|2|||
125570735|NCT00689871|451717318|FG000|Overall Study|Physician Decision|2|||
125570736|NCT00689871|451717319|FG001|Overall Study|Physician Decision|1|||
125570737|NCT00689871|451717320|FG002|Overall Study|Physician Decision|1|||
125570738|NCT00689871|451717321|FG003|Overall Study|Physician Decision|0|||
125570739|NCT00889265|451717326|FG000|Overall Study|Adverse Event|1|||
125570740|NCT00889265|451717326|FG000|Overall Study|Lost to Follow-up|5|||
125570741|NCT00889265|451717326|FG000|Overall Study|Protocol Violation|1|||
125570742|NCT00250835|451717329|FG000|Overall Study|Withdrawal by Subject|1|||
125570743|NCT03885089|451717331|FG000|Overall Study|No informed consent for publication of study results|2|||
125570744|NCT04489888|451717334|FG000|Overall Study|Death|75|||
125570745|NCT04489888|451717334|FG000|Overall Study|Sponsor Decision|26|||
125570746|NCT03349099|451717337|FG000|Overall Study|Physician Decision|3|||
125570747|NCT03349099|451717338|FG001|Overall Study|Physician Decision|4|||
125570748|NCT03349099|451717337|FG000|Overall Study|Stone migrated from the kidney|1|||
125570749|NCT03349099|451717338|FG001|Overall Study|Stone migrated from the kidney|0|||
125570750|NCT00278993|451717339|FG000|Overall Study|Adverse Event|24|||
125570751|NCT00278993|451717339|FG000|Overall Study|Withdrawal by Subject|5|||
125570752|NCT00278993|451717339|FG000|Overall Study|Progressive Disease|65|||
125570753|NCT00278993|451717339|FG000|Overall Study|Physician Decision|9|||
125570754|NCT00278993|451717339|FG000|Overall Study|Not Otherwise Specified|4|||
125570755|NCT02043548|451717343|FG000|Overall Study|Lack of Efficacy|1|||
125570756|NCT02043548|451717344|FG001|Overall Study|Lack of Efficacy|0|||
125570757|NCT02043548|451717343|FG000|Overall Study|Adverse Event|0|||
125570758|NCT02043548|451717344|FG001|Overall Study|Adverse Event|1|||
125570759|NCT03829657|451717347|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
125570760|NCT03829657|451717348|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
125570761|NCT03829657|451717349|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
125570762|NCT03829657|451717350|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
125570763|NCT03829657|451717351|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
125570764|NCT03829657|451717347|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
125570765|NCT03829657|451717348|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
125570766|NCT03829657|451717349|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
125570767|NCT03829657|451717350|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
125570768|NCT03829657|451717351|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
125570769|NCT03829657|451717347|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
125570770|NCT03829657|451717348|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
125570771|NCT03829657|451717349|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
125570772|NCT03829657|451717350|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
125570773|NCT03829657|451717351|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
125570774|NCT03829657|451717347|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
125570775|NCT03829657|451717348|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
125570776|NCT03829657|451717349|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
125570777|NCT03829657|451717350|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
125570778|NCT03829657|451717351|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
125570779|NCT03829657|451717347|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
125570780|NCT03829657|451717348|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
125570781|NCT03829657|451717349|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
125570782|NCT03829657|451717350|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
125570783|NCT03829657|451717351|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
125570784|NCT03829657|451717347|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
125570785|NCT03829657|451717348|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
125570786|NCT03829657|451717349|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
125570787|NCT03829657|451717350|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
125570788|NCT03829657|451717351|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
125570789|NCT03829657|451717347|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
125570790|NCT03829657|451717348|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
125358133|NCT01460368|450946336|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
125358134|NCT01460368|450946337|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
125570791|NCT03829657|451717349|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
125570792|NCT03829657|451717350|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
125570793|NCT03829657|451717351|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
125570794|NCT03829657|451717347|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
125570795|NCT03829657|451717348|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
125570796|NCT03829657|451717349|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
125570797|NCT03829657|451717350|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
125570798|NCT03829657|451717351|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
125570799|NCT03829657|451717347|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
125570800|NCT03829657|451717348|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
125570801|NCT03829657|451717349|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
125570802|NCT03829657|451717350|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
125358135|NCT01460368|450946338|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
125358136|NCT01460368|450946339|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
125358137|NCT01460368|450946340|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
125358138|NCT01460368|450946341|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
125358139|NCT01460368|450946342|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
125358140|NCT01460368|450946336|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
125358141|NCT01460368|450946337|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
125358142|NCT01460368|450946338|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
125358143|NCT01460368|450946339|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
125358144|NCT01460368|450946340|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
125358145|NCT01460368|450946341|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
125358146|NCT01460368|450946342|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
125358147|NCT01460368|450946336|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
125358148|NCT01460368|450946337|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
125358149|NCT01460368|450946338|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
125358150|NCT01460368|450946339|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
125426900|NCT05163522|451188039|FG004|Overall Study|Withdrawal by Subject|0|||
125570803|NCT03829657|451717351|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
125570804|NCT03829657|451717347|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
125426901|NCT05163522|451188040|FG005|Overall Study|Withdrawal by Subject|0|||
125426902|NCT05163522|451188041|FG006|Overall Study|Withdrawal by Subject|0|||
125426903|NCT05163522|451188042|FG007|Overall Study|Withdrawal by Subject|0|||
125426904|NCT05163522|451188043|FG008|Overall Study|Withdrawal by Subject|0|||
125426905|NCT05163522|451188044|FG009|Overall Study|Withdrawal by Subject|0|||
125426906|NCT05163522|451188045|FG010|Overall Study|Withdrawal by Subject|0|||
125426907|NCT03412396|451188046|FG000|Overall Study|Withdrawal by Subject|2|||
125426908|NCT03412396|451188046|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
125426909|NCT03412396|451188046|FG000|Overall Study|Did not undergo RP|2|||
125426910|NCT02753595|451188054|FG000|Overall Study|Sponsor termination|2|||
125426911|NCT02753595|451188055|FG001|Overall Study|Sponsor termination|2|||
125426912|NCT01570868|451188056|FG000|Overall Study|Adverse Event|8|||
125426913|NCT01570868|451188057|FG001|Overall Study|Adverse Event|1|||
125426914|NCT01570868|451188056|FG000|Overall Study|FDA Recommendation|23|||
125426915|NCT01570868|451188057|FG001|Overall Study|FDA Recommendation|3|||
125426916|NCT01570868|451188056|FG000|Overall Study|Physician Decision|10|||
125426917|NCT01570868|451188057|FG001|Overall Study|Physician Decision|4|||
125426918|NCT01570868|451188056|FG000|Overall Study|Lost to Follow-up|1|||
125426919|NCT01570868|451188057|FG001|Overall Study|Lost to Follow-up|0|||
125426920|NCT01570868|451188056|FG000|Overall Study|Withdrawal by Subject|1|||
125426921|NCT01570868|451188057|FG001|Overall Study|Withdrawal by Subject|0|||
125426922|NCT02515279|451188061|FG000|Overall Study|Adverse Event|7|||
125426923|NCT02515279|451188061|FG000|Overall Study|Lack of Efficacy|31|||
125426924|NCT02515279|451188061|FG000|Overall Study|Lost to Follow-up|9|||
125570805|NCT03829657|451717348|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
125358151|NCT01460368|450946340|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
125426925|NCT02515279|451188061|FG000|Overall Study|Withdrawal by Subject|18|||
125426926|NCT02515279|451188061|FG000|Overall Study|End-of-treatment visit not attended|17|||
125426927|NCT02515279|451188061|FG000|Overall Study|Other|22|||
125426928|NCT03266770|451188062|FG000|Overall Study|Physician Decision|3|||
125426929|NCT03266770|451188062|FG000|Overall Study|Insufficient study supplies|1|||
125570806|NCT03829657|451717349|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
125570807|NCT03829657|451717350|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
125570808|NCT03829657|451717351|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
125570809|NCT04194528|451717352|FG000|Overall Study|Adverse Event|1|||
125570810|NCT00333359|451717355|FG000|Overall Study|Adverse Event|29|||
125570811|NCT00333359|451717356|FG001|Overall Study|Adverse Event|35|||
125570812|NCT00333359|451717355|FG000|Overall Study|Withdrawal by Subject|19|||
125570813|NCT00333359|451717356|FG001|Overall Study|Withdrawal by Subject|37|||
125570814|NCT00333359|451717355|FG000|Overall Study|Physician Decision|2|||
125570815|NCT00333359|451717356|FG001|Overall Study|Physician Decision|2|||
125570816|NCT00333359|451717355|FG000|Overall Study|Protocol Non-compliance|2|||
125570817|NCT00333359|451717356|FG001|Overall Study|Protocol Non-compliance|8|||
125570818|NCT00333359|451717355|FG000|Overall Study|Lost to Follow-up|15|||
125570819|NCT00333359|451717356|FG001|Overall Study|Lost to Follow-up|25|||
125570820|NCT00333359|451717355|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
125570821|NCT00333359|451717356|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
125570822|NCT00333359|451717355|FG000|Overall Study|Treatment Failure|3|||
125570823|NCT00333359|451717356|FG001|Overall Study|Treatment Failure|8|||
125570824|NCT00333359|451717355|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
125570825|NCT00333359|451717356|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
125570826|NCT01394939|451718602|FG000|Overall Study|Adverse Event|1|||
125570827|NCT01394939|451718603|FG001|Overall Study|Adverse Event|3|||
125570828|NCT01394939|451718604|FG002|Overall Study|Adverse Event|0|||
125570829|NCT01394939|451718605|FG003|Overall Study|Adverse Event|2|||
125570830|NCT01394939|451718602|FG000|Overall Study|Death|0|||
125570831|NCT01394939|451718603|FG001|Overall Study|Death|2|||
125570832|NCT01394939|451718604|FG002|Overall Study|Death|0|||
125570833|NCT01394939|451718605|FG003|Overall Study|Death|0|||
125570834|NCT01394939|451718602|FG000|Overall Study|Physician Decision|0|||
125570835|NCT01394939|451718603|FG001|Overall Study|Physician Decision|1|||
125570836|NCT01394939|451718604|FG002|Overall Study|Physician Decision|0|||
125570837|NCT01394939|451718605|FG003|Overall Study|Physician Decision|0|||
125358152|NCT01460368|450946341|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
125358153|NCT01460368|450946342|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
125358154|NCT01460368|450946336|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
125358155|NCT01460368|450946337|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
125570838|NCT01394939|451718602|FG000|Overall Study|Withdrawal by Subject|0|||
125570839|NCT01394939|451718603|FG001|Overall Study|Withdrawal by Subject|2|||
125570840|NCT01394939|451718604|FG002|Overall Study|Withdrawal by Subject|0|||
125570841|NCT01394939|451718605|FG003|Overall Study|Withdrawal by Subject|2|||
125358156|NCT01460368|450946338|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
125570842|NCT01394939|451718602|FG000|Overall Study|Others|0|||
125570843|NCT01394939|451718603|FG001|Overall Study|Others|2|||
125570844|NCT01394939|451718604|FG002|Overall Study|Others|0|||
125570845|NCT01394939|451718605|FG003|Overall Study|Others|3|||
125570846|NCT01339559|451718609|FG000|Overall Study|Adverse Event|92|||
125570847|NCT01339559|451718609|FG000|Overall Study|Death|5|||
125570848|NCT01339559|451718609|FG000|Overall Study|Lack of Efficacy|164|||
125570849|NCT01339559|451718609|FG000|Overall Study|Lost to Follow-up|22|||
125570850|NCT01339559|451718609|FG000|Overall Study|Subject choice|89|||
125570851|NCT01339559|451718609|FG000|Overall Study|Protocol Violation|15|||
125570852|NCT01339559|451718609|FG000|Overall Study|Study closure at site|1|||
125570853|NCT01339559|451718609|FG000|Overall Study|Incarcerated|2|||
125570854|NCT01339559|451718609|FG000|Overall Study|Epilepsy surgery|1|||
125570855|NCT01339559|451718609|FG000|Overall Study|Pregnancy planned|2|||
125570856|NCT01339559|451718609|FG000|Overall Study|Left the country|1|||
125570857|NCT01339559|451718609|FG000|Overall Study|Investigator decision|2|||
125570858|NCT01339559|451718609|FG000|Overall Study|Patient didn't wish to continue|1|||
125570859|NCT01339559|451718609|FG000|Overall Study|PI decision|1|||
125570860|NCT00414453|451718610|FG000|Overall Study|Abnormal lab work|16|||
125570861|NCT01784861|451718619|FG000|Overall Study|Adverse Event|0|||
125570862|NCT01784861|451718620|FG001|Overall Study|Adverse Event|0|||
125570863|NCT01784861|451718621|FG002|Overall Study|Adverse Event|1|||
125570864|NCT01784861|451718622|FG003|Overall Study|Adverse Event|2|||
125570865|NCT01784861|451718623|FG004|Overall Study|Adverse Event|1|||
125570866|NCT01784861|451718624|FG005|Overall Study|Adverse Event|0|||
125570867|NCT01784861|451718619|FG000|Overall Study|Withdrawal by Subject|0|||
125570868|NCT01784861|451718620|FG001|Overall Study|Withdrawal by Subject|0|||
125570869|NCT01784861|451718621|FG002|Overall Study|Withdrawal by Subject|0|||
125570870|NCT01784861|451718622|FG003|Overall Study|Withdrawal by Subject|1|||
125570871|NCT01784861|451718623|FG004|Overall Study|Withdrawal by Subject|0|||
125570872|NCT01784861|451718624|FG005|Overall Study|Withdrawal by Subject|0|||
125426930|NCT03266770|451188062|FG000|Overall Study|Adverse Event|1|||
125426931|NCT02657031|451188063|FG000|Overall Study|Adverse Event|1|||
125426932|NCT02657031|451188064|FG001|Overall Study|Adverse Event|2|||
125426933|NCT03078816|451188065|FG000|Overall Study|Withdrawal by Subject|1|||
125426934|NCT05007392|451188066|FG000|Overall Study|Randomized but not treated|1|||
125426935|NCT05007392|451188067|FG001|Overall Study|Randomized but not treated|2|||
125426936|NCT05007392|451188066|FG000|Overall Study|Other|5|||
125426937|NCT05007392|451188067|FG001|Overall Study|Other|4|||
125426938|NCT05007392|451188066|FG000|Overall Study|Lost to Follow-up|1|||
125426939|NCT05007392|451188067|FG001|Overall Study|Lost to Follow-up|2|||
125426940|NCT05007392|451188066|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
125426941|NCT05007392|451188067|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
125426942|NCT05007392|451188066|FG000|Overall Study|Use of prohibited concomitant drug|1|||
125426943|NCT05007392|451188067|FG001|Overall Study|Use of prohibited concomitant drug|1|||
125426944|NCT05007392|451188066|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
125426945|NCT05007392|451188067|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
125426946|NCT05007392|451188066|FG000|Overall Study|Adverse Event|10|||
125426947|NCT05007392|451188067|FG001|Overall Study|Adverse Event|6|||
125426948|NCT05007392|451188066|FG000|Overall Study|Participant choice|5|||
125426949|NCT05007392|451188067|FG001|Overall Study|Participant choice|10|||
125426950|NCT05007392|451188066|FG000|Overall Study|Withdrawal of consent|5|||
125570873|NCT01784861|451718619|FG000|Overall Study|Physician Decision|0|||
125570874|NCT01784861|451718620|FG001|Overall Study|Physician Decision|0|||
125570875|NCT01784861|451718621|FG002|Overall Study|Physician Decision|0|||
125570876|NCT01784861|451718622|FG003|Overall Study|Physician Decision|2|||
125570877|NCT01784861|451718623|FG004|Overall Study|Physician Decision|0|||
125426951|NCT05007392|451188067|FG001|Overall Study|Withdrawal of consent|4|||
125570878|NCT01784861|451718624|FG005|Overall Study|Physician Decision|1|||
125570879|NCT02432235|451718625|FG000|Overall Study|Death|1|||
125570880|NCT02432235|451718626|FG001|Overall Study|Death|1|||
125570881|NCT02432235|451718627|FG002|Overall Study|Death|2|||
125570882|NCT02432235|451718628|FG003|Overall Study|Death|2|||
125570883|NCT02432235|451718629|FG004|Overall Study|Death|1|||
125570884|NCT02432235|451718630|FG005|Overall Study|Death|3|||
125570885|NCT02432235|451718631|FG006|Overall Study|Death|11|||
125570886|NCT02432235|451718632|FG007|Overall Study|Death|15|||
125570887|NCT02432235|451718633|FG008|Overall Study|Death|15|||
125426952|NCT01218126|451188070|FG000|Overall Study|Adverse Event|8|||
125570888|NCT02432235|451718634|FG009|Overall Study|Death|3|||
125570889|NCT02432235|451718635|FG010|Overall Study|Death|1|||
125570890|NCT02432235|451718636|FG011|Overall Study|Death|0|||
125570891|NCT02432235|451718625|FG000|Overall Study|Withdrawal by Subject|0|||
125570892|NCT02432235|451718626|FG001|Overall Study|Withdrawal by Subject|1|||
125570893|NCT02432235|451718627|FG002|Overall Study|Withdrawal by Subject|0|||
125570894|NCT02432235|451718628|FG003|Overall Study|Withdrawal by Subject|0|||
125570895|NCT02432235|451718629|FG004|Overall Study|Withdrawal by Subject|0|||
125570896|NCT02432235|451718630|FG005|Overall Study|Withdrawal by Subject|2|||
125570897|NCT02432235|451718631|FG006|Overall Study|Withdrawal by Subject|5|||
125570898|NCT02432235|451718632|FG007|Overall Study|Withdrawal by Subject|3|||
125570899|NCT02432235|451718633|FG008|Overall Study|Withdrawal by Subject|1|||
125570900|NCT02432235|451718634|FG009|Overall Study|Withdrawal by Subject|0|||
125570901|NCT02432235|451718635|FG010|Overall Study|Withdrawal by Subject|0|||
125570902|NCT02432235|451718636|FG011|Overall Study|Withdrawal by Subject|0|||
125570903|NCT02432235|451718625|FG000|Overall Study|Lost to Follow-up|0|||
125570904|NCT02432235|451718626|FG001|Overall Study|Lost to Follow-up|0|||
125570905|NCT02432235|451718627|FG002|Overall Study|Lost to Follow-up|0|||
125570906|NCT02432235|451718628|FG003|Overall Study|Lost to Follow-up|0|||
125570907|NCT02432235|451718629|FG004|Overall Study|Lost to Follow-up|0|||
125570908|NCT02432235|451718630|FG005|Overall Study|Lost to Follow-up|1|||
125570909|NCT02432235|451718631|FG006|Overall Study|Lost to Follow-up|0|||
125570910|NCT02432235|451718632|FG007|Overall Study|Lost to Follow-up|0|||
125570911|NCT02432235|451718633|FG008|Overall Study|Lost to Follow-up|1|||
125570912|NCT02432235|451718634|FG009|Overall Study|Lost to Follow-up|0|||
125570913|NCT02432235|451718635|FG010|Overall Study|Lost to Follow-up|0|||
125570914|NCT02432235|451718636|FG011|Overall Study|Lost to Follow-up|0|||
125570915|NCT02432235|451718625|FG000|Overall Study|Miscellaneous|0|||
125570916|NCT02432235|451718626|FG001|Overall Study|Miscellaneous|0|||
125570917|NCT02432235|451718627|FG002|Overall Study|Miscellaneous|0|||
125570918|NCT02432235|451718628|FG003|Overall Study|Miscellaneous|0|||
125570919|NCT02432235|451718629|FG004|Overall Study|Miscellaneous|1|||
125570920|NCT02432235|451718630|FG005|Overall Study|Miscellaneous|6|||
125570921|NCT02432235|451718631|FG006|Overall Study|Miscellaneous|2|||
125570922|NCT02432235|451718632|FG007|Overall Study|Miscellaneous|2|||
125570923|NCT02432235|451718633|FG008|Overall Study|Miscellaneous|4|||
125570924|NCT02432235|451718634|FG009|Overall Study|Miscellaneous|0|||
125570925|NCT02432235|451718635|FG010|Overall Study|Miscellaneous|0|||
125570926|NCT02432235|451718636|FG011|Overall Study|Miscellaneous|1|||
125570927|NCT00794677|451718642|FG000|First Intervention|Withdrawal by Subject|2|||
125570928|NCT00794677|451718643|FG001|First Intervention|Withdrawal by Subject|0|||
125570929|NCT00906087|451718645|FG000|Initial Washout|Withdrawal by Subject|1|||
125570930|NCT00906087|451718645|FG000|Initial Washout|Physician Decision|1|||
125570931|NCT02970292|451718648|FG000|Overall Study|Physician Decision|1|||
125570932|NCT02970292|451718649|FG001|Overall Study|Physician Decision|1|||
125570933|NCT02970292|451718648|FG000|Overall Study|Withdrawal by Subject|11|||
125570934|NCT02970292|451718649|FG001|Overall Study|Withdrawal by Subject|5|||
125570935|NCT02970292|451718648|FG000|Overall Study|Noncompliance with study drug|2|||
125570936|NCT02970292|451718649|FG001|Overall Study|Noncompliance with study drug|2|||
125570937|NCT02970292|451718648|FG000|Overall Study|Adverse Event|5|||
125570938|NCT02970292|451718649|FG001|Overall Study|Adverse Event|0|||
125570939|NCT02970292|451718648|FG000|Overall Study|Lack of Efficacy|1|||
125570940|NCT02970292|451718649|FG001|Overall Study|Lack of Efficacy|0|||
125570941|NCT02970292|451718648|FG000|Overall Study|Lost to Follow-up|1|||
125570942|NCT02970292|451718649|FG001|Overall Study|Lost to Follow-up|0|||
125570943|NCT02970292|451718648|FG000|Overall Study|Protocol Violation|2|||
125570944|NCT02970292|451718649|FG001|Overall Study|Protocol Violation|0|||
125570945|NCT02970292|451718648|FG000|Overall Study|Other|1|||
125570946|NCT02970292|451718649|FG001|Overall Study|Other|0|||
125570947|NCT00513500|451718654|FG000|Overall Study|Lost to Follow-up|35|||
125570948|NCT00513500|451718655|FG001|Overall Study|Lost to Follow-up|39|||
125570949|NCT00513500|451718654|FG000|Overall Study|Death|2|||
125570950|NCT00513500|451718655|FG001|Overall Study|Death|1|||
125570951|NCT00513500|451718654|FG000|Overall Study|Hospitalized|4|||
125570952|NCT00513500|451718655|FG001|Overall Study|Hospitalized|14|||
125570953|NCT00749996|451718658|FG000|Overall Study|Lost to Follow-up|7|||
125570954|NCT00749996|451718659|FG001|Overall Study|Lost to Follow-up|4|||
125570955|NCT00749996|451718658|FG000|Overall Study|Withdrawal by Subject|5|||
125570956|NCT00749996|451718659|FG001|Overall Study|Withdrawal by Subject|4|||
125570957|NCT00749996|451718658|FG000|Overall Study|Protocol Violation|2|||
125570958|NCT00749996|451718659|FG001|Overall Study|Protocol Violation|3|||
125570959|NCT00749996|451718658|FG000|Overall Study|Physician Decision|2|||
125570960|NCT00749996|451718659|FG001|Overall Study|Physician Decision|0|||
125570961|NCT00749996|451718658|FG000|Overall Study|Pregnancy|0|||
125570962|NCT00749996|451718659|FG001|Overall Study|Pregnancy|2|||
125570963|NCT00749996|451718658|FG000|Overall Study|Adverse Event|1|||
125570964|NCT00749996|451718659|FG001|Overall Study|Adverse Event|0|||
125570965|NCT00749996|451718658|FG000|Overall Study|Death|1|||
125570966|NCT00749996|451718659|FG001|Overall Study|Death|0|||
125570967|NCT00109707|451718660|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
125570968|NCT00109707|451718661|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
125570969|NCT00109707|451718662|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
125570970|NCT00109707|451718660|FG000|Overall Study|Abnormal laboratory values|1|||
125570971|NCT00109707|451718661|FG001|Overall Study|Abnormal laboratory values|0|||
125570972|NCT00109707|451718662|FG002|Overall Study|Abnormal laboratory values|0|||
125570973|NCT00109707|451718660|FG000|Overall Study|Administrative problems|2|||
125570974|NCT00109707|451718661|FG001|Overall Study|Administrative problems|0|||
125570975|NCT00109707|451718662|FG002|Overall Study|Administrative problems|1|||
125570976|NCT00109707|451718660|FG000|Overall Study|Adverse Event|10|||
125570977|NCT00109707|451718661|FG001|Overall Study|Adverse Event|2|||
125570978|NCT00109707|451718662|FG002|Overall Study|Adverse Event|3|||
125570979|NCT00109707|451718660|FG000|Overall Study|Death|4|||
125570980|NCT00109707|451718661|FG001|Overall Study|Death|0|||
125570981|NCT00109707|451718662|FG002|Overall Study|Death|0|||
125570982|NCT00109707|451718660|FG000|Overall Study|Disease progression|12|||
125570983|NCT00109707|451718661|FG001|Overall Study|Disease progression|4|||
125570984|NCT00109707|451718662|FG002|Overall Study|Disease progression|3|||
125570985|NCT00109707|451718660|FG000|Overall Study|Lost to Follow-up|3|||
125570986|NCT00109707|451718661|FG001|Overall Study|Lost to Follow-up|0|||
125570987|NCT00109707|451718662|FG002|Overall Study|Lost to Follow-up|0|||
125570988|NCT00109707|451718660|FG000|Overall Study|Protocol Violation|1|||
125570989|NCT00109707|451718661|FG001|Overall Study|Protocol Violation|0|||
125570990|NCT00109707|451718662|FG002|Overall Study|Protocol Violation|0|||
125570991|NCT00109707|451718660|FG000|Overall Study|Patient withdrew consent|6|||
125570992|NCT00109707|451718661|FG001|Overall Study|Patient withdrew consent|1|||
125570993|NCT00109707|451718662|FG002|Overall Study|Patient withdrew consent|0|||
125570994|NCT00446511|451718663|FG000|Overall Study|Adverse Event|7|||
125570995|NCT00446511|451718664|FG001|Overall Study|Adverse Event|2|||
125570996|NCT00446511|451718665|FG002|Overall Study|Adverse Event|3|||
125570997|NCT00446511|451718666|FG003|Overall Study|Adverse Event|1|||
125570998|NCT00446511|451718663|FG000|Overall Study|Protocol Violation|0|||
125570999|NCT00446511|451718664|FG001|Overall Study|Protocol Violation|0|||
125571000|NCT00446511|451718665|FG002|Overall Study|Protocol Violation|0|||
125571001|NCT00446511|451718666|FG003|Overall Study|Protocol Violation|1|||
125571002|NCT00446511|451718663|FG000|Overall Study|Withdrawal by Subject|0|||
125571003|NCT00446511|451718664|FG001|Overall Study|Withdrawal by Subject|0|||
125571004|NCT00446511|451718665|FG002|Overall Study|Withdrawal by Subject|0|||
125571005|NCT00446511|451718666|FG003|Overall Study|Withdrawal by Subject|3|||
125571006|NCT00446511|451718663|FG000|Overall Study|Administrative Problems|3|||
125571007|NCT00446511|451718664|FG001|Overall Study|Administrative Problems|0|||
125571008|NCT00446511|451718665|FG002|Overall Study|Administrative Problems|4|||
125571009|NCT00446511|451718666|FG003|Overall Study|Administrative Problems|1|||
125571010|NCT00606086|451718669|FG000|Overall Study|Adverse Event|1|||
125571011|NCT00606086|451718670|FG001|Overall Study|Adverse Event|1|||
125571012|NCT00606086|451718669|FG000|Overall Study|Lost to Follow-up|4|||
125571013|NCT00606086|451718670|FG001|Overall Study|Lost to Follow-up|8|||
125571014|NCT00606086|451718669|FG000|Overall Study|Protocol Violation|1|||
125571015|NCT00606086|451718670|FG001|Overall Study|Protocol Violation|0|||
125571016|NCT00606086|451718669|FG000|Overall Study|Withdrawal by Subject|5|||
125571017|NCT00606086|451718670|FG001|Overall Study|Withdrawal by Subject|3|||
125571018|NCT00606086|451718669|FG000|Overall Study|Non-compliance|0|||
125571019|NCT00606086|451718670|FG001|Overall Study|Non-compliance|1|||
125571020|NCT00606086|451718669|FG000|Overall Study|Randomized, not treated|1|||
125571021|NCT00606086|451718670|FG001|Overall Study|Randomized, not treated|2|||
125571022|NCT00542269|451718675|FG000|Overall Study|Adverse Event|10|||
125571023|NCT00542269|451718676|FG001|Overall Study|Adverse Event|4|||
125571024|NCT00542269|451718677|FG002|Overall Study|Adverse Event|5|||
125571025|NCT00542269|451718675|FG000|Overall Study|Protocol Violation|1|||
125571026|NCT00542269|451718676|FG001|Overall Study|Protocol Violation|1|||
125571027|NCT00542269|451718677|FG002|Overall Study|Protocol Violation|0|||
125571028|NCT00542269|451718675|FG000|Overall Study|Withdrawal by Subject|1|||
125571029|NCT00542269|451718676|FG001|Overall Study|Withdrawal by Subject|0|||
125571030|NCT00542269|451718677|FG002|Overall Study|Withdrawal by Subject|0|||
125571031|NCT00542269|451718675|FG000|Overall Study|Administrative problems|1|||
125571032|NCT00542269|451718676|FG001|Overall Study|Administrative problems|1|||
125571033|NCT00542269|451718677|FG002|Overall Study|Administrative problems|1|||
125571034|NCT03873714|451718678|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
125571035|NCT00708123|451718679|FG000|Period 1|Protocol Violation|0|||
125571036|NCT00708123|451718680|FG001|Period 1|Protocol Violation|1|||
125571037|NCT00708123|451718681|FG002|Period 1|Protocol Violation|0|||
125571038|NCT00708123|451718682|FG003|Period 1|Protocol Violation|1|||
125571039|NCT00708123|451718683|FG004|Period 1|Protocol Violation|0|||
125571040|NCT00708123|451718679|FG000|Period 1|Adverse Event|0|||
125571041|NCT00708123|451718680|FG001|Period 1|Adverse Event|0|||
125571042|NCT00708123|451718681|FG002|Period 1|Adverse Event|1|||
125571043|NCT00708123|451718682|FG003|Period 1|Adverse Event|0|||
125571044|NCT00708123|451718683|FG004|Period 1|Adverse Event|0|||
125571045|NCT00708123|451718679|FG000|Period 2|Protocol Violation|0|||
125571046|NCT00708123|451718680|FG001|Period 2|Protocol Violation|0|||
125571047|NCT00708123|451718681|FG002|Period 2|Protocol Violation|0|||
125358157|NCT01460368|450946339|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
125358158|NCT01460368|450946340|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
125358159|NCT01460368|450946341|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
125358160|NCT01460368|450946342|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
125358161|NCT00299182|450946352|FG000|Overall Study|Withdrawal by Subject|0|||
125358162|NCT00299182|450946353|FG001|Overall Study|Withdrawal by Subject|0|||
125358163|NCT00299182|450946354|FG002|Overall Study|Withdrawal by Subject|1|||
125358164|NCT00299182|450946355|FG003|Overall Study|Withdrawal by Subject|0|||
125358165|NCT00299182|450946356|FG004|Overall Study|Withdrawal by Subject|1|||
125358166|NCT00299182|450946357|FG005|Overall Study|Withdrawal by Subject|2|||
125358167|NCT00299182|450946358|FG006|Overall Study|Withdrawal by Subject|0|||
125358168|NCT00299182|450946352|FG000|Overall Study|Chemotherapy Changed|0|||
125358169|NCT00299182|450946353|FG001|Overall Study|Chemotherapy Changed|0|||
125358170|NCT00299182|450946354|FG002|Overall Study|Chemotherapy Changed|1|||
125358171|NCT00299182|450946355|FG003|Overall Study|Chemotherapy Changed|0|||
125358172|NCT00299182|450946356|FG004|Overall Study|Chemotherapy Changed|1|||
125358173|NCT00299182|450946357|FG005|Overall Study|Chemotherapy Changed|0|||
125358174|NCT00299182|450946358|FG006|Overall Study|Chemotherapy Changed|1|||
125358175|NCT00299182|450946352|FG000|Overall Study|Adverse Event|0|||
125358176|NCT00299182|450946353|FG001|Overall Study|Adverse Event|0|||
125358177|NCT00299182|450946354|FG002|Overall Study|Adverse Event|0|||
125358178|NCT00299182|450946355|FG003|Overall Study|Adverse Event|0|||
125358179|NCT00299182|450946356|FG004|Overall Study|Adverse Event|0|||
125358180|NCT00299182|450946357|FG005|Overall Study|Adverse Event|1|||
125358181|NCT00299182|450946358|FG006|Overall Study|Adverse Event|0|||
125358182|NCT00299182|450946352|FG000|Overall Study|Not Eligible|0|||
125358183|NCT00299182|450946353|FG001|Overall Study|Not Eligible|0|||
125358184|NCT00299182|450946354|FG002|Overall Study|Not Eligible|0|||
125358185|NCT00299182|450946355|FG003|Overall Study|Not Eligible|0|||
125358186|NCT00299182|450946356|FG004|Overall Study|Not Eligible|1|||
125358187|NCT00299182|450946357|FG005|Overall Study|Not Eligible|0|||
125358188|NCT00299182|450946358|FG006|Overall Study|Not Eligible|0|||
125358189|NCT01631812|450946359|FG000|Overall Study|Adverse Event|25|||
125358190|NCT01631812|450946359|FG000|Overall Study|Lack of Efficacy|5|||
125358191|NCT01631812|450946359|FG000|Overall Study|Withdrawal by Subject|4|||
125358192|NCT01631812|450946359|FG000|Overall Study|Physician Decision|3|||
125358193|NCT00072176|450946362|FG000|Overall Study|Withdrawal by Subject|1|||
125358194|NCT00072176|450946363|FG001|Overall Study|Withdrawal by Subject|0|||
125358195|NCT00072176|450946362|FG000|Overall Study|Protocol Violation|0|||
125358196|NCT00072176|450946363|FG001|Overall Study|Protocol Violation|1|||
125358197|NCT02024555|450946367|FG000|Overall Study|Lost to Follow-up|1|||
125358198|NCT02024555|450946368|FG001|Overall Study|Lost to Follow-up|1|||
125358199|NCT02024555|450946367|FG000|Overall Study|Withdrawal by Subject|5|||
125358200|NCT02024555|450946368|FG001|Overall Study|Withdrawal by Subject|1|||
125358201|NCT03805646|450946370|FG000|Overall Study|Death|40|||
125358202|NCT03805646|450946371|FG001|Overall Study|Death|49|||
125358203|NCT03805646|450946370|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
125358204|NCT03805646|450946371|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
125358205|NCT03350620|450946374|FG000|Stage 2|Adverse Event|0|||
125358206|NCT03350620|450946375|FG001|Stage 2|Adverse Event|1|||
125358207|NCT03350620|450946376|FG002|Stage 2|Adverse Event|1|||
125358208|NCT03350620|450946374|FG000|Stage 2|Lack of Efficacy|0|||
125426953|NCT01218126|451188071|FG001|Overall Study|Adverse Event|10|||
125571048|NCT00708123|451718682|FG003|Period 2|Protocol Violation|1|||
125571049|NCT00708123|451718683|FG004|Period 2|Protocol Violation|0|||
125571050|NCT00708123|451718679|FG000|Period 2|Other Reason|1|||
125358209|NCT03350620|450946375|FG001|Stage 2|Lack of Efficacy|2|||
125358210|NCT03350620|450946376|FG002|Stage 2|Lack of Efficacy|0|||
125358211|NCT03350620|450946374|FG000|Stage 2|Lost to Follow-up|1|||
125358212|NCT03350620|450946375|FG001|Stage 2|Lost to Follow-up|2|||
125358213|NCT03350620|450946376|FG002|Stage 2|Lost to Follow-up|2|||
125358214|NCT03350620|450946374|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
125571051|NCT00708123|451718680|FG001|Period 2|Other Reason|0|||
125571052|NCT00708123|451718681|FG002|Period 2|Other Reason|0|||
125571053|NCT00708123|451718682|FG003|Period 2|Other Reason|0|||
125571054|NCT00708123|451718683|FG004|Period 2|Other Reason|0|||
125571055|NCT00708123|451718679|FG000|Period 3|Lost to Follow-up|0|||
125571056|NCT00708123|451718680|FG001|Period 3|Lost to Follow-up|0|||
125571057|NCT00708123|451718681|FG002|Period 3|Lost to Follow-up|1|||
125571058|NCT00708123|451718682|FG003|Period 3|Lost to Follow-up|1|||
125571059|NCT00708123|451718683|FG004|Period 3|Lost to Follow-up|0|||
125571060|NCT00708123|451718679|FG000|Period 4|Protocol Violation|0|||
125571061|NCT00708123|451718680|FG001|Period 4|Protocol Violation|1|||
125571062|NCT00708123|451718681|FG002|Period 4|Protocol Violation|0|||
125571063|NCT00708123|451718682|FG003|Period 4|Protocol Violation|0|||
125571064|NCT00708123|451718683|FG004|Period 4|Protocol Violation|0|||
125571065|NCT00845650|451718686|FG000|Overall Study|Withdrawal by Subject|0|||
125571066|NCT00845650|451718687|FG001|Overall Study|Withdrawal by Subject|0|||
125571067|NCT00845650|451718688|FG002|Overall Study|Withdrawal by Subject|0|||
125571068|NCT00845650|451718689|FG003|Overall Study|Withdrawal by Subject|0|||
125571069|NCT00845650|451718690|FG004|Overall Study|Withdrawal by Subject|2|||
125571070|NCT00845650|451718691|FG005|Overall Study|Withdrawal by Subject|0|||
125571071|NCT00845650|451718686|FG000|Overall Study|Lost to Follow-up|0|||
125571072|NCT00845650|451718687|FG001|Overall Study|Lost to Follow-up|0|||
125571073|NCT00845650|451718688|FG002|Overall Study|Lost to Follow-up|3|||
125571074|NCT00845650|451718689|FG003|Overall Study|Lost to Follow-up|1|||
125571075|NCT00845650|451718690|FG004|Overall Study|Lost to Follow-up|0|||
125571076|NCT00845650|451718691|FG005|Overall Study|Lost to Follow-up|1|||
125571077|NCT00845650|451718686|FG000|Overall Study|Sponsor hold on dosing|0|||
125571078|NCT00845650|451718687|FG001|Overall Study|Sponsor hold on dosing|0|||
125571079|NCT00845650|451718688|FG002|Overall Study|Sponsor hold on dosing|0|||
125571080|NCT00845650|451718689|FG003|Overall Study|Sponsor hold on dosing|0|||
125571081|NCT00845650|451718690|FG004|Overall Study|Sponsor hold on dosing|1|||
125571082|NCT00845650|451718691|FG005|Overall Study|Sponsor hold on dosing|1|||
125571083|NCT00845650|451718686|FG000|Overall Study|Unable to access IV line|1|||
125571084|NCT00845650|451718687|FG001|Overall Study|Unable to access IV line|0|||
125571085|NCT00845650|451718688|FG002|Overall Study|Unable to access IV line|0|||
125571086|NCT00845650|451718689|FG003|Overall Study|Unable to access IV line|0|||
125571087|NCT00845650|451718690|FG004|Overall Study|Unable to access IV line|0|||
125571088|NCT00845650|451718691|FG005|Overall Study|Unable to access IV line|0|||
125571089|NCT00814892|451718692|FG000|Overall Study|Disease Progression|1|||
125571090|NCT00814892|451718692|FG000|Overall Study|Study Termination|1|||
125571091|NCT04486950|451718693|FG000|Overall Study|Lost to Follow-up|0|||
125571092|NCT04486950|451718694|FG001|Overall Study|Lost to Follow-up|0|||
125571093|NCT04486950|451718695|FG002|Overall Study|Lost to Follow-up|0|||
125571094|NCT04486950|451718696|FG003|Overall Study|Lost to Follow-up|0|||
125571095|NCT04486950|451718697|FG004|Overall Study|Lost to Follow-up|0|||
125571096|NCT04486950|451718698|FG005|Overall Study|Lost to Follow-up|1|||
125571097|NCT04486950|451718699|FG006|Overall Study|Lost to Follow-up|0|||
125571098|NCT00550680|451718702|FG000|Overall Study|Administrative Reasons|1|||
125571099|NCT00550680|451718702|FG000|Overall Study|Adverse Event|5|||
125571100|NCT00550680|451718702|FG000|Overall Study|Death|3|||
125571101|NCT00550680|451718702|FG000|Overall Study|Early Improvement|1|||
125571102|NCT00550680|451718702|FG000|Overall Study|Lost to Follow-up|3|||
125571103|NCT00550680|451718702|FG000|Overall Study|Lack of Efficacy|1|||
125571104|NCT00550680|451718702|FG000|Overall Study|Other|10|||
125571105|NCT00550680|451718702|FG000|Overall Study|Protocol Violation|7|||
125571106|NCT00550680|451718702|FG000|Overall Study|Refused Treatment|19|||
125571107|NCT00550680|451718702|FG000|Overall Study|Screen Failure|6|||
125358215|NCT03350620|450946375|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
125358216|NCT03350620|450946376|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
125571108|NCT01119248|451718703|FG000|Overall Study|Physician Decision|5|||
125571109|NCT00562354|451718704|FG000|Overall Study|Physician Decision|0|||
125571110|NCT00562354|451718705|FG001|Overall Study|Physician Decision|1|||
125571111|NCT00562354|451718704|FG000|Overall Study|Lost to Follow-up|0|||
125571112|NCT00562354|451718705|FG001|Overall Study|Lost to Follow-up|1|||
125571113|NCT00317109|451718706|FG000|Overall Study|Withdrawal by Subject|2|||
125571114|NCT00317109|451718707|FG001|Overall Study|Withdrawal by Subject|0|||
125571115|NCT00317109|451718706|FG000|Overall Study|Migated/moved from study area|1|||
125571116|NCT00317109|451718707|FG001|Overall Study|Migated/moved from study area|0|||
125571117|NCT03693625|451718709|FG000|Overall Study|Adverse Event|2|||
125571118|NCT03693625|451718710|FG001|Overall Study|Adverse Event|0|||
125571119|NCT03693625|451718709|FG000|Overall Study|Study Terminated By Sponsor|20|||
125571120|NCT03693625|451718710|FG001|Overall Study|Study Terminated By Sponsor|7|||
125571121|NCT03693625|451718709|FG000|Overall Study|Withdrawal by Subject|1|||
125571122|NCT03693625|451718710|FG001|Overall Study|Withdrawal by Subject|1|||
125571123|NCT01508702|451718711|FG000|Overall Study|Adverse Event|7|||
125571124|NCT01508702|451718712|FG001|Overall Study|Adverse Event|3|||
125571125|NCT01508702|451718711|FG000|Overall Study|Gout flare|2|||
125571126|NCT01508702|451718712|FG001|Overall Study|Gout flare|0|||
125571127|NCT01508702|451718711|FG000|Overall Study|Protocol Violation|2|||
125571128|NCT01508702|451718712|FG001|Overall Study|Protocol Violation|1|||
125571129|NCT01508702|451718711|FG000|Overall Study|Lost to Follow-up|1|||
125571130|NCT01508702|451718712|FG001|Overall Study|Lost to Follow-up|2|||
125571131|NCT01508702|451718711|FG000|Overall Study|Withdrawal by Subject|11|||
125571132|NCT01508702|451718712|FG001|Overall Study|Withdrawal by Subject|7|||
125571133|NCT01883635|451718714|FG000|Overall Study|Withdrawal by Subject|4|||
125571134|NCT01883635|451718715|FG001|Overall Study|Withdrawal by Subject|0|||
125571135|NCT01187953|451718716|FG000|Overall Study|Death|11|||
125571136|NCT01187953|451718717|FG001|Overall Study|Death|13|||
125571137|NCT01187953|451718716|FG000|Overall Study|Adverse Event|1|||
125571138|NCT01187953|451718717|FG001|Overall Study|Adverse Event|2|||
125571139|NCT01187953|451718716|FG000|Overall Study|Lost to Follow-up|0|||
125571140|NCT01187953|451718717|FG001|Overall Study|Lost to Follow-up|3|||
125571141|NCT01187953|451718716|FG000|Overall Study|Withdrawal by Subject|3|||
125571142|NCT01187953|451718717|FG001|Overall Study|Withdrawal by Subject|3|||
125571143|NCT01464307|451718718|FG000|Main Period|Death|0|||
125571144|NCT01464307|451718719|FG001|Main Period|Death|1|||
125571145|NCT01464307|451718718|FG000|Main Period|Adverse Event|6|||
125571146|NCT01464307|451718719|FG001|Main Period|Adverse Event|1|||
125571147|NCT01464307|451718718|FG000|Main Period|Lack of Efficacy|2|||
125571148|NCT01464307|451718719|FG001|Main Period|Lack of Efficacy|0|||
125571149|NCT01464307|451718718|FG000|Main Period|Withdrawal by Subject|5|||
125571150|NCT01464307|451718719|FG001|Main Period|Withdrawal by Subject|2|||
125571151|NCT01464307|451718718|FG000|Main Period|Predefined discontinuation criteria|2|||
125571152|NCT01464307|451718719|FG001|Main Period|Predefined discontinuation criteria|1|||
125571153|NCT01464307|451718718|FG000|Open-Label Extension Period|Adverse Event|15|||
125571154|NCT01464307|451718719|FG001|Open-Label Extension Period|Adverse Event|0|||
125571155|NCT01464307|451718718|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
125571156|NCT01464307|451718719|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
125571157|NCT01464307|451718718|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
125571158|NCT01464307|451718719|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
125571159|NCT01464307|451718718|FG000|Open-Label Extension Period|Death|1|||
125571160|NCT01464307|451718719|FG001|Open-Label Extension Period|Death|0|||
125358217|NCT01854658|450948177|FG000|Overall Study|Protocol Violation|6|||
125358218|NCT01854658|450948178|FG001|Overall Study|Protocol Violation|2|||
125358219|NCT01854658|450948179|FG002|Overall Study|Protocol Violation|2|||
125358220|NCT01854658|450948180|FG003|Overall Study|Protocol Violation|1|||
125358221|NCT01854658|450948177|FG000|Overall Study|Physician Decision|7|||
125358222|NCT01854658|450948178|FG001|Overall Study|Physician Decision|5|||
125358223|NCT01854658|450948179|FG002|Overall Study|Physician Decision|2|||
125571161|NCT01464307|451718718|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
125571162|NCT01464307|451718719|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
125571163|NCT01464307|451718718|FG000|Open-Label Extension Period|Non-compliance|9|||
125571164|NCT01464307|451718719|FG001|Open-Label Extension Period|Non-compliance|0|||
125571165|NCT01464307|451718718|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
125571166|NCT01464307|451718719|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
125571167|NCT00761514|451718724|FG000|Overall Study|Adverse Event|1|||
125571168|NCT00761514|451718724|FG000|Overall Study|Withdrawal by Subject|2|||
125571169|NCT00761514|451718724|FG000|Overall Study|Lost to Follow-up|1|||
125571170|NCT00761514|451718724|FG000|Overall Study|Health insurance didn't cover study drug|1|||
125571171|NCT00761514|451718724|FG000|Overall Study|Problem complying with study visit|1|||
125571172|NCT00761514|451718724|FG000|Overall Study|Unable to pay for medications|1|||
125571173|NCT02457637|451718725|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
125571174|NCT01836783|451718726|FG000|Overall Study|Withdrawal by Subject|0|||
125571175|NCT01836783|451718727|FG001|Overall Study|Withdrawal by Subject|2|||
125571176|NCT04942925|451718730|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
125571177|NCT04942925|451718731|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
125571178|NCT04942925|451718730|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
125358224|NCT01854658|450948180|FG003|Overall Study|Physician Decision|4|||
125358225|NCT01854658|450948177|FG000|Overall Study|Lost to Follow-up|8|||
125571179|NCT04942925|451718731|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
125571180|NCT01273883|451718732|FG000|First Intervention|Adverse Event|2|||
125571181|NCT01273883|451718733|FG001|First Intervention|Adverse Event|1|||
125571182|NCT01273883|451718732|FG000|Second Intervention|Lost to Follow-up|1|||
125571183|NCT01273883|451718733|FG001|Second Intervention|Lost to Follow-up|1|||
125571184|NCT01273883|451718732|FG000|Second Intervention|Lack of Efficacy|1|||
125571185|NCT01273883|451718733|FG001|Second Intervention|Lack of Efficacy|0|||
125571186|NCT00159861|451718734|FG000|Core Study - 16 Weeks|Death|3|||
125571187|NCT00159861|451718735|FG001|Core Study - 16 Weeks|Death|0|||
125571188|NCT00159861|451718734|FG000|Core Study - 16 Weeks|Adverse Event|12|||
125571189|NCT00159861|451718735|FG001|Core Study - 16 Weeks|Adverse Event|6|||
125571190|NCT00159861|451718734|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
125571191|NCT00159861|451718735|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
125571192|NCT00159861|451718734|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
125571193|NCT00159861|451718735|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
125571194|NCT00159861|451718734|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
125571195|NCT00159861|451718735|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
125571196|NCT00159861|451718734|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
125571197|NCT00159861|451718735|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
125571198|NCT00159861|451718734|FG000|Extension Study - up to 3 Years|Death|24|||
125571199|NCT00159861|451718735|FG001|Extension Study - up to 3 Years|Death|28|||
125571200|NCT00159861|451718734|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
125571201|NCT00159861|451718735|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
125571202|NCT00159861|451718734|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
125571203|NCT00159861|451718735|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
125571204|NCT00159861|451718734|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
125571205|NCT00159861|451718735|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
125571206|NCT00159861|451718734|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
125571207|NCT00159861|451718735|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
125571208|NCT01430455|451718741|FG000|Overall Study|Withdrawal by Subject|1|||
125571209|NCT01430455|451718741|FG000|Overall Study|Switched to follow-up phase|1|||
125571210|NCT01014689|451718743|FG000|Overall Study|Lack of Efficacy|0|||
125571211|NCT01014689|451718744|FG001|Overall Study|Lack of Efficacy|1|||
125571212|NCT01014689|451718743|FG000|Overall Study|Adverse Event|3|||
125571213|NCT01014689|451718744|FG001|Overall Study|Adverse Event|0|||
125571214|NCT01014689|451718743|FG000|Overall Study|Withdrawal by Subject|5|||
125571215|NCT01014689|451718744|FG001|Overall Study|Withdrawal by Subject|4|||
125571216|NCT01014689|451718743|FG000|Overall Study|Protocol Violation|1|||
125571217|NCT01014689|451718744|FG001|Overall Study|Protocol Violation|1|||
125571218|NCT01014689|451718743|FG000|Overall Study|Lost to Follow-up|3|||
125571219|NCT01014689|451718744|FG001|Overall Study|Lost to Follow-up|7|||
125571220|NCT01014689|451718743|FG000|Overall Study|Pregnancy|1|||
125571221|NCT01014689|451718744|FG001|Overall Study|Pregnancy|0|||
125571222|NCT02867995|451718747|FG000|Overall Study|Withdrawal by Subject|0|||
125571223|NCT02867995|451718748|FG001|Overall Study|Withdrawal by Subject|1|||
125571224|NCT02867995|451718747|FG000|Overall Study|Lost to Follow-up|0|||
125571225|NCT02867995|451718748|FG001|Overall Study|Lost to Follow-up|2|||
125571226|NCT04682405|451720816|FG000|Overall Study|Adverse Event|0|||
125571227|NCT04682405|451720817|FG001|Overall Study|Adverse Event|1|||
125571228|NCT01049035|451720820|FG000|Overall Study|Serious adverse event|0|||
125571229|NCT01049035|451720821|FG001|Overall Study|Serious adverse event|1|||
125571230|NCT01049035|451720822|FG002|Overall Study|Serious adverse event|1|||
125571231|NCT01049035|451720823|FG003|Overall Study|Serious adverse event|2|||
125571232|NCT01049035|451720824|FG004|Overall Study|Serious adverse event|0|||
125571233|NCT01049035|451720825|FG005|Overall Study|Serious adverse event|0|||
125571234|NCT01049035|451720826|FG006|Overall Study|Serious adverse event|0|||
125571235|NCT01049035|451720820|FG000|Overall Study|Other adverse event (AE)|0|||
125571236|NCT01049035|451720821|FG001|Overall Study|Other adverse event (AE)|0|||
125571237|NCT01049035|451720822|FG002|Overall Study|Other adverse event (AE)|0|||
125571238|NCT01049035|451720823|FG003|Overall Study|Other adverse event (AE)|1|||
125571239|NCT01049035|451720824|FG004|Overall Study|Other adverse event (AE)|0|||
125571240|NCT01049035|451720825|FG005|Overall Study|Other adverse event (AE)|0|||
125571241|NCT01049035|451720826|FG006|Overall Study|Other adverse event (AE)|0|||
125571242|NCT01049035|451720820|FG000|Overall Study|Non-compliance with the protocol|12|||
125571243|NCT01049035|451720821|FG001|Overall Study|Non-compliance with the protocol|6|||
125571244|NCT01049035|451720822|FG002|Overall Study|Non-compliance with the protocol|14|||
125571245|NCT01049035|451720823|FG003|Overall Study|Non-compliance with the protocol|5|||
125571246|NCT01049035|451720824|FG004|Overall Study|Non-compliance with the protocol|3|||
125571247|NCT01049035|451720825|FG005|Overall Study|Non-compliance with the protocol|4|||
125571248|NCT01049035|451720826|FG006|Overall Study|Non-compliance with the protocol|10|||
125571249|NCT01049035|451720820|FG000|Overall Study|Lost to Follow-up|5|||
125571250|NCT01049035|451720821|FG001|Overall Study|Lost to Follow-up|4|||
125571251|NCT01049035|451720822|FG002|Overall Study|Lost to Follow-up|4|||
125571252|NCT01049035|451720823|FG003|Overall Study|Lost to Follow-up|1|||
125571253|NCT01049035|451720824|FG004|Overall Study|Lost to Follow-up|0|||
125571254|NCT01049035|451720825|FG005|Overall Study|Lost to Follow-up|3|||
125571255|NCT01049035|451720826|FG006|Overall Study|Lost to Follow-up|3|||
125571256|NCT01049035|451720820|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
125571257|NCT01049035|451720821|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
125571258|NCT01049035|451720822|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
125571259|NCT01049035|451720823|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
125571260|NCT01049035|451720824|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
125571261|NCT01049035|451720825|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
125571262|NCT01049035|451720826|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
125571263|NCT02095535|451720827|FG000|Recruitment|Protocol Violation|2|||
125571264|NCT00623480|451720828|FG000|Overall Study|Lost to Follow-up|0|||
125571265|NCT00623480|451720829|FG001|Overall Study|Lost to Follow-up|1|||
125571266|NCT00623480|451720828|FG000|Overall Study|Withdrawal by Subject|2|||
125571267|NCT00623480|451720829|FG001|Overall Study|Withdrawal by Subject|4|||
125571268|NCT00623480|451720828|FG000|Overall Study|Lack of Efficacy|1|||
125571269|NCT00623480|451720829|FG001|Overall Study|Lack of Efficacy|0|||
125571270|NCT00623480|451720828|FG000|Overall Study|Non-compliant with study medication|4|||
125571271|NCT00623480|451720829|FG001|Overall Study|Non-compliant with study medication|0|||
125571272|NCT00623480|451720828|FG000|Overall Study|Protocol Violation|0|||
125571273|NCT00623480|451720829|FG001|Overall Study|Protocol Violation|1|||
125571274|NCT00623480|451720828|FG000|Overall Study|Site closed by sponsor|0|||
125571275|NCT00623480|451720829|FG001|Overall Study|Site closed by sponsor|1|||
125571276|NCT01877187|451720830|FG000|Overall Study|Death|2|||
125571277|NCT01877187|451720830|FG000|Overall Study|Withdrawal by Subject|4|||
125571278|NCT01877187|451720830|FG000|Overall Study|Lost to Follow-up|3|||
125571279|NCT01877187|451720830|FG000|Overall Study|Declining clinical status|11|||
125571280|NCT01877187|451720830|FG000|Overall Study|Liver transplant|2|||
125571281|NCT03548558|451720831|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
125571282|NCT03548558|451720832|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
125571283|NCT03548558|451720833|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
125571284|NCT03548558|451720834|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
125571285|NCT03548558|451720835|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
125571286|NCT03548558|451720836|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
125571287|NCT03548558|451720837|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
125571288|NCT03548558|451720831|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
125571289|NCT03548558|451720832|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
125571290|NCT03548558|451720833|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
125571291|NCT03548558|451720834|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
125571292|NCT03548558|451720835|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
125571293|NCT03548558|451720836|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
125571294|NCT03548558|451720837|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
125571295|NCT03548558|451720831|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
125571296|NCT03548558|451720832|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
125571297|NCT03548558|451720833|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
125571298|NCT03548558|451720834|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
125571299|NCT03548558|451720835|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
125571300|NCT03548558|451720836|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
125571301|NCT03548558|451720837|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
125571302|NCT03548558|451720831|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
125571303|NCT03548558|451720832|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
125571304|NCT03548558|451720833|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
125571305|NCT03548558|451720834|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
125571306|NCT03548558|451720835|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
125571307|NCT03548558|451720836|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
125571308|NCT03548558|451720837|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
125571309|NCT03548558|451720831|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
125571310|NCT03548558|451720832|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
125571311|NCT03548558|451720833|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
125571312|NCT03548558|451720834|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
125571313|NCT03548558|451720835|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
125571314|NCT03548558|451720836|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
125571315|NCT03548558|451720837|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
125571316|NCT03548558|451720831|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
125571317|NCT03548558|451720832|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
125571318|NCT03548558|451720833|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
125571319|NCT03548558|451720834|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
125571320|NCT03548558|451720835|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
125571321|NCT03548558|451720836|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
125571322|NCT03548558|451720837|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
125571323|NCT03273166|451720847|FG000|Overall Study|Withdrawn prior to Completion|31|||
125571324|NCT02669017|451720848|FG000|Overall Study|Death|1|||
125571325|NCT02669017|451720849|FG001|Overall Study|Death|2|||
125571326|NCT02669017|451720850|FG002|Overall Study|Death|2|||
125571327|NCT02669017|451720851|FG003|Overall Study|Death|3|||
125571328|NCT02669017|451720852|FG004|Overall Study|Death|8|||
125571329|NCT02669017|451720853|FG005|Overall Study|Death|18|||
125571330|NCT02669017|451720854|FG006|Overall Study|Death|10|||
125571331|NCT02669017|451720855|FG007|Overall Study|Death|47|||
125571332|NCT02669017|451720856|FG008|Overall Study|Death|20|||
125571333|NCT02669017|451720848|FG000|Overall Study|Withdrawal by Subject|0|||
125571334|NCT02669017|451720849|FG001|Overall Study|Withdrawal by Subject|0|||
125571335|NCT02669017|451720850|FG002|Overall Study|Withdrawal by Subject|0|||
125571336|NCT02669017|451720851|FG003|Overall Study|Withdrawal by Subject|1|||
125571337|NCT02669017|451720852|FG004|Overall Study|Withdrawal by Subject|2|||
125571338|NCT02669017|451720853|FG005|Overall Study|Withdrawal by Subject|0|||
125571339|NCT02669017|451720854|FG006|Overall Study|Withdrawal by Subject|0|||
125571340|NCT02669017|451720855|FG007|Overall Study|Withdrawal by Subject|2|||
125571341|NCT02669017|451720856|FG008|Overall Study|Withdrawal by Subject|2|||
125571342|NCT02669017|451720848|FG000|Overall Study|Lost to Follow-up|0|||
125571343|NCT02669017|451720849|FG001|Overall Study|Lost to Follow-up|0|||
125571344|NCT02669017|451720850|FG002|Overall Study|Lost to Follow-up|0|||
125571345|NCT02669017|451720851|FG003|Overall Study|Lost to Follow-up|0|||
125571346|NCT02669017|451720852|FG004|Overall Study|Lost to Follow-up|0|||
125571347|NCT02669017|451720853|FG005|Overall Study|Lost to Follow-up|0|||
125571348|NCT02669017|451720854|FG006|Overall Study|Lost to Follow-up|0|||
125571349|NCT02669017|451720855|FG007|Overall Study|Lost to Follow-up|0|||
125571350|NCT02669017|451720856|FG008|Overall Study|Lost to Follow-up|1|||
125571351|NCT02669017|451720848|FG000|Overall Study|Miscellaneous|0|||
125358226|NCT01854658|450948178|FG001|Overall Study|Lost to Follow-up|9|||
125358227|NCT01854658|450948179|FG002|Overall Study|Lost to Follow-up|8|||
125358228|NCT01854658|450948180|FG003|Overall Study|Lost to Follow-up|4|||
125358229|NCT01854658|450948177|FG000|Overall Study|Withdrawal by Subject|28|||
125358230|NCT01854658|450948178|FG001|Overall Study|Withdrawal by Subject|21|||
125358231|NCT01854658|450948179|FG002|Overall Study|Withdrawal by Subject|29|||
125358232|NCT01854658|450948180|FG003|Overall Study|Withdrawal by Subject|15|||
125358233|NCT01854658|450948177|FG000|Overall Study|Protocol-specified criteria|15|||
125358234|NCT01854658|450948178|FG001|Overall Study|Protocol-specified criteria|15|||
125358235|NCT01854658|450948179|FG002|Overall Study|Protocol-specified criteria|10|||
125571352|NCT02669017|451720849|FG001|Overall Study|Miscellaneous|0|||
125571353|NCT02669017|451720850|FG002|Overall Study|Miscellaneous|0|||
125571354|NCT02669017|451720851|FG003|Overall Study|Miscellaneous|0|||
125358236|NCT01854658|450948180|FG003|Overall Study|Protocol-specified criteria|7|||
125358237|NCT01854658|450948177|FG000|Overall Study|Lack of Efficacy|3|||
125571355|NCT02669017|451720852|FG004|Overall Study|Miscellaneous|2|||
125358238|NCT01854658|450948178|FG001|Overall Study|Lack of Efficacy|8|||
125358239|NCT01854658|450948179|FG002|Overall Study|Lack of Efficacy|4|||
125358240|NCT01854658|450948180|FG003|Overall Study|Lack of Efficacy|7|||
125571356|NCT02669017|451720853|FG005|Overall Study|Miscellaneous|1|||
125571357|NCT02669017|451720854|FG006|Overall Study|Miscellaneous|1|||
125571358|NCT02669017|451720855|FG007|Overall Study|Miscellaneous|13|||
125571359|NCT02669017|451720856|FG008|Overall Study|Miscellaneous|2|||
125571360|NCT01289015|451720857|FG000|Overall Study|Protocol Violation|12|||
125571361|NCT01289015|451720858|FG001|Overall Study|Protocol Violation|9|||
125571362|NCT01289015|451720857|FG000|Overall Study|Adverse Event|3|||
125571363|NCT01289015|451720858|FG001|Overall Study|Adverse Event|0|||
125571364|NCT01289015|451720857|FG000|Overall Study|Lost to Follow-up|33|||
125571365|NCT01289015|451720858|FG001|Overall Study|Lost to Follow-up|17|||
125571366|NCT01289015|451720857|FG000|Overall Study|Withdrawal by Subject|17|||
125571367|NCT01289015|451720858|FG001|Overall Study|Withdrawal by Subject|8|||
125358241|NCT01854658|450948177|FG000|Overall Study|Adverse Event|21|||
125358242|NCT01854658|450948178|FG001|Overall Study|Adverse Event|14|||
125358243|NCT01854658|450948179|FG002|Overall Study|Adverse Event|23|||
125358244|NCT01854658|450948180|FG003|Overall Study|Adverse Event|19|||
125358245|NCT01854658|450948177|FG000|Overall Study|Administrative reasons|5|||
125358246|NCT01854658|450948178|FG001|Overall Study|Administrative reasons|1|||
125358247|NCT01854658|450948179|FG002|Overall Study|Administrative reasons|2|||
125358248|NCT01854658|450948180|FG003|Overall Study|Administrative reasons|2|||
125358249|NCT01858376|450948181|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
125358250|NCT02436304|450948187|FG000|Overall Study|Lost to Follow-up|0|||
125358251|NCT02436304|450948188|FG001|Overall Study|Lost to Follow-up|1|||
125358252|NCT02436304|450948189|FG002|Overall Study|Lost to Follow-up|0|||
125358253|NCT02436304|450948187|FG000|Overall Study|Withdrawal by Subject|0|||
125358254|NCT02436304|450948188|FG001|Overall Study|Withdrawal by Subject|1|||
125358255|NCT02436304|450948189|FG002|Overall Study|Withdrawal by Subject|0|||
125358256|NCT02436304|450948187|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
125358257|NCT02436304|450948188|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
125358258|NCT02436304|450948189|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
125358259|NCT03793556|450948190|FG000|Overall Study|Withdrawal by Subject|12|||
125358260|NCT03793556|450948191|FG001|Overall Study|Withdrawal by Subject|1|||
125358261|NCT03793556|450948190|FG000|Overall Study|Lost to Follow-up|1|||
125358262|NCT03793556|450948191|FG001|Overall Study|Lost to Follow-up|1|||
125358263|NCT04416633|450948192|FG000|Overall Study|Death|1|||
125358264|NCT04416633|450948192|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
125571368|NCT01289015|451720857|FG000|Overall Study|Disease progression|1|||
125571369|NCT01289015|451720858|FG001|Overall Study|Disease progression|0|||
125571370|NCT01289015|451720857|FG000|Overall Study|Negative baseline culture and others|33|||
125571371|NCT01289015|451720858|FG001|Overall Study|Negative baseline culture and others|20|||
125571372|NCT02797808|451720863|FG000|Overall Study|Withdrawal by Subject|1|||
125571373|NCT02797808|451720864|FG001|Overall Study|Withdrawal by Subject|1|||
125571374|NCT02797808|451720863|FG000|Overall Study|Physician Decision|6|||
125571375|NCT02797808|451720864|FG001|Overall Study|Physician Decision|2|||
125571376|NCT03509350|451720865|FG000|Overall Study|Withdrawal by Subject|0|||
125571377|NCT03509350|451720866|FG001|Overall Study|Withdrawal by Subject|2|||
125571378|NCT01425203|451720869|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
125571379|NCT01425203|451720870|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
125571380|NCT01425203|451720871|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
125571381|NCT01425203|451720869|FG000|Treatment Phase|Failure at futility timepoint|8|||
125571382|NCT01425203|451720870|FG001|Treatment Phase|Failure at futility timepoint|27|||
125571383|NCT01425203|451720871|FG002|Treatment Phase|Failure at futility timepoint|0|||
125571384|NCT01425203|451720869|FG000|Treatment Phase|Other virologic failure criteria|5|||
125571385|NCT01425203|451720870|FG001|Treatment Phase|Other virologic failure criteria|3|||
125571386|NCT01425203|451720871|FG002|Treatment Phase|Other virologic failure criteria|0|||
125571387|NCT01425203|451720869|FG000|Treatment Phase|Unidentified reasons|11|||
125571388|NCT01425203|451720870|FG001|Treatment Phase|Unidentified reasons|5|||
125571389|NCT01425203|451720871|FG002|Treatment Phase|Unidentified reasons|0|||
125571390|NCT01425203|451720869|FG000|Treatment Phase|Did not receive treatment|0|||
125571391|NCT01425203|451720870|FG001|Treatment Phase|Did not receive treatment|1|||
125426954|NCT01218126|451188072|FG002|Overall Study|Adverse Event|12|||
125426955|NCT01218126|451188073|FG003|Overall Study|Adverse Event|16|||
125571392|NCT01425203|451720871|FG002|Treatment Phase|Did not receive treatment|0|||
125571393|NCT01425203|451720869|FG000|Crossover Phase|Failure at futility timepoint|0|||
125571394|NCT01425203|451720870|FG001|Crossover Phase|Failure at futility timepoint|0|||
125210785|NCT02134353|450395684|FG000|Overall Study|Withdrawal by Subject|12|||
125210786|NCT02134353|450395685|FG001|Overall Study|Withdrawal by Subject|13|||
125210787|NCT02134353|450395684|FG000|Overall Study|Death|0|||
125210788|NCT02134353|450395685|FG001|Overall Study|Death|1|||
125210789|NCT02134353|450395684|FG000|Overall Study|Pregnancy|0|||
125210790|NCT02134353|450395685|FG001|Overall Study|Pregnancy|1|||
125210791|NCT02134353|450395684|FG000|Overall Study|Relocation|1|||
125210792|NCT02134353|450395685|FG001|Overall Study|Relocation|0|||
125210793|NCT02134353|450395684|FG000|Overall Study|Other - Patient's Choice|0|||
125210794|NCT02134353|450395685|FG001|Overall Study|Other - Patient's Choice|1|||
125210795|NCT00477607|450395686|FG000|Overall Study|Lost to Follow-up|7|||
125210796|NCT00477607|450395687|FG001|Overall Study|Lost to Follow-up|7|||
125210797|NCT00474786|450395688|FG000|Overall Study|Not Meeting Study Criteria|0|||
125210798|NCT00474786|450395689|FG001|Overall Study|Not Meeting Study Criteria|1|||
125210799|NCT00474786|450395688|FG000|Overall Study|Investigator Request|2|||
125210800|NCT00474786|450395689|FG001|Overall Study|Investigator Request|1|||
125210801|NCT00474786|450395688|FG000|Overall Study|Death|189|||
125210802|NCT00474786|450395689|FG001|Overall Study|Death|170|||
125210803|NCT00474786|450395688|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
125210804|NCT00474786|450395689|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
125210805|NCT00474786|450395688|FG000|Overall Study|Lost to Follow-up|4|||
125210806|NCT00474786|450395689|FG001|Overall Study|Lost to Follow-up|7|||
125210807|NCT00474786|450395688|FG000|Overall Study|Protocol Violation|2|||
125210808|NCT00474786|450395689|FG001|Overall Study|Protocol Violation|0|||
125210809|NCT00474786|450395688|FG000|Overall Study|Withdrawal by Subject|15|||
125210810|NCT00474786|450395689|FG001|Overall Study|Withdrawal by Subject|15|||
125210811|NCT00474786|450395688|FG000|Overall Study|Other|5|||
125210812|NCT00474786|450395689|FG001|Overall Study|Other|0|||
125210813|NCT00358956|450395690|FG000|Overall Study|Adverse Event|3|||
125210814|NCT00358956|450395690|FG000|Overall Study|condition under investigation worsened|4|||
125210815|NCT00358956|450395690|FG000|Overall Study|Withdrawal by Subject|1|||
125210816|NCT02578940|450396653|FG000|Overall Study|Screening failure|5|||
125210817|NCT02578940|450396653|FG000|Overall Study|Lost to Follow-up|1|||
125210818|NCT04942210|450396659|FG000|Overall Study|Adverse Event|0|||
125210819|NCT04942210|450396660|FG001|Overall Study|Adverse Event|1|||
125210820|NCT04942210|450396659|FG000|Overall Study|Protocol Deviation|4|||
125210821|NCT04942210|450396660|FG001|Overall Study|Protocol Deviation|1|||
125210822|NCT04942210|450396659|FG000|Overall Study|Withdrawal by Subject|5|||
125210823|NCT04942210|450396660|FG001|Overall Study|Withdrawal by Subject|2|||
125210824|NCT04942210|450396659|FG000|Overall Study|Lost to Follow-up|16|||
125210825|NCT04942210|450396660|FG001|Overall Study|Lost to Follow-up|7|||
125210826|NCT04942210|450396659|FG000|Overall Study|Ongoing at the time of DBL date|60|||
125210827|NCT04942210|450396660|FG001|Overall Study|Ongoing at the time of DBL date|25|||
125210828|NCT04942210|450396659|FG000|Overall Study|Randomized but did not receive vaccination|3|||
125210829|NCT04942210|450396660|FG001|Overall Study|Randomized but did not receive vaccination|0|||
125210830|NCT05697627|450396663|FG000|Overall Study|Adverse Event|1|||
125210831|NCT02570750|450396664|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
125210832|NCT02570750|450396665|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
125210833|NCT02570750|450396664|FG000|Overall Study|Protocol deviation|4|||
125210834|NCT02570750|450396665|FG001|Overall Study|Protocol deviation|2|||
125210835|NCT02570750|450396664|FG000|Overall Study|Withdrawal by Subject|5|||
125358265|NCT04416633|450948192|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
125358266|NCT04416633|450948192|FG000|Overall Study|Adverse Event|6|||
125358267|NCT04416633|450948192|FG000|Overall Study|Withdrawal by Subject|6|||
125358268|NCT04612790|450948193|FG000|DB Period (Up to 36 Weeks)|Death|1|||
125571395|NCT01425203|451720871|FG002|Crossover Phase|Failure at futility timepoint|3|||
125571396|NCT01425203|451720869|FG000|Crossover Phase|Other virologic failure criteria|0|||
125571397|NCT01425203|451720870|FG001|Crossover Phase|Other virologic failure criteria|0|||
125571398|NCT01425203|451720871|FG002|Crossover Phase|Other virologic failure criteria|3|||
125571399|NCT00535132|451720872|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
125571400|NCT00535132|451720873|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
125571401|NCT00535132|451720872|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
125571402|NCT00535132|451720873|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
125571403|NCT02590588|451720874|FG000|Overall Study|Adverse Event|1|||
125210836|NCT02570750|450396665|FG001|Overall Study|Withdrawal by Subject|0|||
125210837|NCT02570750|450396664|FG000|Overall Study|Lost to Follow-up|2|||
125210838|NCT02570750|450396665|FG001|Overall Study|Lost to Follow-up|2|||
125210839|NCT02570750|450396664|FG000|Overall Study|Adverse Event|2|||
125210840|NCT02570750|450396665|FG001|Overall Study|Adverse Event|1|||
125210841|NCT01410240|450396666|FG000|Overall Study|Physician Decision|0|||
125210842|NCT01410240|450396667|FG001|Overall Study|Physician Decision|0|||
125210843|NCT01410240|450396668|FG002|Overall Study|Physician Decision|1|||
125210844|NCT01410240|450396666|FG000|Overall Study|Missed week 6 assessments|1|||
125210845|NCT01410240|450396667|FG001|Overall Study|Missed week 6 assessments|1|||
125571404|NCT00290433|451720877|FG000|Overall Study|Disease Progression|13|||
125571405|NCT00290433|451720877|FG000|Overall Study|Adverse Event|14|||
125571406|NCT00290433|451720877|FG000|Overall Study|Withdrawal by Subject|1|||
125571407|NCT00290433|451720877|FG000|Overall Study|Non-Compliance|1|||
125571408|NCT00290433|451720877|FG000|Overall Study|Congestive Heart Failure|1|||
125571409|NCT00290433|451720877|FG000|Overall Study|Transplant in CR|5|||
125571410|NCT00290433|451720877|FG000|Overall Study|Unrelated Infection/Death|1|||
125571411|NCT02559687|451720878|FG000|Overall Study|Death|112|||
125571412|NCT02559687|451720878|FG000|Overall Study|Sponsor Decision|5|||
125571413|NCT02559687|451720878|FG000|Overall Study|Withdrawal by Subject|4|||
125571414|NCT03031301|451720879|FG000|Overall Study|Protocol Violation|4|||
125571415|NCT03031301|451720880|FG001|Overall Study|Protocol Violation|8|||
125571416|NCT03031301|451720879|FG000|Overall Study|Withdrawal by Subject|7|||
125571417|NCT03031301|451720880|FG001|Overall Study|Withdrawal by Subject|4|||
125571418|NCT03031301|451720879|FG000|Overall Study|Lost to Follow-up|4|||
125571419|NCT03031301|451720880|FG001|Overall Study|Lost to Follow-up|12|||
125571420|NCT03031301|451720879|FG000|Overall Study|Noncompliance|1|||
125571421|NCT03031301|451720880|FG001|Overall Study|Noncompliance|3|||
125571422|NCT03031301|451720879|FG000|Overall Study|Technical issue|1|||
125571423|NCT03031301|451720880|FG001|Overall Study|Technical issue|1|||
125571424|NCT03031301|451720879|FG000|Overall Study|Adverse Event|1|||
125571425|NCT03031301|451720880|FG001|Overall Study|Adverse Event|0|||
125571426|NCT05098041|451720883|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
125571427|NCT03948178|451720885|FG000|Overall Study|Protocol Violation|1|||
125571428|NCT03948178|451720885|FG000|Overall Study|Lost to Follow-up|2|||
125571429|NCT03948178|451720885|FG000|Overall Study|Withdrawal by Subject|2|||
125571430|NCT03948178|451720885|FG000|Overall Study|Reason not known|2|||
125571431|NCT03948178|451720885|FG000|Overall Study|Personal reason|14|||
125571432|NCT03948178|451720885|FG000|Overall Study|Disease progression|30|||
125571433|NCT03948178|451720885|FG000|Overall Study|Adverse Event|12|||
125571434|NCT03948178|451720885|FG000|Overall Study|Sponsor terminated study|164|||
125571435|NCT00382993|451720888|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
125571436|NCT00382993|451720889|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
125571437|NCT00382993|451720888|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
125571438|NCT00382993|451720889|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
125571439|NCT00382993|451720888|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
125571440|NCT00382993|451720889|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
125571441|NCT00382993|451720888|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
125571442|NCT00382993|451720889|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
125571443|NCT00382993|451720888|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
125571444|NCT00382993|451720889|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
125571445|NCT00382993|451720888|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
125571446|NCT00382993|451720889|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
125571447|NCT00382993|451720888|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
125571448|NCT00382993|451720889|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
125571449|NCT00382993|451720888|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
125571450|NCT00382993|451720889|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
125571451|NCT00382993|451720888|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
125571452|NCT00382993|451720889|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
125571453|NCT00382993|451720888|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
125571454|NCT00382993|451720889|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
125571455|NCT01857869|451720890|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
125571456|NCT01857869|451720891|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
125571457|NCT01857869|451720892|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
125571458|NCT01857869|451720893|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
125571459|NCT01857869|451720894|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
125571460|NCT01857869|451720895|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
125571461|NCT01857869|451720896|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
125571462|NCT01857869|451720897|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
125571463|NCT01857869|451720898|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
125571464|NCT01857869|451720899|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
125571465|NCT01857869|451720890|FG000|Primary/Challenge Phase|Pregnancy|1|||
125571466|NCT01857869|451720891|FG001|Primary/Challenge Phase|Pregnancy|0|||
125571467|NCT01857869|451720892|FG002|Primary/Challenge Phase|Pregnancy|0|||
125571468|NCT01857869|451720893|FG003|Primary/Challenge Phase|Pregnancy|0|||
125358269|NCT04612790|450948194|FG001|DB Period (Up to 36 Weeks)|Death|1|||
125571469|NCT01857869|451720894|FG004|Primary/Challenge Phase|Pregnancy|0|||
125571470|NCT01857869|451720895|FG005|Primary/Challenge Phase|Pregnancy|0|||
125571471|NCT01857869|451720896|FG006|Primary/Challenge Phase|Pregnancy|0|||
125571472|NCT01857869|451720897|FG007|Primary/Challenge Phase|Pregnancy|0|||
125571473|NCT01857869|451720898|FG008|Primary/Challenge Phase|Pregnancy|0|||
125571474|NCT01857869|451720899|FG009|Primary/Challenge Phase|Pregnancy|0|||
125571475|NCT01857869|451720890|FG000|Primary/Challenge Phase|Protocol Violation|1|||
125571476|NCT01857869|451720891|FG001|Primary/Challenge Phase|Protocol Violation|0|||
125571477|NCT01857869|451720892|FG002|Primary/Challenge Phase|Protocol Violation|0|||
125571478|NCT01857869|451720893|FG003|Primary/Challenge Phase|Protocol Violation|0|||
125571479|NCT01857869|451720894|FG004|Primary/Challenge Phase|Protocol Violation|0|||
125571480|NCT01857869|451720895|FG005|Primary/Challenge Phase|Protocol Violation|0|||
125571481|NCT01857869|451720896|FG006|Primary/Challenge Phase|Protocol Violation|0|||
125571482|NCT01857869|451720897|FG007|Primary/Challenge Phase|Protocol Violation|0|||
125571483|NCT01857869|451720898|FG008|Primary/Challenge Phase|Protocol Violation|0|||
125571484|NCT01857869|451720899|FG009|Primary/Challenge Phase|Protocol Violation|0|||
125571485|NCT01857869|451720890|FG000|Primary/Challenge Phase|Other|1|||
125571486|NCT01857869|451720891|FG001|Primary/Challenge Phase|Other|1|||
125571487|NCT01857869|451720892|FG002|Primary/Challenge Phase|Other|0|||
125571488|NCT01857869|451720893|FG003|Primary/Challenge Phase|Other|0|||
125571489|NCT01857869|451720894|FG004|Primary/Challenge Phase|Other|0|||
125571490|NCT01857869|451720895|FG005|Primary/Challenge Phase|Other|0|||
125571491|NCT01857869|451720896|FG006|Primary/Challenge Phase|Other|0|||
125571492|NCT01857869|451720897|FG007|Primary/Challenge Phase|Other|0|||
125571493|NCT01857869|451720898|FG008|Primary/Challenge Phase|Other|0|||
125571494|NCT01857869|451720899|FG009|Primary/Challenge Phase|Other|0|||
125571495|NCT01857869|451720890|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125571496|NCT01857869|451720891|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125571497|NCT01857869|451720892|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125571498|NCT01857869|451720893|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
125571499|NCT01857869|451720894|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125571500|NCT01857869|451720895|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125571501|NCT01857869|451720896|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125571502|NCT01857869|451720897|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125571503|NCT01857869|451720898|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125571504|NCT01857869|451720899|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
125571505|NCT01857869|451720890|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125571506|NCT01857869|451720891|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125571507|NCT01857869|451720892|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125571508|NCT01857869|451720893|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
125571509|NCT01857869|451720894|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125571510|NCT01857869|451720895|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125571511|NCT01857869|451720896|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125571512|NCT01857869|451720897|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125571513|NCT01857869|451720898|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125571514|NCT01857869|451720899|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
125571515|NCT02898259|451720900|FG000|Overall Study|Adverse Event|0|||
125571516|NCT02898259|451720901|FG001|Overall Study|Adverse Event|0|||
125571517|NCT02898259|451720902|FG002|Overall Study|Adverse Event|1|||
125571518|NCT02898259|451720903|FG003|Overall Study|Adverse Event|0|||
125571519|NCT02898259|451720904|FG004|Overall Study|Adverse Event|0|||
125571520|NCT02898259|451720900|FG000|Overall Study|Lack of Efficacy|1|||
125571521|NCT02898259|451720901|FG001|Overall Study|Lack of Efficacy|1|||
125571522|NCT02898259|451720902|FG002|Overall Study|Lack of Efficacy|3|||
125571523|NCT02898259|451720903|FG003|Overall Study|Lack of Efficacy|0|||
125571524|NCT02898259|451720904|FG004|Overall Study|Lack of Efficacy|0|||
125571525|NCT02898259|451720900|FG000|Overall Study|Lost to Follow-up|0|||
125571526|NCT02898259|451720901|FG001|Overall Study|Lost to Follow-up|0|||
125571527|NCT02898259|451720902|FG002|Overall Study|Lost to Follow-up|1|||
125571528|NCT02898259|451720903|FG003|Overall Study|Lost to Follow-up|0|||
125571529|NCT02898259|451720904|FG004|Overall Study|Lost to Follow-up|0|||
125571530|NCT02898259|451720900|FG000|Overall Study|Transformation before study began|0|||
125571531|NCT02898259|451720901|FG001|Overall Study|Transformation before study began|0|||
125571532|NCT02898259|451720902|FG002|Overall Study|Transformation before study began|0|||
125571533|NCT02898259|451720903|FG003|Overall Study|Transformation before study began|1|||
125571534|NCT02898259|451720904|FG004|Overall Study|Transformation before study began|0|||
125571535|NCT01046877|451720905|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
125571536|NCT01046877|451720905|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
125571537|NCT03016325|451720906|FG000|Treatment Period|Participant withdrew consent|0|||
125571538|NCT03016325|451720907|FG001|Treatment Period|Participant withdrew consent|1|||
125571539|NCT03016325|451720908|FG002|Treatment Period|Participant withdrew consent|0|||
125571540|NCT03016325|451720909|FG003|Treatment Period|Participant withdrew consent|0|||
125571541|NCT03016325|451720910|FG004|Treatment Period|Participant withdrew consent|0|||
125571542|NCT03016325|451720911|FG005|Treatment Period|Participant withdrew consent|0|||
125571543|NCT03016325|451720912|FG006|Treatment Period|Participant withdrew consent|0|||
125571544|NCT03016325|451720913|FG007|Treatment Period|Participant withdrew consent|0|||
125571545|NCT03016325|451720906|FG000|Treatment Period|Death|0|||
125571546|NCT03016325|451720907|FG001|Treatment Period|Death|0|||
125571547|NCT03016325|451720908|FG002|Treatment Period|Death|0|||
125571548|NCT03016325|451720909|FG003|Treatment Period|Death|0|||
125571549|NCT03016325|451720910|FG004|Treatment Period|Death|2|||
125571550|NCT03016325|451720911|FG005|Treatment Period|Death|0|||
125571551|NCT03016325|451720912|FG006|Treatment Period|Death|0|||
125571552|NCT03016325|451720913|FG007|Treatment Period|Death|0|||
125571553|NCT03016325|451720906|FG000|Treatment Period|Participant refuses assessments|0|||
125571554|NCT03016325|451720907|FG001|Treatment Period|Participant refuses assessments|0|||
125571555|NCT03016325|451720908|FG002|Treatment Period|Participant refuses assessments|1|||
125571556|NCT03016325|451720909|FG003|Treatment Period|Participant refuses assessments|0|||
125571557|NCT03016325|451720910|FG004|Treatment Period|Participant refuses assessments|0|||
125571558|NCT03016325|451720911|FG005|Treatment Period|Participant refuses assessments|0|||
125571559|NCT03016325|451720912|FG006|Treatment Period|Participant refuses assessments|0|||
125571560|NCT03016325|451720913|FG007|Treatment Period|Participant refuses assessments|0|||
125571561|NCT03016325|451720906|FG000|32-Day Follow-Up Period|Death|2|||
125571562|NCT03016325|451720907|FG001|32-Day Follow-Up Period|Death|0|||
125210846|NCT01410240|450396668|FG002|Overall Study|Missed week 6 assessments|1|||
125210847|NCT02722746|450396673|FG000|Overall Study|Withdrawal by Subject|0|||
125210848|NCT02722746|450396674|FG001|Overall Study|Withdrawal by Subject|1|||
125210849|NCT02722746|450396675|FG002|Overall Study|Withdrawal by Subject|0|||
125210850|NCT02722746|450396673|FG000|Overall Study|Protocol Violation|8|||
125210851|NCT02722746|450396674|FG001|Overall Study|Protocol Violation|4|||
125210852|NCT02722746|450396675|FG002|Overall Study|Protocol Violation|6|||
125210853|NCT01134263|450396682|FG000|Overall Study|Serious adverse event|2|||
125210854|NCT01134263|450396683|FG001|Overall Study|Serious adverse event|1|||
125210855|NCT01134263|450396684|FG002|Overall Study|Serious adverse event|1|||
125210856|NCT01134263|450396685|FG003|Overall Study|Serious adverse event|1|||
125210857|NCT01134263|450396686|FG004|Overall Study|Serious adverse event|1|||
125210858|NCT01134263|450396682|FG000|Overall Study|Other adverse event|1|||
125210859|NCT01134263|450396683|FG001|Overall Study|Other adverse event|2|||
125210860|NCT01134263|450396684|FG002|Overall Study|Other adverse event|5|||
125210861|NCT01134263|450396685|FG003|Overall Study|Other adverse event|3|||
125210862|NCT01134263|450396686|FG004|Overall Study|Other adverse event|0|||
125210863|NCT01134263|450396682|FG000|Overall Study|Protocol Violation|8|||
125210864|NCT01134263|450396683|FG001|Overall Study|Protocol Violation|7|||
125210865|NCT01134263|450396684|FG002|Overall Study|Protocol Violation|2|||
125210866|NCT01134263|450396685|FG003|Overall Study|Protocol Violation|4|||
125210867|NCT01134263|450396686|FG004|Overall Study|Protocol Violation|2|||
125210868|NCT01134263|450396682|FG000|Overall Study|Lost to Follow-up|4|||
125210869|NCT01134263|450396683|FG001|Overall Study|Lost to Follow-up|3|||
125210870|NCT01134263|450396684|FG002|Overall Study|Lost to Follow-up|5|||
125210871|NCT01134263|450396685|FG003|Overall Study|Lost to Follow-up|3|||
125210872|NCT01134263|450396686|FG004|Overall Study|Lost to Follow-up|1|||
125210873|NCT01134263|450396682|FG000|Overall Study|Withdrawal by Subject|8|||
125210874|NCT01134263|450396683|FG001|Overall Study|Withdrawal by Subject|6|||
125210875|NCT01134263|450396684|FG002|Overall Study|Withdrawal by Subject|16|||
125210876|NCT01134263|450396685|FG003|Overall Study|Withdrawal by Subject|7|||
125210877|NCT01134263|450396686|FG004|Overall Study|Withdrawal by Subject|5|||
125210878|NCT01134263|450396682|FG000|Overall Study|Enrolled, but not treated|1|||
125210879|NCT01134263|450396683|FG001|Overall Study|Enrolled, but not treated|1|||
125210880|NCT01134263|450396684|FG002|Overall Study|Enrolled, but not treated|0|||
125210881|NCT01134263|450396685|FG003|Overall Study|Enrolled, but not treated|1|||
125358270|NCT04612790|450948195|FG002|DB Period (Up to 36 Weeks)|Death|0|||
125571563|NCT03016325|451720908|FG002|32-Day Follow-Up Period|Death|5|||
125571564|NCT03016325|451720909|FG003|32-Day Follow-Up Period|Death|6|||
125571565|NCT03016325|451720910|FG004|32-Day Follow-Up Period|Death|3|||
125571566|NCT03016325|451720911|FG005|32-Day Follow-Up Period|Death|0|||
125571567|NCT03016325|451720912|FG006|32-Day Follow-Up Period|Death|0|||
125571568|NCT03016325|451720913|FG007|32-Day Follow-Up Period|Death|0|||
125571569|NCT03016325|451720906|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
125571570|NCT03016325|451720907|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
125571571|NCT03016325|451720908|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
125571572|NCT03016325|451720909|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
125571573|NCT03016325|451720910|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
125571574|NCT03016325|451720911|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
125571575|NCT03016325|451720912|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
125571576|NCT03016325|451720913|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
125571577|NCT03016325|451720906|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
125571578|NCT03016325|451720907|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
125571579|NCT03016325|451720908|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
125571580|NCT03016325|451720909|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
125571581|NCT03016325|451720910|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
125571582|NCT03016325|451720911|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
125571583|NCT03016325|451720912|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
125571584|NCT03016325|451720913|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
125571585|NCT03016325|451720906|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
125571586|NCT03016325|451720907|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
125571587|NCT03016325|451720908|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
125571588|NCT03016325|451720909|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
125571589|NCT03016325|451720910|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
125571590|NCT03016325|451720911|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
125571591|NCT03016325|451720912|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
125210882|NCT01134263|450396686|FG004|Overall Study|Enrolled, but not treated|0|||
125210883|NCT02305446|450396689|FG000|Overall Study|Adverse Event|1|||
125210884|NCT00957424|450396690|FG000|Overall Study|Lost to Follow-up|19|||
125210885|NCT00957424|450396690|FG000|Overall Study|Protocol Violation|3|||
125210886|NCT00957424|450396690|FG000|Overall Study|Withdrawal by Subject|1|||
125210887|NCT05182606|450396698|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
125210888|NCT01955109|450396701|FG000|Overall Study|Adverse Event|2|||
125358271|NCT04612790|450948196|FG003|DB Period (Up to 36 Weeks)|Death|0|||
125571592|NCT03016325|451720913|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
125358272|NCT04612790|450948193|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
125358273|NCT04612790|450948194|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
125358274|NCT04612790|450948195|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
125358275|NCT04612790|450948196|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
125358276|NCT04612790|450948193|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
125571593|NCT03016325|451720906|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
125571594|NCT03016325|451720907|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
125571595|NCT03016325|451720908|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
125571596|NCT03016325|451720909|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
125571597|NCT03016325|451720910|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
125571598|NCT03016325|451720911|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
125571599|NCT03016325|451720912|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
125571600|NCT03016325|451720913|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
125571601|NCT03016325|451720906|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
125571602|NCT03016325|451720907|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
125571603|NCT03016325|451720908|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
125571604|NCT03016325|451720909|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
125571605|NCT03016325|451720910|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
125571606|NCT03016325|451720911|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
125571607|NCT03016325|451720912|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
125571608|NCT03016325|451720913|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
125571609|NCT03016325|451720906|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
125571610|NCT03016325|451720907|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
125571611|NCT03016325|451720908|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
125571612|NCT03016325|451720909|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
125571613|NCT03016325|451720910|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
125571614|NCT03016325|451720911|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
125571615|NCT03016325|451720912|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
125571616|NCT03016325|451720913|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
125571617|NCT03016325|451720906|FG000|182-Day Follow-Up Period|Death|3|||
125571618|NCT03016325|451720907|FG001|182-Day Follow-Up Period|Death|3|||
125571619|NCT03016325|451720908|FG002|182-Day Follow-Up Period|Death|11|||
125571620|NCT03016325|451720909|FG003|182-Day Follow-Up Period|Death|12|||
125571621|NCT03016325|451720910|FG004|182-Day Follow-Up Period|Death|9|||
125571622|NCT03016325|451720911|FG005|182-Day Follow-Up Period|Death|0|||
125571623|NCT03016325|451720912|FG006|182-Day Follow-Up Period|Death|0|||
125571624|NCT03016325|451720913|FG007|182-Day Follow-Up Period|Death|1|||
125571625|NCT03016325|451720906|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
125571626|NCT03016325|451720907|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125571627|NCT03016325|451720908|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125571628|NCT03016325|451720909|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125571629|NCT03016325|451720910|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125571630|NCT03016325|451720911|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125571631|NCT03016325|451720912|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125571632|NCT03016325|451720913|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
125571633|NCT03016325|451720906|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
125571634|NCT03016325|451720907|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
125571635|NCT03016325|451720908|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
125571636|NCT03016325|451720909|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
125571637|NCT03016325|451720910|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
125571638|NCT03016325|451720911|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
125571639|NCT03016325|451720912|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
125571640|NCT03016325|451720913|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
125571641|NCT03016325|451720906|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125571642|NCT03016325|451720907|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125571643|NCT03016325|451720908|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125571644|NCT03016325|451720909|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125571645|NCT03016325|451720910|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
125571646|NCT03016325|451720911|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125571647|NCT03016325|451720912|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125358277|NCT04612790|450948194|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
125358278|NCT04612790|450948195|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
125426956|NCT01218126|451188070|FG000|Overall Study|Lack of Efficacy|7|||
125426957|NCT01218126|451188071|FG001|Overall Study|Lack of Efficacy|2|||
125426958|NCT01218126|451188072|FG002|Overall Study|Lack of Efficacy|2|||
125426959|NCT01218126|451188073|FG003|Overall Study|Lack of Efficacy|6|||
125426960|NCT01218126|451188070|FG000|Overall Study|Protocol Violation|5|||
125571648|NCT03016325|451720913|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
125571649|NCT03016325|451720906|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
125571650|NCT03016325|451720907|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
125571651|NCT03016325|451720908|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
125571652|NCT03016325|451720909|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
125571653|NCT03016325|451720910|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
125571654|NCT03016325|451720911|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
125571655|NCT03016325|451720912|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
125571656|NCT03016325|451720913|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
125571657|NCT03016325|451720906|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125571658|NCT03016325|451720907|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125358279|NCT04612790|450948196|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
125571659|NCT03016325|451720908|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125571660|NCT03016325|451720909|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
125571661|NCT03016325|451720910|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125571662|NCT03016325|451720911|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125571663|NCT03016325|451720912|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125571664|NCT03016325|451720913|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
125571665|NCT03016325|451720906|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
125571666|NCT03016325|451720907|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
125571667|NCT03016325|451720908|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
125571668|NCT03016325|451720909|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
125571669|NCT03016325|451720910|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
125571670|NCT03016325|451720911|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
125571671|NCT03016325|451720912|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
125571672|NCT03016325|451720913|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
125571673|NCT03016325|451720906|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
125571674|NCT03016325|451720907|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
125571675|NCT03016325|451720908|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
125571676|NCT03016325|451720909|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
125571677|NCT03016325|451720910|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
125571678|NCT03016325|451720911|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
125571679|NCT03016325|451720912|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
125571680|NCT03016325|451720913|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
125571681|NCT01902290|451720918|FG000|Overall Study|Withdrawal by Subject|19|||
125571682|NCT01902290|451720919|FG001|Overall Study|Withdrawal by Subject|27|||
125571683|NCT01902290|451720918|FG000|Overall Study|Lost to Follow-up|2|||
125571684|NCT01902290|451720919|FG001|Overall Study|Lost to Follow-up|2|||
125571685|NCT01902290|451720918|FG000|Overall Study|Death|1|||
125571686|NCT01902290|451720919|FG001|Overall Study|Death|0|||
125571687|NCT01902290|451720918|FG000|Overall Study|Sponsor Decision|26|||
125571688|NCT01902290|451720919|FG001|Overall Study|Sponsor Decision|24|||
125571689|NCT02199080|451720928|FG000|Overall Study|Protocol Violation|12|||
125571690|NCT02250274|451720929|FG000|Overall Study|Insufficient blood draw amount|7|||
125571691|NCT02250274|451720930|FG001|Overall Study|Insufficient blood draw amount|6|||
125571692|NCT01277549|451720931|FG000|Overall Study|Failed to meet eligibility criteria|13|||
125571693|NCT01277549|451720932|FG001|Overall Study|Failed to meet eligibility criteria|9|||
125571694|NCT01277549|451720931|FG000|Overall Study|Withdrawal by Subject|1|||
125571695|NCT01277549|451720932|FG001|Overall Study|Withdrawal by Subject|3|||
125571696|NCT01277549|451720931|FG000|Overall Study|Protocol Violation|10|||
125571697|NCT01277549|451720932|FG001|Overall Study|Protocol Violation|1|||
125571698|NCT01277549|451720931|FG000|Overall Study|Physician Decision|2|||
125571699|NCT01277549|451720932|FG001|Overall Study|Physician Decision|1|||
125571700|NCT01618214|451720933|FG000|Overall Study|Adverse Event|3|||
125571701|NCT01618214|451720934|FG001|Overall Study|Adverse Event|1|||
125571702|NCT01618214|451720933|FG000|Overall Study|Lack of Efficacy|1|||
125571703|NCT01618214|451720934|FG001|Overall Study|Lack of Efficacy|1|||
125571704|NCT01618214|451720933|FG000|Overall Study|Protocol Violation|1|||
125571705|NCT01618214|451720934|FG001|Overall Study|Protocol Violation|4|||
125571706|NCT01618214|451720933|FG000|Overall Study|Withdrawal Criteria|1|||
125571707|NCT01618214|451720934|FG001|Overall Study|Withdrawal Criteria|2|||
125571708|NCT01618214|451720933|FG000|Overall Study|Unclassified|4|||
125571709|NCT01618214|451720934|FG001|Overall Study|Unclassified|5|||
125571710|NCT00391222|451720935|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
125571711|NCT00391222|451720936|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
125571712|NCT00391222|451720937|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
125571713|NCT00391222|451720938|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
125571714|NCT00391222|451720935|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
125571715|NCT00391222|451720936|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
125571716|NCT00391222|451720937|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
125571717|NCT00391222|451720938|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
125571718|NCT00391222|451720935|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
125571719|NCT00391222|451720936|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
125358280|NCT04612790|450948193|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
125358281|NCT04612790|450948194|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
125358282|NCT04612790|450948195|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
125571720|NCT00391222|451720937|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
125571721|NCT00391222|451720938|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
125571722|NCT00391222|451720935|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
125571723|NCT00391222|451720936|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
125571724|NCT00391222|451720937|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
125571725|NCT00391222|451720938|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
125571726|NCT00391222|451720935|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
125571727|NCT00391222|451720936|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
125571728|NCT00391222|451720937|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
125571729|NCT00391222|451720938|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
125571730|NCT00391222|451720935|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
125571731|NCT00391222|451720936|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
125571732|NCT00391222|451720937|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
125571733|NCT00391222|451720938|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
125571734|NCT00391222|451720935|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
125571735|NCT00391222|451720936|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
125571736|NCT00391222|451720937|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
125571737|NCT00391222|451720938|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
125571738|NCT00391222|451720935|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
125571739|NCT00391222|451720936|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
125571740|NCT00391222|451720937|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
125571741|NCT00391222|451720938|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
125571742|NCT00391222|451720935|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
125571743|NCT00391222|451720936|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
125571744|NCT00391222|451720937|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
125571745|NCT00391222|451720938|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
125571746|NCT00391222|451720935|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
125571747|NCT00391222|451720936|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
125571748|NCT00391222|451720937|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
125571749|NCT00391222|451720938|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
125571750|NCT00391222|451720935|FG000|Period III (Double-Blind Treatment)|Other|6|||
125571751|NCT00391222|451720936|FG001|Period III (Double-Blind Treatment)|Other|1|||
125571752|NCT00391222|451720937|FG002|Period III (Double-Blind Treatment)|Other|6|||
125571753|NCT00391222|451720938|FG003|Period III (Double-Blind Treatment)|Other|0|||
125571754|NCT00574275|451720939|FG000|Overall Study|Randomized but not treated|2|||
125571755|NCT00574275|451720940|FG001|Overall Study|Randomized but not treated|3|||
125571756|NCT00574275|451720939|FG000|Overall Study|Adverse Event|32|||
125571757|NCT00574275|451720940|FG001|Overall Study|Adverse Event|76|||
125571758|NCT00574275|451720939|FG000|Overall Study|Disease progression|160|||
125571759|NCT00574275|451720940|FG001|Overall Study|Disease progression|146|||
125571760|NCT00574275|451720939|FG000|Overall Study|Lost to Follow-up|2|||
125571761|NCT00574275|451720940|FG001|Overall Study|Lost to Follow-up|1|||
125571762|NCT00574275|451720939|FG000|Overall Study|Study stopped based on DMC decision|62|||
125571763|NCT00574275|451720940|FG001|Overall Study|Study stopped based on DMC decision|23|||
125571764|NCT00574275|451720939|FG000|Overall Study|Withdrawal by Subject|15|||
125571765|NCT00574275|451720940|FG001|Overall Study|Withdrawal by Subject|17|||
125571766|NCT00574275|451720939|FG000|Overall Study|Error calculating tumor measurement|1|||
125571767|NCT00574275|451720940|FG001|Overall Study|Error calculating tumor measurement|0|||
125571768|NCT00574275|451720939|FG000|Overall Study|Physician Decision|1|||
125571769|NCT00574275|451720940|FG001|Overall Study|Physician Decision|1|||
125571770|NCT00574275|451720939|FG000|Overall Study|Protocol Violation|0|||
125571771|NCT00574275|451720940|FG001|Overall Study|Protocol Violation|1|||
125571772|NCT00574275|451720939|FG000|Overall Study|Patient and Investigator decision|0|||
125571773|NCT00574275|451720940|FG001|Overall Study|Patient and Investigator decision|1|||
125571774|NCT00574275|451720939|FG000|Overall Study|Insurance change|0|||
125571775|NCT00574275|451720940|FG001|Overall Study|Insurance change|1|||
125571776|NCT00574275|451720939|FG000|Overall Study|Operation for curative intent|0|||
125358283|NCT04612790|450948196|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
125358284|NCT04612790|450948193|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
125358285|NCT04612790|450948194|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
125571777|NCT00574275|451720940|FG001|Overall Study|Operation for curative intent|1|||
125571778|NCT00652366|451720941|FG000|Overall Study|Adverse Event|8|||
125571779|NCT00652366|451720942|FG001|Overall Study|Adverse Event|4|||
125358286|NCT04612790|450948195|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
125571780|NCT00652366|451720943|FG002|Overall Study|Adverse Event|7|||
125571781|NCT00652366|451720944|FG003|Overall Study|Adverse Event|17|||
125571782|NCT00652366|451720945|FG004|Overall Study|Adverse Event|13|||
125571783|NCT00652366|451720941|FG000|Overall Study|Death|5|||
125571784|NCT00652366|451720942|FG001|Overall Study|Death|4|||
125571785|NCT00652366|451720943|FG002|Overall Study|Death|1|||
125571786|NCT00652366|451720944|FG003|Overall Study|Death|8|||
125571787|NCT00652366|451720945|FG004|Overall Study|Death|5|||
125571788|NCT00652366|451720941|FG000|Overall Study|Lack of Efficacy|84|||
125571789|NCT00652366|451720942|FG001|Overall Study|Lack of Efficacy|58|||
125571790|NCT00652366|451720943|FG002|Overall Study|Lack of Efficacy|53|||
125571791|NCT00652366|451720944|FG003|Overall Study|Lack of Efficacy|133|||
125571792|NCT00652366|451720945|FG004|Overall Study|Lack of Efficacy|13|||
125571793|NCT00652366|451720941|FG000|Overall Study|Violation of Selection Criteria|0|||
125571794|NCT00652366|451720942|FG001|Overall Study|Violation of Selection Criteria|0|||
125571795|NCT00652366|451720943|FG002|Overall Study|Violation of Selection Criteria|1|||
125571796|NCT00652366|451720944|FG003|Overall Study|Violation of Selection Criteria|0|||
125571797|NCT00652366|451720945|FG004|Overall Study|Violation of Selection Criteria|0|||
125571798|NCT00652366|451720941|FG000|Overall Study|Protocol Violation|1|||
125571799|NCT00652366|451720942|FG001|Overall Study|Protocol Violation|0|||
125571800|NCT00652366|451720943|FG002|Overall Study|Protocol Violation|0|||
125571801|NCT00652366|451720944|FG003|Overall Study|Protocol Violation|0|||
125571802|NCT00652366|451720945|FG004|Overall Study|Protocol Violation|0|||
125571803|NCT00652366|451720941|FG000|Overall Study|Refused treatment|3|||
125571804|NCT00652366|451720942|FG001|Overall Study|Refused treatment|7|||
125571805|NCT00652366|451720943|FG002|Overall Study|Refused treatment|6|||
125571806|NCT00652366|451720944|FG003|Overall Study|Refused treatment|17|||
125571807|NCT00652366|451720945|FG004|Overall Study|Refused treatment|5|||
125571808|NCT00652366|451720941|FG000|Overall Study|Other|5|||
125571809|NCT00652366|451720942|FG001|Overall Study|Other|2|||
125571810|NCT00652366|451720943|FG002|Overall Study|Other|3|||
125571811|NCT00652366|451720944|FG003|Overall Study|Other|4|||
125571812|NCT00652366|451720945|FG004|Overall Study|Other|0|||
125571813|NCT03028870|451720951|FG000|Overall Study|Adverse Event|7|||
125571814|NCT03028870|451720952|FG001|Overall Study|Adverse Event|4|||
125571815|NCT03028870|451720953|FG002|Overall Study|Adverse Event|3|||
125571816|NCT03028870|451720954|FG003|Overall Study|Adverse Event|3|||
125571817|NCT03028870|451720951|FG000|Overall Study|Withdrawal by Subject|1|||
125571818|NCT03028870|451720952|FG001|Overall Study|Withdrawal by Subject|1|||
125571819|NCT03028870|451720953|FG002|Overall Study|Withdrawal by Subject|1|||
125571820|NCT03028870|451720954|FG003|Overall Study|Withdrawal by Subject|2|||
125571821|NCT03028870|451720951|FG000|Overall Study|Lost to Follow-up|1|||
125571822|NCT03028870|451720952|FG001|Overall Study|Lost to Follow-up|0|||
125571823|NCT03028870|451720953|FG002|Overall Study|Lost to Follow-up|0|||
125571824|NCT03028870|451720954|FG003|Overall Study|Lost to Follow-up|0|||
125571825|NCT03028870|451720951|FG000|Overall Study|Lack of Efficacy|3|||
125571826|NCT03028870|451720952|FG001|Overall Study|Lack of Efficacy|0|||
125571827|NCT03028870|451720953|FG002|Overall Study|Lack of Efficacy|0|||
125571828|NCT03028870|451720954|FG003|Overall Study|Lack of Efficacy|0|||
125571829|NCT03028870|451720951|FG000|Overall Study|Administrative|5|||
125571830|NCT03028870|451720952|FG001|Overall Study|Administrative|5|||
125571831|NCT03028870|451720953|FG002|Overall Study|Administrative|12|||
125571832|NCT03028870|451720954|FG003|Overall Study|Administrative|4|||
125571833|NCT00137111|451720957|FG000|Total Therapy|Death|35|||
125571834|NCT00137111|451720958|FG001|Total Therapy|Death|0|||
125571835|NCT00137111|451720959|FG002|Total Therapy|Death|0|||
125210889|NCT01955109|450396702|FG001|Overall Study|Adverse Event|0|||
125571836|NCT00137111|451720960|FG003|Total Therapy|Death|0|||
125210890|NCT01955109|450396701|FG000|Overall Study|Participant unwilling to continue|35|||
125571837|NCT00137111|451720957|FG000|Total Therapy|Non Compliance|5|||
125571838|NCT00137111|451720958|FG001|Total Therapy|Non Compliance|0|||
125571839|NCT00137111|451720959|FG002|Total Therapy|Non Compliance|0|||
125571840|NCT00137111|451720960|FG003|Total Therapy|Non Compliance|0|||
125571841|NCT04703075|451720961|FG000|Overall Study|Adverse Event|11|||
125571842|NCT04703075|451720962|FG001|Overall Study|Adverse Event|7|||
125426961|NCT01218126|451188071|FG001|Overall Study|Protocol Violation|2|||
125571843|NCT04703075|451720961|FG000|Overall Study|Lost to Follow-up|6|||
125571844|NCT04703075|451720962|FG001|Overall Study|Lost to Follow-up|12|||
125571845|NCT04703075|451720961|FG000|Overall Study|Physician Decision|3|||
125571846|NCT04703075|451720962|FG001|Overall Study|Physician Decision|0|||
125571847|NCT04703075|451720961|FG000|Overall Study|Moved|0|||
125571848|NCT04703075|451720962|FG001|Overall Study|Moved|2|||
125571849|NCT04703075|451720961|FG000|Overall Study|Index INH Resistant|0|||
125571850|NCT04703075|451720962|FG001|Overall Study|Index INH Resistant|1|||
125571851|NCT04703075|451720961|FG000|Overall Study|Lack of Efficacy|6|||
125571852|NCT04703075|451720962|FG001|Overall Study|Lack of Efficacy|18|||
125571853|NCT02425826|451720966|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
125571854|NCT02425826|451720967|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
125571855|NCT02425826|451720968|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
125571856|NCT02425826|451720966|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
125571857|NCT02425826|451720967|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
125571858|NCT02425826|451720968|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
125571859|NCT02425826|451720966|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
125571860|NCT02425826|451720967|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
125571861|NCT02425826|451720968|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
125571862|NCT02425826|451720966|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
125571863|NCT02425826|451720967|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
125571864|NCT02425826|451720968|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
125571865|NCT02425826|451720966|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
125571866|NCT02425826|451720967|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
125571867|NCT02425826|451720968|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
125571868|NCT02425826|451720966|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
125571869|NCT02425826|451720967|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
125571870|NCT02425826|451720968|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
125571871|NCT02425826|451720966|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
125571872|NCT02425826|451720967|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
125571873|NCT02425826|451720968|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
125571874|NCT02425826|451720966|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
125571875|NCT02425826|451720967|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
125571876|NCT02425826|451720968|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
125571877|NCT02425826|451720966|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
125571878|NCT02425826|451720967|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
125571879|NCT02425826|451720968|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
125571880|NCT02425826|451720966|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
125571881|NCT02425826|451720967|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
125571882|NCT02425826|451720968|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
125571883|NCT02124564|451720973|FG000|Treatment Period|Adverse Event|2|||
125571884|NCT02124564|451720973|FG000|Treatment Period|Lack of Efficacy|3|||
125571885|NCT02124564|451720973|FG000|Treatment Period|Withdrawal by Subject|2|||
125571886|NCT01425008|451720980|FG000|Dose Escalation Phase|Progressive Disease|2|||
125571887|NCT01425008|451720981|FG001|Dose Escalation Phase|Progressive Disease|3|||
125571888|NCT01425008|451720982|FG002|Dose Escalation Phase|Progressive Disease|2|||
125571889|NCT01425008|451720983|FG003|Dose Escalation Phase|Progressive Disease|3|||
125571890|NCT01425008|451720984|FG004|Dose Escalation Phase|Progressive Disease|5|||
125571891|NCT01425008|451720985|FG005|Dose Escalation Phase|Progressive Disease|4|||
125571892|NCT01425008|451720986|FG006|Dose Escalation Phase|Progressive Disease|0|||
125571893|NCT01425008|451720987|FG007|Dose Escalation Phase|Progressive Disease|2|||
125571894|NCT01425008|451720988|FG008|Dose Escalation Phase|Progressive Disease|6|||
125571895|NCT01425008|451720989|FG009|Dose Escalation Phase|Progressive Disease|2|||
125571896|NCT01425008|451720990|FG010|Dose Escalation Phase|Progressive Disease|0|||
125571897|NCT01425008|451720991|FG011|Dose Escalation Phase|Progressive Disease|0|||
125571898|NCT01425008|451720992|FG012|Dose Escalation Phase|Progressive Disease|0|||
125571899|NCT01425008|451720993|FG013|Dose Escalation Phase|Progressive Disease|0|||
125571900|NCT01425008|451720994|FG014|Dose Escalation Phase|Progressive Disease|0|||
125571901|NCT01425008|451720995|FG015|Dose Escalation Phase|Progressive Disease|0|||
125571902|NCT01425008|451720996|FG016|Dose Escalation Phase|Progressive Disease|0|||
125571903|NCT01425008|451720997|FG017|Dose Escalation Phase|Progressive Disease|0|||
125571904|NCT01425008|451720998|FG018|Dose Escalation Phase|Progressive Disease|0|||
125571905|NCT01425008|451720980|FG000|Dose Escalation Phase|Adverse Event|2|||
125571906|NCT01425008|451720981|FG001|Dose Escalation Phase|Adverse Event|0|||
125571907|NCT01425008|451720982|FG002|Dose Escalation Phase|Adverse Event|0|||
125571908|NCT01425008|451720983|FG003|Dose Escalation Phase|Adverse Event|0|||
125571909|NCT01425008|451720984|FG004|Dose Escalation Phase|Adverse Event|0|||
125571910|NCT01425008|451720985|FG005|Dose Escalation Phase|Adverse Event|2|||
125571911|NCT01425008|451720986|FG006|Dose Escalation Phase|Adverse Event|0|||
125571912|NCT01425008|451720987|FG007|Dose Escalation Phase|Adverse Event|0|||
125571913|NCT01425008|451720988|FG008|Dose Escalation Phase|Adverse Event|2|||
125571914|NCT01425008|451720989|FG009|Dose Escalation Phase|Adverse Event|0|||
125571915|NCT01425008|451720990|FG010|Dose Escalation Phase|Adverse Event|0|||
125571916|NCT01425008|451720991|FG011|Dose Escalation Phase|Adverse Event|0|||
125571917|NCT01425008|451720992|FG012|Dose Escalation Phase|Adverse Event|0|||
125571918|NCT01425008|451720993|FG013|Dose Escalation Phase|Adverse Event|0|||
125571919|NCT01425008|451720994|FG014|Dose Escalation Phase|Adverse Event|0|||
125571920|NCT01425008|451720995|FG015|Dose Escalation Phase|Adverse Event|0|||
125571921|NCT01425008|451720996|FG016|Dose Escalation Phase|Adverse Event|0|||
125571922|NCT01425008|451720997|FG017|Dose Escalation Phase|Adverse Event|0|||
125571923|NCT01425008|451720998|FG018|Dose Escalation Phase|Adverse Event|0|||
125571924|NCT01425008|451720980|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571925|NCT01425008|451720981|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571926|NCT01425008|451720982|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571927|NCT01425008|451720983|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571928|NCT01425008|451720984|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
125571929|NCT01425008|451720985|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571930|NCT01425008|451720986|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
125571931|NCT01425008|451720987|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
125571932|NCT01425008|451720988|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
125571933|NCT01425008|451720989|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571934|NCT01425008|451720990|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571935|NCT01425008|451720991|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571936|NCT01425008|451720992|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571937|NCT01425008|451720993|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571938|NCT01425008|451720994|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571939|NCT01425008|451720995|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571940|NCT01425008|451720996|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571941|NCT01425008|451720997|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571942|NCT01425008|451720998|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125571943|NCT01425008|451720980|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
125571944|NCT01425008|451720981|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
125571945|NCT01425008|451720982|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
125571946|NCT01425008|451720983|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
125571947|NCT01425008|451720984|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
125571948|NCT01425008|451720985|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
125571949|NCT01425008|451720986|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
125571950|NCT01425008|451720987|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
125571951|NCT01425008|451720988|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
125571952|NCT01425008|451720989|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
125571953|NCT01425008|451720990|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
125571954|NCT01425008|451720991|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
125571955|NCT01425008|451720992|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
125571956|NCT01425008|451720993|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
125571957|NCT01425008|451720994|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
125571958|NCT01425008|451720995|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
125571959|NCT01425008|451720996|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
125571960|NCT01425008|451720997|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
125571961|NCT01425008|451720998|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
125571962|NCT01425008|451720980|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571963|NCT01425008|451720981|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571964|NCT01425008|451720982|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
125571965|NCT01425008|451720983|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571966|NCT01425008|451720984|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571967|NCT01425008|451720985|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571968|NCT01425008|451720986|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571969|NCT01425008|451720987|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571970|NCT01425008|451720988|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
125571971|NCT01425008|451720989|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
125571972|NCT01425008|451720990|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571973|NCT01425008|451720991|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571974|NCT01425008|451720992|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571975|NCT01425008|451720993|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571976|NCT01425008|451720994|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571977|NCT01425008|451720995|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571978|NCT01425008|451720996|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571979|NCT01425008|451720997|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571980|NCT01425008|451720998|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
125571981|NCT01425008|451720980|FG000|Dose Escalation Phase|Other|0|||
125571982|NCT01425008|451720981|FG001|Dose Escalation Phase|Other|0|||
125571983|NCT01425008|451720982|FG002|Dose Escalation Phase|Other|0|||
125571984|NCT01425008|451720983|FG003|Dose Escalation Phase|Other|0|||
125571985|NCT01425008|451720984|FG004|Dose Escalation Phase|Other|0|||
125571986|NCT01425008|451720985|FG005|Dose Escalation Phase|Other|0|||
125571987|NCT01425008|451720986|FG006|Dose Escalation Phase|Other|0|||
125571988|NCT01425008|451720987|FG007|Dose Escalation Phase|Other|0|||
125571989|NCT01425008|451720988|FG008|Dose Escalation Phase|Other|1|||
125571990|NCT01425008|451720989|FG009|Dose Escalation Phase|Other|0|||
125571991|NCT01425008|451720990|FG010|Dose Escalation Phase|Other|0|||
125571992|NCT01425008|451720991|FG011|Dose Escalation Phase|Other|0|||
125571993|NCT01425008|451720992|FG012|Dose Escalation Phase|Other|0|||
125571994|NCT01425008|451720993|FG013|Dose Escalation Phase|Other|0|||
125571995|NCT01425008|451720994|FG014|Dose Escalation Phase|Other|0|||
125571996|NCT01425008|451720995|FG015|Dose Escalation Phase|Other|0|||
125571997|NCT01425008|451720996|FG016|Dose Escalation Phase|Other|0|||
125571998|NCT01425008|451720997|FG017|Dose Escalation Phase|Other|0|||
125571999|NCT01425008|451720998|FG018|Dose Escalation Phase|Other|0|||
125572000|NCT01425008|451720980|FG000|Dose Expansion Phase|Progressive Disease|0|||
125572001|NCT01425008|451720981|FG001|Dose Expansion Phase|Progressive Disease|0|||
125572002|NCT01425008|451720982|FG002|Dose Expansion Phase|Progressive Disease|0|||
125572003|NCT01425008|451720983|FG003|Dose Expansion Phase|Progressive Disease|0|||
125572004|NCT01425008|451720984|FG004|Dose Expansion Phase|Progressive Disease|0|||
125572005|NCT01425008|451720985|FG005|Dose Expansion Phase|Progressive Disease|0|||
125572006|NCT01425008|451720986|FG006|Dose Expansion Phase|Progressive Disease|0|||
125572007|NCT01425008|451720987|FG007|Dose Expansion Phase|Progressive Disease|0|||
125572008|NCT01425008|451720988|FG008|Dose Expansion Phase|Progressive Disease|0|||
125572009|NCT01425008|451720989|FG009|Dose Expansion Phase|Progressive Disease|0|||
125572010|NCT01425008|451720990|FG010|Dose Expansion Phase|Progressive Disease|10|||
125572011|NCT01425008|451720991|FG011|Dose Expansion Phase|Progressive Disease|4|||
125572012|NCT01425008|451720992|FG012|Dose Expansion Phase|Progressive Disease|12|||
125572013|NCT01425008|451720993|FG013|Dose Expansion Phase|Progressive Disease|1|||
125572014|NCT01425008|451720994|FG014|Dose Expansion Phase|Progressive Disease|5|||
125572015|NCT01425008|451720995|FG015|Dose Expansion Phase|Progressive Disease|8|||
125572016|NCT01425008|451720996|FG016|Dose Expansion Phase|Progressive Disease|9|||
125572017|NCT01425008|451720997|FG017|Dose Expansion Phase|Progressive Disease|2|||
125572018|NCT01425008|451720998|FG018|Dose Expansion Phase|Progressive Disease|10|||
125572019|NCT01425008|451720980|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
125572020|NCT01425008|451720981|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
125572021|NCT01425008|451720982|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
125572022|NCT01425008|451720983|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
125572023|NCT01425008|451720984|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
125572024|NCT01425008|451720985|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
125572025|NCT01425008|451720986|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
125572026|NCT01425008|451720987|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
125572027|NCT01425008|451720988|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
125572028|NCT01425008|451720989|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
125572029|NCT01425008|451720990|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
125572030|NCT01425008|451720991|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
125572031|NCT01425008|451720992|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
125572032|NCT01425008|451720993|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
125572033|NCT01425008|451720994|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
125572034|NCT01425008|451720995|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
125572035|NCT01425008|451720996|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
125572036|NCT01425008|451720997|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
125572037|NCT01425008|451720998|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
125572038|NCT01425008|451720980|FG000|Dose Expansion Phase|Other|0|||
125572039|NCT01425008|451720981|FG001|Dose Expansion Phase|Other|0|||
125572040|NCT01425008|451720982|FG002|Dose Expansion Phase|Other|0|||
125572041|NCT01425008|451720983|FG003|Dose Expansion Phase|Other|0|||
125572042|NCT01425008|451720984|FG004|Dose Expansion Phase|Other|0|||
125572043|NCT01425008|451720985|FG005|Dose Expansion Phase|Other|0|||
125572044|NCT01425008|451720986|FG006|Dose Expansion Phase|Other|0|||
125572045|NCT01425008|451720987|FG007|Dose Expansion Phase|Other|0|||
125572046|NCT01425008|451720988|FG008|Dose Expansion Phase|Other|0|||
125572047|NCT01425008|451720989|FG009|Dose Expansion Phase|Other|0|||
125572048|NCT01425008|451720990|FG010|Dose Expansion Phase|Other|0|||
125572049|NCT01425008|451720991|FG011|Dose Expansion Phase|Other|0|||
125572050|NCT01425008|451720992|FG012|Dose Expansion Phase|Other|1|||
125572051|NCT01425008|451720993|FG013|Dose Expansion Phase|Other|0|||
125572052|NCT01425008|451720994|FG014|Dose Expansion Phase|Other|0|||
125572053|NCT01425008|451720995|FG015|Dose Expansion Phase|Other|0|||
125572054|NCT01425008|451720996|FG016|Dose Expansion Phase|Other|2|||
125572055|NCT01425008|451720997|FG017|Dose Expansion Phase|Other|0|||
125572056|NCT01425008|451720998|FG018|Dose Expansion Phase|Other|4|||
125572057|NCT01425008|451720980|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572058|NCT01425008|451720981|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572059|NCT01425008|451720982|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572060|NCT01425008|451720983|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572061|NCT01425008|451720984|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572062|NCT01425008|451720985|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572063|NCT01425008|451720986|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572064|NCT01425008|451720987|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572065|NCT01425008|451720988|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572066|NCT01425008|451720989|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572067|NCT01425008|451720990|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
125572068|NCT01425008|451720991|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
125572069|NCT01425008|451720992|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572070|NCT01425008|451720993|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572071|NCT01425008|451720994|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572072|NCT01425008|451720995|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
125572073|NCT01425008|451720996|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
125572074|NCT01425008|451720997|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
125572075|NCT01425008|451720998|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
125572076|NCT01425008|451720980|FG000|Dose Expansion Phase|Adverse Event|0|||
125572077|NCT01425008|451720981|FG001|Dose Expansion Phase|Adverse Event|0|||
125572078|NCT01425008|451720982|FG002|Dose Expansion Phase|Adverse Event|0|||
125572079|NCT01425008|451720983|FG003|Dose Expansion Phase|Adverse Event|0|||
125572080|NCT01425008|451720984|FG004|Dose Expansion Phase|Adverse Event|0|||
125572081|NCT01425008|451720985|FG005|Dose Expansion Phase|Adverse Event|0|||
125572082|NCT01425008|451720986|FG006|Dose Expansion Phase|Adverse Event|0|||
125572083|NCT01425008|451720987|FG007|Dose Expansion Phase|Adverse Event|0|||
125572084|NCT01425008|451720988|FG008|Dose Expansion Phase|Adverse Event|0|||
125572085|NCT01425008|451720989|FG009|Dose Expansion Phase|Adverse Event|0|||
125572086|NCT01425008|451720990|FG010|Dose Expansion Phase|Adverse Event|2|||
125572087|NCT01425008|451720991|FG011|Dose Expansion Phase|Adverse Event|3|||
125572088|NCT01425008|451720992|FG012|Dose Expansion Phase|Adverse Event|3|||
125572089|NCT01425008|451720993|FG013|Dose Expansion Phase|Adverse Event|0|||
125572090|NCT01425008|451720994|FG014|Dose Expansion Phase|Adverse Event|1|||
125572091|NCT01425008|451720995|FG015|Dose Expansion Phase|Adverse Event|1|||
125572092|NCT01425008|451720996|FG016|Dose Expansion Phase|Adverse Event|5|||
125572093|NCT01425008|451720997|FG017|Dose Expansion Phase|Adverse Event|0|||
125572094|NCT01425008|451720998|FG018|Dose Expansion Phase|Adverse Event|3|||
125572095|NCT01425008|451720980|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
125572096|NCT01425008|451720981|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
125572097|NCT01425008|451720982|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
125572098|NCT01425008|451720983|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
125572099|NCT01425008|451720984|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
125572100|NCT01425008|451720985|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
125572101|NCT01425008|451720986|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
125572102|NCT01425008|451720987|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
125572103|NCT01425008|451720988|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
125572104|NCT01425008|451720989|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
125572105|NCT01425008|451720990|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
125572106|NCT01425008|451720991|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
125572107|NCT01425008|451720992|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
125572108|NCT01425008|451720993|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
125572109|NCT01425008|451720994|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
125572110|NCT01425008|451720995|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
125572111|NCT01425008|451720996|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
125572112|NCT01425008|451720997|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
125572113|NCT01425008|451720998|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
125572114|NCT01425008|451720980|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572115|NCT01425008|451720981|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572116|NCT01425008|451720982|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572117|NCT01425008|451720983|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572118|NCT01425008|451720984|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572119|NCT01425008|451720985|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572120|NCT01425008|451720986|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125358287|NCT04612790|450948196|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
125358288|NCT04612790|450948193|FG000|DB Period (Up to 36 Weeks)|Other|1|||
125572121|NCT01425008|451720987|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572122|NCT01425008|451720988|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572123|NCT01425008|451720989|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572124|NCT01425008|451720990|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572125|NCT01425008|451720991|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572126|NCT01425008|451720992|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572127|NCT01425008|451720993|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572128|NCT01425008|451720994|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572129|NCT01425008|451720995|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572130|NCT01425008|451720996|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572131|NCT01425008|451720997|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125572132|NCT01425008|451720998|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
125572133|NCT00562588|451720999|FG000|Overall Study|Adverse Event|40|||
125572134|NCT00562588|451721000|FG001|Overall Study|Adverse Event|58|||
125572135|NCT00562588|451720999|FG000|Overall Study|Protocol Violation|30|||
125572136|NCT00562588|451721000|FG001|Overall Study|Protocol Violation|26|||
125572137|NCT00562588|451720999|FG000|Overall Study|Lost to Follow-up|12|||
125572138|NCT00562588|451721000|FG001|Overall Study|Lost to Follow-up|4|||
125572139|NCT00562588|451720999|FG000|Overall Study|Withdrawal by Subject|10|||
125572140|NCT00562588|451721000|FG001|Overall Study|Withdrawal by Subject|9|||
125572141|NCT00562588|451720999|FG000|Overall Study|Other|0|||
125358289|NCT04612790|450948194|FG001|DB Period (Up to 36 Weeks)|Other|0|||
125358290|NCT04612790|450948195|FG002|DB Period (Up to 36 Weeks)|Other|0|||
125572142|NCT00562588|451721000|FG001|Overall Study|Other|2|||
125572143|NCT03315871|451721001|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
125572144|NCT03315871|451721002|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
125572145|NCT03315871|451721003|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
125572146|NCT03315871|451721001|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
125572147|NCT03315871|451721002|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
125572148|NCT03315871|451721003|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
125572149|NCT03315871|451721001|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
125572150|NCT03315871|451721002|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
125572151|NCT03315871|451721003|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
125572152|NCT03315871|451721001|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
125358291|NCT04612790|450948196|FG003|DB Period (Up to 36 Weeks)|Other|0|||
125358292|NCT04612790|450948193|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
125572153|NCT03315871|451721002|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
125572154|NCT03315871|451721003|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
125572155|NCT03315871|451721001|FG000|PROSTVAC + CV301|Progressive disease|0|||
125572156|NCT03315871|451721002|FG001|PROSTVAC + CV301|Progressive disease|0|||
125572157|NCT03315871|451721003|FG002|PROSTVAC + CV301|Progressive disease|1|||
125572158|NCT03315871|451721001|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
125572159|NCT03315871|451721002|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
125572160|NCT03315871|451721003|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
125572161|NCT05032157|451724296|FG000|Overall Study|Adverse Event|12|||
125572162|NCT05032157|451724297|FG001|Overall Study|Adverse Event|7|||
125572163|NCT05032157|451724296|FG000|Overall Study|Pregnancy|0|||
125572164|NCT05032157|451724297|FG001|Overall Study|Pregnancy|2|||
125572165|NCT05032157|451724296|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125572166|NCT05032157|451724297|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
125572167|NCT05032157|451724296|FG000|Overall Study|Protocol Deviation|8|||
125572168|NCT05032157|451724297|FG001|Overall Study|Protocol Deviation|4|||
125572169|NCT05032157|451724296|FG000|Overall Study|Lost to Follow-up|1|||
125572170|NCT05032157|451724297|FG001|Overall Study|Lost to Follow-up|3|||
125572171|NCT05032157|451724296|FG000|Overall Study|Physician Decision|7|||
125572172|NCT05032157|451724297|FG001|Overall Study|Physician Decision|2|||
125572173|NCT05032157|451724296|FG000|Overall Study|Patient Decision|38|||
125572174|NCT05032157|451724297|FG001|Overall Study|Patient Decision|19|||
125572175|NCT00150592|451724298|FG000|Overall Study|Adverse Event|4|||
125572176|NCT00150592|451724299|FG001|Overall Study|Adverse Event|1|||
125572177|NCT00150592|451724298|FG000|Overall Study|Protocol Violation|1|||
125572178|NCT00150592|451724299|FG001|Overall Study|Protocol Violation|0|||
125572179|NCT00150592|451724298|FG000|Overall Study|Withdrawal by Subject|1|||
125572180|NCT00150592|451724299|FG001|Overall Study|Withdrawal by Subject|2|||
125358293|NCT04612790|450948194|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
125426962|NCT01218126|451188072|FG002|Overall Study|Protocol Violation|2|||
125572181|NCT00150592|451724298|FG000|Overall Study|Non-compliance|1|||
125572182|NCT00150592|451724299|FG001|Overall Study|Non-compliance|0|||
125572183|NCT03047980|451724300|FG000|Overall Study|Adverse Event|1|||
125572184|NCT00874120|451724305|FG000|First Intervention|Adverse Event|0|||
125572185|NCT00874120|451724306|FG001|First Intervention|Adverse Event|1|||
125572186|NCT00874120|451724305|FG000|First Intervention|Withdrawal by Subject|2|||
125572187|NCT00874120|451724306|FG001|First Intervention|Withdrawal by Subject|0|||
125572188|NCT00874120|451724305|FG000|First Intervention|Lost to Follow-up|0|||
125572189|NCT00874120|451724306|FG001|First Intervention|Lost to Follow-up|1|||
125572190|NCT00874120|451724305|FG000|First Intervention|Protocol Violation|3|||
125572191|NCT00874120|451724306|FG001|First Intervention|Protocol Violation|0|||
125572192|NCT00874120|451724305|FG000|First Intervention|positive drug test|1|||
125572193|NCT00874120|451724306|FG001|First Intervention|positive drug test|0|||
125572194|NCT00874120|451724305|FG000|Second Intervention|Withdrawal by Subject|1|||
125358294|NCT04612790|450948195|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
125358295|NCT04612790|450948196|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
125358296|NCT04612790|450948193|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
125358297|NCT04612790|450948194|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
125358298|NCT04612790|450948195|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
125358299|NCT04612790|450948196|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
125358300|NCT04612790|450948193|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
125358301|NCT04612790|450948194|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
125358302|NCT04612790|450948195|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
125358303|NCT04612790|450948196|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
125358304|NCT04612790|450948193|FG000|OLE Period (Up to 1 Year)|Other|0|||
125358305|NCT04612790|450948194|FG001|OLE Period (Up to 1 Year)|Other|0|||
125358306|NCT04612790|450948195|FG002|OLE Period (Up to 1 Year)|Other|0|||
125358307|NCT04612790|450948196|FG003|OLE Period (Up to 1 Year)|Other|1|||
125358308|NCT00785928|450948197|FG000|Treatment Phase|Adverse Event|1|||
125358309|NCT00785928|450948198|FG001|Treatment Phase|Adverse Event|1|||
125358310|NCT00785928|450948199|FG002|Treatment Phase|Adverse Event|2|||
125358311|NCT00785928|450948200|FG003|Treatment Phase|Adverse Event|0|||
125358312|NCT00785928|450948201|FG004|Treatment Phase|Adverse Event|0|||
125358313|NCT00785928|450948202|FG005|Treatment Phase|Adverse Event|0|||
125358314|NCT00785928|450948203|FG006|Treatment Phase|Adverse Event|2|||
125358315|NCT00785928|450948197|FG000|Treatment Phase|Inadequate Response|0|||
125358316|NCT00785928|450948198|FG001|Treatment Phase|Inadequate Response|1|||
125358317|NCT00785928|450948199|FG002|Treatment Phase|Inadequate Response|0|||
125358318|NCT00785928|450948200|FG003|Treatment Phase|Inadequate Response|0|||
125358319|NCT00785928|450948201|FG004|Treatment Phase|Inadequate Response|0|||
125358320|NCT00785928|450948202|FG005|Treatment Phase|Inadequate Response|0|||
125358321|NCT00785928|450948203|FG006|Treatment Phase|Inadequate Response|0|||
125358322|NCT00785928|450948197|FG000|Treatment Phase|Lack of Efficacy|0|||
125358323|NCT00785928|450948198|FG001|Treatment Phase|Lack of Efficacy|1|||
125358324|NCT00785928|450948199|FG002|Treatment Phase|Lack of Efficacy|1|||
125358325|NCT00785928|450948200|FG003|Treatment Phase|Lack of Efficacy|0|||
125358326|NCT00785928|450948201|FG004|Treatment Phase|Lack of Efficacy|0|||
125358327|NCT00785928|450948202|FG005|Treatment Phase|Lack of Efficacy|0|||
125358328|NCT00785928|450948203|FG006|Treatment Phase|Lack of Efficacy|0|||
125358329|NCT00785928|450948197|FG000|Treatment Phase|Physician Decision|0|||
125358330|NCT00785928|450948198|FG001|Treatment Phase|Physician Decision|0|||
125358331|NCT00785928|450948199|FG002|Treatment Phase|Physician Decision|0|||
125358332|NCT00785928|450948200|FG003|Treatment Phase|Physician Decision|0|||
125358333|NCT00785928|450948201|FG004|Treatment Phase|Physician Decision|1|||
125358334|NCT00785928|450948202|FG005|Treatment Phase|Physician Decision|0|||
125358335|NCT00785928|450948203|FG006|Treatment Phase|Physician Decision|0|||
125358336|NCT00785928|450948197|FG000|Treatment Phase|Sponsor Decision|1|||
125358337|NCT00785928|450948198|FG001|Treatment Phase|Sponsor Decision|0|||
125358338|NCT00785928|450948199|FG002|Treatment Phase|Sponsor Decision|0|||
125358339|NCT00785928|450948200|FG003|Treatment Phase|Sponsor Decision|0|||
125358340|NCT00785928|450948201|FG004|Treatment Phase|Sponsor Decision|0|||
125358341|NCT00785928|450948202|FG005|Treatment Phase|Sponsor Decision|0|||
125572195|NCT00874120|451724306|FG001|Second Intervention|Withdrawal by Subject|0|||
125572196|NCT00874120|451724305|FG000|Second Intervention|Protocol Violation|1|||
125572197|NCT00874120|451724306|FG001|Second Intervention|Protocol Violation|0|||
125572198|NCT01823679|451724307|FG000|Overall Study|Death|1|||
125358342|NCT00785928|450948203|FG006|Treatment Phase|Sponsor Decision|1|||
125358343|NCT00785928|450948197|FG000|Treatment Phase|Withdrawal by Subject|1|||
125358344|NCT00785928|450948198|FG001|Treatment Phase|Withdrawal by Subject|2|||
125358345|NCT00785928|450948199|FG002|Treatment Phase|Withdrawal by Subject|0|||
125358346|NCT00785928|450948200|FG003|Treatment Phase|Withdrawal by Subject|0|||
125358347|NCT00785928|450948201|FG004|Treatment Phase|Withdrawal by Subject|1|||
125358348|NCT00785928|450948202|FG005|Treatment Phase|Withdrawal by Subject|0|||
125358349|NCT00785928|450948203|FG006|Treatment Phase|Withdrawal by Subject|0|||
125358350|NCT00570765|450948208|FG000|DB Phase|Withdrawal by Subject|1|||
125358351|NCT00570765|450948209|FG001|DB Phase|Withdrawal by Subject|0|||
125358352|NCT00570765|450948210|FG002|DB Phase|Withdrawal by Subject|0|||
125572199|NCT02164981|451724308|FG000|Started|Withdrawal by Subject|2|||
125572200|NCT02164981|451724309|FG001|Started|Withdrawal by Subject|1|||
125572201|NCT02164981|451724310|FG002|Started|Withdrawal by Subject|0|||
125572202|NCT02164981|451724308|FG000|Started|Protocol Violation|2|||
125572203|NCT02164981|451724309|FG001|Started|Protocol Violation|0|||
125572204|NCT02164981|451724310|FG002|Started|Protocol Violation|0|||
125572205|NCT02164981|451724308|FG000|Started|Adverse Event|1|||
125572206|NCT02164981|451724309|FG001|Started|Adverse Event|2|||
125572207|NCT02164981|451724310|FG002|Started|Adverse Event|0|||
125572208|NCT02164981|451724308|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
125572209|NCT02164981|451724309|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
125572210|NCT02164981|451724310|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
125572211|NCT02164981|451724308|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
125572212|NCT02164981|451724309|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
125572213|NCT02164981|451724310|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
125572214|NCT02164981|451724308|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
125572215|NCT02164981|451724309|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
125572216|NCT02164981|451724310|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
125572217|NCT02404103|451724311|FG000|Overall Study|Adverse Event|1|||
125572218|NCT02404103|451724312|FG001|Overall Study|Adverse Event|0|||
125572219|NCT02404103|451724311|FG000|Overall Study|Lost to Follow-up|3|||
125572220|NCT02404103|451724312|FG001|Overall Study|Lost to Follow-up|3|||
125572221|NCT00328627|451724313|FG000|Overall Study|Hyperglycemic Rescue|41|||
125572222|NCT00328627|451724314|FG001|Overall Study|Hyperglycemic Rescue|18|||
125572223|NCT00328627|451724315|FG002|Overall Study|Hyperglycemic Rescue|16|||
125572224|NCT00328627|451724316|FG003|Overall Study|Hyperglycemic Rescue|13|||
125572225|NCT00328627|451724317|FG004|Overall Study|Hyperglycemic Rescue|6|||
125572226|NCT00328627|451724318|FG005|Overall Study|Hyperglycemic Rescue|5|||
125572227|NCT00328627|451724319|FG006|Overall Study|Hyperglycemic Rescue|19|||
125572228|NCT00328627|451724320|FG007|Overall Study|Hyperglycemic Rescue|6|||
125572229|NCT00328627|451724321|FG008|Overall Study|Hyperglycemic Rescue|6|||
125572230|NCT00328627|451724322|FG009|Overall Study|Hyperglycemic Rescue|11|||
125572231|NCT00328627|451724323|FG010|Overall Study|Hyperglycemic Rescue|3|||
125572232|NCT00328627|451724324|FG011|Overall Study|Hyperglycemic Rescue|2|||
125572233|NCT00328627|451724313|FG000|Overall Study|Adverse Event|3|||
125572234|NCT00328627|451724314|FG001|Overall Study|Adverse Event|1|||
125572235|NCT00328627|451724315|FG002|Overall Study|Adverse Event|2|||
125572236|NCT00328627|451724316|FG003|Overall Study|Adverse Event|3|||
125572237|NCT00328627|451724317|FG004|Overall Study|Adverse Event|1|||
125572238|NCT00328627|451724318|FG005|Overall Study|Adverse Event|2|||
125572239|NCT00328627|451724319|FG006|Overall Study|Adverse Event|1|||
125572240|NCT00328627|451724320|FG007|Overall Study|Adverse Event|2|||
125572241|NCT00328627|451724321|FG008|Overall Study|Adverse Event|0|||
125572242|NCT00328627|451724322|FG009|Overall Study|Adverse Event|7|||
125572243|NCT00328627|451724323|FG010|Overall Study|Adverse Event|5|||
125572244|NCT00328627|451724324|FG011|Overall Study|Adverse Event|4|||
125572245|NCT00328627|451724313|FG000|Overall Study|Protocol Violation|2|||
125572246|NCT00328627|451724314|FG001|Overall Study|Protocol Violation|2|||
125572247|NCT00328627|451724315|FG002|Overall Study|Protocol Violation|2|||
125426963|NCT01218126|451188073|FG003|Overall Study|Protocol Violation|3|||
125572248|NCT00328627|451724316|FG003|Overall Study|Protocol Violation|8|||
125572249|NCT00328627|451724317|FG004|Overall Study|Protocol Violation|5|||
125572250|NCT00328627|451724318|FG005|Overall Study|Protocol Violation|5|||
125572251|NCT00328627|451724319|FG006|Overall Study|Protocol Violation|6|||
125572252|NCT00328627|451724320|FG007|Overall Study|Protocol Violation|2|||
125572253|NCT00328627|451724321|FG008|Overall Study|Protocol Violation|1|||
125572254|NCT00328627|451724322|FG009|Overall Study|Protocol Violation|4|||
125572255|NCT00328627|451724323|FG010|Overall Study|Protocol Violation|6|||
125572256|NCT00328627|451724324|FG011|Overall Study|Protocol Violation|2|||
125572257|NCT00328627|451724313|FG000|Overall Study|Lost to Follow-up|4|||
125572258|NCT00328627|451724314|FG001|Overall Study|Lost to Follow-up|2|||
125572259|NCT00328627|451724315|FG002|Overall Study|Lost to Follow-up|2|||
125572260|NCT00328627|451724316|FG003|Overall Study|Lost to Follow-up|4|||
125572261|NCT00328627|451724317|FG004|Overall Study|Lost to Follow-up|0|||
125572262|NCT00328627|451724318|FG005|Overall Study|Lost to Follow-up|2|||
125572263|NCT00328627|451724319|FG006|Overall Study|Lost to Follow-up|3|||
125572264|NCT00328627|451724320|FG007|Overall Study|Lost to Follow-up|0|||
125572265|NCT00328627|451724321|FG008|Overall Study|Lost to Follow-up|3|||
125572266|NCT00328627|451724322|FG009|Overall Study|Lost to Follow-up|2|||
125572267|NCT00328627|451724323|FG010|Overall Study|Lost to Follow-up|0|||
125572268|NCT00328627|451724324|FG011|Overall Study|Lost to Follow-up|1|||
125572269|NCT00328627|451724313|FG000|Overall Study|Withdrawal by Subject|5|||
125572270|NCT00328627|451724314|FG001|Overall Study|Withdrawal by Subject|4|||
125572271|NCT00328627|451724315|FG002|Overall Study|Withdrawal by Subject|5|||
125572272|NCT00328627|451724316|FG003|Overall Study|Withdrawal by Subject|6|||
125572273|NCT00328627|451724317|FG004|Overall Study|Withdrawal by Subject|2|||
125572274|NCT00328627|451724318|FG005|Overall Study|Withdrawal by Subject|5|||
125572275|NCT00328627|451724319|FG006|Overall Study|Withdrawal by Subject|4|||
125572276|NCT00328627|451724320|FG007|Overall Study|Withdrawal by Subject|4|||
125572277|NCT00328627|451724321|FG008|Overall Study|Withdrawal by Subject|4|||
125572278|NCT00328627|451724322|FG009|Overall Study|Withdrawal by Subject|5|||
125572279|NCT00328627|451724323|FG010|Overall Study|Withdrawal by Subject|2|||
125358353|NCT00570765|450948211|FG003|DB Phase|Withdrawal by Subject|0|||
125572280|NCT00328627|451724324|FG011|Overall Study|Withdrawal by Subject|7|||
125572281|NCT00328627|451724313|FG000|Overall Study|Pregnancy|0|||
125572282|NCT00328627|451724314|FG001|Overall Study|Pregnancy|1|||
125572283|NCT00328627|451724315|FG002|Overall Study|Pregnancy|0|||
125358354|NCT00570765|450948208|FG000|DB Phase|Protocol Violation|0|||
125358355|NCT00570765|450948209|FG001|DB Phase|Protocol Violation|1|||
125358356|NCT00570765|450948210|FG002|DB Phase|Protocol Violation|0|||
125358357|NCT00570765|450948211|FG003|DB Phase|Protocol Violation|0|||
125358358|NCT00570765|450948208|FG000|DB Phase|Adverse Event|3|||
125358359|NCT00570765|450948209|FG001|DB Phase|Adverse Event|6|||
125358360|NCT00570765|450948210|FG002|DB Phase|Adverse Event|0|||
125572284|NCT00328627|451724316|FG003|Overall Study|Pregnancy|0|||
125572285|NCT00328627|451724317|FG004|Overall Study|Pregnancy|0|||
125572286|NCT00328627|451724318|FG005|Overall Study|Pregnancy|0|||
125572287|NCT00328627|451724319|FG006|Overall Study|Pregnancy|0|||
125572288|NCT00328627|451724320|FG007|Overall Study|Pregnancy|0|||
125572289|NCT00328627|451724321|FG008|Overall Study|Pregnancy|0|||
125572290|NCT00328627|451724322|FG009|Overall Study|Pregnancy|0|||
125572291|NCT00328627|451724323|FG010|Overall Study|Pregnancy|0|||
125572292|NCT00328627|451724324|FG011|Overall Study|Pregnancy|0|||
125572293|NCT00328627|451724313|FG000|Overall Study|Physician Decision|4|||
125572294|NCT00328627|451724314|FG001|Overall Study|Physician Decision|3|||
125572295|NCT00328627|451724315|FG002|Overall Study|Physician Decision|1|||
125572296|NCT00328627|451724316|FG003|Overall Study|Physician Decision|2|||
125572297|NCT00328627|451724317|FG004|Overall Study|Physician Decision|1|||
125572298|NCT00328627|451724318|FG005|Overall Study|Physician Decision|1|||
125572299|NCT00328627|451724319|FG006|Overall Study|Physician Decision|1|||
125572300|NCT00328627|451724320|FG007|Overall Study|Physician Decision|0|||
125572301|NCT00328627|451724321|FG008|Overall Study|Physician Decision|3|||
125572302|NCT00328627|451724322|FG009|Overall Study|Physician Decision|2|||
125572303|NCT00328627|451724323|FG010|Overall Study|Physician Decision|1|||
125572304|NCT00328627|451724324|FG011|Overall Study|Physician Decision|0|||
125572305|NCT00328627|451724313|FG000|Overall Study|Other|0|||
125572306|NCT00328627|451724314|FG001|Overall Study|Other|0|||
125572307|NCT00328627|451724315|FG002|Overall Study|Other|0|||
125572308|NCT00328627|451724316|FG003|Overall Study|Other|1|||
125572309|NCT00328627|451724317|FG004|Overall Study|Other|0|||
125572310|NCT00328627|451724318|FG005|Overall Study|Other|0|||
125572311|NCT00328627|451724319|FG006|Overall Study|Other|1|||
125572312|NCT00328627|451724320|FG007|Overall Study|Other|0|||
125572313|NCT00328627|451724321|FG008|Overall Study|Other|0|||
125572314|NCT00328627|451724322|FG009|Overall Study|Other|1|||
125572315|NCT00328627|451724323|FG010|Overall Study|Other|1|||
125358361|NCT00570765|450948211|FG003|DB Phase|Adverse Event|0|||
125426964|NCT01218126|451188070|FG000|Overall Study|Protocol-defined stopping criteria|1|||
125572316|NCT00328627|451724324|FG011|Overall Study|Other|0|||
125572317|NCT00522431|451724325|FG000|Overall Study|Adverse Event|5|||
125572318|NCT00522431|451724325|FG000|Overall Study|Protocol Violation|2|||
125572319|NCT00522431|451724325|FG000|Overall Study|Withdrawal by Subject|2|||
125572320|NCT00522431|451724325|FG000|Overall Study|Subject non-compliance|1|||
125358362|NCT00570765|450948208|FG000|DB Phase|Did Not Receive Study Drug|0|||
125358363|NCT00570765|450948209|FG001|DB Phase|Did Not Receive Study Drug|0|||
125426965|NCT01218126|451188071|FG001|Overall Study|Protocol-defined stopping criteria|1|||
125572321|NCT00522431|451724325|FG000|Overall Study|Other/unknown|1|||
125572322|NCT01137773|451724326|FG000|Overall Study|Death|3|||
125572323|NCT01137773|451724327|FG001|Overall Study|Death|3|||
125572324|NCT01137773|451724326|FG000|Overall Study|Lost to Follow-up|6|||
125572325|NCT01137773|451724327|FG001|Overall Study|Lost to Follow-up|0|||
125572326|NCT03548051|451724328|FG000|Overall Study|Death|1|||
125210891|NCT01955109|450396702|FG001|Overall Study|Participant unwilling to continue|7|||
125426966|NCT01218126|451188072|FG002|Overall Study|Protocol-defined stopping criteria|0|||
125426967|NCT01218126|451188073|FG003|Overall Study|Protocol-defined stopping criteria|0|||
125426968|NCT01218126|451188070|FG000|Overall Study|Lost to Follow-up|0|||
125426969|NCT01218126|451188071|FG001|Overall Study|Lost to Follow-up|0|||
125426970|NCT01218126|451188072|FG002|Overall Study|Lost to Follow-up|0|||
125426971|NCT01218126|451188073|FG003|Overall Study|Lost to Follow-up|2|||
125426972|NCT01218126|451188070|FG000|Overall Study|Physician Decision|1|||
125426973|NCT01218126|451188071|FG001|Overall Study|Physician Decision|2|||
125426974|NCT01218126|451188072|FG002|Overall Study|Physician Decision|4|||
125426975|NCT01218126|451188073|FG003|Overall Study|Physician Decision|2|||
125426976|NCT01218126|451188070|FG000|Overall Study|Withdrawal by Subject|2|||
125426977|NCT01218126|451188071|FG001|Overall Study|Withdrawal by Subject|5|||
125426978|NCT01218126|451188072|FG002|Overall Study|Withdrawal by Subject|4|||
125426979|NCT01218126|451188073|FG003|Overall Study|Withdrawal by Subject|6|||
125426980|NCT01860703|451188075|FG000|Overall Study|Adverse Event|1|||
125572327|NCT03548051|451724329|FG001|Overall Study|Death|1|||
125572328|NCT03548051|451724328|FG000|Overall Study|Withdrawal by Subject|1|||
125572329|NCT03548051|451724329|FG001|Overall Study|Withdrawal by Subject|0|||
125572330|NCT03927105|451724330|FG000|Overall Study|Death|1|||
125572331|NCT03927105|451724330|FG000|Overall Study|In observation for potential re-treatment|2|||
125210892|NCT01955109|450396701|FG000|Overall Study|Physician Decision|2|||
125210893|NCT01955109|450396702|FG001|Overall Study|Physician Decision|0|||
125210894|NCT01955109|450396701|FG000|Overall Study|Lost to Follow-up|3|||
125210895|NCT01955109|450396702|FG001|Overall Study|Lost to Follow-up|1|||
125210896|NCT01955109|450396701|FG000|Overall Study|Non-compliance|3|||
125210897|NCT01955109|450396702|FG001|Overall Study|Non-compliance|1|||
125210898|NCT01618916|450396704|FG000|Overall Study|Adverse Event|1|||
125210899|NCT01618916|450396705|FG001|Overall Study|Adverse Event|0|||
125210900|NCT01618916|450396706|FG002|Overall Study|Adverse Event|0|||
125210901|NCT01618916|450396707|FG003|Overall Study|Adverse Event|0|||
125210902|NCT01618916|450396708|FG004|Overall Study|Adverse Event|0|||
125210903|NCT01618916|450396709|FG005|Overall Study|Adverse Event|0|||
125210904|NCT01618916|450396704|FG000|Overall Study|Withdrawal by Subject|0|||
125210905|NCT01618916|450396705|FG001|Overall Study|Withdrawal by Subject|1|||
125210906|NCT01618916|450396706|FG002|Overall Study|Withdrawal by Subject|1|||
125210907|NCT01618916|450396707|FG003|Overall Study|Withdrawal by Subject|0|||
125210908|NCT01618916|450396708|FG004|Overall Study|Withdrawal by Subject|1|||
125210909|NCT01618916|450396709|FG005|Overall Study|Withdrawal by Subject|0|||
125572332|NCT03927105|451724330|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
125572333|NCT02684981|451724334|FG000|Overall Study|Permanently discontinued the treatment|157|||
125572334|NCT02684981|451724335|FG001|Overall Study|Permanently discontinued the treatment|161|||
125572335|NCT02684981|451724336|FG002|Overall Study|Permanently discontinued the treatment|110|||
125572336|NCT02684981|451724334|FG000|Overall Study|Other|83|||
125572337|NCT02684981|451724335|FG001|Overall Study|Other|49|||
125572338|NCT02684981|451724336|FG002|Overall Study|Other|17|||
125572339|NCT00820898|451724337|FG000|Overall Study|Inelgible - wrong primary site|1|||
125572340|NCT00647556|451724340|FG000|Overall Study|Adverse Event|0|||
125572341|NCT00647556|451724341|FG001|Overall Study|Adverse Event|1|||
125572342|NCT00647556|451724340|FG000|Overall Study|Lost to Follow-up|1|||
125572343|NCT00647556|451724341|FG001|Overall Study|Lost to Follow-up|0|||
125210910|NCT01618916|450396704|FG000|Overall Study|Lost to Follow-up|1|||
125210911|NCT01618916|450396705|FG001|Overall Study|Lost to Follow-up|0|||
125210912|NCT01618916|450396706|FG002|Overall Study|Lost to Follow-up|0|||
125426981|NCT01860703|451188076|FG001|Overall Study|Adverse Event|4|||
125426982|NCT01860703|451188077|FG002|Overall Study|Adverse Event|0|||
125426983|NCT01860703|451188078|FG003|Overall Study|Adverse Event|2|||
125426984|NCT01860703|451188075|FG000|Overall Study|Withdrawal by Subject|0|||
125426985|NCT01860703|451188076|FG001|Overall Study|Withdrawal by Subject|1|||
125426986|NCT01860703|451188077|FG002|Overall Study|Withdrawal by Subject|0|||
125426987|NCT01860703|451188078|FG003|Overall Study|Withdrawal by Subject|0|||
125426988|NCT01860703|451188075|FG000|Overall Study|Personal reason|1|||
125572344|NCT00647556|451724340|FG000|Overall Study|Protocol Violation|0|||
125572345|NCT00647556|451724341|FG001|Overall Study|Protocol Violation|1|||
125572346|NCT00647556|451724340|FG000|Overall Study|Withdrawal by Subject|1|||
125572347|NCT00647556|451724341|FG001|Overall Study|Withdrawal by Subject|0|||
125572348|NCT00647556|451724340|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
125210913|NCT01618916|450396707|FG003|Overall Study|Lost to Follow-up|2|||
125210914|NCT01618916|450396708|FG004|Overall Study|Lost to Follow-up|0|||
125210915|NCT01618916|450396709|FG005|Overall Study|Lost to Follow-up|0|||
125210916|NCT04521114|450396710|FG000|Overall Study|Lost to Follow-up|1|||
125210917|NCT04521114|450396711|FG001|Overall Study|Lost to Follow-up|2|||
125426989|NCT01860703|451188076|FG001|Overall Study|Personal reason|0|||
125426990|NCT01860703|451188077|FG002|Overall Study|Personal reason|1|||
125572349|NCT00647556|451724341|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
125572350|NCT01652287|451724342|FG000|Overall Study|Withdrawal by Subject|2|||
125210918|NCT04521114|450396712|FG002|Overall Study|Lost to Follow-up|0|||
125358364|NCT00570765|450948210|FG002|DB Phase|Did Not Receive Study Drug|1|||
125358365|NCT00570765|450948211|FG003|DB Phase|Did Not Receive Study Drug|0|||
125358366|NCT00570765|450948208|FG000|LTSE Phase|Withdrawal by Subject|0|||
125358367|NCT00570765|450948209|FG001|LTSE Phase|Withdrawal by Subject|0|||
125358368|NCT00570765|450948210|FG002|LTSE Phase|Withdrawal by Subject|0|||
125358369|NCT00570765|450948211|FG003|LTSE Phase|Withdrawal by Subject|1|||
125358370|NCT00570765|450948208|FG000|LTSE Phase|Adverse Event|0|||
125572351|NCT01652287|451724343|FG001|Overall Study|Withdrawal by Subject|0|||
125572352|NCT00179309|451724344|FG000|Treatment|Toxicity|2|||
125572353|NCT00179309|451724345|FG001|Treatment|Toxicity|3|||
125572354|NCT00179309|451724344|FG000|Treatment|Withdrawal by Subject|1|||
125572355|NCT00179309|451724345|FG001|Treatment|Withdrawal by Subject|2|||
125572356|NCT00179309|451724344|FG000|Treatment|Allergy|1|||
125572357|NCT00179309|451724345|FG001|Treatment|Allergy|0|||
125572358|NCT01709149|451724350|FG000|Open-label Lead-in Phase|Adverse Event|109|||
125572359|NCT01709149|451724351|FG001|Open-label Lead-in Phase|Adverse Event|0|||
125572360|NCT01709149|451724352|FG002|Open-label Lead-in Phase|Adverse Event|0|||
125572361|NCT01709149|451724350|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
125572362|NCT01709149|451724351|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
125572363|NCT01709149|451724352|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
125572364|NCT01709149|451724350|FG000|Open-label Lead-in Phase|Death|1|||
125572365|NCT01709149|451724351|FG001|Open-label Lead-in Phase|Death|0|||
125572366|NCT01709149|451724352|FG002|Open-label Lead-in Phase|Death|0|||
125572367|NCT01709149|451724350|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
125572368|NCT01709149|451724351|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
125572369|NCT01709149|451724352|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
125572370|NCT01709149|451724350|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
125572371|NCT01709149|451724351|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
125572372|NCT01709149|451724352|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
125210919|NCT04521114|450396710|FG000|Overall Study|Withdrawal by Subject|1|||
125572373|NCT01709149|451724350|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125572374|NCT01709149|451724351|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
125358371|NCT00570765|450948209|FG001|LTSE Phase|Adverse Event|0|||
125358372|NCT00570765|450948210|FG002|LTSE Phase|Adverse Event|0|||
125358373|NCT00570765|450948211|FG003|LTSE Phase|Adverse Event|7|||
125358374|NCT00570765|450948208|FG000|LTSE Phase|Physician Decision|0|||
125358375|NCT00570765|450948209|FG001|LTSE Phase|Physician Decision|0|||
125358376|NCT00570765|450948210|FG002|LTSE Phase|Physician Decision|0|||
125358377|NCT00570765|450948211|FG003|LTSE Phase|Physician Decision|4|||
125358378|NCT03387683|450948212|FG000|Overall Study|In receipt of disallowed medication|1|||
125358379|NCT03387683|450948213|FG001|Overall Study|In receipt of disallowed medication|0|||
125358380|NCT03387683|450948212|FG000|Overall Study|Did not receive treatment|1|||
125358381|NCT03387683|450948213|FG001|Overall Study|Did not receive treatment|0|||
125572375|NCT01709149|451724352|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
125572376|NCT01709149|451724350|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125358382|NCT00875979|450948214|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
125572377|NCT01709149|451724351|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
125572378|NCT01709149|451724352|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
125572379|NCT01709149|451724350|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
125572380|NCT01709149|451724351|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
125572381|NCT01709149|451724352|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
125572382|NCT01709149|451724350|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
125572383|NCT01709149|451724351|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
125572384|NCT01709149|451724352|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
125572385|NCT01709149|451724350|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125572386|NCT01709149|451724351|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
125572387|NCT01709149|451724352|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125572388|NCT02192827|451724353|FG000|Overall Study|Lost to Follow-up|25|||
125572389|NCT02192827|451724354|FG001|Overall Study|Lost to Follow-up|27|||
125572390|NCT02192827|451724353|FG000|Overall Study|Given additional steroids with admission|13|||
125572391|NCT02192827|451724354|FG001|Overall Study|Given additional steroids with admission|11|||
125572392|NCT02941627|451724392|FG000|Overall Study|Death|1|||
125572393|NCT02941627|451724392|FG000|Overall Study|Surgical failure|1|||
125572394|NCT02941627|451724392|FG000|Overall Study|cholesteatoma prevented implantation|1|||
125572395|NCT03594227|451724393|FG000|Overall Study|Adverse Event|2|||
125572396|NCT03594227|451724394|FG001|Overall Study|Adverse Event|1|||
125572397|NCT03594227|451724395|FG002|Overall Study|Adverse Event|0|||
125572398|NCT03594227|451724396|FG003|Overall Study|Adverse Event|2|||
125572399|NCT03594227|451724393|FG000|Overall Study|Lost to Follow-up|1|||
125572400|NCT03594227|451724394|FG001|Overall Study|Lost to Follow-up|1|||
125572401|NCT03594227|451724395|FG002|Overall Study|Lost to Follow-up|1|||
125572402|NCT03594227|451724396|FG003|Overall Study|Lost to Follow-up|0|||
125572403|NCT03594227|451724393|FG000|Overall Study|Withdrawal by Subject|1|||
125572404|NCT03594227|451724394|FG001|Overall Study|Withdrawal by Subject|1|||
125572405|NCT03594227|451724395|FG002|Overall Study|Withdrawal by Subject|1|||
125572406|NCT03594227|451724396|FG003|Overall Study|Withdrawal by Subject|1|||
125572407|NCT03594227|451724393|FG000|Overall Study|Pregnancy|0|||
125572408|NCT03594227|451724394|FG001|Overall Study|Pregnancy|1|||
125572409|NCT03594227|451724395|FG002|Overall Study|Pregnancy|0|||
125572410|NCT03594227|451724396|FG003|Overall Study|Pregnancy|0|||
125572411|NCT03594227|451724393|FG000|Overall Study|Sponsor Decision|0|||
125572412|NCT03594227|451724394|FG001|Overall Study|Sponsor Decision|0|||
125572413|NCT03594227|451724395|FG002|Overall Study|Sponsor Decision|0|||
125572414|NCT03594227|451724396|FG003|Overall Study|Sponsor Decision|1|||
125572415|NCT03594227|451724393|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
125572416|NCT03594227|451724394|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
125572417|NCT03594227|451724395|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
125572418|NCT03594227|451724396|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
125572419|NCT00790907|451724397|FG000|Overall Study|Adverse Event|9|||
125358383|NCT00875979|450948215|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
125358384|NCT00875979|450948214|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
125358385|NCT00875979|450948215|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
125572420|NCT00790907|451724398|FG001|Overall Study|Adverse Event|7|||
125572421|NCT00790907|451724399|FG002|Overall Study|Adverse Event|6|||
125572422|NCT00790907|451724397|FG000|Overall Study|Physician Decision|304|||
125572423|NCT00790907|451724398|FG001|Overall Study|Physician Decision|271|||
125572424|NCT00790907|451724399|FG002|Overall Study|Physician Decision|255|||
125572425|NCT00790907|451724397|FG000|Overall Study|Withdrawal by Subject|1|||
125572426|NCT00790907|451724398|FG001|Overall Study|Withdrawal by Subject|7|||
125572427|NCT00790907|451724399|FG002|Overall Study|Withdrawal by Subject|5|||
125572428|NCT00790907|451724397|FG000|Overall Study|Bleeding Event|11|||
125572429|NCT00790907|451724398|FG001|Overall Study|Bleeding Event|16|||
125572430|NCT00790907|451724399|FG002|Overall Study|Bleeding Event|21|||
125572431|NCT00790907|451724397|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
125572432|NCT00790907|451724398|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
125572433|NCT00790907|451724399|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
125572434|NCT00790907|451724397|FG000|Overall Study|Qualifying Condition Not Present|29|||
125572435|NCT00790907|451724398|FG001|Overall Study|Qualifying Condition Not Present|14|||
125572436|NCT00790907|451724399|FG002|Overall Study|Qualifying Condition Not Present|16|||
125572437|NCT00790907|451724397|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
125572438|NCT00790907|451724398|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
125572439|NCT00790907|451724399|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
125572440|NCT00790907|451724397|FG000|Overall Study|Did Not Receive Study Drug|10|||
125572441|NCT00790907|451724398|FG001|Overall Study|Did Not Receive Study Drug|0|||
125572442|NCT00790907|451724399|FG002|Overall Study|Did Not Receive Study Drug|0|||
125572443|NCT01888640|451724400|FG000|Overall Study|Lost to Follow-up|1|||
125572444|NCT01888640|451724401|FG001|Overall Study|Lost to Follow-up|2|||
125572445|NCT01888640|451724402|FG002|Overall Study|Lost to Follow-up|0|||
125572446|NCT01888640|451724400|FG000|Overall Study|Withdrawal by Subject|15|||
125572447|NCT01888640|451724401|FG001|Overall Study|Withdrawal by Subject|11|||
125572448|NCT01888640|451724402|FG002|Overall Study|Withdrawal by Subject|4|||
125572449|NCT01888640|451724400|FG000|Overall Study|Minimum dose not met|10|||
125572450|NCT01888640|451724401|FG001|Overall Study|Minimum dose not met|16|||
125572451|NCT01888640|451724402|FG002|Overall Study|Minimum dose not met|0|||
125572452|NCT01888640|451724400|FG000|Overall Study|Given wrong unit (placebo)|1|||
125572453|NCT01888640|451724401|FG001|Overall Study|Given wrong unit (placebo)|0|||
125572454|NCT01888640|451724402|FG002|Overall Study|Given wrong unit (placebo)|0|||
125572455|NCT01888640|451724400|FG000|Overall Study|Excluded for prior TENS|0|||
125572456|NCT01888640|451724401|FG001|Overall Study|Excluded for prior TENS|1|||
125572457|NCT01888640|451724402|FG002|Overall Study|Excluded for prior TENS|0|||
125572458|NCT01888640|451724400|FG000|Overall Study|Researcher Termination of Participant|0|||
125572459|NCT01888640|451724401|FG001|Overall Study|Researcher Termination of Participant|1|||
125572460|NCT01888640|451724402|FG002|Overall Study|Researcher Termination of Participant|1|||
125572461|NCT03436862|451724405|FG000|Overall Study|Adverse Event|4|||
125572462|NCT03436862|451724405|FG000|Overall Study|Progressive Disease|2|||
125572463|NCT02228590|451724407|FG000|Overall Study|Withdrawal by Subject|1|||
125572464|NCT01097863|451724408|FG000|Overall Study|Discomfort|1|||
125572465|NCT01097863|451724409|FG001|Overall Study|Discomfort|0|||
125572466|NCT01097863|451724410|FG002|Overall Study|Discomfort|1|||
125572467|NCT01097863|451724408|FG000|Overall Study|Did not return for final visit|0|||
125572468|NCT01097863|451724409|FG001|Overall Study|Did not return for final visit|0|||
125572469|NCT01097863|451724410|FG002|Overall Study|Did not return for final visit|1|||
125572470|NCT00960843|451724411|FG000|Overall Study|Lost to Follow-up|2|||
125572471|NCT00960843|451724412|FG001|Overall Study|Lost to Follow-up|0|||
125572472|NCT00960843|451724411|FG000|Overall Study|Protocol Violation|0|||
125572473|NCT00960843|451724412|FG001|Overall Study|Protocol Violation|4|||
125572474|NCT00960843|451724411|FG000|Overall Study|Repeated needle dislodgment|0|||
125572475|NCT00960843|451724412|FG001|Overall Study|Repeated needle dislodgment|1|||
125572476|NCT00490451|451724415|FG000|Overall Study|Adverse Event|3|||
125572477|NCT00490451|451724416|FG001|Overall Study|Adverse Event|3|||
125572478|NCT00490451|451724415|FG000|Overall Study|Death|3|||
125572479|NCT00490451|451724416|FG001|Overall Study|Death|1|||
125572480|NCT00490451|451724415|FG000|Overall Study|Withdrawal by Subject|2|||
125572481|NCT00490451|451724416|FG001|Overall Study|Withdrawal by Subject|0|||
125572482|NCT00490451|451724415|FG000|Overall Study|Investigator Decision|1|||
125572483|NCT00490451|451724416|FG001|Overall Study|Investigator Decision|0|||
125572484|NCT00490451|451724415|FG000|Overall Study|Protocol Violation|1|||
125572485|NCT00490451|451724416|FG001|Overall Study|Protocol Violation|0|||
125572486|NCT00490451|451724415|FG000|Overall Study|Progressive Disease|53|||
125572487|NCT00490451|451724416|FG001|Overall Study|Progressive Disease|34|||
125572488|NCT01181011|451724417|FG000|Overall Study|Adverse Event|2|||
125358386|NCT00875979|450948214|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
125572489|NCT01181011|451724417|FG000|Overall Study|Lost to Follow-up|1|||
125572490|NCT02788747|451724418|FG000|Overall Study|Adverse Event|1|||
125572491|NCT02788747|451724419|FG001|Overall Study|Adverse Event|0|||
125572492|NCT02788747|451724420|FG002|Overall Study|Adverse Event|0|||
125572493|NCT01967550|451724421|FG000|Overall Study|Withdrawal by Subject|1|||
125572494|NCT01967550|451724422|FG001|Overall Study|Withdrawal by Subject|0|||
125572495|NCT01967550|451724421|FG000|Overall Study|Adverse Event|2|||
125572496|NCT01967550|451724422|FG001|Overall Study|Adverse Event|0|||
125572497|NCT01967550|451724421|FG000|Overall Study|Protocol Violation|2|||
125572498|NCT01967550|451724422|FG001|Overall Study|Protocol Violation|1|||
125572499|NCT01967550|451724421|FG000|Overall Study|Non Compliance|0|||
125572500|NCT01967550|451724422|FG001|Overall Study|Non Compliance|1|||
125572501|NCT00784654|451724425|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
125572502|NCT00784654|451724426|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
125572503|NCT00784654|451724427|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
125572504|NCT00784654|451724425|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
125572505|NCT00784654|451724426|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
125572506|NCT00784654|451724427|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
125572507|NCT00784654|451724425|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
125572508|NCT00784654|451724426|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
125572509|NCT00784654|451724427|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
125572510|NCT00784654|451724425|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
125572511|NCT00784654|451724426|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
125572512|NCT00784654|451724427|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
125572513|NCT00784654|451724425|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
125572514|NCT00784654|451724426|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
125572515|NCT00784654|451724427|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
125572516|NCT00784654|451724425|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
125572517|NCT00784654|451724426|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
125572518|NCT00784654|451724427|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
125572519|NCT00784654|451724425|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
125572520|NCT00784654|451724426|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
125572521|NCT00784654|451724427|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
125572522|NCT00784654|451724425|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
125572523|NCT00784654|451724426|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
125572524|NCT00784654|451724427|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
125572525|NCT00784654|451724425|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
125572526|NCT00784654|451724426|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
125572527|NCT00784654|451724427|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
125572528|NCT00784654|451724425|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
125572529|NCT00784654|451724426|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
125572530|NCT00784654|451724427|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
125572531|NCT00784654|451724425|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
125572532|NCT00784654|451724426|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
125572533|NCT00784654|451724427|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
125572534|NCT00784654|451724425|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
125572535|NCT00784654|451724426|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
125210920|NCT04521114|450396711|FG001|Overall Study|Withdrawal by Subject|2|||
125210921|NCT04521114|450396712|FG002|Overall Study|Withdrawal by Subject|2|||
125210922|NCT04521114|450396710|FG000|Overall Study|Adverse Event|1|||
125210923|NCT04521114|450396711|FG001|Overall Study|Adverse Event|0|||
125210924|NCT04521114|450396712|FG002|Overall Study|Adverse Event|0|||
125210925|NCT04521114|450396710|FG000|Overall Study|Sponsor Wish|1|||
125210926|NCT04521114|450396711|FG001|Overall Study|Sponsor Wish|0|||
125210927|NCT04521114|450396712|FG002|Overall Study|Sponsor Wish|0|||
125210928|NCT04521114|450396710|FG000|Overall Study|Withdrawal of Consent|2|||
125210929|NCT04521114|450396711|FG001|Overall Study|Withdrawal of Consent|2|||
125210930|NCT04521114|450396712|FG002|Overall Study|Withdrawal of Consent|0|||
125210931|NCT01133288|450396715|FG000|Eligibility Assessment|met exclusion criteria|5|||
125210932|NCT01133288|450396715|FG000|Intervention Allocation|study terminated|2|||
125210933|NCT00438256|450396716|FG000|Overall Study|Ineligible for Resection|2|||
125210934|NCT00438256|450396717|FG001|Overall Study|Ineligible for Resection|1|||
125210935|NCT00438256|450396718|FG002|Overall Study|Ineligible for Resection|1|||
125210936|NCT00438256|450396719|FG003|Overall Study|Ineligible for Resection|7|||
125210937|NCT00438256|450396716|FG000|Overall Study|Excluded final Diagnosis|0|||
125210938|NCT00438256|450396717|FG001|Overall Study|Excluded final Diagnosis|0|||
125210939|NCT00438256|450396718|FG002|Overall Study|Excluded final Diagnosis|0|||
125210940|NCT00438256|450396719|FG003|Overall Study|Excluded final Diagnosis|2|||
125210941|NCT00750919|450396728|FG000|Overall Study|Adverse Event|9|||
125210942|NCT00750919|450396728|FG000|Overall Study|Withdrawal by Subject|1|||
125210943|NCT00750919|450396728|FG000|Overall Study|Lack of Efficacy|8|||
125210944|NCT00750919|450396728|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
125210945|NCT00750919|450396728|FG000|Overall Study|Other|36|||
125210946|NCT01404949|450396734|FG000|Overall Study|Not Treated|1|||
125210947|NCT00380718|450396737|FG000|Overall Study|Adverse Event|1|||
125210948|NCT00380718|450396737|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
125210949|NCT01094782|450396738|FG000|Overall Study|Withdrawal by Subject|5|||
125210950|NCT01094782|450396739|FG001|Overall Study|Withdrawal by Subject|5|||
125210951|NCT01094782|450396740|FG002|Overall Study|Withdrawal by Subject|1|||
125210952|NCT01094782|450396741|FG003|Overall Study|Withdrawal by Subject|5|||
125210953|NCT01094782|450396742|FG004|Overall Study|Withdrawal by Subject|5|||
125210954|NCT01094782|450396743|FG005|Overall Study|Withdrawal by Subject|0|||
125210955|NCT01094782|450396738|FG000|Overall Study|Lost to Follow-up|1|||
125210956|NCT01094782|450396739|FG001|Overall Study|Lost to Follow-up|0|||
125210957|NCT01094782|450396740|FG002|Overall Study|Lost to Follow-up|0|||
125210958|NCT01094782|450396741|FG003|Overall Study|Lost to Follow-up|2|||
125210959|NCT01094782|450396742|FG004|Overall Study|Lost to Follow-up|1|||
125210960|NCT01094782|450396743|FG005|Overall Study|Lost to Follow-up|4|||
125210961|NCT01094782|450396738|FG000|Overall Study|Positive Drug Screen|2|||
125210962|NCT01094782|450396739|FG001|Overall Study|Positive Drug Screen|2|||
125210963|NCT01094782|450396740|FG002|Overall Study|Positive Drug Screen|1|||
125210964|NCT01094782|450396741|FG003|Overall Study|Positive Drug Screen|1|||
125210965|NCT01094782|450396742|FG004|Overall Study|Positive Drug Screen|3|||
125210966|NCT01094782|450396743|FG005|Overall Study|Positive Drug Screen|2|||
125210967|NCT01094782|450396738|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
125210968|NCT01094782|450396739|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
125210969|NCT01094782|450396740|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
125210970|NCT01094782|450396741|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
125210971|NCT01094782|450396742|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
125210972|NCT01094782|450396743|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
125210973|NCT01094782|450396738|FG000|Overall Study|Unable to Complete Questionnaires|0|||
125210974|NCT01094782|450396739|FG001|Overall Study|Unable to Complete Questionnaires|1|||
125210975|NCT01094782|450396740|FG002|Overall Study|Unable to Complete Questionnaires|0|||
125210976|NCT01094782|450396741|FG003|Overall Study|Unable to Complete Questionnaires|0|||
125210977|NCT01094782|450396742|FG004|Overall Study|Unable to Complete Questionnaires|0|||
125210978|NCT01094782|450396743|FG005|Overall Study|Unable to Complete Questionnaires|0|||
125210979|NCT01094782|450396738|FG000|Overall Study|Healthy Subject Had Pain|0|||
125210980|NCT01094782|450396739|FG001|Overall Study|Healthy Subject Had Pain|1|||
125210981|NCT01094782|450396740|FG002|Overall Study|Healthy Subject Had Pain|0|||
125210982|NCT01094782|450396741|FG003|Overall Study|Healthy Subject Had Pain|0|||
125210983|NCT01094782|450396742|FG004|Overall Study|Healthy Subject Had Pain|0|||
125210984|NCT01094782|450396743|FG005|Overall Study|Healthy Subject Had Pain|0|||
125210985|NCT01094782|450396738|FG000|Overall Study|Hypertension|0|||
125210986|NCT01094782|450396739|FG001|Overall Study|Hypertension|0|||
125210987|NCT01094782|450396740|FG002|Overall Study|Hypertension|1|||
125210988|NCT01094782|450396741|FG003|Overall Study|Hypertension|0|||
125210989|NCT01094782|450396742|FG004|Overall Study|Hypertension|0|||
125210990|NCT01094782|450396743|FG005|Overall Study|Hypertension|0|||
125210991|NCT01094782|450396738|FG000|Overall Study|Wrong Pain Condition|0|||
125210992|NCT01094782|450396739|FG001|Overall Study|Wrong Pain Condition|0|||
125210993|NCT01094782|450396740|FG002|Overall Study|Wrong Pain Condition|0|||
125210994|NCT01094782|450396741|FG003|Overall Study|Wrong Pain Condition|2|||
125210995|NCT01094782|450396742|FG004|Overall Study|Wrong Pain Condition|1|||
125210996|NCT01094782|450396743|FG005|Overall Study|Wrong Pain Condition|1|||
125210997|NCT01094782|450396738|FG000|Overall Study|Recent Interventional Injection|0|||
125210998|NCT01094782|450396739|FG001|Overall Study|Recent Interventional Injection|0|||
125210999|NCT01094782|450396740|FG002|Overall Study|Recent Interventional Injection|0|||
125211000|NCT01094782|450396741|FG003|Overall Study|Recent Interventional Injection|0|||
125211001|NCT01094782|450396742|FG004|Overall Study|Recent Interventional Injection|0|||
125211002|NCT01094782|450396743|FG005|Overall Study|Recent Interventional Injection|1|||
125211003|NCT01094782|450396738|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
125211004|NCT01094782|450396739|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
125211005|NCT01094782|450396740|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
125211006|NCT01094782|450396741|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
125211007|NCT01094782|450396742|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
125211008|NCT01094782|450396743|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
125211009|NCT01094782|450396738|FG000|Overall Study|Noncompliance With Study Schedule|0|||
125211010|NCT01094782|450396739|FG001|Overall Study|Noncompliance With Study Schedule|0|||
125211011|NCT01094782|450396740|FG002|Overall Study|Noncompliance With Study Schedule|0|||
125211012|NCT01094782|450396741|FG003|Overall Study|Noncompliance With Study Schedule|1|||
125211013|NCT01094782|450396742|FG004|Overall Study|Noncompliance With Study Schedule|0|||
125211014|NCT01094782|450396743|FG005|Overall Study|Noncompliance With Study Schedule|0|||
125211015|NCT02912455|450396746|FG000|Overall Study|Withdrawal by Subject|0|||
125211016|NCT02912455|450396747|FG001|Overall Study|Withdrawal by Subject|1|||
125211017|NCT02912455|450396746|FG000|Overall Study|Lack of Efficacy|0|||
125211018|NCT02912455|450396747|FG001|Overall Study|Lack of Efficacy|1|||
125211019|NCT02912455|450396746|FG000|Overall Study|Lost to Follow-up|2|||
125211020|NCT02912455|450396747|FG001|Overall Study|Lost to Follow-up|1|||
125211021|NCT00957905|450396752|FG000|Part B|Not Treated|0|||
125211022|NCT00957905|450396753|FG001|Part B|Not Treated|1|||
125572536|NCT00784654|451724427|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
125572537|NCT00784654|451724425|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
125572538|NCT00784654|451724426|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
125572539|NCT00784654|451724427|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
125572540|NCT00784654|451724425|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125572541|NCT00784654|451724426|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
125572542|NCT00784654|451724427|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
125572543|NCT00784654|451724425|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
125572544|NCT00784654|451724426|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
125572545|NCT00784654|451724427|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
125572546|NCT00784654|451724425|FG000|Randomized Withdrawal Period|Adverse Event|0|||
125572547|NCT00784654|451724426|FG001|Randomized Withdrawal Period|Adverse Event|1|||
125572548|NCT00784654|451724427|FG002|Randomized Withdrawal Period|Adverse Event|1|||
125572549|NCT00784654|451724425|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
125572550|NCT00784654|451724426|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
125572551|NCT00784654|451724427|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
125572552|NCT00784654|451724425|FG000|Randomized Withdrawal Period|Family reasons|0|||
125572553|NCT00784654|451724426|FG001|Randomized Withdrawal Period|Family reasons|0|||
125572554|NCT00784654|451724427|FG002|Randomized Withdrawal Period|Family reasons|1|||
125572555|NCT01180660|451724428|FG000|Overall Study|Changed to open surgery|1|||
125572556|NCT01180660|451724429|FG001|Overall Study|Changed to open surgery|0|||
125211023|NCT00957905|450396752|FG000|Part B|Physician Decision|0|||
125211024|NCT00957905|450396753|FG001|Part B|Physician Decision|1|||
125572557|NCT00852995|451724430|FG000|Overall Study|Adverse Event|1|||
125211025|NCT00957905|450396752|FG000|Part B|Death|0|||
125211026|NCT00957905|450396753|FG001|Part B|Death|1|||
125211027|NCT00957905|450396752|FG000|Part B|Protocol Violation|0|||
125211028|NCT00957905|450396753|FG001|Part B|Protocol Violation|1|||
125211029|NCT02073656|450396754|FG000|Primary Study|Lost to Follow-up|6|||
125211030|NCT02073656|450396754|FG000|Primary Study|Death|1|||
125211031|NCT02073656|450396754|FG000|Primary Study|Withdrew Consent|1|||
125211032|NCT01048099|450396760|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
125572558|NCT00852995|451724431|FG001|Overall Study|Adverse Event|0|||
125358387|NCT00875979|450948215|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
125358388|NCT00875979|450948214|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
125358389|NCT00875979|450948215|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
125572559|NCT00852995|451724432|FG002|Overall Study|Adverse Event|4|||
125572560|NCT00852995|451724433|FG003|Overall Study|Adverse Event|0|||
125572561|NCT00852995|451724434|FG004|Overall Study|Adverse Event|0|||
125572562|NCT00852995|451724430|FG000|Overall Study|Lost to Follow-up|0|||
125572563|NCT00852995|451724431|FG001|Overall Study|Lost to Follow-up|1|||
125572564|NCT00852995|451724432|FG002|Overall Study|Lost to Follow-up|1|||
125572565|NCT00852995|451724433|FG003|Overall Study|Lost to Follow-up|0|||
125572566|NCT00852995|451724434|FG004|Overall Study|Lost to Follow-up|0|||
125572567|NCT00852995|451724430|FG000|Overall Study|Withdrawal by Subject|4|||
125572568|NCT00852995|451724431|FG001|Overall Study|Withdrawal by Subject|0|||
125572569|NCT00852995|451724432|FG002|Overall Study|Withdrawal by Subject|0|||
125572570|NCT00852995|451724433|FG003|Overall Study|Withdrawal by Subject|1|||
125572571|NCT00852995|451724434|FG004|Overall Study|Withdrawal by Subject|2|||
125572572|NCT00852995|451724430|FG000|Overall Study|Non-Compliance|0|||
125572573|NCT00852995|451724431|FG001|Overall Study|Non-Compliance|0|||
125572574|NCT00852995|451724432|FG002|Overall Study|Non-Compliance|0|||
125572575|NCT00852995|451724433|FG003|Overall Study|Non-Compliance|2|||
125211033|NCT01048099|450396760|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
125211034|NCT00508157|450396761|FG000|Overall Study|Adverse Event|0|||
125572576|NCT00852995|451724434|FG004|Overall Study|Non-Compliance|0|||
125572577|NCT00852995|451724430|FG000|Overall Study|Progressive Disease|1|||
125572578|NCT00852995|451724431|FG001|Overall Study|Progressive Disease|0|||
125572579|NCT00852995|451724432|FG002|Overall Study|Progressive Disease|0|||
125572580|NCT00852995|451724433|FG003|Overall Study|Progressive Disease|2|||
125572581|NCT00852995|451724434|FG004|Overall Study|Progressive Disease|1|||
125572582|NCT00852995|451724430|FG000|Overall Study|Physician Decision|1|||
125572583|NCT00852995|451724431|FG001|Overall Study|Physician Decision|0|||
125572584|NCT00852995|451724432|FG002|Overall Study|Physician Decision|0|||
125572585|NCT00852995|451724433|FG003|Overall Study|Physician Decision|0|||
125572586|NCT00852995|451724434|FG004|Overall Study|Physician Decision|0|||
125572587|NCT00852995|451724430|FG000|Overall Study|Protocol Violation|0|||
125572588|NCT00852995|451724431|FG001|Overall Study|Protocol Violation|0|||
125572589|NCT00852995|451724432|FG002|Overall Study|Protocol Violation|0|||
125572590|NCT00852995|451724433|FG003|Overall Study|Protocol Violation|0|||
125572591|NCT00852995|451724434|FG004|Overall Study|Protocol Violation|1|||
125572592|NCT00852995|451724430|FG000|Overall Study|Moved Out of Area|1|||
125572593|NCT00852995|451724431|FG001|Overall Study|Moved Out of Area|0|||
125572594|NCT00852995|451724432|FG002|Overall Study|Moved Out of Area|0|||
125572595|NCT00852995|451724433|FG003|Overall Study|Moved Out of Area|0|||
125572596|NCT00852995|451724434|FG004|Overall Study|Moved Out of Area|0|||
125572597|NCT04418076|451724437|FG000|Overall Study|Death|1|||
125358390|NCT00875979|450948214|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
125572598|NCT04418076|451724438|FG001|Overall Study|Death|0|||
125572599|NCT04418076|451724439|FG002|Overall Study|Death|0|||
125572600|NCT04418076|451724440|FG003|Overall Study|Death|0|||
125572601|NCT04418076|451724437|FG000|Overall Study|Lost to Follow-up|2|||
125572602|NCT04418076|451724438|FG001|Overall Study|Lost to Follow-up|5|||
125572603|NCT04418076|451724439|FG002|Overall Study|Lost to Follow-up|1|||
125572604|NCT04418076|451724440|FG003|Overall Study|Lost to Follow-up|2|||
125572605|NCT04418076|451724437|FG000|Overall Study|Withdrawal by Subject|1|||
125572606|NCT04418076|451724438|FG001|Overall Study|Withdrawal by Subject|0|||
125572607|NCT04418076|451724439|FG002|Overall Study|Withdrawal by Subject|1|||
125572608|NCT04418076|451724440|FG003|Overall Study|Withdrawal by Subject|1|||
125572609|NCT04418076|451724437|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
125572610|NCT04418076|451724438|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
125572611|NCT04418076|451724439|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
125572612|NCT04418076|451724440|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
125572613|NCT01471782|451724441|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
125572614|NCT01471782|451724442|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
125572615|NCT01471782|451724443|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
125572616|NCT01471782|451724444|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
125572617|NCT01471782|451724445|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
125572618|NCT01471782|451724446|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
125572619|NCT01471782|451724441|FG000|Overall Study|Lack of Efficacy|1|||
125572620|NCT01471782|451724442|FG001|Overall Study|Lack of Efficacy|2|||
125572621|NCT01471782|451724443|FG002|Overall Study|Lack of Efficacy|1|||
125572622|NCT01471782|451724444|FG003|Overall Study|Lack of Efficacy|1|||
125572623|NCT01471782|451724445|FG004|Overall Study|Lack of Efficacy|5|||
125572624|NCT01471782|451724446|FG005|Overall Study|Lack of Efficacy|18|||
125572625|NCT01471782|451724441|FG000|Overall Study|Adverse Event|1|||
125572626|NCT01471782|451724442|FG001|Overall Study|Adverse Event|1|||
125572627|NCT01471782|451724443|FG002|Overall Study|Adverse Event|2|||
125572628|NCT01471782|451724444|FG003|Overall Study|Adverse Event|2|||
125572629|NCT01471782|451724445|FG004|Overall Study|Adverse Event|3|||
125572630|NCT01471782|451724446|FG005|Overall Study|Adverse Event|1|||
125572631|NCT01471782|451724441|FG000|Overall Study|Other|0|||
125572632|NCT01471782|451724442|FG001|Overall Study|Other|0|||
125572633|NCT01471782|451724443|FG002|Overall Study|Other|1|||
125572634|NCT01471782|451724444|FG003|Overall Study|Other|1|||
125572635|NCT01471782|451724445|FG004|Overall Study|Other|6|||
125572636|NCT01471782|451724446|FG005|Overall Study|Other|5|||
125211035|NCT00508157|450396762|FG001|Overall Study|Adverse Event|1|||
125572637|NCT01471782|451724441|FG000|Overall Study|Change of Chemotherapy|1|||
125572638|NCT01471782|451724442|FG001|Overall Study|Change of Chemotherapy|1|||
125572639|NCT01471782|451724443|FG002|Overall Study|Change of Chemotherapy|0|||
125572640|NCT01471782|451724444|FG003|Overall Study|Change of Chemotherapy|0|||
125572641|NCT01471782|451724445|FG004|Overall Study|Change of Chemotherapy|1|||
125572642|NCT01471782|451724446|FG005|Overall Study|Change of Chemotherapy|4|||
125572643|NCT01471782|451724441|FG000|Overall Study|Disease Relapse|0|||
125572644|NCT01471782|451724442|FG001|Overall Study|Disease Relapse|0|||
125572645|NCT01471782|451724443|FG002|Overall Study|Disease Relapse|0|||
125572646|NCT01471782|451724444|FG003|Overall Study|Disease Relapse|1|||
125572647|NCT01471782|451724445|FG004|Overall Study|Disease Relapse|2|||
125572648|NCT01471782|451724446|FG005|Overall Study|Disease Relapse|1|||
125572649|NCT01471782|451724441|FG000|Overall Study|Physician Decision|0|||
125572650|NCT01471782|451724442|FG001|Overall Study|Physician Decision|0|||
125572651|NCT01471782|451724443|FG002|Overall Study|Physician Decision|0|||
125572652|NCT01471782|451724444|FG003|Overall Study|Physician Decision|0|||
125572653|NCT01471782|451724445|FG004|Overall Study|Physician Decision|3|||
125572654|NCT01471782|451724446|FG005|Overall Study|Physician Decision|8|||
125572655|NCT01471782|451724441|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125572656|NCT01471782|451724442|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125572657|NCT01471782|451724443|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125572658|NCT01471782|451724444|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125572659|NCT01471782|451724445|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
125572660|NCT01471782|451724446|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
125572661|NCT01471782|451724441|FG000|Overall Study|Death|0|||
125572662|NCT01471782|451724442|FG001|Overall Study|Death|0|||
125572663|NCT01471782|451724443|FG002|Overall Study|Death|0|||
125572664|NCT01471782|451724444|FG003|Overall Study|Death|0|||
125572665|NCT01471782|451724445|FG004|Overall Study|Death|0|||
125572666|NCT01471782|451724446|FG005|Overall Study|Death|1|||
125572667|NCT01314716|451724447|FG000|Double-Blind Phase|Randomized but not treated|1|||
125572668|NCT01314716|451724448|FG001|Double-Blind Phase|Randomized but not treated|1|||
125572669|NCT01314716|451724447|FG000|Double-Blind Phase|Adverse Event|10|||
125572670|NCT01314716|451724448|FG001|Double-Blind Phase|Adverse Event|4|||
125572671|NCT01314716|451724447|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
125572672|NCT01314716|451724448|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
125572673|NCT01314716|451724447|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125572674|NCT01314716|451724448|FG001|Double-Blind Phase|Lost to Follow-up|1|||
125572675|NCT01314716|451724447|FG000|Double-Blind Phase|Sponsor request|1|||
125572676|NCT01314716|451724448|FG001|Double-Blind Phase|Sponsor request|2|||
125572677|NCT01314716|451724447|FG000|Double-Blind Phase|Physician Decision|0|||
125572678|NCT01314716|451724448|FG001|Double-Blind Phase|Physician Decision|1|||
125572679|NCT01314716|451724447|FG000|Open-Label Phase|Adverse Event|4|||
125572680|NCT01314716|451724448|FG001|Open-Label Phase|Adverse Event|6|||
125572681|NCT01314716|451724447|FG000|Open-Label Phase|Withdrawal by Subject|1|||
125572682|NCT01314716|451724448|FG001|Open-Label Phase|Withdrawal by Subject|2|||
125572683|NCT01314716|451724447|FG000|Open-Label Phase|Physician Decision|5|||
125572684|NCT01314716|451724448|FG001|Open-Label Phase|Physician Decision|4|||
125572685|NCT00805480|451724451|FG000|Overall Study|Withdrawal by Subject|13|||
125572686|NCT00805480|451724452|FG001|Overall Study|Withdrawal by Subject|5|||
125572687|NCT00805480|451724453|FG002|Overall Study|Withdrawal by Subject|11|||
125572688|NCT00805480|451724454|FG003|Overall Study|Withdrawal by Subject|5|||
125572689|NCT00805480|451724451|FG000|Overall Study|Lost to Follow-up|1|||
125572690|NCT00805480|451724452|FG001|Overall Study|Lost to Follow-up|2|||
125572691|NCT00805480|451724453|FG002|Overall Study|Lost to Follow-up|0|||
125358391|NCT00875979|450948215|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
125572692|NCT00805480|451724454|FG003|Overall Study|Lost to Follow-up|0|||
125572693|NCT00805480|451724451|FG000|Overall Study|Adverse Event|0|||
125572694|NCT00805480|451724452|FG001|Overall Study|Adverse Event|0|||
125358392|NCT00875979|450948214|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
125572695|NCT00805480|451724453|FG002|Overall Study|Adverse Event|1|||
125572696|NCT00805480|451724454|FG003|Overall Study|Adverse Event|0|||
125572697|NCT01452152|451724455|FG000|Overall Study|Study termination by sponsor|5|||
125572698|NCT01452152|451724456|FG001|Overall Study|Study termination by sponsor|0|||
125572699|NCT01452152|451724457|FG002|Overall Study|Study termination by sponsor|4|||
125572700|NCT04099251|451725878|FG000|Pre-Treatment|Other reasons|1|||
125572701|NCT04099251|451725879|FG001|Pre-Treatment|Other reasons|0|||
125572702|NCT04099251|451725878|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
125572703|NCT04099251|451725879|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
125572704|NCT04099251|451725878|FG000|Blinded Treatment Phase|Other reasons|16|||
125572705|NCT04099251|451725879|FG001|Blinded Treatment Phase|Other reasons|7|||
125572706|NCT04099251|451725878|FG000|Blinded Treatment Phase|Disease recurrence|26|||
125572707|NCT04099251|451725879|FG001|Blinded Treatment Phase|Disease recurrence|41|||
125572708|NCT04099251|451725878|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
125572709|NCT04099251|451725879|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
125572710|NCT04099251|451725878|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
125572711|NCT04099251|451725879|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
125572712|NCT04099251|451725878|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
125572713|NCT04099251|451725879|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
125572714|NCT04099251|451725878|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
125572715|NCT04099251|451725879|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
125358393|NCT00875979|450948215|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
125358394|NCT00875979|450948214|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
125358395|NCT00875979|450948215|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
125358396|NCT00875979|450948214|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
125378928|NCT00531050|451019209|FG001|Part 1: Period 1|Protocol Deviation|0|||
125572716|NCT04099251|451725878|FG000|Blinded Treatment Phase|Death|6|||
125572717|NCT04099251|451725879|FG001|Blinded Treatment Phase|Death|2|||
125572718|NCT04099251|451725878|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
125572719|NCT04099251|451725879|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
125572720|NCT04099251|451725878|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
125572721|NCT04099251|451725879|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
125572722|NCT04099251|451725878|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
125572723|NCT04099251|451725879|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
125572724|NCT04099251|451725878|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
125572725|NCT04099251|451725879|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
125572726|NCT04099251|451725878|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
125572727|NCT04099251|451725879|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
125572728|NCT04099251|451725878|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
125572729|NCT04099251|451725879|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
125572730|NCT04099251|451725878|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
125572731|NCT04099251|451725879|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
125572732|NCT04099251|451725878|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
125572733|NCT04099251|451725879|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
125572734|NCT04099251|451725878|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
125572735|NCT04099251|451725879|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
125572736|NCT01783678|451725880|FG000|Overall Study|Randomized but Not Treated|0|||
125572737|NCT01783678|451725881|FG001|Overall Study|Randomized but Not Treated|0|||
125572738|NCT01783678|451725882|FG002|Overall Study|Randomized but Not Treated|0|||
125572739|NCT01783678|451725883|FG003|Overall Study|Randomized but Not Treated|1|||
125572740|NCT01783678|451725884|FG004|Overall Study|Randomized but Not Treated|0|||
125572741|NCT01783678|451725885|FG005|Overall Study|Randomized but Not Treated|0|||
125572742|NCT01783678|451725880|FG000|Overall Study|Lack of Efficacy|1|||
125572743|NCT01783678|451725881|FG001|Overall Study|Lack of Efficacy|13|||
125572744|NCT01783678|451725882|FG002|Overall Study|Lack of Efficacy|1|||
125572745|NCT01783678|451725883|FG003|Overall Study|Lack of Efficacy|3|||
125572746|NCT01783678|451725884|FG004|Overall Study|Lack of Efficacy|6|||
125572747|NCT01783678|451725885|FG005|Overall Study|Lack of Efficacy|5|||
125572748|NCT01783678|451725880|FG000|Overall Study|Lost to Follow-up|0|||
125572749|NCT01783678|451725881|FG001|Overall Study|Lost to Follow-up|4|||
125572750|NCT01783678|451725882|FG002|Overall Study|Lost to Follow-up|0|||
125572751|NCT01783678|451725883|FG003|Overall Study|Lost to Follow-up|2|||
125572752|NCT01783678|451725884|FG004|Overall Study|Lost to Follow-up|1|||
125572753|NCT01783678|451725885|FG005|Overall Study|Lost to Follow-up|0|||
125572754|NCT01783678|451725880|FG000|Overall Study|Withdrew Consent|1|||
125572755|NCT01783678|451725881|FG001|Overall Study|Withdrew Consent|1|||
125572756|NCT01783678|451725882|FG002|Overall Study|Withdrew Consent|0|||
125572757|NCT01783678|451725883|FG003|Overall Study|Withdrew Consent|2|||
125572758|NCT01783678|451725884|FG004|Overall Study|Withdrew Consent|0|||
125572759|NCT01783678|451725885|FG005|Overall Study|Withdrew Consent|0|||
125572760|NCT01995071|451725886|FG000|Overall Study|Adverse Event|0|||
125572761|NCT01995071|451725887|FG001|Overall Study|Adverse Event|0|||
125572762|NCT01995071|451725888|FG002|Overall Study|Adverse Event|0|||
125572763|NCT01995071|451725889|FG003|Overall Study|Adverse Event|0|||
125572764|NCT01995071|451725890|FG004|Overall Study|Adverse Event|0|||
125572765|NCT01995071|451725891|FG005|Overall Study|Adverse Event|0|||
125572766|NCT01995071|451725892|FG006|Overall Study|Adverse Event|1|||
125572767|NCT01995071|451725893|FG007|Overall Study|Adverse Event|0|||
125572768|NCT01995071|451725894|FG008|Overall Study|Adverse Event|0|||
125572769|NCT01995071|451725895|FG009|Overall Study|Adverse Event|0|||
125572770|NCT01995071|451725896|FG010|Overall Study|Adverse Event|0|||
125572771|NCT01995071|451725897|FG011|Overall Study|Adverse Event|0|||
125572772|NCT01995071|451725886|FG000|Overall Study|Moved|0|||
125572773|NCT01995071|451725887|FG001|Overall Study|Moved|0|||
125572774|NCT01995071|451725888|FG002|Overall Study|Moved|1|||
125572775|NCT01995071|451725889|FG003|Overall Study|Moved|0|||
125572776|NCT01995071|451725890|FG004|Overall Study|Moved|1|||
125572777|NCT01995071|451725891|FG005|Overall Study|Moved|0|||
125572778|NCT01995071|451725892|FG006|Overall Study|Moved|0|||
125572779|NCT01995071|451725893|FG007|Overall Study|Moved|0|||
125572780|NCT01995071|451725894|FG008|Overall Study|Moved|0|||
125572781|NCT01995071|451725895|FG009|Overall Study|Moved|0|||
125572782|NCT01995071|451725896|FG010|Overall Study|Moved|1|||
125572783|NCT01995071|451725897|FG011|Overall Study|Moved|0|||
125572784|NCT01995071|451725886|FG000|Overall Study|Lost to Follow-up|1|||
125572785|NCT01995071|451725887|FG001|Overall Study|Lost to Follow-up|0|||
125572786|NCT01995071|451725888|FG002|Overall Study|Lost to Follow-up|0|||
125572787|NCT01995071|451725889|FG003|Overall Study|Lost to Follow-up|0|||
125572788|NCT01995071|451725890|FG004|Overall Study|Lost to Follow-up|0|||
125572789|NCT01995071|451725891|FG005|Overall Study|Lost to Follow-up|0|||
125572790|NCT01995071|451725892|FG006|Overall Study|Lost to Follow-up|0|||
125572791|NCT01995071|451725893|FG007|Overall Study|Lost to Follow-up|1|||
125572792|NCT01995071|451725894|FG008|Overall Study|Lost to Follow-up|1|||
125572793|NCT01995071|451725895|FG009|Overall Study|Lost to Follow-up|0|||
125572794|NCT01995071|451725896|FG010|Overall Study|Lost to Follow-up|0|||
125572795|NCT01995071|451725897|FG011|Overall Study|Lost to Follow-up|0|||
125572796|NCT01995071|451725886|FG000|Overall Study|Incarcerated|0|||
125572797|NCT01995071|451725887|FG001|Overall Study|Incarcerated|0|||
125572798|NCT01995071|451725888|FG002|Overall Study|Incarcerated|0|||
125572799|NCT01995071|451725889|FG003|Overall Study|Incarcerated|0|||
125572800|NCT01995071|451725890|FG004|Overall Study|Incarcerated|0|||
125572801|NCT01995071|451725891|FG005|Overall Study|Incarcerated|0|||
125572802|NCT01995071|451725892|FG006|Overall Study|Incarcerated|0|||
125572803|NCT01995071|451725893|FG007|Overall Study|Incarcerated|1|||
125572804|NCT01995071|451725894|FG008|Overall Study|Incarcerated|0|||
125572805|NCT01995071|451725895|FG009|Overall Study|Incarcerated|0|||
125572806|NCT01995071|451725896|FG010|Overall Study|Incarcerated|0|||
125572807|NCT01995071|451725897|FG011|Overall Study|Incarcerated|0|||
125572808|NCT02543528|451725898|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
125572809|NCT02543528|451725899|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
125572810|NCT02543528|451725900|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
125572811|NCT02543528|451725901|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
125572812|NCT02543528|451725902|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
125572813|NCT02543528|451725898|FG000|Adaptation Period|Lens Handling Difficultes|0|||
125572814|NCT02543528|451725899|FG001|Adaptation Period|Lens Handling Difficultes|0|||
125572815|NCT02543528|451725900|FG002|Adaptation Period|Lens Handling Difficultes|0|||
125572816|NCT02543528|451725901|FG003|Adaptation Period|Lens Handling Difficultes|0|||
125572817|NCT02543528|451725902|FG004|Adaptation Period|Lens Handling Difficultes|8|||
125572818|NCT02543528|451725898|FG000|Adaptation Period|Lost to Follow-up|0|||
125572819|NCT02543528|451725899|FG001|Adaptation Period|Lost to Follow-up|0|||
125572820|NCT02543528|451725900|FG002|Adaptation Period|Lost to Follow-up|0|||
125572821|NCT02543528|451725901|FG003|Adaptation Period|Lost to Follow-up|0|||
125572822|NCT02543528|451725902|FG004|Adaptation Period|Lost to Follow-up|14|||
125572823|NCT02543528|451725898|FG000|Adaptation Period|Adverse Event|0|||
125572824|NCT02543528|451725899|FG001|Adaptation Period|Adverse Event|0|||
125572825|NCT02543528|451725900|FG002|Adaptation Period|Adverse Event|0|||
125572826|NCT02543528|451725901|FG003|Adaptation Period|Adverse Event|0|||
125572827|NCT02543528|451725902|FG004|Adaptation Period|Adverse Event|2|||
125572828|NCT02543528|451725898|FG000|Extended Wear Period|Adverse Event|17|||
125572829|NCT02543528|451725899|FG001|Extended Wear Period|Adverse Event|11|||
125572830|NCT02543528|451725900|FG002|Extended Wear Period|Adverse Event|16|||
125572831|NCT02543528|451725901|FG003|Extended Wear Period|Adverse Event|3|||
125572832|NCT02543528|451725902|FG004|Extended Wear Period|Adverse Event|0|||
125572833|NCT02543528|451725898|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
125572834|NCT02543528|451725899|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
125572835|NCT02543528|451725900|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
125572836|NCT02543528|451725901|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
125572837|NCT02543528|451725902|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
125572838|NCT02543528|451725898|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
125572839|NCT02543528|451725899|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
125572840|NCT02543528|451725900|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
125572841|NCT02543528|451725901|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
125572842|NCT02543528|451725902|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
125572843|NCT02543528|451725898|FG000|Extended Wear Period|Lost to Follow-up|0|||
125572844|NCT02543528|451725899|FG001|Extended Wear Period|Lost to Follow-up|1|||
125572845|NCT02543528|451725900|FG002|Extended Wear Period|Lost to Follow-up|2|||
125572846|NCT02543528|451725901|FG003|Extended Wear Period|Lost to Follow-up|1|||
125572847|NCT02543528|451725902|FG004|Extended Wear Period|Lost to Follow-up|0|||
125572848|NCT02543528|451725898|FG000|Extended Wear Period|Withdrawal by Subject|10|||
125572849|NCT02543528|451725899|FG001|Extended Wear Period|Withdrawal by Subject|9|||
125572850|NCT02543528|451725900|FG002|Extended Wear Period|Withdrawal by Subject|4|||
125572851|NCT02543528|451725901|FG003|Extended Wear Period|Withdrawal by Subject|5|||
125572852|NCT02543528|451725902|FG004|Extended Wear Period|Withdrawal by Subject|0|||
125572853|NCT02049944|451725903|FG000|Overall Study|Protocol Violation|2|||
125572854|NCT01765673|451725904|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
125572855|NCT01042600|451725905|FG000|Overall Study|Ineligible|1|||
125572856|NCT01042600|451725906|FG001|Overall Study|Ineligible|0|||
125572857|NCT00605085|451725912|FG000|Overall Study|Withdrawal by Subject|8|||
125572858|NCT00605085|451725913|FG001|Overall Study|Withdrawal by Subject|5|||
125572859|NCT00605085|451725912|FG000|Overall Study|Adverse Event|9|||
125572860|NCT00605085|451725913|FG001|Overall Study|Adverse Event|5|||
125572861|NCT00605085|451725912|FG000|Overall Study|Pregnancy|2|||
125572862|NCT00605085|451725913|FG001|Overall Study|Pregnancy|0|||
125572863|NCT00605085|451725912|FG000|Overall Study|Protocol Violation|3|||
125572864|NCT00605085|451725913|FG001|Overall Study|Protocol Violation|2|||
125572865|NCT00605085|451725912|FG000|Overall Study|Lost to Follow-up|10|||
125572866|NCT00605085|451725913|FG001|Overall Study|Lost to Follow-up|5|||
125572867|NCT00605085|451725912|FG000|Overall Study|administrative reasons|18|||
125572868|NCT00605085|451725913|FG001|Overall Study|administrative reasons|8|||
125572869|NCT00621504|451725914|FG000|Overall Study|Adverse Event|1|||
125572870|NCT00621504|451725915|FG001|Overall Study|Adverse Event|3|||
125572871|NCT00621504|451725914|FG000|Overall Study|At the request of sponsor/investigator|1|||
125572872|NCT00621504|451725915|FG001|Overall Study|At the request of sponsor/investigator|0|||
125572873|NCT00621504|451725914|FG000|Overall Study|Withdrew consent|9|||
125572874|NCT00621504|451725915|FG001|Overall Study|Withdrew consent|6|||
125572875|NCT00621504|451725914|FG000|Overall Study|Lost to Follow-up|8|||
125572876|NCT00621504|451725915|FG001|Overall Study|Lost to Follow-up|10|||
125572877|NCT00621504|451725914|FG000|Overall Study|Other|1|||
125572878|NCT00621504|451725915|FG001|Overall Study|Other|0|||
125572879|NCT00621504|451725914|FG000|Overall Study|Death|6|||
125572880|NCT00621504|451725915|FG001|Overall Study|Death|6|||
125572881|NCT03257267|451725918|FG000|Overall Study|Adverse Event|17|||
125572882|NCT03257267|451725919|FG001|Overall Study|Adverse Event|7|||
125572883|NCT03257267|451725918|FG000|Overall Study|Death|96|||
125572884|NCT03257267|451725919|FG001|Overall Study|Death|98|||
125572885|NCT03257267|451725918|FG000|Overall Study|Lost to Follow-up|2|||
125572886|NCT03257267|451725919|FG001|Overall Study|Lost to Follow-up|2|||
125572887|NCT03257267|451725918|FG000|Overall Study|Non-compliance with Study Drug|0|||
125572888|NCT03257267|451725919|FG001|Overall Study|Non-compliance with Study Drug|2|||
125572889|NCT03257267|451725918|FG000|Overall Study|Participant Decision|35|||
125572890|NCT03257267|451725919|FG001|Overall Study|Participant Decision|43|||
125572891|NCT03257267|451725918|FG000|Overall Study|Sponsor Decision|1|||
125572892|NCT03257267|451725919|FG001|Overall Study|Sponsor Decision|0|||
125572893|NCT03257267|451725918|FG000|Overall Study|Physician Decision|1|||
125572894|NCT03257267|451725919|FG001|Overall Study|Physician Decision|3|||
125572895|NCT03257267|451725918|FG000|Overall Study|Disease Progression|109|||
125572896|NCT03257267|451725919|FG001|Overall Study|Disease Progression|121|||
125572897|NCT03257267|451725918|FG000|Overall Study|Withdrawal by Subject|8|||
125572898|NCT03257267|451725919|FG001|Overall Study|Withdrawal by Subject|26|||
125572899|NCT03257267|451725918|FG000|Overall Study|Other|0|||
125572900|NCT03257267|451725919|FG001|Overall Study|Other|2|||
125572901|NCT01979523|451725920|FG000|Overall Study|Withdrawal by Subject|1|||
125572902|NCT01979523|451725921|FG001|Overall Study|Withdrawal by Subject|0|||
125572903|NCT03311711|451725922|FG000|Overall Study|Death|1|||
125572904|NCT03311711|451725923|FG001|Overall Study|Death|0|||
125572905|NCT03311711|451725924|FG002|Overall Study|Death|0|||
125572906|NCT03311711|451725925|FG003|Overall Study|Death|0|||
125572907|NCT03311711|451725926|FG004|Overall Study|Death|0|||
125572908|NCT03311711|451725927|FG005|Overall Study|Death|0|||
125572909|NCT03311711|451725928|FG006|Overall Study|Death|1|||
125572910|NCT03311711|451725929|FG007|Overall Study|Death|0|||
125572911|NCT03311711|451725930|FG008|Overall Study|Death|1|||
125572912|NCT03311711|451725931|FG009|Overall Study|Death|0|||
125572913|NCT03311711|451725922|FG000|Overall Study|Death of dyad partner|0|||
125572914|NCT03311711|451725923|FG001|Overall Study|Death of dyad partner|1|||
125572915|NCT03311711|451725924|FG002|Overall Study|Death of dyad partner|0|||
125572916|NCT03311711|451725925|FG003|Overall Study|Death of dyad partner|0|||
125572917|NCT03311711|451725926|FG004|Overall Study|Death of dyad partner|0|||
125572918|NCT03311711|451725927|FG005|Overall Study|Death of dyad partner|0|||
125572919|NCT03311711|451725928|FG006|Overall Study|Death of dyad partner|0|||
125572920|NCT03311711|451725929|FG007|Overall Study|Death of dyad partner|1|||
125572921|NCT03311711|451725930|FG008|Overall Study|Death of dyad partner|0|||
125572922|NCT03311711|451725931|FG009|Overall Study|Death of dyad partner|1|||
125572923|NCT03311711|451725922|FG000|Overall Study|Lost to Follow-up|2|||
125572924|NCT03311711|451725923|FG001|Overall Study|Lost to Follow-up|2|||
125572925|NCT03311711|451725924|FG002|Overall Study|Lost to Follow-up|0|||
125572926|NCT03311711|451725925|FG003|Overall Study|Lost to Follow-up|0|||
125572927|NCT03311711|451725926|FG004|Overall Study|Lost to Follow-up|0|||
125572928|NCT03311711|451725927|FG005|Overall Study|Lost to Follow-up|0|||
125572929|NCT03311711|451725928|FG006|Overall Study|Lost to Follow-up|1|||
125572930|NCT03311711|451725929|FG007|Overall Study|Lost to Follow-up|1|||
125426991|NCT01860703|451188078|FG003|Overall Study|Personal reason|0|||
125426992|NCT02453685|451188080|FG000|Overall Study|Adverse Event|0|||
125426993|NCT02453685|451188081|FG001|Overall Study|Adverse Event|1|||
125426994|NCT02453685|451188080|FG000|Overall Study|Protocol Violation|7|||
125572931|NCT03311711|451725930|FG008|Overall Study|Lost to Follow-up|0|||
125426995|NCT02453685|451188081|FG001|Overall Study|Protocol Violation|4|||
125426996|NCT02453685|451188080|FG000|Overall Study|Lost to Follow-up|0|||
125426997|NCT02453685|451188081|FG001|Overall Study|Lost to Follow-up|1|||
125426998|NCT02453685|451188080|FG000|Overall Study|Withdrawal by Subject|8|||
125426999|NCT02453685|451188081|FG001|Overall Study|Withdrawal by Subject|4|||
125427000|NCT02453685|451188080|FG000|Overall Study|Unclassified|4|||
125572932|NCT03311711|451725931|FG009|Overall Study|Lost to Follow-up|0|||
125572933|NCT03311711|451725922|FG000|Overall Study|Withdrawal by Subject|1|||
125572934|NCT03311711|451725923|FG001|Overall Study|Withdrawal by Subject|1|||
125211036|NCT00508157|450396761|FG000|Overall Study|Subject Withdrew Consent|1|||
125427001|NCT02453685|451188081|FG001|Overall Study|Unclassified|2|||
125427002|NCT00552084|451188086|FG000|Overall Study|Adverse Event|2|||
125572935|NCT03311711|451725924|FG002|Overall Study|Withdrawal by Subject|0|||
125572936|NCT03311711|451725925|FG003|Overall Study|Withdrawal by Subject|0|||
125572937|NCT03311711|451725926|FG004|Overall Study|Withdrawal by Subject|0|||
125572938|NCT03311711|451725927|FG005|Overall Study|Withdrawal by Subject|0|||
125572939|NCT03311711|451725928|FG006|Overall Study|Withdrawal by Subject|3|||
125572940|NCT03311711|451725929|FG007|Overall Study|Withdrawal by Subject|3|||
125572941|NCT03311711|451725930|FG008|Overall Study|Withdrawal by Subject|0|||
125572942|NCT03311711|451725931|FG009|Overall Study|Withdrawal by Subject|0|||
125572943|NCT01623271|451725936|FG000|Overall Study|Withdrawal by Subject|2|||
125572944|NCT00706134|451725937|FG000|Overall Study|Adverse Event|8|||
125572945|NCT00706134|451725938|FG001|Overall Study|Adverse Event|7|||
125572946|NCT00706134|451725939|FG002|Overall Study|Adverse Event|2|||
125572947|NCT00706134|451725940|FG003|Overall Study|Adverse Event|3|||
125572948|NCT00706134|451725937|FG000|Overall Study|Lost to Follow-up|0|||
125211037|NCT00508157|450396762|FG001|Overall Study|Subject Withdrew Consent|0|||
125211038|NCT00508157|450396761|FG000|Overall Study|Lost to Follow-up|1|||
125211039|NCT00508157|450396762|FG001|Overall Study|Lost to Follow-up|0|||
125211040|NCT00508157|450396761|FG000|Overall Study|Subject no longer met study criteria|0|||
125572949|NCT00706134|451725938|FG001|Overall Study|Lost to Follow-up|1|||
125572950|NCT00706134|451725939|FG002|Overall Study|Lost to Follow-up|0|||
125572951|NCT00706134|451725940|FG003|Overall Study|Lost to Follow-up|0|||
125572952|NCT00706134|451725937|FG000|Overall Study|Protocol Violation|0|||
125572953|NCT00706134|451725938|FG001|Overall Study|Protocol Violation|6|||
125572954|NCT00706134|451725939|FG002|Overall Study|Protocol Violation|0|||
125572955|NCT00706134|451725940|FG003|Overall Study|Protocol Violation|3|||
125572956|NCT00706134|451725937|FG000|Overall Study|Withdrawal by Subject|1|||
125572957|NCT00706134|451725938|FG001|Overall Study|Withdrawal by Subject|2|||
125572958|NCT00706134|451725939|FG002|Overall Study|Withdrawal by Subject|1|||
125572959|NCT00706134|451725940|FG003|Overall Study|Withdrawal by Subject|0|||
125572960|NCT00706134|451725937|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
125572961|NCT00706134|451725938|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125572962|NCT00706134|451725939|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
125572963|NCT00706134|451725940|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
125572964|NCT00706134|451725937|FG000|Overall Study|Did not meet study criteria|2|||
125572965|NCT00706134|451725938|FG001|Overall Study|Did not meet study criteria|0|||
125572966|NCT00706134|451725939|FG002|Overall Study|Did not meet study criteria|0|||
125572967|NCT00706134|451725940|FG003|Overall Study|Did not meet study criteria|0|||
125572968|NCT01982292|451725941|FG000|Overall Study|Adverse Event|2|||
125572969|NCT01982292|451725942|FG001|Overall Study|Adverse Event|0|||
125572970|NCT01982292|451725941|FG000|Overall Study|Death|1|||
125572971|NCT01982292|451725942|FG001|Overall Study|Death|0|||
125572972|NCT01982292|451725941|FG000|Overall Study|Lost to Follow-up|2|||
125572973|NCT01982292|451725942|FG001|Overall Study|Lost to Follow-up|0|||
125572974|NCT01982292|451725941|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
125572975|NCT01982292|451725942|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
125572976|NCT01982292|451725941|FG000|Overall Study|Protocol Deviation|1|||
125572977|NCT01982292|451725942|FG001|Overall Study|Protocol Deviation|0|||
125572978|NCT01982292|451725941|FG000|Overall Study|Patient/Guardian Decision|3|||
125572979|NCT01982292|451725942|FG001|Overall Study|Patient/Guardian Decision|1|||
125572980|NCT01982292|451725941|FG000|Overall Study|Technical Problems|2|||
125572981|NCT01982292|451725942|FG001|Overall Study|Technical Problems|0|||
125572982|NCT00082888|451725944|FG000|Overall Study|Ineligible|1|||
125572983|NCT00082888|451725945|FG001|Overall Study|Ineligible|0|||
125572984|NCT00082888|451725946|FG002|Overall Study|Ineligible|0|||
125572985|NCT01745146|451725948|FG000|Overall Study|Withdrawal by Subject|1|||
125572986|NCT01745146|451725949|FG001|Overall Study|Withdrawal by Subject|3|||
125572987|NCT01745146|451725948|FG000|Overall Study|Lost to Follow-up|2|||
125572988|NCT01745146|451725949|FG001|Overall Study|Lost to Follow-up|0|||
125572989|NCT04623242|451725950|FG000|Overall Study|Withdrawal by Subject|7|||
125572990|NCT04623242|451725951|FG001|Overall Study|Withdrawal by Subject|12|||
125572991|NCT04623242|451725952|FG002|Overall Study|Withdrawal by Subject|5|||
125572992|NCT04623242|451725953|FG003|Overall Study|Withdrawal by Subject|7|||
125572993|NCT04623242|451725954|FG004|Overall Study|Withdrawal by Subject|0|||
125572994|NCT04623242|451725950|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
125572995|NCT04623242|451725951|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
125572996|NCT04623242|451725952|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
125572997|NCT04623242|451725953|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
125572998|NCT04623242|451725954|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
125572999|NCT04623242|451725950|FG000|Overall Study|Subject unblinded to mutation status|0|||
125573000|NCT04623242|451725951|FG001|Overall Study|Subject unblinded to mutation status|0|||
125211041|NCT00508157|450396762|FG001|Overall Study|Subject no longer met study criteria|1|||
125211042|NCT00508157|450396761|FG000|Overall Study|Other known cause|0|||
125573001|NCT04623242|451725952|FG002|Overall Study|Subject unblinded to mutation status|0|||
125573002|NCT04623242|451725953|FG003|Overall Study|Subject unblinded to mutation status|13|||
125211043|NCT00508157|450396762|FG001|Overall Study|Other known cause|1|||
125211044|NCT01625689|450396765|FG000|Overall Study|Migration|2|||
125573003|NCT04623242|451725954|FG004|Overall Study|Subject unblinded to mutation status|0|||
125573004|NCT05594173|451725955|FG000|Overall Study|Adverse Event|1|||
125573005|NCT05594173|451725955|FG000|Overall Study|COVID-19 Pandemic|2|||
125573006|NCT00763139|451725959|FG000|Overall Study|Adverse Event|4|||
125573007|NCT00763139|451725960|FG001|Overall Study|Adverse Event|2|||
125573008|NCT00763139|451725959|FG000|Overall Study|Withdrawal by Subject|0|||
125573009|NCT00763139|451725960|FG001|Overall Study|Withdrawal by Subject|1|||
125573010|NCT00763139|451725959|FG000|Overall Study|med change not allowed by protocol|1|||
125573011|NCT00763139|451725960|FG001|Overall Study|med change not allowed by protocol|0|||
125573012|NCT00488982|451725964|FG000|Course 1|Physician Decision|0|||
125573013|NCT00488982|451725965|FG001|Course 1|Physician Decision|2|||
125573014|NCT00488982|451725966|FG002|Course 1|Physician Decision|4|||
125573015|NCT00488982|451725964|FG000|Course 1|Withdrawal by Subject|0|||
125573016|NCT00488982|451725965|FG001|Course 1|Withdrawal by Subject|8|||
125573017|NCT00488982|451725966|FG002|Course 1|Withdrawal by Subject|2|||
125573018|NCT00488982|451725964|FG000|Course 1|nonprotocol therapy|0|||
125573019|NCT00488982|451725965|FG001|Course 1|nonprotocol therapy|2|||
125573020|NCT00488982|451725966|FG002|Course 1|nonprotocol therapy|2|||
125573021|NCT00488982|451725964|FG000|Course 1|Adverse Event|0|||
125573022|NCT00488982|451725965|FG001|Course 1|Adverse Event|0|||
125573023|NCT00488982|451725966|FG002|Course 1|Adverse Event|6|||
125573024|NCT01678144|451725967|FG000|Stage 1: MAR Classic|Adverse Event|1|||
125573025|NCT02363686|451725968|FG000|Overall Study|Withdrawal by Subject|22|||
125211045|NCT01625689|450396766|FG001|Overall Study|Migration|1|||
125211046|NCT03089853|450398539|FG000|Overall Study|Lost to Follow-up|2|||
125211047|NCT03089853|450398540|FG001|Overall Study|Lost to Follow-up|1|||
125211048|NCT04114656|450398541|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
125573026|NCT02363686|451725968|FG000|Overall Study|incomplete FEES examinations|13|||
125573027|NCT01780831|451725971|FG000|Overall Study|Withdrawal by Subject|0|||
125573028|NCT01780831|451725972|FG001|Overall Study|Withdrawal by Subject|0|||
125573029|NCT01780831|451725973|FG002|Overall Study|Withdrawal by Subject|4|||
125573030|NCT01780831|451725974|FG003|Overall Study|Withdrawal by Subject|0|||
125573031|NCT01780831|451725971|FG000|Overall Study|Lost to Follow-up|0|||
125211049|NCT04114656|450398542|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
125211050|NCT04114656|450398541|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
125211051|NCT04114656|450398542|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
125211052|NCT04114656|450398541|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
125211053|NCT04114656|450398542|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
125211054|NCT04114656|450398541|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
125211055|NCT04114656|450398542|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
125211056|NCT04114656|450398541|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
125211057|NCT04114656|450398542|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
125211058|NCT03326518|450398548|FG000|Overall Study|Protocol Violation|1|||
125211059|NCT03326518|450398549|FG001|Overall Study|Protocol Violation|0|||
125211060|NCT03326518|450398550|FG002|Overall Study|Protocol Violation|0|||
125211061|NCT03326518|450398548|FG000|Overall Study|Withdrawal by Subject|1|||
125211062|NCT03326518|450398549|FG001|Overall Study|Withdrawal by Subject|0|||
125211063|NCT03326518|450398550|FG002|Overall Study|Withdrawal by Subject|0|||
125211064|NCT03326518|450398548|FG000|Overall Study|Lost to Follow-up|1|||
125211065|NCT03326518|450398549|FG001|Overall Study|Lost to Follow-up|0|||
125211066|NCT03326518|450398550|FG002|Overall Study|Lost to Follow-up|1|||
125211067|NCT01375374|450398553|FG000|Overall Study|Adverse Event|1|||
125211068|NCT01908582|450398554|FG000|Period 2|Physician Decision|1|||
125211069|NCT01908582|450398554|FG000|Period 2|Withdrawal by Subject|1|||
125211070|NCT01108237|450398556|FG000|Overall Study|No alignment data|2|||
125211071|NCT01108237|450398557|FG001|Overall Study|No alignment data|15|||
125211072|NCT01108237|450398556|FG000|Overall Study|Did not meet criteria for analysis|7|||
125211073|NCT01108237|450398557|FG001|Overall Study|Did not meet criteria for analysis|0|||
125211074|NCT02065518|450398559|FG000|Overall Study|Lost to Follow-up|3|||
125211075|NCT02065518|450398560|FG001|Overall Study|Lost to Follow-up|4|||
125211076|NCT02065518|450398561|FG002|Overall Study|Lost to Follow-up|0|||
125211077|NCT02065518|450398562|FG003|Overall Study|Lost to Follow-up|3|||
125211078|NCT02065518|450398559|FG000|Overall Study|Withdrawal by Subject|3|||
125211079|NCT02065518|450398560|FG001|Overall Study|Withdrawal by Subject|4|||
125211080|NCT02065518|450398561|FG002|Overall Study|Withdrawal by Subject|9|||
125211081|NCT02065518|450398562|FG003|Overall Study|Withdrawal by Subject|2|||
125211082|NCT03484403|450398565|FG000|Overall Study|Withdrawal by Subject|6|||
125211083|NCT03484403|450398566|FG001|Overall Study|Withdrawal by Subject|4|||
125211084|NCT02173379|450398567|FG000|Overall Study|Lost to Follow-up|89|||
125211085|NCT02173379|450398568|FG001|Overall Study|Lost to Follow-up|81|||
125211086|NCT02173379|450398567|FG000|Overall Study|Withdrawal by Subject|24|||
125211087|NCT02173379|450398568|FG001|Overall Study|Withdrawal by Subject|29|||
125211088|NCT02173379|450398567|FG000|Overall Study|Physician Decision|8|||
125573032|NCT01780831|451725972|FG001|Overall Study|Lost to Follow-up|0|||
125573033|NCT01780831|451725973|FG002|Overall Study|Lost to Follow-up|0|||
125573034|NCT01780831|451725974|FG003|Overall Study|Lost to Follow-up|1|||
125573035|NCT02264990|451725977|FG000|Overall Study|Death|255|||
125573036|NCT02264990|451725978|FG001|Overall Study|Death|250|||
125573037|NCT02264990|451725977|FG000|Overall Study|Withdrawal by Subject|4|||
125211089|NCT02173379|450398568|FG001|Overall Study|Physician Decision|8|||
125211090|NCT02173379|450398567|FG000|Overall Study|Death|75|||
125211091|NCT02173379|450398568|FG001|Overall Study|Death|72|||
125211092|NCT02173379|450398567|FG000|Overall Study|Other Reason|1|||
125573038|NCT02264990|451725978|FG001|Overall Study|Withdrawal by Subject|5|||
125573039|NCT02264990|451725977|FG000|Overall Study|Lost to Follow-up|1|||
125573040|NCT02264990|451725978|FG001|Overall Study|Lost to Follow-up|3|||
125211093|NCT02173379|450398568|FG001|Overall Study|Other Reason|0|||
125573041|NCT02264990|451725977|FG000|Overall Study|Other|0|||
125573042|NCT02264990|451725978|FG001|Overall Study|Other|1|||
125211094|NCT06226649|450398576|FG000|Overall Study|Withdrawal by Subject|4|||
125211095|NCT06226649|450398577|FG001|Overall Study|Withdrawal by Subject|1|||
125211096|NCT04767529|450398578|FG000|Overall Study|Adverse Event|0|||
125211097|NCT04767529|450398579|FG001|Overall Study|Adverse Event|4|||
125211098|NCT04767529|450398580|FG002|Overall Study|Adverse Event|3|||
125211099|NCT04767529|450398578|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
125211100|NCT04767529|450398579|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
125427003|NCT00552084|451188087|FG001|Overall Study|Adverse Event|3|||
125573043|NCT00267748|451725980|FG000|Non-randomized Period|Progressive disease|10|||
125573044|NCT00267748|451725981|FG001|Non-randomized Period|Progressive disease|0|||
125573045|NCT00267748|451725982|FG002|Non-randomized Period|Progressive disease|0|||
125573046|NCT00267748|451725980|FG000|Non-randomized Period|Adverse Event|8|||
125573047|NCT00267748|451725981|FG001|Non-randomized Period|Adverse Event|0|||
125573048|NCT00267748|451725982|FG002|Non-randomized Period|Adverse Event|0|||
125573049|NCT00267748|451725980|FG000|Non-randomized Period|Death|1|||
125573050|NCT00267748|451725981|FG001|Non-randomized Period|Death|0|||
125573051|NCT00267748|451725982|FG002|Non-randomized Period|Death|0|||
125573052|NCT00267748|451725980|FG000|Non-randomized Period|Participant not willing to participate|1|||
125573053|NCT00267748|451725981|FG001|Non-randomized Period|Participant not willing to participate|0|||
125573054|NCT00267748|451725982|FG002|Non-randomized Period|Participant not willing to participate|0|||
125573055|NCT00267748|451725980|FG000|Non-randomized Period|Other|3|||
125573056|NCT00267748|451725981|FG001|Non-randomized Period|Other|0|||
125573057|NCT00267748|451725982|FG002|Non-randomized Period|Other|0|||
125573058|NCT00267748|451725980|FG000|Randomized Period|Death|0|||
125573059|NCT00267748|451725981|FG001|Randomized Period|Death|2|||
125573060|NCT00267748|451725982|FG002|Randomized Period|Death|3|||
125573061|NCT00267748|451725980|FG000|Randomized Period|Adverse Event|0|||
125573062|NCT00267748|451725981|FG001|Randomized Period|Adverse Event|23|||
125573063|NCT00267748|451725982|FG002|Randomized Period|Adverse Event|25|||
125573064|NCT00267748|451725980|FG000|Randomized Period|Global deterioration of health status|0|||
125573065|NCT00267748|451725981|FG001|Randomized Period|Global deterioration of health status|6|||
125573066|NCT00267748|451725982|FG002|Randomized Period|Global deterioration of health status|7|||
125573067|NCT00267748|451725980|FG000|Randomized Period|Lost to Follow-up|0|||
125573068|NCT00267748|451725981|FG001|Randomized Period|Lost to Follow-up|1|||
125573069|NCT00267748|451725982|FG002|Randomized Period|Lost to Follow-up|0|||
125573070|NCT00267748|451725980|FG000|Randomized Period|Objective progression or relapse|0|||
125573071|NCT00267748|451725981|FG001|Randomized Period|Objective progression or relapse|77|||
125573072|NCT00267748|451725982|FG002|Randomized Period|Objective progression or relapse|86|||
125573073|NCT00267748|451725980|FG000|Randomized Period|Withdrawal by Subject|0|||
125573074|NCT00267748|451725981|FG001|Randomized Period|Withdrawal by Subject|9|||
125573075|NCT00267748|451725982|FG002|Randomized Period|Withdrawal by Subject|2|||
125573076|NCT00267748|451725980|FG000|Randomized Period|Other|0|||
125573077|NCT00267748|451725981|FG001|Randomized Period|Other|9|||
125573078|NCT00267748|451725982|FG002|Randomized Period|Other|6|||
125573079|NCT00267748|451725980|FG000|Randomized Period|randomized but not treated|0|||
125573080|NCT00267748|451725981|FG001|Randomized Period|randomized but not treated|0|||
125573081|NCT00267748|451725982|FG002|Randomized Period|randomized but not treated|3|||
125573082|NCT01294800|451725983|FG000|Overall Study|Adverse Event|7|||
125573083|NCT01294800|451725984|FG001|Overall Study|Adverse Event|6|||
125573084|NCT01294800|451725985|FG002|Overall Study|Adverse Event|12|||
125573085|NCT01294800|451725986|FG003|Overall Study|Adverse Event|5|||
125573086|NCT01294800|451725983|FG000|Overall Study|Subject Withdrew Consent|2|||
125573087|NCT01294800|451725984|FG001|Overall Study|Subject Withdrew Consent|2|||
125573088|NCT01294800|451725985|FG002|Overall Study|Subject Withdrew Consent|2|||
125573089|NCT01294800|451725986|FG003|Overall Study|Subject Withdrew Consent|11|||
125573090|NCT01294800|451725983|FG000|Overall Study|Lost to Follow-up|0|||
125573091|NCT01294800|451725984|FG001|Overall Study|Lost to Follow-up|0|||
125573092|NCT01294800|451725985|FG002|Overall Study|Lost to Follow-up|1|||
125573093|NCT01294800|451725986|FG003|Overall Study|Lost to Follow-up|0|||
125573094|NCT01294800|451725983|FG000|Overall Study|Non-compliance With Protocol|0|||
125573095|NCT01294800|451725984|FG001|Overall Study|Non-compliance With Protocol|1|||
125573096|NCT01294800|451725985|FG002|Overall Study|Non-compliance With Protocol|1|||
125573097|NCT01294800|451725986|FG003|Overall Study|Non-compliance With Protocol|0|||
125573098|NCT01294800|451725983|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
125573099|NCT01294800|451725984|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
125573100|NCT01294800|451725985|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
125573101|NCT01294800|451725986|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
125573102|NCT01662895|451725990|FG000|Overall Study|Lost to Follow-up|0|||
125573103|NCT01662895|451725991|FG001|Overall Study|Lost to Follow-up|1|||
125573104|NCT00797732|451725995|FG000|Overall Study|Withdrawal by Subject|3|||
125573105|NCT00797732|451725996|FG001|Overall Study|Withdrawal by Subject|3|||
125573106|NCT00797732|451725997|FG002|Overall Study|Withdrawal by Subject|0|||
125573107|NCT00797732|451725995|FG000|Overall Study|Lost to Follow-up|1|||
125573108|NCT00797732|451725996|FG001|Overall Study|Lost to Follow-up|0|||
125573109|NCT00797732|451725997|FG002|Overall Study|Lost to Follow-up|0|||
125573110|NCT00797732|451725995|FG000|Overall Study|Death|1|||
125573111|NCT00797732|451725996|FG001|Overall Study|Death|0|||
125573112|NCT00797732|451725997|FG002|Overall Study|Death|0|||
125573113|NCT00797732|451725995|FG000|Overall Study|Not meet inclusion criteria|0|||
125573114|NCT00797732|451725996|FG001|Overall Study|Not meet inclusion criteria|0|||
125573115|NCT00797732|451725997|FG002|Overall Study|Not meet inclusion criteria|7|||
125573116|NCT00797732|451725995|FG000|Overall Study|Excluded due to time constraints|0|||
125573117|NCT00797732|451725996|FG001|Overall Study|Excluded due to time constraints|0|||
125573118|NCT00797732|451725997|FG002|Overall Study|Excluded due to time constraints|24|||
125573119|NCT00797732|451725995|FG000|Overall Study|Refused to Participate|0|||
125573120|NCT00797732|451725996|FG001|Overall Study|Refused to Participate|0|||
125573121|NCT00797732|451725997|FG002|Overall Study|Refused to Participate|123|||
125573122|NCT00401752|451726000|FG000|Overall Study|Adverse Event|2|||
125573123|NCT00401752|451726001|FG001|Overall Study|Adverse Event|5|||
125573124|NCT00401752|451726000|FG000|Overall Study|Withdrawal by Subject|2|||
125573125|NCT00401752|451726001|FG001|Overall Study|Withdrawal by Subject|6|||
125573126|NCT00401752|451726000|FG000|Overall Study|Lost to Follow-up|1|||
125573127|NCT00401752|451726001|FG001|Overall Study|Lost to Follow-up|4|||
125573128|NCT00401752|451726000|FG000|Overall Study|Development of any exclusion criteria|4|||
125573129|NCT00401752|451726001|FG001|Overall Study|Development of any exclusion criteria|2|||
125573130|NCT00401752|451726000|FG000|Overall Study|Physician Decision|1|||
125573131|NCT00401752|451726001|FG001|Overall Study|Physician Decision|1|||
125573132|NCT01895322|451726002|FG000|Overall Study|Adverse Event|1|||
125573133|NCT01895322|451726002|FG000|Overall Study|Withdrawal by Subject|2|||
125573134|NCT01895322|451726002|FG000|Overall Study|Protocol Violation|10|||
125573135|NCT02275338|451726003|FG000|Overall Study|Adverse Event|15|||
125573136|NCT02275338|451726003|FG000|Overall Study|Lack of Efficacy|3|||
125573137|NCT02275338|451726003|FG000|Overall Study|Withdrawal by Subject|4|||
125573138|NCT02275338|451726003|FG000|Overall Study|Disease progression (death)|1|||
125573139|NCT02275338|451726003|FG000|Overall Study|Ineligible to start Phase 2|4|||
125573140|NCT02275338|451726003|FG000|Overall Study|Reason not specified|5|||
125573141|NCT02275338|451726003|FG000|Overall Study|Does not meet entry criteria|1|||
125573142|NCT04607733|451726006|FG000|Overall Study|Lost to Follow-up|1|||
125573143|NCT04607733|451726007|FG001|Overall Study|Lost to Follow-up|0|||
125573144|NCT04607733|451726008|FG002|Overall Study|Lost to Follow-up|0|||
125573145|NCT04607733|451726009|FG003|Overall Study|Lost to Follow-up|1|||
125573146|NCT04607733|451726010|FG004|Overall Study|Lost to Follow-up|1|||
125573147|NCT04607733|451726011|FG005|Overall Study|Lost to Follow-up|0|||
125573148|NCT04607733|451726006|FG000|Overall Study|Withdrawal by Subject|0|||
125573149|NCT04607733|451726007|FG001|Overall Study|Withdrawal by Subject|0|||
125573150|NCT04607733|451726008|FG002|Overall Study|Withdrawal by Subject|0|||
125573151|NCT04607733|451726009|FG003|Overall Study|Withdrawal by Subject|0|||
125573152|NCT04607733|451726010|FG004|Overall Study|Withdrawal by Subject|1|||
125573153|NCT04607733|451726011|FG005|Overall Study|Withdrawal by Subject|0|||
125573154|NCT01827670|451726014|FG000|Overall Study|Withdrawal of Consent|3|||
125573155|NCT01827670|451726015|FG001|Overall Study|Withdrawal of Consent|2|||
125573156|NCT01827670|451726014|FG000|Overall Study|Lost to Follow-up|0|||
125573157|NCT01827670|451726015|FG001|Overall Study|Lost to Follow-up|1|||
125573158|NCT03603496|451726020|FG000|Overall Study|Death|19|||
125573159|NCT03603496|451726021|FG001|Overall Study|Death|24|||
125573160|NCT03603496|451726020|FG000|Overall Study|Lost to Follow-up|141|||
125573161|NCT03603496|451726021|FG001|Overall Study|Lost to Follow-up|141|||
125573162|NCT03603496|451726020|FG000|Overall Study|Withdrawal by Subject|26|||
125573163|NCT03603496|451726021|FG001|Overall Study|Withdrawal by Subject|20|||
125573164|NCT00774345|451726022|FG000|Pre-treatment|Other reasons|2|||
125573165|NCT00774345|451726023|FG001|Pre-treatment|Other reasons|0|||
125573166|NCT00774345|451726022|FG000|Treatment|Adverse Event|61|||
125573167|NCT00774345|451726023|FG001|Treatment|Adverse Event|15|||
125573168|NCT00774345|451726022|FG000|Treatment|Progressive Disease without histologic transformation|51|||
125573169|NCT00774345|451726023|FG001|Treatment|Progressive Disease without histologic transformation|111|||
125573170|NCT00774345|451726022|FG000|Treatment|Progressive Disease with histologic transformation|4|||
125573171|NCT00774345|451726023|FG001|Treatment|Progressive Disease with histologic transformation|2|||
125573172|NCT00774345|451726022|FG000|Treatment|Withdrawal by Subject|5|||
125573173|NCT00774345|451726023|FG001|Treatment|Withdrawal by Subject|2|||
125573174|NCT00774345|451726022|FG000|Treatment|Lost to Follow-up|1|||
125573175|NCT00774345|451726023|FG001|Treatment|Lost to Follow-up|1|||
125573176|NCT00774345|451726022|FG000|Treatment|Death|4|||
125573177|NCT00774345|451726023|FG001|Treatment|Death|0|||
125573178|NCT00774345|451726022|FG000|Treatment|Other Reasons|32|||
125573179|NCT00774345|451726023|FG001|Treatment|Other Reasons|26|||
125573180|NCT00835237|451726024|FG000|Overall Study|Lost to Follow-up|4|||
125573181|NCT00835237|451726025|FG001|Overall Study|Lost to Follow-up|0|||
125573182|NCT00835237|451726024|FG000|Overall Study|Withdrawal by Subject|2|||
125573183|NCT00835237|451726025|FG001|Overall Study|Withdrawal by Subject|0|||
125573184|NCT01265550|451726028|FG000|Pre Randomization|Withdrawal by Subject|0|||
125573185|NCT01265550|451726029|FG001|Pre Randomization|Withdrawal by Subject|0|||
125573186|NCT01265550|451726030|FG002|Pre Randomization|Withdrawal by Subject|0|||
125573187|NCT01265550|451726031|FG003|Pre Randomization|Withdrawal by Subject|70|||
125573188|NCT01265550|451726028|FG000|Pre Randomization|Technical Exclusions|0|||
125573189|NCT01265550|451726029|FG001|Pre Randomization|Technical Exclusions|0|||
125573190|NCT01265550|451726030|FG002|Pre Randomization|Technical Exclusions|0|||
125573191|NCT01265550|451726031|FG003|Pre Randomization|Technical Exclusions|54|||
125573192|NCT01265550|451726028|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
125573193|NCT01265550|451726029|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
125573194|NCT01265550|451726030|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
125573195|NCT01265550|451726031|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
125573196|NCT01265550|451726028|FG000|Pre Randomization|Non-GERD organic disorders|0|||
125573197|NCT01265550|451726029|FG001|Pre Randomization|Non-GERD organic disorders|0|||
125573198|NCT01265550|451726030|FG002|Pre Randomization|Non-GERD organic disorders|0|||
125573199|NCT01265550|451726031|FG003|Pre Randomization|Non-GERD organic disorders|23|||
125573200|NCT01265550|451726028|FG000|Pre Randomization|Functional heartburn|0|||
125573201|NCT01265550|451726029|FG001|Pre Randomization|Functional heartburn|0|||
125573202|NCT01265550|451726030|FG002|Pre Randomization|Functional heartburn|0|||
125573203|NCT01265550|451726031|FG003|Pre Randomization|Functional heartburn|99|||
125573204|NCT00623428|451726032|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
125573205|NCT00623428|451726033|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
125573206|NCT00623428|451726032|FG000|Treatment Period|Death|0|||
125573207|NCT00623428|451726033|FG001|Treatment Period|Death|1|||
125573208|NCT00623428|451726032|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
125573209|NCT00623428|451726033|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
125573210|NCT00623428|451726032|FG000|Treatment Period|Insufficient therapeutic response|0|||
125573211|NCT00623428|451726033|FG001|Treatment Period|Insufficient therapeutic response|2|||
125573212|NCT00623428|451726032|FG000|Treatment Period|Other|0|||
125573213|NCT00623428|451726033|FG001|Treatment Period|Other|1|||
125573214|NCT00623428|451726032|FG000|Treatment Period|Withdrawal by Subject|0|||
125573215|NCT00623428|451726033|FG001|Treatment Period|Withdrawal by Subject|1|||
125573216|NCT00623428|451726032|FG000|Follow-up Period|Relapse post-treatment|11|||
125573217|NCT00623428|451726033|FG001|Follow-up Period|Relapse post-treatment|3|||
125573218|NCT00623428|451726032|FG000|Follow-up Period|Failure to return|10|||
125358397|NCT00875979|450948215|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
125358398|NCT00875979|450948214|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
125358399|NCT00875979|450948215|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
125573219|NCT00623428|451726033|FG001|Follow-up Period|Failure to return|2|||
125573220|NCT00623428|451726032|FG000|Follow-up Period|Patient withdrew consent|5|||
125573221|NCT00623428|451726033|FG001|Follow-up Period|Patient withdrew consent|4|||
125573222|NCT00623428|451726032|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
125573223|NCT00623428|451726033|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
125573224|NCT00623428|451726032|FG000|Follow-up Period|Did not cooperate|0|||
125573225|NCT00623428|451726033|FG001|Follow-up Period|Did not cooperate|3|||
125573226|NCT00623428|451726032|FG000|Follow-up Period|Reason not specified|1|||
125573227|NCT00623428|451726033|FG001|Follow-up Period|Reason not specified|1|||
125573228|NCT00623428|451726032|FG000|Follow-up Period|Death|0|||
125573229|NCT00623428|451726033|FG001|Follow-up Period|Death|1|||
125573230|NCT01929408|451726037|FG000|Overall Study|received HCT as initial treatment|8|||
125573231|NCT00293579|451726038|FG000|Overall Study|Withdrawal by Subject|1|||
125573232|NCT03127384|451726039|FG000|Overall Study|Lost to Follow-up|4|||
125573233|NCT03127384|451726039|FG000|Overall Study|Subject request|2|||
125573234|NCT00844753|451726043|FG000|Overall Study|Lack of Efficacy|1|||
125573235|NCT00844753|451726044|FG001|Overall Study|Lack of Efficacy|0|||
125573236|NCT00844753|451726045|FG002|Overall Study|Lack of Efficacy|2|||
125573237|NCT00844753|451726046|FG003|Overall Study|Lack of Efficacy|2|||
125573238|NCT00844753|451726043|FG000|Overall Study|Adverse Event|3|||
125573239|NCT00844753|451726044|FG001|Overall Study|Adverse Event|2|||
125573240|NCT00844753|451726045|FG002|Overall Study|Adverse Event|5|||
125573241|NCT00844753|451726046|FG003|Overall Study|Adverse Event|5|||
125573242|NCT00844753|451726043|FG000|Overall Study|Lost to Follow-up|1|||
125573243|NCT00844753|451726044|FG001|Overall Study|Lost to Follow-up|1|||
125573244|NCT00844753|451726045|FG002|Overall Study|Lost to Follow-up|0|||
125573245|NCT00844753|451726046|FG003|Overall Study|Lost to Follow-up|1|||
125573246|NCT00844753|451726043|FG000|Overall Study|could not swallow medication|2|||
125573247|NCT00844753|451726044|FG001|Overall Study|could not swallow medication|0|||
125573248|NCT00844753|451726045|FG002|Overall Study|could not swallow medication|0|||
125573249|NCT00844753|451726046|FG003|Overall Study|could not swallow medication|0|||
125573250|NCT00844753|451726043|FG000|Overall Study|Withdrawal by Subject|1|||
125573251|NCT00844753|451726044|FG001|Overall Study|Withdrawal by Subject|0|||
125573252|NCT00844753|451726045|FG002|Overall Study|Withdrawal by Subject|0|||
125573253|NCT00844753|451726046|FG003|Overall Study|Withdrawal by Subject|3|||
125573254|NCT02500121|451726049|FG000|Overall Study|Lost to Follow-up|0|||
125573255|NCT02500121|451726050|FG001|Overall Study|Lost to Follow-up|1|||
125573256|NCT02500121|451726049|FG000|Overall Study|Withdrawal by Subject|1|||
125573257|NCT02500121|451726050|FG001|Overall Study|Withdrawal by Subject|1|||
125573258|NCT02500121|451726049|FG000|Overall Study|Death|26|||
125573259|NCT02500121|451726050|FG001|Overall Study|Death|24|||
125573260|NCT04518462|451726052|FG000|Overall Study|Withdrawal by Subject|0|||
125573261|NCT04518462|451726053|FG001|Overall Study|Withdrawal by Subject|0|||
125573262|NCT04518462|451726054|FG002|Overall Study|Withdrawal by Subject|1|||
125573263|NCT04518462|451726052|FG000|Overall Study|Physician Decision|1|||
125573264|NCT04518462|451726053|FG001|Overall Study|Physician Decision|1|||
125573265|NCT04518462|451726054|FG002|Overall Study|Physician Decision|0|||
125573266|NCT03657043|451727763|FG000|Overall Study|Withdrawal by Subject|1|||
125573267|NCT03657043|451727764|FG001|Overall Study|Withdrawal by Subject|1|||
125573268|NCT03657043|451727765|FG002|Overall Study|Withdrawal by Subject|0|||
125573269|NCT03657043|451727766|FG003|Overall Study|Withdrawal by Subject|0|||
125573270|NCT03657043|451727767|FG004|Overall Study|Withdrawal by Subject|4|||
125573271|NCT03657043|451727763|FG000|Overall Study|Study closure by Sponsor|0|||
125573272|NCT03657043|451727764|FG001|Overall Study|Study closure by Sponsor|2|||
125573273|NCT03657043|451727765|FG002|Overall Study|Study closure by Sponsor|0|||
125573274|NCT03657043|451727766|FG003|Overall Study|Study closure by Sponsor|0|||
125573275|NCT03657043|451727767|FG004|Overall Study|Study closure by Sponsor|17|||
125573276|NCT03657043|451727763|FG000|Overall Study|Lost to Follow-up|0|||
125573277|NCT03657043|451727764|FG001|Overall Study|Lost to Follow-up|0|||
125573278|NCT03657043|451727765|FG002|Overall Study|Lost to Follow-up|0|||
125573279|NCT03657043|451727766|FG003|Overall Study|Lost to Follow-up|0|||
125573280|NCT03657043|451727767|FG004|Overall Study|Lost to Follow-up|4|||
125358400|NCT01649804|450948216|FG000|Overall Study|Administrative/Other|8|||
125573281|NCT03657043|451727763|FG000|Overall Study|Death|6|||
125573282|NCT03657043|451727764|FG001|Overall Study|Death|5|||
125573283|NCT03657043|451727765|FG002|Overall Study|Death|0|||
125573284|NCT03657043|451727766|FG003|Overall Study|Death|0|||
125573285|NCT03657043|451727767|FG004|Overall Study|Death|53|||
125573286|NCT03657043|451727763|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
125573287|NCT03657043|451727764|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
125573288|NCT03657043|451727765|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
125573289|NCT03657043|451727766|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
125573290|NCT03657043|451727767|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
125573291|NCT03657043|451727763|FG000|Overall Study|Adverse Event|0|||
125573292|NCT03657043|451727764|FG001|Overall Study|Adverse Event|0|||
125573293|NCT03657043|451727765|FG002|Overall Study|Adverse Event|0|||
125573294|NCT03657043|451727766|FG003|Overall Study|Adverse Event|0|||
125573295|NCT03657043|451727767|FG004|Overall Study|Adverse Event|2|||
125573296|NCT03657043|451727763|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
125573297|NCT03657043|451727764|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
125573298|NCT03657043|451727765|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
125573299|NCT03657043|451727766|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
125573300|NCT03657043|451727767|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
125573301|NCT03657043|451727763|FG000|Overall Study|Withdrawal - declined follow-up|0|||
125573302|NCT03657043|451727764|FG001|Overall Study|Withdrawal - declined follow-up|0|||
125573303|NCT03657043|451727765|FG002|Overall Study|Withdrawal - declined follow-up|0|||
125573304|NCT03657043|451727766|FG003|Overall Study|Withdrawal - declined follow-up|0|||
125573305|NCT03657043|451727767|FG004|Overall Study|Withdrawal - declined follow-up|1|||
125573306|NCT02627495|451727770|FG000|Overall Study|Withdrawal by Subject|4|||
125573307|NCT00880893|451727771|FG000|Overall Study|Protocol Violation|13|||
125573308|NCT00880893|451727772|FG001|Overall Study|Protocol Violation|1|||
125573309|NCT00880893|451727771|FG000|Overall Study|Withdrawal by Subject|15|||
125573310|NCT00880893|451727772|FG001|Overall Study|Withdrawal by Subject|11|||
125573311|NCT00880893|451727771|FG000|Overall Study|Lost to Follow-up|76|||
125573312|NCT00880893|451727772|FG001|Overall Study|Lost to Follow-up|33|||
125573313|NCT00880893|451727771|FG000|Overall Study|Serious adverse event|3|||
125573314|NCT00880893|451727772|FG001|Overall Study|Serious adverse event|0|||
125573315|NCT01736579|451727773|FG000|Overall Study|Termination of Study by Sponsor|2|||
125573316|NCT01736579|451727774|FG001|Overall Study|Termination of Study by Sponsor|2|||
125573317|NCT01408147|451727782|FG000|Overall Study|Withdrawal by Subject|0|||
125573318|NCT01408147|451727783|FG001|Overall Study|Withdrawal by Subject|1|||
125573319|NCT01662440|451727784|FG000|Overall Study|Adverse Event|1|||
125573320|NCT01662440|451727785|FG001|Overall Study|Adverse Event|0|||
125573321|NCT01662440|451727786|FG002|Overall Study|Adverse Event|0|||
125573322|NCT01662440|451727787|FG003|Overall Study|Adverse Event|1|||
125573323|NCT01662440|451727784|FG000|Overall Study|Death|0|||
125573324|NCT01662440|451727785|FG001|Overall Study|Death|1|||
125573325|NCT01662440|451727786|FG002|Overall Study|Death|0|||
125573326|NCT01662440|451727787|FG003|Overall Study|Death|0|||
125573327|NCT01662440|451727784|FG000|Overall Study|Lost to Follow-up|2|||
125573328|NCT01662440|451727785|FG001|Overall Study|Lost to Follow-up|2|||
125573329|NCT01662440|451727786|FG002|Overall Study|Lost to Follow-up|4|||
125573330|NCT01662440|451727787|FG003|Overall Study|Lost to Follow-up|1|||
125573331|NCT01662440|451727784|FG000|Overall Study|Subject moved to another country.|0|||
125573332|NCT01662440|451727785|FG001|Overall Study|Subject moved to another country.|1|||
125573333|NCT01662440|451727786|FG002|Overall Study|Subject moved to another country.|0|||
125573334|NCT01662440|451727787|FG003|Overall Study|Subject moved to another country.|0|||
125573335|NCT01662440|451727784|FG000|Overall Study|Protocol Violation|1|||
125573336|NCT01662440|451727785|FG001|Overall Study|Protocol Violation|0|||
125573337|NCT01662440|451727786|FG002|Overall Study|Protocol Violation|0|||
125573338|NCT01662440|451727787|FG003|Overall Study|Protocol Violation|0|||
125573339|NCT01662440|451727784|FG000|Overall Study|Withdrawal by Subject|5|||
125573340|NCT01662440|451727785|FG001|Overall Study|Withdrawal by Subject|2|||
125573341|NCT01662440|451727786|FG002|Overall Study|Withdrawal by Subject|2|||
125573342|NCT01662440|451727787|FG003|Overall Study|Withdrawal by Subject|2|||
125573343|NCT00112905|451727788|FG000|Overall Study|Adverse Event|4|||
125573344|NCT00112905|451727788|FG000|Overall Study|Death|1|||
125573345|NCT00112905|451727788|FG000|Overall Study|Ineligibility|5|||
125573346|NCT00112905|451727788|FG000|Overall Study|Alternative treatment|1|||
125573347|NCT00112905|451727788|FG000|Overall Study|performance status was deteiorating|1|||
125573348|NCT02600507|451727789|FG000|Overall Study|Adverse Event|3|||
125573349|NCT02600507|451727790|FG001|Overall Study|Adverse Event|15|||
125573350|NCT02600507|451727791|FG002|Overall Study|Adverse Event|5|||
125573351|NCT02600507|451727789|FG000|Overall Study|Lack of Efficacy|3|||
125573352|NCT02600507|451727790|FG001|Overall Study|Lack of Efficacy|8|||
125573353|NCT02600507|451727791|FG002|Overall Study|Lack of Efficacy|5|||
125573354|NCT02600507|451727789|FG000|Overall Study|Lost to Follow-up|3|||
125573355|NCT02600507|451727790|FG001|Overall Study|Lost to Follow-up|5|||
125573356|NCT02600507|451727791|FG002|Overall Study|Lost to Follow-up|2|||
125573357|NCT02600507|451727789|FG000|Overall Study|Protocol Violation|12|||
125573358|NCT02600507|451727790|FG001|Overall Study|Protocol Violation|4|||
125573359|NCT02600507|451727791|FG002|Overall Study|Protocol Violation|4|||
125573360|NCT02600507|451727789|FG000|Overall Study|Physician Decision|1|||
125573361|NCT02600507|451727790|FG001|Overall Study|Physician Decision|0|||
125573362|NCT02600507|451727791|FG002|Overall Study|Physician Decision|1|||
125573363|NCT02600507|451727789|FG000|Overall Study|Withdrawal by Subject|7|||
125573364|NCT02600507|451727790|FG001|Overall Study|Withdrawal by Subject|11|||
125573365|NCT02600507|451727791|FG002|Overall Study|Withdrawal by Subject|7|||
125573366|NCT02600507|451727789|FG000|Overall Study|Other|0|||
125573367|NCT02600507|451727790|FG001|Overall Study|Other|1|||
125573368|NCT02600507|451727791|FG002|Overall Study|Other|1|||
125573369|NCT05048719|451727792|FG000|Overall Study|Withdrawal by Subject|2|||
125573370|NCT05048719|451727793|FG001|Overall Study|Withdrawal by Subject|1|||
125573371|NCT05048719|451727794|FG002|Overall Study|Withdrawal by Subject|3|||
125573372|NCT05048719|451727795|FG003|Overall Study|Withdrawal by Subject|1|||
125573373|NCT05048719|451727796|FG004|Overall Study|Withdrawal by Subject|0|||
125573374|NCT05048719|451727797|FG005|Overall Study|Withdrawal by Subject|2|||
125573375|NCT05048719|451727798|FG006|Overall Study|Withdrawal by Subject|1|||
125573376|NCT05048719|451727799|FG007|Overall Study|Withdrawal by Subject|1|||
125573377|NCT05048719|451727800|FG008|Overall Study|Withdrawal by Subject|0|||
125211101|NCT04767529|450398580|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
125427004|NCT00552084|451188086|FG000|Overall Study|Withdrawal by Subject|4|||
125427005|NCT00552084|451188087|FG001|Overall Study|Withdrawal by Subject|5|||
125573378|NCT05048719|451727792|FG000|Overall Study|Death|1|||
125573379|NCT05048719|451727793|FG001|Overall Study|Death|0|||
125573380|NCT05048719|451727794|FG002|Overall Study|Death|0|||
125573381|NCT05048719|451727795|FG003|Overall Study|Death|0|||
125573382|NCT05048719|451727796|FG004|Overall Study|Death|0|||
125573383|NCT05048719|451727797|FG005|Overall Study|Death|0|||
125573384|NCT05048719|451727798|FG006|Overall Study|Death|0|||
125573385|NCT05048719|451727799|FG007|Overall Study|Death|0|||
125573386|NCT05048719|451727800|FG008|Overall Study|Death|0|||
125573387|NCT05048719|451727792|FG000|Overall Study|Adverse Event|0|||
125573388|NCT05048719|451727793|FG001|Overall Study|Adverse Event|1|||
125573389|NCT05048719|451727794|FG002|Overall Study|Adverse Event|2|||
125573390|NCT05048719|451727795|FG003|Overall Study|Adverse Event|0|||
125573391|NCT05048719|451727796|FG004|Overall Study|Adverse Event|1|||
125573392|NCT05048719|451727797|FG005|Overall Study|Adverse Event|0|||
125573393|NCT05048719|451727798|FG006|Overall Study|Adverse Event|0|||
125573394|NCT05048719|451727799|FG007|Overall Study|Adverse Event|0|||
125573395|NCT05048719|451727800|FG008|Overall Study|Adverse Event|0|||
125573396|NCT05048719|451727792|FG000|Overall Study|Lost to Follow-up|0|||
125573397|NCT05048719|451727793|FG001|Overall Study|Lost to Follow-up|0|||
125573398|NCT05048719|451727794|FG002|Overall Study|Lost to Follow-up|1|||
125573399|NCT05048719|451727795|FG003|Overall Study|Lost to Follow-up|3|||
125573400|NCT05048719|451727796|FG004|Overall Study|Lost to Follow-up|1|||
125573401|NCT05048719|451727797|FG005|Overall Study|Lost to Follow-up|1|||
125573402|NCT05048719|451727798|FG006|Overall Study|Lost to Follow-up|1|||
125573403|NCT05048719|451727799|FG007|Overall Study|Lost to Follow-up|1|||
125573404|NCT05048719|451727800|FG008|Overall Study|Lost to Follow-up|0|||
125573405|NCT05048719|451727792|FG000|Overall Study|Physician Decision|0|||
125573406|NCT05048719|451727793|FG001|Overall Study|Physician Decision|0|||
125573407|NCT05048719|451727794|FG002|Overall Study|Physician Decision|0|||
125573408|NCT05048719|451727795|FG003|Overall Study|Physician Decision|0|||
125573409|NCT05048719|451727796|FG004|Overall Study|Physician Decision|0|||
125573410|NCT05048719|451727797|FG005|Overall Study|Physician Decision|0|||
125573411|NCT05048719|451727798|FG006|Overall Study|Physician Decision|0|||
125573412|NCT05048719|451727799|FG007|Overall Study|Physician Decision|1|||
125573413|NCT05048719|451727800|FG008|Overall Study|Physician Decision|1|||
125573414|NCT05048719|451727792|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
125573415|NCT05048719|451727793|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125573416|NCT05048719|451727794|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125573417|NCT05048719|451727795|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125573418|NCT05048719|451727796|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125573419|NCT05048719|451727797|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125573420|NCT05048719|451727798|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125573421|NCT05048719|451727799|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125573422|NCT05048719|451727800|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
125573423|NCT05048719|451727792|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125573424|NCT05048719|451727793|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
125573425|NCT05048719|451727794|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125573426|NCT05048719|451727795|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125573427|NCT05048719|451727796|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125573428|NCT05048719|451727797|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125573429|NCT05048719|451727798|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125573430|NCT05048719|451727799|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125573431|NCT05048719|451727800|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
125573432|NCT05048719|451727792|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125573433|NCT05048719|451727793|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
125573434|NCT05048719|451727794|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125573435|NCT05048719|451727795|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125573436|NCT05048719|451727796|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125573437|NCT05048719|451727797|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125573438|NCT05048719|451727798|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125573439|NCT05048719|451727799|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125573440|NCT05048719|451727800|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
125573441|NCT05048719|451727792|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125637214|NCT03073200|451952835|FG003|Extension Period|Withdrawal by Subject|0|||
125358401|NCT01123850|450948223|FG000|Overall Study|Slow enrollment|45|||
125358402|NCT02083081|450948224|FG000|Overall Study|Lost to Follow-up|31|||
125358403|NCT02083081|450948225|FG001|Overall Study|Lost to Follow-up|9|||
125358404|NCT02028871|450948228|FG000|Overall Study|Positive urine drug screen|1|||
125358405|NCT02028871|450948229|FG001|Overall Study|Positive urine drug screen|1|||
125358406|NCT02028871|450948228|FG000|Overall Study|Withdrawal by Subject|1|||
125358407|NCT02028871|450948229|FG001|Overall Study|Withdrawal by Subject|2|||
125358408|NCT02028871|450948228|FG000|Overall Study|IV placement difficulty|1|||
125358409|NCT02028871|450948229|FG001|Overall Study|IV placement difficulty|0|||
125358410|NCT02028871|450948228|FG000|Overall Study|Current Illness|1|||
125358411|NCT02028871|450948229|FG001|Overall Study|Current Illness|0|||
125358412|NCT01691898|450948230|FG000|Overall Study|Death|34|||
125358413|NCT01691898|450948231|FG001|Overall Study|Death|32|||
125358414|NCT01691898|450948232|FG002|Overall Study|Death|6|||
125358415|NCT01691898|450948233|FG003|Overall Study|Death|3|||
125358416|NCT01691898|450948234|FG004|Overall Study|Death|8|||
125358417|NCT01691898|450948235|FG005|Overall Study|Death|31|||
125358418|NCT01691898|450948230|FG000|Overall Study|Adverse Event|0|||
125358419|NCT01691898|450948231|FG001|Overall Study|Adverse Event|1|||
125358420|NCT01691898|450948232|FG002|Overall Study|Adverse Event|0|||
125573442|NCT05048719|451727793|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125573443|NCT05048719|451727794|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125573444|NCT05048719|451727795|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
125573445|NCT05048719|451727796|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125573446|NCT05048719|451727797|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125573447|NCT05048719|451727798|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125573448|NCT05048719|451727799|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125573449|NCT05048719|451727800|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
125358421|NCT01691898|450948233|FG003|Overall Study|Adverse Event|1|||
125358422|NCT01691898|450948234|FG004|Overall Study|Adverse Event|1|||
125358423|NCT01691898|450948235|FG005|Overall Study|Adverse Event|0|||
125573450|NCT05048719|451727792|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125573451|NCT05048719|451727793|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125573452|NCT05048719|451727794|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125573453|NCT05048719|451727795|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125573454|NCT05048719|451727796|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125573455|NCT05048719|451727797|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
125573456|NCT05048719|451727798|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125573457|NCT05048719|451727799|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125573458|NCT05048719|451727800|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
125573459|NCT04541004|451727801|FG000|Overall Study|Adverse Event|2|||
125573460|NCT02229552|451727805|FG000|Baseline|Withdrawal by Subject|6|||
125573461|NCT02229552|451727805|FG000|1-year Follow up|Withdrawal by Subject|7|||
125573462|NCT02229552|451727805|FG000|1-year Follow up|Lost to Follow-up|18|||
125573463|NCT02229552|451727805|FG000|2-Year Follow up|Withdrawal by Subject|9|||
125573464|NCT02229552|451727805|FG000|2-Year Follow up|Lost to Follow-up|17|||
125573465|NCT04872101|451727806|FG000|Overall Study|Withdrawal by Subject|10|||
125358424|NCT01691898|450948230|FG000|Overall Study|Progression of Disease|1|||
125573466|NCT04872101|451727807|FG001|Overall Study|Withdrawal by Subject|16|||
125573467|NCT04872101|451727806|FG000|Overall Study|Lack of Efficacy|6|||
125358425|NCT01691898|450948231|FG001|Overall Study|Progression of Disease|2|||
125358426|NCT01691898|450948232|FG002|Overall Study|Progression of Disease|1|||
125358427|NCT01691898|450948233|FG003|Overall Study|Progression of Disease|0|||
125358428|NCT01691898|450948234|FG004|Overall Study|Progression of Disease|0|||
125358429|NCT01691898|450948235|FG005|Overall Study|Progression of Disease|1|||
125358430|NCT01691898|450948230|FG000|Overall Study|Lost to Follow-up|3|||
125358431|NCT01691898|450948231|FG001|Overall Study|Lost to Follow-up|1|||
125358432|NCT01691898|450948232|FG002|Overall Study|Lost to Follow-up|0|||
125358433|NCT01691898|450948233|FG003|Overall Study|Lost to Follow-up|0|||
125358434|NCT01691898|450948234|FG004|Overall Study|Lost to Follow-up|1|||
125573468|NCT04872101|451727807|FG001|Overall Study|Lack of Efficacy|14|||
125573469|NCT04872101|451727806|FG000|Overall Study|Adverse Event|1|||
125573470|NCT04872101|451727807|FG001|Overall Study|Adverse Event|6|||
125573471|NCT04872101|451727806|FG000|Overall Study|Lost to Follow-up|2|||
125573472|NCT04872101|451727807|FG001|Overall Study|Lost to Follow-up|1|||
125573473|NCT04872101|451727806|FG000|Overall Study|Pregnancy|2|||
125573474|NCT04872101|451727807|FG001|Overall Study|Pregnancy|0|||
125573475|NCT04872101|451727806|FG000|Overall Study|Prohibited Medication|1|||
125573476|NCT04872101|451727807|FG001|Overall Study|Prohibited Medication|0|||
125573477|NCT04872101|451727806|FG000|Overall Study|Not dosed|1|||
125573478|NCT04872101|451727807|FG001|Overall Study|Not dosed|0|||
125573479|NCT00971945|451727808|FG000|Overall Study|Progressive Disease|3|||
125573480|NCT00971945|451727808|FG000|Overall Study|Change in treatment policy|1|||
125573481|NCT00971945|451727808|FG000|Overall Study|Other reasons|2|||
125573482|NCT03354663|451727809|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
125573483|NCT03354663|451727809|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
125573484|NCT03354663|451727809|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
125573485|NCT03354663|451727809|FG000|Completed 30-day Visit|Missed Visit|1|||
125573486|NCT03691974|451727810|FG000|Overall Study|Physician Decision|1|||
125573487|NCT03691974|451727811|FG001|Overall Study|Physician Decision|0|||
125573488|NCT03691974|451727810|FG000|Overall Study|Adverse Event|1|||
125573489|NCT03691974|451727811|FG001|Overall Study|Adverse Event|0|||
125358435|NCT01691898|450948235|FG005|Overall Study|Lost to Follow-up|0|||
125358436|NCT01691898|450948230|FG000|Overall Study|Withdrawal by Subject|9|||
125573490|NCT03691974|451727810|FG000|Overall Study|Withdrawal by Subject|11|||
125573491|NCT03691974|451727811|FG001|Overall Study|Withdrawal by Subject|9|||
125358437|NCT01691898|450948231|FG001|Overall Study|Withdrawal by Subject|8|||
125358438|NCT01691898|450948232|FG002|Overall Study|Withdrawal by Subject|2|||
125573492|NCT03691974|451727810|FG000|Overall Study|Protocol Violation|1|||
125573493|NCT03691974|451727811|FG001|Overall Study|Protocol Violation|0|||
125573494|NCT03691974|451727810|FG000|Overall Study|Lost to Follow-up|8|||
125573495|NCT03691974|451727811|FG001|Overall Study|Lost to Follow-up|7|||
125573496|NCT01661140|451727814|FG000|Open-Label Period|Adverse Event|44|||
125573497|NCT01661140|451727815|FG001|Open-Label Period|Adverse Event|0|||
125573498|NCT01661140|451727816|FG002|Open-Label Period|Adverse Event|0|||
125573499|NCT01661140|451727814|FG000|Open-Label Period|Protocol Violation|3|||
125573500|NCT01661140|451727815|FG001|Open-Label Period|Protocol Violation|0|||
125573501|NCT01661140|451727816|FG002|Open-Label Period|Protocol Violation|0|||
125573502|NCT01661140|451727814|FG000|Open-Label Period|Withdrawal by Subject|5|||
125573503|NCT01661140|451727815|FG001|Open-Label Period|Withdrawal by Subject|0|||
125573504|NCT01661140|451727816|FG002|Open-Label Period|Withdrawal by Subject|0|||
125573505|NCT01661140|451727814|FG000|Open-Label Period|Investigator Decision|3|||
125573506|NCT01661140|451727815|FG001|Open-Label Period|Investigator Decision|0|||
125573507|NCT01661140|451727816|FG002|Open-Label Period|Investigator Decision|0|||
125573508|NCT01661140|451727814|FG000|Open-Label Period|Death|1|||
125573509|NCT01661140|451727815|FG001|Open-Label Period|Death|0|||
125573510|NCT01661140|451727816|FG002|Open-Label Period|Death|0|||
125573511|NCT01661140|451727814|FG000|Open-Label Period|Administrative/Other|1|||
125573512|NCT01661140|451727815|FG001|Open-Label Period|Administrative/Other|0|||
125573513|NCT01661140|451727816|FG002|Open-Label Period|Administrative/Other|0|||
125573514|NCT01661140|451727814|FG000|Open-Label Period|Sponsor termination|16|||
125573515|NCT01661140|451727815|FG001|Open-Label Period|Sponsor termination|0|||
125573516|NCT01661140|451727816|FG002|Open-Label Period|Sponsor termination|0|||
125573517|NCT01661140|451727814|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
125573518|NCT01661140|451727815|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
125573519|NCT01661140|451727816|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
125573520|NCT01661140|451727814|FG000|Open-Label Period|Lost to Follow-up|2|||
125573521|NCT01661140|451727815|FG001|Open-Label Period|Lost to Follow-up|0|||
125573522|NCT01661140|451727816|FG002|Open-Label Period|Lost to Follow-up|0|||
125573523|NCT01661140|451727814|FG000|Double-Blind Period|Refused Treatment|0|||
125573524|NCT01661140|451727815|FG001|Double-Blind Period|Refused Treatment|0|||
125573525|NCT01661140|451727816|FG002|Double-Blind Period|Refused Treatment|1|||
125573526|NCT01661140|451727814|FG000|Double-Blind Period|Adverse Event|0|||
125573527|NCT01661140|451727815|FG001|Double-Blind Period|Adverse Event|16|||
125573528|NCT01661140|451727816|FG002|Double-Blind Period|Adverse Event|18|||
125573529|NCT01661140|451727814|FG000|Double-Blind Period|Protocol Violation|0|||
125573530|NCT01661140|451727815|FG001|Double-Blind Period|Protocol Violation|2|||
125573531|NCT01661140|451727816|FG002|Double-Blind Period|Protocol Violation|3|||
125573532|NCT01661140|451727814|FG000|Double-Blind Period|Withdrawal by Subject|0|||
125573533|NCT01661140|451727815|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125573534|NCT01661140|451727816|FG002|Double-Blind Period|Withdrawal by Subject|3|||
125573535|NCT01661140|451727814|FG000|Double-Blind Period|Investigator's Decision|0|||
125573536|NCT01661140|451727815|FG001|Double-Blind Period|Investigator's Decision|1|||
125573537|NCT01661140|451727816|FG002|Double-Blind Period|Investigator's Decision|2|||
125573538|NCT01661140|451727814|FG000|Double-Blind Period|Sponsor Termination|0|||
125573539|NCT01661140|451727815|FG001|Double-Blind Period|Sponsor Termination|14|||
125573540|NCT01661140|451727816|FG002|Double-Blind Period|Sponsor Termination|17|||
125573541|NCT01661140|451727814|FG000|Double-Blind Period|Administrative/Other|0|||
125573542|NCT01661140|451727815|FG001|Double-Blind Period|Administrative/Other|7|||
125573543|NCT01661140|451727816|FG002|Double-Blind Period|Administrative/Other|6|||
125573544|NCT00746252|451727817|FG000|Overall Study|weight gain >7.5 %|1|||
125573545|NCT00746252|451727818|FG001|Overall Study|weight gain >7.5 %|2|||
125573546|NCT02239939|451727819|FG000|Overall Study|Adverse Event|1|||
125573547|NCT02239939|451727820|FG001|Overall Study|Adverse Event|0|||
125573548|NCT02239939|451727819|FG000|Overall Study|Withdrawal by Subject|1|||
125573549|NCT02239939|451727820|FG001|Overall Study|Withdrawal by Subject|1|||
125573550|NCT02239939|451727819|FG000|Overall Study|Lost to Follow-up|0|||
125573551|NCT02239939|451727820|FG001|Overall Study|Lost to Follow-up|1|||
125573552|NCT01659320|451727821|FG000|Overall Study|Withdrawal by Subject|2|||
125573553|NCT01659320|451727821|FG000|Overall Study|Physician Decision|1|||
125573554|NCT01514682|451727822|FG000|Overall Study|Withdrawal by Subject|2|||
125573555|NCT01514682|451727823|FG001|Overall Study|Withdrawal by Subject|3|||
125573556|NCT01514682|451727822|FG000|Overall Study|Physician Decision|4|||
125358439|NCT01691898|450948233|FG003|Overall Study|Withdrawal by Subject|1|||
125358440|NCT01691898|450948234|FG004|Overall Study|Withdrawal by Subject|3|||
125358441|NCT01691898|450948235|FG005|Overall Study|Withdrawal by Subject|3|||
125358442|NCT01691898|450948230|FG000|Overall Study|Non-Compliance|0|||
125358443|NCT01691898|450948231|FG001|Overall Study|Non-Compliance|0|||
125358444|NCT01691898|450948232|FG002|Overall Study|Non-Compliance|0|||
125358445|NCT01691898|450948233|FG003|Overall Study|Non-Compliance|0|||
125358446|NCT01691898|450948234|FG004|Overall Study|Non-Compliance|1|||
125358447|NCT01691898|450948235|FG005|Overall Study|Non-Compliance|0|||
125358448|NCT01104155|450948236|FG000|Overall Study|Adverse Event|15|||
125358449|NCT01104155|450948237|FG001|Overall Study|Adverse Event|8|||
125358450|NCT01104155|450948236|FG000|Overall Study|Participant choice|6|||
125358451|NCT01104155|450948237|FG001|Overall Study|Participant choice|5|||
125573557|NCT01514682|451727823|FG001|Overall Study|Physician Decision|3|||
125573558|NCT01870401|451727824|FG000|Overall Study|Death|48|||
125573559|NCT01870401|451727825|FG001|Overall Study|Death|24|||
125573560|NCT01870401|451727824|FG000|Overall Study|Withdrawal by Subject|39|||
125573561|NCT01870401|451727825|FG001|Overall Study|Withdrawal by Subject|26|||
125573562|NCT01870401|451727824|FG000|Overall Study|Lost to Follow-up|19|||
125573563|NCT01870401|451727825|FG001|Overall Study|Lost to Follow-up|14|||
125573564|NCT01870401|451727824|FG000|Overall Study|Other|9|||
125573565|NCT01870401|451727825|FG001|Overall Study|Other|7|||
125573566|NCT01870401|451727824|FG000|Overall Study|On-going in the Study|35|||
125573567|NCT01870401|451727825|FG001|Overall Study|On-going in the Study|25|||
125573568|NCT02105454|451727828|FG000|Overall Study|Withdrawal by Subject|1|||
125573569|NCT00272038|451727830|FG000|Overall Study|withdrew before they received 2 cycles|7|||
125573570|NCT00493870|451727831|FG000|Overall Study|Lost to Follow-up|12|||
125573571|NCT00493870|451727832|FG001|Overall Study|Lost to Follow-up|15|||
125573572|NCT03605680|451727833|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
125573573|NCT03605680|451727834|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
125573574|NCT03605680|451727835|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
125573575|NCT03605680|451727836|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
125573576|NCT03605680|451727833|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
125573577|NCT03605680|451727834|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
125573578|NCT03605680|451727835|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
125573579|NCT03605680|451727836|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
125573580|NCT03605680|451727833|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
125573581|NCT03605680|451727834|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
125573582|NCT03605680|451727835|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
125573583|NCT03605680|451727836|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
125573584|NCT03605680|451727833|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
125573585|NCT03605680|451727834|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
125573586|NCT03605680|451727835|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
125573587|NCT03605680|451727836|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
125573588|NCT03605680|451727833|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
125573589|NCT03605680|451727834|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
125573590|NCT03605680|451727835|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
125573591|NCT03605680|451727836|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
125573592|NCT03605680|451727833|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
125573593|NCT03605680|451727834|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
125573594|NCT03605680|451727835|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
125358452|NCT01104155|450948236|FG000|Overall Study|Withdrawal of consent|1|||
125358453|NCT01104155|450948237|FG001|Overall Study|Withdrawal of consent|1|||
125358454|NCT01104155|450948236|FG000|Overall Study|Other|3|||
125573595|NCT03605680|451727836|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
125573596|NCT03605680|451727833|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
125358455|NCT01104155|450948237|FG001|Overall Study|Other|4|||
125573597|NCT03605680|451727834|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
125573598|NCT03605680|451727835|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
125573599|NCT03605680|451727836|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
125573600|NCT03605680|451727833|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
125573601|NCT03605680|451727834|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
125573602|NCT03605680|451727835|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
125573603|NCT03605680|451727836|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
125573604|NCT03605680|451727833|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
125573605|NCT03605680|451727834|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
125573606|NCT03605680|451727835|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
125573607|NCT03605680|451727836|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
125573608|NCT03605680|451727833|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
125573609|NCT03605680|451727834|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
125573610|NCT03605680|451727835|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
125573611|NCT03605680|451727836|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
125573612|NCT03605680|451727833|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
125573613|NCT03605680|451727834|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
125358456|NCT01484132|450948238|FG000|Overall Study|Lost to Follow-up|8|||
125358457|NCT01484132|450948238|FG000|Overall Study|Difficulty with time commitment|2|||
125358458|NCT01484132|450948238|FG000|Overall Study|Ineligible|1|||
125358459|NCT01484132|450948238|FG000|Overall Study|No pre-treatment urine sample collected|1|||
125358460|NCT01484132|450948238|FG000|Overall Study|No post-treatment urine sample collected|10|||
125358461|NCT02808650|450948240|FG000|Overall Study|Death|0|||
125358462|NCT02808650|450948241|FG001|Overall Study|Death|0|||
125358463|NCT02808650|450948242|FG002|Overall Study|Death|0|||
125358464|NCT02808650|450948243|FG003|Overall Study|Death|0|||
125358465|NCT02808650|450948244|FG004|Overall Study|Death|1|||
125358466|NCT02808650|450948240|FG000|Overall Study|Lack of Efficacy|5|||
125358467|NCT02808650|450948241|FG001|Overall Study|Lack of Efficacy|5|||
125358468|NCT02808650|450948242|FG002|Overall Study|Lack of Efficacy|6|||
125358469|NCT02808650|450948243|FG003|Overall Study|Lack of Efficacy|5|||
125358470|NCT02808650|450948244|FG004|Overall Study|Lack of Efficacy|4|||
125358471|NCT02808650|450948240|FG000|Overall Study|Physician Decision|1|||
125358472|NCT02808650|450948241|FG001|Overall Study|Physician Decision|1|||
125358473|NCT02808650|450948242|FG002|Overall Study|Physician Decision|0|||
125358474|NCT02808650|450948243|FG003|Overall Study|Physician Decision|0|||
125358475|NCT02808650|450948244|FG004|Overall Study|Physician Decision|0|||
125358476|NCT02808650|450948240|FG000|Overall Study|Withdrawal by Subject|0|||
125358477|NCT02808650|450948241|FG001|Overall Study|Withdrawal by Subject|0|||
125358478|NCT02808650|450948242|FG002|Overall Study|Withdrawal by Subject|0|||
125358479|NCT02808650|450948243|FG003|Overall Study|Withdrawal by Subject|1|||
125358480|NCT02808650|450948244|FG004|Overall Study|Withdrawal by Subject|1|||
125358481|NCT02939079|450948245|FG000|Overall Study|Adverse Event|2|||
125358482|NCT02939079|450948246|FG001|Overall Study|Adverse Event|1|||
125358483|NCT02939079|450948245|FG000|Overall Study|Lost to Follow-up|0|||
125358484|NCT02939079|450948246|FG001|Overall Study|Lost to Follow-up|2|||
125358485|NCT02939079|450948245|FG000|Overall Study|Protocol Violation|1|||
125573614|NCT03605680|451727835|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
125573615|NCT03605680|451727836|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
125573616|NCT03605680|451727833|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125573617|NCT03605680|451727834|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125573618|NCT03605680|451727835|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125573619|NCT03605680|451727836|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
125573620|NCT03605680|451727833|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
125573621|NCT03605680|451727834|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
125573622|NCT03605680|451727835|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
125573623|NCT03605680|451727836|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
125573624|NCT03605680|451727833|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
125573625|NCT03605680|451727834|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
125573626|NCT03605680|451727835|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
125573627|NCT03605680|451727836|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
125573628|NCT03605680|451727833|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
125573629|NCT03605680|451727834|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
125573630|NCT03605680|451727835|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
125573631|NCT03605680|451727836|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
125573632|NCT03605680|451727833|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
125573633|NCT03605680|451727834|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
125573634|NCT03605680|451727835|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
125573635|NCT03605680|451727836|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
125573636|NCT03605680|451727833|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
125573637|NCT03605680|451727834|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
125573638|NCT03605680|451727835|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
125573639|NCT03605680|451727836|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
125573640|NCT03605680|451727833|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
125573641|NCT03605680|451727834|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
125573642|NCT03605680|451727835|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
125573643|NCT03605680|451727836|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
125573644|NCT03605680|451727833|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
125573645|NCT03605680|451727834|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
125573646|NCT03605680|451727835|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
125573647|NCT03605680|451727836|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
125573648|NCT02721355|451727837|FG000|Overall Study|Lost to Follow-up|6|||
125573649|NCT02721355|451727838|FG001|Overall Study|Lost to Follow-up|1|||
125573650|NCT00356278|451727839|FG000|Overall Study|Withdrawal by Subject|25|||
125573651|NCT00356278|451727840|FG001|Overall Study|Withdrawal by Subject|15|||
125573652|NCT00356278|451727841|FG002|Overall Study|Withdrawal by Subject|19|||
125573653|NCT00883337|451727842|FG000|Core Treatment Period|Adverse Event|9|||
125573654|NCT00883337|451727843|FG001|Core Treatment Period|Adverse Event|12|||
125573655|NCT00883337|451727844|FG002|Core Treatment Period|Adverse Event|22|||
125573656|NCT00883337|451727842|FG000|Core Treatment Period|Lack of Efficacy|7|||
125573657|NCT00883337|451727843|FG001|Core Treatment Period|Lack of Efficacy|4|||
125573658|NCT00883337|451727844|FG002|Core Treatment Period|Lack of Efficacy|2|||
125573659|NCT00883337|451727842|FG000|Core Treatment Period|Lost to Follow-up|1|||
125573660|NCT00883337|451727843|FG001|Core Treatment Period|Lost to Follow-up|1|||
125573661|NCT00883337|451727844|FG002|Core Treatment Period|Lost to Follow-up|0|||
125573662|NCT00883337|451727842|FG000|Core Treatment Period|Withdrawal by Subject|2|||
125573663|NCT00883337|451727843|FG001|Core Treatment Period|Withdrawal by Subject|2|||
125573664|NCT00883337|451727844|FG002|Core Treatment Period|Withdrawal by Subject|6|||
125573665|NCT00883337|451727842|FG000|Core Treatment Period|Wish to be pregnant|1|||
125573666|NCT00883337|451727843|FG001|Core Treatment Period|Wish to be pregnant|2|||
125573667|NCT00883337|451727844|FG002|Core Treatment Period|Wish to be pregnant|1|||
125211102|NCT04767529|450398578|FG000|Overall Study|Required use of a prohibited medication|0|||
125211103|NCT04767529|450398579|FG001|Overall Study|Required use of a prohibited medication|1|||
125211104|NCT04767529|450398580|FG002|Overall Study|Required use of a prohibited medication|0|||
125211105|NCT04767529|450398578|FG000|Overall Study|Withdrawal by Subject|7|||
125211106|NCT04767529|450398579|FG001|Overall Study|Withdrawal by Subject|5|||
125211107|NCT04767529|450398580|FG002|Overall Study|Withdrawal by Subject|4|||
125573668|NCT00883337|451727842|FG000|Core Treatment Period|Poor compliance to protocol|0|||
125573669|NCT00883337|451727843|FG001|Core Treatment Period|Poor compliance to protocol|0|||
125358486|NCT02939079|450948246|FG001|Overall Study|Protocol Violation|0|||
125573670|NCT00883337|451727844|FG002|Core Treatment Period|Poor compliance to protocol|1|||
125573671|NCT00883337|451727842|FG000|Core Treatment Period|Other than above|0|||
125217428|NCT01348100|450423522|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125358487|NCT02939079|450948245|FG000|Overall Study|Withdrawal by Subject|0|||
125573672|NCT00883337|451727843|FG001|Core Treatment Period|Other than above|1|||
125573673|NCT00883337|451727844|FG002|Core Treatment Period|Other than above|1|||
125573674|NCT00883337|451727842|FG000|Extension Treatment Period|Adverse Event|8|||
125573675|NCT00883337|451727843|FG001|Extension Treatment Period|Adverse Event|5|||
125573676|NCT00883337|451727844|FG002|Extension Treatment Period|Adverse Event|5|||
125573677|NCT00883337|451727842|FG000|Extension Treatment Period|Lack of Efficacy|8|||
125573678|NCT00883337|451727843|FG001|Extension Treatment Period|Lack of Efficacy|8|||
125573679|NCT00883337|451727844|FG002|Extension Treatment Period|Lack of Efficacy|8|||
125573680|NCT00883337|451727842|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
125573681|NCT00883337|451727843|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
125573682|NCT00883337|451727844|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
125573683|NCT00883337|451727842|FG000|Extension Treatment Period|Lost to Follow-up|1|||
125573684|NCT00883337|451727843|FG001|Extension Treatment Period|Lost to Follow-up|0|||
125573685|NCT00883337|451727844|FG002|Extension Treatment Period|Lost to Follow-up|0|||
125573686|NCT00883337|451727842|FG000|Extension Treatment Period|Other than above|10|||
125573687|NCT00883337|451727843|FG001|Extension Treatment Period|Other than above|9|||
125573688|NCT00883337|451727844|FG002|Extension Treatment Period|Other than above|5|||
125573689|NCT00527605|451727845|FG000|Overall Study|Adverse Event|3|||
125573690|NCT00527605|451727846|FG001|Overall Study|Adverse Event|0|||
125573691|NCT00527605|451727845|FG000|Overall Study|Withdrawal by Subject|3|||
125573692|NCT00527605|451727846|FG001|Overall Study|Withdrawal by Subject|7|||
125573693|NCT00527605|451727845|FG000|Overall Study|Lost to Follow-up|6|||
125573694|NCT00527605|451727846|FG001|Overall Study|Lost to Follow-up|2|||
125573695|NCT00527605|451727845|FG000|Overall Study|Protocol Violation|1|||
125573696|NCT00527605|451727846|FG001|Overall Study|Protocol Violation|2|||
125573697|NCT01592760|451727847|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
125573698|NCT01592760|451727848|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
125573699|NCT01592760|451727849|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
125573700|NCT04312009|451727850|FG000|Overall Study|Withdrawal by Subject|2|||
125573701|NCT04312009|451727851|FG001|Overall Study|Withdrawal by Subject|1|||
125573702|NCT01485627|451727857|FG000|Overall Study|Patient withdrew|6|||
125573703|NCT01485627|451727858|FG001|Overall Study|Patient withdrew|5|||
125573704|NCT01485627|451727857|FG000|Overall Study|Patient died|3|||
125573705|NCT01485627|451727858|FG001|Overall Study|Patient died|1|||
125573706|NCT01485627|451727857|FG000|Overall Study|Patient lost to followup|0|||
125573707|NCT01485627|451727858|FG001|Overall Study|Patient lost to followup|1|||
125573708|NCT01485627|451727857|FG000|Overall Study|Caregiver withdrew|3|||
125573709|NCT01485627|451727858|FG001|Overall Study|Caregiver withdrew|3|||
125573710|NCT01485627|451727857|FG000|Overall Study|Caregiver lost to follow up|11|||
125573711|NCT01485627|451727858|FG001|Overall Study|Caregiver lost to follow up|12|||
125573712|NCT01485627|451727857|FG000|Overall Study|Caregiver died|1|||
125573713|NCT01485627|451727858|FG001|Overall Study|Caregiver died|0|||
125573714|NCT01485627|451727857|FG000|Overall Study|caregiver was not bereaved|42|||
125573715|NCT01485627|451727858|FG001|Overall Study|caregiver was not bereaved|35|||
125573716|NCT00075504|451727872|FG000|Overall Study|Withdrawal by Subject|9|||
125573717|NCT00075504|451727873|FG001|Overall Study|Withdrawal by Subject|7|||
125573718|NCT01692301|451727874|FG000|Overall Study|Adverse Event|15|||
125573719|NCT01692301|451727875|FG001|Overall Study|Adverse Event|12|||
125573720|NCT01692301|451727874|FG000|Overall Study|Death|1|||
125573721|NCT01692301|451727875|FG001|Overall Study|Death|2|||
125573722|NCT01692301|451727874|FG000|Overall Study|Lack of Efficacy|0|||
125573723|NCT01692301|451727875|FG001|Overall Study|Lack of Efficacy|5|||
125573724|NCT01692301|451727874|FG000|Overall Study|Non-compliance with study treatment|1|||
125573725|NCT01692301|451727875|FG001|Overall Study|Non-compliance with study treatment|2|||
125573726|NCT01692301|451727874|FG000|Overall Study|Protocol deviation|9|||
125573727|NCT01692301|451727875|FG001|Overall Study|Protocol deviation|2|||
125573728|NCT01692301|451727874|FG000|Overall Study|Patient/guardian decision|16|||
125573729|NCT01692301|451727875|FG001|Overall Study|Patient/guardian decision|15|||
125573730|NCT01692301|451727874|FG000|Overall Study|Technical problems|0|||
125573731|NCT01692301|451727875|FG001|Overall Study|Technical problems|1|||
125573732|NCT01692301|451727874|FG000|Overall Study|Physician Decision|2|||
125573733|NCT01692301|451727875|FG001|Overall Study|Physician Decision|2|||
125573734|NCT01692301|451727874|FG000|Overall Study|Lost to Follow-up|1|||
125573735|NCT01692301|451727875|FG001|Overall Study|Lost to Follow-up|1|||
125573736|NCT01142726|451727876|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
125358488|NCT02939079|450948246|FG001|Overall Study|Withdrawal by Subject|1|||
125573737|NCT01142726|451727877|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
125573738|NCT01142726|451727878|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
125573739|NCT01142726|451727876|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
125573740|NCT01142726|451727877|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
125573741|NCT01142726|451727878|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
125573742|NCT01142726|451727876|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
125573743|NCT01142726|451727877|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
125573744|NCT01142726|451727878|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
125573745|NCT01142726|451727876|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
125573746|NCT01142726|451727877|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
125573747|NCT01142726|451727878|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
125573748|NCT01142726|451727876|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
125573749|NCT01142726|451727877|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
125573750|NCT01142726|451727878|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
125573751|NCT01142726|451727876|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
125573752|NCT01142726|451727877|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
125573753|NCT01142726|451727878|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
125573754|NCT01142726|451727876|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
125573755|NCT01142726|451727877|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
125573756|NCT01142726|451727878|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
125573757|NCT01142726|451727876|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
125573758|NCT01142726|451727877|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
125573759|NCT01142726|451727878|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
125573760|NCT01142726|451727876|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
125573761|NCT01142726|451727877|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
125573762|NCT01142726|451727878|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
125573763|NCT01142726|451727876|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
125573764|NCT01142726|451727877|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
125573765|NCT01142726|451727878|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
125573766|NCT01142726|451727876|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
125573767|NCT01142726|451727877|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
125573768|NCT01142726|451727878|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
125573769|NCT01142726|451727876|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
125573770|NCT01142726|451727877|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
125573771|NCT01142726|451727878|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
125573772|NCT01142726|451727876|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
125573773|NCT01142726|451727877|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
125573774|NCT01142726|451727878|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
125573775|NCT01142726|451727876|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
125573776|NCT01142726|451727877|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
125573777|NCT01142726|451727878|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
125573778|NCT01142726|451727876|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
125573779|NCT01142726|451727877|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
125573780|NCT01142726|451727878|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
125573781|NCT01142726|451727876|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
125573782|NCT01142726|451727877|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
125573783|NCT01142726|451727878|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
125573784|NCT01568593|451727879|FG000|Overall Study|Lack of Efficacy|4|||
125573785|NCT01568593|451727880|FG001|Overall Study|Lack of Efficacy|1|||
125573786|NCT01568593|451727879|FG000|Overall Study|Adverse Event|3|||
125573787|NCT01568593|451727880|FG001|Overall Study|Adverse Event|2|||
125573788|NCT02109484|451727881|FG000|Overall Study|Lost to Follow-up|0|||
125573789|NCT02109484|451727882|FG001|Overall Study|Lost to Follow-up|0|||
125573790|NCT02109484|451727883|FG002|Overall Study|Lost to Follow-up|0|||
125573791|NCT02109484|451727884|FG003|Overall Study|Lost to Follow-up|1|||
125573792|NCT02109484|451727885|FG004|Overall Study|Lost to Follow-up|1|||
125573793|NCT02109484|451727886|FG005|Overall Study|Lost to Follow-up|0|||
125573794|NCT02109484|451727887|FG006|Overall Study|Lost to Follow-up|1|||
125573795|NCT02109484|451727888|FG007|Overall Study|Lost to Follow-up|0|||
125573796|NCT02109484|451727881|FG000|Overall Study|Withdrawal by Subject|0|||
125573797|NCT02109484|451727882|FG001|Overall Study|Withdrawal by Subject|0|||
125573798|NCT02109484|451727883|FG002|Overall Study|Withdrawal by Subject|0|||
125573799|NCT02109484|451727884|FG003|Overall Study|Withdrawal by Subject|0|||
125573800|NCT02109484|451727885|FG004|Overall Study|Withdrawal by Subject|1|||
125573801|NCT02109484|451727886|FG005|Overall Study|Withdrawal by Subject|1|||
125573802|NCT02109484|451727887|FG006|Overall Study|Withdrawal by Subject|1|||
125573803|NCT02109484|451727888|FG007|Overall Study|Withdrawal by Subject|0|||
125573804|NCT02109484|451727881|FG000|Overall Study|Physician Decision|0|||
125573805|NCT02109484|451727882|FG001|Overall Study|Physician Decision|0|||
125573806|NCT02109484|451727883|FG002|Overall Study|Physician Decision|0|||
125573807|NCT02109484|451727884|FG003|Overall Study|Physician Decision|0|||
125573808|NCT02109484|451727885|FG004|Overall Study|Physician Decision|2|||
125573809|NCT02109484|451727886|FG005|Overall Study|Physician Decision|0|||
125573810|NCT02109484|451727887|FG006|Overall Study|Physician Decision|0|||
125573811|NCT02109484|451727888|FG007|Overall Study|Physician Decision|0|||
125573812|NCT02109484|451727881|FG000|Overall Study|Death|0|||
125427006|NCT00552084|451188086|FG000|Overall Study|Protocol Violation|1|||
125427007|NCT00552084|451188087|FG001|Overall Study|Protocol Violation|0|||
125427008|NCT00552084|451188086|FG000|Overall Study|change in anti-arrythmic drug|1|||
125427009|NCT00552084|451188087|FG001|Overall Study|change in anti-arrythmic drug|1|||
125427010|NCT01338025|451188088|FG000|Overall Study|Unexpected closure of study|10|||
125427011|NCT01338025|451188089|FG001|Overall Study|Unexpected closure of study|9|||
125427012|NCT01338025|451188088|FG000|Overall Study|Withdrawal by Subject|0|||
125427013|NCT01338025|451188089|FG001|Overall Study|Withdrawal by Subject|2|||
125573813|NCT02109484|451727882|FG001|Overall Study|Death|0|||
125573814|NCT02109484|451727883|FG002|Overall Study|Death|0|||
125573815|NCT02109484|451727884|FG003|Overall Study|Death|0|||
125573816|NCT02109484|451727885|FG004|Overall Study|Death|0|||
125573817|NCT02109484|451727886|FG005|Overall Study|Death|0|||
125573818|NCT02109484|451727887|FG006|Overall Study|Death|0|||
125573819|NCT02109484|451727888|FG007|Overall Study|Death|2|||
125573820|NCT02109484|451727881|FG000|Overall Study|Moved away from study area|0|||
125573821|NCT02109484|451727882|FG001|Overall Study|Moved away from study area|0|||
125573822|NCT02109484|451727883|FG002|Overall Study|Moved away from study area|0|||
125573823|NCT02109484|451727884|FG003|Overall Study|Moved away from study area|0|||
125573824|NCT02109484|451727885|FG004|Overall Study|Moved away from study area|0|||
125573825|NCT02109484|451727886|FG005|Overall Study|Moved away from study area|0|||
125427014|NCT01338025|451188088|FG000|Overall Study|Found ineligible after starting|1|||
125427015|NCT01338025|451188089|FG001|Overall Study|Found ineligible after starting|0|||
125573826|NCT02109484|451727887|FG006|Overall Study|Moved away from study area|1|||
125573827|NCT02109484|451727888|FG007|Overall Study|Moved away from study area|1|||
125573828|NCT03713944|451727893|FG000|Study Treatment|Patient non-compliance|1|||
125573829|NCT03713944|451727893|FG000|Study Treatment|Alternative Cancer Therapy|3|||
125573830|NCT03713944|451727893|FG000|Study Treatment|Disease Progression|18|||
125573831|NCT03713944|451727893|FG000|Study Treatment|AE/Side Effects/Complications|2|||
125427016|NCT04120233|451188090|FG000|Overall Study|Adverse Event|0|||
125427017|NCT04120233|451188091|FG001|Overall Study|Adverse Event|0|||
125427018|NCT04120233|451188092|FG002|Overall Study|Adverse Event|0|||
125573832|NCT03713944|451727893|FG000|Study Treatment|Death|2|||
125427019|NCT04120233|451188093|FG003|Overall Study|Adverse Event|0|||
125427020|NCT04120233|451188094|FG004|Overall Study|Adverse Event|1|||
125427021|NCT04120233|451188095|FG005|Overall Study|Adverse Event|0|||
125427022|NCT03779906|451188096|FG000|Overall Study|Lost to Follow-up|7|||
125573833|NCT03713944|451727893|FG000|Study Treatment|Withdrawal by Subject|1|||
125573834|NCT03713944|451727893|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
125573835|NCT03713944|451727893|FG000|Study Treatment|Symptomatic Deterioration|2|||
125573836|NCT03713944|451727893|FG000|Follow up|Withdrawal by Subject|2|||
125573837|NCT03713944|451727893|FG000|Follow up|Death|11|||
125573838|NCT03713944|451727893|FG000|Follow up|Study Terminated|3|||
125573839|NCT02111993|451727894|FG000|Overall Study|Physician Decision|5|||
125573840|NCT02111993|451727895|FG001|Overall Study|Physician Decision|4|||
125573841|NCT00419380|451727896|FG000|Overall Study|Lack of Efficacy|1|||
125427023|NCT03779906|451188096|FG000|Overall Study|COVID pandemic|1|||
125427024|NCT01194570|451189250|FG000|Overall Study|Adverse Event|22|||
125427025|NCT01194570|451189251|FG001|Overall Study|Adverse Event|40|||
125427026|NCT01194570|451189250|FG000|Overall Study|Death|6|||
125427027|NCT01194570|451189251|FG001|Overall Study|Death|20|||
125427028|NCT01194570|451189250|FG000|Overall Study|Lack of Efficacy|32|||
125427029|NCT01194570|451189251|FG001|Overall Study|Lack of Efficacy|33|||
125427030|NCT01194570|451189250|FG000|Overall Study|Lost to Follow-up|4|||
125427031|NCT01194570|451189251|FG001|Overall Study|Lost to Follow-up|15|||
125427032|NCT01194570|451189250|FG000|Overall Study|Non-Compliance|2|||
125427033|NCT01194570|451189251|FG001|Overall Study|Non-Compliance|2|||
125427034|NCT01194570|451189250|FG000|Overall Study|Non-Compliance With Study Drug|2|||
125427035|NCT01194570|451189251|FG001|Overall Study|Non-Compliance With Study Drug|2|||
125427036|NCT01194570|451189250|FG000|Overall Study|Other|18|||
125427037|NCT01194570|451189251|FG001|Overall Study|Other|47|||
125427038|NCT01194570|451189250|FG000|Overall Study|Physician Decision|10|||
125573842|NCT00419380|451727897|FG001|Overall Study|Lack of Efficacy|7|||
125427039|NCT01194570|451189251|FG001|Overall Study|Physician Decision|25|||
125427040|NCT01194570|451189250|FG000|Overall Study|Protocol Violation|1|||
125427041|NCT01194570|451189251|FG001|Overall Study|Protocol Violation|2|||
125427042|NCT01194570|451189250|FG000|Overall Study|Study Terminated By Sponsor|0|||
125427043|NCT01194570|451189251|FG001|Overall Study|Study Terminated By Sponsor|1|||
125427044|NCT01194570|451189250|FG000|Overall Study|Withdrawal by Subject|57|||
125427045|NCT01194570|451189251|FG001|Overall Study|Withdrawal by Subject|82|||
125427046|NCT01194570|451189250|FG000|Overall Study|Pregnancy|1|||
125427047|NCT01194570|451189251|FG001|Overall Study|Pregnancy|1|||
125573843|NCT00419380|451727896|FG000|Overall Study|Physician Decision|0|||
125573844|NCT00419380|451727897|FG001|Overall Study|Physician Decision|1|||
125573845|NCT00419380|451727896|FG000|Overall Study|Lost to Follow-up|0|||
125573846|NCT00419380|451727897|FG001|Overall Study|Lost to Follow-up|1|||
125573847|NCT00419380|451727896|FG000|Overall Study|Withdrawal by Subject|0|||
125573848|NCT00419380|451727897|FG001|Overall Study|Withdrawal by Subject|1|||
125573849|NCT02703311|451727918|FG000|Overall Study|Death|5|||
125573850|NCT02703311|451727918|FG000|Overall Study|Withdrawal by Subject|3|||
125573851|NCT02069899|451727919|FG000|Overall Study|Adverse Event|6|||
125573852|NCT02069899|451727920|FG001|Overall Study|Adverse Event|0|||
125573853|NCT02069899|451727921|FG002|Overall Study|Adverse Event|1|||
125358489|NCT02939079|450948245|FG000|Overall Study|relapse during the study|1|||
125573854|NCT02069899|451727919|FG000|Overall Study|Withdrawal by Participant|2|||
125358490|NCT02939079|450948246|FG001|Overall Study|relapse during the study|1|||
125573855|NCT02069899|451727920|FG001|Overall Study|Withdrawal by Participant|0|||
125573856|NCT02069899|451727921|FG002|Overall Study|Withdrawal by Participant|0|||
125573857|NCT02069899|451727919|FG000|Overall Study|Lost to Follow-up|1|||
125573858|NCT02069899|451727920|FG001|Overall Study|Lost to Follow-up|0|||
125573859|NCT02069899|451727921|FG002|Overall Study|Lost to Follow-up|1|||
125573860|NCT02069899|451727919|FG000|Overall Study|Other|4|||
125573861|NCT02069899|451727920|FG001|Overall Study|Other|0|||
125573862|NCT02069899|451727921|FG002|Overall Study|Other|0|||
125573863|NCT02069899|451727919|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
125573864|NCT02069899|451727920|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
125573865|NCT02069899|451727921|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
125573866|NCT02069899|451727919|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
125573867|NCT02069899|451727920|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
125573868|NCT02069899|451727921|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
125573869|NCT01026831|451727924|FG000|Overall Study|Adverse Event|4|||
125573870|NCT01026831|451727925|FG001|Overall Study|Adverse Event|3|||
125573871|NCT01026831|451727924|FG000|Overall Study|Lost to Follow-up|2|||
125573872|NCT01026831|451727925|FG001|Overall Study|Lost to Follow-up|0|||
125573873|NCT01026831|451727924|FG000|Overall Study|Physician Decision|1|||
125573874|NCT01026831|451727925|FG001|Overall Study|Physician Decision|1|||
125573875|NCT01026831|451727924|FG000|Overall Study|Protocol Violation|0|||
125573876|NCT01026831|451727925|FG001|Overall Study|Protocol Violation|2|||
125573877|NCT01026831|451727924|FG000|Overall Study|Withdrawal by Subject|7|||
125573878|NCT01026831|451727925|FG001|Overall Study|Withdrawal by Subject|5|||
125573879|NCT04417894|451727926|FG000|Overall Study|Lost to Follow-up|3|||
125573880|NCT04417894|451727927|FG001|Overall Study|Lost to Follow-up|0|||
125573881|NCT04417894|451727926|FG000|Overall Study|Withdrawal by Subject|7|||
125573882|NCT04417894|451727927|FG001|Overall Study|Withdrawal by Subject|6|||
125573883|NCT04417894|451727926|FG000|Overall Study|Lack of Efficacy|3|||
125573884|NCT04417894|451727927|FG001|Overall Study|Lack of Efficacy|1|||
125573885|NCT00262873|451727928|FG000|Overall Study|Adverse Event|3|||
125573886|NCT00262873|451727928|FG000|Overall Study|Withdrawal by Subject|5|||
125573887|NCT03440814|451727929|FG000|Overall Study|Adverse Event|2|||
125573888|NCT03440814|451727930|FG001|Overall Study|Adverse Event|1|||
125573889|NCT03440814|451727929|FG000|Overall Study|Lost to Follow-up|2|||
125573890|NCT03440814|451727930|FG001|Overall Study|Lost to Follow-up|0|||
125573891|NCT03440814|451727929|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
125573892|NCT03440814|451727930|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
125573893|NCT02678390|451727931|FG000|AE (1 Day)|Withdrawal by Subject|0|||
125573894|NCT02678390|451727932|FG001|AE (1 Day)|Withdrawal by Subject|1|||
125573895|NCT00498173|451727933|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
125573896|NCT00498173|451727934|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
125573897|NCT00498173|451727935|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
125573898|NCT01110200|451727936|FG000|Overall Study|Adverse Event|28|||
125573899|NCT01110200|451727937|FG001|Overall Study|Adverse Event|28|||
125573900|NCT01110200|451727936|FG000|Overall Study|Withdrawal by Subject|25|||
125573901|NCT01110200|451727937|FG001|Overall Study|Withdrawal by Subject|32|||
125573902|NCT01110200|451727936|FG000|Overall Study|Lack of Efficacy|16|||
125573903|NCT01110200|451727937|FG001|Overall Study|Lack of Efficacy|25|||
125573904|NCT01110200|451727936|FG000|Overall Study|Protocol Violation|14|||
125573905|NCT01110200|451727937|FG001|Overall Study|Protocol Violation|12|||
125573906|NCT01110200|451727936|FG000|Overall Study|Physician Decision|13|||
125573907|NCT01110200|451727937|FG001|Overall Study|Physician Decision|17|||
125573908|NCT01110200|451727936|FG000|Overall Study|Lost to Follow-up|10|||
125573909|NCT01110200|451727937|FG001|Overall Study|Lost to Follow-up|7|||
125573910|NCT01632566|451727938|FG000|Overall Study|Withdrawal by Subject|0|||
125573911|NCT01632566|451727939|FG001|Overall Study|Withdrawal by Subject|1|||
125573912|NCT01632566|451727940|FG002|Overall Study|Withdrawal by Subject|0|||
125573913|NCT01632566|451727941|FG003|Overall Study|Withdrawal by Subject|0|||
125573914|NCT01632566|451727942|FG004|Overall Study|Withdrawal by Subject|0|||
125573915|NCT01632566|451727938|FG000|Overall Study|Sponsor Decision|0|||
125573916|NCT01632566|451727939|FG001|Overall Study|Sponsor Decision|2|||
125573917|NCT01632566|451727940|FG002|Overall Study|Sponsor Decision|9|||
125573918|NCT01632566|451727941|FG003|Overall Study|Sponsor Decision|2|||
125573919|NCT01632566|451727942|FG004|Overall Study|Sponsor Decision|2|||
125573920|NCT01318109|451727943|FG000|Overall Study|Adverse Event|0|||
125573921|NCT01318109|451727944|FG001|Overall Study|Adverse Event|2|||
125573922|NCT01318109|451727945|FG002|Overall Study|Adverse Event|0|||
125573923|NCT01318109|451727943|FG000|Overall Study|Withdrawal by Subject|1|||
125573924|NCT01318109|451727944|FG001|Overall Study|Withdrawal by Subject|0|||
125573925|NCT01318109|451727945|FG002|Overall Study|Withdrawal by Subject|0|||
125573926|NCT01318109|451727943|FG000|Overall Study|Schedule Conflict|0|||
125573927|NCT01318109|451727944|FG001|Overall Study|Schedule Conflict|1|||
125573928|NCT01318109|451727945|FG002|Overall Study|Schedule Conflict|0|||
125573929|NCT00264238|451727948|FG000|Overall Study|Protocol Violation|1|||
125573930|NCT01411085|451727949|FG000|Overall Study|Physician Decision|1|||
125573931|NCT01411085|451727949|FG000|Overall Study|Protocol Violation|1|||
125573932|NCT01411085|451727949|FG000|Overall Study|Adverse Event|1|||
125573933|NCT02193074|451727950|FG000|Overall Study|Withdrawal by Subject|1|||
125573934|NCT02193074|451727951|FG001|Overall Study|Withdrawal by Subject|2|||
125573935|NCT02193074|451727950|FG000|Overall Study|Adverse Event|16|||
125573936|NCT02193074|451727951|FG001|Overall Study|Adverse Event|13|||
125573937|NCT01534533|451727952|FG000|Overall Study|Lost to Follow-up|3|||
125573938|NCT01534533|451727953|FG001|Overall Study|Lost to Follow-up|0|||
125573939|NCT01534533|451727954|FG002|Overall Study|Lost to Follow-up|4|||
125573940|NCT01534533|451727955|FG003|Overall Study|Lost to Follow-up|3|||
125573941|NCT01534533|451727952|FG000|Overall Study|Withdrawal by Subject|5|||
125573942|NCT01534533|451727953|FG001|Overall Study|Withdrawal by Subject|3|||
125573943|NCT01534533|451727954|FG002|Overall Study|Withdrawal by Subject|4|||
125573944|NCT01534533|451727955|FG003|Overall Study|Withdrawal by Subject|1|||
125573945|NCT04311502|451729395|FG000|Overall Study|Death|1|||
125573946|NCT04311502|451729396|FG001|Overall Study|Death|1|||
125573947|NCT04311502|451729397|FG002|Overall Study|Death|1|||
125573948|NCT04311502|451729395|FG000|Overall Study|Lost to Follow-up|2|||
125573949|NCT04311502|451729396|FG001|Overall Study|Lost to Follow-up|3|||
125573950|NCT04311502|451729397|FG002|Overall Study|Lost to Follow-up|0|||
125573951|NCT04311502|451729395|FG000|Overall Study|Participant is in prison|1|||
125573952|NCT04311502|451729396|FG001|Overall Study|Participant is in prison|0|||
125573953|NCT04311502|451729397|FG002|Overall Study|Participant is in prison|0|||
125573954|NCT04311502|451729395|FG000|Overall Study|Participant moved out of country|1|||
125573955|NCT04311502|451729396|FG001|Overall Study|Participant moved out of country|0|||
125573956|NCT04311502|451729397|FG002|Overall Study|Participant moved out of country|0|||
125573957|NCT04311502|451729395|FG000|Overall Study|Withdrawal by Subject|2|||
125573958|NCT04311502|451729396|FG001|Overall Study|Withdrawal by Subject|0|||
125573959|NCT04311502|451729397|FG002|Overall Study|Withdrawal by Subject|0|||
125573960|NCT04311502|451729395|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
125573961|NCT04311502|451729396|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
125573962|NCT04311502|451729397|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
125573963|NCT03040999|451729398|FG000|Overall Study|Lost to Follow-up|2|||
125573964|NCT03040999|451729399|FG001|Overall Study|Lost to Follow-up|2|||
125573965|NCT03040999|451729398|FG000|Overall Study|Withdrawal by Subject|12|||
125573966|NCT03040999|451729399|FG001|Overall Study|Withdrawal by Subject|13|||
125573967|NCT03040999|451729398|FG000|Overall Study|Death|155|||
125573968|NCT03040999|451729399|FG001|Overall Study|Death|171|||
125573969|NCT03040999|451729398|FG000|Overall Study|Physician Decision|0|||
125573970|NCT03040999|451729399|FG001|Overall Study|Physician Decision|3|||
125573971|NCT03368170|451729400|FG000|Overall Study|Adverse Event|2|||
125573972|NCT03368170|451729401|FG001|Overall Study|Adverse Event|1|||
125573973|NCT02068547|451729402|FG000|Overall Study|Lost to Follow-up|3|||
125573974|NCT02068547|451729403|FG001|Overall Study|Lost to Follow-up|3|||
125573975|NCT02068547|451729402|FG000|Overall Study|Physician Decision|1|||
125573976|NCT02068547|451729403|FG001|Overall Study|Physician Decision|0|||
125573977|NCT00691483|451729408|FG000|Overall Study|Adverse Event|14|||
125573978|NCT00691483|451729409|FG001|Overall Study|Adverse Event|6|||
125573979|NCT00691483|451729408|FG000|Overall Study|Lost to Follow-up|17|||
125573980|NCT00691483|451729409|FG001|Overall Study|Lost to Follow-up|10|||
125573981|NCT00691483|451729408|FG000|Overall Study|Withdrawal by Subject|24|||
125573982|NCT00691483|451729409|FG001|Overall Study|Withdrawal by Subject|7|||
125573983|NCT00691483|451729408|FG000|Overall Study|Other known cause|6|||
125573984|NCT00691483|451729409|FG001|Overall Study|Other known cause|1|||
125573985|NCT00691483|451729408|FG000|Overall Study|Randomized by not treated|7|||
125573986|NCT00691483|451729409|FG001|Overall Study|Randomized by not treated|1|||
125573987|NCT01391000|451729411|FG000|Overall Study|Lost to Follow-up|2|||
125573988|NCT01391000|451729412|FG001|Overall Study|Lost to Follow-up|0|||
125573989|NCT00049673|451729413|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
125573990|NCT00049673|451729414|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
125573991|NCT00817531|451729415|FG000|Overall Study|Adverse Event|1|||
125573992|NCT00817531|451729415|FG000|Overall Study|Lack of Efficacy|1|||
125573993|NCT02475681|451729418|FG000|Overall Study|Death|16|||
125573994|NCT02475681|451729419|FG001|Overall Study|Death|6|||
125573995|NCT02475681|451729420|FG002|Overall Study|Death|9|||
125573996|NCT02475681|451729418|FG000|Overall Study|Physician Decision|0|||
125573997|NCT02475681|451729419|FG001|Overall Study|Physician Decision|3|||
125573998|NCT02475681|451729420|FG002|Overall Study|Physician Decision|1|||
125358491|NCT04093414|450948247|FG000|3 Month Follow up|Physician Decision|0|||
125358492|NCT04093414|450948248|FG001|3 Month Follow up|Physician Decision|1|||
125573999|NCT02475681|451729418|FG000|Overall Study|Withdrawal by Subject|12|||
125574000|NCT02475681|451729419|FG001|Overall Study|Withdrawal by Subject|6|||
125574001|NCT02475681|451729420|FG002|Overall Study|Withdrawal by Subject|9|||
125574002|NCT02475681|451729418|FG000|Overall Study|Lost to Follow-up|2|||
125574003|NCT02475681|451729419|FG001|Overall Study|Lost to Follow-up|1|||
125574004|NCT02475681|451729420|FG002|Overall Study|Lost to Follow-up|3|||
125574005|NCT02475681|451729418|FG000|Overall Study|Ongoing in Study|0|||
125574006|NCT02475681|451729419|FG001|Overall Study|Ongoing in Study|163|||
125574007|NCT02475681|451729420|FG002|Overall Study|Ongoing in Study|157|||
125574008|NCT02475681|451729418|FG000|Overall Study|Reasons other than above listed|2|||
125574009|NCT02475681|451729419|FG001|Overall Study|Reasons other than above listed|0|||
125574010|NCT02475681|451729420|FG002|Overall Study|Reasons other than above listed|0|||
125574011|NCT03325673|451729430|FG000|Overall Study|Adverse Event|4|||
125574012|NCT03325673|451729431|FG001|Overall Study|Adverse Event|0|||
125574013|NCT00590590|451729432|FG000|Overall Study|Lack of Efficacy|1|||
125574014|NCT00590590|451729433|FG001|Overall Study|Lack of Efficacy|2|||
125574015|NCT00590590|451729434|FG002|Overall Study|Lack of Efficacy|0|||
125574016|NCT00590590|451729432|FG000|Overall Study|Adverse Event|1|||
125574017|NCT00590590|451729433|FG001|Overall Study|Adverse Event|0|||
125574018|NCT00590590|451729434|FG002|Overall Study|Adverse Event|0|||
125574019|NCT00590590|451729432|FG000|Overall Study|Protocol Violation|0|||
125574020|NCT00590590|451729433|FG001|Overall Study|Protocol Violation|0|||
125574021|NCT00590590|451729434|FG002|Overall Study|Protocol Violation|2|||
125574022|NCT00590590|451729432|FG000|Overall Study|Lost to Follow-up|4|||
125574023|NCT00590590|451729433|FG001|Overall Study|Lost to Follow-up|1|||
125574024|NCT00590590|451729434|FG002|Overall Study|Lost to Follow-up|2|||
125574025|NCT00590590|451729432|FG000|Overall Study|Withdrawal by Subject|0|||
125574026|NCT00590590|451729433|FG001|Overall Study|Withdrawal by Subject|1|||
125574027|NCT00590590|451729434|FG002|Overall Study|Withdrawal by Subject|1|||
125574028|NCT00590590|451729432|FG000|Overall Study|Did not complete due to study closure|1|||
125574029|NCT00590590|451729433|FG001|Overall Study|Did not complete due to study closure|1|||
125574030|NCT00590590|451729434|FG002|Overall Study|Did not complete due to study closure|1|||
125574031|NCT00590590|451729432|FG000|Overall Study|Did not complete study|0|||
125574032|NCT00590590|451729433|FG001|Overall Study|Did not complete study|1|||
125574033|NCT00590590|451729434|FG002|Overall Study|Did not complete study|0|||
125574034|NCT00132132|451729437|FG000|Overall Study|Lost to Follow-up|7|||
125574035|NCT00132132|451729438|FG001|Overall Study|Lost to Follow-up|2|||
125574036|NCT00494091|451729439|FG000|Overall Study|Death|5|||
125574037|NCT00494091|451729440|FG001|Overall Study|Death|54|||
125574038|NCT00494091|451729439|FG000|Overall Study|Lost to Follow-up|0|||
125574039|NCT00494091|451729440|FG001|Overall Study|Lost to Follow-up|4|||
125574040|NCT00494091|451729439|FG000|Overall Study|Other|1|||
125574041|NCT00494091|451729440|FG001|Overall Study|Other|11|||
125574042|NCT00494091|451729439|FG000|Overall Study|Withdrawal by Subject|0|||
125574043|NCT00494091|451729440|FG001|Overall Study|Withdrawal by Subject|7|||
125574044|NCT00326898|451729443|FG000|Overall Study|Disease progression|52|||
125574045|NCT00326898|451729444|FG001|Overall Study|Disease progression|54|||
125574046|NCT00326898|451729445|FG002|Overall Study|Disease progression|102|||
125574047|NCT00326898|451729443|FG000|Overall Study|Adverse Event|124|||
125574048|NCT00326898|451729444|FG001|Overall Study|Adverse Event|128|||
125574049|NCT00326898|451729445|FG002|Overall Study|Adverse Event|33|||
125574050|NCT00326898|451729443|FG000|Overall Study|Death|2|||
125574051|NCT00326898|451729444|FG001|Overall Study|Death|0|||
125574052|NCT00326898|451729445|FG002|Overall Study|Death|0|||
125574053|NCT00326898|451729443|FG000|Overall Study|Withdrawal by Subject|134|||
125574054|NCT00326898|451729444|FG001|Overall Study|Withdrawal by Subject|128|||
125574055|NCT00326898|451729445|FG002|Overall Study|Withdrawal by Subject|32|||
125574056|NCT00326898|451729443|FG000|Overall Study|Alternative therapy|1|||
125574057|NCT00326898|451729444|FG001|Overall Study|Alternative therapy|0|||
125574058|NCT00326898|451729445|FG002|Overall Study|Alternative therapy|0|||
125574059|NCT00326898|451729443|FG000|Overall Study|Other complicating disease|5|||
125574060|NCT00326898|451729444|FG001|Overall Study|Other complicating disease|5|||
125574061|NCT00326898|451729445|FG002|Overall Study|Other complicating disease|4|||
125574062|NCT00326898|451729443|FG000|Overall Study|Other/Missing/Unknown|33|||
125574063|NCT00326898|451729444|FG001|Overall Study|Other/Missing/Unknown|28|||
125574064|NCT00326898|451729445|FG002|Overall Study|Other/Missing/Unknown|32|||
125574065|NCT03847987|451729446|FG000|Overall Study|Lost to Follow-up|1|||
125574066|NCT03847987|451729447|FG001|Overall Study|Lost to Follow-up|0|||
125574067|NCT03847987|451729446|FG000|Overall Study|Adverse Event|2|||
125574068|NCT03847987|451729447|FG001|Overall Study|Adverse Event|0|||
125574069|NCT02111564|451729448|FG000|Overall Study|Death|109|||
125574070|NCT02111564|451729449|FG001|Overall Study|Death|120|||
125574071|NCT02111564|451729448|FG000|Overall Study|Lost to Follow-up|2|||
125574072|NCT02111564|451729449|FG001|Overall Study|Lost to Follow-up|3|||
125358493|NCT04093414|450948247|FG000|6month Follow up|Physician Decision|1|||
125358494|NCT04093414|450948248|FG001|6month Follow up|Physician Decision|3|||
125358495|NCT04209348|450948249|FG000|Overall Study|Lost to Follow-up|1|||
125358496|NCT04209348|450948250|FG001|Overall Study|Lost to Follow-up|0|||
125358497|NCT05394350|450948252|FG000|Overall Study|Death|2|||
125574073|NCT02111564|451729448|FG000|Overall Study|Withdrawal by Subject|20|||
125574074|NCT02111564|451729449|FG001|Overall Study|Withdrawal by Subject|20|||
125574075|NCT00687362|451729450|FG000|Overall Study|Protocol Violation|2|||
125574076|NCT00687362|451729450|FG000|Overall Study|Withdrawal by Subject|1|||
125574077|NCT02354703|451729451|FG000|Overall Study|Withdrawal by Subject|1|||
125574078|NCT02354703|451729452|FG001|Overall Study|Withdrawal by Subject|1|||
125574079|NCT02354703|451729453|FG002|Overall Study|Withdrawal by Subject|1|||
125574080|NCT02354703|451729454|FG003|Overall Study|Withdrawal by Subject|1|||
125574081|NCT02354703|451729451|FG000|Overall Study|Lost to Follow-up|2|||
125574082|NCT02354703|451729452|FG001|Overall Study|Lost to Follow-up|7|||
125574083|NCT02354703|451729453|FG002|Overall Study|Lost to Follow-up|9|||
125574084|NCT02354703|451729454|FG003|Overall Study|Lost to Follow-up|2|||
125574085|NCT02354703|451729451|FG000|Overall Study|Adverse Event|0|||
125574086|NCT02354703|451729452|FG001|Overall Study|Adverse Event|0|||
125574087|NCT02354703|451729453|FG002|Overall Study|Adverse Event|1|||
125574088|NCT02354703|451729454|FG003|Overall Study|Adverse Event|0|||
125574089|NCT03468309|451729457|FG000|Overall Study|Lost to Follow-up|4|||
125574090|NCT03468309|451729457|FG000|Overall Study|Withdrawal by Subject|2|||
125574091|NCT01496885|451729469|FG000|Overall Study|Lost to Follow-up|13|||
125574092|NCT01496885|451729469|FG000|Overall Study|Withdrawal by Subject|7|||
125574093|NCT01496885|451729469|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
125574094|NCT01496885|451729469|FG000|Overall Study|Death|1|||
125574095|NCT02728830|451729476|FG000|Overall Study|Exclusionary Surgery|9|||
125574096|NCT02728830|451729476|FG000|Overall Study|Exclusionary Pathology|6|||
125574097|NCT02728830|451729476|FG000|Overall Study|Physician Decision|3|||
125574098|NCT02728830|451729476|FG000|Overall Study|Withdrawal by Subject|2|||
125358498|NCT05394350|450948253|FG001|Overall Study|Death|2|||
125574099|NCT02728830|451729476|FG000|Overall Study|Lost to Follow-up|1|||
125358499|NCT05394350|450948254|FG002|Overall Study|Death|4|||
125358500|NCT05394350|450948255|FG003|Overall Study|Death|0|||
125358501|NCT05394350|450948256|FG004|Overall Study|Death|1|||
125574100|NCT02728830|451729476|FG000|Overall Study|Exclusionary Lab Values|1|||
125574101|NCT02728830|451729476|FG000|Overall Study|Contraindicated Illness|1|||
125574102|NCT02728830|451729476|FG000|Overall Study|Language Barrier|1|||
125574103|NCT00143455|451729477|FG000|Cohort 1|Adverse Event|8|||
125427048|NCT01337674|451189252|FG000|Treatment Period 1|Adverse Event|0|||
125427049|NCT01337674|451189253|FG001|Treatment Period 1|Adverse Event|1|||
125427050|NCT01337674|451189254|FG002|Treatment Period 1|Adverse Event|0|||
125427051|NCT01337674|451189255|FG003|Treatment Period 1|Adverse Event|0|||
125427052|NCT01337674|451189252|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
125427053|NCT01337674|451189253|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
125427054|NCT01337674|451189254|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
125427055|NCT01337674|451189255|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
125427056|NCT01337674|451189252|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125427057|NCT01337674|451189253|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125427058|NCT01337674|451189254|FG002|Treatment Period 2|Withdrawal by Subject|1|||
125427059|NCT01337674|451189255|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125427060|NCT00939484|451189259|FG000|Overall Study|Progression/Relapse|8|||
125427061|NCT00939484|451189260|FG001|Overall Study|Progression/Relapse|20|||
125427062|NCT00939484|451189261|FG002|Overall Study|Progression/Relapse|3|||
125427063|NCT01224925|451189262|FG000|Overall Study|Lost to Follow-up|3|||
125427064|NCT01224925|451189263|FG001|Overall Study|Lost to Follow-up|2|||
125427065|NCT02178059|451189264|FG000|Washout|Physician Decision|1|||
125427066|NCT02178059|451189265|FG001|Washout|Physician Decision|0|||
125427067|NCT05178121|451189266|FG000|Overall Study|Other|4|||
125427068|NCT05178121|451189266|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
125427069|NCT00245102|451189267|FG000|Overall Study|Not Treated|1|||
125427070|NCT00245102|451189268|FG001|Overall Study|Not Treated|0|||
125427071|NCT00245102|451189269|FG002|Overall Study|Not Treated|1|||
125427072|NCT00245102|451189270|FG003|Overall Study|Not Treated|0|||
125427073|NCT00245102|451189271|FG004|Overall Study|Not Treated|0|||
125427074|NCT00245102|451189272|FG005|Overall Study|Not Treated|0|||
125427075|NCT00245102|451189267|FG000|Overall Study|Protocol Violation|1|||
125427076|NCT00245102|451189268|FG001|Overall Study|Protocol Violation|0|||
125427077|NCT00245102|451189269|FG002|Overall Study|Protocol Violation|0|||
125427078|NCT00245102|451189270|FG003|Overall Study|Protocol Violation|0|||
125427079|NCT00245102|451189271|FG004|Overall Study|Protocol Violation|0|||
125427080|NCT00245102|451189272|FG005|Overall Study|Protocol Violation|0|||
125427081|NCT00245102|451189267|FG000|Overall Study|Death|0|||
125427082|NCT00245102|451189268|FG001|Overall Study|Death|0|||
125427083|NCT00245102|451189269|FG002|Overall Study|Death|0|||
125427084|NCT00245102|451189270|FG003|Overall Study|Death|1|||
125427085|NCT00245102|451189271|FG004|Overall Study|Death|0|||
125427086|NCT00245102|451189272|FG005|Overall Study|Death|0|||
125427087|NCT00245102|451189267|FG000|Overall Study|Adverse Event|4|||
125427088|NCT00245102|451189268|FG001|Overall Study|Adverse Event|2|||
125427089|NCT00245102|451189269|FG002|Overall Study|Adverse Event|5|||
125427090|NCT00245102|451189270|FG003|Overall Study|Adverse Event|1|||
125427091|NCT00245102|451189271|FG004|Overall Study|Adverse Event|0|||
125427092|NCT00245102|451189272|FG005|Overall Study|Adverse Event|2|||
125427093|NCT00245102|451189267|FG000|Overall Study|Decline in performance|0|||
125427094|NCT00245102|451189268|FG001|Overall Study|Decline in performance|2|||
125427095|NCT00245102|451189269|FG002|Overall Study|Decline in performance|0|||
125427096|NCT00245102|451189270|FG003|Overall Study|Decline in performance|1|||
125427097|NCT00245102|451189271|FG004|Overall Study|Decline in performance|0|||
125427098|NCT00245102|451189272|FG005|Overall Study|Decline in performance|2|||
125574104|NCT00143455|451729478|FG001|Cohort 1|Adverse Event|4|||
125574105|NCT00143455|451729479|FG002|Cohort 1|Adverse Event|0|||
125574106|NCT00143455|451729480|FG003|Cohort 1|Adverse Event|0|||
125574107|NCT00143455|451729477|FG000|Cohort 1|Death|5|||
125574108|NCT00143455|451729478|FG001|Cohort 1|Death|2|||
125574109|NCT00143455|451729479|FG002|Cohort 1|Death|0|||
125217429|NCT01348100|450423523|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125427099|NCT00245102|451189267|FG000|Overall Study|Participant needed surgery|0|||
125427100|NCT00245102|451189268|FG001|Overall Study|Participant needed surgery|0|||
125427101|NCT00245102|451189269|FG002|Overall Study|Participant needed surgery|1|||
125427102|NCT00245102|451189270|FG003|Overall Study|Participant needed surgery|0|||
125427103|NCT00245102|451189271|FG004|Overall Study|Participant needed surgery|0|||
125427104|NCT00245102|451189272|FG005|Overall Study|Participant needed surgery|0|||
125427105|NCT00245102|451189267|FG000|Overall Study|Clinical progression|1|||
125427106|NCT00245102|451189268|FG001|Overall Study|Clinical progression|0|||
125427107|NCT00245102|451189269|FG002|Overall Study|Clinical progression|0|||
125427108|NCT00245102|451189270|FG003|Overall Study|Clinical progression|0|||
125574110|NCT00143455|451729480|FG003|Cohort 1|Death|0|||
125427109|NCT00245102|451189271|FG004|Overall Study|Clinical progression|0|||
125427110|NCT00245102|451189272|FG005|Overall Study|Clinical progression|0|||
125574111|NCT00143455|451729477|FG000|Cohort 1|Progressive Disease|0|||
125427111|NCT02035332|451189275|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
125427112|NCT00838682|451189276|FG000|Overall Study|Lost to Follow-up|21|||
125427113|NCT00838682|451189277|FG001|Overall Study|Lost to Follow-up|14|||
125427114|NCT00838682|451189276|FG000|Overall Study|detection of exclusion criteria|4|||
125574112|NCT00143455|451729478|FG001|Cohort 1|Progressive Disease|6|||
125574113|NCT00143455|451729479|FG002|Cohort 1|Progressive Disease|0|||
125574114|NCT00143455|451729480|FG003|Cohort 1|Progressive Disease|0|||
125574115|NCT00143455|451729477|FG000|Cohort 1|Withdrawal by Subject|1|||
125574116|NCT00143455|451729478|FG001|Cohort 1|Withdrawal by Subject|4|||
125574117|NCT00143455|451729479|FG002|Cohort 1|Withdrawal by Subject|0|||
125574118|NCT00143455|451729480|FG003|Cohort 1|Withdrawal by Subject|0|||
125574119|NCT00143455|451729477|FG000|Cohort 1|Randomized But Not Treated|0|||
125574120|NCT00143455|451729478|FG001|Cohort 1|Randomized But Not Treated|1|||
125574121|NCT00143455|451729479|FG002|Cohort 1|Randomized But Not Treated|0|||
125574122|NCT00143455|451729480|FG003|Cohort 1|Randomized But Not Treated|0|||
125574123|NCT00143455|451729477|FG000|Cohort 2|Adverse Event|0|||
125574124|NCT00143455|451729478|FG001|Cohort 2|Adverse Event|0|||
125574125|NCT00143455|451729479|FG002|Cohort 2|Adverse Event|42|||
125574126|NCT00143455|451729480|FG003|Cohort 2|Adverse Event|30|||
125574127|NCT00143455|451729477|FG000|Cohort 2|No Longer Required Study Treatment|0|||
125574128|NCT00143455|451729478|FG001|Cohort 2|No Longer Required Study Treatment|0|||
125574129|NCT00143455|451729479|FG002|Cohort 2|No Longer Required Study Treatment|1|||
125574130|NCT00143455|451729480|FG003|Cohort 2|No Longer Required Study Treatment|0|||
125574131|NCT00143455|451729477|FG000|Cohort 2|Protocol Violation|0|||
125574132|NCT00143455|451729478|FG001|Cohort 2|Protocol Violation|0|||
125574133|NCT00143455|451729479|FG002|Cohort 2|Protocol Violation|1|||
125574134|NCT00143455|451729480|FG003|Cohort 2|Protocol Violation|1|||
125574135|NCT00143455|451729477|FG000|Cohort 2|Lost to Follow-up|0|||
125574136|NCT00143455|451729478|FG001|Cohort 2|Lost to Follow-up|0|||
125574137|NCT00143455|451729479|FG002|Cohort 2|Lost to Follow-up|1|||
125574138|NCT00143455|451729480|FG003|Cohort 2|Lost to Follow-up|4|||
125574139|NCT00143455|451729477|FG000|Cohort 2|Death|0|||
125574140|NCT00143455|451729478|FG001|Cohort 2|Death|0|||
125574141|NCT00143455|451729479|FG002|Cohort 2|Death|20|||
125574142|NCT00143455|451729480|FG003|Cohort 2|Death|12|||
125574143|NCT00143455|451729477|FG000|Cohort 2|Progressive Disease|0|||
125574144|NCT00143455|451729478|FG001|Cohort 2|Progressive Disease|0|||
125574145|NCT00143455|451729479|FG002|Cohort 2|Progressive Disease|20|||
125574146|NCT00143455|451729480|FG003|Cohort 2|Progressive Disease|27|||
125574147|NCT00143455|451729477|FG000|Cohort 2|Withdrawal by Subject|0|||
125574148|NCT00143455|451729478|FG001|Cohort 2|Withdrawal by Subject|0|||
125574149|NCT00143455|451729479|FG002|Cohort 2|Withdrawal by Subject|13|||
125574150|NCT00143455|451729480|FG003|Cohort 2|Withdrawal by Subject|12|||
125574151|NCT00143455|451729477|FG000|Cohort 2|Other|0|||
125574152|NCT00143455|451729478|FG001|Cohort 2|Other|0|||
125574153|NCT00143455|451729479|FG002|Cohort 2|Other|7|||
125574154|NCT00143455|451729480|FG003|Cohort 2|Other|6|||
125574155|NCT00143455|451729477|FG000|Cohort 2|Randomized But Not Treated|0|||
125427115|NCT00838682|451189277|FG001|Overall Study|detection of exclusion criteria|3|||
125574156|NCT00143455|451729478|FG001|Cohort 2|Randomized But Not Treated|0|||
125574157|NCT00143455|451729479|FG002|Cohort 2|Randomized But Not Treated|1|||
125574158|NCT00143455|451729480|FG003|Cohort 2|Randomized But Not Treated|1|||
125574159|NCT01325428|451729481|FG000|Part A|Progressive disease according to RECIST|9|||
125574160|NCT01325428|451729481|FG000|Part A|Clinical signs, symptoms of progression|2|||
125574161|NCT01325428|451729481|FG000|Part A|Other adverse event|1|||
125574162|NCT01325428|451729481|FG000|Part A|Refused continue taking trial medication|2|||
125574163|NCT01325428|451729481|FG000|Part A|Other reason not defined above|2|||
125574164|NCT01325428|451729481|FG000|Part B|Refused continue taking trial medication|2|||
125574165|NCT01325428|451729481|FG000|Part B|Other reason not defined above|1|||
125574166|NCT03099707|451729484|FG000|Overall Study|Withdrawal by Subject|0|||
125574167|NCT03099707|451729485|FG001|Overall Study|Withdrawal by Subject|3|||
125574168|NCT03099707|451729484|FG000|Overall Study|Lost to Follow-up|0|||
125574169|NCT03099707|451729485|FG001|Overall Study|Lost to Follow-up|1|||
125574170|NCT00343889|451729496|FG000|Overall Study|Lost to Follow-up|2|||
125574171|NCT00343889|451729497|FG001|Overall Study|Lost to Follow-up|0|||
125574172|NCT00343889|451729496|FG000|Overall Study|Withdrawal by Subject|0|||
125574173|NCT00343889|451729497|FG001|Overall Study|Withdrawal by Subject|1|||
125427116|NCT00838682|451189276|FG000|Overall Study|Protocol Violation|0|||
125574174|NCT00343889|451729496|FG000|Overall Study|Protocol Violation|1|||
125574175|NCT00343889|451729497|FG001|Overall Study|Protocol Violation|0|||
125574176|NCT01294579|451729498|FG000|Overall Study|Disease progression|12|||
125427117|NCT00838682|451189277|FG001|Overall Study|Protocol Violation|1|||
125427118|NCT00838682|451189276|FG000|Overall Study|Withdrawal by Subject|0|||
125427119|NCT00838682|451189277|FG001|Overall Study|Withdrawal by Subject|1|||
125574177|NCT01294579|451729498|FG000|Overall Study|Adverse Event|11|||
125574178|NCT01294579|451729498|FG000|Overall Study|Study closed/terminated|3|||
125427120|NCT03315143|451189280|FG000|Overall Study|Death|240|||
125574179|NCT01294579|451729498|FG000|Overall Study|Lost to Follow-up|1|||
125574180|NCT01294579|451729498|FG000|Overall Study|Physician Decision|3|||
125574181|NCT01294579|451729498|FG000|Overall Study|Withdrawal by Subject|5|||
125574182|NCT00487539|451729499|FG000|Overall Study|Adverse Event|3|||
125574183|NCT00487539|451729500|FG001|Overall Study|Adverse Event|2|||
125574184|NCT00487539|451729501|FG002|Overall Study|Adverse Event|1|||
125574185|NCT00487539|451729502|FG003|Overall Study|Adverse Event|1|||
125574186|NCT00487539|451729499|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125574187|NCT00487539|451729500|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125574188|NCT00487539|451729501|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125574189|NCT00487539|451729502|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
125574190|NCT00487539|451729499|FG000|Overall Study|Other|3|||
125574191|NCT00487539|451729500|FG001|Overall Study|Other|1|||
125574192|NCT00487539|451729501|FG002|Overall Study|Other|2|||
125574193|NCT00487539|451729502|FG003|Overall Study|Other|2|||
125574194|NCT00879697|451729503|FG000|Overall Study|Physician Decision|2|||
125574195|NCT00879697|451729504|FG001|Overall Study|Physician Decision|2|||
125574196|NCT02751502|451729505|FG000|Overall Study|Lack of funding|4|||
125574197|NCT00088374|451729506|FG000|Overall Study|patient did not receive any 17AAG|1|||
125574198|NCT00088374|451729506|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
125574199|NCT03499028|451729507|FG000|Overall Study|Lost to Follow-up|12|||
125574200|NCT03499028|451729508|FG001|Overall Study|Lost to Follow-up|9|||
125574201|NCT03499028|451729507|FG000|Overall Study|Withdrawal by Subject|5|||
125574202|NCT03499028|451729508|FG001|Overall Study|Withdrawal by Subject|8|||
125574203|NCT03499028|451729507|FG000|Overall Study|Unplanned SNF discharge|5|||
125574204|NCT03499028|451729508|FG001|Overall Study|Unplanned SNF discharge|8|||
125574205|NCT01437397|451729509|FG000|Overall Study|Lost to Follow-up|9|||
125574206|NCT01437397|451729510|FG001|Overall Study|Lost to Follow-up|4|||
125574207|NCT01437397|451729511|FG002|Overall Study|Lost to Follow-up|2|||
125574208|NCT01437397|451729512|FG003|Overall Study|Lost to Follow-up|4|||
125574209|NCT01437397|451729513|FG004|Overall Study|Lost to Follow-up|5|||
125574210|NCT01437397|451729509|FG000|Overall Study|Withdrawal by Subject|11|||
125574211|NCT01437397|451729510|FG001|Overall Study|Withdrawal by Subject|12|||
125574212|NCT01437397|451729511|FG002|Overall Study|Withdrawal by Subject|24|||
125574213|NCT01437397|451729512|FG003|Overall Study|Withdrawal by Subject|11|||
125574214|NCT01437397|451729513|FG004|Overall Study|Withdrawal by Subject|22|||
125574215|NCT01437397|451729509|FG000|Overall Study|Protocol Violation|10|||
125574216|NCT01437397|451729510|FG001|Overall Study|Protocol Violation|12|||
125574217|NCT01437397|451729511|FG002|Overall Study|Protocol Violation|13|||
125574218|NCT01437397|451729512|FG003|Overall Study|Protocol Violation|21|||
125574219|NCT01437397|451729513|FG004|Overall Study|Protocol Violation|19|||
125574220|NCT01437397|451729509|FG000|Overall Study|Lack of Efficacy|5|||
125574221|NCT01437397|451729510|FG001|Overall Study|Lack of Efficacy|4|||
125574222|NCT01437397|451729511|FG002|Overall Study|Lack of Efficacy|8|||
125574223|NCT01437397|451729512|FG003|Overall Study|Lack of Efficacy|10|||
125574224|NCT01437397|451729513|FG004|Overall Study|Lack of Efficacy|20|||
125574225|NCT01437397|451729509|FG000|Overall Study|Adverse Event|21|||
125574226|NCT01437397|451729510|FG001|Overall Study|Adverse Event|22|||
125574227|NCT01437397|451729511|FG002|Overall Study|Adverse Event|16|||
125574228|NCT01437397|451729512|FG003|Overall Study|Adverse Event|14|||
125574229|NCT01437397|451729513|FG004|Overall Study|Adverse Event|21|||
125574230|NCT01437397|451729509|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
125574231|NCT01437397|451729510|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
125574232|NCT01437397|451729511|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
125574233|NCT01437397|451729512|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
125574234|NCT01437397|451729513|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
125574235|NCT00371865|451729514|FG000|Overall Study|Lack of Efficacy|0|||
125574236|NCT00371865|451729515|FG001|Overall Study|Lack of Efficacy|2|||
125574237|NCT00371865|451729514|FG000|Overall Study|Protocol Violation|3|||
125574238|NCT00371865|451729515|FG001|Overall Study|Protocol Violation|2|||
125574239|NCT00371865|451729514|FG000|Overall Study|Withdrawal by Subject|12|||
125574240|NCT00371865|451729515|FG001|Overall Study|Withdrawal by Subject|10|||
125574241|NCT01328951|451729517|FG000|Overall Study|Disease Progression|17|||
125574242|NCT01328951|451729518|FG001|Overall Study|Disease Progression|14|||
125574243|NCT01328951|451729517|FG000|Overall Study|Adverse Event|2|||
125574244|NCT01328951|451729518|FG001|Overall Study|Adverse Event|0|||
125574245|NCT01328951|451729517|FG000|Overall Study|Death|243|||
125574246|NCT01328951|451729518|FG001|Overall Study|Death|258|||
125427121|NCT03315143|451189281|FG001|Overall Study|Death|246|||
125427122|NCT03315143|451189280|FG000|Overall Study|Withdrawal by Subject|57|||
125427123|NCT03315143|451189281|FG001|Overall Study|Withdrawal by Subject|68|||
125427124|NCT03315143|451189280|FG000|Overall Study|Site Terminated by Sponsor|256|||
125427125|NCT03315143|451189281|FG001|Overall Study|Site Terminated by Sponsor|282|||
125427126|NCT03315143|451189280|FG000|Overall Study|Study Terminated by Sponsor|4723|||
125427127|NCT03315143|451189281|FG001|Overall Study|Study Terminated by Sponsor|4664|||
125574247|NCT01328951|451729517|FG000|Overall Study|Lost to Follow-up|6|||
125574248|NCT01328951|451729518|FG001|Overall Study|Lost to Follow-up|7|||
125574249|NCT01328951|451729517|FG000|Overall Study|Withdrawal by Subject|6|||
125574250|NCT01328951|451729518|FG001|Overall Study|Withdrawal by Subject|6|||
125574251|NCT01328951|451729517|FG000|Overall Study|Study Closed by the Sponsor|36|||
125574252|NCT01328951|451729518|FG001|Overall Study|Study Closed by the Sponsor|31|||
125574253|NCT01328951|451729517|FG000|Overall Study|Other|11|||
125574254|NCT01328951|451729518|FG001|Overall Study|Other|6|||
125574255|NCT04042103|451729519|FG000|Overall Study|Lost to Follow-up|1|||
125574256|NCT04042103|451729519|FG000|Overall Study|Withdrawal by Subject|1|||
125574257|NCT01003210|451729520|FG000|Overall Study|Lost to Follow-up|1|||
125574258|NCT01003210|451729521|FG001|Overall Study|Lost to Follow-up|3|||
125358502|NCT05394350|450948257|FG005|Overall Study|Death|0|||
125358503|NCT05394350|450948252|FG000|Overall Study|Study terminated by sponsor|1|||
125358504|NCT05394350|450948253|FG001|Overall Study|Study terminated by sponsor|1|||
125358505|NCT05394350|450948254|FG002|Overall Study|Study terminated by sponsor|7|||
125358506|NCT05394350|450948255|FG003|Overall Study|Study terminated by sponsor|3|||
125574259|NCT00271817|451729522|FG000|Part 1|Adverse Event|68|||
125574260|NCT00271817|451729523|FG001|Part 1|Adverse Event|25|||
125574261|NCT00271817|451729524|FG002|Part 1|Adverse Event|156|||
125574262|NCT00271817|451729522|FG000|Part 1|Lost to Follow-up|6|||
125574263|NCT00271817|451729523|FG001|Part 1|Lost to Follow-up|8|||
125574264|NCT00271817|451729524|FG002|Part 1|Lost to Follow-up|24|||
125574265|NCT00271817|451729522|FG000|Part 1|Protocol Violation|5|||
125574266|NCT00271817|451729523|FG001|Part 1|Protocol Violation|4|||
125574267|NCT00271817|451729524|FG002|Part 1|Protocol Violation|7|||
125574268|NCT00271817|451729522|FG000|Part 1|Patient Moved|3|||
125574269|NCT00271817|451729523|FG001|Part 1|Patient Moved|1|||
125574270|NCT00271817|451729524|FG002|Part 1|Patient Moved|5|||
125574271|NCT00271817|451729522|FG000|Part 1|Withdrawal by Subject|23|||
125574272|NCT00271817|451729523|FG001|Part 1|Withdrawal by Subject|17|||
125574273|NCT00271817|451729524|FG002|Part 1|Withdrawal by Subject|45|||
125574274|NCT00271817|451729522|FG000|Part 1|LDL < 50 mg/dL|1|||
125574275|NCT00271817|451729523|FG001|Part 1|LDL < 50 mg/dL|4|||
125574276|NCT00271817|451729524|FG002|Part 1|LDL < 50 mg/dL|48|||
125574277|NCT00271817|451729522|FG000|Part 2|Adverse Event|0|||
125574278|NCT00271817|451729523|FG001|Part 2|Adverse Event|17|||
125574279|NCT00271817|451729524|FG002|Part 2|Adverse Event|33|||
125574280|NCT00271817|451729522|FG000|Part 2|Lack of Efficacy|0|||
125574281|NCT00271817|451729523|FG001|Part 2|Lack of Efficacy|1|||
125574282|NCT00271817|451729524|FG002|Part 2|Lack of Efficacy|6|||
125574283|NCT00271817|451729522|FG000|Part 2|Lost to Follow-up|0|||
125574284|NCT00271817|451729523|FG001|Part 2|Lost to Follow-up|6|||
125574285|NCT00271817|451729524|FG002|Part 2|Lost to Follow-up|18|||
125574286|NCT00271817|451729522|FG000|Part 2|Protocol Violation|0|||
125574287|NCT00271817|451729523|FG001|Part 2|Protocol Violation|3|||
125574288|NCT00271817|451729524|FG002|Part 2|Protocol Violation|5|||
125574289|NCT00271817|451729522|FG000|Part 2|Patient Moved|0|||
125574290|NCT00271817|451729523|FG001|Part 2|Patient Moved|0|||
125574291|NCT00271817|451729524|FG002|Part 2|Patient Moved|5|||
125574292|NCT00271817|451729522|FG000|Part 2|Withdrawal by Subject|0|||
125574293|NCT00271817|451729523|FG001|Part 2|Withdrawal by Subject|2|||
125574294|NCT00271817|451729524|FG002|Part 2|Withdrawal by Subject|13|||
125574295|NCT00271817|451729522|FG000|Part 2|LDL < 50 mg/dL|0|||
125574296|NCT00271817|451729523|FG001|Part 2|LDL < 50 mg/dL|3|||
125574297|NCT00271817|451729524|FG002|Part 2|LDL < 50 mg/dL|4|||
125574298|NCT00700271|451729525|FG000|Overall Study|Adverse Event|4|||
125574299|NCT00700271|451729526|FG001|Overall Study|Adverse Event|6|||
125574300|NCT00700271|451729525|FG000|Overall Study|Protocol Violation|1|||
125574301|NCT00700271|451729526|FG001|Overall Study|Protocol Violation|0|||
125574302|NCT00700271|451729525|FG000|Overall Study|Administrative Reasons|1|||
125574303|NCT00700271|451729526|FG001|Overall Study|Administrative Reasons|0|||
125358507|NCT05394350|450948256|FG004|Overall Study|Study terminated by sponsor|2|||
125358508|NCT05394350|450948257|FG005|Overall Study|Study terminated by sponsor|4|||
125358509|NCT01336569|450948260|FG000|Overall Study|Lost to Follow-up|4|||
125358510|NCT02963935|450948261|FG000|Overall Study|Adverse Event|12|||
125358511|NCT02963935|450948262|FG001|Overall Study|Adverse Event|6|||
125358512|NCT02963935|450948261|FG000|Overall Study|Protocol Violation|2|||
125358513|NCT02963935|450948262|FG001|Overall Study|Protocol Violation|1|||
125358514|NCT02963935|450948261|FG000|Overall Study|Lack of Efficacy|0|||
125358515|NCT02963935|450948262|FG001|Overall Study|Lack of Efficacy|2|||
125358516|NCT02963935|450948261|FG000|Overall Study|Lost to Follow-up|1|||
125358517|NCT02963935|450948262|FG001|Overall Study|Lost to Follow-up|6|||
125358518|NCT02963935|450948261|FG000|Overall Study|Unclassified|13|||
125358519|NCT02963935|450948262|FG001|Overall Study|Unclassified|22|||
125358520|NCT02770170|450948269|FG000|Overall Study|Withdrawal by Subject|0|||
125358521|NCT02770170|450948270|FG001|Overall Study|Withdrawal by Subject|0|||
125358522|NCT02770170|450948271|FG002|Overall Study|Withdrawal by Subject|0|||
125358523|NCT02770170|450948272|FG003|Overall Study|Withdrawal by Subject|2|||
125358524|NCT02770170|450948269|FG000|Overall Study|due to pregnancy|1|||
125574304|NCT00700271|451729525|FG000|Overall Study|Withdrawal by Subject|6|||
125574305|NCT00700271|451729526|FG001|Overall Study|Withdrawal by Subject|4|||
125574306|NCT00700271|451729525|FG000|Overall Study|Lost to Follow-up|2|||
125574307|NCT00700271|451729526|FG001|Overall Study|Lost to Follow-up|2|||
125358525|NCT02770170|450948270|FG001|Overall Study|due to pregnancy|0|||
125574308|NCT00861744|451729527|FG000|Overall Study|Adverse Event|0|||
125574309|NCT00861744|451729528|FG001|Overall Study|Adverse Event|0|||
125358526|NCT02770170|450948271|FG002|Overall Study|due to pregnancy|0|||
125358527|NCT02770170|450948272|FG003|Overall Study|due to pregnancy|0|||
125574310|NCT00861744|451729529|FG002|Overall Study|Adverse Event|0|||
125574311|NCT00861744|451729530|FG003|Overall Study|Adverse Event|1|||
125574312|NCT00861744|451729527|FG000|Overall Study|Lost to Follow-up|7|||
125574313|NCT00861744|451729528|FG001|Overall Study|Lost to Follow-up|19|||
125427128|NCT03315143|451189280|FG000|Overall Study|Reason not Specified|16|||
125427129|NCT03315143|451189281|FG001|Overall Study|Reason not Specified|32|||
125427130|NCT00549757|451189282|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
125427131|NCT00549757|451189283|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
125427132|NCT00549757|451189282|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
125427133|NCT00549757|451189283|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
125427134|NCT00549757|451189282|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
125427135|NCT00549757|451189283|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
125427136|NCT00549757|451189282|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
125427137|NCT00549757|451189283|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
125427138|NCT00549757|451189282|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
125427139|NCT00549757|451189283|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
125427140|NCT00549757|451189282|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
125427141|NCT00549757|451189283|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
125427142|NCT00549757|451189282|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
125427143|NCT00549757|451189283|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
125427144|NCT00549757|451189282|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
125427145|NCT00549757|451189283|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
125427146|NCT00549757|451189282|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
125427147|NCT00549757|451189283|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
125427148|NCT00549757|451189282|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
125427149|NCT00549757|451189283|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
125358528|NCT02770170|450948269|FG000|Overall Study|Lack of Efficacy|2|||
125358529|NCT02770170|450948270|FG001|Overall Study|Lack of Efficacy|0|||
125358530|NCT02770170|450948271|FG002|Overall Study|Lack of Efficacy|0|||
125358531|NCT02770170|450948272|FG003|Overall Study|Lack of Efficacy|1|||
125358532|NCT02770170|450948269|FG000|Overall Study|Adverse Event|4|||
125358533|NCT02770170|450948270|FG001|Overall Study|Adverse Event|3|||
125358534|NCT02770170|450948271|FG002|Overall Study|Adverse Event|5|||
125358535|NCT02770170|450948272|FG003|Overall Study|Adverse Event|3|||
125358536|NCT02770170|450948269|FG000|Overall Study|due to disease worsening|0|||
125358537|NCT02770170|450948270|FG001|Overall Study|due to disease worsening|0|||
125358538|NCT02770170|450948271|FG002|Overall Study|due to disease worsening|0|||
125427150|NCT00549757|451189282|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
125427151|NCT00549757|451189283|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
125427152|NCT00549757|451189282|FG000|Extension Period (in Average 9 Months)|Death|143|||
125427153|NCT00549757|451189283|FG001|Extension Period (in Average 9 Months)|Death|136|||
125427154|NCT00549757|451189282|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
125427155|NCT00549757|451189283|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
125427156|NCT00549757|451189282|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
125427157|NCT00549757|451189283|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
125427158|NCT00549757|451189282|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
125427159|NCT00549757|451189283|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
125427160|NCT02641392|451189284|FG000|Overall Study|Lost to Follow-up|0|||
125427161|NCT02641392|451189285|FG001|Overall Study|Lost to Follow-up|0|||
125427162|NCT02641392|451189286|FG002|Overall Study|Lost to Follow-up|2|||
125427163|NCT02641392|451189284|FG000|Overall Study|Withdrawal by Subject|0|||
125427164|NCT02641392|451189285|FG001|Overall Study|Withdrawal by Subject|0|||
125427165|NCT02641392|451189286|FG002|Overall Study|Withdrawal by Subject|17|||
125427166|NCT02641392|451189284|FG000|Overall Study|Adverse Event|0|||
125427167|NCT02641392|451189285|FG001|Overall Study|Adverse Event|1|||
125427168|NCT02641392|451189286|FG002|Overall Study|Adverse Event|25|||
125427169|NCT02641392|451189284|FG000|Overall Study|Study Terminated by Sponsor|4|||
125427170|NCT02641392|451189285|FG001|Overall Study|Study Terminated by Sponsor|12|||
125427171|NCT02641392|451189286|FG002|Overall Study|Study Terminated by Sponsor|144|||
125427172|NCT02641392|451189284|FG000|Overall Study|Lack of Efficacy|0|||
125427173|NCT02641392|451189285|FG001|Overall Study|Lack of Efficacy|0|||
125427174|NCT02641392|451189286|FG002|Overall Study|Lack of Efficacy|101|||
125427175|NCT02641392|451189284|FG000|Overall Study|Miscellaneous|0|||
125427176|NCT02641392|451189285|FG001|Overall Study|Miscellaneous|0|||
125211108|NCT04767529|450398578|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
125358539|NCT02770170|450948272|FG003|Overall Study|due to disease worsening|1|||
125358540|NCT00445978|450948273|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
125358541|NCT00445978|450948273|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
125427177|NCT02641392|451189286|FG002|Overall Study|Miscellaneous|3|||
125427178|NCT02641392|451189284|FG000|Overall Study|Death|0|||
125427179|NCT02641392|451189285|FG001|Overall Study|Death|0|||
125427180|NCT02641392|451189286|FG002|Overall Study|Death|1|||
125427181|NCT04067401|451189287|FG000|Overall Study|Withdrawal by Subject|7|||
125427182|NCT04067401|451189288|FG001|Overall Study|Withdrawal by Subject|0|||
125211109|NCT04767529|450398579|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
125358542|NCT00445978|450948273|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
125358543|NCT00445978|450948273|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
125358544|NCT00445978|450948273|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
125358545|NCT00445978|450948273|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
125358546|NCT00445978|450948273|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
125358547|NCT00445978|450948273|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
125358548|NCT00445978|450948273|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
125358549|NCT01822496|450948276|FG000|Overall Study|Protocol Violation|2|||
125358550|NCT01822496|450948277|FG001|Overall Study|Protocol Violation|2|||
125358551|NCT01822496|450948278|FG002|Overall Study|Protocol Violation|0|||
125358552|NCT01822496|450948279|FG003|Overall Study|Protocol Violation|1|||
125358553|NCT01822496|450948276|FG000|Overall Study|Withdrawal by Subject|0|||
125358554|NCT01822496|450948277|FG001|Overall Study|Withdrawal by Subject|0|||
125358555|NCT01822496|450948278|FG002|Overall Study|Withdrawal by Subject|0|||
125358556|NCT01822496|450948279|FG003|Overall Study|Withdrawal by Subject|3|||
125358557|NCT00304239|450948280|FG000|Overall Study|Protocol Deviations/Violations|15|||
125358558|NCT00304239|450948281|FG001|Overall Study|Protocol Deviations/Violations|0|||
125358559|NCT00304239|450948280|FG000|Overall Study|Adverse Event|2|||
125358560|NCT00304239|450948281|FG001|Overall Study|Adverse Event|0|||
125358561|NCT02979197|450948282|FG000|Overall Study|Adverse Event|4|||
125358562|NCT02979197|450948283|FG001|Overall Study|Adverse Event|2|||
125358563|NCT02979197|450948284|FG002|Overall Study|Adverse Event|0|||
125358564|NCT02979197|450948282|FG000|Overall Study|Protocol Violation|0|||
125358565|NCT02979197|450948283|FG001|Overall Study|Protocol Violation|1|||
125358566|NCT02979197|450948284|FG002|Overall Study|Protocol Violation|0|||
125358567|NCT02979197|450948282|FG000|Overall Study|Subject unable to commit to study dates|0|||
125358568|NCT02979197|450948283|FG001|Overall Study|Subject unable to commit to study dates|1|||
125358569|NCT02979197|450948284|FG002|Overall Study|Subject unable to commit to study dates|0|||
125358570|NCT03643159|450948285|FG000|Overall Study|Adverse Event|1|||
125358571|NCT03643159|450948285|FG000|Overall Study|Withdrawal by Subject|1|||
125358572|NCT01898208|450948288|FG000|Overall Study|Positive blood culture|17|||
125358573|NCT01898208|450948289|FG001|Overall Study|Positive blood culture|23|||
125358574|NCT01898208|450948290|FG002|Overall Study|Positive blood culture|15|||
125358575|NCT01898208|450948288|FG000|Overall Study|Death/comfort care within 24 hours|10|||
125358576|NCT01898208|450948289|FG001|Overall Study|Death/comfort care within 24 hours|9|||
125574314|NCT00861744|451729529|FG002|Overall Study|Lost to Follow-up|17|||
125574315|NCT00861744|451729530|FG003|Overall Study|Lost to Follow-up|12|||
125574316|NCT00861744|451729527|FG000|Overall Study|Withdrawal by Subject|10|||
125574317|NCT00861744|451729528|FG001|Overall Study|Withdrawal by Subject|6|||
125574318|NCT00861744|451729529|FG002|Overall Study|Withdrawal by Subject|6|||
125574319|NCT00861744|451729530|FG003|Overall Study|Withdrawal by Subject|19|||
125574320|NCT00861744|451729527|FG000|Overall Study|Protocol Violation|0|||
125574321|NCT00861744|451729528|FG001|Overall Study|Protocol Violation|1|||
125574322|NCT00861744|451729529|FG002|Overall Study|Protocol Violation|0|||
125574323|NCT00861744|451729530|FG003|Overall Study|Protocol Violation|0|||
125574324|NCT00861744|451729527|FG000|Overall Study|Migration from study area|0|||
125574325|NCT00861744|451729528|FG001|Overall Study|Migration from study area|3|||
125574326|NCT00861744|451729529|FG002|Overall Study|Migration from study area|1|||
125574327|NCT00861744|451729530|FG003|Overall Study|Migration from study area|0|||
125574328|NCT00861744|451729527|FG000|Overall Study|Blood draws|0|||
125574329|NCT00861744|451729528|FG001|Overall Study|Blood draws|0|||
125574330|NCT00861744|451729529|FG002|Overall Study|Blood draws|0|||
125574331|NCT00861744|451729530|FG003|Overall Study|Blood draws|1|||
125574332|NCT05107765|451729531|FG000|Overall Study|Lost to Follow-up|4|||
125574333|NCT05107765|451729532|FG001|Overall Study|Lost to Follow-up|1|||
125574334|NCT05107765|451729531|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
125574335|NCT05107765|451729532|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
125574336|NCT05107765|451729531|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
125574337|NCT05107765|451729532|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
125574338|NCT03124563|451729535|FG000|Overall Study|Lost to Follow-up|1|||
125574339|NCT03124563|451729536|FG001|Overall Study|Lost to Follow-up|1|||
125574340|NCT03124563|451729535|FG000|Overall Study|Withdrawal by Subject|1|||
125574341|NCT03124563|451729536|FG001|Overall Study|Withdrawal by Subject|1|||
125574342|NCT00452699|451730667|FG000|Overall Study|Adverse Event|10|||
125574343|NCT00452699|451730668|FG001|Overall Study|Adverse Event|3|||
125358577|NCT01898208|450948290|FG002|Overall Study|Death/comfort care within 24 hours|8|||
125358578|NCT01898208|450948288|FG000|Overall Study|Negative Gram Stain|6|||
125358579|NCT01898208|450948289|FG001|Overall Study|Negative Gram Stain|9|||
125358580|NCT01898208|450948290|FG002|Overall Study|Negative Gram Stain|6|||
125358581|NCT01898208|450948288|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
125574344|NCT00452699|451730667|FG000|Overall Study|Lack of Efficacy|6|||
125574345|NCT00452699|451730668|FG001|Overall Study|Lack of Efficacy|4|||
125574346|NCT00452699|451730667|FG000|Overall Study|Lost to Follow-up|6|||
125574347|NCT00452699|451730668|FG001|Overall Study|Lost to Follow-up|9|||
125574348|NCT00452699|451730667|FG000|Overall Study|Protocol Violation|21|||
125358582|NCT01898208|450948289|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
125358583|NCT01898208|450948290|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
125358584|NCT01898208|450948288|FG000|Overall Study|System/Technical Error|1|||
125358585|NCT01898208|450948289|FG001|Overall Study|System/Technical Error|2|||
125358586|NCT01898208|450948290|FG002|Overall Study|System/Technical Error|3|||
125358587|NCT01898208|450948288|FG000|Overall Study|Lost to Follow-up|3|||
125574349|NCT00452699|451730668|FG001|Overall Study|Protocol Violation|25|||
125574350|NCT00452699|451730667|FG000|Overall Study|Withdrawal by Subject|26|||
125574351|NCT00452699|451730668|FG001|Overall Study|Withdrawal by Subject|25|||
125574352|NCT00452699|451730667|FG000|Overall Study|Other|12|||
125574353|NCT00452699|451730668|FG001|Overall Study|Other|7|||
125574354|NCT03733392|451730674|FG000|Overall Study|Withdrawal by Subject|11|||
125574355|NCT03733392|451730675|FG001|Overall Study|Withdrawal by Subject|1|||
125574356|NCT03733392|451730674|FG000|Overall Study|Death|1|||
125574357|NCT03733392|451730675|FG001|Overall Study|Death|0|||
125574358|NCT03733392|451730674|FG000|Overall Study|Lost to Follow-up|5|||
125574359|NCT03733392|451730675|FG001|Overall Study|Lost to Follow-up|0|||
125574360|NCT03733392|451730674|FG000|Overall Study|Protocol Violation|0|||
125574361|NCT03733392|451730675|FG001|Overall Study|Protocol Violation|1|||
125574362|NCT03733392|451730674|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
125574363|NCT03733392|451730675|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
125574364|NCT03733392|451730674|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
125574365|NCT03733392|451730675|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
125574366|NCT03733392|451730674|FG000|Overall Study|Patient Non-Compliance|2|||
125574367|NCT03733392|451730675|FG001|Overall Study|Patient Non-Compliance|1|||
125574368|NCT03733392|451730674|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
125574369|NCT03733392|451730675|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
125574370|NCT03733392|451730674|FG000|Overall Study|Withdrawal prior to procedure|5|||
125574371|NCT03733392|451730675|FG001|Overall Study|Withdrawal prior to procedure|2|||
125574372|NCT02615990|451730683|FG000|Overall Study|study terminated|1|||
125574373|NCT02615990|451730684|FG001|Overall Study|study terminated|1|||
125574374|NCT01363986|451730685|FG000|Overall Study|Disease progression|1|||
125574375|NCT01637142|451730686|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
125574376|NCT00925015|451730687|FG000|Overall Study|Adverse Event|1|||
125574377|NCT00925015|451730688|FG001|Overall Study|Adverse Event|2|||
125574378|NCT00925015|451730689|FG002|Overall Study|Adverse Event|1|||
125574379|NCT00925015|451730687|FG000|Overall Study|Physician Decision|0|||
125574380|NCT00925015|451730688|FG001|Overall Study|Physician Decision|1|||
125574381|NCT00925015|451730689|FG002|Overall Study|Physician Decision|0|||
125574382|NCT00925015|451730687|FG000|Overall Study|Progressive Disease|7|||
125574383|NCT00925015|451730688|FG001|Overall Study|Progressive Disease|3|||
125574384|NCT00925015|451730689|FG002|Overall Study|Progressive Disease|4|||
125574385|NCT00925015|451730687|FG000|Overall Study|Withdrawal by Subject|0|||
125574386|NCT00925015|451730688|FG001|Overall Study|Withdrawal by Subject|0|||
125574387|NCT00925015|451730689|FG002|Overall Study|Withdrawal by Subject|1|||
125574388|NCT01368835|451730690|FG000|Overall Study|Inclusion criteria/photography quality|22|||
125574389|NCT01368835|451730690|FG000|Overall Study|Lost to Follow-up|11|||
125574390|NCT02754726|451730691|FG000|Overall Study|Progressive Disease by RECIST|13|||
125574391|NCT02754726|451730691|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
125574392|NCT02754726|451730691|FG000|Overall Study|Clinical Disease Progression|5|||
125574393|NCT02754726|451730691|FG000|Overall Study|Adverse Event|3|||
125574394|NCT02754726|451730691|FG000|Overall Study|Withdrawal by Subject|1|||
125574395|NCT02754726|451730691|FG000|Overall Study|Tolerability|1|||
125574396|NCT01885000|451730692|FG000|Overall Study|Adverse Event|1|||
125574397|NCT01885000|451730693|FG001|Overall Study|Adverse Event|0|||
125574398|NCT01885000|451730692|FG000|Overall Study|Withdrawal by Subject|1|||
125358588|NCT01898208|450948289|FG001|Overall Study|Lost to Follow-up|1|||
125358589|NCT01898208|450948290|FG002|Overall Study|Lost to Follow-up|1|||
125358590|NCT02436681|450948291|FG000|Overall Study|Lost to Follow-up|10|||
125358591|NCT02436681|450948291|FG000|Overall Study|Withdrawal by Subject|2|||
125358592|NCT02436681|450948291|FG000|Overall Study|Death|2|||
125358593|NCT02030938|450948292|FG000|Overall Study|Lost to Follow-up|4|||
125358594|NCT02030938|450948292|FG000|Overall Study|Withdrawal by Subject|1|||
125358595|NCT03954132|450948296|FG000|Overall Study|Adverse Event|2|||
125358596|NCT03954132|450948297|FG001|Overall Study|Adverse Event|0|||
125574399|NCT01885000|451730693|FG001|Overall Study|Withdrawal by Subject|1|||
125574400|NCT01885000|451730692|FG000|Overall Study|Protocol Violation|0|||
125574401|NCT01885000|451730693|FG001|Overall Study|Protocol Violation|1|||
125574402|NCT03124784|451730694|FG000|Overall Study|Adverse Event|1|||
125358597|NCT03954132|450948296|FG000|Overall Study|Patient's wish|5|||
125358598|NCT03954132|450948297|FG001|Overall Study|Patient's wish|0|||
125358599|NCT03954132|450948296|FG000|Overall Study|Lost to Follow-up|10|||
125574403|NCT03124784|451730694|FG000|Overall Study|Computer/Equip Malfunction|1|||
125574404|NCT01777152|451730700|FG000|Overall Study|Withdrawal by Subject|22|||
125574405|NCT01777152|451730701|FG001|Overall Study|Withdrawal by Subject|16|||
125574406|NCT01777152|451730700|FG000|Overall Study|Lost to Follow-up|3|||
125574407|NCT01777152|451730701|FG001|Overall Study|Lost to Follow-up|5|||
125574408|NCT01777152|451730700|FG000|Overall Study|Death|68|||
125574409|NCT01777152|451730701|FG001|Overall Study|Death|89|||
125574410|NCT01777152|451730700|FG000|Overall Study|Not eligible, no study drug received|1|||
125574411|NCT01777152|451730701|FG001|Overall Study|Not eligible, no study drug received|0|||
125574412|NCT01777152|451730700|FG000|Overall Study|Change of diagnosis|1|||
125574413|NCT01777152|451730701|FG001|Overall Study|Change of diagnosis|0|||
125574414|NCT02792842|451730702|FG000|Overall Study|Adverse Event|4|||
125574415|NCT02792842|451730703|FG001|Overall Study|Adverse Event|2|||
125574416|NCT02792842|451730704|FG002|Overall Study|Adverse Event|3|||
125574417|NCT02792842|451730702|FG000|Overall Study|Withdrawal by Subject|0|||
125574418|NCT02792842|451730703|FG001|Overall Study|Withdrawal by Subject|1|||
125574419|NCT02792842|451730704|FG002|Overall Study|Withdrawal by Subject|2|||
125574420|NCT02792842|451730702|FG000|Overall Study|Lost to Follow-up|0|||
125574421|NCT02792842|451730703|FG001|Overall Study|Lost to Follow-up|0|||
125574422|NCT02792842|451730704|FG002|Overall Study|Lost to Follow-up|1|||
125574423|NCT02792842|451730702|FG000|Overall Study|Schedule delay|0|||
125574424|NCT02792842|451730703|FG001|Overall Study|Schedule delay|1|||
125574425|NCT02792842|451730704|FG002|Overall Study|Schedule delay|1|||
125574426|NCT03446885|451730706|FG000|Overall Study|Lost to Follow-up|1|||
125574427|NCT03446885|451730707|FG001|Overall Study|Lost to Follow-up|0|||
125574428|NCT03446885|451730706|FG000|Overall Study|Did not complete entire visit|1|||
125574429|NCT03446885|451730707|FG001|Overall Study|Did not complete entire visit|0|||
125574430|NCT01098071|451730711|FG000|Overall Study|Surgery (adenoidectomy)|2|||
125574431|NCT01098071|451730711|FG000|Overall Study|Lost to Follow-up|13|||
125574432|NCT04372927|451730714|FG000|Overall Study|Death|1|||
125574433|NCT01665807|451730715|FG000|Overall Study|Withdrawal by Subject|2|||
125574434|NCT01665807|451730716|FG001|Overall Study|Withdrawal by Subject|0|||
125574435|NCT01665807|451730717|FG002|Overall Study|Withdrawal by Subject|1|||
125574436|NCT01081795|451730718|FG000|Overall Study|Adverse Event|18|||
125574437|NCT01081795|451730719|FG001|Overall Study|Adverse Event|23|||
125574438|NCT01081795|451730720|FG002|Overall Study|Adverse Event|6|||
125574439|NCT01081795|451730718|FG000|Overall Study|Lack of Efficacy|7|||
125574440|NCT01081795|451730719|FG001|Overall Study|Lack of Efficacy|5|||
125574441|NCT01081795|451730720|FG002|Overall Study|Lack of Efficacy|19|||
125574442|NCT01081795|451730718|FG000|Overall Study|Subject's schedule|1|||
125574443|NCT01081795|451730719|FG001|Overall Study|Subject's schedule|1|||
125574444|NCT01081795|451730720|FG002|Overall Study|Subject's schedule|2|||
125574445|NCT01081795|451730718|FG000|Overall Study|Revocation of informed consent|2|||
125574446|NCT01081795|451730719|FG001|Overall Study|Revocation of informed consent|0|||
125574447|NCT01081795|451730720|FG002|Overall Study|Revocation of informed consent|0|||
125574448|NCT01081795|451730718|FG000|Overall Study|Ineligible for participation|1|||
125574449|NCT01081795|451730719|FG001|Overall Study|Ineligible for participation|0|||
125574450|NCT01081795|451730720|FG002|Overall Study|Ineligible for participation|0|||
125574451|NCT01081795|451730718|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
125574452|NCT01081795|451730719|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
125574453|NCT01081795|451730720|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
125574454|NCT01081795|451730718|FG000|Overall Study|Using drug with restricted days of use|2|||
125574455|NCT01081795|451730719|FG001|Overall Study|Using drug with restricted days of use|3|||
125574456|NCT01081795|451730720|FG002|Overall Study|Using drug with restricted days of use|2|||
125574457|NCT01081795|451730718|FG000|Overall Study|Other|1|||
125574458|NCT01081795|451730719|FG001|Overall Study|Other|2|||
125574459|NCT01081795|451730720|FG002|Overall Study|Other|0|||
125574460|NCT00661271|451730721|FG000|Overall Study|Lost to Follow-up|28|||
125574461|NCT00661271|451730722|FG001|Overall Study|Lost to Follow-up|25|||
125574462|NCT01707693|451730724|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
125574463|NCT01707693|451730725|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
125574464|NCT01707693|451730724|FG000|Overall Study Allocation|Protocol Violation|4|||
125358600|NCT03954132|450948297|FG001|Overall Study|Lost to Follow-up|0|||
125358601|NCT03954132|450948296|FG000|Overall Study|Screening failure|0|||
125358602|NCT03954132|450948297|FG001|Overall Study|Screening failure|1|||
125358603|NCT03954132|450948296|FG000|Overall Study|No registration after Visit 1|5|||
125358604|NCT03954132|450948297|FG001|Overall Study|No registration after Visit 1|2|||
125358605|NCT03954132|450948296|FG000|Overall Study|Other reason than listed|2|||
125358606|NCT03954132|450948297|FG001|Overall Study|Other reason than listed|2|||
125358607|NCT03954132|450948296|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
125358608|NCT03954132|450948297|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
125574465|NCT01707693|451730725|FG001|Overall Study Allocation|Protocol Violation|3|||
125574466|NCT01707693|451730724|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
125574467|NCT01707693|451730725|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
125574468|NCT01707693|451730724|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
125574469|NCT01707693|451730725|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
125574470|NCT03847610|451730726|FG000|Overall Study|Withdrawal by Subject|1|||
125574471|NCT03298022|451730727|FG000|Overall Study|Lack of Efficacy|4|||
125574472|NCT03298022|451730727|FG000|Overall Study|Withdrawal by Subject|7|||
125358609|NCT03954132|450948296|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
125574473|NCT03298022|451730727|FG000|Overall Study|Adverse Event|1|||
125574474|NCT03298022|451730727|FG000|Overall Study|disease relapse|1|||
125574475|NCT01445769|451730730|FG000|Overall Study|Consent Withdrawn|2|||
125574476|NCT01445769|451730730|FG000|Overall Study|Disease Progression|1|||
125574477|NCT01445769|451730730|FG000|Overall Study|Lost to Follow-up|5|||
125574478|NCT05130463|451730734|FG000|Overall Study|Unspecified reasons|2|||
125574479|NCT05130463|451730734|FG000|Overall Study|off-label indication dose|435|||
125574480|NCT03461757|451730735|FG000|Overall Study|Adverse Event|1|||
125574481|NCT03461757|451730736|FG001|Overall Study|Adverse Event|0|||
125574482|NCT03461757|451730735|FG000|Overall Study|Lost to Follow-up|13|||
125574483|NCT03461757|451730736|FG001|Overall Study|Lost to Follow-up|7|||
125574484|NCT03461757|451730735|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
125574485|NCT03461757|451730736|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
125574486|NCT03461757|451730735|FG000|Overall Study|Non-compliance with study treatment|0|||
125574487|NCT03461757|451730736|FG001|Overall Study|Non-compliance with study treatment|1|||
125574488|NCT03461757|451730735|FG000|Overall Study|Pregnancy|2|||
125574489|NCT03461757|451730736|FG001|Overall Study|Pregnancy|0|||
125574490|NCT03461757|451730735|FG000|Overall Study|Protocol Violation|1|||
125574491|NCT03461757|451730736|FG001|Overall Study|Protocol Violation|1|||
125574492|NCT03461757|451730735|FG000|Overall Study|Withdrawal by Subject|7|||
125574493|NCT03461757|451730736|FG001|Overall Study|Withdrawal by Subject|7|||
125574494|NCT03461757|451730735|FG000|Overall Study|Other Reasons|1|||
125574495|NCT03461757|451730736|FG001|Overall Study|Other Reasons|4|||
125574496|NCT03652662|451730737|FG000|Overall Study|Withdrawal by Subject|2|||
125574497|NCT03652662|451730738|FG001|Overall Study|Withdrawal by Subject|1|||
125574498|NCT03652662|451730737|FG000|Overall Study|Lost to Follow-up|1|||
125574499|NCT03652662|451730738|FG001|Overall Study|Lost to Follow-up|0|||
125574500|NCT03861559|451730739|FG000|Overall Study|Adverse Event|0|||
125574501|NCT03861559|451730740|FG001|Overall Study|Adverse Event|2|||
125574502|NCT03861559|451730739|FG000|Overall Study|Treatment failure|0|||
125574503|NCT03861559|451730740|FG001|Overall Study|Treatment failure|2|||
125574504|NCT03861559|451730739|FG000|Overall Study|Noncompliance|1|||
125574505|NCT03861559|451730740|FG001|Overall Study|Noncompliance|1|||
125574506|NCT03861559|451730739|FG000|Overall Study|Did not meet eligibility requirements|1|||
125574507|NCT03861559|451730740|FG001|Overall Study|Did not meet eligibility requirements|0|||
125574508|NCT00720109|451730741|FG000|Induction Period|Did not meet eligibility criteria|3|||
125574509|NCT00720109|451730742|FG001|Induction Period|Did not meet eligibility criteria|0|||
125574510|NCT00720109|451730743|FG002|Induction Period|Did not meet eligibility criteria|0|||
125574511|NCT00720109|451730741|FG000|Induction Period|Bone Marrow Transplant|2|||
125574512|NCT00720109|451730742|FG001|Induction Period|Bone Marrow Transplant|0|||
125574513|NCT00720109|451730743|FG002|Induction Period|Bone Marrow Transplant|0|||
125574514|NCT00720109|451730741|FG000|Induction Period|Physician Decision|1|||
125574515|NCT00720109|451730742|FG001|Induction Period|Physician Decision|0|||
125574516|NCT00720109|451730743|FG002|Induction Period|Physician Decision|0|||
125574517|NCT00720109|451730741|FG000|Risk Stratification Period|Adverse Event|0|||
125574518|NCT00720109|451730742|FG001|Risk Stratification Period|Adverse Event|1|||
125574519|NCT00720109|451730743|FG002|Risk Stratification Period|Adverse Event|0|||
125574520|NCT00720109|451730741|FG000|Risk Stratification Period|Physician Decision|0|||
125574521|NCT00720109|451730742|FG001|Risk Stratification Period|Physician Decision|2|||
125574522|NCT00720109|451730743|FG002|Risk Stratification Period|Physician Decision|1|||
125574523|NCT00720109|451730741|FG000|Risk Stratification Period|Bone marrow transplant|0|||
125574524|NCT00720109|451730742|FG001|Risk Stratification Period|Bone marrow transplant|9|||
125574525|NCT00720109|451730743|FG002|Risk Stratification Period|Bone marrow transplant|7|||
125574526|NCT00720109|451730741|FG000|Risk Stratification Period|Disease progression or relapse|0|||
125574527|NCT00720109|451730742|FG001|Risk Stratification Period|Disease progression or relapse|2|||
125574528|NCT00720109|451730743|FG002|Risk Stratification Period|Disease progression or relapse|0|||
125574529|NCT00720109|451730741|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
125574530|NCT00720109|451730742|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
125574531|NCT00720109|451730743|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
125574532|NCT03595553|451730744|FG000|Overall Study|Withdrawal by Subject|20|||
125427183|NCT04067401|451189287|FG000|Overall Study|no data provided|1|||
125574533|NCT03595553|451730745|FG001|Overall Study|Withdrawal by Subject|8|||
125574534|NCT03595553|451730744|FG000|Overall Study|Physician Decision|3|||
125574535|NCT03595553|451730745|FG001|Overall Study|Physician Decision|2|||
125574536|NCT03595553|451730744|FG000|Overall Study|Adverse Event|2|||
125574537|NCT03595553|451730745|FG001|Overall Study|Adverse Event|5|||
125574538|NCT03595553|451730744|FG000|Overall Study|Death|24|||
125574539|NCT03595553|451730745|FG001|Overall Study|Death|22|||
125574540|NCT03595553|451730744|FG000|Overall Study|Lost to Follow-up|6|||
125574541|NCT03595553|451730745|FG001|Overall Study|Lost to Follow-up|7|||
125574542|NCT03595553|451730744|FG000|Overall Study|Other as indicated in CSR|3|||
125574543|NCT03595553|451730745|FG001|Overall Study|Other as indicated in CSR|3|||
125574544|NCT03595553|451730744|FG000|Overall Study|Sponsor Decision|0|||
125574545|NCT03595553|451730745|FG001|Overall Study|Sponsor Decision|1|||
125358610|NCT03954132|450948297|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
125574546|NCT00903175|451730746|FG000|Period 1 - First Line|Adverse Event|36|||
125574547|NCT00903175|451730747|FG001|Period 1 - First Line|Adverse Event|50|||
125574548|NCT00903175|451730746|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
125574549|NCT00903175|451730747|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
125574550|NCT00903175|451730746|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
125574551|NCT00903175|451730747|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
125574552|NCT00903175|451730746|FG000|Period 1 - First Line|Protocol Violation|3|||
125574553|NCT00903175|451730747|FG001|Period 1 - First Line|Protocol Violation|3|||
125574554|NCT00903175|451730746|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
125574555|NCT00903175|451730747|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
125574556|NCT00903175|451730746|FG000|Period 1 - First Line|Administrative problems|12|||
125574557|NCT00903175|451730747|FG001|Period 1 - First Line|Administrative problems|13|||
125574558|NCT00903175|451730746|FG000|Period 1 - First Line|Death|17|||
125574559|NCT00903175|451730747|FG001|Period 1 - First Line|Death|10|||
125574560|NCT00903175|451730746|FG000|Period 2 - Second Line|Missing|1|||
125574561|NCT00903175|451730747|FG001|Period 2 - Second Line|Missing|0|||
125574562|NCT00903175|451730746|FG000|Period 2 - Second Line|Adverse Event|16|||
125574563|NCT00903175|451730747|FG001|Period 2 - Second Line|Adverse Event|20|||
125574564|NCT00903175|451730746|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
125574565|NCT00903175|451730747|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
125574566|NCT00903175|451730746|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
125574567|NCT00903175|451730747|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
125574568|NCT00903175|451730746|FG000|Period 2 - Second Line|Administrative problems|19|||
125574569|NCT00903175|451730747|FG001|Period 2 - Second Line|Administrative problems|9|||
125574570|NCT00903175|451730746|FG000|Period 2 - Second Line|Death|5|||
125574571|NCT00903175|451730747|FG001|Period 2 - Second Line|Death|2|||
125574572|NCT01687712|451730748|FG000|Cycle 1|Not Biochemically Pregnant|386|||
125574573|NCT01687712|451730749|FG001|Cycle 1|Not Biochemically Pregnant|348|||
125574574|NCT01687712|451730748|FG000|Cycle 1|Early Pregnancy Loss|43|||
125574575|NCT01687712|451730749|FG001|Cycle 1|Early Pregnancy Loss|60|||
125574576|NCT01687712|451730748|FG000|Cycle 1|Ectopic Pregnancy|5|||
125574577|NCT01687712|451730749|FG001|Cycle 1|Ectopic Pregnancy|5|||
125574578|NCT01687712|451730748|FG000|Cycle 1|Heterotropic Pregnancy|1|||
125574579|NCT01687712|451730749|FG001|Cycle 1|Heterotropic Pregnancy|0|||
125574580|NCT01687712|451730748|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
125574581|NCT01687712|451730749|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
125574582|NCT01687712|451730748|FG000|Cycle 1|Abortion|3|||
125574583|NCT01687712|451730749|FG001|Cycle 1|Abortion|0|||
125574584|NCT01687712|451730748|FG000|Cycle 1|Intrauterine Fetal Death|0|||
125574585|NCT01687712|451730749|FG001|Cycle 1|Intrauterine Fetal Death|1|||
125574586|NCT01687712|451730748|FG000|Cycle 1|Lost to Follow-up|1|||
125574587|NCT01687712|451730749|FG001|Cycle 1|Lost to Follow-up|1|||
125574588|NCT01687712|451730748|FG000|Cycle 2|Not Biochemically Pregnant|74|||
125574589|NCT01687712|451730749|FG001|Cycle 2|Not Biochemically Pregnant|77|||
125574590|NCT01687712|451730748|FG000|Cycle 2|Early Pregnancy Loss|18|||
125574591|NCT01687712|451730749|FG001|Cycle 2|Early Pregnancy Loss|16|||
125574592|NCT01687712|451730748|FG000|Cycle 2|Ectopic Pregnancy|0|||
125574593|NCT01687712|451730749|FG001|Cycle 2|Ectopic Pregnancy|1|||
125574594|NCT01687712|451730748|FG000|Cycle 2|Still Birth|1|||
125574595|NCT01687712|451730749|FG001|Cycle 2|Still Birth|0|||
125574596|NCT01687712|451730748|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
125574597|NCT01687712|451730749|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
125574598|NCT01687712|451730748|FG000|Cycle 3|Not Biochemically Pregnant|21|||
125574599|NCT01687712|451730749|FG001|Cycle 3|Not Biochemically Pregnant|22|||
125574600|NCT01687712|451730748|FG000|Cycle 3|Early Pregnancy Loss|1|||
125574601|NCT01687712|451730749|FG001|Cycle 3|Early Pregnancy Loss|2|||
125574602|NCT01687712|451730748|FG000|Cycle 3|Ectopic Pregnancy|1|||
125574603|NCT01687712|451730749|FG001|Cycle 3|Ectopic Pregnancy|0|||
125574604|NCT01687712|451730748|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
125574605|NCT01687712|451730749|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
125574606|NCT03074474|451730754|FG000|Overall Study|Lost to Follow-up|10|||
125574607|NCT03074474|451730754|FG000|Overall Study|Withdrawal by Subject|10|||
125574608|NCT03074474|451730754|FG000|Overall Study|Death|4|||
125574609|NCT03074474|451730754|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
125574610|NCT01035905|451730757|FG000|Overall Study|Lack of Efficacy|1|||
125574611|NCT01035905|451730758|FG001|Overall Study|Lack of Efficacy|1|||
125574612|NCT04153188|451730763|FG000|Overall Study|Lost to Follow-up|1|||
125574613|NCT04153188|451730764|FG001|Overall Study|Lost to Follow-up|1|||
125574614|NCT04153188|451730763|FG000|Overall Study|Withdrawal by Subject|2|||
125574615|NCT04153188|451730764|FG001|Overall Study|Withdrawal by Subject|0|||
125574616|NCT04153188|451730763|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
125574617|NCT04153188|451730764|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
125574618|NCT03809611|451730765|FG000|Overall Study|Withdrawal by Subject|1|||
125574619|NCT03809611|451730766|FG001|Overall Study|Withdrawal by Subject|1|||
125574620|NCT02926950|451730767|FG000|Overall Study|Adverse Event|4|||
125574621|NCT02926950|451730768|FG001|Overall Study|Adverse Event|6|||
125574622|NCT02926950|451730767|FG000|Overall Study|At the participant's own request|21|||
125574623|NCT02926950|451730768|FG001|Overall Study|At the participant's own request|25|||
125574624|NCT02926950|451730767|FG000|Overall Study|Reason not Specified|17|||
125574625|NCT02926950|451730768|FG001|Overall Study|Reason not Specified|9|||
125574626|NCT02926950|451730767|FG000|Overall Study|Lost to Follow-up|7|||
125574627|NCT02926950|451730768|FG001|Overall Study|Lost to Follow-up|8|||
125574628|NCT00264004|451732347|FG000|Overall Study|Adverse Event|2|||
125574629|NCT00264004|451732348|FG001|Overall Study|Adverse Event|3|||
125574630|NCT00264004|451732349|FG002|Overall Study|Adverse Event|6|||
125574631|NCT00264004|451732350|FG003|Overall Study|Adverse Event|4|||
125574632|NCT00264004|451732347|FG000|Overall Study|Withdrawal by Subject|0|||
125574633|NCT00264004|451732348|FG001|Overall Study|Withdrawal by Subject|1|||
125574634|NCT00264004|451732349|FG002|Overall Study|Withdrawal by Subject|2|||
125574635|NCT00264004|451732350|FG003|Overall Study|Withdrawal by Subject|2|||
125574636|NCT00264004|451732347|FG000|Overall Study|Other|2|||
125574637|NCT00264004|451732348|FG001|Overall Study|Other|2|||
125574638|NCT00264004|451732349|FG002|Overall Study|Other|0|||
125574639|NCT00264004|451732350|FG003|Overall Study|Other|3|||
125574640|NCT00264004|451732347|FG000|Overall Study|Development study specific disc. crit.|1|||
125574641|NCT00264004|451732348|FG001|Overall Study|Development study specific disc. crit.|0|||
125574642|NCT00264004|451732349|FG002|Overall Study|Development study specific disc. crit.|1|||
125574643|NCT00264004|451732350|FG003|Overall Study|Development study specific disc. crit.|0|||
125574644|NCT00264004|451732347|FG000|Overall Study|Cond. under inv. worsened|9|||
125574645|NCT00264004|451732348|FG001|Overall Study|Cond. under inv. worsened|5|||
125574646|NCT00264004|451732349|FG002|Overall Study|Cond. under inv. worsened|3|||
125574647|NCT00264004|451732350|FG003|Overall Study|Cond. under inv. worsened|4|||
125574648|NCT00264004|451732347|FG000|Overall Study|Not treated|3|||
125574649|NCT00264004|451732348|FG001|Overall Study|Not treated|0|||
125574650|NCT00264004|451732349|FG002|Overall Study|Not treated|2|||
125574651|NCT00264004|451732350|FG003|Overall Study|Not treated|2|||
125574652|NCT01535729|451732351|FG000|Overall Study|Withdrawal by Subject|2|||
125574653|NCT01535729|451732351|FG000|Overall Study|Disease progression|230|||
125574654|NCT01535729|451732351|FG000|Overall Study|Discontinued treatment|25|||
125574655|NCT01535729|451732351|FG000|Overall Study|Lost to Follow-up|8|||
125574656|NCT01535729|451732351|FG000|Overall Study|Death|52|||
125574657|NCT01535729|451732351|FG000|Overall Study|Other|19|||
125574658|NCT01535729|451732351|FG000|Overall Study|Did not sign informed consent|1|||
125574659|NCT01535729|451732351|FG000|Overall Study|No previous chemotherapy|33|||
125574660|NCT01535729|451732351|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
125574661|NCT01535729|451732351|FG000|Overall Study|Protocol Violation|11|||
125574662|NCT01535729|451732351|FG000|Overall Study|Screening failure|1|||
125574663|NCT01535729|451732351|FG000|Overall Study|Not treated|9|||
125574664|NCT01535729|451732351|FG000|Overall Study|No participant record available|5|||
125574665|NCT01262365|451732352|FG000|Overall Study|Lack of Efficacy|35|||
125574666|NCT01262365|451732353|FG001|Overall Study|Lack of Efficacy|30|||
125574667|NCT01262365|451732354|FG002|Overall Study|Lack of Efficacy|47|||
125574668|NCT01262365|451732352|FG000|Overall Study|Protocol Violation|3|||
125574669|NCT01262365|451732353|FG001|Overall Study|Protocol Violation|1|||
125574670|NCT01262365|451732354|FG002|Overall Study|Protocol Violation|1|||
125574671|NCT01262365|451732352|FG000|Overall Study|Lost to Follow-up|3|||
125574672|NCT01262365|451732353|FG001|Overall Study|Lost to Follow-up|7|||
125574673|NCT01262365|451732354|FG002|Overall Study|Lost to Follow-up|6|||
125574674|NCT01262365|451732352|FG000|Overall Study|Withdrawal by Subject|17|||
125574675|NCT01262365|451732353|FG001|Overall Study|Withdrawal by Subject|22|||
125574676|NCT01262365|451732354|FG002|Overall Study|Withdrawal by Subject|22|||
125574677|NCT01262365|451732352|FG000|Overall Study|Death|1|||
125574678|NCT01262365|451732353|FG001|Overall Study|Death|2|||
125574679|NCT01262365|451732354|FG002|Overall Study|Death|1|||
125574680|NCT01262365|451732352|FG000|Overall Study|Adverse Event|26|||
125574681|NCT01262365|451732353|FG001|Overall Study|Adverse Event|16|||
125574682|NCT01262365|451732354|FG002|Overall Study|Adverse Event|11|||
125574683|NCT01262365|451732352|FG000|Overall Study|sponsor decision|1|||
125574684|NCT01262365|451732353|FG001|Overall Study|sponsor decision|1|||
125574685|NCT01262365|451732354|FG002|Overall Study|sponsor decision|0|||
125574686|NCT01262365|451732352|FG000|Overall Study|Randomization error|1|||
125574687|NCT01262365|451732353|FG001|Overall Study|Randomization error|0|||
125574688|NCT01262365|451732354|FG002|Overall Study|Randomization error|2|||
125574689|NCT01262365|451732352|FG000|Overall Study|Non-compliance|1|||
125574690|NCT01262365|451732353|FG001|Overall Study|Non-compliance|0|||
125574691|NCT01262365|451732354|FG002|Overall Study|Non-compliance|2|||
125574692|NCT01262365|451732352|FG000|Overall Study|Suspected pregnancy|1|||
125574693|NCT01262365|451732353|FG001|Overall Study|Suspected pregnancy|0|||
125574694|NCT01262365|451732354|FG002|Overall Study|Suspected pregnancy|0|||
125574695|NCT01262365|451732352|FG000|Overall Study|Patient pregnant|1|||
125574696|NCT01262365|451732353|FG001|Overall Study|Patient pregnant|0|||
125574697|NCT01262365|451732354|FG002|Overall Study|Patient pregnant|1|||
125574698|NCT01262365|451732352|FG000|Overall Study|Toxicity related to study drug|0|||
125574699|NCT01262365|451732353|FG001|Overall Study|Toxicity related to study drug|1|||
125574700|NCT01262365|451732354|FG002|Overall Study|Toxicity related to study drug|0|||
125574701|NCT01262365|451732352|FG000|Overall Study|Cannot tolerate the protocol|0|||
125574702|NCT01262365|451732353|FG001|Overall Study|Cannot tolerate the protocol|1|||
125574703|NCT01262365|451732354|FG002|Overall Study|Cannot tolerate the protocol|0|||
125574704|NCT01262365|451732352|FG000|Overall Study|Patient unavailable|0|||
125574705|NCT01262365|451732353|FG001|Overall Study|Patient unavailable|0|||
125574706|NCT01262365|451732354|FG002|Overall Study|Patient unavailable|1|||
125574707|NCT02787850|451732355|FG000|Overall Study|Withdrawal by Subject|0|||
125574708|NCT02787850|451732356|FG001|Overall Study|Withdrawal by Subject|1|||
125574709|NCT02921971|451732359|FG000|Overall Study|Adverse Event|1|||
125574710|NCT02921971|451732360|FG001|Overall Study|Adverse Event|2|||
125574711|NCT02921971|451732359|FG000|Overall Study|Lack of Efficacy|3|||
125574712|NCT02921971|451732360|FG001|Overall Study|Lack of Efficacy|1|||
125574713|NCT02921971|451732359|FG000|Overall Study|Other than specified above|2|||
125574714|NCT02921971|451732360|FG001|Overall Study|Other than specified above|1|||
125574715|NCT02322710|451732361|FG000|Overall Study|No efficacy assessment post-baseline|0|||
125574716|NCT02322710|451732362|FG001|Overall Study|No efficacy assessment post-baseline|1|||
125574717|NCT02322710|451732361|FG000|Overall Study|Protocol Violation|20|||
125574718|NCT02322710|451732362|FG001|Overall Study|Protocol Violation|25|||
125574719|NCT04161131|451732363|FG000|Overall Study|Ineligible|2|||
125574720|NCT04161131|451732363|FG000|Overall Study|Lost to Follow-up|4|||
125574721|NCT04316585|451732364|FG000|Overall Study|Adverse Event|2|||
125574722|NCT04316585|451732365|FG001|Overall Study|Adverse Event|1|||
125574723|NCT04316585|451732364|FG000|Overall Study|Lost to Follow-up|1|||
125574724|NCT04316585|451732365|FG001|Overall Study|Lost to Follow-up|0|||
125574725|NCT04316585|451732364|FG000|Overall Study|Withdrawal by Subject|2|||
125574726|NCT04316585|451732365|FG001|Overall Study|Withdrawal by Subject|3|||
125574727|NCT04316585|451732364|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
125574728|NCT04316585|451732365|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
125574729|NCT04316585|451732364|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
125574730|NCT04316585|451732365|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
125574731|NCT00130832|451732366|FG000|Overall Study|Adverse Event|1|||
125574732|NCT00130832|451732367|FG001|Overall Study|Adverse Event|1|||
125574733|NCT00130832|451732366|FG000|Overall Study|Lost to Follow-up|1|||
125574734|NCT00130832|451732367|FG001|Overall Study|Lost to Follow-up|2|||
125574735|NCT00130832|451732366|FG000|Overall Study|Protocol Violation|6|||
125574736|NCT00130832|451732367|FG001|Overall Study|Protocol Violation|8|||
125574737|NCT00130832|451732366|FG000|Overall Study|Withdrawal by Subject|6|||
125574738|NCT00130832|451732367|FG001|Overall Study|Withdrawal by Subject|1|||
125574739|NCT00130832|451732366|FG000|Overall Study|Moved|2|||
125574740|NCT00130832|451732367|FG001|Overall Study|Moved|2|||
125574741|NCT00130832|451732366|FG000|Overall Study|Other|0|||
125574742|NCT00130832|451732367|FG001|Overall Study|Other|3|||
125574743|NCT03905863|451732368|FG000|Overall Study|Adverse Event|2|||
125574744|NCT03905863|451732369|FG001|Overall Study|Adverse Event|4|||
125574745|NCT03905863|451732368|FG000|Overall Study|Withdrawal by Subject|2|||
125574746|NCT03905863|451732369|FG001|Overall Study|Withdrawal by Subject|2|||
125574747|NCT03905863|451732368|FG000|Overall Study|Physician Decision|0|||
125574748|NCT03905863|451732369|FG001|Overall Study|Physician Decision|3|||
125574749|NCT03905863|451732368|FG000|Overall Study|Lost to Follow-up|1|||
125574750|NCT03905863|451732369|FG001|Overall Study|Lost to Follow-up|0|||
125358611|NCT00932737|450948303|FG000|Overall Study|Not treated in second episode|1|||
125358612|NCT00932737|450948304|FG001|Overall Study|Not treated in second episode|0|||
125574751|NCT03905863|451732368|FG000|Overall Study|Protocol Violation|0|||
125574752|NCT03905863|451732369|FG001|Overall Study|Protocol Violation|2|||
125574753|NCT03905863|451732368|FG000|Overall Study|Death|0|||
125358613|NCT00932737|450948303|FG000|Overall Study|Adverse Event|0|||
125574754|NCT03905863|451732369|FG001|Overall Study|Death|1|||
125574755|NCT02944448|451732371|FG000|Overall Study|Adverse Event|37|||
125574756|NCT02944448|451732372|FG001|Overall Study|Adverse Event|6|||
125574757|NCT02944448|451732371|FG000|Overall Study|Lack of Efficacy|8|||
125574758|NCT02944448|451732372|FG001|Overall Study|Lack of Efficacy|5|||
125574759|NCT02944448|451732371|FG000|Overall Study|Lost to Follow-up|3|||
125574760|NCT02944448|451732372|FG001|Overall Study|Lost to Follow-up|1|||
125574761|NCT02944448|451732371|FG000|Overall Study|Protocol Violation|25|||
125574762|NCT02944448|451732372|FG001|Overall Study|Protocol Violation|7|||
125574763|NCT02944448|451732371|FG000|Overall Study|Withdrawal by Subject|14|||
125574764|NCT02944448|451732372|FG001|Overall Study|Withdrawal by Subject|4|||
125574765|NCT02944448|451732371|FG000|Overall Study|Sponsor did not supply drug in time|0|||
125574766|NCT02944448|451732372|FG001|Overall Study|Sponsor did not supply drug in time|1|||
125574767|NCT02944448|451732371|FG000|Overall Study|Noncompliant with dosing|1|||
125574768|NCT02944448|451732372|FG001|Overall Study|Noncompliant with dosing|0|||
125574769|NCT02944448|451732371|FG000|Overall Study|Abnormal laboratory values|1|||
125574770|NCT02944448|451732372|FG001|Overall Study|Abnormal laboratory values|0|||
125574771|NCT05499559|451732375|FG000|Overall Study|Lost to Follow-up|467|||
125574772|NCT04681170|451732376|FG000|Stratified Enrolment & run-in|Death|1|||
125574773|NCT04681170|451732377|FG001|Stratified Enrolment & run-in|Death|0|||
125574774|NCT04681170|451732376|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
125574775|NCT04681170|451732377|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
125574776|NCT04681170|451732376|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
125574777|NCT04681170|451732377|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
125574778|NCT04681170|451732376|FG000|Open Label Efficacy Phase|Adverse Event|0|||
125574779|NCT04681170|451732377|FG001|Open Label Efficacy Phase|Adverse Event|2|||
125574780|NCT04681170|451732376|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
125574781|NCT04681170|451732377|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
125574782|NCT04681170|451732376|FG000|Open Label Safety Phase|AEs and none compliance|0|||
125574783|NCT04681170|451732377|FG001|Open Label Safety Phase|AEs and none compliance|1|||
125574784|NCT04986202|451732378|FG000|Overall Study|Death|10|||
125574785|NCT04986202|451732379|FG001|Overall Study|Death|3|||
125574786|NCT04986202|451732380|FG002|Overall Study|Death|10|||
125574787|NCT04986202|451732378|FG000|Overall Study|Physician Decision|3|||
125574788|NCT04986202|451732379|FG001|Overall Study|Physician Decision|1|||
125574789|NCT04986202|451732380|FG002|Overall Study|Physician Decision|2|||
125574790|NCT04986202|451732378|FG000|Overall Study|Withdrawal by Subject|4|||
125574791|NCT04986202|451732379|FG001|Overall Study|Withdrawal by Subject|2|||
125574792|NCT04986202|451732380|FG002|Overall Study|Withdrawal by Subject|4|||
125574793|NCT02468648|451732381|FG000|Overall Study|Death|1|||
125574794|NCT02118792|451732382|FG000|Overall Study|Withdrawal by Subject|6|||
125574795|NCT02118792|451732383|FG001|Overall Study|Withdrawal by Subject|3|||
125574796|NCT02118792|451732382|FG000|Overall Study|Lost to Follow-up|4|||
125574797|NCT02118792|451732383|FG001|Overall Study|Lost to Follow-up|4|||
125574798|NCT02118792|451732382|FG000|Overall Study|Adverse Event|5|||
125574799|NCT02118792|451732383|FG001|Overall Study|Adverse Event|4|||
125574800|NCT02118792|451732382|FG000|Overall Study|Withdrawal by parent/guardian|14|||
125574801|NCT02118792|451732383|FG001|Overall Study|Withdrawal by parent/guardian|20|||
125574802|NCT02118792|451732382|FG000|Overall Study|Other|1|||
125574803|NCT02118792|451732383|FG001|Overall Study|Other|6|||
125574804|NCT02118792|451732382|FG000|Overall Study|Randomised but not treated|1|||
125574805|NCT02118792|451732383|FG001|Overall Study|Randomised but not treated|0|||
125574806|NCT05131204|451732384|FG000|Overall Study|Sponsor request|2|||
125574807|NCT05131204|451732385|FG001|Overall Study|Sponsor request|1|||
125574808|NCT02787863|451732386|FG000|Overall Study|Death|1|||
125574809|NCT02787863|451732387|FG001|Overall Study|Death|0|||
125574810|NCT02787863|451732388|FG002|Overall Study|Death|1|||
125574811|NCT02787863|451732389|FG003|Overall Study|Death|0|||
125574812|NCT02787863|451732390|FG004|Overall Study|Death|0|||
125574813|NCT02787863|451732391|FG005|Overall Study|Death|0|||
125574814|NCT02787863|451732392|FG006|Overall Study|Death|0|||
125574815|NCT02787863|451732393|FG007|Overall Study|Death|0|||
125574816|NCT02787863|451732386|FG000|Overall Study|Withdrawal by Subject|0|||
125574817|NCT02787863|451732387|FG001|Overall Study|Withdrawal by Subject|1|||
125574818|NCT02787863|451732388|FG002|Overall Study|Withdrawal by Subject|1|||
125574819|NCT02787863|451732389|FG003|Overall Study|Withdrawal by Subject|0|||
125574820|NCT02787863|451732390|FG004|Overall Study|Withdrawal by Subject|0|||
125574821|NCT02787863|451732391|FG005|Overall Study|Withdrawal by Subject|0|||
125574822|NCT02787863|451732392|FG006|Overall Study|Withdrawal by Subject|0|||
125574823|NCT02787863|451732393|FG007|Overall Study|Withdrawal by Subject|0|||
125574824|NCT01415752|451732399|FG000|Induction (Step 1)|Ineligible|4|||
125574825|NCT01415752|451732400|FG001|Induction (Step 1)|Ineligible|3|||
125574826|NCT01415752|451732401|FG002|Induction (Step 1)|Ineligible|4|||
125574827|NCT01415752|451732402|FG003|Induction (Step 1)|Ineligible|4|||
125574828|NCT01415752|451732399|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
125574829|NCT01415752|451732400|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
125574830|NCT01415752|451732401|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
125574831|NCT01415752|451732402|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
125574832|NCT01415752|451732399|FG000|Maintenance (Step 2)|Adverse Event|3|||
125358614|NCT00932737|450948304|FG001|Overall Study|Adverse Event|1|||
125358615|NCT04399837|450948305|FG000|Overall Study|Other than listed|0|||
125358616|NCT04399837|450948306|FG001|Overall Study|Other than listed|2|||
125358617|NCT04399837|450948307|FG002|Overall Study|Other than listed|2|||
125358618|NCT04399837|450948308|FG003|Overall Study|Other than listed|3|||
125358619|NCT04399837|450948305|FG000|Overall Study|Withdrawal by Subject|1|||
125358620|NCT04399837|450948306|FG001|Overall Study|Withdrawal by Subject|2|||
125358621|NCT04399837|450948307|FG002|Overall Study|Withdrawal by Subject|1|||
125358622|NCT04399837|450948308|FG003|Overall Study|Withdrawal by Subject|1|||
125358623|NCT01066000|450948311|FG000|Overall Study|Protocol Violation|4|||
125358624|NCT01066000|450948311|FG000|Overall Study|Death|3|||
125358625|NCT01066000|450948311|FG000|Overall Study|Withdrawal by Subject|1|||
125358626|NCT01066000|450948311|FG000|Overall Study|Adverse Event|1|||
125358627|NCT00566111|450948312|FG000|Overall Study|Adverse Event|0|||
125358628|NCT00566111|450948313|FG001|Overall Study|Adverse Event|2|||
125574833|NCT01415752|451732400|FG001|Maintenance (Step 2)|Adverse Event|4|||
125574834|NCT01415752|451732401|FG002|Maintenance (Step 2)|Adverse Event|9|||
125574835|NCT01415752|451732402|FG003|Maintenance (Step 2)|Adverse Event|6|||
125574836|NCT01415752|451732399|FG000|Maintenance (Step 2)|Death|1|||
125574837|NCT01415752|451732400|FG001|Maintenance (Step 2)|Death|1|||
125574838|NCT01415752|451732401|FG002|Maintenance (Step 2)|Death|2|||
125574839|NCT01415752|451732402|FG003|Maintenance (Step 2)|Death|0|||
125574840|NCT01415752|451732399|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
125574841|NCT01415752|451732400|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
125574842|NCT01415752|451732401|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
125574843|NCT01415752|451732402|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
125574844|NCT01415752|451732399|FG000|Maintenance (Step 2)|Alternative therapy|0|||
125574845|NCT01415752|451732400|FG001|Maintenance (Step 2)|Alternative therapy|1|||
125574846|NCT01415752|451732401|FG002|Maintenance (Step 2)|Alternative therapy|0|||
125574847|NCT01415752|451732402|FG003|Maintenance (Step 2)|Alternative therapy|0|||
125574848|NCT01415752|451732399|FG000|Maintenance (Step 2)|Other reasons|3|||
125574849|NCT01415752|451732400|FG001|Maintenance (Step 2)|Other reasons|6|||
125574850|NCT01415752|451732401|FG002|Maintenance (Step 2)|Other reasons|4|||
125574851|NCT01415752|451732402|FG003|Maintenance (Step 2)|Other reasons|6|||
125574852|NCT01415752|451732399|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
125574853|NCT01415752|451732400|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
125574854|NCT01415752|451732401|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
125574855|NCT01415752|451732402|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
125574856|NCT01415752|451732399|FG000|Maintenance (Step 2)|ineligible|1|||
125574857|NCT01415752|451732400|FG001|Maintenance (Step 2)|ineligible|1|||
125574858|NCT01415752|451732401|FG002|Maintenance (Step 2)|ineligible|1|||
125574859|NCT01415752|451732402|FG003|Maintenance (Step 2)|ineligible|0|||
125574860|NCT01415752|451732399|FG000|Maintenance (Step 2)|Missing|4|||
125574861|NCT01415752|451732400|FG001|Maintenance (Step 2)|Missing|1|||
125574862|NCT01415752|451732401|FG002|Maintenance (Step 2)|Missing|4|||
125358629|NCT01554397|450948314|FG000|Overall Study|Withdrawal by Subject|1|||
125574863|NCT01415752|451732402|FG003|Maintenance (Step 2)|Missing|3|||
125574864|NCT00252057|451732405|FG000|Overall Study|Withdrawal by Subject|2|||
125574865|NCT00252057|451732406|FG001|Overall Study|Withdrawal by Subject|5|||
125574866|NCT00252057|451732405|FG000|Overall Study|Death|1|||
125574867|NCT00252057|451732406|FG001|Overall Study|Death|2|||
125574868|NCT00252057|451732405|FG000|Overall Study|Participant previously enrolled|0|||
125574869|NCT00252057|451732406|FG001|Overall Study|Participant previously enrolled|1|||
125358630|NCT01554397|450948315|FG001|Overall Study|Withdrawal by Subject|0|||
125358631|NCT01554397|450948314|FG000|Overall Study|Ineligible|7|||
125358632|NCT01554397|450948315|FG001|Overall Study|Ineligible|0|||
125358633|NCT05021081|450950563|FG000|Phase 2|Subject enrolled in error|1|||
125358634|NCT05021081|450950564|FG001|Phase 2|Subject enrolled in error|1|||
125358635|NCT05021081|450950565|FG002|Phase 2|Subject enrolled in error|0|||
125574870|NCT02926209|451732408|FG000|Study Cohort|Poor Bowel Preparation|1|||
125574871|NCT02926209|451732409|FG001|Study Cohort|Poor Bowel Preparation|0|||
125574872|NCT01903837|451732416|FG000|Part A|Withdrawal by Subject|4|||
125574873|NCT01903837|451732417|FG001|Part A|Withdrawal by Subject|9|||
125574874|NCT01903837|451732418|FG002|Part A|Withdrawal by Subject|8|||
125574875|NCT01903837|451732419|FG003|Part A|Withdrawal by Subject|5|||
125574876|NCT01903837|451732416|FG000|Part A|Adverse Event|3|||
125574877|NCT01903837|451732417|FG001|Part A|Adverse Event|6|||
125574878|NCT01903837|451732418|FG002|Part A|Adverse Event|9|||
125574879|NCT01903837|451732419|FG003|Part A|Adverse Event|6|||
125574880|NCT01903837|451732416|FG000|Part A|Lost to Follow-up|9|||
125574881|NCT01903837|451732417|FG001|Part A|Lost to Follow-up|7|||
125574882|NCT01903837|451732418|FG002|Part A|Lost to Follow-up|7|||
125574883|NCT01903837|451732419|FG003|Part A|Lost to Follow-up|2|||
125574884|NCT01903837|451732416|FG000|Part A|Non-compliance with study drug|1|||
125574885|NCT01903837|451732417|FG001|Part A|Non-compliance with study drug|4|||
125574886|NCT01903837|451732418|FG002|Part A|Non-compliance with study drug|4|||
125574887|NCT01903837|451732419|FG003|Part A|Non-compliance with study drug|0|||
125574888|NCT01903837|451732416|FG000|Part A|Physician Decision|1|||
125574889|NCT01903837|451732417|FG001|Part A|Physician Decision|1|||
125574890|NCT01903837|451732418|FG002|Part A|Physician Decision|0|||
125574891|NCT01903837|451732419|FG003|Part A|Physician Decision|0|||
125574892|NCT01903837|451732416|FG000|Part A|Protocol Violation|1|||
125574893|NCT01903837|451732417|FG001|Part A|Protocol Violation|1|||
125574894|NCT01903837|451732418|FG002|Part A|Protocol Violation|0|||
125574895|NCT01903837|451732419|FG003|Part A|Protocol Violation|0|||
125574896|NCT01903837|451732416|FG000|Part B|Lost to Follow-up|0|||
125574897|NCT01903837|451732417|FG001|Part B|Lost to Follow-up|3|||
125574898|NCT01903837|451732418|FG002|Part B|Lost to Follow-up|3|||
125574899|NCT01903837|451732419|FG003|Part B|Lost to Follow-up|4|||
125574900|NCT01903837|451732416|FG000|Part B|Withdrawal by Subject|1|||
125574901|NCT01903837|451732417|FG001|Part B|Withdrawal by Subject|2|||
125574902|NCT01903837|451732418|FG002|Part B|Withdrawal by Subject|0|||
125574903|NCT01903837|451732419|FG003|Part B|Withdrawal by Subject|3|||
125574904|NCT01903837|451732416|FG000|Part B|Adverse Event|3|||
125574905|NCT01903837|451732417|FG001|Part B|Adverse Event|0|||
125574906|NCT01903837|451732418|FG002|Part B|Adverse Event|2|||
125574907|NCT01903837|451732419|FG003|Part B|Adverse Event|0|||
125574908|NCT01903837|451732416|FG000|Part B|Non-compliance with study drug|2|||
125574909|NCT01903837|451732417|FG001|Part B|Non-compliance with study drug|0|||
125574910|NCT01903837|451732418|FG002|Part B|Non-compliance with study drug|0|||
125574911|NCT01903837|451732419|FG003|Part B|Non-compliance with study drug|1|||
125574912|NCT01903837|451732416|FG000|Part B|Incarceration|2|||
125574913|NCT01903837|451732417|FG001|Part B|Incarceration|0|||
125574914|NCT01903837|451732418|FG002|Part B|Incarceration|0|||
125574915|NCT01903837|451732419|FG003|Part B|Incarceration|1|||
125574916|NCT01903837|451732416|FG000|Part B|Physician Decision|1|||
125574917|NCT01903837|451732417|FG001|Part B|Physician Decision|0|||
125574918|NCT01903837|451732418|FG002|Part B|Physician Decision|0|||
125574919|NCT01903837|451732419|FG003|Part B|Physician Decision|2|||
125574920|NCT01903837|451732416|FG000|Part B|Lack of Efficacy|0|||
125574921|NCT01903837|451732417|FG001|Part B|Lack of Efficacy|1|||
125574922|NCT01903837|451732418|FG002|Part B|Lack of Efficacy|0|||
125574923|NCT01903837|451732419|FG003|Part B|Lack of Efficacy|0|||
125574924|NCT00705939|451732420|FG000|Overall Study|Protocol Violation|0|||
125574925|NCT00705939|451732421|FG001|Overall Study|Protocol Violation|0|||
125358636|NCT00369122|450950566|FG000|Overall Study|Ineligible|10|||
125358637|NCT00369122|450950566|FG000|Overall Study|No protocol treatment|1|||
125358638|NCT02651467|450950567|FG000|Overall Study|Withdrawal by Subject|0|||
125358639|NCT02651467|450950568|FG001|Overall Study|Withdrawal by Subject|0|||
125574926|NCT00705939|451732422|FG002|Overall Study|Protocol Violation|1|||
125574927|NCT00705939|451732420|FG000|Overall Study|Withdrawal by Subject|0|||
125574928|NCT00705939|451732421|FG001|Overall Study|Withdrawal by Subject|1|||
125574929|NCT00705939|451732422|FG002|Overall Study|Withdrawal by Subject|3|||
125574930|NCT00705939|451732420|FG000|Overall Study|Physician Decision|0|||
125574931|NCT00705939|451732421|FG001|Overall Study|Physician Decision|1|||
125574932|NCT00705939|451732422|FG002|Overall Study|Physician Decision|0|||
125574933|NCT05048342|451732423|FG000|Overall Study|Adverse Event|1|||
125574934|NCT05048342|451732423|FG000|Overall Study|Subject decision|2|||
125574935|NCT03345472|451732428|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
125574936|NCT03345472|451732428|FG000|Implant to 3 Months|Physician Decision|1|||
125574937|NCT03345472|451732428|FG000|Implant to 3 Months|Adverse Event|1|||
125574938|NCT03345472|451732428|FG000|3 Months to 12 Months|Physician Decision|3|||
125574939|NCT03345472|451732428|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
125574940|NCT03345472|451732428|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
125358640|NCT02651467|450950569|FG002|Overall Study|Withdrawal by Subject|2|||
125574941|NCT03345472|451732428|FG000|3 Months to 12 Months|Adverse Event|1|||
125574942|NCT03345472|451732428|FG000|3 Months to 12 Months|Death|1|||
125574943|NCT01926782|451732429|FG000|Overall Study|Participant moved|2|||
125574944|NCT01926782|451732430|FG001|Overall Study|Participant moved|0|||
125574945|NCT01926782|451732431|FG002|Overall Study|Participant moved|1|||
125574946|NCT01926782|451732432|FG003|Overall Study|Participant moved|1|||
125574947|NCT01926782|451732433|FG004|Overall Study|Participant moved|0|||
125574948|NCT01926782|451732434|FG005|Overall Study|Participant moved|3|||
125574949|NCT01926782|451732429|FG000|Overall Study|Physician Decision|0|||
125574950|NCT01926782|451732430|FG001|Overall Study|Physician Decision|2|||
125574951|NCT01926782|451732431|FG002|Overall Study|Physician Decision|1|||
125574952|NCT01926782|451732432|FG003|Overall Study|Physician Decision|1|||
125574953|NCT01926782|451732433|FG004|Overall Study|Physician Decision|0|||
125574954|NCT01926782|451732434|FG005|Overall Study|Physician Decision|0|||
125574955|NCT01926782|451732429|FG000|Overall Study|Other than specified|2|||
125574956|NCT01926782|451732430|FG001|Overall Study|Other than specified|3|||
125574957|NCT01926782|451732431|FG002|Overall Study|Other than specified|5|||
125574958|NCT01926782|451732432|FG003|Overall Study|Other than specified|12|||
125574959|NCT01926782|451732433|FG004|Overall Study|Other than specified|4|||
125574960|NCT01926782|451732434|FG005|Overall Study|Other than specified|11|||
125574961|NCT01926782|451732429|FG000|Overall Study|Adverse Event|13|||
125574962|NCT01926782|451732430|FG001|Overall Study|Adverse Event|4|||
125574963|NCT01926782|451732431|FG002|Overall Study|Adverse Event|17|||
125574964|NCT01926782|451732432|FG003|Overall Study|Adverse Event|4|||
125574965|NCT01926782|451732433|FG004|Overall Study|Adverse Event|3|||
125574966|NCT01926782|451732434|FG005|Overall Study|Adverse Event|14|||
125574967|NCT01926782|451732429|FG000|Overall Study|Poor compliance to protocol|5|||
125574968|NCT01926782|451732430|FG001|Overall Study|Poor compliance to protocol|3|||
125574969|NCT01926782|451732431|FG002|Overall Study|Poor compliance to protocol|8|||
125574970|NCT01926782|451732432|FG003|Overall Study|Poor compliance to protocol|0|||
125574971|NCT01926782|451732433|FG004|Overall Study|Poor compliance to protocol|1|||
125574972|NCT01926782|451732434|FG005|Overall Study|Poor compliance to protocol|6|||
125574973|NCT01926782|451732429|FG000|Overall Study|Randomized and not treated|0|||
125574974|NCT01926782|451732430|FG001|Overall Study|Randomized and not treated|0|||
125574975|NCT01926782|451732431|FG002|Overall Study|Randomized and not treated|0|||
125574976|NCT01926782|451732432|FG003|Overall Study|Randomized and not treated|1|||
125574977|NCT01926782|451732433|FG004|Overall Study|Randomized and not treated|0|||
125574978|NCT01926782|451732434|FG005|Overall Study|Randomized and not treated|0|||
125574979|NCT01926782|451732429|FG000|Overall Study|Withdrawal by Subject|6|||
125574980|NCT01926782|451732430|FG001|Overall Study|Withdrawal by Subject|1|||
125574981|NCT01926782|451732431|FG002|Overall Study|Withdrawal by Subject|8|||
125574982|NCT01926782|451732432|FG003|Overall Study|Withdrawal by Subject|1|||
125574983|NCT01926782|451732433|FG004|Overall Study|Withdrawal by Subject|0|||
125574984|NCT01926782|451732434|FG005|Overall Study|Withdrawal by Subject|5|||
125574985|NCT01926782|451732429|FG000|Overall Study|Related to study drug administration|0|||
125574986|NCT01926782|451732430|FG001|Overall Study|Related to study drug administration|0|||
125574987|NCT01926782|451732431|FG002|Overall Study|Related to study drug administration|0|||
125574988|NCT01926782|451732432|FG003|Overall Study|Related to study drug administration|0|||
125574989|NCT01926782|451732433|FG004|Overall Study|Related to study drug administration|0|||
125574990|NCT01926782|451732434|FG005|Overall Study|Related to study drug administration|2|||
125574991|NCT02462473|451732435|FG000|Overall Study|Death|1|||
125574992|NCT02462473|451732435|FG000|Overall Study|Other|3|||
125574993|NCT01400451|451732436|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
125574994|NCT01400451|451732437|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
125574995|NCT01400451|451732438|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
125574996|NCT01400451|451732436|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
125574997|NCT01400451|451732437|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
125574998|NCT01400451|451732438|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
125574999|NCT01400451|451732436|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
125575000|NCT01400451|451732437|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
125575001|NCT01400451|451732438|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
125575002|NCT01400451|451732436|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
125575003|NCT01400451|451732437|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
125575004|NCT01400451|451732438|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
125575005|NCT01400451|451732436|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
125575006|NCT01400451|451732437|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
125575007|NCT01400451|451732438|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
125575008|NCT01967537|451732443|FG000|Overall Study|Withdrawal by Subject|52|||
125575009|NCT01967537|451732443|FG000|Overall Study|Refuse treatment|2|||
125575010|NCT01967537|451732443|FG000|Overall Study|Lost to Follow-up|6|||
125575011|NCT02158091|451732450|FG000|Overall Study|DLT|2|||
125575012|NCT02158091|451732451|FG001|Overall Study|DLT|1|||
125575013|NCT02158091|451732452|FG002|Overall Study|DLT|0|||
125575014|NCT03977467|451732453|FG000|Overall Study|Disease Progression|1|||
125575015|NCT03977467|451732454|FG001|Overall Study|Disease Progression|1|||
125575016|NCT03977467|451732455|FG002|Overall Study|Disease Progression|30|||
125575017|NCT03977467|451732456|FG003|Overall Study|Disease Progression|0|||
125575018|NCT03977467|451732453|FG000|Overall Study|Adverse Event|0|||
125575019|NCT03977467|451732454|FG001|Overall Study|Adverse Event|1|||
125575020|NCT03977467|451732455|FG002|Overall Study|Adverse Event|0|||
125575021|NCT03977467|451732456|FG003|Overall Study|Adverse Event|0|||
125575022|NCT03977467|451732453|FG000|Overall Study|Death|0|||
125575023|NCT03977467|451732454|FG001|Overall Study|Death|0|||
125575024|NCT03977467|451732455|FG002|Overall Study|Death|3|||
125575025|NCT03977467|451732456|FG003|Overall Study|Death|0|||
125575026|NCT03977467|451732453|FG000|Overall Study|Lack of Efficacy|0|||
125575027|NCT03977467|451732454|FG001|Overall Study|Lack of Efficacy|0|||
125575028|NCT03977467|451732455|FG002|Overall Study|Lack of Efficacy|1|||
125575029|NCT03977467|451732456|FG003|Overall Study|Lack of Efficacy|0|||
125575030|NCT03977467|451732453|FG000|Overall Study|Withdrawal by Subject|2|||
125575031|NCT03977467|451732454|FG001|Overall Study|Withdrawal by Subject|1|||
125575032|NCT03977467|451732455|FG002|Overall Study|Withdrawal by Subject|4|||
125575033|NCT03977467|451732456|FG003|Overall Study|Withdrawal by Subject|0|||
125575034|NCT03977467|451732453|FG000|Overall Study|Study Terminated|1|||
125575035|NCT03977467|451732454|FG001|Overall Study|Study Terminated|0|||
125575036|NCT03977467|451732455|FG002|Overall Study|Study Terminated|0|||
125575037|NCT03977467|451732456|FG003|Overall Study|Study Terminated|1|||
125575038|NCT05913232|451732457|FG000|Overall Study|Adverse Event|0|||
125575039|NCT05913232|451732458|FG001|Overall Study|Adverse Event|2|||
125575040|NCT05913232|451732459|FG002|Overall Study|Adverse Event|1|||
125575041|NCT05913232|451732460|FG003|Overall Study|Adverse Event|1|||
125575042|NCT01627899|451732461|FG000|Overall Study|Study terminated early by sponsor.|5|||
125575043|NCT01358864|451732469|FG000|Overall Study|Adverse Event|0|||
125575044|NCT01358864|451732470|FG001|Overall Study|Adverse Event|6|||
125575045|NCT01358864|451732471|FG002|Overall Study|Adverse Event|9|||
125575046|NCT01358864|451732472|FG003|Overall Study|Adverse Event|0|||
125575047|NCT01358864|451732473|FG004|Overall Study|Adverse Event|4|||
125575048|NCT01358864|451732474|FG005|Overall Study|Adverse Event|8|||
125575049|NCT01358864|451732475|FG006|Overall Study|Adverse Event|12|||
125575050|NCT01358864|451732476|FG007|Overall Study|Adverse Event|7|||
125575051|NCT01358864|451732469|FG000|Overall Study|Lack of Efficacy|26|||
125575052|NCT01358864|451732470|FG001|Overall Study|Lack of Efficacy|3|||
125575053|NCT01358864|451732471|FG002|Overall Study|Lack of Efficacy|4|||
125575054|NCT01358864|451732472|FG003|Overall Study|Lack of Efficacy|19|||
125575055|NCT01358864|451732473|FG004|Overall Study|Lack of Efficacy|7|||
125575056|NCT01358864|451732474|FG005|Overall Study|Lack of Efficacy|4|||
125358641|NCT02651467|450950567|FG000|Overall Study|Other (Not specified)|1|||
125358642|NCT02651467|450950568|FG001|Overall Study|Other (Not specified)|0|||
125358643|NCT02651467|450950569|FG002|Overall Study|Other (Not specified)|2|||
125358644|NCT00004635|450950572|FG000|Period One|refused|2|||
125358645|NCT00004635|450950573|FG001|Period One|refused|1|||
125358646|NCT00004635|450950572|FG000|Period One|Withdrawal by Subject|1|||
125358647|NCT00004635|450950573|FG001|Period One|Withdrawal by Subject|1|||
125358648|NCT00004635|450950572|FG000|Period One|Protocol Violation|1|||
125358649|NCT00004635|450950573|FG001|Period One|Protocol Violation|0|||
125358650|NCT00004635|450950572|FG000|Period One|PSA did not go <5 ng/mL|1|||
125358651|NCT00004635|450950573|FG001|Period One|PSA did not go <5 ng/mL|0|||
125575057|NCT01358864|451732475|FG006|Overall Study|Lack of Efficacy|49|||
125575058|NCT01358864|451732476|FG007|Overall Study|Lack of Efficacy|44|||
125575059|NCT01358864|451732469|FG000|Overall Study|Lost to Follow-up|0|||
125575060|NCT01358864|451732470|FG001|Overall Study|Lost to Follow-up|0|||
125575061|NCT01358864|451732471|FG002|Overall Study|Lost to Follow-up|1|||
125575062|NCT01358864|451732472|FG003|Overall Study|Lost to Follow-up|0|||
125575063|NCT01358864|451732473|FG004|Overall Study|Lost to Follow-up|0|||
125575064|NCT01358864|451732474|FG005|Overall Study|Lost to Follow-up|0|||
125575065|NCT01358864|451732475|FG006|Overall Study|Lost to Follow-up|0|||
125575066|NCT01358864|451732476|FG007|Overall Study|Lost to Follow-up|1|||
125575067|NCT01358864|451732469|FG000|Overall Study|Withdrawal by Subject|3|||
125575068|NCT01358864|451732470|FG001|Overall Study|Withdrawal by Subject|4|||
125575069|NCT01358864|451732471|FG002|Overall Study|Withdrawal by Subject|2|||
125575070|NCT01358864|451732472|FG003|Overall Study|Withdrawal by Subject|0|||
125358652|NCT00004635|450950572|FG000|Period One|second malignancy|1|||
125575071|NCT01358864|451732473|FG004|Overall Study|Withdrawal by Subject|0|||
125575072|NCT01358864|451732474|FG005|Overall Study|Withdrawal by Subject|1|||
125358653|NCT00004635|450950573|FG001|Period One|second malignancy|0|||
125358654|NCT00004635|450950572|FG000|Period One|progressed|0|||
125575073|NCT01358864|451732475|FG006|Overall Study|Withdrawal by Subject|1|||
125575074|NCT01358864|451732476|FG007|Overall Study|Withdrawal by Subject|3|||
125575075|NCT01358864|451732469|FG000|Overall Study|Other reason not defined above|2|||
125575076|NCT01358864|451732470|FG001|Overall Study|Other reason not defined above|0|||
125575077|NCT01358864|451732471|FG002|Overall Study|Other reason not defined above|0|||
125575078|NCT01358864|451732472|FG003|Overall Study|Other reason not defined above|0|||
125575079|NCT01358864|451732473|FG004|Overall Study|Other reason not defined above|0|||
125575080|NCT01358864|451732474|FG005|Overall Study|Other reason not defined above|0|||
125575081|NCT01358864|451732475|FG006|Overall Study|Other reason not defined above|2|||
125575082|NCT01358864|451732476|FG007|Overall Study|Other reason not defined above|0|||
125575083|NCT01358864|451732469|FG000|Overall Study|Not treated|0|||
125575084|NCT01358864|451732470|FG001|Overall Study|Not treated|0|||
125575085|NCT01358864|451732471|FG002|Overall Study|Not treated|0|||
125575086|NCT01358864|451732472|FG003|Overall Study|Not treated|0|||
125575087|NCT01358864|451732473|FG004|Overall Study|Not treated|0|||
125575088|NCT01358864|451732474|FG005|Overall Study|Not treated|0|||
125575089|NCT01358864|451732475|FG006|Overall Study|Not treated|1|||
125575090|NCT01358864|451732476|FG007|Overall Study|Not treated|0|||
125575091|NCT04158648|451732484|FG000|Overall Study|Ongoing in the Study|69|||
125575092|NCT04158648|451732484|FG000|Overall Study|Withdrawal by Subject|4|||
125575093|NCT04209855|451732485|FG000|Overall Study|Death|161|||
125575094|NCT04209855|451732486|FG001|Overall Study|Death|177|||
125575095|NCT04209855|451732485|FG000|Overall Study|PI Discretion|1|||
125575096|NCT04209855|451732486|FG001|Overall Study|PI Discretion|1|||
125575097|NCT04209855|451732485|FG000|Overall Study|Lost to Follow-up|5|||
125575098|NCT04209855|451732486|FG001|Overall Study|Lost to Follow-up|2|||
125575099|NCT04209855|451732485|FG000|Overall Study|Withdrew consent|10|||
125575100|NCT04209855|451732486|FG001|Overall Study|Withdrew consent|24|||
125575101|NCT04209855|451732485|FG000|Overall Study|Sponsor decision|44|||
125575102|NCT04209855|451732486|FG001|Overall Study|Sponsor decision|18|||
125575103|NCT04209855|451732485|FG000|Overall Study|Other than specified|6|||
125575104|NCT04209855|451732486|FG001|Overall Study|Other than specified|4|||
125575105|NCT01250379|451732489|FG000|Overall Study|Death|141|||
125575106|NCT01250379|451732490|FG001|Overall Study|Death|148|||
125575107|NCT01250379|451732489|FG000|Overall Study|Withdrawal by Subject|32|||
125575108|NCT01250379|451732490|FG001|Overall Study|Withdrawal by Subject|20|||
125575109|NCT01250379|451732489|FG000|Overall Study|Physician Decision|11|||
125575110|NCT01250379|451732490|FG001|Overall Study|Physician Decision|3|||
125575111|NCT01250379|451732489|FG000|Overall Study|Protocol Violation|2|||
125575112|NCT01250379|451732490|FG001|Overall Study|Protocol Violation|8|||
125575113|NCT01250379|451732489|FG000|Overall Study|Lost to Follow-up|9|||
125575114|NCT01250379|451732490|FG001|Overall Study|Lost to Follow-up|6|||
125575115|NCT01250379|451732489|FG000|Overall Study|Adverse Event|5|||
125575116|NCT01250379|451732490|FG001|Overall Study|Adverse Event|4|||
125575117|NCT01250379|451732489|FG000|Overall Study|Other|0|||
125575118|NCT01250379|451732490|FG001|Overall Study|Other|4|||
125575119|NCT01250379|451732489|FG000|Overall Study|Participant noncompliance|2|||
125575120|NCT01250379|451732490|FG001|Overall Study|Participant noncompliance|0|||
125575121|NCT05902364|451732491|FG000|Overall Study|Adverse Event|1|||
125575122|NCT05902364|451732492|FG001|Overall Study|Adverse Event|0|||
125575123|NCT01489527|451732494|FG000|Overall Study|Pregnancy|9|||
125575124|NCT01489527|451732495|FG001|Overall Study|Pregnancy|14|||
125575125|NCT01489527|451732494|FG000|Overall Study|Participant moved|6|||
125575126|NCT01489527|451732495|FG001|Overall Study|Participant moved|7|||
125575127|NCT01489527|451732494|FG000|Overall Study|Withdrawal by Subject|0|||
125575128|NCT01489527|451732495|FG001|Overall Study|Withdrawal by Subject|4|||
125575129|NCT01489527|451732494|FG000|Overall Study|Lost to Follow-up|5|||
125358655|NCT00004635|450950573|FG001|Period One|progressed|2|||
125358656|NCT00004635|450950572|FG000|Period One|health problem|0|||
125575130|NCT01489527|451732495|FG001|Overall Study|Lost to Follow-up|1|||
125358657|NCT00004635|450950573|FG001|Period One|health problem|1|||
125575131|NCT01489527|451732494|FG000|Overall Study|Procedures|1|||
125575132|NCT01489527|451732495|FG001|Overall Study|Procedures|0|||
125575133|NCT01489527|451732494|FG000|Overall Study|Not compliant|1|||
125575134|NCT01489527|451732495|FG001|Overall Study|Not compliant|0|||
125575135|NCT01984268|451732496|FG000|Overall Study|Study Terminated|15|||
125575136|NCT04899232|451732497|FG000|Screening Period|Physician Decision|1|||
125575137|NCT04899232|451732498|FG001|Screening Period|Physician Decision|0|||
125575138|NCT04899232|451732499|FG002|Screening Period|Physician Decision|0|||
125575139|NCT04899232|451732497|FG000|Screening Period|Withdrawal by Subject|1|||
125575140|NCT04899232|451732498|FG001|Screening Period|Withdrawal by Subject|0|||
125575141|NCT04899232|451732499|FG002|Screening Period|Withdrawal by Subject|0|||
125575142|NCT04899232|451732497|FG000|Screening Period|Participant discharged before receiving intervention|3|||
125575143|NCT04899232|451732498|FG001|Screening Period|Participant discharged before receiving intervention|0|||
125575144|NCT04899232|451732499|FG002|Screening Period|Participant discharged before receiving intervention|0|||
125575145|NCT00936208|451732500|FG000|Overall Study|Protocol Violation|37|||
125575146|NCT00936208|451732501|FG001|Overall Study|Protocol Violation|22|||
125575147|NCT01344876|451732505|FG000|Overall Study|Adverse Event|0|||
125575148|NCT01344876|451732506|FG001|Overall Study|Adverse Event|0|||
125575149|NCT01344876|451732507|FG002|Overall Study|Adverse Event|0|||
125575150|NCT01344876|451732508|FG003|Overall Study|Adverse Event|0|||
125575151|NCT01344876|451732509|FG004|Overall Study|Adverse Event|1|||
125575152|NCT01344876|451732505|FG000|Overall Study|Withdrawal by Subject|0|||
125575153|NCT01344876|451732506|FG001|Overall Study|Withdrawal by Subject|0|||
125575154|NCT01344876|451732507|FG002|Overall Study|Withdrawal by Subject|1|||
125575155|NCT01344876|451732508|FG003|Overall Study|Withdrawal by Subject|0|||
125575156|NCT01344876|451732509|FG004|Overall Study|Withdrawal by Subject|0|||
125575157|NCT01344876|451732505|FG000|Overall Study|Definite progression of primary disease|1|||
125575158|NCT01344876|451732506|FG001|Overall Study|Definite progression of primary disease|0|||
125575159|NCT01344876|451732507|FG002|Overall Study|Definite progression of primary disease|0|||
125575160|NCT01344876|451732508|FG003|Overall Study|Definite progression of primary disease|3|||
125575161|NCT01344876|451732509|FG004|Overall Study|Definite progression of primary disease|0|||
125575162|NCT04428424|451732510|FG000|Overall Study|Does not meet entrance criteria|132|||
125575163|NCT04428424|451732510|FG000|Overall Study|Lost to Follow-up|115|||
125575164|NCT04622046|451732514|FG000|Intervention Period|Adverse Event|1|||
125575165|NCT04622046|451732514|FG000|Intervention Period|Withdrawal by Subject|2|||
125575166|NCT04622046|451732514|FG000|Extension Period|Ongoing in the Extension Period|21|||
125575167|NCT04647253|451732515|FG000|Overall Study|Death ≤ 365 Days|16|||
125575168|NCT04647253|451732516|FG001|Overall Study|Death ≤ 365 Days|7|||
125575169|NCT04647253|451732515|FG000|Overall Study|Physician Decision|0|||
125575170|NCT04647253|451732516|FG001|Overall Study|Physician Decision|1|||
125575171|NCT04647253|451732515|FG000|Overall Study|Withdrawal by Subject|7|||
125575172|NCT04647253|451732516|FG001|Overall Study|Withdrawal by Subject|2|||
125575173|NCT04647253|451732515|FG000|Overall Study|Missed 12-Month Visit|9|||
125575174|NCT04647253|451732516|FG001|Overall Study|Missed 12-Month Visit|7|||
125575175|NCT04647253|451732515|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
125575176|NCT04647253|451732516|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
125575177|NCT02396589|451732517|FG000|Intervention|Lost to Follow-up|1|||
125575178|NCT02396589|451732518|FG001|Intervention|Lost to Follow-up|0|||
125575179|NCT02396589|451732517|FG000|6 Month Follow-up|change in health status|0|||
125575180|NCT02396589|451732518|FG001|6 Month Follow-up|change in health status|1|||
125575181|NCT02396589|451732517|FG000|9 Month Follow-up|Death|0|||
125575182|NCT02396589|451732518|FG001|9 Month Follow-up|Death|1|||
125575183|NCT02396589|451732517|FG000|12 Month Follow up|Lost to Follow-up|0|||
125575184|NCT02396589|451732518|FG001|12 Month Follow up|Lost to Follow-up|2|||
125575185|NCT04341948|451732519|FG000|Overall Study|Adverse Event|0|||
125575186|NCT04341948|451732520|FG001|Overall Study|Adverse Event|1|||
125575187|NCT04341948|451732519|FG000|Overall Study|Lost to Follow-up|6|||
125575188|NCT04341948|451732520|FG001|Overall Study|Lost to Follow-up|1|||
125575189|NCT04341948|451732519|FG000|Overall Study|Physician Decision|1|||
125575190|NCT04341948|451732520|FG001|Overall Study|Physician Decision|2|||
125575191|NCT04341948|451732519|FG000|Overall Study|Withdrawal by Participant|6|||
125575192|NCT04341948|451732520|FG001|Overall Study|Withdrawal by Participant|3|||
125575193|NCT04341948|451732519|FG000|Overall Study|Lack of compliance by Participant|1|||
125575194|NCT04341948|451732520|FG001|Overall Study|Lack of compliance by Participant|0|||
125575195|NCT01284114|451734022|FG000|Overall Study|viral infection|1|||
125575196|NCT01284114|451734022|FG000|Overall Study|From the results of ALLTITUDE study|1|||
125575197|NCT01284114|451734022|FG000|Overall Study|Symptomatic hypotension|1|||
125575198|NCT01284114|451734022|FG000|Overall Study|dizziness|1|||
125575199|NCT03445000|451734024|FG000|Overall Study|Disease progression|8|||
125575200|NCT03445000|451734024|FG000|Overall Study|Adverse Event|3|||
125575201|NCT03445000|451734024|FG000|Overall Study|Death|2|||
125575202|NCT03445000|451734024|FG000|Overall Study|Physician Decision|1|||
125575203|NCT03409744|451734025|FG000|Overall Study|Death|2|||
125575204|NCT03409744|451734025|FG000|Overall Study|Physician Decision|5|||
125575205|NCT03409744|451734025|FG000|Overall Study|Pregnancy|1|||
125575206|NCT03409744|451734025|FG000|Overall Study|Lost to Follow-up|1|||
125575207|NCT03409744|451734025|FG000|Overall Study|Protocol Violation|1|||
125575208|NCT03704194|451734038|FG000|Overall Study|Withdrawal by Subject|0|||
125575209|NCT03704194|451734039|FG001|Overall Study|Withdrawal by Subject|1|||
125575210|NCT04656652|451734044|FG000|Overall Study|Lost to Follow-up|2|||
125575211|NCT04656652|451734045|FG001|Overall Study|Lost to Follow-up|2|||
125575212|NCT04656652|451734044|FG000|Overall Study|Death|213|||
125575213|NCT04656652|451734045|FG001|Overall Study|Death|212|||
125575214|NCT04656652|451734044|FG000|Overall Study|Other|1|||
125575215|NCT04656652|451734045|FG001|Overall Study|Other|0|||
125575216|NCT04656652|451734044|FG000|Overall Study|Withdrawal by Subject|15|||
125575217|NCT04656652|451734045|FG001|Overall Study|Withdrawal by Subject|29|||
125575218|NCT03118297|451734046|FG000|Overall Study|Lost to Follow-up|0|||
125575219|NCT03118297|451734047|FG001|Overall Study|Lost to Follow-up|2|||
125575220|NCT02479802|451734048|FG000|Overall Study|Lost to Follow-up|1|||
125575221|NCT02479802|451734048|FG000|Overall Study|Adverse Event|1|||
125575222|NCT01978093|451734049|FG000|Overall Study|Death|1|||
125575223|NCT01978093|451734050|FG001|Overall Study|Death|0|||
125575224|NCT01978093|451734049|FG000|Overall Study|Adverse Event|0|||
125575225|NCT01978093|451734050|FG001|Overall Study|Adverse Event|5|||
125575226|NCT01978093|451734049|FG000|Overall Study|Protocol Violation|8|||
125575227|NCT01978093|451734050|FG001|Overall Study|Protocol Violation|2|||
125575228|NCT01978093|451734049|FG000|Overall Study|Withdrawal by Subject|29|||
125575229|NCT01978093|451734050|FG001|Overall Study|Withdrawal by Subject|25|||
125575230|NCT01978093|451734049|FG000|Overall Study|Lost to Follow-up|11|||
125575231|NCT01978093|451734050|FG001|Overall Study|Lost to Follow-up|15|||
125575232|NCT01978093|451734049|FG000|Overall Study|Migrated/moved from study area|11|||
125575233|NCT01978093|451734050|FG001|Overall Study|Migrated/moved from study area|13|||
125575234|NCT01978093|451734049|FG000|Overall Study|Loss of kaiser coverage|4|||
125575235|NCT01978093|451734050|FG001|Overall Study|Loss of kaiser coverage|10|||
125575236|NCT01978093|451734049|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
125575237|NCT01978093|451734050|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
125575238|NCT01978093|451734049|FG000|Overall Study|Mother lost custody of child|0|||
125575239|NCT01978093|451734050|FG001|Overall Study|Mother lost custody of child|1|||
125575240|NCT01978093|451734049|FG000|Overall Study|Child was in care of grandmother|0|||
125575241|NCT01978093|451734050|FG001|Overall Study|Child was in care of grandmother|1|||
125427184|NCT04067401|451189288|FG001|Overall Study|no data provided|0|||
125427185|NCT01477853|451189289|FG000|Phase A|Adverse Event|1|||
125427186|NCT01477853|451189290|FG001|Phase A|Adverse Event|2|||
125427187|NCT01477853|451189291|FG002|Phase A|Adverse Event|2|||
125427188|NCT01477853|451189289|FG000|Phase A|Lost to Follow-up|4|||
125427189|NCT01477853|451189290|FG001|Phase A|Lost to Follow-up|3|||
125427190|NCT01477853|451189291|FG002|Phase A|Lost to Follow-up|2|||
125427191|NCT01477853|451189289|FG000|Phase A|Physician Decision|1|||
125427192|NCT01477853|451189290|FG001|Phase A|Physician Decision|0|||
125427193|NCT01477853|451189291|FG002|Phase A|Physician Decision|1|||
125427194|NCT01477853|451189289|FG000|Phase A|Study terminated by sponsor|37|||
125427195|NCT01477853|451189290|FG001|Phase A|Study terminated by sponsor|40|||
125427196|NCT01477853|451189291|FG002|Phase A|Study terminated by sponsor|39|||
125427197|NCT01477853|451189289|FG000|Phase B|Lost to Follow-up|0|||
125427198|NCT01477853|451189290|FG001|Phase B|Lost to Follow-up|1|||
125575242|NCT01978093|451734049|FG000|Overall Study|N/A for vaccine administration|0|||
125427199|NCT01477853|451189291|FG002|Phase B|Lost to Follow-up|0|||
125427200|NCT01477853|451189289|FG000|Phase B|Study terminated by sponsor|12|||
125427201|NCT01477853|451189290|FG001|Phase B|Study terminated by sponsor|10|||
125427202|NCT01477853|451189291|FG002|Phase B|Study terminated by sponsor|11|||
125575243|NCT01978093|451734050|FG001|Overall Study|N/A for vaccine administration|1|||
125575244|NCT02469090|451734054|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
125575245|NCT02469090|451734055|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
125575246|NCT02469090|451734056|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
125575247|NCT02469090|451734054|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
125575248|NCT02469090|451734055|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
125575249|NCT02469090|451734056|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
125575250|NCT02469090|451734054|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
125575251|NCT02469090|451734055|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
125575252|NCT02469090|451734056|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
125575253|NCT02469090|451734054|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
125575254|NCT02469090|451734055|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
125575255|NCT02469090|451734056|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
125575256|NCT02469090|451734054|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
125575257|NCT02469090|451734055|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
125575258|NCT02469090|451734056|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
125575259|NCT02469090|451734054|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
125575260|NCT02469090|451734055|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
125575261|NCT02469090|451734056|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
125575262|NCT02469090|451734054|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
125575263|NCT02469090|451734055|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
125575264|NCT02469090|451734056|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
125575265|NCT02469090|451734054|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
125575266|NCT02469090|451734055|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
125575267|NCT02469090|451734056|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
125575268|NCT03286842|451734059|FG000|Overall Study|Patients rolled over to another study|80|||
125575269|NCT01391507|451734063|FG000|Overall Study|Death|0|||
125575270|NCT01391507|451734064|FG001|Overall Study|Death|0|||
125575271|NCT01391507|451734065|FG002|Overall Study|Death|0|||
125575272|NCT01391507|451734066|FG003|Overall Study|Death|1|||
125575273|NCT01391507|451734063|FG000|Overall Study|Adverse Event|1|||
125575274|NCT01391507|451734064|FG001|Overall Study|Adverse Event|1|||
125575275|NCT01391507|451734065|FG002|Overall Study|Adverse Event|2|||
125575276|NCT01391507|451734066|FG003|Overall Study|Adverse Event|2|||
125575277|NCT01391507|451734063|FG000|Overall Study|Withdrawal by Subject|1|||
125575278|NCT01391507|451734064|FG001|Overall Study|Withdrawal by Subject|2|||
125575279|NCT01391507|451734065|FG002|Overall Study|Withdrawal by Subject|1|||
125575280|NCT01391507|451734066|FG003|Overall Study|Withdrawal by Subject|1|||
125575281|NCT01391507|451734063|FG000|Overall Study|Lack of Efficacy|0|||
125575282|NCT01391507|451734064|FG001|Overall Study|Lack of Efficacy|0|||
125575283|NCT01391507|451734065|FG002|Overall Study|Lack of Efficacy|0|||
125575284|NCT01391507|451734066|FG003|Overall Study|Lack of Efficacy|1|||
125575285|NCT01391507|451734063|FG000|Overall Study|Protocol Violation|2|||
125575286|NCT01391507|451734064|FG001|Overall Study|Protocol Violation|1|||
125575287|NCT01391507|451734065|FG002|Overall Study|Protocol Violation|1|||
125358658|NCT00004635|450950572|FG000|Period One|discrepancy in data entry|0|||
125358659|NCT00004635|450950573|FG001|Period One|discrepancy in data entry|1|||
125358660|NCT00004635|450950572|FG000|Period Two|progression|2|||
125358661|NCT00004635|450950573|FG001|Period Two|progression|3|||
125358662|NCT00004635|450950572|FG000|Period Two|Adverse Event|1|||
125358663|NCT00004635|450950573|FG001|Period Two|Adverse Event|0|||
125358664|NCT00004635|450950572|FG000|Period Two|refused|0|||
125358665|NCT00004635|450950573|FG001|Period Two|refused|2|||
125358666|NCT00004635|450950572|FG000|Period Two|health problem|1|||
125358667|NCT00004635|450950573|FG001|Period Two|health problem|1|||
125358668|NCT00004635|450950572|FG000|Period Two|travel issues|0|||
125358669|NCT00004635|450950573|FG001|Period Two|travel issues|1|||
125358670|NCT00004635|450950572|FG000|Period Two|secondary malignancy|1|||
125358671|NCT00004635|450950573|FG001|Period Two|secondary malignancy|1|||
125358672|NCT00004635|450950572|FG000|Period Two|Lost to Follow-up|1|||
125358673|NCT00004635|450950573|FG001|Period Two|Lost to Follow-up|0|||
125358674|NCT00004635|450950572|FG000|Period Two|discrepancy in data entry|0|||
125358675|NCT00004635|450950573|FG001|Period Two|discrepancy in data entry|1|||
125358676|NCT00408629|450950574|FG000|Overall Study|Adverse Event|13|||
125358677|NCT00408629|450950575|FG001|Overall Study|Adverse Event|27|||
125575288|NCT01391507|451734066|FG003|Overall Study|Protocol Violation|2|||
125575289|NCT01453855|451734067|FG000|Overall Study|Adverse Event|3|||
125575290|NCT01453855|451734068|FG001|Overall Study|Adverse Event|4|||
125575291|NCT01453855|451734067|FG000|Overall Study|Lost to Follow-up|2|||
125575292|NCT01453855|451734068|FG001|Overall Study|Lost to Follow-up|1|||
125575293|NCT01453855|451734067|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
125575294|NCT01453855|451734068|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
125575295|NCT01453855|451734067|FG000|Overall Study|Noncompliance|1|||
125575296|NCT01453855|451734068|FG001|Overall Study|Noncompliance|0|||
125575297|NCT01453855|451734067|FG000|Overall Study|Inadequate Control of IOP|1|||
125575298|NCT01453855|451734068|FG001|Overall Study|Inadequate Control of IOP|5|||
125575299|NCT01453855|451734067|FG000|Overall Study|Other|0|||
125575300|NCT01453855|451734068|FG001|Overall Study|Other|1|||
125575301|NCT01562548|451734077|FG000|Overall Study|Lost to Follow-up|0|||
125575302|NCT01562548|451734078|FG001|Overall Study|Lost to Follow-up|0|||
125575303|NCT01562548|451734079|FG002|Overall Study|Lost to Follow-up|1|||
125575304|NCT01562548|451734080|FG003|Overall Study|Lost to Follow-up|0|||
125575305|NCT01496066|451734081|FG000|Overall Study|Lost to Follow-up|8|||
125575306|NCT01496066|451734082|FG001|Overall Study|Lost to Follow-up|5|||
125575307|NCT01496066|451734081|FG000|Overall Study|Explant|3|||
125575308|NCT01496066|451734082|FG001|Overall Study|Explant|0|||
125575309|NCT01496066|451734081|FG000|Overall Study|Death|1|||
125575310|NCT01496066|451734082|FG001|Overall Study|Death|4|||
125575311|NCT01441063|451734083|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
125575312|NCT01441063|451734083|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
125575313|NCT01079182|451734102|FG000|Overall Study|Lost to Follow-up|1634|||
125575314|NCT01079182|451734102|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
125575315|NCT01079182|451734102|FG000|Overall Study|Lack of Efficacy|514|||
125575316|NCT01079182|451734102|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
125575317|NCT01079182|451734102|FG000|Overall Study|Reasons not Evaluated|271|||
125575318|NCT00903929|451734105|FG000|Overall Study|Withdrawal by Subject|0|||
125575319|NCT00903929|451734106|FG001|Overall Study|Withdrawal by Subject|0|||
125575320|NCT00903929|451734107|FG002|Overall Study|Withdrawal by Subject|1|||
125575321|NCT00903929|451734108|FG003|Overall Study|Withdrawal by Subject|2|||
125575322|NCT00903929|451734105|FG000|Overall Study|Adverse Event|0|||
125575323|NCT00903929|451734106|FG001|Overall Study|Adverse Event|0|||
125575324|NCT00903929|451734107|FG002|Overall Study|Adverse Event|0|||
125575325|NCT00903929|451734108|FG003|Overall Study|Adverse Event|1|||
125575326|NCT00516737|451734109|FG000|Overall Study|Lost to Follow-up|2|||
125575327|NCT00516737|451734110|FG001|Overall Study|Lost to Follow-up|0|||
125575328|NCT00516737|451734109|FG000|Overall Study|Physician Decision|0|||
125575329|NCT00516737|451734110|FG001|Overall Study|Physician Decision|1|||
125575330|NCT00516737|451734109|FG000|Overall Study|Withdrawal by Subject|0|||
125575331|NCT00516737|451734110|FG001|Overall Study|Withdrawal by Subject|1|||
125575332|NCT00516737|451734109|FG000|Overall Study|Lack of Qualifying Event|9|||
125575333|NCT00516737|451734110|FG001|Overall Study|Lack of Qualifying Event|6|||
125575334|NCT01844895|451734111|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
125575335|NCT01844895|451734111|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
125575336|NCT01844895|451734111|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
125575337|NCT01844895|451734111|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
125575338|NCT01844895|451734111|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
125575339|NCT01844895|451734111|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
125575340|NCT01844895|451734111|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
125575341|NCT00512798|451734112|FG000|Overall Study|Death|0|||
125575342|NCT00512798|451734113|FG001|Overall Study|Death|3|||
125575343|NCT00512798|451734112|FG000|Overall Study|Adverse Event|2|||
125575344|NCT00512798|451734113|FG001|Overall Study|Adverse Event|4|||
125575345|NCT00512798|451734112|FG000|Overall Study|Progression of disease|14|||
125575346|NCT00512798|451734113|FG001|Overall Study|Progression of disease|20|||
125575347|NCT00512798|451734112|FG000|Overall Study|Withdrawal by Subject|3|||
125575348|NCT00512798|451734113|FG001|Overall Study|Withdrawal by Subject|0|||
125575349|NCT02508194|451734116|FG000|Overall Study|Death|5|||
125575350|NCT02508194|451734117|FG001|Overall Study|Death|3|||
125575351|NCT02508194|451734116|FG000|Overall Study|Lost to Follow-up|25|||
125575352|NCT02508194|451734117|FG001|Overall Study|Lost to Follow-up|18|||
125575353|NCT02508194|451734116|FG000|Overall Study|Withdrawal by Subject|20|||
125575354|NCT02508194|451734117|FG001|Overall Study|Withdrawal by Subject|18|||
125575355|NCT02508194|451734116|FG000|Overall Study|Error in Randomization|1|||
125575356|NCT02508194|451734117|FG001|Overall Study|Error in Randomization|3|||
125575357|NCT02508194|451734116|FG000|Overall Study|Principal Investigator Decision|1|||
125575358|NCT02508194|451734117|FG001|Overall Study|Principal Investigator Decision|2|||
125575359|NCT00511355|451734118|FG000|Overall Study|Adverse Event|4|||
125575360|NCT00511355|451734119|FG001|Overall Study|Adverse Event|4|||
125575361|NCT00511355|451734118|FG000|Overall Study|Pregnancy Wish|1|||
125427203|NCT01050816|451189292|FG000|Overall Study|Lost to Follow-up|2|||
125427204|NCT01050816|451189292|FG000|Overall Study|patient's refusal|2|||
125427205|NCT00948974|451189298|FG000|Overall Study|Lost to Follow-up|23|||
125427206|NCT00948974|451189299|FG001|Overall Study|Lost to Follow-up|20|||
125427207|NCT00238433|451189301|FG000|Overall Study|Screen failure|1|||
125427208|NCT00238433|451189301|FG000|Overall Study|Lost to Follow-up|1|||
125427209|NCT00238433|451189301|FG000|Overall Study|Death|1|||
125427210|NCT01814748|451189304|FG000|Overall Study|Lost to Follow-up|1|||
125211110|NCT04767529|450398580|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
125427211|NCT01814748|451189305|FG001|Overall Study|Lost to Follow-up|2|||
125575362|NCT00511355|451734119|FG001|Overall Study|Pregnancy Wish|0|||
125575363|NCT00511355|451734118|FG000|Overall Study|Lost to Follow-up|2|||
125575364|NCT00511355|451734119|FG001|Overall Study|Lost to Follow-up|1|||
125575365|NCT00511355|451734118|FG000|Overall Study|Other Reason|0|||
125575366|NCT00511355|451734119|FG001|Overall Study|Other Reason|1|||
125575367|NCT00511355|451734118|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
125575368|NCT00511355|451734119|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
125575369|NCT00511355|451734118|FG000|Overall Study|Withdrawal of informed consent|0|||
125427212|NCT01814748|451189304|FG000|Overall Study|Study site terminated by sponsor|1|||
125575370|NCT00511355|451734119|FG001|Overall Study|Withdrawal of informed consent|1|||
125575371|NCT00511355|451734118|FG000|Overall Study|Other reason pre-treatment|0|||
125575372|NCT00511355|451734119|FG001|Overall Study|Other reason pre-treatment|1|||
125575373|NCT00454805|451734126|FG000|Overall Study|Withdrawal by Subject|9|||
125575374|NCT00454805|451734127|FG001|Overall Study|Withdrawal by Subject|2|||
125575375|NCT00454805|451734126|FG000|Overall Study|Death|0|||
125575376|NCT00454805|451734127|FG001|Overall Study|Death|2|||
125575377|NCT00454805|451734126|FG000|Overall Study|Disease progression|16|||
125575378|NCT00454805|451734127|FG001|Overall Study|Disease progression|19|||
125575379|NCT00454805|451734126|FG000|Overall Study|In order to begin radiotherapy|1|||
125575380|NCT00454805|451734127|FG001|Overall Study|In order to begin radiotherapy|0|||
125575381|NCT03742037|451734128|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
125427213|NCT01814748|451189305|FG001|Overall Study|Study site terminated by sponsor|1|||
125427214|NCT01814748|451189304|FG000|Overall Study|Withdrawal by Subject|6|||
125575382|NCT03742037|451734129|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
125427215|NCT01814748|451189305|FG001|Overall Study|Withdrawal by Subject|4|||
125427216|NCT01445652|451189307|FG000|Overall Study|Not comfortable in lenses|5|||
125427217|NCT01445652|451189308|FG001|Overall Study|Not comfortable in lenses|0|||
125427218|NCT01445652|451189307|FG000|Overall Study|Failed to attend scheduled visit|2|||
125427219|NCT01445652|451189308|FG001|Overall Study|Failed to attend scheduled visit|3|||
125427220|NCT01445652|451189307|FG000|Overall Study|Failed teach session|2|||
125427221|NCT01445652|451189308|FG001|Overall Study|Failed teach session|0|||
125427222|NCT01445652|451189307|FG000|Overall Study|Adverse Event|1|||
125427223|NCT01445652|451189308|FG001|Overall Study|Adverse Event|0|||
125427224|NCT02436811|451189309|FG000|Overall Study|Lost to Follow-up|2|||
125427225|NCT02436811|451189310|FG001|Overall Study|Lost to Follow-up|9|||
125427226|NCT02436811|451189311|FG002|Overall Study|Lost to Follow-up|7|||
125427227|NCT03595332|451189312|FG000|Overall Study|Lost to Follow-up|16|||
125427228|NCT03595332|451189313|FG001|Overall Study|Lost to Follow-up|22|||
125427229|NCT03595332|451189312|FG000|Overall Study|Unable to retrieve ID from school|0|||
125427230|NCT03595332|451189313|FG001|Overall Study|Unable to retrieve ID from school|2|||
125427231|NCT02227875|451189314|FG000|Overall Study|Protocol Violation|10|||
125427232|NCT02227875|451189315|FG001|Overall Study|Protocol Violation|7|||
125427233|NCT02227875|451189314|FG000|Overall Study|Other|1|||
125427234|NCT02227875|451189315|FG001|Overall Study|Other|3|||
125427235|NCT02227875|451189314|FG000|Overall Study|Physician Decision|1|||
125427236|NCT02227875|451189315|FG001|Overall Study|Physician Decision|0|||
125427237|NCT02227875|451189314|FG000|Overall Study|Adverse Event|3|||
125427238|NCT02227875|451189315|FG001|Overall Study|Adverse Event|0|||
125427239|NCT02227875|451189314|FG000|Overall Study|Withdrawal by Subject|12|||
125427240|NCT02227875|451189315|FG001|Overall Study|Withdrawal by Subject|13|||
125427241|NCT02227875|451189314|FG000|Overall Study|Lost to Follow-up|10|||
125427242|NCT02227875|451189315|FG001|Overall Study|Lost to Follow-up|10|||
125427243|NCT04209725|451189318|FG000|Overall Study|Adverse Event|1|||
125427244|NCT01201811|451189319|FG000|Overall Study|Adverse Event|6|||
125427245|NCT01201811|451189319|FG000|Overall Study|Disease progression|3|||
125427246|NCT01201811|451189319|FG000|Overall Study|Withdrawal by Subject|3|||
125427247|NCT01201811|451189319|FG000|Overall Study|Death|4|||
125427248|NCT01201811|451189319|FG000|Overall Study|Treatment Failure|2|||
125427249|NCT01201811|451189319|FG000|Overall Study|Physician Decision|1|||
125427250|NCT02657317|451189320|FG000|Overall Study|Withdrawal by Subject|2|||
125575383|NCT03742037|451734130|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
125575384|NCT03742037|451734131|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
125427251|NCT02657317|451189321|FG001|Overall Study|Withdrawal by Subject|0|||
125427252|NCT02657317|451189320|FG000|Overall Study|Lost to Follow-up|3|||
125427253|NCT02657317|451189321|FG001|Overall Study|Lost to Follow-up|3|||
125427254|NCT00117676|451189322|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
125427255|NCT00117676|451189323|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
125427256|NCT00117676|451189322|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
125427257|NCT00117676|451189323|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
125575385|NCT03742037|451734132|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
125575386|NCT03742037|451734133|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
125427258|NCT00117676|451189322|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
125427259|NCT00117676|451189323|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
125427260|NCT00117676|451189322|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
125575387|NCT03742037|451734134|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
125575388|NCT03742037|451734128|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
125575389|NCT03742037|451734129|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
125575390|NCT03742037|451734130|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
125575391|NCT03742037|451734131|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
125575392|NCT03742037|451734132|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
125575393|NCT03742037|451734133|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
125575394|NCT03742037|451734134|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
125575395|NCT03742037|451734128|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
125575396|NCT03742037|451734129|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
125575397|NCT03742037|451734130|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
125575398|NCT03742037|451734131|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
125575399|NCT03742037|451734132|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
125575400|NCT03742037|451734133|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
125575401|NCT03742037|451734134|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
125575402|NCT03742037|451734128|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
125575403|NCT03742037|451734129|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
125575404|NCT03742037|451734130|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
125575405|NCT03742037|451734131|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
125575406|NCT03742037|451734132|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
125575407|NCT03742037|451734133|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
125575408|NCT03742037|451734134|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
125575409|NCT03742037|451734128|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
125575410|NCT03742037|451734129|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
125575411|NCT03742037|451734130|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
125575412|NCT03742037|451734131|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
125575413|NCT03742037|451734132|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
125575414|NCT03742037|451734133|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
125575415|NCT03742037|451734134|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
125575416|NCT03742037|451734128|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
125575417|NCT03742037|451734129|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
125575418|NCT03742037|451734130|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
125575419|NCT03742037|451734131|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
125575420|NCT03742037|451734132|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
125575421|NCT03742037|451734133|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
125575422|NCT03742037|451734134|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
125575423|NCT03742037|451734128|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
125575424|NCT03742037|451734129|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
125575425|NCT03742037|451734130|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
125575426|NCT03742037|451734131|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
125575427|NCT03742037|451734132|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
125575428|NCT03742037|451734133|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
125575429|NCT03742037|451734134|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
125575430|NCT03742037|451734128|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
125575431|NCT03742037|451734129|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
125575432|NCT03742037|451734130|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
125575433|NCT03742037|451734131|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
125575434|NCT03742037|451734132|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
125575435|NCT03742037|451734133|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
125575436|NCT03742037|451734134|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
125575437|NCT03742037|451734128|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
125575438|NCT03742037|451734129|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
125575439|NCT03742037|451734130|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
125575440|NCT03742037|451734131|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
125575441|NCT03742037|451734132|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
125575442|NCT03742037|451734133|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
125575443|NCT03742037|451734134|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
125575444|NCT03742037|451734128|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
125575445|NCT03742037|451734129|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
125575446|NCT03742037|451734130|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
125211111|NCT04767529|450398578|FG000|Overall Study|Lost to Follow-up|0|||
125211112|NCT04767529|450398579|FG001|Overall Study|Lost to Follow-up|2|||
125358678|NCT00408629|450950574|FG000|Overall Study|Withdrawal by Subject|8|||
125358679|NCT00408629|450950575|FG001|Overall Study|Withdrawal by Subject|4|||
125358680|NCT00408629|450950574|FG000|Overall Study|Lost to Follow-up|1|||
125358681|NCT00408629|450950575|FG001|Overall Study|Lost to Follow-up|1|||
125358682|NCT00408629|450950574|FG000|Overall Study|Lack of Efficacy|63|||
125575447|NCT03742037|451734131|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
125575448|NCT03742037|451734132|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
125575449|NCT03742037|451734133|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
125575450|NCT03742037|451734134|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
125575451|NCT03742037|451734128|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
125575452|NCT03742037|451734129|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
125575453|NCT03742037|451734130|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
125575454|NCT03742037|451734131|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
125575455|NCT03742037|451734132|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
125575456|NCT03742037|451734133|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
125575457|NCT03742037|451734134|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
125575458|NCT03742037|451734128|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
125575459|NCT03742037|451734129|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
125575460|NCT03742037|451734130|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
125575461|NCT03742037|451734131|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
125575462|NCT03742037|451734132|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
125575463|NCT03742037|451734133|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
125575464|NCT03742037|451734134|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
125575465|NCT03742037|451734128|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
125575466|NCT03742037|451734129|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
125575467|NCT03742037|451734130|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
125575468|NCT03742037|451734131|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
125575469|NCT03742037|451734132|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
125575470|NCT03742037|451734133|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
125575471|NCT03742037|451734134|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
125575472|NCT03742037|451734128|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
125575473|NCT03742037|451734129|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
125575474|NCT03742037|451734130|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
125575475|NCT03742037|451734131|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
125575476|NCT03742037|451734132|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
125575477|NCT03742037|451734133|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
125575478|NCT03742037|451734134|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
125575479|NCT03742037|451734128|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
125575480|NCT03742037|451734129|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
125575481|NCT03742037|451734130|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
125575482|NCT03742037|451734131|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
125575483|NCT03742037|451734132|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
125575484|NCT03742037|451734133|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
125575485|NCT03742037|451734134|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
125575486|NCT03208231|451734145|FG000|Overall Study|Death|1|||
125575487|NCT03208231|451734146|FG001|Overall Study|Death|2|||
125575488|NCT03208231|451734145|FG000|Overall Study|Moved and unable to get to clinic|1|||
125575489|NCT03208231|451734146|FG001|Overall Study|Moved and unable to get to clinic|0|||
125575490|NCT03208231|451734145|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
125575491|NCT03208231|451734146|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
125575492|NCT04347239|451734150|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
125575493|NCT04347239|451734151|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
125575494|NCT04347239|451734152|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
125575495|NCT04347239|451734150|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
125575496|NCT04347239|451734151|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
125575497|NCT04347239|451734152|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
125575498|NCT02289950|451734154|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
125575499|NCT02289950|451734155|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
125575500|NCT02289950|451734154|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
125575501|NCT02289950|451734155|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
125575502|NCT02289950|451734154|FG000|Overall Study|Lost to Follow-up|1|||
125575503|NCT02289950|451734155|FG001|Overall Study|Lost to Follow-up|0|||
125575504|NCT02289950|451734154|FG000|Overall Study|Physician Decision|9|||
125575505|NCT02289950|451734155|FG001|Overall Study|Physician Decision|3|||
125575506|NCT02289950|451734154|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
125358683|NCT00408629|450950575|FG001|Overall Study|Lack of Efficacy|73|||
125575507|NCT02289950|451734155|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
125575508|NCT02289950|451734154|FG000|Overall Study|Withdrawal by Subject|1|||
125575509|NCT02289950|451734155|FG001|Overall Study|Withdrawal by Subject|3|||
125575510|NCT02289950|451734154|FG000|Overall Study|Test article held for greater than 28 days|0|||
125575511|NCT02289950|451734155|FG001|Overall Study|Test article held for greater than 28 days|1|||
125575512|NCT02289950|451734154|FG000|Overall Study|Adverse Event|11|||
125575513|NCT02289950|451734155|FG001|Overall Study|Adverse Event|3|||
125575514|NCT02289950|451734154|FG000|Overall Study|Death|1|||
125575515|NCT02289950|451734155|FG001|Overall Study|Death|1|||
125575516|NCT02289950|451734154|FG000|Overall Study|Other|5|||
125575517|NCT02289950|451734155|FG001|Overall Study|Other|2|||
125575518|NCT02289950|451734154|FG000|Overall Study|Not Treated|2|||
125575519|NCT02289950|451734155|FG001|Overall Study|Not Treated|1|||
125575520|NCT02270242|451734156|FG000|Overall Study|Withdrawal by Subject|18|||
125575521|NCT02270242|451734157|FG001|Overall Study|Withdrawal by Subject|25|||
125575522|NCT02270242|451734156|FG000|Overall Study|Lost to Follow-up|41|||
125575523|NCT02270242|451734157|FG001|Overall Study|Lost to Follow-up|27|||
125575524|NCT02270242|451734156|FG000|Overall Study|Physician Decision|0|||
125575525|NCT02270242|451734157|FG001|Overall Study|Physician Decision|1|||
125575526|NCT02321436|451734160|FG000|Overall Study|Withdrawal by Subject|1|||
125575527|NCT02321436|451734161|FG001|Overall Study|Withdrawal by Subject|0|||
125575528|NCT02321436|451734160|FG000|Overall Study|Lost to Follow-up|0|||
125575529|NCT02321436|451734161|FG001|Overall Study|Lost to Follow-up|1|||
125575530|NCT00644787|451734162|FG000|Period 1: Titration Phase|Adverse Event|11|||
125575531|NCT00644787|451734163|FG001|Period 1: Titration Phase|Adverse Event|0|||
125575532|NCT00644787|451734164|FG002|Period 1: Titration Phase|Adverse Event|0|||
125575533|NCT00644787|451734162|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
125575534|NCT00644787|451734163|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
125575535|NCT00644787|451734164|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
125575536|NCT00644787|451734162|FG000|Period 1: Titration Phase|Physician Decision|1|||
125575537|NCT00644787|451734163|FG001|Period 1: Titration Phase|Physician Decision|0|||
125575538|NCT00644787|451734164|FG002|Period 1: Titration Phase|Physician Decision|0|||
125575539|NCT00644787|451734162|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
125575540|NCT00644787|451734163|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
125575541|NCT00644787|451734164|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
125575542|NCT00644787|451734162|FG000|Period 1: Titration Phase|Worsening of complications|1|||
125575543|NCT00644787|451734163|FG001|Period 1: Titration Phase|Worsening of complications|0|||
125575544|NCT00644787|451734164|FG002|Period 1: Titration Phase|Worsening of complications|0|||
125575545|NCT00644787|451734162|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
125575546|NCT00644787|451734163|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
125575547|NCT00644787|451734164|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
125575548|NCT00644787|451734162|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
125575549|NCT00644787|451734163|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
125575550|NCT00644787|451734164|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
125575551|NCT00644787|451734162|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
125575552|NCT00644787|451734163|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
125575553|NCT00644787|451734164|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
125575554|NCT00644787|451734162|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
125575555|NCT00644787|451734163|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
125575556|NCT00644787|451734164|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
125575557|NCT00644787|451734162|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
125575558|NCT00644787|451734163|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
125575559|NCT00644787|451734164|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
125575560|NCT00644787|451734162|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
125575561|NCT00644787|451734163|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
125575562|NCT00644787|451734164|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
125575563|NCT00644787|451734162|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
125575564|NCT00644787|451734163|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
125575565|NCT00644787|451734164|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
125575566|NCT03355300|451734165|FG000|Overall Study|Physician Decision|0|||
125575567|NCT03355300|451734166|FG001|Overall Study|Physician Decision|1|||
125358684|NCT00408629|450950574|FG000|Overall Study|Protocol Violation|1|||
125358685|NCT00408629|450950575|FG001|Overall Study|Protocol Violation|5|||
125575568|NCT03355300|451734165|FG000|Overall Study|Lack of Efficacy|2|||
125575569|NCT03355300|451734166|FG001|Overall Study|Lack of Efficacy|1|||
125575570|NCT03355300|451734165|FG000|Overall Study|Other reason|1|||
125575571|NCT03355300|451734166|FG001|Overall Study|Other reason|0|||
125575572|NCT03048422|451734167|FG000|Overall Study|Death|1|||
125575573|NCT03048422|451734168|FG001|Overall Study|Death|0|||
125575574|NCT03048422|451734169|FG002|Overall Study|Death|0|||
125358686|NCT00408629|450950574|FG000|Overall Study|Miscellaneous|11|||
125575575|NCT03048422|451734167|FG000|Overall Study|Lost to Follow-up|5|||
125575576|NCT03048422|451734168|FG001|Overall Study|Lost to Follow-up|0|||
125575577|NCT03048422|451734169|FG002|Overall Study|Lost to Follow-up|1|||
125575578|NCT03048422|451734167|FG000|Overall Study|Withdrawal by Subject|5|||
125575579|NCT03048422|451734168|FG001|Overall Study|Withdrawal by Subject|7|||
125575580|NCT03048422|451734169|FG002|Overall Study|Withdrawal by Subject|4|||
125575581|NCT03048422|451734167|FG000|Overall Study|Moved|3|||
125575582|NCT03048422|451734168|FG001|Overall Study|Moved|2|||
125575583|NCT03048422|451734169|FG002|Overall Study|Moved|2|||
125575584|NCT03048422|451734167|FG000|Overall Study|Noncompliant with Study Requirements|2|||
125575585|NCT03048422|451734168|FG001|Overall Study|Noncompliant with Study Requirements|1|||
125575586|NCT03048422|451734169|FG002|Overall Study|Noncompliant with Study Requirements|2|||
125575587|NCT03048422|451734167|FG000|Overall Study|Not Able to Get to Clinic|1|||
125575588|NCT03048422|451734168|FG001|Overall Study|Not Able to Get to Clinic|0|||
125575589|NCT03048422|451734169|FG002|Overall Study|Not Able to Get to Clinic|0|||
125575590|NCT03110224|451734170|FG000|Overall Study|Death|3|||
125575591|NCT03110224|451734170|FG000|Overall Study|Lost to Follow-up|132|||
125575592|NCT03110224|451734170|FG000|Overall Study|Physician Decision|2|||
125575593|NCT03110224|451734170|FG000|Overall Study|Site Closed by Physician|35|||
125575594|NCT03110224|451734170|FG000|Overall Study|Site Closed by Sponsor|202|||
125575595|NCT03110224|451734170|FG000|Overall Study|Withdrawal by Subject|9|||
125575596|NCT04818593|451734171|FG000|Overall Study|Low Oocyte Yield|8|||
125575597|NCT04818593|451734172|FG001|Overall Study|Low Oocyte Yield|8|||
125575598|NCT04818593|451734171|FG000|Overall Study|Not ICSI Insemination|7|||
125575599|NCT04818593|451734172|FG001|Overall Study|Not ICSI Insemination|7|||
125575600|NCT04818593|451734171|FG000|Overall Study|Poor Sperm Quality|2|||
125575601|NCT04818593|451734172|FG001|Overall Study|Poor Sperm Quality|2|||
125575602|NCT04818593|451734171|FG000|Overall Study|Withdrawal by Subject|2|||
125575603|NCT04818593|451734172|FG001|Overall Study|Withdrawal by Subject|2|||
125575604|NCT04818593|451734171|FG000|Overall Study|Conversion to IUI due to low response|1|||
125575605|NCT04818593|451734172|FG001|Overall Study|Conversion to IUI due to low response|1|||
125575606|NCT01564862|451734173|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
125575607|NCT01564862|451734174|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
125575608|NCT01564862|451734175|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
125575609|NCT01564862|451734173|FG000|Overall Study|Major Protocol Deviation|3|||
125575610|NCT01564862|451734174|FG001|Overall Study|Major Protocol Deviation|3|||
125575611|NCT01564862|451734175|FG002|Overall Study|Major Protocol Deviation|4|||
125575612|NCT01564862|451734173|FG000|Overall Study|Lost to Follow-up|10|||
125575613|NCT01564862|451734174|FG001|Overall Study|Lost to Follow-up|8|||
125575614|NCT01564862|451734175|FG002|Overall Study|Lost to Follow-up|6|||
125575615|NCT01564862|451734173|FG000|Overall Study|Voluntary Withdrawal|9|||
125575616|NCT01564862|451734174|FG001|Overall Study|Voluntary Withdrawal|6|||
125575617|NCT01564862|451734175|FG002|Overall Study|Voluntary Withdrawal|8|||
125575618|NCT01564862|451734173|FG000|Overall Study|Lack of Efficacy|1|||
125575619|NCT01564862|451734174|FG001|Overall Study|Lack of Efficacy|5|||
125575620|NCT01564862|451734175|FG002|Overall Study|Lack of Efficacy|6|||
125575621|NCT01564862|451734173|FG000|Overall Study|Other reason(s)|1|||
125575622|NCT01564862|451734174|FG001|Overall Study|Other reason(s)|0|||
125575623|NCT01564862|451734175|FG002|Overall Study|Other reason(s)|0|||
125575624|NCT04526665|451734176|FG000|Overall Study|Withdrawal by Subject|6|||
125575625|NCT04526665|451734177|FG001|Overall Study|Withdrawal by Subject|3|||
125575626|NCT04526665|451734176|FG000|Overall Study|Adverse Event|4|||
125575627|NCT04526665|451734177|FG001|Overall Study|Adverse Event|1|||
125575628|NCT04526665|451734176|FG000|Overall Study|Physician Decision|2|||
125575629|NCT04526665|451734177|FG001|Overall Study|Physician Decision|2|||
125575630|NCT04526665|451734176|FG000|Overall Study|Death|2|||
125575631|NCT04526665|451734177|FG001|Overall Study|Death|0|||
125575632|NCT04526665|451734176|FG000|Overall Study|Other|0|||
125575633|NCT04526665|451734177|FG001|Overall Study|Other|1|||
125575634|NCT01844986|451734178|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
125575635|NCT01844986|451734179|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
125575636|NCT01844986|451734178|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
125575637|NCT01844986|451734179|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
125575638|NCT01844986|451734178|FG000|Overall Study (Global Cohort)|Death|55|||
125575639|NCT01844986|451734179|FG001|Overall Study (Global Cohort)|Death|26|||
125575640|NCT01844986|451734178|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
125575641|NCT01844986|451734179|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
125575642|NCT01844986|451734178|FG000|Overall Study (China Cohort)|Death|10|||
125575643|NCT01844986|451734179|FG001|Overall Study (China Cohort)|Death|6|||
125575644|NCT02028455|451734180|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
125575645|NCT02028455|451734181|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
125575646|NCT02028455|451734182|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
125575647|NCT02028455|451734183|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
125575648|NCT02028455|451734184|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
125575649|NCT02028455|451734185|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
125575650|NCT02028455|451734186|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
125575651|NCT02028455|451734187|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
125575652|NCT02028455|451734180|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
125575653|NCT02028455|451734181|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
125575654|NCT02028455|451734182|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
125575655|NCT02028455|451734183|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
125575656|NCT02028455|451734184|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
125575657|NCT02028455|451734185|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
125575658|NCT02028455|451734186|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
125575659|NCT02028455|451734187|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
125575660|NCT02028455|451734180|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
125575661|NCT02028455|451734181|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
125575662|NCT02028455|451734182|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
125575663|NCT02028455|451734183|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
125575664|NCT02028455|451734184|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
125575665|NCT02028455|451734185|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
125575666|NCT02028455|451734186|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
125575667|NCT02028455|451734187|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
125575668|NCT02028455|451734180|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
125575669|NCT02028455|451734181|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
125575670|NCT02028455|451734182|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
125575671|NCT02028455|451734183|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
125575672|NCT02028455|451734184|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
125575673|NCT02028455|451734185|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
125575674|NCT02028455|451734186|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
125575675|NCT02028455|451734187|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
125575676|NCT01761266|451736144|FG000|Overall Study|Death|415|||
125575677|NCT01761266|451736145|FG001|Overall Study|Death|402|||
125575678|NCT01761266|451736144|FG000|Overall Study|Lost to Follow-up|8|||
125575679|NCT01761266|451736145|FG001|Overall Study|Lost to Follow-up|12|||
125575680|NCT01761266|451736144|FG000|Overall Study|Withdrawal by Subject|14|||
125575681|NCT01761266|451736145|FG001|Overall Study|Withdrawal by Subject|10|||
125575682|NCT01761266|451736144|FG000|Overall Study|Sponsor Decision|41|||
125575683|NCT01761266|451736145|FG001|Overall Study|Sponsor Decision|52|||
125575684|NCT02740478|451736146|FG000|Overall Study|Withdrawal by Subject|1|||
125575685|NCT03269344|451736147|FG000|Overall Study|Protocol Violation|4|||
125575686|NCT03269344|451736148|FG001|Overall Study|Protocol Violation|3|||
125575687|NCT02597855|451736149|FG000|Overall Study|Lost to Follow-up|2|||
125575688|NCT02597855|451736150|FG001|Overall Study|Lost to Follow-up|1|||
125575689|NCT01449708|451736151|FG000|Overall Study|Protocol Violation|0|||
125575690|NCT01449708|451736152|FG001|Overall Study|Protocol Violation|1|||
125575691|NCT01449708|451736151|FG000|Overall Study|surgical complication|1|||
125575692|NCT01449708|451736152|FG001|Overall Study|surgical complication|2|||
125575693|NCT01449708|451736151|FG000|Overall Study|respiratory failure|1|||
125575694|NCT01449708|451736152|FG001|Overall Study|respiratory failure|0|||
125575695|NCT00559507|451736153|FG000|Overall Study|Not treated, patient ineligible|3|||
125575696|NCT02889796|451736154|FG000|Overall Study|Withdrew Consent|18|||
125575697|NCT02889796|451736155|FG001|Overall Study|Withdrew Consent|29|||
125575698|NCT02889796|451736156|FG002|Overall Study|Withdrew Consent|20|||
125575699|NCT02889796|451736157|FG003|Overall Study|Withdrew Consent|1|||
125211113|NCT04767529|450398580|FG002|Overall Study|Lost to Follow-up|3|||
125211114|NCT04122625|450398585|FG000|Part A (up to 2.92 Years)|Death|2|||
125211115|NCT04122625|450398586|FG001|Part A (up to 2.92 Years)|Death|4|||
125358687|NCT00408629|450950575|FG001|Overall Study|Miscellaneous|15|||
125358688|NCT00191906|450950576|FG000|Study Period II|Adverse Event|0|||
125211116|NCT04122625|450398587|FG002|Part A (up to 2.92 Years)|Death|0|||
125575700|NCT02889796|451736158|FG004|Overall Study|Withdrew Consent|2|||
125575701|NCT02889796|451736159|FG005|Overall Study|Withdrew Consent|35|||
125575702|NCT02889796|451736154|FG000|Overall Study|Investigator's Discretion|10|||
125575703|NCT02889796|451736155|FG001|Overall Study|Investigator's Discretion|9|||
125575704|NCT02889796|451736156|FG002|Overall Study|Investigator's Discretion|10|||
125575705|NCT02889796|451736157|FG003|Overall Study|Investigator's Discretion|3|||
125575706|NCT02889796|451736158|FG004|Overall Study|Investigator's Discretion|0|||
125575707|NCT02889796|451736159|FG005|Overall Study|Investigator's Discretion|15|||
125575708|NCT02889796|451736154|FG000|Overall Study|Adverse Event|17|||
125575709|NCT02889796|451736155|FG001|Overall Study|Adverse Event|8|||
125575710|NCT02889796|451736156|FG002|Overall Study|Adverse Event|8|||
125575711|NCT02889796|451736157|FG003|Overall Study|Adverse Event|4|||
125575712|NCT02889796|451736158|FG004|Overall Study|Adverse Event|1|||
125575713|NCT02889796|451736159|FG005|Overall Study|Adverse Event|7|||
125575714|NCT02889796|451736154|FG000|Overall Study|Lost to Follow-up|5|||
125575715|NCT02889796|451736155|FG001|Overall Study|Lost to Follow-up|7|||
125575716|NCT02889796|451736156|FG002|Overall Study|Lost to Follow-up|2|||
125575717|NCT02889796|451736157|FG003|Overall Study|Lost to Follow-up|0|||
125575718|NCT02889796|451736158|FG004|Overall Study|Lost to Follow-up|2|||
125575719|NCT02889796|451736159|FG005|Overall Study|Lost to Follow-up|6|||
125575720|NCT02889796|451736154|FG000|Overall Study|Protocol Violation|0|||
125575721|NCT02889796|451736155|FG001|Overall Study|Protocol Violation|1|||
125575722|NCT02889796|451736156|FG002|Overall Study|Protocol Violation|3|||
125575723|NCT02889796|451736157|FG003|Overall Study|Protocol Violation|0|||
125575724|NCT02889796|451736158|FG004|Overall Study|Protocol Violation|0|||
125575725|NCT02889796|451736159|FG005|Overall Study|Protocol Violation|4|||
125575726|NCT02889796|451736154|FG000|Overall Study|Non-compliance With Study Drug|0|||
125575727|NCT02889796|451736155|FG001|Overall Study|Non-compliance With Study Drug|2|||
125575728|NCT02889796|451736156|FG002|Overall Study|Non-compliance With Study Drug|0|||
125575729|NCT02889796|451736157|FG003|Overall Study|Non-compliance With Study Drug|0|||
125575730|NCT02889796|451736158|FG004|Overall Study|Non-compliance With Study Drug|1|||
125575731|NCT02889796|451736159|FG005|Overall Study|Non-compliance With Study Drug|2|||
125575732|NCT02889796|451736154|FG000|Overall Study|Death|1|||
125575733|NCT02889796|451736155|FG001|Overall Study|Death|1|||
125575734|NCT02889796|451736156|FG002|Overall Study|Death|0|||
125575735|NCT02889796|451736157|FG003|Overall Study|Death|1|||
125575736|NCT02889796|451736158|FG004|Overall Study|Death|0|||
125575737|NCT02889796|451736159|FG005|Overall Study|Death|1|||
125575738|NCT02889796|451736154|FG000|Overall Study|Pregnancy|0|||
125575739|NCT02889796|451736155|FG001|Overall Study|Pregnancy|1|||
125575740|NCT02889796|451736156|FG002|Overall Study|Pregnancy|1|||
125575741|NCT02889796|451736157|FG003|Overall Study|Pregnancy|0|||
125575742|NCT02889796|451736158|FG004|Overall Study|Pregnancy|0|||
125575743|NCT02889796|451736159|FG005|Overall Study|Pregnancy|0|||
125575744|NCT02889796|451736154|FG000|Overall Study|Randomized but not Dosed|2|||
125575745|NCT02889796|451736155|FG001|Overall Study|Randomized but not Dosed|0|||
125575746|NCT02889796|451736156|FG002|Overall Study|Randomized but not Dosed|0|||
125575747|NCT02889796|451736157|FG003|Overall Study|Randomized but not Dosed|0|||
125575748|NCT02889796|451736158|FG004|Overall Study|Randomized but not Dosed|0|||
125575749|NCT02889796|451736159|FG005|Overall Study|Randomized but not Dosed|2|||
125575750|NCT01407926|451736165|FG000|Overall Study|Lost to Follow-up|55|||
125575751|NCT02814565|451736166|FG000|Overall Study|Lack of Efficacy|0|||
125575752|NCT02814565|451736167|FG001|Overall Study|Lack of Efficacy|1|||
125575753|NCT02814565|451736166|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
125358689|NCT00191906|450950577|FG001|Study Period II|Adverse Event|1|||
125358690|NCT00191906|450950578|FG002|Study Period II|Adverse Event|0|||
125575754|NCT02814565|451736167|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
125575755|NCT01414257|451736168|FG000|Overall Study|No Visit After First Day of Treatment|12|||
125575756|NCT01414257|451736168|FG000|Overall Study|Protocol Violation|10|||
125575757|NCT01882907|451736172|FG000|Overall Study|Adverse Event|3|||
125575758|NCT01882907|451736173|FG001|Overall Study|Adverse Event|1|||
125575759|NCT01882907|451736172|FG000|Overall Study|Lack of Efficacy|0|||
125575760|NCT01882907|451736173|FG001|Overall Study|Lack of Efficacy|3|||
125358691|NCT00191906|450950579|FG003|Study Period II|Adverse Event|0|||
125575761|NCT01882907|451736172|FG000|Overall Study|Lost to Follow-up|1|||
125575762|NCT01882907|451736173|FG001|Overall Study|Lost to Follow-up|4|||
125575763|NCT01882907|451736172|FG000|Overall Study|Protocol Violation|10|||
125575764|NCT01882907|451736173|FG001|Overall Study|Protocol Violation|14|||
125575765|NCT01882907|451736172|FG000|Overall Study|Withdrawal by Subject|0|||
125575766|NCT01882907|451736173|FG001|Overall Study|Withdrawal by Subject|6|||
125575767|NCT01784965|451736174|FG000|Overall Study|Withdrawal by Subject|6|||
125575768|NCT01784965|451736175|FG001|Overall Study|Withdrawal by Subject|3|||
125575769|NCT01784965|451736174|FG000|Overall Study|Adverse Event|0|||
125575770|NCT01784965|451736175|FG001|Overall Study|Adverse Event|8|||
125575771|NCT03178487|451736178|FG000|Period 1|Adverse Event|1|||
125575772|NCT03178487|451736179|FG001|Period 1|Adverse Event|2|||
125575773|NCT03178487|451736178|FG000|Period 1|Withdrawal by Subject|2|||
125575774|NCT03178487|451736179|FG001|Period 1|Withdrawal by Subject|1|||
125575775|NCT03178487|451736178|FG000|Period 1|Lost to Follow-up|1|||
125575776|NCT03178487|451736179|FG001|Period 1|Lost to Follow-up|0|||
125575777|NCT03178487|451736178|FG000|Period 1|Other|0|||
125575778|NCT03178487|451736179|FG001|Period 1|Other|1|||
125575779|NCT03178487|451736178|FG000|Period 2|Adverse Event|4|||
125575780|NCT03178487|451736179|FG001|Period 2|Adverse Event|4|||
125575781|NCT03178487|451736178|FG000|Period 2|Withdrawal by Subject|6|||
125575782|NCT03178487|451736179|FG001|Period 2|Withdrawal by Subject|6|||
125575783|NCT03178487|451736178|FG000|Period 2|Lost to Follow-up|2|||
125575784|NCT03178487|451736179|FG001|Period 2|Lost to Follow-up|2|||
125575785|NCT03178487|451736178|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
125575786|NCT03178487|451736179|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
125575787|NCT03178487|451736178|FG000|Period 2|Other|8|||
125575788|NCT03178487|451736179|FG001|Period 2|Other|7|||
125575789|NCT00493038|451736182|FG000|Treatment|Adverse Event|8|||
125575790|NCT00493038|451736183|FG001|Treatment|Adverse Event|4|||
125575791|NCT00493038|451736182|FG000|Treatment|Lost to Follow-up|5|||
125575792|NCT00493038|451736183|FG001|Treatment|Lost to Follow-up|3|||
125575793|NCT00493038|451736182|FG000|Treatment|Withdrawal by Subject|11|||
125575794|NCT00493038|451736183|FG001|Treatment|Withdrawal by Subject|12|||
125575795|NCT00493038|451736182|FG000|Treatment|Other|0|||
125575796|NCT00493038|451736183|FG001|Treatment|Other|1|||
125575797|NCT00493038|451736182|FG000|Follow-up|Lost to Follow-up|1|||
125575798|NCT00493038|451736183|FG001|Follow-up|Lost to Follow-up|0|||
125575799|NCT01847885|451736184|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
125575800|NCT01847885|451736185|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
125575801|NCT01847885|451736186|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
125575802|NCT01847885|451736184|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
125575803|NCT01847885|451736185|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
125575804|NCT01847885|451736186|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
125575805|NCT01847885|451736184|FG000|Initial Enrollment (Consented)|Screen failure|39|||
125575806|NCT01847885|451736185|FG001|Initial Enrollment (Consented)|Screen failure|0|||
125575807|NCT01847885|451736186|FG002|Initial Enrollment (Consented)|Screen failure|0|||
125575808|NCT01847885|451736184|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
125575809|NCT01847885|451736185|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
125575810|NCT01847885|451736186|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
125575811|NCT01847885|451736184|FG000|Randomization|Protocol Violation|0|||
125575812|NCT01847885|451736185|FG001|Randomization|Protocol Violation|1|||
125575813|NCT01847885|451736186|FG002|Randomization|Protocol Violation|0|||
125575814|NCT01847885|451736184|FG000|Randomization|Withdrawal by Subject|0|||
125575815|NCT01847885|451736185|FG001|Randomization|Withdrawal by Subject|0|||
125575816|NCT01847885|451736186|FG002|Randomization|Withdrawal by Subject|2|||
125575817|NCT01847885|451736184|FG000|Randomization|Screen Failure|0|||
125575818|NCT01847885|451736185|FG001|Randomization|Screen Failure|3|||
125575819|NCT01847885|451736186|FG002|Randomization|Screen Failure|0|||
125575820|NCT02574637|451736187|FG000|Double-blind Period|Adverse Event|1|||
125575821|NCT02574637|451736188|FG001|Double-blind Period|Adverse Event|0|||
125575822|NCT02574637|451736189|FG002|Double-blind Period|Adverse Event|0|||
125575823|NCT02574637|451736190|FG003|Double-blind Period|Adverse Event|0|||
125575824|NCT02574637|451736191|FG004|Double-blind Period|Adverse Event|0|||
125575825|NCT02574637|451736192|FG005|Double-blind Period|Adverse Event|0|||
125575826|NCT02574637|451736193|FG006|Double-blind Period|Adverse Event|0|||
125575827|NCT02574637|451736194|FG007|Double-blind Period|Adverse Event|0|||
125575828|NCT02574637|451736195|FG008|Double-blind Period|Adverse Event|0|||
125575829|NCT02574637|451736196|FG009|Double-blind Period|Adverse Event|0|||
125575830|NCT02574637|451736187|FG000|Double-blind Period|Lack of Efficacy|0|||
125575831|NCT02574637|451736188|FG001|Double-blind Period|Lack of Efficacy|0|||
125575832|NCT02574637|451736189|FG002|Double-blind Period|Lack of Efficacy|2|||
125575833|NCT02574637|451736190|FG003|Double-blind Period|Lack of Efficacy|0|||
125575834|NCT02574637|451736191|FG004|Double-blind Period|Lack of Efficacy|0|||
125575835|NCT02574637|451736192|FG005|Double-blind Period|Lack of Efficacy|0|||
125575836|NCT02574637|451736193|FG006|Double-blind Period|Lack of Efficacy|0|||
125575837|NCT02574637|451736194|FG007|Double-blind Period|Lack of Efficacy|0|||
125575838|NCT02574637|451736195|FG008|Double-blind Period|Lack of Efficacy|0|||
125575839|NCT02574637|451736196|FG009|Double-blind Period|Lack of Efficacy|0|||
125575840|NCT02574637|451736187|FG000|Double-blind Period|Protocol Deviation|1|||
125575841|NCT02574637|451736188|FG001|Double-blind Period|Protocol Deviation|0|||
125575842|NCT02574637|451736189|FG002|Double-blind Period|Protocol Deviation|0|||
125575843|NCT02574637|451736190|FG003|Double-blind Period|Protocol Deviation|0|||
125575844|NCT02574637|451736191|FG004|Double-blind Period|Protocol Deviation|0|||
125575845|NCT02574637|451736192|FG005|Double-blind Period|Protocol Deviation|0|||
125575846|NCT02574637|451736193|FG006|Double-blind Period|Protocol Deviation|0|||
125575847|NCT02574637|451736194|FG007|Double-blind Period|Protocol Deviation|0|||
125575848|NCT02574637|451736195|FG008|Double-blind Period|Protocol Deviation|0|||
125575849|NCT02574637|451736196|FG009|Double-blind Period|Protocol Deviation|0|||
125575850|NCT02574637|451736187|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
125575851|NCT02574637|451736188|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
125575852|NCT02574637|451736189|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
125575853|NCT02574637|451736190|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
125575854|NCT02574637|451736191|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
125575855|NCT02574637|451736192|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
125575856|NCT02574637|451736193|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
125575857|NCT02574637|451736194|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
125575858|NCT02574637|451736195|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
125575859|NCT02574637|451736196|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
125575860|NCT02574637|451736187|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
125575861|NCT02574637|451736188|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
125575862|NCT02574637|451736189|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
125575863|NCT02574637|451736190|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
125575864|NCT02574637|451736191|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
125575865|NCT02574637|451736192|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
125575866|NCT02574637|451736193|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
125575867|NCT02574637|451736194|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
125575868|NCT02574637|451736195|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
125575869|NCT02574637|451736196|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
125575870|NCT02574637|451736187|FG000|Double-blind Period|Reason Not Specified|0|||
125575871|NCT02574637|451736188|FG001|Double-blind Period|Reason Not Specified|0|||
125575872|NCT02574637|451736189|FG002|Double-blind Period|Reason Not Specified|0|||
125575873|NCT02574637|451736190|FG003|Double-blind Period|Reason Not Specified|1|||
125575874|NCT02574637|451736191|FG004|Double-blind Period|Reason Not Specified|0|||
125575875|NCT02574637|451736192|FG005|Double-blind Period|Reason Not Specified|0|||
125575876|NCT02574637|451736193|FG006|Double-blind Period|Reason Not Specified|0|||
125575877|NCT02574637|451736194|FG007|Double-blind Period|Reason Not Specified|0|||
125575878|NCT02574637|451736195|FG008|Double-blind Period|Reason Not Specified|0|||
125575879|NCT02574637|451736196|FG009|Double-blind Period|Reason Not Specified|0|||
125358692|NCT00191906|450950576|FG000|Study Period II|Withdrawal by Subject|0|||
125358693|NCT00191906|450950577|FG001|Study Period II|Withdrawal by Subject|3|||
125358694|NCT00191906|450950578|FG002|Study Period II|Withdrawal by Subject|0|||
125358695|NCT00191906|450950579|FG003|Study Period II|Withdrawal by Subject|0|||
125358696|NCT00191906|450950576|FG000|Study Period II|Parent/Caregiver Decision|0|||
125358697|NCT00191906|450950577|FG001|Study Period II|Parent/Caregiver Decision|1|||
125358698|NCT00191906|450950578|FG002|Study Period II|Parent/Caregiver Decision|0|||
125358699|NCT00191906|450950579|FG003|Study Period II|Parent/Caregiver Decision|0|||
125358700|NCT00191906|450950576|FG000|Study Period II|Entry Criteria Exclusion|0|||
125358701|NCT00191906|450950577|FG001|Study Period II|Entry Criteria Exclusion|0|||
125358702|NCT00191906|450950578|FG002|Study Period II|Entry Criteria Exclusion|1|||
125358703|NCT00191906|450950579|FG003|Study Period II|Entry Criteria Exclusion|0|||
125358704|NCT00191906|450950576|FG000|Study Period III|Adverse Event|1|||
125358705|NCT00191906|450950577|FG001|Study Period III|Adverse Event|0|||
125358706|NCT00191906|450950578|FG002|Study Period III|Adverse Event|0|||
125358707|NCT00191906|450950579|FG003|Study Period III|Adverse Event|0|||
125358708|NCT00191906|450950576|FG000|Study Period III|Lost to Follow-up|0|||
125358709|NCT00191906|450950577|FG001|Study Period III|Lost to Follow-up|1|||
125358710|NCT00191906|450950578|FG002|Study Period III|Lost to Follow-up|0|||
125358711|NCT00191906|450950579|FG003|Study Period III|Lost to Follow-up|0|||
125358712|NCT00191906|450950576|FG000|Study Period III|Parent/Caregiver Decision|1|||
125358713|NCT00191906|450950577|FG001|Study Period III|Parent/Caregiver Decision|0|||
125358714|NCT00191906|450950578|FG002|Study Period III|Parent/Caregiver Decision|0|||
125358715|NCT00191906|450950579|FG003|Study Period III|Parent/Caregiver Decision|0|||
125358716|NCT00191906|450950576|FG000|Study Period III|Lack of Efficacy|3|||
125358717|NCT00191906|450950577|FG001|Study Period III|Lack of Efficacy|3|||
125358718|NCT00191906|450950578|FG002|Study Period III|Lack of Efficacy|0|||
125358719|NCT00191906|450950579|FG003|Study Period III|Lack of Efficacy|0|||
125358720|NCT00573937|450950580|FG000|Overall Study|Study Terminated|0|||
125575880|NCT02574637|451736187|FG000|Open-label (OL) Period|Adverse Event|0|||
125575881|NCT02574637|451736188|FG001|Open-label (OL) Period|Adverse Event|0|||
125575882|NCT02574637|451736189|FG002|Open-label (OL) Period|Adverse Event|0|||
125575883|NCT02574637|451736190|FG003|Open-label (OL) Period|Adverse Event|0|||
125575884|NCT02574637|451736191|FG004|Open-label (OL) Period|Adverse Event|0|||
125575885|NCT02574637|451736192|FG005|Open-label (OL) Period|Adverse Event|0|||
125575886|NCT02574637|451736193|FG006|Open-label (OL) Period|Adverse Event|0|||
125575887|NCT02574637|451736194|FG007|Open-label (OL) Period|Adverse Event|0|||
125575888|NCT02574637|451736195|FG008|Open-label (OL) Period|Adverse Event|1|||
125575889|NCT02574637|451736196|FG009|Open-label (OL) Period|Adverse Event|0|||
125575890|NCT02574637|451736187|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
125575891|NCT02574637|451736188|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
125575892|NCT02574637|451736189|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
125575893|NCT02574637|451736190|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
125575894|NCT02574637|451736191|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
125575895|NCT02574637|451736192|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
125575896|NCT02574637|451736193|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
125575897|NCT02574637|451736194|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
125575898|NCT02574637|451736195|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
125575899|NCT02574637|451736196|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
125575900|NCT02574637|451736187|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
125575901|NCT02574637|451736188|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
125575902|NCT02574637|451736189|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
125575903|NCT02574637|451736190|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
125358721|NCT00573937|450950581|FG001|Overall Study|Study Terminated|1|||
125358722|NCT00333801|450950582|FG000|Overall Study|Moved to another state|5|||
125575904|NCT02574637|451736191|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
125358723|NCT00333801|450950583|FG001|Overall Study|Moved to another state|3|||
125575905|NCT02574637|451736192|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
125575906|NCT02574637|451736193|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
125575907|NCT02574637|451736194|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
125575908|NCT02574637|451736195|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
125575909|NCT02574637|451736196|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
125575910|NCT00070941|451736200|FG000|Overall Study|Adverse Event|10|||
125575911|NCT00070941|451736201|FG001|Overall Study|Adverse Event|8|||
125575912|NCT00070941|451736202|FG002|Overall Study|Adverse Event|4|||
125575913|NCT00094055|451736203|FG000|Overall Study|Adverse Event|11|||
125575914|NCT00094055|451736203|FG000|Overall Study|Death|4|||
125575915|NCT00094055|451736203|FG000|Overall Study|Lack of Efficacy|17|||
125575916|NCT00094055|451736203|FG000|Overall Study|Lost to Follow-up|2|||
125575917|NCT00094055|451736203|FG000|Overall Study|progressive disease|2|||
125575918|NCT00094055|451736203|FG000|Overall Study|clinical progression|1|||
125575919|NCT00094055|451736203|FG000|Overall Study|roll-over to another study|14|||
125575920|NCT00094055|451736203|FG000|Overall Study|Withdrawal by Subject|9|||
125575921|NCT00411554|451736207|FG000|Overall Study|Adverse Event|2|||
125575922|NCT00411554|451736208|FG001|Overall Study|Adverse Event|4|||
125575923|NCT00411554|451736207|FG000|Overall Study|Lack of Efficacy|2|||
125575924|NCT00411554|451736208|FG001|Overall Study|Lack of Efficacy|5|||
125575925|NCT00411554|451736207|FG000|Overall Study|Withdrawal by Subject|3|||
125575926|NCT00411554|451736208|FG001|Overall Study|Withdrawal by Subject|0|||
125575927|NCT00411554|451736207|FG000|Overall Study|Patient Moved|1|||
125575928|NCT00411554|451736208|FG001|Overall Study|Patient Moved|0|||
125575929|NCT00699907|451736209|FG000|Overall Study|Withdrawal by Subject|2|||
125575930|NCT00699907|451736210|FG001|Overall Study|Withdrawal by Subject|1|||
125575931|NCT00699907|451736211|FG002|Overall Study|Withdrawal by Subject|0|||
125575932|NCT00699907|451736209|FG000|Overall Study|No usable sample|0|||
125575933|NCT00699907|451736210|FG001|Overall Study|No usable sample|9|||
125575934|NCT00699907|451736211|FG002|Overall Study|No usable sample|8|||
125575935|NCT02161211|451736212|FG000|Overall Study|Lost to Follow-up|21|||
125575936|NCT02161211|451736213|FG001|Overall Study|Lost to Follow-up|27|||
125575937|NCT02161211|451736214|FG002|Overall Study|Lost to Follow-up|21|||
125575938|NCT02161211|451736212|FG000|Overall Study|Dropped|12|||
125575939|NCT02161211|451736213|FG001|Overall Study|Dropped|5|||
125575940|NCT02161211|451736214|FG002|Overall Study|Dropped|9|||
125575941|NCT00430508|451736215|FG000|Overall Study|Adverse Event|2|||
125575942|NCT00430508|451736216|FG001|Overall Study|Adverse Event|3|||
125575943|NCT00430508|451736217|FG002|Overall Study|Adverse Event|5|||
125575944|NCT00430508|451736218|FG003|Overall Study|Adverse Event|3|||
125575945|NCT00430508|451736215|FG000|Overall Study|Withdrawal by Subject|0|||
125575946|NCT00430508|451736216|FG001|Overall Study|Withdrawal by Subject|1|||
125575947|NCT00430508|451736217|FG002|Overall Study|Withdrawal by Subject|1|||
125575948|NCT00430508|451736218|FG003|Overall Study|Withdrawal by Subject|1|||
125358724|NCT00333801|450950582|FG000|Overall Study|Lost to Follow-up|2|||
125358725|NCT00333801|450950583|FG001|Overall Study|Lost to Follow-up|0|||
125575949|NCT00430508|451736215|FG000|Overall Study|responder at visit 4|0|||
125575950|NCT00430508|451736216|FG001|Overall Study|responder at visit 4|0|||
125575951|NCT00430508|451736217|FG002|Overall Study|responder at visit 4|2|||
125575952|NCT00430508|451736218|FG003|Overall Study|responder at visit 4|0|||
125575953|NCT00430508|451736215|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
125575954|NCT00430508|451736216|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
125575955|NCT00430508|451736217|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
125575956|NCT00430508|451736218|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
125575957|NCT00430508|451736215|FG000|Overall Study|Other|1|||
125575958|NCT00430508|451736216|FG001|Overall Study|Other|1|||
125358726|NCT00333801|450950582|FG000|Overall Study|Incarcerated|1|||
125358727|NCT00333801|450950583|FG001|Overall Study|Incarcerated|2|||
125358728|NCT00333801|450950582|FG000|Overall Study|Withdrawal by Subject|0|||
125358729|NCT00333801|450950583|FG001|Overall Study|Withdrawal by Subject|1|||
125358730|NCT04171765|450950584|FG000|Overall Study|Adverse Event|2|||
125358731|NCT04171765|450950585|FG001|Overall Study|Adverse Event|0|||
125358732|NCT04171765|450950586|FG002|Overall Study|Adverse Event|1|||
125358733|NCT04171765|450950587|FG003|Overall Study|Adverse Event|0|||
125358734|NCT04171765|450950584|FG000|Overall Study|Lost to Follow-up|0|||
125358735|NCT04171765|450950585|FG001|Overall Study|Lost to Follow-up|2|||
125358736|NCT04171765|450950586|FG002|Overall Study|Lost to Follow-up|2|||
125358737|NCT04171765|450950587|FG003|Overall Study|Lost to Follow-up|2|||
125358738|NCT04171765|450950584|FG000|Overall Study|Week 58 visit missed|0|||
125427261|NCT00117676|451189323|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
125575959|NCT00430508|451736217|FG002|Overall Study|Other|3|||
125358739|NCT04171765|450950585|FG001|Overall Study|Week 58 visit missed|0|||
125358740|NCT04171765|450950586|FG002|Overall Study|Week 58 visit missed|1|||
125358741|NCT04171765|450950587|FG003|Overall Study|Week 58 visit missed|0|||
125358742|NCT04171765|450950584|FG000|Overall Study|Study terminated by sponsor|2|||
125575960|NCT00430508|451736218|FG003|Overall Study|Other|0|||
125575961|NCT03728309|451736222|FG000|Overall Study|Randomized but not Treated|0|||
125575962|NCT03728309|451736223|FG001|Overall Study|Randomized but not Treated|1|||
125575963|NCT03728309|451736222|FG000|Overall Study|Adverse Event|0|||
125575964|NCT03728309|451736223|FG001|Overall Study|Adverse Event|1|||
125575965|NCT03728309|451736222|FG000|Overall Study|Withdrawal by Subject|2|||
125575966|NCT03728309|451736223|FG001|Overall Study|Withdrawal by Subject|8|||
125575967|NCT03728309|451736222|FG000|Overall Study|Lost to Follow-up|9|||
125575968|NCT03728309|451736223|FG001|Overall Study|Lost to Follow-up|10|||
125575969|NCT03728309|451736222|FG000|Overall Study|Protocol Deviation|0|||
125575970|NCT03728309|451736223|FG001|Overall Study|Protocol Deviation|1|||
125575971|NCT03728309|451736222|FG000|Overall Study|Due to COVID|1|||
125575972|NCT03728309|451736223|FG001|Overall Study|Due to COVID|3|||
125575973|NCT00953758|451736224|FG000|Overall Study|Death|2|||
125575974|NCT00953758|451736225|FG001|Overall Study|Death|0|||
125427262|NCT00117676|451189322|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
125575975|NCT00953758|451736226|FG002|Overall Study|Death|1|||
125575976|NCT00953758|451736227|FG003|Overall Study|Death|1|||
125575977|NCT00953758|451736228|FG004|Overall Study|Death|1|||
125575978|NCT00953758|451736229|FG005|Overall Study|Death|1|||
125575979|NCT00953758|451736230|FG006|Overall Study|Death|1|||
125575980|NCT00953758|451736231|FG007|Overall Study|Death|3|||
125575981|NCT00953758|451736232|FG008|Overall Study|Death|1|||
125575982|NCT00953758|451736233|FG009|Overall Study|Death|0|||
125575983|NCT00953758|451736224|FG000|Overall Study|Participant refused further follow-up|0|||
125575984|NCT00953758|451736225|FG001|Overall Study|Participant refused further follow-up|0|||
125575985|NCT00953758|451736226|FG002|Overall Study|Participant refused further follow-up|1|||
125575986|NCT00953758|451736227|FG003|Overall Study|Participant refused further follow-up|0|||
125575987|NCT00953758|451736228|FG004|Overall Study|Participant refused further follow-up|3|||
125575988|NCT00953758|451736229|FG005|Overall Study|Participant refused further follow-up|0|||
125575989|NCT00953758|451736230|FG006|Overall Study|Participant refused further follow-up|0|||
125575990|NCT00953758|451736231|FG007|Overall Study|Participant refused further follow-up|0|||
125575991|NCT00953758|451736232|FG008|Overall Study|Participant refused further follow-up|1|||
125575992|NCT00953758|451736233|FG009|Overall Study|Participant refused further follow-up|0|||
125575993|NCT00953758|451736224|FG000|Overall Study|Lost to Follow-up|0|||
125575994|NCT00953758|451736225|FG001|Overall Study|Lost to Follow-up|0|||
125575995|NCT00953758|451736226|FG002|Overall Study|Lost to Follow-up|0|||
125575996|NCT00953758|451736227|FG003|Overall Study|Lost to Follow-up|1|||
125575997|NCT00953758|451736228|FG004|Overall Study|Lost to Follow-up|0|||
125575998|NCT00953758|451736229|FG005|Overall Study|Lost to Follow-up|0|||
125575999|NCT00953758|451736230|FG006|Overall Study|Lost to Follow-up|0|||
125576000|NCT00953758|451736231|FG007|Overall Study|Lost to Follow-up|1|||
125576001|NCT00953758|451736232|FG008|Overall Study|Lost to Follow-up|0|||
125576002|NCT00953758|451736233|FG009|Overall Study|Lost to Follow-up|1|||
125576003|NCT00953758|451736224|FG000|Overall Study|Physician Decision|0|||
125576004|NCT00953758|451736225|FG001|Overall Study|Physician Decision|0|||
125576005|NCT00953758|451736226|FG002|Overall Study|Physician Decision|0|||
125576006|NCT00953758|451736227|FG003|Overall Study|Physician Decision|0|||
125576007|NCT00953758|451736228|FG004|Overall Study|Physician Decision|1|||
125576008|NCT00953758|451736229|FG005|Overall Study|Physician Decision|0|||
125576009|NCT00953758|451736230|FG006|Overall Study|Physician Decision|0|||
125576010|NCT00953758|451736231|FG007|Overall Study|Physician Decision|0|||
125576011|NCT00953758|451736232|FG008|Overall Study|Physician Decision|0|||
125576012|NCT00953758|451736233|FG009|Overall Study|Physician Decision|0|||
125576013|NCT00953758|451736224|FG000|Overall Study|Disease progression|0|||
125576014|NCT00953758|451736225|FG001|Overall Study|Disease progression|0|||
125576015|NCT00953758|451736226|FG002|Overall Study|Disease progression|0|||
125576016|NCT00953758|451736227|FG003|Overall Study|Disease progression|0|||
125576017|NCT00953758|451736228|FG004|Overall Study|Disease progression|1|||
125427263|NCT00117676|451189323|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
125427264|NCT00117676|451189322|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
125576018|NCT00953758|451736229|FG005|Overall Study|Disease progression|0|||
125576019|NCT00953758|451736230|FG006|Overall Study|Disease progression|0|||
125576020|NCT00953758|451736231|FG007|Overall Study|Disease progression|0|||
125576021|NCT00953758|451736232|FG008|Overall Study|Disease progression|0|||
125576022|NCT00953758|451736233|FG009|Overall Study|Disease progression|0|||
125576023|NCT00953758|451736224|FG000|Overall Study|Participant went for transplant|0|||
125576024|NCT00953758|451736225|FG001|Overall Study|Participant went for transplant|0|||
125576025|NCT00953758|451736226|FG002|Overall Study|Participant went for transplant|0|||
125576026|NCT00953758|451736227|FG003|Overall Study|Participant went for transplant|0|||
125576027|NCT00953758|451736228|FG004|Overall Study|Participant went for transplant|0|||
125576028|NCT00953758|451736229|FG005|Overall Study|Participant went for transplant|0|||
125576029|NCT00953758|451736230|FG006|Overall Study|Participant went for transplant|0|||
125576030|NCT00953758|451736231|FG007|Overall Study|Participant went for transplant|0|||
125576031|NCT00953758|451736232|FG008|Overall Study|Participant went for transplant|1|||
125576032|NCT00953758|451736233|FG009|Overall Study|Participant went for transplant|0|||
125576033|NCT01164722|451736234|FG000|Overall Study|Adverse Event|0|||
125576034|NCT01164722|451736235|FG001|Overall Study|Adverse Event|1|||
125576035|NCT01164722|451736234|FG000|Overall Study|Withdrawal by Subject|3|||
125576036|NCT01164722|451736235|FG001|Overall Study|Withdrawal by Subject|4|||
125576037|NCT01164722|451736234|FG000|Overall Study|Lost to Follow-up|3|||
125576038|NCT01164722|451736235|FG001|Overall Study|Lost to Follow-up|6|||
125576039|NCT01164722|451736234|FG000|Overall Study|met protocol criteria for non-treatment|11|||
125576040|NCT01164722|451736235|FG001|Overall Study|met protocol criteria for non-treatment|1|||
125576041|NCT01164722|451736234|FG000|Overall Study|enrolled on other study, concomitant med|1|||
125576042|NCT01164722|451736235|FG001|Overall Study|enrolled on other study, concomitant med|3|||
125576043|NCT00999908|451736236|FG000|Treatment Period 1|Subject withdrew consent|2|||
125576044|NCT00999908|451736237|FG001|Treatment Period 1|Subject withdrew consent|0|||
125576045|NCT00999908|451736238|FG002|Treatment Period 1|Subject withdrew consent|0|||
125576046|NCT00999908|451736236|FG000|Treatment Period 2|Protocol Violation|1|||
125576047|NCT00999908|451736237|FG001|Treatment Period 2|Protocol Violation|0|||
125576048|NCT00999908|451736238|FG002|Treatment Period 2|Protocol Violation|0|||
125358743|NCT04171765|450950585|FG001|Overall Study|Study terminated by sponsor|0|||
125576049|NCT01703858|451736241|FG000|Overall Study|Withdrawal by Subject|0|||
125358744|NCT04171765|450950586|FG002|Overall Study|Study terminated by sponsor|0|||
125358745|NCT04171765|450950587|FG003|Overall Study|Study terminated by sponsor|0|||
125358746|NCT04171765|450950584|FG000|Overall Study|Withdrawal by Subject|1|||
125358747|NCT04171765|450950585|FG001|Overall Study|Withdrawal by Subject|0|||
125358748|NCT04171765|450950586|FG002|Overall Study|Withdrawal by Subject|0|||
125358749|NCT04171765|450950587|FG003|Overall Study|Withdrawal by Subject|3|||
125358750|NCT03633617|450950588|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
125358751|NCT03633617|450950589|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
125358752|NCT03633617|450950590|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125358753|NCT03633617|450950591|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125358754|NCT03633617|450950592|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125358755|NCT03633617|450950593|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125358756|NCT03633617|450950594|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125358757|NCT03633617|450950595|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125358758|NCT03633617|450950596|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125358759|NCT03633617|450950597|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125576050|NCT01703858|451736242|FG001|Overall Study|Withdrawal by Subject|1|||
125576051|NCT01703858|451736243|FG002|Overall Study|Withdrawal by Subject|0|||
125576052|NCT01290692|451736248|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
125576053|NCT00993031|451736249|FG000|Overall Study|Death|0|||
125576054|NCT00993031|451736250|FG001|Overall Study|Death|1|||
125576055|NCT00993031|451736249|FG000|Overall Study|Physician Decision|0|||
125576056|NCT00993031|451736250|FG001|Overall Study|Physician Decision|2|||
125576057|NCT00993031|451736249|FG000|Overall Study|Withdrawal by Subject|3|||
125358760|NCT03633617|450950598|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
125358761|NCT03633617|450950588|FG000|Part A|Unconfirmed early termination visit|1|||
125358762|NCT03633617|450950589|FG001|Part A|Unconfirmed early termination visit|0|||
125358763|NCT03633617|450950590|FG002|Part A|Unconfirmed early termination visit|0|||
125358764|NCT03633617|450950591|FG003|Part A|Unconfirmed early termination visit|0|||
125358765|NCT03633617|450950592|FG004|Part A|Unconfirmed early termination visit|0|||
125358766|NCT03633617|450950593|FG005|Part A|Unconfirmed early termination visit|0|||
125358767|NCT03633617|450950594|FG006|Part A|Unconfirmed early termination visit|0|||
125358768|NCT03633617|450950595|FG007|Part A|Unconfirmed early termination visit|0|||
125358769|NCT03633617|450950596|FG008|Part A|Unconfirmed early termination visit|0|||
125358770|NCT03633617|450950597|FG009|Part A|Unconfirmed early termination visit|0|||
125358771|NCT03633617|450950598|FG010|Part A|Unconfirmed early termination visit|0|||
125358772|NCT03633617|450950588|FG000|Part A|Adverse Event|0|||
125358773|NCT03633617|450950589|FG001|Part A|Adverse Event|1|||
125358774|NCT03633617|450950590|FG002|Part A|Adverse Event|0|||
125358775|NCT03633617|450950591|FG003|Part A|Adverse Event|0|||
125358776|NCT03633617|450950592|FG004|Part A|Adverse Event|0|||
125358777|NCT03633617|450950593|FG005|Part A|Adverse Event|0|||
125358778|NCT03633617|450950594|FG006|Part A|Adverse Event|0|||
125358779|NCT03633617|450950595|FG007|Part A|Adverse Event|0|||
125358780|NCT03633617|450950596|FG008|Part A|Adverse Event|0|||
125358781|NCT03633617|450950597|FG009|Part A|Adverse Event|0|||
125358782|NCT03633617|450950598|FG010|Part A|Adverse Event|0|||
125358783|NCT03633617|450950588|FG000|Part A|Pregnancy|1|||
125358784|NCT03633617|450950589|FG001|Part A|Pregnancy|0|||
125358785|NCT03633617|450950590|FG002|Part A|Pregnancy|0|||
125358786|NCT03633617|450950591|FG003|Part A|Pregnancy|0|||
125358787|NCT03633617|450950592|FG004|Part A|Pregnancy|0|||
125358788|NCT03633617|450950593|FG005|Part A|Pregnancy|0|||
125358789|NCT03633617|450950594|FG006|Part A|Pregnancy|0|||
125358790|NCT03633617|450950595|FG007|Part A|Pregnancy|0|||
125358791|NCT03633617|450950596|FG008|Part A|Pregnancy|0|||
125358792|NCT03633617|450950597|FG009|Part A|Pregnancy|0|||
125576058|NCT00993031|451736250|FG001|Overall Study|Withdrawal by Subject|3|||
125576059|NCT00993031|451736249|FG000|Overall Study|Lost to Follow-up|19|||
125576060|NCT00993031|451736250|FG001|Overall Study|Lost to Follow-up|13|||
125576061|NCT04673786|451736251|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
125576062|NCT04673786|451736252|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
125576063|NCT04673786|451736253|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
125358793|NCT03633617|450950598|FG010|Part A|Pregnancy|0|||
125358794|NCT03633617|450950588|FG000|Part A|Withdrawal by Subject|0|||
125358795|NCT03633617|450950589|FG001|Part A|Withdrawal by Subject|1|||
125358796|NCT03633617|450950590|FG002|Part A|Withdrawal by Subject|0|||
125358797|NCT03633617|450950591|FG003|Part A|Withdrawal by Subject|0|||
125358798|NCT03633617|450950592|FG004|Part A|Withdrawal by Subject|0|||
125358799|NCT03633617|450950593|FG005|Part A|Withdrawal by Subject|0|||
125358800|NCT03633617|450950594|FG006|Part A|Withdrawal by Subject|0|||
125358801|NCT03633617|450950595|FG007|Part A|Withdrawal by Subject|0|||
125358802|NCT03633617|450950596|FG008|Part A|Withdrawal by Subject|0|||
125576064|NCT04673786|451736251|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
125576065|NCT04673786|451736252|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
125576066|NCT04673786|451736253|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
125576067|NCT04673786|451736251|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
125576068|NCT04673786|451736252|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
125576069|NCT04673786|451736253|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
125576070|NCT04673786|451736251|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
125576071|NCT04673786|451736252|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
125576072|NCT04673786|451736253|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
125576073|NCT04673786|451736251|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
125576074|NCT04673786|451736252|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
125576075|NCT04673786|451736253|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
125576076|NCT04673786|451736251|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
125576077|NCT04673786|451736252|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
125576078|NCT04673786|451736253|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
125576079|NCT03870555|451736254|FG000|Period 3 (2 Days)|Adverse Event|1|||
125576080|NCT03870555|451736255|FG001|Period 3 (2 Days)|Adverse Event|0|||
125576081|NCT03870555|451736256|FG002|Period 3 (2 Days)|Adverse Event|0|||
125576082|NCT01422239|451736259|FG000|Overall Study|Lost to Follow-up|4|||
125576083|NCT01422239|451736260|FG001|Overall Study|Lost to Follow-up|3|||
125576084|NCT03167073|451736262|FG000|Overall Study|Stillbirth|1|||
125576085|NCT03167073|451736263|FG001|Overall Study|Stillbirth|0|||
125576086|NCT01276236|451736264|FG000|Overall Study|Lack of Efficacy|2|||
125576087|NCT01276236|451736264|FG000|Overall Study|Withdrawal by Subject|4|||
125576088|NCT00044512|451736265|FG000|Follow Up|Lost to Follow-up|2|||
125576089|NCT00357500|451736269|FG000|Overall Study|Adverse Event|3|||
125576090|NCT00357500|451736269|FG000|Overall Study|Withdrawal by Subject|5|||
125576091|NCT00357500|451736269|FG000|Overall Study|Progressive Disease|65|||
125576092|NCT00357500|451736269|FG000|Overall Study|Not Started Protocol Therapy|4|||
125576093|NCT02695628|451736270|FG000|Overall Study|Withdrawal by Subject|1|||
125576094|NCT02573155|451736271|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
125576095|NCT02573155|451736272|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
125576096|NCT02573155|451736271|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
125576097|NCT02573155|451736272|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
125576098|NCT02573155|451736271|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
125576099|NCT02573155|451736272|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
125576100|NCT02573155|451736271|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
125576101|NCT02573155|451736272|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
125576102|NCT02573155|451736271|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
125576103|NCT02573155|451736272|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
125576104|NCT02573155|451736271|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
125576105|NCT02573155|451736272|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
125576106|NCT02573155|451736271|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
125576107|NCT02573155|451736272|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
125576108|NCT02573155|451736271|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
125576109|NCT02573155|451736272|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
125576110|NCT01681433|451736273|FG000|Overall Study|Lack of Efficacy|23|||
125576111|NCT01681433|451736274|FG001|Overall Study|Lack of Efficacy|23|||
125576112|NCT01681433|451736273|FG000|Overall Study|Withdrawal by Subject|5|||
125576113|NCT01681433|451736274|FG001|Overall Study|Withdrawal by Subject|5|||
125576114|NCT01681433|451736273|FG000|Overall Study|Protocol Violation|2|||
125576115|NCT01681433|451736274|FG001|Overall Study|Protocol Violation|0|||
125576116|NCT01681433|451736273|FG000|Overall Study|Adverse Event|2|||
125576117|NCT01681433|451736274|FG001|Overall Study|Adverse Event|4|||
125576118|NCT01681433|451736273|FG000|Overall Study|Lost to Follow-up|0|||
125576119|NCT01681433|451736274|FG001|Overall Study|Lost to Follow-up|1|||
125576120|NCT02301403|451736275|FG000|Overall Study|Withdrawal by Subject|28|||
125576121|NCT02301403|451736276|FG001|Overall Study|Withdrawal by Subject|41|||
125576122|NCT03505021|451736296|FG000|Overall Study|Protocol Violation|1|||
125576123|NCT03505021|451736297|FG001|Overall Study|Protocol Violation|0|||
125576124|NCT03505021|451736296|FG000|Overall Study|Death|9|||
125576125|NCT03505021|451736297|FG001|Overall Study|Death|8|||
125576126|NCT03505021|451736296|FG000|Overall Study|Consent withdrawn by subject|6|||
125576127|NCT03505021|451736297|FG001|Overall Study|Consent withdrawn by subject|1|||
125211117|NCT04122625|450398588|FG003|Part A (up to 2.92 Years)|Death|0|||
125211118|NCT04122625|450398589|FG004|Part A (up to 2.92 Years)|Death|0|||
125211119|NCT04122625|450398590|FG005|Part A (up to 2.92 Years)|Death|0|||
125211120|NCT04122625|450398585|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
125211121|NCT04122625|450398586|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
125211122|NCT04122625|450398587|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
125211123|NCT04122625|450398588|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
125211124|NCT04122625|450398589|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
125211125|NCT04122625|450398590|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
125211126|NCT04122625|450398585|FG000|Part B (up to 2.33 Years)|Death|0|||
125211127|NCT04122625|450398586|FG001|Part B (up to 2.33 Years)|Death|0|||
125211128|NCT04122625|450398587|FG002|Part B (up to 2.33 Years)|Death|5|||
125211129|NCT04122625|450398588|FG003|Part B (up to 2.33 Years)|Death|7|||
125211130|NCT04122625|450398589|FG004|Part B (up to 2.33 Years)|Death|6|||
125211131|NCT04122625|450398590|FG005|Part B (up to 2.33 Years)|Death|7|||
125211132|NCT04348500|450398591|FG000|Overall Study|Death|2|||
125211133|NCT04348500|450398592|FG001|Overall Study|Death|2|||
125211134|NCT04348500|450398591|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
125211135|NCT04348500|450398592|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
125211136|NCT02776670|450398593|FG000|Overall Study|Adverse Event|0|||
125211137|NCT02776670|450398594|FG001|Overall Study|Adverse Event|2|||
125211138|NCT02776670|450398593|FG000|Overall Study|Protocol Violation|0|||
125211139|NCT02776670|450398594|FG001|Overall Study|Protocol Violation|2|||
125211140|NCT02776670|450398593|FG000|Overall Study|Withdrawal by Subject|0|||
125211141|NCT02776670|450398594|FG001|Overall Study|Withdrawal by Subject|1|||
125211142|NCT02776670|450398593|FG000|Overall Study|Other - Reason not given|0|||
125211143|NCT02776670|450398594|FG001|Overall Study|Other - Reason not given|1|||
125211144|NCT01937884|450398595|FG000|Overall Study|Withdrawal by Subject|1|||
125211145|NCT01937884|450398596|FG001|Overall Study|Withdrawal by Subject|0|||
125211146|NCT00004088|450398597|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
125211147|NCT00004088|450398597|FG000|Overall Study|Withdrawal by Subject|1|||
125211148|NCT00004088|450398597|FG000|Overall Study|Protocol Violation|3|||
125211149|NCT00004088|450398597|FG000|Overall Study|Physician Decision|1|||
125211150|NCT00981058|450398598|FG000|Overall Study|Progressive Disease|38|||
125211151|NCT00981058|450398599|FG001|Overall Study|Progressive Disease|31|||
125211152|NCT00981058|450398598|FG000|Overall Study|Lost to Follow-up|3|||
125211153|NCT00981058|450398599|FG001|Overall Study|Lost to Follow-up|2|||
125211154|NCT00981058|450398598|FG000|Overall Study|Physician Decision|4|||
125211155|NCT00981058|450398599|FG001|Overall Study|Physician Decision|5|||
125211156|NCT00981058|450398598|FG000|Overall Study|Randomization Error|0|||
125211157|NCT00981058|450398599|FG001|Overall Study|Randomization Error|1|||
125211158|NCT00981058|450398598|FG000|Overall Study|Withdrawal by Subject|24|||
125211159|NCT00981058|450398599|FG001|Overall Study|Withdrawal by Subject|22|||
125211160|NCT02667587|450398600|FG000|Pre-Treatment|Not reported|1|||
125211161|NCT02667587|450398601|FG001|Pre-Treatment|Not reported|0|||
125211162|NCT02667587|450398600|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
125211163|NCT02667587|450398601|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
125211164|NCT02667587|450398600|FG000|Pre-Treatment|Participant withdrew consent|0|||
125211165|NCT02667587|450398601|FG001|Pre-Treatment|Participant withdrew consent|1|||
125211166|NCT02667587|450398600|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
125211167|NCT02667587|450398601|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
125211168|NCT02667587|450398600|FG000|End of Treatment|Disease Progression|193|||
125211169|NCT02667587|450398601|FG001|End of Treatment|Disease Progression|226|||
125211170|NCT02667587|450398600|FG000|End of Treatment|Study Drug Toxicity|75|||
125211171|NCT02667587|450398601|FG001|End of Treatment|Study Drug Toxicity|19|||
125211172|NCT02667587|450398600|FG000|End of Treatment|Death|2|||
125211173|NCT02667587|450398601|FG001|End of Treatment|Death|1|||
125211174|NCT02667587|450398600|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
125211175|NCT02667587|450398601|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
125211176|NCT02667587|450398600|FG000|End of Treatment|participant request to discontinue treatment|33|||
125576128|NCT03505021|451736296|FG000|Overall Study|Lost to Follow-up|5|||
125576129|NCT03505021|451736297|FG001|Overall Study|Lost to Follow-up|3|||
125211177|NCT02667587|450398601|FG001|End of Treatment|participant request to discontinue treatment|35|||
125211178|NCT02667587|450398600|FG000|End of Treatment|participant withdrew consent|5|||
125211179|NCT02667587|450398601|FG001|End of Treatment|participant withdrew consent|6|||
125211180|NCT02667587|450398600|FG000|End of Treatment|Lost to Follow-up|1|||
125211181|NCT02667587|450398601|FG001|End of Treatment|Lost to Follow-up|2|||
125576130|NCT03505021|451736296|FG000|Overall Study|Adverse Event|26|||
125576131|NCT03505021|451736297|FG001|Overall Study|Adverse Event|9|||
125211182|NCT02667587|450398600|FG000|End of Treatment|maximum clinical benefit|4|||
125211183|NCT02667587|450398601|FG001|End of Treatment|maximum clinical benefit|4|||
125576132|NCT03505021|451736296|FG000|Overall Study|Disease progression|33|||
125211184|NCT02667587|450398600|FG000|End of Treatment|poor or non compliant|0|||
125211185|NCT02667587|450398601|FG001|End of Treatment|poor or non compliant|1|||
125211186|NCT02667587|450398600|FG000|End of Treatment|participant no longer meets study criteria|1|||
125358803|NCT03633617|450950597|FG009|Part A|Withdrawal by Subject|0|||
125358804|NCT03633617|450950598|FG010|Part A|Withdrawal by Subject|0|||
125576133|NCT03505021|451736297|FG001|Overall Study|Disease progression|17|||
125576134|NCT03505021|451736296|FG000|Overall Study|Other|11|||
125576135|NCT03505021|451736297|FG001|Overall Study|Other|5|||
125576136|NCT03505021|451736296|FG000|Overall Study|Personal reason|21|||
125576137|NCT03505021|451736297|FG001|Overall Study|Personal reason|12|||
125576138|NCT04705051|451738213|FG000|Overall Study|Enrolled but not treated|1|||
125211187|NCT02667587|450398601|FG001|End of Treatment|participant no longer meets study criteria|1|||
125211188|NCT02667587|450398600|FG000|End of Treatment|administrative reason by sponsor|1|||
125211189|NCT02667587|450398601|FG001|End of Treatment|administrative reason by sponsor|29|||
125211190|NCT02667587|450398600|FG000|End of Treatment|other reasonse|21|||
125211191|NCT02667587|450398601|FG001|End of Treatment|other reasonse|10|||
125211192|NCT04165135|450398602|FG000|Overall Study|Protocol Violation|10|||
125211193|NCT04165135|450398602|FG000|Overall Study|Participants withdrawal of consent|5|||
125211194|NCT02886884|450398608|FG000|Follow-up|Withdrawal by Subject|0|||
125211195|NCT02886884|450398609|FG001|Follow-up|Withdrawal by Subject|0|||
125211196|NCT02886884|450398610|FG002|Follow-up|Withdrawal by Subject|0|||
125211197|NCT02886884|450398611|FG003|Follow-up|Withdrawal by Subject|1|||
125211198|NCT00575510|450398614|FG000|Overall Study|Lost to Follow-up|4|||
125211199|NCT00575510|450398615|FG001|Overall Study|Lost to Follow-up|6|||
125211200|NCT00575510|450398616|FG002|Overall Study|Lost to Follow-up|9|||
125211201|NCT00575510|450398614|FG000|Overall Study|Withdrawal by Subject|1|||
125211202|NCT00575510|450398615|FG001|Overall Study|Withdrawal by Subject|0|||
125211203|NCT00575510|450398616|FG002|Overall Study|Withdrawal by Subject|0|||
125211204|NCT00575510|450398614|FG000|Overall Study|Clinic Called Patient|7|||
125211205|NCT00575510|450398615|FG001|Overall Study|Clinic Called Patient|7|||
125211206|NCT00575510|450398616|FG002|Overall Study|Clinic Called Patient|7|||
125211207|NCT00575510|450398614|FG000|Overall Study|Pregnancy|0|||
125211208|NCT00575510|450398615|FG001|Overall Study|Pregnancy|0|||
125211209|NCT00575510|450398616|FG002|Overall Study|Pregnancy|1|||
125211210|NCT00106639|450398620|FG000|Overall Study|Adverse Event|3|||
125211211|NCT00106639|450398621|FG001|Overall Study|Adverse Event|4|||
125211212|NCT00106639|450398622|FG002|Overall Study|Adverse Event|1|||
125211213|NCT00106639|450398620|FG000|Overall Study|Protocol Violation|0|||
125211214|NCT00106639|450398621|FG001|Overall Study|Protocol Violation|1|||
125211215|NCT00106639|450398622|FG002|Overall Study|Protocol Violation|0|||
125211216|NCT00106639|450398620|FG000|Overall Study|Withdrawal by Subject|0|||
125211217|NCT00106639|450398621|FG001|Overall Study|Withdrawal by Subject|1|||
125211218|NCT00106639|450398622|FG002|Overall Study|Withdrawal by Subject|0|||
125211219|NCT00106639|450398620|FG000|Overall Study|Participant defaulted|0|||
125211220|NCT00106639|450398621|FG001|Overall Study|Participant defaulted|1|||
125211221|NCT00106639|450398622|FG002|Overall Study|Participant defaulted|1|||
125211222|NCT00594386|450398624|FG000|Overall Study|Major protocol violation|2|||
125211223|NCT00594386|450398624|FG000|Overall Study|Lack of Efficacy|12|||
125211224|NCT00594386|450398624|FG000|Overall Study|Adverse Event|68|||
125211225|NCT00594386|450398624|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
125211226|NCT00594386|450398624|FG000|Overall Study|Subject withdrew consent|35|||
125211227|NCT00594386|450398624|FG000|Overall Study|Study ended per sponsor|115|||
125211228|NCT00594386|450398624|FG000|Overall Study|Lost to Follow-up|6|||
125211229|NCT00594386|450398624|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
125211230|NCT00594386|450398624|FG000|Overall Study|Other: Subject moved to Seattle|1|||
125211231|NCT00594386|450398624|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
125211232|NCT00594386|450398624|FG000|Overall Study|Other: Study terminated per investigator|2|||
125211233|NCT00594386|450398624|FG000|Overall Study|Other: Sponsor closure of study|1|||
125358805|NCT03633617|450950588|FG000|Part B|Adverse Event|0|||
125358806|NCT03633617|450950589|FG001|Part B|Adverse Event|0|||
125358807|NCT03633617|450950590|FG002|Part B|Adverse Event|2|||
125358808|NCT03633617|450950591|FG003|Part B|Adverse Event|2|||
125358809|NCT03633617|450950592|FG004|Part B|Adverse Event|1|||
125358810|NCT03633617|450950593|FG005|Part B|Adverse Event|0|||
125576139|NCT04705051|451738213|FG000|Overall Study|Study terminated by sponsor|23|||
125576140|NCT01790503|451738214|FG000|Overall Study|Adverse Event|1|||
125576141|NCT01790503|451738215|FG001|Overall Study|Adverse Event|0|||
125358811|NCT03633617|450950594|FG006|Part B|Adverse Event|0|||
125576142|NCT01790503|451738216|FG002|Overall Study|Adverse Event|0|||
125211234|NCT00594386|450398624|FG000|Overall Study|Other: Site terminated participation|1|||
125211235|NCT00594386|450398624|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
125211236|NCT00594386|450398624|FG000|Overall Study|Other: Loss of drivers license|1|||
125211237|NCT01210144|450398625|FG000|Overall Study|Lack of ovarian response|1|||
125211238|NCT01210144|450398626|FG001|Overall Study|Lack of ovarian response|0|||
125211239|NCT01210144|450398625|FG000|Overall Study|No fertilization|1|||
125211240|NCT01210144|450398626|FG001|Overall Study|No fertilization|0|||
125358812|NCT03633617|450950595|FG007|Part B|Adverse Event|0|||
125576143|NCT01790503|451738217|FG003|Overall Study|Adverse Event|0|||
125576144|NCT01790503|451738218|FG004|Overall Study|Adverse Event|0|||
125358813|NCT03633617|450950596|FG008|Part B|Adverse Event|0|||
125358814|NCT03633617|450950597|FG009|Part B|Adverse Event|0|||
125576145|NCT01790503|451738219|FG005|Overall Study|Adverse Event|2|||
125576146|NCT01790503|451738220|FG006|Overall Study|Adverse Event|0|||
125576147|NCT01790503|451738221|FG007|Overall Study|Adverse Event|0|||
125576148|NCT01790503|451738222|FG008|Overall Study|Adverse Event|2|||
125576149|NCT01790503|451738223|FG009|Overall Study|Adverse Event|4|||
125576150|NCT01790503|451738224|FG010|Overall Study|Adverse Event|7|||
125576151|NCT01790503|451738214|FG000|Overall Study|Withdrawal by Subject|0|||
125576152|NCT01790503|451738215|FG001|Overall Study|Withdrawal by Subject|0|||
125576153|NCT01790503|451738216|FG002|Overall Study|Withdrawal by Subject|1|||
125576154|NCT01790503|451738217|FG003|Overall Study|Withdrawal by Subject|1|||
125576155|NCT01790503|451738218|FG004|Overall Study|Withdrawal by Subject|1|||
125576156|NCT01790503|451738219|FG005|Overall Study|Withdrawal by Subject|2|||
125576157|NCT01790503|451738220|FG006|Overall Study|Withdrawal by Subject|1|||
125576158|NCT01790503|451738221|FG007|Overall Study|Withdrawal by Subject|0|||
125576159|NCT01790503|451738222|FG008|Overall Study|Withdrawal by Subject|0|||
125576160|NCT01790503|451738223|FG009|Overall Study|Withdrawal by Subject|0|||
125576161|NCT01790503|451738224|FG010|Overall Study|Withdrawal by Subject|1|||
125576162|NCT01790503|451738214|FG000|Overall Study|Disease progression|2|||
125576163|NCT01790503|451738215|FG001|Overall Study|Disease progression|1|||
125576164|NCT01790503|451738216|FG002|Overall Study|Disease progression|0|||
125576165|NCT01790503|451738217|FG003|Overall Study|Disease progression|1|||
125576166|NCT01790503|451738218|FG004|Overall Study|Disease progression|2|||
125576167|NCT01790503|451738219|FG005|Overall Study|Disease progression|1|||
125576168|NCT01790503|451738220|FG006|Overall Study|Disease progression|0|||
125358815|NCT03633617|450950598|FG010|Part B|Adverse Event|0|||
125358816|NCT03633617|450950588|FG000|Part B|Withdrawal by Subject|0|||
125358817|NCT03633617|450950589|FG001|Part B|Withdrawal by Subject|0|||
125358818|NCT03633617|450950590|FG002|Part B|Withdrawal by Subject|1|||
125358819|NCT03633617|450950591|FG003|Part B|Withdrawal by Subject|0|||
125358820|NCT03633617|450950592|FG004|Part B|Withdrawal by Subject|2|||
125358821|NCT03633617|450950593|FG005|Part B|Withdrawal by Subject|0|||
125576169|NCT01790503|451738221|FG007|Overall Study|Disease progression|1|||
125576170|NCT01790503|451738222|FG008|Overall Study|Disease progression|0|||
125576171|NCT01790503|451738223|FG009|Overall Study|Disease progression|17|||
125576172|NCT01790503|451738224|FG010|Overall Study|Disease progression|7|||
125576173|NCT01790503|451738214|FG000|Overall Study|Protocol Violation|0|||
125576174|NCT01790503|451738215|FG001|Overall Study|Protocol Violation|0|||
125576175|NCT01790503|451738216|FG002|Overall Study|Protocol Violation|0|||
125576176|NCT01790503|451738217|FG003|Overall Study|Protocol Violation|0|||
125576177|NCT01790503|451738218|FG004|Overall Study|Protocol Violation|0|||
125576178|NCT01790503|451738219|FG005|Overall Study|Protocol Violation|0|||
125576179|NCT01790503|451738220|FG006|Overall Study|Protocol Violation|0|||
125576180|NCT01790503|451738221|FG007|Overall Study|Protocol Violation|0|||
125576181|NCT01790503|451738222|FG008|Overall Study|Protocol Violation|0|||
125576182|NCT01790503|451738223|FG009|Overall Study|Protocol Violation|1|||
125576183|NCT01790503|451738224|FG010|Overall Study|Protocol Violation|0|||
125576184|NCT01790503|451738214|FG000|Overall Study|Physician Decision|0|||
125576185|NCT01790503|451738215|FG001|Overall Study|Physician Decision|0|||
125576186|NCT01790503|451738216|FG002|Overall Study|Physician Decision|0|||
125576187|NCT01790503|451738217|FG003|Overall Study|Physician Decision|0|||
125576188|NCT01790503|451738218|FG004|Overall Study|Physician Decision|0|||
125576189|NCT01790503|451738219|FG005|Overall Study|Physician Decision|0|||
125576190|NCT01790503|451738220|FG006|Overall Study|Physician Decision|0|||
125576191|NCT01790503|451738221|FG007|Overall Study|Physician Decision|0|||
125576192|NCT01790503|451738222|FG008|Overall Study|Physician Decision|0|||
125576193|NCT01790503|451738223|FG009|Overall Study|Physician Decision|1|||
125576194|NCT01790503|451738224|FG010|Overall Study|Physician Decision|1|||
125576195|NCT01790503|451738214|FG000|Overall Study|Death|0|||
125576196|NCT01790503|451738215|FG001|Overall Study|Death|0|||
125358822|NCT03633617|450950594|FG006|Part B|Withdrawal by Subject|0|||
125358823|NCT03633617|450950595|FG007|Part B|Withdrawal by Subject|0|||
125576197|NCT01790503|451738216|FG002|Overall Study|Death|0|||
125576198|NCT01790503|451738217|FG003|Overall Study|Death|0|||
125576199|NCT01790503|451738218|FG004|Overall Study|Death|0|||
125576200|NCT01790503|451738219|FG005|Overall Study|Death|0|||
125576201|NCT01790503|451738220|FG006|Overall Study|Death|0|||
125576202|NCT01790503|451738221|FG007|Overall Study|Death|0|||
125576203|NCT01790503|451738222|FG008|Overall Study|Death|0|||
125576204|NCT01790503|451738223|FG009|Overall Study|Death|1|||
125576205|NCT01790503|451738224|FG010|Overall Study|Death|0|||
125358824|NCT03633617|450950596|FG008|Part B|Withdrawal by Subject|0|||
125576206|NCT01790503|451738214|FG000|Overall Study|Non Compliance|0|||
125576207|NCT01790503|451738215|FG001|Overall Study|Non Compliance|0|||
125576208|NCT01790503|451738216|FG002|Overall Study|Non Compliance|0|||
125576209|NCT01790503|451738217|FG003|Overall Study|Non Compliance|0|||
125576210|NCT01790503|451738218|FG004|Overall Study|Non Compliance|1|||
125358825|NCT03633617|450950597|FG009|Part B|Withdrawal by Subject|0|||
125358826|NCT03633617|450950598|FG010|Part B|Withdrawal by Subject|0|||
125576211|NCT01790503|451738219|FG005|Overall Study|Non Compliance|0|||
125576212|NCT01790503|451738220|FG006|Overall Study|Non Compliance|0|||
125576213|NCT01790503|451738221|FG007|Overall Study|Non Compliance|0|||
125358827|NCT03633617|450950588|FG000|Part B|Lost to Follow-up|0|||
125576214|NCT01790503|451738222|FG008|Overall Study|Non Compliance|0|||
125576215|NCT01790503|451738223|FG009|Overall Study|Non Compliance|0|||
125576216|NCT01790503|451738224|FG010|Overall Study|Non Compliance|0|||
125576217|NCT01790503|451738214|FG000|Overall Study|Other|0|||
125576218|NCT01790503|451738215|FG001|Overall Study|Other|0|||
125576219|NCT01790503|451738216|FG002|Overall Study|Other|0|||
125576220|NCT01790503|451738217|FG003|Overall Study|Other|0|||
125576221|NCT01790503|451738218|FG004|Overall Study|Other|1|||
125576222|NCT01790503|451738219|FG005|Overall Study|Other|0|||
125576223|NCT01790503|451738220|FG006|Overall Study|Other|0|||
125576224|NCT01790503|451738221|FG007|Overall Study|Other|0|||
125576225|NCT01790503|451738222|FG008|Overall Study|Other|1|||
125576226|NCT01790503|451738223|FG009|Overall Study|Other|2|||
125576227|NCT01790503|451738224|FG010|Overall Study|Other|0|||
125576228|NCT00984204|451738236|FG000|Overall Study|Death|1|||
125576229|NCT00984204|451738236|FG000|Overall Study|Lost to Follow-up|4|||
125576230|NCT00984204|451738236|FG000|Overall Study|Lack of Efficacy|10|||
125576231|NCT00699348|451738245|FG000|Overall Study|Death|6|||
125576232|NCT00699348|451738245|FG000|Overall Study|Adverse Event|15|||
125576233|NCT00699348|451738245|FG000|Overall Study|Withdrawal by Subject|11|||
125576234|NCT00699348|451738245|FG000|Overall Study|Protocol Violation|10|||
125576235|NCT00699348|451738245|FG000|Overall Study|Lack of Efficacy|8|||
125576236|NCT00699348|451738245|FG000|Overall Study|Failure to return|1|||
125576237|NCT00699348|451738245|FG000|Overall Study|Blood transfusion|24|||
125576238|NCT00699348|451738245|FG000|Overall Study|Renal transplantation|10|||
125576239|NCT00699348|451738245|FG000|Overall Study|Other|5|||
125576240|NCT00223496|451738250|FG000|Overall Study|screen failure|9|||
125576241|NCT00223496|451738250|FG000|Overall Study|Lost to Follow-up|4|||
125576242|NCT00223496|451738250|FG000|Overall Study|Lack of Efficacy|6|||
125576243|NCT00223496|451738250|FG000|Overall Study|Withdrawal by Subject|1|||
125576244|NCT00223496|451738250|FG000|Overall Study|Physician Decision|2|||
125576245|NCT05702515|451738251|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
125576246|NCT00424827|451738255|FG000|Overall Study|Adverse Event|1|||
125576247|NCT00159432|451738256|FG000|Overall Study|Adverse Event|1|||
125576248|NCT00159432|451738256|FG000|Overall Study|Death|1|||
125576249|NCT00159432|451738256|FG000|Overall Study|Lack of Efficacy|8|||
125576250|NCT01491178|451738257|FG000|Overall Study|Adverse Event|1016|||
125576251|NCT01491178|451738257|FG000|Overall Study|Improvement of NVAF|210|||
125576252|NCT01491178|451738257|FG000|Overall Study|To conduct invasive treatment|59|||
125576253|NCT01491178|451738257|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
125576254|NCT01491178|451738257|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
125576255|NCT01491178|451738257|FG000|Overall Study|To take a contraindication|20|||
125576256|NCT01491178|451738257|FG000|Overall Study|Other than specified above|657|||
125576257|NCT05218499|451738258|FG000|Overall Study|Not treated|1|||
125576258|NCT05218499|451738259|FG001|Overall Study|Not treated|1|||
125576259|NCT05218499|451738260|FG002|Overall Study|Not treated|8|||
125576260|NCT05218499|451738258|FG000|Overall Study|Death|2|||
125576261|NCT05218499|451738259|FG001|Overall Study|Death|0|||
125576262|NCT05218499|451738260|FG002|Overall Study|Death|0|||
125576263|NCT05218499|451738258|FG000|Overall Study|Other than listed|3|||
125576264|NCT05218499|451738259|FG001|Overall Study|Other than listed|7|||
125576265|NCT05218499|451738260|FG002|Overall Study|Other than listed|10|||
125576266|NCT05218499|451738258|FG000|Overall Study|Protocol deviation|5|||
125576267|NCT05218499|451738259|FG001|Overall Study|Protocol deviation|6|||
125576268|NCT05218499|451738260|FG002|Overall Study|Protocol deviation|4|||
125576269|NCT05218499|451738258|FG000|Overall Study|Technical problems|0|||
125576270|NCT05218499|451738259|FG001|Overall Study|Technical problems|1|||
125576271|NCT05218499|451738260|FG002|Overall Study|Technical problems|0|||
125576272|NCT05218499|451738258|FG000|Overall Study|Burden of trial procedures|0|||
125576273|NCT05218499|451738259|FG001|Overall Study|Burden of trial procedures|1|||
125576274|NCT05218499|451738260|FG002|Overall Study|Burden of trial procedures|2|||
125576275|NCT05218499|451738258|FG000|Overall Study|Clinical disease progression|6|||
125576276|NCT05218499|451738259|FG001|Overall Study|Clinical disease progression|6|||
125576277|NCT05218499|451738260|FG002|Overall Study|Clinical disease progression|11|||
125576278|NCT05218499|451738258|FG000|Overall Study|Objective disease progression|44|||
125576279|NCT05218499|451738259|FG001|Overall Study|Objective disease progression|61|||
125576280|NCT05218499|451738260|FG002|Overall Study|Objective disease progression|42|||
125576281|NCT05218499|451738258|FG000|Overall Study|Adverse Event|11|||
125576282|NCT05218499|451738259|FG001|Overall Study|Adverse Event|36|||
125576283|NCT05218499|451738260|FG002|Overall Study|Adverse Event|9|||
125576284|NCT05218499|451738258|FG000|Overall Study|On treatment at time of snapshot|18|||
125576285|NCT05218499|451738259|FG001|Overall Study|On treatment at time of snapshot|29|||
125576286|NCT05218499|451738260|FG002|Overall Study|On treatment at time of snapshot|0|||
125576287|NCT05689047|451738261|FG000|Overall Study|Lost to Follow-up|0|||
125211241|NCT01210144|450398625|FG000|Overall Study|No transfer|1|||
125211242|NCT01210144|450398626|FG001|Overall Study|No transfer|0|||
125211243|NCT00094536|450398633|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
125211244|NCT00094536|450398633|FG000|Treatment and Follow-up|Adverse Event|4|||
125211245|NCT00094536|450398633|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
125211246|NCT00094536|450398633|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
125211247|NCT00094536|450398633|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
125211248|NCT00094536|450398633|FG000|Treatment and Follow-up|Subject non-compliance|9|||
125211249|NCT00094536|450398633|FG000|Treatment and Follow-up|Unable to attend visits|1|||
125211250|NCT00494221|450398634|FG000|Overall Study|Death|15|||
125211251|NCT00494221|450398635|FG001|Overall Study|Death|9|||
125211252|NCT00494221|450398636|FG002|Overall Study|Death|14|||
125211253|NCT00494221|450398634|FG000|Overall Study|Withdrawal by Subject|1|||
125211254|NCT00494221|450398635|FG001|Overall Study|Withdrawal by Subject|2|||
125211255|NCT00494221|450398636|FG002|Overall Study|Withdrawal by Subject|0|||
125211256|NCT01900431|450398641|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
125211257|NCT01900431|450398642|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
125211258|NCT01900431|450398643|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
125211259|NCT01900431|450398641|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
125211260|NCT01900431|450398642|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
125211261|NCT01900431|450398643|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
125211262|NCT01900431|450398641|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
125211263|NCT01900431|450398642|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
125211264|NCT01900431|450398643|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
125211265|NCT01900431|450398641|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
125211266|NCT01900431|450398642|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
125211267|NCT01900431|450398643|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
125211268|NCT01900431|450398641|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
125211269|NCT01900431|450398642|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
125576288|NCT05689047|451738262|FG001|Overall Study|Lost to Follow-up|1|||
125576289|NCT05689047|451738261|FG000|Overall Study|Protocol Deviation|1|||
125576290|NCT05689047|451738262|FG001|Overall Study|Protocol Deviation|0|||
125576291|NCT01604512|451738263|FG000|Overall Study|Withdrawal by Subject|3|||
125576292|NCT01604512|451738263|FG000|Overall Study|Not treated|4|||
125576293|NCT03655756|451738264|FG000|Overall Study|Death|1|||
125576294|NCT00253630|451738265|FG000|Overall Study|ineligible|2|||
125576295|NCT03237065|451738266|FG000|Overall Study|Adverse Event|0|||
125576296|NCT03237065|451738267|FG001|Overall Study|Adverse Event|2|||
125576297|NCT03237065|451738266|FG000|Overall Study|Protocol Violation|0|||
125576298|NCT03237065|451738267|FG001|Overall Study|Protocol Violation|1|||
125576299|NCT03237065|451738266|FG000|Overall Study|Withdrawal by Subject|3|||
125576300|NCT03237065|451738267|FG001|Overall Study|Withdrawal by Subject|0|||
125576301|NCT03237065|451738266|FG000|Overall Study|Lost to Follow-up|1|||
125576302|NCT03237065|451738267|FG001|Overall Study|Lost to Follow-up|0|||
125576303|NCT03237065|451738266|FG000|Overall Study|Unable to obtain venous access|0|||
125576304|NCT03237065|451738267|FG001|Overall Study|Unable to obtain venous access|1|||
125576305|NCT00209339|451738268|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
125576306|NCT00209339|451738268|FG000|At 12 Months Follow-up|Death|1|||
125576307|NCT00209339|451738268|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
125576308|NCT00209339|451738268|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
125576309|NCT00209339|451738268|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
125576310|NCT00209339|451738268|FG000|At 24 Months Follow-up|Death|1|||
125576311|NCT00209339|451738268|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
125576312|NCT00209339|451738268|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
125576313|NCT00209339|451738268|FG000|At 4 Years Follow-up|Death|1|||
125576314|NCT00209339|451738268|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
125576315|NCT00209339|451738268|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
125576316|NCT00209339|451738268|FG000|At 5 Years Follow-up|Death|1|||
125576317|NCT00429858|451738269|FG000|Overall Study|Withdrawal by Subject|1|||
125576318|NCT00429858|451738269|FG000|Overall Study|Study Termination|1|||
125576319|NCT02268058|451738270|FG000|Overall Study|Protocol Violation|1|||
125576320|NCT02268058|451738271|FG001|Overall Study|Protocol Violation|0|||
125576321|NCT02268058|451738272|FG002|Overall Study|Protocol Violation|0|||
125576322|NCT02268058|451738273|FG003|Overall Study|Protocol Violation|0|||
125576323|NCT04781816|451738274|FG000|Overall Study|Adverse Event|0|||
125211270|NCT01900431|450398643|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
125427265|NCT00117676|451189323|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
125211271|NCT01900431|450398641|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
125211272|NCT01900431|450398642|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
125211273|NCT01900431|450398643|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
125211274|NCT01900431|450398641|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
125576324|NCT04781816|451738275|FG001|Overall Study|Adverse Event|1|||
125576325|NCT04781816|451738274|FG000|Overall Study|Withdrawal by Subject|1|||
125576326|NCT04781816|451738275|FG001|Overall Study|Withdrawal by Subject|1|||
125576327|NCT04781816|451738274|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
125576328|NCT04781816|451738275|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
125576329|NCT01121393|451738276|FG000|Overall Study|Progressive disease|201|||
125576330|NCT01121393|451738277|FG001|Overall Study|Progressive disease|20|||
125576331|NCT01121393|451738276|FG000|Overall Study|Other Adverse events|24|||
125576332|NCT01121393|451738277|FG001|Overall Study|Other Adverse events|45|||
125576333|NCT01121393|451738276|FG000|Overall Study|Non-compliant with protocol|0|||
125576334|NCT01121393|451738277|FG001|Overall Study|Non-compliant with protocol|3|||
125576335|NCT01121393|451738276|FG000|Overall Study|Lost to Follow-up|1|||
125576336|NCT01121393|451738277|FG001|Overall Study|Lost to Follow-up|0|||
125576337|NCT01121393|451738276|FG000|Overall Study|Refused cont. medication|7|||
125576338|NCT01121393|451738277|FG001|Overall Study|Refused cont. medication|7|||
125576339|NCT01121393|451738276|FG000|Overall Study|Not treated|3|||
125576340|NCT01121393|451738277|FG001|Overall Study|Not treated|9|||
125576341|NCT01121393|451738276|FG000|Overall Study|Other than listed|6|||
125576342|NCT01121393|451738277|FG001|Overall Study|Other than listed|0|||
125576343|NCT01100944|451738278|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
125576344|NCT01100944|451738279|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
125576345|NCT01100944|451738280|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
125576346|NCT01100944|451738278|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
125576347|NCT01100944|451738279|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
125576348|NCT01100944|451738280|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
125576349|NCT01100944|451738278|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
125576350|NCT01100944|451738279|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
125576351|NCT01100944|451738280|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
125576352|NCT01100944|451738278|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
125427266|NCT00117676|451189322|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
125427267|NCT00117676|451189323|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
125427268|NCT00117676|451189322|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
125427269|NCT00117676|451189323|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
125427270|NCT00117676|451189322|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
125427271|NCT00117676|451189323|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
125427272|NCT00117676|451189322|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
125427273|NCT00117676|451189323|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
125427274|NCT00117676|451189322|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
125427275|NCT00117676|451189323|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
125427276|NCT00117676|451189322|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
125427277|NCT00117676|451189323|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
125427278|NCT00117676|451189322|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
125427279|NCT00117676|451189323|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
125427280|NCT00117676|451189322|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
125427281|NCT00117676|451189323|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
125427282|NCT00117676|451189322|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
125427283|NCT00117676|451189323|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
125427284|NCT00117676|451189322|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
125427285|NCT00117676|451189323|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
125427286|NCT00117676|451189322|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
125427287|NCT00117676|451189323|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
125427288|NCT00117676|451189322|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
125427289|NCT00117676|451189323|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
125427290|NCT00117676|451189322|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
125427291|NCT00117676|451189323|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
125427292|NCT00117676|451189322|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
125427293|NCT00117676|451189323|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
125427294|NCT00117676|451189322|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
125427295|NCT00117676|451189323|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
125427296|NCT00117676|451189322|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
125427297|NCT00117676|451189323|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
125427298|NCT00117676|451189322|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
125427299|NCT00117676|451189323|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
125576353|NCT01100944|451738279|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
125576354|NCT01100944|451738280|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
125576355|NCT00577993|451738281|FG000|Overall Study|Adverse Event|1|||
125576356|NCT00577993|451738282|FG001|Overall Study|Adverse Event|0|||
125576357|NCT00577993|451738283|FG002|Overall Study|Adverse Event|0|||
125576358|NCT00577993|451738281|FG000|Overall Study|Death|0|||
125576359|NCT00577993|451738282|FG001|Overall Study|Death|1|||
125576360|NCT00577993|451738283|FG002|Overall Study|Death|1|||
125576361|NCT00577993|451738281|FG000|Overall Study|Lack of Efficacy|0|||
125576362|NCT00577993|451738282|FG001|Overall Study|Lack of Efficacy|1|||
125576363|NCT00577993|451738283|FG002|Overall Study|Lack of Efficacy|0|||
125576364|NCT00577993|451738281|FG000|Overall Study|Protocol Violation|2|||
125576365|NCT00577993|451738282|FG001|Overall Study|Protocol Violation|3|||
125576366|NCT00577993|451738283|FG002|Overall Study|Protocol Violation|0|||
125576367|NCT00577993|451738281|FG000|Overall Study|Withdrawal by Subject|1|||
125576368|NCT00577993|451738282|FG001|Overall Study|Withdrawal by Subject|0|||
125576369|NCT00577993|451738283|FG002|Overall Study|Withdrawal by Subject|2|||
125576370|NCT00577993|451738281|FG000|Overall Study|Conversion|2|||
125576371|NCT00577993|451738282|FG001|Overall Study|Conversion|5|||
125576372|NCT00577993|451738283|FG002|Overall Study|Conversion|0|||
125576373|NCT00577993|451738281|FG000|Overall Study|Uninsured|1|||
125576374|NCT00577993|451738282|FG001|Overall Study|Uninsured|0|||
125576375|NCT00577993|451738283|FG002|Overall Study|Uninsured|0|||
125576376|NCT02217566|451738284|FG000|Overall Study|Lost to Follow-up|2|||
125576377|NCT02217566|451738284|FG000|Overall Study|Death|3|||
125576378|NCT02217566|451738284|FG000|Overall Study|Early study termination|6|||
125576379|NCT02296242|451738285|FG000|Overall Study|Death|1|||
125576380|NCT02296242|451738286|FG001|Overall Study|Death|1|||
125576381|NCT02296242|451738287|FG002|Overall Study|Death|1|||
125576382|NCT02296242|451738288|FG003|Overall Study|Death|1|||
125576383|NCT02296242|451738289|FG004|Overall Study|Death|1|||
125576384|NCT02296242|451738285|FG000|Overall Study|Withdrawal by Subject|0|||
125576385|NCT02296242|451738286|FG001|Overall Study|Withdrawal by Subject|0|||
125576386|NCT02296242|451738287|FG002|Overall Study|Withdrawal by Subject|1|||
125576387|NCT02296242|451738288|FG003|Overall Study|Withdrawal by Subject|1|||
125576388|NCT02296242|451738289|FG004|Overall Study|Withdrawal by Subject|3|||
125576389|NCT02296242|451738285|FG000|Overall Study|Disease Progression|1|||
125576390|NCT02296242|451738286|FG001|Overall Study|Disease Progression|3|||
125576391|NCT02296242|451738287|FG002|Overall Study|Disease Progression|2|||
125576392|NCT02296242|451738288|FG003|Overall Study|Disease Progression|8|||
125576393|NCT02296242|451738289|FG004|Overall Study|Disease Progression|11|||
125576394|NCT02296242|451738285|FG000|Overall Study|Unacceptable Toxicity|0|||
125576395|NCT02296242|451738286|FG001|Overall Study|Unacceptable Toxicity|0|||
125576396|NCT02296242|451738287|FG002|Overall Study|Unacceptable Toxicity|0|||
125576397|NCT02296242|451738288|FG003|Overall Study|Unacceptable Toxicity|0|||
125576398|NCT02296242|451738289|FG004|Overall Study|Unacceptable Toxicity|1|||
125576399|NCT02296242|451738285|FG000|Overall Study|Patient Condition Changed|0|||
125576400|NCT02296242|451738286|FG001|Overall Study|Patient Condition Changed|0|||
125576401|NCT02296242|451738287|FG002|Overall Study|Patient Condition Changed|2|||
125576402|NCT02296242|451738288|FG003|Overall Study|Patient Condition Changed|0|||
125576403|NCT02296242|451738289|FG004|Overall Study|Patient Condition Changed|1|||
125576404|NCT02296242|451738285|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
125576405|NCT02296242|451738286|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
125576406|NCT02296242|451738287|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
125576407|NCT02296242|451738288|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
125576408|NCT02296242|451738289|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
125576409|NCT02296242|451738285|FG000|Overall Study|Lost to Follow-up|1|||
125576410|NCT02296242|451738286|FG001|Overall Study|Lost to Follow-up|0|||
125576411|NCT02296242|451738287|FG002|Overall Study|Lost to Follow-up|0|||
125576412|NCT02296242|451738288|FG003|Overall Study|Lost to Follow-up|0|||
125576413|NCT02296242|451738289|FG004|Overall Study|Lost to Follow-up|0|||
125576414|NCT02296242|451738285|FG000|Overall Study|Need for Hydroxyurea|2|||
125576415|NCT02296242|451738286|FG001|Overall Study|Need for Hydroxyurea|0|||
125576416|NCT02296242|451738287|FG002|Overall Study|Need for Hydroxyurea|0|||
125576417|NCT02296242|451738288|FG003|Overall Study|Need for Hydroxyurea|0|||
125576418|NCT02296242|451738289|FG004|Overall Study|Need for Hydroxyurea|0|||
125576419|NCT02296242|451738285|FG000|Overall Study|Screened for Other Protocol|0|||
125576420|NCT02296242|451738286|FG001|Overall Study|Screened for Other Protocol|1|||
125576421|NCT02296242|451738287|FG002|Overall Study|Screened for Other Protocol|0|||
125211275|NCT01900431|450398642|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
125576422|NCT02296242|451738288|FG003|Overall Study|Screened for Other Protocol|0|||
125576423|NCT02296242|451738289|FG004|Overall Study|Screened for Other Protocol|0|||
125576424|NCT02296242|451738285|FG000|Overall Study|Physician Decision|0|||
125576425|NCT02296242|451738286|FG001|Overall Study|Physician Decision|1|||
125576426|NCT02296242|451738287|FG002|Overall Study|Physician Decision|0|||
125576427|NCT02296242|451738288|FG003|Overall Study|Physician Decision|1|||
125576428|NCT02296242|451738289|FG004|Overall Study|Physician Decision|0|||
125576429|NCT02296242|451738285|FG000|Overall Study|Alternative Treatment|0|||
125576430|NCT02296242|451738286|FG001|Overall Study|Alternative Treatment|0|||
125576431|NCT02296242|451738287|FG002|Overall Study|Alternative Treatment|0|||
125576432|NCT02296242|451738288|FG003|Overall Study|Alternative Treatment|1|||
125576433|NCT02296242|451738289|FG004|Overall Study|Alternative Treatment|0|||
125576434|NCT02296242|451738285|FG000|Overall Study|Adverse Event|0|||
125576435|NCT02296242|451738286|FG001|Overall Study|Adverse Event|0|||
125576436|NCT02296242|451738287|FG002|Overall Study|Adverse Event|0|||
125576437|NCT02296242|451738288|FG003|Overall Study|Adverse Event|1|||
125576438|NCT02296242|451738289|FG004|Overall Study|Adverse Event|0|||
125576439|NCT02296242|451738285|FG000|Overall Study|Lack of Efficacy|0|||
125576440|NCT02296242|451738286|FG001|Overall Study|Lack of Efficacy|0|||
125576441|NCT02296242|451738287|FG002|Overall Study|Lack of Efficacy|0|||
125576442|NCT02296242|451738288|FG003|Overall Study|Lack of Efficacy|0|||
125576443|NCT02296242|451738289|FG004|Overall Study|Lack of Efficacy|3|||
125576444|NCT04029519|451738294|FG000|Overall Study|Protocol Violation|1|||
125576445|NCT04029519|451738294|FG000|Overall Study|Withdrawal by Subject|3|||
125576446|NCT04029519|451738294|FG000|Overall Study|Lost to Follow-up|1|||
125576447|NCT02064387|451738295|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125576448|NCT02064387|451738296|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125576449|NCT02064387|451738297|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125576450|NCT02064387|451738298|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125576451|NCT02064387|451738299|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125576452|NCT02064387|451738300|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125576453|NCT02064387|451738301|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125576454|NCT02064387|451738302|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
125576455|NCT02064387|451738303|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125576456|NCT02064387|451738304|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
125576457|NCT02064387|451738305|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125576458|NCT02064387|451738306|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
125576459|NCT02064387|451738295|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125576460|NCT02064387|451738296|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125576461|NCT02064387|451738297|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125576462|NCT02064387|451738298|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125576463|NCT02064387|451738299|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125576464|NCT02064387|451738300|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125576465|NCT02064387|451738301|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125576466|NCT02064387|451738302|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
125576467|NCT02064387|451738303|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125576468|NCT02064387|451738304|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125211276|NCT01900431|450398643|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
125211277|NCT01900431|450398641|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
125576469|NCT02064387|451738305|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125576470|NCT02064387|451738306|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
125576471|NCT02064387|451738295|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125576472|NCT02064387|451738296|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125576473|NCT02064387|451738297|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125576474|NCT02064387|451738298|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125576475|NCT02064387|451738299|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125358828|NCT03633617|450950589|FG001|Part B|Lost to Follow-up|0|||
125358829|NCT03633617|450950590|FG002|Part B|Lost to Follow-up|0|||
125358830|NCT03633617|450950591|FG003|Part B|Lost to Follow-up|0|||
125358831|NCT03633617|450950592|FG004|Part B|Lost to Follow-up|1|||
125358832|NCT03633617|450950593|FG005|Part B|Lost to Follow-up|0|||
125358833|NCT03633617|450950594|FG006|Part B|Lost to Follow-up|0|||
125358834|NCT03633617|450950595|FG007|Part B|Lost to Follow-up|0|||
125358835|NCT03633617|450950596|FG008|Part B|Lost to Follow-up|0|||
125358836|NCT03633617|450950597|FG009|Part B|Lost to Follow-up|0|||
125358837|NCT03633617|450950598|FG010|Part B|Lost to Follow-up|0|||
125358838|NCT03633617|450950588|FG000|Part B|Physician Decision|0|||
125358839|NCT03633617|450950589|FG001|Part B|Physician Decision|0|||
125358840|NCT03633617|450950590|FG002|Part B|Physician Decision|0|||
125358841|NCT03633617|450950591|FG003|Part B|Physician Decision|0|||
125358842|NCT03633617|450950592|FG004|Part B|Physician Decision|1|||
125358843|NCT03633617|450950593|FG005|Part B|Physician Decision|0|||
125358844|NCT03633617|450950594|FG006|Part B|Physician Decision|0|||
125358845|NCT03633617|450950595|FG007|Part B|Physician Decision|0|||
125358846|NCT03633617|450950596|FG008|Part B|Physician Decision|0|||
125358847|NCT03633617|450950597|FG009|Part B|Physician Decision|0|||
125358848|NCT03633617|450950598|FG010|Part B|Physician Decision|0|||
125358849|NCT03633617|450950588|FG000|Part B|COVID-19 Restrictions|0|||
125358850|NCT03633617|450950589|FG001|Part B|COVID-19 Restrictions|0|||
125358851|NCT03633617|450950590|FG002|Part B|COVID-19 Restrictions|1|||
125358852|NCT03633617|450950591|FG003|Part B|COVID-19 Restrictions|0|||
125358853|NCT03633617|450950592|FG004|Part B|COVID-19 Restrictions|0|||
125358854|NCT03633617|450950593|FG005|Part B|COVID-19 Restrictions|0|||
125358855|NCT03633617|450950594|FG006|Part B|COVID-19 Restrictions|0|||
125358856|NCT03633617|450950595|FG007|Part B|COVID-19 Restrictions|0|||
125358857|NCT03633617|450950596|FG008|Part B|COVID-19 Restrictions|0|||
125358858|NCT03633617|450950597|FG009|Part B|COVID-19 Restrictions|0|||
125358859|NCT03633617|450950598|FG010|Part B|COVID-19 Restrictions|0|||
125358860|NCT03633617|450950588|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125358861|NCT03633617|450950589|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125358862|NCT03633617|450950590|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
125358863|NCT03633617|450950591|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125358864|NCT03633617|450950592|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125358865|NCT03633617|450950593|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125358866|NCT03633617|450950594|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125358867|NCT03633617|450950595|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125358868|NCT03633617|450950596|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125358869|NCT03633617|450950597|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125358870|NCT03633617|450950598|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
125358871|NCT03633617|450950588|FG000|Part C (& Follow-up)|Adverse Event|0|||
125358872|NCT03633617|450950589|FG001|Part C (& Follow-up)|Adverse Event|0|||
125358873|NCT03633617|450950590|FG002|Part C (& Follow-up)|Adverse Event|0|||
125427300|NCT00117676|451189322|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
125427301|NCT00117676|451189323|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
125576476|NCT02064387|451738300|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125576477|NCT02064387|451738301|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125576478|NCT02064387|451738302|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125576479|NCT02064387|451738303|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
125576480|NCT02064387|451738304|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125576481|NCT02064387|451738305|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125576482|NCT02064387|451738306|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
125576483|NCT02064387|451738295|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
125576484|NCT02064387|451738296|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
125576485|NCT02064387|451738297|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
125576486|NCT02064387|451738298|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
125576487|NCT02064387|451738299|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
125576488|NCT02064387|451738300|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
125576489|NCT02064387|451738301|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
125576490|NCT02064387|451738302|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
125358874|NCT03633617|450950591|FG003|Part C (& Follow-up)|Adverse Event|0|||
125358875|NCT03633617|450950592|FG004|Part C (& Follow-up)|Adverse Event|0|||
125358876|NCT03633617|450950593|FG005|Part C (& Follow-up)|Adverse Event|1|||
125576491|NCT02064387|451738303|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
125576492|NCT02064387|451738304|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
125576493|NCT02064387|451738305|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
125576494|NCT02064387|451738306|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
125576495|NCT02064387|451738295|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125576496|NCT02064387|451738296|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125576497|NCT02064387|451738297|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125576498|NCT02064387|451738298|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125576499|NCT02064387|451738299|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125576500|NCT02064387|451738300|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125576501|NCT02064387|451738301|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125576502|NCT02064387|451738302|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125576503|NCT02064387|451738303|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125576504|NCT02064387|451738304|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125576505|NCT02064387|451738305|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
125576506|NCT02064387|451738306|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
125576507|NCT02706730|451738307|FG000|Overall Study|Adverse Event|3|||
125576508|NCT02706730|451738307|FG000|Overall Study|Lack of Efficacy|5|||
125576509|NCT02706730|451738307|FG000|Overall Study|Withdrawal by Subject|11|||
125576510|NCT02706730|451738307|FG000|Overall Study|Study Terminated by Sponsor|11|||
125576511|NCT02706730|451738307|FG000|Overall Study|Subject chose not to receive injection|3|||
125576512|NCT02499029|451738308|FG000|Overall Study|Lost to Follow-up|2|||
125576513|NCT02499029|451738309|FG001|Overall Study|Lost to Follow-up|2|||
125576514|NCT02499029|451738308|FG000|Overall Study|Physician Decision|2|||
125576515|NCT02499029|451738309|FG001|Overall Study|Physician Decision|1|||
125576516|NCT02499029|451738308|FG000|Overall Study|Death|1|||
125576517|NCT02499029|451738309|FG001|Overall Study|Death|0|||
125576518|NCT01536860|451738312|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
125576519|NCT01536860|451738313|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
125576520|NCT01536860|451738314|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
125576521|NCT03889639|451738315|FG000|Overall Study|Withdrawal by Subject|0|||
125576522|NCT03889639|451738316|FG001|Overall Study|Withdrawal by Subject|0|||
125576523|NCT03889639|451738317|FG002|Overall Study|Withdrawal by Subject|0|||
125576524|NCT03889639|451738318|FG003|Overall Study|Withdrawal by Subject|0|||
125576525|NCT03889639|451738319|FG004|Overall Study|Withdrawal by Subject|0|||
125576526|NCT03889639|451738320|FG005|Overall Study|Withdrawal by Subject|0|||
125576527|NCT03889639|451738321|FG006|Overall Study|Withdrawal by Subject|0|||
125576528|NCT03889639|451738322|FG007|Overall Study|Withdrawal by Subject|1|||
125576529|NCT00927095|451738323|FG000|Overall Study|Adverse Event|3|||
125576530|NCT00927095|451738324|FG001|Overall Study|Adverse Event|1|||
125576531|NCT00927095|451738325|FG002|Overall Study|Adverse Event|0|||
125576532|NCT00927095|451738323|FG000|Overall Study|Withdrawal by Subject|2|||
125576533|NCT00927095|451738324|FG001|Overall Study|Withdrawal by Subject|1|||
125576534|NCT00927095|451738325|FG002|Overall Study|Withdrawal by Subject|1|||
125576535|NCT00927095|451738323|FG000|Overall Study|Physician Decision|1|||
125576536|NCT00927095|451738324|FG001|Overall Study|Physician Decision|2|||
125576537|NCT00927095|451738325|FG002|Overall Study|Physician Decision|1|||
125576538|NCT02556255|451738329|FG000|Overall Study|Lost to Follow-up|4|||
125576539|NCT03115151|451738330|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
125576540|NCT03115151|451738331|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
125576541|NCT03115151|451738330|FG000|Overall Study|Epidural catheter removal|1|||
125576542|NCT03115151|451738331|FG001|Overall Study|Epidural catheter removal|0|||
125576543|NCT03115151|451738330|FG000|Overall Study|Withdrawal by Subject|0|||
125576544|NCT03115151|451738331|FG001|Overall Study|Withdrawal by Subject|1|||
125576545|NCT03115151|451738330|FG000|Overall Study|Intervention not received according to the protocol.|1|||
125576546|NCT03115151|451738331|FG001|Overall Study|Intervention not received according to the protocol.|1|||
125576547|NCT03115151|451738330|FG000|Overall Study|Physician Decision|1|||
125576548|NCT03115151|451738331|FG001|Overall Study|Physician Decision|0|||
125576549|NCT03115151|451738330|FG000|Overall Study|Randomization not applied|1|||
125576550|NCT03115151|451738331|FG001|Overall Study|Randomization not applied|1|||
125576551|NCT01543087|451738337|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
125576552|NCT01543087|451738338|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
125576553|NCT01543087|451738339|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
125576554|NCT01543087|451738340|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
125576555|NCT01543087|451738341|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
125576556|NCT01543087|451738342|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
125576557|NCT01543087|451738337|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
125576558|NCT01543087|451738338|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
125576559|NCT01543087|451738339|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
125576560|NCT01543087|451738340|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
125576561|NCT01543087|451738341|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
125576562|NCT01543087|451738342|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
125576563|NCT01543087|451738337|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
125576564|NCT01543087|451738338|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
125576565|NCT01543087|451738339|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
125576566|NCT01543087|451738340|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
125576567|NCT01543087|451738341|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
125576568|NCT01543087|451738342|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
125576569|NCT01543087|451738337|FG000|Stage 1 (48 Months)|Other than specified|5|||
125576570|NCT01543087|451738338|FG001|Stage 1 (48 Months)|Other than specified|0|||
125576571|NCT01543087|451738339|FG002|Stage 1 (48 Months)|Other than specified|9|||
125576572|NCT01543087|451738340|FG003|Stage 1 (48 Months)|Other than specified|0|||
125576573|NCT01543087|451738341|FG004|Stage 1 (48 Months)|Other than specified|0|||
125576574|NCT01543087|451738342|FG005|Stage 1 (48 Months)|Other than specified|0|||
125576575|NCT01543087|451738337|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
125576576|NCT01543087|451738338|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
125576577|NCT01543087|451738339|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
125576578|NCT01543087|451738340|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
125576579|NCT01543087|451738341|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
125576580|NCT01543087|451738342|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
125576581|NCT01543087|451738337|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
125576582|NCT01543087|451738338|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
125576583|NCT01543087|451738339|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
125576584|NCT01543087|451738340|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
125576585|NCT01543087|451738341|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
125211278|NCT01900431|450398642|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
125211279|NCT01900431|450398643|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
125211280|NCT01900431|450398641|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
125358877|NCT03633617|450950594|FG006|Part C (& Follow-up)|Adverse Event|0|||
125576586|NCT01543087|451738342|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
125576587|NCT01543087|451738337|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
125576588|NCT01543087|451738338|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
125576589|NCT01543087|451738339|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
125576590|NCT01543087|451738340|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
125576591|NCT01543087|451738341|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
125576592|NCT01543087|451738342|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
125576593|NCT00706030|451738343|FG000|Overall Study|Disease Progression|4|||
125576594|NCT00706030|451738344|FG001|Overall Study|Disease Progression|6|||
125576595|NCT00706030|451738345|FG002|Overall Study|Disease Progression|46|||
125576596|NCT00706030|451738346|FG003|Overall Study|Disease Progression|12|||
125576597|NCT00706030|451738343|FG000|Overall Study|Adverse Event|1|||
125576598|NCT00706030|451738344|FG001|Overall Study|Adverse Event|0|||
125576599|NCT00706030|451738345|FG002|Overall Study|Adverse Event|4|||
125576600|NCT00706030|451738346|FG003|Overall Study|Adverse Event|2|||
125576601|NCT00706030|451738343|FG000|Overall Study|Withdrawal by Subject|1|||
125576602|NCT00706030|451738344|FG001|Overall Study|Withdrawal by Subject|0|||
125576603|NCT00706030|451738345|FG002|Overall Study|Withdrawal by Subject|2|||
125576604|NCT00706030|451738346|FG003|Overall Study|Withdrawal by Subject|0|||
125576605|NCT00706030|451738343|FG000|Overall Study|Physician Decision|0|||
125576606|NCT00706030|451738344|FG001|Overall Study|Physician Decision|0|||
125576607|NCT00706030|451738345|FG002|Overall Study|Physician Decision|2|||
125576608|NCT00706030|451738346|FG003|Overall Study|Physician Decision|0|||
125576609|NCT00706030|451738343|FG000|Overall Study|Not recorded|0|||
125576610|NCT00706030|451738344|FG001|Overall Study|Not recorded|0|||
125576611|NCT00706030|451738345|FG002|Overall Study|Not recorded|2|||
125576612|NCT00706030|451738346|FG003|Overall Study|Not recorded|0|||
125576613|NCT00706030|451738343|FG000|Overall Study|Protocol Violation|0|||
125576614|NCT00706030|451738344|FG001|Overall Study|Protocol Violation|0|||
125576615|NCT00706030|451738345|FG002|Overall Study|Protocol Violation|1|||
125576616|NCT00706030|451738346|FG003|Overall Study|Protocol Violation|1|||
125576617|NCT00706030|451738343|FG000|Overall Study|Failed to return|0|||
125576618|NCT00706030|451738344|FG001|Overall Study|Failed to return|0|||
125576619|NCT00706030|451738345|FG002|Overall Study|Failed to return|1|||
125576620|NCT00706030|451738346|FG003|Overall Study|Failed to return|0|||
125576621|NCT00706030|451738343|FG000|Overall Study|Symptomatic Deterioration|0|||
125576622|NCT00706030|451738344|FG001|Overall Study|Symptomatic Deterioration|0|||
125576623|NCT00706030|451738345|FG002|Overall Study|Symptomatic Deterioration|1|||
125576624|NCT00706030|451738346|FG003|Overall Study|Symptomatic Deterioration|0|||
125576625|NCT00706030|451738343|FG000|Overall Study|No treatment received|0|||
125576626|NCT00706030|451738344|FG001|Overall Study|No treatment received|0|||
125576627|NCT00706030|451738345|FG002|Overall Study|No treatment received|0|||
125576628|NCT00706030|451738346|FG003|Overall Study|No treatment received|1|||
125576629|NCT00706030|451738343|FG000|Overall Study|Death|0|||
125576630|NCT00706030|451738344|FG001|Overall Study|Death|0|||
125576631|NCT00706030|451738345|FG002|Overall Study|Death|1|||
125576632|NCT00706030|451738346|FG003|Overall Study|Death|0|||
125576633|NCT02682901|451738349|FG000|Overall Study|Adverse Event|10|||
125576634|NCT02682901|451738350|FG001|Overall Study|Adverse Event|3|||
125576635|NCT02682901|451738349|FG000|Overall Study|Lack of Efficacy|0|||
125576636|NCT02682901|451738350|FG001|Overall Study|Lack of Efficacy|1|||
125576637|NCT03694925|451738352|FG000|Overall Study|Inadequate laboratory testing|0|||
125576638|NCT03694925|451738353|FG001|Overall Study|Inadequate laboratory testing|3|||
125576639|NCT03694925|451738354|FG002|Overall Study|Inadequate laboratory testing|0|||
125576640|NCT02799069|451738357|FG000|Overall Study|Adverse Event|0|||
125576641|NCT02799069|451738358|FG001|Overall Study|Adverse Event|2|||
125576642|NCT02799069|451738359|FG002|Overall Study|Adverse Event|2|||
125576643|NCT02799069|451738357|FG000|Overall Study|Lack of Efficacy|2|||
125576644|NCT02799069|451738358|FG001|Overall Study|Lack of Efficacy|0|||
125576645|NCT02799069|451738359|FG002|Overall Study|Lack of Efficacy|0|||
125576646|NCT02799069|451738357|FG000|Overall Study|Lost to Follow-up|1|||
125576647|NCT02799069|451738358|FG001|Overall Study|Lost to Follow-up|1|||
125576648|NCT02799069|451738359|FG002|Overall Study|Lost to Follow-up|0|||
125576649|NCT02799069|451738357|FG000|Overall Study|Withdrawal by Subject|4|||
125576650|NCT02799069|451738358|FG001|Overall Study|Withdrawal by Subject|4|||
125576651|NCT02799069|451738359|FG002|Overall Study|Withdrawal by Subject|3|||
125576652|NCT02799069|451738357|FG000|Overall Study|Protocol Violation|1|||
125576653|NCT02799069|451738358|FG001|Overall Study|Protocol Violation|0|||
125576654|NCT02799069|451738359|FG002|Overall Study|Protocol Violation|2|||
125576655|NCT03033875|451738360|FG000|Overall Study|Withdrawal by Subject|5|||
125576656|NCT03033875|451738361|FG001|Overall Study|Withdrawal by Subject|9|||
125576657|NCT03033875|451738362|FG002|Overall Study|Withdrawal by Subject|4|||
125576658|NCT03033875|451738360|FG000|Overall Study|Other|14|||
125576659|NCT03033875|451738361|FG001|Overall Study|Other|15|||
125576660|NCT03033875|451738362|FG002|Overall Study|Other|8|||
125576661|NCT00730639|451738364|FG000|Overall Study|Adverse Event|3|||
125576662|NCT00730639|451738365|FG001|Overall Study|Adverse Event|0|||
125576663|NCT00730639|451738366|FG002|Overall Study|Adverse Event|9|||
125576664|NCT00730639|451738367|FG003|Overall Study|Adverse Event|8|||
125576665|NCT00730639|451738368|FG004|Overall Study|Adverse Event|23|||
125576666|NCT00730639|451738364|FG000|Overall Study|Complete Response|0|||
125576667|NCT00730639|451738365|FG001|Overall Study|Complete Response|0|||
125576668|NCT00730639|451738366|FG002|Overall Study|Complete Response|2|||
125576669|NCT00730639|451738367|FG003|Overall Study|Complete Response|2|||
125576670|NCT00730639|451738368|FG004|Overall Study|Complete Response|1|||
125576671|NCT00730639|451738364|FG000|Overall Study|Completed Maximum Cycles|0|||
125576672|NCT00730639|451738365|FG001|Overall Study|Completed Maximum Cycles|0|||
125576673|NCT00730639|451738366|FG002|Overall Study|Completed Maximum Cycles|11|||
125576674|NCT00730639|451738367|FG003|Overall Study|Completed Maximum Cycles|3|||
125358878|NCT03633617|450950595|FG007|Part C (& Follow-up)|Adverse Event|1|||
125358879|NCT03633617|450950596|FG008|Part C (& Follow-up)|Adverse Event|0|||
125358880|NCT03633617|450950597|FG009|Part C (& Follow-up)|Adverse Event|0|||
125358881|NCT03633617|450950598|FG010|Part C (& Follow-up)|Adverse Event|0|||
125358882|NCT03633617|450950588|FG000|Part C (& Follow-up)|Pregnancy|0|||
125358883|NCT03633617|450950589|FG001|Part C (& Follow-up)|Pregnancy|0|||
125358884|NCT03633617|450950590|FG002|Part C (& Follow-up)|Pregnancy|0|||
125358885|NCT03633617|450950591|FG003|Part C (& Follow-up)|Pregnancy|0|||
125358886|NCT03633617|450950592|FG004|Part C (& Follow-up)|Pregnancy|0|||
125358887|NCT03633617|450950593|FG005|Part C (& Follow-up)|Pregnancy|0|||
125358888|NCT03633617|450950594|FG006|Part C (& Follow-up)|Pregnancy|0|||
125358889|NCT03633617|450950595|FG007|Part C (& Follow-up)|Pregnancy|0|||
125358890|NCT03633617|450950596|FG008|Part C (& Follow-up)|Pregnancy|0|||
125358891|NCT03633617|450950597|FG009|Part C (& Follow-up)|Pregnancy|1|||
125358892|NCT03633617|450950598|FG010|Part C (& Follow-up)|Pregnancy|0|||
125358893|NCT03633617|450950588|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
125358894|NCT03633617|450950589|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
125358895|NCT03633617|450950590|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
125358896|NCT03633617|450950591|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
125358897|NCT03633617|450950592|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
125358898|NCT03633617|450950593|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
125358899|NCT03633617|450950594|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
125358900|NCT03633617|450950595|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
125358901|NCT03633617|450950596|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
125358902|NCT03633617|450950597|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
125358903|NCT03633617|450950598|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
125358904|NCT03633617|450950588|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
125358905|NCT03633617|450950589|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
125358906|NCT03633617|450950590|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
125358907|NCT03633617|450950591|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
125358908|NCT03633617|450950592|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
125358909|NCT03633617|450950593|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
125358910|NCT03633617|450950594|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
125358911|NCT03633617|450950595|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
125358912|NCT03633617|450950596|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
125358913|NCT03633617|450950597|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
125358914|NCT03633617|450950598|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
125358915|NCT03633617|450950588|FG000|Part C (& Follow-up)|Physician Decision|0|||
125358916|NCT03633617|450950589|FG001|Part C (& Follow-up)|Physician Decision|0|||
125358917|NCT03633617|450950590|FG002|Part C (& Follow-up)|Physician Decision|0|||
125358918|NCT03633617|450950591|FG003|Part C (& Follow-up)|Physician Decision|0|||
125358919|NCT03633617|450950592|FG004|Part C (& Follow-up)|Physician Decision|0|||
125358920|NCT03633617|450950593|FG005|Part C (& Follow-up)|Physician Decision|0|||
125358921|NCT03633617|450950594|FG006|Part C (& Follow-up)|Physician Decision|0|||
125358922|NCT03633617|450950595|FG007|Part C (& Follow-up)|Physician Decision|1|||
125358923|NCT03633617|450950596|FG008|Part C (& Follow-up)|Physician Decision|0|||
125358924|NCT03633617|450950597|FG009|Part C (& Follow-up)|Physician Decision|0|||
125358925|NCT03633617|450950598|FG010|Part C (& Follow-up)|Physician Decision|1|||
125358926|NCT03633617|450950588|FG000|Part C (& Follow-up)|COVID-19 related|0|||
125358927|NCT03633617|450950589|FG001|Part C (& Follow-up)|COVID-19 related|0|||
125358928|NCT03633617|450950590|FG002|Part C (& Follow-up)|COVID-19 related|0|||
125358929|NCT03633617|450950591|FG003|Part C (& Follow-up)|COVID-19 related|0|||
125358930|NCT03633617|450950592|FG004|Part C (& Follow-up)|COVID-19 related|0|||
125358931|NCT03633617|450950593|FG005|Part C (& Follow-up)|COVID-19 related|1|||
125358932|NCT03633617|450950594|FG006|Part C (& Follow-up)|COVID-19 related|0|||
125358933|NCT03633617|450950595|FG007|Part C (& Follow-up)|COVID-19 related|0|||
125358934|NCT03633617|450950596|FG008|Part C (& Follow-up)|COVID-19 related|0|||
125358935|NCT03633617|450950597|FG009|Part C (& Follow-up)|COVID-19 related|0|||
125358936|NCT03633617|450950598|FG010|Part C (& Follow-up)|COVID-19 related|0|||
125358937|NCT03633617|450950588|FG000|Part C (& Follow-up)|Protocol Violation|0|||
125358938|NCT03633617|450950589|FG001|Part C (& Follow-up)|Protocol Violation|0|||
125358939|NCT03633617|450950590|FG002|Part C (& Follow-up)|Protocol Violation|0|||
125358940|NCT03633617|450950591|FG003|Part C (& Follow-up)|Protocol Violation|0|||
125358941|NCT03633617|450950592|FG004|Part C (& Follow-up)|Protocol Violation|0|||
125358942|NCT03633617|450950593|FG005|Part C (& Follow-up)|Protocol Violation|0|||
125358943|NCT03633617|450950594|FG006|Part C (& Follow-up)|Protocol Violation|0|||
125358944|NCT03633617|450950595|FG007|Part C (& Follow-up)|Protocol Violation|0|||
125358945|NCT03633617|450950596|FG008|Part C (& Follow-up)|Protocol Violation|0|||
125358946|NCT03633617|450950597|FG009|Part C (& Follow-up)|Protocol Violation|3|||
125358947|NCT03633617|450950598|FG010|Part C (& Follow-up)|Protocol Violation|1|||
125358948|NCT03633617|450950588|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
125358949|NCT03633617|450950589|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
125358950|NCT03633617|450950590|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
125358951|NCT03633617|450950591|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
125358952|NCT03633617|450950592|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
125576675|NCT00730639|451738368|FG004|Overall Study|Completed Maximum Cycles|6|||
125576676|NCT00730639|451738364|FG000|Overall Study|Death|0|||
125576677|NCT00730639|451738365|FG001|Overall Study|Death|0|||
125576678|NCT00730639|451738366|FG002|Overall Study|Death|0|||
125576679|NCT00730639|451738367|FG003|Overall Study|Death|0|||
125576680|NCT00730639|451738368|FG004|Overall Study|Death|2|||
125576681|NCT00730639|451738364|FG000|Overall Study|Disease Progression|12|||
125576682|NCT00730639|451738365|FG001|Overall Study|Disease Progression|13|||
125576683|NCT00730639|451738366|FG002|Overall Study|Disease Progression|48|||
125576684|NCT00730639|451738367|FG003|Overall Study|Disease Progression|32|||
125576685|NCT00730639|451738368|FG004|Overall Study|Disease Progression|88|||
125576686|NCT00730639|451738364|FG000|Overall Study|non-specified|0|||
125576687|NCT00730639|451738365|FG001|Overall Study|non-specified|0|||
125576688|NCT00730639|451738366|FG002|Overall Study|non-specified|4|||
125576689|NCT00730639|451738367|FG003|Overall Study|non-specified|2|||
125576690|NCT00730639|451738368|FG004|Overall Study|non-specified|3|||
125576691|NCT00730639|451738364|FG000|Overall Study|Protocol Violation|0|||
125576692|NCT00730639|451738365|FG001|Overall Study|Protocol Violation|0|||
125576693|NCT00730639|451738366|FG002|Overall Study|Protocol Violation|1|||
125576694|NCT00730639|451738367|FG003|Overall Study|Protocol Violation|0|||
125576695|NCT00730639|451738368|FG004|Overall Study|Protocol Violation|0|||
125576696|NCT00730639|451738364|FG000|Overall Study|Withdrawal by Subject|0|||
125576697|NCT00730639|451738365|FG001|Overall Study|Withdrawal by Subject|0|||
125576698|NCT00730639|451738366|FG002|Overall Study|Withdrawal by Subject|6|||
125576699|NCT00730639|451738367|FG003|Overall Study|Withdrawal by Subject|3|||
125576700|NCT00730639|451738368|FG004|Overall Study|Withdrawal by Subject|4|||
125576701|NCT00730639|451738364|FG000|Overall Study|Treatment on-going|2|||
125576702|NCT00730639|451738365|FG001|Overall Study|Treatment on-going|5|||
125576703|NCT00730639|451738366|FG002|Overall Study|Treatment on-going|5|||
125576704|NCT00730639|451738367|FG003|Overall Study|Treatment on-going|4|||
125576705|NCT00730639|451738368|FG004|Overall Study|Treatment on-going|4|||
125576706|NCT02665286|451738369|FG000|Overall Study|Lost to Follow-up|3|||
125576707|NCT02665286|451738370|FG001|Overall Study|Lost to Follow-up|2|||
125576708|NCT02665286|451738371|FG002|Overall Study|Lost to Follow-up|1|||
125576709|NCT03434977|451738377|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
125576710|NCT03434977|451738378|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
125576711|NCT03064841|451738379|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
125576712|NCT03064841|451738379|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
125576713|NCT03064841|451738379|FG000|Overall Study|Screen failure|2|||
125576714|NCT00217087|451738380|FG000|Overall Study|decided to have esophagectomy|1|||
125576715|NCT00217087|451738381|FG001|Overall Study|decided to have esophagectomy|2|||
125576716|NCT00217087|451738380|FG000|Overall Study|completed less than 12 months return|10|||
125576717|NCT00217087|451738381|FG001|Overall Study|completed less than 12 months return|18|||
125576718|NCT03920670|451738382|FG000|Overall Study|Protocol Violation|2|||
125576719|NCT03920670|451738383|FG001|Overall Study|Protocol Violation|2|||
125576720|NCT03920670|451738382|FG000|Overall Study|Adverse Event|1|||
125576721|NCT03920670|451738383|FG001|Overall Study|Adverse Event|0|||
125576722|NCT05574062|451738384|FG000|Pre Run-In|Screening failure|3|||
125576723|NCT05574062|451738385|FG001|Pre Run-In|Screening failure|0|||
125576724|NCT05574062|451738386|FG002|Pre Run-In|Screening failure|0|||
125576725|NCT05574062|451738387|FG003|Pre Run-In|Screening failure|0|||
125576726|NCT05574062|451738388|FG004|Pre Run-In|Screening failure|0|||
125576727|NCT05574062|451738384|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
125576728|NCT05574062|451738385|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
125576729|NCT05574062|451738386|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
125576730|NCT05574062|451738387|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
125576731|NCT05574062|451738388|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
125576732|NCT05574062|451738384|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
125576733|NCT05574062|451738385|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
125576734|NCT05574062|451738386|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
125576735|NCT05574062|451738387|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
125576736|NCT05574062|451738388|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
125576737|NCT05574062|451738384|FG000|Continuation Phase Period 1|Physician Decision|1|||
125576738|NCT05574062|451738385|FG001|Continuation Phase Period 1|Physician Decision|0|||
125576739|NCT05574062|451738386|FG002|Continuation Phase Period 1|Physician Decision|0|||
125576740|NCT05574062|451738387|FG003|Continuation Phase Period 1|Physician Decision|0|||
125576741|NCT05574062|451738388|FG004|Continuation Phase Period 1|Physician Decision|0|||
125576742|NCT05574062|451738384|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
125576743|NCT05574062|451738385|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
125576744|NCT05574062|451738386|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
125576745|NCT05574062|451738387|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
125358953|NCT03633617|450950593|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
125358954|NCT03633617|450950594|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
125358955|NCT03633617|450950595|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
125358956|NCT03633617|450950596|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
125358957|NCT03633617|450950597|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
125358958|NCT03633617|450950598|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
125576746|NCT05574062|451738388|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
125576747|NCT05574062|451738384|FG000|Continuation Phase Period 1|Adverse Event|1|||
125576748|NCT05574062|451738385|FG001|Continuation Phase Period 1|Adverse Event|0|||
125576749|NCT05574062|451738386|FG002|Continuation Phase Period 1|Adverse Event|0|||
125358959|NCT01890746|450950599|FG000|Overall Study|Death|39|||
125576750|NCT05574062|451738387|FG003|Continuation Phase Period 1|Adverse Event|0|||
125576751|NCT05574062|451738388|FG004|Continuation Phase Period 1|Adverse Event|0|||
125576752|NCT05574062|451738384|FG000|Continuation Phase Period 1|Death|1|||
125576753|NCT05574062|451738385|FG001|Continuation Phase Period 1|Death|0|||
125576754|NCT05574062|451738386|FG002|Continuation Phase Period 1|Death|0|||
125576755|NCT05574062|451738387|FG003|Continuation Phase Period 1|Death|0|||
125576756|NCT05574062|451738388|FG004|Continuation Phase Period 1|Death|0|||
125576757|NCT05574062|451738384|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
125576758|NCT05574062|451738385|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
125576759|NCT05574062|451738386|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
125358960|NCT01890746|450950600|FG001|Overall Study|Death|30|||
125427302|NCT00117676|451189322|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
125427303|NCT00117676|451189323|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
125427304|NCT00117676|451189322|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
125427305|NCT00117676|451189323|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
125427306|NCT00117676|451189322|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
125427307|NCT00117676|451189323|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
125427308|NCT00117676|451189322|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
125427309|NCT00117676|451189323|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
125427310|NCT00117676|451189322|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
125427311|NCT00117676|451189323|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
125427312|NCT00117676|451189322|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
125427313|NCT00117676|451189323|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
125427314|NCT00117676|451189322|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
125427315|NCT00117676|451189323|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
125427316|NCT00117676|451189322|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
125427317|NCT00117676|451189323|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
125427318|NCT00117676|451189322|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
125427319|NCT00117676|451189323|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
125427320|NCT00117676|451189322|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
125427321|NCT00117676|451189323|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
125427322|NCT00117676|451189322|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
125427323|NCT00117676|451189323|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
125427324|NCT03033225|451189329|FG000|Overall Study|Withdrawal by Subject|5|||
125427325|NCT01800968|451189331|FG000|Overall Study|Death|23|||
125427326|NCT01800968|451189332|FG001|Overall Study|Death|16|||
125427327|NCT01800968|451189331|FG000|Overall Study|Lost to Follow-up|5|||
125427328|NCT01800968|451189332|FG001|Overall Study|Lost to Follow-up|7|||
125427329|NCT01800968|451189331|FG000|Overall Study|Withdrawal by Subject|7|||
125427330|NCT01800968|451189332|FG001|Overall Study|Withdrawal by Subject|9|||
125427331|NCT01800968|451189331|FG000|Overall Study|Physician Decision|1|||
125427332|NCT01800968|451189332|FG001|Overall Study|Physician Decision|0|||
125427333|NCT02220894|451189335|FG000|Overall Study|Adverse Event|127|||
125427334|NCT02220894|451189336|FG001|Overall Study|Adverse Event|74|||
125427335|NCT02220894|451189335|FG000|Overall Study|Death|418|||
125427336|NCT02220894|451189336|FG001|Overall Study|Death|508|||
125427337|NCT02220894|451189335|FG000|Overall Study|Lost to Follow-up|0|||
125427338|NCT02220894|451189336|FG001|Overall Study|Lost to Follow-up|4|||
125427339|NCT02220894|451189335|FG000|Overall Study|Site Terminated by Sponsor|2|||
125427340|NCT02220894|451189336|FG001|Overall Study|Site Terminated by Sponsor|0|||
125427341|NCT02220894|451189335|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
125427342|NCT02220894|451189336|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
125427343|NCT02220894|451189335|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125427344|NCT02220894|451189336|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125427345|NCT02220894|451189335|FG000|Overall Study|Withdrawal by Subject|10|||
125576760|NCT05574062|451738387|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
125576761|NCT05574062|451738388|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
125576762|NCT03864653|451738389|FG000|Overall Study|Withdrawal by Subject|1|||
125358961|NCT01890746|450950599|FG000|Overall Study|Adverse Event|1|||
125358962|NCT01890746|450950600|FG001|Overall Study|Adverse Event|0|||
125576763|NCT00546052|451738390|FG000|Overall Study|Adverse Event|47|||
125576764|NCT00546052|451738390|FG000|Overall Study|Lost to Follow-up|144|||
125576765|NCT00546052|451738390|FG000|Overall Study|Protocol Violation|9|||
125576766|NCT00546052|451738390|FG000|Overall Study|Withdrawal by Subject|20|||
125576767|NCT00546052|451738390|FG000|Overall Study|Non Compliance|7|||
125576768|NCT02482129|451738391|FG000|Overall Study|Adverse Event-prior to treatment|0|||
125576769|NCT02482129|451738392|FG001|Overall Study|Adverse Event-prior to treatment|1|||
125576770|NCT02482129|451738391|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
125576771|NCT02482129|451738392|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
125576772|NCT02482129|451738391|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
125576773|NCT02482129|451738392|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
125576774|NCT02482129|451738391|FG000|Overall Study|Criteria not met-prior to treatment|1|||
125576775|NCT02482129|451738392|FG001|Overall Study|Criteria not met-prior to treatment|0|||
125576776|NCT02482129|451738391|FG000|Overall Study|Adverse Event|1|||
125576777|NCT02482129|451738392|FG001|Overall Study|Adverse Event|0|||
125576778|NCT02482129|451738391|FG000|Overall Study|Withdrawal by Subject|2|||
125576779|NCT02482129|451738392|FG001|Overall Study|Withdrawal by Subject|0|||
125576780|NCT02482129|451738391|FG000|Overall Study|Criteria not met|1|||
125576781|NCT02482129|451738392|FG001|Overall Study|Criteria not met|0|||
125576782|NCT01928381|451738393|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
125576783|NCT01928381|451738394|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
125576784|NCT01928381|451738395|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
125576785|NCT01928381|451738396|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
125576786|NCT01928381|451738397|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
125576787|NCT01928381|451738398|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
125427346|NCT02220894|451189336|FG001|Overall Study|Withdrawal by Subject|9|||
125427347|NCT00453986|451189337|FG000|Overall Study|Lost to Follow-up|6|||
125427348|NCT00453986|451189338|FG001|Overall Study|Lost to Follow-up|5|||
125427349|NCT00453986|451189339|FG002|Overall Study|Lost to Follow-up|6|||
125427350|NCT00453986|451189340|FG003|Overall Study|Lost to Follow-up|2|||
125427351|NCT00453986|451189341|FG004|Overall Study|Lost to Follow-up|0|||
125427352|NCT02778100|451189345|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
125427353|NCT02778100|451189346|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
125427354|NCT00522626|451189347|FG000|Overall Study|Lost to Follow-up|7|||
125427355|NCT03017079|451189350|FG000|Overall Study|Physician Decision|1|||
125427356|NCT03017079|451189351|FG001|Overall Study|Physician Decision|1|||
125576788|NCT01928381|451738399|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
125576789|NCT01928381|451738393|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
125576790|NCT01928381|451738394|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
125576791|NCT01928381|451738395|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
125576792|NCT01928381|451738396|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
125576793|NCT01928381|451738397|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
125576794|NCT01928381|451738398|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
125576795|NCT01928381|451738399|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
125427357|NCT03017079|451189350|FG000|Overall Study|Death|3|||
125427358|NCT03017079|451189351|FG001|Overall Study|Death|2|||
125576796|NCT01928381|451738393|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
125576797|NCT01928381|451738394|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
125576798|NCT01928381|451738395|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
125576799|NCT01928381|451738396|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
125576800|NCT01928381|451738397|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
125576801|NCT01928381|451738398|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
125576802|NCT01928381|451738399|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
125576803|NCT01928381|451738393|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
125576804|NCT01928381|451738394|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
125576805|NCT01928381|451738395|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
125576806|NCT01928381|451738396|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
125576807|NCT01928381|451738397|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
125576808|NCT01928381|451738398|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
125576809|NCT01928381|451738399|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
125576810|NCT01928381|451738393|FG000|Part 1 - Pain Training|Protocol Violation|1|||
125576811|NCT01928381|451738394|FG001|Part 1 - Pain Training|Protocol Violation|0|||
125576812|NCT01928381|451738395|FG002|Part 1 - Pain Training|Protocol Violation|0|||
125576813|NCT01928381|451738396|FG003|Part 1 - Pain Training|Protocol Violation|0|||
125576814|NCT01928381|451738397|FG004|Part 1 - Pain Training|Protocol Violation|0|||
125576815|NCT01928381|451738398|FG005|Part 1 - Pain Training|Protocol Violation|0|||
125576816|NCT01928381|451738399|FG006|Part 1 - Pain Training|Protocol Violation|0|||
125576817|NCT01928381|451738393|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
125576818|NCT01928381|451738394|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
125576819|NCT01928381|451738395|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
125576820|NCT01928381|451738396|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
125576821|NCT01928381|451738397|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
125576822|NCT01928381|451738398|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
125576823|NCT01928381|451738399|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
125576824|NCT01928381|451738393|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
125576825|NCT01928381|451738394|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
125576826|NCT01928381|451738395|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
125576827|NCT01928381|451738396|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
125576828|NCT01928381|451738397|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
125576829|NCT01928381|451738398|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
125576830|NCT01928381|451738399|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
125576831|NCT01928381|451738393|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
125576832|NCT01928381|451738394|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
125576833|NCT01928381|451738395|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
125576834|NCT01928381|451738396|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
125576835|NCT01928381|451738397|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
125576836|NCT01928381|451738398|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
125576837|NCT01928381|451738399|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
125576838|NCT01928381|451738393|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
125576839|NCT01928381|451738394|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
125576840|NCT01928381|451738395|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
125576841|NCT01928381|451738396|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
125576842|NCT01928381|451738397|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
125576843|NCT01928381|451738398|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
125576844|NCT01928381|451738399|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
125576845|NCT01928381|451738393|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
125576846|NCT01928381|451738394|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
125576847|NCT01928381|451738395|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
125576848|NCT01928381|451738396|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
125576849|NCT01928381|451738397|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
125576850|NCT01928381|451738398|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
125576851|NCT01928381|451738399|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
125576852|NCT01928381|451738393|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
125576853|NCT01928381|451738394|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
125576854|NCT01928381|451738395|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
125576855|NCT01928381|451738396|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
125576856|NCT01928381|451738397|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
125576857|NCT01928381|451738398|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
125576858|NCT01928381|451738399|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
125576859|NCT01928381|451738393|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
125576860|NCT01928381|451738394|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
125576861|NCT01928381|451738395|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
125576862|NCT01928381|451738396|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
125576863|NCT01928381|451738397|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
125576864|NCT01928381|451738398|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
125576865|NCT01928381|451738399|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
125576866|NCT01928381|451738393|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
125576867|NCT01928381|451738394|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
125576868|NCT01928381|451738395|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
125576869|NCT01928381|451738396|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
125576870|NCT01928381|451738397|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
125576871|NCT01928381|451738398|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
125576872|NCT01928381|451738399|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
125576873|NCT01928381|451738393|FG000|Washout First Intervention|Protocol Violation|0|||
125576874|NCT01928381|451738394|FG001|Washout First Intervention|Protocol Violation|0|||
125576875|NCT01928381|451738395|FG002|Washout First Intervention|Protocol Violation|0|||
125576876|NCT01928381|451738396|FG003|Washout First Intervention|Protocol Violation|0|||
125576877|NCT01928381|451738397|FG004|Washout First Intervention|Protocol Violation|1|||
125576878|NCT01928381|451738398|FG005|Washout First Intervention|Protocol Violation|0|||
125576879|NCT01928381|451738399|FG006|Washout First Intervention|Protocol Violation|0|||
125576880|NCT01928381|451738393|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
125576881|NCT01928381|451738394|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
125576882|NCT01928381|451738395|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
125576883|NCT01928381|451738396|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
125576884|NCT01928381|451738397|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
125576885|NCT01928381|451738398|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
125576886|NCT01928381|451738399|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
125576887|NCT01928381|451738393|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
125576888|NCT01928381|451738394|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
125576889|NCT01928381|451738395|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
125576890|NCT01928381|451738396|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
125576891|NCT01928381|451738397|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
125576892|NCT01928381|451738398|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
125576893|NCT01928381|451738399|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
125576894|NCT05036083|451738400|FG000|Overall Study|Physician Decision|1|||
125576895|NCT05036083|451738400|FG000|Overall Study|Withdrawal by Subject|1|||
125576896|NCT05036083|451738400|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
125576897|NCT05036083|451738400|FG000|Overall Study|IV not sustainable|1|||
125576898|NCT03656562|451740824|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
125576899|NCT03656562|451740825|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
125576900|NCT03656562|451740826|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
125576901|NCT03656562|451740827|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
125576902|NCT03656562|451740824|FG000|Overall Study|Physician Decision|1|||
125576903|NCT03656562|451740825|FG001|Overall Study|Physician Decision|2|||
125576904|NCT03656562|451740826|FG002|Overall Study|Physician Decision|0|||
125576905|NCT03656562|451740827|FG003|Overall Study|Physician Decision|0|||
125576906|NCT03656562|451740824|FG000|Overall Study|Subject Decision|3|||
125576907|NCT03656562|451740825|FG001|Overall Study|Subject Decision|5|||
125576908|NCT03656562|451740826|FG002|Overall Study|Subject Decision|0|||
125576909|NCT03656562|451740827|FG003|Overall Study|Subject Decision|2|||
125576910|NCT01178138|451740828|FG000|Overall Study|Lost to Follow-up|8|||
125576911|NCT01178138|451740828|FG000|Overall Study|Withdrawal by Subject|7|||
125576912|NCT01178138|451740828|FG000|Overall Study|Physician Decision|8|||
125576913|NCT01241708|451740829|FG000|Overall Study|Withdrawal by Subject|6|||
125576914|NCT01241708|451740829|FG000|Overall Study|Screen Failure|6|||
125576915|NCT01241708|451740829|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
125576916|NCT01241708|451740829|FG000|Overall Study|Lost to Follow-up|5|||
125576917|NCT02968810|451740830|FG000|Overall Study|Lost to Follow-up|1|||
125358963|NCT01890746|450950599|FG000|Overall Study|Lost to Follow-up|4|||
125358964|NCT01890746|450950600|FG001|Overall Study|Lost to Follow-up|1|||
125576918|NCT02968810|451740831|FG001|Overall Study|Lost to Follow-up|0|||
125576919|NCT02968810|451740830|FG000|Overall Study|Physician Decision|1|||
125576920|NCT02968810|451740831|FG001|Overall Study|Physician Decision|0|||
125576921|NCT02968810|451740830|FG000|Overall Study|Withdrawal by Subject|1|||
125576922|NCT02968810|451740831|FG001|Overall Study|Withdrawal by Subject|3|||
125576923|NCT02968810|451740830|FG000|Overall Study|Disease Progression|0|||
125576924|NCT02968810|451740831|FG001|Overall Study|Disease Progression|1|||
125576925|NCT04137887|451740832|FG000|Overall Study|Death|102|||
125576926|NCT04137887|451740833|FG001|Overall Study|Death|92|||
125576927|NCT04137887|451740832|FG000|Overall Study|Withdrawal by Subject|2|||
125576928|NCT04137887|451740833|FG001|Overall Study|Withdrawal by Subject|3|||
125576929|NCT04137887|451740832|FG000|Overall Study|Randomized but not treated|0|||
125576930|NCT04137887|451740833|FG001|Overall Study|Randomized but not treated|1|||
125358965|NCT01890746|450950599|FG000|Overall Study|Physician Decision|3|||
125576931|NCT04183335|451740836|FG000|Overall Study|Adverse Event|1|||
125576932|NCT04183335|451740837|FG001|Overall Study|Adverse Event|0|||
125576933|NCT04183335|451740836|FG000|Overall Study|Withdrawal by Subject|12|||
125576934|NCT04183335|451740837|FG001|Overall Study|Withdrawal by Subject|3|||
125576935|NCT02605642|451740838|FG000|Overall Study|Other|11|||
125576936|NCT02605642|451740839|FG001|Overall Study|Other|1|||
125576937|NCT02605642|451740838|FG000|Overall Study|Participant non-compliance|2|||
125576938|NCT02605642|451740839|FG001|Overall Study|Participant non-compliance|4|||
125576939|NCT02605642|451740838|FG000|Overall Study|Physician Decision|10|||
125576940|NCT02605642|451740839|FG001|Overall Study|Physician Decision|0|||
125576941|NCT02605642|451740838|FG000|Overall Study|Lost to Follow-up|12|||
125576942|NCT02605642|451740839|FG001|Overall Study|Lost to Follow-up|1|||
125576943|NCT02605642|451740838|FG000|Overall Study|Adverse Event|14|||
125576944|NCT02605642|451740839|FG001|Overall Study|Adverse Event|2|||
125576945|NCT02605642|451740838|FG000|Overall Study|Withdrawal by Subject|23|||
125576946|NCT02605642|451740839|FG001|Overall Study|Withdrawal by Subject|2|||
125576947|NCT02605642|451740838|FG000|Overall Study|Lack of response|24|||
125576948|NCT02605642|451740839|FG001|Overall Study|Lack of response|11|||
125576949|NCT01268293|451740842|FG000|Overall Study|Disease progression|7|||
125576950|NCT01268293|451740842|FG000|Overall Study|Adverse Event|1|||
125211281|NCT01900431|450398642|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
125211282|NCT01900431|450398643|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
125211283|NCT03172364|450398644|FG000|Overall Study|Adverse Event|1|||
125211284|NCT03172364|450398645|FG001|Overall Study|Adverse Event|1|||
125211285|NCT03172364|450398644|FG000|Overall Study|Protocol Violation|1|||
125211286|NCT03172364|450398645|FG001|Overall Study|Protocol Violation|0|||
125211287|NCT03755518|450398646|FG000|Overall Study|Lack of Efficacy|10|||
125211288|NCT03755518|450398646|FG000|Overall Study|Adverse Event|7|||
125211289|NCT03755518|450398646|FG000|Overall Study|Study Terminated by Sponsor|5|||
125211290|NCT03755518|450398646|FG000|Overall Study|Death|1|||
125211291|NCT03755518|450398646|FG000|Overall Study|Withdrawal by Subject|3|||
125211292|NCT03755518|450398646|FG000|Overall Study|Progressive Disease|4|||
125211293|NCT03755518|450398646|FG000|Overall Study|Bone Marrow Transplant|4|||
125211294|NCT03755518|450398646|FG000|Overall Study|Physicians Decision|1|||
125211295|NCT03755518|450398646|FG000|Overall Study|Relapse|1|||
125211296|NCT03755518|450398646|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
125358966|NCT01890746|450950600|FG001|Overall Study|Physician Decision|2|||
125358967|NCT01890746|450950599|FG000|Overall Study|Withdrawal by Subject|5|||
125358968|NCT01890746|450950600|FG001|Overall Study|Withdrawal by Subject|8|||
125358969|NCT02642029|450950601|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
125358970|NCT02642029|450950602|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
125358971|NCT02642029|450950603|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
125358972|NCT02642029|450950604|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
125358973|NCT02642029|450950605|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
125358974|NCT02642029|450950606|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
125358975|NCT02642029|450950601|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
125358976|NCT02642029|450950602|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
125358977|NCT02642029|450950603|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
125358978|NCT02642029|450950604|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
125358979|NCT02642029|450950605|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
125358980|NCT02642029|450950606|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
125358981|NCT02642029|450950601|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
125358982|NCT02642029|450950602|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
125358983|NCT02642029|450950603|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
125358984|NCT02642029|450950604|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
125576951|NCT01268293|451740842|FG000|Overall Study|Subject choice|1|||
125576952|NCT00618748|451740843|FG000|Overall Study|Adverse Event|4|||
125576953|NCT00618748|451740844|FG001|Overall Study|Adverse Event|3|||
125576954|NCT00618748|451740845|FG002|Overall Study|Adverse Event|8|||
125576955|NCT00618748|451740843|FG000|Overall Study|Physician Decision|3|||
125576956|NCT00618748|451740844|FG001|Overall Study|Physician Decision|1|||
125576957|NCT00618748|451740845|FG002|Overall Study|Physician Decision|1|||
125576958|NCT00618748|451740843|FG000|Overall Study|Withdrawal by Subject|4|||
125211297|NCT03755518|450398646|FG000|Overall Study|Withdrawal by PI|1|||
125211298|NCT01714609|450398647|FG000|Overall Study|Protocol Violation|1|||
125211299|NCT01714609|450398648|FG001|Overall Study|Protocol Violation|0|||
125211300|NCT00630747|450398649|FG000|Overall Study|Death|1|||
125211301|NCT00630747|450398649|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
125358985|NCT02642029|450950605|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
125358986|NCT02642029|450950606|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
125358987|NCT02642029|450950601|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
125358988|NCT02642029|450950602|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
125358989|NCT02642029|450950603|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
125358990|NCT02642029|450950604|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
125358991|NCT02642029|450950605|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
125358992|NCT02642029|450950606|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
125358993|NCT02642029|450950601|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
125358994|NCT02642029|450950602|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
125358995|NCT02642029|450950603|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
125358996|NCT02642029|450950604|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
125576959|NCT00618748|451740844|FG001|Overall Study|Withdrawal by Subject|1|||
125358997|NCT02642029|450950605|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
125358998|NCT02642029|450950606|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
125358999|NCT02642029|450950601|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
125359000|NCT02642029|450950602|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
125359001|NCT02642029|450950603|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
125359002|NCT02642029|450950604|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
125359003|NCT02642029|450950605|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
125576960|NCT00618748|451740845|FG002|Overall Study|Withdrawal by Subject|5|||
125576961|NCT01396005|451740848|FG000|Overall Study|Withdrawal by Subject|0|||
125576962|NCT01396005|451740849|FG001|Overall Study|Withdrawal by Subject|1|||
125211302|NCT00630747|450398649|FG000|Overall Study|Returned to country of origin|1|||
125211303|NCT02306694|450398652|FG000|Overall Study|Withdrawal by Subject|3|||
125576963|NCT01396005|451740848|FG000|Overall Study|Non-compliance with protocol|0|||
125576964|NCT01396005|451740849|FG001|Overall Study|Non-compliance with protocol|1|||
125576965|NCT03757988|451740850|FG000|Overall Study|Withdrawal by Subject|1|||
125576966|NCT03806127|451740851|FG000|Overall Study|Withdrawal by Subject|4|||
125576967|NCT03806127|451740852|FG001|Overall Study|Withdrawal by Subject|5|||
125576968|NCT03806127|451740851|FG000|Overall Study|Protocol Violation|3|||
125576969|NCT03806127|451740852|FG001|Overall Study|Protocol Violation|1|||
125576970|NCT03806127|451740851|FG000|Overall Study|Adverse Event|3|||
125576971|NCT03806127|451740852|FG001|Overall Study|Adverse Event|0|||
125576972|NCT03806127|451740851|FG000|Overall Study|Unable to Complete Procedures|0|||
125576973|NCT03806127|451740852|FG001|Overall Study|Unable to Complete Procedures|1|||
125576974|NCT03806127|451740851|FG000|Overall Study|Pregnancy|0|||
125576975|NCT03806127|451740852|FG001|Overall Study|Pregnancy|1|||
125576976|NCT03806127|451740851|FG000|Overall Study|Lost to Follow-up|5|||
125576977|NCT03806127|451740852|FG001|Overall Study|Lost to Follow-up|1|||
125576978|NCT03806127|451740851|FG000|Overall Study|Physician Decision|1|||
125576979|NCT03806127|451740852|FG001|Overall Study|Physician Decision|1|||
125576980|NCT03806127|451740851|FG000|Overall Study|Could Not Come Due to Covid|1|||
125576981|NCT03806127|451740852|FG001|Overall Study|Could Not Come Due to Covid|0|||
125576982|NCT03806127|451740851|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
125576983|NCT03806127|451740852|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
125576984|NCT03806127|451740851|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
125576985|NCT03806127|451740852|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
125576986|NCT03806127|451740851|FG000|Overall Study|Covid 19 Restrictions|2|||
125359004|NCT02642029|450950606|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
125359005|NCT00631696|450950613|FG000|Overall Study|Entered, not randomized to treatment|1|||
125359006|NCT00631696|450950614|FG001|Overall Study|Entered, not randomized to treatment|1|||
125359007|NCT00631696|450950613|FG000|Overall Study|Discontinued after database release date|1|||
125359008|NCT00631696|450950614|FG001|Overall Study|Discontinued after database release date|0|||
125359009|NCT00631696|450950613|FG000|Overall Study|Follow up after database release date|1|||
125359010|NCT00631696|450950614|FG001|Overall Study|Follow up after database release date|0|||
125359011|NCT00631696|450950613|FG000|Overall Study|Lost to Follow-up|7|||
125359012|NCT00631696|450950614|FG001|Overall Study|Lost to Follow-up|10|||
125359013|NCT00631696|450950613|FG000|Overall Study|Withdrawal by Subject|2|||
125359014|NCT00631696|450950614|FG001|Overall Study|Withdrawal by Subject|9|||
125359015|NCT00631696|450950613|FG000|Overall Study|Other|8|||
125576987|NCT03806127|451740852|FG001|Overall Study|Covid 19 Restrictions|0|||
125576988|NCT03806127|451740851|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
125576989|NCT03806127|451740852|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
125576990|NCT03806127|451740851|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
125359016|NCT00631696|450950614|FG001|Overall Study|Other|8|||
125359017|NCT00631696|450950613|FG000|Overall Study|Protocol Violation|9|||
125359018|NCT00631696|450950614|FG001|Overall Study|Protocol Violation|9|||
125359019|NCT00631696|450950613|FG000|Overall Study|Study terminated by sponsor|3|||
125359020|NCT00631696|450950614|FG001|Overall Study|Study terminated by sponsor|3|||
125359021|NCT00631696|450950613|FG000|Overall Study|Adverse Event|5|||
125359022|NCT00631696|450950614|FG001|Overall Study|Adverse Event|0|||
125359023|NCT01050543|450950616|FG000|Overall Study|Withdrawal by Subject|0|||
125359024|NCT01050543|450950617|FG001|Overall Study|Withdrawal by Subject|2|||
125359025|NCT01050543|450950616|FG000|Overall Study|Protocol Violation|0|||
125359026|NCT01050543|450950617|FG001|Overall Study|Protocol Violation|1|||
125359027|NCT01050543|450950616|FG000|Overall Study|Administrative|4|||
125359028|NCT01050543|450950617|FG001|Overall Study|Administrative|1|||
125359029|NCT00676338|450950618|FG000|Overall Study|Adverse Event|6|||
125576991|NCT03806127|451740852|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
125576992|NCT01467492|451740853|FG000|Overall Study|Withdrawal by Subject|6|||
125576993|NCT01467492|451740854|FG001|Overall Study|Withdrawal by Subject|4|||
125576994|NCT01467492|451740853|FG000|Overall Study|Study Terminated by Sponsor|6|||
125576995|NCT01467492|451740854|FG001|Overall Study|Study Terminated by Sponsor|4|||
125576996|NCT01467492|451740853|FG000|Overall Study|Adverse Event|4|||
125576997|NCT01467492|451740854|FG001|Overall Study|Adverse Event|3|||
125576998|NCT01467492|451740853|FG000|Overall Study|Lost to Follow-up|3|||
125576999|NCT01467492|451740854|FG001|Overall Study|Lost to Follow-up|2|||
125577000|NCT01467492|451740853|FG000|Overall Study|Undefined|2|||
125577001|NCT01467492|451740854|FG001|Overall Study|Undefined|0|||
125577002|NCT01467492|451740853|FG000|Overall Study|Enrolled But Not Treated|1|||
125577003|NCT01467492|451740854|FG001|Overall Study|Enrolled But Not Treated|0|||
125577004|NCT03946670|451740861|FG000|Overall Study|Progressive Disease|26|||
125577005|NCT03946670|451740862|FG001|Overall Study|Progressive Disease|23|||
125577006|NCT03946670|451740861|FG000|Overall Study|Adverse Event|7|||
125577007|NCT03946670|451740862|FG001|Overall Study|Adverse Event|9|||
125577008|NCT03946670|451740861|FG000|Overall Study|Death|5|||
125577009|NCT03946670|451740862|FG001|Overall Study|Death|6|||
125577010|NCT03946670|451740861|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
125577011|NCT03946670|451740862|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
125577012|NCT03946670|451740861|FG000|Overall Study|Subject Decision|4|||
125577013|NCT03946670|451740862|FG001|Overall Study|Subject Decision|4|||
125359030|NCT00676338|450950619|FG001|Overall Study|Adverse Event|6|||
125577014|NCT03946670|451740861|FG000|Overall Study|Physician Decision|3|||
125577015|NCT03946670|451740862|FG001|Overall Study|Physician Decision|3|||
125577016|NCT03946670|451740861|FG000|Overall Study|New Therapy for Study Indication|1|||
125577017|NCT03946670|451740862|FG001|Overall Study|New Therapy for Study Indication|0|||
125359031|NCT00676338|450950620|FG002|Overall Study|Adverse Event|5|||
125359032|NCT00676338|450950621|FG003|Overall Study|Adverse Event|1|||
125359033|NCT00676338|450950618|FG000|Overall Study|Lost to Follow-up|4|||
125359034|NCT00676338|450950619|FG001|Overall Study|Lost to Follow-up|1|||
125359035|NCT00676338|450950620|FG002|Overall Study|Lost to Follow-up|3|||
125359036|NCT00676338|450950621|FG003|Overall Study|Lost to Follow-up|4|||
125359037|NCT00676338|450950618|FG000|Overall Study|Physician Decision|3|||
125359038|NCT00676338|450950619|FG001|Overall Study|Physician Decision|3|||
125359039|NCT00676338|450950620|FG002|Overall Study|Physician Decision|2|||
125359040|NCT00676338|450950621|FG003|Overall Study|Physician Decision|3|||
125359041|NCT00676338|450950618|FG000|Overall Study|Protocol Violation|5|||
125359042|NCT00676338|450950619|FG001|Overall Study|Protocol Violation|9|||
125359043|NCT00676338|450950620|FG002|Overall Study|Protocol Violation|2|||
125359044|NCT00676338|450950621|FG003|Overall Study|Protocol Violation|5|||
125359045|NCT00676338|450950618|FG000|Overall Study|Withdrawal by Subject|17|||
125359046|NCT00676338|450950619|FG001|Overall Study|Withdrawal by Subject|9|||
125359047|NCT00676338|450950620|FG002|Overall Study|Withdrawal by Subject|12|||
125359048|NCT00676338|450950621|FG003|Overall Study|Withdrawal by Subject|6|||
125359049|NCT00676338|450950618|FG000|Overall Study|Entry Criteria Not Met|0|||
125359050|NCT00676338|450950619|FG001|Overall Study|Entry Criteria Not Met|2|||
125359051|NCT00676338|450950620|FG002|Overall Study|Entry Criteria Not Met|1|||
125359052|NCT00676338|450950621|FG003|Overall Study|Entry Criteria Not Met|1|||
125359053|NCT00676338|450950618|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
125359054|NCT00676338|450950619|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
125359055|NCT00676338|450950620|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
125359056|NCT00676338|450950621|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
125359057|NCT00412542|450950624|FG000|Overall Study|Withdrawal by Subject|0|||
125359058|NCT00412542|450950625|FG001|Overall Study|Withdrawal by Subject|2|||
125359059|NCT00412542|450950624|FG000|Overall Study|Not Eligible|0|||
125359060|NCT00412542|450950625|FG001|Overall Study|Not Eligible|1|||
125359061|NCT03161093|450950628|FG000|Overall Study|Protocol Violation|11|||
125359062|NCT03161093|450950629|FG001|Overall Study|Protocol Violation|14|||
125359063|NCT03161093|450950630|FG002|Overall Study|Protocol Violation|6|||
125359064|NCT03161093|450950631|FG003|Overall Study|Protocol Violation|13|||
125359065|NCT03161093|450950632|FG004|Overall Study|Protocol Violation|1|||
125359066|NCT03161093|450950633|FG005|Overall Study|Protocol Violation|0|||
125359067|NCT03161093|450950628|FG000|Overall Study|Adverse Event|5|||
125359068|NCT03161093|450950629|FG001|Overall Study|Adverse Event|21|||
125359069|NCT03161093|450950630|FG002|Overall Study|Adverse Event|16|||
125359070|NCT03161093|450950631|FG003|Overall Study|Adverse Event|35|||
125359071|NCT03161093|450950632|FG004|Overall Study|Adverse Event|2|||
125359072|NCT03161093|450950633|FG005|Overall Study|Adverse Event|1|||
125359073|NCT03161093|450950628|FG000|Overall Study|Lack of Efficacy|9|||
125577018|NCT03946670|451740861|FG000|Overall Study|Not treated|1|||
125577019|NCT03946670|451740862|FG001|Overall Study|Not treated|1|||
125359074|NCT03161093|450950629|FG001|Overall Study|Lack of Efficacy|13|||
125359075|NCT03161093|450950630|FG002|Overall Study|Lack of Efficacy|9|||
125359076|NCT03161093|450950631|FG003|Overall Study|Lack of Efficacy|24|||
125359077|NCT03161093|450950632|FG004|Overall Study|Lack of Efficacy|4|||
125359078|NCT03161093|450950633|FG005|Overall Study|Lack of Efficacy|1|||
125359079|NCT03161093|450950628|FG000|Overall Study|Physician Decision|0|||
125359080|NCT03161093|450950629|FG001|Overall Study|Physician Decision|1|||
125359081|NCT03161093|450950630|FG002|Overall Study|Physician Decision|0|||
125359082|NCT03161093|450950631|FG003|Overall Study|Physician Decision|2|||
125577020|NCT03132636|451740863|FG000|Overall Study|Adverse Event|1|||
125577021|NCT03132636|451740864|FG001|Overall Study|Adverse Event|2|||
125577022|NCT03132636|451740863|FG000|Overall Study|Death|4|||
125577023|NCT03132636|451740864|FG001|Overall Study|Death|7|||
125577024|NCT03132636|451740863|FG000|Overall Study|Lost to Follow-up|3|||
125359083|NCT03161093|450950632|FG004|Overall Study|Physician Decision|17|||
125577025|NCT03132636|451740864|FG001|Overall Study|Lost to Follow-up|2|||
125577026|NCT03132636|451740863|FG000|Overall Study|Non compliance with protocol by participant|1|||
125577027|NCT03132636|451740864|FG001|Overall Study|Non compliance with protocol by participant|1|||
125577028|NCT03132636|451740863|FG000|Overall Study|Subject decision|1|||
125577029|NCT03132636|451740864|FG001|Overall Study|Subject decision|9|||
125577030|NCT03132636|451740863|FG000|Overall Study|Sponsor decision|0|||
125577031|NCT03132636|451740864|FG001|Overall Study|Sponsor decision|1|||
125577032|NCT03132636|451740863|FG000|Overall Study|Physician Decision|1|||
125577033|NCT03132636|451740864|FG001|Overall Study|Physician Decision|0|||
125577034|NCT03132636|451740863|FG000|Overall Study|Progressive disease|33|||
125577035|NCT03132636|451740864|FG001|Overall Study|Progressive disease|36|||
125577036|NCT03132636|451740863|FG000|Overall Study|Withdrawal of consent|2|||
125577037|NCT03132636|451740864|FG001|Overall Study|Withdrawal of consent|5|||
125577038|NCT03132636|451740863|FG000|Overall Study|Did not re-consent|1|||
125577039|NCT03132636|451740864|FG001|Overall Study|Did not re-consent|0|||
125577040|NCT03132636|451740863|FG000|Overall Study|Lost insurance coverage|1|||
125577041|NCT03132636|451740864|FG001|Overall Study|Lost insurance coverage|0|||
125577042|NCT03132636|451740863|FG000|Overall Study|Related to radiological outcomes|0|||
125577043|NCT03132636|451740864|FG001|Overall Study|Related to radiological outcomes|1|||
125577044|NCT03132636|451740863|FG000|Overall Study|Unable to come to site for continued visits|0|||
125577045|NCT03132636|451740864|FG001|Overall Study|Unable to come to site for continued visits|1|||
125577046|NCT04537208|451740869|FG000|Overall Study|Adverse Event|0|||
125577047|NCT04537208|451740870|FG001|Overall Study|Adverse Event|0|||
125577048|NCT04537208|451740871|FG002|Overall Study|Adverse Event|0|||
125577049|NCT04537208|451740872|FG003|Overall Study|Adverse Event|0|||
125577050|NCT04537208|451740873|FG004|Overall Study|Adverse Event|0|||
125577051|NCT04537208|451740874|FG005|Overall Study|Adverse Event|0|||
125577052|NCT04537208|451740875|FG006|Overall Study|Adverse Event|0|||
125577053|NCT04537208|451740876|FG007|Overall Study|Adverse Event|0|||
125577054|NCT04537208|451740877|FG008|Overall Study|Adverse Event|1|||
125577055|NCT04537208|451740878|FG009|Overall Study|Adverse Event|0|||
125577056|NCT04537208|451740879|FG010|Overall Study|Adverse Event|0|||
125577057|NCT04537208|451740869|FG000|Overall Study|Protocol deviation|0|||
125577058|NCT04537208|451740870|FG001|Overall Study|Protocol deviation|0|||
125577059|NCT04537208|451740871|FG002|Overall Study|Protocol deviation|2|||
125577060|NCT04537208|451740872|FG003|Overall Study|Protocol deviation|0|||
125577061|NCT04537208|451740873|FG004|Overall Study|Protocol deviation|0|||
125577062|NCT04537208|451740874|FG005|Overall Study|Protocol deviation|2|||
125577063|NCT04537208|451740875|FG006|Overall Study|Protocol deviation|4|||
125577064|NCT04537208|451740876|FG007|Overall Study|Protocol deviation|0|||
125577065|NCT04537208|451740877|FG008|Overall Study|Protocol deviation|1|||
125577066|NCT04537208|451740878|FG009|Overall Study|Protocol deviation|0|||
125577067|NCT04537208|451740879|FG010|Overall Study|Protocol deviation|2|||
125577068|NCT04537208|451740869|FG000|Overall Study|Withdrawal by Subject|4|||
125577069|NCT04537208|451740870|FG001|Overall Study|Withdrawal by Subject|2|||
125577070|NCT04537208|451740871|FG002|Overall Study|Withdrawal by Subject|1|||
125577071|NCT04537208|451740872|FG003|Overall Study|Withdrawal by Subject|3|||
125577072|NCT04537208|451740873|FG004|Overall Study|Withdrawal by Subject|5|||
125577073|NCT04537208|451740874|FG005|Overall Study|Withdrawal by Subject|1|||
125577074|NCT04537208|451740875|FG006|Overall Study|Withdrawal by Subject|6|||
125577075|NCT04537208|451740876|FG007|Overall Study|Withdrawal by Subject|1|||
125577076|NCT04537208|451740877|FG008|Overall Study|Withdrawal by Subject|7|||
125577077|NCT04537208|451740878|FG009|Overall Study|Withdrawal by Subject|2|||
125577078|NCT04537208|451740879|FG010|Overall Study|Withdrawal by Subject|4|||
125577079|NCT04537208|451740869|FG000|Overall Study|Lost to Follow-up|4|||
125577080|NCT04537208|451740870|FG001|Overall Study|Lost to Follow-up|1|||
125577081|NCT04537208|451740871|FG002|Overall Study|Lost to Follow-up|3|||
125577082|NCT04537208|451740872|FG003|Overall Study|Lost to Follow-up|4|||
125577083|NCT04537208|451740873|FG004|Overall Study|Lost to Follow-up|3|||
125577084|NCT04537208|451740874|FG005|Overall Study|Lost to Follow-up|2|||
125577085|NCT04537208|451740875|FG006|Overall Study|Lost to Follow-up|3|||
125577086|NCT04537208|451740876|FG007|Overall Study|Lost to Follow-up|2|||
125577087|NCT04537208|451740877|FG008|Overall Study|Lost to Follow-up|7|||
125577088|NCT04537208|451740878|FG009|Overall Study|Lost to Follow-up|2|||
125577089|NCT04537208|451740879|FG010|Overall Study|Lost to Follow-up|2|||
125577090|NCT03042468|451740881|FG000|Overall Study|Death|0|||
125577091|NCT03042468|451740882|FG001|Overall Study|Death|1|||
125577092|NCT03042468|451740883|FG002|Overall Study|Death|1|||
125577093|NCT03042468|451740884|FG003|Overall Study|Death|0|||
125577094|NCT03042468|451740885|FG004|Overall Study|Death|0|||
125577095|NCT03042468|451740886|FG005|Overall Study|Death|0|||
125577096|NCT03042468|451740881|FG000|Overall Study|Withdrawal by Subject|0|||
125577097|NCT03042468|451740882|FG001|Overall Study|Withdrawal by Subject|0|||
125577098|NCT03042468|451740883|FG002|Overall Study|Withdrawal by Subject|0|||
125577099|NCT03042468|451740884|FG003|Overall Study|Withdrawal by Subject|0|||
125577100|NCT03042468|451740885|FG004|Overall Study|Withdrawal by Subject|0|||
125577101|NCT03042468|451740886|FG005|Overall Study|Withdrawal by Subject|1|||
125577102|NCT03042468|451740881|FG000|Overall Study|Lost to Follow-up|0|||
125577103|NCT03042468|451740882|FG001|Overall Study|Lost to Follow-up|0|||
125577104|NCT03042468|451740883|FG002|Overall Study|Lost to Follow-up|0|||
125577105|NCT03042468|451740884|FG003|Overall Study|Lost to Follow-up|0|||
125577106|NCT03042468|451740885|FG004|Overall Study|Lost to Follow-up|1|||
125577107|NCT03042468|451740886|FG005|Overall Study|Lost to Follow-up|1|||
125577108|NCT04161495|451740887|FG000|Overall Study|Withdrawal by Subject|3|||
125577109|NCT04161495|451740888|FG001|Overall Study|Withdrawal by Subject|0|||
125577110|NCT04161495|451740887|FG000|Overall Study|Protocol Violation|1|||
125577111|NCT04161495|451740888|FG001|Overall Study|Protocol Violation|0|||
125577112|NCT04161495|451740887|FG000|Overall Study|Prohibited concomitant medication|3|||
125577113|NCT04161495|451740888|FG001|Overall Study|Prohibited concomitant medication|0|||
125577114|NCT04161495|451740887|FG000|Overall Study|Adverse Event|1|||
125577115|NCT04161495|451740888|FG001|Overall Study|Adverse Event|0|||
125577116|NCT04161495|451740887|FG000|Overall Study|Other - Unspecified|1|||
125577117|NCT04161495|451740888|FG001|Overall Study|Other - Unspecified|0|||
125577118|NCT04161495|451740887|FG000|Overall Study|Death|0|||
125577119|NCT04161495|451740888|FG001|Overall Study|Death|1|||
125577120|NCT01587079|451740889|FG000|Overall Study|Protocol-specified criteria|9|||
125577121|NCT01587079|451740889|FG000|Overall Study|Protocol Violation|5|||
125577122|NCT01587079|451740889|FG000|Overall Study|Lost to Follow-up|2|||
125577123|NCT01587079|451740889|FG000|Overall Study|Physician Decision|2|||
125577124|NCT01587079|451740889|FG000|Overall Study|Withdrawal by Subject|7|||
125577125|NCT01587079|451740889|FG000|Overall Study|Adverse Event|14|||
125577126|NCT01239160|451740891|FG000|Overall Study|Lost to Follow-up|3|||
125577127|NCT01239160|451740892|FG001|Overall Study|Lost to Follow-up|5|||
125577128|NCT01239160|451740893|FG002|Overall Study|Lost to Follow-up|0|||
125577129|NCT01239160|451740891|FG000|Overall Study|Withdrawal by Subject|17|||
125577130|NCT01239160|451740892|FG001|Overall Study|Withdrawal by Subject|6|||
125577131|NCT01239160|451740893|FG002|Overall Study|Withdrawal by Subject|2|||
125577132|NCT01239160|451740891|FG000|Overall Study|Physician Decision|5|||
125577133|NCT01239160|451740892|FG001|Overall Study|Physician Decision|7|||
125577134|NCT01239160|451740893|FG002|Overall Study|Physician Decision|2|||
125577135|NCT01239160|451740891|FG000|Overall Study|Early Termination Due to Study Closure|0|||
125577136|NCT01239160|451740892|FG001|Overall Study|Early Termination Due to Study Closure|1|||
125577137|NCT01239160|451740893|FG002|Overall Study|Early Termination Due to Study Closure|6|||
125577138|NCT01764633|451740894|FG000|Overall Study|Withdrawal by Subject|105|||
125577139|NCT01764633|451740895|FG001|Overall Study|Withdrawal by Subject|88|||
125577140|NCT01764633|451740894|FG000|Overall Study|Lost to Follow-up|13|||
125577141|NCT01764633|451740895|FG001|Overall Study|Lost to Follow-up|5|||
125577142|NCT00704964|451740897|FG000|Overall Study|Not completed on time|328|||
125577143|NCT04418765|451740898|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
125577144|NCT04418765|451740899|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
125577145|NCT04418765|451740900|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
125577146|NCT04418765|451740898|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
125577147|NCT04418765|451740899|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
125577148|NCT04418765|451740900|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
125577149|NCT04418765|451740898|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
125577150|NCT04418765|451740899|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
125577151|NCT04418765|451740900|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
125577152|NCT04418765|451740898|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
125577153|NCT04418765|451740899|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
125577154|NCT04418765|451740900|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
125577155|NCT04418765|451740898|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
125577156|NCT04418765|451740899|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
125577157|NCT04418765|451740900|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
125577158|NCT04418765|451740898|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
125577159|NCT04418765|451740899|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
125577160|NCT04418765|451740900|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
125359084|NCT03161093|450950633|FG005|Overall Study|Physician Decision|15|||
125359085|NCT03161093|450950628|FG000|Overall Study|Withdrawal by Subject|24|||
125577161|NCT04418765|451740898|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
125359086|NCT03161093|450950629|FG001|Overall Study|Withdrawal by Subject|73|||
125359087|NCT03161093|450950630|FG002|Overall Study|Withdrawal by Subject|44|||
125359088|NCT03161093|450950631|FG003|Overall Study|Withdrawal by Subject|97|||
125359089|NCT03161093|450950632|FG004|Overall Study|Withdrawal by Subject|11|||
125577162|NCT04418765|451740899|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
125577163|NCT04418765|451740900|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
125577164|NCT04418765|451740898|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
125577165|NCT04418765|451740899|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
125359090|NCT03161093|450950633|FG005|Overall Study|Withdrawal by Subject|10|||
125577166|NCT04418765|451740900|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
125577167|NCT04418765|451740898|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
125577168|NCT04418765|451740899|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
125577169|NCT04418765|451740900|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
125577170|NCT04418765|451740898|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
125577171|NCT04418765|451740899|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
125577172|NCT04418765|451740900|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
125577173|NCT04418765|451740898|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
125577174|NCT04418765|451740899|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
125577175|NCT04418765|451740900|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
125577176|NCT04418765|451740898|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
125577177|NCT04418765|451740899|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
125577178|NCT04418765|451740900|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
125577179|NCT04418765|451740898|FG000|Extension Period (48 Weeks)|Other than specified|0|||
125577180|NCT04418765|451740899|FG001|Extension Period (48 Weeks)|Other than specified|5|||
125577181|NCT04418765|451740900|FG002|Extension Period (48 Weeks)|Other than specified|2|||
125577182|NCT01789970|451740901|FG000|Open-label Titration Period|Adverse Event|68|||
125577183|NCT01789970|451740902|FG001|Open-label Titration Period|Adverse Event|0|||
125577184|NCT01789970|451740903|FG002|Open-label Titration Period|Adverse Event|0|||
125577185|NCT01789970|451740901|FG000|Open-label Titration Period|Lack of Efficacy|31|||
125577186|NCT01789970|451740902|FG001|Open-label Titration Period|Lack of Efficacy|0|||
125577187|NCT01789970|451740903|FG002|Open-label Titration Period|Lack of Efficacy|0|||
125577188|NCT01789970|451740901|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
125577189|NCT01789970|451740902|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
125577190|NCT01789970|451740903|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
125577191|NCT01789970|451740901|FG000|Open-label Titration Period|Protocol Violation|18|||
125577192|NCT01789970|451740902|FG001|Open-label Titration Period|Protocol Violation|0|||
125577193|NCT01789970|451740903|FG002|Open-label Titration Period|Protocol Violation|0|||
125577194|NCT01789970|451740901|FG000|Open-label Titration Period|Lost to Follow-up|5|||
125577195|NCT01789970|451740902|FG001|Open-label Titration Period|Lost to Follow-up|0|||
125577196|NCT01789970|451740903|FG002|Open-label Titration Period|Lost to Follow-up|0|||
125577197|NCT01789970|451740901|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
125577198|NCT01789970|451740902|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
125577199|NCT01789970|451740903|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
125577200|NCT01789970|451740901|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
125577201|NCT01789970|451740902|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
125577202|NCT01789970|451740903|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
125577203|NCT01789970|451740901|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
125577204|NCT01789970|451740902|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
125577205|NCT01789970|451740903|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
125577206|NCT01789970|451740901|FG000|Open-label Titration Period|Pregnancy|2|||
125577207|NCT01789970|451740902|FG001|Open-label Titration Period|Pregnancy|0|||
125577208|NCT01789970|451740903|FG002|Open-label Titration Period|Pregnancy|0|||
125577209|NCT01789970|451740901|FG000|Open-label Titration Period|Other|76|||
125577210|NCT01789970|451740902|FG001|Open-label Titration Period|Other|0|||
125577211|NCT01789970|451740903|FG002|Open-label Titration Period|Other|0|||
125577212|NCT01789970|451740901|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
125577213|NCT01789970|451740902|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
125577214|NCT01789970|451740903|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
125577215|NCT01789970|451740901|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
125577216|NCT01789970|451740902|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
125577217|NCT01789970|451740903|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
125577218|NCT01789970|451740901|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
125577219|NCT01789970|451740902|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
125577220|NCT01789970|451740903|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
125577221|NCT01789970|451740901|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
125577222|NCT01789970|451740902|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
125577223|NCT01789970|451740903|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
125577224|NCT01789970|451740901|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
125577225|NCT01789970|451740902|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
125577226|NCT01789970|451740903|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
125577227|NCT01789970|451740901|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
125577228|NCT01789970|451740902|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
125577229|NCT01789970|451740903|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
125427359|NCT03017079|451189350|FG000|Overall Study|Lack of Efficacy|2|||
125427360|NCT03017079|451189351|FG001|Overall Study|Lack of Efficacy|2|||
125427361|NCT03017079|451189350|FG000|Overall Study|Protocol Violation|0|||
125427362|NCT03017079|451189351|FG001|Overall Study|Protocol Violation|1|||
125427363|NCT03538951|451189352|FG000|Overall Study|Withdrawal by Subject|1|||
125577230|NCT01789970|451740901|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
125577231|NCT01789970|451740902|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
125577232|NCT01789970|451740903|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
125577233|NCT01789970|451740901|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
125577234|NCT01789970|451740902|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
125577235|NCT01789970|451740903|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
125577236|NCT01789970|451740901|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
125577237|NCT01789970|451740902|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
125577238|NCT01789970|451740903|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
125577239|NCT01789970|451740901|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
125577240|NCT01789970|451740902|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
125577241|NCT01789970|451740903|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
125577242|NCT01789970|451740901|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
125577243|NCT01789970|451740902|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
125577244|NCT01789970|451740903|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
125577245|NCT01639833|451740914|FG000|Overall Study|Death|4|||
125577246|NCT01639833|451740915|FG001|Overall Study|Death|2|||
125577247|NCT01639833|451740914|FG000|Overall Study|Withdrawal by Subject|2|||
125577248|NCT01639833|451740915|FG001|Overall Study|Withdrawal by Subject|2|||
125577249|NCT02450578|451740916|FG000|Overall Study|ECG abnormality so not treated|1|||
125577250|NCT02450578|451740917|FG001|Overall Study|ECG abnormality so not treated|0|||
125577251|NCT02450578|451740918|FG002|Overall Study|ECG abnormality so not treated|0|||
125577252|NCT02450578|451740919|FG003|Overall Study|ECG abnormality so not treated|0|||
125577253|NCT04016311|451740920|FG000|Overall Study|Withdrawal by Subject|1|||
125577254|NCT04016311|451740921|FG001|Overall Study|Withdrawal by Subject|0|||
125577255|NCT01999582|451740926|FG000|Overall Study|Withdrawal by Subject|0|||
125577256|NCT01999582|451740927|FG001|Overall Study|Withdrawal by Subject|0|||
125577257|NCT01999582|451740928|FG002|Overall Study|Withdrawal by Subject|0|||
125577258|NCT01999582|451740929|FG003|Overall Study|Withdrawal by Subject|1|||
125577259|NCT01999582|451740930|FG004|Overall Study|Withdrawal by Subject|0|||
125577260|NCT01999582|451740931|FG005|Overall Study|Withdrawal by Subject|0|||
125577261|NCT01999582|451740926|FG000|Overall Study|Adverse Event|0|||
125577262|NCT01999582|451740927|FG001|Overall Study|Adverse Event|0|||
125577263|NCT01999582|451740928|FG002|Overall Study|Adverse Event|3|||
125577264|NCT01999582|451740929|FG003|Overall Study|Adverse Event|0|||
125577265|NCT01999582|451740930|FG004|Overall Study|Adverse Event|1|||
125577266|NCT01999582|451740931|FG005|Overall Study|Adverse Event|0|||
125577267|NCT01999582|451740926|FG000|Overall Study|Other Reasons|1|||
125577268|NCT01999582|451740927|FG001|Overall Study|Other Reasons|0|||
125577269|NCT01999582|451740928|FG002|Overall Study|Other Reasons|3|||
125577270|NCT01999582|451740929|FG003|Overall Study|Other Reasons|1|||
125577271|NCT01999582|451740930|FG004|Overall Study|Other Reasons|1|||
125577272|NCT01999582|451740931|FG005|Overall Study|Other Reasons|2|||
125577273|NCT01999582|451740926|FG000|Overall Study|Protocol Violation|1|||
125359091|NCT03161093|450950628|FG000|Overall Study|Lost to Follow-up|3|||
125359092|NCT03161093|450950629|FG001|Overall Study|Lost to Follow-up|12|||
125359093|NCT03161093|450950630|FG002|Overall Study|Lost to Follow-up|4|||
125359094|NCT03161093|450950631|FG003|Overall Study|Lost to Follow-up|7|||
125359095|NCT03161093|450950632|FG004|Overall Study|Lost to Follow-up|8|||
125359096|NCT03161093|450950633|FG005|Overall Study|Lost to Follow-up|13|||
125359097|NCT03161093|450950628|FG000|Overall Study|Death|3|||
125359098|NCT03161093|450950629|FG001|Overall Study|Death|9|||
125359099|NCT03161093|450950630|FG002|Overall Study|Death|7|||
125359100|NCT03161093|450950631|FG003|Overall Study|Death|9|||
125359101|NCT03161093|450950632|FG004|Overall Study|Death|0|||
125359102|NCT03161093|450950633|FG005|Overall Study|Death|0|||
125359103|NCT03161093|450950628|FG000|Overall Study|Unknown - Not reported|0|||
125359104|NCT03161093|450950629|FG001|Overall Study|Unknown - Not reported|1|||
125359105|NCT03161093|450950630|FG002|Overall Study|Unknown - Not reported|0|||
125359106|NCT03161093|450950631|FG003|Overall Study|Unknown - Not reported|0|||
125359107|NCT03161093|450950632|FG004|Overall Study|Unknown - Not reported|0|||
125427364|NCT03538951|451189353|FG001|Overall Study|Withdrawal by Subject|2|||
125427365|NCT02553460|451189359|FG000|Overall Study|Death|3|||
125427366|NCT02553460|451189359|FG000|Overall Study|Withdrawal by Subject|1|||
125427367|NCT02553460|451189359|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
125577274|NCT01999582|451740927|FG001|Overall Study|Protocol Violation|0|||
125577275|NCT01999582|451740928|FG002|Overall Study|Protocol Violation|0|||
125577276|NCT01999582|451740929|FG003|Overall Study|Protocol Violation|0|||
125577277|NCT01999582|451740930|FG004|Overall Study|Protocol Violation|0|||
125577278|NCT01999582|451740931|FG005|Overall Study|Protocol Violation|1|||
125577279|NCT01999582|451740926|FG000|Overall Study|Lack of Efficacy|1|||
125577280|NCT01999582|451740927|FG001|Overall Study|Lack of Efficacy|3|||
125577281|NCT01999582|451740928|FG002|Overall Study|Lack of Efficacy|0|||
125577282|NCT01999582|451740929|FG003|Overall Study|Lack of Efficacy|1|||
125577283|NCT01999582|451740930|FG004|Overall Study|Lack of Efficacy|0|||
125577284|NCT01999582|451740931|FG005|Overall Study|Lack of Efficacy|0|||
125577285|NCT02436876|451740938|FG000|Overall Study|Lost to Follow-up|0|||
125577286|NCT02436876|451740939|FG001|Overall Study|Lost to Follow-up|1|||
125577287|NCT02436876|451740940|FG002|Overall Study|Lost to Follow-up|1|||
125577288|NCT02436876|451740941|FG003|Overall Study|Lost to Follow-up|1|||
125577289|NCT02436876|451740938|FG000|Overall Study|Withdrawal by Subject|1|||
125577290|NCT02436876|451740939|FG001|Overall Study|Withdrawal by Subject|0|||
125577291|NCT02436876|451740940|FG002|Overall Study|Withdrawal by Subject|0|||
125577292|NCT02436876|451740941|FG003|Overall Study|Withdrawal by Subject|1|||
125577293|NCT02436876|451740938|FG000|Overall Study|Physician Decision|0|||
125577294|NCT02436876|451740939|FG001|Overall Study|Physician Decision|2|||
125577295|NCT02436876|451740940|FG002|Overall Study|Physician Decision|1|||
125577296|NCT02436876|451740941|FG003|Overall Study|Physician Decision|0|||
125577297|NCT02436876|451740938|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
125577298|NCT02436876|451740939|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
125577299|NCT02436876|451740940|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
125577300|NCT02436876|451740941|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
125577301|NCT02809833|451740942|FG000|Overall Study|Death|3|||
125577302|NCT02809833|451740942|FG000|Overall Study|Intolerance|54|||
125577303|NCT02809833|451740942|FG000|Overall Study|Lack of Efficacy|89|||
125577304|NCT02809833|451740942|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
125577305|NCT02809833|451740942|FG000|Overall Study|Noncompliance|1|||
125577306|NCT02809833|451740942|FG000|Overall Study|Withdrawal by Subject|34|||
125577307|NCT02809833|451740942|FG000|Overall Study|Lost to Follow-up|35|||
125577308|NCT02809833|451740942|FG000|Overall Study|Adverse Event (AE)|24|||
125577309|NCT02809833|451740942|FG000|Overall Study|Other|5|||
125577310|NCT02809833|451740942|FG000|Overall Study|Missing Information|52|||
125577311|NCT05779072|451740946|FG000|Overall Study|Lost to Follow-up|0|||
125577312|NCT05779072|451740947|FG001|Overall Study|Lost to Follow-up|1|||
125427368|NCT02553460|451189359|FG000|Overall Study|Relapse or Transplant|14|||
125577313|NCT05779072|451740946|FG000|Overall Study|Withdrawal by Subject|1|||
125577314|NCT05779072|451740947|FG001|Overall Study|Withdrawal by Subject|5|||
125577315|NCT02387580|451740949|FG000|Overall Study|Withdrawal by Subject|0|||
125577316|NCT02387580|451740950|FG001|Overall Study|Withdrawal by Subject|0|||
125577317|NCT02387580|451740951|FG002|Overall Study|Withdrawal by Subject|0|||
125577318|NCT02387580|451740952|FG003|Overall Study|Withdrawal by Subject|1|||
125577319|NCT02387580|451740953|FG004|Overall Study|Withdrawal by Subject|0|||
125577320|NCT02387580|451740954|FG005|Overall Study|Withdrawal by Subject|0|||
125577321|NCT00725075|451740955|FG000|Overall Study|Use of Excluded Medication|0|||
125577322|NCT00725075|451740956|FG001|Overall Study|Use of Excluded Medication|1|||
125359108|NCT03161093|450950633|FG005|Overall Study|Unknown - Not reported|1|||
125359109|NCT02124161|450950634|FG000|Overall Study|Other unspecified|0|||
125359110|NCT02124161|450950635|FG001|Overall Study|Other unspecified|1|||
125359111|NCT02124161|450950634|FG000|Overall Study|Death|1|||
125427369|NCT02553460|451189359|FG000|Overall Study|No response to treatment|2|||
125427370|NCT02553460|451189359|FG000|Overall Study|CAR T cells|2|||
125359112|NCT02124161|450950635|FG001|Overall Study|Death|0|||
125577323|NCT00725075|451740957|FG002|Overall Study|Use of Excluded Medication|0|||
125577324|NCT00725075|451740955|FG000|Overall Study|Protocol Violation|0|||
125577325|NCT00725075|451740956|FG001|Overall Study|Protocol Violation|0|||
125577326|NCT00725075|451740957|FG002|Overall Study|Protocol Violation|1|||
125577327|NCT00725075|451740955|FG000|Overall Study|Lost to Follow-up|1|||
125577328|NCT00725075|451740956|FG001|Overall Study|Lost to Follow-up|0|||
125577329|NCT00725075|451740957|FG002|Overall Study|Lost to Follow-up|0|||
125577330|NCT00725075|451740955|FG000|Overall Study|Withdrawal by Subject|4|||
125577331|NCT00725075|451740956|FG001|Overall Study|Withdrawal by Subject|5|||
125577332|NCT00725075|451740957|FG002|Overall Study|Withdrawal by Subject|4|||
125577333|NCT00725075|451740955|FG000|Overall Study|Adverse Event|2|||
125577334|NCT00725075|451740956|FG001|Overall Study|Adverse Event|1|||
125577335|NCT00725075|451740957|FG002|Overall Study|Adverse Event|1|||
125577336|NCT00725075|451740955|FG000|Overall Study|Worsening of Disease|2|||
125577337|NCT00725075|451740956|FG001|Overall Study|Worsening of Disease|1|||
125577338|NCT00725075|451740957|FG002|Overall Study|Worsening of Disease|2|||
125577339|NCT00725075|451740955|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
125577340|NCT00725075|451740956|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
125577341|NCT00725075|451740957|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
125577342|NCT00725075|451740955|FG000|Overall Study|Other|1|||
125577343|NCT00725075|451740956|FG001|Overall Study|Other|0|||
125577344|NCT00725075|451740957|FG002|Overall Study|Other|0|||
125577345|NCT03984305|451740959|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
125577346|NCT03984305|451740960|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
125577347|NCT03984305|451740959|FG000|Overall Study|Withdrawal by Subject|3|||
125577348|NCT03984305|451740960|FG001|Overall Study|Withdrawal by Subject|3|||
125577349|NCT03984305|451740959|FG000|Overall Study|Lost to Follow-up|1|||
125577350|NCT03984305|451740960|FG001|Overall Study|Lost to Follow-up|0|||
125577351|NCT02340663|451740961|FG000|Overall Study|Lost to Follow-up|1|||
125577352|NCT02340663|451740962|FG001|Overall Study|Lost to Follow-up|0|||
125577353|NCT02340663|451740961|FG000|Overall Study|Protocol Violation|1|||
125577354|NCT02340663|451740962|FG001|Overall Study|Protocol Violation|0|||
125577355|NCT02340663|451740961|FG000|Overall Study|Withdrawal by Subject|3|||
125577356|NCT02340663|451740962|FG001|Overall Study|Withdrawal by Subject|1|||
125577357|NCT02979431|451740963|FG000|Overall Study|Parent/guardian withdrew consent|2|||
125577358|NCT02979431|451740964|FG001|Overall Study|Parent/guardian withdrew consent|1|||
125577359|NCT02979431|451740965|FG002|Overall Study|Parent/guardian withdrew consent|1|||
125577360|NCT02979431|451740966|FG003|Overall Study|Parent/guardian withdrew consent|1|||
125577361|NCT02979431|451740963|FG000|Overall Study|Randomized but received no study drug|1|||
125577362|NCT02979431|451740964|FG001|Overall Study|Randomized but received no study drug|1|||
125577363|NCT02979431|451740965|FG002|Overall Study|Randomized but received no study drug|0|||
125577364|NCT02979431|451740966|FG003|Overall Study|Randomized but received no study drug|0|||
125577365|NCT02979431|451740963|FG000|Overall Study|Adverse Event|0|||
125577366|NCT02979431|451740964|FG001|Overall Study|Adverse Event|0|||
125577367|NCT02979431|451740965|FG002|Overall Study|Adverse Event|1|||
125577368|NCT02979431|451740966|FG003|Overall Study|Adverse Event|0|||
125577369|NCT02979431|451740963|FG000|Overall Study|Subject left country after Day14|1|||
125577370|NCT02979431|451740964|FG001|Overall Study|Subject left country after Day14|0|||
125577371|NCT02979431|451740965|FG002|Overall Study|Subject left country after Day14|0|||
125577372|NCT02979431|451740966|FG003|Overall Study|Subject left country after Day14|0|||
125577373|NCT01656434|451740967|FG000|Overall Study|Adverse Event|199|||
125577374|NCT01656434|451740968|FG001|Overall Study|Adverse Event|63|||
125577375|NCT01656434|451740967|FG000|Overall Study|Enrollment terminated at trial site|2|||
125577376|NCT01656434|451740968|FG001|Overall Study|Enrollment terminated at trial site|0|||
125577377|NCT01656434|451740967|FG000|Overall Study|Lost to Follow-up|309|||
125577378|NCT01656434|451740968|FG001|Overall Study|Lost to Follow-up|76|||
125577379|NCT01656434|451740967|FG000|Overall Study|Site discontinued study participation|24|||
125577380|NCT01656434|451740968|FG001|Overall Study|Site discontinued study participation|9|||
125577381|NCT01656434|451740967|FG000|Overall Study|Screen failure|2|||
125577382|NCT01656434|451740968|FG001|Overall Study|Screen failure|0|||
125577383|NCT01656434|451740967|FG000|Overall Study|Protocol Violation|7|||
125577384|NCT01656434|451740968|FG001|Overall Study|Protocol Violation|0|||
125577385|NCT01656434|451740967|FG000|Overall Study|Pregnancy wish|18|||
125577386|NCT01656434|451740968|FG001|Overall Study|Pregnancy wish|6|||
125577387|NCT01656434|451740967|FG000|Overall Study|Pregnancy|45|||
125577388|NCT01656434|451740968|FG001|Overall Study|Pregnancy|10|||
125577389|NCT01656434|451740967|FG000|Overall Study|Physician Decision|7|||
125577390|NCT01656434|451740968|FG001|Overall Study|Physician Decision|2|||
125577391|NCT01656434|451740967|FG000|Overall Study|Non-compliance with study drug|48|||
125577392|NCT01656434|451740968|FG001|Overall Study|Non-compliance with study drug|9|||
125577393|NCT01656434|451740967|FG000|Overall Study|Study terminated by sponsor|1501|||
125577394|NCT01656434|451740968|FG001|Overall Study|Study terminated by sponsor|348|||
125577395|NCT01656434|451740967|FG000|Overall Study|Participant discontinued; drug related|13|||
125577396|NCT01656434|451740968|FG001|Overall Study|Participant discontinued; drug related|4|||
125577397|NCT01656434|451740967|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
125577398|NCT01656434|451740968|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
125577399|NCT01656434|451740967|FG000|Overall Study|Non-compliance with protocol|39|||
125577400|NCT01656434|451740968|FG001|Overall Study|Non-compliance with protocol|15|||
125577401|NCT01656434|451740967|FG000|Overall Study|Participant moved|40|||
125577402|NCT01656434|451740968|FG001|Overall Study|Participant moved|12|||
125577403|NCT01656434|451740967|FG000|Overall Study|Participant withdrew consent|28|||
125577404|NCT01656434|451740968|FG001|Overall Study|Participant withdrew consent|9|||
125577405|NCT01656434|451740967|FG000|Overall Study|Withdrawal by Subject|64|||
125577406|NCT01656434|451740968|FG001|Overall Study|Withdrawal by Subject|7|||
125577407|NCT02004873|451740969|FG000|Overall Study|Implant unsuccessful|6|||
125577408|NCT02004873|451740969|FG000|Overall Study|Awaiting 6-month visit|390|||
125577409|NCT02004873|451740969|FG000|Overall Study|Missed 6-month visit|4|||
125577410|NCT02004873|451740969|FG000|Overall Study|Death|23|||
125577411|NCT02004873|451740969|FG000|Overall Study|Withdrawal by Subject|1|||
125577412|NCT01614093|451740973|FG000|Overall Study|Withdrawal by Subject|1|||
125577413|NCT00848354|451740974|FG000|Phase 1|Adverse Event|5|||
125577414|NCT00848354|451740975|FG001|Phase 1|Adverse Event|4|||
125577415|NCT00848354|451740974|FG000|Phase 1|Discontinuation of study by sponsor|2|||
125577416|NCT00848354|451740975|FG001|Phase 1|Discontinuation of study by sponsor|1|||
125577417|NCT00848354|451740974|FG000|Phase 1|Failed to return|0|||
125577418|NCT00848354|451740975|FG001|Phase 1|Failed to return|1|||
125577419|NCT00848354|451740974|FG000|Phase 1|Lost to Follow-up|1|||
125577420|NCT00848354|451740975|FG001|Phase 1|Lost to Follow-up|1|||
125577421|NCT00848354|451740974|FG000|Phase 1|Unspecified Reason|1|||
125577422|NCT00848354|451740975|FG001|Phase 1|Unspecified Reason|1|||
125577423|NCT00848354|451740974|FG000|Phase 1|Protocol Violation|1|||
125577424|NCT00848354|451740975|FG001|Phase 1|Protocol Violation|1|||
125577425|NCT00848354|451740974|FG000|Phase 1|Withdrawal by Subject|2|||
125577426|NCT00848354|451740975|FG001|Phase 1|Withdrawal by Subject|4|||
125577427|NCT00848354|451740974|FG000|Phase 1|Lack of Efficacy|0|||
125577428|NCT00848354|451740975|FG001|Phase 1|Lack of Efficacy|1|||
125577429|NCT00848354|451740974|FG000|Phase 2 Year 1|Adverse Event|7|||
125577430|NCT00848354|451740975|FG001|Phase 2 Year 1|Adverse Event|2|||
125577431|NCT00848354|451740974|FG000|Phase 2 Year 1|Death|1|||
125577432|NCT00848354|451740975|FG001|Phase 2 Year 1|Death|0|||
125577433|NCT00848354|451740974|FG000|Phase 2 Year 1|Failed to Return|1|||
125577434|NCT00848354|451740975|FG001|Phase 2 Year 1|Failed to Return|1|||
125577435|NCT00848354|451740974|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
125577436|NCT00848354|451740975|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
125577437|NCT00848354|451740974|FG000|Phase 2 Year 1|Unspecified Reason|3|||
125577438|NCT00848354|451740975|FG001|Phase 2 Year 1|Unspecified Reason|0|||
125577439|NCT00848354|451740974|FG000|Phase 2 Year 1|Protocol Violation|4|||
125577440|NCT00848354|451740975|FG001|Phase 2 Year 1|Protocol Violation|1|||
125577441|NCT00848354|451740974|FG000|Phase 2 Year 1|Subject Request|1|||
125577442|NCT00848354|451740975|FG001|Phase 2 Year 1|Subject Request|2|||
125577443|NCT00848354|451740974|FG000|Phase 2 Year 2|Adverse Event|12|||
125577444|NCT00848354|451740975|FG001|Phase 2 Year 2|Adverse Event|2|||
125577445|NCT00848354|451740974|FG000|Phase 2 Year 2|Death|2|||
125577446|NCT00848354|451740975|FG001|Phase 2 Year 2|Death|0|||
125577447|NCT00848354|451740974|FG000|Phase 2 Year 2|Failed to return|3|||
125577448|NCT00848354|451740975|FG001|Phase 2 Year 2|Failed to return|0|||
125577449|NCT00848354|451740974|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
125577450|NCT00848354|451740975|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
125577451|NCT00848354|451740974|FG000|Phase 2 Year 2|Unspecified Reason|1|||
125577452|NCT00848354|451740975|FG001|Phase 2 Year 2|Unspecified Reason|0|||
125577453|NCT00848354|451740974|FG000|Phase 2 Year 2|Protocol Violation|1|||
125577454|NCT00848354|451740975|FG001|Phase 2 Year 2|Protocol Violation|1|||
125577455|NCT00848354|451740974|FG000|Phase 2 Year 2|Subject Request|1|||
125577456|NCT00848354|451740975|FG001|Phase 2 Year 2|Subject Request|1|||
125577457|NCT00848354|451740974|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
125577458|NCT00848354|451740975|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
125577459|NCT01972074|451740978|FG000|Overall Study|Adverse Event|4|||
125577460|NCT01972074|451740979|FG001|Overall Study|Adverse Event|1|||
125577461|NCT01972074|451740980|FG002|Overall Study|Adverse Event|0|||
125577462|NCT01972074|451740978|FG000|Overall Study|Lack of Efficacy|1|||
125577463|NCT01972074|451740979|FG001|Overall Study|Lack of Efficacy|1|||
125577464|NCT01972074|451740980|FG002|Overall Study|Lack of Efficacy|0|||
125577465|NCT01972074|451740978|FG000|Overall Study|Lost to Follow-up|0|||
125577466|NCT01972074|451740979|FG001|Overall Study|Lost to Follow-up|1|||
125577467|NCT01972074|451740980|FG002|Overall Study|Lost to Follow-up|1|||
125577468|NCT01972074|451740978|FG000|Overall Study|Withdrawal by Subject|1|||
125577469|NCT01972074|451740979|FG001|Overall Study|Withdrawal by Subject|1|||
125577470|NCT01972074|451740980|FG002|Overall Study|Withdrawal by Subject|1|||
125577471|NCT01972074|451740978|FG000|Overall Study|Scanner Unavailable|0|||
125577472|NCT01972074|451740979|FG001|Overall Study|Scanner Unavailable|0|||
125577473|NCT01972074|451740980|FG002|Overall Study|Scanner Unavailable|1|||
125577474|NCT04770779|451740983|FG000|Overall Study|Randomized, never treated|0|||
125359113|NCT02124161|450950634|FG000|Overall Study|Protocol Violation|2|||
125577475|NCT04770779|451740984|FG001|Overall Study|Randomized, never treated|1|||
125577476|NCT04770779|451740983|FG000|Overall Study|Adverse Event|9|||
125577477|NCT04770779|451740984|FG001|Overall Study|Adverse Event|1|||
125577478|NCT04770779|451740983|FG000|Overall Study|Withdrawal by Subject|7|||
125577479|NCT04770779|451740984|FG001|Overall Study|Withdrawal by Subject|1|||
125577480|NCT04770779|451740983|FG000|Overall Study|Pregnancy|0|||
125577481|NCT04770779|451740984|FG001|Overall Study|Pregnancy|1|||
125577482|NCT04820309|451740985|FG000|Overall Study|Adverse Event|96|||
125577483|NCT04820309|451740985|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
125577484|NCT04820309|451740985|FG000|Overall Study|Consent Withdrawn|93|||
125577485|NCT04820309|451740985|FG000|Overall Study|failure to adhere to protocol|32|||
125577486|NCT04820309|451740985|FG000|Overall Study|alcohol or drug use|6|||
125577487|NCT04820309|451740985|FG000|Overall Study|Lost to Follow-up|46|||
125577488|NCT04820309|451740985|FG000|Overall Study|Death|2|||
125577489|NCT04820309|451740985|FG000|Overall Study|Pregnancy|1|||
125577490|NCT04820309|451740985|FG000|Overall Study|Other reasons|12|||
125577491|NCT03692052|451740986|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
125577492|NCT03692052|451740986|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
125577493|NCT03692052|451740986|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
125577494|NCT03692052|451740986|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
125577495|NCT05600309|451740989|FG000|Overall Study|Death|41|||
125577496|NCT05600309|451740990|FG001|Overall Study|Death|38|||
125577497|NCT05600309|451740989|FG000|Overall Study|Sponsor Decision|9|||
125577498|NCT05600309|451740990|FG001|Overall Study|Sponsor Decision|6|||
125577499|NCT00980538|451740997|FG000|Overall Study|Lost to Follow-up|20|||
125577500|NCT00980538|451740997|FG000|Overall Study|Sponsor's Decision|4|||
125577501|NCT00980538|451740997|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
125577502|NCT00980538|451740997|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
125577503|NCT00980538|451740997|FG000|Overall Study|Switch to Commercially Available Medication|25|||
125577504|NCT00980538|451740997|FG000|Overall Study|Participant Non-Compliant|9|||
125577505|NCT00980538|451740997|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
125577506|NCT00980538|451740997|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
125577507|NCT00980538|451740997|FG000|Overall Study|Other|60|||
125577508|NCT00980538|451740997|FG000|Overall Study|Other|1|||
125577509|NCT03087955|451742517|FG000|Overall Study|Death|4|||
125577510|NCT03087955|451742518|FG001|Overall Study|Death|0|||
125577511|NCT03087955|451742517|FG000|Overall Study|Lack of Efficacy|2|||
125577512|NCT03087955|451742518|FG001|Overall Study|Lack of Efficacy|0|||
125577513|NCT03087955|451742517|FG000|Overall Study|Lost to Follow-up|1|||
125577514|NCT03087955|451742518|FG001|Overall Study|Lost to Follow-up|0|||
125577515|NCT04441905|451742519|FG000|Overall Study|Lost to Follow-up|1|||
125577516|NCT04441905|451742520|FG001|Overall Study|Lost to Follow-up|0|||
125577517|NCT04441905|451742521|FG002|Overall Study|Lost to Follow-up|0|||
125577518|NCT04441905|451742522|FG003|Overall Study|Lost to Follow-up|0|||
125577519|NCT04441905|451742523|FG004|Overall Study|Lost to Follow-up|0|||
125577520|NCT04441905|451742524|FG005|Overall Study|Lost to Follow-up|0|||
125577521|NCT04441905|451742519|FG000|Overall Study|Enrolled but treatment not administered|0|||
125577522|NCT04441905|451742520|FG001|Overall Study|Enrolled but treatment not administered|1|||
125577523|NCT04441905|451742521|FG002|Overall Study|Enrolled but treatment not administered|0|||
125577524|NCT04441905|451742522|FG003|Overall Study|Enrolled but treatment not administered|0|||
125577525|NCT04441905|451742523|FG004|Overall Study|Enrolled but treatment not administered|0|||
125577526|NCT04441905|451742524|FG005|Overall Study|Enrolled but treatment not administered|0|||
125577527|NCT04441905|451742519|FG000|Overall Study|Became ineligible after enrollment|0|||
125577528|NCT04441905|451742520|FG001|Overall Study|Became ineligible after enrollment|0|||
125577529|NCT04441905|451742521|FG002|Overall Study|Became ineligible after enrollment|0|||
125577530|NCT04441905|451742522|FG003|Overall Study|Became ineligible after enrollment|0|||
125577531|NCT04441905|451742523|FG004|Overall Study|Became ineligible after enrollment|1|||
125577532|NCT04441905|451742524|FG005|Overall Study|Became ineligible after enrollment|0|||
125577533|NCT04770753|451742525|FG000|Overall Study|Randomized, never treated|1|||
125577534|NCT04770753|451742526|FG001|Overall Study|Randomized, never treated|1|||
125577535|NCT04770753|451742525|FG000|Overall Study|Withdrawal by Subject|3|||
125577536|NCT04770753|451742526|FG001|Overall Study|Withdrawal by Subject|1|||
125577537|NCT04770753|451742525|FG000|Overall Study|Adverse Event|2|||
125577538|NCT04770753|451742526|FG001|Overall Study|Adverse Event|0|||
125577539|NCT04770753|451742525|FG000|Overall Study|Pregnancy|1|||
125577540|NCT04770753|451742526|FG001|Overall Study|Pregnancy|0|||
125359114|NCT02124161|450950635|FG001|Overall Study|Protocol Violation|1|||
125577541|NCT04770753|451742525|FG000|Overall Study|Other un-specified|1|||
125577542|NCT04770753|451742526|FG001|Overall Study|Other un-specified|0|||
125359115|NCT02124161|450950634|FG000|Overall Study|Withdrawal by Subject|1|||
125359116|NCT02124161|450950635|FG001|Overall Study|Withdrawal by Subject|2|||
125577543|NCT02775851|451742527|FG000|Overall Study|Adverse Event|1|||
125577544|NCT02775851|451742528|FG001|Overall Study|Adverse Event|10|||
125577545|NCT02775851|451742527|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
125577546|NCT02775851|451742528|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
125577547|NCT02775851|451742527|FG000|Overall Study|Progression/Relapse|0|||
125577548|NCT02775851|451742528|FG001|Overall Study|Progression/Relapse|4|||
125577549|NCT02775851|451742527|FG000|Overall Study|Other - Not Protocol Specified|0|||
125577550|NCT02775851|451742528|FG001|Overall Study|Other - Not Protocol Specified|7|||
125577551|NCT02775851|451742527|FG000|Overall Study|Withdrawal by Subject|1|||
125577552|NCT02775851|451742528|FG001|Overall Study|Withdrawal by Subject|0|||
125577553|NCT02392429|451742529|FG000|Screening|Screen failure|15|||
125577554|NCT02392429|451742529|FG000|Enrolled Participants|Ineligible due to disease|3|||
125577555|NCT02392429|451742529|FG000|Enrolled Participants|Withdrawal by Subject|4|||
125577556|NCT02392429|451742529|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
125577557|NCT02392429|451742529|FG000|Evaluable|Death|5|||
125577558|NCT02392429|451742529|FG000|Evaluable|Withdrawal by Subject|1|||
125577559|NCT02392429|451742529|FG000|Evaluable|Adverse Event|1|||
125577560|NCT02392429|451742529|FG000|Evaluable|remission bone marrow biopsy|3|||
125577561|NCT03266016|451742533|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
125577562|NCT03266016|451742534|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
125577563|NCT03266016|451742535|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
125577564|NCT03266016|451742536|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
125577565|NCT03266016|451742533|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
125577566|NCT03266016|451742534|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
125577567|NCT03266016|451742535|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
125577568|NCT03266016|451742536|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
125577569|NCT00482014|451742537|FG000|Overall Study|Withdrawal by Subject|1|||
125577570|NCT00482014|451742538|FG001|Overall Study|Withdrawal by Subject|2|||
125577571|NCT00482014|451742539|FG002|Overall Study|Withdrawal by Subject|3|||
125577572|NCT00482014|451742540|FG003|Overall Study|Withdrawal by Subject|4|||
125577573|NCT00482014|451742537|FG000|Overall Study|Adverse Event|3|||
125577574|NCT00482014|451742538|FG001|Overall Study|Adverse Event|0|||
125577575|NCT00482014|451742539|FG002|Overall Study|Adverse Event|2|||
125577576|NCT00482014|451742540|FG003|Overall Study|Adverse Event|8|||
125577577|NCT00482014|451742537|FG000|Overall Study|Death|1|||
125577578|NCT00482014|451742538|FG001|Overall Study|Death|2|||
125577579|NCT00482014|451742539|FG002|Overall Study|Death|1|||
125577580|NCT00482014|451742540|FG003|Overall Study|Death|4|||
125577581|NCT00482014|451742537|FG000|Overall Study|Lack of Efficacy|1|||
125577582|NCT00482014|451742538|FG001|Overall Study|Lack of Efficacy|0|||
125577583|NCT00482014|451742539|FG002|Overall Study|Lack of Efficacy|4|||
125577584|NCT00482014|451742540|FG003|Overall Study|Lack of Efficacy|6|||
125577585|NCT00482014|451742537|FG000|Overall Study|Sponsor Decision|1|||
125577586|NCT00482014|451742538|FG001|Overall Study|Sponsor Decision|2|||
125577587|NCT00482014|451742539|FG002|Overall Study|Sponsor Decision|1|||
125577588|NCT00482014|451742540|FG003|Overall Study|Sponsor Decision|1|||
125577589|NCT03686397|451742541|FG000|Overall Study|Lack of Efficacy|3|||
125577590|NCT03686397|451742542|FG001|Overall Study|Lack of Efficacy|5|||
125577591|NCT03686397|451742541|FG000|Overall Study|Adverse Event|0|||
125577592|NCT03686397|451742542|FG001|Overall Study|Adverse Event|1|||
125577593|NCT03686397|451742541|FG000|Overall Study|Protocol Violation|0|||
125577594|NCT03686397|451742542|FG001|Overall Study|Protocol Violation|1|||
125577595|NCT03686397|451742541|FG000|Overall Study|Withdrawal by Subject|0|||
125577596|NCT03686397|451742542|FG001|Overall Study|Withdrawal by Subject|1|||
125577597|NCT03686397|451742541|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
125577598|NCT03686397|451742542|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
125577599|NCT03718143|451742549|FG000|Overall Study|Death|1|||
125577600|NCT03718143|451742550|FG001|Overall Study|Death|0|||
125577601|NCT03718143|451742551|FG002|Overall Study|Death|0|||
125577602|NCT03718143|451742549|FG000|Overall Study|Progression of Disease|1|||
125577603|NCT03718143|451742550|FG001|Overall Study|Progression of Disease|0|||
125577604|NCT03718143|451742551|FG002|Overall Study|Progression of Disease|0|||
125577605|NCT03718143|451742549|FG000|Overall Study|Withdrawal of Informed Consent|1|||
125577606|NCT03718143|451742550|FG001|Overall Study|Withdrawal of Informed Consent|2|||
125577607|NCT03718143|451742551|FG002|Overall Study|Withdrawal of Informed Consent|1|||
125577608|NCT05064059|451742552|FG000|Overall Study|Death|199|||
125577609|NCT05064059|451742553|FG001|Overall Study|Death|196|||
125577610|NCT05064059|451742552|FG000|Overall Study|Physician Decision|4|||
125577611|NCT05064059|451742553|FG001|Overall Study|Physician Decision|2|||
125577612|NCT05064059|451742552|FG000|Overall Study|Sponsor Decision|14|||
125577613|NCT05064059|451742553|FG001|Overall Study|Sponsor Decision|11|||
125427371|NCT04814368|451189360|FG000|Overall Study|Study Terminated by Sponsor|0|||
125427372|NCT04814368|451189361|FG001|Overall Study|Study Terminated by Sponsor|3|||
125577614|NCT05064059|451742552|FG000|Overall Study|Withdrawal by Subject|4|||
125427373|NCT04814368|451189362|FG002|Overall Study|Study Terminated by Sponsor|0|||
125577615|NCT05064059|451742553|FG001|Overall Study|Withdrawal by Subject|11|||
125577616|NCT01934140|451742554|FG000|Persistence Phase (Year 6-10)|Other|24|||
125577617|NCT01934140|451742555|FG001|Persistence Phase (Year 6-10)|Other|6|||
125577618|NCT01934140|451742554|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
125577619|NCT01934140|451742555|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
125577620|NCT01934140|451742554|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
125577621|NCT01934140|451742555|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
125577622|NCT01934140|451742554|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
125577623|NCT01934140|451742555|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
125577624|NCT01934140|451742554|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
125577625|NCT01934140|451742555|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
125577626|NCT01934140|451742554|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
125577627|NCT01934140|451742555|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
125577628|NCT01934140|451742554|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
125577629|NCT01934140|451742555|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
125577630|NCT01934140|451742554|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
125577631|NCT01934140|451742555|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
125577632|NCT00200850|451742556|FG000|Overall Study|relocation|1|||
125577633|NCT00200850|451742557|FG001|Overall Study|relocation|0|||
125577634|NCT00200850|451742558|FG002|Overall Study|relocation|1|||
125577635|NCT00200850|451742556|FG000|Overall Study|too busy|1|||
125577636|NCT00200850|451742557|FG001|Overall Study|too busy|0|||
125577637|NCT00200850|451742558|FG002|Overall Study|too busy|0|||
125577638|NCT00200850|451742556|FG000|Overall Study|Pregnancy|0|||
125577639|NCT00200850|451742557|FG001|Overall Study|Pregnancy|0|||
125577640|NCT00200850|451742558|FG002|Overall Study|Pregnancy|1|||
125577641|NCT00200850|451742556|FG000|Overall Study|Poor adherence|0|||
125577642|NCT00200850|451742557|FG001|Overall Study|Poor adherence|0|||
125577643|NCT00200850|451742558|FG002|Overall Study|Poor adherence|1|||
125577644|NCT00200850|451742556|FG000|Overall Study|optic neuritis|0|||
125577645|NCT00200850|451742557|FG001|Overall Study|optic neuritis|0|||
125577646|NCT00200850|451742558|FG002|Overall Study|optic neuritis|1|||
125577647|NCT00200850|451742556|FG000|Overall Study|Adverse Event|1|||
125577648|NCT00200850|451742557|FG001|Overall Study|Adverse Event|1|||
125577649|NCT00200850|451742558|FG002|Overall Study|Adverse Event|2|||
125577650|NCT00805740|451742559|FG000|Overall Study|Death|7|||
125577651|NCT00805740|451742560|FG001|Overall Study|Death|4|||
125577652|NCT00805740|451742559|FG000|Overall Study|Withdrawal by Subject|1|||
125577653|NCT00805740|451742560|FG001|Overall Study|Withdrawal by Subject|0|||
125577654|NCT00805740|451742559|FG000|Overall Study|Lost to Follow-up|1|||
125577655|NCT00805740|451742560|FG001|Overall Study|Lost to Follow-up|0|||
125577656|NCT00805740|451742559|FG000|Overall Study|Randomized, but not treated|2|||
125577657|NCT00805740|451742560|FG001|Overall Study|Randomized, but not treated|0|||
125577658|NCT02595879|451742561|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
125577659|NCT02595879|451742562|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
125577660|NCT04294459|451742563|FG000|Overall Study|Adverse Event|0|||
125577661|NCT04294459|451742564|FG001|Overall Study|Adverse Event|1|||
125577662|NCT02908880|451742565|FG000|Overall Study|Lost to Follow-up|4|||
125577663|NCT02908880|451742565|FG000|Overall Study|Explantation of the device|1|||
125577664|NCT02908880|451742565|FG000|Overall Study|Withdrawal by Subject|17|||
125577665|NCT02908880|451742565|FG000|Overall Study|Death|5|||
125577666|NCT03823391|451742570|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
125577667|NCT03823391|451742571|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
125577668|NCT03823391|451742570|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
125577669|NCT03823391|451742571|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
125359117|NCT02124161|450950634|FG000|Overall Study|Adverse Event|2|||
125359118|NCT02124161|450950635|FG001|Overall Study|Adverse Event|0|||
125359119|NCT02124161|450950634|FG000|Overall Study|Does not meet entrance criteria|2|||
125577670|NCT02450487|451742572|FG000|Overall Study|Lost to Follow-up|3|||
125577671|NCT01790048|451742573|FG000|Overall Study|Incorrect Age|9|||
125577672|NCT01790048|451742574|FG001|Overall Study|Incorrect Age|14|||
125577673|NCT01790048|451742573|FG000|Overall Study|data entry error|0|||
125577674|NCT01790048|451742574|FG001|Overall Study|data entry error|1|||
125577675|NCT01790048|451742573|FG000|Overall Study|Other|0|||
125577676|NCT01790048|451742574|FG001|Overall Study|Other|2|||
125577677|NCT01790048|451742573|FG000|Overall Study|SAM at Enrollment|2|||
125577678|NCT01790048|451742574|FG001|Overall Study|SAM at Enrollment|0|||
125577679|NCT01790048|451742573|FG000|Overall Study|Measurement error|1|||
125577680|NCT01790048|451742574|FG001|Overall Study|Measurement error|0|||
125359120|NCT02124161|450950635|FG001|Overall Study|Does not meet entrance criteria|3|||
125577681|NCT05030311|451742575|FG000|Overall Study|Technical problems|0|||
125577682|NCT05030311|451742576|FG001|Overall Study|Technical problems|1|||
125577683|NCT05030311|451742575|FG000|Overall Study|Withdrawal by Subject|31|||
125577684|NCT05030311|451742576|FG001|Overall Study|Withdrawal by Subject|17|||
125577685|NCT05030311|451742575|FG000|Overall Study|Adverse Event|13|||
125577686|NCT05030311|451742576|FG001|Overall Study|Adverse Event|5|||
125577687|NCT05030311|451742575|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125577688|NCT05030311|451742576|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125577689|NCT05030311|451742575|FG000|Overall Study|Physician Decision|5|||
125577690|NCT05030311|451742576|FG001|Overall Study|Physician Decision|2|||
125577691|NCT05030311|451742575|FG000|Overall Study|Lost to Follow-up|5|||
125577692|NCT05030311|451742576|FG001|Overall Study|Lost to Follow-up|1|||
125577693|NCT05030311|451742575|FG000|Overall Study|Protocol Violation|4|||
125577694|NCT05030311|451742576|FG001|Overall Study|Protocol Violation|4|||
125577695|NCT03083886|451742577|FG000|Overall Study|Withdrawal by Subject|51|||
125577696|NCT03083886|451742578|FG001|Overall Study|Withdrawal by Subject|73|||
125577697|NCT03083886|451742579|FG002|Overall Study|Withdrawal by Subject|104|||
125577698|NCT03083886|451742577|FG000|Overall Study|Missing Baseline data|43|||
125577699|NCT03083886|451742578|FG001|Overall Study|Missing Baseline data|42|||
125577700|NCT03083886|451742579|FG002|Overall Study|Missing Baseline data|31|||
125577701|NCT03083886|451742577|FG000|Overall Study|Investigator terminated|1|||
125577702|NCT03083886|451742578|FG001|Overall Study|Investigator terminated|6|||
125577703|NCT03083886|451742579|FG002|Overall Study|Investigator terminated|3|||
125577704|NCT02062658|451742580|FG000|Overall Study|Withdrawal by Subject|1|||
125577705|NCT02062658|451742580|FG000|Overall Study|Lack of Efficacy|1|||
125577706|NCT02161562|451742581|FG000|Overall Study|Withdrawal by Subject|5|||
125577707|NCT02161562|451742582|FG001|Overall Study|Withdrawal by Subject|8|||
125577708|NCT02161562|451742581|FG000|Overall Study|Protocol Violation|9|||
125577709|NCT02161562|451742582|FG001|Overall Study|Protocol Violation|4|||
125577710|NCT02161562|451742581|FG000|Overall Study|Pregnancy|1|||
125577711|NCT02161562|451742582|FG001|Overall Study|Pregnancy|2|||
125577712|NCT02161562|451742581|FG000|Overall Study|Lost to Follow-up|3|||
125577713|NCT02161562|451742582|FG001|Overall Study|Lost to Follow-up|1|||
125577714|NCT02161562|451742581|FG000|Overall Study|Lack of Efficacy|4|||
125577715|NCT02161562|451742582|FG001|Overall Study|Lack of Efficacy|1|||
125577716|NCT02161562|451742581|FG000|Overall Study|Adverse Event|1|||
125577717|NCT02161562|451742582|FG001|Overall Study|Adverse Event|1|||
125577718|NCT02161562|451742581|FG000|Overall Study|Participant moved back to home country|1|||
125577719|NCT02161562|451742582|FG001|Overall Study|Participant moved back to home country|0|||
125577720|NCT02161562|451742581|FG000|Overall Study|Withdrew due to being out of the country|1|||
125577721|NCT02161562|451742582|FG001|Overall Study|Withdrew due to being out of the country|0|||
125577722|NCT02161562|451742581|FG000|Overall Study|Participant moved out of province|1|||
125577723|NCT02161562|451742582|FG001|Overall Study|Participant moved out of province|0|||
125577724|NCT03033745|451742583|FG000|Overall Study|Protocol Violation|0|||
125577725|NCT03033745|451742584|FG001|Overall Study|Protocol Violation|0|||
125577726|NCT03033745|451742585|FG002|Overall Study|Protocol Violation|1|||
125577727|NCT03033745|451742583|FG000|Overall Study|Adverse Event|1|||
125577728|NCT03033745|451742584|FG001|Overall Study|Adverse Event|0|||
125577729|NCT03033745|451742585|FG002|Overall Study|Adverse Event|1|||
125577730|NCT03033745|451742583|FG000|Overall Study|Withdrawal by Subject|0|||
125577731|NCT03033745|451742584|FG001|Overall Study|Withdrawal by Subject|1|||
125577732|NCT03033745|451742585|FG002|Overall Study|Withdrawal by Subject|0|||
125577733|NCT00662792|451742587|FG000|Period 1|Personal Reasons|0|||
125577734|NCT00662792|451742588|FG001|Period 1|Personal Reasons|0|||
125577735|NCT00662792|451742589|FG002|Period 1|Personal Reasons|1|||
125577736|NCT00662792|451742590|FG003|Period 1|Personal Reasons|0|||
125577737|NCT00662792|451742587|FG000|Period 1|Refused continuing medication|0|||
125577738|NCT00662792|451742588|FG001|Period 1|Refused continuing medication|1|||
125577739|NCT00662792|451742589|FG002|Period 1|Refused continuing medication|1|||
125577740|NCT00662792|451742590|FG003|Period 1|Refused continuing medication|0|||
125577741|NCT00662792|451742587|FG000|Period 1|Lost to Follow-up|1|||
125577742|NCT00662792|451742588|FG001|Period 1|Lost to Follow-up|0|||
125577743|NCT00662792|451742589|FG002|Period 1|Lost to Follow-up|0|||
125577744|NCT00662792|451742590|FG003|Period 1|Lost to Follow-up|0|||
125577745|NCT00662792|451742587|FG000|Period 1|Other adverse event (AE)|0|||
125577746|NCT00662792|451742588|FG001|Period 1|Other adverse event (AE)|2|||
125577747|NCT00662792|451742589|FG002|Period 1|Other adverse event (AE)|0|||
125577748|NCT00662792|451742590|FG003|Period 1|Other adverse event (AE)|0|||
125577749|NCT00662792|451742587|FG000|Period 1|Worsening of disease under study (AE)|1|||
125577750|NCT00662792|451742588|FG001|Period 1|Worsening of disease under study (AE)|3|||
125577751|NCT00662792|451742589|FG002|Period 1|Worsening of disease under study (AE)|2|||
125577752|NCT00662792|451742590|FG003|Period 1|Worsening of disease under study (AE)|0|||
125577753|NCT00662792|451742587|FG000|Period 1|Not treated|0|||
125359121|NCT02124161|450950634|FG000|Overall Study|No longer meets eligibility criteria|5|||
125577754|NCT00662792|451742588|FG001|Period 1|Not treated|1|||
125577755|NCT00662792|451742589|FG002|Period 1|Not treated|0|||
125577756|NCT00662792|451742590|FG003|Period 1|Not treated|0|||
125359122|NCT02124161|450950635|FG001|Overall Study|No longer meets eligibility criteria|4|||
125577757|NCT00662792|451742587|FG000|Period 2|Worsening of disease under study|1|||
125577758|NCT00662792|451742588|FG001|Period 2|Worsening of disease under study|0|||
125577759|NCT00662792|451742589|FG002|Period 2|Worsening of disease under study|0|||
125577760|NCT00662792|451742590|FG003|Period 2|Worsening of disease under study|3|||
125577761|NCT00662792|451742587|FG000|Period 3|Refused continuing medication|1|||
125577762|NCT00662792|451742588|FG001|Period 3|Refused continuing medication|0|||
125577763|NCT00662792|451742589|FG002|Period 3|Refused continuing medication|1|||
125577764|NCT00662792|451742590|FG003|Period 3|Refused continuing medication|0|||
125577765|NCT00662792|451742587|FG000|Period 3|Other adverse event (AE)|0|||
125577766|NCT00662792|451742588|FG001|Period 3|Other adverse event (AE)|0|||
125577767|NCT00662792|451742589|FG002|Period 3|Other adverse event (AE)|1|||
125577768|NCT00662792|451742590|FG003|Period 3|Other adverse event (AE)|1|||
125577769|NCT00662792|451742587|FG000|Period 4|Refused continuing medication|0|||
125577770|NCT00662792|451742588|FG001|Period 4|Refused continuing medication|1|||
125577771|NCT00662792|451742589|FG002|Period 4|Refused continuing medication|0|||
125577772|NCT00662792|451742590|FG003|Period 4|Refused continuing medication|0|||
125577773|NCT00662792|451742587|FG000|Period 4|Other adverse event (AE)|1|||
125577774|NCT00662792|451742588|FG001|Period 4|Other adverse event (AE)|0|||
125577775|NCT00662792|451742589|FG002|Period 4|Other adverse event (AE)|0|||
125577776|NCT00662792|451742590|FG003|Period 4|Other adverse event (AE)|0|||
125577777|NCT00662792|451742587|FG000|Period 4|Worsening of disease under study (AE)|0|||
125577778|NCT00662792|451742588|FG001|Period 4|Worsening of disease under study (AE)|0|||
125577779|NCT00662792|451742589|FG002|Period 4|Worsening of disease under study (AE)|0|||
125577780|NCT00662792|451742590|FG003|Period 4|Worsening of disease under study (AE)|1|||
125577781|NCT00090545|451742591|FG000|Overall Study|Disease progression on study|21|||
125577782|NCT00090545|451742592|FG001|Overall Study|Disease progression on study|17|||
125577783|NCT00090545|451742591|FG000|Overall Study|Refused further treatment|1|||
125577784|NCT00090545|451742592|FG001|Overall Study|Refused further treatment|4|||
125577785|NCT00090545|451742591|FG000|Overall Study|Death|0|||
125577786|NCT00090545|451742592|FG001|Overall Study|Death|1|||
125577787|NCT00090545|451742591|FG000|Overall Study|Adverse Event|0|||
125577788|NCT00090545|451742592|FG001|Overall Study|Adverse Event|2|||
125577789|NCT03403205|451742595|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
125577790|NCT03403205|451742596|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
125577791|NCT03403205|451742597|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
125577792|NCT03403205|451742598|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
125577793|NCT03403205|451742599|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125577794|NCT03403205|451742600|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125577795|NCT03403205|451742595|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
125577796|NCT03403205|451742596|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125577797|NCT03403205|451742597|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
125577798|NCT03403205|451742598|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125577799|NCT03403205|451742599|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125577800|NCT03403205|451742600|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125577801|NCT03403205|451742595|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
125577802|NCT03403205|451742596|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
125577803|NCT03403205|451742597|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
125577804|NCT03403205|451742598|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
125577805|NCT03403205|451742599|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
125577806|NCT03403205|451742600|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
125577807|NCT03403205|451742595|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
125577808|NCT03403205|451742596|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
125577809|NCT03403205|451742597|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
125577810|NCT03403205|451742598|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
125577811|NCT03403205|451742599|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
125577812|NCT03403205|451742600|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
125577813|NCT03403205|451742595|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
125577814|NCT03403205|451742596|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
125577815|NCT03403205|451742597|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
125577816|NCT03403205|451742598|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
125577817|NCT03403205|451742599|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
125577818|NCT03403205|451742600|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
125577819|NCT03403205|451742595|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
125577820|NCT03403205|451742596|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
125577821|NCT03403205|451742597|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
125577822|NCT03403205|451742598|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
125577823|NCT03403205|451742599|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
125577824|NCT03403205|451742600|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
125577825|NCT03403205|451742595|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
125577826|NCT03403205|451742596|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
125577827|NCT03403205|451742597|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
125577828|NCT03403205|451742598|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
125577829|NCT03403205|451742599|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
125577830|NCT03403205|451742600|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
125577831|NCT03403205|451742595|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
125577832|NCT03403205|451742596|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
125577833|NCT03403205|451742597|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
125577834|NCT03403205|451742598|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
125577835|NCT03403205|451742599|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
125577836|NCT03403205|451742600|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
125577837|NCT03403205|451742595|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
125577838|NCT03403205|451742596|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
125577839|NCT03403205|451742597|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
125577840|NCT03403205|451742598|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
125577841|NCT03403205|451742599|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
125577842|NCT03403205|451742600|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
125577843|NCT03403205|451742595|FG000|Extension Period (Up to 60 Months)|Death|1|||
125577844|NCT03403205|451742596|FG001|Extension Period (Up to 60 Months)|Death|0|||
125577845|NCT03403205|451742597|FG002|Extension Period (Up to 60 Months)|Death|0|||
125577846|NCT03403205|451742598|FG003|Extension Period (Up to 60 Months)|Death|0|||
125577847|NCT03403205|451742599|FG004|Extension Period (Up to 60 Months)|Death|0|||
125577848|NCT03403205|451742600|FG005|Extension Period (Up to 60 Months)|Death|0|||
125577849|NCT03403205|451742595|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
125577850|NCT03403205|451742596|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
125577851|NCT03403205|451742597|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
125577852|NCT03403205|451742598|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
125577853|NCT03403205|451742599|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
125577854|NCT03403205|451742600|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
125577855|NCT03403205|451742595|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
125577856|NCT03403205|451742596|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
125577857|NCT03403205|451742597|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
125577858|NCT03403205|451742598|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
125577859|NCT03403205|451742599|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
125577860|NCT03403205|451742600|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
125577861|NCT03403205|451742595|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
125577862|NCT03403205|451742596|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
125577863|NCT03403205|451742597|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
125577864|NCT03403205|451742598|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
125577865|NCT03403205|451742599|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
125577866|NCT03403205|451742600|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
125577867|NCT03403205|451742595|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
125577868|NCT03403205|451742596|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
125577869|NCT03403205|451742597|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
125577870|NCT03403205|451742598|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
125577871|NCT03403205|451742599|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
125577872|NCT03403205|451742600|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
125577873|NCT03403205|451742595|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
125577874|NCT03403205|451742596|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
125577875|NCT03403205|451742597|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
125577876|NCT03403205|451742598|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
125577877|NCT03403205|451742599|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
125577878|NCT03403205|451742600|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
125577879|NCT03403205|451742595|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
125577880|NCT03403205|451742596|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
125577881|NCT03403205|451742597|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
125577882|NCT03403205|451742598|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
125577883|NCT03403205|451742599|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
125577884|NCT03403205|451742600|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
125577885|NCT01834729|451742601|FG000|Overall Study|Did not return bowel diaries|0|||
125577886|NCT01834729|451742602|FG001|Overall Study|Did not return bowel diaries|0|||
125577887|NCT01834729|451742603|FG002|Overall Study|Did not return bowel diaries|3|||
125577888|NCT01834729|451742604|FG003|Overall Study|Did not return bowel diaries|0|||
125577889|NCT01834729|451742601|FG000|Overall Study|Withdrawal by Subject|1|||
125577890|NCT01834729|451742602|FG001|Overall Study|Withdrawal by Subject|1|||
125577891|NCT01834729|451742603|FG002|Overall Study|Withdrawal by Subject|0|||
125577892|NCT01834729|451742604|FG003|Overall Study|Withdrawal by Subject|0|||
125577893|NCT01834729|451742601|FG000|Overall Study|Adverse Event|0|||
125577894|NCT01834729|451742602|FG001|Overall Study|Adverse Event|0|||
125577895|NCT01834729|451742603|FG002|Overall Study|Adverse Event|0|||
125577896|NCT01834729|451742604|FG003|Overall Study|Adverse Event|2|||
125577897|NCT02971670|451742605|FG000|Overall Study|Withdrawal by Subject|4|||
125577898|NCT02971670|451742606|FG001|Overall Study|Withdrawal by Subject|1|||
125577899|NCT02971670|451742607|FG002|Overall Study|Withdrawal by Subject|1|||
125577900|NCT02971670|451742608|FG003|Overall Study|Withdrawal by Subject|2|||
125577901|NCT00288080|451742609|FG000|Overall Study|Withdrawal by Subject|1|||
125359123|NCT02124161|450950634|FG000|Overall Study|Lost to Follow-up|3|||
125359124|NCT02124161|450950635|FG001|Overall Study|Lost to Follow-up|4|||
125359125|NCT02517866|450950636|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
125359126|NCT02517866|450950637|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
125359127|NCT02517866|450950638|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
125359128|NCT02517866|450950636|FG000|Overall Study|Significant Protocol Deviation|4|||
125359129|NCT02517866|450950637|FG001|Overall Study|Significant Protocol Deviation|1|||
125359130|NCT02517866|450950638|FG002|Overall Study|Significant Protocol Deviation|0|||
125359131|NCT02517866|450950636|FG000|Overall Study|Lost to Follow-up|1|||
125359132|NCT02517866|450950637|FG001|Overall Study|Lost to Follow-up|0|||
125359133|NCT02517866|450950638|FG002|Overall Study|Lost to Follow-up|0|||
125359134|NCT02517866|450950636|FG000|Overall Study|Voluntary Withdrawal|2|||
125359135|NCT02517866|450950637|FG001|Overall Study|Voluntary Withdrawal|2|||
125359136|NCT02517866|450950638|FG002|Overall Study|Voluntary Withdrawal|0|||
125359137|NCT02517866|450950636|FG000|Overall Study|Investigator Decision|2|||
125359138|NCT02517866|450950637|FG001|Overall Study|Investigator Decision|1|||
125359139|NCT02517866|450950638|FG002|Overall Study|Investigator Decision|0|||
125359140|NCT02517866|450950636|FG000|Overall Study|Reason not specified|2|||
125359141|NCT02517866|450950637|FG001|Overall Study|Reason not specified|0|||
125359142|NCT02517866|450950638|FG002|Overall Study|Reason not specified|0|||
125359143|NCT01147640|450950640|FG000|Overall Study|Adverse Event|2|||
125359144|NCT01147640|450950641|FG001|Overall Study|Adverse Event|0|||
125359145|NCT01147640|450950640|FG000|Overall Study|Physician Decision|1|||
125359146|NCT01147640|450950641|FG001|Overall Study|Physician Decision|0|||
125359147|NCT01147640|450950640|FG000|Overall Study|Withdrawal by Subject|1|||
125359148|NCT01147640|450950641|FG001|Overall Study|Withdrawal by Subject|0|||
125359149|NCT01147640|450950640|FG000|Overall Study|Lost to Follow-up|0|||
125359150|NCT01147640|450950641|FG001|Overall Study|Lost to Follow-up|1|||
125359151|NCT01147640|450950640|FG000|Overall Study|Didn't meet eligibility criteria|1|||
125359152|NCT01147640|450950641|FG001|Overall Study|Didn't meet eligibility criteria|0|||
125359153|NCT01797731|450950642|FG000|Overall Study|Didn't have proper radiographs required|3|||
125359154|NCT01797731|450950643|FG001|Overall Study|Didn't have proper radiographs required|3|||
125359155|NCT01954342|450950644|FG000|Overall Study|Missing data from 13-16week study visit|0|||
125359156|NCT01954342|450950645|FG001|Overall Study|Missing data from 13-16week study visit|0|||
125359157|NCT01954342|450950646|FG002|Overall Study|Missing data from 13-16week study visit|0|||
125359158|NCT01954342|450950647|FG003|Overall Study|Missing data from 13-16week study visit|1|||
125359159|NCT01954342|450950644|FG000|Overall Study|Miscarriage|0|||
125359160|NCT01954342|450950645|FG001|Overall Study|Miscarriage|0|||
125359161|NCT01954342|450950646|FG002|Overall Study|Miscarriage|0|||
125359162|NCT01954342|450950647|FG003|Overall Study|Miscarriage|3|||
125359163|NCT01954342|450950644|FG000|Overall Study|Lost to Follow-up|0|||
125359164|NCT01954342|450950645|FG001|Overall Study|Lost to Follow-up|0|||
125359165|NCT01954342|450950646|FG002|Overall Study|Lost to Follow-up|0|||
125359166|NCT01954342|450950647|FG003|Overall Study|Lost to Follow-up|5|||
125359167|NCT01954342|450950644|FG000|Overall Study|Preterm delivery|0|||
125359168|NCT01954342|450950645|FG001|Overall Study|Preterm delivery|0|||
125359169|NCT01954342|450950646|FG002|Overall Study|Preterm delivery|0|||
125359170|NCT01954342|450950647|FG003|Overall Study|Preterm delivery|3|||
125359171|NCT01954342|450950644|FG000|Overall Study|Pre-eclampsia|0|||
125359172|NCT01954342|450950645|FG001|Overall Study|Pre-eclampsia|0|||
125359173|NCT01954342|450950646|FG002|Overall Study|Pre-eclampsia|0|||
125359174|NCT01954342|450950647|FG003|Overall Study|Pre-eclampsia|4|||
125359175|NCT01954342|450950644|FG000|Overall Study|Unreliable Data|0|||
125359176|NCT01954342|450950645|FG001|Overall Study|Unreliable Data|0|||
125359177|NCT01954342|450950646|FG002|Overall Study|Unreliable Data|0|||
125359178|NCT01954342|450950647|FG003|Overall Study|Unreliable Data|2|||
125359179|NCT00629772|450950652|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
125359180|NCT00629772|450950653|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
125359181|NCT00629772|450950652|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
125359182|NCT00629772|450950653|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
125577902|NCT00288080|451742610|FG001|Overall Study|Withdrawal by Subject|3|||
125577903|NCT00288080|451742609|FG000|Overall Study|Protocol Violation|25|||
125577904|NCT00288080|451742610|FG001|Overall Study|Protocol Violation|20|||
125577905|NCT00087646|451742611|FG000|Overall Study|Adverse Event|37|||
125359183|NCT01497275|450950654|FG000|Overall Study|Death|1|||
125359184|NCT01497275|450950654|FG000|Overall Study|Adverse Event|1|||
125359185|NCT01950169|450950655|FG000|Overall Study|Withdrawal by Subject|2|||
125577906|NCT00087646|451742612|FG001|Overall Study|Adverse Event|6|||
125359186|NCT01950169|450950656|FG001|Overall Study|Withdrawal by Subject|8|||
125359187|NCT01950169|450950657|FG002|Overall Study|Withdrawal by Subject|1|||
125359188|NCT01950169|450950655|FG000|Overall Study|Death|1|||
125577907|NCT00087646|451742613|FG002|Overall Study|Adverse Event|18|||
125359189|NCT01950169|450950656|FG001|Overall Study|Death|0|||
125359190|NCT01950169|450950657|FG002|Overall Study|Death|0|||
125359191|NCT00285818|450950668|FG000|Overall Study|Withdrawal by Subject|3|||
125359192|NCT00285818|450950669|FG001|Overall Study|Withdrawal by Subject|2|||
125359193|NCT00285818|450950668|FG000|Overall Study|Lost to Follow-up|1|||
125577908|NCT00087646|451742614|FG003|Overall Study|Adverse Event|20|||
125577909|NCT00087646|451742611|FG000|Overall Study|Death|0|||
125577910|NCT00087646|451742612|FG001|Overall Study|Death|1|||
125577911|NCT00087646|451742613|FG002|Overall Study|Death|0|||
125577912|NCT00087646|451742614|FG003|Overall Study|Death|0|||
125577913|NCT00087646|451742611|FG000|Overall Study|Withdrawal by Subject|6|||
125577914|NCT00087646|451742612|FG001|Overall Study|Withdrawal by Subject|1|||
125577915|NCT00087646|451742613|FG002|Overall Study|Withdrawal by Subject|2|||
125359194|NCT00285818|450950669|FG001|Overall Study|Lost to Follow-up|0|||
125577916|NCT00087646|451742614|FG003|Overall Study|Withdrawal by Subject|2|||
125577917|NCT00087646|451742611|FG000|Overall Study|Insufficient therapeutic response|64|||
125577918|NCT00087646|451742612|FG001|Overall Study|Insufficient therapeutic response|24|||
125577919|NCT00087646|451742613|FG002|Overall Study|Insufficient therapeutic response|38|||
125577920|NCT00087646|451742614|FG003|Overall Study|Insufficient therapeutic response|51|||
125577921|NCT00087646|451742611|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
125577922|NCT00087646|451742612|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
125577923|NCT00087646|451742613|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
125577924|NCT00087646|451742614|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
125577925|NCT00087646|451742611|FG000|Overall Study|Failure to Return|5|||
125577926|NCT00087646|451742612|FG001|Overall Study|Failure to Return|2|||
125577927|NCT00087646|451742613|FG002|Overall Study|Failure to Return|2|||
125577928|NCT00087646|451742614|FG003|Overall Study|Failure to Return|3|||
125577929|NCT00087646|451742611|FG000|Overall Study|Administrative/Other|6|||
125577930|NCT00087646|451742612|FG001|Overall Study|Administrative/Other|1|||
125577931|NCT00087646|451742613|FG002|Overall Study|Administrative/Other|1|||
125577932|NCT00087646|451742614|FG003|Overall Study|Administrative/Other|2|||
125577933|NCT00087646|451742611|FG000|Overall Study|Other Protocol Violation|3|||
125577934|NCT00087646|451742612|FG001|Overall Study|Other Protocol Violation|1|||
125577935|NCT00087646|451742613|FG002|Overall Study|Other Protocol Violation|0|||
125577936|NCT00087646|451742614|FG003|Overall Study|Other Protocol Violation|0|||
125577937|NCT00087646|451742611|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
125577938|NCT00087646|451742612|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
125577939|NCT00087646|451742613|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
125577940|NCT00087646|451742614|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
125577941|NCT01235962|451742615|FG000|Overall Study|Withdrawal by Subject|20|||
125577942|NCT01235962|451742616|FG001|Overall Study|Withdrawal by Subject|19|||
125577943|NCT01235962|451742617|FG002|Overall Study|Withdrawal by Subject|62|||
125577944|NCT01235962|451742618|FG003|Overall Study|Withdrawal by Subject|49|||
125577945|NCT01235962|451742615|FG000|Overall Study|Lost to Follow-up|21|||
125577946|NCT01235962|451742616|FG001|Overall Study|Lost to Follow-up|16|||
125577947|NCT01235962|451742617|FG002|Overall Study|Lost to Follow-up|47|||
125577948|NCT01235962|451742618|FG003|Overall Study|Lost to Follow-up|32|||
125577949|NCT01235962|451742615|FG000|Overall Study|Physician Decision|5|||
125577950|NCT01235962|451742616|FG001|Overall Study|Physician Decision|0|||
125577951|NCT01235962|451742617|FG002|Overall Study|Physician Decision|9|||
125577952|NCT01235962|451742618|FG003|Overall Study|Physician Decision|5|||
125577953|NCT01580397|451742621|FG000|Overall Study|Lack of Efficacy|14|||
125577954|NCT06098729|451742629|FG000|Overall Study|Withdrawal by Subject|1|||
125577955|NCT04925752|451742638|FG000|Overall Study|Still on Study|1826|||
125577956|NCT04925752|451742639|FG001|Overall Study|Still on Study|926|||
125577957|NCT04925752|451742638|FG000|Overall Study|Withdrew Consent|128|||
125577958|NCT04925752|451742639|FG001|Overall Study|Withdrew Consent|59|||
125577959|NCT04925752|451742638|FG000|Overall Study|Lost to Follow-up|73|||
125577960|NCT04925752|451742639|FG001|Overall Study|Lost to Follow-up|47|||
125577961|NCT04925752|451742638|FG000|Overall Study|Randomized but Never Treated|12|||
125577962|NCT04925752|451742639|FG001|Overall Study|Randomized but Never Treated|9|||
125577963|NCT04925752|451742638|FG000|Overall Study|Hiv-1 Infection|6|||
125577964|NCT04925752|451742639|FG001|Overall Study|Hiv-1 Infection|7|||
125577965|NCT04925752|451742638|FG000|Overall Study|Investigator's discretion|8|||
125577966|NCT04925752|451742639|FG001|Overall Study|Investigator's discretion|5|||
125577967|NCT04925752|451742638|FG000|Overall Study|Non-compliance with Study Drug|8|||
125577968|NCT04925752|451742639|FG001|Overall Study|Non-compliance with Study Drug|5|||
125577969|NCT04925752|451742638|FG000|Overall Study|Adverse Event|5|||
125577970|NCT04925752|451742639|FG001|Overall Study|Adverse Event|2|||
125577971|NCT04925752|451742638|FG000|Overall Study|Death|4|||
125359195|NCT01230710|450950674|FG000|Overall Study|Disease Progression|41|||
125359196|NCT01230710|450950674|FG000|Overall Study|Lost to Follow-up|3|||
125577972|NCT04925752|451742639|FG001|Overall Study|Death|2|||
125577973|NCT04925752|451742638|FG000|Overall Study|Protocol Violation|1|||
125577974|NCT04925752|451742639|FG001|Overall Study|Protocol Violation|3|||
125577975|NCT04925752|451742638|FG000|Overall Study|Withdrew Assent|1|||
125577976|NCT04925752|451742639|FG001|Overall Study|Withdrew Assent|0|||
125577977|NCT03467958|451742640|FG000|Overall Study|Adverse Event|20|||
125577978|NCT03467958|451742641|FG001|Overall Study|Adverse Event|32|||
125577979|NCT03467958|451742642|FG002|Overall Study|Adverse Event|5|||
125359197|NCT01230710|450950674|FG000|Overall Study|Death|4|||
125577980|NCT03467958|451742643|FG003|Overall Study|Adverse Event|3|||
125427374|NCT04814368|451189363|FG003|Overall Study|Study Terminated by Sponsor|2|||
125427375|NCT04814368|451189360|FG000|Overall Study|Subject Decision|1|||
125427376|NCT04814368|451189361|FG001|Overall Study|Subject Decision|2|||
125427377|NCT04814368|451189362|FG002|Overall Study|Subject Decision|0|||
125427378|NCT04814368|451189363|FG003|Overall Study|Subject Decision|0|||
125427379|NCT01953003|451190891|FG000|Overall Study|Not treated|0|||
125427380|NCT01953003|451190892|FG001|Overall Study|Not treated|1|||
125427381|NCT01953003|451190891|FG000|Overall Study|Progressive disease|35|||
125427382|NCT01953003|451190892|FG001|Overall Study|Progressive disease|45|||
125427383|NCT01953003|451190891|FG000|Overall Study|Related Adverse events|7|||
125427384|NCT01953003|451190892|FG001|Overall Study|Related Adverse events|2|||
125427385|NCT01953003|451190891|FG000|Overall Study|Non-related adverse events|0|||
125427386|NCT01953003|451190892|FG001|Overall Study|Non-related adverse events|2|||
125427387|NCT01953003|451190891|FG000|Overall Study|Protocol Violation|0|||
125427388|NCT01953003|451190892|FG001|Overall Study|Protocol Violation|1|||
125427389|NCT01953003|451190891|FG000|Overall Study|Withdrawal by Subject|14|||
125427390|NCT01953003|451190892|FG001|Overall Study|Withdrawal by Subject|4|||
125427391|NCT03092375|451190893|FG000|Overall Study|Lack of Efficacy|0|||
125427392|NCT03092375|451190894|FG001|Overall Study|Lack of Efficacy|1|||
125427393|NCT03092375|451190895|FG002|Overall Study|Lack of Efficacy|1|||
125427394|NCT03092375|451190896|FG003|Overall Study|Lack of Efficacy|0|||
125427395|NCT00553501|451190901|FG000|Overall Study|Adverse Event|2|||
125427396|NCT00553501|451190901|FG000|Overall Study|Death|1|||
125427397|NCT00553501|451190901|FG000|Overall Study|Progression|1|||
125427398|NCT02293395|451190902|FG000|Overall Study|Lost to Follow-up|1|||
125427399|NCT02293395|451190903|FG001|Overall Study|Lost to Follow-up|0|||
125427400|NCT02293395|451190902|FG000|Overall Study|Withdrawal by Subject|8|||
125427401|NCT02293395|451190903|FG001|Overall Study|Withdrawal by Subject|7|||
125427402|NCT01464021|451190905|FG000|Overall Study|Withdrawal by Subject|13|||
125427403|NCT01464021|451190905|FG000|Overall Study|Lost to Follow-up|1|||
125427404|NCT01464021|451190905|FG000|Overall Study|Lack of Efficacy|1|||
125427405|NCT01464021|451190905|FG000|Overall Study|various|11|||
125577981|NCT03467958|451742644|FG004|Overall Study|Adverse Event|3|||
125577982|NCT03467958|451742645|FG005|Overall Study|Adverse Event|3|||
125577983|NCT03467958|451742646|FG006|Overall Study|Adverse Event|6|||
125577984|NCT03467958|451742647|FG007|Overall Study|Adverse Event|5|||
125577985|NCT03467958|451742648|FG008|Overall Study|Adverse Event|0|||
125577986|NCT03467958|451742640|FG000|Overall Study|Lack of Efficacy|59|||
125577987|NCT03467958|451742641|FG001|Overall Study|Lack of Efficacy|120|||
125427406|NCT00224770|451190911|FG000|Overall Study|Lost to Follow-up|4|||
125427407|NCT00224770|451190912|FG001|Overall Study|Lost to Follow-up|2|||
125427408|NCT00224770|451190913|FG002|Overall Study|Lost to Follow-up|0|||
125427409|NCT01106430|451190914|FG000|Overall Study|Adverse Event|8|||
125427410|NCT01106430|451190915|FG001|Overall Study|Adverse Event|10|||
125427411|NCT01106430|451190914|FG000|Overall Study|Lack of Efficacy|2|||
125427412|NCT01106430|451190915|FG001|Overall Study|Lack of Efficacy|13|||
125427413|NCT01106430|451190914|FG000|Overall Study|Lost to Follow-up|5|||
125577988|NCT03467958|451742642|FG002|Overall Study|Lack of Efficacy|6|||
125359198|NCT01230710|450950674|FG000|Overall Study|Withdrawal of Consent|1|||
125359199|NCT00464269|450950675|FG000|Overall Study|Lack of Efficacy|1|||
125359200|NCT00464269|450950676|FG001|Overall Study|Lack of Efficacy|0|||
125359201|NCT00464269|450950677|FG002|Overall Study|Lack of Efficacy|0|||
125359202|NCT00464269|450950678|FG003|Overall Study|Lack of Efficacy|0|||
125359203|NCT00464269|450950675|FG000|Overall Study|Lost to Follow-up|0|||
125359204|NCT00464269|450950676|FG001|Overall Study|Lost to Follow-up|4|||
125359205|NCT00464269|450950677|FG002|Overall Study|Lost to Follow-up|0|||
125359206|NCT00464269|450950678|FG003|Overall Study|Lost to Follow-up|1|||
125359207|NCT00464269|450950675|FG000|Overall Study|Withdrawal by Subject|0|||
125359208|NCT00464269|450950676|FG001|Overall Study|Withdrawal by Subject|2|||
125359209|NCT00464269|450950677|FG002|Overall Study|Withdrawal by Subject|1|||
125359210|NCT00464269|450950678|FG003|Overall Study|Withdrawal by Subject|1|||
125359211|NCT00464269|450950675|FG000|Overall Study|Other reason|3|||
125359212|NCT00464269|450950676|FG001|Overall Study|Other reason|3|||
125359213|NCT00464269|450950677|FG002|Overall Study|Other reason|1|||
125359214|NCT00464269|450950678|FG003|Overall Study|Other reason|1|||
125359215|NCT00464269|450950675|FG000|Overall Study|AE, serious fatal|0|||
125359216|NCT00464269|450950676|FG001|Overall Study|AE, serious fatal|0|||
125359217|NCT00464269|450950677|FG002|Overall Study|AE, serious fatal|1|||
125359218|NCT00464269|450950678|FG003|Overall Study|AE, serious fatal|1|||
125359219|NCT00464269|450950675|FG000|Overall Study|SAE, non-fatal|0|||
125359220|NCT00464269|450950676|FG001|Overall Study|SAE, non-fatal|0|||
125359221|NCT00464269|450950677|FG002|Overall Study|SAE, non-fatal|0|||
125359222|NCT00464269|450950678|FG003|Overall Study|SAE, non-fatal|1|||
125359223|NCT00464269|450950675|FG000|Overall Study|AE, non-serious non-fatal|2|||
125359224|NCT00464269|450950676|FG001|Overall Study|AE, non-serious non-fatal|8|||
125359225|NCT00464269|450950677|FG002|Overall Study|AE, non-serious non-fatal|3|||
125359226|NCT00464269|450950678|FG003|Overall Study|AE, non-serious non-fatal|4|||
125359227|NCT00464269|450950675|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
125359228|NCT00464269|450950676|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
125359229|NCT00464269|450950677|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
125359230|NCT00464269|450950678|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
125359231|NCT02337738|450950679|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
125359232|NCT02337738|450950680|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
125359233|NCT02337738|450950681|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
125359234|NCT02337738|450950679|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
125359235|NCT02337738|450950680|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
125359236|NCT02337738|450950681|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
125359237|NCT02337738|450950679|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
125359238|NCT02337738|450950680|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
125359239|NCT02337738|450950681|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
125359240|NCT02337738|450950679|FG000|Overall Study|Voluntary Withdrawal|10|||
125359241|NCT02337738|450950680|FG001|Overall Study|Voluntary Withdrawal|5|||
125359242|NCT02337738|450950681|FG002|Overall Study|Voluntary Withdrawal|2|||
125359243|NCT02337738|450950679|FG000|Overall Study|Lack of Efficacy|2|||
125359244|NCT02337738|450950680|FG001|Overall Study|Lack of Efficacy|4|||
125359245|NCT02337738|450950681|FG002|Overall Study|Lack of Efficacy|0|||
125359246|NCT02337738|450950679|FG000|Overall Study|Investigator's Judgment|1|||
125359247|NCT02337738|450950680|FG001|Overall Study|Investigator's Judgment|1|||
125359248|NCT02337738|450950681|FG002|Overall Study|Investigator's Judgment|3|||
125359249|NCT00406354|450950682|FG000|All Randomized Patients|Protocol Violation|0|||
125359250|NCT00406354|450950683|FG001|All Randomized Patients|Protocol Violation|0|||
125359251|NCT00406354|450950684|FG002|All Randomized Patients|Protocol Violation|1|||
125359252|NCT00406354|450950682|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
125359253|NCT00406354|450950683|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
125359254|NCT00406354|450950684|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
125427414|NCT01106430|451190915|FG001|Overall Study|Lost to Follow-up|1|||
125427415|NCT01106430|451190914|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
125577989|NCT03467958|451742643|FG003|Overall Study|Lack of Efficacy|9|||
125577990|NCT03467958|451742644|FG004|Overall Study|Lack of Efficacy|8|||
125577991|NCT03467958|451742645|FG005|Overall Study|Lack of Efficacy|9|||
125577992|NCT03467958|451742646|FG006|Overall Study|Lack of Efficacy|11|||
125359255|NCT00406354|450950682|FG000|All Randomized and Treated Patients|Adverse Event|6|||
125359256|NCT00406354|450950683|FG001|All Randomized and Treated Patients|Adverse Event|2|||
125359257|NCT00406354|450950684|FG002|All Randomized and Treated Patients|Adverse Event|1|||
125359258|NCT00406354|450950682|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
125359259|NCT00406354|450950683|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
125359260|NCT00406354|450950684|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
125359261|NCT00406354|450950682|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
125359262|NCT00406354|450950683|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
125359263|NCT00406354|450950684|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
125577993|NCT03467958|451742647|FG007|Overall Study|Lack of Efficacy|9|||
125577994|NCT03467958|451742648|FG008|Overall Study|Lack of Efficacy|3|||
125577995|NCT03467958|451742640|FG000|Overall Study|Lost to Follow-up|1|||
125577996|NCT03467958|451742641|FG001|Overall Study|Lost to Follow-up|2|||
125577997|NCT03467958|451742642|FG002|Overall Study|Lost to Follow-up|1|||
125577998|NCT03467958|451742643|FG003|Overall Study|Lost to Follow-up|0|||
125577999|NCT03467958|451742644|FG004|Overall Study|Lost to Follow-up|4|||
125578000|NCT03467958|451742645|FG005|Overall Study|Lost to Follow-up|0|||
125578001|NCT03467958|451742646|FG006|Overall Study|Lost to Follow-up|0|||
125578002|NCT03467958|451742647|FG007|Overall Study|Lost to Follow-up|0|||
125578003|NCT03467958|451742648|FG008|Overall Study|Lost to Follow-up|0|||
125578004|NCT03467958|451742640|FG000|Overall Study|Other reasons|8|||
125578005|NCT03467958|451742641|FG001|Overall Study|Other reasons|14|||
125578006|NCT03467958|451742642|FG002|Overall Study|Other reasons|2|||
125578007|NCT03467958|451742643|FG003|Overall Study|Other reasons|1|||
125578008|NCT03467958|451742644|FG004|Overall Study|Other reasons|4|||
125578009|NCT03467958|451742645|FG005|Overall Study|Other reasons|0|||
125578010|NCT03467958|451742646|FG006|Overall Study|Other reasons|1|||
125578011|NCT03467958|451742647|FG007|Overall Study|Other reasons|0|||
125578012|NCT03467958|451742648|FG008|Overall Study|Other reasons|1|||
125578013|NCT03467958|451742640|FG000|Overall Study|Pregnancy|1|||
125578014|NCT03467958|451742641|FG001|Overall Study|Pregnancy|0|||
125578015|NCT03467958|451742642|FG002|Overall Study|Pregnancy|0|||
125578016|NCT03467958|451742643|FG003|Overall Study|Pregnancy|0|||
125578017|NCT03467958|451742644|FG004|Overall Study|Pregnancy|0|||
125578018|NCT03467958|451742645|FG005|Overall Study|Pregnancy|1|||
125578019|NCT03467958|451742646|FG006|Overall Study|Pregnancy|0|||
125578020|NCT03467958|451742647|FG007|Overall Study|Pregnancy|0|||
125578021|NCT03467958|451742648|FG008|Overall Study|Pregnancy|0|||
125578022|NCT03467958|451742640|FG000|Overall Study|Study terminated by sponsor|65|||
125578023|NCT03467958|451742641|FG001|Overall Study|Study terminated by sponsor|117|||
125427416|NCT01106430|451190915|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
125427417|NCT01106430|451190914|FG000|Overall Study|Moved Out Of State|0|||
125427418|NCT01106430|451190915|FG001|Overall Study|Moved Out Of State|1|||
125427419|NCT01106430|451190914|FG000|Overall Study|Refused To Take Medication|0|||
125427420|NCT01106430|451190915|FG001|Overall Study|Refused To Take Medication|1|||
125427421|NCT01106430|451190914|FG000|Overall Study|Noncompliance|0|||
125427422|NCT01106430|451190915|FG001|Overall Study|Noncompliance|1|||
125427423|NCT01106430|451190914|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
125427424|NCT01106430|451190915|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
125427425|NCT01106430|451190914|FG000|Overall Study|Previous Use Of Marijuana|1|||
125427426|NCT01106430|451190915|FG001|Overall Study|Previous Use Of Marijuana|0|||
125427427|NCT01106430|451190914|FG000|Overall Study|Protocol Violation|7|||
125427428|NCT01106430|451190915|FG001|Overall Study|Protocol Violation|2|||
125427429|NCT01106430|451190914|FG000|Overall Study|Withdrawal by Subject|8|||
125427430|NCT01106430|451190915|FG001|Overall Study|Withdrawal by Subject|4|||
125427431|NCT00861614|451190918|FG000|Overall Study|Disease Progression|182|||
125427432|NCT00861614|451190919|FG001|Overall Study|Disease Progression|263|||
125427433|NCT00861614|451190918|FG000|Overall Study|Study Drug Toxicity|79|||
125427434|NCT00861614|451190919|FG001|Overall Study|Study Drug Toxicity|6|||
125427435|NCT00861614|451190918|FG000|Overall Study|Death|32|||
125427436|NCT00861614|451190919|FG001|Overall Study|Death|19|||
125427437|NCT00861614|451190918|FG000|Overall Study|Adverse Event|27|||
125427438|NCT00861614|451190919|FG001|Overall Study|Adverse Event|23|||
125427439|NCT00861614|451190918|FG000|Overall Study|Withdrawal by Subject|34|||
125427440|NCT00861614|451190919|FG001|Overall Study|Withdrawal by Subject|35|||
125427441|NCT00861614|451190918|FG000|Overall Study|Other|17|||
125427442|NCT00861614|451190919|FG001|Overall Study|Other|22|||
125427443|NCT03391765|451190920|FG000|Overall Study|Adverse Event|2|||
125427444|NCT03391765|451190921|FG001|Overall Study|Adverse Event|0|||
125427445|NCT03391765|451190922|FG002|Overall Study|Adverse Event|0|||
125427446|NCT03391765|451190923|FG003|Overall Study|Adverse Event|2|||
125427447|NCT03391765|451190920|FG000|Overall Study|Withdrew consent|5|||
125427448|NCT03391765|451190921|FG001|Overall Study|Withdrew consent|7|||
125427449|NCT03391765|451190922|FG002|Overall Study|Withdrew consent|2|||
125427450|NCT03391765|451190923|FG003|Overall Study|Withdrew consent|5|||
125427451|NCT03391765|451190920|FG000|Overall Study|Other, not specified|44|||
125427452|NCT03391765|451190921|FG001|Overall Study|Other, not specified|38|||
125427453|NCT03391765|451190922|FG002|Overall Study|Other, not specified|21|||
125427454|NCT03391765|451190923|FG003|Overall Study|Other, not specified|16|||
125427455|NCT01255592|451190924|FG000|Overall Study|Adverse Event|5|||
125427456|NCT01255592|451190925|FG001|Overall Study|Adverse Event|0|||
125427457|NCT01255592|451190924|FG000|Overall Study|Withdrawal by Subject|1|||
125427458|NCT01255592|451190925|FG001|Overall Study|Withdrawal by Subject|0|||
125427459|NCT01255592|451190924|FG000|Overall Study|Other|0|||
125427460|NCT01255592|451190925|FG001|Overall Study|Other|1|||
125427461|NCT01424930|451190932|FG000|Overall Study|Adverse Event|0|||
125427462|NCT01424930|451190933|FG001|Overall Study|Adverse Event|1|||
125427463|NCT01424930|451190932|FG000|Overall Study|Death|1|||
125578024|NCT03467958|451742642|FG002|Overall Study|Study terminated by sponsor|45|||
125578025|NCT03467958|451742643|FG003|Overall Study|Study terminated by sponsor|64|||
125578026|NCT03467958|451742644|FG004|Overall Study|Study terminated by sponsor|66|||
125578027|NCT03467958|451742645|FG005|Overall Study|Study terminated by sponsor|17|||
125578028|NCT03467958|451742646|FG006|Overall Study|Study terminated by sponsor|11|||
125578029|NCT03467958|451742647|FG007|Overall Study|Study terminated by sponsor|5|||
125578030|NCT03467958|451742648|FG008|Overall Study|Study terminated by sponsor|5|||
125578031|NCT03467958|451742640|FG000|Overall Study|Withdrawal by Subject|25|||
125578032|NCT03467958|451742641|FG001|Overall Study|Withdrawal by Subject|44|||
125578033|NCT03467958|451742642|FG002|Overall Study|Withdrawal by Subject|7|||
125578034|NCT03467958|451742643|FG003|Overall Study|Withdrawal by Subject|8|||
125578035|NCT03467958|451742644|FG004|Overall Study|Withdrawal by Subject|6|||
125578036|NCT03467958|451742645|FG005|Overall Study|Withdrawal by Subject|8|||
125578037|NCT03467958|451742646|FG006|Overall Study|Withdrawal by Subject|4|||
125578038|NCT03467958|451742647|FG007|Overall Study|Withdrawal by Subject|1|||
125578039|NCT03467958|451742648|FG008|Overall Study|Withdrawal by Subject|4|||
125578040|NCT02925156|451742650|FG000|Overall Study|Lost to Follow-up|27|||
125578041|NCT02925156|451742651|FG001|Overall Study|Lost to Follow-up|53|||
125578042|NCT02925156|451742652|FG002|Overall Study|Lost to Follow-up|51|||
125578043|NCT02925156|451742653|FG003|Overall Study|Lost to Follow-up|59|||
125427464|NCT01424930|451190933|FG001|Overall Study|Death|0|||
125427465|NCT01424930|451190932|FG000|Overall Study|Progressive Disease|3|||
125578044|NCT02925156|451742654|FG004|Overall Study|Lost to Follow-up|89|||
125578045|NCT02925156|451742655|FG005|Overall Study|Lost to Follow-up|107|||
125578046|NCT02925156|451742656|FG006|Overall Study|Lost to Follow-up|34|||
125211304|NCT02306694|450398652|FG000|Overall Study|Lost to Follow-up|1|||
125578047|NCT02925156|451742657|FG007|Overall Study|Lost to Follow-up|36|||
125427466|NCT01424930|451190933|FG001|Overall Study|Progressive Disease|6|||
125427467|NCT01424930|451190932|FG000|Overall Study|Screen Failure|0|||
125427468|NCT01424930|451190933|FG001|Overall Study|Screen Failure|1|||
125427469|NCT01424930|451190932|FG000|Overall Study|Reason not specified|0|||
125427470|NCT01424930|451190933|FG001|Overall Study|Reason not specified|6|||
125427471|NCT01078155|451190934|FG000|Overall Study|Adverse Event|7|||
125427472|NCT01078155|451190934|FG000|Overall Study|Lack of Efficacy|16|||
125427473|NCT01078155|451190934|FG000|Overall Study|Participant's Decision|6|||
125427474|NCT01078155|451190934|FG000|Overall Study|Lost to Follow-up|15|||
125427475|NCT03286751|451190935|FG000|Washout Period 1|Withdrawal by Subject|0|||
125427476|NCT03286751|451190936|FG001|Washout Period 1|Withdrawal by Subject|0|||
125427477|NCT03286751|451190937|FG002|Washout Period 1|Withdrawal by Subject|0|||
125427478|NCT03286751|451190938|FG003|Washout Period 1|Withdrawal by Subject|0|||
125427479|NCT03286751|451190939|FG004|Washout Period 1|Withdrawal by Subject|1|||
125427480|NCT03286751|451190940|FG005|Washout Period 1|Withdrawal by Subject|0|||
125427481|NCT03286751|451190935|FG000|Washout Period 2|Personal Reasons|0|||
125578048|NCT02925156|451742658|FG008|Overall Study|Lost to Follow-up|73|||
125578049|NCT02925156|451742659|FG009|Overall Study|Lost to Follow-up|34|||
125578050|NCT00866307|451742660|FG000|Induction|Adverse Event|5|||
125578051|NCT00866307|451742661|FG001|Induction|Adverse Event|0|||
125578052|NCT00866307|451742662|FG002|Induction|Adverse Event|0|||
125578053|NCT00866307|451742660|FG000|Induction|Death|2|||
125578054|NCT00866307|451742661|FG001|Induction|Death|0|||
125578055|NCT00866307|451742662|FG002|Induction|Death|0|||
125578056|NCT00866307|451742660|FG000|Induction|Physician Decision|5|||
125578057|NCT00866307|451742661|FG001|Induction|Physician Decision|0|||
125578058|NCT00866307|451742662|FG002|Induction|Physician Decision|0|||
125578059|NCT00866307|451742660|FG000|Induction|Progressive Disease|1|||
125578060|NCT00866307|451742661|FG001|Induction|Progressive Disease|0|||
125578061|NCT00866307|451742662|FG002|Induction|Progressive Disease|0|||
125578062|NCT00866307|451742660|FG000|Induction|Identification of Patients with Day 29 M|3|||
125578063|NCT00866307|451742661|FG001|Induction|Identification of Patients with Day 29 M|0|||
125578064|NCT00866307|451742662|FG002|Induction|Identification of Patients with Day 29 M|0|||
125578065|NCT00866307|451742660|FG000|Induction|Inadequate cytognetic samples th|1|||
125578066|NCT00866307|451742661|FG001|Induction|Inadequate cytognetic samples th|0|||
125578067|NCT00866307|451742662|FG002|Induction|Inadequate cytognetic samples th|0|||
125578068|NCT00866307|451742660|FG000|Induction|Improper post-induction consent|2|||
125578069|NCT00866307|451742661|FG001|Induction|Improper post-induction consent|0|||
125578070|NCT00866307|451742662|FG002|Induction|Improper post-induction consent|0|||
125578071|NCT00866307|451742660|FG000|Induction|Study was closed at the time|1|||
125578072|NCT00866307|451742661|FG001|Induction|Study was closed at the time|0|||
125578073|NCT00866307|451742662|FG002|Induction|Study was closed at the time|0|||
125578074|NCT00866307|451742660|FG000|Consolidation/Maintenance|Adverse Event|0|||
125578075|NCT00866307|451742661|FG001|Consolidation/Maintenance|Adverse Event|0|||
125578076|NCT00866307|451742662|FG002|Consolidation/Maintenance|Adverse Event|8|||
125578077|NCT00866307|451742660|FG000|Consolidation/Maintenance|Death|0|||
125578078|NCT00866307|451742661|FG001|Consolidation/Maintenance|Death|0|||
125578079|NCT00866307|451742662|FG002|Consolidation/Maintenance|Death|1|||
125578080|NCT00866307|451742660|FG000|Consolidation/Maintenance|Physician Decision|0|||
125578081|NCT00866307|451742661|FG001|Consolidation/Maintenance|Physician Decision|3|||
125578082|NCT00866307|451742662|FG002|Consolidation/Maintenance|Physician Decision|2|||
125578083|NCT00866307|451742660|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
125578084|NCT00866307|451742661|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
125427482|NCT03286751|451190936|FG001|Washout Period 2|Personal Reasons|1|||
125427483|NCT03286751|451190937|FG002|Washout Period 2|Personal Reasons|0|||
125427484|NCT03286751|451190938|FG003|Washout Period 2|Personal Reasons|0|||
125427485|NCT03286751|451190939|FG004|Washout Period 2|Personal Reasons|0|||
125427486|NCT03286751|451190940|FG005|Washout Period 2|Personal Reasons|0|||
125427487|NCT03286751|451190935|FG000|Washout Period 5|Adverse Event|0|||
125427488|NCT03286751|451190936|FG001|Washout Period 5|Adverse Event|0|||
125427489|NCT03286751|451190937|FG002|Washout Period 5|Adverse Event|0|||
125427490|NCT03286751|451190938|FG003|Washout Period 5|Adverse Event|0|||
125427491|NCT03286751|451190939|FG004|Washout Period 5|Adverse Event|1|||
125427492|NCT03286751|451190940|FG005|Washout Period 5|Adverse Event|0|||
125427493|NCT01621880|451190941|FG000|Overall Study|Adverse Event|5|||
125427494|NCT01621880|451190942|FG001|Overall Study|Adverse Event|1|||
125427495|NCT01621880|451190941|FG000|Overall Study|Withdrawal by Subject|5|||
125427496|NCT01621880|451190942|FG001|Overall Study|Withdrawal by Subject|4|||
125427497|NCT01127646|451190943|FG000|Overall Study|Entry Criteria Not Met|1|||
125427498|NCT01127646|451190944|FG001|Overall Study|Entry Criteria Not Met|0|||
125578085|NCT00866307|451742662|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
125578086|NCT00866307|451742660|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
125211305|NCT00603382|450398653|FG000|Overall Study|Adverse Event|0|||
125427499|NCT01127646|451190943|FG000|Overall Study|Protocol Violation|0|||
125578087|NCT00866307|451742661|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
125578088|NCT00866307|451742662|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
125578089|NCT00866307|451742660|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
125578090|NCT00866307|451742661|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
125578091|NCT00866307|451742662|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
125578092|NCT00866307|451742660|FG000|Consolidation/Maintenance|Therapy error|0|||
125578093|NCT00866307|451742661|FG001|Consolidation/Maintenance|Therapy error|1|||
125578094|NCT00866307|451742662|FG002|Consolidation/Maintenance|Therapy error|0|||
125578095|NCT00866307|451742660|FG000|Consolidation/Maintenance|Non-compliance|0|||
125578096|NCT00866307|451742661|FG001|Consolidation/Maintenance|Non-compliance|0|||
125578097|NCT00866307|451742662|FG002|Consolidation/Maintenance|Non-compliance|1|||
125578098|NCT00866307|451742660|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
125578099|NCT00866307|451742661|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
125578100|NCT00866307|451742662|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
125578101|NCT01060059|451742665|FG000|Overall Study|Adverse Event|1|||
125578102|NCT01060059|451742666|FG001|Overall Study|Adverse Event|1|||
125578103|NCT01060059|451742665|FG000|Overall Study|Death|2|||
125578104|NCT01060059|451742666|FG001|Overall Study|Death|3|||
125578105|NCT01060059|451742665|FG000|Overall Study|Lost to Follow-up|18|||
125578106|NCT01060059|451742666|FG001|Overall Study|Lost to Follow-up|34|||
125578107|NCT01060059|451742665|FG000|Overall Study|entry criteria not met|4|||
125578108|NCT01060059|451742666|FG001|Overall Study|entry criteria not met|3|||
125578109|NCT01060059|451742665|FG000|Overall Study|Withdrawal by Subject|35|||
125578110|NCT01060059|451742666|FG001|Overall Study|Withdrawal by Subject|23|||
125578111|NCT01060059|451742665|FG000|Overall Study|lack of glycemic control|2|||
125578112|NCT01060059|451742666|FG001|Overall Study|lack of glycemic control|1|||
125578113|NCT01060059|451742665|FG000|Overall Study|lack of compliance|5|||
125578114|NCT01060059|451742666|FG001|Overall Study|lack of compliance|2|||
125578115|NCT04202679|451742667|FG000|Overall Study|Adverse Event|2|||
125578116|NCT04202679|451742668|FG001|Overall Study|Adverse Event|0|||
125578117|NCT04202679|451742667|FG000|Overall Study|Poor compliance to protocol|1|||
125578118|NCT04202679|451742668|FG001|Overall Study|Poor compliance to protocol|0|||
125578119|NCT04202679|451742667|FG000|Overall Study|Withdrawal by Subject|23|||
125578120|NCT04202679|451742668|FG001|Overall Study|Withdrawal by Subject|6|||
125578121|NCT03406897|451742671|FG000|Overall Study|Lost to Follow-up|1|||
125578122|NCT03406897|451742672|FG001|Overall Study|Lost to Follow-up|2|||
125578123|NCT03406897|451742671|FG000|Overall Study|Withdrawal by Subject|4|||
125578124|NCT03406897|451742672|FG001|Overall Study|Withdrawal by Subject|4|||
125578125|NCT03406897|451742671|FG000|Overall Study|Physician Decision|0|||
125578126|NCT03406897|451742672|FG001|Overall Study|Physician Decision|1|||
125578127|NCT00598975|451744377|FG000|Overall Study|Adverse Event|1|||
125578128|NCT00598975|451744378|FG001|Overall Study|Adverse Event|1|||
125578129|NCT00598975|451744377|FG000|Overall Study|Brain metastases|1|||
125578130|NCT00598975|451744378|FG001|Overall Study|Brain metastases|0|||
125578131|NCT00598975|451744377|FG000|Overall Study|Withdrawal by Subject|1|||
125578132|NCT00598975|451744378|FG001|Overall Study|Withdrawal by Subject|1|||
125578133|NCT00598975|451744377|FG000|Overall Study|Withdrawal of consent|0|||
125578134|NCT00598975|451744378|FG001|Overall Study|Withdrawal of consent|1|||
125578135|NCT00598975|451744377|FG000|Overall Study|Disease progression|8|||
125578136|NCT00598975|451744378|FG001|Overall Study|Disease progression|3|||
125578137|NCT00598975|451744377|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
125578138|NCT00598975|451744378|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
125427500|NCT01127646|451190944|FG001|Overall Study|Protocol Violation|1|||
125427501|NCT01662063|451190945|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
125427502|NCT01662063|451190946|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
125427503|NCT01662063|451190947|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
125427504|NCT01662063|451190945|FG000|Overall Study|Lack of Efficacy|1|||
125427505|NCT01662063|451190946|FG001|Overall Study|Lack of Efficacy|6|||
125427506|NCT01662063|451190947|FG002|Overall Study|Lack of Efficacy|0|||
125427507|NCT01662063|451190945|FG000|Overall Study|Lost to Follow-up|0|||
125427508|NCT01662063|451190946|FG001|Overall Study|Lost to Follow-up|4|||
125427509|NCT01662063|451190947|FG002|Overall Study|Lost to Follow-up|0|||
125427510|NCT01662063|451190945|FG000|Overall Study|Protocol Violation|1|||
125427511|NCT01662063|451190946|FG001|Overall Study|Protocol Violation|0|||
125578139|NCT05227690|451744388|FG000|Overall Study|Adverse Event|5|||
125578140|NCT05227690|451744389|FG001|Overall Study|Adverse Event|6|||
125427512|NCT01662063|451190947|FG002|Overall Study|Protocol Violation|0|||
125427513|NCT01662063|451190945|FG000|Overall Study|Withdrawal by Subject|2|||
125427514|NCT01662063|451190946|FG001|Overall Study|Withdrawal by Subject|4|||
125578141|NCT05227690|451744390|FG002|Overall Study|Adverse Event|10|||
125578142|NCT05227690|451744388|FG000|Overall Study|Lack of Efficacy|2|||
125578143|NCT05227690|451744389|FG001|Overall Study|Lack of Efficacy|4|||
125427515|NCT01662063|451190947|FG002|Overall Study|Withdrawal by Subject|1|||
125427516|NCT01662063|451190945|FG000|Overall Study|Physician Decision|0|||
125427517|NCT01662063|451190946|FG001|Overall Study|Physician Decision|2|||
125578144|NCT05227690|451744390|FG002|Overall Study|Lack of Efficacy|1|||
125578145|NCT05227690|451744388|FG000|Overall Study|Physician Decision|6|||
125578146|NCT05227690|451744389|FG001|Overall Study|Physician Decision|0|||
125578147|NCT05227690|451744390|FG002|Overall Study|Physician Decision|4|||
125578148|NCT05227690|451744388|FG000|Overall Study|Withdrawal of consent|28|||
125578149|NCT05227690|451744389|FG001|Overall Study|Withdrawal of consent|27|||
125578150|NCT05227690|451744390|FG002|Overall Study|Withdrawal of consent|21|||
125578151|NCT05227690|451744388|FG000|Overall Study|Other, not specified|2|||
125578152|NCT05227690|451744389|FG001|Overall Study|Other, not specified|2|||
125578153|NCT05227690|451744390|FG002|Overall Study|Other, not specified|1|||
125578154|NCT04033367|451744391|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
125578155|NCT04033367|451744392|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
125578156|NCT04033367|451744391|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
125578157|NCT04033367|451744392|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
125578158|NCT04033367|451744391|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
125578159|NCT04033367|451744392|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
125578160|NCT04033367|451744391|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
125578161|NCT04033367|451744392|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
125578162|NCT02723201|451744393|FG000|Second Intervention Period|Protocol Violation|1|||
125578163|NCT02723201|451744394|FG001|Second Intervention Period|Protocol Violation|0|||
125578164|NCT02723201|451744395|FG002|Second Intervention Period|Protocol Violation|0|||
125578165|NCT02723201|451744393|FG000|Second Intervention Period|Adverse Event|1|||
125578166|NCT02723201|451744394|FG001|Second Intervention Period|Adverse Event|0|||
125578167|NCT02723201|451744395|FG002|Second Intervention Period|Adverse Event|0|||
125578168|NCT03472560|451744396|FG000|Overall Study|Subject transfer to continuation protocol|0|||
125578169|NCT03472560|451744397|FG001|Overall Study|Subject transfer to continuation protocol|1|||
125578170|NCT03472560|451744396|FG000|Overall Study|Withdrawal by Subject|4|||
125578171|NCT03472560|451744397|FG001|Overall Study|Withdrawal by Subject|0|||
125578172|NCT03472560|451744396|FG000|Overall Study|Progressive disease|24|||
125578173|NCT03472560|451744397|FG001|Overall Study|Progressive disease|8|||
125578174|NCT03472560|451744396|FG000|Overall Study|Physician Decision|1|||
125578175|NCT03472560|451744397|FG001|Overall Study|Physician Decision|0|||
125578176|NCT03472560|451744396|FG000|Overall Study|Death|7|||
125578177|NCT03472560|451744397|FG001|Overall Study|Death|4|||
125578178|NCT03472560|451744396|FG000|Overall Study|Adverse Event|5|||
125578179|NCT03472560|451744397|FG001|Overall Study|Adverse Event|3|||
125578180|NCT03472560|451744396|FG000|Overall Study|Global deterioration of health status|0|||
125359264|NCT00406354|450950682|FG000|All Randomized and Treated Patients|Physician Decision|0|||
125359265|NCT00406354|450950683|FG001|All Randomized and Treated Patients|Physician Decision|0|||
125359266|NCT00406354|450950684|FG002|All Randomized and Treated Patients|Physician Decision|1|||
125359267|NCT00747461|450950685|FG000|Overall Study|study terminated by sponsor|5|||
125359268|NCT01565642|450950700|FG000|Overall Study|Withdrawal by Subject|2|||
125359269|NCT01565642|450950701|FG001|Overall Study|Withdrawal by Subject|1|||
125359270|NCT02711345|450950703|FG000|Overall Study|Adverse Event|0|||
125359271|NCT02711345|450950704|FG001|Overall Study|Adverse Event|0|||
125359272|NCT02711345|450950705|FG002|Overall Study|Adverse Event|0|||
125359273|NCT02711345|450950706|FG003|Overall Study|Adverse Event|1|||
125578181|NCT03472560|451744397|FG001|Overall Study|Global deterioration of health status|4|||
125578182|NCT01534676|451744398|FG000|Overall Study|Study closed due to poor enrollment|2|||
125578183|NCT01534676|451744399|FG001|Overall Study|Study closed due to poor enrollment|1|||
125578184|NCT00491179|451744403|FG000|Overall Study|Adverse Event|5|||
125578185|NCT00491179|451744404|FG001|Overall Study|Adverse Event|1|||
125578186|NCT00491179|451744403|FG000|Overall Study|Withdrawal by Subject|2|||
125578187|NCT00491179|451744404|FG001|Overall Study|Withdrawal by Subject|1|||
125578188|NCT04269395|451744405|FG000|Overall Study|Lost to Follow-up|1|||
125578189|NCT04269395|451744406|FG001|Overall Study|Lost to Follow-up|0|||
125578190|NCT04269395|451744405|FG000|Overall Study|Study terminated by Sponsor|13|||
125578191|NCT04269395|451744406|FG001|Overall Study|Study terminated by Sponsor|10|||
125578192|NCT00584233|451744407|FG000|Overall Study|Withdrawal by Subject|5|||
125578193|NCT00584233|451744407|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
125578194|NCT03529773|451744408|FG000|Overall Study|Adverse Event|0|||
125578195|NCT03529773|451744409|FG001|Overall Study|Adverse Event|0|||
125578196|NCT03529773|451744410|FG002|Overall Study|Adverse Event|0|||
125578197|NCT03529773|451744411|FG003|Overall Study|Adverse Event|0|||
125578198|NCT03529773|451744412|FG004|Overall Study|Adverse Event|0|||
125578199|NCT03529773|451744413|FG005|Overall Study|Adverse Event|0|||
125578200|NCT03529773|451744414|FG006|Overall Study|Adverse Event|0|||
125578201|NCT03529773|451744415|FG007|Overall Study|Adverse Event|0|||
125578202|NCT03529773|451744416|FG008|Overall Study|Adverse Event|0|||
125578203|NCT03529773|451744417|FG009|Overall Study|Adverse Event|0|||
125578204|NCT03529773|451744418|FG010|Overall Study|Adverse Event|0|||
125578205|NCT03529773|451744419|FG011|Overall Study|Adverse Event|0|||
125578206|NCT03529773|451744420|FG012|Overall Study|Adverse Event|0|||
125578207|NCT03529773|451744421|FG013|Overall Study|Adverse Event|0|||
125578208|NCT03529773|451744422|FG014|Overall Study|Adverse Event|0|||
125578209|NCT03529773|451744423|FG015|Overall Study|Adverse Event|0|||
125578210|NCT03529773|451744424|FG016|Overall Study|Adverse Event|0|||
125578211|NCT03529773|451744425|FG017|Overall Study|Adverse Event|0|||
125578212|NCT03529773|451744426|FG018|Overall Study|Adverse Event|0|||
125578213|NCT03529773|451744427|FG019|Overall Study|Adverse Event|0|||
125211306|NCT00603382|450398654|FG001|Overall Study|Adverse Event|1|||
125211307|NCT00603382|450398655|FG002|Overall Study|Adverse Event|1|||
125359274|NCT02711345|450950707|FG004|Overall Study|Adverse Event|1|||
125359275|NCT02711345|450950708|FG005|Overall Study|Adverse Event|2|||
125359276|NCT02711345|450950709|FG006|Overall Study|Adverse Event|1|||
125359277|NCT02711345|450950710|FG007|Overall Study|Adverse Event|0|||
125359278|NCT02711345|450950711|FG008|Overall Study|Adverse Event|0|||
125359279|NCT02711345|450950712|FG009|Overall Study|Adverse Event|2|||
125359280|NCT02711345|450950703|FG000|Overall Study|Physician Decision|0|||
125359281|NCT02711345|450950704|FG001|Overall Study|Physician Decision|0|||
125359282|NCT02711345|450950705|FG002|Overall Study|Physician Decision|1|||
125359283|NCT02711345|450950706|FG003|Overall Study|Physician Decision|0|||
125359284|NCT02711345|450950707|FG004|Overall Study|Physician Decision|0|||
125359285|NCT02711345|450950708|FG005|Overall Study|Physician Decision|0|||
125359286|NCT02711345|450950709|FG006|Overall Study|Physician Decision|0|||
125359287|NCT02711345|450950710|FG007|Overall Study|Physician Decision|0|||
125359288|NCT02711345|450950711|FG008|Overall Study|Physician Decision|1|||
125359289|NCT02711345|450950712|FG009|Overall Study|Physician Decision|0|||
125359290|NCT02711345|450950703|FG000|Overall Study|Progressive disease|1|||
125359291|NCT02711345|450950704|FG001|Overall Study|Progressive disease|3|||
125359292|NCT02711345|450950705|FG002|Overall Study|Progressive disease|5|||
125359293|NCT02711345|450950706|FG003|Overall Study|Progressive disease|3|||
125359294|NCT02711345|450950707|FG004|Overall Study|Progressive disease|7|||
125359295|NCT02711345|450950708|FG005|Overall Study|Progressive disease|2|||
125359296|NCT02711345|450950709|FG006|Overall Study|Progressive disease|8|||
125359297|NCT02711345|450950710|FG007|Overall Study|Progressive disease|4|||
125359298|NCT02711345|450950711|FG008|Overall Study|Progressive disease|5|||
125359299|NCT02711345|450950712|FG009|Overall Study|Progressive disease|6|||
125359300|NCT02711345|450950703|FG000|Overall Study|Subject/guardian decision|0|||
125359301|NCT02711345|450950704|FG001|Overall Study|Subject/guardian decision|0|||
125359302|NCT02711345|450950705|FG002|Overall Study|Subject/guardian decision|0|||
125359303|NCT02711345|450950706|FG003|Overall Study|Subject/guardian decision|0|||
125359304|NCT02711345|450950707|FG004|Overall Study|Subject/guardian decision|0|||
125359305|NCT02711345|450950708|FG005|Overall Study|Subject/guardian decision|2|||
125359306|NCT02711345|450950709|FG006|Overall Study|Subject/guardian decision|3|||
125359307|NCT02711345|450950710|FG007|Overall Study|Subject/guardian decision|1|||
125359308|NCT02711345|450950711|FG008|Overall Study|Subject/guardian decision|0|||
125359309|NCT02711345|450950712|FG009|Overall Study|Subject/guardian decision|4|||
125359310|NCT02711345|450950703|FG000|Overall Study|Death|1|||
125359311|NCT02711345|450950704|FG001|Overall Study|Death|0|||
125359312|NCT02711345|450950705|FG002|Overall Study|Death|0|||
125427518|NCT01662063|451190947|FG002|Overall Study|Physician Decision|0|||
125578214|NCT03529773|451744428|FG020|Overall Study|Adverse Event|0|||
125578215|NCT03529773|451744429|FG021|Overall Study|Adverse Event|0|||
125578216|NCT03529773|451744430|FG022|Overall Study|Adverse Event|0|||
125578217|NCT03529773|451744431|FG023|Overall Study|Adverse Event|0|||
125578218|NCT03529773|451744432|FG024|Overall Study|Adverse Event|0|||
125578219|NCT03529773|451744433|FG025|Overall Study|Adverse Event|0|||
125578220|NCT03529773|451744434|FG026|Overall Study|Adverse Event|0|||
125578221|NCT03529773|451744435|FG027|Overall Study|Adverse Event|0|||
125359313|NCT02711345|450950706|FG003|Overall Study|Death|0|||
125359314|NCT02711345|450950707|FG004|Overall Study|Death|0|||
125359315|NCT02711345|450950708|FG005|Overall Study|Death|0|||
125359316|NCT02711345|450950709|FG006|Overall Study|Death|0|||
125211308|NCT00603382|450398656|FG003|Overall Study|Adverse Event|2|||
125578222|NCT03529773|451744436|FG028|Overall Study|Adverse Event|0|||
125578223|NCT03529773|451744437|FG029|Overall Study|Adverse Event|0|||
125578224|NCT03529773|451744438|FG030|Overall Study|Adverse Event|1|||
125578225|NCT03529773|451744439|FG031|Overall Study|Adverse Event|0|||
125578226|NCT03529773|451744440|FG032|Overall Study|Adverse Event|0|||
125578227|NCT03529773|451744441|FG033|Overall Study|Adverse Event|0|||
125578228|NCT03529773|451744442|FG034|Overall Study|Adverse Event|0|||
125578229|NCT03529773|451744443|FG035|Overall Study|Adverse Event|1|||
125578230|NCT03529773|451744444|FG036|Overall Study|Adverse Event|0|||
125578231|NCT03529773|451744445|FG037|Overall Study|Adverse Event|0|||
125578232|NCT03529773|451744446|FG038|Overall Study|Adverse Event|1|||
125578233|NCT03529773|451744447|FG039|Overall Study|Adverse Event|1|||
125578234|NCT03529773|451744408|FG000|Overall Study|Death|0|||
125578235|NCT03529773|451744409|FG001|Overall Study|Death|0|||
125578236|NCT03529773|451744410|FG002|Overall Study|Death|0|||
125578237|NCT03529773|451744411|FG003|Overall Study|Death|0|||
125578238|NCT03529773|451744412|FG004|Overall Study|Death|0|||
125578239|NCT03529773|451744413|FG005|Overall Study|Death|0|||
125578240|NCT03529773|451744414|FG006|Overall Study|Death|0|||
125578241|NCT03529773|451744415|FG007|Overall Study|Death|0|||
125578242|NCT03529773|451744416|FG008|Overall Study|Death|0|||
125578243|NCT03529773|451744417|FG009|Overall Study|Death|0|||
125578244|NCT03529773|451744418|FG010|Overall Study|Death|0|||
125359317|NCT02711345|450950710|FG007|Overall Study|Death|1|||
125578245|NCT03529773|451744419|FG011|Overall Study|Death|0|||
125578246|NCT03529773|451744420|FG012|Overall Study|Death|1|||
125578247|NCT03529773|451744421|FG013|Overall Study|Death|0|||
125578248|NCT03529773|451744422|FG014|Overall Study|Death|0|||
125578249|NCT03529773|451744423|FG015|Overall Study|Death|0|||
125578250|NCT03529773|451744424|FG016|Overall Study|Death|0|||
125359318|NCT02711345|450950711|FG008|Overall Study|Death|0|||
125359319|NCT02711345|450950712|FG009|Overall Study|Death|0|||
125359320|NCT00961649|450950713|FG000|Overall Study|Adverse Event|4|||
125359321|NCT00961649|450950714|FG001|Overall Study|Adverse Event|0|||
125578251|NCT03529773|451744425|FG017|Overall Study|Death|0|||
125578252|NCT03529773|451744426|FG018|Overall Study|Death|0|||
125578253|NCT03529773|451744427|FG019|Overall Study|Death|1|||
125578254|NCT03529773|451744428|FG020|Overall Study|Death|0|||
125578255|NCT03529773|451744429|FG021|Overall Study|Death|0|||
125578256|NCT03529773|451744430|FG022|Overall Study|Death|1|||
125578257|NCT03529773|451744431|FG023|Overall Study|Death|0|||
125578258|NCT03529773|451744432|FG024|Overall Study|Death|0|||
125578259|NCT03529773|451744433|FG025|Overall Study|Death|0|||
125578260|NCT03529773|451744434|FG026|Overall Study|Death|0|||
125578261|NCT03529773|451744435|FG027|Overall Study|Death|0|||
125359322|NCT00961649|450950715|FG002|Overall Study|Adverse Event|0|||
125359323|NCT00961649|450950716|FG003|Overall Study|Adverse Event|2|||
125359324|NCT00961649|450950713|FG000|Overall Study|Inadequate control of IOP|0|||
125359325|NCT00961649|450950714|FG001|Overall Study|Inadequate control of IOP|0|||
125359326|NCT00961649|450950715|FG002|Overall Study|Inadequate control of IOP|0|||
125359327|NCT00961649|450950716|FG003|Overall Study|Inadequate control of IOP|1|||
125359328|NCT00961649|450950713|FG000|Overall Study|Patient has travel plans during holidays|0|||
125359329|NCT00961649|450950714|FG001|Overall Study|Patient has travel plans during holidays|0|||
125359330|NCT00961649|450950715|FG002|Overall Study|Patient has travel plans during holidays|1|||
125359331|NCT00961649|450950716|FG003|Overall Study|Patient has travel plans during holidays|0|||
125359332|NCT00961649|450950713|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
125359333|NCT00961649|450950714|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
125359334|NCT00961649|450950715|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
125359335|NCT00961649|450950716|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
125359336|NCT00961649|450950713|FG000|Overall Study|Study terminated by sponsor|4|||
125359337|NCT00961649|450950714|FG001|Overall Study|Study terminated by sponsor|4|||
125359338|NCT00961649|450950715|FG002|Overall Study|Study terminated by sponsor|4|||
125359339|NCT00961649|450950716|FG003|Overall Study|Study terminated by sponsor|1|||
125359340|NCT04043728|450950717|FG000|Overall Study|Lost to Follow-up|1|||
125359341|NCT04043728|450950718|FG001|Overall Study|Lost to Follow-up|2|||
125359342|NCT04043728|450950719|FG002|Overall Study|Lost to Follow-up|0|||
125359343|NCT01033851|450950720|FG000|Overall Study|Withdrawal by Subject|3|||
125427519|NCT01662063|451190945|FG000|Overall Study|Other|0|||
125427520|NCT01662063|451190946|FG001|Overall Study|Other|1|||
125578262|NCT03529773|451744436|FG028|Overall Study|Death|0|||
125578263|NCT03529773|451744437|FG029|Overall Study|Death|0|||
125578264|NCT03529773|451744438|FG030|Overall Study|Death|0|||
125578265|NCT03529773|451744439|FG031|Overall Study|Death|0|||
125211309|NCT00603382|450398657|FG004|Overall Study|Adverse Event|1|||
125211310|NCT00603382|450398658|FG005|Overall Study|Adverse Event|2|||
125211311|NCT00603382|450398653|FG000|Overall Study|Lack of Efficacy|14|||
125211312|NCT00603382|450398654|FG001|Overall Study|Lack of Efficacy|9|||
125211313|NCT00603382|450398655|FG002|Overall Study|Lack of Efficacy|3|||
125211314|NCT00603382|450398656|FG003|Overall Study|Lack of Efficacy|6|||
125211315|NCT00603382|450398657|FG004|Overall Study|Lack of Efficacy|6|||
125211316|NCT00603382|450398658|FG005|Overall Study|Lack of Efficacy|11|||
125211317|NCT00603382|450398653|FG000|Overall Study|Protocol Violation|1|||
125211318|NCT00603382|450398654|FG001|Overall Study|Protocol Violation|0|||
125211319|NCT00603382|450398655|FG002|Overall Study|Protocol Violation|1|||
125211320|NCT00603382|450398656|FG003|Overall Study|Protocol Violation|2|||
125211321|NCT00603382|450398657|FG004|Overall Study|Protocol Violation|1|||
125211322|NCT00603382|450398658|FG005|Overall Study|Protocol Violation|0|||
125211323|NCT00603382|450398653|FG000|Overall Study|Lost to Follow-up|0|||
125211324|NCT00603382|450398654|FG001|Overall Study|Lost to Follow-up|1|||
125211325|NCT00603382|450398655|FG002|Overall Study|Lost to Follow-up|1|||
125211326|NCT00603382|450398656|FG003|Overall Study|Lost to Follow-up|1|||
125211327|NCT00603382|450398657|FG004|Overall Study|Lost to Follow-up|0|||
125211328|NCT00603382|450398658|FG005|Overall Study|Lost to Follow-up|1|||
125211329|NCT00603382|450398653|FG000|Overall Study|Physician Decision|0|||
125211330|NCT00603382|450398654|FG001|Overall Study|Physician Decision|0|||
125211331|NCT00603382|450398655|FG002|Overall Study|Physician Decision|2|||
125211332|NCT00603382|450398656|FG003|Overall Study|Physician Decision|0|||
125211333|NCT00603382|450398657|FG004|Overall Study|Physician Decision|1|||
125211334|NCT00603382|450398658|FG005|Overall Study|Physician Decision|3|||
125211335|NCT00603382|450398653|FG000|Overall Study|Withdrawal by Subject|3|||
125211336|NCT00603382|450398654|FG001|Overall Study|Withdrawal by Subject|3|||
125211337|NCT00603382|450398655|FG002|Overall Study|Withdrawal by Subject|1|||
125211338|NCT00603382|450398656|FG003|Overall Study|Withdrawal by Subject|1|||
125211339|NCT00603382|450398657|FG004|Overall Study|Withdrawal by Subject|0|||
125211340|NCT00603382|450398658|FG005|Overall Study|Withdrawal by Subject|1|||
125211341|NCT00395642|450398659|FG000|Overall Study|Death|4|||
125211342|NCT00395642|450398659|FG000|Overall Study|Lost to Follow-up|1|||
125211343|NCT00395642|450398659|FG000|Overall Study|Physician Decision|7|||
125211344|NCT00395642|450398659|FG000|Overall Study|Withdrawal by Subject|1|||
125211345|NCT02012959|450398660|FG000|Treatment Phase A|Adverse Event|2|||
125211346|NCT02012959|450398661|FG001|Treatment Phase A|Adverse Event|0|||
125211347|NCT02012959|450398662|FG002|Treatment Phase A|Adverse Event|0|||
125211348|NCT02012959|450398663|FG003|Treatment Phase A|Adverse Event|0|||
125211349|NCT02012959|450398664|FG004|Treatment Phase A|Adverse Event|0|||
125211350|NCT02333383|450398667|FG000|Overall Study|Adalimumab discontinuation|21|||
125211351|NCT02333383|450398667|FG000|Overall Study|Lost to Follow-up|15|||
125211352|NCT02333383|450398667|FG000|Overall Study|Withdrawal by Subject|3|||
125211353|NCT02333383|450398667|FG000|Overall Study|Transfer to another hospital|2|||
125211354|NCT01905592|450398680|FG000|Overall Study|Disease Progression|51|||
125211355|NCT01905592|450398681|FG001|Overall Study|Disease Progression|110|||
125211356|NCT01905592|450398680|FG000|Overall Study|Toxicity|1|||
125211357|NCT01905592|450398681|FG001|Overall Study|Toxicity|16|||
125211358|NCT01905592|450398680|FG000|Overall Study|Physician Decision|0|||
125211359|NCT01905592|450398681|FG001|Overall Study|Physician Decision|2|||
125211360|NCT01905592|450398680|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
125211361|NCT01905592|450398681|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
125211362|NCT01905592|450398680|FG000|Overall Study|Protocol Violation|0|||
125211363|NCT01905592|450398681|FG001|Overall Study|Protocol Violation|1|||
125211364|NCT01905592|450398680|FG000|Overall Study|Sponsor's decision|1|||
125211365|NCT01905592|450398681|FG001|Overall Study|Sponsor's decision|1|||
125578266|NCT03529773|451744440|FG032|Overall Study|Death|0|||
125578267|NCT03529773|451744441|FG033|Overall Study|Death|1|||
125578268|NCT03529773|451744442|FG034|Overall Study|Death|1|||
125578269|NCT03529773|451744443|FG035|Overall Study|Death|0|||
125211366|NCT01905592|450398680|FG000|Overall Study|Not treated|7|||
125359344|NCT01033851|450950721|FG001|Overall Study|Withdrawal by Subject|7|||
125359345|NCT02349542|450950722|FG000|Overall Study|Withdrawal by Subject|5|||
125578270|NCT03529773|451744444|FG036|Overall Study|Death|1|||
125578271|NCT03529773|451744445|FG037|Overall Study|Death|0|||
125578272|NCT03529773|451744446|FG038|Overall Study|Death|0|||
125578273|NCT03529773|451744447|FG039|Overall Study|Death|0|||
125211367|NCT01905592|450398681|FG001|Overall Study|Not treated|3|||
125211368|NCT01905592|450398680|FG000|Overall Study|Withdrawal by Subject|10|||
125211369|NCT01905592|450398681|FG001|Overall Study|Withdrawal by Subject|2|||
125211370|NCT01687283|450399674|FG000|Overall Study|Adverse Event|11|||
125211371|NCT01687283|450399675|FG001|Overall Study|Adverse Event|4|||
125211372|NCT01687283|450399674|FG000|Overall Study|Lack of Efficacy|3|||
125211373|NCT01687283|450399675|FG001|Overall Study|Lack of Efficacy|1|||
125211374|NCT01687283|450399674|FG000|Overall Study|Protocol Violation|1|||
125211375|NCT01687283|450399675|FG001|Overall Study|Protocol Violation|3|||
125211376|NCT01687283|450399674|FG000|Overall Study|protocol defined stopping criteria|8|||
125211377|NCT01687283|450399675|FG001|Overall Study|protocol defined stopping criteria|10|||
125211378|NCT01687283|450399674|FG000|Overall Study|Lost to Follow-up|1|||
125578274|NCT03529773|451744408|FG000|Overall Study|Lost to Follow-up|0|||
125578275|NCT03529773|451744409|FG001|Overall Study|Lost to Follow-up|0|||
125578276|NCT03529773|451744410|FG002|Overall Study|Lost to Follow-up|1|||
125578277|NCT03529773|451744411|FG003|Overall Study|Lost to Follow-up|0|||
125578278|NCT03529773|451744412|FG004|Overall Study|Lost to Follow-up|1|||
125578279|NCT03529773|451744413|FG005|Overall Study|Lost to Follow-up|1|||
125578280|NCT03529773|451744414|FG006|Overall Study|Lost to Follow-up|0|||
125578281|NCT03529773|451744415|FG007|Overall Study|Lost to Follow-up|0|||
125578282|NCT03529773|451744416|FG008|Overall Study|Lost to Follow-up|0|||
125578283|NCT03529773|451744417|FG009|Overall Study|Lost to Follow-up|0|||
125578284|NCT03529773|451744418|FG010|Overall Study|Lost to Follow-up|0|||
125578285|NCT03529773|451744419|FG011|Overall Study|Lost to Follow-up|0|||
125578286|NCT03529773|451744420|FG012|Overall Study|Lost to Follow-up|0|||
125578287|NCT03529773|451744421|FG013|Overall Study|Lost to Follow-up|1|||
125578288|NCT03529773|451744422|FG014|Overall Study|Lost to Follow-up|4|||
125578289|NCT03529773|451744423|FG015|Overall Study|Lost to Follow-up|1|||
125578290|NCT03529773|451744424|FG016|Overall Study|Lost to Follow-up|1|||
125578291|NCT03529773|451744425|FG017|Overall Study|Lost to Follow-up|0|||
125578292|NCT03529773|451744426|FG018|Overall Study|Lost to Follow-up|1|||
125578293|NCT03529773|451744427|FG019|Overall Study|Lost to Follow-up|1|||
125578294|NCT03529773|451744428|FG020|Overall Study|Lost to Follow-up|2|||
125578295|NCT03529773|451744429|FG021|Overall Study|Lost to Follow-up|4|||
125578296|NCT03529773|451744430|FG022|Overall Study|Lost to Follow-up|3|||
125578297|NCT03529773|451744431|FG023|Overall Study|Lost to Follow-up|4|||
125578298|NCT03529773|451744432|FG024|Overall Study|Lost to Follow-up|3|||
125578299|NCT03529773|451744433|FG025|Overall Study|Lost to Follow-up|5|||
125578300|NCT03529773|451744434|FG026|Overall Study|Lost to Follow-up|5|||
125578301|NCT03529773|451744435|FG027|Overall Study|Lost to Follow-up|0|||
125578302|NCT03529773|451744436|FG028|Overall Study|Lost to Follow-up|0|||
125578303|NCT03529773|451744437|FG029|Overall Study|Lost to Follow-up|0|||
125578304|NCT03529773|451744438|FG030|Overall Study|Lost to Follow-up|1|||
125578305|NCT03529773|451744439|FG031|Overall Study|Lost to Follow-up|0|||
125578306|NCT03529773|451744440|FG032|Overall Study|Lost to Follow-up|0|||
125578307|NCT03529773|451744441|FG033|Overall Study|Lost to Follow-up|1|||
125578308|NCT03529773|451744442|FG034|Overall Study|Lost to Follow-up|1|||
125578309|NCT03529773|451744443|FG035|Overall Study|Lost to Follow-up|0|||
125578310|NCT03529773|451744444|FG036|Overall Study|Lost to Follow-up|0|||
125578311|NCT03529773|451744445|FG037|Overall Study|Lost to Follow-up|3|||
125578312|NCT03529773|451744446|FG038|Overall Study|Lost to Follow-up|1|||
125578313|NCT03529773|451744447|FG039|Overall Study|Lost to Follow-up|1|||
125578314|NCT03529773|451744408|FG000|Overall Study|No longer meets eligibility criteria|0|||
125578315|NCT03529773|451744409|FG001|Overall Study|No longer meets eligibility criteria|0|||
125578316|NCT03529773|451744410|FG002|Overall Study|No longer meets eligibility criteria|0|||
125578317|NCT03529773|451744411|FG003|Overall Study|No longer meets eligibility criteria|0|||
125578318|NCT03529773|451744412|FG004|Overall Study|No longer meets eligibility criteria|0|||
125578319|NCT03529773|451744413|FG005|Overall Study|No longer meets eligibility criteria|0|||
125578320|NCT03529773|451744414|FG006|Overall Study|No longer meets eligibility criteria|0|||
125578321|NCT03529773|451744415|FG007|Overall Study|No longer meets eligibility criteria|0|||
125578322|NCT03529773|451744416|FG008|Overall Study|No longer meets eligibility criteria|0|||
125578323|NCT03529773|451744417|FG009|Overall Study|No longer meets eligibility criteria|0|||
125578324|NCT03529773|451744418|FG010|Overall Study|No longer meets eligibility criteria|0|||
125427521|NCT01662063|451190947|FG002|Overall Study|Other|0|||
125427522|NCT02313909|451190949|FG000|Overall Study|Consent withdrawn by participant|33|||
125578325|NCT03529773|451744419|FG011|Overall Study|No longer meets eligibility criteria|0|||
125578326|NCT03529773|451744420|FG012|Overall Study|No longer meets eligibility criteria|0|||
125578327|NCT03529773|451744421|FG013|Overall Study|No longer meets eligibility criteria|0|||
125578328|NCT03529773|451744422|FG014|Overall Study|No longer meets eligibility criteria|0|||
125578329|NCT03529773|451744423|FG015|Overall Study|No longer meets eligibility criteria|0|||
125578330|NCT03529773|451744424|FG016|Overall Study|No longer meets eligibility criteria|0|||
125578331|NCT03529773|451744425|FG017|Overall Study|No longer meets eligibility criteria|0|||
125578332|NCT03529773|451744426|FG018|Overall Study|No longer meets eligibility criteria|0|||
125578333|NCT03529773|451744427|FG019|Overall Study|No longer meets eligibility criteria|0|||
125427523|NCT02313909|451190950|FG001|Overall Study|Consent withdrawn by participant|33|||
125427524|NCT02313909|451190949|FG000|Overall Study|Lost to Follow-up|24|||
125578334|NCT03529773|451744428|FG020|Overall Study|No longer meets eligibility criteria|0|||
125578335|NCT03529773|451744429|FG021|Overall Study|No longer meets eligibility criteria|0|||
125578336|NCT03529773|451744430|FG022|Overall Study|No longer meets eligibility criteria|1|||
125578337|NCT03529773|451744431|FG023|Overall Study|No longer meets eligibility criteria|0|||
125578338|NCT03529773|451744432|FG024|Overall Study|No longer meets eligibility criteria|0|||
125578339|NCT03529773|451744433|FG025|Overall Study|No longer meets eligibility criteria|0|||
125578340|NCT03529773|451744434|FG026|Overall Study|No longer meets eligibility criteria|0|||
125578341|NCT03529773|451744435|FG027|Overall Study|No longer meets eligibility criteria|0|||
125578342|NCT03529773|451744436|FG028|Overall Study|No longer meets eligibility criteria|0|||
125427525|NCT02313909|451190950|FG001|Overall Study|Lost to Follow-up|17|||
125578343|NCT03529773|451744437|FG029|Overall Study|No longer meets eligibility criteria|0|||
125578344|NCT03529773|451744438|FG030|Overall Study|No longer meets eligibility criteria|0|||
125578345|NCT03529773|451744439|FG031|Overall Study|No longer meets eligibility criteria|0|||
125578346|NCT03529773|451744440|FG032|Overall Study|No longer meets eligibility criteria|0|||
125578347|NCT03529773|451744441|FG033|Overall Study|No longer meets eligibility criteria|0|||
125578348|NCT03529773|451744442|FG034|Overall Study|No longer meets eligibility criteria|0|||
125578349|NCT03529773|451744443|FG035|Overall Study|No longer meets eligibility criteria|0|||
125578350|NCT03529773|451744444|FG036|Overall Study|No longer meets eligibility criteria|0|||
125578351|NCT03529773|451744445|FG037|Overall Study|No longer meets eligibility criteria|0|||
125578352|NCT03529773|451744446|FG038|Overall Study|No longer meets eligibility criteria|1|||
125578353|NCT03529773|451744447|FG039|Overall Study|No longer meets eligibility criteria|0|||
125578354|NCT03529773|451744408|FG000|Overall Study|Other|0|||
125578355|NCT03529773|451744409|FG001|Overall Study|Other|0|||
125578356|NCT03529773|451744410|FG002|Overall Study|Other|0|||
125578357|NCT03529773|451744411|FG003|Overall Study|Other|0|||
125578358|NCT03529773|451744412|FG004|Overall Study|Other|0|||
125578359|NCT03529773|451744413|FG005|Overall Study|Other|0|||
125578360|NCT03529773|451744414|FG006|Overall Study|Other|0|||
125578361|NCT03529773|451744415|FG007|Overall Study|Other|0|||
125578362|NCT03529773|451744416|FG008|Overall Study|Other|0|||
125578363|NCT03529773|451744417|FG009|Overall Study|Other|0|||
125578364|NCT03529773|451744418|FG010|Overall Study|Other|0|||
125578365|NCT03529773|451744419|FG011|Overall Study|Other|0|||
125578366|NCT03529773|451744420|FG012|Overall Study|Other|1|||
125578367|NCT03529773|451744421|FG013|Overall Study|Other|0|||
125578368|NCT03529773|451744422|FG014|Overall Study|Other|2|||
125578369|NCT03529773|451744423|FG015|Overall Study|Other|0|||
125578370|NCT03529773|451744424|FG016|Overall Study|Other|0|||
125578371|NCT03529773|451744425|FG017|Overall Study|Other|3|||
125578372|NCT03529773|451744426|FG018|Overall Study|Other|0|||
125578373|NCT03529773|451744427|FG019|Overall Study|Other|0|||
125578374|NCT03529773|451744428|FG020|Overall Study|Other|1|||
125578375|NCT03529773|451744429|FG021|Overall Study|Other|0|||
125578376|NCT03529773|451744430|FG022|Overall Study|Other|1|||
125578377|NCT03529773|451744431|FG023|Overall Study|Other|0|||
125578378|NCT03529773|451744432|FG024|Overall Study|Other|3|||
125578379|NCT03529773|451744433|FG025|Overall Study|Other|2|||
125578380|NCT03529773|451744434|FG026|Overall Study|Other|2|||
125578381|NCT03529773|451744435|FG027|Overall Study|Other|0|||
125578382|NCT03529773|451744436|FG028|Overall Study|Other|0|||
125578383|NCT03529773|451744437|FG029|Overall Study|Other|0|||
125578384|NCT03529773|451744438|FG030|Overall Study|Other|0|||
125578385|NCT03529773|451744439|FG031|Overall Study|Other|0|||
125578386|NCT03529773|451744440|FG032|Overall Study|Other|0|||
125578387|NCT03529773|451744441|FG033|Overall Study|Other|0|||
125578388|NCT03529773|451744442|FG034|Overall Study|Other|1|||
125578389|NCT03529773|451744443|FG035|Overall Study|Other|1|||
125578390|NCT03529773|451744444|FG036|Overall Study|Other|0|||
125578391|NCT03529773|451744445|FG037|Overall Study|Other|0|||
125578392|NCT03529773|451744446|FG038|Overall Study|Other|0|||
125578393|NCT03529773|451744447|FG039|Overall Study|Other|0|||
125578394|NCT03529773|451744408|FG000|Overall Study|Physician Decision|0|||
125578395|NCT03529773|451744409|FG001|Overall Study|Physician Decision|0|||
125578396|NCT03529773|451744410|FG002|Overall Study|Physician Decision|0|||
125578397|NCT03529773|451744411|FG003|Overall Study|Physician Decision|0|||
125578398|NCT03529773|451744412|FG004|Overall Study|Physician Decision|0|||
125578399|NCT03529773|451744413|FG005|Overall Study|Physician Decision|0|||
125578400|NCT03529773|451744414|FG006|Overall Study|Physician Decision|0|||
125578401|NCT03529773|451744415|FG007|Overall Study|Physician Decision|0|||
125578402|NCT03529773|451744416|FG008|Overall Study|Physician Decision|0|||
125578403|NCT03529773|451744417|FG009|Overall Study|Physician Decision|0|||
125578404|NCT03529773|451744418|FG010|Overall Study|Physician Decision|0|||
125578405|NCT03529773|451744419|FG011|Overall Study|Physician Decision|0|||
125578406|NCT03529773|451744420|FG012|Overall Study|Physician Decision|0|||
125578407|NCT03529773|451744421|FG013|Overall Study|Physician Decision|0|||
125578408|NCT03529773|451744422|FG014|Overall Study|Physician Decision|0|||
125578409|NCT03529773|451744423|FG015|Overall Study|Physician Decision|0|||
125578410|NCT03529773|451744424|FG016|Overall Study|Physician Decision|0|||
125578411|NCT03529773|451744425|FG017|Overall Study|Physician Decision|0|||
125578412|NCT03529773|451744426|FG018|Overall Study|Physician Decision|0|||
125578413|NCT03529773|451744427|FG019|Overall Study|Physician Decision|1|||
125578414|NCT03529773|451744428|FG020|Overall Study|Physician Decision|1|||
125578415|NCT03529773|451744429|FG021|Overall Study|Physician Decision|0|||
125578416|NCT03529773|451744430|FG022|Overall Study|Physician Decision|0|||
125578417|NCT03529773|451744431|FG023|Overall Study|Physician Decision|0|||
125578418|NCT03529773|451744432|FG024|Overall Study|Physician Decision|0|||
125578419|NCT03529773|451744433|FG025|Overall Study|Physician Decision|0|||
125578420|NCT03529773|451744434|FG026|Overall Study|Physician Decision|0|||
125578421|NCT03529773|451744435|FG027|Overall Study|Physician Decision|0|||
125211379|NCT01687283|450399675|FG001|Overall Study|Lost to Follow-up|1|||
125578422|NCT03529773|451744436|FG028|Overall Study|Physician Decision|0|||
125578423|NCT03529773|451744437|FG029|Overall Study|Physician Decision|0|||
125211380|NCT01687283|450399674|FG000|Overall Study|Investigator discretion|2|||
125211381|NCT01687283|450399675|FG001|Overall Study|Investigator discretion|0|||
125211382|NCT01687283|450399674|FG000|Overall Study|Withdrawal by Subject|9|||
125211383|NCT01687283|450399675|FG001|Overall Study|Withdrawal by Subject|8|||
125578424|NCT03529773|451744438|FG030|Overall Study|Physician Decision|0|||
125211384|NCT00642954|450399676|FG000|Overall Study|Progressive Disease|3|||
125578425|NCT03529773|451744439|FG031|Overall Study|Physician Decision|0|||
125578426|NCT03529773|451744440|FG032|Overall Study|Physician Decision|0|||
125578427|NCT03529773|451744441|FG033|Overall Study|Physician Decision|0|||
125578428|NCT03529773|451744442|FG034|Overall Study|Physician Decision|0|||
125578429|NCT03529773|451744443|FG035|Overall Study|Physician Decision|0|||
125578430|NCT03529773|451744444|FG036|Overall Study|Physician Decision|0|||
125578431|NCT03529773|451744445|FG037|Overall Study|Physician Decision|0|||
125578432|NCT03529773|451744446|FG038|Overall Study|Physician Decision|0|||
125578433|NCT03529773|451744447|FG039|Overall Study|Physician Decision|0|||
125578434|NCT03529773|451744408|FG000|Overall Study|Protocol Violation|0|||
125211385|NCT00642954|450399677|FG001|Overall Study|Progressive Disease|3|||
125211386|NCT00642954|450399678|FG002|Overall Study|Progressive Disease|3|||
125211387|NCT00642954|450399679|FG003|Overall Study|Progressive Disease|3|||
125211388|NCT00642954|450399680|FG004|Overall Study|Progressive Disease|9|||
125211389|NCT00642954|450399676|FG000|Overall Study|Withdrawal by Subject|0|||
125211390|NCT00642954|450399677|FG001|Overall Study|Withdrawal by Subject|0|||
125211391|NCT00642954|450399678|FG002|Overall Study|Withdrawal by Subject|0|||
125211392|NCT00642954|450399679|FG003|Overall Study|Withdrawal by Subject|0|||
125211393|NCT00642954|450399680|FG004|Overall Study|Withdrawal by Subject|1|||
125211394|NCT00642954|450399676|FG000|Overall Study|Adverse Event|1|||
125211395|NCT00642954|450399677|FG001|Overall Study|Adverse Event|1|||
125211396|NCT00642954|450399678|FG002|Overall Study|Adverse Event|0|||
125211397|NCT00642954|450399679|FG003|Overall Study|Adverse Event|0|||
125211398|NCT00642954|450399680|FG004|Overall Study|Adverse Event|6|||
125211399|NCT01663857|450399681|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
125211400|NCT01663857|450399682|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
125211401|NCT01663857|450399683|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
125211402|NCT01663857|450399684|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
125211403|NCT01663857|450399681|FG000|Overall Study|Lost to Follow-up|0|||
125211404|NCT01663857|450399682|FG001|Overall Study|Lost to Follow-up|0|||
125211405|NCT01663857|450399683|FG002|Overall Study|Lost to Follow-up|3|||
125211406|NCT01663857|450399684|FG003|Overall Study|Lost to Follow-up|1|||
125211407|NCT03041467|450399685|FG000|Overall Study|Death|46|||
125359346|NCT01011738|450950723|FG000|Overall Study|Death|12|||
125578435|NCT03529773|451744409|FG001|Overall Study|Protocol Violation|0|||
125578436|NCT03529773|451744410|FG002|Overall Study|Protocol Violation|0|||
125578437|NCT03529773|451744411|FG003|Overall Study|Protocol Violation|0|||
125578438|NCT03529773|451744412|FG004|Overall Study|Protocol Violation|0|||
125578439|NCT03529773|451744413|FG005|Overall Study|Protocol Violation|0|||
125578440|NCT03529773|451744414|FG006|Overall Study|Protocol Violation|0|||
125578441|NCT03529773|451744415|FG007|Overall Study|Protocol Violation|0|||
125578442|NCT03529773|451744416|FG008|Overall Study|Protocol Violation|0|||
125578443|NCT03529773|451744417|FG009|Overall Study|Protocol Violation|0|||
125211408|NCT03041467|450399686|FG001|Overall Study|Death|39|||
125211409|NCT03041467|450399685|FG000|Overall Study|Withdrawal by Subject|36|||
125359347|NCT01011738|450950724|FG001|Overall Study|Death|3|||
125359348|NCT01011738|450950725|FG002|Overall Study|Death|0|||
125359349|NCT01011738|450950723|FG000|Overall Study|Unknown reasons|312|||
125359350|NCT01011738|450950724|FG001|Overall Study|Unknown reasons|291|||
125359351|NCT01011738|450950725|FG002|Overall Study|Unknown reasons|17|||
125578444|NCT03529773|451744418|FG010|Overall Study|Protocol Violation|0|||
125578445|NCT03529773|451744419|FG011|Overall Study|Protocol Violation|0|||
125211410|NCT03041467|450399686|FG001|Overall Study|Withdrawal by Subject|37|||
125211411|NCT03041467|450399685|FG000|Overall Study|Lost to Follow-up|6|||
125211412|NCT03041467|450399686|FG001|Overall Study|Lost to Follow-up|8|||
125211413|NCT03041467|450399685|FG000|Overall Study|Declined consent for study extension|21|||
125211414|NCT03041467|450399686|FG001|Overall Study|Declined consent for study extension|33|||
125359352|NCT01163266|450950728|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
125359353|NCT01163266|450950729|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
125359354|NCT01163266|450950730|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
125359355|NCT01163266|450950728|FG000|Overall Study|Lack of Efficacy|1|||
125578446|NCT03529773|451744420|FG012|Overall Study|Protocol Violation|0|||
125578447|NCT03529773|451744421|FG013|Overall Study|Protocol Violation|0|||
125578448|NCT03529773|451744422|FG014|Overall Study|Protocol Violation|0|||
125578449|NCT03529773|451744423|FG015|Overall Study|Protocol Violation|0|||
125578450|NCT03529773|451744424|FG016|Overall Study|Protocol Violation|0|||
125578451|NCT03529773|451744425|FG017|Overall Study|Protocol Violation|0|||
125211415|NCT03041467|450399685|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
125211416|NCT03041467|450399686|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
125211417|NCT02732015|450399687|FG000|Overall Study|Lost to Follow-up|0|||
125211418|NCT02732015|450399688|FG001|Overall Study|Lost to Follow-up|1|||
125211419|NCT03052920|450399689|FG000|Overall Study|Withdrawal by Subject|1|||
125578452|NCT03529773|451744426|FG018|Overall Study|Protocol Violation|0|||
125578453|NCT03529773|451744427|FG019|Overall Study|Protocol Violation|0|||
125578454|NCT03529773|451744428|FG020|Overall Study|Protocol Violation|0|||
125578455|NCT03529773|451744429|FG021|Overall Study|Protocol Violation|0|||
125578456|NCT03529773|451744430|FG022|Overall Study|Protocol Violation|0|||
125578457|NCT03529773|451744431|FG023|Overall Study|Protocol Violation|0|||
125578458|NCT03529773|451744432|FG024|Overall Study|Protocol Violation|0|||
125578459|NCT03529773|451744433|FG025|Overall Study|Protocol Violation|0|||
125578460|NCT03529773|451744434|FG026|Overall Study|Protocol Violation|0|||
125578461|NCT03529773|451744435|FG027|Overall Study|Protocol Violation|0|||
125578462|NCT03529773|451744436|FG028|Overall Study|Protocol Violation|0|||
125578463|NCT03529773|451744437|FG029|Overall Study|Protocol Violation|0|||
125578464|NCT03529773|451744438|FG030|Overall Study|Protocol Violation|1|||
125578465|NCT03529773|451744439|FG031|Overall Study|Protocol Violation|0|||
125578466|NCT03529773|451744440|FG032|Overall Study|Protocol Violation|0|||
125578467|NCT03529773|451744441|FG033|Overall Study|Protocol Violation|0|||
125578468|NCT03529773|451744442|FG034|Overall Study|Protocol Violation|0|||
125578469|NCT03529773|451744443|FG035|Overall Study|Protocol Violation|0|||
125578470|NCT03529773|451744444|FG036|Overall Study|Protocol Violation|0|||
125578471|NCT03529773|451744445|FG037|Overall Study|Protocol Violation|0|||
125578472|NCT03529773|451744446|FG038|Overall Study|Protocol Violation|0|||
125578473|NCT03529773|451744447|FG039|Overall Study|Protocol Violation|0|||
125578474|NCT03529773|451744408|FG000|Overall Study|Withdrawal by Subject|0|||
125578475|NCT03529773|451744409|FG001|Overall Study|Withdrawal by Subject|0|||
125578476|NCT03529773|451744410|FG002|Overall Study|Withdrawal by Subject|0|||
125578477|NCT03529773|451744411|FG003|Overall Study|Withdrawal by Subject|0|||
125578478|NCT03529773|451744412|FG004|Overall Study|Withdrawal by Subject|0|||
125578479|NCT03529773|451744413|FG005|Overall Study|Withdrawal by Subject|0|||
125578480|NCT03529773|451744414|FG006|Overall Study|Withdrawal by Subject|0|||
125578481|NCT03529773|451744415|FG007|Overall Study|Withdrawal by Subject|1|||
125578482|NCT03529773|451744416|FG008|Overall Study|Withdrawal by Subject|0|||
125578483|NCT03529773|451744417|FG009|Overall Study|Withdrawal by Subject|1|||
125578484|NCT03529773|451744418|FG010|Overall Study|Withdrawal by Subject|1|||
125578485|NCT03529773|451744419|FG011|Overall Study|Withdrawal by Subject|0|||
125578486|NCT03529773|451744420|FG012|Overall Study|Withdrawal by Subject|0|||
125578487|NCT03529773|451744421|FG013|Overall Study|Withdrawal by Subject|0|||
125578488|NCT03529773|451744422|FG014|Overall Study|Withdrawal by Subject|0|||
125578489|NCT03529773|451744423|FG015|Overall Study|Withdrawal by Subject|3|||
125578490|NCT03529773|451744424|FG016|Overall Study|Withdrawal by Subject|0|||
125578491|NCT03529773|451744425|FG017|Overall Study|Withdrawal by Subject|2|||
125578492|NCT03529773|451744426|FG018|Overall Study|Withdrawal by Subject|3|||
125578493|NCT03529773|451744427|FG019|Overall Study|Withdrawal by Subject|1|||
125578494|NCT03529773|451744428|FG020|Overall Study|Withdrawal by Subject|3|||
125578495|NCT03529773|451744429|FG021|Overall Study|Withdrawal by Subject|1|||
125578496|NCT03529773|451744430|FG022|Overall Study|Withdrawal by Subject|1|||
125578497|NCT03529773|451744431|FG023|Overall Study|Withdrawal by Subject|2|||
125578498|NCT03529773|451744432|FG024|Overall Study|Withdrawal by Subject|2|||
125578499|NCT03529773|451744433|FG025|Overall Study|Withdrawal by Subject|4|||
125578500|NCT03529773|451744434|FG026|Overall Study|Withdrawal by Subject|2|||
125578501|NCT03529773|451744435|FG027|Overall Study|Withdrawal by Subject|1|||
125578502|NCT03529773|451744436|FG028|Overall Study|Withdrawal by Subject|1|||
125578503|NCT03529773|451744437|FG029|Overall Study|Withdrawal by Subject|0|||
125578504|NCT03529773|451744438|FG030|Overall Study|Withdrawal by Subject|0|||
125578505|NCT03529773|451744439|FG031|Overall Study|Withdrawal by Subject|0|||
125578506|NCT03529773|451744440|FG032|Overall Study|Withdrawal by Subject|0|||
125578507|NCT03529773|451744441|FG033|Overall Study|Withdrawal by Subject|0|||
125578508|NCT03529773|451744442|FG034|Overall Study|Withdrawal by Subject|1|||
125578509|NCT03529773|451744443|FG035|Overall Study|Withdrawal by Subject|2|||
125578510|NCT03529773|451744444|FG036|Overall Study|Withdrawal by Subject|0|||
125578511|NCT03529773|451744445|FG037|Overall Study|Withdrawal by Subject|2|||
125578512|NCT03529773|451744446|FG038|Overall Study|Withdrawal by Subject|1|||
125578513|NCT03529773|451744447|FG039|Overall Study|Withdrawal by Subject|1|||
125578514|NCT03529773|451744408|FG000|Overall Study|Screen Failure|0|||
125427526|NCT00293267|451190956|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
125578515|NCT03529773|451744409|FG001|Overall Study|Screen Failure|0|||
125578516|NCT03529773|451744410|FG002|Overall Study|Screen Failure|0|||
125578517|NCT03529773|451744411|FG003|Overall Study|Screen Failure|0|||
125578518|NCT03529773|451744412|FG004|Overall Study|Screen Failure|0|||
125578519|NCT03529773|451744413|FG005|Overall Study|Screen Failure|0|||
125578520|NCT03529773|451744414|FG006|Overall Study|Screen Failure|0|||
125578521|NCT03529773|451744415|FG007|Overall Study|Screen Failure|0|||
125578522|NCT03529773|451744416|FG008|Overall Study|Screen Failure|0|||
125578523|NCT03529773|451744417|FG009|Overall Study|Screen Failure|0|||
125578524|NCT03529773|451744418|FG010|Overall Study|Screen Failure|0|||
125578525|NCT03529773|451744419|FG011|Overall Study|Screen Failure|0|||
125578526|NCT03529773|451744420|FG012|Overall Study|Screen Failure|0|||
125578527|NCT03529773|451744421|FG013|Overall Study|Screen Failure|0|||
125578528|NCT03529773|451744422|FG014|Overall Study|Screen Failure|0|||
125578529|NCT03529773|451744423|FG015|Overall Study|Screen Failure|0|||
125578530|NCT03529773|451744424|FG016|Overall Study|Screen Failure|0|||
125578531|NCT03529773|451744425|FG017|Overall Study|Screen Failure|0|||
125578532|NCT03529773|451744426|FG018|Overall Study|Screen Failure|0|||
125578533|NCT03529773|451744427|FG019|Overall Study|Screen Failure|0|||
125578534|NCT03529773|451744428|FG020|Overall Study|Screen Failure|0|||
125578535|NCT03529773|451744429|FG021|Overall Study|Screen Failure|0|||
125578536|NCT03529773|451744430|FG022|Overall Study|Screen Failure|0|||
125578537|NCT03529773|451744431|FG023|Overall Study|Screen Failure|0|||
125578538|NCT03529773|451744432|FG024|Overall Study|Screen Failure|0|||
125578539|NCT03529773|451744433|FG025|Overall Study|Screen Failure|0|||
125578540|NCT03529773|451744434|FG026|Overall Study|Screen Failure|0|||
125578541|NCT03529773|451744435|FG027|Overall Study|Screen Failure|0|||
125578542|NCT03529773|451744436|FG028|Overall Study|Screen Failure|0|||
125578543|NCT03529773|451744437|FG029|Overall Study|Screen Failure|0|||
125578544|NCT03529773|451744438|FG030|Overall Study|Screen Failure|0|||
125578545|NCT03529773|451744439|FG031|Overall Study|Screen Failure|0|||
125578546|NCT03529773|451744440|FG032|Overall Study|Screen Failure|0|||
125578547|NCT03529773|451744441|FG033|Overall Study|Screen Failure|0|||
125578548|NCT03529773|451744442|FG034|Overall Study|Screen Failure|0|||
125578549|NCT03529773|451744443|FG035|Overall Study|Screen Failure|0|||
125578550|NCT03529773|451744444|FG036|Overall Study|Screen Failure|1|||
125578551|NCT03529773|451744445|FG037|Overall Study|Screen Failure|1|||
125578552|NCT03529773|451744446|FG038|Overall Study|Screen Failure|0|||
125578553|NCT03529773|451744447|FG039|Overall Study|Screen Failure|1|||
125578554|NCT03529773|451744408|FG000|Overall Study|Randomized but not vaccinated|0|||
125578555|NCT03529773|451744409|FG001|Overall Study|Randomized but not vaccinated|0|||
125578556|NCT03529773|451744410|FG002|Overall Study|Randomized but not vaccinated|0|||
125578557|NCT03529773|451744411|FG003|Overall Study|Randomized but not vaccinated|0|||
125578558|NCT03529773|451744412|FG004|Overall Study|Randomized but not vaccinated|0|||
125578559|NCT03529773|451744413|FG005|Overall Study|Randomized but not vaccinated|0|||
125578560|NCT03529773|451744414|FG006|Overall Study|Randomized but not vaccinated|0|||
125578561|NCT03529773|451744415|FG007|Overall Study|Randomized but not vaccinated|0|||
125578562|NCT03529773|451744416|FG008|Overall Study|Randomized but not vaccinated|0|||
125578563|NCT03529773|451744417|FG009|Overall Study|Randomized but not vaccinated|0|||
125578564|NCT03529773|451744418|FG010|Overall Study|Randomized but not vaccinated|0|||
125578565|NCT03529773|451744419|FG011|Overall Study|Randomized but not vaccinated|0|||
125578566|NCT03529773|451744420|FG012|Overall Study|Randomized but not vaccinated|0|||
125578567|NCT03529773|451744421|FG013|Overall Study|Randomized but not vaccinated|0|||
125578568|NCT03529773|451744422|FG014|Overall Study|Randomized but not vaccinated|0|||
125578569|NCT03529773|451744423|FG015|Overall Study|Randomized but not vaccinated|0|||
125578570|NCT03529773|451744424|FG016|Overall Study|Randomized but not vaccinated|0|||
125578571|NCT03529773|451744425|FG017|Overall Study|Randomized but not vaccinated|1|||
125578572|NCT03529773|451744426|FG018|Overall Study|Randomized but not vaccinated|0|||
125578573|NCT03529773|451744427|FG019|Overall Study|Randomized but not vaccinated|0|||
125578574|NCT03529773|451744428|FG020|Overall Study|Randomized but not vaccinated|0|||
125578575|NCT03529773|451744429|FG021|Overall Study|Randomized but not vaccinated|0|||
125578576|NCT03529773|451744430|FG022|Overall Study|Randomized but not vaccinated|0|||
125578577|NCT03529773|451744431|FG023|Overall Study|Randomized but not vaccinated|0|||
125578578|NCT03529773|451744432|FG024|Overall Study|Randomized but not vaccinated|0|||
125578579|NCT03529773|451744433|FG025|Overall Study|Randomized but not vaccinated|0|||
125578580|NCT03529773|451744434|FG026|Overall Study|Randomized but not vaccinated|0|||
125578581|NCT03529773|451744435|FG027|Overall Study|Randomized but not vaccinated|1|||
125578582|NCT03529773|451744436|FG028|Overall Study|Randomized but not vaccinated|0|||
125578583|NCT03529773|451744437|FG029|Overall Study|Randomized but not vaccinated|0|||
125578584|NCT03529773|451744438|FG030|Overall Study|Randomized but not vaccinated|0|||
125578585|NCT03529773|451744439|FG031|Overall Study|Randomized but not vaccinated|0|||
125578586|NCT03529773|451744440|FG032|Overall Study|Randomized but not vaccinated|0|||
125578587|NCT03529773|451744441|FG033|Overall Study|Randomized but not vaccinated|0|||
125578588|NCT03529773|451744442|FG034|Overall Study|Randomized but not vaccinated|0|||
125578589|NCT03529773|451744443|FG035|Overall Study|Randomized but not vaccinated|0|||
125578590|NCT03529773|451744444|FG036|Overall Study|Randomized but not vaccinated|0|||
125359356|NCT01163266|450950729|FG001|Overall Study|Lack of Efficacy|3|||
125578591|NCT03529773|451744445|FG037|Overall Study|Randomized but not vaccinated|0|||
125578592|NCT03529773|451744446|FG038|Overall Study|Randomized but not vaccinated|0|||
125578593|NCT03529773|451744447|FG039|Overall Study|Randomized but not vaccinated|0|||
125578594|NCT01340209|451744448|FG000|Overall Study|Adverse Event|1|||
125578595|NCT01340209|451744449|FG001|Overall Study|Adverse Event|1|||
125578596|NCT01340209|451744450|FG002|Overall Study|Adverse Event|2|||
125578597|NCT01340209|451744448|FG000|Overall Study|Protocol Violation|1|||
125578598|NCT01340209|451744449|FG001|Overall Study|Protocol Violation|2|||
125578599|NCT01340209|451744450|FG002|Overall Study|Protocol Violation|1|||
125578600|NCT01340209|451744448|FG000|Overall Study|Withdrawal by Subject|0|||
125578601|NCT01340209|451744449|FG001|Overall Study|Withdrawal by Subject|0|||
125578602|NCT01340209|451744450|FG002|Overall Study|Withdrawal by Subject|1|||
125578603|NCT01340209|451744448|FG000|Overall Study|Other reason not defined above|3|||
125578604|NCT01340209|451744449|FG001|Overall Study|Other reason not defined above|5|||
125578605|NCT01340209|451744450|FG002|Overall Study|Other reason not defined above|4|||
125578606|NCT01537211|451744455|FG000|Overall Study|Lost to Follow-up|0|||
125578607|NCT01537211|451744456|FG001|Overall Study|Lost to Follow-up|1|||
125578608|NCT02475655|451744459|FG000|Overall Study|Lost to Follow-up|0|||
125578609|NCT02475655|451744460|FG001|Overall Study|Lost to Follow-up|1|||
125578610|NCT00257010|451744482|FG000|Overall Study|Lack of Efficacy|11|||
125578611|NCT00257010|451744482|FG000|Overall Study|Lost to Follow-up|53|||
125578612|NCT00257010|451744482|FG000|Overall Study|Withdrawal by Subject|34|||
125578613|NCT00257010|451744482|FG000|Overall Study|Adverse Event|10|||
125578614|NCT00257010|451744482|FG000|Overall Study|various|11|||
125578615|NCT00257010|451744482|FG000|Overall Study|no headache reported|9|||
125578616|NCT00608985|451744485|FG000|Overall Study|Adverse Event|2|||
125578617|NCT00608985|451744486|FG001|Overall Study|Adverse Event|7|||
125578618|NCT00608985|451744487|FG002|Overall Study|Adverse Event|4|||
125578619|NCT00608985|451744488|FG003|Overall Study|Adverse Event|6|||
125578620|NCT00608985|451744485|FG000|Overall Study|Administrative/Other|7|||
125578621|NCT00608985|451744486|FG001|Overall Study|Administrative/Other|4|||
125578622|NCT00608985|451744487|FG002|Overall Study|Administrative/Other|1|||
125578623|NCT00608985|451744488|FG003|Overall Study|Administrative/Other|2|||
125578624|NCT00608985|451744485|FG000|Overall Study|Withdrawal of Consent|5|||
125578625|NCT00608985|451744486|FG001|Overall Study|Withdrawal of Consent|1|||
125578626|NCT00608985|451744487|FG002|Overall Study|Withdrawal of Consent|1|||
125578627|NCT00608985|451744488|FG003|Overall Study|Withdrawal of Consent|1|||
125578628|NCT00608985|451744485|FG000|Overall Study|Lost to Follow-up|2|||
125578629|NCT00608985|451744486|FG001|Overall Study|Lost to Follow-up|1|||
125578630|NCT00608985|451744487|FG002|Overall Study|Lost to Follow-up|0|||
125578631|NCT00608985|451744488|FG003|Overall Study|Lost to Follow-up|0|||
125578632|NCT00323557|451744489|FG000|Overall Study|Physician Decision|1|||
125578633|NCT00323557|451744490|FG001|Overall Study|Physician Decision|0|||
125578634|NCT01699087|451744493|FG000|Overall Study|Lost to Follow-up|7|||
125578635|NCT01699087|451744493|FG000|Overall Study|Screen failure (prior to treatment)|15|||
125578636|NCT01699087|451744493|FG000|Overall Study|Unable to make future visits|2|||
125578637|NCT03021642|451744496|FG000|Washout Period (21 Days)|Adverse Event|1|||
125578638|NCT03021642|451744497|FG001|Washout Period (21 Days)|Adverse Event|1|||
125578639|NCT00441545|451744498|FG000|First Intervention|Adverse Event|6|||
125578640|NCT00441545|451744499|FG001|First Intervention|Adverse Event|5|||
125578641|NCT00441545|451744498|FG000|First Intervention|Protocol Violation|2|||
125578642|NCT00441545|451744499|FG001|First Intervention|Protocol Violation|2|||
125578643|NCT00441545|451744498|FG000|First Intervention|Withdrawal by Subject|3|||
125578644|NCT00441545|451744499|FG001|First Intervention|Withdrawal by Subject|3|||
125427527|NCT00293267|451190957|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
125427528|NCT00293267|451190956|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
125427529|NCT00293267|451190957|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
125427530|NCT00293267|451190956|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
125427531|NCT00293267|451190957|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
125427532|NCT00293267|451190956|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
125427533|NCT00293267|451190957|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
125427534|NCT00293267|451190956|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
125427535|NCT00293267|451190957|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
125427536|NCT00293267|451190956|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
125427537|NCT00293267|451190957|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
125427538|NCT00293267|451190956|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
125427539|NCT00293267|451190957|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
125427540|NCT00293267|451190956|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
125427541|NCT00293267|451190957|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
125427542|NCT00293267|451190956|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
125427543|NCT00293267|451190957|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
125578645|NCT00441545|451744498|FG000|First Intervention|Kidney transplant|1|||
125578646|NCT00441545|451744499|FG001|First Intervention|Kidney transplant|1|||
125578647|NCT00441545|451744498|FG000|First Intervention|Lack of Efficacy|2|||
125578648|NCT00441545|451744499|FG001|First Intervention|Lack of Efficacy|0|||
125578649|NCT00441545|451744498|FG000|First Intervention|Subject exceeded safety criteria|0|||
125578650|NCT00441545|451744499|FG001|First Intervention|Subject exceeded safety criteria|1|||
125578651|NCT00441545|451744498|FG000|First Intervention|Subject met an exclusionary criteria|1|||
125578652|NCT00441545|451744499|FG001|First Intervention|Subject met an exclusionary criteria|0|||
125578653|NCT00441545|451744498|FG000|First Intervention|Extended hospitalization|1|||
125578654|NCT00441545|451744499|FG001|First Intervention|Extended hospitalization|0|||
125578655|NCT00441545|451744498|FG000|First Intervention|Site error|1|||
125578656|NCT00441545|451744499|FG001|First Intervention|Site error|0|||
125578657|NCT00441545|451744498|FG000|First Intervention|Sponsor's request|1|||
125578658|NCT00441545|451744499|FG001|First Intervention|Sponsor's request|0|||
125578659|NCT00441545|451744498|FG000|Second Intervention|Adverse Event|5|||
125578660|NCT00441545|451744499|FG001|Second Intervention|Adverse Event|2|||
125578661|NCT00441545|451744498|FG000|Second Intervention|Protocol Violation|4|||
125578662|NCT00441545|451744499|FG001|Second Intervention|Protocol Violation|1|||
125578663|NCT00441545|451744498|FG000|Second Intervention|Withdrawal by Subject|1|||
125578664|NCT00441545|451744499|FG001|Second Intervention|Withdrawal by Subject|1|||
125578665|NCT00441545|451744498|FG000|Second Intervention|Kidney Transplant|1|||
125578666|NCT00441545|451744499|FG001|Second Intervention|Kidney Transplant|1|||
125578667|NCT00441545|451744498|FG000|Second Intervention|Lack of Efficacy|0|||
125578668|NCT00441545|451744499|FG001|Second Intervention|Lack of Efficacy|1|||
125578669|NCT00441545|451744498|FG000|Second Intervention|Subject exceeded safety criteria|1|||
125578670|NCT00441545|451744499|FG001|Second Intervention|Subject exceeded safety criteria|0|||
125578671|NCT00441545|451744498|FG000|Second Intervention|Subject moved|0|||
125578672|NCT00441545|451744499|FG001|Second Intervention|Subject moved|1|||
125578673|NCT02347176|451744500|FG000|Overall Study|Lost to Follow-up|2|||
125578674|NCT02347176|451744501|FG001|Overall Study|Lost to Follow-up|3|||
125578675|NCT02347176|451744502|FG002|Overall Study|Lost to Follow-up|1|||
125578676|NCT02347176|451744503|FG003|Overall Study|Lost to Follow-up|1|||
125578677|NCT02347176|451744500|FG000|Overall Study|Withdrawal by Subject|9|||
125578678|NCT02347176|451744501|FG001|Overall Study|Withdrawal by Subject|5|||
125578679|NCT02347176|451744502|FG002|Overall Study|Withdrawal by Subject|5|||
125578680|NCT02347176|451744503|FG003|Overall Study|Withdrawal by Subject|3|||
125578681|NCT02347176|451744500|FG000|Overall Study|Other|1|||
125578682|NCT02347176|451744501|FG001|Overall Study|Other|2|||
125427544|NCT00293267|451190956|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
125427545|NCT00293267|451190957|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
125427546|NCT00293267|451190956|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
125427547|NCT00293267|451190957|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
125427548|NCT00293267|451190956|FG000|Extension - Double-Blind Week 49-156|Death|3|||
125427549|NCT00293267|451190957|FG001|Extension - Double-Blind Week 49-156|Death|0|||
125427550|NCT00293267|451190956|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
125427551|NCT00293267|451190957|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
125427552|NCT00293267|451190956|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
125427553|NCT00293267|451190957|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
125427554|NCT00293267|451190956|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
125427555|NCT00293267|451190957|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
125427556|NCT00293267|451190956|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
125427557|NCT00293267|451190957|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
125427558|NCT00293267|451190956|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
125427559|NCT00293267|451190957|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
125427560|NCT00293267|451190956|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
125427561|NCT00293267|451190957|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
125427562|NCT00293267|451190956|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
125427563|NCT00293267|451190957|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
125427564|NCT00293267|451190956|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
125427565|NCT00293267|451190957|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
125427566|NCT00293267|451190956|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
125427567|NCT00293267|451190957|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
125427568|NCT00293267|451190956|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
125427569|NCT00293267|451190957|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
125427570|NCT00293267|451190956|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
125578683|NCT02347176|451744502|FG002|Overall Study|Other|2|||
125578684|NCT02347176|451744503|FG003|Overall Study|Other|0|||
125578685|NCT02474082|451744504|FG000|Overall Study|Adverse Event|2|||
125578686|NCT02474082|451744505|FG001|Overall Study|Adverse Event|32|||
125578687|NCT02474082|451744504|FG000|Overall Study|Withdrawal of informed consent|1|||
125578688|NCT02474082|451744505|FG001|Overall Study|Withdrawal of informed consent|11|||
125578689|NCT02474082|451744504|FG000|Overall Study|Lost to Follow-up|2|||
125578690|NCT02474082|451744505|FG001|Overall Study|Lost to Follow-up|2|||
125578691|NCT02474082|451744504|FG000|Overall Study|Dose tapering not achieved|0|||
125578692|NCT02474082|451744505|FG001|Overall Study|Dose tapering not achieved|4|||
125578693|NCT02474082|451744504|FG000|Overall Study|Participant/guardian decision|1|||
125578694|NCT02474082|451744505|FG001|Overall Study|Participant/guardian decision|2|||
125578695|NCT02474082|451744504|FG000|Overall Study|Non-compliance with study treatment|0|||
125578696|NCT02474082|451744505|FG001|Overall Study|Non-compliance with study treatment|2|||
125578697|NCT02474082|451744504|FG000|Overall Study|Protocol deviation|0|||
125578698|NCT02474082|451744505|FG001|Overall Study|Protocol deviation|1|||
125578699|NCT00744874|451744508|FG000|Overall Study|Lost to Follow-up|1|||
125578700|NCT00744874|451744508|FG000|Overall Study|Withdrawal by Subject|1|||
125578701|NCT00744874|451744508|FG000|Overall Study|Study Device not available at procedure|1|||
125578702|NCT00744874|451744508|FG000|Overall Study|Unable to accomodate schedule|1|||
125578703|NCT01017952|451744509|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
125578704|NCT01017952|451744510|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125578705|NCT01017952|451744511|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125578706|NCT01017952|451744512|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125578707|NCT01017952|451744513|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125578708|NCT01017952|451744509|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
125578709|NCT01017952|451744510|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
125578710|NCT01017952|451744511|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
125578711|NCT01017952|451744512|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
125578712|NCT01017952|451744513|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
125578713|NCT01017952|451744509|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
125578714|NCT01017952|451744510|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
125578715|NCT01017952|451744511|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
125578716|NCT01017952|451744512|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
125578717|NCT01017952|451744513|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
125578718|NCT01017952|451744509|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
125578719|NCT01017952|451744510|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125578720|NCT01017952|451744511|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125578721|NCT01017952|451744512|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125578722|NCT01017952|451744513|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125578723|NCT01017952|451744509|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
125578724|NCT01017952|451744510|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
125578725|NCT01017952|451744511|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
125578726|NCT01017952|451744512|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
125578727|NCT01017952|451744513|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
125578728|NCT01017952|451744509|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
125578729|NCT01017952|451744510|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125578730|NCT01017952|451744511|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125578731|NCT01017952|451744512|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125578732|NCT01017952|451744513|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125578733|NCT01017952|451744509|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
125578734|NCT01017952|451744510|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
125578735|NCT01017952|451744511|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
125578736|NCT01017952|451744512|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
125578737|NCT01017952|451744513|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
125578738|NCT01017952|451744509|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125578739|NCT01017952|451744510|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
125578740|NCT01017952|451744511|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
125578741|NCT01017952|451744512|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
125578742|NCT01017952|451744513|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
125578743|NCT01017952|451744509|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
125578744|NCT01017952|451744510|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
125578745|NCT01017952|451744511|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
125578746|NCT01017952|451744512|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
125578747|NCT01017952|451744513|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
125578748|NCT01017952|451744509|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
125578749|NCT01017952|451744510|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
125578750|NCT01017952|451744511|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
125578751|NCT01017952|451744512|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
125578752|NCT01017952|451744513|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
125578753|NCT01017952|451744509|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
125578754|NCT01017952|451744510|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
125578755|NCT01017952|451744511|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
125578756|NCT01017952|451744512|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
125578757|NCT01017952|451744513|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
125578758|NCT01017952|451744509|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
125578759|NCT01017952|451744510|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
125578760|NCT01017952|451744511|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
125578761|NCT01017952|451744512|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
125578762|NCT01017952|451744513|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
125578763|NCT01017952|451744509|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125578764|NCT01017952|451744510|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
125578765|NCT01017952|451744511|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
125578766|NCT01017952|451744512|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
125578767|NCT01017952|451744513|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
125578768|NCT01017952|451744509|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
125578769|NCT01017952|451744510|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
125578770|NCT01017952|451744511|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
125578771|NCT01017952|451744512|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
125578772|NCT01017952|451744513|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
125578773|NCT01064167|451744514|FG000|Overall Study|Protocol Violation|14|||
125578774|NCT01064167|451744515|FG001|Overall Study|Protocol Violation|15|||
125578775|NCT02902120|451744516|FG000|Overall Study|Lack of Efficacy|1|||
125578776|NCT02435914|451744517|FG000|Overall Study|Ocular Adverse Event|1|||
125578777|NCT02435914|451744518|FG001|Overall Study|Ocular Adverse Event|0|||
125578778|NCT02435914|451744519|FG002|Overall Study|Ocular Adverse Event|0|||
125578779|NCT02435914|451744520|FG003|Overall Study|Ocular Adverse Event|0|||
125578780|NCT02435914|451744517|FG000|Overall Study|Withdrawal by Subject|0|||
125578781|NCT02435914|451744518|FG001|Overall Study|Withdrawal by Subject|1|||
125578782|NCT02435914|451744519|FG002|Overall Study|Withdrawal by Subject|0|||
125578783|NCT02435914|451744520|FG003|Overall Study|Withdrawal by Subject|0|||
125578784|NCT02435914|451744517|FG000|Overall Study|Other Miscellaneous Reason|0|||
125578785|NCT02435914|451744518|FG001|Overall Study|Other Miscellaneous Reason|0|||
125578786|NCT02435914|451744519|FG002|Overall Study|Other Miscellaneous Reason|1|||
125578787|NCT02435914|451744520|FG003|Overall Study|Other Miscellaneous Reason|0|||
125578788|NCT01353703|451744521|FG000|Overall Study|Migrated/moved from study area|1|||
125578789|NCT01353703|451744522|FG001|Overall Study|Migrated/moved from study area|0|||
125578790|NCT02286947|451744538|FG000|Overall Study|Withdrawal by Subject|2|||
125578791|NCT03979274|451744539|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125578792|NCT03979274|451744540|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125578793|NCT01665144|451744541|FG000|Core Part|Withdrawal by Subject|96|||
125578794|NCT01665144|451744542|FG001|Core Part|Withdrawal by Subject|77|||
125578795|NCT01665144|451744543|FG002|Core Part|Withdrawal by Subject|0|||
125578796|NCT01665144|451744541|FG000|Core Part|Adverse Event|45|||
125578797|NCT01665144|451744542|FG001|Core Part|Adverse Event|18|||
125578798|NCT01665144|451744543|FG002|Core Part|Adverse Event|0|||
125578799|NCT01665144|451744541|FG000|Core Part|Lack of Efficacy|16|||
125578800|NCT01665144|451744542|FG001|Core Part|Lack of Efficacy|11|||
125578801|NCT01665144|451744543|FG002|Core Part|Lack of Efficacy|0|||
125578802|NCT01665144|451744541|FG000|Core Part|Lost to Follow-up|9|||
125578803|NCT01665144|451744542|FG001|Core Part|Lost to Follow-up|8|||
125578804|NCT01665144|451744543|FG002|Core Part|Lost to Follow-up|0|||
125578805|NCT01665144|451744541|FG000|Core Part|Physician Decision|13|||
125578806|NCT01665144|451744542|FG001|Core Part|Physician Decision|1|||
125578807|NCT01665144|451744543|FG002|Core Part|Physician Decision|0|||
125578808|NCT01665144|451744541|FG000|Core Part|Progressive disease|8|||
125578809|NCT01665144|451744542|FG001|Core Part|Progressive disease|4|||
125578810|NCT01665144|451744543|FG002|Core Part|Progressive disease|0|||
125578811|NCT01665144|451744541|FG000|Core Part|Non-compliance with study treatment|5|||
125578812|NCT01665144|451744542|FG001|Core Part|Non-compliance with study treatment|0|||
125578813|NCT01665144|451744543|FG002|Core Part|Non-compliance with study treatment|0|||
125578814|NCT01665144|451744541|FG000|Core Part|Death|3|||
125578815|NCT01665144|451744542|FG001|Core Part|Death|1|||
125578816|NCT01665144|451744543|FG002|Core Part|Death|0|||
125578817|NCT01665144|451744541|FG000|Core Part|Protocol deviation|3|||
125578818|NCT01665144|451744542|FG001|Core Part|Protocol deviation|1|||
125578819|NCT01665144|451744543|FG002|Core Part|Protocol deviation|0|||
125578820|NCT01665144|451744541|FG000|Core Part|New therapy for study indication|2|||
125578821|NCT01665144|451744542|FG001|Core Part|New therapy for study indication|1|||
125578822|NCT01665144|451744543|FG002|Core Part|New therapy for study indication|0|||
125578823|NCT01665144|451744541|FG000|Core Part|Technical problems|2|||
125578824|NCT01665144|451744542|FG001|Core Part|Technical problems|0|||
125578825|NCT01665144|451744543|FG002|Core Part|Technical problems|0|||
125578826|NCT01665144|451744541|FG000|Extension Part|Patient/guardian decision|180|||
125578827|NCT01665144|451744542|FG001|Extension Part|Patient/guardian decision|0|||
125578828|NCT01665144|451744543|FG002|Extension Part|Patient/guardian decision|98|||
125578829|NCT01665144|451744541|FG000|Extension Part|Adverse Event|104|||
125578830|NCT01665144|451744542|FG001|Extension Part|Adverse Event|0|||
125578831|NCT01665144|451744543|FG002|Extension Part|Adverse Event|59|||
125578832|NCT01665144|451744541|FG000|Extension Part|Study closed early|42|||
125578833|NCT01665144|451744542|FG001|Extension Part|Study closed early|0|||
125578834|NCT01665144|451744543|FG002|Extension Part|Study closed early|19|||
125578835|NCT01665144|451744541|FG000|Extension Part|Progressive disease|36|||
125578836|NCT01665144|451744542|FG001|Extension Part|Progressive disease|0|||
125578837|NCT01665144|451744543|FG002|Extension Part|Progressive disease|14|||
125578838|NCT01665144|451744541|FG000|Extension Part|Lack of Efficacy|37|||
125578839|NCT01665144|451744542|FG001|Extension Part|Lack of Efficacy|0|||
125578840|NCT01665144|451744543|FG002|Extension Part|Lack of Efficacy|12|||
125578841|NCT01665144|451744541|FG000|Extension Part|Physician Decision|29|||
125578842|NCT01665144|451744542|FG001|Extension Part|Physician Decision|0|||
125578843|NCT01665144|451744543|FG002|Extension Part|Physician Decision|13|||
125578844|NCT01665144|451744541|FG000|Extension Part|Technical problems|20|||
125578845|NCT01665144|451744542|FG001|Extension Part|Technical problems|0|||
125578846|NCT01665144|451744543|FG002|Extension Part|Technical problems|8|||
125578847|NCT01665144|451744541|FG000|Extension Part|Death|20|||
125578848|NCT01665144|451744542|FG001|Extension Part|Death|0|||
125578849|NCT01665144|451744543|FG002|Extension Part|Death|4|||
125578850|NCT01665144|451744541|FG000|Extension Part|Missing|12|||
125578851|NCT01665144|451744542|FG001|Extension Part|Missing|0|||
125578852|NCT01665144|451744543|FG002|Extension Part|Missing|6|||
125578853|NCT01665144|451744541|FG000|Extension Part|Lost to Follow-up|9|||
125578854|NCT01665144|451744542|FG001|Extension Part|Lost to Follow-up|0|||
125578855|NCT01665144|451744543|FG002|Extension Part|Lost to Follow-up|5|||
125578856|NCT01665144|451744541|FG000|Extension Part|New therapy for study indication|3|||
125578857|NCT01665144|451744542|FG001|Extension Part|New therapy for study indication|0|||
125578858|NCT01665144|451744543|FG002|Extension Part|New therapy for study indication|2|||
125578859|NCT01665144|451744541|FG000|Extension Part|Protocol deviation|3|||
125578860|NCT01665144|451744542|FG001|Extension Part|Protocol deviation|0|||
125578861|NCT01665144|451744543|FG002|Extension Part|Protocol deviation|0|||
125578862|NCT01913483|451744546|FG000|Overall Study|Withdrawal by Subject|1|||
125578863|NCT01913483|451744547|FG001|Overall Study|Withdrawal by Subject|2|||
125578864|NCT01913483|451744546|FG000|Overall Study|Lost to Follow-up|6|||
125578865|NCT01913483|451744547|FG001|Overall Study|Lost to Follow-up|3|||
125578866|NCT01913483|451744546|FG000|Overall Study|Death|14|||
125578867|NCT01913483|451744547|FG001|Overall Study|Death|17|||
125578868|NCT02302963|451744548|FG000|Overall Study|Withdrawal by Subject|2|||
125578869|NCT02302963|451744549|FG001|Overall Study|Withdrawal by Subject|1|||
125578870|NCT02302963|451744548|FG000|Overall Study|Steroid injection|0|||
125578871|NCT02302963|451744549|FG001|Overall Study|Steroid injection|1|||
125578872|NCT02302963|451744548|FG000|Overall Study|Physician Decision|1|||
125578873|NCT02302963|451744549|FG001|Overall Study|Physician Decision|0|||
125578874|NCT00915343|451744550|FG000|Part B - Open Label Period|Treatment switch|0|||
125578875|NCT00915343|451744551|FG001|Part B - Open Label Period|Treatment switch|0|||
125578876|NCT00915343|451744552|FG002|Part B - Open Label Period|Treatment switch|1|||
125359357|NCT01163266|450950730|FG002|Overall Study|Lack of Efficacy|1|||
125578877|NCT00915343|451744550|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
125578878|NCT00915343|451744551|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
125578879|NCT00915343|451744552|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
125578880|NCT03687502|451744555|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
125578881|NCT03687502|451744555|FG000|Overall Study|Lumason not available|1|||
125578882|NCT01777581|451744556|FG000|Overall Study|Lost to Follow-up|1|||
125578883|NCT01777581|451744557|FG001|Overall Study|Lost to Follow-up|1|||
125578884|NCT01777581|451744556|FG000|Overall Study|Adverse Event|2|||
125578885|NCT01777581|451744557|FG001|Overall Study|Adverse Event|0|||
125578886|NCT01777581|451744556|FG000|Overall Study|Lack of Efficacy|0|||
125578887|NCT01777581|451744557|FG001|Overall Study|Lack of Efficacy|1|||
125578888|NCT01634555|451744562|FG000|Overall Study|Adverse Event|3|||
125578889|NCT01634555|451744562|FG000|Overall Study|Physician Decision|1|||
125578890|NCT06228586|451744563|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
125578891|NCT06228586|451744564|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
125578892|NCT01299766|451746236|FG000|Overall Study|Death|5|||
125578893|NCT01299766|451746237|FG001|Overall Study|Death|4|||
125578894|NCT01299766|451746236|FG000|Overall Study|Withdrawal by Subject|29|||
125578895|NCT01299766|451746237|FG001|Overall Study|Withdrawal by Subject|19|||
125578896|NCT00403260|451746238|FG000|Overall Study|Adverse Event|5|||
125578897|NCT00403260|451746239|FG001|Overall Study|Adverse Event|4|||
125578898|NCT00403260|451746238|FG000|Overall Study|Withdrawal by Subject|5|||
125578899|NCT00403260|451746239|FG001|Overall Study|Withdrawal by Subject|6|||
125578900|NCT00403260|451746238|FG000|Overall Study|Lost to Follow-up|49|||
125578901|NCT00403260|451746239|FG001|Overall Study|Lost to Follow-up|25|||
125578902|NCT00403260|451746238|FG000|Overall Study|Re-appearance of P. falciparum|34|||
125578903|NCT00403260|451746239|FG001|Overall Study|Re-appearance of P. falciparum|25|||
125578904|NCT00403260|451746238|FG000|Overall Study|P. vivax infection|26|||
125578905|NCT00403260|451746239|FG001|Overall Study|P. vivax infection|4|||
125578906|NCT00403260|451746238|FG000|Overall Study|Mixed infection with P. vivax|2|||
125578907|NCT00403260|451746239|FG001|Overall Study|Mixed infection with P. vivax|0|||
125578908|NCT00403260|451746238|FG000|Overall Study|Mixed infection with P. falciparum|1|||
125578909|NCT00403260|451746239|FG001|Overall Study|Mixed infection with P. falciparum|0|||
125578910|NCT00403260|451746238|FG000|Overall Study|P. vivax infection at screening|1|||
125578911|NCT00403260|451746239|FG001|Overall Study|P. vivax infection at screening|0|||
125578912|NCT00403260|451746238|FG000|Overall Study|P. ovale infection|1|||
125578913|NCT00403260|451746239|FG001|Overall Study|P. ovale infection|0|||
125578914|NCT00403260|451746238|FG000|Overall Study|Gametocyte re-appearance|1|||
125578915|NCT00403260|451746239|FG001|Overall Study|Gametocyte re-appearance|1|||
125578916|NCT00403260|451746238|FG000|Overall Study|Withdrawn from study accidentally|0|||
125578917|NCT00403260|451746239|FG001|Overall Study|Withdrawn from study accidentally|1|||
125578918|NCT01354028|451746240|FG000|Overall Study|Physician Decision|0|||
125578919|NCT01354028|451746241|FG001|Overall Study|Physician Decision|2|||
125578920|NCT01354028|451746240|FG000|Overall Study|Discharged before study start|2|||
125578921|NCT01354028|451746241|FG001|Overall Study|Discharged before study start|2|||
125578922|NCT01354028|451746240|FG000|Overall Study|No quiet alert state|0|||
125578923|NCT01354028|451746241|FG001|Overall Study|No quiet alert state|1|||
125578924|NCT00935883|451746242|FG000|Treatment Period|Physician Decision|1|||
125578925|NCT00935883|451746243|FG001|Treatment Period|Physician Decision|0|||
125578926|NCT00935883|451746242|FG000|Treatment Period|Withdrawal by Subject|0|||
125578927|NCT00935883|451746243|FG001|Treatment Period|Withdrawal by Subject|2|||
125578928|NCT00975156|451746250|FG000|Overall Study|Protocol Violation|0|||
125578929|NCT00975156|451746251|FG001|Overall Study|Protocol Violation|1|||
125578930|NCT01946178|451746256|FG000|Overall Study|Pregnancy|1|||
125578931|NCT01946178|451746256|FG000|Overall Study|Lost to Follow-up|1|||
125578932|NCT02421887|451746257|FG000|Overall Study|Lost to Follow-up|5|||
125578933|NCT02421887|451746258|FG001|Overall Study|Lost to Follow-up|0|||
125578934|NCT02421887|451746257|FG000|Overall Study|Withdrawal by Subject|8|||
125578935|NCT02421887|451746258|FG001|Overall Study|Withdrawal by Subject|5|||
125578936|NCT02421887|451746257|FG000|Overall Study|Physician Decision|2|||
125578937|NCT02421887|451746258|FG001|Overall Study|Physician Decision|4|||
125578938|NCT02421887|451746257|FG000|Overall Study|Adverse Event|2|||
125578939|NCT02421887|451746258|FG001|Overall Study|Adverse Event|0|||
125578940|NCT01505894|451746259|FG000|Overall Study|Adverse Event|1|||
125578941|NCT01505894|451746260|FG001|Overall Study|Adverse Event|0|||
125578942|NCT01505894|451746261|FG002|Overall Study|Adverse Event|0|||
125578943|NCT01505894|451746262|FG003|Overall Study|Adverse Event|0|||
125578944|NCT01505894|451746263|FG004|Overall Study|Adverse Event|0|||
125578945|NCT01505894|451746264|FG005|Overall Study|Adverse Event|0|||
125578946|NCT01505894|451746265|FG006|Overall Study|Adverse Event|0|||
125578947|NCT01505894|451746266|FG007|Overall Study|Adverse Event|0|||
125578948|NCT01505894|451746267|FG008|Overall Study|Adverse Event|0|||
125578949|NCT01505894|451746259|FG000|Overall Study|Other than specified|0|||
125578950|NCT01505894|451746260|FG001|Overall Study|Other than specified|0|||
125578951|NCT01505894|451746261|FG002|Overall Study|Other than specified|0|||
125578952|NCT01505894|451746262|FG003|Overall Study|Other than specified|0|||
125578953|NCT01505894|451746263|FG004|Overall Study|Other than specified|1|||
125578954|NCT01505894|451746264|FG005|Overall Study|Other than specified|0|||
125578955|NCT01505894|451746265|FG006|Overall Study|Other than specified|0|||
125578956|NCT01505894|451746266|FG007|Overall Study|Other than specified|0|||
125578957|NCT01505894|451746267|FG008|Overall Study|Other than specified|0|||
125578958|NCT01622569|451746268|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
125578959|NCT01622569|451746269|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
125578960|NCT01622569|451746270|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
125578961|NCT01622569|451746271|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
125578962|NCT01622569|451746268|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
125578963|NCT01622569|451746269|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
125578964|NCT01622569|451746270|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
125578965|NCT01622569|451746271|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
125578966|NCT01622569|451746268|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
125578967|NCT01622569|451746269|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
125578968|NCT01622569|451746270|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
125578969|NCT01622569|451746271|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
125578970|NCT01622569|451746268|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
125578971|NCT01622569|451746269|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
125578972|NCT01622569|451746270|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
125578973|NCT01622569|451746271|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
125578974|NCT01622569|451746268|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
125578975|NCT01622569|451746269|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
125578976|NCT01622569|451746270|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
125578977|NCT01622569|451746271|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
125578978|NCT01622569|451746268|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
125578979|NCT01622569|451746269|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
125578980|NCT01622569|451746270|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
125578981|NCT01622569|451746271|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
125578982|NCT01622569|451746268|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
125578983|NCT01622569|451746269|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
125578984|NCT01622569|451746270|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
125578985|NCT01622569|451746271|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
125578986|NCT01622569|451746268|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
125578987|NCT01622569|451746269|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
125578988|NCT01622569|451746270|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
125578989|NCT01622569|451746271|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
125578990|NCT01001702|451746272|FG000|Overall Study|Lost to Follow-up|7|||
125578991|NCT01001702|451746272|FG000|Overall Study|Adverse Event|7|||
125578992|NCT01001702|451746272|FG000|Overall Study|Sponsor Discontinued Study|4|||
125578993|NCT01001702|451746272|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
125578994|NCT01001702|451746272|FG000|Overall Study|Investigator withdrew Subject|10|||
125578995|NCT01001702|451746272|FG000|Overall Study|Withdrawal by Subject|19|||
125578996|NCT01001702|451746272|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
125578997|NCT02222714|451746275|FG000|Overall Study|Death|0|||
125578998|NCT02222714|451746276|FG001|Overall Study|Death|2|||
125578999|NCT02222714|451746277|FG002|Overall Study|Death|3|||
125579000|NCT02222714|451746278|FG003|Overall Study|Death|4|||
125579001|NCT02222714|451746279|FG004|Overall Study|Death|6|||
125579002|NCT02222714|451746275|FG000|Overall Study|Withdrawal by Subject|0|||
125579003|NCT02222714|451746276|FG001|Overall Study|Withdrawal by Subject|0|||
125579004|NCT02222714|451746277|FG002|Overall Study|Withdrawal by Subject|1|||
125579005|NCT02222714|451746278|FG003|Overall Study|Withdrawal by Subject|0|||
125579006|NCT02222714|451746279|FG004|Overall Study|Withdrawal by Subject|1|||
125579007|NCT01940484|451746280|FG000|Overall Study|Withdrawal by Subject|3|||
125579008|NCT01940484|451746280|FG000|Overall Study|Underwent transplantation|4|||
125579009|NCT01940484|451746280|FG000|Overall Study|Death|2|||
125579010|NCT01940484|451746280|FG000|Overall Study|Adverse Event|1|||
125579011|NCT01285908|451746281|FG000|Baseline Measurement|unable to insert catheter|1|||
125579012|NCT01285908|451746282|FG001|Baseline Measurement|unable to insert catheter|0|||
125579013|NCT01285908|451746283|FG002|Baseline Measurement|unable to insert catheter|0|||
125579014|NCT01285908|451746281|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
125579015|NCT01285908|451746282|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
125579016|NCT01285908|451746283|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
125579017|NCT01285908|451746281|FG000|Baseline Measurement|unable to tolerate procedure|1|||
125579018|NCT01285908|451746282|FG001|Baseline Measurement|unable to tolerate procedure|0|||
125579019|NCT01285908|451746283|FG002|Baseline Measurement|unable to tolerate procedure|0|||
125579020|NCT04142983|451746286|FG000|Overall Study|Lost to Follow-up|73|||
125579021|NCT04142983|451746286|FG000|Overall Study|Withdrawal by Subject|10|||
125579022|NCT04142983|451746286|FG000|Overall Study|Physician Decision|1|||
125579023|NCT04142983|451746286|FG000|Overall Study|Adverse Event|1|||
125579024|NCT04142983|451746286|FG000|Overall Study|No longer eligible|4|||
125579025|NCT04142983|451746286|FG000|Overall Study|Screen Failure|10|||
125359358|NCT01163266|450950728|FG000|Overall Study|Noncompliance with Study Drug|0|||
125359359|NCT01163266|450950729|FG001|Overall Study|Noncompliance with Study Drug|2|||
125359360|NCT01163266|450950730|FG002|Overall Study|Noncompliance with Study Drug|0|||
125359361|NCT01163266|450950728|FG000|Overall Study|Protocol Deviations|2|||
125359362|NCT01163266|450950729|FG001|Overall Study|Protocol Deviations|2|||
125579026|NCT00643994|451746289|FG000|Overall Study|Death|24|||
125579027|NCT00643994|451746289|FG000|Overall Study|Lost to Follow-up|72|||
125579028|NCT00197054|451746290|FG000|Overall Study|Withdrawal by Subject|9|||
125579029|NCT00197054|451746291|FG001|Overall Study|Withdrawal by Subject|3|||
125579030|NCT00197054|451746292|FG002|Overall Study|Withdrawal by Subject|3|||
125579031|NCT00197054|451746290|FG000|Overall Study|Moved from area|7|||
125579032|NCT00197054|451746291|FG001|Overall Study|Moved from area|14|||
125579033|NCT00197054|451746292|FG002|Overall Study|Moved from area|9|||
125579034|NCT00197054|451746290|FG000|Overall Study|Lost to Follow-up|1|||
125579035|NCT00197054|451746291|FG001|Overall Study|Lost to Follow-up|4|||
125579036|NCT00197054|451746292|FG002|Overall Study|Lost to Follow-up|0|||
125579037|NCT04823949|451746294|FG000|Overall Study|Withdrawal by Subject|0|||
125579038|NCT04823949|451746295|FG001|Overall Study|Withdrawal by Subject|4|||
125579039|NCT04823949|451746294|FG000|Overall Study|Physician Decision|0|||
125579040|NCT04823949|451746295|FG001|Overall Study|Physician Decision|1|||
125579041|NCT04317274|451746296|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
125579042|NCT04317274|451746297|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
125579043|NCT04317274|451746298|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
125579044|NCT04317274|451746299|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
125579045|NCT00797823|451746302|FG000|First Period (Initial Randomization)|Physician Decision|1|||
125579046|NCT00797823|451746303|FG001|First Period (Initial Randomization)|Physician Decision|0|||
125579047|NCT00797823|451746304|FG002|First Period (Initial Randomization)|Physician Decision|0|||
125579048|NCT02568046|451746305|FG000|Overall Study|Adverse Event|0|||
125579049|NCT02568046|451746306|FG001|Overall Study|Adverse Event|1|||
125579050|NCT02568046|451746305|FG000|Overall Study|Death|2|||
125579051|NCT02568046|451746306|FG001|Overall Study|Death|0|||
125579052|NCT02568046|451746305|FG000|Overall Study|Progressive Disease|1|||
125579053|NCT02568046|451746306|FG001|Overall Study|Progressive Disease|0|||
125579054|NCT02568046|451746305|FG000|Overall Study|Withdrawal by Subject|2|||
125579055|NCT02568046|451746306|FG001|Overall Study|Withdrawal by Subject|1|||
125579056|NCT02568046|451746305|FG000|Overall Study|Other Events|0|||
125579057|NCT02568046|451746306|FG001|Overall Study|Other Events|1|||
125579058|NCT00523991|451746307|FG000|Overall Study|Adverse Event|6|||
125579059|NCT00523991|451746308|FG001|Overall Study|Adverse Event|5|||
125579060|NCT00523991|451746307|FG000|Overall Study|Protocol Violation|1|||
125579061|NCT00523991|451746308|FG001|Overall Study|Protocol Violation|4|||
125579062|NCT00523991|451746307|FG000|Overall Study|Lost to Follow-up|4|||
125579063|NCT00523991|451746308|FG001|Overall Study|Lost to Follow-up|1|||
125579064|NCT00523991|451746307|FG000|Overall Study|Withdrawal by Subject|7|||
125579065|NCT00523991|451746308|FG001|Overall Study|Withdrawal by Subject|17|||
125579066|NCT00523991|451746307|FG000|Overall Study|Other reason (not specified)|3|||
125579067|NCT00523991|451746308|FG001|Overall Study|Other reason (not specified)|0|||
125579068|NCT00193063|451746310|FG000|Overall Study|Lack of Efficacy|3|||
125579069|NCT00193063|451746310|FG000|Overall Study|Adverse Event|1|||
125579070|NCT00379795|451746316|FG000|Overall Study|Death|31|||
125579071|NCT00379795|451746317|FG001|Overall Study|Death|8|||
125579072|NCT00379795|451746318|FG002|Overall Study|Death|6|||
125579073|NCT00379795|451746319|FG003|Overall Study|Death|4|||
125579074|NCT00379795|451746320|FG004|Overall Study|Death|7|||
125579075|NCT00379795|451746316|FG000|Overall Study|Adverse Event|17|||
125579076|NCT00379795|451746317|FG001|Overall Study|Adverse Event|3|||
125579077|NCT00379795|451746318|FG002|Overall Study|Adverse Event|3|||
125579078|NCT00379795|451746319|FG003|Overall Study|Adverse Event|1|||
125579079|NCT00379795|451746320|FG004|Overall Study|Adverse Event|4|||
125579080|NCT00379795|451746316|FG000|Overall Study|Lost to Follow-up|8|||
125579081|NCT00379795|451746317|FG001|Overall Study|Lost to Follow-up|1|||
125579082|NCT00379795|451746318|FG002|Overall Study|Lost to Follow-up|2|||
125579083|NCT00379795|451746319|FG003|Overall Study|Lost to Follow-up|1|||
125579084|NCT00379795|451746320|FG004|Overall Study|Lost to Follow-up|4|||
125579085|NCT00379795|451746316|FG000|Overall Study|Physician Decision|25|||
125579086|NCT00379795|451746317|FG001|Overall Study|Physician Decision|0|||
125579087|NCT00379795|451746318|FG002|Overall Study|Physician Decision|2|||
125579088|NCT00379795|451746319|FG003|Overall Study|Physician Decision|2|||
125579089|NCT00379795|451746320|FG004|Overall Study|Physician Decision|2|||
125579090|NCT00379795|451746316|FG000|Overall Study|Withdrawal by Subject|94|||
125579091|NCT00379795|451746317|FG001|Overall Study|Withdrawal by Subject|11|||
125579092|NCT00379795|451746318|FG002|Overall Study|Withdrawal by Subject|19|||
125579093|NCT00379795|451746319|FG003|Overall Study|Withdrawal by Subject|7|||
125579094|NCT00379795|451746320|FG004|Overall Study|Withdrawal by Subject|14|||
125579095|NCT00379795|451746316|FG000|Overall Study|Subject non-compliance|7|||
125579096|NCT00379795|451746317|FG001|Overall Study|Subject non-compliance|2|||
125579097|NCT00379795|451746318|FG002|Overall Study|Subject non-compliance|0|||
125359363|NCT01163266|450950730|FG002|Overall Study|Protocol Deviations|5|||
125579098|NCT00379795|451746319|FG003|Overall Study|Subject non-compliance|0|||
125579099|NCT00379795|451746320|FG004|Overall Study|Subject non-compliance|1|||
125579100|NCT00379795|451746316|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
125579101|NCT00379795|451746317|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
125579102|NCT00379795|451746318|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
125579103|NCT00379795|451746319|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
125579104|NCT00379795|451746320|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
125579105|NCT00379795|451746316|FG000|Overall Study|Subjects condition mandated intervention|34|||
125579106|NCT00379795|451746317|FG001|Overall Study|Subjects condition mandated intervention|9|||
125579107|NCT00379795|451746318|FG002|Overall Study|Subjects condition mandated intervention|7|||
125579108|NCT00379795|451746319|FG003|Overall Study|Subjects condition mandated intervention|5|||
125579109|NCT00379795|451746320|FG004|Overall Study|Subjects condition mandated intervention|7|||
125579110|NCT00379795|451746316|FG000|Overall Study|Sponsor's decision|257|||
125579111|NCT00379795|451746317|FG001|Overall Study|Sponsor's decision|17|||
125579112|NCT00379795|451746318|FG002|Overall Study|Sponsor's decision|54|||
125579113|NCT00379795|451746319|FG003|Overall Study|Sponsor's decision|47|||
125579114|NCT00379795|451746320|FG004|Overall Study|Sponsor's decision|10|||
125211420|NCT01980628|450399690|FG000|Overall Study|Adverse Event|12|||
125211421|NCT01980628|450399690|FG000|Overall Study|Physician Decision|5|||
125211422|NCT01980628|450399690|FG000|Overall Study|Withdrawal by Subject|4|||
125211423|NCT01980628|450399690|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
125579115|NCT02435849|451746321|FG000|Overall Study|Death|23|||
125579116|NCT02435849|451746322|FG001|Overall Study|Death|0|||
125579117|NCT02435849|451746321|FG000|Overall Study|Lack of Efficacy|10|||
125579118|NCT02435849|451746322|FG001|Overall Study|Lack of Efficacy|0|||
125579119|NCT02435849|451746321|FG000|Overall Study|New therapy for study indication|8|||
125579120|NCT02435849|451746322|FG001|Overall Study|New therapy for study indication|0|||
125579121|NCT02435849|451746321|FG000|Overall Study|Subject/guardian decision|5|||
125579122|NCT02435849|451746322|FG001|Overall Study|Subject/guardian decision|1|||
125211424|NCT00564278|450399691|FG000|Overall Study|Lost to Follow-up|35|||
125211425|NCT00564278|450399692|FG001|Overall Study|Lost to Follow-up|33|||
125211426|NCT00564278|450399691|FG000|Overall Study|Physician Decision|1|||
125211427|NCT00564278|450399692|FG001|Overall Study|Physician Decision|2|||
125211428|NCT00564278|450399691|FG000|Overall Study|Withdrawal by Subject|11|||
125211429|NCT00564278|450399692|FG001|Overall Study|Withdrawal by Subject|7|||
125579123|NCT02435849|451746321|FG000|Overall Study|Lost to Follow-up|1|||
125579124|NCT02435849|451746322|FG001|Overall Study|Lost to Follow-up|0|||
125579125|NCT02435849|451746321|FG000|Overall Study|Physician Decision|1|||
125579126|NCT02435849|451746322|FG001|Overall Study|Physician Decision|0|||
125579127|NCT04849780|451746323|FG000|Period 1|Covid-19 Related|1|||
125211430|NCT06439095|450399693|FG000|Overall Study|Lost to Follow-up|2|||
125579128|NCT04849780|451746324|FG001|Period 1|Covid-19 Related|0|||
125579129|NCT04849780|451746323|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
125579130|NCT04849780|451746324|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
125579131|NCT04849780|451746323|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
125579132|NCT04849780|451746324|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
125579133|NCT02175680|451746325|FG000|Overall Study|non-compliance|1|||
125579134|NCT02175680|451746325|FG000|Overall Study|other non-medical reason|1|||
125579135|NCT01816243|451746330|FG000|Overall Study|Adverse Event|6|||
125579136|NCT01816243|451746330|FG000|Overall Study|Lost to Follow-up|1|||
125579137|NCT01816243|451746330|FG000|Overall Study|Lack of Efficacy|1|||
125579138|NCT01816243|451746330|FG000|Overall Study|Not eligible for the study|1|||
125579139|NCT01816243|451746330|FG000|Overall Study|Amputation|3|||
125579140|NCT01920711|451746331|FG000|Overall Study|Death|347|||
125579141|NCT01920711|451746332|FG001|Overall Study|Death|356|||
125579142|NCT01920711|451746331|FG000|Overall Study|Lost to Follow-up|13|||
125579143|NCT01920711|451746332|FG001|Overall Study|Lost to Follow-up|14|||
125579144|NCT01920711|451746331|FG000|Overall Study|Withdrawal by Subject|4|||
125579145|NCT01920711|451746332|FG001|Overall Study|Withdrawal by Subject|3|||
125579146|NCT02319044|451746333|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
125359364|NCT01163266|450950728|FG000|Overall Study|Withdrawal of Consent|5|||
125359365|NCT01163266|450950729|FG001|Overall Study|Withdrawal of Consent|7|||
125359366|NCT01163266|450950730|FG002|Overall Study|Withdrawal of Consent|3|||
125359367|NCT01163266|450950728|FG000|Overall Study|Lost to Follow-up|7|||
125359368|NCT01163266|450950729|FG001|Overall Study|Lost to Follow-up|7|||
125579147|NCT02319044|451746334|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
125579148|NCT02319044|451746335|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
125579149|NCT02319044|451746333|FG000|Overall Study|Withdrawal by Subject|3|||
125359369|NCT01163266|450950730|FG002|Overall Study|Lost to Follow-up|10|||
125359370|NCT01163266|450950728|FG000|Overall Study|Other|1|||
125359371|NCT01163266|450950729|FG001|Overall Study|Other|1|||
125359372|NCT01163266|450950730|FG002|Overall Study|Other|2|||
125359373|NCT02586064|450950731|FG000|Overall Study|Other Obligations|6|||
125359374|NCT02586064|450950732|FG001|Overall Study|Other Obligations|6|||
125359375|NCT02586064|450950731|FG000|Overall Study|Other|3|||
125359376|NCT02586064|450950732|FG001|Overall Study|Other|7|||
125359377|NCT02586064|450950731|FG000|Overall Study|Never Started|3|||
125359378|NCT02586064|450950732|FG001|Overall Study|Never Started|3|||
125359379|NCT02586064|450950731|FG000|Overall Study|Lost Interest|1|||
125359380|NCT02586064|450950732|FG001|Overall Study|Lost Interest|4|||
125359381|NCT02586064|450950731|FG000|Overall Study|Miscellaneous Life Issues|0|||
125359382|NCT02586064|450950732|FG001|Overall Study|Miscellaneous Life Issues|5|||
125359383|NCT02586064|450950731|FG000|Overall Study|Infrequent Attendance|2|||
125359384|NCT02586064|450950732|FG001|Overall Study|Infrequent Attendance|1|||
125359385|NCT02586064|450950731|FG000|Overall Study|Timed Out|2|||
125359386|NCT02586064|450950732|FG001|Overall Study|Timed Out|0|||
125359387|NCT02586064|450950731|FG000|Overall Study|AUD relapse|0|||
125359388|NCT02586064|450950732|FG001|Overall Study|AUD relapse|2|||
125359389|NCT02586064|450950731|FG000|Overall Study|Legal Issue|1|||
125359390|NCT02586064|450950732|FG001|Overall Study|Legal Issue|0|||
125359391|NCT02919696|450950733|FG000|Overall Study|Adverse Event|1|||
125359392|NCT02919696|450950734|FG001|Overall Study|Adverse Event|2|||
125359393|NCT02919696|450950733|FG000|Overall Study|Withdrawal by Subject|2|||
125359394|NCT02919696|450950734|FG001|Overall Study|Withdrawal by Subject|1|||
125359395|NCT02919696|450950733|FG000|Overall Study|Sponsor Decision|1|||
125359396|NCT02919696|450950734|FG001|Overall Study|Sponsor Decision|1|||
125359397|NCT02919696|450950733|FG000|Overall Study|Never Treated|0|||
125359398|NCT02919696|450950734|FG001|Overall Study|Never Treated|1|||
125359399|NCT04308304|450950735|FG000|Overall Study|Withdrawal by Subject|4|||
125359400|NCT04308304|450950736|FG001|Overall Study|Withdrawal by Subject|0|||
125359401|NCT04308304|450950735|FG000|Overall Study|Protocol Violation|1|||
125359402|NCT04308304|450950736|FG001|Overall Study|Protocol Violation|0|||
125359403|NCT00945555|450950737|FG000|Overall Study|Referred to another hospital|5|||
125359404|NCT00945555|450950737|FG000|Overall Study|Worsening condition, intensive care unit|1|||
125359405|NCT00945555|450950737|FG000|Overall Study|Withdrawal by Subject|2|||
125359406|NCT00945555|450950737|FG000|Overall Study|Participant continued treatment at home|1|||
125579150|NCT02319044|451746334|FG001|Overall Study|Withdrawal by Subject|3|||
125579151|NCT02319044|451746335|FG002|Overall Study|Withdrawal by Subject|6|||
125579152|NCT02319044|451746333|FG000|Overall Study|Condition under investigation worsened|100|||
125359407|NCT00945555|450950737|FG000|Overall Study|Death|18|||
125359408|NCT00945555|450950737|FG000|Overall Study|Other|1|||
125359409|NCT04502979|450950741|FG000|Overall Study|Lost to Follow-up|1|||
125359410|NCT04502979|450950742|FG001|Overall Study|Lost to Follow-up|3|||
125359411|NCT04502979|450950741|FG000|Overall Study|Withdrawal by Subject|2|||
125359412|NCT04502979|450950742|FG001|Overall Study|Withdrawal by Subject|1|||
125359413|NCT01558739|450950751|FG000|Overall Study|Adverse Event|7|||
125359414|NCT01558739|450950751|FG000|Overall Study|Withdrawal by Subject|2|||
125359415|NCT01558739|450950751|FG000|Overall Study|Death|3|||
125211431|NCT03341936|450399694|FG000|Overall Study|Ineligible|1|||
125211432|NCT03341936|450399694|FG000|Overall Study|Disease Progression|2|||
125211433|NCT03341936|450399694|FG000|Overall Study|Withdrew Consent|4|||
125211434|NCT03341936|450399694|FG000|Overall Study|Non-Compliance|1|||
125211435|NCT03341936|450399694|FG000|Overall Study|Physician Decision|1|||
125211436|NCT03341936|450399694|FG000|Overall Study|Withdrawal by Subject|1|||
125211437|NCT03341936|450399694|FG000|Overall Study|Other|1|||
125211438|NCT02368886|450399695|FG000|Overall Study|Cancel|1|||
125211439|NCT02368886|450399696|FG001|Overall Study|Cancel|1|||
125211440|NCT02368886|450399697|FG002|Overall Study|Cancel|1|||
125211441|NCT02368886|450399698|FG003|Overall Study|Cancel|3|||
125211442|NCT02368886|450399695|FG000|Overall Study|Ineligible|0|||
125211443|NCT02368886|450399696|FG001|Overall Study|Ineligible|0|||
125211444|NCT02368886|450399697|FG002|Overall Study|Ineligible|0|||
125211445|NCT02368886|450399698|FG003|Overall Study|Ineligible|1|||
125211446|NCT04849416|450399700|FG000|Overall Study|Ongoing Treatment|12|||
125211447|NCT04849416|450399701|FG001|Overall Study|Ongoing Treatment|5|||
125211448|NCT04849416|450399702|FG002|Overall Study|Ongoing Treatment|3|||
125211449|NCT04849416|450399700|FG000|Overall Study|On Post-Treatment Follow-up|8|||
125211450|NCT04849416|450399701|FG001|Overall Study|On Post-Treatment Follow-up|9|||
125211451|NCT04849416|450399702|FG002|Overall Study|On Post-Treatment Follow-up|10|||
125211452|NCT04849416|450399700|FG000|Overall Study|Withdrawal by Subject|0|||
125211453|NCT04849416|450399701|FG001|Overall Study|Withdrawal by Subject|0|||
125211454|NCT04849416|450399702|FG002|Overall Study|Withdrawal by Subject|1|||
125427571|NCT00293267|451190957|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
125427572|NCT00293267|451190956|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
125427573|NCT00293267|451190957|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
125579153|NCT02319044|451746334|FG001|Overall Study|Condition under investigation worsened|50|||
125579154|NCT02319044|451746335|FG002|Overall Study|Condition under investigation worsened|46|||
125579155|NCT02319044|451746333|FG000|Overall Study|Adverse Event|17|||
125579156|NCT02319044|451746334|FG001|Overall Study|Adverse Event|2|||
125579157|NCT02319044|451746335|FG002|Overall Study|Adverse Event|8|||
125579158|NCT02319044|451746333|FG000|Overall Study|Study specific discontinuation criteria|2|||
125579159|NCT02319044|451746334|FG001|Overall Study|Study specific discontinuation criteria|2|||
125579160|NCT02319044|451746335|FG002|Overall Study|Study specific discontinuation criteria|1|||
125579161|NCT02319044|451746333|FG000|Overall Study|Not treated|0|||
125579162|NCT02319044|451746334|FG001|Overall Study|Not treated|2|||
125579163|NCT02319044|451746335|FG002|Overall Study|Not treated|2|||
125579164|NCT03434379|451746336|FG000|Global Period|Lost to Follow-up|3|||
125579165|NCT03434379|451746337|FG001|Global Period|Lost to Follow-up|6|||
125579166|NCT03434379|451746338|FG002|Global Period|Lost to Follow-up|0|||
125579167|NCT03434379|451746339|FG003|Global Period|Lost to Follow-up|0|||
125579168|NCT03434379|451746336|FG000|Global Period|Death|115|||
125579169|NCT03434379|451746337|FG001|Global Period|Death|228|||
125579170|NCT03434379|451746338|FG002|Global Period|Death|0|||
125579171|NCT03434379|451746339|FG003|Global Period|Death|0|||
125579172|NCT03434379|451746336|FG000|Global Period|Withdrawal by Subject|20|||
125579173|NCT03434379|451746337|FG001|Global Period|Withdrawal by Subject|21|||
125579174|NCT03434379|451746338|FG002|Global Period|Withdrawal by Subject|0|||
125579175|NCT03434379|451746339|FG003|Global Period|Withdrawal by Subject|0|||
125579176|NCT03434379|451746336|FG000|Global Period|Reason Unspecified|0|||
125579177|NCT03434379|451746337|FG001|Global Period|Reason Unspecified|1|||
125579178|NCT03434379|451746338|FG002|Global Period|Reason Unspecified|0|||
125579179|NCT03434379|451746339|FG003|Global Period|Reason Unspecified|0|||
125579180|NCT03434379|451746336|FG000|Global Period|Study Ended by Sponsor|26|||
125579181|NCT03434379|451746337|FG001|Global Period|Study Ended by Sponsor|80|||
125579182|NCT03434379|451746338|FG002|Global Period|Study Ended by Sponsor|0|||
125579183|NCT03434379|451746339|FG003|Global Period|Study Ended by Sponsor|0|||
125579184|NCT03434379|451746336|FG000|Global Period|Physician Decision|1|||
125579185|NCT03434379|451746337|FG001|Global Period|Physician Decision|0|||
125211455|NCT04849416|450399700|FG000|Overall Study|Lost to Follow-up|1|||
125211456|NCT04849416|450399701|FG001|Overall Study|Lost to Follow-up|0|||
125211457|NCT04849416|450399702|FG002|Overall Study|Lost to Follow-up|0|||
125211458|NCT02131636|450399707|FG000|Overall Study|Personal Reasons|4|||
125211459|NCT02131636|450399708|FG001|Overall Study|Personal Reasons|4|||
125211460|NCT02131636|450399707|FG000|Overall Study|Lost to Follow-up|4|||
125211461|NCT02131636|450399708|FG001|Overall Study|Lost to Follow-up|0|||
125211462|NCT02131636|450399707|FG000|Overall Study|Adverse Event|4|||
125211463|NCT02131636|450399708|FG001|Overall Study|Adverse Event|1|||
125211464|NCT04847232|450399711|FG000|Overall Study|Death|123|||
125211465|NCT04847232|450399712|FG001|Overall Study|Death|115|||
125579186|NCT03434379|451746338|FG002|Global Period|Physician Decision|0|||
125579187|NCT03434379|451746339|FG003|Global Period|Physician Decision|0|||
125579188|NCT03434379|451746336|FG000|China Extension Period|Lost to Follow-up|0|||
125579189|NCT03434379|451746337|FG001|China Extension Period|Lost to Follow-up|0|||
125579190|NCT03434379|451746338|FG002|China Extension Period|Lost to Follow-up|2|||
125211466|NCT04847232|450399711|FG000|Overall Study|Lost to Follow-up|3|||
125211467|NCT04847232|450399712|FG001|Overall Study|Lost to Follow-up|10|||
125427574|NCT00293267|451190956|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
125427575|NCT00293267|451190957|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
125427576|NCT00293267|451190956|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
125427577|NCT00293267|451190957|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
125427578|NCT00293267|451190956|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
125427579|NCT00293267|451190957|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
125427580|NCT00293267|451190956|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
125427581|NCT00293267|451190957|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
125427582|NCT03086330|451190958|FG000|Overall Study|Withdrawal by Subject|3|||
125579191|NCT03434379|451746339|FG003|China Extension Period|Lost to Follow-up|3|||
125579192|NCT03434379|451746336|FG000|China Extension Period|Death|0|||
125579193|NCT03434379|451746337|FG001|China Extension Period|Death|0|||
125579194|NCT03434379|451746338|FG002|China Extension Period|Death|46|||
125579195|NCT03434379|451746339|FG003|China Extension Period|Death|88|||
125579196|NCT03434379|451746336|FG000|China Extension Period|Withdrawal by Subject|0|||
125579197|NCT03434379|451746337|FG001|China Extension Period|Withdrawal by Subject|0|||
125579198|NCT03434379|451746338|FG002|China Extension Period|Withdrawal by Subject|8|||
125579199|NCT03434379|451746339|FG003|China Extension Period|Withdrawal by Subject|6|||
125579200|NCT03434379|451746336|FG000|China Extension Period|Study Ended by Sponsor|0|||
125579201|NCT03434379|451746337|FG001|China Extension Period|Study Ended by Sponsor|0|||
125579202|NCT03434379|451746338|FG002|China Extension Period|Study Ended by Sponsor|5|||
125579203|NCT03434379|451746339|FG003|China Extension Period|Study Ended by Sponsor|36|||
125579204|NCT01145066|451746340|FG000|Overall Study|To resume NSAIDs|2|||
125579205|NCT01145066|451746341|FG001|Overall Study|To resume NSAIDs|2|||
125427583|NCT03086330|451190959|FG001|Overall Study|Withdrawal by Subject|2|||
125579206|NCT01145066|451746342|FG002|Overall Study|To resume NSAIDs|1|||
125579207|NCT01145066|451746340|FG000|Overall Study|Non-related surgery|0|||
125579208|NCT01145066|451746341|FG001|Overall Study|Non-related surgery|0|||
125579209|NCT01145066|451746342|FG002|Overall Study|Non-related surgery|1|||
125579210|NCT01145066|451746340|FG000|Overall Study|Withdrawal by Subject|0|||
125579211|NCT01145066|451746341|FG001|Overall Study|Withdrawal by Subject|0|||
125579212|NCT01145066|451746342|FG002|Overall Study|Withdrawal by Subject|2|||
125579213|NCT01145066|451746340|FG000|Overall Study|To start new med|1|||
125579214|NCT01145066|451746341|FG001|Overall Study|To start new med|0|||
125579215|NCT01145066|451746342|FG002|Overall Study|To start new med|0|||
125579216|NCT01145066|451746340|FG000|Overall Study|problems swallowing capsule|1|||
125579217|NCT01145066|451746341|FG001|Overall Study|problems swallowing capsule|0|||
125579218|NCT01145066|451746342|FG002|Overall Study|problems swallowing capsule|0|||
125579219|NCT01145066|451746340|FG000|Overall Study|Abdominal discomfort|0|||
125579220|NCT01145066|451746341|FG001|Overall Study|Abdominal discomfort|1|||
125579221|NCT01145066|451746342|FG002|Overall Study|Abdominal discomfort|0|||
125579222|NCT01145066|451746340|FG000|Overall Study|Low platelet count|0|||
125211468|NCT04847232|450399711|FG000|Overall Study|Withdrawal by Subject|73|||
125211469|NCT04847232|450399712|FG001|Overall Study|Withdrawal by Subject|101|||
125211470|NCT04847232|450399711|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
125211471|NCT04847232|450399712|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
125211472|NCT02290925|450399718|FG000|First Period of Three Months|Lost to Follow-up|2|||
125211473|NCT02290925|450399719|FG001|First Period of Three Months|Lost to Follow-up|1|||
125211474|NCT02290925|450399718|FG000|First Period of Three Months|Death|1|||
125211475|NCT02290925|450399719|FG001|First Period of Three Months|Death|0|||
125211476|NCT02290925|450399718|FG000|First Period of Three Months|Insulin Started|1|||
125211477|NCT02290925|450399719|FG001|First Period of Three Months|Insulin Started|1|||
125211478|NCT02290925|450399718|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
125211479|NCT02290925|450399719|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
125211480|NCT02290925|450399718|FG000|Second Period of 3 Months|insulin started|0|||
125211481|NCT02290925|450399719|FG001|Second Period of 3 Months|insulin started|1|||
125211482|NCT01716520|450399720|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
125211483|NCT01716520|450399721|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
125211484|NCT01716520|450399722|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
125211485|NCT01716520|450399723|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
125211486|NCT01716520|450399724|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
125211487|NCT01716520|450399725|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
125211488|NCT01716520|450399720|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
125211489|NCT01716520|450399721|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
125359416|NCT01558739|450950751|FG000|Overall Study|Disease Progression|4|||
125359417|NCT01558739|450950751|FG000|Overall Study|Protocol Violation|1|||
125359418|NCT02719327|450950754|FG000|Overall Study|Withdrawal by Subject|11|||
125359419|NCT02719327|450950755|FG001|Overall Study|Withdrawal by Subject|8|||
125359420|NCT01067976|450950758|FG000|Overall Study|Study drug never administered|20|||
125359421|NCT01067976|450950758|FG000|Overall Study|Study prematurely discontinued|2|||
125359422|NCT05268055|450950759|FG000|Overall Study|Lost to Follow-up|68|||
125359423|NCT05268055|450950760|FG001|Overall Study|Lost to Follow-up|68|||
125359424|NCT05268055|450950759|FG000|Overall Study|Withdrawal by Subject|12|||
125359425|NCT05268055|450950760|FG001|Overall Study|Withdrawal by Subject|8|||
125359426|NCT02497612|450952316|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
125359427|NCT02497612|450952317|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
125359428|NCT02497612|450952318|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
125359429|NCT02497612|450952319|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
125359430|NCT02497612|450952316|FG000|Overall Study|Participant's request|2|||
125359431|NCT02497612|450952317|FG001|Overall Study|Participant's request|3|||
125359432|NCT02497612|450952318|FG002|Overall Study|Participant's request|4|||
125359433|NCT02497612|450952319|FG003|Overall Study|Participant's request|1|||
125359434|NCT02497612|450952316|FG000|Overall Study|Investigator's judgement|1|||
125359435|NCT02497612|450952317|FG001|Overall Study|Investigator's judgement|0|||
125359436|NCT02497612|450952318|FG002|Overall Study|Investigator's judgement|0|||
125359437|NCT02497612|450952319|FG003|Overall Study|Investigator's judgement|2|||
125579223|NCT01145066|451746341|FG001|Overall Study|Low platelet count|1|||
125359438|NCT02497612|450952316|FG000|Overall Study|Adverse Event|3|||
125359439|NCT02497612|450952317|FG001|Overall Study|Adverse Event|1|||
125579224|NCT01145066|451746342|FG002|Overall Study|Low platelet count|0|||
125359440|NCT02497612|450952318|FG002|Overall Study|Adverse Event|4|||
125359441|NCT02497612|450952319|FG003|Overall Study|Adverse Event|1|||
125359442|NCT02497612|450952316|FG000|Overall Study|Lost to Follow-up|1|||
125359443|NCT02497612|450952317|FG001|Overall Study|Lost to Follow-up|1|||
125359444|NCT02497612|450952318|FG002|Overall Study|Lost to Follow-up|0|||
125359445|NCT02497612|450952319|FG003|Overall Study|Lost to Follow-up|1|||
125359446|NCT02497612|450952316|FG000|Overall Study|Other unspecified|1|||
125359447|NCT02497612|450952317|FG001|Overall Study|Other unspecified|1|||
125359448|NCT02497612|450952318|FG002|Overall Study|Other unspecified|2|||
125359449|NCT02497612|450952319|FG003|Overall Study|Other unspecified|0|||
125359450|NCT02497612|450952316|FG000|Overall Study|Not eligible|1|||
125359451|NCT02497612|450952317|FG001|Overall Study|Not eligible|0|||
125359452|NCT02497612|450952318|FG002|Overall Study|Not eligible|0|||
125359453|NCT02497612|450952319|FG003|Overall Study|Not eligible|1|||
125359454|NCT02024529|450952322|FG000|Overall Study|Withdrawal by Subject|11|||
125359455|NCT02024529|450952323|FG001|Overall Study|Withdrawal by Subject|21|||
125359456|NCT02024529|450952322|FG000|Overall Study|Lost to Follow-up|2|||
125359457|NCT02024529|450952323|FG001|Overall Study|Lost to Follow-up|4|||
125359458|NCT01426438|450952324|FG000|Overall Study|Lost to Follow-up|1|||
125359459|NCT01426438|450952325|FG001|Overall Study|Lost to Follow-up|3|||
125359460|NCT01426438|450952324|FG000|Overall Study|Off study Treatment|9|||
125359461|NCT01426438|450952325|FG001|Overall Study|Off study Treatment|3|||
125359462|NCT01426438|450952324|FG000|Overall Study|Poor scan quality|3|||
125359463|NCT01426438|450952325|FG001|Overall Study|Poor scan quality|2|||
125359464|NCT01426438|450952324|FG000|Overall Study|Missed Scan|2|||
125359465|NCT01426438|450952325|FG001|Overall Study|Missed Scan|2|||
125359466|NCT01134731|450952326|FG000|Overall Study|Adverse Event|3|||
125359467|NCT01134731|450952327|FG001|Overall Study|Adverse Event|2|||
125359468|NCT01134731|450952328|FG002|Overall Study|Adverse Event|1|||
125359469|NCT01134731|450952326|FG000|Overall Study|Physician Decision|2|||
125359470|NCT01134731|450952327|FG001|Overall Study|Physician Decision|2|||
125359471|NCT01134731|450952328|FG002|Overall Study|Physician Decision|2|||
125359472|NCT01134731|450952326|FG000|Overall Study|Lack of Efficacy|0|||
125359473|NCT01134731|450952327|FG001|Overall Study|Lack of Efficacy|0|||
125359474|NCT01134731|450952328|FG002|Overall Study|Lack of Efficacy|1|||
125359475|NCT01134731|450952326|FG000|Overall Study|Withdrawal by Subject|3|||
125359476|NCT01134731|450952327|FG001|Overall Study|Withdrawal by Subject|3|||
125359477|NCT01134731|450952328|FG002|Overall Study|Withdrawal by Subject|1|||
125359478|NCT01134731|450952326|FG000|Overall Study|Lost to Follow-up|5|||
125359479|NCT01134731|450952327|FG001|Overall Study|Lost to Follow-up|4|||
125359480|NCT01134731|450952328|FG002|Overall Study|Lost to Follow-up|3|||
125359481|NCT02122458|450952329|FG000|Overall Study|Withdrawal by Subject|0|||
125359482|NCT02122458|450952330|FG001|Overall Study|Withdrawal by Subject|0|||
125359483|NCT02122458|450952331|FG002|Overall Study|Withdrawal by Subject|0|||
125359484|NCT02122458|450952332|FG003|Overall Study|Withdrawal by Subject|4|||
125359485|NCT02122458|450952333|FG004|Overall Study|Withdrawal by Subject|4|||
125359486|NCT02122458|450952334|FG005|Overall Study|Withdrawal by Subject|4|||
125359487|NCT02122458|450952335|FG006|Overall Study|Withdrawal by Subject|0|||
125359488|NCT02122458|450952329|FG000|Overall Study|Lost to Follow-up|1|||
125359489|NCT02122458|450952330|FG001|Overall Study|Lost to Follow-up|3|||
125359490|NCT02122458|450952331|FG002|Overall Study|Lost to Follow-up|0|||
125359491|NCT02122458|450952332|FG003|Overall Study|Lost to Follow-up|7|||
125359492|NCT02122458|450952333|FG004|Overall Study|Lost to Follow-up|5|||
125359493|NCT02122458|450952334|FG005|Overall Study|Lost to Follow-up|15|||
125359494|NCT02122458|450952335|FG006|Overall Study|Lost to Follow-up|1|||
125359495|NCT02122458|450952329|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
125427584|NCT03086330|451190958|FG000|Overall Study|Lost to Follow-up|1|||
125427585|NCT03086330|451190959|FG001|Overall Study|Lost to Follow-up|2|||
125359496|NCT02122458|450952330|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
125359497|NCT02122458|450952331|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
125359498|NCT02122458|450952332|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
125359499|NCT02122458|450952333|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
125359500|NCT02122458|450952334|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
125359501|NCT02122458|450952335|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
125359502|NCT02122458|450952329|FG000|Overall Study|Adverse Event|1|||
125359503|NCT02122458|450952330|FG001|Overall Study|Adverse Event|0|||
125359504|NCT02122458|450952331|FG002|Overall Study|Adverse Event|0|||
125359505|NCT02122458|450952332|FG003|Overall Study|Adverse Event|0|||
125359506|NCT02122458|450952333|FG004|Overall Study|Adverse Event|0|||
125359507|NCT02122458|450952334|FG005|Overall Study|Adverse Event|0|||
125359508|NCT02122458|450952335|FG006|Overall Study|Adverse Event|0|||
125359509|NCT02122458|450952329|FG000|Overall Study|Experimental Error|0|||
125359510|NCT02122458|450952330|FG001|Overall Study|Experimental Error|0|||
125359511|NCT02122458|450952331|FG002|Overall Study|Experimental Error|0|||
125359512|NCT02122458|450952332|FG003|Overall Study|Experimental Error|0|||
125211490|NCT01716520|450399722|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
125211491|NCT01716520|450399723|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
125211492|NCT01716520|450399724|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
125211493|NCT01716520|450399725|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
125359513|NCT02122458|450952333|FG004|Overall Study|Experimental Error|3|||
125359514|NCT02122458|450952334|FG005|Overall Study|Experimental Error|0|||
125359515|NCT02122458|450952335|FG006|Overall Study|Experimental Error|0|||
125359516|NCT02122458|450952329|FG000|Overall Study|Deployed or Moved|0|||
125359517|NCT02122458|450952330|FG001|Overall Study|Deployed or Moved|0|||
125359518|NCT02122458|450952331|FG002|Overall Study|Deployed or Moved|0|||
125359519|NCT02122458|450952332|FG003|Overall Study|Deployed or Moved|0|||
125359520|NCT02122458|450952333|FG004|Overall Study|Deployed or Moved|1|||
125359521|NCT02122458|450952334|FG005|Overall Study|Deployed or Moved|0|||
125359522|NCT02122458|450952335|FG006|Overall Study|Deployed or Moved|0|||
125359523|NCT02122458|450952329|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
125359524|NCT02122458|450952330|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
125359525|NCT02122458|450952331|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
125359526|NCT02122458|450952332|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
125359527|NCT02122458|450952333|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
125359528|NCT02122458|450952334|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
125359529|NCT02122458|450952335|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
125359530|NCT02122458|450952329|FG000|Overall Study|Noncompliance|0|||
125359531|NCT02122458|450952330|FG001|Overall Study|Noncompliance|1|||
125359532|NCT02122458|450952331|FG002|Overall Study|Noncompliance|0|||
125359533|NCT02122458|450952332|FG003|Overall Study|Noncompliance|0|||
125359534|NCT02122458|450952333|FG004|Overall Study|Noncompliance|0|||
125359535|NCT02122458|450952334|FG005|Overall Study|Noncompliance|0|||
125359536|NCT02122458|450952335|FG006|Overall Study|Noncompliance|0|||
125359537|NCT00091442|450952336|FG000|Overall Study|Progressive Disease|220|||
125359538|NCT00091442|450952337|FG001|Overall Study|Progressive Disease|189|||
125359539|NCT00091442|450952336|FG000|Overall Study|Physician Decision|61|||
125359540|NCT00091442|450952337|FG001|Overall Study|Physician Decision|58|||
125359541|NCT00091442|450952336|FG000|Overall Study|Withdrawal by Subject|38|||
125359542|NCT00091442|450952337|FG001|Overall Study|Withdrawal by Subject|46|||
125359543|NCT00091442|450952336|FG000|Overall Study|Adverse Event|29|||
125359544|NCT00091442|450952337|FG001|Overall Study|Adverse Event|48|||
125359545|NCT00091442|450952336|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
125359546|NCT00091442|450952337|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
125359547|NCT00091442|450952336|FG000|Overall Study|Death|9|||
125359548|NCT00091442|450952337|FG001|Overall Study|Death|7|||
125359549|NCT00091442|450952336|FG000|Overall Study|Lost to Follow-up|1|||
125359550|NCT00091442|450952337|FG001|Overall Study|Lost to Follow-up|3|||
125359551|NCT00091442|450952336|FG000|Overall Study|Other|2|||
125359552|NCT00091442|450952337|FG001|Overall Study|Other|6|||
125359553|NCT01332331|450952339|FG000|Overall Study|Lost to Follow-up|0|||
125359554|NCT01332331|450952340|FG001|Overall Study|Lost to Follow-up|1|||
125359555|NCT01332331|450952339|FG000|Overall Study|Adverse Event|1|||
125359556|NCT01332331|450952340|FG001|Overall Study|Adverse Event|1|||
125359557|NCT01332331|450952339|FG000|Overall Study|Physician Decision|1|||
125359558|NCT01332331|450952340|FG001|Overall Study|Physician Decision|0|||
125359559|NCT04810481|450952344|FG000|Overall Study|Disqualified data sets|10|||
125359560|NCT04810481|450952345|FG001|Overall Study|Disqualified data sets|28|||
125359561|NCT05055128|450952354|FG000|Overall Study|Adverse Event|0|||
125359562|NCT05055128|450952355|FG001|Overall Study|Adverse Event|0|||
125359563|NCT05055128|450952356|FG002|Overall Study|Adverse Event|0|||
125359564|NCT05055128|450952357|FG003|Overall Study|Adverse Event|1|||
125359565|NCT05055128|450952358|FG004|Overall Study|Adverse Event|1|||
125427586|NCT04044456|451190962|FG000|Overall Study|Lost to Follow-up|4|||
125427587|NCT04044456|451190963|FG001|Overall Study|Lost to Follow-up|1|||
125427588|NCT04044456|451190962|FG000|Overall Study|Withdrawal by Subject|1|||
125427589|NCT04044456|451190963|FG001|Overall Study|Withdrawal by Subject|0|||
125427590|NCT01972529|451190964|FG000|Overall Study|Adverse Event|0|||
125427591|NCT01972529|451190965|FG001|Overall Study|Adverse Event|1|||
125427592|NCT01972529|451190966|FG002|Overall Study|Adverse Event|0|||
125427593|NCT01972529|451190967|FG003|Overall Study|Adverse Event|0|||
125427594|NCT01972529|451190964|FG000|Overall Study|Lost to Follow-up|1|||
125427595|NCT01972529|451190965|FG001|Overall Study|Lost to Follow-up|0|||
125427596|NCT01972529|451190966|FG002|Overall Study|Lost to Follow-up|0|||
125427597|NCT01972529|451190967|FG003|Overall Study|Lost to Follow-up|0|||
125427598|NCT01972529|451190964|FG000|Overall Study|Participant Choice|0|||
125427599|NCT01972529|451190965|FG001|Overall Study|Participant Choice|1|||
125427600|NCT01972529|451190966|FG002|Overall Study|Participant Choice|0|||
125427601|NCT01972529|451190967|FG003|Overall Study|Participant Choice|0|||
125427602|NCT01972529|451190964|FG000|Overall Study|Withdrawl of Consent|1|||
125427603|NCT01972529|451190965|FG001|Overall Study|Withdrawl of Consent|2|||
125427604|NCT01972529|451190966|FG002|Overall Study|Withdrawl of Consent|0|||
125427605|NCT01972529|451190967|FG003|Overall Study|Withdrawl of Consent|1|||
125427606|NCT01972529|451190964|FG000|Overall Study|Other|0|||
125427607|NCT01972529|451190965|FG001|Overall Study|Other|0|||
125427608|NCT01972529|451190966|FG002|Overall Study|Other|0|||
125427609|NCT01972529|451190967|FG003|Overall Study|Other|2|||
125427610|NCT01972529|451190964|FG000|Overall Study|Not treated|0|||
125427611|NCT01972529|451190965|FG001|Overall Study|Not treated|1|||
125427612|NCT01972529|451190966|FG002|Overall Study|Not treated|2|||
125427613|NCT01972529|451190967|FG003|Overall Study|Not treated|1|||
125427614|NCT02274857|451190968|FG000|Overall Study|Adverse Event|1|||
125427615|NCT02274857|451190969|FG001|Overall Study|Adverse Event|0|||
125427616|NCT02274857|451190968|FG000|Overall Study|Death|1|||
125427617|NCT02274857|451190969|FG001|Overall Study|Death|2|||
125427618|NCT02274857|451190968|FG000|Overall Study|Lost to Follow-up|3|||
125427619|NCT02274857|451190969|FG001|Overall Study|Lost to Follow-up|0|||
125427620|NCT02274857|451190968|FG000|Overall Study|Physician Decision|2|||
125427621|NCT02274857|451190969|FG001|Overall Study|Physician Decision|0|||
125427622|NCT02274857|451190968|FG000|Overall Study|Trial screen failure|0|||
125427623|NCT02274857|451190969|FG001|Overall Study|Trial screen failure|2|||
125427624|NCT02274857|451190968|FG000|Overall Study|Withdrawal by Subject|11|||
125427625|NCT02274857|451190969|FG001|Overall Study|Withdrawal by Subject|2|||
125427626|NCT02274857|451190968|FG000|Overall Study|Other|2|||
125427627|NCT02274857|451190969|FG001|Overall Study|Other|0|||
125427628|NCT00330174|451190972|FG000|Overall Study|Withdrawal by Subject|7|||
125427629|NCT00330174|451190973|FG001|Overall Study|Withdrawal by Subject|7|||
125427630|NCT00330174|451190972|FG000|Overall Study|Lost to Follow-up|4|||
125427631|NCT00330174|451190973|FG001|Overall Study|Lost to Follow-up|1|||
125427632|NCT00330174|451190972|FG000|Overall Study|Clinical deterioration|1|||
125427633|NCT00330174|451190973|FG001|Overall Study|Clinical deterioration|2|||
125427634|NCT00330174|451190972|FG000|Overall Study|Excessive missed visits|3|||
125427635|NCT00330174|451190973|FG001|Overall Study|Excessive missed visits|8|||
125427636|NCT00330174|451190972|FG000|Overall Study|Miscellaneous reasons|7|||
125427637|NCT00330174|451190973|FG001|Overall Study|Miscellaneous reasons|1|||
125427638|NCT02403180|451190975|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
125427639|NCT02403180|451190976|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
125427640|NCT02403180|451190975|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
125427641|NCT02403180|451190976|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
125427642|NCT00118716|451190981|FG000|Overall Study|Adverse Event|2|||
125427643|NCT00118716|451190982|FG001|Overall Study|Adverse Event|7|||
125359566|NCT05055128|450952354|FG000|Overall Study|Protocol Violation|0|||
125427644|NCT00118716|451190981|FG000|Overall Study|Protocol Violation|5|||
125427645|NCT00118716|451190982|FG001|Overall Study|Protocol Violation|4|||
125427646|NCT00118716|451190981|FG000|Overall Study|Withdrawal by Subject|0|||
125427647|NCT00118716|451190982|FG001|Overall Study|Withdrawal by Subject|1|||
125427648|NCT00118716|451190981|FG000|Overall Study|Exacerbation|2|||
125427649|NCT00118716|451190982|FG001|Overall Study|Exacerbation|2|||
125427650|NCT00118716|451190981|FG000|Overall Study|Discontinued by sponsor|1|||
125427651|NCT00118716|451190982|FG001|Overall Study|Discontinued by sponsor|1|||
125579225|NCT01724528|451746346|FG000|Overall Study|Death|3|||
125579226|NCT01724528|451746347|FG001|Overall Study|Death|0|||
125579227|NCT01724528|451746346|FG000|Overall Study|Withdrawal by Subject|0|||
125579228|NCT01724528|451746347|FG001|Overall Study|Withdrawal by Subject|2|||
125579229|NCT01724528|451746346|FG000|Overall Study|Protocol Violation|0|||
125579230|NCT01724528|451746347|FG001|Overall Study|Protocol Violation|1|||
125579231|NCT01724528|451746346|FG000|Overall Study|Patient refused to attend last visit|1|||
125579232|NCT01724528|451746347|FG001|Overall Study|Patient refused to attend last visit|0|||
125427652|NCT00118716|451190981|FG000|Overall Study|Non-compliance|1|||
125427653|NCT00118716|451190982|FG001|Overall Study|Non-compliance|3|||
125427654|NCT00118716|451190981|FG000|Overall Study|misrandomized|1|||
125427655|NCT00118716|451190982|FG001|Overall Study|misrandomized|1|||
125427656|NCT00118716|451190981|FG000|Overall Study|Expired drug use|1|||
125427657|NCT00118716|451190982|FG001|Overall Study|Expired drug use|2|||
125427658|NCT00118716|451190981|FG000|Overall Study|Investigator discretion|0|||
125427659|NCT00118716|451190982|FG001|Overall Study|Investigator discretion|1|||
125427660|NCT00454571|451190984|FG000|Overall Study|Adverse Event|2|||
125427661|NCT00454571|451190985|FG001|Overall Study|Adverse Event|0|||
125427662|NCT00454571|451190984|FG000|Overall Study|Physician Decision|0|||
125427663|NCT00454571|451190985|FG001|Overall Study|Physician Decision|1|||
125427664|NCT00454571|451190984|FG000|Overall Study|Protocol Violation|1|||
125427665|NCT00454571|451190985|FG001|Overall Study|Protocol Violation|0|||
125427666|NCT00454571|451190984|FG000|Overall Study|Withdrawal by Subject|10|||
125427667|NCT00454571|451190985|FG001|Overall Study|Withdrawal by Subject|5|||
125427668|NCT00952822|451190986|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
125427669|NCT00952822|451190987|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
125427670|NCT00952822|451190988|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
125427671|NCT00952822|451190989|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
125427672|NCT00952822|451190986|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
125427673|NCT00952822|451190987|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
125427674|NCT00952822|451190988|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
125427675|NCT00952822|451190989|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
125427676|NCT04555096|451190990|FG000|Overall Study|Death|4|||
125427677|NCT04555096|451190991|FG001|Overall Study|Death|4|||
125427678|NCT04555096|451190990|FG000|Overall Study|Withdrawal by Subject|1|||
125427679|NCT04555096|451190991|FG001|Overall Study|Withdrawal by Subject|0|||
125427680|NCT04555096|451190990|FG000|Overall Study|Other|0|||
125427681|NCT04555096|451190991|FG001|Overall Study|Other|1|||
125427682|NCT04899245|451191012|FG000|Overall Study|Withdrawal by Subject|3|||
125427683|NCT04899245|451191013|FG001|Overall Study|Withdrawal by Subject|5|||
125427684|NCT04899245|451191014|FG002|Overall Study|Withdrawal by Subject|2|||
125427685|NCT04899245|451191012|FG000|Overall Study|No longer eligible - Left staff position|0|||
125427686|NCT04899245|451191013|FG001|Overall Study|No longer eligible - Left staff position|0|||
125427687|NCT04899245|451191014|FG002|Overall Study|No longer eligible - Left staff position|1|||
125427688|NCT04899245|451191012|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
125427689|NCT04899245|451191013|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
125427690|NCT04899245|451191014|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
125427691|NCT04899245|451191012|FG000|Overall Study|No longer eligible - Moved away from area|2|||
125427692|NCT04899245|451191013|FG001|Overall Study|No longer eligible - Moved away from area|2|||
125427693|NCT04899245|451191014|FG002|Overall Study|No longer eligible - Moved away from area|0|||
125427694|NCT03371940|451191026|FG000|Overall Study|Withdrawal by Subject|8|||
125427695|NCT03371940|451191027|FG001|Overall Study|Withdrawal by Subject|1|||
125427696|NCT03371940|451191028|FG002|Overall Study|Withdrawal by Subject|3|||
125427697|NCT03371940|451191029|FG003|Overall Study|Withdrawal by Subject|4|||
125427698|NCT05099926|451191035|FG000|Overall Study|Lost to Follow-up|1|||
125427699|NCT00724152|451191038|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
125427700|NCT00724152|451191039|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
125427701|NCT00724152|451191040|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
125427702|NCT00724152|451191038|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
125427703|NCT00724152|451191039|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
125427704|NCT00724152|451191040|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
125427705|NCT00031486|451191046|FG000|Overall Study|Adverse Event|1|||
125427706|NCT00031486|451191047|FG001|Overall Study|Adverse Event|0|||
125579233|NCT04949841|451746351|FG000|Overall Study|Adverse Event|7|||
125579234|NCT04949841|451746351|FG000|Overall Study|Death|1|||
125579235|NCT04949841|451746351|FG000|Overall Study|Withdrawal by Subject|52|||
125579236|NCT04949841|451746351|FG000|Overall Study|Pregnancy|4|||
125579237|NCT04949841|451746351|FG000|Overall Study|Lost to Follow-up|9|||
125579238|NCT04949841|451746351|FG000|Overall Study|Lack of Efficacy|55|||
125579239|NCT04949841|451746351|FG000|Overall Study|Various reasons|9|||
125579240|NCT01227902|451747934|FG000|Overall Study|Adverse Event|12|||
125427707|NCT00031486|451191046|FG000|Overall Study|Lost to Follow-up|0|||
125427708|NCT00031486|451191047|FG001|Overall Study|Lost to Follow-up|1|||
125427709|NCT00031486|451191046|FG000|Overall Study|Withdrawal by Subject|3|||
125579241|NCT01227902|451747935|FG001|Overall Study|Adverse Event|8|||
125427710|NCT00031486|451191047|FG001|Overall Study|Withdrawal by Subject|2|||
125427711|NCT00031486|451191046|FG000|Overall Study|Death|0|||
125427712|NCT00031486|451191047|FG001|Overall Study|Death|3|||
125427713|NCT00031486|451191046|FG000|Overall Study|Non-compliant|0|||
125579242|NCT01227902|451747936|FG002|Overall Study|Adverse Event|11|||
125427714|NCT00031486|451191047|FG001|Overall Study|Non-compliant|4|||
125427715|NCT00031486|451191046|FG000|Overall Study|Did not meet eligibility requirement|2|||
125579243|NCT01227902|451747937|FG003|Overall Study|Adverse Event|4|||
125579244|NCT01227902|451747934|FG000|Overall Study|Lack of Efficacy|1|||
125579245|NCT01227902|451747935|FG001|Overall Study|Lack of Efficacy|2|||
125579246|NCT01227902|451747936|FG002|Overall Study|Lack of Efficacy|2|||
125579247|NCT01227902|451747937|FG003|Overall Study|Lack of Efficacy|1|||
125579248|NCT01227902|451747934|FG000|Overall Study|Protocol Violation|1|||
125579249|NCT01227902|451747935|FG001|Overall Study|Protocol Violation|0|||
125579250|NCT01227902|451747936|FG002|Overall Study|Protocol Violation|0|||
125579251|NCT01227902|451747937|FG003|Overall Study|Protocol Violation|0|||
125579252|NCT01227902|451747934|FG000|Overall Study|Lost to Follow-up|0|||
125579253|NCT01227902|451747935|FG001|Overall Study|Lost to Follow-up|0|||
125579254|NCT01227902|451747936|FG002|Overall Study|Lost to Follow-up|1|||
125579255|NCT01227902|451747937|FG003|Overall Study|Lost to Follow-up|2|||
125579256|NCT01227902|451747934|FG000|Overall Study|Physician Decision|0|||
125579257|NCT01227902|451747935|FG001|Overall Study|Physician Decision|1|||
125579258|NCT01227902|451747936|FG002|Overall Study|Physician Decision|1|||
125579259|NCT01227902|451747937|FG003|Overall Study|Physician Decision|0|||
125579260|NCT01227902|451747934|FG000|Overall Study|Withdrawal by Subject|4|||
125579261|NCT01227902|451747935|FG001|Overall Study|Withdrawal by Subject|2|||
125579262|NCT01227902|451747936|FG002|Overall Study|Withdrawal by Subject|4|||
125579263|NCT01227902|451747937|FG003|Overall Study|Withdrawal by Subject|3|||
125579264|NCT02527707|451747938|FG000|Overall Study|Adverse Event|1|||
125579265|NCT02527707|451747938|FG000|Overall Study|Adverse Event|1|||
125579266|NCT00930059|451747939|FG000|Overall Study|Death|1|||
125579267|NCT00930059|451747940|FG001|Overall Study|Death|0|||
125579268|NCT00930059|451747939|FG000|Overall Study|Did not meet entrance criteria|1|||
125579269|NCT00930059|451747940|FG001|Overall Study|Did not meet entrance criteria|1|||
125579270|NCT00930059|451747939|FG000|Overall Study|Withdrawal by Subject|3|||
125579271|NCT00930059|451747940|FG001|Overall Study|Withdrawal by Subject|4|||
125579272|NCT00930059|451747939|FG000|Overall Study|Other|1|||
125579273|NCT00930059|451747940|FG001|Overall Study|Other|0|||
125579274|NCT00930059|451747939|FG000|Overall Study|1 site terminated by sponsor|1|||
125579275|NCT00930059|451747940|FG001|Overall Study|1 site terminated by sponsor|1|||
125579276|NCT00930059|451747939|FG000|Overall Study|Adverse Event|1|||
125579277|NCT00930059|451747940|FG001|Overall Study|Adverse Event|6|||
125579278|NCT04002310|451747943|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
125579279|NCT04002310|451747944|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
125579280|NCT04002310|451747945|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
125579281|NCT04002310|451747946|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
125579282|NCT04002310|451747947|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
125359567|NCT05055128|450952355|FG001|Overall Study|Protocol Violation|0|||
125359568|NCT05055128|450952356|FG002|Overall Study|Protocol Violation|0|||
125579283|NCT00542997|451747948|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
125579284|NCT00542997|451747948|FG000|Wash in / Wash Out Period|Adverse Event|3|||
125579285|NCT00542997|451747948|FG000|Efficacy Period|Adverse Event|3|||
125579286|NCT02949128|451747951|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
125579287|NCT02949128|451747951|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
125579288|NCT02949128|451747951|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
125579289|NCT02949128|451747951|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
125579290|NCT02949128|451747951|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
125579291|NCT02949128|451747951|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
125579292|NCT02949128|451747951|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
125579293|NCT02949128|451747951|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
125579294|NCT02949128|451747951|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
125579295|NCT02949128|451747951|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
125579296|NCT03064763|451747954|FG000|Overall Study|Lost to Follow-up|1|||
125579297|NCT03064763|451747954|FG000|Overall Study|Death|8|||
125579298|NCT00808444|451747965|FG000|Overall Study|Withdrawal by Subject|1|||
125579299|NCT00808444|451747966|FG001|Overall Study|Withdrawal by Subject|0|||
125579300|NCT00808444|451747965|FG000|Overall Study|Lost to Follow-up|0|||
125579301|NCT00808444|451747966|FG001|Overall Study|Lost to Follow-up|1|||
125579302|NCT02770326|451747967|FG000|Overall Study|Death|3|||
125579303|NCT02770326|451747967|FG000|Overall Study|Lost to Follow-up|1|||
125359569|NCT05055128|450952357|FG003|Overall Study|Protocol Violation|1|||
125359570|NCT05055128|450952358|FG004|Overall Study|Protocol Violation|0|||
125579304|NCT02971202|451747968|FG000|Overall Study|Pregnancy|1|||
125579305|NCT02971202|451747969|FG001|Overall Study|Pregnancy|0|||
125359571|NCT05055128|450952354|FG000|Overall Study|Withdrawal by Subject|5|||
125579306|NCT02971202|451747970|FG002|Overall Study|Pregnancy|0|||
125579307|NCT02971202|451747968|FG000|Overall Study|screen fail after consent|1|||
125579308|NCT02971202|451747969|FG001|Overall Study|screen fail after consent|0|||
125579309|NCT02971202|451747970|FG002|Overall Study|screen fail after consent|1|||
125579310|NCT02634580|451747971|FG000|Double-blind Treatment Period|Subject Request|1|||
125579311|NCT02634580|451747972|FG001|Double-blind Treatment Period|Subject Request|0|||
125579312|NCT02634580|451747973|FG002|Double-blind Treatment Period|Subject Request|1|||
125579313|NCT02634580|451747974|FG003|Double-blind Treatment Period|Subject Request|1|||
125579314|NCT02634580|451747971|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
125579315|NCT02634580|451747972|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
125579316|NCT02634580|451747973|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
125579317|NCT02634580|451747974|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
125579318|NCT03106779|451747978|FG000|Overall Study|Lack of Efficacy|33|||
125579319|NCT03106779|451747979|FG001|Overall Study|Lack of Efficacy|24|||
125579320|NCT03106779|451747978|FG000|Overall Study|Adverse Event|8|||
125579321|NCT03106779|451747979|FG001|Overall Study|Adverse Event|16|||
125359572|NCT05055128|450952355|FG001|Overall Study|Withdrawal by Subject|2|||
125359573|NCT05055128|450952356|FG002|Overall Study|Withdrawal by Subject|2|||
125359574|NCT05055128|450952357|FG003|Overall Study|Withdrawal by Subject|4|||
125359575|NCT05055128|450952358|FG004|Overall Study|Withdrawal by Subject|2|||
125359576|NCT05055128|450952354|FG000|Overall Study|Randomized By Mistake|0|||
125359577|NCT05055128|450952355|FG001|Overall Study|Randomized By Mistake|1|||
125359578|NCT05055128|450952356|FG002|Overall Study|Randomized By Mistake|0|||
125359579|NCT05055128|450952357|FG003|Overall Study|Randomized By Mistake|0|||
125359580|NCT05055128|450952358|FG004|Overall Study|Randomized By Mistake|0|||
125359581|NCT05055128|450952354|FG000|Overall Study|Other|1|||
125359582|NCT05055128|450952355|FG001|Overall Study|Other|0|||
125359583|NCT05055128|450952356|FG002|Overall Study|Other|0|||
125359584|NCT05055128|450952357|FG003|Overall Study|Other|0|||
125359585|NCT05055128|450952358|FG004|Overall Study|Other|0|||
125359586|NCT01385371|450952359|FG000|Overall Study|Adverse Event|54|||
125359587|NCT01385371|450952360|FG001|Overall Study|Adverse Event|19|||
125359588|NCT01385371|450952359|FG000|Overall Study|Lost to Follow-up|16|||
125359589|NCT01385371|450952360|FG001|Overall Study|Lost to Follow-up|16|||
125359590|NCT01385371|450952359|FG000|Overall Study|Withdrawal by Subject|52|||
125359591|NCT01385371|450952360|FG001|Overall Study|Withdrawal by Subject|39|||
125359592|NCT01385371|450952359|FG000|Overall Study|Protocol Violation|25|||
125359593|NCT01385371|450952360|FG001|Overall Study|Protocol Violation|21|||
125359594|NCT01385371|450952359|FG000|Overall Study|Administrative|2|||
125359595|NCT01385371|450952360|FG001|Overall Study|Administrative|2|||
125359596|NCT00936611|450952361|FG000|Overall Study|Progressive Disease|3|||
125359597|NCT00936611|450952361|FG000|Overall Study|New Systemic Therapy|22|||
125359598|NCT00936611|450952361|FG000|Overall Study|Lost to Follow-up|1|||
125359599|NCT00936611|450952361|FG000|Overall Study|Withdrawal by Subject|2|||
125359600|NCT00936611|450952361|FG000|Overall Study|Still on Follow-up|1|||
125359601|NCT00936611|450952361|FG000|Overall Study|Still on Active Therapy|7|||
125359602|NCT00936611|450952361|FG000|Overall Study|Ineligible for Study Drug|3|||
125359603|NCT01346969|450952362|FG000|Overall Study|Withdrawal by Subject|0|||
125359604|NCT01346969|450952363|FG001|Overall Study|Withdrawal by Subject|0|||
125359605|NCT01346969|450952364|FG002|Overall Study|Withdrawal by Subject|1|||
125359606|NCT01346969|450952365|FG003|Overall Study|Withdrawal by Subject|0|||
125359607|NCT01346969|450952362|FG000|Overall Study|Lost to Follow-up|1|||
125359608|NCT01346969|450952363|FG001|Overall Study|Lost to Follow-up|0|||
125359609|NCT01346969|450952364|FG002|Overall Study|Lost to Follow-up|2|||
125359610|NCT01346969|450952365|FG003|Overall Study|Lost to Follow-up|0|||
125359611|NCT01346969|450952362|FG000|Overall Study|Physician Decision|0|||
125359612|NCT01346969|450952363|FG001|Overall Study|Physician Decision|0|||
125359613|NCT01346969|450952364|FG002|Overall Study|Physician Decision|0|||
125359614|NCT01346969|450952365|FG003|Overall Study|Physician Decision|1|||
125359615|NCT01346969|450952362|FG000|Overall Study|Randomized but not treated|1|||
125359616|NCT01346969|450952363|FG001|Overall Study|Randomized but not treated|0|||
125359617|NCT01346969|450952364|FG002|Overall Study|Randomized but not treated|0|||
125359618|NCT01346969|450952365|FG003|Overall Study|Randomized but not treated|0|||
125359619|NCT02906332|450952369|FG000|Overall Study|Withdrawal by Subject|1|||
125359620|NCT02949700|450952370|FG000|Phase I|Withdrawal by Subject|1|||
125359621|NCT02949700|450952371|FG001|Phase I|Withdrawal by Subject|1|||
125359622|NCT02949700|450952372|FG002|Phase I|Withdrawal by Subject|0|||
125359623|NCT02949700|450952373|FG003|Phase I|Withdrawal by Subject|0|||
125359624|NCT02949700|450952370|FG000|Phase I|Protocol Violation|1|||
125359625|NCT02949700|450952371|FG001|Phase I|Protocol Violation|0|||
125579322|NCT03106779|451747978|FG000|Overall Study|Physician Decision|10|||
125359626|NCT02949700|450952372|FG002|Phase I|Protocol Violation|0|||
125359627|NCT02949700|450952373|FG003|Phase I|Protocol Violation|0|||
125359628|NCT02949700|450952370|FG000|Phase II|Withdrawal by Subject|0|||
125359629|NCT02949700|450952371|FG001|Phase II|Withdrawal by Subject|0|||
125359630|NCT02949700|450952372|FG002|Phase II|Withdrawal by Subject|0|||
125359631|NCT02949700|450952373|FG003|Phase II|Withdrawal by Subject|2|||
125359632|NCT02949700|450952370|FG000|Phase II|Protocol Violation|0|||
125359633|NCT02949700|450952371|FG001|Phase II|Protocol Violation|0|||
125359634|NCT02949700|450952372|FG002|Phase II|Protocol Violation|1|||
125359635|NCT02949700|450952373|FG003|Phase II|Protocol Violation|3|||
125359636|NCT03945266|450952374|FG000|Overall Study|Withdrawal by Subject|1|||
125579323|NCT03106779|451747979|FG001|Overall Study|Physician Decision|6|||
125359637|NCT03945266|450952375|FG001|Overall Study|Withdrawal by Subject|0|||
125359638|NCT03945266|450952374|FG000|Overall Study|Miscarriage|0|||
125359639|NCT03945266|450952375|FG001|Overall Study|Miscarriage|2|||
125359640|NCT03945266|450952374|FG000|Overall Study|Lost to Follow-up|1|||
125359641|NCT03945266|450952375|FG001|Overall Study|Lost to Follow-up|0|||
125359642|NCT01686828|450952376|FG000|Overall Study|Physician Decision|1|||
125359643|NCT01686828|450952377|FG001|Overall Study|Physician Decision|0|||
125359644|NCT01686828|450952378|FG002|Overall Study|Physician Decision|0|||
125359645|NCT01686828|450952379|FG003|Overall Study|Physician Decision|0|||
125359646|NCT01686828|450952376|FG000|Overall Study|New Job|0|||
125359647|NCT01686828|450952377|FG001|Overall Study|New Job|1|||
125359648|NCT01686828|450952378|FG002|Overall Study|New Job|0|||
125359649|NCT01686828|450952379|FG003|Overall Study|New Job|0|||
125359650|NCT01686828|450952376|FG000|Overall Study|Weight Loss|0|||
125359651|NCT01686828|450952377|FG001|Overall Study|Weight Loss|0|||
125359652|NCT01686828|450952378|FG002|Overall Study|Weight Loss|1|||
125359653|NCT01686828|450952379|FG003|Overall Study|Weight Loss|0|||
125359654|NCT03553927|450952382|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
125359655|NCT03553927|450952383|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
125359656|NCT03553927|450952382|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
125359657|NCT03553927|450952383|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
125359658|NCT04176705|450952384|FG000|Overall Study|Withdrawal by Subject|4|||
125359659|NCT04176705|450952385|FG001|Overall Study|Withdrawal by Subject|4|||
125359660|NCT04176705|450952384|FG000|Overall Study|Death|1|||
125359661|NCT04176705|450952385|FG001|Overall Study|Death|1|||
125359662|NCT04176705|450952384|FG000|Overall Study|Lost to Follow-up|3|||
125359663|NCT04176705|450952385|FG001|Overall Study|Lost to Follow-up|3|||
125359664|NCT02423772|450952386|FG000|Overall Study|Lost to Follow-up|3|||
125359665|NCT02423772|450952387|FG001|Overall Study|Lost to Follow-up|3|||
125359666|NCT02423772|450952386|FG000|Overall Study|Did not begin intervention|2|||
125359667|NCT02423772|450952387|FG001|Overall Study|Did not begin intervention|5|||
125359668|NCT03698331|450952391|FG000|Overall Study|Adverse Event|2|||
125359669|NCT03698331|450952392|FG001|Overall Study|Adverse Event|3|||
125359670|NCT03698331|450952391|FG000|Overall Study|Withdrawal by Subject|1|||
125359671|NCT03698331|450952392|FG001|Overall Study|Withdrawal by Subject|1|||
125359672|NCT03698331|450952391|FG000|Overall Study|Lost to Follow-up|0|||
125359673|NCT03698331|450952392|FG001|Overall Study|Lost to Follow-up|2|||
125359674|NCT03698331|450952391|FG000|Overall Study|Non-compliance with study drug|1|||
125359675|NCT03698331|450952392|FG001|Overall Study|Non-compliance with study drug|0|||
125359676|NCT01193842|450952393|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
125359677|NCT01193842|450952394|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
125359678|NCT01193842|450952395|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
125359679|NCT01193842|450952396|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
125359680|NCT01193842|450952397|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
125359681|NCT01193842|450952393|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
125359682|NCT01193842|450952394|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
125359683|NCT01193842|450952395|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
125359684|NCT01193842|450952396|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
125359685|NCT01193842|450952397|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
125359686|NCT01193842|450952393|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
125359687|NCT01193842|450952394|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
125359688|NCT01193842|450952395|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
125359689|NCT01193842|450952396|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
125359690|NCT01193842|450952397|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
125359691|NCT01193842|450952393|FG000|Phase II: Randomized Groups|Death|0|||
125359692|NCT01193842|450952394|FG001|Phase II: Randomized Groups|Death|0|||
125359693|NCT01193842|450952395|FG002|Phase II: Randomized Groups|Death|0|||
125359694|NCT01193842|450952396|FG003|Phase II: Randomized Groups|Death|1|||
125359695|NCT01193842|450952397|FG004|Phase II: Randomized Groups|Death|1|||
125359696|NCT01193842|450952393|FG000|Phase II: Randomized Groups|Adverse Event|0|||
125359697|NCT01193842|450952394|FG001|Phase II: Randomized Groups|Adverse Event|0|||
125427716|NCT00031486|451191047|FG001|Overall Study|Did not meet eligibility requirement|1|||
125359698|NCT01193842|450952395|FG002|Phase II: Randomized Groups|Adverse Event|0|||
125579324|NCT03106779|451747978|FG000|Overall Study|Patient/guardian decision|4|||
125579325|NCT03106779|451747979|FG001|Overall Study|Patient/guardian decision|3|||
125579326|NCT03106779|451747978|FG000|Overall Study|Progressive disease|1|||
125579327|NCT03106779|451747979|FG001|Overall Study|Progressive disease|3|||
125579328|NCT03106779|451747978|FG000|Overall Study|Lost to Follow-up|1|||
125579329|NCT03106779|451747979|FG001|Overall Study|Lost to Follow-up|2|||
125359699|NCT01193842|450952396|FG003|Phase II: Randomized Groups|Adverse Event|5|||
125359700|NCT01193842|450952397|FG004|Phase II: Randomized Groups|Adverse Event|3|||
125359701|NCT01193842|450952393|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
125359702|NCT01193842|450952394|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
125359703|NCT01193842|450952395|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
125359704|NCT01193842|450952396|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
125359705|NCT01193842|450952397|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
125359706|NCT01193842|450952393|FG000|Phase II: Randomized Groups|Ineligible|0|||
125359707|NCT01193842|450952394|FG001|Phase II: Randomized Groups|Ineligible|0|||
125359708|NCT01193842|450952395|FG002|Phase II: Randomized Groups|Ineligible|0|||
125359709|NCT01193842|450952396|FG003|Phase II: Randomized Groups|Ineligible|0|||
125359710|NCT01193842|450952397|FG004|Phase II: Randomized Groups|Ineligible|1|||
125359711|NCT01193842|450952393|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
125359712|NCT01193842|450952394|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
125359713|NCT01193842|450952395|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
125359714|NCT01193842|450952396|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
125359715|NCT01193842|450952397|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
125359716|NCT02130024|450952399|FG000|Overall Study|Adverse Event|10|||
125579330|NCT03106779|451747978|FG000|Overall Study|Death|1|||
125579331|NCT03106779|451747979|FG001|Overall Study|Death|0|||
125579332|NCT03106779|451747978|FG000|Overall Study|Protocol Violation|1|||
125579333|NCT03106779|451747979|FG001|Overall Study|Protocol Violation|0|||
125579334|NCT03106779|451747978|FG000|Overall Study|Not treated|1|||
125579335|NCT03106779|451747979|FG001|Overall Study|Not treated|0|||
125579336|NCT02288247|451747980|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
125579337|NCT02288247|451747981|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
125579338|NCT02288247|451747980|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
125579339|NCT02288247|451747981|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
125579340|NCT02288247|451747980|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
125579341|NCT02288247|451747981|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
125579342|NCT02288247|451747980|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
125579343|NCT02288247|451747981|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
125579344|NCT02288247|451747980|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
125579345|NCT02288247|451747981|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
125579346|NCT02288247|451747980|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
125579347|NCT02288247|451747981|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
125579348|NCT02288247|451747980|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
125579349|NCT02288247|451747981|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
125579350|NCT02288247|451747980|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
125579351|NCT02288247|451747981|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
125579352|NCT02288247|451747980|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
125579353|NCT02288247|451747981|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
125579354|NCT02288247|451747980|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
125579355|NCT02288247|451747981|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
125579356|NCT02288247|451747980|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
125579357|NCT02288247|451747981|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
125579358|NCT02288247|451747980|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
125579359|NCT02288247|451747981|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
125579360|NCT02288247|451747980|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
125579361|NCT02288247|451747981|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
125579362|NCT02288247|451747980|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
125579363|NCT02288247|451747981|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
125579364|NCT02288247|451747980|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
125579365|NCT02288247|451747981|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
125579366|NCT02288247|451747980|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
125359717|NCT02130024|450952400|FG001|Overall Study|Adverse Event|11|||
125359718|NCT02130024|450952399|FG000|Overall Study|Death|2|||
125359719|NCT02130024|450952400|FG001|Overall Study|Death|2|||
125359720|NCT02130024|450952399|FG000|Overall Study|Lost to Follow-up|1|||
125359721|NCT02130024|450952400|FG001|Overall Study|Lost to Follow-up|1|||
125359722|NCT02130024|450952399|FG000|Overall Study|Physician Decision|1|||
125359723|NCT02130024|450952400|FG001|Overall Study|Physician Decision|3|||
125359724|NCT02130024|450952399|FG000|Overall Study|Protocol Deviation|4|||
125359725|NCT02130024|450952400|FG001|Overall Study|Protocol Deviation|0|||
125359726|NCT02130024|450952399|FG000|Overall Study|Site Administration Problems|1|||
125359727|NCT02130024|450952400|FG001|Overall Study|Site Administration Problems|0|||
125359728|NCT02130024|450952399|FG000|Overall Study|Subject Withdrew Consent|6|||
125359729|NCT02130024|450952400|FG001|Overall Study|Subject Withdrew Consent|14|||
125359730|NCT01467583|450952401|FG000|Overall Study|Death|1|||
125211494|NCT01716520|450399720|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125211495|NCT01716520|450399721|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125211496|NCT01716520|450399722|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125211497|NCT01716520|450399723|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125211498|NCT01716520|450399724|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125211499|NCT01716520|450399725|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125211500|NCT01716520|450399720|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
125211501|NCT01716520|450399721|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
125211502|NCT01716520|450399722|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
125211503|NCT01716520|450399723|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
125211504|NCT01716520|450399724|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
125211505|NCT01716520|450399725|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
125211506|NCT01716520|450399720|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125211507|NCT01716520|450399721|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125359731|NCT01467583|450952402|FG001|Overall Study|Death|1|||
125359732|NCT01467583|450952403|FG002|Overall Study|Death|0|||
125359733|NCT01467583|450952401|FG000|Overall Study|Withdrawal by Subject|1|||
125359734|NCT01467583|450952402|FG001|Overall Study|Withdrawal by Subject|0|||
125359735|NCT01467583|450952403|FG002|Overall Study|Withdrawal by Subject|0|||
125359736|NCT01467583|450952401|FG000|Overall Study|Protocol Violation|0|||
125359737|NCT01467583|450952402|FG001|Overall Study|Protocol Violation|0|||
125359738|NCT01467583|450952403|FG002|Overall Study|Protocol Violation|2|||
125359739|NCT05274165|450952405|FG000|Overall Study|Withdrawal by Subject|3|||
125359740|NCT05274165|450952406|FG001|Overall Study|Withdrawal by Subject|3|||
125359741|NCT02484690|450952409|FG000|Overall Study|Adverse Event|1|||
125359742|NCT02484690|450952410|FG001|Overall Study|Adverse Event|3|||
125359743|NCT02484690|450952411|FG002|Overall Study|Adverse Event|0|||
125359744|NCT02484690|450952412|FG003|Overall Study|Adverse Event|0|||
125359745|NCT02484690|450952413|FG004|Overall Study|Adverse Event|5|||
125359746|NCT02484690|450952409|FG000|Overall Study|Death|0|||
125359747|NCT02484690|450952410|FG001|Overall Study|Death|0|||
125359748|NCT02484690|450952411|FG002|Overall Study|Death|0|||
125359749|NCT02484690|450952412|FG003|Overall Study|Death|0|||
125359750|NCT02484690|450952413|FG004|Overall Study|Death|1|||
125359751|NCT02484690|450952409|FG000|Overall Study|Withdrawal by Subject|1|||
125359752|NCT02484690|450952410|FG001|Overall Study|Withdrawal by Subject|3|||
125359753|NCT02484690|450952411|FG002|Overall Study|Withdrawal by Subject|1|||
125359754|NCT02484690|450952412|FG003|Overall Study|Withdrawal by Subject|2|||
125359755|NCT02484690|450952413|FG004|Overall Study|Withdrawal by Subject|0|||
125359756|NCT02484690|450952409|FG000|Overall Study|Physician Decision|2|||
125359757|NCT02484690|450952410|FG001|Overall Study|Physician Decision|0|||
125359758|NCT02484690|450952411|FG002|Overall Study|Physician Decision|1|||
125359759|NCT02484690|450952412|FG003|Overall Study|Physician Decision|0|||
125359760|NCT02484690|450952413|FG004|Overall Study|Physician Decision|0|||
125359761|NCT02484690|450952409|FG000|Overall Study|Lost to Follow-up|0|||
125359762|NCT02484690|450952410|FG001|Overall Study|Lost to Follow-up|0|||
125359763|NCT02484690|450952411|FG002|Overall Study|Lost to Follow-up|1|||
125359764|NCT02484690|450952412|FG003|Overall Study|Lost to Follow-up|0|||
125359765|NCT02484690|450952413|FG004|Overall Study|Lost to Follow-up|0|||
125359766|NCT03360747|450952414|FG000|Overall Study|Voluntary Withdrawal|1|||
125359767|NCT01759511|450952418|FG000|Overall Study|Adverse Event|4|||
125359768|NCT01759511|450952418|FG000|Overall Study|Death|2|||
125359769|NCT01759511|450952418|FG000|Overall Study|Lack of Efficacy|2|||
125359770|NCT01759511|450952418|FG000|Overall Study|Physician Decision|1|||
125359771|NCT01759511|450952418|FG000|Overall Study|Progressive Disease|5|||
125359772|NCT01759511|450952418|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
125579367|NCT02288247|451747981|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
125579368|NCT04093531|451747982|FG000|Overall Study|failed screening|4|||
125579369|NCT03222349|451747983|FG000|Overall Study|Treatment B not done|5|||
125579370|NCT03222349|451747984|FG001|Overall Study|Treatment B not done|0|||
125579371|NCT03222349|451747983|FG000|Overall Study|Lost to Follow-up|1|||
125579372|NCT03222349|451747984|FG001|Overall Study|Lost to Follow-up|2|||
125427717|NCT00031486|451191046|FG000|Overall Study|Other|1|||
125579373|NCT03222349|451747983|FG000|Overall Study|Withdrawal by Subject|1|||
125579374|NCT03222349|451747984|FG001|Overall Study|Withdrawal by Subject|0|||
125579375|NCT03222349|451747983|FG000|Overall Study|Treatment A not done|0|||
125579376|NCT03222349|451747984|FG001|Overall Study|Treatment A not done|5|||
125579377|NCT03222349|451747983|FG000|Overall Study|Study terminated by sponsor|1|||
125579378|NCT03222349|451747984|FG001|Overall Study|Study terminated by sponsor|0|||
125579379|NCT00094757|451747988|FG000|Overall Study|Adverse Event|11|||
125579380|NCT00094757|451747989|FG001|Overall Study|Adverse Event|9|||
125579381|NCT00094757|451747990|FG002|Overall Study|Adverse Event|6|||
125579382|NCT00094757|451747988|FG000|Overall Study|Lack of Efficacy|11|||
125579383|NCT00094757|451747989|FG001|Overall Study|Lack of Efficacy|15|||
125427718|NCT00031486|451191047|FG001|Overall Study|Other|1|||
125579384|NCT00094757|451747990|FG002|Overall Study|Lack of Efficacy|8|||
125579385|NCT00094757|451747988|FG000|Overall Study|Lost to Follow-up|3|||
125359773|NCT01759511|450952418|FG000|Overall Study|Study Terminated by Sponsor|13|||
125359774|NCT01759511|450952418|FG000|Overall Study|Withdrawal by Subject|3|||
125359775|NCT04916769|450952419|FG000|Period 1|Physician Decision|0|||
125359776|NCT04916769|450952420|FG001|Period 1|Physician Decision|0|||
125359777|NCT04916769|450952421|FG002|Period 1|Physician Decision|0|||
125359778|NCT04916769|450952422|FG003|Period 1|Physician Decision|0|||
125359779|NCT04916769|450952423|FG004|Period 1|Physician Decision|0|||
125359780|NCT04916769|450952424|FG005|Period 1|Physician Decision|1|||
125359781|NCT04916769|450952419|FG000|Period 2|Physician Decision|0|||
125359782|NCT04916769|450952420|FG001|Period 2|Physician Decision|1|||
125359783|NCT04916769|450952421|FG002|Period 2|Physician Decision|0|||
125359784|NCT04916769|450952422|FG003|Period 2|Physician Decision|0|||
125359785|NCT04916769|450952423|FG004|Period 2|Physician Decision|0|||
125359786|NCT04916769|450952424|FG005|Period 2|Physician Decision|0|||
125359787|NCT04526509|450952437|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
125359788|NCT04526509|450952438|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
125359789|NCT04526509|450952439|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
125359790|NCT04526509|450952440|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
125359791|NCT04526509|450952441|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
125359792|NCT04526509|450952442|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
125359793|NCT04526509|450952443|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
125359794|NCT04526509|450952437|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
125359795|NCT04526509|450952438|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
125359796|NCT04526509|450952439|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
125359797|NCT04526509|450952440|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
125359798|NCT04526509|450952441|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
125359799|NCT04526509|450952442|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
125359800|NCT04526509|450952443|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
125359801|NCT04526509|450952437|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
125359802|NCT04526509|450952438|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
125359803|NCT04526509|450952439|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
125359804|NCT04526509|450952440|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
125359805|NCT04526509|450952441|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
125359806|NCT04526509|450952442|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
125359807|NCT04526509|450952443|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
125359808|NCT04526509|450952437|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
125359809|NCT04526509|450952438|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
125359810|NCT04526509|450952439|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
125359811|NCT04526509|450952440|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
125359812|NCT04526509|450952441|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
125359813|NCT04526509|450952442|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
125359814|NCT04526509|450952443|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
125359815|NCT04526509|450952437|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
125359816|NCT04526509|450952438|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
125359817|NCT04526509|450952439|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
125359818|NCT04526509|450952440|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
125359819|NCT04526509|450952441|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
125359820|NCT04526509|450952442|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
125359821|NCT04526509|450952443|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
125359822|NCT04526509|450952437|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
125359823|NCT04526509|450952438|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
125359824|NCT04526509|450952439|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
125359825|NCT04526509|450952440|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
125359826|NCT04526509|450952441|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
125359827|NCT04526509|450952442|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
125359828|NCT04526509|450952443|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
125359829|NCT04526509|450952437|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
125359830|NCT04526509|450952438|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
125359831|NCT04526509|450952439|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
125359832|NCT04526509|450952440|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
125359833|NCT04526509|450952441|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
125359834|NCT04526509|450952442|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
125359835|NCT04526509|450952443|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
125359836|NCT04526509|450952437|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
125359837|NCT04526509|450952438|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
125359838|NCT04526509|450952439|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
125359839|NCT04526509|450952440|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
125359840|NCT04526509|450952441|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
125359841|NCT04526509|450952442|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
125359842|NCT04526509|450952443|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
125359843|NCT04526509|450952437|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
125359844|NCT04526509|450952438|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
125359845|NCT04526509|450952439|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
125359846|NCT04526509|450952440|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
125427719|NCT03685591|451191048|FG000|Overall Study|Global Deterioration of Health Status|0|||
125427720|NCT03685591|451191049|FG001|Overall Study|Global Deterioration of Health Status|0|||
125378929|NCT00531050|451019210|FG002|Part 1: Period 1|Protocol Deviation|0|||
125359847|NCT04526509|450952441|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
125359848|NCT04526509|450952442|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
125359849|NCT04526509|450952443|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
125359850|NCT04526509|450952437|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
125359851|NCT04526509|450952438|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
125359852|NCT04526509|450952439|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
125359853|NCT04526509|450952440|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
125359854|NCT04526509|450952441|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
125359855|NCT04526509|450952442|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
125359856|NCT04526509|450952443|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
125359857|NCT04526509|450952437|FG000|Enrolled|Study Terminated by Sponsor|0|||
125359858|NCT04526509|450952438|FG001|Enrolled|Study Terminated by Sponsor|0|||
125359859|NCT04526509|450952439|FG002|Enrolled|Study Terminated by Sponsor|0|||
125359860|NCT04526509|450952440|FG003|Enrolled|Study Terminated by Sponsor|0|||
125359861|NCT04526509|450952441|FG004|Enrolled|Study Terminated by Sponsor|0|||
125359862|NCT04526509|450952442|FG005|Enrolled|Study Terminated by Sponsor|0|||
125359863|NCT04526509|450952443|FG006|Enrolled|Study Terminated by Sponsor|1|||
125359864|NCT04526509|450952437|FG000|Enrolled|Death prior to lymphodepletion|0|||
125359865|NCT04526509|450952438|FG001|Enrolled|Death prior to lymphodepletion|0|||
125579386|NCT00094757|451747989|FG001|Overall Study|Lost to Follow-up|5|||
125579387|NCT00094757|451747990|FG002|Overall Study|Lost to Follow-up|6|||
125579388|NCT00094757|451747988|FG000|Overall Study|Patient Moved|2|||
125579389|NCT00094757|451747989|FG001|Overall Study|Patient Moved|1|||
125579390|NCT00094757|451747990|FG002|Overall Study|Patient Moved|1|||
125579391|NCT00094757|451747988|FG000|Overall Study|Protocol Violation|8|||
125579392|NCT00094757|451747989|FG001|Overall Study|Protocol Violation|5|||
125579393|NCT00094757|451747990|FG002|Overall Study|Protocol Violation|3|||
125579394|NCT00094757|451747988|FG000|Overall Study|Withdrawal by Subject|14|||
125579395|NCT00094757|451747989|FG001|Overall Study|Withdrawal by Subject|21|||
125579396|NCT00094757|451747990|FG002|Overall Study|Withdrawal by Subject|5|||
125579397|NCT00094757|451747988|FG000|Overall Study|Other|3|||
125579398|NCT00094757|451747989|FG001|Overall Study|Other|3|||
125579399|NCT00094757|451747990|FG002|Overall Study|Other|1|||
125579400|NCT00094757|451747988|FG000|Overall Study|Protocol specified discontinuation|1|||
125579401|NCT00094757|451747989|FG001|Overall Study|Protocol specified discontinuation|3|||
125579402|NCT00094757|451747990|FG002|Overall Study|Protocol specified discontinuation|0|||
125579403|NCT00756938|451747991|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
125579404|NCT00756938|451747992|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
125579405|NCT00756938|451747993|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
125579406|NCT00756938|451747994|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
125579407|NCT00756938|451747991|FG000|12-week Base Study|Protocol Violation|0|||
125579408|NCT00756938|451747992|FG001|12-week Base Study|Protocol Violation|0|||
125579409|NCT00756938|451747993|FG002|12-week Base Study|Protocol Violation|1|||
125211508|NCT01716520|450399722|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125211509|NCT01716520|450399723|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125211510|NCT01716520|450399724|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125211511|NCT01716520|450399725|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
125211512|NCT01716520|450399720|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
125211513|NCT01716520|450399721|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
125211514|NCT01716520|450399722|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
125211515|NCT01716520|450399723|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
125211516|NCT01716520|450399724|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
125211517|NCT01716520|450399725|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
125211518|NCT01716520|450399720|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
125211519|NCT01716520|450399721|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
125211520|NCT01716520|450399722|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
125211521|NCT01716520|450399723|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
125211522|NCT01716520|450399724|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
125211523|NCT01716520|450399725|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
125211524|NCT01716520|450399720|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125211525|NCT01716520|450399721|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125211526|NCT01716520|450399722|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125211527|NCT01716520|450399723|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125211528|NCT01716520|450399724|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
125211529|NCT01716520|450399725|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125211530|NCT01716520|450399720|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
125211531|NCT01716520|450399721|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
125211532|NCT01716520|450399722|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
125211533|NCT01716520|450399723|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
125211534|NCT01716520|450399724|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
125211535|NCT01716520|450399725|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
125211536|NCT01716520|450399720|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
125211537|NCT01716520|450399721|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
125211538|NCT01716520|450399722|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
125211539|NCT01716520|450399723|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
125211540|NCT01716520|450399724|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
125211541|NCT01716520|450399725|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
125211542|NCT01716520|450399720|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
125211543|NCT01716520|450399721|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
125211544|NCT01716520|450399722|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
125211545|NCT01716520|450399723|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
125211546|NCT01716520|450399724|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
125211547|NCT01716520|450399725|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
125211548|NCT01716520|450399720|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
125211549|NCT01716520|450399721|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
125211550|NCT01716520|450399722|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
125211551|NCT01716520|450399723|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
125211552|NCT01716520|450399724|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
125211553|NCT01716520|450399725|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
125211554|NCT01716520|450399720|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
125211555|NCT01716520|450399721|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
125211556|NCT01716520|450399722|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
125211557|NCT01716520|450399723|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
125211558|NCT01716520|450399724|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
125211559|NCT01716520|450399725|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
125211560|NCT01716520|450399720|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125211561|NCT01716520|450399721|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125211562|NCT01716520|450399722|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125211563|NCT01716520|450399723|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125211564|NCT01716520|450399724|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125211565|NCT01716520|450399725|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
125211566|NCT01716520|450399720|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125211567|NCT01716520|450399721|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125211568|NCT01716520|450399722|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
125211569|NCT01716520|450399723|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125359866|NCT04526509|450952439|FG002|Enrolled|Death prior to lymphodepletion|0|||
125359867|NCT04526509|450952440|FG003|Enrolled|Death prior to lymphodepletion|1|||
125359868|NCT04526509|450952441|FG004|Enrolled|Death prior to lymphodepletion|0|||
125359869|NCT04526509|450952442|FG005|Enrolled|Death prior to lymphodepletion|0|||
125359870|NCT04526509|450952443|FG006|Enrolled|Death prior to lymphodepletion|0|||
125359871|NCT04526509|450952437|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
125359872|NCT04526509|450952438|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
125359873|NCT04526509|450952439|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
125359874|NCT04526509|450952440|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
125359875|NCT04526509|450952441|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
125359876|NCT04526509|450952442|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
125359877|NCT04526509|450952443|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
125359878|NCT04526509|450952437|FG000|Enrolled|Physician Decision|0|||
125359879|NCT04526509|450952438|FG001|Enrolled|Physician Decision|1|||
125359880|NCT04526509|450952439|FG002|Enrolled|Physician Decision|0|||
125359881|NCT04526509|450952440|FG003|Enrolled|Physician Decision|0|||
125359882|NCT04526509|450952441|FG004|Enrolled|Physician Decision|0|||
125359883|NCT04526509|450952442|FG005|Enrolled|Physician Decision|0|||
125359884|NCT04526509|450952443|FG006|Enrolled|Physician Decision|0|||
125359885|NCT04340193|450952445|FG000|Overall Study|Other reason|0|||
125359886|NCT04340193|450952446|FG001|Overall Study|Other reason|0|||
125579410|NCT00756938|451747994|FG003|12-week Base Study|Protocol Violation|0|||
125579411|NCT00756938|451747991|FG000|12-week Base Study|Lost to Follow-up|1|||
125579412|NCT00756938|451747992|FG001|12-week Base Study|Lost to Follow-up|0|||
125579413|NCT00756938|451747993|FG002|12-week Base Study|Lost to Follow-up|0|||
125579414|NCT00756938|451747994|FG003|12-week Base Study|Lost to Follow-up|0|||
125579415|NCT00756938|451747991|FG000|Optional Extension|Lack of Efficacy|0|||
125579416|NCT00756938|451747992|FG001|Optional Extension|Lack of Efficacy|0|||
125579417|NCT00756938|451747993|FG002|Optional Extension|Lack of Efficacy|0|||
125579418|NCT00756938|451747994|FG003|Optional Extension|Lack of Efficacy|1|||
125579419|NCT00756938|451747991|FG000|Optional Extension|End of Study|0|||
125579420|NCT00756938|451747992|FG001|Optional Extension|End of Study|0|||
125579421|NCT00756938|451747993|FG002|Optional Extension|End of Study|0|||
125579422|NCT00756938|451747994|FG003|Optional Extension|End of Study|11|||
125579423|NCT00756938|451747991|FG000|Optional Extension|Protocol-specific criteria met|0|||
125579424|NCT00756938|451747992|FG001|Optional Extension|Protocol-specific criteria met|0|||
125579425|NCT00756938|451747993|FG002|Optional Extension|Protocol-specific criteria met|0|||
125579426|NCT00756938|451747994|FG003|Optional Extension|Protocol-specific criteria met|9|||
125579427|NCT00756938|451747991|FG000|Optional Extension|Physician Decision|0|||
125579428|NCT00756938|451747992|FG001|Optional Extension|Physician Decision|0|||
125579429|NCT00756938|451747993|FG002|Optional Extension|Physician Decision|0|||
125579430|NCT00756938|451747994|FG003|Optional Extension|Physician Decision|3|||
125579431|NCT00756938|451747991|FG000|Optional Extension|Lost to Follow-up|0|||
125579432|NCT00756938|451747992|FG001|Optional Extension|Lost to Follow-up|0|||
125579433|NCT00756938|451747993|FG002|Optional Extension|Lost to Follow-up|0|||
125579434|NCT00756938|451747994|FG003|Optional Extension|Lost to Follow-up|1|||
125579435|NCT00756938|451747991|FG000|Optional Extension|Protocol Violation|0|||
125579436|NCT00756938|451747992|FG001|Optional Extension|Protocol Violation|0|||
125579437|NCT00756938|451747993|FG002|Optional Extension|Protocol Violation|0|||
125579438|NCT00756938|451747994|FG003|Optional Extension|Protocol Violation|1|||
125579439|NCT00756938|451747991|FG000|Optional Extension|Withdrawal by Subject|0|||
125579440|NCT00756938|451747992|FG001|Optional Extension|Withdrawal by Subject|0|||
125579441|NCT00756938|451747993|FG002|Optional Extension|Withdrawal by Subject|0|||
125579442|NCT00756938|451747994|FG003|Optional Extension|Withdrawal by Subject|10|||
125579443|NCT00756938|451747991|FG000|Optional Extension|Adverse Event|0|||
125579444|NCT00756938|451747992|FG001|Optional Extension|Adverse Event|0|||
125579445|NCT00756938|451747993|FG002|Optional Extension|Adverse Event|0|||
125579446|NCT00756938|451747994|FG003|Optional Extension|Adverse Event|1|||
125579447|NCT01127165|451747996|FG000|Overall Study|Adverse Event|2|||
125579448|NCT01127165|451747997|FG001|Overall Study|Adverse Event|2|||
125579449|NCT01127165|451747996|FG000|Overall Study|Lack of Efficacy|10|||
125579450|NCT01127165|451747997|FG001|Overall Study|Lack of Efficacy|8|||
125579451|NCT01127165|451747996|FG000|Overall Study|Lost to Follow-up|3|||
125579452|NCT01127165|451747997|FG001|Overall Study|Lost to Follow-up|5|||
125579453|NCT01127165|451747996|FG000|Overall Study|Withdrawal by Subject|1|||
125579454|NCT01127165|451747997|FG001|Overall Study|Withdrawal by Subject|3|||
125579455|NCT01127165|451747996|FG000|Overall Study|Protocol Violation|0|||
125579456|NCT01127165|451747997|FG001|Overall Study|Protocol Violation|1|||
125579457|NCT00763321|451747998|FG000|Open-label Period|Adverse Event|24|||
125579458|NCT00763321|451747999|FG001|Open-label Period|Adverse Event|0|||
125211570|NCT01716520|450399724|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125579459|NCT00763321|451748000|FG002|Open-label Period|Adverse Event|0|||
125579460|NCT00763321|451747998|FG000|Open-label Period|Lost to Follow-up|14|||
125579461|NCT00763321|451747999|FG001|Open-label Period|Lost to Follow-up|0|||
125579462|NCT00763321|451748000|FG002|Open-label Period|Lost to Follow-up|0|||
125579463|NCT00763321|451747998|FG000|Open-label Period|Withdrawal by Subject|7|||
125579464|NCT00763321|451747999|FG001|Open-label Period|Withdrawal by Subject|0|||
125579465|NCT00763321|451748000|FG002|Open-label Period|Withdrawal by Subject|0|||
125579466|NCT00763321|451747998|FG000|Open-label Period|Subject noncompliant|7|||
125579467|NCT00763321|451747999|FG001|Open-label Period|Subject noncompliant|0|||
125579468|NCT00763321|451748000|FG002|Open-label Period|Subject noncompliant|0|||
125579469|NCT00763321|451747998|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
125579470|NCT00763321|451747999|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
125579471|NCT00763321|451748000|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
125579472|NCT00763321|451747998|FG000|Open-label Period|Lack of Efficacy|2|||
125579473|NCT00763321|451747999|FG001|Open-label Period|Lack of Efficacy|0|||
125579474|NCT00763321|451748000|FG002|Open-label Period|Lack of Efficacy|0|||
125427721|NCT03685591|451191050|FG002|Overall Study|Global Deterioration of Health Status|0|||
125427722|NCT03685591|451191051|FG003|Overall Study|Global Deterioration of Health Status|1|||
125427723|NCT03685591|451191052|FG004|Overall Study|Global Deterioration of Health Status|2|||
125427724|NCT03685591|451191053|FG005|Overall Study|Global Deterioration of Health Status|4|||
125427725|NCT03685591|451191054|FG006|Overall Study|Global Deterioration of Health Status|1|||
125427726|NCT03685591|451191055|FG007|Overall Study|Global Deterioration of Health Status|1|||
125427727|NCT03685591|451191056|FG008|Overall Study|Global Deterioration of Health Status|0|||
125427728|NCT03685591|451191048|FG000|Overall Study|Progressive Disease|1|||
125427729|NCT03685591|451191049|FG001|Overall Study|Progressive Disease|1|||
125427730|NCT03685591|451191050|FG002|Overall Study|Progressive Disease|0|||
125427731|NCT03685591|451191051|FG003|Overall Study|Progressive Disease|3|||
125427732|NCT03685591|451191052|FG004|Overall Study|Progressive Disease|5|||
125427733|NCT03685591|451191053|FG005|Overall Study|Progressive Disease|4|||
125427734|NCT03685591|451191054|FG006|Overall Study|Progressive Disease|3|||
125427735|NCT03685591|451191055|FG007|Overall Study|Progressive Disease|2|||
125427736|NCT03685591|451191056|FG008|Overall Study|Progressive Disease|1|||
125427737|NCT03685591|451191048|FG000|Overall Study|Other|0|||
125427738|NCT03685591|451191049|FG001|Overall Study|Other|0|||
125427739|NCT03685591|451191050|FG002|Overall Study|Other|1|||
125427740|NCT03685591|451191051|FG003|Overall Study|Other|0|||
125427741|NCT03685591|451191052|FG004|Overall Study|Other|2|||
125427742|NCT03685591|451191053|FG005|Overall Study|Other|3|||
125427743|NCT03685591|451191054|FG006|Overall Study|Other|0|||
125427744|NCT03685591|451191055|FG007|Overall Study|Other|0|||
125427745|NCT03685591|451191056|FG008|Overall Study|Other|0|||
125427746|NCT03685591|451191048|FG000|Overall Study|Withdrawal by Subject|0|||
125427747|NCT03685591|451191049|FG001|Overall Study|Withdrawal by Subject|0|||
125427748|NCT03685591|451191050|FG002|Overall Study|Withdrawal by Subject|0|||
125427749|NCT03685591|451191051|FG003|Overall Study|Withdrawal by Subject|0|||
125427750|NCT03685591|451191052|FG004|Overall Study|Withdrawal by Subject|3|||
125427751|NCT03685591|451191053|FG005|Overall Study|Withdrawal by Subject|2|||
125427752|NCT03685591|451191054|FG006|Overall Study|Withdrawal by Subject|0|||
125427753|NCT03685591|451191055|FG007|Overall Study|Withdrawal by Subject|0|||
125427754|NCT03685591|451191056|FG008|Overall Study|Withdrawal by Subject|1|||
125427755|NCT03685591|451191048|FG000|Overall Study|Adverse Event|0|||
125427756|NCT03685591|451191049|FG001|Overall Study|Adverse Event|0|||
125427757|NCT03685591|451191050|FG002|Overall Study|Adverse Event|0|||
125427758|NCT03685591|451191051|FG003|Overall Study|Adverse Event|1|||
125427759|NCT03685591|451191052|FG004|Overall Study|Adverse Event|1|||
125427760|NCT03685591|451191053|FG005|Overall Study|Adverse Event|4|||
125427761|NCT03685591|451191054|FG006|Overall Study|Adverse Event|0|||
125427762|NCT03685591|451191055|FG007|Overall Study|Adverse Event|1|||
125427763|NCT03685591|451191056|FG008|Overall Study|Adverse Event|1|||
125427764|NCT01777321|451192433|FG000|Overall Study|Withdrawal by Subject|0|||
125427765|NCT01777321|451192434|FG001|Overall Study|Withdrawal by Subject|1|||
125427766|NCT00089141|451192435|FG000|Overall Study|Termination of trial|18|||
125427767|NCT00089141|451192436|FG001|Overall Study|Termination of trial|24|||
125427768|NCT00508261|451192437|FG000|Overall Study|Other|0|||
125427769|NCT00508261|451192438|FG001|Overall Study|Other|1|||
125427770|NCT00508261|451192439|FG002|Overall Study|Other|1|||
125579475|NCT00763321|451747998|FG000|Open-label Period|Other|4|||
125427771|NCT00508261|451192440|FG003|Overall Study|Other|0|||
125427772|NCT00508261|451192437|FG000|Overall Study|Serious Adverse Event|0|||
125427773|NCT00508261|451192438|FG001|Overall Study|Serious Adverse Event|1|||
125427774|NCT00508261|451192439|FG002|Overall Study|Serious Adverse Event|0|||
125427775|NCT00508261|451192440|FG003|Overall Study|Serious Adverse Event|0|||
125427776|NCT00508261|451192437|FG000|Overall Study|Withdrawal by Subject|3|||
125579476|NCT00763321|451747999|FG001|Open-label Period|Other|0|||
125427777|NCT00508261|451192438|FG001|Overall Study|Withdrawal by Subject|4|||
125427778|NCT00508261|451192439|FG002|Overall Study|Withdrawal by Subject|4|||
125427779|NCT00508261|451192440|FG003|Overall Study|Withdrawal by Subject|0|||
125427780|NCT00508261|451192437|FG000|Overall Study|Migrated/ moved from study area|0|||
125427781|NCT00508261|451192438|FG001|Overall Study|Migrated/ moved from study area|1|||
125427782|NCT00508261|451192439|FG002|Overall Study|Migrated/ moved from study area|0|||
125427783|NCT00508261|451192440|FG003|Overall Study|Migrated/ moved from study area|0|||
125427784|NCT00508261|451192437|FG000|Overall Study|Lost to Follow-up|0|||
125427785|NCT00508261|451192438|FG001|Overall Study|Lost to Follow-up|1|||
125427786|NCT00508261|451192439|FG002|Overall Study|Lost to Follow-up|1|||
125427787|NCT00508261|451192440|FG003|Overall Study|Lost to Follow-up|1|||
125427788|NCT00180479|451192441|FG000|Overall Study|Death|4|||
125359887|NCT04340193|450952447|FG002|Overall Study|Other reason|1|||
125359888|NCT04340193|450952445|FG000|Overall Study|Disease recurrence|0|||
125359889|NCT04340193|450952446|FG001|Overall Study|Disease recurrence|1|||
125359890|NCT04340193|450952447|FG002|Overall Study|Disease recurrence|0|||
125359891|NCT04340193|450952445|FG000|Overall Study|Study drug toxicity|1|||
125359892|NCT04340193|450952446|FG001|Overall Study|Study drug toxicity|0|||
125359893|NCT04340193|450952447|FG002|Overall Study|Study drug toxicity|0|||
125359894|NCT04340193|450952445|FG000|Overall Study|Disease progression|1|||
125359895|NCT04340193|450952446|FG001|Overall Study|Disease progression|2|||
125359896|NCT04340193|450952447|FG002|Overall Study|Disease progression|3|||
125359897|NCT04340193|450952445|FG000|Overall Study|Administrative reasons by sponsor|0|||
125359898|NCT04340193|450952446|FG001|Overall Study|Administrative reasons by sponsor|1|||
125359899|NCT04340193|450952447|FG002|Overall Study|Administrative reasons by sponsor|0|||
125359900|NCT04340193|450952445|FG000|Overall Study|Adverse Event|1|||
125359901|NCT04340193|450952446|FG001|Overall Study|Adverse Event|1|||
125359902|NCT04340193|450952447|FG002|Overall Study|Adverse Event|0|||
125359903|NCT03001882|450952448|FG000|Overall Study|Death|1|||
125359904|NCT03001882|450952449|FG001|Overall Study|Death|0|||
125359905|NCT03001882|450952450|FG002|Overall Study|Death|0|||
125359906|NCT03001882|450952451|FG003|Overall Study|Death|3|||
125359907|NCT03001882|450952448|FG000|Overall Study|Participant withdrew consent|0|||
125359908|NCT03001882|450952449|FG001|Overall Study|Participant withdrew consent|1|||
125359909|NCT03001882|450952450|FG002|Overall Study|Participant withdrew consent|0|||
125359910|NCT03001882|450952451|FG003|Overall Study|Participant withdrew consent|5|||
125359911|NCT03001882|450952448|FG000|Overall Study|Other reasons|1|||
125359912|NCT03001882|450952449|FG001|Overall Study|Other reasons|2|||
125359913|NCT03001882|450952450|FG002|Overall Study|Other reasons|0|||
125359914|NCT03001882|450952451|FG003|Overall Study|Other reasons|5|||
125359915|NCT03001882|450952448|FG000|Overall Study|Administrative reason by sponsor|0|||
125359916|NCT03001882|450952449|FG001|Overall Study|Administrative reason by sponsor|0|||
125579477|NCT00763321|451748000|FG002|Open-label Period|Other|0|||
125579478|NCT00763321|451747998|FG000|Double-blind Period|Lack of Efficacy|0|||
125579479|NCT00763321|451747999|FG001|Double-blind Period|Lack of Efficacy|9|||
125579480|NCT00763321|451748000|FG002|Double-blind Period|Lack of Efficacy|17|||
125579481|NCT00763321|451747998|FG000|Double-blind Period|Adverse Event|0|||
125579482|NCT00763321|451747999|FG001|Double-blind Period|Adverse Event|4|||
125579483|NCT00763321|451748000|FG002|Double-blind Period|Adverse Event|4|||
125579484|NCT00763321|451747998|FG000|Double-blind Period|Lost to Follow-up|0|||
125579485|NCT00763321|451747999|FG001|Double-blind Period|Lost to Follow-up|4|||
125579486|NCT00763321|451748000|FG002|Double-blind Period|Lost to Follow-up|2|||
125579487|NCT00763321|451747998|FG000|Double-blind Period|Withdrawal by Subject|0|||
125579488|NCT00763321|451747999|FG001|Double-blind Period|Withdrawal by Subject|2|||
125579489|NCT00763321|451748000|FG002|Double-blind Period|Withdrawal by Subject|3|||
125579490|NCT00763321|451747998|FG000|Double-blind Period|Other|0|||
125579491|NCT00763321|451747999|FG001|Double-blind Period|Other|2|||
125579492|NCT00763321|451748000|FG002|Double-blind Period|Other|3|||
125359917|NCT03001882|450952450|FG002|Overall Study|Administrative reason by sponsor|0|||
125359918|NCT03001882|450952451|FG003|Overall Study|Administrative reason by sponsor|1|||
125359919|NCT03001882|450952448|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
125579493|NCT03175549|451748001|FG000|Overall Study|Lost to Follow-up|2|||
125579494|NCT03175549|451748002|FG001|Overall Study|Lost to Follow-up|2|||
125579495|NCT03175549|451748001|FG000|Overall Study|Medication non-compliance|2|||
125359920|NCT03001882|450952449|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
125359921|NCT03001882|450952450|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
125359922|NCT03001882|450952451|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
125359923|NCT03001882|450952448|FG000|Overall Study|Not reported|0|||
125359924|NCT03001882|450952449|FG001|Overall Study|Not reported|0|||
125359925|NCT03001882|450952450|FG002|Overall Study|Not reported|0|||
125359926|NCT03001882|450952451|FG003|Overall Study|Not reported|6|||
125359927|NCT03001882|450952448|FG000|Overall Study|Maximum clinical benefit|2|||
125359928|NCT03001882|450952449|FG001|Overall Study|Maximum clinical benefit|3|||
125359929|NCT03001882|450952450|FG002|Overall Study|Maximum clinical benefit|0|||
125359930|NCT03001882|450952451|FG003|Overall Study|Maximum clinical benefit|10|||
125359931|NCT03001882|450952448|FG000|Overall Study|AE unrelated to study drug|3|||
125359932|NCT03001882|450952449|FG001|Overall Study|AE unrelated to study drug|3|||
125579496|NCT03175549|451748002|FG001|Overall Study|Medication non-compliance|2|||
125579497|NCT02486757|451748003|FG000|Overall Study|Lost to Follow-up|1|||
125579498|NCT02793232|451748004|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125579499|NCT02793232|451748005|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125359933|NCT03001882|450952450|FG002|Overall Study|AE unrelated to study drug|0|||
125359934|NCT03001882|450952451|FG003|Overall Study|AE unrelated to study drug|11|||
125359935|NCT03001882|450952448|FG000|Overall Study|Study Drug Toxicity|8|||
125359936|NCT03001882|450952449|FG001|Overall Study|Study Drug Toxicity|5|||
125579500|NCT02793232|451748006|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125579501|NCT02793232|451748007|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125579502|NCT02793232|451748008|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
125579503|NCT02793232|451748009|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125579504|NCT02793232|451748010|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
125579505|NCT02793232|451748011|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125579506|NCT02793232|451748012|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
125359937|NCT03001882|450952450|FG002|Overall Study|Study Drug Toxicity|0|||
125359938|NCT03001882|450952451|FG003|Overall Study|Study Drug Toxicity|37|||
125359939|NCT03001882|450952448|FG000|Overall Study|Disease progression|16|||
125359940|NCT03001882|450952449|FG001|Overall Study|Disease progression|14|||
125359941|NCT03001882|450952450|FG002|Overall Study|Disease progression|1|||
125359942|NCT03001882|450952451|FG003|Overall Study|Disease progression|90|||
125359943|NCT01386008|450952452|FG000|Overall Study|exited w/o incident /study discontinued|17|||
125359944|NCT01386008|450952452|FG000|Overall Study|Adverse Event|3|||
125359945|NCT00589290|450952453|FG000|Overall Study|Withdrawal by Subject|1|||
125359946|NCT04449861|450952454|FG000|Overall Study|Withdrawal by Subject|4|||
125359947|NCT04449861|450952454|FG000|Overall Study|Lost to Follow-up|5|||
125359948|NCT04449861|450952454|FG000|Overall Study|Death|112|||
125359949|NCT00976677|450952455|FG000|Overall Study|Adverse Event|1|||
125359950|NCT00976677|450952456|FG001|Overall Study|Adverse Event|0|||
125359951|NCT00976677|450952455|FG000|Overall Study|Withdrawal by Subject|0|||
125359952|NCT00976677|450952456|FG001|Overall Study|Withdrawal by Subject|2|||
125359953|NCT00976677|450952455|FG000|Overall Study|Disease progression|1|||
125359954|NCT00976677|450952456|FG001|Overall Study|Disease progression|1|||
125359955|NCT00976677|450952455|FG000|Overall Study|Trial unblinded|2|||
125359956|NCT00976677|450952456|FG001|Overall Study|Trial unblinded|2|||
125359957|NCT00976677|450952455|FG000|Overall Study|Unknown/Missing|1|||
125359958|NCT00976677|450952456|FG001|Overall Study|Unknown/Missing|0|||
125359959|NCT03507400|450952457|FG000|Overall Study|discontinued|5|||
125359960|NCT03507400|450952458|FG001|Overall Study|discontinued|1|||
125359961|NCT03507400|450952457|FG000|Overall Study|Lost to Follow-up|8|||
125359962|NCT03507400|450952458|FG001|Overall Study|Lost to Follow-up|6|||
125359963|NCT03507400|450952457|FG000|Overall Study|Protocol Violation|0|||
125359964|NCT03507400|450952458|FG001|Overall Study|Protocol Violation|1|||
125359965|NCT01555983|450952463|FG000|Overall Study|Withdrawal by Subject|1|||
125359966|NCT01555983|450952464|FG001|Overall Study|Withdrawal by Subject|0|||
125359967|NCT01555983|450952465|FG002|Overall Study|Withdrawal by Subject|0|||
125359968|NCT01555983|450952466|FG003|Overall Study|Withdrawal by Subject|0|||
125359969|NCT01555983|450952467|FG004|Overall Study|Withdrawal by Subject|1|||
125579507|NCT01298492|451748013|FG000|Overall Study|Death|2|||
125579508|NCT01298492|451748013|FG000|Overall Study|Insufficient Clinical Response|22|||
125359970|NCT01555983|450952468|FG005|Overall Study|Withdrawal by Subject|1|||
125359971|NCT02598960|450954272|FG000|Treatment Period|Disease Progression|4|||
125359972|NCT02598960|450954273|FG001|Treatment Period|Disease Progression|4|||
125359973|NCT02598960|450954274|FG002|Treatment Period|Disease Progression|4|||
125359974|NCT02598960|450954275|FG003|Treatment Period|Disease Progression|6|||
125359975|NCT02598960|450954276|FG004|Treatment Period|Disease Progression|8|||
125579509|NCT01298492|451748013|FG000|Overall Study|Lost to Follow-up|12|||
125579510|NCT01298492|451748013|FG000|Overall Study|Withdrawal by Subject|47|||
125579511|NCT01298492|451748013|FG000|Overall Study|Other (Unspecified)|7|||
125579512|NCT01298492|451748013|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
125579513|NCT01298492|451748013|FG000|Overall Study|Protocol Violation|2|||
125579514|NCT01298492|451748013|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
125579515|NCT01298492|451748013|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
125579516|NCT00352105|451748014|FG000|Overall Study|Death|5|||
125579517|NCT00352105|451748014|FG000|Overall Study|Withdrawal by Subject|5|||
125579518|NCT00352105|451748014|FG000|Overall Study|Lack of Efficacy|9|||
125579519|NCT00352105|451748014|FG000|Overall Study|Adverse Event|19|||
125579520|NCT00352105|451748014|FG000|Overall Study|Protocol Violation|2|||
125579521|NCT01405053|451748015|FG000|Overall Study|Adverse Event|3|||
125579522|NCT01405053|451748016|FG001|Overall Study|Adverse Event|0|||
125579523|NCT01405053|451748015|FG000|Overall Study|Lost to Follow-up|0|||
125579524|NCT01405053|451748016|FG001|Overall Study|Lost to Follow-up|1|||
125579525|NCT01405053|451748015|FG000|Overall Study|Participant choice|2|||
125579526|NCT01405053|451748016|FG001|Overall Study|Participant choice|1|||
125579527|NCT01405053|451748015|FG000|Overall Study|Inadequate therapeutic effect|2|||
125579528|NCT01405053|451748016|FG001|Overall Study|Inadequate therapeutic effect|1|||
125579529|NCT01405053|451748015|FG000|Overall Study|Withdrawal by Subject|3|||
125579530|NCT01405053|451748016|FG001|Overall Study|Withdrawal by Subject|4|||
125579531|NCT01405053|451748015|FG000|Overall Study|Other|0|||
125579532|NCT01405053|451748016|FG001|Overall Study|Other|1|||
125579533|NCT02551159|451748017|FG000|Overall Study|Death|352|||
125579534|NCT02551159|451748018|FG001|Overall Study|Death|174|||
125579535|NCT02551159|451748019|FG002|Overall Study|Death|161|||
125579536|NCT02551159|451748017|FG000|Overall Study|Withdrawal by Subject|8|||
125579537|NCT02551159|451748018|FG001|Overall Study|Withdrawal by Subject|5|||
125579538|NCT02551159|451748019|FG002|Overall Study|Withdrawal by Subject|16|||
125579539|NCT02551159|451748017|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
125579540|NCT02551159|451748018|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
125579541|NCT02551159|451748019|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
125579542|NCT00268242|451748020|FG000|Overall Study|Death|1|||
125579543|NCT00993928|451748021|FG000|Overall Study|Withdrawal by Subject|4|||
125579544|NCT00993928|451748022|FG001|Overall Study|Withdrawal by Subject|7|||
125579545|NCT00993928|451748021|FG000|Overall Study|ineligible|1|||
125579546|NCT00993928|451748022|FG001|Overall Study|ineligible|0|||
125579547|NCT04871711|451748023|FG000|Overall Study|Withdrawal by Subject|11|||
125579548|NCT04871711|451748024|FG001|Overall Study|Withdrawal by Subject|5|||
125579549|NCT04871711|451748023|FG000|Overall Study|Lack of Efficacy|5|||
125579550|NCT04871711|451748024|FG001|Overall Study|Lack of Efficacy|7|||
125579551|NCT04871711|451748023|FG000|Overall Study|Adverse Event|2|||
125579552|NCT04871711|451748024|FG001|Overall Study|Adverse Event|6|||
125579553|NCT04871711|451748023|FG000|Overall Study|Various reasons|2|||
125579554|NCT04871711|451748024|FG001|Overall Study|Various reasons|1|||
125579555|NCT04871711|451748023|FG000|Overall Study|Lost to Follow-up|0|||
125579556|NCT04871711|451748024|FG001|Overall Study|Lost to Follow-up|2|||
125579557|NCT03551743|451748028|FG000|Overall Study|Adverse Event|1|||
125579558|NCT03551743|451748029|FG001|Overall Study|Adverse Event|0|||
125579559|NCT03551743|451748030|FG002|Overall Study|Adverse Event|0|||
125579560|NCT03551743|451748031|FG003|Overall Study|Adverse Event|0|||
125579561|NCT03551743|451748028|FG000|Overall Study|Withdrawal by Subject|1|||
125579562|NCT03551743|451748029|FG001|Overall Study|Withdrawal by Subject|0|||
125579563|NCT03551743|451748030|FG002|Overall Study|Withdrawal by Subject|0|||
125579564|NCT03551743|451748031|FG003|Overall Study|Withdrawal by Subject|0|||
125579565|NCT00911989|451748032|FG000|Overall Study|Adverse Event|1|||
125579566|NCT04556617|451748038|FG000|Overall Study|progressive disease|0|||
125579567|NCT04556617|451748039|FG001|Overall Study|progressive disease|2|||
125579568|NCT04556617|451748040|FG002|Overall Study|progressive disease|2|||
125579569|NCT04556617|451748041|FG003|Overall Study|progressive disease|1|||
125579570|NCT04556617|451748042|FG004|Overall Study|progressive disease|1|||
125579571|NCT04556617|451748038|FG000|Overall Study|Physician Decision|0|||
125579572|NCT04556617|451748039|FG001|Overall Study|Physician Decision|0|||
125579573|NCT04556617|451748040|FG002|Overall Study|Physician Decision|2|||
125579574|NCT04556617|451748041|FG003|Overall Study|Physician Decision|0|||
125579575|NCT04556617|451748042|FG004|Overall Study|Physician Decision|0|||
125579576|NCT04556617|451748038|FG000|Overall Study|Adverse Event|0|||
125579577|NCT04556617|451748039|FG001|Overall Study|Adverse Event|0|||
125579578|NCT04556617|451748040|FG002|Overall Study|Adverse Event|2|||
125579579|NCT04556617|451748041|FG003|Overall Study|Adverse Event|3|||
125579580|NCT04556617|451748042|FG004|Overall Study|Adverse Event|0|||
125579581|NCT04556617|451748038|FG000|Overall Study|Withdrawal by Subject|0|||
125579582|NCT04556617|451748039|FG001|Overall Study|Withdrawal by Subject|2|||
125579583|NCT04556617|451748040|FG002|Overall Study|Withdrawal by Subject|1|||
125579584|NCT04556617|451748041|FG003|Overall Study|Withdrawal by Subject|1|||
125579585|NCT04556617|451748042|FG004|Overall Study|Withdrawal by Subject|0|||
125579586|NCT04556617|451748038|FG000|Overall Study|PSA increase|0|||
125579587|NCT04556617|451748039|FG001|Overall Study|PSA increase|1|||
125579588|NCT04556617|451748040|FG002|Overall Study|PSA increase|0|||
125579589|NCT04556617|451748041|FG003|Overall Study|PSA increase|0|||
125579590|NCT04556617|451748042|FG004|Overall Study|PSA increase|0|||
125579591|NCT04556617|451748038|FG000|Overall Study|Sponsor study termination|1|||
125579592|NCT04556617|451748039|FG001|Overall Study|Sponsor study termination|0|||
125579593|NCT04556617|451748040|FG002|Overall Study|Sponsor study termination|0|||
125579594|NCT04556617|451748041|FG003|Overall Study|Sponsor study termination|0|||
125579595|NCT04556617|451748042|FG004|Overall Study|Sponsor study termination|0|||
125579596|NCT03179436|451748043|FG000|Overall Study|Withdrawal by Subject|1|||
125579597|NCT03179436|451748044|FG001|Overall Study|Withdrawal by Subject|0|||
125579598|NCT03179436|451748045|FG002|Overall Study|Withdrawal by Subject|0|||
125579599|NCT03179436|451748046|FG003|Overall Study|Withdrawal by Subject|4|||
125579600|NCT03179436|451748047|FG004|Overall Study|Withdrawal by Subject|2|||
125579601|NCT03179436|451748048|FG005|Overall Study|Withdrawal by Subject|2|||
125579602|NCT03179436|451748049|FG006|Overall Study|Withdrawal by Subject|5|||
125579603|NCT03179436|451748050|FG007|Overall Study|Withdrawal by Subject|0|||
125579604|NCT03179436|451748051|FG008|Overall Study|Withdrawal by Subject|3|||
125579605|NCT03179436|451748052|FG009|Overall Study|Withdrawal by Subject|0|||
125579606|NCT03179436|451748053|FG010|Overall Study|Withdrawal by Subject|0|||
125579607|NCT03179436|451748054|FG011|Overall Study|Withdrawal by Subject|0|||
125579608|NCT03179436|451748043|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125579609|NCT03179436|451748044|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125579610|NCT03179436|451748045|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125579611|NCT03179436|451748046|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125579612|NCT03179436|451748047|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125579613|NCT03179436|451748048|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
125579614|NCT03179436|451748049|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
125579615|NCT03179436|451748050|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
125579616|NCT03179436|451748051|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
125579617|NCT03179436|451748052|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
125579618|NCT03179436|451748053|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
125579619|NCT03179436|451748054|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
125359976|NCT02598960|450954277|FG005|Treatment Period|Disease Progression|2|||
125359977|NCT02598960|450954278|FG006|Treatment Period|Disease Progression|2|||
125359978|NCT02598960|450954279|FG007|Treatment Period|Disease Progression|3|||
125359979|NCT02598960|450954280|FG008|Treatment Period|Disease Progression|7|||
125359980|NCT02598960|450954281|FG009|Treatment Period|Disease Progression|9|||
125359981|NCT02598960|450954282|FG010|Treatment Period|Disease Progression|7|||
125359982|NCT02598960|450954283|FG011|Treatment Period|Disease Progression|143|||
125359983|NCT02598960|450954284|FG012|Treatment Period|Disease Progression|23|||
125359984|NCT02598960|450954272|FG000|Treatment Period|Study drug toxicity|0|||
125359985|NCT02598960|450954273|FG001|Treatment Period|Study drug toxicity|0|||
125359986|NCT02598960|450954274|FG002|Treatment Period|Study drug toxicity|0|||
125359987|NCT02598960|450954275|FG003|Treatment Period|Study drug toxicity|0|||
125359988|NCT02598960|450954276|FG004|Treatment Period|Study drug toxicity|0|||
125359989|NCT02598960|450954277|FG005|Treatment Period|Study drug toxicity|0|||
125359990|NCT02598960|450954278|FG006|Treatment Period|Study drug toxicity|0|||
125359991|NCT02598960|450954279|FG007|Treatment Period|Study drug toxicity|0|||
125359992|NCT02598960|450954280|FG008|Treatment Period|Study drug toxicity|0|||
125359993|NCT02598960|450954281|FG009|Treatment Period|Study drug toxicity|1|||
125359994|NCT02598960|450954282|FG010|Treatment Period|Study drug toxicity|0|||
125359995|NCT02598960|450954283|FG011|Treatment Period|Study drug toxicity|3|||
125359996|NCT02598960|450954284|FG012|Treatment Period|Study drug toxicity|0|||
125359997|NCT02598960|450954272|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
125359998|NCT02598960|450954273|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
125359999|NCT02598960|450954274|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
125360000|NCT02598960|450954275|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
125360001|NCT02598960|450954276|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
125360002|NCT02598960|450954277|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
125360003|NCT02598960|450954278|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
125360004|NCT02598960|450954279|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
125360005|NCT02598960|450954280|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
125360006|NCT02598960|450954281|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
125360007|NCT02598960|450954282|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
125360008|NCT02598960|450954283|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
125360009|NCT02598960|450954284|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
125360010|NCT02598960|450954272|FG000|Treatment Period|participant request to discontinue|0|||
125579620|NCT03179436|451748043|FG000|Overall Study|Sponsor Decision|0|||
125579621|NCT03179436|451748044|FG001|Overall Study|Sponsor Decision|0|||
125579622|NCT03179436|451748045|FG002|Overall Study|Sponsor Decision|1|||
125579623|NCT03179436|451748046|FG003|Overall Study|Sponsor Decision|3|||
125427789|NCT00180479|451192442|FG001|Overall Study|Death|2|||
125427790|NCT00180479|451192441|FG000|Overall Study|Lost to Follow-up|9|||
125427791|NCT00180479|451192442|FG001|Overall Study|Lost to Follow-up|7|||
125427792|NCT00180479|451192441|FG000|Overall Study|Withdrawal by Subject|3|||
125427793|NCT00180479|451192442|FG001|Overall Study|Withdrawal by Subject|3|||
125427794|NCT00180479|451192441|FG000|Overall Study|Informed consent not signed|0|||
125427795|NCT00180479|451192442|FG001|Overall Study|Informed consent not signed|1|||
125427796|NCT00526630|451192451|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
125427797|NCT00526630|451192452|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
125427798|NCT00526630|451192451|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
125427799|NCT00526630|451192452|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
125427800|NCT03518125|451192454|FG000|Overall Study|Lost to Follow-up|0|||
125579624|NCT03179436|451748047|FG004|Overall Study|Sponsor Decision|9|||
125579625|NCT03179436|451748048|FG005|Overall Study|Sponsor Decision|7|||
125579626|NCT03179436|451748049|FG006|Overall Study|Sponsor Decision|2|||
125360011|NCT02598960|450954273|FG001|Treatment Period|participant request to discontinue|1|||
125360012|NCT02598960|450954274|FG002|Treatment Period|participant request to discontinue|0|||
125360013|NCT02598960|450954275|FG003|Treatment Period|participant request to discontinue|0|||
125360014|NCT02598960|450954276|FG004|Treatment Period|participant request to discontinue|1|||
125360015|NCT02598960|450954277|FG005|Treatment Period|participant request to discontinue|0|||
125427801|NCT03518125|451192455|FG001|Overall Study|Lost to Follow-up|2|||
125427802|NCT03518125|451192456|FG002|Overall Study|Lost to Follow-up|0|||
125427803|NCT03518125|451192457|FG003|Overall Study|Lost to Follow-up|0|||
125579627|NCT03179436|451748050|FG007|Overall Study|Sponsor Decision|4|||
125579628|NCT03179436|451748051|FG008|Overall Study|Sponsor Decision|23|||
125427804|NCT03518125|451192458|FG004|Overall Study|Lost to Follow-up|3|||
125427805|NCT03518125|451192459|FG005|Overall Study|Lost to Follow-up|5|||
125427806|NCT03518125|451192454|FG000|Overall Study|Physician Decision|0|||
125427807|NCT03518125|451192455|FG001|Overall Study|Physician Decision|1|||
125427808|NCT03518125|451192456|FG002|Overall Study|Physician Decision|0|||
125427809|NCT03518125|451192457|FG003|Overall Study|Physician Decision|0|||
125427810|NCT03518125|451192458|FG004|Overall Study|Physician Decision|0|||
125427811|NCT03518125|451192459|FG005|Overall Study|Physician Decision|0|||
125427812|NCT03518125|451192454|FG000|Overall Study|Withdrawal by Subject|1|||
125427813|NCT03518125|451192455|FG001|Overall Study|Withdrawal by Subject|1|||
125427814|NCT03518125|451192456|FG002|Overall Study|Withdrawal by Subject|0|||
125427815|NCT03518125|451192457|FG003|Overall Study|Withdrawal by Subject|1|||
125427816|NCT03518125|451192458|FG004|Overall Study|Withdrawal by Subject|1|||
125427817|NCT03518125|451192459|FG005|Overall Study|Withdrawal by Subject|3|||
125427818|NCT03518125|451192454|FG000|Overall Study|Missed Day 394 Visit|1|||
125427819|NCT03518125|451192455|FG001|Overall Study|Missed Day 394 Visit|0|||
125427820|NCT03518125|451192456|FG002|Overall Study|Missed Day 394 Visit|0|||
125427821|NCT03518125|451192457|FG003|Overall Study|Missed Day 394 Visit|0|||
125427822|NCT03518125|451192458|FG004|Overall Study|Missed Day 394 Visit|0|||
125579629|NCT03179436|451748052|FG009|Overall Study|Sponsor Decision|6|||
125579630|NCT03179436|451748053|FG010|Overall Study|Sponsor Decision|7|||
125427823|NCT03518125|451192459|FG005|Overall Study|Missed Day 394 Visit|0|||
125427824|NCT00106184|451192462|FG000|Overall Study|Withdrawal by Subject|3|||
125427825|NCT00106184|451192463|FG001|Overall Study|Withdrawal by Subject|2|||
125579631|NCT03179436|451748054|FG011|Overall Study|Sponsor Decision|5|||
125579632|NCT03179436|451748043|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
125579633|NCT03179436|451748044|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
125579634|NCT03179436|451748045|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
125579635|NCT03179436|451748046|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
125579636|NCT03179436|451748047|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
125579637|NCT03179436|451748048|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
125579638|NCT03179436|451748049|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
125579639|NCT03179436|451748050|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
125579640|NCT03179436|451748051|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
125579641|NCT03179436|451748052|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
125579642|NCT03179436|451748053|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
125579643|NCT03179436|451748054|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
125579644|NCT03179436|451748043|FG000|Overall Study|Lost to Follow-up|1|||
125579645|NCT03179436|451748044|FG001|Overall Study|Lost to Follow-up|0|||
125579646|NCT03179436|451748045|FG002|Overall Study|Lost to Follow-up|0|||
125579647|NCT03179436|451748046|FG003|Overall Study|Lost to Follow-up|1|||
125579648|NCT03179436|451748047|FG004|Overall Study|Lost to Follow-up|0|||
125579649|NCT03179436|451748048|FG005|Overall Study|Lost to Follow-up|1|||
125579650|NCT03179436|451748049|FG006|Overall Study|Lost to Follow-up|0|||
125579651|NCT03179436|451748050|FG007|Overall Study|Lost to Follow-up|0|||
125579652|NCT03179436|451748051|FG008|Overall Study|Lost to Follow-up|1|||
125579653|NCT03179436|451748052|FG009|Overall Study|Lost to Follow-up|1|||
125579654|NCT03179436|451748053|FG010|Overall Study|Lost to Follow-up|0|||
125579655|NCT03179436|451748054|FG011|Overall Study|Lost to Follow-up|0|||
125579656|NCT03179436|451748043|FG000|Overall Study|Death|12|||
125579657|NCT03179436|451748044|FG001|Overall Study|Death|17|||
125579658|NCT03179436|451748045|FG002|Overall Study|Death|7|||
125579659|NCT03179436|451748046|FG003|Overall Study|Death|32|||
125579660|NCT03179436|451748047|FG004|Overall Study|Death|29|||
125579661|NCT03179436|451748048|FG005|Overall Study|Death|30|||
125579662|NCT03179436|451748049|FG006|Overall Study|Death|33|||
125579663|NCT03179436|451748050|FG007|Overall Study|Death|9|||
125579664|NCT03179436|451748051|FG008|Overall Study|Death|84|||
125579665|NCT03179436|451748052|FG009|Overall Study|Death|33|||
125579666|NCT03179436|451748053|FG010|Overall Study|Death|22|||
125579667|NCT03179436|451748054|FG011|Overall Study|Death|15|||
125579668|NCT01877083|451748059|FG000|Treatment Phase|Disease Progression|10|||
125579669|NCT01877083|451748059|FG000|Treatment Phase|Clinical Progression|1|||
125579670|NCT01877083|451748059|FG000|Treatment Phase|Adverse Event|6|||
125427826|NCT00409682|451192472|FG000|Open-label Induction Period|Adverse Event|1|||
125427827|NCT00409682|451192473|FG001|Open-label Induction Period|Adverse Event|0|||
125427828|NCT00409682|451192474|FG002|Open-label Induction Period|Adverse Event|0|||
125579671|NCT01877083|451748059|FG000|Treatment Phase|Withdrawal by Subject|2|||
125579672|NCT01877083|451748059|FG000|Treatment Phase|Lost to Follow-up|1|||
125427829|NCT00409682|451192472|FG000|Open-label Induction Period|Lack of Efficacy|1|||
125427830|NCT00409682|451192473|FG001|Open-label Induction Period|Lack of Efficacy|0|||
125427831|NCT00409682|451192474|FG002|Open-label Induction Period|Lack of Efficacy|0|||
125427832|NCT00409682|451192472|FG000|Open-label Induction Period|Protocol Violation|1|||
125427833|NCT00409682|451192473|FG001|Open-label Induction Period|Protocol Violation|0|||
125427834|NCT00409682|451192474|FG002|Open-label Induction Period|Protocol Violation|0|||
125427835|NCT00409682|451192472|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
125427836|NCT00409682|451192473|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
125427837|NCT00409682|451192474|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
125427838|NCT00409682|451192472|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
125427839|NCT00409682|451192473|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
125427840|NCT00409682|451192474|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
125427841|NCT00409682|451192472|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
125427842|NCT00409682|451192473|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
125427843|NCT00409682|451192474|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
125427844|NCT00409682|451192472|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
125427845|NCT00409682|451192473|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
125427846|NCT00409682|451192474|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
125427847|NCT00409682|451192472|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
125427848|NCT00409682|451192473|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
125427849|NCT00409682|451192474|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
125427850|NCT00409682|451192472|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
125427851|NCT00409682|451192473|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
125579673|NCT01877083|451748059|FG000|Extension Phase|Disease Progression|3|||
125579674|NCT01877083|451748059|FG000|Extension Phase|Adverse Event|2|||
125579675|NCT00500682|451748062|FG000|Overall Study|Adverse Event|37|||
125579676|NCT00500682|451748063|FG001|Overall Study|Adverse Event|29|||
125579677|NCT00500682|451748062|FG000|Overall Study|Death|25|||
125579678|NCT00500682|451748063|FG001|Overall Study|Death|16|||
125579679|NCT00500682|451748062|FG000|Overall Study|Lost to Follow-up|11|||
125579680|NCT00500682|451748063|FG001|Overall Study|Lost to Follow-up|11|||
125211571|NCT01716520|450399725|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125427852|NCT00409682|451192474|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
125579681|NCT00500682|451748062|FG000|Overall Study|Physician Decision|6|||
125579682|NCT00500682|451748063|FG001|Overall Study|Physician Decision|10|||
125579683|NCT00500682|451748062|FG000|Overall Study|Pregnancy|2|||
125579684|NCT00500682|451748063|FG001|Overall Study|Pregnancy|0|||
125579685|NCT00500682|451748062|FG000|Overall Study|Protocol Violation|1|||
125579686|NCT00500682|451748063|FG001|Overall Study|Protocol Violation|3|||
125579687|NCT00500682|451748062|FG000|Overall Study|Withdrawal by Subject|80|||
125579688|NCT00500682|451748063|FG001|Overall Study|Withdrawal by Subject|74|||
125579689|NCT00500682|451748062|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
125579690|NCT00500682|451748063|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
125579691|NCT00429585|451748066|FG000|Overall Study|Death|1|||
125579692|NCT00429585|451748067|FG001|Overall Study|Death|0|||
125579693|NCT00429585|451748066|FG000|Overall Study|Lost to Follow-up|27|||
125579694|NCT00429585|451748067|FG001|Overall Study|Lost to Follow-up|20|||
125579695|NCT00429585|451748066|FG000|Overall Study|Physician Decision|2|||
125579696|NCT00429585|451748067|FG001|Overall Study|Physician Decision|0|||
125579697|NCT01582308|451748068|FG000|Period 1|Withdrawal by Subject|0|||
125579698|NCT01582308|451748069|FG001|Period 1|Withdrawal by Subject|0|||
125579699|NCT01582308|451748070|FG002|Period 1|Withdrawal by Subject|0|||
125579700|NCT01582308|451748071|FG003|Period 1|Withdrawal by Subject|0|||
125579701|NCT01582308|451748072|FG004|Period 1|Withdrawal by Subject|0|||
125579702|NCT01582308|451748073|FG005|Period 1|Withdrawal by Subject|0|||
125579703|NCT01582308|451748074|FG006|Period 1|Withdrawal by Subject|1|||
125579704|NCT01582308|451748075|FG007|Period 1|Withdrawal by Subject|0|||
125579705|NCT01582308|451748076|FG008|Period 1|Withdrawal by Subject|0|||
125579706|NCT01582308|451748077|FG009|Period 1|Withdrawal by Subject|0|||
125579707|NCT01582308|451748068|FG000|10-day Washout Following Period 1|Physician Decision|0|||
125579708|NCT01582308|451748069|FG001|10-day Washout Following Period 1|Physician Decision|0|||
125579709|NCT01582308|451748070|FG002|10-day Washout Following Period 1|Physician Decision|0|||
125579710|NCT01582308|451748071|FG003|10-day Washout Following Period 1|Physician Decision|0|||
125579711|NCT01582308|451748072|FG004|10-day Washout Following Period 1|Physician Decision|1|||
125579712|NCT01582308|451748073|FG005|10-day Washout Following Period 1|Physician Decision|0|||
125579713|NCT01582308|451748074|FG006|10-day Washout Following Period 1|Physician Decision|0|||
125579714|NCT01582308|451748075|FG007|10-day Washout Following Period 1|Physician Decision|0|||
125579715|NCT01582308|451748076|FG008|10-day Washout Following Period 1|Physician Decision|0|||
125579716|NCT01582308|451748077|FG009|10-day Washout Following Period 1|Physician Decision|0|||
125579717|NCT01582308|451748068|FG000|Period 4|Physician Decision|1|||
125579718|NCT01582308|451748069|FG001|Period 4|Physician Decision|0|||
125579719|NCT01582308|451748070|FG002|Period 4|Physician Decision|0|||
125579720|NCT01582308|451748071|FG003|Period 4|Physician Decision|0|||
125579721|NCT01582308|451748072|FG004|Period 4|Physician Decision|0|||
125579722|NCT01582308|451748073|FG005|Period 4|Physician Decision|1|||
125579723|NCT01582308|451748074|FG006|Period 4|Physician Decision|0|||
125579724|NCT01582308|451748075|FG007|Period 4|Physician Decision|0|||
125579725|NCT01582308|451748076|FG008|Period 4|Physician Decision|0|||
125579726|NCT01582308|451748077|FG009|Period 4|Physician Decision|1|||
125579727|NCT02320487|451748080|FG000|Overall Study|Reason not Specified|1|||
125360016|NCT02598960|450954278|FG006|Treatment Period|participant request to discontinue|0|||
125360017|NCT02598960|450954279|FG007|Treatment Period|participant request to discontinue|0|||
125360018|NCT02598960|450954280|FG008|Treatment Period|participant request to discontinue|0|||
125360019|NCT02598960|450954281|FG009|Treatment Period|participant request to discontinue|0|||
125360020|NCT02598960|450954282|FG010|Treatment Period|participant request to discontinue|1|||
125360021|NCT02598960|450954283|FG011|Treatment Period|participant request to discontinue|4|||
125360022|NCT02598960|450954284|FG012|Treatment Period|participant request to discontinue|0|||
125360023|NCT02598960|450954272|FG000|Treatment Period|participant withdrew consent|0|||
125360024|NCT02598960|450954273|FG001|Treatment Period|participant withdrew consent|0|||
125360025|NCT02598960|450954274|FG002|Treatment Period|participant withdrew consent|0|||
125360026|NCT02598960|450954275|FG003|Treatment Period|participant withdrew consent|0|||
125360027|NCT02598960|450954276|FG004|Treatment Period|participant withdrew consent|0|||
125360028|NCT02598960|450954277|FG005|Treatment Period|participant withdrew consent|0|||
125360029|NCT02598960|450954278|FG006|Treatment Period|participant withdrew consent|0|||
125360030|NCT02598960|450954279|FG007|Treatment Period|participant withdrew consent|0|||
125360031|NCT02598960|450954280|FG008|Treatment Period|participant withdrew consent|0|||
125360032|NCT02598960|450954281|FG009|Treatment Period|participant withdrew consent|0|||
125360033|NCT02598960|450954282|FG010|Treatment Period|participant withdrew consent|0|||
125360034|NCT02598960|450954283|FG011|Treatment Period|participant withdrew consent|3|||
125360035|NCT02598960|450954284|FG012|Treatment Period|participant withdrew consent|0|||
125360036|NCT02598960|450954272|FG000|Treatment Period|No longer meets study criteria|0|||
125360037|NCT02598960|450954273|FG001|Treatment Period|No longer meets study criteria|0|||
125360038|NCT02598960|450954274|FG002|Treatment Period|No longer meets study criteria|0|||
125360039|NCT02598960|450954275|FG003|Treatment Period|No longer meets study criteria|0|||
125360040|NCT02598960|450954276|FG004|Treatment Period|No longer meets study criteria|0|||
125360041|NCT02598960|450954277|FG005|Treatment Period|No longer meets study criteria|0|||
125360042|NCT02598960|450954278|FG006|Treatment Period|No longer meets study criteria|0|||
125360043|NCT02598960|450954279|FG007|Treatment Period|No longer meets study criteria|0|||
125360044|NCT02598960|450954280|FG008|Treatment Period|No longer meets study criteria|0|||
125360045|NCT02598960|450954281|FG009|Treatment Period|No longer meets study criteria|0|||
125360046|NCT02598960|450954282|FG010|Treatment Period|No longer meets study criteria|0|||
125360047|NCT02598960|450954283|FG011|Treatment Period|No longer meets study criteria|1|||
125360048|NCT02598960|450954284|FG012|Treatment Period|No longer meets study criteria|0|||
125360049|NCT02598960|450954272|FG000|Treatment Period|Other Reasons|0|||
125579728|NCT02320487|451748080|FG000|Overall Study|Physician Decision|5|||
125579729|NCT02320487|451748080|FG000|Overall Study|Withdrawal by Subject|1|||
125579730|NCT02320487|451748080|FG000|Overall Study|Death|3|||
125579731|NCT02320487|451748080|FG000|Overall Study|Adverse Event|11|||
125579732|NCT01182428|451748081|FG000|Overall Study|Physician Decision|1|||
125579733|NCT01182428|451748082|FG001|Overall Study|Physician Decision|0|||
125579734|NCT01182428|451748081|FG000|Overall Study|Lost to Follow-up|9|||
125579735|NCT01182428|451748082|FG001|Overall Study|Lost to Follow-up|1|||
125579736|NCT01182428|451748081|FG000|Overall Study|Withdrawal by Subject|1|||
125579737|NCT01182428|451748082|FG001|Overall Study|Withdrawal by Subject|0|||
125579738|NCT05280756|451749815|FG000|Overall Study|Lost to Follow-up|1|||
125579739|NCT05280756|451749816|FG001|Overall Study|Lost to Follow-up|1|||
125579740|NCT03160560|451749824|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
125211572|NCT03699540|450399726|FG000|Overall Study|Lost to Follow-up|1|||
125360050|NCT02598960|450954273|FG001|Treatment Period|Other Reasons|0|||
125579741|NCT03160560|451749825|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125579742|NCT03160560|451749826|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125360051|NCT02598960|450954274|FG002|Treatment Period|Other Reasons|0|||
125360052|NCT02598960|450954275|FG003|Treatment Period|Other Reasons|0|||
125579743|NCT03160560|451749827|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
125579744|NCT03160560|451749824|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
125579745|NCT03160560|451749825|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
125427853|NCT00409682|451192472|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
125427854|NCT00409682|451192473|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
125427855|NCT00409682|451192474|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
125427856|NCT01089374|451192479|FG000|Overall Study|Lost to Follow-up|3|||
125427857|NCT01089374|451192480|FG001|Overall Study|Lost to Follow-up|0|||
125427858|NCT01089374|451192479|FG000|Overall Study|Withdrawal by Subject|1|||
125427859|NCT01089374|451192480|FG001|Overall Study|Withdrawal by Subject|0|||
125427860|NCT01089374|451192479|FG000|Overall Study|Study closed early - low accrual|6|||
125427861|NCT01089374|451192480|FG001|Overall Study|Study closed early - low accrual|0|||
125427862|NCT02856113|451192481|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
125427863|NCT02856113|451192482|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
125427864|NCT02856113|451192481|FG000|Overall Study|Significant Protocol Deviation|1|||
125427865|NCT02856113|451192482|FG001|Overall Study|Significant Protocol Deviation|0|||
125427866|NCT02856113|451192481|FG000|Overall Study|Lost to Follow-up|3|||
125427867|NCT02856113|451192482|FG001|Overall Study|Lost to Follow-up|5|||
125427868|NCT02856113|451192481|FG000|Overall Study|Voluntary Withdrawal|3|||
125427869|NCT02856113|451192482|FG001|Overall Study|Voluntary Withdrawal|5|||
125427870|NCT02856113|451192481|FG000|Overall Study|Pregnancy|0|||
125427871|NCT02856113|451192482|FG001|Overall Study|Pregnancy|1|||
125427872|NCT02856113|451192481|FG000|Overall Study|Principal Investigator Discretion|2|||
125427873|NCT02856113|451192482|FG001|Overall Study|Principal Investigator Discretion|1|||
125427874|NCT02856113|451192481|FG000|Overall Study|Randomized but not Treated|1|||
125427875|NCT02856113|451192482|FG001|Overall Study|Randomized but not Treated|0|||
125427876|NCT02856113|451192481|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
125427877|NCT02856113|451192482|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
125427878|NCT01422408|451192483|FG000|Overall Study|Adverse Event|1|||
125360053|NCT02598960|450954276|FG004|Treatment Period|Other Reasons|0|||
125360054|NCT02598960|450954277|FG005|Treatment Period|Other Reasons|0|||
125360055|NCT02598960|450954278|FG006|Treatment Period|Other Reasons|0|||
125360056|NCT02598960|450954279|FG007|Treatment Period|Other Reasons|0|||
125360057|NCT02598960|450954280|FG008|Treatment Period|Other Reasons|0|||
125360058|NCT02598960|450954281|FG009|Treatment Period|Other Reasons|0|||
125360059|NCT02598960|450954282|FG010|Treatment Period|Other Reasons|0|||
125360060|NCT02598960|450954283|FG011|Treatment Period|Other Reasons|0|||
125360061|NCT02598960|450954284|FG012|Treatment Period|Other Reasons|1|||
125360062|NCT02598960|450954272|FG000|Participants Entering Follow Up Period|Death|1|||
125360063|NCT02598960|450954273|FG001|Participants Entering Follow Up Period|Death|0|||
125360064|NCT02598960|450954274|FG002|Participants Entering Follow Up Period|Death|0|||
125360065|NCT02598960|450954275|FG003|Participants Entering Follow Up Period|Death|0|||
125360066|NCT02598960|450954276|FG004|Participants Entering Follow Up Period|Death|0|||
125360067|NCT02598960|450954277|FG005|Participants Entering Follow Up Period|Death|0|||
125360068|NCT02598960|450954278|FG006|Participants Entering Follow Up Period|Death|0|||
125360069|NCT02598960|450954279|FG007|Participants Entering Follow Up Period|Death|0|||
125360070|NCT02598960|450954280|FG008|Participants Entering Follow Up Period|Death|0|||
125360071|NCT02598960|450954281|FG009|Participants Entering Follow Up Period|Death|1|||
125360072|NCT02598960|450954282|FG010|Participants Entering Follow Up Period|Death|0|||
125360073|NCT02598960|450954283|FG011|Participants Entering Follow Up Period|Death|11|||
125360074|NCT02598960|450954284|FG012|Participants Entering Follow Up Period|Death|2|||
125360075|NCT02598960|450954272|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
125360076|NCT02598960|450954273|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
125360077|NCT02598960|450954274|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
125427879|NCT01422408|451192483|FG000|Overall Study|Withdrawal by Subject|3|||
125360078|NCT02598960|450954275|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
125360079|NCT02598960|450954276|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
125427880|NCT03185481|451192484|FG000|Overall Study|Adverse Event|1|||
125427881|NCT03185481|451192484|FG000|Overall Study|Study Terminated by Sponsor|4|||
125427882|NCT00701038|451192487|FG000|Overall Study|study amended pilot group of patients|4|||
125427883|NCT00701038|451192488|FG001|Overall Study|study amended pilot group of patients|4|||
125427884|NCT00386022|451192490|FG000|Plus Estrogen|Lost to Follow-up|2|||
125427885|NCT00386022|451192491|FG001|Plus Estrogen|Lost to Follow-up|0|||
125427886|NCT00386022|451192490|FG000|Plus Estrogen|Adverse Event|0|||
125427887|NCT00386022|451192491|FG001|Plus Estrogen|Adverse Event|1|||
125427888|NCT01064297|451192495|FG000|Overall Study|Lost to Follow-up|791|||
125427889|NCT01064297|451192496|FG001|Overall Study|Lost to Follow-up|48|||
125427890|NCT01064297|451192497|FG002|Overall Study|Lost to Follow-up|133|||
125427891|NCT00168038|451192503|FG000|Overall Study|Adverse Event|1|||
125427892|NCT00168038|451192503|FG000|Overall Study|Therapy failure|1|||
125427893|NCT01685138|451192504|FG000|Overall Study|Lost to Follow-up|1|||
125427894|NCT01685138|451192504|FG000|Overall Study|Protocol Violation|1|||
125579746|NCT03160560|451749826|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
125579747|NCT03160560|451749827|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
125579748|NCT01430442|451749832|FG000|Overall Study|Subject Withdrew Consent|3|||
125579749|NCT01430442|451749833|FG001|Overall Study|Subject Withdrew Consent|0|||
125579750|NCT01430442|451749834|FG002|Overall Study|Subject Withdrew Consent|1|||
125579751|NCT01430442|451749835|FG003|Overall Study|Subject Withdrew Consent|0|||
125579752|NCT01430442|451749836|FG004|Overall Study|Subject Withdrew Consent|2|||
125579753|NCT01430442|451749837|FG005|Overall Study|Subject Withdrew Consent|1|||
125579754|NCT01430442|451749838|FG006|Overall Study|Subject Withdrew Consent|5|||
125211573|NCT02697591|450399731|FG000|Overall Study|Lost to Follow-up|0|||
125211574|NCT02697591|450399732|FG001|Overall Study|Lost to Follow-up|0|||
125211575|NCT02697591|450399733|FG002|Overall Study|Lost to Follow-up|0|||
125211576|NCT02697591|450399734|FG003|Overall Study|Lost to Follow-up|0|||
125211577|NCT02697591|450399735|FG004|Overall Study|Lost to Follow-up|0|||
125211578|NCT02697591|450399736|FG005|Overall Study|Lost to Follow-up|1|||
125211579|NCT02697591|450399737|FG006|Overall Study|Lost to Follow-up|1|||
125211580|NCT02697591|450399738|FG007|Overall Study|Lost to Follow-up|0|||
125211581|NCT02697591|450399739|FG008|Overall Study|Lost to Follow-up|0|||
125211582|NCT02697591|450399740|FG009|Overall Study|Lost to Follow-up|1|||
125211583|NCT02697591|450399731|FG000|Overall Study|Withdrawal by Subject|1|||
125211584|NCT02697591|450399732|FG001|Overall Study|Withdrawal by Subject|1|||
125211585|NCT02697591|450399733|FG002|Overall Study|Withdrawal by Subject|2|||
125211586|NCT02697591|450399734|FG003|Overall Study|Withdrawal by Subject|1|||
125211587|NCT02697591|450399735|FG004|Overall Study|Withdrawal by Subject|7|||
125211588|NCT02697591|450399736|FG005|Overall Study|Withdrawal by Subject|6|||
125211589|NCT02697591|450399737|FG006|Overall Study|Withdrawal by Subject|9|||
125427895|NCT01685138|451192504|FG000|Overall Study|No longer requires treatment|1|||
125427896|NCT01685138|451192504|FG000|Overall Study|Subject/guardian decision|2|||
125427897|NCT01685138|451192504|FG000|Overall Study|Physician Decision|6|||
125427898|NCT01685138|451192504|FG000|Overall Study|Death|10|||
125427899|NCT01685138|451192504|FG000|Overall Study|Adverse Event|18|||
125427900|NCT01685138|451192504|FG000|Overall Study|Progressive disease|53|||
125427901|NCT02068495|451192509|FG000|Overall Study|Case Report Forms Uncollected|60|||
125427902|NCT02068495|451192509|FG000|Overall Study|Protocol Deviation|49|||
125427903|NCT00689026|451192510|FG000|Overall Study|Withdrawal by Subject|13|||
125427904|NCT00689026|451192511|FG001|Overall Study|Withdrawal by Subject|6|||
125579755|NCT01430442|451749839|FG007|Overall Study|Subject Withdrew Consent|2|||
125579756|NCT01430442|451749832|FG000|Overall Study|Lost to Follow-up|2|||
125579757|NCT01430442|451749833|FG001|Overall Study|Lost to Follow-up|0|||
125579758|NCT01430442|451749834|FG002|Overall Study|Lost to Follow-up|1|||
125579759|NCT01430442|451749835|FG003|Overall Study|Lost to Follow-up|2|||
125579760|NCT01430442|451749836|FG004|Overall Study|Lost to Follow-up|2|||
125427905|NCT02703922|451192514|FG000|Overall Study|Death|5|||
125211590|NCT02697591|450399738|FG007|Overall Study|Withdrawal by Subject|1|||
125211591|NCT02697591|450399739|FG008|Overall Study|Withdrawal by Subject|6|||
125211592|NCT02697591|450399740|FG009|Overall Study|Withdrawal by Subject|10|||
125211593|NCT02697591|450399731|FG000|Overall Study|Physician Decision|1|||
125211594|NCT02697591|450399732|FG001|Overall Study|Physician Decision|0|||
125211595|NCT02697591|450399733|FG002|Overall Study|Physician Decision|0|||
125427906|NCT02703922|451192515|FG001|Overall Study|Death|8|||
125427907|NCT02703922|451192514|FG000|Overall Study|Lost to Follow-up|10|||
125427908|NCT02703922|451192515|FG001|Overall Study|Lost to Follow-up|10|||
125427909|NCT00394355|451192517|FG000|Overall Study|Adverse Event|10|||
125427910|NCT00394355|451192518|FG001|Overall Study|Adverse Event|6|||
125579761|NCT01430442|451749837|FG005|Overall Study|Lost to Follow-up|1|||
125579762|NCT01430442|451749838|FG006|Overall Study|Lost to Follow-up|5|||
125579763|NCT01430442|451749839|FG007|Overall Study|Lost to Follow-up|1|||
125579764|NCT01430442|451749832|FG000|Overall Study|Pregnancy|1|||
125579765|NCT01430442|451749833|FG001|Overall Study|Pregnancy|0|||
125579766|NCT01430442|451749834|FG002|Overall Study|Pregnancy|0|||
125579767|NCT01430442|451749835|FG003|Overall Study|Pregnancy|0|||
125579768|NCT01430442|451749836|FG004|Overall Study|Pregnancy|0|||
125579769|NCT01430442|451749837|FG005|Overall Study|Pregnancy|1|||
125579770|NCT01430442|451749838|FG006|Overall Study|Pregnancy|0|||
125579771|NCT01430442|451749839|FG007|Overall Study|Pregnancy|0|||
125579772|NCT01430442|451749832|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
125579773|NCT01430442|451749833|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
125579774|NCT01430442|451749834|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
125579775|NCT01430442|451749835|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
125579776|NCT01430442|451749836|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
125579777|NCT01430442|451749837|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
125360080|NCT02598960|450954277|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
125360081|NCT02598960|450954278|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
125360082|NCT02598960|450954279|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
125360083|NCT02598960|450954280|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
125360084|NCT02598960|450954281|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
125360085|NCT02598960|450954282|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
125360086|NCT02598960|450954283|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
125360087|NCT02598960|450954284|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
125360088|NCT02598960|450954272|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
125360089|NCT02598960|450954273|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
125579778|NCT01430442|451749838|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
125579779|NCT01430442|451749839|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
125579780|NCT01641939|451749840|FG000|Overall Study|Death|90|||
125579781|NCT01641939|451749841|FG001|Overall Study|Death|187|||
125579782|NCT01641939|451749842|FG002|Overall Study|Death|61|||
125579783|NCT01641939|451749840|FG000|Overall Study|Lost to Follow-up|3|||
125579784|NCT01641939|451749841|FG001|Overall Study|Lost to Follow-up|2|||
125579785|NCT01641939|451749842|FG002|Overall Study|Lost to Follow-up|1|||
125579786|NCT01641939|451749840|FG000|Overall Study|Withdrawal by Subject|14|||
125579787|NCT01641939|451749841|FG001|Overall Study|Withdrawal by Subject|11|||
125579788|NCT01641939|451749842|FG002|Overall Study|Withdrawal by Subject|5|||
125579789|NCT01641939|451749840|FG000|Overall Study|Study Terminated by Sponsor|10|||
125211596|NCT02697591|450399734|FG003|Overall Study|Physician Decision|0|||
125579790|NCT01641939|451749841|FG001|Overall Study|Study Terminated by Sponsor|28|||
125579791|NCT01641939|451749842|FG002|Overall Study|Study Terminated by Sponsor|3|||
125579792|NCT01461044|451749843|FG000|Overall Study|Death|58|||
125579793|NCT01461044|451749844|FG001|Overall Study|Death|35|||
125579794|NCT01461044|451749843|FG000|Overall Study|Lost to Follow-up|12|||
125579795|NCT01461044|451749844|FG001|Overall Study|Lost to Follow-up|5|||
125427911|NCT00394355|451192519|FG002|Overall Study|Adverse Event|7|||
125360090|NCT02598960|450954274|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
125360091|NCT02598960|450954275|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
125360092|NCT02598960|450954276|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
125360093|NCT02598960|450954277|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
125360094|NCT02598960|450954278|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
125579796|NCT00716976|451749845|FG000|Overall Study|Adverse Event|2|||
125579797|NCT00716976|451749846|FG001|Overall Study|Adverse Event|0|||
125579798|NCT00716976|451749845|FG000|Overall Study|Death|1|||
125579799|NCT00716976|451749846|FG001|Overall Study|Death|0|||
125579800|NCT00716976|451749845|FG000|Overall Study|Physician Decision|2|||
125579801|NCT00716976|451749846|FG001|Overall Study|Physician Decision|2|||
125579802|NCT00716976|451749845|FG000|Overall Study|Withdrawal by Subject|5|||
125579803|NCT00716976|451749846|FG001|Overall Study|Withdrawal by Subject|1|||
125579804|NCT00716976|451749845|FG000|Overall Study|Premature discontinuation cisplatin|5|||
125579805|NCT00716976|451749846|FG001|Overall Study|Premature discontinuation cisplatin|4|||
125579806|NCT00716976|451749845|FG000|Overall Study|Radiation during protocol|1|||
125360095|NCT02598960|450954279|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
125360096|NCT02598960|450954280|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
125360097|NCT02598960|450954281|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
125360098|NCT02598960|450954282|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
125579807|NCT00716976|451749846|FG001|Overall Study|Radiation during protocol|0|||
125579808|NCT00716976|451749845|FG000|Overall Study|Ineligibles|4|||
125579809|NCT00716976|451749846|FG001|Overall Study|Ineligibles|2|||
125579810|NCT00122135|451749847|FG000|Overall Study|Withdrawal by Subject|3|||
125579811|NCT00122135|451749848|FG001|Overall Study|Withdrawal by Subject|0|||
125579812|NCT03068325|451749849|FG000|Overall Study|Lost to Follow-up|5|||
125579813|NCT05425563|451749855|FG000|Overall Study|Withdrawal by Subject|17|||
125360099|NCT02598960|450954283|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
125579814|NCT00168831|451749856|FG000|Overall Study|Adverse Event|36|||
125579815|NCT00168831|451749857|FG001|Overall Study|Adverse Event|47|||
125579816|NCT00168831|451749858|FG002|Overall Study|Adverse Event|74|||
125579817|NCT00168831|451749856|FG000|Overall Study|Lost to Follow-up|5|||
125579818|NCT00168831|451749857|FG001|Overall Study|Lost to Follow-up|6|||
125579819|NCT00168831|451749858|FG002|Overall Study|Lost to Follow-up|4|||
125579820|NCT00168831|451749856|FG000|Overall Study|Withdrawal by Subject|7|||
125579821|NCT00168831|451749857|FG001|Overall Study|Withdrawal by Subject|14|||
125579822|NCT00168831|451749858|FG002|Overall Study|Withdrawal by Subject|19|||
125579823|NCT00168831|451749856|FG000|Overall Study|Protocol Violation|6|||
125579824|NCT00168831|451749857|FG001|Overall Study|Protocol Violation|11|||
125579825|NCT00168831|451749858|FG002|Overall Study|Protocol Violation|11|||
125579826|NCT00168831|451749856|FG000|Overall Study|Other|6|||
125579827|NCT00168831|451749857|FG001|Overall Study|Other|3|||
125579828|NCT00168831|451749858|FG002|Overall Study|Other|6|||
125579829|NCT02009878|451749861|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
125579830|NCT02009878|451749862|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
125579831|NCT02009878|451749863|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
125579832|NCT04652804|451749866|FG000|Overall Study|Ineligible post randomization|1|||
125579833|NCT04652804|451749867|FG001|Overall Study|Ineligible post randomization|0|||
125579834|NCT04652804|451749868|FG002|Overall Study|Ineligible post randomization|1|||
125579835|NCT04652804|451749869|FG003|Overall Study|Ineligible post randomization|0|||
125579836|NCT04652804|451749870|FG004|Overall Study|Ineligible post randomization|1|||
125360100|NCT02598960|450954284|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
125360101|NCT02598960|450954272|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125360102|NCT02598960|450954273|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125360103|NCT02598960|450954274|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125360104|NCT02598960|450954275|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125360105|NCT02598960|450954276|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125427912|NCT00394355|451192520|FG003|Overall Study|Adverse Event|8|||
125427913|NCT00394355|451192517|FG000|Overall Study|Did not meet protocol eligibility|1|||
125579837|NCT04652804|451749871|FG005|Overall Study|Ineligible post randomization|1|||
125579838|NCT04652804|451749866|FG000|Overall Study|Missing SVR lab results|2|||
125579839|NCT04652804|451749867|FG001|Overall Study|Missing SVR lab results|0|||
125579840|NCT04652804|451749868|FG002|Overall Study|Missing SVR lab results|0|||
125579841|NCT04652804|451749869|FG003|Overall Study|Missing SVR lab results|0|||
125579842|NCT04652804|451749870|FG004|Overall Study|Missing SVR lab results|0|||
125579843|NCT04652804|451749871|FG005|Overall Study|Missing SVR lab results|0|||
125579844|NCT03634800|451749872|FG000|Overall Study|Adverse Event|1|||
125579845|NCT03634800|451749872|FG000|Overall Study|Disease Progression|4|||
125579846|NCT03634800|451749872|FG000|Overall Study|Withdrawal by Subject|1|||
125579847|NCT00343512|451749879|FG000|Overall Study|Withdrawal by Subject|2|||
125579848|NCT00634569|451749880|FG000|Overall Study|Withdrawal by Subject|0|||
125579849|NCT00634569|451749881|FG001|Overall Study|Withdrawal by Subject|4|||
125579850|NCT00634569|451749880|FG000|Overall Study|Physician Decision|0|||
125579851|NCT00634569|451749881|FG001|Overall Study|Physician Decision|1|||
125579852|NCT02918019|451749882|FG000|Overall Study|Death|0|||
125579853|NCT02918019|451749883|FG001|Overall Study|Death|0|||
125579854|NCT02918019|451749884|FG002|Overall Study|Death|1|||
125579855|NCT02918019|451749885|FG003|Overall Study|Death|0|||
125579856|NCT02918019|451749882|FG000|Overall Study|Lost to Follow-up|1|||
125579857|NCT02918019|451749883|FG001|Overall Study|Lost to Follow-up|1|||
125579858|NCT02918019|451749884|FG002|Overall Study|Lost to Follow-up|0|||
125579859|NCT02918019|451749885|FG003|Overall Study|Lost to Follow-up|1|||
125579860|NCT02918019|451749882|FG000|Overall Study|Principal investigator request|0|||
125579861|NCT02918019|451749883|FG001|Overall Study|Principal investigator request|0|||
125579862|NCT02918019|451749884|FG002|Overall Study|Principal investigator request|0|||
125579863|NCT02918019|451749885|FG003|Overall Study|Principal investigator request|1|||
125579864|NCT02918019|451749882|FG000|Overall Study|Physician Decision|1|||
125579865|NCT02918019|451749883|FG001|Overall Study|Physician Decision|3|||
125579866|NCT02918019|451749884|FG002|Overall Study|Physician Decision|2|||
125579867|NCT02918019|451749885|FG003|Overall Study|Physician Decision|0|||
125579868|NCT02918019|451749882|FG000|Overall Study|Protocol deviation|1|||
125579869|NCT02918019|451749883|FG001|Overall Study|Protocol deviation|1|||
125579870|NCT02918019|451749884|FG002|Overall Study|Protocol deviation|0|||
125579871|NCT02918019|451749885|FG003|Overall Study|Protocol deviation|2|||
125579872|NCT02918019|451749882|FG000|Overall Study|Withdrawal by Subject|3|||
125579873|NCT02918019|451749883|FG001|Overall Study|Withdrawal by Subject|4|||
125211597|NCT02697591|450399735|FG004|Overall Study|Physician Decision|1|||
125360106|NCT02598960|450954277|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125579874|NCT02918019|451749884|FG002|Overall Study|Withdrawal by Subject|6|||
125579875|NCT02918019|451749885|FG003|Overall Study|Withdrawal by Subject|4|||
125579876|NCT02918019|451749882|FG000|Overall Study|Adverse Event|0|||
125579877|NCT02918019|451749883|FG001|Overall Study|Adverse Event|1|||
125579878|NCT02918019|451749884|FG002|Overall Study|Adverse Event|0|||
125579879|NCT02918019|451749885|FG003|Overall Study|Adverse Event|1|||
125579880|NCT01212185|451749886|FG000|Overall Study|Protocol Violation|2|||
125579881|NCT01212185|451749887|FG001|Overall Study|Protocol Violation|1|||
125579882|NCT01808612|451749888|FG000|Treatment Period|Adverse Event|8|||
125579883|NCT01808612|451749889|FG001|Treatment Period|Adverse Event|4|||
125579884|NCT01808612|451749890|FG002|Treatment Period|Adverse Event|3|||
125579885|NCT01808612|451749888|FG000|Treatment Period|Lost to Follow-up|2|||
125579886|NCT01808612|451749889|FG001|Treatment Period|Lost to Follow-up|2|||
125579887|NCT01808612|451749890|FG002|Treatment Period|Lost to Follow-up|1|||
125579888|NCT01808612|451749888|FG000|Treatment Period|Protocol Violation|1|||
125579889|NCT01808612|451749889|FG001|Treatment Period|Protocol Violation|0|||
125579890|NCT01808612|451749890|FG002|Treatment Period|Protocol Violation|0|||
125579891|NCT01808612|451749888|FG000|Treatment Period|Withdrawal by Subject|1|||
125579892|NCT01808612|451749889|FG001|Treatment Period|Withdrawal by Subject|0|||
125579893|NCT01808612|451749890|FG002|Treatment Period|Withdrawal by Subject|4|||
125579894|NCT01808612|451749888|FG000|Treatment Period|Physician Decision|1|||
125579895|NCT01808612|451749889|FG001|Treatment Period|Physician Decision|0|||
125579896|NCT01808612|451749890|FG002|Treatment Period|Physician Decision|4|||
125579897|NCT01808612|451749888|FG000|Treatment Period|Sponsor Decision|1|||
125579898|NCT01808612|451749889|FG001|Treatment Period|Sponsor Decision|0|||
125579899|NCT01808612|451749890|FG002|Treatment Period|Sponsor Decision|0|||
125579900|NCT01808612|451749888|FG000|Treatment Period|Lack of Efficacy|1|||
125579901|NCT01808612|451749889|FG001|Treatment Period|Lack of Efficacy|1|||
125579902|NCT01808612|451749890|FG002|Treatment Period|Lack of Efficacy|2|||
125579903|NCT01808612|451749888|FG000|Discontinuation Period|Adverse Event|1|||
125579904|NCT01808612|451749889|FG001|Discontinuation Period|Adverse Event|0|||
125579905|NCT01808612|451749890|FG002|Discontinuation Period|Adverse Event|0|||
125579906|NCT01808612|451749888|FG000|Discontinuation Period|Physician Decision|1|||
125579907|NCT01808612|451749889|FG001|Discontinuation Period|Physician Decision|0|||
125579908|NCT01808612|451749890|FG002|Discontinuation Period|Physician Decision|0|||
125579909|NCT01808612|451749888|FG000|Discontinuation Period|Lost to Follow-up|0|||
125579910|NCT01808612|451749889|FG001|Discontinuation Period|Lost to Follow-up|1|||
125579911|NCT01808612|451749890|FG002|Discontinuation Period|Lost to Follow-up|0|||
125579912|NCT01700192|451749891|FG000|Overall Study|Adverse Event|73|||
125579913|NCT01700192|451749892|FG001|Overall Study|Adverse Event|18|||
125579914|NCT01700192|451749891|FG000|Overall Study|Lack of Efficacy|1|||
125579915|NCT01700192|451749892|FG001|Overall Study|Lack of Efficacy|0|||
125579916|NCT01700192|451749891|FG000|Overall Study|Lost to Follow-up|42|||
125579917|NCT01700192|451749892|FG001|Overall Study|Lost to Follow-up|29|||
125579918|NCT01700192|451749891|FG000|Overall Study|Noncompliance with study drug|0|||
125579919|NCT01700192|451749892|FG001|Overall Study|Noncompliance with study drug|5|||
125579920|NCT01700192|451749891|FG000|Overall Study|Physician Decision|2|||
125579921|NCT01700192|451749892|FG001|Overall Study|Physician Decision|3|||
125579922|NCT01700192|451749891|FG000|Overall Study|Pregnancy|1|||
125579923|NCT01700192|451749892|FG001|Overall Study|Pregnancy|4|||
125579924|NCT01700192|451749891|FG000|Overall Study|Progressive disease|1|||
125579925|NCT01700192|451749892|FG001|Overall Study|Progressive disease|0|||
125579926|NCT01700192|451749891|FG000|Overall Study|Protocol Violation|3|||
125360107|NCT02598960|450954278|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125360108|NCT02598960|450954279|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125360109|NCT02598960|450954280|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125360110|NCT02598960|450954281|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125360111|NCT02598960|450954282|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125360112|NCT02598960|450954283|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
125360113|NCT02598960|450954284|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
125360114|NCT02598960|450954272|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
125360115|NCT02598960|450954273|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
125360116|NCT02598960|450954274|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
125579927|NCT01700192|451749892|FG001|Overall Study|Protocol Violation|4|||
125579928|NCT01700192|451749891|FG000|Overall Study|Technical problems|0|||
125579929|NCT01700192|451749892|FG001|Overall Study|Technical problems|1|||
125579930|NCT01700192|451749891|FG000|Overall Study|Withdrawal by Subject|56|||
125579931|NCT01700192|451749892|FG001|Overall Study|Withdrawal by Subject|64|||
125579932|NCT01700192|451749891|FG000|Overall Study|Never received study drug|1|||
125579933|NCT01700192|451749892|FG001|Overall Study|Never received study drug|0|||
125579934|NCT03403192|451749895|FG000|Overall Study|Lost to Follow-up|1|||
125579935|NCT03403192|451749896|FG001|Overall Study|Lost to Follow-up|2|||
125579936|NCT03403192|451749897|FG002|Overall Study|Lost to Follow-up|0|||
125579937|NCT03403192|451749898|FG003|Overall Study|Lost to Follow-up|0|||
125579938|NCT03403192|451749895|FG000|Overall Study|Unable to respond|0|||
125579939|NCT03403192|451749896|FG001|Overall Study|Unable to respond|1|||
125579940|NCT03403192|451749897|FG002|Overall Study|Unable to respond|0|||
125579941|NCT03403192|451749898|FG003|Overall Study|Unable to respond|0|||
125579942|NCT03403192|451749895|FG000|Overall Study|Incomplete|3|||
125579943|NCT03403192|451749896|FG001|Overall Study|Incomplete|1|||
125579944|NCT03403192|451749897|FG002|Overall Study|Incomplete|3|||
125579945|NCT03403192|451749898|FG003|Overall Study|Incomplete|6|||
125579946|NCT03543410|451749899|FG000|Overall Study|Adverse Event|10|||
125211598|NCT02697591|450399736|FG005|Overall Study|Physician Decision|2|||
125211599|NCT02697591|450399737|FG006|Overall Study|Physician Decision|0|||
125211600|NCT02697591|450399738|FG007|Overall Study|Physician Decision|0|||
125211601|NCT02697591|450399739|FG008|Overall Study|Physician Decision|1|||
125579947|NCT03543410|451749900|FG001|Overall Study|Adverse Event|8|||
125579948|NCT03543410|451749901|FG002|Overall Study|Adverse Event|2|||
125579949|NCT03543410|451749899|FG000|Overall Study|Lack of Efficacy|0|||
125211602|NCT02697591|450399740|FG009|Overall Study|Physician Decision|1|||
125211603|NCT02697591|450399731|FG000|Overall Study|Death|2|||
125211604|NCT02697591|450399732|FG001|Overall Study|Death|3|||
125211605|NCT02697591|450399733|FG002|Overall Study|Death|1|||
125211606|NCT02697591|450399734|FG003|Overall Study|Death|1|||
125211607|NCT02697591|450399735|FG004|Overall Study|Death|4|||
125211608|NCT02697591|450399736|FG005|Overall Study|Death|5|||
125211609|NCT02697591|450399737|FG006|Overall Study|Death|3|||
125211610|NCT02697591|450399738|FG007|Overall Study|Death|1|||
125211611|NCT02697591|450399739|FG008|Overall Study|Death|1|||
125211612|NCT02697591|450399740|FG009|Overall Study|Death|5|||
125211613|NCT02697591|450399731|FG000|Overall Study|Reason not Specified|0|||
125211614|NCT02697591|450399732|FG001|Overall Study|Reason not Specified|0|||
125211615|NCT02697591|450399733|FG002|Overall Study|Reason not Specified|0|||
125211616|NCT02697591|450399734|FG003|Overall Study|Reason not Specified|1|||
125211617|NCT02697591|450399735|FG004|Overall Study|Reason not Specified|1|||
125211618|NCT02697591|450399736|FG005|Overall Study|Reason not Specified|2|||
125360117|NCT02598960|450954275|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
125360118|NCT02598960|450954276|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
125360119|NCT02598960|450954277|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
125360120|NCT02598960|450954278|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
125360121|NCT02598960|450954279|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
125360122|NCT02598960|450954280|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
125360123|NCT02598960|450954281|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
125360124|NCT02598960|450954282|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
125360125|NCT02598960|450954283|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
125360126|NCT02598960|450954284|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
125360127|NCT00108433|450954285|FG000|Overall Study|Lack of Efficacy|1|||
125360128|NCT00108433|450954286|FG001|Overall Study|Lack of Efficacy|2|||
125360129|NCT00108433|450954285|FG000|Overall Study|Death|3|||
125360130|NCT00108433|450954286|FG001|Overall Study|Death|0|||
125360131|NCT00108433|450954285|FG000|Overall Study|Adverse Event|3|||
125360132|NCT00108433|450954286|FG001|Overall Study|Adverse Event|1|||
125360133|NCT00108433|450954285|FG000|Overall Study|Other|14|||
125360134|NCT00108433|450954286|FG001|Overall Study|Other|14|||
125360135|NCT04195906|450954287|FG000|Part 1|Adverse Event|3|||
125360136|NCT04195906|450954288|FG001|Part 1|Adverse Event|7|||
125360137|NCT04195906|450954287|FG000|Part 1|Withdrawal by Subject|0|||
125360138|NCT04195906|450954288|FG001|Part 1|Withdrawal by Subject|1|||
125360139|NCT04195906|450954287|FG000|Part 2|Adverse Event|1|||
125360140|NCT04195906|450954288|FG001|Part 2|Adverse Event|1|||
125360141|NCT04195906|450954287|FG000|Part 2|Withdrawal by Subject|0|||
125360142|NCT04195906|450954288|FG001|Part 2|Withdrawal by Subject|3|||
125360143|NCT04195906|450954287|FG000|Part 2|Other|1|||
125360144|NCT04195906|450954288|FG001|Part 2|Other|3|||
125360145|NCT00371826|450954294|FG000|Core Phase (12 Months)|Adverse Event|15|||
125360146|NCT00371826|450954295|FG001|Core Phase (12 Months)|Adverse Event|4|||
125360147|NCT00371826|450954296|FG002|Core Phase (12 Months)|Adverse Event|9|||
125360148|NCT00371826|450954294|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
125360149|NCT00371826|450954295|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
125360150|NCT00371826|450954296|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
125360151|NCT00371826|450954294|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
125360152|NCT00371826|450954295|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
125360153|NCT00371826|450954296|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
125427914|NCT00394355|451192518|FG001|Overall Study|Did not meet protocol eligibility|5|||
125427915|NCT00394355|451192519|FG002|Overall Study|Did not meet protocol eligibility|4|||
125579950|NCT03543410|451749900|FG001|Overall Study|Lack of Efficacy|1|||
125211619|NCT02697591|450399737|FG006|Overall Study|Reason not Specified|3|||
125211620|NCT02697591|450399738|FG007|Overall Study|Reason not Specified|1|||
125211621|NCT02697591|450399739|FG008|Overall Study|Reason not Specified|1|||
125211622|NCT02697591|450399740|FG009|Overall Study|Reason not Specified|3|||
125360154|NCT00371826|450954294|FG000|Core Phase (12 Months)|Protocol Violation|1|||
125360155|NCT00371826|450954295|FG001|Core Phase (12 Months)|Protocol Violation|0|||
125360156|NCT00371826|450954296|FG002|Core Phase (12 Months)|Protocol Violation|1|||
125360157|NCT00371826|450954294|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
125579951|NCT03543410|451749901|FG002|Overall Study|Lack of Efficacy|0|||
125211623|NCT00624832|450399741|FG000|Overall Study|Adverse Event|0|||
125211624|NCT00624832|450399742|FG001|Overall Study|Adverse Event|1|||
125211625|NCT00624832|450399743|FG002|Overall Study|Adverse Event|0|||
125579952|NCT03543410|451749899|FG000|Overall Study|Lost to Follow-up|0|||
125427916|NCT00394355|451192520|FG003|Overall Study|Did not meet protocol eligibility|2|||
125427917|NCT00394355|451192517|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
125427918|NCT00394355|451192518|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
125427919|NCT00394355|451192519|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
125427920|NCT00394355|451192520|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
125427921|NCT00394355|451192517|FG000|Overall Study|Subject withdrawal - related to drug|1|||
125427922|NCT00394355|451192518|FG001|Overall Study|Subject withdrawal - related to drug|0|||
125427923|NCT00394355|451192519|FG002|Overall Study|Subject withdrawal - related to drug|0|||
125427924|NCT00394355|451192520|FG003|Overall Study|Subject withdrawal - related to drug|0|||
125427925|NCT00394355|451192517|FG000|Overall Study|Lost to Follow-up|7|||
125427926|NCT00394355|451192518|FG001|Overall Study|Lost to Follow-up|5|||
125427927|NCT00394355|451192519|FG002|Overall Study|Lost to Follow-up|4|||
125427928|NCT00394355|451192520|FG003|Overall Study|Lost to Follow-up|3|||
125427929|NCT00394355|451192517|FG000|Overall Study|Noncompliance with protocol|4|||
125427930|NCT00394355|451192518|FG001|Overall Study|Noncompliance with protocol|3|||
125427931|NCT00394355|451192519|FG002|Overall Study|Noncompliance with protocol|10|||
125427932|NCT00394355|451192520|FG003|Overall Study|Noncompliance with protocol|8|||
125427933|NCT00394355|451192517|FG000|Overall Study|Administrative|0|||
125427934|NCT00394355|451192518|FG001|Overall Study|Administrative|1|||
125427935|NCT00394355|451192519|FG002|Overall Study|Administrative|1|||
125427936|NCT00394355|451192520|FG003|Overall Study|Administrative|1|||
125427937|NCT00394355|451192517|FG000|Overall Study|Lack of Efficacy|0|||
125427938|NCT00394355|451192518|FG001|Overall Study|Lack of Efficacy|0|||
125427939|NCT00394355|451192519|FG002|Overall Study|Lack of Efficacy|2|||
125427940|NCT00394355|451192520|FG003|Overall Study|Lack of Efficacy|3|||
125427941|NCT00500903|451192521|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
125427942|NCT00500903|451192522|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
125427943|NCT00500903|451192523|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
125427944|NCT00500903|451192521|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
125427945|NCT00500903|451192522|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
125427946|NCT00500903|451192523|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
125427947|NCT00500903|451192521|FG000|Overall Study|Progressive Disease|41|||
125427948|NCT00500903|451192522|FG001|Overall Study|Progressive Disease|2|||
125427949|NCT00500903|451192523|FG002|Overall Study|Progressive Disease|15|||
125427950|NCT00500903|451192521|FG000|Overall Study|Patient Declined Further Treatment|0|||
125427951|NCT00500903|451192522|FG001|Overall Study|Patient Declined Further Treatment|0|||
125427952|NCT00500903|451192523|FG002|Overall Study|Patient Declined Further Treatment|3|||
125427953|NCT00500903|451192521|FG000|Overall Study|Symptomatic Deterioration|2|||
125427954|NCT00500903|451192522|FG001|Overall Study|Symptomatic Deterioration|0|||
125427955|NCT00500903|451192523|FG002|Overall Study|Symptomatic Deterioration|0|||
125427956|NCT00500903|451192521|FG000|Overall Study|Reason Not Specified|10|||
125427957|NCT00500903|451192522|FG001|Overall Study|Reason Not Specified|0|||
125427958|NCT00500903|451192523|FG002|Overall Study|Reason Not Specified|2|||
125427959|NCT01648348|451192528|FG000|Overall Study|Cancel|1|||
125427960|NCT01648348|451192529|FG001|Overall Study|Cancel|0|||
125427961|NCT01648348|451192530|FG002|Overall Study|Cancel|0|||
125427962|NCT01648348|451192531|FG003|Overall Study|Cancel|0|||
125427963|NCT01648348|451192532|FG004|Overall Study|Cancel|3|||
125427964|NCT01648348|451192533|FG005|Overall Study|Cancel|6|||
125427965|NCT01648348|451192528|FG000|Overall Study|Replaced for MTD analysis|1|||
125427966|NCT01648348|451192529|FG001|Overall Study|Replaced for MTD analysis|0|||
125579953|NCT03543410|451749900|FG001|Overall Study|Lost to Follow-up|1|||
125579954|NCT03543410|451749901|FG002|Overall Study|Lost to Follow-up|0|||
125579955|NCT03543410|451749899|FG000|Overall Study|Withdrawal by Subject|5|||
125579956|NCT03543410|451749900|FG001|Overall Study|Withdrawal by Subject|2|||
125579957|NCT03543410|451749901|FG002|Overall Study|Withdrawal by Subject|8|||
125579958|NCT03543410|451749899|FG000|Overall Study|Protocol Violation|0|||
125579959|NCT03543410|451749900|FG001|Overall Study|Protocol Violation|1|||
125579960|NCT03543410|451749901|FG002|Overall Study|Protocol Violation|0|||
125211626|NCT00624832|450399744|FG003|Overall Study|Adverse Event|1|||
125211627|NCT00624832|450399741|FG000|Overall Study|Abnormal Laboratory Value|2|||
125211628|NCT00624832|450399742|FG001|Overall Study|Abnormal Laboratory Value|0|||
125211629|NCT00624832|450399743|FG002|Overall Study|Abnormal Laboratory Value|0|||
125211630|NCT00624832|450399744|FG003|Overall Study|Abnormal Laboratory Value|0|||
125427967|NCT01648348|451192530|FG002|Overall Study|Replaced for MTD analysis|1|||
125427968|NCT01648348|451192531|FG003|Overall Study|Replaced for MTD analysis|0|||
125427969|NCT01648348|451192532|FG004|Overall Study|Replaced for MTD analysis|0|||
125427970|NCT01648348|451192533|FG005|Overall Study|Replaced for MTD analysis|0|||
125427971|NCT00696410|451192534|FG000|Overall Study|Lost to Follow-up|2|||
125427972|NCT00696410|451192535|FG001|Overall Study|Lost to Follow-up|0|||
125427973|NCT00696410|451192534|FG000|Overall Study|Withdrawal by Subject|8|||
125427974|NCT00696410|451192535|FG001|Overall Study|Withdrawal by Subject|0|||
125427975|NCT00696410|451192534|FG000|Overall Study|Physician Decision|3|||
125427976|NCT00696410|451192535|FG001|Overall Study|Physician Decision|0|||
125427977|NCT01951638|451192537|FG000|Treatment Period|Protocol Violation|0|||
125579961|NCT03543410|451749899|FG000|Overall Study|Due to COVID-19|4|||
125579962|NCT03543410|451749900|FG001|Overall Study|Due to COVID-19|0|||
125579963|NCT03543410|451749901|FG002|Overall Study|Due to COVID-19|2|||
125579964|NCT03543410|451749899|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
125579965|NCT03543410|451749900|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
125579966|NCT03543410|451749901|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
125579967|NCT03543410|451749899|FG000|Overall Study|Not Due to COVID-19|2|||
125579968|NCT03543410|451749900|FG001|Overall Study|Not Due to COVID-19|0|||
125579969|NCT03543410|451749901|FG002|Overall Study|Not Due to COVID-19|1|||
125579970|NCT02883244|451749902|FG000|Overall Study|Lost to Follow-up|0|||
125579971|NCT02883244|451749903|FG001|Overall Study|Lost to Follow-up|1|||
125579972|NCT02317562|451749910|FG000|Overall Study|Physician Decision|1|||
125579973|NCT02317562|451749910|FG000|Overall Study|early termination of the study|8|||
125579974|NCT02317562|451749910|FG000|Overall Study|Lack of Efficacy|4|||
125579975|NCT02317562|451749910|FG000|Overall Study|Withdrawal by Subject|1|||
125579976|NCT03891901|451749911|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
125579977|NCT03891901|451749912|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125579978|NCT03891901|451749913|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125579979|NCT03891901|451749914|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125579980|NCT03891901|451749915|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125579981|NCT03891901|451749916|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125211631|NCT04379700|450399745|FG000|Overall Study|Withdrawal by Subject|10|||
125211632|NCT04379700|450399745|FG000|Overall Study|Screen Fail|4|||
125211633|NCT04379700|450399745|FG000|Overall Study|Lost to Follow-up|3|||
125211634|NCT00592592|450399746|FG000|Overall Study|Patient found ineligible upon chart review|1|||
125579982|NCT03891901|451749917|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125579983|NCT03891901|451749918|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125579984|NCT03891901|451749919|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
125579985|NCT03891901|451749911|FG000|Overall Study|Adverse Event|2|||
125579986|NCT03891901|451749912|FG001|Overall Study|Adverse Event|2|||
125579987|NCT03891901|451749913|FG002|Overall Study|Adverse Event|0|||
125579988|NCT03891901|451749914|FG003|Overall Study|Adverse Event|0|||
125579989|NCT03891901|451749915|FG004|Overall Study|Adverse Event|0|||
125579990|NCT03891901|451749916|FG005|Overall Study|Adverse Event|0|||
125579991|NCT03891901|451749917|FG006|Overall Study|Adverse Event|0|||
125579992|NCT03891901|451749918|FG007|Overall Study|Adverse Event|0|||
125579993|NCT03891901|451749919|FG008|Overall Study|Adverse Event|0|||
125579994|NCT03891901|451749911|FG000|Overall Study|Poor venous access|1|||
125579995|NCT03891901|451749912|FG001|Overall Study|Poor venous access|0|||
125579996|NCT03891901|451749913|FG002|Overall Study|Poor venous access|0|||
125360158|NCT00371826|450954295|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
125360159|NCT00371826|450954296|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
125360160|NCT00371826|450954294|FG000|Core Phase (12 Months)|Administrative problems|1|||
125360161|NCT00371826|450954295|FG001|Core Phase (12 Months)|Administrative problems|0|||
125360162|NCT00371826|450954296|FG002|Core Phase (12 Months)|Administrative problems|8|||
125579997|NCT03891901|451749914|FG003|Overall Study|Poor venous access|0|||
125579998|NCT03891901|451749915|FG004|Overall Study|Poor venous access|0|||
125579999|NCT03891901|451749916|FG005|Overall Study|Poor venous access|0|||
125580000|NCT03891901|451749917|FG006|Overall Study|Poor venous access|0|||
125580001|NCT03891901|451749918|FG007|Overall Study|Poor venous access|0|||
125580002|NCT03891901|451749919|FG008|Overall Study|Poor venous access|0|||
125580003|NCT03891901|451749911|FG000|Overall Study|Withdrawal by Subject|0|||
125580004|NCT03891901|451749912|FG001|Overall Study|Withdrawal by Subject|2|||
125580005|NCT03891901|451749913|FG002|Overall Study|Withdrawal by Subject|0|||
125580006|NCT03891901|451749914|FG003|Overall Study|Withdrawal by Subject|0|||
125360163|NCT00371826|450954294|FG000|Core Phase (12 Months)|Graft Loss|0|||
125360164|NCT00371826|450954295|FG001|Core Phase (12 Months)|Graft Loss|1|||
125360165|NCT00371826|450954296|FG002|Core Phase (12 Months)|Graft Loss|0|||
125360166|NCT00371826|450954294|FG000|Extension Phase (24 Months)|Adverse Event|4|||
125360167|NCT00371826|450954295|FG001|Extension Phase (24 Months)|Adverse Event|5|||
125360168|NCT00371826|450954296|FG002|Extension Phase (24 Months)|Adverse Event|0|||
125580007|NCT03891901|451749915|FG004|Overall Study|Withdrawal by Subject|0|||
125580008|NCT03891901|451749916|FG005|Overall Study|Withdrawal by Subject|0|||
125360169|NCT00371826|450954294|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
125580009|NCT03891901|451749917|FG006|Overall Study|Withdrawal by Subject|0|||
125580010|NCT03891901|451749918|FG007|Overall Study|Withdrawal by Subject|0|||
125580011|NCT03891901|451749919|FG008|Overall Study|Withdrawal by Subject|0|||
125580012|NCT00603915|451749920|FG000|Overall Study|Physician Decision|1|||
125580013|NCT00573794|451749928|FG000|Overall Study|Adverse Event|81|||
125580014|NCT00573794|451749928|FG000|Overall Study|Withdrew Consent|90|||
125580015|NCT00573794|451749928|FG000|Overall Study|Lost to Follow-up|13|||
125211635|NCT01038752|450399748|FG000|Overall Study|Tumor Progression|2|||
125360170|NCT00371826|450954295|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
125580016|NCT00573794|451749928|FG000|Overall Study|Protocol Violation|6|||
125580017|NCT00573794|451749928|FG000|Overall Study|Lack of Efficacy|94|||
125580018|NCT00573794|451749928|FG000|Overall Study|Other|46|||
125580019|NCT02026063|451749929|FG000|Overall Study|Physician Decision|0|||
125580020|NCT02026063|451749930|FG001|Overall Study|Physician Decision|10|||
125580021|NCT02026063|451749929|FG000|Overall Study|Noncompliance with Study Drug|1|||
125360171|NCT00371826|450954296|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
125360172|NCT00371826|450954294|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
125360173|NCT00371826|450954295|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
125360174|NCT00371826|450954296|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
125360175|NCT00371826|450954294|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
125360176|NCT00371826|450954295|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
125360177|NCT00371826|450954296|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
125360178|NCT00371826|450954294|FG000|Extension Phase (24 Months)|Administrative problems|0|||
125360179|NCT00371826|450954295|FG001|Extension Phase (24 Months)|Administrative problems|0|||
125360180|NCT00371826|450954296|FG002|Extension Phase (24 Months)|Administrative problems|2|||
125360181|NCT00734474|450954299|FG000|Overall Study|Entry Criteria Not Met|0|||
125360182|NCT00734474|450954300|FG001|Overall Study|Entry Criteria Not Met|0|||
125360183|NCT00734474|450954301|FG002|Overall Study|Entry Criteria Not Met|5|||
125360184|NCT00734474|450954302|FG003|Overall Study|Entry Criteria Not Met|0|||
125360185|NCT00734474|450954303|FG004|Overall Study|Entry Criteria Not Met|3|||
125360186|NCT00734474|450954304|FG005|Overall Study|Entry Criteria Not Met|1|||
125360187|NCT00734474|450954305|FG006|Overall Study|Entry Criteria Not Met|0|||
125360188|NCT00734474|450954306|FG007|Overall Study|Entry Criteria Not Met|1|||
125360189|NCT00734474|450954307|FG008|Overall Study|Entry Criteria Not Met|1|||
125360190|NCT00734474|450954299|FG000|Overall Study|Lost to Follow-up|1|||
125360191|NCT00734474|450954300|FG001|Overall Study|Lost to Follow-up|0|||
125360192|NCT00734474|450954301|FG002|Overall Study|Lost to Follow-up|13|||
125360193|NCT00734474|450954302|FG003|Overall Study|Lost to Follow-up|0|||
125360194|NCT00734474|450954303|FG004|Overall Study|Lost to Follow-up|11|||
125360195|NCT00734474|450954304|FG005|Overall Study|Lost to Follow-up|1|||
125360196|NCT00734474|450954305|FG006|Overall Study|Lost to Follow-up|0|||
125360197|NCT00734474|450954306|FG007|Overall Study|Lost to Follow-up|9|||
125360198|NCT00734474|450954307|FG008|Overall Study|Lost to Follow-up|4|||
125360199|NCT00734474|450954299|FG000|Overall Study|Withdrawal by Subject|2|||
125360200|NCT00734474|450954300|FG001|Overall Study|Withdrawal by Subject|1|||
125360201|NCT00734474|450954301|FG002|Overall Study|Withdrawal by Subject|18|||
125360202|NCT00734474|450954302|FG003|Overall Study|Withdrawal by Subject|0|||
125360203|NCT00734474|450954303|FG004|Overall Study|Withdrawal by Subject|24|||
125360204|NCT00734474|450954304|FG005|Overall Study|Withdrawal by Subject|2|||
125360205|NCT00734474|450954305|FG006|Overall Study|Withdrawal by Subject|0|||
125360206|NCT00734474|450954306|FG007|Overall Study|Withdrawal by Subject|36|||
125360207|NCT00734474|450954307|FG008|Overall Study|Withdrawal by Subject|21|||
125360208|NCT00734474|450954299|FG000|Overall Study|Physician Decision|0|||
125360209|NCT00734474|450954300|FG001|Overall Study|Physician Decision|0|||
125360210|NCT00734474|450954301|FG002|Overall Study|Physician Decision|4|||
125360211|NCT00734474|450954302|FG003|Overall Study|Physician Decision|1|||
125360212|NCT00734474|450954303|FG004|Overall Study|Physician Decision|11|||
125360213|NCT00734474|450954304|FG005|Overall Study|Physician Decision|0|||
125360214|NCT00734474|450954305|FG006|Overall Study|Physician Decision|0|||
125360215|NCT00734474|450954306|FG007|Overall Study|Physician Decision|9|||
125360216|NCT00734474|450954307|FG008|Overall Study|Physician Decision|9|||
125360217|NCT00734474|450954299|FG000|Overall Study|Adverse Event|4|||
125360218|NCT00734474|450954300|FG001|Overall Study|Adverse Event|4|||
125360219|NCT00734474|450954301|FG002|Overall Study|Adverse Event|63|||
125360220|NCT00734474|450954302|FG003|Overall Study|Adverse Event|1|||
125360221|NCT00734474|450954303|FG004|Overall Study|Adverse Event|64|||
125360222|NCT00734474|450954304|FG005|Overall Study|Adverse Event|0|||
125360223|NCT00734474|450954305|FG006|Overall Study|Adverse Event|1|||
125360224|NCT00734474|450954306|FG007|Overall Study|Adverse Event|65|||
125360225|NCT00734474|450954307|FG008|Overall Study|Adverse Event|39|||
125360226|NCT00734474|450954299|FG000|Overall Study|Protocol Violation|0|||
125360227|NCT00734474|450954300|FG001|Overall Study|Protocol Violation|0|||
125580022|NCT02026063|451749930|FG001|Overall Study|Noncompliance with Study Drug|1|||
125360228|NCT00734474|450954301|FG002|Overall Study|Protocol Violation|4|||
125360229|NCT00734474|450954302|FG003|Overall Study|Protocol Violation|0|||
125360230|NCT00734474|450954303|FG004|Overall Study|Protocol Violation|3|||
125360231|NCT00734474|450954304|FG005|Overall Study|Protocol Violation|0|||
125360232|NCT00734474|450954305|FG006|Overall Study|Protocol Violation|0|||
125580023|NCT02026063|451749929|FG000|Overall Study|Withdrawal of Consent|1|||
125360233|NCT00734474|450954306|FG007|Overall Study|Protocol Violation|3|||
125360234|NCT00734474|450954307|FG008|Overall Study|Protocol Violation|1|||
125360235|NCT00734474|450954299|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
125360236|NCT00734474|450954300|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
125360237|NCT00734474|450954301|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
125360238|NCT00734474|450954302|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
125360239|NCT00734474|450954303|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
125427978|NCT01951638|451192538|FG001|Treatment Period|Protocol Violation|0|||
125427979|NCT01951638|451192539|FG002|Treatment Period|Protocol Violation|0|||
125427980|NCT01951638|451192540|FG003|Treatment Period|Protocol Violation|2|||
125427981|NCT01951638|451192541|FG004|Treatment Period|Protocol Violation|0|||
125427982|NCT01951638|451192537|FG000|Treatment Period|Protocol-driven decision point|1|||
125427983|NCT01951638|451192538|FG001|Treatment Period|Protocol-driven decision point|3|||
125427984|NCT01951638|451192539|FG002|Treatment Period|Protocol-driven decision point|0|||
125427985|NCT01951638|451192540|FG003|Treatment Period|Protocol-driven decision point|0|||
125427986|NCT01951638|451192541|FG004|Treatment Period|Protocol-driven decision point|0|||
125427987|NCT01951638|451192537|FG000|Treatment Period|Logistical difficulties|0|||
125427988|NCT01951638|451192538|FG001|Treatment Period|Logistical difficulties|1|||
125427989|NCT01951638|451192539|FG002|Treatment Period|Logistical difficulties|1|||
125427990|NCT01951638|451192540|FG003|Treatment Period|Logistical difficulties|0|||
125427991|NCT01951638|451192541|FG004|Treatment Period|Logistical difficulties|0|||
125427992|NCT01951638|451192537|FG000|Treatment Period|Withdrawal by Subject|9|||
125580024|NCT02026063|451749930|FG001|Overall Study|Withdrawal of Consent|6|||
125580025|NCT02026063|451749929|FG000|Overall Study|Adverse Event|5|||
125580026|NCT02026063|451749930|FG001|Overall Study|Adverse Event|20|||
125580027|NCT02026063|451749929|FG000|Overall Study|Lack of Efficacy|0|||
125580028|NCT02026063|451749930|FG001|Overall Study|Lack of Efficacy|4|||
125580029|NCT02026063|451749929|FG000|Overall Study|Lost to Follow-up|0|||
125580030|NCT02026063|451749930|FG001|Overall Study|Lost to Follow-up|1|||
125580031|NCT02026063|451749929|FG000|Overall Study|Reason not Specified|2|||
125580032|NCT02026063|451749930|FG001|Overall Study|Reason not Specified|7|||
125580033|NCT01116544|451749932|FG000|Overall Study|Protocol Violation|1|||
125580034|NCT01116544|451749933|FG001|Overall Study|Protocol Violation|0|||
125580035|NCT01116544|451749932|FG000|Overall Study|Withdrawal by Subject|1|||
125580036|NCT01116544|451749933|FG001|Overall Study|Withdrawal by Subject|1|||
125580037|NCT02183519|451749934|FG000|Overall Study|computer error|3|||
125580038|NCT02183519|451749935|FG001|Overall Study|computer error|0|||
125580039|NCT02183519|451749934|FG000|Overall Study|Did not respond to cough inducter|0|||
125580040|NCT02183519|451749935|FG001|Overall Study|Did not respond to cough inducter|3|||
125580041|NCT02542072|451749936|FG000|First Intervention (1 Month)|Adverse Event|1|||
125427993|NCT01951638|451192538|FG001|Treatment Period|Withdrawal by Subject|6|||
125427994|NCT01951638|451192539|FG002|Treatment Period|Withdrawal by Subject|4|||
125427995|NCT01951638|451192540|FG003|Treatment Period|Withdrawal by Subject|5|||
125427996|NCT01951638|451192541|FG004|Treatment Period|Withdrawal by Subject|4|||
125427997|NCT01951638|451192537|FG000|Treatment Period|Death|0|||
125427998|NCT01951638|451192538|FG001|Treatment Period|Death|0|||
125427999|NCT01951638|451192539|FG002|Treatment Period|Death|0|||
125428000|NCT01951638|451192540|FG003|Treatment Period|Death|3|||
125428001|NCT01951638|451192541|FG004|Treatment Period|Death|1|||
125428002|NCT01951638|451192537|FG000|Treatment Period|Adverse Event|3|||
125428003|NCT01951638|451192538|FG001|Treatment Period|Adverse Event|4|||
125580042|NCT02542072|451749937|FG001|First Intervention (1 Month)|Adverse Event|1|||
125580043|NCT02542072|451749936|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
125580044|NCT02542072|451749937|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
125580045|NCT02542072|451749936|FG000|First Intervention (1 Month)|Lens discomfort|1|||
125428004|NCT01951638|451192539|FG002|Treatment Period|Adverse Event|8|||
125428005|NCT01951638|451192540|FG003|Treatment Period|Adverse Event|6|||
125428006|NCT01951638|451192541|FG004|Treatment Period|Adverse Event|5|||
125580046|NCT02542072|451749937|FG001|First Intervention (1 Month)|Lens discomfort|2|||
125580047|NCT02542072|451749936|FG000|First Intervention (1 Month)|Protocol Violation|1|||
125580048|NCT02542072|451749937|FG001|First Intervention (1 Month)|Protocol Violation|0|||
125580049|NCT02542072|451749936|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
125580050|NCT02542072|451749937|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
125580051|NCT02542072|451749936|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
125580052|NCT02542072|451749937|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
125580053|NCT05168267|451749940|FG000|Overall Study|Withdrawal by Subject|2|||
125580054|NCT05168267|451749941|FG001|Overall Study|Withdrawal by Subject|1|||
125580055|NCT05168267|451749940|FG000|Overall Study|Withdrawn by Therapist|1|||
125580056|NCT05168267|451749941|FG001|Overall Study|Withdrawn by Therapist|1|||
125580057|NCT05168267|451749940|FG000|Overall Study|Left Facility|1|||
125580058|NCT05168267|451749941|FG001|Overall Study|Left Facility|0|||
125580059|NCT05702736|451749942|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
125580060|NCT05702736|451749943|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
125580061|NCT05702736|451749942|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
125580062|NCT05702736|451749943|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
125580063|NCT01356589|451749946|FG000|Overall Study|Enrolled, but not treated|3|||
125580064|NCT01356589|451749946|FG000|Overall Study|Dose data not recorded|2|||
125580065|NCT02937350|451749947|FG000|Overall Study|Withdrawal by Subject|0|||
125580066|NCT02937350|451749948|FG001|Overall Study|Withdrawal by Subject|1|||
125580067|NCT02937350|451749949|FG002|Overall Study|Withdrawal by Subject|0|||
125580068|NCT00695565|451749950|FG000|Overall Study|Lost to Follow-up|4|||
125580069|NCT00695565|451749951|FG001|Overall Study|Lost to Follow-up|4|||
125580070|NCT00695565|451749950|FG000|Overall Study|Adverse Event|3|||
125580071|NCT00695565|451749951|FG001|Overall Study|Adverse Event|1|||
125580072|NCT00695565|451749950|FG000|Overall Study|Protocol Violation|3|||
125580073|NCT00695565|451749951|FG001|Overall Study|Protocol Violation|1|||
125580074|NCT00695565|451749950|FG000|Overall Study|Withdrawal by Subject|1|||
125580075|NCT00695565|451749951|FG001|Overall Study|Withdrawal by Subject|1|||
125580076|NCT00695565|451749950|FG000|Overall Study|Lack of Efficacy|1|||
125580077|NCT00695565|451749951|FG001|Overall Study|Lack of Efficacy|1|||
125580078|NCT00695565|451749950|FG000|Overall Study|Subject did not follow instructions|1|||
125580079|NCT00695565|451749951|FG001|Overall Study|Subject did not follow instructions|1|||
125580080|NCT01106846|451749952|FG000|Overall Study|Change in surgical procedure|0|||
125580081|NCT01106846|451749953|FG001|Overall Study|Change in surgical procedure|1|||
125580082|NCT00803179|451749964|FG000|Overall Study|Lost to Follow-up|3|||
125580083|NCT04811716|451749965|FG000|Overall Study|Withdrawal by Subject|2|||
125580084|NCT04811716|451749966|FG001|Overall Study|Withdrawal by Subject|0|||
125580085|NCT02447848|451749967|FG000|Overall Study|Patient discharged|3|||
125580086|NCT02447848|451749967|FG000|Overall Study|Lack of Efficacy|4|||
125580087|NCT02447848|451749967|FG000|Overall Study|Withdrawal by Subject|4|||
125580088|NCT00684957|451749973|FG000|Overall Study|Withdrawal by Subject|1|||
125580089|NCT00684957|451749974|FG001|Overall Study|Withdrawal by Subject|1|||
125580090|NCT00684957|451749973|FG000|Overall Study|Lost to Follow-up|1|||
125580091|NCT00684957|451749974|FG001|Overall Study|Lost to Follow-up|0|||
125580092|NCT04439175|451751565|FG000|Overall Study|Never started treatment|4|||
125428007|NCT01951638|451192537|FG000|Follow-up Period|Protocol Violation|0|||
125428008|NCT01951638|451192538|FG001|Follow-up Period|Protocol Violation|0|||
125428009|NCT01951638|451192539|FG002|Follow-up Period|Protocol Violation|0|||
125428010|NCT01951638|451192540|FG003|Follow-up Period|Protocol Violation|1|||
125428011|NCT01951638|451192541|FG004|Follow-up Period|Protocol Violation|0|||
125428012|NCT01951638|451192537|FG000|Follow-up Period|Logistical difficulties|0|||
125428013|NCT01951638|451192538|FG001|Follow-up Period|Logistical difficulties|2|||
125428014|NCT01951638|451192539|FG002|Follow-up Period|Logistical difficulties|0|||
125428015|NCT01951638|451192540|FG003|Follow-up Period|Logistical difficulties|0|||
125428016|NCT01951638|451192541|FG004|Follow-up Period|Logistical difficulties|1|||
125428017|NCT01951638|451192537|FG000|Follow-up Period|Withdrawal by Subject|1|||
125428018|NCT01951638|451192538|FG001|Follow-up Period|Withdrawal by Subject|5|||
125428019|NCT01951638|451192539|FG002|Follow-up Period|Withdrawal by Subject|2|||
125428020|NCT01951638|451192540|FG003|Follow-up Period|Withdrawal by Subject|1|||
125428021|NCT01951638|451192541|FG004|Follow-up Period|Withdrawal by Subject|2|||
125428022|NCT01951638|451192537|FG000|Follow-up Period|Lost to Follow-up|0|||
125428023|NCT01951638|451192538|FG001|Follow-up Period|Lost to Follow-up|1|||
125428024|NCT01951638|451192539|FG002|Follow-up Period|Lost to Follow-up|0|||
125428025|NCT01951638|451192540|FG003|Follow-up Period|Lost to Follow-up|1|||
125580093|NCT04439175|451751565|FG000|Overall Study|Ineligible|5|||
125580094|NCT04439175|451751565|FG000|Overall Study|Adverse Event|6|||
125580095|NCT04439175|451751565|FG000|Overall Study|Death|4|||
125580096|NCT04439175|451751565|FG000|Overall Study|Disease progression|44|||
125580097|NCT04439175|451751565|FG000|Overall Study|Withdrawal by Subject|4|||
125580098|NCT04439175|451751565|FG000|Overall Study|Alternative Therapy|1|||
125428026|NCT01951638|451192541|FG004|Follow-up Period|Lost to Follow-up|0|||
125428027|NCT01951638|451192537|FG000|Follow-up Period|Death|1|||
125428028|NCT01951638|451192538|FG001|Follow-up Period|Death|0|||
125428029|NCT01951638|451192539|FG002|Follow-up Period|Death|1|||
125428030|NCT01951638|451192540|FG003|Follow-up Period|Death|4|||
125428031|NCT01951638|451192541|FG004|Follow-up Period|Death|1|||
125428032|NCT01951638|451192537|FG000|Follow-up Period|Adverse Event|0|||
125428033|NCT01951638|451192538|FG001|Follow-up Period|Adverse Event|1|||
125428034|NCT01951638|451192539|FG002|Follow-up Period|Adverse Event|2|||
125428035|NCT01951638|451192540|FG003|Follow-up Period|Adverse Event|1|||
125428036|NCT01951638|451192541|FG004|Follow-up Period|Adverse Event|1|||
125428037|NCT00459342|451192544|FG000|Overall Study|Not eligible|1|||
125428038|NCT02686034|451192545|FG000|Run-In Period 1|Eligibility|12|||
125428039|NCT02686034|451192546|FG001|Run-In Period 1|Eligibility|10|||
125428040|NCT02686034|451192545|FG000|Run-In Period 1|Withdrawal by Subject|4|||
125428041|NCT02686034|451192546|FG001|Run-In Period 1|Withdrawal by Subject|3|||
125428042|NCT02686034|451192545|FG000|Run-In Period 1|Lost to Follow-up|4|||
125428043|NCT02686034|451192546|FG001|Run-In Period 1|Lost to Follow-up|4|||
125428044|NCT02686034|451192545|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
125428045|NCT02686034|451192546|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
125428046|NCT02686034|451192545|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
125428047|NCT02686034|451192546|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
125428048|NCT02686034|451192545|FG000|Randomized Controlled Period 2|Adverse Event|0|||
125428049|NCT02686034|451192546|FG001|Randomized Controlled Period 2|Adverse Event|2|||
125428050|NCT02686034|451192545|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
125428051|NCT02686034|451192546|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
125428052|NCT02686034|451192545|FG000|Open Label Period 3|Lost to Follow-up|0|||
125428053|NCT02686034|451192546|FG001|Open Label Period 3|Lost to Follow-up|1|||
125428054|NCT01345630|451193771|FG000|Overall Study|Adverse Event|22|||
125428055|NCT01345630|451193772|FG001|Overall Study|Adverse Event|23|||
125428056|NCT01345630|451193771|FG000|Overall Study|Lost to Follow-up|17|||
125428057|NCT01345630|451193772|FG001|Overall Study|Lost to Follow-up|16|||
125428058|NCT01345630|451193771|FG000|Overall Study|Protocol Violation|4|||
125428059|NCT01345630|451193772|FG001|Overall Study|Protocol Violation|1|||
125428060|NCT01345630|451193771|FG000|Overall Study|Medication error without associated AE|0|||
125428061|NCT01345630|451193772|FG001|Overall Study|Medication error without associated AE|1|||
125428062|NCT01345630|451193771|FG000|Overall Study|Study terminated by sponsor|254|||
125428063|NCT01345630|451193772|FG001|Overall Study|Study terminated by sponsor|285|||
125428064|NCT01345630|451193771|FG000|Overall Study|Other reasons|6|||
125428065|NCT01345630|451193772|FG001|Overall Study|Other reasons|8|||
125428066|NCT01345630|451193771|FG000|Overall Study|Withdrawn due to pregnancy|1|||
125428067|NCT01345630|451193772|FG001|Overall Study|Withdrawn due to pregnancy|2|||
125428068|NCT01345630|451193771|FG000|Overall Study|No longer willing to participate|9|||
125428069|NCT01345630|451193772|FG001|Overall Study|No longer willing to participate|12|||
125428070|NCT01345630|451193771|FG000|Overall Study|Insufficient clinical response|48|||
125428071|NCT01345630|451193772|FG001|Overall Study|Insufficient clinical response|11|||
125428072|NCT04233372|451193773|FG000|Overall Study|Lost to Follow-up|104|||
125428073|NCT04233372|451193773|FG000|Overall Study|Adverse Event|8|||
125428074|NCT04233372|451193773|FG000|Overall Study|Withdrawal by Subject|2|||
125428075|NCT01090310|451193774|FG000|Core Study|Adverse Event|2|||
125428076|NCT01090310|451193775|FG001|Core Study|Adverse Event|2|||
125428077|NCT01090310|451193776|FG002|Core Study|Adverse Event|1|||
125428078|NCT01090310|451193777|FG003|Core Study|Adverse Event|1|||
125428079|NCT01090310|451193774|FG000|Core Study|Subject withdrew consent|0|||
125428080|NCT01090310|451193775|FG001|Core Study|Subject withdrew consent|3|||
125428081|NCT01090310|451193776|FG002|Core Study|Subject withdrew consent|1|||
125428082|NCT01090310|451193777|FG003|Core Study|Subject withdrew consent|1|||
125428083|NCT01090310|451193774|FG000|Core Study|Abnormal test procedure result|0|||
125428084|NCT01090310|451193775|FG001|Core Study|Abnormal test procedure result|0|||
125428085|NCT01090310|451193776|FG002|Core Study|Abnormal test procedure result|1|||
125428086|NCT01090310|451193777|FG003|Core Study|Abnormal test procedure result|0|||
125428087|NCT01090310|451193774|FG000|Core Study|Administrative reasons|5|||
125211636|NCT01038752|450399749|FG001|Overall Study|Tumor Progression|2|||
125428088|NCT01090310|451193775|FG001|Core Study|Administrative reasons|6|||
125428089|NCT01090310|451193776|FG002|Core Study|Administrative reasons|4|||
125428090|NCT01090310|451193777|FG003|Core Study|Administrative reasons|4|||
125428091|NCT01090310|451193774|FG000|Core Study|Protocol deviation|1|||
125428092|NCT01090310|451193775|FG001|Core Study|Protocol deviation|0|||
125428093|NCT01090310|451193776|FG002|Core Study|Protocol deviation|0|||
125428094|NCT01090310|451193777|FG003|Core Study|Protocol deviation|1|||
125428095|NCT01090310|451193774|FG000|Extension Study|Aministrative problems|13|||
125580099|NCT04439175|451751565|FG000|Overall Study|Other|2|||
125580100|NCT02363478|451751567|FG000|Overall Study|Lost to Follow-up|4|||
125580101|NCT02363478|451751567|FG000|Overall Study|Adverse Event|4|||
125580102|NCT00768898|451751568|FG000|Overall Study|Unrelated injury|1|||
125580103|NCT00768898|451751568|FG000|Overall Study|Headache|1|||
125580104|NCT02554929|451751569|FG000|Overall Study|Lost to Follow-up|4|||
125360240|NCT00734474|450954304|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
125360241|NCT00734474|450954305|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
125360242|NCT00734474|450954306|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
125360243|NCT00734474|450954307|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
125360244|NCT00734474|450954299|FG000|Overall Study|Sponsor Decision|0|||
125360245|NCT00734474|450954300|FG001|Overall Study|Sponsor Decision|0|||
125360246|NCT00734474|450954301|FG002|Overall Study|Sponsor Decision|0|||
125360247|NCT00734474|450954302|FG003|Overall Study|Sponsor Decision|0|||
125360248|NCT00734474|450954303|FG004|Overall Study|Sponsor Decision|2|||
125360249|NCT00734474|450954304|FG005|Overall Study|Sponsor Decision|0|||
125360250|NCT00734474|450954305|FG006|Overall Study|Sponsor Decision|0|||
125360251|NCT00734474|450954306|FG007|Overall Study|Sponsor Decision|0|||
125360252|NCT00734474|450954307|FG008|Overall Study|Sponsor Decision|0|||
125360253|NCT00734474|450954299|FG000|Overall Study|Death|0|||
125360254|NCT00734474|450954300|FG001|Overall Study|Death|0|||
125360255|NCT00734474|450954301|FG002|Overall Study|Death|1|||
125360256|NCT00734474|450954302|FG003|Overall Study|Death|0|||
125360257|NCT00734474|450954303|FG004|Overall Study|Death|0|||
125360258|NCT00734474|450954304|FG005|Overall Study|Death|0|||
125360259|NCT00734474|450954305|FG006|Overall Study|Death|0|||
125360260|NCT00734474|450954306|FG007|Overall Study|Death|2|||
125360261|NCT00734474|450954307|FG008|Overall Study|Death|1|||
125360262|NCT00734474|450954299|FG000|Overall Study|Lack of Efficacy|0|||
125360263|NCT00734474|450954300|FG001|Overall Study|Lack of Efficacy|0|||
125360264|NCT00734474|450954301|FG002|Overall Study|Lack of Efficacy|4|||
125360265|NCT00734474|450954302|FG003|Overall Study|Lack of Efficacy|0|||
125360266|NCT00734474|450954303|FG004|Overall Study|Lack of Efficacy|0|||
125360267|NCT00734474|450954304|FG005|Overall Study|Lack of Efficacy|0|||
125360268|NCT00734474|450954305|FG006|Overall Study|Lack of Efficacy|0|||
125360269|NCT00734474|450954306|FG007|Overall Study|Lack of Efficacy|4|||
125360270|NCT00734474|450954307|FG008|Overall Study|Lack of Efficacy|6|||
125360271|NCT00385762|450954316|FG000|Overall Study|Adverse Event|1|||
125360272|NCT00385762|450954316|FG000|Overall Study|Lost to Follow-up|1|||
125360273|NCT00573183|450954317|FG000|Overall Study|Lost to Follow-up|52|||
125360274|NCT00573183|450954318|FG001|Overall Study|Lost to Follow-up|50|||
125360275|NCT00573183|450954317|FG000|Overall Study|Withdrawal by Subject|8|||
125360276|NCT00573183|450954318|FG001|Overall Study|Withdrawal by Subject|2|||
125360277|NCT00573183|450954317|FG000|Overall Study|Death|0|||
125360278|NCT00573183|450954318|FG001|Overall Study|Death|1|||
125360279|NCT00573183|450954317|FG000|Overall Study|Adverse Event|2|||
125360280|NCT00573183|450954318|FG001|Overall Study|Adverse Event|0|||
125360281|NCT00573183|450954317|FG000|Overall Study|Incarceration|5|||
125360282|NCT00573183|450954318|FG001|Overall Study|Incarceration|8|||
125360283|NCT00573183|450954317|FG000|Overall Study|Other|5|||
125360284|NCT00573183|450954318|FG001|Overall Study|Other|2|||
125360285|NCT00428792|450954321|FG000|Overall Study|Lack of Efficacy|1|||
125360286|NCT00428792|450954322|FG001|Overall Study|Lack of Efficacy|3|||
125360287|NCT00428792|450954321|FG000|Overall Study|Lost to Follow-up|0|||
125360288|NCT00428792|450954322|FG001|Overall Study|Lost to Follow-up|1|||
125360289|NCT02570074|450954323|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
125360290|NCT02570074|450954324|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
125360291|NCT03270644|450954329|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
125360292|NCT03270644|450954329|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
125360293|NCT00354614|450954331|FG000|Overall Study|Lack of Efficacy|28|||
125580105|NCT02554929|451751570|FG001|Overall Study|Lost to Follow-up|4|||
125580106|NCT02554929|451751569|FG000|Overall Study|Withdrawal by Subject|2|||
125580107|NCT02554929|451751570|FG001|Overall Study|Withdrawal by Subject|8|||
125580108|NCT00546364|451751571|FG000|Overall Study|Disease progression|5|||
125580109|NCT00546364|451751572|FG001|Overall Study|Disease progression|11|||
125360294|NCT01500031|450954332|FG000|Overall Study|Death|1|||
125580110|NCT00546364|451751573|FG002|Overall Study|Disease progression|8|||
125360295|NCT01500031|450954332|FG000|Overall Study|Withdrawal by Subject|4|||
125360296|NCT01856907|450954334|FG000|Overall Study|Pregnancy|0|||
125360297|NCT01856907|450954335|FG001|Overall Study|Pregnancy|1|||
125360298|NCT01856907|450954336|FG002|Overall Study|Pregnancy|0|||
125360299|NCT01856907|450954334|FG000|Overall Study|Pregnancy|0|||
125360300|NCT01856907|450954335|FG001|Overall Study|Pregnancy|1|||
125360301|NCT01856907|450954336|FG002|Overall Study|Pregnancy|0|||
125580111|NCT00546364|451751571|FG000|Overall Study|Completed and off treatment|1|||
125360302|NCT01856907|450954334|FG000|Overall Study|Withdrawal by Subject|0|||
125360303|NCT01856907|450954335|FG001|Overall Study|Withdrawal by Subject|1|||
125360304|NCT01856907|450954336|FG002|Overall Study|Withdrawal by Subject|0|||
125360305|NCT01604408|450954339|FG000|Treatment Period 1|Protocol Violation|0|||
125360306|NCT01604408|450954340|FG001|Treatment Period 1|Protocol Violation|1|||
125580112|NCT00546364|451751572|FG001|Overall Study|Completed and off treatment|0|||
125580113|NCT00546364|451751573|FG002|Overall Study|Completed and off treatment|2|||
125580114|NCT00546364|451751571|FG000|Overall Study|Administrative reason by sponsor|1|||
125580115|NCT00546364|451751572|FG001|Overall Study|Administrative reason by sponsor|0|||
125580116|NCT00546364|451751573|FG002|Overall Study|Administrative reason by sponsor|0|||
125580117|NCT00546364|451751571|FG000|Overall Study|Poor compliance/noncompliance|0|||
125580118|NCT00546364|451751572|FG001|Overall Study|Poor compliance/noncompliance|0|||
125580119|NCT00546364|451751573|FG002|Overall Study|Poor compliance/noncompliance|1|||
125580120|NCT00546364|451751571|FG000|Overall Study|No longer meets study criteria|1|||
125580121|NCT00546364|451751572|FG001|Overall Study|No longer meets study criteria|1|||
125580122|NCT00546364|451751573|FG002|Overall Study|No longer meets study criteria|0|||
125580123|NCT00546364|451751571|FG000|Overall Study|Withdrawal by Subject|5|||
125211637|NCT01038752|450399748|FG000|Overall Study|Lost to Follow-up|3|||
125211638|NCT01038752|450399749|FG001|Overall Study|Lost to Follow-up|3|||
125211639|NCT00530790|450399750|FG000|Overall Study|Adverse Event|2|||
125211640|NCT00530790|450399750|FG000|Overall Study|Withdrawal by Subject|2|||
125211641|NCT00530790|450399750|FG000|Overall Study|Physician Decision|1|||
125211642|NCT02005627|450399753|FG000|Overall Study|Lost to Follow-up|1|||
125211643|NCT02005627|450399754|FG001|Overall Study|Lost to Follow-up|2|||
125211644|NCT02005627|450399753|FG000|Overall Study|Withdrawal by Subject|1|||
125211645|NCT02005627|450399754|FG001|Overall Study|Withdrawal by Subject|2|||
125211646|NCT01693185|450399757|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
125211647|NCT01693185|450399758|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
125211648|NCT01084538|450399759|FG000|Overall Study|Drug not available|30|||
125211649|NCT01084538|450399759|FG000|Overall Study|Adverse Event|9|||
125211650|NCT01084538|450399759|FG000|Overall Study|Kidney transplant|6|||
125211651|NCT01084538|450399759|FG000|Overall Study|Serious Adverse Event|3|||
125211652|NCT01084538|450399759|FG000|Overall Study|Lack of effectiveness|2|||
125211653|NCT01084538|450399759|FG000|Overall Study|Patient noncompliance|2|||
125211654|NCT01084538|450399759|FG000|Overall Study|Hyperphosphatemia|2|||
125211655|NCT01084538|450399759|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
125211656|NCT01084538|450399759|FG000|Overall Study|Change of residence|2|||
125211657|NCT01084538|450399759|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
125211658|NCT01084538|450399759|FG000|Overall Study|Reason unknown|8|||
125211659|NCT02279745|450399760|FG000|Overall Study|Adverse Event|7|||
125211660|NCT02279745|450399760|FG000|Overall Study|Death|6|||
125211661|NCT02279745|450399760|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
125211662|NCT02279745|450399760|FG000|Overall Study|Withdrawal by Subject|2|||
125211663|NCT02279745|450399760|FG000|Overall Study|Pregnancy|1|||
125360307|NCT01604408|450954339|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125360308|NCT01604408|450954340|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125360309|NCT01604408|450954339|FG000|Treatment Period 2|Protocol Violation|1|||
125360310|NCT01604408|450954340|FG001|Treatment Period 2|Protocol Violation|0|||
125360311|NCT01604408|450954339|FG000|Treatment Period 2|Adverse Event|0|||
125360312|NCT01604408|450954340|FG001|Treatment Period 2|Adverse Event|1|||
125360313|NCT01604408|450954339|FG000|Treatment Period 3|Protocol Violation|1|||
125360314|NCT01604408|450954340|FG001|Treatment Period 3|Protocol Violation|1|||
125360315|NCT01604408|450954339|FG000|Treatment Period 3|Adverse Event|0|||
125360316|NCT01604408|450954340|FG001|Treatment Period 3|Adverse Event|3|||
125360317|NCT01604408|450954339|FG000|Treatment Period 3|Withdrawal by Subject|3|||
125360318|NCT01604408|450954340|FG001|Treatment Period 3|Withdrawal by Subject|1|||
125360319|NCT01604408|450954339|FG000|Treatment Period 3|Sponsor Decision|1|||
125360320|NCT01604408|450954340|FG001|Treatment Period 3|Sponsor Decision|0|||
125360321|NCT01604408|450954339|FG000|Treatment Period 4|Death|1|||
125360322|NCT01604408|450954340|FG001|Treatment Period 4|Death|0|||
125360323|NCT01604408|450954339|FG000|Treatment Period 4|Withdrawal by Subject|2|||
125580124|NCT00546364|451751572|FG001|Overall Study|Withdrawal by Subject|6|||
125580125|NCT00546364|451751573|FG002|Overall Study|Withdrawal by Subject|3|||
125580126|NCT00546364|451751571|FG000|Overall Study|Prior taxotere|1|||
125580127|NCT00546364|451751572|FG001|Overall Study|Prior taxotere|0|||
125211664|NCT02279745|450399760|FG000|Overall Study|Study Non-compliance|1|||
125211665|NCT02279745|450399760|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
125211666|NCT01606748|450399765|FG000|Overall Study|Adverse Event|1|||
125211667|NCT01606748|450399766|FG001|Overall Study|Adverse Event|0|||
125360324|NCT01604408|450954340|FG001|Treatment Period 4|Withdrawal by Subject|1|||
125360325|NCT01604408|450954339|FG000|Treatment Period 4|Adverse Event|0|||
125360326|NCT01604408|450954340|FG001|Treatment Period 4|Adverse Event|1|||
125360327|NCT01604408|450954339|FG000|Treatment Period 5|Adverse Event|4|||
125580128|NCT00546364|451751573|FG002|Overall Study|Prior taxotere|0|||
125580129|NCT00546364|451751571|FG000|Overall Study|Mixed response|1|||
125580130|NCT00546364|451751572|FG001|Overall Study|Mixed response|0|||
125580131|NCT00546364|451751573|FG002|Overall Study|Mixed response|0|||
125580132|NCT00546364|451751571|FG000|Overall Study|Palliative treatment|1|||
125580133|NCT00546364|451751572|FG001|Overall Study|Palliative treatment|0|||
125211668|NCT01606748|450399765|FG000|Overall Study|Progressive Disease|1|||
125211669|NCT01606748|450399766|FG001|Overall Study|Progressive Disease|0|||
125580134|NCT00546364|451751573|FG002|Overall Study|Palliative treatment|1|||
125580135|NCT00546364|451751571|FG000|Overall Study|Target lesions resected|1|||
125580136|NCT00546364|451751572|FG001|Overall Study|Target lesions resected|0|||
125580137|NCT00546364|451751573|FG002|Overall Study|Target lesions resected|0|||
125580138|NCT00546364|451751571|FG000|Overall Study|Physician Decision|0|||
125580139|NCT00546364|451751572|FG001|Overall Study|Physician Decision|0|||
125580140|NCT00546364|451751573|FG002|Overall Study|Physician Decision|1|||
125580141|NCT00546364|451751571|FG000|Overall Study|Sponsor decision|0|||
125580142|NCT00546364|451751572|FG001|Overall Study|Sponsor decision|0|||
125580143|NCT00546364|451751573|FG002|Overall Study|Sponsor decision|1|||
125580144|NCT00667576|451751574|FG000|Overall Study|Withdrawal by Subject|1|||
125580145|NCT00667576|451751575|FG001|Overall Study|Withdrawal by Subject|0|||
125580146|NCT00667576|451751576|FG002|Overall Study|Withdrawal by Subject|1|||
125580147|NCT00667576|451751577|FG003|Overall Study|Withdrawal by Subject|1|||
125580148|NCT00667576|451751578|FG004|Overall Study|Withdrawal by Subject|1|||
125580149|NCT00667576|451751574|FG000|Overall Study|Adverse Event|1|||
125580150|NCT00667576|451751575|FG001|Overall Study|Adverse Event|1|||
125580151|NCT00667576|451751576|FG002|Overall Study|Adverse Event|0|||
125580152|NCT00667576|451751577|FG003|Overall Study|Adverse Event|0|||
125580153|NCT00667576|451751578|FG004|Overall Study|Adverse Event|0|||
125580154|NCT00667576|451751574|FG000|Overall Study|Lost to Follow-up|0|||
125580155|NCT00667576|451751575|FG001|Overall Study|Lost to Follow-up|0|||
125580156|NCT00667576|451751576|FG002|Overall Study|Lost to Follow-up|1|||
125580157|NCT00667576|451751577|FG003|Overall Study|Lost to Follow-up|0|||
125580158|NCT00667576|451751578|FG004|Overall Study|Lost to Follow-up|0|||
125580159|NCT00667576|451751574|FG000|Overall Study|Protocol Violation|0|||
125580160|NCT00667576|451751575|FG001|Overall Study|Protocol Violation|0|||
125580161|NCT00667576|451751576|FG002|Overall Study|Protocol Violation|0|||
125580162|NCT00667576|451751577|FG003|Overall Study|Protocol Violation|1|||
125580163|NCT00667576|451751578|FG004|Overall Study|Protocol Violation|0|||
125580164|NCT00667576|451751574|FG000|Overall Study|Physician Decision|0|||
125580165|NCT00667576|451751575|FG001|Overall Study|Physician Decision|0|||
125580166|NCT00667576|451751576|FG002|Overall Study|Physician Decision|0|||
125580167|NCT00667576|451751577|FG003|Overall Study|Physician Decision|1|||
125580168|NCT00667576|451751578|FG004|Overall Study|Physician Decision|0|||
125580169|NCT00667576|451751574|FG000|Overall Study|Missed Visit|0|||
125580170|NCT00667576|451751575|FG001|Overall Study|Missed Visit|0|||
125580171|NCT00667576|451751576|FG002|Overall Study|Missed Visit|0|||
125580172|NCT00667576|451751577|FG003|Overall Study|Missed Visit|1|||
125580173|NCT00667576|451751578|FG004|Overall Study|Missed Visit|0|||
125580174|NCT01390389|451751579|FG000|Overall Study|Withdrawal by Subject|2|||
125580175|NCT01390389|451751580|FG001|Overall Study|Withdrawal by Subject|0|||
125580176|NCT01390389|451751579|FG000|Overall Study|Screen Fail|2|||
125580177|NCT01390389|451751580|FG001|Overall Study|Screen Fail|1|||
125580178|NCT02002975|451751581|FG000|Overall Study|Case Report Forms Uncollected|135|||
125580179|NCT02002975|451751581|FG000|Overall Study|Protocol Deviation|437|||
125580180|NCT03569202|451751589|FG000|Part 3|Physician Decision|1|||
125580181|NCT03569202|451751590|FG001|Part 3|Physician Decision|0|||
125580182|NCT03569202|451751589|FG000|Part 3|Other|1|||
125580183|NCT03569202|451751590|FG001|Part 3|Other|1|||
125580184|NCT00420511|451751591|FG000|Overall Study|Adverse Event|1|||
125580185|NCT00420511|451751592|FG001|Overall Study|Adverse Event|1|||
125580186|NCT00420511|451751591|FG000|Overall Study|Lost to Follow-up|1|||
125580187|NCT00420511|451751592|FG001|Overall Study|Lost to Follow-up|0|||
125580188|NCT02415712|451751593|FG000|Overall Study|Protocol Violation|16|||
125580189|NCT01668654|451751594|FG000|Overall Study|Study Closed/Terminated|3|||
125580190|NCT01668654|451751594|FG000|Overall Study|Withdrawal by Subject|1|||
125580191|NCT04557384|451751595|FG000|Overall Study|Study Terminated by Sponsor|1|||
125580192|NCT04557384|451751595|FG000|Overall Study|Death|1|||
125580193|NCT00454779|451751596|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
125580194|NCT00454779|451751597|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
125580195|NCT00454779|451751596|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
125580196|NCT00454779|451751597|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
125580197|NCT00454779|451751596|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
125580198|NCT00454779|451751597|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
125580199|NCT00454779|451751596|FG000|First-line Treatment Phase|Protocol Violation|0|||
125580200|NCT00454779|451751597|FG001|First-line Treatment Phase|Protocol Violation|1|||
125580201|NCT00454779|451751596|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
125580202|NCT00454779|451751597|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
125580203|NCT00454779|451751596|FG000|First-line Treatment Phase|Ongoing|1|||
125580204|NCT00454779|451751597|FG001|First-line Treatment Phase|Ongoing|0|||
125580205|NCT00454779|451751596|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
125580206|NCT00454779|451751597|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
125580207|NCT00454779|451751596|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
125580208|NCT00454779|451751597|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
125580209|NCT00454779|451751596|FG000|Second-line Treatment Phase|Ongoing|0|||
125580210|NCT00454779|451751597|FG001|Second-line Treatment Phase|Ongoing|1|||
125360328|NCT01604408|450954340|FG001|Treatment Period 5|Adverse Event|0|||
125360329|NCT01604408|450954339|FG000|Treatment Period 6|Lost to Follow-up|0|||
125360330|NCT01604408|450954340|FG001|Treatment Period 6|Lost to Follow-up|1|||
125360331|NCT01604408|450954339|FG000|Treatment Period 6|Adverse Event|2|||
125360332|NCT01604408|450954340|FG001|Treatment Period 6|Adverse Event|0|||
125360333|NCT01604408|450954339|FG000|Treatment Period 6|Sponsor decision|0|||
125360334|NCT01604408|450954340|FG001|Treatment Period 6|Sponsor decision|1|||
125360335|NCT01604408|450954339|FG000|Observation Period|Adverse Event|1|||
125360336|NCT01604408|450954340|FG001|Observation Period|Adverse Event|1|||
125360337|NCT01604408|450954339|FG000|Observation Period|Withdrawal by Subject|0|||
125360338|NCT01604408|450954340|FG001|Observation Period|Withdrawal by Subject|2|||
125360339|NCT00917501|450954342|FG000|Overall Study|Lost to Follow-up|4|||
125360340|NCT00917501|450954343|FG001|Overall Study|Lost to Follow-up|1|||
125360341|NCT00917501|450954342|FG000|Overall Study|Withdrawal by Subject|3|||
125360342|NCT00917501|450954343|FG001|Overall Study|Withdrawal by Subject|1|||
125360343|NCT00917501|450954342|FG000|Overall Study|Lack of Efficacy|1|||
125360344|NCT00917501|450954343|FG001|Overall Study|Lack of Efficacy|2|||
125360345|NCT00917501|450954342|FG000|Overall Study|trouble swollowing capsules|0|||
125360346|NCT00917501|450954343|FG001|Overall Study|trouble swollowing capsules|1|||
125360347|NCT05095454|450954344|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
125360348|NCT05095454|450954345|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
125360349|NCT01393301|450954346|FG000|Overall Study|Lost to Follow-up|5|||
125360350|NCT01393301|450954347|FG001|Overall Study|Lost to Follow-up|3|||
125360351|NCT01393301|450954346|FG000|Overall Study|Withdrawal by Subject|2|||
125360352|NCT01393301|450954347|FG001|Overall Study|Withdrawal by Subject|0|||
125211670|NCT01606748|450399765|FG000|Overall Study|Withdrawal by Subject|1|||
125211671|NCT01606748|450399766|FG001|Overall Study|Withdrawal by Subject|0|||
125211672|NCT03084315|450399768|FG000|Overall Study|Lost to Follow-up|8|||
125211673|NCT03084315|450399769|FG001|Overall Study|Lost to Follow-up|7|||
125211674|NCT03084315|450399768|FG000|Overall Study|Withdrawal by Subject|2|||
125360353|NCT01393301|450954346|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
125428096|NCT01090310|451193775|FG001|Extension Study|Aministrative problems|15|||
125428097|NCT01090310|451193776|FG002|Extension Study|Aministrative problems|14|||
125428098|NCT01090310|451193777|FG003|Extension Study|Aministrative problems|18|||
125428099|NCT01090310|451193774|FG000|Extension Study|Adverse Event|0|||
125428100|NCT01090310|451193775|FG001|Extension Study|Adverse Event|0|||
125428101|NCT01090310|451193776|FG002|Extension Study|Adverse Event|0|||
125580211|NCT02397473|451751598|FG000|Treatment Phase|Adverse Event|1|||
125580212|NCT02397473|451751599|FG001|Treatment Phase|Adverse Event|2|||
125580213|NCT02397473|451751598|FG000|Treatment Phase|Lack of Efficacy|8|||
125580214|NCT02397473|451751599|FG001|Treatment Phase|Lack of Efficacy|1|||
125580215|NCT02397473|451751598|FG000|Treatment Phase|Lost to Follow-up|1|||
125580216|NCT02397473|451751599|FG001|Treatment Phase|Lost to Follow-up|0|||
125580217|NCT02397473|451751598|FG000|Treatment Phase|Withdrawal by Subject|2|||
125580218|NCT02397473|451751599|FG001|Treatment Phase|Withdrawal by Subject|1|||
125580219|NCT02397473|451751598|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
125580220|NCT02397473|451751599|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
125580221|NCT02397473|451751598|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
125580222|NCT02397473|451751599|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
125580223|NCT02397473|451751598|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
125580224|NCT02397473|451751599|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
125580225|NCT02397473|451751598|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
125580226|NCT02397473|451751599|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
125580227|NCT02397473|451751598|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
125580228|NCT02397473|451751599|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
125580229|NCT00584194|451751602|FG000|Overall Study|Other|135|||
125580230|NCT00927368|451751606|FG000|Overall Study|enrollment in another study|1|||
125211675|NCT03084315|450399769|FG001|Overall Study|Withdrawal by Subject|2|||
125580231|NCT00927368|451751607|FG001|Overall Study|enrollment in another study|1|||
125580232|NCT00927368|451751608|FG002|Overall Study|enrollment in another study|2|||
125580233|NCT00927368|451751606|FG000|Overall Study|Lost to Follow-up|4|||
125211676|NCT01952080|450399770|FG000|Overall Study|Withdrawal by Subject|0|||
125211677|NCT01952080|450399771|FG001|Overall Study|Withdrawal by Subject|0|||
125211678|NCT01952080|450399772|FG002|Overall Study|Withdrawal by Subject|0|||
125211679|NCT01952080|450399773|FG003|Overall Study|Withdrawal by Subject|1|||
125360354|NCT01393301|450954347|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
125360355|NCT02758171|450954348|FG000|Wash-out|Withdrawal by Subject|1|||
125360356|NCT02758171|450954349|FG001|Wash-out|Withdrawal by Subject|0|||
125580234|NCT00927368|451751607|FG001|Overall Study|Lost to Follow-up|0|||
125580235|NCT00927368|451751608|FG002|Overall Study|Lost to Follow-up|0|||
125580236|NCT00927368|451751606|FG000|Overall Study|equipment failure|1|||
125580237|NCT00927368|451751607|FG001|Overall Study|equipment failure|0|||
125580238|NCT00927368|451751608|FG002|Overall Study|equipment failure|0|||
125580239|NCT00927368|451751606|FG000|Overall Study|ineligible post randomization|0|||
125580240|NCT00927368|451751607|FG001|Overall Study|ineligible post randomization|3|||
125360357|NCT02758171|450954348|FG000|Wash-out|Other reason|1|||
125360358|NCT02758171|450954349|FG001|Wash-out|Other reason|0|||
125360359|NCT01999114|450954350|FG000|Overall Study|Adverse Event|8|||
125580241|NCT00927368|451751608|FG002|Overall Study|ineligible post randomization|1|||
125580242|NCT00927368|451751606|FG000|Overall Study|cancellation of surgery|0|||
125580243|NCT00927368|451751607|FG001|Overall Study|cancellation of surgery|1|||
125580244|NCT00927368|451751608|FG002|Overall Study|cancellation of surgery|2|||
125580245|NCT02624492|451751609|FG000|Overall Study|Adverse Event|2|||
125580246|NCT02624492|451751610|FG001|Overall Study|Adverse Event|2|||
125580247|NCT02624492|451751611|FG002|Overall Study|Adverse Event|2|||
125580248|NCT02624492|451751609|FG000|Overall Study|Progressive disease|0|||
125580249|NCT02624492|451751610|FG001|Overall Study|Progressive disease|2|||
125580250|NCT02624492|451751611|FG002|Overall Study|Progressive disease|3|||
125580251|NCT00364689|451751613|FG000|Overall Study|Lost to Follow-up|1|||
125580252|NCT00684515|451751619|FG000|Overall Study|Adverse Event|3|||
125580253|NCT00684515|451751620|FG001|Overall Study|Adverse Event|3|||
125580254|NCT00684515|451751621|FG002|Overall Study|Adverse Event|1|||
125580255|NCT00684515|451751619|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
125580256|NCT00684515|451751620|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
125580257|NCT00684515|451751621|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
125580258|NCT00191451|451751622|FG000|Overall Study|Withdrawal by Subject|2|||
125580259|NCT00191451|451751623|FG001|Overall Study|Withdrawal by Subject|3|||
125580260|NCT00191451|451751624|FG002|Overall Study|Withdrawal by Subject|5|||
125580261|NCT00191451|451751622|FG000|Overall Study|Physician Decision|2|||
125580262|NCT00191451|451751623|FG001|Overall Study|Physician Decision|9|||
125580263|NCT00191451|451751624|FG002|Overall Study|Physician Decision|6|||
125580264|NCT00191451|451751622|FG000|Overall Study|Sponsor Decision|1|||
125580265|NCT00191451|451751623|FG001|Overall Study|Sponsor Decision|0|||
125580266|NCT00191451|451751624|FG002|Overall Study|Sponsor Decision|0|||
125580267|NCT00191451|451751622|FG000|Overall Study|Ineligible|0|||
125580268|NCT00191451|451751623|FG001|Overall Study|Ineligible|1|||
125580269|NCT00191451|451751624|FG002|Overall Study|Ineligible|0|||
125580270|NCT00191451|451751622|FG000|Overall Study|Reason Not Specified|2|||
125580271|NCT00191451|451751623|FG001|Overall Study|Reason Not Specified|1|||
125580272|NCT00191451|451751624|FG002|Overall Study|Reason Not Specified|3|||
125580273|NCT01114529|451751628|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
125580274|NCT01114529|451751629|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
125580275|NCT01114529|451751630|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
125580276|NCT01114529|451751628|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
125580277|NCT01114529|451751629|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
125580278|NCT01114529|451751630|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
125580279|NCT01114529|451751628|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
125360360|NCT01999114|450954351|FG001|Overall Study|Adverse Event|7|||
125360361|NCT01999114|450954352|FG002|Overall Study|Adverse Event|2|||
125360362|NCT01999114|450954353|FG003|Overall Study|Adverse Event|2|||
125360363|NCT01999114|450954354|FG004|Overall Study|Adverse Event|1|||
125360364|NCT01999114|450954350|FG000|Overall Study|Withdrawal by Subject|0|||
125360365|NCT01999114|450954351|FG001|Overall Study|Withdrawal by Subject|0|||
125360366|NCT01999114|450954352|FG002|Overall Study|Withdrawal by Subject|1|||
125360367|NCT01999114|450954353|FG003|Overall Study|Withdrawal by Subject|0|||
125360368|NCT01999114|450954354|FG004|Overall Study|Withdrawal by Subject|1|||
125360369|NCT01999114|450954350|FG000|Overall Study|Lost to Follow-up|0|||
125360370|NCT01999114|450954351|FG001|Overall Study|Lost to Follow-up|0|||
125360371|NCT01999114|450954352|FG002|Overall Study|Lost to Follow-up|1|||
125360372|NCT01999114|450954353|FG003|Overall Study|Lost to Follow-up|0|||
125360373|NCT01999114|450954354|FG004|Overall Study|Lost to Follow-up|0|||
125360374|NCT01999114|450954350|FG000|Overall Study|Administrative|0|||
125360375|NCT01999114|450954351|FG001|Overall Study|Administrative|0|||
125360376|NCT01999114|450954352|FG002|Overall Study|Administrative|1|||
125360377|NCT01999114|450954353|FG003|Overall Study|Administrative|1|||
125360378|NCT01999114|450954354|FG004|Overall Study|Administrative|2|||
125360379|NCT00722423|450954357|FG000|Overall Study|Protocol Violation|0|||
125360380|NCT00722423|450954358|FG001|Overall Study|Protocol Violation|1|||
125360381|NCT03643575|450954359|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
125360382|NCT03643575|450954360|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
125580280|NCT01114529|451751629|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
125580281|NCT01114529|451751630|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
125360383|NCT03643575|450954361|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
125580282|NCT01114529|451751628|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
125580283|NCT01114529|451751629|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
125580284|NCT01114529|451751630|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
125580285|NCT01114529|451751628|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
125360384|NCT03643575|450954362|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
125360385|NCT03643575|450954363|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
125360386|NCT03643575|450954364|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
125360387|NCT03643575|450954359|FG000|Washout: 7 Days|Adverse Event|1|||
125360388|NCT03643575|450954360|FG001|Washout: 7 Days|Adverse Event|0|||
125360389|NCT03643575|450954361|FG002|Washout: 7 Days|Adverse Event|0|||
125360390|NCT03643575|450954362|FG003|Washout: 7 Days|Adverse Event|0|||
125360391|NCT03643575|450954363|FG004|Washout: 7 Days|Adverse Event|0|||
125360392|NCT03643575|450954364|FG005|Washout: 7 Days|Adverse Event|0|||
125360393|NCT03643575|450954359|FG000|Washout: 7 Days|Non compliance check in|0|||
125580286|NCT01114529|451751629|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
125580287|NCT01114529|451751630|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
125580288|NCT01114529|451751628|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
125580289|NCT01114529|451751629|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
125580290|NCT01114529|451751630|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
125580291|NCT01114529|451751628|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
125580292|NCT01114529|451751629|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
125580293|NCT01114529|451751630|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
125580294|NCT01114529|451751628|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
125580295|NCT01114529|451751629|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
125580296|NCT01114529|451751630|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
125580297|NCT01114529|451751628|FG000|Completed Study Medication at Month 24|Death|2|||
125580298|NCT01114529|451751629|FG001|Completed Study Medication at Month 24|Death|1|||
125580299|NCT01114529|451751630|FG002|Completed Study Medication at Month 24|Death|2|||
125580300|NCT01114529|451751628|FG000|Completed Study Medication at Month 24|Graft loss|0|||
125580301|NCT01114529|451751629|FG001|Completed Study Medication at Month 24|Graft loss|2|||
125580302|NCT01114529|451751630|FG002|Completed Study Medication at Month 24|Graft loss|0|||
125580303|NCT01114529|451751628|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
125580304|NCT01114529|451751629|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
125580305|NCT01114529|451751630|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
125580306|NCT01114529|451751628|FG000|Completed Study Medication at Month 24|Missing|2|||
125580307|NCT01114529|451751629|FG001|Completed Study Medication at Month 24|Missing|0|||
125580308|NCT01114529|451751630|FG002|Completed Study Medication at Month 24|Missing|0|||
125580309|NCT01114529|451751628|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
125580310|NCT01114529|451751629|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
125580311|NCT01114529|451751630|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
125580312|NCT01114529|451751628|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
125580313|NCT01114529|451751629|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
125580314|NCT01114529|451751630|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
125580315|NCT01114529|451751628|FG000|Completed Study Phase at Month 24|Death|8|||
125580316|NCT01114529|451751629|FG001|Completed Study Phase at Month 24|Death|5|||
125580317|NCT01114529|451751630|FG002|Completed Study Phase at Month 24|Death|4|||
125580318|NCT01114529|451751628|FG000|Completed Study Phase at Month 24|Other|2|||
125580319|NCT01114529|451751629|FG001|Completed Study Phase at Month 24|Other|0|||
125580320|NCT01114529|451751630|FG002|Completed Study Phase at Month 24|Other|0|||
125360394|NCT03643575|450954360|FG001|Washout: 7 Days|Non compliance check in|1|||
125360395|NCT03643575|450954361|FG002|Washout: 7 Days|Non compliance check in|0|||
125360396|NCT03643575|450954362|FG003|Washout: 7 Days|Non compliance check in|0|||
125360397|NCT03643575|450954363|FG004|Washout: 7 Days|Non compliance check in|0|||
125360398|NCT03643575|450954364|FG005|Washout: 7 Days|Non compliance check in|0|||
125580321|NCT01114529|451751628|FG000|Completed Study Phase at Month 24|Missing|2|||
125580322|NCT01114529|451751629|FG001|Completed Study Phase at Month 24|Missing|0|||
125580323|NCT01114529|451751630|FG002|Completed Study Phase at Month 24|Missing|0|||
125580324|NCT04428411|451751632|FG000|Overall Study|Lost to Follow-up|114|||
125580325|NCT00331409|451751633|FG000|Overall Study|Lack of Efficacy|4|||
125360399|NCT01309165|450954365|FG000|Overall Study|Lost to Follow-up|4|||
125360400|NCT01309165|450954366|FG001|Overall Study|Lost to Follow-up|3|||
125580326|NCT00272987|451751634|FG000|Overall Study|Adverse Event|1|||
125580327|NCT00272987|451751635|FG001|Overall Study|Adverse Event|0|||
125580328|NCT00272987|451751636|FG002|Overall Study|Adverse Event|0|||
125580329|NCT00272987|451751634|FG000|Overall Study|Lost to Follow-up|3|||
125580330|NCT00272987|451751635|FG001|Overall Study|Lost to Follow-up|1|||
125580331|NCT00272987|451751636|FG002|Overall Study|Lost to Follow-up|1|||
125580332|NCT00272987|451751634|FG000|Overall Study|Withdrawal by Subject|1|||
125580333|NCT00272987|451751635|FG001|Overall Study|Withdrawal by Subject|0|||
125360401|NCT01309165|450954365|FG000|Overall Study|Return to work|1|||
125580334|NCT00272987|451751636|FG002|Overall Study|Withdrawal by Subject|3|||
125580335|NCT00272987|451751634|FG000|Overall Study|Sponsor Terminated study|0|||
125580336|NCT00272987|451751635|FG001|Overall Study|Sponsor Terminated study|1|||
125360402|NCT01309165|450954366|FG001|Overall Study|Return to work|2|||
125360403|NCT01309165|450954365|FG000|Overall Study|Left country|0|||
125360404|NCT01309165|450954366|FG001|Overall Study|Left country|1|||
125360405|NCT01309165|450954365|FG000|Overall Study|No transportation|0|||
125580337|NCT00272987|451751636|FG002|Overall Study|Sponsor Terminated study|1|||
125580338|NCT00272987|451751634|FG000|Overall Study|Disease progression|1|||
125580339|NCT00272987|451751635|FG001|Overall Study|Disease progression|1|||
125580340|NCT00272987|451751636|FG002|Overall Study|Disease progression|2|||
125580341|NCT00272987|451751634|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
125580342|NCT00272987|451751635|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
125580343|NCT00272987|451751636|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
125580344|NCT00272987|451751634|FG000|Overall Study|Death|1|||
125580345|NCT00272987|451751635|FG001|Overall Study|Death|0|||
125580346|NCT00272987|451751636|FG002|Overall Study|Death|0|||
125580347|NCT01163786|451751637|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
125580348|NCT01163786|451751637|FG000|Treatment With Bortezomib|Adverse Event|2|||
125580349|NCT01163786|451751637|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
125580350|NCT03555266|451751642|FG000|Overall Study|Protocol Violation|6|||
125580351|NCT03555266|451751643|FG001|Overall Study|Protocol Violation|4|||
125580352|NCT02167945|451751644|FG000|Overall Study|Adverse Event|16|||
125580353|NCT02167945|451751644|FG000|Overall Study|Withdrew Consent|42|||
125580354|NCT02167945|451751644|FG000|Overall Study|Lost to Follow-up|122|||
125580355|NCT02167945|451751644|FG000|Overall Study|COVID-19 logistical restrictions|6|||
125580356|NCT02167945|451751644|FG000|Overall Study|Other, not specified|63|||
125580357|NCT00132730|451751645|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
125580358|NCT00132730|451751646|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
125580359|NCT00132730|451751647|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
125580360|NCT00132730|451751648|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
125580361|NCT00132730|451751649|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
125580362|NCT00132730|451751650|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
125580363|NCT00132730|451751645|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
125580364|NCT00132730|451751646|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
125580365|NCT00132730|451751647|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
125580366|NCT00132730|451751648|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
125580367|NCT00132730|451751649|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
125580368|NCT00132730|451751650|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
125580369|NCT00132730|451751645|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
125580370|NCT00132730|451751646|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
125580371|NCT00132730|451751647|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
125580372|NCT00132730|451751648|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
125580373|NCT00132730|451751649|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
125580374|NCT00132730|451751650|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
125580375|NCT00132730|451751645|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
125580376|NCT00132730|451751646|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
125580377|NCT00132730|451751647|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
125580378|NCT00132730|451751648|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
125580379|NCT00132730|451751649|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
125580380|NCT00132730|451751650|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
125580381|NCT00132730|451751645|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
125580382|NCT00132730|451751646|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
125580383|NCT00132730|451751647|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
125580384|NCT00132730|451751648|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
125580385|NCT00132730|451751649|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
125580386|NCT00132730|451751650|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
125580387|NCT00132730|451751645|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
125580388|NCT00132730|451751646|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
125580389|NCT00132730|451751647|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
125360406|NCT01309165|450954366|FG001|Overall Study|No transportation|1|||
125360407|NCT01309165|450954365|FG000|Overall Study|Admitted to hospital for second stroke|1|||
125360408|NCT01309165|450954366|FG001|Overall Study|Admitted to hospital for second stroke|0|||
125360409|NCT02410551|450954368|FG000|Overall Study|Adverse Event|1|||
125360410|NCT02410551|450954368|FG000|Overall Study|Withdrawal by Subject|1|||
125580390|NCT00132730|451751648|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
125360411|NCT02410551|450954368|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
125580391|NCT00132730|451751649|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
125580392|NCT00132730|451751650|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
125360412|NCT01739309|450954370|FG000|Overall Study|Adverse Event|1|||
125360413|NCT01739309|450954370|FG000|Overall Study|Withdrawal by Subject|1|||
125360414|NCT00986830|450954373|FG000|Overall Study|Death|1|||
125360415|NCT00986830|450954373|FG000|Overall Study|Lost to Follow-up|1|||
125360416|NCT00986830|450954373|FG000|Overall Study|Lack of Efficacy|1|||
125360417|NCT00986830|450954373|FG000|Overall Study|Unable to access sinus with device|5|||
125360418|NCT01495975|450954374|FG000|Overall Study|Lost to Follow-up|1|||
125360419|NCT01495975|450954375|FG001|Overall Study|Lost to Follow-up|0|||
125360420|NCT05085730|450954378|FG000|Overall Study|Withdrawal by Subject|4|||
125360421|NCT05085730|450954378|FG000|Overall Study|Physician Decision|1|||
125360422|NCT05447897|450954379|FG000|Overall Study|Did not participate in survey|2|||
125360423|NCT01453725|450954380|FG000|Overall Study|Adverse Event|3|||
125360424|NCT01453725|450954381|FG001|Overall Study|Adverse Event|3|||
125360425|NCT01453725|450954380|FG000|Overall Study|Lost to Follow-up|4|||
125360426|NCT01453725|450954381|FG001|Overall Study|Lost to Follow-up|0|||
125360427|NCT01453725|450954380|FG000|Overall Study|Non-compliance With Protocol|1|||
125360428|NCT01453725|450954381|FG001|Overall Study|Non-compliance With Protocol|2|||
125360429|NCT01453725|450954380|FG000|Overall Study|Protocol Violation|1|||
125360430|NCT01453725|450954381|FG001|Overall Study|Protocol Violation|0|||
125360431|NCT01453725|450954380|FG000|Overall Study|Withdrawal by Subject|2|||
125360432|NCT01453725|450954381|FG001|Overall Study|Withdrawal by Subject|3|||
125360433|NCT01453725|450954380|FG000|Overall Study|Pregnancy Wish|0|||
125580393|NCT00132730|451751645|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
125580394|NCT00132730|451751646|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
125580395|NCT00132730|451751647|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
125580396|NCT00132730|451751648|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
125580397|NCT00132730|451751649|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
125580398|NCT00132730|451751650|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
125580399|NCT00132730|451751645|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
125580400|NCT00132730|451751646|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
125580401|NCT00132730|451751647|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
125580402|NCT00132730|451751648|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
125580403|NCT00132730|451751649|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
125580404|NCT00132730|451751650|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
125580405|NCT00132730|451751645|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
125580406|NCT00132730|451751646|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
125580407|NCT00132730|451751647|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
125580408|NCT00132730|451751648|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
125580409|NCT00132730|451751649|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
125580410|NCT00132730|451751650|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
125580411|NCT00132730|451751645|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
125580412|NCT00132730|451751646|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
125580413|NCT00132730|451751647|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
125580414|NCT00132730|451751648|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
125580415|NCT00132730|451751649|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
125580416|NCT00132730|451751650|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
125580417|NCT00132730|451751645|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
125580418|NCT00132730|451751646|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
125580419|NCT00132730|451751647|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
125580420|NCT00132730|451751648|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
125580421|NCT00132730|451751649|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
125580422|NCT00132730|451751650|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
125580423|NCT00132730|451751645|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
125580424|NCT00132730|451751646|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
125360434|NCT01453725|450954381|FG001|Overall Study|Pregnancy Wish|2|||
125360435|NCT01453725|450954380|FG000|Overall Study|Pregnancy|1|||
125360436|NCT01453725|450954381|FG001|Overall Study|Pregnancy|0|||
125360437|NCT01453725|450954380|FG000|Overall Study|Physician Decision|1|||
125580425|NCT00132730|451751647|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
125580426|NCT00132730|451751648|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
125580427|NCT00132730|451751649|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
125580428|NCT00132730|451751650|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
125580429|NCT01554579|451751651|FG000|Overall Study|Adverse Event|6|||
125580430|NCT01554579|451751652|FG001|Overall Study|Adverse Event|25|||
125360438|NCT01453725|450954381|FG001|Overall Study|Physician Decision|1|||
125360439|NCT03605212|450954382|FG000|Treatment Period|Adverse Event|1|||
125360440|NCT03605212|450954383|FG001|Treatment Period|Adverse Event|0|||
125360441|NCT03605212|450954384|FG002|Treatment Period|Adverse Event|0|||
125211680|NCT01952080|450399770|FG000|Overall Study|Protocol Non-compliance|0|||
125360442|NCT03605212|450954385|FG003|Treatment Period|Adverse Event|0|||
125360443|NCT03605212|450954386|FG004|Treatment Period|Adverse Event|0|||
125360444|NCT03605212|450954382|FG000|Treatment Period|Physician Decision|0|||
125580431|NCT01554579|451751651|FG000|Overall Study|Lack of Efficacy|2|||
125580432|NCT01554579|451751652|FG001|Overall Study|Lack of Efficacy|1|||
125580433|NCT01554579|451751651|FG000|Overall Study|Withdrawal by Subject|2|||
125580434|NCT01554579|451751652|FG001|Overall Study|Withdrawal by Subject|1|||
125580435|NCT01192347|451751656|FG000|Overall Study|Death|3|||
125580436|NCT01192347|451751656|FG000|Overall Study|Lost to Follow-up|3|||
125580437|NCT01192347|451751656|FG000|Overall Study|Withdrawal by Subject|1|||
125580438|NCT01192347|451751656|FG000|Overall Study|Adverse Event|1|||
125580439|NCT01192347|451751656|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
125580440|NCT01192347|451751656|FG000|Overall Study|Patient seen in different hospital|1|||
125580441|NCT01192347|451751656|FG000|Overall Study|Patient not visiting hospital regularly|1|||
125580442|NCT01192347|451751656|FG000|Overall Study|Patient did not show up for visits|1|||
125580443|NCT01046695|451751658|FG000|Overall Study|Subject had a pacemaker|0|||
125580444|NCT01046695|451751659|FG001|Overall Study|Subject had a pacemaker|1|||
125580445|NCT01046695|451751658|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
125580446|NCT01046695|451751659|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
125580447|NCT00939692|451751660|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
125580448|NCT00939692|451751661|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
125580449|NCT00939692|451751660|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
125580450|NCT00939692|451751661|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
125580451|NCT03433781|451751667|FG000|Overall Study|Progression of Disease|1|||
125580452|NCT03433781|451751668|FG001|Overall Study|Progression of Disease|0|||
125580453|NCT03433781|451751669|FG002|Overall Study|Progression of Disease|0|||
125580454|NCT03433781|451751667|FG000|Overall Study|Physician Decision|0|||
125580455|NCT03433781|451751668|FG001|Overall Study|Physician Decision|1|||
125580456|NCT03433781|451751669|FG002|Overall Study|Physician Decision|0|||
125580457|NCT00408694|451751670|FG000|Overall Study|Ineligible|1|||
125580458|NCT00408694|451751670|FG000|Overall Study|No protocol treatment|1|||
125580459|NCT03261531|451751673|FG000|Overall Study|Withdrawal by Subject|4|||
125580460|NCT00820755|451751676|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
125580461|NCT00820755|451751677|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
125580462|NCT00820755|451751678|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
125580463|NCT00820755|451751676|FG000|Period 1: Combination Therapy Phase|Death|28|||
125580464|NCT00820755|451751677|FG001|Period 1: Combination Therapy Phase|Death|0|||
125580465|NCT00820755|451751678|FG002|Period 1: Combination Therapy Phase|Death|0|||
125580466|NCT00820755|451751676|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
125580467|NCT00820755|451751677|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
125580468|NCT00820755|451751678|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
125580469|NCT00820755|451751676|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
125580470|NCT00820755|451751677|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
125580471|NCT00820755|451751678|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
125580472|NCT00820755|451751676|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
125580473|NCT00820755|451751677|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
125580474|NCT00820755|451751678|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
125580475|NCT00820755|451751676|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
125580476|NCT00820755|451751677|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
125580477|NCT00820755|451751678|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
125580478|NCT00820755|451751676|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
125580479|NCT00820755|451751677|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
125580480|NCT00820755|451751678|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
125580481|NCT00820755|451751676|FG000|Period 1: Combination Therapy Phase|Other|11|||
125580482|NCT00820755|451751677|FG001|Period 1: Combination Therapy Phase|Other|0|||
125580483|NCT00820755|451751678|FG002|Period 1: Combination Therapy Phase|Other|0|||
125580484|NCT00820755|451751676|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
125580485|NCT00820755|451751677|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
125580486|NCT00820755|451751678|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
125580487|NCT00091832|451751691|FG000|Overall Study|Physician Decision|1|||
125580488|NCT00091832|451751692|FG001|Overall Study|Physician Decision|0|||
125580489|NCT00091832|451751693|FG002|Overall Study|Physician Decision|0|||
125580490|NCT00091832|451751694|FG003|Overall Study|Physician Decision|0|||
125580491|NCT00091832|451751695|FG004|Overall Study|Physician Decision|0|||
125580492|NCT00091832|451751696|FG005|Overall Study|Physician Decision|0|||
125580493|NCT00091832|451751691|FG000|Overall Study|Adverse Event|0|||
125580494|NCT00091832|451751692|FG001|Overall Study|Adverse Event|0|||
125580495|NCT00091832|451751693|FG002|Overall Study|Adverse Event|0|||
125580496|NCT00091832|451751694|FG003|Overall Study|Adverse Event|1|||
125580497|NCT00091832|451751695|FG004|Overall Study|Adverse Event|3|||
125580498|NCT00091832|451751696|FG005|Overall Study|Adverse Event|0|||
125580499|NCT00091832|451751691|FG000|Overall Study|Withdrawal by Subject|4|||
125580500|NCT00091832|451751692|FG001|Overall Study|Withdrawal by Subject|5|||
125580501|NCT00091832|451751693|FG002|Overall Study|Withdrawal by Subject|0|||
125580502|NCT00091832|451751694|FG003|Overall Study|Withdrawal by Subject|1|||
125580503|NCT00091832|451751695|FG004|Overall Study|Withdrawal by Subject|3|||
125580504|NCT00091832|451751696|FG005|Overall Study|Withdrawal by Subject|1|||
125580505|NCT00091832|451751691|FG000|Overall Study|Death|6|||
125580506|NCT00091832|451751692|FG001|Overall Study|Death|4|||
125580507|NCT00091832|451751693|FG002|Overall Study|Death|5|||
125580508|NCT00091832|451751694|FG003|Overall Study|Death|8|||
125580509|NCT00091832|451751695|FG004|Overall Study|Death|5|||
125580510|NCT00091832|451751696|FG005|Overall Study|Death|6|||
125580511|NCT00091832|451751691|FG000|Overall Study|Disease Progression|2|||
125580512|NCT00091832|451751692|FG001|Overall Study|Disease Progression|0|||
125580513|NCT00091832|451751693|FG002|Overall Study|Disease Progression|0|||
125580514|NCT00091832|451751694|FG003|Overall Study|Disease Progression|1|||
125580515|NCT00091832|451751695|FG004|Overall Study|Disease Progression|1|||
125580516|NCT00091832|451751696|FG005|Overall Study|Disease Progression|2|||
125580517|NCT00091832|451751691|FG000|Overall Study|Ineligibility Determined|0|||
125580518|NCT00091832|451751692|FG001|Overall Study|Ineligibility Determined|0|||
125580519|NCT00091832|451751693|FG002|Overall Study|Ineligibility Determined|1|||
125580520|NCT00091832|451751694|FG003|Overall Study|Ineligibility Determined|0|||
125580521|NCT00091832|451751695|FG004|Overall Study|Ineligibility Determined|1|||
125580522|NCT00091832|451751696|FG005|Overall Study|Ineligibility Determined|0|||
125580523|NCT00091832|451751691|FG000|Overall Study|Lost to Follow-up|1|||
125580524|NCT00091832|451751692|FG001|Overall Study|Lost to Follow-up|0|||
125580525|NCT00091832|451751693|FG002|Overall Study|Lost to Follow-up|3|||
125580526|NCT00091832|451751694|FG003|Overall Study|Lost to Follow-up|3|||
125580527|NCT00091832|451751695|FG004|Overall Study|Lost to Follow-up|2|||
125580528|NCT00091832|451751696|FG005|Overall Study|Lost to Follow-up|1|||
125580529|NCT00091832|451751691|FG000|Overall Study|Noncompliance|0|||
125580530|NCT00091832|451751692|FG001|Overall Study|Noncompliance|1|||
125580531|NCT00091832|451751693|FG002|Overall Study|Noncompliance|0|||
125580532|NCT00091832|451751694|FG003|Overall Study|Noncompliance|0|||
125580533|NCT00091832|451751695|FG004|Overall Study|Noncompliance|0|||
125580534|NCT00091832|451751696|FG005|Overall Study|Noncompliance|0|||
125580535|NCT00091832|451751691|FG000|Overall Study|Other|0|||
125580536|NCT00091832|451751692|FG001|Overall Study|Other|1|||
125580537|NCT00091832|451751693|FG002|Overall Study|Other|2|||
125580538|NCT00091832|451751694|FG003|Overall Study|Other|0|||
125580539|NCT00091832|451751695|FG004|Overall Study|Other|0|||
125580540|NCT00091832|451751696|FG005|Overall Study|Other|0|||
125580541|NCT00091832|451751691|FG000|Overall Study|Protocol Violation|0|||
125580542|NCT00091832|451751692|FG001|Overall Study|Protocol Violation|0|||
125580543|NCT00091832|451751693|FG002|Overall Study|Protocol Violation|1|||
125580544|NCT00091832|451751694|FG003|Overall Study|Protocol Violation|0|||
125580545|NCT00091832|451751695|FG004|Overall Study|Protocol Violation|0|||
125360445|NCT03605212|450954383|FG001|Treatment Period|Physician Decision|0|||
125360446|NCT03605212|450954384|FG002|Treatment Period|Physician Decision|0|||
125360447|NCT03605212|450954385|FG003|Treatment Period|Physician Decision|0|||
125360448|NCT03605212|450954386|FG004|Treatment Period|Physician Decision|1|||
125580546|NCT00091832|451751696|FG005|Overall Study|Protocol Violation|1|||
125580547|NCT00626093|451751698|FG000|Overall Study|Lost to Follow-up|5|||
125580548|NCT00626093|451751698|FG000|Overall Study|Death|1|||
125580549|NCT00626093|451751698|FG000|Overall Study|Physician Decision|4|||
125580550|NCT00626093|451751698|FG000|Overall Study|Withdrawal by Subject|6|||
125360449|NCT01756053|450954387|FG000|Period 1 (10 Days)|Protocol Violation|1|||
125580551|NCT00626093|451751698|FG000|Overall Study|Protocol Violation|1|||
125580552|NCT00626093|451751698|FG000|Overall Study|One of the required devices not implante|6|||
125580553|NCT02154087|451751702|FG000|Overall Study|Study Termination|1|||
125360450|NCT01756053|450954388|FG001|Period 1 (10 Days)|Protocol Violation|1|||
125360451|NCT01756053|450954387|FG000|Period 2 (10 Days)|Protocol Violation|0|||
125360452|NCT01756053|450954388|FG001|Period 2 (10 Days)|Protocol Violation|2|||
125360453|NCT01986140|450954389|FG000|Overall Study|Withdrawal by Subject|31|||
125360454|NCT01986140|450954390|FG001|Overall Study|Withdrawal by Subject|25|||
125360455|NCT01986140|450954389|FG000|Overall Study|alternative treatment|1|||
125360456|NCT01986140|450954390|FG001|Overall Study|alternative treatment|1|||
125360457|NCT01986140|450954389|FG000|Overall Study|found not eligible|3|||
125360458|NCT01986140|450954390|FG001|Overall Study|found not eligible|0|||
125360459|NCT01986140|450954389|FG000|Overall Study|Adverse Event|0|||
125360460|NCT01986140|450954390|FG001|Overall Study|Adverse Event|1|||
125360461|NCT01986140|450954389|FG000|Overall Study|progression disease|0|||
125360462|NCT01986140|450954390|FG001|Overall Study|progression disease|1|||
125360463|NCT01069627|450954393|FG000|Overall Study|Disease progression|7|||
125360464|NCT01069627|450954393|FG000|Overall Study|Adverse Event|12|||
125360465|NCT01069627|450954393|FG000|Overall Study|Protocol Violation|1|||
125360466|NCT00471146|450954394|FG000|Overall Study|Adverse Event|32|||
125360467|NCT00471146|450954395|FG001|Overall Study|Adverse Event|33|||
125360468|NCT00471146|450954394|FG000|Overall Study|Withdrawal by Subject|14|||
125360469|NCT00471146|450954395|FG001|Overall Study|Withdrawal by Subject|11|||
125360470|NCT00471146|450954394|FG000|Overall Study|Death|11|||
125360471|NCT00471146|450954395|FG001|Overall Study|Death|12|||
125360472|NCT00471146|450954394|FG000|Overall Study|Lost to Follow-up|4|||
125360473|NCT00471146|450954395|FG001|Overall Study|Lost to Follow-up|2|||
125360474|NCT00471146|450954394|FG000|Overall Study|Protocol Violation|2|||
125360475|NCT00471146|450954395|FG001|Overall Study|Protocol Violation|2|||
125360476|NCT00471146|450954394|FG000|Overall Study|Objective progression or relapse|84|||
125360477|NCT00471146|450954395|FG001|Overall Study|Objective progression or relapse|87|||
125360478|NCT00471146|450954394|FG000|Overall Study|Global deterioration of health status|12|||
125360479|NCT00471146|450954395|FG001|Overall Study|Global deterioration of health status|14|||
125360480|NCT00471146|450954394|FG000|Overall Study|Randomized but not treated|9|||
125360481|NCT00471146|450954395|FG001|Overall Study|Randomized but not treated|8|||
125360482|NCT00471146|450954394|FG000|Overall Study|Other|4|||
125360483|NCT00471146|450954395|FG001|Overall Study|Other|5|||
125360484|NCT02149875|450954396|FG000|Overall Study|Lost to Follow-up|3|||
125360485|NCT02149875|450954397|FG001|Overall Study|Lost to Follow-up|4|||
125428102|NCT01090310|451193777|FG003|Extension Study|Adverse Event|1|||
125580554|NCT00486278|451751703|FG000|Overall Study|Adverse Event|5|||
125580555|NCT00486278|451751703|FG000|Overall Study|Withdrawal by Subject|2|||
125580556|NCT00486278|451751703|FG000|Overall Study|Physician Decision|2|||
125580557|NCT05501119|451751704|FG000|Overall Study|Withdrawal by Subject|2|||
125580558|NCT05501119|451751704|FG000|Overall Study|Lost to Follow-up|5|||
125580559|NCT01462266|451751708|FG000|Overall Study|Adverse Event|7|||
125580560|NCT01462266|451751709|FG001|Overall Study|Adverse Event|6|||
125580561|NCT01462266|451751708|FG000|Overall Study|Death|2|||
125580562|NCT01462266|451751709|FG001|Overall Study|Death|1|||
125580563|NCT01462266|451751708|FG000|Overall Study|Lack of Efficacy|0|||
125580564|NCT01462266|451751709|FG001|Overall Study|Lack of Efficacy|2|||
125580565|NCT01462266|451751708|FG000|Overall Study|Lost to Follow-up|4|||
125580566|NCT01462266|451751709|FG001|Overall Study|Lost to Follow-up|3|||
125580567|NCT01462266|451751708|FG000|Overall Study|Non-compliance with study drug|3|||
125580568|NCT01462266|451751709|FG001|Overall Study|Non-compliance with study drug|0|||
125580569|NCT01462266|451751708|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
125580570|NCT01462266|451751709|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
125580571|NCT01462266|451751708|FG000|Overall Study|Physician Decision|2|||
125580572|NCT01462266|451751709|FG001|Overall Study|Physician Decision|5|||
125580573|NCT01462266|451751708|FG000|Overall Study|Protocol Violation|1|||
125580574|NCT01462266|451751709|FG001|Overall Study|Protocol Violation|3|||
125580575|NCT01462266|451751708|FG000|Overall Study|Withdrawal by Subject|7|||
125580576|NCT01462266|451751709|FG001|Overall Study|Withdrawal by Subject|2|||
125580577|NCT01462266|451751708|FG000|Overall Study|Screen failure|1|||
125580578|NCT01462266|451751709|FG001|Overall Study|Screen failure|1|||
125580579|NCT02419508|451751710|FG000|Overall Study|Adverse Event|9|||
125360486|NCT02149875|450954398|FG002|Overall Study|Lost to Follow-up|5|||
125360487|NCT02149875|450954396|FG000|Overall Study|Withdrawal by Subject|3|||
125211681|NCT01952080|450399771|FG001|Overall Study|Protocol Non-compliance|1|||
125211682|NCT01952080|450399772|FG002|Overall Study|Protocol Non-compliance|0|||
125211683|NCT01952080|450399773|FG003|Overall Study|Protocol Non-compliance|0|||
125211684|NCT02732327|450399774|FG000|Overall Study|Protocol Violation|0|||
125211685|NCT02732327|450399775|FG001|Overall Study|Protocol Violation|1|||
125211686|NCT04503668|450399776|FG000|Overall Study|Incomplete data|4|||
125211687|NCT04503668|450399777|FG001|Overall Study|Incomplete data|3|||
125211688|NCT04503668|450399776|FG000|Overall Study|Withdrawal by Subject|1|||
125211689|NCT04503668|450399777|FG001|Overall Study|Withdrawal by Subject|1|||
125211690|NCT04503668|450399776|FG000|Overall Study|Adverse Event|2|||
125211691|NCT04503668|450399777|FG001|Overall Study|Adverse Event|0|||
125211692|NCT03782974|450399778|FG000|Overall Study|Withdrawal by Subject|7|||
125211693|NCT03782974|450399779|FG001|Overall Study|Withdrawal by Subject|7|||
125211694|NCT03782974|450399778|FG000|Overall Study|Pregnancy|1|||
125211695|NCT03782974|450399779|FG001|Overall Study|Pregnancy|0|||
125211696|NCT01783821|450399780|FG000|Overall Study|Screen Failure|1|||
125211697|NCT01783821|450399781|FG001|Overall Study|Screen Failure|1|||
125211698|NCT01907217|450399782|FG000|Overall Study|Withdrawal by Subject|0|||
125211699|NCT01907217|450399783|FG001|Overall Study|Withdrawal by Subject|2|||
125211700|NCT00659776|450399784|FG000|Overall Study|Withdrawal by Subject|12|||
125211701|NCT00659776|450399785|FG001|Overall Study|Withdrawal by Subject|2|||
125211702|NCT00659776|450399786|FG002|Overall Study|Withdrawal by Subject|0|||
125211703|NCT01180049|450399787|FG000|Overall Study|Other|9|||
125211704|NCT01180049|450399788|FG001|Overall Study|Other|7|||
125211705|NCT01180049|450399787|FG000|Overall Study|Lost to Follow-up|8|||
125211706|NCT01180049|450399788|FG001|Overall Study|Lost to Follow-up|6|||
125211707|NCT01180049|450399787|FG000|Overall Study|Death|36|||
125211708|NCT01180049|450399788|FG001|Overall Study|Death|35|||
125211709|NCT00350779|450399790|FG000|Overall Study|Adverse Event|4|||
125211710|NCT00350779|450399791|FG001|Overall Study|Adverse Event|2|||
125211711|NCT00350779|450399790|FG000|Overall Study|Lack of Efficacy|0|||
125211712|NCT00350779|450399791|FG001|Overall Study|Lack of Efficacy|4|||
125211713|NCT00350779|450399790|FG000|Overall Study|Lost to Follow-up|2|||
125211714|NCT00350779|450399791|FG001|Overall Study|Lost to Follow-up|0|||
125211715|NCT00350779|450399790|FG000|Overall Study|Physician Decision|2|||
125211716|NCT00350779|450399791|FG001|Overall Study|Physician Decision|4|||
125211717|NCT00350779|450399790|FG000|Overall Study|Protocol Violation|3|||
125211718|NCT00350779|450399791|FG001|Overall Study|Protocol Violation|1|||
125211719|NCT00350779|450399790|FG000|Overall Study|Withdrawal by Subject|9|||
125211720|NCT00350779|450399791|FG001|Overall Study|Withdrawal by Subject|8|||
125211721|NCT00350779|450399790|FG000|Overall Study|Patient Moved|2|||
125211722|NCT00350779|450399791|FG001|Overall Study|Patient Moved|1|||
125211723|NCT00350779|450399790|FG000|Overall Study|Non-compliance with study procedures|0|||
125211724|NCT00350779|450399791|FG001|Overall Study|Non-compliance with study procedures|1|||
125211725|NCT03015194|450401308|FG000|Overall Study|Death|10|||
125211726|NCT03015194|450401308|FG000|Overall Study|Withdrawal by Subject|2|||
125211727|NCT02469168|450401311|FG000|Overall Study|Trial closed|1|||
125211728|NCT02469168|450401312|FG001|Overall Study|Trial closed|0|||
125211729|NCT00433017|450401313|FG000|Overall Study|Adverse Event|5|||
125211730|NCT00433017|450401314|FG001|Overall Study|Adverse Event|3|||
125211731|NCT00433017|450401313|FG000|Overall Study|Withdrawal by Subject|4|||
125211732|NCT00433017|450401314|FG001|Overall Study|Withdrawal by Subject|5|||
125211733|NCT00433017|450401313|FG000|Overall Study|Lost to Follow-up|3|||
125211734|NCT00433017|450401314|FG001|Overall Study|Lost to Follow-up|4|||
125211735|NCT00433017|450401313|FG000|Overall Study|Administrative problems|80|||
125211736|NCT00433017|450401314|FG001|Overall Study|Administrative problems|86|||
125211737|NCT00433017|450401313|FG000|Overall Study|Protocol Violation|1|||
125211738|NCT00433017|450401314|FG001|Overall Study|Protocol Violation|0|||
125211739|NCT00433017|450401313|FG000|Overall Study|Death|2|||
125211740|NCT00433017|450401314|FG001|Overall Study|Death|2|||
125211741|NCT00433017|450401313|FG000|Overall Study|Subject no longer requires study drug|1|||
125360488|NCT02149875|450954397|FG001|Overall Study|Withdrawal by Subject|2|||
125360489|NCT02149875|450954398|FG002|Overall Study|Withdrawal by Subject|2|||
125360490|NCT02149875|450954396|FG000|Overall Study|Physician Decision|1|||
125211742|NCT00433017|450401314|FG001|Overall Study|Subject no longer requires study drug|1|||
125211743|NCT00255840|450401317|FG000|Overall Study|Lost to Follow-up|10|||
125211744|NCT00255840|450401318|FG001|Overall Study|Lost to Follow-up|14|||
125211745|NCT00255840|450401317|FG000|Overall Study|Discontinued intervention|53|||
125211746|NCT00255840|450401318|FG001|Overall Study|Discontinued intervention|56|||
125211747|NCT00715520|450401319|FG000|Overall Study|Screen failure|8|||
125211748|NCT00715520|450401320|FG001|Overall Study|Screen failure|1|||
125211749|NCT00715520|450401321|FG002|Overall Study|Screen failure|1|||
125211750|NCT00715520|450401319|FG000|Overall Study|Withdrawal by Subject|2|||
125211751|NCT00715520|450401320|FG001|Overall Study|Withdrawal by Subject|0|||
125211752|NCT00715520|450401321|FG002|Overall Study|Withdrawal by Subject|1|||
125211753|NCT03332095|450401322|FG000|Overall Study|Lost to Follow-up|1|||
125211754|NCT03332095|450401323|FG001|Overall Study|Lost to Follow-up|0|||
125211755|NCT03332095|450401322|FG000|Overall Study|Pregnancy|0|||
125211756|NCT03332095|450401323|FG001|Overall Study|Pregnancy|1|||
125580580|NCT02419508|451751711|FG001|Overall Study|Adverse Event|3|||
125580581|NCT02419508|451751710|FG000|Overall Study|Withdrawal by Subject|1|||
125580582|NCT02419508|451751711|FG001|Overall Study|Withdrawal by Subject|0|||
125580583|NCT02419508|451751710|FG000|Overall Study|Other - Reason not specified|0|||
125580584|NCT02419508|451751711|FG001|Overall Study|Other - Reason not specified|1|||
125580585|NCT03110900|451751712|FG000|Overall Study|Sponsor withdrew|1|||
125580586|NCT03110900|451751713|FG001|Overall Study|Sponsor withdrew|1|||
125360491|NCT02149875|450954397|FG001|Overall Study|Physician Decision|2|||
125580587|NCT01738971|451751724|FG000|Overall Study|Lost to Follow-up|19|||
125580588|NCT01738971|451751725|FG001|Overall Study|Lost to Follow-up|30|||
125580589|NCT01738971|451751726|FG002|Overall Study|Lost to Follow-up|17|||
125580590|NCT01031446|451751727|FG000|Overall Study|Disease Progression|38|||
125360492|NCT02149875|450954398|FG002|Overall Study|Physician Decision|2|||
125360493|NCT02478372|450954399|FG000|Overall Study|Protocol Violation|12|||
125360494|NCT02478372|450954400|FG001|Overall Study|Protocol Violation|8|||
125580591|NCT01031446|451751727|FG000|Overall Study|Adverse Event|9|||
125360495|NCT02478372|450954399|FG000|Overall Study|Lost to Follow-up|1|||
125360496|NCT02478372|450954400|FG001|Overall Study|Lost to Follow-up|4|||
125360497|NCT02478372|450954399|FG000|Overall Study|Death|0|||
125360498|NCT02478372|450954400|FG001|Overall Study|Death|2|||
125360499|NCT03800173|450954407|FG000|Overall Study|Lost to Follow-up|0|||
125360500|NCT03800173|450954408|FG001|Overall Study|Lost to Follow-up|0|||
125360501|NCT03800173|450954409|FG002|Overall Study|Lost to Follow-up|0|||
125360502|NCT03800173|450954410|FG003|Overall Study|Lost to Follow-up|0|||
125360503|NCT03800173|450954411|FG004|Overall Study|Lost to Follow-up|1|||
125360504|NCT02507973|450954412|FG000|Overall Study|Adverse Event|1|||
125580592|NCT01031446|451751727|FG000|Overall Study|Physician Decision|4|||
125580593|NCT01031446|451751727|FG000|Overall Study|Withdrawal by Subject|3|||
125360505|NCT00910273|450954413|FG000|Overall Study|Lack of Efficacy|6|||
125360506|NCT00910273|450954414|FG001|Overall Study|Lack of Efficacy|9|||
125360507|NCT00910273|450954413|FG000|Overall Study|Adverse Event|1|||
125580594|NCT01031446|451751727|FG000|Overall Study|Still on treatment|1|||
125580595|NCT04484285|451753435|FG000|Overall Study|Unable to operate stimulator|3|||
125580596|NCT04484285|451753436|FG001|Overall Study|Unable to operate stimulator|0|||
125580597|NCT05888103|451753437|FG000|Overall Study|Participant decision|3|||
125580598|NCT05888103|451753438|FG001|Overall Study|Participant decision|3|||
125580599|NCT03968419|451753439|FG000|Treatment Period|Adverse Event|0|||
125580600|NCT03968419|451753440|FG001|Treatment Period|Adverse Event|0|||
125580601|NCT03968419|451753441|FG002|Treatment Period|Adverse Event|1|||
125580602|NCT03968419|451753439|FG000|Safety Follow-up Period|Death|3|||
125211757|NCT05053035|450401328|FG000|Overall Study|Withdrawal by Subject|1|||
125211758|NCT05053035|450401329|FG001|Overall Study|Withdrawal by Subject|0|||
125211759|NCT03003000|450401336|FG000|Overall Study|Adverse Event|1|||
125211760|NCT03003000|450401337|FG001|Overall Study|Adverse Event|2|||
125211761|NCT03003000|450401338|FG002|Overall Study|Adverse Event|3|||
125211762|NCT03003000|450401336|FG000|Overall Study|Lack of Efficacy|1|||
125211763|NCT03003000|450401337|FG001|Overall Study|Lack of Efficacy|0|||
125211764|NCT03003000|450401338|FG002|Overall Study|Lack of Efficacy|0|||
125211765|NCT03003000|450401336|FG000|Overall Study|Non-compliant with protocol|0|||
125211766|NCT03003000|450401337|FG001|Overall Study|Non-compliant with protocol|1|||
125211767|NCT03003000|450401338|FG002|Overall Study|Non-compliant with protocol|1|||
125211768|NCT03003000|450401336|FG000|Overall Study|Refused to continue medication|2|||
125211769|NCT03003000|450401337|FG001|Overall Study|Refused to continue medication|0|||
125211770|NCT03003000|450401338|FG002|Overall Study|Refused to continue medication|0|||
125211771|NCT03003000|450401336|FG000|Overall Study|Other than listed|1|||
125211772|NCT03003000|450401337|FG001|Overall Study|Other than listed|1|||
125211773|NCT03003000|450401338|FG002|Overall Study|Other than listed|1|||
125211774|NCT04933617|450401341|FG000|Dose Escalation|Early closure of study|0|||
125211775|NCT04933617|450401342|FG001|Dose Escalation|Early closure of study|3|||
125211776|NCT04933617|450401343|FG002|Dose Escalation|Early closure of study|0|||
125211777|NCT04933617|450401344|FG003|Dose Escalation|Early closure of study|0|||
125211778|NCT04933617|450401345|FG004|Dose Escalation|Early closure of study|0|||
125211779|NCT02191046|450401348|FG000|Overall Study|low compliance|5|||
125211780|NCT02191046|450401349|FG001|Overall Study|low compliance|1|||
125211781|NCT03760458|450401350|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
125211782|NCT03760458|450401351|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
125211783|NCT03760458|450401352|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
125211784|NCT03760458|450401353|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
125211785|NCT03760458|450401354|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
125211786|NCT00048997|450401359|FG000|Overall Study|Protocol Violation|7|||
125211787|NCT00048997|450401360|FG001|Overall Study|Protocol Violation|2|||
125360508|NCT00910273|450954414|FG001|Overall Study|Adverse Event|1|||
125360509|NCT00910273|450954413|FG000|Overall Study|Withdrawal by Subject|1|||
125360510|NCT00910273|450954414|FG001|Overall Study|Withdrawal by Subject|0|||
125360511|NCT00910273|450954413|FG000|Overall Study|Discontinuation of study by sponsor|8|||
125580603|NCT03968419|451753440|FG001|Safety Follow-up Period|Death|2|||
125211788|NCT00048997|450401359|FG000|Overall Study|Withdrawal by Subject|6|||
125580604|NCT03968419|451753441|FG002|Safety Follow-up Period|Death|1|||
125580605|NCT03968419|451753439|FG000|Safety Follow-up Period|Subject Decision|2|||
125580606|NCT03968419|451753440|FG001|Safety Follow-up Period|Subject Decision|1|||
125211789|NCT00048997|450401360|FG001|Overall Study|Withdrawal by Subject|1|||
125211790|NCT02819440|450401361|FG000|Overall Study|Adverse Event|3|||
125211791|NCT02819440|450401362|FG001|Overall Study|Adverse Event|1|||
125211792|NCT02819440|450401361|FG000|Overall Study|Lost to Follow-up|1|||
125580607|NCT03968419|451753441|FG002|Safety Follow-up Period|Subject Decision|0|||
125580608|NCT00772629|451753442|FG000|Overall Study|Subject was not vaccinated|1|||
125211793|NCT02819440|450401362|FG001|Overall Study|Lost to Follow-up|3|||
125360512|NCT00910273|450954414|FG001|Overall Study|Discontinuation of study by sponsor|2|||
125580609|NCT00772629|451753443|FG001|Overall Study|Subject was not vaccinated|0|||
125360513|NCT00910273|450954413|FG000|Overall Study|Protocol Violation|1|||
125360514|NCT00910273|450954414|FG001|Overall Study|Protocol Violation|0|||
125360515|NCT00910273|450954413|FG000|Overall Study|Lost to Follow-up|1|||
125580610|NCT02894840|451753444|FG000|Overall Study|Lost to Follow-up|1|||
125580611|NCT02894840|451753445|FG001|Overall Study|Lost to Follow-up|0|||
125580612|NCT02894840|451753446|FG002|Overall Study|Lost to Follow-up|3|||
125580613|NCT02894840|451753447|FG003|Overall Study|Lost to Follow-up|0|||
125580614|NCT05162066|451753452|FG000|Overall Study|Adverse Event|1|||
125580615|NCT05162066|451753453|FG001|Overall Study|Adverse Event|0|||
125580616|NCT05162066|451753454|FG002|Overall Study|Adverse Event|0|||
125580617|NCT05162066|451753452|FG000|Overall Study|Perceived lack of efficacy|1|||
125580618|NCT05162066|451753453|FG001|Overall Study|Perceived lack of efficacy|0|||
125580619|NCT05162066|451753454|FG002|Overall Study|Perceived lack of efficacy|0|||
125580620|NCT01072344|451753455|FG000|Overall Study|Relasped-reached end point|7|||
125580621|NCT01072344|451753456|FG001|Overall Study|Relasped-reached end point|12|||
125580622|NCT01072344|451753455|FG000|Overall Study|Protocol Violation|1|||
125580623|NCT01072344|451753456|FG001|Overall Study|Protocol Violation|2|||
125580624|NCT01072344|451753455|FG000|Overall Study|Lost to Follow-up|3|||
125580625|NCT01072344|451753456|FG001|Overall Study|Lost to Follow-up|4|||
125580626|NCT00167245|451753457|FG000|Overall Study|Lost to Follow-up|20|||
125580627|NCT00167245|451753458|FG001|Overall Study|Lost to Follow-up|31|||
125580628|NCT00167245|451753457|FG000|Overall Study|Withdrawal by Subject|5|||
125580629|NCT00167245|451753458|FG001|Overall Study|Withdrawal by Subject|8|||
125580630|NCT00167245|451753457|FG000|Overall Study|Incarcerated|3|||
125580631|NCT00167245|451753458|FG001|Overall Study|Incarcerated|2|||
125580632|NCT00167245|451753457|FG000|Overall Study|Drowsy|1|||
125580633|NCT00167245|451753458|FG001|Overall Study|Drowsy|0|||
125580634|NCT01871090|451753461|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
125580635|NCT01871090|451753462|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
125580636|NCT01871090|451753461|FG000|Overall Study|Interrogation not completed correctly|1|||
125580637|NCT01871090|451753462|FG001|Overall Study|Interrogation not completed correctly|0|||
125580638|NCT01871090|451753461|FG000|Overall Study|Subject Non-Compliance|0|||
125580639|NCT01871090|451753462|FG001|Overall Study|Subject Non-Compliance|1|||
125580640|NCT00804687|451753465|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
125580641|NCT00804687|451753466|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
125580642|NCT00804687|451753467|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
125580643|NCT00804687|451753468|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
125580644|NCT00804687|451753469|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
125580645|NCT00804687|451753470|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
125580646|NCT00804687|451753465|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
125580647|NCT00804687|451753466|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
125580648|NCT00804687|451753467|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
125580649|NCT00804687|451753468|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
125580650|NCT00804687|451753469|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
125580651|NCT00804687|451753470|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
125580652|NCT00804687|451753465|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
125580653|NCT00804687|451753466|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
125580654|NCT00804687|451753467|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
125580655|NCT00804687|451753468|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
125580656|NCT00804687|451753469|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
125580657|NCT00804687|451753470|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
125580658|NCT00804687|451753465|FG000|Period 5: Treatment Period|Positive drug test|1|||
125580659|NCT00804687|451753466|FG001|Period 5: Treatment Period|Positive drug test|0|||
125580660|NCT00804687|451753467|FG002|Period 5: Treatment Period|Positive drug test|0|||
125580661|NCT00804687|451753468|FG003|Period 5: Treatment Period|Positive drug test|0|||
125580662|NCT00804687|451753469|FG004|Period 5: Treatment Period|Positive drug test|0|||
125360516|NCT00910273|450954414|FG001|Overall Study|Lost to Follow-up|1|||
125360517|NCT03841448|450954415|FG000|Double-blind Treatment (DBT) Period|Death|1|||
125360518|NCT03841448|450954416|FG001|Double-blind Treatment (DBT) Period|Death|1|||
125360519|NCT03841448|450954417|FG002|Double-blind Treatment (DBT) Period|Death|0|||
125580663|NCT00804687|451753470|FG005|Period 5: Treatment Period|Positive drug test|0|||
125580664|NCT00688909|451753473|FG000|Overall Study|Adverse Event|28|||
125580665|NCT00688909|451753473|FG000|Overall Study|Patient withdrew consent|2|||
125580666|NCT00688909|451753473|FG000|Overall Study|Administrative problems|1|||
125580667|NCT00688909|451753473|FG000|Overall Study|Protocol Violation|2|||
125580668|NCT01220414|451753474|FG000|Overall Study|Withdrawal by Subject|1|||
125580669|NCT01220414|451753475|FG001|Overall Study|Withdrawal by Subject|0|||
125580670|NCT01220414|451753476|FG002|Overall Study|Withdrawal by Subject|0|||
125580671|NCT01220414|451753477|FG003|Overall Study|Withdrawal by Subject|1|||
125580672|NCT00860158|451753487|FG000|Overall Study|Study Terminated|1|||
125580673|NCT00669617|451753489|FG000|Period 1|Withdrawal by Subject|0|||
125580674|NCT00669617|451753490|FG001|Period 1|Withdrawal by Subject|0|||
125580675|NCT00669617|451753491|FG002|Period 1|Withdrawal by Subject|1|||
125580676|NCT00669617|451753492|FG003|Period 1|Withdrawal by Subject|0|||
125580677|NCT00669617|451753493|FG004|Period 1|Withdrawal by Subject|0|||
125580678|NCT00669617|451753489|FG000|Period 1|Protocol Deviation|0|||
125580679|NCT00669617|451753490|FG001|Period 1|Protocol Deviation|0|||
125580680|NCT00669617|451753491|FG002|Period 1|Protocol Deviation|0|||
125580681|NCT00669617|451753492|FG003|Period 1|Protocol Deviation|0|||
125580682|NCT00669617|451753493|FG004|Period 1|Protocol Deviation|1|||
125360520|NCT03841448|450954418|FG003|Double-blind Treatment (DBT) Period|Death|0|||
125360521|NCT03841448|450954415|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
125580683|NCT00669617|451753489|FG000|Period 3|Lost to Follow-up|1|||
125580684|NCT00669617|451753490|FG001|Period 3|Lost to Follow-up|0|||
125360522|NCT03841448|450954416|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
125360523|NCT03841448|450954417|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
125360524|NCT03841448|450954418|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
125360525|NCT03841448|450954415|FG000|Open-Label Extension (OLE) Period|Death|0|||
125360526|NCT03841448|450954416|FG001|Open-Label Extension (OLE) Period|Death|0|||
125360527|NCT03841448|450954417|FG002|Open-Label Extension (OLE) Period|Death|0|||
125360528|NCT03841448|450954418|FG003|Open-Label Extension (OLE) Period|Death|1|||
125360529|NCT03841448|450954415|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
125360530|NCT03841448|450954416|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
125360531|NCT03841448|450954417|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
125360532|NCT03841448|450954418|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
125360533|NCT03841448|450954415|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
125360534|NCT03841448|450954416|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
125360535|NCT03841448|450954417|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
125360536|NCT03841448|450954418|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
125360537|NCT03841448|450954415|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
125360538|NCT03841448|450954416|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
125580685|NCT00669617|451753491|FG002|Period 3|Lost to Follow-up|0|||
125580686|NCT00669617|451753492|FG003|Period 3|Lost to Follow-up|0|||
125360539|NCT03841448|450954417|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
125360540|NCT03841448|450954418|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
125360541|NCT00543543|450954419|FG000|Base Study|Adverse Event|1|||
125360542|NCT00543543|450954420|FG001|Base Study|Adverse Event|11|||
125360543|NCT00543543|450954421|FG002|Base Study|Adverse Event|0|||
125360544|NCT00543543|450954422|FG003|Base Study|Adverse Event|5|||
125360545|NCT00543543|450954419|FG000|Base Study|Lost to Follow-up|12|||
125580687|NCT00669617|451753493|FG004|Period 3|Lost to Follow-up|0|||
125580688|NCT05499520|451753494|FG000|Overall Study|Lost to Follow-up|0|||
125580689|NCT05499520|451753495|FG001|Overall Study|Lost to Follow-up|0|||
125580690|NCT05499520|451753496|FG002|Overall Study|Lost to Follow-up|38|||
125580691|NCT05499520|451753497|FG003|Overall Study|Lost to Follow-up|41|||
125580692|NCT05499520|451753498|FG004|Overall Study|Lost to Follow-up|46|||
125580693|NCT05499520|451753499|FG005|Overall Study|Lost to Follow-up|0|||
125580694|NCT05499520|451753500|FG006|Overall Study|Lost to Follow-up|31|||
125580695|NCT05499520|451753501|FG007|Overall Study|Lost to Follow-up|45|||
125580696|NCT05499520|451753502|FG008|Overall Study|Lost to Follow-up|42|||
125580697|NCT05499520|451753503|FG009|Overall Study|Lost to Follow-up|0|||
125580698|NCT05499520|451753504|FG010|Overall Study|Lost to Follow-up|0|||
125580699|NCT05499520|451753505|FG011|Overall Study|Lost to Follow-up|37|||
125580700|NCT05499520|451753506|FG012|Overall Study|Lost to Follow-up|53|||
125580701|NCT05499520|451753507|FG013|Overall Study|Lost to Follow-up|49|||
125580702|NCT05499520|451753508|FG014|Overall Study|Lost to Follow-up|0|||
125580703|NCT05499520|451753509|FG015|Overall Study|Lost to Follow-up|36|||
125580704|NCT05499520|451753510|FG016|Overall Study|Lost to Follow-up|58|||
125580705|NCT05499520|451753511|FG017|Overall Study|Lost to Follow-up|53|||
125580706|NCT01613326|451753512|FG000|Overall Study|Adverse Event|7|||
125580707|NCT01613326|451753513|FG001|Overall Study|Adverse Event|5|||
125580708|NCT01613326|451753512|FG000|Overall Study|Withdrawal by Subject|3|||
125580709|NCT01613326|451753513|FG001|Overall Study|Withdrawal by Subject|4|||
125580710|NCT01613326|451753512|FG000|Overall Study|Abnormal test procedure result(s)|2|||
125580711|NCT01613326|451753513|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125580712|NCT01613326|451753512|FG000|Overall Study|inability to use device|1|||
125580713|NCT01613326|451753513|FG001|Overall Study|inability to use device|0|||
125580714|NCT01613326|451753512|FG000|Overall Study|Lack of Efficacy|0|||
125580715|NCT01613326|451753513|FG001|Overall Study|Lack of Efficacy|1|||
125580716|NCT01613326|451753512|FG000|Overall Study|Lost to Follow-up|0|||
125580717|NCT01613326|451753513|FG001|Overall Study|Lost to Follow-up|1|||
125580718|NCT01613326|451753512|FG000|Overall Study|Administrative|0|||
125580719|NCT01613326|451753513|FG001|Overall Study|Administrative|2|||
125580720|NCT01613326|451753512|FG000|Overall Study|Protocol Violation|0|||
125580721|NCT01613326|451753513|FG001|Overall Study|Protocol Violation|1|||
125580722|NCT03980938|451753514|FG000|Treatment Period 1|Study Terminated|1|||
125360546|NCT00543543|450954420|FG001|Base Study|Lost to Follow-up|749|||
125580723|NCT03980938|451753515|FG001|Treatment Period 1|Study Terminated|1|||
125360547|NCT00543543|450954421|FG002|Base Study|Lost to Follow-up|9|||
125360548|NCT00543543|450954422|FG003|Base Study|Lost to Follow-up|701|||
125580724|NCT03980938|451753514|FG000|Treatment Period 2|Study Terminated|2|||
125580725|NCT03980938|451753515|FG001|Treatment Period 2|Study Terminated|2|||
125580726|NCT00840827|451753516|FG000|Overall Study|Adverse Event|1|||
125580727|NCT00840827|451753516|FG000|Overall Study|Lack of Efficacy|4|||
125360549|NCT00543543|450954419|FG000|Base Study|Physician Decision|0|||
125360550|NCT00543543|450954420|FG001|Base Study|Physician Decision|4|||
125580728|NCT00840827|451753516|FG000|Overall Study|Physician Decision|1|||
125580729|NCT01445535|451753517|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
125580730|NCT01445535|451753518|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
125580731|NCT01445535|451753519|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
125580732|NCT01445535|451753520|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
125580733|NCT01445535|451753517|FG000|Overall Study|Disease progression|1|||
125580734|NCT01445535|451753518|FG001|Overall Study|Disease progression|0|||
125580735|NCT01445535|451753519|FG002|Overall Study|Disease progression|1|||
125580736|NCT01445535|451753520|FG003|Overall Study|Disease progression|0|||
125580737|NCT01445535|451753517|FG000|Overall Study|PI discretion|0|||
125360551|NCT00543543|450954421|FG002|Base Study|Physician Decision|0|||
125360552|NCT00543543|450954422|FG003|Base Study|Physician Decision|7|||
125360553|NCT00543543|450954419|FG000|Base Study|Protocol Violation|0|||
125360554|NCT00543543|450954420|FG001|Base Study|Protocol Violation|6|||
125360555|NCT00543543|450954421|FG002|Base Study|Protocol Violation|0|||
125360556|NCT00543543|450954422|FG003|Base Study|Protocol Violation|6|||
125360557|NCT00543543|450954419|FG000|Base Study|Withdrawal by Subject|7|||
125360558|NCT00543543|450954420|FG001|Base Study|Withdrawal by Subject|482|||
125360559|NCT00543543|450954421|FG002|Base Study|Withdrawal by Subject|5|||
125360560|NCT00543543|450954422|FG003|Base Study|Withdrawal by Subject|503|||
125360561|NCT00543543|450954419|FG000|Extension Study|Adverse Event|0|||
125360562|NCT00543543|450954420|FG001|Extension Study|Adverse Event|0|||
125360563|NCT00543543|450954421|FG002|Extension Study|Adverse Event|0|||
125360564|NCT00543543|450954422|FG003|Extension Study|Adverse Event|5|||
125360565|NCT00543543|450954419|FG000|Extension Study|Lost to Follow-up|0|||
125360566|NCT00543543|450954420|FG001|Extension Study|Lost to Follow-up|0|||
125360567|NCT00543543|450954421|FG002|Extension Study|Lost to Follow-up|0|||
125360568|NCT00543543|450954422|FG003|Extension Study|Lost to Follow-up|77|||
125360569|NCT00543543|450954419|FG000|Extension Study|Physician Decision|0|||
125360570|NCT00543543|450954420|FG001|Extension Study|Physician Decision|0|||
125360571|NCT00543543|450954421|FG002|Extension Study|Physician Decision|0|||
125360572|NCT00543543|450954422|FG003|Extension Study|Physician Decision|7|||
125360573|NCT00543543|450954419|FG000|Extension Study|Pregnancy|0|||
125360574|NCT00543543|450954420|FG001|Extension Study|Pregnancy|0|||
125360575|NCT00543543|450954421|FG002|Extension Study|Pregnancy|0|||
125360576|NCT00543543|450954422|FG003|Extension Study|Pregnancy|6|||
125360577|NCT00543543|450954419|FG000|Extension Study|Protocol Violation|0|||
125360578|NCT00543543|450954420|FG001|Extension Study|Protocol Violation|0|||
125360579|NCT00543543|450954421|FG002|Extension Study|Protocol Violation|0|||
125360580|NCT00543543|450954422|FG003|Extension Study|Protocol Violation|11|||
125580738|NCT01445535|451753518|FG001|Overall Study|PI discretion|0|||
125580739|NCT01445535|451753519|FG002|Overall Study|PI discretion|0|||
125580740|NCT01445535|451753520|FG003|Overall Study|PI discretion|1|||
125580741|NCT01337973|451753524|FG000|Overall Study|Lost to Follow-up|2|||
125580742|NCT01337973|451753525|FG001|Overall Study|Lost to Follow-up|4|||
125580743|NCT01337973|451753526|FG002|Overall Study|Lost to Follow-up|3|||
125580744|NCT01337973|451753524|FG000|Overall Study|Death|1|||
125580745|NCT01337973|451753525|FG001|Overall Study|Death|2|||
125580746|NCT01337973|451753526|FG002|Overall Study|Death|1|||
125580747|NCT01337973|451753524|FG000|Overall Study|Withdrawal by Subject|10|||
125580748|NCT01337973|451753525|FG001|Overall Study|Withdrawal by Subject|8|||
125580749|NCT01337973|451753526|FG002|Overall Study|Withdrawal by Subject|4|||
125580750|NCT01337973|451753524|FG000|Overall Study|missing data on primary outcome|3|||
125580751|NCT01337973|451753525|FG001|Overall Study|missing data on primary outcome|1|||
125580752|NCT01337973|451753526|FG002|Overall Study|missing data on primary outcome|3|||
125580753|NCT02494596|451753527|FG000|Overall Study|Insufficient Therapeutic Response|3|||
125580754|NCT02494596|451753528|FG001|Overall Study|Insufficient Therapeutic Response|3|||
125580755|NCT02494596|451753529|FG002|Overall Study|Insufficient Therapeutic Response|1|||
125580756|NCT02494596|451753527|FG000|Overall Study|Adverse Event|0|||
125580757|NCT02494596|451753528|FG001|Overall Study|Adverse Event|1|||
125580758|NCT02494596|451753529|FG002|Overall Study|Adverse Event|0|||
125580759|NCT02494596|451753527|FG000|Overall Study|Refused Treatment|0|||
125360581|NCT00543543|450954419|FG000|Extension Study|Withdrawal by Subject|0|||
125360582|NCT00543543|450954420|FG001|Extension Study|Withdrawal by Subject|0|||
125360583|NCT00543543|450954421|FG002|Extension Study|Withdrawal by Subject|0|||
125360584|NCT00543543|450954422|FG003|Extension Study|Withdrawal by Subject|120|||
125580760|NCT02494596|451753528|FG001|Overall Study|Refused Treatment|1|||
125580761|NCT02494596|451753529|FG002|Overall Study|Refused Treatment|0|||
125580762|NCT00254566|451753530|FG000|Overall Study|Death|1|||
125580763|NCT00254566|451753531|FG001|Overall Study|Death|0|||
125580764|NCT00254566|451753530|FG000|Overall Study|Adverse Event|5|||
125580765|NCT00254566|451753531|FG001|Overall Study|Adverse Event|4|||
125360585|NCT01361568|450954423|FG000|Overall Study|Adverse Event|0|||
125360586|NCT01361568|450954424|FG001|Overall Study|Adverse Event|0|||
125580766|NCT00254566|451753530|FG000|Overall Study|Lack of Efficacy|12|||
125580767|NCT00254566|451753531|FG001|Overall Study|Lack of Efficacy|9|||
125580768|NCT00254566|451753530|FG000|Overall Study|Other|1|||
125360587|NCT01361568|450954425|FG002|Overall Study|Adverse Event|0|||
125580769|NCT00254566|451753531|FG001|Overall Study|Other|5|||
125360588|NCT01361568|450954426|FG003|Overall Study|Adverse Event|0|||
125580770|NCT00254566|451753530|FG000|Overall Study|Withdrawal by Subject|5|||
125360589|NCT01361568|450954427|FG004|Overall Study|Adverse Event|1|||
125360590|NCT01361568|450954428|FG005|Overall Study|Adverse Event|0|||
125360591|NCT01361568|450954423|FG000|Overall Study|Physician Decision|0|||
125360592|NCT01361568|450954424|FG001|Overall Study|Physician Decision|0|||
125360593|NCT01361568|450954425|FG002|Overall Study|Physician Decision|0|||
125360594|NCT01361568|450954426|FG003|Overall Study|Physician Decision|0|||
125580771|NCT00254566|451753531|FG001|Overall Study|Withdrawal by Subject|6|||
125580772|NCT00254566|451753530|FG000|Overall Study|Lost to Follow-up|7|||
125580773|NCT00254566|451753531|FG001|Overall Study|Lost to Follow-up|2|||
125211794|NCT02819440|450401361|FG000|Overall Study|Withdrawal by Subject|9|||
125211795|NCT02819440|450401362|FG001|Overall Study|Withdrawal by Subject|8|||
125360595|NCT01361568|450954427|FG004|Overall Study|Physician Decision|0|||
125580774|NCT00059202|451753532|FG000|Overall Study|Withdrawal by Subject|5|||
125580775|NCT00059202|451753533|FG001|Overall Study|Withdrawal by Subject|9|||
125580776|NCT00059202|451753532|FG000|Overall Study|Protocol Violation|1|||
125580777|NCT00059202|451753533|FG001|Overall Study|Protocol Violation|3|||
125580778|NCT00059202|451753532|FG000|Overall Study|drug toxicity|0|||
125580779|NCT00059202|451753533|FG001|Overall Study|drug toxicity|3|||
125580780|NCT02658448|451753537|FG000|Overall Study|Lost to Follow-up|1|||
125580781|NCT02623335|451753538|FG000|Overall Study|Death|8|||
125580782|NCT02623335|451753539|FG001|Overall Study|Death|7|||
125580783|NCT02623335|451753538|FG000|Overall Study|Lost to Follow-up|15|||
125580784|NCT02623335|451753539|FG001|Overall Study|Lost to Follow-up|23|||
125580785|NCT02623335|451753538|FG000|Overall Study|Withdrawal by Subject|2|||
125580786|NCT02623335|451753539|FG001|Overall Study|Withdrawal by Subject|5|||
125580787|NCT02623335|451753538|FG000|Overall Study|Protocol Violation|2|||
125580788|NCT02623335|451753539|FG001|Overall Study|Protocol Violation|1|||
125580789|NCT03739528|451753540|FG000|Overall Study|Not treated|8|||
125580790|NCT03739528|451753541|FG001|Overall Study|Not treated|12|||
125580791|NCT03739528|451753540|FG000|Overall Study|Treatment and study discontinued|6|||
125580792|NCT03739528|451753541|FG001|Overall Study|Treatment and study discontinued|2|||
125580793|NCT03739528|451753540|FG000|Overall Study|Treatment discontinued + study completed|1|||
125580794|NCT03739528|451753541|FG001|Overall Study|Treatment discontinued + study completed|3|||
125580795|NCT02239263|451753542|FG000|Overall Study|Protocol Violation|6|||
125580796|NCT03072160|451753543|FG000|Overall Study|Adverse Event|3|||
125580797|NCT03072160|451753544|FG001|Overall Study|Adverse Event|1|||
125580798|NCT03072160|451753543|FG000|Overall Study|Refused further treatment|6|||
125580799|NCT03072160|451753544|FG001|Overall Study|Refused further treatment|1|||
125580800|NCT03072160|451753543|FG000|Overall Study|Physician Decision|1|||
125580801|NCT03072160|451753544|FG001|Overall Study|Physician Decision|0|||
125580802|NCT03072160|451753543|FG000|Overall Study|Disease progression on study|1|||
125580803|NCT03072160|451753544|FG001|Overall Study|Disease progression on study|1|||
125580804|NCT03072160|451753543|FG000|Overall Study|No contact|0|||
125580805|NCT03072160|451753544|FG001|Overall Study|No contact|1|||
125580806|NCT01058096|451753546|FG000|Double-blind Treatment Phase|Adverse Event|11|||
125580807|NCT01058096|451753547|FG001|Double-blind Treatment Phase|Adverse Event|15|||
125580808|NCT01058096|451753546|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
125580809|NCT01058096|451753547|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
125580810|NCT01058096|451753546|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
125580811|NCT01058096|451753547|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
125580812|NCT01058096|451753546|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
125580813|NCT01058096|451753547|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
125580814|NCT01058096|451753546|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
125360596|NCT01361568|450954428|FG005|Overall Study|Physician Decision|1|||
125580815|NCT01058096|451753547|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
125580816|NCT01058096|451753546|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
125580817|NCT01058096|451753547|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
125580818|NCT04276207|451753548|FG000|Period 1|Withdrawal by Subject|0|||
125580819|NCT04276207|451753549|FG001|Period 1|Withdrawal by Subject|1|||
125360597|NCT01361568|450954423|FG000|Overall Study|Withdrawal by Subject|2|||
125580820|NCT01463098|451753550|FG000|Part A (11 Days)|Participant Choice|2|||
125580821|NCT01463098|451753551|FG001|Part A (11 Days)|Participant Choice|0|||
125580822|NCT01463098|451753552|FG002|Part A (11 Days)|Participant Choice|0|||
125580823|NCT01463098|451753553|FG003|Part A (11 Days)|Participant Choice|0|||
125580824|NCT01463098|451753554|FG004|Part A (11 Days)|Participant Choice|0|||
125580825|NCT01463098|451753555|FG005|Part A (11 Days)|Participant Choice|0|||
125580826|NCT01463098|451753556|FG006|Part A (11 Days)|Participant Choice|0|||
125580827|NCT01463098|451753557|FG007|Part A (11 Days)|Participant Choice|0|||
125580828|NCT01463098|451753558|FG008|Part A (11 Days)|Participant Choice|1|||
125580829|NCT01463098|451753559|FG009|Part A (11 Days)|Participant Choice|0|||
125580830|NCT01463098|451753560|FG010|Part A (11 Days)|Participant Choice|0|||
125580831|NCT01463098|451753561|FG011|Part A (11 Days)|Participant Choice|0|||
125580832|NCT01463098|451753562|FG012|Part A (11 Days)|Participant Choice|0|||
125580833|NCT01463098|451753563|FG013|Part A (11 Days)|Participant Choice|0|||
125580834|NCT01463098|451753550|FG000|Part A (11 Days)|Lost to Follow-up|0|||
125580835|NCT01463098|451753551|FG001|Part A (11 Days)|Lost to Follow-up|0|||
125580836|NCT01463098|451753552|FG002|Part A (11 Days)|Lost to Follow-up|0|||
125580837|NCT01463098|451753553|FG003|Part A (11 Days)|Lost to Follow-up|0|||
125580838|NCT01463098|451753554|FG004|Part A (11 Days)|Lost to Follow-up|1|||
125580839|NCT01463098|451753555|FG005|Part A (11 Days)|Lost to Follow-up|0|||
125580840|NCT01463098|451753556|FG006|Part A (11 Days)|Lost to Follow-up|0|||
125580841|NCT01463098|451753557|FG007|Part A (11 Days)|Lost to Follow-up|0|||
125580842|NCT01463098|451753558|FG008|Part A (11 Days)|Lost to Follow-up|0|||
125580843|NCT01463098|451753559|FG009|Part A (11 Days)|Lost to Follow-up|0|||
125580844|NCT01463098|451753560|FG010|Part A (11 Days)|Lost to Follow-up|0|||
125580845|NCT01463098|451753561|FG011|Part A (11 Days)|Lost to Follow-up|0|||
125580846|NCT01463098|451753562|FG012|Part A (11 Days)|Lost to Follow-up|0|||
125580847|NCT01463098|451753563|FG013|Part A (11 Days)|Lost to Follow-up|0|||
125580848|NCT01463098|451753550|FG000|Part B (11 Days)|Participant Choice|0|||
125580849|NCT01463098|451753551|FG001|Part B (11 Days)|Participant Choice|0|||
125580850|NCT01463098|451753552|FG002|Part B (11 Days)|Participant Choice|0|||
125580851|NCT01463098|451753553|FG003|Part B (11 Days)|Participant Choice|0|||
125580852|NCT01463098|451753554|FG004|Part B (11 Days)|Participant Choice|0|||
125360598|NCT01361568|450954424|FG001|Overall Study|Withdrawal by Subject|1|||
125360599|NCT01361568|450954425|FG002|Overall Study|Withdrawal by Subject|0|||
125360600|NCT01361568|450954426|FG003|Overall Study|Withdrawal by Subject|0|||
125360601|NCT01361568|450954427|FG004|Overall Study|Withdrawal by Subject|0|||
125360602|NCT01361568|450954428|FG005|Overall Study|Withdrawal by Subject|1|||
125360603|NCT02959983|450954429|FG000|Overall Study|Protocol Violation|0|||
125360604|NCT02959983|450954430|FG001|Overall Study|Protocol Violation|1|||
125360605|NCT02959983|450954429|FG000|Overall Study|Lack of Efficacy|0|||
125360606|NCT02959983|450954430|FG001|Overall Study|Lack of Efficacy|1|||
125360607|NCT02959983|450954429|FG000|Overall Study|Lost to Follow-up|12|||
125360608|NCT02959983|450954430|FG001|Overall Study|Lost to Follow-up|9|||
125360609|NCT02959983|450954429|FG000|Overall Study|Other|1|||
125360610|NCT02959983|450954430|FG001|Overall Study|Other|1|||
125360611|NCT02959983|450954429|FG000|Overall Study|Physician Decision|1|||
125360612|NCT02959983|450954430|FG001|Overall Study|Physician Decision|0|||
125360613|NCT02959983|450954429|FG000|Overall Study|Adverse Event|5|||
125360614|NCT02959983|450954430|FG001|Overall Study|Adverse Event|1|||
125360615|NCT02959983|450954429|FG000|Overall Study|Withdrawal by Subject|7|||
125360616|NCT02959983|450954430|FG001|Overall Study|Withdrawal by Subject|12|||
125360617|NCT00484094|450954431|FG000|Overall Study|Discontinued|39|||
125360618|NCT00484094|450954431|FG000|Overall Study|Other|3|||
125360619|NCT00586625|450954432|FG000|Overall Study|Adverse Event|6|||
125360620|NCT00586625|450954433|FG001|Overall Study|Adverse Event|6|||
125360621|NCT00586625|450954432|FG000|Overall Study|Protocol Violation|3|||
125360622|NCT00586625|450954433|FG001|Overall Study|Protocol Violation|0|||
125360623|NCT00586625|450954432|FG000|Overall Study|Withdrawal by Subject|32|||
125360624|NCT00586625|450954433|FG001|Overall Study|Withdrawal by Subject|10|||
125360625|NCT00586625|450954432|FG000|Overall Study|Subject non-compliance|0|||
125580853|NCT01463098|451753555|FG005|Part B (11 Days)|Participant Choice|0|||
125580854|NCT01463098|451753556|FG006|Part B (11 Days)|Participant Choice|0|||
125580855|NCT01463098|451753557|FG007|Part B (11 Days)|Participant Choice|0|||
125580856|NCT01463098|451753558|FG008|Part B (11 Days)|Participant Choice|0|||
125580857|NCT01463098|451753559|FG009|Part B (11 Days)|Participant Choice|0|||
125580858|NCT01463098|451753560|FG010|Part B (11 Days)|Participant Choice|0|||
125580859|NCT01463098|451753561|FG011|Part B (11 Days)|Participant Choice|1|||
125580860|NCT01463098|451753562|FG012|Part B (11 Days)|Participant Choice|0|||
125580861|NCT01463098|451753563|FG013|Part B (11 Days)|Participant Choice|0|||
125580862|NCT02769624|451753568|FG000|Overall Study|Lost to Follow-up|0|||
125580863|NCT02769624|451753569|FG001|Overall Study|Lost to Follow-up|1|||
125580864|NCT05099640|451753570|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
125580865|NCT05099640|451753571|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
125580866|NCT05099640|451753572|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
125580867|NCT05099640|451753570|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
125580868|NCT05099640|451753571|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
125580869|NCT05099640|451753572|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
125580870|NCT05099640|451753570|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
125580871|NCT05099640|451753571|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
125580872|NCT05099640|451753572|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
125580873|NCT05099640|451753570|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
125580874|NCT05099640|451753571|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
125580875|NCT05099640|451753572|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
125580876|NCT05099640|451753570|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
125580877|NCT05099640|451753571|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
125580878|NCT05099640|451753572|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
125580879|NCT05099640|451753570|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
125580880|NCT05099640|451753571|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
125360626|NCT00586625|450954433|FG001|Overall Study|Subject non-compliance|1|||
125360627|NCT00586625|450954432|FG000|Overall Study|Subject unable to return for visit|2|||
125360628|NCT00586625|450954433|FG001|Overall Study|Subject unable to return for visit|0|||
125360629|NCT00165984|450954434|FG000|Overall Study|Death|15|||
125360630|NCT01736124|450954435|FG000|Post-intervention Assessment|Death|2|||
125360631|NCT01736124|450954436|FG001|Post-intervention Assessment|Death|2|||
125360632|NCT01736124|450954435|FG000|Post-intervention Assessment|lost computer access|1|||
125360633|NCT01736124|450954436|FG001|Post-intervention Assessment|lost computer access|1|||
125360634|NCT01736124|450954435|FG000|Post-intervention Assessment|Moved away|3|||
125360635|NCT01736124|450954436|FG001|Post-intervention Assessment|Moved away|1|||
125360636|NCT01736124|450954435|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
125360637|NCT01736124|450954436|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
125360638|NCT01736124|450954435|FG000|Post-intervention Assessment|Illness|3|||
125360639|NCT01736124|450954436|FG001|Post-intervention Assessment|Illness|2|||
125360640|NCT01736124|450954435|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
125360641|NCT01736124|450954436|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
125360642|NCT01736124|450954435|FG000|Post-intervention Assessment|Temporarily away|3|||
125360643|NCT01736124|450954436|FG001|Post-intervention Assessment|Temporarily away|1|||
125360644|NCT01736124|450954435|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
125360645|NCT01736124|450954436|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
125360646|NCT01736124|450954435|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
125360647|NCT01736124|450954436|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
125360648|NCT01736124|450954435|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
125360649|NCT01736124|450954436|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
125360650|NCT01736124|450954435|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
125360651|NCT01736124|450954436|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
125360652|NCT01736124|450954435|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
125360653|NCT01736124|450954436|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
125360654|NCT01736124|450954435|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
125360655|NCT01736124|450954436|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
125360656|NCT01736124|450954435|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
125360657|NCT01736124|450954436|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
125360658|NCT01736124|450954435|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
125360659|NCT01736124|450954436|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
125360660|NCT01736124|450954435|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
125360661|NCT01736124|450954436|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
125360662|NCT00615108|450955783|FG000|Overall Study|Adverse Event|122|||
125360663|NCT00615108|450955783|FG000|Overall Study|Other|370|||
125360664|NCT00615108|450955783|FG000|Overall Study|Lost to Follow-up|15|||
125360665|NCT00853073|450955784|FG000|Overall Study|Withdrawal by Subject|3|||
125360666|NCT00853073|450955785|FG001|Overall Study|Withdrawal by Subject|2|||
125360667|NCT01189604|450955786|FG000|Overall Study|Impossible to visit|0|||
125360668|NCT01189604|450955787|FG001|Overall Study|Impossible to visit|0|||
125360669|NCT01189604|450955788|FG002|Overall Study|Impossible to visit|0|||
125360670|NCT01189604|450955789|FG003|Overall Study|Impossible to visit|0|||
125360671|NCT01189604|450955790|FG004|Overall Study|Impossible to visit|0|||
125360672|NCT01189604|450955791|FG005|Overall Study|Impossible to visit|1|||
125360673|NCT01189604|450955792|FG006|Overall Study|Impossible to visit|0|||
125360674|NCT01189604|450955786|FG000|Overall Study|Adverse Event|0|||
125360675|NCT01189604|450955787|FG001|Overall Study|Adverse Event|1|||
125360676|NCT01189604|450955788|FG002|Overall Study|Adverse Event|0|||
125360677|NCT01189604|450955789|FG003|Overall Study|Adverse Event|0|||
125360678|NCT01189604|450955790|FG004|Overall Study|Adverse Event|2|||
125360679|NCT01189604|450955791|FG005|Overall Study|Adverse Event|0|||
125360680|NCT01189604|450955792|FG006|Overall Study|Adverse Event|1|||
125360681|NCT01189604|450955786|FG000|Overall Study|Withdrawal by Subject|1|||
125360682|NCT01189604|450955787|FG001|Overall Study|Withdrawal by Subject|0|||
125360683|NCT01189604|450955788|FG002|Overall Study|Withdrawal by Subject|0|||
125360684|NCT01189604|450955789|FG003|Overall Study|Withdrawal by Subject|0|||
125360685|NCT01189604|450955790|FG004|Overall Study|Withdrawal by Subject|0|||
125360686|NCT01189604|450955791|FG005|Overall Study|Withdrawal by Subject|0|||
125360687|NCT01189604|450955792|FG006|Overall Study|Withdrawal by Subject|0|||
125360688|NCT04553679|450955793|FG000|Overall Study|Withdrawal by Subject|2|||
125360689|NCT04553679|450955794|FG001|Overall Study|Withdrawal by Subject|0|||
125360690|NCT04553679|450955793|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
125360691|NCT04553679|450955794|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
125580881|NCT05099640|451753572|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
125580882|NCT00179959|451753573|FG000|Overall Study|Lost to Follow-up|3|||
125580883|NCT00179959|451753574|FG001|Overall Study|Lost to Follow-up|1|||
125580884|NCT00179959|451753573|FG000|Overall Study|Withdrawal by Subject|3|||
125580885|NCT00179959|451753574|FG001|Overall Study|Withdrawal by Subject|2|||
125580886|NCT00448708|451753575|FG000|Overall Study|Death|21|||
125580887|NCT00448708|451753576|FG001|Overall Study|Death|17|||
125580888|NCT00448708|451753575|FG000|Overall Study|Withdrawal by Subject|8|||
125580889|NCT00448708|451753576|FG001|Overall Study|Withdrawal by Subject|4|||
125580890|NCT00448708|451753575|FG000|Overall Study|Lost to Follow-up|6|||
125580891|NCT00448708|451753576|FG001|Overall Study|Lost to Follow-up|8|||
125580892|NCT00448708|451753575|FG000|Overall Study|not listed|0|||
125428103|NCT01090310|451193774|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
125580893|NCT00448708|451753576|FG001|Overall Study|not listed|2|||
125580894|NCT00713219|451753581|FG000|Overall Study|Death|1|||
125580895|NCT00713219|451753581|FG000|Overall Study|Protocol Violation|1|||
125580896|NCT00880256|451753582|FG000|Overall Study|Lost to Follow-up|28|||
125580897|NCT00480857|451753583|FG000|Overall Study|Lack of Efficacy|2|||
125580898|NCT01890421|451753584|FG000|Overall Study|Adverse Event|1|||
125580899|NCT01890421|451753584|FG000|Overall Study|Other reason|10|||
125580900|NCT00946309|451753585|FG000|Overall Study|Protocol Violation|1|||
125580901|NCT00946309|451753586|FG001|Overall Study|Protocol Violation|0|||
125580902|NCT00946309|451753585|FG000|Overall Study|Lost to Follow-up|0|||
125580903|NCT00946309|451753586|FG001|Overall Study|Lost to Follow-up|1|||
125580904|NCT00946309|451753585|FG000|Overall Study|Procedure cancelled/discontinued|0|||
125580905|NCT00946309|451753586|FG001|Overall Study|Procedure cancelled/discontinued|3|||
125580906|NCT00428597|451753593|FG000|Overall Study|Randomized but not treated|3|||
125580907|NCT00428597|451753594|FG001|Overall Study|Randomized but not treated|3|||
125580908|NCT00428597|451753593|FG000|Overall Study|Objective Progression or Relapse|19|||
125580909|NCT00428597|451753594|FG001|Overall Study|Objective Progression or Relapse|47|||
125580910|NCT00428597|451753593|FG000|Overall Study|Study Terminated by Sponsor|41|||
125580911|NCT00428597|451753594|FG001|Overall Study|Study Terminated by Sponsor|16|||
125580912|NCT00428597|451753593|FG000|Overall Study|Adverse Event|15|||
125580913|NCT00428597|451753594|FG001|Overall Study|Adverse Event|7|||
125580914|NCT00428597|451753593|FG000|Overall Study|Global Deterioration of Health Status|1|||
125580915|NCT00428597|451753594|FG001|Overall Study|Global Deterioration of Health Status|5|||
125580916|NCT00428597|451753593|FG000|Overall Study|Protocol Violation|2|||
125580917|NCT00428597|451753594|FG001|Overall Study|Protocol Violation|1|||
125580918|NCT00428597|451753593|FG000|Overall Study|Withdrawal by Subject|2|||
125580919|NCT00428597|451753594|FG001|Overall Study|Withdrawal by Subject|1|||
125580920|NCT00428597|451753593|FG000|Overall Study|Other|1|||
125580921|NCT00428597|451753594|FG001|Overall Study|Other|1|||
125580922|NCT00428597|451753593|FG000|Overall Study|Lost to Follow-up|0|||
125580923|NCT00428597|451753594|FG001|Overall Study|Lost to Follow-up|1|||
125580924|NCT00428597|451753593|FG000|Overall Study|Pregnancy|1|||
125580925|NCT00428597|451753594|FG001|Overall Study|Pregnancy|0|||
125580926|NCT00428597|451753593|FG000|Overall Study|Death|1|||
125580927|NCT00428597|451753594|FG001|Overall Study|Death|3|||
125580928|NCT00686647|451753595|FG000|Overall Study|Lost to Follow-up|1|||
125580929|NCT00686647|451753595|FG000|Overall Study|Death|1|||
125580930|NCT01725750|451753601|FG000|Overall Study|Adverse Event|1|||
125360692|NCT02038881|450955795|FG000|Overall Study|Withdrawal by Subject|0|||
125360693|NCT02038881|450955796|FG001|Overall Study|Withdrawal by Subject|0|||
125360694|NCT02038881|450955797|FG002|Overall Study|Withdrawal by Subject|1|||
125360695|NCT02038881|450955795|FG000|Overall Study|Lost to Follow-up|2|||
125360696|NCT02038881|450955796|FG001|Overall Study|Lost to Follow-up|0|||
125360697|NCT02038881|450955797|FG002|Overall Study|Lost to Follow-up|0|||
125360698|NCT02038881|450955795|FG000|Overall Study|incarcerated|1|||
125360699|NCT02038881|450955796|FG001|Overall Study|incarcerated|0|||
125360700|NCT02038881|450955797|FG002|Overall Study|incarcerated|0|||
125360701|NCT00333840|450955798|FG000|First-line Treatment Period|Adverse Event|38|||
125360702|NCT00333840|450955799|FG001|First-line Treatment Period|Adverse Event|37|||
125360703|NCT00333840|450955800|FG002|First-line Treatment Period|Adverse Event|0|||
125580931|NCT01725750|451753602|FG001|Overall Study|Adverse Event|0|||
125580932|NCT01725750|451753601|FG000|Overall Study|Lost to Follow-up|1|||
125580933|NCT01725750|451753602|FG001|Overall Study|Lost to Follow-up|1|||
125580934|NCT01725750|451753601|FG000|Overall Study|Withdrawal by Subject|0|||
125580935|NCT01725750|451753602|FG001|Overall Study|Withdrawal by Subject|9|||
125360704|NCT00333840|450955801|FG003|First-line Treatment Period|Adverse Event|0|||
125360705|NCT00333840|450955798|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
125360706|NCT00333840|450955799|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
125360707|NCT00333840|450955800|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
125360708|NCT00333840|450955801|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
125360709|NCT00333840|450955798|FG000|First-line Treatment Period|Abnormal procedure|2|||
125360710|NCT00333840|450955799|FG001|First-line Treatment Period|Abnormal procedure|0|||
125360711|NCT00333840|450955800|FG002|First-line Treatment Period|Abnormal procedure|0|||
125360712|NCT00333840|450955801|FG003|First-line Treatment Period|Abnormal procedure|0|||
125360713|NCT00333840|450955798|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
125360714|NCT00333840|450955799|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
125360715|NCT00333840|450955800|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
125360716|NCT00333840|450955801|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
125360717|NCT00333840|450955798|FG000|First-line Treatment Period|No longer required study drug|21|||
125360718|NCT00333840|450955799|FG001|First-line Treatment Period|No longer required study drug|8|||
125360719|NCT00333840|450955800|FG002|First-line Treatment Period|No longer required study drug|0|||
125360720|NCT00333840|450955801|FG003|First-line Treatment Period|No longer required study drug|0|||
125428104|NCT01090310|451193775|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
125580936|NCT00654498|451753607|FG000|Overall Study|Not Treated|1|||
125580937|NCT00654498|451753608|FG001|Overall Study|Not Treated|0|||
125580938|NCT00654498|451753607|FG000|Overall Study|Adverse Event|6|||
125580939|NCT00654498|451753608|FG001|Overall Study|Adverse Event|1|||
125580940|NCT00654498|451753607|FG000|Overall Study|Protocol Violation|1|||
125580941|NCT00654498|451753608|FG001|Overall Study|Protocol Violation|1|||
125580942|NCT00654498|451753607|FG000|Overall Study|Lost to Follow-up|1|||
125580943|NCT00654498|451753608|FG001|Overall Study|Lost to Follow-up|5|||
125580944|NCT00654498|451753607|FG000|Overall Study|Withdrawal by Subject|1|||
125580945|NCT00654498|451753608|FG001|Overall Study|Withdrawal by Subject|0|||
125580946|NCT00654498|451753607|FG000|Overall Study|Other reason not defined above|4|||
125580947|NCT00654498|451753608|FG001|Overall Study|Other reason not defined above|5|||
125580948|NCT02531646|451753615|FG000|Overall Study|equip. image processing issue|5|||
125580949|NCT02531646|451753616|FG001|Overall Study|equip. image processing issue|1|||
125580950|NCT02531646|451753617|FG002|Overall Study|equip. image processing issue|0|||
125580951|NCT00772668|451753620|FG000|Overall Study|Physician Decision|3|||
125580952|NCT02152345|451755340|FG000|Overall Study|Case Cancellations|2|||
125580953|NCT02152345|451755341|FG001|Overall Study|Case Cancellations|4|||
125580954|NCT02152345|451755340|FG000|Overall Study|Withdrawal by Subject|2|||
125580955|NCT02152345|451755341|FG001|Overall Study|Withdrawal by Subject|1|||
125580956|NCT01916980|451755342|FG000|Overall Study|Adverse Event|4|||
125580957|NCT01916980|451755343|FG001|Overall Study|Adverse Event|2|||
125580958|NCT01916980|451755342|FG000|Overall Study|Lack of Efficacy|2|||
125580959|NCT01916980|451755343|FG001|Overall Study|Lack of Efficacy|2|||
125580960|NCT01916980|451755342|FG000|Overall Study|Withdrawal by Subject|1|||
125580961|NCT01916980|451755343|FG001|Overall Study|Withdrawal by Subject|0|||
125580962|NCT04439279|451755344|FG000|Overall Study|Adverse Event|7|||
125580963|NCT04439279|451755344|FG000|Overall Study|Death|4|||
125580964|NCT04439279|451755344|FG000|Overall Study|Disease progression|17|||
125580965|NCT04439279|451755344|FG000|Overall Study|Complicating disease|3|||
125580966|NCT04439279|451755344|FG000|Overall Study|Withdrawal by Subject|2|||
125580967|NCT04439279|451755344|FG000|Overall Study|Ineligible|1|||
125580968|NCT04439279|451755344|FG000|Overall Study|Treatment still ongoing|1|||
125428105|NCT01090310|451193776|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
125428106|NCT01090310|451193777|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
125428107|NCT01090310|451193774|FG000|Extension Study|Subject withdrew consent|0|||
125428108|NCT01090310|451193775|FG001|Extension Study|Subject withdrew consent|1|||
125131363|NCT01854047|450108127|FG000|Overall Study|Poor compliance to protocol|3|||
125428109|NCT01090310|451193776|FG002|Extension Study|Subject withdrew consent|0|||
125360721|NCT00333840|450955798|FG000|First-line Treatment Period|Protocol Violation|17|||
125580969|NCT02324270|451755345|FG000|Overall Study|Withdrawal by Subject|0|||
125580970|NCT02324270|451755346|FG001|Overall Study|Withdrawal by Subject|1|||
125580971|NCT02324270|451755347|FG002|Overall Study|Withdrawal by Subject|0|||
125360722|NCT00333840|450955799|FG001|First-line Treatment Period|Protocol Violation|17|||
125360723|NCT00333840|450955800|FG002|First-line Treatment Period|Protocol Violation|0|||
125360724|NCT00333840|450955801|FG003|First-line Treatment Period|Protocol Violation|0|||
125360725|NCT00333840|450955798|FG000|First-line Treatment Period|Subject withdrew consent|57|||
125580972|NCT02324270|451755345|FG000|Overall Study|Lost to Follow-up|4|||
125580973|NCT02324270|451755346|FG001|Overall Study|Lost to Follow-up|3|||
125360726|NCT00333840|450955799|FG001|First-line Treatment Period|Subject withdrew consent|77|||
125360727|NCT00333840|450955800|FG002|First-line Treatment Period|Subject withdrew consent|0|||
125360728|NCT00333840|450955801|FG003|First-line Treatment Period|Subject withdrew consent|0|||
125580974|NCT02324270|451755347|FG002|Overall Study|Lost to Follow-up|4|||
125580975|NCT02324270|451755345|FG000|Overall Study|Protocol Violation|0|||
125580976|NCT02324270|451755346|FG001|Overall Study|Protocol Violation|1|||
125580977|NCT02324270|451755347|FG002|Overall Study|Protocol Violation|1|||
125580978|NCT02324270|451755345|FG000|Overall Study|Non Compliance with Study Drug|1|||
125580979|NCT02324270|451755346|FG001|Overall Study|Non Compliance with Study Drug|2|||
125580980|NCT02324270|451755347|FG002|Overall Study|Non Compliance with Study Drug|0|||
125580981|NCT03521791|451755348|FG000|Overall Study|Protocol Violation|7|||
125580982|NCT03521791|451755349|FG001|Overall Study|Protocol Violation|17|||
125580983|NCT00680836|451755351|FG000|Overall Study|Withdrawal by Subject|3|||
125580984|NCT00680836|451755352|FG001|Overall Study|Withdrawal by Subject|0|||
125580985|NCT00680836|451755351|FG000|Overall Study|Lost to Follow-up|3|||
125580986|NCT00680836|451755352|FG001|Overall Study|Lost to Follow-up|1|||
125580987|NCT00680836|451755351|FG000|Overall Study|Physician Decision|2|||
125580988|NCT00680836|451755352|FG001|Overall Study|Physician Decision|1|||
125580989|NCT03786432|451755353|FG000|Overall Study|Screen Failure after consent|1|||
125580990|NCT03786432|451755353|FG000|Overall Study|Lost to Follow-up|4|||
125580991|NCT03786432|451755353|FG000|Overall Study|did not complete 12 month CT scan|1|||
125580992|NCT03593915|451755357|FG000|Overall Study|Adverse Event|0|||
125580993|NCT03593915|451755358|FG001|Overall Study|Adverse Event|0|||
125580994|NCT03593915|451755359|FG002|Overall Study|Adverse Event|0|||
125580995|NCT03593915|451755360|FG003|Overall Study|Adverse Event|1|||
125580996|NCT03593915|451755361|FG004|Overall Study|Adverse Event|0|||
125580997|NCT03593915|451755362|FG005|Overall Study|Adverse Event|0|||
125580998|NCT03593915|451755357|FG000|Overall Study|Physician Decision|0|||
125580999|NCT03593915|451755358|FG001|Overall Study|Physician Decision|0|||
125581000|NCT03593915|451755359|FG002|Overall Study|Physician Decision|0|||
125581001|NCT03593915|451755360|FG003|Overall Study|Physician Decision|0|||
125581002|NCT03593915|451755361|FG004|Overall Study|Physician Decision|0|||
125581003|NCT03593915|451755362|FG005|Overall Study|Physician Decision|1|||
125581004|NCT05512949|451755363|FG000|Overall Study|Lost to Follow-up|4|||
125581005|NCT05512949|451755364|FG001|Overall Study|Lost to Follow-up|6|||
125581006|NCT05512949|451755365|FG002|Overall Study|Lost to Follow-up|2|||
125581007|NCT05512949|451755363|FG000|Overall Study|Protocol Violation|0|||
125581008|NCT05512949|451755364|FG001|Overall Study|Protocol Violation|0|||
125581009|NCT05512949|451755365|FG002|Overall Study|Protocol Violation|1|||
125581010|NCT05512949|451755363|FG000|Overall Study|Withdrawal by Subject|1|||
125581011|NCT05512949|451755364|FG001|Overall Study|Withdrawal by Subject|1|||
125581012|NCT05512949|451755365|FG002|Overall Study|Withdrawal by Subject|2|||
125581013|NCT05512949|451755363|FG000|Overall Study|Completion status unknown|1|||
125581014|NCT05512949|451755364|FG001|Overall Study|Completion status unknown|3|||
125581015|NCT05512949|451755365|FG002|Overall Study|Completion status unknown|0|||
125211796|NCT02007278|450401372|FG000|Overall Study|Failure to comply with an eligibility|0|||
125581016|NCT02614079|451755368|FG000|Overall Study|Withdrawal by Subject|1|||
125581017|NCT03683394|451755369|FG000|Overall Study|Withdrawal by Subject|4|||
125581018|NCT03683394|451755370|FG001|Overall Study|Withdrawal by Subject|8|||
125581019|NCT03683394|451755369|FG000|Overall Study|Lost to Follow-up|7|||
125581020|NCT03683394|451755370|FG001|Overall Study|Lost to Follow-up|0|||
125581021|NCT03683394|451755369|FG000|Overall Study|Death|3|||
125581022|NCT03683394|451755370|FG001|Overall Study|Death|1|||
125581023|NCT04451330|451755371|FG000|Overall Study|Adverse Event|1|||
125581024|NCT04451330|451755372|FG001|Overall Study|Adverse Event|2|||
125581025|NCT04451330|451755371|FG000|Overall Study|Lost to Follow-up|5|||
125581026|NCT04451330|451755372|FG001|Overall Study|Lost to Follow-up|0|||
125581027|NCT04451330|451755371|FG000|Overall Study|Withdrawal by Subject|3|||
125360729|NCT00333840|450955798|FG000|First-line Treatment Period|Lost to Follow-up|15|||
125581028|NCT04451330|451755372|FG001|Overall Study|Withdrawal by Subject|1|||
125581029|NCT04451330|451755371|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125581030|NCT04451330|451755372|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125581031|NCT04451330|451755371|FG000|Overall Study|Other than specified|0|||
125581032|NCT04451330|451755372|FG001|Overall Study|Other than specified|1|||
125581033|NCT01528787|451755373|FG000|Overall Study|Withdrawal by Subject|0|||
125581034|NCT01528787|451755374|FG001|Overall Study|Withdrawal by Subject|0|||
125581035|NCT01528787|451755375|FG002|Overall Study|Withdrawal by Subject|0|||
125581036|NCT01528787|451755376|FG003|Overall Study|Withdrawal by Subject|1|||
125581037|NCT01528787|451755373|FG000|Overall Study|Family Emergency|0|||
125581038|NCT01528787|451755374|FG001|Overall Study|Family Emergency|0|||
125581039|NCT01528787|451755375|FG002|Overall Study|Family Emergency|1|||
125360730|NCT00333840|450955799|FG001|First-line Treatment Period|Lost to Follow-up|6|||
125428110|NCT01090310|451193777|FG003|Extension Study|Subject withdrew consent|0|||
125428111|NCT00695786|451193778|FG000|Overall Study|Adverse Event|0|||
125428112|NCT00695786|451193779|FG001|Overall Study|Adverse Event|3|||
125428113|NCT00695786|451193780|FG002|Overall Study|Adverse Event|4|||
125428114|NCT00695786|451193781|FG003|Overall Study|Adverse Event|2|||
125428115|NCT00695786|451193778|FG000|Overall Study|Lost to Follow-up|0|||
125428116|NCT00695786|451193779|FG001|Overall Study|Lost to Follow-up|5|||
125428117|NCT00695786|451193780|FG002|Overall Study|Lost to Follow-up|1|||
125428118|NCT00695786|451193781|FG003|Overall Study|Lost to Follow-up|1|||
125428119|NCT00695786|451193778|FG000|Overall Study|Withdrawal by Subject|0|||
125428120|NCT00695786|451193779|FG001|Overall Study|Withdrawal by Subject|4|||
125428121|NCT00695786|451193780|FG002|Overall Study|Withdrawal by Subject|3|||
125428122|NCT00695786|451193781|FG003|Overall Study|Withdrawal by Subject|1|||
125428123|NCT00695786|451193778|FG000|Overall Study|Deemed Ineligible|1|||
125428124|NCT00695786|451193779|FG001|Overall Study|Deemed Ineligible|0|||
125428125|NCT00695786|451193780|FG002|Overall Study|Deemed Ineligible|0|||
125428126|NCT00695786|451193781|FG003|Overall Study|Deemed Ineligible|0|||
125428127|NCT00695786|451193778|FG000|Overall Study|Lack of Efficacy|0|||
125428128|NCT00695786|451193779|FG001|Overall Study|Lack of Efficacy|0|||
125428129|NCT00695786|451193780|FG002|Overall Study|Lack of Efficacy|0|||
125428130|NCT00695786|451193781|FG003|Overall Study|Lack of Efficacy|4|||
125428131|NCT01364922|451193782|FG000|Open-label (OL) Period|Adverse Event|7|||
125428132|NCT01364922|451193783|FG001|Open-label (OL) Period|Adverse Event|0|||
125428133|NCT01364922|451193784|FG002|Open-label (OL) Period|Adverse Event|0|||
125428134|NCT01364922|451193782|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
125428135|NCT01364922|451193783|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
125428136|NCT01364922|451193784|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
125428137|NCT01364922|451193782|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
125428138|NCT01364922|451193783|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
125428139|NCT01364922|451193784|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
125428140|NCT01364922|451193782|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
125428141|NCT01364922|451193783|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
125428142|NCT01364922|451193784|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
125428143|NCT01364922|451193782|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
125428144|NCT01364922|451193783|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
125428145|NCT01364922|451193784|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
125360731|NCT00333840|450955800|FG002|First-line Treatment Period|Lost to Follow-up|0|||
125360732|NCT00333840|450955801|FG003|First-line Treatment Period|Lost to Follow-up|0|||
125360733|NCT00333840|450955798|FG000|First-line Treatment Period|Administrative problems|12|||
125360734|NCT00333840|450955799|FG001|First-line Treatment Period|Administrative problems|6|||
125360735|NCT00333840|450955800|FG002|First-line Treatment Period|Administrative problems|0|||
125428146|NCT01364922|451193782|FG000|Open-label (OL) Period|Other, Unspecified|1|||
125428147|NCT01364922|451193783|FG001|Open-label (OL) Period|Other, Unspecified|0|||
125428148|NCT01364922|451193784|FG002|Open-label (OL) Period|Other, Unspecified|0|||
125428149|NCT01364922|451193782|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
125428150|NCT01364922|451193783|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
125428151|NCT01364922|451193784|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
125581040|NCT01528787|451755376|FG003|Overall Study|Family Emergency|0|||
125581041|NCT03882424|451755377|FG000|Overall Study|Lost to Follow-up|3|||
125581042|NCT03882424|451755378|FG001|Overall Study|Lost to Follow-up|0|||
125581043|NCT03882424|451755379|FG002|Overall Study|Lost to Follow-up|0|||
125428152|NCT01364922|451193782|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
125428153|NCT01364922|451193783|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
125428154|NCT01364922|451193784|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
125428155|NCT01364922|451193782|FG000|Double-Blind (DB) Period|Adverse Event|0|||
125428156|NCT01364922|451193783|FG001|Double-Blind (DB) Period|Adverse Event|0|||
125428157|NCT01364922|451193784|FG002|Double-Blind (DB) Period|Adverse Event|1|||
125428158|NCT01364922|451193782|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
125428159|NCT01364922|451193783|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
125428160|NCT01364922|451193784|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
125428161|NCT01787097|451193788|FG000|Overall Study|Withdrawal by Subject|1|||
125428162|NCT01787097|451193789|FG001|Overall Study|Withdrawal by Subject|0|||
125428163|NCT01787097|451193790|FG002|Overall Study|Withdrawal by Subject|0|||
125428164|NCT01787097|451193791|FG003|Overall Study|Withdrawal by Subject|0|||
125428165|NCT00949884|451193792|FG000|Overall Study|Adverse Event|14|||
125428166|NCT00949884|451193793|FG001|Overall Study|Adverse Event|3|||
125428167|NCT00949884|451193794|FG002|Overall Study|Adverse Event|12|||
125428168|NCT00949884|451193792|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
125428169|NCT00949884|451193793|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
125428170|NCT00949884|451193794|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
125428171|NCT00949884|451193792|FG000|Overall Study|Lost to Follow-up|7|||
125428172|NCT00949884|451193793|FG001|Overall Study|Lost to Follow-up|5|||
125428173|NCT00949884|451193794|FG002|Overall Study|Lost to Follow-up|5|||
125428174|NCT00949884|451193792|FG000|Overall Study|Physician Decision|5|||
125428175|NCT00949884|451193793|FG001|Overall Study|Physician Decision|0|||
125428176|NCT00949884|451193794|FG002|Overall Study|Physician Decision|6|||
125428177|NCT00949884|451193792|FG000|Overall Study|Treatment non-compliance|5|||
125428178|NCT00949884|451193793|FG001|Overall Study|Treatment non-compliance|0|||
125428179|NCT00949884|451193794|FG002|Overall Study|Treatment non-compliance|8|||
125428180|NCT00949884|451193792|FG000|Overall Study|Withdrawal by Subject|13|||
125428181|NCT00949884|451193793|FG001|Overall Study|Withdrawal by Subject|4|||
125428182|NCT00949884|451193794|FG002|Overall Study|Withdrawal by Subject|16|||
125428183|NCT00949884|451193792|FG000|Overall Study|Lack of Efficacy|4|||
125428184|NCT00949884|451193793|FG001|Overall Study|Lack of Efficacy|2|||
125428185|NCT00949884|451193794|FG002|Overall Study|Lack of Efficacy|7|||
125428186|NCT00949884|451193792|FG000|Overall Study|Study terminated by sponsor|0|||
125428187|NCT00949884|451193793|FG001|Overall Study|Study terminated by sponsor|0|||
125428188|NCT00949884|451193794|FG002|Overall Study|Study terminated by sponsor|1|||
125428189|NCT00944658|451193801|FG000|Treatment 12 Weeks|Adverse Event|0|||
125428190|NCT00944658|451193802|FG001|Treatment 12 Weeks|Adverse Event|2|||
125428191|NCT02832622|451193809|FG000|Overall Study|MPP not programmed|1259|||
125428192|NCT02832622|451193809|FG000|Overall Study|Withdrawal by Subject|123|||
125428193|NCT02832622|451193809|FG000|Overall Study|Death|119|||
125428194|NCT02832622|451193809|FG000|Overall Study|Unsuccessful CRT implant|93|||
125428195|NCT02832622|451193809|FG000|Overall Study|Lost to Follow-up|45|||
125428196|NCT02832622|451193809|FG000|Overall Study|Patient non-compliance|42|||
125428197|NCT02832622|451193809|FG000|Overall Study|Withdrawal by other reasons|25|||
125428198|NCT02832622|451193809|FG000|Overall Study|System explant|24|||
125428199|NCT02832622|451193809|FG000|Overall Study|Physician Decision|6|||
125428200|NCT02243280|451193810|FG000|Treated|Adverse Event|1|||
125428201|NCT02243280|451193811|FG001|Treated|Adverse Event|0|||
125428202|NCT02243280|451193812|FG002|Treated|Adverse Event|0|||
125428203|NCT02243280|451193813|FG003|Treated|Adverse Event|0|||
125428204|NCT02243280|451193814|FG004|Treated|Adverse Event|0|||
125428205|NCT02243280|451193815|FG005|Treated|Adverse Event|0|||
125428206|NCT02243280|451193816|FG006|Treated|Adverse Event|0|||
125428207|NCT02243280|451193817|FG007|Treated|Adverse Event|0|||
125428208|NCT02243280|451193818|FG008|Treated|Adverse Event|0|||
125428209|NCT02243280|451193819|FG009|Treated|Adverse Event|0|||
125428210|NCT02243280|451193820|FG010|Treated|Adverse Event|1|||
125428211|NCT02243280|451193810|FG000|Treated|Lost to Follow-up|0|||
125428212|NCT02243280|451193811|FG001|Treated|Lost to Follow-up|0|||
125428213|NCT02243280|451193812|FG002|Treated|Lost to Follow-up|0|||
125428214|NCT02243280|451193813|FG003|Treated|Lost to Follow-up|0|||
125428215|NCT02243280|451193814|FG004|Treated|Lost to Follow-up|0|||
125428216|NCT02243280|451193815|FG005|Treated|Lost to Follow-up|0|||
125428217|NCT02243280|451193816|FG006|Treated|Lost to Follow-up|0|||
125428218|NCT02243280|451193817|FG007|Treated|Lost to Follow-up|0|||
125428219|NCT02243280|451193818|FG008|Treated|Lost to Follow-up|1|||
125428220|NCT02243280|451193819|FG009|Treated|Lost to Follow-up|0|||
125428221|NCT02243280|451193820|FG010|Treated|Lost to Follow-up|2|||
125428222|NCT02472652|451193821|FG000|Overall Study|Lost to Follow-up|1|||
125428223|NCT00998400|451193826|FG000|Overall Study|Lack of interest/motivation|1|||
125428224|NCT00998400|451193827|FG001|Overall Study|Lack of interest/motivation|2|||
125428225|NCT00998400|451193826|FG000|Overall Study|Logistical problems|1|||
125428226|NCT00998400|451193827|FG001|Overall Study|Logistical problems|0|||
125428227|NCT03704584|451193828|FG000|Overall Study|Withdrawal by Subject|1|||
125428228|NCT03704584|451193829|FG001|Overall Study|Withdrawal by Subject|0|||
125428229|NCT03185832|451193830|FG000|Overall Study|Death|9|||
125428230|NCT03185832|451193831|FG001|Overall Study|Death|14|||
125428231|NCT03185832|451193832|FG002|Overall Study|Death|9|||
125428232|NCT03185832|451193833|FG003|Overall Study|Death|7|||
125428233|NCT03185832|451193830|FG000|Overall Study|Withdrawn - vital status available|0|||
125428234|NCT03185832|451193831|FG001|Overall Study|Withdrawn - vital status available|1|||
125428235|NCT03185832|451193832|FG002|Overall Study|Withdrawn - vital status available|1|||
125428236|NCT03185832|451193833|FG003|Overall Study|Withdrawn - vital status available|4|||
125428237|NCT01083641|451193834|FG000|Overall Study|Withdrawal by Subject|2|||
125428238|NCT03439189|451193835|FG000|Overall Study|Protocol Violation|19|||
125428239|NCT03439189|451193835|FG000|Overall Study|Lack of Efficacy|63|||
125428240|NCT01807156|451193836|FG000|Overall Study|Physician Decision|1|||
125428241|NCT03122119|451193839|FG000|Overall Study|Did not meet eligibility critria|1|||
125428242|NCT01493687|451193841|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
125428243|NCT01493687|451193842|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
125428244|NCT01493687|451193841|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
125428245|NCT01493687|451193842|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
125428246|NCT01493687|451193841|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
125428247|NCT01493687|451193842|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
125428248|NCT01493687|451193841|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
125428249|NCT01493687|451193842|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
125428250|NCT01493687|451193841|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
125428251|NCT01493687|451193842|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
125428252|NCT01493687|451193841|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
125428253|NCT01493687|451193842|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
125428254|NCT01493687|451193841|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
125428255|NCT01493687|451193842|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
125428256|NCT01493687|451193841|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
125428257|NCT01493687|451193842|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
125428258|NCT01493687|451193841|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
125428259|NCT01493687|451193842|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
125428260|NCT01493687|451193841|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
125428261|NCT01493687|451193842|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
125428262|NCT01493687|451193841|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
125428263|NCT01493687|451193842|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
125428264|NCT01493687|451193841|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
125428265|NCT01493687|451193842|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
125428266|NCT01493687|451193841|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
125428267|NCT01493687|451193842|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
125428268|NCT01493687|451193841|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
125428269|NCT01493687|451193842|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
125428270|NCT01493687|451193841|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
125428271|NCT01493687|451193842|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
125428272|NCT02364180|451193846|FG000|Overall Study|Screen Fail|1|||
125428273|NCT02323646|451193847|FG000|Treatment Course 1|Adverse Event|1|||
125428274|NCT02323646|451193848|FG001|Treatment Course 1|Adverse Event|0|||
125428275|NCT02323646|451193849|FG002|Treatment Course 1|Adverse Event|1|||
125428276|NCT02323646|451193847|FG000|Treatment Course 1|Heavy Bleeding|1|||
125428277|NCT02323646|451193848|FG001|Treatment Course 1|Heavy Bleeding|1|||
125428278|NCT02323646|451193849|FG002|Treatment Course 1|Heavy Bleeding|0|||
125428279|NCT02323646|451193847|FG000|Treatment Course 1|Lost to Follow-up|1|||
125428280|NCT02323646|451193848|FG001|Treatment Course 1|Lost to Follow-up|0|||
125428281|NCT02323646|451193849|FG002|Treatment Course 1|Lost to Follow-up|2|||
125428282|NCT02323646|451193847|FG000|Treatment Course 1|Withdrawal by Subject|0|||
125428283|NCT02323646|451193848|FG001|Treatment Course 1|Withdrawal by Subject|2|||
125428284|NCT02323646|451193849|FG002|Treatment Course 1|Withdrawal by Subject|0|||
125428285|NCT02323646|451193847|FG000|Treatment Course 2|Adverse Event|1|||
125428286|NCT02323646|451193848|FG001|Treatment Course 2|Adverse Event|0|||
125428287|NCT02323646|451193849|FG002|Treatment Course 2|Adverse Event|1|||
125428288|NCT02323646|451193847|FG000|Treatment Course 2|Lost to Follow-up|0|||
125428289|NCT02323646|451193848|FG001|Treatment Course 2|Lost to Follow-up|0|||
125428290|NCT02323646|451193849|FG002|Treatment Course 2|Lost to Follow-up|1|||
125428291|NCT02323646|451193847|FG000|Treatment Course 2|Non-compliance|0|||
125428292|NCT02323646|451193848|FG001|Treatment Course 2|Non-compliance|1|||
125428293|NCT02323646|451193849|FG002|Treatment Course 2|Non-compliance|1|||
125428294|NCT00521144|451193850|FG000|Overall Study|Not Treated|0|||
125428295|NCT00521144|451193851|FG001|Overall Study|Not Treated|0|||
125428296|NCT00521144|451193852|FG002|Overall Study|Not Treated|0|||
125428297|NCT00521144|451193853|FG003|Overall Study|Not Treated|1|||
125428298|NCT00521144|451193854|FG004|Overall Study|Not Treated|0|||
125428299|NCT00521144|451193850|FG000|Overall Study|Adverse Event|0|||
125428300|NCT00521144|451193851|FG001|Overall Study|Adverse Event|1|||
125428301|NCT00521144|451193852|FG002|Overall Study|Adverse Event|0|||
125428302|NCT00521144|451193853|FG003|Overall Study|Adverse Event|0|||
125581044|NCT03882424|451755377|FG000|Overall Study|schedule conflict|1|||
125581045|NCT03882424|451755378|FG001|Overall Study|schedule conflict|0|||
125581046|NCT03882424|451755379|FG002|Overall Study|schedule conflict|0|||
125581047|NCT00236080|451755380|FG000|Overall Study|Adverse Event|0|||
125360736|NCT00333840|450955801|FG003|First-line Treatment Period|Administrative problems|0|||
125360737|NCT00333840|450955798|FG000|First-line Treatment Period|Death|19|||
125360738|NCT00333840|450955799|FG001|First-line Treatment Period|Death|2|||
125360739|NCT00333840|450955800|FG002|First-line Treatment Period|Death|0|||
125360740|NCT00333840|450955801|FG003|First-line Treatment Period|Death|0|||
125360741|NCT00333840|450955798|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
125360742|NCT00333840|450955799|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
125360743|NCT00333840|450955800|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
125360744|NCT00333840|450955801|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
125360745|NCT00333840|450955798|FG000|Second-line Treatment Period|Adverse Event|0|||
125360746|NCT00333840|450955799|FG001|Second-line Treatment Period|Adverse Event|0|||
125360747|NCT00333840|450955800|FG002|Second-line Treatment Period|Adverse Event|3|||
125360748|NCT00333840|450955801|FG003|Second-line Treatment Period|Adverse Event|34|||
125360749|NCT00333840|450955798|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
125360750|NCT00333840|450955799|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
125360751|NCT00333840|450955800|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
125360752|NCT00333840|450955801|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
125360753|NCT00333840|450955798|FG000|Second-line Treatment Period|Abnormal procedure|0|||
125360754|NCT00333840|450955799|FG001|Second-line Treatment Period|Abnormal procedure|0|||
125360755|NCT00333840|450955800|FG002|Second-line Treatment Period|Abnormal procedure|0|||
125360756|NCT00333840|450955801|FG003|Second-line Treatment Period|Abnormal procedure|1|||
125360757|NCT00333840|450955798|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
125360758|NCT00333840|450955799|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
125360759|NCT00333840|450955800|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
125360760|NCT00333840|450955801|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
125360761|NCT00333840|450955798|FG000|Second-line Treatment Period|No longer required study drug|0|||
125360762|NCT00333840|450955799|FG001|Second-line Treatment Period|No longer required study drug|0|||
125360763|NCT00333840|450955800|FG002|Second-line Treatment Period|No longer required study drug|1|||
125360764|NCT00333840|450955801|FG003|Second-line Treatment Period|No longer required study drug|14|||
125360765|NCT00333840|450955798|FG000|Second-line Treatment Period|Protocol Violation|0|||
125360766|NCT00333840|450955799|FG001|Second-line Treatment Period|Protocol Violation|0|||
125360767|NCT00333840|450955800|FG002|Second-line Treatment Period|Protocol Violation|1|||
125360768|NCT00333840|450955801|FG003|Second-line Treatment Period|Protocol Violation|10|||
125360769|NCT00333840|450955798|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
125360770|NCT00333840|450955799|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
125360771|NCT00333840|450955800|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
125360772|NCT00333840|450955801|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
125360773|NCT00333840|450955798|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
125360774|NCT00333840|450955799|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
125360775|NCT00333840|450955800|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
125360776|NCT00333840|450955801|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
125360777|NCT00333840|450955798|FG000|Second-line Treatment Period|Administrative problems|0|||
125360778|NCT00333840|450955799|FG001|Second-line Treatment Period|Administrative problems|0|||
125360779|NCT00333840|450955800|FG002|Second-line Treatment Period|Administrative problems|0|||
125360780|NCT00333840|450955801|FG003|Second-line Treatment Period|Administrative problems|7|||
125360781|NCT00333840|450955798|FG000|Second-line Treatment Period|Death|0|||
125360782|NCT00333840|450955799|FG001|Second-line Treatment Period|Death|0|||
125360783|NCT00333840|450955800|FG002|Second-line Treatment Period|Death|0|||
125360784|NCT00333840|450955801|FG003|Second-line Treatment Period|Death|9|||
125360785|NCT03945214|450955802|FG000|Overall Study|Lost to Follow-up|3|||
125360786|NCT03945214|450955803|FG001|Overall Study|Lost to Follow-up|4|||
125360787|NCT03945214|450955804|FG002|Overall Study|Lost to Follow-up|7|||
125360788|NCT03945214|450955805|FG003|Overall Study|Lost to Follow-up|4|||
125360789|NCT00850070|450955809|FG000|Overall Study|Lack of Efficacy|1|||
125360790|NCT00850070|450955810|FG001|Overall Study|Lack of Efficacy|1|||
125360791|NCT00850070|450955809|FG000|Overall Study|Adverse Event|2|||
125360792|NCT00850070|450955810|FG001|Overall Study|Adverse Event|0|||
125360793|NCT00074984|450955811|FG000|Overall Study|Death|1|||
125360794|NCT00074984|450955812|FG001|Overall Study|Death|2|||
125360795|NCT00074984|450955811|FG000|Overall Study|Withdrawal by Subject|2|||
125360796|NCT00074984|450955812|FG001|Overall Study|Withdrawal by Subject|3|||
125360797|NCT00074984|450955811|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
125360798|NCT00074984|450955812|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
125360799|NCT03719586|450955814|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
125360800|NCT03719586|450955815|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
125360801|NCT03719586|450955816|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
125581048|NCT00236080|451755381|FG001|Overall Study|Adverse Event|0|||
125211797|NCT02007278|450401373|FG001|Overall Study|Failure to comply with an eligibility|1|||
125581049|NCT00236080|451755382|FG002|Overall Study|Adverse Event|3|||
125581050|NCT00236080|451755383|FG003|Overall Study|Adverse Event|1|||
125581051|NCT00236080|451755384|FG004|Overall Study|Adverse Event|0|||
125581052|NCT00236080|451755380|FG000|Overall Study|Lost to Follow-up|0|||
125581053|NCT00236080|451755381|FG001|Overall Study|Lost to Follow-up|1|||
125581054|NCT00236080|451755382|FG002|Overall Study|Lost to Follow-up|0|||
125581055|NCT00236080|451755383|FG003|Overall Study|Lost to Follow-up|0|||
125581056|NCT00236080|451755384|FG004|Overall Study|Lost to Follow-up|0|||
125581057|NCT00236080|451755380|FG000|Overall Study|Physician Decision|1|||
125581058|NCT00236080|451755381|FG001|Overall Study|Physician Decision|0|||
125581059|NCT00236080|451755382|FG002|Overall Study|Physician Decision|1|||
125581060|NCT00236080|451755383|FG003|Overall Study|Physician Decision|1|||
125581061|NCT00236080|451755384|FG004|Overall Study|Physician Decision|1|||
125581062|NCT00236080|451755380|FG000|Overall Study|Withdrawal by Subject|1|||
125581063|NCT00236080|451755381|FG001|Overall Study|Withdrawal by Subject|0|||
125581064|NCT00236080|451755382|FG002|Overall Study|Withdrawal by Subject|0|||
125581065|NCT00236080|451755383|FG003|Overall Study|Withdrawal by Subject|0|||
125581066|NCT00236080|451755384|FG004|Overall Study|Withdrawal by Subject|0|||
125581067|NCT00236080|451755380|FG000|Overall Study|Miscellaneous|0|||
125581068|NCT00236080|451755381|FG001|Overall Study|Miscellaneous|0|||
125581069|NCT00236080|451755382|FG002|Overall Study|Miscellaneous|1|||
125581070|NCT00236080|451755383|FG003|Overall Study|Miscellaneous|0|||
125581071|NCT00236080|451755384|FG004|Overall Study|Miscellaneous|0|||
125581072|NCT02400255|451755385|FG000|Overall Study|Relapse|4|||
125581073|NCT02400255|451755386|FG001|Overall Study|Relapse|1|||
125581074|NCT02400255|451755387|FG002|Overall Study|Relapse|1|||
125581075|NCT02400255|451755388|FG003|Overall Study|Relapse|2|||
125581076|NCT02400255|451755385|FG000|Overall Study|Adverse Event|6|||
125581077|NCT02400255|451755386|FG001|Overall Study|Adverse Event|3|||
125581078|NCT02400255|451755387|FG002|Overall Study|Adverse Event|0|||
125581079|NCT02400255|451755388|FG003|Overall Study|Adverse Event|0|||
125360802|NCT03719586|450955817|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
125360803|NCT00178633|450955822|FG000|Overall Study|Lost to Follow-up|6|||
125360804|NCT00369707|450955826|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
125360805|NCT00369707|450955826|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
125360806|NCT00369707|450955826|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
125360807|NCT00369707|450955826|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
125360808|NCT00369707|450955826|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
125360809|NCT00369707|450955826|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
125360810|NCT00369707|450955826|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
125360811|NCT00369707|450955826|FG000|Follow up for 2 Years After Treatment|Death|1|||
125360812|NCT00369707|450955826|FG000|Follow up for 2 Years After Treatment|Other|2|||
125360813|NCT02046733|450955830|FG000|Overall Study|never initiated 'treatment visits'|6|||
125360814|NCT02046733|450955831|FG001|Overall Study|never initiated 'treatment visits'|0|||
125360815|NCT01254292|450955836|FG000|Comparative Phase|Adverse Event|25|||
125360816|NCT01254292|450955837|FG001|Comparative Phase|Adverse Event|25|||
125360817|NCT01254292|450955836|FG000|Comparative Phase|Lost to Follow-up|3|||
125360818|NCT01254292|450955837|FG001|Comparative Phase|Lost to Follow-up|21|||
125360819|NCT01254292|450955836|FG000|Comparative Phase|Pregnancy|2|||
125360820|NCT01254292|450955837|FG001|Comparative Phase|Pregnancy|6|||
125360821|NCT01254292|450955836|FG000|Comparative Phase|Withdrawal by Subject|20|||
125360822|NCT01254292|450955837|FG001|Comparative Phase|Withdrawal by Subject|21|||
125360823|NCT01254292|450955836|FG000|Comparative Phase|Protocol Violation|1|||
125360824|NCT01254292|450955837|FG001|Comparative Phase|Protocol Violation|2|||
125360825|NCT01254292|450955836|FG000|Comparative Phase|Wish for pregnancy|4|||
125360826|NCT01254292|450955837|FG001|Comparative Phase|Wish for pregnancy|6|||
125360827|NCT01254292|450955836|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
125581080|NCT02400255|451755385|FG000|Overall Study|Physician Decision|6|||
125581081|NCT02400255|451755386|FG001|Overall Study|Physician Decision|0|||
125581082|NCT02400255|451755387|FG002|Overall Study|Physician Decision|0|||
125581083|NCT02400255|451755388|FG003|Overall Study|Physician Decision|0|||
125581084|NCT02400255|451755385|FG000|Overall Study|Loss of insurance|1|||
125581085|NCT02400255|451755386|FG001|Overall Study|Loss of insurance|0|||
125581086|NCT02400255|451755387|FG002|Overall Study|Loss of insurance|0|||
125360828|NCT01254292|450955837|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
125360829|NCT01254292|450955836|FG000|LCS12 Extension Phase|Adverse Event|9|||
125360830|NCT01254292|450955837|FG001|LCS12 Extension Phase|Adverse Event|0|||
125360831|NCT01254292|450955836|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
125360832|NCT01254292|450955837|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
125360833|NCT01254292|450955836|FG000|LCS12 Extension Phase|Other unknown|4|||
125360834|NCT01254292|450955837|FG001|LCS12 Extension Phase|Other unknown|0|||
125360835|NCT01254292|450955836|FG000|LCS12 Extension Phase|Pregnancy|2|||
125360836|NCT01254292|450955837|FG001|LCS12 Extension Phase|Pregnancy|0|||
125360837|NCT01254292|450955836|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
125360838|NCT01254292|450955837|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
125360839|NCT04041375|450955838|FG000|Intervention Phase|Withdrawal by Subject|2|||
125360840|NCT04041375|450955839|FG001|Intervention Phase|Withdrawal by Subject|2|||
125360841|NCT04041375|450955838|FG000|Follow-up Phase|Death|2|||
125360842|NCT04041375|450955839|FG001|Follow-up Phase|Death|0|||
125360843|NCT04041375|450955838|FG000|Follow-up Phase|Lost to Follow-up|2|||
125360844|NCT04041375|450955839|FG001|Follow-up Phase|Lost to Follow-up|1|||
125360845|NCT04041375|450955838|FG000|Follow-up Phase|Too ill|3|||
125360846|NCT04041375|450955839|FG001|Follow-up Phase|Too ill|0|||
125360847|NCT04674644|450955845|FG000|Overall Study|with missing data|37|||
125360848|NCT00199875|450955846|FG000|Overall Study|Withdrawal by Subject|0|||
125360849|NCT00199875|450955847|FG001|Overall Study|Withdrawal by Subject|0|||
125360850|NCT00199875|450955848|FG002|Overall Study|Withdrawal by Subject|0|||
125360851|NCT00199875|450955849|FG003|Overall Study|Withdrawal by Subject|0|||
125360852|NCT00199875|450955850|FG004|Overall Study|Withdrawal by Subject|1|||
125360853|NCT03277690|450955854|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
125360854|NCT03277690|450955855|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
125360855|NCT03277690|450955854|FG000|Dose Titration and Maintenance|Physician Decision|1|||
125360856|NCT03277690|450955855|FG001|Dose Titration and Maintenance|Physician Decision|0|||
125360857|NCT03277690|450955854|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
125360858|NCT03277690|450955855|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
125360859|NCT03277690|450955854|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
125581087|NCT02400255|451755388|FG003|Overall Study|Loss of insurance|0|||
125581088|NCT01961544|451755392|FG000|Overall Study|Protocol Violation|1|||
125581089|NCT01961544|451755392|FG000|Overall Study|Withdrawal by Subject|7|||
125581090|NCT01961544|451755392|FG000|Overall Study|Adverse Event|1|||
125581091|NCT01961544|451755392|FG000|Overall Study|Physician Decision|2|||
125581092|NCT01961544|451755392|FG000|Overall Study|Poor Tolerance|1|||
125581093|NCT01961544|451755392|FG000|Overall Study|Aggravation of Steral Pain|1|||
125581094|NCT03213366|451755395|FG000|Overall Study|Lost to Follow-up|9|||
125581095|NCT03213366|451755396|FG001|Overall Study|Lost to Follow-up|4|||
125581096|NCT00666926|451755397|FG000|Overall Study|Adverse Event|0|||
125581097|NCT00666926|451755398|FG001|Overall Study|Adverse Event|0|||
125581098|NCT00666926|451755399|FG002|Overall Study|Adverse Event|0|||
125581099|NCT00666926|451755400|FG003|Overall Study|Adverse Event|0|||
125581100|NCT00666926|451755401|FG004|Overall Study|Adverse Event|0|||
125581101|NCT00666926|451755402|FG005|Overall Study|Adverse Event|0|||
125581102|NCT00666926|451755403|FG006|Overall Study|Adverse Event|0|||
125360860|NCT03277690|450955855|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
125360861|NCT03277690|450955854|FG000|Dose Titration and Maintenance|Adverse Event|15|||
125360862|NCT03277690|450955855|FG001|Dose Titration and Maintenance|Adverse Event|0|||
125360863|NCT03277690|450955854|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
125360864|NCT03277690|450955855|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
125360865|NCT03277690|450955854|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
125360866|NCT03277690|450955855|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
125360867|NCT00747812|450955856|FG000|Overall Study|Research Site Staff Relocation|5|||
125360868|NCT00747812|450955857|FG001|Overall Study|Research Site Staff Relocation|3|||
125360869|NCT01013350|450955858|FG000|Overall Study|Lost to Follow-up|15|||
125360870|NCT01013350|450955859|FG001|Overall Study|Lost to Follow-up|95|||
125360871|NCT01013350|450955858|FG000|Overall Study|Adverse Event|0|||
125360872|NCT01013350|450955859|FG001|Overall Study|Adverse Event|1|||
125360873|NCT01013350|450955858|FG000|Overall Study|Physician Decision|4|||
125360874|NCT01013350|450955859|FG001|Overall Study|Physician Decision|20|||
125360875|NCT01013350|450955858|FG000|Overall Study|Withdrawal by Subject|15|||
125360876|NCT01013350|450955859|FG001|Overall Study|Withdrawal by Subject|38|||
125360877|NCT01013350|450955858|FG000|Overall Study|Death|3|||
125428303|NCT00521144|451193854|FG004|Overall Study|Adverse Event|1|||
125360878|NCT01013350|450955859|FG001|Overall Study|Death|5|||
125428304|NCT00521144|451193850|FG000|Overall Study|Progressive Disease|4|||
125428305|NCT00521144|451193851|FG001|Overall Study|Progressive Disease|2|||
125360879|NCT01013350|450955858|FG000|Overall Study|Participant entered interventional study|0|||
125360880|NCT01013350|450955859|FG001|Overall Study|Participant entered interventional study|8|||
125360881|NCT01013350|450955858|FG000|Overall Study|Other|1|||
125581103|NCT00666926|451755404|FG007|Overall Study|Adverse Event|0|||
125581104|NCT00666926|451755405|FG008|Overall Study|Adverse Event|0|||
125581105|NCT00666926|451755406|FG009|Overall Study|Adverse Event|2|||
125581106|NCT00666926|451755407|FG010|Overall Study|Adverse Event|2|||
125581107|NCT00666926|451755408|FG011|Overall Study|Adverse Event|2|||
125581108|NCT00666926|451755409|FG012|Overall Study|Adverse Event|0|||
125581109|NCT00666926|451755410|FG013|Overall Study|Adverse Event|1|||
125581110|NCT00666926|451755411|FG014|Overall Study|Adverse Event|0|||
125581111|NCT00666926|451755412|FG015|Overall Study|Adverse Event|0|||
125581112|NCT00666926|451755397|FG000|Overall Study|Laboratory abnormality|0|||
125581113|NCT00666926|451755398|FG001|Overall Study|Laboratory abnormality|0|||
125581114|NCT00666926|451755399|FG002|Overall Study|Laboratory abnormality|0|||
125581115|NCT00666926|451755400|FG003|Overall Study|Laboratory abnormality|0|||
125581116|NCT00666926|451755401|FG004|Overall Study|Laboratory abnormality|0|||
125581117|NCT00666926|451755402|FG005|Overall Study|Laboratory abnormality|0|||
125581118|NCT00666926|451755403|FG006|Overall Study|Laboratory abnormality|0|||
125581119|NCT00666926|451755404|FG007|Overall Study|Laboratory abnormality|0|||
125581120|NCT00666926|451755405|FG008|Overall Study|Laboratory abnormality|0|||
125581121|NCT00666926|451755406|FG009|Overall Study|Laboratory abnormality|0|||
125581122|NCT00666926|451755407|FG010|Overall Study|Laboratory abnormality|1|||
125581123|NCT00666926|451755408|FG011|Overall Study|Laboratory abnormality|0|||
125581124|NCT00666926|451755409|FG012|Overall Study|Laboratory abnormality|0|||
125581125|NCT00666926|451755410|FG013|Overall Study|Laboratory abnormality|0|||
125581126|NCT00666926|451755411|FG014|Overall Study|Laboratory abnormality|0|||
125581127|NCT00666926|451755412|FG015|Overall Study|Laboratory abnormality|1|||
125581128|NCT00666926|451755397|FG000|Overall Study|Lack of Efficacy|0|||
125581129|NCT00666926|451755398|FG001|Overall Study|Lack of Efficacy|0|||
125581130|NCT00666926|451755399|FG002|Overall Study|Lack of Efficacy|0|||
125581131|NCT00666926|451755400|FG003|Overall Study|Lack of Efficacy|0|||
125581132|NCT00666926|451755401|FG004|Overall Study|Lack of Efficacy|0|||
125581133|NCT00666926|451755402|FG005|Overall Study|Lack of Efficacy|1|||
125581134|NCT00666926|451755403|FG006|Overall Study|Lack of Efficacy|0|||
125581135|NCT00666926|451755404|FG007|Overall Study|Lack of Efficacy|0|||
125581136|NCT00666926|451755405|FG008|Overall Study|Lack of Efficacy|0|||
125581137|NCT00666926|451755406|FG009|Overall Study|Lack of Efficacy|0|||
125581138|NCT00666926|451755407|FG010|Overall Study|Lack of Efficacy|0|||
125581139|NCT00666926|451755408|FG011|Overall Study|Lack of Efficacy|1|||
125581140|NCT00666926|451755409|FG012|Overall Study|Lack of Efficacy|0|||
125581141|NCT00666926|451755410|FG013|Overall Study|Lack of Efficacy|0|||
125581142|NCT00666926|451755411|FG014|Overall Study|Lack of Efficacy|0|||
125581143|NCT00666926|451755412|FG015|Overall Study|Lack of Efficacy|0|||
125581144|NCT00666926|451755397|FG000|Overall Study|Lost to Follow-up|0|||
125581145|NCT00666926|451755398|FG001|Overall Study|Lost to Follow-up|0|||
125581146|NCT00666926|451755399|FG002|Overall Study|Lost to Follow-up|0|||
125581147|NCT00666926|451755400|FG003|Overall Study|Lost to Follow-up|1|||
125581148|NCT00666926|451755401|FG004|Overall Study|Lost to Follow-up|0|||
125581149|NCT00666926|451755402|FG005|Overall Study|Lost to Follow-up|0|||
125581150|NCT00666926|451755403|FG006|Overall Study|Lost to Follow-up|0|||
125581151|NCT00666926|451755404|FG007|Overall Study|Lost to Follow-up|0|||
125581152|NCT00666926|451755405|FG008|Overall Study|Lost to Follow-up|0|||
125581153|NCT00666926|451755406|FG009|Overall Study|Lost to Follow-up|0|||
125581154|NCT00666926|451755407|FG010|Overall Study|Lost to Follow-up|0|||
125581155|NCT00666926|451755408|FG011|Overall Study|Lost to Follow-up|0|||
125581156|NCT00666926|451755409|FG012|Overall Study|Lost to Follow-up|0|||
125581157|NCT00666926|451755410|FG013|Overall Study|Lost to Follow-up|0|||
125581158|NCT00666926|451755411|FG014|Overall Study|Lost to Follow-up|0|||
125581159|NCT00666926|451755412|FG015|Overall Study|Lost to Follow-up|0|||
125581160|NCT00666926|451755397|FG000|Overall Study|Other|2|||
125581161|NCT00666926|451755398|FG001|Overall Study|Other|4|||
125581162|NCT00666926|451755399|FG002|Overall Study|Other|3|||
125581163|NCT00666926|451755400|FG003|Overall Study|Other|3|||
125581164|NCT00666926|451755401|FG004|Overall Study|Other|3|||
125581165|NCT00666926|451755402|FG005|Overall Study|Other|3|||
125581166|NCT00666926|451755403|FG006|Overall Study|Other|4|||
125581167|NCT00666926|451755404|FG007|Overall Study|Other|0|||
125581168|NCT00666926|451755405|FG008|Overall Study|Other|3|||
125581169|NCT00666926|451755406|FG009|Overall Study|Other|5|||
125360882|NCT01013350|450955859|FG001|Overall Study|Other|25|||
125581170|NCT00666926|451755407|FG010|Overall Study|Other|3|||
125581171|NCT00666926|451755408|FG011|Overall Study|Other|26|||
125581172|NCT00666926|451755409|FG012|Overall Study|Other|3|||
125581173|NCT00666926|451755410|FG013|Overall Study|Other|2|||
125581174|NCT00666926|451755411|FG014|Overall Study|Other|4|||
125581175|NCT00666926|451755412|FG015|Overall Study|Other|4|||
125581176|NCT00666926|451755397|FG000|Overall Study|Withdrawal by Subject|0|||
125581177|NCT00666926|451755398|FG001|Overall Study|Withdrawal by Subject|0|||
125581178|NCT00666926|451755399|FG002|Overall Study|Withdrawal by Subject|0|||
125581179|NCT00666926|451755400|FG003|Overall Study|Withdrawal by Subject|0|||
125581180|NCT00666926|451755401|FG004|Overall Study|Withdrawal by Subject|0|||
125581181|NCT00666926|451755402|FG005|Overall Study|Withdrawal by Subject|0|||
125581182|NCT00666926|451755403|FG006|Overall Study|Withdrawal by Subject|0|||
125581183|NCT00666926|451755404|FG007|Overall Study|Withdrawal by Subject|1|||
125581184|NCT00666926|451755405|FG008|Overall Study|Withdrawal by Subject|0|||
125581185|NCT00666926|451755406|FG009|Overall Study|Withdrawal by Subject|3|||
125581186|NCT00666926|451755407|FG010|Overall Study|Withdrawal by Subject|0|||
125581187|NCT00666926|451755408|FG011|Overall Study|Withdrawal by Subject|3|||
125581188|NCT00666926|451755409|FG012|Overall Study|Withdrawal by Subject|0|||
125581189|NCT00666926|451755410|FG013|Overall Study|Withdrawal by Subject|1|||
125581190|NCT00666926|451755411|FG014|Overall Study|Withdrawal by Subject|3|||
125581191|NCT00666926|451755412|FG015|Overall Study|Withdrawal by Subject|3|||
125581192|NCT00666926|451755397|FG000|Overall Study|Death|0|||
125581193|NCT00666926|451755398|FG001|Overall Study|Death|0|||
125581194|NCT00666926|451755399|FG002|Overall Study|Death|0|||
125581195|NCT00666926|451755400|FG003|Overall Study|Death|0|||
125581196|NCT00666926|451755401|FG004|Overall Study|Death|0|||
125581197|NCT00666926|451755402|FG005|Overall Study|Death|0|||
125581198|NCT00666926|451755403|FG006|Overall Study|Death|0|||
125581199|NCT00666926|451755404|FG007|Overall Study|Death|0|||
125581200|NCT00666926|451755405|FG008|Overall Study|Death|0|||
125581201|NCT00666926|451755406|FG009|Overall Study|Death|0|||
125581202|NCT00666926|451755407|FG010|Overall Study|Death|0|||
125581203|NCT00666926|451755408|FG011|Overall Study|Death|1|||
125581204|NCT00666926|451755409|FG012|Overall Study|Death|0|||
125581205|NCT00666926|451755410|FG013|Overall Study|Death|0|||
125581206|NCT00666926|451755411|FG014|Overall Study|Death|0|||
125581207|NCT00666926|451755412|FG015|Overall Study|Death|0|||
125581208|NCT01727258|451755413|FG000|Overall Study|Adverse Event|0|||
125581209|NCT01727258|451755414|FG001|Overall Study|Adverse Event|2|||
125581210|NCT01727258|451755415|FG002|Overall Study|Adverse Event|0|||
125581211|NCT01727258|451755413|FG000|Overall Study|Noncompliance with Study Drug|0|||
125581212|NCT01727258|451755414|FG001|Overall Study|Noncompliance with Study Drug|0|||
125581213|NCT01727258|451755415|FG002|Overall Study|Noncompliance with Study Drug|1|||
125581214|NCT01727258|451755413|FG000|Overall Study|Withdrawal by Subject|1|||
125581215|NCT01727258|451755414|FG001|Overall Study|Withdrawal by Subject|1|||
125581216|NCT01727258|451755415|FG002|Overall Study|Withdrawal by Subject|0|||
125581217|NCT01727258|451755413|FG000|Overall Study|Lost to Follow-up|1|||
125581218|NCT01727258|451755414|FG001|Overall Study|Lost to Follow-up|0|||
125581219|NCT01727258|451755415|FG002|Overall Study|Lost to Follow-up|0|||
125581220|NCT02471716|451755420|FG000|Overall Study|Withdrawal by Subject|0|||
125581221|NCT02471716|451755421|FG001|Overall Study|Withdrawal by Subject|1|||
125581222|NCT02471716|451755422|FG002|Overall Study|Withdrawal by Subject|0|||
125581223|NCT02471716|451755423|FG003|Overall Study|Withdrawal by Subject|2|||
125581224|NCT02471716|451755424|FG004|Overall Study|Withdrawal by Subject|5|||
125581225|NCT02471716|451755420|FG000|Overall Study|Study Terminiated by sponsor|0|||
125581226|NCT02471716|451755421|FG001|Overall Study|Study Terminiated by sponsor|0|||
125581227|NCT02471716|451755422|FG002|Overall Study|Study Terminiated by sponsor|0|||
125581228|NCT02471716|451755423|FG003|Overall Study|Study Terminiated by sponsor|1|||
125581229|NCT02471716|451755424|FG004|Overall Study|Study Terminiated by sponsor|0|||
125581230|NCT02471716|451755420|FG000|Overall Study|Lost to Follow-up|0|||
125581231|NCT02471716|451755421|FG001|Overall Study|Lost to Follow-up|0|||
125581232|NCT02471716|451755422|FG002|Overall Study|Lost to Follow-up|0|||
125581233|NCT02471716|451755423|FG003|Overall Study|Lost to Follow-up|3|||
125581234|NCT02471716|451755424|FG004|Overall Study|Lost to Follow-up|2|||
125360883|NCT01708161|450955860|FG000|Overall Study|Adverse Event|1|||
125360884|NCT01708161|450955861|FG001|Overall Study|Adverse Event|3|||
125360885|NCT01708161|450955862|FG002|Overall Study|Adverse Event|4|||
125360886|NCT01708161|450955863|FG003|Overall Study|Adverse Event|2|||
125360887|NCT01708161|450955864|FG004|Overall Study|Adverse Event|3|||
125360888|NCT01708161|450955865|FG005|Overall Study|Adverse Event|0|||
125360889|NCT01708161|450955860|FG000|Overall Study|Death|0|||
125360890|NCT01708161|450955861|FG001|Overall Study|Death|0|||
125360891|NCT01708161|450955862|FG002|Overall Study|Death|0|||
125360892|NCT01708161|450955863|FG003|Overall Study|Death|1|||
125360893|NCT01708161|450955864|FG004|Overall Study|Death|0|||
125360894|NCT01708161|450955865|FG005|Overall Study|Death|1|||
125360895|NCT01708161|450955860|FG000|Overall Study|Withdrawal by Subject|0|||
125360896|NCT01708161|450955861|FG001|Overall Study|Withdrawal by Subject|1|||
125360897|NCT01708161|450955862|FG002|Overall Study|Withdrawal by Subject|1|||
125360898|NCT01708161|450955863|FG003|Overall Study|Withdrawal by Subject|0|||
125360899|NCT01708161|450955864|FG004|Overall Study|Withdrawal by Subject|0|||
125360900|NCT01708161|450955865|FG005|Overall Study|Withdrawal by Subject|0|||
125360901|NCT01708161|450955860|FG000|Overall Study|Administrative problems|0|||
125360902|NCT01708161|450955861|FG001|Overall Study|Administrative problems|1|||
125360903|NCT01708161|450955862|FG002|Overall Study|Administrative problems|0|||
125360904|NCT01708161|450955863|FG003|Overall Study|Administrative problems|0|||
125360905|NCT01708161|450955864|FG004|Overall Study|Administrative problems|0|||
125360906|NCT01708161|450955865|FG005|Overall Study|Administrative problems|0|||
125360907|NCT01708161|450955860|FG000|Overall Study|Disease progression|3|||
125360908|NCT01708161|450955861|FG001|Overall Study|Disease progression|5|||
125360909|NCT01708161|450955862|FG002|Overall Study|Disease progression|5|||
125360910|NCT01708161|450955863|FG003|Overall Study|Disease progression|13|||
125360911|NCT01708161|450955864|FG004|Overall Study|Disease progression|3|||
125360912|NCT01708161|450955865|FG005|Overall Study|Disease progression|0|||
125360913|NCT02019277|450955866|FG000|Overall Study|Withdrawal by Subject|3|||
125360914|NCT02019277|450955866|FG000|Overall Study|Death|7|||
125360915|NCT02019277|450955866|FG000|Overall Study|Did no Cooperate|1|||
125360916|NCT02019277|450955866|FG000|Overall Study|Adverse Event|1|||
125360917|NCT02633501|450955868|FG000|Overall Study|Adverse Event|0|||
125360918|NCT02633501|450955869|FG001|Overall Study|Adverse Event|0|||
125360919|NCT02633501|450955870|FG002|Overall Study|Adverse Event|1|||
125360920|NCT02633501|450955871|FG003|Overall Study|Adverse Event|0|||
125360921|NCT02633501|450955872|FG004|Overall Study|Adverse Event|1|||
125360922|NCT02633501|450955873|FG005|Overall Study|Adverse Event|1|||
125360923|NCT02633501|450955868|FG000|Overall Study|Withdrawal by Subject|2|||
125360924|NCT02633501|450955869|FG001|Overall Study|Withdrawal by Subject|1|||
125360925|NCT02633501|450955870|FG002|Overall Study|Withdrawal by Subject|2|||
125211798|NCT02007278|450401372|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
125211799|NCT02007278|450401373|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
125360926|NCT02633501|450955871|FG003|Overall Study|Withdrawal by Subject|2|||
125360927|NCT02633501|450955872|FG004|Overall Study|Withdrawal by Subject|1|||
125360928|NCT02633501|450955873|FG005|Overall Study|Withdrawal by Subject|3|||
125360929|NCT02633501|450955868|FG000|Overall Study|Various other reasons|0|||
125581235|NCT02471716|451755420|FG000|Overall Study|Death|0|||
125581236|NCT02471716|451755421|FG001|Overall Study|Death|0|||
125360930|NCT02633501|450955869|FG001|Overall Study|Various other reasons|2|||
125360931|NCT02633501|450955870|FG002|Overall Study|Various other reasons|4|||
125360932|NCT02633501|450955871|FG003|Overall Study|Various other reasons|1|||
125360933|NCT02633501|450955872|FG004|Overall Study|Various other reasons|7|||
125360934|NCT02633501|450955873|FG005|Overall Study|Various other reasons|11|||
125360935|NCT02633501|450955868|FG000|Overall Study|Lost to Follow-up|0|||
125360936|NCT02633501|450955869|FG001|Overall Study|Lost to Follow-up|0|||
125360937|NCT02633501|450955870|FG002|Overall Study|Lost to Follow-up|0|||
125360938|NCT02633501|450955871|FG003|Overall Study|Lost to Follow-up|1|||
125360939|NCT02633501|450955872|FG004|Overall Study|Lost to Follow-up|2|||
125360940|NCT02633501|450955873|FG005|Overall Study|Lost to Follow-up|0|||
125360941|NCT00395733|450955874|FG000|Period 2|Withdrawal by Subject|1|||
125360942|NCT00395733|450955875|FG001|Period 2|Withdrawal by Subject|2|||
125360943|NCT00395733|450955874|FG000|Period 2|Protocol Violation|0|||
125360944|NCT00395733|450955875|FG001|Period 2|Protocol Violation|1|||
125360945|NCT00395733|450955874|FG000|Period 2|Adverse Event|0|||
125360946|NCT00395733|450955875|FG001|Period 2|Adverse Event|2|||
125360947|NCT00395733|450955874|FG000|Period 2|Technical problems|1|||
125360948|NCT00395733|450955875|FG001|Period 2|Technical problems|0|||
125360949|NCT01672736|450955877|FG000|Overall Study|Available drug expired on 31 May 16|3|||
125360950|NCT02853344|450955882|FG000|Overall Study|Lost to Follow-up|1|||
125360951|NCT02853344|450955883|FG001|Overall Study|Lost to Follow-up|1|||
125360952|NCT02853344|450955882|FG000|Overall Study|Withdrawal by Subject|2|||
125360953|NCT02853344|450955883|FG001|Overall Study|Withdrawal by Subject|4|||
125360954|NCT02853344|450955882|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
125360955|NCT02853344|450955883|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
125360956|NCT02853344|450955882|FG000|Overall Study|Death|70|||
125360957|NCT02853344|450955883|FG001|Overall Study|Death|112|||
125360958|NCT02913612|450955884|FG000|Overall Study|Lost to Follow-up|6|||
125360959|NCT02913612|450955885|FG001|Overall Study|Lost to Follow-up|5|||
125360960|NCT02913612|450955886|FG002|Overall Study|Lost to Follow-up|2|||
125581237|NCT02471716|451755422|FG002|Overall Study|Death|0|||
125581238|NCT02471716|451755423|FG003|Overall Study|Death|1|||
125581239|NCT02471716|451755424|FG004|Overall Study|Death|0|||
125581240|NCT02471716|451755420|FG000|Overall Study|Other|0|||
125581241|NCT02471716|451755421|FG001|Overall Study|Other|0|||
125581242|NCT02471716|451755422|FG002|Overall Study|Other|0|||
125581243|NCT02471716|451755423|FG003|Overall Study|Other|8|||
125581244|NCT02471716|451755424|FG004|Overall Study|Other|9|||
125581245|NCT03604445|451755425|FG000|Overall Study|Death|0|||
125581246|NCT03604445|451755426|FG001|Overall Study|Death|0|||
125581247|NCT03604445|451755427|FG002|Overall Study|Death|0|||
125581248|NCT03604445|451755428|FG003|Overall Study|Death|0|||
125581249|NCT03604445|451755429|FG004|Overall Study|Death|0|||
125581250|NCT03604445|451755430|FG005|Overall Study|Death|0|||
125581251|NCT03604445|451755431|FG006|Overall Study|Death|0|||
125581252|NCT03604445|451755432|FG007|Overall Study|Death|0|||
125581253|NCT03604445|451755433|FG008|Overall Study|Death|1|||
125581254|NCT03604445|451755425|FG000|Overall Study|Withdrawal by Subject|0|||
125581255|NCT03604445|451755426|FG001|Overall Study|Withdrawal by Subject|0|||
125581256|NCT03604445|451755427|FG002|Overall Study|Withdrawal by Subject|0|||
125581257|NCT03604445|451755428|FG003|Overall Study|Withdrawal by Subject|0|||
125581258|NCT03604445|451755429|FG004|Overall Study|Withdrawal by Subject|0|||
125581259|NCT03604445|451755430|FG005|Overall Study|Withdrawal by Subject|0|||
125581260|NCT03604445|451755431|FG006|Overall Study|Withdrawal by Subject|1|||
125581261|NCT03604445|451755432|FG007|Overall Study|Withdrawal by Subject|0|||
125581262|NCT03604445|451755433|FG008|Overall Study|Withdrawal by Subject|0|||
125581263|NCT03604445|451755425|FG000|Overall Study|Missing visit|0|||
125581264|NCT03604445|451755426|FG001|Overall Study|Missing visit|0|||
125581265|NCT03604445|451755427|FG002|Overall Study|Missing visit|0|||
125581266|NCT03604445|451755428|FG003|Overall Study|Missing visit|0|||
125581267|NCT03604445|451755429|FG004|Overall Study|Missing visit|0|||
125581268|NCT03604445|451755430|FG005|Overall Study|Missing visit|1|||
125581269|NCT03604445|451755431|FG006|Overall Study|Missing visit|0|||
125581270|NCT03604445|451755432|FG007|Overall Study|Missing visit|1|||
125581271|NCT03604445|451755433|FG008|Overall Study|Missing visit|0|||
125581272|NCT03604445|451755425|FG000|Overall Study|Adverse Event|0|||
125581273|NCT03604445|451755426|FG001|Overall Study|Adverse Event|0|||
125581274|NCT03604445|451755427|FG002|Overall Study|Adverse Event|0|||
125581275|NCT03604445|451755428|FG003|Overall Study|Adverse Event|1|||
125581276|NCT03604445|451755429|FG004|Overall Study|Adverse Event|0|||
125581277|NCT03604445|451755430|FG005|Overall Study|Adverse Event|0|||
125581278|NCT03604445|451755431|FG006|Overall Study|Adverse Event|0|||
125581279|NCT03604445|451755432|FG007|Overall Study|Adverse Event|0|||
125581280|NCT03604445|451755433|FG008|Overall Study|Adverse Event|1|||
125581281|NCT00130286|451755436|FG000|Overall Study|Withdrawal by Subject|0|||
125581282|NCT00130286|451755437|FG001|Overall Study|Withdrawal by Subject|1|||
125581283|NCT00130286|451755438|FG002|Overall Study|Withdrawal by Subject|2|||
125581284|NCT00130286|451755439|FG003|Overall Study|Withdrawal by Subject|2|||
125581285|NCT00130286|451755436|FG000|Overall Study|Adverse Event|0|||
125581286|NCT00130286|451755437|FG001|Overall Study|Adverse Event|0|||
125581287|NCT00130286|451755438|FG002|Overall Study|Adverse Event|2|||
125581288|NCT00130286|451755439|FG003|Overall Study|Adverse Event|0|||
125581289|NCT00130286|451755436|FG000|Overall Study|Missing lab specimens|0|||
125360961|NCT02913612|450955887|FG003|Overall Study|Lost to Follow-up|0|||
125360962|NCT02913612|450955884|FG000|Overall Study|Physician Decision|1|||
125360963|NCT02913612|450955885|FG001|Overall Study|Physician Decision|4|||
125360964|NCT02913612|450955886|FG002|Overall Study|Physician Decision|1|||
125360965|NCT02913612|450955887|FG003|Overall Study|Physician Decision|0|||
125360966|NCT02913612|450955884|FG000|Overall Study|Withdrawal by Subject|2|||
125360967|NCT02913612|450955885|FG001|Overall Study|Withdrawal by Subject|4|||
125360968|NCT02913612|450955886|FG002|Overall Study|Withdrawal by Subject|0|||
125360969|NCT02913612|450955887|FG003|Overall Study|Withdrawal by Subject|0|||
125360970|NCT02913612|450955884|FG000|Overall Study|Hemangioma resolved|1|||
125360971|NCT02913612|450955885|FG001|Overall Study|Hemangioma resolved|0|||
125360972|NCT02913612|450955886|FG002|Overall Study|Hemangioma resolved|0|||
125360973|NCT02913612|450955887|FG003|Overall Study|Hemangioma resolved|0|||
125360974|NCT02913612|450955884|FG000|Overall Study|Local IRB decision|1|||
125360975|NCT02913612|450955885|FG001|Overall Study|Local IRB decision|0|||
125428306|NCT00521144|451193852|FG002|Overall Study|Progressive Disease|2|||
125428307|NCT00521144|451193853|FG003|Overall Study|Progressive Disease|0|||
125581290|NCT00130286|451755437|FG001|Overall Study|Missing lab specimens|2|||
125581291|NCT00130286|451755438|FG002|Overall Study|Missing lab specimens|0|||
125581292|NCT00130286|451755439|FG003|Overall Study|Missing lab specimens|0|||
125581293|NCT01360645|451755444|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
125581294|NCT01360645|451755445|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
125581295|NCT01360645|451755446|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
125581296|NCT01360645|451755447|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
125581297|NCT01360645|451755444|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
125581298|NCT01360645|451755445|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
125581299|NCT01360645|451755446|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
125581300|NCT01360645|451755447|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
125581301|NCT01360645|451755444|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
125581302|NCT01360645|451755445|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
125581303|NCT01360645|451755446|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
125581304|NCT01360645|451755447|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
125581305|NCT01360645|451755444|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
125581306|NCT01360645|451755445|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
125581307|NCT01360645|451755446|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
125581308|NCT01360645|451755447|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
125581309|NCT01360645|451755444|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
125581310|NCT01360645|451755445|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
125581311|NCT01360645|451755446|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
125581312|NCT01360645|451755447|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
125581313|NCT01360645|451755444|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
125581314|NCT01360645|451755445|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
125581315|NCT01360645|451755446|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
125581316|NCT01360645|451755447|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
125581317|NCT01360645|451755444|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
125581318|NCT01360645|451755445|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
125581319|NCT01360645|451755446|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
125581320|NCT01360645|451755447|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
125581321|NCT01360645|451755444|FG000|Phase B (6 Weeks)|Adverse Event|0|||
125581322|NCT01360645|451755445|FG001|Phase B (6 Weeks)|Adverse Event|6|||
125581323|NCT01360645|451755446|FG002|Phase B (6 Weeks)|Adverse Event|0|||
125581324|NCT01360645|451755447|FG003|Phase B (6 Weeks)|Adverse Event|0|||
125581325|NCT01360645|451755444|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
125581326|NCT01360645|451755445|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
125581327|NCT01360645|451755446|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
125581328|NCT01360645|451755447|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
125581329|NCT01360645|451755444|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
125581330|NCT01360645|451755445|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
125581331|NCT01360645|451755446|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
125581332|NCT01360645|451755447|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
125581333|NCT01360645|451755444|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
125581334|NCT01360645|451755445|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
125581335|NCT01360645|451755446|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
125581336|NCT01360645|451755447|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
125581337|NCT01360645|451755444|FG000|Phase A+|Lost to Follow-up|0|||
125581338|NCT01360645|451755445|FG001|Phase A+|Lost to Follow-up|0|||
125581339|NCT01360645|451755446|FG002|Phase A+|Lost to Follow-up|0|||
125581340|NCT01360645|451755447|FG003|Phase A+|Lost to Follow-up|7|||
125581341|NCT01360645|451755444|FG000|Phase A+|Adverse Event|0|||
125581342|NCT01360645|451755445|FG001|Phase A+|Adverse Event|0|||
125581343|NCT01360645|451755446|FG002|Phase A+|Adverse Event|0|||
125581344|NCT01360645|451755447|FG003|Phase A+|Adverse Event|2|||
125581345|NCT01360645|451755444|FG000|Phase A+|Met Withdrawal Criteria|0|||
125581346|NCT01360645|451755445|FG001|Phase A+|Met Withdrawal Criteria|0|||
125581347|NCT01360645|451755446|FG002|Phase A+|Met Withdrawal Criteria|0|||
125581348|NCT01360645|451755447|FG003|Phase A+|Met Withdrawal Criteria|4|||
125581349|NCT01360645|451755444|FG000|Phase A+|Physician Decision|0|||
125581350|NCT01360645|451755445|FG001|Phase A+|Physician Decision|0|||
125360976|NCT02913612|450955886|FG002|Overall Study|Local IRB decision|0|||
125581351|NCT01360645|451755446|FG002|Phase A+|Physician Decision|0|||
125360977|NCT02913612|450955887|FG003|Overall Study|Local IRB decision|0|||
125581352|NCT01360645|451755447|FG003|Phase A+|Physician Decision|2|||
125581353|NCT01360645|451755444|FG000|Phase A+|Withdrawal by Subject|0|||
125581354|NCT01360645|451755445|FG001|Phase A+|Withdrawal by Subject|0|||
125581355|NCT01360645|451755446|FG002|Phase A+|Withdrawal by Subject|0|||
125581356|NCT01360645|451755447|FG003|Phase A+|Withdrawal by Subject|5|||
125581357|NCT01360645|451755444|FG000|Phase A+|Protocol Deviation|0|||
125581358|NCT01360645|451755445|FG001|Phase A+|Protocol Deviation|0|||
125581359|NCT01360645|451755446|FG002|Phase A+|Protocol Deviation|0|||
125581360|NCT01360645|451755447|FG003|Phase A+|Protocol Deviation|4|||
125581361|NCT01014585|451755448|FG000|Overall Study|Adverse Event|0|||
125581362|NCT01014585|451755449|FG001|Overall Study|Adverse Event|2|||
125581363|NCT01014585|451755450|FG002|Overall Study|Adverse Event|0|||
125581364|NCT01014585|451755451|FG003|Overall Study|Adverse Event|3|||
125581365|NCT01014585|451755448|FG000|Overall Study|Withdrawal by Subject|2|||
125581366|NCT01014585|451755449|FG001|Overall Study|Withdrawal by Subject|0|||
125581367|NCT01014585|451755450|FG002|Overall Study|Withdrawal by Subject|1|||
125581368|NCT01014585|451755451|FG003|Overall Study|Withdrawal by Subject|3|||
125581369|NCT01014585|451755448|FG000|Overall Study|Lost to Follow-up|0|||
125581370|NCT01014585|451755449|FG001|Overall Study|Lost to Follow-up|0|||
125581371|NCT01014585|451755450|FG002|Overall Study|Lost to Follow-up|0|||
125581372|NCT01014585|451755451|FG003|Overall Study|Lost to Follow-up|2|||
125581373|NCT01014585|451755448|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
125581374|NCT01014585|451755449|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
125581375|NCT01014585|451755450|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
125581376|NCT01014585|451755451|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
125581377|NCT04178772|451755460|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
125581378|NCT04178772|451755460|FG000|Overall Study|study terminated early due to COVID-19|7|||
125581379|NCT00773279|451755464|FG000|Period 1|Adverse Event|2|||
125581380|NCT00773279|451755465|FG001|Period 1|Adverse Event|1|||
125581381|NCT00773279|451755464|FG000|Period 1|Lack of Efficacy|0|||
125581382|NCT00773279|451755465|FG001|Period 1|Lack of Efficacy|2|||
125581383|NCT00773279|451755464|FG000|Period 1|Unclassified|5|||
125581384|NCT00773279|451755465|FG001|Period 1|Unclassified|1|||
125581385|NCT00773279|451755464|FG000|Period 2|Adverse Event|0|||
125581386|NCT00773279|451755465|FG001|Period 2|Adverse Event|1|||
125581387|NCT00773279|451755464|FG000|Period 2|Lack of Efficacy|1|||
125581388|NCT00773279|451755465|FG001|Period 2|Lack of Efficacy|0|||
125581389|NCT00773279|451755464|FG000|Period 2|Protocol Violation|0|||
125581390|NCT00773279|451755465|FG001|Period 2|Protocol Violation|3|||
125581391|NCT00773279|451755464|FG000|Period 2|Unclassified|2|||
125581392|NCT00773279|451755465|FG001|Period 2|Unclassified|2|||
125581393|NCT02817087|451755466|FG000|Overall Study|Withdrawal by Subject|2|||
125581394|NCT02817087|451755467|FG001|Overall Study|Withdrawal by Subject|0|||
125581395|NCT00508391|451755468|FG000|First Treatment|Withdrawal by Subject|6|||
125581396|NCT00508391|451755469|FG001|First Treatment|Withdrawal by Subject|3|||
125581397|NCT00508391|451755468|FG000|Second Treatment|Withdrawal by Subject|2|||
125581398|NCT00508391|451755469|FG001|Second Treatment|Withdrawal by Subject|0|||
125581399|NCT00802360|451755470|FG000|Overall Study|Stimulation failure|4|||
125581400|NCT00802360|451755471|FG001|Overall Study|Stimulation failure|0|||
125581401|NCT00802360|451755472|FG002|Overall Study|Stimulation failure|3|||
125581402|NCT00802360|451755473|FG003|Overall Study|Stimulation failure|3|||
125581403|NCT00802360|451755470|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
125581404|NCT00802360|451755471|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
125581405|NCT00802360|451755472|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
125581406|NCT00802360|451755473|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
125581407|NCT00802360|451755470|FG000|Overall Study|Cycle cancelled|0|||
125581408|NCT00802360|451755471|FG001|Overall Study|Cycle cancelled|1|||
125581409|NCT00802360|451755472|FG002|Overall Study|Cycle cancelled|1|||
125581410|NCT00802360|451755473|FG003|Overall Study|Cycle cancelled|1|||
125581411|NCT00802360|451755470|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
125581412|NCT00802360|451755471|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
125360978|NCT02913612|450955884|FG000|Overall Study|Study drug non-compliance|1|||
125360979|NCT02913612|450955885|FG001|Overall Study|Study drug non-compliance|1|||
125360980|NCT02913612|450955886|FG002|Overall Study|Study drug non-compliance|0|||
125581413|NCT00802360|451755472|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
125581414|NCT00802360|451755473|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
125581415|NCT00802360|451755470|FG000|Overall Study|No positive serum pregnancy|17|||
125581416|NCT00802360|451755471|FG001|Overall Study|No positive serum pregnancy|20|||
125581417|NCT00802360|451755472|FG002|Overall Study|No positive serum pregnancy|14|||
125360981|NCT02913612|450955887|FG003|Overall Study|Study drug non-compliance|0|||
125360982|NCT02913612|450955884|FG000|Overall Study|Insurance issues|0|||
125581418|NCT00802360|451755473|FG003|Overall Study|No positive serum pregnancy|10|||
125581419|NCT00802360|451755470|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
125581420|NCT00802360|451755471|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
125581421|NCT00802360|451755472|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
125581422|NCT00802360|451755473|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
125581423|NCT00802360|451755470|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
125581424|NCT00802360|451755471|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
125581425|NCT00802360|451755472|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
125581426|NCT00802360|451755473|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
125581427|NCT00802360|451755470|FG000|Overall Study|Other|2|||
125581428|NCT00802360|451755471|FG001|Overall Study|Other|3|||
125581429|NCT00802360|451755472|FG002|Overall Study|Other|6|||
125581430|NCT00802360|451755473|FG003|Overall Study|Other|3|||
125581431|NCT02041962|451755474|FG000|Overall Study|Lost Aetna Coverage|43|||
125581432|NCT02041962|451755475|FG001|Overall Study|Lost Aetna Coverage|40|||
125581433|NCT02041962|451755474|FG000|Overall Study|Death|1|||
125581434|NCT02041962|451755475|FG001|Overall Study|Death|1|||
125581435|NCT02041962|451755474|FG000|Overall Study|Lost to Follow-up|37|||
125581436|NCT02041962|451755475|FG001|Overall Study|Lost to Follow-up|32|||
125581437|NCT02041962|451755474|FG000|Overall Study|Withdrawal by Subject|0|||
125581438|NCT02041962|451755475|FG001|Overall Study|Withdrawal by Subject|11|||
125581439|NCT01225562|451755476|FG000|Overall Study|Withdrawal by Subject|52|||
125581440|NCT01225562|451755477|FG001|Overall Study|Withdrawal by Subject|50|||
125581441|NCT01225562|451755478|FG002|Overall Study|Withdrawal by Subject|52|||
125581442|NCT01225562|451755476|FG000|Overall Study|Lost to Follow-up|3|||
125581443|NCT01225562|451755477|FG001|Overall Study|Lost to Follow-up|6|||
125581444|NCT01225562|451755478|FG002|Overall Study|Lost to Follow-up|1|||
125581445|NCT01481896|451755481|FG000|Overall Study|Lost to Follow-up|12|||
125581446|NCT01818726|451755482|FG000|Overall Study|Administrative reasons|5|||
125581447|NCT01818726|451755483|FG001|Overall Study|Administrative reasons|1|||
125581448|NCT01818726|451755482|FG000|Overall Study|Withdrawal by Subject|0|||
125581449|NCT01818726|451755483|FG001|Overall Study|Withdrawal by Subject|1|||
125581450|NCT01818726|451755482|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
125581451|NCT01818726|451755483|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
125581452|NCT03336502|451755484|FG000|Overall Study|Physician Decision|0|||
125581453|NCT03336502|451755485|FG001|Overall Study|Physician Decision|1|||
125581454|NCT03336502|451755484|FG000|Overall Study|Prohibited Drugs|1|||
125581455|NCT03336502|451755485|FG001|Overall Study|Prohibited Drugs|1|||
125581456|NCT03336502|451755484|FG000|Overall Study|Death|1|||
125581457|NCT03336502|451755485|FG001|Overall Study|Death|2|||
125581458|NCT03336502|451755484|FG000|Overall Study|Adverse Event|2|||
125581459|NCT03336502|451755485|FG001|Overall Study|Adverse Event|5|||
125581460|NCT00611247|451755487|FG000|Overall Study|Death|1|||
125581461|NCT00611247|451755488|FG001|Overall Study|Death|5|||
125581462|NCT00611247|451755487|FG000|Overall Study|Lack of Efficacy|1|||
125581463|NCT00611247|451755488|FG001|Overall Study|Lack of Efficacy|16|||
125581464|NCT00565617|451755489|FG000|Overall Study|Withdrawal by Subject|1|||
125581465|NCT01446419|451755493|FG000|Overall Study|Death|1|||
125581466|NCT01446419|451755494|FG001|Overall Study|Death|0|||
125581467|NCT01446419|451755493|FG000|Overall Study|Withdrawal by Subject|1|||
125581468|NCT01446419|451755494|FG001|Overall Study|Withdrawal by Subject|1|||
125581469|NCT01446419|451755493|FG000|Overall Study|Terminated per protocol|3|||
125581470|NCT01446419|451755494|FG001|Overall Study|Terminated per protocol|0|||
125581471|NCT00464178|451755495|FG000|Overall Study|Protocol Violation|1|||
125581472|NCT00464178|451755495|FG000|Overall Study|Withdrawal by Subject|1|||
125581473|NCT01557166|451755500|FG000|Overall Study|Adverse Event|20|||
125581474|NCT01557166|451755501|FG001|Overall Study|Adverse Event|6|||
125581475|NCT01557166|451755500|FG000|Overall Study|Lack of Efficacy|2|||
125581476|NCT01557166|451755501|FG001|Overall Study|Lack of Efficacy|1|||
125581477|NCT01557166|451755500|FG000|Overall Study|Protocol Violation|8|||
125581478|NCT01557166|451755501|FG001|Overall Study|Protocol Violation|5|||
125581479|NCT01557166|451755500|FG000|Overall Study|Withdrawn consent|12|||
125581480|NCT01557166|451755501|FG001|Overall Study|Withdrawn consent|20|||
125581481|NCT01557166|451755500|FG000|Overall Study|Target dose not tolerated|1|||
125581482|NCT01557166|451755501|FG001|Overall Study|Target dose not tolerated|0|||
125581483|NCT01557166|451755500|FG000|Overall Study|Psychiatric disorder|1|||
125581484|NCT01557166|451755501|FG001|Overall Study|Psychiatric disorder|0|||
125581485|NCT01557166|451755500|FG000|Overall Study|Unclassified|2|||
125581486|NCT01557166|451755501|FG001|Overall Study|Unclassified|5|||
125581487|NCT01465659|451755505|FG000|Completed 1 Cycle of Treatment|Death|0|||
125581488|NCT01465659|451755506|FG001|Completed 1 Cycle of Treatment|Death|1|||
125581489|NCT01465659|451755507|FG002|Completed 1 Cycle of Treatment|Death|0|||
125581490|NCT01465659|451755508|FG003|Completed 1 Cycle of Treatment|Death|0|||
125581491|NCT01465659|451755505|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
125581492|NCT01465659|451755506|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
125581493|NCT01465659|451755507|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
125581494|NCT01465659|451755508|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
125581495|NCT01465659|451755505|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
125581496|NCT01465659|451755506|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
125581497|NCT01465659|451755507|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
125581498|NCT01465659|451755508|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
125581499|NCT01465659|451755505|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
125360983|NCT02913612|450955885|FG001|Overall Study|Insurance issues|1|||
125360984|NCT02913612|450955886|FG002|Overall Study|Insurance issues|0|||
125360985|NCT02913612|450955887|FG003|Overall Study|Insurance issues|0|||
125360986|NCT02913612|450955884|FG000|Overall Study|Needed to treat second hemangioma|0|||
125581500|NCT01465659|451755506|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
125581501|NCT01465659|451755507|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
125581502|NCT01465659|451755508|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
125581503|NCT01465659|451755505|FG000|Completed Follow for 1 Year|Death|6|||
125581504|NCT01465659|451755506|FG001|Completed Follow for 1 Year|Death|3|||
125581505|NCT01465659|451755507|FG002|Completed Follow for 1 Year|Death|2|||
125581506|NCT01465659|451755508|FG003|Completed Follow for 1 Year|Death|4|||
125581507|NCT02445586|451755510|FG000|Overall Study|Death|14|||
125581508|NCT02445586|451755510|FG000|Overall Study|Withdrawal by Subject|13|||
125360987|NCT02913612|450955885|FG001|Overall Study|Needed to treat second hemangioma|1|||
125360988|NCT02913612|450955886|FG002|Overall Study|Needed to treat second hemangioma|0|||
125428308|NCT00521144|451193854|FG004|Overall Study|Progressive Disease|6|||
125581509|NCT02445586|451755510|FG000|Overall Study|Disease Progression|10|||
125581510|NCT02445586|451755510|FG000|Overall Study|Protocol Violation|1|||
125581511|NCT02445586|451755510|FG000|Overall Study|Medical Condition|1|||
125581512|NCT01469000|451755511|FG000|Overall Study|Withdrawal by Subject|16|||
125581513|NCT01469000|451755512|FG001|Overall Study|Withdrawal by Subject|3|||
125581514|NCT01469000|451755511|FG000|Overall Study|Sponsor Decision|4|||
125581515|NCT01469000|451755512|FG001|Overall Study|Sponsor Decision|1|||
125581516|NCT01990261|451755519|FG000|Overall Study|Death Before Treatment Start|2|||
125581517|NCT01990261|451755519|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
125581518|NCT01990261|451755519|FG000|Overall Study|Death From other Causes|1|||
125581519|NCT01990261|451755519|FG000|Overall Study|Disease Progression (PD)|8|||
125581520|NCT01990261|451755519|FG000|Overall Study|PD Before Treatment Start|1|||
125581521|NCT01990261|451755519|FG000|Overall Study|Dossier not Approved|1|||
125581522|NCT01990261|451755519|FG000|Overall Study|Lost to Follow-up|2|||
125581523|NCT01445678|451755528|FG000|Overall Study|Adverse Event|12|||
125581524|NCT01445678|451755529|FG001|Overall Study|Adverse Event|8|||
125581525|NCT01445678|451755528|FG000|Overall Study|Lack of Efficacy|0|||
125581526|NCT01445678|451755529|FG001|Overall Study|Lack of Efficacy|2|||
125581527|NCT01445678|451755528|FG000|Overall Study|Lost to Follow-up|8|||
125581528|NCT01445678|451755529|FG001|Overall Study|Lost to Follow-up|5|||
125581529|NCT01445678|451755528|FG000|Overall Study|Protocol Violation|1|||
125581530|NCT01445678|451755529|FG001|Overall Study|Protocol Violation|1|||
125581531|NCT01445678|451755528|FG000|Overall Study|Withdrawal by Subject|9|||
125581532|NCT01445678|451755529|FG001|Overall Study|Withdrawal by Subject|5|||
125581533|NCT02307370|451755530|FG000|Overall Study|Death|5|||
125581534|NCT02307370|451755530|FG000|Overall Study|Lost to Follow-up|1|||
125581535|NCT02307370|451755530|FG000|Overall Study|Withdrawal by Subject|1|||
125581536|NCT02307370|451755530|FG000|Overall Study|Declined Addendum ICF|6|||
125581537|NCT02307370|451755530|FG000|Overall Study|No response during telephone contact|5|||
125581538|NCT02307370|451755530|FG000|Overall Study|Protocol Violation|1|||
125581539|NCT03344003|451755531|FG000|Overall Study|Switched to alternative treatment|1|||
125581540|NCT03344003|451755532|FG001|Overall Study|Switched to alternative treatment|0|||
125581541|NCT03344003|451755531|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
125581542|NCT03344003|451755532|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
125581543|NCT03631706|451755533|FG000|Overall Study|Randomized, not treated|1|||
125581544|NCT03631706|451755534|FG001|Overall Study|Randomized, not treated|0|||
125581545|NCT06272370|451758518|FG000|Overall Study|Lost to Follow-up|0|||
125581546|NCT06272370|451758519|FG001|Overall Study|Lost to Follow-up|3|||
125581547|NCT06272370|451758520|FG002|Overall Study|Lost to Follow-up|1|||
125581548|NCT06272370|451758521|FG003|Overall Study|Lost to Follow-up|1|||
125581549|NCT00544869|451758523|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
125581550|NCT00544869|451758524|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
125581551|NCT00544869|451758525|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
125581552|NCT00544869|451758523|FG000|Overall Study|Adverse Event|6|||
125581553|NCT00544869|451758524|FG001|Overall Study|Adverse Event|1|||
125581554|NCT00544869|451758525|FG002|Overall Study|Adverse Event|0|||
125581555|NCT00544869|451758523|FG000|Overall Study|Lack of Efficacy|1|||
125581556|NCT00544869|451758524|FG001|Overall Study|Lack of Efficacy|1|||
125581557|NCT00544869|451758525|FG002|Overall Study|Lack of Efficacy|0|||
125581558|NCT00544869|451758523|FG000|Overall Study|Physician Decision|2|||
125581559|NCT00544869|451758524|FG001|Overall Study|Physician Decision|0|||
125360989|NCT02913612|450955887|FG003|Overall Study|Needed to treat second hemangioma|0|||
125360990|NCT02913612|450955884|FG000|Overall Study|Study completion criteria not met|0|||
125360991|NCT02913612|450955885|FG001|Overall Study|Study completion criteria not met|1|||
125360992|NCT02913612|450955886|FG002|Overall Study|Study completion criteria not met|0|||
125360993|NCT02913612|450955887|FG003|Overall Study|Study completion criteria not met|0|||
125581560|NCT00544869|451758525|FG002|Overall Study|Physician Decision|0|||
125581561|NCT00925600|451758526|FG000|Overall Study|Withdrawal by Subject|16|||
125581562|NCT00925600|451758527|FG001|Overall Study|Withdrawal by Subject|14|||
125581563|NCT00925600|451758526|FG000|Overall Study|Death|4|||
125360994|NCT02913612|450955884|FG000|Overall Study|Ineligible|0|||
125360995|NCT02913612|450955885|FG001|Overall Study|Ineligible|1|||
125360996|NCT02913612|450955886|FG002|Overall Study|Ineligible|0|||
125581564|NCT00925600|451758527|FG001|Overall Study|Death|3|||
125581565|NCT00925600|451758526|FG000|Overall Study|Lost to Follow-up|2|||
125581566|NCT00925600|451758527|FG001|Overall Study|Lost to Follow-up|2|||
125581567|NCT00925600|451758526|FG000|Overall Study|Disease Progression|1|||
125581568|NCT00925600|451758527|FG001|Overall Study|Disease Progression|3|||
125581569|NCT00925600|451758526|FG000|Overall Study|Administrative Decision|1|||
125581570|NCT00925600|451758527|FG001|Overall Study|Administrative Decision|1|||
125581571|NCT00925600|451758526|FG000|Overall Study|Noncompliance|2|||
125581572|NCT00925600|451758527|FG001|Overall Study|Noncompliance|0|||
125581573|NCT00925600|451758526|FG000|Overall Study|Ineligibility Determined|2|||
125581574|NCT00925600|451758527|FG001|Overall Study|Ineligibility Determined|0|||
125581575|NCT00925600|451758526|FG000|Overall Study|Protocol Deviation|0|||
125581576|NCT00925600|451758527|FG001|Overall Study|Protocol Deviation|1|||
125581577|NCT00925600|451758526|FG000|Overall Study|Requirement for Alternative Therapy|0|||
125581578|NCT00925600|451758527|FG001|Overall Study|Requirement for Alternative Therapy|1|||
125581579|NCT00925600|451758526|FG000|Overall Study|Other|3|||
125581580|NCT00925600|451758527|FG001|Overall Study|Other|1|||
125581581|NCT00925600|451758526|FG000|Overall Study|Adverse Event|1|||
125581582|NCT00925600|451758527|FG001|Overall Study|Adverse Event|2|||
125581583|NCT01974817|451758528|FG000|Overall Study|Death|4|||
125581584|NCT01974817|451758528|FG000|Overall Study|Lost to Follow-up|2|||
125581585|NCT01974817|451758528|FG000|Overall Study|Protocol Violation|2|||
125581586|NCT04660643|451758529|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
125581587|NCT04660643|451758530|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
125581588|NCT04660643|451758531|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
125581589|NCT04660643|451758529|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
125581590|NCT04660643|451758530|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
125581591|NCT04660643|451758531|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
125581592|NCT04660643|451758529|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
125581593|NCT04660643|451758530|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
125581594|NCT04660643|451758531|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
125581595|NCT04660643|451758529|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
125581596|NCT04660643|451758530|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
125581597|NCT04660643|451758531|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
125581598|NCT04660643|451758529|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
125581599|NCT04660643|451758530|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
125581600|NCT04660643|451758531|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
125360997|NCT02913612|450955887|FG003|Overall Study|Ineligible|0|||
125581601|NCT04660643|451758529|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
125581602|NCT04660643|451758530|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
125581603|NCT04660643|451758531|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
125581604|NCT04660643|451758529|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
125360998|NCT03452228|450955888|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125360999|NCT03452228|450955889|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
125581605|NCT04660643|451758530|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
125581606|NCT04660643|451758531|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
125581607|NCT04660643|451758529|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
125581608|NCT04660643|451758530|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
125581609|NCT04660643|451758531|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
125581610|NCT04660643|451758529|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
125581611|NCT04660643|451758530|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
125581612|NCT04660643|451758531|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
125581613|NCT04660643|451758529|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
125581614|NCT04660643|451758530|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
125581615|NCT04660643|451758531|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
125581616|NCT04660643|451758529|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
125581617|NCT04660643|451758530|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
125581618|NCT04660643|451758531|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
125361000|NCT03452228|450955890|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
125581619|NCT04660643|451758529|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
125361001|NCT03452228|450955888|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
125581620|NCT04660643|451758530|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
125581621|NCT04660643|451758531|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
125581622|NCT04660643|451758529|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
125581623|NCT04660643|451758530|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
125581624|NCT04660643|451758531|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
125581625|NCT04660643|451758529|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
125581626|NCT04660643|451758530|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
125581627|NCT04660643|451758531|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
125581628|NCT04660643|451758529|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
125581629|NCT04660643|451758530|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
125581630|NCT04660643|451758531|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
125581631|NCT04660643|451758529|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
125581632|NCT04660643|451758530|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
125581633|NCT04660643|451758531|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
125581634|NCT03988907|451758532|FG000|Overall Study|Unable to complete visit|0|||
125581635|NCT03988907|451758533|FG001|Overall Study|Unable to complete visit|1|||
125581636|NCT02810964|451758534|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
125581637|NCT02810964|451758535|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
125581638|NCT02810964|451758534|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
125581639|NCT02810964|451758535|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
125581640|NCT02810964|451758534|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
125581641|NCT02810964|451758535|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
125581642|NCT02810964|451758534|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
125581643|NCT02810964|451758535|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
125581644|NCT00568555|451758542|FG000|Overall Study|Withdrawal by Subject|1|||
125581645|NCT00568555|451758543|FG001|Overall Study|Withdrawal by Subject|1|||
125581646|NCT01307033|451758544|FG000|8-week Double-blind Period|Adverse Event|2|||
125581647|NCT01307033|451758545|FG001|8-week Double-blind Period|Adverse Event|0|||
125581648|NCT01307033|451758546|FG002|8-week Double-blind Period|Adverse Event|0|||
125581649|NCT01307033|451758547|FG003|8-week Double-blind Period|Adverse Event|0|||
125581650|NCT01307033|451758544|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
125581651|NCT01307033|451758545|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
125581652|NCT01307033|451758546|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
125581653|NCT01307033|451758547|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
125581654|NCT01307033|451758544|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
125581655|NCT01307033|451758545|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
125581656|NCT01307033|451758546|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
125581657|NCT01307033|451758547|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
125581658|NCT01307033|451758544|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
125581659|NCT01307033|451758545|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
125581660|NCT01307033|451758546|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
125581661|NCT01307033|451758547|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
125581662|NCT01307033|451758544|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
125581663|NCT01307033|451758545|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
125581664|NCT01307033|451758546|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
125581665|NCT01307033|451758547|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
125581666|NCT01307033|451758544|FG000|44-week Open-label Extension|Adverse Event|0|||
125581667|NCT01307033|451758545|FG001|44-week Open-label Extension|Adverse Event|0|||
125581668|NCT01307033|451758546|FG002|44-week Open-label Extension|Adverse Event|2|||
125581669|NCT01307033|451758547|FG003|44-week Open-label Extension|Adverse Event|1|||
125581670|NCT01307033|451758544|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
125581671|NCT01307033|451758545|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
125581672|NCT01307033|451758546|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
125581673|NCT01307033|451758547|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
125581674|NCT01307033|451758544|FG000|44-week Open-label Extension|Physician Decision|0|||
125581675|NCT01307033|451758545|FG001|44-week Open-label Extension|Physician Decision|0|||
125581676|NCT01307033|451758546|FG002|44-week Open-label Extension|Physician Decision|1|||
125581677|NCT01307033|451758547|FG003|44-week Open-label Extension|Physician Decision|0|||
125581678|NCT01307033|451758544|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
125581679|NCT01307033|451758545|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
125581680|NCT01307033|451758546|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
125581681|NCT01307033|451758547|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
125581682|NCT01307033|451758544|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
125581683|NCT01307033|451758545|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
125581684|NCT01307033|451758546|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
125581685|NCT01307033|451758547|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
125581686|NCT01307033|451758544|FG000|44-week Open-label Extension|Death|0|||
125581687|NCT01307033|451758545|FG001|44-week Open-label Extension|Death|0|||
125581688|NCT01307033|451758546|FG002|44-week Open-label Extension|Death|0|||
125581689|NCT01307033|451758547|FG003|44-week Open-label Extension|Death|1|||
125581690|NCT01231555|451758548|FG000|Overall Study|Study terminated|8|||
125581691|NCT01231555|451758549|FG001|Overall Study|Study terminated|5|||
125581692|NCT01231555|451758550|FG002|Overall Study|Study terminated|8|||
125581693|NCT01231555|451758548|FG000|Overall Study|Withdrawal by Subject|0|||
125581694|NCT01231555|451758549|FG001|Overall Study|Withdrawal by Subject|2|||
125581695|NCT01231555|451758550|FG002|Overall Study|Withdrawal by Subject|0|||
125581696|NCT00947531|451758551|FG000|Overall Study|Withdrawal by Subject|10|||
125581697|NCT00947531|451758552|FG001|Overall Study|Withdrawal by Subject|7|||
125581698|NCT00947531|451758551|FG000|Overall Study|Administrative Reason|0|||
125581699|NCT00947531|451758552|FG001|Overall Study|Administrative Reason|1|||
125581700|NCT00947531|451758551|FG000|Overall Study|Adverse Event|2|||
125581701|NCT00947531|451758552|FG001|Overall Study|Adverse Event|2|||
125581702|NCT00947531|451758551|FG000|Overall Study|Lack of Efficacy|1|||
125581703|NCT00947531|451758552|FG001|Overall Study|Lack of Efficacy|0|||
125581704|NCT00947531|451758551|FG000|Overall Study|Other|1|||
125581705|NCT00947531|451758552|FG001|Overall Study|Other|1|||
125581706|NCT01773421|451758554|FG000|Treatment Phase|Other|0|||
125581707|NCT01773421|451758555|FG001|Treatment Phase|Other|0|||
125581708|NCT01773421|451758556|FG002|Treatment Phase|Other|2|||
125581709|NCT01773421|451758557|FG003|Treatment Phase|Other|0|||
125581710|NCT01773421|451758558|FG004|Treatment Phase|Other|0|||
125581711|NCT01773421|451758559|FG005|Treatment Phase|Other|0|||
125581712|NCT01773421|451758560|FG006|Treatment Phase|Other|0|||
125581713|NCT01773421|451758554|FG000|Treatment Phase|Adverse Event|0|||
125581714|NCT01773421|451758555|FG001|Treatment Phase|Adverse Event|0|||
125581715|NCT01773421|451758556|FG002|Treatment Phase|Adverse Event|3|||
125581716|NCT01773421|451758557|FG003|Treatment Phase|Adverse Event|1|||
125581717|NCT01773421|451758558|FG004|Treatment Phase|Adverse Event|0|||
125581718|NCT01773421|451758559|FG005|Treatment Phase|Adverse Event|0|||
125581719|NCT01773421|451758560|FG006|Treatment Phase|Adverse Event|0|||
125581720|NCT01773421|451758554|FG000|Treatment Phase|Withdrawal by Subject|0|||
125581721|NCT01773421|451758555|FG001|Treatment Phase|Withdrawal by Subject|0|||
125581722|NCT01773421|451758556|FG002|Treatment Phase|Withdrawal by Subject|1|||
125581723|NCT01773421|451758557|FG003|Treatment Phase|Withdrawal by Subject|1|||
125581724|NCT01773421|451758558|FG004|Treatment Phase|Withdrawal by Subject|0|||
125361002|NCT03452228|450955889|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
125581725|NCT01773421|451758559|FG005|Treatment Phase|Withdrawal by Subject|0|||
125581726|NCT01773421|451758560|FG006|Treatment Phase|Withdrawal by Subject|0|||
125581727|NCT01773421|451758554|FG000|Extension Phase|Other|0|||
125581728|NCT01773421|451758555|FG001|Extension Phase|Other|0|||
125581729|NCT01773421|451758556|FG002|Extension Phase|Other|0|||
125581730|NCT01773421|451758557|FG003|Extension Phase|Other|0|||
125581731|NCT01773421|451758558|FG004|Extension Phase|Other|1|||
125581732|NCT01773421|451758559|FG005|Extension Phase|Other|2|||
125581733|NCT01773421|451758560|FG006|Extension Phase|Other|0|||
125581734|NCT01773421|451758554|FG000|Extension Phase|Adverse Event|0|||
125581735|NCT01773421|451758555|FG001|Extension Phase|Adverse Event|0|||
125581736|NCT01773421|451758556|FG002|Extension Phase|Adverse Event|0|||
125581737|NCT01773421|451758557|FG003|Extension Phase|Adverse Event|0|||
125581738|NCT01773421|451758558|FG004|Extension Phase|Adverse Event|2|||
125581739|NCT01773421|451758559|FG005|Extension Phase|Adverse Event|0|||
125581740|NCT01773421|451758560|FG006|Extension Phase|Adverse Event|0|||
125581741|NCT02804763|451758561|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
125581742|NCT02804763|451758562|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
125581743|NCT02804763|451758563|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
125581744|NCT02804763|451758564|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
125361003|NCT03452228|450955890|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
125361004|NCT03452228|450955888|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
125361005|NCT03452228|450955889|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
125361006|NCT03452228|450955890|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
125361007|NCT03452228|450955888|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
125581745|NCT02804763|451758561|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
125581746|NCT02804763|451758562|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
125581747|NCT02804763|451758563|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
125581748|NCT02804763|451758564|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
125581749|NCT02804763|451758561|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
125581750|NCT02804763|451758562|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
125637215|NCT03073200|451952836|FG004|Extension Period|Withdrawal by Subject|0|||
125581751|NCT02804763|451758563|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
125581752|NCT02804763|451758564|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
125581753|NCT02804763|451758561|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
125581754|NCT02804763|451758562|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
125581755|NCT02804763|451758563|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
125581756|NCT02804763|451758564|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
125581757|NCT02804763|451758561|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
125581758|NCT02804763|451758562|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
125581759|NCT02804763|451758563|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
125581760|NCT02804763|451758564|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
125581761|NCT02804763|451758561|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
125581762|NCT02804763|451758562|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
125581763|NCT02804763|451758563|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
125581764|NCT02804763|451758564|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
125581765|NCT04656990|451758565|FG000|Baseline|pandemic|20|||
125581766|NCT04656990|451758566|FG001|Baseline|pandemic|24|||
125581767|NCT04656990|451758565|FG000|Follow Up Period|Lost to Follow-up|61|||
125581768|NCT04656990|451758566|FG001|Follow Up Period|Lost to Follow-up|73|||
125581769|NCT00282243|451758569|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
125581770|NCT00282243|451758569|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
125581771|NCT00282243|451758569|FG000|Extension Treatment Period|Adverse Event|15|||
125581772|NCT00282243|451758569|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
125581773|NCT00282243|451758569|FG000|Extension Treatment Period|Non-compliance|2|||
125581774|NCT00282243|451758569|FG000|Extension Treatment Period|Physician Decision|1|||
125581775|NCT01070329|451758570|FG000|Overall Study|Adverse Event|13|||
125581776|NCT01070329|451758571|FG001|Overall Study|Adverse Event|10|||
125581777|NCT01070329|451758570|FG000|Overall Study|Lost to Follow-up|22|||
125581778|NCT01070329|451758571|FG001|Overall Study|Lost to Follow-up|12|||
125581779|NCT01070329|451758570|FG000|Overall Study|Withdrawal by Subject|9|||
125581780|NCT01070329|451758571|FG001|Overall Study|Withdrawal by Subject|11|||
125581781|NCT01070329|451758570|FG000|Overall Study|Protocol Violation|3|||
125581782|NCT01070329|451758571|FG001|Overall Study|Protocol Violation|8|||
125581783|NCT01070329|451758570|FG000|Overall Study|Lack of Efficacy|2|||
125581784|NCT01070329|451758571|FG001|Overall Study|Lack of Efficacy|6|||
125581785|NCT01070329|451758570|FG000|Overall Study|Physician Decision|2|||
125581786|NCT01070329|451758571|FG001|Overall Study|Physician Decision|1|||
125581787|NCT01070329|451758570|FG000|Overall Study|Entry Criteria Not Met|1|||
125581788|NCT01070329|451758571|FG001|Overall Study|Entry Criteria Not Met|0|||
125581789|NCT01070329|451758570|FG000|Overall Study|Sponsor Decision|0|||
125581790|NCT01070329|451758571|FG001|Overall Study|Sponsor Decision|1|||
125581791|NCT02863848|451758572|FG000|Overall Study|Lost to Follow-up|1|||
125581792|NCT02863848|451758573|FG001|Overall Study|Lost to Follow-up|1|||
125581793|NCT02863848|451758572|FG000|Overall Study|Protocol Violation|1|||
125581794|NCT02863848|451758573|FG001|Overall Study|Protocol Violation|2|||
125581795|NCT00700180|451758577|FG000|Overall Study|Death|99|||
125581796|NCT00700180|451758578|FG001|Overall Study|Death|114|||
125581797|NCT00700180|451758577|FG000|Overall Study|Alive on treatment|5|||
125581798|NCT00700180|451758578|FG001|Overall Study|Alive on treatment|3|||
125581799|NCT00700180|451758577|FG000|Overall Study|Alive in follow-up|46|||
125581800|NCT00700180|451758578|FG001|Overall Study|Alive in follow-up|27|||
125581801|NCT00700180|451758577|FG000|Overall Study|Lost to Follow-up|4|||
125581802|NCT00700180|451758578|FG001|Overall Study|Lost to Follow-up|5|||
125581803|NCT03588741|451758580|FG000|Overall Study|Withdrawal by Subject|1|||
125581804|NCT00793793|451758581|FG000|Overall Study|Adverse Event|0|||
125581805|NCT00793793|451758582|FG001|Overall Study|Adverse Event|0|||
125581806|NCT00793793|451758583|FG002|Overall Study|Adverse Event|1|||
125581807|NCT00793793|451758584|FG003|Overall Study|Adverse Event|1|||
125581808|NCT00793793|451758585|FG004|Overall Study|Adverse Event|0|||
125581809|NCT00793793|451758586|FG005|Overall Study|Adverse Event|1|||
125581810|NCT00793793|451758587|FG006|Overall Study|Adverse Event|2|||
125581811|NCT00793793|451758588|FG007|Overall Study|Adverse Event|0|||
125581812|NCT00793793|451758589|FG008|Overall Study|Adverse Event|0|||
125581813|NCT00793793|451758590|FG009|Overall Study|Adverse Event|0|||
125581814|NCT00793793|451758591|FG010|Overall Study|Adverse Event|0|||
125581815|NCT00793793|451758592|FG011|Overall Study|Adverse Event|2|||
125581816|NCT00793793|451758581|FG000|Overall Study|Protocol Violation|0|||
125581817|NCT00793793|451758582|FG001|Overall Study|Protocol Violation|0|||
125581818|NCT00793793|451758583|FG002|Overall Study|Protocol Violation|0|||
125581819|NCT00793793|451758584|FG003|Overall Study|Protocol Violation|1|||
125361008|NCT03452228|450955889|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
125581820|NCT00793793|451758585|FG004|Overall Study|Protocol Violation|0|||
125581821|NCT00793793|451758586|FG005|Overall Study|Protocol Violation|0|||
125581822|NCT00793793|451758587|FG006|Overall Study|Protocol Violation|0|||
125581823|NCT00793793|451758588|FG007|Overall Study|Protocol Violation|0|||
125581824|NCT00793793|451758589|FG008|Overall Study|Protocol Violation|0|||
125581825|NCT00793793|451758590|FG009|Overall Study|Protocol Violation|0|||
125581826|NCT00793793|451758591|FG010|Overall Study|Protocol Violation|0|||
125581827|NCT00793793|451758592|FG011|Overall Study|Protocol Violation|0|||
125581828|NCT00793793|451758581|FG000|Overall Study|Lost to Follow-up|0|||
125581829|NCT00793793|451758582|FG001|Overall Study|Lost to Follow-up|0|||
125581830|NCT00793793|451758583|FG002|Overall Study|Lost to Follow-up|1|||
125581831|NCT00793793|451758584|FG003|Overall Study|Lost to Follow-up|0|||
125581832|NCT00793793|451758585|FG004|Overall Study|Lost to Follow-up|0|||
125581833|NCT00793793|451758586|FG005|Overall Study|Lost to Follow-up|0|||
125581834|NCT00793793|451758587|FG006|Overall Study|Lost to Follow-up|0|||
125581835|NCT00793793|451758588|FG007|Overall Study|Lost to Follow-up|0|||
125581836|NCT00793793|451758589|FG008|Overall Study|Lost to Follow-up|1|||
125581837|NCT00793793|451758590|FG009|Overall Study|Lost to Follow-up|3|||
125581838|NCT00793793|451758591|FG010|Overall Study|Lost to Follow-up|1|||
125581839|NCT00793793|451758592|FG011|Overall Study|Lost to Follow-up|0|||
125581840|NCT00793793|451758581|FG000|Overall Study|Withdrawal by Subject|0|||
125581841|NCT00793793|451758582|FG001|Overall Study|Withdrawal by Subject|0|||
125581842|NCT00793793|451758583|FG002|Overall Study|Withdrawal by Subject|0|||
125581843|NCT00793793|451758584|FG003|Overall Study|Withdrawal by Subject|0|||
125581844|NCT00793793|451758585|FG004|Overall Study|Withdrawal by Subject|1|||
125581845|NCT00793793|451758586|FG005|Overall Study|Withdrawal by Subject|0|||
125581846|NCT00793793|451758587|FG006|Overall Study|Withdrawal by Subject|0|||
125581847|NCT00793793|451758588|FG007|Overall Study|Withdrawal by Subject|0|||
125581848|NCT00793793|451758589|FG008|Overall Study|Withdrawal by Subject|1|||
125581849|NCT00793793|451758590|FG009|Overall Study|Withdrawal by Subject|0|||
125581850|NCT00793793|451758591|FG010|Overall Study|Withdrawal by Subject|0|||
125581851|NCT00793793|451758592|FG011|Overall Study|Withdrawal by Subject|0|||
125581852|NCT00793793|451758581|FG000|Overall Study|reason not specified|0|||
125581853|NCT00793793|451758582|FG001|Overall Study|reason not specified|1|||
125581854|NCT00793793|451758583|FG002|Overall Study|reason not specified|0|||
125581855|NCT00793793|451758584|FG003|Overall Study|reason not specified|1|||
125581856|NCT00793793|451758585|FG004|Overall Study|reason not specified|1|||
125581857|NCT00793793|451758586|FG005|Overall Study|reason not specified|1|||
125581858|NCT00793793|451758587|FG006|Overall Study|reason not specified|2|||
125581859|NCT00793793|451758588|FG007|Overall Study|reason not specified|0|||
125581860|NCT00793793|451758589|FG008|Overall Study|reason not specified|7|||
125581861|NCT00793793|451758590|FG009|Overall Study|reason not specified|6|||
125581862|NCT00793793|451758591|FG010|Overall Study|reason not specified|2|||
125581863|NCT00793793|451758592|FG011|Overall Study|reason not specified|4|||
125581864|NCT00950170|451758593|FG000|Overall Study|Parent/Legal Guardian Request|1|||
125581865|NCT00950170|451758593|FG000|Overall Study|Adverse Event|2|||
125581866|NCT00950170|451758593|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
125581867|NCT02661594|451758594|FG000|Overall Study|Protocol Violation|1|||
125581868|NCT02661594|451758595|FG001|Overall Study|Protocol Violation|0|||
125581869|NCT02661594|451758596|FG002|Overall Study|Protocol Violation|1|||
125581870|NCT02661594|451758597|FG003|Overall Study|Protocol Violation|0|||
125581871|NCT02522767|451758598|FG000|Double-blind|Withdrawal by Subject|8|||
125581872|NCT02522767|451758599|FG001|Double-blind|Withdrawal by Subject|11|||
125581873|NCT02522767|451758598|FG000|Double-blind|Lost to Follow-up|1|||
125581874|NCT02522767|451758599|FG001|Double-blind|Lost to Follow-up|0|||
125581875|NCT02522767|451758598|FG000|Double-blind|Adverse Event|1|||
125581876|NCT02522767|451758599|FG001|Double-blind|Adverse Event|10|||
125581877|NCT02522767|451758598|FG000|Double-blind|Protocol Violation|0|||
125581878|NCT02522767|451758599|FG001|Double-blind|Protocol Violation|1|||
125581879|NCT02522767|451758598|FG000|Double-blind|Lack of Efficacy|0|||
125581880|NCT02522767|451758599|FG001|Double-blind|Lack of Efficacy|2|||
125581881|NCT02522767|451758598|FG000|Double-blind|Protocol Deviation|1|||
125581882|NCT02522767|451758599|FG001|Double-blind|Protocol Deviation|0|||
125581883|NCT02522767|451758598|FG000|Open-label|Withdrawal by Subject|2|||
125581884|NCT02522767|451758599|FG001|Open-label|Withdrawal by Subject|3|||
125581885|NCT02522767|451758598|FG000|Open-label|Lost to Follow-up|0|||
125581886|NCT02522767|451758599|FG001|Open-label|Lost to Follow-up|1|||
125581887|NCT02522767|451758598|FG000|Open-label|Adverse Event|2|||
125581888|NCT02522767|451758599|FG001|Open-label|Adverse Event|1|||
125581889|NCT02522767|451758598|FG000|Open-label|Lack of Efficacy|1|||
125581890|NCT02522767|451758599|FG001|Open-label|Lack of Efficacy|1|||
125581891|NCT02522767|451758598|FG000|Open-label|Protocol Violation|0|||
125581892|NCT02522767|451758599|FG001|Open-label|Protocol Violation|1|||
125581893|NCT01705691|451758600|FG000|Overall Study|Death|1|||
125581894|NCT01705691|451758601|FG001|Overall Study|Death|2|||
125581895|NCT01705691|451758600|FG000|Overall Study|Withdrawal by Subject|1|||
125581896|NCT01705691|451758601|FG001|Overall Study|Withdrawal by Subject|2|||
125581897|NCT01705691|451758600|FG000|Overall Study|Lost to Follow-up|1|||
125581898|NCT01705691|451758601|FG001|Overall Study|Lost to Follow-up|1|||
125581899|NCT01705691|451758600|FG000|Overall Study|Other|0|||
125581900|NCT01705691|451758601|FG001|Overall Study|Other|1|||
125581901|NCT00214461|451758602|FG000|Overall Study|Adverse Event|0|||
125581902|NCT00214461|451758603|FG001|Overall Study|Adverse Event|0|||
125581903|NCT00214461|451758604|FG002|Overall Study|Adverse Event|1|||
125581904|NCT00214461|451758605|FG003|Overall Study|Adverse Event|1|||
125581905|NCT00214461|451758602|FG000|Overall Study|Withdrawal by Subject|0|||
125581906|NCT00214461|451758603|FG001|Overall Study|Withdrawal by Subject|0|||
125581907|NCT00214461|451758604|FG002|Overall Study|Withdrawal by Subject|1|||
125581908|NCT00214461|451758605|FG003|Overall Study|Withdrawal by Subject|0|||
125581909|NCT02913313|451758606|FG000|Overall Study|DISEASE PROGRESSION|1|||
125581910|NCT02913313|451758607|FG001|Overall Study|DISEASE PROGRESSION|2|||
125581911|NCT02913313|451758608|FG002|Overall Study|DISEASE PROGRESSION|2|||
125581912|NCT02913313|451758609|FG003|Overall Study|DISEASE PROGRESSION|4|||
125581913|NCT02913313|451758610|FG004|Overall Study|DISEASE PROGRESSION|6|||
125581914|NCT02913313|451758611|FG005|Overall Study|DISEASE PROGRESSION|4|||
125581915|NCT02913313|451758612|FG006|Overall Study|DISEASE PROGRESSION|19|||
125581916|NCT02913313|451758613|FG007|Overall Study|DISEASE PROGRESSION|3|||
125581917|NCT02913313|451758614|FG008|Overall Study|DISEASE PROGRESSION|4|||
125581918|NCT02913313|451758615|FG009|Overall Study|DISEASE PROGRESSION|4|||
125581919|NCT02913313|451758616|FG010|Overall Study|DISEASE PROGRESSION|11|||
125581920|NCT02913313|451758617|FG011|Overall Study|DISEASE PROGRESSION|5|||
125581921|NCT02913313|451758618|FG012|Overall Study|DISEASE PROGRESSION|14|||
125581922|NCT02913313|451758619|FG013|Overall Study|DISEASE PROGRESSION|3|||
125581923|NCT02913313|451758606|FG000|Overall Study|Not Reported|0|||
125581924|NCT02913313|451758607|FG001|Overall Study|Not Reported|0|||
125581925|NCT02913313|451758608|FG002|Overall Study|Not Reported|0|||
125581926|NCT02913313|451758609|FG003|Overall Study|Not Reported|0|||
125581927|NCT02913313|451758610|FG004|Overall Study|Not Reported|1|||
125581928|NCT02913313|451758611|FG005|Overall Study|Not Reported|0|||
125581929|NCT02913313|451758612|FG006|Overall Study|Not Reported|0|||
125581930|NCT02913313|451758613|FG007|Overall Study|Not Reported|0|||
125581931|NCT02913313|451758614|FG008|Overall Study|Not Reported|0|||
125581932|NCT02913313|451758615|FG009|Overall Study|Not Reported|0|||
125581933|NCT02913313|451758616|FG010|Overall Study|Not Reported|4|||
125581934|NCT02913313|451758617|FG011|Overall Study|Not Reported|0|||
125581935|NCT02913313|451758618|FG012|Overall Study|Not Reported|0|||
125581936|NCT02913313|451758619|FG013|Overall Study|Not Reported|0|||
125581937|NCT02913313|451758606|FG000|Overall Study|Other reasons|0|||
125581938|NCT02913313|451758607|FG001|Overall Study|Other reasons|0|||
125581939|NCT02913313|451758608|FG002|Overall Study|Other reasons|0|||
125581940|NCT02913313|451758609|FG003|Overall Study|Other reasons|0|||
125581941|NCT02913313|451758610|FG004|Overall Study|Other reasons|1|||
125581942|NCT02913313|451758611|FG005|Overall Study|Other reasons|0|||
125581943|NCT02913313|451758612|FG006|Overall Study|Other reasons|0|||
125581944|NCT02913313|451758613|FG007|Overall Study|Other reasons|0|||
125581945|NCT02913313|451758614|FG008|Overall Study|Other reasons|0|||
125581946|NCT02913313|451758615|FG009|Overall Study|Other reasons|0|||
125581947|NCT02913313|451758616|FG010|Overall Study|Other reasons|1|||
125581948|NCT02913313|451758617|FG011|Overall Study|Other reasons|0|||
125581949|NCT02913313|451758618|FG012|Overall Study|Other reasons|0|||
125581950|NCT02913313|451758619|FG013|Overall Study|Other reasons|0|||
125581951|NCT02913313|451758606|FG000|Overall Study|Withdrawal by Subject|0|||
125581952|NCT02913313|451758607|FG001|Overall Study|Withdrawal by Subject|0|||
125581953|NCT02913313|451758608|FG002|Overall Study|Withdrawal by Subject|1|||
125581954|NCT02913313|451758609|FG003|Overall Study|Withdrawal by Subject|0|||
125581955|NCT02913313|451758610|FG004|Overall Study|Withdrawal by Subject|0|||
125581956|NCT02913313|451758611|FG005|Overall Study|Withdrawal by Subject|0|||
125581957|NCT02913313|451758612|FG006|Overall Study|Withdrawal by Subject|1|||
125581958|NCT02913313|451758613|FG007|Overall Study|Withdrawal by Subject|1|||
125581959|NCT02913313|451758614|FG008|Overall Study|Withdrawal by Subject|0|||
125581960|NCT02913313|451758615|FG009|Overall Study|Withdrawal by Subject|0|||
125581961|NCT02913313|451758616|FG010|Overall Study|Withdrawal by Subject|1|||
125581962|NCT02913313|451758617|FG011|Overall Study|Withdrawal by Subject|0|||
125581963|NCT02913313|451758618|FG012|Overall Study|Withdrawal by Subject|0|||
125581964|NCT02913313|451758619|FG013|Overall Study|Withdrawal by Subject|0|||
125581965|NCT02913313|451758606|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125581966|NCT02913313|451758607|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125581967|NCT02913313|451758608|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125581968|NCT02913313|451758609|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125581969|NCT02913313|451758610|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125581970|NCT02913313|451758611|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125581971|NCT02913313|451758612|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125581972|NCT02913313|451758613|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125581973|NCT02913313|451758614|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125581974|NCT02913313|451758615|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125581975|NCT02913313|451758616|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
125581976|NCT02913313|451758617|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
125581977|NCT02913313|451758618|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
125581978|NCT02913313|451758619|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
125581979|NCT02913313|451758606|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
125581980|NCT02913313|451758607|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
125581981|NCT02913313|451758608|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
125581982|NCT02913313|451758609|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
125581983|NCT02913313|451758610|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
125581984|NCT02913313|451758611|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
125581985|NCT02913313|451758612|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
125581986|NCT02913313|451758613|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
125581987|NCT02913313|451758614|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
125581988|NCT02913313|451758615|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
125581989|NCT02913313|451758616|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
125581990|NCT02913313|451758617|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
125581991|NCT02913313|451758618|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
125581992|NCT02913313|451758619|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
125581993|NCT04233229|451758622|FG000|Overall Study|Withdrawal by Subject|0|||
125581994|NCT04233229|451758623|FG001|Overall Study|Withdrawal by Subject|1|||
125581995|NCT04233229|451758622|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
125581996|NCT04233229|451758623|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
125581997|NCT04233229|451758622|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
125581998|NCT04233229|451758623|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
125581999|NCT00841763|451758624|FG000|Overall Study|Withdrawal by Subject|60|||
125582000|NCT00841763|451758625|FG001|Overall Study|Withdrawal by Subject|17|||
125582001|NCT00841763|451758626|FG002|Overall Study|Withdrawal by Subject|4|||
125582002|NCT00841763|451758627|FG003|Overall Study|Withdrawal by Subject|1|||
125582003|NCT00841763|451758624|FG000|Overall Study|Adverse Event|9|||
125582004|NCT00841763|451758625|FG001|Overall Study|Adverse Event|10|||
125582005|NCT00841763|451758626|FG002|Overall Study|Adverse Event|3|||
125582006|NCT00841763|451758627|FG003|Overall Study|Adverse Event|2|||
125582007|NCT00841763|451758624|FG000|Overall Study|Lost to Follow-up|63|||
125582008|NCT00841763|451758625|FG001|Overall Study|Lost to Follow-up|25|||
125582009|NCT00841763|451758626|FG002|Overall Study|Lost to Follow-up|0|||
125582010|NCT00841763|451758627|FG003|Overall Study|Lost to Follow-up|0|||
125582011|NCT00841763|451758624|FG000|Overall Study|Protocol Violation|20|||
125582012|NCT00841763|451758625|FG001|Overall Study|Protocol Violation|3|||
125582013|NCT00841763|451758626|FG002|Overall Study|Protocol Violation|1|||
125582014|NCT00841763|451758627|FG003|Overall Study|Protocol Violation|0|||
125582015|NCT00841763|451758624|FG000|Overall Study|Administrative Reasons|3|||
125582016|NCT00841763|451758625|FG001|Overall Study|Administrative Reasons|1|||
125582017|NCT00841763|451758626|FG002|Overall Study|Administrative Reasons|0|||
125582018|NCT00841763|451758627|FG003|Overall Study|Administrative Reasons|0|||
125582019|NCT00841763|451758624|FG000|Overall Study|Unable to Classify|7|||
125582020|NCT00841763|451758625|FG001|Overall Study|Unable to Classify|1|||
125582021|NCT00841763|451758626|FG002|Overall Study|Unable to Classify|0|||
125582022|NCT00841763|451758627|FG003|Overall Study|Unable to Classify|0|||
125582023|NCT02631538|451758628|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
125582024|NCT02631538|451758629|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
125582025|NCT02631538|451758630|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
125582026|NCT02631538|451758631|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
125582027|NCT02631538|451758628|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
125582028|NCT02631538|451758629|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
125582029|NCT02631538|451758630|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
125582030|NCT02631538|451758631|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
125582031|NCT02631538|451758628|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
125582032|NCT02631538|451758629|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
125582033|NCT02631538|451758630|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
125582034|NCT02631538|451758631|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
125582035|NCT02631538|451758628|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
125582036|NCT02631538|451758629|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
125582037|NCT02631538|451758630|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
125582038|NCT02631538|451758631|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
125582039|NCT02631538|451758628|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
125582040|NCT02631538|451758629|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
125582041|NCT02631538|451758630|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
125582042|NCT02631538|451758631|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
125582043|NCT02631538|451758628|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
125582044|NCT02631538|451758629|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
125582045|NCT02631538|451758630|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
125582046|NCT02631538|451758631|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
125582047|NCT00648167|451758632|FG000|Overall Study|Adverse Event|6|||
125582048|NCT00648167|451758632|FG000|Overall Study|unable to swallow tablets|1|||
125582049|NCT01688050|451758633|FG000|Overall Study|Death|7|||
125582050|NCT01688050|451758633|FG000|Overall Study|Conversion to open repair|1|||
125582051|NCT01688050|451758633|FG000|Overall Study|Lost to Follow-up|13|||
125582052|NCT01688050|451758633|FG000|Overall Study|Withdrawal by Subject|10|||
125582053|NCT01482910|451758638|FG000|Overall Study|Adverse Event|6|||
125582054|NCT01482910|451758639|FG001|Overall Study|Adverse Event|5|||
125582055|NCT01482910|451758638|FG000|Overall Study|Lost to Follow-up|0|||
125582056|NCT01482910|451758639|FG001|Overall Study|Lost to Follow-up|1|||
125582057|NCT01482910|451758638|FG000|Overall Study|Protocol Violation|1|||
125582058|NCT01482910|451758639|FG001|Overall Study|Protocol Violation|1|||
125582059|NCT01482910|451758638|FG000|Overall Study|Withdrawal by Subject|7|||
125582060|NCT01482910|451758639|FG001|Overall Study|Withdrawal by Subject|2|||
125582061|NCT01482910|451758638|FG000|Overall Study|Death|1|||
125582062|NCT01482910|451758639|FG001|Overall Study|Death|0|||
125582063|NCT00440726|451758641|FG000|Phase 1|Dose-Limiting Toxicity|0|||
125582064|NCT00440726|451758642|FG001|Phase 1|Dose-Limiting Toxicity|1|||
125582065|NCT00440726|451758643|FG002|Phase 1|Dose-Limiting Toxicity|0|||
125582066|NCT00440726|451758641|FG000|Phase 1|Physician Decision|1|||
125582067|NCT00440726|451758642|FG001|Phase 1|Physician Decision|0|||
125582068|NCT00440726|451758643|FG002|Phase 1|Physician Decision|0|||
125582069|NCT00440726|451758641|FG000|Phase 2|Death|0|||
125582070|NCT00440726|451758642|FG001|Phase 2|Death|0|||
125582071|NCT00440726|451758643|FG002|Phase 2|Death|1|||
125582072|NCT00440726|451758641|FG000|Phase 2|Adverse Event|0|||
125582073|NCT00440726|451758642|FG001|Phase 2|Adverse Event|0|||
125582074|NCT00440726|451758643|FG002|Phase 2|Adverse Event|1|||
125582075|NCT03370770|451758644|FG000|Overall Study|Patient was followed in another hospital center|1|||
125582076|NCT03370770|451758644|FG000|Overall Study|Progressive Disease|98|||
125582077|NCT03370770|451758644|FG000|Overall Study|Adverse Event|2|||
125582078|NCT03370770|451758644|FG000|Overall Study|Death|5|||
125361009|NCT03452228|450955890|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
125361010|NCT01262573|450955891|FG000|Overall Study|Withdrawal by Subject|0|||
125361011|NCT01262573|450955892|FG001|Overall Study|Withdrawal by Subject|1|||
125361012|NCT02955797|450955893|FG000|Overall Study|Protocol Violation|1|||
125361013|NCT02955797|450955894|FG001|Overall Study|Protocol Violation|0|||
125582079|NCT00234039|451758645|FG000|Overall Study|Adverse Event|2|||
125582080|NCT00234039|451758645|FG000|Overall Study|Progression/relapse|34|||
125582081|NCT00234039|451758645|FG000|Overall Study|Other - Not Protocol Specified|3|||
125582082|NCT00234039|451758645|FG000|Overall Study|Ineligible|9|||
125582083|NCT00234039|451758645|FG000|Overall Study|No Protocol Treatment Received|2|||
125582084|NCT00110019|451758648|FG000|Overall Study|Lack of Efficacy|253|||
125582085|NCT00110019|451758649|FG001|Overall Study|Lack of Efficacy|285|||
125582086|NCT00110019|451758648|FG000|Overall Study|Adverse Event|61|||
125361014|NCT02955797|450955895|FG002|Overall Study|Protocol Violation|0|||
125582087|NCT00110019|451758649|FG001|Overall Study|Adverse Event|40|||
125582088|NCT00110019|451758648|FG000|Overall Study|Death|13|||
125582089|NCT00110019|451758649|FG001|Overall Study|Death|15|||
125582090|NCT00110019|451758648|FG000|Overall Study|Withdrawal by Subject|21|||
125582091|NCT00110019|451758649|FG001|Overall Study|Withdrawal by Subject|9|||
125582092|NCT00110019|451758648|FG000|Overall Study|alternative therapy|5|||
125582093|NCT00110019|451758649|FG001|Overall Study|alternative therapy|1|||
125582094|NCT00110019|451758648|FG000|Overall Study|complicating disease|1|||
125582095|NCT00110019|451758649|FG001|Overall Study|complicating disease|1|||
125582096|NCT00110019|451758648|FG000|Overall Study|symptom deterioration|13|||
125582097|NCT00110019|451758649|FG001|Overall Study|symptom deterioration|16|||
125582098|NCT00110019|451758648|FG000|Overall Study|Not start protocol therapy|17|||
125582099|NCT00110019|451758649|FG001|Overall Study|Not start protocol therapy|16|||
125582100|NCT00110019|451758648|FG000|Overall Study|other reasons|22|||
125582101|NCT00110019|451758649|FG001|Overall Study|other reasons|30|||
125582102|NCT04426695|451758652|FG000|Overall Study|Death|2|||
125582103|NCT04426695|451758653|FG001|Overall Study|Death|0|||
125582104|NCT04426695|451758654|FG002|Overall Study|Death|1|||
125582105|NCT04426695|451758655|FG003|Overall Study|Death|27|||
125582106|NCT04426695|451758656|FG004|Overall Study|Death|25|||
125582107|NCT04426695|451758657|FG005|Overall Study|Death|21|||
125582108|NCT04426695|451758658|FG006|Overall Study|Death|42|||
125361015|NCT02955797|450955896|FG003|Overall Study|Protocol Violation|1|||
125361016|NCT02955797|450955893|FG000|Overall Study|Withdrawal by Subject|2|||
125361017|NCT02955797|450955894|FG001|Overall Study|Withdrawal by Subject|2|||
125582109|NCT04426695|451758659|FG007|Overall Study|Death|23|||
125582110|NCT04426695|451758660|FG008|Overall Study|Death|37|||
125582111|NCT04426695|451758661|FG009|Overall Study|Death|14|||
125582112|NCT04426695|451758662|FG010|Overall Study|Death|8|||
125582113|NCT04426695|451758663|FG011|Overall Study|Death|7|||
125582114|NCT04426695|451758664|FG012|Overall Study|Death|13|||
125582115|NCT04426695|451758665|FG013|Overall Study|Death|25|||
125361018|NCT02955797|450955895|FG002|Overall Study|Withdrawal by Subject|0|||
125582116|NCT04426695|451758666|FG014|Overall Study|Death|19|||
125582117|NCT04426695|451758667|FG015|Overall Study|Death|7|||
125582118|NCT04426695|451758668|FG016|Overall Study|Death|8|||
125582119|NCT04426695|451758669|FG017|Overall Study|Death|4|||
125582120|NCT04426695|451758652|FG000|Overall Study|Lost to Follow-up|2|||
125582121|NCT04426695|451758653|FG001|Overall Study|Lost to Follow-up|4|||
125582122|NCT04426695|451758654|FG002|Overall Study|Lost to Follow-up|1|||
125582123|NCT04426695|451758655|FG003|Overall Study|Lost to Follow-up|19|||
125582124|NCT04426695|451758656|FG004|Overall Study|Lost to Follow-up|10|||
125361019|NCT02955797|450955896|FG003|Overall Study|Withdrawal by Subject|1|||
125361020|NCT02955797|450955893|FG000|Overall Study|Lost to Follow-up|0|||
125361021|NCT02955797|450955894|FG001|Overall Study|Lost to Follow-up|1|||
125361022|NCT02955797|450955895|FG002|Overall Study|Lost to Follow-up|0|||
125361023|NCT02955797|450955896|FG003|Overall Study|Lost to Follow-up|0|||
125361024|NCT02081183|450955898|FG000|Overall Study|Lost to Follow-up|0|||
125361025|NCT02081183|450955899|FG001|Overall Study|Lost to Follow-up|1|||
125361026|NCT02081183|450955898|FG000|Overall Study|Protocol Violation|1|||
125361027|NCT02081183|450955899|FG001|Overall Study|Protocol Violation|0|||
125361028|NCT02081183|450955898|FG000|Overall Study|Other|3|||
125361029|NCT02081183|450955899|FG001|Overall Study|Other|3|||
125361030|NCT04128371|450955904|FG000|Overall Study|Lack of Efficacy|1|||
125361031|NCT00968864|450955905|FG000|Overall Study|Protocol exception/ not evaluable|1|||
125361032|NCT00397215|450955917|FG000|Month 0 (Day 0)|Adverse Event|0|||
125361033|NCT00397215|450955918|FG001|Month 0 (Day 0)|Adverse Event|1|||
125361034|NCT00397215|450955919|FG002|Month 0 (Day 0)|Adverse Event|0|||
125361035|NCT00397215|450955920|FG003|Month 0 (Day 0)|Adverse Event|0|||
125361036|NCT00397215|450955917|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
125361037|NCT00397215|450955918|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
125361038|NCT00397215|450955919|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
125361039|NCT00397215|450955920|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
125361040|NCT00397215|450955917|FG000|Month 0 (Day 0)|Other|4|||
125361041|NCT00397215|450955918|FG001|Month 0 (Day 0)|Other|1|||
125361042|NCT00397215|450955919|FG002|Month 0 (Day 0)|Other|3|||
125361043|NCT00397215|450955920|FG003|Month 0 (Day 0)|Other|3|||
125361044|NCT00397215|450955917|FG000|Month 6 (Day 180)|Adverse Event|0|||
125361045|NCT00397215|450955918|FG001|Month 6 (Day 180)|Adverse Event|3|||
125361046|NCT00397215|450955919|FG002|Month 6 (Day 180)|Adverse Event|2|||
125361047|NCT00397215|450955920|FG003|Month 6 (Day 180)|Adverse Event|0|||
125361048|NCT00397215|450955917|FG000|Month 6 (Day 180)|Other|2|||
125361049|NCT00397215|450955918|FG001|Month 6 (Day 180)|Other|0|||
125361050|NCT00397215|450955919|FG002|Month 6 (Day 180)|Other|3|||
125361051|NCT00397215|450955920|FG003|Month 6 (Day 180)|Other|0|||
125361052|NCT02128932|450955921|FG000|Overall Study|Withdrawal by Subject|11|||
125361053|NCT02128932|450955922|FG001|Overall Study|Withdrawal by Subject|7|||
125361054|NCT02128932|450955923|FG002|Overall Study|Withdrawal by Subject|8|||
125361055|NCT02128932|450955921|FG000|Overall Study|Death|2|||
125361056|NCT02128932|450955922|FG001|Overall Study|Death|0|||
125361057|NCT02128932|450955923|FG002|Overall Study|Death|2|||
125361058|NCT02128932|450955921|FG000|Overall Study|Lost to Follow-up|2|||
125361059|NCT02128932|450955922|FG001|Overall Study|Lost to Follow-up|1|||
125361060|NCT02128932|450955923|FG002|Overall Study|Lost to Follow-up|1|||
125361061|NCT02128932|450955921|FG000|Overall Study|No reason for withdrawal|12|||
125361062|NCT02128932|450955922|FG001|Overall Study|No reason for withdrawal|11|||
125361063|NCT02128932|450955923|FG002|Overall Study|No reason for withdrawal|7|||
125361064|NCT00657358|450955928|FG000|Overall Study|Lack of Efficacy|6|||
125361065|NCT02728596|450955929|FG000|Overall Study|Refusal unrelated to adverse event|3|||
125361066|NCT02728596|450955930|FG001|Overall Study|Refusal unrelated to adverse event|6|||
125361067|NCT02728596|450955931|FG002|Overall Study|Refusal unrelated to adverse event|7|||
125361068|NCT02728596|450955932|FG003|Overall Study|Refusal unrelated to adverse event|7|||
125582125|NCT04426695|451758657|FG005|Overall Study|Lost to Follow-up|14|||
125582126|NCT04426695|451758658|FG006|Overall Study|Lost to Follow-up|5|||
125582127|NCT04426695|451758659|FG007|Overall Study|Lost to Follow-up|14|||
125582128|NCT04426695|451758660|FG008|Overall Study|Lost to Follow-up|10|||
125582129|NCT04426695|451758661|FG009|Overall Study|Lost to Follow-up|11|||
125582130|NCT04426695|451758662|FG010|Overall Study|Lost to Follow-up|12|||
125582131|NCT04426695|451758663|FG011|Overall Study|Lost to Follow-up|6|||
125582132|NCT04426695|451758664|FG012|Overall Study|Lost to Follow-up|2|||
125582133|NCT04426695|451758665|FG013|Overall Study|Lost to Follow-up|2|||
125361069|NCT02728596|450955929|FG000|Overall Study|Death|44|||
125361070|NCT02728596|450955930|FG001|Overall Study|Death|42|||
125361071|NCT02728596|450955931|FG002|Overall Study|Death|123|||
125361072|NCT02728596|450955932|FG003|Overall Study|Death|68|||
125361073|NCT01414608|450955938|FG000|Overall Study|Ineligible|5|||
125361074|NCT01414608|450955939|FG001|Overall Study|Ineligible|2|||
125361075|NCT03672643|450955940|FG000|Overall Study|Adverse Event|3|||
125361076|NCT03672643|450955940|FG000|Overall Study|Death|2|||
125582134|NCT04426695|451758666|FG014|Overall Study|Lost to Follow-up|2|||
125582135|NCT04426695|451758667|FG015|Overall Study|Lost to Follow-up|0|||
125361077|NCT03672643|450955940|FG000|Overall Study|Withdrawal by Subject|1|||
125361078|NCT03672643|450955940|FG000|Overall Study|Progressive disease|11|||
125361079|NCT03672643|450955940|FG000|Overall Study|Global deterioration of health status|1|||
125361080|NCT03672643|450955940|FG000|Overall Study|Refused further treatment|7|||
125361081|NCT03672643|450955940|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
125582136|NCT04426695|451758668|FG016|Overall Study|Lost to Follow-up|0|||
125582137|NCT04426695|451758669|FG017|Overall Study|Lost to Follow-up|0|||
125582138|NCT04426695|451758652|FG000|Overall Study|Participant Decision|1|||
125582139|NCT04426695|451758653|FG001|Overall Study|Participant Decision|2|||
125582140|NCT04426695|451758654|FG002|Overall Study|Participant Decision|2|||
125582141|NCT04426695|451758655|FG003|Overall Study|Participant Decision|12|||
125582142|NCT04426695|451758656|FG004|Overall Study|Participant Decision|18|||
125582143|NCT04426695|451758657|FG005|Overall Study|Participant Decision|22|||
125582144|NCT04426695|451758658|FG006|Overall Study|Participant Decision|13|||
125582145|NCT04426695|451758659|FG007|Overall Study|Participant Decision|13|||
125582146|NCT04426695|451758660|FG008|Overall Study|Participant Decision|10|||
125582147|NCT04426695|451758661|FG009|Overall Study|Participant Decision|15|||
125582148|NCT04426695|451758662|FG010|Overall Study|Participant Decision|16|||
125582149|NCT04426695|451758663|FG011|Overall Study|Participant Decision|17|||
125582150|NCT04426695|451758664|FG012|Overall Study|Participant Decision|2|||
125582151|NCT04426695|451758665|FG013|Overall Study|Participant Decision|1|||
125582152|NCT04426695|451758666|FG014|Overall Study|Participant Decision|2|||
125582153|NCT04426695|451758667|FG015|Overall Study|Participant Decision|0|||
125582154|NCT04426695|451758668|FG016|Overall Study|Participant Decision|0|||
125582155|NCT04426695|451758669|FG017|Overall Study|Participant Decision|0|||
125582156|NCT04426695|451758652|FG000|Overall Study|Adverse Event|0|||
125582157|NCT04426695|451758653|FG001|Overall Study|Adverse Event|0|||
125361082|NCT05736224|450955941|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
125361083|NCT02557295|450955942|FG000|Overall Study|Withdrawal by Subject|9|||
125361084|NCT02557295|450955943|FG001|Overall Study|Withdrawal by Subject|2|||
125582158|NCT04426695|451758654|FG002|Overall Study|Adverse Event|0|||
125582159|NCT04426695|451758655|FG003|Overall Study|Adverse Event|0|||
125582160|NCT04426695|451758656|FG004|Overall Study|Adverse Event|0|||
125582161|NCT04426695|451758657|FG005|Overall Study|Adverse Event|0|||
125582162|NCT04426695|451758658|FG006|Overall Study|Adverse Event|0|||
125582163|NCT04426695|451758659|FG007|Overall Study|Adverse Event|1|||
125582164|NCT04426695|451758660|FG008|Overall Study|Adverse Event|0|||
125582165|NCT04426695|451758661|FG009|Overall Study|Adverse Event|0|||
125582166|NCT04426695|451758662|FG010|Overall Study|Adverse Event|1|||
125582167|NCT04426695|451758663|FG011|Overall Study|Adverse Event|1|||
125582168|NCT04426695|451758664|FG012|Overall Study|Adverse Event|0|||
125582169|NCT04426695|451758665|FG013|Overall Study|Adverse Event|0|||
125582170|NCT04426695|451758666|FG014|Overall Study|Adverse Event|0|||
125582171|NCT04426695|451758667|FG015|Overall Study|Adverse Event|0|||
125582172|NCT04426695|451758668|FG016|Overall Study|Adverse Event|0|||
125582173|NCT04426695|451758669|FG017|Overall Study|Adverse Event|0|||
125582174|NCT04426695|451758652|FG000|Overall Study|Sponsor Request|0|||
125582175|NCT04426695|451758653|FG001|Overall Study|Sponsor Request|0|||
125582176|NCT04426695|451758654|FG002|Overall Study|Sponsor Request|0|||
125361085|NCT02557295|450955944|FG002|Overall Study|Withdrawal by Subject|4|||
125361086|NCT02557295|450955945|FG003|Overall Study|Withdrawal by Subject|0|||
125361087|NCT02557295|450955946|FG004|Overall Study|Withdrawal by Subject|0|||
125361088|NCT02557295|450955947|FG005|Overall Study|Withdrawal by Subject|0|||
125361089|NCT02557295|450955948|FG006|Overall Study|Withdrawal by Subject|15|||
125361090|NCT02557295|450955949|FG007|Overall Study|Withdrawal by Subject|1|||
125361091|NCT02557295|450955950|FG008|Overall Study|Withdrawal by Subject|3|||
125361092|NCT02557295|450955942|FG000|Overall Study|Disease Progression|0|||
125361093|NCT02557295|450955943|FG001|Overall Study|Disease Progression|0|||
125361094|NCT02557295|450955944|FG002|Overall Study|Disease Progression|0|||
125361095|NCT02557295|450955945|FG003|Overall Study|Disease Progression|0|||
125361096|NCT02557295|450955946|FG004|Overall Study|Disease Progression|0|||
125361097|NCT02557295|450955947|FG005|Overall Study|Disease Progression|0|||
125361098|NCT02557295|450955948|FG006|Overall Study|Disease Progression|1|||
125361099|NCT02557295|450955949|FG007|Overall Study|Disease Progression|0|||
125361100|NCT02557295|450955950|FG008|Overall Study|Disease Progression|0|||
125361101|NCT02557295|450955942|FG000|Overall Study|Lack of Efficacy|24|||
125361102|NCT02557295|450955943|FG001|Overall Study|Lack of Efficacy|1|||
125361103|NCT02557295|450955944|FG002|Overall Study|Lack of Efficacy|3|||
125361104|NCT02557295|450955945|FG003|Overall Study|Lack of Efficacy|0|||
125361105|NCT02557295|450955946|FG004|Overall Study|Lack of Efficacy|0|||
125582177|NCT04426695|451758655|FG003|Overall Study|Sponsor Request|0|||
125582178|NCT04426695|451758656|FG004|Overall Study|Sponsor Request|0|||
125582179|NCT04426695|451758657|FG005|Overall Study|Sponsor Request|0|||
125582180|NCT04426695|451758658|FG006|Overall Study|Sponsor Request|1|||
125582181|NCT04426695|451758659|FG007|Overall Study|Sponsor Request|0|||
125582182|NCT04426695|451758660|FG008|Overall Study|Sponsor Request|0|||
125582183|NCT04426695|451758661|FG009|Overall Study|Sponsor Request|0|||
125582184|NCT04426695|451758662|FG010|Overall Study|Sponsor Request|0|||
125582185|NCT04426695|451758663|FG011|Overall Study|Sponsor Request|0|||
125361106|NCT02557295|450955947|FG005|Overall Study|Lack of Efficacy|0|||
125361107|NCT02557295|450955948|FG006|Overall Study|Lack of Efficacy|12|||
125361108|NCT02557295|450955949|FG007|Overall Study|Lack of Efficacy|1|||
125361109|NCT02557295|450955950|FG008|Overall Study|Lack of Efficacy|0|||
125361110|NCT02557295|450955942|FG000|Overall Study|Adverse Event|16|||
125361111|NCT02557295|450955943|FG001|Overall Study|Adverse Event|2|||
125361112|NCT02557295|450955944|FG002|Overall Study|Adverse Event|3|||
125361113|NCT02557295|450955945|FG003|Overall Study|Adverse Event|0|||
125361114|NCT02557295|450955946|FG004|Overall Study|Adverse Event|0|||
125361115|NCT02557295|450955947|FG005|Overall Study|Adverse Event|0|||
125361116|NCT02557295|450955948|FG006|Overall Study|Adverse Event|2|||
125361117|NCT02557295|450955949|FG007|Overall Study|Adverse Event|1|||
125361118|NCT02557295|450955950|FG008|Overall Study|Adverse Event|1|||
125361119|NCT02557295|450955942|FG000|Overall Study|Lost to Follow-up|4|||
125361120|NCT02557295|450955943|FG001|Overall Study|Lost to Follow-up|0|||
125361121|NCT02557295|450955944|FG002|Overall Study|Lost to Follow-up|0|||
125361122|NCT02557295|450955945|FG003|Overall Study|Lost to Follow-up|0|||
125361123|NCT02557295|450955946|FG004|Overall Study|Lost to Follow-up|0|||
125361124|NCT02557295|450955947|FG005|Overall Study|Lost to Follow-up|0|||
125361125|NCT02557295|450955948|FG006|Overall Study|Lost to Follow-up|9|||
125428309|NCT01370525|451193855|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
125428310|NCT01370525|451193856|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
125428311|NCT01370525|451193855|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125428312|NCT01370525|451193856|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125582186|NCT04426695|451758664|FG012|Overall Study|Sponsor Request|0|||
125582187|NCT04426695|451758665|FG013|Overall Study|Sponsor Request|0|||
125582188|NCT04426695|451758666|FG014|Overall Study|Sponsor Request|0|||
125582189|NCT04426695|451758667|FG015|Overall Study|Sponsor Request|0|||
125582190|NCT04426695|451758668|FG016|Overall Study|Sponsor Request|0|||
125582191|NCT04426695|451758669|FG017|Overall Study|Sponsor Request|0|||
125582192|NCT04426695|451758652|FG000|Overall Study|Physician Decision|0|||
125582193|NCT04426695|451758653|FG001|Overall Study|Physician Decision|0|||
125582194|NCT04426695|451758654|FG002|Overall Study|Physician Decision|0|||
125582195|NCT04426695|451758655|FG003|Overall Study|Physician Decision|0|||
125582196|NCT04426695|451758656|FG004|Overall Study|Physician Decision|0|||
125582197|NCT04426695|451758657|FG005|Overall Study|Physician Decision|0|||
125582198|NCT04426695|451758658|FG006|Overall Study|Physician Decision|0|||
125582199|NCT04426695|451758659|FG007|Overall Study|Physician Decision|0|||
125582200|NCT04426695|451758660|FG008|Overall Study|Physician Decision|0|||
125582201|NCT04426695|451758661|FG009|Overall Study|Physician Decision|1|||
125582202|NCT04426695|451758662|FG010|Overall Study|Physician Decision|0|||
125582203|NCT04426695|451758663|FG011|Overall Study|Physician Decision|0|||
125582204|NCT04426695|451758664|FG012|Overall Study|Physician Decision|1|||
125582205|NCT04426695|451758665|FG013|Overall Study|Physician Decision|0|||
125582206|NCT04426695|451758666|FG014|Overall Study|Physician Decision|0|||
125582207|NCT04426695|451758667|FG015|Overall Study|Physician Decision|0|||
125582208|NCT04426695|451758668|FG016|Overall Study|Physician Decision|0|||
125582209|NCT04426695|451758669|FG017|Overall Study|Physician Decision|0|||
125582210|NCT04426695|451758652|FG000|Overall Study|Randomized but Never Treated|3|||
125582211|NCT04426695|451758653|FG001|Overall Study|Randomized but Never Treated|1|||
125582212|NCT04426695|451758654|FG002|Overall Study|Randomized but Never Treated|0|||
125582213|NCT04426695|451758655|FG003|Overall Study|Randomized but Never Treated|4|||
125582214|NCT04426695|451758656|FG004|Overall Study|Randomized but Never Treated|5|||
125582215|NCT04426695|451758657|FG005|Overall Study|Randomized but Never Treated|5|||
125361126|NCT02557295|450955949|FG007|Overall Study|Lost to Follow-up|0|||
125428313|NCT01370525|451193855|FG000|Overall Study|Adverse Event|0|||
125428314|NCT01370525|451193856|FG001|Overall Study|Adverse Event|1|||
125428315|NCT01370525|451193855|FG000|Overall Study|Protocol Violation|2|||
125428316|NCT01370525|451193856|FG001|Overall Study|Protocol Violation|1|||
125428317|NCT01370525|451193855|FG000|Overall Study|Lost to follow up|2|||
125428318|NCT01370525|451193856|FG001|Overall Study|Lost to follow up|6|||
125428319|NCT05131165|451193863|FG000|Overall Study|Death|1|||
125428320|NCT05131165|451193864|FG001|Overall Study|Death|1|||
125428321|NCT05131165|451193865|FG002|Overall Study|Death|0|||
125582216|NCT04426695|451758658|FG006|Overall Study|Randomized but Never Treated|4|||
125582217|NCT04426695|451758659|FG007|Overall Study|Randomized but Never Treated|6|||
125361127|NCT02557295|450955950|FG008|Overall Study|Lost to Follow-up|0|||
125361128|NCT02557295|450955942|FG000|Overall Study|Study Close|54|||
125361129|NCT02557295|450955943|FG001|Overall Study|Study Close|3|||
125361130|NCT02557295|450955944|FG002|Overall Study|Study Close|5|||
125361131|NCT02557295|450955945|FG003|Overall Study|Study Close|3|||
125428322|NCT05131165|451193863|FG000|Overall Study|Lost to Follow-up|2|||
125428323|NCT05131165|451193864|FG001|Overall Study|Lost to Follow-up|2|||
125582218|NCT04426695|451758660|FG008|Overall Study|Randomized but Never Treated|6|||
125582219|NCT04426695|451758661|FG009|Overall Study|Randomized but Never Treated|3|||
125361132|NCT02557295|450955946|FG004|Overall Study|Study Close|0|||
125582220|NCT04426695|451758662|FG010|Overall Study|Randomized but Never Treated|3|||
125582221|NCT04426695|451758663|FG011|Overall Study|Randomized but Never Treated|6|||
125361133|NCT02557295|450955947|FG005|Overall Study|Study Close|0|||
125361134|NCT02557295|450955948|FG006|Overall Study|Study Close|37|||
125361135|NCT02557295|450955949|FG007|Overall Study|Study Close|3|||
125361136|NCT02557295|450955950|FG008|Overall Study|Study Close|19|||
125361137|NCT02557295|450955942|FG000|Overall Study|except for study close|4|||
125361138|NCT02557295|450955943|FG001|Overall Study|except for study close|0|||
125361139|NCT02557295|450955944|FG002|Overall Study|except for study close|0|||
125361140|NCT02557295|450955945|FG003|Overall Study|except for study close|0|||
125361141|NCT02557295|450955946|FG004|Overall Study|except for study close|0|||
125361142|NCT02557295|450955947|FG005|Overall Study|except for study close|0|||
125361143|NCT02557295|450955948|FG006|Overall Study|except for study close|5|||
125361144|NCT02557295|450955949|FG007|Overall Study|except for study close|1|||
125361145|NCT02557295|450955950|FG008|Overall Study|except for study close|0|||
125361146|NCT02742441|450958029|FG000|Overall Study|Lost to Follow-up|4|||
125361147|NCT02742441|450958030|FG001|Overall Study|Lost to Follow-up|4|||
125361148|NCT02742441|450958029|FG000|Overall Study|Withdrawal by Subject|2|||
125361149|NCT02742441|450958030|FG001|Overall Study|Withdrawal by Subject|2|||
125361150|NCT02742441|450958029|FG000|Overall Study|Adverse Event|0|||
125361151|NCT02742441|450958030|FG001|Overall Study|Adverse Event|2|||
125361152|NCT04806503|450958034|FG000|Overall Study|Lost to Follow-up|0|||
125361153|NCT04806503|450958035|FG001|Overall Study|Lost to Follow-up|0|||
125361154|NCT04806503|450958036|FG002|Overall Study|Lost to Follow-up|1|||
125361155|NCT04806503|450958037|FG003|Overall Study|Lost to Follow-up|0|||
125361156|NCT04806503|450958038|FG004|Overall Study|Lost to Follow-up|0|||
125361157|NCT04806503|450958034|FG000|Overall Study|Withdrawal by Subject|1|||
125361158|NCT04806503|450958035|FG001|Overall Study|Withdrawal by Subject|0|||
125361159|NCT04806503|450958036|FG002|Overall Study|Withdrawal by Subject|1|||
125361160|NCT04806503|450958037|FG003|Overall Study|Withdrawal by Subject|1|||
125361161|NCT04806503|450958038|FG004|Overall Study|Withdrawal by Subject|1|||
125361162|NCT04806503|450958034|FG000|Overall Study|Adverse Event|1|||
125361163|NCT04806503|450958035|FG001|Overall Study|Adverse Event|1|||
125361164|NCT04806503|450958036|FG002|Overall Study|Adverse Event|0|||
125361165|NCT04806503|450958037|FG003|Overall Study|Adverse Event|1|||
125361166|NCT04806503|450958038|FG004|Overall Study|Adverse Event|0|||
125582222|NCT04426695|451758664|FG012|Overall Study|Randomized but Never Treated|1|||
125582223|NCT04426695|451758665|FG013|Overall Study|Randomized but Never Treated|2|||
125582224|NCT04426695|451758666|FG014|Overall Study|Randomized but Never Treated|0|||
125582225|NCT04426695|451758667|FG015|Overall Study|Randomized but Never Treated|0|||
125582226|NCT04426695|451758668|FG016|Overall Study|Randomized but Never Treated|0|||
125361167|NCT03589469|450958039|FG000|Overall Study|Withdrawal by Subject|8|||
125361168|NCT03589469|450958039|FG000|Overall Study|Physician Decision|20|||
125361169|NCT03589469|450958039|FG000|Overall Study|Death|97|||
125428324|NCT05131165|451193865|FG002|Overall Study|Lost to Follow-up|5|||
125582227|NCT04426695|451758669|FG017|Overall Study|Randomized but Never Treated|0|||
125582228|NCT04303000|451758670|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
125582229|NCT04303000|451758671|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
125582230|NCT04303000|451758672|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
125582231|NCT00559273|451758673|FG000|Correction Period (20 Weeks)|Death|3|||
125361170|NCT03589469|450958039|FG000|Overall Study|Lost to Follow-up|8|||
125361171|NCT03589469|450958039|FG000|Overall Study|Miscellaneous|1|||
125361172|NCT02008318|450958044|FG000|Overall Study|Adverse Event|4|||
125361173|NCT02008318|450958045|FG001|Overall Study|Adverse Event|0|||
125361174|NCT02008318|450958044|FG000|Overall Study|Physician Decision|2|||
125361175|NCT02008318|450958045|FG001|Overall Study|Physician Decision|0|||
125361176|NCT02008318|450958044|FG000|Overall Study|Progressive Disease|2|||
125582232|NCT00559273|451758674|FG001|Correction Period (20 Weeks)|Death|4|||
125582233|NCT00559273|451758673|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
125582234|NCT00559273|451758674|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
125582235|NCT00559273|451758673|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
125582236|NCT00559273|451758674|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
125582237|NCT00559273|451758673|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
125582238|NCT00559273|451758674|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
125582239|NCT00559273|451758673|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
125582240|NCT00559273|451758674|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
125582241|NCT00559273|451758673|FG000|Evaluation Period (8 Weeks)|Death|1|||
125582242|NCT00559273|451758674|FG001|Evaluation Period (8 Weeks)|Death|3|||
125582243|NCT00559273|451758673|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
125361177|NCT02008318|450958045|FG001|Overall Study|Progressive Disease|0|||
125361178|NCT02008318|450958044|FG000|Overall Study|Protocol Violation|1|||
125361179|NCT02008318|450958045|FG001|Overall Study|Protocol Violation|1|||
125361180|NCT02008318|450958044|FG000|Overall Study|Withdrawal by Subject|3|||
125361181|NCT02008318|450958045|FG001|Overall Study|Withdrawal by Subject|0|||
125361182|NCT02281773|450958046|FG000|Overall Study|Adverse Event|6|||
125361183|NCT02281773|450958047|FG001|Overall Study|Adverse Event|1|||
125582244|NCT00559273|451758674|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
125582245|NCT00559273|451758673|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
125582246|NCT00559273|451758674|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
125582247|NCT00559273|451758673|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
125582248|NCT00559273|451758674|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
125582249|NCT00395967|451758679|FG000|Treatment Period|Failed Mobilization|1|||
125582250|NCT00395967|451758679|FG000|Follow-up Period|Death|1|||
125582251|NCT00395967|451758679|FG000|Follow-up Period|Lost to Follow-up|1|||
125582252|NCT03653390|451758680|FG000|Overall Study|Lost to Follow-up|12|||
125582253|NCT03653390|451758681|FG001|Overall Study|Lost to Follow-up|8|||
125582254|NCT03653390|451758682|FG002|Overall Study|Lost to Follow-up|7|||
125582255|NCT03653390|451758680|FG000|Overall Study|Withdrawal by Subject|6|||
125582256|NCT03653390|451758681|FG001|Overall Study|Withdrawal by Subject|1|||
125582257|NCT03653390|451758682|FG002|Overall Study|Withdrawal by Subject|1|||
125582258|NCT03653390|451758680|FG000|Overall Study|Death|1|||
125582259|NCT03653390|451758681|FG001|Overall Study|Death|0|||
125582260|NCT03653390|451758682|FG002|Overall Study|Death|0|||
125582261|NCT03653390|451758680|FG000|Overall Study|Paper Survey Lost|1|||
125582262|NCT03653390|451758681|FG001|Overall Study|Paper Survey Lost|0|||
125582263|NCT03653390|451758682|FG002|Overall Study|Paper Survey Lost|0|||
125582264|NCT03118947|451758683|FG000|Overall Study|Adverse Event|7|||
125582265|NCT03118947|451758683|FG000|Overall Study|Death|3|||
125582266|NCT03118947|451758683|FG000|Overall Study|Lack of Efficacy|4|||
125582267|NCT03118947|451758683|FG000|Overall Study|Non-compliance with study drug|1|||
125582268|NCT03118947|451758683|FG000|Overall Study|Protocol Violation|2|||
125582269|NCT03118947|451758683|FG000|Overall Study|Withdrawal by Subject|3|||
125582270|NCT03118947|451758683|FG000|Overall Study|Withdrawal by caregiver|3|||
125582271|NCT03118947|451758683|FG000|Overall Study|Change in patient's living situation|4|||
125582272|NCT03118947|451758683|FG000|Overall Study|Lost to Follow-up|2|||
125582273|NCT01109940|451758684|FG000|Overall Study|Administrative problems|2|||
125582274|NCT01109940|451758685|FG001|Overall Study|Administrative problems|0|||
125582275|NCT01109940|451758686|FG002|Overall Study|Administrative problems|0|||
125582276|NCT01109940|451758687|FG003|Overall Study|Administrative problems|0|||
125582277|NCT01109940|451758684|FG000|Overall Study|Serious Adverse Event|2|||
125582278|NCT01109940|451758685|FG001|Overall Study|Serious Adverse Event|1|||
125582279|NCT01109940|451758686|FG002|Overall Study|Serious Adverse Event|0|||
125582280|NCT01109940|451758687|FG003|Overall Study|Serious Adverse Event|0|||
125582281|NCT01109940|451758684|FG000|Overall Study|Lost to Follow-up|1|||
125582282|NCT01109940|451758685|FG001|Overall Study|Lost to Follow-up|0|||
125582283|NCT01109940|451758686|FG002|Overall Study|Lost to Follow-up|0|||
125582284|NCT01109940|451758687|FG003|Overall Study|Lost to Follow-up|0|||
125582285|NCT01109940|451758684|FG000|Overall Study|Patient withdrew consent|1|||
125582286|NCT01109940|451758685|FG001|Overall Study|Patient withdrew consent|1|||
125582287|NCT01109940|451758686|FG002|Overall Study|Patient withdrew consent|0|||
125582288|NCT01109940|451758687|FG003|Overall Study|Patient withdrew consent|0|||
125582289|NCT01109940|451758684|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125582290|NCT01109940|451758685|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125582291|NCT01109940|451758686|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
125582292|NCT01109940|451758687|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
125582293|NCT01262976|451758694|FG000|Up to Month 2|Serious Adverse Event|0|||
125582294|NCT01262976|451758695|FG001|Up to Month 2|Serious Adverse Event|0|||
125582295|NCT01262976|451758696|FG002|Up to Month 2|Serious Adverse Event|1|||
125582296|NCT01262976|451758697|FG003|Up to Month 2|Serious Adverse Event|0|||
125582297|NCT01262976|451758698|FG004|Up to Month 2|Serious Adverse Event|0|||
125582298|NCT01262976|451758699|FG005|Up to Month 2|Serious Adverse Event|0|||
125582299|NCT01262976|451758694|FG000|Up to Month 2|Withdrawal by Subject|1|||
125582300|NCT01262976|451758695|FG001|Up to Month 2|Withdrawal by Subject|0|||
125582301|NCT01262976|451758696|FG002|Up to Month 2|Withdrawal by Subject|0|||
125582302|NCT01262976|451758697|FG003|Up to Month 2|Withdrawal by Subject|0|||
125582303|NCT01262976|451758698|FG004|Up to Month 2|Withdrawal by Subject|0|||
125582304|NCT01262976|451758699|FG005|Up to Month 2|Withdrawal by Subject|0|||
125582305|NCT01262976|451758694|FG000|Up to Month 2|Migrated/moved from study area|0|||
125582306|NCT01262976|451758695|FG001|Up to Month 2|Migrated/moved from study area|1|||
125582307|NCT01262976|451758696|FG002|Up to Month 2|Migrated/moved from study area|0|||
125582308|NCT01262976|451758697|FG003|Up to Month 2|Migrated/moved from study area|0|||
125582309|NCT01262976|451758698|FG004|Up to Month 2|Migrated/moved from study area|1|||
125582310|NCT01262976|451758699|FG005|Up to Month 2|Migrated/moved from study area|1|||
125582311|NCT01262976|451758694|FG000|Up to Month 2|Lost to Follow-up|1|||
125582312|NCT01262976|451758695|FG001|Up to Month 2|Lost to Follow-up|0|||
125582313|NCT01262976|451758696|FG002|Up to Month 2|Lost to Follow-up|0|||
125582314|NCT01262976|451758697|FG003|Up to Month 2|Lost to Follow-up|1|||
125582315|NCT01262976|451758698|FG004|Up to Month 2|Lost to Follow-up|1|||
125582316|NCT01262976|451758699|FG005|Up to Month 2|Lost to Follow-up|1|||
125582317|NCT01262976|451758694|FG000|Up to Month 2|Other|1|||
125582318|NCT01262976|451758695|FG001|Up to Month 2|Other|0|||
125582319|NCT01262976|451758696|FG002|Up to Month 2|Other|0|||
125582320|NCT01262976|451758697|FG003|Up to Month 2|Other|1|||
125582321|NCT01262976|451758698|FG004|Up to Month 2|Other|0|||
125582322|NCT01262976|451758699|FG005|Up to Month 2|Other|2|||
125582323|NCT01262976|451758694|FG000|Up to Month 7|Serious Adverse Event|0|||
125582324|NCT01262976|451758695|FG001|Up to Month 7|Serious Adverse Event|0|||
125582325|NCT01262976|451758696|FG002|Up to Month 7|Serious Adverse Event|2|||
125582326|NCT01262976|451758697|FG003|Up to Month 7|Serious Adverse Event|0|||
125582327|NCT01262976|451758698|FG004|Up to Month 7|Serious Adverse Event|0|||
125582328|NCT01262976|451758699|FG005|Up to Month 7|Serious Adverse Event|0|||
125582329|NCT01262976|451758694|FG000|Up to Month 7|Withdrawal by Subject|1|||
125582330|NCT01262976|451758695|FG001|Up to Month 7|Withdrawal by Subject|0|||
125582331|NCT01262976|451758696|FG002|Up to Month 7|Withdrawal by Subject|0|||
125582332|NCT01262976|451758697|FG003|Up to Month 7|Withdrawal by Subject|0|||
125582333|NCT01262976|451758698|FG004|Up to Month 7|Withdrawal by Subject|0|||
125582334|NCT01262976|451758699|FG005|Up to Month 7|Withdrawal by Subject|0|||
125582335|NCT01262976|451758694|FG000|Up to Month 7|Migrated/moved from study area|0|||
125582336|NCT01262976|451758695|FG001|Up to Month 7|Migrated/moved from study area|0|||
125582337|NCT01262976|451758696|FG002|Up to Month 7|Migrated/moved from study area|1|||
125582338|NCT01262976|451758697|FG003|Up to Month 7|Migrated/moved from study area|3|||
125582339|NCT01262976|451758698|FG004|Up to Month 7|Migrated/moved from study area|1|||
125582340|NCT01262976|451758699|FG005|Up to Month 7|Migrated/moved from study area|1|||
125582341|NCT01262976|451758694|FG000|Up to Month 7|Lost to Follow-up|1|||
125582342|NCT01262976|451758695|FG001|Up to Month 7|Lost to Follow-up|0|||
125582343|NCT01262976|451758696|FG002|Up to Month 7|Lost to Follow-up|1|||
125582344|NCT01262976|451758697|FG003|Up to Month 7|Lost to Follow-up|3|||
125582345|NCT01262976|451758698|FG004|Up to Month 7|Lost to Follow-up|1|||
125582346|NCT01262976|451758699|FG005|Up to Month 7|Lost to Follow-up|3|||
125582347|NCT01262976|451758694|FG000|Up to Month 7|Other|3|||
125582348|NCT01262976|451758695|FG001|Up to Month 7|Other|0|||
125582349|NCT01262976|451758696|FG002|Up to Month 7|Other|2|||
125361184|NCT02281773|450958048|FG002|Overall Study|Adverse Event|4|||
125582350|NCT01262976|451758697|FG003|Up to Month 7|Other|0|||
125582351|NCT01262976|451758698|FG004|Up to Month 7|Other|0|||
125582352|NCT01262976|451758699|FG005|Up to Month 7|Other|0|||
125582353|NCT01262976|451758694|FG000|Up to Year 1|Serious Adverse Event|0|||
125582354|NCT01262976|451758695|FG001|Up to Year 1|Serious Adverse Event|0|||
125582355|NCT01262976|451758696|FG002|Up to Year 1|Serious Adverse Event|2|||
125582356|NCT01262976|451758697|FG003|Up to Year 1|Serious Adverse Event|0|||
125582357|NCT01262976|451758698|FG004|Up to Year 1|Serious Adverse Event|0|||
125582358|NCT01262976|451758699|FG005|Up to Year 1|Serious Adverse Event|0|||
125582359|NCT01262976|451758694|FG000|Up to Year 1|Withdrawal by Subject|1|||
125582360|NCT01262976|451758695|FG001|Up to Year 1|Withdrawal by Subject|0|||
125582361|NCT01262976|451758696|FG002|Up to Year 1|Withdrawal by Subject|0|||
125582362|NCT01262976|451758697|FG003|Up to Year 1|Withdrawal by Subject|0|||
125582363|NCT01262976|451758698|FG004|Up to Year 1|Withdrawal by Subject|0|||
125582364|NCT01262976|451758699|FG005|Up to Year 1|Withdrawal by Subject|0|||
125582365|NCT01262976|451758694|FG000|Up to Year 1|Migrated/moved from study area|1|||
125582366|NCT01262976|451758695|FG001|Up to Year 1|Migrated/moved from study area|0|||
125582367|NCT01262976|451758696|FG002|Up to Year 1|Migrated/moved from study area|0|||
125582368|NCT01262976|451758697|FG003|Up to Year 1|Migrated/moved from study area|3|||
125582369|NCT01262976|451758698|FG004|Up to Year 1|Migrated/moved from study area|3|||
125582370|NCT01262976|451758699|FG005|Up to Year 1|Migrated/moved from study area|2|||
125582371|NCT01262976|451758694|FG000|Up to Year 1|Lost to Follow-up|4|||
125582372|NCT01262976|451758695|FG001|Up to Year 1|Lost to Follow-up|0|||
125582373|NCT01262976|451758696|FG002|Up to Year 1|Lost to Follow-up|0|||
125582374|NCT01262976|451758697|FG003|Up to Year 1|Lost to Follow-up|1|||
125582375|NCT01262976|451758698|FG004|Up to Year 1|Lost to Follow-up|6|||
125582376|NCT01262976|451758699|FG005|Up to Year 1|Lost to Follow-up|5|||
125582377|NCT01262976|451758694|FG000|Up to Year 1|Other|3|||
125582378|NCT01262976|451758695|FG001|Up to Year 1|Other|1|||
125582379|NCT01262976|451758696|FG002|Up to Year 1|Other|0|||
125582380|NCT01262976|451758697|FG003|Up to Year 1|Other|0|||
125582381|NCT01262976|451758698|FG004|Up to Year 1|Other|2|||
125582382|NCT01262976|451758699|FG005|Up to Year 1|Other|1|||
125582383|NCT01262976|451758694|FG000|Up to Year 1|Subjects with unknown completion status|0|||
125582384|NCT01262976|451758695|FG001|Up to Year 1|Subjects with unknown completion status|0|||
125582385|NCT01262976|451758696|FG002|Up to Year 1|Subjects with unknown completion status|1|||
125582386|NCT01262976|451758697|FG003|Up to Year 1|Subjects with unknown completion status|0|||
125582387|NCT01262976|451758698|FG004|Up to Year 1|Subjects with unknown completion status|0|||
125582388|NCT01262976|451758699|FG005|Up to Year 1|Subjects with unknown completion status|1|||
125582389|NCT01262976|451758694|FG000|Up to Year 2|Serious Adverse Event|0|||
125582390|NCT01262976|451758695|FG001|Up to Year 2|Serious Adverse Event|0|||
125582391|NCT01262976|451758696|FG002|Up to Year 2|Serious Adverse Event|2|||
125582392|NCT01262976|451758697|FG003|Up to Year 2|Serious Adverse Event|0|||
125582393|NCT01262976|451758698|FG004|Up to Year 2|Serious Adverse Event|0|||
125582394|NCT01262976|451758699|FG005|Up to Year 2|Serious Adverse Event|0|||
125582395|NCT01262976|451758694|FG000|Up to Year 2|Withdrawal by Subject|1|||
125582396|NCT01262976|451758695|FG001|Up to Year 2|Withdrawal by Subject|0|||
125582397|NCT01262976|451758696|FG002|Up to Year 2|Withdrawal by Subject|0|||
125582398|NCT01262976|451758697|FG003|Up to Year 2|Withdrawal by Subject|0|||
125582399|NCT01262976|451758698|FG004|Up to Year 2|Withdrawal by Subject|0|||
125582400|NCT01262976|451758699|FG005|Up to Year 2|Withdrawal by Subject|0|||
125582401|NCT01262976|451758694|FG000|Up to Year 2|Migrated/moved from study area|0|||
125582402|NCT01262976|451758695|FG001|Up to Year 2|Migrated/moved from study area|0|||
125582403|NCT01262976|451758696|FG002|Up to Year 2|Migrated/moved from study area|0|||
125582404|NCT01262976|451758697|FG003|Up to Year 2|Migrated/moved from study area|2|||
125582405|NCT01262976|451758698|FG004|Up to Year 2|Migrated/moved from study area|1|||
125582406|NCT01262976|451758699|FG005|Up to Year 2|Migrated/moved from study area|2|||
125582407|NCT01262976|451758694|FG000|Up to Year 2|Lost to Follow-up|1|||
125582408|NCT01262976|451758695|FG001|Up to Year 2|Lost to Follow-up|1|||
125582409|NCT01262976|451758696|FG002|Up to Year 2|Lost to Follow-up|2|||
125582410|NCT01262976|451758697|FG003|Up to Year 2|Lost to Follow-up|2|||
125582411|NCT01262976|451758698|FG004|Up to Year 2|Lost to Follow-up|3|||
125582412|NCT01262976|451758699|FG005|Up to Year 2|Lost to Follow-up|3|||
125582413|NCT01262976|451758694|FG000|Up to Year 2|Subjects with unknown completion status|0|||
125582414|NCT01262976|451758695|FG001|Up to Year 2|Subjects with unknown completion status|0|||
125582415|NCT01262976|451758696|FG002|Up to Year 2|Subjects with unknown completion status|1|||
125582416|NCT01262976|451758697|FG003|Up to Year 2|Subjects with unknown completion status|0|||
125582417|NCT01262976|451758698|FG004|Up to Year 2|Subjects with unknown completion status|0|||
125582418|NCT01262976|451758699|FG005|Up to Year 2|Subjects with unknown completion status|0|||
125582419|NCT01262976|451758694|FG000|Up to Year 2|Other|3|||
125582420|NCT01262976|451758695|FG001|Up to Year 2|Other|0|||
125582421|NCT01262976|451758696|FG002|Up to Year 2|Other|0|||
125582422|NCT01262976|451758697|FG003|Up to Year 2|Other|0|||
125582423|NCT01262976|451758698|FG004|Up to Year 2|Other|0|||
125582424|NCT01262976|451758699|FG005|Up to Year 2|Other|0|||
125582425|NCT01262976|451758694|FG000|Up to Year 3|Serious Adverse Event|0|||
125582426|NCT01262976|451758695|FG001|Up to Year 3|Serious Adverse Event|0|||
125582427|NCT01262976|451758696|FG002|Up to Year 3|Serious Adverse Event|2|||
125582428|NCT01262976|451758697|FG003|Up to Year 3|Serious Adverse Event|0|||
125582429|NCT01262976|451758698|FG004|Up to Year 3|Serious Adverse Event|0|||
125582430|NCT01262976|451758699|FG005|Up to Year 3|Serious Adverse Event|0|||
125361185|NCT02281773|450958049|FG003|Overall Study|Adverse Event|8|||
125361186|NCT02281773|450958050|FG004|Overall Study|Adverse Event|9|||
125361187|NCT02281773|450958046|FG000|Overall Study|Protocol Violation|1|||
125361188|NCT02281773|450958047|FG001|Overall Study|Protocol Violation|0|||
125361189|NCT02281773|450958048|FG002|Overall Study|Protocol Violation|0|||
125361190|NCT02281773|450958049|FG003|Overall Study|Protocol Violation|2|||
125361191|NCT02281773|450958050|FG004|Overall Study|Protocol Violation|2|||
125361192|NCT02281773|450958046|FG000|Overall Study|Lost to Follow-up|2|||
125361193|NCT02281773|450958047|FG001|Overall Study|Lost to Follow-up|2|||
125361194|NCT02281773|450958048|FG002|Overall Study|Lost to Follow-up|6|||
125361195|NCT02281773|450958049|FG003|Overall Study|Lost to Follow-up|2|||
125361196|NCT02281773|450958050|FG004|Overall Study|Lost to Follow-up|10|||
125361197|NCT02281773|450958046|FG000|Overall Study|Withdrawal by Subject|2|||
125361198|NCT02281773|450958047|FG001|Overall Study|Withdrawal by Subject|8|||
125361199|NCT02281773|450958048|FG002|Overall Study|Withdrawal by Subject|6|||
125361200|NCT02281773|450958049|FG003|Overall Study|Withdrawal by Subject|6|||
125361201|NCT02281773|450958050|FG004|Overall Study|Withdrawal by Subject|8|||
125361202|NCT02281773|450958046|FG000|Overall Study|Other Reason|0|||
125361203|NCT02281773|450958047|FG001|Overall Study|Other Reason|4|||
125361204|NCT02281773|450958048|FG002|Overall Study|Other Reason|2|||
125361205|NCT02281773|450958049|FG003|Overall Study|Other Reason|3|||
125361206|NCT02281773|450958050|FG004|Overall Study|Other Reason|1|||
125361207|NCT05439941|450958051|FG000|Overall Study|Lack of Efficacy|8|||
125361208|NCT05439941|450958052|FG001|Overall Study|Lack of Efficacy|5|||
125361209|NCT05439941|450958053|FG002|Overall Study|Lack of Efficacy|3|||
125361210|NCT05439941|450958051|FG000|Overall Study|Treatment Failure|0|||
125361211|NCT05439941|450958052|FG001|Overall Study|Treatment Failure|1|||
125361212|NCT05439941|450958053|FG002|Overall Study|Treatment Failure|0|||
125361213|NCT05439941|450958051|FG000|Overall Study|Adverse Event|1|||
125361214|NCT05439941|450958052|FG001|Overall Study|Adverse Event|3|||
125361215|NCT05439941|450958053|FG002|Overall Study|Adverse Event|0|||
125361216|NCT05439941|450958051|FG000|Overall Study|Adverse Event - Parent Study|1|||
125361217|NCT05439941|450958052|FG001|Overall Study|Adverse Event - Parent Study|0|||
125361218|NCT05439941|450958053|FG002|Overall Study|Adverse Event - Parent Study|0|||
125361219|NCT05439941|450958051|FG000|Overall Study|Pregnancy|1|||
125361220|NCT05439941|450958052|FG001|Overall Study|Pregnancy|0|||
125361221|NCT05439941|450958053|FG002|Overall Study|Pregnancy|0|||
125361222|NCT05439941|450958051|FG000|Overall Study|Withdrawal by Subject|9|||
125361223|NCT05439941|450958052|FG001|Overall Study|Withdrawal by Subject|6|||
125361224|NCT05439941|450958053|FG002|Overall Study|Withdrawal by Subject|10|||
125361225|NCT05439941|450958051|FG000|Overall Study|Non-Compliance|1|||
125361226|NCT05439941|450958052|FG001|Overall Study|Non-Compliance|1|||
125361227|NCT05439941|450958053|FG002|Overall Study|Non-Compliance|1|||
125361228|NCT05439941|450958051|FG000|Overall Study|Lost to Follow-up|2|||
125361229|NCT05439941|450958052|FG001|Overall Study|Lost to Follow-up|2|||
125361230|NCT05439941|450958053|FG002|Overall Study|Lost to Follow-up|0|||
125361231|NCT05439941|450958051|FG000|Overall Study|Physician Decision|1|||
125361232|NCT05439941|450958052|FG001|Overall Study|Physician Decision|0|||
125361233|NCT05439941|450958053|FG002|Overall Study|Physician Decision|0|||
125361234|NCT05439941|450958051|FG000|Overall Study|Trial Termination by Sponsor|78|||
125361235|NCT05439941|450958052|FG001|Overall Study|Trial Termination by Sponsor|83|||
125361236|NCT05439941|450958053|FG002|Overall Study|Trial Termination by Sponsor|65|||
125361237|NCT05439941|450958051|FG000|Overall Study|Other than Reasons Listed|2|||
125361238|NCT05439941|450958052|FG001|Overall Study|Other than Reasons Listed|1|||
125361239|NCT05439941|450958053|FG002|Overall Study|Other than Reasons Listed|0|||
125361240|NCT02422303|450958054|FG000|Overall Study|Lost to Follow-up|1|||
125361241|NCT02422303|450958055|FG001|Overall Study|Lost to Follow-up|1|||
125361242|NCT02899299|450958056|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
125361243|NCT02899299|450958057|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
125361244|NCT02899299|450958056|FG000|Pre-treatment|Participant withdrew consent|1|||
125361245|NCT02899299|450958057|FG001|Pre-treatment|Participant withdrew consent|11|||
125361246|NCT02899299|450958056|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
125361247|NCT02899299|450958057|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
125361248|NCT02899299|450958056|FG000|Pre-treatment|Not reported|0|||
125361249|NCT02899299|450958057|FG001|Pre-treatment|Not reported|1|||
125361250|NCT02899299|450958056|FG000|Treatment|Disease Progression|182|||
125361251|NCT02899299|450958057|FG001|Treatment|Disease Progression|43|||
125361252|NCT02899299|450958056|FG000|Treatment|Study Drug Toxicity|60|||
125361253|NCT02899299|450958057|FG001|Treatment|Study Drug Toxicity|24|||
125361254|NCT02899299|450958056|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
125361255|NCT02899299|450958057|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
125361256|NCT02899299|450958056|FG000|Treatment|Participant request to discontinue Study treatment|4|||
125361257|NCT02899299|450958057|FG001|Treatment|Participant request to discontinue Study treatment|10|||
125361258|NCT02899299|450958056|FG000|Treatment|Participant withdrew consent|6|||
125361259|NCT02899299|450958057|FG001|Treatment|Participant withdrew consent|3|||
125361260|NCT02899299|450958056|FG000|Treatment|Lost to Follow-up|0|||
125361261|NCT02899299|450958057|FG001|Treatment|Lost to Follow-up|2|||
125361262|NCT02899299|450958056|FG000|Treatment|Maximum Clinical Benefit|11|||
125361263|NCT02899299|450958057|FG001|Treatment|Maximum Clinical Benefit|2|||
125361264|NCT02899299|450958056|FG000|Treatment|Poor/Non-compliance|1|||
125361265|NCT02899299|450958057|FG001|Treatment|Poor/Non-compliance|0|||
125361266|NCT02899299|450958056|FG000|Treatment|Participant no longer meets Study criteria|4|||
125361267|NCT02899299|450958057|FG001|Treatment|Participant no longer meets Study criteria|0|||
125361268|NCT02899299|450958056|FG000|Treatment|Administrative reason by Sponsor|2|||
125361269|NCT02899299|450958057|FG001|Treatment|Administrative reason by Sponsor|0|||
125361270|NCT02899299|450958056|FG000|Treatment|Other reasons|12|||
125361271|NCT02899299|450958057|FG001|Treatment|Other reasons|2|||
125361272|NCT02899299|450958056|FG000|Treatment|Not reported|7|||
125361273|NCT02899299|450958057|FG001|Treatment|Not reported|0|||
125361274|NCT00639678|450958060|FG000|Overall Study|Withdrawal by Subject|3|||
125361275|NCT00639678|450958061|FG001|Overall Study|Withdrawal by Subject|0|||
125361276|NCT00639678|450958062|FG002|Overall Study|Withdrawal by Subject|4|||
125361277|NCT00639678|450958063|FG003|Overall Study|Withdrawal by Subject|0|||
125361278|NCT00639678|450958060|FG000|Overall Study|Lost to Follow-up|1|||
125361279|NCT00639678|450958061|FG001|Overall Study|Lost to Follow-up|0|||
125361280|NCT00639678|450958062|FG002|Overall Study|Lost to Follow-up|6|||
125361281|NCT00639678|450958063|FG003|Overall Study|Lost to Follow-up|0|||
125361282|NCT00639678|450958060|FG000|Overall Study|Adverse Event|0|||
125361283|NCT00639678|450958061|FG001|Overall Study|Adverse Event|1|||
125361284|NCT00639678|450958062|FG002|Overall Study|Adverse Event|0|||
125428325|NCT05131165|451193863|FG000|Overall Study|Transferred out of clinic|1|||
125428326|NCT05131165|451193864|FG001|Overall Study|Transferred out of clinic|0|||
125428327|NCT05131165|451193865|FG002|Overall Study|Transferred out of clinic|3|||
125428328|NCT05131165|451193863|FG000|Overall Study|Dropped out|1|||
125428329|NCT05131165|451193864|FG001|Overall Study|Dropped out|2|||
125582431|NCT01262976|451758694|FG000|Up to Year 3|Withdrawal by Subject|1|||
125582432|NCT01262976|451758695|FG001|Up to Year 3|Withdrawal by Subject|0|||
125582433|NCT01262976|451758696|FG002|Up to Year 3|Withdrawal by Subject|0|||
125582434|NCT01262976|451758697|FG003|Up to Year 3|Withdrawal by Subject|0|||
125582435|NCT01262976|451758698|FG004|Up to Year 3|Withdrawal by Subject|0|||
125582436|NCT01262976|451758699|FG005|Up to Year 3|Withdrawal by Subject|0|||
125582437|NCT01262976|451758694|FG000|Up to Year 3|Migrated/moved from study area|0|||
125582438|NCT01262976|451758695|FG001|Up to Year 3|Migrated/moved from study area|0|||
125582439|NCT01262976|451758696|FG002|Up to Year 3|Migrated/moved from study area|0|||
125582440|NCT01262976|451758697|FG003|Up to Year 3|Migrated/moved from study area|2|||
125582441|NCT01262976|451758698|FG004|Up to Year 3|Migrated/moved from study area|1|||
125582442|NCT01262976|451758699|FG005|Up to Year 3|Migrated/moved from study area|1|||
125582443|NCT01262976|451758694|FG000|Up to Year 3|Lost to Follow-up|2|||
125582444|NCT01262976|451758695|FG001|Up to Year 3|Lost to Follow-up|2|||
125582445|NCT01262976|451758696|FG002|Up to Year 3|Lost to Follow-up|4|||
125582446|NCT01262976|451758697|FG003|Up to Year 3|Lost to Follow-up|3|||
125582447|NCT01262976|451758698|FG004|Up to Year 3|Lost to Follow-up|1|||
125582448|NCT01262976|451758699|FG005|Up to Year 3|Lost to Follow-up|3|||
125582449|NCT01262976|451758694|FG000|Up to Year 3|Subjects with unknown completion status|0|||
125582450|NCT01262976|451758695|FG001|Up to Year 3|Subjects with unknown completion status|0|||
125582451|NCT01262976|451758696|FG002|Up to Year 3|Subjects with unknown completion status|1|||
125582452|NCT01262976|451758697|FG003|Up to Year 3|Subjects with unknown completion status|0|||
125582453|NCT01262976|451758698|FG004|Up to Year 3|Subjects with unknown completion status|0|||
125582454|NCT01262976|451758699|FG005|Up to Year 3|Subjects with unknown completion status|0|||
125582455|NCT01262976|451758694|FG000|Up to Year 3|Other|3|||
125582456|NCT01262976|451758695|FG001|Up to Year 3|Other|0|||
125582457|NCT01262976|451758696|FG002|Up to Year 3|Other|0|||
125582458|NCT01262976|451758697|FG003|Up to Year 3|Other|0|||
125361285|NCT00639678|450958063|FG003|Overall Study|Adverse Event|0|||
125361286|NCT00639678|450958060|FG000|Overall Study|Lack of Compliance|0|||
125428330|NCT05131165|451193865|FG002|Overall Study|Dropped out|0|||
125428331|NCT02459262|451193871|FG000|Overall Study|Withdrawal by Subject|0|||
125428332|NCT02459262|451193872|FG001|Overall Study|Withdrawal by Subject|0|||
125428333|NCT02459262|451193873|FG002|Overall Study|Withdrawal by Subject|0|||
125582459|NCT01262976|451758698|FG004|Up to Year 3|Other|0|||
125361287|NCT00639678|450958061|FG001|Overall Study|Lack of Compliance|0|||
125361288|NCT00639678|450958062|FG002|Overall Study|Lack of Compliance|1|||
125361289|NCT00639678|450958063|FG003|Overall Study|Lack of Compliance|0|||
125361290|NCT01926015|450958064|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125361291|NCT01926015|450958065|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125361292|NCT01926015|450958064|FG000|Overall Study|Randomized not treated|2|||
125361293|NCT01926015|450958065|FG001|Overall Study|Randomized not treated|0|||
125582460|NCT01262976|451758699|FG005|Up to Year 3|Other|0|||
125582461|NCT03665285|451758701|FG000|Overall Study|Started New Anticancer Treatment|1|||
125582462|NCT03665285|451758702|FG001|Overall Study|Started New Anticancer Treatment|1|||
125582463|NCT03665285|451758703|FG002|Overall Study|Started New Anticancer Treatment|2|||
125428334|NCT02459262|451193874|FG003|Overall Study|Withdrawal by Subject|0|||
125428335|NCT02459262|451193875|FG004|Overall Study|Withdrawal by Subject|0|||
125582464|NCT03665285|451758704|FG003|Overall Study|Started New Anticancer Treatment|4|||
125131364|NCT01854047|450108128|FG001|Overall Study|Poor compliance to protocol|0|||
125131365|NCT01854047|450108129|FG002|Overall Study|Poor compliance to protocol|2|||
125131366|NCT01854047|450108130|FG003|Overall Study|Poor compliance to protocol|0|||
125131367|NCT01854047|450108131|FG004|Overall Study|Poor compliance to protocol|0|||
125131368|NCT01854047|450108127|FG000|Overall Study|Adverse Event|5|||
125131369|NCT01854047|450108128|FG001|Overall Study|Adverse Event|4|||
125131370|NCT01854047|450108129|FG002|Overall Study|Adverse Event|6|||
125131371|NCT01854047|450108130|FG003|Overall Study|Adverse Event|10|||
125131372|NCT01854047|450108131|FG004|Overall Study|Adverse Event|7|||
125131373|NCT01854047|450108127|FG000|Overall Study|Randomized but not treated|0|||
125131374|NCT01854047|450108128|FG001|Overall Study|Randomized but not treated|1|||
125131375|NCT01854047|450108129|FG002|Overall Study|Randomized but not treated|2|||
125131376|NCT01854047|450108130|FG003|Overall Study|Randomized but not treated|0|||
125131377|NCT01854047|450108131|FG004|Overall Study|Randomized but not treated|4|||
125131378|NCT01854047|450108127|FG000|Overall Study|Other than specified above|3|||
125131379|NCT01854047|450108128|FG001|Overall Study|Other than specified above|3|||
125131380|NCT01854047|450108129|FG002|Overall Study|Other than specified above|3|||
125131381|NCT01854047|450108130|FG003|Overall Study|Other than specified above|5|||
125131382|NCT01854047|450108131|FG004|Overall Study|Other than specified above|8|||
125582465|NCT03665285|451758705|FG004|Overall Study|Started New Anticancer Treatment|1|||
125582466|NCT03665285|451758706|FG005|Overall Study|Started New Anticancer Treatment|1|||
125582467|NCT03665285|451758707|FG006|Overall Study|Started New Anticancer Treatment|2|||
125582468|NCT03665285|451758708|FG007|Overall Study|Started New Anticancer Treatment|15|||
125582469|NCT03665285|451758709|FG008|Overall Study|Started New Anticancer Treatment|1|||
125582470|NCT03665285|451758701|FG000|Overall Study|Disease Progression|0|||
125582471|NCT03665285|451758702|FG001|Overall Study|Disease Progression|0|||
125582472|NCT03665285|451758703|FG002|Overall Study|Disease Progression|3|||
125582473|NCT03665285|451758704|FG003|Overall Study|Disease Progression|1|||
125582474|NCT03665285|451758705|FG004|Overall Study|Disease Progression|0|||
125582475|NCT03665285|451758706|FG005|Overall Study|Disease Progression|0|||
125131383|NCT02847650|450109958|FG000|Overall Study|Adverse Event|2|||
125131384|NCT02847650|450109959|FG001|Overall Study|Adverse Event|4|||
125131385|NCT02847650|450109958|FG000|Overall Study|Lost to Follow-up|1|||
125131386|NCT02847650|450109959|FG001|Overall Study|Lost to Follow-up|0|||
125131387|NCT02847650|450109958|FG000|Overall Study|Protocol Violation|0|||
125582476|NCT03665285|451758707|FG006|Overall Study|Disease Progression|0|||
125582477|NCT03665285|451758708|FG007|Overall Study|Disease Progression|7|||
125582478|NCT03665285|451758709|FG008|Overall Study|Disease Progression|1|||
125582479|NCT03665285|451758701|FG000|Overall Study|Hospice|0|||
125582480|NCT03665285|451758702|FG001|Overall Study|Hospice|0|||
125582481|NCT03665285|451758703|FG002|Overall Study|Hospice|0|||
125582482|NCT03665285|451758704|FG003|Overall Study|Hospice|0|||
125131388|NCT02847650|450109959|FG001|Overall Study|Protocol Violation|1|||
125131389|NCT02847650|450109958|FG000|Overall Study|Withdrawal by Subject|1|||
125131390|NCT02847650|450109959|FG001|Overall Study|Withdrawal by Subject|1|||
125131391|NCT03818581|450109960|FG000|Overall Study|Adverse Event|1|||
125582483|NCT03665285|451758705|FG004|Overall Study|Hospice|0|||
125582484|NCT03665285|451758706|FG005|Overall Study|Hospice|0|||
125582485|NCT03665285|451758707|FG006|Overall Study|Hospice|0|||
125582486|NCT03665285|451758708|FG007|Overall Study|Hospice|2|||
125582487|NCT03665285|451758709|FG008|Overall Study|Hospice|0|||
125582488|NCT03665285|451758701|FG000|Overall Study|Withdrawal by Subject|0|||
125582489|NCT03665285|451758702|FG001|Overall Study|Withdrawal by Subject|0|||
125582490|NCT03665285|451758703|FG002|Overall Study|Withdrawal by Subject|0|||
125582491|NCT03665285|451758704|FG003|Overall Study|Withdrawal by Subject|0|||
125582492|NCT03665285|451758705|FG004|Overall Study|Withdrawal by Subject|1|||
125361294|NCT01364649|450958066|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
125361295|NCT01364649|450958067|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
125361296|NCT01364649|450958066|FG000|Overall Study|Lack of Efficacy|6|||
125582493|NCT03665285|451758706|FG005|Overall Study|Withdrawal by Subject|0|||
125361297|NCT01364649|450958067|FG001|Overall Study|Lack of Efficacy|0|||
125361298|NCT01364649|450958066|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
125582494|NCT03665285|451758707|FG006|Overall Study|Withdrawal by Subject|0|||
125582495|NCT03665285|451758708|FG007|Overall Study|Withdrawal by Subject|2|||
125582496|NCT03665285|451758709|FG008|Overall Study|Withdrawal by Subject|0|||
125131392|NCT03818581|450109961|FG001|Overall Study|Adverse Event|0|||
125582497|NCT03665285|451758701|FG000|Overall Study|Physician Decision|0|||
125582498|NCT03665285|451758702|FG001|Overall Study|Physician Decision|0|||
125582499|NCT03665285|451758703|FG002|Overall Study|Physician Decision|0|||
125582500|NCT03665285|451758704|FG003|Overall Study|Physician Decision|0|||
125582501|NCT03665285|451758705|FG004|Overall Study|Physician Decision|0|||
125582502|NCT03665285|451758706|FG005|Overall Study|Physician Decision|0|||
125582503|NCT03665285|451758707|FG006|Overall Study|Physician Decision|0|||
125582504|NCT03665285|451758708|FG007|Overall Study|Physician Decision|2|||
125582505|NCT03665285|451758709|FG008|Overall Study|Physician Decision|0|||
125582506|NCT00354601|451758710|FG000|Overall Study|Protocol Violation|1|||
125582507|NCT00354601|451758710|FG000|Overall Study|progression|1|||
125582508|NCT03603652|451758711|FG000|Overall Study|Death|2|||
125582509|NCT02532855|451758714|FG000|Overall Study|Lost to Follow-up|4|||
125582510|NCT02532855|451758715|FG001|Overall Study|Lost to Follow-up|3|||
125582511|NCT02532855|451758714|FG000|Overall Study|Withdrawal by Subject|4|||
125582512|NCT02532855|451758715|FG001|Overall Study|Withdrawal by Subject|8|||
125582513|NCT01960855|451758716|FG000|Overall Study|Subject noncompliant|1|||
125582514|NCT01960855|451758717|FG001|Overall Study|Subject noncompliant|0|||
125582515|NCT01960855|451758718|FG002|Overall Study|Subject noncompliant|0|||
125582516|NCT01960855|451758719|FG003|Overall Study|Subject noncompliant|0|||
125582517|NCT01960855|451758720|FG004|Overall Study|Subject noncompliant|0|||
125582518|NCT01960855|451758716|FG000|Overall Study|Adverse Event|2|||
125582519|NCT01960855|451758717|FG001|Overall Study|Adverse Event|0|||
125582520|NCT01960855|451758718|FG002|Overall Study|Adverse Event|6|||
125582521|NCT01960855|451758719|FG003|Overall Study|Adverse Event|2|||
125582522|NCT01960855|451758720|FG004|Overall Study|Adverse Event|2|||
125582523|NCT01960855|451758716|FG000|Overall Study|Lack of Efficacy|1|||
125582524|NCT01960855|451758717|FG001|Overall Study|Lack of Efficacy|1|||
125582525|NCT01960855|451758718|FG002|Overall Study|Lack of Efficacy|0|||
125582526|NCT01960855|451758719|FG003|Overall Study|Lack of Efficacy|0|||
125582527|NCT01960855|451758720|FG004|Overall Study|Lack of Efficacy|0|||
125582528|NCT01960855|451758716|FG000|Overall Study|Other|2|||
125582529|NCT01960855|451758717|FG001|Overall Study|Other|1|||
125582530|NCT01960855|451758718|FG002|Overall Study|Other|1|||
125582531|NCT01960855|451758719|FG003|Overall Study|Other|1|||
125582532|NCT01960855|451758720|FG004|Overall Study|Other|0|||
125582533|NCT01960855|451758716|FG000|Overall Study|Consent withdrawn by subject|3|||
125582534|NCT01960855|451758717|FG001|Overall Study|Consent withdrawn by subject|1|||
125582535|NCT01960855|451758718|FG002|Overall Study|Consent withdrawn by subject|2|||
125582536|NCT01960855|451758719|FG003|Overall Study|Consent withdrawn by subject|1|||
125582537|NCT01960855|451758720|FG004|Overall Study|Consent withdrawn by subject|1|||
125582538|NCT01960855|451758716|FG000|Overall Study|Lost to Follow-up|2|||
125582539|NCT01960855|451758717|FG001|Overall Study|Lost to Follow-up|1|||
125582540|NCT01960855|451758718|FG002|Overall Study|Lost to Follow-up|0|||
125582541|NCT01960855|451758719|FG003|Overall Study|Lost to Follow-up|0|||
125582542|NCT01960855|451758720|FG004|Overall Study|Lost to Follow-up|2|||
125582543|NCT02058147|451758721|FG000|Overall Study|Randomized but not treated|0|||
125582544|NCT02058147|451758722|FG001|Overall Study|Randomized but not treated|0|||
125582545|NCT02058147|451758723|FG002|Overall Study|Randomized but not treated|1|||
125582546|NCT02058147|451758721|FG000|Overall Study|Adverse Event|12|||
125582547|NCT02058147|451758722|FG001|Overall Study|Adverse Event|9|||
125582548|NCT02058147|451758723|FG002|Overall Study|Adverse Event|21|||
125582549|NCT02058147|451758721|FG000|Overall Study|Lack of Efficacy|1|||
125582550|NCT02058147|451758722|FG001|Overall Study|Lack of Efficacy|0|||
125582551|NCT02058147|451758723|FG002|Overall Study|Lack of Efficacy|3|||
125582552|NCT02058147|451758721|FG000|Overall Study|Poor compliance to protocol|8|||
125582553|NCT02058147|451758722|FG001|Overall Study|Poor compliance to protocol|9|||
125582554|NCT02058147|451758723|FG002|Overall Study|Poor compliance to protocol|4|||
125582555|NCT02058147|451758721|FG000|Overall Study|Other than specified|8|||
125428336|NCT02459262|451193876|FG005|Overall Study|Withdrawal by Subject|0|||
125428337|NCT02459262|451193877|FG006|Overall Study|Withdrawal by Subject|0|||
125582556|NCT02058147|451758722|FG001|Overall Study|Other than specified|9|||
125582557|NCT02058147|451758723|FG002|Overall Study|Other than specified|0|||
125582558|NCT02154425|451758726|FG000|Screening Period|Adverse Event|1|||
125582559|NCT02908516|451758727|FG000|Overall Study|Study Terminated|3|||
125582560|NCT02908516|451758728|FG001|Overall Study|Study Terminated|3|||
125582561|NCT01162421|451758729|FG000|Overall Study|Did not receive study drug|2|||
125582562|NCT01162421|451758730|FG001|Overall Study|Did not receive study drug|1|||
125582563|NCT01162421|451758729|FG000|Overall Study|Adverse Event|2|||
125582564|NCT01162421|451758730|FG001|Overall Study|Adverse Event|5|||
125582565|NCT01162421|451758729|FG000|Overall Study|Lost to Follow-up|0|||
125582566|NCT01162421|451758730|FG001|Overall Study|Lost to Follow-up|2|||
125582567|NCT01162421|451758729|FG000|Overall Study|Lack of Efficacy|2|||
125582568|NCT01162421|451758730|FG001|Overall Study|Lack of Efficacy|2|||
125582569|NCT01162421|451758729|FG000|Overall Study|Other|2|||
125582570|NCT01162421|451758730|FG001|Overall Study|Other|3|||
125582571|NCT02867761|451758736|FG000|Overall Study|Participant withdrawn by investigator|0|||
125582572|NCT02867761|451758737|FG001|Overall Study|Participant withdrawn by investigator|1|||
125361299|NCT01364649|450958067|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
125361300|NCT01364649|450958066|FG000|Overall Study|Protocol Deviations|4|||
125361301|NCT01364649|450958067|FG001|Overall Study|Protocol Deviations|8|||
125361302|NCT01364649|450958066|FG000|Overall Study|Withdrawal of Consent|9|||
125361303|NCT01364649|450958067|FG001|Overall Study|Withdrawal of Consent|7|||
125361304|NCT01364649|450958066|FG000|Overall Study|Lost to Follow-up|12|||
125361305|NCT01364649|450958067|FG001|Overall Study|Lost to Follow-up|13|||
125361306|NCT01364649|450958066|FG000|Overall Study|Other|4|||
125361307|NCT01364649|450958067|FG001|Overall Study|Other|1|||
125361308|NCT00617851|450958068|FG000|Overall Study|Death|0|||
125361309|NCT00617851|450958069|FG001|Overall Study|Death|0|||
125361310|NCT00617851|450958070|FG002|Overall Study|Death|0|||
125361311|NCT00617851|450958071|FG003|Overall Study|Death|1|||
125361312|NCT00617851|450958068|FG000|Overall Study|Withdrawal by Subject|14|||
125361313|NCT00617851|450958069|FG001|Overall Study|Withdrawal by Subject|7|||
125361314|NCT00617851|450958070|FG002|Overall Study|Withdrawal by Subject|12|||
125361315|NCT00617851|450958071|FG003|Overall Study|Withdrawal by Subject|4|||
125361316|NCT00617851|450958068|FG000|Overall Study|Lost to Follow-up|27|||
125361317|NCT00617851|450958069|FG001|Overall Study|Lost to Follow-up|29|||
125361318|NCT00617851|450958070|FG002|Overall Study|Lost to Follow-up|31|||
125361319|NCT00617851|450958071|FG003|Overall Study|Lost to Follow-up|19|||
125361320|NCT00617851|450958068|FG000|Overall Study|Inappropriate Enrollment|5|||
125361321|NCT00617851|450958069|FG001|Overall Study|Inappropriate Enrollment|4|||
125361322|NCT00617851|450958070|FG002|Overall Study|Inappropriate Enrollment|1|||
125582573|NCT02867761|451758736|FG000|Overall Study|Lost to Follow-up|25|||
125582574|NCT02867761|451758737|FG001|Overall Study|Lost to Follow-up|18|||
125582575|NCT02867761|451758736|FG000|Overall Study|Unable to complete protocol|3|||
125582576|NCT02867761|451758737|FG001|Overall Study|Unable to complete protocol|7|||
125582577|NCT04506294|451758738|FG000|Overall Study|Lost to Follow-up|70|||
125582578|NCT04506294|451758739|FG001|Overall Study|Lost to Follow-up|20|||
125582579|NCT04506294|451758738|FG000|Overall Study|Withdrawal by Subject|16|||
125582580|NCT04506294|451758739|FG001|Overall Study|Withdrawal by Subject|2|||
125582581|NCT01931059|451758740|FG000|Day 1|Pregnancy|0|||
125582582|NCT01931059|451758741|FG001|Day 1|Pregnancy|1|||
125582583|NCT01931059|451758740|FG000|Day3|Lost to Follow-up|1|||
125582584|NCT01931059|451758741|FG001|Day3|Lost to Follow-up|0|||
125582585|NCT00578643|451758742|FG000|Overall Study|Death|1|||
125582586|NCT00578643|451758742|FG000|Overall Study|Lost to Follow-up|1|||
125582587|NCT04698629|451758743|FG000|Overall Study|Adverse Event|1|||
125582588|NCT05847686|451760614|FG000|Overall Study|Withdrawal by Subject|3|||
125582589|NCT00352534|451760616|FG000|Initial Staging|Ineligible|8|||
125582590|NCT00352534|451760617|FG001|Initial Staging|Ineligible|9|||
125582591|NCT00352534|451760618|FG002|Initial Staging|Ineligible|0|||
125582592|NCT00352534|451760619|FG003|Initial Staging|Ineligible|0|||
125582593|NCT00352534|451760620|FG004|Initial Staging|Ineligible|0|||
125582594|NCT00352534|451760621|FG005|Initial Staging|Ineligible|0|||
125582595|NCT00352534|451760622|FG006|Initial Staging|Ineligible|0|||
125582596|NCT00352534|451760616|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
125582597|NCT00352534|451760617|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
125582598|NCT00352534|451760618|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
125582599|NCT00352534|451760619|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
125582600|NCT00352534|451760620|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
125361323|NCT00617851|450958071|FG003|Overall Study|Inappropriate Enrollment|1|||
125361324|NCT00617851|450958068|FG000|Overall Study|Unable to classify|1|||
125361325|NCT00617851|450958069|FG001|Overall Study|Unable to classify|0|||
125361326|NCT00617851|450958070|FG002|Overall Study|Unable to classify|1|||
125361327|NCT00617851|450958071|FG003|Overall Study|Unable to classify|0|||
125361328|NCT00902668|450958078|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
125361329|NCT01914757|450958079|FG000|Overall Study|Severe non-compliance to protocol|3|||
125361330|NCT01914757|450958080|FG001|Overall Study|Severe non-compliance to protocol|1|||
125361331|NCT01914757|450958081|FG002|Overall Study|Severe non-compliance to protocol|2|||
125361332|NCT01914757|450958079|FG000|Overall Study|Lost to Follow-up|5|||
125361333|NCT01914757|450958080|FG001|Overall Study|Lost to Follow-up|8|||
125361334|NCT01914757|450958081|FG002|Overall Study|Lost to Follow-up|6|||
125361335|NCT01914757|450958079|FG000|Overall Study|Withdrawal by Subject|15|||
125361336|NCT01914757|450958080|FG001|Overall Study|Withdrawal by Subject|27|||
125361337|NCT01914757|450958081|FG002|Overall Study|Withdrawal by Subject|19|||
125582601|NCT00352534|451760621|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
125582602|NCT00352534|451760622|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
125582603|NCT00352534|451760616|FG000|Final Risk Group Assignment|Physician Decision|0|||
125582604|NCT00352534|451760617|FG001|Final Risk Group Assignment|Physician Decision|0|||
125582605|NCT00352534|451760618|FG002|Final Risk Group Assignment|Physician Decision|0|||
125582606|NCT00352534|451760619|FG003|Final Risk Group Assignment|Physician Decision|0|||
125582607|NCT00352534|451760620|FG004|Final Risk Group Assignment|Physician Decision|0|||
125582608|NCT00352534|451760621|FG005|Final Risk Group Assignment|Physician Decision|8|||
125582609|NCT00352534|451760622|FG006|Final Risk Group Assignment|Physician Decision|0|||
125582610|NCT00352534|451760616|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
125582611|NCT00352534|451760617|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
125582612|NCT00352534|451760618|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
125582613|NCT00352534|451760619|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
125582614|NCT00352534|451760620|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
125582615|NCT00352534|451760621|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
125582616|NCT00352534|451760622|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
125582617|NCT00352534|451760616|FG000|Final Risk Group Assignment|Ineligible|0|||
125582618|NCT00352534|451760617|FG001|Final Risk Group Assignment|Ineligible|0|||
125582619|NCT00352534|451760618|FG002|Final Risk Group Assignment|Ineligible|3|||
125582620|NCT00352534|451760619|FG003|Final Risk Group Assignment|Ineligible|1|||
125582621|NCT00352534|451760620|FG004|Final Risk Group Assignment|Ineligible|0|||
125582622|NCT00352534|451760621|FG005|Final Risk Group Assignment|Ineligible|13|||
125582623|NCT00352534|451760622|FG006|Final Risk Group Assignment|Ineligible|0|||
125582624|NCT00352534|451760616|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
125582625|NCT00352534|451760617|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
125582626|NCT00352534|451760618|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
125582627|NCT00352534|451760619|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
125582628|NCT00352534|451760620|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
125582629|NCT00352534|451760621|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
125582630|NCT00352534|451760622|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
125582631|NCT00352534|451760616|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
125582632|NCT00352534|451760617|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
125582633|NCT00352534|451760618|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
125582634|NCT00352534|451760619|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
125582635|NCT00352534|451760620|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
125582636|NCT00352534|451760621|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
125582637|NCT00352534|451760622|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
125582638|NCT00352534|451760616|FG000|Final Risk Group Assignment|Death|0|||
125582639|NCT00352534|451760617|FG001|Final Risk Group Assignment|Death|0|||
125582640|NCT00352534|451760618|FG002|Final Risk Group Assignment|Death|0|||
125582641|NCT00352534|451760619|FG003|Final Risk Group Assignment|Death|0|||
125582642|NCT00352534|451760620|FG004|Final Risk Group Assignment|Death|0|||
125582643|NCT00352534|451760621|FG005|Final Risk Group Assignment|Death|2|||
125582644|NCT00352534|451760622|FG006|Final Risk Group Assignment|Death|0|||
125582645|NCT01602341|451760623|FG000|Overall Study|Adverse Event|0|||
125582646|NCT01602341|451760624|FG001|Overall Study|Adverse Event|1|||
125582647|NCT02090855|451760625|FG000|Overall Study|no evaluable Standard of Truth results|2|||
125582648|NCT00388947|451760626|FG000|Overall Study|Protocol Violation|47|||
125582649|NCT03038308|451760627|FG000|Overall Study|Surgical resection|1|||
125582650|NCT03038308|451760627|FG000|Overall Study|Withdrawal by Subject|2|||
125582651|NCT03038308|451760627|FG000|Overall Study|Lost to Follow-up|1|||
125582652|NCT04187092|451760628|FG000|Overall Study|Lost to Follow-up|1|||
125582653|NCT04187092|451760629|FG001|Overall Study|Lost to Follow-up|1|||
125582654|NCT04187092|451760628|FG000|Overall Study|Withdrawal by Subject|1|||
125582655|NCT04187092|451760629|FG001|Overall Study|Withdrawal by Subject|1|||
125428338|NCT02459262|451193878|FG007|Overall Study|Withdrawal by Subject|0|||
125428339|NCT02459262|451193879|FG008|Overall Study|Withdrawal by Subject|0|||
125428340|NCT02459262|451193880|FG009|Overall Study|Withdrawal by Subject|1|||
125428341|NCT02459262|451193881|FG010|Overall Study|Withdrawal by Subject|0|||
125428342|NCT05168579|451193882|FG000|Overall Study|Lack of Consent|1|||
125428343|NCT05168579|451193883|FG001|Overall Study|Lack of Consent|0|||
125428344|NCT05168579|451193882|FG000|Overall Study|Conflicts with time|2|||
125428345|NCT05168579|451193883|FG001|Overall Study|Conflicts with time|0|||
125428346|NCT05168579|451193882|FG000|Overall Study|Time slots were full|3|||
125428347|NCT05168579|451193883|FG001|Overall Study|Time slots were full|0|||
125428348|NCT05168579|451193882|FG000|Overall Study|Lost to Follow-up|0|||
125428349|NCT05168579|451193883|FG001|Overall Study|Lost to Follow-up|15|||
125428350|NCT01242748|451193884|FG000|Overall Study|Adverse Event|10|||
125582656|NCT04187092|451760628|FG000|Overall Study|Adverse Event|0|||
125582657|NCT04187092|451760629|FG001|Overall Study|Adverse Event|1|||
125582658|NCT01777763|451760643|FG000|Overall Study|Adverse Event|2|||
125582659|NCT01777763|451760644|FG001|Overall Study|Adverse Event|32|||
125428351|NCT01242748|451193885|FG001|Overall Study|Adverse Event|5|||
125428352|NCT01242748|451193884|FG000|Overall Study|Lost to Follow-up|6|||
125428353|NCT01242748|451193885|FG001|Overall Study|Lost to Follow-up|2|||
125428354|NCT01242748|451193884|FG000|Overall Study|Physician Decision|3|||
125428355|NCT01242748|451193885|FG001|Overall Study|Physician Decision|2|||
125582660|NCT01777763|451760643|FG000|Overall Study|Protocol Violation|1|||
125582661|NCT01777763|451760644|FG001|Overall Study|Protocol Violation|7|||
125582662|NCT01777763|451760643|FG000|Overall Study|Withdrawal by Subject|0|||
125582663|NCT01777763|451760644|FG001|Overall Study|Withdrawal by Subject|2|||
125582664|NCT01777763|451760643|FG000|Overall Study|Treatment Failure|1|||
125582665|NCT01777763|451760644|FG001|Overall Study|Treatment Failure|6|||
125582666|NCT03969875|451760654|FG000|Overall Study|did not receive allocated intervention|3|||
125582667|NCT03969875|451760655|FG001|Overall Study|did not receive allocated intervention|3|||
125582668|NCT03969875|451760656|FG002|Overall Study|did not receive allocated intervention|4|||
125582669|NCT03969875|451760654|FG000|Overall Study|Protocol Violation|4|||
125582670|NCT03969875|451760655|FG001|Overall Study|Protocol Violation|2|||
125582671|NCT03969875|451760656|FG002|Overall Study|Protocol Violation|2|||
125361338|NCT01914757|450958079|FG000|Overall Study|Death|2|||
125361339|NCT01914757|450958080|FG001|Overall Study|Death|2|||
125361340|NCT01914757|450958081|FG002|Overall Study|Death|1|||
125361341|NCT01914757|450958079|FG000|Overall Study|Adverse Event|4|||
125361342|NCT01914757|450958080|FG001|Overall Study|Adverse Event|3|||
125361343|NCT01914757|450958081|FG002|Overall Study|Adverse Event|4|||
125361344|NCT01914757|450958079|FG000|Overall Study|Study specific withdrawal criteria|0|||
125361345|NCT01914757|450958080|FG001|Overall Study|Study specific withdrawal criteria|1|||
125361346|NCT01914757|450958081|FG002|Overall Study|Study specific withdrawal criteria|0|||
125361347|NCT01914757|450958079|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125361348|NCT01914757|450958080|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125361349|NCT01914757|450958081|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
125361350|NCT01914757|450958079|FG000|Overall Study|Other reasons|5|||
125361351|NCT01914757|450958080|FG001|Overall Study|Other reasons|9|||
125361352|NCT01914757|450958081|FG002|Overall Study|Other reasons|4|||
125361353|NCT02833350|450958088|FG000|Overall Study|Adverse Event|0|||
125361354|NCT02833350|450958089|FG001|Overall Study|Adverse Event|3|||
125361355|NCT02833350|450958090|FG002|Overall Study|Adverse Event|4|||
125361356|NCT02833350|450958091|FG003|Overall Study|Adverse Event|4|||
125582672|NCT02327260|451760657|FG000|Overall Study|Lost to Follow-up|2|||
125582673|NCT02327260|451760658|FG001|Overall Study|Lost to Follow-up|3|||
125582674|NCT02327260|451760659|FG002|Overall Study|Lost to Follow-up|2|||
125582675|NCT02327260|451760657|FG000|Overall Study|invalid phone number|1|||
125582676|NCT02327260|451760658|FG001|Overall Study|invalid phone number|1|||
125582677|NCT02327260|451760659|FG002|Overall Study|invalid phone number|0|||
125582678|NCT02327260|451760657|FG000|Overall Study|non-adherence to protocol|2|||
125582679|NCT02327260|451760658|FG001|Overall Study|non-adherence to protocol|0|||
125582680|NCT02327260|451760659|FG002|Overall Study|non-adherence to protocol|0|||
125582681|NCT02327260|451760657|FG000|Overall Study|cognitive concerns|1|||
125582682|NCT02327260|451760658|FG001|Overall Study|cognitive concerns|0|||
125582683|NCT02327260|451760659|FG002|Overall Study|cognitive concerns|0|||
125582684|NCT03502330|451760660|FG000|Overall Study|Adverse Event|2|||
125582685|NCT03502330|451760661|FG001|Overall Study|Adverse Event|1|||
125582686|NCT03502330|451760662|FG002|Overall Study|Adverse Event|0|||
125582687|NCT03502330|451760663|FG003|Overall Study|Adverse Event|0|||
125582688|NCT03502330|451760664|FG004|Overall Study|Adverse Event|1|||
125582689|NCT03502330|451760665|FG005|Overall Study|Adverse Event|0|||
125582690|NCT03502330|451760666|FG006|Overall Study|Adverse Event|1|||
125582691|NCT03502330|451760667|FG007|Overall Study|Adverse Event|1|||
125582692|NCT03502330|451760668|FG008|Overall Study|Adverse Event|0|||
125582693|NCT03502330|451760660|FG000|Overall Study|Lack of Efficacy|1|||
125582694|NCT03502330|451760661|FG001|Overall Study|Lack of Efficacy|5|||
125582695|NCT03502330|451760662|FG002|Overall Study|Lack of Efficacy|3|||
125582696|NCT03502330|451760663|FG003|Overall Study|Lack of Efficacy|5|||
125582697|NCT03502330|451760664|FG004|Overall Study|Lack of Efficacy|1|||
125582698|NCT03502330|451760665|FG005|Overall Study|Lack of Efficacy|5|||
125582699|NCT03502330|451760666|FG006|Overall Study|Lack of Efficacy|5|||
125582700|NCT03502330|451760667|FG007|Overall Study|Lack of Efficacy|6|||
125582701|NCT03502330|451760668|FG008|Overall Study|Lack of Efficacy|0|||
125582702|NCT03502330|451760660|FG000|Overall Study|Physician Decision|0|||
125582703|NCT03502330|451760661|FG001|Overall Study|Physician Decision|0|||
125582704|NCT03502330|451760662|FG002|Overall Study|Physician Decision|0|||
125582705|NCT03502330|451760663|FG003|Overall Study|Physician Decision|0|||
125582706|NCT03502330|451760664|FG004|Overall Study|Physician Decision|1|||
125582707|NCT03502330|451760665|FG005|Overall Study|Physician Decision|0|||
125361357|NCT02833350|450958092|FG004|Overall Study|Adverse Event|1|||
125361358|NCT02833350|450958093|FG005|Overall Study|Adverse Event|0|||
125361359|NCT02833350|450958094|FG006|Overall Study|Adverse Event|1|||
125361360|NCT02833350|450958088|FG000|Overall Study|Death|0|||
125361361|NCT02833350|450958089|FG001|Overall Study|Death|0|||
125361362|NCT02833350|450958090|FG002|Overall Study|Death|1|||
125361363|NCT02833350|450958091|FG003|Overall Study|Death|0|||
125361364|NCT02833350|450958092|FG004|Overall Study|Death|0|||
125361365|NCT02833350|450958093|FG005|Overall Study|Death|0|||
125582708|NCT03502330|451760666|FG006|Overall Study|Physician Decision|0|||
125582709|NCT03502330|451760667|FG007|Overall Study|Physician Decision|0|||
125582710|NCT03502330|451760668|FG008|Overall Study|Physician Decision|0|||
125582711|NCT03502330|451760660|FG000|Overall Study|Withdrawal by Subject|0|||
125582712|NCT03502330|451760661|FG001|Overall Study|Withdrawal by Subject|0|||
125582713|NCT03502330|451760662|FG002|Overall Study|Withdrawal by Subject|0|||
125582714|NCT03502330|451760663|FG003|Overall Study|Withdrawal by Subject|0|||
125582715|NCT03502330|451760664|FG004|Overall Study|Withdrawal by Subject|0|||
125582716|NCT03502330|451760665|FG005|Overall Study|Withdrawal by Subject|1|||
125582717|NCT03502330|451760666|FG006|Overall Study|Withdrawal by Subject|0|||
125361366|NCT02833350|450958094|FG006|Overall Study|Death|0|||
125361367|NCT02833350|450958088|FG000|Overall Study|Lack of Efficacy|0|||
125582718|NCT03502330|451760667|FG007|Overall Study|Withdrawal by Subject|1|||
125361368|NCT02833350|450958089|FG001|Overall Study|Lack of Efficacy|2|||
125361369|NCT02833350|450958090|FG002|Overall Study|Lack of Efficacy|1|||
125361370|NCT02833350|450958091|FG003|Overall Study|Lack of Efficacy|4|||
125361371|NCT02833350|450958092|FG004|Overall Study|Lack of Efficacy|0|||
125361372|NCT02833350|450958093|FG005|Overall Study|Lack of Efficacy|1|||
125361373|NCT02833350|450958094|FG006|Overall Study|Lack of Efficacy|1|||
125361374|NCT02833350|450958088|FG000|Overall Study|Lost to Follow-up|0|||
125361375|NCT02833350|450958089|FG001|Overall Study|Lost to Follow-up|1|||
125361376|NCT02833350|450958090|FG002|Overall Study|Lost to Follow-up|0|||
125361377|NCT02833350|450958091|FG003|Overall Study|Lost to Follow-up|0|||
125582719|NCT03502330|451760668|FG008|Overall Study|Withdrawal by Subject|0|||
125582720|NCT03502330|451760660|FG000|Overall Study|Death|0|||
125582721|NCT03502330|451760661|FG001|Overall Study|Death|0|||
125582722|NCT03502330|451760662|FG002|Overall Study|Death|0|||
125582723|NCT03502330|451760663|FG003|Overall Study|Death|0|||
125582724|NCT03502330|451760664|FG004|Overall Study|Death|0|||
125582725|NCT03502330|451760665|FG005|Overall Study|Death|0|||
125582726|NCT03502330|451760666|FG006|Overall Study|Death|2|||
125582727|NCT03502330|451760667|FG007|Overall Study|Death|0|||
125582728|NCT03502330|451760668|FG008|Overall Study|Death|0|||
125582729|NCT00548548|451760669|FG000|Overall Study|Death|345|||
125582730|NCT00548548|451760670|FG001|Overall Study|Death|348|||
125582731|NCT00548548|451760669|FG000|Overall Study|Lost to Follow-up|17|||
125582732|NCT00548548|451760670|FG001|Overall Study|Lost to Follow-up|18|||
125582733|NCT03502187|451760671|FG000|Overall Study|Withdrawal by Subject|4|||
125582734|NCT03502187|451760672|FG001|Overall Study|Withdrawal by Subject|3|||
125361378|NCT02833350|450958092|FG004|Overall Study|Lost to Follow-up|0|||
125361379|NCT02833350|450958093|FG005|Overall Study|Lost to Follow-up|0|||
125428356|NCT01242748|451193884|FG000|Overall Study|Protocol Violation|1|||
125428357|NCT01242748|451193885|FG001|Overall Study|Protocol Violation|0|||
125428358|NCT01242748|451193884|FG000|Overall Study|Withdrawal by Subject|10|||
125428359|NCT01242748|451193885|FG001|Overall Study|Withdrawal by Subject|2|||
125428360|NCT01242748|451193884|FG000|Overall Study|Miscellaneous reasons|8|||
125428361|NCT01242748|451193885|FG001|Overall Study|Miscellaneous reasons|3|||
125428362|NCT00840801|451193886|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
125428363|NCT00840801|451193887|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
125428364|NCT00840801|451193888|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
125428365|NCT00840801|451193886|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
125428366|NCT00840801|451193887|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
125428367|NCT00840801|451193888|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
125428368|NCT00840801|451193886|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
125428369|NCT00840801|451193887|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
125428370|NCT00840801|451193888|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
125428371|NCT00840801|451193886|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
125428372|NCT00840801|451193887|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
125428373|NCT00840801|451193888|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
125428374|NCT01896869|451193895|FG000|Overall Study|Withdrawal by Subject|0|||
125428375|NCT01896869|451193896|FG001|Overall Study|Withdrawal by Subject|6|||
125428376|NCT01896869|451193895|FG000|Overall Study|Lost to Follow-up|1|||
125428377|NCT01896869|451193896|FG001|Overall Study|Lost to Follow-up|0|||
125428378|NCT03494166|451193900|FG000|Overall Study|Death|0|||
125582735|NCT03502187|451760673|FG002|Overall Study|Withdrawal by Subject|3|||
125582736|NCT03502187|451760671|FG000|Overall Study|Lost to Follow-up|5|||
125582737|NCT03502187|451760672|FG001|Overall Study|Lost to Follow-up|4|||
125582738|NCT03502187|451760673|FG002|Overall Study|Lost to Follow-up|5|||
125582739|NCT02908100|451760675|FG000|Overall Study|Adverse Event|7|||
125582740|NCT02908100|451760676|FG001|Overall Study|Adverse Event|6|||
125582741|NCT02908100|451760677|FG002|Overall Study|Adverse Event|9|||
125582742|NCT02908100|451760675|FG000|Overall Study|Death|2|||
125361380|NCT02833350|450958094|FG006|Overall Study|Lost to Follow-up|1|||
125361381|NCT02833350|450958088|FG000|Overall Study|Withdrawal by Subject|3|||
125361382|NCT02833350|450958089|FG001|Overall Study|Withdrawal by Subject|3|||
125428379|NCT03494166|451193901|FG001|Overall Study|Death|0|||
125428380|NCT03494166|451193902|FG002|Overall Study|Death|0|||
125428381|NCT03494166|451193903|FG003|Overall Study|Death|1|||
125428382|NCT03494166|451193904|FG004|Overall Study|Death|3|||
125428383|NCT03494166|451193905|FG005|Overall Study|Death|0|||
125582743|NCT02908100|451760676|FG001|Overall Study|Death|0|||
125582744|NCT02908100|451760677|FG002|Overall Study|Death|0|||
125582745|NCT02908100|451760675|FG000|Overall Study|Lack of Efficacy|2|||
125582746|NCT02908100|451760676|FG001|Overall Study|Lack of Efficacy|3|||
125582747|NCT02908100|451760677|FG002|Overall Study|Lack of Efficacy|3|||
125582748|NCT02908100|451760675|FG000|Overall Study|Lost to Follow-up|0|||
125582749|NCT02908100|451760676|FG001|Overall Study|Lost to Follow-up|1|||
125582750|NCT02908100|451760677|FG002|Overall Study|Lost to Follow-up|2|||
125582751|NCT02908100|451760675|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125582752|NCT02908100|451760676|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125582753|NCT02908100|451760677|FG002|Overall Study|Non-Compliance With Study Drug|2|||
125582754|NCT02908100|451760675|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
125582755|NCT02908100|451760676|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
125582756|NCT02908100|451760677|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
125428384|NCT03494166|451193900|FG000|Overall Study|Lost to Follow-up|2|||
125428385|NCT03494166|451193901|FG001|Overall Study|Lost to Follow-up|2|||
125428386|NCT03494166|451193902|FG002|Overall Study|Lost to Follow-up|2|||
125428387|NCT03494166|451193903|FG003|Overall Study|Lost to Follow-up|2|||
125428388|NCT03494166|451193904|FG004|Overall Study|Lost to Follow-up|14|||
125428389|NCT03494166|451193905|FG005|Overall Study|Lost to Follow-up|0|||
125428390|NCT03494166|451193900|FG000|Overall Study|Withdrawal by Subject|10|||
125428391|NCT03494166|451193901|FG001|Overall Study|Withdrawal by Subject|7|||
125428392|NCT03494166|451193902|FG002|Overall Study|Withdrawal by Subject|0|||
125428393|NCT03494166|451193903|FG003|Overall Study|Withdrawal by Subject|5|||
125428394|NCT03494166|451193904|FG004|Overall Study|Withdrawal by Subject|3|||
125428395|NCT03494166|451193905|FG005|Overall Study|Withdrawal by Subject|17|||
125428396|NCT03494166|451193900|FG000|Overall Study|Screen failure|1|||
125428397|NCT03494166|451193901|FG001|Overall Study|Screen failure|0|||
125428398|NCT03494166|451193902|FG002|Overall Study|Screen failure|0|||
125428399|NCT03494166|451193903|FG003|Overall Study|Screen failure|0|||
125428400|NCT03494166|451193904|FG004|Overall Study|Screen failure|1|||
125428401|NCT03494166|451193905|FG005|Overall Study|Screen failure|0|||
125428402|NCT02857426|451193906|FG000|Overall Study|Disease progression|34|||
125428403|NCT02857426|451193907|FG001|Overall Study|Disease progression|13|||
125428404|NCT02857426|451193906|FG000|Overall Study|Study drug toxicity|4|||
125428405|NCT02857426|451193907|FG001|Overall Study|Study drug toxicity|1|||
125428406|NCT02857426|451193906|FG000|Overall Study|Death|1|||
125428407|NCT02857426|451193907|FG001|Overall Study|Death|0|||
125428408|NCT02857426|451193906|FG000|Overall Study|Adverse event unrelated to study drug|6|||
125428409|NCT02857426|451193907|FG001|Overall Study|Adverse event unrelated to study drug|2|||
125428410|NCT02857426|451193906|FG000|Overall Study|Participant withdrew consent|1|||
125428411|NCT02857426|451193907|FG001|Overall Study|Participant withdrew consent|1|||
125428412|NCT02857426|451193906|FG000|Overall Study|Maximum clinical benefit|1|||
125428413|NCT02857426|451193907|FG001|Overall Study|Maximum clinical benefit|0|||
125428414|NCT02857426|451193906|FG000|Overall Study|Completed treatment|0|||
125428415|NCT02857426|451193907|FG001|Overall Study|Completed treatment|2|||
125428416|NCT02110901|451193911|FG000|Overall Study|Death|6|||
125428417|NCT02110901|451193912|FG001|Overall Study|Death|3|||
125428418|NCT02110901|451193911|FG000|Overall Study|Lost to Follow-up|12|||
125428419|NCT02110901|451193912|FG001|Overall Study|Lost to Follow-up|8|||
125428420|NCT02110901|451193911|FG000|Overall Study|Withdrawal by Subject|7|||
125428421|NCT02110901|451193912|FG001|Overall Study|Withdrawal by Subject|3|||
125428422|NCT02110901|451193911|FG000|Overall Study|received a kidney transplant|5|||
125428423|NCT02110901|451193912|FG001|Overall Study|received a kidney transplant|0|||
125428424|NCT00758459|451193913|FG000|Overall Study|Adverse Event|3|||
125428425|NCT00758459|451193914|FG001|Overall Study|Adverse Event|2|||
125428426|NCT00758459|451193913|FG000|Overall Study|Protocol Violation|0|||
125428427|NCT00758459|451193914|FG001|Overall Study|Protocol Violation|1|||
125582757|NCT02908100|451760675|FG000|Overall Study|Physician Decision|0|||
125582758|NCT02908100|451760676|FG001|Overall Study|Physician Decision|1|||
125582759|NCT02908100|451760677|FG002|Overall Study|Physician Decision|0|||
125582760|NCT02908100|451760675|FG000|Overall Study|Pregnancy|1|||
125582761|NCT02908100|451760676|FG001|Overall Study|Pregnancy|2|||
125582762|NCT02908100|451760677|FG002|Overall Study|Pregnancy|0|||
125428428|NCT00758459|451193913|FG000|Overall Study|Withdrawal by Subject|0|||
125428429|NCT00758459|451193914|FG001|Overall Study|Withdrawal by Subject|1|||
125428430|NCT02831257|451193916|FG000|Overall Study|Lack of Efficacy|3|||
125428431|NCT02831257|451193916|FG000|Overall Study|Adverse Event|2|||
125428432|NCT02831257|451193916|FG000|Overall Study|Physician Decision|1|||
125428433|NCT02831257|451193916|FG000|Overall Study|Withdrawal by Subject|6|||
125428434|NCT00855595|451193917|FG000|Overall Study|Withdrawal by Subject|1|||
125428435|NCT00855595|451193918|FG001|Overall Study|Withdrawal by Subject|2|||
125428436|NCT00855595|451193917|FG000|Overall Study|Lost to Follow-up|3|||
125428437|NCT00855595|451193918|FG001|Overall Study|Lost to Follow-up|3|||
125428438|NCT00855595|451193917|FG000|Overall Study|Adverse Event|1|||
125428439|NCT00855595|451193918|FG001|Overall Study|Adverse Event|1|||
125428440|NCT00855595|451193917|FG000|Overall Study|patient moved out of state|1|||
125428441|NCT00855595|451193918|FG001|Overall Study|patient moved out of state|0|||
125428442|NCT00855595|451193917|FG000|Overall Study|patient left country|0|||
125428443|NCT00855595|451193918|FG001|Overall Study|patient left country|1|||
125428444|NCT01780935|451193919|FG000|Overall Study|Admin problems due to early termination|321|||
125428445|NCT01780935|451193920|FG001|Overall Study|Admin problems due to early termination|309|||
125428446|NCT01780935|451193919|FG000|Overall Study|Adverse Event|2|||
125428447|NCT01780935|451193920|FG001|Overall Study|Adverse Event|4|||
125428448|NCT01780935|451193919|FG000|Overall Study|Death|1|||
125428449|NCT01780935|451193920|FG001|Overall Study|Death|6|||
125428450|NCT01780935|451193919|FG000|Overall Study|Lost to Follow-up|2|||
125428451|NCT01780935|451193920|FG001|Overall Study|Lost to Follow-up|6|||
125428452|NCT01780935|451193919|FG000|Overall Study|Physician Decision|1|||
125428453|NCT01780935|451193920|FG001|Overall Study|Physician Decision|1|||
125428454|NCT01780935|451193919|FG000|Overall Study|Protocol deviation|0|||
125428455|NCT01780935|451193920|FG001|Overall Study|Protocol deviation|1|||
125428456|NCT01780935|451193919|FG000|Overall Study|Patient withdrew consent|8|||
125428457|NCT01780935|451193920|FG001|Overall Study|Patient withdrew consent|9|||
125428458|NCT01281202|451193921|FG000|Overall Study|Adverse Event|2|||
125428459|NCT01281202|451193922|FG001|Overall Study|Adverse Event|0|||
125428460|NCT01281202|451193921|FG000|Overall Study|Withdrawal by Subject|2|||
125428461|NCT01281202|451193922|FG001|Overall Study|Withdrawal by Subject|2|||
125428462|NCT01281202|451193921|FG000|Overall Study|Protocol Violation|11|||
125428463|NCT01281202|451193922|FG001|Overall Study|Protocol Violation|10|||
125428464|NCT01281202|451193921|FG000|Overall Study|Administrative|2|||
125428465|NCT01281202|451193922|FG001|Overall Study|Administrative|8|||
125428466|NCT01281202|451193921|FG000|Overall Study|Lost to Follow-up|11|||
125428467|NCT01281202|451193922|FG001|Overall Study|Lost to Follow-up|13|||
125428468|NCT01281202|451193921|FG000|Overall Study|Incarceration|0|||
125428469|NCT01281202|451193922|FG001|Overall Study|Incarceration|3|||
125428470|NCT00166296|451193923|FG000|Overall Study|Withdrawal by Subject|1|||
125428471|NCT00166296|451193924|FG001|Overall Study|Withdrawal by Subject|3|||
125428472|NCT00166296|451193923|FG000|Overall Study|Adverse Event|2|||
125428473|NCT00166296|451193924|FG001|Overall Study|Adverse Event|4|||
125428474|NCT00166296|451193923|FG000|Overall Study|Lost to Follow-up|4|||
125428475|NCT00166296|451193924|FG001|Overall Study|Lost to Follow-up|2|||
125428476|NCT04035200|451193925|FG000|Overall Study|Lost to Follow-up|0|||
125428477|NCT04035200|451193926|FG001|Overall Study|Lost to Follow-up|1|||
125428478|NCT04035200|451193927|FG002|Overall Study|Lost to Follow-up|0|||
125428479|NCT04035200|451193925|FG000|Overall Study|Withdrawal by Subject|1|||
125428480|NCT04035200|451193926|FG001|Overall Study|Withdrawal by Subject|4|||
125428481|NCT04035200|451193927|FG002|Overall Study|Withdrawal by Subject|4|||
125428482|NCT04035200|451193925|FG000|Overall Study|COVID-19|1|||
125428483|NCT04035200|451193926|FG001|Overall Study|COVID-19|0|||
125582763|NCT02908100|451760675|FG000|Overall Study|Withdrawal by Subject|8|||
125582764|NCT02908100|451760676|FG001|Overall Study|Withdrawal by Subject|7|||
125582765|NCT02908100|451760677|FG002|Overall Study|Withdrawal by Subject|5|||
125582766|NCT02908100|451760675|FG000|Overall Study|Randomised in Error|1|||
125582767|NCT02908100|451760676|FG001|Overall Study|Randomised in Error|0|||
125582768|NCT02908100|451760677|FG002|Overall Study|Randomised in Error|0|||
125582769|NCT04088409|451760678|FG000|Part A|Withdrawal by Subject|2|||
125582770|NCT04088409|451760679|FG001|Part A|Withdrawal by Subject|1|||
125582771|NCT04088409|451760678|FG000|Part A|Did Not Meet Randomization Criteria|2|||
125582772|NCT04088409|451760679|FG001|Part A|Did Not Meet Randomization Criteria|0|||
125582773|NCT04088409|451760678|FG000|Part A|Lack of Efficacy|9|||
125582774|NCT04088409|451760679|FG001|Part A|Lack of Efficacy|0|||
125582775|NCT04088409|451760678|FG000|Part A|Lost to Follow-up|1|||
125582776|NCT04088409|451760679|FG001|Part A|Lost to Follow-up|0|||
125582777|NCT04088409|451760678|FG000|Part A|Adverse Event|1|||
125582778|NCT04088409|451760679|FG001|Part A|Adverse Event|0|||
125582779|NCT04088409|451760678|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
125582780|NCT04088409|451760679|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
125582781|NCT04088409|451760678|FG000|Part B|Ongoing Treatment|10|||
125582782|NCT04088409|451760679|FG001|Part B|Ongoing Treatment|0|||
125428484|NCT04035200|451193927|FG002|Overall Study|COVID-19|0|||
125428485|NCT04035200|451193925|FG000|Overall Study|Early Termination|0|||
125428486|NCT04035200|451193926|FG001|Overall Study|Early Termination|1|||
125428487|NCT04035200|451193927|FG002|Overall Study|Early Termination|0|||
125428488|NCT04035200|451193925|FG000|Overall Study|Non-compliance|0|||
125428489|NCT04035200|451193926|FG001|Overall Study|Non-compliance|1|||
125428490|NCT04035200|451193927|FG002|Overall Study|Non-compliance|0|||
125428491|NCT00946296|451193928|FG000|Overall Study|Physician Decision|3|||
125428492|NCT00946296|451193929|FG001|Overall Study|Physician Decision|0|||
125428493|NCT00766675|451195438|FG000|Overall Study|Adverse Event|16|||
125428494|NCT00766675|451195438|FG000|Overall Study|Lost to Follow-up|2|||
125428495|NCT00766675|451195438|FG000|Overall Study|Withdrawal by Subject|11|||
125428496|NCT00766675|451195438|FG000|Overall Study|Protocol Violation|8|||
125582783|NCT00400400|451760680|FG000|Overall Study|Adverse Event|9|||
125361383|NCT02833350|450958090|FG002|Overall Study|Withdrawal by Subject|2|||
125361384|NCT02833350|450958091|FG003|Overall Study|Withdrawal by Subject|0|||
125361385|NCT02833350|450958092|FG004|Overall Study|Withdrawal by Subject|2|||
125361386|NCT02833350|450958093|FG005|Overall Study|Withdrawal by Subject|0|||
125361387|NCT02833350|450958094|FG006|Overall Study|Withdrawal by Subject|2|||
125361388|NCT03342963|450958095|FG000|Overall Study|Adverse Event|1|||
125361389|NCT03342963|450958096|FG001|Overall Study|Adverse Event|2|||
125361390|NCT03342963|450958097|FG002|Overall Study|Adverse Event|0|||
125361391|NCT03342963|450958098|FG003|Overall Study|Adverse Event|0|||
125361392|NCT03342963|450958095|FG000|Overall Study|Withdrawal by Subject|1|||
125361393|NCT03342963|450958096|FG001|Overall Study|Withdrawal by Subject|0|||
125361394|NCT03342963|450958097|FG002|Overall Study|Withdrawal by Subject|0|||
125361395|NCT03342963|450958098|FG003|Overall Study|Withdrawal by Subject|0|||
125361396|NCT03626168|450958102|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125361397|NCT03626168|450958103|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
125361398|NCT03626168|450958102|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
125361399|NCT03626168|450958103|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
125361400|NCT03626168|450958102|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
125361401|NCT03626168|450958103|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
125361402|NCT02248701|450958104|FG000|Overall Study|Withdrawal by Subject|2|||
125361403|NCT02248701|450958105|FG001|Overall Study|Withdrawal by Subject|1|||
125361404|NCT02248701|450958104|FG000|Overall Study|Physician Decision|0|||
125361405|NCT02248701|450958105|FG001|Overall Study|Physician Decision|1|||
125361406|NCT02248701|450958104|FG000|Overall Study|Adverse Event|1|||
125361407|NCT02248701|450958105|FG001|Overall Study|Adverse Event|0|||
125361408|NCT02248701|450958104|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
125361409|NCT02248701|450958105|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
125361410|NCT00808483|450958106|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
125361411|NCT00808483|450958107|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
125361412|NCT00808483|450958106|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
125361413|NCT00808483|450958107|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
125361414|NCT00808483|450958106|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
125361415|NCT00808483|450958107|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
125361416|NCT02357979|450958108|FG000|Overall Study|Lost to Follow-up|5|||
125361417|NCT02357979|450958109|FG001|Overall Study|Lost to Follow-up|5|||
125361418|NCT00880542|450958110|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
125428497|NCT00766675|451195438|FG000|Overall Study|Participant took prohibited medication|1|||
125582784|NCT00400400|451760681|FG001|Overall Study|Adverse Event|8|||
125582785|NCT00400400|451760680|FG000|Overall Study|Protocol Violation|2|||
125582786|NCT00400400|451760681|FG001|Overall Study|Protocol Violation|0|||
125582787|NCT00400400|451760680|FG000|Overall Study|Withdrawal by Subject|1|||
125582788|NCT00400400|451760681|FG001|Overall Study|Withdrawal by Subject|3|||
125582789|NCT00400400|451760680|FG000|Overall Study|Administrative Problem|1|||
125582790|NCT00400400|451760681|FG001|Overall Study|Administrative Problem|0|||
125582791|NCT00400400|451760680|FG000|Overall Study|Lost to Follow-up|0|||
125582792|NCT00400400|451760681|FG001|Overall Study|Lost to Follow-up|1|||
125582793|NCT00400400|451760680|FG000|Overall Study|Did not receive study drug|1|||
125582794|NCT00400400|451760681|FG001|Overall Study|Did not receive study drug|3|||
125582795|NCT01552681|451760682|FG000|Overall Study|Withdrawal by Subject|4|||
125582796|NCT01552681|451760683|FG001|Overall Study|Withdrawal by Subject|0|||
125582797|NCT01552681|451760682|FG000|Overall Study|Physician Decision|1|||
125582798|NCT01552681|451760683|FG001|Overall Study|Physician Decision|0|||
125582799|NCT01552681|451760682|FG000|Overall Study|Subject moved away|0|||
125582800|NCT01552681|451760683|FG001|Overall Study|Subject moved away|1|||
125582801|NCT02690194|451760684|FG000|Overall Study|Withdrawal by Subject|1|||
125582802|NCT02690194|451760685|FG001|Overall Study|Withdrawal by Subject|4|||
125582803|NCT02690194|451760686|FG002|Overall Study|Withdrawal by Subject|0|||
125582804|NCT01987908|451760687|FG000|Placebo Lead-in Period|Adverse Event|2|||
125582805|NCT01987908|451760688|FG001|Placebo Lead-in Period|Adverse Event|0|||
125582806|NCT01987908|451760689|FG002|Placebo Lead-in Period|Adverse Event|0|||
125582807|NCT01987908|451760687|FG000|Placebo Lead-in Period|Physician Decision|2|||
125582808|NCT01987908|451760688|FG001|Placebo Lead-in Period|Physician Decision|0|||
125582809|NCT01987908|451760689|FG002|Placebo Lead-in Period|Physician Decision|0|||
125582810|NCT01987908|451760687|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
125582811|NCT01987908|451760688|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
125361419|NCT00880542|450958110|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
125361420|NCT00880542|450958110|FG000|REP: Surgical Resection|progressive disease|1|||
125361421|NCT05047770|450958111|FG000|Overall Study|Withdrawal by Subject|15|||
125428498|NCT00766675|451195438|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
125211800|NCT02007278|450401372|FG000|Overall Study|Incorrect medication administration|1|||
125428499|NCT00766675|451195438|FG000|Overall Study|Insufficient therapy|1|||
125582812|NCT01987908|451760689|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
125582813|NCT01987908|451760687|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
125582814|NCT01987908|451760688|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
125582815|NCT01987908|451760689|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
125582816|NCT01987908|451760687|FG000|Treatment Period|Adverse Event|0|||
125582817|NCT01987908|451760688|FG001|Treatment Period|Adverse Event|1|||
125582818|NCT01987908|451760689|FG002|Treatment Period|Adverse Event|1|||
125582819|NCT01987908|451760687|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
125582820|NCT01987908|451760688|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
125361422|NCT05047770|450958112|FG001|Overall Study|Withdrawal by Subject|10|||
125361423|NCT05047770|450958113|FG002|Overall Study|Withdrawal by Subject|6|||
125361424|NCT05047770|450958114|FG003|Overall Study|Withdrawal by Subject|12|||
125361425|NCT05047770|450958111|FG000|Overall Study|Lost to Follow-up|7|||
125361426|NCT05047770|450958112|FG001|Overall Study|Lost to Follow-up|5|||
125361427|NCT05047770|450958113|FG002|Overall Study|Lost to Follow-up|12|||
125361428|NCT05047770|450958114|FG003|Overall Study|Lost to Follow-up|13|||
125361429|NCT05047770|450958111|FG000|Overall Study|Other|1|||
125361430|NCT05047770|450958112|FG001|Overall Study|Other|0|||
125361431|NCT05047770|450958113|FG002|Overall Study|Other|1|||
125361432|NCT05047770|450958114|FG003|Overall Study|Other|0|||
125361433|NCT04289623|450958117|FG000|Wave 1 Emails|Email was not delivered|268|||
125361434|NCT04289623|450958118|FG001|Wave 1 Emails|Email was not delivered|257|||
125361435|NCT04289623|450958119|FG002|Wave 1 Emails|Email was not delivered|0|||
125361436|NCT04289623|450958120|FG003|Wave 1 Emails|Email was not delivered|0|||
125361437|NCT04289623|450958121|FG004|Wave 1 Emails|Email was not delivered|0|||
125361438|NCT04289623|450958122|FG005|Wave 1 Emails|Email was not delivered|0|||
125361439|NCT03758443|450958123|FG000|Induction Period|Adverse Event|2|||
125361440|NCT03758443|450958124|FG001|Induction Period|Adverse Event|4|||
125361441|NCT03758443|450958125|FG002|Induction Period|Adverse Event|2|||
125361442|NCT03758443|450958126|FG003|Induction Period|Adverse Event|3|||
125361443|NCT03758443|450958123|FG000|Induction Period|Physician Decision|1|||
125361444|NCT03758443|450958124|FG001|Induction Period|Physician Decision|1|||
125361445|NCT03758443|450958125|FG002|Induction Period|Physician Decision|3|||
125361446|NCT03758443|450958126|FG003|Induction Period|Physician Decision|0|||
125361447|NCT03758443|450958123|FG000|Induction Period|Protocol Violation|0|||
125361448|NCT03758443|450958124|FG001|Induction Period|Protocol Violation|0|||
125361449|NCT03758443|450958125|FG002|Induction Period|Protocol Violation|0|||
125361450|NCT03758443|450958126|FG003|Induction Period|Protocol Violation|1|||
125582821|NCT01987908|451760689|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
125582822|NCT01987908|451760687|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
125582823|NCT01987908|451760688|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
125582824|NCT01987908|451760689|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
125582825|NCT02789657|451760692|FG000|Overall Study|Withdrawal by Subject|2|||
125582826|NCT02789657|451760693|FG001|Overall Study|Withdrawal by Subject|0|||
125582827|NCT02789657|451760694|FG002|Overall Study|Withdrawal by Subject|0|||
125582828|NCT02789657|451760695|FG003|Overall Study|Withdrawal by Subject|0|||
125582829|NCT01214044|451760696|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
125582830|NCT01214044|451760696|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
125582831|NCT01214044|451760696|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
125582832|NCT01214044|451760696|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
125582833|NCT01214044|451760696|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
125582834|NCT01214044|451760696|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
125582835|NCT02772757|451760697|FG000|Overall Study|Withdrawal by Subject|1|||
125582836|NCT02772757|451760698|FG001|Overall Study|Withdrawal by Subject|0|||
125582837|NCT02772757|451760699|FG002|Overall Study|Withdrawal by Subject|1|||
125582838|NCT02772757|451760697|FG000|Overall Study|Protocol Violation|0|||
125582839|NCT02772757|451760698|FG001|Overall Study|Protocol Violation|0|||
125582840|NCT02772757|451760699|FG002|Overall Study|Protocol Violation|1|||
125582841|NCT02772757|451760697|FG000|Overall Study|Physician Decision|0|||
125361451|NCT03758443|450958123|FG000|Induction Period|Withdrawal by Subject|3|||
125361452|NCT03758443|450958124|FG001|Induction Period|Withdrawal by Subject|2|||
125361453|NCT03758443|450958125|FG002|Induction Period|Withdrawal by Subject|2|||
125361454|NCT03758443|450958126|FG003|Induction Period|Withdrawal by Subject|4|||
125361455|NCT03758443|450958123|FG000|Extended Induction Period|Adverse Event|1|||
125361456|NCT03758443|450958124|FG001|Extended Induction Period|Adverse Event|1|||
125582842|NCT02772757|451760698|FG001|Overall Study|Physician Decision|3|||
125582843|NCT02772757|451760699|FG002|Overall Study|Physician Decision|3|||
125582844|NCT04698525|451760700|FG000|Overall Study|Lost to Follow-up|1|||
125361457|NCT03758443|450958125|FG002|Extended Induction Period|Adverse Event|0|||
125582845|NCT04698525|451760701|FG001|Overall Study|Lost to Follow-up|2|||
125582846|NCT04698525|451760700|FG000|Overall Study|Three suffered of Covid-19|2|||
125582847|NCT04698525|451760701|FG001|Overall Study|Three suffered of Covid-19|1|||
125582848|NCT00510276|451760705|FG000|Acute Double-Blind Phase|Adverse Event|21|||
125582849|NCT00510276|451760706|FG001|Acute Double-Blind Phase|Adverse Event|6|||
125582850|NCT00510276|451760705|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
125582851|NCT00510276|451760706|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
125582852|NCT00510276|451760705|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
125582853|NCT00510276|451760706|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
125582854|NCT00510276|451760705|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
125582855|NCT00510276|451760706|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
125582856|NCT00510276|451760705|FG000|Acute Double-Blind Phase|Physician Decision|0|||
125582857|NCT00510276|451760706|FG001|Acute Double-Blind Phase|Physician Decision|3|||
125582858|NCT00510276|451760705|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
125582859|NCT00510276|451760706|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
125582860|NCT00510276|451760705|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
125582861|NCT00510276|451760706|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
125582862|NCT00510276|451760705|FG000|Acute Double-Blind Phase|Subject Decision|26|||
125582863|NCT00510276|451760706|FG001|Acute Double-Blind Phase|Subject Decision|28|||
125582864|NCT00510276|451760705|FG000|Extension Open-Label Phase|Adverse Event|9|||
125582865|NCT00510276|451760706|FG001|Extension Open-Label Phase|Adverse Event|18|||
125582866|NCT00510276|451760705|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
125582867|NCT00510276|451760706|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
125582868|NCT00510276|451760705|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
125582869|NCT00510276|451760706|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
125582870|NCT00510276|451760705|FG000|Extension Open-Label Phase|Physician Decision|2|||
125582871|NCT00510276|451760706|FG001|Extension Open-Label Phase|Physician Decision|3|||
125582872|NCT00510276|451760705|FG000|Extension Open-Label Phase|Protocol Violation|0|||
125582873|NCT00510276|451760706|FG001|Extension Open-Label Phase|Protocol Violation|1|||
125582874|NCT00510276|451760705|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
125582875|NCT00510276|451760706|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
125582876|NCT00510276|451760705|FG000|Extension Open-Label Phase|Subject Decision|7|||
125582877|NCT00510276|451760706|FG001|Extension Open-Label Phase|Subject Decision|9|||
125582878|NCT03486392|451760709|FG000|Overall Study|Lost to Follow-up|0|||
125582879|NCT03486392|451760710|FG001|Overall Study|Lost to Follow-up|0|||
125582880|NCT03486392|451760711|FG002|Overall Study|Lost to Follow-up|8|||
125582881|NCT03486392|451760712|FG003|Overall Study|Lost to Follow-up|5|||
125582882|NCT03486392|451760713|FG004|Overall Study|Lost to Follow-up|2|||
125582883|NCT03486392|451760709|FG000|Overall Study|Withdrawal by Subject|3|||
125582884|NCT03486392|451760710|FG001|Overall Study|Withdrawal by Subject|0|||
125582885|NCT03486392|451760711|FG002|Overall Study|Withdrawal by Subject|6|||
125582886|NCT03486392|451760712|FG003|Overall Study|Withdrawal by Subject|4|||
125582887|NCT03486392|451760713|FG004|Overall Study|Withdrawal by Subject|1|||
125582888|NCT03486392|451760709|FG000|Overall Study|Death|0|||
125582889|NCT03486392|451760710|FG001|Overall Study|Death|0|||
125582890|NCT03486392|451760711|FG002|Overall Study|Death|0|||
125582891|NCT03486392|451760712|FG003|Overall Study|Death|0|||
125582892|NCT03486392|451760713|FG004|Overall Study|Death|1|||
125582893|NCT01731678|451760716|FG000|Overall Study|Withdrawal by Subject|3|||
125582894|NCT01731678|451760716|FG000|Overall Study|Did not meet inclusion criteria|1|||
125582895|NCT01731678|451760716|FG000|Overall Study|RMT too high, making TMS difficult|3|||
125582896|NCT00888355|451760723|FG000|Overall Study|Adverse Event|10|||
125582897|NCT00888355|451760724|FG001|Overall Study|Adverse Event|0|||
125582898|NCT00888355|451760725|FG002|Overall Study|Adverse Event|3|||
125582899|NCT00888355|451760726|FG003|Overall Study|Adverse Event|3|||
125582900|NCT00888355|451760723|FG000|Overall Study|Lack of Efficacy|9|||
125582901|NCT00888355|451760724|FG001|Overall Study|Lack of Efficacy|2|||
125582902|NCT00888355|451760725|FG002|Overall Study|Lack of Efficacy|5|||
125582903|NCT00888355|451760726|FG003|Overall Study|Lack of Efficacy|2|||
125582904|NCT00888355|451760723|FG000|Overall Study|Lost to Follow-up|0|||
125582905|NCT00888355|451760724|FG001|Overall Study|Lost to Follow-up|2|||
125582906|NCT00888355|451760725|FG002|Overall Study|Lost to Follow-up|2|||
125582907|NCT00888355|451760726|FG003|Overall Study|Lost to Follow-up|0|||
125582908|NCT00888355|451760723|FG000|Overall Study|Protocol Violation|3|||
125582909|NCT00888355|451760724|FG001|Overall Study|Protocol Violation|2|||
125582910|NCT00888355|451760725|FG002|Overall Study|Protocol Violation|1|||
125582911|NCT00888355|451760726|FG003|Overall Study|Protocol Violation|2|||
125582912|NCT00888355|451760723|FG000|Overall Study|Withdrawal by Subject|0|||
125582913|NCT00888355|451760724|FG001|Overall Study|Withdrawal by Subject|3|||
125582914|NCT00888355|451760725|FG002|Overall Study|Withdrawal by Subject|1|||
125582915|NCT00888355|451760726|FG003|Overall Study|Withdrawal by Subject|3|||
125582916|NCT01551693|451760728|FG000|Overall Study|Disease Progression|1|||
125582917|NCT01551693|451760729|FG001|Overall Study|Disease Progression|0|||
125582918|NCT01551693|451760728|FG000|Overall Study|Adverse Event|0|||
125582919|NCT01551693|451760729|FG001|Overall Study|Adverse Event|1|||
125361458|NCT03758443|450958126|FG003|Extended Induction Period|Adverse Event|1|||
125361459|NCT03758443|450958123|FG000|Extended Induction Period|Lost to Follow-up|1|||
125361460|NCT03758443|450958124|FG001|Extended Induction Period|Lost to Follow-up|0|||
125361461|NCT03758443|450958125|FG002|Extended Induction Period|Lost to Follow-up|0|||
125582920|NCT01551693|451760728|FG000|Overall Study|Withdrawal by Subject|0|||
125582921|NCT01551693|451760729|FG001|Overall Study|Withdrawal by Subject|1|||
125582922|NCT04897867|451760731|FG000|Overall Study|Withdrawal of Consent|1|||
125582923|NCT04897867|451760731|FG000|Overall Study|Pregnancy|1|||
125582924|NCT04897867|451760731|FG000|Overall Study|Lost to Follow-up|7|||
125582925|NCT04897867|451760731|FG000|Overall Study|Reason not Specified|2|||
125361462|NCT03758443|450958126|FG003|Extended Induction Period|Lost to Follow-up|0|||
125361463|NCT03758443|450958123|FG000|Extended Induction Period|Physician Decision|2|||
125361464|NCT03758443|450958124|FG001|Extended Induction Period|Physician Decision|1|||
125361465|NCT03758443|450958125|FG002|Extended Induction Period|Physician Decision|2|||
125361466|NCT03758443|450958126|FG003|Extended Induction Period|Physician Decision|2|||
125361467|NCT03758443|450958123|FG000|Extended Induction Period|Protocol Violation|0|||
125361468|NCT03758443|450958124|FG001|Extended Induction Period|Protocol Violation|0|||
125361469|NCT03758443|450958125|FG002|Extended Induction Period|Protocol Violation|0|||
125361470|NCT03758443|450958126|FG003|Extended Induction Period|Protocol Violation|1|||
125361471|NCT03758443|450958123|FG000|Extended Induction Period|Withdrawal by Subject|8|||
125361472|NCT03758443|450958124|FG001|Extended Induction Period|Withdrawal by Subject|1|||
125361473|NCT03758443|450958125|FG002|Extended Induction Period|Withdrawal by Subject|7|||
125361474|NCT03758443|450958126|FG003|Extended Induction Period|Withdrawal by Subject|3|||
125361475|NCT03758443|450958123|FG000|Extended Induction Period|Miscellaneous|1|||
125361476|NCT03758443|450958124|FG001|Extended Induction Period|Miscellaneous|0|||
125361477|NCT03758443|450958125|FG002|Extended Induction Period|Miscellaneous|0|||
125428500|NCT02240108|451195439|FG000|Overall Study|Other than specified|8|||
125361478|NCT03758443|450958126|FG003|Extended Induction Period|Miscellaneous|0|||
125361479|NCT03758443|450958123|FG000|Maintenance Period|Adverse Event|1|||
125361480|NCT03758443|450958124|FG001|Maintenance Period|Adverse Event|2|||
125582926|NCT02251912|451760732|FG000|Overall Study|Withdrawal by Subject|2|||
125582927|NCT02251912|451760733|FG001|Overall Study|Withdrawal by Subject|3|||
125582928|NCT02251912|451760732|FG000|Overall Study|Adverse Event|0|||
125582929|NCT02251912|451760733|FG001|Overall Study|Adverse Event|2|||
125361481|NCT03758443|450958125|FG002|Maintenance Period|Adverse Event|0|||
125361482|NCT03758443|450958126|FG003|Maintenance Period|Adverse Event|0|||
125582930|NCT01107444|451760734|FG000|Overall Study|Withdrawal by Subject|8|||
125582931|NCT01107444|451760735|FG001|Overall Study|Withdrawal by Subject|12|||
125582932|NCT01107444|451760734|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
125582933|NCT01107444|451760735|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
125582934|NCT01948830|451760738|FG000|Overall Study|Physician Decision|1|||
125582935|NCT01948830|451760739|FG001|Overall Study|Physician Decision|3|||
125582936|NCT01948830|451760738|FG000|Overall Study|Protocol deviation|1|||
125582937|NCT01948830|451760739|FG001|Overall Study|Protocol deviation|2|||
125582938|NCT01948830|451760738|FG000|Overall Study|Lost to Follow-up|5|||
125582939|NCT01948830|451760739|FG001|Overall Study|Lost to Follow-up|4|||
125582940|NCT01948830|451760738|FG000|Overall Study|Withdrawal by Subject|14|||
125428501|NCT02240108|451195440|FG001|Overall Study|Other than specified|6|||
125428502|NCT02240108|451195439|FG000|Overall Study|Adverse Event|1|||
125428503|NCT02240108|451195440|FG001|Overall Study|Adverse Event|9|||
125428504|NCT02240108|451195439|FG000|Overall Study|Pregnancy|1|||
125428505|NCT02240108|451195440|FG001|Overall Study|Pregnancy|0|||
125428506|NCT02240108|451195439|FG000|Overall Study|Withdrawal by Subject|4|||
125428507|NCT02240108|451195440|FG001|Overall Study|Withdrawal by Subject|9|||
125428508|NCT02240108|451195439|FG000|Overall Study|StudyTerminated by Sponsor|0|||
125428509|NCT02240108|451195440|FG001|Overall Study|StudyTerminated by Sponsor|1|||
125428510|NCT03938454|451195441|FG000|Overall Study|Protocol Violation|1|||
125428511|NCT03938454|451195441|FG000|Overall Study|Withdrawal by Subject|2|||
125428512|NCT03938454|451195441|FG000|Overall Study|Lost to Follow-up|3|||
125428513|NCT04244396|451195442|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
125428514|NCT04244396|451195442|FG000|Overall Study|Withdrawal by Subject|2|||
125428515|NCT04244396|451195442|FG000|Overall Study|Study termination|37|||
125428516|NCT02093663|451195447|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
125428517|NCT02093663|451195448|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
125428518|NCT02093663|451195449|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
125428519|NCT02093663|451195450|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
125428520|NCT02093663|451195451|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
125428521|NCT02093663|451195447|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
125428522|NCT02093663|451195448|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125428523|NCT02093663|451195449|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125428524|NCT02093663|451195450|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125428525|NCT02093663|451195451|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125428526|NCT02093663|451195447|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
125428527|NCT02093663|451195448|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
125428528|NCT02093663|451195449|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
125428529|NCT02093663|451195450|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
125428530|NCT02093663|451195451|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
125428531|NCT02093663|451195447|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
125428532|NCT02093663|451195448|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
125428533|NCT02093663|451195449|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
125428534|NCT02093663|451195450|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
125428535|NCT02093663|451195451|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
125428536|NCT02093663|451195447|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125428537|NCT02093663|451195448|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125428538|NCT02093663|451195449|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
125428539|NCT02093663|451195450|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125428540|NCT02093663|451195451|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
125428541|NCT02093663|451195447|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
125428542|NCT02093663|451195448|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
125428543|NCT02093663|451195449|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
125428544|NCT02093663|451195450|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
125428545|NCT02093663|451195451|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
125428546|NCT02093663|451195447|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
125428547|NCT02093663|451195448|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
125428548|NCT02093663|451195449|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
125428549|NCT02093663|451195450|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
125428550|NCT02093663|451195451|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
125428551|NCT02093663|451195447|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
125428552|NCT02093663|451195448|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
125428553|NCT02093663|451195449|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
125428554|NCT02093663|451195450|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
125428555|NCT02093663|451195451|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
125428556|NCT02093663|451195447|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
125428557|NCT02093663|451195448|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
125428558|NCT02093663|451195449|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
125428559|NCT02093663|451195450|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
125582941|NCT01948830|451760739|FG001|Overall Study|Withdrawal by Subject|17|||
125582942|NCT01948830|451760738|FG000|Overall Study|Adverse Event|9|||
125582943|NCT01948830|451760739|FG001|Overall Study|Adverse Event|2|||
125582944|NCT01948830|451760738|FG000|Overall Study|Death|3|||
125582945|NCT01948830|451760739|FG001|Overall Study|Death|4|||
125582946|NCT01133171|451760740|FG000|Overall Study|Withdrawal by Subject|1|||
125582947|NCT01133171|451760741|FG001|Overall Study|Withdrawal by Subject|2|||
125582948|NCT01133171|451760742|FG002|Overall Study|Withdrawal by Subject|0|||
125582949|NCT02526550|451760743|FG000|Overall Study|Lost to Follow-up|1|||
125582950|NCT03969888|451760746|FG000|Overall Study|Never Received Study Drug|0|||
125361483|NCT03758443|450958123|FG000|Maintenance Period|Lost to Follow-up|0|||
125361484|NCT03758443|450958124|FG001|Maintenance Period|Lost to Follow-up|0|||
125361485|NCT03758443|450958125|FG002|Maintenance Period|Lost to Follow-up|0|||
125361486|NCT03758443|450958126|FG003|Maintenance Period|Lost to Follow-up|1|||
125361487|NCT03758443|450958123|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
125361488|NCT03758443|450958124|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
125361489|NCT03758443|450958125|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
125361490|NCT03758443|450958126|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
125361491|NCT03758443|450958123|FG000|Maintenance Period|Protocol Violation|0|||
125361492|NCT03758443|450958124|FG001|Maintenance Period|Protocol Violation|1|||
125361493|NCT03758443|450958125|FG002|Maintenance Period|Protocol Violation|0|||
125361494|NCT03758443|450958126|FG003|Maintenance Period|Protocol Violation|0|||
125361495|NCT03758443|450958123|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
125361496|NCT03758443|450958124|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
125361497|NCT03758443|450958125|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
125361498|NCT03758443|450958126|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
125361499|NCT03758443|450958123|FG000|Maintenance Period|Withdrawal by Subject|1|||
125361500|NCT03758443|450958124|FG001|Maintenance Period|Withdrawal by Subject|0|||
125361501|NCT03758443|450958125|FG002|Maintenance Period|Withdrawal by Subject|1|||
125361502|NCT03758443|450958126|FG003|Maintenance Period|Withdrawal by Subject|1|||
125361503|NCT03758443|450958123|FG000|Maintenance Period|Miscellaneous|0|||
125361504|NCT03758443|450958124|FG001|Maintenance Period|Miscellaneous|0|||
125361505|NCT03758443|450958125|FG002|Maintenance Period|Miscellaneous|1|||
125361506|NCT03758443|450958126|FG003|Maintenance Period|Miscellaneous|0|||
125361507|NCT01436396|450958127|FG000|Overall Study|Protocol Violation|7|||
125361508|NCT01436396|450958128|FG001|Overall Study|Protocol Violation|5|||
125361509|NCT01436396|450958127|FG000|Overall Study|Adverse Event|1|||
125361510|NCT01436396|450958128|FG001|Overall Study|Adverse Event|2|||
125361511|NCT01436396|450958127|FG000|Overall Study|Withdrawal by Subject|19|||
125361512|NCT01436396|450958128|FG001|Overall Study|Withdrawal by Subject|29|||
125361513|NCT01436396|450958127|FG000|Overall Study|Serious adverse event|2|||
125361514|NCT01436396|450958128|FG001|Overall Study|Serious adverse event|3|||
125361515|NCT01436396|450958127|FG000|Overall Study|Lost to Follow-up|3|||
125361516|NCT01436396|450958128|FG001|Overall Study|Lost to Follow-up|3|||
125361517|NCT01772160|450958132|FG000|Overall Study|Death|3|||
125361518|NCT01772160|450958132|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
125582951|NCT03969888|451760747|FG001|Overall Study|Never Received Study Drug|0|||
125582952|NCT03969888|451760748|FG002|Overall Study|Never Received Study Drug|1|||
125361519|NCT01772160|450958132|FG000|Overall Study|Consent withdrawal|3|||
125361520|NCT01772160|450958132|FG000|Overall Study|Migrated / moved from the study area|4|||
125361521|NCT01772160|450958132|FG000|Overall Study|Lost to Follow-up|30|||
125361522|NCT01772160|450958132|FG000|Overall Study|Other|5|||
125361523|NCT01522248|450958133|FG000|Overall Study|Lost to Follow-up|1|||
125361524|NCT01522248|450958134|FG001|Overall Study|Lost to Follow-up|0|||
125361525|NCT00538291|450958135|FG000|Overall Study|Adverse Event|2|||
125361526|NCT00538291|450958135|FG000|Overall Study|Withdrawal by Subject|1|||
125361527|NCT00591344|450958136|FG000|Overall Study|Transportation issues|1|||
125361528|NCT00591344|450958137|FG001|Overall Study|Transportation issues|0|||
125361529|NCT00591344|450958136|FG000|Overall Study|Moved out of state|1|||
125361530|NCT00591344|450958137|FG001|Overall Study|Moved out of state|0|||
125582953|NCT03969888|451760749|FG003|Overall Study|Never Received Study Drug|0|||
125582954|NCT03969888|451760750|FG004|Overall Study|Never Received Study Drug|0|||
125582955|NCT03969888|451760751|FG005|Overall Study|Never Received Study Drug|0|||
125582956|NCT03969888|451760752|FG006|Overall Study|Never Received Study Drug|1|||
125582957|NCT03969888|451760753|FG007|Overall Study|Never Received Study Drug|0|||
125582958|NCT03969888|451760746|FG000|Overall Study|Reason Not Specified|0|||
125582959|NCT03969888|451760747|FG001|Overall Study|Reason Not Specified|0|||
125582960|NCT03969888|451760748|FG002|Overall Study|Reason Not Specified|0|||
125582961|NCT03969888|451760749|FG003|Overall Study|Reason Not Specified|0|||
125582962|NCT03969888|451760750|FG004|Overall Study|Reason Not Specified|0|||
125582963|NCT03969888|451760751|FG005|Overall Study|Reason Not Specified|0|||
125582964|NCT03969888|451760752|FG006|Overall Study|Reason Not Specified|0|||
125582965|NCT03969888|451760753|FG007|Overall Study|Reason Not Specified|1|||
125582966|NCT01282229|451760763|FG000|Overall Study|Protocol Violation|2|||
125582967|NCT00769119|451760765|FG000|Overall Study|Voluntary discontinuation|0|||
125582968|NCT00769119|451760766|FG001|Overall Study|Voluntary discontinuation|2|||
125582969|NCT00769119|451760765|FG000|Overall Study|Adverse Event|1|||
125582970|NCT00769119|451760766|FG001|Overall Study|Adverse Event|1|||
125582971|NCT00769119|451760765|FG000|Overall Study|Disallowed medication|1|||
125582972|NCT00769119|451760766|FG001|Overall Study|Disallowed medication|0|||
125582973|NCT03094195|451760776|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
125582974|NCT03094195|451760777|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
125582975|NCT03094195|451760778|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
125582976|NCT03094195|451760779|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125582977|NCT03094195|451760780|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125582978|NCT03094195|451760781|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125582979|NCT03094195|451760782|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125582980|NCT03094195|451760783|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125582981|NCT03094195|451760776|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
125582982|NCT03094195|451760777|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
125582983|NCT03094195|451760778|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
125582984|NCT03094195|451760779|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125582985|NCT03094195|451760780|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125582986|NCT03094195|451760781|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125582987|NCT03094195|451760782|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125582988|NCT03094195|451760783|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125582989|NCT03094195|451760776|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125582990|NCT03094195|451760777|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125582991|NCT03094195|451760778|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
125582992|NCT03094195|451760779|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125582993|NCT03094195|451760780|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125582994|NCT03094195|451760781|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125582995|NCT03094195|451760782|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125582996|NCT03094195|451760783|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125582997|NCT03094195|451760776|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125428560|NCT02093663|451195451|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
125361531|NCT00591344|450958136|FG000|Overall Study|Medical complications|1|||
125361532|NCT00591344|450958137|FG001|Overall Study|Medical complications|3|||
125361533|NCT00591344|450958136|FG000|Overall Study|Underwent DBS|2|||
125361534|NCT00591344|450958137|FG001|Overall Study|Underwent DBS|2|||
125361535|NCT00591344|450958136|FG000|Overall Study|Death|0|||
125361536|NCT00591344|450958137|FG001|Overall Study|Death|1|||
125361537|NCT00591344|450958136|FG000|Overall Study|Lost to Follow-up|0|||
125361538|NCT00591344|450958137|FG001|Overall Study|Lost to Follow-up|1|||
125361539|NCT00591344|450958136|FG000|Overall Study|Did not want to come off medication|0|||
125361540|NCT00591344|450958137|FG001|Overall Study|Did not want to come off medication|1|||
125428561|NCT00508404|451195452|FG000|Overall Study|Ongoing at Data Cut-off|12|||
125428562|NCT00508404|451195452|FG000|Overall Study|Adverse Event|2|||
125582998|NCT03094195|451760777|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
125582999|NCT03094195|451760778|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
125583000|NCT03094195|451760779|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125583001|NCT03094195|451760780|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125583002|NCT03094195|451760781|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125583003|NCT03094195|451760782|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125583004|NCT03094195|451760783|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125583005|NCT01961115|451760784|FG000|Overall Study|Disease Progression|1|||
125583006|NCT01961115|451760785|FG001|Overall Study|Disease Progression|0|||
125583007|NCT01961115|451760786|FG002|Overall Study|Disease Progression|3|||
125583008|NCT01961115|451760784|FG000|Overall Study|Adverse Event|1|||
125583009|NCT01961115|451760785|FG001|Overall Study|Adverse Event|0|||
125583010|NCT01961115|451760786|FG002|Overall Study|Adverse Event|1|||
125583011|NCT02440581|451760790|FG000|Overall Study|Death|0|||
125583012|NCT02440581|451760791|FG001|Overall Study|Death|0|||
125583013|NCT02440581|451760792|FG002|Overall Study|Death|7|||
125583014|NCT02440581|451760793|FG003|Overall Study|Death|5|||
125583015|NCT02440581|451760790|FG000|Overall Study|Transplanted|1|||
125583016|NCT02440581|451760791|FG001|Overall Study|Transplanted|0|||
125583017|NCT02440581|451760792|FG002|Overall Study|Transplanted|3|||
125583018|NCT02440581|451760793|FG003|Overall Study|Transplanted|2|||
125583019|NCT02440581|451760790|FG000|Overall Study|Withdrawal by Subject|4|||
125361541|NCT00694707|450958138|FG000|Overall Study|Did Not Receive Treatment|0|||
125361542|NCT00694707|450958139|FG001|Overall Study|Did Not Receive Treatment|0|||
125361543|NCT00694707|450958140|FG002|Overall Study|Did Not Receive Treatment|1|||
125361544|NCT00694707|450958141|FG003|Overall Study|Did Not Receive Treatment|1|||
125361545|NCT00694707|450958142|FG004|Overall Study|Did Not Receive Treatment|1|||
125361546|NCT00694707|450958138|FG000|Overall Study|Adverse Event|22|||
125361547|NCT00694707|450958139|FG001|Overall Study|Adverse Event|14|||
125361548|NCT00694707|450958140|FG002|Overall Study|Adverse Event|8|||
125361549|NCT00694707|450958141|FG003|Overall Study|Adverse Event|12|||
125361550|NCT00694707|450958142|FG004|Overall Study|Adverse Event|13|||
125361551|NCT00694707|450958138|FG000|Overall Study|Insufficient Therapeutic Response|33|||
125361552|NCT00694707|450958139|FG001|Overall Study|Insufficient Therapeutic Response|18|||
125361553|NCT00694707|450958140|FG002|Overall Study|Insufficient Therapeutic Response|17|||
125361554|NCT00694707|450958141|FG003|Overall Study|Insufficient Therapeutic Response|15|||
125361555|NCT00694707|450958142|FG004|Overall Study|Insufficient Therapeutic Response|10|||
125361556|NCT00694707|450958138|FG000|Overall Study|Protocol Violation|1|||
125361557|NCT00694707|450958139|FG001|Overall Study|Protocol Violation|2|||
125361558|NCT00694707|450958140|FG002|Overall Study|Protocol Violation|1|||
125361559|NCT00694707|450958141|FG003|Overall Study|Protocol Violation|3|||
125361560|NCT00694707|450958142|FG004|Overall Study|Protocol Violation|1|||
125361561|NCT00694707|450958138|FG000|Overall Study|Withdrawal of Consent|14|||
125361562|NCT00694707|450958139|FG001|Overall Study|Withdrawal of Consent|18|||
125361563|NCT00694707|450958140|FG002|Overall Study|Withdrawal of Consent|22|||
125361564|NCT00694707|450958141|FG003|Overall Study|Withdrawal of Consent|16|||
125361565|NCT00694707|450958142|FG004|Overall Study|Withdrawal of Consent|15|||
125361566|NCT00694707|450958138|FG000|Overall Study|Lost to Follow-up|0|||
125361567|NCT00694707|450958139|FG001|Overall Study|Lost to Follow-up|1|||
125361568|NCT00694707|450958140|FG002|Overall Study|Lost to Follow-up|2|||
125361569|NCT00694707|450958141|FG003|Overall Study|Lost to Follow-up|0|||
125361570|NCT00694707|450958142|FG004|Overall Study|Lost to Follow-up|0|||
125361571|NCT00694707|450958138|FG000|Overall Study|Jeopardizing Parole Status|1|||
125361572|NCT00694707|450958139|FG001|Overall Study|Jeopardizing Parole Status|0|||
125361573|NCT00694707|450958140|FG002|Overall Study|Jeopardizing Parole Status|0|||
125361574|NCT00694707|450958141|FG003|Overall Study|Jeopardizing Parole Status|0|||
125361575|NCT00694707|450958142|FG004|Overall Study|Jeopardizing Parole Status|0|||
125361576|NCT00694707|450958138|FG000|Overall Study|Death in the Family|1|||
125361577|NCT00694707|450958139|FG001|Overall Study|Death in the Family|0|||
125361578|NCT00694707|450958140|FG002|Overall Study|Death in the Family|0|||
125583020|NCT02440581|451760791|FG001|Overall Study|Withdrawal by Subject|11|||
125583021|NCT02440581|451760792|FG002|Overall Study|Withdrawal by Subject|3|||
125361579|NCT00694707|450958141|FG003|Overall Study|Death in the Family|0|||
125361580|NCT00694707|450958142|FG004|Overall Study|Death in the Family|0|||
125361581|NCT00694707|450958138|FG000|Overall Study|Arrest by Police|0|||
125361582|NCT00694707|450958139|FG001|Overall Study|Arrest by Police|1|||
125361583|NCT00694707|450958140|FG002|Overall Study|Arrest by Police|0|||
125361584|NCT00694707|450958141|FG003|Overall Study|Arrest by Police|0|||
125583022|NCT02440581|451760793|FG003|Overall Study|Withdrawal by Subject|7|||
125583023|NCT03828487|451760794|FG000|Overall Study|Physician Decision|1|||
125583024|NCT03430986|451760795|FG000|24-week Control Period|Adverse Event|1|||
125583025|NCT03430986|451760796|FG001|24-week Control Period|Adverse Event|0|||
125583026|NCT03430986|451760795|FG000|24-week Control Period|Lost to Follow-up|2|||
125583027|NCT03430986|451760796|FG001|24-week Control Period|Lost to Follow-up|2|||
125583028|NCT03430986|451760795|FG000|24-week Control Period|Withdrawal by Participant|5|||
125583029|NCT03430986|451760796|FG001|24-week Control Period|Withdrawal by Participant|0|||
125583030|NCT03430986|451760795|FG000|24-week Control Period|Protocol Deviation|0|||
125583031|NCT03430986|451760796|FG001|24-week Control Period|Protocol Deviation|2|||
125583032|NCT03430986|451760795|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
125583033|NCT03430986|451760796|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
125583034|NCT03430986|451760795|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
125583035|NCT03430986|451760796|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
125583036|NCT01078805|451760798|FG000|Overall Study|Clinically significant abnormal lab|5|||
125583037|NCT01078805|451760798|FG000|Overall Study|Death|134|||
125583038|NCT01078805|451760798|FG000|Overall Study|Lost to Follow-up|676|||
125583039|NCT01078805|451760798|FG000|Overall Study|Physician Decision|169|||
125583040|NCT01078805|451760798|FG000|Overall Study|Serious adverse event|26|||
125583041|NCT01078805|451760798|FG000|Overall Study|Sponsor decision|46|||
125583042|NCT01078805|451760798|FG000|Overall Study|Withdrawal by Subject|739|||
125583043|NCT01078805|451760798|FG000|Overall Study|Other|173|||
125583044|NCT01078805|451760798|FG000|Overall Study|Didn't take study drug|82|||
125583045|NCT01609842|451760799|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
125583046|NCT01609842|451760800|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
125583047|NCT02474329|451760801|FG000|Overall Study|Withdraw or did not contribute data.|13|||
125583048|NCT03186989|451760802|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125583049|NCT03186989|451760803|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125583050|NCT03186989|451760804|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
125583051|NCT03186989|451760805|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
125583052|NCT03186989|451760806|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
125583053|NCT03186989|451760807|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125361585|NCT00694707|450958142|FG004|Overall Study|Arrest by Police|0|||
125361586|NCT00694707|450958138|FG000|Overall Study|Administrative Reasons|0|||
125361587|NCT00694707|450958139|FG001|Overall Study|Administrative Reasons|1|||
125361588|NCT00694707|450958140|FG002|Overall Study|Administrative Reasons|0|||
125361589|NCT00694707|450958141|FG003|Overall Study|Administrative Reasons|2|||
125361590|NCT00694707|450958142|FG004|Overall Study|Administrative Reasons|0|||
125361591|NCT00694707|450958138|FG000|Overall Study|Notification of Past Head Injury|0|||
125361592|NCT00694707|450958139|FG001|Overall Study|Notification of Past Head Injury|0|||
125361593|NCT00694707|450958140|FG002|Overall Study|Notification of Past Head Injury|0|||
125361594|NCT00694707|450958141|FG003|Overall Study|Notification of Past Head Injury|1|||
125361595|NCT00694707|450958142|FG004|Overall Study|Notification of Past Head Injury|0|||
125361596|NCT01904058|450958150|FG000|Overall Study|Adverse Event|2|||
125361597|NCT01904058|450958151|FG001|Overall Study|Adverse Event|0|||
125361598|NCT01904058|450958152|FG002|Overall Study|Adverse Event|0|||
125361599|NCT01904058|450958153|FG003|Overall Study|Adverse Event|0|||
125361600|NCT01904058|450958150|FG000|Overall Study|Withdrawal by Subject|1|||
125361601|NCT01904058|450958151|FG001|Overall Study|Withdrawal by Subject|0|||
125361602|NCT01904058|450958152|FG002|Overall Study|Withdrawal by Subject|1|||
125361603|NCT01904058|450958153|FG003|Overall Study|Withdrawal by Subject|0|||
125361604|NCT01904058|450958150|FG000|Overall Study|Pregnancy|0|||
125361605|NCT01904058|450958151|FG001|Overall Study|Pregnancy|0|||
125361606|NCT01904058|450958152|FG002|Overall Study|Pregnancy|0|||
125583054|NCT03186989|451760808|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125583055|NCT03186989|451760809|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125583056|NCT03186989|451760810|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125583057|NCT03186989|451760811|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125583058|NCT03186989|451760812|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
125583059|NCT03186989|451760802|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125583060|NCT03186989|451760803|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125583061|NCT03186989|451760804|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125583062|NCT03186989|451760805|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125583063|NCT03186989|451760806|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125583064|NCT03186989|451760807|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
125428563|NCT00508404|451195452|FG000|Overall Study|Death|16|||
125583065|NCT03186989|451760808|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125131393|NCT03818581|450109962|FG002|Overall Study|Adverse Event|0|||
125361607|NCT01904058|450958153|FG003|Overall Study|Pregnancy|1|||
125361608|NCT03096483|450958154|FG000|Overall Study|Withdrawal by site|1|||
125361609|NCT01024231|450958155|FG000|Overall Study|Other Reasons|1|||
125361610|NCT01024231|450958156|FG001|Overall Study|Other Reasons|2|||
125361611|NCT01024231|450958157|FG002|Overall Study|Other Reasons|0|||
125428564|NCT00508404|451195452|FG000|Overall Study|Physician Decision|2|||
125583066|NCT03186989|451760809|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125583067|NCT03186989|451760810|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125583068|NCT03186989|451760811|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125583069|NCT03186989|451760812|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
125583070|NCT03186989|451760802|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125583071|NCT03186989|451760803|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125583072|NCT03186989|451760804|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125583073|NCT03186989|451760805|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125583074|NCT03186989|451760806|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125583075|NCT03186989|451760807|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125583076|NCT03186989|451760808|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
125583077|NCT03186989|451760809|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125583078|NCT03186989|451760810|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125583079|NCT03186989|451760811|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125583080|NCT03186989|451760812|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
125583081|NCT03186989|451760802|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125583082|NCT03186989|451760803|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125583083|NCT03186989|451760804|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125583084|NCT03186989|451760805|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125583085|NCT03186989|451760806|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125583086|NCT03186989|451760807|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
125583087|NCT03186989|451760808|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
125583088|NCT03186989|451760809|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125583089|NCT03186989|451760810|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
125583090|NCT03186989|451760811|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125583091|NCT03186989|451760812|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
125583092|NCT00865020|451760821|FG000|Overall Study|Withdrawal by Subject|22|||
125583093|NCT00865020|451760822|FG001|Overall Study|Withdrawal by Subject|16|||
125583094|NCT00865020|451760821|FG000|Overall Study|Adverse Event|9|||
125583095|NCT00865020|451760822|FG001|Overall Study|Adverse Event|14|||
125583096|NCT00865020|451760821|FG000|Overall Study|Abnormal test procedure result(s)|6|||
125583097|NCT00865020|451760822|FG001|Overall Study|Abnormal test procedure result(s)|8|||
125583098|NCT00865020|451760821|FG000|Overall Study|Lost to Follow-up|6|||
125583099|NCT00865020|451760822|FG001|Overall Study|Lost to Follow-up|4|||
125583100|NCT00865020|451760821|FG000|Overall Study|Protocol deviation|4|||
125583101|NCT00865020|451760822|FG001|Overall Study|Protocol deviation|1|||
125583102|NCT00865020|451760821|FG000|Overall Study|Administrative problems|0|||
125583103|NCT00865020|451760822|FG001|Overall Study|Administrative problems|2|||
125583104|NCT00865020|451760821|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125583105|NCT00865020|451760822|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125583106|NCT00865020|451760821|FG000|Overall Study|Death|0|||
125583107|NCT00865020|451760822|FG001|Overall Study|Death|1|||
125583108|NCT00865020|451760821|FG000|Overall Study|Randomized but discontinued|2|||
125583109|NCT00865020|451760822|FG001|Overall Study|Randomized but discontinued|4|||
125583110|NCT03641560|451760823|FG000|Overall Study|Withdrawal by Subject|6|||
125583111|NCT03641560|451760823|FG000|Overall Study|Progressive disease|40|||
125583112|NCT03641560|451760823|FG000|Overall Study|Death|6|||
125583113|NCT05900115|451762224|FG000|Overall Study|Lost to Follow-up|129|||
125583114|NCT05900115|451762225|FG001|Overall Study|Lost to Follow-up|98|||
125583115|NCT00619502|451762226|FG000|Overall Study|Lost to Follow-up|8|||
125583116|NCT00619502|451762227|FG001|Overall Study|Lost to Follow-up|10|||
125583117|NCT00771472|451762228|FG000|Overall Study|Physician Decision|2|||
125583118|NCT00771472|451762229|FG001|Overall Study|Physician Decision|3|||
125583119|NCT00771472|451762228|FG000|Overall Study|Progressive Disease|3|||
125583120|NCT00771472|451762229|FG001|Overall Study|Progressive Disease|1|||
125583121|NCT00771472|451762228|FG000|Overall Study|Protocol Violation|1|||
125583122|NCT00771472|451762229|FG001|Overall Study|Protocol Violation|0|||
125583123|NCT00880750|451762232|FG000|First Intervention|Adverse Event|1|||
125583124|NCT00880750|451762233|FG001|First Intervention|Adverse Event|0|||
125583125|NCT00880750|451762232|FG000|First Intervention|Unable to collect urine|4|||
125583126|NCT00880750|451762233|FG001|First Intervention|Unable to collect urine|0|||
125583127|NCT00880750|451762232|FG000|First Intervention|Non-compliance with meals|0|||
125583128|NCT00880750|451762233|FG001|First Intervention|Non-compliance with meals|1|||
125428565|NCT00508404|451195452|FG000|Overall Study|Withdrawal by Subject|3|||
125583129|NCT00880750|451762232|FG000|First Intervention|Withdrawal by Subject|2|||
125583130|NCT00880750|451762233|FG001|First Intervention|Withdrawal by Subject|0|||
125583131|NCT00880750|451762232|FG000|First Intervention|Lost to Follow-up|2|||
125583132|NCT00880750|451762233|FG001|First Intervention|Lost to Follow-up|0|||
125583133|NCT00880750|451762232|FG000|Second Intervention|Withdrawal by Subject|2|||
125583134|NCT00880750|451762233|FG001|Second Intervention|Withdrawal by Subject|2|||
125583135|NCT00880750|451762232|FG000|Second Intervention|Protocol Violation|1|||
125583136|NCT00880750|451762233|FG001|Second Intervention|Protocol Violation|0|||
125583137|NCT00880750|451762232|FG000|Second Intervention|Unable to collect urine|1|||
125583138|NCT00880750|451762233|FG001|Second Intervention|Unable to collect urine|0|||
125583139|NCT00483327|451762234|FG000|Overall Study|Adverse Event|1|||
125583140|NCT00483327|451762234|FG000|Overall Study|Withdrawal by Subject|3|||
125583141|NCT00483327|451762234|FG000|Overall Study|Lost to Follow-up|4|||
125583142|NCT00483327|451762234|FG000|Overall Study|Patient Non Compliance|2|||
125583143|NCT00670007|451762235|FG000|Overall Study|Drug abuse|1|||
125583144|NCT00670007|451762235|FG000|Overall Study|Lung transplant|1|||
125583145|NCT00670007|451762235|FG000|Overall Study|Travel/Vacation|1|||
125583146|NCT00670007|451762235|FG000|Overall Study|Adverse event, serious fatal|1|||
125583147|NCT00670007|451762235|FG000|Overall Study|Adverse Event|1|||
125583148|NCT00670007|451762235|FG000|Overall Study|Withdrawal by Subject|4|||
125361612|NCT01024231|450958158|FG003|Overall Study|Other Reasons|0|||
125361613|NCT01024231|450958159|FG004|Overall Study|Other Reasons|2|||
125361614|NCT01024231|450958160|FG005|Overall Study|Other Reasons|0|||
125361615|NCT01024231|450958161|FG006|Overall Study|Other Reasons|1|||
125361616|NCT01024231|450958155|FG000|Overall Study|Maximum Clinical Benefit|1|||
125361617|NCT01024231|450958156|FG001|Overall Study|Maximum Clinical Benefit|2|||
125361618|NCT01024231|450958157|FG002|Overall Study|Maximum Clinical Benefit|0|||
125361619|NCT01024231|450958158|FG003|Overall Study|Maximum Clinical Benefit|1|||
125361620|NCT01024231|450958159|FG004|Overall Study|Maximum Clinical Benefit|1|||
125361621|NCT01024231|450958160|FG005|Overall Study|Maximum Clinical Benefit|0|||
125361622|NCT01024231|450958161|FG006|Overall Study|Maximum Clinical Benefit|0|||
125361623|NCT01024231|450958155|FG000|Overall Study|Disease Progression|3|||
125361624|NCT01024231|450958156|FG001|Overall Study|Disease Progression|1|||
125361625|NCT01024231|450958157|FG002|Overall Study|Disease Progression|3|||
125361626|NCT01024231|450958158|FG003|Overall Study|Disease Progression|0|||
125361627|NCT01024231|450958159|FG004|Overall Study|Disease Progression|4|||
125361628|NCT01024231|450958160|FG005|Overall Study|Disease Progression|11|||
125361629|NCT01024231|450958161|FG006|Overall Study|Disease Progression|6|||
125361630|NCT01024231|450958155|FG000|Overall Study|AE unrelated to Study Drug|0|||
125361631|NCT01024231|450958156|FG001|Overall Study|AE unrelated to Study Drug|1|||
125583149|NCT00618722|451762236|FG000|Overall Study|Refusal of Treatment|0|||
125583150|NCT00618722|451762237|FG001|Overall Study|Refusal of Treatment|0|||
125583151|NCT00618722|451762238|FG002|Overall Study|Refusal of Treatment|1|||
125583152|NCT00618722|451762239|FG003|Overall Study|Refusal of Treatment|0|||
125583153|NCT00618722|451762236|FG000|Overall Study|Patient Request|1|||
125583154|NCT00618722|451762237|FG001|Overall Study|Patient Request|1|||
125361632|NCT01024231|450958157|FG002|Overall Study|AE unrelated to Study Drug|0|||
125361633|NCT01024231|450958158|FG003|Overall Study|AE unrelated to Study Drug|0|||
125361634|NCT01024231|450958159|FG004|Overall Study|AE unrelated to Study Drug|0|||
125583155|NCT00618722|451762238|FG002|Overall Study|Patient Request|1|||
125583156|NCT00618722|451762239|FG003|Overall Study|Patient Request|1|||
125583157|NCT00618722|451762236|FG000|Overall Study|Inability to Complete Study Procedure|0|||
125583158|NCT00618722|451762237|FG001|Overall Study|Inability to Complete Study Procedure|1|||
125361635|NCT01024231|450958160|FG005|Overall Study|AE unrelated to Study Drug|0|||
125361636|NCT01024231|450958161|FG006|Overall Study|AE unrelated to Study Drug|0|||
125361637|NCT01024231|450958155|FG000|Overall Study|No longer meets criteria|0|||
125361638|NCT01024231|450958156|FG001|Overall Study|No longer meets criteria|0|||
125583159|NCT00618722|451762238|FG002|Overall Study|Inability to Complete Study Procedure|0|||
125583160|NCT00618722|451762239|FG003|Overall Study|Inability to Complete Study Procedure|0|||
125583161|NCT00618722|451762236|FG000|Overall Study|Lost to Follow-up|2|||
125361639|NCT01024231|450958157|FG002|Overall Study|No longer meets criteria|0|||
125361640|NCT01024231|450958158|FG003|Overall Study|No longer meets criteria|0|||
125361641|NCT01024231|450958159|FG004|Overall Study|No longer meets criteria|1|||
125583162|NCT00618722|451762237|FG001|Overall Study|Lost to Follow-up|0|||
125583163|NCT00618722|451762238|FG002|Overall Study|Lost to Follow-up|0|||
125583164|NCT00618722|451762239|FG003|Overall Study|Lost to Follow-up|2|||
125583165|NCT00618722|451762236|FG000|Overall Study|Miscellaneous Reasons|0|||
125361642|NCT01024231|450958160|FG005|Overall Study|No longer meets criteria|0|||
125361643|NCT01024231|450958161|FG006|Overall Study|No longer meets criteria|1|||
125361644|NCT01024231|450958155|FG000|Overall Study|Study Drug Toxicity|1|||
125361645|NCT01024231|450958156|FG001|Overall Study|Study Drug Toxicity|6|||
125361646|NCT01024231|450958157|FG002|Overall Study|Study Drug Toxicity|6|||
125361647|NCT01024231|450958158|FG003|Overall Study|Study Drug Toxicity|4|||
125361648|NCT01024231|450958159|FG004|Overall Study|Study Drug Toxicity|2|||
125361649|NCT01024231|450958160|FG005|Overall Study|Study Drug Toxicity|0|||
125361650|NCT01024231|450958161|FG006|Overall Study|Study Drug Toxicity|7|||
125361651|NCT01024231|450958155|FG000|Overall Study|Death|6|||
125361652|NCT01024231|450958156|FG001|Overall Study|Death|2|||
125361653|NCT01024231|450958157|FG002|Overall Study|Death|1|||
125361654|NCT01024231|450958158|FG003|Overall Study|Death|0|||
125361655|NCT01024231|450958159|FG004|Overall Study|Death|4|||
125361656|NCT01024231|450958160|FG005|Overall Study|Death|3|||
125361657|NCT01024231|450958161|FG006|Overall Study|Death|5|||
125361658|NCT01024231|450958155|FG000|Overall Study|Lost to Follow-up|0|||
125361659|NCT01024231|450958156|FG001|Overall Study|Lost to Follow-up|0|||
125361660|NCT01024231|450958157|FG002|Overall Study|Lost to Follow-up|0|||
125361661|NCT01024231|450958158|FG003|Overall Study|Lost to Follow-up|0|||
125361662|NCT01024231|450958159|FG004|Overall Study|Lost to Follow-up|0|||
125361663|NCT01024231|450958160|FG005|Overall Study|Lost to Follow-up|0|||
125361664|NCT01024231|450958161|FG006|Overall Study|Lost to Follow-up|1|||
125361665|NCT01024231|450958155|FG000|Overall Study|Withdrew Consent|0|||
125361666|NCT01024231|450958156|FG001|Overall Study|Withdrew Consent|1|||
125361667|NCT01024231|450958157|FG002|Overall Study|Withdrew Consent|0|||
125361668|NCT01024231|450958158|FG003|Overall Study|Withdrew Consent|0|||
125361669|NCT01024231|450958159|FG004|Overall Study|Withdrew Consent|0|||
125361670|NCT01024231|450958160|FG005|Overall Study|Withdrew Consent|0|||
125361671|NCT01024231|450958161|FG006|Overall Study|Withdrew Consent|0|||
125361672|NCT01024231|450958155|FG000|Overall Study|Continuing on Treatment|0|||
125583166|NCT00618722|451762237|FG001|Overall Study|Miscellaneous Reasons|0|||
125361673|NCT01024231|450958156|FG001|Overall Study|Continuing on Treatment|0|||
125361674|NCT01024231|450958157|FG002|Overall Study|Continuing on Treatment|0|||
125361675|NCT01024231|450958158|FG003|Overall Study|Continuing on Treatment|0|||
125361676|NCT01024231|450958159|FG004|Overall Study|Continuing on Treatment|3|||
125361677|NCT01024231|450958160|FG005|Overall Study|Continuing on Treatment|2|||
125361678|NCT01024231|450958161|FG006|Overall Study|Continuing on Treatment|0|||
125361679|NCT00973674|450958165|FG000|Overall Study|Protocol Violation|2|||
125361680|NCT00973674|450958166|FG001|Overall Study|Protocol Violation|0|||
125361681|NCT02713204|450958167|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
125361682|NCT02713204|450958168|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
125583167|NCT00618722|451762238|FG002|Overall Study|Miscellaneous Reasons|1|||
125361683|NCT02713204|450958169|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
125361684|NCT02713204|450958170|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
125583168|NCT00618722|451762239|FG003|Overall Study|Miscellaneous Reasons|1|||
125583169|NCT00778830|451762244|FG000|Overall Study|Ongoing at data cut-off|0|||
125583170|NCT00778830|451762245|FG001|Overall Study|Ongoing at data cut-off|1|||
125583171|NCT01891643|451762246|FG000|Overall Study|Adverse event unrelated to study drug|2|||
125583172|NCT01891643|451762247|FG001|Overall Study|Adverse event unrelated to study drug|5|||
125583173|NCT01891643|451762246|FG000|Overall Study|Disease Progression|4|||
125361685|NCT02713204|450958171|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
125361686|NCT02713204|450958172|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
125583174|NCT01891643|451762247|FG001|Overall Study|Disease Progression|3|||
125583175|NCT01891643|451762246|FG000|Overall Study|Study Drug Toxicity|3|||
125583176|NCT01891643|451762247|FG001|Overall Study|Study Drug Toxicity|0|||
125583177|NCT01891643|451762246|FG000|Overall Study|Maximum Clinical Benefit|0|||
125583178|NCT01891643|451762247|FG001|Overall Study|Maximum Clinical Benefit|1|||
125583179|NCT01891643|451762246|FG000|Overall Study|Poor/Non-compliance|0|||
125583180|NCT01891643|451762247|FG001|Overall Study|Poor/Non-compliance|1|||
125583181|NCT01891643|451762246|FG000|Overall Study|Participant request to discontinue|1|||
125583182|NCT01891643|451762247|FG001|Overall Study|Participant request to discontinue|0|||
125583183|NCT01583179|451762248|FG000|Overall Study|Screen failure|1|||
125583184|NCT01583179|451762249|FG001|Overall Study|Screen failure|2|||
125583185|NCT01246206|451762250|FG000|Overall Study|Patient did not receive study regiments.|1|||
125583186|NCT04047797|451762251|FG000|Overall Study|Progressive Disease|1|||
125583187|NCT03523351|451762252|FG000|Overall Study|Death|13|||
125583188|NCT03523351|451762253|FG001|Overall Study|Death|11|||
125583189|NCT03523351|451762252|FG000|Overall Study|Lost to Follow-up|2|||
125583190|NCT03523351|451762253|FG001|Overall Study|Lost to Follow-up|3|||
125583191|NCT03523351|451762252|FG000|Overall Study|Withdrawal by Subject|4|||
125583192|NCT03523351|451762253|FG001|Overall Study|Withdrawal by Subject|0|||
125583193|NCT03523351|451762252|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
125583194|NCT03523351|451762253|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
125583195|NCT01097629|451762262|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
125583196|NCT01097629|451762263|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
125583197|NCT01097629|451762264|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
125583198|NCT01097629|451762265|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125583199|NCT01097629|451762266|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125583200|NCT01097629|451762267|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125583201|NCT01097629|451762268|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125583202|NCT01097629|451762269|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125583203|NCT01097629|451762262|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
125583204|NCT01097629|451762263|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
125583205|NCT01097629|451762264|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
125583206|NCT01097629|451762265|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125583207|NCT01097629|451762266|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125583208|NCT01097629|451762267|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125583209|NCT01097629|451762268|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125583210|NCT01097629|451762269|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125583211|NCT01097629|451762262|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
125583212|NCT01097629|451762263|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
125583213|NCT01097629|451762264|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
125583214|NCT01097629|451762265|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125583215|NCT01097629|451762266|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125583216|NCT01097629|451762267|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125583217|NCT01097629|451762268|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125583218|NCT01097629|451762269|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125583219|NCT01097629|451762262|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
125583220|NCT01097629|451762263|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
125583221|NCT01097629|451762264|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
125583222|NCT01097629|451762265|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125583223|NCT01097629|451762266|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125583224|NCT01097629|451762267|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125583225|NCT01097629|451762268|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125583226|NCT01097629|451762269|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125361687|NCT02713204|450958173|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
125361688|NCT02713204|450958174|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
125361689|NCT02713204|450958167|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125361690|NCT02713204|450958168|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125361691|NCT02713204|450958169|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
125361692|NCT02713204|450958170|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125583227|NCT01097629|451762262|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
125583228|NCT01097629|451762263|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
125583229|NCT01097629|451762264|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
125583230|NCT01097629|451762265|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125583231|NCT01097629|451762266|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125583232|NCT01097629|451762267|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125583233|NCT01097629|451762268|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125583234|NCT01097629|451762269|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125583235|NCT01097629|451762262|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
125583236|NCT01097629|451762263|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
125583237|NCT01097629|451762264|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125583238|NCT01097629|451762265|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125583239|NCT01097629|451762266|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125583240|NCT01097629|451762267|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125583241|NCT01097629|451762268|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125583242|NCT01097629|451762269|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125583243|NCT01097629|451762262|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
125583244|NCT01097629|451762263|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
125583245|NCT01097629|451762264|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
125583246|NCT01097629|451762265|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125583247|NCT01097629|451762266|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125583248|NCT01097629|451762267|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125583249|NCT01097629|451762268|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125583250|NCT01097629|451762269|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125583251|NCT01097629|451762262|FG000|DB RO Phase|Withdrawal by Subject|0|||
125583252|NCT01097629|451762263|FG001|DB RO Phase|Withdrawal by Subject|0|||
125583253|NCT01097629|451762264|FG002|DB RO Phase|Withdrawal by Subject|0|||
125583254|NCT01097629|451762265|FG003|DB RO Phase|Withdrawal by Subject|0|||
125583255|NCT01097629|451762266|FG004|DB RO Phase|Withdrawal by Subject|0|||
125583256|NCT01097629|451762267|FG005|DB RO Phase|Withdrawal by Subject|0|||
125583257|NCT01097629|451762268|FG006|DB RO Phase|Withdrawal by Subject|0|||
125583258|NCT01097629|451762269|FG007|DB RO Phase|Withdrawal by Subject|1|||
125583259|NCT01097629|451762262|FG000|DB RO Phase|Protocol Violation|0|||
125583260|NCT01097629|451762263|FG001|DB RO Phase|Protocol Violation|0|||
125583261|NCT01097629|451762264|FG002|DB RO Phase|Protocol Violation|0|||
125583262|NCT01097629|451762265|FG003|DB RO Phase|Protocol Violation|1|||
125583263|NCT01097629|451762266|FG004|DB RO Phase|Protocol Violation|0|||
125583264|NCT01097629|451762267|FG005|DB RO Phase|Protocol Violation|1|||
125583265|NCT01097629|451762268|FG006|DB RO Phase|Protocol Violation|1|||
125583266|NCT01097629|451762269|FG007|DB RO Phase|Protocol Violation|0|||
125583267|NCT01097629|451762262|FG000|DB RO Phase|Lost to Follow-up|0|||
125583268|NCT01097629|451762263|FG001|DB RO Phase|Lost to Follow-up|0|||
125583269|NCT01097629|451762264|FG002|DB RO Phase|Lost to Follow-up|0|||
125583270|NCT01097629|451762265|FG003|DB RO Phase|Lost to Follow-up|0|||
125583271|NCT01097629|451762266|FG004|DB RO Phase|Lost to Follow-up|0|||
125583272|NCT01097629|451762267|FG005|DB RO Phase|Lost to Follow-up|0|||
125583273|NCT01097629|451762268|FG006|DB RO Phase|Lost to Follow-up|2|||
125583274|NCT01097629|451762269|FG007|DB RO Phase|Lost to Follow-up|0|||
125583275|NCT00132041|451762270|FG000|Baseline|Ineligible|6|||
125583276|NCT00132041|451762270|FG000|3 Months Post Ablation|Transplant|1|||
125583277|NCT00132041|451762270|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
125583278|NCT00132041|451762270|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
125583279|NCT00132041|451762270|FG000|6 Months Post Ablation|Death|2|||
125583280|NCT00132041|451762270|FG000|6 Months Post Ablation|Transplant|6|||
125583281|NCT00132041|451762270|FG000|9 Months Post Ablation|Death|1|||
125583282|NCT00132041|451762270|FG000|9 Months Post Ablation|Transplant|1|||
125583283|NCT00132041|451762270|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
125583284|NCT00132041|451762270|FG000|12 Months Post Ablation|Death|1|||
125583285|NCT00132041|451762270|FG000|12 Months Post Ablation|Transplant|1|||
125583286|NCT00132041|451762270|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
125583287|NCT00132041|451762270|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
125583288|NCT00132041|451762270|FG000|15 Months Post Ablation|Death|1|||
125361693|NCT02713204|450958171|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125583289|NCT00132041|451762270|FG000|15 Months Post Ablation|Transplant|5|||
125583290|NCT00132041|451762270|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
125361694|NCT02713204|450958172|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125361695|NCT02713204|450958173|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125361696|NCT02713204|450958174|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125583291|NCT00132041|451762270|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
125361697|NCT02713204|450958167|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125361698|NCT02713204|450958168|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
125361699|NCT02713204|450958169|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125361700|NCT02713204|450958170|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125361701|NCT02713204|450958171|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125361702|NCT02713204|450958172|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125361703|NCT02713204|450958173|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125361704|NCT02713204|450958174|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125361705|NCT02713204|450958167|FG000|From Week 12 up to Week 36|Adverse Event|1|||
125361706|NCT02713204|450958168|FG001|From Week 12 up to Week 36|Adverse Event|0|||
125361707|NCT02713204|450958169|FG002|From Week 12 up to Week 36|Adverse Event|0|||
125361708|NCT02713204|450958170|FG003|From Week 12 up to Week 36|Adverse Event|1|||
125361709|NCT02713204|450958171|FG004|From Week 12 up to Week 36|Adverse Event|1|||
125361710|NCT02713204|450958172|FG005|From Week 12 up to Week 36|Adverse Event|0|||
125361711|NCT02713204|450958173|FG006|From Week 12 up to Week 36|Adverse Event|2|||
125361712|NCT02713204|450958174|FG007|From Week 12 up to Week 36|Adverse Event|1|||
125361713|NCT02713204|450958167|FG000|From Week 12 up to Week 36|Death|0|||
125361714|NCT02713204|450958168|FG001|From Week 12 up to Week 36|Death|0|||
125361715|NCT02713204|450958169|FG002|From Week 12 up to Week 36|Death|0|||
125361716|NCT02713204|450958170|FG003|From Week 12 up to Week 36|Death|1|||
125361717|NCT02713204|450958171|FG004|From Week 12 up to Week 36|Death|0|||
125361718|NCT02713204|450958172|FG005|From Week 12 up to Week 36|Death|1|||
125361719|NCT02713204|450958173|FG006|From Week 12 up to Week 36|Death|0|||
125361720|NCT02713204|450958174|FG007|From Week 12 up to Week 36|Death|3|||
125361721|NCT02713204|450958167|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
125361722|NCT02713204|450958168|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
125361723|NCT02713204|450958169|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
125361724|NCT02713204|450958170|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
125361725|NCT02713204|450958171|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
125361726|NCT02713204|450958172|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
125361727|NCT02713204|450958173|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
125361728|NCT02713204|450958174|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
125361729|NCT02713204|450958167|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
125361730|NCT02713204|450958168|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
125361731|NCT02713204|450958169|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
125361732|NCT02713204|450958170|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
125361733|NCT02713204|450958171|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
125361734|NCT02713204|450958172|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
125583292|NCT00132041|451762270|FG000|18 Months Post Ablation|Transplant|1|||
125583293|NCT00132041|451762270|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
125583294|NCT00132041|451762270|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
125583295|NCT03609619|451762272|FG000|Overall Study|Adverse Event|1|||
125583296|NCT03609619|451762273|FG001|Overall Study|Adverse Event|0|||
125583297|NCT03609619|451762272|FG000|Overall Study|Lack of Efficacy|1|||
125583298|NCT03609619|451762273|FG001|Overall Study|Lack of Efficacy|2|||
125583299|NCT03609619|451762272|FG000|Overall Study|Protocol Violation|5|||
125583300|NCT03609619|451762273|FG001|Overall Study|Protocol Violation|0|||
125583301|NCT03609619|451762272|FG000|Overall Study|Withdrawal by Subject|2|||
125583302|NCT03609619|451762273|FG001|Overall Study|Withdrawal by Subject|3|||
125583303|NCT03609619|451762272|FG000|Overall Study|Lost to Follow-up|1|||
125583304|NCT03609619|451762273|FG001|Overall Study|Lost to Follow-up|1|||
125583305|NCT01171820|451762274|FG000|Overall Study|Death|3|||
125583306|NCT01171820|451762275|FG001|Overall Study|Death|3|||
125583307|NCT01171820|451762274|FG000|Overall Study|Lost to Follow-up|0|||
125583308|NCT01171820|451762275|FG001|Overall Study|Lost to Follow-up|1|||
125583309|NCT01171820|451762274|FG000|Overall Study|Withdrawal by Subject|2|||
125583310|NCT01171820|451762275|FG001|Overall Study|Withdrawal by Subject|0|||
125583311|NCT01171820|451762274|FG000|Overall Study|Physician Decision|0|||
125583312|NCT01171820|451762275|FG001|Overall Study|Physician Decision|1|||
125583313|NCT01171820|451762274|FG000|Overall Study|1-Year Missed Visit|1|||
125583314|NCT01171820|451762275|FG001|Overall Study|1-Year Missed Visit|1|||
125583315|NCT00956943|451762276|FG000|Overall Study|Lost to Follow-up|9|||
125583316|NCT00956943|451762277|FG001|Overall Study|Lost to Follow-up|10|||
125583317|NCT02613208|451762278|FG000|Overall Study|Withdrawal by Subject|1|||
125361735|NCT02713204|450958173|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
125583318|NCT02613208|451762278|FG000|Overall Study|Change of address|2|||
125583319|NCT02613208|451762278|FG000|Overall Study|Physician Decision|2|||
125583320|NCT02613208|451762278|FG000|Overall Study|Lost to Follow-up|5|||
125583321|NCT02613208|451762278|FG000|Overall Study|Death|37|||
125583322|NCT02663895|451762279|FG000|Overall Study|Adverse Event|3|||
125583323|NCT02663895|451762279|FG000|Overall Study|Physician Decision|2|||
125583324|NCT02663895|451762279|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
125361736|NCT02713204|450958174|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
125361737|NCT01710046|450958176|FG000|Overall Study|Lost to Follow-up|1|||
125583325|NCT02663895|451762279|FG000|Overall Study|Withdrawal by Subject|1|||
125583326|NCT02472847|451762285|FG000|Overall Study|Withdrawal by Subject|1|||
125583327|NCT02472847|451762286|FG001|Overall Study|Withdrawal by Subject|5|||
125583328|NCT00623831|451762287|FG000|Overall Study|Withdrawal by Subject|1|||
125131394|NCT03818581|450109963|FG003|Overall Study|Adverse Event|0|||
125583329|NCT00623831|451762288|FG001|Overall Study|Withdrawal by Subject|0|||
125583330|NCT00623831|451762287|FG000|Overall Study|Progressive Disease|0|||
125583331|NCT00623831|451762288|FG001|Overall Study|Progressive Disease|1|||
125583332|NCT00270894|451762289|FG000|Overall Study|Adverse Event|1|||
125583333|NCT00270894|451762289|FG000|Overall Study|Withdrawal by Subject|1|||
125583334|NCT01748071|451762292|FG000|Overall Study|Adverse Event|2|||
125583335|NCT01748071|451762293|FG001|Overall Study|Adverse Event|2|||
125583336|NCT01748071|451762294|FG002|Overall Study|Adverse Event|0|||
125583337|NCT02720757|451762295|FG000|Overall Study|Other reason|5|||
125583338|NCT02720757|451762295|FG000|Overall Study|Loss of contact|4|||
125583339|NCT02720757|451762295|FG000|Overall Study|Informed consent withdrawal|1|||
125583340|NCT02720757|451762295|FG000|Overall Study|Patients wish to withdraw|2|||
125583341|NCT02720757|451762295|FG000|Overall Study|Missing|3|||
125583342|NCT02720757|451762295|FG000|Overall Study|General exclusion|3|||
125583343|NCT00883493|451762296|FG000|Overall Study|Adverse Event|11|||
125583344|NCT00883493|451762297|FG001|Overall Study|Adverse Event|12|||
125583345|NCT00883493|451762296|FG000|Overall Study|Lack of Efficacy|4|||
125583346|NCT00883493|451762297|FG001|Overall Study|Lack of Efficacy|3|||
125583347|NCT00883493|451762296|FG000|Overall Study|Lost to Follow-up|7|||
125583348|NCT00883493|451762297|FG001|Overall Study|Lost to Follow-up|6|||
125583349|NCT00883493|451762296|FG000|Overall Study|Withdrawal by Subject|11|||
125583350|NCT00883493|451762297|FG001|Overall Study|Withdrawal by Subject|20|||
125583351|NCT00883493|451762296|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
125583352|NCT00883493|451762297|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
125583353|NCT00883493|451762296|FG000|Overall Study|Study specific disc. criteria|2|||
125583354|NCT00883493|451762297|FG001|Overall Study|Study specific disc. criteria|0|||
125583355|NCT00883493|451762296|FG000|Overall Study|Other|5|||
125583356|NCT00883493|451762297|FG001|Overall Study|Other|3|||
125583357|NCT01084551|451762298|FG000|Overall Study|Adverse Event|2|||
125583358|NCT01084551|451762299|FG001|Overall Study|Adverse Event|9|||
125583359|NCT01084551|451762300|FG002|Overall Study|Adverse Event|4|||
125583360|NCT01084551|451762298|FG000|Overall Study|Lack of Efficacy|2|||
125583361|NCT01084551|451762299|FG001|Overall Study|Lack of Efficacy|0|||
125583362|NCT01084551|451762300|FG002|Overall Study|Lack of Efficacy|1|||
125428566|NCT00508404|451195452|FG000|Overall Study|Protocol-specified Criteria|2|||
125583363|NCT01084551|451762298|FG000|Overall Study|Withdrawal by Subject|2|||
125583364|NCT01084551|451762299|FG001|Overall Study|Withdrawal by Subject|1|||
125583365|NCT01084551|451762300|FG002|Overall Study|Withdrawal by Subject|0|||
125583366|NCT01084551|451762298|FG000|Overall Study|Protocol Violation|2|||
125583367|NCT01084551|451762299|FG001|Overall Study|Protocol Violation|4|||
125583368|NCT01084551|451762300|FG002|Overall Study|Protocol Violation|0|||
125583369|NCT01084551|451762298|FG000|Overall Study|Lost to Follow-up|0|||
125583370|NCT01084551|451762299|FG001|Overall Study|Lost to Follow-up|0|||
125583371|NCT01084551|451762300|FG002|Overall Study|Lost to Follow-up|3|||
125583372|NCT01084551|451762298|FG000|Overall Study|Physician Decision|1|||
125583373|NCT01084551|451762299|FG001|Overall Study|Physician Decision|0|||
125583374|NCT01084551|451762300|FG002|Overall Study|Physician Decision|0|||
125583375|NCT00463476|451762301|FG000|Overall Study|Withdrawal by Subject|1|||
125583376|NCT00463476|451762302|FG001|Overall Study|Withdrawal by Subject|2|||
125583377|NCT00463476|451762301|FG000|Overall Study|Lost to Follow-up|1|||
125583378|NCT00463476|451762302|FG001|Overall Study|Lost to Follow-up|1|||
125583379|NCT00988247|451762303|FG000|Overall Study|Adverse Event|17|||
125583380|NCT00988247|451762304|FG001|Overall Study|Adverse Event|3|||
125583381|NCT00988247|451762303|FG000|Overall Study|Withdrawal by Subject|44|||
125583382|NCT00988247|451762304|FG001|Overall Study|Withdrawal by Subject|13|||
125583383|NCT00988247|451762303|FG000|Overall Study|Pregnancy|1|||
125583384|NCT00988247|451762304|FG001|Overall Study|Pregnancy|2|||
125583385|NCT00988247|451762303|FG000|Overall Study|Lost to Follow-up|11|||
125583386|NCT00988247|451762304|FG001|Overall Study|Lost to Follow-up|2|||
125583387|NCT00988247|451762303|FG000|Overall Study|Protocol Violation|4|||
125583388|NCT00988247|451762304|FG001|Overall Study|Protocol Violation|5|||
125583389|NCT00988247|451762303|FG000|Overall Study|Sponsor requested withdrawal|3|||
125583390|NCT00988247|451762304|FG001|Overall Study|Sponsor requested withdrawal|1|||
125583391|NCT00988247|451762303|FG000|Overall Study|Other|3|||
125583392|NCT00988247|451762304|FG001|Overall Study|Other|0|||
125583393|NCT04173741|451762305|FG000|Overall Study|IVC measurement cannot be done|1|||
125583394|NCT04173741|451762306|FG001|Overall Study|IVC measurement cannot be done|1|||
125583395|NCT00289913|451762307|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125583396|NCT00289913|451762308|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
125583397|NCT00289913|451762309|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125583398|NCT00289913|451762310|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125583399|NCT00289913|451762311|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125583400|NCT00289913|451762307|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
125583401|NCT00289913|451762308|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
125583402|NCT00289913|451762309|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
125583403|NCT00289913|451762310|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
125583404|NCT00289913|451762311|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
125583405|NCT00289913|451762307|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
125211801|NCT02007278|450401373|FG001|Overall Study|Incorrect medication administration|0|||
125583406|NCT00289913|451762308|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
125583407|NCT00289913|451762309|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125211802|NCT02007278|450401372|FG000|Overall Study|Mis-randomization|1|||
125211803|NCT02007278|450401373|FG001|Overall Study|Mis-randomization|1|||
125583408|NCT00289913|451762310|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
125583409|NCT00289913|451762311|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
125583410|NCT00289913|451762307|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
125583411|NCT00289913|451762308|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
125583412|NCT00289913|451762309|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
125583413|NCT00289913|451762310|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
125583414|NCT00289913|451762311|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
125583415|NCT00289913|451762307|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125583416|NCT00289913|451762308|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125583417|NCT00289913|451762309|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125583418|NCT00289913|451762310|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
125583419|NCT00289913|451762311|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125583420|NCT00289913|451762307|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
125361738|NCT01710046|450958177|FG001|Overall Study|Lost to Follow-up|0|||
125361739|NCT03896165|450958178|FG000|Overall Study|Withdrawal by Subject|2|||
125361740|NCT03181893|450958179|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125361741|NCT03181893|450958180|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
125583421|NCT00289913|451762308|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
125583422|NCT00289913|451762309|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
125583423|NCT00289913|451762310|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
125583424|NCT00289913|451762311|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
125583425|NCT00289913|451762307|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
125583426|NCT00289913|451762308|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
125583427|NCT00289913|451762309|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
125583428|NCT00289913|451762310|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
125583429|NCT00289913|451762311|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
125583430|NCT00289913|451762307|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
125361742|NCT03181893|450958181|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125361743|NCT03181893|450958182|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125361744|NCT03181893|450958183|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125361745|NCT03181893|450958184|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125361746|NCT03181893|450958185|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125361747|NCT03181893|450958186|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125583431|NCT00289913|451762308|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
125583432|NCT00289913|451762309|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
125361748|NCT03181893|450958187|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125361749|NCT03181893|450958188|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125361750|NCT03181893|450958189|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
125361751|NCT03181893|450958179|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
125361752|NCT03181893|450958180|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
125361753|NCT03181893|450958181|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125361754|NCT03181893|450958182|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125361755|NCT03181893|450958183|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125361756|NCT03181893|450958184|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125361757|NCT03181893|450958185|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125361758|NCT03181893|450958186|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125361759|NCT03181893|450958187|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125361760|NCT03181893|450958188|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125361761|NCT03181893|450958189|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
125361762|NCT03181893|450958179|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125361763|NCT03181893|450958180|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125361764|NCT03181893|450958181|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125361765|NCT03181893|450958182|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125361766|NCT03181893|450958183|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125361767|NCT03181893|450958184|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125361768|NCT03181893|450958185|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125361769|NCT03181893|450958186|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
125583433|NCT00289913|451762310|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
125583434|NCT00289913|451762311|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
125361770|NCT03181893|450958187|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
125361771|NCT03181893|450958188|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125361772|NCT03181893|450958189|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
125361773|NCT03181893|450958179|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125361774|NCT03181893|450958180|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125361775|NCT03181893|450958181|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125583435|NCT00289913|451762307|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
125583436|NCT00289913|451762308|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125583437|NCT00289913|451762309|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
125583438|NCT00289913|451762310|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125583439|NCT00289913|451762311|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125583440|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125583441|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125583442|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
125583443|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125583444|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125583445|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
125583446|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
125583447|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
125583448|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
125583449|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
125583450|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
125583451|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
125583452|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
125583453|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
125583454|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
125583455|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
125583456|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
125583457|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
125583458|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125583459|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125583460|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
125583461|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125583462|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
125583463|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125583464|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125583465|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
125583466|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
125583467|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
125583468|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
125583469|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
125583470|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
125583471|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
125583472|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
125583473|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
125583474|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
125583475|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
125583476|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
125583477|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
125583478|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
125583479|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
125583480|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
125583481|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
125583482|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
125583483|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
125583484|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
125583485|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
125583486|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
125583487|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
125583488|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
125583489|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
125583490|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
125583491|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
125583492|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
125583493|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
125583494|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
125583495|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
125583496|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
125583497|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
125583498|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
125583499|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
125583500|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
125583501|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
125583502|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
125583503|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
125583504|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
125583505|NCT00289913|451762307|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
125583506|NCT00289913|451762308|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
125583507|NCT00289913|451762309|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
125583508|NCT00289913|451762310|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
125583509|NCT00289913|451762311|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
125583510|NCT00289913|451762307|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125583511|NCT00289913|451762308|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
125583512|NCT00289913|451762309|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125583513|NCT00289913|451762310|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125583514|NCT00289913|451762311|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
125583515|NCT00289913|451762307|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
125583516|NCT00289913|451762308|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
125583517|NCT00289913|451762309|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
125583518|NCT00289913|451762310|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
125583519|NCT00289913|451762311|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
125583520|NCT00289913|451762307|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125583521|NCT00289913|451762308|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125583522|NCT00289913|451762309|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125583523|NCT00289913|451762310|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
125583524|NCT00289913|451762311|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
125583525|NCT00289913|451762307|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125583526|NCT00289913|451762308|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125583527|NCT00289913|451762309|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125583528|NCT00289913|451762310|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
125583529|NCT00289913|451762311|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
125583530|NCT00289913|451762307|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
125583531|NCT00289913|451762308|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
125583532|NCT00289913|451762309|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
125583533|NCT00289913|451762310|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
125583534|NCT00289913|451762311|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
125583535|NCT00289913|451762307|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
125583536|NCT00289913|451762308|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
125583537|NCT00289913|451762309|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
125583538|NCT00289913|451762310|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
125583539|NCT00289913|451762311|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
125583540|NCT00289913|451762307|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
125583541|NCT00289913|451762308|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
125583542|NCT00289913|451762309|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
125583543|NCT00289913|451762310|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
125583544|NCT00289913|451762311|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
125583545|NCT00289913|451762307|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125583546|NCT00289913|451762308|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
125583547|NCT00289913|451762309|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125583548|NCT00289913|451762310|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125583549|NCT00289913|451762311|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
125583550|NCT01169779|451762314|FG000|Overall Study|Adverse Event|3|||
125583551|NCT01169779|451762315|FG001|Overall Study|Adverse Event|11|||
125583552|NCT01169779|451762314|FG000|Overall Study|Lack of Efficacy|1|||
125583553|NCT01169779|451762315|FG001|Overall Study|Lack of Efficacy|0|||
125583554|NCT01169779|451762314|FG000|Overall Study|Protocol Violation|1|||
125583555|NCT01169779|451762315|FG001|Overall Study|Protocol Violation|1|||
125583556|NCT01169779|451762314|FG000|Overall Study|Withdrawal by Subject|3|||
125583557|NCT01169779|451762315|FG001|Overall Study|Withdrawal by Subject|2|||
125583558|NCT01169779|451762314|FG000|Overall Study|Familial and personal reasons|3|||
125583559|NCT01169779|451762315|FG001|Overall Study|Familial and personal reasons|3|||
125428567|NCT00508404|451195452|FG000|Overall Study|Lost to Follow-up|2|||
125428568|NCT00508404|451195452|FG000|Overall Study|Other - Not Specified|3|||
125583560|NCT03617705|451762320|FG000|Overall Study|Withdrawal by Subject|2|||
125583561|NCT03617705|451762320|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
125583562|NCT03617705|451762320|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
125583563|NCT01061008|451762321|FG000|Overall Study|Badiocephalic fistula failed|3|||
125583564|NCT01061008|451762322|FG001|Overall Study|Badiocephalic fistula failed|2|||
125583565|NCT01061008|451762321|FG000|Overall Study|Death|1|||
125583566|NCT01061008|451762322|FG001|Overall Study|Death|0|||
125583567|NCT01061008|451762321|FG000|Overall Study|Withdrawal by Subject|1|||
125583568|NCT01061008|451762322|FG001|Overall Study|Withdrawal by Subject|3|||
125583569|NCT01061008|451762321|FG000|Overall Study|Unable to exercise following surgery|1|||
125583570|NCT01061008|451762322|FG001|Overall Study|Unable to exercise following surgery|0|||
125583571|NCT01061008|451762321|FG000|Overall Study|Adverse Event|0|||
125583572|NCT01061008|451762322|FG001|Overall Study|Adverse Event|1|||
125583573|NCT02024971|451762323|FG000|Overall Study|Data Not Available|30|||
125583574|NCT02024971|451762323|FG000|Overall Study|Lost to Follow-up|6|||
125583575|NCT00189462|451762335|FG000|Overall Study|Lack of Efficacy|5|||
125583576|NCT00189462|451762336|FG001|Overall Study|Lack of Efficacy|1|||
125583577|NCT00189462|451762335|FG000|Overall Study|Lost to Follow-up|18|||
125583578|NCT00189462|451762336|FG001|Overall Study|Lost to Follow-up|20|||
125583579|NCT00849667|451762337|FG000|Overall Study|Withdrawal by Subject|16|||
125583580|NCT00849667|451762338|FG001|Overall Study|Withdrawal by Subject|33|||
125583581|NCT00849667|451762339|FG002|Overall Study|Withdrawal by Subject|35|||
125583582|NCT00849667|451762337|FG000|Overall Study|Lost to Follow-up|8|||
125583583|NCT00849667|451762338|FG001|Overall Study|Lost to Follow-up|8|||
125583584|NCT00849667|451762339|FG002|Overall Study|Lost to Follow-up|8|||
125583585|NCT00849667|451762337|FG000|Overall Study|Adverse Event|1|||
125583586|NCT00849667|451762338|FG001|Overall Study|Adverse Event|2|||
125583587|NCT00849667|451762339|FG002|Overall Study|Adverse Event|0|||
125583588|NCT00849667|451762337|FG000|Overall Study|Other|18|||
125583589|NCT00849667|451762338|FG001|Overall Study|Other|19|||
125583590|NCT00849667|451762339|FG002|Overall Study|Other|18|||
125583591|NCT00849667|451762337|FG000|Overall Study|Progressive disease|119|||
125583592|NCT00849667|451762338|FG001|Overall Study|Progressive disease|100|||
125583593|NCT00849667|451762339|FG002|Overall Study|Progressive disease|112|||
125583594|NCT00849667|451762337|FG000|Overall Study|Sponsor decision|208|||
125583595|NCT00849667|451762338|FG001|Overall Study|Sponsor decision|204|||
125583596|NCT00849667|451762339|FG002|Overall Study|Sponsor decision|190|||
125583597|NCT00849667|451762337|FG000|Overall Study|Investigator discretion|0|||
125583598|NCT00849667|451762338|FG001|Overall Study|Investigator discretion|0|||
125583599|NCT00849667|451762339|FG002|Overall Study|Investigator discretion|1|||
125583600|NCT01262625|451762340|FG000|Overall Study|Administrative Error|1|||
125583601|NCT01262625|451762341|FG001|Overall Study|Administrative Error|1|||
125583602|NCT01262625|451762340|FG000|Overall Study|Site Closed|1|||
125583603|NCT01262625|451762341|FG001|Overall Study|Site Closed|0|||
125583604|NCT00944034|451762345|FG000|Overall Study|Inappropriate enrollment|0|||
125583605|NCT00944034|451762346|FG001|Overall Study|Inappropriate enrollment|1|||
125583606|NCT00944034|451762347|FG002|Overall Study|Inappropriate enrollment|0|||
125583607|NCT00944034|451762348|FG003|Overall Study|Inappropriate enrollment|1|||
125583608|NCT00944034|451762349|FG004|Overall Study|Inappropriate enrollment|2|||
125583609|NCT00944034|451762350|FG005|Overall Study|Inappropriate enrollment|1|||
125583610|NCT00944034|451762351|FG006|Overall Study|Inappropriate enrollment|0|||
125583611|NCT00944034|451762352|FG007|Overall Study|Inappropriate enrollment|0|||
125583612|NCT00944034|451762353|FG008|Overall Study|Inappropriate enrollment|1|||
125583613|NCT00944034|451762354|FG009|Overall Study|Inappropriate enrollment|1|||
125583614|NCT00944034|451762355|FG010|Overall Study|Inappropriate enrollment|0|||
125583615|NCT00944034|451762356|FG011|Overall Study|Inappropriate enrollment|0|||
125583616|NCT00944034|451762345|FG000|Overall Study|Withdrawal by Subject|3|||
125583617|NCT00944034|451762346|FG001|Overall Study|Withdrawal by Subject|2|||
125583618|NCT00944034|451762347|FG002|Overall Study|Withdrawal by Subject|6|||
125583619|NCT00944034|451762348|FG003|Overall Study|Withdrawal by Subject|2|||
125211804|NCT00435188|450401375|FG000|Overall Study|Death|1|||
125583620|NCT00944034|451762349|FG004|Overall Study|Withdrawal by Subject|5|||
125583621|NCT00944034|451762350|FG005|Overall Study|Withdrawal by Subject|8|||
125583622|NCT00944034|451762351|FG006|Overall Study|Withdrawal by Subject|2|||
125583623|NCT00944034|451762352|FG007|Overall Study|Withdrawal by Subject|2|||
125583624|NCT00944034|451762353|FG008|Overall Study|Withdrawal by Subject|3|||
125583625|NCT00944034|451762354|FG009|Overall Study|Withdrawal by Subject|4|||
125583626|NCT00944034|451762355|FG010|Overall Study|Withdrawal by Subject|0|||
125583627|NCT00944034|451762356|FG011|Overall Study|Withdrawal by Subject|4|||
125583628|NCT00944034|451762345|FG000|Overall Study|Lost to Follow-up|0|||
125583629|NCT00944034|451762346|FG001|Overall Study|Lost to Follow-up|4|||
125583630|NCT00944034|451762347|FG002|Overall Study|Lost to Follow-up|2|||
125583631|NCT00944034|451762348|FG003|Overall Study|Lost to Follow-up|0|||
125583632|NCT00944034|451762349|FG004|Overall Study|Lost to Follow-up|5|||
125211805|NCT00435188|450401376|FG001|Overall Study|Death|6|||
125211806|NCT00435188|450401375|FG000|Overall Study|Withdrawal by Subject|16|||
125583633|NCT00944034|451762350|FG005|Overall Study|Lost to Follow-up|7|||
125583634|NCT00944034|451762351|FG006|Overall Study|Lost to Follow-up|0|||
125583635|NCT00944034|451762352|FG007|Overall Study|Lost to Follow-up|1|||
125583636|NCT00944034|451762353|FG008|Overall Study|Lost to Follow-up|5|||
125583637|NCT00944034|451762354|FG009|Overall Study|Lost to Follow-up|1|||
125583638|NCT00944034|451762355|FG010|Overall Study|Lost to Follow-up|1|||
125583639|NCT00944034|451762356|FG011|Overall Study|Lost to Follow-up|0|||
125583640|NCT00944034|451762345|FG000|Overall Study|Death|0|||
125583641|NCT00944034|451762346|FG001|Overall Study|Death|0|||
125583642|NCT00944034|451762347|FG002|Overall Study|Death|1|||
125583643|NCT00944034|451762348|FG003|Overall Study|Death|0|||
125583644|NCT00944034|451762349|FG004|Overall Study|Death|0|||
125583645|NCT00944034|451762350|FG005|Overall Study|Death|0|||
125583646|NCT00944034|451762351|FG006|Overall Study|Death|0|||
125583647|NCT00944034|451762352|FG007|Overall Study|Death|0|||
125583648|NCT00944034|451762353|FG008|Overall Study|Death|0|||
125583649|NCT00944034|451762354|FG009|Overall Study|Death|0|||
125583650|NCT00944034|451762355|FG010|Overall Study|Death|0|||
125583651|NCT00944034|451762356|FG011|Overall Study|Death|0|||
125583652|NCT00944034|451762345|FG000|Overall Study|Protocol Violation|2|||
125583653|NCT00944034|451762346|FG001|Overall Study|Protocol Violation|0|||
125428569|NCT01591382|451195467|FG000|Overall Study|Discharged Prior to Study Completion|2|||
125428570|NCT01591382|451195468|FG001|Overall Study|Discharged Prior to Study Completion|1|||
125583654|NCT00944034|451762347|FG002|Overall Study|Protocol Violation|0|||
125583655|NCT00944034|451762348|FG003|Overall Study|Protocol Violation|1|||
125583656|NCT00944034|451762349|FG004|Overall Study|Protocol Violation|2|||
125583657|NCT00944034|451762350|FG005|Overall Study|Protocol Violation|3|||
125583658|NCT00944034|451762351|FG006|Overall Study|Protocol Violation|0|||
125583659|NCT00944034|451762352|FG007|Overall Study|Protocol Violation|1|||
125583660|NCT00944034|451762353|FG008|Overall Study|Protocol Violation|1|||
125583661|NCT00944034|451762354|FG009|Overall Study|Protocol Violation|4|||
125583662|NCT00944034|451762355|FG010|Overall Study|Protocol Violation|0|||
125583663|NCT00944034|451762356|FG011|Overall Study|Protocol Violation|0|||
125583664|NCT00944034|451762345|FG000|Overall Study|Unable to classify|0|||
125583665|NCT00944034|451762346|FG001|Overall Study|Unable to classify|0|||
125583666|NCT00944034|451762347|FG002|Overall Study|Unable to classify|0|||
125583667|NCT00944034|451762348|FG003|Overall Study|Unable to classify|0|||
125583668|NCT00944034|451762349|FG004|Overall Study|Unable to classify|0|||
125583669|NCT00944034|451762350|FG005|Overall Study|Unable to classify|1|||
125583670|NCT00944034|451762351|FG006|Overall Study|Unable to classify|1|||
125583671|NCT00944034|451762352|FG007|Overall Study|Unable to classify|1|||
125583672|NCT00944034|451762353|FG008|Overall Study|Unable to classify|0|||
125583673|NCT00944034|451762354|FG009|Overall Study|Unable to classify|0|||
125428571|NCT01591382|451195467|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
125428572|NCT01591382|451195468|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
125428573|NCT03170375|451195474|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
125428574|NCT03170375|451195475|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
125428575|NCT03170375|451195476|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
125428576|NCT03170375|451195474|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
125428577|NCT03170375|451195475|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
125428578|NCT03170375|451195476|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
125428579|NCT00855062|451195477|FG000|Step1|Early Study Closure|5|||
125428580|NCT00855062|451195478|FG001|Step1|Early Study Closure|7|||
125428581|NCT00855062|451195477|FG000|Step1|Adverse Event|1|||
125428582|NCT00855062|451195478|FG001|Step1|Adverse Event|1|||
125428583|NCT00855062|451195477|FG000|Step1|Protocol Violation|1|||
125428584|NCT00855062|451195478|FG001|Step1|Protocol Violation|0|||
125428585|NCT00855062|451195477|FG000|Step1|Pregnancy|1|||
125428586|NCT00855062|451195478|FG001|Step1|Pregnancy|0|||
125428587|NCT00855062|451195477|FG000|Step1|Withdrawal by Subject|2|||
125428588|NCT00855062|451195478|FG001|Step1|Withdrawal by Subject|3|||
125428589|NCT00855062|451195477|FG000|Step2|Early Study Closure|6|||
125428590|NCT00855062|451195478|FG001|Step2|Early Study Closure|2|||
125583674|NCT00944034|451762355|FG010|Overall Study|Unable to classify|0|||
125583675|NCT00944034|451762356|FG011|Overall Study|Unable to classify|0|||
125583676|NCT00944034|451762345|FG000|Overall Study|Administrative reason|0|||
125583677|NCT00944034|451762346|FG001|Overall Study|Administrative reason|0|||
125583678|NCT00944034|451762347|FG002|Overall Study|Administrative reason|0|||
125583679|NCT00944034|451762348|FG003|Overall Study|Administrative reason|0|||
125583680|NCT00944034|451762349|FG004|Overall Study|Administrative reason|0|||
125583681|NCT00944034|451762350|FG005|Overall Study|Administrative reason|0|||
125131395|NCT03818581|450109964|FG004|Overall Study|Adverse Event|0|||
125428591|NCT00855062|451195477|FG000|Step2|Adverse Event|0|||
125428592|NCT00855062|451195478|FG001|Step2|Adverse Event|3|||
125428593|NCT00855062|451195477|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
125428594|NCT00855062|451195478|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
125428595|NCT01376323|451195480|FG000|Overall Study|Adverse Event|1|||
125428596|NCT01376323|451195481|FG001|Overall Study|Adverse Event|0|||
125583682|NCT00944034|451762351|FG006|Overall Study|Administrative reason|1|||
125583683|NCT00944034|451762352|FG007|Overall Study|Administrative reason|0|||
125583684|NCT00944034|451762353|FG008|Overall Study|Administrative reason|0|||
125583685|NCT00944034|451762354|FG009|Overall Study|Administrative reason|0|||
125583686|NCT00944034|451762355|FG010|Overall Study|Administrative reason|0|||
125428597|NCT01376323|451195482|FG002|Overall Study|Adverse Event|0|||
125428598|NCT01376323|451195483|FG003|Overall Study|Adverse Event|2|||
125428599|NCT01376323|451195484|FG004|Overall Study|Adverse Event|0|||
125428600|NCT01376323|451195480|FG000|Overall Study|Lost to Follow-up|0|||
125428601|NCT01376323|451195481|FG001|Overall Study|Lost to Follow-up|0|||
125428602|NCT01376323|451195482|FG002|Overall Study|Lost to Follow-up|0|||
125428603|NCT01376323|451195483|FG003|Overall Study|Lost to Follow-up|2|||
125428604|NCT01376323|451195484|FG004|Overall Study|Lost to Follow-up|0|||
125428605|NCT01376323|451195480|FG000|Overall Study|Physician Decision|1|||
125428606|NCT01376323|451195481|FG001|Overall Study|Physician Decision|0|||
125428607|NCT01376323|451195482|FG002|Overall Study|Physician Decision|2|||
125428608|NCT01376323|451195483|FG003|Overall Study|Physician Decision|1|||
125428609|NCT01376323|451195484|FG004|Overall Study|Physician Decision|1|||
125428610|NCT01376323|451195480|FG000|Overall Study|Withdrawal by Subject|0|||
125428611|NCT01376323|451195481|FG001|Overall Study|Withdrawal by Subject|1|||
125428612|NCT01376323|451195482|FG002|Overall Study|Withdrawal by Subject|1|||
125428613|NCT01376323|451195483|FG003|Overall Study|Withdrawal by Subject|0|||
125428614|NCT01376323|451195484|FG004|Overall Study|Withdrawal by Subject|0|||
125428615|NCT01960725|451195485|FG000|Overall Study|Lost to Follow-up|4|||
125428616|NCT01960725|451195486|FG001|Overall Study|Lost to Follow-up|3|||
125428617|NCT01960725|451195485|FG000|Overall Study|Withdrawal by Subject|1|||
125428618|NCT01960725|451195486|FG001|Overall Study|Withdrawal by Subject|0|||
125428619|NCT01960725|451195485|FG000|Overall Study|unable to obtain blood sample|1|||
125428620|NCT01960725|451195486|FG001|Overall Study|unable to obtain blood sample|2|||
125428621|NCT02634788|451195487|FG000|Overall Study|Adverse Event|0|||
125428622|NCT02634788|451195488|FG001|Overall Study|Adverse Event|8|||
125428623|NCT02634788|451195489|FG002|Overall Study|Adverse Event|3|||
125428624|NCT02634788|451195490|FG003|Overall Study|Adverse Event|1|||
125428625|NCT02634788|451195487|FG000|Overall Study|Lack of Efficacy|4|||
125428626|NCT02634788|451195488|FG001|Overall Study|Lack of Efficacy|0|||
125428627|NCT02634788|451195489|FG002|Overall Study|Lack of Efficacy|1|||
125428628|NCT02634788|451195490|FG003|Overall Study|Lack of Efficacy|4|||
125428629|NCT02634788|451195487|FG000|Overall Study|Lost to Follow-up|0|||
125361776|NCT03181893|450958182|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125583687|NCT00944034|451762356|FG011|Overall Study|Administrative reason|0|||
125583688|NCT01318122|451762365|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125583689|NCT01318122|451762366|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125583690|NCT01318122|451762367|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
125583691|NCT01318122|451762368|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
125583692|NCT01318122|451762365|FG000|Enrolled - Long-Term Extension Study|Other|1|||
125583693|NCT01318122|451762366|FG001|Enrolled - Long-Term Extension Study|Other|0|||
125583694|NCT01318122|451762367|FG002|Enrolled - Long-Term Extension Study|Other|0|||
125583695|NCT01318122|451762368|FG003|Enrolled - Long-Term Extension Study|Other|0|||
125583696|NCT01318122|451762365|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
125583697|NCT01318122|451762366|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
125583698|NCT01318122|451762367|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
125361777|NCT03181893|450958183|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125361778|NCT03181893|450958184|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125361779|NCT03181893|450958185|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125361780|NCT03181893|450958186|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125361781|NCT03181893|450958187|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125361782|NCT03181893|450958188|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
125361783|NCT03181893|450958189|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
125361784|NCT03181893|450958179|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125361785|NCT03181893|450958180|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125361786|NCT03181893|450958181|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125361787|NCT03181893|450958182|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125361788|NCT03181893|450958183|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125361789|NCT03181893|450958184|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125361790|NCT03181893|450958185|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125428630|NCT02634788|451195488|FG001|Overall Study|Lost to Follow-up|1|||
125428631|NCT02634788|451195489|FG002|Overall Study|Lost to Follow-up|0|||
125428632|NCT02634788|451195490|FG003|Overall Study|Lost to Follow-up|0|||
125428633|NCT02634788|451195487|FG000|Overall Study|Withdrawal by Subject|0|||
125428634|NCT02634788|451195488|FG001|Overall Study|Withdrawal by Subject|1|||
125428635|NCT02634788|451195489|FG002|Overall Study|Withdrawal by Subject|1|||
125428636|NCT02634788|451195490|FG003|Overall Study|Withdrawal by Subject|0|||
125428637|NCT02277990|451195496|FG000|Overall Study|Death|170|||
125428638|NCT02277990|451195497|FG001|Overall Study|Death|188|||
125428639|NCT02277990|451195496|FG000|Overall Study|Withdrawal by Subject|64|||
125583699|NCT01318122|451762368|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
125428640|NCT02277990|451195497|FG001|Overall Study|Withdrawal by Subject|53|||
125361791|NCT03181893|450958186|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125361792|NCT03181893|450958187|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125361793|NCT03181893|450958188|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
125361794|NCT03181893|450958189|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
125361795|NCT03000569|450958190|FG000|Overall Study|Withdrawal by Subject|1|||
125361796|NCT03000569|450958191|FG001|Overall Study|Withdrawal by Subject|0|||
125361797|NCT04815031|450958192|FG000|Overall Study|No adverse event information (missing information)|33|||
125361798|NCT04122534|450958193|FG000|Overall Study|Lost to Follow-up|4|||
125361799|NCT01254630|450958197|FG000|Overall Study|Adverse Event|36|||
125361800|NCT01254630|450958198|FG001|Overall Study|Adverse Event|15|||
125361801|NCT01254630|450958199|FG002|Overall Study|Adverse Event|40|||
125361802|NCT01254630|450958200|FG003|Overall Study|Adverse Event|8|||
125361803|NCT01254630|450958197|FG000|Overall Study|Death|461|||
125361804|NCT01254630|450958198|FG001|Overall Study|Death|151|||
125361805|NCT01254630|450958199|FG002|Overall Study|Death|478|||
125361806|NCT01254630|450958200|FG003|Overall Study|Death|139|||
125361807|NCT01254630|450958197|FG000|Overall Study|Lost to Follow-up|80|||
125361808|NCT01254630|450958198|FG001|Overall Study|Lost to Follow-up|26|||
125361809|NCT01254630|450958199|FG002|Overall Study|Lost to Follow-up|89|||
125361810|NCT01254630|450958200|FG003|Overall Study|Lost to Follow-up|32|||
125361811|NCT01254630|450958197|FG000|Overall Study|Physician Decision|24|||
125361812|NCT01254630|450958198|FG001|Overall Study|Physician Decision|8|||
125361813|NCT01254630|450958199|FG002|Overall Study|Physician Decision|16|||
125361814|NCT01254630|450958200|FG003|Overall Study|Physician Decision|7|||
125361815|NCT01254630|450958197|FG000|Overall Study|Withdrawal by Subject|201|||
125361816|NCT01254630|450958198|FG001|Overall Study|Withdrawal by Subject|94|||
125361817|NCT01254630|450958199|FG002|Overall Study|Withdrawal by Subject|188|||
125361818|NCT01254630|450958200|FG003|Overall Study|Withdrawal by Subject|89|||
125361819|NCT01254630|450958197|FG000|Overall Study|Study terminated by sponsor|0|||
125361820|NCT01254630|450958198|FG001|Overall Study|Study terminated by sponsor|994|||
125361821|NCT01254630|450958199|FG002|Overall Study|Study terminated by sponsor|0|||
125361822|NCT01254630|450958200|FG003|Overall Study|Study terminated by sponsor|1010|||
125361823|NCT01254630|450958197|FG000|Overall Study|Status not recorded|0|||
125361824|NCT01254630|450958198|FG001|Overall Study|Status not recorded|0|||
125361825|NCT01254630|450958199|FG002|Overall Study|Status not recorded|1|||
125361826|NCT01254630|450958200|FG003|Overall Study|Status not recorded|0|||
125361827|NCT02020577|450958201|FG000|Overall Study|Progressive disease|3|||
125361828|NCT02020577|450958202|FG001|Overall Study|Progressive disease|38|||
125361829|NCT02020577|450958201|FG000|Overall Study|Other AE or clinical progression|0|||
125361830|NCT02020577|450958202|FG001|Overall Study|Other AE or clinical progression|15|||
125361831|NCT02020577|450958201|FG000|Overall Study|Withdrawal by Subject|0|||
125361832|NCT02020577|450958202|FG001|Overall Study|Withdrawal by Subject|1|||
125361833|NCT02020577|450958201|FG000|Overall Study|Other than stated above|0|||
125361834|NCT02020577|450958202|FG001|Overall Study|Other than stated above|1|||
125361835|NCT00761631|450958203|FG000|Overall Study|Parent/legal guardian request|8|||
125361836|NCT00761631|450958204|FG001|Overall Study|Parent/legal guardian request|3|||
125361837|NCT00761631|450958205|FG002|Overall Study|Parent/legal guardian request|8|||
125361838|NCT00761631|450958206|FG003|Overall Study|Parent/legal guardian request|0|||
125361839|NCT00761631|450958207|FG004|Overall Study|Parent/legal guardian request|5|||
125361840|NCT00761631|450958208|FG005|Overall Study|Parent/legal guardian request|0|||
125361841|NCT00761631|450958203|FG000|Overall Study|Lost to Follow-up|2|||
125361842|NCT00761631|450958204|FG001|Overall Study|Lost to Follow-up|4|||
125361843|NCT00761631|450958205|FG002|Overall Study|Lost to Follow-up|7|||
125361844|NCT00761631|450958206|FG003|Overall Study|Lost to Follow-up|1|||
125361845|NCT00761631|450958207|FG004|Overall Study|Lost to Follow-up|6|||
125361846|NCT00761631|450958208|FG005|Overall Study|Lost to Follow-up|1|||
125361847|NCT00761631|450958203|FG000|Overall Study|Protocol Violation|2|||
125361848|NCT00761631|450958204|FG001|Overall Study|Protocol Violation|0|||
125361849|NCT00761631|450958205|FG002|Overall Study|Protocol Violation|0|||
125361850|NCT00761631|450958206|FG003|Overall Study|Protocol Violation|1|||
125361851|NCT00761631|450958207|FG004|Overall Study|Protocol Violation|5|||
125361852|NCT00761631|450958208|FG005|Overall Study|Protocol Violation|1|||
125361853|NCT00761631|450958203|FG000|Overall Study|Randomized, not treated|1|||
125361854|NCT00761631|450958204|FG001|Overall Study|Randomized, not treated|0|||
125361855|NCT00761631|450958205|FG002|Overall Study|Randomized, not treated|0|||
125361856|NCT00761631|450958206|FG003|Overall Study|Randomized, not treated|0|||
125361857|NCT00761631|450958207|FG004|Overall Study|Randomized, not treated|0|||
125361858|NCT00761631|450958208|FG005|Overall Study|Randomized, not treated|0|||
125361859|NCT00761631|450958203|FG000|Overall Study|Failed to return|1|||
125361860|NCT00761631|450958204|FG001|Overall Study|Failed to return|0|||
125583700|NCT01318122|451762365|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
125583701|NCT01318122|451762366|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125583702|NCT01318122|451762367|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125583703|NCT01318122|451762368|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125583704|NCT01318122|451762365|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
125583705|NCT01318122|451762366|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
125583706|NCT01318122|451762367|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
125583707|NCT01318122|451762368|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
125583708|NCT01318122|451762365|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
125583709|NCT01318122|451762366|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
125583710|NCT01318122|451762367|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
125361861|NCT00761631|450958205|FG002|Overall Study|Failed to return|1|||
125361862|NCT00761631|450958206|FG003|Overall Study|Failed to return|1|||
125361863|NCT00761631|450958207|FG004|Overall Study|Failed to return|5|||
125361864|NCT00761631|450958208|FG005|Overall Study|Failed to return|2|||
125583711|NCT01318122|451762368|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
125583712|NCT01486199|451762369|FG000|Two Year Period Between Study Days|Physician Decision|1|||
125583713|NCT01486199|451762370|FG001|Two Year Period Between Study Days|Physician Decision|0|||
125583714|NCT00200057|451763861|FG000|Overall Study|Lack of Efficacy|3|||
125583715|NCT00200057|451763861|FG000|Overall Study|Exited due to terminal illness of PI|2|||
125583716|NCT00200057|451763861|FG000|Overall Study|Withdrawal by Subject|1|||
125583717|NCT00200057|451763861|FG000|Overall Study|Change in medical condition|1|||
125583718|NCT00200057|451763861|FG000|Overall Study|Infection|1|||
125583719|NCT00200057|451763861|FG000|Overall Study|Death|1|||
125583720|NCT02965716|451763864|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
125583721|NCT02965716|451763865|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
125583722|NCT02965716|451763864|FG000|Overall Study|Progression/Relapse|8|||
125583723|NCT02965716|451763865|FG001|Overall Study|Progression/Relapse|16|||
125583724|NCT02965716|451763864|FG000|Overall Study|Death|1|||
125583725|NCT02965716|451763865|FG001|Overall Study|Death|0|||
125583726|NCT02965716|451763864|FG000|Overall Study|Not Protocol Specified|1|||
125583727|NCT02965716|451763865|FG001|Overall Study|Not Protocol Specified|3|||
125583728|NCT01400932|451763866|FG000|Overall Study|Adverse Event|10|||
125583729|NCT01400932|451763867|FG001|Overall Study|Adverse Event|5|||
125583730|NCT01400932|451763866|FG000|Overall Study|Lack of Efficacy|0|||
125583731|NCT01400932|451763867|FG001|Overall Study|Lack of Efficacy|3|||
125583732|NCT01400932|451763866|FG000|Overall Study|Withdrawal by Subject|2|||
125583733|NCT01400932|451763867|FG001|Overall Study|Withdrawal by Subject|6|||
125583734|NCT01400932|451763866|FG000|Overall Study|Lost to Follow-up|1|||
125583735|NCT01400932|451763867|FG001|Overall Study|Lost to Follow-up|0|||
125583736|NCT01400932|451763866|FG000|Overall Study|Protocol Deviation|0|||
125583737|NCT01400932|451763867|FG001|Overall Study|Protocol Deviation|1|||
125583738|NCT01400932|451763866|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125583739|NCT01400932|451763867|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
125583740|NCT03244059|451763868|FG000|Specific Aim 1|Physician Decision|1|||
125583741|NCT03244059|451763869|FG001|Specific Aim 1|Physician Decision|0|||
125361865|NCT00761631|450958203|FG000|Overall Study|Physician Decision|1|||
125361866|NCT00761631|450958204|FG001|Overall Study|Physician Decision|0|||
125361867|NCT00761631|450958205|FG002|Overall Study|Physician Decision|0|||
125361868|NCT00761631|450958206|FG003|Overall Study|Physician Decision|0|||
125583742|NCT03244059|451763868|FG000|Specific Aim 2|Physician Decision|1|||
125583743|NCT03244059|451763869|FG001|Specific Aim 2|Physician Decision|0|||
125583744|NCT01276821|451763870|FG000|Overall Study|Protocol Violation|0|||
125583745|NCT01276821|451763871|FG001|Overall Study|Protocol Violation|1|||
125583746|NCT00605267|451763872|FG000|Overall Study|Adverse Event|0|||
125583747|NCT00605267|451763873|FG001|Overall Study|Adverse Event|1|||
125583748|NCT00605267|451763872|FG000|Overall Study|Lack of Efficacy|1|||
125583749|NCT00605267|451763873|FG001|Overall Study|Lack of Efficacy|5|||
125583750|NCT00605267|451763872|FG000|Overall Study|Withdrawal by Subject|2|||
125583751|NCT00605267|451763873|FG001|Overall Study|Withdrawal by Subject|3|||
125583752|NCT02939131|451763874|FG000|Overall Study|Unable to get to clinic|6|||
125583753|NCT02939131|451763875|FG001|Overall Study|Unable to get to clinic|4|||
125583754|NCT02939131|451763874|FG000|Overall Study|Lost to Follow-up|2|||
125583755|NCT02939131|451763875|FG001|Overall Study|Lost to Follow-up|4|||
125583756|NCT02939131|451763874|FG000|Overall Study|severe debilitation|1|||
125583757|NCT02939131|451763875|FG001|Overall Study|severe debilitation|0|||
125583758|NCT02939131|451763874|FG000|Overall Study|Other|0|||
125583759|NCT02939131|451763875|FG001|Overall Study|Other|1|||
125583760|NCT02939131|451763874|FG000|Overall Study|not willing to adhere to protocol|2|||
125583761|NCT02939131|451763875|FG001|Overall Study|not willing to adhere to protocol|0|||
125583762|NCT00556426|451763876|FG000|Overall Study|Withdrawal by Subject|3|||
125583763|NCT00556426|451763876|FG000|Overall Study|Death|6|||
125583764|NCT01299727|451763878|FG000|Overall Study|Withdrawal by Subject|1|||
125583765|NCT01299727|451763879|FG001|Overall Study|Withdrawal by Subject|0|||
125583766|NCT01299727|451763880|FG002|Overall Study|Withdrawal by Subject|0|||
125583767|NCT01299727|451763878|FG000|Overall Study|Adverse Event|0|||
125583768|NCT01299727|451763879|FG001|Overall Study|Adverse Event|0|||
125583769|NCT01299727|451763880|FG002|Overall Study|Adverse Event|1|||
125583770|NCT01299727|451763878|FG000|Overall Study|Completed the Treatment Period|3|||
125583771|NCT01299727|451763879|FG001|Overall Study|Completed the Treatment Period|4|||
125583772|NCT01299727|451763880|FG002|Overall Study|Completed the Treatment Period|3|||
125583773|NCT00531960|451763882|FG000|Overall Study|Adverse Event|5|||
125583774|NCT00531960|451763883|FG001|Overall Study|Adverse Event|4|||
125583775|NCT00531960|451763882|FG000|Overall Study|Death|3|||
125583776|NCT00531960|451763883|FG001|Overall Study|Death|2|||
125583777|NCT00531960|451763882|FG000|Overall Study|Lack of Efficacy|42|||
125583778|NCT00531960|451763883|FG001|Overall Study|Lack of Efficacy|41|||
125583779|NCT00531960|451763882|FG000|Overall Study|Violation of Selection Criteria|2|||
125428641|NCT02277990|451195496|FG000|Overall Study|Physician Decision|40|||
125428642|NCT02277990|451195497|FG001|Overall Study|Physician Decision|34|||
125428643|NCT02277990|451195496|FG000|Overall Study|Lost to Follow-up|66|||
125428644|NCT02277990|451195497|FG001|Overall Study|Lost to Follow-up|69|||
125428645|NCT02277990|451195496|FG000|Overall Study|Had other reason|26|||
125428646|NCT02277990|451195497|FG001|Overall Study|Had other reason|32|||
125428647|NCT04711603|451195498|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
125428648|NCT04711603|451195499|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
125428649|NCT04711603|451195500|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
125428650|NCT04711603|451195501|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
125428651|NCT04711603|451195498|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
125428652|NCT04711603|451195499|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
125428653|NCT04711603|451195500|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
125428654|NCT04711603|451195501|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
125428655|NCT04711603|451195498|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
125428656|NCT04711603|451195499|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
125428657|NCT04711603|451195500|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
125428658|NCT04711603|451195501|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
125428659|NCT04711603|451195498|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
125428660|NCT04711603|451195499|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
125428661|NCT04711603|451195500|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
125428662|NCT04711603|451195501|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
125428663|NCT04711603|451195498|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
125583780|NCT00531960|451763883|FG001|Overall Study|Violation of Selection Criteria|0|||
125428664|NCT04711603|451195499|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
125583781|NCT00531960|451763882|FG000|Overall Study|Refused Treatment|5|||
125583782|NCT00531960|451763883|FG001|Overall Study|Refused Treatment|6|||
125583783|NCT00531960|451763882|FG000|Overall Study|Other|4|||
125583784|NCT00531960|451763883|FG001|Overall Study|Other|10|||
125583785|NCT01500057|451763884|FG000|Overall Study|Lost to Follow-up|6|||
125583786|NCT01500057|451763885|FG001|Overall Study|Lost to Follow-up|4|||
125583787|NCT00441792|451763887|FG000|Overall Study|Lost to Follow-up|0|||
125583788|NCT00441792|451763888|FG001|Overall Study|Lost to Follow-up|2|||
125583789|NCT02649634|451763899|FG000|Overall Study|Withdrawal by Subject|3|||
125583790|NCT02649634|451763900|FG001|Overall Study|Withdrawal by Subject|5|||
125583791|NCT02649634|451763899|FG000|Overall Study|Lost to Follow-up|0|||
125583792|NCT02649634|451763900|FG001|Overall Study|Lost to Follow-up|1|||
125583793|NCT02211261|451763903|FG000|Overall Study|Withdrawal by Subject|0|||
125583794|NCT02211261|451763904|FG001|Overall Study|Withdrawal by Subject|0|||
125583795|NCT02211261|451763905|FG002|Overall Study|Withdrawal by Subject|1|||
125583796|NCT02211261|451763906|FG003|Overall Study|Withdrawal by Subject|0|||
125583797|NCT02211261|451763907|FG004|Overall Study|Withdrawal by Subject|2|||
125583798|NCT02211261|451763908|FG005|Overall Study|Withdrawal by Subject|0|||
125583799|NCT02211261|451763909|FG006|Overall Study|Withdrawal by Subject|0|||
125583800|NCT02211261|451763910|FG007|Overall Study|Withdrawal by Subject|0|||
125583801|NCT02211261|451763911|FG008|Overall Study|Withdrawal by Subject|0|||
125583802|NCT02211261|451763912|FG009|Overall Study|Withdrawal by Subject|0|||
125583803|NCT02211261|451763913|FG010|Overall Study|Withdrawal by Subject|0|||
125583804|NCT02211261|451763903|FG000|Overall Study|Other|0|||
125583805|NCT02211261|451763904|FG001|Overall Study|Other|0|||
125583806|NCT02211261|451763905|FG002|Overall Study|Other|0|||
125583807|NCT02211261|451763906|FG003|Overall Study|Other|0|||
125583808|NCT02211261|451763907|FG004|Overall Study|Other|0|||
125583809|NCT02211261|451763908|FG005|Overall Study|Other|1|||
125583810|NCT02211261|451763909|FG006|Overall Study|Other|0|||
125583811|NCT02211261|451763910|FG007|Overall Study|Other|0|||
125583812|NCT02211261|451763911|FG008|Overall Study|Other|0|||
125583813|NCT02211261|451763912|FG009|Overall Study|Other|2|||
125583814|NCT02211261|451763913|FG010|Overall Study|Other|0|||
125583815|NCT02211261|451763903|FG000|Overall Study|Lost to Follow-up|0|||
125583816|NCT02211261|451763904|FG001|Overall Study|Lost to Follow-up|0|||
125583817|NCT02211261|451763905|FG002|Overall Study|Lost to Follow-up|0|||
125583818|NCT02211261|451763906|FG003|Overall Study|Lost to Follow-up|0|||
125583819|NCT02211261|451763907|FG004|Overall Study|Lost to Follow-up|0|||
125361869|NCT00761631|450958207|FG004|Overall Study|Physician Decision|0|||
125361870|NCT00761631|450958208|FG005|Overall Study|Physician Decision|0|||
125361871|NCT00761631|450958203|FG000|Overall Study|Other|0|||
125361872|NCT00761631|450958204|FG001|Overall Study|Other|0|||
125361873|NCT00761631|450958205|FG002|Overall Study|Other|0|||
125361874|NCT00761631|450958206|FG003|Overall Study|Other|0|||
125361875|NCT00761631|450958207|FG004|Overall Study|Other|1|||
125361876|NCT00761631|450958208|FG005|Overall Study|Other|1|||
125361877|NCT03673046|450959489|FG000|Overall Study|Adverse Event|1|||
125361878|NCT03673046|450959490|FG001|Overall Study|Adverse Event|1|||
125361879|NCT03673046|450959489|FG000|Overall Study|Withdrawal by Subject|8|||
125361880|NCT03673046|450959490|FG001|Overall Study|Withdrawal by Subject|2|||
125361881|NCT03817879|450959491|FG000|Overall Study|Drop out|5|||
125361882|NCT03817879|450959492|FG001|Overall Study|Drop out|12|||
125361883|NCT03817879|450959491|FG000|Overall Study|Withdrawal by Subject|0|||
125361884|NCT03817879|450959492|FG001|Overall Study|Withdrawal by Subject|1|||
125361885|NCT01896050|450959495|FG000|Overall Study|Adverse Event|37|||
125361886|NCT01896050|450959496|FG001|Overall Study|Adverse Event|2|||
125361887|NCT01896050|450959495|FG000|Overall Study|Death|1|||
125361888|NCT01896050|450959496|FG001|Overall Study|Death|0|||
125361889|NCT00392015|450959497|FG000|Overall Study|Lost to Follow-up|2|||
125361890|NCT00392015|450959498|FG001|Overall Study|Lost to Follow-up|0|||
125361891|NCT00392015|450959499|FG002|Overall Study|Lost to Follow-up|2|||
125361892|NCT00392015|450959500|FG003|Overall Study|Lost to Follow-up|1|||
125361893|NCT00392015|450959501|FG004|Overall Study|Lost to Follow-up|1|||
125583820|NCT02211261|451763908|FG005|Overall Study|Lost to Follow-up|0|||
125583821|NCT02211261|451763909|FG006|Overall Study|Lost to Follow-up|0|||
125583822|NCT02211261|451763910|FG007|Overall Study|Lost to Follow-up|1|||
125583823|NCT02211261|451763911|FG008|Overall Study|Lost to Follow-up|0|||
125583824|NCT02211261|451763912|FG009|Overall Study|Lost to Follow-up|0|||
125583825|NCT02211261|451763913|FG010|Overall Study|Lost to Follow-up|0|||
125583826|NCT01737931|451763917|FG000|Overall Study|Withdrawal by Subject|0|||
125583827|NCT01737931|451763918|FG001|Overall Study|Withdrawal by Subject|1|||
125583828|NCT01737931|451763919|FG002|Overall Study|Withdrawal by Subject|1|||
125583829|NCT01737931|451763917|FG000|Overall Study|Physician Decision|0|||
125583830|NCT01737931|451763918|FG001|Overall Study|Physician Decision|1|||
125583831|NCT01737931|451763919|FG002|Overall Study|Physician Decision|0|||
125583832|NCT03183128|451763929|FG000|Overall Study|Adverse Event|1|||
125583833|NCT03183128|451763930|FG001|Overall Study|Adverse Event|2|||
125583834|NCT03183128|451763929|FG000|Overall Study|Withdrawal by Subject|1|||
125583835|NCT03183128|451763930|FG001|Overall Study|Withdrawal by Subject|8|||
125583836|NCT03183128|451763929|FG000|Overall Study|Protocol Violation|2|||
125583837|NCT03183128|451763930|FG001|Overall Study|Protocol Violation|0|||
125583838|NCT03183128|451763929|FG000|Overall Study|Lack of Efficacy|4|||
125583839|NCT03183128|451763930|FG001|Overall Study|Lack of Efficacy|27|||
125583840|NCT03183128|451763929|FG000|Overall Study|Lost to Follow-up|1|||
125583841|NCT03183128|451763930|FG001|Overall Study|Lost to Follow-up|0|||
125583842|NCT03183128|451763929|FG000|Overall Study|Death|2|||
125583843|NCT03183128|451763930|FG001|Overall Study|Death|0|||
125583844|NCT03183128|451763929|FG000|Overall Study|Physician Decision|1|||
125583845|NCT03183128|451763930|FG001|Overall Study|Physician Decision|0|||
125583846|NCT00330187|451763933|FG000|Overall Study|Lost to Follow-up|12|||
125583847|NCT00330187|451763934|FG001|Overall Study|Lost to Follow-up|13|||
125583848|NCT00330187|451763935|FG002|Overall Study|Lost to Follow-up|14|||
125583849|NCT00330187|451763936|FG003|Overall Study|Lost to Follow-up|10|||
125583850|NCT00330187|451763933|FG000|Overall Study|Withdrawal by Subject|8|||
125361894|NCT00392015|450959502|FG005|Overall Study|Lost to Follow-up|0|||
125361895|NCT00392015|450959497|FG000|Overall Study|Withdrawal by Subject|0|||
125361896|NCT00392015|450959498|FG001|Overall Study|Withdrawal by Subject|0|||
125361897|NCT00392015|450959499|FG002|Overall Study|Withdrawal by Subject|2|||
125361898|NCT00392015|450959500|FG003|Overall Study|Withdrawal by Subject|0|||
125361899|NCT00392015|450959501|FG004|Overall Study|Withdrawal by Subject|0|||
125361900|NCT00392015|450959502|FG005|Overall Study|Withdrawal by Subject|0|||
125361901|NCT00392015|450959497|FG000|Overall Study|Adverse Event|0|||
125361902|NCT00392015|450959498|FG001|Overall Study|Adverse Event|0|||
125361903|NCT00392015|450959499|FG002|Overall Study|Adverse Event|0|||
125361904|NCT00392015|450959500|FG003|Overall Study|Adverse Event|0|||
125361905|NCT00392015|450959501|FG004|Overall Study|Adverse Event|1|||
125361906|NCT00392015|450959502|FG005|Overall Study|Adverse Event|0|||
125361907|NCT00392015|450959497|FG000|Overall Study|Previous trial recipient|0|||
125361908|NCT00392015|450959498|FG001|Overall Study|Previous trial recipient|0|||
125361909|NCT00392015|450959499|FG002|Overall Study|Previous trial recipient|0|||
125361910|NCT00392015|450959500|FG003|Overall Study|Previous trial recipient|0|||
125361911|NCT00392015|450959501|FG004|Overall Study|Previous trial recipient|1|||
125583851|NCT00330187|451763934|FG001|Overall Study|Withdrawal by Subject|5|||
125583852|NCT00330187|451763935|FG002|Overall Study|Withdrawal by Subject|4|||
125583853|NCT00330187|451763936|FG003|Overall Study|Withdrawal by Subject|4|||
125583854|NCT03258814|451763937|FG000|Overall Study|Early Termination|4|||
125428665|NCT04711603|451195500|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
125428666|NCT04711603|451195501|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
125428667|NCT04711603|451195498|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
125428668|NCT04711603|451195499|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
125428669|NCT04711603|451195500|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
125428670|NCT04711603|451195501|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
125428671|NCT04711603|451195498|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
125428672|NCT04711603|451195499|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
125428673|NCT04711603|451195500|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
125428674|NCT04711603|451195501|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
125428675|NCT04711603|451195498|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
125428676|NCT04711603|451195499|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
125428677|NCT04711603|451195500|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
125428678|NCT04711603|451195501|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
125428679|NCT04711603|451195498|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
125428680|NCT04711603|451195499|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
125428681|NCT04711603|451195500|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
125428682|NCT04711603|451195501|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
125428683|NCT04711603|451195498|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
125428684|NCT04711603|451195499|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
125428685|NCT04711603|451195500|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
125428686|NCT04711603|451195501|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
125436534|NCT02597933|451224423|FG001|Overall Study|Withdrawal by Subject|5|||
125211807|NCT00435188|450401376|FG001|Overall Study|Withdrawal by Subject|11|||
125428687|NCT04711603|451195498|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
125428688|NCT04711603|451195499|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
125428689|NCT04711603|451195500|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
125428690|NCT04711603|451195501|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
125428691|NCT04711603|451195498|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
125428692|NCT04711603|451195499|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
125428693|NCT04711603|451195500|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
125428694|NCT04711603|451195501|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
125428695|NCT03138733|451195502|FG000|Overall Study|Death|17|||
125428696|NCT03138733|451195503|FG001|Overall Study|Death|18|||
125428697|NCT03138733|451195502|FG000|Overall Study|Withdrawal by Subject|11|||
125428698|NCT03138733|451195503|FG001|Overall Study|Withdrawal by Subject|6|||
125428699|NCT03138733|451195502|FG000|Overall Study|Lost to Follow-up|3|||
125428700|NCT03138733|451195503|FG001|Overall Study|Lost to Follow-up|2|||
125428701|NCT03138733|451195502|FG000|Overall Study|Adverse Event|1|||
125428702|NCT03138733|451195503|FG001|Overall Study|Adverse Event|0|||
125428703|NCT03138733|451195502|FG000|Overall Study|Protocol Violation|1|||
125428704|NCT03138733|451195503|FG001|Overall Study|Protocol Violation|3|||
125428705|NCT03138733|451195502|FG000|Overall Study|Administrative or logistical reason|1|||
125428706|NCT03138733|451195503|FG001|Overall Study|Administrative or logistical reason|0|||
125428707|NCT03138733|451195502|FG000|Overall Study|The patient was transferred to another hospital|1|||
125428708|NCT03138733|451195503|FG001|Overall Study|The patient was transferred to another hospital|0|||
125428709|NCT04252742|451195507|FG000|Overall Study|Decision by sponsor|0|||
125428710|NCT04252742|451195508|FG001|Overall Study|Decision by sponsor|2|||
125428711|NCT04252742|451195507|FG000|Overall Study|Withdrawal by Subject|15|||
125428712|NCT04252742|451195508|FG001|Overall Study|Withdrawal by Subject|9|||
125428713|NCT04252742|451195507|FG000|Overall Study|Lost to Follow-up|0|||
125428714|NCT04252742|451195508|FG001|Overall Study|Lost to Follow-up|1|||
125428715|NCT04270747|451195511|FG000|Through Week 16|Adverse Event|1|||
125428716|NCT04270747|451195512|FG001|Through Week 16|Adverse Event|2|||
125428717|NCT04270747|451195513|FG002|Through Week 16|Adverse Event|0|||
125428718|NCT04270747|451195511|FG000|Through Week 16|Death|0|||
125428719|NCT04270747|451195512|FG001|Through Week 16|Death|2|||
125428720|NCT04270747|451195513|FG002|Through Week 16|Death|0|||
125428721|NCT04270747|451195511|FG000|Through Week 16|Consent Withdrawn|3|||
125428722|NCT04270747|451195512|FG001|Through Week 16|Consent Withdrawn|3|||
125428723|NCT04270747|451195513|FG002|Through Week 16|Consent Withdrawn|0|||
125428724|NCT04270747|451195511|FG000|Through Week 16|Physician Decision|1|||
125428725|NCT04270747|451195512|FG001|Through Week 16|Physician Decision|1|||
125428726|NCT04270747|451195513|FG002|Through Week 16|Physician Decision|0|||
125428727|NCT04270747|451195511|FG000|Through Week 16|Lost to Follow-up|2|||
125428728|NCT04270747|451195512|FG001|Through Week 16|Lost to Follow-up|0|||
125428729|NCT04270747|451195513|FG002|Through Week 16|Lost to Follow-up|0|||
125428730|NCT04270747|451195511|FG000|Through Week 16|Protocol Violation|1|||
125428731|NCT04270747|451195512|FG001|Through Week 16|Protocol Violation|2|||
125428732|NCT04270747|451195513|FG002|Through Week 16|Protocol Violation|0|||
125428733|NCT04270747|451195511|FG000|Through Week 16|Protocol Specified Criteria|6|||
125428734|NCT04270747|451195512|FG001|Through Week 16|Protocol Specified Criteria|7|||
125428735|NCT04270747|451195513|FG002|Through Week 16|Protocol Specified Criteria|0|||
125428736|NCT04270747|451195511|FG000|Through Week 16|Miscellaneous|1|||
125428737|NCT04270747|451195512|FG001|Through Week 16|Miscellaneous|1|||
125428738|NCT04270747|451195513|FG002|Through Week 16|Miscellaneous|0|||
125428739|NCT04270747|451195511|FG000|Post Week 16|Adverse Event|7|||
125428740|NCT04270747|451195512|FG001|Post Week 16|Adverse Event|5|||
125428741|NCT04270747|451195513|FG002|Post Week 16|Adverse Event|1|||
125428742|NCT04270747|451195511|FG000|Post Week 16|Death|2|||
125428743|NCT04270747|451195512|FG001|Post Week 16|Death|0|||
125428744|NCT04270747|451195513|FG002|Post Week 16|Death|2|||
125211808|NCT00435188|450401375|FG000|Overall Study|Lost to Follow-up|5|||
125361912|NCT00392015|450959502|FG005|Overall Study|Previous trial recipient|0|||
125361913|NCT02180724|450959503|FG000|Overall Study|Death|26|||
125361914|NCT02180724|450959504|FG001|Overall Study|Death|1|||
125361915|NCT02180724|450959503|FG000|Overall Study|Lost to Follow-up|3|||
125361916|NCT02180724|450959504|FG001|Overall Study|Lost to Follow-up|1|||
125361917|NCT02180724|450959503|FG000|Overall Study|Withdrawal by Subject|4|||
125361918|NCT02180724|450959504|FG001|Overall Study|Withdrawal by Subject|2|||
125361919|NCT02180724|450959503|FG000|Overall Study|PI Decision|5|||
125361920|NCT02180724|450959504|FG001|Overall Study|PI Decision|2|||
125361921|NCT02180724|450959503|FG000|Overall Study|Study terminated by sponsor|54|||
125361922|NCT02180724|450959504|FG001|Overall Study|Study terminated by sponsor|8|||
125361923|NCT03693300|450959505|FG000|Overall Study|Withdrawal by Subject|6|||
125361924|NCT03693300|450959506|FG001|Overall Study|Withdrawal by Subject|0|||
125361925|NCT03693300|450959505|FG000|Overall Study|Death|50|||
125361926|NCT03693300|450959506|FG001|Overall Study|Death|2|||
125361927|NCT03693300|450959505|FG000|Overall Study|Lost to Follow-up|2|||
125361928|NCT03693300|450959506|FG001|Overall Study|Lost to Follow-up|0|||
125361929|NCT02206048|450959507|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
125361930|NCT02925923|450959511|FG000|Overall Study|blood samples hemolyzed|0|||
125361931|NCT02925923|450959512|FG001|Overall Study|blood samples hemolyzed|2|||
125361932|NCT00866788|450959513|FG000|Overall Study|Adverse Event|0|||
125361933|NCT00866788|450959514|FG001|Overall Study|Adverse Event|2|||
125361934|NCT00866788|450959515|FG002|Overall Study|Adverse Event|0|||
125361935|NCT00866788|450959516|FG003|Overall Study|Adverse Event|1|||
125361936|NCT00866788|450959513|FG000|Overall Study|Lost to Follow-up|1|||
125583855|NCT03258814|451763938|FG001|Overall Study|Early Termination|3|||
125583856|NCT03258814|451763939|FG002|Overall Study|Early Termination|10|||
125583857|NCT01413958|451763940|FG000|Overall Study|Lost to Follow-up|0|||
125583858|NCT01413958|451763941|FG001|Overall Study|Lost to Follow-up|1|||
125583859|NCT01900002|451763942|FG000|Overall Study|Withdrawal by Subject|2|||
125583860|NCT01900002|451763942|FG000|Overall Study|ineligible for Y-90|4|||
125583861|NCT00364182|451763949|FG000|First Intervention|Secondary prophylaxis|1|||
125583862|NCT00364182|451763950|FG001|First Intervention|Secondary prophylaxis|0|||
125583863|NCT00364182|451763951|FG002|First Intervention|Secondary prophylaxis|0|||
125583864|NCT00364182|451763949|FG000|First Intervention|Withdrawal by Subject|2|||
125583865|NCT00364182|451763950|FG001|First Intervention|Withdrawal by Subject|0|||
125583866|NCT00364182|451763951|FG002|First Intervention|Withdrawal by Subject|0|||
125583867|NCT00364182|451763949|FG000|Second Intervention|non-compliance|0|||
125583868|NCT00364182|451763950|FG001|Second Intervention|non-compliance|1|||
125583869|NCT00364182|451763951|FG002|Second Intervention|non-compliance|1|||
125583870|NCT00364182|451763949|FG000|Second Intervention|Protocol Violation|0|||
125583871|NCT00364182|451763950|FG001|Second Intervention|Protocol Violation|1|||
125583872|NCT00364182|451763951|FG002|Second Intervention|Protocol Violation|0|||
125583873|NCT00364182|451763949|FG000|Second Intervention|Adverse Event|0|||
125583874|NCT00364182|451763950|FG001|Second Intervention|Adverse Event|0|||
125583875|NCT00364182|451763951|FG002|Second Intervention|Adverse Event|1|||
125583876|NCT00364182|451763949|FG000|Third Intervention|non-compliance|0|||
125583877|NCT00364182|451763950|FG001|Third Intervention|non-compliance|1|||
125583878|NCT00364182|451763951|FG002|Third Intervention|non-compliance|0|||
125583879|NCT00364182|451763949|FG000|Third Intervention|Lost to Follow-up|0|||
125583880|NCT00364182|451763950|FG001|Third Intervention|Lost to Follow-up|0|||
125583881|NCT00364182|451763951|FG002|Third Intervention|Lost to Follow-up|1|||
125583882|NCT02601573|451763955|FG000|Overall Study|Lost to Follow-up|0|||
125583883|NCT02601573|451763956|FG001|Overall Study|Lost to Follow-up|3|||
125583884|NCT02601573|451763957|FG002|Overall Study|Lost to Follow-up|1|||
125583885|NCT02601573|451763958|FG003|Overall Study|Lost to Follow-up|0|||
125583886|NCT02601573|451763959|FG004|Overall Study|Lost to Follow-up|2|||
125583887|NCT02601573|451763955|FG000|Overall Study|Withdrawal by Subject|0|||
125583888|NCT02601573|451763956|FG001|Overall Study|Withdrawal by Subject|1|||
125583889|NCT02601573|451763957|FG002|Overall Study|Withdrawal by Subject|0|||
125583890|NCT02601573|451763958|FG003|Overall Study|Withdrawal by Subject|1|||
125583891|NCT02601573|451763959|FG004|Overall Study|Withdrawal by Subject|0|||
125583892|NCT02921425|451763960|FG000|Overall Study|Protocol Violation|9|||
125583893|NCT03403400|451763961|FG000|Overall Study|Lost to Follow-up|1|||
125583894|NCT03403400|451763962|FG001|Overall Study|Lost to Follow-up|0|||
125583895|NCT03403400|451763963|FG002|Overall Study|Lost to Follow-up|1|||
125583896|NCT03403400|451763961|FG000|Overall Study|Hospitalization|1|||
125583897|NCT03403400|451763962|FG001|Overall Study|Hospitalization|0|||
125583898|NCT03403400|451763963|FG002|Overall Study|Hospitalization|0|||
125583899|NCT03403400|451763961|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
125583900|NCT03403400|451763962|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
125583901|NCT03403400|451763963|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
125583902|NCT01171612|451763967|FG000|Overall Study|Lost to Follow-up|51|||
125583903|NCT00243659|451763968|FG000|Overall Study|Withdrawal by Subject|1|||
125583904|NCT00243659|451763969|FG001|Overall Study|Withdrawal by Subject|1|||
125583905|NCT00243659|451763968|FG000|Overall Study|Protocol Violation|1|||
125583906|NCT00243659|451763969|FG001|Overall Study|Protocol Violation|2|||
125428745|NCT04270747|451195511|FG000|Post Week 16|Consent Withdrawn|4|||
125428746|NCT04270747|451195512|FG001|Post Week 16|Consent Withdrawn|3|||
125428747|NCT04270747|451195513|FG002|Post Week 16|Consent Withdrawn|6|||
125428748|NCT04270747|451195511|FG000|Post Week 16|Physician Decision|3|||
125428749|NCT04270747|451195512|FG001|Post Week 16|Physician Decision|1|||
125428750|NCT04270747|451195513|FG002|Post Week 16|Physician Decision|1|||
125428751|NCT04270747|451195511|FG000|Post Week 16|Lost to Follow-up|2|||
125428752|NCT04270747|451195512|FG001|Post Week 16|Lost to Follow-up|1|||
125428753|NCT04270747|451195513|FG002|Post Week 16|Lost to Follow-up|0|||
125428754|NCT04270747|451195511|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
125428755|NCT04270747|451195512|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
125583907|NCT03310970|451763970|FG000|Overall Study|Withdrawal by Subject|0|||
125583908|NCT03310970|451763971|FG001|Overall Study|Withdrawal by Subject|1|||
125583909|NCT01273064|451763972|FG000|Overall Study|Adverse Event|5|||
125583910|NCT01273064|451763973|FG001|Overall Study|Adverse Event|1|||
125583911|NCT01273064|451763974|FG002|Overall Study|Adverse Event|3|||
125583912|NCT01273064|451763975|FG003|Overall Study|Adverse Event|2|||
125583913|NCT01273064|451763976|FG004|Overall Study|Adverse Event|1|||
125583914|NCT01273064|451763972|FG000|Overall Study|Withdrawal by Subject|4|||
125583915|NCT01273064|451763973|FG001|Overall Study|Withdrawal by Subject|2|||
125583916|NCT01273064|451763974|FG002|Overall Study|Withdrawal by Subject|2|||
125583917|NCT01273064|451763975|FG003|Overall Study|Withdrawal by Subject|2|||
125583918|NCT01273064|451763976|FG004|Overall Study|Withdrawal by Subject|0|||
125583919|NCT01273064|451763972|FG000|Overall Study|Study Termination|13|||
125583920|NCT01273064|451763973|FG001|Overall Study|Study Termination|27|||
125583921|NCT01273064|451763974|FG002|Overall Study|Study Termination|26|||
125583922|NCT01273064|451763975|FG003|Overall Study|Study Termination|16|||
125583923|NCT01273064|451763976|FG004|Overall Study|Study Termination|8|||
125583924|NCT01273064|451763972|FG000|Overall Study|Lost to Follow-up|1|||
125583925|NCT01273064|451763973|FG001|Overall Study|Lost to Follow-up|0|||
125583926|NCT01273064|451763974|FG002|Overall Study|Lost to Follow-up|0|||
125583927|NCT01273064|451763975|FG003|Overall Study|Lost to Follow-up|0|||
125583928|NCT01273064|451763976|FG004|Overall Study|Lost to Follow-up|0|||
125583929|NCT01273064|451763972|FG000|Overall Study|Physician Decision|0|||
125583930|NCT01273064|451763973|FG001|Overall Study|Physician Decision|0|||
125583931|NCT01273064|451763974|FG002|Overall Study|Physician Decision|0|||
125583932|NCT01273064|451763975|FG003|Overall Study|Physician Decision|0|||
125583933|NCT01273064|451763976|FG004|Overall Study|Physician Decision|1|||
125583934|NCT04062214|451763977|FG000|Week 12|Death|1|||
125583935|NCT04062214|451763978|FG001|Week 12|Death|1|||
125583936|NCT04062214|451763977|FG000|Week 12|Withdrawal by Subject|14|||
125583937|NCT04062214|451763978|FG001|Week 12|Withdrawal by Subject|13|||
125583938|NCT04062214|451763977|FG000|Week 12|Lost to Follow-up|55|||
125583939|NCT04062214|451763978|FG001|Week 12|Lost to Follow-up|68|||
125583940|NCT04062214|451763977|FG000|Week 12|Intermittent missing|31|||
125583941|NCT04062214|451763978|FG001|Week 12|Intermittent missing|29|||
125583942|NCT04062214|451763977|FG000|Week 36|Withdrawal by Subject|4|||
125583943|NCT04062214|451763978|FG001|Week 36|Withdrawal by Subject|5|||
125583944|NCT04062214|451763977|FG000|Week 36|Lost to Follow-up|50|||
125583945|NCT04062214|451763978|FG001|Week 36|Lost to Follow-up|46|||
125583946|NCT04062214|451763977|FG000|Week 36|Death|0|||
125583947|NCT04062214|451763978|FG001|Week 36|Death|1|||
125583948|NCT00291551|451763979|FG000|Overall Study|Death|7|||
125583949|NCT00291551|451763979|FG000|Overall Study|Withdrawal by Subject|6|||
125583950|NCT04666038|451763980|FG000|Overall Study|Progressive Disease|2|||
125583951|NCT04666038|451763981|FG001|Overall Study|Progressive Disease|0|||
125583952|NCT04666038|451763980|FG000|Overall Study|Death|38|||
125583953|NCT04666038|451763981|FG001|Overall Study|Death|32|||
125583954|NCT04666038|451763980|FG000|Overall Study|Withdrawal by Subject|10|||
125583955|NCT04666038|451763981|FG001|Overall Study|Withdrawal by Subject|19|||
125583956|NCT04666038|451763980|FG000|Overall Study|Lost to Follow-up|0|||
125583957|NCT04666038|451763981|FG001|Overall Study|Lost to Follow-up|2|||
125583958|NCT04666038|451763980|FG000|Overall Study|On Study Treatment|46|||
125583959|NCT04666038|451763981|FG001|Overall Study|On Study Treatment|5|||
125583960|NCT04666038|451763980|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
125583961|NCT04666038|451763981|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
125583962|NCT03887130|451763986|FG000|Overall Study|Progressive disease|23|||
125583963|NCT03887130|451763987|FG001|Overall Study|Progressive disease|14|||
125583964|NCT03887130|451763988|FG002|Overall Study|Progressive disease|7|||
125583965|NCT03887130|451763986|FG000|Overall Study|Protocol Violation|3|||
125583966|NCT03887130|451763987|FG001|Overall Study|Protocol Violation|1|||
125583967|NCT03887130|451763988|FG002|Overall Study|Protocol Violation|2|||
125583968|NCT03887130|451763986|FG000|Overall Study|Drug related toxicity|7|||
125583969|NCT03887130|451763987|FG001|Overall Study|Drug related toxicity|7|||
125583970|NCT03887130|451763988|FG002|Overall Study|Drug related toxicity|13|||
125583971|NCT03887130|451763986|FG000|Overall Study|Non drug related toxicity|3|||
125211809|NCT00435188|450401376|FG001|Overall Study|Lost to Follow-up|6|||
125361937|NCT00866788|450959514|FG001|Overall Study|Lost to Follow-up|1|||
125361938|NCT00866788|450959515|FG002|Overall Study|Lost to Follow-up|0|||
125583972|NCT03887130|451763987|FG001|Overall Study|Non drug related toxicity|0|||
125583973|NCT03887130|451763988|FG002|Overall Study|Non drug related toxicity|0|||
125583974|NCT03887130|451763986|FG000|Overall Study|Death|2|||
125583975|NCT03887130|451763987|FG001|Overall Study|Death|2|||
125583976|NCT03887130|451763988|FG002|Overall Study|Death|1|||
125583977|NCT03887130|451763986|FG000|Overall Study|Withdrawal by Subject|7|||
125583978|NCT03887130|451763987|FG001|Overall Study|Withdrawal by Subject|6|||
125583979|NCT03887130|451763988|FG002|Overall Study|Withdrawal by Subject|11|||
125583980|NCT03887130|451763986|FG000|Overall Study|other reason|6|||
125428756|NCT04270747|451195513|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
125428757|NCT04270747|451195511|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
125428758|NCT04270747|451195512|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
125428759|NCT04270747|451195513|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
125428760|NCT04270747|451195511|FG000|Post Week 16|Miscellaneous|1|||
125428761|NCT04270747|451195512|FG001|Post Week 16|Miscellaneous|0|||
125428762|NCT04270747|451195513|FG002|Post Week 16|Miscellaneous|1|||
125428763|NCT01784068|451195517|FG000|NTCS Phase|Adverse Event|5|||
125428764|NCT01784068|451195518|FG001|NTCS Phase|Adverse Event|0|||
125428765|NCT01784068|451195517|FG000|NTCS Phase|Physician Decision|2|||
125428766|NCT01784068|451195518|FG001|NTCS Phase|Physician Decision|0|||
125428767|NCT01784068|451195517|FG000|NTCS Phase|Patient/guardian decision|3|||
125428768|NCT01784068|451195518|FG001|NTCS Phase|Patient/guardian decision|0|||
125428769|NCT01784068|451195517|FG000|NTCS Phase|Death|2|||
125428770|NCT01784068|451195518|FG001|NTCS Phase|Death|0|||
125428771|NCT01784068|451195517|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
125428772|NCT01784068|451195518|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
125428773|NCT01784068|451195517|FG000|TFR Phase|Physician Decision|0|||
125428774|NCT01784068|451195518|FG001|TFR Phase|Physician Decision|1|||
125428775|NCT01784068|451195517|FG000|TFR Phase|Patient/guardian decision|0|||
125428776|NCT01784068|451195518|FG001|TFR Phase|Patient/guardian decision|3|||
125428777|NCT01784068|451195517|FG000|TFR Phase|Death|0|||
125428778|NCT01784068|451195518|FG001|TFR Phase|Death|1|||
125428779|NCT01784068|451195517|FG000|TFR Phase|Lack of Efficacy|0|||
125428780|NCT01784068|451195518|FG001|TFR Phase|Lack of Efficacy|88|||
125428781|NCT05614089|451195519|FG000|Overall Study|Pregnancy|5|||
125428782|NCT05614089|451195520|FG001|Overall Study|Pregnancy|2|||
125428783|NCT05614089|451195519|FG000|Overall Study|Lost to Follow-up|5|||
125428784|NCT05614089|451195520|FG001|Overall Study|Lost to Follow-up|1|||
125428785|NCT05614089|451195519|FG000|Overall Study|Death|0|||
125428786|NCT05614089|451195520|FG001|Overall Study|Death|1|||
125361939|NCT00866788|450959516|FG003|Overall Study|Lost to Follow-up|2|||
125361940|NCT00866788|450959513|FG000|Overall Study|Withdrawal by Subject|2|||
125361941|NCT00866788|450959514|FG001|Overall Study|Withdrawal by Subject|1|||
125361942|NCT00866788|450959515|FG002|Overall Study|Withdrawal by Subject|0|||
125361943|NCT00866788|450959516|FG003|Overall Study|Withdrawal by Subject|1|||
125361944|NCT00866788|450959513|FG000|Overall Study|Pregnancy|0|||
125428787|NCT05614089|451195519|FG000|Overall Study|Adverse Event|1|||
125428788|NCT05614089|451195520|FG001|Overall Study|Adverse Event|0|||
125428789|NCT02612064|451195531|FG000|Overall Study|Withdrawal by Subject|1|||
125428790|NCT02612064|451195532|FG001|Overall Study|Withdrawal by Subject|1|||
125428791|NCT02612064|451195531|FG000|Overall Study|Other|0|||
125428792|NCT02612064|451195532|FG001|Overall Study|Other|2|||
125428793|NCT01669798|451195533|FG000|Overall Study|Physician Decision|5|||
125428794|NCT00717860|451195535|FG000|Overall Study|Clinical adverse experience|5|||
125428795|NCT00717860|451195536|FG001|Overall Study|Clinical adverse experience|9|||
125428796|NCT00717860|451195535|FG000|Overall Study|Laboratory adverse experience|2|||
125428797|NCT00717860|451195536|FG001|Overall Study|Laboratory adverse experience|2|||
125428798|NCT00717860|451195535|FG000|Overall Study|Lack of Efficacy|7|||
125428799|NCT00717860|451195536|FG001|Overall Study|Lack of Efficacy|13|||
125428800|NCT00717860|451195535|FG000|Overall Study|Discontinued for other reason|6|||
125428801|NCT00717860|451195536|FG001|Overall Study|Discontinued for other reason|1|||
125428802|NCT00717860|451195535|FG000|Overall Study|Withdrew consent|7|||
125428803|NCT00717860|451195536|FG001|Overall Study|Withdrew consent|3|||
125428804|NCT04058353|451195540|FG000|Overall Study|Adverse Event|2|||
125428805|NCT04058353|451195541|FG001|Overall Study|Adverse Event|1|||
125428806|NCT04058353|451195540|FG000|Overall Study|Physician Decision|1|||
125428807|NCT04058353|451195541|FG001|Overall Study|Physician Decision|0|||
125361945|NCT00866788|450959514|FG001|Overall Study|Pregnancy|1|||
125361946|NCT00866788|450959515|FG002|Overall Study|Pregnancy|0|||
125361947|NCT00866788|450959516|FG003|Overall Study|Pregnancy|0|||
125361948|NCT00866788|450959513|FG000|Overall Study|Disease progression|3|||
125361949|NCT00866788|450959514|FG001|Overall Study|Disease progression|1|||
125361950|NCT00866788|450959515|FG002|Overall Study|Disease progression|1|||
125361951|NCT00866788|450959516|FG003|Overall Study|Disease progression|0|||
125361952|NCT00866788|450959513|FG000|Overall Study|Physician Decision|0|||
125361953|NCT00866788|450959514|FG001|Overall Study|Physician Decision|0|||
125361954|NCT00866788|450959515|FG002|Overall Study|Physician Decision|1|||
125361955|NCT00866788|450959516|FG003|Overall Study|Physician Decision|1|||
125361956|NCT01824342|450959521|FG000|Overall Study|Withdrawal by Subject|0|||
125361957|NCT01824342|450959522|FG001|Overall Study|Withdrawal by Subject|3|||
125361958|NCT01824342|450959521|FG000|Overall Study|Adverse Event|1|||
125361959|NCT01824342|450959522|FG001|Overall Study|Adverse Event|1|||
125361960|NCT01824342|450959521|FG000|Overall Study|Disease Progression|1|||
125361961|NCT01824342|450959522|FG001|Overall Study|Disease Progression|1|||
125361962|NCT01824342|450959521|FG000|Overall Study|Physician Decision|5|||
125361963|NCT01824342|450959522|FG001|Overall Study|Physician Decision|0|||
125361964|NCT01824342|450959521|FG000|Overall Study|Death|2|||
125361965|NCT01824342|450959522|FG001|Overall Study|Death|0|||
125361966|NCT02104752|450959524|FG000|Overall Study|Withdrawal by Subject|1|||
125361967|NCT02104752|450959525|FG001|Overall Study|Withdrawal by Subject|0|||
125361968|NCT02104752|450959524|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
125428808|NCT04058353|451195540|FG000|Overall Study|Other|1|||
125428809|NCT04058353|451195541|FG001|Overall Study|Other|0|||
125428810|NCT00698646|451195542|FG000|Overall Study|Adverse Event|8|||
125428811|NCT00698646|451195543|FG001|Overall Study|Adverse Event|7|||
125428812|NCT00698646|451195544|FG002|Overall Study|Adverse Event|8|||
125428813|NCT00698646|451195542|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
125361969|NCT02104752|450959525|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
125361970|NCT00231842|450959526|FG000|Overall Study|Withdrawal by Subject|3|||
125361971|NCT00231842|450959526|FG000|Overall Study|Did not complete the last 3 cycle|8|||
125361972|NCT00313300|450959527|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
125361973|NCT00313300|450959528|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
125428814|NCT00698646|451195543|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
125428815|NCT00698646|451195544|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
125428816|NCT00698646|451195542|FG000|Overall Study|Protocol Deviation|6|||
125428817|NCT00698646|451195543|FG001|Overall Study|Protocol Deviation|2|||
125428818|NCT00698646|451195544|FG002|Overall Study|Protocol Deviation|3|||
125428819|NCT00698646|451195542|FG000|Overall Study|Withdrawal by Subject|10|||
125361974|NCT00313300|450959529|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
125361975|NCT00313300|450959530|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
125361976|NCT00313300|450959531|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
125361977|NCT00313300|450959527|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
125361978|NCT00313300|450959528|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
125361979|NCT00313300|450959529|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
125361980|NCT00313300|450959530|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
125361981|NCT00313300|450959531|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
125361982|NCT00313300|450959527|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
125428820|NCT00698646|451195543|FG001|Overall Study|Withdrawal by Subject|11|||
125428821|NCT00698646|451195544|FG002|Overall Study|Withdrawal by Subject|8|||
125428822|NCT00698646|451195542|FG000|Overall Study|Lost to Follow-up|0|||
125428823|NCT00698646|451195543|FG001|Overall Study|Lost to Follow-up|0|||
125428824|NCT00698646|451195544|FG002|Overall Study|Lost to Follow-up|2|||
125428825|NCT00698646|451195542|FG000|Overall Study|Administrative problems|1|||
125428826|NCT00698646|451195543|FG001|Overall Study|Administrative problems|0|||
125428827|NCT00698646|451195544|FG002|Overall Study|Administrative problems|1|||
125428828|NCT00279201|451195545|FG000|Initiation|Death|1|||
125428829|NCT00279201|451195546|FG001|Initiation|Death|5|||
125428830|NCT00279201|451195547|FG002|Initiation|Death|0|||
125428831|NCT00279201|451195548|FG003|Initiation|Death|0|||
125428832|NCT00279201|451195549|FG004|Initiation|Death|0|||
125428833|NCT00279201|451195550|FG005|Initiation|Death|0|||
125428834|NCT00279201|451195545|FG000|Initiation|Adverse Event|6|||
125428835|NCT00279201|451195546|FG001|Initiation|Adverse Event|15|||
125428836|NCT00279201|451195547|FG002|Initiation|Adverse Event|0|||
125428837|NCT00279201|451195548|FG003|Initiation|Adverse Event|0|||
125428838|NCT00279201|451195549|FG004|Initiation|Adverse Event|0|||
125428839|NCT00279201|451195550|FG005|Initiation|Adverse Event|0|||
125428840|NCT00279201|451195545|FG000|Initiation|Lost to Follow-up|42|||
125428841|NCT00279201|451195546|FG001|Initiation|Lost to Follow-up|41|||
125428842|NCT00279201|451195547|FG002|Initiation|Lost to Follow-up|0|||
125428843|NCT00279201|451195548|FG003|Initiation|Lost to Follow-up|0|||
125428844|NCT00279201|451195549|FG004|Initiation|Lost to Follow-up|0|||
125428845|NCT00279201|451195550|FG005|Initiation|Lost to Follow-up|0|||
125428846|NCT00279201|451195545|FG000|Initiation|Entry Criteria Exclusion|7|||
125428847|NCT00279201|451195546|FG001|Initiation|Entry Criteria Exclusion|9|||
125428848|NCT00279201|451195547|FG002|Initiation|Entry Criteria Exclusion|0|||
125428849|NCT00279201|451195548|FG003|Initiation|Entry Criteria Exclusion|0|||
125428850|NCT00279201|451195549|FG004|Initiation|Entry Criteria Exclusion|0|||
125428851|NCT00279201|451195550|FG005|Initiation|Entry Criteria Exclusion|0|||
125428852|NCT00279201|451195545|FG000|Initiation|Protocol Violation|9|||
125428853|NCT00279201|451195546|FG001|Initiation|Protocol Violation|10|||
125428854|NCT00279201|451195547|FG002|Initiation|Protocol Violation|0|||
125583981|NCT03887130|451763987|FG001|Overall Study|other reason|20|||
125583982|NCT03887130|451763988|FG002|Overall Study|other reason|17|||
125583983|NCT04082663|451763989|FG000|Overall Study|Adverse Event|6|||
125583984|NCT04082663|451763989|FG000|Overall Study|Lost to Follow-up|1|||
125583985|NCT00705263|451763990|FG000|Overall Study|Withdrawal by Subject|2|||
125583986|NCT01752023|451763991|FG000|Overall Study|Physician Decision|2|||
125583987|NCT01752023|451763992|FG001|Overall Study|Physician Decision|1|||
125583988|NCT02899156|451763996|FG000|Overall Study|Death|1|||
125583989|NCT02899156|451763997|FG001|Overall Study|Death|0|||
125583990|NCT02899156|451763996|FG000|Overall Study|Physician Decision|0|||
125583991|NCT02899156|451763997|FG001|Overall Study|Physician Decision|1|||
125583992|NCT00787787|451763998|FG000|Overall Study|Lack of Efficacy|4|||
125583993|NCT00787787|451763998|FG000|Overall Study|Adverse Event|3|||
125583994|NCT01412957|451763999|FG000|Overall Study|Withdrawal by Subject|6|||
125583995|NCT01412957|451764000|FG001|Overall Study|Withdrawal by Subject|22|||
125583996|NCT01412957|451763999|FG000|Overall Study|Lost to Follow-up|7|||
125583997|NCT01412957|451764000|FG001|Overall Study|Lost to Follow-up|2|||
125583998|NCT01412957|451763999|FG000|Overall Study|Death|136|||
125583999|NCT01412957|451764000|FG001|Overall Study|Death|133|||
125584000|NCT04722991|451764001|FG000|Overall Study|Adverse Event|12|||
125584001|NCT04722991|451764002|FG001|Overall Study|Adverse Event|4|||
125584002|NCT04722991|451764001|FG000|Overall Study|Death|2|||
125584003|NCT04722991|451764002|FG001|Overall Study|Death|0|||
125584004|NCT04722991|451764001|FG000|Overall Study|Lost to Follow-up|1|||
125584005|NCT04722991|451764002|FG001|Overall Study|Lost to Follow-up|1|||
125584006|NCT04722991|451764001|FG000|Overall Study|Withdrawal cirterion met|2|||
125584007|NCT04722991|451764002|FG001|Overall Study|Withdrawal cirterion met|2|||
125428855|NCT00279201|451195548|FG003|Initiation|Protocol Violation|0|||
125584008|NCT04722991|451764001|FG000|Overall Study|Other|1|||
125584009|NCT04722991|451764002|FG001|Overall Study|Other|0|||
125428856|NCT00279201|451195549|FG004|Initiation|Protocol Violation|0|||
125428857|NCT00279201|451195550|FG005|Initiation|Protocol Violation|0|||
125428858|NCT00279201|451195545|FG000|Initiation|Withdrawal by Subject|35|||
125428859|NCT00279201|451195546|FG001|Initiation|Withdrawal by Subject|41|||
125428860|NCT00279201|451195547|FG002|Initiation|Withdrawal by Subject|0|||
125584010|NCT04722991|451764001|FG000|Overall Study|Non-compliance|0|||
125584011|NCT04722991|451764002|FG001|Overall Study|Non-compliance|1|||
125584012|NCT04722991|451764001|FG000|Overall Study|Withdrawal by Subject|0|||
125584013|NCT04722991|451764002|FG001|Overall Study|Withdrawal by Subject|1|||
125584014|NCT02246621|451764005|FG000|Overall Study|Withdrawal by Subject|28|||
125584015|NCT02246621|451764006|FG001|Overall Study|Withdrawal by Subject|16|||
125584016|NCT02246621|451764005|FG000|Overall Study|Lost to Follow-up|1|||
125428861|NCT00279201|451195548|FG003|Initiation|Withdrawal by Subject|0|||
125428862|NCT00279201|451195549|FG004|Initiation|Withdrawal by Subject|0|||
125428863|NCT00279201|451195550|FG005|Initiation|Withdrawal by Subject|0|||
125428864|NCT00279201|451195545|FG000|Initiation|Physician Decision|15|||
125584017|NCT02246621|451764006|FG001|Overall Study|Lost to Follow-up|0|||
125428865|NCT00279201|451195546|FG001|Initiation|Physician Decision|18|||
125428866|NCT00279201|451195547|FG002|Initiation|Physician Decision|0|||
125428867|NCT00279201|451195548|FG003|Initiation|Physician Decision|0|||
125428868|NCT00279201|451195549|FG004|Initiation|Physician Decision|0|||
125428869|NCT00279201|451195550|FG005|Initiation|Physician Decision|0|||
125428870|NCT00279201|451195545|FG000|Initiation|Sponsor Decision|13|||
125428871|NCT00279201|451195546|FG001|Initiation|Sponsor Decision|5|||
125428872|NCT00279201|451195547|FG002|Initiation|Sponsor Decision|0|||
125428873|NCT00279201|451195548|FG003|Initiation|Sponsor Decision|0|||
125584018|NCT02246621|451764005|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
125584019|NCT02246621|451764006|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
125584020|NCT01583374|451764007|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
125584021|NCT01583374|451764008|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
125584022|NCT01583374|451764009|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
125584023|NCT01583374|451764010|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125428874|NCT00279201|451195549|FG004|Initiation|Sponsor Decision|0|||
125428875|NCT00279201|451195550|FG005|Initiation|Sponsor Decision|0|||
125428876|NCT00279201|451195545|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
125584024|NCT01583374|451764011|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125584025|NCT01583374|451764012|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125584026|NCT01583374|451764013|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125584027|NCT01583374|451764014|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125584028|NCT01583374|451764015|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125584029|NCT01583374|451764007|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
125584030|NCT01583374|451764008|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
125584031|NCT01583374|451764009|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
125584032|NCT01583374|451764010|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125584033|NCT01583374|451764011|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125584034|NCT01583374|451764012|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125584035|NCT01583374|451764013|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125584036|NCT01583374|451764014|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125584037|NCT01583374|451764015|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125584038|NCT01583374|451764007|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
125584039|NCT01583374|451764008|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
125584040|NCT01583374|451764009|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125584041|NCT01583374|451764010|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125584042|NCT01583374|451764011|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125584043|NCT01583374|451764012|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125584044|NCT01583374|451764013|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125584045|NCT01583374|451764014|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125584046|NCT01583374|451764015|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125584047|NCT01583374|451764007|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
125584048|NCT01583374|451764008|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
125584049|NCT01583374|451764009|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
125584050|NCT01583374|451764010|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125584051|NCT01583374|451764011|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125584052|NCT01583374|451764012|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125584053|NCT01583374|451764013|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125584054|NCT01583374|451764014|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125584055|NCT01583374|451764015|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125584056|NCT01583374|451764007|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
125428877|NCT00279201|451195546|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
125428878|NCT00279201|451195547|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
125428879|NCT00279201|451195548|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
125428880|NCT00279201|451195549|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
125428881|NCT00279201|451195550|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
125428882|NCT00279201|451195545|FG000|Maintenance|Lack of Efficacy|32|||
125428883|NCT00279201|451195546|FG001|Maintenance|Lack of Efficacy|30|||
125428884|NCT00279201|451195547|FG002|Maintenance|Lack of Efficacy|0|||
125584057|NCT01583374|451764008|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
125584058|NCT01583374|451764009|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
125584059|NCT01583374|451764010|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
125428885|NCT00279201|451195548|FG003|Maintenance|Lack of Efficacy|0|||
125428886|NCT00279201|451195549|FG004|Maintenance|Lack of Efficacy|0|||
125428887|NCT00279201|451195550|FG005|Maintenance|Lack of Efficacy|0|||
125428888|NCT00279201|451195545|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
125428889|NCT00279201|451195546|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
125361983|NCT00313300|450959528|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
125361984|NCT00313300|450959529|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
125361985|NCT00313300|450959530|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
125361986|NCT00313300|450959531|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
125361987|NCT00313300|450959527|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
125361988|NCT00313300|450959528|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
125361989|NCT00313300|450959529|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
125361990|NCT00313300|450959530|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
125361991|NCT00313300|450959531|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
125361992|NCT00313300|450959527|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
125361993|NCT00313300|450959528|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
125584060|NCT01583374|451764011|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
125584061|NCT01583374|451764012|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
125584062|NCT01583374|451764013|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
125584063|NCT01583374|451764014|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
125584064|NCT01583374|451764015|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
125584065|NCT01583374|451764007|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125584066|NCT01583374|451764008|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125584067|NCT01583374|451764009|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
125584068|NCT01583374|451764010|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125584069|NCT01583374|451764011|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125584070|NCT01583374|451764012|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125584071|NCT01583374|451764013|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125584072|NCT01583374|451764014|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125361994|NCT00313300|450959529|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
125361995|NCT00313300|450959530|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
125361996|NCT00313300|450959531|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
125361997|NCT00313300|450959527|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
125361998|NCT00313300|450959528|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
125584073|NCT01583374|451764015|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125584074|NCT01583374|451764007|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
125584075|NCT01583374|451764008|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
125584076|NCT01583374|451764009|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
125584077|NCT01583374|451764010|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
125584078|NCT01583374|451764011|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
125584079|NCT01583374|451764012|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
125584080|NCT01583374|451764013|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
125584081|NCT01583374|451764014|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
125584082|NCT01583374|451764015|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
125584083|NCT01583374|451764007|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125584084|NCT01583374|451764008|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125584085|NCT01583374|451764009|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125584086|NCT01583374|451764010|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125584087|NCT01583374|451764011|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125584088|NCT01583374|451764012|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125584089|NCT01583374|451764013|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125584090|NCT01583374|451764014|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
125584091|NCT01583374|451764015|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125584092|NCT01583374|451764007|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
125584093|NCT01583374|451764008|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
125584094|NCT01583374|451764009|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
125584095|NCT01583374|451764010|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
125584096|NCT01583374|451764011|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
125584097|NCT01583374|451764012|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
125584098|NCT01583374|451764013|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
125584099|NCT01583374|451764014|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
125584100|NCT01583374|451764015|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
125584101|NCT01583374|451764007|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
125584102|NCT01583374|451764008|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
125584103|NCT01583374|451764009|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
125584104|NCT01583374|451764010|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
125584105|NCT01583374|451764011|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
125584106|NCT01583374|451764012|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
125584107|NCT01583374|451764013|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
125584108|NCT01583374|451764014|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
125361999|NCT00313300|450959529|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
125584109|NCT01583374|451764015|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
125584110|NCT01583374|451764007|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
125584111|NCT01583374|451764008|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
125584112|NCT01583374|451764009|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
125584113|NCT01583374|451764010|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
125584114|NCT01583374|451764011|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
125584115|NCT01583374|451764012|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
125584116|NCT01583374|451764013|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
125584117|NCT01583374|451764014|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
125584118|NCT01583374|451764015|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
125584119|NCT01583374|451764007|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
125584120|NCT01583374|451764008|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
125584121|NCT01583374|451764009|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
125584122|NCT01583374|451764010|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
125584123|NCT01583374|451764011|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
125584124|NCT01583374|451764012|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
125584125|NCT01583374|451764013|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
125584126|NCT01583374|451764014|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
125584127|NCT01583374|451764015|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
125584128|NCT01583374|451764007|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
125584129|NCT01583374|451764008|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
125584130|NCT01583374|451764009|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
125584131|NCT01583374|451764010|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
125584132|NCT01583374|451764011|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
125584133|NCT01583374|451764012|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
125584134|NCT01583374|451764013|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
125584135|NCT01583374|451764014|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
125584136|NCT01583374|451764015|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
125584137|NCT01583374|451764007|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
125584138|NCT01583374|451764008|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
125584139|NCT01583374|451764009|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
125584140|NCT01583374|451764010|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
125584141|NCT01583374|451764011|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
125584142|NCT01583374|451764012|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
125584143|NCT01583374|451764013|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
125584144|NCT01583374|451764014|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
125584145|NCT01583374|451764015|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
125584146|NCT01583374|451764007|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
125584147|NCT01583374|451764008|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
125584148|NCT01583374|451764009|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
125584149|NCT01583374|451764010|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
125584150|NCT01583374|451764011|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
125584151|NCT01583374|451764012|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
125584152|NCT01583374|451764013|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
125584153|NCT01583374|451764014|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
125584154|NCT01583374|451764015|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
125584155|NCT01583374|451764007|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
125584156|NCT01583374|451764008|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
125584157|NCT01583374|451764009|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
125584158|NCT01583374|451764010|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
125584159|NCT01583374|451764011|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
125584160|NCT01583374|451764012|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
125584161|NCT01583374|451764013|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
125584162|NCT01583374|451764014|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
125584163|NCT01583374|451764015|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
125584164|NCT01583374|451764007|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
125362000|NCT00313300|450959530|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
125362001|NCT00313300|450959531|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
125362002|NCT00313300|450959527|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
125362003|NCT00313300|450959528|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
125362004|NCT00313300|450959529|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
125362005|NCT00313300|450959530|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
125362006|NCT00313300|450959531|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
125362007|NCT00313300|450959527|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
125362008|NCT00313300|450959528|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
125362009|NCT00313300|450959529|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
125362010|NCT00313300|450959530|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
125362011|NCT00313300|450959531|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
125362012|NCT00313300|450959527|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
125362013|NCT00313300|450959528|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
125362014|NCT00313300|450959529|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
125362015|NCT00313300|450959530|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
125362016|NCT00313300|450959531|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
125362017|NCT00313300|450959527|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
125362018|NCT00313300|450959528|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
125362019|NCT00313300|450959529|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
125362020|NCT00313300|450959530|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
125362021|NCT00313300|450959531|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
125362022|NCT00313300|450959527|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
125362023|NCT00313300|450959528|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
125362024|NCT00313300|450959529|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
125362025|NCT00313300|450959530|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
125362026|NCT00313300|450959531|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
125362027|NCT00313300|450959527|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
125362028|NCT00313300|450959528|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
125362029|NCT00313300|450959529|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
125362030|NCT00313300|450959530|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
125362031|NCT00313300|450959531|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
125362032|NCT00313300|450959527|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
125362033|NCT00313300|450959528|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
125362034|NCT00313300|450959529|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
125362035|NCT00313300|450959530|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
125362036|NCT00313300|450959531|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
125362037|NCT00313300|450959527|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
125362038|NCT00313300|450959528|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
125362039|NCT00313300|450959529|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
125362040|NCT00313300|450959530|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
125362041|NCT00313300|450959531|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
125362042|NCT00313300|450959527|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
125362043|NCT00313300|450959528|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
125362044|NCT00313300|450959529|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
125362045|NCT00313300|450959530|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
125362046|NCT00313300|450959531|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
125362047|NCT00313300|450959527|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
125362048|NCT00313300|450959528|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
125362049|NCT00313300|450959529|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
125362050|NCT00313300|450959530|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
125362051|NCT00313300|450959531|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
125428890|NCT00279201|451195547|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
125428891|NCT00279201|451195548|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
125584165|NCT01583374|451764008|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
125584166|NCT01583374|451764009|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
125584167|NCT01583374|451764010|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
125584168|NCT01583374|451764011|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
125584169|NCT01583374|451764012|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
125584170|NCT01583374|451764013|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
125584171|NCT01583374|451764014|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
125584172|NCT01583374|451764015|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
125584173|NCT01583374|451764007|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
125584174|NCT01583374|451764008|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
125584175|NCT01583374|451764009|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
125584176|NCT01583374|451764010|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
125584177|NCT01583374|451764011|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
125584178|NCT01583374|451764012|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
125584179|NCT01583374|451764013|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
125584180|NCT01583374|451764014|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
125584181|NCT01583374|451764015|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
125428892|NCT00279201|451195549|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
125584182|NCT01583374|451764007|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
125584183|NCT01583374|451764008|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
125584184|NCT01583374|451764009|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
125584185|NCT01583374|451764010|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
125584186|NCT01583374|451764011|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
125584187|NCT01583374|451764012|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
125584188|NCT01583374|451764013|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
125584189|NCT01583374|451764014|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
125584190|NCT01583374|451764015|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
125584191|NCT02591615|451765687|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
125584192|NCT02591615|451765688|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
125584193|NCT02591615|451765689|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
125584194|NCT02591615|451765690|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
125584195|NCT02591615|451765687|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
125584196|NCT02591615|451765688|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
125584197|NCT02591615|451765689|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
125584198|NCT02591615|451765690|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
125584199|NCT02591615|451765687|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
125584200|NCT02591615|451765688|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
125584201|NCT02591615|451765689|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
125584202|NCT02591615|451765690|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
125584203|NCT02591615|451765687|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
125584204|NCT02591615|451765688|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
125584205|NCT02591615|451765689|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
125584206|NCT02591615|451765690|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
125584207|NCT02591615|451765687|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
125584208|NCT02591615|451765688|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
125584209|NCT02591615|451765689|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
125584210|NCT02591615|451765690|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
125584211|NCT02591615|451765687|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
125584212|NCT02591615|451765688|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
125584213|NCT02591615|451765689|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
125584214|NCT02591615|451765690|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
125584215|NCT02591615|451765687|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
125584216|NCT02591615|451765688|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
125584217|NCT02591615|451765689|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
125584218|NCT02591615|451765690|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
125584219|NCT02591615|451765687|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
125584220|NCT02591615|451765688|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
125584221|NCT02591615|451765689|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
125584222|NCT02591615|451765690|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
125584223|NCT02591615|451765687|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
125584224|NCT02591615|451765688|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
125584225|NCT02591615|451765689|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
125584226|NCT02591615|451765690|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
125584227|NCT02591615|451765687|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
125584228|NCT02591615|451765688|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
125584229|NCT02591615|451765689|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
125584230|NCT02591615|451765690|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
125584231|NCT02591615|451765687|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
125584232|NCT02591615|451765688|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
125584233|NCT02591615|451765689|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
125584234|NCT02591615|451765690|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
125584235|NCT02591615|451765687|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
125584236|NCT02591615|451765688|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
125584237|NCT02591615|451765689|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
125584238|NCT02591615|451765690|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
125584239|NCT02591615|451765687|FG000|Maintenance MK-3475|Adverse Event|0|||
125584240|NCT02591615|451765688|FG001|Maintenance MK-3475|Adverse Event|3|||
125584241|NCT02591615|451765689|FG002|Maintenance MK-3475|Adverse Event|1|||
125584242|NCT02591615|451765690|FG003|Maintenance MK-3475|Adverse Event|2|||
125584243|NCT02591615|451765687|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
125584244|NCT02591615|451765688|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
125584245|NCT02591615|451765689|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
125584246|NCT02591615|451765690|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
125584247|NCT02591615|451765687|FG000|Maintenance MK-3475|Death|0|||
125584248|NCT02591615|451765688|FG001|Maintenance MK-3475|Death|1|||
125584249|NCT02591615|451765689|FG002|Maintenance MK-3475|Death|1|||
125584250|NCT02591615|451765690|FG003|Maintenance MK-3475|Death|0|||
125211810|NCT00055497|450401381|FG000|Overall Study|Adverse Event|1|||
125584251|NCT02591615|451765687|FG000|Maintenance MK-3475|Physician discretion|0|||
125584252|NCT02591615|451765688|FG001|Maintenance MK-3475|Physician discretion|0|||
125584253|NCT02591615|451765689|FG002|Maintenance MK-3475|Physician discretion|1|||
125584254|NCT02591615|451765690|FG003|Maintenance MK-3475|Physician discretion|0|||
125584255|NCT02591615|451765687|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
125584256|NCT02591615|451765688|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
125584257|NCT02591615|451765689|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
125584258|NCT02591615|451765690|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
125584259|NCT02591615|451765687|FG000|Maintenance MK-3475|In active treatment|2|||
125584260|NCT02591615|451765688|FG001|Maintenance MK-3475|In active treatment|0|||
125584261|NCT02591615|451765689|FG002|Maintenance MK-3475|In active treatment|0|||
125584262|NCT02591615|451765690|FG003|Maintenance MK-3475|In active treatment|1|||
125584263|NCT04188197|451765691|FG000|Overall Study|Lost to Follow-up|4|||
125584264|NCT04188197|451765692|FG001|Overall Study|Lost to Follow-up|1|||
125584265|NCT04188197|451765691|FG000|Overall Study|Withdrawal by Subject|1|||
125584266|NCT04188197|451765692|FG001|Overall Study|Withdrawal by Subject|1|||
125584267|NCT04188197|451765691|FG000|Overall Study|Pregnancy|0|||
125584268|NCT04188197|451765692|FG001|Overall Study|Pregnancy|1|||
125584269|NCT02107703|451765693|FG000|Overall Study|Withdrawal by Subject|46|||
125584270|NCT02107703|451765694|FG001|Overall Study|Withdrawal by Subject|21|||
125584271|NCT02107703|451765693|FG000|Overall Study|Lost to Follow-up|20|||
125584272|NCT02107703|451765694|FG001|Overall Study|Lost to Follow-up|9|||
125584273|NCT02107703|451765693|FG000|Overall Study|On study treatment/follow up|48|||
125584274|NCT02107703|451765694|FG001|Overall Study|On study treatment/follow up|5|||
125584275|NCT04574999|451765695|FG000|Overall Study|Adverse Event|1|||
125584276|NCT04574999|451765696|FG001|Overall Study|Adverse Event|0|||
125584277|NCT04574999|451765695|FG000|Overall Study|Lack of Efficacy|2|||
125584278|NCT04574999|451765696|FG001|Overall Study|Lack of Efficacy|3|||
125584279|NCT04574999|451765695|FG000|Overall Study|Protocol Violation|1|||
125584280|NCT04574999|451765696|FG001|Overall Study|Protocol Violation|0|||
125584281|NCT04574999|451765695|FG000|Overall Study|Withdrawal by Subject|2|||
125584282|NCT04574999|451765696|FG001|Overall Study|Withdrawal by Subject|2|||
125584283|NCT04574999|451765695|FG000|Overall Study|Lost to Follow-up|1|||
125584284|NCT04574999|451765696|FG001|Overall Study|Lost to Follow-up|0|||
125584285|NCT04574999|451765695|FG000|Overall Study|Personal problems|1|||
125584286|NCT04574999|451765696|FG001|Overall Study|Personal problems|0|||
125584287|NCT04574999|451765695|FG000|Overall Study|Previous planned surgery|1|||
125584288|NCT04574999|451765696|FG001|Overall Study|Previous planned surgery|0|||
125584289|NCT00398112|451765714|FG000|Overall Study|Adverse Event|4|||
125584290|NCT00398112|451765714|FG000|Overall Study|Disease progression|9|||
125584291|NCT00398112|451765714|FG000|Overall Study|Alternative treatment|1|||
125584292|NCT00398112|451765714|FG000|Overall Study|Withdrawal by Subject|3|||
125584293|NCT00398112|451765714|FG000|Overall Study|Death|1|||
125584294|NCT00008385|451765715|FG000|Overall Study|Off treatment reasons not reported|79|||
125584295|NCT00008385|451765716|FG001|Overall Study|Off treatment reasons not reported|70|||
125584296|NCT00008385|451765715|FG000|Overall Study|Progressive disease|52|||
125584297|NCT00008385|451765716|FG001|Overall Study|Progressive disease|117|||
125584298|NCT00008385|451765715|FG000|Overall Study|Adverse Event|8|||
125362052|NCT00313300|450959527|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
125362053|NCT00313300|450959528|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
125584299|NCT00008385|451765716|FG001|Overall Study|Adverse Event|20|||
125584300|NCT00008385|451765715|FG000|Overall Study|Death|12|||
125584301|NCT00008385|451765716|FG001|Overall Study|Death|18|||
125584302|NCT00008385|451765715|FG000|Overall Study|Withdrawal by Subject|67|||
125584303|NCT00008385|451765716|FG001|Overall Study|Withdrawal by Subject|157|||
125584304|NCT00008385|451765715|FG000|Overall Study|Start non-protocol therapy|3|||
125584305|NCT00008385|451765716|FG001|Overall Study|Start non-protocol therapy|1|||
125584306|NCT00008385|451765715|FG000|Overall Study|Other complicating disease|17|||
125584307|NCT00008385|451765716|FG001|Overall Study|Other complicating disease|30|||
125584308|NCT00008385|451765715|FG000|Overall Study|Maximum dose reached|0|||
125584309|NCT00008385|451765716|FG001|Overall Study|Maximum dose reached|2|||
125584310|NCT00008385|451765715|FG000|Overall Study|Other|105|||
125584311|NCT00008385|451765716|FG001|Overall Study|Other|212|||
125584312|NCT00008385|451765715|FG000|Overall Study|Not start protocol therapy|44|||
125584313|NCT00008385|451765716|FG001|Overall Study|Not start protocol therapy|175|||
125584314|NCT00365989|451765719|FG000|Overall Study|Withdrawal by Subject|1|||
125584315|NCT00365989|451765719|FG000|Overall Study|Non-compliance|1|||
125584316|NCT02318095|451765720|FG000|Overall Study|Adverse Event|1|||
125584317|NCT00686127|451765721|FG000|Overall Study|Withdrawal by Subject|14|||
125584318|NCT00686127|451765722|FG001|Overall Study|Withdrawal by Subject|6|||
125584319|NCT06441877|451765723|FG000|Overall Study|Withdrawal by Subject|0|||
125584320|NCT06441877|451765724|FG001|Overall Study|Withdrawal by Subject|2|||
125584321|NCT06441877|451765725|FG002|Overall Study|Withdrawal by Subject|0|||
125584322|NCT06441877|451765726|FG003|Overall Study|Withdrawal by Subject|0|||
125211811|NCT00055497|450401382|FG001|Overall Study|Adverse Event|1|||
125584323|NCT00066690|451765727|FG000|Overall Study|Adverse Event|145|||
125584324|NCT00066690|451765728|FG001|Overall Study|Adverse Event|58|||
125584325|NCT00066690|451765729|FG002|Overall Study|Adverse Event|126|||
125584326|NCT00066690|451765727|FG000|Overall Study|Death|3|||
125584327|NCT00066690|451765728|FG001|Overall Study|Death|0|||
125584328|NCT00066690|451765729|FG002|Overall Study|Death|2|||
125584329|NCT00066690|451765727|FG000|Overall Study|Lack of Efficacy|114|||
125584330|NCT00066690|451765728|FG001|Overall Study|Lack of Efficacy|110|||
125584331|NCT00066690|451765729|FG002|Overall Study|Lack of Efficacy|76|||
125584332|NCT00066690|451765727|FG000|Overall Study|Lost to Follow-up|40|||
125584333|NCT00066690|451765728|FG001|Overall Study|Lost to Follow-up|21|||
125584334|NCT00066690|451765729|FG002|Overall Study|Lost to Follow-up|29|||
125584335|NCT00066690|451765727|FG000|Overall Study|Withdrawal by Subject|50|||
125584336|NCT00066690|451765728|FG001|Overall Study|Withdrawal by Subject|55|||
125584337|NCT00066690|451765729|FG002|Overall Study|Withdrawal by Subject|49|||
125584338|NCT00066690|451765727|FG000|Overall Study|Treatment Ongoing|246|||
125584339|NCT00066690|451765728|FG001|Overall Study|Treatment Ongoing|278|||
125584340|NCT00066690|451765729|FG002|Overall Study|Treatment Ongoing|282|||
125584341|NCT03706365|451765733|FG000|Overall Study|Lost to Follow-up|7|||
125584342|NCT03706365|451765734|FG001|Overall Study|Lost to Follow-up|0|||
125584343|NCT03706365|451765733|FG000|Overall Study|Withdrawal by Subject|17|||
125584344|NCT03706365|451765734|FG001|Overall Study|Withdrawal by Subject|15|||
125584345|NCT03706365|451765733|FG000|Overall Study|On Study Treatment|51|||
125584346|NCT03706365|451765734|FG001|Overall Study|On Study Treatment|51|||
125584347|NCT02162862|451765735|FG000|Overall Study|Lost to Follow-up|0|||
125584348|NCT02162862|451765736|FG001|Overall Study|Lost to Follow-up|11|||
125584349|NCT02162862|451765737|FG002|Overall Study|Lost to Follow-up|0|||
125584350|NCT02162862|451765735|FG000|Overall Study|Subject did not feel the med was needed|0|||
125584351|NCT02162862|451765736|FG001|Overall Study|Subject did not feel the med was needed|0|||
125584352|NCT02162862|451765737|FG002|Overall Study|Subject did not feel the med was needed|4|||
125584353|NCT03116113|451765738|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125584354|NCT03116113|451765739|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125584355|NCT03116113|451765740|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125584356|NCT03116113|451765741|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125584357|NCT03116113|451765742|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125584358|NCT03116113|451765743|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125584359|NCT03116113|451765744|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
125584360|NCT03116113|451765745|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
125584361|NCT03116113|451765746|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
125584362|NCT02159807|451765748|FG000|Overall Study|Adverse Event|0|||
125428893|NCT00279201|451195550|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
125428894|NCT00279201|451195545|FG000|Maintenance|Adverse Event|4|||
125428895|NCT00279201|451195546|FG001|Maintenance|Adverse Event|4|||
125428896|NCT00279201|451195547|FG002|Maintenance|Adverse Event|0|||
125584363|NCT02159807|451765749|FG001|Overall Study|Adverse Event|0|||
125584364|NCT02159807|451765750|FG002|Overall Study|Adverse Event|1|||
125584365|NCT02159807|451765748|FG000|Overall Study|No CSF|1|||
125584366|NCT02159807|451765749|FG001|Overall Study|No CSF|1|||
125584367|NCT02159807|451765750|FG002|Overall Study|No CSF|1|||
125584368|NCT02159807|451765748|FG000|Overall Study|elevated blood pressure|0|||
125584369|NCT02159807|451765749|FG001|Overall Study|elevated blood pressure|0|||
125584370|NCT02159807|451765750|FG002|Overall Study|elevated blood pressure|1|||
125584371|NCT05195528|451765751|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
125584372|NCT05195528|451765752|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
125584373|NCT05195528|451765753|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
125584374|NCT05195528|451765754|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
125584375|NCT05195528|451765755|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
125584376|NCT05195528|451765751|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
125584377|NCT05195528|451765752|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
125584378|NCT05195528|451765753|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
125584379|NCT05195528|451765754|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
125584380|NCT05195528|451765755|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
125584381|NCT05195528|451765751|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
125584382|NCT05195528|451765752|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
125584383|NCT05195528|451765753|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
125584384|NCT05195528|451765754|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
125584385|NCT05195528|451765755|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
125584386|NCT05195528|451765751|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
125584387|NCT05195528|451765752|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
125428897|NCT00279201|451195548|FG003|Maintenance|Adverse Event|0|||
125428898|NCT00279201|451195549|FG004|Maintenance|Adverse Event|0|||
125428899|NCT00279201|451195550|FG005|Maintenance|Adverse Event|0|||
125428900|NCT00279201|451195545|FG000|Maintenance|Death|4|||
125584388|NCT05195528|451765753|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
125584389|NCT05195528|451765754|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
125584390|NCT05195528|451765755|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
125584391|NCT05195528|451765751|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
125584392|NCT05195528|451765752|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
125584393|NCT05195528|451765753|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
125584394|NCT05195528|451765754|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
125584395|NCT05195528|451765755|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
125584396|NCT05195528|451765751|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
125584397|NCT05195528|451765752|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
125584398|NCT05195528|451765753|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
125584399|NCT05195528|451765754|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
125584400|NCT05195528|451765755|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
125584401|NCT05195528|451765751|FG000|Placebo-controlled Treatment Period|Other|0|||
125584402|NCT05195528|451765752|FG001|Placebo-controlled Treatment Period|Other|0|||
125584403|NCT05195528|451765753|FG002|Placebo-controlled Treatment Period|Other|1|||
125584404|NCT05195528|451765754|FG003|Placebo-controlled Treatment Period|Other|0|||
125584405|NCT05195528|451765755|FG004|Placebo-controlled Treatment Period|Other|0|||
125584406|NCT05195528|451765751|FG000|Extension Period|PTE or AE or SAE|0|||
125584407|NCT05195528|451765752|FG001|Extension Period|PTE or AE or SAE|4|||
125584408|NCT05195528|451765753|FG002|Extension Period|PTE or AE or SAE|5|||
125584409|NCT05195528|451765754|FG003|Extension Period|PTE or AE or SAE|4|||
125584410|NCT05195528|451765755|FG004|Extension Period|PTE or AE or SAE|4|||
125584411|NCT05195528|451765751|FG000|Extension Period|Protocol Violation|0|||
125584412|NCT05195528|451765752|FG001|Extension Period|Protocol Violation|2|||
125584413|NCT05195528|451765753|FG002|Extension Period|Protocol Violation|1|||
125584414|NCT05195528|451765754|FG003|Extension Period|Protocol Violation|0|||
125584415|NCT05195528|451765755|FG004|Extension Period|Protocol Violation|1|||
125584416|NCT05195528|451765751|FG000|Extension Period|Lost to Follow-up|0|||
125584417|NCT05195528|451765752|FG001|Extension Period|Lost to Follow-up|6|||
125584418|NCT05195528|451765753|FG002|Extension Period|Lost to Follow-up|13|||
125584419|NCT05195528|451765754|FG003|Extension Period|Lost to Follow-up|3|||
125584420|NCT05195528|451765755|FG004|Extension Period|Lost to Follow-up|7|||
125584421|NCT05195528|451765751|FG000|Extension Period|Withdrawal by Subject|0|||
125584422|NCT05195528|451765752|FG001|Extension Period|Withdrawal by Subject|12|||
125584423|NCT05195528|451765753|FG002|Extension Period|Withdrawal by Subject|9|||
125584424|NCT05195528|451765754|FG003|Extension Period|Withdrawal by Subject|6|||
125584425|NCT05195528|451765755|FG004|Extension Period|Withdrawal by Subject|5|||
125584426|NCT05195528|451765751|FG000|Extension Period|Lack of Efficacy|0|||
125584427|NCT05195528|451765752|FG001|Extension Period|Lack of Efficacy|3|||
125584428|NCT05195528|451765753|FG002|Extension Period|Lack of Efficacy|0|||
125584429|NCT05195528|451765754|FG003|Extension Period|Lack of Efficacy|0|||
125584430|NCT05195528|451765755|FG004|Extension Period|Lack of Efficacy|2|||
125584431|NCT05195528|451765751|FG000|Extension Period|Not Treated|0|||
125584432|NCT05195528|451765752|FG001|Extension Period|Not Treated|0|||
125584433|NCT05195528|451765753|FG002|Extension Period|Not Treated|2|||
125584434|NCT05195528|451765754|FG003|Extension Period|Not Treated|3|||
125584435|NCT05195528|451765755|FG004|Extension Period|Not Treated|0|||
125584436|NCT05195528|451765751|FG000|Extension Period|Other|0|||
125584437|NCT05195528|451765752|FG001|Extension Period|Other|1|||
125584438|NCT05195528|451765753|FG002|Extension Period|Other|1|||
125584439|NCT05195528|451765754|FG003|Extension Period|Other|0|||
125584440|NCT05195528|451765755|FG004|Extension Period|Other|0|||
125584441|NCT01552902|451765756|FG000|Overall Study|Adverse Event|1|||
125584442|NCT01552902|451765757|FG001|Overall Study|Adverse Event|15|||
125584443|NCT01552902|451765758|FG002|Overall Study|Adverse Event|14|||
125584444|NCT01552902|451765756|FG000|Overall Study|Protocol Violation|3|||
125584445|NCT01552902|451765757|FG001|Overall Study|Protocol Violation|3|||
125584446|NCT01552902|451765758|FG002|Overall Study|Protocol Violation|3|||
125584447|NCT01552902|451765756|FG000|Overall Study|Lack of Efficacy|4|||
125584448|NCT01552902|451765757|FG001|Overall Study|Lack of Efficacy|3|||
125584449|NCT01552902|451765758|FG002|Overall Study|Lack of Efficacy|1|||
125584450|NCT01552902|451765756|FG000|Overall Study|Withdrawal by Subject|1|||
125584451|NCT01552902|451765757|FG001|Overall Study|Withdrawal by Subject|9|||
125584452|NCT01552902|451765758|FG002|Overall Study|Withdrawal by Subject|6|||
125584453|NCT01552902|451765756|FG000|Overall Study|Lost to Follow-up|1|||
125584454|NCT01552902|451765757|FG001|Overall Study|Lost to Follow-up|3|||
125584455|NCT01552902|451765758|FG002|Overall Study|Lost to Follow-up|6|||
125584456|NCT01552902|451765756|FG000|Overall Study|Other|3|||
125584457|NCT01552902|451765757|FG001|Overall Study|Other|4|||
125584458|NCT01552902|451765758|FG002|Overall Study|Other|3|||
125584459|NCT02487108|451765762|FG000|Overall Study|Adverse Event|1|||
125584460|NCT02487108|451765763|FG001|Overall Study|Adverse Event|6|||
125584461|NCT02487108|451765764|FG002|Overall Study|Adverse Event|12|||
125584462|NCT02487108|451765765|FG003|Overall Study|Adverse Event|6|||
125584463|NCT02487108|451765762|FG000|Overall Study|Withdrawal by Subject|8|||
125584464|NCT02487108|451765763|FG001|Overall Study|Withdrawal by Subject|5|||
125584465|NCT02487108|451765764|FG002|Overall Study|Withdrawal by Subject|5|||
125584466|NCT02487108|451765765|FG003|Overall Study|Withdrawal by Subject|0|||
125362054|NCT00313300|450959529|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
125362055|NCT00313300|450959530|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
125584467|NCT02487108|451765762|FG000|Overall Study|Non-compliance to study medication|3|||
125584468|NCT02487108|451765763|FG001|Overall Study|Non-compliance to study medication|2|||
125584469|NCT02487108|451765764|FG002|Overall Study|Non-compliance to study medication|5|||
125584470|NCT02487108|451765765|FG003|Overall Study|Non-compliance to study medication|4|||
125584471|NCT02487108|451765762|FG000|Overall Study|Protocol Violation|1|||
125584472|NCT02487108|451765763|FG001|Overall Study|Protocol Violation|1|||
125584473|NCT02487108|451765764|FG002|Overall Study|Protocol Violation|2|||
125584474|NCT02487108|451765765|FG003|Overall Study|Protocol Violation|0|||
125211812|NCT00055497|450401383|FG002|Overall Study|Adverse Event|1|||
125211813|NCT00055497|450401384|FG003|Overall Study|Adverse Event|28|||
125211814|NCT00055497|450401381|FG000|Overall Study|Withdrawal by Subject|3|||
125362056|NCT00313300|450959531|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
125584475|NCT02487108|451765762|FG000|Overall Study|Non-compliance to study procedures|0|||
125584476|NCT02487108|451765763|FG001|Overall Study|Non-compliance to study procedures|0|||
125584477|NCT02487108|451765764|FG002|Overall Study|Non-compliance to study procedures|0|||
125584478|NCT02487108|451765765|FG003|Overall Study|Non-compliance to study procedures|1|||
125584479|NCT02487108|451765762|FG000|Overall Study|Other than specified|3|||
125584480|NCT02487108|451765763|FG001|Overall Study|Other than specified|2|||
125584481|NCT02487108|451765764|FG002|Overall Study|Other than specified|2|||
125584482|NCT02487108|451765765|FG003|Overall Study|Other than specified|0|||
125584483|NCT01254669|451765766|FG000|Overall Study|Withdrawal by Subject|0|||
125584484|NCT01254669|451765767|FG001|Overall Study|Withdrawal by Subject|1|||
125584485|NCT01254669|451765766|FG000|Overall Study|time constraint|2|||
125584486|NCT01254669|451765767|FG001|Overall Study|time constraint|2|||
125584487|NCT01254669|451765766|FG000|Overall Study|called to clinic during intervention|1|||
125584488|NCT01254669|451765767|FG001|Overall Study|called to clinic during intervention|1|||
125584489|NCT00600171|451765768|FG000|Overall Study|Adverse Event|0|||
125584490|NCT00600171|451765769|FG001|Overall Study|Adverse Event|1|||
125584491|NCT00600171|451765770|FG002|Overall Study|Adverse Event|0|||
125584492|NCT00600171|451765771|FG003|Overall Study|Adverse Event|0|||
125584493|NCT00600171|451765772|FG004|Overall Study|Adverse Event|1|||
125584494|NCT00600171|451765773|FG005|Overall Study|Adverse Event|0|||
125584495|NCT00600171|451765768|FG000|Overall Study|Lack of Efficacy|9|||
125584496|NCT00600171|451765769|FG001|Overall Study|Lack of Efficacy|12|||
125584497|NCT00600171|451765770|FG002|Overall Study|Lack of Efficacy|3|||
125584498|NCT00600171|451765771|FG003|Overall Study|Lack of Efficacy|5|||
125584499|NCT00600171|451765772|FG004|Overall Study|Lack of Efficacy|4|||
125584500|NCT00600171|451765773|FG005|Overall Study|Lack of Efficacy|0|||
125584501|NCT00600171|451765768|FG000|Overall Study|Protocol Violation|1|||
125362057|NCT00313300|450959527|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
125362058|NCT00313300|450959528|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
125362059|NCT00313300|450959529|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
125584502|NCT00600171|451765769|FG001|Overall Study|Protocol Violation|2|||
125584503|NCT00600171|451765770|FG002|Overall Study|Protocol Violation|0|||
125584504|NCT00600171|451765771|FG003|Overall Study|Protocol Violation|1|||
125584505|NCT00600171|451765772|FG004|Overall Study|Protocol Violation|0|||
125584506|NCT00600171|451765773|FG005|Overall Study|Protocol Violation|0|||
125584507|NCT00600171|451765768|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
125584508|NCT00600171|451765769|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125362060|NCT00313300|450959530|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
125362061|NCT00313300|450959531|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
125362062|NCT00313300|450959527|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
125362063|NCT00313300|450959528|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
125362064|NCT00313300|450959529|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
125362065|NCT00313300|450959530|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
125362066|NCT00313300|450959531|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
125362067|NCT00313300|450959527|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
125428901|NCT00279201|451195546|FG001|Maintenance|Death|4|||
125584509|NCT00600171|451765770|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
125584510|NCT00600171|451765771|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
125584511|NCT00600171|451765772|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
125584512|NCT00600171|451765773|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
125584513|NCT00600171|451765768|FG000|Overall Study|Withdrawal by Subject|3|||
125584514|NCT00600171|451765769|FG001|Overall Study|Withdrawal by Subject|0|||
125584515|NCT00600171|451765770|FG002|Overall Study|Withdrawal by Subject|0|||
125584516|NCT00600171|451765771|FG003|Overall Study|Withdrawal by Subject|1|||
125584517|NCT00600171|451765772|FG004|Overall Study|Withdrawal by Subject|1|||
125584518|NCT00600171|451765773|FG005|Overall Study|Withdrawal by Subject|1|||
125584519|NCT00600171|451765768|FG000|Overall Study|Physician Decision|0|||
125584520|NCT00600171|451765769|FG001|Overall Study|Physician Decision|1|||
125584521|NCT00600171|451765770|FG002|Overall Study|Physician Decision|0|||
125584522|NCT00600171|451765771|FG003|Overall Study|Physician Decision|1|||
125584523|NCT00600171|451765772|FG004|Overall Study|Physician Decision|0|||
125584524|NCT00600171|451765773|FG005|Overall Study|Physician Decision|2|||
125584525|NCT00600171|451765768|FG000|Overall Study|Lost to Follow-up|0|||
125584526|NCT00600171|451765769|FG001|Overall Study|Lost to Follow-up|0|||
125584527|NCT00600171|451765770|FG002|Overall Study|Lost to Follow-up|0|||
125584528|NCT00600171|451765771|FG003|Overall Study|Lost to Follow-up|1|||
125584529|NCT00600171|451765772|FG004|Overall Study|Lost to Follow-up|0|||
125584530|NCT00600171|451765773|FG005|Overall Study|Lost to Follow-up|0|||
125584531|NCT02367521|451765774|FG000|Overall Study|severe headache after intervention|2|||
125584532|NCT02367521|451765775|FG001|Overall Study|severe headache after intervention|0|||
125584533|NCT02367521|451765774|FG000|Overall Study|unable to find transportation|2|||
125584534|NCT02367521|451765775|FG001|Overall Study|unable to find transportation|0|||
125584535|NCT00542191|451765779|FG000|Overall Study|Death|3|||
125584536|NCT00469612|451765780|FG000|Overall Study|Study terminated before data collected|2|||
125584537|NCT00469612|451765781|FG001|Overall Study|Study terminated before data collected|0|||
125584538|NCT04684420|451765784|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125584539|NCT04684420|451765785|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125584540|NCT04684420|451765786|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
125584541|NCT04684420|451765787|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
125584542|NCT04684420|451765784|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
125584543|NCT04684420|451765785|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
125584544|NCT04684420|451765786|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
125584545|NCT04684420|451765787|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
125584546|NCT03480802|451765788|FG000|Overall Study|Lost to Follow-up|5|||
125584547|NCT03480802|451765789|FG001|Overall Study|Lost to Follow-up|1|||
125584548|NCT03480802|451765788|FG000|Overall Study|Withdrawal by Subject|2|||
125584549|NCT03480802|451765789|FG001|Overall Study|Withdrawal by Subject|1|||
125584550|NCT03480802|451765788|FG000|Overall Study|Relocated|0|||
125584551|NCT03480802|451765789|FG001|Overall Study|Relocated|1|||
125584552|NCT03822884|451765790|FG000|Overall Study|Withdrawal by Subject|0|||
125584553|NCT03822884|451765791|FG001|Overall Study|Withdrawal by Subject|0|||
125584554|NCT03822884|451765792|FG002|Overall Study|Withdrawal by Subject|0|||
125584555|NCT03822884|451765793|FG003|Overall Study|Withdrawal by Subject|0|||
125584556|NCT03822884|451765794|FG004|Overall Study|Withdrawal by Subject|1|||
125584557|NCT03822884|451765795|FG005|Overall Study|Withdrawal by Subject|0|||
125584558|NCT01279057|451765802|FG000|Overall Study|Adverse Event|1|||
125584559|NCT01279057|451765803|FG001|Overall Study|Adverse Event|0|||
125584560|NCT01279057|451765804|FG002|Overall Study|Adverse Event|1|||
125584561|NCT01279057|451765802|FG000|Overall Study|Insufficient therapeutic response|0|||
125584562|NCT01279057|451765803|FG001|Overall Study|Insufficient therapeutic response|0|||
125584563|NCT01279057|451765804|FG002|Overall Study|Insufficient therapeutic response|1|||
125584564|NCT01279057|451765802|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
125584565|NCT01279057|451765803|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
125584566|NCT01279057|451765804|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
125584567|NCT01279057|451765802|FG000|Overall Study|Withdrew consent|2|||
125584568|NCT01279057|451765803|FG001|Overall Study|Withdrew consent|0|||
125584569|NCT01279057|451765804|FG002|Overall Study|Withdrew consent|1|||
125584570|NCT01279057|451765802|FG000|Overall Study|Pregnancy|0|||
125584571|NCT01279057|451765803|FG001|Overall Study|Pregnancy|1|||
125584572|NCT01279057|451765804|FG002|Overall Study|Pregnancy|0|||
125584573|NCT01279057|451765802|FG000|Overall Study|Other|3|||
125362068|NCT00313300|450959528|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
125584574|NCT01279057|451765803|FG001|Overall Study|Other|3|||
125362069|NCT00313300|450959529|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
125362070|NCT00313300|450959530|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
125362071|NCT00313300|450959531|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
125362072|NCT00313300|450959527|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
125428902|NCT00279201|451195547|FG002|Maintenance|Death|0|||
125584575|NCT01279057|451765804|FG002|Overall Study|Other|0|||
125584576|NCT01427309|451765806|FG000|Overall Study|Lost to Follow-up|130|||
125584577|NCT01427309|451765807|FG001|Overall Study|Lost to Follow-up|145|||
125584578|NCT01427309|451765808|FG002|Overall Study|Lost to Follow-up|122|||
125584579|NCT01427309|451765809|FG003|Overall Study|Lost to Follow-up|135|||
125584580|NCT01427309|451765806|FG000|Overall Study|Protocol Violation|42|||
125584581|NCT01427309|451765807|FG001|Overall Study|Protocol Violation|69|||
125584582|NCT01427309|451765808|FG002|Overall Study|Protocol Violation|125|||
125584583|NCT01427309|451765809|FG003|Overall Study|Protocol Violation|124|||
125584584|NCT01427309|451765806|FG000|Overall Study|Adverse Event|0|||
125584585|NCT01427309|451765807|FG001|Overall Study|Adverse Event|0|||
125584586|NCT01427309|451765808|FG002|Overall Study|Adverse Event|3|||
125584587|NCT01427309|451765809|FG003|Overall Study|Adverse Event|1|||
125584588|NCT01427309|451765806|FG000|Overall Study|Serious adverse event|52|||
125584589|NCT01427309|451765807|FG001|Overall Study|Serious adverse event|45|||
125584590|NCT01427309|451765808|FG002|Overall Study|Serious adverse event|50|||
125584591|NCT01427309|451765809|FG003|Overall Study|Serious adverse event|61|||
125584592|NCT01427309|451765806|FG000|Overall Study|Withdrawal by Subject|148|||
125584593|NCT01427309|451765807|FG001|Overall Study|Withdrawal by Subject|148|||
125584594|NCT01427309|451765808|FG002|Overall Study|Withdrawal by Subject|61|||
125584595|NCT01427309|451765809|FG003|Overall Study|Withdrawal by Subject|55|||
125584596|NCT00849017|451765810|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
125584597|NCT00849017|451765811|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
125584598|NCT00849017|451765812|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
125584599|NCT00849017|451765810|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
125584600|NCT00849017|451765811|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
125584601|NCT00849017|451765812|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
125584602|NCT00849017|451765810|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
125584603|NCT00849017|451765811|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
125584604|NCT00849017|451765812|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
125584605|NCT00849017|451765810|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
125584606|NCT00849017|451765811|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
125584607|NCT00849017|451765812|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
125584608|NCT00849017|451765810|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
125584609|NCT00849017|451765811|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
125584610|NCT00849017|451765812|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
125584611|NCT00849017|451765810|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
125584612|NCT00849017|451765811|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
125584613|NCT00849017|451765812|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
125584614|NCT00849017|451765810|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
125584615|NCT00849017|451765811|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
125584616|NCT00849017|451765812|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
125584617|NCT00849017|451765810|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
125584618|NCT00849017|451765811|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
125584619|NCT00849017|451765812|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
125584620|NCT00849017|451765810|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
125584621|NCT00849017|451765811|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
125584622|NCT00849017|451765812|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
125584623|NCT00849017|451765810|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
125584624|NCT00849017|451765811|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
125584625|NCT00849017|451765812|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
125584626|NCT00849017|451765810|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
125584627|NCT00849017|451765811|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
125584628|NCT00849017|451765812|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
125584629|NCT00849017|451765810|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
125584630|NCT00849017|451765811|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
125584631|NCT00849017|451765812|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
125584632|NCT00849017|451765810|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
125584633|NCT00849017|451765811|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
125584634|NCT00849017|451765812|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
125584635|NCT00849017|451765810|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
125584636|NCT00849017|451765811|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
125584637|NCT00849017|451765812|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
125584638|NCT00849017|451765810|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
125584639|NCT00849017|451765811|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
125584640|NCT00849017|451765812|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
125584641|NCT00849017|451765810|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
125584642|NCT00849017|451765811|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
125584643|NCT00849017|451765812|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
125584644|NCT00849017|451765810|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
125584645|NCT00849017|451765811|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
125584646|NCT00849017|451765812|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
125584647|NCT00849017|451765810|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
125584648|NCT00849017|451765811|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
125584649|NCT00849017|451765812|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
125584650|NCT00849017|451765810|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
125584651|NCT00849017|451765811|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
125584652|NCT00849017|451765812|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
125584653|NCT05254418|451765816|FG000|Overall Study|Adverse Event|2|||
125584654|NCT03624946|451765821|FG000|Overall Study|Lost to Follow-up|0|||
125584655|NCT03624946|451765822|FG001|Overall Study|Lost to Follow-up|1|||
125584656|NCT01869348|451765823|FG000|Overall Study|Withdrawal by Subject|1|||
125584657|NCT01869348|451765824|FG001|Overall Study|Withdrawal by Subject|1|||
125584658|NCT00624520|451765826|FG000|Overall Study|Withdrawal by Subject|12|||
125584659|NCT00624520|451765827|FG001|Overall Study|Withdrawal by Subject|7|||
125584660|NCT00624520|451765826|FG000|Overall Study|Death|0|||
125584661|NCT00624520|451765827|FG001|Overall Study|Death|1|||
125584662|NCT01925209|451765828|FG000|Treatment Epoch|Physician Decision|1|||
125584663|NCT01925209|451765829|FG001|Treatment Epoch|Physician Decision|0|||
125584664|NCT01925209|451765830|FG002|Treatment Epoch|Physician Decision|0|||
125584665|NCT01925209|451765831|FG003|Treatment Epoch|Physician Decision|0|||
125584666|NCT01925209|451765828|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
125584667|NCT01925209|451765829|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
125584668|NCT01925209|451765830|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
125584669|NCT01925209|451765831|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
125584670|NCT01925209|451765828|FG000|Treatment Epoch|Death|1|||
125584671|NCT01925209|451765829|FG001|Treatment Epoch|Death|0|||
125584672|NCT01925209|451765830|FG002|Treatment Epoch|Death|0|||
125584673|NCT01925209|451765831|FG003|Treatment Epoch|Death|0|||
125584674|NCT01925209|451765828|FG000|Treatment Epoch|Protocol deviation|0|||
125584675|NCT01925209|451765829|FG001|Treatment Epoch|Protocol deviation|0|||
125584676|NCT01925209|451765830|FG002|Treatment Epoch|Protocol deviation|1|||
125584677|NCT01925209|451765831|FG003|Treatment Epoch|Protocol deviation|1|||
125584678|NCT01925209|451765828|FG000|Treatment Epoch|Withdrawal by Subject|4|||
125584679|NCT01925209|451765829|FG001|Treatment Epoch|Withdrawal by Subject|3|||
125584680|NCT01925209|451765830|FG002|Treatment Epoch|Withdrawal by Subject|3|||
125584681|NCT01925209|451765831|FG003|Treatment Epoch|Withdrawal by Subject|2|||
125584682|NCT01925209|451765828|FG000|Treatment Epoch|Adverse Event|3|||
125584683|NCT01925209|451765829|FG001|Treatment Epoch|Adverse Event|5|||
125584684|NCT01925209|451765830|FG002|Treatment Epoch|Adverse Event|3|||
125584685|NCT01925209|451765831|FG003|Treatment Epoch|Adverse Event|1|||
125584686|NCT01925209|451765828|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
125584687|NCT01925209|451765829|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
125584688|NCT01925209|451765830|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
125584689|NCT01925209|451765831|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
125584690|NCT01925209|451765828|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
125584691|NCT01925209|451765829|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
125584692|NCT01925209|451765830|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
125584693|NCT01925209|451765831|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
125584694|NCT01925209|451765828|FG000|Follow-up|Adverse Event|1|||
125584695|NCT01925209|451765829|FG001|Follow-up|Adverse Event|4|||
125584696|NCT01925209|451765830|FG002|Follow-up|Adverse Event|0|||
125584697|NCT01925209|451765831|FG003|Follow-up|Adverse Event|1|||
125584698|NCT01925209|451765828|FG000|Follow-up|Physician Decision|0|||
125584699|NCT01925209|451765829|FG001|Follow-up|Physician Decision|0|||
125584700|NCT01925209|451765830|FG002|Follow-up|Physician Decision|1|||
125584701|NCT01925209|451765831|FG003|Follow-up|Physician Decision|0|||
125584702|NCT01925209|451765828|FG000|Follow-up|Non-compliance with study treatment|0|||
125584703|NCT01925209|451765829|FG001|Follow-up|Non-compliance with study treatment|0|||
125584704|NCT01925209|451765830|FG002|Follow-up|Non-compliance with study treatment|0|||
125584705|NCT01925209|451765831|FG003|Follow-up|Non-compliance with study treatment|1|||
125584706|NCT01925209|451765828|FG000|Follow-up|Withdrawal by Subject|0|||
125584707|NCT01925209|451765829|FG001|Follow-up|Withdrawal by Subject|2|||
125584708|NCT01925209|451765830|FG002|Follow-up|Withdrawal by Subject|0|||
125584709|NCT01925209|451765831|FG003|Follow-up|Withdrawal by Subject|2|||
125584710|NCT03075163|451765832|FG000|Overall Study|not eligible for treatment limb|138|||
125584711|NCT03075163|451765833|FG001|Overall Study|not eligible for treatment limb|138|||
125584712|NCT02796755|451765834|FG000|Overall Study|Adverse Event|2|||
125584713|NCT02796755|451765835|FG001|Overall Study|Adverse Event|0|||
125584714|NCT00110994|451765836|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
125584715|NCT00110994|451765837|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
125584716|NCT00110994|451765836|FG000|Double-blind (DB) Treatment|Death|1|||
125584717|NCT00110994|451765837|FG001|Double-blind (DB) Treatment|Death|0|||
125584718|NCT00110994|451765836|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
125584719|NCT00110994|451765837|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
125584720|NCT00110994|451765836|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
125584721|NCT00110994|451765837|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
125584722|NCT00110994|451765836|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
125584723|NCT00110994|451765837|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
125584724|NCT00110994|451765836|FG000|Double-blind (DB) Treatment|other reasons|2|||
125584725|NCT00110994|451765837|FG001|Double-blind (DB) Treatment|other reasons|3|||
125584726|NCT00110994|451765836|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
125584727|NCT00110994|451765837|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
125584728|NCT00110994|451765836|FG000|Active Follow-up|Other reasons|0|||
125584729|NCT00110994|451765837|FG001|Active Follow-up|Other reasons|2|||
125584730|NCT00110994|451765836|FG000|Long Term Follow-up|Death|19|||
125584731|NCT00110994|451765837|FG001|Long Term Follow-up|Death|17|||
125584732|NCT01879410|451765841|FG000|Overall Study|Adverse Event|9|||
125584733|NCT01879410|451765842|FG001|Overall Study|Adverse Event|14|||
125584734|NCT01879410|451765841|FG000|Overall Study|Lack of Efficacy|4|||
125584735|NCT01879410|451765842|FG001|Overall Study|Lack of Efficacy|6|||
125584736|NCT01879410|451765841|FG000|Overall Study|Protocol Violation|1|||
125584737|NCT01879410|451765842|FG001|Overall Study|Protocol Violation|7|||
125584738|NCT01879410|451765841|FG000|Overall Study|Lost to Follow-up|2|||
125362073|NCT00313300|450959528|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
125584739|NCT01879410|451765842|FG001|Overall Study|Lost to Follow-up|1|||
125584740|NCT01879410|451765841|FG000|Overall Study|Withdrawal by Subject|7|||
125584741|NCT01879410|451765842|FG001|Overall Study|Withdrawal by Subject|8|||
125584742|NCT01879410|451765841|FG000|Overall Study|Randomised in Error|1|||
125584743|NCT01879410|451765842|FG001|Overall Study|Randomised in Error|2|||
125362074|NCT00313300|450959529|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
125362075|NCT00313300|450959530|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
125362076|NCT00313300|450959531|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
125362077|NCT02336373|450959532|FG000|Overall Study|Protocol closed early|4|||
125362078|NCT02336373|450959532|FG000|Overall Study|Physician Decision|14|||
125362079|NCT00850343|450959534|FG000|Overall Study|Withdrawal by Subject|11|||
125362080|NCT00850343|450959535|FG001|Overall Study|Withdrawal by Subject|0|||
125362081|NCT00850343|450959536|FG002|Overall Study|Withdrawal by Subject|3|||
125362082|NCT00850343|450959537|FG003|Overall Study|Withdrawal by Subject|2|||
125362083|NCT00850343|450959534|FG000|Overall Study|Adverse Event|15|||
125362084|NCT00850343|450959535|FG001|Overall Study|Adverse Event|2|||
125362085|NCT00850343|450959536|FG002|Overall Study|Adverse Event|6|||
125362086|NCT00850343|450959537|FG003|Overall Study|Adverse Event|6|||
125362087|NCT00850343|450959534|FG000|Overall Study|Pregnancy|0|||
125362088|NCT00850343|450959535|FG001|Overall Study|Pregnancy|0|||
125362089|NCT00850343|450959536|FG002|Overall Study|Pregnancy|0|||
125362090|NCT00850343|450959537|FG003|Overall Study|Pregnancy|1|||
125362091|NCT00850343|450959534|FG000|Overall Study|Lack of Efficacy|17|||
125362092|NCT00850343|450959535|FG001|Overall Study|Lack of Efficacy|0|||
125362093|NCT00850343|450959536|FG002|Overall Study|Lack of Efficacy|3|||
125362094|NCT00850343|450959537|FG003|Overall Study|Lack of Efficacy|2|||
125362095|NCT00850343|450959534|FG000|Overall Study|Non-compliance with Study Procedures|1|||
125362096|NCT00850343|450959535|FG001|Overall Study|Non-compliance with Study Procedures|0|||
125362097|NCT00850343|450959536|FG002|Overall Study|Non-compliance with Study Procedures|1|||
125584744|NCT00974220|451765846|FG000|Treatment Period 1|Adverse Event|2|||
125584745|NCT00974220|451765847|FG001|Treatment Period 1|Adverse Event|1|||
125584746|NCT00974220|451765846|FG000|Treatment Period 1|noncompliant subjects|0|||
125584747|NCT00974220|451765847|FG001|Treatment Period 1|noncompliant subjects|1|||
125584748|NCT01384292|451765848|FG000|Part B|Severe non-compliance to protocol|1|||
125584749|NCT01384292|451765849|FG001|Part B|Severe non-compliance to protocol|0|||
125584750|NCT01384292|451765850|FG002|Part B|Severe non-compliance to protocol|0|||
125584751|NCT03158220|451765851|FG000|Overall Study|Screen Failure|0|||
125584752|NCT03158220|451765852|FG001|Overall Study|Screen Failure|1|||
125584753|NCT03158220|451765851|FG000|Overall Study|Withdrawal by Subject|8|||
125584754|NCT03158220|451765852|FG001|Overall Study|Withdrawal by Subject|9|||
125584755|NCT03158220|451765851|FG000|Overall Study|Status unknown|0|||
125584756|NCT03158220|451765852|FG001|Overall Study|Status unknown|1|||
125584757|NCT03158220|451765851|FG000|Overall Study|Lost to Follow-up|8|||
125584758|NCT03158220|451765852|FG001|Overall Study|Lost to Follow-up|5|||
125584759|NCT03158220|451765851|FG000|Overall Study|Physician Decision|1|||
125584760|NCT03158220|451765852|FG001|Overall Study|Physician Decision|0|||
125584761|NCT00848120|451765853|FG000|Overall Study|Adverse Event|1|||
125584762|NCT01988090|451765857|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
125584763|NCT01988090|451765858|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
125584764|NCT01988090|451765857|FG000|Start Treament After Randomization|Protocol Violation|0|||
125584765|NCT01988090|451765858|FG001|Start Treament After Randomization|Protocol Violation|1|||
125584766|NCT01988090|451765857|FG000|Complete Study After Start|Withdrawal by Subject|2|||
125584767|NCT01988090|451765858|FG001|Complete Study After Start|Withdrawal by Subject|0|||
125362098|NCT00850343|450959537|FG003|Overall Study|Non-compliance with Study Procedures|1|||
125362099|NCT00850343|450959534|FG000|Overall Study|Physician Decision|2|||
125584768|NCT01988090|451765857|FG000|Complete Study After Start|Protocol Violation|1|||
125584769|NCT01988090|451765858|FG001|Complete Study After Start|Protocol Violation|1|||
125584770|NCT00413959|451765867|FG000|Overall Study|Pt had only one cycle.|1|||
125362100|NCT00850343|450959535|FG001|Overall Study|Physician Decision|1|||
125362101|NCT00850343|450959536|FG002|Overall Study|Physician Decision|1|||
125362102|NCT00850343|450959537|FG003|Overall Study|Physician Decision|1|||
125584771|NCT04343651|451765869|FG000|Overall Study|Physician Decision|2|||
125584772|NCT04343651|451765870|FG001|Overall Study|Physician Decision|1|||
125584773|NCT04343651|451765869|FG000|Overall Study|Lost to Follow-up|2|||
125584774|NCT04343651|451765870|FG001|Overall Study|Lost to Follow-up|1|||
125362103|NCT02468232|450959540|FG000|Core Part of Study|Adverse Event|0|||
125362104|NCT02468232|450959541|FG001|Core Part of Study|Adverse Event|1|||
125428903|NCT00279201|451195548|FG003|Maintenance|Death|0|||
125428904|NCT00279201|451195549|FG004|Maintenance|Death|0|||
125428905|NCT00279201|451195550|FG005|Maintenance|Death|0|||
125428906|NCT00279201|451195545|FG000|Maintenance|Lost to Follow-up|17|||
125428907|NCT00279201|451195546|FG001|Maintenance|Lost to Follow-up|13|||
125428908|NCT00279201|451195547|FG002|Maintenance|Lost to Follow-up|0|||
125428909|NCT00279201|451195548|FG003|Maintenance|Lost to Follow-up|0|||
125428910|NCT00279201|451195549|FG004|Maintenance|Lost to Follow-up|0|||
125428911|NCT00279201|451195550|FG005|Maintenance|Lost to Follow-up|0|||
125428912|NCT00279201|451195545|FG000|Maintenance|Entry Criteria Exclusion|1|||
125428913|NCT00279201|451195546|FG001|Maintenance|Entry Criteria Exclusion|4|||
125428914|NCT00279201|451195547|FG002|Maintenance|Entry Criteria Exclusion|0|||
125428915|NCT00279201|451195548|FG003|Maintenance|Entry Criteria Exclusion|0|||
125428916|NCT00279201|451195549|FG004|Maintenance|Entry Criteria Exclusion|0|||
125428917|NCT00279201|451195550|FG005|Maintenance|Entry Criteria Exclusion|0|||
125428918|NCT00279201|451195545|FG000|Maintenance|Protocol Violation|16|||
125428919|NCT00279201|451195546|FG001|Maintenance|Protocol Violation|24|||
125428920|NCT00279201|451195547|FG002|Maintenance|Protocol Violation|0|||
125428921|NCT00279201|451195548|FG003|Maintenance|Protocol Violation|0|||
125428922|NCT00279201|451195549|FG004|Maintenance|Protocol Violation|0|||
125428923|NCT00279201|451195550|FG005|Maintenance|Protocol Violation|0|||
125362105|NCT02468232|450959542|FG002|Core Part of Study|Adverse Event|0|||
125362106|NCT02468232|450959543|FG003|Core Part of Study|Adverse Event|0|||
125362107|NCT02468232|450959540|FG000|Core Part of Study|Death|20|||
125362108|NCT02468232|450959541|FG001|Core Part of Study|Death|17|||
125362109|NCT02468232|450959542|FG002|Core Part of Study|Death|0|||
125362110|NCT02468232|450959543|FG003|Core Part of Study|Death|0|||
125362111|NCT02468232|450959540|FG000|Core Part of Study|Technical Problems|1|||
125362112|NCT02468232|450959541|FG001|Core Part of Study|Technical Problems|1|||
125362113|NCT02468232|450959542|FG002|Core Part of Study|Technical Problems|0|||
125362114|NCT02468232|450959543|FG003|Core Part of Study|Technical Problems|0|||
125362115|NCT02468232|450959540|FG000|OLE Part of Study|Adverse Event|0|||
125362116|NCT02468232|450959541|FG001|OLE Part of Study|Adverse Event|0|||
125362117|NCT02468232|450959542|FG002|OLE Part of Study|Adverse Event|4|||
125362118|NCT02468232|450959543|FG003|OLE Part of Study|Adverse Event|5|||
125362119|NCT02468232|450959540|FG000|OLE Part of Study|Death|0|||
125362120|NCT02468232|450959541|FG001|OLE Part of Study|Death|0|||
125362121|NCT02468232|450959542|FG002|OLE Part of Study|Death|4|||
125362122|NCT02468232|450959543|FG003|OLE Part of Study|Death|2|||
125362123|NCT02468232|450959540|FG000|OLE Part of Study|Physician Decision|0|||
125362124|NCT02468232|450959541|FG001|OLE Part of Study|Physician Decision|0|||
125362125|NCT02468232|450959542|FG002|OLE Part of Study|Physician Decision|4|||
125362126|NCT02468232|450959543|FG003|OLE Part of Study|Physician Decision|0|||
125362127|NCT02468232|450959540|FG000|OLE Part of Study|Subject/Guardian decision|0|||
125362128|NCT02468232|450959541|FG001|OLE Part of Study|Subject/Guardian decision|0|||
125362129|NCT02468232|450959542|FG002|OLE Part of Study|Subject/Guardian decision|2|||
125362130|NCT02468232|450959543|FG003|OLE Part of Study|Subject/Guardian decision|5|||
125362131|NCT00246753|450959544|FG000|Overall Study|Withdrawal by Subject|2|||
125362132|NCT00246753|450959544|FG000|Overall Study|Physician Decision|2|||
125362133|NCT00246753|450959544|FG000|Overall Study|Adverse Event|2|||
125362134|NCT00246753|450959544|FG000|Overall Study|Unacceptable toxicity|2|||
125362135|NCT02764333|450959553|FG000|Overall Study|Ineligible|1|||
125362136|NCT01303861|450959567|FG000|Overall Study|Lost to Follow-up|34|||
125362137|NCT01303861|450959568|FG001|Overall Study|Lost to Follow-up|14|||
125362138|NCT01303861|450959569|FG002|Overall Study|Lost to Follow-up|27|||
125362139|NCT01303861|450959570|FG003|Overall Study|Lost to Follow-up|31|||
125362140|NCT01303861|450959567|FG000|Overall Study|Lack of Efficacy|3|||
125362141|NCT01303861|450959568|FG001|Overall Study|Lack of Efficacy|2|||
125362142|NCT01303861|450959569|FG002|Overall Study|Lack of Efficacy|1|||
125362143|NCT01303861|450959570|FG003|Overall Study|Lack of Efficacy|0|||
125428924|NCT00279201|451195545|FG000|Maintenance|Withdrawal by Subject|18|||
125362144|NCT01303861|450959567|FG000|Overall Study|Withdrawal by Subject|16|||
125428925|NCT00279201|451195546|FG001|Maintenance|Withdrawal by Subject|18|||
125428926|NCT00279201|451195547|FG002|Maintenance|Withdrawal by Subject|0|||
125428927|NCT00279201|451195548|FG003|Maintenance|Withdrawal by Subject|0|||
125362145|NCT01303861|450959568|FG001|Overall Study|Withdrawal by Subject|8|||
125362146|NCT01303861|450959569|FG002|Overall Study|Withdrawal by Subject|8|||
125428928|NCT00279201|451195549|FG004|Maintenance|Withdrawal by Subject|0|||
125428929|NCT00279201|451195550|FG005|Maintenance|Withdrawal by Subject|0|||
125428930|NCT00279201|451195545|FG000|Maintenance|Physician Decision|9|||
125362147|NCT01303861|450959570|FG003|Overall Study|Withdrawal by Subject|23|||
125362148|NCT01303861|450959567|FG000|Overall Study|Adverse Event|4|||
125362149|NCT01303861|450959568|FG001|Overall Study|Adverse Event|1|||
125362150|NCT01303861|450959569|FG002|Overall Study|Adverse Event|0|||
125362151|NCT01303861|450959570|FG003|Overall Study|Adverse Event|5|||
125362152|NCT01303861|450959567|FG000|Overall Study|Pregnancy|1|||
125362153|NCT01303861|450959568|FG001|Overall Study|Pregnancy|0|||
125362154|NCT01303861|450959569|FG002|Overall Study|Pregnancy|0|||
125362155|NCT01303861|450959570|FG003|Overall Study|Pregnancy|0|||
125428931|NCT00279201|451195546|FG001|Maintenance|Physician Decision|9|||
125584775|NCT04343651|451765869|FG000|Overall Study|Protocol Violation|4|||
125584776|NCT04343651|451765870|FG001|Overall Study|Protocol Violation|6|||
125584777|NCT04343651|451765869|FG000|Overall Study|Missing|3|||
125584778|NCT04343651|451765870|FG001|Overall Study|Missing|9|||
125584779|NCT04343651|451765869|FG000|Overall Study|Withdrawal by Subject|0|||
125584780|NCT04343651|451765870|FG001|Overall Study|Withdrawal by Subject|4|||
125584781|NCT04343651|451765869|FG000|Overall Study|Death|0|||
125584782|NCT04343651|451765870|FG001|Overall Study|Death|1|||
125584783|NCT04343651|451765869|FG000|Overall Study|Did not start treatment|1|||
125584784|NCT04343651|451765870|FG001|Overall Study|Did not start treatment|1|||
125584785|NCT04343651|451765869|FG000|Overall Study|Patient did not complete visits 3-6|0|||
125584786|NCT04343651|451765870|FG001|Overall Study|Patient did not complete visits 3-6|1|||
125584787|NCT01292057|451765876|FG000|Overall Study|Protocol Violation|1|||
125584788|NCT01292057|451765877|FG001|Overall Study|Protocol Violation|1|||
125584789|NCT01292057|451765876|FG000|Overall Study|Lost to Follow-up|1|||
125584790|NCT01292057|451765877|FG001|Overall Study|Lost to Follow-up|1|||
125584791|NCT01459614|451765878|FG000|Overall Study|Adverse Event|1|||
125584792|NCT01459614|451765879|FG001|Overall Study|Adverse Event|0|||
125584793|NCT01506882|451765883|FG000|Overall Study|Lack of Efficacy|4|||
125584794|NCT01506882|451765884|FG001|Overall Study|Lack of Efficacy|3|||
125362156|NCT01788046|450959572|FG000|Overall Study|Withdrawal by Subject|12|||
125362157|NCT01788046|450959573|FG001|Overall Study|Withdrawal by Subject|12|||
125362158|NCT01788046|450959572|FG000|Overall Study|Lost to Follow-up|12|||
125362159|NCT01788046|450959573|FG001|Overall Study|Lost to Follow-up|19|||
125362160|NCT01788046|450959572|FG000|Overall Study|Death|7|||
125584795|NCT01506882|451765883|FG000|Overall Study|Lost to Follow-up|1|||
125362161|NCT01788046|450959573|FG001|Overall Study|Death|5|||
125362162|NCT01788046|450959572|FG000|Overall Study|Protocol Specified Criteria|25|||
125362163|NCT01788046|450959573|FG001|Overall Study|Protocol Specified Criteria|1|||
125362164|NCT01031706|450959576|FG000|Overall Study|Adverse Event|1|||
125362165|NCT01031706|450959577|FG001|Overall Study|Adverse Event|0|||
125362166|NCT01031706|450959576|FG000|Overall Study|Withdrawal by Subject|1|||
125362167|NCT01031706|450959577|FG001|Overall Study|Withdrawal by Subject|1|||
125362168|NCT03840174|450959578|FG000|Overall Study|Withdrawal by Subject|1|||
125362169|NCT03840174|450959579|FG001|Overall Study|Withdrawal by Subject|0|||
125362170|NCT03840174|450959580|FG002|Overall Study|Withdrawal by Subject|0|||
125362171|NCT03840174|450959581|FG003|Overall Study|Withdrawal by Subject|0|||
125362172|NCT00131508|450959584|FG000|Overall Study|Disease progression|0|||
125362173|NCT00131508|450959585|FG001|Overall Study|Disease progression|2|||
125362174|NCT00131508|450959584|FG000|Overall Study|Non-Compliance|2|||
125362175|NCT00131508|450959585|FG001|Overall Study|Non-Compliance|4|||
125362176|NCT00131508|450959584|FG000|Overall Study|Withdrawal by Subject|1|||
125362177|NCT00131508|450959585|FG001|Overall Study|Withdrawal by Subject|2|||
125362178|NCT01268150|450959589|FG000|Treatment Phase|Progression of disease|18|||
125362179|NCT01268150|450959589|FG000|Treatment Phase|Adverse Event|3|||
125362180|NCT01268150|450959589|FG000|Treatment Phase|Withdrawal by Subject|3|||
125362181|NCT01268150|450959589|FG000|Treatment Phase|Other|4|||
125362182|NCT01268150|450959589|FG000|Extension Phase|Adverse Event|3|||
125362183|NCT01268150|450959589|FG000|Extension Phase|Disease progression|18|||
125362184|NCT01268150|450959589|FG000|Extension Phase|Other|6|||
125362185|NCT04738734|450959591|FG000|Overall Study|Withdrawal by Subject|2|||
125362186|NCT04738734|450959592|FG001|Overall Study|Withdrawal by Subject|4|||
125362187|NCT04738734|450959591|FG000|Overall Study|Lost to Follow-up|5|||
125362188|NCT04738734|450959592|FG001|Overall Study|Lost to Follow-up|2|||
125362189|NCT04738734|450959591|FG000|Overall Study|Physician Decision|0|||
125362190|NCT04738734|450959592|FG001|Overall Study|Physician Decision|1|||
125584796|NCT01506882|451765884|FG001|Overall Study|Lost to Follow-up|0|||
125584797|NCT01506882|451765883|FG000|Overall Study|Withdrawal by Subject|9|||
125584798|NCT01506882|451765884|FG001|Overall Study|Withdrawal by Subject|3|||
125584799|NCT01506882|451765883|FG000|Overall Study|SAE, non-fatal|2|||
125362191|NCT04738734|450959591|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
125584800|NCT01506882|451765884|FG001|Overall Study|SAE, non-fatal|0|||
125362192|NCT04738734|450959592|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
125362193|NCT02435147|450959595|FG000|Overall Study|non-evaluable DXA scan|11|||
125362194|NCT04402060|450959596|FG000|Overall Study|Death|1|||
125362195|NCT04402060|450959597|FG001|Overall Study|Death|12|||
125362196|NCT04402060|450959598|FG002|Overall Study|Death|7|||
125362197|NCT04402060|450959596|FG000|Overall Study|Adverse Event|0|||
125362198|NCT04402060|450959597|FG001|Overall Study|Adverse Event|0|||
125362199|NCT04402060|450959598|FG002|Overall Study|Adverse Event|1|||
125362200|NCT04402060|450959596|FG000|Overall Study|Withdrawal by Subject|0|||
125362201|NCT04402060|450959597|FG001|Overall Study|Withdrawal by Subject|1|||
125362202|NCT04402060|450959598|FG002|Overall Study|Withdrawal by Subject|2|||
125584801|NCT01506882|451765883|FG000|Overall Study|AE, non-serious non-fatal|3|||
125584802|NCT01506882|451765884|FG001|Overall Study|AE, non-serious non-fatal|1|||
125584803|NCT01506882|451765883|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
125362203|NCT04402060|450959596|FG000|Overall Study|Sponsor Request|0|||
125362204|NCT04402060|450959597|FG001|Overall Study|Sponsor Request|2|||
125362205|NCT04402060|450959598|FG002|Overall Study|Sponsor Request|0|||
125362206|NCT04402060|450959596|FG000|Overall Study|Physician Decision|0|||
125584804|NCT01506882|451765884|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
125584805|NCT01506882|451765883|FG000|Overall Study|Other Reason|2|||
125584806|NCT01506882|451765884|FG001|Overall Study|Other Reason|0|||
125584807|NCT00821678|451765889|FG000|Overall Study|Withdrawal by Subject|8|||
125584808|NCT00821678|451765890|FG001|Overall Study|Withdrawal by Subject|0|||
125584809|NCT00821678|451765889|FG000|Overall Study|Lost to Follow-up|13|||
125584810|NCT00821678|451765890|FG001|Overall Study|Lost to Follow-up|12|||
125584811|NCT00821678|451765889|FG000|Overall Study|Death|0|||
125584812|NCT00821678|451765890|FG001|Overall Study|Death|2|||
125584813|NCT05742984|451768058|FG000|Overall Study|Adverse Event|0|||
125584814|NCT05742984|451768059|FG001|Overall Study|Adverse Event|0|||
125584815|NCT05742984|451768060|FG002|Overall Study|Adverse Event|1|||
125584816|NCT05742984|451768061|FG003|Overall Study|Adverse Event|0|||
125584817|NCT05742984|451768062|FG004|Overall Study|Adverse Event|1|||
125584818|NCT05742984|451768063|FG005|Overall Study|Adverse Event|1|||
125584819|NCT05742984|451768058|FG000|Overall Study|Withdrawal by Subject|0|||
125584820|NCT05742984|451768059|FG001|Overall Study|Withdrawal by Subject|1|||
125584821|NCT05742984|451768060|FG002|Overall Study|Withdrawal by Subject|0|||
125584822|NCT05742984|451768061|FG003|Overall Study|Withdrawal by Subject|0|||
125584823|NCT05742984|451768062|FG004|Overall Study|Withdrawal by Subject|0|||
125584824|NCT05742984|451768063|FG005|Overall Study|Withdrawal by Subject|2|||
125584825|NCT00379340|451768064|FG000|Overall Study|Death|0|||
125584826|NCT00379340|451768065|FG001|Overall Study|Death|0|||
125584827|NCT00379340|451768066|FG002|Overall Study|Death|0|||
125584828|NCT00379340|451768067|FG003|Overall Study|Death|2|||
125584829|NCT00379340|451768068|FG004|Overall Study|Death|0|||
125584830|NCT00379340|451768064|FG000|Overall Study|Lack of Efficacy|6|||
125584831|NCT00379340|451768065|FG001|Overall Study|Lack of Efficacy|1|||
125584832|NCT00379340|451768066|FG002|Overall Study|Lack of Efficacy|0|||
125584833|NCT00379340|451768067|FG003|Overall Study|Lack of Efficacy|4|||
125584834|NCT00379340|451768068|FG004|Overall Study|Lack of Efficacy|3|||
125584835|NCT00379340|451768064|FG000|Overall Study|Physician Decision|6|||
125584836|NCT00379340|451768065|FG001|Overall Study|Physician Decision|2|||
125584837|NCT00379340|451768066|FG002|Overall Study|Physician Decision|1|||
125584838|NCT00379340|451768067|FG003|Overall Study|Physician Decision|2|||
125584839|NCT00379340|451768068|FG004|Overall Study|Physician Decision|3|||
125584840|NCT00379340|451768064|FG000|Overall Study|Withdrawal by Subject|0|||
125584841|NCT00379340|451768065|FG001|Overall Study|Withdrawal by Subject|0|||
125584842|NCT00379340|451768066|FG002|Overall Study|Withdrawal by Subject|0|||
125584843|NCT00379340|451768067|FG003|Overall Study|Withdrawal by Subject|1|||
125584844|NCT00379340|451768068|FG004|Overall Study|Withdrawal by Subject|0|||
125584845|NCT00379340|451768064|FG000|Overall Study|Refusal of further protocol therapy|1|||
125584846|NCT00379340|451768065|FG001|Overall Study|Refusal of further protocol therapy|0|||
125584847|NCT00379340|451768066|FG002|Overall Study|Refusal of further protocol therapy|1|||
125584848|NCT00379340|451768067|FG003|Overall Study|Refusal of further protocol therapy|1|||
125584849|NCT00379340|451768068|FG004|Overall Study|Refusal of further protocol therapy|7|||
125584850|NCT00379340|451768064|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
125584851|NCT00379340|451768065|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
125584852|NCT00379340|451768066|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
125584853|NCT00379340|451768067|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
125584854|NCT00379340|451768068|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
125584855|NCT00379340|451768064|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
125584856|NCT00379340|451768065|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
125584857|NCT00379340|451768066|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
125584858|NCT00379340|451768067|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
125584859|NCT00379340|451768068|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
125584860|NCT00103012|451768074|FG000|Overall Study|Withdrawal by Subject|2|||
125584861|NCT00103012|451768075|FG001|Overall Study|Withdrawal by Subject|1|||
125584862|NCT00103012|451768076|FG002|Overall Study|Withdrawal by Subject|2|||
125584863|NCT00103012|451768074|FG000|Overall Study|Pregnancy|1|||
125584864|NCT00103012|451768075|FG001|Overall Study|Pregnancy|0|||
125362207|NCT04402060|450959597|FG001|Overall Study|Physician Decision|0|||
125362208|NCT04402060|450959598|FG002|Overall Study|Physician Decision|1|||
125362209|NCT04402060|450959596|FG000|Overall Study|Other|0|||
125362210|NCT04402060|450959597|FG001|Overall Study|Other|1|||
125584865|NCT00103012|451768076|FG002|Overall Study|Pregnancy|0|||
125584866|NCT00103012|451768074|FG000|Overall Study|Adverse Event|0|||
125584867|NCT00103012|451768075|FG001|Overall Study|Adverse Event|0|||
125584868|NCT00103012|451768076|FG002|Overall Study|Adverse Event|1|||
125584869|NCT00103012|451768074|FG000|Overall Study|Subject non-compliant with medications|0|||
125362211|NCT04402060|450959598|FG002|Overall Study|Other|0|||
125584870|NCT00103012|451768075|FG001|Overall Study|Subject non-compliant with medications|0|||
125584871|NCT00103012|451768076|FG002|Overall Study|Subject non-compliant with medications|1|||
125584872|NCT00430755|451768077|FG000|Overall Study|Withdrawal by Subject|53|||
125584873|NCT05019131|451768083|FG000|Overall Study|Lost to Follow-up|0|||
125584874|NCT05019131|451768084|FG001|Overall Study|Lost to Follow-up|3|||
125584875|NCT01703000|451768086|FG000|Overall Study|Death|1|||
125584876|NCT06118385|451768090|FG000|Overall Study|Protocol Violation|0|||
125584877|NCT06118385|451768091|FG001|Overall Study|Protocol Violation|0|||
125584878|NCT06118385|451768092|FG002|Overall Study|Protocol Violation|0|||
125584879|NCT06118385|451768093|FG003|Overall Study|Protocol Violation|0|||
125584880|NCT06118385|451768094|FG004|Overall Study|Protocol Violation|0|||
125584881|NCT06118385|451768095|FG005|Overall Study|Protocol Violation|0|||
125584882|NCT06118385|451768096|FG006|Overall Study|Protocol Violation|0|||
125584883|NCT06118385|451768097|FG007|Overall Study|Protocol Violation|0|||
125584884|NCT06118385|451768098|FG008|Overall Study|Protocol Violation|1|||
125584885|NCT06118385|451768099|FG009|Overall Study|Protocol Violation|0|||
125584886|NCT06118385|451768100|FG010|Overall Study|Protocol Violation|0|||
125584887|NCT06118385|451768101|FG011|Overall Study|Protocol Violation|0|||
125584888|NCT06118385|451768090|FG000|Overall Study|Out-of-range blood tests|0|||
125584889|NCT06118385|451768091|FG001|Overall Study|Out-of-range blood tests|0|||
125584890|NCT06118385|451768092|FG002|Overall Study|Out-of-range blood tests|0|||
125584891|NCT06118385|451768093|FG003|Overall Study|Out-of-range blood tests|0|||
125584892|NCT06118385|451768094|FG004|Overall Study|Out-of-range blood tests|0|||
125584893|NCT06118385|451768095|FG005|Overall Study|Out-of-range blood tests|0|||
125584894|NCT06118385|451768096|FG006|Overall Study|Out-of-range blood tests|0|||
125584895|NCT06118385|451768097|FG007|Overall Study|Out-of-range blood tests|0|||
125584896|NCT06118385|451768098|FG008|Overall Study|Out-of-range blood tests|1|||
125584897|NCT06118385|451768099|FG009|Overall Study|Out-of-range blood tests|0|||
125584898|NCT06118385|451768100|FG010|Overall Study|Out-of-range blood tests|0|||
125584899|NCT06118385|451768101|FG011|Overall Study|Out-of-range blood tests|0|||
125584900|NCT01323478|451768102|FG000|Overall Study|Adverse Event|7|||
125584901|NCT01323478|451768102|FG000|Overall Study|Lack of Efficacy|4|||
125584902|NCT01323478|451768102|FG000|Overall Study|Non-compliance With Study Product|3|||
125584903|NCT01323478|451768102|FG000|Overall Study|Protocol Violation|1|||
125584904|NCT01323478|451768102|FG000|Overall Study|Withdrawal of Consent|1|||
125584905|NCT01323478|451768102|FG000|Overall Study|Administrative or Other Reasons|8|||
125584906|NCT02411448|451768103|FG000|Overall Study|Withdrawal by Subject|1|||
125584907|NCT02411448|451768104|FG001|Overall Study|Withdrawal by Subject|14|||
125584908|NCT02411448|451768105|FG002|Overall Study|Withdrawal by Subject|9|||
125584909|NCT02411448|451768103|FG000|Overall Study|Other|0|||
125584910|NCT02411448|451768104|FG001|Overall Study|Other|2|||
125584911|NCT02411448|451768105|FG002|Overall Study|Other|0|||
125584912|NCT02411448|451768103|FG000|Overall Study|Did not receive study treatment|0|||
125584913|NCT02411448|451768104|FG001|Overall Study|Did not receive study treatment|3|||
125584914|NCT02411448|451768105|FG002|Overall Study|Did not receive study treatment|0|||
125584915|NCT02411448|451768103|FG000|Overall Study|Alive on study treatment|3|||
125584916|NCT02411448|451768104|FG001|Overall Study|Alive on study treatment|64|||
125584917|NCT02411448|451768105|FG002|Overall Study|Alive on study treatment|43|||
125584918|NCT02771522|451768108|FG000|Overall Study|Lost to Follow-up|3|||
125584919|NCT02771522|451768108|FG000|Overall Study|Withdrawal by Subject|2|||
125584920|NCT02771522|451768108|FG000|Overall Study|No white spot lesions|3|||
125584921|NCT05655377|451768111|FG000|Overall Study|Withdrawal by Subject|2|||
125584922|NCT01256177|451768112|FG000|Overall Study|Withdrawal by Subject|23|||
125584923|NCT01256177|451768113|FG001|Overall Study|Withdrawal by Subject|22|||
125362212|NCT02155881|450959606|FG000|Overall Study|Withdrawal by Subject|0|||
125362213|NCT02155881|450959607|FG001|Overall Study|Withdrawal by Subject|2|||
125362214|NCT02155881|450959606|FG000|Overall Study|Inappropriately randomized|2|||
125362215|NCT02155881|450959607|FG001|Overall Study|Inappropriately randomized|2|||
125362216|NCT04032652|450959610|FG000|Overall Study|The study was terminated and the PI has|1|||
125362217|NCT04032652|450959611|FG001|Overall Study|The study was terminated and the PI has|1|||
125362218|NCT06238362|450959612|FG000|Overall Study|Insufficient total sleep time|1|||
125362219|NCT06238362|450959613|FG001|Overall Study|Insufficient total sleep time|0|||
125362220|NCT06238362|450959612|FG000|Overall Study|Inadequate signal quality|1|||
125362221|NCT06238362|450959613|FG001|Overall Study|Inadequate signal quality|0|||
125362222|NCT05136690|450959614|FG000|Period 1|Withdrawal by Subject|0|||
125362223|NCT05136690|450959615|FG001|Period 1|Withdrawal by Subject|1|||
125362224|NCT05136690|450959614|FG000|Period 2|Lost to Follow-up|0|||
125362225|NCT05136690|450959615|FG001|Period 2|Lost to Follow-up|3|||
125362226|NCT05136690|450959614|FG000|Period 2|Withdrawal by Subject|0|||
125362227|NCT05136690|450959615|FG001|Period 2|Withdrawal by Subject|1|||
125362228|NCT01863953|450961052|FG000|Overall Study|Adverse Event|0|||
125362229|NCT01863953|450961053|FG001|Overall Study|Adverse Event|0|||
125362230|NCT01863953|450961054|FG002|Overall Study|Adverse Event|1|||
125584924|NCT01256177|451768112|FG000|Overall Study|Lost to Follow-up|2|||
125584925|NCT01256177|451768113|FG001|Overall Study|Lost to Follow-up|2|||
125584926|NCT01256177|451768112|FG000|Overall Study|Adverse Event|8|||
125584927|NCT01256177|451768113|FG001|Overall Study|Adverse Event|9|||
125584928|NCT01256177|451768112|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
125584929|NCT01256177|451768113|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
125584930|NCT01256177|451768112|FG000|Overall Study|Condition under Investigation Worsened|1|||
125584931|NCT01256177|451768113|FG001|Overall Study|Condition under Investigation Worsened|0|||
125584932|NCT01256177|451768112|FG000|Overall Study|Lack of Efficacy|11|||
125584933|NCT01256177|451768113|FG001|Overall Study|Lack of Efficacy|2|||
125584934|NCT01256177|451768112|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
125584935|NCT01256177|451768113|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
125584936|NCT00553462|451768115|FG000|Overall Study|Adverse Event|4|||
125584937|NCT00553462|451768115|FG000|Overall Study|Progression|4|||
125584938|NCT00553462|451768115|FG000|Overall Study|Withdrawal by Subject|5|||
125584939|NCT00553462|451768115|FG000|Overall Study|Physician Decision|1|||
125584940|NCT01728779|451768116|FG000|Overall Study|Withdrawal by Subject|1|||
125584941|NCT00675025|451768117|FG000|Overall Study|Study Terminated by Sponsor|38|||
125584942|NCT00675025|451768118|FG001|Overall Study|Study Terminated by Sponsor|42|||
125584943|NCT00675025|451768117|FG000|Overall Study|Adverse Event|6|||
125584944|NCT00675025|451768118|FG001|Overall Study|Adverse Event|11|||
125584945|NCT00675025|451768117|FG000|Overall Study|Lost to Follow-up|6|||
125584946|NCT00675025|451768118|FG001|Overall Study|Lost to Follow-up|4|||
125584947|NCT00675025|451768117|FG000|Overall Study|Withdrawal by Subject|4|||
125584948|NCT00675025|451768118|FG001|Overall Study|Withdrawal by Subject|6|||
125584949|NCT04398732|451768119|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
125584950|NCT01596257|451768121|FG000|Overall Study|Inadequate Collection|23|||
125584951|NCT01596257|451768122|FG001|Overall Study|Inadequate Collection|19|||
125584952|NCT01570244|451768123|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
125584953|NCT00792298|451768129|FG000|Treatment Period 1|Adverse Event|0|||
125584954|NCT00792298|451768130|FG001|Treatment Period 1|Adverse Event|1|||
125584955|NCT00792298|451768131|FG002|Treatment Period 1|Adverse Event|0|||
125584956|NCT00792298|451768132|FG003|Treatment Period 1|Adverse Event|1|||
125584957|NCT00792298|451768133|FG004|Treatment Period 1|Adverse Event|0|||
125584958|NCT00792298|451768134|FG005|Treatment Period 1|Adverse Event|1|||
125584959|NCT00792298|451768135|FG006|Treatment Period 1|Adverse Event|1|||
125584960|NCT00792298|451768136|FG007|Treatment Period 1|Adverse Event|0|||
125584961|NCT00792298|451768129|FG000|Treatment Period 1|Lack of Efficacy|0|||
125584962|NCT00792298|451768130|FG001|Treatment Period 1|Lack of Efficacy|0|||
125584963|NCT00792298|451768131|FG002|Treatment Period 1|Lack of Efficacy|1|||
125584964|NCT00792298|451768132|FG003|Treatment Period 1|Lack of Efficacy|0|||
125584965|NCT00792298|451768133|FG004|Treatment Period 1|Lack of Efficacy|0|||
125584966|NCT00792298|451768134|FG005|Treatment Period 1|Lack of Efficacy|0|||
125584967|NCT00792298|451768135|FG006|Treatment Period 1|Lack of Efficacy|0|||
125584968|NCT00792298|451768136|FG007|Treatment Period 1|Lack of Efficacy|0|||
125584969|NCT00792298|451768129|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125584970|NCT00792298|451768130|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125584971|NCT00792298|451768131|FG002|Treatment Period 1|Withdrawal by Subject|1|||
125584972|NCT00792298|451768132|FG003|Treatment Period 1|Withdrawal by Subject|2|||
125584973|NCT00792298|451768133|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125584974|NCT00792298|451768134|FG005|Treatment Period 1|Withdrawal by Subject|2|||
125584975|NCT00792298|451768135|FG006|Treatment Period 1|Withdrawal by Subject|1|||
125584976|NCT00792298|451768136|FG007|Treatment Period 1|Withdrawal by Subject|0|||
125584977|NCT00792298|451768129|FG000|Treatment Period 1|Lost to Follow-up|0|||
125584978|NCT00792298|451768130|FG001|Treatment Period 1|Lost to Follow-up|0|||
125584979|NCT00792298|451768131|FG002|Treatment Period 1|Lost to Follow-up|0|||
125584980|NCT00792298|451768132|FG003|Treatment Period 1|Lost to Follow-up|0|||
125584981|NCT00792298|451768133|FG004|Treatment Period 1|Lost to Follow-up|0|||
125428932|NCT00279201|451195547|FG002|Maintenance|Physician Decision|0|||
125428933|NCT00279201|451195548|FG003|Maintenance|Physician Decision|0|||
125584982|NCT00792298|451768134|FG005|Treatment Period 1|Lost to Follow-up|0|||
125584983|NCT00792298|451768135|FG006|Treatment Period 1|Lost to Follow-up|1|||
125584984|NCT00792298|451768136|FG007|Treatment Period 1|Lost to Follow-up|0|||
125584985|NCT00792298|451768129|FG000|Treatment Period 1|Physician Decision|0|||
125584986|NCT00792298|451768130|FG001|Treatment Period 1|Physician Decision|0|||
125584987|NCT00792298|451768131|FG002|Treatment Period 1|Physician Decision|0|||
125584988|NCT00792298|451768132|FG003|Treatment Period 1|Physician Decision|1|||
125584989|NCT00792298|451768133|FG004|Treatment Period 1|Physician Decision|0|||
125584990|NCT00792298|451768134|FG005|Treatment Period 1|Physician Decision|0|||
125584991|NCT00792298|451768135|FG006|Treatment Period 1|Physician Decision|1|||
125584992|NCT00792298|451768136|FG007|Treatment Period 1|Physician Decision|0|||
125584993|NCT00792298|451768129|FG000|Treatment Period 1|Protocol Violation|0|||
125584994|NCT00792298|451768130|FG001|Treatment Period 1|Protocol Violation|0|||
125584995|NCT00792298|451768131|FG002|Treatment Period 1|Protocol Violation|0|||
125584996|NCT00792298|451768132|FG003|Treatment Period 1|Protocol Violation|0|||
125584997|NCT00792298|451768133|FG004|Treatment Period 1|Protocol Violation|0|||
125584998|NCT00792298|451768134|FG005|Treatment Period 1|Protocol Violation|0|||
125584999|NCT00792298|451768135|FG006|Treatment Period 1|Protocol Violation|0|||
125585000|NCT00792298|451768136|FG007|Treatment Period 1|Protocol Violation|1|||
125585001|NCT00792298|451768129|FG000|Washout|Adverse Event|0|||
125585002|NCT00792298|451768130|FG001|Washout|Adverse Event|0|||
125585003|NCT00792298|451768131|FG002|Washout|Adverse Event|0|||
125585004|NCT00792298|451768132|FG003|Washout|Adverse Event|0|||
125585005|NCT00792298|451768133|FG004|Washout|Adverse Event|0|||
125585006|NCT00792298|451768134|FG005|Washout|Adverse Event|1|||
125585007|NCT00792298|451768135|FG006|Washout|Adverse Event|0|||
125585008|NCT00792298|451768136|FG007|Washout|Adverse Event|0|||
125585009|NCT00792298|451768129|FG000|Washout|Withdrawal by Subject|0|||
125585010|NCT00792298|451768130|FG001|Washout|Withdrawal by Subject|0|||
125585011|NCT00792298|451768131|FG002|Washout|Withdrawal by Subject|1|||
125585012|NCT00792298|451768132|FG003|Washout|Withdrawal by Subject|0|||
125585013|NCT00792298|451768133|FG004|Washout|Withdrawal by Subject|0|||
125585014|NCT00792298|451768134|FG005|Washout|Withdrawal by Subject|1|||
125585015|NCT00792298|451768135|FG006|Washout|Withdrawal by Subject|0|||
125585016|NCT00792298|451768136|FG007|Washout|Withdrawal by Subject|0|||
125585017|NCT00792298|451768129|FG000|Treatment Period 2|Lack of Efficacy|0|||
125585018|NCT00792298|451768130|FG001|Treatment Period 2|Lack of Efficacy|0|||
125585019|NCT00792298|451768131|FG002|Treatment Period 2|Lack of Efficacy|0|||
125585020|NCT00792298|451768132|FG003|Treatment Period 2|Lack of Efficacy|0|||
125585021|NCT00792298|451768133|FG004|Treatment Period 2|Lack of Efficacy|1|||
125585022|NCT00792298|451768134|FG005|Treatment Period 2|Lack of Efficacy|0|||
125585023|NCT00792298|451768135|FG006|Treatment Period 2|Lack of Efficacy|0|||
125585024|NCT00792298|451768136|FG007|Treatment Period 2|Lack of Efficacy|0|||
125585025|NCT00792298|451768129|FG000|Treatment Period 2|Physician Decision|0|||
125585026|NCT00792298|451768130|FG001|Treatment Period 2|Physician Decision|0|||
125585027|NCT00792298|451768131|FG002|Treatment Period 2|Physician Decision|0|||
125585028|NCT00792298|451768132|FG003|Treatment Period 2|Physician Decision|0|||
125585029|NCT00792298|451768133|FG004|Treatment Period 2|Physician Decision|0|||
125585030|NCT00792298|451768134|FG005|Treatment Period 2|Physician Decision|0|||
125585031|NCT00792298|451768135|FG006|Treatment Period 2|Physician Decision|1|||
125585032|NCT00792298|451768136|FG007|Treatment Period 2|Physician Decision|0|||
125585033|NCT00792298|451768129|FG000|Treatment Period 2|Pregnancy|0|||
125585034|NCT00792298|451768130|FG001|Treatment Period 2|Pregnancy|0|||
125585035|NCT00792298|451768131|FG002|Treatment Period 2|Pregnancy|1|||
125585036|NCT00792298|451768132|FG003|Treatment Period 2|Pregnancy|0|||
125585037|NCT00792298|451768133|FG004|Treatment Period 2|Pregnancy|0|||
125585038|NCT00792298|451768134|FG005|Treatment Period 2|Pregnancy|0|||
125585039|NCT00792298|451768135|FG006|Treatment Period 2|Pregnancy|0|||
125585040|NCT00792298|451768136|FG007|Treatment Period 2|Pregnancy|0|||
125585041|NCT00792298|451768129|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125585042|NCT00792298|451768130|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125585043|NCT00792298|451768131|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125585044|NCT00792298|451768132|FG003|Treatment Period 2|Withdrawal by Subject|2|||
125585045|NCT00792298|451768133|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125585046|NCT00792298|451768134|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125585047|NCT00792298|451768135|FG006|Treatment Period 2|Withdrawal by Subject|0|||
125585048|NCT00792298|451768136|FG007|Treatment Period 2|Withdrawal by Subject|2|||
125585049|NCT04258579|451768138|FG000|Overall Study|Withdrawal by Subject|7|||
125585050|NCT04258579|451768138|FG000|Overall Study|Lost to Follow-up|3|||
125585051|NCT04258579|451768138|FG000|Overall Study|Protocol Violation|2|||
125585052|NCT04258579|451768138|FG000|Overall Study|Adverse Event|1|||
125585053|NCT02388295|451768139|FG000|Dose Escalation Week 1|Adverse Event|1|||
125585054|NCT02388295|451768140|FG001|Dose Escalation Week 1|Adverse Event|2|||
125585055|NCT02388295|451768141|FG002|Dose Escalation Week 1|Adverse Event|1|||
125585056|NCT02388295|451768139|FG000|Dose Escalation Week 1|Determined not eligible|1|||
125585057|NCT02388295|451768140|FG001|Dose Escalation Week 1|Determined not eligible|1|||
125585058|NCT02388295|451768141|FG002|Dose Escalation Week 1|Determined not eligible|1|||
125585059|NCT02388295|451768139|FG000|Dose Escalation Week 2|Protocol Violation|0|||
125585060|NCT02388295|451768140|FG001|Dose Escalation Week 2|Protocol Violation|1|||
125585061|NCT02388295|451768141|FG002|Dose Escalation Week 2|Protocol Violation|0|||
125585062|NCT02388295|451768139|FG000|Dose Escalation Week 2|Determined not eligible|1|||
125585063|NCT02388295|451768140|FG001|Dose Escalation Week 2|Determined not eligible|1|||
125585064|NCT02388295|451768141|FG002|Dose Escalation Week 2|Determined not eligible|1|||
125585065|NCT02388295|451768139|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
125585066|NCT02388295|451768140|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
125585067|NCT02388295|451768141|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
125585068|NCT02076165|451768142|FG000|Overall Study|Lost to Follow-up|7|||
125585069|NCT02076165|451768143|FG001|Overall Study|Lost to Follow-up|5|||
125585070|NCT02076165|451768142|FG000|Overall Study|Refused follow-up assessment|1|||
125585071|NCT02076165|451768143|FG001|Overall Study|Refused follow-up assessment|1|||
125585072|NCT04134494|451768147|FG000|Overall Study|Lost to Follow-up|2|||
125585073|NCT01950819|451768148|FG000|Overall Study|Graft Loss|35|||
125585074|NCT01950819|451768149|FG001|Overall Study|Graft Loss|30|||
125585075|NCT01950819|451768148|FG000|Overall Study|Death|29|||
125585076|NCT01950819|451768149|FG001|Overall Study|Death|34|||
125585077|NCT01950819|451768148|FG000|Overall Study|Subject / Gardian decision|54|||
125585078|NCT01950819|451768149|FG001|Overall Study|Subject / Gardian decision|51|||
125585079|NCT01950819|451768148|FG000|Overall Study|technical problems|2|||
125585080|NCT01950819|451768149|FG001|Overall Study|technical problems|0|||
125585081|NCT01950819|451768148|FG000|Overall Study|Pregnancy|0|||
125585082|NCT01950819|451768149|FG001|Overall Study|Pregnancy|2|||
125585083|NCT01950819|451768148|FG000|Overall Study|Lost to Follow-up|9|||
125585084|NCT01950819|451768149|FG001|Overall Study|Lost to Follow-up|17|||
125585085|NCT00781365|451768151|FG000|Overall Study|Withdrawal by Subject|13|||
125585086|NCT00781365|451768152|FG001|Overall Study|Withdrawal by Subject|8|||
125585087|NCT00781365|451768151|FG000|Overall Study|Did Not Attend Visit|20|||
125585088|NCT00781365|451768152|FG001|Overall Study|Did Not Attend Visit|28|||
125585089|NCT00781365|451768151|FG000|Overall Study|Language barrier|1|||
125585090|NCT00781365|451768152|FG001|Overall Study|Language barrier|0|||
125585091|NCT01756456|451768153|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
125585092|NCT01756456|451768154|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
125585093|NCT01756456|451768155|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
125585094|NCT01756456|451768156|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
125585095|NCT01756456|451768157|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
125585096|NCT01756456|451768158|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
125585097|NCT01756456|451768153|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
125585098|NCT01756456|451768154|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
125585099|NCT01756456|451768155|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
125585100|NCT01756456|451768156|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
125585101|NCT01756456|451768157|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
125585102|NCT01756456|451768158|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
125585103|NCT01756456|451768153|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
125585104|NCT01756456|451768154|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
125585105|NCT01756456|451768155|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
125585106|NCT01756456|451768156|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
125585107|NCT01756456|451768157|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
125585108|NCT01756456|451768158|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
125585109|NCT01756456|451768153|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
125585110|NCT01756456|451768154|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
125585111|NCT01756456|451768155|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
125585112|NCT01756456|451768156|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
125585113|NCT01756456|451768157|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
125585114|NCT01756456|451768158|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
125585115|NCT01756456|451768153|FG000|Treatment Period: Phase I/II|Other causes|0|||
125585116|NCT01756456|451768154|FG001|Treatment Period: Phase I/II|Other causes|0|||
125585117|NCT01756456|451768155|FG002|Treatment Period: Phase I/II|Other causes|0|||
125585118|NCT01756456|451768156|FG003|Treatment Period: Phase I/II|Other causes|1|||
125585119|NCT01756456|451768157|FG004|Treatment Period: Phase I/II|Other causes|2|||
125585120|NCT01756456|451768158|FG005|Treatment Period: Phase I/II|Other causes|2|||
125585121|NCT01756456|451768153|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
125585122|NCT01756456|451768154|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
125585123|NCT01756456|451768155|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
125585124|NCT01756456|451768156|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
125585125|NCT01756456|451768157|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
125585126|NCT01756456|451768158|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
125585127|NCT01756456|451768153|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
125362231|NCT02202837|450961055|FG000|Overall Study|Enbrel treatment discontinued|36|||
125362232|NCT02202837|450961056|FG001|Overall Study|Enbrel treatment discontinued|4|||
125362233|NCT02202837|450961055|FG000|Overall Study|Other|10|||
125362234|NCT02202837|450961056|FG001|Overall Study|Other|0|||
125362235|NCT02202837|450961055|FG000|Overall Study|Lost to Follow-up|7|||
125362236|NCT02202837|450961056|FG001|Overall Study|Lost to Follow-up|1|||
125362237|NCT01313858|450961057|FG000|Overall Study|Premature Treatment Termination|251|||
125362238|NCT01313858|450961058|FG001|Overall Study|Premature Treatment Termination|219|||
125362239|NCT01313858|450961059|FG002|Overall Study|Premature Treatment Termination|191|||
125362240|NCT01313858|450961057|FG000|Overall Study|Lost to Follow-up|35|||
125362241|NCT01313858|450961058|FG001|Overall Study|Lost to Follow-up|51|||
125362242|NCT01313858|450961059|FG002|Overall Study|Lost to Follow-up|47|||
125362243|NCT01626456|450961071|FG000|Overall Study|Withdrawal by Subject|21|||
125362244|NCT01626456|450961072|FG001|Overall Study|Withdrawal by Subject|46|||
125362245|NCT01626456|450961071|FG000|Overall Study|Adverse Event|2|||
125362246|NCT01626456|450961072|FG001|Overall Study|Adverse Event|27|||
125362247|NCT01626456|450961071|FG000|Overall Study|Lost to Follow-up|2|||
125362248|NCT01626456|450961072|FG001|Overall Study|Lost to Follow-up|27|||
125362249|NCT01626456|450961071|FG000|Overall Study|Lack of Efficacy|6|||
125362250|NCT01626456|450961072|FG001|Overall Study|Lack of Efficacy|7|||
125585128|NCT01756456|451768154|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
125585129|NCT01756456|451768155|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
125585130|NCT01756456|451768156|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
125585131|NCT01756456|451768157|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
125585132|NCT01756456|451768158|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
125585133|NCT01756456|451768153|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
125585134|NCT01756456|451768154|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
125585135|NCT01756456|451768155|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
125585136|NCT01756456|451768156|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
125585137|NCT01756456|451768157|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
125585138|NCT01756456|451768158|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
125585139|NCT01756456|451768153|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
125585140|NCT01756456|451768154|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
125585141|NCT01756456|451768155|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
125585142|NCT01756456|451768156|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
125585143|NCT01756456|451768157|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
125585144|NCT01756456|451768158|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
125585145|NCT01756456|451768153|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
125585146|NCT01756456|451768154|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
125585147|NCT01756456|451768155|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
125585148|NCT01756456|451768156|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
125585149|NCT01756456|451768157|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
125585150|NCT01756456|451768158|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
125585151|NCT01756456|451768153|FG000|Follow Up Period Phase I/II|Other causes|0|||
125585152|NCT01756456|451768154|FG001|Follow Up Period Phase I/II|Other causes|0|||
125585153|NCT01756456|451768155|FG002|Follow Up Period Phase I/II|Other causes|0|||
125585154|NCT01756456|451768156|FG003|Follow Up Period Phase I/II|Other causes|1|||
125585155|NCT01756456|451768157|FG004|Follow Up Period Phase I/II|Other causes|3|||
125585156|NCT01756456|451768158|FG005|Follow Up Period Phase I/II|Other causes|5|||
125585157|NCT01573910|451768159|FG000|Overall Study|Adverse Event|4|||
125585158|NCT01573910|451768160|FG001|Overall Study|Adverse Event|4|||
125585159|NCT01573910|451768159|FG000|Overall Study|Lost to Follow-up|2|||
125585160|NCT01573910|451768160|FG001|Overall Study|Lost to Follow-up|1|||
125585161|NCT01573910|451768159|FG000|Overall Study|Withdrawal by Subject|0|||
125585162|NCT01573910|451768160|FG001|Overall Study|Withdrawal by Subject|1|||
125585163|NCT01573910|451768159|FG000|Overall Study|Protocol Violation|3|||
125585164|NCT01573910|451768160|FG001|Overall Study|Protocol Violation|0|||
125585165|NCT01573910|451768159|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
125585166|NCT01573910|451768160|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
125585167|NCT01850615|451768167|FG000|Overall Study|Protocol Violation|4|||
125585168|NCT01850615|451768168|FG001|Overall Study|Protocol Violation|1|||
125585169|NCT01850615|451768167|FG000|Overall Study|Adverse Event|2|||
125585170|NCT01850615|451768168|FG001|Overall Study|Adverse Event|1|||
125585171|NCT01850615|451768167|FG000|Overall Study|Withdrawal by Subject|3|||
125585172|NCT01850615|451768168|FG001|Overall Study|Withdrawal by Subject|1|||
125585173|NCT01850615|451768167|FG000|Overall Study|Lost to Follow-up|0|||
125585174|NCT01850615|451768168|FG001|Overall Study|Lost to Follow-up|1|||
125585175|NCT01850615|451768167|FG000|Overall Study|Unclassified|0|||
125585176|NCT01850615|451768168|FG001|Overall Study|Unclassified|1|||
125585177|NCT01227967|451768169|FG000|Overall Study|Protocol Violation|3|||
125585178|NCT01227967|451768170|FG001|Overall Study|Protocol Violation|1|||
125585179|NCT01227967|451768169|FG000|Overall Study|Death|0|||
125585180|NCT01227967|451768170|FG001|Overall Study|Death|1|||
125585181|NCT01227967|451768169|FG000|Overall Study|Lost to Follow-up|8|||
125585182|NCT01227967|451768170|FG001|Overall Study|Lost to Follow-up|3|||
125585183|NCT01227967|451768169|FG000|Overall Study|Withdrawal by Subject|4|||
125585184|NCT01227967|451768170|FG001|Overall Study|Withdrawal by Subject|3|||
125585185|NCT01227967|451768169|FG000|Overall Study|Physician Decision|0|||
125585186|NCT01227967|451768170|FG001|Overall Study|Physician Decision|1|||
125585187|NCT01227967|451768169|FG000|Overall Study|Never Started Treatment|0|||
125585188|NCT01227967|451768170|FG001|Overall Study|Never Started Treatment|4|||
125585189|NCT01227967|451768169|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
125585190|NCT01227967|451768170|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
125585191|NCT01763164|451768171|FG000|Treatment Phase|Participant/Guardian decision|26|||
125585192|NCT01763164|451768172|FG001|Treatment Phase|Participant/Guardian decision|14|||
125585193|NCT01763164|451768171|FG000|Treatment Phase|Protocol Violation|1|||
125585194|NCT01763164|451768172|FG001|Treatment Phase|Protocol Violation|1|||
125585195|NCT01763164|451768171|FG000|Treatment Phase|Progressive Disease|142|||
125585196|NCT01763164|451768172|FG001|Treatment Phase|Progressive Disease|76|||
125585197|NCT01763164|451768171|FG000|Treatment Phase|Physician Decision|24|||
125585198|NCT01763164|451768172|FG001|Treatment Phase|Physician Decision|13|||
125585199|NCT01763164|451768171|FG000|Treatment Phase|Death|10|||
125585200|NCT01763164|451768172|FG001|Treatment Phase|Death|1|||
125585201|NCT01763164|451768171|FG000|Treatment Phase|Adverse Event|66|||
125585202|NCT01763164|451768172|FG001|Treatment Phase|Adverse Event|8|||
125131396|NCT03818581|450109960|FG000|Overall Study|Covid-19|2|||
125585203|NCT01763164|451768171|FG000|Treatment Phase|Randomized but not Treated|0|||
125585204|NCT01763164|451768172|FG001|Treatment Phase|Randomized but not Treated|19|||
125585205|NCT01763164|451768171|FG000|Treatment Phase|Other|0|||
125585206|NCT01763164|451768172|FG001|Treatment Phase|Other|1|||
125585207|NCT01763164|451768171|FG000|Follow up Phase|New therapy for study indication|12|||
125585208|NCT01763164|451768172|FG001|Follow up Phase|New therapy for study indication|3|||
125585209|NCT01763164|451768171|FG000|Follow up Phase|Death|21|||
125585210|NCT01763164|451768172|FG001|Follow up Phase|Death|4|||
125585211|NCT01763164|451768171|FG000|Follow up Phase|Subject/guardian decision|9|||
125585212|NCT01763164|451768172|FG001|Follow up Phase|Subject/guardian decision|2|||
125585213|NCT01763164|451768171|FG000|Follow up Phase|Progressive disease|127|||
125585214|NCT01763164|451768172|FG001|Follow up Phase|Progressive disease|62|||
125585215|NCT01763164|451768171|FG000|Follow up Phase|Physician Decision|10|||
125585216|NCT01763164|451768172|FG001|Follow up Phase|Physician Decision|3|||
125585217|NCT01763164|451768171|FG000|Follow up Phase|Lost to Follow-up|1|||
125585218|NCT01763164|451768172|FG001|Follow up Phase|Lost to Follow-up|0|||
125585219|NCT01763164|451768171|FG000|Follow up Phase|Adverse Event|17|||
125585220|NCT01763164|451768172|FG001|Follow up Phase|Adverse Event|1|||
125585221|NCT01375764|451768183|FG000|Overall Study|Lost to Follow-up|0|||
125585222|NCT01375764|451768184|FG001|Overall Study|Lost to Follow-up|1|||
125585223|NCT01375764|451768185|FG002|Overall Study|Lost to Follow-up|0|||
125585224|NCT01375764|451768186|FG003|Overall Study|Lost to Follow-up|0|||
125585225|NCT01375764|451768187|FG004|Overall Study|Lost to Follow-up|0|||
125585226|NCT01375764|451768183|FG000|Overall Study|Withdrawal by Subject|2|||
125585227|NCT01375764|451768184|FG001|Overall Study|Withdrawal by Subject|0|||
125585228|NCT01375764|451768185|FG002|Overall Study|Withdrawal by Subject|0|||
125585229|NCT01375764|451768186|FG003|Overall Study|Withdrawal by Subject|0|||
125585230|NCT01375764|451768187|FG004|Overall Study|Withdrawal by Subject|1|||
125585231|NCT01375764|451768183|FG000|Overall Study|Other|0|||
125585232|NCT01375764|451768184|FG001|Overall Study|Other|0|||
125585233|NCT01375764|451768185|FG002|Overall Study|Other|0|||
125585234|NCT01375764|451768186|FG003|Overall Study|Other|1|||
125585235|NCT01375764|451768187|FG004|Overall Study|Other|0|||
125585236|NCT03595280|451768188|FG000|Overall Study|Lost to Follow-up|6|||
125585237|NCT03595280|451768189|FG001|Overall Study|Lost to Follow-up|9|||
125585238|NCT03595280|451768190|FG002|Overall Study|Lost to Follow-up|15|||
125585239|NCT02658812|451768191|FG000|Overall Study|Disease Progression|7|||
125585240|NCT02658812|451768191|FG000|Overall Study|Unrelated to study treatment|1|||
125585241|NCT02658812|451768191|FG000|Overall Study|Adverse Event|1|||
125585242|NCT01512264|451768192|FG000|Overall Study|Lost to Follow-up|0|||
125585243|NCT01512264|451768193|FG001|Overall Study|Lost to Follow-up|0|||
125585244|NCT01512264|451768194|FG002|Overall Study|Lost to Follow-up|0|||
125585245|NCT01512264|451768195|FG003|Overall Study|Lost to Follow-up|1|||
125585246|NCT00584870|451768196|FG000|Overall Study|Adverse Event|4|||
125585247|NCT00584870|451768197|FG001|Overall Study|Adverse Event|3|||
125585248|NCT00584870|451768198|FG002|Overall Study|Adverse Event|2|||
125585249|NCT00584870|451768196|FG000|Overall Study|Lost to Follow-up|4|||
125585250|NCT00584870|451768197|FG001|Overall Study|Lost to Follow-up|1|||
125585251|NCT00584870|451768198|FG002|Overall Study|Lost to Follow-up|1|||
125585252|NCT00584870|451768196|FG000|Overall Study|Lack of Efficacy|7|||
125585253|NCT00584870|451768197|FG001|Overall Study|Lack of Efficacy|14|||
125585254|NCT00584870|451768198|FG002|Overall Study|Lack of Efficacy|8|||
125585255|NCT00584870|451768196|FG000|Overall Study|Withdrawal by Subject|10|||
125585256|NCT00584870|451768197|FG001|Overall Study|Withdrawal by Subject|5|||
125585257|NCT00584870|451768198|FG002|Overall Study|Withdrawal by Subject|3|||
125585258|NCT00584870|451768196|FG000|Overall Study|Protocol Violation|1|||
125585259|NCT00584870|451768197|FG001|Overall Study|Protocol Violation|1|||
125585260|NCT00584870|451768198|FG002|Overall Study|Protocol Violation|2|||
125362251|NCT01626456|450961071|FG000|Overall Study|Physician Decision|1|||
125585261|NCT00584870|451768196|FG000|Overall Study|Did not met entrance criteria|1|||
125585262|NCT00584870|451768197|FG001|Overall Study|Did not met entrance criteria|0|||
125362252|NCT01626456|450961072|FG001|Overall Study|Physician Decision|4|||
125362253|NCT01626456|450961071|FG000|Overall Study|Protocol Violation|1|||
125362254|NCT01626456|450961072|FG001|Overall Study|Protocol Violation|1|||
125362255|NCT01626456|450961071|FG000|Overall Study|Site Closure|2|||
125585263|NCT00584870|451768198|FG002|Overall Study|Did not met entrance criteria|0|||
125585264|NCT00584870|451768196|FG000|Overall Study|Other|2|||
125585265|NCT00584870|451768197|FG001|Overall Study|Other|0|||
125585266|NCT00584870|451768198|FG002|Overall Study|Other|0|||
125585267|NCT00584870|451768196|FG000|Overall Study|Randomized but not treated|0|||
125585268|NCT00584870|451768197|FG001|Overall Study|Randomized but not treated|1|||
125131397|NCT03818581|450109961|FG001|Overall Study|Covid-19|0|||
125585269|NCT00584870|451768198|FG002|Overall Study|Randomized but not treated|2|||
125585270|NCT01194440|451768199|FG000|Baseline (First Dose)|Reason not specified|4|||
125585271|NCT01194440|451768199|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
125585272|NCT01194440|451768199|FG000|Baseline (First Dose)|Change in therapy|1|||
125585273|NCT01194440|451768199|FG000|Baseline (First Dose)|Adverse Event|1|||
125585274|NCT01194440|451768199|FG000|6-months (2nd Dose)|Change in therapy|4|||
125585275|NCT00854828|451768200|FG000|Overall Study|Death|1|||
125585276|NCT00854828|451768201|FG001|Overall Study|Death|0|||
125585277|NCT00854828|451768202|FG002|Overall Study|Death|0|||
125585278|NCT00854828|451768203|FG003|Overall Study|Death|0|||
125585279|NCT00854828|451768200|FG000|Overall Study|Withdrawal by Subject|1|||
125585280|NCT00854828|451768201|FG001|Overall Study|Withdrawal by Subject|1|||
125585281|NCT00854828|451768202|FG002|Overall Study|Withdrawal by Subject|0|||
125585282|NCT00854828|451768203|FG003|Overall Study|Withdrawal by Subject|9|||
125585283|NCT00854828|451768200|FG000|Overall Study|Missed 24mo visit|1|||
125585284|NCT00854828|451768201|FG001|Overall Study|Missed 24mo visit|1|||
125585285|NCT00854828|451768202|FG002|Overall Study|Missed 24mo visit|8|||
125585286|NCT00854828|451768203|FG003|Overall Study|Missed 24mo visit|8|||
125585287|NCT04957290|451768205|FG000|Overall Study|Progressive disease|3|||
125585288|NCT04957290|451768206|FG001|Overall Study|Progressive disease|3|||
125585289|NCT04957290|451768207|FG002|Overall Study|Progressive disease|2|||
125585290|NCT04957290|451768208|FG003|Overall Study|Progressive disease|0|||
125585291|NCT04957290|451768209|FG004|Overall Study|Progressive disease|0|||
125585292|NCT04957290|451768210|FG005|Overall Study|Progressive disease|0|||
125585293|NCT04957290|451768205|FG000|Overall Study|Withdrawal by Subject|1|||
125585294|NCT04957290|451768206|FG001|Overall Study|Withdrawal by Subject|0|||
125585295|NCT04957290|451768207|FG002|Overall Study|Withdrawal by Subject|1|||
125362256|NCT01626456|450961072|FG001|Overall Study|Site Closure|3|||
125362257|NCT01626456|450961071|FG000|Overall Study|Incarceration|0|||
125362258|NCT01626456|450961072|FG001|Overall Study|Incarceration|2|||
125362259|NCT00506662|450961073|FG000|Overall Study|Adverse Event|0|||
125362260|NCT00506662|450961074|FG001|Overall Study|Adverse Event|2|||
125362261|NCT00506662|450961073|FG000|Overall Study|Lack of Efficacy|1|||
125362262|NCT00506662|450961074|FG001|Overall Study|Lack of Efficacy|0|||
125362263|NCT00506662|450961073|FG000|Overall Study|Protocol Violation|2|||
125362264|NCT00506662|450961074|FG001|Overall Study|Protocol Violation|4|||
125362265|NCT00506662|450961073|FG000|Overall Study|Trial terminated|10|||
125362266|NCT00506662|450961074|FG001|Overall Study|Trial terminated|16|||
125362267|NCT00506662|450961073|FG000|Overall Study|Not recorded|4|||
125362268|NCT00506662|450961074|FG001|Overall Study|Not recorded|6|||
125362269|NCT04015336|450961075|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
125362270|NCT01816074|450961080|FG000|Phase 1|Time commitment issues|0|||
125362271|NCT01816074|450961081|FG001|Phase 1|Time commitment issues|0|||
125362272|NCT01816074|450961082|FG002|Phase 1|Time commitment issues|1|||
125362273|NCT01816074|450961083|FG003|Phase 1|Time commitment issues|0|||
125362274|NCT01816074|450961080|FG000|Phase 2|Time commitment Issues|0|||
125362275|NCT01816074|450961081|FG001|Phase 2|Time commitment Issues|2|||
125362276|NCT01816074|450961082|FG002|Phase 2|Time commitment Issues|0|||
125362277|NCT01816074|450961083|FG003|Phase 2|Time commitment Issues|0|||
125362278|NCT01816074|450961080|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
125362279|NCT01816074|450961081|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
125362280|NCT01816074|450961082|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
125362281|NCT01816074|450961083|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
125362282|NCT01816074|450961080|FG000|Phase 2|Physician Decision|0|||
125362283|NCT01816074|450961081|FG001|Phase 2|Physician Decision|0|||
125362284|NCT01816074|450961082|FG002|Phase 2|Physician Decision|0|||
125362285|NCT01816074|450961083|FG003|Phase 2|Physician Decision|1|||
125362286|NCT01816074|450961080|FG000|Phase 2|Withdrawal by Subject|1|||
125362287|NCT01816074|450961081|FG001|Phase 2|Withdrawal by Subject|0|||
125362288|NCT01816074|450961082|FG002|Phase 2|Withdrawal by Subject|0|||
125362289|NCT01816074|450961083|FG003|Phase 2|Withdrawal by Subject|0|||
125362290|NCT01200524|450961085|FG000|Overall Study|Withdrawal by Subject|1|||
125362291|NCT01200524|450961086|FG001|Overall Study|Withdrawal by Subject|1|||
125362292|NCT01200524|450961087|FG002|Overall Study|Withdrawal by Subject|3|||
125362293|NCT01200524|450961085|FG000|Overall Study|Adverse Event|1|||
125362294|NCT01200524|450961086|FG001|Overall Study|Adverse Event|0|||
125362295|NCT01200524|450961087|FG002|Overall Study|Adverse Event|0|||
125362296|NCT01200524|450961085|FG000|Overall Study|Non availability of study nurse|0|||
125362297|NCT01200524|450961086|FG001|Overall Study|Non availability of study nurse|0|||
125362298|NCT01200524|450961087|FG002|Overall Study|Non availability of study nurse|1|||
125362299|NCT02476201|450961090|FG000|Overall Study|Unable to program MPP|9|||
125362300|NCT02476201|450961090|FG000|Overall Study|Study echo not performed|5|||
125428934|NCT00279201|451195549|FG004|Maintenance|Physician Decision|0|||
125585296|NCT04957290|451768208|FG003|Overall Study|Withdrawal by Subject|0|||
125585297|NCT04957290|451768209|FG004|Overall Study|Withdrawal by Subject|0|||
125585298|NCT04957290|451768210|FG005|Overall Study|Withdrawal by Subject|0|||
125362301|NCT02476201|450961090|FG000|Overall Study|Adverse Event|4|||
125362302|NCT02476201|450961090|FG000|Overall Study|Death|2|||
125362303|NCT02476201|450961090|FG000|Overall Study|Lost to Follow-up|2|||
125362304|NCT02476201|450961090|FG000|Overall Study|MPP programmed to OFF|2|||
125585299|NCT04957290|451768205|FG000|Overall Study|Death|0|||
125585300|NCT04957290|451768206|FG001|Overall Study|Death|2|||
125585301|NCT04957290|451768207|FG002|Overall Study|Death|1|||
125585302|NCT04957290|451768208|FG003|Overall Study|Death|0|||
125585303|NCT04957290|451768209|FG004|Overall Study|Death|0|||
125585304|NCT04957290|451768210|FG005|Overall Study|Death|0|||
125585305|NCT04957290|451768205|FG000|Overall Study|non compliance with study drug|0|||
125585306|NCT04957290|451768206|FG001|Overall Study|non compliance with study drug|1|||
125585307|NCT04957290|451768207|FG002|Overall Study|non compliance with study drug|0|||
125585308|NCT04957290|451768208|FG003|Overall Study|non compliance with study drug|0|||
125585309|NCT04957290|451768209|FG004|Overall Study|non compliance with study drug|0|||
125585310|NCT04957290|451768210|FG005|Overall Study|non compliance with study drug|0|||
125585311|NCT04957290|451768205|FG000|Overall Study|none specified.|0|||
125585312|NCT04957290|451768206|FG001|Overall Study|none specified.|1|||
125585313|NCT04957290|451768207|FG002|Overall Study|none specified.|2|||
125585314|NCT04957290|451768208|FG003|Overall Study|none specified.|0|||
125211815|NCT00055497|450401382|FG001|Overall Study|Withdrawal by Subject|1|||
125585315|NCT04957290|451768209|FG004|Overall Study|none specified.|0|||
125211816|NCT00055497|450401383|FG002|Overall Study|Withdrawal by Subject|1|||
125211817|NCT00055497|450401384|FG003|Overall Study|Withdrawal by Subject|15|||
125585316|NCT04957290|451768210|FG005|Overall Study|none specified.|0|||
125585317|NCT04957290|451768205|FG000|Overall Study|unacceptable toxicity|0|||
125585318|NCT04957290|451768206|FG001|Overall Study|unacceptable toxicity|0|||
125585319|NCT04957290|451768207|FG002|Overall Study|unacceptable toxicity|1|||
125585320|NCT04957290|451768208|FG003|Overall Study|unacceptable toxicity|0|||
125585321|NCT04957290|451768209|FG004|Overall Study|unacceptable toxicity|0|||
125585322|NCT04957290|451768210|FG005|Overall Study|unacceptable toxicity|0|||
125585323|NCT04957290|451768205|FG000|Overall Study|Adverse Event|0|||
125585324|NCT04957290|451768206|FG001|Overall Study|Adverse Event|0|||
125585325|NCT04957290|451768207|FG002|Overall Study|Adverse Event|1|||
125585326|NCT04957290|451768208|FG003|Overall Study|Adverse Event|0|||
125585327|NCT04957290|451768209|FG004|Overall Study|Adverse Event|0|||
125585328|NCT04957290|451768210|FG005|Overall Study|Adverse Event|0|||
125585329|NCT04957290|451768205|FG000|Overall Study|study terminated by sponsor|0|||
125585330|NCT04957290|451768206|FG001|Overall Study|study terminated by sponsor|0|||
125585331|NCT04957290|451768207|FG002|Overall Study|study terminated by sponsor|2|||
125585332|NCT04957290|451768208|FG003|Overall Study|study terminated by sponsor|0|||
125585333|NCT04957290|451768209|FG004|Overall Study|study terminated by sponsor|0|||
125585334|NCT04957290|451768210|FG005|Overall Study|study terminated by sponsor|0|||
125585335|NCT00896532|451768211|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585336|NCT00896532|451768212|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585337|NCT00896532|451768213|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125211818|NCT00055497|450401381|FG000|Overall Study|Lost to Follow-up|0|||
125211819|NCT00055497|450401382|FG001|Overall Study|Lost to Follow-up|1|||
125211820|NCT00055497|450401383|FG002|Overall Study|Lost to Follow-up|0|||
125211821|NCT00055497|450401384|FG003|Overall Study|Lost to Follow-up|5|||
125211822|NCT00055497|450401381|FG000|Overall Study|Protocol Violation|0|||
125211823|NCT00055497|450401382|FG001|Overall Study|Protocol Violation|0|||
125211824|NCT00055497|450401383|FG002|Overall Study|Protocol Violation|0|||
125211825|NCT00055497|450401384|FG003|Overall Study|Protocol Violation|3|||
125211826|NCT00055497|450401381|FG000|Overall Study|Lack of Efficacy|1|||
125211827|NCT00055497|450401382|FG001|Overall Study|Lack of Efficacy|0|||
125211828|NCT00055497|450401383|FG002|Overall Study|Lack of Efficacy|0|||
125211829|NCT00055497|450401384|FG003|Overall Study|Lack of Efficacy|27|||
125211830|NCT00055497|450401381|FG000|Overall Study|Administrative Reasons|0|||
125211831|NCT00055497|450401382|FG001|Overall Study|Administrative Reasons|0|||
125211832|NCT00055497|450401383|FG002|Overall Study|Administrative Reasons|0|||
125362305|NCT02476201|450961090|FG000|Overall Study|Withdrawal by Subject|1|||
125362306|NCT02476201|450961090|FG000|Overall Study|Unsuccessful implant|1|||
125362307|NCT00491764|450961095|FG000|Overall Study|Adverse Event|1|||
125362308|NCT00491764|450961096|FG001|Overall Study|Adverse Event|2|||
125362309|NCT00491764|450961097|FG002|Overall Study|Adverse Event|4|||
125362310|NCT00491764|450961098|FG003|Overall Study|Adverse Event|4|||
125362311|NCT00491764|450961099|FG004|Overall Study|Adverse Event|0|||
125362312|NCT00491764|450961100|FG005|Overall Study|Adverse Event|1|||
125362313|NCT00491764|450961095|FG000|Overall Study|Lost to Follow-up|0|||
125362314|NCT00491764|450961096|FG001|Overall Study|Lost to Follow-up|1|||
125362315|NCT00491764|450961097|FG002|Overall Study|Lost to Follow-up|0|||
125362316|NCT00491764|450961098|FG003|Overall Study|Lost to Follow-up|1|||
125362317|NCT00491764|450961099|FG004|Overall Study|Lost to Follow-up|0|||
125362318|NCT00491764|450961100|FG005|Overall Study|Lost to Follow-up|3|||
125211833|NCT00055497|450401384|FG003|Overall Study|Administrative Reasons|1|||
125362319|NCT00491764|450961095|FG000|Overall Study|Withdrawal by Subject|2|||
125362320|NCT00491764|450961096|FG001|Overall Study|Withdrawal by Subject|3|||
125211834|NCT00055497|450401381|FG000|Overall Study|Other|0|||
125585338|NCT00896532|451768214|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
125585339|NCT00896532|451768215|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585340|NCT00896532|451768216|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
125585341|NCT00896532|451768217|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585342|NCT00896532|451768218|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585343|NCT00896532|451768219|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585344|NCT00896532|451768220|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585345|NCT00896532|451768221|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585346|NCT00896532|451768222|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585347|NCT00896532|451768223|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585348|NCT00896532|451768224|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585349|NCT00896532|451768225|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585350|NCT00896532|451768226|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585351|NCT00896532|451768227|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585352|NCT00896532|451768228|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585353|NCT00896532|451768229|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585354|NCT00896532|451768230|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585355|NCT00896532|451768231|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585356|NCT00896532|451768232|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585357|NCT00896532|451768233|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
125585358|NCT00896532|451768211|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
125585359|NCT00896532|451768212|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
125585360|NCT00896532|451768213|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
125585361|NCT00896532|451768214|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
125585362|NCT00896532|451768215|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
125585363|NCT00896532|451768216|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
125585364|NCT00896532|451768217|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
125585365|NCT00896532|451768218|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585366|NCT00896532|451768219|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585367|NCT00896532|451768220|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585368|NCT00896532|451768221|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585369|NCT00896532|451768222|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585370|NCT00896532|451768223|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585371|NCT00896532|451768224|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585372|NCT00896532|451768225|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585373|NCT00896532|451768226|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585374|NCT00896532|451768227|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585375|NCT00896532|451768228|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585376|NCT00896532|451768229|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585377|NCT00896532|451768230|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585378|NCT00896532|451768231|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585379|NCT00896532|451768232|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585380|NCT00896532|451768233|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
125585381|NCT00896532|451768211|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
125585382|NCT00896532|451768212|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
125585383|NCT00896532|451768213|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
125585384|NCT00896532|451768214|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
125585385|NCT00896532|451768215|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
125585386|NCT00896532|451768216|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
125585387|NCT00896532|451768217|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
125585388|NCT00896532|451768218|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
125585389|NCT00896532|451768219|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585390|NCT00896532|451768220|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585391|NCT00896532|451768221|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585392|NCT00896532|451768222|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585393|NCT00896532|451768223|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585394|NCT00896532|451768224|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585395|NCT00896532|451768225|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585396|NCT00896532|451768226|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585397|NCT00896532|451768227|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585398|NCT00896532|451768228|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585399|NCT00896532|451768229|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585400|NCT00896532|451768230|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585401|NCT00896532|451768231|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585402|NCT00896532|451768232|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585403|NCT00896532|451768233|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
125585404|NCT00896532|451768211|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585405|NCT00896532|451768212|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585406|NCT00896532|451768213|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
125585407|NCT00896532|451768214|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585408|NCT00896532|451768215|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
125585409|NCT00896532|451768216|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585410|NCT00896532|451768217|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585411|NCT00896532|451768218|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585412|NCT00896532|451768219|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585413|NCT00896532|451768220|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585414|NCT00896532|451768221|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585415|NCT00896532|451768222|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585416|NCT00896532|451768223|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585417|NCT00896532|451768224|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585418|NCT00896532|451768225|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585419|NCT00896532|451768226|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585420|NCT00896532|451768227|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585421|NCT00896532|451768228|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585422|NCT00896532|451768229|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585423|NCT00896532|451768230|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585424|NCT00896532|451768231|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585425|NCT00896532|451768232|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585426|NCT00896532|451768233|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
125585427|NCT00896532|451768211|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
125585428|NCT00896532|451768212|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125362321|NCT00491764|450961097|FG002|Overall Study|Withdrawal by Subject|1|||
125362322|NCT00491764|450961098|FG003|Overall Study|Withdrawal by Subject|2|||
125362323|NCT00491764|450961099|FG004|Overall Study|Withdrawal by Subject|2|||
125362324|NCT00491764|450961100|FG005|Overall Study|Withdrawal by Subject|4|||
125362325|NCT00491764|450961095|FG000|Overall Study|Non Compliance with the Protocol|1|||
125362326|NCT00491764|450961096|FG001|Overall Study|Non Compliance with the Protocol|0|||
125585429|NCT00896532|451768213|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585430|NCT00896532|451768214|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
125362327|NCT00491764|450961097|FG002|Overall Study|Non Compliance with the Protocol|0|||
125362328|NCT00491764|450961098|FG003|Overall Study|Non Compliance with the Protocol|0|||
125362329|NCT00491764|450961099|FG004|Overall Study|Non Compliance with the Protocol|0|||
125362330|NCT00491764|450961100|FG005|Overall Study|Non Compliance with the Protocol|0|||
125362331|NCT00491764|450961095|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
125362332|NCT00491764|450961096|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
125362333|NCT00491764|450961097|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
125362334|NCT00491764|450961098|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
125362335|NCT00491764|450961099|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
125362336|NCT00491764|450961100|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
125362337|NCT00491764|450961095|FG000|Overall Study|Administrative|1|||
125362338|NCT00491764|450961096|FG001|Overall Study|Administrative|0|||
125362339|NCT00491764|450961097|FG002|Overall Study|Administrative|2|||
125362340|NCT00491764|450961098|FG003|Overall Study|Administrative|1|||
125362341|NCT00491764|450961099|FG004|Overall Study|Administrative|0|||
125362342|NCT00491764|450961100|FG005|Overall Study|Administrative|0|||
125362343|NCT00845858|450961112|FG000|Overall Study|Withdrawal by Subject|5|||
125362344|NCT00845858|450961113|FG001|Overall Study|Withdrawal by Subject|1|||
125362345|NCT00845858|450961114|FG002|Overall Study|Withdrawal by Subject|1|||
125362346|NCT00845858|450961112|FG000|Overall Study|Adverse Event|3|||
125362347|NCT00845858|450961113|FG001|Overall Study|Adverse Event|8|||
125362348|NCT00845858|450961114|FG002|Overall Study|Adverse Event|4|||
125362349|NCT00845858|450961112|FG000|Overall Study|Protocol Violation|0|||
125362350|NCT00845858|450961113|FG001|Overall Study|Protocol Violation|0|||
125362351|NCT00845858|450961114|FG002|Overall Study|Protocol Violation|1|||
125362352|NCT00845858|450961112|FG000|Overall Study|not eligible|0|||
125362353|NCT00845858|450961113|FG001|Overall Study|not eligible|3|||
125362354|NCT00845858|450961114|FG002|Overall Study|not eligible|2|||
125362355|NCT02191137|450961115|FG000|Treatment|Death|4|||
125585431|NCT00896532|451768215|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585432|NCT00896532|451768216|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585433|NCT00896532|451768217|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585434|NCT00896532|451768218|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585435|NCT00896532|451768219|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585436|NCT00896532|451768220|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585437|NCT00896532|451768221|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585438|NCT00896532|451768222|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585439|NCT00896532|451768223|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585440|NCT00896532|451768224|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585441|NCT00896532|451768225|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585442|NCT00896532|451768226|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585443|NCT00896532|451768227|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585444|NCT00896532|451768228|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585445|NCT00896532|451768229|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585446|NCT00896532|451768230|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585447|NCT00896532|451768231|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585448|NCT00896532|451768232|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585449|NCT00896532|451768233|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
125585450|NCT00896532|451768211|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585451|NCT00896532|451768212|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585452|NCT00896532|451768213|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
125585453|NCT00896532|451768214|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585454|NCT00896532|451768215|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585455|NCT00896532|451768216|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585456|NCT00896532|451768217|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585457|NCT00896532|451768218|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585458|NCT00896532|451768219|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585459|NCT00896532|451768220|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585460|NCT00896532|451768221|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585461|NCT00896532|451768222|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585462|NCT00896532|451768223|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585463|NCT00896532|451768224|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585464|NCT00896532|451768225|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585465|NCT00896532|451768226|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585466|NCT00896532|451768227|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585467|NCT00896532|451768228|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585468|NCT00896532|451768229|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585469|NCT00896532|451768230|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585470|NCT00896532|451768231|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585471|NCT00896532|451768232|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585472|NCT00896532|451768233|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
125585473|NCT00896532|451768211|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585474|NCT00896532|451768212|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585475|NCT00896532|451768213|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
125585476|NCT00896532|451768214|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585477|NCT00896532|451768215|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585478|NCT00896532|451768216|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585479|NCT00896532|451768217|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585480|NCT00896532|451768218|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585481|NCT00896532|451768219|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585482|NCT00896532|451768220|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585483|NCT00896532|451768221|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585484|NCT00896532|451768222|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585485|NCT00896532|451768223|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585486|NCT00896532|451768224|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585487|NCT00896532|451768225|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585488|NCT00896532|451768226|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585489|NCT00896532|451768227|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585490|NCT00896532|451768228|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585491|NCT00896532|451768229|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585492|NCT00896532|451768230|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585493|NCT00896532|451768231|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585494|NCT00896532|451768232|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585495|NCT00896532|451768233|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
125585496|NCT00896532|451768211|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585497|NCT00896532|451768212|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585498|NCT00896532|451768213|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585499|NCT00896532|451768214|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
125585500|NCT00896532|451768215|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585501|NCT00896532|451768216|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585502|NCT00896532|451768217|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585503|NCT00896532|451768218|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585504|NCT00896532|451768219|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585505|NCT00896532|451768220|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585506|NCT00896532|451768221|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585507|NCT00896532|451768222|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585508|NCT00896532|451768223|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585509|NCT00896532|451768224|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585510|NCT00896532|451768225|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585511|NCT00896532|451768226|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585512|NCT00896532|451768227|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585513|NCT00896532|451768228|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585514|NCT00896532|451768229|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585515|NCT00896532|451768230|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585516|NCT00896532|451768231|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585517|NCT00896532|451768232|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585518|NCT00896532|451768233|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
125585519|NCT00896532|451768211|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585520|NCT00896532|451768212|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
125585521|NCT00896532|451768213|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585522|NCT00896532|451768214|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
125585523|NCT00896532|451768215|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
125585524|NCT00896532|451768216|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585525|NCT00896532|451768217|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585526|NCT00896532|451768218|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585527|NCT00896532|451768219|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585528|NCT00896532|451768220|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585529|NCT00896532|451768221|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585530|NCT00896532|451768222|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585531|NCT00896532|451768223|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585532|NCT00896532|451768224|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585533|NCT00896532|451768225|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585534|NCT00896532|451768226|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585535|NCT00896532|451768227|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585536|NCT00896532|451768228|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585537|NCT00896532|451768229|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585538|NCT00896532|451768230|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585539|NCT00896532|451768231|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585540|NCT00896532|451768232|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585541|NCT00896532|451768233|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
125585542|NCT00896532|451768211|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585543|NCT00896532|451768212|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585544|NCT00896532|451768213|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585545|NCT00896532|451768214|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585546|NCT00896532|451768215|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585547|NCT00896532|451768216|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585548|NCT00896532|451768217|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585549|NCT00896532|451768218|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585550|NCT00896532|451768219|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
125585551|NCT00896532|451768220|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585552|NCT00896532|451768221|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585553|NCT00896532|451768222|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585554|NCT00896532|451768223|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585555|NCT00896532|451768224|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585556|NCT00896532|451768225|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585557|NCT00896532|451768226|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585558|NCT00896532|451768227|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585559|NCT00896532|451768228|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585560|NCT00896532|451768229|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585561|NCT00896532|451768230|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585562|NCT00896532|451768231|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585563|NCT00896532|451768232|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585564|NCT00896532|451768233|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
125585565|NCT00896532|451768211|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585566|NCT00896532|451768212|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585567|NCT00896532|451768213|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585568|NCT00896532|451768214|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585569|NCT00896532|451768215|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585570|NCT00896532|451768216|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585571|NCT00896532|451768217|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585572|NCT00896532|451768218|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585573|NCT00896532|451768219|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585574|NCT00896532|451768220|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585575|NCT00896532|451768221|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585576|NCT00896532|451768222|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585577|NCT00896532|451768223|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
125585578|NCT00896532|451768224|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585579|NCT00896532|451768225|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585580|NCT00896532|451768226|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585581|NCT00896532|451768227|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585582|NCT00896532|451768228|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585583|NCT00896532|451768229|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585584|NCT00896532|451768230|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585585|NCT00896532|451768231|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585586|NCT00896532|451768232|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585587|NCT00896532|451768233|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
125585588|NCT00896532|451768211|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585589|NCT00896532|451768212|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585590|NCT00896532|451768213|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585591|NCT00896532|451768214|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585592|NCT00896532|451768215|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585593|NCT00896532|451768216|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585594|NCT00896532|451768217|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585595|NCT00896532|451768218|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585596|NCT00896532|451768219|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585597|NCT00896532|451768220|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585598|NCT00896532|451768221|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
125585599|NCT00896532|451768222|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585600|NCT00896532|451768223|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
125585601|NCT00896532|451768224|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585602|NCT00896532|451768225|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585603|NCT00896532|451768226|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585604|NCT00896532|451768227|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585605|NCT00896532|451768228|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585606|NCT00896532|451768229|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585607|NCT00896532|451768230|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585608|NCT00896532|451768231|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585609|NCT00896532|451768232|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585610|NCT00896532|451768233|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
125585611|NCT00896532|451768211|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585612|NCT00896532|451768212|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125362356|NCT02191137|450961115|FG000|Treatment|Withdrawal by Subject|3|||
125585613|NCT00896532|451768213|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585614|NCT00896532|451768214|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585615|NCT00896532|451768215|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585616|NCT00896532|451768216|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585617|NCT00896532|451768217|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585618|NCT00896532|451768218|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585619|NCT00896532|451768219|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585620|NCT00896532|451768220|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585621|NCT00896532|451768221|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585622|NCT00896532|451768222|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585623|NCT00896532|451768223|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
125585624|NCT00896532|451768224|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
125585625|NCT00896532|451768225|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585626|NCT00896532|451768226|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585627|NCT00896532|451768227|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585628|NCT00896532|451768228|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585629|NCT00896532|451768229|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585630|NCT00896532|451768230|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585631|NCT00896532|451768231|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585632|NCT00896532|451768232|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585633|NCT00896532|451768233|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
125585634|NCT00896532|451768211|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
125585635|NCT00896532|451768212|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
125585636|NCT00896532|451768213|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
125585637|NCT00896532|451768214|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
125585638|NCT00896532|451768215|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
125585639|NCT00896532|451768216|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
125585640|NCT00896532|451768217|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
125585641|NCT00896532|451768218|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
125585642|NCT00896532|451768219|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
125585643|NCT00896532|451768220|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
125585644|NCT00896532|451768221|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
125585645|NCT00896532|451768222|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
125585646|NCT00896532|451768223|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
125585647|NCT00896532|451768224|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
125585648|NCT00896532|451768225|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
125585649|NCT00896532|451768226|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
125585650|NCT00896532|451768227|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
125585651|NCT00896532|451768228|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
125585652|NCT00896532|451768229|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
125585653|NCT00896532|451768230|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
125585654|NCT00896532|451768231|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
125585655|NCT00896532|451768232|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
125585656|NCT00896532|451768233|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
125585657|NCT00896532|451768211|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585658|NCT00896532|451768212|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585659|NCT00896532|451768213|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585660|NCT00896532|451768214|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585661|NCT00896532|451768215|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585662|NCT00896532|451768216|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585663|NCT00896532|451768217|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585664|NCT00896532|451768218|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585665|NCT00896532|451768219|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585666|NCT00896532|451768220|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585667|NCT00896532|451768221|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585668|NCT00896532|451768222|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585669|NCT00896532|451768223|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125362357|NCT02191137|450961115|FG000|Treatment|Adverse Event|2|||
125362358|NCT02191137|450961115|FG000|Treatment|Other|1|||
125362359|NCT02191137|450961115|FG000|Follow-up|Lost to Follow-up|2|||
125362360|NCT02191137|450961115|FG000|Follow-up|Ongoing/unknown|2|||
125362361|NCT02191137|450961115|FG000|Follow-up|Adverse Event|1|||
125362362|NCT03725852|450961122|FG000|Overall Study|Death|1|||
125585670|NCT00896532|451768224|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585671|NCT00896532|451768225|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585672|NCT00896532|451768226|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
125585673|NCT00896532|451768227|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
125585674|NCT00896532|451768228|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585675|NCT00896532|451768229|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585676|NCT00896532|451768230|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585677|NCT00896532|451768231|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585678|NCT00896532|451768232|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585679|NCT00896532|451768233|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
125585680|NCT00896532|451768211|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585681|NCT00896532|451768212|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585682|NCT00896532|451768213|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585683|NCT00896532|451768214|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585684|NCT00896532|451768215|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585685|NCT00896532|451768216|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585686|NCT00896532|451768217|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585687|NCT00896532|451768218|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585688|NCT00896532|451768219|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585689|NCT00896532|451768220|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585690|NCT00896532|451768221|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585691|NCT00896532|451768222|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585692|NCT00896532|451768223|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585693|NCT00896532|451768224|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585694|NCT00896532|451768225|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585695|NCT00896532|451768226|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
125585696|NCT00896532|451768227|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
125585697|NCT00896532|451768228|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
125585698|NCT00896532|451768229|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585699|NCT00896532|451768230|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585700|NCT00896532|451768231|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585701|NCT00896532|451768232|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585702|NCT00896532|451768233|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
125585703|NCT00896532|451768211|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585704|NCT00896532|451768212|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585705|NCT00896532|451768213|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585706|NCT00896532|451768214|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585707|NCT00896532|451768215|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585708|NCT00896532|451768216|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585709|NCT00896532|451768217|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585710|NCT00896532|451768218|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585711|NCT00896532|451768219|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585712|NCT00896532|451768220|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585713|NCT00896532|451768221|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585714|NCT00896532|451768222|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585715|NCT00896532|451768223|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585716|NCT00896532|451768224|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585717|NCT00896532|451768225|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585718|NCT00896532|451768226|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125362363|NCT03725852|450961123|FG001|Overall Study|Death|0|||
125585719|NCT00896532|451768227|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
125362364|NCT03725852|450961122|FG000|Overall Study|Withdrawal by Subject|1|||
125362365|NCT03725852|450961123|FG001|Overall Study|Withdrawal by Subject|0|||
125362366|NCT03725852|450961122|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
125585720|NCT00896532|451768228|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585721|NCT00896532|451768229|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585722|NCT00896532|451768230|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585723|NCT00896532|451768231|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585724|NCT00896532|451768232|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585725|NCT00896532|451768233|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
125585726|NCT00896532|451768211|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
125585727|NCT00896532|451768212|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
125585728|NCT00896532|451768213|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
125585729|NCT00896532|451768214|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
125585730|NCT00896532|451768215|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
125585731|NCT00896532|451768216|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
125585732|NCT00896532|451768217|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
125585733|NCT00896532|451768218|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
125585734|NCT00896532|451768219|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
125585735|NCT00896532|451768220|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
125585736|NCT00896532|451768221|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
125585737|NCT00896532|451768222|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
125585738|NCT00896532|451768223|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
125585739|NCT00896532|451768224|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
125585740|NCT00896532|451768225|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
125585741|NCT00896532|451768226|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
125585742|NCT00896532|451768227|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
125585743|NCT00896532|451768228|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
125585744|NCT00896532|451768229|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
125585745|NCT00896532|451768230|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
125585746|NCT00896532|451768231|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
125585747|NCT00896532|451768232|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
125585748|NCT00896532|451768233|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
125585749|NCT00896532|451768211|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585750|NCT00896532|451768212|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585751|NCT00896532|451768213|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585752|NCT00896532|451768214|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585753|NCT00896532|451768215|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585754|NCT00896532|451768216|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125362367|NCT03725852|450961123|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
125362368|NCT00116428|450961124|FG000|Overall Study|Withdrawal by Subject|2|||
125362369|NCT00116428|450961125|FG001|Overall Study|Withdrawal by Subject|5|||
125362370|NCT00116428|450961124|FG000|Overall Study|Did not meet inclusion criteria|1|||
125362371|NCT00116428|450961125|FG001|Overall Study|Did not meet inclusion criteria|0|||
125362372|NCT00669396|450961126|FG000|Overall Study|Lost to Follow-up|10|||
125362373|NCT00669396|450961127|FG001|Overall Study|Lost to Follow-up|12|||
125362374|NCT01297920|450961128|FG000|Overall Study|Adverse Event|42|||
125362375|NCT01297920|450961129|FG001|Overall Study|Adverse Event|10|||
125362376|NCT01297920|450961130|FG002|Overall Study|Adverse Event|38|||
125362377|NCT01297920|450961128|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
125362378|NCT01297920|450961129|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
125362379|NCT01297920|450961130|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
125362380|NCT01297920|450961128|FG000|Overall Study|Noncompliance|1|||
125362381|NCT01297920|450961129|FG001|Overall Study|Noncompliance|0|||
125362382|NCT01297920|450961130|FG002|Overall Study|Noncompliance|0|||
125585755|NCT00896532|451768217|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585756|NCT00896532|451768218|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585757|NCT00896532|451768219|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585758|NCT00896532|451768220|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585759|NCT00896532|451768221|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125362383|NCT01297920|450961128|FG000|Overall Study|Protocol Violation|1|||
125362384|NCT01297920|450961129|FG001|Overall Study|Protocol Violation|3|||
125362385|NCT01297920|450961130|FG002|Overall Study|Protocol Violation|0|||
125362386|NCT01297920|450961128|FG000|Overall Study|Inadequate Control of IOP|7|||
125362387|NCT01297920|450961129|FG001|Overall Study|Inadequate Control of IOP|9|||
125362388|NCT01297920|450961130|FG002|Overall Study|Inadequate Control of IOP|17|||
125362389|NCT01297920|450961128|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
125362390|NCT01297920|450961129|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
125362391|NCT01297920|450961130|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
125362392|NCT00474760|450961131|FG000|Overall Study|Death|0|||
125362393|NCT00474760|450961132|FG001|Overall Study|Death|0|||
125362394|NCT00474760|450961133|FG002|Overall Study|Death|0|||
125362395|NCT00474760|450961134|FG003|Overall Study|Death|0|||
125362396|NCT00474760|450961135|FG004|Overall Study|Death|2|||
125362397|NCT00474760|450961136|FG005|Overall Study|Death|0|||
125585760|NCT00896532|451768222|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585761|NCT00896532|451768223|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125362398|NCT00474760|450961137|FG006|Overall Study|Death|0|||
125362399|NCT00474760|450961131|FG000|Overall Study|Adverse Event|0|||
125362400|NCT00474760|450961132|FG001|Overall Study|Adverse Event|0|||
125362401|NCT00474760|450961133|FG002|Overall Study|Adverse Event|0|||
125362402|NCT00474760|450961134|FG003|Overall Study|Adverse Event|0|||
125362403|NCT00474760|450961135|FG004|Overall Study|Adverse Event|1|||
125362404|NCT00474760|450961136|FG005|Overall Study|Adverse Event|7|||
125362405|NCT00474760|450961137|FG006|Overall Study|Adverse Event|0|||
125362406|NCT00474760|450961131|FG000|Overall Study|Laboratory abnormality|0|||
125362407|NCT00474760|450961132|FG001|Overall Study|Laboratory abnormality|0|||
125585762|NCT00896532|451768224|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585763|NCT00896532|451768225|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585764|NCT00896532|451768226|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585765|NCT00896532|451768227|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
125585766|NCT00896532|451768228|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585767|NCT00896532|451768229|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585768|NCT00896532|451768230|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585769|NCT00896532|451768231|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585770|NCT00896532|451768232|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585771|NCT00896532|451768233|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
125585772|NCT00896532|451768211|FG000|Months 48-72: Follow-on Phase|Death|0|||
125585773|NCT00896532|451768212|FG001|Months 48-72: Follow-on Phase|Death|0|||
125585774|NCT00896532|451768213|FG002|Months 48-72: Follow-on Phase|Death|0|||
125585775|NCT00896532|451768214|FG003|Months 48-72: Follow-on Phase|Death|0|||
125585776|NCT00896532|451768215|FG004|Months 48-72: Follow-on Phase|Death|0|||
125585777|NCT00896532|451768216|FG005|Months 48-72: Follow-on Phase|Death|0|||
125585778|NCT00896532|451768217|FG006|Months 48-72: Follow-on Phase|Death|0|||
125585779|NCT00896532|451768218|FG007|Months 48-72: Follow-on Phase|Death|0|||
125585780|NCT00896532|451768219|FG008|Months 48-72: Follow-on Phase|Death|0|||
125585781|NCT00896532|451768220|FG009|Months 48-72: Follow-on Phase|Death|0|||
125585782|NCT00896532|451768221|FG010|Months 48-72: Follow-on Phase|Death|0|||
125585783|NCT00896532|451768222|FG011|Months 48-72: Follow-on Phase|Death|0|||
125585784|NCT00896532|451768223|FG012|Months 48-72: Follow-on Phase|Death|0|||
125585785|NCT00896532|451768224|FG013|Months 48-72: Follow-on Phase|Death|0|||
125585786|NCT00896532|451768225|FG014|Months 48-72: Follow-on Phase|Death|0|||
125428935|NCT00279201|451195550|FG005|Maintenance|Physician Decision|0|||
125428936|NCT00279201|451195545|FG000|Maintenance|Sponsor Decision|4|||
125428937|NCT00279201|451195546|FG001|Maintenance|Sponsor Decision|0|||
125585787|NCT00896532|451768226|FG015|Months 48-72: Follow-on Phase|Death|0|||
125585788|NCT00896532|451768227|FG016|Months 48-72: Follow-on Phase|Death|0|||
125585789|NCT00896532|451768228|FG017|Months 48-72: Follow-on Phase|Death|0|||
125362408|NCT00474760|450961133|FG002|Overall Study|Laboratory abnormality|0|||
125362409|NCT00474760|450961134|FG003|Overall Study|Laboratory abnormality|0|||
125362410|NCT00474760|450961135|FG004|Overall Study|Laboratory abnormality|0|||
125362411|NCT00474760|450961136|FG005|Overall Study|Laboratory abnormality|1|||
125428938|NCT00279201|451195547|FG002|Maintenance|Sponsor Decision|0|||
125428939|NCT00279201|451195548|FG003|Maintenance|Sponsor Decision|0|||
125428940|NCT00279201|451195549|FG004|Maintenance|Sponsor Decision|0|||
125428941|NCT00279201|451195550|FG005|Maintenance|Sponsor Decision|0|||
125585790|NCT00896532|451768229|FG018|Months 48-72: Follow-on Phase|Death|1|||
125585791|NCT00896532|451768230|FG019|Months 48-72: Follow-on Phase|Death|0|||
125585792|NCT00896532|451768231|FG020|Months 48-72: Follow-on Phase|Death|0|||
125585793|NCT00896532|451768232|FG021|Months 48-72: Follow-on Phase|Death|0|||
125585794|NCT00896532|451768233|FG022|Months 48-72: Follow-on Phase|Death|0|||
125585795|NCT00896532|451768211|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585796|NCT00896532|451768212|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585797|NCT00896532|451768213|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585798|NCT00896532|451768214|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585799|NCT00896532|451768215|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585800|NCT00896532|451768216|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125362412|NCT00474760|450961137|FG006|Overall Study|Laboratory abnormality|0|||
125362413|NCT00474760|450961131|FG000|Overall Study|Withdrawal by Subject|0|||
125362414|NCT00474760|450961132|FG001|Overall Study|Withdrawal by Subject|0|||
125362415|NCT00474760|450961133|FG002|Overall Study|Withdrawal by Subject|0|||
125585801|NCT00896532|451768217|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585802|NCT00896532|451768218|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125362416|NCT00474760|450961134|FG003|Overall Study|Withdrawal by Subject|1|||
125585803|NCT00896532|451768219|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585804|NCT00896532|451768220|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585805|NCT00896532|451768221|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585806|NCT00896532|451768222|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585807|NCT00896532|451768223|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585808|NCT00896532|451768224|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585809|NCT00896532|451768225|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585810|NCT00896532|451768226|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585811|NCT00896532|451768227|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585812|NCT00896532|451768228|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585813|NCT00896532|451768229|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585814|NCT00896532|451768230|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585815|NCT00896532|451768231|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585816|NCT00896532|451768232|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
125585817|NCT00896532|451768233|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
125585818|NCT00896532|451768211|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585819|NCT00896532|451768212|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585820|NCT00896532|451768213|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585821|NCT00896532|451768214|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585822|NCT00896532|451768215|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585823|NCT00896532|451768216|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585824|NCT00896532|451768217|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585825|NCT00896532|451768218|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585826|NCT00896532|451768219|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125362417|NCT00474760|450961135|FG004|Overall Study|Withdrawal by Subject|0|||
125362418|NCT00474760|450961136|FG005|Overall Study|Withdrawal by Subject|1|||
125362419|NCT00474760|450961137|FG006|Overall Study|Withdrawal by Subject|1|||
125362420|NCT00474760|450961131|FG000|Overall Study|Other|0|||
125585827|NCT00896532|451768220|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585828|NCT00896532|451768221|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585829|NCT00896532|451768222|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585830|NCT00896532|451768223|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585831|NCT00896532|451768224|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585832|NCT00896532|451768225|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585833|NCT00896532|451768226|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585834|NCT00896532|451768227|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585835|NCT00896532|451768228|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585836|NCT00896532|451768229|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585837|NCT00896532|451768230|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585838|NCT00896532|451768231|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585839|NCT00896532|451768232|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
125585840|NCT00896532|451768233|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
125585841|NCT02411747|451768234|FG000|Overall Study|Withdrawal by Subject|1|||
125585842|NCT02411747|451768235|FG001|Overall Study|Withdrawal by Subject|0|||
125585843|NCT02411747|451768234|FG000|Overall Study|Protocol Violation|2|||
125585844|NCT02411747|451768235|FG001|Overall Study|Protocol Violation|4|||
125585845|NCT02149810|451768236|FG000|Overall Study|Physician Decision|1|||
125585846|NCT02149810|451768237|FG001|Overall Study|Physician Decision|2|||
125585847|NCT02149810|451768236|FG000|Overall Study|Lost to Follow-up|2|||
125585848|NCT02149810|451768237|FG001|Overall Study|Lost to Follow-up|1|||
125585849|NCT02149810|451768236|FG000|Overall Study|Withdrawal by Subject|5|||
125585850|NCT02149810|451768237|FG001|Overall Study|Withdrawal by Subject|1|||
125585851|NCT01176916|451768238|FG000|Overall Study|Adverse Event|61|||
125585852|NCT01176916|451768238|FG000|Overall Study|Death|1|||
125585853|NCT01176916|451768238|FG000|Overall Study|Lost to Follow-up|15|||
125585854|NCT01176916|451768238|FG000|Overall Study|Objective progression or relapse|17|||
125585855|NCT01176916|451768238|FG000|Overall Study|Protocol Violation|24|||
125585856|NCT01176916|451768238|FG000|Overall Study|Withdrawal by Subject|37|||
125585857|NCT01176916|451768238|FG000|Overall Study|Other|6|||
125585858|NCT01176916|451768238|FG000|Overall Study|Withdrawal prior to Treatment|6|||
125585859|NCT01015833|451768241|FG000|Overall Study|Death|1|||
125585860|NCT01015833|451768242|FG001|Overall Study|Death|0|||
125585861|NCT01015833|451768241|FG000|Overall Study|Withdrawal by Subject|3|||
125585862|NCT01015833|451768242|FG001|Overall Study|Withdrawal by Subject|2|||
125585863|NCT01015833|451768241|FG000|Overall Study|Adverse Event|0|||
125585864|NCT01015833|451768242|FG001|Overall Study|Adverse Event|1|||
125585865|NCT01015833|451768241|FG000|Overall Study|Physician Decision|2|||
125362421|NCT00474760|450961132|FG001|Overall Study|Other|1|||
125585866|NCT01015833|451768242|FG001|Overall Study|Physician Decision|0|||
125585867|NCT01015833|451768241|FG000|Overall Study|Symptomatic deterioration|0|||
125585868|NCT01015833|451768242|FG001|Overall Study|Symptomatic deterioration|1|||
125585869|NCT01015833|451768241|FG000|Overall Study|Other|5|||
125585870|NCT01015833|451768242|FG001|Overall Study|Other|1|||
125585871|NCT01015833|451768241|FG000|Overall Study|Motor Vehicle Accidents|1|||
125585872|NCT01015833|451768242|FG001|Overall Study|Motor Vehicle Accidents|0|||
125585873|NCT01015833|451768241|FG000|Overall Study|Did not start treatment|1|||
125585874|NCT01015833|451768242|FG001|Overall Study|Did not start treatment|0|||
125585875|NCT00996203|451768243|FG000|Overall Study|Adverse Event|3|||
125585876|NCT00996203|451768243|FG000|Overall Study|Lost to Follow-up|1|||
125585877|NCT00996203|451768243|FG000|Overall Study|Lack of Efficacy|1|||
125585878|NCT00996203|451768243|FG000|Overall Study|Protocol Violation|2|||
125585879|NCT01671280|451768244|FG000|Overall Study|Withdrawal by Subject|2|||
125585880|NCT01959165|451768245|FG000|Overall Study|Adverse Event|0|||
125585881|NCT01959165|451768246|FG001|Overall Study|Adverse Event|0|||
125585882|NCT01959165|451768247|FG002|Overall Study|Adverse Event|0|||
125585883|NCT01959165|451768248|FG003|Overall Study|Adverse Event|1|||
125585884|NCT01959165|451768245|FG000|Overall Study|Lack of Efficacy|1|||
125585885|NCT01959165|451768246|FG001|Overall Study|Lack of Efficacy|0|||
125585886|NCT01959165|451768247|FG002|Overall Study|Lack of Efficacy|0|||
125585887|NCT01959165|451768248|FG003|Overall Study|Lack of Efficacy|0|||
125585888|NCT01959165|451768245|FG000|Overall Study|overdose|0|||
125585889|NCT01959165|451768246|FG001|Overall Study|overdose|0|||
125585890|NCT01959165|451768247|FG002|Overall Study|overdose|0|||
125585891|NCT01959165|451768248|FG003|Overall Study|overdose|1|||
125585892|NCT01959165|451768245|FG000|Overall Study|Welfare recipient|0|||
125585893|NCT01959165|451768246|FG001|Overall Study|Welfare recipient|1|||
125585894|NCT01959165|451768247|FG002|Overall Study|Welfare recipient|0|||
125585895|NCT01959165|451768248|FG003|Overall Study|Welfare recipient|0|||
125585896|NCT03686969|451768250|FG000|Overall Study|Study terminated|1|||
125585897|NCT03686969|451768251|FG001|Overall Study|Study terminated|0|||
125585898|NCT00560755|451768252|FG000|Overall Study|Protocol Violation|15|||
125585899|NCT00560755|451768252|FG000|Overall Study|Withdrawal by Subject|26|||
125585900|NCT00560755|451768252|FG000|Overall Study|Lost to Follow-up|9|||
125585901|NCT00560755|451768252|FG000|Overall Study|Adverse Event|8|||
125585902|NCT00560755|451768252|FG000|Overall Study|Physician Decision|2|||
125585903|NCT01439945|451768255|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
125585904|NCT01439945|451768256|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
125585905|NCT01439945|451768257|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
125585906|NCT01439945|451768258|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
125585907|NCT01439945|451768255|FG000|Double-Blind Treatment Phase|Ineligible|1|||
125585908|NCT01439945|451768256|FG001|Double-Blind Treatment Phase|Ineligible|2|||
125585909|NCT01439945|451768257|FG002|Double-Blind Treatment Phase|Ineligible|0|||
125585910|NCT01439945|451768258|FG003|Double-Blind Treatment Phase|Ineligible|1|||
125585911|NCT00927563|451768271|FG000|Overall Study|Lost to Follow-up|1|||
125585912|NCT00927563|451768271|FG000|Overall Study|Withdrawal by Subject|1|||
125585913|NCT01468987|451768274|FG000|Overall Study|Adverse Event|12|||
125585914|NCT01468987|451768275|FG001|Overall Study|Adverse Event|9|||
125585915|NCT01468987|451768274|FG000|Overall Study|Death|4|||
125585916|NCT01468987|451768275|FG001|Overall Study|Death|1|||
125585917|NCT01468987|451768274|FG000|Overall Study|Lost to Follow-up|10|||
125585918|NCT01468987|451768275|FG001|Overall Study|Lost to Follow-up|5|||
125585919|NCT01468987|451768274|FG000|Overall Study|Protocol Violation|8|||
125585920|NCT01468987|451768275|FG001|Overall Study|Protocol Violation|2|||
125585921|NCT01468987|451768274|FG000|Overall Study|Withdrawal by Subject|28|||
125585922|NCT01468987|451768275|FG001|Overall Study|Withdrawal by Subject|28|||
125585923|NCT01468987|451768274|FG000|Overall Study|Physician Decision|8|||
125585924|NCT01468987|451768275|FG001|Overall Study|Physician Decision|15|||
125585925|NCT01468987|451768274|FG000|Overall Study|Sponsor Decision|1|||
125585926|NCT01468987|451768275|FG001|Overall Study|Sponsor Decision|0|||
125585927|NCT05032950|451768276|FG000|Overall Study|Adverse Event|0|||
125585928|NCT05032950|451768277|FG001|Overall Study|Adverse Event|0|||
125585929|NCT05032950|451768278|FG002|Overall Study|Adverse Event|1|||
125585930|NCT05032950|451768279|FG003|Overall Study|Adverse Event|1|||
125585931|NCT05032950|451768280|FG004|Overall Study|Adverse Event|0|||
125585932|NCT05032950|451768281|FG005|Overall Study|Adverse Event|0|||
125585933|NCT02292771|451768285|FG000|Overall Study|Withdrawal by Subject|2|||
125428942|NCT00279201|451195545|FG000|Maintenance|HbA1c>7.5%|123|||
125585934|NCT02292771|451768286|FG001|Overall Study|Withdrawal by Subject|1|||
125585935|NCT02292771|451768285|FG000|Overall Study|Lost to Follow-up|2|||
125428943|NCT00279201|451195546|FG001|Maintenance|HbA1c>7.5%|126|||
125585936|NCT02292771|451768286|FG001|Overall Study|Lost to Follow-up|1|||
125585937|NCT01475734|451770471|FG000|Overall Study|Withdrawal by Subject|1|||
125585938|NCT01475734|451770472|FG001|Overall Study|Withdrawal by Subject|0|||
125585939|NCT01475734|451770471|FG000|Overall Study|Protocol Violation|1|||
125585940|NCT01475734|451770472|FG001|Overall Study|Protocol Violation|0|||
125585941|NCT01475734|451770471|FG000|Overall Study|Physician Decision|0|||
125585942|NCT01475734|451770472|FG001|Overall Study|Physician Decision|1|||
125428944|NCT00279201|451195547|FG002|Maintenance|HbA1c>7.5%|0|||
125585943|NCT00376961|451770476|FG000|Initial Registration|Adverse Event|1|||
125585944|NCT00376961|451770477|FG001|Initial Registration|Adverse Event|0|||
125585945|NCT00376961|451770476|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
125585946|NCT00376961|451770477|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
125585947|NCT00376961|451770476|FG000|Initial Registration|Progression/relapse|1|||
125585948|NCT00376961|451770477|FG001|Initial Registration|Progression/relapse|0|||
125585949|NCT00376961|451770476|FG000|Initial Registration|Ineligible|3|||
125585950|NCT00376961|451770477|FG001|Initial Registration|Ineligible|0|||
125585951|NCT00376961|451770476|FG000|Maintenance|Adverse Event|0|||
125585952|NCT00376961|451770477|FG001|Maintenance|Adverse Event|1|||
125585953|NCT00376961|451770476|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
125585954|NCT00376961|451770477|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
125585955|NCT00376961|451770476|FG000|Maintenance|Progression/relapse|0|||
125585956|NCT00376961|451770477|FG001|Maintenance|Progression/relapse|18|||
125585957|NCT00376961|451770476|FG000|Maintenance|Ineligible|0|||
125585958|NCT00376961|451770477|FG001|Maintenance|Ineligible|3|||
125585959|NCT01059448|451770478|FG000|Overall Study|Adverse Event|1|||
125585960|NCT01059448|451770479|FG001|Overall Study|Adverse Event|3|||
125585961|NCT01059448|451770480|FG002|Overall Study|Adverse Event|0|||
125585962|NCT01059448|451770481|FG003|Overall Study|Adverse Event|1|||
125585963|NCT01059448|451770478|FG000|Overall Study|Withdrawal by Subject|2|||
125585964|NCT01059448|451770479|FG001|Overall Study|Withdrawal by Subject|0|||
125585965|NCT01059448|451770480|FG002|Overall Study|Withdrawal by Subject|2|||
125585966|NCT01059448|451770481|FG003|Overall Study|Withdrawal by Subject|4|||
125585967|NCT01059448|451770478|FG000|Overall Study|Disease Progression|2|||
125585968|NCT01059448|451770479|FG001|Overall Study|Disease Progression|1|||
125585969|NCT01059448|451770480|FG002|Overall Study|Disease Progression|4|||
125585970|NCT01059448|451770481|FG003|Overall Study|Disease Progression|2|||
125585971|NCT01059448|451770478|FG000|Overall Study|Administrative Decision|43|||
125585972|NCT01059448|451770479|FG001|Overall Study|Administrative Decision|49|||
125585973|NCT01059448|451770480|FG002|Overall Study|Administrative Decision|45|||
125585974|NCT01059448|451770481|FG003|Overall Study|Administrative Decision|46|||
125585975|NCT01059448|451770478|FG000|Overall Study|Lost to Follow-up|0|||
125585976|NCT01059448|451770479|FG001|Overall Study|Lost to Follow-up|0|||
125585977|NCT01059448|451770480|FG002|Overall Study|Lost to Follow-up|2|||
125585978|NCT01059448|451770481|FG003|Overall Study|Lost to Follow-up|0|||
125585979|NCT01059448|451770478|FG000|Overall Study|Death|0|||
125585980|NCT01059448|451770479|FG001|Overall Study|Death|1|||
125585981|NCT01059448|451770480|FG002|Overall Study|Death|0|||
125585982|NCT01059448|451770481|FG003|Overall Study|Death|0|||
125585983|NCT01059448|451770478|FG000|Overall Study|Other|1|||
125585984|NCT01059448|451770479|FG001|Overall Study|Other|1|||
125585985|NCT01059448|451770480|FG002|Overall Study|Other|0|||
125585986|NCT01059448|451770481|FG003|Overall Study|Other|1|||
125585987|NCT02911688|451770482|FG000|Washout|Lost to Follow-up|1|||
125585988|NCT02911688|451770483|FG001|Washout|Lost to Follow-up|1|||
125585989|NCT02911688|451770482|FG000|Washout|Withdrawal by Subject|0|||
125585990|NCT02911688|451770483|FG001|Washout|Withdrawal by Subject|1|||
125585991|NCT00809328|451770484|FG000|Overall Study|Lack of Efficacy|18|||
125585992|NCT00809328|451770484|FG000|Overall Study|Adverse Event|6|||
125585993|NCT00809328|451770484|FG000|Overall Study|Protocol Violation|3|||
125585994|NCT00809328|451770484|FG000|Overall Study|Withdrawal by Subject|2|||
125585995|NCT05148884|451770493|FG000|Overall Study|Withdrawal by Subject|3|||
125585996|NCT05148884|451770494|FG001|Overall Study|Withdrawal by Subject|0|||
125585997|NCT05148884|451770493|FG000|Overall Study|Deep brain stimulation operation|0|||
125585998|NCT05148884|451770494|FG001|Overall Study|Deep brain stimulation operation|1|||
125585999|NCT01993888|451770495|FG000|Overall Study|Death|1|||
125586000|NCT01993888|451770496|FG001|Overall Study|Death|1|||
125586001|NCT01993888|451770495|FG000|Overall Study|Lost to Follow-up|1|||
125586002|NCT01993888|451770496|FG001|Overall Study|Lost to Follow-up|1|||
125586003|NCT01993888|451770495|FG000|Overall Study|Withdrawal by Subject|0|||
125586004|NCT01993888|451770496|FG001|Overall Study|Withdrawal by Subject|1|||
125586005|NCT00832819|451770498|FG000|Overall Study|Adverse Event|0|||
125586006|NCT00832819|451770499|FG001|Overall Study|Adverse Event|1|||
125586007|NCT00832819|451770500|FG002|Overall Study|Adverse Event|0|||
125586008|NCT00832819|451770498|FG000|Overall Study|Protocol Violation|0|||
125586009|NCT00832819|451770499|FG001|Overall Study|Protocol Violation|0|||
125211835|NCT00055497|450401382|FG001|Overall Study|Other|0|||
125211836|NCT00055497|450401383|FG002|Overall Study|Other|0|||
125211837|NCT00055497|450401384|FG003|Overall Study|Other|11|||
125428945|NCT00279201|451195548|FG003|Maintenance|HbA1c>7.5%|0|||
125586010|NCT00832819|451770500|FG002|Overall Study|Protocol Violation|1|||
125586011|NCT00317044|451770501|FG000|Overall Study|Protocol Violation|28|||
125586012|NCT00317044|451770502|FG001|Overall Study|Protocol Violation|22|||
125586013|NCT00317044|451770503|FG002|Overall Study|Protocol Violation|20|||
125586014|NCT00317044|451770501|FG000|Overall Study|Adverse Event|4|||
125586015|NCT00317044|451770502|FG001|Overall Study|Adverse Event|7|||
125586016|NCT00317044|451770503|FG002|Overall Study|Adverse Event|4|||
125586017|NCT00317044|451770501|FG000|Overall Study|Withdrawal by Subject|10|||
125586018|NCT00317044|451770502|FG001|Overall Study|Withdrawal by Subject|7|||
125586019|NCT00317044|451770503|FG002|Overall Study|Withdrawal by Subject|12|||
125586020|NCT00317044|451770501|FG000|Overall Study|Lost to Follow-up|0|||
125586021|NCT00317044|451770502|FG001|Overall Study|Lost to Follow-up|2|||
125586022|NCT00317044|451770503|FG002|Overall Study|Lost to Follow-up|3|||
125586023|NCT00317044|451770501|FG000|Overall Study|Multiple Reasons|6|||
125586024|NCT00317044|451770502|FG001|Overall Study|Multiple Reasons|2|||
125586025|NCT00317044|451770503|FG002|Overall Study|Multiple Reasons|6|||
125586026|NCT02357420|451770504|FG000|Overall Study|Adverse Event|3|||
125586027|NCT02357420|451770505|FG001|Overall Study|Adverse Event|3|||
125586028|NCT02357420|451770506|FG002|Overall Study|Adverse Event|8|||
125586029|NCT02357420|451770507|FG003|Overall Study|Adverse Event|9|||
125586030|NCT02357420|451770504|FG000|Overall Study|Investigator Decision|1|||
125586031|NCT02357420|451770505|FG001|Overall Study|Investigator Decision|0|||
125586032|NCT02357420|451770506|FG002|Overall Study|Investigator Decision|0|||
125586033|NCT02357420|451770507|FG003|Overall Study|Investigator Decision|0|||
125586034|NCT02357420|451770504|FG000|Overall Study|Prohibited Medication|1|||
125586035|NCT02357420|451770505|FG001|Overall Study|Prohibited Medication|1|||
125586036|NCT02357420|451770506|FG002|Overall Study|Prohibited Medication|0|||
125586037|NCT02357420|451770507|FG003|Overall Study|Prohibited Medication|0|||
125586038|NCT02357420|451770504|FG000|Overall Study|Protocol Non-compliance|0|||
125586039|NCT02357420|451770505|FG001|Overall Study|Protocol Non-compliance|0|||
125586040|NCT02357420|451770506|FG002|Overall Study|Protocol Non-compliance|0|||
125586041|NCT02357420|451770507|FG003|Overall Study|Protocol Non-compliance|1|||
125586042|NCT02357420|451770504|FG000|Overall Study|Withdrawn Consent|4|||
125586043|NCT02357420|451770505|FG001|Overall Study|Withdrawn Consent|8|||
125586044|NCT02357420|451770506|FG002|Overall Study|Withdrawn Consent|6|||
125586045|NCT02357420|451770507|FG003|Overall Study|Withdrawn Consent|6|||
125586046|NCT02357420|451770504|FG000|Overall Study|Lost to Follow-up|3|||
125586047|NCT02357420|451770505|FG001|Overall Study|Lost to Follow-up|0|||
125586048|NCT02357420|451770506|FG002|Overall Study|Lost to Follow-up|2|||
125586049|NCT02357420|451770507|FG003|Overall Study|Lost to Follow-up|3|||
125586050|NCT00928070|451770510|FG000|Overall Study|Lost to Follow-up|1|||
125586051|NCT00928070|451770511|FG001|Overall Study|Lost to Follow-up|2|||
125586052|NCT00928070|451770510|FG000|Overall Study|Withdrawal by Subject|10|||
125586053|NCT00928070|451770511|FG001|Overall Study|Withdrawal by Subject|3|||
125586054|NCT00928070|451770510|FG000|Overall Study|Adverse Event|14|||
125586055|NCT00928070|451770511|FG001|Overall Study|Adverse Event|26|||
125586056|NCT00928070|451770510|FG000|Overall Study|Lack of Efficacy|9|||
125586057|NCT00928070|451770511|FG001|Overall Study|Lack of Efficacy|5|||
125586058|NCT00928070|451770510|FG000|Overall Study|Did not meet entrance criteria|16|||
125586059|NCT00928070|451770511|FG001|Overall Study|Did not meet entrance criteria|9|||
125586060|NCT00928070|451770510|FG000|Overall Study|Protocol Violation|6|||
125586061|NCT00928070|451770511|FG001|Overall Study|Protocol Violation|5|||
125586062|NCT00928070|451770510|FG000|Overall Study|Randomized but not treated|2|||
125586063|NCT00928070|451770511|FG001|Overall Study|Randomized but not treated|2|||
125586064|NCT00928070|451770510|FG000|Overall Study|Other|5|||
125586065|NCT00928070|451770511|FG001|Overall Study|Other|5|||
125362422|NCT00474760|450961133|FG002|Overall Study|Other|0|||
125362423|NCT00474760|450961134|FG003|Overall Study|Other|0|||
125586066|NCT04067518|451770512|FG000|Overall Study|Adverse Event|1|||
125586067|NCT04067518|451770513|FG001|Overall Study|Adverse Event|3|||
125586068|NCT04067518|451770512|FG000|Overall Study|Screen failures|0|||
125586069|NCT04067518|451770513|FG001|Overall Study|Screen failures|1|||
125586070|NCT04067518|451770512|FG000|Overall Study|Enrolled but not treated|0|||
125586071|NCT04067518|451770513|FG001|Overall Study|Enrolled but not treated|1|||
125586072|NCT02054702|451770517|FG000|Overall Study|Lost to Follow-up|3|||
125586073|NCT02054702|451770518|FG001|Overall Study|Lost to Follow-up|5|||
125586074|NCT02054702|451770517|FG000|Overall Study|Adverse Event|3|||
125362424|NCT00474760|450961135|FG004|Overall Study|Other|1|||
125586075|NCT02054702|451770518|FG001|Overall Study|Adverse Event|1|||
125586076|NCT02054702|451770517|FG000|Overall Study|Met Withdrawal Criteria|4|||
125586077|NCT02054702|451770518|FG001|Overall Study|Met Withdrawal Criteria|1|||
125586078|NCT02054702|451770517|FG000|Overall Study|Physician Decision|0|||
125586079|NCT02054702|451770518|FG001|Overall Study|Physician Decision|1|||
125586080|NCT02054702|451770517|FG000|Overall Study|Withdrawal by Subject|14|||
125586081|NCT02054702|451770518|FG001|Overall Study|Withdrawal by Subject|4|||
125586082|NCT02318784|451770520|FG000|Overall Study|Adverse Event|13|||
125586083|NCT02318784|451770520|FG000|Overall Study|Death|2|||
125586084|NCT02318784|451770520|FG000|Overall Study|Progressive Disease|37|||
125586085|NCT02318784|451770520|FG000|Overall Study|Withdrawal by Subject|10|||
125586086|NCT00934102|451770521|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
125586087|NCT00934102|451770522|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
125586088|NCT00934102|451770523|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
125586089|NCT02304926|451770525|FG000|Overall Study|Lost to Follow-up|2|||
125362425|NCT00474760|450961136|FG005|Overall Study|Other|0|||
125586090|NCT02304926|451770526|FG001|Overall Study|Lost to Follow-up|1|||
125586091|NCT04007159|451770528|FG000|Induction Phase|(missed study visits)|16|||
125586092|NCT04007159|451770528|FG000|Induction Phase|Withdrawal by Subject|4|||
125362426|NCT00474760|450961137|FG006|Overall Study|Other|0|||
125362427|NCT00474760|450961131|FG000|Overall Study|Progressive disease|3|||
125362428|NCT00474760|450961132|FG001|Overall Study|Progressive disease|2|||
125362429|NCT00474760|450961133|FG002|Overall Study|Progressive disease|3|||
125362430|NCT00474760|450961134|FG003|Overall Study|Progressive disease|2|||
125586093|NCT04007159|451770528|FG000|Induction Phase|Adverse Event|2|||
125586094|NCT04007159|451770528|FG000|Challenge Phase|missed study visits|3|||
125586095|NCT03157531|451770529|FG000|Overall Study|Death|2|||
125586096|NCT03157531|451770529|FG000|Overall Study|Lost to Follow-up|4|||
125586097|NCT00331006|451770530|FG000|Screening Phase|Withdrawal by Subject|1|||
125586098|NCT00331006|451770530|FG000|Screening Phase|enrollment halted|1|||
125362431|NCT00474760|450961135|FG004|Overall Study|Progressive disease|8|||
125362432|NCT00474760|450961136|FG005|Overall Study|Progressive disease|20|||
125362433|NCT00474760|450961137|FG006|Overall Study|Progressive disease|7|||
125362434|NCT00474760|450961131|FG000|Overall Study|Terminated by sponsor|0|||
125362435|NCT00474760|450961132|FG001|Overall Study|Terminated by sponsor|0|||
125362436|NCT00474760|450961133|FG002|Overall Study|Terminated by sponsor|0|||
125362437|NCT00474760|450961134|FG003|Overall Study|Terminated by sponsor|0|||
125586099|NCT00331006|451770530|FG000|Screening Phase|Lost to Follow-up|1|||
125362438|NCT00474760|450961135|FG004|Overall Study|Terminated by sponsor|0|||
125586100|NCT00331006|451770530|FG000|Screening Phase|Ineligible for treatment phase|4|||
125586101|NCT00331006|451770530|FG000|Treatment Phase|Withdrawal by Subject|1|||
125586102|NCT00331006|451770530|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
125586103|NCT00331006|451770530|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
125362439|NCT00474760|450961136|FG005|Overall Study|Terminated by sponsor|0|||
125362440|NCT00474760|450961137|FG006|Overall Study|Terminated by sponsor|2|||
125362441|NCT00331422|450961140|FG000|Overall Study|Did not receive entire study regimen|5|||
125362442|NCT02345226|450961141|FG000|Double-Blind Phase|Adverse Event|5|||
125362443|NCT02345226|450961142|FG001|Double-Blind Phase|Adverse Event|6|||
125362444|NCT02345226|450961141|FG000|Double-Blind Phase|Death|3|||
125362445|NCT02345226|450961142|FG001|Double-Blind Phase|Death|0|||
125362446|NCT02345226|450961141|FG000|Double-Blind Phase|Pregnancy|0|||
125428946|NCT00279201|451195549|FG004|Maintenance|HbA1c>7.5%|0|||
125586104|NCT03804684|451770531|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
125586105|NCT03804684|451770532|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
125586106|NCT00238264|451770539|FG000|Overall Study|Death|7|||
125586107|NCT00238264|451770539|FG000|Overall Study|Lost to Follow-up|18|||
125586108|NCT00238264|451770539|FG000|Overall Study|Withdrawal by Subject|4|||
125586109|NCT00238264|451770539|FG000|Overall Study|Ineligible|7|||
125586110|NCT02706938|451770540|FG000|First Period, 6 Weeks|Adverse Event|8|||
125586111|NCT02706938|451770541|FG001|First Period, 6 Weeks|Adverse Event|0|||
125586112|NCT02706938|451770540|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
125428947|NCT00279201|451195550|FG005|Maintenance|HbA1c>7.5%|0|||
125586113|NCT02706938|451770541|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
125428948|NCT00279201|451195545|FG000|Intensification Addendum|Withdrawal by Subject|0|||
125428949|NCT00279201|451195546|FG001|Intensification Addendum|Withdrawal by Subject|0|||
125586114|NCT02706938|451770540|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
125362447|NCT02345226|450961142|FG001|Double-Blind Phase|Pregnancy|1|||
125362448|NCT02345226|450961141|FG000|Double-Blind Phase|Lack of Efficacy|1|||
125362449|NCT02345226|450961142|FG001|Double-Blind Phase|Lack of Efficacy|0|||
125362450|NCT02345226|450961141|FG000|Double-Blind Phase|Investigator's Discretion|4|||
125586115|NCT02706938|451770541|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
125586116|NCT02706938|451770540|FG000|Second Period, 6 Weeks|Adverse Event|0|||
125586117|NCT02706938|451770541|FG001|Second Period, 6 Weeks|Adverse Event|7|||
125586118|NCT02706938|451770540|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
125586119|NCT02706938|451770541|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
125586120|NCT01838044|451770542|FG000|Overall Study|Adverse Event|4|||
125586121|NCT01838044|451770543|FG001|Overall Study|Adverse Event|6|||
125586122|NCT01838044|451770542|FG000|Overall Study|Protocol Violation|3|||
125586123|NCT01838044|451770543|FG001|Overall Study|Protocol Violation|3|||
125586124|NCT01838044|451770542|FG000|Overall Study|Withdrawal by Subject|0|||
125586125|NCT01838044|451770543|FG001|Overall Study|Withdrawal by Subject|2|||
125586126|NCT01838044|451770542|FG000|Overall Study|Insufficient clinical response|1|||
125586127|NCT01838044|451770543|FG001|Overall Study|Insufficient clinical response|2|||
125586128|NCT01838044|451770542|FG000|Overall Study|Medication error without associated AE|0|||
125586129|NCT01838044|451770543|FG001|Overall Study|Medication error without associated AE|1|||
125586130|NCT01838044|451770542|FG000|Overall Study|Lost to Follow-up|0|||
125586131|NCT01838044|451770543|FG001|Overall Study|Lost to Follow-up|2|||
125586132|NCT00860470|451770547|FG000|Overall Study|Death|6|||
125586133|NCT00860470|451770548|FG001|Overall Study|Death|10|||
125586134|NCT00860470|451770547|FG000|Overall Study|Moved away|8|||
125586135|NCT00860470|451770548|FG001|Overall Study|Moved away|10|||
125586136|NCT00860470|451770547|FG000|Overall Study|Lost to Follow-up|34|||
125586137|NCT00860470|451770548|FG001|Overall Study|Lost to Follow-up|39|||
125586138|NCT01662648|451770550|FG000|Overall Study|Death|1|||
125586139|NCT01662648|451770551|FG001|Overall Study|Death|3|||
125586140|NCT01662648|451770550|FG000|Overall Study|Adverse Event|40|||
125586141|NCT01662648|451770551|FG001|Overall Study|Adverse Event|37|||
125586142|NCT01662648|451770550|FG000|Overall Study|Lack of Efficacy|17|||
125586143|NCT01662648|451770551|FG001|Overall Study|Lack of Efficacy|16|||
125586144|NCT01662648|451770550|FG000|Overall Study|Participant ineligible to continue trial|1|||
125586145|NCT01662648|451770551|FG001|Overall Study|Participant ineligible to continue trial|1|||
125586146|NCT01662648|451770550|FG000|Overall Study|Lost to Follow-up|24|||
125586147|NCT01662648|451770551|FG001|Overall Study|Lost to Follow-up|36|||
125586148|NCT01662648|451770550|FG000|Overall Study|Withdrawal by Subject|36|||
125586149|NCT01662648|451770551|FG001|Overall Study|Withdrawal by Subject|53|||
125586150|NCT01662648|451770550|FG000|Overall Study|Participant non-compliant|16|||
125586151|NCT01662648|451770551|FG001|Overall Study|Participant non-compliant|20|||
125586152|NCT01662648|451770550|FG000|Overall Study|Other|8|||
125586153|NCT01662648|451770551|FG001|Overall Study|Other|11|||
125586154|NCT01662648|451770550|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
125586155|NCT01662648|451770551|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
125586156|NCT01662648|451770550|FG000|Overall Study|LOE and other reason unspecified|1|||
125586157|NCT01662648|451770551|FG001|Overall Study|LOE and other reason unspecified|0|||
125586158|NCT01662648|451770550|FG000|Overall Study|LOE and Participant non-compliant|0|||
125586159|NCT01662648|451770551|FG001|Overall Study|LOE and Participant non-compliant|1|||
125586160|NCT02928952|451770552|FG000|Overall Study|Lost to Follow-up|5|||
125586161|NCT02928952|451770553|FG001|Overall Study|Lost to Follow-up|5|||
125586162|NCT02928952|451770552|FG000|Overall Study|Withdrawal by Subject|5|||
125586163|NCT02928952|451770553|FG001|Overall Study|Withdrawal by Subject|1|||
125586164|NCT02928952|451770552|FG000|Overall Study|Physician Decision|0|||
125586165|NCT02928952|451770553|FG001|Overall Study|Physician Decision|1|||
125586166|NCT03751111|451770554|FG000|Overall Study|Lack of Efficacy|9|||
125586167|NCT03751111|451770555|FG001|Overall Study|Lack of Efficacy|30|||
125586168|NCT03751111|451770554|FG000|Overall Study|Adverse Event|3|||
125586169|NCT03751111|451770555|FG001|Overall Study|Adverse Event|2|||
125586170|NCT00723957|451770556|FG000|Overall Study|Adverse event unrelated to study drug|1|||
125586171|NCT00723957|451770557|FG001|Overall Study|Adverse event unrelated to study drug|4|||
125586172|NCT00723957|451770556|FG000|Overall Study|Death|3|||
125586173|NCT00723957|451770557|FG001|Overall Study|Death|4|||
125586174|NCT00723957|451770556|FG000|Overall Study|Disease progression|27|||
125586175|NCT00723957|451770557|FG001|Overall Study|Disease progression|25|||
125211838|NCT00048165|450401385|FG000|Completed 6 Months Study|Administration/Other|8|||
125362451|NCT02345226|450961142|FG001|Double-Blind Phase|Investigator's Discretion|3|||
125362452|NCT02345226|450961141|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
125362453|NCT02345226|450961142|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
125362454|NCT02345226|450961141|FG000|Double-Blind Phase|Withdrew Consent|41|||
125362455|NCT02345226|450961142|FG001|Double-Blind Phase|Withdrew Consent|39|||
125586176|NCT00723957|451770556|FG000|Overall Study|Maximum clinical benefit|4|||
125586177|NCT00723957|451770557|FG001|Overall Study|Maximum clinical benefit|5|||
125586178|NCT00723957|451770556|FG000|Overall Study|Investigator decision|1|||
125586179|NCT00723957|451770557|FG001|Overall Study|Investigator decision|1|||
125586180|NCT00723957|451770556|FG000|Overall Study|Study drug toxicity|4|||
125586181|NCT00723957|451770557|FG001|Overall Study|Study drug toxicity|6|||
125586182|NCT00723957|451770556|FG000|Overall Study|Withdrawal by Subject|7|||
125586183|NCT00723957|451770557|FG001|Overall Study|Withdrawal by Subject|5|||
125586184|NCT00723957|451770556|FG000|Overall Study|Reason not analyzed|1|||
125586185|NCT00723957|451770557|FG001|Overall Study|Reason not analyzed|0|||
125586186|NCT00723957|451770556|FG000|Overall Study|Never received treatment|3|||
125586187|NCT00723957|451770557|FG001|Overall Study|Never received treatment|3|||
125586188|NCT00706628|451770559|FG000|Overall Study|Other Adverse Event|16|||
125586189|NCT00706628|451770560|FG001|Overall Study|Other Adverse Event|5|||
125586190|NCT00706628|451770561|FG002|Overall Study|Other Adverse Event|5|||
125586191|NCT00706628|451770562|FG003|Overall Study|Other Adverse Event|2|||
125586192|NCT00706628|451770559|FG000|Overall Study|Non compliant with protocol|0|||
125586193|NCT00706628|451770560|FG001|Overall Study|Non compliant with protocol|1|||
125586194|NCT00706628|451770561|FG002|Overall Study|Non compliant with protocol|0|||
125586195|NCT00706628|451770562|FG003|Overall Study|Non compliant with protocol|0|||
125586196|NCT00706628|451770559|FG000|Overall Study|Consent withdrawn|6|||
125586197|NCT00706628|451770560|FG001|Overall Study|Consent withdrawn|1|||
125586198|NCT00706628|451770561|FG002|Overall Study|Consent withdrawn|3|||
125586199|NCT00706628|451770562|FG003|Overall Study|Consent withdrawn|0|||
125586200|NCT00706628|451770559|FG000|Overall Study|Progressive disease|20|||
125586201|NCT00706628|451770560|FG001|Overall Study|Progressive disease|13|||
125586202|NCT00706628|451770561|FG002|Overall Study|Progressive disease|8|||
125586203|NCT00706628|451770562|FG003|Overall Study|Progressive disease|1|||
125586204|NCT00706628|451770559|FG000|Overall Study|Other than those stated above|4|||
125586205|NCT00706628|451770560|FG001|Overall Study|Other than those stated above|0|||
125586206|NCT00706628|451770561|FG002|Overall Study|Other than those stated above|0|||
125586207|NCT00706628|451770562|FG003|Overall Study|Other than those stated above|0|||
125586208|NCT00706628|451770559|FG000|Overall Study|Not treated|1|||
125586209|NCT00706628|451770560|FG001|Overall Study|Not treated|1|||
125586210|NCT00706628|451770561|FG002|Overall Study|Not treated|0|||
125586211|NCT00706628|451770562|FG003|Overall Study|Not treated|0|||
125586212|NCT01264939|451770563|FG000|Overall Study|Adverse Event|1|||
125586213|NCT01264939|451770564|FG001|Overall Study|Adverse Event|3|||
125586214|NCT01264939|451770563|FG000|Overall Study|Lost to Follow-up|0|||
125586215|NCT01264939|451770564|FG001|Overall Study|Lost to Follow-up|3|||
125586216|NCT01264939|451770563|FG000|Overall Study|Physician Decision|1|||
125586217|NCT01264939|451770564|FG001|Overall Study|Physician Decision|1|||
125586218|NCT01264939|451770563|FG000|Overall Study|Patient/Guardian Decision|8|||
125586219|NCT01264939|451770564|FG001|Overall Study|Patient/Guardian Decision|10|||
125586220|NCT01264939|451770563|FG000|Overall Study|Disease Progression|8|||
125586221|NCT01264939|451770564|FG001|Overall Study|Disease Progression|11|||
125586222|NCT02266433|451770569|FG000|Overall Study|Lost to Follow-up|54|||
125586223|NCT02266433|451770570|FG001|Overall Study|Lost to Follow-up|46|||
125586224|NCT02266433|451770569|FG000|Overall Study|Withdrawal by Subject|5|||
125586225|NCT02266433|451770570|FG001|Overall Study|Withdrawal by Subject|7|||
125586226|NCT04525703|451770571|FG000|Overall Study|Lost to Follow-up|6|||
125586227|NCT04525703|451770572|FG001|Overall Study|Lost to Follow-up|15|||
125586228|NCT04525703|451770573|FG002|Overall Study|Lost to Follow-up|8|||
125586229|NCT01285349|451770574|FG000|Overall Study|Lost to Follow-up|27|||
125586230|NCT01285349|451770575|FG001|Overall Study|Lost to Follow-up|20|||
125586231|NCT01285349|451770576|FG002|Overall Study|Lost to Follow-up|27|||
125586232|NCT01145560|451770577|FG000|Overall Study|Withdrawal by Subject|2|||
125586233|NCT01145560|451770578|FG001|Overall Study|Withdrawal by Subject|1|||
125586234|NCT01145560|451770579|FG002|Overall Study|Withdrawal by Subject|0|||
125586235|NCT01145560|451770577|FG000|Overall Study|Lost to Follow-up|1|||
125586236|NCT01145560|451770578|FG001|Overall Study|Lost to Follow-up|1|||
125586237|NCT01145560|451770579|FG002|Overall Study|Lost to Follow-up|1|||
125586238|NCT01145560|451770577|FG000|Overall Study|No study drug by 24h after organ failure|1|||
125586239|NCT01145560|451770578|FG001|Overall Study|No study drug by 24h after organ failure|0|||
125211839|NCT00048165|450401386|FG001|Completed 6 Months Study|Administration/Other|8|||
125211840|NCT00048165|450401385|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
125362456|NCT02345226|450961141|FG000|Double-Blind Phase|Lost to Follow-up|12|||
125362457|NCT02345226|450961142|FG001|Double-Blind Phase|Lost to Follow-up|16|||
125362458|NCT02345226|450961141|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
125586240|NCT01145560|451770579|FG002|Overall Study|No study drug by 24h after organ failure|0|||
125586241|NCT01145560|451770577|FG000|Overall Study|Accidental unblinding of study treatment|0|||
125586242|NCT01145560|451770578|FG001|Overall Study|Accidental unblinding of study treatment|1|||
125586243|NCT01145560|451770579|FG002|Overall Study|Accidental unblinding of study treatment|0|||
125586244|NCT01145560|451770577|FG000|Overall Study|False insurance information|0|||
125586245|NCT01145560|451770578|FG001|Overall Study|False insurance information|1|||
125586246|NCT01145560|451770579|FG002|Overall Study|False insurance information|0|||
125586247|NCT01145560|451770577|FG000|Overall Study|Withdrawal of therapy|0|||
125586248|NCT01145560|451770578|FG001|Overall Study|Withdrawal of therapy|0|||
125586249|NCT01145560|451770579|FG002|Overall Study|Withdrawal of therapy|1|||
125586250|NCT00712348|451770580|FG000|Overall Study|Withdrawal by Subject|1|||
125586251|NCT02452762|451770582|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
125586252|NCT02452762|451770583|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
125428950|NCT00279201|451195547|FG002|Intensification Addendum|Withdrawal by Subject|12|||
125428951|NCT00279201|451195548|FG003|Intensification Addendum|Withdrawal by Subject|14|||
125428952|NCT00279201|451195549|FG004|Intensification Addendum|Withdrawal by Subject|9|||
125428953|NCT00279201|451195550|FG005|Intensification Addendum|Withdrawal by Subject|18|||
125428954|NCT00279201|451195545|FG000|Intensification Addendum|Lost to Follow-up|0|||
125428955|NCT00279201|451195546|FG001|Intensification Addendum|Lost to Follow-up|0|||
125428956|NCT00279201|451195547|FG002|Intensification Addendum|Lost to Follow-up|4|||
125428957|NCT00279201|451195548|FG003|Intensification Addendum|Lost to Follow-up|6|||
125428958|NCT00279201|451195549|FG004|Intensification Addendum|Lost to Follow-up|7|||
125428959|NCT00279201|451195550|FG005|Intensification Addendum|Lost to Follow-up|7|||
125428960|NCT00279201|451195545|FG000|Intensification Addendum|Protocol Violation|0|||
125428961|NCT00279201|451195546|FG001|Intensification Addendum|Protocol Violation|0|||
125428962|NCT00279201|451195547|FG002|Intensification Addendum|Protocol Violation|2|||
125586253|NCT02452762|451770582|FG000|Overall Study|Withdrawal by Subject|1|||
125586254|NCT02452762|451770583|FG001|Overall Study|Withdrawal by Subject|0|||
125586255|NCT02675075|451770584|FG000|Overall Study|Lost to Follow-up|3|||
125586256|NCT02675075|451770585|FG001|Overall Study|Lost to Follow-up|0|||
125586257|NCT02292212|451770586|FG000|ViE Phase|Withdrawal by Subject|1|||
125586258|NCT02292212|451770586|FG000|ViE Phase|Protocol Violation|2|||
125586259|NCT00675597|451770587|FG000|Overall Study|Withdrawal by Subject|3|||
125586260|NCT00631137|451770588|FG000|Overall Study|Withdrawal by Subject|1|||
125586261|NCT00631137|451770589|FG001|Overall Study|Withdrawal by Subject|0|||
125428963|NCT00279201|451195548|FG003|Intensification Addendum|Protocol Violation|2|||
125586262|NCT03682120|451770590|FG000|Overall Study|Lost to Follow-up|11|||
125586263|NCT03682120|451770591|FG001|Overall Study|Lost to Follow-up|4|||
125586264|NCT03682120|451770592|FG002|Overall Study|Lost to Follow-up|5|||
125586265|NCT03682120|451770593|FG003|Overall Study|Lost to Follow-up|2|||
125586266|NCT03682120|451770590|FG000|Overall Study|Physician Decision|1|||
125586267|NCT03682120|451770591|FG001|Overall Study|Physician Decision|0|||
125586268|NCT03682120|451770592|FG002|Overall Study|Physician Decision|0|||
125586269|NCT03682120|451770593|FG003|Overall Study|Physician Decision|0|||
125586270|NCT03682120|451770590|FG000|Overall Study|Withdrawal by Subject|1|||
125586271|NCT03682120|451770591|FG001|Overall Study|Withdrawal by Subject|2|||
125586272|NCT03682120|451770592|FG002|Overall Study|Withdrawal by Subject|3|||
125586273|NCT03682120|451770593|FG003|Overall Study|Withdrawal by Subject|0|||
125586274|NCT03682120|451770590|FG000|Overall Study|Death|0|||
125586275|NCT03682120|451770591|FG001|Overall Study|Death|1|||
125586276|NCT03682120|451770592|FG002|Overall Study|Death|0|||
125586277|NCT03682120|451770593|FG003|Overall Study|Death|0|||
125586278|NCT03682120|451770590|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
125586279|NCT03682120|451770591|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
125586280|NCT03682120|451770592|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
125586281|NCT03682120|451770593|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
125586282|NCT03308188|451770594|FG000|Overall Study|Withdrawal by Subject|0|||
125586283|NCT03308188|451770595|FG001|Overall Study|Withdrawal by Subject|3|||
125586284|NCT03308188|451770594|FG000|Overall Study|Death|0|||
125586285|NCT03308188|451770595|FG001|Overall Study|Death|1|||
125586286|NCT01791855|451770596|FG000|Overall Study|Adverse Event|0|||
125586287|NCT01791855|451770597|FG001|Overall Study|Adverse Event|0|||
125586288|NCT01791855|451770598|FG002|Overall Study|Adverse Event|0|||
125586289|NCT01791855|451770599|FG003|Overall Study|Adverse Event|1|||
125586290|NCT01791855|451770596|FG000|Overall Study|Randomized, not treated|0|||
125586291|NCT01791855|451770597|FG001|Overall Study|Randomized, not treated|1|||
125586292|NCT01791855|451770598|FG002|Overall Study|Randomized, not treated|0|||
125586293|NCT01791855|451770599|FG003|Overall Study|Randomized, not treated|0|||
125586294|NCT00772447|451770600|FG000|Overall Study|Withdrawal by Subject|9|||
125586295|NCT00772447|451770601|FG001|Overall Study|Withdrawal by Subject|5|||
125428964|NCT00279201|451195549|FG004|Intensification Addendum|Protocol Violation|6|||
125586296|NCT00772447|451770600|FG000|Overall Study|Physician Decision|4|||
125586297|NCT00772447|451770601|FG001|Overall Study|Physician Decision|8|||
125586298|NCT00772447|451770600|FG000|Overall Study|Lost to Follow-up|2|||
125586299|NCT00772447|451770601|FG001|Overall Study|Lost to Follow-up|4|||
125586300|NCT00772447|451770600|FG000|Overall Study|incorrect enrolment|3|||
125586301|NCT00772447|451770601|FG001|Overall Study|incorrect enrolment|4|||
125586302|NCT00772447|451770600|FG000|Overall Study|Protocol Violation|0|||
125586303|NCT00772447|451770601|FG001|Overall Study|Protocol Violation|1|||
125586304|NCT00772447|451770600|FG000|Overall Study|all others|2|||
125586305|NCT00772447|451770601|FG001|Overall Study|all others|2|||
125586306|NCT01957137|451770602|FG000|Randomized Portion|Adverse Event|1|||
125586307|NCT01957137|451770602|FG000|Randomized Portion|Withdrawal by Subject|1|||
125586308|NCT02959814|451770604|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
125586309|NCT02959814|451770604|FG000|Overall Study|Excluded based on anatomical criteria|2|||
125586310|NCT02959814|451770604|FG000|Overall Study|Protocol Violation|7|||
125586311|NCT02959814|451770604|FG000|Overall Study|FFR not measured|2|||
125586312|NCT02959814|451770604|FG000|Overall Study|In-procedure QFR not computed|6|||
125586313|NCT02959814|451770604|FG000|Overall Study|Excluded by FFR core-lab|24|||
125586314|NCT02116621|451770605|FG000|Baseline|Withdrawal by Subject|0|||
125586315|NCT02116621|451770606|FG001|Baseline|Withdrawal by Subject|4|||
125586316|NCT02116621|451770605|FG000|Three Month Follow-up|Death|1|||
125586317|NCT02116621|451770606|FG001|Three Month Follow-up|Death|1|||
125586318|NCT02116621|451770605|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
125586319|NCT02116621|451770606|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
125586320|NCT02116621|451770605|FG000|Three Month Follow-up|Lost to Follow-up|0|||
125586321|NCT02116621|451770606|FG001|Three Month Follow-up|Lost to Follow-up|1|||
125586322|NCT02116621|451770605|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
125586323|NCT02116621|451770606|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
125586324|NCT02116621|451770605|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
125586325|NCT02116621|451770606|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
125586326|NCT02116621|451770605|FG000|Six Month Follow-up|Lost to Follow-up|2|||
125586327|NCT02116621|451770606|FG001|Six Month Follow-up|Lost to Follow-up|1|||
125586328|NCT02116621|451770605|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
125586329|NCT02116621|451770606|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
125586330|NCT02116621|451770605|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
125586331|NCT02116621|451770606|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
125586332|NCT02116621|451770605|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
125586333|NCT02116621|451770606|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
125586334|NCT02116621|451770605|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
125586335|NCT02116621|451770606|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
125586336|NCT02116621|451770605|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
125586337|NCT02116621|451770606|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
125586338|NCT00961961|451770607|FG000|Phase I|Withdrawal by Subject|7|||
125586339|NCT00961961|451770608|FG001|Phase I|Withdrawal by Subject|0|||
125586340|NCT00961961|451770609|FG002|Phase I|Withdrawal by Subject|0|||
125586341|NCT00961961|451770610|FG003|Phase I|Withdrawal by Subject|0|||
125586342|NCT00961961|451770607|FG000|Phase I|Lost to Follow-up|10|||
125586343|NCT00961961|451770608|FG001|Phase I|Lost to Follow-up|0|||
125586344|NCT00961961|451770609|FG002|Phase I|Lost to Follow-up|0|||
125586345|NCT00961961|451770610|FG003|Phase I|Lost to Follow-up|0|||
125586346|NCT00961961|451770607|FG000|Phase I|Lack of Efficacy|94|||
125586347|NCT00961961|451770608|FG001|Phase I|Lack of Efficacy|0|||
125586348|NCT00961961|451770609|FG002|Phase I|Lack of Efficacy|0|||
125586349|NCT00961961|451770610|FG003|Phase I|Lack of Efficacy|0|||
125586350|NCT00961961|451770607|FG000|Phase I|Adverse Event|7|||
125586351|NCT00961961|451770608|FG001|Phase I|Adverse Event|0|||
125586352|NCT00961961|451770609|FG002|Phase I|Adverse Event|0|||
125586353|NCT00961961|451770610|FG003|Phase I|Adverse Event|0|||
125586354|NCT00961961|451770607|FG000|Phase I|Physician Decision|8|||
125586355|NCT00961961|451770608|FG001|Phase I|Physician Decision|0|||
125586356|NCT00961961|451770609|FG002|Phase I|Physician Decision|0|||
125586357|NCT00961961|451770610|FG003|Phase I|Physician Decision|0|||
125586358|NCT00961961|451770607|FG000|Phase II|Lost to Follow-up|0|||
125586359|NCT00961961|451770608|FG001|Phase II|Lost to Follow-up|0|||
125586360|NCT00961961|451770609|FG002|Phase II|Lost to Follow-up|10|||
125586361|NCT00961961|451770610|FG003|Phase II|Lost to Follow-up|7|||
125586362|NCT00961961|451770607|FG000|Phase II|Adverse Event|0|||
125586363|NCT00961961|451770608|FG001|Phase II|Adverse Event|0|||
125586364|NCT00961961|451770609|FG002|Phase II|Adverse Event|0|||
125586365|NCT00961961|451770610|FG003|Phase II|Adverse Event|1|||
125586366|NCT00961961|451770607|FG000|Phase II|Physician Decision|0|||
125586367|NCT00961961|451770608|FG001|Phase II|Physician Decision|0|||
125586368|NCT00961961|451770609|FG002|Phase II|Physician Decision|1|||
125586369|NCT00961961|451770610|FG003|Phase II|Physician Decision|0|||
125586370|NCT00961961|451770607|FG000|Phase II|Withdrawal by Subject|0|||
125586371|NCT00961961|451770608|FG001|Phase II|Withdrawal by Subject|0|||
125586372|NCT00961961|451770609|FG002|Phase II|Withdrawal by Subject|1|||
125586373|NCT00961961|451770610|FG003|Phase II|Withdrawal by Subject|0|||
125586374|NCT03437447|451770611|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125586375|NCT03437447|451770612|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125586376|NCT03437447|451770613|FG002|Treatment Period 1|Withdrawal by Subject|1|||
125586377|NCT02764541|451770614|FG000|Overall Study|Withdrawal by Subject|0|||
125586378|NCT02764541|451770615|FG001|Overall Study|Withdrawal by Subject|0|||
125586379|NCT02764541|451770616|FG002|Overall Study|Withdrawal by Subject|0|||
125586380|NCT02764541|451770617|FG003|Overall Study|Withdrawal by Subject|0|||
125586381|NCT02764541|451770618|FG004|Overall Study|Withdrawal by Subject|1|||
125586382|NCT02764541|451770619|FG005|Overall Study|Withdrawal by Subject|1|||
125586383|NCT02764541|451770620|FG006|Overall Study|Withdrawal by Subject|0|||
125586384|NCT02764541|451770621|FG007|Overall Study|Withdrawal by Subject|1|||
125586385|NCT02764541|451770614|FG000|Overall Study|Adverse Event|1|||
125586386|NCT02764541|451770615|FG001|Overall Study|Adverse Event|0|||
125586387|NCT02764541|451770616|FG002|Overall Study|Adverse Event|0|||
125586388|NCT02764541|451770617|FG003|Overall Study|Adverse Event|0|||
125586389|NCT02764541|451770618|FG004|Overall Study|Adverse Event|0|||
125586390|NCT02764541|451770619|FG005|Overall Study|Adverse Event|0|||
125586391|NCT02764541|451770620|FG006|Overall Study|Adverse Event|1|||
125586392|NCT02764541|451770621|FG007|Overall Study|Adverse Event|0|||
125586393|NCT02764541|451770614|FG000|Overall Study|Metastasis|1|||
125586394|NCT02764541|451770615|FG001|Overall Study|Metastasis|0|||
125586395|NCT02764541|451770616|FG002|Overall Study|Metastasis|0|||
125586396|NCT02764541|451770617|FG003|Overall Study|Metastasis|0|||
125586397|NCT02764541|451770618|FG004|Overall Study|Metastasis|0|||
125586398|NCT02764541|451770619|FG005|Overall Study|Metastasis|0|||
125586399|NCT02764541|451770620|FG006|Overall Study|Metastasis|0|||
125586400|NCT02764541|451770621|FG007|Overall Study|Metastasis|0|||
125586401|NCT02764541|451770614|FG000|Overall Study|Disease progression|1|||
125586402|NCT02764541|451770615|FG001|Overall Study|Disease progression|1|||
125586403|NCT02764541|451770616|FG002|Overall Study|Disease progression|0|||
125586404|NCT02764541|451770617|FG003|Overall Study|Disease progression|0|||
125586405|NCT02764541|451770618|FG004|Overall Study|Disease progression|0|||
125586406|NCT02764541|451770619|FG005|Overall Study|Disease progression|0|||
125586407|NCT02764541|451770620|FG006|Overall Study|Disease progression|0|||
125586408|NCT02764541|451770621|FG007|Overall Study|Disease progression|1|||
125586409|NCT02764541|451770614|FG000|Overall Study|Protocol Violation|0|||
125586410|NCT02764541|451770615|FG001|Overall Study|Protocol Violation|0|||
125586411|NCT02764541|451770616|FG002|Overall Study|Protocol Violation|0|||
125586412|NCT02764541|451770617|FG003|Overall Study|Protocol Violation|1|||
125586413|NCT02764541|451770618|FG004|Overall Study|Protocol Violation|0|||
125586414|NCT02764541|451770619|FG005|Overall Study|Protocol Violation|1|||
125586415|NCT02764541|451770620|FG006|Overall Study|Protocol Violation|0|||
125586416|NCT02764541|451770621|FG007|Overall Study|Protocol Violation|0|||
125586417|NCT02764541|451770614|FG000|Overall Study|Physician Decision|0|||
125586418|NCT02764541|451770615|FG001|Overall Study|Physician Decision|0|||
125586419|NCT02764541|451770616|FG002|Overall Study|Physician Decision|0|||
125586420|NCT02764541|451770617|FG003|Overall Study|Physician Decision|1|||
125586421|NCT02764541|451770618|FG004|Overall Study|Physician Decision|0|||
125586422|NCT02764541|451770619|FG005|Overall Study|Physician Decision|0|||
125586423|NCT02764541|451770620|FG006|Overall Study|Physician Decision|0|||
125586424|NCT02764541|451770621|FG007|Overall Study|Physician Decision|1|||
125586425|NCT02764541|451770614|FG000|Overall Study|Three Cycles completed before surgery|0|||
125586426|NCT02764541|451770615|FG001|Overall Study|Three Cycles completed before surgery|0|||
125586427|NCT02764541|451770616|FG002|Overall Study|Three Cycles completed before surgery|0|||
125586428|NCT02764541|451770617|FG003|Overall Study|Three Cycles completed before surgery|1|||
125586429|NCT02764541|451770618|FG004|Overall Study|Three Cycles completed before surgery|0|||
125586430|NCT02764541|451770619|FG005|Overall Study|Three Cycles completed before surgery|0|||
125586431|NCT02764541|451770620|FG006|Overall Study|Three Cycles completed before surgery|0|||
125586432|NCT02764541|451770621|FG007|Overall Study|Three Cycles completed before surgery|0|||
125586433|NCT02764541|451770614|FG000|Overall Study|Patient Compliance|0|||
125586434|NCT02764541|451770615|FG001|Overall Study|Patient Compliance|0|||
125586435|NCT02764541|451770616|FG002|Overall Study|Patient Compliance|1|||
125586436|NCT02764541|451770617|FG003|Overall Study|Patient Compliance|0|||
125586437|NCT02764541|451770618|FG004|Overall Study|Patient Compliance|0|||
125586438|NCT02764541|451770619|FG005|Overall Study|Patient Compliance|0|||
125586439|NCT02764541|451770620|FG006|Overall Study|Patient Compliance|0|||
125586440|NCT02764541|451770621|FG007|Overall Study|Patient Compliance|0|||
125586441|NCT02764541|451770614|FG000|Overall Study|Death|0|||
125586442|NCT02764541|451770615|FG001|Overall Study|Death|0|||
125586443|NCT02764541|451770616|FG002|Overall Study|Death|0|||
125586444|NCT02764541|451770617|FG003|Overall Study|Death|0|||
125586445|NCT02764541|451770618|FG004|Overall Study|Death|0|||
125586446|NCT02764541|451770619|FG005|Overall Study|Death|0|||
125586447|NCT02764541|451770620|FG006|Overall Study|Death|1|||
125586448|NCT02764541|451770621|FG007|Overall Study|Death|0|||
125586449|NCT02764541|451770614|FG000|Overall Study|Insurance reasons|0|||
125586450|NCT02764541|451770615|FG001|Overall Study|Insurance reasons|0|||
125586451|NCT02764541|451770616|FG002|Overall Study|Insurance reasons|0|||
125586452|NCT02764541|451770617|FG003|Overall Study|Insurance reasons|0|||
125586453|NCT02764541|451770618|FG004|Overall Study|Insurance reasons|0|||
125586454|NCT02764541|451770619|FG005|Overall Study|Insurance reasons|0|||
125586455|NCT02764541|451770620|FG006|Overall Study|Insurance reasons|1|||
125586456|NCT02764541|451770621|FG007|Overall Study|Insurance reasons|0|||
125586457|NCT00749190|451770622|FG000|Overall Study|Adverse Event|0|||
125586458|NCT00749190|451770623|FG001|Overall Study|Adverse Event|2|||
125586459|NCT00749190|451770624|FG002|Overall Study|Adverse Event|0|||
125586460|NCT00749190|451770625|FG003|Overall Study|Adverse Event|4|||
125586461|NCT00749190|451770626|FG004|Overall Study|Adverse Event|0|||
125586462|NCT00749190|451770627|FG005|Overall Study|Adverse Event|3|||
125586463|NCT00749190|451770628|FG006|Overall Study|Adverse Event|0|||
125586464|NCT00749190|451770622|FG000|Overall Study|Lack of Efficacy|3|||
125586465|NCT00749190|451770623|FG001|Overall Study|Lack of Efficacy|1|||
125586466|NCT00749190|451770624|FG002|Overall Study|Lack of Efficacy|1|||
125586467|NCT00749190|451770625|FG003|Overall Study|Lack of Efficacy|0|||
125586468|NCT00749190|451770626|FG004|Overall Study|Lack of Efficacy|0|||
125586469|NCT00749190|451770627|FG005|Overall Study|Lack of Efficacy|1|||
125586470|NCT00749190|451770628|FG006|Overall Study|Lack of Efficacy|0|||
125586471|NCT00749190|451770622|FG000|Overall Study|Withdrawal by Subject|2|||
125586472|NCT00749190|451770623|FG001|Overall Study|Withdrawal by Subject|1|||
125586473|NCT00749190|451770624|FG002|Overall Study|Withdrawal by Subject|0|||
125586474|NCT00749190|451770625|FG003|Overall Study|Withdrawal by Subject|0|||
125586475|NCT00749190|451770626|FG004|Overall Study|Withdrawal by Subject|0|||
125586476|NCT00749190|451770627|FG005|Overall Study|Withdrawal by Subject|1|||
125586477|NCT00749190|451770628|FG006|Overall Study|Withdrawal by Subject|0|||
125586478|NCT00749190|451770622|FG000|Overall Study|Protocol Violation|0|||
125586479|NCT00749190|451770623|FG001|Overall Study|Protocol Violation|1|||
125586480|NCT00749190|451770624|FG002|Overall Study|Protocol Violation|0|||
125586481|NCT00749190|451770625|FG003|Overall Study|Protocol Violation|0|||
125586482|NCT00749190|451770626|FG004|Overall Study|Protocol Violation|0|||
125586483|NCT00749190|451770627|FG005|Overall Study|Protocol Violation|0|||
125586484|NCT00749190|451770628|FG006|Overall Study|Protocol Violation|1|||
125586485|NCT00749190|451770622|FG000|Overall Study|Other reason not defined above|0|||
125586486|NCT00749190|451770623|FG001|Overall Study|Other reason not defined above|0|||
125586487|NCT00749190|451770624|FG002|Overall Study|Other reason not defined above|0|||
125586488|NCT00749190|451770625|FG003|Overall Study|Other reason not defined above|1|||
125586489|NCT00749190|451770626|FG004|Overall Study|Other reason not defined above|0|||
125586490|NCT00749190|451770627|FG005|Overall Study|Other reason not defined above|0|||
125586491|NCT00749190|451770628|FG006|Overall Study|Other reason not defined above|0|||
125586492|NCT01245673|451770629|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
125586493|NCT00355121|451770631|FG000|Overall Study|Did not receive study vaccine|1|||
125586494|NCT00355121|451770632|FG001|Overall Study|Did not receive study vaccine|0|||
125586495|NCT00355121|451770633|FG002|Overall Study|Did not receive study vaccine|1|||
125586496|NCT00355121|451770631|FG000|Overall Study|Adverse Event|0|||
125586497|NCT00355121|451770632|FG001|Overall Study|Adverse Event|1|||
125586498|NCT00355121|451770633|FG002|Overall Study|Adverse Event|0|||
125586499|NCT00355121|451770631|FG000|Overall Study|Protocol Violation|7|||
125586500|NCT00355121|451770632|FG001|Overall Study|Protocol Violation|9|||
125586501|NCT00355121|451770633|FG002|Overall Study|Protocol Violation|1|||
125586502|NCT00355121|451770631|FG000|Overall Study|Lost to Follow-up|4|||
125586503|NCT00355121|451770632|FG001|Overall Study|Lost to Follow-up|7|||
125586504|NCT00355121|451770633|FG002|Overall Study|Lost to Follow-up|1|||
125586505|NCT00355121|451770631|FG000|Overall Study|Withdrawal by Subject|9|||
125586506|NCT00355121|451770632|FG001|Overall Study|Withdrawal by Subject|10|||
125586507|NCT00355121|451770633|FG002|Overall Study|Withdrawal by Subject|2|||
125586508|NCT00355121|451770631|FG000|Overall Study|Serious adverse events|0|||
125586509|NCT00355121|451770632|FG001|Overall Study|Serious adverse events|2|||
125586510|NCT00355121|451770633|FG002|Overall Study|Serious adverse events|0|||
125586511|NCT00630331|451770635|FG000|Overall Study|Death|2|||
125586512|NCT00630331|451770636|FG001|Overall Study|Death|1|||
125586513|NCT00630331|451770637|FG002|Overall Study|Death|1|||
125586514|NCT00630331|451770635|FG000|Overall Study|Adverse Event|1|||
125586515|NCT00630331|451770636|FG001|Overall Study|Adverse Event|0|||
125586516|NCT00630331|451770637|FG002|Overall Study|Adverse Event|0|||
125586517|NCT00630331|451770635|FG000|Overall Study|Withdrawal by Subject|12|||
125586518|NCT00630331|451770636|FG001|Overall Study|Withdrawal by Subject|7|||
125586519|NCT00630331|451770637|FG002|Overall Study|Withdrawal by Subject|5|||
125586520|NCT00630331|451770635|FG000|Overall Study|Lost to Follow-up|175|||
125586521|NCT00630331|451770636|FG001|Overall Study|Lost to Follow-up|143|||
125586522|NCT00630331|451770637|FG002|Overall Study|Lost to Follow-up|170|||
125586523|NCT00630331|451770635|FG000|Overall Study|Inappropriate enrollment|3|||
125586524|NCT00630331|451770636|FG001|Overall Study|Inappropriate enrollment|6|||
125586525|NCT00630331|451770637|FG002|Overall Study|Inappropriate enrollment|3|||
125586526|NCT00630331|451770635|FG000|Overall Study|Unable to classify|9|||
125586527|NCT00630331|451770636|FG001|Overall Study|Unable to classify|4|||
125586528|NCT00630331|451770637|FG002|Overall Study|Unable to classify|3|||
125586529|NCT00630331|451770635|FG000|Overall Study|Protocol Violation|4|||
125586530|NCT00630331|451770636|FG001|Overall Study|Protocol Violation|5|||
125586531|NCT00630331|451770637|FG002|Overall Study|Protocol Violation|6|||
125586532|NCT04640766|451770639|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
125586533|NCT01565980|451770640|FG000|Overall Study|Death|1|||
125586534|NCT01565980|451770641|FG001|Overall Study|Death|0|||
125586535|NCT01565980|451770640|FG000|Overall Study|Lost to Follow-up|1|||
125586536|NCT01565980|451770641|FG001|Overall Study|Lost to Follow-up|0|||
125586537|NCT01565980|451770640|FG000|Overall Study|health complications|1|||
125586538|NCT01565980|451770641|FG001|Overall Study|health complications|1|||
125586539|NCT01565980|451770640|FG000|Overall Study|stopped medical treatment|1|||
125586540|NCT01565980|451770641|FG001|Overall Study|stopped medical treatment|0|||
125586541|NCT01565980|451770640|FG000|Overall Study|Withdrawal by Subject|0|||
125586542|NCT01565980|451770641|FG001|Overall Study|Withdrawal by Subject|3|||
125586543|NCT01929135|451770645|FG000|Overall Study|Lost to Follow-up|1|||
125586544|NCT01929135|451770646|FG001|Overall Study|Lost to Follow-up|1|||
125586545|NCT02425098|451770647|FG000|Overall Study|Lost to Follow-up|7|||
125586546|NCT02425098|451770648|FG001|Overall Study|Lost to Follow-up|7|||
125586547|NCT02425098|451770647|FG000|Overall Study|Withdrawal by Subject|4|||
125586548|NCT02425098|451770648|FG001|Overall Study|Withdrawal by Subject|8|||
125586549|NCT02425098|451770647|FG000|Overall Study|Pregnancy|2|||
125586550|NCT02425098|451770648|FG001|Overall Study|Pregnancy|0|||
125586551|NCT02425098|451770647|FG000|Overall Study|Reason not Specified|0|||
125586552|NCT02425098|451770648|FG001|Overall Study|Reason not Specified|1|||
125586553|NCT02078219|451770654|FG000|Overall Study|Other|2|||
125586554|NCT02078219|451770655|FG001|Overall Study|Other|2|||
125586555|NCT02078219|451770656|FG002|Overall Study|Other|3|||
125586556|NCT02078219|451770657|FG003|Overall Study|Other|0|||
125586557|NCT02078219|451770658|FG004|Overall Study|Other|1|||
125586558|NCT02078219|451770654|FG000|Overall Study|Withdrawal by Subject|0|||
125586559|NCT02078219|451770655|FG001|Overall Study|Withdrawal by Subject|1|||
125586560|NCT02078219|451770656|FG002|Overall Study|Withdrawal by Subject|0|||
125586561|NCT02078219|451770657|FG003|Overall Study|Withdrawal by Subject|1|||
125586562|NCT02078219|451770658|FG004|Overall Study|Withdrawal by Subject|1|||
125586563|NCT02078219|451770654|FG000|Overall Study|Protocol Violation|0|||
125586564|NCT02078219|451770655|FG001|Overall Study|Protocol Violation|0|||
125586565|NCT02078219|451770656|FG002|Overall Study|Protocol Violation|0|||
125586566|NCT02078219|451770657|FG003|Overall Study|Protocol Violation|1|||
125586567|NCT02078219|451770658|FG004|Overall Study|Protocol Violation|0|||
125586568|NCT02078219|451770654|FG000|Overall Study|Death|0|||
125586569|NCT02078219|451770655|FG001|Overall Study|Death|0|||
125586570|NCT02078219|451770656|FG002|Overall Study|Death|0|||
125586571|NCT02078219|451770657|FG003|Overall Study|Death|1|||
125586572|NCT02078219|451770658|FG004|Overall Study|Death|0|||
125586573|NCT02078219|451770654|FG000|Overall Study|Adverse Event|1|||
125586574|NCT02078219|451770655|FG001|Overall Study|Adverse Event|1|||
125586575|NCT02078219|451770656|FG002|Overall Study|Adverse Event|3|||
125586576|NCT02078219|451770657|FG003|Overall Study|Adverse Event|1|||
125586577|NCT02078219|451770658|FG004|Overall Study|Adverse Event|0|||
125586578|NCT03283085|451770665|FG000|Overall Study|Adverse Event|18|||
125586579|NCT03283085|451770666|FG001|Overall Study|Adverse Event|3|||
125586580|NCT03283085|451770667|FG002|Overall Study|Adverse Event|13|||
125586581|NCT03283085|451770668|FG003|Overall Study|Adverse Event|0|||
125586582|NCT03283085|451770669|FG004|Overall Study|Adverse Event|0|||
125586583|NCT03283085|451770670|FG005|Overall Study|Adverse Event|5|||
125586584|NCT03283085|451770665|FG000|Overall Study|Death|0|||
125586585|NCT03283085|451770666|FG001|Overall Study|Death|0|||
125586586|NCT03283085|451770667|FG002|Overall Study|Death|3|||
125586587|NCT03283085|451770668|FG003|Overall Study|Death|1|||
125586588|NCT03283085|451770669|FG004|Overall Study|Death|0|||
125586589|NCT03283085|451770670|FG005|Overall Study|Death|0|||
125586590|NCT03283085|451770665|FG000|Overall Study|Withdrawal by Subject|42|||
125586591|NCT03283085|451770666|FG001|Overall Study|Withdrawal by Subject|21|||
125586592|NCT03283085|451770667|FG002|Overall Study|Withdrawal by Subject|66|||
125586593|NCT03283085|451770668|FG003|Overall Study|Withdrawal by Subject|3|||
125586594|NCT03283085|451770669|FG004|Overall Study|Withdrawal by Subject|3|||
125586595|NCT03283085|451770670|FG005|Overall Study|Withdrawal by Subject|5|||
125586596|NCT03283085|451770665|FG000|Overall Study|Physician Decision|14|||
125586597|NCT03283085|451770666|FG001|Overall Study|Physician Decision|8|||
125586598|NCT03283085|451770667|FG002|Overall Study|Physician Decision|19|||
125586599|NCT03283085|451770668|FG003|Overall Study|Physician Decision|0|||
125586600|NCT03283085|451770669|FG004|Overall Study|Physician Decision|0|||
125586601|NCT03283085|451770670|FG005|Overall Study|Physician Decision|2|||
125586602|NCT03283085|451770665|FG000|Overall Study|Site Terminated by Sponsor|1|||
125586603|NCT03283085|451770666|FG001|Overall Study|Site Terminated by Sponsor|0|||
125586604|NCT03283085|451770667|FG002|Overall Study|Site Terminated by Sponsor|3|||
125586605|NCT03283085|451770668|FG003|Overall Study|Site Terminated by Sponsor|0|||
125586606|NCT03283085|451770669|FG004|Overall Study|Site Terminated by Sponsor|0|||
125586607|NCT03283085|451770670|FG005|Overall Study|Site Terminated by Sponsor|0|||
125586608|NCT03283085|451770665|FG000|Overall Study|Lost to Follow-up|2|||
125586609|NCT03283085|451770666|FG001|Overall Study|Lost to Follow-up|0|||
125586610|NCT03283085|451770667|FG002|Overall Study|Lost to Follow-up|2|||
125586611|NCT03283085|451770668|FG003|Overall Study|Lost to Follow-up|0|||
125586612|NCT03283085|451770669|FG004|Overall Study|Lost to Follow-up|0|||
125586613|NCT03283085|451770670|FG005|Overall Study|Lost to Follow-up|1|||
125586614|NCT03283085|451770665|FG000|Overall Study|Pregnancy|0|||
125586615|NCT03283085|451770666|FG001|Overall Study|Pregnancy|0|||
125586616|NCT03283085|451770667|FG002|Overall Study|Pregnancy|1|||
125586617|NCT03283085|451770668|FG003|Overall Study|Pregnancy|0|||
125586618|NCT03283085|451770669|FG004|Overall Study|Pregnancy|0|||
125586619|NCT03283085|451770670|FG005|Overall Study|Pregnancy|0|||
125586620|NCT03283085|451770665|FG000|Overall Study|Lack of Efficacy|12|||
125586621|NCT03283085|451770666|FG001|Overall Study|Lack of Efficacy|6|||
125586622|NCT03283085|451770667|FG002|Overall Study|Lack of Efficacy|24|||
125586623|NCT03283085|451770668|FG003|Overall Study|Lack of Efficacy|1|||
125586624|NCT03283085|451770669|FG004|Overall Study|Lack of Efficacy|1|||
125586625|NCT03283085|451770670|FG005|Overall Study|Lack of Efficacy|0|||
125586626|NCT03283085|451770665|FG000|Overall Study|Reason not Specified|0|||
125586627|NCT03283085|451770666|FG001|Overall Study|Reason not Specified|4|||
125586628|NCT03283085|451770667|FG002|Overall Study|Reason not Specified|8|||
125586629|NCT03283085|451770668|FG003|Overall Study|Reason not Specified|0|||
125586630|NCT03283085|451770669|FG004|Overall Study|Reason not Specified|0|||
125586631|NCT03283085|451770670|FG005|Overall Study|Reason not Specified|1|||
125586632|NCT03136107|451770671|FG000|Overall Study|Other (Not specified)|1|||
125586633|NCT00851903|451772473|FG000|Overall Study|Withdrawal by Subject|2|||
125586634|NCT02300129|451772474|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
125586635|NCT02300129|451772475|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
125586636|NCT02300129|451772476|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
125586637|NCT02300129|451772477|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
125586638|NCT02300129|451772474|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
125586639|NCT02300129|451772475|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
125586640|NCT02300129|451772476|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
125586641|NCT02300129|451772477|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
125586642|NCT02300129|451772474|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
125586643|NCT02300129|451772475|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
125586644|NCT02300129|451772476|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
125586645|NCT02300129|451772477|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
125586646|NCT00522392|451772480|FG000|Overall Study|Disease progression|0|||
125586647|NCT00522392|451772481|FG001|Overall Study|Disease progression|3|||
125586648|NCT00522392|451772480|FG000|Overall Study|Adverse Event|7|||
125586649|NCT00522392|451772481|FG001|Overall Study|Adverse Event|7|||
125586650|NCT00522392|451772480|FG000|Overall Study|Withdrawal by Subject|1|||
125586651|NCT00522392|451772481|FG001|Overall Study|Withdrawal by Subject|1|||
125586652|NCT00522392|451772480|FG000|Overall Study|Physician Decision|0|||
125586653|NCT00522392|451772481|FG001|Overall Study|Physician Decision|1|||
125586654|NCT00522392|451772480|FG000|Overall Study|Non-compliance|0|||
125586655|NCT00522392|451772481|FG001|Overall Study|Non-compliance|1|||
125586656|NCT05211336|451772488|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
125586657|NCT05211336|451772489|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
125586658|NCT05211336|451772488|FG000|Overall Study|Progressive disease|0|||
125586659|NCT05211336|451772489|FG001|Overall Study|Progressive disease|4|||
125586660|NCT05211336|451772488|FG000|Overall Study|Death due to myocardial infarction|0|||
125586661|NCT05211336|451772489|FG001|Overall Study|Death due to myocardial infarction|1|||
125586662|NCT05211336|451772488|FG000|Overall Study|Death due to unknown cause|0|||
125586663|NCT05211336|451772489|FG001|Overall Study|Death due to unknown cause|1|||
125586664|NCT05211336|451772488|FG000|Overall Study|Worsening kidney function and quality of response|0|||
125586665|NCT05211336|451772489|FG001|Overall Study|Worsening kidney function and quality of response|1|||
125586666|NCT00332709|451772495|FG000|Overall Study|Adverse Event|11|||
125586667|NCT00332709|451772496|FG001|Overall Study|Adverse Event|14|||
125586668|NCT00332709|451772495|FG000|Overall Study|Withdrawal by Subject|2|||
125586669|NCT00332709|451772496|FG001|Overall Study|Withdrawal by Subject|3|||
125428965|NCT00279201|451195550|FG005|Intensification Addendum|Protocol Violation|6|||
125586670|NCT00332709|451772495|FG000|Overall Study|Lost to Follow-up|2|||
125586671|NCT00332709|451772496|FG001|Overall Study|Lost to Follow-up|0|||
125586672|NCT00332709|451772495|FG000|Overall Study|Administrative Problems|0|||
125586673|NCT00332709|451772496|FG001|Overall Study|Administrative Problems|3|||
125586674|NCT00332709|451772495|FG000|Overall Study|Abnormal test procedure result|1|||
125586675|NCT00332709|451772496|FG001|Overall Study|Abnormal test procedure result|0|||
125586676|NCT03575104|451772497|FG000|Overall Study|Adverse Event|4|||
125586677|NCT03575104|451772498|FG001|Overall Study|Adverse Event|3|||
125586678|NCT03575104|451772499|FG002|Overall Study|Adverse Event|4|||
125586679|NCT03575104|451772497|FG000|Overall Study|Withdrawal by Subject|13|||
125586680|NCT03575104|451772498|FG001|Overall Study|Withdrawal by Subject|16|||
125586681|NCT03575104|451772499|FG002|Overall Study|Withdrawal by Subject|11|||
125586682|NCT03575104|451772497|FG000|Overall Study|Other reasons|6|||
125586683|NCT03575104|451772498|FG001|Overall Study|Other reasons|8|||
125586684|NCT03575104|451772499|FG002|Overall Study|Other reasons|6|||
125586685|NCT03575104|451772497|FG000|Overall Study|Lost to Follow-up|1|||
125586686|NCT03575104|451772498|FG001|Overall Study|Lost to Follow-up|2|||
125586687|NCT03575104|451772499|FG002|Overall Study|Lost to Follow-up|1|||
125586688|NCT01409928|451772501|FG000|Overall Study|Physician Decision|12|||
125586689|NCT00432237|451772504|FG000|Overall Study|Adverse Event|0|||
125586690|NCT00432237|451772505|FG001|Overall Study|Adverse Event|0|||
125586691|NCT00432237|451772506|FG002|Overall Study|Adverse Event|0|||
125586692|NCT00432237|451772507|FG003|Overall Study|Adverse Event|1|||
125586693|NCT00432237|451772504|FG000|Overall Study|Lack of Efficacy|0|||
125586694|NCT00432237|451772505|FG001|Overall Study|Lack of Efficacy|0|||
125586695|NCT00432237|451772506|FG002|Overall Study|Lack of Efficacy|0|||
125586696|NCT00432237|451772507|FG003|Overall Study|Lack of Efficacy|1|||
125586697|NCT00432237|451772504|FG000|Overall Study|Lost to Follow-up|10|||
125586698|NCT00432237|451772505|FG001|Overall Study|Lost to Follow-up|10|||
125586699|NCT00432237|451772506|FG002|Overall Study|Lost to Follow-up|18|||
125586700|NCT00432237|451772507|FG003|Overall Study|Lost to Follow-up|18|||
125586701|NCT00432237|451772504|FG000|Overall Study|Physician Decision|1|||
125586702|NCT00432237|451772505|FG001|Overall Study|Physician Decision|3|||
125586703|NCT00432237|451772506|FG002|Overall Study|Physician Decision|2|||
125586704|NCT00432237|451772507|FG003|Overall Study|Physician Decision|1|||
125586705|NCT00432237|451772504|FG000|Overall Study|Pregnancy|0|||
125586706|NCT00432237|451772505|FG001|Overall Study|Pregnancy|1|||
125586707|NCT00432237|451772506|FG002|Overall Study|Pregnancy|0|||
125586708|NCT00432237|451772507|FG003|Overall Study|Pregnancy|0|||
125586709|NCT00432237|451772504|FG000|Overall Study|Protocol Violation|13|||
125586710|NCT00432237|451772505|FG001|Overall Study|Protocol Violation|10|||
125586711|NCT00432237|451772506|FG002|Overall Study|Protocol Violation|11|||
125586712|NCT00432237|451772507|FG003|Overall Study|Protocol Violation|8|||
125586713|NCT00432237|451772504|FG000|Overall Study|Withdrawal by Subject|5|||
125586714|NCT00432237|451772505|FG001|Overall Study|Withdrawal by Subject|6|||
125586715|NCT00432237|451772506|FG002|Overall Study|Withdrawal by Subject|9|||
125586716|NCT00432237|451772507|FG003|Overall Study|Withdrawal by Subject|11|||
125586717|NCT00432237|451772504|FG000|Overall Study|Lack of Qualifying Event|38|||
125586718|NCT00432237|451772505|FG001|Overall Study|Lack of Qualifying Event|71|||
125586719|NCT00432237|451772506|FG002|Overall Study|Lack of Qualifying Event|69|||
125586720|NCT00432237|451772507|FG003|Overall Study|Lack of Qualifying Event|84|||
125586721|NCT01354132|451772508|FG000|Randomization|Physician Decision|1|||
125586722|NCT01354132|451772509|FG001|Randomization|Physician Decision|0|||
125586723|NCT01354132|451772508|FG000|Randomization|Withdrawal by Subject|0|||
125586724|NCT01354132|451772509|FG001|Randomization|Withdrawal by Subject|1|||
125586725|NCT01354132|451772508|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
125586726|NCT01354132|451772509|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
125586727|NCT01354132|451772508|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
125586728|NCT01354132|451772509|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
125586729|NCT01354132|451772508|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
125586730|NCT01354132|451772509|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
125586731|NCT00603239|451772510|FG000|Overall Study|Adverse Event|4|||
125586732|NCT00603239|451772511|FG001|Overall Study|Adverse Event|1|||
125586733|NCT00603239|451772510|FG000|Overall Study|Entry criteria not met|0|||
125586734|NCT00603239|451772511|FG001|Overall Study|Entry criteria not met|1|||
125586735|NCT00603239|451772510|FG000|Overall Study|Loss of glucose control|3|||
125586736|NCT00603239|451772511|FG001|Overall Study|Loss of glucose control|0|||
125586737|NCT00603239|451772510|FG000|Overall Study|Lost to Follow-up|2|||
125586738|NCT00603239|451772511|FG001|Overall Study|Lost to Follow-up|1|||
125586739|NCT00603239|451772510|FG000|Overall Study|Physician Decision|2|||
125586740|NCT00603239|451772511|FG001|Overall Study|Physician Decision|0|||
125586741|NCT00603239|451772510|FG000|Overall Study|Protocol Violation|2|||
125586742|NCT00603239|451772511|FG001|Overall Study|Protocol Violation|0|||
125586743|NCT00603239|451772510|FG000|Overall Study|Subject decision|2|||
125586744|NCT00603239|451772511|FG001|Overall Study|Subject decision|1|||
125586745|NCT00191854|451772512|FG000|Overall Study|Death|26|||
125586746|NCT00191854|451772513|FG001|Overall Study|Death|23|||
125586747|NCT00191854|451772514|FG002|Overall Study|Death|29|||
125586748|NCT00191854|451772512|FG000|Overall Study|Lost to Follow-up|7|||
125586749|NCT00191854|451772513|FG001|Overall Study|Lost to Follow-up|5|||
125586750|NCT00191854|451772514|FG002|Overall Study|Lost to Follow-up|5|||
125586751|NCT00191854|451772512|FG000|Overall Study|Withdrawal by Subject|4|||
125586752|NCT00191854|451772513|FG001|Overall Study|Withdrawal by Subject|2|||
125586753|NCT00191854|451772514|FG002|Overall Study|Withdrawal by Subject|3|||
125586754|NCT00191854|451772512|FG000|Overall Study|Sponsor Decision|0|||
125586755|NCT00191854|451772513|FG001|Overall Study|Sponsor Decision|0|||
125586756|NCT00191854|451772514|FG002|Overall Study|Sponsor Decision|1|||
125586757|NCT00191854|451772512|FG000|Overall Study|Screen Failure|0|||
125586758|NCT00191854|451772513|FG001|Overall Study|Screen Failure|0|||
125586759|NCT00191854|451772514|FG002|Overall Study|Screen Failure|1|||
125428966|NCT00279201|451195545|FG000|Intensification Addendum|Adverse Event|0|||
125428967|NCT00279201|451195546|FG001|Intensification Addendum|Adverse Event|0|||
125428968|NCT00279201|451195547|FG002|Intensification Addendum|Adverse Event|0|||
125428969|NCT00279201|451195548|FG003|Intensification Addendum|Adverse Event|4|||
125428970|NCT00279201|451195549|FG004|Intensification Addendum|Adverse Event|1|||
125428971|NCT00279201|451195550|FG005|Intensification Addendum|Adverse Event|3|||
125428972|NCT00279201|451195545|FG000|Intensification Addendum|Physician Decision|0|||
125428973|NCT00279201|451195546|FG001|Intensification Addendum|Physician Decision|0|||
125428974|NCT00279201|451195547|FG002|Intensification Addendum|Physician Decision|4|||
125428975|NCT00279201|451195548|FG003|Intensification Addendum|Physician Decision|1|||
125428976|NCT00279201|451195549|FG004|Intensification Addendum|Physician Decision|3|||
125428977|NCT00279201|451195550|FG005|Intensification Addendum|Physician Decision|2|||
125428978|NCT00279201|451195545|FG000|Intensification Addendum|Sponsor Decision|0|||
125428979|NCT00279201|451195546|FG001|Intensification Addendum|Sponsor Decision|0|||
125428980|NCT00279201|451195547|FG002|Intensification Addendum|Sponsor Decision|0|||
125428981|NCT00279201|451195548|FG003|Intensification Addendum|Sponsor Decision|0|||
125428982|NCT00279201|451195549|FG004|Intensification Addendum|Sponsor Decision|1|||
125428983|NCT00279201|451195550|FG005|Intensification Addendum|Sponsor Decision|1|||
125428984|NCT00279201|451195545|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
125428985|NCT00279201|451195546|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
125428986|NCT00279201|451195547|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
125428987|NCT00279201|451195548|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
125428988|NCT00279201|451195549|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
125428989|NCT00279201|451195550|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
125428990|NCT00279201|451195545|FG000|Intensification Addendum|Lack of Efficacy|0|||
125428991|NCT00279201|451195546|FG001|Intensification Addendum|Lack of Efficacy|0|||
125428992|NCT00279201|451195547|FG002|Intensification Addendum|Lack of Efficacy|0|||
125428993|NCT00279201|451195548|FG003|Intensification Addendum|Lack of Efficacy|1|||
125428994|NCT00279201|451195549|FG004|Intensification Addendum|Lack of Efficacy|1|||
125428995|NCT00279201|451195550|FG005|Intensification Addendum|Lack of Efficacy|0|||
125428996|NCT00279201|451195545|FG000|Intensification Addendum|Death|0|||
125428997|NCT00279201|451195546|FG001|Intensification Addendum|Death|0|||
125428998|NCT00279201|451195547|FG002|Intensification Addendum|Death|0|||
125428999|NCT00279201|451195548|FG003|Intensification Addendum|Death|0|||
125429000|NCT00279201|451195549|FG004|Intensification Addendum|Death|1|||
125429001|NCT00279201|451195550|FG005|Intensification Addendum|Death|0|||
125429002|NCT00316173|451195551|FG000|Run-in Phase|Adverse Event|1|||
125429003|NCT00316173|451195552|FG001|Run-in Phase|Adverse Event|0|||
125429004|NCT00316173|451195551|FG000|Run-in Phase|Protocol Violation|1|||
125429005|NCT00316173|451195552|FG001|Run-in Phase|Protocol Violation|0|||
125429006|NCT00316173|451195551|FG000|Run-in Phase|Study Follow-up Stopped|5|||
125429007|NCT00316173|451195552|FG001|Run-in Phase|Study Follow-up Stopped|0|||
125429008|NCT00316173|451195551|FG000|Treatment Phase|Adverse Event|0|||
125429009|NCT00316173|451195552|FG001|Treatment Phase|Adverse Event|1|||
125429010|NCT00316173|451195551|FG000|Treatment Phase|Lack of Efficacy|0|||
125429011|NCT00316173|451195552|FG001|Treatment Phase|Lack of Efficacy|3|||
125429012|NCT00316173|451195551|FG000|Treatment Phase|Lost to Follow-up|0|||
125586760|NCT00862251|451772516|FG000|Overall Study|Adverse Event|8|||
125586761|NCT00862251|451772517|FG001|Overall Study|Adverse Event|3|||
125586762|NCT00862251|451772518|FG002|Overall Study|Adverse Event|1|||
125586763|NCT00862251|451772516|FG000|Overall Study|Lost to Follow-up|0|||
125586764|NCT00862251|451772517|FG001|Overall Study|Lost to Follow-up|0|||
125586765|NCT00862251|451772518|FG002|Overall Study|Lost to Follow-up|1|||
125586766|NCT00862251|451772516|FG000|Overall Study|Protocol Violation|2|||
125586767|NCT00862251|451772517|FG001|Overall Study|Protocol Violation|0|||
125586768|NCT00862251|451772518|FG002|Overall Study|Protocol Violation|1|||
125586769|NCT00862251|451772516|FG000|Overall Study|Withdrawal by Subject|9|||
125586770|NCT00862251|451772517|FG001|Overall Study|Withdrawal by Subject|2|||
125586771|NCT00862251|451772518|FG002|Overall Study|Withdrawal by Subject|6|||
125586772|NCT00501228|451772523|FG000|Overall Study|Withdrawal by Subject|1|||
125429013|NCT00316173|451195552|FG001|Treatment Phase|Lost to Follow-up|3|||
125429014|NCT00316173|451195551|FG000|Treatment Phase|Withdrawal by Subject|0|||
125429015|NCT00316173|451195552|FG001|Treatment Phase|Withdrawal by Subject|1|||
125429016|NCT00316173|451195551|FG000|Treatment Phase|Study Follow-up Stopped|0|||
125586773|NCT01756274|451772528|FG000|Overall Study|Protocol Violation|2|||
125429017|NCT00316173|451195552|FG001|Treatment Phase|Study Follow-up Stopped|34|||
125429018|NCT02390531|451195553|FG000|Overall Study|Death|0|||
125429019|NCT02390531|451195554|FG001|Overall Study|Death|2|||
125429020|NCT02390531|451195555|FG002|Overall Study|Death|0|||
125429021|NCT02390531|451195556|FG003|Overall Study|Death|1|||
125429022|NCT02390531|451195557|FG004|Overall Study|Death|0|||
125429023|NCT02390531|451195558|FG005|Overall Study|Death|0|||
125586774|NCT01756274|451772528|FG000|Overall Study|Laboratory error|1|||
125586775|NCT01147926|451772529|FG000|Overall Study|Subject Withdrew Consent|9|||
125586776|NCT01147926|451772530|FG001|Overall Study|Subject Withdrew Consent|10|||
125586777|NCT01147926|451772529|FG000|Overall Study|Adverse Event|7|||
125586778|NCT01147926|451772530|FG001|Overall Study|Adverse Event|6|||
125586779|NCT01147926|451772529|FG000|Overall Study|Subject Non-Compliant|5|||
125586780|NCT01147926|451772530|FG001|Overall Study|Subject Non-Compliant|4|||
125586781|NCT01147926|451772529|FG000|Overall Study|Principal investigator left hospital|1|||
125586782|NCT01147926|451772530|FG001|Overall Study|Principal investigator left hospital|3|||
125586783|NCT01147926|451772529|FG000|Overall Study|Selection criteria not met|3|||
125586784|NCT01147926|451772530|FG001|Overall Study|Selection criteria not met|1|||
125586785|NCT01147926|451772529|FG000|Overall Study|Lost to Follow-up|0|||
125586786|NCT01147926|451772530|FG001|Overall Study|Lost to Follow-up|2|||
125586787|NCT01147926|451772529|FG000|Overall Study|Sponsor's Decision|0|||
125586788|NCT01147926|451772530|FG001|Overall Study|Sponsor's Decision|1|||
125586789|NCT01147926|451772529|FG000|Overall Study|Lack of Efficacy|1|||
125586790|NCT01147926|451772530|FG001|Overall Study|Lack of Efficacy|0|||
125586791|NCT01147926|451772529|FG000|Overall Study|Too busy, no time for study|1|||
125586792|NCT01147926|451772530|FG001|Overall Study|Too busy, no time for study|0|||
125586793|NCT01147926|451772529|FG000|Overall Study|Went on holiday|0|||
125586794|NCT01147926|451772530|FG001|Overall Study|Went on holiday|1|||
125586795|NCT01147926|451772529|FG000|Overall Study|Colonoscopy result|0|||
125586796|NCT01147926|451772530|FG001|Overall Study|Colonoscopy result|1|||
125586797|NCT03417440|451772531|FG000|Overall Study|Lost to Follow-up|0|||
125586798|NCT03417440|451772532|FG001|Overall Study|Lost to Follow-up|1|||
125586799|NCT03417440|451772533|FG002|Overall Study|Lost to Follow-up|0|||
125586800|NCT03417440|451772534|FG003|Overall Study|Lost to Follow-up|0|||
125586801|NCT03417440|451772535|FG004|Overall Study|Lost to Follow-up|1|||
125586802|NCT03417440|451772536|FG005|Overall Study|Lost to Follow-up|0|||
125586803|NCT03417440|451772537|FG006|Overall Study|Lost to Follow-up|0|||
125586804|NCT03417440|451772538|FG007|Overall Study|Lost to Follow-up|0|||
125586805|NCT03417440|451772531|FG000|Overall Study|Withdrawal by Subject|2|||
125586806|NCT03417440|451772532|FG001|Overall Study|Withdrawal by Subject|0|||
125586807|NCT03417440|451772533|FG002|Overall Study|Withdrawal by Subject|2|||
125586808|NCT03417440|451772534|FG003|Overall Study|Withdrawal by Subject|1|||
125586809|NCT03417440|451772535|FG004|Overall Study|Withdrawal by Subject|1|||
125586810|NCT03417440|451772536|FG005|Overall Study|Withdrawal by Subject|0|||
125586811|NCT03417440|451772537|FG006|Overall Study|Withdrawal by Subject|0|||
125586812|NCT03417440|451772538|FG007|Overall Study|Withdrawal by Subject|1|||
125586813|NCT03304522|451772542|FG000|Overall Study|Adverse Event|0|||
125586814|NCT03304522|451772543|FG001|Overall Study|Adverse Event|4|||
125586815|NCT03304522|451772542|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
125586816|NCT03304522|451772543|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
125586817|NCT03304522|451772542|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
125586818|NCT03304522|451772543|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
125586819|NCT03304522|451772542|FG000|Overall Study|Other|0|||
125586820|NCT03304522|451772543|FG001|Overall Study|Other|1|||
125586821|NCT00486603|451772546|FG000|Overall Study|Withdrawal by Subject|1|||
125586822|NCT00486603|451772547|FG001|Overall Study|Withdrawal by Subject|0|||
125586823|NCT00486603|451772548|FG002|Overall Study|Withdrawal by Subject|0|||
125586824|NCT00486603|451772549|FG003|Overall Study|Withdrawal by Subject|0|||
125586825|NCT00486603|451772550|FG004|Overall Study|Withdrawal by Subject|0|||
125586826|NCT00486603|451772546|FG000|Overall Study|Physician Decision|0|||
125586827|NCT00486603|451772547|FG001|Overall Study|Physician Decision|1|||
125586828|NCT00486603|451772548|FG002|Overall Study|Physician Decision|0|||
125586829|NCT00486603|451772549|FG003|Overall Study|Physician Decision|0|||
125586830|NCT00486603|451772550|FG004|Overall Study|Physician Decision|0|||
125586831|NCT01670994|451772551|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
125586832|NCT01670994|451772552|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
125586833|NCT01670994|451772551|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
125586834|NCT01670994|451772552|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
125586835|NCT01670994|451772551|FG000|Overall Study|Patient experienced DLT|0|||
125586836|NCT01670994|451772552|FG001|Overall Study|Patient experienced DLT|1|||
125586837|NCT02013544|451772553|FG000|Overall Study|Adverse Event|5|||
125586838|NCT02013544|451772554|FG001|Overall Study|Adverse Event|5|||
125586839|NCT02013544|451772553|FG000|Overall Study|Lost to Follow-up|2|||
125586840|NCT02013544|451772554|FG001|Overall Study|Lost to Follow-up|3|||
125586841|NCT02013544|451772553|FG000|Overall Study|Withdrawal by Subject|2|||
125586842|NCT02013544|451772554|FG001|Overall Study|Withdrawal by Subject|8|||
125586843|NCT02013544|451772553|FG000|Overall Study|Physician Decision|0|||
125586844|NCT02013544|451772554|FG001|Overall Study|Physician Decision|1|||
125586845|NCT02013544|451772553|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
125586846|NCT02013544|451772554|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
125586847|NCT01295125|451772555|FG000|Overall Study|Study stopped prematurely|9|||
125586848|NCT00885365|451772558|FG000|4 Weeks ON Treatment|Adverse Event|2|||
125586849|NCT00885365|451772559|FG001|4 Weeks ON Treatment|Adverse Event|4|||
125586850|NCT00885365|451772558|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
125586851|NCT00885365|451772559|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
125586852|NCT00885365|451772558|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
125586853|NCT00885365|451772559|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
125586854|NCT01824979|451772560|FG000|Overall Study|Withdrawal by Subject|5|||
125586855|NCT01824979|451772561|FG001|Overall Study|Withdrawal by Subject|0|||
125586856|NCT01824979|451772560|FG000|Overall Study|Physician Decision|2|||
125586857|NCT01824979|451772561|FG001|Overall Study|Physician Decision|0|||
125586858|NCT01824979|451772560|FG000|Overall Study|Protocol Violation|6|||
125586859|NCT01824979|451772561|FG001|Overall Study|Protocol Violation|13|||
125586860|NCT02507349|451772563|FG000|Overall Study|Death|12|||
125586861|NCT02507349|451772564|FG001|Overall Study|Death|16|||
125586862|NCT02507349|451772563|FG000|Overall Study|Withdrawal by Subject|1|||
125586863|NCT02507349|451772564|FG001|Overall Study|Withdrawal by Subject|1|||
125586864|NCT02507349|451772563|FG000|Overall Study|Lost to Follow-up|174|||
125586865|NCT02507349|451772564|FG001|Overall Study|Lost to Follow-up|144|||
125586866|NCT00888238|451772565|FG000|Washout Period After Period 2|Adverse Event|0|||
125586867|NCT00888238|451772566|FG001|Washout Period After Period 2|Adverse Event|0|||
125586868|NCT00888238|451772567|FG002|Washout Period After Period 2|Adverse Event|1|||
125586869|NCT03371355|451772578|FG000|Overall Study|Investigator judgment|0|||
125586870|NCT03371355|451772579|FG001|Overall Study|Investigator judgment|0|||
125586871|NCT03371355|451772580|FG002|Overall Study|Investigator judgment|1|||
125586872|NCT03371355|451772581|FG003|Overall Study|Investigator judgment|1|||
125586873|NCT03371355|451772578|FG000|Overall Study|Voluntary withdrawal|1|||
125586874|NCT03371355|451772579|FG001|Overall Study|Voluntary withdrawal|0|||
125586875|NCT03371355|451772580|FG002|Overall Study|Voluntary withdrawal|1|||
125586876|NCT03371355|451772581|FG003|Overall Study|Voluntary withdrawal|2|||
125586877|NCT03371355|451772578|FG000|Overall Study|Adverse Event|0|||
125586878|NCT03371355|451772579|FG001|Overall Study|Adverse Event|1|||
125586879|NCT03371355|451772580|FG002|Overall Study|Adverse Event|2|||
125586880|NCT03371355|451772581|FG003|Overall Study|Adverse Event|3|||
125586881|NCT03371355|451772578|FG000|Overall Study|Reason not Specified|0|||
125586882|NCT03371355|451772579|FG001|Overall Study|Reason not Specified|1|||
125586883|NCT03371355|451772580|FG002|Overall Study|Reason not Specified|0|||
125586884|NCT03371355|451772581|FG003|Overall Study|Reason not Specified|1|||
125586885|NCT00977470|451772584|FG000|Overall Study|Lack of Efficacy|32|||
125586886|NCT00977470|451772585|FG001|Overall Study|Lack of Efficacy|30|||
125586887|NCT00977470|451772584|FG000|Overall Study|Physician Decision|2|||
125586888|NCT00977470|451772585|FG001|Overall Study|Physician Decision|0|||
125586889|NCT00977470|451772584|FG000|Overall Study|Adverse Event|1|||
125586890|NCT00977470|451772585|FG001|Overall Study|Adverse Event|2|||
125586891|NCT00977470|451772584|FG000|Overall Study|Protocol Violation|1|||
125586892|NCT00977470|451772585|FG001|Overall Study|Protocol Violation|0|||
125586893|NCT00977470|451772584|FG000|Overall Study|Withdrawal by Subject|0|||
125586894|NCT00977470|451772585|FG001|Overall Study|Withdrawal by Subject|2|||
125586895|NCT00977470|451772584|FG000|Overall Study|Death|0|||
125586896|NCT00977470|451772585|FG001|Overall Study|Death|2|||
125586897|NCT00977470|451772584|FG000|Overall Study|clinical decline|0|||
125586898|NCT00977470|451772585|FG001|Overall Study|clinical decline|1|||
125586899|NCT00977470|451772584|FG000|Overall Study|prolonged recovery post-surgery|0|||
125586900|NCT00977470|451772585|FG001|Overall Study|prolonged recovery post-surgery|1|||
125586901|NCT00977470|451772584|FG000|Overall Study|Still on-study|2|||
125586902|NCT00977470|451772585|FG001|Overall Study|Still on-study|0|||
125586903|NCT03529409|451772591|FG000|Randomized|Lost to Follow-up|0|||
125586904|NCT03529409|451772592|FG001|Randomized|Lost to Follow-up|0|||
125586905|NCT03529409|451772593|FG002|Randomized|Lost to Follow-up|4|||
125586906|NCT03529409|451772591|FG000|Randomized|Excluded|0|||
125586907|NCT03529409|451772592|FG001|Randomized|Excluded|0|||
125586908|NCT03529409|451772593|FG002|Randomized|Excluded|1|||
125586909|NCT03529409|451772591|FG000|Post-treatment Assessment|Death|1|||
125586910|NCT03529409|451772592|FG001|Post-treatment Assessment|Death|0|||
125586911|NCT03529409|451772593|FG002|Post-treatment Assessment|Death|0|||
125586912|NCT03529409|451772591|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
125586913|NCT03529409|451772592|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
125586914|NCT03529409|451772593|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
125586915|NCT03529409|451772591|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
125586916|NCT03529409|451772592|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
125586917|NCT03529409|451772593|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
125586918|NCT03529409|451772591|FG000|Follow-up Assessment|Death|1|||
125586919|NCT03529409|451772592|FG001|Follow-up Assessment|Death|0|||
125586920|NCT03529409|451772593|FG002|Follow-up Assessment|Death|0|||
125586921|NCT03529409|451772591|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
125586922|NCT03529409|451772592|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
125586923|NCT03529409|451772593|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
125586924|NCT01497262|451772596|FG000|Overall Study|Abnormal Lab Values|4|||
125586925|NCT01497262|451772596|FG000|Overall Study|Abnormal Test Procedure Result|1|||
125586926|NCT01497262|451772596|FG000|Overall Study|Physician Decision|1|||
125586927|NCT01497262|451772596|FG000|Overall Study|Withdrawal by Subject|2|||
125586928|NCT01497262|451772596|FG000|Overall Study|Adverse Event|2|||
125586929|NCT01497262|451772596|FG000|Overall Study|Protocol Violation|1|||
125586930|NCT02497001|451772599|FG000|Overall Study|Lost to Follow-up|10|||
125586931|NCT02497001|451772600|FG001|Overall Study|Lost to Follow-up|2|||
125586932|NCT02497001|451772601|FG002|Overall Study|Lost to Follow-up|0|||
125586933|NCT02497001|451772602|FG003|Overall Study|Lost to Follow-up|2|||
125586934|NCT02497001|451772599|FG000|Overall Study|Adverse Event|28|||
125586935|NCT02497001|451772600|FG001|Overall Study|Adverse Event|30|||
125586936|NCT02497001|451772601|FG002|Overall Study|Adverse Event|11|||
125586937|NCT02497001|451772602|FG003|Overall Study|Adverse Event|11|||
125586938|NCT02497001|451772599|FG000|Overall Study|Withdrawal by Subject|14|||
125586939|NCT02497001|451772600|FG001|Overall Study|Withdrawal by Subject|37|||
125211841|NCT00048165|450401386|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
125211842|NCT00048165|450401385|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
125211843|NCT00048165|450401386|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
125586940|NCT02497001|451772601|FG002|Overall Study|Withdrawal by Subject|19|||
125586941|NCT02497001|451772602|FG003|Overall Study|Withdrawal by Subject|15|||
125586942|NCT02497001|451772599|FG000|Overall Study|Physician Decision|5|||
125586943|NCT02497001|451772600|FG001|Overall Study|Physician Decision|11|||
125586944|NCT02497001|451772601|FG002|Overall Study|Physician Decision|5|||
125586945|NCT02497001|451772602|FG003|Overall Study|Physician Decision|1|||
125586946|NCT02497001|451772599|FG000|Overall Study|subjects that were not treated|1|||
125586947|NCT02497001|451772600|FG001|Overall Study|subjects that were not treated|2|||
125586948|NCT02497001|451772601|FG002|Overall Study|subjects that were not treated|2|||
125586949|NCT02497001|451772602|FG003|Overall Study|subjects that were not treated|1|||
125586950|NCT02497001|451772599|FG000|Overall Study|Major Protocol Deviation|3|||
125586951|NCT02497001|451772600|FG001|Overall Study|Major Protocol Deviation|4|||
125586952|NCT02497001|451772601|FG002|Overall Study|Major Protocol Deviation|4|||
125586953|NCT02497001|451772602|FG003|Overall Study|Major Protocol Deviation|4|||
125586954|NCT02497001|451772599|FG000|Overall Study|Lack of Efficacy|10|||
125586955|NCT02497001|451772600|FG001|Overall Study|Lack of Efficacy|16|||
125586956|NCT02497001|451772601|FG002|Overall Study|Lack of Efficacy|6|||
125586957|NCT02497001|451772602|FG003|Overall Study|Lack of Efficacy|6|||
125586958|NCT02497001|451772599|FG000|Overall Study|Protocol Violation|3|||
125586959|NCT02497001|451772600|FG001|Overall Study|Protocol Violation|1|||
125586960|NCT02497001|451772601|FG002|Overall Study|Protocol Violation|3|||
125586961|NCT02497001|451772602|FG003|Overall Study|Protocol Violation|1|||
125586962|NCT03898063|451772603|FG000|Overall Study|Withdrawal by Subject|10|||
125586963|NCT03898063|451772604|FG001|Overall Study|Withdrawal by Subject|8|||
125586964|NCT02949830|451772605|FG000|Overall Study|Adverse Event|1|||
125586965|NCT02949830|451772605|FG000|Overall Study|Withdrawal by Subject|1|||
125586966|NCT00054132|451772606|FG000|Overall Study|Not Treated|1|||
125586967|NCT01290887|451772607|FG000|Overall Study|Adverse Event|6|||
125586968|NCT01290887|451772608|FG001|Overall Study|Adverse Event|11|||
125586969|NCT01290887|451772607|FG000|Overall Study|Lack of Efficacy|4|||
125586970|NCT01290887|451772608|FG001|Overall Study|Lack of Efficacy|5|||
125586971|NCT01290887|451772607|FG000|Overall Study|Withdrawal by Subject|26|||
125586972|NCT01290887|451772608|FG001|Overall Study|Withdrawal by Subject|32|||
125586973|NCT01290887|451772607|FG000|Overall Study|Protocol Violation|2|||
125586974|NCT01290887|451772608|FG001|Overall Study|Protocol Violation|1|||
125586975|NCT01290887|451772607|FG000|Overall Study|Lost to Follow-up|4|||
125586976|NCT01290887|451772608|FG001|Overall Study|Lost to Follow-up|4|||
125586977|NCT01290887|451772607|FG000|Overall Study|Non-compliance to study procedures|0|||
125586978|NCT01290887|451772608|FG001|Overall Study|Non-compliance to study procedures|1|||
125586979|NCT01290887|451772607|FG000|Overall Study|Non-compliance to study medications|1|||
125586980|NCT01290887|451772608|FG001|Overall Study|Non-compliance to study medications|0|||
125586981|NCT01290887|451772607|FG000|Overall Study|Sponsor closure of study|420|||
125586982|NCT01290887|451772608|FG001|Overall Study|Sponsor closure of study|476|||
125586983|NCT01290887|451772607|FG000|Overall Study|Other|3|||
125586984|NCT01290887|451772608|FG001|Overall Study|Other|6|||
125586985|NCT01795547|451772609|FG000|Overall Study|Adverse Event|16|||
125586986|NCT01795547|451772610|FG001|Overall Study|Adverse Event|27|||
125586987|NCT01795547|451772609|FG000|Overall Study|Lack of Efficacy|8|||
125586988|NCT01795547|451772610|FG001|Overall Study|Lack of Efficacy|3|||
125586989|NCT01795547|451772609|FG000|Overall Study|Protocol Violation|6|||
125586990|NCT01795547|451772610|FG001|Overall Study|Protocol Violation|4|||
125586991|NCT01795547|451772609|FG000|Overall Study|Lost to Follow-up|2|||
125586992|NCT01795547|451772610|FG001|Overall Study|Lost to Follow-up|5|||
125586993|NCT01795547|451772609|FG000|Overall Study|Withdrawal of consent|7|||
125586994|NCT01795547|451772610|FG001|Overall Study|Withdrawal of consent|12|||
125586995|NCT01795547|451772609|FG000|Overall Study|Not Treated|4|||
125586996|NCT01795547|451772610|FG001|Overall Study|Not Treated|10|||
125586997|NCT01795547|451772609|FG000|Overall Study|Non-compliance with IMP|1|||
125586998|NCT01795547|451772610|FG001|Overall Study|Non-compliance with IMP|1|||
125586999|NCT01795547|451772609|FG000|Overall Study|Others|4|||
125587000|NCT01795547|451772610|FG001|Overall Study|Others|1|||
125587001|NCT01795547|451772609|FG000|Overall Study|Not stated|0|||
125587002|NCT01795547|451772610|FG001|Overall Study|Not stated|1|||
125587003|NCT02040142|451772611|FG000|Overall Study|Lost to Follow-up|5|||
125587004|NCT02040142|451772611|FG000|Overall Study|Death|17|||
125587005|NCT02040142|451772611|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
125587006|NCT02330419|451772613|FG000|Overall Study|Lost to Follow-up|3|||
125587007|NCT02330419|451772614|FG001|Overall Study|Lost to Follow-up|7|||
125587008|NCT01813890|451772617|FG000|Overall Study|Adverse Event|0|||
125587009|NCT01813890|451772618|FG001|Overall Study|Adverse Event|3|||
125587010|NCT01813890|451772619|FG002|Overall Study|Adverse Event|4|||
125587011|NCT01813890|451772617|FG000|Overall Study|Lack of Efficacy|9|||
125587012|NCT01813890|451772618|FG001|Overall Study|Lack of Efficacy|1|||
125587013|NCT01813890|451772619|FG002|Overall Study|Lack of Efficacy|2|||
125587014|NCT03952559|451772620|FG000|Double Blind Treatment Period|Adverse Event|0|||
125587015|NCT03952559|451772621|FG001|Double Blind Treatment Period|Adverse Event|2|||
125587016|NCT03952559|451772622|FG002|Double Blind Treatment Period|Adverse Event|1|||
125587017|NCT03952559|451772623|FG003|Double Blind Treatment Period|Adverse Event|0|||
125587018|NCT03952559|451772624|FG004|Double Blind Treatment Period|Adverse Event|1|||
125587019|NCT03952559|451772620|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
125587020|NCT03952559|451772621|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
125587021|NCT03952559|451772622|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
125587022|NCT03952559|451772623|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
125587023|NCT03952559|451772624|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
125587024|NCT03952559|451772620|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
125587025|NCT03952559|451772621|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
125587026|NCT03952559|451772622|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
125587027|NCT03952559|451772623|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
125587028|NCT03952559|451772624|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
125587029|NCT03952559|451772620|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
125587030|NCT03952559|451772621|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
125587031|NCT03952559|451772622|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
125587032|NCT03952559|451772623|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
125587033|NCT03952559|451772624|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
125587034|NCT01870739|451772627|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
125587035|NCT01870739|451772628|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
125587036|NCT01870739|451772627|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
125587037|NCT01870739|451772628|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
125587038|NCT01870739|451772627|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
125587039|NCT01870739|451772628|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
125587040|NCT01870739|451772627|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
125587041|NCT01870739|451772628|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
125587042|NCT01870739|451772627|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
125587043|NCT01870739|451772628|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
125587044|NCT01870739|451772627|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
125587045|NCT01870739|451772628|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
125587046|NCT01870739|451772627|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
125587047|NCT01870739|451772628|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
125587048|NCT01986062|451772629|FG000|Overall Study|Lost to Follow-up|1|||
125587049|NCT01986062|451772630|FG001|Overall Study|Lost to Follow-up|0|||
125429024|NCT02390531|451195559|FG006|Overall Study|Death|0|||
125587050|NCT01986062|451772629|FG000|Overall Study|Withdrawal by Subject|0|||
125587051|NCT01986062|451772630|FG001|Overall Study|Withdrawal by Subject|1|||
125587052|NCT03538743|451772631|FG000|Overall Study|Adverse Event|0|||
125587053|NCT03538743|451772632|FG001|Overall Study|Adverse Event|0|||
125587054|NCT03538743|451772633|FG002|Overall Study|Adverse Event|1|||
125587055|NCT03538743|451772634|FG003|Overall Study|Adverse Event|1|||
125587056|NCT03538743|451772635|FG004|Overall Study|Adverse Event|0|||
125587057|NCT03538743|451772636|FG005|Overall Study|Adverse Event|0|||
125587058|NCT03538743|451772637|FG006|Overall Study|Adverse Event|0|||
125587059|NCT03538743|451772638|FG007|Overall Study|Adverse Event|0|||
125587060|NCT03538743|451772639|FG008|Overall Study|Adverse Event|0|||
125587061|NCT03538743|451772631|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
125587062|NCT03538743|451772632|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
125587063|NCT03538743|451772633|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
125587064|NCT03538743|451772634|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
125587065|NCT03538743|451772635|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
125587066|NCT03538743|451772636|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
125587067|NCT03538743|451772637|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
125587068|NCT03538743|451772638|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
125587069|NCT03538743|451772639|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
125587070|NCT03538743|451772631|FG000|Overall Study|Withdrawal by Subject|0|||
125587071|NCT03538743|451772632|FG001|Overall Study|Withdrawal by Subject|0|||
125587072|NCT03538743|451772633|FG002|Overall Study|Withdrawal by Subject|0|||
125587073|NCT03538743|451772634|FG003|Overall Study|Withdrawal by Subject|1|||
125587074|NCT03538743|451772635|FG004|Overall Study|Withdrawal by Subject|0|||
125587075|NCT03538743|451772636|FG005|Overall Study|Withdrawal by Subject|0|||
125587076|NCT03538743|451772637|FG006|Overall Study|Withdrawal by Subject|0|||
125587077|NCT03538743|451772638|FG007|Overall Study|Withdrawal by Subject|0|||
125587078|NCT03538743|451772639|FG008|Overall Study|Withdrawal by Subject|0|||
125587079|NCT01827384|451772640|FG000|Overall Study|Switched to alternative treatment|0|||
125587080|NCT01827384|451772641|FG001|Overall Study|Switched to alternative treatment|0|||
125587081|NCT01827384|451772642|FG002|Overall Study|Switched to alternative treatment|0|||
125587082|NCT01827384|451772643|FG003|Overall Study|Switched to alternative treatment|0|||
125587083|NCT01827384|451772644|FG004|Overall Study|Switched to alternative treatment|0|||
125587084|NCT01827384|451772645|FG005|Overall Study|Switched to alternative treatment|0|||
125587085|NCT01827384|451772646|FG006|Overall Study|Switched to alternative treatment|0|||
125429025|NCT02390531|451195560|FG007|Overall Study|Death|1|||
125429026|NCT02390531|451195553|FG000|Overall Study|Protocol Violation|0|||
125429027|NCT02390531|451195554|FG001|Overall Study|Protocol Violation|0|||
125587086|NCT01827384|451772647|FG007|Overall Study|Switched to alternative treatment|0|||
125429028|NCT02390531|451195555|FG002|Overall Study|Protocol Violation|0|||
125429029|NCT02390531|451195556|FG003|Overall Study|Protocol Violation|0|||
125429030|NCT02390531|451195557|FG004|Overall Study|Protocol Violation|1|||
125587087|NCT01827384|451772648|FG008|Overall Study|Switched to alternative treatment|0|||
125587088|NCT01827384|451772649|FG009|Overall Study|Switched to alternative treatment|0|||
125587089|NCT01827384|451772650|FG010|Overall Study|Switched to alternative treatment|0|||
125587090|NCT01827384|451772651|FG011|Overall Study|Switched to alternative treatment|0|||
125587091|NCT01827384|451772652|FG012|Overall Study|Switched to alternative treatment|0|||
125587092|NCT01827384|451772653|FG013|Overall Study|Switched to alternative treatment|2|||
125587093|NCT01827384|451772640|FG000|Overall Study|Disease progression before treatment|0|||
125587094|NCT01827384|451772641|FG001|Overall Study|Disease progression before treatment|0|||
125587095|NCT01827384|451772642|FG002|Overall Study|Disease progression before treatment|0|||
125587096|NCT01827384|451772643|FG003|Overall Study|Disease progression before treatment|0|||
125587097|NCT01827384|451772644|FG004|Overall Study|Disease progression before treatment|0|||
125587098|NCT01827384|451772645|FG005|Overall Study|Disease progression before treatment|0|||
125587099|NCT01827384|451772646|FG006|Overall Study|Disease progression before treatment|0|||
125587100|NCT01827384|451772647|FG007|Overall Study|Disease progression before treatment|0|||
125587101|NCT01827384|451772648|FG008|Overall Study|Disease progression before treatment|0|||
125587102|NCT01827384|451772649|FG009|Overall Study|Disease progression before treatment|0|||
125587103|NCT01827384|451772650|FG010|Overall Study|Disease progression before treatment|0|||
125587104|NCT01827384|451772651|FG011|Overall Study|Disease progression before treatment|0|||
125587105|NCT01827384|451772652|FG012|Overall Study|Disease progression before treatment|0|||
125587106|NCT01827384|451772653|FG013|Overall Study|Disease progression before treatment|4|||
125587107|NCT01827384|451772640|FG000|Overall Study|Ineligible|0|||
125587108|NCT01827384|451772641|FG001|Overall Study|Ineligible|0|||
125587109|NCT01827384|451772642|FG002|Overall Study|Ineligible|0|||
125587110|NCT01827384|451772643|FG003|Overall Study|Ineligible|0|||
125587111|NCT01827384|451772644|FG004|Overall Study|Ineligible|0|||
125587112|NCT01827384|451772645|FG005|Overall Study|Ineligible|0|||
125587113|NCT01827384|451772646|FG006|Overall Study|Ineligible|0|||
125587114|NCT01827384|451772647|FG007|Overall Study|Ineligible|0|||
125587115|NCT01827384|451772648|FG008|Overall Study|Ineligible|0|||
125587116|NCT01827384|451772649|FG009|Overall Study|Ineligible|0|||
125587117|NCT01827384|451772650|FG010|Overall Study|Ineligible|0|||
125587118|NCT01827384|451772651|FG011|Overall Study|Ineligible|0|||
125587119|NCT01827384|451772652|FG012|Overall Study|Ineligible|0|||
125587120|NCT01827384|451772653|FG013|Overall Study|Ineligible|19|||
125587121|NCT01827384|451772640|FG000|Overall Study|Participant died before treatment|0|||
125587122|NCT01827384|451772641|FG001|Overall Study|Participant died before treatment|0|||
125587123|NCT01827384|451772642|FG002|Overall Study|Participant died before treatment|0|||
125587124|NCT01827384|451772643|FG003|Overall Study|Participant died before treatment|0|||
125587125|NCT01827384|451772644|FG004|Overall Study|Participant died before treatment|0|||
125587126|NCT01827384|451772645|FG005|Overall Study|Participant died before treatment|0|||
125587127|NCT01827384|451772646|FG006|Overall Study|Participant died before treatment|0|||
125587128|NCT01827384|451772647|FG007|Overall Study|Participant died before treatment|0|||
125587129|NCT01827384|451772648|FG008|Overall Study|Participant died before treatment|0|||
125587130|NCT01827384|451772649|FG009|Overall Study|Participant died before treatment|0|||
125587131|NCT01827384|451772650|FG010|Overall Study|Participant died before treatment|0|||
125587132|NCT01827384|451772651|FG011|Overall Study|Participant died before treatment|0|||
125587133|NCT01827384|451772652|FG012|Overall Study|Participant died before treatment|0|||
125587134|NCT01827384|451772653|FG013|Overall Study|Participant died before treatment|5|||
125587135|NCT01827384|451772640|FG000|Overall Study|Insufficient tumor cells|0|||
125587136|NCT01827384|451772641|FG001|Overall Study|Insufficient tumor cells|0|||
125587137|NCT01827384|451772642|FG002|Overall Study|Insufficient tumor cells|0|||
125587138|NCT01827384|451772643|FG003|Overall Study|Insufficient tumor cells|0|||
125587139|NCT01827384|451772644|FG004|Overall Study|Insufficient tumor cells|0|||
125587140|NCT01827384|451772645|FG005|Overall Study|Insufficient tumor cells|0|||
125587141|NCT01827384|451772646|FG006|Overall Study|Insufficient tumor cells|0|||
125587142|NCT01827384|451772647|FG007|Overall Study|Insufficient tumor cells|0|||
125587143|NCT01827384|451772648|FG008|Overall Study|Insufficient tumor cells|0|||
125587144|NCT01827384|451772649|FG009|Overall Study|Insufficient tumor cells|0|||
125587145|NCT01827384|451772650|FG010|Overall Study|Insufficient tumor cells|0|||
125587146|NCT01827384|451772651|FG011|Overall Study|Insufficient tumor cells|0|||
125587147|NCT01827384|451772652|FG012|Overall Study|Insufficient tumor cells|0|||
125587148|NCT01827384|451772653|FG013|Overall Study|Insufficient tumor cells|13|||
125587149|NCT01827384|451772640|FG000|Overall Study|No actionable mutation|0|||
125587150|NCT01827384|451772641|FG001|Overall Study|No actionable mutation|0|||
125587151|NCT01827384|451772642|FG002|Overall Study|No actionable mutation|0|||
125587152|NCT01827384|451772643|FG003|Overall Study|No actionable mutation|0|||
125587153|NCT01827384|451772644|FG004|Overall Study|No actionable mutation|0|||
125587154|NCT01827384|451772645|FG005|Overall Study|No actionable mutation|0|||
125587155|NCT01827384|451772646|FG006|Overall Study|No actionable mutation|0|||
125587156|NCT01827384|451772647|FG007|Overall Study|No actionable mutation|0|||
125587157|NCT01827384|451772648|FG008|Overall Study|No actionable mutation|0|||
125587158|NCT01827384|451772649|FG009|Overall Study|No actionable mutation|0|||
125429031|NCT02390531|451195558|FG005|Overall Study|Protocol Violation|0|||
125587159|NCT01827384|451772650|FG010|Overall Study|No actionable mutation|0|||
125587160|NCT01827384|451772651|FG011|Overall Study|No actionable mutation|0|||
125587161|NCT01827384|451772652|FG012|Overall Study|No actionable mutation|0|||
125587162|NCT01827384|451772653|FG013|Overall Study|No actionable mutation|73|||
125587163|NCT01827384|451772640|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
125587164|NCT01827384|451772641|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
125587165|NCT01827384|451772642|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
125587166|NCT01827384|451772643|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
125587167|NCT01827384|451772644|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
125587168|NCT01827384|451772645|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
125587169|NCT01827384|451772646|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
125587170|NCT01827384|451772647|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
125587171|NCT01827384|451772648|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
125587172|NCT01827384|451772649|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
125587173|NCT01827384|451772650|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
125587174|NCT01827384|451772651|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
125587175|NCT01827384|451772652|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
125587176|NCT01827384|451772653|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
125587177|NCT03219164|451774344|FG000|Overall Study|Study Terminated by Sponsor|16|||
125587178|NCT03219164|451774345|FG001|Overall Study|Study Terminated by Sponsor|12|||
125587179|NCT03219164|451774344|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
125587180|NCT03219164|451774345|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
125587181|NCT03219164|451774344|FG000|Overall Study|Lost to Follow-up|1|||
125587182|NCT03219164|451774345|FG001|Overall Study|Lost to Follow-up|1|||
125587183|NCT03219164|451774344|FG000|Overall Study|Adverse Event|1|||
125587184|NCT03219164|451774345|FG001|Overall Study|Adverse Event|0|||
125587185|NCT03219164|451774344|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125587186|NCT03219164|451774345|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125587187|NCT03219164|451774344|FG000|Overall Study|Protocol Violation|0|||
125587188|NCT03219164|451774345|FG001|Overall Study|Protocol Violation|1|||
125587189|NCT03219164|451774344|FG000|Overall Study|Withdrew Assent|1|||
125587190|NCT03219164|451774345|FG001|Overall Study|Withdrew Assent|0|||
125587191|NCT02689492|451774346|FG000|Overall Study|Lost to Follow-up|61|||
125587192|NCT02689492|451774346|FG000|Overall Study|Withdrawal by Subject|11|||
125587193|NCT02689492|451774346|FG000|Overall Study|Death|9|||
125587194|NCT02689492|451774346|FG000|Overall Study|Physician Decision|2|||
125587195|NCT02689492|451774346|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
125587196|NCT02689492|451774346|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
125587197|NCT02689492|451774346|FG000|Overall Study|Other than listed|1|||
125587198|NCT02029976|451774347|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
125587199|NCT02029976|451774348|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
125587200|NCT02029976|451774347|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
125587201|NCT02029976|451774348|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
125587202|NCT02029976|451774347|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
125587203|NCT02029976|451774348|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
125587204|NCT02029976|451774347|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
125587205|NCT02029976|451774348|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
125587206|NCT04025632|451774349|FG000|Overall Study|Adverse Event|1|||
125587207|NCT04025632|451774350|FG001|Overall Study|Adverse Event|1|||
125587208|NCT04025632|451774349|FG000|Overall Study|Withdrawal by Subject|1|||
125587209|NCT04025632|451774350|FG001|Overall Study|Withdrawal by Subject|1|||
125587210|NCT04025632|451774349|FG000|Overall Study|Study Terminated by Sponsor|10|||
125587211|NCT04025632|451774350|FG001|Overall Study|Study Terminated by Sponsor|9|||
125587212|NCT04025632|451774349|FG000|Overall Study|Physician Decision|3|||
125587213|NCT04025632|451774350|FG001|Overall Study|Physician Decision|1|||
125587214|NCT00127127|451774351|FG000|Overall Study|Adverse Event|0|||
125587215|NCT00127127|451774352|FG001|Overall Study|Adverse Event|2|||
125587216|NCT00127127|451774353|FG002|Overall Study|Adverse Event|0|||
125587217|NCT00127127|451774354|FG003|Overall Study|Adverse Event|1|||
125587218|NCT00127127|451774351|FG000|Overall Study|Lack of Efficacy|1|||
125587219|NCT00127127|451774352|FG001|Overall Study|Lack of Efficacy|3|||
125587220|NCT00127127|451774353|FG002|Overall Study|Lack of Efficacy|0|||
125587221|NCT00127127|451774354|FG003|Overall Study|Lack of Efficacy|2|||
125587222|NCT01524991|451774357|FG000|Overall Study|Adverse Event|12|||
125587223|NCT01524991|451774357|FG000|Overall Study|Death|1|||
125587224|NCT01524991|451774357|FG000|Overall Study|Disease ProgressionDu|17|||
125587225|NCT01524991|451774357|FG000|Overall Study|Other complicating disease|1|||
125587226|NCT01524991|451774357|FG000|Overall Study|Withdrawal by Subject|2|||
125587227|NCT01524991|451774357|FG000|Overall Study|Symptomatic Deterioration|1|||
125587228|NCT01805180|451774360|FG000|Lead-in Donor Phase|screen failure|1|||
125587229|NCT01805180|451774361|FG001|Lead-in Donor Phase|screen failure|0|||
125587230|NCT01805180|451774362|FG002|Lead-in Donor Phase|screen failure|0|||
125587231|NCT00582556|451774366|FG000|Overall Study|Withdrawal by Subject|0|||
125587232|NCT00582556|451774367|FG001|Overall Study|Withdrawal by Subject|1|||
125587233|NCT00582556|451774368|FG002|Overall Study|Withdrawal by Subject|1|||
125587234|NCT00582556|451774366|FG000|Overall Study|Physician Decision|0|||
125211844|NCT00048165|450401385|FG000|Completed 6 Months Study|Death|12|||
125211845|NCT00048165|450401386|FG001|Completed 6 Months Study|Death|6|||
125587235|NCT00582556|451774367|FG001|Overall Study|Physician Decision|0|||
125587236|NCT00582556|451774368|FG002|Overall Study|Physician Decision|1|||
125587237|NCT01341457|451774369|FG000|Overall Study|Adverse Event|2|||
125587238|NCT01341457|451774370|FG001|Overall Study|Adverse Event|0|||
125587239|NCT03124459|451774371|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
125587240|NCT03124459|451774372|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
125587241|NCT03124459|451774373|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
125587242|NCT03124459|451774374|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
125587243|NCT03124459|451774375|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
125587244|NCT03124459|451774376|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
125587245|NCT03124459|451774371|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
125587246|NCT03124459|451774372|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
125587247|NCT03124459|451774373|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
125587248|NCT03124459|451774374|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
125587249|NCT03124459|451774375|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
125587250|NCT03124459|451774376|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
125587251|NCT03124459|451774371|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
125587252|NCT03124459|451774372|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
125587253|NCT03124459|451774373|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
125587254|NCT03124459|451774374|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
125587255|NCT03124459|451774375|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
125587256|NCT03124459|451774376|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
125587257|NCT03124459|451774371|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
125587258|NCT03124459|451774372|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
125587259|NCT03124459|451774373|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
125587260|NCT03124459|451774374|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
125587261|NCT03124459|451774375|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
125587262|NCT03124459|451774376|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
125587263|NCT03124459|451774371|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
125587264|NCT03124459|451774372|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
125587265|NCT03124459|451774373|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
125587266|NCT03124459|451774374|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
125587267|NCT03124459|451774375|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
125587268|NCT03124459|451774376|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
125587269|NCT03124459|451774371|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
125587270|NCT03124459|451774372|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
125587271|NCT03124459|451774373|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
125587272|NCT03124459|451774374|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
125587273|NCT03124459|451774375|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
125587274|NCT03124459|451774376|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
125587275|NCT00496366|451774377|FG000|Overall Study|Death|1|||
125587276|NCT01717638|451774378|FG000|Overall Study|Lost to Follow-up|0|||
125587277|NCT01717638|451774379|FG001|Overall Study|Lost to Follow-up|0|||
125587278|NCT01717638|451774380|FG002|Overall Study|Lost to Follow-up|0|||
125587279|NCT01717638|451774381|FG003|Overall Study|Lost to Follow-up|0|||
125587280|NCT01717638|451774382|FG004|Overall Study|Lost to Follow-up|0|||
125587281|NCT01717638|451774383|FG005|Overall Study|Lost to Follow-up|1|||
125587282|NCT01717638|451774384|FG006|Overall Study|Lost to Follow-up|0|||
125587283|NCT01717638|451774385|FG007|Overall Study|Lost to Follow-up|0|||
125587284|NCT01717638|451774386|FG008|Overall Study|Lost to Follow-up|0|||
125587285|NCT01717638|451774387|FG009|Overall Study|Lost to Follow-up|0|||
125587286|NCT01717638|451774388|FG010|Overall Study|Lost to Follow-up|0|||
125587287|NCT01717638|451774389|FG011|Overall Study|Lost to Follow-up|0|||
125587288|NCT01717638|451774390|FG012|Overall Study|Lost to Follow-up|0|||
125587289|NCT01717638|451774378|FG000|Overall Study|Father in hospital|0|||
125587290|NCT01717638|451774379|FG001|Overall Study|Father in hospital|0|||
125587291|NCT01717638|451774380|FG002|Overall Study|Father in hospital|0|||
125587292|NCT01717638|451774381|FG003|Overall Study|Father in hospital|0|||
125429032|NCT02390531|451195559|FG006|Overall Study|Protocol Violation|2|||
125429033|NCT02390531|451195560|FG007|Overall Study|Protocol Violation|0|||
125429034|NCT00511875|451195561|FG000|Overall Study|Lost to Follow-up|4|||
125429035|NCT00511875|451195562|FG001|Overall Study|Lost to Follow-up|0|||
125587293|NCT01717638|451774382|FG004|Overall Study|Father in hospital|0|||
125587294|NCT01717638|451774383|FG005|Overall Study|Father in hospital|0|||
125587295|NCT01717638|451774384|FG006|Overall Study|Father in hospital|0|||
125587296|NCT01717638|451774385|FG007|Overall Study|Father in hospital|0|||
125587297|NCT01717638|451774386|FG008|Overall Study|Father in hospital|0|||
125587298|NCT01717638|451774387|FG009|Overall Study|Father in hospital|0|||
125587299|NCT01717638|451774388|FG010|Overall Study|Father in hospital|0|||
125587300|NCT01717638|451774389|FG011|Overall Study|Father in hospital|0|||
125587301|NCT01717638|451774390|FG012|Overall Study|Father in hospital|1|||
125587302|NCT01717638|451774378|FG000|Overall Study|Withdrawal by Subject|0|||
125429036|NCT00511875|451195561|FG000|Overall Study|Missing variables|1|||
125429037|NCT00511875|451195562|FG001|Overall Study|Missing variables|0|||
125429038|NCT02618616|451195563|FG000|Overall Study|Lack of Efficacy|4|||
125429039|NCT02618616|451195564|FG001|Overall Study|Lack of Efficacy|0|||
125429040|NCT02618616|451195563|FG000|Overall Study|Pregnancy|0|||
125429041|NCT02618616|451195564|FG001|Overall Study|Pregnancy|1|||
125429042|NCT02618616|451195563|FG000|Overall Study|Adverse Event|8|||
125429043|NCT02618616|451195564|FG001|Overall Study|Adverse Event|0|||
125429044|NCT02618616|451195563|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
125429045|NCT02618616|451195564|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
125429046|NCT02618616|451195563|FG000|Overall Study|Consent withdrawn by subject|8|||
125587303|NCT01717638|451774379|FG001|Overall Study|Withdrawal by Subject|1|||
125587304|NCT01717638|451774380|FG002|Overall Study|Withdrawal by Subject|1|||
125587305|NCT01717638|451774381|FG003|Overall Study|Withdrawal by Subject|0|||
125587306|NCT01717638|451774382|FG004|Overall Study|Withdrawal by Subject|1|||
125587307|NCT01717638|451774383|FG005|Overall Study|Withdrawal by Subject|0|||
125587308|NCT01717638|451774384|FG006|Overall Study|Withdrawal by Subject|2|||
125587309|NCT01717638|451774385|FG007|Overall Study|Withdrawal by Subject|1|||
125587310|NCT01717638|451774386|FG008|Overall Study|Withdrawal by Subject|2|||
125587311|NCT01717638|451774387|FG009|Overall Study|Withdrawal by Subject|1|||
125587312|NCT01717638|451774388|FG010|Overall Study|Withdrawal by Subject|0|||
125429047|NCT02618616|451195564|FG001|Overall Study|Consent withdrawn by subject|5|||
125429048|NCT02618616|451195563|FG000|Overall Study|Lost to Follow-up|0|||
125429049|NCT02618616|451195564|FG001|Overall Study|Lost to Follow-up|1|||
125429050|NCT00696384|451195565|FG000|Open Label Phase|Adverse Event|27|||
125429051|NCT00696384|451195566|FG001|Open Label Phase|Adverse Event|0|||
125429052|NCT00696384|451195567|FG002|Open Label Phase|Adverse Event|0|||
125429053|NCT00696384|451195565|FG000|Open Label Phase|Protocol Violation|18|||
125429054|NCT00696384|451195566|FG001|Open Label Phase|Protocol Violation|0|||
125429055|NCT00696384|451195567|FG002|Open Label Phase|Protocol Violation|0|||
125429056|NCT00696384|451195565|FG000|Open Label Phase|Lost to Follow-up|24|||
125429057|NCT00696384|451195566|FG001|Open Label Phase|Lost to Follow-up|0|||
125429058|NCT00696384|451195567|FG002|Open Label Phase|Lost to Follow-up|0|||
125429059|NCT00696384|451195565|FG000|Open Label Phase|Withdrawal by Subject|37|||
125429060|NCT00696384|451195566|FG001|Open Label Phase|Withdrawal by Subject|0|||
125429061|NCT00696384|451195567|FG002|Open Label Phase|Withdrawal by Subject|0|||
125429062|NCT00696384|451195565|FG000|Open Label Phase|Other|6|||
125429063|NCT00696384|451195566|FG001|Open Label Phase|Other|0|||
125587313|NCT01717638|451774389|FG011|Overall Study|Withdrawal by Subject|0|||
125587314|NCT01717638|451774390|FG012|Overall Study|Withdrawal by Subject|18|||
125587315|NCT02429856|451774395|FG000|Overall Study|Death|12|||
125587316|NCT02429856|451774396|FG001|Overall Study|Death|13|||
125587317|NCT02429856|451774395|FG000|Overall Study|Lost to Follow-up|6|||
125429064|NCT00696384|451195567|FG002|Open Label Phase|Other|0|||
125429065|NCT00696384|451195565|FG000|Open Label Phase|Lack of Efficacy|3|||
125429066|NCT00696384|451195566|FG001|Open Label Phase|Lack of Efficacy|0|||
125429067|NCT00696384|451195567|FG002|Open Label Phase|Lack of Efficacy|0|||
125587318|NCT02429856|451774396|FG001|Overall Study|Lost to Follow-up|5|||
125587319|NCT02429856|451774395|FG000|Overall Study|Withdrawal by Subject|1|||
125587320|NCT02429856|451774396|FG001|Overall Study|Withdrawal by Subject|1|||
125429068|NCT00696384|451195565|FG000|Open Label Phase|Physician Decision|4|||
125429069|NCT00696384|451195566|FG001|Open Label Phase|Physician Decision|0|||
125587321|NCT03514914|451774398|FG000|Overall Study|Death|3|||
125587322|NCT03514914|451774399|FG001|Overall Study|Death|3|||
125587323|NCT03514914|451774398|FG000|Overall Study|Lost to Follow-up|117|||
125429070|NCT00696384|451195567|FG002|Open Label Phase|Physician Decision|0|||
125587324|NCT03514914|451774399|FG001|Overall Study|Lost to Follow-up|89|||
125587325|NCT01355289|451774401|FG000|Core Study|Adverse Event, Non-Fatal|1|||
125587326|NCT01355289|451774402|FG001|Core Study|Adverse Event, Non-Fatal|0|||
125587327|NCT01355289|451774403|FG002|Core Study|Adverse Event, Non-Fatal|0|||
125587328|NCT01355289|451774404|FG003|Core Study|Adverse Event, Non-Fatal|0|||
125587329|NCT01355289|451774405|FG004|Core Study|Adverse Event, Non-Fatal|0|||
125429071|NCT00696384|451195565|FG000|Double Blind Phase|Adverse Event|0|||
125429072|NCT00696384|451195566|FG001|Double Blind Phase|Adverse Event|2|||
125429073|NCT00696384|451195567|FG002|Double Blind Phase|Adverse Event|2|||
125587330|NCT01355289|451774401|FG000|Core Study|Inadequate Therapeutic Effect|0|||
125587331|NCT01355289|451774402|FG001|Core Study|Inadequate Therapeutic Effect|0|||
125587332|NCT01355289|451774403|FG002|Core Study|Inadequate Therapeutic Effect|0|||
125587333|NCT01355289|451774404|FG003|Core Study|Inadequate Therapeutic Effect|1|||
125587334|NCT01355289|451774405|FG004|Core Study|Inadequate Therapeutic Effect|0|||
125587335|NCT01355289|451774401|FG000|Core Study|Other|0|||
125587336|NCT01355289|451774402|FG001|Core Study|Other|0|||
125587337|NCT01355289|451774403|FG002|Core Study|Other|0|||
125587338|NCT01355289|451774404|FG003|Core Study|Other|1|||
125587339|NCT01355289|451774405|FG004|Core Study|Other|0|||
125587340|NCT01355289|451774401|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
125587341|NCT01355289|451774402|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
125587342|NCT01355289|451774403|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
125587343|NCT01355289|451774404|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
125587344|NCT01355289|451774405|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
125587345|NCT01355289|451774401|FG000|Open Label Extension|Lost to Follow-up|0|||
125587346|NCT01355289|451774402|FG001|Open Label Extension|Lost to Follow-up|0|||
125587347|NCT01355289|451774403|FG002|Open Label Extension|Lost to Follow-up|0|||
125587348|NCT01355289|451774404|FG003|Open Label Extension|Lost to Follow-up|0|||
125587349|NCT01355289|451774405|FG004|Open Label Extension|Lost to Follow-up|1|||
125587350|NCT01355289|451774401|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
125587351|NCT01355289|451774402|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
125587352|NCT01355289|451774403|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
125587353|NCT01355289|451774404|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
125587354|NCT01355289|451774405|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
125587355|NCT01355289|451774401|FG000|Open Label Extension|Other|0|||
125587356|NCT01355289|451774402|FG001|Open Label Extension|Other|0|||
125587357|NCT01355289|451774403|FG002|Open Label Extension|Other|0|||
125587358|NCT01355289|451774404|FG003|Open Label Extension|Other|0|||
125587359|NCT01355289|451774405|FG004|Open Label Extension|Other|3|||
125587360|NCT04336163|451774406|FG000|Overall Study|Lost to Follow-up|55|||
125587361|NCT04336163|451774407|FG001|Overall Study|Lost to Follow-up|0|||
125587362|NCT01085682|451774408|FG000|Overall Study|Withdrawal by Subject|25|||
125587363|NCT01085682|451774409|FG001|Overall Study|Withdrawal by Subject|25|||
125587364|NCT00813995|451774414|FG000|Overall Study|Clinical adverse event|9|||
125587365|NCT00813995|451774415|FG001|Overall Study|Clinical adverse event|3|||
125587366|NCT00813995|451774414|FG000|Overall Study|Laboratory adverse event|0|||
125587367|NCT00813995|451774415|FG001|Overall Study|Laboratory adverse event|2|||
125587368|NCT00813995|451774414|FG000|Overall Study|Lack of Efficacy|1|||
125587369|NCT00813995|451774415|FG001|Overall Study|Lack of Efficacy|0|||
125587370|NCT00813995|451774414|FG000|Overall Study|Lost to Follow-up|4|||
125587371|NCT00813995|451774415|FG001|Overall Study|Lost to Follow-up|2|||
125587372|NCT00813995|451774414|FG000|Overall Study|Other reason|2|||
125587373|NCT00813995|451774415|FG001|Overall Study|Other reason|2|||
125587374|NCT00813995|451774414|FG000|Overall Study|Protocol Violation|3|||
125587375|NCT00813995|451774415|FG001|Overall Study|Protocol Violation|2|||
125587376|NCT00813995|451774414|FG000|Overall Study|Subject moved|4|||
125587377|NCT00813995|451774415|FG001|Overall Study|Subject moved|0|||
125587378|NCT00813995|451774414|FG000|Overall Study|Withdrawal by Subject|0|||
125587379|NCT00813995|451774415|FG001|Overall Study|Withdrawal by Subject|5|||
125587380|NCT01614964|451774416|FG000|Overall Study|Withdrawal by Subject|2|||
125587381|NCT01614964|451774417|FG001|Overall Study|Withdrawal by Subject|0|||
125587382|NCT01614964|451774416|FG000|Overall Study|Lost to Follow-up|3|||
125587383|NCT01614964|451774417|FG001|Overall Study|Lost to Follow-up|0|||
125587384|NCT02700984|451774426|FG000|Overall Study|Death|2|||
125587385|NCT02700984|451774427|FG001|Overall Study|Death|1|||
125587386|NCT02700984|451774426|FG000|Overall Study|Lost to Follow-up|2|||
125587387|NCT02700984|451774427|FG001|Overall Study|Lost to Follow-up|1|||
125587388|NCT02700984|451774426|FG000|Overall Study|Physician Decision|0|||
125587389|NCT02700984|451774427|FG001|Overall Study|Physician Decision|1|||
125587390|NCT02700984|451774426|FG000|Overall Study|Withdrawal by Subject|8|||
125587391|NCT02700984|451774427|FG001|Overall Study|Withdrawal by Subject|9|||
125587392|NCT02700984|451774426|FG000|Overall Study|Reason not specified|3|||
125587393|NCT02700984|451774427|FG001|Overall Study|Reason not specified|2|||
125587394|NCT00473876|451774428|FG000|Overall Study|Lost to Follow-up|3|||
125587395|NCT00473876|451774429|FG001|Overall Study|Lost to Follow-up|1|||
125587396|NCT00348140|451774431|FG000|Overall Study|Adverse Event|46|||
125587397|NCT00348140|451774432|FG001|Overall Study|Adverse Event|49|||
125587398|NCT00348140|451774433|FG002|Overall Study|Adverse Event|78|||
125587399|NCT00348140|451774431|FG000|Overall Study|Lost to Follow-up|4|||
125587400|NCT00348140|451774432|FG001|Overall Study|Lost to Follow-up|4|||
125587401|NCT00348140|451774433|FG002|Overall Study|Lost to Follow-up|4|||
125587402|NCT00348140|451774431|FG000|Overall Study|Protocol Violation|12|||
125587403|NCT00348140|451774432|FG001|Overall Study|Protocol Violation|13|||
125587404|NCT00348140|451774433|FG002|Overall Study|Protocol Violation|14|||
125587405|NCT00348140|451774431|FG000|Overall Study|Withdrawal by Subject|32|||
125587406|NCT00348140|451774432|FG001|Overall Study|Withdrawal by Subject|40|||
125587407|NCT00348140|451774433|FG002|Overall Study|Withdrawal by Subject|40|||
125587408|NCT00348140|451774431|FG000|Overall Study|Non-compliance|8|||
125587409|NCT00348140|451774432|FG001|Overall Study|Non-compliance|13|||
125587410|NCT00348140|451774433|FG002|Overall Study|Non-compliance|5|||
125587411|NCT00348140|451774431|FG000|Overall Study|Participant at risk due to study drug|2|||
125587412|NCT00348140|451774432|FG001|Overall Study|Participant at risk due to study drug|0|||
125587413|NCT00348140|451774433|FG002|Overall Study|Participant at risk due to study drug|0|||
125587414|NCT00348140|451774431|FG000|Overall Study|Conditional medication increased dose|1|||
125587415|NCT00348140|451774432|FG001|Overall Study|Conditional medication increased dose|0|||
125587416|NCT00348140|451774433|FG002|Overall Study|Conditional medication increased dose|0|||
125587417|NCT00348140|451774431|FG000|Overall Study|Caregiver related|4|||
125587418|NCT00348140|451774432|FG001|Overall Study|Caregiver related|7|||
125587419|NCT00348140|451774433|FG002|Overall Study|Caregiver related|3|||
125587420|NCT00348140|451774431|FG000|Overall Study|Participant hospitalised|3|||
125587421|NCT00348140|451774432|FG001|Overall Study|Participant hospitalised|0|||
125587422|NCT00348140|451774433|FG002|Overall Study|Participant hospitalised|0|||
125587423|NCT00348140|451774431|FG000|Overall Study|Efficacy related|1|||
125587424|NCT00348140|451774432|FG001|Overall Study|Efficacy related|1|||
125587425|NCT00348140|451774433|FG002|Overall Study|Efficacy related|0|||
125587426|NCT00348140|451774431|FG000|Overall Study|Administration related|3|||
125587427|NCT00348140|451774432|FG001|Overall Study|Administration related|1|||
125587428|NCT00348140|451774433|FG002|Overall Study|Administration related|1|||
125587429|NCT00348140|451774431|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
125587430|NCT00348140|451774432|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
125587431|NCT00348140|451774433|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
125587432|NCT00348140|451774431|FG000|Overall Study|Participant unwell|1|||
125587433|NCT00348140|451774432|FG001|Overall Study|Participant unwell|0|||
125587434|NCT00348140|451774433|FG002|Overall Study|Participant unwell|0|||
125587435|NCT00348140|451774431|FG000|Overall Study|Screen failure|1|||
125587436|NCT00348140|451774432|FG001|Overall Study|Screen failure|0|||
125587437|NCT00348140|451774433|FG002|Overall Study|Screen failure|0|||
125587438|NCT00348140|451774431|FG000|Overall Study|Investigator decided to discontinue|4|||
125587439|NCT00348140|451774432|FG001|Overall Study|Investigator decided to discontinue|1|||
125587440|NCT00348140|451774433|FG002|Overall Study|Investigator decided to discontinue|4|||
125587441|NCT00348140|451774431|FG000|Overall Study|Decided to discontinue on their own|1|||
125429074|NCT00696384|451195565|FG000|Double Blind Phase|Lost to Follow-up|0|||
125429075|NCT00696384|451195566|FG001|Double Blind Phase|Lost to Follow-up|2|||
125429076|NCT00696384|451195567|FG002|Double Blind Phase|Lost to Follow-up|1|||
125429077|NCT00696384|451195565|FG000|Double Blind Phase|Withdrawal by Subject|0|||
125587442|NCT00348140|451774432|FG001|Overall Study|Decided to discontinue on their own|4|||
125587443|NCT00348140|451774433|FG002|Overall Study|Decided to discontinue on their own|1|||
125587444|NCT00348140|451774431|FG000|Overall Study|Use of prohibited drug|1|||
125587445|NCT00348140|451774432|FG001|Overall Study|Use of prohibited drug|0|||
125587446|NCT00348140|451774433|FG002|Overall Study|Use of prohibited drug|2|||
125587447|NCT00348140|451774431|FG000|Overall Study|Disease progression|1|||
125587448|NCT00348140|451774432|FG001|Overall Study|Disease progression|2|||
125587449|NCT00348140|451774433|FG002|Overall Study|Disease progression|5|||
125587450|NCT00348140|451774431|FG000|Overall Study|Increased risk of cardiac infarction|0|||
125587451|NCT00348140|451774432|FG001|Overall Study|Increased risk of cardiac infarction|1|||
125587452|NCT00348140|451774433|FG002|Overall Study|Increased risk of cardiac infarction|0|||
125587453|NCT00348140|451774431|FG000|Overall Study|Serious adverse event|0|||
125587454|NCT00348140|451774432|FG001|Overall Study|Serious adverse event|1|||
125587455|NCT00348140|451774433|FG002|Overall Study|Serious adverse event|0|||
125587456|NCT00348140|451774431|FG000|Overall Study|Abnormal ECG|0|||
125587457|NCT00348140|451774432|FG001|Overall Study|Abnormal ECG|1|||
125587458|NCT00348140|451774433|FG002|Overall Study|Abnormal ECG|3|||
125587459|NCT00348140|451774431|FG000|Overall Study|Participant died|0|||
125587460|NCT00348140|451774432|FG001|Overall Study|Participant died|1|||
125587461|NCT00348140|451774433|FG002|Overall Study|Participant died|0|||
125587462|NCT00348140|451774431|FG000|Overall Study|Exclusion criteria met|0|||
125587463|NCT00348140|451774432|FG001|Overall Study|Exclusion criteria met|0|||
125587464|NCT00348140|451774433|FG002|Overall Study|Exclusion criteria met|1|||
125587465|NCT00348140|451774431|FG000|Overall Study|Memory declined|0|||
125587466|NCT00348140|451774432|FG001|Overall Study|Memory declined|0|||
125587467|NCT00348140|451774433|FG002|Overall Study|Memory declined|1|||
125587468|NCT01032629|451774434|FG000|Overall Study|Closed Site|21|||
125587469|NCT01032629|451774435|FG001|Overall Study|Closed Site|18|||
125587470|NCT01032629|451774436|FG002|Overall Study|Closed Site|16|||
125587471|NCT01032629|451774434|FG000|Overall Study|Withdrawal by Subject|50|||
125587472|NCT01032629|451774435|FG001|Overall Study|Withdrawal by Subject|36|||
125587473|NCT01032629|451774436|FG002|Overall Study|Withdrawal by Subject|35|||
125429078|NCT00696384|451195566|FG001|Double Blind Phase|Withdrawal by Subject|4|||
125587474|NCT01032629|451774434|FG000|Overall Study|Lost to Follow-up|74|||
125587475|NCT01032629|451774435|FG001|Overall Study|Lost to Follow-up|47|||
125587476|NCT01032629|451774436|FG002|Overall Study|Lost to Follow-up|37|||
125587477|NCT03545282|451774437|FG000|Overall Study|Lost to Follow-up|15|||
125587478|NCT03545282|451774438|FG001|Overall Study|Lost to Follow-up|10|||
125429079|NCT00696384|451195567|FG002|Double Blind Phase|Withdrawal by Subject|3|||
125429080|NCT00696384|451195565|FG000|Double Blind Phase|Lack of Efficacy|0|||
125429081|NCT00696384|451195566|FG001|Double Blind Phase|Lack of Efficacy|1|||
125429082|NCT00696384|451195567|FG002|Double Blind Phase|Lack of Efficacy|0|||
125429083|NCT00696384|451195565|FG000|Double Blind Phase|Physician Decision|0|||
125429084|NCT00696384|451195566|FG001|Double Blind Phase|Physician Decision|2|||
125429085|NCT00696384|451195567|FG002|Double Blind Phase|Physician Decision|0|||
125429086|NCT02027402|451195569|FG000|Overall Study|Withdrawal by Subject|4|||
125429087|NCT02027402|451195570|FG001|Overall Study|Withdrawal by Subject|1|||
125429088|NCT04179721|451195576|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
125429089|NCT04179721|451195577|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
125429090|NCT04179721|451195576|FG000|Overall Study|Lost to Follow-up|0|||
125429091|NCT04179721|451195577|FG001|Overall Study|Lost to Follow-up|1|||
125429092|NCT04225988|451195578|FG000|Overall Study|Withdrawal by Subject|2|||
125429093|NCT04225988|451195579|FG001|Overall Study|Withdrawal by Subject|0|||
125587479|NCT03545282|451774437|FG000|Overall Study|Withdrawal by Subject|2|||
125587480|NCT03545282|451774438|FG001|Overall Study|Withdrawal by Subject|2|||
125587481|NCT00755079|451774439|FG000|Overall Study|Lost to Follow-up|1|||
125587482|NCT00755079|451774440|FG001|Overall Study|Lost to Follow-up|3|||
125587483|NCT00755079|451774439|FG000|Overall Study|Adverse Event|0|||
125587484|NCT00755079|451774440|FG001|Overall Study|Adverse Event|1|||
125587485|NCT00755079|451774439|FG000|Overall Study|Withdrawal by Subject|0|||
125587486|NCT00755079|451774440|FG001|Overall Study|Withdrawal by Subject|2|||
125587487|NCT03377634|451774444|FG000|Study Period|Adverse Event|1|||
125587488|NCT03377634|451774445|FG001|Study Period|Adverse Event|0|||
125587489|NCT03377634|451774444|FG000|Study Period|Withdrawal by Subject|1|||
125587490|NCT03377634|451774445|FG001|Study Period|Withdrawal by Subject|0|||
125587491|NCT00737529|451774450|FG000|Overall Study|Disease Progression|95|||
125587492|NCT00737529|451774450|FG000|Overall Study|Adverse Event|24|||
125587493|NCT00737529|451774450|FG000|Overall Study|Withdrawal by Subject|5|||
125587494|NCT00737529|451774450|FG000|Overall Study|Death|4|||
125587495|NCT00737529|451774450|FG000|Overall Study|Protocol Violation|1|||
125587496|NCT00737529|451774450|FG000|Overall Study|Other|4|||
125587497|NCT01818297|451774458|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
125587498|NCT01818297|451774459|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
125587499|NCT01818297|451774458|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
125587500|NCT01818297|451774459|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
125587501|NCT01818297|451774458|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
125587502|NCT01818297|451774459|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
125587503|NCT01412229|451774460|FG000|Overall Study|Physician Decision|1|||
125587504|NCT01889602|451774461|FG000|First Intervention|Adverse Event|1|||
125587505|NCT01889602|451774462|FG001|First Intervention|Adverse Event|1|||
125429094|NCT01142388|451196551|FG000|Overall Study|Lack of Efficacy|21|||
125429095|NCT01142388|451196552|FG001|Overall Study|Lack of Efficacy|31|||
125429096|NCT01142388|451196551|FG000|Overall Study|Adverse Event|9|||
125429097|NCT01142388|451196552|FG001|Overall Study|Adverse Event|5|||
125429098|NCT01142388|451196551|FG000|Overall Study|Death|3|||
125587506|NCT01889602|451774463|FG002|First Intervention|Adverse Event|1|||
125587507|NCT01889602|451774461|FG000|First Intervention|Protocol Violation|0|||
125587508|NCT01889602|451774462|FG001|First Intervention|Protocol Violation|1|||
125587509|NCT01889602|451774463|FG002|First Intervention|Protocol Violation|1|||
125587510|NCT01889602|451774461|FG000|First Intervention|Study ending|0|||
125587511|NCT01889602|451774462|FG001|First Intervention|Study ending|1|||
125587512|NCT01889602|451774463|FG002|First Intervention|Study ending|0|||
125587513|NCT01889602|451774461|FG000|Second Intervention|Adverse Event|0|||
125587514|NCT01889602|451774462|FG001|Second Intervention|Adverse Event|0|||
125587515|NCT01889602|451774463|FG002|Second Intervention|Adverse Event|1|||
125587516|NCT01889602|451774461|FG000|Second Intervention|Study ending|1|||
125587517|NCT01889602|451774462|FG001|Second Intervention|Study ending|0|||
125587518|NCT01889602|451774463|FG002|Second Intervention|Study ending|0|||
125587519|NCT01889602|451774461|FG000|Second Intervention|Withdrawal by Subject|0|||
125587520|NCT01889602|451774462|FG001|Second Intervention|Withdrawal by Subject|0|||
125587521|NCT01889602|451774463|FG002|Second Intervention|Withdrawal by Subject|1|||
125587522|NCT01889602|451774461|FG000|Third Intervention|Protocol Violation|1|||
125587523|NCT01889602|451774462|FG001|Third Intervention|Protocol Violation|0|||
125429099|NCT01142388|451196552|FG001|Overall Study|Death|2|||
125587524|NCT01889602|451774463|FG002|Third Intervention|Protocol Violation|0|||
125587525|NCT01889602|451774461|FG000|Third Intervention|Withdrawal by Subject|2|||
125587526|NCT01889602|451774462|FG001|Third Intervention|Withdrawal by Subject|2|||
125429100|NCT01142388|451196551|FG000|Overall Study|Withdrawal by Subject|5|||
125587527|NCT01889602|451774463|FG002|Third Intervention|Withdrawal by Subject|0|||
125587528|NCT00404092|451774464|FG000|Overall Study|Death|1|||
125429101|NCT01142388|451196552|FG001|Overall Study|Withdrawal by Subject|3|||
125429102|NCT01142388|451196551|FG000|Overall Study|Alternative therapy|1|||
125429103|NCT01142388|451196552|FG001|Overall Study|Alternative therapy|0|||
125429104|NCT01142388|451196551|FG000|Overall Study|Other complications|0|||
125429105|NCT01142388|451196552|FG001|Overall Study|Other complications|2|||
125429106|NCT01142388|451196551|FG000|Overall Study|Other|1|||
125429107|NCT01142388|451196552|FG001|Overall Study|Other|1|||
125429108|NCT01142388|451196551|FG000|Overall Study|Never started therapy|7|||
125429109|NCT01142388|451196552|FG001|Overall Study|Never started therapy|3|||
125429110|NCT00335452|451196559|FG000|Overall Study|Death|156|||
125429111|NCT00335452|451196560|FG001|Overall Study|Death|144|||
125429112|NCT00335452|451196561|FG002|Overall Study|Death|158|||
125429113|NCT00335452|451196562|FG003|Overall Study|Death|129|||
125429114|NCT00335452|451196559|FG000|Overall Study|Lost to Follow-up|2|||
125429115|NCT00335452|451196560|FG001|Overall Study|Lost to Follow-up|3|||
125429116|NCT00335452|451196561|FG002|Overall Study|Lost to Follow-up|1|||
125429117|NCT00335452|451196562|FG003|Overall Study|Lost to Follow-up|2|||
125429118|NCT01750879|451196576|FG000|Overall Study|Adverse Event|8|||
125429119|NCT01750879|451196577|FG001|Overall Study|Adverse Event|0|||
125429120|NCT01750879|451196576|FG000|Overall Study|Lack of Efficacy|1|||
125429121|NCT01750879|451196577|FG001|Overall Study|Lack of Efficacy|0|||
125429122|NCT01750879|451196576|FG000|Overall Study|Withdrawal by Subject|1|||
125429123|NCT01750879|451196577|FG001|Overall Study|Withdrawal by Subject|0|||
125429124|NCT01750879|451196576|FG000|Overall Study|Did not complete per protocol|0|||
125429125|NCT01750879|451196577|FG001|Overall Study|Did not complete per protocol|3|||
125429126|NCT02421666|451196578|FG000|6-month Follow-up|Lost to Follow-up|8|||
125429127|NCT02421666|451196579|FG001|6-month Follow-up|Lost to Follow-up|7|||
125429128|NCT02421666|451196578|FG000|6-month Follow-up|Withdrawal by Subject|5|||
125429129|NCT02421666|451196579|FG001|6-month Follow-up|Withdrawal by Subject|6|||
125587529|NCT00404092|451774465|FG001|Overall Study|Death|0|||
125587530|NCT00404092|451774466|FG002|Overall Study|Death|0|||
125587531|NCT00404092|451774467|FG003|Overall Study|Death|0|||
125587532|NCT00404092|451774464|FG000|Overall Study|Adverse Event|0|||
125587533|NCT00404092|451774465|FG001|Overall Study|Adverse Event|0|||
125587534|NCT00404092|451774466|FG002|Overall Study|Adverse Event|1|||
125587535|NCT00404092|451774467|FG003|Overall Study|Adverse Event|0|||
125587536|NCT00591734|451774470|FG000|Overall Study|Lack of Efficacy|35|||
125587537|NCT00591734|451774470|FG000|Overall Study|Adverse Event|5|||
125587538|NCT00591734|451774470|FG000|Overall Study|Physician Decision|5|||
125587539|NCT00591734|451774470|FG000|Overall Study|Intercurrent Illness|8|||
125587540|NCT04752384|451774471|FG000|Overall Study|Withdrawal by Subject|1|||
125587541|NCT04752384|451774471|FG000|Overall Study|Death|1|||
125587542|NCT01955707|451774476|FG000|Overall Study|Adverse Event|1|||
125587543|NCT01955707|451774477|FG001|Overall Study|Adverse Event|2|||
125587544|NCT01955707|451774476|FG000|Overall Study|Lost to Follow-up|2|||
125587545|NCT01955707|451774477|FG001|Overall Study|Lost to Follow-up|1|||
125587546|NCT01955707|451774476|FG000|Overall Study|Withdrawal by Subject|0|||
125587547|NCT01955707|451774477|FG001|Overall Study|Withdrawal by Subject|3|||
125587548|NCT01955707|451774476|FG000|Overall Study|Death|13|||
125587549|NCT01955707|451774477|FG001|Overall Study|Death|14|||
125587550|NCT01955707|451774476|FG000|Overall Study|Other|4|||
125587551|NCT01955707|451774477|FG001|Overall Study|Other|2|||
125587552|NCT01817790|451774480|FG000|Overall Study|Adverse Event|0|||
125587553|NCT01817790|451774481|FG001|Overall Study|Adverse Event|2|||
125587554|NCT01817790|451774480|FG000|Overall Study|Lost to Follow-up|0|||
125587555|NCT01817790|451774481|FG001|Overall Study|Lost to Follow-up|1|||
125587556|NCT01817790|451774480|FG000|Overall Study|Protocol Violation|2|||
125587557|NCT01817790|451774481|FG001|Overall Study|Protocol Violation|1|||
125587558|NCT01817790|451774480|FG000|Overall Study|Withdrawal by Subject|1|||
125587559|NCT01817790|451774481|FG001|Overall Study|Withdrawal by Subject|3|||
125587560|NCT01817790|451774480|FG000|Overall Study|Other: Could not attend appointment|1|||
125587561|NCT01817790|451774481|FG001|Overall Study|Other: Could not attend appointment|1|||
125587562|NCT01671345|451774482|FG000|Overall Study|Lost to Follow-up|10|||
125587563|NCT01671345|451774483|FG001|Overall Study|Lost to Follow-up|6|||
125587564|NCT01671345|451774482|FG000|Overall Study|visit with non-participating physician|3|||
125587565|NCT01671345|451774483|FG001|Overall Study|visit with non-participating physician|3|||
125429130|NCT02421666|451196578|FG000|12-month Follow-up|Lost to Follow-up|5|||
125429131|NCT02421666|451196579|FG001|12-month Follow-up|Lost to Follow-up|5|||
125587566|NCT03636906|451774484|FG000|Overall Study|Adverse Event|0|||
125429132|NCT02421666|451196578|FG000|12-month Follow-up|Withdrawal by Subject|6|||
125429133|NCT02421666|451196579|FG001|12-month Follow-up|Withdrawal by Subject|11|||
125429134|NCT01119768|451196582|FG000|Treatment Period|Lack of Efficacy|18|||
125429135|NCT01119768|451196583|FG001|Treatment Period|Lack of Efficacy|25|||
125429136|NCT01059643|451196584|FG000|Overall Study|Adverse Event|3|||
125429137|NCT01059643|451196584|FG000|Overall Study|Withdrawal by Subject|2|||
125429138|NCT01059643|451196584|FG000|Overall Study|Physician Decision|1|||
125587567|NCT03636906|451774485|FG001|Overall Study|Adverse Event|0|||
125587568|NCT03636906|451774486|FG002|Overall Study|Adverse Event|1|||
125587569|NCT03636906|451774484|FG000|Overall Study|Lost to Follow-up|1|||
125587570|NCT03636906|451774485|FG001|Overall Study|Lost to Follow-up|0|||
125429139|NCT00643123|451196591|FG000|Overall Study|Lost to Follow-up|4|||
125429140|NCT00643123|451196592|FG001|Overall Study|Lost to Follow-up|0|||
125429141|NCT00643123|451196591|FG000|Overall Study|Withdrawal by Subject|1|||
125429142|NCT00643123|451196592|FG001|Overall Study|Withdrawal by Subject|1|||
125429143|NCT02923739|451196593|FG000|Overall Study|Withdrawal by Subject|2|||
125429144|NCT02923739|451196594|FG001|Overall Study|Withdrawal by Subject|0|||
125429145|NCT02923739|451196595|FG002|Overall Study|Withdrawal by Subject|0|||
125429146|NCT02923739|451196596|FG003|Overall Study|Withdrawal by Subject|0|||
125429147|NCT02923739|451196593|FG000|Overall Study|Failed Screening|3|||
125429148|NCT02923739|451196594|FG001|Overall Study|Failed Screening|0|||
125429149|NCT02923739|451196595|FG002|Overall Study|Failed Screening|0|||
125429150|NCT02923739|451196596|FG003|Overall Study|Failed Screening|0|||
125429151|NCT01059630|451196601|FG000|Overall Study|Death|100|||
125429152|NCT01059630|451196602|FG001|Overall Study|Death|84|||
125429153|NCT01059630|451196601|FG000|Overall Study|Lost to Follow-up|4|||
125429154|NCT01059630|451196602|FG001|Overall Study|Lost to Follow-up|1|||
125429155|NCT01059630|451196601|FG000|Overall Study|Physician Decision|2|||
125429156|NCT01059630|451196602|FG001|Overall Study|Physician Decision|4|||
125429157|NCT01059630|451196601|FG000|Overall Study|Withdrawal by Subject|21|||
125429158|NCT01059630|451196602|FG001|Overall Study|Withdrawal by Subject|14|||
125429159|NCT00763958|451196605|FG000|Overall Study|did not meet final criteria|4|||
125429160|NCT00763958|451196606|FG001|Overall Study|did not meet final criteria|4|||
125429161|NCT00763958|451196605|FG000|Overall Study|Lost to Follow-up|10|||
125429162|NCT00763958|451196606|FG001|Overall Study|Lost to Follow-up|2|||
125429163|NCT00763958|451196605|FG000|Overall Study|Believed they were receiving placebo|0|||
125429164|NCT00763958|451196606|FG001|Overall Study|Believed they were receiving placebo|5|||
125429165|NCT04681729|451196607|FG000|Overall Study|Lack of Efficacy|2|||
125429166|NCT04681729|451196608|FG001|Overall Study|Lack of Efficacy|2|||
125429167|NCT04681729|451196607|FG000|Overall Study|Withdrawal by Subject|8|||
125429168|NCT04681729|451196608|FG001|Overall Study|Withdrawal by Subject|9|||
125429169|NCT02535364|451196610|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
125429170|NCT02535364|451196610|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
125429171|NCT02535364|451196610|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
125429172|NCT02535364|451196610|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
125429173|NCT02535364|451196610|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
125429174|NCT02535364|451196610|FG000|Part B Screening|Death|2|||
125429175|NCT02535364|451196610|FG000|Part B Screening|Physician Decision|1|||
125429176|NCT02535364|451196610|FG000|Part B Screening|Withdrawal by Subject|1|||
125429177|NCT02535364|451196610|FG000|Part B Screening|Adverse Event|1|||
125429178|NCT02535364|451196610|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
125429179|NCT02535364|451196610|FG000|Study Treatment|Death|1|||
125429180|NCT02535364|451196610|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
125429181|NCT02535364|451196610|FG000|12-Month Follow-up Period|Disease progression|22|||
125429182|NCT02535364|451196610|FG000|12-Month Follow-up Period|Death|5|||
125429183|NCT02535364|451196610|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
125429184|NCT02535364|451196610|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
125429185|NCT02535364|451196610|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
125429186|NCT04766086|451196613|FG000|Overall Study|Lost to Follow-up|3|||
125429187|NCT04766086|451196614|FG001|Overall Study|Lost to Follow-up|5|||
125429188|NCT04766086|451196615|FG002|Overall Study|Lost to Follow-up|3|||
125429189|NCT04766086|451196613|FG000|Overall Study|Withdrawal by Subject|1|||
125429190|NCT04766086|451196614|FG001|Overall Study|Withdrawal by Subject|1|||
125429191|NCT04766086|451196615|FG002|Overall Study|Withdrawal by Subject|2|||
125429192|NCT04766086|451196613|FG000|Overall Study|Other|0|||
125429193|NCT04766086|451196614|FG001|Overall Study|Other|0|||
125429194|NCT04766086|451196615|FG002|Overall Study|Other|1|||
125429195|NCT02496767|451196627|FG000|Open-label Lead-in Phase|Adverse Event|176|||
125429196|NCT02496767|451196628|FG001|Open-label Lead-in Phase|Adverse Event|0|||
125429197|NCT02496767|451196629|FG002|Open-label Lead-in Phase|Adverse Event|0|||
125429198|NCT02496767|451196630|FG003|Open-label Lead-in Phase|Adverse Event|0|||
125429199|NCT02496767|451196631|FG004|Open-label Lead-in Phase|Adverse Event|0|||
125429200|NCT02496767|451196632|FG005|Open-label Lead-in Phase|Adverse Event|0|||
125429201|NCT02496767|451196633|FG006|Open-label Lead-in Phase|Adverse Event|0|||
125429202|NCT02496767|451196634|FG007|Open-label Lead-in Phase|Adverse Event|0|||
125429203|NCT02496767|451196627|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
125429204|NCT02496767|451196628|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
125429205|NCT02496767|451196629|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
125429206|NCT02496767|451196630|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
125429207|NCT02496767|451196631|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
125429208|NCT02496767|451196632|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
125429209|NCT02496767|451196633|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
125429210|NCT02496767|451196634|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
125429211|NCT02496767|451196627|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
125429212|NCT02496767|451196628|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
125436535|NCT02597933|451224422|FG000|Overall Study|Protocol Violation|2|||
125587571|NCT03636906|451774486|FG002|Overall Study|Lost to Follow-up|0|||
125587572|NCT03636906|451774484|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
125587573|NCT03636906|451774485|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
125587574|NCT03636906|451774486|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
125587575|NCT03636906|451774484|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
125587576|NCT03636906|451774485|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125587577|NCT03636906|451774486|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
125587578|NCT03636906|451774484|FG000|Overall Study|Other|0|||
125587579|NCT03636906|451774485|FG001|Overall Study|Other|0|||
125587580|NCT03636906|451774486|FG002|Overall Study|Other|1|||
125587581|NCT01291017|451774487|FG000|Overall Study|Lost to Follow-up|2|||
125587582|NCT01291017|451774487|FG000|Overall Study|Withdrawal by Subject|3|||
125587583|NCT04980391|451774488|FG000|Overall Study|Death|0|||
125587584|NCT04980391|451774489|FG001|Overall Study|Death|0|||
125587585|NCT04980391|451774490|FG002|Overall Study|Death|1|||
125587586|NCT04980391|451774491|FG003|Overall Study|Death|1|||
125587587|NCT04980391|451774488|FG000|Overall Study|Lost to Follow-up|3|||
125587588|NCT04980391|451774489|FG001|Overall Study|Lost to Follow-up|3|||
125587589|NCT04980391|451774490|FG002|Overall Study|Lost to Follow-up|2|||
125587590|NCT04980391|451774491|FG003|Overall Study|Lost to Follow-up|3|||
125587591|NCT04980391|451774488|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
125587592|NCT04980391|451774489|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
125587593|NCT04980391|451774490|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
125587594|NCT04980391|451774491|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
125587595|NCT04980391|451774488|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125587596|NCT04980391|451774489|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125587597|NCT04980391|451774490|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
125587598|NCT04980391|451774491|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125587599|NCT04980391|451774488|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
125587600|NCT04980391|451774489|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
125587601|NCT04980391|451774490|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
125587602|NCT04980391|451774491|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
125587603|NCT03690869|451774492|FG000|Overall Study|Adverse Event|0|||
125587604|NCT03690869|451774493|FG001|Overall Study|Adverse Event|0|||
125587605|NCT03690869|451774494|FG002|Overall Study|Adverse Event|0|||
125587606|NCT03690869|451774495|FG003|Overall Study|Adverse Event|1|||
125587607|NCT03690869|451774496|FG004|Overall Study|Adverse Event|0|||
125587608|NCT03690869|451774497|FG005|Overall Study|Adverse Event|0|||
125587609|NCT03690869|451774498|FG006|Overall Study|Adverse Event|0|||
125587610|NCT03690869|451774499|FG007|Overall Study|Adverse Event|1|||
125587611|NCT03690869|451774500|FG008|Overall Study|Adverse Event|0|||
125587612|NCT03690869|451774501|FG009|Overall Study|Adverse Event|1|||
125587613|NCT03690869|451774492|FG000|Overall Study|Death|1|||
125587614|NCT03690869|451774493|FG001|Overall Study|Death|1|||
125587615|NCT03690869|451774494|FG002|Overall Study|Death|1|||
125587616|NCT03690869|451774495|FG003|Overall Study|Death|4|||
125587617|NCT03690869|451774496|FG004|Overall Study|Death|2|||
125587618|NCT03690869|451774497|FG005|Overall Study|Death|5|||
125587619|NCT03690869|451774498|FG006|Overall Study|Death|3|||
125587620|NCT03690869|451774499|FG007|Overall Study|Death|2|||
125587621|NCT03690869|451774500|FG008|Overall Study|Death|0|||
125587622|NCT03690869|451774501|FG009|Overall Study|Death|3|||
125587623|NCT03690869|451774492|FG000|Overall Study|Lost to Follow-up|0|||
125587624|NCT03690869|451774493|FG001|Overall Study|Lost to Follow-up|0|||
125587625|NCT03690869|451774494|FG002|Overall Study|Lost to Follow-up|1|||
125587626|NCT03690869|451774495|FG003|Overall Study|Lost to Follow-up|0|||
125587627|NCT03690869|451774496|FG004|Overall Study|Lost to Follow-up|0|||
125587628|NCT03690869|451774497|FG005|Overall Study|Lost to Follow-up|0|||
125587629|NCT03690869|451774498|FG006|Overall Study|Lost to Follow-up|0|||
125587630|NCT03690869|451774499|FG007|Overall Study|Lost to Follow-up|0|||
125587631|NCT03690869|451774500|FG008|Overall Study|Lost to Follow-up|0|||
125362459|NCT02345226|450961142|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
125362460|NCT02345226|450961141|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
125362461|NCT02345226|450961142|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
125362462|NCT03386474|450961148|FG000|Overall Study|Death|1|||
125362463|NCT03386474|450961149|FG001|Overall Study|Death|0|||
125587632|NCT03690869|451774501|FG009|Overall Study|Lost to Follow-up|0|||
125587633|NCT03690869|451774492|FG000|Overall Study|Other Treatment|1|||
125587634|NCT03690869|451774493|FG001|Overall Study|Other Treatment|1|||
125587635|NCT03690869|451774494|FG002|Overall Study|Other Treatment|1|||
125587636|NCT03690869|451774495|FG003|Overall Study|Other Treatment|2|||
125587637|NCT03690869|451774496|FG004|Overall Study|Other Treatment|3|||
125587638|NCT03690869|451774497|FG005|Overall Study|Other Treatment|1|||
125587639|NCT03690869|451774498|FG006|Overall Study|Other Treatment|2|||
125587640|NCT03690869|451774499|FG007|Overall Study|Other Treatment|7|||
125587641|NCT03690869|451774500|FG008|Overall Study|Other Treatment|0|||
125587642|NCT03690869|451774501|FG009|Overall Study|Other Treatment|3|||
125587643|NCT03690869|451774492|FG000|Overall Study|Physician Decision|0|||
125587644|NCT03690869|451774493|FG001|Overall Study|Physician Decision|1|||
125587645|NCT03690869|451774494|FG002|Overall Study|Physician Decision|0|||
125587646|NCT03690869|451774495|FG003|Overall Study|Physician Decision|0|||
125587647|NCT03690869|451774496|FG004|Overall Study|Physician Decision|0|||
125587648|NCT03690869|451774497|FG005|Overall Study|Physician Decision|0|||
125587649|NCT03690869|451774498|FG006|Overall Study|Physician Decision|0|||
125587650|NCT03690869|451774499|FG007|Overall Study|Physician Decision|0|||
125587651|NCT03690869|451774500|FG008|Overall Study|Physician Decision|0|||
125587652|NCT03690869|451774501|FG009|Overall Study|Physician Decision|0|||
125587653|NCT03690869|451774492|FG000|Overall Study|Progressive Disease|1|||
125587654|NCT03690869|451774493|FG001|Overall Study|Progressive Disease|2|||
125587655|NCT03690869|451774494|FG002|Overall Study|Progressive Disease|0|||
125587656|NCT03690869|451774495|FG003|Overall Study|Progressive Disease|1|||
125587657|NCT03690869|451774496|FG004|Overall Study|Progressive Disease|0|||
125587658|NCT03690869|451774497|FG005|Overall Study|Progressive Disease|0|||
125587659|NCT03690869|451774498|FG006|Overall Study|Progressive Disease|0|||
125587660|NCT03690869|451774499|FG007|Overall Study|Progressive Disease|0|||
125587661|NCT03690869|451774500|FG008|Overall Study|Progressive Disease|1|||
125587662|NCT03690869|451774501|FG009|Overall Study|Progressive Disease|1|||
125587663|NCT03690869|451774492|FG000|Overall Study|Subject Decision|0|||
125587664|NCT03690869|451774493|FG001|Overall Study|Subject Decision|0|||
125587665|NCT03690869|451774494|FG002|Overall Study|Subject Decision|0|||
125587666|NCT03690869|451774495|FG003|Overall Study|Subject Decision|1|||
125587667|NCT03690869|451774496|FG004|Overall Study|Subject Decision|0|||
125587668|NCT03690869|451774497|FG005|Overall Study|Subject Decision|0|||
125587669|NCT03690869|451774498|FG006|Overall Study|Subject Decision|0|||
125587670|NCT03690869|451774499|FG007|Overall Study|Subject Decision|1|||
125587671|NCT03690869|451774500|FG008|Overall Study|Subject Decision|0|||
125587672|NCT03690869|451774501|FG009|Overall Study|Subject Decision|0|||
125587673|NCT04280081|451774503|FG000|Overall Study|Adverse Event|4|||
125587674|NCT04280081|451774503|FG000|Overall Study|Death|2|||
125587675|NCT04280081|451774503|FG000|Overall Study|Progressive Disease|6|||
125587676|NCT01468311|451774504|FG000|Overall Study|mobilization failure|1|||
125587677|NCT01468311|451774504|FG000|Overall Study|Withdrawal by Subject|1|||
125587678|NCT01750918|451776451|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
125587679|NCT01750918|451776452|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
125587680|NCT01750918|451776453|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
125587681|NCT01750918|451776454|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
125587682|NCT01750918|451776455|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
125587683|NCT01750918|451776456|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
125587684|NCT01750918|451776457|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
125587685|NCT01750918|451776458|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
125587686|NCT01750918|451776451|FG000|Overall Study|Lost to Follow-up|0|||
125587687|NCT01750918|451776452|FG001|Overall Study|Lost to Follow-up|0|||
125587688|NCT01750918|451776453|FG002|Overall Study|Lost to Follow-up|2|||
125362464|NCT03386474|450961148|FG000|Overall Study|Adverse Event|0|||
125587689|NCT01750918|451776454|FG003|Overall Study|Lost to Follow-up|2|||
125587690|NCT01750918|451776455|FG004|Overall Study|Lost to Follow-up|0|||
125587691|NCT01750918|451776456|FG005|Overall Study|Lost to Follow-up|0|||
125587692|NCT01750918|451776457|FG006|Overall Study|Lost to Follow-up|0|||
125587693|NCT01750918|451776458|FG007|Overall Study|Lost to Follow-up|1|||
125587694|NCT01750918|451776451|FG000|Overall Study|Withdrawal by Subject|0|||
125587695|NCT01750918|451776452|FG001|Overall Study|Withdrawal by Subject|0|||
125587696|NCT01750918|451776453|FG002|Overall Study|Withdrawal by Subject|1|||
125587697|NCT01750918|451776454|FG003|Overall Study|Withdrawal by Subject|2|||
125587698|NCT01750918|451776455|FG004|Overall Study|Withdrawal by Subject|1|||
125587699|NCT01750918|451776456|FG005|Overall Study|Withdrawal by Subject|1|||
125587700|NCT01750918|451776457|FG006|Overall Study|Withdrawal by Subject|2|||
125587701|NCT01750918|451776458|FG007|Overall Study|Withdrawal by Subject|2|||
125587702|NCT02338843|451776465|FG000|Overall Study|Adverse Event|2|||
125587703|NCT02338843|451776466|FG001|Overall Study|Adverse Event|1|||
125587704|NCT02338843|451776465|FG000|Overall Study|Death|40|||
125587705|NCT02338843|451776466|FG001|Overall Study|Death|53|||
125587706|NCT02338843|451776465|FG000|Overall Study|Physician Decision|1|||
125587707|NCT02338843|451776466|FG001|Overall Study|Physician Decision|0|||
125587708|NCT02338843|451776465|FG000|Overall Study|Withdrawal by Subject|0|||
125587709|NCT02338843|451776466|FG001|Overall Study|Withdrawal by Subject|2|||
125587710|NCT02338843|451776465|FG000|Overall Study|Subject Recovered|0|||
125587711|NCT02338843|451776466|FG001|Overall Study|Subject Recovered|2|||
125587712|NCT02338843|451776465|FG000|Overall Study|Discontinued prior to randomizat|1|||
125587713|NCT02338843|451776466|FG001|Overall Study|Discontinued prior to randomizat|0|||
125587714|NCT00023322|451776467|FG000|Overall Study|Lost to Follow-up|1|||
125587715|NCT01793792|451776472|FG000|Overall Study|Death|5|||
125587716|NCT01793792|451776472|FG000|Overall Study|Lost to Follow-up|5|||
125587717|NCT01793792|451776472|FG000|Overall Study|Withdrawal by Subject|1|||
125587718|NCT01793792|451776472|FG000|Overall Study|Device Not Implanted|1|||
125587719|NCT02185521|451776473|FG000|Overall Study|Withdrawal by Subject|1|||
125587720|NCT02185521|451776473|FG000|Overall Study|Protocol Violation|1|||
125587721|NCT03902080|451776488|FG000|Overall Study|Adverse Event|17|||
125587722|NCT03902080|451776489|FG001|Overall Study|Adverse Event|15|||
125587723|NCT03902080|451776488|FG000|Overall Study|Withdrawal by Subject|28|||
125587724|NCT03902080|451776489|FG001|Overall Study|Withdrawal by Subject|35|||
125587725|NCT03902080|451776488|FG000|Overall Study|Lost to Follow-up|6|||
125587726|NCT03902080|451776489|FG001|Overall Study|Lost to Follow-up|7|||
125587727|NCT03902080|451776488|FG000|Overall Study|Other|3|||
125587728|NCT03902080|451776489|FG001|Overall Study|Other|5|||
125587729|NCT03902080|451776488|FG000|Overall Study|Non compliance|4|||
125587730|NCT03902080|451776489|FG001|Overall Study|Non compliance|3|||
125587731|NCT03902080|451776488|FG000|Overall Study|Physician Decision|5|||
125587732|NCT03902080|451776489|FG001|Overall Study|Physician Decision|1|||
125587733|NCT03902080|451776488|FG000|Overall Study|Protocol Violation|3|||
125587734|NCT03902080|451776489|FG001|Overall Study|Protocol Violation|3|||
125587735|NCT03902080|451776488|FG000|Overall Study|Lack of Efficacy|1|||
125587736|NCT03902080|451776489|FG001|Overall Study|Lack of Efficacy|3|||
125587737|NCT03902080|451776488|FG000|Overall Study|Withdrawn prior to dosing|0|||
125587738|NCT03902080|451776489|FG001|Overall Study|Withdrawn prior to dosing|1|||
125587739|NCT00434967|451776490|FG000|Overall Study|Adverse Event|2|||
125587740|NCT00434967|451776491|FG001|Overall Study|Adverse Event|4|||
125587741|NCT00434967|451776492|FG002|Overall Study|Adverse Event|3|||
125587742|NCT00434967|451776493|FG003|Overall Study|Adverse Event|3|||
125587743|NCT00434967|451776490|FG000|Overall Study|Lost to Follow-up|0|||
125587744|NCT00434967|451776491|FG001|Overall Study|Lost to Follow-up|0|||
125587745|NCT00434967|451776492|FG002|Overall Study|Lost to Follow-up|1|||
125587746|NCT00434967|451776493|FG003|Overall Study|Lost to Follow-up|0|||
125587747|NCT00434967|451776490|FG000|Overall Study|Withdrawal by Subject|2|||
125587748|NCT00434967|451776491|FG001|Overall Study|Withdrawal by Subject|2|||
125587749|NCT00434967|451776492|FG002|Overall Study|Withdrawal by Subject|4|||
125587750|NCT00434967|451776493|FG003|Overall Study|Withdrawal by Subject|6|||
125587751|NCT00434967|451776490|FG000|Overall Study|Randomized in error|0|||
125587752|NCT00434967|451776491|FG001|Overall Study|Randomized in error|0|||
125587753|NCT00434967|451776492|FG002|Overall Study|Randomized in error|0|||
125587754|NCT00434967|451776493|FG003|Overall Study|Randomized in error|1|||
125587755|NCT00434967|451776490|FG000|Overall Study|Protocol Violation|0|||
125587756|NCT00434967|451776491|FG001|Overall Study|Protocol Violation|1|||
125587757|NCT00434967|451776492|FG002|Overall Study|Protocol Violation|0|||
125587758|NCT00434967|451776493|FG003|Overall Study|Protocol Violation|1|||
125587759|NCT00434967|451776490|FG000|Overall Study|Physician Decision|1|||
125587760|NCT00434967|451776491|FG001|Overall Study|Physician Decision|1|||
125587761|NCT00434967|451776492|FG002|Overall Study|Physician Decision|1|||
125587762|NCT00434967|451776493|FG003|Overall Study|Physician Decision|0|||
125587763|NCT00434967|451776490|FG000|Overall Study|Patient Disposition Challenges|2|||
125587764|NCT00434967|451776491|FG001|Overall Study|Patient Disposition Challenges|0|||
125587765|NCT00434967|451776492|FG002|Overall Study|Patient Disposition Challenges|0|||
125429213|NCT02496767|451196629|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
125587766|NCT00434967|451776493|FG003|Overall Study|Patient Disposition Challenges|3|||
125429214|NCT02496767|451196630|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
125587767|NCT00408005|451776498|FG000|Induction|Adverse Event|19|||
125587768|NCT00408005|451776499|FG001|Induction|Adverse Event|3|||
125587769|NCT00408005|451776500|FG002|Induction|Adverse Event|0|||
125587770|NCT00408005|451776501|FG003|Induction|Adverse Event|0|||
125587771|NCT00408005|451776502|FG004|Induction|Adverse Event|0|||
125587772|NCT00408005|451776503|FG005|Induction|Adverse Event|0|||
125587773|NCT00408005|451776504|FG006|Induction|Adverse Event|0|||
125587774|NCT00408005|451776505|FG007|Induction|Adverse Event|0|||
125587775|NCT00408005|451776498|FG000|Induction|Death|6|||
125587776|NCT00408005|451776499|FG001|Induction|Death|0|||
125587777|NCT00408005|451776500|FG002|Induction|Death|0|||
125587778|NCT00408005|451776501|FG003|Induction|Death|0|||
125587779|NCT00408005|451776502|FG004|Induction|Death|0|||
125587780|NCT00408005|451776503|FG005|Induction|Death|0|||
125587781|NCT00408005|451776504|FG006|Induction|Death|0|||
125587782|NCT00408005|451776505|FG007|Induction|Death|0|||
125587783|NCT00408005|451776498|FG000|Induction|Physician Decision|83|||
125587784|NCT00408005|451776499|FG001|Induction|Physician Decision|9|||
125587785|NCT00408005|451776500|FG002|Induction|Physician Decision|0|||
125587786|NCT00408005|451776501|FG003|Induction|Physician Decision|0|||
125587787|NCT00408005|451776502|FG004|Induction|Physician Decision|0|||
125587788|NCT00408005|451776503|FG005|Induction|Physician Decision|0|||
125587789|NCT00408005|451776504|FG006|Induction|Physician Decision|0|||
125587790|NCT00408005|451776505|FG007|Induction|Physician Decision|0|||
125587791|NCT00408005|451776498|FG000|Induction|Withdrawal by Subject|2|||
125587792|NCT00408005|451776499|FG001|Induction|Withdrawal by Subject|4|||
125587793|NCT00408005|451776500|FG002|Induction|Withdrawal by Subject|0|||
125587794|NCT00408005|451776501|FG003|Induction|Withdrawal by Subject|0|||
125587795|NCT00408005|451776502|FG004|Induction|Withdrawal by Subject|0|||
125587796|NCT00408005|451776503|FG005|Induction|Withdrawal by Subject|0|||
125587797|NCT00408005|451776504|FG006|Induction|Withdrawal by Subject|0|||
125587798|NCT00408005|451776505|FG007|Induction|Withdrawal by Subject|0|||
125587799|NCT00408005|451776498|FG000|Induction|Ineligible|33|||
125587800|NCT00408005|451776499|FG001|Induction|Ineligible|14|||
125587801|NCT00408005|451776500|FG002|Induction|Ineligible|0|||
125587802|NCT00408005|451776501|FG003|Induction|Ineligible|0|||
125587803|NCT00408005|451776502|FG004|Induction|Ineligible|0|||
125587804|NCT00408005|451776503|FG005|Induction|Ineligible|0|||
125587805|NCT00408005|451776504|FG006|Induction|Ineligible|0|||
125587806|NCT00408005|451776505|FG007|Induction|Ineligible|0|||
125587807|NCT00408005|451776498|FG000|Induction|Refusal of Further Protocol Therapy|225|||
125587808|NCT00408005|451776499|FG001|Induction|Refusal of Further Protocol Therapy|44|||
125587809|NCT00408005|451776500|FG002|Induction|Refusal of Further Protocol Therapy|0|||
125587810|NCT00408005|451776501|FG003|Induction|Refusal of Further Protocol Therapy|0|||
125587811|NCT00408005|451776502|FG004|Induction|Refusal of Further Protocol Therapy|0|||
125587812|NCT00408005|451776503|FG005|Induction|Refusal of Further Protocol Therapy|0|||
125587813|NCT00408005|451776504|FG006|Induction|Refusal of Further Protocol Therapy|0|||
125587814|NCT00408005|451776505|FG007|Induction|Refusal of Further Protocol Therapy|0|||
125587815|NCT00408005|451776498|FG000|Induction|Entered another COG therapeutic protocol|4|||
125587816|NCT00408005|451776499|FG001|Induction|Entered another COG therapeutic protocol|0|||
125587817|NCT00408005|451776500|FG002|Induction|Entered another COG therapeutic protocol|0|||
125587818|NCT00408005|451776501|FG003|Induction|Entered another COG therapeutic protocol|0|||
125587819|NCT00408005|451776502|FG004|Induction|Entered another COG therapeutic protocol|0|||
125587820|NCT00408005|451776503|FG005|Induction|Entered another COG therapeutic protocol|0|||
125587821|NCT00408005|451776504|FG006|Induction|Entered another COG therapeutic protocol|0|||
125587822|NCT00408005|451776505|FG007|Induction|Entered another COG therapeutic protocol|0|||
125587823|NCT00408005|451776498|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
125587824|NCT00408005|451776499|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
125587825|NCT00408005|451776500|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
125587826|NCT00408005|451776501|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
125587827|NCT00408005|451776502|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
125587828|NCT00408005|451776503|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
125587829|NCT00408005|451776504|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
125587830|NCT00408005|451776505|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
125587831|NCT00408005|451776498|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
125587832|NCT00408005|451776499|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
125587833|NCT00408005|451776500|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
125587834|NCT00408005|451776501|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
125587835|NCT00408005|451776502|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
125587836|NCT00408005|451776503|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
125587837|NCT00408005|451776504|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
125362465|NCT03386474|450961149|FG001|Overall Study|Adverse Event|1|||
125587838|NCT00408005|451776505|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
125587839|NCT00408005|451776498|FG000|Induction|Progressive Disease|0|||
125587840|NCT00408005|451776499|FG001|Induction|Progressive Disease|1|||
125587841|NCT00408005|451776500|FG002|Induction|Progressive Disease|0|||
125587842|NCT00408005|451776501|FG003|Induction|Progressive Disease|0|||
125362466|NCT02282358|450961150|FG000|Overall Study|Nonevaluable|1|||
125362467|NCT04357782|450961151|FG000|Overall Study|Discharged from hospital|1|||
125362468|NCT04357782|450961152|FG001|Overall Study|Discharged from hospital|0|||
125587843|NCT00408005|451776502|FG004|Induction|Progressive Disease|0|||
125587844|NCT00408005|451776503|FG005|Induction|Progressive Disease|0|||
125587845|NCT00408005|451776504|FG006|Induction|Progressive Disease|0|||
125587846|NCT00408005|451776505|FG007|Induction|Progressive Disease|0|||
125362469|NCT04357782|450961151|FG000|Overall Study|Death|0|||
125587847|NCT00408005|451776498|FG000|Induction|Inevaluable|18|||
125587848|NCT00408005|451776499|FG001|Induction|Inevaluable|14|||
125587849|NCT00408005|451776500|FG002|Induction|Inevaluable|0|||
125587850|NCT00408005|451776501|FG003|Induction|Inevaluable|0|||
125587851|NCT00408005|451776502|FG004|Induction|Inevaluable|0|||
125587852|NCT00408005|451776503|FG005|Induction|Inevaluable|0|||
125587853|NCT00408005|451776504|FG006|Induction|Inevaluable|0|||
125587854|NCT00408005|451776505|FG007|Induction|Inevaluable|0|||
125587855|NCT00408005|451776498|FG000|Induction|Failed to Complete Randomization|3|||
125587856|NCT00408005|451776499|FG001|Induction|Failed to Complete Randomization|2|||
125587857|NCT00408005|451776500|FG002|Induction|Failed to Complete Randomization|0|||
125587858|NCT00408005|451776501|FG003|Induction|Failed to Complete Randomization|0|||
125587859|NCT00408005|451776502|FG004|Induction|Failed to Complete Randomization|0|||
125587860|NCT00408005|451776503|FG005|Induction|Failed to Complete Randomization|0|||
125587861|NCT00408005|451776504|FG006|Induction|Failed to Complete Randomization|0|||
125587862|NCT00408005|451776505|FG007|Induction|Failed to Complete Randomization|0|||
125587863|NCT00408005|451776498|FG000|Induction|Protocol Deviation|3|||
125587864|NCT00408005|451776499|FG001|Induction|Protocol Deviation|1|||
125587865|NCT00408005|451776500|FG002|Induction|Protocol Deviation|0|||
125587866|NCT00408005|451776501|FG003|Induction|Protocol Deviation|0|||
125587867|NCT00408005|451776502|FG004|Induction|Protocol Deviation|0|||
125587868|NCT00408005|451776503|FG005|Induction|Protocol Deviation|0|||
125587869|NCT00408005|451776504|FG006|Induction|Protocol Deviation|0|||
125587870|NCT00408005|451776505|FG007|Induction|Protocol Deviation|0|||
125587871|NCT00408005|451776498|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
125587872|NCT00408005|451776499|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
125587873|NCT00408005|451776500|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
125587874|NCT00408005|451776501|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
125587875|NCT00408005|451776502|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
125587876|NCT00408005|451776503|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
125587877|NCT00408005|451776504|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
125587878|NCT00408005|451776505|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
125587879|NCT00408005|451776498|FG000|Induction|Recurrent leukemia|1|||
125587880|NCT00408005|451776499|FG001|Induction|Recurrent leukemia|0|||
125587881|NCT00408005|451776500|FG002|Induction|Recurrent leukemia|0|||
125587882|NCT00408005|451776501|FG003|Induction|Recurrent leukemia|0|||
125587883|NCT00408005|451776502|FG004|Induction|Recurrent leukemia|0|||
125587884|NCT00408005|451776503|FG005|Induction|Recurrent leukemia|0|||
125587885|NCT00408005|451776504|FG006|Induction|Recurrent leukemia|0|||
125587886|NCT00408005|451776505|FG007|Induction|Recurrent leukemia|0|||
125587887|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
125587888|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
125587889|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
125587890|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
125587891|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
125587892|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
125587893|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
125587894|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
125587895|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
125587896|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
125362470|NCT04357782|450961152|FG001|Overall Study|Death|2|||
125362471|NCT01786148|450961153|FG000|Overall Study|Lost to Follow-up|21|||
125362472|NCT01786148|450961154|FG001|Overall Study|Lost to Follow-up|13|||
125362473|NCT01786148|450961153|FG000|Overall Study|Death|0|||
125362474|NCT01786148|450961154|FG001|Overall Study|Death|1|||
125362475|NCT01786148|450961153|FG000|Overall Study|Withdrawal by Subject|0|||
125362476|NCT01786148|450961154|FG001|Overall Study|Withdrawal by Subject|7|||
125362477|NCT01786148|450961153|FG000|Overall Study|Incarceration|1|||
125362478|NCT01786148|450961154|FG001|Overall Study|Incarceration|1|||
125362479|NCT03780543|450961156|FG000|Overall Study|Adverse Event|1|||
125587897|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
125587898|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
125587899|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
125587900|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
125587901|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
125587902|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
125587903|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
125587904|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
125587905|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
125587906|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
125587907|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
125362480|NCT03780543|450961157|FG001|Overall Study|Adverse Event|0|||
125362481|NCT03780543|450961158|FG002|Overall Study|Adverse Event|2|||
125362482|NCT03780543|450961156|FG000|Overall Study|Lost to Follow-up|2|||
125587908|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
125587909|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
125587910|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
125587911|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
125587912|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
125362483|NCT03780543|450961157|FG001|Overall Study|Lost to Follow-up|0|||
125362484|NCT03780543|450961158|FG002|Overall Study|Lost to Follow-up|1|||
125362485|NCT03780543|450961156|FG000|Overall Study|Study terminated by Sponsor|8|||
125362486|NCT03780543|450961157|FG001|Overall Study|Study terminated by Sponsor|7|||
125362487|NCT03780543|450961158|FG002|Overall Study|Study terminated by Sponsor|13|||
125362488|NCT03780543|450961156|FG000|Overall Study|Withdrawal by Subject|1|||
125362489|NCT03780543|450961157|FG001|Overall Study|Withdrawal by Subject|8|||
125362490|NCT03780543|450961158|FG002|Overall Study|Withdrawal by Subject|1|||
125362491|NCT03780543|450961156|FG000|Overall Study|Noncompliance with study drug|1|||
125362492|NCT03780543|450961157|FG001|Overall Study|Noncompliance with study drug|0|||
125362493|NCT03780543|450961158|FG002|Overall Study|Noncompliance with study drug|0|||
125362494|NCT00066729|450961164|FG000|Overall Study|Lost to Follow-up|1|||
125362495|NCT00066729|450961164|FG000|Overall Study|Disease progression|1|||
125362496|NCT01811225|450961167|FG000|Treatment Period 1|Adverse Event|2|||
125362497|NCT01811225|450961168|FG001|Treatment Period 1|Adverse Event|3|||
125362498|NCT01811225|450961167|FG000|Treatment Period 1|Lost to Follow-up|12|||
125362499|NCT01811225|450961168|FG001|Treatment Period 1|Lost to Follow-up|8|||
125362500|NCT01811225|450961167|FG000|Treatment Period 1|transporation|1|||
125362501|NCT01811225|450961168|FG001|Treatment Period 1|transporation|0|||
125362502|NCT01811225|450961167|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
125362503|NCT01811225|450961168|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
125362504|NCT01811225|450961167|FG000|Treatment Period 2|Lost to Follow-up|1|||
125362505|NCT01811225|450961168|FG001|Treatment Period 2|Lost to Follow-up|2|||
125362506|NCT01811225|450961167|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
125362507|NCT01811225|450961168|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
125587913|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
125587914|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
125587915|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
125587916|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
125587917|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
125587918|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
125587919|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
125587920|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
125587921|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
125587922|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
125587923|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
125587924|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
125587925|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
125587926|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
125587927|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
125587928|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
125587929|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
125587930|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
125587931|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
125587932|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
125587933|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
125587934|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
125587935|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125587936|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125587937|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125587938|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125587939|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
125587940|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125587941|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125587942|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
125587943|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
125587944|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
125362508|NCT02158975|450961169|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
125362509|NCT02840721|450961172|FG000|Treatment Period|Adverse Event|1|||
125362510|NCT02840721|450961172|FG000|Follow-Up|Lack of Efficacy|1|||
125429215|NCT02496767|451196631|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
125587945|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
125587946|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
125587947|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
125587948|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
125587949|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
125587950|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
125587951|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
125587952|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
125587953|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
125587954|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
125587955|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
125587956|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
125587957|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
125587958|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
125587959|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125587960|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125587961|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125587962|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125587963|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125587964|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
125587965|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125587966|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
125587967|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
125587968|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
125587969|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
125587970|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
125587971|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
125587972|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
125587973|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
125587974|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
125587975|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
125587976|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
125587977|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
125587978|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
125587979|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
125587980|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
125587981|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
125587982|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
125587983|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
125587984|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
125587985|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
125587986|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
125587987|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
125587988|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
125587989|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
125587990|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
125587991|NCT00408005|451776498|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
125587992|NCT00408005|451776499|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
125587993|NCT00408005|451776500|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
125587994|NCT00408005|451776501|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
125587995|NCT00408005|451776502|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
125587996|NCT00408005|451776503|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
125587997|NCT00408005|451776504|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
125587998|NCT00408005|451776505|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
125587999|NCT01701258|451776507|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
125588000|NCT01701258|451776508|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
125429216|NCT02496767|451196632|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
125429217|NCT02496767|451196633|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
125588001|NCT01701258|451776509|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
125588002|NCT01701258|451776510|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
125588003|NCT01701258|451776511|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
125588004|NCT01701258|451776512|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
125588005|NCT01701258|451776513|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
125588006|NCT01701258|451776514|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
125588007|NCT01701258|451776515|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
125588008|NCT01701258|451776516|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
125588009|NCT01701258|451776517|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
125588010|NCT01701258|451776518|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
125588011|NCT01701258|451776519|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
125588012|NCT01701258|451776507|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
125588013|NCT01701258|451776508|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
125588014|NCT01701258|451776509|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
125588015|NCT01701258|451776510|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
125588016|NCT01701258|451776511|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
125588017|NCT01701258|451776512|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
125588018|NCT01701258|451776513|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
125588019|NCT01701258|451776514|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
125588020|NCT01701258|451776515|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
125588021|NCT01701258|451776516|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
125588022|NCT01701258|451776517|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
125588023|NCT01701258|451776518|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
125588024|NCT01701258|451776519|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
125588025|NCT01701258|451776507|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
125588026|NCT01701258|451776508|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
125588027|NCT01701258|451776509|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
125588028|NCT01701258|451776510|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
125588029|NCT01701258|451776511|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
125588030|NCT01701258|451776512|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
125588031|NCT01701258|451776513|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
125588032|NCT01701258|451776514|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
125588033|NCT01701258|451776515|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
125588034|NCT01701258|451776516|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
125588035|NCT01701258|451776517|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
125588036|NCT01701258|451776518|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
125588037|NCT01701258|451776519|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
125588038|NCT01701258|451776507|FG000|Assessment and Scheduling|Investigator Terminated|2|||
125588039|NCT01701258|451776508|FG001|Assessment and Scheduling|Investigator Terminated|0|||
125588040|NCT01701258|451776509|FG002|Assessment and Scheduling|Investigator Terminated|0|||
125588041|NCT01701258|451776510|FG003|Assessment and Scheduling|Investigator Terminated|0|||
125588042|NCT01701258|451776511|FG004|Assessment and Scheduling|Investigator Terminated|0|||
125588043|NCT01701258|451776512|FG005|Assessment and Scheduling|Investigator Terminated|0|||
125588044|NCT01701258|451776513|FG006|Assessment and Scheduling|Investigator Terminated|0|||
125588045|NCT01701258|451776514|FG007|Assessment and Scheduling|Investigator Terminated|0|||
125588046|NCT01701258|451776515|FG008|Assessment and Scheduling|Investigator Terminated|0|||
125588047|NCT01701258|451776516|FG009|Assessment and Scheduling|Investigator Terminated|0|||
125588048|NCT01701258|451776517|FG010|Assessment and Scheduling|Investigator Terminated|0|||
125588049|NCT01701258|451776518|FG011|Assessment and Scheduling|Investigator Terminated|0|||
125588050|NCT01701258|451776519|FG012|Assessment and Scheduling|Investigator Terminated|0|||
125588051|NCT03155997|451776520|FG000|Overall Study|Withdrawal by Subject|119|||
125588052|NCT03155997|451776521|FG001|Overall Study|Withdrawal by Subject|134|||
125588053|NCT03155997|451776520|FG000|Overall Study|Lost to Follow-up|12|||
125588054|NCT03155997|451776521|FG001|Overall Study|Lost to Follow-up|13|||
125588055|NCT03155997|451776520|FG000|Overall Study|Missing disposition data|0|||
125588056|NCT03155997|451776521|FG001|Overall Study|Missing disposition data|1|||
125588057|NCT03155997|451776520|FG000|Overall Study|On study treatment|2027|||
125588058|NCT03155997|451776521|FG001|Overall Study|On study treatment|2074|||
125588059|NCT01848145|451776522|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
125588060|NCT01848145|451776522|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
125588061|NCT01848145|451776522|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
125588062|NCT01848145|451776522|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
125588063|NCT01848145|451776522|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
125588064|NCT01848145|451776522|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
125588065|NCT01848145|451776522|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
125588066|NCT03093402|451776523|FG000|Overall Study|Lost to Follow-up|1|||
125588067|NCT03093402|451776524|FG001|Overall Study|Lost to Follow-up|0|||
125588068|NCT03093402|451776525|FG002|Overall Study|Lost to Follow-up|0|||
125588069|NCT03093402|451776526|FG003|Overall Study|Lost to Follow-up|0|||
125588070|NCT03093402|451776523|FG000|Overall Study|Withdrawal by Subject|3|||
125588071|NCT03093402|451776524|FG001|Overall Study|Withdrawal by Subject|3|||
125588072|NCT03093402|451776525|FG002|Overall Study|Withdrawal by Subject|0|||
125588073|NCT03093402|451776526|FG003|Overall Study|Withdrawal by Subject|1|||
125588074|NCT03093402|451776523|FG000|Overall Study|Withdrew prior to dosing|2|||
125588075|NCT03093402|451776524|FG001|Overall Study|Withdrew prior to dosing|1|||
125588076|NCT03093402|451776525|FG002|Overall Study|Withdrew prior to dosing|2|||
125588077|NCT03093402|451776526|FG003|Overall Study|Withdrew prior to dosing|3|||
125588078|NCT03093402|451776523|FG000|Overall Study|Ineligible for study|1|||
125588079|NCT03093402|451776524|FG001|Overall Study|Ineligible for study|0|||
125588080|NCT03093402|451776525|FG002|Overall Study|Ineligible for study|0|||
125588081|NCT03093402|451776526|FG003|Overall Study|Ineligible for study|0|||
125588082|NCT03093402|451776523|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
125588083|NCT03093402|451776524|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
125588084|NCT03093402|451776525|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
125588085|NCT03093402|451776526|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
125588086|NCT02886702|451776527|FG000|Overall Study|Other|4|||
125588087|NCT02886702|451776528|FG001|Overall Study|Other|3|||
125588088|NCT02886702|451776529|FG002|Overall Study|Other|9|||
125588089|NCT02886702|451776527|FG000|Overall Study|Withdrawal by Subject|24|||
125588090|NCT02886702|451776528|FG001|Overall Study|Withdrawal by Subject|18|||
125588091|NCT02886702|451776529|FG002|Overall Study|Withdrawal by Subject|22|||
125588092|NCT02886702|451776527|FG000|Overall Study|Significant Worsening of Condition|0|||
125588093|NCT02886702|451776528|FG001|Overall Study|Significant Worsening of Condition|1|||
125588094|NCT02886702|451776529|FG002|Overall Study|Significant Worsening of Condition|0|||
125588095|NCT02886702|451776527|FG000|Overall Study|Protocol Violation|2|||
125588096|NCT02886702|451776528|FG001|Overall Study|Protocol Violation|2|||
125588097|NCT02886702|451776529|FG002|Overall Study|Protocol Violation|1|||
125588098|NCT02886702|451776527|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125588099|NCT02886702|451776528|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125588100|NCT02886702|451776529|FG002|Overall Study|Non-Compliance With Study Drug|4|||
125588101|NCT02886702|451776527|FG000|Overall Study|Lost to Follow-up|11|||
125588102|NCT02886702|451776528|FG001|Overall Study|Lost to Follow-up|13|||
125588103|NCT02886702|451776529|FG002|Overall Study|Lost to Follow-up|8|||
125588104|NCT02886702|451776527|FG000|Overall Study|Lack of Efficacy|3|||
125588105|NCT02886702|451776528|FG001|Overall Study|Lack of Efficacy|4|||
125588106|NCT02886702|451776529|FG002|Overall Study|Lack of Efficacy|5|||
125588107|NCT02886702|451776527|FG000|Overall Study|Adverse Event|4|||
125588108|NCT02886702|451776528|FG001|Overall Study|Adverse Event|9|||
125588109|NCT02886702|451776529|FG002|Overall Study|Adverse Event|3|||
125588110|NCT02886702|451776527|FG000|Overall Study|Administrative Reasons|0|||
125588111|NCT02886702|451776528|FG001|Overall Study|Administrative Reasons|0|||
125588112|NCT02886702|451776529|FG002|Overall Study|Administrative Reasons|1|||
125588113|NCT02347631|451776530|FG000|First Intervention (2 Months)|Adverse Event|1|||
125588114|NCT02347631|451776531|FG001|First Intervention (2 Months)|Adverse Event|1|||
125588115|NCT02347631|451776530|FG000|First Intervention (2 Months)|Pregnancy|1|||
125588116|NCT02347631|451776531|FG001|First Intervention (2 Months)|Pregnancy|0|||
125588117|NCT02347631|451776530|FG000|First Intervention (2 Months)|Moved out of area|0|||
125588118|NCT02347631|451776531|FG001|First Intervention (2 Months)|Moved out of area|2|||
125588119|NCT02347631|451776530|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
125588120|NCT02347631|451776531|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
125588121|NCT02347631|451776530|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
125588122|NCT02347631|451776531|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
125588123|NCT02347631|451776530|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
125588124|NCT02347631|451776531|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
125588125|NCT02347631|451776530|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
125588126|NCT02347631|451776531|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
125588127|NCT02347631|451776530|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
125588128|NCT02347631|451776531|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
125588129|NCT01451645|451776539|FG000|Overall Study|Protocol Violation|1|||
125588130|NCT01451645|451776540|FG001|Overall Study|Protocol Violation|0|||
125588131|NCT01451645|451776539|FG000|Overall Study|Adverse Event|0|||
125588132|NCT01451645|451776540|FG001|Overall Study|Adverse Event|3|||
125588133|NCT01451645|451776539|FG000|Overall Study|Withdrawal by Subject|4|||
125588134|NCT01451645|451776540|FG001|Overall Study|Withdrawal by Subject|2|||
125588135|NCT01451645|451776539|FG000|Overall Study|Lost to Follow-up|4|||
125588136|NCT01451645|451776540|FG001|Overall Study|Lost to Follow-up|3|||
125588137|NCT05340504|451776545|FG000|Overall Study|Withdrawal by Subject|1|||
125429218|NCT02496767|451196634|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
125429219|NCT02496767|451196627|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
125429220|NCT02496767|451196628|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
125429221|NCT02496767|451196629|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
125429222|NCT02496767|451196630|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
125429223|NCT02496767|451196631|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
125588138|NCT05340504|451776546|FG001|Overall Study|Withdrawal by Subject|0|||
125588139|NCT00619957|451776547|FG000|Month 24 Double-Blind|Adverse Event|9|||
125588140|NCT00619957|451776548|FG001|Month 24 Double-Blind|Adverse Event|7|||
125588141|NCT00619957|451776547|FG000|Month 24 Double-Blind|Protocol Violation|1|||
125588142|NCT00619957|451776548|FG001|Month 24 Double-Blind|Protocol Violation|0|||
125588143|NCT00619957|451776547|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
125588144|NCT00619957|451776548|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
125588145|NCT00619957|451776547|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
125588146|NCT00619957|451776548|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
125588147|NCT00619957|451776547|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
125588148|NCT00619957|451776548|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
125588149|NCT00619957|451776547|FG000|Month 48 Open-Label|Adverse Event|4|||
125588150|NCT00619957|451776548|FG001|Month 48 Open-Label|Adverse Event|4|||
125588151|NCT00619957|451776547|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
125588152|NCT00619957|451776548|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
125588153|NCT00619957|451776547|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
125588154|NCT00619957|451776548|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
125429224|NCT02496767|451196632|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
125429225|NCT02496767|451196633|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
125436536|NCT02597933|451224423|FG001|Overall Study|Protocol Violation|2|||
125588155|NCT01173653|451776549|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
125588156|NCT01173653|451776550|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
125211846|NCT00048165|450401385|FG000|Completed 6 Months Study|Insufficient therapy|1|||
125362511|NCT02840721|450961172|FG000|Follow-Up|Withdrawal by Subject|4|||
125362512|NCT02840721|450961172|FG000|Follow-Up|Withdrawal of Consent|2|||
125588157|NCT01651780|451776556|FG000|Overall Study|Physician decision: No 30-day visit|2|||
125588158|NCT01651780|451776557|FG001|Overall Study|Physician decision: No 30-day visit|1|||
125588159|NCT01651780|451776556|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
125588160|NCT01651780|451776557|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
125588161|NCT01651780|451776556|FG000|Overall Study|Withdrawal by Subject|2|||
125588162|NCT01651780|451776557|FG001|Overall Study|Withdrawal by Subject|0|||
125588163|NCT01651780|451776556|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
125588164|NCT01651780|451776557|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125588165|NCT01651780|451776556|FG000|Overall Study|Lost to Follow-up|1|||
125588166|NCT01651780|451776557|FG001|Overall Study|Lost to Follow-up|2|||
125588167|NCT01651780|451776556|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
125588168|NCT01651780|451776557|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
125588169|NCT00151892|451776564|FG000|Overall Study|Lack of Efficacy|50|||
125588170|NCT00151892|451776565|FG001|Overall Study|Lack of Efficacy|57|||
125588171|NCT00151892|451776564|FG000|Overall Study|Patient request|10|||
125588172|NCT00151892|451776565|FG001|Overall Study|Patient request|7|||
125588173|NCT00151892|451776564|FG000|Overall Study|Lost to Follow-up|5|||
125588174|NCT00151892|451776565|FG001|Overall Study|Lost to Follow-up|10|||
125588175|NCT00151892|451776564|FG000|Overall Study|Adverse Event|6|||
125588176|NCT00151892|451776565|FG001|Overall Study|Adverse Event|3|||
125588177|NCT00151892|451776564|FG000|Overall Study|Protocol Violation|3|||
125588178|NCT00151892|451776565|FG001|Overall Study|Protocol Violation|3|||
125588179|NCT00151892|451776564|FG000|Overall Study|Non-compliance|0|||
125588180|NCT00151892|451776565|FG001|Overall Study|Non-compliance|1|||
125588181|NCT00151892|451776564|FG000|Overall Study|Pregnancy|0|||
125588182|NCT00151892|451776565|FG001|Overall Study|Pregnancy|1|||
125588183|NCT00151892|451776564|FG000|Overall Study|Did not return for a visit|1|||
125588184|NCT00151892|451776565|FG001|Overall Study|Did not return for a visit|0|||
125588185|NCT00151892|451776564|FG000|Overall Study|Used prohibited corticosteroids|1|||
125588186|NCT00151892|451776565|FG001|Overall Study|Used prohibited corticosteroids|0|||
125588187|NCT00151892|451776564|FG000|Overall Study|Lack of study medication at center|0|||
125588188|NCT00151892|451776565|FG001|Overall Study|Lack of study medication at center|1|||
125588189|NCT02901431|451776566|FG000|PK Part|Adverse Event|0|||
125588190|NCT02901431|451776567|FG001|PK Part|Adverse Event|1|||
125588191|NCT02901431|451776568|FG002|PK Part|Adverse Event|0|||
125588192|NCT02901431|451776569|FG003|PK Part|Adverse Event|0|||
125588193|NCT02901431|451776570|FG004|PK Part|Adverse Event|0|||
125588194|NCT02901431|451776571|FG005|PK Part|Adverse Event|0|||
125588195|NCT02901431|451776572|FG006|PK Part|Adverse Event|0|||
125588196|NCT02901431|451776573|FG007|PK Part|Adverse Event|0|||
125588197|NCT02901431|451776574|FG008|PK Part|Adverse Event|0|||
125588198|NCT02901431|451776575|FG009|PK Part|Adverse Event|0|||
125588199|NCT02901431|451776576|FG010|PK Part|Adverse Event|0|||
125588200|NCT02901431|451776577|FG011|PK Part|Adverse Event|0|||
125588201|NCT02901431|451776578|FG012|PK Part|Adverse Event|0|||
125588202|NCT02901431|451776566|FG000|PK Part|Lost to Follow-up|0|||
125588203|NCT02901431|451776567|FG001|PK Part|Lost to Follow-up|0|||
125588204|NCT02901431|451776568|FG002|PK Part|Lost to Follow-up|1|||
125588205|NCT02901431|451776569|FG003|PK Part|Lost to Follow-up|0|||
125588206|NCT02901431|451776570|FG004|PK Part|Lost to Follow-up|0|||
125588207|NCT02901431|451776571|FG005|PK Part|Lost to Follow-up|0|||
125588208|NCT02901431|451776572|FG006|PK Part|Lost to Follow-up|0|||
125588209|NCT02901431|451776573|FG007|PK Part|Lost to Follow-up|0|||
125588210|NCT02901431|451776574|FG008|PK Part|Lost to Follow-up|0|||
125588211|NCT02901431|451776575|FG009|PK Part|Lost to Follow-up|0|||
125588212|NCT02901431|451776576|FG010|PK Part|Lost to Follow-up|0|||
125588213|NCT02901431|451776577|FG011|PK Part|Lost to Follow-up|0|||
125588214|NCT02901431|451776578|FG012|PK Part|Lost to Follow-up|0|||
125588215|NCT02901431|451776566|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
125588216|NCT02901431|451776567|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125588217|NCT02901431|451776568|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125588218|NCT02901431|451776569|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125362513|NCT01967173|450961173|FG000|Overall Study|Lost to Follow-up|5|||
125588219|NCT02901431|451776570|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125588220|NCT02901431|451776571|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125588221|NCT02901431|451776572|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125588222|NCT02901431|451776573|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125588223|NCT02901431|451776574|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125588224|NCT02901431|451776575|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125362514|NCT01967173|450961174|FG001|Overall Study|Lost to Follow-up|3|||
125588225|NCT02901431|451776576|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125588226|NCT02901431|451776577|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125588227|NCT02901431|451776578|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
125588228|NCT02901431|451776566|FG000|PK Part|Pending dose confirmation|0|||
125588229|NCT02901431|451776567|FG001|PK Part|Pending dose confirmation|1|||
125588230|NCT02901431|451776568|FG002|PK Part|Pending dose confirmation|0|||
125588231|NCT02901431|451776569|FG003|PK Part|Pending dose confirmation|0|||
125588232|NCT02901431|451776570|FG004|PK Part|Pending dose confirmation|0|||
125588233|NCT02901431|451776571|FG005|PK Part|Pending dose confirmation|0|||
125588234|NCT02901431|451776572|FG006|PK Part|Pending dose confirmation|0|||
125588235|NCT02901431|451776573|FG007|PK Part|Pending dose confirmation|0|||
125588236|NCT02901431|451776574|FG008|PK Part|Pending dose confirmation|0|||
125588237|NCT02901431|451776575|FG009|PK Part|Pending dose confirmation|0|||
125588238|NCT02901431|451776576|FG010|PK Part|Pending dose confirmation|0|||
125588239|NCT02901431|451776577|FG011|PK Part|Pending dose confirmation|0|||
125588240|NCT02901431|451776578|FG012|PK Part|Pending dose confirmation|0|||
125588241|NCT02901431|451776566|FG000|PK Part|8 weeks of treatment ran out|2|||
125588242|NCT02901431|451776567|FG001|PK Part|8 weeks of treatment ran out|0|||
125588243|NCT02901431|451776568|FG002|PK Part|8 weeks of treatment ran out|0|||
125588244|NCT02901431|451776569|FG003|PK Part|8 weeks of treatment ran out|0|||
125588245|NCT02901431|451776570|FG004|PK Part|8 weeks of treatment ran out|0|||
125588246|NCT02901431|451776571|FG005|PK Part|8 weeks of treatment ran out|0|||
125588247|NCT02901431|451776572|FG006|PK Part|8 weeks of treatment ran out|0|||
125588248|NCT02901431|451776573|FG007|PK Part|8 weeks of treatment ran out|0|||
125588249|NCT02901431|451776574|FG008|PK Part|8 weeks of treatment ran out|0|||
125588250|NCT02901431|451776575|FG009|PK Part|8 weeks of treatment ran out|0|||
125588251|NCT02901431|451776576|FG010|PK Part|8 weeks of treatment ran out|0|||
125588252|NCT02901431|451776577|FG011|PK Part|8 weeks of treatment ran out|0|||
125588253|NCT02901431|451776578|FG012|PK Part|8 weeks of treatment ran out|0|||
125588254|NCT02901431|451776566|FG000|PK Part|Stopped treatment after 8 weeks|1|||
125588255|NCT02901431|451776567|FG001|PK Part|Stopped treatment after 8 weeks|0|||
125588256|NCT02901431|451776568|FG002|PK Part|Stopped treatment after 8 weeks|1|||
125588257|NCT02901431|451776569|FG003|PK Part|Stopped treatment after 8 weeks|0|||
125588258|NCT02901431|451776570|FG004|PK Part|Stopped treatment after 8 weeks|0|||
125588259|NCT02901431|451776571|FG005|PK Part|Stopped treatment after 8 weeks|0|||
125588260|NCT02901431|451776572|FG006|PK Part|Stopped treatment after 8 weeks|0|||
125588261|NCT02901431|451776573|FG007|PK Part|Stopped treatment after 8 weeks|0|||
125588262|NCT02901431|451776574|FG008|PK Part|Stopped treatment after 8 weeks|0|||
125588263|NCT02901431|451776575|FG009|PK Part|Stopped treatment after 8 weeks|0|||
125588264|NCT02901431|451776576|FG010|PK Part|Stopped treatment after 8 weeks|0|||
125588265|NCT02901431|451776577|FG011|PK Part|Stopped treatment after 8 weeks|0|||
125588266|NCT02901431|451776578|FG012|PK Part|Stopped treatment after 8 weeks|0|||
125588267|NCT02901431|451776566|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
125588268|NCT02901431|451776567|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125588269|NCT02901431|451776568|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
125588270|NCT02901431|451776569|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125588271|NCT02901431|451776570|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125588272|NCT02901431|451776571|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125588273|NCT02901431|451776572|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125588274|NCT02901431|451776573|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125588275|NCT02901431|451776574|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125588276|NCT02901431|451776575|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125588277|NCT02901431|451776576|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125588278|NCT02901431|451776577|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125588279|NCT02901431|451776578|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
125588280|NCT02901431|451776566|FG000|PK Part|Discontinued per Sponsor|0|||
125588281|NCT02901431|451776567|FG001|PK Part|Discontinued per Sponsor|3|||
125588282|NCT02901431|451776568|FG002|PK Part|Discontinued per Sponsor|0|||
125588283|NCT02901431|451776569|FG003|PK Part|Discontinued per Sponsor|0|||
125588284|NCT02901431|451776570|FG004|PK Part|Discontinued per Sponsor|0|||
125588285|NCT02901431|451776571|FG005|PK Part|Discontinued per Sponsor|0|||
125588286|NCT02901431|451776572|FG006|PK Part|Discontinued per Sponsor|0|||
125588287|NCT02901431|451776573|FG007|PK Part|Discontinued per Sponsor|0|||
125588288|NCT02901431|451776574|FG008|PK Part|Discontinued per Sponsor|0|||
125588289|NCT02901431|451776575|FG009|PK Part|Discontinued per Sponsor|0|||
125588290|NCT02901431|451776576|FG010|PK Part|Discontinued per Sponsor|0|||
125588291|NCT02901431|451776577|FG011|PK Part|Discontinued per Sponsor|0|||
125588292|NCT02901431|451776578|FG012|PK Part|Discontinued per Sponsor|0|||
125588293|NCT02901431|451776566|FG000|PK Part|Withdrawal by Subject|1|||
125588294|NCT02901431|451776567|FG001|PK Part|Withdrawal by Subject|1|||
125588295|NCT02901431|451776568|FG002|PK Part|Withdrawal by Subject|3|||
125588296|NCT02901431|451776569|FG003|PK Part|Withdrawal by Subject|0|||
125588297|NCT02901431|451776570|FG004|PK Part|Withdrawal by Subject|0|||
125588298|NCT02901431|451776571|FG005|PK Part|Withdrawal by Subject|0|||
125588299|NCT02901431|451776572|FG006|PK Part|Withdrawal by Subject|0|||
125588300|NCT02901431|451776573|FG007|PK Part|Withdrawal by Subject|0|||
125588301|NCT02901431|451776574|FG008|PK Part|Withdrawal by Subject|0|||
125588302|NCT02901431|451776575|FG009|PK Part|Withdrawal by Subject|0|||
125588303|NCT02901431|451776576|FG010|PK Part|Withdrawal by Subject|0|||
125588304|NCT02901431|451776577|FG011|PK Part|Withdrawal by Subject|0|||
125588305|NCT02901431|451776578|FG012|PK Part|Withdrawal by Subject|0|||
125588306|NCT02901431|451776566|FG000|Main Treatment Part|Adverse Event|0|||
125588307|NCT02901431|451776567|FG001|Main Treatment Part|Adverse Event|0|||
125588308|NCT02901431|451776568|FG002|Main Treatment Part|Adverse Event|0|||
125588309|NCT02901431|451776569|FG003|Main Treatment Part|Adverse Event|3|||
125588310|NCT02901431|451776570|FG004|Main Treatment Part|Adverse Event|3|||
125588311|NCT02901431|451776571|FG005|Main Treatment Part|Adverse Event|4|||
125588312|NCT02901431|451776572|FG006|Main Treatment Part|Adverse Event|1|||
125588313|NCT02901431|451776573|FG007|Main Treatment Part|Adverse Event|0|||
125588314|NCT02901431|451776574|FG008|Main Treatment Part|Adverse Event|0|||
125588315|NCT02901431|451776575|FG009|Main Treatment Part|Adverse Event|0|||
125588316|NCT02901431|451776576|FG010|Main Treatment Part|Adverse Event|0|||
125588317|NCT02901431|451776577|FG011|Main Treatment Part|Adverse Event|0|||
125588318|NCT02901431|451776578|FG012|Main Treatment Part|Adverse Event|0|||
125588319|NCT02901431|451776566|FG000|Main Treatment Part|Lack of Efficacy|0|||
125588320|NCT02901431|451776567|FG001|Main Treatment Part|Lack of Efficacy|0|||
125588321|NCT02901431|451776568|FG002|Main Treatment Part|Lack of Efficacy|0|||
125588322|NCT02901431|451776569|FG003|Main Treatment Part|Lack of Efficacy|1|||
125588323|NCT02901431|451776570|FG004|Main Treatment Part|Lack of Efficacy|0|||
125588324|NCT02901431|451776571|FG005|Main Treatment Part|Lack of Efficacy|0|||
125362515|NCT01967173|450961175|FG002|Overall Study|Lost to Follow-up|2|||
125362516|NCT01967173|450961176|FG003|Overall Study|Lost to Follow-up|4|||
125588325|NCT02901431|451776572|FG006|Main Treatment Part|Lack of Efficacy|0|||
125588326|NCT02901431|451776573|FG007|Main Treatment Part|Lack of Efficacy|0|||
125588327|NCT02901431|451776574|FG008|Main Treatment Part|Lack of Efficacy|0|||
125588328|NCT02901431|451776575|FG009|Main Treatment Part|Lack of Efficacy|0|||
125588329|NCT02901431|451776576|FG010|Main Treatment Part|Lack of Efficacy|0|||
125588330|NCT02901431|451776577|FG011|Main Treatment Part|Lack of Efficacy|0|||
125588331|NCT02901431|451776578|FG012|Main Treatment Part|Lack of Efficacy|0|||
125588332|NCT02901431|451776566|FG000|Main Treatment Part|Lost to Follow-up|0|||
125588333|NCT02901431|451776567|FG001|Main Treatment Part|Lost to Follow-up|0|||
125588334|NCT02901431|451776568|FG002|Main Treatment Part|Lost to Follow-up|0|||
125588335|NCT02901431|451776569|FG003|Main Treatment Part|Lost to Follow-up|3|||
125588336|NCT02901431|451776570|FG004|Main Treatment Part|Lost to Follow-up|1|||
125588337|NCT02901431|451776571|FG005|Main Treatment Part|Lost to Follow-up|2|||
125588338|NCT02901431|451776572|FG006|Main Treatment Part|Lost to Follow-up|3|||
125588339|NCT02901431|451776573|FG007|Main Treatment Part|Lost to Follow-up|0|||
125588340|NCT02901431|451776574|FG008|Main Treatment Part|Lost to Follow-up|0|||
125588341|NCT02901431|451776575|FG009|Main Treatment Part|Lost to Follow-up|0|||
125588342|NCT02901431|451776576|FG010|Main Treatment Part|Lost to Follow-up|0|||
125588343|NCT02901431|451776577|FG011|Main Treatment Part|Lost to Follow-up|0|||
125588344|NCT02901431|451776578|FG012|Main Treatment Part|Lost to Follow-up|0|||
125588345|NCT02901431|451776566|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
125588346|NCT02901431|451776567|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
125588347|NCT02901431|451776568|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
125588348|NCT02901431|451776569|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
125588349|NCT02901431|451776570|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
125588350|NCT02901431|451776571|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
125588351|NCT02901431|451776572|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
125588352|NCT02901431|451776573|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
125588353|NCT02901431|451776574|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
125588354|NCT02901431|451776575|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
125588355|NCT02901431|451776576|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
125588356|NCT02901431|451776577|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
125588357|NCT02901431|451776578|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
125588358|NCT02901431|451776566|FG000|Main Treatment Part|Physician Decision|0|||
125588359|NCT02901431|451776567|FG001|Main Treatment Part|Physician Decision|0|||
125588360|NCT02901431|451776568|FG002|Main Treatment Part|Physician Decision|0|||
125588361|NCT02901431|451776569|FG003|Main Treatment Part|Physician Decision|1|||
125588362|NCT02901431|451776570|FG004|Main Treatment Part|Physician Decision|0|||
125588363|NCT02901431|451776571|FG005|Main Treatment Part|Physician Decision|0|||
125588364|NCT02901431|451776572|FG006|Main Treatment Part|Physician Decision|1|||
125588365|NCT02901431|451776573|FG007|Main Treatment Part|Physician Decision|0|||
125588366|NCT02901431|451776574|FG008|Main Treatment Part|Physician Decision|0|||
125588367|NCT02901431|451776575|FG009|Main Treatment Part|Physician Decision|0|||
125588368|NCT02901431|451776576|FG010|Main Treatment Part|Physician Decision|0|||
125588369|NCT02901431|451776577|FG011|Main Treatment Part|Physician Decision|0|||
125588370|NCT02901431|451776578|FG012|Main Treatment Part|Physician Decision|0|||
125588371|NCT02901431|451776566|FG000|Main Treatment Part|Withdrawal by Subject|0|||
125588372|NCT02901431|451776567|FG001|Main Treatment Part|Withdrawal by Subject|0|||
125588373|NCT02901431|451776568|FG002|Main Treatment Part|Withdrawal by Subject|0|||
125588374|NCT02901431|451776569|FG003|Main Treatment Part|Withdrawal by Subject|18|||
125588375|NCT02901431|451776570|FG004|Main Treatment Part|Withdrawal by Subject|3|||
125588376|NCT02901431|451776571|FG005|Main Treatment Part|Withdrawal by Subject|5|||
125588377|NCT02901431|451776572|FG006|Main Treatment Part|Withdrawal by Subject|6|||
125588378|NCT02901431|451776573|FG007|Main Treatment Part|Withdrawal by Subject|0|||
125588379|NCT02901431|451776574|FG008|Main Treatment Part|Withdrawal by Subject|0|||
125588380|NCT02901431|451776575|FG009|Main Treatment Part|Withdrawal by Subject|0|||
125588381|NCT02901431|451776576|FG010|Main Treatment Part|Withdrawal by Subject|0|||
125588382|NCT02901431|451776577|FG011|Main Treatment Part|Withdrawal by Subject|0|||
125588383|NCT02901431|451776578|FG012|Main Treatment Part|Withdrawal by Subject|0|||
125588384|NCT02901431|451776566|FG000|Open Label Part|Adverse Event|0|||
125588385|NCT02901431|451776567|FG001|Open Label Part|Adverse Event|0|||
125588386|NCT02901431|451776568|FG002|Open Label Part|Adverse Event|0|||
125588387|NCT02901431|451776569|FG003|Open Label Part|Adverse Event|0|||
125588388|NCT02901431|451776570|FG004|Open Label Part|Adverse Event|0|||
125588389|NCT02901431|451776571|FG005|Open Label Part|Adverse Event|0|||
125588390|NCT02901431|451776572|FG006|Open Label Part|Adverse Event|0|||
125588391|NCT02901431|451776573|FG007|Open Label Part|Adverse Event|0|||
125588392|NCT02901431|451776574|FG008|Open Label Part|Adverse Event|4|||
125588393|NCT02901431|451776575|FG009|Open Label Part|Adverse Event|4|||
125588394|NCT02901431|451776576|FG010|Open Label Part|Adverse Event|0|||
125588395|NCT02901431|451776577|FG011|Open Label Part|Adverse Event|4|||
125588396|NCT02901431|451776578|FG012|Open Label Part|Adverse Event|1|||
125588397|NCT02901431|451776566|FG000|Open Label Part|Lost to Follow-up|0|||
125588398|NCT02901431|451776567|FG001|Open Label Part|Lost to Follow-up|0|||
125588399|NCT02901431|451776568|FG002|Open Label Part|Lost to Follow-up|0|||
125588400|NCT02901431|451776569|FG003|Open Label Part|Lost to Follow-up|0|||
125588401|NCT02901431|451776570|FG004|Open Label Part|Lost to Follow-up|0|||
125588402|NCT02901431|451776571|FG005|Open Label Part|Lost to Follow-up|0|||
125588403|NCT02901431|451776572|FG006|Open Label Part|Lost to Follow-up|0|||
125588404|NCT02901431|451776573|FG007|Open Label Part|Lost to Follow-up|0|||
125588405|NCT02901431|451776574|FG008|Open Label Part|Lost to Follow-up|2|||
125588406|NCT02901431|451776575|FG009|Open Label Part|Lost to Follow-up|2|||
125588407|NCT02901431|451776576|FG010|Open Label Part|Lost to Follow-up|1|||
125588408|NCT02901431|451776577|FG011|Open Label Part|Lost to Follow-up|1|||
125588409|NCT02901431|451776578|FG012|Open Label Part|Lost to Follow-up|1|||
125588410|NCT02901431|451776566|FG000|Open Label Part|Physician Decision|0|||
125588411|NCT02901431|451776567|FG001|Open Label Part|Physician Decision|0|||
125588412|NCT02901431|451776568|FG002|Open Label Part|Physician Decision|0|||
125588413|NCT02901431|451776569|FG003|Open Label Part|Physician Decision|0|||
125588414|NCT02901431|451776570|FG004|Open Label Part|Physician Decision|0|||
125588415|NCT02901431|451776571|FG005|Open Label Part|Physician Decision|0|||
125588416|NCT02901431|451776572|FG006|Open Label Part|Physician Decision|0|||
125588417|NCT02901431|451776573|FG007|Open Label Part|Physician Decision|0|||
125588418|NCT02901431|451776574|FG008|Open Label Part|Physician Decision|1|||
125588419|NCT02901431|451776575|FG009|Open Label Part|Physician Decision|1|||
125588420|NCT02901431|451776576|FG010|Open Label Part|Physician Decision|0|||
125588421|NCT02901431|451776577|FG011|Open Label Part|Physician Decision|0|||
125588422|NCT02901431|451776578|FG012|Open Label Part|Physician Decision|0|||
125588423|NCT02901431|451776566|FG000|Open Label Part|Study Terminated By Sponsor|0|||
125588424|NCT02901431|451776567|FG001|Open Label Part|Study Terminated By Sponsor|0|||
125588425|NCT02901431|451776568|FG002|Open Label Part|Study Terminated By Sponsor|0|||
125588426|NCT02901431|451776569|FG003|Open Label Part|Study Terminated By Sponsor|0|||
125588427|NCT02901431|451776570|FG004|Open Label Part|Study Terminated By Sponsor|0|||
125588428|NCT02901431|451776571|FG005|Open Label Part|Study Terminated By Sponsor|0|||
125588429|NCT02901431|451776572|FG006|Open Label Part|Study Terminated By Sponsor|0|||
125588430|NCT02901431|451776573|FG007|Open Label Part|Study Terminated By Sponsor|0|||
125588431|NCT02901431|451776574|FG008|Open Label Part|Study Terminated By Sponsor|35|||
125588432|NCT02901431|451776575|FG009|Open Label Part|Study Terminated By Sponsor|12|||
125588433|NCT02901431|451776576|FG010|Open Label Part|Study Terminated By Sponsor|21|||
125588434|NCT02901431|451776577|FG011|Open Label Part|Study Terminated By Sponsor|31|||
125588435|NCT02901431|451776578|FG012|Open Label Part|Study Terminated By Sponsor|0|||
125588436|NCT02901431|451776566|FG000|Open Label Part|Withdrawal by Subject|0|||
125588437|NCT02901431|451776567|FG001|Open Label Part|Withdrawal by Subject|0|||
125588438|NCT02901431|451776568|FG002|Open Label Part|Withdrawal by Subject|0|||
125588439|NCT02901431|451776569|FG003|Open Label Part|Withdrawal by Subject|0|||
125588440|NCT02901431|451776570|FG004|Open Label Part|Withdrawal by Subject|0|||
125588441|NCT02901431|451776571|FG005|Open Label Part|Withdrawal by Subject|0|||
125588442|NCT02901431|451776572|FG006|Open Label Part|Withdrawal by Subject|0|||
125588443|NCT02901431|451776573|FG007|Open Label Part|Withdrawal by Subject|0|||
125588444|NCT02901431|451776574|FG008|Open Label Part|Withdrawal by Subject|6|||
125588445|NCT02901431|451776575|FG009|Open Label Part|Withdrawal by Subject|5|||
125588446|NCT02901431|451776576|FG010|Open Label Part|Withdrawal by Subject|7|||
125588447|NCT02901431|451776577|FG011|Open Label Part|Withdrawal by Subject|3|||
125588448|NCT02901431|451776578|FG012|Open Label Part|Withdrawal by Subject|1|||
125588449|NCT04223609|451776581|FG000|Overall Study|Adverse Event|0|||
125588450|NCT04223609|451776582|FG001|Overall Study|Adverse Event|1|||
125588451|NCT04223609|451776581|FG000|Overall Study|Missed last visit|0|||
125588452|NCT04223609|451776582|FG001|Overall Study|Missed last visit|1|||
125588453|NCT01275222|451776585|FG000|Phase l by Treatment|Adverse Event|1|||
125588454|NCT01275222|451776586|FG001|Phase l by Treatment|Adverse Event|4|||
125588455|NCT01275222|451776587|FG002|Phase l by Treatment|Adverse Event|2|||
125588456|NCT01275222|451776588|FG003|Phase l by Treatment|Adverse Event|3|||
125588457|NCT01275222|451776589|FG004|Phase l by Treatment|Adverse Event|0|||
125588458|NCT01275222|451776590|FG005|Phase l by Treatment|Adverse Event|0|||
125588459|NCT01275222|451776585|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
125588460|NCT01275222|451776586|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
125588461|NCT01275222|451776587|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
125588462|NCT01275222|451776588|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
125588463|NCT01275222|451776589|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
125588464|NCT01275222|451776590|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
125588465|NCT01275222|451776585|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
125588466|NCT01275222|451776586|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
125588467|NCT01275222|451776587|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
125588468|NCT01275222|451776588|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
125588469|NCT01275222|451776589|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
125588470|NCT01275222|451776590|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
125588471|NCT01275222|451776585|FG000|Phase l by Treatment|Disease progression|12|||
125588472|NCT01275222|451776586|FG001|Phase l by Treatment|Disease progression|8|||
125588473|NCT01275222|451776587|FG002|Phase l by Treatment|Disease progression|2|||
125588474|NCT01275222|451776588|FG003|Phase l by Treatment|Disease progression|5|||
125588475|NCT01275222|451776589|FG004|Phase l by Treatment|Disease progression|0|||
125588476|NCT01275222|451776590|FG005|Phase l by Treatment|Disease progression|0|||
125588477|NCT01275222|451776585|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
125588478|NCT01275222|451776586|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
125588479|NCT01275222|451776587|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
125588480|NCT01275222|451776588|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
125588481|NCT01275222|451776589|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
125588482|NCT01275222|451776590|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
125588483|NCT01275222|451776585|FG000|Phase l by Treatment|Death|0|||
125588484|NCT01275222|451776586|FG001|Phase l by Treatment|Death|1|||
125588485|NCT01275222|451776587|FG002|Phase l by Treatment|Death|0|||
125588486|NCT01275222|451776588|FG003|Phase l by Treatment|Death|1|||
125588487|NCT01275222|451776589|FG004|Phase l by Treatment|Death|0|||
125362517|NCT01967173|450961177|FG004|Overall Study|Lost to Follow-up|8|||
125588488|NCT01275222|451776590|FG005|Phase l by Treatment|Death|0|||
125588489|NCT01275222|451776585|FG000|Phase ll by Stratum|Adverse Event|0|||
125588490|NCT01275222|451776586|FG001|Phase ll by Stratum|Adverse Event|0|||
125588491|NCT01275222|451776587|FG002|Phase ll by Stratum|Adverse Event|0|||
125588492|NCT01275222|451776588|FG003|Phase ll by Stratum|Adverse Event|0|||
125588493|NCT01275222|451776589|FG004|Phase ll by Stratum|Adverse Event|2|||
125588494|NCT01275222|451776590|FG005|Phase ll by Stratum|Adverse Event|10|||
125588495|NCT01275222|451776585|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
125588496|NCT01275222|451776586|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
125588497|NCT01275222|451776587|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
125588498|NCT01275222|451776588|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
125588499|NCT01275222|451776589|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
125588500|NCT01275222|451776590|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
125588501|NCT01275222|451776585|FG000|Phase ll by Stratum|Disease progression|0|||
125588502|NCT01275222|451776586|FG001|Phase ll by Stratum|Disease progression|0|||
125588503|NCT01275222|451776587|FG002|Phase ll by Stratum|Disease progression|0|||
125588504|NCT01275222|451776588|FG003|Phase ll by Stratum|Disease progression|0|||
125588505|NCT01275222|451776589|FG004|Phase ll by Stratum|Disease progression|23|||
125588506|NCT01275222|451776590|FG005|Phase ll by Stratum|Disease progression|31|||
125588507|NCT01275222|451776585|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
125588508|NCT01275222|451776586|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
125588509|NCT01275222|451776587|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
125588510|NCT01275222|451776588|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
125588511|NCT01275222|451776589|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
125588512|NCT01275222|451776590|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
125588513|NCT01275222|451776585|FG000|Phase ll by Stratum|Death|0|||
125588514|NCT01275222|451776586|FG001|Phase ll by Stratum|Death|0|||
125588515|NCT01275222|451776587|FG002|Phase ll by Stratum|Death|0|||
125588516|NCT01275222|451776588|FG003|Phase ll by Stratum|Death|0|||
125588517|NCT01275222|451776589|FG004|Phase ll by Stratum|Death|1|||
125588518|NCT01275222|451776590|FG005|Phase ll by Stratum|Death|1|||
125588519|NCT03440944|451776591|FG000|Overall Study|Physician Decision|1|||
125588520|NCT03440944|451776592|FG001|Overall Study|Physician Decision|0|||
125588521|NCT03440944|451776591|FG000|Overall Study|No Acceptable Vasculature|0|||
125588522|NCT03440944|451776592|FG001|Overall Study|No Acceptable Vasculature|1|||
125588523|NCT00484315|451776593|FG000|12-Month Clinical Follow-up|Death|6|||
125588524|NCT00484315|451776594|FG001|12-Month Clinical Follow-up|Death|2|||
125588525|NCT00484315|451776593|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
125588526|NCT00484315|451776594|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
125588527|NCT00484315|451776593|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
125588528|NCT00484315|451776594|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
125588529|NCT00484315|451776593|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
125588530|NCT00484315|451776594|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
125588531|NCT00484315|451776593|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
125588532|NCT00484315|451776594|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
125588533|NCT00484315|451776593|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
125588534|NCT00484315|451776594|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
125588535|NCT00484315|451776593|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
125588536|NCT00484315|451776594|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
125588537|NCT00943683|451776595|FG000|Overall Study|Adverse Event|3|||
125588538|NCT00943683|451776596|FG001|Overall Study|Adverse Event|3|||
125588539|NCT00943683|451776595|FG000|Overall Study|Lost to Follow-up|1|||
125588540|NCT00943683|451776596|FG001|Overall Study|Lost to Follow-up|1|||
125588541|NCT00943683|451776595|FG000|Overall Study|Protocol Violation|1|||
125588542|NCT00943683|451776596|FG001|Overall Study|Protocol Violation|2|||
125588543|NCT00943683|451776595|FG000|Overall Study|Withdrawal by Subject|1|||
125588544|NCT00943683|451776596|FG001|Overall Study|Withdrawal by Subject|0|||
125588545|NCT00943683|451776595|FG000|Overall Study|Patient Moved|1|||
125588546|NCT00943683|451776596|FG001|Overall Study|Patient Moved|0|||
125588547|NCT02500537|451776597|FG000|Overall Study|Death|2|||
125588548|NCT02500537|451776598|FG001|Overall Study|Death|0|||
125588549|NCT02500537|451776597|FG000|Overall Study|Lost to Follow-up|0|||
125588550|NCT02500537|451776598|FG001|Overall Study|Lost to Follow-up|1|||
125588551|NCT02500537|451776597|FG000|Overall Study|Withdrawal by Subject|1|||
125588552|NCT02500537|451776598|FG001|Overall Study|Withdrawal by Subject|0|||
125588553|NCT04672083|451776599|FG000|Overall Study|Lost to Follow-up|1|||
125588554|NCT04672083|451776600|FG001|Overall Study|Lost to Follow-up|0|||
125588555|NCT04672083|451776601|FG002|Overall Study|Lost to Follow-up|0|||
125588556|NCT04672083|451776602|FG003|Overall Study|Lost to Follow-up|0|||
125588557|NCT04672083|451776603|FG004|Overall Study|Lost to Follow-up|0|||
125588558|NCT01551745|451776604|FG000|Overall Study|Withdrawal by Subject|1|||
125588559|NCT01551745|451776604|FG000|Overall Study|Disease Progression|2|||
125588560|NCT01661790|451776605|FG000|Overall Study|Lost to Follow-up|0|||
125588561|NCT01661790|451776606|FG001|Overall Study|Lost to Follow-up|2|||
125588562|NCT02048904|451776611|FG000|Overall Study|Withdrawal by Subject|7|||
125588563|NCT02048904|451776611|FG000|Overall Study|Physician Decision|70|||
125588564|NCT00784758|451776619|FG000|Overall Study|Withdrawal by Subject|3|||
125588565|NCT00784758|451776620|FG001|Overall Study|Withdrawal by Subject|0|||
125588566|NCT00784758|451776619|FG000|Overall Study|Adverse Event|1|||
125588567|NCT00784758|451776620|FG001|Overall Study|Adverse Event|0|||
125588568|NCT04439123|451776624|FG000|Overall Study|Adverse Event|11|||
125588569|NCT04439123|451776624|FG000|Overall Study|Death|1|||
125588570|NCT04439123|451776624|FG000|Overall Study|Disease progression|19|||
125588571|NCT04439123|451776624|FG000|Overall Study|Withdrawal by Subject|2|||
125588572|NCT04439123|451776624|FG000|Overall Study|Still on treatment|2|||
125588573|NCT02875223|451776625|FG000|Overall Study|Other reasons|0|||
125588574|NCT02875223|451776626|FG001|Overall Study|Other reasons|0|||
125588575|NCT02875223|451776627|FG002|Overall Study|Other reasons|1|||
125588576|NCT02875223|451776628|FG003|Overall Study|Other reasons|0|||
125588577|NCT02875223|451776629|FG004|Overall Study|Other reasons|1|||
125588578|NCT02875223|451776630|FG005|Overall Study|Other reasons|2|||
125588579|NCT02875223|451776631|FG006|Overall Study|Other reasons|0|||
125588580|NCT02875223|451776632|FG007|Overall Study|Other reasons|2|||
125588581|NCT02875223|451776633|FG008|Overall Study|Other reasons|0|||
125588582|NCT02875223|451776634|FG009|Overall Study|Other reasons|0|||
125588583|NCT02875223|451776635|FG010|Overall Study|Other reasons|0|||
125588584|NCT02875223|451776636|FG011|Overall Study|Other reasons|0|||
125588585|NCT02875223|451776637|FG012|Overall Study|Other reasons|0|||
125588586|NCT02875223|451776625|FG000|Overall Study|Withdrawal by Subject|0|||
125588587|NCT02875223|451776626|FG001|Overall Study|Withdrawal by Subject|0|||
125588588|NCT02875223|451776627|FG002|Overall Study|Withdrawal by Subject|0|||
125588589|NCT02875223|451776628|FG003|Overall Study|Withdrawal by Subject|0|||
125588590|NCT02875223|451776629|FG004|Overall Study|Withdrawal by Subject|1|||
125588591|NCT02875223|451776630|FG005|Overall Study|Withdrawal by Subject|1|||
125588592|NCT02875223|451776631|FG006|Overall Study|Withdrawal by Subject|0|||
125588593|NCT02875223|451776632|FG007|Overall Study|Withdrawal by Subject|0|||
125588594|NCT02875223|451776633|FG008|Overall Study|Withdrawal by Subject|1|||
125588595|NCT02875223|451776634|FG009|Overall Study|Withdrawal by Subject|0|||
125588596|NCT02875223|451776635|FG010|Overall Study|Withdrawal by Subject|0|||
125588597|NCT02875223|451776636|FG011|Overall Study|Withdrawal by Subject|0|||
125588598|NCT02875223|451776637|FG012|Overall Study|Withdrawal by Subject|0|||
125588599|NCT02875223|451776625|FG000|Overall Study|Progressive disease|0|||
125588600|NCT02875223|451776626|FG001|Overall Study|Progressive disease|0|||
125588601|NCT02875223|451776627|FG002|Overall Study|Progressive disease|1|||
125588602|NCT02875223|451776628|FG003|Overall Study|Progressive disease|0|||
125588603|NCT02875223|451776629|FG004|Overall Study|Progressive disease|0|||
125588604|NCT02875223|451776630|FG005|Overall Study|Progressive disease|0|||
125588605|NCT02875223|451776631|FG006|Overall Study|Progressive disease|0|||
125588606|NCT02875223|451776632|FG007|Overall Study|Progressive disease|0|||
125588607|NCT02875223|451776633|FG008|Overall Study|Progressive disease|0|||
125588608|NCT02875223|451776634|FG009|Overall Study|Progressive disease|12|||
125588609|NCT02875223|451776635|FG010|Overall Study|Progressive disease|2|||
125588610|NCT02875223|451776636|FG011|Overall Study|Progressive disease|3|||
125588611|NCT02875223|451776637|FG012|Overall Study|Progressive disease|6|||
125588612|NCT02875223|451776625|FG000|Overall Study|Death|4|||
125588613|NCT02875223|451776626|FG001|Overall Study|Death|4|||
125588614|NCT02875223|451776627|FG002|Overall Study|Death|3|||
125588615|NCT02875223|451776628|FG003|Overall Study|Death|4|||
125588616|NCT02875223|451776629|FG004|Overall Study|Death|2|||
125588617|NCT02875223|451776630|FG005|Overall Study|Death|3|||
125588618|NCT02875223|451776631|FG006|Overall Study|Death|5|||
125588619|NCT02875223|451776632|FG007|Overall Study|Death|7|||
125588620|NCT02875223|451776633|FG008|Overall Study|Death|3|||
125588621|NCT02875223|451776634|FG009|Overall Study|Death|2|||
125588622|NCT02875223|451776635|FG010|Overall Study|Death|0|||
125588623|NCT02875223|451776636|FG011|Overall Study|Death|0|||
125588624|NCT02875223|451776637|FG012|Overall Study|Death|0|||
125588625|NCT02875223|451776625|FG000|Overall Study|Lost to Follow-up|0|||
125588626|NCT02875223|451776626|FG001|Overall Study|Lost to Follow-up|1|||
125588627|NCT02875223|451776627|FG002|Overall Study|Lost to Follow-up|1|||
125588628|NCT02875223|451776628|FG003|Overall Study|Lost to Follow-up|0|||
125588629|NCT02875223|451776629|FG004|Overall Study|Lost to Follow-up|1|||
125588630|NCT02875223|451776630|FG005|Overall Study|Lost to Follow-up|0|||
125588631|NCT02875223|451776631|FG006|Overall Study|Lost to Follow-up|1|||
125429226|NCT02496767|451196634|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
125429227|NCT02496767|451196627|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
125588632|NCT02875223|451776632|FG007|Overall Study|Lost to Follow-up|1|||
125588633|NCT02875223|451776633|FG008|Overall Study|Lost to Follow-up|0|||
125588634|NCT02875223|451776634|FG009|Overall Study|Lost to Follow-up|0|||
125588635|NCT02875223|451776635|FG010|Overall Study|Lost to Follow-up|0|||
125588636|NCT02875223|451776636|FG011|Overall Study|Lost to Follow-up|0|||
125588637|NCT02875223|451776637|FG012|Overall Study|Lost to Follow-up|0|||
125588638|NCT04211337|451776641|FG000|Overall Study|On Treatment|175|||
125588639|NCT04211337|451776642|FG001|Overall Study|On Treatment|40|||
125588640|NCT04211337|451776641|FG000|Overall Study|Withdrawal by Subject|0|||
125588641|NCT04211337|451776642|FG001|Overall Study|Withdrawal by Subject|2|||
125588642|NCT06119191|451776647|FG000|Overall Study|Adverse Event|0|||
125588643|NCT06119191|451776648|FG001|Overall Study|Adverse Event|1|||
125588644|NCT06119191|451776647|FG000|Overall Study|Protocol Violation|1|||
125588645|NCT06119191|451776648|FG001|Overall Study|Protocol Violation|0|||
125588666|NCT02732951|451779134|FG000|Overall Study|Other than listed|1|||
125588667|NCT02732951|451779135|FG001|Overall Study|Other than listed|0|||
125588668|NCT02732951|451779134|FG000|Overall Study|Lost to Follow-up|0|||
125588669|NCT02732951|451779135|FG001|Overall Study|Lost to Follow-up|1|||
125588670|NCT02732951|451779134|FG000|Overall Study|Adverse Event|4|||
125588671|NCT02732951|451779135|FG001|Overall Study|Adverse Event|4|||
125588672|NCT02732951|451779134|FG000|Overall Study|Protocol Violation|0|||
125588673|NCT02732951|451779135|FG001|Overall Study|Protocol Violation|1|||
125588674|NCT03263806|451779136|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
125588675|NCT03263806|451779137|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
125588676|NCT03263806|451779136|FG000|Overall Study|Withdrawal by Subject|0|||
125588677|NCT03263806|451779137|FG001|Overall Study|Withdrawal by Subject|1|||
125588678|NCT03263806|451779136|FG000|Overall Study|Study Termination|5|||
125588679|NCT03263806|451779137|FG001|Overall Study|Study Termination|6|||
125588680|NCT01412879|451779138|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
125588681|NCT01412879|451779139|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
125588682|NCT01412879|451779140|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
125588683|NCT01412879|451779138|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
125588684|NCT01412879|451779139|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
125588685|NCT01412879|451779140|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
125588686|NCT01412879|451779138|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
125588687|NCT01412879|451779139|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
125588688|NCT01412879|451779140|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
125588689|NCT01412879|451779138|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
125588690|NCT01412879|451779139|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
125588691|NCT01412879|451779140|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
125588692|NCT01412879|451779138|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
125588693|NCT01412879|451779139|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
125588694|NCT01412879|451779140|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
125588695|NCT04840667|451779141|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
125588696|NCT01445171|451779142|FG000|Overall Study|Lost to Follow-up|11|||
125588697|NCT01445171|451779142|FG000|Overall Study|Withdrawal by Subject|16|||
125588698|NCT01445171|451779142|FG000|Overall Study|Death|51|||
125588699|NCT01445171|451779142|FG000|Overall Study|Subjects declined to return for followup|9|||
125588700|NCT01445171|451779142|FG000|Overall Study|Consented but did not receive device|8|||
125588701|NCT03195894|451779149|FG000|Overall Study|"An example is Started other treatment."|4|||
125588702|NCT03195894|451779150|FG001|Overall Study|"An example is Started other treatment."|5|||
125588703|NCT03195894|451779149|FG000|Overall Study|Withdrawal by Subject|15|||
125588704|NCT03195894|451779150|FG001|Overall Study|Withdrawal by Subject|4|||
125588705|NCT03195894|451779149|FG000|Overall Study|Lost to Follow-up|14|||
125588706|NCT03195894|451779150|FG001|Overall Study|Lost to Follow-up|19|||
125362518|NCT01967173|450961178|FG005|Overall Study|Lost to Follow-up|12|||
125362519|NCT01967173|450961179|FG006|Overall Study|Lost to Follow-up|6|||
125362520|NCT01967173|450961180|FG007|Overall Study|Lost to Follow-up|8|||
125588707|NCT00162773|451779151|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
125588708|NCT01903876|451779155|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
125588709|NCT01903876|451779156|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
125362521|NCT01967173|450961173|FG000|Overall Study|Physician Decision|2|||
125588710|NCT01903876|451779155|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
125588711|NCT01903876|451779156|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
125362522|NCT01967173|450961174|FG001|Overall Study|Physician Decision|0|||
125588712|NCT02612909|451779157|FG000|Phase 2|Withdrawal by Subject|2|||
125588713|NCT02612909|451779158|FG001|Phase 2|Withdrawal by Subject|5|||
125588714|NCT02612909|451779159|FG002|Phase 2|Withdrawal by Subject|0|||
125588715|NCT02612909|451779160|FG003|Phase 2|Withdrawal by Subject|0|||
125588716|NCT02612909|451779161|FG004|Phase 2|Withdrawal by Subject|0|||
125588717|NCT02612909|451779157|FG000|Phase 2|Pregnancy|0|||
125588718|NCT02612909|451779158|FG001|Phase 2|Pregnancy|0|||
125588719|NCT02612909|451779159|FG002|Phase 2|Pregnancy|1|||
125588720|NCT02612909|451779160|FG003|Phase 2|Pregnancy|0|||
125588721|NCT02612909|451779161|FG004|Phase 2|Pregnancy|0|||
125588722|NCT02612909|451779157|FG000|Phase 3|Withdrawal by Subject|0|||
125588723|NCT02612909|451779158|FG001|Phase 3|Withdrawal by Subject|0|||
125588724|NCT02612909|451779159|FG002|Phase 3|Withdrawal by Subject|0|||
125588725|NCT02612909|451779160|FG003|Phase 3|Withdrawal by Subject|1|||
125588726|NCT02612909|451779161|FG004|Phase 3|Withdrawal by Subject|0|||
125588727|NCT00450580|451779163|FG000|Overall Study|Adverse Event|5|||
125588728|NCT00450580|451779164|FG001|Overall Study|Adverse Event|7|||
125588729|NCT00450580|451779163|FG000|Overall Study|Lost to Follow-up|4|||
125588730|NCT00450580|451779164|FG001|Overall Study|Lost to Follow-up|5|||
125588731|NCT00450580|451779163|FG000|Overall Study|Withdrawal by Subject|2|||
125588732|NCT00450580|451779164|FG001|Overall Study|Withdrawal by Subject|2|||
125588733|NCT00450580|451779163|FG000|Overall Study|Protocol Violation|1|||
125588734|NCT00450580|451779164|FG001|Overall Study|Protocol Violation|1|||
125588735|NCT00450580|451779163|FG000|Overall Study|Protocol-defined virologic failure|1|||
125588736|NCT00450580|451779164|FG001|Overall Study|Protocol-defined virologic failure|0|||
125588737|NCT00450580|451779163|FG000|Overall Study|Could not comply with scheduled visits|1|||
125588738|NCT00450580|451779164|FG001|Overall Study|Could not comply with scheduled visits|0|||
125588739|NCT00450580|451779163|FG000|Overall Study|Patient went to Brazil|1|||
125588740|NCT00450580|451779164|FG001|Overall Study|Patient went to Brazil|0|||
125588741|NCT00450580|451779163|FG000|Overall Study|Patient could not swallow Norvir|1|||
125588742|NCT00450580|451779164|FG001|Overall Study|Patient could not swallow Norvir|0|||
125588743|NCT00450580|451779163|FG000|Overall Study|Withdrawal due to pregnancy|0|||
125588744|NCT00450580|451779164|FG001|Overall Study|Withdrawal due to pregnancy|1|||
125588745|NCT00393718|451779165|FG000|Overall Study|Adverse Event|20|||
125588746|NCT00393718|451779166|FG001|Overall Study|Adverse Event|8|||
125588747|NCT00393718|451779165|FG000|Overall Study|Protocol Violation|1|||
125588748|NCT00393718|451779166|FG001|Overall Study|Protocol Violation|2|||
125588749|NCT00393718|451779165|FG000|Overall Study|Lack of Efficacy|10|||
125588750|NCT00393718|451779166|FG001|Overall Study|Lack of Efficacy|9|||
125588751|NCT00393718|451779165|FG000|Overall Study|Hypoglycaemia|3|||
125588752|NCT00393718|451779166|FG001|Overall Study|Hypoglycaemia|2|||
125588753|NCT00393718|451779165|FG000|Overall Study|Subject decision|5|||
125588754|NCT00393718|451779166|FG001|Overall Study|Subject decision|0|||
125588755|NCT00393718|451779165|FG000|Overall Study|Withdrawal of consent|2|||
125588756|NCT00393718|451779166|FG001|Overall Study|Withdrawal of consent|1|||
125588757|NCT00393718|451779165|FG000|Overall Study|Missed measurement|1|||
125588758|NCT00393718|451779166|FG001|Overall Study|Missed measurement|0|||
125588759|NCT00393718|451779165|FG000|Overall Study|Move|1|||
125588760|NCT00393718|451779166|FG001|Overall Study|Move|0|||
125588761|NCT04938648|451779167|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
125588762|NCT04938648|451779168|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
125588763|NCT04938648|451779167|FG000|Overall Study|Patient too ill|0|||
125588764|NCT04938648|451779168|FG001|Overall Study|Patient too ill|1|||
125588765|NCT04938648|451779167|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
125588766|NCT04938648|451779168|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
125588767|NCT04938648|451779167|FG000|Overall Study|Patient did not have memory problems|1|||
125588768|NCT04938648|451779168|FG001|Overall Study|Patient did not have memory problems|1|||
125588769|NCT04938648|451779167|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
125588770|NCT04938648|451779168|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
125588771|NCT04938648|451779167|FG000|Overall Study|Care partner could not be reached|0|||
125588772|NCT04938648|451779168|FG001|Overall Study|Care partner could not be reached|1|||
125588773|NCT04938648|451779167|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
125588774|NCT04938648|451779168|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
125588775|NCT04938648|451779167|FG000|Overall Study|Withdrawal by Subject|2|||
125588776|NCT04938648|451779168|FG001|Overall Study|Withdrawal by Subject|1|||
125588777|NCT03293654|451779169|FG000|Overall Study|Lost to Follow-up|0|||
125588778|NCT03293654|451779170|FG001|Overall Study|Lost to Follow-up|1|||
125588779|NCT03293654|451779171|FG002|Overall Study|Lost to Follow-up|0|||
125588780|NCT01919307|451779172|FG000|Overall Study|Withdrawal by Subject|9|||
125588781|NCT00763009|451779175|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
125588782|NCT00891735|451779177|FG000|Overall Study|Adverse Event|2|||
125588783|NCT00891735|451779178|FG001|Overall Study|Adverse Event|0|||
125588784|NCT00891735|451779179|FG002|Overall Study|Adverse Event|2|||
125588785|NCT00891735|451779180|FG003|Overall Study|Adverse Event|0|||
125588786|NCT00891735|451779177|FG000|Overall Study|Death|8|||
125588787|NCT00891735|451779178|FG001|Overall Study|Death|5|||
125588788|NCT00891735|451779179|FG002|Overall Study|Death|4|||
125588789|NCT00891735|451779180|FG003|Overall Study|Death|5|||
125588790|NCT00891735|451779177|FG000|Overall Study|Lost to Follow-up|2|||
125588791|NCT00891735|451779178|FG001|Overall Study|Lost to Follow-up|2|||
125588792|NCT00891735|451779179|FG002|Overall Study|Lost to Follow-up|2|||
125588793|NCT00891735|451779180|FG003|Overall Study|Lost to Follow-up|2|||
125588794|NCT00891735|451779177|FG000|Overall Study|Physician's decision to withdraw patient|1|||
125588795|NCT00891735|451779178|FG001|Overall Study|Physician's decision to withdraw patient|0|||
125588796|NCT00891735|451779179|FG002|Overall Study|Physician's decision to withdraw patient|0|||
125588797|NCT00891735|451779180|FG003|Overall Study|Physician's decision to withdraw patient|0|||
125588798|NCT00891735|451779177|FG000|Overall Study|Patient's decision to withdraw|4|||
125588799|NCT00891735|451779178|FG001|Overall Study|Patient's decision to withdraw|9|||
125588800|NCT00891735|451779179|FG002|Overall Study|Patient's decision to withdraw|4|||
125588801|NCT00891735|451779180|FG003|Overall Study|Patient's decision to withdraw|8|||
125588802|NCT03663166|451779185|FG000|Overall Study|Withdrawal by Subject|1|||
125588803|NCT01686568|451779186|FG000|Main Study|Withdrawal by Subject|1|||
125588804|NCT01686568|451779187|FG001|Main Study|Withdrawal by Subject|3|||
125588805|NCT01686568|451779186|FG000|Main Study|Noncompliance with protocol|0|||
125588806|NCT01686568|451779187|FG001|Main Study|Noncompliance with protocol|1|||
125588807|NCT01686568|451779186|FG000|Main Study|Liver enzymes above range of exclusion|1|||
125588808|NCT01686568|451779187|FG001|Main Study|Liver enzymes above range of exclusion|0|||
125588809|NCT01686568|451779186|FG000|Sub-Study|Not consented for sub-study|2|||
125588810|NCT01686568|451779187|FG001|Sub-Study|Not consented for sub-study|2|||
125211847|NCT00048165|450401386|FG001|Completed 6 Months Study|Insufficient therapy|4|||
125211848|NCT00048165|450401385|FG000|Completed 6 Months Study|Other violation|4|||
125211849|NCT00048165|450401386|FG001|Completed 6 Months Study|Other violation|6|||
125211850|NCT00048165|450401385|FG000|Completed 6 Months Study|Refused treatment|5|||
125211851|NCT00048165|450401386|FG001|Completed 6 Months Study|Refused treatment|5|||
125211852|NCT00048165|450401385|FG000|Completed 6 Months Study|Violation criteria|0|||
125211853|NCT00048165|450401386|FG001|Completed 6 Months Study|Violation criteria|2|||
125211854|NCT00048165|450401385|FG000|Completed 6 Months Study|Did not receive study drug|6|||
125211855|NCT00048165|450401386|FG001|Completed 6 Months Study|Did not receive study drug|6|||
125211856|NCT00048165|450401385|FG000|Completed 12 Months Study|Administration/Other|0|||
125211857|NCT00048165|450401386|FG001|Completed 12 Months Study|Administration/Other|2|||
125211858|NCT00048165|450401385|FG000|Completed 12 Months Study|Death|2|||
125588811|NCT02978222|451779188|FG000|Overall Study|Withdrawal by Subject|2|||
125588812|NCT02978222|451779189|FG001|Overall Study|Withdrawal by Subject|2|||
125588813|NCT02978222|451779188|FG000|Overall Study|Physician Decision|2|||
125588814|NCT02978222|451779189|FG001|Overall Study|Physician Decision|0|||
125588815|NCT02978222|451779188|FG000|Overall Study|Adverse Event|0|||
125588816|NCT02978222|451779189|FG001|Overall Study|Adverse Event|1|||
125588817|NCT02978222|451779188|FG000|Overall Study|Death|1|||
125588818|NCT02978222|451779189|FG001|Overall Study|Death|0|||
125588819|NCT02978222|451779188|FG000|Overall Study|Disease Progression|32|||
125588820|NCT02978222|451779189|FG001|Overall Study|Disease Progression|32|||
125588821|NCT02978222|451779188|FG000|Overall Study|Early Study Termination|24|||
125588822|NCT02978222|451779189|FG001|Overall Study|Early Study Termination|21|||
125588823|NCT03838484|451779190|FG000|Overall Study|Lost to Follow-up|0|||
125588824|NCT03838484|451779191|FG001|Overall Study|Lost to Follow-up|1|||
125588825|NCT03838484|451779192|FG002|Overall Study|Lost to Follow-up|0|||
125588826|NCT03838484|451779193|FG003|Overall Study|Lost to Follow-up|0|||
125588827|NCT00158184|451779199|FG000|Overall Study|personal issues|3|||
125588828|NCT00158184|451779200|FG001|Overall Study|personal issues|1|||
125588829|NCT00158184|451779199|FG000|Overall Study|failed for follow unit/study rules|2|||
125588830|NCT00158184|451779200|FG001|Overall Study|failed for follow unit/study rules|0|||
125588831|NCT00158184|451779199|FG000|Overall Study|Adverse Event|1|||
125588832|NCT00158184|451779200|FG001|Overall Study|Adverse Event|1|||
125588833|NCT02868892|451779203|FG000|Overall Study|Investigator left site and no follow-up|6|||
125588834|NCT02393209|451779207|FG000|Overall Study|Study Terminated by Sponsor|1|||
125588835|NCT02393209|451779208|FG001|Overall Study|Study Terminated by Sponsor|1|||
125588836|NCT02393209|451779209|FG002|Overall Study|Study Terminated by Sponsor|0|||
125588837|NCT02393209|451779210|FG003|Overall Study|Study Terminated by Sponsor|0|||
125588838|NCT02393209|451779207|FG000|Overall Study|Withdrawal by Patient|1|||
125588839|NCT02393209|451779208|FG001|Overall Study|Withdrawal by Patient|0|||
125588840|NCT02393209|451779209|FG002|Overall Study|Withdrawal by Patient|0|||
125588841|NCT02393209|451779210|FG003|Overall Study|Withdrawal by Patient|0|||
125588842|NCT02393209|451779207|FG000|Overall Study|Death|2|||
125588843|NCT02393209|451779208|FG001|Overall Study|Death|2|||
125588844|NCT02393209|451779209|FG002|Overall Study|Death|0|||
125588845|NCT02393209|451779210|FG003|Overall Study|Death|0|||
125588846|NCT02393209|451779207|FG000|Overall Study|Death due to Disease Progression|2|||
125588847|NCT02393209|451779208|FG001|Overall Study|Death due to Disease Progression|2|||
125588848|NCT02393209|451779209|FG002|Overall Study|Death due to Disease Progression|0|||
125588849|NCT02393209|451779210|FG003|Overall Study|Death due to Disease Progression|0|||
125588850|NCT02393209|451779207|FG000|Overall Study|Death from Legionella Infection|0|||
125588851|NCT02393209|451779208|FG001|Overall Study|Death from Legionella Infection|1|||
125588852|NCT02393209|451779209|FG002|Overall Study|Death from Legionella Infection|0|||
125588853|NCT02393209|451779210|FG003|Overall Study|Death from Legionella Infection|0|||
125588854|NCT02393209|451779207|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
125588855|NCT02393209|451779208|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
125588856|NCT02393209|451779209|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
125588857|NCT02393209|451779210|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
125588858|NCT02393209|451779207|FG000|Overall Study|Lost to Follow-up|0|||
125588859|NCT02393209|451779208|FG001|Overall Study|Lost to Follow-up|1|||
125588860|NCT02393209|451779209|FG002|Overall Study|Lost to Follow-up|0|||
125211859|NCT00048165|450401386|FG001|Completed 12 Months Study|Death|1|||
125211860|NCT00048165|450401385|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
125362523|NCT01967173|450961175|FG002|Overall Study|Physician Decision|2|||
125588861|NCT02393209|451779210|FG003|Overall Study|Lost to Follow-up|0|||
125588862|NCT00868790|451779211|FG000|Period 1|Adverse Event|1|||
125588863|NCT00868790|451779212|FG001|Period 1|Adverse Event|0|||
125211861|NCT00048165|450401386|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
125211862|NCT00731731|450401387|FG000|Overall Study|Protocol Violation|0|||
125211863|NCT00731731|450401388|FG001|Overall Study|Protocol Violation|0|||
125588864|NCT00868790|451779213|FG002|Period 1|Adverse Event|0|||
125588865|NCT00868790|451779214|FG003|Period 1|Adverse Event|0|||
125588866|NCT00868790|451779215|FG004|Period 1|Adverse Event|0|||
125588867|NCT00868790|451779216|FG005|Period 1|Adverse Event|0|||
125588868|NCT00868790|451779217|FG006|Period 1|Adverse Event|0|||
125588869|NCT00868790|451779218|FG007|Period 1|Adverse Event|3|||
125362524|NCT01967173|450961176|FG003|Overall Study|Physician Decision|1|||
125362525|NCT01967173|450961177|FG004|Overall Study|Physician Decision|1|||
125362526|NCT01967173|450961178|FG005|Overall Study|Physician Decision|1|||
125362527|NCT01967173|450961179|FG006|Overall Study|Physician Decision|1|||
125588870|NCT00868790|451779219|FG008|Period 1|Adverse Event|1|||
125588871|NCT00868790|451779220|FG009|Period 1|Adverse Event|0|||
125588872|NCT00868790|451779221|FG010|Period 1|Adverse Event|0|||
125588873|NCT00868790|451779222|FG011|Period 1|Adverse Event|0|||
125588874|NCT00868790|451779223|FG012|Period 1|Adverse Event|0|||
125588875|NCT00868790|451779224|FG013|Period 1|Adverse Event|1|||
125588876|NCT00868790|451779211|FG000|Period 1|Protocol Violation|1|||
125588877|NCT00868790|451779212|FG001|Period 1|Protocol Violation|0|||
125588878|NCT00868790|451779213|FG002|Period 1|Protocol Violation|0|||
125588879|NCT00868790|451779214|FG003|Period 1|Protocol Violation|0|||
125588880|NCT00868790|451779215|FG004|Period 1|Protocol Violation|0|||
125588881|NCT00868790|451779216|FG005|Period 1|Protocol Violation|0|||
125588882|NCT00868790|451779217|FG006|Period 1|Protocol Violation|0|||
125588883|NCT00868790|451779218|FG007|Period 1|Protocol Violation|0|||
125588884|NCT00868790|451779219|FG008|Period 1|Protocol Violation|0|||
125588885|NCT00868790|451779220|FG009|Period 1|Protocol Violation|0|||
125588886|NCT00868790|451779221|FG010|Period 1|Protocol Violation|0|||
125588887|NCT00868790|451779222|FG011|Period 1|Protocol Violation|0|||
125588888|NCT00868790|451779223|FG012|Period 1|Protocol Violation|0|||
125588889|NCT00868790|451779224|FG013|Period 1|Protocol Violation|0|||
125588890|NCT00868790|451779211|FG000|Period 1|Withdrawal by Subject|0|||
125588891|NCT00868790|451779212|FG001|Period 1|Withdrawal by Subject|1|||
125588892|NCT00868790|451779213|FG002|Period 1|Withdrawal by Subject|0|||
125588893|NCT00868790|451779214|FG003|Period 1|Withdrawal by Subject|0|||
125588894|NCT00868790|451779215|FG004|Period 1|Withdrawal by Subject|0|||
125588895|NCT00868790|451779216|FG005|Period 1|Withdrawal by Subject|0|||
125588896|NCT00868790|451779217|FG006|Period 1|Withdrawal by Subject|0|||
125588897|NCT00868790|451779218|FG007|Period 1|Withdrawal by Subject|0|||
125588898|NCT00868790|451779219|FG008|Period 1|Withdrawal by Subject|0|||
125588899|NCT00868790|451779220|FG009|Period 1|Withdrawal by Subject|0|||
125588900|NCT00868790|451779221|FG010|Period 1|Withdrawal by Subject|0|||
125588901|NCT00868790|451779222|FG011|Period 1|Withdrawal by Subject|0|||
125588902|NCT00868790|451779223|FG012|Period 1|Withdrawal by Subject|0|||
125588903|NCT00868790|451779224|FG013|Period 1|Withdrawal by Subject|1|||
125588904|NCT00868790|451779211|FG000|Period 1|Abnormal Triglycerides|0|||
125588905|NCT00868790|451779212|FG001|Period 1|Abnormal Triglycerides|0|||
125588906|NCT00868790|451779213|FG002|Period 1|Abnormal Triglycerides|0|||
125588907|NCT00868790|451779214|FG003|Period 1|Abnormal Triglycerides|0|||
125588908|NCT00868790|451779215|FG004|Period 1|Abnormal Triglycerides|1|||
125588909|NCT00868790|451779216|FG005|Period 1|Abnormal Triglycerides|0|||
125588910|NCT00868790|451779217|FG006|Period 1|Abnormal Triglycerides|0|||
125588911|NCT00868790|451779218|FG007|Period 1|Abnormal Triglycerides|0|||
125588912|NCT00868790|451779219|FG008|Period 1|Abnormal Triglycerides|0|||
125588913|NCT00868790|451779220|FG009|Period 1|Abnormal Triglycerides|0|||
125588914|NCT00868790|451779221|FG010|Period 1|Abnormal Triglycerides|0|||
125588915|NCT00868790|451779222|FG011|Period 1|Abnormal Triglycerides|0|||
125588916|NCT00868790|451779223|FG012|Period 1|Abnormal Triglycerides|0|||
125588917|NCT00868790|451779224|FG013|Period 1|Abnormal Triglycerides|0|||
125588918|NCT00868790|451779211|FG000|Period 1|Lost to Follow-up|0|||
125588919|NCT00868790|451779212|FG001|Period 1|Lost to Follow-up|0|||
125588920|NCT00868790|451779213|FG002|Period 1|Lost to Follow-up|0|||
125588921|NCT00868790|451779214|FG003|Period 1|Lost to Follow-up|0|||
125588922|NCT00868790|451779215|FG004|Period 1|Lost to Follow-up|0|||
125588923|NCT00868790|451779216|FG005|Period 1|Lost to Follow-up|1|||
125588924|NCT00868790|451779217|FG006|Period 1|Lost to Follow-up|0|||
125362528|NCT01967173|450961180|FG007|Overall Study|Physician Decision|0|||
125362529|NCT01967173|450961173|FG000|Overall Study|Lack of Efficacy|2|||
125362530|NCT01967173|450961174|FG001|Overall Study|Lack of Efficacy|0|||
125362531|NCT01967173|450961175|FG002|Overall Study|Lack of Efficacy|2|||
125362532|NCT01967173|450961176|FG003|Overall Study|Lack of Efficacy|2|||
125588925|NCT00868790|451779218|FG007|Period 1|Lost to Follow-up|0|||
125588926|NCT00868790|451779219|FG008|Period 1|Lost to Follow-up|0|||
125588927|NCT00868790|451779220|FG009|Period 1|Lost to Follow-up|0|||
125588928|NCT00868790|451779221|FG010|Period 1|Lost to Follow-up|0|||
125588929|NCT00868790|451779222|FG011|Period 1|Lost to Follow-up|0|||
125588930|NCT00868790|451779223|FG012|Period 1|Lost to Follow-up|0|||
125362533|NCT01967173|450961177|FG004|Overall Study|Lack of Efficacy|0|||
125588931|NCT00868790|451779224|FG013|Period 1|Lost to Follow-up|0|||
125588932|NCT00868790|451779211|FG000|Period 2|Adverse Event|0|||
125588933|NCT00868790|451779212|FG001|Period 2|Adverse Event|0|||
125588934|NCT00868790|451779213|FG002|Period 2|Adverse Event|0|||
125588935|NCT00868790|451779214|FG003|Period 2|Adverse Event|0|||
125588936|NCT00868790|451779215|FG004|Period 2|Adverse Event|0|||
125588937|NCT00868790|451779216|FG005|Period 2|Adverse Event|0|||
125588938|NCT00868790|451779217|FG006|Period 2|Adverse Event|0|||
125588939|NCT00868790|451779218|FG007|Period 2|Adverse Event|0|||
125588940|NCT00868790|451779219|FG008|Period 2|Adverse Event|1|||
125588941|NCT00868790|451779220|FG009|Period 2|Adverse Event|0|||
125588942|NCT00868790|451779221|FG010|Period 2|Adverse Event|0|||
125588943|NCT00868790|451779222|FG011|Period 2|Adverse Event|0|||
125588944|NCT00868790|451779223|FG012|Period 2|Adverse Event|0|||
125588945|NCT00868790|451779224|FG013|Period 2|Adverse Event|0|||
125588946|NCT00868790|451779211|FG000|Period 2|Lost to Follow-up|0|||
125588947|NCT00868790|451779212|FG001|Period 2|Lost to Follow-up|1|||
125588948|NCT00868790|451779213|FG002|Period 2|Lost to Follow-up|0|||
125588949|NCT00868790|451779214|FG003|Period 2|Lost to Follow-up|0|||
125588950|NCT00868790|451779215|FG004|Period 2|Lost to Follow-up|0|||
125588951|NCT00868790|451779216|FG005|Period 2|Lost to Follow-up|1|||
125588952|NCT00868790|451779217|FG006|Period 2|Lost to Follow-up|0|||
125588953|NCT00868790|451779218|FG007|Period 2|Lost to Follow-up|0|||
125588954|NCT00868790|451779219|FG008|Period 2|Lost to Follow-up|0|||
125588955|NCT00868790|451779220|FG009|Period 2|Lost to Follow-up|0|||
125588956|NCT00868790|451779221|FG010|Period 2|Lost to Follow-up|0|||
125588957|NCT00868790|451779222|FG011|Period 2|Lost to Follow-up|0|||
125588958|NCT00868790|451779223|FG012|Period 2|Lost to Follow-up|0|||
125588959|NCT00868790|451779224|FG013|Period 2|Lost to Follow-up|0|||
125588960|NCT00868790|451779211|FG000|Period 2|Withdrawal by Subject|0|||
125588961|NCT00868790|451779212|FG001|Period 2|Withdrawal by Subject|0|||
125588962|NCT00868790|451779213|FG002|Period 2|Withdrawal by Subject|0|||
125588963|NCT00868790|451779214|FG003|Period 2|Withdrawal by Subject|0|||
125588964|NCT00868790|451779215|FG004|Period 2|Withdrawal by Subject|0|||
125588965|NCT00868790|451779216|FG005|Period 2|Withdrawal by Subject|0|||
125588966|NCT00868790|451779217|FG006|Period 2|Withdrawal by Subject|0|||
125588967|NCT00868790|451779218|FG007|Period 2|Withdrawal by Subject|0|||
125588968|NCT00868790|451779219|FG008|Period 2|Withdrawal by Subject|1|||
125588969|NCT00868790|451779220|FG009|Period 2|Withdrawal by Subject|0|||
125588970|NCT00868790|451779221|FG010|Period 2|Withdrawal by Subject|0|||
125588971|NCT00868790|451779222|FG011|Period 2|Withdrawal by Subject|0|||
125588972|NCT00868790|451779223|FG012|Period 2|Withdrawal by Subject|0|||
125588973|NCT00868790|451779224|FG013|Period 2|Withdrawal by Subject|1|||
125588974|NCT00868790|451779211|FG000|Period 3|Adverse Event|0|||
125588975|NCT00868790|451779212|FG001|Period 3|Adverse Event|0|||
125588976|NCT00868790|451779213|FG002|Period 3|Adverse Event|0|||
125588977|NCT00868790|451779214|FG003|Period 3|Adverse Event|0|||
125588978|NCT00868790|451779215|FG004|Period 3|Adverse Event|0|||
125588979|NCT00868790|451779216|FG005|Period 3|Adverse Event|0|||
125588980|NCT00868790|451779217|FG006|Period 3|Adverse Event|0|||
125588981|NCT00868790|451779218|FG007|Period 3|Adverse Event|0|||
125588982|NCT00868790|451779219|FG008|Period 3|Adverse Event|0|||
125588983|NCT00868790|451779220|FG009|Period 3|Adverse Event|1|||
125588984|NCT00868790|451779221|FG010|Period 3|Adverse Event|0|||
125588985|NCT00868790|451779222|FG011|Period 3|Adverse Event|0|||
125588986|NCT00868790|451779223|FG012|Period 3|Adverse Event|0|||
125588987|NCT00868790|451779224|FG013|Period 3|Adverse Event|0|||
125588988|NCT00868790|451779211|FG000|Period 3|Protocol Violation|0|||
125588989|NCT00868790|451779212|FG001|Period 3|Protocol Violation|0|||
125588990|NCT00868790|451779213|FG002|Period 3|Protocol Violation|0|||
125588991|NCT00868790|451779214|FG003|Period 3|Protocol Violation|0|||
125588992|NCT00868790|451779215|FG004|Period 3|Protocol Violation|0|||
125588993|NCT00868790|451779216|FG005|Period 3|Protocol Violation|0|||
125588994|NCT00868790|451779217|FG006|Period 3|Protocol Violation|0|||
125588995|NCT00868790|451779218|FG007|Period 3|Protocol Violation|0|||
125588996|NCT00868790|451779219|FG008|Period 3|Protocol Violation|0|||
125588997|NCT00868790|451779220|FG009|Period 3|Protocol Violation|0|||
125429228|NCT02496767|451196628|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
125588998|NCT00868790|451779221|FG010|Period 3|Protocol Violation|1|||
125588999|NCT00868790|451779222|FG011|Period 3|Protocol Violation|0|||
125589000|NCT00868790|451779223|FG012|Period 3|Protocol Violation|0|||
125589001|NCT00868790|451779224|FG013|Period 3|Protocol Violation|0|||
125589002|NCT00868790|451779211|FG000|Period 3|Study Terminated by Sponsor|0|||
125589003|NCT00868790|451779212|FG001|Period 3|Study Terminated by Sponsor|0|||
125589004|NCT00868790|451779213|FG002|Period 3|Study Terminated by Sponsor|0|||
125589005|NCT00868790|451779214|FG003|Period 3|Study Terminated by Sponsor|1|||
125589006|NCT00868790|451779215|FG004|Period 3|Study Terminated by Sponsor|0|||
125589007|NCT00868790|451779216|FG005|Period 3|Study Terminated by Sponsor|0|||
125589008|NCT00868790|451779217|FG006|Period 3|Study Terminated by Sponsor|0|||
125589009|NCT00868790|451779218|FG007|Period 3|Study Terminated by Sponsor|0|||
125589010|NCT00868790|451779219|FG008|Period 3|Study Terminated by Sponsor|0|||
125589011|NCT00868790|451779220|FG009|Period 3|Study Terminated by Sponsor|0|||
125589012|NCT00868790|451779221|FG010|Period 3|Study Terminated by Sponsor|0|||
125589013|NCT00868790|451779222|FG011|Period 3|Study Terminated by Sponsor|0|||
125362534|NCT01967173|450961178|FG005|Overall Study|Lack of Efficacy|1|||
125362535|NCT01967173|450961179|FG006|Overall Study|Lack of Efficacy|0|||
125362536|NCT01967173|450961180|FG007|Overall Study|Lack of Efficacy|2|||
125362537|NCT01967173|450961173|FG000|Overall Study|Pregnancy|0|||
125362538|NCT01967173|450961174|FG001|Overall Study|Pregnancy|0|||
125362539|NCT01967173|450961175|FG002|Overall Study|Pregnancy|0|||
125362540|NCT01967173|450961176|FG003|Overall Study|Pregnancy|0|||
125362541|NCT01967173|450961177|FG004|Overall Study|Pregnancy|0|||
125589014|NCT00868790|451779223|FG012|Period 3|Study Terminated by Sponsor|0|||
125589015|NCT00868790|451779224|FG013|Period 3|Study Terminated by Sponsor|0|||
125589016|NCT00868790|451779211|FG000|Period 4|Adverse Event|0|||
125589017|NCT00868790|451779212|FG001|Period 4|Adverse Event|0|||
125589018|NCT00868790|451779213|FG002|Period 4|Adverse Event|0|||
125589019|NCT00868790|451779214|FG003|Period 4|Adverse Event|0|||
125589020|NCT00868790|451779215|FG004|Period 4|Adverse Event|0|||
125589021|NCT00868790|451779216|FG005|Period 4|Adverse Event|0|||
125589022|NCT00868790|451779217|FG006|Period 4|Adverse Event|0|||
125589023|NCT00868790|451779218|FG007|Period 4|Adverse Event|1|||
125589024|NCT00868790|451779219|FG008|Period 4|Adverse Event|0|||
125589025|NCT00868790|451779220|FG009|Period 4|Adverse Event|0|||
125589026|NCT00868790|451779221|FG010|Period 4|Adverse Event|1|||
125589027|NCT00868790|451779222|FG011|Period 4|Adverse Event|0|||
125589028|NCT00868790|451779223|FG012|Period 4|Adverse Event|1|||
125589029|NCT00868790|451779224|FG013|Period 4|Adverse Event|0|||
125589030|NCT00868790|451779211|FG000|Period 4|Lost to Follow-up|0|||
125589031|NCT00868790|451779212|FG001|Period 4|Lost to Follow-up|0|||
125589032|NCT00868790|451779213|FG002|Period 4|Lost to Follow-up|0|||
125589033|NCT00868790|451779214|FG003|Period 4|Lost to Follow-up|0|||
125589034|NCT00868790|451779215|FG004|Period 4|Lost to Follow-up|0|||
125589035|NCT00868790|451779216|FG005|Period 4|Lost to Follow-up|0|||
125589036|NCT00868790|451779217|FG006|Period 4|Lost to Follow-up|0|||
125589037|NCT00868790|451779218|FG007|Period 4|Lost to Follow-up|1|||
125589038|NCT00868790|451779219|FG008|Period 4|Lost to Follow-up|0|||
125589039|NCT00868790|451779220|FG009|Period 4|Lost to Follow-up|0|||
125589040|NCT00868790|451779221|FG010|Period 4|Lost to Follow-up|0|||
125589041|NCT00868790|451779222|FG011|Period 4|Lost to Follow-up|0|||
125589042|NCT00868790|451779223|FG012|Period 4|Lost to Follow-up|0|||
125589043|NCT00868790|451779224|FG013|Period 4|Lost to Follow-up|0|||
125589044|NCT00868790|451779211|FG000|Period 4|Study Terminated by Sponsor|2|||
125589045|NCT00868790|451779212|FG001|Period 4|Study Terminated by Sponsor|0|||
125589046|NCT00868790|451779213|FG002|Period 4|Study Terminated by Sponsor|0|||
125589047|NCT00868790|451779214|FG003|Period 4|Study Terminated by Sponsor|0|||
125589048|NCT00868790|451779215|FG004|Period 4|Study Terminated by Sponsor|0|||
125589049|NCT00868790|451779216|FG005|Period 4|Study Terminated by Sponsor|0|||
125589050|NCT00868790|451779217|FG006|Period 4|Study Terminated by Sponsor|0|||
125589051|NCT00868790|451779218|FG007|Period 4|Study Terminated by Sponsor|1|||
125589052|NCT00868790|451779219|FG008|Period 4|Study Terminated by Sponsor|2|||
125589053|NCT00868790|451779220|FG009|Period 4|Study Terminated by Sponsor|0|||
125589054|NCT00868790|451779221|FG010|Period 4|Study Terminated by Sponsor|2|||
125589055|NCT00868790|451779222|FG011|Period 4|Study Terminated by Sponsor|1|||
125589056|NCT00868790|451779223|FG012|Period 4|Study Terminated by Sponsor|0|||
125589057|NCT00868790|451779224|FG013|Period 4|Study Terminated by Sponsor|1|||
125589058|NCT00868790|451779211|FG000|Period 4|Abnormal ALT/AST|0|||
125589059|NCT00868790|451779212|FG001|Period 4|Abnormal ALT/AST|0|||
125589060|NCT00868790|451779213|FG002|Period 4|Abnormal ALT/AST|1|||
125589061|NCT00868790|451779214|FG003|Period 4|Abnormal ALT/AST|0|||
125589062|NCT00868790|451779215|FG004|Period 4|Abnormal ALT/AST|0|||
125589063|NCT00868790|451779216|FG005|Period 4|Abnormal ALT/AST|0|||
125589064|NCT00868790|451779217|FG006|Period 4|Abnormal ALT/AST|0|||
125589065|NCT00868790|451779218|FG007|Period 4|Abnormal ALT/AST|0|||
125589066|NCT00868790|451779219|FG008|Period 4|Abnormal ALT/AST|0|||
125589067|NCT00868790|451779220|FG009|Period 4|Abnormal ALT/AST|0|||
125589068|NCT00868790|451779221|FG010|Period 4|Abnormal ALT/AST|0|||
125589069|NCT00868790|451779222|FG011|Period 4|Abnormal ALT/AST|0|||
125589070|NCT00868790|451779223|FG012|Period 4|Abnormal ALT/AST|0|||
125589071|NCT00868790|451779224|FG013|Period 4|Abnormal ALT/AST|0|||
125589072|NCT00868790|451779211|FG000|Post-study|Withdrawal by Subject|0|||
125589073|NCT00868790|451779212|FG001|Post-study|Withdrawal by Subject|0|||
125362542|NCT01967173|450961178|FG005|Overall Study|Pregnancy|0|||
125589074|NCT00868790|451779213|FG002|Post-study|Withdrawal by Subject|0|||
125362543|NCT01967173|450961179|FG006|Overall Study|Pregnancy|1|||
125589075|NCT00868790|451779214|FG003|Post-study|Withdrawal by Subject|0|||
125362544|NCT01967173|450961180|FG007|Overall Study|Pregnancy|1|||
125362545|NCT01967173|450961173|FG000|Overall Study|Adverse Event|0|||
125589076|NCT00868790|451779215|FG004|Post-study|Withdrawal by Subject|1|||
125589077|NCT00868790|451779216|FG005|Post-study|Withdrawal by Subject|0|||
125589078|NCT00868790|451779217|FG006|Post-study|Withdrawal by Subject|0|||
125589079|NCT00868790|451779218|FG007|Post-study|Withdrawal by Subject|0|||
125589080|NCT00868790|451779219|FG008|Post-study|Withdrawal by Subject|0|||
125589081|NCT00868790|451779220|FG009|Post-study|Withdrawal by Subject|0|||
125589082|NCT00868790|451779221|FG010|Post-study|Withdrawal by Subject|0|||
125589083|NCT00868790|451779222|FG011|Post-study|Withdrawal by Subject|0|||
125589084|NCT00868790|451779223|FG012|Post-study|Withdrawal by Subject|0|||
125589085|NCT00868790|451779224|FG013|Post-study|Withdrawal by Subject|0|||
125589086|NCT00868790|451779211|FG000|Post-study|Excluded Medication|0|||
125589087|NCT00868790|451779212|FG001|Post-study|Excluded Medication|0|||
125589088|NCT00868790|451779213|FG002|Post-study|Excluded Medication|0|||
125589089|NCT00868790|451779214|FG003|Post-study|Excluded Medication|0|||
125589090|NCT00868790|451779215|FG004|Post-study|Excluded Medication|0|||
125589091|NCT00868790|451779216|FG005|Post-study|Excluded Medication|0|||
125589092|NCT00868790|451779217|FG006|Post-study|Excluded Medication|0|||
125589093|NCT00868790|451779218|FG007|Post-study|Excluded Medication|2|||
125589094|NCT00868790|451779219|FG008|Post-study|Excluded Medication|0|||
125589095|NCT00868790|451779220|FG009|Post-study|Excluded Medication|1|||
125589096|NCT00868790|451779221|FG010|Post-study|Excluded Medication|0|||
125589097|NCT00868790|451779222|FG011|Post-study|Excluded Medication|0|||
125589098|NCT00868790|451779223|FG012|Post-study|Excluded Medication|0|||
125589099|NCT00868790|451779224|FG013|Post-study|Excluded Medication|0|||
125589100|NCT02582671|451779225|FG000|Overall Study|Failure to return|1|||
125589101|NCT02582671|451779225|FG000|Overall Study|Other, not specified|1|||
125589102|NCT03068715|451779226|FG000|Overall Study|No longer met inclusion criteria|1|||
125589103|NCT03068715|451779227|FG001|Overall Study|No longer met inclusion criteria|0|||
125589104|NCT01276288|451779228|FG000|Overall Study|Adverse Event|1|||
125589105|NCT01276288|451779229|FG001|Overall Study|Adverse Event|1|||
125589106|NCT01276288|451779230|FG002|Overall Study|Adverse Event|0|||
125589107|NCT01276288|451779231|FG003|Overall Study|Adverse Event|0|||
125589108|NCT01276288|451779228|FG000|Overall Study|not treated|1|||
125589109|NCT01276288|451779229|FG001|Overall Study|not treated|0|||
125589110|NCT01276288|451779230|FG002|Overall Study|not treated|0|||
125589111|NCT01276288|451779231|FG003|Overall Study|not treated|0|||
125589112|NCT03168867|451779233|FG000|Overall Study|Withdrawal by Subject|1|||
125589113|NCT03168867|451779234|FG001|Overall Study|Withdrawal by Subject|5|||
125589114|NCT04348851|451779235|FG000|Post-Test 1|Withdrawal by Subject|0|||
125589115|NCT04348851|451779236|FG001|Post-Test 1|Withdrawal by Subject|1|||
125589116|NCT04348851|451779237|FG002|Post-Test 1|Withdrawal by Subject|0|||
125589117|NCT04348851|451779238|FG003|Post-Test 1|Withdrawal by Subject|0|||
125589118|NCT04348851|451779235|FG000|Post-Test 1|Lost to Follow-up|0|||
125589119|NCT04348851|451779236|FG001|Post-Test 1|Lost to Follow-up|1|||
125589120|NCT04348851|451779237|FG002|Post-Test 1|Lost to Follow-up|0|||
125589121|NCT04348851|451779238|FG003|Post-Test 1|Lost to Follow-up|0|||
125589122|NCT04348851|451779235|FG000|Post-Test 2|Stroke survivor death|0|||
125589123|NCT04348851|451779236|FG001|Post-Test 2|Stroke survivor death|1|||
125589124|NCT04348851|451779237|FG002|Post-Test 2|Stroke survivor death|0|||
125589125|NCT04348851|451779238|FG003|Post-Test 2|Stroke survivor death|1|||
125589126|NCT03040024|451779239|FG000|Overall Study|Adverse Event|0|||
125589127|NCT03040024|451779240|FG001|Overall Study|Adverse Event|1|||
125589128|NCT03040024|451779241|FG002|Overall Study|Adverse Event|0|||
125589129|NCT03040024|451779239|FG000|Overall Study|Death|0|||
125589130|NCT03040024|451779240|FG001|Overall Study|Death|1|||
125589131|NCT03040024|451779241|FG002|Overall Study|Death|0|||
125589132|NCT03040024|451779239|FG000|Overall Study|Physician Decision|0|||
125589133|NCT03040024|451779240|FG001|Overall Study|Physician Decision|0|||
125589134|NCT03040024|451779241|FG002|Overall Study|Physician Decision|1|||
125589135|NCT00190775|451779242|FG000|Overall Study|Adverse Event|57|||
125589136|NCT00190775|451779243|FG001|Overall Study|Adverse Event|22|||
125589137|NCT00190775|451779242|FG000|Overall Study|Satisfactory Response|1|||
125589138|NCT00190775|451779243|FG001|Overall Study|Satisfactory Response|0|||
125589139|NCT00190775|451779242|FG000|Overall Study|Lack of Efficacy|28|||
125589140|NCT00190775|451779243|FG001|Overall Study|Lack of Efficacy|32|||
125589141|NCT00190775|451779242|FG000|Overall Study|Lost to Follow-up|31|||
125589142|NCT00190775|451779243|FG001|Overall Study|Lost to Follow-up|23|||
125589143|NCT00190775|451779242|FG000|Overall Study|Participant Moved|0|||
125589144|NCT00190775|451779243|FG001|Overall Study|Participant Moved|1|||
125211864|NCT00731731|450401389|FG002|Overall Study|Protocol Violation|1|||
125589145|NCT00190775|451779242|FG000|Overall Study|Withdrawal by Subject|24|||
125589146|NCT00190775|451779243|FG001|Overall Study|Withdrawal by Subject|13|||
125589147|NCT00190775|451779242|FG000|Overall Study|Sponsor Decision|1|||
125589148|NCT00190775|451779243|FG001|Overall Study|Sponsor Decision|0|||
125589149|NCT00190775|451779242|FG000|Overall Study|Physician Decision|3|||
125589150|NCT00190775|451779243|FG001|Overall Study|Physician Decision|0|||
125589151|NCT00190775|451779242|FG000|Overall Study|Noncompliance|3|||
125589152|NCT00190775|451779243|FG001|Overall Study|Noncompliance|5|||
125589153|NCT00190775|451779242|FG000|Overall Study|Protocol Violation|0|||
125589154|NCT00190775|451779243|FG001|Overall Study|Protocol Violation|1|||
125589155|NCT00190775|451779242|FG000|Overall Study|Exclusion Criteria Met|1|||
125589156|NCT00190775|451779243|FG001|Overall Study|Exclusion Criteria Met|3|||
125589157|NCT01526148|451779244|FG000|Overall Study|Adverse Event|6|||
125589158|NCT01526148|451779245|FG001|Overall Study|Adverse Event|5|||
125589159|NCT01526148|451779244|FG000|Overall Study|Lost to Follow-up|3|||
125589160|NCT01526148|451779245|FG001|Overall Study|Lost to Follow-up|6|||
125589161|NCT01526148|451779244|FG000|Overall Study|Withdrawal by Subject|2|||
125589162|NCT01526148|451779245|FG001|Overall Study|Withdrawal by Subject|0|||
125589163|NCT01526148|451779244|FG000|Overall Study|Unstable Medical Condition|1|||
125589164|NCT01526148|451779245|FG001|Overall Study|Unstable Medical Condition|0|||
125589165|NCT01526148|451779244|FG000|Overall Study|Unable to discontinue concomitant med|1|||
125589166|NCT01526148|451779245|FG001|Overall Study|Unable to discontinue concomitant med|0|||
125589167|NCT01526148|451779244|FG000|Overall Study|Moved out of state|1|||
125589168|NCT01526148|451779245|FG001|Overall Study|Moved out of state|0|||
125589169|NCT01526148|451779244|FG000|Overall Study|Incarcerated|0|||
125589170|NCT01526148|451779245|FG001|Overall Study|Incarcerated|2|||
125589171|NCT00519077|451779246|FG000|Overall Study|Death|6|||
125589172|NCT00519077|451779246|FG000|Overall Study|Other|2|||
125589173|NCT01967225|451779247|FG000|Overall Study|Adverse Event|3|||
125589174|NCT01967225|451779248|FG001|Overall Study|Adverse Event|1|||
125589175|NCT01967225|451779247|FG000|Overall Study|Withdrawal by Subject|2|||
125589176|NCT01967225|451779248|FG001|Overall Study|Withdrawal by Subject|1|||
125589177|NCT01967225|451779247|FG000|Overall Study|Lack of Efficacy|1|||
125589178|NCT01967225|451779248|FG001|Overall Study|Lack of Efficacy|1|||
125589179|NCT01967225|451779247|FG000|Overall Study|Switching to other therapy|2|||
125589180|NCT01967225|451779248|FG001|Overall Study|Switching to other therapy|0|||
125589181|NCT01967225|451779247|FG000|Overall Study|Protocol driven decision point|1|||
125589182|NCT01967225|451779248|FG001|Overall Study|Protocol driven decision point|0|||
125589183|NCT01967225|451779247|FG000|Overall Study|Logistical difficulties|1|||
125589184|NCT01967225|451779248|FG001|Overall Study|Logistical difficulties|0|||
125589185|NCT01967225|451779247|FG000|Overall Study|Protocol Violation|2|||
125589186|NCT01967225|451779248|FG001|Overall Study|Protocol Violation|0|||
125589187|NCT00481065|451779249|FG000|Overall Study|Adverse event or death|1|||
125589188|NCT00481065|451779250|FG001|Overall Study|Adverse event or death|1|||
125589189|NCT00481065|451779251|FG002|Overall Study|Adverse event or death|3|||
125589190|NCT00481065|451779252|FG003|Overall Study|Adverse event or death|0|||
125589191|NCT00481065|451779253|FG004|Overall Study|Adverse event or death|2|||
125589192|NCT00481065|451779254|FG005|Overall Study|Adverse event or death|0|||
125589193|NCT00481065|451779255|FG006|Overall Study|Adverse event or death|1|||
125589194|NCT00481065|451779256|FG007|Overall Study|Adverse event or death|1|||
125589195|NCT00481065|451779249|FG000|Overall Study|Withdrawal by Subject|11|||
125589196|NCT00481065|451779250|FG001|Overall Study|Withdrawal by Subject|12|||
125589197|NCT00481065|451779251|FG002|Overall Study|Withdrawal by Subject|7|||
125589198|NCT00481065|451779252|FG003|Overall Study|Withdrawal by Subject|11|||
125589199|NCT00481065|451779253|FG004|Overall Study|Withdrawal by Subject|13|||
125589200|NCT00481065|451779254|FG005|Overall Study|Withdrawal by Subject|12|||
125589201|NCT00481065|451779255|FG006|Overall Study|Withdrawal by Subject|9|||
125589202|NCT00481065|451779256|FG007|Overall Study|Withdrawal by Subject|10|||
125589203|NCT00481065|451779249|FG000|Overall Study|Lost to Follow-up|4|||
125589204|NCT00481065|451779250|FG001|Overall Study|Lost to Follow-up|2|||
125589205|NCT00481065|451779251|FG002|Overall Study|Lost to Follow-up|4|||
125589206|NCT00481065|451779252|FG003|Overall Study|Lost to Follow-up|3|||
125589207|NCT00481065|451779253|FG004|Overall Study|Lost to Follow-up|3|||
125589208|NCT00481065|451779254|FG005|Overall Study|Lost to Follow-up|3|||
125589209|NCT00481065|451779255|FG006|Overall Study|Lost to Follow-up|2|||
125589210|NCT00481065|451779256|FG007|Overall Study|Lost to Follow-up|5|||
125589211|NCT00481065|451779249|FG000|Overall Study|Inappropriate enrollment|4|||
125589212|NCT00481065|451779250|FG001|Overall Study|Inappropriate enrollment|0|||
125589213|NCT00481065|451779251|FG002|Overall Study|Inappropriate enrollment|2|||
125589214|NCT00481065|451779252|FG003|Overall Study|Inappropriate enrollment|0|||
125589215|NCT00481065|451779253|FG004|Overall Study|Inappropriate enrollment|2|||
125589216|NCT00481065|451779254|FG005|Overall Study|Inappropriate enrollment|1|||
125589217|NCT00481065|451779255|FG006|Overall Study|Inappropriate enrollment|0|||
125589218|NCT00481065|451779256|FG007|Overall Study|Inappropriate enrollment|1|||
125589219|NCT00481065|451779249|FG000|Overall Study|Administrative reason|0|||
125589220|NCT00481065|451779250|FG001|Overall Study|Administrative reason|0|||
125589221|NCT00481065|451779251|FG002|Overall Study|Administrative reason|0|||
125589222|NCT00481065|451779252|FG003|Overall Study|Administrative reason|0|||
125589223|NCT00481065|451779253|FG004|Overall Study|Administrative reason|0|||
125589224|NCT00481065|451779254|FG005|Overall Study|Administrative reason|2|||
125589225|NCT00481065|451779255|FG006|Overall Study|Administrative reason|1|||
125589226|NCT00481065|451779256|FG007|Overall Study|Administrative reason|0|||
125589227|NCT00481065|451779249|FG000|Overall Study|Protocol Violation|2|||
125589228|NCT00481065|451779250|FG001|Overall Study|Protocol Violation|1|||
125589229|NCT00481065|451779251|FG002|Overall Study|Protocol Violation|1|||
125589230|NCT00481065|451779252|FG003|Overall Study|Protocol Violation|1|||
125589231|NCT00481065|451779253|FG004|Overall Study|Protocol Violation|2|||
125589232|NCT00481065|451779254|FG005|Overall Study|Protocol Violation|6|||
125589233|NCT00481065|451779255|FG006|Overall Study|Protocol Violation|3|||
125589234|NCT00481065|451779256|FG007|Overall Study|Protocol Violation|2|||
125589235|NCT00481065|451779249|FG000|Overall Study|Unable to classify|0|||
125589236|NCT00481065|451779250|FG001|Overall Study|Unable to classify|1|||
125589237|NCT00481065|451779251|FG002|Overall Study|Unable to classify|2|||
125589238|NCT00481065|451779252|FG003|Overall Study|Unable to classify|0|||
125589239|NCT00481065|451779253|FG004|Overall Study|Unable to classify|1|||
125589240|NCT00481065|451779254|FG005|Overall Study|Unable to classify|0|||
125589241|NCT00481065|451779255|FG006|Overall Study|Unable to classify|0|||
125589242|NCT00481065|451779256|FG007|Overall Study|Unable to classify|0|||
125589243|NCT01709331|451779259|FG000|Overall Study|Adverse Event|1|||
125589244|NCT01628926|451779262|FG000|Overall Study|Adverse Event|13|||
125589245|NCT01628926|451779263|FG001|Overall Study|Adverse Event|11|||
125589246|NCT01628926|451779264|FG002|Overall Study|Adverse Event|9|||
125589247|NCT01628926|451779262|FG000|Overall Study|Lack of Efficacy|2|||
125589248|NCT01628926|451779263|FG001|Overall Study|Lack of Efficacy|1|||
125589249|NCT01628926|451779264|FG002|Overall Study|Lack of Efficacy|5|||
125589250|NCT01628926|451779262|FG000|Overall Study|Withdrawal by Subject|6|||
125589251|NCT01628926|451779263|FG001|Overall Study|Withdrawal by Subject|4|||
125589252|NCT01628926|451779264|FG002|Overall Study|Withdrawal by Subject|2|||
125589253|NCT01628926|451779262|FG000|Overall Study|Protocol Violation|0|||
125589254|NCT01628926|451779263|FG001|Overall Study|Protocol Violation|1|||
125211865|NCT00731731|450401387|FG000|Overall Study|Cancel prior to treatment|0|||
125362546|NCT01967173|450961174|FG001|Overall Study|Adverse Event|0|||
125362547|NCT01967173|450961175|FG002|Overall Study|Adverse Event|0|||
125362548|NCT01967173|450961176|FG003|Overall Study|Adverse Event|0|||
125589255|NCT01628926|451779264|FG002|Overall Study|Protocol Violation|0|||
125589256|NCT01628926|451779262|FG000|Overall Study|Discontinuation criteria|3|||
125211866|NCT00731731|450401388|FG001|Overall Study|Cancel prior to treatment|0|||
125589257|NCT01628926|451779263|FG001|Overall Study|Discontinuation criteria|4|||
125589258|NCT01628926|451779264|FG002|Overall Study|Discontinuation criteria|0|||
125589259|NCT01628926|451779262|FG000|Overall Study|Physician Decision|2|||
125589260|NCT01628926|451779263|FG001|Overall Study|Physician Decision|2|||
125589261|NCT01628926|451779264|FG002|Overall Study|Physician Decision|1|||
125589262|NCT03029832|451779265|FG000|Overall Study|Safety Follow-Up Completed|2|||
125589263|NCT03029832|451779266|FG001|Overall Study|Safety Follow-Up Completed|0|||
125589264|NCT03029832|451779265|FG000|Overall Study|Death due to Disease Progression|1|||
125589265|NCT03029832|451779266|FG001|Overall Study|Death due to Disease Progression|0|||
125589266|NCT03029832|451779265|FG000|Overall Study|Study Terminated By Sponsor|1|||
125589267|NCT03029832|451779266|FG001|Overall Study|Study Terminated By Sponsor|1|||
125589268|NCT04906707|451779270|FG000|Overall Study|Withdrawal by Subject|2|||
125589269|NCT04906707|451779271|FG001|Overall Study|Withdrawal by Subject|0|||
125589270|NCT04906707|451779270|FG000|Overall Study|Withdrawal due to PI decision|1|||
125589271|NCT04906707|451779271|FG001|Overall Study|Withdrawal due to PI decision|0|||
125589272|NCT04906707|451779270|FG000|Overall Study|Lost to Follow-up|0|||
125589273|NCT04906707|451779271|FG001|Overall Study|Lost to Follow-up|1|||
125589274|NCT01707992|451779272|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
125589275|NCT01707992|451779273|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
125589276|NCT01707992|451779274|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
125589277|NCT01707992|451779275|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
125589278|NCT01707992|451779276|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
125589279|NCT01707992|451779277|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
125589280|NCT01707992|451779272|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
125589281|NCT01707992|451779273|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
125589282|NCT01707992|451779274|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
125589283|NCT01707992|451779275|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
125589284|NCT01707992|451779276|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
125589285|NCT01707992|451779277|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
125589286|NCT01707992|451779272|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
125589287|NCT01707992|451779273|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
125589288|NCT01707992|451779274|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
125589289|NCT01707992|451779275|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
125362549|NCT01967173|450961177|FG004|Overall Study|Adverse Event|0|||
125362550|NCT01967173|450961178|FG005|Overall Study|Adverse Event|0|||
125362551|NCT01967173|450961179|FG006|Overall Study|Adverse Event|0|||
125362552|NCT01967173|450961180|FG007|Overall Study|Adverse Event|1|||
125362553|NCT01967173|450961173|FG000|Overall Study|Withdrawal by Subject|15|||
125362554|NCT01967173|450961174|FG001|Overall Study|Withdrawal by Subject|14|||
125589290|NCT01707992|451779276|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
125589291|NCT01707992|451779277|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
125589292|NCT01707992|451779272|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
125589293|NCT01707992|451779273|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
125589294|NCT01707992|451779274|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
125589295|NCT01707992|451779275|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
125589296|NCT01707992|451779276|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
125589297|NCT01707992|451779277|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
125589298|NCT01707992|451779272|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
125589299|NCT01707992|451779273|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
125589300|NCT01707992|451779274|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
125362555|NCT01967173|450961175|FG002|Overall Study|Withdrawal by Subject|10|||
125362556|NCT01967173|450961176|FG003|Overall Study|Withdrawal by Subject|7|||
125362557|NCT01967173|450961177|FG004|Overall Study|Withdrawal by Subject|8|||
125362558|NCT01967173|450961178|FG005|Overall Study|Withdrawal by Subject|9|||
125362559|NCT01967173|450961179|FG006|Overall Study|Withdrawal by Subject|10|||
125362560|NCT01967173|450961180|FG007|Overall Study|Withdrawal by Subject|12|||
125362561|NCT00423514|450961181|FG000|Overall Study|Ineligible|1|||
125362562|NCT00423514|450961182|FG001|Overall Study|Ineligible|0|||
125362563|NCT03685123|450961183|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
125429229|NCT02496767|451196629|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
125429230|NCT02496767|451196630|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
125429231|NCT02496767|451196631|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
125429232|NCT02496767|451196632|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
125429233|NCT02496767|451196633|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
125429234|NCT02496767|451196634|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
125429235|NCT02496767|451196627|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
125429236|NCT02496767|451196628|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
125429237|NCT02496767|451196629|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
125589301|NCT01707992|451779275|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
125362564|NCT03685123|450961184|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
125362565|NCT03685123|450961185|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
125362566|NCT03685123|450961183|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
125362567|NCT03685123|450961184|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
125429238|NCT02496767|451196630|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
125589302|NCT01707992|451779276|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
125589303|NCT01707992|451779277|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
125589304|NCT01707992|451779272|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
125589305|NCT01707992|451779273|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
125589306|NCT01707992|451779274|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
125589307|NCT01707992|451779275|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
125589308|NCT01707992|451779276|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
125589309|NCT01707992|451779277|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
125589310|NCT01707992|451779272|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
125589311|NCT01707992|451779273|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
125589312|NCT01707992|451779274|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
125589313|NCT01707992|451779275|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
125589314|NCT01707992|451779276|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
125589315|NCT01707992|451779277|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
125589316|NCT01707992|451779272|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
125589317|NCT01707992|451779273|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
125589318|NCT01707992|451779274|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
125589319|NCT01707992|451779275|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
125589320|NCT01707992|451779276|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
125589321|NCT01707992|451779277|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
125589322|NCT01707992|451779272|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
125589323|NCT01707992|451779273|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
125589324|NCT01707992|451779274|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
125589325|NCT01707992|451779275|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
125589326|NCT01707992|451779276|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
125589327|NCT01707992|451779277|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
125589328|NCT01707992|451779272|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
125589329|NCT01707992|451779273|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
125589330|NCT01707992|451779274|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
125429239|NCT02496767|451196631|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
125429240|NCT02496767|451196632|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
125362568|NCT03685123|450961185|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
125362569|NCT03685123|450961183|FG000|Weight Loss Phase|Lost to Follow-up|1|||
125362570|NCT03685123|450961184|FG001|Weight Loss Phase|Lost to Follow-up|0|||
125589331|NCT01707992|451779275|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
125589332|NCT01707992|451779276|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
125589333|NCT01707992|451779277|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
125589334|NCT01707992|451779272|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
125589335|NCT01707992|451779273|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
125589336|NCT01707992|451779274|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
125589337|NCT01707992|451779275|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
125589338|NCT01707992|451779276|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
125589339|NCT01707992|451779277|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
125589340|NCT01707992|451779272|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
125589341|NCT01707992|451779273|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
125589342|NCT01707992|451779274|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
125589343|NCT01707992|451779275|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
125589344|NCT01707992|451779276|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
125589345|NCT01707992|451779277|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
125589346|NCT01707992|451779272|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
125589347|NCT01707992|451779273|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
125589348|NCT01707992|451779274|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
125589349|NCT01707992|451779275|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
125589350|NCT01707992|451779276|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
125589351|NCT01707992|451779277|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
125589352|NCT01707992|451779272|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
125589353|NCT01707992|451779273|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
125362571|NCT03685123|450961185|FG002|Weight Loss Phase|Lost to Follow-up|0|||
125362572|NCT03685123|450961183|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
125362573|NCT03685123|450961184|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
125362574|NCT03685123|450961185|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
125362575|NCT03685123|450961183|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
125362576|NCT03685123|450961184|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
125362577|NCT03685123|450961185|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
125362578|NCT03685123|450961183|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
125362579|NCT03685123|450961184|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
125362580|NCT03685123|450961185|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
125362581|NCT00400764|450961186|FG000|Phase Ib|Adverse Event|1|||
125589354|NCT01707992|451779274|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
125362582|NCT00400764|450961187|FG001|Phase Ib|Adverse Event|0|||
125362583|NCT00400764|450961188|FG002|Phase Ib|Adverse Event|0|||
125362584|NCT00400764|450961189|FG003|Phase Ib|Adverse Event|0|||
125362585|NCT00400764|450961190|FG004|Phase Ib|Adverse Event|0|||
125362586|NCT00400764|450961186|FG000|Phase Ib|Death|1|||
125362587|NCT00400764|450961187|FG001|Phase Ib|Death|0|||
125362588|NCT00400764|450961188|FG002|Phase Ib|Death|0|||
125362589|NCT00400764|450961189|FG003|Phase Ib|Death|0|||
125362590|NCT00400764|450961190|FG004|Phase Ib|Death|0|||
125362591|NCT00400764|450961186|FG000|Phase Ib|Disease Progression|4|||
125362592|NCT00400764|450961187|FG001|Phase Ib|Disease Progression|4|||
125362593|NCT00400764|450961188|FG002|Phase Ib|Disease Progression|0|||
125362594|NCT00400764|450961189|FG003|Phase Ib|Disease Progression|0|||
125362595|NCT00400764|450961190|FG004|Phase Ib|Disease Progression|0|||
125362596|NCT00400764|450961186|FG000|Phase II|Death|0|||
125362597|NCT00400764|450961187|FG001|Phase II|Death|0|||
125362598|NCT00400764|450961188|FG002|Phase II|Death|1|||
125362599|NCT00400764|450961189|FG003|Phase II|Death|2|||
125362600|NCT00400764|450961190|FG004|Phase II|Death|0|||
125362601|NCT00400764|450961186|FG000|Phase II|Lost to Follow-up|0|||
125362602|NCT00400764|450961187|FG001|Phase II|Lost to Follow-up|0|||
125362603|NCT00400764|450961188|FG002|Phase II|Lost to Follow-up|1|||
125362604|NCT00400764|450961189|FG003|Phase II|Lost to Follow-up|0|||
125362605|NCT00400764|450961190|FG004|Phase II|Lost to Follow-up|0|||
125589355|NCT01707992|451779275|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
125589356|NCT01707992|451779276|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
125131398|NCT03818581|450109962|FG002|Overall Study|Covid-19|0|||
125362606|NCT00400764|450961186|FG000|Phase II|Physician Decision|0|||
125362607|NCT00400764|450961187|FG001|Phase II|Physician Decision|0|||
125362608|NCT00400764|450961188|FG002|Phase II|Physician Decision|1|||
125362609|NCT00400764|450961189|FG003|Phase II|Physician Decision|1|||
125362610|NCT00400764|450961190|FG004|Phase II|Physician Decision|0|||
125589357|NCT01707992|451779277|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
125589358|NCT01707992|451779272|FG000|Active Treatment Phase (24 Months)|Death|0|||
125589359|NCT01707992|451779273|FG001|Active Treatment Phase (24 Months)|Death|0|||
125589360|NCT01707992|451779274|FG002|Active Treatment Phase (24 Months)|Death|0|||
125589361|NCT01707992|451779275|FG003|Active Treatment Phase (24 Months)|Death|2|||
125589362|NCT01707992|451779276|FG004|Active Treatment Phase (24 Months)|Death|0|||
125589363|NCT01707992|451779277|FG005|Active Treatment Phase (24 Months)|Death|0|||
125589364|NCT01707992|451779272|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
125589365|NCT01707992|451779273|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
125589366|NCT01707992|451779274|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
125589367|NCT01707992|451779275|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
125589368|NCT01707992|451779276|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
125589369|NCT01707992|451779277|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
125589370|NCT01707992|451779272|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
125589371|NCT01707992|451779273|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
125589372|NCT01707992|451779274|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
125589373|NCT01707992|451779275|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
125589374|NCT01707992|451779276|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
125589375|NCT01707992|451779277|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
125589376|NCT01707992|451779272|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
125589377|NCT01707992|451779273|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
125589378|NCT01707992|451779274|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
125589379|NCT01707992|451779275|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
125589380|NCT01707992|451779276|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
125589381|NCT01707992|451779277|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
125589382|NCT01707992|451779272|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
125589383|NCT01707992|451779273|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
125589384|NCT01707992|451779274|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
125589385|NCT01707992|451779275|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
125589386|NCT01707992|451779276|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
125589387|NCT01707992|451779277|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
125589388|NCT01976806|451779278|FG000|Overall Study|Lost to Follow-up|1|||
125589389|NCT01976806|451779279|FG001|Overall Study|Lost to Follow-up|4|||
125589390|NCT01976806|451779278|FG000|Overall Study|Adverse Event|1|||
125589391|NCT01976806|451779279|FG001|Overall Study|Adverse Event|1|||
125589392|NCT01976806|451779278|FG000|Overall Study|Withdrawal by Subject|1|||
125589393|NCT01976806|451779279|FG001|Overall Study|Withdrawal by Subject|1|||
125589394|NCT02654002|451779287|FG000|Overall Study|Adverse Event|0|||
125131399|NCT03818581|450109963|FG003|Overall Study|Covid-19|0|||
125362611|NCT00400764|450961186|FG000|Phase II|Sponsor's decision to terminate|0|||
125589395|NCT02654002|451779288|FG001|Overall Study|Adverse Event|0|||
125589396|NCT02654002|451779289|FG002|Overall Study|Adverse Event|0|||
125589397|NCT02654002|451779290|FG003|Overall Study|Adverse Event|0|||
125589398|NCT02654002|451779291|FG004|Overall Study|Adverse Event|0|||
125589399|NCT02654002|451779292|FG005|Overall Study|Adverse Event|0|||
125589400|NCT02654002|451779293|FG006|Overall Study|Adverse Event|1|||
125589401|NCT02654002|451779294|FG007|Overall Study|Adverse Event|0|||
125589402|NCT02654002|451779295|FG008|Overall Study|Adverse Event|0|||
125589403|NCT02654002|451779287|FG000|Overall Study|Withdrew Consent|0|||
125589404|NCT02654002|451779288|FG001|Overall Study|Withdrew Consent|0|||
125589405|NCT02654002|451779289|FG002|Overall Study|Withdrew Consent|0|||
125589406|NCT02654002|451779290|FG003|Overall Study|Withdrew Consent|0|||
125589407|NCT02654002|451779291|FG004|Overall Study|Withdrew Consent|0|||
125589408|NCT02654002|451779292|FG005|Overall Study|Withdrew Consent|1|||
125589409|NCT02654002|451779293|FG006|Overall Study|Withdrew Consent|0|||
125589410|NCT02654002|451779294|FG007|Overall Study|Withdrew Consent|1|||
125589411|NCT02654002|451779295|FG008|Overall Study|Withdrew Consent|0|||
125589412|NCT01523873|451779296|FG000|Overall Study|Protocol Violation|422|||
125589413|NCT00891202|451779297|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
125589414|NCT00891202|451779298|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
125589415|NCT00891202|451779299|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
125589416|NCT00891202|451779300|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
125589417|NCT00891202|451779297|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
125589418|NCT00891202|451779298|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
125589419|NCT00891202|451779299|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
125589420|NCT00891202|451779300|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
125589421|NCT00891202|451779297|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
125589422|NCT00891202|451779298|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
125589423|NCT00891202|451779299|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
125589424|NCT00891202|451779300|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
125589425|NCT00891202|451779297|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
125589426|NCT00891202|451779298|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
125589427|NCT00891202|451779299|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
125589428|NCT00891202|451779300|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
125589429|NCT03313050|451779304|FG000|Stage 2: 12 Months|Adverse Event|0|||
125589430|NCT03313050|451779305|FG001|Stage 2: 12 Months|Adverse Event|0|||
125589431|NCT03313050|451779306|FG002|Stage 2: 12 Months|Adverse Event|0|||
125589432|NCT03313050|451779307|FG003|Stage 2: 12 Months|Adverse Event|1|||
125589433|NCT03313050|451779304|FG000|Stage 2: 12 Months|Death|0|||
125589434|NCT03313050|451779305|FG001|Stage 2: 12 Months|Death|0|||
125589435|NCT03313050|451779306|FG002|Stage 2: 12 Months|Death|3|||
125589436|NCT03313050|451779307|FG003|Stage 2: 12 Months|Death|0|||
125589437|NCT03313050|451779304|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
125589438|NCT03313050|451779305|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
125429241|NCT02496767|451196633|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
125589439|NCT03313050|451779306|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
125589440|NCT03313050|451779307|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
125589441|NCT03313050|451779304|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
125589442|NCT03313050|451779305|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
125589443|NCT03313050|451779306|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
125589444|NCT03313050|451779307|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
125589445|NCT03313050|451779304|FG000|Stage 2: 12 Months|Protocol deviation|0|||
125589446|NCT03313050|451779305|FG001|Stage 2: 12 Months|Protocol deviation|0|||
125589447|NCT03313050|451779306|FG002|Stage 2: 12 Months|Protocol deviation|7|||
125589448|NCT03313050|451779307|FG003|Stage 2: 12 Months|Protocol deviation|7|||
125589449|NCT03313050|451779304|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
125589450|NCT03313050|451779305|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
125589451|NCT03313050|451779306|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
125589452|NCT03313050|451779307|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
125211867|NCT00731731|450401389|FG002|Overall Study|Cancel prior to treatment|2|||
125589453|NCT03313050|451779304|FG000|Stage 2: 12 Months|Other|0|||
125589454|NCT03313050|451779305|FG001|Stage 2: 12 Months|Other|0|||
125589455|NCT03313050|451779306|FG002|Stage 2: 12 Months|Other|0|||
125589456|NCT03313050|451779307|FG003|Stage 2: 12 Months|Other|1|||
125589457|NCT02847598|451779310|FG000|Overall Study|Adverse Event|0|||
125589458|NCT02847598|451779311|FG001|Overall Study|Adverse Event|0|||
125589459|NCT02847598|451779312|FG002|Overall Study|Adverse Event|0|||
125589460|NCT02847598|451779313|FG003|Overall Study|Adverse Event|0|||
125589461|NCT02847598|451779314|FG004|Overall Study|Adverse Event|0|||
125589462|NCT02847598|451779315|FG005|Overall Study|Adverse Event|0|||
125589463|NCT02847598|451779316|FG006|Overall Study|Adverse Event|0|||
125589464|NCT02847598|451779317|FG007|Overall Study|Adverse Event|1|||
125589465|NCT02847598|451779310|FG000|Overall Study|Consent withdrawn|2|||
125589466|NCT02847598|451779311|FG001|Overall Study|Consent withdrawn|0|||
125589467|NCT02847598|451779312|FG002|Overall Study|Consent withdrawn|0|||
125589468|NCT02847598|451779313|FG003|Overall Study|Consent withdrawn|4|||
125589469|NCT02847598|451779314|FG004|Overall Study|Consent withdrawn|3|||
125589470|NCT02847598|451779315|FG005|Overall Study|Consent withdrawn|2|||
125589471|NCT02847598|451779316|FG006|Overall Study|Consent withdrawn|1|||
125589472|NCT02847598|451779317|FG007|Overall Study|Consent withdrawn|3|||
125589473|NCT02847598|451779310|FG000|Overall Study|Death|3|||
125589474|NCT02847598|451779311|FG001|Overall Study|Death|0|||
125589475|NCT02847598|451779312|FG002|Overall Study|Death|0|||
125589476|NCT02847598|451779313|FG003|Overall Study|Death|0|||
125589477|NCT02847598|451779314|FG004|Overall Study|Death|0|||
125589478|NCT02847598|451779315|FG005|Overall Study|Death|0|||
125589479|NCT02847598|451779316|FG006|Overall Study|Death|0|||
125589480|NCT02847598|451779317|FG007|Overall Study|Death|0|||
125589481|NCT02847598|451779310|FG000|Overall Study|Lost to Follow-up|0|||
125589482|NCT02847598|451779311|FG001|Overall Study|Lost to Follow-up|0|||
125589483|NCT02847598|451779312|FG002|Overall Study|Lost to Follow-up|0|||
125589484|NCT02847598|451779313|FG003|Overall Study|Lost to Follow-up|0|||
125589485|NCT02847598|451779314|FG004|Overall Study|Lost to Follow-up|0|||
125589486|NCT02847598|451779315|FG005|Overall Study|Lost to Follow-up|1|||
125589487|NCT02847598|451779316|FG006|Overall Study|Lost to Follow-up|1|||
125589488|NCT02847598|451779317|FG007|Overall Study|Lost to Follow-up|0|||
125589489|NCT02848833|451779318|FG000|Overall Study|subject who are duplicated|1|||
125589490|NCT02848833|451779318|FG000|Overall Study|have not taken the study drug|11|||
125589491|NCT02848833|451779318|FG000|Overall Study|follow-up failure|6|||
125589492|NCT02848833|451779318|FG000|Overall Study|Protocol Violation|119|||
125589493|NCT04167345|451779319|FG000|Overall Study|Other|1|||
125589494|NCT04167345|451779320|FG001|Overall Study|Other|1|||
125589495|NCT04167345|451779321|FG002|Overall Study|Other|0|||
125589496|NCT04167345|451779322|FG003|Overall Study|Other|0|||
125589497|NCT04167345|451779323|FG004|Overall Study|Other|0|||
125637216|NCT03073200|451952837|FG005|Extension Period|Withdrawal by Subject|0|||
125637217|NCT03073200|451952838|FG006|Extension Period|Withdrawal by Subject|1|||
125637218|NCT03073200|451952839|FG007|Extension Period|Withdrawal by Subject|2|||
125637219|NCT03073200|451952840|FG008|Extension Period|Withdrawal by Subject|0|||
125637220|NCT03073200|451952841|FG009|Extension Period|Withdrawal by Subject|0|||
125429242|NCT02496767|451196634|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
125637221|NCT03073200|451952842|FG010|Extension Period|Withdrawal by Subject|0|||
125637222|NCT03073200|451952843|FG011|Extension Period|Withdrawal by Subject|0|||
125637223|NCT03073200|451952844|FG012|Extension Period|Withdrawal by Subject|0|||
125637224|NCT03073200|451952845|FG013|Extension Period|Withdrawal by Subject|0|||
125637225|NCT03073200|451952846|FG014|Extension Period|Withdrawal by Subject|0|||
125637226|NCT03073200|451952832|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
125637227|NCT03073200|451952833|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
125637228|NCT03073200|451952834|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
125637229|NCT03073200|451952835|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
125637230|NCT03073200|451952836|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
125637231|NCT03073200|451952837|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
125589498|NCT05047523|451780965|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
125589499|NCT05047523|451780966|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
125589500|NCT05047523|451780967|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
125589501|NCT05047523|451780968|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
125589502|NCT05047523|451780969|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
125589503|NCT05047523|451780970|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
125589504|NCT05047523|451780965|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125589505|NCT05047523|451780966|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
125589506|NCT05047523|451780967|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125589507|NCT05047523|451780968|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125589508|NCT05047523|451780969|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125589509|NCT05047523|451780970|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
125589510|NCT05047523|451780965|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
125589511|NCT05047523|451780966|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
125589512|NCT05047523|451780967|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
125589513|NCT05047523|451780968|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
125589514|NCT05047523|451780969|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
125589515|NCT05047523|451780970|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
125589516|NCT05047523|451780965|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
125589517|NCT05047523|451780966|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125589518|NCT05047523|451780967|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125589519|NCT05047523|451780968|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125589520|NCT05047523|451780969|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125589521|NCT05047523|451780970|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
125589522|NCT05047523|451780965|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
125589523|NCT05047523|451780966|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
125589524|NCT05047523|451780967|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
125589525|NCT05047523|451780968|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
125589526|NCT05047523|451780969|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
125589527|NCT05047523|451780970|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
125589528|NCT05047523|451780965|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
125589529|NCT05047523|451780966|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
125589530|NCT05047523|451780967|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
125589531|NCT05047523|451780968|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
125589532|NCT05047523|451780969|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
125589533|NCT05047523|451780970|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
125589534|NCT03658889|451780971|FG000|Overall Study|Protocol Violation|2|||
125589535|NCT03658889|451780972|FG001|Overall Study|Protocol Violation|0|||
125589536|NCT04317690|451780982|FG000|Overall Study|did not have complete information for primary outcome|0|||
125589537|NCT04317690|451780983|FG001|Overall Study|did not have complete information for primary outcome|4|||
125589538|NCT04317690|451780984|FG002|Overall Study|did not have complete information for primary outcome|0|||
125589539|NCT04317690|451780985|FG003|Overall Study|did not have complete information for primary outcome|2|||
125589540|NCT04317690|451780986|FG004|Overall Study|did not have complete information for primary outcome|0|||
125589541|NCT03323749|451780987|FG000|Double-blind Period|Lost to Follow-up|4|||
125589542|NCT03323749|451780988|FG001|Double-blind Period|Lost to Follow-up|5|||
125589543|NCT03323749|451780987|FG000|Double-blind Period|Adverse Event|3|||
125589544|NCT03323749|451780988|FG001|Double-blind Period|Adverse Event|1|||
125589545|NCT03323749|451780987|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
125589546|NCT03323749|451780988|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
125589547|NCT03323749|451780987|FG000|Open-Label Period|Adverse Event|3|||
125589548|NCT03323749|451780988|FG001|Open-Label Period|Adverse Event|10|||
125589549|NCT03323749|451780987|FG000|Open-Label Period|Withdrawal by Subject|7|||
125589550|NCT03323749|451780988|FG001|Open-Label Period|Withdrawal by Subject|5|||
125589551|NCT01719757|451780989|FG000|Overall Study|Adverse Event|38|||
125589552|NCT01719757|451780989|FG000|Overall Study|Withdrawal by Subject|15|||
125589553|NCT01719757|451780989|FG000|Overall Study|Lost to Follow-up|20|||
125589554|NCT01719757|451780989|FG000|Overall Study|Protocol Violation|1|||
125589555|NCT01719757|451780989|FG000|Overall Study|well controlled pain|27|||
125589556|NCT02626338|451780990|FG000|Overall Study|Lack of Efficacy|3|||
125589557|NCT02626338|451780991|FG001|Overall Study|Lack of Efficacy|2|||
125589558|NCT02626338|451780992|FG002|Overall Study|Lack of Efficacy|0|||
125589559|NCT01901224|451780993|FG000|Overall Study|study was not funded and terminated|2|||
125589560|NCT00391976|451780994|FG000|Overall Study|Adverse Event|0|||
125589561|NCT00391976|451780995|FG001|Overall Study|Adverse Event|0|||
125589562|NCT00391976|451780996|FG002|Overall Study|Adverse Event|1|||
125589563|NCT00391976|451780994|FG000|Overall Study|Withdrawal of consent|0|||
125211868|NCT03970200|450401390|FG000|Overall Study|Death|2|||
125589564|NCT00391976|451780995|FG001|Overall Study|Withdrawal of consent|1|||
125589565|NCT00391976|451780996|FG002|Overall Study|Withdrawal of consent|1|||
125589566|NCT00391976|451780994|FG000|Overall Study|Lost to Follow-up|1|||
125589567|NCT00391976|451780995|FG001|Overall Study|Lost to Follow-up|2|||
125589568|NCT00391976|451780996|FG002|Overall Study|Lost to Follow-up|0|||
125589569|NCT00391976|451780994|FG000|Overall Study|Inappropriate enrollment|1|||
125589570|NCT00391976|451780995|FG001|Overall Study|Inappropriate enrollment|1|||
125589571|NCT00391976|451780996|FG002|Overall Study|Inappropriate enrollment|0|||
125589572|NCT00391976|451780994|FG000|Overall Study|Protocol deviation/violation|4|||
125589573|NCT00391976|451780995|FG001|Overall Study|Protocol deviation/violation|2|||
125589574|NCT00391976|451780996|FG002|Overall Study|Protocol deviation/violation|1|||
125589575|NCT00391976|451780994|FG000|Overall Study|Recurrence/no eradication of infection|21|||
125589576|NCT00391976|451780995|FG001|Overall Study|Recurrence/no eradication of infection|19|||
125589577|NCT00391976|451780996|FG002|Overall Study|Recurrence/no eradication of infection|0|||
125589578|NCT00391976|451780994|FG000|Overall Study|Unable to classify|0|||
125589579|NCT00391976|451780995|FG001|Overall Study|Unable to classify|0|||
125589580|NCT00391976|451780996|FG002|Overall Study|Unable to classify|1|||
125589581|NCT00391976|451780994|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
125589582|NCT00391976|451780995|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
125589583|NCT00391976|451780996|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
125589584|NCT02731742|451781006|FG000|Overall Study|Death|1|||
125211869|NCT03970200|450401391|FG001|Overall Study|Death|2|||
125211870|NCT03970200|450401392|FG002|Overall Study|Death|1|||
125589585|NCT02731742|451781007|FG001|Overall Study|Death|2|||
125589586|NCT02731742|451781008|FG002|Overall Study|Death|5|||
125589587|NCT02731742|451781009|FG003|Overall Study|Death|0|||
125589588|NCT02731742|451781006|FG000|Overall Study|Physician Decision|0|||
125589589|NCT02731742|451781007|FG001|Overall Study|Physician Decision|0|||
125589590|NCT02731742|451781008|FG002|Overall Study|Physician Decision|0|||
125589591|NCT02731742|451781009|FG003|Overall Study|Physician Decision|1|||
125589592|NCT02731742|451781006|FG000|Overall Study|Study Terminated by Sponsor|2|||
125589593|NCT02731742|451781007|FG001|Overall Study|Study Terminated by Sponsor|1|||
125589594|NCT02731742|451781008|FG002|Overall Study|Study Terminated by Sponsor|1|||
125589595|NCT02731742|451781009|FG003|Overall Study|Study Terminated by Sponsor|1|||
125589596|NCT00619229|451781010|FG000|Overall Study|Withdrawal by Subject|1|||
125589597|NCT00619229|451781011|FG001|Overall Study|Withdrawal by Subject|1|||
125589598|NCT00619229|451781010|FG000|Overall Study|Lost to Follow-up|1|||
125589599|NCT00619229|451781011|FG001|Overall Study|Lost to Follow-up|0|||
125589600|NCT00619229|451781010|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
125589601|NCT00619229|451781011|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
125589602|NCT00619229|451781010|FG000|Overall Study|Investigator planned Cataract Operation|1|||
125589603|NCT00619229|451781011|FG001|Overall Study|Investigator planned Cataract Operation|0|||
125589604|NCT02786901|451781012|FG000|Overall Study|Adverse Event|1|||
125589605|NCT02786901|451781013|FG001|Overall Study|Adverse Event|1|||
125589606|NCT02786901|451781014|FG002|Overall Study|Adverse Event|2|||
125589607|NCT02786901|451781012|FG000|Overall Study|Physician Decision|1|||
125589608|NCT02786901|451781013|FG001|Overall Study|Physician Decision|0|||
125589609|NCT02786901|451781014|FG002|Overall Study|Physician Decision|0|||
125589610|NCT02786901|451781012|FG000|Overall Study|Rescue Therapy Use|71|||
125589611|NCT02786901|451781013|FG001|Overall Study|Rescue Therapy Use|49|||
125589612|NCT02786901|451781014|FG002|Overall Study|Rescue Therapy Use|33|||
125589613|NCT02786901|451781012|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
125589614|NCT02786901|451781013|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
125589615|NCT02786901|451781014|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
125589616|NCT02786901|451781012|FG000|Overall Study|Disallowed medication|1|||
125589617|NCT02786901|451781013|FG001|Overall Study|Disallowed medication|1|||
125589618|NCT02786901|451781014|FG002|Overall Study|Disallowed medication|0|||
125589619|NCT02786901|451781012|FG000|Overall Study|Randomized in error|2|||
125589620|NCT02786901|451781013|FG001|Overall Study|Randomized in error|0|||
125589621|NCT02786901|451781014|FG002|Overall Study|Randomized in error|1|||
125589622|NCT03367871|451781015|FG000|Overall Study|Lost to Follow-up|1|||
125589623|NCT01157117|451781016|FG000|Overall Study|Dosing Symptoms|0|||
125589624|NCT01157117|451781017|FG001|Overall Study|Dosing Symptoms|4|||
125589625|NCT01157117|451781018|FG002|Overall Study|Dosing Symptoms|0|||
125589626|NCT01157117|451781016|FG000|Overall Study|Withdrawal by Subject|4|||
125589627|NCT01157117|451781017|FG001|Overall Study|Withdrawal by Subject|1|||
125589628|NCT01157117|451781018|FG002|Overall Study|Withdrawal by Subject|1|||
125589629|NCT01157117|451781016|FG000|Overall Study|Lack of Efficacy|1|||
125589630|NCT01157117|451781017|FG001|Overall Study|Lack of Efficacy|1|||
125589631|NCT01157117|451781018|FG002|Overall Study|Lack of Efficacy|0|||
125589632|NCT01157117|451781016|FG000|Overall Study|Lost to Follow-up|0|||
125589633|NCT01157117|451781017|FG001|Overall Study|Lost to Follow-up|0|||
125589634|NCT01157117|451781018|FG002|Overall Study|Lost to Follow-up|1|||
125589635|NCT01157117|451781016|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
125589636|NCT01157117|451781017|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
125589637|NCT01157117|451781018|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
125589638|NCT01071070|451781023|FG000|Overall Study|Adverse Event|0|||
125436537|NCT02597933|451224422|FG000|Overall Study|Adverse Event|20|||
125362612|NCT00400764|450961187|FG001|Phase II|Sponsor's decision to terminate|0|||
125362613|NCT00400764|450961188|FG002|Phase II|Sponsor's decision to terminate|18|||
125362614|NCT00400764|450961189|FG003|Phase II|Sponsor's decision to terminate|22|||
125362615|NCT00400764|450961190|FG004|Phase II|Sponsor's decision to terminate|11|||
125362616|NCT00400764|450961186|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
125362617|NCT00400764|450961187|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
125362618|NCT00400764|450961188|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
125362619|NCT00400764|450961189|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
125362620|NCT00400764|450961190|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
125362621|NCT00400764|450961186|FG000|Phase II|Withdrawal by Subject|0|||
125362622|NCT00400764|450961187|FG001|Phase II|Withdrawal by Subject|0|||
125362623|NCT00400764|450961188|FG002|Phase II|Withdrawal by Subject|1|||
125362624|NCT00400764|450961189|FG003|Phase II|Withdrawal by Subject|1|||
125362625|NCT00400764|450961190|FG004|Phase II|Withdrawal by Subject|0|||
125362626|NCT02628938|450961191|FG000|Overall Study|Did not attend the follow up recall|2|||
125362627|NCT02628938|450961192|FG001|Overall Study|Did not attend the follow up recall|2|||
125362628|NCT02628938|450961193|FG002|Overall Study|Did not attend the follow up recall|1|||
125362629|NCT02628938|450961191|FG000|Overall Study|Failure to comply with the instructions|3|||
125362630|NCT02628938|450961192|FG001|Overall Study|Failure to comply with the instructions|0|||
125362631|NCT02628938|450961193|FG002|Overall Study|Failure to comply with the instructions|3|||
125362632|NCT03113916|450961194|FG000|Overall Study|Withdrawal by Subject|9|||
125362633|NCT03113916|450961195|FG001|Overall Study|Withdrawal by Subject|7|||
125362634|NCT03113916|450961194|FG000|Overall Study|Pregnancy|1|||
125362635|NCT03113916|450961195|FG001|Overall Study|Pregnancy|3|||
125362636|NCT03113916|450961194|FG000|Overall Study|Lost to Follow-up|1|||
125362637|NCT03113916|450961195|FG001|Overall Study|Lost to Follow-up|2|||
125362638|NCT00241358|450961196|FG000|Overall Study|Determined to be not ineligible|0|||
125362639|NCT00241358|450961197|FG001|Overall Study|Determined to be not ineligible|1|||
125362640|NCT00241358|450961198|FG002|Overall Study|Determined to be not ineligible|1|||
125362641|NCT01758523|450961199|FG000|Overall Study|Adverse Event|2|||
125362642|NCT01758523|450961200|FG001|Overall Study|Adverse Event|1|||
125362643|NCT01758523|450961199|FG000|Overall Study|Lack of Efficacy|4|||
125362644|NCT01758523|450961200|FG001|Overall Study|Lack of Efficacy|2|||
125362645|NCT01758523|450961199|FG000|Overall Study|Lost to Follow-up|3|||
125362646|NCT01758523|450961200|FG001|Overall Study|Lost to Follow-up|4|||
125362647|NCT01758523|450961199|FG000|Overall Study|Withdrawal by Subject|12|||
125362648|NCT01758523|450961200|FG001|Overall Study|Withdrawal by Subject|7|||
125362649|NCT00621959|450961201|FG000|Overall Study|Adverse Event|4|||
125362650|NCT00621959|450961202|FG001|Overall Study|Adverse Event|2|||
125362651|NCT00621959|450961201|FG000|Overall Study|Lack of Efficacy|1|||
125362652|NCT00621959|450961202|FG001|Overall Study|Lack of Efficacy|1|||
125362653|NCT00621959|450961201|FG000|Overall Study|Lost to Follow-up|0|||
125362654|NCT00621959|450961202|FG001|Overall Study|Lost to Follow-up|2|||
125362655|NCT00621959|450961201|FG000|Overall Study|Withdrawal by Subject|1|||
125362656|NCT00621959|450961202|FG001|Overall Study|Withdrawal by Subject|1|||
125362657|NCT00621959|450961201|FG000|Overall Study|Other|1|||
125362658|NCT00621959|450961202|FG001|Overall Study|Other|3|||
125589639|NCT01071070|451781024|FG001|Overall Study|Adverse Event|3|||
125589640|NCT01071070|451781023|FG000|Overall Study|Withdrawal by Subject|1|||
125589641|NCT01071070|451781024|FG001|Overall Study|Withdrawal by Subject|0|||
125589642|NCT01071070|451781023|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
125589643|NCT01071070|451781024|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
125589644|NCT01071070|451781023|FG000|Overall Study|Hypercalcemia|1|||
125589645|NCT01071070|451781024|FG001|Overall Study|Hypercalcemia|0|||
125589646|NCT02207907|451781026|FG000|Overall Study|Lost to Follow-up|3|||
125589647|NCT02207907|451781027|FG001|Overall Study|Lost to Follow-up|1|||
125362659|NCT00590135|450961203|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
125362660|NCT03439657|450961204|FG000|Overall Study|Adverse Event|2|||
125362661|NCT03439657|450961205|FG001|Overall Study|Adverse Event|3|||
125362662|NCT03439657|450961204|FG000|Overall Study|Lost to Follow-up|1|||
125362663|NCT03439657|450961205|FG001|Overall Study|Lost to Follow-up|0|||
125362664|NCT03439657|450961204|FG000|Overall Study|Protocol Violation|1|||
125362665|NCT03439657|450961205|FG001|Overall Study|Protocol Violation|1|||
125362666|NCT03439657|450961204|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
125362667|NCT03439657|450961205|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
125362668|NCT00289016|450961208|FG000|Overall Study|Disease Progression|29|||
125362669|NCT00289016|450961208|FG000|Overall Study|Death|2|||
125362670|NCT00289016|450961208|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
125362671|NCT00289016|450961208|FG000|Overall Study|Withdrawal by Subject|2|||
125589648|NCT02207907|451781026|FG000|Overall Study|Withdrawal by Subject|5|||
125362672|NCT00289016|450961208|FG000|Overall Study|Adverse Event|1|||
125362673|NCT00289016|450961208|FG000|Overall Study|Other|1|||
125362674|NCT02764697|450961209|FG000|Overall Study|Lack of Efficacy|3|||
125362675|NCT00302107|450961210|FG000|Overall Study|Lost to Follow-up|6|||
125362676|NCT00302107|450961211|FG001|Overall Study|Lost to Follow-up|5|||
125362677|NCT00302107|450961210|FG000|Overall Study|Protocol Violation|1|||
125362678|NCT00302107|450961211|FG001|Overall Study|Protocol Violation|0|||
125589649|NCT02207907|451781027|FG001|Overall Study|Withdrawal by Subject|6|||
125589650|NCT02207907|451781026|FG000|Overall Study|Did not meet study criteria|3|||
125589651|NCT02207907|451781027|FG001|Overall Study|Did not meet study criteria|0|||
125589652|NCT02207907|451781026|FG000|Overall Study|Pregnancy|0|||
125589653|NCT02207907|451781027|FG001|Overall Study|Pregnancy|1|||
125589654|NCT02620020|451781028|FG000|Overall Study|Adverse Event|8|||
125589655|NCT02620020|451781029|FG001|Overall Study|Adverse Event|4|||
125589656|NCT02620020|451781030|FG002|Overall Study|Adverse Event|3|||
125589657|NCT02620020|451781031|FG003|Overall Study|Adverse Event|5|||
125589658|NCT02620020|451781028|FG000|Overall Study|Lost to Follow-up|4|||
125589659|NCT02620020|451781029|FG001|Overall Study|Lost to Follow-up|8|||
125362679|NCT00302107|450961210|FG000|Overall Study|Relocation|0|||
125362680|NCT00302107|450961211|FG001|Overall Study|Relocation|1|||
125589660|NCT02620020|451781030|FG002|Overall Study|Lost to Follow-up|1|||
125589661|NCT02620020|451781031|FG003|Overall Study|Lost to Follow-up|4|||
125589662|NCT02620020|451781028|FG000|Overall Study|Physician Decision|7|||
125589663|NCT02620020|451781029|FG001|Overall Study|Physician Decision|4|||
125589664|NCT02620020|451781030|FG002|Overall Study|Physician Decision|3|||
125589665|NCT02620020|451781031|FG003|Overall Study|Physician Decision|4|||
125589666|NCT02620020|451781028|FG000|Overall Study|Protocol Violation|5|||
125589667|NCT02620020|451781029|FG001|Overall Study|Protocol Violation|2|||
125589668|NCT02620020|451781030|FG002|Overall Study|Protocol Violation|1|||
125589669|NCT02620020|451781031|FG003|Overall Study|Protocol Violation|1|||
125589670|NCT02620020|451781028|FG000|Overall Study|Withdrawal by Subject|20|||
125589671|NCT02620020|451781029|FG001|Overall Study|Withdrawal by Subject|16|||
125589672|NCT02620020|451781030|FG002|Overall Study|Withdrawal by Subject|17|||
125589673|NCT02620020|451781031|FG003|Overall Study|Withdrawal by Subject|12|||
125589674|NCT02620020|451781028|FG000|Overall Study|Death|0|||
125589675|NCT02620020|451781029|FG001|Overall Study|Death|1|||
125589676|NCT02620020|451781030|FG002|Overall Study|Death|0|||
125589677|NCT02620020|451781031|FG003|Overall Study|Death|0|||
125589678|NCT02209506|451781033|FG000|Overall Study|Withdrawal by Subject|0|||
125589679|NCT02209506|451781034|FG001|Overall Study|Withdrawal by Subject|0|||
125589680|NCT02209506|451781035|FG002|Overall Study|Withdrawal by Subject|0|||
125589681|NCT02209506|451781036|FG003|Overall Study|Withdrawal by Subject|0|||
125589682|NCT02209506|451781037|FG004|Overall Study|Withdrawal by Subject|1|||
125589683|NCT01287104|451781038|FG000|Overall Study|Patient developed progressive disease|1|||
125362681|NCT00302107|450961210|FG000|Overall Study|Withdrawal by Subject|0|||
125362682|NCT00302107|450961211|FG001|Overall Study|Withdrawal by Subject|3|||
125362683|NCT00302107|450961210|FG000|Overall Study|Adverse Event|1|||
125589684|NCT01287104|451781039|FG001|Overall Study|Patient developed progressive disease|1|||
125589685|NCT01287104|451781040|FG002|Overall Study|Patient developed progressive disease|3|||
125589686|NCT01287104|451781041|FG003|Overall Study|Patient developed progressive disease|2|||
125589687|NCT01287104|451781038|FG000|Overall Study|Donor anaphylaxis|0|||
125589688|NCT01287104|451781039|FG001|Overall Study|Donor anaphylaxis|1|||
125362684|NCT00302107|450961211|FG001|Overall Study|Adverse Event|0|||
125589689|NCT01287104|451781040|FG002|Overall Study|Donor anaphylaxis|0|||
125589690|NCT01287104|451781041|FG003|Overall Study|Donor anaphylaxis|1|||
125589691|NCT01287104|451781038|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
125362685|NCT01790932|450961212|FG000|Overall Study|Disease Progression|41|||
125362686|NCT01790932|450961212|FG000|Overall Study|Adverse Event|7|||
125362687|NCT01790932|450961212|FG000|Overall Study|Physician Decision|1|||
125589692|NCT01287104|451781039|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
125589693|NCT01287104|451781040|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
125589694|NCT01287104|451781041|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
125589695|NCT01287104|451781038|FG000|Overall Study|Low donor chimerism|0|||
125589696|NCT01287104|451781039|FG001|Overall Study|Low donor chimerism|1|||
125589697|NCT01287104|451781040|FG002|Overall Study|Low donor chimerism|0|||
125589698|NCT01287104|451781041|FG003|Overall Study|Low donor chimerism|0|||
125589699|NCT01287104|451781038|FG000|Overall Study|NK cells did not meet release criteria|0|||
125589700|NCT01287104|451781039|FG001|Overall Study|NK cells did not meet release criteria|1|||
125589701|NCT01287104|451781040|FG002|Overall Study|NK cells did not meet release criteria|0|||
125589702|NCT01287104|451781041|FG003|Overall Study|NK cells did not meet release criteria|0|||
125589703|NCT02537678|451781046|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
125589704|NCT02537678|451781047|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
125589705|NCT02537678|451781046|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
125589706|NCT02537678|451781047|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
125362688|NCT01790932|450961212|FG000|Overall Study|Withdrawal by Subject|1|||
125362689|NCT04223973|450961213|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
125362690|NCT04223973|450961214|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
125362691|NCT04223973|450961213|FG000|Overall Study|Adverse Event|4|||
125131400|NCT03818581|450109964|FG004|Overall Study|Covid-19|1|||
125429243|NCT02496767|451196627|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
125589707|NCT02537678|451781046|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
125589708|NCT02537678|451781047|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
125589709|NCT02537678|451781046|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
125589710|NCT02537678|451781047|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
125589711|NCT02537678|451781046|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
125589712|NCT02537678|451781047|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
125589713|NCT02537678|451781046|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
125589714|NCT02537678|451781047|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
125429244|NCT02496767|451196628|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
125589715|NCT02537678|451781046|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
125211871|NCT03970200|450401390|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
125211872|NCT03970200|450401391|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
125211873|NCT03970200|450401392|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
125211874|NCT02112877|450401393|FG000|Overall Study|Withdrawal by Subject|1|||
125211875|NCT02112877|450401394|FG001|Overall Study|Withdrawal by Subject|7|||
125211876|NCT02112877|450401393|FG000|Overall Study|Visit Missed|1|||
125211877|NCT02112877|450401394|FG001|Overall Study|Visit Missed|6|||
125211878|NCT03742258|450401395|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
125211879|NCT03742258|450401396|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
125211880|NCT03742258|450401397|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
125211881|NCT03742258|450401395|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
125211882|NCT03742258|450401396|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
125211883|NCT03742258|450401397|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
125211884|NCT03742258|450401395|FG000|Survival Follow-Up|Still in Follow-up|0|||
125211885|NCT03742258|450401396|FG001|Survival Follow-Up|Still in Follow-up|0|||
125211886|NCT03742258|450401397|FG002|Survival Follow-Up|Still in Follow-up|2|||
125211887|NCT02083653|450401400|FG000|Overall Study|Randomized but not Treated|0|||
125211888|NCT02083653|450401401|FG001|Overall Study|Randomized but not Treated|2|||
125211889|NCT02083653|450401402|FG002|Overall Study|Randomized but not Treated|7|||
125211890|NCT02083653|450401400|FG000|Overall Study|Adverse Event|12|||
125211891|NCT02083653|450401401|FG001|Overall Study|Adverse Event|5|||
125211892|NCT02083653|450401402|FG002|Overall Study|Adverse Event|4|||
125211893|NCT02083653|450401400|FG000|Overall Study|Lost to Follow-up|1|||
125211894|NCT02083653|450401401|FG001|Overall Study|Lost to Follow-up|0|||
125211895|NCT02083653|450401402|FG002|Overall Study|Lost to Follow-up|0|||
125211896|NCT02083653|450401400|FG000|Overall Study|Death|2|||
125211897|NCT02083653|450401401|FG001|Overall Study|Death|2|||
125211898|NCT02083653|450401402|FG002|Overall Study|Death|2|||
125211899|NCT02083653|450401400|FG000|Overall Study|Progressive Disease|65|||
125211900|NCT02083653|450401401|FG001|Overall Study|Progressive Disease|73|||
125211901|NCT02083653|450401402|FG002|Overall Study|Progressive Disease|63|||
125211902|NCT02083653|450401400|FG000|Overall Study|Withdrawal by Subject|2|||
125211903|NCT02083653|450401401|FG001|Overall Study|Withdrawal by Subject|1|||
125211904|NCT02083653|450401402|FG002|Overall Study|Withdrawal by Subject|2|||
125211905|NCT02083653|450401400|FG000|Overall Study|Other Events|0|||
125211906|NCT02083653|450401401|FG001|Overall Study|Other Events|2|||
125211907|NCT02083653|450401402|FG002|Overall Study|Other Events|2|||
125211908|NCT02083653|450401400|FG000|Overall Study|Reason Missing|0|||
125211909|NCT02083653|450401401|FG001|Overall Study|Reason Missing|0|||
125211910|NCT02083653|450401402|FG002|Overall Study|Reason Missing|4|||
125211911|NCT00621517|450401403|FG000|Overall Study|Lost to Follow-up|3|||
125211912|NCT00621517|450401404|FG001|Overall Study|Lost to Follow-up|3|||
125211913|NCT00621517|450401403|FG000|Overall Study|Withdrawal by Subject|3|||
125211914|NCT00621517|450401404|FG001|Overall Study|Withdrawal by Subject|4|||
125589716|NCT02537678|451781047|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
125589717|NCT02965378|451781048|FG000|Overall Study|Progression|16|||
125589718|NCT02965378|451781049|FG001|Overall Study|Progression|4|||
125589719|NCT02965378|451781048|FG000|Overall Study|Adverse Event|5|||
125589720|NCT02965378|451781049|FG001|Overall Study|Adverse Event|2|||
125589721|NCT02965378|451781048|FG000|Overall Study|Death|2|||
125589722|NCT02965378|451781049|FG001|Overall Study|Death|0|||
125589723|NCT02965378|451781048|FG000|Overall Study|Refusal|2|||
125589724|NCT02965378|451781049|FG001|Overall Study|Refusal|1|||
125589725|NCT02965378|451781048|FG000|Overall Study|Not protocol specified|0|||
125589726|NCT02965378|451781049|FG001|Overall Study|Not protocol specified|2|||
125589727|NCT00629083|451781054|FG000|Overall Study|Adverse Event|0|||
125589728|NCT00629083|451781055|FG001|Overall Study|Adverse Event|2|||
125589729|NCT00629083|451781054|FG000|Overall Study|Lack of Efficacy|3|||
125589730|NCT00629083|451781055|FG001|Overall Study|Lack of Efficacy|1|||
125589731|NCT00629083|451781054|FG000|Overall Study|Withdrawal by Subject|10|||
125589732|NCT00629083|451781055|FG001|Overall Study|Withdrawal by Subject|2|||
125589733|NCT00629083|451781054|FG000|Overall Study|Lost to Follow-up|12|||
125211915|NCT00621517|450401403|FG000|Overall Study|Adverse Event|1|||
125211916|NCT00621517|450401404|FG001|Overall Study|Adverse Event|0|||
125589734|NCT00629083|451781055|FG001|Overall Study|Lost to Follow-up|8|||
125589735|NCT00629083|451781054|FG000|Overall Study|Moved out of country/state|2|||
125211917|NCT02155322|450401406|FG000|Overall Study|Adverse Event|1|||
125211918|NCT02155322|450401406|FG000|Overall Study|Physician Decision|1|||
125589736|NCT00629083|451781055|FG001|Overall Study|Moved out of country/state|1|||
125589737|NCT00629083|451781054|FG000|Overall Study|Refused to return for 12 month visit|1|||
125589738|NCT00629083|451781055|FG001|Overall Study|Refused to return for 12 month visit|0|||
125589739|NCT02909153|451781056|FG000|Overall Study|Withdrawal by Subject|0|||
125211919|NCT02155322|450401406|FG000|Overall Study|Relapse/Recurrence|8|||
125211920|NCT02155322|450401406|FG000|Overall Study|Withdrawal by Subject|4|||
125211921|NCT00073008|450401407|FG000|Overall Study|Missing|6|||
125211922|NCT00073008|450401408|FG001|Overall Study|Missing|6|||
125211923|NCT00073008|450401407|FG000|Overall Study|Withdrawal by Subject|2|||
125362692|NCT04223973|450961214|FG001|Overall Study|Adverse Event|0|||
125362693|NCT04223973|450961213|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
125362694|NCT04223973|450961214|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
125362695|NCT04223973|450961213|FG000|Overall Study|Physician Decision|1|||
125362696|NCT04223973|450961214|FG001|Overall Study|Physician Decision|1|||
125589740|NCT02909153|451781057|FG001|Overall Study|Withdrawal by Subject|1|||
125589741|NCT02909153|451781058|FG002|Overall Study|Withdrawal by Subject|0|||
125589742|NCT02909153|451781059|FG003|Overall Study|Withdrawal by Subject|0|||
125589743|NCT02909153|451781060|FG004|Overall Study|Withdrawal by Subject|0|||
125589744|NCT03401749|451781061|FG000|Overall Study|Lost to Follow-up|20|||
125589745|NCT03401749|451781062|FG001|Overall Study|Lost to Follow-up|16|||
125589746|NCT03401749|451781063|FG002|Overall Study|Lost to Follow-up|26|||
125589747|NCT01193686|451781064|FG000|Overall Study|Withdrawal by Subject|4|||
125589748|NCT01193686|451781065|FG001|Overall Study|Withdrawal by Subject|1|||
125589749|NCT01193686|451781064|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
125589750|NCT01193686|451781065|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
125589751|NCT01147809|451781068|FG000|Phase I (168 Days)|Adverse Event|0|||
125589752|NCT01147809|451781069|FG001|Phase I (168 Days)|Adverse Event|0|||
125589753|NCT01147809|451781070|FG002|Phase I (168 Days)|Adverse Event|0|||
125589754|NCT01147809|451781071|FG003|Phase I (168 Days)|Adverse Event|1|||
125589755|NCT01147809|451781072|FG004|Phase I (168 Days)|Adverse Event|0|||
125589756|NCT01147809|451781073|FG005|Phase I (168 Days)|Adverse Event|0|||
125589757|NCT01147809|451781068|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
125589758|NCT01147809|451781069|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
125589759|NCT01147809|451781070|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
125589760|NCT01147809|451781071|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
125589761|NCT01147809|451781072|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
125589762|NCT01147809|451781073|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
125589763|NCT01147809|451781068|FG000|Phase I (168 Days)|Physician Decision|0|||
125589764|NCT01147809|451781069|FG001|Phase I (168 Days)|Physician Decision|1|||
125589765|NCT01147809|451781070|FG002|Phase I (168 Days)|Physician Decision|2|||
125589766|NCT01147809|451781071|FG003|Phase I (168 Days)|Physician Decision|0|||
125589767|NCT01147809|451781072|FG004|Phase I (168 Days)|Physician Decision|0|||
125589768|NCT01147809|451781073|FG005|Phase I (168 Days)|Physician Decision|0|||
125589769|NCT01147809|451781068|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
125589770|NCT01147809|451781069|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
125211924|NCT00073008|450401408|FG001|Overall Study|Withdrawal by Subject|2|||
125211925|NCT00073008|450401407|FG000|Overall Study|Lost to Follow-up|1|||
125211926|NCT00073008|450401408|FG001|Overall Study|Lost to Follow-up|3|||
125211927|NCT00073008|450401407|FG000|Overall Study|Death|46|||
125211928|NCT00073008|450401408|FG001|Overall Study|Death|47|||
125211929|NCT00073008|450401407|FG000|Overall Study|"Other selected on Case Report Form"|7|||
125211930|NCT00073008|450401408|FG001|Overall Study|"Other selected on Case Report Form"|5|||
125211931|NCT00913770|450401409|FG000|Overall Study|Unable to contact|24|||
125211932|NCT00913770|450401410|FG001|Overall Study|Unable to contact|19|||
125211933|NCT00913770|450401411|FG002|Overall Study|Unable to contact|13|||
125211934|NCT00913770|450401409|FG000|Overall Study|Refused|11|||
125211935|NCT00913770|450401410|FG001|Overall Study|Refused|10|||
125211936|NCT00913770|450401411|FG002|Overall Study|Refused|8|||
125211937|NCT03337048|450401412|FG000|Overall Study|Withdrawal by Subject|2|||
125211938|NCT03337048|450401413|FG001|Overall Study|Withdrawal by Subject|0|||
125211939|NCT03337048|450401414|FG002|Overall Study|Withdrawal by Subject|0|||
125211940|NCT02791438|450401417|FG000|Treatment Period|Adverse Event|1|||
125211941|NCT02791438|450401418|FG001|Treatment Period|Adverse Event|0|||
125211942|NCT02791438|450401417|FG000|Treatment Period|Withdrawal by Subject|0|||
125211943|NCT02791438|450401418|FG001|Treatment Period|Withdrawal by Subject|1|||
125211944|NCT02791438|450401417|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
125211945|NCT02791438|450401418|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
125211946|NCT00564395|450401420|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
125589771|NCT01147809|451781070|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
125589772|NCT01147809|451781071|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
125589773|NCT01147809|451781072|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
125589774|NCT01147809|451781073|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
125589775|NCT01147809|451781068|FG000|Phase II (168 Days)|Adverse Event|0|||
125589776|NCT01147809|451781069|FG001|Phase II (168 Days)|Adverse Event|0|||
125589777|NCT01147809|451781070|FG002|Phase II (168 Days)|Adverse Event|0|||
125589778|NCT01147809|451781071|FG003|Phase II (168 Days)|Adverse Event|0|||
125589779|NCT01147809|451781072|FG004|Phase II (168 Days)|Adverse Event|3|||
125589780|NCT01147809|451781073|FG005|Phase II (168 Days)|Adverse Event|6|||
125589781|NCT01147809|451781068|FG000|Phase II (168 Days)|Protocol Violation|0|||
125589782|NCT01147809|451781069|FG001|Phase II (168 Days)|Protocol Violation|0|||
125589783|NCT01147809|451781070|FG002|Phase II (168 Days)|Protocol Violation|0|||
125589784|NCT01147809|451781071|FG003|Phase II (168 Days)|Protocol Violation|0|||
125589785|NCT01147809|451781072|FG004|Phase II (168 Days)|Protocol Violation|0|||
125589786|NCT01147809|451781073|FG005|Phase II (168 Days)|Protocol Violation|1|||
125589787|NCT01147809|451781068|FG000|Phase II (168 Days)|Physician Decision|0|||
125589788|NCT01147809|451781069|FG001|Phase II (168 Days)|Physician Decision|0|||
125589789|NCT01147809|451781070|FG002|Phase II (168 Days)|Physician Decision|0|||
125589790|NCT01147809|451781071|FG003|Phase II (168 Days)|Physician Decision|0|||
125589791|NCT01147809|451781072|FG004|Phase II (168 Days)|Physician Decision|5|||
125589792|NCT01147809|451781073|FG005|Phase II (168 Days)|Physician Decision|11|||
125589793|NCT01147809|451781068|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
125589794|NCT01147809|451781069|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
125589795|NCT01147809|451781070|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
125589796|NCT01147809|451781071|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
125589797|NCT01147809|451781072|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
125589798|NCT01147809|451781073|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
125589799|NCT01147809|451781068|FG000|Phase II (168 Days)|Ongoing|0|||
125589800|NCT01147809|451781069|FG001|Phase II (168 Days)|Ongoing|0|||
125589801|NCT01147809|451781070|FG002|Phase II (168 Days)|Ongoing|0|||
125589802|NCT01147809|451781071|FG003|Phase II (168 Days)|Ongoing|0|||
125589803|NCT01147809|451781072|FG004|Phase II (168 Days)|Ongoing|1|||
125589804|NCT01147809|451781073|FG005|Phase II (168 Days)|Ongoing|0|||
125589805|NCT01307423|451781074|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
125589806|NCT01307423|451781075|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
125211947|NCT00564395|450401421|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
125211948|NCT00564395|450401420|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
125211949|NCT00564395|450401421|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
125211950|NCT01428115|450401422|FG000|Overall Study|Lack of Efficacy|3|||
125211951|NCT01428115|450401422|FG000|Overall Study|Lost to Follow-up|10|||
125589807|NCT01307423|451781076|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
125589808|NCT01307423|451781077|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125589809|NCT01307423|451781078|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125589810|NCT01307423|451781079|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125589811|NCT01307423|451781080|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125589812|NCT01307423|451781081|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125589813|NCT01307423|451781082|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125589814|NCT01307423|451781074|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
125589815|NCT01307423|451781075|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
125589816|NCT01307423|451781076|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
125211952|NCT01428115|450401422|FG000|Overall Study|Pregnancy|1|||
125211953|NCT01428115|450401422|FG000|Overall Study|Protocol Violation|3|||
125211954|NCT01428115|450401422|FG000|Overall Study|Withdrawal by Subject|4|||
125211955|NCT02620384|450401427|FG000|Overall Study|Adverse Event|2|||
125211956|NCT02620384|450401428|FG001|Overall Study|Adverse Event|1|||
125211957|NCT02620384|450401427|FG000|Overall Study|Discharged prior to 2nd dose|2|||
125211958|NCT02620384|450401428|FG001|Overall Study|Discharged prior to 2nd dose|5|||
125211959|NCT02620384|450401427|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
125211960|NCT02620384|450401428|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
125211961|NCT02071082|450401429|FG000|Overall Study|Enrolled and Never Treated|1|||
125211962|NCT02071082|450401430|FG001|Overall Study|Enrolled and Never Treated|1|||
125211963|NCT02071082|450401429|FG000|Overall Study|Adverse Event|0|||
125211964|NCT02071082|450401430|FG001|Overall Study|Adverse Event|1|||
125211965|NCT02071082|450401429|FG000|Overall Study|Withdrew Consent|0|||
125211966|NCT02071082|450401430|FG001|Overall Study|Withdrew Consent|4|||
125211967|NCT02071082|450401429|FG000|Overall Study|Lost to Follow-up|1|||
125211968|NCT02071082|450401430|FG001|Overall Study|Lost to Follow-up|1|||
125211969|NCT02101359|450401431|FG000|Overall Study|Not included|23|||
125211970|NCT02101359|450401432|FG001|Overall Study|Not included|13|||
125211971|NCT02101359|450401431|FG000|Overall Study|Withdrawal by Subject|5|||
125211972|NCT02101359|450401432|FG001|Overall Study|Withdrawal by Subject|4|||
125211973|NCT02101359|450401431|FG000|Overall Study|Lost to Follow-up|1|||
125211974|NCT02101359|450401432|FG001|Overall Study|Lost to Follow-up|0|||
125211975|NCT02101359|450401431|FG000|Overall Study|Protocol Violation|0|||
125211976|NCT02101359|450401432|FG001|Overall Study|Protocol Violation|2|||
125211977|NCT02494401|450401437|FG000|Overall Study|Lost to Follow-up|22|||
125211978|NCT02494401|450401438|FG001|Overall Study|Lost to Follow-up|25|||
125211979|NCT02494401|450401437|FG000|Overall Study|Withdrawal by Subject|3|||
125211980|NCT02494401|450401438|FG001|Overall Study|Withdrawal by Subject|2|||
125211981|NCT00966355|450401439|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
125211982|NCT00966355|450401440|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
125211983|NCT00966355|450401441|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
125211984|NCT00966355|450401439|FG000|Overall Study|newly diagnosed advanced HCC|11|||
125211985|NCT00966355|450401440|FG001|Overall Study|newly diagnosed advanced HCC|12|||
125211986|NCT00966355|450401441|FG002|Overall Study|newly diagnosed advanced HCC|10|||
125589817|NCT01307423|451781077|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125589818|NCT01307423|451781078|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125589819|NCT01307423|451781079|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125589820|NCT01307423|451781080|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125589821|NCT01307423|451781081|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125589822|NCT01307423|451781082|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125589823|NCT01307423|451781074|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
125589824|NCT01307423|451781075|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
125589825|NCT01307423|451781076|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
125211987|NCT00966355|450401439|FG000|Overall Study|Lost to Follow-up|5|||
125211988|NCT00966355|450401440|FG001|Overall Study|Lost to Follow-up|4|||
125211989|NCT00966355|450401441|FG002|Overall Study|Lost to Follow-up|3|||
125211990|NCT00958412|450401442|FG000|Overall Study|Study prematurely terminated|18|||
125211991|NCT02227368|450403233|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
125211992|NCT02227368|450403234|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
125211993|NCT02227368|450403233|FG000|Overall Study|Lost to Follow-up|1|||
125211994|NCT02227368|450403234|FG001|Overall Study|Lost to Follow-up|0|||
125211995|NCT02227368|450403233|FG000|Overall Study|Adverse Event|1|||
125211996|NCT02227368|450403234|FG001|Overall Study|Adverse Event|0|||
125211997|NCT04494425|450403236|FG000|Overall Study|Death|160|||
125211998|NCT04494425|450403237|FG001|Overall Study|Death|166|||
125211999|NCT04494425|450403236|FG000|Overall Study|Withdrawal by Subject|10|||
125212000|NCT04494425|450403237|FG001|Overall Study|Withdrawal by Subject|40|||
125212001|NCT04494425|450403236|FG000|Overall Study|Other|1|||
125212002|NCT04494425|450403237|FG001|Overall Study|Other|1|||
125212003|NCT04494425|450403236|FG000|Overall Study|Ongoing at the time of PCD|265|||
125212004|NCT04494425|450403237|FG001|Overall Study|Ongoing at the time of PCD|223|||
125589826|NCT01307423|451781077|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125589827|NCT01307423|451781078|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125589828|NCT01307423|451781079|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125589829|NCT01307423|451781080|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125589830|NCT01307423|451781081|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125212005|NCT01744483|450403239|FG000|Overall Study|Death|9|||
125212006|NCT01744483|450403240|FG001|Overall Study|Death|4|||
125212007|NCT01744483|450403241|FG002|Overall Study|Death|11|||
125212008|NCT01744483|450403239|FG000|Overall Study|Lost to Follow-up|8|||
125212009|NCT01744483|450403240|FG001|Overall Study|Lost to Follow-up|9|||
125212010|NCT01744483|450403241|FG002|Overall Study|Lost to Follow-up|11|||
125212011|NCT01744483|450403239|FG000|Overall Study|Protocol Violation|1|||
125212012|NCT01744483|450403240|FG001|Overall Study|Protocol Violation|2|||
125212013|NCT01744483|450403241|FG002|Overall Study|Protocol Violation|1|||
125212014|NCT01744483|450403239|FG000|Overall Study|Withdrawal by Subject|4|||
125212015|NCT01744483|450403240|FG001|Overall Study|Withdrawal by Subject|6|||
125212016|NCT01744483|450403241|FG002|Overall Study|Withdrawal by Subject|2|||
125212017|NCT01744483|450403239|FG000|Overall Study|No ICU Admit|5|||
125362697|NCT04223973|450961213|FG000|Overall Study|Withdrawal by Subject|0|||
125362698|NCT04223973|450961214|FG001|Overall Study|Withdrawal by Subject|1|||
125362699|NCT02612129|450961216|FG000|Single Dose Treatment Period|Screening Failure|1|||
125362700|NCT02612129|450961217|FG001|Single Dose Treatment Period|Screening Failure|0|||
125362701|NCT02612129|450961218|FG002|Single Dose Treatment Period|Screening Failure|0|||
125362702|NCT02612129|450961216|FG000|Continuous Treatment Period|Early Escape|0|||
125212018|NCT01744483|450403240|FG001|Overall Study|No ICU Admit|1|||
125362703|NCT02612129|450961217|FG001|Continuous Treatment Period|Early Escape|2|||
125362704|NCT02612129|450961218|FG002|Continuous Treatment Period|Early Escape|0|||
125212019|NCT01744483|450403241|FG002|Overall Study|No ICU Admit|2|||
125429245|NCT02496767|451196629|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
125212020|NCT01744483|450403239|FG000|Overall Study|Routed to OSH|2|||
125212021|NCT01744483|450403240|FG001|Overall Study|Routed to OSH|0|||
125429246|NCT02496767|451196630|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
125212022|NCT01744483|450403241|FG002|Overall Study|Routed to OSH|1|||
125212023|NCT01754766|450403242|FG000|Overall Study|Personal reasons|1|||
125212024|NCT01754766|450403243|FG001|Overall Study|Personal reasons|1|||
125362705|NCT02612129|450961216|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
125589831|NCT01307423|451781082|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125589832|NCT01307423|451781074|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125589833|NCT01307423|451781075|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125589834|NCT01307423|451781076|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
125589835|NCT01307423|451781077|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125589836|NCT01307423|451781078|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125589837|NCT01307423|451781079|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125589838|NCT01307423|451781080|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125589839|NCT01307423|451781081|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125589840|NCT01307423|451781082|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125589841|NCT01307423|451781074|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
125589842|NCT01307423|451781075|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
125589843|NCT01307423|451781076|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
125589844|NCT01307423|451781077|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125589845|NCT01307423|451781078|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125589846|NCT01307423|451781079|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125589847|NCT01307423|451781080|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125589848|NCT01307423|451781081|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125589849|NCT01307423|451781082|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125589850|NCT01307423|451781074|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
125589851|NCT01307423|451781075|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125589852|NCT01307423|451781076|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125589853|NCT01307423|451781077|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125589854|NCT01307423|451781078|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125589855|NCT01307423|451781079|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125589856|NCT01307423|451781080|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125589857|NCT01307423|451781081|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125589858|NCT01307423|451781082|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125589859|NCT01307423|451781074|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
125589860|NCT01307423|451781075|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
125589861|NCT01307423|451781076|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125212025|NCT01754766|450403244|FG002|Overall Study|Personal reasons|0|||
125362706|NCT02612129|450961217|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
125362707|NCT02612129|450961218|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
125362708|NCT02612129|450961216|FG000|Continuous Treatment Period|Safety Reasons|0|||
125212026|NCT01709409|450403245|FG000|Overall Study|Protocol Violation|1|||
125362709|NCT02612129|450961217|FG001|Continuous Treatment Period|Safety Reasons|3|||
125362710|NCT02612129|450961218|FG002|Continuous Treatment Period|Safety Reasons|0|||
125362711|NCT02612129|450961216|FG000|Continuous Treatment Period|Death|0|||
125362712|NCT02612129|450961217|FG001|Continuous Treatment Period|Death|1|||
125362713|NCT02612129|450961218|FG002|Continuous Treatment Period|Death|0|||
125362714|NCT02612129|450961216|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
125362715|NCT02612129|450961217|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
125362716|NCT02612129|450961218|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
125362717|NCT00531934|450963488|FG000|Overall Study|Adverse Event|4|||
125362718|NCT00531934|450963489|FG001|Overall Study|Adverse Event|8|||
125362719|NCT00531934|450963488|FG000|Overall Study|Progression|52|||
125362720|NCT00531934|450963489|FG001|Overall Study|Progression|42|||
125362721|NCT00531934|450963488|FG000|Overall Study|Death|7|||
125362722|NCT00531934|450963489|FG001|Overall Study|Death|10|||
125362723|NCT00531934|450963488|FG000|Overall Study|Withdrawal by Subject|1|||
125362724|NCT00531934|450963489|FG001|Overall Study|Withdrawal by Subject|1|||
125362725|NCT00531934|450963488|FG000|Overall Study|Other|2|||
125362726|NCT00531934|450963489|FG001|Overall Study|Other|2|||
125362727|NCT01543698|450963494|FG000|Phase 1b|Disease progression|2|||
125362728|NCT01543698|450963495|FG001|Phase 1b|Disease progression|4|||
125362729|NCT01543698|450963496|FG002|Phase 1b|Disease progression|3|||
125362730|NCT01543698|450963497|FG003|Phase 1b|Disease progression|2|||
125362731|NCT01543698|450963498|FG004|Phase 1b|Disease progression|10|||
125362732|NCT01543698|450963499|FG005|Phase 1b|Disease progression|6|||
125362733|NCT01543698|450963500|FG006|Phase 1b|Disease progression|5|||
125362734|NCT01543698|450963501|FG007|Phase 1b|Disease progression|3|||
125362735|NCT01543698|450963502|FG008|Phase 1b|Disease progression|4|||
125362736|NCT01543698|450963503|FG009|Phase 1b|Disease progression|5|||
125362737|NCT01543698|450963504|FG010|Phase 1b|Disease progression|1|||
125362738|NCT01543698|450963505|FG011|Phase 1b|Disease progression|0|||
125362739|NCT01543698|450963506|FG012|Phase 1b|Disease progression|0|||
125362740|NCT01543698|450963507|FG013|Phase 1b|Disease progression|0|||
125362741|NCT01543698|450963508|FG014|Phase 1b|Disease progression|0|||
125362742|NCT01543698|450963494|FG000|Phase 1b|Death|0|||
125362743|NCT01543698|450963495|FG001|Phase 1b|Death|0|||
125362744|NCT01543698|450963496|FG002|Phase 1b|Death|1|||
125362745|NCT01543698|450963497|FG003|Phase 1b|Death|1|||
125362746|NCT01543698|450963498|FG004|Phase 1b|Death|0|||
125362747|NCT01543698|450963499|FG005|Phase 1b|Death|0|||
125362748|NCT01543698|450963500|FG006|Phase 1b|Death|0|||
125362749|NCT01543698|450963501|FG007|Phase 1b|Death|0|||
125362750|NCT01543698|450963502|FG008|Phase 1b|Death|0|||
125362751|NCT01543698|450963503|FG009|Phase 1b|Death|0|||
125362752|NCT01543698|450963504|FG010|Phase 1b|Death|1|||
125362753|NCT01543698|450963505|FG011|Phase 1b|Death|0|||
125362754|NCT01543698|450963506|FG012|Phase 1b|Death|0|||
125362755|NCT01543698|450963507|FG013|Phase 1b|Death|0|||
125362756|NCT01543698|450963508|FG014|Phase 1b|Death|0|||
125362757|NCT01543698|450963494|FG000|Phase 1b|Withdrawal by Subject|0|||
125362758|NCT01543698|450963495|FG001|Phase 1b|Withdrawal by Subject|1|||
125362759|NCT01543698|450963496|FG002|Phase 1b|Withdrawal by Subject|0|||
125362760|NCT01543698|450963497|FG003|Phase 1b|Withdrawal by Subject|1|||
125362761|NCT01543698|450963498|FG004|Phase 1b|Withdrawal by Subject|0|||
125362762|NCT01543698|450963499|FG005|Phase 1b|Withdrawal by Subject|0|||
125362763|NCT01543698|450963500|FG006|Phase 1b|Withdrawal by Subject|1|||
125362764|NCT01543698|450963501|FG007|Phase 1b|Withdrawal by Subject|0|||
125362765|NCT01543698|450963502|FG008|Phase 1b|Withdrawal by Subject|0|||
125362766|NCT01543698|450963503|FG009|Phase 1b|Withdrawal by Subject|0|||
125362767|NCT01543698|450963504|FG010|Phase 1b|Withdrawal by Subject|0|||
125362768|NCT01543698|450963505|FG011|Phase 1b|Withdrawal by Subject|0|||
125362769|NCT01543698|450963506|FG012|Phase 1b|Withdrawal by Subject|0|||
125362770|NCT01543698|450963507|FG013|Phase 1b|Withdrawal by Subject|0|||
125362771|NCT01543698|450963508|FG014|Phase 1b|Withdrawal by Subject|0|||
125362772|NCT01543698|450963494|FG000|Phase 1b|Adverse Event|1|||
125362773|NCT01543698|450963495|FG001|Phase 1b|Adverse Event|0|||
125362774|NCT01543698|450963496|FG002|Phase 1b|Adverse Event|0|||
125362775|NCT01543698|450963497|FG003|Phase 1b|Adverse Event|1|||
125362776|NCT01543698|450963498|FG004|Phase 1b|Adverse Event|2|||
125362777|NCT01543698|450963499|FG005|Phase 1b|Adverse Event|2|||
125362778|NCT01543698|450963500|FG006|Phase 1b|Adverse Event|0|||
125362779|NCT01543698|450963501|FG007|Phase 1b|Adverse Event|0|||
125362780|NCT01543698|450963502|FG008|Phase 1b|Adverse Event|1|||
125362781|NCT01543698|450963503|FG009|Phase 1b|Adverse Event|1|||
125362782|NCT01543698|450963504|FG010|Phase 1b|Adverse Event|2|||
125362783|NCT01543698|450963505|FG011|Phase 1b|Adverse Event|0|||
125362784|NCT01543698|450963506|FG012|Phase 1b|Adverse Event|0|||
125362785|NCT01543698|450963507|FG013|Phase 1b|Adverse Event|0|||
125362786|NCT01543698|450963508|FG014|Phase 1b|Adverse Event|0|||
125362787|NCT01543698|450963494|FG000|Phase 1b|Administrative problems|1|||
125362788|NCT01543698|450963495|FG001|Phase 1b|Administrative problems|0|||
125362789|NCT01543698|450963496|FG002|Phase 1b|Administrative problems|0|||
125362790|NCT01543698|450963497|FG003|Phase 1b|Administrative problems|0|||
125362791|NCT01543698|450963498|FG004|Phase 1b|Administrative problems|1|||
125362792|NCT01543698|450963499|FG005|Phase 1b|Administrative problems|0|||
125362793|NCT01543698|450963500|FG006|Phase 1b|Administrative problems|0|||
125362794|NCT01543698|450963501|FG007|Phase 1b|Administrative problems|1|||
125362795|NCT01543698|450963502|FG008|Phase 1b|Administrative problems|0|||
125362796|NCT01543698|450963503|FG009|Phase 1b|Administrative problems|0|||
125362797|NCT01543698|450963504|FG010|Phase 1b|Administrative problems|2|||
125362798|NCT01543698|450963505|FG011|Phase 1b|Administrative problems|0|||
125362799|NCT01543698|450963506|FG012|Phase 1b|Administrative problems|0|||
125362800|NCT01543698|450963507|FG013|Phase 1b|Administrative problems|0|||
125362801|NCT01543698|450963508|FG014|Phase 1b|Administrative problems|0|||
125362802|NCT01543698|450963494|FG000|Phase 1b|Protocol Violation|2|||
125362803|NCT01543698|450963495|FG001|Phase 1b|Protocol Violation|0|||
125362804|NCT01543698|450963496|FG002|Phase 1b|Protocol Violation|0|||
125362805|NCT01543698|450963497|FG003|Phase 1b|Protocol Violation|0|||
125362806|NCT01543698|450963498|FG004|Phase 1b|Protocol Violation|0|||
125362807|NCT01543698|450963499|FG005|Phase 1b|Protocol Violation|0|||
125362808|NCT01543698|450963500|FG006|Phase 1b|Protocol Violation|0|||
125362809|NCT01543698|450963501|FG007|Phase 1b|Protocol Violation|0|||
125362810|NCT01543698|450963502|FG008|Phase 1b|Protocol Violation|0|||
125362811|NCT01543698|450963503|FG009|Phase 1b|Protocol Violation|0|||
125362812|NCT01543698|450963504|FG010|Phase 1b|Protocol Violation|0|||
125362813|NCT01543698|450963505|FG011|Phase 1b|Protocol Violation|0|||
125362814|NCT01543698|450963506|FG012|Phase 1b|Protocol Violation|0|||
125362815|NCT01543698|450963507|FG013|Phase 1b|Protocol Violation|0|||
125362816|NCT01543698|450963508|FG014|Phase 1b|Protocol Violation|0|||
125362817|NCT01543698|450963494|FG000|Phase 2|Protocol Violation|0|||
125362818|NCT01543698|450963495|FG001|Phase 2|Protocol Violation|0|||
125362819|NCT01543698|450963496|FG002|Phase 2|Protocol Violation|0|||
125362820|NCT01543698|450963497|FG003|Phase 2|Protocol Violation|0|||
125362821|NCT01543698|450963498|FG004|Phase 2|Protocol Violation|0|||
125362822|NCT01543698|450963499|FG005|Phase 2|Protocol Violation|0|||
125362823|NCT01543698|450963500|FG006|Phase 2|Protocol Violation|0|||
125362824|NCT01543698|450963501|FG007|Phase 2|Protocol Violation|0|||
125362825|NCT01543698|450963502|FG008|Phase 2|Protocol Violation|0|||
125362826|NCT01543698|450963503|FG009|Phase 2|Protocol Violation|0|||
125362827|NCT01543698|450963504|FG010|Phase 2|Protocol Violation|0|||
125362828|NCT01543698|450963505|FG011|Phase 2|Protocol Violation|0|||
125362829|NCT01543698|450963506|FG012|Phase 2|Protocol Violation|1|||
125362830|NCT01543698|450963507|FG013|Phase 2|Protocol Violation|0|||
125362831|NCT01543698|450963508|FG014|Phase 2|Protocol Violation|0|||
125362832|NCT01543698|450963494|FG000|Phase 2|Disease progression|0|||
125362833|NCT01543698|450963495|FG001|Phase 2|Disease progression|0|||
125362834|NCT01543698|450963496|FG002|Phase 2|Disease progression|0|||
125362835|NCT01543698|450963497|FG003|Phase 2|Disease progression|0|||
125362836|NCT01543698|450963498|FG004|Phase 2|Disease progression|0|||
125362837|NCT01543698|450963499|FG005|Phase 2|Disease progression|0|||
125362838|NCT01543698|450963500|FG006|Phase 2|Disease progression|0|||
125362839|NCT01543698|450963501|FG007|Phase 2|Disease progression|0|||
125362840|NCT01543698|450963502|FG008|Phase 2|Disease progression|0|||
125362841|NCT01543698|450963503|FG009|Phase 2|Disease progression|0|||
125362842|NCT01543698|450963504|FG010|Phase 2|Disease progression|0|||
125362843|NCT01543698|450963505|FG011|Phase 2|Disease progression|10|||
125362844|NCT01543698|450963506|FG012|Phase 2|Disease progression|21|||
125362845|NCT01543698|450963507|FG013|Phase 2|Disease progression|30|||
125362846|NCT01543698|450963508|FG014|Phase 2|Disease progression|25|||
125362847|NCT01543698|450963494|FG000|Phase 2|Death|0|||
125362848|NCT01543698|450963495|FG001|Phase 2|Death|0|||
125362849|NCT01543698|450963496|FG002|Phase 2|Death|0|||
125362850|NCT01543698|450963497|FG003|Phase 2|Death|0|||
125362851|NCT01543698|450963498|FG004|Phase 2|Death|0|||
125362852|NCT01543698|450963499|FG005|Phase 2|Death|0|||
125362853|NCT01543698|450963500|FG006|Phase 2|Death|0|||
125362854|NCT01543698|450963501|FG007|Phase 2|Death|0|||
125589862|NCT01307423|451781077|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125589863|NCT01307423|451781078|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125589864|NCT01307423|451781079|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125589865|NCT01307423|451781080|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125589866|NCT01307423|451781081|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125589867|NCT01307423|451781082|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125589868|NCT01307423|451781074|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125589869|NCT01307423|451781075|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
125589870|NCT01307423|451781076|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
125589871|NCT01307423|451781077|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125589872|NCT01307423|451781078|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125589873|NCT01307423|451781079|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125589874|NCT01307423|451781080|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125589875|NCT01307423|451781081|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125589876|NCT01307423|451781082|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
125589877|NCT01307423|451781074|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
125589878|NCT01307423|451781075|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
125589879|NCT01307423|451781076|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
125589880|NCT01307423|451781077|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
125589881|NCT01307423|451781078|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
125589882|NCT01307423|451781079|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
125589883|NCT01307423|451781080|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
125589884|NCT01307423|451781081|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
125362855|NCT01543698|450963502|FG008|Phase 2|Death|0|||
125362856|NCT01543698|450963503|FG009|Phase 2|Death|0|||
125362857|NCT01543698|450963504|FG010|Phase 2|Death|0|||
125362858|NCT01543698|450963505|FG011|Phase 2|Death|0|||
125362859|NCT01543698|450963506|FG012|Phase 2|Death|1|||
125362860|NCT01543698|450963507|FG013|Phase 2|Death|1|||
125362861|NCT01543698|450963508|FG014|Phase 2|Death|1|||
125362862|NCT01543698|450963494|FG000|Phase 2|Administrative problems|0|||
125362863|NCT01543698|450963495|FG001|Phase 2|Administrative problems|0|||
125362864|NCT01543698|450963496|FG002|Phase 2|Administrative problems|0|||
125362865|NCT01543698|450963497|FG003|Phase 2|Administrative problems|0|||
125362866|NCT01543698|450963498|FG004|Phase 2|Administrative problems|0|||
125362867|NCT01543698|450963499|FG005|Phase 2|Administrative problems|0|||
125362868|NCT01543698|450963500|FG006|Phase 2|Administrative problems|0|||
125362869|NCT01543698|450963501|FG007|Phase 2|Administrative problems|0|||
125362870|NCT01543698|450963502|FG008|Phase 2|Administrative problems|0|||
125362871|NCT01543698|450963503|FG009|Phase 2|Administrative problems|0|||
125362872|NCT01543698|450963504|FG010|Phase 2|Administrative problems|0|||
125362873|NCT01543698|450963505|FG011|Phase 2|Administrative problems|0|||
125362874|NCT01543698|450963506|FG012|Phase 2|Administrative problems|0|||
125362875|NCT01543698|450963507|FG013|Phase 2|Administrative problems|3|||
125362876|NCT01543698|450963508|FG014|Phase 2|Administrative problems|1|||
125362877|NCT01543698|450963494|FG000|Phase 2|Withdrawal by Subject|0|||
125362878|NCT01543698|450963495|FG001|Phase 2|Withdrawal by Subject|0|||
125362879|NCT01543698|450963496|FG002|Phase 2|Withdrawal by Subject|0|||
125362880|NCT01543698|450963497|FG003|Phase 2|Withdrawal by Subject|0|||
125362881|NCT01543698|450963498|FG004|Phase 2|Withdrawal by Subject|0|||
125362882|NCT01543698|450963499|FG005|Phase 2|Withdrawal by Subject|0|||
125362883|NCT01543698|450963500|FG006|Phase 2|Withdrawal by Subject|0|||
125362884|NCT01543698|450963501|FG007|Phase 2|Withdrawal by Subject|0|||
125362885|NCT01543698|450963502|FG008|Phase 2|Withdrawal by Subject|0|||
125362886|NCT01543698|450963503|FG009|Phase 2|Withdrawal by Subject|0|||
125362887|NCT01543698|450963504|FG010|Phase 2|Withdrawal by Subject|0|||
125362888|NCT01543698|450963505|FG011|Phase 2|Withdrawal by Subject|0|||
125362889|NCT01543698|450963506|FG012|Phase 2|Withdrawal by Subject|0|||
125362890|NCT01543698|450963507|FG013|Phase 2|Withdrawal by Subject|3|||
125362891|NCT01543698|450963508|FG014|Phase 2|Withdrawal by Subject|1|||
125362892|NCT01543698|450963494|FG000|Phase 2|Adverse Event|0|||
125362893|NCT01543698|450963495|FG001|Phase 2|Adverse Event|0|||
125362894|NCT01543698|450963496|FG002|Phase 2|Adverse Event|0|||
125362895|NCT01543698|450963497|FG003|Phase 2|Adverse Event|0|||
125362896|NCT01543698|450963498|FG004|Phase 2|Adverse Event|0|||
125362897|NCT01543698|450963499|FG005|Phase 2|Adverse Event|0|||
125362898|NCT01543698|450963500|FG006|Phase 2|Adverse Event|0|||
125362899|NCT01543698|450963501|FG007|Phase 2|Adverse Event|0|||
125362900|NCT01543698|450963502|FG008|Phase 2|Adverse Event|0|||
125362901|NCT01543698|450963503|FG009|Phase 2|Adverse Event|0|||
125362902|NCT01543698|450963504|FG010|Phase 2|Adverse Event|0|||
125362903|NCT01543698|450963505|FG011|Phase 2|Adverse Event|1|||
125362904|NCT01543698|450963506|FG012|Phase 2|Adverse Event|3|||
125362905|NCT01543698|450963507|FG013|Phase 2|Adverse Event|5|||
125362906|NCT01543698|450963508|FG014|Phase 2|Adverse Event|14|||
125362907|NCT00150709|450963509|FG000|Overall Study|Protocol Violation|7|||
125362908|NCT00150709|450963510|FG001|Overall Study|Protocol Violation|8|||
125362909|NCT00150709|450963511|FG002|Overall Study|Protocol Violation|3|||
125362910|NCT00150709|450963512|FG003|Overall Study|Protocol Violation|1|||
125362911|NCT00150709|450963509|FG000|Overall Study|Adverse Event|8|||
125362912|NCT00150709|450963510|FG001|Overall Study|Adverse Event|2|||
125362913|NCT00150709|450963511|FG002|Overall Study|Adverse Event|2|||
125362914|NCT00150709|450963512|FG003|Overall Study|Adverse Event|3|||
125362915|NCT00150709|450963509|FG000|Overall Study|Lack of Efficacy|6|||
125362916|NCT00150709|450963510|FG001|Overall Study|Lack of Efficacy|11|||
125362917|NCT00150709|450963511|FG002|Overall Study|Lack of Efficacy|9|||
125362918|NCT00150709|450963512|FG003|Overall Study|Lack of Efficacy|0|||
125362919|NCT00150709|450963509|FG000|Overall Study|Withdrawal by Subject|7|||
125362920|NCT00150709|450963510|FG001|Overall Study|Withdrawal by Subject|10|||
125362921|NCT00150709|450963511|FG002|Overall Study|Withdrawal by Subject|5|||
125362922|NCT00150709|450963512|FG003|Overall Study|Withdrawal by Subject|0|||
125362923|NCT00150709|450963509|FG000|Overall Study|Lost to Follow-up|3|||
125362924|NCT00150709|450963510|FG001|Overall Study|Lost to Follow-up|2|||
125362925|NCT00150709|450963511|FG002|Overall Study|Lost to Follow-up|0|||
125362926|NCT00150709|450963512|FG003|Overall Study|Lost to Follow-up|0|||
125362927|NCT00150709|450963509|FG000|Overall Study|Sponsor decision|0|||
125362928|NCT00150709|450963510|FG001|Overall Study|Sponsor decision|0|||
125362929|NCT00150709|450963511|FG002|Overall Study|Sponsor decision|0|||
125362930|NCT00150709|450963512|FG003|Overall Study|Sponsor decision|1|||
125362931|NCT00150709|450963509|FG000|Overall Study|Site/Investigator discontinued the study|5|||
125212027|NCT01709409|450403246|FG001|Overall Study|Protocol Violation|0|||
125212028|NCT02412878|450403247|FG000|Overall Study|Withdrawal by Subject|19|||
125212029|NCT02412878|450403248|FG001|Overall Study|Withdrawal by Subject|10|||
125212030|NCT02412878|450403247|FG000|Overall Study|Lost to Follow-up|2|||
125212031|NCT02412878|450403248|FG001|Overall Study|Lost to Follow-up|3|||
125212032|NCT02190721|450403249|FG000|Overall Study|Patient was out of the city|0|||
125212033|NCT02190721|450403250|FG001|Overall Study|Patient was out of the city|1|||
125212034|NCT02190721|450403251|FG002|Overall Study|Patient was out of the city|0|||
125212035|NCT05025332|450403252|FG000|Screening|Screen failure|12|||
125212036|NCT05025332|450403252|FG000|Treatment & Follow Up|Protocol Violation|1|||
125212037|NCT05025332|450403252|FG000|Treatment & Follow Up|Adverse Event|4|||
125212038|NCT01306214|450403253|FG000|Overall Study|Death|0|||
125212039|NCT01306214|450403254|FG001|Overall Study|Death|0|||
125212040|NCT01306214|450403255|FG002|Overall Study|Death|1|||
125362932|NCT00150709|450963510|FG001|Overall Study|Site/Investigator discontinued the study|5|||
125362933|NCT00150709|450963511|FG002|Overall Study|Site/Investigator discontinued the study|2|||
125589885|NCT01307423|451781082|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
125589886|NCT01307423|451781074|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
125589887|NCT01307423|451781075|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
125589888|NCT01307423|451781076|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
125589889|NCT01307423|451781077|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
125589890|NCT01307423|451781078|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
125589891|NCT01307423|451781079|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
125589892|NCT01307423|451781080|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
125589893|NCT01307423|451781081|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
125589894|NCT01307423|451781082|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
125589895|NCT01307423|451781074|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125589896|NCT01307423|451781075|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125589897|NCT01307423|451781076|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125589898|NCT01307423|451781077|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125589899|NCT01307423|451781078|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125589900|NCT01307423|451781079|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
125589901|NCT01307423|451781080|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125589902|NCT01307423|451781081|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125589903|NCT01307423|451781082|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
125589904|NCT01307423|451781074|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
125589905|NCT01307423|451781075|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
125589906|NCT01307423|451781076|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
125589907|NCT01307423|451781077|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
125589908|NCT01307423|451781078|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
125589909|NCT01307423|451781079|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
125589910|NCT01307423|451781080|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
125589911|NCT01307423|451781081|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
125589912|NCT01307423|451781082|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
125589913|NCT01307423|451781074|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125589914|NCT01307423|451781075|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125589915|NCT01307423|451781076|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125589916|NCT01307423|451781077|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
125212041|NCT01306214|450403253|FG000|Overall Study|Lost to Follow-up|3|||
125212042|NCT01306214|450403254|FG001|Overall Study|Lost to Follow-up|5|||
125212043|NCT01306214|450403255|FG002|Overall Study|Lost to Follow-up|4|||
125212044|NCT01306214|450403253|FG000|Overall Study|Withdrawal by Subject|24|||
125362934|NCT00150709|450963512|FG003|Overall Study|Site/Investigator discontinued the study|0|||
125362935|NCT00150709|450963509|FG000|Overall Study|Decision of parent(s)|1|||
125212045|NCT01306214|450403254|FG001|Overall Study|Withdrawal by Subject|22|||
125362936|NCT00150709|450963510|FG001|Overall Study|Decision of parent(s)|2|||
125362937|NCT00150709|450963511|FG002|Overall Study|Decision of parent(s)|0|||
125362938|NCT00150709|450963512|FG003|Overall Study|Decision of parent(s)|0|||
125362939|NCT00150709|450963509|FG000|Overall Study|Decision of parent(s) and investigator|3|||
125362940|NCT00150709|450963510|FG001|Overall Study|Decision of parent(s) and investigator|0|||
125362941|NCT00150709|450963511|FG002|Overall Study|Decision of parent(s) and investigator|0|||
125362942|NCT00150709|450963512|FG003|Overall Study|Decision of parent(s) and investigator|0|||
125212046|NCT01306214|450403255|FG002|Overall Study|Withdrawal by Subject|16|||
125212047|NCT01306214|450403253|FG000|Overall Study|Not treated|1|||
125212048|NCT01306214|450403254|FG001|Overall Study|Not treated|1|||
125362943|NCT00150709|450963509|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
125362944|NCT00150709|450963510|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
125436538|NCT02597933|451224423|FG001|Overall Study|Adverse Event|28|||
125589917|NCT01307423|451781078|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125589918|NCT01307423|451781079|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125589919|NCT01307423|451781080|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125589920|NCT01307423|451781081|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125589921|NCT01307423|451781082|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
125589922|NCT01307423|451781074|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
125589923|NCT01307423|451781075|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
125589924|NCT01307423|451781076|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
125589925|NCT01307423|451781077|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
125589926|NCT01307423|451781078|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
125589927|NCT01307423|451781079|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
125589928|NCT01307423|451781080|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
125589929|NCT01307423|451781081|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
125589930|NCT01307423|451781082|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
125589931|NCT01307423|451781074|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125589932|NCT01307423|451781075|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125589933|NCT01307423|451781076|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125589934|NCT01307423|451781077|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125589935|NCT01307423|451781078|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125589936|NCT01307423|451781079|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
125589937|NCT01307423|451781080|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125589938|NCT01307423|451781081|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125589939|NCT01307423|451781082|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
125589940|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125589941|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
125589942|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
125589943|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125589944|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125589945|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125589946|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
125589947|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
125589948|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
125589949|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125589950|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
125589951|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
125589952|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125589953|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125589954|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125362945|NCT00150709|450963511|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
125589955|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
125589956|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
125589957|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
125589958|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125212049|NCT01306214|450403255|FG002|Overall Study|Not treated|1|||
125212050|NCT01928199|450403258|FG000|Overall Study|Lost to Follow-up|2|||
125212051|NCT01928199|450403259|FG001|Overall Study|Lost to Follow-up|1|||
125212052|NCT01928199|450403258|FG000|Overall Study|Withdrawal by Subject|3|||
125212053|NCT01928199|450403259|FG001|Overall Study|Withdrawal by Subject|5|||
125212054|NCT03959488|450403260|FG000|Season 1|Other|6|||
125212055|NCT03959488|450403261|FG001|Season 1|Other|7|||
125212056|NCT03959488|450403262|FG002|Season 1|Other|0|||
125212057|NCT03959488|450403263|FG003|Season 1|Other|0|||
125212058|NCT03959488|450403264|FG004|Season 1|Other|0|||
125212059|NCT03959488|450403260|FG000|Season 1|Withdrawal by parent/guardian|43|||
125212060|NCT03959488|450403261|FG001|Season 1|Withdrawal by parent/guardian|28|||
125212061|NCT03959488|450403262|FG002|Season 1|Withdrawal by parent/guardian|0|||
125212062|NCT03959488|450403263|FG003|Season 1|Withdrawal by parent/guardian|0|||
125212063|NCT03959488|450403264|FG004|Season 1|Withdrawal by parent/guardian|0|||
125212064|NCT03959488|450403260|FG000|Season 1|Due to COVID-19 pandemic|2|||
125212065|NCT03959488|450403261|FG001|Season 1|Due to COVID-19 pandemic|3|||
125212066|NCT03959488|450403262|FG002|Season 1|Due to COVID-19 pandemic|0|||
125212067|NCT03959488|450403263|FG003|Season 1|Due to COVID-19 pandemic|0|||
125212068|NCT03959488|450403264|FG004|Season 1|Due to COVID-19 pandemic|0|||
125212069|NCT03959488|450403260|FG000|Season 1|Lost to Follow-up|17|||
125212070|NCT03959488|450403261|FG001|Season 1|Lost to Follow-up|7|||
125212071|NCT03959488|450403262|FG002|Season 1|Lost to Follow-up|0|||
125212072|NCT03959488|450403263|FG003|Season 1|Lost to Follow-up|0|||
125212073|NCT03959488|450403264|FG004|Season 1|Lost to Follow-up|0|||
125362946|NCT00150709|450963512|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
125362947|NCT00150709|450963509|FG000|Overall Study|Investigator decision|1|||
125589959|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125589960|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
125589961|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125589962|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125589963|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125589964|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125589965|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125589966|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
125212074|NCT03959488|450403260|FG000|Season 1|Death|5|||
125212075|NCT03959488|450403261|FG001|Season 1|Death|1|||
125212076|NCT03959488|450403262|FG002|Season 1|Death|0|||
125212077|NCT03959488|450403263|FG003|Season 1|Death|0|||
125212078|NCT03959488|450403264|FG004|Season 1|Death|0|||
125212079|NCT03959488|450403260|FG000|Season 2|Other|0|||
125212080|NCT03959488|450403261|FG001|Season 2|Other|0|||
125212081|NCT03959488|450403262|FG002|Season 2|Other|2|||
125362948|NCT00150709|450963510|FG001|Overall Study|Investigator decision|0|||
125212082|NCT03959488|450403263|FG003|Season 2|Other|0|||
125429247|NCT02496767|451196631|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
125429248|NCT02496767|451196632|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
125429249|NCT02496767|451196633|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
125429250|NCT02496767|451196634|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
125429251|NCT02496767|451196627|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125429252|NCT02496767|451196628|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
125429253|NCT02496767|451196629|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
125429254|NCT02496767|451196630|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
125429255|NCT02496767|451196631|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
125429256|NCT02496767|451196632|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125429257|NCT02496767|451196633|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125429258|NCT02496767|451196634|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125429259|NCT02496767|451196627|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125429260|NCT02496767|451196628|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
125429261|NCT02496767|451196629|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
125429262|NCT02496767|451196630|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125429263|NCT02496767|451196631|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125429264|NCT02496767|451196632|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125429265|NCT02496767|451196633|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125429266|NCT02496767|451196634|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
125429267|NCT02496767|451196627|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125429268|NCT02496767|451196628|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
125429269|NCT02496767|451196629|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125429270|NCT02496767|451196630|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
125429271|NCT02496767|451196631|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
125429272|NCT02496767|451196632|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125429273|NCT02496767|451196633|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125429274|NCT02496767|451196634|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125429275|NCT02496767|451196627|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125429276|NCT02496767|451196628|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
125429277|NCT02496767|451196629|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125436539|NCT02597933|451224422|FG000|Overall Study|Not treated|2|||
125212083|NCT03959488|450403264|FG004|Season 2|Other|0|||
125362949|NCT00150709|450963511|FG002|Overall Study|Investigator decision|0|||
125362950|NCT00150709|450963512|FG003|Overall Study|Investigator decision|1|||
125362951|NCT00150709|450963509|FG000|Overall Study|Subject relocated|2|||
125362952|NCT00150709|450963510|FG001|Overall Study|Subject relocated|2|||
125589967|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125589968|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
125589969|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
125589970|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125589971|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125589972|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125589973|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125589974|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
125589975|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
125589976|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125589977|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
125589978|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125589979|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125589980|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125589981|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125589982|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
125589983|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
125589984|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
125589985|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125589986|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
125589987|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
125589988|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125589989|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125589990|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125589991|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
125589992|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
125589993|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
125589994|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125589995|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
125589996|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
125589997|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125589998|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125589999|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125590000|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
125590001|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
125590002|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
125590003|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125590004|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
125590005|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
125362953|NCT00150709|450963511|FG002|Overall Study|Subject relocated|1|||
125362954|NCT00150709|450963512|FG003|Overall Study|Subject relocated|0|||
125362955|NCT00150709|450963509|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
125590006|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125590007|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125590008|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125590009|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125590010|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125590011|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
125590012|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125590013|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
125590014|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
125590015|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125362956|NCT00150709|450963510|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
125362957|NCT00150709|450963511|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
125590016|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125590017|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125590018|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125590019|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
125590020|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
125590021|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125590022|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
125590023|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
125590024|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125590025|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125429278|NCT02496767|451196630|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125590026|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125590027|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
125590028|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
125590029|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
125590030|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125590031|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
125590032|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125590033|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125590034|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125590035|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125590036|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125590037|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
125590038|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
125590039|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125590040|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
125590041|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125590042|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125590043|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125590044|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125590045|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125590046|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125590047|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
125590048|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125590049|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
125429279|NCT02496767|451196631|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125590050|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125590051|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125590052|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125590053|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125590054|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125590055|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
125590056|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
125590057|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125590058|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
125590059|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
125590060|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125590061|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125590062|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125590063|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125590064|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
125590065|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
125590066|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125590067|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125590068|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
125590069|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125590070|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125590071|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125590072|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125590073|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125590074|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
125590075|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125590076|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125590077|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125590078|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125590079|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125590080|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125590081|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125590082|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
125590083|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
125590084|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125590085|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
125590086|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
125590087|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125590088|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125590089|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125590090|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125590091|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
125590092|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
125590093|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125429280|NCT02496767|451196632|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125590094|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
125590095|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
125590096|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125590097|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125590098|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125590099|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125590100|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125590101|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
125590102|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125590103|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
125362958|NCT00150709|450963512|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
125362959|NCT00150709|450963509|FG000|Overall Study|Convenience|0|||
125362960|NCT00150709|450963510|FG001|Overall Study|Convenience|1|||
125362961|NCT00150709|450963511|FG002|Overall Study|Convenience|0|||
125362962|NCT00150709|450963512|FG003|Overall Study|Convenience|0|||
125362963|NCT00150709|450963509|FG000|Overall Study|Subject entered new drug study|0|||
125590104|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
125590105|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125590106|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125362964|NCT00150709|450963510|FG001|Overall Study|Subject entered new drug study|1|||
125590107|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125590108|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125590109|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125590110|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
125590111|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125590112|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
125590113|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125590114|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125590115|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125590116|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125590117|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125590118|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125590119|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
125590120|NCT01307423|451781074|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125590121|NCT01307423|451781075|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125590122|NCT01307423|451781076|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
125590123|NCT01307423|451781077|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125590124|NCT01307423|451781078|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125590125|NCT01307423|451781079|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125590126|NCT01307423|451781080|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
125590127|NCT01307423|451781081|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
125590128|NCT01307423|451781082|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
125362965|NCT00150709|450963511|FG002|Overall Study|Subject entered new drug study|0|||
125362966|NCT00150709|450963512|FG003|Overall Study|Subject entered new drug study|0|||
125362967|NCT00150709|450963509|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
125362968|NCT00150709|450963510|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
125362969|NCT00150709|450963511|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
125362970|NCT00150709|450963512|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
125362971|NCT00150709|450963509|FG000|Overall Study|Lack of ease of swallowing|0|||
125362972|NCT00150709|450963510|FG001|Overall Study|Lack of ease of swallowing|1|||
125362973|NCT00150709|450963511|FG002|Overall Study|Lack of ease of swallowing|0|||
125362974|NCT00150709|450963512|FG003|Overall Study|Lack of ease of swallowing|0|||
125362975|NCT02975336|450963513|FG000|DBPC (52 Weeks)|Adverse Event|16|||
125362976|NCT02975336|450963514|FG001|DBPC (52 Weeks)|Adverse Event|17|||
125362977|NCT02975336|450963515|FG002|DBPC (52 Weeks)|Adverse Event|13|||
125362978|NCT02975336|450963516|FG003|DBPC (52 Weeks)|Adverse Event|18|||
125362979|NCT02975336|450963517|FG004|DBPC (52 Weeks)|Adverse Event|0|||
125362980|NCT02975336|450963518|FG005|DBPC (52 Weeks)|Adverse Event|0|||
125362981|NCT02975336|450963519|FG006|DBPC (52 Weeks)|Adverse Event|0|||
125362982|NCT02975336|450963520|FG007|DBPC (52 Weeks)|Adverse Event|0|||
125362983|NCT02975336|450963513|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
125362984|NCT02975336|450963514|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
125362985|NCT02975336|450963515|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
125362986|NCT02975336|450963516|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
125362987|NCT02975336|450963517|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
125362988|NCT02975336|450963518|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
125590129|NCT03896295|451781083|FG000|Overall Study|Adverse Event|0|||
125590130|NCT03896295|451781084|FG001|Overall Study|Adverse Event|1|||
125590131|NCT03896295|451781083|FG000|Overall Study|COVID-19|7|||
125590132|NCT03896295|451781084|FG001|Overall Study|COVID-19|29|||
125590133|NCT00700804|451781085|FG000|Overall Study|Withdrawal by Subject|1|||
125590134|NCT00700804|451781086|FG001|Overall Study|Withdrawal by Subject|2|||
125590135|NCT00700804|451781085|FG000|Overall Study|Protocol Violation|1|||
125590136|NCT00700804|451781086|FG001|Overall Study|Protocol Violation|1|||
125590137|NCT00700804|451781085|FG000|Overall Study|Loose Stools|1|||
125590138|NCT00700804|451781086|FG001|Overall Study|Loose Stools|1|||
125590139|NCT01511445|451781087|FG000|Overall Study|Lost to Follow-up|3|||
125590140|NCT01511445|451781088|FG001|Overall Study|Lost to Follow-up|1|||
125590141|NCT01511445|451781087|FG000|Overall Study|Protocol Violation|1|||
125590142|NCT01511445|451781088|FG001|Overall Study|Protocol Violation|3|||
125590143|NCT01511445|451781087|FG000|Overall Study|Protocol Violation|1|||
125590144|NCT01511445|451781088|FG001|Overall Study|Protocol Violation|0|||
125590145|NCT04696861|451781089|FG000|Overall Study|Death|1|||
125590146|NCT04696861|451781090|FG001|Overall Study|Death|0|||
125590147|NCT04696861|451781089|FG000|Overall Study|Lost to Follow-up|3|||
125590148|NCT04696861|451781090|FG001|Overall Study|Lost to Follow-up|0|||
125590149|NCT02382133|451781091|FG000|Overall Study|Death|22|||
125590150|NCT02382133|451781091|FG000|Overall Study|transfer out of ICU|4|||
125590151|NCT02382133|451781091|FG000|Overall Study|Physician Decision|2|||
125590152|NCT02382133|451781091|FG000|Overall Study|arterial catheter loss|4|||
125590153|NCT02382133|451781091|FG000|Overall Study|pressure injury both sites|1|||
125590154|NCT00655928|451781092|FG000|Overall Study|Withdrawal by Subject|2|||
125590155|NCT00655928|451781093|FG001|Overall Study|Withdrawal by Subject|1|||
125590156|NCT00655928|451781092|FG000|Overall Study|Physician Decision|1|||
125590157|NCT00655928|451781093|FG001|Overall Study|Physician Decision|1|||
125590158|NCT03946449|451781100|FG000|Treatment Extension II|Rolled over to another study|0|||
125590159|NCT03946449|451781101|FG001|Treatment Extension II|Rolled over to another study|0|||
125590160|NCT03946449|451781102|FG002|Treatment Extension II|Rolled over to another study|2|||
125590161|NCT03946449|451781100|FG000|Treatment Extension II|Withdrawal by Subject|0|||
125590162|NCT03946449|451781101|FG001|Treatment Extension II|Withdrawal by Subject|0|||
125590163|NCT03946449|451781102|FG002|Treatment Extension II|Withdrawal by Subject|1|||
125590164|NCT01609933|451784001|FG000|Overall Study|Adverse Event|1|||
125590165|NCT01609933|451784001|FG000|Overall Study|Withdrawal by Subject|3|||
125590166|NCT00224016|451784002|FG000|Titration Period|Withdrawal by Subject|0|||
125590167|NCT00224016|451784003|FG001|Titration Period|Withdrawal by Subject|1|||
125590168|NCT00224016|451784002|FG000|Titration Period|Lost to Follow-up|1|||
125590169|NCT00224016|451784003|FG001|Titration Period|Lost to Follow-up|0|||
125590170|NCT00224016|451784002|FG000|Maintenance Period|Withdrawal by Subject|2|||
125590171|NCT00224016|451784003|FG001|Maintenance Period|Withdrawal by Subject|0|||
125590172|NCT00224016|451784002|FG000|Maintenance Period|Lost to Follow-up|0|||
125590173|NCT00224016|451784003|FG001|Maintenance Period|Lost to Follow-up|1|||
125590174|NCT01252966|451784004|FG000|Overall Study|Lost to Follow-up|16|||
125590175|NCT01252966|451784005|FG001|Overall Study|Lost to Follow-up|10|||
125590176|NCT01252966|451784004|FG000|Overall Study|Withdrawal by Subject|7|||
125590177|NCT01252966|451784005|FG001|Overall Study|Withdrawal by Subject|3|||
125590178|NCT00206726|451784012|FG000|Overall Study|Delayed recovery of blood counts|1|||
125590179|NCT00206726|451784012|FG000|Overall Study|Progressive disease or relapsed disease|18|||
125590180|NCT00206726|451784012|FG000|Overall Study|Placed on new protocol|1|||
125590181|NCT00206726|451784012|FG000|Overall Study|Bone marrow transplant|1|||
125590182|NCT00206726|451784012|FG000|Overall Study|Adverse Event|17|||
125590183|NCT00206726|451784012|FG000|Overall Study|Death|4|||
125590184|NCT00206726|451784012|FG000|Overall Study|Protocol Violation|1|||
125590185|NCT00206726|451784012|FG000|Overall Study|Withdrawal by Subject|8|||
125590186|NCT01028352|451784015|FG000|Overall Study|Ineligible due to baseline average pain|5|||
125590187|NCT01028352|451784015|FG000|Overall Study|Withdrawal by Subject|1|||
125590188|NCT00768222|451784016|FG000|Overall Study|Lost to Follow-up|1|||
125590189|NCT00768222|451784017|FG001|Overall Study|Lost to Follow-up|1|||
125590190|NCT00768222|451784016|FG000|Overall Study|Withdrawal by Subject|3|||
125590191|NCT00768222|451784017|FG001|Overall Study|Withdrawal by Subject|1|||
125590192|NCT00768222|451784016|FG000|Overall Study|Protocol Violation|0|||
125590193|NCT00768222|451784017|FG001|Overall Study|Protocol Violation|2|||
125590194|NCT02468193|451784018|FG000|Overall Study|Adverse Event|4|||
125590195|NCT02468193|451784018|FG000|Overall Study|Subject/ Guardian decision|2|||
125590196|NCT03312218|451784019|FG000|Overall Study|Never signed in to access the app|54|||
125590197|NCT03312218|451784020|FG001|Overall Study|Never signed in to access the app|58|||
125590198|NCT01887912|451784021|FG000|Overall Study|Serious adverse event|400|||
125590199|NCT01887912|451784022|FG001|Overall Study|Serious adverse event|198|||
125590200|NCT01887912|451784021|FG000|Overall Study|Other Adverse Event|34|||
125590201|NCT01887912|451784022|FG001|Overall Study|Other Adverse Event|15|||
125590202|NCT01887912|451784021|FG000|Overall Study|Protocol Violation|67|||
125590203|NCT01887912|451784022|FG001|Overall Study|Protocol Violation|37|||
125590204|NCT01887912|451784021|FG000|Overall Study|Lost to Follow-up|163|||
125590205|NCT01887912|451784022|FG001|Overall Study|Lost to Follow-up|74|||
125590206|NCT01887912|451784021|FG000|Overall Study|Withdrawal by Subject|606|||
125590207|NCT01887912|451784022|FG001|Overall Study|Withdrawal by Subject|349|||
125590208|NCT01887912|451784021|FG000|Overall Study|Other|122|||
125590209|NCT01887912|451784022|FG001|Overall Study|Other|58|||
125590210|NCT05067127|451784025|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
125590211|NCT05067127|451784026|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
125590212|NCT05067127|451784027|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
125590213|NCT05067127|451784028|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
125590214|NCT05067127|451784025|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
125590215|NCT05067127|451784026|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
125590216|NCT05067127|451784027|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
125590217|NCT05067127|451784028|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
125590218|NCT05067127|451784025|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
125590219|NCT05067127|451784026|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
125590220|NCT05067127|451784027|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
125590221|NCT05067127|451784028|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
125590222|NCT05067127|451784025|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
125590223|NCT05067127|451784026|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
125590224|NCT05067127|451784027|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
125590225|NCT05067127|451784028|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
125590226|NCT05067127|451784025|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
125590227|NCT05067127|451784026|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
125590228|NCT05067127|451784027|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
125590229|NCT05067127|451784028|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
125590230|NCT05067127|451784025|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
125590231|NCT05067127|451784026|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
125590232|NCT05067127|451784027|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
125590233|NCT05067127|451784028|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
125590234|NCT05067127|451784025|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
125590235|NCT05067127|451784026|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
125590236|NCT05067127|451784027|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
125590237|NCT05067127|451784028|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
125590238|NCT04462536|451784029|FG000|Overall Study|Withdrawal by Subject|3|||
125590239|NCT04462536|451784030|FG001|Overall Study|Withdrawal by Subject|9|||
125590240|NCT04462536|451784029|FG000|Overall Study|Lost to Follow-up|2|||
125590241|NCT04462536|451784030|FG001|Overall Study|Lost to Follow-up|4|||
125590242|NCT01154101|451784036|FG000|Overall Study|Adverse Event|0|||
125590243|NCT01154101|451784037|FG001|Overall Study|Adverse Event|2|||
125590244|NCT01154101|451784038|FG002|Overall Study|Adverse Event|1|||
125590245|NCT01154101|451784039|FG003|Overall Study|Adverse Event|1|||
125590246|NCT01154101|451784040|FG004|Overall Study|Adverse Event|0|||
125590247|NCT01154101|451784036|FG000|Overall Study|Lost to Follow-up|0|||
125590248|NCT01154101|451784037|FG001|Overall Study|Lost to Follow-up|1|||
125590249|NCT01154101|451784038|FG002|Overall Study|Lost to Follow-up|0|||
125590250|NCT01154101|451784039|FG003|Overall Study|Lost to Follow-up|1|||
125590251|NCT01154101|451784040|FG004|Overall Study|Lost to Follow-up|0|||
125590252|NCT01154101|451784036|FG000|Overall Study|Withdrawal by Subject|0|||
125590253|NCT01154101|451784037|FG001|Overall Study|Withdrawal by Subject|1|||
125590254|NCT01154101|451784038|FG002|Overall Study|Withdrawal by Subject|2|||
125590255|NCT01154101|451784039|FG003|Overall Study|Withdrawal by Subject|0|||
125590256|NCT01154101|451784040|FG004|Overall Study|Withdrawal by Subject|1|||
125362989|NCT02975336|450963519|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
125590257|NCT04125680|451784042|FG000|Overall Study|Lost to Follow-up|15|||
125590258|NCT01562028|451784043|FG000|Overall Study|Withdrawal by Subject|1|||
125590259|NCT01562028|451784044|FG001|Overall Study|Withdrawal by Subject|1|||
125590260|NCT01562028|451784043|FG000|Overall Study|Lost to Follow-up|2|||
125590261|NCT01562028|451784044|FG001|Overall Study|Lost to Follow-up|1|||
125590262|NCT02360098|451784045|FG000|Overall Study|Physician Decision|7|||
125590263|NCT04439266|451784056|FG000|Overall Study|Ineligible|1|||
125590264|NCT04439266|451784056|FG000|Overall Study|Adverse Event|1|||
125590265|NCT04439266|451784056|FG000|Overall Study|Death|1|||
125590266|NCT04439266|451784056|FG000|Overall Study|Disease progression|1|||
125590267|NCT04439266|451784056|FG000|Overall Study|Still on treatment|1|||
125590268|NCT05040971|451784059|FG000|Overall Study|Withdrawal by Subject|0|||
125590269|NCT05040971|451784060|FG001|Overall Study|Withdrawal by Subject|2|||
125590270|NCT05040971|451784059|FG000|Overall Study|Lost to Follow-up|8|||
125590271|NCT05040971|451784060|FG001|Overall Study|Lost to Follow-up|3|||
125590272|NCT05040971|451784059|FG000|Overall Study|Death|2|||
125590273|NCT05040971|451784060|FG001|Overall Study|Death|0|||
125590274|NCT06161012|451784061|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
125590275|NCT06161012|451784062|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
125590276|NCT02601950|451784063|FG000|Overall Study|Participant enrolled in rollover study|0|||
125590277|NCT02601950|451784064|FG001|Overall Study|Participant enrolled in rollover study|0|||
125590278|NCT02601950|451784065|FG002|Overall Study|Participant enrolled in rollover study|1|||
125429281|NCT02496767|451196633|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125429282|NCT02496767|451196634|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
125429283|NCT02496767|451196627|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
125429284|NCT02496767|451196628|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
125590279|NCT02601950|451784066|FG003|Overall Study|Participant enrolled in rollover study|0|||
125590280|NCT02601950|451784067|FG004|Overall Study|Participant enrolled in rollover study|1|||
125590281|NCT02601950|451784068|FG005|Overall Study|Participant enrolled in rollover study|1|||
125590282|NCT02601950|451784069|FG006|Overall Study|Participant enrolled in rollover study|1|||
125590283|NCT02601950|451784070|FG007|Overall Study|Participant enrolled in rollover study|0|||
125590284|NCT02601950|451784063|FG000|Overall Study|Disease progression - radiological|21|||
125590285|NCT02601950|451784064|FG001|Overall Study|Disease progression - radiological|26|||
125590286|NCT02601950|451784065|FG002|Overall Study|Disease progression - radiological|22|||
125590287|NCT02601950|451784066|FG003|Overall Study|Disease progression - radiological|11|||
125590288|NCT02601950|451784067|FG004|Overall Study|Disease progression - radiological|46|||
125590289|NCT02601950|451784068|FG005|Overall Study|Disease progression - radiological|52|||
125590290|NCT02601950|451784069|FG006|Overall Study|Disease progression - radiological|7|||
125590291|NCT02601950|451784070|FG007|Overall Study|Disease progression - radiological|5|||
125590292|NCT02601950|451784063|FG000|Overall Study|Disease progression - clinical|3|||
125590293|NCT02601950|451784064|FG001|Overall Study|Disease progression - clinical|5|||
125590294|NCT02601950|451784065|FG002|Overall Study|Disease progression - clinical|4|||
125590295|NCT02601950|451784066|FG003|Overall Study|Disease progression - clinical|2|||
125590296|NCT02601950|451784067|FG004|Overall Study|Disease progression - clinical|6|||
125590297|NCT02601950|451784068|FG005|Overall Study|Disease progression - clinical|6|||
125590298|NCT02601950|451784069|FG006|Overall Study|Disease progression - clinical|5|||
125590299|NCT02601950|451784070|FG007|Overall Study|Disease progression - clinical|1|||
125590300|NCT02601950|451784063|FG000|Overall Study|Death|6|||
125590301|NCT02601950|451784064|FG001|Overall Study|Death|0|||
125590302|NCT02601950|451784065|FG002|Overall Study|Death|3|||
125436540|NCT02597933|451224423|FG001|Overall Study|Not treated|2|||
125590303|NCT02601950|451784066|FG003|Overall Study|Death|1|||
125590304|NCT02601950|451784067|FG004|Overall Study|Death|4|||
125590305|NCT02601950|451784068|FG005|Overall Study|Death|1|||
125590306|NCT02601950|451784069|FG006|Overall Study|Death|0|||
125590307|NCT02601950|451784070|FG007|Overall Study|Death|0|||
125590308|NCT02601950|451784063|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125590309|NCT02601950|451784064|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125590310|NCT02601950|451784065|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125590311|NCT02601950|451784066|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125362990|NCT02975336|450963520|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
125590312|NCT02601950|451784067|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125590313|NCT02601950|451784068|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
125590314|NCT02601950|451784069|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125590315|NCT02601950|451784070|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
125590316|NCT02601950|451784063|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
125590317|NCT02601950|451784064|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
125590318|NCT02601950|451784065|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
125590319|NCT02601950|451784066|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
125590320|NCT02601950|451784067|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
125590321|NCT02601950|451784068|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
125590322|NCT02601950|451784069|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
125590323|NCT02601950|451784070|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
125590324|NCT02601950|451784063|FG000|Overall Study|Non-compliance|0|||
125590325|NCT02601950|451784064|FG001|Overall Study|Non-compliance|1|||
125590326|NCT02601950|451784065|FG002|Overall Study|Non-compliance|0|||
125590327|NCT02601950|451784066|FG003|Overall Study|Non-compliance|0|||
125590328|NCT02601950|451784067|FG004|Overall Study|Non-compliance|0|||
125590329|NCT02601950|451784068|FG005|Overall Study|Non-compliance|1|||
125590330|NCT02601950|451784069|FG006|Overall Study|Non-compliance|1|||
125590331|NCT02601950|451784070|FG007|Overall Study|Non-compliance|0|||
125590332|NCT02601950|451784063|FG000|Overall Study|Participant refused further study treatment|0|||
125590333|NCT02601950|451784064|FG001|Overall Study|Participant refused further study treatment|1|||
125590334|NCT02601950|451784065|FG002|Overall Study|Participant refused further study treatment|1|||
125590335|NCT02601950|451784066|FG003|Overall Study|Participant refused further study treatment|0|||
125590336|NCT02601950|451784067|FG004|Overall Study|Participant refused further study treatment|2|||
125590337|NCT02601950|451784068|FG005|Overall Study|Participant refused further study treatment|2|||
125590338|NCT02601950|451784069|FG006|Overall Study|Participant refused further study treatment|2|||
125590339|NCT02601950|451784070|FG007|Overall Study|Participant refused further study treatment|1|||
125590340|NCT02601950|451784063|FG000|Overall Study|Investigator discretion|1|||
125590341|NCT02601950|451784064|FG001|Overall Study|Investigator discretion|0|||
125590342|NCT02601950|451784065|FG002|Overall Study|Investigator discretion|1|||
125590343|NCT02601950|451784066|FG003|Overall Study|Investigator discretion|0|||
125590344|NCT02601950|451784067|FG004|Overall Study|Investigator discretion|1|||
125590345|NCT02601950|451784068|FG005|Overall Study|Investigator discretion|1|||
125590346|NCT02601950|451784069|FG006|Overall Study|Investigator discretion|1|||
125590347|NCT02601950|451784070|FG007|Overall Study|Investigator discretion|0|||
125590348|NCT02601950|451784063|FG000|Overall Study|Other|0|||
125590349|NCT02601950|451784064|FG001|Overall Study|Other|0|||
125590350|NCT02601950|451784065|FG002|Overall Study|Other|0|||
125590351|NCT02601950|451784066|FG003|Overall Study|Other|0|||
125590352|NCT02601950|451784067|FG004|Overall Study|Other|2|||
125590353|NCT02601950|451784068|FG005|Overall Study|Other|2|||
125590354|NCT02601950|451784069|FG006|Overall Study|Other|1|||
125590355|NCT02601950|451784070|FG007|Overall Study|Other|0|||
125590356|NCT05817045|451784077|FG000|Overall Study|Protocol Violation|0|||
125590357|NCT05817045|451784078|FG001|Overall Study|Protocol Violation|3|||
125590358|NCT05817045|451784077|FG000|Overall Study|Withdrawal by Subject|10|||
125590359|NCT05817045|451784078|FG001|Overall Study|Withdrawal by Subject|7|||
125590360|NCT05817045|451784077|FG000|Overall Study|Physician Decision|3|||
125590361|NCT05817045|451784078|FG001|Overall Study|Physician Decision|0|||
125590362|NCT05817045|451784077|FG000|Overall Study|Lost to Follow-up|0|||
125590363|NCT05817045|451784078|FG001|Overall Study|Lost to Follow-up|1|||
125590364|NCT05817045|451784077|FG000|Overall Study|Device Deficiency|1|||
125590365|NCT05817045|451784078|FG001|Overall Study|Device Deficiency|0|||
125590366|NCT05817045|451784077|FG000|Overall Study|System Error|1|||
125590367|NCT05817045|451784078|FG001|Overall Study|System Error|0|||
125590368|NCT04889209|451784079|FG000|All Cohorts Except 15E|Adverse Event|0|||
125590369|NCT04889209|451784080|FG001|All Cohorts Except 15E|Adverse Event|0|||
125590370|NCT04889209|451784081|FG002|All Cohorts Except 15E|Adverse Event|0|||
125590371|NCT04889209|451784082|FG003|All Cohorts Except 15E|Adverse Event|0|||
125362991|NCT02975336|450963513|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
125362992|NCT02975336|450963514|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
125362993|NCT02975336|450963515|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
125362994|NCT02975336|450963516|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
125362995|NCT02975336|450963517|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
125362996|NCT02975336|450963518|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
125362997|NCT02975336|450963519|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
125362998|NCT02975336|450963520|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
125362999|NCT02975336|450963513|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
125363000|NCT02975336|450963514|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
125363001|NCT02975336|450963515|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
125363002|NCT02975336|450963516|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
125363003|NCT02975336|450963517|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
125363004|NCT02975336|450963518|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
125363005|NCT02975336|450963519|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
125363006|NCT02975336|450963520|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
125363007|NCT02975336|450963513|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
125363008|NCT02975336|450963514|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
125363009|NCT02975336|450963515|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
125363010|NCT02975336|450963516|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
125363011|NCT02975336|450963517|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
125363012|NCT02975336|450963518|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
125363013|NCT02975336|450963519|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
125429285|NCT02496767|451196629|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
125429286|NCT02496767|451196630|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
125429287|NCT02496767|451196631|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
125429288|NCT02496767|451196632|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
125429289|NCT02496767|451196633|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
125429290|NCT02496767|451196634|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
125429291|NCT02496767|451196627|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
125429292|NCT02496767|451196628|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
125429293|NCT02496767|451196629|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
125363014|NCT02975336|450963520|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
125363015|NCT02975336|450963513|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
125363016|NCT02975336|450963514|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
125363017|NCT02975336|450963515|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
125363018|NCT02975336|450963516|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
125363019|NCT02975336|450963517|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
125363020|NCT02975336|450963518|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
125363021|NCT02975336|450963519|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
125363022|NCT02975336|450963520|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
125363023|NCT02975336|450963513|FG000|LTE (104 Weeks)|Adverse Event|0|||
125363024|NCT02975336|450963514|FG001|LTE (104 Weeks)|Adverse Event|0|||
125363025|NCT02975336|450963515|FG002|LTE (104 Weeks)|Adverse Event|0|||
125363026|NCT02975336|450963516|FG003|LTE (104 Weeks)|Adverse Event|0|||
125363027|NCT02975336|450963517|FG004|LTE (104 Weeks)|Adverse Event|7|||
125363028|NCT02975336|450963518|FG005|LTE (104 Weeks)|Adverse Event|4|||
125429294|NCT02496767|451196630|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
125429295|NCT02496767|451196631|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
125429296|NCT02496767|451196632|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
125429297|NCT02496767|451196633|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
125429298|NCT02496767|451196634|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
125363029|NCT02975336|450963519|FG006|LTE (104 Weeks)|Adverse Event|2|||
125363030|NCT02975336|450963520|FG007|LTE (104 Weeks)|Adverse Event|0|||
125363031|NCT02975336|450963513|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
125363032|NCT02975336|450963514|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
125363033|NCT02975336|450963515|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
125363034|NCT02975336|450963516|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
125429299|NCT02496767|451196627|FG000|Double-blind, Withdrawal Phase|Death|0|||
125590372|NCT04889209|451784083|FG004|All Cohorts Except 15E|Adverse Event|0|||
125590373|NCT04889209|451784084|FG005|All Cohorts Except 15E|Adverse Event|0|||
125429300|NCT02496767|451196628|FG001|Double-blind, Withdrawal Phase|Death|0|||
125429301|NCT02496767|451196629|FG002|Double-blind, Withdrawal Phase|Death|0|||
125590374|NCT04889209|451784085|FG006|All Cohorts Except 15E|Adverse Event|1|||
125590375|NCT04889209|451784086|FG007|All Cohorts Except 15E|Adverse Event|0|||
125590376|NCT04889209|451784087|FG008|All Cohorts Except 15E|Adverse Event|0|||
125590377|NCT04889209|451784088|FG009|All Cohorts Except 15E|Adverse Event|0|||
125590378|NCT04889209|451784089|FG010|All Cohorts Except 15E|Adverse Event|0|||
125590379|NCT04889209|451784090|FG011|All Cohorts Except 15E|Adverse Event|0|||
125590380|NCT04889209|451784091|FG012|All Cohorts Except 15E|Adverse Event|0|||
125429302|NCT02496767|451196630|FG003|Double-blind, Withdrawal Phase|Death|0|||
125429303|NCT02496767|451196631|FG004|Double-blind, Withdrawal Phase|Death|0|||
125429304|NCT02496767|451196632|FG005|Double-blind, Withdrawal Phase|Death|0|||
125429305|NCT02496767|451196633|FG006|Double-blind, Withdrawal Phase|Death|1|||
125590381|NCT04889209|451784092|FG013|All Cohorts Except 15E|Adverse Event|0|||
125590382|NCT04889209|451784093|FG014|All Cohorts Except 15E|Adverse Event|0|||
125590383|NCT04889209|451784094|FG015|All Cohorts Except 15E|Adverse Event|0|||
125590384|NCT04889209|451784095|FG016|All Cohorts Except 15E|Adverse Event|0|||
125590385|NCT04889209|451784096|FG017|All Cohorts Except 15E|Adverse Event|0|||
125590386|NCT04889209|451784079|FG000|All Cohorts Except 15E|Death|0|||
125363035|NCT02975336|450963517|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
125363036|NCT02975336|450963518|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
125363037|NCT02975336|450963519|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
125363038|NCT02975336|450963520|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
125363039|NCT02975336|450963513|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
125363040|NCT02975336|450963514|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
125363041|NCT02975336|450963515|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
125363042|NCT02975336|450963516|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
125363043|NCT02975336|450963517|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
125363044|NCT02975336|450963518|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
125363045|NCT02975336|450963519|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
125363046|NCT02975336|450963520|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
125363047|NCT02975336|450963513|FG000|LTE (104 Weeks)|Other|0|||
125363048|NCT02975336|450963514|FG001|LTE (104 Weeks)|Other|0|||
125363049|NCT02975336|450963515|FG002|LTE (104 Weeks)|Other|0|||
125363050|NCT02975336|450963516|FG003|LTE (104 Weeks)|Other|0|||
125363051|NCT02975336|450963517|FG004|LTE (104 Weeks)|Other|55|||
125363052|NCT02975336|450963518|FG005|LTE (104 Weeks)|Other|63|||
125363053|NCT02975336|450963519|FG006|LTE (104 Weeks)|Other|76|||
125363054|NCT02975336|450963520|FG007|LTE (104 Weeks)|Other|72|||
125363055|NCT01868503|450963521|FG000|Overall Study|Withdrawal by Subject|1|||
125363056|NCT01868503|450963521|FG000|Overall Study|Protocol Violation|1|||
125363057|NCT03650556|450963522|FG000|Overall Study|Death|2|||
125363058|NCT03650556|450963522|FG000|Overall Study|Withdrawal by Subject|20|||
125363059|NCT03650556|450963522|FG000|Overall Study|Physician Decision|2|||
125363060|NCT03650556|450963522|FG000|Overall Study|Lost to Follow-up|8|||
125363061|NCT03650556|450963522|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
125363062|NCT03650556|450963522|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
125363063|NCT00691301|450963523|FG000|Overall Study|Adverse Event|10|||
125363064|NCT00691301|450963523|FG000|Overall Study|Death|2|||
125363065|NCT00691301|450963523|FG000|Overall Study|Lack of Efficacy|32|||
125363066|NCT00691301|450963523|FG000|Overall Study|Withdrawal by Subject|4|||
125363067|NCT00691301|450963523|FG000|Overall Study|Concurrent illness|2|||
125363068|NCT00691301|450963523|FG000|Overall Study|other reason|3|||
125363069|NCT00691301|450963523|FG000|Overall Study|Did not initiate study treatment|1|||
125363070|NCT01823146|450963524|FG000|Overall Study|Withdrawal by Subject|0|||
125363071|NCT01823146|450963525|FG001|Overall Study|Withdrawal by Subject|1|||
125363072|NCT01823146|450963524|FG000|Overall Study|Lost to Follow-up|2|||
125363073|NCT01823146|450963525|FG001|Overall Study|Lost to Follow-up|1|||
125363074|NCT00463580|450963526|FG000|Overall Study|Lost to Follow-up|1|||
125363075|NCT00463580|450963527|FG001|Overall Study|Lost to Follow-up|0|||
125590387|NCT04889209|451784080|FG001|All Cohorts Except 15E|Death|1|||
125363076|NCT00463580|450963526|FG000|Overall Study|Schedule conflict|2|||
125363077|NCT00463580|450963527|FG001|Overall Study|Schedule conflict|0|||
125363078|NCT00463580|450963526|FG000|Overall Study|Medical/psychiatric complications|0|||
125363079|NCT00463580|450963527|FG001|Overall Study|Medical/psychiatric complications|2|||
125363080|NCT03917459|450963528|FG000|Overall Study|Adverse Event|1|||
125363081|NCT03917459|450963529|FG001|Overall Study|Adverse Event|0|||
125363082|NCT03917459|450963528|FG000|Overall Study|Withdrawal by Subject|0|||
125363083|NCT03917459|450963529|FG001|Overall Study|Withdrawal by Subject|1|||
125363084|NCT00697788|450963530|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125363085|NCT00697788|450963531|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
125363086|NCT00697788|450963532|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125429306|NCT02496767|451196634|FG007|Double-blind, Withdrawal Phase|Death|2|||
125590388|NCT04889209|451784081|FG002|All Cohorts Except 15E|Death|0|||
125590389|NCT04889209|451784082|FG003|All Cohorts Except 15E|Death|0|||
125363087|NCT00697788|450963533|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125363088|NCT00697788|450963534|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125363089|NCT00697788|450963535|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125363090|NCT00697788|450963536|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125363091|NCT00697788|450963537|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
125363092|NCT00697788|450963530|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
125363093|NCT00697788|450963531|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
125363094|NCT00697788|450963532|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
125363095|NCT00697788|450963533|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
125363096|NCT00697788|450963534|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
125363097|NCT00697788|450963535|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
125363098|NCT00697788|450963536|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
125363099|NCT00697788|450963537|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
125363100|NCT00075218|450963539|FG000|Double-Blind Treatment|Adverse Event|23|||
125363101|NCT00075218|450963540|FG001|Double-Blind Treatment|Adverse Event|4|||
125363102|NCT00075218|450963541|FG002|Double-Blind Treatment|Adverse Event|0|||
125363103|NCT00075218|450963539|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
125363104|NCT00075218|450963540|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
125363105|NCT00075218|450963541|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
125363106|NCT00075218|450963539|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
125363107|NCT00075218|450963540|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
125363108|NCT00075218|450963541|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
125363109|NCT00075218|450963539|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
125363110|NCT00075218|450963540|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
125363111|NCT00075218|450963541|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
125363112|NCT00075218|450963539|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
125363113|NCT00075218|450963540|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
125363114|NCT00075218|450963541|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
125363115|NCT00075218|450963539|FG000|Double-Blind Treatment|No study medication taken|2|||
125363116|NCT00075218|450963540|FG001|Double-Blind Treatment|No study medication taken|0|||
125363117|NCT00075218|450963541|FG002|Double-Blind Treatment|No study medication taken|0|||
125363118|NCT00075218|450963539|FG000|Open-Label Treatment|Lack of Efficacy|0|||
125363119|NCT00075218|450963540|FG001|Open-Label Treatment|Lack of Efficacy|0|||
125363120|NCT00075218|450963541|FG002|Open-Label Treatment|Lack of Efficacy|174|||
125363121|NCT00075218|450963539|FG000|Open-Label Treatment|Adverse Event|0|||
125363122|NCT00075218|450963540|FG001|Open-Label Treatment|Adverse Event|0|||
125363123|NCT00075218|450963541|FG002|Open-Label Treatment|Adverse Event|51|||
125363124|NCT00075218|450963539|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
125363125|NCT00075218|450963540|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
125363126|NCT00075218|450963541|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
125363127|NCT00075218|450963539|FG000|Open-Label Treatment|Decision of Sponsor|0|||
125363128|NCT00075218|450963540|FG001|Open-Label Treatment|Decision of Sponsor|0|||
125363129|NCT00075218|450963541|FG002|Open-Label Treatment|Decision of Sponsor|8|||
125363130|NCT00075218|450963539|FG000|Open-Label Treatment|Protocol Violation|0|||
125363131|NCT00075218|450963540|FG001|Open-Label Treatment|Protocol Violation|0|||
125363132|NCT00075218|450963541|FG002|Open-Label Treatment|Protocol Violation|1|||
125363133|NCT00075218|450963539|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
125363134|NCT00075218|450963540|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
125363135|NCT00075218|450963541|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
125363136|NCT00216476|450963542|FG000|Overall Study|Withdrawal by Subject|59|||
125363137|NCT00216476|450963543|FG001|Overall Study|Withdrawal by Subject|72|||
125363138|NCT00216476|450963544|FG002|Overall Study|Withdrawal by Subject|9|||
125363139|NCT00216476|450963542|FG000|Overall Study|Lost to Follow-up|10|||
125363140|NCT00216476|450963543|FG001|Overall Study|Lost to Follow-up|9|||
125363141|NCT00216476|450963544|FG002|Overall Study|Lost to Follow-up|1|||
125363142|NCT00216476|450963542|FG000|Overall Study|Adverse Event|6|||
125363143|NCT00216476|450963543|FG001|Overall Study|Adverse Event|10|||
125363144|NCT00216476|450963544|FG002|Overall Study|Adverse Event|1|||
125363145|NCT00216476|450963542|FG000|Overall Study|Lack of Efficacy|4|||
125363146|NCT00216476|450963543|FG001|Overall Study|Lack of Efficacy|3|||
125363147|NCT00216476|450963544|FG002|Overall Study|Lack of Efficacy|0|||
125590390|NCT04889209|451784083|FG004|All Cohorts Except 15E|Death|0|||
125590391|NCT04889209|451784084|FG005|All Cohorts Except 15E|Death|0|||
125363148|NCT00216476|450963542|FG000|Overall Study|Death|2|||
125363149|NCT00216476|450963543|FG001|Overall Study|Death|0|||
125363150|NCT00216476|450963544|FG002|Overall Study|Death|0|||
125363151|NCT00216476|450963542|FG000|Overall Study|Pregnancy|0|||
125363152|NCT00216476|450963543|FG001|Overall Study|Pregnancy|1|||
125363153|NCT00216476|450963544|FG002|Overall Study|Pregnancy|1|||
125363154|NCT00216476|450963542|FG000|Overall Study|Other|0|||
125363155|NCT00216476|450963543|FG001|Overall Study|Other|0|||
125363156|NCT00216476|450963544|FG002|Overall Study|Other|1|||
125363157|NCT00216476|450963542|FG000|Overall Study|Refuses Injection|11|||
125590392|NCT04889209|451784085|FG006|All Cohorts Except 15E|Death|0|||
125363158|NCT00216476|450963543|FG001|Overall Study|Refuses Injection|0|||
125363159|NCT00216476|450963544|FG002|Overall Study|Refuses Injection|0|||
125363160|NCT00216476|450963542|FG000|Overall Study|No Further Need for Treatment|3|||
125363161|NCT00216476|450963543|FG001|Overall Study|No Further Need for Treatment|4|||
125363162|NCT00216476|450963544|FG002|Overall Study|No Further Need for Treatment|1|||
125363163|NCT00216476|450963542|FG000|Overall Study|Non-compliance|0|||
125363164|NCT00216476|450963543|FG001|Overall Study|Non-compliance|4|||
125363165|NCT00216476|450963544|FG002|Overall Study|Non-compliance|1|||
125363166|NCT00216476|450963542|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
125363167|NCT00216476|450963543|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
125590393|NCT04889209|451784086|FG007|All Cohorts Except 15E|Death|0|||
125590394|NCT04889209|451784087|FG008|All Cohorts Except 15E|Death|0|||
125590395|NCT04889209|451784088|FG009|All Cohorts Except 15E|Death|0|||
125590396|NCT04889209|451784089|FG010|All Cohorts Except 15E|Death|0|||
125363168|NCT00216476|450963544|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
125363169|NCT00216476|450963542|FG000|Overall Study|Administrative Reasons|1|||
125363170|NCT00216476|450963543|FG001|Overall Study|Administrative Reasons|1|||
125429307|NCT02496767|451196627|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
125429308|NCT02496767|451196628|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
125429309|NCT02496767|451196629|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
125429310|NCT02496767|451196630|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
125429311|NCT02496767|451196631|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
125429312|NCT02496767|451196632|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
125429313|NCT02496767|451196633|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
125429314|NCT02496767|451196634|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
125429315|NCT02889133|451196635|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
125429316|NCT02889133|451196636|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
125429317|NCT02889133|451196635|FG000|Completed Primary Outcome|Manufacturing error|3|||
125429318|NCT02889133|451196636|FG001|Completed Primary Outcome|Manufacturing error|8|||
125429319|NCT02889133|451196635|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
125429320|NCT02889133|451196636|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
125429321|NCT02889133|451196635|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
125429322|NCT02889133|451196636|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
125429323|NCT02889133|451196635|FG000|Completed Primary Outcome|Protocol Violation|1|||
125429324|NCT02889133|451196636|FG001|Completed Primary Outcome|Protocol Violation|0|||
125429325|NCT02889133|451196635|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
125429326|NCT02889133|451196636|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
125429327|NCT02889133|451196635|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
125429328|NCT02889133|451196636|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
125429329|NCT02889133|451196635|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
125429330|NCT02889133|451196636|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
125429331|NCT02889133|451196635|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
125429332|NCT02889133|451196636|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
125429333|NCT02889133|451196635|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
125429334|NCT02889133|451196636|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
125429335|NCT05687032|451196637|FG000|Treatment Phase|Adverse Event|13|||
125429336|NCT05687032|451196637|FG000|Treatment Phase|Death|1|||
125429337|NCT05687032|451196637|FG000|Treatment Phase|Physician Decision|3|||
125429338|NCT05687032|451196637|FG000|Treatment Phase|Progressive disease|9|||
125429339|NCT05687032|451196637|FG000|Treatment Phase|Withdrawal by Subject|5|||
125429340|NCT05687032|451196637|FG000|Follow-Up Phase|Death|16|||
125429341|NCT05687032|451196637|FG000|Follow-Up Phase|Ongoing|26|||
125429342|NCT05479604|451196640|FG000|Overall Study|Lost to Follow-up|1|||
125429343|NCT05479604|451196641|FG001|Overall Study|Lost to Follow-up|5|||
125212084|NCT03959488|450403260|FG000|Season 2|Withdrawal by parent/guardian|0|||
125212085|NCT03959488|450403261|FG001|Season 2|Withdrawal by parent/guardian|0|||
125212086|NCT03959488|450403262|FG002|Season 2|Withdrawal by parent/guardian|3|||
125212087|NCT03959488|450403263|FG003|Season 2|Withdrawal by parent/guardian|1|||
125212088|NCT03959488|450403264|FG004|Season 2|Withdrawal by parent/guardian|1|||
125212089|NCT03959488|450403260|FG000|Season 2|Lost to Follow-up|0|||
125212090|NCT03959488|450403261|FG001|Season 2|Lost to Follow-up|0|||
125212091|NCT03959488|450403262|FG002|Season 2|Lost to Follow-up|1|||
125212092|NCT03959488|450403263|FG003|Season 2|Lost to Follow-up|0|||
125212093|NCT03959488|450403264|FG004|Season 2|Lost to Follow-up|1|||
125212094|NCT01760447|450403265|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
125212095|NCT01760447|450403266|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
125212096|NCT01760447|450403267|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
125212097|NCT01760447|450403268|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
125212098|NCT01760447|450403265|FG000|Weeks 0-20|Withdrawal by Subject|2|||
125212099|NCT01760447|450403266|FG001|Weeks 0-20|Withdrawal by Subject|0|||
125429344|NCT05701995|451196646|FG000|Pre-Treatment|Randomization Error|1|||
125429345|NCT05701995|451196647|FG001|Pre-Treatment|Randomization Error|1|||
125429346|NCT05701995|451196646|FG000|Treatment|Withdrawal by Subject|8|||
125429347|NCT05701995|451196647|FG001|Treatment|Withdrawal by Subject|4|||
125590397|NCT04889209|451784090|FG011|All Cohorts Except 15E|Death|0|||
125212100|NCT01760447|450403267|FG002|Weeks 0-20|Withdrawal by Subject|1|||
125212101|NCT01760447|450403268|FG003|Weeks 0-20|Withdrawal by Subject|0|||
125212102|NCT01760447|450403265|FG000|Weeks 0-20|Lost to Follow-up|1|||
125363171|NCT00216476|450963544|FG002|Overall Study|Administrative Reasons|0|||
125363172|NCT00216476|450963542|FG000|Overall Study|Protocol Deviation|5|||
125363173|NCT00216476|450963543|FG001|Overall Study|Protocol Deviation|1|||
125363174|NCT00216476|450963544|FG002|Overall Study|Protocol Deviation|0|||
125363175|NCT00216476|450963542|FG000|Overall Study|Patient Moved|2|||
125363176|NCT00216476|450963543|FG001|Overall Study|Patient Moved|2|||
125363177|NCT00216476|450963544|FG002|Overall Study|Patient Moved|0|||
125363178|NCT02202980|450963547|FG000|Overall Study|Lack of Efficacy|1|||
125363179|NCT02202980|450963548|FG001|Overall Study|Lack of Efficacy|0|||
125363180|NCT02202980|450963549|FG002|Overall Study|Lack of Efficacy|7|||
125363181|NCT02202980|450963550|FG003|Overall Study|Lack of Efficacy|0|||
125363182|NCT02202980|450963551|FG004|Overall Study|Lack of Efficacy|3|||
125590398|NCT04889209|451784091|FG012|All Cohorts Except 15E|Death|0|||
125212103|NCT01760447|450403266|FG001|Weeks 0-20|Lost to Follow-up|0|||
125590399|NCT04889209|451784092|FG013|All Cohorts Except 15E|Death|0|||
125590400|NCT04889209|451784093|FG014|All Cohorts Except 15E|Death|0|||
125590401|NCT04889209|451784094|FG015|All Cohorts Except 15E|Death|0|||
125590402|NCT04889209|451784095|FG016|All Cohorts Except 15E|Death|0|||
125590403|NCT04889209|451784096|FG017|All Cohorts Except 15E|Death|0|||
125590404|NCT04889209|451784079|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
125590405|NCT04889209|451784080|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
125590406|NCT04889209|451784081|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
125590407|NCT04889209|451784082|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
125590408|NCT04889209|451784083|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
125590409|NCT04889209|451784084|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
125590410|NCT04889209|451784085|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
125590411|NCT04889209|451784086|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
125590412|NCT04889209|451784087|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
125590413|NCT04889209|451784088|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
125590414|NCT04889209|451784089|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
125590415|NCT04889209|451784090|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
125590416|NCT04889209|451784091|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
125590417|NCT04889209|451784092|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
125590418|NCT04889209|451784093|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
125590419|NCT04889209|451784094|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
125590420|NCT04889209|451784095|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
125590421|NCT04889209|451784096|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
125590422|NCT04889209|451784079|FG000|All Cohorts Except 15E|Physician Decision|0|||
125590423|NCT04889209|451784080|FG001|All Cohorts Except 15E|Physician Decision|0|||
125590424|NCT04889209|451784081|FG002|All Cohorts Except 15E|Physician Decision|0|||
125590425|NCT04889209|451784082|FG003|All Cohorts Except 15E|Physician Decision|0|||
125590426|NCT04889209|451784083|FG004|All Cohorts Except 15E|Physician Decision|1|||
125590427|NCT04889209|451784084|FG005|All Cohorts Except 15E|Physician Decision|0|||
125590428|NCT04889209|451784085|FG006|All Cohorts Except 15E|Physician Decision|0|||
125212104|NCT01760447|450403267|FG002|Weeks 0-20|Lost to Follow-up|1|||
125212105|NCT01760447|450403268|FG003|Weeks 0-20|Lost to Follow-up|1|||
125212106|NCT01760447|450403265|FG000|Weeks 0-20|Randomized but not treated|0|||
125590429|NCT04889209|451784086|FG007|All Cohorts Except 15E|Physician Decision|1|||
125590430|NCT04889209|451784087|FG008|All Cohorts Except 15E|Physician Decision|0|||
125590431|NCT04889209|451784088|FG009|All Cohorts Except 15E|Physician Decision|1|||
125590432|NCT04889209|451784089|FG010|All Cohorts Except 15E|Physician Decision|0|||
125590433|NCT04889209|451784090|FG011|All Cohorts Except 15E|Physician Decision|1|||
125212107|NCT01760447|450403266|FG001|Weeks 0-20|Randomized but not treated|0|||
125212108|NCT01760447|450403267|FG002|Weeks 0-20|Randomized but not treated|2|||
125212109|NCT01760447|450403268|FG003|Weeks 0-20|Randomized but not treated|0|||
125363183|NCT02202980|450963552|FG005|Overall Study|Lack of Efficacy|1|||
125363184|NCT02202980|450963553|FG006|Overall Study|Lack of Efficacy|11|||
125363185|NCT02202980|450963554|FG007|Overall Study|Lack of Efficacy|2|||
125363186|NCT02202980|450963555|FG008|Overall Study|Lack of Efficacy|2|||
125590434|NCT04889209|451784091|FG012|All Cohorts Except 15E|Physician Decision|1|||
125590435|NCT04889209|451784092|FG013|All Cohorts Except 15E|Physician Decision|0|||
125590436|NCT04889209|451784093|FG014|All Cohorts Except 15E|Physician Decision|0|||
125590437|NCT04889209|451784094|FG015|All Cohorts Except 15E|Physician Decision|0|||
125363187|NCT02202980|450963556|FG009|Overall Study|Lack of Efficacy|0|||
125590438|NCT04889209|451784095|FG016|All Cohorts Except 15E|Physician Decision|0|||
125590439|NCT04889209|451784096|FG017|All Cohorts Except 15E|Physician Decision|0|||
125590440|NCT04889209|451784079|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
125590441|NCT04889209|451784080|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
125590442|NCT04889209|451784081|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
125590443|NCT04889209|451784082|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
125590444|NCT04889209|451784083|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
125590445|NCT04889209|451784084|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
125363188|NCT02202980|450963557|FG010|Overall Study|Lack of Efficacy|0|||
125363189|NCT02202980|450963558|FG011|Overall Study|Lack of Efficacy|3|||
125590446|NCT04889209|451784085|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
125590447|NCT04889209|451784086|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
125590448|NCT04889209|451784087|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
125363190|NCT02202980|450963559|FG012|Overall Study|Lack of Efficacy|10|||
125363191|NCT02202980|450963560|FG013|Overall Study|Lack of Efficacy|0|||
125363192|NCT02202980|450963547|FG000|Overall Study|Protocol Violation|0|||
125363193|NCT02202980|450963548|FG001|Overall Study|Protocol Violation|0|||
125363194|NCT02202980|450963549|FG002|Overall Study|Protocol Violation|0|||
125363195|NCT02202980|450963550|FG003|Overall Study|Protocol Violation|3|||
125363196|NCT02202980|450963551|FG004|Overall Study|Protocol Violation|3|||
125363197|NCT02202980|450963552|FG005|Overall Study|Protocol Violation|0|||
125363198|NCT02202980|450963553|FG006|Overall Study|Protocol Violation|0|||
125363199|NCT02202980|450963554|FG007|Overall Study|Protocol Violation|0|||
125363200|NCT02202980|450963555|FG008|Overall Study|Protocol Violation|0|||
125363201|NCT02202980|450963556|FG009|Overall Study|Protocol Violation|0|||
125363202|NCT02202980|450963557|FG010|Overall Study|Protocol Violation|0|||
125363203|NCT02202980|450963558|FG011|Overall Study|Protocol Violation|0|||
125363204|NCT02202980|450963559|FG012|Overall Study|Protocol Violation|0|||
125363205|NCT02202980|450963560|FG013|Overall Study|Protocol Violation|0|||
125363206|NCT02202980|450963547|FG000|Overall Study|Lost to Follow-up|0|||
125363207|NCT02202980|450963548|FG001|Overall Study|Lost to Follow-up|1|||
125363208|NCT02202980|450963549|FG002|Overall Study|Lost to Follow-up|1|||
125363209|NCT02202980|450963550|FG003|Overall Study|Lost to Follow-up|1|||
125363210|NCT02202980|450963551|FG004|Overall Study|Lost to Follow-up|0|||
125363211|NCT02202980|450963552|FG005|Overall Study|Lost to Follow-up|0|||
125363212|NCT02202980|450963553|FG006|Overall Study|Lost to Follow-up|0|||
125363213|NCT02202980|450963554|FG007|Overall Study|Lost to Follow-up|1|||
125363214|NCT02202980|450963555|FG008|Overall Study|Lost to Follow-up|1|||
125590449|NCT04889209|451784088|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
125590450|NCT04889209|451784089|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
125590451|NCT04889209|451784090|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
125590452|NCT04889209|451784091|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
125363215|NCT02202980|450963556|FG009|Overall Study|Lost to Follow-up|0|||
125363216|NCT02202980|450963557|FG010|Overall Study|Lost to Follow-up|0|||
125363217|NCT02202980|450963558|FG011|Overall Study|Lost to Follow-up|0|||
125363218|NCT02202980|450963559|FG012|Overall Study|Lost to Follow-up|1|||
125363219|NCT02202980|450963560|FG013|Overall Study|Lost to Follow-up|0|||
125363220|NCT02202980|450963547|FG000|Overall Study|Withdrew Consent|0|||
125363221|NCT02202980|450963548|FG001|Overall Study|Withdrew Consent|1|||
125363222|NCT02202980|450963549|FG002|Overall Study|Withdrew Consent|2|||
125363223|NCT02202980|450963550|FG003|Overall Study|Withdrew Consent|0|||
125363224|NCT02202980|450963551|FG004|Overall Study|Withdrew Consent|0|||
125590453|NCT04889209|451784092|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
125590454|NCT04889209|451784093|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
125590455|NCT04889209|451784094|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
125590456|NCT04889209|451784095|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
125590457|NCT04889209|451784096|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
125590458|NCT04889209|451784079|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
125590459|NCT04889209|451784080|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
125590460|NCT04889209|451784081|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125590461|NCT04889209|451784082|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125590462|NCT04889209|451784083|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125590463|NCT04889209|451784084|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
125590464|NCT04889209|451784085|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125590465|NCT04889209|451784086|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
125590466|NCT04889209|451784087|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125590467|NCT04889209|451784088|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
125590468|NCT04889209|451784089|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125590469|NCT04889209|451784090|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125590470|NCT04889209|451784091|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125590471|NCT04889209|451784092|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125590472|NCT04889209|451784093|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125590473|NCT04889209|451784094|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125590474|NCT04889209|451784095|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
125590475|NCT04889209|451784096|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
125590476|NCT04889209|451784079|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590477|NCT04889209|451784080|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590478|NCT04889209|451784081|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590479|NCT04889209|451784082|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
125590480|NCT04889209|451784083|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590481|NCT04889209|451784084|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590482|NCT04889209|451784085|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590483|NCT04889209|451784086|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590484|NCT04889209|451784087|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590485|NCT04889209|451784088|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590486|NCT04889209|451784089|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590487|NCT04889209|451784090|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590488|NCT04889209|451784091|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590489|NCT04889209|451784092|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590490|NCT04889209|451784093|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590491|NCT04889209|451784094|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590492|NCT04889209|451784095|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590493|NCT04889209|451784096|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
125590494|NCT04889209|451784079|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125590495|NCT04889209|451784080|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125590496|NCT04889209|451784081|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125590497|NCT04889209|451784082|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125590498|NCT04889209|451784083|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125590499|NCT04889209|451784084|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125590500|NCT04889209|451784085|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125590501|NCT04889209|451784086|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125590502|NCT04889209|451784087|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125590503|NCT04889209|451784088|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125590504|NCT04889209|451784089|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125590505|NCT04889209|451784090|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125429348|NCT05701995|451196646|FG000|Treatment|Lost to Follow-up|2|||
125212110|NCT01760447|450403265|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
125212111|NCT01760447|450403266|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
125212112|NCT01760447|450403267|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
125212113|NCT01760447|450403268|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
125590506|NCT04889209|451784091|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125363225|NCT02202980|450963552|FG005|Overall Study|Withdrew Consent|0|||
125429349|NCT05701995|451196647|FG001|Treatment|Lost to Follow-up|3|||
125429350|NCT05701995|451196646|FG000|Treatment|Adverse Event|3|||
125590507|NCT04889209|451784092|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125590508|NCT04889209|451784093|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125590509|NCT04889209|451784094|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125590510|NCT04889209|451784095|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
125590511|NCT04889209|451784096|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
125590512|NCT04889209|451784079|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590513|NCT04889209|451784080|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590514|NCT04889209|451784081|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590515|NCT04889209|451784082|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590516|NCT04889209|451784083|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590517|NCT04889209|451784084|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590518|NCT04889209|451784085|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590519|NCT04889209|451784086|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590520|NCT04889209|451784087|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590521|NCT04889209|451784088|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590522|NCT04889209|451784089|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590523|NCT04889209|451784090|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590524|NCT04889209|451784091|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590525|NCT04889209|451784092|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590526|NCT04889209|451784093|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590527|NCT04889209|451784094|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590528|NCT04889209|451784095|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
125590529|NCT04889209|451784096|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
125590530|NCT04889209|451784079|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590531|NCT04889209|451784080|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590532|NCT04889209|451784081|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590533|NCT04889209|451784082|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590534|NCT04889209|451784083|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590535|NCT04889209|451784084|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590536|NCT04889209|451784085|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590537|NCT04889209|451784086|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590538|NCT04889209|451784087|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590539|NCT04889209|451784088|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590540|NCT04889209|451784089|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590541|NCT04889209|451784090|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590542|NCT04889209|451784091|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590543|NCT04889209|451784092|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125590544|NCT04889209|451784093|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125212114|NCT01760447|450403265|FG000|Weeks 20-54|Withdrawal by Subject|2|||
125212115|NCT01760447|450403266|FG001|Weeks 20-54|Withdrawal by Subject|1|||
125363226|NCT02202980|450963553|FG006|Overall Study|Withdrew Consent|0|||
125363227|NCT02202980|450963554|FG007|Overall Study|Withdrew Consent|0|||
125363228|NCT02202980|450963555|FG008|Overall Study|Withdrew Consent|1|||
125363229|NCT02202980|450963556|FG009|Overall Study|Withdrew Consent|0|||
125363230|NCT02202980|450963557|FG010|Overall Study|Withdrew Consent|0|||
125363231|NCT02202980|450963558|FG011|Overall Study|Withdrew Consent|0|||
125363232|NCT02202980|450963559|FG012|Overall Study|Withdrew Consent|0|||
125363233|NCT02202980|450963560|FG013|Overall Study|Withdrew Consent|0|||
125363234|NCT00696800|450963561|FG000|Overall Study|Adverse Event|16|||
125363235|NCT00696800|450963562|FG001|Overall Study|Adverse Event|3|||
125363236|NCT00696800|450963561|FG000|Overall Study|Insufficient compliance with medication|2|||
125363237|NCT00696800|450963562|FG001|Overall Study|Insufficient compliance with medication|1|||
125363238|NCT00696800|450963561|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
125363239|NCT00696800|450963562|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
125590545|NCT04889209|451784094|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125363240|NCT00696800|450963561|FG000|Overall Study|Insufficient ovarian response|4|||
125212116|NCT01760447|450403267|FG002|Weeks 20-54|Withdrawal by Subject|1|||
125363241|NCT00696800|450963562|FG001|Overall Study|Insufficient ovarian response|1|||
125363242|NCT00696800|450963561|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
125429351|NCT05701995|451196647|FG001|Treatment|Adverse Event|1|||
125590546|NCT04889209|451784095|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
125363243|NCT00696800|450963562|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
125363244|NCT00696800|450963561|FG000|Overall Study|Too high ovarian response|6|||
125363245|NCT00696800|450963562|FG001|Overall Study|Too high ovarian response|1|||
125363246|NCT00696800|450963561|FG000|Overall Study|No/too few/bad quality oocytes|4|||
125590547|NCT04889209|451784096|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
125590548|NCT04889209|451784079|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590549|NCT04889209|451784080|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590550|NCT04889209|451784081|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590551|NCT04889209|451784082|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590552|NCT04889209|451784083|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590553|NCT04889209|451784084|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590554|NCT04889209|451784085|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590555|NCT04889209|451784086|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590556|NCT04889209|451784087|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590557|NCT04889209|451784088|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590558|NCT04889209|451784089|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590559|NCT04889209|451784090|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590560|NCT04889209|451784091|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590561|NCT04889209|451784092|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590562|NCT04889209|451784093|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
125590563|NCT04889209|451784094|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590564|NCT04889209|451784095|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590565|NCT04889209|451784096|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
125590566|NCT01725165|451784103|FG000|Overall Study|Death|11|||
125590567|NCT01725165|451784104|FG001|Overall Study|Death|18|||
125590568|NCT05113940|451784107|FG000|Part A (18 Days)|Adverse Event|0|||
125590569|NCT05113940|451784108|FG001|Part A (18 Days)|Adverse Event|0|||
125590570|NCT05113940|451784109|FG002|Part A (18 Days)|Adverse Event|1|||
125590571|NCT05113940|451784110|FG003|Part A (18 Days)|Adverse Event|1|||
125590572|NCT05113940|451784111|FG004|Part A (18 Days)|Adverse Event|1|||
125590573|NCT05113940|451784112|FG005|Part A (18 Days)|Adverse Event|0|||
125590574|NCT05113940|451784113|FG006|Part A (18 Days)|Adverse Event|0|||
125590575|NCT05113940|451784114|FG007|Part A (18 Days)|Adverse Event|0|||
125590576|NCT05113940|451784115|FG008|Part A (18 Days)|Adverse Event|0|||
125590577|NCT05113940|451784116|FG009|Part A (18 Days)|Adverse Event|0|||
125590578|NCT05113940|451784117|FG010|Part A (18 Days)|Adverse Event|0|||
125590579|NCT05113940|451784118|FG011|Part A (18 Days)|Adverse Event|2|||
125590580|NCT05113940|451784119|FG012|Part A (18 Days)|Adverse Event|0|||
125590581|NCT05113940|451784120|FG013|Part A (18 Days)|Adverse Event|0|||
125590582|NCT05113940|451784121|FG014|Part A (18 Days)|Adverse Event|0|||
125590583|NCT05113940|451784107|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590584|NCT05113940|451784108|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590585|NCT05113940|451784109|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590586|NCT05113940|451784110|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590587|NCT05113940|451784111|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590588|NCT05113940|451784112|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590589|NCT05113940|451784113|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590590|NCT05113940|451784114|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590591|NCT05113940|451784115|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590592|NCT05113940|451784116|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590593|NCT05113940|451784117|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590594|NCT05113940|451784118|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590595|NCT05113940|451784119|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590596|NCT05113940|451784120|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
125590597|NCT05113940|451784121|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
125590598|NCT02688647|451784122|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
125590599|NCT02688647|451784123|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
125590600|NCT02688647|451784122|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
125590601|NCT02688647|451784123|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
125590602|NCT02688647|451784122|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
125590603|NCT02688647|451784123|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
125590604|NCT02688647|451784122|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
125590605|NCT02688647|451784123|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
125590606|NCT02688647|451784122|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
125590607|NCT02688647|451784123|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
125363247|NCT00696800|450963562|FG001|Overall Study|No/too few/bad quality oocytes|3|||
125212117|NCT01760447|450403268|FG003|Weeks 20-54|Withdrawal by Subject|2|||
125212118|NCT01760447|450403265|FG000|Weeks 20-54|Lost to Follow-up|0|||
125212119|NCT01760447|450403266|FG001|Weeks 20-54|Lost to Follow-up|0|||
125212120|NCT01760447|450403267|FG002|Weeks 20-54|Lost to Follow-up|1|||
125212121|NCT01760447|450403268|FG003|Weeks 20-54|Lost to Follow-up|2|||
125212122|NCT01641471|450403269|FG000|Overall Study|Withdrawal by Subject|19|||
125212123|NCT01641471|450403270|FG001|Overall Study|Withdrawal by Subject|19|||
125212124|NCT01641471|450403269|FG000|Overall Study|Lost to Follow-up|2|||
125212125|NCT01641471|450403270|FG001|Overall Study|Lost to Follow-up|4|||
125212126|NCT01641471|450403269|FG000|Overall Study|Protocol Violation|2|||
125212127|NCT01641471|450403270|FG001|Overall Study|Protocol Violation|4|||
125212128|NCT04575584|450403271|FG000|Overall Study|Death|6|||
125212129|NCT04575584|450403272|FG001|Overall Study|Death|4|||
125212130|NCT04575584|450403273|FG002|Overall Study|Death|6|||
125212131|NCT04575584|450403274|FG003|Overall Study|Death|2|||
125212132|NCT04575584|450403275|FG004|Overall Study|Death|0|||
125212133|NCT04575584|450403276|FG005|Overall Study|Death|0|||
125212134|NCT04575584|450403271|FG000|Overall Study|Lost to Follow-up|1|||
125212135|NCT04575584|450403272|FG001|Overall Study|Lost to Follow-up|1|||
125212136|NCT04575584|450403273|FG002|Overall Study|Lost to Follow-up|1|||
125212137|NCT04575584|450403274|FG003|Overall Study|Lost to Follow-up|1|||
125212138|NCT04575584|450403275|FG004|Overall Study|Lost to Follow-up|0|||
125212139|NCT04575584|450403276|FG005|Overall Study|Lost to Follow-up|0|||
125212140|NCT04575584|450403271|FG000|Overall Study|Physician Decision|0|||
125363248|NCT00696800|450963561|FG000|Overall Study|No/abnormal fertilization|11|||
125363249|NCT00696800|450963562|FG001|Overall Study|No/abnormal fertilization|13|||
125363250|NCT00696800|450963561|FG000|Overall Study|No/too few/bad quality embryos|24|||
125363251|NCT00696800|450963562|FG001|Overall Study|No/too few/bad quality embryos|18|||
125363252|NCT00696800|450963561|FG000|Overall Study|Other Reasons|5|||
125363253|NCT00696800|450963562|FG001|Overall Study|Other Reasons|3|||
125363254|NCT00696800|450963561|FG000|Overall Study|Not treated|1|||
125363255|NCT00696800|450963562|FG001|Overall Study|Not treated|2|||
125363256|NCT02404220|450963564|FG000|Overall Study|Adverse Event|0|||
125363257|NCT02404220|450963565|FG001|Overall Study|Adverse Event|0|||
125363258|NCT02404220|450963566|FG002|Overall Study|Adverse Event|1|||
125363259|NCT02404220|450963567|FG003|Overall Study|Adverse Event|0|||
125363260|NCT02404220|450963564|FG000|Overall Study|Death|5|||
125363261|NCT02404220|450963565|FG001|Overall Study|Death|5|||
125363262|NCT02404220|450963566|FG002|Overall Study|Death|3|||
125363263|NCT02404220|450963567|FG003|Overall Study|Death|8|||
125363264|NCT02404220|450963564|FG000|Overall Study|Progressive Disease|0|||
125363265|NCT02404220|450963565|FG001|Overall Study|Progressive Disease|0|||
125363266|NCT02404220|450963566|FG002|Overall Study|Progressive Disease|1|||
125212141|NCT04575584|450403272|FG001|Overall Study|Physician Decision|1|||
125363267|NCT02404220|450963567|FG003|Overall Study|Progressive Disease|1|||
125212142|NCT04575584|450403273|FG002|Overall Study|Physician Decision|1|||
125212143|NCT04575584|450403274|FG003|Overall Study|Physician Decision|1|||
125212144|NCT04575584|450403275|FG004|Overall Study|Physician Decision|0|||
125363268|NCT02404220|450963564|FG000|Overall Study|Study Terminated by Sponsor|0|||
125363269|NCT02404220|450963565|FG001|Overall Study|Study Terminated by Sponsor|0|||
125363270|NCT02404220|450963566|FG002|Overall Study|Study Terminated by Sponsor|2|||
125363271|NCT02404220|450963567|FG003|Overall Study|Study Terminated by Sponsor|1|||
125590608|NCT02688647|451784122|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
125590609|NCT02688647|451784123|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
125590610|NCT02688647|451784122|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
125590611|NCT02688647|451784123|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
125590612|NCT03619213|451784124|FG000|Overall Study|Lost to Follow-up|2|||
125590613|NCT03619213|451784125|FG001|Overall Study|Lost to Follow-up|1|||
125590614|NCT03619213|451784124|FG000|Overall Study|Withdrawal by Subject|8|||
125590615|NCT03619213|451784125|FG001|Overall Study|Withdrawal by Subject|10|||
125590616|NCT00382967|451784126|FG000|Overall Study|Protocol Violation|1|||
125590617|NCT00382967|451784127|FG001|Overall Study|Protocol Violation|1|||
125590618|NCT02542267|451784131|FG000|Overall Study|Withdrawal by Subject|10|||
125590619|NCT02542267|451784131|FG000|Overall Study|Physician Decision|6|||
125590620|NCT02542267|451784131|FG000|Overall Study|Lost to Follow-up|4|||
125590621|NCT02542267|451784131|FG000|Overall Study|Death|13|||
125590622|NCT02542267|451784131|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
125590623|NCT02542267|451784131|FG000|Overall Study|Other|9|||
125590624|NCT03049449|451784132|FG000|Overall Study|Did not receive treatment.|0|||
125590625|NCT03049449|451784133|FG001|Overall Study|Did not receive treatment.|0|||
125590626|NCT03049449|451784134|FG002|Overall Study|Did not receive treatment.|0|||
125590627|NCT03049449|451784135|FG003|Overall Study|Did not receive treatment.|0|||
125590628|NCT03049449|451784136|FG004|Overall Study|Did not receive treatment.|0|||
125590629|NCT03049449|451784137|FG005|Overall Study|Did not receive treatment.|0|||
125590630|NCT03049449|451784138|FG006|Overall Study|Did not receive treatment.|0|||
125590631|NCT03049449|451784139|FG007|Overall Study|Did not receive treatment.|0|||
125590632|NCT03049449|451784140|FG008|Overall Study|Did not receive treatment.|1|||
125429352|NCT05701995|451196646|FG000|Treatment|Other Reason|1|||
125429353|NCT05701995|451196647|FG001|Treatment|Other Reason|1|||
125429354|NCT05701995|451196646|FG000|Treatment|Death|1|||
125590633|NCT03049449|451784141|FG009|Overall Study|Did not receive treatment.|0|||
125590634|NCT03049449|451784132|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
125590635|NCT03049449|451784133|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
125590636|NCT03049449|451784134|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
125590637|NCT03049449|451784135|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
125429355|NCT05701995|451196647|FG001|Treatment|Death|0|||
125429356|NCT05701995|451196646|FG000|Treatment|Physician Decision|0|||
125429357|NCT05701995|451196647|FG001|Treatment|Physician Decision|1|||
125429358|NCT04987762|451196651|FG000|Overall Study|Study was Terminated by Sponsor|103|||
125429359|NCT00504426|451196657|FG000|Overall Study|Adverse Event|0|||
125429360|NCT00504426|451196658|FG001|Overall Study|Adverse Event|0|||
125429361|NCT00504426|451196659|FG002|Overall Study|Adverse Event|2|||
125429362|NCT00504426|451196660|FG003|Overall Study|Adverse Event|0|||
125590638|NCT03049449|451784136|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
125590639|NCT03049449|451784137|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
125590640|NCT03049449|451784138|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
125590641|NCT03049449|451784139|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
125590642|NCT03049449|451784140|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
125590643|NCT03049449|451784141|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
125590644|NCT03049449|451784132|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125590645|NCT03049449|451784133|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125590646|NCT03049449|451784134|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125590647|NCT03049449|451784135|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125590648|NCT03049449|451784136|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125590649|NCT03049449|451784137|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125590650|NCT03049449|451784138|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125590651|NCT03049449|451784139|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
125590652|NCT03049449|451784140|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
125590653|NCT03049449|451784141|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
125590654|NCT00474240|451784142|FG000|Overall Study|Withdrawal by Subject|1|||
125590655|NCT00474240|451784143|FG001|Overall Study|Withdrawal by Subject|1|||
125590656|NCT00474240|451784144|FG002|Overall Study|Withdrawal by Subject|0|||
125590657|NCT00474240|451784145|FG003|Overall Study|Withdrawal by Subject|2|||
125590658|NCT00474240|451784146|FG004|Overall Study|Withdrawal by Subject|3|||
125590659|NCT00474240|451784147|FG005|Overall Study|Withdrawal by Subject|1|||
125590660|NCT00474240|451784142|FG000|Overall Study|Adverse Event|0|||
125590661|NCT00474240|451784143|FG001|Overall Study|Adverse Event|0|||
125590662|NCT00474240|451784144|FG002|Overall Study|Adverse Event|9|||
125590663|NCT00474240|451784145|FG003|Overall Study|Adverse Event|14|||
125590664|NCT00474240|451784146|FG004|Overall Study|Adverse Event|5|||
125590665|NCT00474240|451784147|FG005|Overall Study|Adverse Event|16|||
125590666|NCT00474240|451784142|FG000|Overall Study|Removed due to lab value|0|||
125590667|NCT00474240|451784143|FG001|Overall Study|Removed due to lab value|0|||
125590668|NCT00474240|451784144|FG002|Overall Study|Removed due to lab value|0|||
125590669|NCT00474240|451784145|FG003|Overall Study|Removed due to lab value|0|||
125590670|NCT00474240|451784146|FG004|Overall Study|Removed due to lab value|0|||
125590671|NCT00474240|451784147|FG005|Overall Study|Removed due to lab value|1|||
125590672|NCT01147497|451784151|FG000|Overall Study|failed insertion|2|||
125590673|NCT01147497|451784152|FG001|Overall Study|failed insertion|0|||
125590674|NCT01974323|451784155|FG000|Overall Study|Other Reasons|25|||
125590675|NCT01974323|451784156|FG001|Overall Study|Other Reasons|28|||
125590676|NCT01974323|451784155|FG000|Overall Study|Protocol Violation|2|||
125590677|NCT01974323|451784156|FG001|Overall Study|Protocol Violation|2|||
125590678|NCT01974323|451784155|FG000|Overall Study|Personal Reasons|15|||
125590679|NCT01974323|451784156|FG001|Overall Study|Personal Reasons|19|||
125590680|NCT01974323|451784155|FG000|Overall Study|Lost to Follow-up|45|||
125590681|NCT01974323|451784156|FG001|Overall Study|Lost to Follow-up|40|||
125590682|NCT01974323|451784155|FG000|Overall Study|Pregnancy|2|||
125590683|NCT01974323|451784156|FG001|Overall Study|Pregnancy|1|||
125429363|NCT00504426|451196657|FG000|Overall Study|Protocol Violation|1|||
125590684|NCT01974323|451784155|FG000|Overall Study|Lack of Efficacy|1|||
125590685|NCT01974323|451784156|FG001|Overall Study|Lack of Efficacy|1|||
125590686|NCT01974323|451784155|FG000|Overall Study|Adverse Event|2|||
125590687|NCT01974323|451784156|FG001|Overall Study|Adverse Event|2|||
125590688|NCT00331760|451784157|FG000|Overall Study|Ineligible / no protocol treatment|15|||
125590689|NCT00331760|451784158|FG001|Overall Study|Ineligible / no protocol treatment|8|||
125429364|NCT00504426|451196658|FG001|Overall Study|Protocol Violation|1|||
125590690|NCT03093155|451784160|FG000|Overall Study|Not Eligible|1|||
125590691|NCT03093155|451784161|FG001|Overall Study|Not Eligible|0|||
125590692|NCT03093155|451784160|FG000|Overall Study|Withdrawal by Subject|0|||
125590693|NCT03093155|451784161|FG001|Overall Study|Withdrawal by Subject|1|||
125590694|NCT01075178|451784162|FG000|Subject Matching|eligible but not matched|130|||
125429365|NCT00504426|451196659|FG002|Overall Study|Protocol Violation|2|||
125429366|NCT00504426|451196660|FG003|Overall Study|Protocol Violation|0|||
125429367|NCT00504426|451196657|FG000|Overall Study|Withdrawal by Subject|2|||
125429368|NCT00504426|451196658|FG001|Overall Study|Withdrawal by Subject|0|||
125429369|NCT00504426|451196659|FG002|Overall Study|Withdrawal by Subject|0|||
125429370|NCT00504426|451196660|FG003|Overall Study|Withdrawal by Subject|0|||
125429371|NCT03988166|451196661|FG000|Overall Study|Lost to Follow-up|2|||
125429372|NCT03988166|451196661|FG000|Overall Study|Death|1|||
125429373|NCT03248375|451196662|FG000|Overall Study|Lost to Follow-up|5|||
125429374|NCT04992546|451196663|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
125429375|NCT04992546|451196663|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
125429376|NCT04992546|451196663|FG000|Open-Label Treatment Period|Adverse Event|3|||
125429377|NCT04992546|451196663|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
125429378|NCT00633464|451196665|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
125429379|NCT00633464|451196666|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
125429380|NCT00633464|451196665|FG000|Overall Study|Never Treated (Randomized in error)|0|||
125429381|NCT00633464|451196666|FG001|Overall Study|Never Treated (Randomized in error)|1|||
125429382|NCT00542880|451196668|FG000|Period 1|Eligibility criteria not fulfilled|2|||
125429383|NCT00542880|451196669|FG001|Period 1|Eligibility criteria not fulfilled|6|||
125429384|NCT00542880|451196668|FG000|Period 1|Adverse Event|2|||
125429385|NCT00542880|451196669|FG001|Period 1|Adverse Event|2|||
125429386|NCT00542880|451196668|FG000|Period 1|Development of study-specific criteria|1|||
125429387|NCT00542880|451196669|FG001|Period 1|Development of study-specific criteria|2|||
125590695|NCT01075178|451784163|FG001|Subject Matching|eligible but not matched|403|||
125590696|NCT01075178|451784162|FG000|Subject Chart Review|died before chart review period|0|||
125590697|NCT01075178|451784163|FG001|Subject Chart Review|died before chart review period|2|||
125590698|NCT01075178|451784162|FG000|Subject Chart Review|no data collected due to site closure|3|||
125590699|NCT01075178|451784163|FG001|Subject Chart Review|no data collected due to site closure|4|||
125590700|NCT01075178|451784162|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
125429388|NCT00542880|451196668|FG000|Period 1|Withdrawal by Subject|1|||
125429389|NCT00542880|451196669|FG001|Period 1|Withdrawal by Subject|1|||
125429390|NCT00542880|451196668|FG000|Period 1|Protocol Violation|0|||
125429391|NCT00542880|451196669|FG001|Period 1|Protocol Violation|1|||
125429392|NCT00542880|451196668|FG000|Period 2|Adverse Event|5|||
125429393|NCT00542880|451196669|FG001|Period 2|Adverse Event|7|||
125429394|NCT00542880|451196668|FG000|Period 2|Eligibility not fulfilled|0|||
125429395|NCT00542880|451196669|FG001|Period 2|Eligibility not fulfilled|1|||
125429396|NCT00542880|451196668|FG000|Period 2|Discontinuation criteria|2|||
125590701|NCT01075178|451784163|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
125590702|NCT02983604|451784164|FG000|Overall Study|Enrolled but not Treated|0|||
125590703|NCT02983604|451784165|FG001|Overall Study|Enrolled but not Treated|0|||
125590704|NCT02983604|451784166|FG002|Overall Study|Enrolled but not Treated|1|||
125590705|NCT02983604|451784167|FG003|Overall Study|Enrolled but not Treated|0|||
125590706|NCT01111604|451784168|FG000|Overall Study|Lost to Follow-up|0|||
125590707|NCT01111604|451784169|FG001|Overall Study|Lost to Follow-up|0|||
125590708|NCT01111604|451784170|FG002|Overall Study|Lost to Follow-up|1|||
125590709|NCT01111604|451784168|FG000|Overall Study|Withdrew Consent|3|||
125590710|NCT01111604|451784169|FG001|Overall Study|Withdrew Consent|0|||
125590711|NCT01111604|451784170|FG002|Overall Study|Withdrew Consent|2|||
125590712|NCT01111604|451784168|FG000|Overall Study|Withdrawal by Subject|2|||
125590713|NCT01111604|451784169|FG001|Overall Study|Withdrawal by Subject|0|||
125590714|NCT01111604|451784170|FG002|Overall Study|Withdrawal by Subject|0|||
125590715|NCT01111604|451784168|FG000|Overall Study|Death|1|||
125590716|NCT01111604|451784169|FG001|Overall Study|Death|0|||
125590717|NCT01111604|451784170|FG002|Overall Study|Death|0|||
125590718|NCT01111604|451784168|FG000|Overall Study|Met Exclusion Criteria|2|||
125590719|NCT01111604|451784169|FG001|Overall Study|Met Exclusion Criteria|0|||
125590720|NCT01111604|451784170|FG002|Overall Study|Met Exclusion Criteria|0|||
125590721|NCT00316264|451784172|FG000|Overall Study|Lost to Follow-up|0|||
125590722|NCT00316264|451784173|FG001|Overall Study|Lost to Follow-up|1|||
125590723|NCT00316264|451784174|FG002|Overall Study|Lost to Follow-up|0|||
125429397|NCT00542880|451196669|FG001|Period 2|Discontinuation criteria|0|||
125429398|NCT00542880|451196668|FG000|Period 2|Severe non-compliance|0|||
125363272|NCT02404220|450963564|FG000|Overall Study|Withdrawal by Subject|0|||
125363273|NCT02404220|450963565|FG001|Overall Study|Withdrawal by Subject|1|||
125363274|NCT02404220|450963566|FG002|Overall Study|Withdrawal by Subject|0|||
125363275|NCT02404220|450963567|FG003|Overall Study|Withdrawal by Subject|0|||
125363276|NCT02404220|450963564|FG000|Overall Study|Enrolled but Never Treated|0|||
125363277|NCT02404220|450963565|FG001|Overall Study|Enrolled but Never Treated|2|||
125363278|NCT02404220|450963566|FG002|Overall Study|Enrolled but Never Treated|0|||
125363279|NCT02404220|450963567|FG003|Overall Study|Enrolled but Never Treated|0|||
125363280|NCT03469934|450963570|FG000|Overall Study|Withdrawal by Subject|0|||
125363281|NCT03469934|450963571|FG001|Overall Study|Withdrawal by Subject|1|||
125363282|NCT02329080|450963572|FG000|Overall Study|Adverse Event|1|||
125363283|NCT02329080|450963572|FG000|Overall Study|Death|4|||
125363284|NCT02329080|450963572|FG000|Overall Study|Lack of Efficacy|22|||
125363285|NCT02329080|450963572|FG000|Overall Study|Lost to Follow-up|1|||
125363286|NCT02329080|450963572|FG000|Overall Study|Physician Decision|2|||
125363287|NCT02329080|450963572|FG000|Overall Study|Partial response|4|||
125363288|NCT02329080|450963572|FG000|Overall Study|Complete response|4|||
125363289|NCT00071396|450963579|FG000|Overall Study|Withdrawal by Subject|1|||
125363290|NCT00071396|450963579|FG000|Overall Study|Physician Decision|2|||
125363291|NCT03082261|450963580|FG000|Overall Study|Death|4|||
125363292|NCT03082261|450963580|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
125363293|NCT03082261|450963580|FG000|Overall Study|Insurance denial|1|||
125363294|NCT03082261|450963580|FG000|Overall Study|Peripheral lead added|1|||
125363295|NCT03082261|450963580|FG000|Overall Study|Withdrawal by Subject|40|||
125363296|NCT03082261|450963580|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
125363297|NCT03082261|450963580|FG000|Overall Study|Subject implanted with device other than study device|1|||
125363298|NCT03082261|450963580|FG000|Overall Study|Lost to Follow-up|14|||
125363299|NCT03082261|450963580|FG000|Overall Study|Subject moved to a different state|1|||
125363300|NCT03082261|450963580|FG000|Overall Study|Subject non-compliance|2|||
125363301|NCT03082261|450963580|FG000|Overall Study|Subject participation terminated by investigator|9|||
125363302|NCT03082261|450963580|FG000|Overall Study|Subject participation terminated by sponsor|4|||
125363303|NCT03082261|450963580|FG000|Overall Study|System explant|19|||
125363304|NCT03082261|450963580|FG000|Overall Study|Unable to place lead(s)|2|||
125363305|NCT03082261|450963580|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
125363306|NCT02639546|450963581|FG000|Overall Study|Death|2|||
125363307|NCT02639546|450963582|FG001|Overall Study|Death|2|||
125363308|NCT02639546|450963583|FG002|Overall Study|Death|1|||
125363309|NCT02639546|450963584|FG003|Overall Study|Death|2|||
125363310|NCT02639546|450963585|FG004|Overall Study|Death|2|||
125363311|NCT02639546|450963586|FG005|Overall Study|Death|2|||
125363312|NCT02639546|450963587|FG006|Overall Study|Death|0|||
125363313|NCT02639546|450963588|FG007|Overall Study|Death|0|||
125363314|NCT02639546|450963581|FG000|Overall Study|Lost to Follow-up|0|||
125363315|NCT02639546|450963582|FG001|Overall Study|Lost to Follow-up|0|||
125363316|NCT02639546|450963583|FG002|Overall Study|Lost to Follow-up|1|||
125363317|NCT02639546|450963584|FG003|Overall Study|Lost to Follow-up|0|||
125363318|NCT02639546|450963585|FG004|Overall Study|Lost to Follow-up|1|||
125363319|NCT02639546|450963586|FG005|Overall Study|Lost to Follow-up|1|||
125363320|NCT02639546|450963587|FG006|Overall Study|Lost to Follow-up|0|||
125363321|NCT02639546|450963588|FG007|Overall Study|Lost to Follow-up|1|||
125363322|NCT02639546|450963581|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
125363323|NCT02639546|450963582|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
125363324|NCT02639546|450963583|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
125363325|NCT02639546|450963584|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
125363326|NCT02639546|450963585|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
125363327|NCT02639546|450963586|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
125363328|NCT02639546|450963587|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
125363329|NCT02639546|450963588|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
125363330|NCT02639546|450963581|FG000|Overall Study|Study Terminated By Sponsor|0|||
125363331|NCT02639546|450963582|FG001|Overall Study|Study Terminated By Sponsor|2|||
125363332|NCT02639546|450963583|FG002|Overall Study|Study Terminated By Sponsor|3|||
125363333|NCT02639546|450963584|FG003|Overall Study|Study Terminated By Sponsor|4|||
125363334|NCT02639546|450963585|FG004|Overall Study|Study Terminated By Sponsor|4|||
125363335|NCT02639546|450963586|FG005|Overall Study|Study Terminated By Sponsor|3|||
125363336|NCT02639546|450963587|FG006|Overall Study|Study Terminated By Sponsor|3|||
125363337|NCT02639546|450963588|FG007|Overall Study|Study Terminated By Sponsor|9|||
125363338|NCT02639546|450963581|FG000|Overall Study|Withdrawal by Subject|2|||
125363339|NCT02639546|450963582|FG001|Overall Study|Withdrawal by Subject|2|||
125363340|NCT02639546|450963583|FG002|Overall Study|Withdrawal by Subject|1|||
125363341|NCT02639546|450963584|FG003|Overall Study|Withdrawal by Subject|0|||
125363342|NCT02639546|450963585|FG004|Overall Study|Withdrawal by Subject|0|||
125363343|NCT02639546|450963586|FG005|Overall Study|Withdrawal by Subject|1|||
125363344|NCT02639546|450963587|FG006|Overall Study|Withdrawal by Subject|2|||
125429399|NCT00542880|451196669|FG001|Period 2|Severe non-compliance|1|||
125429400|NCT00542880|451196668|FG000|Period 2|Other|0|||
125429401|NCT00542880|451196669|FG001|Period 2|Other|1|||
125429402|NCT00542880|451196668|FG000|Period 3|Adverse Event|0|||
125429403|NCT00542880|451196669|FG001|Period 3|Adverse Event|2|||
125429404|NCT01678131|451196670|FG000|Overall Study|Adverse Event|0|||
125429405|NCT01678131|451196671|FG001|Overall Study|Adverse Event|1|||
125429406|NCT01678131|451196672|FG002|Overall Study|Adverse Event|0|||
125429407|NCT01678131|451196670|FG000|Overall Study|Withdrawal by Subject|0|||
125429408|NCT01678131|451196671|FG001|Overall Study|Withdrawal by Subject|0|||
125429409|NCT01678131|451196672|FG002|Overall Study|Withdrawal by Subject|2|||
125429410|NCT00112580|451196673|FG000|Overall Study|Adverse Event|1|||
125429411|NCT00112580|451196674|FG001|Overall Study|Adverse Event|2|||
125429412|NCT00112580|451196673|FG000|Overall Study|Disease progression|5|||
125429413|NCT00112580|451196674|FG001|Overall Study|Disease progression|16|||
125429414|NCT00112580|451196673|FG000|Overall Study|Participant withdrew consent|2|||
125429415|NCT00112580|451196674|FG001|Overall Study|Participant withdrew consent|1|||
125429416|NCT05619003|451196676|FG000|Overall Study|Adverse Event|1|||
125429417|NCT03444376|451196677|FG000|Part A|Disease relapse or Progression|1|||
125363345|NCT02639546|450963588|FG007|Overall Study|Withdrawal by Subject|1|||
125363346|NCT01032174|450963591|FG000|Overall Study|Adverse Event|0|||
125429418|NCT03444376|451196677|FG000|Part A|Withdrawal by Subject|2|||
125429419|NCT03444376|451196677|FG000|Part A|Adverse Event|1|||
125429420|NCT03444376|451196677|FG000|Part B|Disease relapse or Progression|18|||
125429421|NCT03444376|451196677|FG000|Part B|Withdrawal by Subject|2|||
125363347|NCT01032174|450963592|FG001|Overall Study|Adverse Event|1|||
125363348|NCT00113087|450963594|FG000|Overall Study|Death or Transplant|14|||
125363349|NCT00113087|450963595|FG001|Overall Study|Death or Transplant|16|||
125363350|NCT00113087|450963594|FG000|Overall Study|Family or MD withdrew subject|10|||
125363351|NCT00113087|450963595|FG001|Overall Study|Family or MD withdrew subject|5|||
125363352|NCT01281137|450963596|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
125363353|NCT01281137|450963597|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
125363354|NCT01281137|450963596|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
125363355|NCT01281137|450963597|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
125363356|NCT01281137|450963596|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
125363357|NCT01281137|450963597|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
125363358|NCT01281137|450963596|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
125363359|NCT01281137|450963597|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
125363360|NCT01281137|450963596|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
125363361|NCT01281137|450963597|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
125363362|NCT00386607|450963600|FG000|Core|Adverse Event|40|||
125363363|NCT00386607|450963601|FG001|Core|Adverse Event|0|||
125363364|NCT00386607|450963600|FG000|Core|Abnormal laboratory value(s)|3|||
125363365|NCT00386607|450963601|FG001|Core|Abnormal laboratory value(s)|0|||
125363366|NCT00386607|450963600|FG000|Core|Unsatisfactory therapeutic effect|23|||
125363367|NCT00386607|450963601|FG001|Core|Unsatisfactory therapeutic effect|0|||
125363368|NCT00386607|450963600|FG000|Core|Condition no longer requires study drug|4|||
125363369|NCT00386607|450963601|FG001|Core|Condition no longer requires study drug|0|||
125363370|NCT00386607|450963600|FG000|Core|Patient withdrew consent|15|||
125363371|NCT00386607|450963601|FG001|Core|Patient withdrew consent|0|||
125363372|NCT00386607|450963600|FG000|Core|Lost to Follow-up|23|||
125363373|NCT00386607|450963601|FG001|Core|Lost to Follow-up|0|||
125363374|NCT00386607|450963600|FG000|Core|Administrative problems|1|||
125363375|NCT00386607|450963601|FG001|Core|Administrative problems|0|||
125429422|NCT03444376|451196677|FG000|Part B|Adverse Event|2|||
125429423|NCT03444376|451196677|FG000|Part B|Physician Decision|1|||
125429424|NCT03444376|451196677|FG000|Part C|Disease relapse or Progression|43|||
125429425|NCT03444376|451196677|FG000|Part C|Withdrawal by Subject|5|||
125429426|NCT03444376|451196677|FG000|Part C|Adverse Event|2|||
125590724|NCT00316264|451784172|FG000|Overall Study|Withdrawal of Consent|3|||
125590725|NCT00316264|451784173|FG001|Overall Study|Withdrawal of Consent|5|||
125590726|NCT00316264|451784174|FG002|Overall Study|Withdrawal of Consent|6|||
125590727|NCT00316264|451784172|FG000|Overall Study|Death|2|||
125590728|NCT00316264|451784173|FG001|Overall Study|Death|0|||
125590729|NCT00316264|451784174|FG002|Overall Study|Death|0|||
125590730|NCT00316264|451784172|FG000|Overall Study|Other|1|||
125590731|NCT00316264|451784173|FG001|Overall Study|Other|1|||
125590732|NCT00316264|451784174|FG002|Overall Study|Other|0|||
125590733|NCT00607048|451784175|FG000|Overall Study|Adverse Event|0|||
125590734|NCT00607048|451784176|FG001|Overall Study|Adverse Event|1|||
125590735|NCT00607048|451784177|FG002|Overall Study|Adverse Event|0|||
125590736|NCT00607048|451784178|FG003|Overall Study|Adverse Event|0|||
125590737|NCT00607048|451784179|FG004|Overall Study|Adverse Event|4|||
125590738|NCT00607048|451784180|FG005|Overall Study|Adverse Event|0|||
125590739|NCT00607048|451784175|FG000|Overall Study|Global deterioration of health|1|||
125590740|NCT00607048|451784176|FG001|Overall Study|Global deterioration of health|0|||
125590741|NCT00607048|451784177|FG002|Overall Study|Global deterioration of health|0|||
125590742|NCT00607048|451784178|FG003|Overall Study|Global deterioration of health|0|||
125590743|NCT00607048|451784179|FG004|Overall Study|Global deterioration of health|0|||
125590744|NCT00607048|451784180|FG005|Overall Study|Global deterioration of health|0|||
125590745|NCT00607048|451784175|FG000|Overall Study|Objective disease progression - relapse|1|||
125590746|NCT00607048|451784176|FG001|Overall Study|Objective disease progression - relapse|2|||
125590747|NCT00607048|451784177|FG002|Overall Study|Objective disease progression - relapse|4|||
125590748|NCT00607048|451784178|FG003|Overall Study|Objective disease progression - relapse|2|||
125590749|NCT00607048|451784179|FG004|Overall Study|Objective disease progression - relapse|2|||
125590750|NCT00607048|451784180|FG005|Overall Study|Objective disease progression - relapse|2|||
125590751|NCT00607048|451784175|FG000|Overall Study|Withdrawal by Subject|0|||
125590752|NCT00607048|451784176|FG001|Overall Study|Withdrawal by Subject|0|||
125590753|NCT00607048|451784177|FG002|Overall Study|Withdrawal by Subject|0|||
125590754|NCT00607048|451784178|FG003|Overall Study|Withdrawal by Subject|1|||
125590755|NCT00607048|451784179|FG004|Overall Study|Withdrawal by Subject|0|||
125590756|NCT00607048|451784180|FG005|Overall Study|Withdrawal by Subject|2|||
125590757|NCT00607048|451784175|FG000|Overall Study|Other|1|||
125590758|NCT00607048|451784176|FG001|Overall Study|Other|1|||
125590759|NCT00607048|451784177|FG002|Overall Study|Other|0|||
125590760|NCT00607048|451784178|FG003|Overall Study|Other|0|||
125590761|NCT00607048|451784179|FG004|Overall Study|Other|0|||
125590762|NCT00607048|451784180|FG005|Overall Study|Other|1|||
125590763|NCT00355264|451784181|FG000|Extension (Variable Duration)|Adverse Event|1|||
125590764|NCT00355264|451784181|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
125590765|NCT00826514|451784182|FG000|Overall Study|Adverse Event|1|||
125590766|NCT00826514|451784183|FG001|Overall Study|Adverse Event|1|||
125590767|NCT00826514|451784182|FG000|Overall Study|Lack of Efficacy|0|||
125590768|NCT00826514|451784183|FG001|Overall Study|Lack of Efficacy|1|||
125590769|NCT00826514|451784182|FG000|Overall Study|Withdrawal by Subject|2|||
125590770|NCT00826514|451784183|FG001|Overall Study|Withdrawal by Subject|3|||
125590771|NCT03926143|451784185|FG000|Overall Study|Physician Decision|3|||
125590772|NCT03926143|451784185|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
125590773|NCT03926143|451784185|FG000|Overall Study|Adverse Event|2|||
125590774|NCT03926143|451784185|FG000|Overall Study|Progressive disease|3|||
125590775|NCT02561156|451784186|FG000|Part 2|Adverse Event|0|||
125590776|NCT02561156|451784187|FG001|Part 2|Adverse Event|0|||
125590777|NCT02561156|451784188|FG002|Part 2|Adverse Event|0|||
125590778|NCT02561156|451784189|FG003|Part 2|Adverse Event|0|||
125590779|NCT02561156|451784190|FG004|Part 2|Adverse Event|0|||
125590780|NCT02561156|451784191|FG005|Part 2|Adverse Event|0|||
125590781|NCT02561156|451784192|FG006|Part 2|Adverse Event|0|||
125590782|NCT02561156|451784193|FG007|Part 2|Adverse Event|0|||
125590783|NCT02561156|451784194|FG008|Part 2|Adverse Event|0|||
125590784|NCT02561156|451784195|FG009|Part 2|Adverse Event|0|||
125590785|NCT02561156|451784196|FG010|Part 2|Adverse Event|0|||
125590786|NCT02561156|451784197|FG011|Part 2|Adverse Event|1|||
125590787|NCT02561156|451784198|FG012|Part 2|Adverse Event|0|||
125590788|NCT00098787|451784206|FG000|Overall Study|Never started treatment|3|||
125590789|NCT00098787|451784207|FG001|Overall Study|Never started treatment|2|||
125590790|NCT00098787|451784208|FG002|Overall Study|Never started treatment|1|||
125590791|NCT00098787|451784206|FG000|Overall Study|Ineligible|9|||
125590792|NCT00098787|451784207|FG001|Overall Study|Ineligible|7|||
125590793|NCT00098787|451784208|FG002|Overall Study|Ineligible|3|||
125590794|NCT00098787|451784206|FG000|Overall Study|Disease progression|28|||
125590795|NCT00098787|451784207|FG001|Overall Study|Disease progression|17|||
125590796|NCT00098787|451784208|FG002|Overall Study|Disease progression|23|||
125590797|NCT00098787|451784206|FG000|Overall Study|Adverse Event|8|||
125590798|NCT00098787|451784207|FG001|Overall Study|Adverse Event|17|||
125590799|NCT00098787|451784208|FG002|Overall Study|Adverse Event|8|||
125590800|NCT00098787|451784206|FG000|Overall Study|Death|6|||
125590801|NCT00098787|451784207|FG001|Overall Study|Death|1|||
125590802|NCT00098787|451784208|FG002|Overall Study|Death|0|||
125590803|NCT00098787|451784206|FG000|Overall Study|Withdrawal by Subject|4|||
125590804|NCT00098787|451784207|FG001|Overall Study|Withdrawal by Subject|12|||
125590805|NCT00098787|451784208|FG002|Overall Study|Withdrawal by Subject|6|||
125590806|NCT00098787|451784206|FG000|Overall Study|Alternative therapy|8|||
125590807|NCT00098787|451784207|FG001|Overall Study|Alternative therapy|13|||
125590808|NCT00098787|451784208|FG002|Overall Study|Alternative therapy|13|||
125590809|NCT00098787|451784206|FG000|Overall Study|Other|7|||
125590810|NCT00098787|451784207|FG001|Overall Study|Other|6|||
125590811|NCT00098787|451784208|FG002|Overall Study|Other|9|||
125590812|NCT02203149|451784211|FG000|Part 1|Adverse Event|0|||
125590813|NCT02203149|451784212|FG001|Part 1|Adverse Event|1|||
125590814|NCT02203149|451784213|FG002|Part 1|Adverse Event|0|||
125590815|NCT02203149|451784214|FG003|Part 1|Adverse Event|0|||
125590816|NCT02203149|451784215|FG004|Part 1|Adverse Event|0|||
125590817|NCT02203149|451784211|FG000|Part 2|Death|0|||
125590818|NCT02203149|451784212|FG001|Part 2|Death|0|||
125590819|NCT02203149|451784213|FG002|Part 2|Death|1|||
125590820|NCT02203149|451784214|FG003|Part 2|Death|1|||
125590821|NCT02203149|451784215|FG004|Part 2|Death|0|||
125590822|NCT02203149|451784211|FG000|Part 2|Withdrawal by Subject|0|||
125590823|NCT02203149|451784212|FG001|Part 2|Withdrawal by Subject|0|||
125590824|NCT02203149|451784213|FG002|Part 2|Withdrawal by Subject|0|||
125590825|NCT02203149|451784214|FG003|Part 2|Withdrawal by Subject|1|||
125590826|NCT02203149|451784215|FG004|Part 2|Withdrawal by Subject|0|||
125590827|NCT02203149|451784211|FG000|Part 2|Adverse Event|0|||
125590828|NCT02203149|451784212|FG001|Part 2|Adverse Event|0|||
125590829|NCT02203149|451784213|FG002|Part 2|Adverse Event|0|||
125590830|NCT02203149|451784214|FG003|Part 2|Adverse Event|1|||
125590831|NCT02203149|451784215|FG004|Part 2|Adverse Event|1|||
125590832|NCT01360996|451784216|FG000|Overall Study|Withdrawal by Subject|4|||
125590833|NCT01360996|451784217|FG001|Overall Study|Withdrawal by Subject|3|||
125590834|NCT01360996|451784218|FG002|Overall Study|Withdrawal by Subject|2|||
125590835|NCT01360996|451784216|FG000|Overall Study|Noncompliant|2|||
125590836|NCT01360996|451784217|FG001|Overall Study|Noncompliant|0|||
125590837|NCT01360996|451784218|FG002|Overall Study|Noncompliant|0|||
125590838|NCT01454076|451784219|FG000|Overall Study|Other|2|||
125590839|NCT01454076|451784220|FG001|Overall Study|Other|0|||
125590840|NCT01454076|451784221|FG002|Overall Study|Other|0|||
125590841|NCT01454076|451784222|FG003|Overall Study|Other|1|||
125590842|NCT01454076|451784223|FG004|Overall Study|Other|2|||
125590843|NCT01454076|451784219|FG000|Overall Study|Withdrawal by Subject|3|||
125590844|NCT01454076|451784220|FG001|Overall Study|Withdrawal by Subject|4|||
125590845|NCT01454076|451784221|FG002|Overall Study|Withdrawal by Subject|2|||
125590846|NCT01454076|451784222|FG003|Overall Study|Withdrawal by Subject|1|||
125590847|NCT01454076|451784223|FG004|Overall Study|Withdrawal by Subject|2|||
125590848|NCT01454076|451784219|FG000|Overall Study|Adverse Event|8|||
125590849|NCT01454076|451784220|FG001|Overall Study|Adverse Event|2|||
125590850|NCT01454076|451784221|FG002|Overall Study|Adverse Event|7|||
125590851|NCT01454076|451784222|FG003|Overall Study|Adverse Event|0|||
125590852|NCT01454076|451784223|FG004|Overall Study|Adverse Event|2|||
125590853|NCT04964258|451784224|FG000|Overall Study|Lost to Follow-up|1|||
125590854|NCT04964258|451784225|FG001|Overall Study|Lost to Follow-up|0|||
125590855|NCT04964258|451784226|FG002|Overall Study|Lost to Follow-up|0|||
125590856|NCT04964258|451784227|FG003|Overall Study|Lost to Follow-up|0|||
125590857|NCT04964258|451784228|FG004|Overall Study|Lost to Follow-up|0|||
125590858|NCT04964258|451784229|FG005|Overall Study|Lost to Follow-up|1|||
125590859|NCT04964258|451784230|FG006|Overall Study|Lost to Follow-up|0|||
125429427|NCT03444376|451196677|FG000|Part C|Physician Decision|2|||
125429428|NCT03444376|451196677|FG000|Part C|Death|1|||
125429429|NCT01984697|451198796|FG000|Overall Study|Adverse Event|0|||
125590860|NCT04964258|451784231|FG007|Overall Study|Lost to Follow-up|0|||
125429430|NCT01984697|451198797|FG001|Overall Study|Adverse Event|0|||
125590861|NCT04964258|451784232|FG008|Overall Study|Lost to Follow-up|0|||
125590862|NCT04964258|451784233|FG009|Overall Study|Lost to Follow-up|0|||
125590863|NCT04964258|451784234|FG010|Overall Study|Lost to Follow-up|0|||
125590864|NCT01478958|451784235|FG000|Overall Study|Withdrawal by Subject|1|||
125590865|NCT01478958|451784236|FG001|Overall Study|Withdrawal by Subject|1|||
125590866|NCT01478958|451784237|FG002|Overall Study|Withdrawal by Subject|1|||
125590867|NCT01478958|451784235|FG000|Overall Study|Weight loss|1|||
125590868|NCT01478958|451784236|FG001|Overall Study|Weight loss|0|||
125590869|NCT01478958|451784237|FG002|Overall Study|Weight loss|0|||
125590870|NCT01478958|451784235|FG000|Overall Study|Re-located|0|||
125590871|NCT01478958|451784236|FG001|Overall Study|Re-located|1|||
125590872|NCT01478958|451784237|FG002|Overall Study|Re-located|0|||
125429431|NCT01984697|451198798|FG002|Overall Study|Adverse Event|2|||
125590873|NCT01478958|451784235|FG000|Overall Study|Unable to comply|0|||
125590874|NCT01478958|451784236|FG001|Overall Study|Unable to comply|0|||
125590875|NCT01478958|451784237|FG002|Overall Study|Unable to comply|2|||
125590876|NCT03075839|451784238|FG000|Overall Study|Lost to Follow-up|4|||
125590877|NCT01499290|451784239|FG000|Overall Study|Withdrawal by Subject|22|||
125590878|NCT01499290|451784240|FG001|Overall Study|Withdrawal by Subject|15|||
125590879|NCT01499290|451784239|FG000|Overall Study|Not specified in study report|11|||
125590880|NCT01499290|451784240|FG001|Overall Study|Not specified in study report|5|||
125590881|NCT01499290|451784239|FG000|Overall Study|Condition improved/subject recovered|1|||
125590882|NCT01499290|451784240|FG001|Overall Study|Condition improved/subject recovered|0|||
125590883|NCT01499290|451784239|FG000|Overall Study|Lack of Efficacy|7|||
125590884|NCT01499290|451784240|FG001|Overall Study|Lack of Efficacy|8|||
125590885|NCT01499290|451784239|FG000|Overall Study|Adverse Event|14|||
125590886|NCT01499290|451784240|FG001|Overall Study|Adverse Event|7|||
125590887|NCT04052139|451784241|FG000|Overall Study|Lost to Follow-up|2|||
125590888|NCT04052139|451784242|FG001|Overall Study|Lost to Follow-up|0|||
125590889|NCT04052139|451784243|FG002|Overall Study|Lost to Follow-up|0|||
125590890|NCT04052139|451784241|FG000|Overall Study|Withdrawal by Subject|1|||
125590891|NCT04052139|451784242|FG001|Overall Study|Withdrawal by Subject|0|||
125590892|NCT04052139|451784243|FG002|Overall Study|Withdrawal by Subject|0|||
125590893|NCT02305563|451784244|FG000|Treatment Period|Disease progression|0|||
125590894|NCT02305563|451784245|FG001|Treatment Period|Disease progression|0|||
125590895|NCT02305563|451784246|FG002|Treatment Period|Disease progression|15|||
125590896|NCT02305563|451784247|FG003|Treatment Period|Disease progression|6|||
125590897|NCT02305563|451784248|FG004|Treatment Period|Disease progression|6|||
125590898|NCT02305563|451784244|FG000|Treatment Period|Study drug toxicity|0|||
125590899|NCT02305563|451784245|FG001|Treatment Period|Study drug toxicity|0|||
125590900|NCT02305563|451784246|FG002|Treatment Period|Study drug toxicity|0|||
125590901|NCT02305563|451784247|FG003|Treatment Period|Study drug toxicity|1|||
125590902|NCT02305563|451784248|FG004|Treatment Period|Study drug toxicity|2|||
125590903|NCT02305563|451784244|FG000|Treatment Period|Death|0|||
125590904|NCT02305563|451784245|FG001|Treatment Period|Death|0|||
125590905|NCT02305563|451784246|FG002|Treatment Period|Death|1|||
125590906|NCT02305563|451784247|FG003|Treatment Period|Death|2|||
125590907|NCT02305563|451784248|FG004|Treatment Period|Death|1|||
125590908|NCT02305563|451784244|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
125590909|NCT02305563|451784245|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
125590910|NCT02305563|451784246|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
125590911|NCT02305563|451784247|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
125590912|NCT02305563|451784248|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
125590913|NCT02305563|451784244|FG000|Treatment Period|Participant request to stop therapy|0|||
125590914|NCT02305563|451784245|FG001|Treatment Period|Participant request to stop therapy|2|||
125590915|NCT02305563|451784246|FG002|Treatment Period|Participant request to stop therapy|0|||
125590916|NCT02305563|451784247|FG003|Treatment Period|Participant request to stop therapy|1|||
125590917|NCT02305563|451784248|FG004|Treatment Period|Participant request to stop therapy|0|||
125590918|NCT02305563|451784244|FG000|Treatment Period|Participant withdrew consent|0|||
125590919|NCT02305563|451784245|FG001|Treatment Period|Participant withdrew consent|0|||
125590920|NCT02305563|451784246|FG002|Treatment Period|Participant withdrew consent|1|||
125590921|NCT02305563|451784247|FG003|Treatment Period|Participant withdrew consent|1|||
125590922|NCT02305563|451784248|FG004|Treatment Period|Participant withdrew consent|1|||
125590923|NCT02305563|451784244|FG000|Treatment Period|Maximum clinical benefit|0|||
125590924|NCT02305563|451784245|FG001|Treatment Period|Maximum clinical benefit|0|||
125590925|NCT02305563|451784246|FG002|Treatment Period|Maximum clinical benefit|0|||
125590926|NCT02305563|451784247|FG003|Treatment Period|Maximum clinical benefit|0|||
125590927|NCT02305563|451784248|FG004|Treatment Period|Maximum clinical benefit|1|||
125590928|NCT02305563|451784244|FG000|Treatment Period|Poor/non-compliance|0|||
125590929|NCT02305563|451784245|FG001|Treatment Period|Poor/non-compliance|0|||
125590930|NCT02305563|451784246|FG002|Treatment Period|Poor/non-compliance|0|||
125590931|NCT02305563|451784247|FG003|Treatment Period|Poor/non-compliance|0|||
125590932|NCT02305563|451784248|FG004|Treatment Period|Poor/non-compliance|1|||
125590933|NCT02305563|451784244|FG000|Treatment Period|Administrative reason by Sponsor|0|||
125590934|NCT02305563|451784245|FG001|Treatment Period|Administrative reason by Sponsor|0|||
125590935|NCT02305563|451784246|FG002|Treatment Period|Administrative reason by Sponsor|0|||
125590936|NCT02305563|451784247|FG003|Treatment Period|Administrative reason by Sponsor|0|||
125590937|NCT02305563|451784248|FG004|Treatment Period|Administrative reason by Sponsor|1|||
125590938|NCT02305563|451784244|FG000|Treatment Period|other reason|2|||
125590939|NCT02305563|451784245|FG001|Treatment Period|other reason|0|||
125590940|NCT02305563|451784246|FG002|Treatment Period|other reason|2|||
125590941|NCT02305563|451784247|FG003|Treatment Period|other reason|2|||
125590942|NCT02305563|451784248|FG004|Treatment Period|other reason|1|||
125590943|NCT02305563|451784244|FG000|Treatment Period|Randomized but not treated|0|||
125590944|NCT02305563|451784245|FG001|Treatment Period|Randomized but not treated|0|||
125590945|NCT02305563|451784246|FG002|Treatment Period|Randomized but not treated|0|||
125590946|NCT02305563|451784247|FG003|Treatment Period|Randomized but not treated|0|||
125590947|NCT02305563|451784248|FG004|Treatment Period|Randomized but not treated|2|||
125590948|NCT02305563|451784244|FG000|Treatment Period|added ULO, then disease progression|0|||
125590949|NCT02305563|451784245|FG001|Treatment Period|added ULO, then disease progression|0|||
125590950|NCT02305563|451784246|FG002|Treatment Period|added ULO, then disease progression|0|||
125590951|NCT02305563|451784247|FG003|Treatment Period|added ULO, then disease progression|0|||
125590952|NCT02305563|451784248|FG004|Treatment Period|added ULO, then disease progression|4|||
125590953|NCT02305563|451784244|FG000|Treatment Period|added ULO; then other reason|0|||
125590954|NCT02305563|451784245|FG001|Treatment Period|added ULO; then other reason|0|||
125590955|NCT02305563|451784246|FG002|Treatment Period|added ULO; then other reason|0|||
125590956|NCT02305563|451784247|FG003|Treatment Period|added ULO; then other reason|0|||
125363376|NCT00386607|450963600|FG000|Core|Protocol Deviation|6|||
125363377|NCT00386607|450963601|FG001|Core|Protocol Deviation|0|||
125363378|NCT00386607|450963600|FG000|Extension|Adverse Event|0|||
125363379|NCT00386607|450963601|FG001|Extension|Adverse Event|6|||
125363380|NCT00386607|450963600|FG000|Extension|Abnormal laboratory value(s)|0|||
125363381|NCT00386607|450963601|FG001|Extension|Abnormal laboratory value(s)|1|||
125363382|NCT00386607|450963600|FG000|Extension|Administrative problems|0|||
125363383|NCT00386607|450963601|FG001|Extension|Administrative problems|1|||
125363384|NCT00386607|450963600|FG000|Extension|Lost to Follow-up|0|||
125363385|NCT00386607|450963601|FG001|Extension|Lost to Follow-up|3|||
125363386|NCT00386607|450963600|FG000|Extension|Patient withdrew consent|0|||
125363387|NCT00386607|450963601|FG001|Extension|Patient withdrew consent|5|||
125363388|NCT00386607|450963600|FG000|Extension|Unsatisfactory therapeutic effect|0|||
125363389|NCT00386607|450963601|FG001|Extension|Unsatisfactory therapeutic effect|1|||
125363390|NCT04251273|450963604|FG000|Overall Study|Lost to Follow-up|331|||
125363391|NCT04251273|450963605|FG001|Overall Study|Lost to Follow-up|290|||
125363392|NCT01986907|450963606|FG000|Overall Study|Adverse Event|11|||
125363393|NCT01986907|450963606|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
125363394|NCT01986907|450963606|FG000|Overall Study|Protocol Violation|4|||
125363395|NCT01986907|450963606|FG000|Overall Study|Withdrawal by Subject|76|||
125363396|NCT01986907|450963606|FG000|Overall Study|Lost to Follow-up|38|||
125363397|NCT01986907|450963606|FG000|Overall Study|Death|9|||
125363398|NCT00810693|450963607|FG000|Treatment Period|Adverse Event|8|||
125363399|NCT00810693|450963608|FG001|Treatment Period|Adverse Event|1|||
125363400|NCT00810693|450963609|FG002|Treatment Period|Adverse Event|7|||
125363401|NCT00810693|450963607|FG000|Treatment Period|Death|0|||
125363402|NCT00810693|450963608|FG001|Treatment Period|Death|1|||
125363403|NCT00810693|450963609|FG002|Treatment Period|Death|2|||
125363404|NCT00810693|450963607|FG000|Treatment Period|Lack of Efficacy|0|||
125363405|NCT00810693|450963608|FG001|Treatment Period|Lack of Efficacy|0|||
125363406|NCT00810693|450963609|FG002|Treatment Period|Lack of Efficacy|1|||
125363407|NCT00810693|450963607|FG000|Treatment Period|Lost to Follow-up|1|||
125363408|NCT00810693|450963608|FG001|Treatment Period|Lost to Follow-up|0|||
125363409|NCT00810693|450963609|FG002|Treatment Period|Lost to Follow-up|0|||
125363410|NCT00810693|450963607|FG000|Treatment Period|Non-compliance|1|||
125363411|NCT00810693|450963608|FG001|Treatment Period|Non-compliance|0|||
125363412|NCT00810693|450963609|FG002|Treatment Period|Non-compliance|0|||
125363413|NCT00810693|450963607|FG000|Treatment Period|Protocol Violation|1|||
125363414|NCT00810693|450963608|FG001|Treatment Period|Protocol Violation|2|||
125363415|NCT00810693|450963609|FG002|Treatment Period|Protocol Violation|2|||
125363416|NCT00810693|450963607|FG000|Treatment Period|Withdrawal by Subject|6|||
125363417|NCT00810693|450963608|FG001|Treatment Period|Withdrawal by Subject|2|||
125363418|NCT00810693|450963609|FG002|Treatment Period|Withdrawal by Subject|3|||
125363419|NCT00810693|450963607|FG000|Treatment Period|Not treated|0|||
125363420|NCT00810693|450963608|FG001|Treatment Period|Not treated|1|||
125363421|NCT00810693|450963609|FG002|Treatment Period|Not treated|1|||
125363422|NCT00810693|450963607|FG000|Follow-up Period (FUP)|Adverse Event|3|||
125363423|NCT00810693|450963608|FG001|Follow-up Period (FUP)|Adverse Event|1|||
125363424|NCT00810693|450963609|FG002|Follow-up Period (FUP)|Adverse Event|1|||
125363425|NCT00810693|450963607|FG000|Follow-up Period (FUP)|Death|2|||
125363426|NCT00810693|450963608|FG001|Follow-up Period (FUP)|Death|0|||
125363427|NCT00810693|450963609|FG002|Follow-up Period (FUP)|Death|1|||
125363428|NCT00810693|450963607|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
125363429|NCT00810693|450963608|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
125363430|NCT00810693|450963609|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
125363431|NCT00810693|450963607|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
125363432|NCT00810693|450963608|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
125363433|NCT00810693|450963609|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
125363434|NCT00810693|450963607|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
125363435|NCT00810693|450963608|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
125590957|NCT02305563|451784248|FG004|Treatment Period|added ULO; then other reason|1|||
125590958|NCT02305563|451784244|FG000|Treatment Period|added ULO, then request to stop|0|||
125363436|NCT00810693|450963609|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
125363437|NCT03212690|450963610|FG000|Overall Study|Protocol Violation|1|||
125363438|NCT04203797|450963618|FG000|Overall Study|Adverse Event|1|||
125363439|NCT04203797|450963619|FG001|Overall Study|Adverse Event|0|||
125363440|NCT04203797|450963618|FG000|Overall Study|Did not complete End of Study follow-up|1|||
125363441|NCT04203797|450963619|FG001|Overall Study|Did not complete End of Study follow-up|0|||
125363442|NCT00516074|450963620|FG000|Overall Study|Adverse Event|0|||
125363443|NCT00516074|450963621|FG001|Overall Study|Adverse Event|1|||
125363444|NCT00516074|450963620|FG000|Overall Study|Subject Decision|4|||
125363445|NCT00516074|450963621|FG001|Overall Study|Subject Decision|2|||
125363446|NCT00516074|450963620|FG000|Overall Study|Loss of Glucose Control|2|||
125363447|NCT00516074|450963621|FG001|Overall Study|Loss of Glucose Control|0|||
125363448|NCT02215096|450963623|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
125363449|NCT02215096|450963624|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
125363450|NCT02215096|450963625|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
125429432|NCT01984697|451198799|FG003|Overall Study|Adverse Event|0|||
125590959|NCT02305563|451784245|FG001|Treatment Period|added ULO, then request to stop|0|||
125590960|NCT02305563|451784246|FG002|Treatment Period|added ULO, then request to stop|0|||
125590961|NCT02305563|451784247|FG003|Treatment Period|added ULO, then request to stop|0|||
125590962|NCT02305563|451784248|FG004|Treatment Period|added ULO, then request to stop|1|||
125590963|NCT02305563|451784244|FG000|Follow-up Period|Death|0|||
125590964|NCT02305563|451784245|FG001|Follow-up Period|Death|0|||
125590965|NCT02305563|451784246|FG002|Follow-up Period|Death|5|||
125590966|NCT02305563|451784247|FG003|Follow-up Period|Death|4|||
125590967|NCT02305563|451784248|FG004|Follow-up Period|Death|7|||
125590968|NCT02305563|451784244|FG000|Follow-up Period|Participant withdrew consent|0|||
125590969|NCT02305563|451784245|FG001|Follow-up Period|Participant withdrew consent|0|||
125590970|NCT02305563|451784246|FG002|Follow-up Period|Participant withdrew consent|2|||
125212145|NCT04575584|450403276|FG005|Overall Study|Physician Decision|0|||
125212146|NCT04575584|450403271|FG000|Overall Study|Withdrawal by Subject|7|||
125212147|NCT04575584|450403272|FG001|Overall Study|Withdrawal by Subject|9|||
125212148|NCT04575584|450403273|FG002|Overall Study|Withdrawal by Subject|5|||
125212149|NCT04575584|450403274|FG003|Overall Study|Withdrawal by Subject|3|||
125212150|NCT04575584|450403275|FG004|Overall Study|Withdrawal by Subject|0|||
125212151|NCT04575584|450403276|FG005|Overall Study|Withdrawal by Subject|0|||
125212152|NCT04575584|450403271|FG000|Overall Study|Not recorded|0|||
125212153|NCT04575584|450403272|FG001|Overall Study|Not recorded|0|||
125212154|NCT04575584|450403273|FG002|Overall Study|Not recorded|0|||
125212155|NCT04575584|450403274|FG003|Overall Study|Not recorded|1|||
125212156|NCT04575584|450403275|FG004|Overall Study|Not recorded|0|||
125212157|NCT04575584|450403276|FG005|Overall Study|Not recorded|0|||
125212158|NCT03488563|450403277|FG000|Overall Study|Lost to Follow-up|7|||
125212159|NCT03488563|450403278|FG001|Overall Study|Lost to Follow-up|6|||
125212160|NCT03488563|450403279|FG002|Overall Study|Lost to Follow-up|7|||
125212161|NCT03488563|450403277|FG000|Overall Study|Withdrawal by Subject|8|||
125212162|NCT03488563|450403278|FG001|Overall Study|Withdrawal by Subject|7|||
125212163|NCT03488563|450403279|FG002|Overall Study|Withdrawal by Subject|7|||
125212164|NCT03488563|450403277|FG000|Overall Study|Physician Decision|0|||
125212165|NCT03488563|450403278|FG001|Overall Study|Physician Decision|0|||
125212166|NCT03488563|450403279|FG002|Overall Study|Physician Decision|1|||
125212167|NCT03488563|450403277|FG000|Overall Study|Protocol Violation|3|||
125212168|NCT03488563|450403278|FG001|Overall Study|Protocol Violation|2|||
125212169|NCT03488563|450403279|FG002|Overall Study|Protocol Violation|6|||
125212170|NCT03488563|450403277|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
125212171|NCT03488563|450403278|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
125212172|NCT03488563|450403279|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
125212173|NCT03488563|450403277|FG000|Overall Study|Use of prohibited medication|2|||
125212174|NCT03488563|450403278|FG001|Overall Study|Use of prohibited medication|0|||
125212175|NCT03488563|450403279|FG002|Overall Study|Use of prohibited medication|0|||
125212176|NCT03488563|450403277|FG000|Overall Study|Adverse Event|1|||
125212177|NCT03488563|450403278|FG001|Overall Study|Adverse Event|0|||
125363451|NCT02215096|450963626|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
125363452|NCT02215096|450963627|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
125363453|NCT02215096|450963623|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
125363454|NCT02215096|450963624|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
125363455|NCT02215096|450963625|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
125363456|NCT02215096|450963626|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
125363457|NCT02215096|450963627|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
125363458|NCT02215096|450963623|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
125363459|NCT02215096|450963624|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
125363460|NCT02215096|450963625|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
125363461|NCT02215096|450963626|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
125363462|NCT02215096|450963627|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
125363463|NCT02215096|450963623|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
125363464|NCT02215096|450963624|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
125363465|NCT02215096|450963625|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
125363466|NCT02215096|450963626|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
125363467|NCT02215096|450963627|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
125363468|NCT00287365|450963628|FG000|Overall Study|sample not acquired|13|||
125363469|NCT03021304|450963629|FG000|Overall Study|Lack of Efficacy|1|||
125363470|NCT02663908|450963630|FG000|Overall Study|Withdrawal by Subject|8|||
125363471|NCT02663908|450963631|FG001|Overall Study|Withdrawal by Subject|5|||
125363472|NCT02663908|450963630|FG000|Overall Study|Lost to Follow-up|1|||
125363473|NCT02663908|450963631|FG001|Overall Study|Lost to Follow-up|5|||
125363474|NCT02663908|450963630|FG000|Overall Study|Adverse Event|13|||
125363475|NCT02663908|450963631|FG001|Overall Study|Adverse Event|11|||
125363476|NCT02663908|450963630|FG000|Overall Study|Protocol Violation|1|||
125363477|NCT02663908|450963631|FG001|Overall Study|Protocol Violation|2|||
125590971|NCT02305563|451784247|FG003|Follow-up Period|Participant withdrew consent|1|||
125363478|NCT02663908|450963630|FG000|Overall Study|Lack of therapeutic response|2|||
125363479|NCT02663908|450963631|FG001|Overall Study|Lack of therapeutic response|0|||
125363480|NCT02663908|450963630|FG000|Overall Study|COVID-19|1|||
125363481|NCT02663908|450963631|FG001|Overall Study|COVID-19|0|||
125363482|NCT02663908|450963630|FG000|Overall Study|Site closed|1|||
125363483|NCT02663908|450963631|FG001|Overall Study|Site closed|0|||
125363484|NCT02663908|450963630|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
125363485|NCT02663908|450963631|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
125363486|NCT02663908|450963630|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
125363487|NCT02663908|450963631|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
125363488|NCT02663908|450963630|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
125363489|NCT02663908|450963631|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
125363490|NCT02663908|450963630|FG000|Overall Study|Death|1|||
125363491|NCT02663908|450963631|FG001|Overall Study|Death|0|||
125363492|NCT02663908|450963630|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
125363493|NCT02663908|450963631|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
125363494|NCT02663908|450963630|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
125363495|NCT02663908|450963631|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
125363496|NCT03308786|450963633|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
125363497|NCT00370071|450963636|FG000|Overall Study|Withdrawal by Subject|2|||
125363498|NCT00319501|450963637|FG000|Double-blind Period|Withdrawal by Subject|0|||
125363499|NCT00319501|450963638|FG001|Double-blind Period|Withdrawal by Subject|3|||
125590972|NCT02305563|451784248|FG004|Follow-up Period|Participant withdrew consent|0|||
125590973|NCT02305563|451784244|FG000|Follow-up Period|other reason|0|||
125590974|NCT02305563|451784245|FG001|Follow-up Period|other reason|0|||
125590975|NCT02305563|451784246|FG002|Follow-up Period|other reason|0|||
125590976|NCT02305563|451784247|FG003|Follow-up Period|other reason|0|||
125590977|NCT02305563|451784248|FG004|Follow-up Period|other reason|1|||
125590978|NCT02305563|451784244|FG000|Follow-up Period|Followup no longer required per protocol|3|||
125590979|NCT02305563|451784245|FG001|Follow-up Period|Followup no longer required per protocol|3|||
125590980|NCT02305563|451784246|FG002|Follow-up Period|Followup no longer required per protocol|4|||
125590981|NCT02305563|451784247|FG003|Follow-up Period|Followup no longer required per protocol|1|||
125590982|NCT02305563|451784248|FG004|Follow-up Period|Followup no longer required per protocol|4|||
125590983|NCT01926626|451784251|FG000|Overall Study|Withdrawal by Subject|15|||
125590984|NCT01926626|451784251|FG000|Overall Study|Lost to Follow-up|7|||
125590985|NCT00998738|451784252|FG000|Overall Study|Uknown|1|||
125590986|NCT03896581|451786216|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
125590987|NCT03896581|451786217|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
125590988|NCT03896581|451786216|FG000|Overall Study|Withdrawal by Subject|4|||
125590989|NCT03896581|451786217|FG001|Overall Study|Withdrawal by Subject|1|||
125590990|NCT03896581|451786216|FG000|Overall Study|Lost to Follow-up|1|||
125590991|NCT03896581|451786217|FG001|Overall Study|Lost to Follow-up|0|||
125590992|NCT03896581|451786216|FG000|Overall Study|Lack of Efficacy|2|||
125590993|NCT03896581|451786217|FG001|Overall Study|Lack of Efficacy|1|||
125590994|NCT03896581|451786216|FG000|Overall Study|Adverse event, non-fatal|0|||
125590995|NCT03896581|451786217|FG001|Overall Study|Adverse event, non-fatal|2|||
125590996|NCT04375761|451786218|FG000|Overall Study|Death|1|||
125590997|NCT04375761|451786219|FG001|Overall Study|Death|2|||
125590998|NCT04375761|451786218|FG000|Overall Study|Lost to Follow-up|203|||
125590999|NCT04375761|451786219|FG001|Overall Study|Lost to Follow-up|380|||
125591000|NCT04375761|451786218|FG000|Overall Study|Withdrawal by Subject|47|||
125591001|NCT04375761|451786219|FG001|Overall Study|Withdrawal by Subject|98|||
125591002|NCT04375761|451786218|FG000|Overall Study|Noncompliance with study procedure|121|||
125591003|NCT04375761|451786219|FG001|Overall Study|Noncompliance with study procedure|251|||
125591004|NCT04375761|451786218|FG000|Overall Study|Reimbursement not enough|1|||
125591005|NCT04375761|451786219|FG001|Overall Study|Reimbursement not enough|2|||
125591006|NCT04375761|451786218|FG000|Overall Study|Unforeseen family circumstances|1|||
125591007|NCT04375761|451786219|FG001|Overall Study|Unforeseen family circumstances|3|||
125591008|NCT04375761|451786218|FG000|Overall Study|Test too painful|1|||
125591009|NCT04375761|451786219|FG001|Overall Study|Test too painful|1|||
125591010|NCT04375761|451786218|FG000|Overall Study|Moved|0|||
125591011|NCT04375761|451786219|FG001|Overall Study|Moved|2|||
125591012|NCT04375761|451786218|FG000|Overall Study|Nonresponsive|0|||
125591013|NCT04375761|451786219|FG001|Overall Study|Nonresponsive|5|||
125591014|NCT03797001|451786220|FG000|Overall Study|Withdrawn due to COVID19|4|||
125591015|NCT03797001|451786221|FG001|Overall Study|Withdrawn due to COVID19|0|||
125591016|NCT03797001|451786220|FG000|Overall Study|Withdrawal by Subject|7|||
125591017|NCT03797001|451786221|FG001|Overall Study|Withdrawal by Subject|6|||
125363500|NCT00319501|450963637|FG000|Double-blind Period|Sponsor Request|1|||
125363501|NCT00319501|450963638|FG001|Double-blind Period|Sponsor Request|0|||
125363502|NCT00319501|450963637|FG000|Double-blind Period|Did not receive treatment|42|||
125363503|NCT00319501|450963638|FG001|Double-blind Period|Did not receive treatment|29|||
125363504|NCT00319501|450963637|FG000|Open-label Period|Adverse Event|5|||
125363505|NCT00319501|450963638|FG001|Open-label Period|Adverse Event|0|||
125363506|NCT00319501|450963637|FG000|Open-label Period|Protocol Violation|6|||
125363507|NCT00319501|450963638|FG001|Open-label Period|Protocol Violation|0|||
125363508|NCT00319501|450963637|FG000|Open-label Period|Withdrawal by Subject|38|||
125363509|NCT00319501|450963638|FG001|Open-label Period|Withdrawal by Subject|0|||
125363510|NCT00319501|450963637|FG000|Open-label Period|Principal Investigator decision|6|||
125363511|NCT00319501|450963638|FG001|Open-label Period|Principal Investigator decision|0|||
125363512|NCT00319501|450963637|FG000|Open-label Period|Sponsor request|12|||
125363513|NCT00319501|450963638|FG001|Open-label Period|Sponsor request|0|||
125363514|NCT00319501|450963637|FG000|Open-label Period|Lost to Follow-up|5|||
125363515|NCT00319501|450963638|FG001|Open-label Period|Lost to Follow-up|0|||
125363516|NCT00319501|450963637|FG000|Open-label Period|Did not receive treatment|33|||
125363517|NCT00319501|450963638|FG001|Open-label Period|Did not receive treatment|0|||
125363518|NCT00319501|450963637|FG000|Open-label Period|Other|11|||
125363519|NCT00319501|450963638|FG001|Open-label Period|Other|0|||
125363520|NCT00319501|450963637|FG000|Open-label Extension Period|Adverse Event|2|||
125363521|NCT00319501|450963638|FG001|Open-label Extension Period|Adverse Event|0|||
125363522|NCT00319501|450963637|FG000|Open-label Extension Period|Did not receive treatment|18|||
125363523|NCT00319501|450963638|FG001|Open-label Extension Period|Did not receive treatment|0|||
125363524|NCT00319501|450963637|FG000|Open-label Extension Period|Other|1|||
125363525|NCT00319501|450963638|FG001|Open-label Extension Period|Other|0|||
125363526|NCT00319501|450963637|FG000|Open-label Extension Period|Principal investigator decision|2|||
125363527|NCT00319501|450963638|FG001|Open-label Extension Period|Principal investigator decision|0|||
125363528|NCT00319501|450963637|FG000|Open-label Extension Period|Sponsor request|26|||
125363529|NCT00319501|450963638|FG001|Open-label Extension Period|Sponsor request|0|||
125363530|NCT00319501|450963637|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
125591018|NCT03797001|451786220|FG000|Overall Study|Adverse Event|0|||
125591019|NCT03797001|451786221|FG001|Overall Study|Adverse Event|1|||
125591020|NCT05630846|451786224|FG000|Overall Study|Death|1|||
125591021|NCT05630846|451786225|FG001|Overall Study|Death|0|||
125591022|NCT05630846|451786226|FG002|Overall Study|Death|0|||
125591023|NCT05630846|451786227|FG003|Overall Study|Death|0|||
125363531|NCT00319501|450963638|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
125363532|NCT01441180|450963644|FG000|Overall Study|Lost to Follow-up|1|||
125363533|NCT01441180|450963645|FG001|Overall Study|Lost to Follow-up|1|||
125363534|NCT01441180|450963646|FG002|Overall Study|Lost to Follow-up|1|||
125363535|NCT01441180|450963644|FG000|Overall Study|Discontinued|0|||
125363536|NCT01441180|450963645|FG001|Overall Study|Discontinued|0|||
125363537|NCT01441180|450963646|FG002|Overall Study|Discontinued|2|||
125363538|NCT01402011|450963651|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
125363539|NCT01402011|450963652|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
125363540|NCT01402011|450963653|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
125363541|NCT01402011|450963651|FG000|Active Treatment Period|Withdrawal by Subject|1|||
125363542|NCT01402011|450963652|FG001|Active Treatment Period|Withdrawal by Subject|3|||
125363543|NCT01402011|450963653|FG002|Active Treatment Period|Withdrawal by Subject|0|||
125363544|NCT01402011|450963651|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
125363545|NCT01402011|450963652|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
125363546|NCT01402011|450963653|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
125591024|NCT05630846|451786224|FG000|Overall Study|Withdrawal by Subject|3|||
125363547|NCT00825682|450965127|FG000|Overall Study|personal reasons/ inconvenience|13|||
125363548|NCT00825682|450965128|FG001|Overall Study|personal reasons/ inconvenience|5|||
125363549|NCT00316719|450965129|FG000|Overall Study|Adverse Event|0|||
125363550|NCT00316719|450965130|FG001|Overall Study|Adverse Event|6|||
125363551|NCT00316719|450965129|FG000|Overall Study|Consent withdrawn|2|||
125591025|NCT05630846|451786225|FG001|Overall Study|Withdrawal by Subject|3|||
125591026|NCT05630846|451786226|FG002|Overall Study|Withdrawal by Subject|4|||
125591027|NCT05630846|451786227|FG003|Overall Study|Withdrawal by Subject|1|||
125363552|NCT00316719|450965130|FG001|Overall Study|Consent withdrawn|0|||
125591028|NCT05630846|451786224|FG000|Overall Study|Lost to Follow-up|6|||
125363553|NCT01644565|450965133|FG000|Overall Study|Undisclosed Medical History|1|||
125363554|NCT01644565|450965134|FG001|Overall Study|Undisclosed Medical History|0|||
125363555|NCT01644565|450965135|FG002|Overall Study|Undisclosed Medical History|0|||
125363556|NCT01644565|450965136|FG003|Overall Study|Undisclosed Medical History|0|||
125363557|NCT01644565|450965137|FG004|Overall Study|Undisclosed Medical History|0|||
125363558|NCT01644565|450965138|FG005|Overall Study|Undisclosed Medical History|0|||
125591029|NCT05630846|451786225|FG001|Overall Study|Lost to Follow-up|5|||
125591030|NCT05630846|451786226|FG002|Overall Study|Lost to Follow-up|2|||
125591031|NCT05630846|451786227|FG003|Overall Study|Lost to Follow-up|5|||
125591032|NCT05630846|451786224|FG000|Overall Study|Other|1|||
125591033|NCT05630846|451786225|FG001|Overall Study|Other|0|||
125591034|NCT05630846|451786226|FG002|Overall Study|Other|0|||
125591035|NCT05630846|451786227|FG003|Overall Study|Other|0|||
125591036|NCT00960076|451786239|FG000|Overall Study|Adverse Event|1|||
125591037|NCT00960076|451786240|FG001|Overall Study|Adverse Event|7|||
125591038|NCT00960076|451786239|FG000|Overall Study|No longer met study criteria|1|||
125591039|NCT00960076|451786240|FG001|Overall Study|No longer met study criteria|5|||
125591040|NCT00960076|451786239|FG000|Overall Study|Withdrawal by Subject|1|||
125591041|NCT00960076|451786240|FG001|Overall Study|Withdrawal by Subject|2|||
125591042|NCT00960076|451786239|FG000|Overall Study|Lost to Follow-up|3|||
125591043|NCT00960076|451786240|FG001|Overall Study|Lost to Follow-up|3|||
125591044|NCT00960076|451786239|FG000|Overall Study|Severe non-compliance to protocol|1|||
125591045|NCT00960076|451786240|FG001|Overall Study|Severe non-compliance to protocol|2|||
125591046|NCT00960076|451786239|FG000|Overall Study|Hyperglycemia|1|||
125591047|NCT00960076|451786240|FG001|Overall Study|Hyperglycemia|5|||
125591048|NCT00960076|451786239|FG000|Overall Study|Did not attend the termination visit|0|||
125591049|NCT00960076|451786240|FG001|Overall Study|Did not attend the termination visit|1|||
125591050|NCT00500266|451786241|FG000|Overall Study|Death|3|||
125591051|NCT00500266|451786241|FG000|Overall Study|Lost to Follow-up|3|||
125591052|NCT00500266|451786241|FG000|Overall Study|Withdrawal by Subject|3|||
125591053|NCT00500266|451786241|FG000|Overall Study|Assigned, not treated|4|||
125591054|NCT01431287|451786242|FG000|Overall Study|not treated|0|||
125591055|NCT01431287|451786243|FG001|Overall Study|not treated|0|||
125591056|NCT01431287|451786244|FG002|Overall Study|not treated|1|||
125591057|NCT01431287|451786245|FG003|Overall Study|not treated|0|||
125591058|NCT01431287|451786246|FG004|Overall Study|not treated|0|||
125591059|NCT01431287|451786242|FG000|Overall Study|Adverse Event|59|||
125591060|NCT01431287|451786243|FG001|Overall Study|Adverse Event|57|||
125591061|NCT01431287|451786244|FG002|Overall Study|Adverse Event|53|||
125591062|NCT01431287|451786245|FG003|Overall Study|Adverse Event|33|||
125591063|NCT01431287|451786246|FG004|Overall Study|Adverse Event|41|||
125591064|NCT01431287|451786242|FG000|Overall Study|Non compliant with protocol|6|||
125591065|NCT01431287|451786243|FG001|Overall Study|Non compliant with protocol|6|||
125591066|NCT01431287|451786244|FG002|Overall Study|Non compliant with protocol|5|||
125591067|NCT01431287|451786245|FG003|Overall Study|Non compliant with protocol|6|||
125591068|NCT01431287|451786246|FG004|Overall Study|Non compliant with protocol|5|||
125591069|NCT01431287|451786242|FG000|Overall Study|Lost to Follow-up|0|||
125591070|NCT01431287|451786243|FG001|Overall Study|Lost to Follow-up|3|||
125591071|NCT01431287|451786244|FG002|Overall Study|Lost to Follow-up|2|||
125591072|NCT01431287|451786245|FG003|Overall Study|Lost to Follow-up|3|||
125591073|NCT01431287|451786246|FG004|Overall Study|Lost to Follow-up|1|||
125591074|NCT01431287|451786242|FG000|Overall Study|Consent withdrawn not due to AE|29|||
125212178|NCT03488563|450403279|FG002|Overall Study|Adverse Event|1|||
125212179|NCT03488563|450403277|FG000|Overall Study|Subject returned for ET visit|0|||
125212180|NCT03488563|450403278|FG001|Overall Study|Subject returned for ET visit|1|||
125212181|NCT03488563|450403279|FG002|Overall Study|Subject returned for ET visit|0|||
125212182|NCT03488563|450403277|FG000|Overall Study|Sponsor's decision|0|||
125212183|NCT03488563|450403278|FG001|Overall Study|Sponsor's decision|0|||
125212184|NCT03488563|450403279|FG002|Overall Study|Sponsor's decision|1|||
125212185|NCT02815267|450403287|FG000|Double-Blind Phase|Adverse Event|0|||
125212186|NCT02815267|450403288|FG001|Double-Blind Phase|Adverse Event|3|||
125212187|NCT02815267|450403287|FG000|Double-Blind Phase|Lost to Follow-up|17|||
125591075|NCT01431287|451786243|FG001|Overall Study|Consent withdrawn not due to AE|30|||
125212188|NCT02815267|450403288|FG001|Double-Blind Phase|Lost to Follow-up|9|||
125212189|NCT02815267|450403287|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
125363559|NCT01644565|450965139|FG006|Overall Study|Undisclosed Medical History|0|||
125591076|NCT01431287|451786244|FG002|Overall Study|Consent withdrawn not due to AE|34|||
125591077|NCT01431287|451786245|FG003|Overall Study|Consent withdrawn not due to AE|19|||
125591078|NCT01431287|451786246|FG004|Overall Study|Consent withdrawn not due to AE|29|||
125591079|NCT01431287|451786242|FG000|Overall Study|not stated above|4|||
125591080|NCT01431287|451786243|FG001|Overall Study|not stated above|2|||
125591081|NCT01431287|451786244|FG002|Overall Study|not stated above|2|||
125591082|NCT01431287|451786245|FG003|Overall Study|not stated above|2|||
125591083|NCT01431287|451786246|FG004|Overall Study|not stated above|1|||
125591084|NCT00075881|451786247|FG000|Overall Study|Lack of Efficacy|18|||
125591085|NCT00075881|451786247|FG000|Overall Study|Adverse Event|7|||
125591086|NCT00075881|451786247|FG000|Overall Study|Death|1|||
125591087|NCT00075881|451786247|FG000|Overall Study|Withdrawal by Subject|2|||
125591088|NCT00075881|451786247|FG000|Overall Study|Protocol Violation|4|||
125591089|NCT00075881|451786247|FG000|Overall Study|other complicating disease|3|||
125591090|NCT00075881|451786247|FG000|Overall Study|other|4|||
125591091|NCT00075881|451786247|FG000|Overall Study|missing data|2|||
125591092|NCT00075881|451786247|FG000|Overall Study|Ineligible|1|||
125591093|NCT00075881|451786247|FG000|Overall Study|never start protocol therapy|1|||
125591094|NCT02224664|451786248|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
125591095|NCT02224664|451786249|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
125591096|NCT02224664|451786250|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
125591097|NCT02224664|451786251|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
125591098|NCT02224664|451786252|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
125591099|NCT02224664|451786248|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
125591100|NCT02224664|451786249|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
125591101|NCT02224664|451786250|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
125591102|NCT02224664|451786251|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
125591103|NCT02224664|451786252|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
125591104|NCT02224664|451786248|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
125591105|NCT02224664|451786249|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
125591106|NCT02224664|451786250|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
125591107|NCT02224664|451786251|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
125591108|NCT02224664|451786252|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
125591109|NCT03019549|451786253|FG000|Washout|DId not meet genotype criteria|11|||
125363560|NCT01644565|450965140|FG007|Overall Study|Undisclosed Medical History|0|||
125363561|NCT01644565|450965141|FG008|Overall Study|Undisclosed Medical History|0|||
125429433|NCT01984697|451198800|FG004|Overall Study|Adverse Event|0|||
125591110|NCT03019549|451786253|FG000|Period 2|Adverse Event|2|||
125591111|NCT03019549|451786253|FG000|Period 2|Physician Decision|2|||
125591112|NCT03019549|451786253|FG000|Period 2|Withdrawal by Subject|1|||
125591113|NCT02109029|451786256|FG000|Part B|Adverse Event|0|||
125591114|NCT02109029|451786257|FG001|Part B|Adverse Event|0|||
125591115|NCT02109029|451786258|FG002|Part B|Adverse Event|0|||
125591116|NCT02109029|451786259|FG003|Part B|Adverse Event|0|||
125591117|NCT02109029|451786260|FG004|Part B|Adverse Event|1|||
125591118|NCT02109029|451786261|FG005|Part B|Adverse Event|1|||
125591119|NCT00110305|451786262|FG000|Overall Study|Adverse Event|46|||
125591120|NCT00110305|451786263|FG001|Overall Study|Adverse Event|13|||
125591121|NCT00110305|451786262|FG000|Overall Study|Sponsors Decision|1|||
125591122|NCT00110305|451786263|FG001|Overall Study|Sponsors Decision|0|||
125591123|NCT00110305|451786262|FG000|Overall Study|Subject Non-Compliant|9|||
125591124|NCT00110305|451786263|FG001|Overall Study|Subject Non-Compliant|2|||
125591125|NCT00110305|451786262|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
125591126|NCT00110305|451786263|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
125591127|NCT00110305|451786262|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
125591128|NCT00110305|451786263|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
125591129|NCT00110305|451786262|FG000|Overall Study|Protocol Violation|0|||
125591130|NCT00110305|451786263|FG001|Overall Study|Protocol Violation|1|||
125591131|NCT00110305|451786262|FG000|Overall Study|Withdrawal by Subject|7|||
125591132|NCT00110305|451786263|FG001|Overall Study|Withdrawal by Subject|7|||
125591133|NCT00110305|451786262|FG000|Overall Study|Lost to Follow-up|20|||
125591134|NCT00110305|451786263|FG001|Overall Study|Lost to Follow-up|3|||
125591135|NCT00110305|451786262|FG000|Overall Study|Other|8|||
125591136|NCT00110305|451786263|FG001|Overall Study|Other|2|||
125591137|NCT00215150|451786267|FG000|Open Label Phase|Lost to Follow-up|7|||
125591138|NCT00215150|451786267|FG000|Open Label Phase|Withdrawal by Subject|1|||
125591139|NCT00215150|451786267|FG000|Open Label Phase|Did not complete a post base visit|13|||
125591140|NCT00215150|451786267|FG000|Open Label Phase|Did not meet randomization criteria|9|||
125591141|NCT00215150|451786267|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
125591142|NCT00215150|451786267|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
125591143|NCT00215150|451786267|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
125591144|NCT02251743|451786268|FG000|Overall Study|Withdrawal by Subject|1|||
125591145|NCT02251743|451786269|FG001|Overall Study|Withdrawal by Subject|1|||
125591146|NCT00260208|451786273|FG000|Overall Study|Subject withdrew consent|11|||
125591147|NCT00260208|451786274|FG001|Overall Study|Subject withdrew consent|7|||
125591148|NCT00260208|451786273|FG000|Overall Study|Lost to Follow-up|6|||
125591149|NCT00260208|451786274|FG001|Overall Study|Lost to Follow-up|1|||
125591150|NCT00260208|451786273|FG000|Overall Study|Death|12|||
125591151|NCT00260208|451786274|FG001|Overall Study|Death|10|||
125591152|NCT00260208|451786273|FG000|Overall Study|Missing|18|||
125591153|NCT00260208|451786274|FG001|Overall Study|Missing|16|||
125591154|NCT02091440|451786275|FG000|Overall Study|Death|2|||
125591155|NCT00278629|451786282|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
125591156|NCT03263091|451786284|FG000|OL Component|Withdrawal by Subject|1|||
125591157|NCT03263091|451786285|FG001|OL Component|Withdrawal by Subject|1|||
125591158|NCT03263091|451786286|FG002|OL Component|Withdrawal by Subject|0|||
125591159|NCT03263091|451786287|FG003|OL Component|Withdrawal by Subject|0|||
125591160|NCT03263091|451786288|FG004|OL Component|Withdrawal by Subject|0|||
125591161|NCT03263091|451786289|FG005|OL Component|Withdrawal by Subject|0|||
125591162|NCT03263091|451786284|FG000|OL Component|Physician Decision|0|||
125591163|NCT03263091|451786285|FG001|OL Component|Physician Decision|1|||
125591164|NCT03263091|451786286|FG002|OL Component|Physician Decision|2|||
125591165|NCT03263091|451786287|FG003|OL Component|Physician Decision|0|||
125591166|NCT03263091|451786288|FG004|OL Component|Physician Decision|0|||
125591167|NCT03263091|451786289|FG005|OL Component|Physician Decision|0|||
125363562|NCT01644565|450965133|FG000|Overall Study|Lost to Follow-up|0|||
125591168|NCT03263091|451786284|FG000|OL Component|Death|1|||
125591169|NCT03263091|451786285|FG001|OL Component|Death|0|||
125591170|NCT03263091|451786286|FG002|OL Component|Death|0|||
125591171|NCT03263091|451786287|FG003|OL Component|Death|0|||
125591172|NCT03263091|451786288|FG004|OL Component|Death|0|||
125591173|NCT03263091|451786289|FG005|OL Component|Death|0|||
125591174|NCT03263091|451786284|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
125591175|NCT03263091|451786285|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
125591176|NCT03263091|451786286|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
125591177|NCT03263091|451786287|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
125212190|NCT02815267|450403288|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
125429434|NCT01984697|451198796|FG000|Overall Study|Lost to Follow-up|14|||
125212191|NCT02815267|450403287|FG000|Double-Blind Phase|Protocol Violation|3|||
125363563|NCT01644565|450965134|FG001|Overall Study|Lost to Follow-up|0|||
125363564|NCT01644565|450965135|FG002|Overall Study|Lost to Follow-up|0|||
125591178|NCT03263091|451786288|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
125591179|NCT03263091|451786289|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
125591180|NCT03263091|451786284|FG000|OL High-EPO Component|Physician Decision|0|||
125591181|NCT03263091|451786285|FG001|OL High-EPO Component|Physician Decision|0|||
125591182|NCT03263091|451786286|FG002|OL High-EPO Component|Physician Decision|0|||
125591183|NCT03263091|451786287|FG003|OL High-EPO Component|Physician Decision|1|||
125591184|NCT03263091|451786288|FG004|OL High-EPO Component|Physician Decision|0|||
125591185|NCT03263091|451786289|FG005|OL High-EPO Component|Physician Decision|0|||
125591186|NCT03263091|451786284|FG000|OL High-EPO Component|Death|0|||
125591187|NCT03263091|451786285|FG001|OL High-EPO Component|Death|0|||
125591188|NCT03263091|451786286|FG002|OL High-EPO Component|Death|0|||
125591189|NCT03263091|451786287|FG003|OL High-EPO Component|Death|3|||
125591190|NCT03263091|451786288|FG004|OL High-EPO Component|Death|0|||
125591191|NCT03263091|451786289|FG005|OL High-EPO Component|Death|0|||
125591192|NCT03263091|451786284|FG000|DB Component|Withdrawal by Subject|0|||
125591193|NCT03263091|451786285|FG001|DB Component|Withdrawal by Subject|0|||
125591194|NCT03263091|451786286|FG002|DB Component|Withdrawal by Subject|0|||
125591195|NCT03263091|451786287|FG003|DB Component|Withdrawal by Subject|0|||
125591196|NCT03263091|451786288|FG004|DB Component|Withdrawal by Subject|22|||
125591197|NCT03263091|451786289|FG005|DB Component|Withdrawal by Subject|8|||
125591198|NCT03263091|451786284|FG000|DB Component|Physician Decision|0|||
125591199|NCT03263091|451786285|FG001|DB Component|Physician Decision|0|||
125591200|NCT03263091|451786286|FG002|DB Component|Physician Decision|0|||
125591201|NCT03263091|451786287|FG003|DB Component|Physician Decision|0|||
125591202|NCT03263091|451786288|FG004|DB Component|Physician Decision|3|||
125591203|NCT03263091|451786289|FG005|DB Component|Physician Decision|1|||
125591204|NCT03263091|451786284|FG000|DB Component|Adverse Event|0|||
125591205|NCT03263091|451786285|FG001|DB Component|Adverse Event|0|||
125591206|NCT03263091|451786286|FG002|DB Component|Adverse Event|0|||
125591207|NCT03263091|451786287|FG003|DB Component|Adverse Event|0|||
125591208|NCT03263091|451786288|FG004|DB Component|Adverse Event|2|||
125591209|NCT03263091|451786289|FG005|DB Component|Adverse Event|1|||
125591210|NCT03263091|451786284|FG000|DB Component|Lost to Follow-up|0|||
125591211|NCT03263091|451786285|FG001|DB Component|Lost to Follow-up|0|||
125591212|NCT03263091|451786286|FG002|DB Component|Lost to Follow-up|0|||
125591213|NCT03263091|451786287|FG003|DB Component|Lost to Follow-up|0|||
125591214|NCT03263091|451786288|FG004|DB Component|Lost to Follow-up|2|||
125591215|NCT03263091|451786289|FG005|DB Component|Lost to Follow-up|1|||
125591216|NCT03263091|451786284|FG000|DB Component|Death|0|||
125591217|NCT03263091|451786285|FG001|DB Component|Death|0|||
125591218|NCT03263091|451786286|FG002|DB Component|Death|0|||
125591219|NCT03263091|451786287|FG003|DB Component|Death|0|||
125591220|NCT03263091|451786288|FG004|DB Component|Death|7|||
125591221|NCT03263091|451786289|FG005|DB Component|Death|4|||
125591222|NCT03263091|451786284|FG000|DB Component|Other than specified|0|||
125591223|NCT03263091|451786285|FG001|DB Component|Other than specified|0|||
125591224|NCT03263091|451786286|FG002|DB Component|Other than specified|0|||
125591225|NCT03263091|451786287|FG003|DB Component|Other than specified|0|||
125591226|NCT03263091|451786288|FG004|DB Component|Other than specified|8|||
125591227|NCT03263091|451786289|FG005|DB Component|Other than specified|6|||
125591228|NCT00742781|451786290|FG000|Overall Study|Withdrawal by Subject|3|||
125591229|NCT00826748|451786291|FG000|Overall Study|Withdrawal by Subject|0|||
125591230|NCT00826748|451786292|FG001|Overall Study|Withdrawal by Subject|0|||
125591231|NCT00826748|451786293|FG002|Overall Study|Withdrawal by Subject|2|||
125591232|NCT00826748|451786291|FG000|Overall Study|Physician Decision|0|||
125591233|NCT00826748|451786292|FG001|Overall Study|Physician Decision|0|||
125591234|NCT00826748|451786293|FG002|Overall Study|Physician Decision|1|||
125591235|NCT00826748|451786291|FG000|Overall Study|Samples Did Not pass QC|0|||
125591236|NCT00826748|451786292|FG001|Overall Study|Samples Did Not pass QC|0|||
125591237|NCT00826748|451786293|FG002|Overall Study|Samples Did Not pass QC|1|||
125591238|NCT02443402|451786298|FG000|Overall Study|Withdrawal by Subject|3|||
125591239|NCT02443402|451786299|FG001|Overall Study|Withdrawal by Subject|1|||
125591240|NCT02443402|451786298|FG000|Overall Study|Screen Failure|1|||
125591241|NCT02443402|451786299|FG001|Overall Study|Screen Failure|2|||
125591242|NCT01552057|451786315|FG000|Overall Study|Adverse Event|14|||
125591243|NCT01552057|451786316|FG001|Overall Study|Adverse Event|15|||
125591244|NCT01552057|451786315|FG000|Overall Study|Lack of Efficacy|8|||
125591245|NCT01552057|451786316|FG001|Overall Study|Lack of Efficacy|23|||
125591246|NCT01552057|451786315|FG000|Overall Study|Withdrawal by Subject|5|||
125591247|NCT01552057|451786316|FG001|Overall Study|Withdrawal by Subject|8|||
125591248|NCT01552057|451786315|FG000|Overall Study|Entry Criteria Not Met|2|||
125591249|NCT01552057|451786316|FG001|Overall Study|Entry Criteria Not Met|2|||
125591250|NCT01552057|451786315|FG000|Overall Study|Physician Decision|1|||
125591251|NCT01552057|451786316|FG001|Overall Study|Physician Decision|0|||
125591252|NCT05127486|451786317|FG000|Overall Study|Adverse Event|2|||
125591253|NCT05127486|451786318|FG001|Overall Study|Adverse Event|4|||
125591254|NCT05127486|451786317|FG000|Overall Study|Lack of Efficacy|1|||
125591255|NCT05127486|451786318|FG001|Overall Study|Lack of Efficacy|0|||
125591256|NCT05127486|451786317|FG000|Overall Study|Pregnancy|0|||
125591257|NCT05127486|451786318|FG001|Overall Study|Pregnancy|1|||
125429435|NCT01984697|451198797|FG001|Overall Study|Lost to Follow-up|5|||
125429436|NCT01984697|451198798|FG002|Overall Study|Lost to Follow-up|10|||
125429437|NCT01984697|451198799|FG003|Overall Study|Lost to Follow-up|6|||
125591258|NCT05127486|451786317|FG000|Overall Study|Physician Decision|4|||
125591259|NCT05127486|451786318|FG001|Overall Study|Physician Decision|1|||
125591260|NCT05127486|451786317|FG000|Overall Study|Withdrawal by Subject|14|||
125591261|NCT05127486|451786318|FG001|Overall Study|Withdrawal by Subject|13|||
125591262|NCT05127486|451786317|FG000|Overall Study|Lost to Follow-up|5|||
125591263|NCT05127486|451786318|FG001|Overall Study|Lost to Follow-up|8|||
125591264|NCT01287754|451786319|FG000|Overall Study|Death|2|||
125591265|NCT01287754|451786320|FG001|Overall Study|Death|12|||
125591266|NCT01287754|451786319|FG000|Overall Study|Lost to Follow-up|1|||
125591267|NCT01287754|451786320|FG001|Overall Study|Lost to Follow-up|6|||
125591268|NCT01287754|451786319|FG000|Overall Study|Protocol Violation|0|||
125591269|NCT01287754|451786320|FG001|Overall Study|Protocol Violation|3|||
125591270|NCT04971226|451786321|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
125591271|NCT04971226|451786322|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
125591272|NCT04971226|451786323|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
125591273|NCT04971226|451786324|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
125591274|NCT04971226|451786321|FG000|Overall Study|Adverse Event|6|||
125591275|NCT04971226|451786322|FG001|Overall Study|Adverse Event|5|||
125591276|NCT04971226|451786323|FG002|Overall Study|Adverse Event|11|||
125591277|NCT04971226|451786324|FG003|Overall Study|Adverse Event|10|||
125591278|NCT04971226|451786321|FG000|Overall Study|Progressive disease|2|||
125591279|NCT04971226|451786322|FG001|Overall Study|Progressive disease|0|||
125591280|NCT04971226|451786323|FG002|Overall Study|Progressive disease|3|||
125591281|NCT04971226|451786324|FG003|Overall Study|Progressive disease|1|||
125591282|NCT04971226|451786321|FG000|Overall Study|Protocol Deviation|1|||
125591283|NCT04971226|451786322|FG001|Overall Study|Protocol Deviation|0|||
125591284|NCT04971226|451786323|FG002|Overall Study|Protocol Deviation|1|||
125591285|NCT04971226|451786324|FG003|Overall Study|Protocol Deviation|1|||
125591286|NCT04971226|451786321|FG000|Overall Study|Subject Decision|0|||
125591287|NCT04971226|451786322|FG001|Overall Study|Subject Decision|1|||
125591288|NCT04971226|451786323|FG002|Overall Study|Subject Decision|1|||
125591289|NCT04971226|451786324|FG003|Overall Study|Subject Decision|1|||
125591290|NCT04971226|451786321|FG000|Overall Study|Pregnancy|0|||
125591291|NCT04971226|451786322|FG001|Overall Study|Pregnancy|0|||
125591292|NCT04971226|451786323|FG002|Overall Study|Pregnancy|0|||
125591293|NCT04971226|451786324|FG003|Overall Study|Pregnancy|1|||
125591294|NCT04971226|451786321|FG000|Overall Study|Participants not treated|1|||
125591295|NCT04971226|451786322|FG001|Overall Study|Participants not treated|0|||
125591296|NCT04971226|451786323|FG002|Overall Study|Participants not treated|2|||
125591297|NCT04971226|451786324|FG003|Overall Study|Participants not treated|1|||
125591298|NCT00001337|451786326|FG000|Overall Study|Switched to alternate treatment|2|||
125591299|NCT00001337|451786327|FG001|Overall Study|Switched to alternate treatment|2|||
125591300|NCT00001337|451786328|FG002|Overall Study|Switched to alternate treatment|0|||
125591301|NCT00001337|451786326|FG000|Overall Study|Refused further treatment|2|||
125591302|NCT00001337|451786327|FG001|Overall Study|Refused further treatment|1|||
125591303|NCT00001337|451786328|FG002|Overall Study|Refused further treatment|0|||
125591304|NCT00001337|451786326|FG000|Overall Study|Began other Tx|1|||
125591305|NCT00001337|451786327|FG001|Overall Study|Began other Tx|0|||
125591306|NCT00001337|451786328|FG002|Overall Study|Began other Tx|0|||
125591307|NCT00001337|451786326|FG000|Overall Study|Physician Decision|3|||
125591308|NCT00001337|451786327|FG001|Overall Study|Physician Decision|1|||
125591309|NCT00001337|451786328|FG002|Overall Study|Physician Decision|0|||
125591310|NCT00001337|451786326|FG000|Overall Study|Doesn't have NHL|0|||
125591311|NCT00001337|451786327|FG001|Overall Study|Doesn't have NHL|1|||
125591312|NCT00001337|451786328|FG002|Overall Study|Doesn't have NHL|0|||
125591313|NCT00001337|451786326|FG000|Overall Study|Non protocol tx needed|3|||
125591314|NCT00001337|451786327|FG001|Overall Study|Non protocol tx needed|1|||
125591315|NCT00001337|451786328|FG002|Overall Study|Non protocol tx needed|0|||
125591316|NCT00001337|451786326|FG000|Overall Study|Protocol change|1|||
125591317|NCT00001337|451786327|FG001|Overall Study|Protocol change|0|||
125591318|NCT00001337|451786328|FG002|Overall Study|Protocol change|0|||
125591319|NCT00001337|451786326|FG000|Overall Study|2nd primary disease|0|||
125591320|NCT00001337|451786327|FG001|Overall Study|2nd primary disease|0|||
125591321|NCT00001337|451786328|FG002|Overall Study|2nd primary disease|1|||
125212192|NCT02815267|450403288|FG001|Double-Blind Phase|Protocol Violation|2|||
125212193|NCT02815267|450403287|FG000|Double-Blind Phase|Site withdrawal|1|||
125212194|NCT02815267|450403288|FG001|Double-Blind Phase|Site withdrawal|6|||
125212195|NCT02815267|450403287|FG000|Double-Blind Phase|Received a disallowed medication|1|||
125212196|NCT02815267|450403288|FG001|Double-Blind Phase|Received a disallowed medication|1|||
125212197|NCT02815267|450403287|FG000|Open-Label Phase|Adverse Event|1|||
125591322|NCT00001337|451786326|FG000|Overall Study|Death during follow up period|9|||
125591323|NCT00001337|451786327|FG001|Overall Study|Death during follow up period|4|||
125591324|NCT00001337|451786328|FG002|Overall Study|Death during follow up period|0|||
125591325|NCT00001337|451786326|FG000|Overall Study|Death on study|19|||
125591326|NCT00001337|451786327|FG001|Overall Study|Death on study|9|||
125591327|NCT00001337|451786328|FG002|Overall Study|Death on study|0|||
125591328|NCT00001337|451786326|FG000|Overall Study|Disease progression during follow-up period|3|||
125591329|NCT00001337|451786327|FG001|Overall Study|Disease progression during follow-up period|1|||
125591330|NCT00001337|451786328|FG002|Overall Study|Disease progression during follow-up period|0|||
125591331|NCT00001337|451786326|FG000|Overall Study|Disease progression on study|33|||
125591332|NCT00001337|451786327|FG001|Overall Study|Disease progression on study|41|||
125591333|NCT00001337|451786328|FG002|Overall Study|Disease progression on study|0|||
125591334|NCT00001337|451786326|FG000|Overall Study|Lost to further follow-up|10|||
125591335|NCT00001337|451786327|FG001|Overall Study|Lost to further follow-up|6|||
125591336|NCT00001337|451786328|FG002|Overall Study|Lost to further follow-up|0|||
125591337|NCT00001337|451786326|FG000|Overall Study|2nd malignancy|1|||
125591338|NCT00001337|451786327|FG001|Overall Study|2nd malignancy|0|||
125212198|NCT02815267|450403288|FG001|Open-Label Phase|Adverse Event|1|||
125591339|NCT00001337|451786328|FG002|Overall Study|2nd malignancy|0|||
125212199|NCT02815267|450403287|FG000|Open-Label Phase|Lost to Follow-up|23|||
125212200|NCT02815267|450403288|FG001|Open-Label Phase|Lost to Follow-up|9|||
125429438|NCT01984697|451198800|FG004|Overall Study|Lost to Follow-up|21|||
125591340|NCT00001337|451786326|FG000|Overall Study|Treatment for second lymphoma|0|||
125591341|NCT00001337|451786327|FG001|Overall Study|Treatment for second lymphoma|1|||
125591342|NCT00001337|451786328|FG002|Overall Study|Treatment for second lymphoma|0|||
125591343|NCT00001337|451786326|FG000|Overall Study|Transfer to transplant|0|||
125591344|NCT00001337|451786327|FG001|Overall Study|Transfer to transplant|1|||
125591345|NCT00001337|451786328|FG002|Overall Study|Transfer to transplant|0|||
125591346|NCT00442598|451786329|FG000|Overall Study|Adverse Event|1|||
125591347|NCT00442598|451786330|FG001|Overall Study|Adverse Event|0|||
125591348|NCT00442598|451786331|FG002|Overall Study|Adverse Event|0|||
125591349|NCT00442598|451786329|FG000|Overall Study|Tumor progression|3|||
125591350|NCT00442598|451786330|FG001|Overall Study|Tumor progression|4|||
125591351|NCT00442598|451786331|FG002|Overall Study|Tumor progression|0|||
125591352|NCT00442598|451786329|FG000|Overall Study|Clinical deterioration|1|||
125591353|NCT00442598|451786330|FG001|Overall Study|Clinical deterioration|2|||
125591354|NCT00442598|451786331|FG002|Overall Study|Clinical deterioration|0|||
125591355|NCT00442598|451786329|FG000|Overall Study|CA125 progression|0|||
125591356|NCT00442598|451786330|FG001|Overall Study|CA125 progression|1|||
125591357|NCT00442598|451786331|FG002|Overall Study|CA125 progression|0|||
125591358|NCT00442598|451786329|FG000|Overall Study|Reduced creatinine clearance|1|||
125591359|NCT00442598|451786330|FG001|Overall Study|Reduced creatinine clearance|0|||
125591360|NCT00442598|451786331|FG002|Overall Study|Reduced creatinine clearance|0|||
125591361|NCT00442598|451786329|FG000|Overall Study|Death|0|||
125591362|NCT00442598|451786330|FG001|Overall Study|Death|1|||
125591363|NCT00442598|451786331|FG002|Overall Study|Death|0|||
125591364|NCT01262898|451786332|FG000|Overall Study|Protocol Violation|1|||
125591365|NCT01262898|451786333|FG001|Overall Study|Protocol Violation|1|||
125591366|NCT01262898|451786334|FG002|Overall Study|Protocol Violation|0|||
125591367|NCT01262898|451786335|FG003|Overall Study|Protocol Violation|0|||
125591368|NCT01262898|451786332|FG000|Overall Study|Lost to Follow-up|1|||
125591369|NCT01262898|451786333|FG001|Overall Study|Lost to Follow-up|0|||
125591370|NCT01262898|451786334|FG002|Overall Study|Lost to Follow-up|0|||
125591371|NCT01262898|451786335|FG003|Overall Study|Lost to Follow-up|0|||
125591372|NCT01262898|451786332|FG000|Overall Study|Withdrawal by Subject|1|||
125591373|NCT01262898|451786333|FG001|Overall Study|Withdrawal by Subject|1|||
125591374|NCT01262898|451786334|FG002|Overall Study|Withdrawal by Subject|0|||
125591375|NCT01262898|451786335|FG003|Overall Study|Withdrawal by Subject|0|||
125591376|NCT04026568|451786336|FG000|Overall Study|study terminated|0|||
125591377|NCT04026568|451786337|FG001|Overall Study|study terminated|1|||
125591378|NCT02197377|451786338|FG000|Overall Study|Insertion Failure|0|||
125591379|NCT02197377|451786339|FG001|Overall Study|Insertion Failure|3|||
125591380|NCT00502840|451786340|FG000|Overall Study|Adverse Event|5|||
125591381|NCT00502840|451786340|FG000|Overall Study|Additional or changed therapy|48|||
125591382|NCT00502840|451786340|FG000|Overall Study|Lack of Efficacy|11|||
125591383|NCT00502840|451786340|FG000|Overall Study|Protocol Violation|4|||
125591384|NCT00502840|451786340|FG000|Overall Study|Withdrawal by Subject|5|||
125591385|NCT00502840|451786340|FG000|Overall Study|Lost to Follow-up|6|||
125591386|NCT00502840|451786340|FG000|Overall Study|Administrative problems|1|||
125591387|NCT00502840|451786340|FG000|Overall Study|Other|20|||
125591388|NCT00461175|451786341|FG000|Overall Study|Protocol Violation|522|||
125591389|NCT00461175|451786342|FG001|Overall Study|Protocol Violation|365|||
125591390|NCT01700829|451786343|FG000|Overall Study|Withdrawal by Subject|1|||
125591391|NCT01700829|451786344|FG001|Overall Study|Withdrawal by Subject|1|||
125591392|NCT03406962|451786345|FG000|Overall Study|Death|2|||
125591393|NCT03406962|451786345|FG000|Overall Study|Adverse Event|1|||
125591394|NCT00327444|451786346|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
125591395|NCT00327444|451786347|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
125591396|NCT00327444|451786346|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
125591397|NCT00327444|451786347|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
125591398|NCT00327444|451786346|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
125591399|NCT00327444|451786347|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
125591400|NCT00327444|451786346|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
125591401|NCT00327444|451786347|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
125591402|NCT00327444|451786346|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
125591403|NCT00327444|451786347|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
125591404|NCT00327444|451786346|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
125591405|NCT00327444|451786347|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
125591406|NCT00327444|451786346|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
125591407|NCT00327444|451786347|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
125591408|NCT00327444|451786346|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
125591409|NCT00327444|451786347|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
125591410|NCT04439344|451786348|FG000|Overall Study|Never started threapy|3|||
125591411|NCT04439344|451786348|FG000|Overall Study|Ineligible|3|||
125591412|NCT04439344|451786348|FG000|Overall Study|Adverse Event|13|||
125591413|NCT04439344|451786348|FG000|Overall Study|Death|2|||
125591414|NCT04439344|451786348|FG000|Overall Study|Disease progression|29|||
125591415|NCT04439344|451786348|FG000|Overall Study|Withdrawal by Subject|2|||
125591416|NCT04439344|451786348|FG000|Overall Study|Alternative therapy|1|||
125591417|NCT00552110|451786349|FG000|Overall Study|Serious or Life-Threatening AE|0|||
125591418|NCT00552110|451786350|FG001|Overall Study|Serious or Life-Threatening AE|0|||
125591419|NCT00552110|451786351|FG002|Overall Study|Serious or Life-Threatening AE|1|||
125591420|NCT00552110|451786352|FG003|Overall Study|Serious or Life-Threatening AE|0|||
125591421|NCT00552110|451786353|FG004|Overall Study|Serious or Life-Threatening AE|0|||
125591422|NCT00552110|451786349|FG000|Overall Study|Lack of Efficacy|1|||
125591423|NCT00552110|451786350|FG001|Overall Study|Lack of Efficacy|0|||
125591424|NCT00552110|451786351|FG002|Overall Study|Lack of Efficacy|0|||
125591425|NCT00552110|451786352|FG003|Overall Study|Lack of Efficacy|1|||
125591426|NCT00552110|451786353|FG004|Overall Study|Lack of Efficacy|4|||
125591427|NCT00552110|451786349|FG000|Overall Study|Withdrawal by Subject|0|||
125591428|NCT00552110|451786350|FG001|Overall Study|Withdrawal by Subject|2|||
125591429|NCT00552110|451786351|FG002|Overall Study|Withdrawal by Subject|0|||
125591430|NCT00552110|451786352|FG003|Overall Study|Withdrawal by Subject|3|||
125591431|NCT00552110|451786353|FG004|Overall Study|Withdrawal by Subject|2|||
125591432|NCT00552110|451786349|FG000|Overall Study|Lost to Follow-up|0|||
125591433|NCT00552110|451786350|FG001|Overall Study|Lost to Follow-up|0|||
125591434|NCT00552110|451786351|FG002|Overall Study|Lost to Follow-up|0|||
125591435|NCT00552110|451786352|FG003|Overall Study|Lost to Follow-up|1|||
125591436|NCT00552110|451786353|FG004|Overall Study|Lost to Follow-up|1|||
125591437|NCT00552110|451786349|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
125591438|NCT00552110|451786350|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
125591439|NCT00552110|451786351|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
125591440|NCT00552110|451786352|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
125591441|NCT00552110|451786353|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
125591442|NCT00552110|451786349|FG000|Overall Study|Withdrawn per Sponsor|0|||
125591443|NCT00552110|451786350|FG001|Overall Study|Withdrawn per Sponsor|1|||
125591444|NCT00552110|451786351|FG002|Overall Study|Withdrawn per Sponsor|0|||
125591445|NCT00552110|451786352|FG003|Overall Study|Withdrawn per Sponsor|0|||
125591446|NCT00552110|451786353|FG004|Overall Study|Withdrawn per Sponsor|1|||
125591447|NCT00552110|451786349|FG000|Overall Study|Use of Prohibited Medication|1|||
125591448|NCT00552110|451786350|FG001|Overall Study|Use of Prohibited Medication|1|||
125591449|NCT00552110|451786351|FG002|Overall Study|Use of Prohibited Medication|0|||
125591450|NCT00552110|451786352|FG003|Overall Study|Use of Prohibited Medication|0|||
125591451|NCT00552110|451786353|FG004|Overall Study|Use of Prohibited Medication|0|||
125591452|NCT00552110|451786349|FG000|Overall Study|Delay of Study due to Relabeling|0|||
125591453|NCT00552110|451786350|FG001|Overall Study|Delay of Study due to Relabeling|0|||
125591454|NCT00552110|451786351|FG002|Overall Study|Delay of Study due to Relabeling|0|||
125591455|NCT00552110|451786352|FG003|Overall Study|Delay of Study due to Relabeling|1|||
125591456|NCT00552110|451786353|FG004|Overall Study|Delay of Study due to Relabeling|0|||
125591457|NCT00552110|451786349|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
125591458|NCT00552110|451786350|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
125591459|NCT00552110|451786351|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
125591460|NCT00552110|451786352|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
125591461|NCT00552110|451786353|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
125591462|NCT00552110|451786349|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
125591463|NCT00552110|451786350|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
125591464|NCT00552110|451786351|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
125591465|NCT00552110|451786352|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
125591466|NCT00552110|451786353|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
125591467|NCT00454207|451786354|FG000|Overall Study|Adverse Event|3|||
125591468|NCT00454207|451786355|FG001|Overall Study|Adverse Event|1|||
125591469|NCT00454207|451786354|FG000|Overall Study|Lack of Efficacy|1|||
125591470|NCT00454207|451786355|FG001|Overall Study|Lack of Efficacy|0|||
125591471|NCT00454207|451786354|FG000|Overall Study|Protocol Violation|0|||
125591472|NCT00454207|451786355|FG001|Overall Study|Protocol Violation|1|||
125591473|NCT02272790|451786358|FG000|Overall Study|Physician Decision|0|||
125591474|NCT02272790|451786359|FG001|Overall Study|Physician Decision|1|||
125591475|NCT02272790|451786360|FG002|Overall Study|Physician Decision|0|||
125591476|NCT02272790|451786361|FG003|Overall Study|Physician Decision|0|||
125591477|NCT02272790|451786362|FG004|Overall Study|Physician Decision|0|||
125591478|NCT02272790|451786363|FG005|Overall Study|Physician Decision|0|||
125591479|NCT00332202|451786364|FG000|Overall Study|Adverse Event|72|||
125591480|NCT00332202|451786365|FG001|Overall Study|Adverse Event|28|||
125591481|NCT00332202|451786364|FG000|Overall Study|Lost to Follow-up|2|||
125591482|NCT00332202|451786365|FG001|Overall Study|Lost to Follow-up|1|||
125591483|NCT00332202|451786364|FG000|Overall Study|Physician Decision|6|||
125591484|NCT00332202|451786365|FG001|Overall Study|Physician Decision|8|||
125591485|NCT00332202|451786364|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
125591486|NCT00332202|451786365|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
125212201|NCT02815267|450403287|FG000|Open-Label Phase|Withdrawal by Subject|24|||
125212202|NCT02815267|450403288|FG001|Open-Label Phase|Withdrawal by Subject|13|||
125591487|NCT00332202|451786364|FG000|Overall Study|Protocol Violation|7|||
125591488|NCT00332202|451786365|FG001|Overall Study|Protocol Violation|2|||
125591489|NCT00332202|451786364|FG000|Overall Study|Sponsor Decision|1|||
125591490|NCT00332202|451786365|FG001|Overall Study|Sponsor Decision|2|||
125591491|NCT00332202|451786364|FG000|Overall Study|Withdrawal by Subject|36|||
125591492|NCT00332202|451786365|FG001|Overall Study|Withdrawal by Subject|17|||
125591493|NCT00332202|451786364|FG000|Overall Study|Progressive Disease|106|||
125591494|NCT00332202|451786365|FG001|Overall Study|Progressive Disease|60|||
125591495|NCT00332202|451786364|FG000|Overall Study|Death|5|||
125591496|NCT00332202|451786365|FG001|Overall Study|Death|2|||
125591497|NCT03871491|451786366|FG000|Overall Study|Withdrawal by Subject|14|||
125591498|NCT03871491|451786367|FG001|Overall Study|Withdrawal by Subject|14|||
125591499|NCT03871491|451786368|FG002|Overall Study|Withdrawal by Subject|14|||
125591500|NCT03871491|451786369|FG003|Overall Study|Withdrawal by Subject|14|||
125591501|NCT03871491|451786366|FG000|Overall Study|Physician Decision|0|||
125591502|NCT03871491|451786367|FG001|Overall Study|Physician Decision|0|||
125591503|NCT03871491|451786368|FG002|Overall Study|Physician Decision|1|||
125591504|NCT03871491|451786369|FG003|Overall Study|Physician Decision|1|||
125591505|NCT03871491|451786366|FG000|Overall Study|Lost to Follow-up|50|||
125591506|NCT03871491|451786367|FG001|Overall Study|Lost to Follow-up|15|||
125591507|NCT03871491|451786368|FG002|Overall Study|Lost to Follow-up|36|||
125591508|NCT03871491|451786369|FG003|Overall Study|Lost to Follow-up|11|||
125591509|NCT04439331|451786370|FG000|Overall Study|Never Start Protocol Therapy|2|||
125591510|NCT04439331|451786370|FG000|Overall Study|Ineligible|2|||
125591511|NCT04439331|451786370|FG000|Overall Study|Mutation Status Not Confirmed|1|||
125591512|NCT04439331|451786370|FG000|Overall Study|Adverse Event|1|||
125591513|NCT04439331|451786370|FG000|Overall Study|Death|1|||
125591514|NCT04439331|451786370|FG000|Overall Study|Disease Progression|20|||
125591515|NCT04439331|451786370|FG000|Overall Study|Withdrawal by Subject|6|||
125591516|NCT04439331|451786370|FG000|Overall Study|Physician Decision|1|||
125591517|NCT04439331|451786370|FG000|Overall Study|Other Complicating Disease|1|||
125591518|NCT00490542|451786373|FG000|Overall Study|Lost to Follow-up|3|||
125591519|NCT00490542|451786374|FG001|Overall Study|Lost to Follow-up|0|||
125591520|NCT00490542|451786373|FG000|Overall Study|Adverse Event|3|||
125591521|NCT00490542|451786374|FG001|Overall Study|Adverse Event|3|||
125591522|NCT00490542|451786373|FG000|Overall Study|Lack of Efficacy|1|||
125591523|NCT00490542|451786374|FG001|Overall Study|Lack of Efficacy|1|||
125591524|NCT00818259|451786378|FG000|Part I|Withdrawal by Subject|1|||
125591525|NCT00818259|451786379|FG001|Part I|Withdrawal by Subject|0|||
125591526|NCT00818259|451786380|FG002|Part I|Withdrawal by Subject|0|||
125591527|NCT00818259|451786381|FG003|Part I|Withdrawal by Subject|0|||
125591528|NCT00818259|451786382|FG004|Part I|Withdrawal by Subject|0|||
125591529|NCT00818259|451786383|FG005|Part I|Withdrawal by Subject|0|||
125591530|NCT00818259|451786384|FG006|Part I|Withdrawal by Subject|0|||
125591531|NCT00818259|451786385|FG007|Part I|Withdrawal by Subject|0|||
125591532|NCT00818259|451786386|FG008|Part I|Withdrawal by Subject|0|||
125591533|NCT00818259|451786378|FG000|Part II|Physician Decision|0|||
125591534|NCT00818259|451786379|FG001|Part II|Physician Decision|0|||
125591535|NCT00818259|451786380|FG002|Part II|Physician Decision|1|||
125212203|NCT02815267|450403287|FG000|Open-Label Phase|Protocol Violation|0|||
125429439|NCT01984697|451198796|FG000|Overall Study|Physician Decision|3|||
125591536|NCT00818259|451786381|FG003|Part II|Physician Decision|0|||
125591537|NCT00818259|451786382|FG004|Part II|Physician Decision|0|||
125591538|NCT00818259|451786383|FG005|Part II|Physician Decision|0|||
125591539|NCT00818259|451786384|FG006|Part II|Physician Decision|0|||
125591540|NCT00818259|451786385|FG007|Part II|Physician Decision|0|||
125591541|NCT00818259|451786386|FG008|Part II|Physician Decision|0|||
125591542|NCT00818259|451786378|FG000|Part II|Lack of Efficacy|0|||
125591543|NCT00818259|451786379|FG001|Part II|Lack of Efficacy|0|||
125591544|NCT00818259|451786380|FG002|Part II|Lack of Efficacy|0|||
125591545|NCT00818259|451786381|FG003|Part II|Lack of Efficacy|1|||
125591546|NCT00818259|451786382|FG004|Part II|Lack of Efficacy|0|||
125212204|NCT02815267|450403288|FG001|Open-Label Phase|Protocol Violation|1|||
125363565|NCT01644565|450965136|FG003|Overall Study|Lost to Follow-up|1|||
125363566|NCT01644565|450965137|FG004|Overall Study|Lost to Follow-up|0|||
125591547|NCT00818259|451786383|FG005|Part II|Lack of Efficacy|0|||
125591548|NCT00818259|451786384|FG006|Part II|Lack of Efficacy|0|||
125591549|NCT00818259|451786385|FG007|Part II|Lack of Efficacy|0|||
125591550|NCT00818259|451786386|FG008|Part II|Lack of Efficacy|0|||
125591551|NCT00818259|451786378|FG000|Part II|Not Treated|0|||
125591552|NCT00818259|451786379|FG001|Part II|Not Treated|0|||
125591553|NCT00818259|451786380|FG002|Part II|Not Treated|0|||
125591554|NCT00818259|451786381|FG003|Part II|Not Treated|1|||
125591555|NCT00818259|451786382|FG004|Part II|Not Treated|0|||
125591556|NCT00818259|451786383|FG005|Part II|Not Treated|0|||
125591557|NCT00818259|451786384|FG006|Part II|Not Treated|0|||
125591558|NCT00818259|451786385|FG007|Part II|Not Treated|0|||
125591559|NCT00818259|451786386|FG008|Part II|Not Treated|0|||
125363567|NCT01644565|450965138|FG005|Overall Study|Lost to Follow-up|0|||
125363568|NCT01644565|450965139|FG006|Overall Study|Lost to Follow-up|0|||
125363569|NCT01644565|450965140|FG007|Overall Study|Lost to Follow-up|2|||
125363570|NCT01644565|450965141|FG008|Overall Study|Lost to Follow-up|0|||
125591560|NCT00818259|451786378|FG000|Part IV|Physician Decision|0|||
125591561|NCT00818259|451786379|FG001|Part IV|Physician Decision|0|||
125591562|NCT00818259|451786380|FG002|Part IV|Physician Decision|0|||
125591563|NCT00818259|451786381|FG003|Part IV|Physician Decision|0|||
125363571|NCT01644565|450965133|FG000|Overall Study|Family emergency|0|||
125363572|NCT01644565|450965134|FG001|Overall Study|Family emergency|0|||
125363573|NCT01644565|450965135|FG002|Overall Study|Family emergency|0|||
125591564|NCT00818259|451786382|FG004|Part IV|Physician Decision|0|||
125591565|NCT00818259|451786383|FG005|Part IV|Physician Decision|1|||
125591566|NCT00818259|451786384|FG006|Part IV|Physician Decision|0|||
125591567|NCT00818259|451786385|FG007|Part IV|Physician Decision|0|||
125591568|NCT00818259|451786386|FG008|Part IV|Physician Decision|0|||
125591569|NCT00818259|451786378|FG000|Part V|Adverse Event|0|||
125591570|NCT00818259|451786379|FG001|Part V|Adverse Event|0|||
125591571|NCT00818259|451786380|FG002|Part V|Adverse Event|0|||
125591572|NCT00818259|451786381|FG003|Part V|Adverse Event|0|||
125591573|NCT00818259|451786382|FG004|Part V|Adverse Event|0|||
125591574|NCT00818259|451786383|FG005|Part V|Adverse Event|0|||
125591575|NCT00818259|451786384|FG006|Part V|Adverse Event|0|||
125591576|NCT00818259|451786385|FG007|Part V|Adverse Event|1|||
125591577|NCT00818259|451786386|FG008|Part V|Adverse Event|0|||
125591578|NCT01237951|451786390|FG000|Overall Study|Death|1|||
125591579|NCT00666562|451786393|FG000|Overall Study|Withdrawal by Subject|0|||
125591580|NCT00666562|451786394|FG001|Overall Study|Withdrawal by Subject|1|||
125591581|NCT00666562|451786395|FG002|Overall Study|Withdrawal by Subject|0|||
125591582|NCT00666562|451786393|FG000|Overall Study|Concomitant Medication|0|||
125591583|NCT00666562|451786394|FG001|Overall Study|Concomitant Medication|1|||
125591584|NCT00666562|451786395|FG002|Overall Study|Concomitant Medication|0|||
125591585|NCT04429022|451786398|FG000|Overall Study|Protocol Violation|18|||
125591586|NCT04429022|451786399|FG001|Overall Study|Protocol Violation|1|||
125591587|NCT03274687|451788054|FG000|Overall Study|Protocol Violation|1|||
125591588|NCT03274687|451788055|FG001|Overall Study|Protocol Violation|1|||
125591589|NCT05556616|451788056|FG000|Overall Study|Withdrawal by Subject|1|||
125591590|NCT05556616|451788057|FG001|Overall Study|Withdrawal by Subject|0|||
125591591|NCT05556616|451788058|FG002|Overall Study|Withdrawal by Subject|0|||
125212205|NCT02815267|450403287|FG000|Open-Label Phase|Administrative|21|||
125591592|NCT05556616|451788059|FG003|Overall Study|Withdrawal by Subject|0|||
125591593|NCT05556616|451788060|FG004|Overall Study|Withdrawal by Subject|0|||
125591594|NCT05556616|451788061|FG005|Overall Study|Withdrawal by Subject|0|||
125591595|NCT05556616|451788062|FG006|Overall Study|Withdrawal by Subject|0|||
125591596|NCT05556616|451788056|FG000|Overall Study|Death|0|||
125591597|NCT05556616|451788057|FG001|Overall Study|Death|0|||
125591598|NCT05556616|451788058|FG002|Overall Study|Death|2|||
125591599|NCT05556616|451788059|FG003|Overall Study|Death|1|||
125591600|NCT05556616|451788060|FG004|Overall Study|Death|0|||
125591601|NCT05556616|451788061|FG005|Overall Study|Death|0|||
125591602|NCT05556616|451788062|FG006|Overall Study|Death|0|||
125591603|NCT05556616|451788056|FG000|Overall Study|Study Terminated by Sponsor|0|||
125591604|NCT05556616|451788057|FG001|Overall Study|Study Terminated by Sponsor|3|||
125591605|NCT05556616|451788058|FG002|Overall Study|Study Terminated by Sponsor|0|||
125591606|NCT05556616|451788059|FG003|Overall Study|Study Terminated by Sponsor|0|||
125591607|NCT05556616|451788060|FG004|Overall Study|Study Terminated by Sponsor|0|||
125429440|NCT01984697|451198797|FG001|Overall Study|Physician Decision|0|||
125591608|NCT05556616|451788061|FG005|Overall Study|Study Terminated by Sponsor|0|||
125212206|NCT02815267|450403288|FG001|Open-Label Phase|Administrative|12|||
125212207|NCT02815267|450403287|FG000|Open-Label Phase|Other|2|||
125212208|NCT02815267|450403288|FG001|Open-Label Phase|Other|5|||
125212209|NCT03594955|450403289|FG000|Overall Study|Adverse Event|1|||
125212210|NCT03594955|450403289|FG000|Overall Study|Progressive disease|5|||
125591609|NCT05556616|451788062|FG006|Overall Study|Study Terminated by Sponsor|0|||
125591610|NCT03539432|451788067|FG000|Overall Study|Lost to Follow-up|0|||
125591611|NCT03539432|451788068|FG001|Overall Study|Lost to Follow-up|1|||
125591612|NCT00824564|451788071|FG000|Overall Study|Lost to Follow-up|5|||
125591613|NCT00824564|451788072|FG001|Overall Study|Lost to Follow-up|7|||
125591614|NCT00824564|451788071|FG000|Overall Study|Withdrawal by Subject|1|||
125363574|NCT01644565|450965136|FG003|Overall Study|Family emergency|0|||
125591615|NCT00824564|451788072|FG001|Overall Study|Withdrawal by Subject|1|||
125591616|NCT00824564|451788071|FG000|Overall Study|Other|1|||
125591617|NCT00824564|451788072|FG001|Overall Study|Other|2|||
125591618|NCT00824564|451788071|FG000|Overall Study|Randomized, but not treated|1|||
125591619|NCT00824564|451788072|FG001|Overall Study|Randomized, but not treated|0|||
125591620|NCT00476086|451788073|FG000|Overall Study|Alternative therapy|1|||
125591621|NCT00476086|451788073|FG000|Overall Study|Progressive Disease|4|||
125591622|NCT04178590|451788074|FG000|Overall Study|Pregnancy|1|||
125591623|NCT04178590|451788074|FG000|Overall Study|Lost to Follow-up|1|||
125591624|NCT01389245|451788076|FG000|Overall Study|Protocol Violation|10|||
125591625|NCT01389245|451788076|FG000|Overall Study|Lost to Follow-up|3|||
125591626|NCT01389245|451788076|FG000|Overall Study|Withdrawal by Subject|2|||
125591627|NCT02292849|451788077|FG000|Overall Study|Lost to Follow-up|0|||
125591628|NCT02292849|451788078|FG001|Overall Study|Lost to Follow-up|2|||
125591629|NCT02292849|451788079|FG002|Overall Study|Lost to Follow-up|2|||
125591630|NCT02292849|451788077|FG000|Overall Study|Physician Decision|4|||
125212211|NCT03594955|450403289|FG000|Overall Study|Sponsor's decision|1|||
125363575|NCT01644565|450965137|FG004|Overall Study|Family emergency|1|||
125363576|NCT01644565|450965138|FG005|Overall Study|Family emergency|0|||
125363577|NCT01644565|450965139|FG006|Overall Study|Family emergency|0|||
125363578|NCT01644565|450965140|FG007|Overall Study|Family emergency|0|||
125363579|NCT01644565|450965141|FG008|Overall Study|Family emergency|0|||
125363580|NCT01644565|450965133|FG000|Overall Study|Relocation|0|||
125363581|NCT01644565|450965134|FG001|Overall Study|Relocation|0|||
125591631|NCT02292849|451788078|FG001|Overall Study|Physician Decision|0|||
125212212|NCT04278924|450403294|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
125212213|NCT04278924|450403295|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
125212214|NCT04278924|450403296|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
125212215|NCT04278924|450403297|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
125212216|NCT04278924|450403298|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
125591632|NCT02292849|451788079|FG002|Overall Study|Physician Decision|0|||
125591633|NCT00886938|451788080|FG000|Overall Study|Adverse Event|1|||
125591634|NCT00886938|451788080|FG000|Overall Study|Withdrawal by Subject|1|||
125591635|NCT00364793|451788081|FG000|Overall Study|Adverse Event|2|||
125591636|NCT00364793|451788082|FG001|Overall Study|Adverse Event|0|||
125212217|NCT04278924|450403299|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
125212218|NCT04278924|450403300|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
125363582|NCT01644565|450965135|FG002|Overall Study|Relocation|0|||
125591637|NCT00364793|451788083|FG002|Overall Study|Adverse Event|0|||
125591638|NCT00364793|451788084|FG003|Overall Study|Adverse Event|0|||
125591639|NCT00364793|451788081|FG000|Overall Study|Death|1|||
125591640|NCT00364793|451788082|FG001|Overall Study|Death|0|||
125591641|NCT00364793|451788083|FG002|Overall Study|Death|1|||
125591642|NCT00364793|451788084|FG003|Overall Study|Death|0|||
125591643|NCT00364793|451788081|FG000|Overall Study|Lack of Efficacy|3|||
125591644|NCT00364793|451788082|FG001|Overall Study|Lack of Efficacy|3|||
125591645|NCT00364793|451788083|FG002|Overall Study|Lack of Efficacy|1|||
125591646|NCT00364793|451788084|FG003|Overall Study|Lack of Efficacy|1|||
125591647|NCT00364793|451788081|FG000|Overall Study|Lost to Follow-up|1|||
125591648|NCT00364793|451788082|FG001|Overall Study|Lost to Follow-up|0|||
125591649|NCT00364793|451788083|FG002|Overall Study|Lost to Follow-up|2|||
125591650|NCT00364793|451788084|FG003|Overall Study|Lost to Follow-up|0|||
125591651|NCT00364793|451788081|FG000|Overall Study|Poor or non-compliance|1|||
125591652|NCT00364793|451788082|FG001|Overall Study|Poor or non-compliance|1|||
125591653|NCT00364793|451788083|FG002|Overall Study|Poor or non-compliance|0|||
125591654|NCT00364793|451788084|FG003|Overall Study|Poor or non-compliance|1|||
125591655|NCT00364793|451788081|FG000|Overall Study|No longer meets criteria|0|||
125591656|NCT00364793|451788082|FG001|Overall Study|No longer meets criteria|0|||
125591657|NCT00364793|451788083|FG002|Overall Study|No longer meets criteria|0|||
125591658|NCT00364793|451788084|FG003|Overall Study|No longer meets criteria|1|||
125591659|NCT00364793|451788081|FG000|Overall Study|Withdrawal by Subject|0|||
125363583|NCT01644565|450965136|FG003|Overall Study|Relocation|0|||
125363584|NCT01644565|450965137|FG004|Overall Study|Relocation|0|||
125212219|NCT04278924|450403294|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
125363585|NCT01644565|450965138|FG005|Overall Study|Relocation|0|||
125363586|NCT01644565|450965139|FG006|Overall Study|Relocation|0|||
125363587|NCT01644565|450965140|FG007|Overall Study|Relocation|0|||
125363588|NCT01644565|450965141|FG008|Overall Study|Relocation|1|||
125591660|NCT00364793|451788082|FG001|Overall Study|Withdrawal by Subject|1|||
125591661|NCT00364793|451788083|FG002|Overall Study|Withdrawal by Subject|0|||
125363589|NCT01550289|450965142|FG000|Overall Study|Protocol Violation|1|||
125363590|NCT01550289|450965143|FG001|Overall Study|Protocol Violation|0|||
125363591|NCT01550289|450965142|FG000|Overall Study|Lost to Follow-up|1|||
125363592|NCT01550289|450965143|FG001|Overall Study|Lost to Follow-up|1|||
125363593|NCT01550289|450965142|FG000|Overall Study|Withdrawal by Subject|11|||
125363594|NCT01550289|450965143|FG001|Overall Study|Withdrawal by Subject|3|||
125363595|NCT00094172|450965149|FG000|Overall Study|Adverse Event|0|||
125363596|NCT00094172|450965150|FG001|Overall Study|Adverse Event|1|||
125363597|NCT00094172|450965149|FG000|Overall Study|Lost to Follow-up|2|||
125363598|NCT00094172|450965150|FG001|Overall Study|Lost to Follow-up|0|||
125363599|NCT00094172|450965149|FG000|Overall Study|Protocol Violation|0|||
125363600|NCT00094172|450965150|FG001|Overall Study|Protocol Violation|1|||
125363601|NCT00094172|450965149|FG000|Overall Study|Withdrawal by Subject|10|||
125363602|NCT00094172|450965150|FG001|Overall Study|Withdrawal by Subject|5|||
125363603|NCT00094172|450965149|FG000|Overall Study|Primary endpoint met.|1|||
125363604|NCT00094172|450965150|FG001|Overall Study|Primary endpoint met.|0|||
125363605|NCT00094172|450965149|FG000|Overall Study|Started other MS therapy due to disease|1|||
125363606|NCT00094172|450965150|FG001|Overall Study|Started other MS therapy due to disease|0|||
125363607|NCT00713323|450965151|FG000|Overall Study|Adverse Event|75|||
125363608|NCT00713323|450965151|FG000|Overall Study|Withdrawal by Subject|15|||
125363609|NCT00713323|450965151|FG000|Overall Study|Lost to Follow-up|11|||
125363610|NCT00713323|450965151|FG000|Overall Study|Lack of Efficacy|36|||
125363611|NCT00713323|450965151|FG000|Overall Study|Low creatine clearance at screening|1|||
125363612|NCT00713323|450965151|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
125363613|NCT00713323|450965151|FG000|Overall Study|Surgery cured allodynic pain|1|||
125363614|NCT00713323|450965151|FG000|Overall Study|Pain free|1|||
125363615|NCT00713323|450965151|FG000|Overall Study|Non-compliance|1|||
125363616|NCT00713323|450965151|FG000|Overall Study|Pain resolved|1|||
125363617|NCT00713323|450965151|FG000|Overall Study|Subject travelling to USA|1|||
125363618|NCT00713323|450965151|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
125363619|NCT00713323|450965151|FG000|Overall Study|Treatment that may interact with Sativex|1|||
125363620|NCT02478632|450965152|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
125363621|NCT02478632|450965153|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
125363622|NCT02478632|450965152|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
125363623|NCT02478632|450965153|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
125363624|NCT02478632|450965152|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
125363625|NCT02478632|450965153|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
125363626|NCT04622306|450965154|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
125363627|NCT04622306|450965155|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
125363628|NCT04622306|450965156|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
125363629|NCT04622306|450965157|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
125363630|NCT04622306|450965158|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
125363631|NCT04622306|450965159|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
125363632|NCT04622306|450965154|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
125363633|NCT04622306|450965155|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
125363634|NCT04622306|450965156|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
125591662|NCT00364793|451788084|FG003|Overall Study|Withdrawal by Subject|0|||
125591663|NCT00363415|451788087|FG000|Overall Study|Progressive Disease|196|||
125591664|NCT00363415|451788088|FG001|Overall Study|Progressive Disease|107|||
125591665|NCT00363415|451788087|FG000|Overall Study|Sponsor Decision|67|||
125363635|NCT04622306|450965157|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
125363636|NCT04622306|450965158|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
125363637|NCT04622306|450965159|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
125363638|NCT00864721|450965160|FG000|Overall Study|Patient request|11|||
125591666|NCT00363415|451788088|FG001|Overall Study|Sponsor Decision|31|||
125363639|NCT00864721|450965160|FG000|Overall Study|Hospitalized|1|||
125363640|NCT00864721|450965160|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
125363641|NCT00864721|450965160|FG000|Overall Study|Adverse Event|21|||
125363642|NCT00736944|450965161|FG000|Induction|Death|1|||
125591667|NCT00363415|451788087|FG000|Overall Study|Death|32|||
125591668|NCT00363415|451788088|FG001|Overall Study|Death|29|||
125591669|NCT00363415|451788087|FG000|Overall Study|Adverse Event|24|||
125591670|NCT00363415|451788088|FG001|Overall Study|Adverse Event|15|||
125591671|NCT00363415|451788087|FG000|Overall Study|Physician Decision|18|||
125591672|NCT00363415|451788088|FG001|Overall Study|Physician Decision|35|||
125591673|NCT00363415|451788087|FG000|Overall Study|Entry Criteria Not Met|11|||
125591674|NCT00363415|451788088|FG001|Overall Study|Entry Criteria Not Met|10|||
125591675|NCT00363415|451788087|FG000|Overall Study|Withdrawal by Subject|9|||
125591676|NCT00363415|451788088|FG001|Overall Study|Withdrawal by Subject|15|||
125591677|NCT00363415|451788087|FG000|Overall Study|Lost to Follow-up|3|||
125591678|NCT00363415|451788088|FG001|Overall Study|Lost to Follow-up|3|||
125591679|NCT00363415|451788087|FG000|Overall Study|Protocol Violation|1|||
125591680|NCT00363415|451788088|FG001|Overall Study|Protocol Violation|4|||
125591681|NCT00870688|451788091|FG000|Overall Study|Lost to Follow-up|2|||
125591682|NCT00870688|451788091|FG000|Overall Study|Death, Unrelated|1|||
125591683|NCT00870688|451788091|FG000|Overall Study|Granules in the Stools|1|||
125591684|NCT05027802|451788092|FG000|Overall Study|Adverse Event|2|||
125591685|NCT05027802|451788092|FG000|Overall Study|Withdrawal by Subject|18|||
125591686|NCT05027802|451788092|FG000|Overall Study|Death|2|||
125591687|NCT05027802|451788092|FG000|Overall Study|Other|1|||
125591688|NCT03872180|451788101|FG000|Overall Study|Adverse Event|4|||
125591689|NCT03872180|451788101|FG000|Overall Study|Lack of Efficacy|2|||
125591690|NCT01506141|451788102|FG000|Overall Study|Adverse Event|0|||
125591691|NCT01506141|451788103|FG001|Overall Study|Adverse Event|2|||
125591692|NCT01506141|451788102|FG000|Overall Study|Participation Terminated by Investigator|1|||
125591693|NCT01506141|451788103|FG001|Overall Study|Participation Terminated by Investigator|1|||
125591694|NCT01506141|451788102|FG000|Overall Study|Site Terminated by Sponsor|2|||
125591695|NCT01506141|451788103|FG001|Overall Study|Site Terminated by Sponsor|0|||
125591696|NCT01506141|451788102|FG000|Overall Study|Reason Not Specified|4|||
125591697|NCT01506141|451788103|FG001|Overall Study|Reason Not Specified|2|||
125591698|NCT04607408|451788104|FG000|Overall Study|Lost to Follow-up|0|||
125591699|NCT04607408|451788105|FG001|Overall Study|Lost to Follow-up|0|||
125591700|NCT04607408|451788106|FG002|Overall Study|Lost to Follow-up|0|||
125591701|NCT04607408|451788107|FG003|Overall Study|Lost to Follow-up|1|||
125591702|NCT04607408|451788108|FG004|Overall Study|Lost to Follow-up|0|||
125591703|NCT04607408|451788104|FG000|Overall Study|Withdrawal by Subject|0|||
125591704|NCT04607408|451788105|FG001|Overall Study|Withdrawal by Subject|1|||
125591705|NCT04607408|451788106|FG002|Overall Study|Withdrawal by Subject|0|||
125591706|NCT04607408|451788107|FG003|Overall Study|Withdrawal by Subject|1|||
125591707|NCT04607408|451788108|FG004|Overall Study|Withdrawal by Subject|0|||
125591708|NCT02725788|451788113|FG000|Overall Study|Lost to Follow-up|1|||
125591709|NCT02725788|451788114|FG001|Overall Study|Lost to Follow-up|1|||
125591710|NCT02725788|451788113|FG000|Overall Study|Protocol Violation|0|||
125591711|NCT02725788|451788114|FG001|Overall Study|Protocol Violation|1|||
125591712|NCT05590377|451788115|FG000|Overall Study|Death|1|||
125591713|NCT05590377|451788116|FG001|Overall Study|Death|1|||
125591714|NCT05590377|451788117|FG002|Overall Study|Death|2|||
125591715|NCT05590377|451788118|FG003|Overall Study|Death|0|||
125591716|NCT05590377|451788119|FG004|Overall Study|Death|0|||
125591717|NCT05590377|451788115|FG000|Overall Study|Study Terminated by Sponsor|1|||
125591718|NCT05590377|451788116|FG001|Overall Study|Study Terminated by Sponsor|5|||
125591719|NCT05590377|451788117|FG002|Overall Study|Study Terminated by Sponsor|4|||
125591720|NCT05590377|451788118|FG003|Overall Study|Study Terminated by Sponsor|0|||
125591721|NCT05590377|451788119|FG004|Overall Study|Study Terminated by Sponsor|0|||
125591722|NCT05590377|451788115|FG000|Overall Study|Withdrawal by Subject|1|||
125591723|NCT05590377|451788116|FG001|Overall Study|Withdrawal by Subject|0|||
125591724|NCT05590377|451788117|FG002|Overall Study|Withdrawal by Subject|0|||
125591725|NCT05590377|451788118|FG003|Overall Study|Withdrawal by Subject|0|||
125591726|NCT05590377|451788119|FG004|Overall Study|Withdrawal by Subject|0|||
125591727|NCT00828464|451788120|FG000|Overall Study|Withdrawal by Subject|1|||
125591728|NCT00809133|451788121|FG000|Overall Study|Progressive disease|2|||
125591729|NCT00809133|451788122|FG001|Overall Study|Progressive disease|5|||
125591730|NCT00809133|451788123|FG002|Overall Study|Progressive disease|5|||
125591731|NCT00809133|451788124|FG003|Overall Study|Progressive disease|3|||
125591732|NCT00809133|451788125|FG004|Overall Study|Progressive disease|4|||
125591733|NCT00809133|451788126|FG005|Overall Study|Progressive disease|1|||
125591734|NCT00809133|451788127|FG006|Overall Study|Progressive disease|3|||
125591735|NCT00809133|451788128|FG007|Overall Study|Progressive disease|3|||
125591736|NCT00809133|451788129|FG008|Overall Study|Progressive disease|3|||
125591737|NCT00809133|451788130|FG009|Overall Study|Progressive disease|9|||
125591738|NCT00809133|451788131|FG010|Overall Study|Progressive disease|5|||
125591739|NCT00809133|451788132|FG011|Overall Study|Progressive disease|7|||
125591740|NCT00809133|451788133|FG012|Overall Study|Progressive disease|5|||
125591741|NCT00809133|451788134|FG013|Overall Study|Progressive disease|4|||
125591742|NCT00809133|451788121|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125591743|NCT00809133|451788122|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125591744|NCT00809133|451788123|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125591745|NCT00809133|451788124|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125591746|NCT00809133|451788125|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125591747|NCT00809133|451788126|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125591748|NCT00809133|451788127|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125591749|NCT00809133|451788128|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125591750|NCT00809133|451788129|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125591751|NCT00809133|451788130|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125591752|NCT00809133|451788131|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125591753|NCT00809133|451788132|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125591754|NCT00809133|451788133|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125591755|NCT00809133|451788134|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
125591756|NCT00809133|451788121|FG000|Overall Study|Other adverse event|1|||
125591757|NCT00809133|451788122|FG001|Overall Study|Other adverse event|1|||
125591758|NCT00809133|451788123|FG002|Overall Study|Other adverse event|1|||
125591759|NCT00809133|451788124|FG003|Overall Study|Other adverse event|0|||
125591760|NCT00809133|451788125|FG004|Overall Study|Other adverse event|0|||
125591761|NCT00809133|451788126|FG005|Overall Study|Other adverse event|3|||
125591762|NCT00809133|451788127|FG006|Overall Study|Other adverse event|2|||
125591763|NCT00809133|451788128|FG007|Overall Study|Other adverse event|4|||
125591764|NCT00809133|451788129|FG008|Overall Study|Other adverse event|0|||
125591765|NCT00809133|451788130|FG009|Overall Study|Other adverse event|0|||
125591766|NCT00809133|451788131|FG010|Overall Study|Other adverse event|1|||
125591767|NCT00809133|451788132|FG011|Overall Study|Other adverse event|1|||
125591768|NCT00809133|451788133|FG012|Overall Study|Other adverse event|0|||
125591769|NCT00809133|451788134|FG013|Overall Study|Other adverse event|1|||
125591770|NCT00809133|451788121|FG000|Overall Study|Lost to Follow-up|0|||
125591771|NCT00809133|451788122|FG001|Overall Study|Lost to Follow-up|0|||
125591772|NCT00809133|451788123|FG002|Overall Study|Lost to Follow-up|0|||
125591773|NCT00809133|451788124|FG003|Overall Study|Lost to Follow-up|0|||
125591774|NCT00809133|451788125|FG004|Overall Study|Lost to Follow-up|0|||
125591775|NCT00809133|451788126|FG005|Overall Study|Lost to Follow-up|1|||
125591776|NCT00809133|451788127|FG006|Overall Study|Lost to Follow-up|0|||
125591777|NCT00809133|451788128|FG007|Overall Study|Lost to Follow-up|0|||
125591778|NCT00809133|451788129|FG008|Overall Study|Lost to Follow-up|0|||
125591779|NCT00809133|451788130|FG009|Overall Study|Lost to Follow-up|0|||
125591780|NCT00809133|451788131|FG010|Overall Study|Lost to Follow-up|0|||
125591781|NCT00809133|451788132|FG011|Overall Study|Lost to Follow-up|0|||
125591782|NCT00809133|451788133|FG012|Overall Study|Lost to Follow-up|0|||
125591783|NCT00809133|451788134|FG013|Overall Study|Lost to Follow-up|0|||
125591784|NCT00809133|451788121|FG000|Overall Study|Consent withdrawn|0|||
125591785|NCT00809133|451788122|FG001|Overall Study|Consent withdrawn|0|||
125591786|NCT00809133|451788123|FG002|Overall Study|Consent withdrawn|0|||
125591787|NCT00809133|451788124|FG003|Overall Study|Consent withdrawn|0|||
125212220|NCT04278924|450403295|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
125212221|NCT04278924|450403296|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
125212222|NCT04278924|450403297|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
125212223|NCT04278924|450403298|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
125212224|NCT04278924|450403299|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
125429441|NCT01984697|451198798|FG002|Overall Study|Physician Decision|0|||
125429442|NCT01984697|451198799|FG003|Overall Study|Physician Decision|1|||
125429443|NCT01984697|451198800|FG004|Overall Study|Physician Decision|0|||
125429444|NCT01984697|451198796|FG000|Overall Study|Protocol Violation|8|||
125429445|NCT01984697|451198797|FG001|Overall Study|Protocol Violation|5|||
125429446|NCT01984697|451198798|FG002|Overall Study|Protocol Violation|3|||
125429447|NCT01984697|451198799|FG003|Overall Study|Protocol Violation|2|||
125429448|NCT01984697|451198800|FG004|Overall Study|Protocol Violation|0|||
125429449|NCT01984697|451198796|FG000|Overall Study|Withdrawal by Subject|15|||
125429450|NCT01984697|451198797|FG001|Overall Study|Withdrawal by Subject|21|||
125429451|NCT01984697|451198798|FG002|Overall Study|Withdrawal by Subject|13|||
125429452|NCT01984697|451198799|FG003|Overall Study|Withdrawal by Subject|11|||
125429453|NCT01984697|451198800|FG004|Overall Study|Withdrawal by Subject|13|||
125429454|NCT01984697|451198796|FG000|Overall Study|Missed last follow-up visit|1|||
125429455|NCT01984697|451198797|FG001|Overall Study|Missed last follow-up visit|0|||
125429456|NCT01984697|451198798|FG002|Overall Study|Missed last follow-up visit|0|||
125212225|NCT04278924|450403300|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
125212226|NCT05600036|450403301|FG000|Overall Study|Adverse Event|0|||
125212227|NCT05600036|450403302|FG001|Overall Study|Adverse Event|2|||
125212228|NCT05600036|450403303|FG002|Overall Study|Adverse Event|1|||
125212229|NCT05600036|450403304|FG003|Overall Study|Adverse Event|0|||
125212230|NCT05600036|450403305|FG004|Overall Study|Adverse Event|1|||
125212231|NCT05600036|450403306|FG005|Overall Study|Adverse Event|0|||
125212232|NCT05600036|450403301|FG000|Overall Study|Lost to Follow-up|0|||
125212233|NCT05600036|450403302|FG001|Overall Study|Lost to Follow-up|2|||
125212234|NCT05600036|450403303|FG002|Overall Study|Lost to Follow-up|1|||
125212235|NCT05600036|450403304|FG003|Overall Study|Lost to Follow-up|1|||
125212236|NCT05600036|450403305|FG004|Overall Study|Lost to Follow-up|0|||
125212237|NCT05600036|450403306|FG005|Overall Study|Lost to Follow-up|0|||
125212238|NCT05600036|450403301|FG000|Overall Study|Protocol Violation|0|||
125212239|NCT05600036|450403302|FG001|Overall Study|Protocol Violation|0|||
125212240|NCT05600036|450403303|FG002|Overall Study|Protocol Violation|2|||
125212241|NCT05600036|450403304|FG003|Overall Study|Protocol Violation|0|||
125212242|NCT05600036|450403305|FG004|Overall Study|Protocol Violation|0|||
125212243|NCT05600036|450403306|FG005|Overall Study|Protocol Violation|0|||
125212244|NCT05600036|450403301|FG000|Overall Study|Withdrawal by Subject|0|||
125212245|NCT05600036|450403302|FG001|Overall Study|Withdrawal by Subject|1|||
125212246|NCT05600036|450403303|FG002|Overall Study|Withdrawal by Subject|2|||
125212247|NCT05600036|450403304|FG003|Overall Study|Withdrawal by Subject|0|||
125212248|NCT05600036|450403305|FG004|Overall Study|Withdrawal by Subject|3|||
125212249|NCT05600036|450403306|FG005|Overall Study|Withdrawal by Subject|5|||
125212250|NCT05600036|450403301|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
125212251|NCT05600036|450403302|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
125212252|NCT05600036|450403303|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
125212253|NCT05600036|450403304|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
125429457|NCT01984697|451198799|FG003|Overall Study|Missed last follow-up visit|0|||
125429458|NCT01984697|451198800|FG004|Overall Study|Missed last follow-up visit|0|||
125429459|NCT01984697|451198796|FG000|Overall Study|Death|0|||
125429460|NCT01984697|451198797|FG001|Overall Study|Death|0|||
125429461|NCT01984697|451198798|FG002|Overall Study|Death|0|||
125429462|NCT01984697|451198799|FG003|Overall Study|Death|1|||
125429463|NCT01984697|451198800|FG004|Overall Study|Death|0|||
125429464|NCT01984697|451198796|FG000|Overall Study|Pregnancy|2|||
125429465|NCT01984697|451198797|FG001|Overall Study|Pregnancy|0|||
125429466|NCT01984697|451198798|FG002|Overall Study|Pregnancy|1|||
125429467|NCT01984697|451198799|FG003|Overall Study|Pregnancy|0|||
125429468|NCT01984697|451198800|FG004|Overall Study|Pregnancy|1|||
125429469|NCT03308825|451198801|FG000|Overall Study|Lost to Follow-up|2|||
125429470|NCT03308825|451198802|FG001|Overall Study|Lost to Follow-up|2|||
125429471|NCT03308825|451198803|FG002|Overall Study|Lost to Follow-up|1|||
125429472|NCT03308825|451198804|FG003|Overall Study|Lost to Follow-up|0|||
125429473|NCT03308825|451198801|FG000|Overall Study|Protocol Violation|0|||
125429474|NCT03308825|451198802|FG001|Overall Study|Protocol Violation|2|||
125429475|NCT03308825|451198803|FG002|Overall Study|Protocol Violation|0|||
125212254|NCT05600036|450403305|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
125212255|NCT05600036|450403306|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
125212256|NCT05600036|450403301|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
125429476|NCT03308825|451198804|FG003|Overall Study|Protocol Violation|0|||
125429477|NCT04737109|451198805|FG000|Study Treatment|Disease Progression|5|||
125429478|NCT04737109|451198806|FG001|Study Treatment|Disease Progression|0|||
125429479|NCT04737109|451198807|FG002|Study Treatment|Disease Progression|0|||
125429480|NCT04737109|451198808|FG003|Study Treatment|Disease Progression|0|||
125429481|NCT04737109|451198805|FG000|Study Treatment|Death on study|1|||
125429482|NCT04737109|451198806|FG001|Study Treatment|Death on study|0|||
125429483|NCT04737109|451198807|FG002|Study Treatment|Death on study|0|||
125429484|NCT04737109|451198808|FG003|Study Treatment|Death on study|0|||
125429485|NCT02259517|451198812|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
125591788|NCT00809133|451788125|FG004|Overall Study|Consent withdrawn|1|||
125591789|NCT00809133|451788126|FG005|Overall Study|Consent withdrawn|0|||
125591790|NCT00809133|451788127|FG006|Overall Study|Consent withdrawn|0|||
125591791|NCT00809133|451788128|FG007|Overall Study|Consent withdrawn|0|||
125591792|NCT00809133|451788129|FG008|Overall Study|Consent withdrawn|0|||
125591793|NCT00809133|451788130|FG009|Overall Study|Consent withdrawn|0|||
125591794|NCT00809133|451788131|FG010|Overall Study|Consent withdrawn|0|||
125591795|NCT00809133|451788132|FG011|Overall Study|Consent withdrawn|0|||
125591796|NCT00809133|451788133|FG012|Overall Study|Consent withdrawn|0|||
125591797|NCT00809133|451788134|FG013|Overall Study|Consent withdrawn|0|||
125591798|NCT00809133|451788121|FG000|Overall Study|Other not mentioned above|0|||
125591799|NCT00809133|451788122|FG001|Overall Study|Other not mentioned above|1|||
125591800|NCT00809133|451788123|FG002|Overall Study|Other not mentioned above|0|||
125591801|NCT00809133|451788124|FG003|Overall Study|Other not mentioned above|0|||
125591802|NCT00809133|451788125|FG004|Overall Study|Other not mentioned above|0|||
125591803|NCT00809133|451788126|FG005|Overall Study|Other not mentioned above|1|||
125591804|NCT00809133|451788127|FG006|Overall Study|Other not mentioned above|0|||
125591805|NCT00809133|451788128|FG007|Overall Study|Other not mentioned above|0|||
125591806|NCT00809133|451788129|FG008|Overall Study|Other not mentioned above|0|||
125591807|NCT00809133|451788130|FG009|Overall Study|Other not mentioned above|0|||
125591808|NCT00809133|451788131|FG010|Overall Study|Other not mentioned above|0|||
125591809|NCT00809133|451788132|FG011|Overall Study|Other not mentioned above|0|||
125591810|NCT00809133|451788133|FG012|Overall Study|Other not mentioned above|0|||
125591811|NCT00809133|451788134|FG013|Overall Study|Other not mentioned above|0|||
125591812|NCT01025635|451788138|FG000|Overall Study|Withdrawal by Subject|6|||
125591813|NCT01025635|451788139|FG001|Overall Study|Withdrawal by Subject|7|||
125591814|NCT01025635|451788138|FG000|Overall Study|Protocol Violation|4|||
125591815|NCT01025635|451788139|FG001|Overall Study|Protocol Violation|2|||
125591816|NCT01025635|451788138|FG000|Overall Study|Lack of Efficacy|0|||
125591817|NCT01025635|451788139|FG001|Overall Study|Lack of Efficacy|1|||
125591818|NCT01025635|451788138|FG000|Overall Study|Lost to Follow-up|9|||
125591819|NCT01025635|451788139|FG001|Overall Study|Lost to Follow-up|13|||
125591820|NCT01025635|451788138|FG000|Overall Study|Reason not known|4|||
125591821|NCT01025635|451788139|FG001|Overall Study|Reason not known|2|||
125591822|NCT00727402|451788140|FG000|Overall Study|Physician Decision|116|||
125591823|NCT05292755|451788141|FG000|Overall Study|Lost to Follow-up|5|||
125212257|NCT05600036|450403302|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
125429486|NCT02259517|451198813|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
125429487|NCT02259517|451198814|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
125429488|NCT02259517|451198812|FG000|Overall Study|Withdrawal by Subject|0|||
125429489|NCT02259517|451198813|FG001|Overall Study|Withdrawal by Subject|0|||
125429490|NCT02259517|451198814|FG002|Overall Study|Withdrawal by Subject|3|||
125429491|NCT01289418|451198815|FG000|Day 8 Survey|email address invalid|283|||
125429492|NCT01289418|451198815|FG000|Day 8 Survey|participants did not complete the survey|1935|||
125591824|NCT05292755|451788142|FG001|Overall Study|Lost to Follow-up|9|||
125591825|NCT00432809|451788144|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
125591826|NCT00432809|451788145|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
125591827|NCT00432809|451788146|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
125591828|NCT00432809|451788144|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
125591829|NCT00432809|451788145|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
125591830|NCT00432809|451788146|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
125591831|NCT04433117|451788147|FG000|Overall Study|Withdrawal by Subject|1|||
125591832|NCT04433117|451788148|FG001|Overall Study|Withdrawal by Subject|0|||
125591833|NCT01051739|451788149|FG000|Overall Study|Death|3|||
125591834|NCT01051739|451788150|FG001|Overall Study|Death|3|||
125591835|NCT01051739|451788149|FG000|Overall Study|Withdrawal by Subject|25|||
125591836|NCT01051739|451788150|FG001|Overall Study|Withdrawal by Subject|10|||
125591837|NCT00707577|451788151|FG000|Overall Study|Withdrawal by Subject|3|||
125591838|NCT00707577|451788152|FG001|Overall Study|Withdrawal by Subject|2|||
125591839|NCT00707577|451788151|FG000|Overall Study|Lost to Follow-up|34|||
125429493|NCT01289418|451198815|FG000|Day 29 Survey|email address invalid|283|||
125429494|NCT01289418|451198815|FG000|Day 29 Survey|participants did not complete the survey|2185|||
125591840|NCT00707577|451788152|FG001|Overall Study|Lost to Follow-up|25|||
125591841|NCT00707577|451788151|FG000|Overall Study|Left employment|13|||
125591842|NCT00707577|451788152|FG001|Overall Study|Left employment|10|||
125591843|NCT00707577|451788151|FG000|Overall Study|Pregnancy|4|||
125591844|NCT00707577|451788152|FG001|Overall Study|Pregnancy|1|||
125591845|NCT03853694|451788153|FG000|Overall Study|Protocol Violation|3|||
125591846|NCT03853694|451788154|FG001|Overall Study|Protocol Violation|5|||
125591847|NCT03853694|451788155|FG002|Overall Study|Protocol Violation|3|||
125591848|NCT03853694|451788153|FG000|Overall Study|Delivered early|0|||
125591849|NCT03853694|451788154|FG001|Overall Study|Delivered early|1|||
125591850|NCT03853694|451788155|FG002|Overall Study|Delivered early|0|||
125591851|NCT03853694|451788153|FG000|Overall Study|not suitable to proceed|0|||
125591852|NCT03853694|451788154|FG001|Overall Study|not suitable to proceed|1|||
125591853|NCT03853694|451788155|FG002|Overall Study|not suitable to proceed|0|||
125591854|NCT03853694|451788153|FG000|Overall Study|difficult surgery|0|||
125591855|NCT03853694|451788154|FG001|Overall Study|difficult surgery|0|||
125591856|NCT03853694|451788155|FG002|Overall Study|difficult surgery|1|||
125591857|NCT03853694|451788153|FG000|Overall Study|Lost to Follow-up|0|||
125212258|NCT05600036|450403303|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
125429495|NCT01352585|451198816|FG000|Overall Study|Adverse Event|2|||
125429496|NCT01352585|451198817|FG001|Overall Study|Adverse Event|1|||
125429497|NCT01352585|451198816|FG000|Overall Study|Lost to Follow-up|1|||
125429498|NCT01352585|451198817|FG001|Overall Study|Lost to Follow-up|0|||
125429499|NCT01352585|451198816|FG000|Overall Study|Other|5|||
125429500|NCT01352585|451198817|FG001|Overall Study|Other|2|||
125429501|NCT02276066|451198822|FG000|Overall Study|Lost to Follow-up|21|||
125429502|NCT02276066|451198823|FG001|Overall Study|Lost to Follow-up|11|||
125429503|NCT05050578|451198824|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
125429504|NCT05050578|451198825|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
125429505|NCT05050578|451198824|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
125429506|NCT05050578|451198825|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
125429507|NCT05050578|451198824|FG000|Period 2, 30 Days|Protocol Violation|0|||
125429508|NCT05050578|451198825|FG001|Period 2, 30 Days|Protocol Violation|1|||
125429509|NCT03386032|451198832|FG000|Overall Study|Lack of Efficacy|6|||
125429510|NCT03386032|451198833|FG001|Overall Study|Lack of Efficacy|2|||
125429511|NCT03386032|451198834|FG002|Overall Study|Lack of Efficacy|0|||
125429512|NCT03386032|451198832|FG000|Overall Study|Adverse Event|2|||
125429513|NCT03386032|451198833|FG001|Overall Study|Adverse Event|2|||
125429514|NCT03386032|451198834|FG002|Overall Study|Adverse Event|0|||
125429515|NCT03386032|451198832|FG000|Overall Study|Withdrawal by Subject|1|||
125429516|NCT03386032|451198833|FG001|Overall Study|Withdrawal by Subject|0|||
125429517|NCT03386032|451198834|FG002|Overall Study|Withdrawal by Subject|0|||
125429518|NCT03386032|451198832|FG000|Overall Study|Lost to Follow-up|9|||
125429519|NCT03386032|451198833|FG001|Overall Study|Lost to Follow-up|3|||
125429520|NCT03386032|451198834|FG002|Overall Study|Lost to Follow-up|0|||
125429521|NCT03928028|451198839|FG000|Overall Study|Physician Decision|9|||
125429522|NCT03928028|451198840|FG001|Overall Study|Physician Decision|6|||
125429523|NCT03928028|451198841|FG002|Overall Study|Physician Decision|3|||
125429524|NCT03928028|451198839|FG000|Overall Study|Withdrawal by Subject|12|||
125429525|NCT03928028|451198840|FG001|Overall Study|Withdrawal by Subject|3|||
125429526|NCT03928028|451198841|FG002|Overall Study|Withdrawal by Subject|3|||
125429527|NCT02710292|451198846|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
125429528|NCT02710292|451198847|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
125429529|NCT02710292|451198846|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
125429530|NCT02710292|451198847|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
125429531|NCT04525547|451198848|FG000|Overall Study|Not treated with Ofev|2|||
125429532|NCT04525547|451198848|FG000|Overall Study|Off-label use|2|||
125429533|NCT04525547|451198848|FG000|Overall Study|Lost to Follow-up|1|||
125429534|NCT00800202|451198849|FG000|Overall Study|Adverse Event|7|||
125591858|NCT03853694|451788154|FG001|Overall Study|Lost to Follow-up|1|||
125591859|NCT03853694|451788155|FG002|Overall Study|Lost to Follow-up|0|||
125591860|NCT03853694|451788153|FG000|Overall Study|Withdrawal by Subject|0|||
125429535|NCT00800202|451198850|FG001|Overall Study|Adverse Event|6|||
125591861|NCT03853694|451788154|FG001|Overall Study|Withdrawal by Subject|1|||
125591862|NCT03853694|451788155|FG002|Overall Study|Withdrawal by Subject|0|||
125591863|NCT02499952|451788156|FG000|Overall Study|Lost to Follow-up|1|||
125429536|NCT00800202|451198849|FG000|Overall Study|Death|1|||
125429537|NCT00800202|451198850|FG001|Overall Study|Death|0|||
125429538|NCT00800202|451198849|FG000|Overall Study|Other|5|||
125429539|NCT00800202|451198850|FG001|Overall Study|Other|0|||
125429540|NCT00800202|451198849|FG000|Overall Study|Disease Progression|54|||
125591864|NCT02499952|451788156|FG000|Overall Study|Death|9|||
125591865|NCT05089708|451788157|FG000|Overall Study|Lost to Follow-up|9|||
125591866|NCT05089708|451788158|FG001|Overall Study|Lost to Follow-up|7|||
125429541|NCT00800202|451198850|FG001|Overall Study|Disease Progression|18|||
125591867|NCT05089708|451788157|FG000|Overall Study|Withdrawal by Subject|3|||
125591868|NCT05089708|451788158|FG001|Overall Study|Withdrawal by Subject|1|||
125591869|NCT05089708|451788157|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
125591870|NCT05089708|451788158|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
125591871|NCT05089708|451788157|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
125591872|NCT05089708|451788158|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
125591873|NCT02209766|451788160|FG000|Overall Study|Withdrawal by Subject|0|||
125591874|NCT02209766|451788161|FG001|Overall Study|Withdrawal by Subject|0|||
125591875|NCT02209766|451788162|FG002|Overall Study|Withdrawal by Subject|0|||
125591876|NCT02209766|451788163|FG003|Overall Study|Withdrawal by Subject|1|||
125591877|NCT02209766|451788164|FG004|Overall Study|Withdrawal by Subject|0|||
125591878|NCT00064701|451788165|FG000|One Year Post-transplant|Did not receive study drug|7|||
125591879|NCT00064701|451788166|FG001|One Year Post-transplant|Did not receive study drug|12|||
125591880|NCT00064701|451788167|FG002|One Year Post-transplant|Did not receive study drug|11|||
125591881|NCT00064701|451788165|FG000|One Year Post-transplant|Adverse Event|23|||
125591882|NCT00064701|451788166|FG001|One Year Post-transplant|Adverse Event|19|||
125591883|NCT00064701|451788167|FG002|One Year Post-transplant|Adverse Event|37|||
125591884|NCT00064701|451788165|FG000|One Year Post-transplant|Rejection|0|||
125591885|NCT00064701|451788166|FG001|One Year Post-transplant|Rejection|1|||
125591886|NCT00064701|451788167|FG002|One Year Post-transplant|Rejection|16|||
125591887|NCT00064701|451788165|FG000|One Year Post-transplant|Non-compliance|4|||
125591888|NCT00064701|451788166|FG001|One Year Post-transplant|Non-compliance|2|||
125591889|NCT00064701|451788167|FG002|One Year Post-transplant|Non-compliance|5|||
125591890|NCT00064701|451788165|FG000|One Year Post-transplant|Graft Failure|3|||
125591891|NCT00064701|451788166|FG001|One Year Post-transplant|Graft Failure|2|||
125591892|NCT00064701|451788167|FG002|One Year Post-transplant|Graft Failure|1|||
125591893|NCT00064701|451788165|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
125591894|NCT00064701|451788166|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
125591895|NCT00064701|451788167|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
125591896|NCT00064701|451788165|FG000|One Year Post-transplant|Lost to Follow-up|1|||
125591897|NCT00064701|451788166|FG001|One Year Post-transplant|Lost to Follow-up|0|||
125591898|NCT00064701|451788167|FG002|One Year Post-transplant|Lost to Follow-up|0|||
125591899|NCT00064701|451788165|FG000|One Year Post-transplant|Converted to rapamycin|1|||
125591900|NCT00064701|451788166|FG001|One Year Post-transplant|Converted to rapamycin|0|||
125591901|NCT00064701|451788167|FG002|One Year Post-transplant|Converted to rapamycin|0|||
125591902|NCT00064701|451788165|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
125591903|NCT00064701|451788166|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
125591904|NCT00064701|451788167|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
125591905|NCT00064701|451788165|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
125591906|NCT00064701|451788166|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
125429542|NCT04425902|451198851|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
125591907|NCT00064701|451788167|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
125591908|NCT00064701|451788165|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
125591909|NCT00064701|451788166|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
125591910|NCT00064701|451788167|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
125591911|NCT00064701|451788165|FG000|One Year Post-transplant|Poor absorption|0|||
125212259|NCT05600036|450403304|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
125212260|NCT05600036|450403305|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
125212261|NCT05600036|450403306|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
125212262|NCT05600036|450403301|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
125212263|NCT05600036|450403302|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
125212264|NCT05600036|450403303|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
125212265|NCT05600036|450403304|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
125212266|NCT05600036|450403305|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
125212267|NCT05600036|450403306|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
125591912|NCT00064701|451788166|FG001|One Year Post-transplant|Poor absorption|1|||
125591913|NCT00064701|451788167|FG002|One Year Post-transplant|Poor absorption|0|||
125591914|NCT00064701|451788165|FG000|One Year Post-transplant|Pancreas transplant|0|||
125591915|NCT00064701|451788166|FG001|One Year Post-transplant|Pancreas transplant|0|||
125591916|NCT00064701|451788167|FG002|One Year Post-transplant|Pancreas transplant|1|||
125591917|NCT00064701|451788165|FG000|Clinical Continuation Phase|Adverse Event|12|||
125591918|NCT00064701|451788166|FG001|Clinical Continuation Phase|Adverse Event|21|||
125591919|NCT00064701|451788167|FG002|Clinical Continuation Phase|Adverse Event|14|||
125591920|NCT00064701|451788165|FG000|Clinical Continuation Phase|Non-compliance|8|||
125591921|NCT00064701|451788166|FG001|Clinical Continuation Phase|Non-compliance|6|||
125591922|NCT00064701|451788167|FG002|Clinical Continuation Phase|Non-compliance|7|||
125591923|NCT00064701|451788165|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
125591924|NCT00064701|451788166|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
125591925|NCT00064701|451788167|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
125591926|NCT00064701|451788165|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
125591927|NCT00064701|451788166|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
125591928|NCT00064701|451788167|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
125591929|NCT00064701|451788165|FG000|Clinical Continuation Phase|Graft Failure|5|||
125591930|NCT00064701|451788166|FG001|Clinical Continuation Phase|Graft Failure|5|||
125591931|NCT00064701|451788167|FG002|Clinical Continuation Phase|Graft Failure|2|||
125591932|NCT00064701|451788165|FG000|Clinical Continuation Phase|Rejection|1|||
125591933|NCT00064701|451788166|FG001|Clinical Continuation Phase|Rejection|2|||
125212268|NCT01006590|450403308|FG000|Overall Study|Adverse Event|2|||
125591934|NCT00064701|451788167|FG002|Clinical Continuation Phase|Rejection|2|||
125591935|NCT00064701|451788165|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
125591936|NCT00064701|451788166|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
125591937|NCT00064701|451788167|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
125591938|NCT00064701|451788165|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
125591939|NCT00064701|451788166|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
125591940|NCT00064701|451788167|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
125591941|NCT00064701|451788165|FG000|Clinical Continuation Phase|Physician Decision|1|||
125591942|NCT00064701|451788166|FG001|Clinical Continuation Phase|Physician Decision|3|||
125591943|NCT00064701|451788167|FG002|Clinical Continuation Phase|Physician Decision|0|||
125591944|NCT00064701|451788165|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
125591945|NCT00064701|451788166|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
125591946|NCT00064701|451788167|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
125591947|NCT00064701|451788165|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
125591948|NCT00064701|451788166|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
125591949|NCT00064701|451788167|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
125591950|NCT00064701|451788165|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
125591951|NCT00064701|451788166|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
125591952|NCT00064701|451788167|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
125591953|NCT00064701|451788165|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
125591954|NCT00064701|451788166|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
125591955|NCT00064701|451788167|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
125591956|NCT00064701|451788165|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
125591957|NCT00064701|451788166|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
125591958|NCT00064701|451788167|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
125591959|NCT00064701|451788165|FG000|Clinical Continuation Phase|Patient opted out|0|||
125591960|NCT00064701|451788166|FG001|Clinical Continuation Phase|Patient opted out|0|||
125591961|NCT00064701|451788167|FG002|Clinical Continuation Phase|Patient opted out|1|||
125591962|NCT01491945|451788169|FG000|Overall Study|Death|30|||
125591963|NCT01491945|451788169|FG000|Overall Study|Withdrwan/LTF|16|||
125591964|NCT01491945|451788169|FG000|Overall Study|Conversion|4|||
125591965|NCT01491945|451788169|FG000|Overall Study|Missed Visit|1|||
125591966|NCT03770403|451788170|FG000|Overall Study|Adverse Event|8|||
125591967|NCT03770403|451788170|FG000|Overall Study|Death|5|||
125591968|NCT03770403|451788170|FG000|Overall Study|Physician Decision|1|||
125591969|NCT03770403|451788170|FG000|Overall Study|Sponsor decision|1|||
125591970|NCT03770403|451788170|FG000|Overall Study|Study terminated by Sponsor|1|||
125591971|NCT03770403|451788170|FG000|Overall Study|Withdrawal by Subject|13|||
125591972|NCT03770403|451788170|FG000|Overall Study|Other|88|||
125591973|NCT02700451|451788175|FG000|Overall Study|Protocol Violation|2|||
125591974|NCT02700451|451788176|FG001|Overall Study|Protocol Violation|2|||
125591975|NCT02700451|451788177|FG002|Overall Study|Protocol Violation|3|||
125591976|NCT02700451|451788175|FG000|Overall Study|Discontinued intervention|14|||
125591977|NCT02700451|451788176|FG001|Overall Study|Discontinued intervention|15|||
125591978|NCT02700451|451788177|FG002|Overall Study|Discontinued intervention|14|||
125591979|NCT04373460|451788178|FG000|Overall Study|Did not receive tranfusion|18|||
125591980|NCT04373460|451788179|FG001|Overall Study|Did not receive tranfusion|26|||
125591981|NCT01672957|451788180|FG000|Overall Study|Protocol Violation|48|||
125591982|NCT01672957|451788180|FG000|Overall Study|Death|2|||
125591983|NCT01672957|451788180|FG000|Overall Study|ICF Signed After Transplantation|5|||
125591984|NCT02115308|451788183|FG000|Overall Study|Safety Screening|2|||
125591985|NCT02115308|451788184|FG001|Overall Study|Safety Screening|2|||
125591986|NCT00642642|451788185|FG000|Treatment & Follow Up|Adverse Event|2|||
125591987|NCT00642642|451788185|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
125591988|NCT00642642|451788185|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
125591989|NCT02344576|451788186|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
125591990|NCT02344576|451788187|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
125591991|NCT02344576|451788188|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
125591992|NCT02344576|451788189|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
125591993|NCT02344576|451788186|FG000|1-Month Follow-Up|Death|13|||
125591994|NCT02344576|451788187|FG001|1-Month Follow-Up|Death|8|||
125591995|NCT02344576|451788188|FG002|1-Month Follow-Up|Death|0|||
125591996|NCT02344576|451788189|FG003|1-Month Follow-Up|Death|0|||
125591997|NCT02344576|451788186|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
125591998|NCT02344576|451788187|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
125591999|NCT02344576|451788188|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
125592000|NCT02344576|451788189|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
125592001|NCT02344576|451788186|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
125592002|NCT02344576|451788187|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
125592003|NCT02344576|451788188|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
125592004|NCT02344576|451788189|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
125592005|NCT02344576|451788186|FG000|6-Month Follow-Up|Death|14|||
125592006|NCT02344576|451788187|FG001|6-Month Follow-Up|Death|14|||
125592007|NCT02344576|451788188|FG002|6-Month Follow-Up|Death|0|||
125592008|NCT02344576|451788189|FG003|6-Month Follow-Up|Death|0|||
125592009|NCT02344576|451788186|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
125592010|NCT02344576|451788187|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
125592011|NCT02344576|451788188|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
125592012|NCT02344576|451788189|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
125592013|NCT02344576|451788186|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
125592014|NCT02344576|451788187|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
125592015|NCT02344576|451788188|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
125592016|NCT02344576|451788189|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
125592017|NCT02337387|451788192|FG000|Overall Study|Adverse Event|0|||
125592018|NCT02337387|451788193|FG001|Overall Study|Adverse Event|1|||
125592019|NCT02337387|451788194|FG002|Overall Study|Adverse Event|0|||
125592020|NCT02337387|451788195|FG003|Overall Study|Adverse Event|0|||
125592021|NCT02337387|451788192|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
125592022|NCT02337387|451788193|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
125592023|NCT02337387|451788194|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
125592024|NCT02337387|451788195|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
125592025|NCT01053429|451788196|FG000|Overall Study|Adverse Event|64|||
125592026|NCT01053429|451788196|FG000|Overall Study|Other|309|||
125592027|NCT00924703|451788197|FG000|Overall Study|Withdrawal by Subject|11|||
125592028|NCT00924703|451788197|FG000|Overall Study|Physician Decision|5|||
125592029|NCT00924703|451788197|FG000|Overall Study|Lost to Follow-up|3|||
125592030|NCT00924703|451788197|FG000|Overall Study|Adverse Event|2|||
125592031|NCT00924703|451788197|FG000|Overall Study|Withdrawal by Sponsor|1|||
125592032|NCT01587989|451788198|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
125592033|NCT01587989|451788199|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
125592034|NCT01587989|451788200|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
125592035|NCT01587989|451788198|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
125592036|NCT01587989|451788199|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
125592037|NCT01587989|451788200|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
125592038|NCT01587989|451788198|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
125592039|NCT01587989|451788199|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
125592040|NCT01587989|451788200|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
125592041|NCT01587989|451788198|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
125592042|NCT01587989|451788199|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
125592043|NCT01587989|451788200|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
125592044|NCT01587989|451788198|FG000|Randomized Study Treatment|Screening failure|0|||
125592045|NCT01587989|451788199|FG001|Randomized Study Treatment|Screening failure|1|||
125592046|NCT01587989|451788200|FG002|Randomized Study Treatment|Screening failure|0|||
125592047|NCT01587989|451788198|FG000|Randomized Study Treatment|Physician Decision|0|||
125592048|NCT01587989|451788199|FG001|Randomized Study Treatment|Physician Decision|0|||
125592049|NCT01587989|451788200|FG002|Randomized Study Treatment|Physician Decision|1|||
125592050|NCT02582658|451788202|FG000|Overall Study|Failure to Return|10|||
125592051|NCT02582658|451788202|FG000|Overall Study|Insufficient Virological Response|2|||
125592052|NCT02582658|451788202|FG000|Overall Study|Withdrawn Consent|1|||
125592053|NCT02582658|451788202|FG000|Overall Study|Death|1|||
125592054|NCT02582658|451788202|FG000|Overall Study|Not further specified|11|||
125592055|NCT03095703|451790931|FG000|Overall Study|Withdrawal by Subject|1|||
125592056|NCT01381094|451790932|FG000|Overall Study|Adverse Event|1|||
125592057|NCT01381094|451790933|FG001|Overall Study|Adverse Event|2|||
125592058|NCT01381094|451790934|FG002|Overall Study|Adverse Event|0|||
125592059|NCT01381094|451790935|FG003|Overall Study|Adverse Event|1|||
125592060|NCT01381094|451790936|FG004|Overall Study|Adverse Event|0|||
125592061|NCT01381094|451790932|FG000|Overall Study|Lost to Follow-up|0|||
125592062|NCT01381094|451790933|FG001|Overall Study|Lost to Follow-up|0|||
125592063|NCT01381094|451790934|FG002|Overall Study|Lost to Follow-up|0|||
125592064|NCT01381094|451790935|FG003|Overall Study|Lost to Follow-up|0|||
125592065|NCT01381094|451790936|FG004|Overall Study|Lost to Follow-up|1|||
125592066|NCT01381094|451790932|FG000|Overall Study|Withdrawal of informed consent|0|||
125592067|NCT01381094|451790933|FG001|Overall Study|Withdrawal of informed consent|1|||
125592068|NCT01381094|451790934|FG002|Overall Study|Withdrawal of informed consent|0|||
125363643|NCT00736944|450965161|FG000|Definitive Treatment|Physician Decision|1|||
125363644|NCT05350410|450965162|FG000|Overall Study|Withdrawal by Subject|1|||
125363645|NCT01601132|450965163|FG000|Overall Study|Patient withdrew consent|1|||
125592069|NCT01381094|451790935|FG003|Overall Study|Withdrawal of informed consent|0|||
125592070|NCT01381094|451790936|FG004|Overall Study|Withdrawal of informed consent|0|||
125592071|NCT01381094|451790932|FG000|Overall Study|Participant given Aranesp injection|1|||
125592072|NCT01381094|451790933|FG001|Overall Study|Participant given Aranesp injection|0|||
125592073|NCT01381094|451790934|FG002|Overall Study|Participant given Aranesp injection|0|||
125592074|NCT01381094|451790935|FG003|Overall Study|Participant given Aranesp injection|0|||
125592075|NCT01381094|451790936|FG004|Overall Study|Participant given Aranesp injection|0|||
125592076|NCT01934504|451790939|FG000|Overall Study|Protocol Deviation|0|||
125592077|NCT01934504|451790940|FG001|Overall Study|Protocol Deviation|0|||
125592078|NCT01934504|451790941|FG002|Overall Study|Protocol Deviation|0|||
125363646|NCT01601132|450965163|FG000|Overall Study|Protocol deviation|1|||
125363647|NCT02110238|450965164|FG000|12 Week Pivotal Phase|Adverse Event|3|||
125363648|NCT02110238|450965165|FG001|12 Week Pivotal Phase|Adverse Event|0|||
125592079|NCT01934504|451790942|FG003|Overall Study|Protocol Deviation|2|||
125592080|NCT01934504|451790939|FG000|Overall Study|Study Terminated by Sponsor|1|||
125592081|NCT01934504|451790940|FG001|Overall Study|Study Terminated by Sponsor|0|||
125592082|NCT01934504|451790941|FG002|Overall Study|Study Terminated by Sponsor|5|||
125592083|NCT01934504|451790942|FG003|Overall Study|Study Terminated by Sponsor|5|||
125363649|NCT02110238|450965164|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
125363650|NCT02110238|450965165|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
125363651|NCT02110238|450965164|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
125363652|NCT02110238|450965165|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
125592084|NCT02665689|451790943|FG000|Overall Study|Adverse Event|1|||
125592085|NCT02665689|451790944|FG001|Overall Study|Adverse Event|0|||
125592086|NCT02665689|451790943|FG000|Overall Study|Trial termination|1|||
125592087|NCT02665689|451790944|FG001|Overall Study|Trial termination|1|||
125592088|NCT02665689|451790943|FG000|Overall Study|Lost to Follow-up|0|||
125592089|NCT02665689|451790944|FG001|Overall Study|Lost to Follow-up|1|||
125592090|NCT00541307|451790945|FG000|Overall Study|Death|5|||
125592091|NCT00541307|451790945|FG000|Overall Study|Physician Decision|3|||
125592092|NCT00541307|451790945|FG000|Overall Study|Withdrawal by Subject|6|||
125592093|NCT00541307|451790945|FG000|Overall Study|Lost to Follow-up|4|||
125592094|NCT00541307|451790945|FG000|Overall Study|Subject returned early (outside window)|1|||
125592095|NCT00541307|451790945|FG000|Overall Study|Surgical Bypass|5|||
125592096|NCT02455557|451790946|FG000|Overall Study|Withdrawal by Subject|2|||
125592097|NCT03615222|451790947|FG000|Overall Study|Ineligible|26|||
125592098|NCT03615222|451790947|FG000|Overall Study|Withdrawal by Subject|7|||
125592099|NCT03615222|451790947|FG000|Overall Study|Death|1|||
125592100|NCT02900092|451790948|FG000|Overall Study|Adverse Event|1|||
125592101|NCT03895203|451790949|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
125592102|NCT03895203|451790950|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
125592103|NCT03895203|451790951|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
125592104|NCT03895203|451790952|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
125592105|NCT03895203|451790953|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
125592106|NCT03895203|451790954|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
125592107|NCT03895203|451790949|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
125592108|NCT03895203|451790950|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
125592109|NCT03895203|451790951|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
125592110|NCT03895203|451790952|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
125592111|NCT03895203|451790953|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
125592112|NCT03895203|451790954|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
125592113|NCT03895203|451790949|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
125592114|NCT03895203|451790950|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
125592115|NCT03895203|451790951|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
125592116|NCT03895203|451790952|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
125592117|NCT03895203|451790953|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
125592118|NCT03895203|451790954|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
125592119|NCT03895203|451790949|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
125592120|NCT03895203|451790950|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
125592121|NCT03895203|451790951|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
125592122|NCT03895203|451790952|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
125592123|NCT03895203|451790953|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
125592124|NCT03895203|451790954|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
125592125|NCT03895203|451790949|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
125592126|NCT03895203|451790950|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
125592127|NCT03895203|451790951|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
125592128|NCT03895203|451790952|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
125592129|NCT03895203|451790953|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
125592130|NCT03895203|451790954|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
125592131|NCT03895203|451790949|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
125592132|NCT03895203|451790950|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
125592133|NCT03895203|451790951|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
125592134|NCT03895203|451790952|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
125592135|NCT03895203|451790953|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
125592136|NCT03895203|451790954|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
125592137|NCT03895203|451790949|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
125592138|NCT03895203|451790950|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
125592139|NCT03895203|451790951|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
125592140|NCT03895203|451790952|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
125363653|NCT02110238|450965164|FG000|12 Week Pivotal Phase|Physician Decision|0|||
125363654|NCT02110238|450965165|FG001|12 Week Pivotal Phase|Physician Decision|2|||
125592141|NCT03895203|451790953|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
125592142|NCT03895203|451790954|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
125592143|NCT03895203|451790949|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
125363655|NCT02110238|450965164|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
125363656|NCT02110238|450965165|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
125363657|NCT02110238|450965164|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
125363658|NCT02110238|450965165|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
125363659|NCT02110238|450965164|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
125363660|NCT02110238|450965165|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
125592144|NCT03895203|451790950|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
125592145|NCT03895203|451790951|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
125592146|NCT03895203|451790952|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
125592147|NCT03895203|451790953|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
125592148|NCT03895203|451790954|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
125592149|NCT03895203|451790949|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
125592150|NCT03895203|451790950|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
125592151|NCT03895203|451790951|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
125592152|NCT03895203|451790952|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
125592153|NCT03895203|451790953|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
125592154|NCT03895203|451790954|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
125592155|NCT03895203|451790949|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
125592156|NCT03895203|451790950|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
125592157|NCT03895203|451790951|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
125592158|NCT03895203|451790952|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
125592159|NCT03895203|451790953|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
125592160|NCT03895203|451790954|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
125592161|NCT03895203|451790949|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
125592162|NCT03895203|451790950|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
125592163|NCT03895203|451790951|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
125592164|NCT03895203|451790952|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
125592165|NCT03895203|451790953|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
125592166|NCT03895203|451790954|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
125592167|NCT03895203|451790949|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
125592168|NCT03895203|451790950|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
125592169|NCT03895203|451790951|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
125592170|NCT03895203|451790952|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
125592171|NCT03895203|451790953|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
125592172|NCT03895203|451790954|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
125592173|NCT03895203|451790949|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
125592174|NCT03895203|451790950|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
125592175|NCT03895203|451790951|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
125592176|NCT03895203|451790952|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
125592177|NCT03895203|451790953|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
125592178|NCT03895203|451790954|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
125592179|NCT03895203|451790949|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
125592180|NCT03895203|451790950|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
125592181|NCT03895203|451790951|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
125592182|NCT03895203|451790952|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
125592183|NCT03895203|451790953|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
125592184|NCT03895203|451790954|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
125592185|NCT00996840|451790955|FG000|Overall Study|Adverse Event|0|||
125592186|NCT00996840|451790956|FG001|Overall Study|Adverse Event|1|||
125363661|NCT02110238|450965164|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
125592187|NCT00996840|451790957|FG002|Overall Study|Adverse Event|0|||
125592188|NCT00996840|451790958|FG003|Overall Study|Adverse Event|0|||
125592189|NCT00996840|451790959|FG004|Overall Study|Adverse Event|0|||
125592190|NCT00996840|451790955|FG000|Overall Study|Physician Decision|0|||
125592191|NCT00996840|451790956|FG001|Overall Study|Physician Decision|0|||
125592192|NCT00996840|451790957|FG002|Overall Study|Physician Decision|1|||
125592193|NCT00996840|451790958|FG003|Overall Study|Physician Decision|1|||
125592194|NCT00996840|451790959|FG004|Overall Study|Physician Decision|2|||
125592195|NCT00996840|451790955|FG000|Overall Study|Withdrawal by Subject|1|||
125592196|NCT00996840|451790956|FG001|Overall Study|Withdrawal by Subject|1|||
125592197|NCT00996840|451790957|FG002|Overall Study|Withdrawal by Subject|0|||
125592198|NCT00996840|451790958|FG003|Overall Study|Withdrawal by Subject|0|||
125592199|NCT00996840|451790959|FG004|Overall Study|Withdrawal by Subject|0|||
125592200|NCT01485614|451790961|FG000|Randomization|Not Treated|1|||
125592201|NCT01485614|451790962|FG001|Randomization|Not Treated|0|||
125592202|NCT01485614|451790963|FG002|Randomization|Not Treated|0|||
125592203|NCT01485614|451790964|FG003|Randomization|Not Treated|0|||
125592204|NCT01485614|451790961|FG000|Weeks 0-20|Lost to Follow-up|2|||
125212269|NCT01006590|450403309|FG001|Overall Study|Adverse Event|3|||
125363662|NCT02110238|450965165|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
125363663|NCT02110238|450965164|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
125363664|NCT02110238|450965165|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
125363665|NCT02110238|450965164|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
125363666|NCT02110238|450965165|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
125363667|NCT02110238|450965164|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
125363668|NCT02110238|450965165|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
125363669|NCT01419626|450965172|FG000|Overall Study|Protocol Violation|3|||
125363670|NCT01419626|450965173|FG001|Overall Study|Protocol Violation|2|||
125363671|NCT01419626|450965174|FG002|Overall Study|Protocol Violation|2|||
125363672|NCT01419626|450965172|FG000|Overall Study|Withdrawal by Subject|1|||
125363673|NCT01419626|450965173|FG001|Overall Study|Withdrawal by Subject|0|||
125363674|NCT01419626|450965174|FG002|Overall Study|Withdrawal by Subject|0|||
125363675|NCT01419626|450965172|FG000|Overall Study|Lost to Follow-up|0|||
125363676|NCT01419626|450965173|FG001|Overall Study|Lost to Follow-up|1|||
125363677|NCT01419626|450965174|FG002|Overall Study|Lost to Follow-up|1|||
125363678|NCT01365052|450965175|FG000|Overall Study|Adverse Event|4|||
125363679|NCT01365052|450965176|FG001|Overall Study|Adverse Event|4|||
125363680|NCT01145625|450965177|FG000|Overall Study|Lost to Follow-up|8|||
125363681|NCT01145625|450965178|FG001|Overall Study|Lost to Follow-up|9|||
125363682|NCT01145625|450965177|FG000|Overall Study|Adverse Event|6|||
125363683|NCT01145625|450965178|FG001|Overall Study|Adverse Event|4|||
125363684|NCT01145625|450965177|FG000|Overall Study|Protocol Violation|3|||
125363685|NCT01145625|450965178|FG001|Overall Study|Protocol Violation|1|||
125363686|NCT01145625|450965177|FG000|Overall Study|Withdrawal by Subject|7|||
125363687|NCT01145625|450965178|FG001|Overall Study|Withdrawal by Subject|16|||
125363688|NCT01145625|450965177|FG000|Overall Study|Pregnancy|0|||
125363689|NCT01145625|450965178|FG001|Overall Study|Pregnancy|1|||
125363690|NCT03080454|450965179|FG000|Baseline|Adverse Event|2|||
125363691|NCT03080454|450965179|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
125363692|NCT03080454|450965179|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
125363693|NCT05224141|450965184|FG000|Overall Study|Ongoing|75|||
125363694|NCT05224141|450965185|FG001|Overall Study|Ongoing|88|||
125363695|NCT05224141|450965184|FG000|Overall Study|Withdrawal by Subject|2|||
125363696|NCT05224141|450965185|FG001|Overall Study|Withdrawal by Subject|4|||
125363697|NCT05224141|450965184|FG000|Overall Study|Death|153|||
125363698|NCT05224141|450965185|FG001|Overall Study|Death|138|||
125363699|NCT01609231|450965194|FG000|Overall Study|Adverse Event|1|||
125363700|NCT01609231|450965195|FG001|Overall Study|Adverse Event|3|||
125363701|NCT01609231|450965194|FG000|Overall Study|Physician Decision|1|||
125363702|NCT01609231|450965195|FG001|Overall Study|Physician Decision|0|||
125363703|NCT01609231|450965194|FG000|Overall Study|Withdrawal by Subject|1|||
125363704|NCT01609231|450965195|FG001|Overall Study|Withdrawal by Subject|0|||
125592205|NCT01485614|451790962|FG001|Weeks 0-20|Lost to Follow-up|0|||
125592206|NCT01485614|451790963|FG002|Weeks 0-20|Lost to Follow-up|0|||
125592207|NCT01485614|451790964|FG003|Weeks 0-20|Lost to Follow-up|0|||
125592208|NCT01485614|451790961|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
125592209|NCT01485614|451790962|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
125592210|NCT01485614|451790963|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
125592211|NCT01485614|451790964|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
125592212|NCT01485614|451790961|FG000|Weeks 0-20|Withdrawal by Subject|3|||
125592213|NCT01485614|451790962|FG001|Weeks 0-20|Withdrawal by Subject|2|||
125592214|NCT01485614|451790963|FG002|Weeks 0-20|Withdrawal by Subject|1|||
125592215|NCT01485614|451790964|FG003|Weeks 0-20|Withdrawal by Subject|0|||
125592216|NCT01485614|451790961|FG000|Weeks 20-54|Lost to Follow-up|4|||
125592217|NCT01485614|451790962|FG001|Weeks 20-54|Lost to Follow-up|3|||
125592218|NCT01485614|451790963|FG002|Weeks 20-54|Lost to Follow-up|1|||
125592219|NCT01485614|451790964|FG003|Weeks 20-54|Lost to Follow-up|0|||
125592220|NCT01485614|451790961|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
125592221|NCT01485614|451790962|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
125592222|NCT01485614|451790963|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
125592223|NCT01485614|451790964|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
125592224|NCT01485614|451790961|FG000|Weeks 20-54|Withdrawal by Subject|5|||
125592225|NCT01485614|451790962|FG001|Weeks 20-54|Withdrawal by Subject|3|||
125592226|NCT01485614|451790963|FG002|Weeks 20-54|Withdrawal by Subject|0|||
125592227|NCT01485614|451790964|FG003|Weeks 20-54|Withdrawal by Subject|0|||
125592228|NCT02210780|451790965|FG000|Overall Study|Adverse Event|0|||
125592229|NCT02210780|451790966|FG001|Overall Study|Adverse Event|5|||
125592230|NCT02210780|451790965|FG000|Overall Study|Lost to Follow-up|2|||
125592231|NCT02210780|451790966|FG001|Overall Study|Lost to Follow-up|1|||
125592232|NCT02210780|451790965|FG000|Overall Study|Withdrawal by Subject|1|||
125592233|NCT02210780|451790966|FG001|Overall Study|Withdrawal by Subject|1|||
125592234|NCT02210780|451790965|FG000|Overall Study|Physician Decision|1|||
125592235|NCT02210780|451790966|FG001|Overall Study|Physician Decision|0|||
125592236|NCT02210780|451790965|FG000|Overall Study|Protocol Violation|1|||
125592237|NCT02210780|451790966|FG001|Overall Study|Protocol Violation|0|||
125363705|NCT01927627|450965202|FG000|Overall Study|Adverse Event|3|||
125363706|NCT01927627|450965202|FG000|Overall Study|Lack of Efficacy|1|||
125363707|NCT01927627|450965202|FG000|Overall Study|Financial Concerns|1|||
125592238|NCT02210780|451790965|FG000|Overall Study|Other than specified above|0|||
125592239|NCT02210780|451790966|FG001|Overall Study|Other than specified above|1|||
125592240|NCT02582515|451790967|FG000|Overall Study|Withdrawal by Subject|0|||
125592241|NCT02582515|451790968|FG001|Overall Study|Withdrawal by Subject|1|||
125592242|NCT00775021|451790969|FG000|First Intervention|Lost to Follow-up|1|||
125592243|NCT00775021|451790970|FG001|First Intervention|Lost to Follow-up|0|||
125592244|NCT00775021|451790969|FG000|Second Intervention|Adverse Event|0|||
125592245|NCT00775021|451790970|FG001|Second Intervention|Adverse Event|1|||
125592246|NCT00929240|451790975|FG000|Initial Treatment Phase|Adverse Event|31|||
125592247|NCT00929240|451790976|FG001|Initial Treatment Phase|Adverse Event|0|||
125592248|NCT00929240|451790977|FG002|Initial Treatment Phase|Adverse Event|0|||
125592249|NCT00929240|451790975|FG000|Initial Treatment Phase|Disease progression|41|||
125592250|NCT00929240|451790976|FG001|Initial Treatment Phase|Disease progression|0|||
125592251|NCT00929240|451790977|FG002|Initial Treatment Phase|Disease progression|0|||
125592252|NCT00929240|451790975|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
125592253|NCT00929240|451790976|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
125592254|NCT00929240|451790977|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
125592255|NCT00929240|451790975|FG000|Initial Treatment Phase|Protocol Violation|5|||
125592256|NCT00929240|451790976|FG001|Initial Treatment Phase|Protocol Violation|0|||
125592257|NCT00929240|451790977|FG002|Initial Treatment Phase|Protocol Violation|0|||
125592258|NCT00929240|451790975|FG000|Initial Treatment Phase|Death|2|||
125592259|NCT00929240|451790976|FG001|Initial Treatment Phase|Death|0|||
125592260|NCT00929240|451790977|FG002|Initial Treatment Phase|Death|0|||
125363708|NCT00467857|450965203|FG000|Overall Study|Adverse Event|1|||
125592261|NCT00929240|451790975|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
125592262|NCT00929240|451790976|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
125592263|NCT00929240|451790977|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
125592264|NCT00929240|451790975|FG000|Initial Treatment Phase|Physician Decision|4|||
125592265|NCT00929240|451790976|FG001|Initial Treatment Phase|Physician Decision|0|||
125592266|NCT00929240|451790977|FG002|Initial Treatment Phase|Physician Decision|0|||
125592267|NCT00929240|451790975|FG000|Maintenance Phase|Disease progression|0|||
125592268|NCT00929240|451790976|FG001|Maintenance Phase|Disease progression|73|||
125592269|NCT00929240|451790977|FG002|Maintenance Phase|Disease progression|60|||
125592270|NCT00929240|451790975|FG000|Maintenance Phase|Adverse Event|0|||
125592271|NCT00929240|451790976|FG001|Maintenance Phase|Adverse Event|9|||
125592272|NCT00929240|451790977|FG002|Maintenance Phase|Adverse Event|12|||
125592273|NCT00929240|451790975|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125592274|NCT00929240|451790976|FG001|Maintenance Phase|Withdrawal by Subject|2|||
125592275|NCT00929240|451790977|FG002|Maintenance Phase|Withdrawal by Subject|6|||
125592276|NCT00929240|451790975|FG000|Maintenance Phase|Protocol Violation|0|||
125592277|NCT00929240|451790976|FG001|Maintenance Phase|Protocol Violation|1|||
125592278|NCT00929240|451790977|FG002|Maintenance Phase|Protocol Violation|0|||
125592279|NCT00929240|451790975|FG000|Maintenance Phase|Health authority/Study termination|0|||
125592280|NCT00929240|451790976|FG001|Maintenance Phase|Health authority/Study termination|1|||
125592281|NCT00929240|451790977|FG002|Maintenance Phase|Health authority/Study termination|2|||
125592282|NCT00929240|451790975|FG000|Maintenance Phase|Physician Decision|0|||
125592283|NCT00929240|451790976|FG001|Maintenance Phase|Physician Decision|2|||
125592284|NCT00929240|451790977|FG002|Maintenance Phase|Physician Decision|1|||
125592285|NCT00929240|451790975|FG000|Maintenance Phase|Change of treatment|0|||
125592286|NCT00929240|451790976|FG001|Maintenance Phase|Change of treatment|4|||
125592287|NCT00929240|451790977|FG002|Maintenance Phase|Change of treatment|0|||
125592288|NCT00929240|451790975|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
125592289|NCT00929240|451790976|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
125592290|NCT00929240|451790977|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
125592291|NCT00929240|451790975|FG000|Maintenance Phase|Participant not treated|0|||
125592292|NCT00929240|451790976|FG001|Maintenance Phase|Participant not treated|2|||
125592293|NCT00929240|451790977|FG002|Maintenance Phase|Participant not treated|0|||
125592294|NCT02371629|451790978|FG000|Overall Study|Patient decision|14|||
125592295|NCT02371629|451790979|FG001|Overall Study|Patient decision|10|||
125592296|NCT02371629|451790978|FG000|Overall Study|Adverse Event|8|||
125592297|NCT02371629|451790979|FG001|Overall Study|Adverse Event|8|||
125592298|NCT02371629|451790978|FG000|Overall Study|Physician Decision|2|||
125592299|NCT02371629|451790979|FG001|Overall Study|Physician Decision|3|||
125592300|NCT02371629|451790978|FG000|Overall Study|Death|1|||
125592301|NCT02371629|451790979|FG001|Overall Study|Death|1|||
125592302|NCT02371629|451790978|FG000|Overall Study|Noncompliance with study treatment|1|||
125592303|NCT02371629|451790979|FG001|Overall Study|Noncompliance with study treatment|0|||
125592304|NCT02371629|451790978|FG000|Overall Study|Lack of Efficacy|0|||
125592305|NCT02371629|451790979|FG001|Overall Study|Lack of Efficacy|2|||
125592306|NCT02371629|451790978|FG000|Overall Study|Protocol deviation|0|||
125592307|NCT02371629|451790979|FG001|Overall Study|Protocol deviation|1|||
125592308|NCT00805207|451790980|FG000|Overall Study|Protocol Violation|0|||
125592309|NCT00805207|451790981|FG001|Overall Study|Protocol Violation|0|||
125592310|NCT00805207|451790982|FG002|Overall Study|Protocol Violation|1|||
125592311|NCT00805207|451790983|FG003|Overall Study|Protocol Violation|0|||
125592312|NCT00805207|451790984|FG004|Overall Study|Protocol Violation|0|||
125592313|NCT00805207|451790985|FG005|Overall Study|Protocol Violation|0|||
125592314|NCT00805207|451790986|FG006|Overall Study|Protocol Violation|0|||
125592315|NCT00805207|451790987|FG007|Overall Study|Protocol Violation|0|||
125592316|NCT00805207|451790988|FG008|Overall Study|Protocol Violation|0|||
125592317|NCT00805207|451790980|FG000|Overall Study|Physician Decision|0|||
125592318|NCT00805207|451790981|FG001|Overall Study|Physician Decision|1|||
125592319|NCT00805207|451790982|FG002|Overall Study|Physician Decision|0|||
125592320|NCT00805207|451790983|FG003|Overall Study|Physician Decision|0|||
125592321|NCT00805207|451790984|FG004|Overall Study|Physician Decision|0|||
125592322|NCT00805207|451790985|FG005|Overall Study|Physician Decision|1|||
125592323|NCT00805207|451790986|FG006|Overall Study|Physician Decision|0|||
125592324|NCT00805207|451790987|FG007|Overall Study|Physician Decision|0|||
125592325|NCT00805207|451790988|FG008|Overall Study|Physician Decision|0|||
125592326|NCT00805207|451790980|FG000|Overall Study|Withdrawal by Subject|0|||
125592327|NCT00805207|451790981|FG001|Overall Study|Withdrawal by Subject|1|||
125592328|NCT00805207|451790982|FG002|Overall Study|Withdrawal by Subject|0|||
125592329|NCT00805207|451790983|FG003|Overall Study|Withdrawal by Subject|0|||
125592330|NCT00805207|451790984|FG004|Overall Study|Withdrawal by Subject|1|||
125592331|NCT00805207|451790985|FG005|Overall Study|Withdrawal by Subject|2|||
125592332|NCT00805207|451790986|FG006|Overall Study|Withdrawal by Subject|0|||
125592333|NCT00805207|451790987|FG007|Overall Study|Withdrawal by Subject|0|||
125592334|NCT00805207|451790988|FG008|Overall Study|Withdrawal by Subject|0|||
125212270|NCT01006590|450403308|FG000|Overall Study|Death|1|||
125592335|NCT02469246|451790989|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
125592336|NCT02469246|451790990|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
125592337|NCT02469246|451790989|FG000|Double-Blind Phase|Adverse Event|12|||
125592338|NCT02469246|451790990|FG001|Double-Blind Phase|Adverse Event|9|||
125592339|NCT02469246|451790989|FG000|Double-Blind Phase|Death|2|||
125592340|NCT02469246|451790990|FG001|Double-Blind Phase|Death|0|||
125592341|NCT02469246|451790989|FG000|Double-Blind Phase|Lack of Efficacy|2|||
125592342|NCT02469246|451790990|FG001|Double-Blind Phase|Lack of Efficacy|1|||
125592343|NCT02469246|451790989|FG000|Double-Blind Phase|Investigator's Discretion|8|||
125592344|NCT02469246|451790990|FG001|Double-Blind Phase|Investigator's Discretion|8|||
125592345|NCT02469246|451790989|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
125592346|NCT02469246|451790990|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
125592347|NCT02469246|451790989|FG000|Double-Blind Phase|Protocol Violation|1|||
125592348|NCT02469246|451790990|FG001|Double-Blind Phase|Protocol Violation|1|||
125592349|NCT02469246|451790989|FG000|Double-Blind Phase|Withdrew Consent|25|||
125592350|NCT02469246|451790990|FG001|Double-Blind Phase|Withdrew Consent|25|||
125592351|NCT02469246|451790989|FG000|Double-Blind Phase|Lost to Follow-up|9|||
125592352|NCT02469246|451790990|FG001|Double-Blind Phase|Lost to Follow-up|5|||
125592353|NCT05681715|451790994|FG000|Training Period (6-weeks)|Adverse Event|3|||
125592354|NCT05681715|451790995|FG001|Training Period (6-weeks)|Adverse Event|0|||
125592355|NCT05681715|451790996|FG002|Training Period (6-weeks)|Adverse Event|0|||
125592356|NCT05681715|451790994|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
125592357|NCT05681715|451790995|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
125592358|NCT05681715|451790996|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
125592359|NCT05681715|451790994|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
125592360|NCT05681715|451790995|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
125592361|NCT05681715|451790996|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
125592362|NCT05681715|451790994|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
125592363|NCT05681715|451790995|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
125592364|NCT05681715|451790996|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
125592365|NCT05681715|451790994|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
125592366|NCT05681715|451790995|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
125592367|NCT05681715|451790996|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
125592368|NCT05681715|451790994|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
125592369|NCT05681715|451790995|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
125592370|NCT05681715|451790996|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
125592371|NCT05681715|451790994|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
125592372|NCT05681715|451790995|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
125592373|NCT05681715|451790996|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
125592374|NCT05681715|451790994|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
125592375|NCT05681715|451790995|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
125592376|NCT05681715|451790996|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
125592377|NCT05564052|451790997|FG000|Overall Study|Withdrawal by Subject|0|||
125592378|NCT05564052|451790998|FG001|Overall Study|Withdrawal by Subject|0|||
125592379|NCT05564052|451790999|FG002|Overall Study|Withdrawal by Subject|0|||
125592380|NCT05564052|451791000|FG003|Overall Study|Withdrawal by Subject|1|||
125592381|NCT05564052|451790997|FG000|Overall Study|Ongoing|8|||
125592382|NCT05564052|451790998|FG001|Overall Study|Ongoing|5|||
125592383|NCT05564052|451790999|FG002|Overall Study|Ongoing|4|||
125592384|NCT05564052|451791000|FG003|Overall Study|Ongoing|1|||
125592385|NCT04325503|451791040|FG000|Overall Study|Withdrawal by Subject|1|||
125592386|NCT04325503|451791040|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
125592387|NCT03832387|451791041|FG000|Overall Study|Protocol Violation|2|||
125592388|NCT03832387|451791042|FG001|Overall Study|Protocol Violation|6|||
125592389|NCT03832387|451791041|FG000|Overall Study|EXCLUSION CRITERIA|3|||
125592390|NCT03832387|451791042|FG001|Overall Study|EXCLUSION CRITERIA|1|||
125592391|NCT01856114|451791043|FG000|Overall Study|Withdrawal by Subject|1|||
125592392|NCT01856114|451791044|FG001|Overall Study|Withdrawal by Subject|0|||
125592393|NCT01856114|451791043|FG000|Overall Study|Adverse Event|1|||
125592394|NCT01856114|451791044|FG001|Overall Study|Adverse Event|0|||
125592395|NCT00144170|451791045|FG000|Overall Study|Adverse Event|84|||
125592396|NCT00144170|451791046|FG001|Overall Study|Adverse Event|41|||
125592397|NCT00144170|451791045|FG000|Overall Study|Protocol Violation|23|||
125592398|NCT00144170|451791046|FG001|Overall Study|Protocol Violation|16|||
125592399|NCT00144170|451791045|FG000|Overall Study|Lost to Follow-up|5|||
125592400|NCT00144170|451791046|FG001|Overall Study|Lost to Follow-up|10|||
125592401|NCT00144170|451791045|FG000|Overall Study|Withdrawal by Subject|29|||
125592402|NCT00144170|451791046|FG001|Overall Study|Withdrawal by Subject|13|||
125363709|NCT00467857|450965204|FG001|Overall Study|Adverse Event|0|||
125363710|NCT00467857|450965203|FG000|Overall Study|Withdrew consent|2|||
125429543|NCT04669600|451198860|FG000|Overall Study|Withdrawal by Subject|1|||
125429544|NCT04669600|451198860|FG000|Overall Study|Other|6|||
125429545|NCT00710606|451198863|FG000|Overall Study|Adverse Event|0|||
125429546|NCT00710606|451198864|FG001|Overall Study|Adverse Event|2|||
125429547|NCT00514683|451198869|FG000|Overall Study|Not treated|2|||
125429548|NCT00514683|451198870|FG001|Overall Study|Not treated|1|||
125429549|NCT00514683|451198871|FG002|Overall Study|Not treated|0|||
125429550|NCT00514683|451198872|FG003|Overall Study|Not treated|0|||
125429551|NCT00514683|451198873|FG004|Overall Study|Not treated|1|||
125429552|NCT00514683|451198869|FG000|Overall Study|Adverse Event|21|||
125429553|NCT00514683|451198870|FG001|Overall Study|Adverse Event|20|||
125429554|NCT00514683|451198871|FG002|Overall Study|Adverse Event|15|||
125363711|NCT00467857|450965204|FG001|Overall Study|Withdrew consent|0|||
125363712|NCT00467857|450965203|FG000|Overall Study|Death|0|||
125363713|NCT00467857|450965204|FG001|Overall Study|Death|1|||
125429555|NCT00514683|451198872|FG003|Overall Study|Adverse Event|13|||
125429556|NCT00514683|451198873|FG004|Overall Study|Adverse Event|27|||
125429557|NCT00514683|451198869|FG000|Overall Study|Protocol Violation|1|||
125429558|NCT00514683|451198870|FG001|Overall Study|Protocol Violation|1|||
125429559|NCT00514683|451198871|FG002|Overall Study|Protocol Violation|0|||
125429560|NCT00514683|451198872|FG003|Overall Study|Protocol Violation|1|||
125429561|NCT00514683|451198873|FG004|Overall Study|Protocol Violation|0|||
125429562|NCT00514683|451198869|FG000|Overall Study|Withdrawal by Subject|2|||
125363714|NCT00467857|450965203|FG000|Overall Study|Discharged from court service|0|||
125363715|NCT00467857|450965204|FG001|Overall Study|Discharged from court service|1|||
125363716|NCT00467857|450965203|FG000|Overall Study|Emergency care required|0|||
125363717|NCT00467857|450965204|FG001|Overall Study|Emergency care required|1|||
125363718|NCT00467857|450965203|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
125363719|NCT00467857|450965204|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
125363720|NCT00467857|450965203|FG000|Overall Study|Discontinuation reason missing|0|||
125363721|NCT00467857|450965204|FG001|Overall Study|Discontinuation reason missing|3|||
125363722|NCT00338104|450965205|FG000|Overall Study|Protocol Violation|2|||
125363723|NCT00338104|450965206|FG001|Overall Study|Protocol Violation|1|||
125363724|NCT00338104|450965207|FG002|Overall Study|Protocol Violation|3|||
125363725|NCT00633750|450965208|FG000|Overall Study|Adverse Event|2|||
125363726|NCT00633750|450965208|FG000|Overall Study|Withdrawal by Subject|3|||
125363727|NCT02298023|450965211|FG000|Overall Study|Withdrawal by Subject|1|||
125363728|NCT02298023|450965212|FG001|Overall Study|Withdrawal by Subject|0|||
125363729|NCT02298023|450965213|FG002|Overall Study|Withdrawal by Subject|0|||
125363730|NCT03307785|450965217|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
125363731|NCT03307785|450965218|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
125363732|NCT03307785|450965219|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
125363733|NCT03307785|450965220|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
125363734|NCT03307785|450965221|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
125363735|NCT03307785|450965222|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
125363736|NCT03307785|450965223|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
125363737|NCT03307785|450965224|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
125363738|NCT03307785|450965225|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
125363739|NCT03307785|450965226|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
125363740|NCT03307785|450965227|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
125363741|NCT03307785|450965217|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
125363742|NCT03307785|450965218|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
125363743|NCT03307785|450965219|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125363744|NCT03307785|450965220|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125363745|NCT03307785|450965221|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125363746|NCT03307785|450965222|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125363747|NCT03307785|450965223|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125363748|NCT03307785|450965224|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125363749|NCT03307785|450965225|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125363750|NCT03307785|450965226|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125429563|NCT00514683|451198870|FG001|Overall Study|Withdrawal by Subject|2|||
125429564|NCT00514683|451198871|FG002|Overall Study|Withdrawal by Subject|1|||
125429565|NCT00514683|451198872|FG003|Overall Study|Withdrawal by Subject|0|||
125429566|NCT00514683|451198873|FG004|Overall Study|Withdrawal by Subject|4|||
125429567|NCT00514683|451198869|FG000|Overall Study|Reason other than listed above|0|||
125429568|NCT00514683|451198870|FG001|Overall Study|Reason other than listed above|1|||
125592403|NCT00144170|451791045|FG000|Overall Study|Other reason not defined above|211|||
125592404|NCT00144170|451791046|FG001|Overall Study|Other reason not defined above|316|||
125592405|NCT00981526|451791047|FG000|Overall Study|Withdrawal by Subject|0|||
125592406|NCT00981526|451791048|FG001|Overall Study|Withdrawal by Subject|2|||
125592407|NCT00981526|451791047|FG000|Overall Study|Physician Decision|4|||
125592408|NCT00981526|451791048|FG001|Overall Study|Physician Decision|4|||
125592409|NCT01564784|451791049|FG000|Overall Study|Other|1|||
125592410|NCT01564784|451791050|FG001|Overall Study|Other|0|||
125592411|NCT01564784|451791049|FG000|Overall Study|Subject refused further follow-up|1|||
125592412|NCT01564784|451791050|FG001|Overall Study|Subject refused further follow-up|6|||
125592413|NCT01564784|451791049|FG000|Overall Study|Lost to Follow-up|1|||
125592414|NCT01564784|451791050|FG001|Overall Study|Lost to Follow-up|1|||
125592415|NCT01564784|451791049|FG000|Overall Study|Death|131|||
125592416|NCT01564784|451791050|FG001|Overall Study|Death|126|||
125592417|NCT05202808|451791051|FG000|Overall Study|Lost to Follow-up|3|||
125592418|NCT05202808|451791052|FG001|Overall Study|Lost to Follow-up|1|||
125592419|NCT02495948|451791053|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
125592420|NCT02495948|451791054|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
125592421|NCT02495948|451791053|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
125592422|NCT02495948|451791054|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
125592423|NCT02747004|451791056|FG000|Overall Study|Withdrawal by Subject|8|||
125592424|NCT02747004|451791057|FG001|Overall Study|Withdrawal by Subject|5|||
125592425|NCT02747004|451791058|FG002|Overall Study|Withdrawal by Subject|4|||
125592426|NCT02747004|451791056|FG000|Overall Study|Lost to Follow-up|1|||
125592427|NCT02747004|451791057|FG001|Overall Study|Lost to Follow-up|2|||
125592428|NCT02747004|451791058|FG002|Overall Study|Lost to Follow-up|2|||
125592429|NCT02747004|451791056|FG000|Overall Study|on study treatment/follow-up|48|||
125592430|NCT02747004|451791057|FG001|Overall Study|on study treatment/follow-up|42|||
125592431|NCT02747004|451791058|FG002|Overall Study|on study treatment/follow-up|41|||
125592432|NCT06218251|451791059|FG000|Overall Study|Lost to Follow-up|4|||
125592433|NCT05087030|451791060|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
125592434|NCT05087030|451791061|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
125592435|NCT05087030|451791062|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
125592436|NCT05087030|451791063|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
125592437|NCT05087030|451791064|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
125592438|NCT05087030|451791060|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
125592439|NCT05087030|451791061|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
125592440|NCT05087030|451791062|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
125592441|NCT05087030|451791063|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
125592442|NCT05087030|451791064|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
125592443|NCT05087030|451791060|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
125592444|NCT05087030|451791061|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
125592445|NCT05087030|451791062|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
125592446|NCT05087030|451791063|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
125592447|NCT05087030|451791064|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
125592448|NCT05087030|451791060|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
125592449|NCT05087030|451791061|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
125592450|NCT05087030|451791062|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
125592451|NCT05087030|451791063|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
125592452|NCT05087030|451791064|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
125592453|NCT05087030|451791060|FG000|Main Period (Week 0 to Week 52)|Death|0|||
125592454|NCT05087030|451791061|FG001|Main Period (Week 0 to Week 52)|Death|1|||
125592455|NCT05087030|451791062|FG002|Main Period (Week 0 to Week 52)|Death|0|||
125592456|NCT05087030|451791063|FG003|Main Period (Week 0 to Week 52)|Death|0|||
125592457|NCT05087030|451791064|FG004|Main Period (Week 0 to Week 52)|Death|0|||
125592458|NCT05087030|451791060|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
125592459|NCT05087030|451791061|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
125592460|NCT05087030|451791062|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
125592461|NCT05087030|451791063|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
125592462|NCT05087030|451791064|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
125592463|NCT05087030|451791060|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
125592464|NCT05087030|451791061|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
125592465|NCT05087030|451791062|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
125592466|NCT05087030|451791063|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
125592467|NCT05087030|451791064|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
125592468|NCT05087030|451791060|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
125592469|NCT05087030|451791061|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
125592470|NCT05087030|451791062|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
125592471|NCT05087030|451791063|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
125592472|NCT05087030|451791064|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
125592473|NCT05087030|451791060|FG000|Main Period (Week 0 to Week 52)|Other|1|||
125592474|NCT05087030|451791061|FG001|Main Period (Week 0 to Week 52)|Other|2|||
125592475|NCT05087030|451791062|FG002|Main Period (Week 0 to Week 52)|Other|0|||
125592476|NCT05087030|451791063|FG003|Main Period (Week 0 to Week 52)|Other|0|||
125592477|NCT05087030|451791064|FG004|Main Period (Week 0 to Week 52)|Other|0|||
125592478|NCT05087030|451791060|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
125592479|NCT05087030|451791061|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
125592480|NCT05087030|451791062|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
125592481|NCT05087030|451791063|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
125592482|NCT05087030|451791064|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
125592483|NCT01444300|451791065|FG000|Overall Study|Adverse Event|4|||
125363751|NCT03307785|450965227|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
125363752|NCT03307785|450965217|FG000|Part A: Up to 28.5 Months|Death|4|||
125363753|NCT03307785|450965218|FG001|Part A: Up to 28.5 Months|Death|4|||
125363754|NCT03307785|450965219|FG002|Part A: Up to 28.5 Months|Death|0|||
125592484|NCT01444300|451791066|FG001|Overall Study|Adverse Event|0|||
125592485|NCT00752986|451791067|FG000|Overall Study|Withdrawal by Subject|2|||
125592486|NCT00752986|451791068|FG001|Overall Study|Withdrawal by Subject|1|||
125592487|NCT00752986|451791069|FG002|Overall Study|Withdrawal by Subject|2|||
125592488|NCT00752986|451791067|FG000|Overall Study|Protocol Violation|3|||
125592489|NCT00752986|451791068|FG001|Overall Study|Protocol Violation|0|||
125592490|NCT00752986|451791069|FG002|Overall Study|Protocol Violation|0|||
125592491|NCT02370121|451791073|FG000|Overall Study|Lost to Follow-up|1|||
125592492|NCT02370121|451791074|FG001|Overall Study|Lost to Follow-up|1|||
125592493|NCT00275561|451791077|FG000|Overall Study|Withdrawal by Subject|0|||
125592494|NCT00275561|451791078|FG001|Overall Study|Withdrawal by Subject|1|||
125592495|NCT00275561|451791077|FG000|Overall Study|Travel|1|||
125592496|NCT00275561|451791078|FG001|Overall Study|Travel|1|||
125592497|NCT00275561|451791077|FG000|Overall Study|Scheduling|1|||
125592498|NCT00275561|451791078|FG001|Overall Study|Scheduling|2|||
125592499|NCT00275561|451791077|FG000|Overall Study|Family Issues|0|||
125592500|NCT00275561|451791078|FG001|Overall Study|Family Issues|2|||
125592501|NCT01769105|451791083|FG000|First Intervention|Protocol Violation|2|||
125592502|NCT01769105|451791084|FG001|First Intervention|Protocol Violation|2|||
125592503|NCT01769105|451791083|FG000|Cross-over|Lost to Follow-up|5|||
125592504|NCT01769105|451791084|FG001|Cross-over|Lost to Follow-up|0|||
125592505|NCT00963807|451791085|FG000|Overall Study|Physician Decision|2|||
125592506|NCT00963807|451791085|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
125592507|NCT00963807|451791085|FG000|Overall Study|Disease progression|15|||
125592508|NCT00684177|451791086|FG000|Overall Study|Adverse Event|4|||
125592509|NCT00684177|451791087|FG001|Overall Study|Adverse Event|3|||
125592510|NCT00684177|451791086|FG000|Overall Study|Lack of Efficacy|10|||
125363755|NCT03307785|450965220|FG003|Part A: Up to 28.5 Months|Death|0|||
125363756|NCT03307785|450965221|FG004|Part A: Up to 28.5 Months|Death|0|||
125363757|NCT03307785|450965222|FG005|Part A: Up to 28.5 Months|Death|0|||
125363758|NCT03307785|450965223|FG006|Part A: Up to 28.5 Months|Death|0|||
125363759|NCT03307785|450965224|FG007|Part A: Up to 28.5 Months|Death|0|||
125363760|NCT03307785|450965225|FG008|Part A: Up to 28.5 Months|Death|0|||
125363761|NCT03307785|450965226|FG009|Part A: Up to 28.5 Months|Death|0|||
125363762|NCT03307785|450965227|FG010|Part A: Up to 28.5 Months|Death|0|||
125363763|NCT03307785|450965217|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
125363764|NCT03307785|450965218|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
125363765|NCT03307785|450965219|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
125363766|NCT03307785|450965220|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
125363767|NCT03307785|450965221|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
125363768|NCT03307785|450965222|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
125363769|NCT03307785|450965223|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
125363770|NCT03307785|450965224|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
125592511|NCT00684177|451791087|FG001|Overall Study|Lack of Efficacy|15|||
125592512|NCT00684177|451791086|FG000|Overall Study|Protocol Violation|1|||
125592513|NCT00684177|451791087|FG001|Overall Study|Protocol Violation|0|||
125592514|NCT00684177|451791086|FG000|Overall Study|Lost to Follow-up|2|||
125592515|NCT00684177|451791087|FG001|Overall Study|Lost to Follow-up|1|||
125592516|NCT00684177|451791086|FG000|Overall Study|Physician Decision|2|||
125592517|NCT00684177|451791087|FG001|Overall Study|Physician Decision|0|||
125363771|NCT03307785|450965225|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
125592518|NCT00684177|451791086|FG000|Overall Study|Withdrawal by Subject|1|||
125592519|NCT00684177|451791087|FG001|Overall Study|Withdrawal by Subject|2|||
125592520|NCT00684177|451791086|FG000|Overall Study|Other|1|||
125592521|NCT00684177|451791087|FG001|Overall Study|Other|2|||
125592522|NCT04238819|451791088|FG000|Overall Study|Ongoing Treatment|0|||
125592523|NCT04238819|451791089|FG001|Overall Study|Ongoing Treatment|0|||
125592524|NCT04238819|451791090|FG002|Overall Study|Ongoing Treatment|0|||
125592525|NCT04238819|451791091|FG003|Overall Study|Ongoing Treatment|0|||
125592526|NCT04238819|451791092|FG004|Overall Study|Ongoing Treatment|1|||
125592527|NCT04238819|451791093|FG005|Overall Study|Ongoing Treatment|4|||
125592528|NCT04238819|451791094|FG006|Overall Study|Ongoing Treatment|0|||
125592529|NCT04238819|451791088|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
125592530|NCT04238819|451791089|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
125592531|NCT04238819|451791090|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
125592532|NCT04238819|451791091|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
125592533|NCT04238819|451791092|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
125592534|NCT04238819|451791093|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
125592535|NCT04238819|451791094|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
125592536|NCT00045032|451791097|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
125592537|NCT00045032|451791098|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
125592538|NCT00045032|451791099|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
125592539|NCT00045032|451791097|FG000|Overall Study|Death|22|||
125592540|NCT00045032|451791098|FG001|Overall Study|Death|24|||
125592541|NCT00045032|451791099|FG002|Overall Study|Death|17|||
125592542|NCT00045032|451791097|FG000|Overall Study|Insufficient Therapeutic Response|542|||
125592543|NCT00045032|451791098|FG001|Overall Study|Insufficient Therapeutic Response|437|||
125592544|NCT00045032|451791099|FG002|Overall Study|Insufficient Therapeutic Response|445|||
125592545|NCT00045032|451791097|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
125592546|NCT00045032|451791098|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
125592547|NCT00045032|451791099|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
125592548|NCT00045032|451791097|FG000|Overall Study|Other Protocol Violation|2|||
125592549|NCT00045032|451791098|FG001|Overall Study|Other Protocol Violation|0|||
125592550|NCT00045032|451791099|FG002|Overall Study|Other Protocol Violation|1|||
125592551|NCT00045032|451791097|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
125592552|NCT00045032|451791098|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
125592553|NCT00045032|451791099|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
125592554|NCT00045032|451791097|FG000|Overall Study|Failure to Return|57|||
125592555|NCT00045032|451791098|FG001|Overall Study|Failure to Return|62|||
125592556|NCT00045032|451791099|FG002|Overall Study|Failure to Return|61|||
125592557|NCT00045032|451791097|FG000|Overall Study|Other|93|||
125592558|NCT00045032|451791098|FG001|Overall Study|Other|84|||
125592559|NCT00045032|451791099|FG002|Overall Study|Other|105|||
125592560|NCT02581995|451791107|FG000|Overall Study|Unspecified other|3|||
125592561|NCT02581995|451791107|FG000|Overall Study|Adverse Event|6|||
125592562|NCT02581995|451791107|FG000|Overall Study|Lost to Follow-up|5|||
125429569|NCT00514683|451198871|FG002|Overall Study|Reason other than listed above|2|||
125592563|NCT02581995|451791107|FG000|Overall Study|Withdrawal by participant|12|||
125592564|NCT02581995|451791107|FG000|Overall Study|Physician Decision|1|||
125212271|NCT01006590|450403309|FG001|Overall Study|Death|1|||
125592565|NCT02581995|451791107|FG000|Overall Study|Death|4|||
125592566|NCT02031679|451792619|FG000|Overall Study|Protocol Violation|0|||
125592567|NCT02031679|451792620|FG001|Overall Study|Protocol Violation|1|||
125592568|NCT02031679|451792619|FG000|Overall Study|Lack of Efficacy|0|||
125592569|NCT02031679|451792620|FG001|Overall Study|Lack of Efficacy|1|||
125592570|NCT04030195|451792621|FG000|Overall Study|Withdrawal by Subject|2|||
125592571|NCT04030195|451792622|FG001|Overall Study|Withdrawal by Subject|0|||
125592572|NCT04030195|451792623|FG002|Overall Study|Withdrawal by Subject|0|||
125592573|NCT01024244|451792624|FG000|Overall Study|Adverse Event|1|||
125592574|NCT01024244|451792625|FG001|Overall Study|Adverse Event|2|||
125592575|NCT01024244|451792626|FG002|Overall Study|Adverse Event|0|||
125592576|NCT01024244|451792627|FG003|Overall Study|Adverse Event|1|||
125592577|NCT01024244|451792628|FG004|Overall Study|Adverse Event|2|||
125592578|NCT01024244|451792624|FG000|Overall Study|Entry Criteria Not Met|0|||
125592579|NCT01024244|451792625|FG001|Overall Study|Entry Criteria Not Met|1|||
125592580|NCT01024244|451792626|FG002|Overall Study|Entry Criteria Not Met|0|||
125592581|NCT01024244|451792627|FG003|Overall Study|Entry Criteria Not Met|0|||
125592582|NCT01024244|451792628|FG004|Overall Study|Entry Criteria Not Met|0|||
125592583|NCT01024244|451792624|FG000|Overall Study|Lack of Efficacy|1|||
125592584|NCT01024244|451792625|FG001|Overall Study|Lack of Efficacy|0|||
125592585|NCT01024244|451792626|FG002|Overall Study|Lack of Efficacy|0|||
125592586|NCT01024244|451792627|FG003|Overall Study|Lack of Efficacy|0|||
125592587|NCT01024244|451792628|FG004|Overall Study|Lack of Efficacy|0|||
125592588|NCT01024244|451792624|FG000|Overall Study|Protocol Violation|1|||
125592589|NCT01024244|451792625|FG001|Overall Study|Protocol Violation|0|||
125592590|NCT01024244|451792626|FG002|Overall Study|Protocol Violation|0|||
125592591|NCT01024244|451792627|FG003|Overall Study|Protocol Violation|0|||
125592592|NCT01024244|451792628|FG004|Overall Study|Protocol Violation|2|||
125592593|NCT01024244|451792624|FG000|Overall Study|Sponsor Decision|14|||
125592594|NCT01024244|451792625|FG001|Overall Study|Sponsor Decision|7|||
125592595|NCT01024244|451792626|FG002|Overall Study|Sponsor Decision|14|||
125592596|NCT01024244|451792627|FG003|Overall Study|Sponsor Decision|12|||
125592597|NCT01024244|451792628|FG004|Overall Study|Sponsor Decision|10|||
125592598|NCT01024244|451792624|FG000|Overall Study|Withdrawal by Subject|0|||
125592599|NCT01024244|451792625|FG001|Overall Study|Withdrawal by Subject|1|||
125363772|NCT03307785|450965226|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
125363773|NCT03307785|450965227|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
125363774|NCT03307785|450965217|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
125363775|NCT03307785|450965218|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
125592600|NCT01024244|451792626|FG002|Overall Study|Withdrawal by Subject|0|||
125592601|NCT01024244|451792627|FG003|Overall Study|Withdrawal by Subject|0|||
125592602|NCT01024244|451792628|FG004|Overall Study|Withdrawal by Subject|0|||
125592603|NCT02660580|451792634|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
125592604|NCT02660580|451792635|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
125592605|NCT02660580|451792636|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
125592606|NCT02660580|451792637|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
125592607|NCT02660580|451792638|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
125429570|NCT00514683|451198872|FG003|Overall Study|Reason other than listed above|0|||
125429571|NCT00514683|451198873|FG004|Overall Study|Reason other than listed above|1|||
125429572|NCT02736825|451198874|FG000|Overall Study|Lost to Follow-up|10|||
125429573|NCT02736825|451198875|FG001|Overall Study|Lost to Follow-up|11|||
125429574|NCT02736825|451198874|FG000|Overall Study|Early Termination|0|||
125429575|NCT02736825|451198875|FG001|Overall Study|Early Termination|1|||
125429576|NCT00790452|451198877|FG000|Overall Study|Drug supply issue|1|||
125429577|NCT00790452|451198878|FG001|Overall Study|Drug supply issue|0|||
125429578|NCT01564368|451198879|FG000|Overall Study|Ineligible|18|||
125429579|NCT01564368|451198879|FG000|Overall Study|Not Randomized in Parent study|116|||
125429580|NCT01564368|451198879|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
125429581|NCT01564368|451198879|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
125429582|NCT02901626|451198880|FG000|Overall Study|Lost to Follow-up|1|||
125429583|NCT02901626|451198881|FG001|Overall Study|Lost to Follow-up|1|||
125429584|NCT00331344|451198882|FG000|Phase I|Adverse Event|0|||
125429585|NCT00331344|451198883|FG001|Phase I|Adverse Event|0|||
125429586|NCT00331344|451198884|FG002|Phase I|Adverse Event|0|||
125363776|NCT03307785|450965219|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
125363777|NCT03307785|450965220|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
125363778|NCT03307785|450965221|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
125363779|NCT03307785|450965222|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
125363780|NCT03307785|450965223|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
125363781|NCT03307785|450965224|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
125363782|NCT03307785|450965225|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
125363783|NCT03307785|450965226|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
125363784|NCT03307785|450965227|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
125363785|NCT03307785|450965217|FG000|Part B: Up to Approx. 66 Months|Death|0|||
125363786|NCT03307785|450965218|FG001|Part B: Up to Approx. 66 Months|Death|0|||
125363787|NCT03307785|450965219|FG002|Part B: Up to Approx. 66 Months|Death|7|||
125363788|NCT03307785|450965220|FG003|Part B: Up to Approx. 66 Months|Death|0|||
125363789|NCT03307785|450965221|FG004|Part B: Up to Approx. 66 Months|Death|0|||
125363790|NCT03307785|450965222|FG005|Part B: Up to Approx. 66 Months|Death|0|||
125363791|NCT03307785|450965223|FG006|Part B: Up to Approx. 66 Months|Death|0|||
125429587|NCT00331344|451198885|FG003|Phase I|Adverse Event|1|||
125429588|NCT00331344|451198886|FG004|Phase I|Adverse Event|2|||
125429589|NCT00331344|451198887|FG005|Phase I|Adverse Event|2|||
125429590|NCT00331344|451198888|FG006|Phase I|Adverse Event|0|||
125429591|NCT00331344|451198889|FG007|Phase I|Adverse Event|1|||
125592608|NCT02660580|451792634|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
125592609|NCT02660580|451792635|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
125592610|NCT02660580|451792636|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
125592611|NCT02660580|451792637|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
125592612|NCT02660580|451792638|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
125592613|NCT02660580|451792634|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
125592614|NCT02660580|451792635|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
125212272|NCT01006590|450403308|FG000|Overall Study|Lost to Follow-up|1|||
125212273|NCT01006590|450403309|FG001|Overall Study|Lost to Follow-up|1|||
125212274|NCT01006590|450403308|FG000|Overall Study|Protocol Violation|1|||
125592615|NCT02660580|451792636|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
125592616|NCT02660580|451792637|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
125592617|NCT02660580|451792638|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
125592618|NCT02660580|451792634|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
125592619|NCT02660580|451792635|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
125592620|NCT02660580|451792636|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
125592621|NCT02660580|451792637|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
125592622|NCT02660580|451792638|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
125592623|NCT02660580|451792634|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
125592624|NCT02660580|451792635|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
125592625|NCT02660580|451792636|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
125592626|NCT02660580|451792637|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
125592627|NCT02660580|451792638|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
125592628|NCT02660580|451792634|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
125592629|NCT02660580|451792635|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
125592630|NCT02660580|451792636|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
125592631|NCT02660580|451792637|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
125592632|NCT02660580|451792638|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
125592633|NCT02660580|451792634|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
125592634|NCT02660580|451792635|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
125592635|NCT02660580|451792636|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
125592636|NCT02660580|451792637|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
125592637|NCT02660580|451792638|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
125592638|NCT02660580|451792634|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
125592639|NCT02660580|451792635|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
125592640|NCT02660580|451792636|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
125592641|NCT02660580|451792637|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
125592642|NCT02660580|451792638|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
125592643|NCT02660580|451792634|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
125592644|NCT02660580|451792635|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
125592645|NCT02660580|451792636|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
125592646|NCT02660580|451792637|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
125592647|NCT02660580|451792638|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
125592648|NCT02660580|451792634|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
125592649|NCT02660580|451792635|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
125592650|NCT02660580|451792636|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
125592651|NCT02660580|451792637|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
125592652|NCT02660580|451792638|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
125592653|NCT02660580|451792634|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
125592654|NCT02660580|451792635|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
125592655|NCT02660580|451792636|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
125592656|NCT02660580|451792637|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
125592657|NCT02660580|451792638|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
125592658|NCT02660580|451792634|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
125592659|NCT02660580|451792635|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
125592660|NCT02660580|451792636|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
125592661|NCT02660580|451792637|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
125592662|NCT02660580|451792638|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
125592663|NCT02660580|451792634|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
125592664|NCT02660580|451792635|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
125592665|NCT02660580|451792636|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
125592666|NCT02660580|451792637|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
125592667|NCT02660580|451792638|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
125592668|NCT00377962|451792639|FG000|Core Study: 0-12 Months|Adverse Event|18|||
125592669|NCT00377962|451792640|FG001|Core Study: 0-12 Months|Adverse Event|2|||
125592670|NCT00377962|451792639|FG000|Core Study: 0-12 Months|Death|3|||
125592671|NCT00377962|451792640|FG001|Core Study: 0-12 Months|Death|0|||
125592672|NCT00377962|451792639|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
125592673|NCT00377962|451792640|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
125592674|NCT00377962|451792639|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
125592675|NCT00377962|451792640|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
125592676|NCT00377962|451792639|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
125592677|NCT00377962|451792640|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
125592678|NCT00377962|451792639|FG000|Extension Study: 12-24 Months|Death|1|||
125592679|NCT00377962|451792640|FG001|Extension Study: 12-24 Months|Death|1|||
125592680|NCT00377962|451792639|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
125592681|NCT00377962|451792640|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
125592682|NCT00377962|451792639|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
125592683|NCT00377962|451792640|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
125592684|NCT00377962|451792639|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
125592685|NCT00377962|451792640|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
125592686|NCT00486902|451792643|FG000|Overall Study|Withdrawal by Subject|1|||
125592687|NCT00486902|451792644|FG001|Overall Study|Withdrawal by Subject|2|||
125592688|NCT00486902|451792643|FG000|Overall Study|decision for postpartum tubal ligation|3|||
125592689|NCT00486902|451792644|FG001|Overall Study|decision for postpartum tubal ligation|1|||
125592690|NCT00486902|451792643|FG000|Overall Study|spinal anesthetic protocal violation|1|||
125592691|NCT00486902|451792644|FG001|Overall Study|spinal anesthetic protocal violation|1|||
125592692|NCT00486902|451792643|FG000|Overall Study|Did not meet inclusion criteria|1|||
125592693|NCT00486902|451792644|FG001|Overall Study|Did not meet inclusion criteria|0|||
125592694|NCT00486902|451792643|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
125592695|NCT00486902|451792644|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
125592696|NCT04645797|451792647|FG000|Overall Study|Disease Progression|3|||
125592697|NCT04645797|451792648|FG001|Overall Study|Disease Progression|3|||
125592698|NCT04645797|451792649|FG002|Overall Study|Disease Progression|1|||
125592699|NCT04645797|451792650|FG003|Overall Study|Disease Progression|0|||
125592700|NCT04645797|451792651|FG004|Overall Study|Disease Progression|0|||
125592701|NCT04645797|451792652|FG005|Overall Study|Disease Progression|0|||
125592702|NCT04645797|451792653|FG006|Overall Study|Disease Progression|0|||
125592703|NCT04645797|451792647|FG000|Overall Study|Death|3|||
125592704|NCT04645797|451792648|FG001|Overall Study|Death|1|||
125592705|NCT04645797|451792649|FG002|Overall Study|Death|0|||
125592706|NCT04645797|451792650|FG003|Overall Study|Death|0|||
125592707|NCT04645797|451792651|FG004|Overall Study|Death|0|||
125592708|NCT04645797|451792652|FG005|Overall Study|Death|0|||
125592709|NCT04645797|451792653|FG006|Overall Study|Death|0|||
125592710|NCT00733902|451792654|FG000|Overall Study|Death|0|||
125592711|NCT00733902|451792655|FG001|Overall Study|Death|0|||
125592712|NCT00733902|451792656|FG002|Overall Study|Death|0|||
125592713|NCT00733902|451792657|FG003|Overall Study|Death|1|||
125592714|NCT00733902|451792654|FG000|Overall Study|Adverse Event|3|||
125592715|NCT00733902|451792655|FG001|Overall Study|Adverse Event|4|||
125592716|NCT00733902|451792656|FG002|Overall Study|Adverse Event|7|||
125592717|NCT00733902|451792657|FG003|Overall Study|Adverse Event|11|||
125592718|NCT00733902|451792654|FG000|Overall Study|Lack of Efficacy|56|||
125592719|NCT00733902|451792655|FG001|Overall Study|Lack of Efficacy|21|||
125592720|NCT00733902|451792656|FG002|Overall Study|Lack of Efficacy|34|||
125592721|NCT00733902|451792657|FG003|Overall Study|Lack of Efficacy|23|||
125592722|NCT00733902|451792654|FG000|Overall Study|Protocol Violation|4|||
125592723|NCT00733902|451792655|FG001|Overall Study|Protocol Violation|6|||
125592724|NCT00733902|451792656|FG002|Overall Study|Protocol Violation|3|||
125592725|NCT00733902|451792657|FG003|Overall Study|Protocol Violation|3|||
125592726|NCT00733902|451792654|FG000|Overall Study|Withdrawal by Subject|10|||
125592727|NCT00733902|451792655|FG001|Overall Study|Withdrawal by Subject|5|||
125592728|NCT00733902|451792656|FG002|Overall Study|Withdrawal by Subject|4|||
125592729|NCT00733902|451792657|FG003|Overall Study|Withdrawal by Subject|16|||
125592730|NCT00733902|451792654|FG000|Overall Study|Entered extension study|89|||
125592731|NCT00733902|451792655|FG001|Overall Study|Entered extension study|124|||
125592732|NCT00733902|451792656|FG002|Overall Study|Entered extension study|111|||
125592733|NCT00733902|451792657|FG003|Overall Study|Entered extension study|109|||
125592734|NCT00733902|451792654|FG000|Overall Study|Randomized but not treated|2|||
125592735|NCT00733902|451792655|FG001|Overall Study|Randomized but not treated|2|||
125592736|NCT00733902|451792656|FG002|Overall Study|Randomized but not treated|2|||
125592737|NCT00733902|451792657|FG003|Overall Study|Randomized but not treated|1|||
125592738|NCT00049127|451792658|FG000|Overall Study|Withdrawal by Subject|0|||
125592739|NCT00049127|451792659|FG001|Overall Study|Withdrawal by Subject|0|||
125592740|NCT00049127|451792660|FG002|Overall Study|Withdrawal by Subject|1|||
125592741|NCT00049127|451792661|FG003|Overall Study|Withdrawal by Subject|0|||
125592742|NCT00049127|451792662|FG004|Overall Study|Withdrawal by Subject|0|||
125592743|NCT02599402|451792663|FG000|Overall Study|Disease progression|153|||
125592744|NCT02599402|451792663|FG000|Overall Study|Study drug toxicity|201|||
125592745|NCT02599402|451792663|FG000|Overall Study|Death|26|||
125592746|NCT02599402|451792663|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
125363792|NCT03307785|450965224|FG007|Part B: Up to Approx. 66 Months|Death|0|||
125363793|NCT03307785|450965225|FG008|Part B: Up to Approx. 66 Months|Death|0|||
125363794|NCT03307785|450965226|FG009|Part B: Up to Approx. 66 Months|Death|0|||
125363795|NCT03307785|450965227|FG010|Part B: Up to Approx. 66 Months|Death|0|||
125363796|NCT03307785|450965217|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125592747|NCT02599402|451792663|FG000|Overall Study|Participant request to discontinue study treatment|13|||
125592748|NCT02599402|451792663|FG000|Overall Study|Participant withdrew consent|5|||
125592749|NCT02599402|451792663|FG000|Overall Study|Lost to Follow-up|1|||
125592750|NCT02599402|451792663|FG000|Overall Study|Maximum Clinical Benefit|7|||
125592751|NCT02599402|451792663|FG000|Overall Study|Poor/non-compliance|1|||
125592752|NCT02599402|451792663|FG000|Overall Study|Pregnancy|1|||
125363797|NCT03307785|450965218|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125363798|NCT03307785|450965219|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
125363799|NCT03307785|450965220|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125363800|NCT03307785|450965221|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125363801|NCT03307785|450965222|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125363802|NCT03307785|450965223|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125363803|NCT03307785|450965224|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125363804|NCT03307785|450965225|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125363805|NCT03307785|450965226|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125363806|NCT03307785|450965227|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
125363807|NCT03307785|450965217|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125363808|NCT03307785|450965218|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125363809|NCT03307785|450965219|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
125363810|NCT03307785|450965220|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125363811|NCT03307785|450965221|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125429592|NCT00331344|451198890|FG008|Phase I|Adverse Event|0|||
125592753|NCT02599402|451792663|FG000|Overall Study|Participant no longer met study criteria|7|||
125592754|NCT02599402|451792663|FG000|Overall Study|Other Reasons|95|||
125592755|NCT00833092|451792664|FG000|Overall Study|Withdrawal by Subject|2|||
125592756|NCT00833092|451792665|FG001|Overall Study|Withdrawal by Subject|3|||
125592757|NCT00833092|451792664|FG000|Overall Study|Protocol Violation|2|||
125592758|NCT00833092|451792665|FG001|Overall Study|Protocol Violation|1|||
125592759|NCT00833092|451792664|FG000|Overall Study|Diarrhea|0|||
125592760|NCT00833092|451792665|FG001|Overall Study|Diarrhea|2|||
125592761|NCT00833092|451792664|FG000|Overall Study|constipation|0|||
125592762|NCT00833092|451792665|FG001|Overall Study|constipation|1|||
125592763|NCT00699192|451792666|FG000|Overall Study|Missing|1|||
125592764|NCT00699192|451792667|FG001|Overall Study|Missing|1|||
125592765|NCT00699192|451792668|FG002|Overall Study|Missing|1|||
125592766|NCT00699192|451792666|FG000|Overall Study|Adverse Event|9|||
125592767|NCT00699192|451792667|FG001|Overall Study|Adverse Event|4|||
125592768|NCT00699192|451792668|FG002|Overall Study|Adverse Event|3|||
125592769|NCT00699192|451792666|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125592770|NCT00699192|451792667|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125592771|NCT00699192|451792668|FG002|Overall Study|Abnormal test procedure result(s)|1|||
125592772|NCT00699192|451792666|FG000|Overall Study|Lack of Efficacy|0|||
125592773|NCT00699192|451792667|FG001|Overall Study|Lack of Efficacy|0|||
125592774|NCT00699192|451792668|FG002|Overall Study|Lack of Efficacy|1|||
125592775|NCT00699192|451792666|FG000|Overall Study|Withdrawal by Subject|3|||
125592776|NCT00699192|451792667|FG001|Overall Study|Withdrawal by Subject|2|||
125592777|NCT00699192|451792668|FG002|Overall Study|Withdrawal by Subject|4|||
125592778|NCT00699192|451792666|FG000|Overall Study|Administrative problems|1|||
125592779|NCT00699192|451792667|FG001|Overall Study|Administrative problems|3|||
125592780|NCT00699192|451792668|FG002|Overall Study|Administrative problems|1|||
125592781|NCT00699192|451792666|FG000|Overall Study|Protocol Violation|2|||
125592782|NCT00699192|451792667|FG001|Overall Study|Protocol Violation|2|||
125592783|NCT00699192|451792668|FG002|Overall Study|Protocol Violation|0|||
125592784|NCT01773473|451792669|FG000|Overall Study|Adverse Event|3|||
125592785|NCT01773473|451792670|FG001|Overall Study|Adverse Event|2|||
125592786|NCT01773473|451792669|FG000|Overall Study|Protocol Violation|0|||
125592787|NCT01773473|451792670|FG001|Overall Study|Protocol Violation|4|||
125592788|NCT01773473|451792669|FG000|Overall Study|Physician Decision|3|||
125592789|NCT01773473|451792670|FG001|Overall Study|Physician Decision|5|||
125592790|NCT01773473|451792669|FG000|Overall Study|Sponsor Decision|2|||
125592791|NCT01773473|451792670|FG001|Overall Study|Sponsor Decision|0|||
125592792|NCT01773473|451792669|FG000|Overall Study|Lack of Efficacy|0|||
125592793|NCT01773473|451792670|FG001|Overall Study|Lack of Efficacy|1|||
125592794|NCT01773473|451792669|FG000|Overall Study|Non-Compliance with study drug|1|||
125592795|NCT01773473|451792670|FG001|Overall Study|Non-Compliance with study drug|4|||
125592796|NCT01773473|451792669|FG000|Overall Study|Withdrawal by Subject|5|||
125592797|NCT01773473|451792670|FG001|Overall Study|Withdrawal by Subject|3|||
125592798|NCT01773473|451792669|FG000|Overall Study|Lost to Follow-up|2|||
125363812|NCT03307785|450965222|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125363813|NCT03307785|450965223|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125363814|NCT03307785|450965224|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125363815|NCT03307785|450965225|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125363816|NCT03307785|450965226|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125363817|NCT03307785|450965227|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
125363818|NCT03307785|450965217|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125363819|NCT03307785|450965218|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125363820|NCT03307785|450965219|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
125363821|NCT03307785|450965220|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125363822|NCT03307785|450965221|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125363823|NCT03307785|450965222|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125363824|NCT03307785|450965223|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125363825|NCT03307785|450965224|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125429593|NCT00331344|451198882|FG000|Phase II|Death|0|||
125592799|NCT01773473|451792670|FG001|Overall Study|Lost to Follow-up|0|||
125592800|NCT04927312|451792673|FG000|Overall Study|Adverse Event|1|||
125592801|NCT04927312|451792673|FG000|Overall Study|Death|1|||
125592802|NCT04927312|451792673|FG000|Overall Study|Withdrawal by Subject|1|||
125592803|NCT04927312|451792673|FG000|Overall Study|Other|1|||
125592804|NCT04919564|451792676|FG000|Overall Study|Lost to Follow-up|1|||
125592805|NCT04919564|451792677|FG001|Overall Study|Lost to Follow-up|0|||
125592806|NCT04919564|451792676|FG000|Overall Study|Physician Decision|1|||
125592807|NCT04919564|451792677|FG001|Overall Study|Physician Decision|1|||
125592808|NCT01241786|451792678|FG000|Overall Study|Lack of Efficacy|5|||
125592809|NCT01122927|451792680|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
125592810|NCT01122927|451792681|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
125363826|NCT03307785|450965225|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125363827|NCT03307785|450965226|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125363828|NCT03307785|450965227|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
125363829|NCT03307785|450965217|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125363830|NCT03307785|450965218|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125363831|NCT03307785|450965219|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125363832|NCT03307785|450965220|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
125363833|NCT03307785|450965221|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
125363834|NCT03307785|450965222|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125363835|NCT03307785|450965223|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125363836|NCT03307785|450965224|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125363837|NCT03307785|450965225|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125363838|NCT03307785|450965226|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125363839|NCT03307785|450965227|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
125363840|NCT03307785|450965217|FG000|Part C: Up to Approx. 60 Months|Death|0|||
125363841|NCT03307785|450965218|FG001|Part C: Up to Approx. 60 Months|Death|0|||
125363842|NCT03307785|450965219|FG002|Part C: Up to Approx. 60 Months|Death|0|||
125363843|NCT03307785|450965220|FG003|Part C: Up to Approx. 60 Months|Death|2|||
125363844|NCT03307785|450965221|FG004|Part C: Up to Approx. 60 Months|Death|5|||
125363845|NCT03307785|450965222|FG005|Part C: Up to Approx. 60 Months|Death|0|||
125363846|NCT03307785|450965223|FG006|Part C: Up to Approx. 60 Months|Death|0|||
125363847|NCT03307785|450965224|FG007|Part C: Up to Approx. 60 Months|Death|0|||
125363848|NCT03307785|450965225|FG008|Part C: Up to Approx. 60 Months|Death|0|||
125363849|NCT03307785|450965226|FG009|Part C: Up to Approx. 60 Months|Death|0|||
125363850|NCT03307785|450965227|FG010|Part C: Up to Approx. 60 Months|Death|0|||
125363851|NCT03307785|450965217|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125363852|NCT03307785|450965218|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125363853|NCT03307785|450965219|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125363854|NCT03307785|450965220|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
125363855|NCT03307785|450965221|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125363856|NCT03307785|450965222|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125363857|NCT03307785|450965223|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125363858|NCT03307785|450965224|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125363859|NCT03307785|450965225|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125363860|NCT03307785|450965226|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125363861|NCT03307785|450965227|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
125363862|NCT03307785|450965217|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125363863|NCT03307785|450965218|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125363864|NCT03307785|450965219|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125363865|NCT03307785|450965220|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125363866|NCT03307785|450965221|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
125363867|NCT03307785|450965222|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125363868|NCT03307785|450965223|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125363869|NCT03307785|450965224|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125363870|NCT03307785|450965225|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125363871|NCT03307785|450965226|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125363872|NCT03307785|450965227|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
125363873|NCT03307785|450965217|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125363874|NCT03307785|450965218|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125363875|NCT03307785|450965219|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125363876|NCT03307785|450965220|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125592811|NCT01122927|451792680|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
125592812|NCT01122927|451792681|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
125592813|NCT01122927|451792680|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
125592814|NCT01122927|451792681|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
125363877|NCT03307785|450965221|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125363878|NCT03307785|450965222|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
125363879|NCT03307785|450965223|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125429594|NCT00331344|451198883|FG001|Phase II|Death|0|||
125592815|NCT01122927|451792680|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
125592816|NCT01122927|451792681|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
125363880|NCT03307785|450965224|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125363881|NCT03307785|450965225|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125363882|NCT03307785|450965226|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125363883|NCT03307785|450965227|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
125363884|NCT03307785|450965217|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
125429595|NCT00331344|451198884|FG002|Phase II|Death|0|||
125592817|NCT01122927|451792680|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
125592818|NCT01122927|451792681|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
125592819|NCT01122927|451792680|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
125592820|NCT01122927|451792681|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
125592821|NCT01122927|451792680|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
125592822|NCT01122927|451792681|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
125592823|NCT01122927|451792680|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
125592824|NCT01122927|451792681|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
125592825|NCT01122927|451792680|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
125592826|NCT01122927|451792681|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
125592827|NCT01122927|451792680|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
125592828|NCT01122927|451792681|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
125592829|NCT01122927|451792680|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
125592830|NCT01122927|451792681|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
125592831|NCT01122927|451792680|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
125592832|NCT01122927|451792681|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
125592833|NCT02286102|451792684|FG000|Overall Study|Screen Failure|1|||
125592834|NCT02286102|451792685|FG001|Overall Study|Screen Failure|1|||
125592835|NCT01440101|451792686|FG000|Overall Study|Adverse Event|2|||
125592836|NCT01440101|451792687|FG001|Overall Study|Adverse Event|0|||
125592837|NCT01440101|451792688|FG002|Overall Study|Adverse Event|0|||
125592838|NCT01440101|451792686|FG000|Overall Study|Withdrawal by Subject|0|||
125592839|NCT01440101|451792687|FG001|Overall Study|Withdrawal by Subject|3|||
125592840|NCT01440101|451792688|FG002|Overall Study|Withdrawal by Subject|1|||
125592841|NCT01440101|451792686|FG000|Overall Study|Other|0|||
125592842|NCT01440101|451792687|FG001|Overall Study|Other|1|||
125592843|NCT01440101|451792688|FG002|Overall Study|Other|0|||
125592844|NCT00201851|451792689|FG000|Overall Study|Lost to Follow-up|2|||
125592845|NCT00201851|451792690|FG001|Overall Study|Lost to Follow-up|1|||
125592846|NCT00201851|451792691|FG002|Overall Study|Lost to Follow-up|0|||
125592847|NCT00201851|451792689|FG000|Overall Study|Ineligible post enrollment|6|||
125592848|NCT00201851|451792690|FG001|Overall Study|Ineligible post enrollment|1|||
125592849|NCT00201851|451792691|FG002|Overall Study|Ineligible post enrollment|1|||
125592850|NCT00636818|451792692|FG000|Overall Study|Adverse Event|1|||
125592851|NCT00636818|451792692|FG000|Overall Study|Lost to Follow-up|2|||
125592852|NCT00636818|451792692|FG000|Overall Study|Entry Criteria Exclusion|3|||
125592853|NCT00636818|451792692|FG000|Overall Study|Protocol Violation|1|||
125592854|NCT00636818|451792692|FG000|Overall Study|Withdrawal by Subject|4|||
125592855|NCT00074958|451792693|FG000|Overall Study|Adverse Event|1|||
125592856|NCT01658514|451792697|FG000|Overall Study|Protocol Violation|1|||
125592857|NCT01658514|451792698|FG001|Overall Study|Protocol Violation|0|||
125592858|NCT01658514|451792699|FG002|Overall Study|Protocol Violation|2|||
125592859|NCT01243268|451792700|FG000|Overall Study|Lost to Follow-up|4|||
125592860|NCT01243268|451792700|FG000|Overall Study|Protocol Violation|51|||
125592861|NCT01243268|451792700|FG000|Overall Study|Deviation with contract date|7|||
125592862|NCT01243268|451792700|FG000|Overall Study|Duplicate subject|2|||
125363885|NCT03307785|450965218|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
125363886|NCT03307785|450965219|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
125363887|NCT03307785|450965220|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
125363888|NCT03307785|450965221|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
125363889|NCT03307785|450965222|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
125592863|NCT00957853|451792701|FG000|Overall Study|Withdrawal by Subject|1|||
125592864|NCT00957853|451792702|FG001|Overall Study|Withdrawal by Subject|0|||
125592865|NCT00957853|451792703|FG002|Overall Study|Withdrawal by Subject|0|||
125592866|NCT00702143|451792704|FG000|Overall Study|Lost to Follow-up|0|||
125592867|NCT00702143|451792705|FG001|Overall Study|Lost to Follow-up|0|||
125592868|NCT00702143|451792706|FG002|Overall Study|Lost to Follow-up|1|||
125592869|NCT00741819|451792709|FG000|Overall Study|Adverse Event|3|||
125592870|NCT00741819|451792709|FG000|Overall Study|Withdrawal by Subject|3|||
125592871|NCT00741819|451792709|FG000|Overall Study|Death|1|||
125592872|NCT00741819|451792709|FG000|Overall Study|Disease progression|1|||
125592873|NCT00609622|451792710|FG000|Overall Study|Adverse Event|14|||
125592874|NCT00609622|451792711|FG001|Overall Study|Adverse Event|10|||
125592875|NCT00609622|451792710|FG000|Overall Study|Withdrawal by Subject|4|||
125592876|NCT00609622|451792711|FG001|Overall Study|Withdrawal by Subject|20|||
125592877|NCT00609622|451792710|FG000|Overall Study|Death|1|||
125592878|NCT00609622|451792711|FG001|Overall Study|Death|4|||
125592879|NCT00609622|451792710|FG000|Overall Study|Protocol Violation|1|||
125363890|NCT03307785|450965223|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
125363891|NCT03307785|450965224|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
125363892|NCT03307785|450965225|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
125592880|NCT00609622|451792711|FG001|Overall Study|Protocol Violation|1|||
125592881|NCT00609622|451792710|FG000|Overall Study|Objective progression or relapse|47|||
125592882|NCT00609622|451792711|FG001|Overall Study|Objective progression or relapse|41|||
125592883|NCT00609622|451792710|FG000|Overall Study|Study terminated by sponsor|16|||
125592884|NCT00609622|451792711|FG001|Overall Study|Study terminated by sponsor|3|||
125592885|NCT00609622|451792710|FG000|Overall Study|Other|7|||
125592886|NCT00609622|451792711|FG001|Overall Study|Other|14|||
125592887|NCT00609622|451792710|FG000|Overall Study|Global deterioration of health status|6|||
125592888|NCT00609622|451792711|FG001|Overall Study|Global deterioration of health status|2|||
125592889|NCT02970929|451792715|FG000|Overall Study|Adverse Event|18|||
125592890|NCT02970929|451792715|FG000|Overall Study|Lack of Efficacy|8|||
125592891|NCT02970929|451792715|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
125592892|NCT02970929|451792715|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
125592893|NCT02970929|451792715|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
125592894|NCT02970929|451792715|FG000|Overall Study|LOST TO FOLLOWUP|6|||
125592895|NCT02970929|451792715|FG000|Overall Study|MOVED OUT OF STATE|1|||
125592896|NCT02970929|451792715|FG000|Overall Study|Withdrawal by Subject|16|||
125592897|NCT04321343|451792723|FG000|Overall Study|Adverse Event|0|||
125592898|NCT04321343|451792724|FG001|Overall Study|Adverse Event|0|||
125592899|NCT04321343|451792725|FG002|Overall Study|Adverse Event|1|||
125592900|NCT04321343|451792726|FG003|Overall Study|Adverse Event|0|||
125592901|NCT04321343|451792723|FG000|Overall Study|Death|0|||
125592902|NCT04321343|451792724|FG001|Overall Study|Death|0|||
125592903|NCT04321343|451792725|FG002|Overall Study|Death|0|||
125592904|NCT04321343|451792726|FG003|Overall Study|Death|1|||
125592905|NCT04321343|451792723|FG000|Overall Study|Pregnancy|1|||
125592906|NCT04321343|451792724|FG001|Overall Study|Pregnancy|0|||
125592907|NCT04321343|451792725|FG002|Overall Study|Pregnancy|0|||
125592908|NCT04321343|451792726|FG003|Overall Study|Pregnancy|0|||
125592909|NCT04321343|451792723|FG000|Overall Study|Protocol Violation|1|||
125592910|NCT04321343|451792724|FG001|Overall Study|Protocol Violation|1|||
125592911|NCT04321343|451792725|FG002|Overall Study|Protocol Violation|1|||
125592912|NCT04321343|451792726|FG003|Overall Study|Protocol Violation|1|||
125592913|NCT04321343|451792723|FG000|Overall Study|Withdrawal by Subject|0|||
125592914|NCT04321343|451792724|FG001|Overall Study|Withdrawal by Subject|6|||
125592915|NCT04321343|451792725|FG002|Overall Study|Withdrawal by Subject|0|||
125592916|NCT04321343|451792726|FG003|Overall Study|Withdrawal by Subject|2|||
125592917|NCT04321343|451792723|FG000|Overall Study|Lost to Follow-up|2|||
125592918|NCT04321343|451792724|FG001|Overall Study|Lost to Follow-up|2|||
125592919|NCT04321343|451792725|FG002|Overall Study|Lost to Follow-up|1|||
125592920|NCT04321343|451792726|FG003|Overall Study|Lost to Follow-up|3|||
125592921|NCT04194944|451792727|FG000|Overall Study|Lost to Follow-up|3|||
125592922|NCT04194944|451792728|FG001|Overall Study|Lost to Follow-up|0|||
125592923|NCT04194944|451792727|FG000|Overall Study|Withdrawal by Subject|2|||
125592924|NCT04194944|451792728|FG001|Overall Study|Withdrawal by Subject|2|||
125592925|NCT04194944|451792727|FG000|Overall Study|On Treatment|93|||
125592926|NCT04194944|451792728|FG001|Overall Study|On Treatment|30|||
125429596|NCT00331344|451198885|FG003|Phase II|Death|0|||
125592927|NCT03277196|451792739|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
125592928|NCT03277196|451792739|FG000|Overall Study|Lost to Follow-up|3|||
125592929|NCT03277196|451792739|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
125592930|NCT03277196|451792739|FG000|Overall Study|Other|2|||
125592931|NCT05224258|451794231|FG000|Overall Study|Withdrawal by Subject|1|||
125592932|NCT05224258|451794232|FG001|Overall Study|Withdrawal by Subject|1|||
125592933|NCT05224258|451794231|FG000|Overall Study|Physician Decision|1|||
125592934|NCT05224258|451794232|FG001|Overall Study|Physician Decision|1|||
125592935|NCT05224258|451794231|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125592936|NCT05224258|451794232|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125592937|NCT05224258|451794231|FG000|Overall Study|Study Product No Longer in Use|1|||
125592938|NCT05224258|451794232|FG001|Overall Study|Study Product No Longer in Use|0|||
125592939|NCT05224258|451794231|FG000|Overall Study|Adverse Event|0|||
125592940|NCT05224258|451794232|FG001|Overall Study|Adverse Event|1|||
125592941|NCT05224258|451794231|FG000|Overall Study|Protocol Deviation|0|||
125429597|NCT00331344|451198886|FG004|Phase II|Death|0|||
125429598|NCT00331344|451198887|FG005|Phase II|Death|0|||
125429599|NCT00331344|451198888|FG006|Phase II|Death|0|||
125429600|NCT00331344|451198889|FG007|Phase II|Death|0|||
125429601|NCT00331344|451198890|FG008|Phase II|Death|4|||
125429602|NCT01373931|451198893|FG000|Lead-in Period|Adverse Event|2|||
125429603|NCT01373931|451198894|FG001|Lead-in Period|Adverse Event|0|||
125429604|NCT01373931|451198893|FG000|Period 1|Adverse Event|2|||
125429605|NCT01373931|451198894|FG001|Period 1|Adverse Event|0|||
125429606|NCT01373931|451198893|FG000|Period 1|Withdrawal by Subject|0|||
125429607|NCT01373931|451198894|FG001|Period 1|Withdrawal by Subject|2|||
125429608|NCT04857034|451198895|FG000|Placebo-Controlled Period|Request to discontinue|2|||
125429609|NCT04857034|451198896|FG001|Placebo-Controlled Period|Request to discontinue|2|||
125429610|NCT04857034|451198897|FG002|Placebo-Controlled Period|Request to discontinue|0|||
125429611|NCT04857034|451198898|FG003|Placebo-Controlled Period|Request to discontinue|0|||
125429612|NCT04857034|451198899|FG004|Placebo-Controlled Period|Request to discontinue|0|||
125429613|NCT04857034|451198895|FG000|Placebo-Controlled Period|withdrew consent|1|||
125429614|NCT04857034|451198896|FG001|Placebo-Controlled Period|withdrew consent|1|||
125429615|NCT04857034|451198897|FG002|Placebo-Controlled Period|withdrew consent|2|||
125429616|NCT04857034|451198898|FG003|Placebo-Controlled Period|withdrew consent|0|||
125429617|NCT04857034|451198899|FG004|Placebo-Controlled Period|withdrew consent|0|||
125429618|NCT04857034|451198895|FG000|Placebo-Controlled Period|Pregnancy|1|||
125592942|NCT05224258|451794232|FG001|Overall Study|Protocol Deviation|1|||
125592943|NCT00684814|451794242|FG000|Washout Period of 7 Days|Adverse Event|1|||
125592944|NCT00684814|451794243|FG001|Washout Period of 7 Days|Adverse Event|2|||
125592945|NCT00684814|451794242|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
125592946|NCT00684814|451794243|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
125592947|NCT00684814|451794242|FG000|Second Intervention|Adverse Event|1|||
125592948|NCT00684814|451794243|FG001|Second Intervention|Adverse Event|0|||
125592949|NCT01676961|451794244|FG000|Overall Study|Death|3|||
125592950|NCT01676961|451794244|FG000|Overall Study|Lost to Follow-up|1|||
125592951|NCT01676961|451794244|FG000|Overall Study|Withdrawal by Subject|1|||
125592952|NCT00117312|451794245|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
125592953|NCT00117312|451794246|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
125592954|NCT00117312|451794247|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
125592955|NCT00117312|451794248|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
125592956|NCT00117312|451794245|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
125592957|NCT00117312|451794246|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
125592958|NCT00117312|451794247|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
125592959|NCT00117312|451794248|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
125592960|NCT00117312|451794245|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
125592961|NCT00117312|451794246|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
125592962|NCT00117312|451794247|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
125592963|NCT00117312|451794248|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
125592964|NCT00117312|451794245|FG000|Overall Study|Other|0|||
125592965|NCT00117312|451794246|FG001|Overall Study|Other|1|||
125592966|NCT00117312|451794247|FG002|Overall Study|Other|3|||
125592967|NCT00117312|451794248|FG003|Overall Study|Other|1|||
125592968|NCT00117312|451794245|FG000|Overall Study|Patient choice|0|||
125592969|NCT00117312|451794246|FG001|Overall Study|Patient choice|0|||
125592970|NCT00117312|451794247|FG002|Overall Study|Patient choice|2|||
125592971|NCT00117312|451794248|FG003|Overall Study|Patient choice|1|||
125592972|NCT00117312|451794245|FG000|Overall Study|Adverse Event|0|||
125592973|NCT00117312|451794246|FG001|Overall Study|Adverse Event|2|||
125592974|NCT00117312|451794247|FG002|Overall Study|Adverse Event|0|||
125592975|NCT00117312|451794248|FG003|Overall Study|Adverse Event|0|||
125429619|NCT04857034|451198896|FG001|Placebo-Controlled Period|Pregnancy|1|||
125429620|NCT04857034|451198897|FG002|Placebo-Controlled Period|Pregnancy|0|||
125429621|NCT04857034|451198898|FG003|Placebo-Controlled Period|Pregnancy|0|||
125429622|NCT04857034|451198899|FG004|Placebo-Controlled Period|Pregnancy|0|||
125429623|NCT04857034|451198895|FG000|Placebo-Controlled Period|Ongoing study period|0|||
125592976|NCT00117312|451794245|FG000|Overall Study|Protocol Violation|0|||
125592977|NCT00117312|451794246|FG001|Overall Study|Protocol Violation|1|||
125592978|NCT00117312|451794247|FG002|Overall Study|Protocol Violation|3|||
125429624|NCT04857034|451198896|FG001|Placebo-Controlled Period|Ongoing study period|1|||
125592979|NCT00117312|451794248|FG003|Overall Study|Protocol Violation|0|||
125592980|NCT00117312|451794245|FG000|Overall Study|PSA decrease <=50%|0|||
125592981|NCT00117312|451794246|FG001|Overall Study|PSA decrease <=50%|2|||
125592982|NCT00117312|451794247|FG002|Overall Study|PSA decrease <=50%|2|||
125363893|NCT03307785|450965226|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
125363894|NCT03307785|450965227|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
125363895|NCT03307785|450965217|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125363896|NCT03307785|450965218|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125363897|NCT03307785|450965219|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125363898|NCT03307785|450965220|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125363899|NCT03307785|450965221|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125363900|NCT03307785|450965222|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
125363901|NCT03307785|450965223|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125363902|NCT03307785|450965224|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125363903|NCT03307785|450965225|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125363904|NCT03307785|450965226|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125363905|NCT03307785|450965227|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
125363906|NCT03307785|450965217|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125363907|NCT03307785|450965218|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125363908|NCT03307785|450965219|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125363909|NCT03307785|450965220|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125363910|NCT03307785|450965221|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125363911|NCT03307785|450965222|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
125363912|NCT03307785|450965223|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125363913|NCT03307785|450965224|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125363914|NCT03307785|450965225|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125363915|NCT03307785|450965226|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125363916|NCT03307785|450965227|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
125363917|NCT03307785|450965217|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125363918|NCT03307785|450965218|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125363919|NCT03307785|450965219|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125363920|NCT03307785|450965220|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125363921|NCT03307785|450965221|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125363922|NCT03307785|450965222|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
125363923|NCT03307785|450965223|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125363924|NCT03307785|450965224|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125363925|NCT03307785|450965225|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125363926|NCT03307785|450965226|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125363927|NCT03307785|450965227|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
125363928|NCT03307785|450965217|FG000|Part E: Up to 4.4 Months|Death|0|||
125363929|NCT03307785|450965218|FG001|Part E: Up to 4.4 Months|Death|0|||
125363930|NCT03307785|450965219|FG002|Part E: Up to 4.4 Months|Death|0|||
125363931|NCT03307785|450965220|FG003|Part E: Up to 4.4 Months|Death|0|||
125363932|NCT03307785|450965221|FG004|Part E: Up to 4.4 Months|Death|0|||
125363933|NCT03307785|450965222|FG005|Part E: Up to 4.4 Months|Death|0|||
125363934|NCT03307785|450965223|FG006|Part E: Up to 4.4 Months|Death|1|||
125363935|NCT03307785|450965224|FG007|Part E: Up to 4.4 Months|Death|0|||
125363936|NCT03307785|450965225|FG008|Part E: Up to 4.4 Months|Death|0|||
125363937|NCT03307785|450965226|FG009|Part E: Up to 4.4 Months|Death|0|||
125363938|NCT03307785|450965227|FG010|Part E: Up to 4.4 Months|Death|0|||
125363939|NCT03307785|450965217|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
125363940|NCT03307785|450965218|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
125363941|NCT03307785|450965219|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
125363942|NCT03307785|450965220|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
125363943|NCT03307785|450965221|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
125363944|NCT03307785|450965222|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
125363945|NCT03307785|450965223|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
125363946|NCT03307785|450965224|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
125363947|NCT03307785|450965225|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
125363948|NCT03307785|450965226|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
125363949|NCT03307785|450965227|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
125363950|NCT03307785|450965217|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
125363951|NCT03307785|450965218|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
125363952|NCT03307785|450965219|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
125363953|NCT03307785|450965220|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
125363954|NCT03307785|450965221|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
125592983|NCT00117312|451794248|FG003|Overall Study|PSA decrease <=50%|4|||
125363955|NCT03307785|450965222|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
125429625|NCT04857034|451198897|FG002|Placebo-Controlled Period|Ongoing study period|0|||
125429626|NCT04857034|451198898|FG003|Placebo-Controlled Period|Ongoing study period|0|||
125363956|NCT03307785|450965223|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
125363957|NCT03307785|450965224|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
125363958|NCT03307785|450965225|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
125363959|NCT03307785|450965226|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
125363960|NCT03307785|450965227|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
125363961|NCT00492531|450965229|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
125363962|NCT00492531|450965230|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
125363963|NCT00843856|450965232|FG000|Overall Study|Lost to Follow-up|1|||
125363964|NCT00843856|450965233|FG001|Overall Study|Lost to Follow-up|2|||
125363965|NCT04729621|450965234|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
125363966|NCT04729621|450965235|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
125363967|NCT04729621|450965236|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
125363968|NCT04729621|450965237|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
125363969|NCT04729621|450965238|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
125363970|NCT04729621|450965234|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
125363971|NCT04729621|450965235|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
125363972|NCT04729621|450965236|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
125363973|NCT04729621|450965237|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
125363974|NCT04729621|450965238|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
125363975|NCT04729621|450965234|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
125363976|NCT04729621|450965235|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
125363977|NCT04729621|450965236|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
125363978|NCT04729621|450965237|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
125363979|NCT04729621|450965238|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
125363980|NCT04729621|450965234|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
125363981|NCT04729621|450965235|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
125363982|NCT04729621|450965236|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
125363983|NCT04729621|450965237|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
125363984|NCT04729621|450965238|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
125363985|NCT04729621|450965234|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
125363986|NCT04729621|450965235|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
125363987|NCT04729621|450965236|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
125363988|NCT04729621|450965237|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
125363989|NCT04729621|450965238|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
125363990|NCT04729621|450965234|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
125363991|NCT04729621|450965235|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
125363992|NCT04729621|450965236|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
125363993|NCT04729621|450965237|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
125363994|NCT04729621|450965238|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
125363995|NCT01696071|450965243|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
125363996|NCT01696071|450965244|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
125363997|NCT02569671|450965250|FG000|Overall Study|Lost to Follow-up|2|||
125363998|NCT02569671|450965251|FG001|Overall Study|Lost to Follow-up|1|||
125363999|NCT02569671|450965250|FG000|Overall Study|Withdrawal by Subject|1|||
125364000|NCT02569671|450965251|FG001|Overall Study|Withdrawal by Subject|3|||
125364001|NCT03487549|450965252|FG000|Overall Study|Protocol Violation|0|||
125364002|NCT03487549|450965253|FG001|Overall Study|Protocol Violation|1|||
125364003|NCT03487549|450965252|FG000|Overall Study|Lost to Follow-up|2|||
125364004|NCT03487549|450965253|FG001|Overall Study|Lost to Follow-up|1|||
125364005|NCT03487549|450965252|FG000|Overall Study|Withdrawal by Subject|2|||
125364006|NCT03487549|450965253|FG001|Overall Study|Withdrawal by Subject|0|||
125364007|NCT03730012|450965254|FG000|Overall Study|Adverse Event|0|||
125364008|NCT03730012|450965255|FG001|Overall Study|Adverse Event|1|||
125364009|NCT03730012|450965254|FG000|Overall Study|Lack of Efficacy|1|||
125364010|NCT03730012|450965255|FG001|Overall Study|Lack of Efficacy|5|||
125364011|NCT03730012|450965254|FG000|Overall Study|Withdrawal by Subject|0|||
125364012|NCT03730012|450965255|FG001|Overall Study|Withdrawal by Subject|1|||
125364013|NCT03730012|450965254|FG000|Overall Study|Miscellaneous|2|||
125364014|NCT03730012|450965255|FG001|Overall Study|Miscellaneous|1|||
125364015|NCT05147428|450965256|FG000|Overall Study|Removed prior to mailing|289|||
125364016|NCT05147428|450965257|FG001|Overall Study|Removed prior to mailing|306|||
125364017|NCT05147428|450965258|FG002|Overall Study|Removed prior to mailing|270|||
125364018|NCT05147428|450965256|FG000|Overall Study|Died or disenrolled during blackout period|239|||
125364019|NCT05147428|450965257|FG001|Overall Study|Died or disenrolled during blackout period|278|||
125364020|NCT05147428|450965258|FG002|Overall Study|Died or disenrolled during blackout period|273|||
125364021|NCT01977794|450967010|FG000|Overall Study|Adverse Event|2|||
125364022|NCT01977794|450967011|FG001|Overall Study|Adverse Event|2|||
125364023|NCT01977794|450967010|FG000|Overall Study|Lost to Follow-up|2|||
125364024|NCT01977794|450967011|FG001|Overall Study|Lost to Follow-up|1|||
125212275|NCT01006590|450403309|FG001|Overall Study|Protocol Violation|0|||
125212276|NCT01006590|450403308|FG000|Overall Study|Withdrawal by Subject|4|||
125592984|NCT00117312|451794245|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
125592985|NCT00117312|451794246|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
125592986|NCT00117312|451794247|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
125592987|NCT00117312|451794248|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
125592988|NCT00117312|451794245|FG000|Overall Study|Hepatic abnormality|0|||
125592989|NCT00117312|451794246|FG001|Overall Study|Hepatic abnormality|1|||
125592990|NCT00117312|451794247|FG002|Overall Study|Hepatic abnormality|0|||
125592991|NCT00117312|451794248|FG003|Overall Study|Hepatic abnormality|1|||
125592992|NCT00117312|451794245|FG000|Overall Study|Withdrawal by Subject|0|||
125592993|NCT00117312|451794246|FG001|Overall Study|Withdrawal by Subject|2|||
125592994|NCT00117312|451794247|FG002|Overall Study|Withdrawal by Subject|0|||
125592995|NCT00117312|451794248|FG003|Overall Study|Withdrawal by Subject|0|||
125592996|NCT00195650|451794249|FG000|Overall Study|Adverse Event|194|||
125592997|NCT00195650|451794249|FG000|Overall Study|Lack of Efficacy|99|||
125592998|NCT00195650|451794249|FG000|Overall Study|Withdrawal by Subject|67|||
125592999|NCT00195650|451794249|FG000|Overall Study|Lost to Follow-up|44|||
125593000|NCT00195650|451794249|FG000|Overall Study|Death|23|||
125593001|NCT00195650|451794249|FG000|Overall Study|Protocol Violation|15|||
125593002|NCT00195650|451794249|FG000|Overall Study|Administrative reasons|83|||
125593003|NCT03375320|451794250|FG000|Overall Study|Adverse Event|34|||
125593004|NCT03375320|451794251|FG001|Overall Study|Adverse Event|9|||
125593005|NCT03375320|451794252|FG002|Overall Study|Adverse Event|10|||
125593006|NCT03375320|451794253|FG003|Overall Study|Adverse Event|0|||
125593007|NCT03375320|451794250|FG000|Overall Study|Death|6|||
125593008|NCT03375320|451794251|FG001|Overall Study|Death|3|||
125593009|NCT03375320|451794252|FG002|Overall Study|Death|0|||
125593010|NCT03375320|451794253|FG003|Overall Study|Death|0|||
125593011|NCT03375320|451794250|FG000|Overall Study|Withdrawal by Subject|7|||
125593012|NCT03375320|451794251|FG001|Overall Study|Withdrawal by Subject|4|||
125593013|NCT03375320|451794252|FG002|Overall Study|Withdrawal by Subject|5|||
125593014|NCT03375320|451794253|FG003|Overall Study|Withdrawal by Subject|4|||
125593015|NCT03375320|451794250|FG000|Overall Study|Progressive disease|55|||
125593016|NCT03375320|451794251|FG001|Overall Study|Progressive disease|41|||
125593017|NCT03375320|451794252|FG002|Overall Study|Progressive disease|29|||
125593018|NCT03375320|451794253|FG003|Overall Study|Progressive disease|24|||
125593019|NCT03375320|451794250|FG000|Overall Study|Alternative treatment|6|||
125593020|NCT03375320|451794251|FG001|Overall Study|Alternative treatment|1|||
125593021|NCT03375320|451794252|FG002|Overall Study|Alternative treatment|1|||
125593022|NCT03375320|451794253|FG003|Overall Study|Alternative treatment|0|||
125593023|NCT03375320|451794250|FG000|Overall Study|Other disease|1|||
125593024|NCT03375320|451794251|FG001|Overall Study|Other disease|1|||
125593025|NCT03375320|451794252|FG002|Overall Study|Other disease|3|||
125593026|NCT03375320|451794253|FG003|Overall Study|Other disease|0|||
125593027|NCT03375320|451794250|FG000|Overall Study|Withdrawal prior to initiation|2|||
125593028|NCT03375320|451794251|FG001|Overall Study|Withdrawal prior to initiation|2|||
125593029|NCT03375320|451794252|FG002|Overall Study|Withdrawal prior to initiation|1|||
125593030|NCT03375320|451794253|FG003|Overall Study|Withdrawal prior to initiation|0|||
125593031|NCT03375320|451794250|FG000|Overall Study|Physician Decision|1|||
125593032|NCT03375320|451794251|FG001|Overall Study|Physician Decision|1|||
125593033|NCT03375320|451794252|FG002|Overall Study|Physician Decision|1|||
125593034|NCT03375320|451794253|FG003|Overall Study|Physician Decision|1|||
125593035|NCT03375320|451794250|FG000|Overall Study|Non-compliance|1|||
125593036|NCT03375320|451794251|FG001|Overall Study|Non-compliance|0|||
125593037|NCT03375320|451794252|FG002|Overall Study|Non-compliance|0|||
125593038|NCT03375320|451794253|FG003|Overall Study|Non-compliance|0|||
125593039|NCT01128387|451794254|FG000|Overall Study|Physician Decision|0|||
125593040|NCT01128387|451794255|FG001|Overall Study|Physician Decision|1|||
125593041|NCT02635204|451794256|FG000|Overall Study|Adverse Event|1|||
125593042|NCT02635204|451794257|FG001|Overall Study|Adverse Event|0|||
125593043|NCT02635204|451794256|FG000|Overall Study|Lost to Follow-up|1|||
125593044|NCT02635204|451794257|FG001|Overall Study|Lost to Follow-up|1|||
125593045|NCT01535235|451794258|FG000|Overall Study|Adverse Event|1|||
125593046|NCT01535235|451794259|FG001|Overall Study|Adverse Event|0|||
125593047|NCT00858832|451794261|FG000|Overall Study|became ineligible: delivered vaginally|1|||
125593048|NCT00858832|451794262|FG001|Overall Study|became ineligible: delivered vaginally|0|||
125593049|NCT00858832|451794261|FG000|Overall Study|Adverse Event|0|||
125593050|NCT00858832|451794262|FG001|Overall Study|Adverse Event|1|||
125593051|NCT00389207|451794263|FG000|Overall Study|Adverse Event|26|||
125593052|NCT00389207|451794264|FG001|Overall Study|Adverse Event|32|||
125593053|NCT00389207|451794265|FG002|Overall Study|Adverse Event|10|||
125593054|NCT00389207|451794263|FG000|Overall Study|Protocol Violation|3|||
125593055|NCT00389207|451794264|FG001|Overall Study|Protocol Violation|1|||
125593056|NCT00389207|451794265|FG002|Overall Study|Protocol Violation|4|||
125593057|NCT00389207|451794263|FG000|Overall Study|Lost to Follow-up|12|||
125593058|NCT00389207|451794264|FG001|Overall Study|Lost to Follow-up|9|||
125593059|NCT00389207|451794265|FG002|Overall Study|Lost to Follow-up|7|||
125593060|NCT00389207|451794263|FG000|Overall Study|Withdrawal by Subject|5|||
125593061|NCT00389207|451794264|FG001|Overall Study|Withdrawal by Subject|7|||
125593062|NCT00389207|451794265|FG002|Overall Study|Withdrawal by Subject|11|||
125593063|NCT00389207|451794263|FG000|Overall Study|Other|17|||
125593064|NCT00389207|451794264|FG001|Overall Study|Other|23|||
125593065|NCT00389207|451794265|FG002|Overall Study|Other|9|||
125593066|NCT01794780|451794274|FG000|Overall Study|Adverse Event|0|||
125593067|NCT01794780|451794275|FG001|Overall Study|Adverse Event|1|||
125593068|NCT01794780|451794276|FG002|Overall Study|Adverse Event|2|||
125593069|NCT01794780|451794277|FG003|Overall Study|Adverse Event|0|||
125593070|NCT01794780|451794278|FG004|Overall Study|Adverse Event|0|||
125593071|NCT01794780|451794279|FG005|Overall Study|Adverse Event|0|||
125593072|NCT01794780|451794280|FG006|Overall Study|Adverse Event|0|||
125593073|NCT01794780|451794281|FG007|Overall Study|Adverse Event|0|||
125593074|NCT01794780|451794274|FG000|Overall Study|Death|0|||
125593075|NCT01794780|451794275|FG001|Overall Study|Death|2|||
125593076|NCT01794780|451794276|FG002|Overall Study|Death|14|||
125593077|NCT01794780|451794277|FG003|Overall Study|Death|1|||
125593078|NCT01794780|451794278|FG004|Overall Study|Death|0|||
125593079|NCT01794780|451794279|FG005|Overall Study|Death|9|||
125593080|NCT01794780|451794280|FG006|Overall Study|Death|4|||
125593081|NCT01794780|451794281|FG007|Overall Study|Death|0|||
125593082|NCT01794780|451794274|FG000|Overall Study|Lost to Follow-up|10|||
125593083|NCT01794780|451794275|FG001|Overall Study|Lost to Follow-up|64|||
125593084|NCT01794780|451794276|FG002|Overall Study|Lost to Follow-up|165|||
125593085|NCT01794780|451794277|FG003|Overall Study|Lost to Follow-up|53|||
125593086|NCT01794780|451794278|FG004|Overall Study|Lost to Follow-up|2|||
125593087|NCT01794780|451794279|FG005|Overall Study|Lost to Follow-up|99|||
125593088|NCT01794780|451794280|FG006|Overall Study|Lost to Follow-up|30|||
125593089|NCT01794780|451794281|FG007|Overall Study|Lost to Follow-up|5|||
125593090|NCT01794780|451794274|FG000|Overall Study|Withdrew informed consent|7|||
125593091|NCT01794780|451794275|FG001|Overall Study|Withdrew informed consent|17|||
125593092|NCT01794780|451794276|FG002|Overall Study|Withdrew informed consent|36|||
125593093|NCT01794780|451794277|FG003|Overall Study|Withdrew informed consent|9|||
125593094|NCT01794780|451794278|FG004|Overall Study|Withdrew informed consent|0|||
125593095|NCT01794780|451794279|FG005|Overall Study|Withdrew informed consent|48|||
125593096|NCT01794780|451794280|FG006|Overall Study|Withdrew informed consent|4|||
125593097|NCT01794780|451794281|FG007|Overall Study|Withdrew informed consent|3|||
125593098|NCT01794780|451794274|FG000|Overall Study|Other|0|||
125593099|NCT01794780|451794275|FG001|Overall Study|Other|12|||
125593100|NCT01794780|451794276|FG002|Overall Study|Other|25|||
125593101|NCT01794780|451794277|FG003|Overall Study|Other|20|||
125593102|NCT01794780|451794278|FG004|Overall Study|Other|1|||
125593103|NCT01794780|451794279|FG005|Overall Study|Other|24|||
125593104|NCT01794780|451794280|FG006|Overall Study|Other|4|||
125593105|NCT01794780|451794281|FG007|Overall Study|Other|1|||
125593106|NCT02690701|451794285|FG000|Treatment Period 1|Adverse Event|2|||
125593107|NCT02690701|451794286|FG001|Treatment Period 1|Adverse Event|2|||
125593108|NCT02690701|451794285|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125593109|NCT02690701|451794286|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125593110|NCT02690701|451794285|FG000|Treatment Period 2|Adverse Event|2|||
125593111|NCT02690701|451794286|FG001|Treatment Period 2|Adverse Event|0|||
125593112|NCT02690701|451794285|FG000|Treatment Period 2|Lack of Efficacy|1|||
125593113|NCT02690701|451794286|FG001|Treatment Period 2|Lack of Efficacy|0|||
125593114|NCT02690701|451794285|FG000|Treatment Period 2|Lost to Follow-up|0|||
125593115|NCT02690701|451794286|FG001|Treatment Period 2|Lost to Follow-up|2|||
125593116|NCT02690701|451794285|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125593117|NCT02690701|451794286|FG001|Treatment Period 2|Withdrawal by Subject|2|||
125593118|NCT02690701|451794285|FG000|Treatment Period 2|Protocol Violation|0|||
125593119|NCT02690701|451794286|FG001|Treatment Period 2|Protocol Violation|1|||
125593120|NCT01442181|451794287|FG000|Overall Study|patient refused surgery|1|||
125593121|NCT01442181|451794288|FG001|Overall Study|patient refused surgery|0|||
125593122|NCT01442181|451794287|FG000|Overall Study|no insurance for surgery|1|||
125593123|NCT01442181|451794288|FG001|Overall Study|no insurance for surgery|0|||
125593124|NCT01442181|451794287|FG000|Overall Study|low ejection factor|0|||
125593125|NCT01442181|451794288|FG001|Overall Study|low ejection factor|1|||
125593126|NCT01442181|451794287|FG000|Overall Study|Lost to Follow-up|1|||
125593127|NCT01442181|451794288|FG001|Overall Study|Lost to Follow-up|1|||
125593128|NCT01442181|451794287|FG000|Overall Study|patient in an additional study|1|||
125593129|NCT01442181|451794288|FG001|Overall Study|patient in an additional study|0|||
125593130|NCT01442181|451794287|FG000|Overall Study|atrial fibrillation not noted|0|||
125593131|NCT01442181|451794288|FG001|Overall Study|atrial fibrillation not noted|1|||
125593132|NCT00749203|451794289|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
125593133|NCT00749203|451794290|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
125593134|NCT00749203|451794289|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
125593135|NCT00749203|451794290|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
125593136|NCT00749203|451794289|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
125593137|NCT00749203|451794290|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
125593138|NCT00749203|451794289|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
125593139|NCT00749203|451794290|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
125593140|NCT00749203|451794289|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
125593141|NCT00749203|451794290|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
125593142|NCT00749203|451794289|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
125593143|NCT00749203|451794290|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
125593144|NCT02853760|451794292|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
125593145|NCT02853760|451794293|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
125593146|NCT02853760|451794294|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
125593147|NCT02853760|451794295|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
125593148|NCT02853760|451794296|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
125593149|NCT02853760|451794297|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
125593150|NCT01642212|451794298|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
125593151|NCT01642212|451794299|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
125593152|NCT01642212|451794300|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
125593153|NCT01642212|451794301|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
125593154|NCT01642212|451794302|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
125593155|NCT01642212|451794298|FG000|Double-blind Treatment|Other|0|||
125593156|NCT01642212|451794299|FG001|Double-blind Treatment|Other|2|||
125593157|NCT01642212|451794300|FG002|Double-blind Treatment|Other|1|||
125593158|NCT01642212|451794301|FG003|Double-blind Treatment|Other|0|||
125593159|NCT01642212|451794302|FG004|Double-blind Treatment|Other|0|||
125593160|NCT01642212|451794298|FG000|Double-blind Treatment|Non-compliance|0|||
125593161|NCT01642212|451794299|FG001|Double-blind Treatment|Non-compliance|1|||
125593162|NCT01642212|451794300|FG002|Double-blind Treatment|Non-compliance|0|||
125593163|NCT01642212|451794301|FG003|Double-blind Treatment|Non-compliance|0|||
125593164|NCT01642212|451794302|FG004|Double-blind Treatment|Non-compliance|0|||
125593165|NCT01642212|451794298|FG000|Double-blind Treatment|Adverse Event|0|||
125593166|NCT01642212|451794299|FG001|Double-blind Treatment|Adverse Event|0|||
125593167|NCT01642212|451794300|FG002|Double-blind Treatment|Adverse Event|1|||
125593168|NCT01642212|451794301|FG003|Double-blind Treatment|Adverse Event|0|||
125593169|NCT01642212|451794302|FG004|Double-blind Treatment|Adverse Event|0|||
125593170|NCT01642212|451794298|FG000|Open-label Extension|Adverse Event|0|||
125593171|NCT01642212|451794299|FG001|Open-label Extension|Adverse Event|0|||
125593172|NCT01642212|451794300|FG002|Open-label Extension|Adverse Event|0|||
125593173|NCT01642212|451794301|FG003|Open-label Extension|Adverse Event|3|||
125593174|NCT01642212|451794302|FG004|Open-label Extension|Adverse Event|0|||
125593175|NCT01642212|451794298|FG000|Open-label Extension|Sponsor Decision|0|||
125429627|NCT04857034|451198899|FG004|Placebo-Controlled Period|Ongoing study period|0|||
125429628|NCT04857034|451198895|FG000|Active Treatment Period|Lack of Efficacy|1|||
125429629|NCT04857034|451198896|FG001|Active Treatment Period|Lack of Efficacy|0|||
125593176|NCT01642212|451794299|FG001|Open-label Extension|Sponsor Decision|0|||
125593177|NCT01642212|451794300|FG002|Open-label Extension|Sponsor Decision|0|||
125593178|NCT01642212|451794301|FG003|Open-label Extension|Sponsor Decision|7|||
125593179|NCT01642212|451794302|FG004|Open-label Extension|Sponsor Decision|4|||
125593180|NCT01642212|451794298|FG000|Open-label Extension|Consent Withdrawn|0|||
125593181|NCT01642212|451794299|FG001|Open-label Extension|Consent Withdrawn|0|||
125593182|NCT01642212|451794300|FG002|Open-label Extension|Consent Withdrawn|0|||
125593183|NCT01642212|451794301|FG003|Open-label Extension|Consent Withdrawn|0|||
125593184|NCT01642212|451794302|FG004|Open-label Extension|Consent Withdrawn|2|||
125593185|NCT01642212|451794298|FG000|Open-label Extension|Lost to Follow-up|0|||
125593186|NCT01642212|451794299|FG001|Open-label Extension|Lost to Follow-up|0|||
125593187|NCT01642212|451794300|FG002|Open-label Extension|Lost to Follow-up|0|||
125593188|NCT01642212|451794301|FG003|Open-label Extension|Lost to Follow-up|0|||
125593189|NCT01642212|451794302|FG004|Open-label Extension|Lost to Follow-up|1|||
125593190|NCT01642212|451794298|FG000|Open-label Extension|Other|0|||
125593191|NCT01642212|451794299|FG001|Open-label Extension|Other|0|||
125593192|NCT01642212|451794300|FG002|Open-label Extension|Other|0|||
125593193|NCT01642212|451794301|FG003|Open-label Extension|Other|0|||
125593194|NCT01642212|451794302|FG004|Open-label Extension|Other|1|||
125593195|NCT01299025|451794303|FG000|Overall Study|Withdrawal by Subject|2|||
125593196|NCT01299025|451794304|FG001|Overall Study|Withdrawal by Subject|1|||
125593197|NCT01299025|451794303|FG000|Overall Study|Lost to Follow-up|1|||
125593198|NCT01299025|451794304|FG001|Overall Study|Lost to Follow-up|0|||
125593199|NCT00004980|451794305|FG000|Overall Study|Withdrawal by Subject|1|||
125593200|NCT00004980|451794306|FG001|Overall Study|Withdrawal by Subject|0|||
125593201|NCT00004980|451794305|FG000|Overall Study|memory difficulties|1|||
125593202|NCT00004980|451794306|FG001|Overall Study|memory difficulties|1|||
125593203|NCT00004980|451794305|FG000|Overall Study|Physician Decision|0|||
125593204|NCT00004980|451794306|FG001|Overall Study|Physician Decision|1|||
125593205|NCT03577990|451794307|FG000|Overall Study|Lost to Follow-up|4|||
125593206|NCT03577990|451794308|FG001|Overall Study|Lost to Follow-up|6|||
125593207|NCT03577990|451794307|FG000|Overall Study|Withdrawal by Subject|4|||
125593208|NCT03577990|451794308|FG001|Overall Study|Withdrawal by Subject|7|||
125593209|NCT02793544|451794313|FG000|Overall Study|Death|10|||
125593210|NCT02793544|451794314|FG001|Overall Study|Death|8|||
125593211|NCT02793544|451794313|FG000|Overall Study|Lost to Follow-up|2|||
125593212|NCT02793544|451794314|FG001|Overall Study|Lost to Follow-up|0|||
125593213|NCT02793544|451794313|FG000|Overall Study|Withdrawal by Subject|1|||
125593214|NCT02793544|451794314|FG001|Overall Study|Withdrawal by Subject|0|||
125593215|NCT00100048|451794315|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
125593216|NCT00100048|451794316|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
125593217|NCT00100048|451794317|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
125593218|NCT00100048|451794318|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
125593219|NCT00100048|451794319|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
125593220|NCT00100048|451794320|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
125593221|NCT00100048|451794315|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
125593222|NCT00100048|451794316|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
125593223|NCT00100048|451794317|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
125593224|NCT00100048|451794318|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
125593225|NCT00100048|451794319|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
125593226|NCT00100048|451794320|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
125593227|NCT00100048|451794315|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
125593228|NCT00100048|451794316|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
125593229|NCT00100048|451794317|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
125593230|NCT00100048|451794318|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
125593231|NCT00100048|451794319|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
125593232|NCT00100048|451794320|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
125593233|NCT00100048|451794315|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
125593234|NCT00100048|451794316|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
125593235|NCT00100048|451794317|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
125593236|NCT00100048|451794318|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
125593237|NCT00100048|451794319|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
125593238|NCT00100048|451794320|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
125593239|NCT00100048|451794315|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
125593240|NCT00100048|451794316|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
125593241|NCT00100048|451794317|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
125593242|NCT00100048|451794318|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
125593243|NCT00100048|451794319|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
125593244|NCT00100048|451794320|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
125593245|NCT00100048|451794315|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
125593246|NCT00100048|451794316|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
125593247|NCT00100048|451794317|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
125593248|NCT00100048|451794318|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
125593249|NCT00100048|451794319|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
125593250|NCT00100048|451794320|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
125593251|NCT00100048|451794315|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
125593252|NCT00100048|451794316|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
125593253|NCT00100048|451794317|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
125593254|NCT00100048|451794318|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
125593255|NCT00100048|451794319|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
125593256|NCT00100048|451794320|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
125637232|NCT03073200|451952838|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
125364025|NCT01977794|450967010|FG000|Overall Study|Protocol Violation|1|||
125364026|NCT01977794|450967011|FG001|Overall Study|Protocol Violation|0|||
125364027|NCT01977794|450967010|FG000|Overall Study|Death|1|||
125364028|NCT01977794|450967011|FG001|Overall Study|Death|1|||
125364029|NCT01977794|450967010|FG000|Overall Study|Withdrew consent|2|||
125364030|NCT01977794|450967011|FG001|Overall Study|Withdrew consent|1|||
125364031|NCT01977794|450967010|FG000|Overall Study|Other|0|||
125364032|NCT01977794|450967011|FG001|Overall Study|Other|1|||
125364033|NCT00827502|450967014|FG000|Overall Study|randomized but not treated|11|||
125364034|NCT00827502|450967014|FG000|Overall Study|Adverse Event|1|||
125364035|NCT00827502|450967014|FG000|Overall Study|Lost to Follow-up|4|||
125364036|NCT00827502|450967014|FG000|Overall Study|Withdrawal by Subject|5|||
125364037|NCT01705730|450967015|FG000|Overall Study|Lack of Efficacy|1|||
125364038|NCT01705730|450967015|FG000|Overall Study|Adverse Event|3|||
125364039|NCT01705730|450967015|FG000|Overall Study|Lost to Follow-up|1|||
125364040|NCT01705730|450967015|FG000|Overall Study|Reason not Specified|4|||
125364041|NCT01773733|450967016|FG000|Overall Study|Adverse Event|3286|||
125364042|NCT01773733|450967017|FG001|Overall Study|Adverse Event|540|||
125364043|NCT01773733|450967016|FG000|Overall Study|Pregnancy|28|||
125364044|NCT01773733|450967017|FG001|Overall Study|Pregnancy|0|||
125364045|NCT01773733|450967016|FG000|Overall Study|Other different categories of not compl|55415|||
125364046|NCT01773733|450967017|FG001|Overall Study|Other different categories of not compl|7781|||
125364047|NCT03228433|450967018|FG000|Overall Study|Lost to Follow-up|1|||
125364048|NCT03228433|450967019|FG001|Overall Study|Lost to Follow-up|0|||
125364049|NCT03228433|450967020|FG002|Overall Study|Lost to Follow-up|0|||
125364050|NCT03228433|450967021|FG003|Overall Study|Lost to Follow-up|0|||
125364051|NCT03228433|450967022|FG004|Overall Study|Lost to Follow-up|0|||
125364052|NCT03228433|450967023|FG005|Overall Study|Lost to Follow-up|0|||
125364053|NCT03228433|450967018|FG000|Overall Study|Positive alcohol test|0|||
125364054|NCT03228433|450967019|FG001|Overall Study|Positive alcohol test|0|||
125364055|NCT03228433|450967020|FG002|Overall Study|Positive alcohol test|0|||
125364056|NCT03228433|450967021|FG003|Overall Study|Positive alcohol test|1|||
125364057|NCT03228433|450967022|FG004|Overall Study|Positive alcohol test|0|||
125364058|NCT03228433|450967023|FG005|Overall Study|Positive alcohol test|0|||
125364059|NCT01030536|450967024|FG000|Overall Study|Withdrawal by Subject|0|||
125364060|NCT01030536|450967025|FG001|Overall Study|Withdrawal by Subject|0|||
125364061|NCT01030536|450967026|FG002|Overall Study|Withdrawal by Subject|1|||
125364062|NCT01030536|450967027|FG003|Overall Study|Withdrawal by Subject|0|||
125364063|NCT01030536|450967028|FG004|Overall Study|Withdrawal by Subject|0|||
125364064|NCT01030536|450967024|FG000|Overall Study|undefined|1|||
125364065|NCT01030536|450967025|FG001|Overall Study|undefined|0|||
125364066|NCT01030536|450967026|FG002|Overall Study|undefined|1|||
125364067|NCT01030536|450967027|FG003|Overall Study|undefined|1|||
125364068|NCT01030536|450967028|FG004|Overall Study|undefined|0|||
125364069|NCT01030536|450967024|FG000|Overall Study|Adverse Event|0|||
125364070|NCT01030536|450967025|FG001|Overall Study|Adverse Event|3|||
125364071|NCT01030536|450967026|FG002|Overall Study|Adverse Event|1|||
125364072|NCT01030536|450967027|FG003|Overall Study|Adverse Event|0|||
125364073|NCT01030536|450967028|FG004|Overall Study|Adverse Event|1|||
125364074|NCT01030536|450967024|FG000|Overall Study|Progressive disease|6|||
125364075|NCT01030536|450967025|FG001|Overall Study|Progressive disease|2|||
125364076|NCT01030536|450967026|FG002|Overall Study|Progressive disease|3|||
125364077|NCT01030536|450967027|FG003|Overall Study|Progressive disease|2|||
125364078|NCT01030536|450967028|FG004|Overall Study|Progressive disease|0|||
125364079|NCT01030536|450967024|FG000|Overall Study|Death|0|||
125364080|NCT01030536|450967025|FG001|Overall Study|Death|1|||
125364081|NCT01030536|450967026|FG002|Overall Study|Death|0|||
125364082|NCT01030536|450967027|FG003|Overall Study|Death|0|||
125364083|NCT01030536|450967028|FG004|Overall Study|Death|0|||
125364084|NCT01330030|450967033|FG000|Overall Study|Lost to Follow-up|16|||
125364085|NCT01330030|450967034|FG001|Overall Study|Lost to Follow-up|17|||
125364086|NCT01146912|450967035|FG000|Overall Study|Already received influenza vaccination|817|||
125364087|NCT01146912|450967036|FG001|Overall Study|Already received influenza vaccination|822|||
125364088|NCT01146912|450967037|FG002|Overall Study|Already received influenza vaccination|13|||
125364089|NCT01146912|450967038|FG003|Overall Study|Already received influenza vaccination|15|||
125364090|NCT01146912|450967039|FG004|Overall Study|Already received influenza vaccination|41|||
125364091|NCT01146912|450967040|FG005|Overall Study|Already received influenza vaccination|61|||
125364092|NCT01146912|450967041|FG006|Overall Study|Already received influenza vaccination|56|||
125364093|NCT01146912|450967042|FG007|Overall Study|Already received influenza vaccination|0|||
125364094|NCT01146912|450967035|FG000|Overall Study|< 14 weeks gestational age|0|||
125364095|NCT01146912|450967036|FG001|Overall Study|< 14 weeks gestational age|0|||
125364096|NCT01146912|450967037|FG002|Overall Study|< 14 weeks gestational age|3|||
125364097|NCT01146912|450967038|FG003|Overall Study|< 14 weeks gestational age|2|||
125364098|NCT01146912|450967039|FG004|Overall Study|< 14 weeks gestational age|0|||
125364099|NCT01146912|450967040|FG005|Overall Study|< 14 weeks gestational age|0|||
125429630|NCT04857034|451198897|FG002|Active Treatment Period|Lack of Efficacy|0|||
125429631|NCT04857034|451198898|FG003|Active Treatment Period|Lack of Efficacy|0|||
125429632|NCT04857034|451198899|FG004|Active Treatment Period|Lack of Efficacy|0|||
125429633|NCT04857034|451198895|FG000|Active Treatment Period|request to discontinue|0|||
125429634|NCT04857034|451198896|FG001|Active Treatment Period|request to discontinue|1|||
125429635|NCT04857034|451198897|FG002|Active Treatment Period|request to discontinue|0|||
125429636|NCT04857034|451198898|FG003|Active Treatment Period|request to discontinue|1|||
125429637|NCT04857034|451198899|FG004|Active Treatment Period|request to discontinue|0|||
125429638|NCT04857034|451198895|FG000|Active Treatment Period|administrative reason by sponsor|1|||
125429639|NCT04857034|451198896|FG001|Active Treatment Period|administrative reason by sponsor|5|||
125429640|NCT04857034|451198897|FG002|Active Treatment Period|administrative reason by sponsor|0|||
125429641|NCT04857034|451198898|FG003|Active Treatment Period|administrative reason by sponsor|2|||
125429642|NCT04857034|451198899|FG004|Active Treatment Period|administrative reason by sponsor|2|||
125593257|NCT00100048|451794315|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
125593258|NCT00100048|451794316|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
125593259|NCT00100048|451794317|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
125593260|NCT00100048|451794318|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
125593261|NCT00100048|451794319|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
125593262|NCT00100048|451794320|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
125593263|NCT01822561|451794321|FG000|Overall Study|Withdrawal by Subject|2|||
125593264|NCT04826900|451794322|FG000|Overall Study|Family factor|1|||
125593265|NCT04826900|451794323|FG001|Overall Study|Family factor|1|||
125593266|NCT03372941|451794324|FG000|Overall Study|Lost to Follow-up|2|||
125593267|NCT03372941|451794325|FG001|Overall Study|Lost to Follow-up|4|||
125593268|NCT01126580|451794326|FG000|Overall Study|Adverse Event|14|||
125593269|NCT01126580|451794327|FG001|Overall Study|Adverse Event|8|||
125593270|NCT01126580|451794328|FG002|Overall Study|Adverse Event|12|||
125593271|NCT01126580|451794326|FG000|Overall Study|Withdrawal by Subject|11|||
125593272|NCT01126580|451794327|FG001|Overall Study|Withdrawal by Subject|19|||
125593273|NCT01126580|451794328|FG002|Overall Study|Withdrawal by Subject|14|||
125593274|NCT01126580|451794326|FG000|Overall Study|Sponsor Decision|5|||
125364100|NCT01146912|450967041|FG006|Overall Study|< 14 weeks gestational age|0|||
125364101|NCT01146912|450967042|FG007|Overall Study|< 14 weeks gestational age|0|||
125364102|NCT01146912|450967035|FG000|Overall Study|Duplicate patient|0|||
125364103|NCT01146912|450967036|FG001|Overall Study|Duplicate patient|0|||
125364104|NCT01146912|450967037|FG002|Overall Study|Duplicate patient|1|||
125364105|NCT01146912|450967038|FG003|Overall Study|Duplicate patient|0|||
125364106|NCT01146912|450967039|FG004|Overall Study|Duplicate patient|0|||
125364107|NCT01146912|450967040|FG005|Overall Study|Duplicate patient|0|||
125364108|NCT01146912|450967041|FG006|Overall Study|Duplicate patient|0|||
125364109|NCT01146912|450967042|FG007|Overall Study|Duplicate patient|0|||
125364110|NCT04891978|450967048|FG000|Baseline|Protocol Violation|2|||
125364111|NCT04891978|450967049|FG001|Baseline|Protocol Violation|1|||
125364112|NCT04891978|450967050|FG002|Baseline|Protocol Violation|0|||
125364113|NCT04891978|450967048|FG000|Baseline|Missing AIRQ|1|||
125364114|NCT04891978|450967049|FG001|Baseline|Missing AIRQ|0|||
125364115|NCT04891978|450967050|FG002|Baseline|Missing AIRQ|0|||
125429643|NCT04857034|451198895|FG000|Active Treatment Period|other reasons|1|||
125593275|NCT01126580|451794327|FG001|Overall Study|Sponsor Decision|4|||
125364116|NCT04891978|450967048|FG000|Baseline|Did not attend a baseline visit|0|||
125364117|NCT04891978|450967049|FG001|Baseline|Did not attend a baseline visit|0|||
125593276|NCT01126580|451794328|FG002|Overall Study|Sponsor Decision|7|||
125364118|NCT04891978|450967050|FG002|Baseline|Did not attend a baseline visit|9|||
125364119|NCT01781975|450967056|FG000|Overall Study|Death|1|||
125364120|NCT01781975|450967057|FG001|Overall Study|Death|0|||
125593277|NCT01126580|451794326|FG000|Overall Study|Physician Decision|1|||
125429644|NCT04857034|451198896|FG001|Active Treatment Period|other reasons|1|||
125429645|NCT04857034|451198897|FG002|Active Treatment Period|other reasons|0|||
125429646|NCT04857034|451198898|FG003|Active Treatment Period|other reasons|0|||
125429647|NCT04857034|451198899|FG004|Active Treatment Period|other reasons|1|||
125429648|NCT04857034|451198895|FG000|Active Treatment Period|Ongoing Study Period|2|||
125593278|NCT01126580|451794327|FG001|Overall Study|Physician Decision|1|||
125593279|NCT01126580|451794328|FG002|Overall Study|Physician Decision|2|||
125593280|NCT01126580|451794326|FG000|Overall Study|Entry Criteria Not Met|1|||
125593281|NCT01126580|451794327|FG001|Overall Study|Entry Criteria Not Met|1|||
125593282|NCT01126580|451794328|FG002|Overall Study|Entry Criteria Not Met|2|||
125593283|NCT01126580|451794326|FG000|Overall Study|Lack of Efficacy|2|||
125593284|NCT01126580|451794327|FG001|Overall Study|Lack of Efficacy|3|||
125593285|NCT01126580|451794328|FG002|Overall Study|Lack of Efficacy|4|||
125593286|NCT01126580|451794326|FG000|Overall Study|Protocol Violation|0|||
125593287|NCT01126580|451794327|FG001|Overall Study|Protocol Violation|1|||
125593288|NCT01126580|451794328|FG002|Overall Study|Protocol Violation|2|||
125593289|NCT01126580|451794326|FG000|Overall Study|Lost to Follow-up|15|||
125593290|NCT01126580|451794327|FG001|Overall Study|Lost to Follow-up|13|||
125593291|NCT01126580|451794328|FG002|Overall Study|Lost to Follow-up|9|||
125593292|NCT01126580|451794326|FG000|Overall Study|Treatment Non-compliance|0|||
125593293|NCT01126580|451794327|FG001|Overall Study|Treatment Non-compliance|2|||
125593294|NCT01126580|451794328|FG002|Overall Study|Treatment Non-compliance|3|||
125593295|NCT00686543|451794329|FG000|Overall Study|Adverse Event|9|||
125429649|NCT04857034|451198896|FG001|Active Treatment Period|Ongoing Study Period|4|||
125429650|NCT04857034|451198897|FG002|Active Treatment Period|Ongoing Study Period|0|||
125429651|NCT04857034|451198898|FG003|Active Treatment Period|Ongoing Study Period|1|||
125593296|NCT00686543|451794330|FG001|Overall Study|Adverse Event|1|||
125593297|NCT00686543|451794331|FG002|Overall Study|Adverse Event|3|||
125593298|NCT00686543|451794332|FG003|Overall Study|Adverse Event|2|||
125593299|NCT00686543|451794329|FG000|Overall Study|Withdrawal by Subject|2|||
125593300|NCT00686543|451794330|FG001|Overall Study|Withdrawal by Subject|0|||
125593301|NCT00686543|451794331|FG002|Overall Study|Withdrawal by Subject|0|||
125593302|NCT00686543|451794332|FG003|Overall Study|Withdrawal by Subject|0|||
125593303|NCT00686543|451794329|FG000|Overall Study|Protocol Violation|3|||
125593304|NCT00686543|451794330|FG001|Overall Study|Protocol Violation|0|||
125593305|NCT00686543|451794331|FG002|Overall Study|Protocol Violation|2|||
125593306|NCT00686543|451794332|FG003|Overall Study|Protocol Violation|1|||
125593307|NCT01708057|451794335|FG000|Overall Study|Withdrawal due to study termination.|1|||
125593308|NCT01708057|451794336|FG001|Overall Study|Withdrawal due to study termination.|1|||
125429652|NCT04857034|451198899|FG004|Active Treatment Period|Ongoing Study Period|0|||
125429653|NCT02940574|451198900|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
125429654|NCT02940574|451198901|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
125429655|NCT02940574|451198900|FG000|1-year Follow-up|Lost to Follow-up|3|||
125429656|NCT02940574|451198901|FG001|1-year Follow-up|Lost to Follow-up|4|||
125429657|NCT00387894|451198902|FG000|Overall Study|Withdrawal by Subject|1|||
125429658|NCT00659490|451198903|FG000|Overall Study|Lost to Follow-up|2|||
125429659|NCT00659490|451198904|FG001|Overall Study|Lost to Follow-up|0|||
125429660|NCT00659490|451198905|FG002|Overall Study|Lost to Follow-up|1|||
125429661|NCT05674890|451198910|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
125429662|NCT05674890|451198911|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
125429663|NCT05674890|451198910|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
125429664|NCT05674890|451198911|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
125429665|NCT05674890|451198910|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
125429666|NCT05674890|451198911|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
125429667|NCT00827541|451198912|FG000|Overall Study|Exitus|1|||
125429668|NCT00827541|451198913|FG001|Overall Study|Exitus|8|||
125429669|NCT00827541|451198912|FG000|Overall Study|Other|1|||
125429670|NCT00827541|451198913|FG001|Overall Study|Other|3|||
125429671|NCT00827541|451198912|FG000|Overall Study|Pathogen not susceptible|1|||
125429672|NCT00827541|451198913|FG001|Overall Study|Pathogen not susceptible|0|||
125593309|NCT01708057|451794337|FG002|Overall Study|Withdrawal due to study termination.|1|||
125593310|NCT00947349|451794340|FG000|Triple Treatment Combination Period|Adverse Event|0|||
125593311|NCT00947349|451794341|FG001|Triple Treatment Combination Period|Adverse Event|1|||
125593312|NCT00947349|451794342|FG002|Triple Treatment Combination Period|Adverse Event|0|||
125429673|NCT00827541|451198912|FG000|Overall Study|Lack of effectiveness|1|||
125429674|NCT00827541|451198913|FG001|Overall Study|Lack of effectiveness|0|||
125593313|NCT00947349|451794343|FG003|Triple Treatment Combination Period|Adverse Event|0|||
125593314|NCT00947349|451794340|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
125593315|NCT00947349|451794341|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
125593316|NCT00947349|451794342|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
125593317|NCT00947349|451794343|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
125593318|NCT00947349|451794340|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
125593319|NCT00947349|451794341|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
125593320|NCT00947349|451794342|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
125593321|NCT00947349|451794343|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
125593322|NCT00947349|451794340|FG000|Overall Study Standard of Care|Other|0|||
125593323|NCT00947349|451794341|FG001|Overall Study Standard of Care|Other|0|||
125593324|NCT00947349|451794342|FG002|Overall Study Standard of Care|Other|0|||
125593325|NCT00947349|451794343|FG003|Overall Study Standard of Care|Other|1|||
125593326|NCT01697345|451794344|FG000|Overall Study|Withdrawal by Subject|1|||
125593327|NCT00538681|451794345|FG000|Overall Study|Progressive Disease|7|||
125593328|NCT00538681|451794346|FG001|Overall Study|Progressive Disease|0|||
125593329|NCT00538681|451794347|FG002|Overall Study|Progressive Disease|1|||
125593330|NCT00538681|451794348|FG003|Overall Study|Progressive Disease|0|||
125593331|NCT00538681|451794345|FG000|Overall Study|Sponsor Decision|1|||
125593332|NCT00538681|451794346|FG001|Overall Study|Sponsor Decision|3|||
125593333|NCT00538681|451794347|FG002|Overall Study|Sponsor Decision|8|||
125593334|NCT00538681|451794348|FG003|Overall Study|Sponsor Decision|9|||
125593335|NCT00538681|451794345|FG000|Overall Study|Adverse Event|1|||
125593336|NCT00538681|451794346|FG001|Overall Study|Adverse Event|1|||
125593337|NCT00538681|451794347|FG002|Overall Study|Adverse Event|1|||
125364121|NCT01781975|450967056|FG000|Overall Study|Withdrawal by Subject|1|||
125593338|NCT00538681|451794348|FG003|Overall Study|Adverse Event|0|||
125593339|NCT00538681|451794345|FG000|Overall Study|Death|0|||
125593340|NCT00538681|451794346|FG001|Overall Study|Death|0|||
125593341|NCT00538681|451794347|FG002|Overall Study|Death|1|||
125593342|NCT00538681|451794348|FG003|Overall Study|Death|1|||
125593343|NCT00538681|451794345|FG000|Overall Study|Investigator Decision|0|||
125593344|NCT00538681|451794346|FG001|Overall Study|Investigator Decision|0|||
125593345|NCT00538681|451794347|FG002|Overall Study|Investigator Decision|0|||
125593346|NCT00538681|451794348|FG003|Overall Study|Investigator Decision|1|||
125593347|NCT05369806|451794349|FG000|Overall Study|Lost to Follow-up|1|||
125593348|NCT00140855|451794350|FG000|Overall Study|Progressive disease|2|||
125593349|NCT03929250|451794355|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
125593350|NCT03929250|451794356|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
125593351|NCT01097044|451794358|FG000|Overall Study|Withdrawal by Subject|4|||
125593352|NCT01097044|451794359|FG001|Overall Study|Withdrawal by Subject|4|||
125593353|NCT01097044|451794358|FG000|Overall Study|Lost to Follow-up|1|||
125593354|NCT01097044|451794359|FG001|Overall Study|Lost to Follow-up|0|||
125593355|NCT01097044|451794358|FG000|Overall Study|Withdrawal by Sponsor|0|||
125593356|NCT01097044|451794359|FG001|Overall Study|Withdrawal by Sponsor|1|||
125593357|NCT03972488|451794360|FG000|Overall Study|Progressive disease|42|||
125593358|NCT03972488|451794361|FG001|Overall Study|Progressive disease|44|||
125593359|NCT03972488|451794360|FG000|Overall Study|Physician Decision|13|||
125593360|NCT03972488|451794361|FG001|Overall Study|Physician Decision|7|||
125593361|NCT03972488|451794360|FG000|Overall Study|Adverse Event|8|||
125593362|NCT03972488|451794361|FG001|Overall Study|Adverse Event|1|||
125593363|NCT03972488|451794360|FG000|Overall Study|Death|4|||
125593364|NCT03972488|451794361|FG001|Overall Study|Death|4|||
125593365|NCT03972488|451794360|FG000|Overall Study|Withdrawal by Subject|3|||
125593366|NCT03972488|451794361|FG001|Overall Study|Withdrawal by Subject|4|||
125593367|NCT03972488|451794360|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
125593368|NCT03972488|451794361|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
125593369|NCT04865731|451794363|FG000|Overall Study|Physician Decision|2|||
125593370|NCT04865731|451794364|FG001|Overall Study|Physician Decision|1|||
125593371|NCT04865731|451794363|FG000|Overall Study|Adverse Event|1|||
125593372|NCT04865731|451794364|FG001|Overall Study|Adverse Event|0|||
125593373|NCT04865731|451794363|FG000|Overall Study|Withdrawal by Subject|0|||
125593374|NCT04865731|451794364|FG001|Overall Study|Withdrawal by Subject|1|||
125593375|NCT02770807|451794365|FG000|Overall Study|Adverse Event|3|||
125593376|NCT02770807|451794366|FG001|Overall Study|Adverse Event|3|||
125593377|NCT02770807|451794367|FG002|Overall Study|Adverse Event|1|||
125593378|NCT02770807|451794365|FG000|Overall Study|Withdrawal by Subject|7|||
125593379|NCT02770807|451794366|FG001|Overall Study|Withdrawal by Subject|3|||
125593380|NCT02770807|451794367|FG002|Overall Study|Withdrawal by Subject|4|||
125593381|NCT02770807|451794365|FG000|Overall Study|Other|0|||
125593382|NCT02770807|451794366|FG001|Overall Study|Other|1|||
125593383|NCT02770807|451794367|FG002|Overall Study|Other|0|||
125593384|NCT02770807|451794365|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
125593385|NCT02770807|451794366|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
125593386|NCT02770807|451794367|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
125593387|NCT02770807|451794365|FG000|Overall Study|Physician Decision|0|||
125593388|NCT02770807|451794366|FG001|Overall Study|Physician Decision|0|||
125593389|NCT02770807|451794367|FG002|Overall Study|Physician Decision|1|||
125593390|NCT03874234|451795818|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125593391|NCT03874234|451795819|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125593392|NCT03874234|451795820|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125593393|NCT03874234|451795821|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
125593394|NCT03874234|451795822|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125593395|NCT03874234|451795823|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125593396|NCT03874234|451795824|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125593397|NCT03874234|451795825|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125593398|NCT03874234|451795826|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125593399|NCT03874234|451795827|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125593400|NCT03874234|451795828|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125593401|NCT03874234|451795829|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125593402|NCT03874234|451795830|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
125593403|NCT03874234|451795818|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
125593404|NCT03874234|451795819|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125593405|NCT03874234|451795820|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125593406|NCT03874234|451795821|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125593407|NCT03874234|451795822|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125593408|NCT03874234|451795823|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125593409|NCT03874234|451795824|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125593410|NCT03874234|451795825|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125593411|NCT03874234|451795826|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125593412|NCT03874234|451795827|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125593413|NCT03874234|451795828|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125593414|NCT03874234|451795829|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125593415|NCT03874234|451795830|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
125593416|NCT03874234|451795818|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125593417|NCT03874234|451795819|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125593418|NCT03874234|451795820|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125593419|NCT03874234|451795821|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
125593420|NCT03874234|451795822|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125593421|NCT03874234|451795823|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125593422|NCT03874234|451795824|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125593423|NCT03874234|451795825|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125593424|NCT03874234|451795826|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125593425|NCT03874234|451795827|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125593426|NCT03874234|451795828|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125593427|NCT03874234|451795829|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125593428|NCT03874234|451795830|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
125593429|NCT03874234|451795818|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125593430|NCT03874234|451795819|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125593431|NCT03874234|451795820|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125593432|NCT03874234|451795821|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125593433|NCT03874234|451795822|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
125593434|NCT03874234|451795823|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125593435|NCT03874234|451795824|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125593436|NCT03874234|451795825|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125593437|NCT03874234|451795826|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125593438|NCT03874234|451795827|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125593439|NCT03874234|451795828|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125593440|NCT03874234|451795829|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125593441|NCT03874234|451795830|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
125593442|NCT03874234|451795818|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125593443|NCT03874234|451795819|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125593444|NCT03874234|451795820|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125593445|NCT03874234|451795821|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125593446|NCT03874234|451795822|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125593447|NCT03874234|451795823|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125593448|NCT03874234|451795824|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125593449|NCT03874234|451795825|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
125593450|NCT03874234|451795826|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125593451|NCT03874234|451795827|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125593452|NCT03874234|451795828|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125593453|NCT03874234|451795829|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125593454|NCT03874234|451795830|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
125429675|NCT02228967|451198914|FG000|Overall Study|Lost to Follow-up|146|||
125429676|NCT02228967|451198915|FG001|Overall Study|Lost to Follow-up|142|||
125429677|NCT02228967|451198914|FG000|Overall Study|Withdrawal by Subject|13|||
125429678|NCT02228967|451198915|FG001|Overall Study|Withdrawal by Subject|18|||
125429679|NCT00520975|451198916|FG000|Overall Study|Disease progression|31|||
125429680|NCT00520975|451198917|FG001|Overall Study|Disease progression|23|||
125429681|NCT00520975|451198916|FG000|Overall Study|Adverse Event|7|||
125429682|NCT00520975|451198917|FG001|Overall Study|Adverse Event|10|||
125429683|NCT00520975|451198916|FG000|Overall Study|Death|0|||
125429684|NCT00520975|451198917|FG001|Overall Study|Death|2|||
125429685|NCT00520975|451198916|FG000|Overall Study|Withdrawal by Subject|3|||
125429686|NCT00520975|451198917|FG001|Overall Study|Withdrawal by Subject|5|||
125429687|NCT00520975|451198916|FG000|Overall Study|Other therapy|2|||
125429688|NCT00520975|451198917|FG001|Overall Study|Other therapy|4|||
125429689|NCT00520975|451198916|FG000|Overall Study|Other reasons|4|||
125429690|NCT00520975|451198917|FG001|Overall Study|Other reasons|2|||
125429691|NCT00520975|451198916|FG000|Overall Study|Not start protocol therapy|1|||
125429692|NCT00520975|451198917|FG001|Overall Study|Not start protocol therapy|2|||
125429693|NCT04810221|451198918|FG000|Overall Study|Physician Decision|3|||
125429694|NCT03642938|451198919|FG000|Overall Study|Withdrawal by Subject|0|||
125429695|NCT03642938|451198920|FG001|Overall Study|Withdrawal by Subject|0|||
125429696|NCT03642938|451198921|FG002|Overall Study|Withdrawal by Subject|0|||
125429697|NCT03642938|451198922|FG003|Overall Study|Withdrawal by Subject|1|||
125429698|NCT00105235|451198923|FG000|Overall Study|Death|4|||
125429699|NCT00105235|451198923|FG000|Overall Study|Physician Decision|1|||
125429700|NCT00105235|451198923|FG000|Overall Study|Withdrawal by Subject|2|||
125429701|NCT01964326|451198924|FG000|Overall Study|Adverse Event|48|||
125429702|NCT01964326|451198924|FG000|Overall Study|Death|2|||
125429703|NCT01964326|451198924|FG000|Overall Study|Protocol Violation|4|||
125429704|NCT01964326|451198924|FG000|Overall Study|Lost to Follow-up|88|||
125429705|NCT01964326|451198924|FG000|Overall Study|Withdrawal by Subject|87|||
125429706|NCT01964326|451198924|FG000|Overall Study|Pregnancy|1|||
125429707|NCT01964326|451198924|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
125429708|NCT01964326|451198924|FG000|Overall Study|Physician Decision|55|||
125429709|NCT01964326|451198924|FG000|Overall Study|Investigator Discretion|1|||
125429710|NCT01964326|451198924|FG000|Overall Study|Other|9|||
125429711|NCT01964326|451198924|FG000|Overall Study|Did not meet eligibility criteria|1|||
125429712|NCT01995539|451198925|FG000|Overall Study|Screening Failure|1|||
125429713|NCT01995539|451198925|FG000|Overall Study|Withdrawal by Investigator|15|||
125429714|NCT01995539|451198925|FG000|Overall Study|Withdrawal by Subject|11|||
125429715|NCT01995539|451198925|FG000|Overall Study|Lost to Follow-up|5|||
125429716|NCT01995539|451198925|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
125429717|NCT00261495|451198926|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
125593455|NCT03874234|451795818|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125593456|NCT03874234|451795819|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125593457|NCT03874234|451795820|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125593458|NCT03874234|451795821|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125593459|NCT03874234|451795822|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
125593460|NCT03874234|451795823|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
125593461|NCT03874234|451795824|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125429718|NCT00261495|451198927|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
125429719|NCT00261495|451198926|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
125429720|NCT00261495|451198927|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
125429721|NCT00261495|451198926|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
125429722|NCT00261495|451198927|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
125429723|NCT00261495|451198926|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
125212277|NCT01006590|450403309|FG001|Overall Study|Withdrawal by Subject|2|||
125593462|NCT03874234|451795825|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125593463|NCT03874234|451795826|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125593464|NCT03874234|451795827|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125593465|NCT03874234|451795828|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125593466|NCT03874234|451795829|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125593467|NCT03874234|451795830|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
125593468|NCT03874234|451795818|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125593469|NCT03874234|451795819|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125593470|NCT03874234|451795820|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125593471|NCT03874234|451795821|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125593472|NCT03874234|451795822|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125593473|NCT03874234|451795823|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125593474|NCT03874234|451795824|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
125593475|NCT03874234|451795825|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125593476|NCT03874234|451795826|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125593477|NCT03874234|451795827|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125593478|NCT03874234|451795828|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125593479|NCT03874234|451795829|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125593480|NCT03874234|451795830|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
125593481|NCT03874234|451795818|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125593482|NCT03874234|451795819|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125593483|NCT03874234|451795820|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125593484|NCT03874234|451795821|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125593485|NCT03874234|451795822|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
125593486|NCT03874234|451795823|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125593487|NCT03874234|451795824|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125593488|NCT03874234|451795825|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125593489|NCT03874234|451795826|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125593490|NCT03874234|451795827|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125593491|NCT03874234|451795828|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125593492|NCT03874234|451795829|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125593493|NCT03874234|451795830|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
125593494|NCT00783289|451795831|FG000|Overall Study|Protocol Violation|0|||
125593495|NCT00783289|451795832|FG001|Overall Study|Protocol Violation|1|||
125593496|NCT00783289|451795833|FG002|Overall Study|Protocol Violation|0|||
125593497|NCT00783289|451795834|FG003|Overall Study|Protocol Violation|0|||
125593498|NCT00506389|451795835|FG000|In-treatment Period|Other|3|||
125593499|NCT00506389|451795836|FG001|In-treatment Period|Other|3|||
125593500|NCT00506389|451795837|FG002|In-treatment Period|Other|4|||
125593501|NCT00506389|451795835|FG000|In-treatment Period|Lost to Follow-up|0|||
125593502|NCT00506389|451795836|FG001|In-treatment Period|Lost to Follow-up|0|||
125593503|NCT00506389|451795837|FG002|In-treatment Period|Lost to Follow-up|1|||
125593504|NCT00506389|451795835|FG000|In-treatment Period|Lack of compliance|1|||
125593505|NCT00506389|451795836|FG001|In-treatment Period|Lack of compliance|0|||
125593506|NCT00506389|451795837|FG002|In-treatment Period|Lack of compliance|0|||
125593507|NCT00506389|451795835|FG000|In-treatment Period|Reasons not related to trial|4|||
125593508|NCT00506389|451795836|FG001|In-treatment Period|Reasons not related to trial|1|||
125593509|NCT00506389|451795837|FG002|In-treatment Period|Reasons not related to trial|0|||
125593510|NCT00506389|451795835|FG000|In-treatment Period|Withdrawal by Subject|3|||
125593511|NCT00506389|451795836|FG001|In-treatment Period|Withdrawal by Subject|3|||
125593512|NCT00506389|451795837|FG002|In-treatment Period|Withdrawal by Subject|4|||
125593513|NCT00506389|451795835|FG000|In-treatment Period|Lack of Efficacy|0|||
125364122|NCT01781975|450967057|FG001|Overall Study|Withdrawal by Subject|1|||
125593514|NCT00506389|451795836|FG001|In-treatment Period|Lack of Efficacy|2|||
125212278|NCT01006590|450403308|FG000|Overall Study|Study specific discontinuation criteria|16|||
125593515|NCT00506389|451795837|FG002|In-treatment Period|Lack of Efficacy|0|||
125593516|NCT00506389|451795835|FG000|In-treatment Period|Adverse Event|11|||
125593517|NCT00506389|451795836|FG001|In-treatment Period|Adverse Event|5|||
125593518|NCT00506389|451795837|FG002|In-treatment Period|Adverse Event|2|||
125593519|NCT00506389|451795835|FG000|In-treatment Period|Randomized but not treated|4|||
125593520|NCT00506389|451795836|FG001|In-treatment Period|Randomized but not treated|1|||
125593521|NCT00506389|451795837|FG002|In-treatment Period|Randomized but not treated|1|||
125593522|NCT01503021|451795846|FG000|Overall Study|Adverse Event|7|||
125593523|NCT01503021|451795847|FG001|Overall Study|Adverse Event|6|||
125593524|NCT01503021|451795846|FG000|Overall Study|Death|0|||
125593525|NCT01503021|451795847|FG001|Overall Study|Death|2|||
125593526|NCT01503021|451795846|FG000|Overall Study|Lost to Follow-up|2|||
125593527|NCT01503021|451795847|FG001|Overall Study|Lost to Follow-up|0|||
125593528|NCT01503021|451795846|FG000|Overall Study|Physician Decision|3|||
125593529|NCT01503021|451795847|FG001|Overall Study|Physician Decision|0|||
125593530|NCT01503021|451795846|FG000|Overall Study|Protocol Violation|1|||
125364123|NCT01622231|450967058|FG000|Overall Study|Physician Decision|1|||
125364124|NCT01622231|450967058|FG000|Overall Study|Withdrawal by Subject|1|||
125364125|NCT02589405|450967060|FG000|Overall Study|Adverse Event|3|||
125364126|NCT02589405|450967060|FG000|Overall Study|Withdrawal by Subject|1|||
125364127|NCT02264639|450967062|FG000|Overall Study|Death (after completing single-dose phase)|1|||
125364128|NCT02264639|450967063|FG001|Overall Study|Death (after completing single-dose phase)|0|||
125364129|NCT02264639|450967064|FG002|Overall Study|Death (after completing single-dose phase)|0|||
125364130|NCT02264639|450967065|FG003|Overall Study|Death (after completing single-dose phase)|0|||
125364131|NCT02264639|450967066|FG004|Overall Study|Death (after completing single-dose phase)|0|||
125364132|NCT02264639|450967062|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
125364133|NCT02264639|450967063|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
125364134|NCT02264639|450967064|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
125364135|NCT02264639|450967065|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
125364136|NCT02264639|450967066|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
125364137|NCT02264639|450967062|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
125364138|NCT02264639|450967063|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
125364139|NCT02264639|450967064|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
125364140|NCT02264639|450967065|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
125364141|NCT02264639|450967066|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
125364142|NCT02264639|450967062|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
125364143|NCT02264639|450967063|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
125364144|NCT02264639|450967064|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
125364145|NCT02264639|450967065|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
125364146|NCT02264639|450967066|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
125364147|NCT04889222|450967070|FG000|Overall Study|Did not meet eligibility criteria|8|||
125364148|NCT04889222|450967070|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
125364149|NCT04889222|450967070|FG000|Overall Study|Did not proceed due to time constraints|5|||
125364150|NCT01180647|450967071|FG000|Overall Study|Lost to Follow-up|5|||
125364151|NCT01180647|450967072|FG001|Overall Study|Lost to Follow-up|6|||
125364152|NCT00702689|450967075|FG000|Overall Study|Withdrawal by Subject|4|||
125364153|NCT00702689|450967075|FG000|Overall Study|Recurrent malignancy|1|||
125364154|NCT00702689|450967075|FG000|Overall Study|Adverse Event|1|||
125364155|NCT02846324|450967078|FG000|Overall Study|Other|1|||
125364156|NCT02846324|450967079|FG001|Overall Study|Other|0|||
125364157|NCT02846324|450967080|FG002|Overall Study|Other|0|||
125364158|NCT02846324|450967081|FG003|Overall Study|Other|0|||
125364159|NCT02846324|450967078|FG000|Overall Study|Withdrawal by Subject|1|||
125364160|NCT02846324|450967079|FG001|Overall Study|Withdrawal by Subject|0|||
125364161|NCT02846324|450967080|FG002|Overall Study|Withdrawal by Subject|4|||
125364162|NCT02846324|450967081|FG003|Overall Study|Withdrawal by Subject|0|||
125364163|NCT02716805|450967088|FG000|Overall Study|Progressive disease|2|||
125364164|NCT02716805|450967089|FG001|Overall Study|Progressive disease|0|||
125364165|NCT02716805|450967090|FG002|Overall Study|Progressive disease|0|||
125364166|NCT02716805|450967091|FG003|Overall Study|Progressive disease|0|||
125364167|NCT03208127|450967098|FG000|Overall Study|Death|1|||
125364168|NCT02121522|450967103|FG000|Overall Study|Adverse Event|1|||
125364169|NCT01903031|450967105|FG000|Overall Study|Not Able to Attend Clinic|1|||
125364170|NCT01903031|450967106|FG001|Overall Study|Not Able to Attend Clinic|1|||
125364171|NCT01903031|450967107|FG002|Overall Study|Not Able to Attend Clinic|0|||
125364172|NCT01903031|450967105|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
125364173|NCT01903031|450967106|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
125364174|NCT01903031|450967107|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
125364175|NCT01903031|450967105|FG000|Overall Study|Adverse Event|0|||
125364176|NCT01903031|450967106|FG001|Overall Study|Adverse Event|1|||
125364177|NCT01903031|450967107|FG002|Overall Study|Adverse Event|0|||
125364178|NCT01903031|450967105|FG000|Overall Study|Withdrawal by Subject|0|||
125364179|NCT01903031|450967106|FG001|Overall Study|Withdrawal by Subject|1|||
125364180|NCT01903031|450967107|FG002|Overall Study|Withdrawal by Subject|1|||
125364181|NCT01903031|450967105|FG000|Overall Study|Protocol Violation|0|||
125364182|NCT01903031|450967106|FG001|Overall Study|Protocol Violation|0|||
125364183|NCT01903031|450967107|FG002|Overall Study|Protocol Violation|2|||
125364184|NCT01903031|450967105|FG000|Overall Study|Lost to Follow-up|0|||
125364185|NCT01903031|450967106|FG001|Overall Study|Lost to Follow-up|0|||
125364186|NCT01903031|450967107|FG002|Overall Study|Lost to Follow-up|1|||
125364187|NCT01903031|450967105|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
125364188|NCT01903031|450967106|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
125364189|NCT01903031|450967107|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
125364190|NCT03540030|450967108|FG000|Overall Study|Withdrawal by Subject|2|||
125593531|NCT01503021|451795847|FG001|Overall Study|Protocol Violation|3|||
125593532|NCT01503021|451795846|FG000|Overall Study|Withdrawal by Subject|9|||
125593533|NCT01503021|451795847|FG001|Overall Study|Withdrawal by Subject|8|||
125593534|NCT01503021|451795846|FG000|Overall Study|Moved, received transplant, etc.|5|||
125593535|NCT01503021|451795847|FG001|Overall Study|Moved, received transplant, etc.|7|||
125593536|NCT00283387|451795855|FG000|First Intervention|Subject non-compliant|1|||
125593537|NCT00283387|451795856|FG001|First Intervention|Subject non-compliant|1|||
125593538|NCT00283387|451795855|FG000|First Intervention|Withdrawal by Subject|0|||
125593539|NCT00283387|451795856|FG001|First Intervention|Withdrawal by Subject|1|||
125593540|NCT01931865|451795857|FG000|Overall Study|Lost to Follow-up|2|||
125593541|NCT01931865|451795857|FG000|Overall Study|Withdrawal by Subject|2|||
125593542|NCT00446030|451795858|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
125593543|NCT00446030|451795859|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
125593544|NCT00446030|451795858|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
125593545|NCT00446030|451795859|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
125593546|NCT00446030|451795858|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
125593547|NCT00446030|451795859|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
125593548|NCT00446030|451795858|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
125593549|NCT00446030|451795859|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
125593550|NCT00446030|451795858|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
125593551|NCT00446030|451795859|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
125593552|NCT00446030|451795858|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
125593553|NCT00446030|451795859|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
125593554|NCT00446030|451795858|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
125593555|NCT00446030|451795859|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
125593556|NCT00446030|451795858|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
125593557|NCT00446030|451795859|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
125593558|NCT00446030|451795858|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
125593559|NCT00446030|451795859|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
125593560|NCT00446030|451795858|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
125593561|NCT00446030|451795859|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
125593562|NCT00446030|451795858|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
125593563|NCT00446030|451795859|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
125593564|NCT00446030|451795858|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
125593565|NCT00446030|451795859|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
125593566|NCT00446030|451795858|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
125593567|NCT00446030|451795859|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
125593568|NCT00446030|451795858|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
125593569|NCT00446030|451795859|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
125593570|NCT00446030|451795858|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
125593571|NCT00446030|451795859|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
125593572|NCT00446030|451795858|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
125593573|NCT00446030|451795859|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
125593574|NCT00446030|451795858|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
125593575|NCT00446030|451795859|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
125593576|NCT00446030|451795858|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
125364191|NCT03540030|450967109|FG001|Overall Study|Withdrawal by Subject|1|||
125593577|NCT00446030|451795859|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
125593578|NCT00446030|451795858|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
125593579|NCT00446030|451795859|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
125593580|NCT02886715|451795862|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125593581|NCT02886715|451795863|FG001|Overall Study|Non-Compliance With Study Drug|2|||
125593582|NCT02886715|451795864|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125593583|NCT02886715|451795862|FG000|Overall Study|Adverse Event|4|||
125364192|NCT03540030|450967108|FG000|Overall Study|screen fail|7|||
125593584|NCT02886715|451795863|FG001|Overall Study|Adverse Event|2|||
125593585|NCT02886715|451795864|FG002|Overall Study|Adverse Event|0|||
125593586|NCT02886715|451795862|FG000|Overall Study|Lack of Efficacy|0|||
125593587|NCT02886715|451795863|FG001|Overall Study|Lack of Efficacy|2|||
125593588|NCT02886715|451795864|FG002|Overall Study|Lack of Efficacy|1|||
125593589|NCT02886715|451795862|FG000|Overall Study|Lost to Follow-up|29|||
125593590|NCT02886715|451795863|FG001|Overall Study|Lost to Follow-up|26|||
125593591|NCT02886715|451795864|FG002|Overall Study|Lost to Follow-up|10|||
125593592|NCT02886715|451795862|FG000|Overall Study|Pregnancy|1|||
125593593|NCT02886715|451795863|FG001|Overall Study|Pregnancy|1|||
125593594|NCT02886715|451795864|FG002|Overall Study|Pregnancy|1|||
125593595|NCT02886715|451795862|FG000|Overall Study|Protocol Violation|3|||
125593596|NCT02886715|451795863|FG001|Overall Study|Protocol Violation|2|||
125593597|NCT02886715|451795864|FG002|Overall Study|Protocol Violation|1|||
125593598|NCT02886715|451795862|FG000|Overall Study|Withdrawal by Subject|20|||
125593599|NCT02886715|451795863|FG001|Overall Study|Withdrawal by Subject|18|||
125593600|NCT02886715|451795864|FG002|Overall Study|Withdrawal by Subject|5|||
125593601|NCT02886715|451795862|FG000|Overall Study|missing|7|||
125593602|NCT02886715|451795863|FG001|Overall Study|missing|2|||
125593603|NCT02886715|451795864|FG002|Overall Study|missing|2|||
125593604|NCT00503399|451795865|FG000|Overall Study|Death|2|||
125593605|NCT00503399|451795866|FG001|Overall Study|Death|1|||
125593606|NCT00503399|451795865|FG000|Overall Study|Protocol Violation|1|||
125593607|NCT00503399|451795866|FG001|Overall Study|Protocol Violation|0|||
125593608|NCT00503399|451795865|FG000|Overall Study|Withdrawal by Subject|4|||
125593609|NCT00503399|451795866|FG001|Overall Study|Withdrawal by Subject|2|||
125593610|NCT00503399|451795865|FG000|Overall Study|Adverse Event|0|||
125593611|NCT00503399|451795866|FG001|Overall Study|Adverse Event|3|||
125593612|NCT00503399|451795865|FG000|Overall Study|Lost to Follow-up|0|||
125364193|NCT03540030|450967109|FG001|Overall Study|screen fail|1|||
125364194|NCT03540030|450967108|FG000|Overall Study|never had surgery after signing consent|9|||
125364195|NCT03540030|450967109|FG001|Overall Study|never had surgery after signing consent|1|||
125364196|NCT03666624|450967111|FG000|Overall Study|participant grieving over recent death of parent|1|||
125364197|NCT03666624|450967112|FG001|Overall Study|participant grieving over recent death of parent|0|||
125364198|NCT00569270|450967117|FG000|Period: First Intervention|Protocol Violation|0|||
125364199|NCT00569270|450967118|FG001|Period: First Intervention|Protocol Violation|1|||
125593613|NCT00503399|451795866|FG001|Overall Study|Lost to Follow-up|2|||
125593614|NCT03812510|451795867|FG000|Overall Study|Lost to Follow-up|39|||
125593615|NCT03812510|451795867|FG000|Overall Study|Withdrawal by Subject|42|||
125593616|NCT03812510|451795867|FG000|Overall Study|Physician Decision|2|||
125593617|NCT03812510|451795867|FG000|Overall Study|Study Terminated by Sponsor|9|||
125593618|NCT03812510|451795867|FG000|Overall Study|Did Not Start Study Medication|55|||
125593619|NCT03812510|451795867|FG000|Overall Study|Adverse Event|5|||
125593620|NCT00768560|451795868|FG000|Intervention Set 1|Adverse Event|0|||
125593621|NCT00768560|451795869|FG001|Intervention Set 1|Adverse Event|1|||
125593622|NCT00768560|451795870|FG002|Intervention Set 1|Adverse Event|0|||
125593623|NCT00768560|451795871|FG003|Intervention Set 1|Adverse Event|0|||
125593624|NCT00768560|451795872|FG004|Intervention Set 1|Adverse Event|0|||
125593625|NCT00768560|451795873|FG005|Intervention Set 1|Adverse Event|0|||
125593626|NCT01120626|451795874|FG000|Overall Study|Withdrawal by Subject|1|||
125593627|NCT01120626|451795875|FG001|Overall Study|Withdrawal by Subject|0|||
125593628|NCT01073943|451795878|FG000|Overall Study|Withdrawal by Subject|8|||
125593629|NCT01073943|451795879|FG001|Overall Study|Withdrawal by Subject|2|||
125593630|NCT01073943|451795878|FG000|Overall Study|Protocol Violation|2|||
125593631|NCT01073943|451795879|FG001|Overall Study|Protocol Violation|1|||
125593632|NCT01073943|451795878|FG000|Overall Study|Adverse Event|1|||
125593633|NCT01073943|451795879|FG001|Overall Study|Adverse Event|1|||
125593634|NCT01073943|451795878|FG000|Overall Study|Lost to Follow-up|0|||
125593635|NCT01073943|451795879|FG001|Overall Study|Lost to Follow-up|2|||
125593636|NCT01073943|451795878|FG000|Overall Study|Power outage; colonoscopy not done|1|||
125593637|NCT01073943|451795879|FG001|Overall Study|Power outage; colonoscopy not done|0|||
125593638|NCT01073943|451795878|FG000|Overall Study|Subject forgot|0|||
125593639|NCT01073943|451795879|FG001|Overall Study|Subject forgot|1|||
125593640|NCT01073943|451795878|FG000|Overall Study|Unable to return for follow-up|0|||
125593641|NCT01073943|451795879|FG001|Overall Study|Unable to return for follow-up|1|||
125593642|NCT01073943|451795878|FG000|Overall Study|Could not tolerate prep|1|||
125593643|NCT01073943|451795879|FG001|Overall Study|Could not tolerate prep|0|||
125593644|NCT03527043|451795886|FG000|Overall Study|Withdrawal by Subject|1|||
125593645|NCT03527043|451795887|FG001|Overall Study|Withdrawal by Subject|0|||
125593646|NCT03830281|451795888|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
125593647|NCT03830281|451795889|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
125364200|NCT00447005|450967119|FG000|Overall Study|Adverse Event|1|||
125364201|NCT00447005|450967119|FG000|Overall Study|Lack of Efficacy|11|||
125364202|NCT03822182|450967123|FG000|Overall Study|Protocol Violation|0|||
125364203|NCT03822182|450967124|FG001|Overall Study|Protocol Violation|1|||
125364204|NCT03822182|450967125|FG002|Overall Study|Protocol Violation|1|||
125364205|NCT00810355|450967126|FG000|Overall Study|Lost to Follow-up|13|||
125364206|NCT00810355|450967127|FG001|Overall Study|Lost to Follow-up|17|||
125364207|NCT00810355|450967128|FG002|Overall Study|Lost to Follow-up|11|||
125364208|NCT00810355|450967126|FG000|Overall Study|Withdrawal by Subject|1|||
125364209|NCT00810355|450967127|FG001|Overall Study|Withdrawal by Subject|0|||
125364210|NCT00810355|450967128|FG002|Overall Study|Withdrawal by Subject|0|||
125364211|NCT01484275|450967129|FG000|Overall Study|Study terminated by sponsor|28|||
125364212|NCT01484275|450967130|FG001|Overall Study|Study terminated by sponsor|32|||
125364213|NCT01484275|450967129|FG000|Overall Study|Other|10|||
125364214|NCT01484275|450967130|FG001|Overall Study|Other|0|||
125364215|NCT01484275|450967129|FG000|Overall Study|Death|3|||
125364216|NCT01484275|450967130|FG001|Overall Study|Death|4|||
125364217|NCT01484275|450967129|FG000|Overall Study|Withdrawal by Subject|1|||
125364218|NCT01484275|450967130|FG001|Overall Study|Withdrawal by Subject|5|||
125364219|NCT01484275|450967129|FG000|Overall Study|Lost to Follow-up|1|||
125364220|NCT01484275|450967130|FG001|Overall Study|Lost to Follow-up|1|||
125593648|NCT03830281|451795888|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
125593649|NCT03830281|451795889|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
125593650|NCT03830281|451795888|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
125593651|NCT03830281|451795889|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
125593652|NCT03830281|451795888|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
125593653|NCT03830281|451795889|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
125593654|NCT03830281|451795888|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
125593655|NCT03830281|451795889|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
125593656|NCT03830281|451795888|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
125364221|NCT00003487|450967131|FG000|Overall Study|Not evaluable|2|||
125364222|NCT04154930|450967134|FG000|Overall Study|Withdrawal by Subject|15|||
125364223|NCT04154930|450967135|FG001|Overall Study|Withdrawal by Subject|6|||
125364224|NCT04154930|450967134|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
125593657|NCT03830281|451795889|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
125593658|NCT03830281|451795888|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
125593659|NCT03830281|451795889|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
125593660|NCT03830281|451795888|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
125593661|NCT03830281|451795889|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
125593662|NCT03830281|451795888|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
125593663|NCT03830281|451795889|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
125593664|NCT01985321|451795890|FG000|Overall Study|Protocol Violation|4|||
125593665|NCT01985321|451795891|FG001|Overall Study|Protocol Violation|3|||
125593666|NCT01985321|451795890|FG000|Overall Study|Withdrawal by Subject|1|||
125593667|NCT01985321|451795891|FG001|Overall Study|Withdrawal by Subject|0|||
125593668|NCT01985321|451795890|FG000|Overall Study|Lost to Follow-up|5|||
125593669|NCT01985321|451795891|FG001|Overall Study|Lost to Follow-up|2|||
125593670|NCT01985321|451795890|FG000|Overall Study|Subject treated wrong type of sore|1|||
125593671|NCT01985321|451795891|FG001|Overall Study|Subject treated wrong type of sore|0|||
125593672|NCT03293680|451795892|FG000|Overall Study|Death|1|||
125593673|NCT03293680|451795892|FG000|Overall Study|Did not meet inclusion criteria|8|||
125593674|NCT02201940|451795893|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
125593675|NCT02201940|451795894|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
125593676|NCT02201940|451795893|FG000|Overall Study|Lack of Efficacy|2|||
125593677|NCT02201940|451795894|FG001|Overall Study|Lack of Efficacy|113|||
125593678|NCT02201940|451795893|FG000|Overall Study|Lost to Follow-up|5|||
125593679|NCT02201940|451795894|FG001|Overall Study|Lost to Follow-up|0|||
125593680|NCT02201940|451795893|FG000|Overall Study|Withdrew Consent|2|||
125593681|NCT02201940|451795894|FG001|Overall Study|Withdrew Consent|1|||
125593682|NCT02201940|451795893|FG000|Overall Study|Investigator's Discretion|1|||
125593683|NCT02201940|451795894|FG001|Overall Study|Investigator's Discretion|1|||
125593684|NCT02201940|451795893|FG000|Overall Study|Death|1|||
125593685|NCT02201940|451795894|FG001|Overall Study|Death|0|||
125593686|NCT02201940|451795893|FG000|Overall Study|Adverse Event|0|||
125593687|NCT02201940|451795894|FG001|Overall Study|Adverse Event|1|||
125593688|NCT03192904|451795895|FG000|Overall Study|Physician Decision|3|||
125593689|NCT03192904|451795896|FG001|Overall Study|Physician Decision|1|||
125593690|NCT03192904|451795895|FG000|Overall Study|Lost to Follow-up|0|||
125593691|NCT03192904|451795896|FG001|Overall Study|Lost to Follow-up|1|||
125593692|NCT01309737|451795897|FG000|Week 0 to 16|Death|1|||
125593693|NCT01309737|451795898|FG001|Week 0 to 16|Death|0|||
125593694|NCT01309737|451795899|FG002|Week 0 to 16|Death|1|||
125593695|NCT01309737|451795900|FG003|Week 0 to 16|Death|0|||
125593696|NCT01309737|451795901|FG004|Week 0 to 16|Death|0|||
125593697|NCT01309737|451795897|FG000|Week 0 to 16|Adverse Event|11|||
125593698|NCT01309737|451795898|FG001|Week 0 to 16|Adverse Event|10|||
125593699|NCT01309737|451795899|FG002|Week 0 to 16|Adverse Event|5|||
125593700|NCT01309737|451795900|FG003|Week 0 to 16|Adverse Event|0|||
125593701|NCT01309737|451795901|FG004|Week 0 to 16|Adverse Event|0|||
125593702|NCT01309737|451795897|FG000|Week 0 to 16|Lack of Efficacy|15|||
125593703|NCT01309737|451795898|FG001|Week 0 to 16|Lack of Efficacy|2|||
125593704|NCT01309737|451795899|FG002|Week 0 to 16|Lack of Efficacy|24|||
125593705|NCT01309737|451795900|FG003|Week 0 to 16|Lack of Efficacy|0|||
125593706|NCT01309737|451795901|FG004|Week 0 to 16|Lack of Efficacy|0|||
125593707|NCT01309737|451795897|FG000|Week 0 to 16|Lost to Follow-up|7|||
125593708|NCT01309737|451795898|FG001|Week 0 to 16|Lost to Follow-up|8|||
125593709|NCT01309737|451795899|FG002|Week 0 to 16|Lost to Follow-up|3|||
125593710|NCT01309737|451795900|FG003|Week 0 to 16|Lost to Follow-up|0|||
125593711|NCT01309737|451795901|FG004|Week 0 to 16|Lost to Follow-up|0|||
125593712|NCT01309737|451795897|FG000|Week 0 to 16|Withdrawal by Subject|7|||
125593713|NCT01309737|451795898|FG001|Week 0 to 16|Withdrawal by Subject|6|||
125593714|NCT01309737|451795899|FG002|Week 0 to 16|Withdrawal by Subject|7|||
125593715|NCT01309737|451795900|FG003|Week 0 to 16|Withdrawal by Subject|0|||
125593716|NCT01309737|451795901|FG004|Week 0 to 16|Withdrawal by Subject|0|||
125593717|NCT01309737|451795897|FG000|Week 0 to 16|Other|10|||
125593718|NCT01309737|451795898|FG001|Week 0 to 16|Other|14|||
125593719|NCT01309737|451795899|FG002|Week 0 to 16|Other|4|||
125593720|NCT01309737|451795900|FG003|Week 0 to 16|Other|0|||
125593721|NCT01309737|451795901|FG004|Week 0 to 16|Other|0|||
125364225|NCT04154930|450967135|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
125364226|NCT04154930|450967134|FG000|Overall Study|Lost to Follow-up|14|||
125364227|NCT04154930|450967135|FG001|Overall Study|Lost to Follow-up|6|||
125364228|NCT04154930|450967134|FG000|Overall Study|Other|6|||
125364229|NCT04154930|450967135|FG001|Overall Study|Other|0|||
125364230|NCT03855228|450967139|FG000|Overall Study|Adverse Event|2|||
125364231|NCT03855228|450967140|FG001|Overall Study|Adverse Event|4|||
125364232|NCT03855228|450967141|FG002|Overall Study|Adverse Event|4|||
125364233|NCT03855228|450967142|FG003|Overall Study|Adverse Event|8|||
125364234|NCT03855228|450967139|FG000|Overall Study|Treatment Failure|1|||
125364235|NCT03855228|450967140|FG001|Overall Study|Treatment Failure|2|||
125364236|NCT03855228|450967141|FG002|Overall Study|Treatment Failure|1|||
125364237|NCT03855228|450967142|FG003|Overall Study|Treatment Failure|8|||
125364238|NCT03855228|450967139|FG000|Overall Study|Lost to Follow-up|0|||
125364239|NCT03855228|450967140|FG001|Overall Study|Lost to Follow-up|0|||
125364240|NCT03855228|450967141|FG002|Overall Study|Lost to Follow-up|0|||
125364241|NCT03855228|450967142|FG003|Overall Study|Lost to Follow-up|1|||
125364242|NCT03855228|450967139|FG000|Overall Study|Protocol Violation|0|||
125364243|NCT03855228|450967140|FG001|Overall Study|Protocol Violation|1|||
125364244|NCT03855228|450967141|FG002|Overall Study|Protocol Violation|2|||
125364245|NCT03855228|450967142|FG003|Overall Study|Protocol Violation|1|||
125364246|NCT03855228|450967139|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
125364247|NCT03855228|450967140|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
125364248|NCT03855228|450967141|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
125364249|NCT03855228|450967142|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
125364250|NCT01893203|450967144|FG000|Overall Study|Withdrawal by Subject|1|||
125364251|NCT02130297|450967145|FG000|Overall Study|Lost to Follow-up|4|||
125364252|NCT00347360|450967156|FG000|Overall Study|Adverse Event|1|||
125364253|NCT00347360|450967157|FG001|Overall Study|Adverse Event|2|||
125364254|NCT00347360|450967158|FG002|Overall Study|Adverse Event|0|||
125364255|NCT00347360|450967159|FG003|Overall Study|Adverse Event|4|||
125364256|NCT00347360|450967160|FG004|Overall Study|Adverse Event|1|||
125364257|NCT00347360|450967161|FG005|Overall Study|Adverse Event|2|||
125364258|NCT00347360|450967162|FG006|Overall Study|Adverse Event|2|||
125364259|NCT00347360|450967163|FG007|Overall Study|Adverse Event|0|||
125364260|NCT00347360|450967164|FG008|Overall Study|Adverse Event|2|||
125364261|NCT00347360|450967165|FG009|Overall Study|Adverse Event|3|||
125364262|NCT00347360|450967166|FG010|Overall Study|Adverse Event|3|||
125364263|NCT00347360|450967167|FG011|Overall Study|Adverse Event|1|||
125364264|NCT00347360|450967168|FG012|Overall Study|Adverse Event|3|||
125364265|NCT00347360|450967169|FG013|Overall Study|Adverse Event|2|||
125364266|NCT00347360|450967170|FG014|Overall Study|Adverse Event|2|||
125364267|NCT00347360|450967156|FG000|Overall Study|Lost to Follow-up|0|||
125364268|NCT00347360|450967157|FG001|Overall Study|Lost to Follow-up|0|||
125364269|NCT00347360|450967158|FG002|Overall Study|Lost to Follow-up|0|||
125364270|NCT00347360|450967159|FG003|Overall Study|Lost to Follow-up|2|||
125364271|NCT00347360|450967160|FG004|Overall Study|Lost to Follow-up|1|||
125364272|NCT00347360|450967161|FG005|Overall Study|Lost to Follow-up|1|||
125364273|NCT00347360|450967162|FG006|Overall Study|Lost to Follow-up|0|||
125364274|NCT00347360|450967163|FG007|Overall Study|Lost to Follow-up|1|||
125364275|NCT00347360|450967164|FG008|Overall Study|Lost to Follow-up|1|||
125364276|NCT00347360|450967165|FG009|Overall Study|Lost to Follow-up|2|||
125364277|NCT00347360|450967166|FG010|Overall Study|Lost to Follow-up|0|||
125364278|NCT00347360|450967167|FG011|Overall Study|Lost to Follow-up|0|||
125364279|NCT00347360|450967168|FG012|Overall Study|Lost to Follow-up|1|||
125364280|NCT00347360|450967169|FG013|Overall Study|Lost to Follow-up|0|||
125364281|NCT00347360|450967170|FG014|Overall Study|Lost to Follow-up|0|||
125364282|NCT00347360|450967156|FG000|Overall Study|Protocol Violation|2|||
125364283|NCT00347360|450967157|FG001|Overall Study|Protocol Violation|3|||
125364284|NCT00347360|450967158|FG002|Overall Study|Protocol Violation|1|||
125364285|NCT00347360|450967159|FG003|Overall Study|Protocol Violation|2|||
125364286|NCT00347360|450967160|FG004|Overall Study|Protocol Violation|1|||
125364287|NCT00347360|450967161|FG005|Overall Study|Protocol Violation|2|||
125364288|NCT00347360|450967162|FG006|Overall Study|Protocol Violation|0|||
125364289|NCT00347360|450967163|FG007|Overall Study|Protocol Violation|0|||
125364290|NCT00347360|450967164|FG008|Overall Study|Protocol Violation|1|||
125364291|NCT00347360|450967165|FG009|Overall Study|Protocol Violation|2|||
125364292|NCT00347360|450967166|FG010|Overall Study|Protocol Violation|0|||
125364293|NCT00347360|450967167|FG011|Overall Study|Protocol Violation|0|||
125364294|NCT00347360|450967168|FG012|Overall Study|Protocol Violation|0|||
125364295|NCT00347360|450967169|FG013|Overall Study|Protocol Violation|1|||
125364296|NCT00347360|450967170|FG014|Overall Study|Protocol Violation|0|||
125212279|NCT01006590|450403309|FG001|Overall Study|Study specific discontinuation criteria|23|||
125212280|NCT01006590|450403308|FG000|Overall Study|Other|3|||
125212281|NCT01006590|450403309|FG001|Overall Study|Other|2|||
125212282|NCT00329745|450403310|FG000|Overall Study|Protocol Violation|1|||
125212283|NCT00329745|450403311|FG001|Overall Study|Protocol Violation|0|||
125212284|NCT00329745|450403310|FG000|Overall Study|Withdrawal by Subject|0|||
125212285|NCT00329745|450403311|FG001|Overall Study|Withdrawal by Subject|1|||
125212286|NCT00329745|450403310|FG000|Overall Study|Lost to Follow-up|86|||
125212287|NCT00329745|450403311|FG001|Overall Study|Lost to Follow-up|101|||
125212288|NCT02700698|450403315|FG000|Overall Study|Withdrawal by Subject|1|||
125212289|NCT02700698|450403316|FG001|Overall Study|Withdrawal by Subject|0|||
125212290|NCT00703118|450403317|FG000|Overall Study|Adverse Event|1|||
125212291|NCT00703118|450403318|FG001|Overall Study|Adverse Event|2|||
125212292|NCT00703118|450403319|FG002|Overall Study|Adverse Event|2|||
125212293|NCT00703118|450403317|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
125212294|NCT00703118|450403318|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
125212295|NCT00703118|450403319|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
125593722|NCT01309737|451795897|FG000|Week 0 to 16|Randomized, but not treated|1|||
125593723|NCT01309737|451795898|FG001|Week 0 to 16|Randomized, but not treated|0|||
125593724|NCT01309737|451795899|FG002|Week 0 to 16|Randomized, but not treated|0|||
125593725|NCT01309737|451795900|FG003|Week 0 to 16|Randomized, but not treated|0|||
125593726|NCT01309737|451795901|FG004|Week 0 to 16|Randomized, but not treated|0|||
125593727|NCT01309737|451795897|FG000|Week 16 to 52|Death|0|||
125593728|NCT01309737|451795898|FG001|Week 16 to 52|Death|0|||
125593729|NCT01309737|451795899|FG002|Week 16 to 52|Death|0|||
125593730|NCT01309737|451795900|FG003|Week 16 to 52|Death|0|||
125593731|NCT01309737|451795901|FG004|Week 16 to 52|Death|1|||
125593732|NCT01309737|451795897|FG000|Week 16 to 52|Adverse Event|7|||
125593733|NCT01309737|451795898|FG001|Week 16 to 52|Adverse Event|7|||
125593734|NCT01309737|451795899|FG002|Week 16 to 52|Adverse Event|0|||
125593735|NCT01309737|451795900|FG003|Week 16 to 52|Adverse Event|6|||
125593736|NCT01309737|451795901|FG004|Week 16 to 52|Adverse Event|5|||
125593737|NCT01309737|451795897|FG000|Week 16 to 52|Lack of Efficacy|107|||
125593738|NCT01309737|451795898|FG001|Week 16 to 52|Lack of Efficacy|76|||
125593739|NCT01309737|451795899|FG002|Week 16 to 52|Lack of Efficacy|0|||
125593740|NCT01309737|451795900|FG003|Week 16 to 52|Lack of Efficacy|25|||
125593741|NCT01309737|451795901|FG004|Week 16 to 52|Lack of Efficacy|21|||
125593742|NCT01309737|451795897|FG000|Week 16 to 52|Lost to Follow-up|4|||
125593743|NCT01309737|451795898|FG001|Week 16 to 52|Lost to Follow-up|2|||
125593744|NCT01309737|451795899|FG002|Week 16 to 52|Lost to Follow-up|0|||
125593745|NCT01309737|451795900|FG003|Week 16 to 52|Lost to Follow-up|1|||
125593746|NCT01309737|451795901|FG004|Week 16 to 52|Lost to Follow-up|4|||
125593747|NCT01309737|451795897|FG000|Week 16 to 52|Withdrawal by Subject|5|||
125593748|NCT01309737|451795898|FG001|Week 16 to 52|Withdrawal by Subject|6|||
125593749|NCT01309737|451795899|FG002|Week 16 to 52|Withdrawal by Subject|0|||
125593750|NCT01309737|451795900|FG003|Week 16 to 52|Withdrawal by Subject|0|||
125593751|NCT01309737|451795901|FG004|Week 16 to 52|Withdrawal by Subject|2|||
125593752|NCT01309737|451795897|FG000|Week 16 to 52|Other|10|||
125593753|NCT01309737|451795898|FG001|Week 16 to 52|Other|12|||
125593754|NCT01309737|451795899|FG002|Week 16 to 52|Other|0|||
125593755|NCT01309737|451795900|FG003|Week 16 to 52|Other|2|||
125593756|NCT01309737|451795901|FG004|Week 16 to 52|Other|0|||
125593757|NCT00709202|451795903|FG000|Overall Study|Withdrawal by Subject|6|||
125593758|NCT00709202|451795904|FG001|Overall Study|Withdrawal by Subject|6|||
125593759|NCT03934684|451795911|FG000|Overall Study|Participants continuing in study|11|||
125593760|NCT03934684|451795912|FG001|Overall Study|Participants continuing in study|4|||
125593761|NCT03934684|451795911|FG000|Overall Study|Discontinuation of carfilzomib|20|||
125593762|NCT03934684|451795912|FG001|Overall Study|Discontinuation of carfilzomib|30|||
125593763|NCT03934684|451795911|FG000|Overall Study|Death|2|||
125593764|NCT03934684|451795912|FG001|Overall Study|Death|2|||
125212296|NCT00703118|450403317|FG000|Overall Study|Lost to Follow-up|6|||
125212297|NCT00703118|450403318|FG001|Overall Study|Lost to Follow-up|4|||
125593765|NCT03934684|451795911|FG000|Overall Study|Lost to Follow-up|2|||
125212298|NCT00703118|450403319|FG002|Overall Study|Lost to Follow-up|4|||
125212299|NCT00703118|450403317|FG000|Overall Study|Withdrawal by Subject|8|||
125593766|NCT03934684|451795912|FG001|Overall Study|Lost to Follow-up|5|||
125593767|NCT03934684|451795911|FG000|Overall Study|Withdrawal by Subject|7|||
125593768|NCT03934684|451795912|FG001|Overall Study|Withdrawal by Subject|8|||
125593769|NCT04996797|451795913|FG000|Overall Study|Adverse Event|0|||
125212300|NCT00703118|450403318|FG001|Overall Study|Withdrawal by Subject|7|||
125593770|NCT04996797|451795914|FG001|Overall Study|Adverse Event|2|||
125593771|NCT04996797|451795915|FG002|Overall Study|Adverse Event|0|||
125593772|NCT04996797|451795916|FG003|Overall Study|Adverse Event|1|||
125593773|NCT04996797|451795913|FG000|Overall Study|Lack of Efficacy|0|||
125593774|NCT04996797|451795914|FG001|Overall Study|Lack of Efficacy|2|||
125593775|NCT04996797|451795915|FG002|Overall Study|Lack of Efficacy|0|||
125593776|NCT04996797|451795916|FG003|Overall Study|Lack of Efficacy|0|||
125593777|NCT04996797|451795913|FG000|Overall Study|Prohibited Medication|0|||
125593778|NCT04996797|451795914|FG001|Overall Study|Prohibited Medication|1|||
125593779|NCT04996797|451795915|FG002|Overall Study|Prohibited Medication|0|||
125593780|NCT04996797|451795916|FG003|Overall Study|Prohibited Medication|0|||
125593781|NCT04996797|451795913|FG000|Overall Study|Ongoing|68|||
125593782|NCT04996797|451795914|FG001|Overall Study|Ongoing|60|||
125593783|NCT04996797|451795915|FG002|Overall Study|Ongoing|22|||
125593784|NCT04996797|451795916|FG003|Overall Study|Ongoing|20|||
125593785|NCT04996797|451795913|FG000|Overall Study|Withdrawal by Subject|0|||
125593786|NCT04996797|451795914|FG001|Overall Study|Withdrawal by Subject|2|||
125593787|NCT04996797|451795915|FG002|Overall Study|Withdrawal by Subject|0|||
125593788|NCT04996797|451795916|FG003|Overall Study|Withdrawal by Subject|0|||
125593789|NCT04091217|451795917|FG000|Overall Study|Lost to Follow-up|2|||
125593790|NCT05662332|451795918|FG000|Overall Study|Death|3|||
125593791|NCT05662332|451795919|FG001|Overall Study|Death|3|||
125593792|NCT05662332|451795918|FG000|Overall Study|Lost to Follow-up|3|||
125593793|NCT05662332|451795919|FG001|Overall Study|Lost to Follow-up|8|||
125593794|NCT05662332|451795918|FG000|Overall Study|Physician Decision|1|||
125593795|NCT05662332|451795919|FG001|Overall Study|Physician Decision|2|||
125593796|NCT05662332|451795918|FG000|Overall Study|Protocol Deviation|2|||
125593797|NCT05662332|451795919|FG001|Overall Study|Protocol Deviation|1|||
125593798|NCT05662332|451795918|FG000|Overall Study|Withdrawal by Subject|14|||
125593799|NCT05662332|451795919|FG001|Overall Study|Withdrawal by Subject|14|||
125593800|NCT05662332|451795918|FG000|Overall Study|Assigned Treatment by Mistake|5|||
125593801|NCT05662332|451795919|FG001|Overall Study|Assigned Treatment by Mistake|7|||
125593802|NCT05662332|451795918|FG000|Overall Study|Non-compliance with study drug|4|||
125593803|NCT05662332|451795919|FG001|Overall Study|Non-compliance with study drug|1|||
125593804|NCT05662332|451795918|FG000|Overall Study|Due to Bariatric surgery|1|||
125593805|NCT05662332|451795919|FG001|Overall Study|Due to Bariatric surgery|0|||
125593806|NCT05662332|451795918|FG000|Overall Study|Subject Moving out of State|0|||
125593807|NCT05662332|451795919|FG001|Overall Study|Subject Moving out of State|1|||
125593808|NCT05662332|451795918|FG000|Overall Study|Subject Missed the Schedule|1|||
125593809|NCT05662332|451795919|FG001|Overall Study|Subject Missed the Schedule|0|||
125593810|NCT05662332|451795918|FG000|Overall Study|The Patient Moved to Another City|1|||
125593811|NCT05662332|451795919|FG001|Overall Study|The Patient Moved to Another City|0|||
125593812|NCT01624142|451795921|FG000|Overall Study|Withdrawal by Subject|14|||
125593813|NCT01624142|451795922|FG001|Overall Study|Withdrawal by Subject|4|||
125593814|NCT01624142|451795921|FG000|Overall Study|Death|3|||
125593815|NCT01624142|451795922|FG001|Overall Study|Death|6|||
125593816|NCT01624142|451795921|FG000|Overall Study|Study Closure|12|||
125593817|NCT01624142|451795922|FG001|Overall Study|Study Closure|6|||
125593818|NCT01624142|451795921|FG000|Overall Study|Lost to Follow-up|2|||
125593819|NCT01624142|451795922|FG001|Overall Study|Lost to Follow-up|0|||
125593820|NCT01624142|451795921|FG000|Overall Study|Other|1|||
125593821|NCT01624142|451795922|FG001|Overall Study|Other|0|||
125593822|NCT02597062|451795925|FG000|Overall Study|Ineligible|1|||
125593823|NCT05262764|451795927|FG000|Overall Study|Case report form not collected|9|||
125593824|NCT05262764|451795927|FG000|Overall Study|No patient visits after entry|23|||
125593825|NCT05262764|451795927|FG000|Overall Study|Registration rule not followed|2|||
125593826|NCT05262764|451795927|FG000|Overall Study|Patient of non-chronic heart failure|1|||
125593827|NCT01392183|451795928|FG000|First Drug Administration|Adverse Event|3|||
125212301|NCT00703118|450403319|FG002|Overall Study|Withdrawal by Subject|13|||
125212302|NCT00703118|450403317|FG000|Overall Study|Other|0|||
125212303|NCT00703118|450403318|FG001|Overall Study|Other|0|||
125212304|NCT00703118|450403319|FG002|Overall Study|Other|1|||
125593828|NCT01392183|451795929|FG001|First Drug Administration|Adverse Event|2|||
125593829|NCT01392183|451795928|FG000|First Drug Administration|Death|1|||
125593830|NCT01392183|451795929|FG001|First Drug Administration|Death|0|||
125593831|NCT01392183|451795928|FG000|First Drug Administration|Withdrawal by Subject|10|||
125593832|NCT01392183|451795929|FG001|First Drug Administration|Withdrawal by Subject|17|||
125593833|NCT03430310|451795930|FG000|Overall Study|Protocol Violation|2|||
125593834|NCT03430310|451795931|FG001|Overall Study|Protocol Violation|0|||
125593835|NCT03430310|451795930|FG000|Overall Study|Withdrawal by Subject|3|||
125212305|NCT01204918|450403324|FG000|Overall Study|Withdrawal by Subject|4|||
125593836|NCT03430310|451795931|FG001|Overall Study|Withdrawal by Subject|2|||
125593837|NCT03430310|451795930|FG000|Overall Study|COVID shutdown March 2020|0|||
125593838|NCT03430310|451795931|FG001|Overall Study|COVID shutdown March 2020|1|||
125593839|NCT03476239|451795933|FG000|Overall Study|Withdrawal by Subject|10|||
125593840|NCT03476239|451795933|FG000|Overall Study|Death|80|||
125593841|NCT03476239|451795933|FG000|Overall Study|Lost to Follow-up|8|||
125212306|NCT01204918|450403325|FG001|Overall Study|Withdrawal by Subject|10|||
125593842|NCT01446809|451795937|FG000|Overall Study|Adverse Event|0|||
125593843|NCT01446809|451795938|FG001|Overall Study|Adverse Event|0|||
125593844|NCT01446809|451795939|FG002|Overall Study|Adverse Event|1|||
125593845|NCT01446809|451795937|FG000|Overall Study|Failure to complete study procedures|0|||
125593846|NCT01446809|451795938|FG001|Overall Study|Failure to complete study procedures|0|||
125593847|NCT01446809|451795939|FG002|Overall Study|Failure to complete study procedures|1|||
125593848|NCT01331161|451795940|FG000|Overall Study|Physician Decision|1|||
125593849|NCT01331161|451795941|FG001|Overall Study|Physician Decision|0|||
125593850|NCT01331161|451795940|FG000|Overall Study|Lost to Follow-up|0|||
125593851|NCT01331161|451795941|FG001|Overall Study|Lost to Follow-up|1|||
125593852|NCT01331161|451795940|FG000|Overall Study|Pregnancy|0|||
125593853|NCT01331161|451795941|FG001|Overall Study|Pregnancy|1|||
125593854|NCT00785577|451795942|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
125593855|NCT00785577|451795943|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
125593856|NCT00785577|451795944|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
125593857|NCT00785577|451795945|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
125593858|NCT00785577|451795946|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
125593859|NCT00785577|451795942|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
125593860|NCT00785577|451795943|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
125593861|NCT00785577|451795944|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
125593862|NCT00785577|451795945|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
125593863|NCT00785577|451795946|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
125593864|NCT00785577|451795942|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
125593865|NCT00785577|451795943|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
125593866|NCT00785577|451795944|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
125593867|NCT00785577|451795945|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
125593868|NCT00785577|451795946|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
125593869|NCT00785577|451795942|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
125593870|NCT00785577|451795943|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
125593871|NCT00785577|451795944|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
125593872|NCT00785577|451795945|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
125593873|NCT00785577|451795946|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
125593874|NCT00785577|451795942|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
125593875|NCT00785577|451795943|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
125593876|NCT00785577|451795944|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
125593877|NCT00785577|451795945|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
125593878|NCT00785577|451795946|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
125593879|NCT00785577|451795942|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
125593880|NCT00785577|451795943|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
125593881|NCT00785577|451795944|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
125593882|NCT00785577|451795945|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
125593883|NCT00785577|451795946|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
125593884|NCT00785577|451795942|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
125593885|NCT00785577|451795943|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
125593886|NCT00785577|451795944|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
125593887|NCT00785577|451795945|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
125593888|NCT00785577|451795946|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
125593889|NCT00785577|451795942|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
125593890|NCT00785577|451795943|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
125593891|NCT00785577|451795944|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
125593892|NCT00785577|451795945|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
125593893|NCT00785577|451795946|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
125593894|NCT00785577|451795942|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
125593895|NCT00785577|451795943|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
125593896|NCT00785577|451795944|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
125593897|NCT00785577|451795945|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
125593898|NCT00785577|451795946|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
125593899|NCT00785577|451795942|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
125593900|NCT00785577|451795943|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
125593901|NCT00785577|451795944|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
125593902|NCT00785577|451795945|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
125593903|NCT00785577|451795946|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
125593904|NCT01682044|451795950|FG000|Overall Study|Death|1|||
125593905|NCT01682044|451795950|FG000|Overall Study|Progression|3|||
125593906|NCT01659151|451795951|FG000|Overall Study|Inadequate TIL growth|1|||
125593907|NCT01826214|451797276|FG000|Overall Study|Adverse Event|7|||
125593908|NCT01826214|451797277|FG001|Overall Study|Adverse Event|6|||
125593909|NCT01826214|451797276|FG000|Overall Study|Death|3|||
125593910|NCT01826214|451797277|FG001|Overall Study|Death|1|||
125593911|NCT01826214|451797276|FG000|Overall Study|Lost to Follow-up|1|||
125593912|NCT01826214|451797277|FG001|Overall Study|Lost to Follow-up|0|||
125593913|NCT01826214|451797276|FG000|Overall Study|Physician Decision|0|||
125593914|NCT01826214|451797277|FG001|Overall Study|Physician Decision|2|||
125593915|NCT01826214|451797276|FG000|Overall Study|Progressive disease|22|||
125593916|NCT01826214|451797277|FG001|Overall Study|Progressive disease|21|||
125593917|NCT01826214|451797276|FG000|Overall Study|Study terminated by Sponsor|0|||
125593918|NCT01826214|451797277|FG001|Overall Study|Study terminated by Sponsor|1|||
125593919|NCT01826214|451797276|FG000|Overall Study|Subject/guardian decision|2|||
125593920|NCT01826214|451797277|FG001|Overall Study|Subject/guardian decision|3|||
125593921|NCT01056107|451797290|FG000|Overall Study|Withdrawal by Subject|0|||
125593922|NCT01056107|451797291|FG001|Overall Study|Withdrawal by Subject|1|||
125593923|NCT01056107|451797292|FG002|Overall Study|Withdrawal by Subject|3|||
125593924|NCT01056107|451797293|FG003|Overall Study|Withdrawal by Subject|0|||
125593925|NCT02017444|451797294|FG000|Overall Study|Physician Decision|1|||
125593926|NCT02017444|451797295|FG001|Overall Study|Physician Decision|0|||
125593927|NCT02017444|451797294|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
125593928|NCT02017444|451797295|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
125593929|NCT01614457|451797296|FG000|Overall Study|Non-Compliance|1|||
125593930|NCT01614457|451797297|FG001|Overall Study|Non-Compliance|0|||
125593931|NCT01614457|451797296|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
125593932|NCT01614457|451797297|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
125593933|NCT00374556|451797298|FG000|Overall Study|Lost to Follow-up|1|||
125593934|NCT00374556|451797299|FG001|Overall Study|Lost to Follow-up|0|||
125593935|NCT00374556|451797298|FG000|Overall Study|Removed at baseline due to medical cond|0|||
125593936|NCT00374556|451797299|FG001|Overall Study|Removed at baseline due to medical cond|1|||
125593937|NCT00473694|451797300|FG000|Overall Study|Adverse Event|0|||
125593938|NCT00473694|451797301|FG001|Overall Study|Adverse Event|1|||
125593939|NCT00473694|451797302|FG002|Overall Study|Adverse Event|0|||
125593940|NCT00473694|451797303|FG003|Overall Study|Adverse Event|0|||
125593941|NCT00473694|451797300|FG000|Overall Study|Participants did not receive treatment|11|||
125593942|NCT00473694|451797301|FG001|Overall Study|Participants did not receive treatment|3|||
125593943|NCT00473694|451797302|FG002|Overall Study|Participants did not receive treatment|5|||
125593944|NCT00473694|451797303|FG003|Overall Study|Participants did not receive treatment|6|||
125593945|NCT00473694|451797300|FG000|Overall Study|Lost to Follow-up|0|||
125593946|NCT00473694|451797301|FG001|Overall Study|Lost to Follow-up|0|||
125593947|NCT00473694|451797302|FG002|Overall Study|Lost to Follow-up|0|||
125593948|NCT00473694|451797303|FG003|Overall Study|Lost to Follow-up|1|||
125593949|NCT00469079|451797313|FG000|Overall Study|Lack of Efficacy|3|||
125593950|NCT00469079|451797314|FG001|Overall Study|Lack of Efficacy|8|||
125593951|NCT00469079|451797315|FG002|Overall Study|Lack of Efficacy|5|||
125593952|NCT00469079|451797313|FG000|Overall Study|Adverse Event|1|||
125593953|NCT00469079|451797314|FG001|Overall Study|Adverse Event|3|||
125593954|NCT00469079|451797315|FG002|Overall Study|Adverse Event|2|||
125593955|NCT00469079|451797313|FG000|Overall Study|Lost to Follow-up|4|||
125593956|NCT00469079|451797314|FG001|Overall Study|Lost to Follow-up|8|||
125593957|NCT00469079|451797315|FG002|Overall Study|Lost to Follow-up|10|||
125593958|NCT00469079|451797313|FG000|Overall Study|Withdrawal by Subject|1|||
125593959|NCT00469079|451797314|FG001|Overall Study|Withdrawal by Subject|2|||
125593960|NCT00469079|451797315|FG002|Overall Study|Withdrawal by Subject|2|||
125593961|NCT00469079|451797313|FG000|Overall Study|Ineligible|0|||
125593962|NCT00469079|451797314|FG001|Overall Study|Ineligible|1|||
125593963|NCT00469079|451797315|FG002|Overall Study|Ineligible|0|||
125593964|NCT00942162|451797316|FG000|Overall Study|Death|45|||
125593965|NCT00942162|451797317|FG001|Overall Study|Death|35|||
125593966|NCT00942162|451797318|FG002|Overall Study|Death|0|||
125593967|NCT00942162|451797316|FG000|Overall Study|Withdrawal by Subject|7|||
125593968|NCT00942162|451797317|FG001|Overall Study|Withdrawal by Subject|2|||
125593969|NCT00942162|451797318|FG002|Overall Study|Withdrawal by Subject|0|||
125593970|NCT00942162|451797316|FG000|Overall Study|Lost to Follow-up|4|||
125593971|NCT00942162|451797317|FG001|Overall Study|Lost to Follow-up|0|||
125593972|NCT00942162|451797318|FG002|Overall Study|Lost to Follow-up|0|||
125593973|NCT00942162|451797316|FG000|Overall Study|Other|14|||
125593974|NCT00942162|451797317|FG001|Overall Study|Other|13|||
125593975|NCT00942162|451797318|FG002|Overall Study|Other|2|||
125212307|NCT01204918|450403326|FG002|Overall Study|Withdrawal by Subject|5|||
125212308|NCT01853696|450403329|FG000|Overall Study|Withdrawal by Subject|1|||
125429724|NCT00261495|451198927|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
125429725|NCT00261495|451198926|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
125429726|NCT00261495|451198927|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
125429727|NCT00261495|451198926|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
125429728|NCT00261495|451198927|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
125429729|NCT00261495|451198926|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
125429730|NCT00261495|451198927|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
125429731|NCT00261495|451198926|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
125429732|NCT00261495|451198927|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
125429733|NCT00261495|451198926|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
125429734|NCT00261495|451198927|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
125429735|NCT00261495|451198926|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
125429736|NCT00261495|451198927|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
125429737|NCT00261495|451198926|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
125429738|NCT00261495|451198927|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
125429739|NCT00261495|451198926|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
125429740|NCT00261495|451198927|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
125429741|NCT00261495|451198926|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
125429742|NCT00261495|451198927|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
125429743|NCT00261495|451198926|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
125429744|NCT00261495|451198927|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
125429745|NCT00261495|451198926|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
125429746|NCT00261495|451198927|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
125429747|NCT00261495|451198926|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
125429748|NCT00261495|451198927|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
125429749|NCT00261495|451198926|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
125429750|NCT00261495|451198927|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
125429751|NCT00261495|451198926|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
125429752|NCT00261495|451198927|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
125429753|NCT00261495|451198926|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
125429754|NCT00261495|451198927|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
125429755|NCT00261495|451198926|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
125429756|NCT00261495|451198927|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
125429757|NCT00261495|451198926|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
125429758|NCT00261495|451198927|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
125429759|NCT00642902|451198928|FG000|Overall Study|Adverse Event|0|||
125212309|NCT01853696|450403330|FG001|Overall Study|Withdrawal by Subject|1|||
125593976|NCT02799381|451797328|FG000|Overall Study|Withdrew consent|3|||
125593977|NCT02799381|451797329|FG001|Overall Study|Withdrew consent|2|||
125593978|NCT02799381|451797328|FG000|Overall Study|Adverse Event|0|||
125593979|NCT02799381|451797329|FG001|Overall Study|Adverse Event|1|||
125593980|NCT02799381|451797328|FG000|Overall Study|Participant did not take any study drug|1|||
125593981|NCT02799381|451797329|FG001|Overall Study|Participant did not take any study drug|0|||
125593982|NCT01821963|451797330|FG000|Overall Study|Adverse Event|1|||
125593983|NCT03952130|451797331|FG000|Overall Study|Adverse Event|0|||
125593984|NCT03952130|451797332|FG001|Overall Study|Adverse Event|1|||
125593985|NCT03952130|451797331|FG000|Overall Study|Lost to Follow-up|1|||
125593986|NCT03952130|451797332|FG001|Overall Study|Lost to Follow-up|0|||
125593987|NCT03952130|451797331|FG000|Overall Study|Withdrawal by Subject|1|||
125593988|NCT03952130|451797332|FG001|Overall Study|Withdrawal by Subject|5|||
125593989|NCT01713348|451797333|FG000|Overall Study|Withdrawal by Subject|3|||
125593990|NCT01713348|451797334|FG001|Overall Study|Withdrawal by Subject|2|||
125593991|NCT01713348|451797335|FG002|Overall Study|Withdrawal by Subject|2|||
125593992|NCT01713348|451797336|FG003|Overall Study|Withdrawal by Subject|0|||
125593993|NCT01713348|451797333|FG000|Overall Study|Lost to Follow-up|1|||
125593994|NCT01713348|451797334|FG001|Overall Study|Lost to Follow-up|0|||
125593995|NCT01713348|451797335|FG002|Overall Study|Lost to Follow-up|0|||
125593996|NCT01713348|451797336|FG003|Overall Study|Lost to Follow-up|0|||
125593997|NCT01896232|451797337|FG000|Overall Study|Death|6|||
125593998|NCT01896232|451797338|FG001|Overall Study|Death|10|||
125593999|NCT01896232|451797337|FG000|Overall Study|Withdrawal by Subject|32|||
125594000|NCT01896232|451797338|FG001|Overall Study|Withdrawal by Subject|31|||
125594001|NCT01896232|451797337|FG000|Overall Study|Sponsor Decision|2|||
125594002|NCT01896232|451797338|FG001|Overall Study|Sponsor Decision|0|||
125594003|NCT01896232|451797337|FG000|Overall Study|Lost to Follow-up|9|||
125594004|NCT01896232|451797338|FG001|Overall Study|Lost to Follow-up|12|||
125594005|NCT00686205|451797347|FG000|Overall Study|Protocol Violation|127|||
125594006|NCT00686205|451797348|FG001|Overall Study|Protocol Violation|0|||
125594007|NCT00686205|451797347|FG000|Overall Study|Withdrawal by Subject|2|||
125594008|NCT00686205|451797348|FG001|Overall Study|Withdrawal by Subject|0|||
125594009|NCT00686205|451797347|FG000|Overall Study|Specimen handling procedure altered|5878|||
125594010|NCT00686205|451797348|FG001|Overall Study|Specimen handling procedure altered|0|||
125594011|NCT00686205|451797347|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
125594012|NCT00686205|451797348|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
125594013|NCT00265941|451797349|FG000|Overall Study|Protocol Violation|22|||
125594014|NCT00265941|451797350|FG001|Overall Study|Protocol Violation|25|||
125594015|NCT00265941|451797349|FG000|Overall Study|Lost to Follow-up|1|||
125594016|NCT00265941|451797350|FG001|Overall Study|Lost to Follow-up|1|||
125594017|NCT03816995|451797353|FG000|Overall Study|Withdrawal by Subject|3|||
125594018|NCT03816995|451797354|FG001|Overall Study|Withdrawal by Subject|1|||
125594019|NCT03816995|451797353|FG000|Overall Study|Cancelled Surgery|8|||
125594020|NCT03816995|451797354|FG001|Overall Study|Cancelled Surgery|12|||
125364297|NCT00347360|450967156|FG000|Overall Study|Withdrawal by Subject|0|||
125364298|NCT00347360|450967157|FG001|Overall Study|Withdrawal by Subject|1|||
125364299|NCT00347360|450967158|FG002|Overall Study|Withdrawal by Subject|2|||
125364300|NCT00347360|450967159|FG003|Overall Study|Withdrawal by Subject|4|||
125364301|NCT00347360|450967160|FG004|Overall Study|Withdrawal by Subject|1|||
125364302|NCT00347360|450967161|FG005|Overall Study|Withdrawal by Subject|2|||
125594021|NCT03816995|451797353|FG000|Overall Study|No wound protector used|11|||
125594022|NCT03816995|451797354|FG001|Overall Study|No wound protector used|17|||
125364303|NCT00347360|450967162|FG006|Overall Study|Withdrawal by Subject|1|||
125364304|NCT00347360|450967163|FG007|Overall Study|Withdrawal by Subject|1|||
125364305|NCT00347360|450967164|FG008|Overall Study|Withdrawal by Subject|1|||
125594023|NCT03816995|451797353|FG000|Overall Study|Protocol Violation|2|||
125594024|NCT03816995|451797354|FG001|Overall Study|Protocol Violation|3|||
125594025|NCT05882890|451797356|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
125594026|NCT00613314|451797359|FG000|Overall Study|Adverse Event|5|||
125594027|NCT00613314|451797359|FG000|Overall Study|Protocol Violation|14|||
125594028|NCT00613314|451797359|FG000|Overall Study|Lost to Follow-up|46|||
125594029|NCT00613314|451797359|FG000|Overall Study|Other reason not defined above|90|||
125594030|NCT00719810|451797360|FG000|Overall Study|Adverse Event|0|||
125594031|NCT00719810|451797361|FG001|Overall Study|Adverse Event|2|||
125364306|NCT00347360|450967165|FG009|Overall Study|Withdrawal by Subject|1|||
125364307|NCT00347360|450967166|FG010|Overall Study|Withdrawal by Subject|0|||
125594032|NCT00719810|451797362|FG002|Overall Study|Adverse Event|3|||
125594033|NCT00719810|451797360|FG000|Overall Study|Lost to Follow-up|2|||
125594034|NCT00719810|451797361|FG001|Overall Study|Lost to Follow-up|0|||
125594035|NCT00719810|451797362|FG002|Overall Study|Lost to Follow-up|3|||
125594036|NCT00719810|451797360|FG000|Overall Study|Physician Decision|0|||
125594037|NCT00719810|451797361|FG001|Overall Study|Physician Decision|1|||
125594038|NCT00719810|451797362|FG002|Overall Study|Physician Decision|0|||
125594039|NCT00719810|451797360|FG000|Overall Study|Withdrawal by Subject|1|||
125594040|NCT00719810|451797361|FG001|Overall Study|Withdrawal by Subject|1|||
125594041|NCT00719810|451797362|FG002|Overall Study|Withdrawal by Subject|2|||
125594042|NCT03090191|451797363|FG000|Overall Study|Adverse Event|90|||
125594043|NCT03090191|451797364|FG001|Overall Study|Adverse Event|72|||
125364308|NCT00347360|450967167|FG011|Overall Study|Withdrawal by Subject|3|||
125364309|NCT00347360|450967168|FG012|Overall Study|Withdrawal by Subject|4|||
125364310|NCT00347360|450967169|FG013|Overall Study|Withdrawal by Subject|2|||
125364311|NCT00347360|450967170|FG014|Overall Study|Withdrawal by Subject|1|||
125364312|NCT00347360|450967156|FG000|Overall Study|Lack of Efficacy|1|||
125364313|NCT00347360|450967157|FG001|Overall Study|Lack of Efficacy|1|||
125364314|NCT00347360|450967158|FG002|Overall Study|Lack of Efficacy|3|||
125364315|NCT00347360|450967159|FG003|Overall Study|Lack of Efficacy|1|||
125364316|NCT00347360|450967160|FG004|Overall Study|Lack of Efficacy|0|||
125364317|NCT00347360|450967161|FG005|Overall Study|Lack of Efficacy|1|||
125364318|NCT00347360|450967162|FG006|Overall Study|Lack of Efficacy|0|||
125364319|NCT00347360|450967163|FG007|Overall Study|Lack of Efficacy|1|||
125364320|NCT00347360|450967164|FG008|Overall Study|Lack of Efficacy|1|||
125364321|NCT00347360|450967165|FG009|Overall Study|Lack of Efficacy|0|||
125429760|NCT00642902|451198929|FG001|Overall Study|Adverse Event|1|||
125429761|NCT00642902|451198930|FG002|Overall Study|Adverse Event|3|||
125429762|NCT00642902|451198931|FG003|Overall Study|Adverse Event|1|||
125429763|NCT00642902|451198928|FG000|Overall Study|Lost to Follow-up|1|||
125429764|NCT00642902|451198929|FG001|Overall Study|Lost to Follow-up|1|||
125429765|NCT00642902|451198930|FG002|Overall Study|Lost to Follow-up|0|||
125429766|NCT00642902|451198931|FG003|Overall Study|Lost to Follow-up|0|||
125429767|NCT00642902|451198928|FG000|Overall Study|Lack of Efficacy|0|||
125429768|NCT00642902|451198929|FG001|Overall Study|Lack of Efficacy|3|||
125594044|NCT03090191|451797363|FG000|Overall Study|Death|365|||
125364322|NCT00347360|450967166|FG010|Overall Study|Lack of Efficacy|0|||
125364323|NCT00347360|450967167|FG011|Overall Study|Lack of Efficacy|0|||
125364324|NCT00347360|450967168|FG012|Overall Study|Lack of Efficacy|0|||
125364325|NCT00347360|450967169|FG013|Overall Study|Lack of Efficacy|0|||
125364326|NCT00347360|450967170|FG014|Overall Study|Lack of Efficacy|0|||
125364327|NCT00347360|450967156|FG000|Overall Study|Reason not listed/blank|1|||
125364328|NCT00347360|450967157|FG001|Overall Study|Reason not listed/blank|0|||
125364329|NCT00347360|450967158|FG002|Overall Study|Reason not listed/blank|0|||
125364330|NCT00347360|450967159|FG003|Overall Study|Reason not listed/blank|0|||
125364331|NCT00347360|450967160|FG004|Overall Study|Reason not listed/blank|0|||
125364332|NCT00347360|450967161|FG005|Overall Study|Reason not listed/blank|0|||
125364333|NCT00347360|450967162|FG006|Overall Study|Reason not listed/blank|1|||
125364334|NCT00347360|450967163|FG007|Overall Study|Reason not listed/blank|0|||
125364335|NCT00347360|450967164|FG008|Overall Study|Reason not listed/blank|0|||
125364336|NCT00347360|450967165|FG009|Overall Study|Reason not listed/blank|0|||
125364337|NCT00347360|450967166|FG010|Overall Study|Reason not listed/blank|0|||
125364338|NCT00347360|450967167|FG011|Overall Study|Reason not listed/blank|0|||
125364339|NCT00347360|450967168|FG012|Overall Study|Reason not listed/blank|0|||
125364340|NCT00347360|450967169|FG013|Overall Study|Reason not listed/blank|1|||
125364341|NCT00347360|450967170|FG014|Overall Study|Reason not listed/blank|0|||
125364342|NCT00347360|450967156|FG000|Overall Study|Per sponsors instruction|0|||
125364343|NCT00347360|450967157|FG001|Overall Study|Per sponsors instruction|1|||
125364344|NCT00347360|450967158|FG002|Overall Study|Per sponsors instruction|0|||
125364345|NCT00347360|450967159|FG003|Overall Study|Per sponsors instruction|0|||
125594045|NCT03090191|451797364|FG001|Overall Study|Death|358|||
125594046|NCT03090191|451797363|FG000|Overall Study|Lost to Follow-up|382|||
125594047|NCT03090191|451797364|FG001|Overall Study|Lost to Follow-up|394|||
125594048|NCT03090191|451797363|FG000|Overall Study|Physician Decision|77|||
125594049|NCT03090191|451797364|FG001|Overall Study|Physician Decision|66|||
125594050|NCT03090191|451797363|FG000|Overall Study|Protocol Violation|43|||
125364346|NCT00347360|450967160|FG004|Overall Study|Per sponsors instruction|0|||
125429769|NCT00642902|451198930|FG002|Overall Study|Lack of Efficacy|3|||
125429770|NCT00642902|451198931|FG003|Overall Study|Lack of Efficacy|0|||
125429771|NCT00642902|451198928|FG000|Overall Study|Death|1|||
125364347|NCT00347360|450967161|FG005|Overall Study|Per sponsors instruction|0|||
125364348|NCT00347360|450967162|FG006|Overall Study|Per sponsors instruction|0|||
125429772|NCT00642902|451198929|FG001|Overall Study|Death|0|||
125429773|NCT00642902|451198930|FG002|Overall Study|Death|0|||
125594051|NCT03090191|451797364|FG001|Overall Study|Protocol Violation|52|||
125594052|NCT03090191|451797363|FG000|Overall Study|Withdrawal by Subject|2160|||
125594053|NCT03090191|451797364|FG001|Overall Study|Withdrawal by Subject|2133|||
125429774|NCT00642902|451198931|FG003|Overall Study|Death|0|||
125429775|NCT00642902|451198928|FG000|Overall Study|Premature termination of clinical trial|37|||
125594054|NCT03090191|451797363|FG000|Overall Study|Site terminated|7|||
125594055|NCT03090191|451797364|FG001|Overall Study|Site terminated|8|||
125594056|NCT03090191|451797363|FG000|Overall Study|Other|66|||
125594057|NCT03090191|451797364|FG001|Overall Study|Other|60|||
125594058|NCT03090191|451797363|FG000|Overall Study|Withdrawn before any study vaccination|43|||
125594059|NCT03090191|451797364|FG001|Overall Study|Withdrawn before any study vaccination|52|||
125594060|NCT02432807|451797365|FG000|Overall Study|Adverse Event|0|||
125594061|NCT02432807|451797366|FG001|Overall Study|Adverse Event|2|||
125594062|NCT02432807|451797365|FG000|Overall Study|Lost to Follow-up|1|||
125594063|NCT02432807|451797366|FG001|Overall Study|Lost to Follow-up|0|||
125594064|NCT02432807|451797365|FG000|Overall Study|Withdrawal by Subject|1|||
125594065|NCT02432807|451797366|FG001|Overall Study|Withdrawal by Subject|1|||
125594066|NCT02432807|451797365|FG000|Overall Study|Other|1|||
125594067|NCT02432807|451797366|FG001|Overall Study|Other|1|||
125594068|NCT03976401|451797367|FG000|Overall Study|Adverse Event|2|||
125594069|NCT03976401|451797368|FG001|Overall Study|Adverse Event|0|||
125594070|NCT03976401|451797369|FG002|Overall Study|Adverse Event|4|||
125594071|NCT03976401|451797370|FG003|Overall Study|Adverse Event|1|||
125594072|NCT03976401|451797371|FG004|Overall Study|Adverse Event|1|||
125594073|NCT03976401|451797372|FG005|Overall Study|Adverse Event|0|||
125594074|NCT03976401|451797367|FG000|Overall Study|Withdrawal by Subject|0|||
125594075|NCT03976401|451797368|FG001|Overall Study|Withdrawal by Subject|1|||
125594076|NCT03976401|451797369|FG002|Overall Study|Withdrawal by Subject|0|||
125594077|NCT03976401|451797370|FG003|Overall Study|Withdrawal by Subject|0|||
125594078|NCT03976401|451797371|FG004|Overall Study|Withdrawal by Subject|0|||
125594079|NCT03976401|451797372|FG005|Overall Study|Withdrawal by Subject|1|||
125594080|NCT03976401|451797367|FG000|Overall Study|Physician Decision|0|||
125594081|NCT03976401|451797368|FG001|Overall Study|Physician Decision|0|||
125594082|NCT03976401|451797369|FG002|Overall Study|Physician Decision|1|||
125594083|NCT03976401|451797370|FG003|Overall Study|Physician Decision|0|||
125594084|NCT03976401|451797371|FG004|Overall Study|Physician Decision|0|||
125594085|NCT03976401|451797372|FG005|Overall Study|Physician Decision|0|||
125594086|NCT03976401|451797367|FG000|Overall Study|Lost to Follow-up|1|||
125594087|NCT03976401|451797368|FG001|Overall Study|Lost to Follow-up|2|||
125594088|NCT03976401|451797369|FG002|Overall Study|Lost to Follow-up|0|||
125594089|NCT03976401|451797370|FG003|Overall Study|Lost to Follow-up|0|||
125594090|NCT03976401|451797371|FG004|Overall Study|Lost to Follow-up|0|||
125594091|NCT03976401|451797372|FG005|Overall Study|Lost to Follow-up|0|||
125594092|NCT03976401|451797367|FG000|Overall Study|Protocol Violation|0|||
125594093|NCT03976401|451797368|FG001|Overall Study|Protocol Violation|1|||
125594094|NCT03976401|451797369|FG002|Overall Study|Protocol Violation|0|||
125429776|NCT00642902|451198929|FG001|Overall Study|Premature termination of clinical trial|32|||
125429777|NCT00642902|451198930|FG002|Overall Study|Premature termination of clinical trial|35|||
125429778|NCT00642902|451198931|FG003|Overall Study|Premature termination of clinical trial|35|||
125429779|NCT00642902|451198928|FG000|Overall Study|Randomized, but not treated|0|||
125594095|NCT03976401|451797370|FG003|Overall Study|Protocol Violation|0|||
125594096|NCT03976401|451797371|FG004|Overall Study|Protocol Violation|0|||
125594097|NCT03976401|451797372|FG005|Overall Study|Protocol Violation|0|||
125594098|NCT03976401|451797367|FG000|Overall Study|Withdrew Consent|0|||
125594099|NCT03976401|451797368|FG001|Overall Study|Withdrew Consent|0|||
125594100|NCT03976401|451797369|FG002|Overall Study|Withdrew Consent|0|||
125594101|NCT03976401|451797370|FG003|Overall Study|Withdrew Consent|1|||
125594102|NCT03976401|451797371|FG004|Overall Study|Withdrew Consent|0|||
125594103|NCT03976401|451797372|FG005|Overall Study|Withdrew Consent|0|||
125594104|NCT01845025|451797373|FG000|Overall Study|Adverse Event|6|||
125594105|NCT01845025|451797374|FG001|Overall Study|Adverse Event|3|||
125594106|NCT01845025|451797373|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125594107|NCT01845025|451797374|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125594108|NCT01845025|451797373|FG000|Overall Study|Withdrawal by Subject|48|||
125594109|NCT01845025|451797374|FG001|Overall Study|Withdrawal by Subject|44|||
125429780|NCT00642902|451198929|FG001|Overall Study|Randomized, but not treated|0|||
125429781|NCT00642902|451198930|FG002|Overall Study|Randomized, but not treated|1|||
125594110|NCT01845025|451797373|FG000|Overall Study|Lost to Follow-up|13|||
125594111|NCT01845025|451797374|FG001|Overall Study|Lost to Follow-up|13|||
125594112|NCT01845025|451797373|FG000|Overall Study|Administrative problems|8|||
125594113|NCT01845025|451797374|FG001|Overall Study|Administrative problems|8|||
125594114|NCT01845025|451797373|FG000|Overall Study|Death|2|||
125594115|NCT01845025|451797374|FG001|Overall Study|Death|0|||
125594116|NCT01845025|451797373|FG000|Overall Study|Protocol deviation|3|||
125594117|NCT01845025|451797374|FG001|Overall Study|Protocol deviation|6|||
125594118|NCT01845025|451797373|FG000|Overall Study|Missing|1|||
125594119|NCT01845025|451797374|FG001|Overall Study|Missing|1|||
125594120|NCT01324830|451797376|FG000|Overall Study|Progressive Disease|3|||
125594121|NCT01324830|451797377|FG001|Overall Study|Progressive Disease|2|||
125594122|NCT01324830|451797378|FG002|Overall Study|Progressive Disease|3|||
125594123|NCT01324830|451797379|FG003|Overall Study|Progressive Disease|3|||
125594124|NCT01324830|451797380|FG004|Overall Study|Progressive Disease|6|||
125364349|NCT00347360|450967163|FG007|Overall Study|Per sponsors instruction|0|||
125364350|NCT00347360|450967164|FG008|Overall Study|Per sponsors instruction|0|||
125364351|NCT00347360|450967165|FG009|Overall Study|Per sponsors instruction|0|||
125364352|NCT00347360|450967166|FG010|Overall Study|Per sponsors instruction|0|||
125364353|NCT00347360|450967167|FG011|Overall Study|Per sponsors instruction|0|||
125364354|NCT00347360|450967168|FG012|Overall Study|Per sponsors instruction|0|||
125364355|NCT00347360|450967169|FG013|Overall Study|Per sponsors instruction|0|||
125364356|NCT00347360|450967170|FG014|Overall Study|Per sponsors instruction|0|||
125364357|NCT00347360|450967156|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
125364358|NCT00347360|450967157|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
125364359|NCT00347360|450967158|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
125364360|NCT00347360|450967159|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
125364361|NCT00347360|450967160|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
125364362|NCT00347360|450967161|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
125364363|NCT00347360|450967162|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
125364364|NCT00347360|450967163|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
125364365|NCT00347360|450967164|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
125364366|NCT00347360|450967165|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
125364367|NCT00347360|450967166|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
125364368|NCT00347360|450967167|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
125364369|NCT00347360|450967168|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
125364370|NCT00347360|450967169|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
125364371|NCT00347360|450967170|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
125364372|NCT00347360|450967156|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
125364373|NCT00347360|450967157|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
125364374|NCT00347360|450967158|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
125364375|NCT00347360|450967159|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
125364376|NCT00347360|450967160|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
125364377|NCT00347360|450967161|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
125364378|NCT00347360|450967162|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
125364379|NCT00347360|450967163|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
125364380|NCT00347360|450967164|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
125364381|NCT00347360|450967165|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
125364382|NCT00347360|450967166|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
125364383|NCT00347360|450967167|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
125594125|NCT01324830|451797381|FG005|Overall Study|Progressive Disease|6|||
125212310|NCT01853696|450403329|FG000|Overall Study|Lost to Follow-up|5|||
125212311|NCT01853696|450403330|FG001|Overall Study|Lost to Follow-up|4|||
125212312|NCT00431067|450403333|FG000|Overall Study|Other Adverse Event|9|||
125212313|NCT00431067|450403333|FG000|Overall Study|Progressive disease|30|||
125212314|NCT00431067|450403333|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
125212315|NCT00849290|450403334|FG000|Overall Study|Adverse Event|3|||
125212316|NCT00849290|450403334|FG000|Overall Study|Death|14|||
125212317|NCT00849290|450403334|FG000|Overall Study|Withdrawal by Subject|11|||
125212318|NCT00849290|450403334|FG000|Overall Study|Lost to Follow-up|2|||
125212319|NCT00849290|450403334|FG000|Overall Study|Protocol Violation|5|||
125212320|NCT00849290|450403334|FG000|Overall Study|Disease Progression|20|||
125212321|NCT00548249|450403335|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
125212322|NCT00548249|450403336|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
125212323|NCT00548249|450403337|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
125212324|NCT00548249|450403338|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
125212325|NCT00548249|450403339|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
125212326|NCT00548249|450403335|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
125212327|NCT00548249|450403336|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
125212328|NCT00548249|450403337|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
125212329|NCT00548249|450403338|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
125212330|NCT00548249|450403339|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
125212331|NCT00548249|450403335|FG000|Overall Study|Protocol Violation|1|||
125212332|NCT00548249|450403336|FG001|Overall Study|Protocol Violation|1|||
125212333|NCT00548249|450403337|FG002|Overall Study|Protocol Violation|4|||
125212334|NCT00548249|450403338|FG003|Overall Study|Protocol Violation|0|||
125212335|NCT00548249|450403339|FG004|Overall Study|Protocol Violation|3|||
125212336|NCT00548249|450403335|FG000|Overall Study|Miscellaneous|2|||
125212337|NCT00548249|450403336|FG001|Overall Study|Miscellaneous|3|||
125212338|NCT00548249|450403337|FG002|Overall Study|Miscellaneous|2|||
125212339|NCT00548249|450403338|FG003|Overall Study|Miscellaneous|0|||
125212340|NCT00548249|450403339|FG004|Overall Study|Miscellaneous|2|||
125212341|NCT00548249|450403335|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
125212342|NCT00548249|450403336|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
125212343|NCT00548249|450403337|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
125212344|NCT00548249|450403338|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
125212345|NCT00548249|450403339|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
125212346|NCT00548249|450403335|FG000|Overall Study|Adverse Event|2|||
125429782|NCT00642902|451198931|FG003|Overall Study|Randomized, but not treated|0|||
125429783|NCT00642902|451198928|FG000|Overall Study|Other|1|||
125429784|NCT00642902|451198929|FG001|Overall Study|Other|5|||
125429785|NCT00642902|451198930|FG002|Overall Study|Other|1|||
125429786|NCT00642902|451198931|FG003|Overall Study|Other|4|||
125429787|NCT03953898|451198934|FG000|Overall Study|Lack of Efficacy|8|||
125429788|NCT03953898|451198934|FG000|Overall Study|Death|3|||
125429789|NCT03953898|451198934|FG000|Overall Study|Withdrawal by Subject|2|||
125429790|NCT03953898|451198934|FG000|Overall Study|Adverse Event|1|||
125594126|NCT01324830|451797382|FG006|Overall Study|Progressive Disease|3|||
125594127|NCT01324830|451797383|FG007|Overall Study|Progressive Disease|3|||
125594128|NCT01324830|451797384|FG008|Overall Study|Progressive Disease|3|||
125594129|NCT01324830|451797385|FG009|Overall Study|Progressive Disease|6|||
125594130|NCT01324830|451797386|FG010|Overall Study|Progressive Disease|2|||
125594131|NCT01324830|451797387|FG011|Overall Study|Progressive Disease|1|||
125594132|NCT01324830|451797388|FG012|Overall Study|Progressive Disease|1|||
125594133|NCT01324830|451797389|FG013|Overall Study|Progressive Disease|1|||
125594134|NCT01324830|451797390|FG014|Overall Study|Progressive Disease|1|||
125594135|NCT01324830|451797391|FG015|Overall Study|Progressive Disease|3|||
125594136|NCT01324830|451797392|FG016|Overall Study|Progressive Disease|2|||
125594137|NCT01324830|451797393|FG017|Overall Study|Progressive Disease|3|||
125594138|NCT01324830|451797394|FG018|Overall Study|Progressive Disease|4|||
125594139|NCT01324830|451797376|FG000|Overall Study|Dose limiting toxicity|0|||
125594140|NCT01324830|451797377|FG001|Overall Study|Dose limiting toxicity|0|||
125594141|NCT01324830|451797378|FG002|Overall Study|Dose limiting toxicity|0|||
125594142|NCT01324830|451797379|FG003|Overall Study|Dose limiting toxicity|0|||
125594143|NCT01324830|451797380|FG004|Overall Study|Dose limiting toxicity|1|||
125594144|NCT01324830|451797381|FG005|Overall Study|Dose limiting toxicity|0|||
125212347|NCT00548249|450403336|FG001|Overall Study|Adverse Event|2|||
125212348|NCT00548249|450403337|FG002|Overall Study|Adverse Event|0|||
125429791|NCT01932697|451198935|FG000|Overall Study|Received a different amount of tx|1|||
125212349|NCT00548249|450403338|FG003|Overall Study|Adverse Event|1|||
125429792|NCT01932697|451198936|FG001|Overall Study|Received a different amount of tx|0|||
125594145|NCT01324830|451797382|FG006|Overall Study|Dose limiting toxicity|0|||
125594146|NCT01324830|451797383|FG007|Overall Study|Dose limiting toxicity|0|||
125594147|NCT01324830|451797384|FG008|Overall Study|Dose limiting toxicity|0|||
125594148|NCT01324830|451797385|FG009|Overall Study|Dose limiting toxicity|0|||
125212350|NCT00548249|450403339|FG004|Overall Study|Adverse Event|1|||
125212351|NCT00548249|450403335|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
125364384|NCT00347360|450967168|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
125594149|NCT01324830|451797386|FG010|Overall Study|Dose limiting toxicity|0|||
125594150|NCT01324830|451797387|FG011|Overall Study|Dose limiting toxicity|0|||
125594151|NCT01324830|451797388|FG012|Overall Study|Dose limiting toxicity|0|||
125594152|NCT01324830|451797389|FG013|Overall Study|Dose limiting toxicity|0|||
125594153|NCT01324830|451797390|FG014|Overall Study|Dose limiting toxicity|0|||
125594154|NCT01324830|451797391|FG015|Overall Study|Dose limiting toxicity|0|||
125594155|NCT01324830|451797392|FG016|Overall Study|Dose limiting toxicity|1|||
125594156|NCT01324830|451797393|FG017|Overall Study|Dose limiting toxicity|1|||
125594157|NCT01324830|451797394|FG018|Overall Study|Dose limiting toxicity|1|||
125594158|NCT01324830|451797376|FG000|Overall Study|Reason not mentioned above|0|||
125594159|NCT01324830|451797377|FG001|Overall Study|Reason not mentioned above|0|||
125594160|NCT01324830|451797378|FG002|Overall Study|Reason not mentioned above|0|||
125594161|NCT01324830|451797379|FG003|Overall Study|Reason not mentioned above|0|||
125594162|NCT01324830|451797380|FG004|Overall Study|Reason not mentioned above|0|||
125594163|NCT01324830|451797381|FG005|Overall Study|Reason not mentioned above|0|||
125594164|NCT01324830|451797382|FG006|Overall Study|Reason not mentioned above|0|||
125594165|NCT01324830|451797383|FG007|Overall Study|Reason not mentioned above|0|||
125594166|NCT01324830|451797384|FG008|Overall Study|Reason not mentioned above|0|||
125594167|NCT01324830|451797385|FG009|Overall Study|Reason not mentioned above|0|||
125594168|NCT01324830|451797386|FG010|Overall Study|Reason not mentioned above|0|||
125594169|NCT01324830|451797387|FG011|Overall Study|Reason not mentioned above|0|||
125594170|NCT01324830|451797388|FG012|Overall Study|Reason not mentioned above|0|||
125594171|NCT01324830|451797389|FG013|Overall Study|Reason not mentioned above|0|||
125594172|NCT01324830|451797390|FG014|Overall Study|Reason not mentioned above|0|||
125594173|NCT01324830|451797391|FG015|Overall Study|Reason not mentioned above|0|||
125594174|NCT01324830|451797392|FG016|Overall Study|Reason not mentioned above|0|||
125594175|NCT01324830|451797393|FG017|Overall Study|Reason not mentioned above|1|||
125594176|NCT01324830|451797394|FG018|Overall Study|Reason not mentioned above|0|||
125594177|NCT01324830|451797376|FG000|Overall Study|Adverse Event, serious fatal|0|||
125594178|NCT01324830|451797377|FG001|Overall Study|Adverse Event, serious fatal|1|||
125594179|NCT01324830|451797378|FG002|Overall Study|Adverse Event, serious fatal|0|||
125594180|NCT01324830|451797379|FG003|Overall Study|Adverse Event, serious fatal|0|||
125594181|NCT01324830|451797380|FG004|Overall Study|Adverse Event, serious fatal|0|||
125594182|NCT01324830|451797381|FG005|Overall Study|Adverse Event, serious fatal|0|||
125594183|NCT01324830|451797382|FG006|Overall Study|Adverse Event, serious fatal|0|||
125594184|NCT01324830|451797383|FG007|Overall Study|Adverse Event, serious fatal|0|||
125594185|NCT01324830|451797384|FG008|Overall Study|Adverse Event, serious fatal|0|||
125594186|NCT01324830|451797385|FG009|Overall Study|Adverse Event, serious fatal|0|||
125594187|NCT01324830|451797386|FG010|Overall Study|Adverse Event, serious fatal|0|||
125594188|NCT01324830|451797387|FG011|Overall Study|Adverse Event, serious fatal|0|||
125594189|NCT01324830|451797388|FG012|Overall Study|Adverse Event, serious fatal|0|||
125594190|NCT01324830|451797389|FG013|Overall Study|Adverse Event, serious fatal|0|||
125594191|NCT01324830|451797390|FG014|Overall Study|Adverse Event, serious fatal|0|||
125594192|NCT01324830|451797391|FG015|Overall Study|Adverse Event, serious fatal|0|||
125594193|NCT01324830|451797392|FG016|Overall Study|Adverse Event, serious fatal|0|||
125594194|NCT01324830|451797393|FG017|Overall Study|Adverse Event, serious fatal|0|||
125594195|NCT01324830|451797394|FG018|Overall Study|Adverse Event, serious fatal|0|||
125594196|NCT01324830|451797376|FG000|Overall Study|Adverse Event, non-fatal|0|||
125594197|NCT01324830|451797377|FG001|Overall Study|Adverse Event, non-fatal|0|||
125594198|NCT01324830|451797378|FG002|Overall Study|Adverse Event, non-fatal|0|||
125594199|NCT01324830|451797379|FG003|Overall Study|Adverse Event, non-fatal|0|||
125594200|NCT01324830|451797380|FG004|Overall Study|Adverse Event, non-fatal|0|||
125594201|NCT01324830|451797381|FG005|Overall Study|Adverse Event, non-fatal|0|||
125594202|NCT01324830|451797382|FG006|Overall Study|Adverse Event, non-fatal|0|||
125594203|NCT01324830|451797383|FG007|Overall Study|Adverse Event, non-fatal|0|||
125594204|NCT01324830|451797384|FG008|Overall Study|Adverse Event, non-fatal|2|||
125594205|NCT01324830|451797385|FG009|Overall Study|Adverse Event, non-fatal|0|||
125594206|NCT01324830|451797386|FG010|Overall Study|Adverse Event, non-fatal|1|||
125594207|NCT01324830|451797387|FG011|Overall Study|Adverse Event, non-fatal|0|||
125364385|NCT00347360|450967169|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
125364386|NCT00347360|450967170|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
125364387|NCT00347360|450967156|FG000|Overall Study|Abnormal lab values|0|||
125364388|NCT00347360|450967157|FG001|Overall Study|Abnormal lab values|0|||
125594208|NCT01324830|451797388|FG012|Overall Study|Adverse Event, non-fatal|0|||
125594209|NCT01324830|451797389|FG013|Overall Study|Adverse Event, non-fatal|0|||
125594210|NCT01324830|451797390|FG014|Overall Study|Adverse Event, non-fatal|0|||
125594211|NCT01324830|451797391|FG015|Overall Study|Adverse Event, non-fatal|0|||
125594212|NCT01324830|451797392|FG016|Overall Study|Adverse Event, non-fatal|0|||
125594213|NCT01324830|451797393|FG017|Overall Study|Adverse Event, non-fatal|1|||
125594214|NCT01324830|451797394|FG018|Overall Study|Adverse Event, non-fatal|0|||
125594215|NCT01324830|451797376|FG000|Overall Study|Withdrawal by Subject|0|||
125594216|NCT01324830|451797377|FG001|Overall Study|Withdrawal by Subject|0|||
125429793|NCT01932697|451198935|FG000|Overall Study|Ineligible|1|||
125429794|NCT01932697|451198936|FG001|Overall Study|Ineligible|0|||
125429795|NCT01538472|451198937|FG000|Overall Study|Disease Progression|3|||
125429796|NCT01538472|451198937|FG000|Overall Study|Death|1|||
125429797|NCT02309112|451198938|FG000|Overall Study|Withdrawal by Subject|1|||
125429798|NCT02309112|451198939|FG001|Overall Study|Withdrawal by Subject|0|||
125429799|NCT02309112|451198940|FG002|Overall Study|Withdrawal by Subject|1|||
125212352|NCT00548249|450403336|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
125212353|NCT00548249|450403337|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
125212354|NCT00548249|450403338|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
125212355|NCT00548249|450403339|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
125212356|NCT00548249|450403335|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
125212357|NCT00548249|450403336|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
125212358|NCT00548249|450403337|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
125212359|NCT00548249|450403338|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
125364389|NCT00347360|450967158|FG002|Overall Study|Abnormal lab values|0|||
125364390|NCT00347360|450967159|FG003|Overall Study|Abnormal lab values|0|||
125364391|NCT00347360|450967160|FG004|Overall Study|Abnormal lab values|0|||
125364392|NCT00347360|450967161|FG005|Overall Study|Abnormal lab values|0|||
125364393|NCT00347360|450967162|FG006|Overall Study|Abnormal lab values|1|||
125364394|NCT00347360|450967163|FG007|Overall Study|Abnormal lab values|0|||
125364395|NCT00347360|450967164|FG008|Overall Study|Abnormal lab values|0|||
125364396|NCT00347360|450967165|FG009|Overall Study|Abnormal lab values|0|||
125364397|NCT00347360|450967166|FG010|Overall Study|Abnormal lab values|0|||
125364398|NCT00347360|450967167|FG011|Overall Study|Abnormal lab values|0|||
125364399|NCT00347360|450967168|FG012|Overall Study|Abnormal lab values|0|||
125364400|NCT00347360|450967169|FG013|Overall Study|Abnormal lab values|0|||
125364401|NCT00347360|450967170|FG014|Overall Study|Abnormal lab values|0|||
125364402|NCT00347360|450967156|FG000|Overall Study|PI recommended early withdrawal|0|||
125364403|NCT00347360|450967157|FG001|Overall Study|PI recommended early withdrawal|0|||
125364404|NCT00347360|450967158|FG002|Overall Study|PI recommended early withdrawal|0|||
125364405|NCT00347360|450967159|FG003|Overall Study|PI recommended early withdrawal|0|||
125364406|NCT00347360|450967160|FG004|Overall Study|PI recommended early withdrawal|0|||
125364407|NCT00347360|450967161|FG005|Overall Study|PI recommended early withdrawal|0|||
125364408|NCT00347360|450967162|FG006|Overall Study|PI recommended early withdrawal|0|||
125364409|NCT00347360|450967163|FG007|Overall Study|PI recommended early withdrawal|0|||
125364410|NCT00347360|450967164|FG008|Overall Study|PI recommended early withdrawal|0|||
125364411|NCT00347360|450967165|FG009|Overall Study|PI recommended early withdrawal|1|||
125364412|NCT00347360|450967166|FG010|Overall Study|PI recommended early withdrawal|0|||
125364413|NCT00347360|450967167|FG011|Overall Study|PI recommended early withdrawal|0|||
125364414|NCT00347360|450967168|FG012|Overall Study|PI recommended early withdrawal|0|||
125364415|NCT00347360|450967169|FG013|Overall Study|PI recommended early withdrawal|0|||
125364416|NCT00347360|450967170|FG014|Overall Study|PI recommended early withdrawal|0|||
125364417|NCT00347360|450967156|FG000|Overall Study|Did not meet criteria before ABPM|0|||
125364418|NCT00347360|450967157|FG001|Overall Study|Did not meet criteria before ABPM|0|||
125364419|NCT00347360|450967158|FG002|Overall Study|Did not meet criteria before ABPM|0|||
125364420|NCT00347360|450967159|FG003|Overall Study|Did not meet criteria before ABPM|0|||
125364421|NCT00347360|450967160|FG004|Overall Study|Did not meet criteria before ABPM|0|||
125364422|NCT00347360|450967161|FG005|Overall Study|Did not meet criteria before ABPM|0|||
125364423|NCT00347360|450967162|FG006|Overall Study|Did not meet criteria before ABPM|0|||
125364424|NCT00347360|450967163|FG007|Overall Study|Did not meet criteria before ABPM|0|||
125364425|NCT00347360|450967164|FG008|Overall Study|Did not meet criteria before ABPM|0|||
125429800|NCT02309112|451198938|FG000|Overall Study|Lost to Follow-up|0|||
125594217|NCT01324830|451797378|FG002|Overall Study|Withdrawal by Subject|0|||
125594218|NCT01324830|451797379|FG003|Overall Study|Withdrawal by Subject|0|||
125594219|NCT01324830|451797380|FG004|Overall Study|Withdrawal by Subject|0|||
125594220|NCT01324830|451797381|FG005|Overall Study|Withdrawal by Subject|1|||
125594221|NCT01324830|451797382|FG006|Overall Study|Withdrawal by Subject|0|||
125594222|NCT01324830|451797383|FG007|Overall Study|Withdrawal by Subject|0|||
125594223|NCT01324830|451797384|FG008|Overall Study|Withdrawal by Subject|0|||
125594224|NCT01324830|451797385|FG009|Overall Study|Withdrawal by Subject|0|||
125594225|NCT01324830|451797386|FG010|Overall Study|Withdrawal by Subject|1|||
125594226|NCT01324830|451797387|FG011|Overall Study|Withdrawal by Subject|0|||
125594227|NCT01324830|451797388|FG012|Overall Study|Withdrawal by Subject|0|||
125594228|NCT01324830|451797389|FG013|Overall Study|Withdrawal by Subject|0|||
125594229|NCT01324830|451797390|FG014|Overall Study|Withdrawal by Subject|0|||
125594230|NCT01324830|451797391|FG015|Overall Study|Withdrawal by Subject|0|||
125594231|NCT01324830|451797392|FG016|Overall Study|Withdrawal by Subject|0|||
125594232|NCT01324830|451797393|FG017|Overall Study|Withdrawal by Subject|0|||
125364426|NCT00347360|450967165|FG009|Overall Study|Did not meet criteria before ABPM|0|||
125364427|NCT00347360|450967166|FG010|Overall Study|Did not meet criteria before ABPM|1|||
125364428|NCT00347360|450967167|FG011|Overall Study|Did not meet criteria before ABPM|0|||
125364429|NCT00347360|450967168|FG012|Overall Study|Did not meet criteria before ABPM|0|||
125429801|NCT02309112|451198939|FG001|Overall Study|Lost to Follow-up|1|||
125364430|NCT00347360|450967169|FG013|Overall Study|Did not meet criteria before ABPM|0|||
125364431|NCT00347360|450967170|FG014|Overall Study|Did not meet criteria before ABPM|0|||
125364432|NCT00347360|450967156|FG000|Overall Study|Randomized in error|0|||
125364433|NCT00347360|450967157|FG001|Overall Study|Randomized in error|0|||
125364434|NCT00347360|450967158|FG002|Overall Study|Randomized in error|0|||
125594233|NCT01324830|451797394|FG018|Overall Study|Withdrawal by Subject|1|||
125594234|NCT00942409|451797395|FG000|Overall Study|Lack of Efficacy|1|||
125594235|NCT00942409|451797395|FG000|Overall Study|study drug unavailable|2|||
125594236|NCT00817414|451797398|FG000|Overall Study|Adverse Event|1|||
125594237|NCT00817414|451797399|FG001|Overall Study|Adverse Event|1|||
125594238|NCT00817414|451797400|FG002|Overall Study|Adverse Event|1|||
125594239|NCT00817414|451797401|FG003|Overall Study|Adverse Event|0|||
125594240|NCT00817414|451797402|FG004|Overall Study|Adverse Event|0|||
125594241|NCT00817414|451797398|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
125594242|NCT00817414|451797399|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
125594243|NCT00817414|451797400|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
125594244|NCT00817414|451797401|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
125594245|NCT00817414|451797402|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
125594246|NCT00817414|451797398|FG000|Overall Study|Withdrawal by Subject|1|||
125594247|NCT00817414|451797399|FG001|Overall Study|Withdrawal by Subject|1|||
125594248|NCT00817414|451797400|FG002|Overall Study|Withdrawal by Subject|0|||
125594249|NCT00817414|451797401|FG003|Overall Study|Withdrawal by Subject|0|||
125594250|NCT00817414|451797402|FG004|Overall Study|Withdrawal by Subject|0|||
125594251|NCT00817414|451797398|FG000|Overall Study|Lost to Follow-up|0|||
125594252|NCT00817414|451797399|FG001|Overall Study|Lost to Follow-up|0|||
125594253|NCT00817414|451797400|FG002|Overall Study|Lost to Follow-up|1|||
125594254|NCT00817414|451797401|FG003|Overall Study|Lost to Follow-up|1|||
125594255|NCT00817414|451797402|FG004|Overall Study|Lost to Follow-up|1|||
125594256|NCT00817414|451797398|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
125594257|NCT00817414|451797399|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
125594258|NCT00817414|451797400|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
125594259|NCT00817414|451797401|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
125594260|NCT00817414|451797402|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
125594261|NCT00817414|451797398|FG000|Overall Study|Protocol Violation|0|||
125594262|NCT00817414|451797399|FG001|Overall Study|Protocol Violation|0|||
125594263|NCT00817414|451797400|FG002|Overall Study|Protocol Violation|0|||
125594264|NCT00817414|451797401|FG003|Overall Study|Protocol Violation|0|||
125594265|NCT00817414|451797402|FG004|Overall Study|Protocol Violation|1|||
125594266|NCT02966314|451797403|FG000|Overall Study|Lost to Follow-up|1|||
125594267|NCT02966314|451797404|FG001|Overall Study|Lost to Follow-up|0|||
125594268|NCT03584009|451797408|FG000|Overall Study|Death|25|||
125594269|NCT03584009|451797409|FG001|Overall Study|Death|18|||
125594270|NCT03584009|451797408|FG000|Overall Study|Lost to Follow-up|0|||
125594271|NCT03584009|451797409|FG001|Overall Study|Lost to Follow-up|1|||
125594272|NCT03584009|451797408|FG000|Overall Study|Physician Decision|1|||
125594273|NCT03584009|451797409|FG001|Overall Study|Physician Decision|1|||
125594274|NCT03584009|451797408|FG000|Overall Study|Study Terminated by Sponsor|22|||
125594275|NCT03584009|451797409|FG001|Overall Study|Study Terminated by Sponsor|30|||
125594276|NCT03584009|451797408|FG000|Overall Study|Withdrawal by Subject|3|||
125594277|NCT03584009|451797409|FG001|Overall Study|Withdrawal by Subject|2|||
125594278|NCT00222105|451797410|FG000|Overall Study|Removed due to wrong diagnosis|1|||
125594279|NCT00222105|451797410|FG000|Overall Study|Withdrawal by Subject|1|||
125594280|NCT00222105|451797410|FG000|Overall Study|Adverse Event|8|||
125594281|NCT00222105|451797410|FG000|Overall Study|Treatment delays|2|||
125594282|NCT00222105|451797410|FG000|Overall Study|Death|2|||
125594283|NCT00824421|451797422|FG000|Overall Study|Adverse Event|6|||
125594284|NCT00824421|451797423|FG001|Overall Study|Adverse Event|6|||
125594285|NCT00824421|451797424|FG002|Overall Study|Adverse Event|6|||
125594286|NCT00824421|451797422|FG000|Overall Study|Death|0|||
125364435|NCT00347360|450967159|FG003|Overall Study|Randomized in error|0|||
125364436|NCT00347360|450967160|FG004|Overall Study|Randomized in error|0|||
125429802|NCT02309112|451198940|FG002|Overall Study|Lost to Follow-up|0|||
125429803|NCT03815019|451198941|FG000|Overall Study|Withdrawal by Subject|6|||
125364437|NCT00347360|450967161|FG005|Overall Study|Randomized in error|0|||
125364438|NCT00347360|450967162|FG006|Overall Study|Randomized in error|0|||
125594287|NCT00824421|451797423|FG001|Overall Study|Death|1|||
125594288|NCT00824421|451797424|FG002|Overall Study|Death|0|||
125594289|NCT00824421|451797422|FG000|Overall Study|Lack of Efficacy|5|||
125594290|NCT00824421|451797423|FG001|Overall Study|Lack of Efficacy|7|||
125594291|NCT00824421|451797424|FG002|Overall Study|Lack of Efficacy|4|||
125594292|NCT00824421|451797422|FG000|Overall Study|Lost to Follow-up|2|||
125594293|NCT00824421|451797423|FG001|Overall Study|Lost to Follow-up|3|||
125594294|NCT00824421|451797424|FG002|Overall Study|Lost to Follow-up|0|||
125364439|NCT00347360|450967163|FG007|Overall Study|Randomized in error|0|||
125594295|NCT00824421|451797422|FG000|Overall Study|Pregnancy|1|||
125364440|NCT00347360|450967164|FG008|Overall Study|Randomized in error|0|||
125364441|NCT00347360|450967165|FG009|Overall Study|Randomized in error|0|||
125364442|NCT00347360|450967166|FG010|Overall Study|Randomized in error|0|||
125364443|NCT00347360|450967167|FG011|Overall Study|Randomized in error|1|||
125364444|NCT00347360|450967168|FG012|Overall Study|Randomized in error|0|||
125364445|NCT00347360|450967169|FG013|Overall Study|Randomized in error|0|||
125364446|NCT00347360|450967170|FG014|Overall Study|Randomized in error|0|||
125364447|NCT00347360|450967156|FG000|Overall Study|Failed inclusion criteria #4|0|||
125364448|NCT00347360|450967157|FG001|Overall Study|Failed inclusion criteria #4|0|||
125364449|NCT00347360|450967158|FG002|Overall Study|Failed inclusion criteria #4|0|||
125364450|NCT00347360|450967159|FG003|Overall Study|Failed inclusion criteria #4|0|||
125364451|NCT00347360|450967160|FG004|Overall Study|Failed inclusion criteria #4|0|||
125364452|NCT00347360|450967161|FG005|Overall Study|Failed inclusion criteria #4|0|||
125364453|NCT00347360|450967162|FG006|Overall Study|Failed inclusion criteria #4|0|||
125364454|NCT00347360|450967163|FG007|Overall Study|Failed inclusion criteria #4|0|||
125429804|NCT03815019|451198942|FG001|Overall Study|Withdrawal by Subject|8|||
125594296|NCT00824421|451797423|FG001|Overall Study|Pregnancy|0|||
125594297|NCT00824421|451797424|FG002|Overall Study|Pregnancy|1|||
125594298|NCT00824421|451797422|FG000|Overall Study|Withdrawal by Subject|2|||
125594299|NCT00824421|451797423|FG001|Overall Study|Withdrawal by Subject|3|||
125594300|NCT00824421|451797424|FG002|Overall Study|Withdrawal by Subject|3|||
125594301|NCT00824421|451797422|FG000|Overall Study|Randomized but not Treated|1|||
125594302|NCT00824421|451797423|FG001|Overall Study|Randomized but not Treated|1|||
125594303|NCT00824421|451797424|FG002|Overall Study|Randomized but not Treated|0|||
125594304|NCT00824421|451797422|FG000|Overall Study|Other|0|||
125594305|NCT00824421|451797423|FG001|Overall Study|Other|1|||
125594306|NCT00824421|451797424|FG002|Overall Study|Other|0|||
125594307|NCT02120417|451797426|FG000|Overall Study|Death|5|||
125594308|NCT02120417|451797427|FG001|Overall Study|Death|1|||
125594309|NCT02120417|451797426|FG000|Overall Study|Adverse Event|3|||
125594310|NCT02120417|451797427|FG001|Overall Study|Adverse Event|9|||
125594311|NCT02120417|451797426|FG000|Overall Study|Participant decision|4|||
125594312|NCT02120417|451797427|FG001|Overall Study|Participant decision|4|||
125594313|NCT02120417|451797426|FG000|Overall Study|Disease progression|41|||
125594314|NCT02120417|451797427|FG001|Overall Study|Disease progression|45|||
125594315|NCT02120417|451797426|FG000|Overall Study|Noncompliance with study treatment|0|||
125594316|NCT02120417|451797427|FG001|Overall Study|Noncompliance with study treatment|2|||
125594317|NCT02120417|451797426|FG000|Overall Study|Physician Decision|2|||
125594318|NCT02120417|451797427|FG001|Overall Study|Physician Decision|3|||
125594319|NCT02120417|451797426|FG000|Overall Study|Other unspecified|5|||
125594320|NCT02120417|451797427|FG001|Overall Study|Other unspecified|4|||
125594321|NCT00927485|451797428|FG000|Overall Study|Adverse Event|4|||
125594322|NCT00927485|451797429|FG001|Overall Study|Adverse Event|2|||
125364455|NCT00347360|450967164|FG008|Overall Study|Failed inclusion criteria #4|0|||
125594323|NCT00927485|451797428|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
125594324|NCT00927485|451797429|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
125594325|NCT02604264|451797430|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
125364456|NCT00347360|450967165|FG009|Overall Study|Failed inclusion criteria #4|0|||
125429805|NCT03759834|451198943|FG000|Overall Study|Withdrawal by Subject|1|||
125594326|NCT02604264|451797431|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
125594327|NCT00256295|451797434|FG000|Overall Study|Withdrawal by Subject|3|||
125594328|NCT00256295|451797434|FG000|Overall Study|Death|1|||
125594329|NCT01731002|451797444|FG000|Overall Study|Adverse Event|0|||
125594330|NCT01731002|451797445|FG001|Overall Study|Adverse Event|2|||
125594331|NCT01731002|451797446|FG002|Overall Study|Adverse Event|2|||
125594332|NCT01731002|451797444|FG000|Overall Study|Non-Compliant|0|||
125594333|NCT01731002|451797445|FG001|Overall Study|Non-Compliant|1|||
125594334|NCT01731002|451797446|FG002|Overall Study|Non-Compliant|0|||
125594335|NCT01731002|451797444|FG000|Overall Study|Lost to Follow-up|1|||
125594336|NCT01731002|451797445|FG001|Overall Study|Lost to Follow-up|0|||
125594337|NCT01731002|451797446|FG002|Overall Study|Lost to Follow-up|0|||
125594338|NCT01731002|451797444|FG000|Overall Study|Test Agent Discontinuation|0|||
125594339|NCT01731002|451797445|FG001|Overall Study|Test Agent Discontinuation|1|||
125594340|NCT01731002|451797446|FG002|Overall Study|Test Agent Discontinuation|0|||
125594341|NCT01731002|451797444|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
125594342|NCT01731002|451797445|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
125594343|NCT01731002|451797446|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
125594344|NCT01731002|451797444|FG000|Overall Study|Elevated IOP|1|||
125594345|NCT01731002|451797445|FG001|Overall Study|Elevated IOP|0|||
125594346|NCT01731002|451797446|FG002|Overall Study|Elevated IOP|0|||
125594347|NCT01731002|451797444|FG000|Overall Study|Inappropriate use of study medications|0|||
125594348|NCT01731002|451797445|FG001|Overall Study|Inappropriate use of study medications|0|||
125594349|NCT01731002|451797446|FG002|Overall Study|Inappropriate use of study medications|1|||
125594350|NCT00628355|451797449|FG000|Overall Study|Withdrawal by Subject|1|||
125594351|NCT00628355|451797450|FG001|Overall Study|Withdrawal by Subject|1|||
125594352|NCT03542682|451797451|FG000|Overall Study|COVID-19 Protocol|0|||
125594353|NCT03542682|451797452|FG001|Overall Study|COVID-19 Protocol|1|||
125594354|NCT00853632|451798777|FG000|Overall Study|Death|88|||
125594355|NCT00853632|451798777|FG000|Overall Study|Withdrawal by Subject|45|||
125594356|NCT00853632|451798777|FG000|Overall Study|Lost to Follow-up|30|||
125594357|NCT00853632|451798777|FG000|Overall Study|Reoperation/Explant|17|||
125594358|NCT00853632|451798777|FG000|Overall Study|Exit with other reason|22|||
125594359|NCT00886821|451798783|FG000|Stage 2|Adverse Event|0|||
125594360|NCT00886821|451798784|FG001|Stage 2|Adverse Event|0|||
125594361|NCT00886821|451798785|FG002|Stage 2|Adverse Event|0|||
125594362|NCT00886821|451798786|FG003|Stage 2|Adverse Event|0|||
125594363|NCT00886821|451798787|FG004|Stage 2|Adverse Event|0|||
125594364|NCT00886821|451798788|FG005|Stage 2|Adverse Event|0|||
125594365|NCT00886821|451798789|FG006|Stage 2|Adverse Event|0|||
125594366|NCT00886821|451798790|FG007|Stage 2|Adverse Event|0|||
125594367|NCT00886821|451798791|FG008|Stage 2|Adverse Event|0|||
125594368|NCT00886821|451798792|FG009|Stage 2|Adverse Event|0|||
125594369|NCT00886821|451798793|FG010|Stage 2|Adverse Event|0|||
125594370|NCT00886821|451798794|FG011|Stage 2|Adverse Event|1|||
125594371|NCT00886821|451798795|FG012|Stage 2|Adverse Event|3|||
125594372|NCT00886821|451798796|FG013|Stage 2|Adverse Event|0|||
125594373|NCT00886821|451798783|FG000|Stage 2|Lost to Follow-up|0|||
125594374|NCT00886821|451798784|FG001|Stage 2|Lost to Follow-up|0|||
125594375|NCT00886821|451798785|FG002|Stage 2|Lost to Follow-up|0|||
125594376|NCT00886821|451798786|FG003|Stage 2|Lost to Follow-up|0|||
125594377|NCT00886821|451798787|FG004|Stage 2|Lost to Follow-up|0|||
125594378|NCT00886821|451798788|FG005|Stage 2|Lost to Follow-up|0|||
125594379|NCT00886821|451798789|FG006|Stage 2|Lost to Follow-up|0|||
125594380|NCT00886821|451798790|FG007|Stage 2|Lost to Follow-up|0|||
125594381|NCT00886821|451798791|FG008|Stage 2|Lost to Follow-up|0|||
125594382|NCT00886821|451798792|FG009|Stage 2|Lost to Follow-up|0|||
125594383|NCT00886821|451798793|FG010|Stage 2|Lost to Follow-up|0|||
125594384|NCT00886821|451798794|FG011|Stage 2|Lost to Follow-up|0|||
125594385|NCT00886821|451798795|FG012|Stage 2|Lost to Follow-up|2|||
125594386|NCT00886821|451798796|FG013|Stage 2|Lost to Follow-up|1|||
125594387|NCT00914628|451798797|FG000|Overall Study|Death|35|||
125594388|NCT00914628|451798798|FG001|Overall Study|Death|17|||
125594389|NCT00914628|451798797|FG000|Overall Study|Medical decision|4|||
125594390|NCT00914628|451798798|FG001|Overall Study|Medical decision|0|||
125594391|NCT00914628|451798797|FG000|Overall Study|Protocol Violation|1|||
125594392|NCT00914628|451798798|FG001|Overall Study|Protocol Violation|0|||
125594393|NCT00914628|451798797|FG000|Overall Study|Lack of Efficacy|1|||
125594394|NCT00914628|451798798|FG001|Overall Study|Lack of Efficacy|0|||
125594395|NCT00914628|451798797|FG000|Overall Study|non-randomized|1|||
125594396|NCT00914628|451798798|FG001|Overall Study|non-randomized|0|||
125594397|NCT00914628|451798797|FG000|Overall Study|Relapse|1|||
125594398|NCT00914628|451798798|FG001|Overall Study|Relapse|2|||
125594399|NCT00914628|451798797|FG000|Overall Study|Study terminated by Sponsor|14|||
125594400|NCT00914628|451798798|FG001|Overall Study|Study terminated by Sponsor|8|||
125594401|NCT00914628|451798797|FG000|Overall Study|Patients who did not receive a single dose|7|||
125594402|NCT00914628|451798798|FG001|Overall Study|Patients who did not receive a single dose|1|||
125429806|NCT03937219|451198944|FG000|Overall Study|Death|223|||
125429807|NCT03937219|451198945|FG001|Overall Study|Death|211|||
125429808|NCT03937219|451198944|FG000|Overall Study|Withdrawal by Subject|17|||
125429809|NCT03937219|451198945|FG001|Overall Study|Withdrawal by Subject|25|||
125429810|NCT03937219|451198944|FG000|Overall Study|Lost to Follow-up|3|||
125429811|NCT03937219|451198945|FG001|Overall Study|Lost to Follow-up|4|||
125429812|NCT04803214|451198946|FG000|Overall Study|Adverse Event|1|||
125429813|NCT04803214|451198947|FG001|Overall Study|Adverse Event|0|||
125364457|NCT00347360|450967166|FG010|Overall Study|Failed inclusion criteria #4|0|||
125364458|NCT00347360|450967167|FG011|Overall Study|Failed inclusion criteria #4|1|||
125364459|NCT00347360|450967168|FG012|Overall Study|Failed inclusion criteria #4|0|||
125364460|NCT00347360|450967169|FG013|Overall Study|Failed inclusion criteria #4|0|||
125364461|NCT00347360|450967170|FG014|Overall Study|Failed inclusion criteria #4|0|||
125364462|NCT00347360|450967156|FG000|Overall Study|Prolonged duration between visits|0|||
125429814|NCT04803214|451198946|FG000|Overall Study|Withdrawal by Subject|1|||
125429815|NCT04803214|451198947|FG001|Overall Study|Withdrawal by Subject|2|||
125429816|NCT04803214|451198946|FG000|Overall Study|Lost to Follow-up|2|||
125429817|NCT04803214|451198947|FG001|Overall Study|Lost to Follow-up|4|||
125429818|NCT04803214|451198946|FG000|Overall Study|Physician Decision|1|||
125429819|NCT04803214|451198947|FG001|Overall Study|Physician Decision|1|||
125429820|NCT04803214|451198946|FG000|Overall Study|Missed 12 month visit|0|||
125429821|NCT04803214|451198947|FG001|Overall Study|Missed 12 month visit|3|||
125429822|NCT00941798|451198953|FG000|Overall Study|Withdrawal by Subject|72|||
125429823|NCT00941798|451198954|FG001|Overall Study|Withdrawal by Subject|74|||
125429824|NCT00941798|451198953|FG000|Overall Study|Adverse Event|43|||
125429825|NCT00941798|451198954|FG001|Overall Study|Adverse Event|23|||
125429826|NCT00941798|451198953|FG000|Overall Study|Lost to Follow-up|29|||
125429827|NCT00941798|451198954|FG001|Overall Study|Lost to Follow-up|23|||
125429828|NCT00941798|451198953|FG000|Overall Study|Protocol Violation|17|||
125429829|NCT00941798|451198954|FG001|Overall Study|Protocol Violation|20|||
125429830|NCT00941798|451198953|FG000|Overall Study|Administrative problems|13|||
125429831|NCT00941798|451198954|FG001|Overall Study|Administrative problems|23|||
125429832|NCT00941798|451198953|FG000|Overall Study|Lack of Efficacy|10|||
125429833|NCT00941798|451198954|FG001|Overall Study|Lack of Efficacy|17|||
125429834|NCT00941798|451198953|FG000|Overall Study|Patient's inability to use device|6|||
125429835|NCT00941798|451198954|FG001|Overall Study|Patient's inability to use device|1|||
125364463|NCT00347360|450967157|FG001|Overall Study|Prolonged duration between visits|0|||
125364464|NCT00347360|450967158|FG002|Overall Study|Prolonged duration between visits|0|||
125364465|NCT00347360|450967159|FG003|Overall Study|Prolonged duration between visits|0|||
125364466|NCT00347360|450967160|FG004|Overall Study|Prolonged duration between visits|0|||
125364467|NCT00347360|450967161|FG005|Overall Study|Prolonged duration between visits|0|||
125364468|NCT00347360|450967162|FG006|Overall Study|Prolonged duration between visits|0|||
125364469|NCT00347360|450967163|FG007|Overall Study|Prolonged duration between visits|0|||
125364470|NCT00347360|450967164|FG008|Overall Study|Prolonged duration between visits|0|||
125364471|NCT00347360|450967165|FG009|Overall Study|Prolonged duration between visits|0|||
125364472|NCT00347360|450967166|FG010|Overall Study|Prolonged duration between visits|0|||
125364473|NCT00347360|450967167|FG011|Overall Study|Prolonged duration between visits|0|||
125364474|NCT00347360|450967168|FG012|Overall Study|Prolonged duration between visits|1|||
125364475|NCT00347360|450967169|FG013|Overall Study|Prolonged duration between visits|0|||
125364476|NCT00347360|450967170|FG014|Overall Study|Prolonged duration between visits|0|||
125364477|NCT00347360|450967156|FG000|Overall Study|Subject left town, ran out of study drug|0|||
125364478|NCT00347360|450967157|FG001|Overall Study|Subject left town, ran out of study drug|0|||
125364479|NCT00347360|450967158|FG002|Overall Study|Subject left town, ran out of study drug|0|||
125212360|NCT00548249|450403339|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
125429836|NCT00941798|451198953|FG000|Overall Study|Abnormal test procedure results|3|||
125429837|NCT00941798|451198954|FG001|Overall Study|Abnormal test procedure results|1|||
125429838|NCT00941798|451198953|FG000|Overall Study|Abnormal laboratory values|1|||
125364480|NCT00347360|450967159|FG003|Overall Study|Subject left town, ran out of study drug|0|||
125364481|NCT00347360|450967160|FG004|Overall Study|Subject left town, ran out of study drug|0|||
125364482|NCT00347360|450967161|FG005|Overall Study|Subject left town, ran out of study drug|0|||
125594403|NCT03404960|451798799|FG000|Overall Study|Adverse Event|0|||
125594404|NCT03404960|451798800|FG001|Overall Study|Adverse Event|2|||
125594405|NCT03404960|451798799|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
125594406|NCT03404960|451798800|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
125594407|NCT03404960|451798799|FG000|Overall Study|Bowel obstruction|0|||
125594408|NCT03404960|451798800|FG001|Overall Study|Bowel obstruction|1|||
125594409|NCT03404960|451798799|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
125594410|NCT03404960|451798800|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
125594411|NCT03311126|451798801|FG000|Induction|Death|1|||
125594412|NCT03311126|451798801|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
125594413|NCT03368859|451798804|FG000|Overall Study|Withdrew Consent|5|||
125594414|NCT03368859|451798805|FG001|Overall Study|Withdrew Consent|4|||
125594415|NCT03368859|451798804|FG000|Overall Study|Death|12|||
125594416|NCT03368859|451798805|FG001|Overall Study|Death|6|||
125594417|NCT03368859|451798804|FG000|Overall Study|Study terminated by Sponsor|18|||
125594418|NCT03368859|451798805|FG001|Overall Study|Study terminated by Sponsor|23|||
125594419|NCT03368859|451798804|FG000|Overall Study|Other|1|||
125594420|NCT03368859|451798805|FG001|Overall Study|Other|1|||
125594421|NCT02698410|451798806|FG000|Overall Study|Adverse Event|2|||
125594422|NCT02698410|451798806|FG000|Overall Study|Withdrawal by Subject|1|||
125594423|NCT02698410|451798806|FG000|Overall Study|Other|1|||
125594424|NCT02559505|451798807|FG000|Overall Study|Lost to Follow-up|23|||
125594425|NCT02559505|451798808|FG001|Overall Study|Lost to Follow-up|20|||
125594426|NCT02559505|451798807|FG000|Overall Study|Withdrawal by Subject|4|||
125594427|NCT02559505|451798808|FG001|Overall Study|Withdrawal by Subject|2|||
125594428|NCT01584024|451798809|FG000|Overall Study|Lost to Follow-up|10|||
125594429|NCT01584024|451798809|FG000|Overall Study|Withdrawal by Subject|3|||
125594430|NCT01217606|451798810|FG000|Initial Treatment Phase|Other Reasons|0|||
125594431|NCT01217606|451798811|FG001|Initial Treatment Phase|Other Reasons|2|||
125594432|NCT01217606|451798810|FG000|Initial Treatment Phase|Protocol Violation|3|||
125594433|NCT01217606|451798811|FG001|Initial Treatment Phase|Protocol Violation|2|||
125594434|NCT01217606|451798810|FG000|Initial Treatment Phase|Personal Reasons|0|||
125594435|NCT01217606|451798811|FG001|Initial Treatment Phase|Personal Reasons|2|||
125594436|NCT01217606|451798810|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
125594437|NCT01217606|451798811|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
125594438|NCT01217606|451798810|FG000|Initial Treatment Phase|Adverse Event|10|||
125594439|NCT01217606|451798811|FG001|Initial Treatment Phase|Adverse Event|6|||
125594440|NCT01217606|451798810|FG000|9-Month Masked Extension|Adverse Event|3|||
125594441|NCT01217606|451798811|FG001|9-Month Masked Extension|Adverse Event|6|||
125594442|NCT01217606|451798810|FG000|9-Month Masked Extension|Other Reasons|4|||
125594443|NCT01217606|451798811|FG001|9-Month Masked Extension|Other Reasons|4|||
125594444|NCT01217606|451798810|FG000|9-Month Masked Extension|Personal Reasons|2|||
125594445|NCT01217606|451798811|FG001|9-Month Masked Extension|Personal Reasons|1|||
125594446|NCT01217606|451798810|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
125594447|NCT01217606|451798811|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
125594448|NCT01217606|451798810|FG000|9-Month Masked Extension|Pregnancy|1|||
125594449|NCT01217606|451798811|FG001|9-Month Masked Extension|Pregnancy|0|||
125594450|NCT01217606|451798810|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
125594451|NCT01217606|451798811|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
125594452|NCT00893789|451798821|FG000|Overall Study|Withdrawal by Subject|3|||
125594453|NCT00893789|451798822|FG001|Overall Study|Withdrawal by Subject|1|||
125594454|NCT00893789|451798823|FG002|Overall Study|Withdrawal by Subject|3|||
125594455|NCT00893789|451798824|FG003|Overall Study|Withdrawal by Subject|1|||
125594456|NCT00893789|451798821|FG000|Overall Study|Noncompliance With Study Drug|1|||
125594457|NCT00893789|451798822|FG001|Overall Study|Noncompliance With Study Drug|0|||
125594458|NCT00893789|451798823|FG002|Overall Study|Noncompliance With Study Drug|1|||
125594459|NCT00893789|451798824|FG003|Overall Study|Noncompliance With Study Drug|2|||
125594460|NCT00893789|451798821|FG000|Overall Study|Noncompliance With Study Procedures|1|||
125594461|NCT00893789|451798822|FG001|Overall Study|Noncompliance With Study Procedures|0|||
125594462|NCT00893789|451798823|FG002|Overall Study|Noncompliance With Study Procedures|0|||
125594463|NCT00893789|451798824|FG003|Overall Study|Noncompliance With Study Procedures|0|||
125594464|NCT00893789|451798821|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
125594465|NCT00893789|451798822|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
125594466|NCT00893789|451798823|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
125594467|NCT00893789|451798824|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
125594468|NCT00893789|451798821|FG000|Overall Study|Adverse Event|0|||
125594469|NCT00893789|451798822|FG001|Overall Study|Adverse Event|2|||
125594470|NCT00893789|451798823|FG002|Overall Study|Adverse Event|1|||
125429839|NCT00941798|451198954|FG001|Overall Study|Abnormal laboratory values|2|||
125429840|NCT00941798|451198953|FG000|Overall Study|Death|0|||
125429841|NCT00941798|451198954|FG001|Overall Study|Death|1|||
125429842|NCT05597722|451198955|FG000|Overall Study|Study was terminated|6|||
125429843|NCT05597722|451198956|FG001|Overall Study|Study was terminated|1|||
125429844|NCT04108000|451198957|FG000|Overall Study|Death of patient|1|||
125429845|NCT04108000|451198958|FG001|Overall Study|Death of patient|0|||
125429846|NCT04108000|451198959|FG002|Overall Study|Death of patient|1|||
125429847|NCT04108000|451198960|FG003|Overall Study|Death of patient|0|||
125429848|NCT04108000|451198957|FG000|Overall Study|Withdrawal by Subject|2|||
125429849|NCT04108000|451198958|FG001|Overall Study|Withdrawal by Subject|2|||
125364483|NCT00347360|450967162|FG006|Overall Study|Subject left town, ran out of study drug|0|||
125364484|NCT00347360|450967163|FG007|Overall Study|Subject left town, ran out of study drug|0|||
125364485|NCT00347360|450967164|FG008|Overall Study|Subject left town, ran out of study drug|0|||
125364486|NCT00347360|450967165|FG009|Overall Study|Subject left town, ran out of study drug|0|||
125364487|NCT00347360|450967166|FG010|Overall Study|Subject left town, ran out of study drug|0|||
125364488|NCT00347360|450967167|FG011|Overall Study|Subject left town, ran out of study drug|0|||
125364489|NCT00347360|450967168|FG012|Overall Study|Subject left town, ran out of study drug|0|||
125364490|NCT00347360|450967169|FG013|Overall Study|Subject left town, ran out of study drug|1|||
125364491|NCT00347360|450967170|FG014|Overall Study|Subject left town, ran out of study drug|0|||
125364492|NCT00347360|450967156|FG000|Overall Study|Subject refuse to sign updated consent|0|||
125364493|NCT00347360|450967157|FG001|Overall Study|Subject refuse to sign updated consent|0|||
125364494|NCT00347360|450967158|FG002|Overall Study|Subject refuse to sign updated consent|0|||
125364495|NCT00347360|450967159|FG003|Overall Study|Subject refuse to sign updated consent|0|||
125364496|NCT00347360|450967160|FG004|Overall Study|Subject refuse to sign updated consent|0|||
125364497|NCT00347360|450967161|FG005|Overall Study|Subject refuse to sign updated consent|0|||
125364498|NCT00347360|450967162|FG006|Overall Study|Subject refuse to sign updated consent|0|||
125364499|NCT00347360|450967163|FG007|Overall Study|Subject refuse to sign updated consent|0|||
125364500|NCT00347360|450967164|FG008|Overall Study|Subject refuse to sign updated consent|0|||
125429850|NCT04108000|451198959|FG002|Overall Study|Withdrawal by Subject|0|||
125429851|NCT04108000|451198960|FG003|Overall Study|Withdrawal by Subject|0|||
125429852|NCT04108000|451198957|FG000|Overall Study|Death of surrogate partner|0|||
125429853|NCT04108000|451198958|FG001|Overall Study|Death of surrogate partner|1|||
125429854|NCT04108000|451198959|FG002|Overall Study|Death of surrogate partner|0|||
125429855|NCT04108000|451198960|FG003|Overall Study|Death of surrogate partner|1|||
125429856|NCT00685945|451200107|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
125429857|NCT03183388|451200108|FG000|Overall Study|Lost to Follow-up|3|||
125429858|NCT03183388|451200109|FG001|Overall Study|Lost to Follow-up|5|||
125429859|NCT03183388|451200108|FG000|Overall Study|Physician Decision|1|||
125429860|NCT03183388|451200109|FG001|Overall Study|Physician Decision|4|||
125429861|NCT03183388|451200108|FG000|Overall Study|Withdrawal by Subject|4|||
125429862|NCT03183388|451200109|FG001|Overall Study|Withdrawal by Subject|1|||
125429863|NCT03183388|451200108|FG000|Overall Study|Moved|1|||
125429864|NCT03183388|451200109|FG001|Overall Study|Moved|0|||
125429865|NCT03183388|451200108|FG000|Overall Study|Met Exclusion Criteria|2|||
125429866|NCT03183388|451200109|FG001|Overall Study|Met Exclusion Criteria|2|||
125429867|NCT03183388|451200108|FG000|Overall Study|COVID Pandemic Related|2|||
125429868|NCT03183388|451200109|FG001|Overall Study|COVID Pandemic Related|4|||
125429869|NCT00847405|451200110|FG000|First Intervention|Adverse Event|0|||
125429870|NCT00847405|451200111|FG001|First Intervention|Adverse Event|1|||
125429871|NCT00847405|451200110|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125429872|NCT00847405|451200111|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125429873|NCT01728792|451200112|FG000|Overall Study|Withdrawal of Consent|1|||
125594471|NCT00893789|451798824|FG003|Overall Study|Adverse Event|5|||
125594472|NCT00893789|451798821|FG000|Overall Study|Protocol Violation|0|||
125594473|NCT00893789|451798822|FG001|Overall Study|Protocol Violation|1|||
125594474|NCT00893789|451798823|FG002|Overall Study|Protocol Violation|1|||
125594475|NCT00893789|451798824|FG003|Overall Study|Protocol Violation|4|||
125594476|NCT00893789|451798821|FG000|Overall Study|Lost to Follow-up|0|||
125594477|NCT00893789|451798822|FG001|Overall Study|Lost to Follow-up|0|||
125594478|NCT00893789|451798823|FG002|Overall Study|Lost to Follow-up|0|||
125594479|NCT00893789|451798824|FG003|Overall Study|Lost to Follow-up|1|||
125594480|NCT04723537|451798825|FG000|Overall Study|Withdrawal by Subject|3|||
125594481|NCT04723537|451798826|FG001|Overall Study|Withdrawal by Subject|0|||
125594482|NCT04723537|451798827|FG002|Overall Study|Withdrawal by Subject|0|||
125594483|NCT04723537|451798825|FG000|Overall Study|Physician Decision|0|||
125594484|NCT04723537|451798826|FG001|Overall Study|Physician Decision|0|||
125594485|NCT04723537|451798827|FG002|Overall Study|Physician Decision|1|||
125429874|NCT01728792|451200113|FG001|Overall Study|Withdrawal of Consent|1|||
125429875|NCT01728792|451200114|FG002|Overall Study|Withdrawal of Consent|0|||
125429876|NCT01728792|451200115|FG003|Overall Study|Withdrawal of Consent|1|||
125594486|NCT04723537|451798825|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
125594487|NCT04723537|451798826|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
125429877|NCT01728792|451200116|FG004|Overall Study|Withdrawal of Consent|0|||
125429878|NCT01728792|451200112|FG000|Overall Study|Lost to Follow-up|2|||
125429879|NCT01728792|451200113|FG001|Overall Study|Lost to Follow-up|1|||
125429880|NCT01728792|451200114|FG002|Overall Study|Lost to Follow-up|4|||
125429881|NCT01728792|451200115|FG003|Overall Study|Lost to Follow-up|2|||
125429882|NCT01728792|451200116|FG004|Overall Study|Lost to Follow-up|0|||
125429883|NCT04277455|451200119|FG000|Overall Study|Lost to Follow-up|1|||
125594488|NCT04723537|451798827|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
125594489|NCT05408858|451798828|FG000|Overall Study|no longer met eligibility criteria|1|||
125594490|NCT04419506|451798829|FG000|Overall Study|Adverse Event|0|||
125594491|NCT04419506|451798830|FG001|Overall Study|Adverse Event|10|||
125594492|NCT04419506|451798831|FG002|Overall Study|Adverse Event|0|||
125594493|NCT04419506|451798832|FG003|Overall Study|Adverse Event|3|||
125594494|NCT04419506|451798829|FG000|Overall Study|Withdrawal by Subject|0|||
125594495|NCT04419506|451798830|FG001|Overall Study|Withdrawal by Subject|0|||
125594496|NCT04419506|451798831|FG002|Overall Study|Withdrawal by Subject|0|||
125594497|NCT04419506|451798832|FG003|Overall Study|Withdrawal by Subject|1|||
125594498|NCT04419506|451798829|FG000|Overall Study|poor-compliance|0|||
125594499|NCT04419506|451798830|FG001|Overall Study|poor-compliance|0|||
125594500|NCT04419506|451798831|FG002|Overall Study|poor-compliance|0|||
125594501|NCT04419506|451798832|FG003|Overall Study|poor-compliance|1|||
125594502|NCT01973283|451798839|FG000|Overall Study|Lost to Follow-up|4|||
125594503|NCT00097539|451798842|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
125594504|NCT00097539|451798843|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
125594505|NCT00097539|451798844|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
125594506|NCT00097539|451798845|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
125594507|NCT00097539|451798846|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
125594508|NCT00097539|451798847|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
125594509|NCT00097539|451798848|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
125594510|NCT00097539|451798842|FG000|Overall Study|Withdrawal by Subject|925|||
125429884|NCT00949715|451200120|FG000|Overall Study|Physician Decision|1|||
125594511|NCT00097539|451798843|FG001|Overall Study|Withdrawal by Subject|323|||
125212361|NCT00548249|450403335|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
125594512|NCT00097539|451798844|FG002|Overall Study|Withdrawal by Subject|346|||
125594513|NCT00097539|451798845|FG003|Overall Study|Withdrawal by Subject|217|||
125594514|NCT00097539|451798846|FG004|Overall Study|Withdrawal by Subject|68|||
125594515|NCT00097539|451798847|FG005|Overall Study|Withdrawal by Subject|229|||
125594516|NCT00097539|451798848|FG006|Overall Study|Withdrawal by Subject|3|||
125594517|NCT00097539|451798842|FG000|Overall Study|Participant Non-compliant|2140|||
125364501|NCT00347360|450967165|FG009|Overall Study|Subject refuse to sign updated consent|0|||
125364502|NCT00347360|450967166|FG010|Overall Study|Subject refuse to sign updated consent|0|||
125364503|NCT00347360|450967167|FG011|Overall Study|Subject refuse to sign updated consent|0|||
125364504|NCT00347360|450967168|FG012|Overall Study|Subject refuse to sign updated consent|0|||
125364505|NCT00347360|450967169|FG013|Overall Study|Subject refuse to sign updated consent|0|||
125364506|NCT00347360|450967170|FG014|Overall Study|Subject refuse to sign updated consent|1|||
125364507|NCT00347360|450967156|FG000|Overall Study|Visits conflicted with new job|0|||
125364508|NCT00347360|450967157|FG001|Overall Study|Visits conflicted with new job|0|||
125594518|NCT00097539|451798843|FG001|Overall Study|Participant Non-compliant|567|||
125594519|NCT00097539|451798844|FG002|Overall Study|Participant Non-compliant|1067|||
125594520|NCT00097539|451798845|FG003|Overall Study|Participant Non-compliant|353|||
125594521|NCT00097539|451798846|FG004|Overall Study|Participant Non-compliant|136|||
125594522|NCT00097539|451798847|FG005|Overall Study|Participant Non-compliant|543|||
125594523|NCT00097539|451798848|FG006|Overall Study|Participant Non-compliant|18|||
125594524|NCT00097539|451798842|FG000|Overall Study|Lack of Efficacy|249|||
125594525|NCT00097539|451798843|FG001|Overall Study|Lack of Efficacy|122|||
125594526|NCT00097539|451798844|FG002|Overall Study|Lack of Efficacy|202|||
125594527|NCT00097539|451798845|FG003|Overall Study|Lack of Efficacy|105|||
125594528|NCT00097539|451798846|FG004|Overall Study|Lack of Efficacy|45|||
125594529|NCT00097539|451798847|FG005|Overall Study|Lack of Efficacy|228|||
125594530|NCT00097539|451798848|FG006|Overall Study|Lack of Efficacy|5|||
125594531|NCT00097539|451798842|FG000|Overall Study|Adverse Event|78|||
125594532|NCT00097539|451798843|FG001|Overall Study|Adverse Event|133|||
125594533|NCT00097539|451798844|FG002|Overall Study|Adverse Event|37|||
125594534|NCT00097539|451798845|FG003|Overall Study|Adverse Event|27|||
125594535|NCT00097539|451798846|FG004|Overall Study|Adverse Event|30|||
125594536|NCT00097539|451798847|FG005|Overall Study|Adverse Event|59|||
125594537|NCT00097539|451798848|FG006|Overall Study|Adverse Event|1|||
125594538|NCT00097539|451798842|FG000|Overall Study|Death|2|||
125594539|NCT00097539|451798843|FG001|Overall Study|Death|7|||
125594540|NCT00097539|451798844|FG002|Overall Study|Death|0|||
125594541|NCT00097539|451798845|FG003|Overall Study|Death|0|||
125594542|NCT00097539|451798846|FG004|Overall Study|Death|1|||
125594543|NCT00097539|451798847|FG005|Overall Study|Death|3|||
125594544|NCT00097539|451798848|FG006|Overall Study|Death|0|||
125594545|NCT00097539|451798842|FG000|Overall Study|Reasons Other Than Above|3602|||
125594546|NCT00097539|451798843|FG001|Overall Study|Reasons Other Than Above|1382|||
125594547|NCT00097539|451798844|FG002|Overall Study|Reasons Other Than Above|1757|||
125594548|NCT00097539|451798845|FG003|Overall Study|Reasons Other Than Above|692|||
125594549|NCT00097539|451798846|FG004|Overall Study|Reasons Other Than Above|361|||
125594550|NCT00097539|451798847|FG005|Overall Study|Reasons Other Than Above|1244|||
125594551|NCT00097539|451798848|FG006|Overall Study|Reasons Other Than Above|34|||
125594552|NCT00097539|451798842|FG000|Overall Study|Reason not Specified|111|||
125594553|NCT00097539|451798843|FG001|Overall Study|Reason not Specified|49|||
125594554|NCT00097539|451798844|FG002|Overall Study|Reason not Specified|53|||
125594555|NCT00097539|451798845|FG003|Overall Study|Reason not Specified|21|||
125594556|NCT00097539|451798846|FG004|Overall Study|Reason not Specified|11|||
125212362|NCT00548249|450403336|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
125594557|NCT00097539|451798847|FG005|Overall Study|Reason not Specified|40|||
125594558|NCT00097539|451798848|FG006|Overall Study|Reason not Specified|2|||
125594559|NCT03941548|451798852|FG000|Overall Study|Adverse Event|0|||
125594560|NCT03941548|451798853|FG001|Overall Study|Adverse Event|1|||
125594561|NCT03941548|451798852|FG000|Overall Study|Lost to Follow-up|0|||
125594562|NCT03941548|451798853|FG001|Overall Study|Lost to Follow-up|1|||
125594563|NCT03941548|451798852|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
125594564|NCT03941548|451798853|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
125594565|NCT03717922|451798856|FG000|Overall Study|Lost to Follow-up|2|||
125594566|NCT03717922|451798857|FG001|Overall Study|Lost to Follow-up|2|||
125594567|NCT01242111|451798858|FG000|Overall Study|Adverse Event|1|||
125594568|NCT01242111|451798858|FG000|Overall Study|Withdrawal by Subject|1|||
125594569|NCT01242111|451798858|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
125594570|NCT01021007|451798861|FG000|Overall Study|Lost to Follow-up|1|||
125594571|NCT01021007|451798862|FG001|Overall Study|Lost to Follow-up|1|||
125594572|NCT01021007|451798861|FG000|Overall Study|Adverse Event|1|||
125594573|NCT01021007|451798862|FG001|Overall Study|Adverse Event|3|||
125594574|NCT02015819|451798863|FG000|Overall Study|Rickham catheter was misaligned|0|||
125594575|NCT02015819|451798864|FG001|Overall Study|Rickham catheter was misaligned|0|||
125594576|NCT02015819|451798865|FG002|Overall Study|Rickham catheter was misaligned|0|||
125594577|NCT02015819|451798866|FG003|Overall Study|Rickham catheter was misaligned|1|||
125594578|NCT02945657|451798867|FG000|Overall Study|Adverse Event|1|||
125594579|NCT02945657|451798867|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
125594580|NCT00087438|451798869|FG000|Overall Study|Ineligible / No protocol treatment|4|||
125594581|NCT00466505|451798870|FG000|Overall Study|disease progression|13|||
125594582|NCT00466505|451798870|FG000|Overall Study|Adverse Event|4|||
125594583|NCT00811252|451798871|FG000|Overall Study|Adverse Event|6|||
125594584|NCT00811252|451798872|FG001|Overall Study|Adverse Event|10|||
125594585|NCT00811252|451798873|FG002|Overall Study|Adverse Event|15|||
125594586|NCT00811252|451798871|FG000|Overall Study|Lack of Efficacy|7|||
125594587|NCT00811252|451798872|FG001|Overall Study|Lack of Efficacy|2|||
125594588|NCT00811252|451798873|FG002|Overall Study|Lack of Efficacy|0|||
125594589|NCT00811252|451798871|FG000|Overall Study|Protocol Violation|3|||
125594590|NCT00811252|451798872|FG001|Overall Study|Protocol Violation|3|||
125594591|NCT00811252|451798873|FG002|Overall Study|Protocol Violation|2|||
125594592|NCT00811252|451798871|FG000|Overall Study|Withdrawal of Consent|1|||
125594593|NCT00811252|451798872|FG001|Overall Study|Withdrawal of Consent|2|||
125594594|NCT00811252|451798873|FG002|Overall Study|Withdrawal of Consent|2|||
125594595|NCT00811252|451798871|FG000|Overall Study|Lost to Follow-up|0|||
125594596|NCT00811252|451798872|FG001|Overall Study|Lost to Follow-up|0|||
125594597|NCT00811252|451798873|FG002|Overall Study|Lost to Follow-up|2|||
125594598|NCT00811252|451798871|FG000|Overall Study|Administrative or Other Reasons|0|||
125594599|NCT00811252|451798872|FG001|Overall Study|Administrative or Other Reasons|3|||
125594600|NCT00811252|451798873|FG002|Overall Study|Administrative or Other Reasons|2|||
125594601|NCT01486264|451798874|FG000|Overall Study|Death|1|||
125594602|NCT01486264|451798875|FG001|Overall Study|Death|1|||
125594603|NCT01486264|451798874|FG000|Overall Study|Adverse Event|3|||
125594604|NCT01486264|451798875|FG001|Overall Study|Adverse Event|3|||
125594605|NCT01486264|451798874|FG000|Overall Study|Lack of Efficacy|6|||
125594606|NCT01486264|451798875|FG001|Overall Study|Lack of Efficacy|10|||
125594607|NCT01486264|451798874|FG000|Overall Study|Withdrawal by Subject|7|||
125594608|NCT01486264|451798875|FG001|Overall Study|Withdrawal by Subject|18|||
125594609|NCT01486264|451798874|FG000|Overall Study|Physician Decision|1|||
125594610|NCT01486264|451798875|FG001|Overall Study|Physician Decision|1|||
125594611|NCT01486264|451798874|FG000|Overall Study|Protocol Violation|3|||
125594612|NCT01486264|451798875|FG001|Overall Study|Protocol Violation|0|||
125594613|NCT01486264|451798874|FG000|Overall Study|Lost to Follow-up|3|||
125594614|NCT01486264|451798875|FG001|Overall Study|Lost to Follow-up|2|||
125594615|NCT01486264|451798874|FG000|Overall Study|Other|5|||
125594616|NCT01486264|451798875|FG001|Overall Study|Other|11|||
125594617|NCT01486264|451798874|FG000|Overall Study|Not treated|0|||
125594618|NCT01486264|451798875|FG001|Overall Study|Not treated|1|||
125594619|NCT00813748|451798876|FG000|Skin Test Substudy|Physician Decision|0|||
125594620|NCT00813748|451798877|FG001|Skin Test Substudy|Physician Decision|1|||
125594621|NCT00424398|451798884|FG000|Overall Study|Withdrawal by Subject|2|||
125594622|NCT00424398|451798885|FG001|Overall Study|Withdrawal by Subject|1|||
125594623|NCT00424398|451798886|FG002|Overall Study|Withdrawal by Subject|0|||
125594624|NCT00424398|451798884|FG000|Overall Study|Subject met exclusion criteria|1|||
125594625|NCT00424398|451798885|FG001|Overall Study|Subject met exclusion criteria|0|||
125594626|NCT00424398|451798886|FG002|Overall Study|Subject met exclusion criteria|0|||
125594627|NCT00855439|451798887|FG000|Overall Study|Withdrawal by Subject|2|||
125594628|NCT00855439|451798888|FG001|Overall Study|Withdrawal by Subject|0|||
125594629|NCT00855439|451798887|FG000|Overall Study|Pregnancy|1|||
125594630|NCT00855439|451798888|FG001|Overall Study|Pregnancy|0|||
125594631|NCT05480514|451798890|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
125594632|NCT05480514|451798891|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
125594633|NCT05480514|451798890|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
125594634|NCT05480514|451798891|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
125594635|NCT05480514|451798890|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125594636|NCT05480514|451798891|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
125594637|NCT05480514|451798890|FG000|Period 1|Covid-19 Related|1|||
125594638|NCT05480514|451798891|FG001|Period 1|Covid-19 Related|0|||
125594639|NCT05480514|451798890|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
125594640|NCT05480514|451798891|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
125594641|NCT00457639|451798892|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
125594642|NCT00457639|451798893|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
125594643|NCT00457639|451798892|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
125594644|NCT00457639|451798893|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
125594645|NCT00457639|451798892|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
125594646|NCT00457639|451798893|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
125594647|NCT04885257|451798894|FG000|Overall Study|Withdrawal by Subject|1|||
125594648|NCT04885257|451798895|FG001|Overall Study|Withdrawal by Subject|0|||
125594649|NCT01672892|451800503|FG000|Overall Study|Protocol Violation|7|||
125594650|NCT01672892|451800504|FG001|Overall Study|Protocol Violation|3|||
125594651|NCT02579603|451800508|FG000|Overall Study|Not treated|1|||
125594652|NCT02579603|451800509|FG001|Overall Study|Not treated|0|||
125594653|NCT02579603|451800508|FG000|Overall Study|Adverse Event|2|||
125594654|NCT02579603|451800509|FG001|Overall Study|Adverse Event|2|||
125594655|NCT02579603|451800508|FG000|Overall Study|Other than stated|1|||
125594656|NCT02579603|451800509|FG001|Overall Study|Other than stated|0|||
125594657|NCT01006356|451800510|FG000|Overall Study|Adverse Event|6|||
125212363|NCT00548249|450403337|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
125212364|NCT00548249|450403338|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
125212365|NCT00548249|450403339|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
125594658|NCT01006356|451800510|FG000|Overall Study|Physician Decision|1|||
125594659|NCT01006356|451800510|FG000|Overall Study|Paticipants did not cooperate|6|||
125594660|NCT01006356|451800510|FG000|Overall Study|Withdrawal by Subject|1|||
125594661|NCT01006356|451800510|FG000|Overall Study|Choice by participants|2|||
125594662|NCT01006356|451800510|FG000|Overall Study|Protocol Violation|3|||
125594663|NCT01006356|451800510|FG000|Overall Study|Other|23|||
125594664|NCT01756157|451800513|FG000|First Intervention Period|Withdrawal by Subject|1|||
125594665|NCT01756157|451800514|FG001|First Intervention Period|Withdrawal by Subject|0|||
125594666|NCT01756157|451800513|FG000|First Intervention Period|Lost to Follow-up|0|||
125594667|NCT01756157|451800514|FG001|First Intervention Period|Lost to Follow-up|2|||
125594668|NCT03715465|451800515|FG000|Overall Study|Withdrawal by Subject|1|||
125594669|NCT03715465|451800516|FG001|Overall Study|Withdrawal by Subject|2|||
125594670|NCT04331899|451800524|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
125594671|NCT04331899|451800525|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
125594672|NCT02424539|451800528|FG000|Overall Study|Adverse Event|0|||
125594673|NCT02424539|451800529|FG001|Overall Study|Adverse Event|0|||
125594674|NCT02424539|451800530|FG002|Overall Study|Adverse Event|1|||
125594675|NCT02424539|451800528|FG000|Overall Study|Physician Decision|0|||
125594676|NCT02424539|451800529|FG001|Overall Study|Physician Decision|0|||
125594677|NCT02424539|451800530|FG002|Overall Study|Physician Decision|1|||
125594678|NCT02424539|451800528|FG000|Overall Study|Withdrawal by Subject|3|||
125594679|NCT02424539|451800529|FG001|Overall Study|Withdrawal by Subject|1|||
125212366|NCT00548249|450403335|FG000|Overall Study|Prolonged hospitalization|0|||
125364509|NCT00347360|450967158|FG002|Overall Study|Visits conflicted with new job|0|||
125364510|NCT00347360|450967159|FG003|Overall Study|Visits conflicted with new job|0|||
125594680|NCT02424539|451800530|FG002|Overall Study|Withdrawal by Subject|0|||
125594681|NCT02424539|451800528|FG000|Overall Study|Other: Reached stopping criteria|11|||
125594682|NCT02424539|451800529|FG001|Overall Study|Other: Reached stopping criteria|7|||
125594683|NCT02424539|451800530|FG002|Overall Study|Other: Reached stopping criteria|6|||
125594684|NCT01697215|451800540|FG000|Overall Study|Physician Decision|5|||
125594685|NCT01697215|451800540|FG000|Overall Study|Malfunction|9|||
125594686|NCT01697215|451800540|FG000|Overall Study|CXR not available|9|||
125594687|NCT01829048|451800541|FG000|Overall Study|Withdrawal by Subject|0|||
125594688|NCT01829048|451800542|FG001|Overall Study|Withdrawal by Subject|0|||
125594689|NCT01829048|451800543|FG002|Overall Study|Withdrawal by Subject|0|||
125594690|NCT01829048|451800544|FG003|Overall Study|Withdrawal by Subject|2|||
125594691|NCT01829048|451800545|FG004|Overall Study|Withdrawal by Subject|0|||
125594692|NCT00504257|451800546|FG000|Overall Study|Withdrawal by Subject|2|||
125594693|NCT00504257|451800546|FG000|Overall Study|ineligible histology|2|||
125594694|NCT02317510|451800550|FG000|Overall Study|Adverse Event|0|||
125594695|NCT02317510|451800551|FG001|Overall Study|Adverse Event|1|||
125594696|NCT00728416|451800560|FG000|Overall Study|Adverse Event|1|||
125594697|NCT00728416|451800561|FG001|Overall Study|Adverse Event|1|||
125594698|NCT00728416|451800560|FG000|Overall Study|Treatment Failure|0|||
125594699|NCT00728416|451800561|FG001|Overall Study|Treatment Failure|1|||
125594700|NCT00728416|451800560|FG000|Overall Study|Withdrawal by Subject|1|||
125594701|NCT00728416|451800561|FG001|Overall Study|Withdrawal by Subject|0|||
125594702|NCT01244737|451800569|FG000|Overall Study|Physician Decision|2|||
125594703|NCT01244737|451800570|FG001|Overall Study|Physician Decision|18|||
125594704|NCT01244737|451800571|FG002|Overall Study|Physician Decision|5|||
125594705|NCT01244737|451800569|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
125594706|NCT01244737|451800570|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
125594707|NCT01244737|451800571|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
125594708|NCT01244737|451800569|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
125594709|NCT01244737|451800570|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
125594710|NCT01244737|451800571|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
125594711|NCT01244737|451800569|FG000|Overall Study|MIB immunopathology results not available|3|||
125594712|NCT01244737|451800570|FG001|Overall Study|MIB immunopathology results not available|2|||
125594713|NCT01244737|451800571|FG002|Overall Study|MIB immunopathology results not available|0|||
125594714|NCT01244737|451800569|FG000|Overall Study|PET data failure|0|||
125594715|NCT01244737|451800570|FG001|Overall Study|PET data failure|1|||
125594716|NCT01244737|451800571|FG002|Overall Study|PET data failure|0|||
125594717|NCT01244737|451800569|FG000|Overall Study|Withdrawal by Subject|0|||
125594718|NCT01244737|451800570|FG001|Overall Study|Withdrawal by Subject|0|||
125594719|NCT01244737|451800571|FG002|Overall Study|Withdrawal by Subject|1|||
125594720|NCT00730236|451800574|FG000|Overall Study|Adverse Event|4|||
125594721|NCT00730236|451800574|FG000|Overall Study|Withdrawal by Subject|1|||
125594722|NCT00730236|451800574|FG000|Overall Study|Non-compliance|1|||
125594723|NCT01772134|451800579|FG000|Overall Study|Adverse Event|6|||
125594724|NCT01772134|451800580|FG001|Overall Study|Adverse Event|5|||
125594725|NCT01772134|451800581|FG002|Overall Study|Adverse Event|10|||
125594726|NCT01772134|451800579|FG000|Overall Study|Withdrew Consent|3|||
125594727|NCT01772134|451800580|FG001|Overall Study|Withdrew Consent|1|||
125594728|NCT01772134|451800581|FG002|Overall Study|Withdrew Consent|5|||
125594729|NCT01772134|451800579|FG000|Overall Study|Lost to Follow-up|2|||
125594730|NCT01772134|451800580|FG001|Overall Study|Lost to Follow-up|0|||
125594731|NCT01772134|451800581|FG002|Overall Study|Lost to Follow-up|0|||
125594732|NCT01772134|451800579|FG000|Overall Study|Protocol Deviation|4|||
125594733|NCT01772134|451800580|FG001|Overall Study|Protocol Deviation|3|||
125594734|NCT01772134|451800581|FG002|Overall Study|Protocol Deviation|3|||
125594735|NCT01772134|451800579|FG000|Overall Study|Lack of Efficacy|11|||
125594736|NCT01772134|451800580|FG001|Overall Study|Lack of Efficacy|5|||
125594737|NCT01772134|451800581|FG002|Overall Study|Lack of Efficacy|3|||
125594738|NCT01772134|451800579|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
125594739|NCT01772134|451800580|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
125594740|NCT01772134|451800581|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
125594741|NCT01772134|451800579|FG000|Overall Study|Randomized Study Medication Not Received|2|||
125594742|NCT01772134|451800580|FG001|Overall Study|Randomized Study Medication Not Received|0|||
125594743|NCT01772134|451800581|FG002|Overall Study|Randomized Study Medication Not Received|1|||
125594744|NCT00594399|451800586|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
125594745|NCT00594399|451800587|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
125594746|NCT00594399|451800588|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
125594747|NCT00594399|451800586|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
125594748|NCT00594399|451800587|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
125594749|NCT00594399|451800588|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
125594750|NCT00594399|451800586|FG000|Initial 3 Month Counseling|Personal issues|2|||
125594751|NCT00594399|451800587|FG001|Initial 3 Month Counseling|Personal issues|0|||
125594752|NCT00594399|451800588|FG002|Initial 3 Month Counseling|Personal issues|0|||
125594753|NCT00594399|451800586|FG000|Initial 3 Month Counseling|Too busy|7|||
125594754|NCT00594399|451800587|FG001|Initial 3 Month Counseling|Too busy|1|||
125594755|NCT00594399|451800588|FG002|Initial 3 Month Counseling|Too busy|0|||
125594756|NCT00594399|451800586|FG000|Initial 3 Month Counseling|Pain|2|||
125594757|NCT00594399|451800587|FG001|Initial 3 Month Counseling|Pain|0|||
125594758|NCT00594399|451800588|FG002|Initial 3 Month Counseling|Pain|0|||
125594759|NCT00594399|451800586|FG000|Initial 3 Month Counseling|Moved|1|||
125594760|NCT00594399|451800587|FG001|Initial 3 Month Counseling|Moved|0|||
125594761|NCT00594399|451800588|FG002|Initial 3 Month Counseling|Moved|0|||
125594762|NCT00594399|451800586|FG000|Initial 3 Month Counseling|Family illness|1|||
125594763|NCT00594399|451800587|FG001|Initial 3 Month Counseling|Family illness|0|||
125594764|NCT00594399|451800588|FG002|Initial 3 Month Counseling|Family illness|0|||
125594765|NCT00594399|451800586|FG000|Rerandomization Arm 1 Only|Death|2|||
125594766|NCT00594399|451800587|FG001|Rerandomization Arm 1 Only|Death|1|||
125594767|NCT00594399|451800588|FG002|Rerandomization Arm 1 Only|Death|0|||
125594768|NCT00594399|451800586|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
125594769|NCT00594399|451800587|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
125594770|NCT00594399|451800588|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
125594771|NCT03953118|451800589|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
125594772|NCT03953118|451800590|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
125594773|NCT01023789|451800592|FG000|3 - Year Visit|Death|29|||
125594774|NCT01023789|451800592|FG000|3 - Year Visit|Withdrawal of consent|1|||
125594775|NCT01023789|451800592|FG000|3 - Year Visit|Lost to Follow-up|13|||
125594776|NCT02034123|451800594|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125429885|NCT00949715|451200121|FG001|Overall Study|Physician Decision|0|||
125594777|NCT02034123|451800595|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594778|NCT02034123|451800596|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594779|NCT02034123|451800597|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594780|NCT02034123|451800598|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
125594781|NCT02034123|451800599|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594782|NCT02034123|451800600|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594783|NCT02034123|451800601|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
125594784|NCT02034123|451800602|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
125594785|NCT02034123|451800603|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594786|NCT02034123|451800604|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594787|NCT02034123|451800605|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594788|NCT02034123|451800606|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594789|NCT02034123|451800607|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594790|NCT02034123|451800608|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594791|NCT02034123|451800609|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594792|NCT02034123|451800610|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594793|NCT02034123|451800611|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
125594794|NCT02034123|451800594|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594795|NCT02034123|451800595|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594796|NCT02034123|451800596|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594797|NCT02034123|451800597|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
125594798|NCT02034123|451800598|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594799|NCT02034123|451800599|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594800|NCT02034123|451800600|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594801|NCT02034123|451800601|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594802|NCT02034123|451800602|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594803|NCT02034123|451800603|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594804|NCT02034123|451800604|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594805|NCT02034123|451800605|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594806|NCT02034123|451800606|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594807|NCT02034123|451800607|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594808|NCT02034123|451800608|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594809|NCT02034123|451800609|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594810|NCT02034123|451800610|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594811|NCT02034123|451800611|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
125594812|NCT02034123|451800594|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594813|NCT02034123|451800595|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594814|NCT02034123|451800596|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594815|NCT02034123|451800597|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594816|NCT02034123|451800598|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594817|NCT02034123|451800599|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594818|NCT02034123|451800600|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594819|NCT02034123|451800601|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594820|NCT02034123|451800602|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
125594821|NCT02034123|451800603|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594822|NCT02034123|451800604|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594823|NCT02034123|451800605|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594824|NCT02034123|451800606|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594825|NCT02034123|451800607|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594826|NCT02034123|451800608|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594827|NCT02034123|451800609|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594828|NCT02034123|451800610|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594829|NCT02034123|451800611|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
125594830|NCT02034123|451800594|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594831|NCT02034123|451800595|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594832|NCT02034123|451800596|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594833|NCT02034123|451800597|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
125594834|NCT02034123|451800598|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
125594835|NCT02034123|451800599|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594836|NCT02034123|451800600|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594837|NCT02034123|451800601|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594838|NCT02034123|451800602|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594839|NCT02034123|451800603|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594840|NCT02034123|451800604|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594841|NCT02034123|451800605|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594842|NCT02034123|451800606|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594843|NCT02034123|451800607|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594844|NCT02034123|451800608|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594845|NCT02034123|451800609|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594846|NCT02034123|451800610|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594847|NCT02034123|451800611|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
125594848|NCT02698189|451800612|FG000|Overall Study|Physician Decision|3|||
125594849|NCT02698189|451800613|FG001|Overall Study|Physician Decision|0|||
125594850|NCT02698189|451800612|FG000|Overall Study|Progressive disease|0|||
125594851|NCT02698189|451800613|FG001|Overall Study|Progressive disease|5|||
125594852|NCT02698189|451800612|FG000|Overall Study|Study terminated by sponsor|0|||
125594853|NCT02698189|451800613|FG001|Overall Study|Study terminated by sponsor|1|||
125594854|NCT02240706|451800616|FG000|Overall Study|Lack of Efficacy|2|||
125594855|NCT02240706|451800617|FG001|Overall Study|Lack of Efficacy|2|||
125594856|NCT02240706|451800618|FG002|Overall Study|Lack of Efficacy|2|||
125594857|NCT02240706|451800619|FG003|Overall Study|Lack of Efficacy|2|||
125594858|NCT02240706|451800620|FG004|Overall Study|Lack of Efficacy|5|||
125594859|NCT02240706|451800621|FG005|Overall Study|Lack of Efficacy|0|||
125594860|NCT02240706|451800622|FG006|Overall Study|Lack of Efficacy|0|||
125594861|NCT02240706|451800616|FG000|Overall Study|Adverse Event|1|||
125594862|NCT02240706|451800617|FG001|Overall Study|Adverse Event|0|||
125594863|NCT02240706|451800618|FG002|Overall Study|Adverse Event|1|||
125594864|NCT02240706|451800619|FG003|Overall Study|Adverse Event|0|||
125594865|NCT02240706|451800620|FG004|Overall Study|Adverse Event|2|||
125594866|NCT02240706|451800621|FG005|Overall Study|Adverse Event|0|||
125594867|NCT02240706|451800622|FG006|Overall Study|Adverse Event|0|||
125594868|NCT02240706|451800616|FG000|Overall Study|Progressive disease|0|||
125594869|NCT02240706|451800617|FG001|Overall Study|Progressive disease|0|||
125594870|NCT02240706|451800618|FG002|Overall Study|Progressive disease|0|||
125594871|NCT02240706|451800619|FG003|Overall Study|Progressive disease|0|||
125594872|NCT02240706|451800620|FG004|Overall Study|Progressive disease|1|||
125594873|NCT02240706|451800621|FG005|Overall Study|Progressive disease|0|||
125594874|NCT02240706|451800622|FG006|Overall Study|Progressive disease|0|||
125594875|NCT02240706|451800616|FG000|Overall Study|Dose limiting toxicity|0|||
125594876|NCT02240706|451800617|FG001|Overall Study|Dose limiting toxicity|0|||
125594877|NCT02240706|451800618|FG002|Overall Study|Dose limiting toxicity|0|||
125594878|NCT02240706|451800619|FG003|Overall Study|Dose limiting toxicity|0|||
125594879|NCT02240706|451800620|FG004|Overall Study|Dose limiting toxicity|1|||
125594880|NCT02240706|451800621|FG005|Overall Study|Dose limiting toxicity|0|||
125594881|NCT02240706|451800622|FG006|Overall Study|Dose limiting toxicity|0|||
125594882|NCT02240706|451800616|FG000|Overall Study|Refused to continue taking medication|0|||
125594883|NCT02240706|451800617|FG001|Overall Study|Refused to continue taking medication|1|||
125594884|NCT02240706|451800618|FG002|Overall Study|Refused to continue taking medication|3|||
125594885|NCT02240706|451800619|FG003|Overall Study|Refused to continue taking medication|1|||
125594886|NCT02240706|451800620|FG004|Overall Study|Refused to continue taking medication|2|||
125594887|NCT02240706|451800621|FG005|Overall Study|Refused to continue taking medication|0|||
125594888|NCT02240706|451800622|FG006|Overall Study|Refused to continue taking medication|0|||
125594889|NCT02240706|451800616|FG000|Overall Study|Insurance billing concerns|0|||
125594890|NCT02240706|451800617|FG001|Overall Study|Insurance billing concerns|0|||
125594891|NCT02240706|451800618|FG002|Overall Study|Insurance billing concerns|0|||
125594892|NCT02240706|451800619|FG003|Overall Study|Insurance billing concerns|1|||
125594893|NCT02240706|451800620|FG004|Overall Study|Insurance billing concerns|0|||
125594894|NCT02240706|451800621|FG005|Overall Study|Insurance billing concerns|0|||
125594895|NCT02240706|451800622|FG006|Overall Study|Insurance billing concerns|0|||
125594896|NCT03301857|451800623|FG000|Overall Study|Death|0|||
125594897|NCT03301857|451800624|FG001|Overall Study|Death|2|||
125594898|NCT03301857|451800623|FG000|Overall Study|Lost to Follow-up|4|||
125594899|NCT03301857|451800624|FG001|Overall Study|Lost to Follow-up|2|||
125594900|NCT03301857|451800623|FG000|Overall Study|Decision by Sponsor|6|||
125594901|NCT03301857|451800624|FG001|Overall Study|Decision by Sponsor|0|||
125594902|NCT03301857|451800623|FG000|Overall Study|Withdrawal by Subject|12|||
125594903|NCT03301857|451800624|FG001|Overall Study|Withdrawal by Subject|4|||
125594904|NCT00613626|451800625|FG000|Overall Study|Ineligible|0|||
125594905|NCT00613626|451800626|FG001|Overall Study|Ineligible|1|||
125594906|NCT00613626|451800627|FG002|Overall Study|Ineligible|0|||
125594907|NCT00816036|451800628|FG000|Overall Study|Death|47|||
125594908|NCT00816036|451800629|FG001|Overall Study|Death|28|||
125594909|NCT00816036|451800628|FG000|Overall Study|Lost to Follow-up|75|||
125594910|NCT00816036|451800629|FG001|Overall Study|Lost to Follow-up|57|||
125594911|NCT00816036|451800628|FG000|Overall Study|Withdrawal by Subject|54|||
125594912|NCT00816036|451800629|FG001|Overall Study|Withdrawal by Subject|23|||
125594913|NCT03212261|451800630|FG000|Overall Study|Became ineligible d/t tech|2|||
125594914|NCT03212261|451800630|FG000|Overall Study|Tech Trouble- No first study visit|1|||
125594915|NCT03212261|451800630|FG000|Overall Study|Lost to Follow-up|7|||
125594916|NCT03212261|451800630|FG000|Overall Study|Family Emergency|1|||
125594917|NCT03212261|451800630|FG000|Overall Study|Too busy/ No time|5|||
125594918|NCT01076179|451800631|FG000|Overall Study|Withdrawal by Subject|1|||
125594919|NCT00986349|451800634|FG000|Overall Study|Unsuccessful implant procedure|3|||
125594920|NCT00986349|451800634|FG000|Overall Study|Adverse Event|2|||
125594921|NCT00986349|451800634|FG000|Overall Study|Physician Decision|1|||
125594922|NCT00986349|451800634|FG000|Overall Study|device migration|1|||
125594923|NCT02299934|451800635|FG000|Overall Study|Termination of study|13|||
125594924|NCT02722044|451800636|FG000|Overall Study|Adverse Event|2|||
125594925|NCT02722044|451800636|FG000|Overall Study|Physician Decision|1|||
125594926|NCT02722044|451800636|FG000|Overall Study|Withdrawal by Subject|1|||
125594927|NCT02722044|451800636|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
125594928|NCT02117687|451800637|FG000|Overall Study|Lost to Follow-up|0|||
125594929|NCT02117687|451800638|FG001|Overall Study|Lost to Follow-up|1|||
125594930|NCT02117687|451800637|FG000|Overall Study|Adverse Event|0|||
125594931|NCT02117687|451800638|FG001|Overall Study|Adverse Event|2|||
125594932|NCT02117687|451800637|FG000|Overall Study|Other Reasons|1|||
125594933|NCT02117687|451800638|FG001|Overall Study|Other Reasons|1|||
125594934|NCT01901328|451800646|FG000|Overall Study|Lost to Follow-up|1|||
125594935|NCT01901328|451800647|FG001|Overall Study|Lost to Follow-up|0|||
125594936|NCT01901328|451800646|FG000|Overall Study|Physician Decision|0|||
125594937|NCT01901328|451800647|FG001|Overall Study|Physician Decision|1|||
125594938|NCT01901328|451800646|FG000|Overall Study|Protocol Violation|1|||
125594939|NCT01901328|451800647|FG001|Overall Study|Protocol Violation|1|||
125594940|NCT01901328|451800646|FG000|Overall Study|Study Terminated by Sponsor|19|||
125594941|NCT01901328|451800647|FG001|Overall Study|Study Terminated by Sponsor|16|||
125594942|NCT01901328|451800646|FG000|Overall Study|Withdrawal by Subject|1|||
125594943|NCT01901328|451800647|FG001|Overall Study|Withdrawal by Subject|2|||
125594944|NCT01901328|451800646|FG000|Overall Study|Lack of Efficacy|0|||
125594945|NCT01901328|451800647|FG001|Overall Study|Lack of Efficacy|1|||
125594946|NCT03232073|451800648|FG000|Overall Study|Death|1|||
125594947|NCT03232073|451800649|FG001|Overall Study|Death|0|||
125594948|NCT03232073|451800648|FG000|Overall Study|Adverse Event|7|||
125594949|NCT03232073|451800649|FG001|Overall Study|Adverse Event|12|||
125594950|NCT03232073|451800648|FG000|Overall Study|Lost to Follow-up|6|||
125594951|NCT03232073|451800649|FG001|Overall Study|Lost to Follow-up|6|||
125594952|NCT03232073|451800648|FG000|Overall Study|Lack of Efficacy|10|||
125594953|NCT03232073|451800649|FG001|Overall Study|Lack of Efficacy|8|||
125594954|NCT03232073|451800648|FG000|Overall Study|Physician Decision|9|||
125594955|NCT03232073|451800649|FG001|Overall Study|Physician Decision|2|||
125594956|NCT03232073|451800648|FG000|Overall Study|Withdrawal by Subject|54|||
125594957|NCT03232073|451800649|FG001|Overall Study|Withdrawal by Subject|39|||
125594958|NCT03528681|451802658|FG000|Open-Label Phase|Physician Decision|2|||
125594959|NCT03528681|451802659|FG001|Open-Label Phase|Physician Decision|0|||
125594960|NCT03528681|451802660|FG002|Open-Label Phase|Physician Decision|0|||
125594961|NCT03528681|451802661|FG003|Open-Label Phase|Physician Decision|0|||
125594962|NCT03528681|451802658|FG000|Open-Label Phase|Withdrawal by Subject|8|||
125594963|NCT03528681|451802659|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125594964|NCT03528681|451802660|FG002|Open-Label Phase|Withdrawal by Subject|0|||
125594965|NCT03528681|451802661|FG003|Open-Label Phase|Withdrawal by Subject|0|||
125594966|NCT03528681|451802658|FG000|Open-Label Phase|(Not collected)|4|||
125594967|NCT03528681|451802659|FG001|Open-Label Phase|(Not collected)|0|||
125594968|NCT03528681|451802660|FG002|Open-Label Phase|(Not collected)|0|||
125594969|NCT03528681|451802661|FG003|Open-Label Phase|(Not collected)|0|||
125594970|NCT03528681|451802658|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
125594971|NCT03528681|451802659|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
125594972|NCT03528681|451802660|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
125594973|NCT03528681|451802661|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
125594974|NCT03528681|451802658|FG000|Randomized Treatment Phase|Physician Decision|0|||
125594975|NCT03528681|451802659|FG001|Randomized Treatment Phase|Physician Decision|5|||
125594976|NCT03528681|451802660|FG002|Randomized Treatment Phase|Physician Decision|1|||
125594977|NCT03528681|451802661|FG003|Randomized Treatment Phase|Physician Decision|2|||
125594978|NCT03528681|451802658|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
125594979|NCT03528681|451802659|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
125594980|NCT03528681|451802660|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
125594981|NCT03528681|451802661|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
125594982|NCT03528681|451802658|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
125594983|NCT03528681|451802659|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
125594984|NCT03528681|451802660|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
125594985|NCT03528681|451802661|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
125594986|NCT03528681|451802658|FG000|Randomized Treatment Phase|(Not collected)|0|||
125594987|NCT03528681|451802659|FG001|Randomized Treatment Phase|(Not collected)|4|||
125594988|NCT03528681|451802660|FG002|Randomized Treatment Phase|(Not collected)|6|||
125594989|NCT03528681|451802661|FG003|Randomized Treatment Phase|(Not collected)|5|||
125594990|NCT02981472|451802669|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
125594991|NCT02981472|451802670|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
125594992|NCT02981472|451802669|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
125594993|NCT02981472|451802670|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125594994|NCT02981472|451802669|FG000|Treatment Period|Adverse Event|6|||
125594995|NCT02981472|451802670|FG001|Treatment Period|Adverse Event|1|||
125594996|NCT02981472|451802669|FG000|Treatment Period|Participant withdrew consent|1|||
125594997|NCT02981472|451802670|FG001|Treatment Period|Participant withdrew consent|0|||
125594998|NCT02981472|451802669|FG000|Treatment Period|Lost to Follow-up|0|||
125594999|NCT02981472|451802670|FG001|Treatment Period|Lost to Follow-up|1|||
125595000|NCT00621023|451802673|FG000|Overall Study|Death|5|||
125595001|NCT00621023|451802673|FG000|Overall Study|Follow up discontinued|1|||
125595002|NCT04430348|451802682|FG000|Overall Study|Death|3|||
125595003|NCT04430348|451802683|FG001|Overall Study|Death|2|||
125595004|NCT04430348|451802684|FG002|Overall Study|Death|2|||
125595005|NCT04430348|451802685|FG003|Overall Study|Death|2|||
125595006|NCT04430348|451802686|FG004|Overall Study|Death|2|||
125595007|NCT04430348|451802687|FG005|Overall Study|Death|3|||
125595008|NCT04430348|451802682|FG000|Overall Study|Lost to Follow-up|0|||
125595009|NCT04430348|451802683|FG001|Overall Study|Lost to Follow-up|0|||
125595010|NCT04430348|451802684|FG002|Overall Study|Lost to Follow-up|0|||
125595011|NCT04430348|451802685|FG003|Overall Study|Lost to Follow-up|1|||
125595012|NCT04430348|451802686|FG004|Overall Study|Lost to Follow-up|0|||
125595013|NCT04430348|451802687|FG005|Overall Study|Lost to Follow-up|0|||
125595014|NCT04430348|451802682|FG000|Overall Study|Adverse Event|0|||
125595015|NCT04430348|451802683|FG001|Overall Study|Adverse Event|0|||
125595016|NCT04430348|451802684|FG002|Overall Study|Adverse Event|0|||
125595017|NCT04430348|451802685|FG003|Overall Study|Adverse Event|0|||
125595018|NCT04430348|451802686|FG004|Overall Study|Adverse Event|0|||
125595019|NCT04430348|451802687|FG005|Overall Study|Adverse Event|1|||
125595020|NCT04430348|451802682|FG000|Overall Study|Withdrawal by Subject|0|||
125595021|NCT04430348|451802683|FG001|Overall Study|Withdrawal by Subject|1|||
125595022|NCT04430348|451802684|FG002|Overall Study|Withdrawal by Subject|0|||
125595023|NCT04430348|451802685|FG003|Overall Study|Withdrawal by Subject|0|||
125595024|NCT04430348|451802686|FG004|Overall Study|Withdrawal by Subject|0|||
125595025|NCT04430348|451802687|FG005|Overall Study|Withdrawal by Subject|1|||
125595026|NCT04430348|451802682|FG000|Overall Study|Study Terminated by Sponsor|0|||
125595027|NCT04430348|451802683|FG001|Overall Study|Study Terminated by Sponsor|0|||
125595028|NCT04430348|451802684|FG002|Overall Study|Study Terminated by Sponsor|2|||
125595029|NCT04430348|451802685|FG003|Overall Study|Study Terminated by Sponsor|0|||
125595030|NCT04430348|451802686|FG004|Overall Study|Study Terminated by Sponsor|1|||
125595031|NCT04430348|451802687|FG005|Overall Study|Study Terminated by Sponsor|1|||
125595032|NCT04893265|451802690|FG000|Overall Study|Withdrawal by Subject|2|||
125595033|NCT04893265|451802691|FG001|Overall Study|Withdrawal by Subject|5|||
125595034|NCT04893265|451802690|FG000|Overall Study|Lost to Follow-up|0|||
125595035|NCT04893265|451802691|FG001|Overall Study|Lost to Follow-up|4|||
125595036|NCT00573131|451802692|FG000|Overall Study|Withdrawal by Subject|10|||
125595037|NCT00573131|451802693|FG001|Overall Study|Withdrawal by Subject|8|||
125595038|NCT02024464|451802695|FG000|Overall Study|Discontinued|5|||
125595039|NCT02024464|451802696|FG001|Overall Study|Discontinued|4|||
125595040|NCT02024464|451802695|FG000|Overall Study|Missed Visits|1|||
125595041|NCT02024464|451802696|FG001|Overall Study|Missed Visits|0|||
125595042|NCT02024464|451802695|FG000|Overall Study|Lost to Follow-up|4|||
125595043|NCT02024464|451802696|FG001|Overall Study|Lost to Follow-up|7|||
125595044|NCT02037919|451802700|FG000|Overall Study|Lost to Follow-up|30|||
125595045|NCT02037919|451802701|FG001|Overall Study|Lost to Follow-up|45|||
125595046|NCT00756002|451802709|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
125595047|NCT00756002|451802710|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
125595048|NCT00756002|451802709|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125595049|NCT00756002|451802710|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
125595050|NCT00756002|451802709|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
125595051|NCT00756002|451802710|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
125595052|NCT00756002|451802709|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
125595053|NCT00756002|451802710|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
125595054|NCT00756002|451802709|FG000|Double-Blind Treatment Period|Other|2|||
125595055|NCT00756002|451802710|FG001|Double-Blind Treatment Period|Other|2|||
125595056|NCT04899271|451802717|FG000|Overall Study|Lost to Follow-up|1|||
125595057|NCT04899271|451802718|FG001|Overall Study|Lost to Follow-up|0|||
125595058|NCT04899271|451802717|FG000|Overall Study|Subject request/consent withdrawal|2|||
125595059|NCT04899271|451802718|FG001|Overall Study|Subject request/consent withdrawal|0|||
125595060|NCT01929083|451802721|FG000|Intervention 1|Lost to Follow-up|2|||
125595061|NCT01929083|451802722|FG001|Intervention 1|Lost to Follow-up|0|||
125595062|NCT01929083|451802721|FG000|Intervention 1|Nonadherent to study medications|1|||
125595063|NCT01929083|451802722|FG001|Intervention 1|Nonadherent to study medications|0|||
125595064|NCT01929083|451802721|FG000|Intervention 2|Adverse Event|0|||
125595065|NCT01929083|451802722|FG001|Intervention 2|Adverse Event|1|||
125595066|NCT02586805|451802727|FG000|Overall Study|Withdrawal by Subject|3|||
125595067|NCT02586805|451802728|FG001|Overall Study|Withdrawal by Subject|1|||
125595068|NCT02586805|451802729|FG002|Overall Study|Withdrawal by Subject|1|||
125595069|NCT02586805|451802730|FG003|Overall Study|Withdrawal by Subject|2|||
125595070|NCT02586805|451802727|FG000|Overall Study|Adverse Event|2|||
125595071|NCT02586805|451802728|FG001|Overall Study|Adverse Event|0|||
125595072|NCT02586805|451802729|FG002|Overall Study|Adverse Event|1|||
125595073|NCT02586805|451802730|FG003|Overall Study|Adverse Event|0|||
125595074|NCT02586805|451802727|FG000|Overall Study|Lost to Follow-up|0|||
125595075|NCT02586805|451802728|FG001|Overall Study|Lost to Follow-up|0|||
125595076|NCT02586805|451802729|FG002|Overall Study|Lost to Follow-up|1|||
125595077|NCT02586805|451802730|FG003|Overall Study|Lost to Follow-up|0|||
125595078|NCT02586805|451802727|FG000|Overall Study|Physician Decision|1|||
125595079|NCT02586805|451802728|FG001|Overall Study|Physician Decision|0|||
125595080|NCT02586805|451802729|FG002|Overall Study|Physician Decision|0|||
125595081|NCT02586805|451802730|FG003|Overall Study|Physician Decision|0|||
125595082|NCT02504541|451802731|FG000|Overall Study|Adverse Event|4|||
125595083|NCT02504541|451802731|FG000|Overall Study|Withdrawal by Subject|4|||
125595084|NCT02504541|451802731|FG000|Overall Study|Lost to Follow-up|1|||
125595085|NCT02504541|451802731|FG000|Overall Study|Met Stopping Criteria|1|||
125595086|NCT02504541|451802731|FG000|Overall Study|Protocol Violation|2|||
125595087|NCT02504541|451802731|FG000|Overall Study|Termination by Sponsor|1|||
125595088|NCT02504541|451802731|FG000|Overall Study|Other|2|||
125595089|NCT02504541|451802731|FG000|Overall Study|Multiple|5|||
125595090|NCT00500071|451802732|FG000|Screening and Washout Phase|Protocol Violation|1|||
125595091|NCT00500071|451802732|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
125595092|NCT00500071|451802732|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
125595093|NCT00500071|451802732|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
125595094|NCT00500071|451802732|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
125595095|NCT00500071|451802732|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
125595096|NCT00500071|451802732|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
125595097|NCT00472303|451802733|FG000|Titration Phase|Adverse Event|22|||
125595098|NCT00472303|451802734|FG001|Titration Phase|Adverse Event|12|||
125595099|NCT00472303|451802735|FG002|Titration Phase|Adverse Event|0|||
125595100|NCT00472303|451802733|FG000|Titration Phase|Death|4|||
125595101|NCT00472303|451802734|FG001|Titration Phase|Death|2|||
125595102|NCT00472303|451802735|FG002|Titration Phase|Death|0|||
125595103|NCT00472303|451802733|FG000|Titration Phase|Lack of Efficacy|10|||
125595104|NCT00472303|451802734|FG001|Titration Phase|Lack of Efficacy|0|||
125595105|NCT00472303|451802735|FG002|Titration Phase|Lack of Efficacy|0|||
125595106|NCT00472303|451802733|FG000|Titration Phase|Withdrawal by Subject|16|||
125595107|NCT00472303|451802734|FG001|Titration Phase|Withdrawal by Subject|13|||
125595108|NCT00472303|451802735|FG002|Titration Phase|Withdrawal by Subject|0|||
125595109|NCT00472303|451802733|FG000|Titration Phase|Trial Medication non-compliant|4|||
125595110|NCT00472303|451802734|FG001|Titration Phase|Trial Medication non-compliant|1|||
125595111|NCT00472303|451802735|FG002|Titration Phase|Trial Medication non-compliant|0|||
125595112|NCT00472303|451802733|FG000|Titration Phase|Other|3|||
125595113|NCT00472303|451802734|FG001|Titration Phase|Other|1|||
125595114|NCT00472303|451802735|FG002|Titration Phase|Other|0|||
125595115|NCT00472303|451802733|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
125595116|NCT00472303|451802734|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
125595117|NCT00472303|451802735|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
125595118|NCT00472303|451802733|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
125595119|NCT00472303|451802734|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
125595120|NCT00472303|451802735|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
125595121|NCT00472303|451802733|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
125595122|NCT00472303|451802734|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
125595123|NCT00472303|451802735|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
125595124|NCT00472303|451802733|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
125595125|NCT00472303|451802734|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
125595126|NCT00472303|451802735|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
125595127|NCT00472303|451802733|FG000|Discontinuations After Titration Phase|Other|5|||
125595128|NCT00472303|451802734|FG001|Discontinuations After Titration Phase|Other|0|||
125595129|NCT00472303|451802735|FG002|Discontinuations After Titration Phase|Other|0|||
125364511|NCT00347360|450967160|FG004|Overall Study|Visits conflicted with new job|0|||
125364512|NCT00347360|450967161|FG005|Overall Study|Visits conflicted with new job|0|||
125364513|NCT00347360|450967162|FG006|Overall Study|Visits conflicted with new job|1|||
125364514|NCT00347360|450967163|FG007|Overall Study|Visits conflicted with new job|0|||
125364515|NCT00347360|450967164|FG008|Overall Study|Visits conflicted with new job|0|||
125595130|NCT00472303|451802733|FG000|Maintenance Phase|Adverse Event|5|||
125595131|NCT00472303|451802734|FG001|Maintenance Phase|Adverse Event|6|||
125595132|NCT00472303|451802735|FG002|Maintenance Phase|Adverse Event|6|||
125595133|NCT00472303|451802733|FG000|Maintenance Phase|Death|3|||
125595134|NCT00472303|451802734|FG001|Maintenance Phase|Death|0|||
125595135|NCT00472303|451802735|FG002|Maintenance Phase|Death|2|||
125595136|NCT00472303|451802733|FG000|Maintenance Phase|Lack of Efficacy|2|||
125595137|NCT00472303|451802734|FG001|Maintenance Phase|Lack of Efficacy|2|||
125595138|NCT00472303|451802735|FG002|Maintenance Phase|Lack of Efficacy|4|||
125595139|NCT00472303|451802733|FG000|Maintenance Phase|Withdrawal by Subject|6|||
125595140|NCT00472303|451802734|FG001|Maintenance Phase|Withdrawal by Subject|7|||
125595141|NCT00472303|451802735|FG002|Maintenance Phase|Withdrawal by Subject|3|||
125595142|NCT00472303|451802733|FG000|Maintenance Phase|Trial medication non-compliant|0|||
125595143|NCT00472303|451802734|FG001|Maintenance Phase|Trial medication non-compliant|0|||
125595144|NCT00472303|451802735|FG002|Maintenance Phase|Trial medication non-compliant|1|||
125595145|NCT00472303|451802733|FG000|Maintenance Phase|Resolution of pain|0|||
125595146|NCT00472303|451802734|FG001|Maintenance Phase|Resolution of pain|0|||
125595147|NCT00472303|451802735|FG002|Maintenance Phase|Resolution of pain|1|||
125595148|NCT00472303|451802733|FG000|Maintenance Phase|Other|1|||
125595149|NCT00472303|451802734|FG001|Maintenance Phase|Other|1|||
125595150|NCT00472303|451802735|FG002|Maintenance Phase|Other|0|||
125595151|NCT03182738|451802736|FG000|Overall Study|Lost to Follow-up|9|||
125595152|NCT03182738|451802737|FG001|Overall Study|Lost to Follow-up|3|||
125595153|NCT03182738|451802736|FG000|Overall Study|Pregnancy|0|||
125595154|NCT03182738|451802737|FG001|Overall Study|Pregnancy|1|||
125595155|NCT03182738|451802736|FG000|Overall Study|Withdrawal by Subject|0|||
125595156|NCT03182738|451802737|FG001|Overall Study|Withdrawal by Subject|1|||
125595157|NCT01486238|451802743|FG000|Overall Study|Death|0|||
125595158|NCT01486238|451802744|FG001|Overall Study|Death|2|||
125595159|NCT01486238|451802743|FG000|Overall Study|Withdrawal by Subject|2|||
125595160|NCT01486238|451802744|FG001|Overall Study|Withdrawal by Subject|1|||
125595161|NCT01486238|451802743|FG000|Overall Study|Lost to Follow-up|0|||
125595162|NCT01486238|451802744|FG001|Overall Study|Lost to Follow-up|3|||
125595163|NCT00356915|451802746|FG000|Overall Study|Non compliance|1|||
125595164|NCT00356915|451802747|FG001|Overall Study|Non compliance|2|||
125595165|NCT00356915|451802748|FG002|Overall Study|Non compliance|1|||
125595166|NCT00356915|451802746|FG000|Overall Study|Protocol Violation|2|||
125595167|NCT00356915|451802747|FG001|Overall Study|Protocol Violation|3|||
125595168|NCT00356915|451802748|FG002|Overall Study|Protocol Violation|2|||
125595169|NCT00356915|451802746|FG000|Overall Study|Withdrawal by Subject|14|||
125595170|NCT00356915|451802747|FG001|Overall Study|Withdrawal by Subject|14|||
125595171|NCT00356915|451802748|FG002|Overall Study|Withdrawal by Subject|10|||
125595172|NCT00356915|451802746|FG000|Overall Study|Lack of Efficacy|0|||
125595173|NCT00356915|451802747|FG001|Overall Study|Lack of Efficacy|0|||
125595174|NCT00356915|451802748|FG002|Overall Study|Lack of Efficacy|3|||
125595175|NCT00356915|451802746|FG000|Overall Study|Lost to Follow-up|27|||
125595176|NCT00356915|451802747|FG001|Overall Study|Lost to Follow-up|34|||
125595177|NCT00356915|451802748|FG002|Overall Study|Lost to Follow-up|14|||
125595178|NCT00356915|451802746|FG000|Overall Study|Administrative Decision|0|||
125595179|NCT00356915|451802747|FG001|Overall Study|Administrative Decision|0|||
125595180|NCT00356915|451802748|FG002|Overall Study|Administrative Decision|1|||
125595181|NCT00356915|451802746|FG000|Overall Study|Physician Decision|0|||
125595182|NCT00356915|451802747|FG001|Overall Study|Physician Decision|2|||
125212367|NCT00548249|450403336|FG001|Overall Study|Prolonged hospitalization|0|||
125595183|NCT00356915|451802748|FG002|Overall Study|Physician Decision|0|||
125595184|NCT00356915|451802746|FG000|Overall Study|Adverse Event|21|||
125595185|NCT00356915|451802747|FG001|Overall Study|Adverse Event|31|||
125595186|NCT00356915|451802748|FG002|Overall Study|Adverse Event|8|||
125595187|NCT00356915|451802746|FG000|Overall Study|Miscellaneous reasons|11|||
125595188|NCT00356915|451802747|FG001|Overall Study|Miscellaneous reasons|8|||
125595189|NCT00356915|451802748|FG002|Overall Study|Miscellaneous reasons|3|||
125595190|NCT00509106|451802749|FG000|Overall Study|Adverse Event|3|||
125595191|NCT00509106|451802750|FG001|Overall Study|Adverse Event|2|||
125595192|NCT00509106|451802749|FG000|Overall Study|Noncompliance|0|||
125595193|NCT00509106|451802750|FG001|Overall Study|Noncompliance|1|||
125595194|NCT00509106|451802749|FG000|Overall Study|At the request of sponsor/investigator|1|||
125595195|NCT00509106|451802750|FG001|Overall Study|At the request of sponsor/investigator|2|||
125595196|NCT00509106|451802749|FG000|Overall Study|Withdrew consent|4|||
125595197|NCT00509106|451802750|FG001|Overall Study|Withdrew consent|8|||
125595198|NCT00509106|451802749|FG000|Overall Study|Lost to Follow-up|16|||
125595199|NCT00509106|451802750|FG001|Overall Study|Lost to Follow-up|10|||
125595200|NCT00509106|451802749|FG000|Overall Study|Other|1|||
125595201|NCT00509106|451802750|FG001|Overall Study|Other|0|||
125595202|NCT00509106|451802749|FG000|Overall Study|Death|6|||
125595203|NCT00509106|451802750|FG001|Overall Study|Death|6|||
125595204|NCT02318602|451802751|FG000|Overall Study|Adverse Event|0|||
125595205|NCT02318602|451802752|FG001|Overall Study|Adverse Event|1|||
125595206|NCT02318602|451802753|FG002|Overall Study|Adverse Event|1|||
125595207|NCT02318602|451802751|FG000|Overall Study|Withdrawal by Subject|0|||
125595208|NCT02318602|451802752|FG001|Overall Study|Withdrawal by Subject|3|||
125595209|NCT02318602|451802753|FG002|Overall Study|Withdrawal by Subject|0|||
125595210|NCT02318602|451802751|FG000|Overall Study|Death|1|||
125595211|NCT02318602|451802752|FG001|Overall Study|Death|0|||
125595212|NCT02318602|451802753|FG002|Overall Study|Death|0|||
125595213|NCT02318602|451802751|FG000|Overall Study|Guardian decision to withdraw|0|||
125595214|NCT02318602|451802752|FG001|Overall Study|Guardian decision to withdraw|0|||
125595215|NCT02318602|451802753|FG002|Overall Study|Guardian decision to withdraw|1|||
125595216|NCT00693706|451802754|FG000|Overall Study|Protocol Violation|0|||
125595217|NCT00693706|451802755|FG001|Overall Study|Protocol Violation|1|||
125595218|NCT00488631|451802756|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
125595219|NCT00488631|451802757|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
125595220|NCT00488631|451802758|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
125595221|NCT00488631|451802759|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
125595222|NCT00488631|451802760|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
125595223|NCT00488631|451802761|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
125595224|NCT00488631|451802762|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
125595225|NCT00488631|451802763|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
125595226|NCT00488631|451802764|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
125595227|NCT00488631|451802765|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
125595228|NCT00488631|451802756|FG000|Double Blind Period (Week 0-54)|Death|0|||
125595229|NCT00488631|451802757|FG001|Double Blind Period (Week 0-54)|Death|0|||
125595230|NCT00488631|451802758|FG002|Double Blind Period (Week 0-54)|Death|0|||
125595231|NCT00488631|451802759|FG003|Double Blind Period (Week 0-54)|Death|0|||
125595232|NCT00488631|451802760|FG004|Double Blind Period (Week 0-54)|Death|0|||
125595233|NCT00488631|451802761|FG005|Double Blind Period (Week 0-54)|Death|1|||
125595234|NCT00488631|451802762|FG006|Double Blind Period (Week 0-54)|Death|0|||
125595235|NCT00488631|451802763|FG007|Double Blind Period (Week 0-54)|Death|0|||
125595236|NCT00488631|451802764|FG008|Double Blind Period (Week 0-54)|Death|0|||
125595237|NCT00488631|451802765|FG009|Double Blind Period (Week 0-54)|Death|0|||
125595238|NCT00488631|451802756|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
125595239|NCT00488631|451802757|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
125595240|NCT00488631|451802758|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
125595241|NCT00488631|451802759|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
125595242|NCT00488631|451802760|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
125595243|NCT00488631|451802761|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
125595244|NCT00488631|451802762|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
125595245|NCT00488631|451802763|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
125595246|NCT00488631|451802764|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
125595247|NCT00488631|451802765|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
125595248|NCT00488631|451802756|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
125595249|NCT00488631|451802757|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
125595250|NCT00488631|451802758|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
125595251|NCT00488631|451802759|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
125595252|NCT00488631|451802760|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
125595253|NCT00488631|451802761|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
125595254|NCT00488631|451802762|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
125595255|NCT00488631|451802763|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
125595256|NCT00488631|451802764|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
125595257|NCT00488631|451802765|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
125595258|NCT00488631|451802756|FG000|Double Blind Period (Week 0-54)|Other|6|||
125595259|NCT00488631|451802757|FG001|Double Blind Period (Week 0-54)|Other|12|||
125595260|NCT00488631|451802758|FG002|Double Blind Period (Week 0-54)|Other|10|||
125595261|NCT00488631|451802759|FG003|Double Blind Period (Week 0-54)|Other|11|||
125595262|NCT00488631|451802760|FG004|Double Blind Period (Week 0-54)|Other|14|||
125595263|NCT00488631|451802761|FG005|Double Blind Period (Week 0-54)|Other|34|||
125595264|NCT00488631|451802762|FG006|Double Blind Period (Week 0-54)|Other|0|||
125595265|NCT00488631|451802763|FG007|Double Blind Period (Week 0-54)|Other|0|||
125595266|NCT00488631|451802764|FG008|Double Blind Period (Week 0-54)|Other|0|||
125595267|NCT00488631|451802765|FG009|Double Blind Period (Week 0-54)|Other|0|||
125595268|NCT00488631|451802756|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125595269|NCT00488631|451802757|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125595270|NCT00488631|451802758|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125595271|NCT00488631|451802759|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125595272|NCT00488631|451802760|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125595273|NCT00488631|451802761|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125595274|NCT00488631|451802762|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
125595275|NCT00488631|451802763|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
125595276|NCT00488631|451802764|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
125595277|NCT00488631|451802765|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
125595278|NCT00488631|451802756|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
125595279|NCT00488631|451802757|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
125595280|NCT00488631|451802758|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
125595281|NCT00488631|451802759|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
125595282|NCT00488631|451802760|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
125595283|NCT00488631|451802761|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
125595284|NCT00488631|451802762|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
125595285|NCT00488631|451802763|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
125595286|NCT00488631|451802764|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
125595287|NCT00488631|451802765|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
125595288|NCT00488631|451802756|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
125595289|NCT00488631|451802757|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
125595290|NCT00488631|451802758|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
125595291|NCT00488631|451802759|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
125595292|NCT00488631|451802760|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
125595293|NCT00488631|451802761|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
125595294|NCT00488631|451802762|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
125595295|NCT00488631|451802763|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
125595296|NCT00488631|451802764|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
125595297|NCT00488631|451802765|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
125595298|NCT00488631|451802756|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125595299|NCT00488631|451802757|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125595300|NCT00488631|451802758|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125595301|NCT00488631|451802759|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125595302|NCT00488631|451802760|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125595303|NCT00488631|451802761|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125595304|NCT00488631|451802762|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
125595305|NCT00488631|451802763|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125595306|NCT00488631|451802764|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
125595307|NCT00488631|451802765|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
125595308|NCT00488631|451802756|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125595309|NCT00488631|451802757|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125595310|NCT00488631|451802758|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125595311|NCT00488631|451802759|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125595312|NCT00488631|451802760|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125595313|NCT00488631|451802761|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125595314|NCT00488631|451802762|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
125595315|NCT00488631|451802763|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
125595316|NCT00488631|451802764|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
125595317|NCT00488631|451802765|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
125595318|NCT01873950|451802766|FG000|Period 5|Withdrawal by Subject|0|||
125595319|NCT01873950|451802767|FG001|Period 5|Withdrawal by Subject|0|||
125595320|NCT01873950|451802768|FG002|Period 5|Withdrawal by Subject|0|||
125595321|NCT01873950|451802769|FG003|Period 5|Withdrawal by Subject|1|||
125595322|NCT01873950|451802770|FG004|Period 5|Withdrawal by Subject|0|||
125595323|NCT01193335|451802772|FG000|After Infant Series|Lost to Follow-up|1|||
125595324|NCT01193335|451802773|FG001|After Infant Series|Lost to Follow-up|2|||
125595325|NCT01193335|451802772|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
125595326|NCT01193335|451802773|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
125595327|NCT01193335|451802772|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
125595328|NCT01193335|451802773|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
125595329|NCT01193335|451802772|FG000|1-Year Follow-up|Lost to Follow-up|4|||
125595330|NCT01193335|451802773|FG001|1-Year Follow-up|Lost to Follow-up|0|||
125595331|NCT01193335|451802772|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
125595332|NCT01193335|451802773|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
125595333|NCT01193335|451802772|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
125595334|NCT01193335|451802773|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
125595335|NCT01733329|451802774|FG000|Overall Study|Protocol Violation|1|||
125595336|NCT01733329|451802775|FG001|Overall Study|Protocol Violation|1|||
125595337|NCT01733329|451802774|FG000|Overall Study|Uterine artery injury|1|||
125364516|NCT00347360|450967165|FG009|Overall Study|Visits conflicted with new job|0|||
125364517|NCT00347360|450967166|FG010|Overall Study|Visits conflicted with new job|0|||
125364518|NCT00347360|450967167|FG011|Overall Study|Visits conflicted with new job|0|||
125595338|NCT01733329|451802775|FG001|Overall Study|Uterine artery injury|0|||
125595339|NCT02500550|451802782|FG000|Overall Study|Death|7|||
125212368|NCT00548249|450403337|FG002|Overall Study|Prolonged hospitalization|2|||
125429886|NCT00949715|451200120|FG000|Overall Study|Lost to Follow-up|1|||
125595340|NCT04003610|451802788|FG000|Overall Study|Lost to Follow-up|0|||
125595341|NCT04003610|451802789|FG001|Overall Study|Lost to Follow-up|1|||
125595342|NCT04003610|451802790|FG002|Overall Study|Lost to Follow-up|0|||
125595343|NCT04003610|451802788|FG000|Overall Study|Death|0|||
125595344|NCT04003610|451802789|FG001|Overall Study|Death|0|||
125595345|NCT04003610|451802790|FG002|Overall Study|Death|3|||
125595346|NCT04003610|451802788|FG000|Overall Study|Study Terminated by Sponsor|0|||
125595347|NCT04003610|451802789|FG001|Overall Study|Study Terminated by Sponsor|0|||
125595348|NCT04003610|451802790|FG002|Overall Study|Study Terminated by Sponsor|3|||
125595349|NCT02502864|451802796|FG000|Overall Study|Withdrawal by Subject|1|||
125595350|NCT03772327|451802797|FG000|Overall Study|Lost to Follow-up|3|||
125595351|NCT03772327|451802798|FG001|Overall Study|Lost to Follow-up|4|||
125595352|NCT03772327|451802797|FG000|Overall Study|Withdrawal by Subject|2|||
125595353|NCT03772327|451802798|FG001|Overall Study|Withdrawal by Subject|3|||
125595354|NCT00246259|451802800|FG000|Overall Study|Other|3|||
125595355|NCT00246259|451802801|FG001|Overall Study|Other|3|||
125595356|NCT00246259|451802800|FG000|Overall Study|Not stable by Week 18|2|||
125595357|NCT00246259|451802801|FG001|Overall Study|Not stable by Week 18|1|||
125595358|NCT00246259|451802800|FG000|Overall Study|Participant non-compliant|4|||
125595359|NCT00246259|451802801|FG001|Overall Study|Participant non-compliant|9|||
125595360|NCT00246259|451802800|FG000|Overall Study|Lack of Efficacy|2|||
125595361|NCT00246259|451802801|FG001|Overall Study|Lack of Efficacy|2|||
125595362|NCT00246259|451802800|FG000|Overall Study|Investigator withdrew participant|2|||
125595363|NCT00246259|451802801|FG001|Overall Study|Investigator withdrew participant|0|||
125595364|NCT00246259|451802800|FG000|Overall Study|Adverse Event|5|||
125595365|NCT00246259|451802801|FG001|Overall Study|Adverse Event|0|||
125595366|NCT00246259|451802800|FG000|Overall Study|Lost to Follow-up|3|||
125595367|NCT00246259|451802801|FG001|Overall Study|Lost to Follow-up|4|||
125595368|NCT00246259|451802800|FG000|Overall Study|Withdrawal by Subject|5|||
125595369|NCT00246259|451802801|FG001|Overall Study|Withdrawal by Subject|1|||
125595370|NCT00246259|451802800|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
125595371|NCT00246259|451802801|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
125595372|NCT03133767|451802808|FG000|Overall Study|Lost to Follow-up|38|||
125595373|NCT03133767|451802809|FG001|Overall Study|Lost to Follow-up|24|||
125595374|NCT03133767|451802808|FG000|Overall Study|Protocol Violation|0|||
125595375|NCT03133767|451802809|FG001|Overall Study|Protocol Violation|1|||
125595376|NCT04233424|451802810|FG000|Overall Study|Death|15|||
125595377|NCT04233424|451802811|FG001|Overall Study|Death|16|||
125595378|NCT04233424|451802810|FG000|Overall Study|Withdrawal by Subject|2|||
125595379|NCT04233424|451802811|FG001|Overall Study|Withdrawal by Subject|8|||
125595380|NCT04233424|451802810|FG000|Overall Study|Physician Decision|1|||
125595381|NCT04233424|451802811|FG001|Overall Study|Physician Decision|3|||
125595382|NCT04233424|451802810|FG000|Overall Study|Protocol Violation|3|||
125595383|NCT04233424|451802811|FG001|Overall Study|Protocol Violation|1|||
125595384|NCT04233424|451802810|FG000|Overall Study|Lost to Follow-up|1|||
125595385|NCT04233424|451802811|FG001|Overall Study|Lost to Follow-up|3|||
125595386|NCT04233424|451802810|FG000|Overall Study|subject refuse to visit site|2|||
125595387|NCT04233424|451802811|FG001|Overall Study|subject refuse to visit site|0|||
125595388|NCT05502289|451802816|FG000|Period 1|Out Of Window|1|||
125595389|NCT05502289|451802817|FG001|Period 1|Out Of Window|0|||
125595390|NCT02333227|451802823|FG000|Overall Study|Lost to Follow-up|137|||
125595391|NCT02333227|451802824|FG001|Overall Study|Lost to Follow-up|106|||
125595392|NCT02333227|451802823|FG000|Overall Study|Pregnancy Interrupted|42|||
125595393|NCT02333227|451802824|FG001|Overall Study|Pregnancy Interrupted|89|||
125595394|NCT02333227|451802823|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
125595395|NCT02333227|451802824|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
125595396|NCT01624194|451802827|FG000|Overall Study|Lost to Follow-up|1|||
125595397|NCT01624194|451802828|FG001|Overall Study|Lost to Follow-up|0|||
125595398|NCT01624194|451802827|FG000|Overall Study|Withdrawal by Subject|1|||
125595399|NCT01624194|451802828|FG001|Overall Study|Withdrawal by Subject|0|||
125595400|NCT00561353|451802829|FG000|Overall Study|Subject reached a virologic endpoint|2|||
125595401|NCT00561353|451802830|FG001|Overall Study|Subject reached a virologic endpoint|1|||
125595402|NCT00561353|451802831|FG002|Overall Study|Subject reached a virologic endpoint|1|||
125595403|NCT00561353|451802832|FG003|Overall Study|Subject reached a virologic endpoint|4|||
125595404|NCT00561353|451802833|FG004|Overall Study|Subject reached a virologic endpoint|1|||
125595405|NCT00561353|451802834|FG005|Overall Study|Subject reached a virologic endpoint|3|||
125595406|NCT00561353|451802835|FG006|Overall Study|Subject reached a virologic endpoint|4|||
125595407|NCT00561353|451802836|FG007|Overall Study|Subject reached a virologic endpoint|4|||
125595408|NCT00561353|451802837|FG008|Overall Study|Subject reached a virologic endpoint|5|||
125595409|NCT00561353|451802838|FG009|Overall Study|Subject reached a virologic endpoint|0|||
125595410|NCT00561353|451802829|FG000|Overall Study|Subject ineligible to continue the trial|0|||
125595411|NCT00561353|451802830|FG001|Overall Study|Subject ineligible to continue the trial|0|||
125595412|NCT00561353|451802831|FG002|Overall Study|Subject ineligible to continue the trial|0|||
125595413|NCT00561353|451802832|FG003|Overall Study|Subject ineligible to continue the trial|0|||
125595414|NCT00561353|451802833|FG004|Overall Study|Subject ineligible to continue the trial|0|||
125595415|NCT00561353|451802834|FG005|Overall Study|Subject ineligible to continue the trial|1|||
125595416|NCT00561353|451802835|FG006|Overall Study|Subject ineligible to continue the trial|1|||
125595417|NCT00561353|451802836|FG007|Overall Study|Subject ineligible to continue the trial|0|||
125595418|NCT00561353|451802837|FG008|Overall Study|Subject ineligible to continue the trial|2|||
125595419|NCT00561353|451802838|FG009|Overall Study|Subject ineligible to continue the trial|1|||
125429887|NCT00949715|451200121|FG001|Overall Study|Lost to Follow-up|0|||
125595420|NCT00561353|451802829|FG000|Overall Study|Other|1|||
125595421|NCT00561353|451802830|FG001|Overall Study|Other|0|||
125595422|NCT00561353|451802831|FG002|Overall Study|Other|1|||
125595423|NCT00561353|451802832|FG003|Overall Study|Other|0|||
125595424|NCT00561353|451802833|FG004|Overall Study|Other|0|||
125595425|NCT00561353|451802834|FG005|Overall Study|Other|2|||
125595426|NCT00561353|451802835|FG006|Overall Study|Other|0|||
125595427|NCT00561353|451802836|FG007|Overall Study|Other|0|||
125595428|NCT00561353|451802837|FG008|Overall Study|Other|0|||
125595429|NCT00561353|451802838|FG009|Overall Study|Other|0|||
125595430|NCT00561353|451802829|FG000|Overall Study|Adverse Event|0|||
125595431|NCT00561353|451802830|FG001|Overall Study|Adverse Event|0|||
125595432|NCT00561353|451802831|FG002|Overall Study|Adverse Event|0|||
125595433|NCT00561353|451802832|FG003|Overall Study|Adverse Event|2|||
125595434|NCT00561353|451802833|FG004|Overall Study|Adverse Event|0|||
125595435|NCT00561353|451802834|FG005|Overall Study|Adverse Event|0|||
125595436|NCT00561353|451802835|FG006|Overall Study|Adverse Event|1|||
125595437|NCT00561353|451802836|FG007|Overall Study|Adverse Event|0|||
125595438|NCT00561353|451802837|FG008|Overall Study|Adverse Event|0|||
125595439|NCT00561353|451802838|FG009|Overall Study|Adverse Event|1|||
125595440|NCT00561353|451802829|FG000|Overall Study|Lost to Follow-up|2|||
125595441|NCT00561353|451802830|FG001|Overall Study|Lost to Follow-up|0|||
125595442|NCT00561353|451802831|FG002|Overall Study|Lost to Follow-up|1|||
125595443|NCT00561353|451802832|FG003|Overall Study|Lost to Follow-up|0|||
125595444|NCT00561353|451802833|FG004|Overall Study|Lost to Follow-up|0|||
125595445|NCT00561353|451802834|FG005|Overall Study|Lost to Follow-up|0|||
125595446|NCT00561353|451802835|FG006|Overall Study|Lost to Follow-up|0|||
125595447|NCT00561353|451802836|FG007|Overall Study|Lost to Follow-up|0|||
125595448|NCT00561353|451802837|FG008|Overall Study|Lost to Follow-up|0|||
125595449|NCT00561353|451802838|FG009|Overall Study|Lost to Follow-up|0|||
125595450|NCT00561353|451802829|FG000|Overall Study|Withdrawal by Subject|0|||
125595451|NCT00561353|451802830|FG001|Overall Study|Withdrawal by Subject|2|||
125595452|NCT00561353|451802831|FG002|Overall Study|Withdrawal by Subject|0|||
125595453|NCT00561353|451802832|FG003|Overall Study|Withdrawal by Subject|0|||
125595454|NCT00561353|451802833|FG004|Overall Study|Withdrawal by Subject|0|||
125595455|NCT00561353|451802834|FG005|Overall Study|Withdrawal by Subject|0|||
125595456|NCT00561353|451802835|FG006|Overall Study|Withdrawal by Subject|0|||
125595457|NCT00561353|451802836|FG007|Overall Study|Withdrawal by Subject|0|||
125595458|NCT00561353|451802837|FG008|Overall Study|Withdrawal by Subject|0|||
125595459|NCT00561353|451802838|FG009|Overall Study|Withdrawal by Subject|0|||
125595460|NCT01084252|451804609|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125595461|NCT01084252|451804610|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125595462|NCT01084252|451804611|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125595463|NCT01084252|451804612|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125595464|NCT01084252|451804613|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125595465|NCT01084252|451804614|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125595466|NCT01084252|451804615|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125595467|NCT01084252|451804616|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125595468|NCT01084252|451804617|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125595469|NCT01084252|451804618|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125595470|NCT01084252|451804619|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125595471|NCT01084252|451804620|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125595472|NCT01084252|451804621|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
125595473|NCT01084252|451804622|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
125595474|NCT04909463|451804623|FG000|Overall Study|Withdrawal by Subject|0|||
125595475|NCT04909463|451804624|FG001|Overall Study|Withdrawal by Subject|1|||
125595476|NCT04909463|451804625|FG002|Overall Study|Withdrawal by Subject|0|||
125595477|NCT04909463|451804626|FG003|Overall Study|Withdrawal by Subject|0|||
125595478|NCT04909463|451804623|FG000|Overall Study|Lost to Follow-up|2|||
125595479|NCT04909463|451804624|FG001|Overall Study|Lost to Follow-up|1|||
125595480|NCT04909463|451804625|FG002|Overall Study|Lost to Follow-up|1|||
125595481|NCT04909463|451804626|FG003|Overall Study|Lost to Follow-up|0|||
125595482|NCT00955110|451804627|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
125595483|NCT00955110|451804627|FG000|Treatment Phase|Adverse Event|2|||
125595484|NCT00955110|451804627|FG000|Treatment Phase|Administrative reasons|2|||
125595485|NCT00955110|451804627|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
125595486|NCT00955110|451804627|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
125595487|NCT00698516|451804632|FG000|Overall Study|Study Termination|2|||
125595488|NCT00698516|451804632|FG000|Overall Study|Withdrawal by Subject|3|||
125595489|NCT02586207|451804637|FG000|Overall Study|Physician Decision|1|||
125595490|NCT02586207|451804637|FG000|Overall Study|Withdrawal by Subject|1|||
125595491|NCT02158533|451804640|FG000|Stage 1|Adverse Event|6|||
125595492|NCT02158533|451804641|FG001|Stage 1|Adverse Event|4|||
125595493|NCT02158533|451804642|FG002|Stage 1|Adverse Event|7|||
125595494|NCT02158533|451804643|FG003|Stage 1|Adverse Event|0|||
125595495|NCT02158533|451804644|FG004|Stage 1|Adverse Event|0|||
125595496|NCT02158533|451804645|FG005|Stage 1|Adverse Event|0|||
125595497|NCT02158533|451804640|FG000|Stage 1|Withdrawal by Subject|3|||
125595498|NCT02158533|451804641|FG001|Stage 1|Withdrawal by Subject|2|||
125595499|NCT02158533|451804642|FG002|Stage 1|Withdrawal by Subject|1|||
125595500|NCT02158533|451804643|FG003|Stage 1|Withdrawal by Subject|0|||
125595501|NCT02158533|451804644|FG004|Stage 1|Withdrawal by Subject|0|||
125595502|NCT02158533|451804645|FG005|Stage 1|Withdrawal by Subject|0|||
125595503|NCT02158533|451804640|FG000|Stage 1|Lack of Efficacy|1|||
125595504|NCT02158533|451804641|FG001|Stage 1|Lack of Efficacy|0|||
125595505|NCT02158533|451804642|FG002|Stage 1|Lack of Efficacy|0|||
125595506|NCT02158533|451804643|FG003|Stage 1|Lack of Efficacy|0|||
125595507|NCT02158533|451804644|FG004|Stage 1|Lack of Efficacy|0|||
125595508|NCT02158533|451804645|FG005|Stage 1|Lack of Efficacy|0|||
125595509|NCT02158533|451804640|FG000|Stage 1|Lost to Follow-up|3|||
125595510|NCT02158533|451804641|FG001|Stage 1|Lost to Follow-up|1|||
125595511|NCT02158533|451804642|FG002|Stage 1|Lost to Follow-up|0|||
125595512|NCT02158533|451804643|FG003|Stage 1|Lost to Follow-up|0|||
125595513|NCT02158533|451804644|FG004|Stage 1|Lost to Follow-up|0|||
125595514|NCT02158533|451804645|FG005|Stage 1|Lost to Follow-up|0|||
125595515|NCT02158533|451804640|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
125595516|NCT02158533|451804641|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
125595517|NCT02158533|451804642|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
125595518|NCT02158533|451804643|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
125595519|NCT02158533|451804644|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
125595520|NCT02158533|451804645|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
125595521|NCT02158533|451804640|FG000|Stage 1|Non-compliance with study visits|1|||
125595522|NCT02158533|451804641|FG001|Stage 1|Non-compliance with study visits|0|||
125595523|NCT02158533|451804642|FG002|Stage 1|Non-compliance with study visits|0|||
125595524|NCT02158533|451804643|FG003|Stage 1|Non-compliance with study visits|0|||
125595525|NCT02158533|451804644|FG004|Stage 1|Non-compliance with study visits|0|||
125595526|NCT02158533|451804645|FG005|Stage 1|Non-compliance with study visits|0|||
125595527|NCT02158533|451804640|FG000|Stage 2|Adverse Event|0|||
125595528|NCT02158533|451804641|FG001|Stage 2|Adverse Event|0|||
125595529|NCT02158533|451804642|FG002|Stage 2|Adverse Event|0|||
125595530|NCT02158533|451804643|FG003|Stage 2|Adverse Event|0|||
125595531|NCT02158533|451804644|FG004|Stage 2|Adverse Event|0|||
125595532|NCT02158533|451804645|FG005|Stage 2|Adverse Event|1|||
125595533|NCT02158533|451804640|FG000|Stage 2|Lack of Efficacy|0|||
125595534|NCT02158533|451804641|FG001|Stage 2|Lack of Efficacy|0|||
125595535|NCT02158533|451804642|FG002|Stage 2|Lack of Efficacy|0|||
125364519|NCT00347360|450967168|FG012|Overall Study|Visits conflicted with new job|0|||
125595536|NCT02158533|451804643|FG003|Stage 2|Lack of Efficacy|0|||
125595537|NCT02158533|451804644|FG004|Stage 2|Lack of Efficacy|1|||
125595538|NCT02158533|451804645|FG005|Stage 2|Lack of Efficacy|0|||
125595539|NCT02158533|451804640|FG000|Stage 2|Lost to Follow-up|0|||
125595540|NCT02158533|451804641|FG001|Stage 2|Lost to Follow-up|0|||
125595541|NCT02158533|451804642|FG002|Stage 2|Lost to Follow-up|0|||
125595542|NCT02158533|451804643|FG003|Stage 2|Lost to Follow-up|1|||
125595543|NCT02158533|451804644|FG004|Stage 2|Lost to Follow-up|1|||
125595544|NCT02158533|451804645|FG005|Stage 2|Lost to Follow-up|2|||
125595545|NCT02158533|451804640|FG000|Stage 2|Withdrawal by Subject|0|||
125595546|NCT02158533|451804641|FG001|Stage 2|Withdrawal by Subject|0|||
125595547|NCT02158533|451804642|FG002|Stage 2|Withdrawal by Subject|0|||
125595548|NCT02158533|451804643|FG003|Stage 2|Withdrawal by Subject|0|||
125595549|NCT02158533|451804644|FG004|Stage 2|Withdrawal by Subject|1|||
125595550|NCT02158533|451804645|FG005|Stage 2|Withdrawal by Subject|2|||
125595551|NCT02158533|451804640|FG000|Stage 2|Physician Decision|0|||
125595552|NCT02158533|451804641|FG001|Stage 2|Physician Decision|0|||
125595553|NCT02158533|451804642|FG002|Stage 2|Physician Decision|0|||
125595554|NCT02158533|451804643|FG003|Stage 2|Physician Decision|0|||
125595555|NCT02158533|451804644|FG004|Stage 2|Physician Decision|1|||
125595556|NCT02158533|451804645|FG005|Stage 2|Physician Decision|0|||
125595557|NCT02158533|451804640|FG000|Stage 2|Pregnancy|0|||
125595558|NCT02158533|451804641|FG001|Stage 2|Pregnancy|0|||
125595559|NCT02158533|451804642|FG002|Stage 2|Pregnancy|0|||
125595560|NCT02158533|451804643|FG003|Stage 2|Pregnancy|1|||
125595561|NCT02158533|451804644|FG004|Stage 2|Pregnancy|0|||
125595562|NCT02158533|451804645|FG005|Stage 2|Pregnancy|0|||
125595563|NCT02158533|451804640|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
125595564|NCT02158533|451804641|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
125595565|NCT02158533|451804642|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
125595566|NCT02158533|451804643|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
125595567|NCT02158533|451804644|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
125595568|NCT02158533|451804645|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
125595569|NCT02158533|451804640|FG000|Stage 2|Non-adherence with study visits|0|||
125595570|NCT02158533|451804641|FG001|Stage 2|Non-adherence with study visits|0|||
125595571|NCT02158533|451804642|FG002|Stage 2|Non-adherence with study visits|0|||
125595572|NCT02158533|451804643|FG003|Stage 2|Non-adherence with study visits|0|||
125595573|NCT02158533|451804644|FG004|Stage 2|Non-adherence with study visits|0|||
125595574|NCT02158533|451804645|FG005|Stage 2|Non-adherence with study visits|1|||
125595575|NCT00345605|451804652|FG000|Arm 1|Adverse Event|0|||
125595576|NCT00345605|451804653|FG001|Arm 1|Adverse Event|1|||
125595577|NCT00345605|451804652|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
125595578|NCT00345605|451804653|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
125595579|NCT01335971|451804654|FG000|Overall Study|Withdrawal by Subject|1|||
125595580|NCT01335971|451804655|FG001|Overall Study|Withdrawal by Subject|0|||
125595581|NCT01335971|451804656|FG002|Overall Study|Withdrawal by Subject|0|||
125595582|NCT01335971|451804654|FG000|Overall Study|Did not complete bronchoscopy|1|||
125595583|NCT01335971|451804655|FG001|Overall Study|Did not complete bronchoscopy|1|||
125595584|NCT01335971|451804656|FG002|Overall Study|Did not complete bronchoscopy|1|||
125595585|NCT00384956|451804657|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
125595586|NCT00917384|451804658|FG000|Overall Study|Lost to Follow-up|4|||
125595587|NCT00917384|451804659|FG001|Overall Study|Lost to Follow-up|2|||
125595588|NCT00917384|451804658|FG000|Overall Study|Withdrawal by Subject|10|||
125595589|NCT00917384|451804659|FG001|Overall Study|Withdrawal by Subject|2|||
125595590|NCT00149214|451804660|FG000|Overall Study|Adverse Event|12|||
125595591|NCT00149214|451804661|FG001|Overall Study|Adverse Event|9|||
125595592|NCT00149214|451804660|FG000|Overall Study|Withdrawal by Subject|4|||
125595593|NCT00149214|451804661|FG001|Overall Study|Withdrawal by Subject|1|||
125595594|NCT00149214|451804660|FG000|Overall Study|Physician Decision|3|||
125595595|NCT00149214|451804661|FG001|Overall Study|Physician Decision|3|||
125595596|NCT00149214|451804660|FG000|Overall Study|Sponsor Decision|0|||
125595597|NCT00149214|451804661|FG001|Overall Study|Sponsor Decision|1|||
125595598|NCT00149214|451804660|FG000|Overall Study|Progressive Disease|7|||
125595599|NCT00149214|451804661|FG001|Overall Study|Progressive Disease|3|||
125595600|NCT01859403|451804666|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
125595601|NCT01859403|451804667|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
125595602|NCT01859403|451804666|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
125595603|NCT01859403|451804667|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
125595604|NCT01859403|451804666|FG000|Primary Endpoint Measure|Physician Decision|0|||
125595605|NCT01859403|451804667|FG001|Primary Endpoint Measure|Physician Decision|1|||
125595606|NCT01859403|451804666|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
125595607|NCT01859403|451804667|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
125595608|NCT00892437|451804675|FG000|Randomized Phase|Randomized but not treated|6|||
125595609|NCT00892437|451804676|FG001|Randomized Phase|Randomized but not treated|0|||
125595610|NCT00892437|451804675|FG000|Randomized Phase|Adverse Event|2|||
125595611|NCT00892437|451804676|FG001|Randomized Phase|Adverse Event|2|||
125595612|NCT00892437|451804675|FG000|Randomized Phase|Lost to Follow-up|1|||
125595613|NCT00892437|451804676|FG001|Randomized Phase|Lost to Follow-up|3|||
125595614|NCT00892437|451804675|FG000|Randomized Phase|Investigator's Discretion|1|||
125595615|NCT00892437|451804676|FG001|Randomized Phase|Investigator's Discretion|0|||
125595616|NCT00892437|451804675|FG000|Randomized Phase|Withdrew Consent|1|||
125595617|NCT00892437|451804676|FG001|Randomized Phase|Withdrew Consent|0|||
125595618|NCT00892437|451804675|FG000|Open-Label Extension Phase|Adverse Event|4|||
125595619|NCT00892437|451804676|FG001|Open-Label Extension Phase|Adverse Event|2|||
125595620|NCT00892437|451804675|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
125595621|NCT00892437|451804676|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
125595622|NCT00892437|451804675|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
125595623|NCT00892437|451804676|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
125595624|NCT00892437|451804675|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
125595625|NCT00892437|451804676|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
125364520|NCT00347360|450967169|FG013|Overall Study|Visits conflicted with new job|0|||
125364521|NCT00347360|450967170|FG014|Overall Study|Visits conflicted with new job|0|||
125595626|NCT00892437|451804675|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
125595627|NCT00892437|451804676|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
125595628|NCT02750410|451804678|FG000|Double-Blind Treatment Period|Adverse Event|2|||
125595629|NCT02750410|451804679|FG001|Double-Blind Treatment Period|Adverse Event|2|||
125595630|NCT02750410|451804678|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125595631|NCT02750410|451804679|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125595632|NCT02750410|451804678|FG000|Open-Label Extension Period|Adverse Event|5|||
125595633|NCT02750410|451804679|FG001|Open-Label Extension Period|Adverse Event|3|||
125364522|NCT00806351|450967176|FG000|Overall Study|Death|5|||
125595634|NCT02750410|451804678|FG000|Open-Label Extension Period|Protocol Violation|0|||
125595635|NCT02750410|451804679|FG001|Open-Label Extension Period|Protocol Violation|1|||
125595636|NCT02750410|451804678|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
125595637|NCT02750410|451804679|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
125595638|NCT01531725|451804683|FG000|Overall Study|Protocol Violation|5|||
125595639|NCT03596164|451804685|FG000|Overall Study|Adverse Event|0|||
125595640|NCT03596164|451804686|FG001|Overall Study|Adverse Event|1|||
125595641|NCT03596164|451804685|FG000|Overall Study|Death|1|||
125595642|NCT03596164|451804686|FG001|Overall Study|Death|0|||
125595643|NCT04112914|451804687|FG000|Overall Study|Lost to Follow-up|13|||
125595644|NCT04112914|451804688|FG001|Overall Study|Lost to Follow-up|9|||
125595645|NCT04112914|451804687|FG000|Overall Study|Withdrawal by Subject|1|||
125595646|NCT04112914|451804688|FG001|Overall Study|Withdrawal by Subject|0|||
125595647|NCT03427073|451804689|FG000|Overall Study|Disease Progression|1|||
125595648|NCT03427073|451804690|FG001|Overall Study|Disease Progression|1|||
125595649|NCT03427073|451804691|FG002|Overall Study|Disease Progression|1|||
125595650|NCT03427073|451804692|FG003|Overall Study|Disease Progression|3|||
125595651|NCT03427073|451804693|FG004|Overall Study|Disease Progression|3|||
125595652|NCT03427073|451804694|FG005|Overall Study|Disease Progression|4|||
125595653|NCT03427073|451804695|FG006|Overall Study|Disease Progression|2|||
125595654|NCT03427073|451804696|FG007|Overall Study|Disease Progression|3|||
125595655|NCT03427073|451804689|FG000|Overall Study|Physician Decision|0|||
125595656|NCT03427073|451804690|FG001|Overall Study|Physician Decision|0|||
125595657|NCT03427073|451804691|FG002|Overall Study|Physician Decision|0|||
125595658|NCT03427073|451804692|FG003|Overall Study|Physician Decision|0|||
125595659|NCT03427073|451804693|FG004|Overall Study|Physician Decision|0|||
125595660|NCT03427073|451804694|FG005|Overall Study|Physician Decision|0|||
125595661|NCT03427073|451804695|FG006|Overall Study|Physician Decision|1|||
125595662|NCT03427073|451804696|FG007|Overall Study|Physician Decision|1|||
125595663|NCT02835495|451804699|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
125595664|NCT02835495|451804700|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
125595665|NCT02835495|451804699|FG000|Overall Study|Declined in-person follow-up visit|4|||
125595666|NCT02835495|451804700|FG001|Overall Study|Declined in-person follow-up visit|2|||
125595667|NCT05421754|451804701|FG000|Overall Study|Technical issue with sensor|1|||
125595668|NCT02580058|451804704|FG000|Overall Study|Adverse Event|16|||
125595669|NCT02580058|451804705|FG001|Overall Study|Adverse Event|30|||
125595670|NCT02580058|451804706|FG002|Overall Study|Adverse Event|20|||
125595671|NCT02580058|451804704|FG000|Overall Study|Death|4|||
125595672|NCT02580058|451804705|FG001|Overall Study|Death|4|||
125595673|NCT02580058|451804706|FG002|Overall Study|Death|5|||
125595674|NCT02580058|451804704|FG000|Overall Study|Physician Decision|1|||
125595675|NCT02580058|451804705|FG001|Overall Study|Physician Decision|3|||
125595676|NCT02580058|451804706|FG002|Overall Study|Physician Decision|11|||
125595677|NCT02580058|451804704|FG000|Overall Study|Other|5|||
125595678|NCT02580058|451804705|FG001|Overall Study|Other|1|||
125595679|NCT02580058|451804706|FG002|Overall Study|Other|3|||
125595680|NCT02580058|451804704|FG000|Overall Study|Withdrawal by Subject|4|||
125595681|NCT02580058|451804705|FG001|Overall Study|Withdrawal by Subject|7|||
125595682|NCT02580058|451804706|FG002|Overall Study|Withdrawal by Subject|31|||
125595683|NCT02580058|451804704|FG000|Overall Study|Global Deterioration of Health Status|19|||
125595684|NCT02580058|451804705|FG001|Overall Study|Global Deterioration of Health Status|18|||
125595685|NCT02580058|451804706|FG002|Overall Study|Global Deterioration of Health Status|24|||
125595686|NCT02580058|451804704|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
125595687|NCT02580058|451804705|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125595688|NCT02580058|451804706|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
125595689|NCT02580058|451804704|FG000|Overall Study|Progressive Disease|137|||
125595690|NCT02580058|451804705|FG001|Overall Study|Progressive Disease|125|||
125595691|NCT02580058|451804706|FG002|Overall Study|Progressive Disease|94|||
125595692|NCT02580058|451804704|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125595693|NCT02580058|451804705|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125595694|NCT02580058|451804706|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125595695|NCT03486314|451804707|FG000|Part A|Adverse Event|1|||
125595696|NCT03486314|451804708|FG001|Part A|Adverse Event|0|||
125595697|NCT03486314|451804709|FG002|Part A|Adverse Event|0|||
125595698|NCT03486314|451804707|FG000|Part A|Symptomatic Deterioration|2|||
125595699|NCT03486314|451804708|FG001|Part A|Symptomatic Deterioration|0|||
125595700|NCT03486314|451804709|FG002|Part A|Symptomatic Deterioration|0|||
125595701|NCT00659438|451804710|FG000|Overall Study|Withdrawal by Subject|2|||
125595702|NCT00659438|451804711|FG001|Overall Study|Withdrawal by Subject|2|||
125595703|NCT00659438|451804710|FG000|Overall Study|Death|11|||
125595704|NCT00659438|451804711|FG001|Overall Study|Death|6|||
125595705|NCT00659438|451804710|FG000|Overall Study|Lost to Follow-up|1|||
125595706|NCT00659438|451804711|FG001|Overall Study|Lost to Follow-up|0|||
125595707|NCT02388776|451804712|FG000|Overall Study|Death|1|||
125595708|NCT02388776|451804712|FG000|Overall Study|Lost to Follow-up|1|||
125595709|NCT03826914|451804713|FG000|Overall Study|Withdrawal by Subject|1|||
125595710|NCT03826914|451804714|FG001|Overall Study|Withdrawal by Subject|1|||
125595711|NCT04334148|451804715|FG000|Overall Study|positive nasal swab at baseline|0|||
125595712|NCT04334148|451804716|FG001|Overall Study|positive nasal swab at baseline|1|||
125595713|NCT00542828|451804717|FG000|Overall Study|Physician Decision|1|||
125595714|NCT00542828|451804717|FG000|Overall Study|Need for Prohibited Treatment|3|||
125595715|NCT00542828|451804717|FG000|Overall Study|Study Prematurely Discontinued|7|||
125595716|NCT00542828|451804717|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
125595717|NCT03228186|451804720|FG000|Overall Study|Patient never started treatment|1|||
125595718|NCT04246047|451804723|FG000|Overall Study|Death|50|||
125595719|NCT04246047|451804724|FG001|Overall Study|Death|77|||
125595720|NCT04246047|451804723|FG000|Overall Study|Lost to Follow-up|1|||
125595721|NCT04246047|451804724|FG001|Overall Study|Lost to Follow-up|3|||
125595722|NCT04246047|451804723|FG000|Overall Study|Physician Decision|4|||
125595723|NCT04246047|451804724|FG001|Overall Study|Physician Decision|10|||
125595724|NCT04246047|451804723|FG000|Overall Study|Withdrawal by Subject|19|||
125595725|NCT04246047|451804724|FG001|Overall Study|Withdrawal by Subject|26|||
125595726|NCT04246047|451804723|FG000|Overall Study|Ongoing|169|||
125595727|NCT04246047|451804724|FG001|Overall Study|Ongoing|135|||
125595728|NCT05139030|451804728|FG000|Overall Study|Withdrawal by Subject|1|||
125595729|NCT05139030|451804729|FG001|Overall Study|Withdrawal by Subject|3|||
125595730|NCT05139030|451804728|FG000|Overall Study|Adverse Event|0|||
125595731|NCT05139030|451804729|FG001|Overall Study|Adverse Event|1|||
125595732|NCT05139030|451804728|FG000|Overall Study|Failure to meet continuation criteria|0|||
125595733|NCT05139030|451804729|FG001|Overall Study|Failure to meet continuation criteria|1|||
125595734|NCT03517436|451804730|FG000|Overall Study|Death|3|||
125595735|NCT03517436|451804730|FG000|Overall Study|Withdrawal by Subject|4|||
125595736|NCT03517436|451804730|FG000|Overall Study|Did not receive study valve.|1|||
125595737|NCT01254344|451804733|FG000|Overall Study|Adverse Event|2|||
125595738|NCT01254344|451804734|FG001|Overall Study|Adverse Event|5|||
125595739|NCT01254344|451804733|FG000|Overall Study|Physician Decision|7|||
125595740|NCT01254344|451804734|FG001|Overall Study|Physician Decision|4|||
125595741|NCT01254344|451804733|FG000|Overall Study|Protocol Violation|1|||
125595742|NCT01254344|451804734|FG001|Overall Study|Protocol Violation|4|||
125595743|NCT01254344|451804733|FG000|Overall Study|Withdrawal by Subject|3|||
125595744|NCT01254344|451804734|FG001|Overall Study|Withdrawal by Subject|6|||
125595745|NCT03022461|451804735|FG000|Overall Study|Death|3|||
125595746|NCT01982630|451804736|FG000|Overall Study|Adverse Event|2|||
125595747|NCT01982630|451804737|FG001|Overall Study|Adverse Event|0|||
125595748|NCT01982630|451804738|FG002|Overall Study|Adverse Event|1|||
125595749|NCT01982630|451804739|FG003|Overall Study|Adverse Event|0|||
125595750|NCT01982630|451804740|FG004|Overall Study|Adverse Event|1|||
125595751|NCT01982630|451804741|FG005|Overall Study|Adverse Event|2|||
125595752|NCT01982630|451804742|FG006|Overall Study|Adverse Event|1|||
125595753|NCT01982630|451804743|FG007|Overall Study|Adverse Event|0|||
125595754|NCT01982630|451804736|FG000|Overall Study|Physician Decision|1|||
125595755|NCT01982630|451804737|FG001|Overall Study|Physician Decision|0|||
125595756|NCT01982630|451804738|FG002|Overall Study|Physician Decision|2|||
125595757|NCT01982630|451804739|FG003|Overall Study|Physician Decision|1|||
125595758|NCT01982630|451804740|FG004|Overall Study|Physician Decision|2|||
125595759|NCT01982630|451804741|FG005|Overall Study|Physician Decision|0|||
125595760|NCT01982630|451804742|FG006|Overall Study|Physician Decision|0|||
125595761|NCT01982630|451804743|FG007|Overall Study|Physician Decision|0|||
125595762|NCT01982630|451804736|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125595763|NCT01982630|451804737|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125595764|NCT01982630|451804738|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
125595765|NCT01982630|451804739|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125595766|NCT01982630|451804740|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125595767|NCT01982630|451804741|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125595768|NCT01982630|451804742|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125595769|NCT01982630|451804743|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
125595770|NCT01982630|451804736|FG000|Overall Study|Withdrawal by Subject|0|||
125595771|NCT01982630|451804737|FG001|Overall Study|Withdrawal by Subject|0|||
125595772|NCT01982630|451804738|FG002|Overall Study|Withdrawal by Subject|0|||
125595773|NCT01982630|451804739|FG003|Overall Study|Withdrawal by Subject|0|||
125595774|NCT01982630|451804740|FG004|Overall Study|Withdrawal by Subject|0|||
125595775|NCT01982630|451804741|FG005|Overall Study|Withdrawal by Subject|1|||
125595776|NCT01982630|451804742|FG006|Overall Study|Withdrawal by Subject|0|||
125595777|NCT01982630|451804743|FG007|Overall Study|Withdrawal by Subject|0|||
125364523|NCT00806351|450967177|FG001|Overall Study|Death|4|||
125595778|NCT03459040|451804744|FG000|Overall Study|Death|8|||
125595779|NCT03459040|451804744|FG000|Overall Study|Withdrawal by Subject|1|||
125595780|NCT01273818|451804745|FG000|Overall Study|Physician Decision|13|||
125595781|NCT01273818|451804746|FG001|Overall Study|Physician Decision|2|||
125595782|NCT01273818|451804747|FG002|Overall Study|Physician Decision|9|||
125595783|NCT03815175|451804748|FG000|Overall Study|Subject Lost to Follow-up|6|||
125429888|NCT00949715|451200120|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
125429889|NCT00949715|451200121|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
125595784|NCT03815175|451804748|FG000|Overall Study|Subject Withdrew Consent|48|||
125595785|NCT03815175|451804748|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
125595786|NCT03815175|451804748|FG000|Overall Study|Death|86|||
125595787|NCT03815175|451804748|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
125595788|NCT03815175|451804748|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
125595789|NCT03815175|451804748|FG000|Overall Study|Other Status Change Reason|1|||
125595790|NCT03815175|451804748|FG000|Overall Study|Missed Visit|12|||
125595791|NCT00820040|451804749|FG000|Overall Study|Death|1|||
125595792|NCT00820040|451804749|FG000|Overall Study|Sponsor terminated study|1|||
125595793|NCT00820040|451804749|FG000|Overall Study|Screen failure|1|||
125595794|NCT02493751|451804750|FG000|Overall Study|Withdrawal by Subject|2|||
125595795|NCT02493751|451804751|FG001|Overall Study|Withdrawal by Subject|8|||
125595796|NCT02493751|451804750|FG000|Overall Study|Death|6|||
125595797|NCT02493751|451804751|FG001|Overall Study|Death|13|||
125595798|NCT02493751|451804750|FG000|Overall Study|Lost to Follow-up|2|||
125595799|NCT02493751|451804751|FG001|Overall Study|Lost to Follow-up|3|||
125595800|NCT02493751|451804750|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
125595801|NCT02493751|451804751|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
125595802|NCT01824602|451804754|FG000|Overall Study|Withdrawal by Subject|0|||
125595803|NCT01824602|451804755|FG001|Overall Study|Withdrawal by Subject|0|||
125595804|NCT01824602|451804756|FG002|Overall Study|Withdrawal by Subject|1|||
125595805|NCT01824602|451804757|FG003|Overall Study|Withdrawal by Subject|2|||
125595806|NCT01824602|451804754|FG000|Overall Study|Patient non-compliance|0|||
125595807|NCT01824602|451804755|FG001|Overall Study|Patient non-compliance|0|||
125595808|NCT01824602|451804756|FG002|Overall Study|Patient non-compliance|1|||
125595809|NCT01824602|451804757|FG003|Overall Study|Patient non-compliance|0|||
125595810|NCT01824602|451804754|FG000|Overall Study|Adverse Event|1|||
125595811|NCT01824602|451804755|FG001|Overall Study|Adverse Event|0|||
125595812|NCT01824602|451804756|FG002|Overall Study|Adverse Event|2|||
125595813|NCT01824602|451804757|FG003|Overall Study|Adverse Event|2|||
125595814|NCT01824602|451804754|FG000|Overall Study|Treatment failure|0|||
125595815|NCT01824602|451804755|FG001|Overall Study|Treatment failure|0|||
125595816|NCT01824602|451804756|FG002|Overall Study|Treatment failure|0|||
125595817|NCT01824602|451804757|FG003|Overall Study|Treatment failure|1|||
125595818|NCT02485717|451804760|FG000|Overall Study|Lost to Follow-up|6|||
125595819|NCT02485717|451804761|FG001|Overall Study|Lost to Follow-up|0|||
125595820|NCT02485717|451804762|FG002|Overall Study|Lost to Follow-up|0|||
125595821|NCT02485717|451804760|FG000|Overall Study|Withdrawal by Subject|0|||
125595822|NCT02485717|451804761|FG001|Overall Study|Withdrawal by Subject|0|||
125595823|NCT02485717|451804762|FG002|Overall Study|Withdrawal by Subject|1|||
125595824|NCT02485717|451804760|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
125595825|NCT02485717|451804761|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
125595826|NCT02485717|451804762|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
125595827|NCT02485717|451804760|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
125595828|NCT02485717|451804761|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
125595829|NCT02485717|451804762|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
125595830|NCT03822468|451804765|FG000|Treatment Period|Progressive disease|98|||
125595831|NCT03822468|451804766|FG001|Treatment Period|Progressive disease|94|||
125595832|NCT03822468|451804765|FG000|Treatment Period|Adverse Event|21|||
125595833|NCT03822468|451804766|FG001|Treatment Period|Adverse Event|24|||
125595834|NCT03822468|451804765|FG000|Treatment Period|Withdrawal by Subject|9|||
125595835|NCT03822468|451804766|FG001|Treatment Period|Withdrawal by Subject|5|||
125595836|NCT03822468|451804765|FG000|Treatment Period|Physician Decision|9|||
125595837|NCT03822468|451804766|FG001|Treatment Period|Physician Decision|7|||
125595838|NCT03822468|451804765|FG000|Treatment Period|Protocol Violation|2|||
125595839|NCT03822468|451804766|FG001|Treatment Period|Protocol Violation|1|||
125595840|NCT03822468|451804765|FG000|Treatment Period|Death|2|||
125595841|NCT03822468|451804766|FG001|Treatment Period|Death|3|||
125595842|NCT03822468|451804765|FG000|Treatment Period|Lost to Follow-up|1|||
125595843|NCT03822468|451804766|FG001|Treatment Period|Lost to Follow-up|1|||
125595844|NCT03822468|451804765|FG000|Treatment Period|Sponsor decision|46|||
125595845|NCT03822468|451804766|FG001|Treatment Period|Sponsor decision|53|||
125595846|NCT03822468|451804765|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
125595847|NCT03822468|451804766|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
125595848|NCT03822468|451804765|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
125595849|NCT03822468|451804766|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
125595850|NCT03822468|451804765|FG000|Post-treatment Efficacy Follow-up|Death|1|||
125595851|NCT03822468|451804766|FG001|Post-treatment Efficacy Follow-up|Death|0|||
125595852|NCT03822468|451804765|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125595853|NCT03822468|451804766|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
125595854|NCT03822468|451804765|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
125429890|NCT04082884|451200123|FG000|Overall Study|Withdrawal by Subject|1|||
125595855|NCT03822468|451804766|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125595856|NCT03822468|451804765|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
125595857|NCT03822468|451804766|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125595858|NCT03822468|451804765|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
125595859|NCT03822468|451804766|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
125595860|NCT05300087|451804767|FG000|Overall Study|Withdrawal by Subject|0|||
125595861|NCT05300087|451804768|FG001|Overall Study|Withdrawal by Subject|1|||
125595862|NCT03248128|451804769|FG000|Overall Study|Lost to Follow-up|1|||
125595863|NCT03248128|451804770|FG001|Overall Study|Lost to Follow-up|0|||
125595864|NCT03248128|451804769|FG000|Overall Study|Withdrawal by Subject|16|||
125595865|NCT03248128|451804770|FG001|Overall Study|Withdrawal by Subject|14|||
125595866|NCT03248128|451804769|FG000|Overall Study|Site Closed|4|||
125595867|NCT03248128|451804770|FG001|Overall Study|Site Closed|3|||
125595868|NCT03248128|451804769|FG000|Overall Study|Randomized, but did not receive treatment|1|||
125595869|NCT03248128|451804770|FG001|Overall Study|Randomized, but did not receive treatment|3|||
125595870|NCT01914679|451804771|FG000|Overall Study|Lack of Efficacy|1|||
125595871|NCT01914679|451804771|FG000|Overall Study|Sponsor terminated study|4|||
125595872|NCT00002850|451804773|FG000|Overall Study|Death|4|||
125595873|NCT00002850|451804774|FG001|Overall Study|Death|1|||
125595874|NCT00002850|451804775|FG002|Overall Study|Death|3|||
125595875|NCT00002850|451804773|FG000|Overall Study|Protocol Violation|1|||
125595876|NCT00002850|451804774|FG001|Overall Study|Protocol Violation|0|||
125595877|NCT00002850|451804775|FG002|Overall Study|Protocol Violation|1|||
125595878|NCT00002850|451804773|FG000|Overall Study|Withdrawal by Subject|0|||
125595879|NCT00002850|451804774|FG001|Overall Study|Withdrawal by Subject|1|||
125595880|NCT00002850|451804775|FG002|Overall Study|Withdrawal by Subject|0|||
125364524|NCT00913380|450967178|FG000|Clinical Outcomes|Lost to Follow-up|6|||
125364525|NCT00913380|450967179|FG001|Clinical Outcomes|Lost to Follow-up|6|||
125364526|NCT02187744|450967180|FG000|Study|Participant refused further follow-up|1|||
125364527|NCT02187744|450967181|FG001|Study|Participant refused further follow-up|0|||
125429891|NCT01649232|451200124|FG000|Overall Study|Physician Decision|2|||
125429892|NCT01649232|451200125|FG001|Overall Study|Physician Decision|0|||
125429893|NCT02347657|451200126|FG000|Overall Study|Physician Decision|0|||
125429894|NCT02347657|451200127|FG001|Overall Study|Physician Decision|1|||
125429895|NCT02347657|451200126|FG000|Overall Study|Adverse Event|8|||
125429896|NCT02347657|451200127|FG001|Overall Study|Adverse Event|4|||
125429897|NCT02347657|451200126|FG000|Overall Study|Withdrawal by Subject|6|||
125364528|NCT02187744|450967180|FG000|Study|Other|2|||
125364529|NCT02187744|450967181|FG001|Study|Other|1|||
125429898|NCT02347657|451200127|FG001|Overall Study|Withdrawal by Subject|7|||
125429899|NCT02347657|451200126|FG000|Overall Study|Randomized but not treated|1|||
125429900|NCT02347657|451200127|FG001|Overall Study|Randomized but not treated|0|||
125364530|NCT02187744|450967180|FG000|Study|Lost to Follow-up|0|||
125364531|NCT02187744|450967181|FG001|Study|Lost to Follow-up|2|||
125364532|NCT02187744|450967180|FG000|Study|Related adverse event, not serious|0|||
125364533|NCT02187744|450967181|FG001|Study|Related adverse event, not serious|2|||
125364534|NCT02187744|450967180|FG000|Study|Death|1|||
125364535|NCT02187744|450967181|FG001|Study|Death|0|||
125364536|NCT02187744|450967180|FG000|Study|Related adverse event, serious non-fatal|0|||
125364537|NCT02187744|450967181|FG001|Study|Related adverse event, serious non-fatal|1|||
125364538|NCT02187744|450967180|FG000|Treatment|Death|1|||
125364539|NCT02187744|450967181|FG001|Treatment|Death|0|||
125364540|NCT02187744|450967180|FG000|Treatment|Related adverse event, serious non-fatal|0|||
125364541|NCT02187744|450967181|FG001|Treatment|Related adverse event, serious non-fatal|1|||
125364542|NCT02187744|450967180|FG000|Treatment|Related adverse event, not serious|0|||
125364543|NCT02187744|450967181|FG001|Treatment|Related adverse event, not serious|2|||
125364544|NCT02187744|450967180|FG000|Treatment|Lost to Follow-up|0|||
125364545|NCT02187744|450967181|FG001|Treatment|Lost to Follow-up|1|||
125364546|NCT02187744|450967180|FG000|Treatment|Other|2|||
125364547|NCT02187744|450967181|FG001|Treatment|Other|0|||
125364548|NCT02187744|450967180|FG000|Treatment|Participant refused continued treatment|1|||
125364549|NCT02187744|450967181|FG001|Treatment|Participant refused continued treatment|1|||
125364550|NCT00508755|450967187|FG000|Overall Study|Withdrawal by Subject|1|||
125364551|NCT02004522|450967193|FG000|Overall Study|Adverse Event|55|||
125595881|NCT02452359|451804779|FG000|Overall Study|Adverse Event|1|||
125595882|NCT02452359|451804779|FG000|Overall Study|Lost to Follow-up|15|||
125364552|NCT02004522|450967194|FG001|Overall Study|Adverse Event|6|||
125364553|NCT02004522|450967193|FG000|Overall Study|Withdrawal by Subject|13|||
125364554|NCT02004522|450967194|FG001|Overall Study|Withdrawal by Subject|7|||
125364555|NCT02004522|450967193|FG000|Overall Study|Death|12|||
125364556|NCT02004522|450967194|FG001|Overall Study|Death|3|||
125429901|NCT02347657|451200126|FG000|Overall Study|Other|3|||
125595883|NCT02452359|451804779|FG000|Overall Study|Pregnancy|1|||
125364557|NCT02004522|450967193|FG000|Overall Study|Physician Decision|3|||
125364558|NCT02004522|450967194|FG001|Overall Study|Physician Decision|4|||
125364559|NCT02004522|450967193|FG000|Overall Study|Protocol Violation|1|||
125364560|NCT02004522|450967194|FG001|Overall Study|Protocol Violation|0|||
125364561|NCT02004522|450967193|FG000|Overall Study|Other is reason listed by PI|4|||
125364562|NCT02004522|450967194|FG001|Overall Study|Other is reason listed by PI|1|||
125364563|NCT02004522|450967193|FG000|Overall Study|Never Dosed|2|||
125364564|NCT02004522|450967194|FG001|Overall Study|Never Dosed|4|||
125364565|NCT02004522|450967193|FG000|Overall Study|Disease Progression|35|||
125364566|NCT02004522|450967194|FG001|Overall Study|Disease Progression|31|||
125364567|NCT02004522|450967193|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
125364568|NCT02004522|450967194|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
125364569|NCT01787331|450967195|FG000|Overall Study|Physician Decision|1|||
125364570|NCT01787331|450967195|FG000|Overall Study|Withdrawal by Subject|1|||
125364571|NCT01999868|450967196|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
125364572|NCT01999868|450967197|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
125364573|NCT01999868|450967198|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
125364574|NCT01999868|450967196|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
125364575|NCT01999868|450967197|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
125364576|NCT01999868|450967198|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
125364577|NCT01999868|450967196|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
125364578|NCT01999868|450967197|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
125364579|NCT01999868|450967198|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
125364580|NCT01999868|450967196|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
125364581|NCT01999868|450967197|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
125364582|NCT01999868|450967198|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
125364583|NCT01999868|450967196|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
125364584|NCT01999868|450967197|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
125364585|NCT01999868|450967198|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
125364586|NCT01999868|450967196|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
125364587|NCT01999868|450967197|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
125364588|NCT01999868|450967198|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
125364589|NCT01999868|450967196|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
125364590|NCT01999868|450967197|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
125364591|NCT01999868|450967198|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
125364592|NCT01999868|450967196|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
125364593|NCT01999868|450967197|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
125364594|NCT01999868|450967198|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
125364595|NCT01999868|450967196|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
125364596|NCT01999868|450967197|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
125364597|NCT01999868|450967198|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
125364598|NCT01999868|450967196|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
125364599|NCT01999868|450967197|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
125364600|NCT01999868|450967198|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
125364601|NCT01999868|450967196|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
125364602|NCT01999868|450967197|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
125364603|NCT01999868|450967198|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
125364604|NCT01999868|450967196|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
125364605|NCT01999868|450967197|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
125364606|NCT01999868|450967198|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
125364607|NCT01999868|450967196|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
125364608|NCT01999868|450967197|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
125364609|NCT01999868|450967198|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
125364610|NCT01999868|450967196|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
125364611|NCT01999868|450967197|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
125364612|NCT01999868|450967198|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
125364613|NCT01999868|450967196|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
125364614|NCT01999868|450967197|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
125364615|NCT01999868|450967198|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
125364616|NCT00450255|450967204|FG000|Overall Study|Prior RFA ablation of liver|1|||
125364617|NCT00678080|450967205|FG000|Overall Study|Physician Decision|2|||
125364618|NCT00678080|450967206|FG001|Overall Study|Physician Decision|0|||
125364619|NCT00678080|450967205|FG000|Overall Study|Lost to Follow-up|1|||
125364620|NCT00678080|450967206|FG001|Overall Study|Lost to Follow-up|0|||
125364621|NCT00678080|450967205|FG000|Overall Study|Withdrawal by Subject|0|||
125364622|NCT00678080|450967206|FG001|Overall Study|Withdrawal by Subject|1|||
125364623|NCT01757535|450967207|FG000|Overall Study|Disease Relapse|151|||
125364624|NCT01757535|450967208|FG001|Overall Study|Disease Relapse|181|||
125364625|NCT01757535|450967207|FG000|Overall Study|Other Reasons|28|||
125364626|NCT01757535|450967208|FG001|Overall Study|Other Reasons|27|||
125364627|NCT01757535|450967207|FG000|Overall Study|Adverse Event|31|||
125364628|NCT01757535|450967208|FG001|Overall Study|Adverse Event|11|||
125364629|NCT01757535|450967207|FG000|Overall Study|Withdrew Consent|19|||
125364630|NCT01757535|450967208|FG001|Overall Study|Withdrew Consent|13|||
125364631|NCT01757535|450967207|FG000|Overall Study|Physician Decision|7|||
125364632|NCT01757535|450967208|FG001|Overall Study|Physician Decision|0|||
125364633|NCT01757535|450967207|FG000|Overall Study|Death|2|||
125364634|NCT01757535|450967208|FG001|Overall Study|Death|2|||
125364635|NCT04680052|450968787|FG000|Overall Study|Ongoing|244|||
125364636|NCT04680052|450968788|FG001|Overall Study|Ongoing|229|||
125364637|NCT04680052|450968789|FG002|Overall Study|Ongoing|39|||
125364638|NCT04680052|450968790|FG003|Overall Study|Ongoing|46|||
125364639|NCT04680052|450968787|FG000|Overall Study|Death|15|||
125364640|NCT04680052|450968788|FG001|Overall Study|Death|22|||
125364641|NCT04680052|450968789|FG002|Overall Study|Death|7|||
125364642|NCT04680052|450968790|FG003|Overall Study|Death|1|||
125364643|NCT04680052|450968787|FG000|Overall Study|Lost to Follow-up|3|||
125364644|NCT04680052|450968788|FG001|Overall Study|Lost to Follow-up|2|||
125364645|NCT04680052|450968789|FG002|Overall Study|Lost to Follow-up|0|||
125364646|NCT04680052|450968790|FG003|Overall Study|Lost to Follow-up|1|||
125364647|NCT04680052|450968787|FG000|Overall Study|Withdrawal by Subject|11|||
125364648|NCT04680052|450968788|FG001|Overall Study|Withdrawal by Subject|19|||
125364649|NCT04680052|450968789|FG002|Overall Study|Withdrawal by Subject|7|||
125364650|NCT04680052|450968790|FG003|Overall Study|Withdrawal by Subject|5|||
125364651|NCT04680052|450968787|FG000|Overall Study|Missing|0|||
125364652|NCT04680052|450968788|FG001|Overall Study|Missing|1|||
125364653|NCT04680052|450968789|FG002|Overall Study|Missing|0|||
125364654|NCT04680052|450968790|FG003|Overall Study|Missing|0|||
125364655|NCT04680052|450968787|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
125364656|NCT04680052|450968788|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
125364657|NCT04680052|450968789|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
125364658|NCT04680052|450968790|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
125364659|NCT04680052|450968787|FG000|Overall Study|Physician Decision|0|||
125364660|NCT04680052|450968788|FG001|Overall Study|Physician Decision|1|||
125364661|NCT04680052|450968789|FG002|Overall Study|Physician Decision|0|||
125364662|NCT04680052|450968790|FG003|Overall Study|Physician Decision|0|||
125364663|NCT03320057|450968791|FG000|Overall Study|Lost to Follow-up|4|||
125364664|NCT03320057|450968792|FG001|Overall Study|Lost to Follow-up|17|||
125364665|NCT03320057|450968791|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
125364666|NCT03320057|450968792|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
125364667|NCT01367002|450968795|FG000|Overall Study|Withdrawal by Subject|1|||
125364668|NCT01367002|450968796|FG001|Overall Study|Withdrawal by Subject|0|||
125364669|NCT01367002|450968795|FG000|Overall Study|Physician Decision|0|||
125364670|NCT01367002|450968796|FG001|Overall Study|Physician Decision|2|||
125364671|NCT00717093|450968798|FG000|Overall Study|Adverse Event|19|||
125364672|NCT00717093|450968799|FG001|Overall Study|Adverse Event|9|||
125364673|NCT00717093|450968798|FG000|Overall Study|Lack of Efficacy|3|||
125364674|NCT00717093|450968799|FG001|Overall Study|Lack of Efficacy|13|||
125364675|NCT00717093|450968798|FG000|Overall Study|Lost to Follow-up|9|||
125364676|NCT00717093|450968799|FG001|Overall Study|Lost to Follow-up|6|||
125364677|NCT00717093|450968798|FG000|Overall Study|Withdrawal by Subject|12|||
125364678|NCT00717093|450968799|FG001|Overall Study|Withdrawal by Subject|19|||
125364679|NCT00717093|450968798|FG000|Overall Study|Other|0|||
125364680|NCT00717093|450968799|FG001|Overall Study|Other|1|||
125364681|NCT00717093|450968798|FG000|Overall Study|Randomized but not treated|1|||
125364682|NCT00717093|450968799|FG001|Overall Study|Randomized but not treated|0|||
125364683|NCT01516437|450968800|FG000|Overall Study|Reason not specified|0|||
125364684|NCT01516437|450968801|FG001|Overall Study|Reason not specified|0|||
125364685|NCT01516437|450968802|FG002|Overall Study|Reason not specified|1|||
125364686|NCT01516437|450968803|FG003|Overall Study|Reason not specified|1|||
125364687|NCT00217620|450968804|FG000|Overall Study|Adverse Event|2|||
125364688|NCT00217620|450968804|FG000|Overall Study|Progression|31|||
125364689|NCT00217620|450968804|FG000|Overall Study|Not Protocol Specified|4|||
125364690|NCT00217620|450968804|FG000|Overall Study|Ineligible|13|||
125364691|NCT00217620|450968804|FG000|Overall Study|Never received treatment|1|||
125595884|NCT02452359|451804779|FG000|Overall Study|Withdrawal by Subject|4|||
125364692|NCT02468674|450968809|FG000|Overall Study|Adverse Event|0|||
125595885|NCT05635838|451806308|FG000|16-Week DBVC Period|Adverse Event|2|||
125364693|NCT02468674|450968810|FG001|Overall Study|Adverse Event|0|||
125595886|NCT05635838|451806309|FG001|16-Week DBVC Period|Adverse Event|0|||
125595887|NCT05635838|451806310|FG002|16-Week DBVC Period|Adverse Event|0|||
125364694|NCT02468674|450968811|FG002|Overall Study|Adverse Event|0|||
125364695|NCT02468674|450968812|FG003|Overall Study|Adverse Event|1|||
125364696|NCT02468674|450968813|FG004|Overall Study|Adverse Event|0|||
125364697|NCT02468674|450968814|FG005|Overall Study|Adverse Event|1|||
125364698|NCT02468674|450968815|FG006|Overall Study|Adverse Event|0|||
125364699|NCT02468674|450968816|FG007|Overall Study|Adverse Event|0|||
125364700|NCT02468674|450968817|FG008|Overall Study|Adverse Event|0|||
125364701|NCT02468674|450968809|FG000|Overall Study|Lost to Follow-up|1|||
125364702|NCT02468674|450968810|FG001|Overall Study|Lost to Follow-up|0|||
125364703|NCT02468674|450968811|FG002|Overall Study|Lost to Follow-up|0|||
125364704|NCT02468674|450968812|FG003|Overall Study|Lost to Follow-up|0|||
125364705|NCT02468674|450968813|FG004|Overall Study|Lost to Follow-up|0|||
125364706|NCT02468674|450968814|FG005|Overall Study|Lost to Follow-up|0|||
125364707|NCT02468674|450968815|FG006|Overall Study|Lost to Follow-up|0|||
125364708|NCT02468674|450968816|FG007|Overall Study|Lost to Follow-up|1|||
125364709|NCT02468674|450968817|FG008|Overall Study|Lost to Follow-up|1|||
125364710|NCT02468674|450968809|FG000|Overall Study|Physician Decision|0|||
125364711|NCT02468674|450968810|FG001|Overall Study|Physician Decision|0|||
125364712|NCT02468674|450968811|FG002|Overall Study|Physician Decision|0|||
125364713|NCT02468674|450968812|FG003|Overall Study|Physician Decision|0|||
125364714|NCT02468674|450968813|FG004|Overall Study|Physician Decision|0|||
125364715|NCT02468674|450968814|FG005|Overall Study|Physician Decision|0|||
125364716|NCT02468674|450968815|FG006|Overall Study|Physician Decision|1|||
125364717|NCT02468674|450968816|FG007|Overall Study|Physician Decision|0|||
125364718|NCT02468674|450968817|FG008|Overall Study|Physician Decision|0|||
125364719|NCT02468674|450968809|FG000|Overall Study|Patient/Guardian Decision|0|||
125364720|NCT02468674|450968810|FG001|Overall Study|Patient/Guardian Decision|0|||
125364721|NCT02468674|450968811|FG002|Overall Study|Patient/Guardian Decision|0|||
125364722|NCT02468674|450968812|FG003|Overall Study|Patient/Guardian Decision|0|||
125364723|NCT02468674|450968813|FG004|Overall Study|Patient/Guardian Decision|1|||
125364724|NCT02468674|450968814|FG005|Overall Study|Patient/Guardian Decision|0|||
125364725|NCT02468674|450968815|FG006|Overall Study|Patient/Guardian Decision|0|||
125364726|NCT02468674|450968816|FG007|Overall Study|Patient/Guardian Decision|2|||
125364727|NCT02468674|450968817|FG008|Overall Study|Patient/Guardian Decision|1|||
125364728|NCT02468674|450968809|FG000|Overall Study|Protocol Deviation|0|||
125364729|NCT02468674|450968810|FG001|Overall Study|Protocol Deviation|0|||
125364730|NCT02468674|450968811|FG002|Overall Study|Protocol Deviation|0|||
125364731|NCT02468674|450968812|FG003|Overall Study|Protocol Deviation|0|||
125364732|NCT02468674|450968813|FG004|Overall Study|Protocol Deviation|0|||
125364733|NCT02468674|450968814|FG005|Overall Study|Protocol Deviation|0|||
125364734|NCT02468674|450968815|FG006|Overall Study|Protocol Deviation|0|||
125212369|NCT00548249|450403338|FG003|Overall Study|Prolonged hospitalization|1|||
125212370|NCT00548249|450403339|FG004|Overall Study|Prolonged hospitalization|0|||
125212371|NCT00548249|450403335|FG000|Overall Study|Withdrawal by Subject|2|||
125212372|NCT00548249|450403336|FG001|Overall Study|Withdrawal by Subject|0|||
125212373|NCT00548249|450403337|FG002|Overall Study|Withdrawal by Subject|0|||
125212374|NCT00548249|450403338|FG003|Overall Study|Withdrawal by Subject|0|||
125212375|NCT00548249|450403339|FG004|Overall Study|Withdrawal by Subject|0|||
125212376|NCT00548249|450403335|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
125212377|NCT00548249|450403336|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
125212378|NCT00548249|450403337|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
125212379|NCT00548249|450403338|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
125212380|NCT00548249|450403339|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
125212381|NCT00548249|450403335|FG000|Overall Study|Sponsor's request|0|||
125212382|NCT00548249|450403336|FG001|Overall Study|Sponsor's request|0|||
125212383|NCT00548249|450403337|FG002|Overall Study|Sponsor's request|0|||
125212384|NCT00548249|450403338|FG003|Overall Study|Sponsor's request|1|||
125212385|NCT00548249|450403339|FG004|Overall Study|Sponsor's request|0|||
125212386|NCT00938587|450403340|FG000|Overall Study|Adverse Event|2|||
125364735|NCT02468674|450968816|FG007|Overall Study|Protocol Deviation|1|||
125212387|NCT00938587|450403341|FG001|Overall Study|Adverse Event|0|||
125212388|NCT00938587|450403342|FG002|Overall Study|Adverse Event|0|||
125212389|NCT00938587|450403343|FG003|Overall Study|Adverse Event|2|||
125364736|NCT02468674|450968817|FG008|Overall Study|Protocol Deviation|1|||
125364737|NCT01897454|450968818|FG000|Overall Study|Withdrawal by Subject|1|||
125364738|NCT03689530|450968823|FG000|Overall Study|Withdrawal by Subject|53|||
125595888|NCT05635838|451806311|FG003|16-Week DBVC Period|Adverse Event|0|||
125595889|NCT05635838|451806308|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
125595890|NCT05635838|451806309|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
125595891|NCT05635838|451806310|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
125595892|NCT05635838|451806311|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
125212390|NCT00938587|450403340|FG000|Overall Study|Did not meet entrance criteria|0|||
125212391|NCT00938587|450403341|FG001|Overall Study|Did not meet entrance criteria|0|||
125364739|NCT03689530|450968824|FG001|Overall Study|Withdrawal by Subject|16|||
125364740|NCT01392443|450968825|FG000|Overall Study|Disease progression|30|||
125364741|NCT01392443|450968825|FG000|Overall Study|Adverse Event|24|||
125364742|NCT01392443|450968825|FG000|Overall Study|Death|7|||
125364743|NCT01392443|450968825|FG000|Overall Study|Withdrawal by Subject|5|||
125364744|NCT01392443|450968825|FG000|Overall Study|Lost to Follow-up|1|||
125364745|NCT01392443|450968825|FG000|Overall Study|Protocol Violation|1|||
125364746|NCT00533897|450968828|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
125364747|NCT00533897|450968829|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
125364748|NCT00533897|450968830|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
125364749|NCT00533897|450968831|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
125212392|NCT00938587|450403342|FG002|Overall Study|Did not meet entrance criteria|1|||
125212393|NCT00938587|450403343|FG003|Overall Study|Did not meet entrance criteria|0|||
125212394|NCT00938587|450403340|FG000|Overall Study|Withdrawal by Subject|1|||
125212395|NCT00938587|450403341|FG001|Overall Study|Withdrawal by Subject|1|||
125364750|NCT00533897|450968832|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
125364751|NCT00533897|450968833|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
125364752|NCT00533897|450968834|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
125364753|NCT00533897|450968835|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
125364754|NCT00533897|450968828|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
125595893|NCT05635838|451806308|FG000|16-Week DBVC Period|Physician Decision|0|||
125595894|NCT05635838|451806309|FG001|16-Week DBVC Period|Physician Decision|1|||
125595895|NCT05635838|451806310|FG002|16-Week DBVC Period|Physician Decision|0|||
125364755|NCT00533897|450968829|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125364756|NCT00533897|450968830|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125364757|NCT00533897|450968831|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125364758|NCT00533897|450968832|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125364759|NCT00533897|450968833|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125364760|NCT00533897|450968834|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125364761|NCT00533897|450968835|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
125364762|NCT00533897|450968828|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
125364763|NCT00533897|450968829|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125364764|NCT00533897|450968830|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125364765|NCT00533897|450968831|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125364766|NCT00533897|450968832|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125364767|NCT00533897|450968833|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125364768|NCT00533897|450968834|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125364769|NCT00533897|450968835|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
125364770|NCT00533897|450968828|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
125364771|NCT00533897|450968829|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125364772|NCT00533897|450968830|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125364773|NCT00533897|450968831|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125364774|NCT00533897|450968832|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125364775|NCT00533897|450968833|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125364776|NCT00533897|450968834|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125364777|NCT00533897|450968835|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
125364778|NCT00533897|450968828|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
125364779|NCT00533897|450968829|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125364780|NCT00533897|450968830|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125364781|NCT00533897|450968831|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125364782|NCT00533897|450968832|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125364783|NCT00533897|450968833|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125364784|NCT00533897|450968834|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125364785|NCT00533897|450968835|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
125364786|NCT00533897|450968828|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
125364787|NCT00533897|450968829|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125364788|NCT00533897|450968830|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125364789|NCT00533897|450968831|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125364790|NCT00533897|450968832|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125364791|NCT00533897|450968833|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125364792|NCT00533897|450968834|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125364793|NCT00533897|450968835|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
125364794|NCT00533897|450968828|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
125364795|NCT00533897|450968829|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
125364796|NCT00533897|450968830|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
125364797|NCT00533897|450968831|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
125364798|NCT00533897|450968832|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
125364799|NCT00533897|450968833|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
125364800|NCT00533897|450968834|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
125364801|NCT00533897|450968835|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
125364802|NCT00533897|450968828|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125364803|NCT00533897|450968829|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125364804|NCT00533897|450968830|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
125364805|NCT00533897|450968831|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125364806|NCT00533897|450968832|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125364807|NCT00533897|450968833|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125364808|NCT00533897|450968834|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125364809|NCT00533897|450968835|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
125364810|NCT00533897|450968828|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125364811|NCT00533897|450968829|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125364812|NCT00533897|450968830|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125364813|NCT00533897|450968831|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125364814|NCT00533897|450968832|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125364815|NCT00533897|450968833|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
125364816|NCT00533897|450968834|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125364817|NCT00533897|450968835|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
125364818|NCT00533897|450968828|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125364819|NCT00533897|450968829|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125364820|NCT00533897|450968830|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125364821|NCT00533897|450968831|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125364822|NCT00533897|450968832|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125429902|NCT02347657|451200127|FG001|Overall Study|Other|3|||
125429903|NCT00621543|451200128|FG000|Overall Study|Lost to Follow-up|23|||
125429904|NCT00499863|451200133|FG000|Overall Study|Lack of Efficacy|21|||
125429905|NCT00499863|451200134|FG001|Overall Study|Lack of Efficacy|27|||
125429906|NCT00499863|451200133|FG000|Overall Study|Protocol Violation|12|||
125429907|NCT00499863|451200134|FG001|Overall Study|Protocol Violation|7|||
125429908|NCT00499863|451200133|FG000|Overall Study|Withdrawal by Subject|6|||
125364823|NCT00533897|450968833|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
125364824|NCT00533897|450968834|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125364825|NCT00533897|450968835|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
125364826|NCT00533897|450968828|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
125364827|NCT00533897|450968829|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
125364828|NCT00533897|450968830|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
125364829|NCT00533897|450968831|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
125364830|NCT00533897|450968832|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
125364831|NCT00533897|450968833|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
125364832|NCT00533897|450968834|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
125364833|NCT00533897|450968835|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
125364834|NCT00533897|450968828|FG000|Long Term Extension (LTE)|Death|0|||
125364835|NCT00533897|450968829|FG001|Long Term Extension (LTE)|Death|0|||
125364836|NCT00533897|450968830|FG002|Long Term Extension (LTE)|Death|0|||
125364837|NCT00533897|450968831|FG003|Long Term Extension (LTE)|Death|0|||
125364838|NCT00533897|450968832|FG004|Long Term Extension (LTE)|Death|0|||
125364839|NCT00533897|450968833|FG005|Long Term Extension (LTE)|Death|0|||
125364840|NCT00533897|450968834|FG006|Long Term Extension (LTE)|Death|1|||
125364841|NCT00533897|450968835|FG007|Long Term Extension (LTE)|Death|3|||
125364842|NCT00533897|450968828|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
125364843|NCT00533897|450968829|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
125364844|NCT00533897|450968830|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
125429909|NCT00499863|451200134|FG001|Overall Study|Withdrawal by Subject|4|||
125429910|NCT00499863|451200133|FG000|Overall Study|Adverse Event|8|||
125429911|NCT00499863|451200134|FG001|Overall Study|Adverse Event|2|||
125429912|NCT00499863|451200133|FG000|Overall Study|Sponsor decision|2|||
125429913|NCT00499863|451200134|FG001|Overall Study|Sponsor decision|2|||
125429914|NCT00499863|451200133|FG000|Overall Study|Lost to Follow-up|1|||
125429915|NCT00499863|451200134|FG001|Overall Study|Lost to Follow-up|1|||
125364845|NCT00533897|450968831|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
125364846|NCT00533897|450968832|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
125364847|NCT00533897|450968833|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
125364848|NCT00533897|450968834|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
125364849|NCT00533897|450968835|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
125364850|NCT00533897|450968828|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125364851|NCT00533897|450968829|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125364852|NCT00533897|450968830|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125364853|NCT00533897|450968831|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125364854|NCT00533897|450968832|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125364855|NCT00533897|450968833|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125364856|NCT00533897|450968834|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
125364857|NCT00533897|450968835|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
125364858|NCT00533897|450968828|FG000|Long Term Extension (LTE)|Adverse Event|0|||
125364859|NCT00533897|450968829|FG001|Long Term Extension (LTE)|Adverse Event|0|||
125364860|NCT00533897|450968830|FG002|Long Term Extension (LTE)|Adverse Event|0|||
125364861|NCT00533897|450968831|FG003|Long Term Extension (LTE)|Adverse Event|0|||
125364862|NCT00533897|450968832|FG004|Long Term Extension (LTE)|Adverse Event|0|||
125364863|NCT00533897|450968833|FG005|Long Term Extension (LTE)|Adverse Event|0|||
125364864|NCT00533897|450968834|FG006|Long Term Extension (LTE)|Adverse Event|2|||
125364865|NCT00533897|450968835|FG007|Long Term Extension (LTE)|Adverse Event|5|||
125364866|NCT00533897|450968828|FG000|Long Term Extension (LTE)|Pregnancy|0|||
125364867|NCT00533897|450968829|FG001|Long Term Extension (LTE)|Pregnancy|0|||
125364868|NCT00533897|450968830|FG002|Long Term Extension (LTE)|Pregnancy|0|||
125364869|NCT00533897|450968831|FG003|Long Term Extension (LTE)|Pregnancy|0|||
125364870|NCT00533897|450968832|FG004|Long Term Extension (LTE)|Pregnancy|0|||
125364871|NCT00533897|450968833|FG005|Long Term Extension (LTE)|Pregnancy|0|||
125364872|NCT00533897|450968834|FG006|Long Term Extension (LTE)|Pregnancy|0|||
125364873|NCT00533897|450968835|FG007|Long Term Extension (LTE)|Pregnancy|2|||
125364874|NCT00533897|450968828|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
125364875|NCT00533897|450968829|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
125364876|NCT00533897|450968830|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
125364877|NCT00533897|450968831|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
125364878|NCT00533897|450968832|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
125364879|NCT00533897|450968833|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
125364880|NCT00533897|450968834|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
125364881|NCT00533897|450968835|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
125364882|NCT00533897|450968828|FG000|Long Term Extension (LTE)|Other|0|||
125364883|NCT00533897|450968829|FG001|Long Term Extension (LTE)|Other|0|||
125364884|NCT00533897|450968830|FG002|Long Term Extension (LTE)|Other|0|||
125364885|NCT00533897|450968831|FG003|Long Term Extension (LTE)|Other|0|||
125364886|NCT00533897|450968832|FG004|Long Term Extension (LTE)|Other|0|||
125364887|NCT00533897|450968833|FG005|Long Term Extension (LTE)|Other|0|||
125364888|NCT00533897|450968834|FG006|Long Term Extension (LTE)|Other|1|||
125364889|NCT00533897|450968835|FG007|Long Term Extension (LTE)|Other|6|||
125364890|NCT02555683|450968836|FG000|Overall Study|Physician Decision|1|||
125364891|NCT02555683|450968837|FG001|Overall Study|Physician Decision|0|||
125364892|NCT02555683|450968838|FG002|Overall Study|Physician Decision|2|||
125364893|NCT02555683|450968836|FG000|Overall Study|Lost to Follow-up|2|||
125364894|NCT02555683|450968837|FG001|Overall Study|Lost to Follow-up|1|||
125364895|NCT02555683|450968838|FG002|Overall Study|Lost to Follow-up|2|||
125364896|NCT02555683|450968836|FG000|Overall Study|Technical Problems|1|||
125364897|NCT02555683|450968837|FG001|Overall Study|Technical Problems|1|||
125364898|NCT02555683|450968838|FG002|Overall Study|Technical Problems|0|||
125364899|NCT02555683|450968836|FG000|Overall Study|Protocol deviation|0|||
125131401|NCT03818581|450109960|FG000|Overall Study|Withdrawal by Subject|0|||
125364900|NCT02555683|450968837|FG001|Overall Study|Protocol deviation|1|||
125364901|NCT02555683|450968838|FG002|Overall Study|Protocol deviation|0|||
125364902|NCT02555683|450968836|FG000|Overall Study|Lack of Efficacy|2|||
125364903|NCT02555683|450968837|FG001|Overall Study|Lack of Efficacy|0|||
125364904|NCT02555683|450968838|FG002|Overall Study|Lack of Efficacy|0|||
125364905|NCT02555683|450968836|FG000|Overall Study|Death|0|||
125364906|NCT02555683|450968837|FG001|Overall Study|Death|1|||
125364907|NCT02555683|450968838|FG002|Overall Study|Death|2|||
125364908|NCT02555683|450968836|FG000|Overall Study|Adverse Event|1|||
125364909|NCT02555683|450968837|FG001|Overall Study|Adverse Event|0|||
125364910|NCT02555683|450968838|FG002|Overall Study|Adverse Event|1|||
125364911|NCT02555683|450968836|FG000|Overall Study|Subject/guardian decision|12|||
125364912|NCT02555683|450968837|FG001|Overall Study|Subject/guardian decision|12|||
125364913|NCT02555683|450968838|FG002|Overall Study|Subject/guardian decision|22|||
125364914|NCT02555683|450968836|FG000|Overall Study|Death post Treatment/safety period|0|||
125364915|NCT02555683|450968837|FG001|Overall Study|Death post Treatment/safety period|1|||
125364916|NCT02555683|450968838|FG002|Overall Study|Death post Treatment/safety period|0|||
125364917|NCT05074667|450968839|FG000|Overall Study|Death|1|||
125364918|NCT05074667|450968839|FG000|Overall Study|Withdrawal by Subject|4|||
125364919|NCT05074667|450968839|FG000|Overall Study|Lost to Follow-up|10|||
125364920|NCT01826604|450968841|FG000|Overall Study|Lost to Follow-up|8|||
125364921|NCT01826604|450968842|FG001|Overall Study|Lost to Follow-up|9|||
125364922|NCT00491075|450968843|FG000|Overall Study|Withdrawal by Subject|1|||
125364923|NCT00491075|450968843|FG000|Overall Study|Physician Decision|1|||
125364924|NCT03019185|450968850|FG000|Overall Study|Lost to Follow-up|3|||
125364925|NCT03019185|450968851|FG001|Overall Study|Lost to Follow-up|0|||
125364926|NCT03019185|450968852|FG002|Overall Study|Lost to Follow-up|2|||
125364927|NCT03019185|450968850|FG000|Overall Study|Withdrawal by Subject|1|||
125364928|NCT03019185|450968851|FG001|Overall Study|Withdrawal by Subject|1|||
125364929|NCT03019185|450968852|FG002|Overall Study|Withdrawal by Subject|0|||
125364930|NCT03019185|450968850|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
125364931|NCT03019185|450968851|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
125364932|NCT03019185|450968852|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
125364933|NCT03019185|450968850|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
125364934|NCT03019185|450968851|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
125364935|NCT03019185|450968852|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
125364936|NCT00705289|450968855|FG000|Overall Study|Subject or treating physician's choice|131|||
125364937|NCT02601027|450968856|FG000|Registration to Surgery|Withdrawal by Subject|20|||
125364938|NCT02601027|450968857|FG001|Registration to Surgery|Withdrawal by Subject|10|||
125364939|NCT02609828|450968858|FG000|Overall Study|Adverse Event|8|||
125364940|NCT02609828|450968859|FG001|Overall Study|Adverse Event|1|||
125364941|NCT02609828|450968860|FG002|Overall Study|Adverse Event|0|||
125364942|NCT02609828|450968861|FG003|Overall Study|Adverse Event|6|||
125364943|NCT02609828|450968858|FG000|Overall Study|Death|15|||
125364944|NCT02609828|450968859|FG001|Overall Study|Death|1|||
125364945|NCT02609828|450968860|FG002|Overall Study|Death|1|||
125364946|NCT02609828|450968861|FG003|Overall Study|Death|19|||
125364947|NCT02609828|450968858|FG000|Overall Study|Insufficient clinical response|2|||
125364948|NCT02609828|450968859|FG001|Overall Study|Insufficient clinical response|1|||
125364949|NCT02609828|450968860|FG002|Overall Study|Insufficient clinical response|0|||
125364950|NCT02609828|450968861|FG003|Overall Study|Insufficient clinical response|0|||
125364951|NCT02609828|450968858|FG000|Overall Study|Lost to Follow-up|0|||
125364952|NCT02609828|450968859|FG001|Overall Study|Lost to Follow-up|0|||
125364953|NCT02609828|450968860|FG002|Overall Study|Lost to Follow-up|0|||
125364954|NCT02609828|450968861|FG003|Overall Study|Lost to Follow-up|1|||
125364955|NCT02609828|450968858|FG000|Overall Study|Protocol Violation|2|||
125364956|NCT02609828|450968859|FG001|Overall Study|Protocol Violation|0|||
125364957|NCT02609828|450968860|FG002|Overall Study|Protocol Violation|0|||
125364958|NCT02609828|450968861|FG003|Overall Study|Protocol Violation|1|||
125364959|NCT02609828|450968858|FG000|Overall Study|Withdrawal by Subject|12|||
125364960|NCT02609828|450968859|FG001|Overall Study|Withdrawal by Subject|1|||
125364961|NCT02609828|450968860|FG002|Overall Study|Withdrawal by Subject|0|||
125364962|NCT02609828|450968861|FG003|Overall Study|Withdrawal by Subject|10|||
125364963|NCT02609828|450968858|FG000|Overall Study|Other|3|||
125364964|NCT02609828|450968859|FG001|Overall Study|Other|0|||
125364965|NCT02609828|450968860|FG002|Overall Study|Other|0|||
125364966|NCT02609828|450968861|FG003|Overall Study|Other|6|||
125364967|NCT02609828|450968858|FG000|Overall Study|Randomized but not treated|1|||
125364968|NCT02609828|450968859|FG001|Overall Study|Randomized but not treated|0|||
125364969|NCT02609828|450968860|FG002|Overall Study|Randomized but not treated|0|||
125364970|NCT02609828|450968861|FG003|Overall Study|Randomized but not treated|0|||
125364971|NCT02980783|450968862|FG000|Overall Study|Lost to Follow-up|1|||
125364972|NCT01696695|450968863|FG000|Overall Study|Disease progression|373|||
125364973|NCT01696695|450968863|FG000|Overall Study|Death|29|||
125364974|NCT01696695|450968863|FG000|Overall Study|Adverse Event|74|||
125364975|NCT01696695|450968863|FG000|Overall Study|Withdrawal by Subject|92|||
125364976|NCT01696695|450968863|FG000|Overall Study|Lost to Follow-up|48|||
125364977|NCT01696695|450968863|FG000|Overall Study|Other|74|||
125364978|NCT01696695|450968863|FG000|Overall Study|Major Protocol Violation|192|||
125364979|NCT03173313|450968866|FG000|Overall Study|Lost to Follow-up|2|||
125364980|NCT03173313|450968867|FG001|Overall Study|Lost to Follow-up|3|||
125364981|NCT03173313|450968866|FG000|Overall Study|Withdrawal by Subject|0|||
125364982|NCT03173313|450968867|FG001|Overall Study|Withdrawal by Subject|1|||
125364983|NCT03173313|450968866|FG000|Overall Study|Death|5|||
125364984|NCT03173313|450968867|FG001|Overall Study|Death|0|||
125364985|NCT03173313|450968866|FG000|Overall Study|Physician Decision|1|||
125364986|NCT03173313|450968867|FG001|Overall Study|Physician Decision|0|||
125364987|NCT03173313|450968866|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
125364988|NCT03173313|450968867|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
125364989|NCT03173313|450968866|FG000|Overall Study|Bone Fracture|1|||
125364990|NCT03173313|450968867|FG001|Overall Study|Bone Fracture|0|||
125364991|NCT03863197|450968868|FG000|Overall Study|Lost to Follow-up|2|||
125364992|NCT03863197|450968869|FG001|Overall Study|Lost to Follow-up|3|||
125364993|NCT03863197|450968868|FG000|Overall Study|Withdrawal by Subject|4|||
125364994|NCT03863197|450968869|FG001|Overall Study|Withdrawal by Subject|0|||
125364995|NCT03863197|450968868|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
125364996|NCT03863197|450968869|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
125364997|NCT01065597|450968877|FG000|Overall Study|Adverse Event|1|||
125364998|NCT02905149|450968880|FG000|Overall Study|Lost to Follow-up|2|||
125364999|NCT02905149|450968881|FG001|Overall Study|Lost to Follow-up|0|||
125365000|NCT00839852|450968882|FG000|Overall Study|Adverse Event|10|||
125365001|NCT00839852|450968882|FG000|Overall Study|Insufficient Therapeutic Response|3|||
125365002|NCT00839852|450968882|FG000|Overall Study|Protocol Violation|9|||
125365003|NCT00839852|450968882|FG000|Overall Study|Withdrawal of Consent|16|||
125365004|NCT00839852|450968882|FG000|Overall Study|Lost to Follow-up|7|||
125365005|NCT00839852|450968882|FG000|Overall Study|Lack of Compliance While in Jail|1|||
125365006|NCT00839852|450968882|FG000|Overall Study|Pregnancy|1|||
125365007|NCT02761733|450968883|FG000|Overall Study|Death|3|||
125365008|NCT02761733|450968884|FG001|Overall Study|Death|5|||
125365009|NCT02761733|450968885|FG002|Overall Study|Death|1|||
125365010|NCT02761733|450968886|FG003|Overall Study|Death|1|||
125365011|NCT02761733|450968883|FG000|Overall Study|Lost to Follow-up|6|||
125365012|NCT02761733|450968884|FG001|Overall Study|Lost to Follow-up|7|||
125365013|NCT02761733|450968885|FG002|Overall Study|Lost to Follow-up|0|||
125365014|NCT02761733|450968886|FG003|Overall Study|Lost to Follow-up|3|||
125365015|NCT02761733|450968883|FG000|Overall Study|Physician Decision|4|||
125365016|NCT02761733|450968884|FG001|Overall Study|Physician Decision|0|||
125365017|NCT02761733|450968885|FG002|Overall Study|Physician Decision|0|||
125365018|NCT02761733|450968886|FG003|Overall Study|Physician Decision|0|||
125365019|NCT02761733|450968883|FG000|Overall Study|Withdrawal by Subject|2|||
125365020|NCT02761733|450968884|FG001|Overall Study|Withdrawal by Subject|0|||
125365021|NCT02761733|450968885|FG002|Overall Study|Withdrawal by Subject|0|||
125365022|NCT02761733|450968886|FG003|Overall Study|Withdrawal by Subject|0|||
125365023|NCT02761733|450968883|FG000|Overall Study|Discharged from Study Site|10|||
125365024|NCT02761733|450968884|FG001|Overall Study|Discharged from Study Site|9|||
125365025|NCT02761733|450968885|FG002|Overall Study|Discharged from Study Site|25|||
125365026|NCT02761733|450968886|FG003|Overall Study|Discharged from Study Site|11|||
125365027|NCT02761733|450968883|FG000|Overall Study|Cognitive Impairment|5|||
125365028|NCT02761733|450968884|FG001|Overall Study|Cognitive Impairment|0|||
125365029|NCT02761733|450968885|FG002|Overall Study|Cognitive Impairment|1|||
125365030|NCT02761733|450968886|FG003|Overall Study|Cognitive Impairment|0|||
125365031|NCT04295772|450968889|FG000|Overall Study|Protocol Violation|1|||
125365032|NCT04295772|450968890|FG001|Overall Study|Protocol Violation|0|||
125365033|NCT04295772|450968889|FG000|Overall Study|Ongoing for safety monitoring|14|||
125365034|NCT04295772|450968890|FG001|Overall Study|Ongoing for safety monitoring|1|||
125365035|NCT04295772|450968889|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
125365036|NCT04295772|450968890|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
125365037|NCT02805972|450968894|FG000|Washout Period|Lost to Follow-up|3|||
125365038|NCT02805972|450968895|FG001|Washout Period|Lost to Follow-up|0|||
125365039|NCT01206166|450968896|FG000|Overall Study|No evaluable data|2|||
125365040|NCT01206166|450968897|FG001|Overall Study|No evaluable data|3|||
125365041|NCT00932126|450968898|FG000|Overall Study|Adverse Event|0|||
125365042|NCT00932126|450968899|FG001|Overall Study|Adverse Event|0|||
125365043|NCT00932126|450968900|FG002|Overall Study|Adverse Event|0|||
125365044|NCT00932126|450968901|FG003|Overall Study|Adverse Event|0|||
125365045|NCT00932126|450968902|FG004|Overall Study|Adverse Event|0|||
125365046|NCT00932126|450968903|FG005|Overall Study|Adverse Event|0|||
125365047|NCT00932126|450968904|FG006|Overall Study|Adverse Event|1|||
125365048|NCT00932126|450968905|FG007|Overall Study|Adverse Event|2|||
125365049|NCT00932126|450968898|FG000|Overall Study|Protocol Violation|0|||
125365050|NCT00932126|450968899|FG001|Overall Study|Protocol Violation|0|||
125365051|NCT00932126|450968900|FG002|Overall Study|Protocol Violation|0|||
125365052|NCT00932126|450968901|FG003|Overall Study|Protocol Violation|0|||
125365053|NCT00932126|450968902|FG004|Overall Study|Protocol Violation|1|||
125365054|NCT00932126|450968903|FG005|Overall Study|Protocol Violation|0|||
125365055|NCT00932126|450968904|FG006|Overall Study|Protocol Violation|0|||
125365056|NCT00932126|450968905|FG007|Overall Study|Protocol Violation|0|||
125365057|NCT00932126|450968898|FG000|Overall Study|Withdrawal by Subject|0|||
125365058|NCT00932126|450968899|FG001|Overall Study|Withdrawal by Subject|0|||
125365059|NCT00932126|450968900|FG002|Overall Study|Withdrawal by Subject|1|||
125365060|NCT00932126|450968901|FG003|Overall Study|Withdrawal by Subject|0|||
125365061|NCT00932126|450968902|FG004|Overall Study|Withdrawal by Subject|0|||
125365062|NCT00932126|450968903|FG005|Overall Study|Withdrawal by Subject|0|||
125365063|NCT00932126|450968904|FG006|Overall Study|Withdrawal by Subject|0|||
125365064|NCT00932126|450968905|FG007|Overall Study|Withdrawal by Subject|1|||
125365065|NCT00932126|450968898|FG000|Overall Study|Objective progression or relapse|3|||
125365066|NCT00932126|450968899|FG001|Overall Study|Objective progression or relapse|3|||
125365067|NCT00932126|450968900|FG002|Overall Study|Objective progression or relapse|2|||
125365068|NCT00932126|450968901|FG003|Overall Study|Objective progression or relapse|3|||
125365069|NCT00932126|450968902|FG004|Overall Study|Objective progression or relapse|3|||
125365070|NCT00932126|450968903|FG005|Overall Study|Objective progression or relapse|3|||
125365071|NCT00932126|450968904|FG006|Overall Study|Objective progression or relapse|3|||
125365072|NCT00932126|450968905|FG007|Overall Study|Objective progression or relapse|5|||
125365073|NCT00932126|450968898|FG000|Overall Study|Other|0|||
125365074|NCT00932126|450968899|FG001|Overall Study|Other|0|||
125365075|NCT00932126|450968900|FG002|Overall Study|Other|0|||
125365076|NCT00932126|450968901|FG003|Overall Study|Other|0|||
125365077|NCT00932126|450968902|FG004|Overall Study|Other|1|||
125365078|NCT00932126|450968903|FG005|Overall Study|Other|0|||
125365079|NCT00932126|450968904|FG006|Overall Study|Other|1|||
125365080|NCT00932126|450968905|FG007|Overall Study|Other|2|||
125365081|NCT03576495|450968909|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
125365082|NCT03576495|450968910|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
125365083|NCT02635776|450968911|FG000|Overall Study|Physician Decision|1|||
125365084|NCT02635776|450968912|FG001|Overall Study|Physician Decision|0|||
125365085|NCT02635776|450968911|FG000|Overall Study|Adverse Event|51|||
125365086|NCT02635776|450968912|FG001|Overall Study|Adverse Event|3|||
125365087|NCT02635776|450968911|FG000|Overall Study|Withdrawal by Subject|41|||
125365088|NCT02635776|450968912|FG001|Overall Study|Withdrawal by Subject|7|||
125365089|NCT02635776|450968911|FG000|Overall Study|Lost to Follow-up|4|||
125365090|NCT02635776|450968912|FG001|Overall Study|Lost to Follow-up|0|||
125365091|NCT02635776|450968911|FG000|Overall Study|Other reasons|5|||
125365092|NCT02635776|450968912|FG001|Overall Study|Other reasons|1|||
125365093|NCT00788073|450968914|FG000|STX209 Then Placebo|Adverse Event|1|||
125365094|NCT00788073|450968915|FG001|STX209 Then Placebo|Adverse Event|0|||
125365095|NCT00788073|450968914|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
125365096|NCT00788073|450968915|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
125365097|NCT00788073|450968914|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
125365098|NCT00788073|450968915|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
125365099|NCT00788073|450968914|FG000|STX209 Then Placebo|unable to return due to travel|0|||
125365100|NCT00788073|450968915|FG001|STX209 Then Placebo|unable to return due to travel|1|||
125365101|NCT00788073|450968914|FG000|Placebo Then STX209|Adverse Event|2|||
125365102|NCT00788073|450968915|FG001|Placebo Then STX209|Adverse Event|0|||
125365103|NCT00788073|450968914|FG000|Placebo Then STX209|Protocol Violation|0|||
125365104|NCT00788073|450968915|FG001|Placebo Then STX209|Protocol Violation|1|||
125365105|NCT03608254|450968916|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
125365106|NCT03608254|450968916|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
125365107|NCT00660673|450968918|FG000|Overall Study|Adverse Event|84|||
125365108|NCT00660673|450968918|FG000|Overall Study|Lack of Efficacy|7|||
125365109|NCT00660673|450968918|FG000|Overall Study|Withdrawal by Subject|22|||
125365110|NCT00660673|450968918|FG000|Overall Study|Administrative|2|||
125365111|NCT00660673|450968918|FG000|Overall Study|Protocol Violation|2|||
125365112|NCT00579098|450968919|FG000|Overall Study|Lost to Follow-up|2|||
125365113|NCT00579098|450968920|FG001|Overall Study|Lost to Follow-up|0|||
125365114|NCT00579098|450968919|FG000|Overall Study|Adverse Event|2|||
125365115|NCT00579098|450968920|FG001|Overall Study|Adverse Event|3|||
125365116|NCT00579098|450968919|FG000|Overall Study|Withdrawal by Subject|2|||
125365117|NCT00579098|450968920|FG001|Overall Study|Withdrawal by Subject|3|||
125365118|NCT00579098|450968919|FG000|Overall Study|AF returned after ablation|3|||
125365119|NCT00579098|450968920|FG001|Overall Study|AF returned after ablation|2|||
125365120|NCT00437983|450968924|FG000|Overall Study|Adverse Event|6|||
125365121|NCT00437983|450968925|FG001|Overall Study|Adverse Event|6|||
125365122|NCT00437983|450968924|FG000|Overall Study|Protocol Violation|2|||
125365123|NCT00437983|450968925|FG001|Overall Study|Protocol Violation|1|||
125365124|NCT00437983|450968924|FG000|Overall Study|Withdrawal by Subject|5|||
125365125|NCT00437983|450968925|FG001|Overall Study|Withdrawal by Subject|6|||
125365126|NCT00672646|450968928|FG000|Overall Study|Lost to Follow-up|0|||
125365127|NCT00672646|450968929|FG001|Overall Study|Lost to Follow-up|1|||
125365128|NCT00672646|450968930|FG002|Overall Study|Lost to Follow-up|2|||
125365129|NCT00672646|450968928|FG000|Overall Study|Withdrawal by Subject|0|||
125365130|NCT00672646|450968929|FG001|Overall Study|Withdrawal by Subject|0|||
125365131|NCT00672646|450968930|FG002|Overall Study|Withdrawal by Subject|1|||
125365132|NCT00142298|450968931|FG000|Overall Study|Adverse Event|10|||
125365133|NCT00142298|450968932|FG001|Overall Study|Adverse Event|10|||
125365134|NCT00142298|450968933|FG002|Overall Study|Adverse Event|1|||
125365135|NCT00142298|450968934|FG003|Overall Study|Adverse Event|5|||
125365136|NCT00142298|450968935|FG004|Overall Study|Adverse Event|2|||
125365137|NCT00142298|450968936|FG005|Overall Study|Adverse Event|2|||
125365138|NCT00142298|450968937|FG006|Overall Study|Adverse Event|0|||
125365139|NCT00142298|450968938|FG007|Overall Study|Adverse Event|0|||
125365140|NCT00142298|450968939|FG008|Overall Study|Adverse Event|0|||
125365141|NCT00142298|450968940|FG009|Overall Study|Adverse Event|0|||
125365142|NCT00142298|450968931|FG000|Overall Study|Clinical disease progression|1|||
125365143|NCT00142298|450968932|FG001|Overall Study|Clinical disease progression|0|||
125365144|NCT00142298|450968933|FG002|Overall Study|Clinical disease progression|0|||
125365145|NCT00142298|450968934|FG003|Overall Study|Clinical disease progression|0|||
125365146|NCT00142298|450968935|FG004|Overall Study|Clinical disease progression|0|||
125365147|NCT00142298|450968936|FG005|Overall Study|Clinical disease progression|0|||
125365148|NCT00142298|450968937|FG006|Overall Study|Clinical disease progression|0|||
125365149|NCT00142298|450968938|FG007|Overall Study|Clinical disease progression|0|||
125365150|NCT00142298|450968939|FG008|Overall Study|Clinical disease progression|0|||
125365151|NCT00142298|450968940|FG009|Overall Study|Clinical disease progression|0|||
125365152|NCT00142298|450968931|FG000|Overall Study|Death|1|||
125365153|NCT00142298|450968932|FG001|Overall Study|Death|1|||
125365154|NCT00142298|450968933|FG002|Overall Study|Death|1|||
125365155|NCT00142298|450968934|FG003|Overall Study|Death|0|||
125365156|NCT00142298|450968935|FG004|Overall Study|Death|0|||
125365157|NCT00142298|450968936|FG005|Overall Study|Death|6|||
125365158|NCT00142298|450968937|FG006|Overall Study|Death|0|||
125365159|NCT00142298|450968938|FG007|Overall Study|Death|0|||
125365160|NCT00142298|450968939|FG008|Overall Study|Death|0|||
125365161|NCT00142298|450968940|FG009|Overall Study|Death|0|||
125365162|NCT00142298|450968931|FG000|Overall Study|Lack of Efficacy|44|||
125365163|NCT00142298|450968932|FG001|Overall Study|Lack of Efficacy|62|||
125365164|NCT00142298|450968933|FG002|Overall Study|Lack of Efficacy|9|||
125365165|NCT00142298|450968934|FG003|Overall Study|Lack of Efficacy|12|||
125365166|NCT00142298|450968935|FG004|Overall Study|Lack of Efficacy|1|||
125365167|NCT00142298|450968936|FG005|Overall Study|Lack of Efficacy|0|||
125365168|NCT00142298|450968937|FG006|Overall Study|Lack of Efficacy|0|||
125365169|NCT00142298|450968938|FG007|Overall Study|Lack of Efficacy|1|||
125365170|NCT00142298|450968939|FG008|Overall Study|Lack of Efficacy|0|||
125365171|NCT00142298|450968940|FG009|Overall Study|Lack of Efficacy|0|||
125365172|NCT00142298|450968931|FG000|Overall Study|Non-compliance|15|||
125365173|NCT00142298|450968932|FG001|Overall Study|Non-compliance|13|||
125365174|NCT00142298|450968933|FG002|Overall Study|Non-compliance|0|||
125365175|NCT00142298|450968934|FG003|Overall Study|Non-compliance|6|||
125365176|NCT00142298|450968935|FG004|Overall Study|Non-compliance|1|||
125365177|NCT00142298|450968936|FG005|Overall Study|Non-compliance|0|||
125365178|NCT00142298|450968937|FG006|Overall Study|Non-compliance|0|||
125365179|NCT00142298|450968938|FG007|Overall Study|Non-compliance|3|||
125365180|NCT00142298|450968939|FG008|Overall Study|Non-compliance|3|||
125365181|NCT00142298|450968940|FG009|Overall Study|Non-compliance|0|||
125365182|NCT00142298|450968931|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
125365183|NCT00142298|450968932|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
125365184|NCT00142298|450968933|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
125365185|NCT00142298|450968934|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
125365186|NCT00142298|450968935|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
125365187|NCT00142298|450968936|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
125365188|NCT00142298|450968937|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
125365189|NCT00142298|450968938|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
125365190|NCT00142298|450968939|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
125365191|NCT00142298|450968940|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
125365192|NCT00142298|450968931|FG000|Overall Study|Pregnancy|4|||
125365193|NCT00142298|450968932|FG001|Overall Study|Pregnancy|4|||
125365194|NCT00142298|450968933|FG002|Overall Study|Pregnancy|2|||
125365195|NCT00142298|450968934|FG003|Overall Study|Pregnancy|3|||
125365196|NCT00142298|450968935|FG004|Overall Study|Pregnancy|0|||
125365197|NCT00142298|450968936|FG005|Overall Study|Pregnancy|0|||
125365198|NCT00142298|450968937|FG006|Overall Study|Pregnancy|0|||
125365199|NCT00142298|450968938|FG007|Overall Study|Pregnancy|0|||
125365200|NCT00142298|450968939|FG008|Overall Study|Pregnancy|1|||
125365201|NCT00142298|450968940|FG009|Overall Study|Pregnancy|0|||
125365202|NCT00142298|450968931|FG000|Overall Study|Virologic breakthrough|19|||
125365203|NCT00142298|450968932|FG001|Overall Study|Virologic breakthrough|23|||
125365204|NCT00142298|450968933|FG002|Overall Study|Virologic breakthrough|9|||
125365205|NCT00142298|450968934|FG003|Overall Study|Virologic breakthrough|7|||
125365206|NCT00142298|450968935|FG004|Overall Study|Virologic breakthrough|2|||
125365207|NCT00142298|450968936|FG005|Overall Study|Virologic breakthrough|3|||
125365208|NCT00142298|450968937|FG006|Overall Study|Virologic breakthrough|3|||
125365209|NCT00142298|450968938|FG007|Overall Study|Virologic breakthrough|0|||
125365210|NCT00142298|450968939|FG008|Overall Study|Virologic breakthrough|0|||
125365211|NCT00142298|450968940|FG009|Overall Study|Virologic breakthrough|0|||
125365212|NCT00142298|450968931|FG000|Overall Study|Other- not specified|0|||
125365213|NCT00142298|450968932|FG001|Overall Study|Other- not specified|3|||
125365214|NCT00142298|450968933|FG002|Overall Study|Other- not specified|0|||
125365215|NCT00142298|450968934|FG003|Overall Study|Other- not specified|1|||
125365216|NCT00142298|450968935|FG004|Overall Study|Other- not specified|0|||
125365217|NCT00142298|450968936|FG005|Overall Study|Other- not specified|0|||
125365218|NCT00142298|450968937|FG006|Overall Study|Other- not specified|0|||
125365219|NCT00142298|450968938|FG007|Overall Study|Other- not specified|0|||
125365220|NCT00142298|450968939|FG008|Overall Study|Other- not specified|0|||
125365221|NCT00142298|450968940|FG009|Overall Study|Other- not specified|0|||
125365222|NCT00142298|450968931|FG000|Overall Study|Lost to Follow-up|0|||
125365223|NCT00142298|450968932|FG001|Overall Study|Lost to Follow-up|0|||
125365224|NCT00142298|450968933|FG002|Overall Study|Lost to Follow-up|0|||
125365225|NCT00142298|450968934|FG003|Overall Study|Lost to Follow-up|0|||
125365226|NCT00142298|450968935|FG004|Overall Study|Lost to Follow-up|0|||
125365227|NCT00142298|450968936|FG005|Overall Study|Lost to Follow-up|0|||
125365228|NCT00142298|450968937|FG006|Overall Study|Lost to Follow-up|2|||
125365229|NCT00142298|450968938|FG007|Overall Study|Lost to Follow-up|0|||
125365230|NCT00142298|450968939|FG008|Overall Study|Lost to Follow-up|0|||
125365231|NCT00142298|450968940|FG009|Overall Study|Lost to Follow-up|0|||
125365232|NCT00142298|450968931|FG000|Overall Study|Treatment Failure|0|||
125365233|NCT00142298|450968932|FG001|Overall Study|Treatment Failure|0|||
125365234|NCT00142298|450968933|FG002|Overall Study|Treatment Failure|0|||
125365235|NCT00142298|450968934|FG003|Overall Study|Treatment Failure|0|||
125365236|NCT00142298|450968935|FG004|Overall Study|Treatment Failure|0|||
125365237|NCT00142298|450968936|FG005|Overall Study|Treatment Failure|2|||
125365238|NCT00142298|450968937|FG006|Overall Study|Treatment Failure|2|||
125365239|NCT00142298|450968938|FG007|Overall Study|Treatment Failure|0|||
125365240|NCT00142298|450968939|FG008|Overall Study|Treatment Failure|0|||
125365241|NCT00142298|450968940|FG009|Overall Study|Treatment Failure|0|||
125365242|NCT00300274|450968941|FG000|Overall Study|Withdrawal by Subject|12|||
125365243|NCT00300274|450968942|FG001|Overall Study|Withdrawal by Subject|3|||
125365244|NCT00300274|450968943|FG002|Overall Study|Withdrawal by Subject|14|||
125365245|NCT00300274|450968941|FG000|Overall Study|Lost to Follow-up|3|||
125365246|NCT00300274|450968942|FG001|Overall Study|Lost to Follow-up|4|||
125365247|NCT00300274|450968943|FG002|Overall Study|Lost to Follow-up|5|||
125365248|NCT00300274|450968941|FG000|Overall Study|Death|31|||
125365249|NCT00300274|450968942|FG001|Overall Study|Death|20|||
125365250|NCT00300274|450968943|FG002|Overall Study|Death|25|||
125365251|NCT00300274|450968941|FG000|Overall Study|Re-transplant|0|||
125365252|NCT00300274|450968942|FG001|Overall Study|Re-transplant|0|||
125365253|NCT00300274|450968943|FG002|Overall Study|Re-transplant|1|||
125365254|NCT04439201|450968944|FG000|Overall Study|Ineligible|2|||
125365255|NCT04439201|450968944|FG000|Overall Study|Never start protocol therapy|1|||
125365256|NCT04439201|450968944|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
125365257|NCT04439201|450968944|FG000|Overall Study|Mutation status not confirmed|4|||
125365258|NCT04439201|450968944|FG000|Overall Study|Adverse Event|1|||
125365259|NCT04439201|450968944|FG000|Overall Study|Death|7|||
125365260|NCT04439201|450968944|FG000|Overall Study|Withdrawal by Subject|2|||
125365261|NCT04439201|450968944|FG000|Overall Study|Disease progression|20|||
125365262|NCT04439201|450968944|FG000|Overall Study|Alternative therapy|1|||
125365263|NCT04439201|450968944|FG000|Overall Study|Physician Decision|1|||
125365264|NCT01546207|450970368|FG000|Overall Study|Death|1|||
125365265|NCT03355365|450970371|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
125365266|NCT03355365|450970372|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
125365267|NCT03355365|450970371|FG000|Year 1, First Intervention|Protocol Violation|1|||
125365268|NCT03355365|450970372|FG001|Year 1, First Intervention|Protocol Violation|0|||
125365269|NCT03355365|450970371|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
125365270|NCT03355365|450970372|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
125365271|NCT03355365|450970371|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
125365272|NCT03355365|450970372|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
125365273|NCT03355365|450970371|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
125365274|NCT03355365|450970372|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
125365275|NCT03355365|450970371|FG000|Year 2, Crossover Intervention|severe COVID|0|||
125365276|NCT03355365|450970372|FG001|Year 2, Crossover Intervention|severe COVID|1|||
125365277|NCT03355365|450970371|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
125365278|NCT03355365|450970372|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
125365279|NCT00142935|450970375|FG000|Overall Study|Other reason|1|||
125365280|NCT00142935|450970376|FG001|Overall Study|Other reason|1|||
125365281|NCT00142935|450970377|FG002|Overall Study|Other reason|1|||
125365282|NCT00142935|450970375|FG000|Overall Study|Lost to Follow-up|2|||
125365283|NCT00142935|450970376|FG001|Overall Study|Lost to Follow-up|5|||
125365284|NCT00142935|450970377|FG002|Overall Study|Lost to Follow-up|5|||
125365285|NCT00142935|450970375|FG000|Overall Study|Death|0|||
125365286|NCT00142935|450970376|FG001|Overall Study|Death|2|||
125365287|NCT00142935|450970377|FG002|Overall Study|Death|1|||
125365288|NCT01952145|450970381|FG000|Overall Study|Protocol Violation|2|||
125365289|NCT01952145|450970382|FG001|Overall Study|Protocol Violation|1|||
125365290|NCT01952145|450970381|FG000|Overall Study|Death|0|||
125365291|NCT01952145|450970382|FG001|Overall Study|Death|1|||
125365292|NCT01952145|450970381|FG000|Overall Study|Adverse Event|9|||
125365293|NCT01952145|450970382|FG001|Overall Study|Adverse Event|0|||
125365294|NCT01952145|450970381|FG000|Overall Study|Withdrawal Criteria|16|||
125365295|NCT01952145|450970382|FG001|Overall Study|Withdrawal Criteria|11|||
125365296|NCT01952145|450970381|FG000|Overall Study|Unclassified|1|||
125365297|NCT01952145|450970382|FG001|Overall Study|Unclassified|1|||
125365298|NCT03758066|450970383|FG000|Overall Study|Lost to Follow-up|14|||
125365299|NCT04138810|450970387|FG000|Overall Study|Withdrawal by Subject|0|||
125365300|NCT04138810|450970388|FG001|Overall Study|Withdrawal by Subject|1|||
125365301|NCT04138810|450970387|FG000|Overall Study|Subject cancelled surgery|1|||
125365302|NCT04138810|450970388|FG001|Overall Study|Subject cancelled surgery|0|||
125365303|NCT01786668|450970389|FG000|Overall Study|Adverse Event|0|||
125365304|NCT01786668|450970390|FG001|Overall Study|Adverse Event|1|||
125365305|NCT01786668|450970391|FG002|Overall Study|Adverse Event|1|||
125365306|NCT01786668|450970392|FG003|Overall Study|Adverse Event|2|||
125365307|NCT01786668|450970389|FG000|Overall Study|Withdrawal by Subject|0|||
125365308|NCT01786668|450970390|FG001|Overall Study|Withdrawal by Subject|0|||
125365309|NCT01786668|450970391|FG002|Overall Study|Withdrawal by Subject|3|||
125365310|NCT01786668|450970392|FG003|Overall Study|Withdrawal by Subject|1|||
125365311|NCT01786668|450970389|FG000|Overall Study|Pregnancy|0|||
125365312|NCT01786668|450970390|FG001|Overall Study|Pregnancy|0|||
125365313|NCT01786668|450970391|FG002|Overall Study|Pregnancy|0|||
125365314|NCT01786668|450970392|FG003|Overall Study|Pregnancy|1|||
125365315|NCT01786668|450970389|FG000|Overall Study|Lost to Follow-up|1|||
125365316|NCT01786668|450970390|FG001|Overall Study|Lost to Follow-up|0|||
125365317|NCT01786668|450970391|FG002|Overall Study|Lost to Follow-up|1|||
125365318|NCT01786668|450970392|FG003|Overall Study|Lost to Follow-up|0|||
125365319|NCT00762385|450970395|FG000|First Intervention|Lens Issue|1|||
125365320|NCT00762385|450970396|FG001|First Intervention|Lens Issue|1|||
125365321|NCT00762385|450970395|FG000|First Intervention|Lost to Follow-up|0|||
125365322|NCT00762385|450970396|FG001|First Intervention|Lost to Follow-up|2|||
125365323|NCT00762385|450970395|FG000|First Intervention|Ineligible|1|||
125365324|NCT00762385|450970396|FG001|First Intervention|Ineligible|0|||
125365325|NCT00762385|450970395|FG000|First Intervention|Protocol Violation|0|||
125365326|NCT00762385|450970396|FG001|First Intervention|Protocol Violation|1|||
125365327|NCT00762385|450970395|FG000|Second Intervention|Protocol Violation|3|||
125365328|NCT00762385|450970396|FG001|Second Intervention|Protocol Violation|3|||
125365329|NCT01540838|450970397|FG000|Overall Study|Open nasogastric tube|9|||
125365330|NCT01540838|450970398|FG001|Overall Study|Open nasogastric tube|7|||
125365331|NCT01540838|450970397|FG000|Overall Study|Treatment doses missing|8|||
125365332|NCT01540838|450970398|FG001|Overall Study|Treatment doses missing|12|||
125365333|NCT01540838|450970397|FG000|Overall Study|Additional antibiotic treatment|1|||
125365334|NCT01540838|450970398|FG001|Overall Study|Additional antibiotic treatment|2|||
125365335|NCT01540838|450970397|FG000|Overall Study|Died before treatment initiation|1|||
125365336|NCT01540838|450970398|FG001|Overall Study|Died before treatment initiation|1|||
125365337|NCT01540838|450970397|FG000|Overall Study|Not BM. Other treatment|3|||
125365338|NCT01540838|450970398|FG001|Overall Study|Not BM. Other treatment|1|||
125365339|NCT02130570|450970399|FG000|Overall Study|Death|3|||
125365340|NCT02130570|450970400|FG001|Overall Study|Death|5|||
125365341|NCT02130570|450970399|FG000|Overall Study|Withdrawal by Subject|6|||
125365342|NCT02130570|450970400|FG001|Overall Study|Withdrawal by Subject|3|||
125365343|NCT02130570|450970399|FG000|Overall Study|Part of practice that discontinued study|0|||
125365344|NCT02130570|450970400|FG001|Overall Study|Part of practice that discontinued study|5|||
125365345|NCT00493025|450970401|FG000|Overall Study|Physician Decision|19|||
125365346|NCT05338216|450970402|FG000|Overall Study|Withdrawal by Subject|1|||
125365347|NCT05338216|450970403|FG001|Overall Study|Withdrawal by Subject|1|||
125365348|NCT00413244|450970404|FG000|Overall Study|Withdrawal by Subject|10|||
125365349|NCT00413244|450970405|FG001|Overall Study|Withdrawal by Subject|1|||
125365350|NCT00446251|450970406|FG000|Overall Study|On-study Transplants|2|||
125365351|NCT00446251|450970406|FG000|Overall Study|Rituximab Infusion Reaction|2|||
125365352|NCT00446251|450970406|FG000|Overall Study|Lost to Follow-up|1|||
125365353|NCT00753766|450970411|FG000|Overall Study|Physician Decision|1|||
125212396|NCT00938587|450403342|FG002|Overall Study|Withdrawal by Subject|0|||
125212397|NCT00938587|450403343|FG003|Overall Study|Withdrawal by Subject|0|||
125365354|NCT00753766|450970412|FG001|Overall Study|Physician Decision|0|||
125365355|NCT04545554|450970413|FG000|Overall Study|Withdrawal by Subject|0|||
125365356|NCT04545554|450970414|FG001|Overall Study|Withdrawal by Subject|0|||
125365357|NCT04545554|450970415|FG002|Overall Study|Withdrawal by Subject|0|||
125365358|NCT04545554|450970416|FG003|Overall Study|Withdrawal by Subject|1|||
125365359|NCT04545554|450970417|FG004|Overall Study|Withdrawal by Subject|0|||
125365360|NCT04545554|450970418|FG005|Overall Study|Withdrawal by Subject|0|||
125365361|NCT00494299|450970419|FG000|Overall Study|Adverse Event|93|||
125365362|NCT00494299|450970420|FG001|Overall Study|Adverse Event|13|||
125365363|NCT00494299|450970419|FG000|Overall Study|Lost to Follow-up|1|||
125365364|NCT00494299|450970420|FG001|Overall Study|Lost to Follow-up|0|||
125365365|NCT00494299|450970419|FG000|Overall Study|Physician Decision|0|||
125365366|NCT00494299|450970420|FG001|Overall Study|Physician Decision|2|||
125365367|NCT00494299|450970419|FG000|Overall Study|Protocol Violation|1|||
125365368|NCT00494299|450970420|FG001|Overall Study|Protocol Violation|2|||
125365369|NCT00494299|450970419|FG000|Overall Study|Withdrawal by Subject|8|||
125365370|NCT00494299|450970420|FG001|Overall Study|Withdrawal by Subject|3|||
125365371|NCT00494299|450970419|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
125365372|NCT00494299|450970420|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
125365373|NCT00494299|450970419|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
125365374|NCT00494299|450970420|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
125365375|NCT00494299|450970419|FG000|Overall Study|Site Closed by Sponsor|6|||
125365376|NCT00494299|450970420|FG001|Overall Study|Site Closed by Sponsor|0|||
125365377|NCT00494299|450970419|FG000|Overall Study|Protocol Driven Decision Point|11|||
125365378|NCT00494299|450970420|FG001|Overall Study|Protocol Driven Decision Point|22|||
125365379|NCT00066365|450970421|FG000|Overall Study|Adverse Event|1|||
125365380|NCT00066365|450970422|FG001|Overall Study|Adverse Event|0|||
125365381|NCT00066365|450970421|FG000|Overall Study|Lack of Efficacy|15|||
125365382|NCT00066365|450970422|FG001|Overall Study|Lack of Efficacy|12|||
125365383|NCT00066365|450970421|FG000|Overall Study|Physician Decision|1|||
125365384|NCT00066365|450970422|FG001|Overall Study|Physician Decision|0|||
125365385|NCT00066365|450970421|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
125365386|NCT00066365|450970422|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
125365387|NCT00066365|450970421|FG000|Overall Study|Ineligible|4|||
125365388|NCT00066365|450970422|FG001|Overall Study|Ineligible|2|||
125365389|NCT00239590|450970425|FG000|Randomized|Lost to Follow-up|0|||
125365390|NCT00239590|450970426|FG001|Randomized|Lost to Follow-up|1|||
125365391|NCT00239590|450970425|FG000|Randomized|Withdrawal by Subject|0|||
125365392|NCT00239590|450970426|FG001|Randomized|Withdrawal by Subject|1|||
125365393|NCT00239590|450970425|FG000|Completed Study Protocol|Adverse Event|1|||
125365394|NCT00239590|450970426|FG001|Completed Study Protocol|Adverse Event|1|||
125365395|NCT00239590|450970425|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
125365396|NCT00239590|450970426|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
125365397|NCT02362269|450970430|FG000|Overall Study|Moved|1|||
125365398|NCT02362269|450970431|FG001|Overall Study|Moved|0|||
125365399|NCT02362269|450970430|FG000|Overall Study|Lost to Follow-up|0|||
125365400|NCT02362269|450970431|FG001|Overall Study|Lost to Follow-up|6|||
125365401|NCT05213481|450970432|FG000|Overall Study|Adverse Event|3|||
125365402|NCT05213481|450970432|FG000|Overall Study|Lost to Follow-up|1|||
125365403|NCT00415168|450970436|FG000|Overall Study|Death|26|||
125365404|NCT00415168|450970436|FG000|Overall Study|Lost to Follow-up|3|||
125365405|NCT00415168|450970436|FG000|Overall Study|Physician Decision|13|||
125365406|NCT00415168|450970436|FG000|Overall Study|Sponsor Decision|4|||
125365407|NCT00415168|450970436|FG000|Overall Study|Withdrawal by Subject|6|||
125365408|NCT02058693|450970442|FG000|Phase 1|Withdrawal by Subject|3|||
125365409|NCT02058693|450970443|FG001|Phase 1|Withdrawal by Subject|2|||
125365410|NCT02058693|450970442|FG000|Phase 1|Adverse Event|0|||
125365411|NCT02058693|450970443|FG001|Phase 1|Adverse Event|1|||
125365412|NCT02058693|450970442|FG000|Phase 1|Lack of Efficacy|1|||
125365413|NCT02058693|450970443|FG001|Phase 1|Lack of Efficacy|0|||
125365414|NCT02058693|450970442|FG000|Phase 1|Physician Decision|1|||
125365415|NCT02058693|450970443|FG001|Phase 1|Physician Decision|1|||
125365416|NCT02058693|450970442|FG000|Phase 2|Withdrawal by Subject|0|||
125365417|NCT02058693|450970443|FG001|Phase 2|Withdrawal by Subject|2|||
125365418|NCT00722800|450970444|FG000|Overall Study|Withdrawal by Subject|1|||
125365419|NCT00722800|450970445|FG001|Overall Study|Withdrawal by Subject|0|||
125595896|NCT05635838|451806311|FG003|16-Week DBVC Period|Physician Decision|0|||
125365420|NCT00722800|450970444|FG000|Overall Study|Physician Decision|1|||
125365421|NCT00722800|450970445|FG001|Overall Study|Physician Decision|0|||
125365422|NCT02925117|450970448|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
125365423|NCT02925117|450970449|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
125365424|NCT02925117|450970450|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
125365425|NCT02925117|450970451|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
125365426|NCT02925117|450970452|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125365427|NCT02925117|450970453|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125365428|NCT02925117|450970454|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125365429|NCT02925117|450970455|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125365430|NCT02925117|450970456|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125365431|NCT02925117|450970457|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125365432|NCT02925117|450970458|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125365433|NCT02925117|450970459|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
125365434|NCT02925117|450970448|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
125365435|NCT02925117|450970449|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
125365436|NCT02925117|450970450|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
125365437|NCT02925117|450970451|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125365438|NCT02925117|450970452|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125365439|NCT02925117|450970453|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125365440|NCT02925117|450970454|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125365441|NCT02925117|450970455|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125365442|NCT02925117|450970456|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125365443|NCT02925117|450970457|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125365444|NCT02925117|450970458|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125365445|NCT02925117|450970459|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
125365446|NCT02925117|450970448|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
125365447|NCT02925117|450970449|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
125365448|NCT02925117|450970450|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125365449|NCT02925117|450970451|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125365450|NCT02925117|450970452|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125365451|NCT02925117|450970453|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125365452|NCT02925117|450970454|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125365453|NCT02925117|450970455|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125365454|NCT02925117|450970456|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125365455|NCT02925117|450970457|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125365456|NCT02925117|450970458|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125365457|NCT02925117|450970459|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
125365458|NCT02925117|450970448|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
125365459|NCT02925117|450970449|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
125365460|NCT02925117|450970450|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
125365461|NCT02925117|450970451|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
125365462|NCT02925117|450970452|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
125365463|NCT02925117|450970453|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
125365464|NCT02925117|450970454|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
125365465|NCT02925117|450970455|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
125365466|NCT02925117|450970456|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
125365467|NCT02925117|450970457|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
125365468|NCT02925117|450970458|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
125365469|NCT02925117|450970459|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
125365470|NCT02925117|450970448|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125365471|NCT02925117|450970449|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125365472|NCT02925117|450970450|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125365473|NCT02925117|450970451|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125365474|NCT02925117|450970452|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125365475|NCT02925117|450970453|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
125365476|NCT02925117|450970454|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125365477|NCT02925117|450970455|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125365478|NCT02925117|450970456|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125365479|NCT02925117|450970457|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
125365480|NCT02925117|450970458|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
125365481|NCT02925117|450970459|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
125365482|NCT02925117|450970448|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
125365483|NCT02925117|450970449|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
125365484|NCT02925117|450970450|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
125365485|NCT02925117|450970451|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
125365486|NCT02925117|450970452|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
125365487|NCT02925117|450970453|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
125365488|NCT02925117|450970454|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
125365489|NCT02925117|450970455|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
125365490|NCT02925117|450970456|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
125365491|NCT02925117|450970457|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
125365492|NCT02925117|450970458|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
125365493|NCT02925117|450970459|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
125365494|NCT02925117|450970448|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
125365495|NCT02925117|450970449|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
125365496|NCT02925117|450970450|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
125365497|NCT02925117|450970451|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
125365498|NCT02925117|450970452|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
125365499|NCT02925117|450970453|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
125365500|NCT02925117|450970454|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
125365501|NCT02925117|450970455|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
125365502|NCT02925117|450970456|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
125365503|NCT02925117|450970457|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
125365504|NCT02925117|450970458|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
125365505|NCT02925117|450970459|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
125365506|NCT02925117|450970448|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
125365507|NCT02925117|450970449|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
125365508|NCT02925117|450970450|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
125365509|NCT02925117|450970451|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
125365510|NCT02925117|450970452|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
125365511|NCT02925117|450970453|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
125365512|NCT02925117|450970454|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
125365513|NCT02925117|450970455|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
125365514|NCT02925117|450970456|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
125365515|NCT02925117|450970457|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
125365516|NCT02925117|450970458|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
125365517|NCT02925117|450970459|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
125365518|NCT01449539|450970464|FG000|Overall Study|Withdrawal by Subject|3|||
125365519|NCT01449539|450970464|FG000|Overall Study|Toxicity not study related|1|||
125365520|NCT01972568|450970465|FG000|Overall Study|Other events|3|||
125365521|NCT01972568|450970466|FG001|Overall Study|Other events|0|||
125365522|NCT01972568|450970467|FG002|Overall Study|Other events|0|||
125365523|NCT01972568|450970465|FG000|Overall Study|Lack of Efficacy|0|||
125365524|NCT01972568|450970466|FG001|Overall Study|Lack of Efficacy|1|||
125365525|NCT01972568|450970467|FG002|Overall Study|Lack of Efficacy|2|||
125365526|NCT01972568|450970465|FG000|Overall Study|Protocol Violation|1|||
125365527|NCT01972568|450970466|FG001|Overall Study|Protocol Violation|2|||
125365528|NCT01972568|450970467|FG002|Overall Study|Protocol Violation|2|||
125365529|NCT01972568|450970465|FG000|Overall Study|Withdrawal by Subject|6|||
125365530|NCT01972568|450970466|FG001|Overall Study|Withdrawal by Subject|3|||
125365531|NCT01972568|450970467|FG002|Overall Study|Withdrawal by Subject|7|||
125365532|NCT01972568|450970465|FG000|Overall Study|Lost to Follow-up|1|||
125365533|NCT01972568|450970466|FG001|Overall Study|Lost to Follow-up|0|||
125365534|NCT01972568|450970467|FG002|Overall Study|Lost to Follow-up|0|||
125365535|NCT01972568|450970465|FG000|Overall Study|Adverse Event|5|||
125365536|NCT01972568|450970466|FG001|Overall Study|Adverse Event|6|||
125365537|NCT01972568|450970467|FG002|Overall Study|Adverse Event|5|||
125365538|NCT02572401|450970468|FG000|Overall Study|Lost to Follow-up|5|||
125365539|NCT02572401|450970469|FG001|Overall Study|Lost to Follow-up|8|||
125365540|NCT02572401|450970470|FG002|Overall Study|Lost to Follow-up|9|||
125365541|NCT02572401|450970471|FG003|Overall Study|Lost to Follow-up|9|||
125365542|NCT02572401|450970468|FG000|Overall Study|Death|0|||
125365543|NCT02572401|450970469|FG001|Overall Study|Death|0|||
125365544|NCT02572401|450970470|FG002|Overall Study|Death|0|||
125365545|NCT02572401|450970471|FG003|Overall Study|Death|1|||
125365546|NCT00306189|450970472|FG000|Overall Study|Physician Decision|0|||
125365547|NCT00306189|450970473|FG001|Overall Study|Physician Decision|0|||
125365548|NCT00306189|450970474|FG002|Overall Study|Physician Decision|0|||
125365549|NCT00306189|450970475|FG003|Overall Study|Physician Decision|1|||
125365550|NCT00306189|450970472|FG000|Overall Study|Adverse Event|3|||
125365551|NCT00306189|450970473|FG001|Overall Study|Adverse Event|3|||
125365552|NCT00306189|450970474|FG002|Overall Study|Adverse Event|2|||
125365553|NCT00306189|450970475|FG003|Overall Study|Adverse Event|2|||
125365554|NCT00306189|450970472|FG000|Overall Study|Withdrawal by Subject|4|||
125365555|NCT00306189|450970473|FG001|Overall Study|Withdrawal by Subject|2|||
125365556|NCT00306189|450970474|FG002|Overall Study|Withdrawal by Subject|8|||
125365557|NCT00306189|450970475|FG003|Overall Study|Withdrawal by Subject|1|||
125365558|NCT00306189|450970472|FG000|Overall Study|Ineligibility determined|1|||
125365559|NCT00306189|450970473|FG001|Overall Study|Ineligibility determined|1|||
125365560|NCT00306189|450970474|FG002|Overall Study|Ineligibility determined|1|||
125365561|NCT00306189|450970475|FG003|Overall Study|Ineligibility determined|1|||
125365562|NCT00306189|450970472|FG000|Overall Study|Other|1|||
125365563|NCT00306189|450970473|FG001|Overall Study|Other|0|||
125365564|NCT00306189|450970474|FG002|Overall Study|Other|0|||
125365565|NCT00306189|450970475|FG003|Overall Study|Other|0|||
125365566|NCT02059408|450970476|FG000|Overall Study|Did not get tested|0|||
125365567|NCT02059408|450970477|FG001|Overall Study|Did not get tested|330|||
125429916|NCT00571701|451200135|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
125429917|NCT00571701|451200136|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
125429918|NCT00571701|451200135|FG000|First Intervention 12 Months|Death|1|||
125429919|NCT00571701|451200136|FG001|First Intervention 12 Months|Death|0|||
125429920|NCT00571701|451200135|FG000|Second Intervention 12 Months|Adverse Event|0|||
125429921|NCT00571701|451200136|FG001|Second Intervention 12 Months|Adverse Event|1|||
125429922|NCT00571701|451200135|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
125429923|NCT00571701|451200136|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
125429924|NCT03351738|451200141|FG000|Overall Study|Withdrawal by Subject|0|||
125429925|NCT03351738|451200142|FG001|Overall Study|Withdrawal by Subject|1|||
125429926|NCT03351738|451200143|FG002|Overall Study|Withdrawal by Subject|0|||
125429927|NCT03351738|451200144|FG003|Overall Study|Withdrawal by Subject|1|||
125429928|NCT03351738|451200145|FG004|Overall Study|Withdrawal by Subject|0|||
125429929|NCT03351738|451200146|FG005|Overall Study|Withdrawal by Subject|0|||
125429930|NCT01375205|451200149|FG000|Overall Study|Lost to Follow-up|15|||
125429931|NCT01375205|451200150|FG001|Overall Study|Lost to Follow-up|12|||
125429932|NCT01375205|451200149|FG000|Overall Study|Withdrawal by Subject|6|||
125429933|NCT01375205|451200150|FG001|Overall Study|Withdrawal by Subject|1|||
125429934|NCT03056534|451200152|FG000|Overall Study|Participant withdrew consent|8|||
125429935|NCT03056534|451200152|FG000|Overall Study|Participant not able to return|6|||
125429936|NCT03056534|451200152|FG000|Overall Study|Lost to Follow-up|37|||
125429937|NCT03056534|451200152|FG000|Overall Study|Investigator judgment|1|||
125429938|NCT03056534|451200152|FG000|Overall Study|Death|4|||
125429939|NCT03056534|451200152|FG000|Overall Study|Adverse Event|1|||
125429940|NCT03056534|451200152|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
125429941|NCT02063828|451200153|FG000|Overall Study|Withdrawal by Subject|4|||
125429942|NCT02063828|451200154|FG001|Overall Study|Withdrawal by Subject|6|||
125429943|NCT02063828|451200155|FG002|Overall Study|Withdrawal by Subject|3|||
125429944|NCT02063828|451200153|FG000|Overall Study|Death|0|||
125429945|NCT02063828|451200154|FG001|Overall Study|Death|0|||
125429946|NCT02063828|451200155|FG002|Overall Study|Death|1|||
125429947|NCT03483038|451200156|FG000|Overall Study|Subjects still in follow-up|18|||
125429948|NCT02134925|451200157|FG000|Overall Study|Withdrawal by Subject|1|||
125429949|NCT02134925|451200158|FG001|Overall Study|Withdrawal by Subject|0|||
125429950|NCT02134925|451200157|FG000|Overall Study|Cancel|1|||
125429951|NCT02134925|451200158|FG001|Overall Study|Cancel|6|||
125429952|NCT00654901|451200163|FG000|Overall Study|Lost to Follow-up|1|||
125429953|NCT00654901|451200164|FG001|Overall Study|Lost to Follow-up|0|||
125429954|NCT00654901|451200165|FG002|Overall Study|Lost to Follow-up|1|||
125429955|NCT00654901|451200166|FG003|Overall Study|Lost to Follow-up|0|||
125429956|NCT00654901|451200163|FG000|Overall Study|Withdrawal by Subject|3|||
125429957|NCT00654901|451200164|FG001|Overall Study|Withdrawal by Subject|0|||
125429958|NCT00654901|451200165|FG002|Overall Study|Withdrawal by Subject|1|||
125429959|NCT00654901|451200166|FG003|Overall Study|Withdrawal by Subject|0|||
125429960|NCT02332590|451200167|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
125429961|NCT02332590|451200168|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
125429962|NCT02332590|451200167|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
125429963|NCT02332590|451200168|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
125429964|NCT02332590|451200167|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
125429965|NCT02332590|451200168|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
125429966|NCT02332590|451200167|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
125429967|NCT02332590|451200168|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
125429968|NCT02332590|451200167|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
125429969|NCT02332590|451200168|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
125429970|NCT02332590|451200167|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
125429971|NCT02332590|451200168|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
125429972|NCT02332590|451200167|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
125429973|NCT02332590|451200168|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
125429974|NCT02332590|451200167|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
125429975|NCT02332590|451200168|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
125429976|NCT02332590|451200167|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
125429977|NCT02332590|451200168|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
125429978|NCT03764072|451200173|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
125429979|NCT03764072|451200174|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
125429980|NCT03764072|451200175|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
125429981|NCT03764072|451200176|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
125429982|NCT03764072|451200177|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
125429983|NCT03764072|451200178|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
125429984|NCT03764072|451200173|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
125429985|NCT03764072|451200174|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
125429986|NCT03764072|451200175|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
125365568|NCT02059408|450970478|FG002|Overall Study|Did not get tested|358|||
125365569|NCT00945893|450970479|FG000|Overall Study|Lost to Follow-up|2|||
125365570|NCT00945893|450970480|FG001|Overall Study|Lost to Follow-up|8|||
125365571|NCT00945893|450970479|FG000|Overall Study|Withdrawal of consent|1|||
125365572|NCT00945893|450970480|FG001|Overall Study|Withdrawal of consent|2|||
125365573|NCT01681472|450970482|FG000|Overall Study|Adverse Event|0|||
125365574|NCT01681472|450970483|FG001|Overall Study|Adverse Event|1|||
125365575|NCT01681472|450970484|FG002|Overall Study|Adverse Event|0|||
125365576|NCT01681472|450970485|FG003|Overall Study|Adverse Event|0|||
125365577|NCT00667875|450970486|FG000|Overall Study|Adverse Event|0|||
125365578|NCT00667875|450970487|FG001|Overall Study|Adverse Event|2|||
125365579|NCT00667875|450970488|FG002|Overall Study|Adverse Event|6|||
125365580|NCT00667875|450970486|FG000|Overall Study|Withdrawal by Subject|10|||
125365581|NCT00667875|450970487|FG001|Overall Study|Withdrawal by Subject|9|||
125365582|NCT00667875|450970488|FG002|Overall Study|Withdrawal by Subject|7|||
125365583|NCT01187433|450970496|FG000|Overall Study|Protocol Violation|6|||
125365584|NCT01187433|450970497|FG001|Overall Study|Protocol Violation|2|||
125365585|NCT01187433|450970496|FG000|Overall Study|Withdrawal by Subject|5|||
125365586|NCT01187433|450970497|FG001|Overall Study|Withdrawal by Subject|2|||
125365587|NCT00242216|450970503|FG000|Overall Study|Lost to Follow-up|12|||
125365588|NCT00242216|450970504|FG001|Overall Study|Lost to Follow-up|17|||
125365589|NCT00242216|450970503|FG000|Overall Study|Death|4|||
125365590|NCT00242216|450970504|FG001|Overall Study|Death|2|||
125365591|NCT00242216|450970503|FG000|Overall Study|Lack of Efficacy|1|||
125365592|NCT00242216|450970504|FG001|Overall Study|Lack of Efficacy|2|||
125365593|NCT00242216|450970503|FG000|Overall Study|no medicaiton dispensed|1|||
125365594|NCT00242216|450970504|FG001|Overall Study|no medicaiton dispensed|1|||
125365595|NCT01995825|450972387|FG000|Overall Study|Withdrawal by Subject|1|||
125365596|NCT01995825|450972388|FG001|Overall Study|Withdrawal by Subject|0|||
125365597|NCT06956170|450972389|FG000|Overall Study|Death|2|||
125365598|NCT06956170|450972390|FG001|Overall Study|Death|1|||
125365599|NCT06956170|450972389|FG000|Overall Study|Withdrawal by Subject|1|||
125365600|NCT06956170|450972390|FG001|Overall Study|Withdrawal by Subject|0|||
125365601|NCT06956170|450972389|FG000|Overall Study|Ongoing|7|||
125365602|NCT06956170|450972390|FG001|Overall Study|Ongoing|10|||
125365603|NCT01385566|450972391|FG000|Overall Study|Lost to Follow-up|1|||
125365604|NCT01385566|450972392|FG001|Overall Study|Lost to Follow-up|0|||
125365605|NCT01385566|450972393|FG002|Overall Study|Lost to Follow-up|0|||
125365606|NCT01385566|450972394|FG003|Overall Study|Lost to Follow-up|0|||
125365607|NCT01385566|450972395|FG004|Overall Study|Lost to Follow-up|0|||
125365608|NCT01385566|450972396|FG005|Overall Study|Lost to Follow-up|0|||
125365609|NCT01385566|450972391|FG000|Overall Study|Withdrawal by Subject|0|||
125365610|NCT01385566|450972392|FG001|Overall Study|Withdrawal by Subject|0|||
125365611|NCT01385566|450972393|FG002|Overall Study|Withdrawal by Subject|0|||
125365612|NCT01385566|450972394|FG003|Overall Study|Withdrawal by Subject|1|||
125365613|NCT01385566|450972395|FG004|Overall Study|Withdrawal by Subject|0|||
125365614|NCT01385566|450972396|FG005|Overall Study|Withdrawal by Subject|0|||
125365615|NCT00403234|450972399|FG000|Overall Study|Withdrawal by Subject|0|||
125365616|NCT00403234|450972400|FG001|Overall Study|Withdrawal by Subject|1|||
125365617|NCT00403234|450972401|FG002|Overall Study|Withdrawal by Subject|0|||
125365618|NCT00403234|450972402|FG003|Overall Study|Withdrawal by Subject|0|||
125365619|NCT00403234|450972399|FG000|Overall Study|Adverse Event|1|||
125365620|NCT00403234|450972400|FG001|Overall Study|Adverse Event|0|||
125365621|NCT00403234|450972401|FG002|Overall Study|Adverse Event|1|||
125365622|NCT00403234|450972402|FG003|Overall Study|Adverse Event|0|||
125365623|NCT00560105|450972405|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
125365624|NCT00560105|450972406|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
125365625|NCT02400333|450972409|FG000|Overall Study|Withdrawal by Subject|0|||
125365626|NCT02400333|450972410|FG001|Overall Study|Withdrawal by Subject|1|||
125365627|NCT02400333|450972411|FG002|Overall Study|Withdrawal by Subject|0|||
125365628|NCT02400333|450972412|FG003|Overall Study|Withdrawal by Subject|1|||
125365629|NCT02400333|450972409|FG000|Overall Study|Protocol Violation|1|||
125365630|NCT02400333|450972410|FG001|Overall Study|Protocol Violation|0|||
125365631|NCT02400333|450972411|FG002|Overall Study|Protocol Violation|2|||
125365632|NCT02400333|450972412|FG003|Overall Study|Protocol Violation|1|||
125365633|NCT02280304|450972418|FG000|Overall Study|Lost to Follow-up|7|||
125365634|NCT02280304|450972419|FG001|Overall Study|Lost to Follow-up|8|||
125365635|NCT04218695|450972423|FG000|Overall Study|Adverse Event|1|||
125365636|NCT04218695|450972424|FG001|Overall Study|Adverse Event|0|||
125365637|NCT03166735|450972425|FG000|Overall Study|Not Treated|1|||
125365638|NCT03166735|450972426|FG001|Overall Study|Not Treated|0|||
125365639|NCT03166735|450972427|FG002|Overall Study|Not Treated|0|||
125365640|NCT03166735|450972428|FG003|Overall Study|Not Treated|0|||
125365641|NCT03166735|450972429|FG004|Overall Study|Not Treated|0|||
125365642|NCT03166735|450972425|FG000|Overall Study|follow-up not completed as planned|0|||
125365643|NCT03166735|450972426|FG001|Overall Study|follow-up not completed as planned|1|||
125365644|NCT03166735|450972427|FG002|Overall Study|follow-up not completed as planned|1|||
125365645|NCT03166735|450972428|FG003|Overall Study|follow-up not completed as planned|0|||
125365646|NCT03166735|450972429|FG004|Overall Study|follow-up not completed as planned|1|||
125365647|NCT03166735|450972425|FG000|Overall Study|Withdrawal by Subject|0|||
125365648|NCT03166735|450972426|FG001|Overall Study|Withdrawal by Subject|0|||
125365649|NCT03166735|450972427|FG002|Overall Study|Withdrawal by Subject|1|||
125365650|NCT03166735|450972428|FG003|Overall Study|Withdrawal by Subject|1|||
125365651|NCT03166735|450972429|FG004|Overall Study|Withdrawal by Subject|2|||
125365652|NCT03166735|450972425|FG000|Overall Study|Lost to Follow-up|0|||
125365653|NCT03166735|450972426|FG001|Overall Study|Lost to Follow-up|2|||
125365654|NCT03166735|450972427|FG002|Overall Study|Lost to Follow-up|1|||
125365655|NCT03166735|450972428|FG003|Overall Study|Lost to Follow-up|0|||
125365656|NCT03166735|450972429|FG004|Overall Study|Lost to Follow-up|1|||
125365657|NCT00003473|450972430|FG000|Overall Study|Three patients were not evaluable.|3|||
125365658|NCT03372096|450972435|FG000|Overall Study|Study Closed|8|||
125365659|NCT01947582|450972440|FG000|Overall Study|Withdrawal by Subject|1|||
125365660|NCT01603355|450972441|FG000|Overall Study|Lack of Efficacy|2|||
125365661|NCT05154578|450972442|FG000|Overall Study|Withdrawal by Subject|2|||
125365662|NCT05154578|450972443|FG001|Overall Study|Withdrawal by Subject|3|||
125365663|NCT05154578|450972444|FG002|Overall Study|Withdrawal by Subject|2|||
125365664|NCT05154578|450972445|FG003|Overall Study|Withdrawal by Subject|4|||
125365665|NCT05154578|450972446|FG004|Overall Study|Withdrawal by Subject|0|||
125365666|NCT05154578|450972442|FG000|Overall Study|Lost to Follow-up|0|||
125365667|NCT05154578|450972443|FG001|Overall Study|Lost to Follow-up|1|||
125365668|NCT05154578|450972444|FG002|Overall Study|Lost to Follow-up|0|||
125365669|NCT05154578|450972445|FG003|Overall Study|Lost to Follow-up|3|||
125365670|NCT05154578|450972446|FG004|Overall Study|Lost to Follow-up|0|||
125365671|NCT05154578|450972442|FG000|Overall Study|Adverse Event|0|||
125365672|NCT05154578|450972443|FG001|Overall Study|Adverse Event|0|||
125365673|NCT05154578|450972444|FG002|Overall Study|Adverse Event|0|||
125365674|NCT05154578|450972445|FG003|Overall Study|Adverse Event|1|||
125365675|NCT05154578|450972446|FG004|Overall Study|Adverse Event|0|||
125365676|NCT05154578|450972442|FG000|Overall Study|Relocated to another province|0|||
125365677|NCT05154578|450972443|FG001|Overall Study|Relocated to another province|0|||
125365678|NCT05154578|450972444|FG002|Overall Study|Relocated to another province|1|||
125365679|NCT05154578|450972445|FG003|Overall Study|Relocated to another province|0|||
125365680|NCT05154578|450972446|FG004|Overall Study|Relocated to another province|1|||
125365681|NCT05154578|450972442|FG000|Overall Study|Baby loss|0|||
125365682|NCT05154578|450972443|FG001|Overall Study|Baby loss|1|||
125365683|NCT05154578|450972444|FG002|Overall Study|Baby loss|0|||
125365684|NCT05154578|450972445|FG003|Overall Study|Baby loss|0|||
125365685|NCT05154578|450972446|FG004|Overall Study|Baby loss|0|||
125365686|NCT02924571|450972452|FG000|Overall Study|Lost to Follow-up|1|||
125365687|NCT02924571|450972453|FG001|Overall Study|Lost to Follow-up|1|||
125365688|NCT02924571|450972454|FG002|Overall Study|Lost to Follow-up|0|||
125365689|NCT00434954|450972455|FG000|Overall Study|Adverse Event|17|||
125365690|NCT00434954|450972456|FG001|Overall Study|Adverse Event|2|||
125365691|NCT00434954|450972455|FG000|Overall Study|Entry criteria not met|14|||
125365692|NCT00434954|450972456|FG001|Overall Study|Entry criteria not met|16|||
125365693|NCT00434954|450972455|FG000|Overall Study|Lost to Follow-up|0|||
125365694|NCT00434954|450972456|FG001|Overall Study|Lost to Follow-up|1|||
125365695|NCT00434954|450972455|FG000|Overall Study|Physician Decision|6|||
125365696|NCT00434954|450972456|FG001|Overall Study|Physician Decision|3|||
125365697|NCT00434954|450972455|FG000|Overall Study|Protocol Violation|36|||
125365698|NCT00434954|450972456|FG001|Overall Study|Protocol Violation|27|||
125365699|NCT00434954|450972455|FG000|Overall Study|Sponsor decision|1|||
125365700|NCT00434954|450972456|FG001|Overall Study|Sponsor decision|0|||
125365701|NCT00434954|450972455|FG000|Overall Study|Subject decision|8|||
125365702|NCT00434954|450972456|FG001|Overall Study|Subject decision|22|||
125365703|NCT00894166|450972457|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
125365704|NCT00894166|450972458|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
125365705|NCT00894166|450972459|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
125365706|NCT00894166|450972460|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
125365707|NCT00894166|450972461|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
125365708|NCT00894166|450972462|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
125365709|NCT00894166|450972463|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
125365710|NCT00894166|450972464|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
125365711|NCT00894166|450972457|FG000|Overall Study|Death|0|||
125365712|NCT00894166|450972458|FG001|Overall Study|Death|0|||
125365713|NCT00894166|450972459|FG002|Overall Study|Death|0|||
125365714|NCT00894166|450972460|FG003|Overall Study|Death|1|||
125365715|NCT00894166|450972461|FG004|Overall Study|Death|0|||
125365716|NCT00894166|450972462|FG005|Overall Study|Death|0|||
125365717|NCT00894166|450972463|FG006|Overall Study|Death|0|||
125365718|NCT00894166|450972464|FG007|Overall Study|Death|0|||
125365719|NCT03750955|450972472|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
125365720|NCT03750955|450972473|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
125365721|NCT03750955|450972472|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
125365722|NCT03750955|450972473|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
125365723|NCT01180985|450972474|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
125365724|NCT01180985|450972475|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
125365725|NCT00129272|450972480|FG000|Overall Study|Lost to Follow-up|12|||
125429987|NCT03764072|451200176|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
125365726|NCT00129272|450972481|FG001|Overall Study|Lost to Follow-up|11|||
125365727|NCT00129272|450972480|FG000|Overall Study|Withdrawal by Subject|5|||
125365728|NCT00129272|450972481|FG001|Overall Study|Withdrawal by Subject|11|||
125365729|NCT03345914|450972482|FG000|Overall Study|Transition to another study at week 16|80|||
125365730|NCT03345914|450972483|FG001|Overall Study|Transition to another study at week 16|86|||
125365731|NCT03345914|450972484|FG002|Overall Study|Transition to another study at week 16|78|||
125365732|NCT03345914|450972482|FG000|Overall Study|Transition to OLE during follow-up|37|||
125365733|NCT03345914|450972483|FG001|Overall Study|Transition to OLE during follow-up|33|||
125365734|NCT03345914|450972484|FG002|Overall Study|Transition to OLE during follow-up|39|||
125365735|NCT03345914|450972482|FG000|Overall Study|Physician Decision|0|||
125365736|NCT03345914|450972483|FG001|Overall Study|Physician Decision|1|||
125365737|NCT03345914|450972484|FG002|Overall Study|Physician Decision|1|||
125365738|NCT03345914|450972482|FG000|Overall Study|Withdrawal by Subject|5|||
125365739|NCT03345914|450972483|FG001|Overall Study|Withdrawal by Subject|1|||
125365740|NCT03345914|450972484|FG002|Overall Study|Withdrawal by Subject|2|||
125365741|NCT03345914|450972482|FG000|Overall Study|Other|1|||
125365742|NCT03345914|450972483|FG001|Overall Study|Other|1|||
125365743|NCT03345914|450972484|FG002|Overall Study|Other|1|||
125365744|NCT03345914|450972482|FG000|Overall Study|Ongoing|0|||
125365745|NCT03345914|450972483|FG001|Overall Study|Ongoing|0|||
125365746|NCT03345914|450972484|FG002|Overall Study|Ongoing|1|||
125365747|NCT03570697|450972487|FG000|Overall Study|Lost to Follow-up|0|||
125365748|NCT03570697|450972488|FG001|Overall Study|Lost to Follow-up|1|||
125429988|NCT03764072|451200177|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
125365749|NCT03570697|450972487|FG000|Overall Study|Death|2|||
125365750|NCT03570697|450972488|FG001|Overall Study|Death|0|||
125365751|NCT03570697|450972487|FG000|Overall Study|Withdrawal by Subject|4|||
125365752|NCT03570697|450972488|FG001|Overall Study|Withdrawal by Subject|2|||
125365753|NCT01849783|450972489|FG000|Overall Study|Adverse Event|5|||
125365754|NCT01849783|450972489|FG000|Overall Study|Death|2|||
125365755|NCT01849783|450972489|FG000|Overall Study|Physician Decision|1|||
125365756|NCT01849783|450972489|FG000|Overall Study|Withdrawal by Subject|1|||
125365757|NCT01849783|450972489|FG000|Overall Study|Unable to comply|2|||
125365758|NCT01849783|450972489|FG000|Overall Study|Disease progression|11|||
125365759|NCT01776840|450972490|FG000|Overall Study|Lost to Follow-up|12|||
125365760|NCT01776840|450972491|FG001|Overall Study|Lost to Follow-up|7|||
125365761|NCT01776840|450972490|FG000|Overall Study|Withdrawal by Subject|32|||
125365762|NCT01776840|450972491|FG001|Overall Study|Withdrawal by Subject|48|||
125365763|NCT01776840|450972490|FG000|Overall Study|Sponsor decision|89|||
125365764|NCT01776840|450972491|FG001|Overall Study|Sponsor decision|87|||
125365765|NCT03641339|450972493|FG000|Overall Study|Physician Decision|1|||
125365766|NCT03641339|450972494|FG001|Overall Study|Physician Decision|0|||
125365767|NCT03641339|450972495|FG002|Overall Study|Physician Decision|0|||
125365768|NCT03641339|450972496|FG003|Overall Study|Physician Decision|0|||
125365769|NCT03641339|450972497|FG004|Overall Study|Physician Decision|0|||
125365770|NCT03641339|450972498|FG005|Overall Study|Physician Decision|0|||
125365771|NCT03641339|450972493|FG000|Overall Study|Withdrawal by Subject|0|||
125365772|NCT03641339|450972494|FG001|Overall Study|Withdrawal by Subject|2|||
125365773|NCT03641339|450972495|FG002|Overall Study|Withdrawal by Subject|0|||
125365774|NCT03641339|450972496|FG003|Overall Study|Withdrawal by Subject|2|||
125365775|NCT03641339|450972497|FG004|Overall Study|Withdrawal by Subject|0|||
125365776|NCT03641339|450972498|FG005|Overall Study|Withdrawal by Subject|1|||
125365777|NCT03068455|450972499|FG000|Pre-treatment Period|Disease progression|0|||
125365778|NCT03068455|450972500|FG001|Pre-treatment Period|Disease progression|1|||
125365779|NCT03068455|450972499|FG000|Pre-treatment Period|Participant withdrew consent|1|||
125365780|NCT03068455|450972500|FG001|Pre-treatment Period|Participant withdrew consent|1|||
125365781|NCT03068455|450972499|FG000|Pre-treatment Period|Poor/non-compliance|0|||
125365782|NCT03068455|450972500|FG001|Pre-treatment Period|Poor/non-compliance|1|||
125365783|NCT03068455|450972499|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
125365784|NCT03068455|450972500|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
125365785|NCT03068455|450972499|FG000|Pre-treatment Period|Not reported|2|||
125365786|NCT03068455|450972500|FG001|Pre-treatment Period|Not reported|1|||
125365787|NCT03068455|450972499|FG000|Treatment Period|Disease progression|166|||
125365788|NCT03068455|450972500|FG001|Treatment Period|Disease progression|208|||
125365789|NCT03068455|450972499|FG000|Treatment Period|Study drug toxicity|317|||
125365790|NCT03068455|450972500|FG001|Treatment Period|Study drug toxicity|104|||
125365791|NCT03068455|450972499|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
125365792|NCT03068455|450972500|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
125365793|NCT03068455|450972499|FG000|Treatment Period|Participant request to stop therapy|33|||
125365794|NCT03068455|450972500|FG001|Treatment Period|Participant request to stop therapy|20|||
125365795|NCT03068455|450972499|FG000|Treatment Period|Participant withdrew consent|5|||
125365796|NCT03068455|450972500|FG001|Treatment Period|Participant withdrew consent|10|||
125365797|NCT03068455|450972499|FG000|Treatment Period|Poor/non-compliance|3|||
125365798|NCT03068455|450972500|FG001|Treatment Period|Poor/non-compliance|0|||
125365799|NCT03068455|450972499|FG000|Treatment Period|Participant no longer meets study criteria|1|||
125365800|NCT03068455|450972500|FG001|Treatment Period|Participant no longer meets study criteria|3|||
125365801|NCT03068455|450972499|FG000|Treatment Period|Other reasons|12|||
125365802|NCT03068455|450972500|FG001|Treatment Period|Other reasons|4|||
125365803|NCT01042678|450972502|FG000|Overall Study|Physician Decision|1|||
125365804|NCT01042678|450972503|FG001|Overall Study|Physician Decision|0|||
125365805|NCT01042678|450972504|FG002|Overall Study|Physician Decision|0|||
125365806|NCT01042678|450972505|FG003|Overall Study|Physician Decision|0|||
125365807|NCT01042678|450972506|FG004|Overall Study|Physician Decision|0|||
125365808|NCT01042678|450972507|FG005|Overall Study|Physician Decision|0|||
125365809|NCT01058655|450972512|FG000|Overall Study|Withdrawal by Subject|1|||
125365810|NCT01058655|450972513|FG001|Overall Study|Withdrawal by Subject|0|||
125365811|NCT01058655|450972514|FG002|Overall Study|Withdrawal by Subject|3|||
125365812|NCT01058655|450972515|FG003|Overall Study|Withdrawal by Subject|4|||
125365813|NCT01058655|450972512|FG000|Overall Study|Prolonged Treatment Delay|0|||
125365814|NCT01058655|450972513|FG001|Overall Study|Prolonged Treatment Delay|0|||
125365815|NCT01058655|450972514|FG002|Overall Study|Prolonged Treatment Delay|0|||
125365816|NCT01058655|450972515|FG003|Overall Study|Prolonged Treatment Delay|2|||
125365817|NCT01058655|450972512|FG000|Overall Study|Symptomatic Deterioration|0|||
125365818|NCT01058655|450972513|FG001|Overall Study|Symptomatic Deterioration|0|||
125365819|NCT01058655|450972514|FG002|Overall Study|Symptomatic Deterioration|0|||
125365820|NCT01058655|450972515|FG003|Overall Study|Symptomatic Deterioration|1|||
125365821|NCT01058655|450972512|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
125365822|NCT01058655|450972513|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
125365823|NCT01058655|450972514|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
125365824|NCT01058655|450972515|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
125429989|NCT03764072|451200178|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
125365825|NCT01058655|450972512|FG000|Overall Study|Death|0|||
125365826|NCT01058655|450972513|FG001|Overall Study|Death|1|||
125365827|NCT01058655|450972514|FG002|Overall Study|Death|1|||
125365828|NCT01058655|450972515|FG003|Overall Study|Death|0|||
125365829|NCT01058655|450972512|FG000|Overall Study|Disease Progression|1|||
125365830|NCT01058655|450972513|FG001|Overall Study|Disease Progression|2|||
125365831|NCT01058655|450972514|FG002|Overall Study|Disease Progression|4|||
125365832|NCT01058655|450972515|FG003|Overall Study|Disease Progression|24|||
125365833|NCT01058655|450972512|FG000|Overall Study|Other|0|||
125365834|NCT01058655|450972513|FG001|Overall Study|Other|0|||
125365835|NCT01058655|450972514|FG002|Overall Study|Other|0|||
125365836|NCT01058655|450972515|FG003|Overall Study|Other|4|||
125365837|NCT01416272|450972518|FG000|Overall Study|Unacceptable distance visual acuity|2|||
125365838|NCT01416272|450972518|FG000|Overall Study|Lost to Follow-up|1|||
125365839|NCT01416272|450972518|FG000|Overall Study|Study related complaints|1|||
125365840|NCT04545060|450972519|FG000|Overall Study|Adverse Event|0|||
125365841|NCT04545060|450972520|FG001|Overall Study|Adverse Event|1|||
125365842|NCT04545060|450972519|FG000|Overall Study|Death|0|||
125365843|NCT04545060|450972520|FG001|Overall Study|Death|5|||
125365844|NCT04545060|450972519|FG000|Overall Study|Lost to Follow-up|10|||
125365845|NCT04545060|450972520|FG001|Overall Study|Lost to Follow-up|13|||
125365846|NCT04545060|450972519|FG000|Overall Study|Physician Decision|3|||
125365847|NCT04545060|450972520|FG001|Overall Study|Physician Decision|0|||
125365848|NCT04545060|450972519|FG000|Overall Study|Withdrawal by Subject|17|||
125365849|NCT04545060|450972520|FG001|Overall Study|Withdrawal by Subject|22|||
125365850|NCT00619177|450972523|FG000|Overall Study|Adverse Event|18|||
125365851|NCT00619177|450972523|FG000|Overall Study|Lost to Follow-up|2|||
125365852|NCT00619177|450972523|FG000|Overall Study|Lack of Efficacy|1|||
125365853|NCT00619177|450972523|FG000|Overall Study|Missing termination information|481|||
125365854|NCT00619177|450972523|FG000|Overall Study|Not specified reasons|6|||
125365855|NCT02319837|450972524|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
125365856|NCT02319837|450972525|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
125365857|NCT02319837|450972526|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
125365858|NCT02319837|450972524|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
125365859|NCT02319837|450972525|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
125365860|NCT02319837|450972526|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
125365861|NCT02319837|450972524|FG000|Study Treatment Phase|Adverse Event|73|||
125365862|NCT02319837|450972525|FG001|Study Treatment Phase|Adverse Event|36|||
125365863|NCT02319837|450972526|FG002|Study Treatment Phase|Adverse Event|63|||
125365864|NCT02319837|450972524|FG000|Study Treatment Phase|Development of castration resistance|0|||
125365865|NCT02319837|450972525|FG001|Study Treatment Phase|Development of castration resistance|2|||
125365866|NCT02319837|450972526|FG002|Study Treatment Phase|Development of castration resistance|0|||
125365867|NCT02319837|450972524|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
125365868|NCT02319837|450972525|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
125365869|NCT02319837|450972526|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
125365870|NCT02319837|450972524|FG000|Study Treatment Phase|Protocol Violation|2|||
125365871|NCT02319837|450972525|FG001|Study Treatment Phase|Protocol Violation|2|||
125365872|NCT02319837|450972526|FG002|Study Treatment Phase|Protocol Violation|1|||
125365873|NCT02319837|450972524|FG000|Study Treatment Phase|Lost to Follow-up|0|||
125365874|NCT02319837|450972525|FG001|Study Treatment Phase|Lost to Follow-up|1|||
125365875|NCT02319837|450972526|FG002|Study Treatment Phase|Lost to Follow-up|0|||
125365876|NCT02319837|450972524|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
125595897|NCT05635838|451806308|FG000|16-Week DBVC Period|Protocol Violation|1|||
125212398|NCT00002525|450403348|FG000|Overall Study|Adverse Event|36|||
125212399|NCT00002525|450403349|FG001|Overall Study|Adverse Event|0|||
125365877|NCT02319837|450972525|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
125365878|NCT02319837|450972526|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
125365879|NCT02319837|450972524|FG000|Study Treatment Phase|Other|0|||
125365880|NCT02319837|450972525|FG001|Study Treatment Phase|Other|1|||
125365881|NCT02319837|450972526|FG002|Study Treatment Phase|Other|0|||
125365882|NCT02319837|450972524|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
125365883|NCT02319837|450972525|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
125365884|NCT02319837|450972526|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
125365885|NCT02319837|450972524|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
125365886|NCT02319837|450972525|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
125365887|NCT02319837|450972526|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
125365888|NCT02319837|450972524|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
125378930|NCT00531050|451019211|FG003|Part 1: Period 1|Protocol Deviation|1|||
125212400|NCT00002525|450403348|FG000|Overall Study|Death|5|||
125365889|NCT02319837|450972525|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
125365890|NCT02319837|450972526|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
125365891|NCT02319837|450972524|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
125365892|NCT02319837|450972525|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
125365893|NCT02319837|450972526|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
125365894|NCT02319837|450972524|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
125365895|NCT02319837|450972525|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
125365896|NCT02319837|450972526|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
125365897|NCT02319837|450972524|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
125365898|NCT02319837|450972525|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
125365899|NCT02319837|450972526|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
125365900|NCT02319837|450972524|FG000|Long-Term Follow-Up Phase|Death|33|||
125365901|NCT02319837|450972525|FG001|Long-Term Follow-Up Phase|Death|54|||
125365902|NCT02319837|450972526|FG002|Long-Term Follow-Up Phase|Death|42|||
125365903|NCT01313312|450972527|FG000|Overall Study|Adverse Event|5|||
125365904|NCT01313312|450972527|FG000|Overall Study|Withdrawal by Subject|18|||
125365905|NCT01313312|450972527|FG000|Overall Study|Lack of Efficacy|3|||
125365906|NCT01313312|450972527|FG000|Overall Study|Investigator Decision|1|||
125365907|NCT01313312|450972527|FG000|Overall Study|Observational Phase|1|||
125365908|NCT01313312|450972527|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
125365909|NCT01313312|450972527|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
125365910|NCT00892047|450972528|FG000|Overall Study|Adverse Event|2|||
125365911|NCT00892047|450972529|FG001|Overall Study|Adverse Event|2|||
125365912|NCT00892047|450972528|FG000|Overall Study|subject burden|2|||
125365913|NCT00892047|450972529|FG001|Overall Study|subject burden|3|||
125365914|NCT00892047|450972528|FG000|Overall Study|Lack of Efficacy|0|||
125365915|NCT00892047|450972529|FG001|Overall Study|Lack of Efficacy|2|||
125365916|NCT05306977|450972530|FG000|Overall Study|Withdrawal by Subject|1|||
125365917|NCT01387789|450972536|FG000|Overall Study|Adverse Event|5|||
125365918|NCT01387789|450972536|FG000|Overall Study|Lack of Efficacy|2|||
125365919|NCT01387789|450972536|FG000|Overall Study|Lost to Follow-up|1|||
125365920|NCT00181155|450972537|FG000|Overall Study|Physician Decision|1|||
125365921|NCT00181155|450972538|FG001|Overall Study|Physician Decision|0|||
125365922|NCT00181155|450972537|FG000|Overall Study|Withdrawal by Subject|1|||
125365923|NCT00181155|450972538|FG001|Overall Study|Withdrawal by Subject|0|||
125365924|NCT01788228|450972539|FG000|Overall Study|Migrated/moved from study area|1|||
125365925|NCT01788228|450972540|FG001|Overall Study|Migrated/moved from study area|0|||
125365926|NCT01548287|450972543|FG000|Screening|No reason provided|0|||
125365927|NCT01548287|450972544|FG001|Screening|No reason provided|0|||
125365928|NCT01548287|450972545|FG002|Screening|No reason provided|0|||
125365929|NCT01548287|450972546|FG003|Screening|No reason provided|0|||
125365930|NCT01548287|450972547|FG004|Screening|No reason provided|9|||
125365931|NCT01548287|450972543|FG000|Screening|Did not meet eligibility criteria|0|||
125365932|NCT01548287|450972544|FG001|Screening|Did not meet eligibility criteria|0|||
125365933|NCT01548287|450972545|FG002|Screening|Did not meet eligibility criteria|0|||
125365934|NCT01548287|450972546|FG003|Screening|Did not meet eligibility criteria|0|||
125365935|NCT01548287|450972547|FG004|Screening|Did not meet eligibility criteria|74|||
125365936|NCT01548287|450972543|FG000|Randomized Period|Did not meet inclusion criteria|0|||
125365937|NCT01548287|450972544|FG001|Randomized Period|Did not meet inclusion criteria|0|||
125365938|NCT01548287|450972545|FG002|Randomized Period|Did not meet inclusion criteria|2|||
125595898|NCT05635838|451806309|FG001|16-Week DBVC Period|Protocol Violation|0|||
125365939|NCT01548287|450972546|FG003|Randomized Period|Did not meet inclusion criteria|0|||
125365940|NCT01548287|450972547|FG004|Randomized Period|Did not meet inclusion criteria|0|||
125365941|NCT01548287|450972543|FG000|Randomized Period|Adverse Event|0|||
125365942|NCT01548287|450972544|FG001|Randomized Period|Adverse Event|2|||
125365943|NCT01548287|450972545|FG002|Randomized Period|Adverse Event|5|||
125365944|NCT01548287|450972546|FG003|Randomized Period|Adverse Event|0|||
125365945|NCT01548287|450972547|FG004|Randomized Period|Adverse Event|0|||
125365946|NCT00289783|450972554|FG000|Primary Phase|Adverse Event|10|||
125365947|NCT00289783|450972555|FG001|Primary Phase|Adverse Event|1|||
125365948|NCT00289783|450972554|FG000|Primary Phase|Protocol Violation|27|||
125365949|NCT00289783|450972555|FG001|Primary Phase|Protocol Violation|6|||
125365950|NCT00289783|450972554|FG000|Primary Phase|Withdrawal by Subject|93|||
125365951|NCT00289783|450972555|FG001|Primary Phase|Withdrawal by Subject|40|||
125365952|NCT00289783|450972554|FG000|Primary Phase|Lost to Follow-up|60|||
125365953|NCT00289783|450972555|FG001|Primary Phase|Lost to Follow-up|14|||
125365954|NCT00289783|450972554|FG000|Primary Phase|Migration from the study area|26|||
125365955|NCT00289783|450972555|FG001|Primary Phase|Migration from the study area|10|||
125365956|NCT00289783|450972554|FG000|Primary Phase|Other|32|||
125365957|NCT00289783|450972555|FG001|Primary Phase|Other|12|||
125365958|NCT00289783|450972554|FG000|Fourth Dose Phase|Adverse Event|1|||
125365959|NCT00289783|450972555|FG001|Fourth Dose Phase|Adverse Event|0|||
125365960|NCT00289783|450972554|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
125365961|NCT00289783|450972555|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
125365962|NCT00289783|450972554|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
125365963|NCT00289783|450972555|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
125365964|NCT00289783|450972554|FG000|Fourth Dose Phase|Migration from the study area|1|||
125365965|NCT00289783|450972555|FG001|Fourth Dose Phase|Migration from the study area|1|||
125365966|NCT00289783|450972554|FG000|Fourth Dose Phase|Other|22|||
125365967|NCT00289783|450972555|FG001|Fourth Dose Phase|Other|10|||
125365968|NCT00566995|450972558|FG000|Overall Study|Toxicity|4|||
125365969|NCT00566995|450972558|FG000|Overall Study|Withdrew consent|3|||
125365970|NCT03128047|450972559|FG000|Overall Study|Withdrawal by Subject|1|||
125365971|NCT00283400|450973947|FG000|Overall Study|Withdrawal by Subject|1|||
125365972|NCT00283400|450973948|FG001|Overall Study|Withdrawal by Subject|1|||
125365973|NCT00283400|450973949|FG002|Overall Study|Withdrawal by Subject|0|||
125365974|NCT00283400|450973950|FG003|Overall Study|Withdrawal by Subject|0|||
125365975|NCT00283400|450973947|FG000|Overall Study|Death|1|||
125365976|NCT00283400|450973948|FG001|Overall Study|Death|0|||
125365977|NCT00283400|450973949|FG002|Overall Study|Death|1|||
125365978|NCT00283400|450973950|FG003|Overall Study|Death|0|||
125365979|NCT01034631|450973952|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
125365980|NCT01034631|450973953|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
125365981|NCT01034631|450973954|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
125365982|NCT01034631|450973952|FG000|Phase II|Not Evaluable per protocol|0|||
125365983|NCT01034631|450973953|FG001|Phase II|Not Evaluable per protocol|0|||
125365984|NCT01034631|450973954|FG002|Phase II|Not Evaluable per protocol|2|||
125365985|NCT01034631|450973952|FG000|Phase II|Determined Ineligible per protocol|0|||
125365986|NCT01034631|450973953|FG001|Phase II|Determined Ineligible per protocol|1|||
125365987|NCT01034631|450973954|FG002|Phase II|Determined Ineligible per protocol|0|||
125365988|NCT01560403|450973955|FG000|Overall Study|Lost to Follow-up|0|||
125365989|NCT01560403|450973956|FG001|Overall Study|Lost to Follow-up|1|||
125365990|NCT01890473|450973957|FG000|Overall Study|Lost to Follow-up|1|||
125365991|NCT01890473|450973958|FG001|Overall Study|Lost to Follow-up|0|||
125365992|NCT01890473|450973957|FG000|Overall Study|Poor/non-compliance|1|||
125365993|NCT01890473|450973958|FG001|Overall Study|Poor/non-compliance|0|||
125365994|NCT00983437|450973959|FG000|Overall Study|Adverse Event|9|||
125365995|NCT00983437|450973959|FG000|Overall Study|Lack of Efficacy|1|||
125365996|NCT00983437|450973959|FG000|Overall Study|Withdrawal by Subject|8|||
125365997|NCT00983437|450973959|FG000|Overall Study|Noncompliance to Study Procedures|1|||
125365998|NCT00983437|450973959|FG000|Overall Study|Lost to Follow-up|2|||
125365999|NCT00983437|450973959|FG000|Overall Study|Other Reason|26|||
125366000|NCT04019288|450973960|FG000|Overall Study|Death|1|||
125366001|NCT04019288|450973961|FG001|Overall Study|Death|0|||
125366002|NCT04019288|450973962|FG002|Overall Study|Death|0|||
125366003|NCT00934089|450973963|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
125366004|NCT00934089|450973964|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
125366005|NCT00934089|450973963|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
125366006|NCT00934089|450973964|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
125366007|NCT00541931|450973970|FG000|Overall Study|Adverse Event|1|||
125366008|NCT00541931|450973971|FG001|Overall Study|Adverse Event|0|||
125212401|NCT00002525|450403349|FG001|Overall Study|Death|0|||
125212402|NCT00002525|450403348|FG000|Overall Study|Withdrawal by Subject|11|||
125212403|NCT00002525|450403349|FG001|Overall Study|Withdrawal by Subject|0|||
125212404|NCT00002525|450403348|FG000|Overall Study|Start non-protocol therapy|1|||
125212405|NCT00002525|450403349|FG001|Overall Study|Start non-protocol therapy|0|||
125212406|NCT00002525|450403348|FG000|Overall Study|Other complicating disease|1|||
125212407|NCT00002525|450403349|FG001|Overall Study|Other complicating disease|0|||
125212408|NCT00002525|450403348|FG000|Overall Study|Duke's A, B1, D disease|92|||
125212409|NCT00002525|450403349|FG001|Overall Study|Duke's A, B1, D disease|0|||
125212410|NCT00002525|450403348|FG000|Overall Study|Error|6|||
125212411|NCT00002525|450403349|FG001|Overall Study|Error|0|||
125212412|NCT00002525|450403348|FG000|Overall Study|Other|26|||
125212413|NCT00002525|450403349|FG001|Overall Study|Other|0|||
125212414|NCT00002525|450403348|FG000|Overall Study|Never start protocol therapy|8|||
125212415|NCT00002525|450403349|FG001|Overall Study|Never start protocol therapy|0|||
125212416|NCT03304184|450403350|FG000|Overall Study|Withdrawal by Subject|1|||
125212417|NCT03304184|450403351|FG001|Overall Study|Withdrawal by Subject|2|||
125212418|NCT03230838|450403352|FG000|Overall Study|Withdrawal by Subject|3|||
125212419|NCT03230838|450403353|FG001|Overall Study|Withdrawal by Subject|0|||
125212420|NCT03230838|450403352|FG000|Overall Study|Temperature excursion|1|||
125212421|NCT03230838|450403353|FG001|Overall Study|Temperature excursion|0|||
125212422|NCT01915771|450403356|FG000|Day 1|Withdrawal by Subject|1|||
125212423|NCT01915771|450403356|FG000|Day 15|Withdrawal by Subject|1|||
125212424|NCT03420222|450403362|FG000|Overall Study|Withdrawal by Subject|5|||
125212425|NCT03420222|450403363|FG001|Overall Study|Withdrawal by Subject|0|||
125212426|NCT03420222|450403362|FG000|Overall Study|Physician Decision|0|||
125212427|NCT03420222|450403363|FG001|Overall Study|Physician Decision|1|||
125212428|NCT02697734|450403364|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
125212429|NCT02697734|450403365|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
125212430|NCT02697734|450403364|FG000|Core Phase - up to Week 48|Adverse Event|1|||
125212431|NCT02697734|450403365|FG001|Core Phase - up to Week 48|Adverse Event|2|||
125212432|NCT02697734|450403364|FG000|Core Phase - up to Week 48|Physician Decision|1|||
125212433|NCT02697734|450403365|FG001|Core Phase - up to Week 48|Physician Decision|0|||
125212434|NCT02697734|450403364|FG000|Optional Extension Phase|Adverse Event|5|||
125212435|NCT02697734|450403365|FG001|Optional Extension Phase|Adverse Event|1|||
125212436|NCT02697734|450403364|FG000|Optional Extension Phase|Physician Decision|0|||
125212437|NCT02697734|450403365|FG001|Optional Extension Phase|Physician Decision|1|||
125212438|NCT02334384|450403367|FG000|Overall Study|Lost to Follow-up|1|||
125212439|NCT02334384|450403368|FG001|Overall Study|Lost to Follow-up|1|||
125212440|NCT02651688|450403369|FG000|Overall Study|Non-compliance|0|||
125212441|NCT02651688|450403370|FG001|Overall Study|Non-compliance|0|||
125212442|NCT02651688|450403371|FG002|Overall Study|Non-compliance|1|||
125212443|NCT02651688|450403369|FG000|Overall Study|Principal Investigator (PI) decision|0|||
125212444|NCT02651688|450403370|FG001|Overall Study|Principal Investigator (PI) decision|2|||
125212445|NCT02651688|450403371|FG002|Overall Study|Principal Investigator (PI) decision|0|||
125212446|NCT02651688|450403369|FG000|Overall Study|Lost to Follow-up|1|||
125212447|NCT02651688|450403370|FG001|Overall Study|Lost to Follow-up|3|||
125212448|NCT02651688|450403371|FG002|Overall Study|Lost to Follow-up|0|||
125212449|NCT02651688|450403369|FG000|Overall Study|Withdrawal by Subject|1|||
125212450|NCT02651688|450403370|FG001|Overall Study|Withdrawal by Subject|0|||
125212451|NCT02651688|450403371|FG002|Overall Study|Withdrawal by Subject|2|||
125212452|NCT04527978|450403372|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
125212453|NCT04527978|450403373|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
125212454|NCT01429441|450403374|FG000|Overall Study|Adverse Event|5|||
125212455|NCT01429441|450403375|FG001|Overall Study|Adverse Event|1|||
125429990|NCT03764072|451200173|FG000|Overall Study|Lost to Follow-up|0|||
125429991|NCT03764072|451200174|FG001|Overall Study|Lost to Follow-up|0|||
125212456|NCT01429441|450403374|FG000|Overall Study|Death|0|||
125212457|NCT01429441|450403375|FG001|Overall Study|Death|2|||
125212458|NCT01429441|450403374|FG000|Overall Study|Lost to Follow-up|5|||
125212459|NCT01429441|450403375|FG001|Overall Study|Lost to Follow-up|2|||
125212460|NCT01429441|450403374|FG000|Overall Study|Physician Decision|1|||
125212461|NCT01429441|450403375|FG001|Overall Study|Physician Decision|0|||
125212462|NCT01429441|450403374|FG000|Overall Study|Withdrawal by Subject|27|||
125212463|NCT01429441|450403375|FG001|Overall Study|Withdrawal by Subject|18|||
125212464|NCT01578499|450403381|FG000|Overall Study|Reason not Specified|0|||
125212465|NCT01578499|450403382|FG001|Overall Study|Reason not Specified|1|||
125212466|NCT01578499|450403381|FG000|Overall Study|Lost to Follow-up|2|||
125212467|NCT01578499|450403382|FG001|Overall Study|Lost to Follow-up|1|||
125212468|NCT01578499|450403381|FG000|Overall Study|Withdrawal by Subject|10|||
125212469|NCT01578499|450403382|FG001|Overall Study|Withdrawal by Subject|16|||
125212470|NCT01578499|450403381|FG000|Overall Study|Death|20|||
125212471|NCT01578499|450403382|FG001|Overall Study|Death|25|||
125212472|NCT01578499|450403381|FG000|Overall Study|Died and End of Study Page not Completed|2|||
125212473|NCT01578499|450403382|FG001|Overall Study|Died and End of Study Page not Completed|0|||
125212474|NCT00830518|450403383|FG000|Overall Study|Progressive Disease|18|||
125212475|NCT00830518|450403384|FG001|Overall Study|Progressive Disease|8|||
125366009|NCT00541931|450973970|FG000|Overall Study|Lost to Follow-up|3|||
125366010|NCT00541931|450973971|FG001|Overall Study|Lost to Follow-up|3|||
125366011|NCT00541931|450973970|FG000|Overall Study|Withdrawal by Subject|1|||
125366012|NCT00541931|450973971|FG001|Overall Study|Withdrawal by Subject|0|||
125366013|NCT00541931|450973970|FG000|Overall Study|Transportation Issue|0|||
125366014|NCT00541931|450973971|FG001|Overall Study|Transportation Issue|1|||
125366015|NCT00040365|450973972|FG000|Overall Study|Death|1|||
125366016|NCT00040365|450973972|FG000|Overall Study|Progressive disease|7|||
125366017|NCT00040365|450973972|FG000|Overall Study|Lost to Follow-up|3|||
125366018|NCT00680017|450973973|FG000|Overall Study|Adverse Event|13|||
125366019|NCT00680017|450973974|FG001|Overall Study|Adverse Event|7|||
125366020|NCT00680017|450973973|FG000|Overall Study|Withdrawal by Subject|2|||
125366021|NCT00680017|450973974|FG001|Overall Study|Withdrawal by Subject|5|||
125366022|NCT00680017|450973973|FG000|Overall Study|Lost to Follow-up|2|||
125366023|NCT00680017|450973974|FG001|Overall Study|Lost to Follow-up|0|||
125366024|NCT00612040|450973975|FG000|Overall Study|Adverse Event|0|||
125366025|NCT00612040|450973976|FG001|Overall Study|Adverse Event|2|||
125366026|NCT00612040|450973977|FG002|Overall Study|Adverse Event|1|||
125366027|NCT00612040|450973975|FG000|Overall Study|Protocol Violation|1|||
125366028|NCT00612040|450973976|FG001|Overall Study|Protocol Violation|2|||
125366029|NCT00612040|450973977|FG002|Overall Study|Protocol Violation|1|||
125366030|NCT00612040|450973975|FG000|Overall Study|Lack of Efficacy|2|||
125366031|NCT00612040|450973976|FG001|Overall Study|Lack of Efficacy|1|||
125366032|NCT00612040|450973977|FG002|Overall Study|Lack of Efficacy|0|||
125366033|NCT00612040|450973975|FG000|Overall Study|Unclassified|2|||
125366034|NCT00612040|450973976|FG001|Overall Study|Unclassified|2|||
125366035|NCT00612040|450973977|FG002|Overall Study|Unclassified|5|||
125366036|NCT01086033|450973979|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
125366037|NCT01086033|450973979|FG000|Overall Study|Lost to Follow-up|86|||
125366038|NCT01086033|450973979|FG000|Overall Study|Adverse Event|42|||
125366039|NCT01086033|450973979|FG000|Overall Study|Withdrawal by Subject|41|||
125366040|NCT01086033|450973979|FG000|Overall Study|Other|14|||
125366041|NCT01086033|450973979|FG000|Overall Study|Other|13|||
125366042|NCT01086033|450973979|FG000|Overall Study|AE and Withdrew Consent|5|||
125366043|NCT01086033|450973979|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
125366044|NCT01086033|450973979|FG000|Overall Study|Withdrew consent and Other Reason|4|||
125366045|NCT01086033|450973979|FG000|Overall Study|AE and Lack of Efficacy|4|||
125366046|NCT01086033|450973979|FG000|Overall Study|Death|1|||
125366047|NCT01086033|450973979|FG000|Overall Study|AE and Lost to Follow-up|1|||
125366048|NCT01086033|450973979|FG000|Overall Study|AE and Other Reason|1|||
125366049|NCT01086033|450973979|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
125366050|NCT04572633|450973980|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
125366051|NCT03478657|450973987|FG000|Overall Study|Withdrawal by Subject|0|||
125366052|NCT03478657|450973988|FG001|Overall Study|Withdrawal by Subject|1|||
125366053|NCT02590003|450973989|FG000|Overall Study|Death|1|||
125366054|NCT02590003|450973990|FG001|Overall Study|Death|2|||
125366055|NCT03948581|450973991|FG000|Overall Study|Lost to Follow-up|0|||
125366056|NCT03948581|450973992|FG001|Overall Study|Lost to Follow-up|1|||
125366057|NCT01876420|450973993|FG000|Overall Study|Missed 30 day visit|1|||
125366058|NCT04515394|450973994|FG000|Overall Study|Participant did not receive treatment|1|||
125366059|NCT04472429|450973996|FG000|Randomized Period|Ongoing|90|||
125429992|NCT03764072|451200175|FG002|Overall Study|Lost to Follow-up|0|||
125212476|NCT00830518|450403383|FG000|Overall Study|Symptomatic Deterioration|4|||
125366060|NCT04472429|450973997|FG001|Randomized Period|Ongoing|40|||
125366061|NCT04472429|450973998|FG002|Randomized Period|Ongoing|0|||
125366062|NCT04472429|450973996|FG000|Randomized Period|Death|52|||
125366063|NCT04472429|450973997|FG001|Randomized Period|Death|37|||
125366064|NCT04472429|450973998|FG002|Randomized Period|Death|0|||
125366065|NCT04472429|450973996|FG000|Randomized Period|Lost to Follow-up|4|||
125366066|NCT04472429|450973997|FG001|Randomized Period|Lost to Follow-up|0|||
125366067|NCT04472429|450973998|FG002|Randomized Period|Lost to Follow-up|0|||
125366068|NCT04472429|450973996|FG000|Randomized Period|Physician Decision|1|||
125366069|NCT04472429|450973997|FG001|Randomized Period|Physician Decision|2|||
125366070|NCT04472429|450973998|FG002|Randomized Period|Physician Decision|0|||
125366071|NCT04472429|450973996|FG000|Randomized Period|Withdrawal by Subject|6|||
125366072|NCT04472429|450973997|FG001|Randomized Period|Withdrawal by Subject|5|||
125366073|NCT04472429|450973998|FG002|Randomized Period|Withdrawal by Subject|0|||
125366074|NCT04472429|450973996|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
125366075|NCT04472429|450973997|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
125366076|NCT04472429|450973998|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
125366077|NCT04472429|450973996|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
125366078|NCT04472429|450973997|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
125366079|NCT04472429|450973998|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
125366080|NCT04472429|450973996|FG000|Open-label Monotherapy Period|Ongoing|0|||
125366081|NCT04472429|450973997|FG001|Open-label Monotherapy Period|Ongoing|0|||
125366082|NCT04472429|450973998|FG002|Open-label Monotherapy Period|Ongoing|32|||
125366083|NCT04472429|450973996|FG000|Open-label Monotherapy Period|Death|0|||
125366084|NCT04472429|450973997|FG001|Open-label Monotherapy Period|Death|0|||
125366085|NCT04472429|450973998|FG002|Open-label Monotherapy Period|Death|35|||
125366086|NCT04472429|450973996|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
125366087|NCT04472429|450973997|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
125366088|NCT04472429|450973998|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
125366089|NCT01719783|450974001|FG000|Dose 2|Physician Decision|1|||
125366090|NCT01719783|450974002|FG001|Dose 2|Physician Decision|0|||
125366091|NCT01612858|450974004|FG000|Overall Study|Withdrawal by Subject|5|||
125366092|NCT01612858|450974005|FG001|Overall Study|Withdrawal by Subject|1|||
125366093|NCT03988088|450974006|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
125366094|NCT03988088|450974007|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
125366095|NCT03988088|450974008|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
125366096|NCT03988088|450974009|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
125366097|NCT03988088|450974006|FG000|Open-Label Addendum|Lost to Follow-up|0|||
125366098|NCT03988088|450974007|FG001|Open-Label Addendum|Lost to Follow-up|0|||
125366099|NCT03988088|450974008|FG002|Open-Label Addendum|Lost to Follow-up|1|||
125366100|NCT03988088|450974009|FG003|Open-Label Addendum|Lost to Follow-up|0|||
125366101|NCT02993757|450974013|FG000|Overall Study|Non compliance with the protocol|155|||
125366102|NCT02993757|450974014|FG001|Overall Study|Non compliance with the protocol|170|||
125366103|NCT02993757|450974013|FG000|Overall Study|Lost to Follow-up|1|||
125366104|NCT02993757|450974014|FG001|Overall Study|Lost to Follow-up|0|||
125366105|NCT02993757|450974013|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
125366106|NCT02993757|450974014|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
125366107|NCT00259610|450974017|FG000|Overall Study|Withdrawal by Subject|33|||
125366108|NCT00259610|450974018|FG001|Overall Study|Withdrawal by Subject|25|||
125366109|NCT00259610|450974019|FG002|Overall Study|Withdrawal by Subject|29|||
125366110|NCT00259610|450974020|FG003|Overall Study|Withdrawal by Subject|19|||
125366111|NCT00259610|450974017|FG000|Overall Study|Lost to Follow-up|19|||
125366112|NCT00259610|450974018|FG001|Overall Study|Lost to Follow-up|8|||
125366113|NCT00259610|450974019|FG002|Overall Study|Lost to Follow-up|18|||
125366114|NCT00259610|450974020|FG003|Overall Study|Lost to Follow-up|15|||
125366115|NCT00259610|450974017|FG000|Overall Study|Physician Decision|6|||
125366116|NCT00259610|450974018|FG001|Overall Study|Physician Decision|4|||
125366117|NCT00259610|450974019|FG002|Overall Study|Physician Decision|7|||
125366118|NCT00259610|450974020|FG003|Overall Study|Physician Decision|2|||
125366119|NCT00259610|450974017|FG000|Overall Study|Death|1|||
125366120|NCT00259610|450974018|FG001|Overall Study|Death|1|||
125366121|NCT00259610|450974019|FG002|Overall Study|Death|2|||
125366122|NCT00259610|450974020|FG003|Overall Study|Death|0|||
125366123|NCT00259610|450974017|FG000|Overall Study|non medical reason|6|||
125366124|NCT00259610|450974018|FG001|Overall Study|non medical reason|2|||
125366125|NCT00259610|450974019|FG002|Overall Study|non medical reason|10|||
125366126|NCT00259610|450974020|FG003|Overall Study|non medical reason|3|||
125366127|NCT00259610|450974017|FG000|Overall Study|Adverse Event|3|||
125366128|NCT00259610|450974018|FG001|Overall Study|Adverse Event|4|||
125366129|NCT00259610|450974019|FG002|Overall Study|Adverse Event|5|||
125366130|NCT00259610|450974020|FG003|Overall Study|Adverse Event|2|||
125366131|NCT00259610|450974017|FG000|Overall Study|Serious Adverse Event|8|||
125366132|NCT00259610|450974018|FG001|Overall Study|Serious Adverse Event|2|||
125366133|NCT00259610|450974019|FG002|Overall Study|Serious Adverse Event|2|||
125366134|NCT00259610|450974020|FG003|Overall Study|Serious Adverse Event|2|||
125366135|NCT00957580|450974023|FG000|Overall Study|Ongoing at data cut-off|0|||
125366136|NCT00957580|450974024|FG001|Overall Study|Ongoing at data cut-off|1|||
125366137|NCT00957580|450974025|FG002|Overall Study|Ongoing at data cut-off|0|||
125366138|NCT00957580|450974023|FG000|Overall Study|Enrolled but not treated|0|||
125366139|NCT00957580|450974024|FG001|Overall Study|Enrolled but not treated|1|||
125366140|NCT00957580|450974025|FG002|Overall Study|Enrolled but not treated|0|||
125366141|NCT01090492|450974026|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
125366142|NCT01090492|450974027|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
125366143|NCT01090492|450974028|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
125366144|NCT01090492|450974029|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
125366145|NCT01090492|450974030|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
125429993|NCT03764072|451200176|FG003|Overall Study|Lost to Follow-up|0|||
125366146|NCT01090492|450974031|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
125366147|NCT01090492|450974032|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
125366148|NCT01090492|450974033|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
125366149|NCT01090492|450974026|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
125366150|NCT01090492|450974027|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
125366151|NCT01090492|450974028|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
125366152|NCT01090492|450974029|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
125366153|NCT01090492|450974030|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
125366154|NCT01090492|450974031|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
125366155|NCT01090492|450974032|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
125366156|NCT01090492|450974033|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
125366157|NCT01090492|450974026|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366158|NCT01090492|450974027|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366159|NCT01090492|450974028|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
125366160|NCT01090492|450974029|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366161|NCT01090492|450974030|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366162|NCT01090492|450974031|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366163|NCT01090492|450974032|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366164|NCT01090492|450974033|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366165|NCT01090492|450974026|FG000|First Intervention Period (4 Weeks)|Other|0|||
125366166|NCT01090492|450974027|FG001|First Intervention Period (4 Weeks)|Other|0|||
125366167|NCT01090492|450974028|FG002|First Intervention Period (4 Weeks)|Other|1|||
125366168|NCT01090492|450974029|FG003|First Intervention Period (4 Weeks)|Other|1|||
125366169|NCT01090492|450974030|FG004|First Intervention Period (4 Weeks)|Other|2|||
125366170|NCT01090492|450974031|FG005|First Intervention Period (4 Weeks)|Other|0|||
125366171|NCT01090492|450974032|FG006|First Intervention Period (4 Weeks)|Other|0|||
125366172|NCT01090492|450974033|FG007|First Intervention Period (4 Weeks)|Other|0|||
125366173|NCT01090492|450974026|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
125366174|NCT01090492|450974027|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
125366175|NCT01090492|450974028|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
125366176|NCT01090492|450974029|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
125366177|NCT01090492|450974030|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
125366178|NCT01090492|450974031|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
125366179|NCT01090492|450974032|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
125366180|NCT01090492|450974033|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
125366181|NCT01090492|450974026|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
125366182|NCT01090492|450974027|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
125366183|NCT01090492|450974028|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
125366184|NCT01090492|450974029|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
125366185|NCT01090492|450974030|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
125366186|NCT01090492|450974031|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
125366187|NCT01090492|450974032|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
125366188|NCT01090492|450974033|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
125366189|NCT01090492|450974026|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
125366190|NCT01090492|450974027|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
125366191|NCT01090492|450974028|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
125366192|NCT01090492|450974029|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
125366193|NCT01090492|450974030|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
125366194|NCT01090492|450974031|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
125366195|NCT01090492|450974032|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
125366196|NCT01090492|450974033|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
125366197|NCT01090492|450974026|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125366198|NCT01090492|450974027|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
125366199|NCT01090492|450974028|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125366200|NCT01090492|450974029|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125366201|NCT01090492|450974030|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125366202|NCT01090492|450974031|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125366203|NCT01090492|450974032|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125366204|NCT01090492|450974033|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
125366205|NCT01090492|450974026|FG000|Second Intervention Period (4 Weeks)|Other|0|||
125366206|NCT01090492|450974027|FG001|Second Intervention Period (4 Weeks)|Other|1|||
125366207|NCT01090492|450974028|FG002|Second Intervention Period (4 Weeks)|Other|1|||
125366208|NCT01090492|450974029|FG003|Second Intervention Period (4 Weeks)|Other|0|||
125429994|NCT03764072|451200177|FG004|Overall Study|Lost to Follow-up|1|||
125366209|NCT01090492|450974030|FG004|Second Intervention Period (4 Weeks)|Other|0|||
125366210|NCT01090492|450974031|FG005|Second Intervention Period (4 Weeks)|Other|0|||
125366211|NCT01090492|450974032|FG006|Second Intervention Period (4 Weeks)|Other|0|||
125366212|NCT01090492|450974033|FG007|Second Intervention Period (4 Weeks)|Other|0|||
125366213|NCT01090492|450974026|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
125366214|NCT01090492|450974027|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
125366215|NCT01090492|450974028|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
125366216|NCT01090492|450974029|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
125366217|NCT01090492|450974030|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
125366218|NCT01090492|450974031|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
125366219|NCT01090492|450974032|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
125366220|NCT01090492|450974033|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
125366221|NCT01090492|450974026|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366222|NCT01090492|450974027|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366223|NCT01090492|450974028|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366224|NCT01090492|450974029|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366225|NCT01090492|450974030|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366226|NCT01090492|450974031|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366227|NCT01090492|450974032|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
125366228|NCT01090492|450974033|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
125366229|NCT03113071|450974034|FG000|Overall Study|Withdrawal by Subject|1|||
125366230|NCT03113071|450974035|FG001|Overall Study|Withdrawal by Subject|0|||
125366231|NCT01602120|450974036|FG000|Overall Study|Adverse Event|3|||
125366232|NCT01602120|450974037|FG001|Overall Study|Adverse Event|6|||
125366233|NCT01602120|450974038|FG002|Overall Study|Adverse Event|0|||
125366234|NCT01602120|450974039|FG003|Overall Study|Adverse Event|2|||
125366235|NCT01602120|450974036|FG000|Overall Study|Death|0|||
125366236|NCT01602120|450974037|FG001|Overall Study|Death|4|||
125366237|NCT01602120|450974038|FG002|Overall Study|Death|0|||
125366238|NCT01602120|450974039|FG003|Overall Study|Death|0|||
125366239|NCT01602120|450974036|FG000|Overall Study|Lost to Follow-up|0|||
125366240|NCT01602120|450974037|FG001|Overall Study|Lost to Follow-up|1|||
125366241|NCT01602120|450974038|FG002|Overall Study|Lost to Follow-up|0|||
125366242|NCT01602120|450974039|FG003|Overall Study|Lost to Follow-up|1|||
125366243|NCT01602120|450974036|FG000|Overall Study|Protocol Violation|1|||
125366244|NCT01602120|450974037|FG001|Overall Study|Protocol Violation|1|||
125366245|NCT01602120|450974038|FG002|Overall Study|Protocol Violation|0|||
125366246|NCT01602120|450974039|FG003|Overall Study|Protocol Violation|0|||
125366247|NCT01602120|450974036|FG000|Overall Study|Non-compliance|0|||
125366248|NCT01602120|450974037|FG001|Overall Study|Non-compliance|3|||
125366249|NCT01602120|450974038|FG002|Overall Study|Non-compliance|0|||
125366250|NCT01602120|450974039|FG003|Overall Study|Non-compliance|1|||
125366251|NCT01602120|450974036|FG000|Overall Study|Withdrawal by Subject|8|||
125366252|NCT01602120|450974037|FG001|Overall Study|Withdrawal by Subject|17|||
125366253|NCT01602120|450974038|FG002|Overall Study|Withdrawal by Subject|0|||
125366254|NCT01602120|450974039|FG003|Overall Study|Withdrawal by Subject|3|||
125366255|NCT01602120|450974036|FG000|Overall Study|Study Terminated by Sponsor|12|||
125366256|NCT01602120|450974037|FG001|Overall Study|Study Terminated by Sponsor|24|||
125366257|NCT01602120|450974038|FG002|Overall Study|Study Terminated by Sponsor|17|||
125366258|NCT01602120|450974039|FG003|Overall Study|Study Terminated by Sponsor|44|||
125366259|NCT01602120|450974036|FG000|Overall Study|Physician Decision|2|||
125366260|NCT01602120|450974037|FG001|Overall Study|Physician Decision|3|||
125366261|NCT01602120|450974038|FG002|Overall Study|Physician Decision|0|||
125366262|NCT01602120|450974039|FG003|Overall Study|Physician Decision|0|||
125366263|NCT01602120|450974036|FG000|Overall Study|Unspecified Reason|3|||
125366264|NCT01602120|450974037|FG001|Overall Study|Unspecified Reason|1|||
125366265|NCT01602120|450974038|FG002|Overall Study|Unspecified Reason|0|||
125366266|NCT01602120|450974039|FG003|Overall Study|Unspecified Reason|2|||
125366267|NCT01611155|450974040|FG000|Overall Study|Adverse Event|1|||
125366268|NCT01611155|450974041|FG001|Overall Study|Adverse Event|1|||
125366269|NCT01611155|450974040|FG000|Overall Study|Refused further treatment|6|||
125366270|NCT01611155|450974041|FG001|Overall Study|Refused further treatment|4|||
125366271|NCT01611155|450974040|FG000|Overall Study|Disease progression|1|||
125366272|NCT01611155|450974041|FG001|Overall Study|Disease progression|0|||
125366273|NCT01611155|450974040|FG000|Overall Study|Withdrawal by Subject|1|||
125366274|NCT01611155|450974041|FG001|Overall Study|Withdrawal by Subject|0|||
125366275|NCT01611155|450974040|FG000|Overall Study|Alternative treatment|0|||
125366276|NCT01611155|450974041|FG001|Overall Study|Alternative treatment|1|||
125366277|NCT01611155|450974040|FG000|Overall Study|Ineligible patient|0|||
125366278|NCT01611155|450974041|FG001|Overall Study|Ineligible patient|1|||
125366279|NCT00868608|450974048|FG000|Overall Study|Withdrawal by Subject|3|||
125366280|NCT00868608|450974049|FG001|Overall Study|Withdrawal by Subject|1|||
125366281|NCT00868608|450974050|FG002|Overall Study|Withdrawal by Subject|0|||
125366282|NCT00868608|450974048|FG000|Overall Study|Lost to Follow-up|3|||
125429995|NCT03764072|451200178|FG005|Overall Study|Lost to Follow-up|0|||
125429996|NCT00558064|451200181|FG000|Overall Study|Adverse Event|3|||
125366283|NCT00868608|450974049|FG001|Overall Study|Lost to Follow-up|0|||
125366284|NCT00868608|450974050|FG002|Overall Study|Lost to Follow-up|1|||
125366285|NCT00868608|450974048|FG000|Overall Study|Death|16|||
125366286|NCT00868608|450974049|FG001|Overall Study|Death|2|||
125366287|NCT00868608|450974050|FG002|Overall Study|Death|4|||
125366288|NCT00868608|450974048|FG000|Overall Study|Other - Unspecified|1|||
125366289|NCT00868608|450974049|FG001|Overall Study|Other - Unspecified|0|||
125366290|NCT00868608|450974050|FG002|Overall Study|Other - Unspecified|0|||
125366291|NCT03344796|450974051|FG000|Overall Study|Lost to Follow-up|0|||
125366292|NCT03344796|450974052|FG001|Overall Study|Lost to Follow-up|0|||
125366293|NCT03344796|450974053|FG002|Overall Study|Lost to Follow-up|0|||
125366294|NCT03344796|450974054|FG003|Overall Study|Lost to Follow-up|0|||
125366295|NCT03344796|450974055|FG004|Overall Study|Lost to Follow-up|0|||
125366296|NCT03344796|450974056|FG005|Overall Study|Lost to Follow-up|2|||
125366297|NCT01999179|450974057|FG000|Overall Study|Adverse Event|1|||
125366298|NCT01999179|450974057|FG000|Overall Study|Lost to Follow-up|1|||
125366299|NCT01999179|450974057|FG000|Overall Study|Change in Therapy|3|||
125366300|NCT01999179|450974057|FG000|Overall Study|New catheter|2|||
125366301|NCT02564796|450974058|FG000|Overall Study|Physician Decision|2|||
125366302|NCT02564796|450974059|FG001|Overall Study|Physician Decision|2|||
125366303|NCT00594659|450974067|FG000|Overall Study|Lost to Follow-up|13|||
125366304|NCT00594659|450974068|FG001|Overall Study|Lost to Follow-up|9|||
125366305|NCT00594659|450974069|FG002|Overall Study|Lost to Follow-up|7|||
125366306|NCT00660699|450974070|FG000|Overall Study|Withdrawal by Subject|2|||
125366307|NCT05358444|450974081|FG000|Overall Study|Withdrawal by Subject|0|||
125366308|NCT05358444|450974082|FG001|Overall Study|Withdrawal by Subject|1|||
125366309|NCT05358444|450974081|FG000|Overall Study|Lost to Follow-up|0|||
125366310|NCT05358444|450974082|FG001|Overall Study|Lost to Follow-up|3|||
125366311|NCT02900976|450974085|FG000|Overall Study|Adverse Event|0|||
125366312|NCT02900976|450974086|FG001|Overall Study|Adverse Event|1|||
125366313|NCT02900976|450974085|FG000|Overall Study|Physician Decision|0|||
125366314|NCT02900976|450974086|FG001|Overall Study|Physician Decision|2|||
125366315|NCT02900976|450974085|FG000|Overall Study|Progressive disease|0|||
125366316|NCT02900976|450974086|FG001|Overall Study|Progressive disease|6|||
125366317|NCT04997304|450974087|FG000|Overall Study|Lost to Follow-up|11|||
125366318|NCT04997304|450974087|FG000|Overall Study|Death|1|||
125366319|NCT04997304|450974087|FG000|Overall Study|Withdrawal by Subject|14|||
125366320|NCT01752985|450974088|FG000|Treatment Period|Subject request to discontinue treatment|1|||
125366321|NCT01752985|450974089|FG001|Treatment Period|Subject request to discontinue treatment|0|||
125366322|NCT01752985|450974090|FG002|Treatment Period|Subject request to discontinue treatment|1|||
125366323|NCT01752985|450974088|FG000|Treatment Period|Subject no longer meets study criteria|0|||
125366324|NCT01752985|450974089|FG001|Treatment Period|Subject no longer meets study criteria|1|||
125366325|NCT01752985|450974090|FG002|Treatment Period|Subject no longer meets study criteria|1|||
125366326|NCT01752985|450974088|FG000|Treatment Period|Adverse Event|2|||
125366327|NCT01752985|450974089|FG001|Treatment Period|Adverse Event|1|||
125366328|NCT01752985|450974090|FG002|Treatment Period|Adverse Event|2|||
125366329|NCT01752985|450974088|FG000|Treatment Period|Withdrawal by Subject|1|||
125366330|NCT01752985|450974089|FG001|Treatment Period|Withdrawal by Subject|1|||
125366331|NCT01752985|450974090|FG002|Treatment Period|Withdrawal by Subject|0|||
125366332|NCT01752985|450974088|FG000|Treatment Period|Lost to Follow-up|0|||
125366333|NCT01752985|450974089|FG001|Treatment Period|Lost to Follow-up|0|||
125366334|NCT01752985|450974090|FG002|Treatment Period|Lost to Follow-up|1|||
125366335|NCT06934993|450974091|FG000|Overall Study|Withdrawal by Subject|29|||
125366336|NCT06934993|450974091|FG000|Overall Study|elevated postoperative creatinine level|11|||
125366337|NCT06934993|450974091|FG000|Overall Study|Death|3|||
125366338|NCT04092582|450975505|FG000|Overall Study|Death|1|||
125212477|NCT00830518|450403384|FG001|Overall Study|Symptomatic Deterioration|1|||
125212478|NCT00830518|450403383|FG000|Overall Study|Adverse Event|14|||
125212479|NCT00830518|450403384|FG001|Overall Study|Adverse Event|1|||
125212480|NCT00830518|450403383|FG000|Overall Study|Withdrawal by Patient|2|||
125212481|NCT00830518|450403384|FG001|Overall Study|Withdrawal by Patient|0|||
125212482|NCT00830518|450403383|FG000|Overall Study|Reason not Specified|8|||
125212483|NCT00830518|450403384|FG001|Overall Study|Reason not Specified|1|||
125212484|NCT02669667|450403388|FG000|Overall Study|Lost to Follow-up|0|||
125212485|NCT02669667|450403389|FG001|Overall Study|Lost to Follow-up|0|||
125212486|NCT02669667|450403390|FG002|Overall Study|Lost to Follow-up|0|||
125366339|NCT04092582|450975506|FG001|Overall Study|Death|1|||
125366340|NCT04092582|450975505|FG000|Overall Study|Withdrawal by Subject|4|||
125366341|NCT04092582|450975506|FG001|Overall Study|Withdrawal by Subject|1|||
125366342|NCT04092582|450975505|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
125366343|NCT04092582|450975506|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
125366344|NCT02025621|450975516|FG000|Overall Study|Withdrawal by Subject|1|||
125366345|NCT02025621|450975517|FG001|Overall Study|Withdrawal by Subject|0|||
125366346|NCT02025621|450975516|FG000|Overall Study|Death|0|||
125366347|NCT02025621|450975517|FG001|Overall Study|Death|1|||
125366348|NCT02025621|450975516|FG000|Overall Study|No longer eligible|10|||
125366349|NCT02025621|450975517|FG001|Overall Study|No longer eligible|15|||
125366350|NCT02025621|450975516|FG000|Overall Study|Surgery initiated before infusion|3|||
125366351|NCT02025621|450975517|FG001|Overall Study|Surgery initiated before infusion|3|||
125366352|NCT00739674|450975518|FG000|Overall Study|Screening failures|19|||
125366353|NCT00739674|450975519|FG001|Overall Study|Screening failures|17|||
125366354|NCT00739674|450975518|FG000|Overall Study|Site 212 removal|19|||
125366355|NCT00739674|450975519|FG001|Overall Study|Site 212 removal|13|||
125366356|NCT00739674|450975518|FG000|Overall Study|No follow-up data|33|||
125366357|NCT00739674|450975519|FG001|Overall Study|No follow-up data|18|||
125366358|NCT00739674|450975518|FG000|Overall Study|Dietician consultation >30 days|1|||
125366359|NCT00739674|450975519|FG001|Overall Study|Dietician consultation >30 days|9|||
125366360|NCT00739674|450975518|FG000|Overall Study|Adverse Event|22|||
125366361|NCT00739674|450975519|FG001|Overall Study|Adverse Event|13|||
125366362|NCT00739674|450975518|FG000|Overall Study|Death|1|||
125366363|NCT00739674|450975519|FG001|Overall Study|Death|0|||
125366364|NCT00739674|450975518|FG000|Overall Study|Lack of Efficacy|1|||
125366365|NCT00739674|450975519|FG001|Overall Study|Lack of Efficacy|0|||
125366366|NCT00739674|450975518|FG000|Overall Study|Lost to Follow-up|52|||
125366367|NCT00739674|450975519|FG001|Overall Study|Lost to Follow-up|30|||
125366368|NCT00739674|450975518|FG000|Overall Study|Protocol Violation|5|||
125366369|NCT00739674|450975519|FG001|Overall Study|Protocol Violation|5|||
125366370|NCT00739674|450975518|FG000|Overall Study|Withdrawal by Subject|9|||
125366371|NCT00739674|450975519|FG001|Overall Study|Withdrawal by Subject|9|||
125366372|NCT00739674|450975518|FG000|Overall Study|Reason missing|2|||
125366373|NCT00739674|450975519|FG001|Overall Study|Reason missing|0|||
125366374|NCT00739674|450975518|FG000|Overall Study|Clinic closed|6|||
125366375|NCT00739674|450975519|FG001|Overall Study|Clinic closed|4|||
125366376|NCT00739674|450975518|FG000|Overall Study|Patient moved|3|||
125366377|NCT00739674|450975519|FG001|Overall Study|Patient moved|2|||
125366378|NCT00739674|450975518|FG000|Overall Study|Non compliant|4|||
125366379|NCT00739674|450975519|FG001|Overall Study|Non compliant|0|||
125366380|NCT00739674|450975518|FG000|Overall Study|Unable to attend visit|3|||
125366381|NCT00739674|450975519|FG001|Overall Study|Unable to attend visit|1|||
125366382|NCT00739674|450975518|FG000|Overall Study|Home monitoring off meds|1|||
125366383|NCT00739674|450975519|FG001|Overall Study|Home monitoring off meds|0|||
125366384|NCT00739674|450975518|FG000|Overall Study|Erectile dysfunction|0|||
125366385|NCT00739674|450975519|FG001|Overall Study|Erectile dysfunction|1|||
125366386|NCT01594281|450975520|FG000|Interventional Core Phase|Protocol Deviation|1|||
125366387|NCT01594281|450975521|FG001|Interventional Core Phase|Protocol Deviation|0|||
125212487|NCT02669667|450403391|FG003|Overall Study|Lost to Follow-up|0|||
125212488|NCT02669667|450403392|FG004|Overall Study|Lost to Follow-up|0|||
125366388|NCT01594281|450975522|FG002|Interventional Core Phase|Protocol Deviation|0|||
125366389|NCT01594281|450975520|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
125429997|NCT00558064|451200182|FG001|Overall Study|Adverse Event|2|||
125366390|NCT01594281|450975521|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
125366391|NCT01594281|450975522|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
125366392|NCT01594281|450975520|FG000|Interventional Core Phase|Death|1|||
125366393|NCT01594281|450975521|FG001|Interventional Core Phase|Death|1|||
125366394|NCT01594281|450975522|FG002|Interventional Core Phase|Death|2|||
125366395|NCT01594281|450975520|FG000|Interventional Core Phase|Lost to Follow-up|1|||
125366396|NCT01594281|450975521|FG001|Interventional Core Phase|Lost to Follow-up|4|||
125366397|NCT01594281|450975522|FG002|Interventional Core Phase|Lost to Follow-up|1|||
125366398|NCT01594281|450975520|FG000|Interventional Core Phase|Adverse Event|4|||
125366399|NCT01594281|450975521|FG001|Interventional Core Phase|Adverse Event|4|||
125366400|NCT01594281|450975522|FG002|Interventional Core Phase|Adverse Event|4|||
125366401|NCT01594281|450975520|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
125366402|NCT01594281|450975521|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
125366403|NCT01594281|450975522|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
125366404|NCT01594281|450975520|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
125366405|NCT01594281|450975521|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
125366406|NCT01594281|450975522|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
125366407|NCT01594281|450975520|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
125366408|NCT01594281|450975521|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
125366409|NCT01594281|450975522|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
125366410|NCT04805541|450975524|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
125366411|NCT01871532|450975528|FG000|Overall Study|Withdrawal by Subject|1|||
125366412|NCT01871532|450975529|FG001|Overall Study|Withdrawal by Subject|2|||
125366413|NCT01543958|450975531|FG000|Overall Study|Loss to follow-up|3|||
125366414|NCT01543958|450975531|FG000|Overall Study|ART initiation|1|||
125366415|NCT01945281|450975532|FG000|Overall Study|Adverse Event|1|||
125366416|NCT01945281|450975533|FG001|Overall Study|Adverse Event|0|||
125366417|NCT01945281|450975532|FG000|Overall Study|Death|3|||
125366418|NCT01945281|450975533|FG001|Overall Study|Death|3|||
125366419|NCT01945281|450975532|FG000|Overall Study|Physician Decision|1|||
125366420|NCT01945281|450975533|FG001|Overall Study|Physician Decision|1|||
125366421|NCT01945281|450975532|FG000|Overall Study|Technical Problems|1|||
125366422|NCT01945281|450975533|FG001|Overall Study|Technical Problems|0|||
125366423|NCT04401423|450975535|FG000|Overall Study|Withdrawal by Subject|3|||
125366424|NCT04401423|450975536|FG001|Overall Study|Withdrawal by Subject|1|||
125366425|NCT04401423|450975535|FG000|Overall Study|Physician Decision|2|||
125366426|NCT04401423|450975536|FG001|Overall Study|Physician Decision|1|||
125366427|NCT01020981|450975539|FG000|Overall Study|Did not return mailed survey|74|||
125366428|NCT01020981|450975540|FG001|Overall Study|Did not return mailed survey|58|||
125366429|NCT01020981|450975539|FG000|Overall Study|Survey returned undeliverable|8|||
125366430|NCT01020981|450975540|FG001|Overall Study|Survey returned undeliverable|32|||
125366431|NCT01020981|450975539|FG000|Overall Study|Participant declined to complete survey|2|||
125366432|NCT01020981|450975540|FG001|Overall Study|Participant declined to complete survey|0|||
125366433|NCT00799383|450975545|FG000|Overall Study|Protocol Violation|1|||
125366434|NCT00799383|450975546|FG001|Overall Study|Protocol Violation|1|||
125366435|NCT00799383|450975545|FG000|Overall Study|Adverse Event|0|||
125366436|NCT00799383|450975546|FG001|Overall Study|Adverse Event|1|||
125366437|NCT00799383|450975545|FG000|Overall Study|Lost to Follow-up|1|||
125366438|NCT00799383|450975546|FG001|Overall Study|Lost to Follow-up|2|||
125366439|NCT00799383|450975545|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
125366440|NCT00799383|450975546|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
125366441|NCT00799383|450975545|FG000|Overall Study|Withdrawal by Subject|0|||
125366442|NCT00799383|450975546|FG001|Overall Study|Withdrawal by Subject|1|||
125366443|NCT00726986|450975547|FG000|Induction Phase|Adverse Event|4|||
125366444|NCT00726986|450975547|FG000|Induction Phase|Withdrawal by Subject|2|||
125366445|NCT00726986|450975547|FG000|Induction Phase|Death|2|||
125366446|NCT00726986|450975547|FG000|Induction Phase|Lack of Efficacy|5|||
125366447|NCT00726986|450975547|FG000|Induction Phase|Secondary Disease|2|||
125366448|NCT00726986|450975547|FG000|Maintenance Phase|Adverse Event|1|||
125366449|NCT00726986|450975547|FG000|Maintenance Phase|Lack of Efficacy|2|||
125366450|NCT00064337|450975554|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
125366451|NCT00064337|450975554|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
125366452|NCT00064337|450975554|FG000|PBSCC or Induction/PBSCC|Progression|3|||
125366453|NCT00064337|450975554|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
125366454|NCT00064337|450975554|FG000|PBSCC or Induction/PBSCC|Death|2|||
125366455|NCT00064337|450975554|FG000|Transplant|Adverse Event|9|||
125366456|NCT00064337|450975554|FG000|Transplant|Not protocol-specified|5|||
125366457|NCT00064337|450975554|FG000|Transplant|Death|3|||
125366458|NCT00064337|450975554|FG000|Transplant|Patient Refusal|2|||
125212489|NCT02669667|450403393|FG005|Overall Study|Lost to Follow-up|1|||
125212490|NCT02669667|450403394|FG006|Overall Study|Lost to Follow-up|0|||
125212491|NCT02839876|450403399|FG000|Overall Study|Protocol Violation|10|||
125212492|NCT02839876|450403400|FG001|Overall Study|Protocol Violation|11|||
125212493|NCT01156051|450403404|FG000|Overall Study|Lost to Follow-up|1|||
125212494|NCT01156051|450403405|FG001|Overall Study|Lost to Follow-up|0|||
125212495|NCT01156051|450403404|FG000|Overall Study|patient not compliant with protocol|0|||
125212496|NCT01156051|450403405|FG001|Overall Study|patient not compliant with protocol|1|||
125212497|NCT01926197|450403408|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
125212498|NCT01926197|450403409|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
125212499|NCT01926197|450403408|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
125212500|NCT01926197|450403409|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
125212501|NCT01483599|450403411|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
125212502|NCT01483599|450403412|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212503|NCT01483599|450403413|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212504|NCT01483599|450403414|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
125212505|NCT01483599|450403415|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
125212506|NCT01483599|450403416|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
125212507|NCT01483599|450403417|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
125212508|NCT01483599|450403418|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212509|NCT01483599|450403419|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212510|NCT01483599|450403420|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212511|NCT01483599|450403421|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212512|NCT01483599|450403422|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212513|NCT01483599|450403423|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212514|NCT01483599|450403424|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
125212515|NCT01483599|450403411|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212516|NCT01483599|450403412|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
125212517|NCT01483599|450403413|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212518|NCT01483599|450403414|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
125212519|NCT01483599|450403415|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212520|NCT01483599|450403416|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212521|NCT01483599|450403417|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
125212522|NCT01483599|450403418|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212523|NCT01483599|450403419|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212524|NCT01483599|450403420|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212525|NCT01483599|450403421|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212526|NCT01483599|450403422|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125366459|NCT00064337|450975554|FG000|Transplant|Progression|2|||
125366460|NCT00064337|450975554|FG000|Maintenance|Adverse Event|3|||
125366461|NCT00064337|450975554|FG000|Maintenance|Progression|2|||
125366462|NCT00064337|450975554|FG000|Maintenance|On treatment at time of analysis|2|||
125366463|NCT00064337|450975554|FG000|Maintenance|Not protocol-specified|2|||
125366464|NCT00064337|450975554|FG000|Maintenance|Death|1|||
125212527|NCT01483599|450403423|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125212528|NCT01483599|450403424|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
125366465|NCT02279420|450975555|FG000|Overall Study|Lost to Follow-up|23|||
125366466|NCT05096221|450975558|FG000|Part 2|Physician Decision|0|||
125366467|NCT05096221|450975559|FG001|Part 2|Physician Decision|1|||
125366468|NCT01896102|450975560|FG000|Overall Study|Death|1|||
125366469|NCT01896102|450975560|FG000|Overall Study|Participant to receive allogenic transplant|2|||
125366470|NCT03330288|450975574|FG000|Overall Study|Other reason|1|||
125366471|NCT03330288|450975575|FG001|Overall Study|Other reason|1|||
125366472|NCT03330288|450975574|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
125366473|NCT03330288|450975575|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
125366474|NCT03330288|450975574|FG000|Overall Study|Adverse Event|1|||
125366475|NCT03330288|450975575|FG001|Overall Study|Adverse Event|0|||
125366476|NCT03330288|450975574|FG000|Overall Study|Withdrawal by Subject|1|||
125366477|NCT03330288|450975575|FG001|Overall Study|Withdrawal by Subject|0|||
125366478|NCT03330288|450975574|FG000|Overall Study|Lost to Follow-up|26|||
125366479|NCT03330288|450975575|FG001|Overall Study|Lost to Follow-up|7|||
125366480|NCT01254331|450975581|FG000|Initial Phase|Adverse Event|3|||
125366481|NCT01254331|450975581|FG000|Initial Phase|Withdrawal by Subject|1|||
125366482|NCT01254331|450975581|FG000|Initial Phase|Pregnancy|1|||
125366483|NCT01254331|450975581|FG000|Extension Phase|Lack of Efficacy|1|||
125366484|NCT01254331|450975581|FG000|Extension Phase|Lost to Follow-up|3|||
125366485|NCT01443078|450975582|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
125366486|NCT01443078|450975582|FG000|Overall Study|Withdrawal by Subject|1|||
125366487|NCT01443078|450975582|FG000|Overall Study|Patient had brain mets|1|||
125366488|NCT02762578|450975591|FG000|Overall Study|Adverse Event|1|||
125366489|NCT02762578|450975592|FG001|Overall Study|Adverse Event|6|||
125366490|NCT02762578|450975591|FG000|Overall Study|Protocol Violation|4|||
125366491|NCT02762578|450975592|FG001|Overall Study|Protocol Violation|2|||
125366492|NCT02762578|450975591|FG000|Overall Study|Withdrawal by Subject|4|||
125366493|NCT02762578|450975592|FG001|Overall Study|Withdrawal by Subject|2|||
125366494|NCT02762578|450975591|FG000|Overall Study|Unclassified|6|||
125366495|NCT02762578|450975592|FG001|Overall Study|Unclassified|0|||
125366496|NCT01768286|450975593|FG000|Overall Study|Randomized But Not Treated|0|||
125366497|NCT01768286|450975594|FG001|Overall Study|Randomized But Not Treated|0|||
125366498|NCT01768286|450975595|FG002|Overall Study|Randomized But Not Treated|1|||
125366499|NCT01768286|450975596|FG003|Overall Study|Randomized But Not Treated|0|||
125366500|NCT01768286|450975593|FG000|Overall Study|Lack of Efficacy|7|||
125366501|NCT01768286|450975594|FG001|Overall Study|Lack of Efficacy|4|||
125366502|NCT01768286|450975595|FG002|Overall Study|Lack of Efficacy|0|||
125366503|NCT01768286|450975596|FG003|Overall Study|Lack of Efficacy|1|||
125366504|NCT01768286|450975593|FG000|Overall Study|Withdrew Consent|0|||
125366505|NCT01768286|450975594|FG001|Overall Study|Withdrew Consent|0|||
125366506|NCT01768286|450975595|FG002|Overall Study|Withdrew Consent|1|||
125366507|NCT01768286|450975596|FG003|Overall Study|Withdrew Consent|0|||
125366508|NCT02699593|450975598|FG000|Period 1|Unsatisfactory Visual Response|0|||
125366509|NCT02699593|450975599|FG001|Period 1|Unsatisfactory Visual Response|1|||
125366510|NCT02699593|450975598|FG000|Period 1|Torn Contact Len|4|||
125366511|NCT02699593|450975599|FG001|Period 1|Torn Contact Len|3|||
125366512|NCT02699593|450975598|FG000|Period 1|Protocol Violation|0|||
125366513|NCT02699593|450975599|FG001|Period 1|Protocol Violation|1|||
125366514|NCT02699593|450975598|FG000|Period 1|Withdrawal by Subject|0|||
125366515|NCT02699593|450975599|FG001|Period 1|Withdrawal by Subject|1|||
125366516|NCT02699593|450975598|FG000|Period 1|Adverse Event|1|||
125366517|NCT02699593|450975599|FG001|Period 1|Adverse Event|1|||
125366518|NCT02699593|450975598|FG000|Period 2|Adverse Event|1|||
125366519|NCT02699593|450975599|FG001|Period 2|Adverse Event|1|||
125366520|NCT02699593|450975598|FG000|Period 2|Lost Contact Lens|0|||
125366521|NCT02699593|450975599|FG001|Period 2|Lost Contact Lens|1|||
125366522|NCT02699593|450975598|FG000|Period 2|Torn Contact Lens|1|||
125366523|NCT02699593|450975599|FG001|Period 2|Torn Contact Lens|0|||
125366524|NCT00911547|450975600|FG000|Overall Study|Adverse Event|8|||
125366525|NCT00911547|450975601|FG001|Overall Study|Adverse Event|27|||
125366526|NCT00911547|450975602|FG002|Overall Study|Adverse Event|11|||
125366527|NCT00911547|450975603|FG003|Overall Study|Adverse Event|6|||
125366528|NCT00911547|450975600|FG000|Overall Study|Lost to Follow-up|0|||
125366529|NCT00911547|450975601|FG001|Overall Study|Lost to Follow-up|0|||
125366530|NCT00911547|450975602|FG002|Overall Study|Lost to Follow-up|2|||
125366531|NCT00911547|450975603|FG003|Overall Study|Lost to Follow-up|1|||
125366532|NCT00911547|450975600|FG000|Overall Study|Protocol Violation|0|||
125366533|NCT00911547|450975601|FG001|Overall Study|Protocol Violation|5|||
125366534|NCT00911547|450975602|FG002|Overall Study|Protocol Violation|5|||
125366535|NCT00911547|450975603|FG003|Overall Study|Protocol Violation|1|||
125366536|NCT00911547|450975600|FG000|Overall Study|Withdrawal by Subject|3|||
125366537|NCT00911547|450975601|FG001|Overall Study|Withdrawal by Subject|10|||
125366538|NCT00911547|450975602|FG002|Overall Study|Withdrawal by Subject|4|||
125366539|NCT00911547|450975603|FG003|Overall Study|Withdrawal by Subject|8|||
125366540|NCT00915278|450975604|FG000|Overall Study|Death|1|||
125366541|NCT00915278|450975605|FG001|Overall Study|Death|0|||
125366542|NCT00915278|450975606|FG002|Overall Study|Death|0|||
125366543|NCT00915278|450975607|FG003|Overall Study|Death|0|||
125366544|NCT00915278|450975608|FG004|Overall Study|Death|0|||
125366545|NCT00915278|450975609|FG005|Overall Study|Death|0|||
125366546|NCT00915278|450975604|FG000|Overall Study|Lost to Follow-up|0|||
125366547|NCT00915278|450975605|FG001|Overall Study|Lost to Follow-up|1|||
125366548|NCT00915278|450975606|FG002|Overall Study|Lost to Follow-up|0|||
125366549|NCT00915278|450975607|FG003|Overall Study|Lost to Follow-up|0|||
125366550|NCT00915278|450975608|FG004|Overall Study|Lost to Follow-up|0|||
125366551|NCT00915278|450975609|FG005|Overall Study|Lost to Follow-up|0|||
125366552|NCT00915278|450975604|FG000|Overall Study|Withdrawal by Subject|0|||
125366553|NCT00915278|450975605|FG001|Overall Study|Withdrawal by Subject|1|||
125366554|NCT00915278|450975606|FG002|Overall Study|Withdrawal by Subject|0|||
125366555|NCT00915278|450975607|FG003|Overall Study|Withdrawal by Subject|0|||
125366556|NCT00915278|450975608|FG004|Overall Study|Withdrawal by Subject|1|||
125366557|NCT00915278|450975609|FG005|Overall Study|Withdrawal by Subject|4|||
125366558|NCT00915278|450975604|FG000|Overall Study|Adverse Event|4|||
125366559|NCT00915278|450975605|FG001|Overall Study|Adverse Event|1|||
125366560|NCT00915278|450975606|FG002|Overall Study|Adverse Event|0|||
125366561|NCT00915278|450975607|FG003|Overall Study|Adverse Event|0|||
125366562|NCT00915278|450975608|FG004|Overall Study|Adverse Event|0|||
125366563|NCT00915278|450975609|FG005|Overall Study|Adverse Event|0|||
125366564|NCT00915278|450975604|FG000|Overall Study|Progressive disease/clinical progression|0|||
125366565|NCT00915278|450975605|FG001|Overall Study|Progressive disease/clinical progression|0|||
125366566|NCT00915278|450975606|FG002|Overall Study|Progressive disease/clinical progression|0|||
125366567|NCT00915278|450975607|FG003|Overall Study|Progressive disease/clinical progression|3|||
125366568|NCT00915278|450975608|FG004|Overall Study|Progressive disease/clinical progression|1|||
125366569|NCT00915278|450975609|FG005|Overall Study|Progressive disease/clinical progression|2|||
125366570|NCT00915278|450975604|FG000|Overall Study|Infusion related AEs|0|||
125366571|NCT00915278|450975605|FG001|Overall Study|Infusion related AEs|0|||
125366572|NCT00915278|450975606|FG002|Overall Study|Infusion related AEs|0|||
125366573|NCT00915278|450975607|FG003|Overall Study|Infusion related AEs|0|||
125366574|NCT00915278|450975608|FG004|Overall Study|Infusion related AEs|0|||
125366575|NCT00915278|450975609|FG005|Overall Study|Infusion related AEs|2|||
125366576|NCT00915278|450975604|FG000|Overall Study|Admission to hospice|0|||
125366577|NCT00915278|450975605|FG001|Overall Study|Admission to hospice|0|||
125366578|NCT00915278|450975606|FG002|Overall Study|Admission to hospice|1|||
125366579|NCT00915278|450975607|FG003|Overall Study|Admission to hospice|0|||
125429998|NCT00558064|451200181|FG000|Overall Study|Lack of Efficacy|0|||
125429999|NCT00558064|451200182|FG001|Overall Study|Lack of Efficacy|1|||
125366580|NCT00915278|450975608|FG004|Overall Study|Admission to hospice|0|||
125366581|NCT00915278|450975609|FG005|Overall Study|Admission to hospice|0|||
125366582|NCT00453063|450975614|FG000|Overall Study|Adverse Event|1|||
125366583|NCT00453063|450975615|FG001|Overall Study|Adverse Event|2|||
125366584|NCT00453063|450975614|FG000|Overall Study|Withdrawal by Subject|1|||
125366585|NCT00453063|450975615|FG001|Overall Study|Withdrawal by Subject|1|||
125430000|NCT00558064|451200181|FG000|Overall Study|Protocol Violation|1|||
125366586|NCT00453063|450975614|FG000|Overall Study|Protocol Violation|1|||
125366587|NCT00453063|450975615|FG001|Overall Study|Protocol Violation|0|||
125366588|NCT00228384|450975616|FG000|Overall Study|Death|9|||
125366589|NCT00228384|450975617|FG001|Overall Study|Death|3|||
125366590|NCT00228384|450975616|FG000|Overall Study|Lost to Follow-up|6|||
125366591|NCT00228384|450975617|FG001|Overall Study|Lost to Follow-up|10|||
125366592|NCT00228384|450975616|FG000|Overall Study|Surgical Intervention (bypass)|5|||
125366593|NCT00228384|450975617|FG001|Overall Study|Surgical Intervention (bypass)|5|||
125366594|NCT00228384|450975616|FG000|Overall Study|Withdrawal by Subject|9|||
125430001|NCT00558064|451200182|FG001|Overall Study|Protocol Violation|0|||
125430002|NCT00558064|451200181|FG000|Overall Study|Lost to Follow-up|0|||
125430003|NCT00558064|451200182|FG001|Overall Study|Lost to Follow-up|1|||
125430004|NCT00558064|451200181|FG000|Overall Study|Withdrawal by Subject|0|||
125430005|NCT00558064|451200182|FG001|Overall Study|Withdrawal by Subject|1|||
125430006|NCT00558064|451200181|FG000|Overall Study|No visit within allowance period|1|||
125430007|NCT00558064|451200182|FG001|Overall Study|No visit within allowance period|0|||
125430008|NCT00982930|451200185|FG000|Overall Study|Adverse Event|1|||
125430009|NCT00982930|451200185|FG000|Overall Study|Withdrawal by Subject|1|||
125430010|NCT00982930|451200185|FG000|Overall Study|Administrative Problems|2|||
125430011|NCT01489189|451200186|FG000|Overall Study|Withdrawal by Subject|20|||
125430012|NCT01489189|451200187|FG001|Overall Study|Withdrawal by Subject|23|||
125430013|NCT01489189|451200186|FG000|Overall Study|Death|10|||
125430014|NCT01489189|451200187|FG001|Overall Study|Death|8|||
125430015|NCT01489189|451200186|FG000|Overall Study|Missed Visit|1|||
125430016|NCT01489189|451200187|FG001|Overall Study|Missed Visit|4|||
125430017|NCT03750006|451200190|FG000|Overall Study|Withdrawal by Subject|8|||
125430018|NCT03750006|451200190|FG000|Overall Study|COVID PANDEMIC|11|||
125430019|NCT04739761|451200192|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
125430020|NCT04739761|451200193|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
125430021|NCT04739761|451200192|FG000|Overall Study|By complete response from the participant|1|||
125430022|NCT04739761|451200193|FG001|Overall Study|By complete response from the participant|0|||
125430023|NCT04739761|451200192|FG000|Overall Study|Lost to Follow-up|3|||
125430024|NCT04739761|451200193|FG001|Overall Study|Lost to Follow-up|3|||
125430025|NCT04739761|451200192|FG000|Overall Study|Death|13|||
125430026|NCT04739761|451200193|FG001|Overall Study|Death|13|||
125430027|NCT04739761|451200192|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
125430028|NCT04739761|451200193|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
125430029|NCT04739761|451200192|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
125430030|NCT04739761|451200193|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
125430031|NCT04739761|451200192|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
125430032|NCT04739761|451200193|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
125430033|NCT04739761|451200192|FG000|Overall Study|Adverse Event|0|||
125430034|NCT04739761|451200193|FG001|Overall Study|Adverse Event|3|||
125430035|NCT04739761|451200192|FG000|Overall Study|Participant decision|1|||
125430036|NCT04739761|451200193|FG001|Overall Study|Participant decision|0|||
125430037|NCT04739761|451200192|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
125430038|NCT04739761|451200193|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
125430039|NCT04739761|451200192|FG000|Overall Study|Participant immediately started next line of treatment|1|||
125430040|NCT04739761|451200193|FG001|Overall Study|Participant immediately started next line of treatment|0|||
125430041|NCT04739761|451200192|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
125430042|NCT04739761|451200193|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
125430043|NCT04739761|451200192|FG000|Overall Study|Lack of clinical benefit|1|||
125430044|NCT04739761|451200193|FG001|Overall Study|Lack of clinical benefit|0|||
125430045|NCT04739761|451200192|FG000|Overall Study|Disease progression|5|||
125430046|NCT04739761|451200193|FG001|Overall Study|Disease progression|5|||
125430047|NCT04739761|451200192|FG000|Overall Study|Withdrawal by Subject|14|||
125430048|NCT04739761|451200193|FG001|Overall Study|Withdrawal by Subject|13|||
125430049|NCT04739761|451200192|FG000|Overall Study|Protocol Violation|1|||
125430050|NCT04739761|451200193|FG001|Overall Study|Protocol Violation|0|||
125430051|NCT04739761|451200192|FG000|Overall Study|Physician Decision|2|||
125430052|NCT04739761|451200193|FG001|Overall Study|Physician Decision|0|||
125430053|NCT03881696|451200197|FG000|Overall Study|Adverse Event|2|||
125430054|NCT03881696|451200198|FG001|Overall Study|Adverse Event|0|||
125430055|NCT03881696|451200197|FG000|Overall Study|Withdrawal by Subject|2|||
125430056|NCT03881696|451200198|FG001|Overall Study|Withdrawal by Subject|0|||
125430057|NCT03881696|451200197|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
125430058|NCT03881696|451200198|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
125430059|NCT03881696|451200197|FG000|Overall Study|Failure to meet continuation criteria|1|||
125430060|NCT03881696|451200198|FG001|Overall Study|Failure to meet continuation criteria|0|||
125430061|NCT01582789|451201457|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
125430062|NCT01582789|451201458|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
125430063|NCT01191840|451201466|FG000|Overall Study|withdrew consent|2|||
125430064|NCT01191840|451201467|FG001|Overall Study|withdrew consent|1|||
125430065|NCT01191840|451201466|FG000|Overall Study|Subject discontinued treatment|1|||
125430066|NCT01191840|451201467|FG001|Overall Study|Subject discontinued treatment|2|||
125430067|NCT01191840|451201466|FG000|Overall Study|Lost to Follow-up|4|||
125430068|NCT01191840|451201467|FG001|Overall Study|Lost to Follow-up|6|||
125430069|NCT01191840|451201466|FG000|Overall Study|Non Staph Infection|4|||
125212529|NCT01483599|450403411|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
125212530|NCT01483599|450403412|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212531|NCT01483599|450403413|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212532|NCT01483599|450403414|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212533|NCT01483599|450403415|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212534|NCT01483599|450403416|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212535|NCT01483599|450403417|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212536|NCT01483599|450403418|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125366595|NCT00228384|450975617|FG001|Overall Study|Withdrawal by Subject|10|||
125366596|NCT00228384|450975616|FG000|Overall Study|Physician Decision|0|||
125366597|NCT00228384|450975617|FG001|Overall Study|Physician Decision|1|||
125366598|NCT01785069|450975623|FG000|Overall Study|Implanted with nonstudy device|1|||
125366599|NCT01785069|450975624|FG001|Overall Study|Implanted with nonstudy device|2|||
125366600|NCT01785069|450975625|FG002|Overall Study|Implanted with nonstudy device|1|||
125366601|NCT01785069|450975626|FG003|Overall Study|Implanted with nonstudy device|0|||
125366602|NCT01785069|450975623|FG000|Overall Study|Death|0|||
125366603|NCT01785069|450975624|FG001|Overall Study|Death|0|||
125366604|NCT01785069|450975625|FG002|Overall Study|Death|2|||
125366605|NCT01785069|450975626|FG003|Overall Study|Death|0|||
125366606|NCT01785069|450975623|FG000|Overall Study|Subject choice|2|||
125366607|NCT01785069|450975624|FG001|Overall Study|Subject choice|2|||
125366608|NCT01785069|450975625|FG002|Overall Study|Subject choice|0|||
125366609|NCT01785069|450975626|FG003|Overall Study|Subject choice|1|||
125366610|NCT01785069|450975623|FG000|Overall Study|Lost to Follow-up|1|||
125366611|NCT01785069|450975624|FG001|Overall Study|Lost to Follow-up|2|||
125366612|NCT01785069|450975625|FG002|Overall Study|Lost to Follow-up|4|||
125366613|NCT01785069|450975626|FG003|Overall Study|Lost to Follow-up|1|||
125366614|NCT01785069|450975623|FG000|Overall Study|Reason not Specified|1|||
125366615|NCT01785069|450975624|FG001|Overall Study|Reason not Specified|2|||
125366616|NCT01785069|450975625|FG002|Overall Study|Reason not Specified|1|||
125366617|NCT01785069|450975626|FG003|Overall Study|Reason not Specified|4|||
125366618|NCT01785069|450975623|FG000|Overall Study|Not evaluable|7|||
125366619|NCT01785069|450975624|FG001|Overall Study|Not evaluable|4|||
125366620|NCT01785069|450975625|FG002|Overall Study|Not evaluable|5|||
125366621|NCT01785069|450975626|FG003|Overall Study|Not evaluable|8|||
125366622|NCT01453361|450975629|FG000|Overall Study|Disease Progression|6|||
125366623|NCT01453361|450975629|FG000|Overall Study|Screen-Failures|10|||
125366624|NCT04560998|450975630|FG000|Overall Study|Withdrawal by Subject|18|||
125366625|NCT04560998|450975631|FG001|Overall Study|Withdrawal by Subject|12|||
125366626|NCT04560998|450975630|FG000|Overall Study|Lost to Follow-up|8|||
125366627|NCT04560998|450975631|FG001|Overall Study|Lost to Follow-up|5|||
125366628|NCT04560998|450975630|FG000|Overall Study|Physician Decision|4|||
125366629|NCT04560998|450975631|FG001|Overall Study|Physician Decision|0|||
125378931|NCT00531050|451019212|FG004|Part 1: Period 1|Protocol Deviation|0|||
125378932|NCT00531050|451019213|FG005|Part 1: Period 1|Protocol Deviation|0|||
125378933|NCT00531050|451019208|FG000|Part 1: Period 3|Adverse Event|1|||
125378934|NCT00531050|451019209|FG001|Part 1: Period 3|Adverse Event|0|||
125378935|NCT00531050|451019210|FG002|Part 1: Period 3|Adverse Event|0|||
125378936|NCT00531050|451019211|FG003|Part 1: Period 3|Adverse Event|0|||
125378937|NCT00531050|451019212|FG004|Part 1: Period 3|Adverse Event|0|||
125378938|NCT00531050|451019213|FG005|Part 1: Period 3|Adverse Event|0|||
125378939|NCT00531050|451019208|FG000|Part 2: Period 1|Adverse Event|0|||
125378940|NCT00531050|451019209|FG001|Part 2: Period 1|Adverse Event|0|||
125378941|NCT00531050|451019210|FG002|Part 2: Period 1|Adverse Event|0|||
125378942|NCT00531050|451019211|FG003|Part 2: Period 1|Adverse Event|0|||
125378943|NCT00531050|451019212|FG004|Part 2: Period 1|Adverse Event|0|||
125378944|NCT00531050|451019213|FG005|Part 2: Period 1|Adverse Event|1|||
125378945|NCT00531050|451019208|FG000|Part 2: Period 3|Abnormal test procedure|1|||
125378946|NCT00531050|451019209|FG001|Part 2: Period 3|Abnormal test procedure|0|||
125378947|NCT00531050|451019210|FG002|Part 2: Period 3|Abnormal test procedure|0|||
125378948|NCT00531050|451019211|FG003|Part 2: Period 3|Abnormal test procedure|0|||
125378949|NCT00531050|451019212|FG004|Part 2: Period 3|Abnormal test procedure|0|||
125378950|NCT00531050|451019213|FG005|Part 2: Period 3|Abnormal test procedure|1|||
125212537|NCT01483599|450403419|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125378951|NCT02233309|451019215|FG000|Overall Study|Physician Decision|5|||
125378952|NCT00799487|451019222|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
125378953|NCT00799487|451019223|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
125378954|NCT00799487|451019224|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
125378955|NCT00799487|451019222|FG000|Dose Adjustment Period|Adverse Event|2|||
125378956|NCT00799487|451019223|FG001|Dose Adjustment Period|Adverse Event|0|||
125378957|NCT00799487|451019224|FG002|Dose Adjustment Period|Adverse Event|0|||
125378958|NCT00799487|451019222|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
125378959|NCT00799487|451019223|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
125378960|NCT00799487|451019224|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
125378961|NCT00799487|451019222|FG000|Dose Adjustment Period|Investigator Discretion|2|||
125212538|NCT01483599|450403420|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212539|NCT01483599|450403421|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212540|NCT01483599|450403422|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212541|NCT01483599|450403423|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212542|NCT01483599|450403424|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
125212543|NCT01483599|450403411|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
125212544|NCT01483599|450403412|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
125212545|NCT01483599|450403413|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
125212546|NCT01483599|450403414|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
125212547|NCT01483599|450403415|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
125212548|NCT01483599|450403416|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
125212549|NCT01483599|450403417|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
125212550|NCT01483599|450403418|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
125212551|NCT01483599|450403419|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
125212552|NCT01483599|450403420|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
125212553|NCT01483599|450403421|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
125212554|NCT01483599|450403422|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
125212555|NCT01483599|450403423|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
125212556|NCT01483599|450403424|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
125212557|NCT01483599|450403411|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
125366630|NCT01798004|450977160|FG000|Overall Study|Death|2|||
125366631|NCT01798004|450977160|FG000|Overall Study|Lack of Efficacy|8|||
125366632|NCT01798004|450977160|FG000|Overall Study|Physician Decision|25|||
125366633|NCT01798004|450977160|FG000|Overall Study|Withdrawal by Subject|4|||
125366634|NCT01798004|450977160|FG000|Overall Study|Ineligible|4|||
125366635|NCT01798004|450977160|FG000|Overall Study|Patient/parent refusal|7|||
125366636|NCT01798004|450977160|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
125366637|NCT01798004|450977160|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
125366638|NCT03539081|450977168|FG000|Overall Study|Withdrawal by Subject|2|||
125366639|NCT03539081|450977169|FG001|Overall Study|Withdrawal by Subject|3|||
125366640|NCT03539081|450977170|FG002|Overall Study|Withdrawal by Subject|0|||
125366641|NCT03539081|450977168|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
125366642|NCT03539081|450977169|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
125366643|NCT03539081|450977170|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
125366644|NCT01673867|450977174|FG000|Randomization|Adverse event unrelated to study drug|1|||
125366645|NCT01673867|450977175|FG001|Randomization|Adverse event unrelated to study drug|0|||
125366646|NCT01673867|450977174|FG000|Randomization|Participant request to discontinue study treatment|0|||
125366647|NCT01673867|450977175|FG001|Randomization|Participant request to discontinue study treatment|4|||
125366648|NCT01673867|450977174|FG000|Randomization|Withdrawal by participant|0|||
125366649|NCT01673867|450977175|FG001|Randomization|Withdrawal by participant|12|||
125366650|NCT01673867|450977174|FG000|Randomization|Lost to Follow-up|0|||
125366651|NCT01673867|450977175|FG001|Randomization|Lost to Follow-up|1|||
125366652|NCT01673867|450977174|FG000|Randomization|Participant no longer meets study criteria|4|||
125366653|NCT01673867|450977175|FG001|Randomization|Participant no longer meets study criteria|5|||
125366654|NCT01673867|450977174|FG000|Treatment|Disease Progression|208|||
125366655|NCT01673867|450977175|FG001|Treatment|Disease Progression|178|||
125366656|NCT01673867|450977174|FG000|Treatment|Study Drug Toxicity|23|||
125366657|NCT01673867|450977175|FG001|Treatment|Study Drug Toxicity|43|||
125366658|NCT01673867|450977174|FG000|Treatment|Death|2|||
125366659|NCT01673867|450977175|FG001|Treatment|Death|3|||
125366660|NCT01673867|450977174|FG000|Treatment|Adverse event unrelated to study drug|23|||
125366661|NCT01673867|450977175|FG001|Treatment|Adverse event unrelated to study drug|10|||
125366662|NCT01673867|450977174|FG000|Treatment|Participant request to discontinue study treatment|7|||
125366663|NCT01673867|450977175|FG001|Treatment|Participant request to discontinue study treatment|17|||
125366664|NCT01673867|450977174|FG000|Treatment|Withdrawal by participant|5|||
125366665|NCT01673867|450977175|FG001|Treatment|Withdrawal by participant|5|||
125366666|NCT01673867|450977174|FG000|Treatment|Maximum clinical benefit|1|||
125366667|NCT01673867|450977175|FG001|Treatment|Maximum clinical benefit|10|||
125366668|NCT01673867|450977174|FG000|Treatment|Participant no longer meets study criteria|2|||
125366669|NCT01673867|450977175|FG001|Treatment|Participant no longer meets study criteria|0|||
125212558|NCT01483599|450403412|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
125366670|NCT01673867|450977174|FG000|Treatment|Administrative reason by sponsor|3|||
125212559|NCT01483599|450403413|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
125212560|NCT01483599|450403414|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
125366671|NCT01673867|450977175|FG001|Treatment|Administrative reason by sponsor|0|||
125366672|NCT01673867|450977174|FG000|Treatment|Other reason|11|||
125366673|NCT01673867|450977175|FG001|Treatment|Other reason|2|||
125366674|NCT02550106|450977178|FG000|Overall Study|Adverse Event|1|||
125366675|NCT02550106|450977178|FG000|Overall Study|Lack of Efficacy|3|||
125366676|NCT02550106|450977178|FG000|Overall Study|Protocol Violation|6|||
125366677|NCT02550106|450977178|FG000|Overall Study|Withdrawal by Subject|2|||
125366678|NCT02195583|450977179|FG000|Overall Study|Lost to Follow-up|1|||
125366679|NCT02195583|450977179|FG000|Overall Study|Withdrawal by Subject|4|||
125366680|NCT02195583|450977179|FG000|Overall Study|Adverse Event|2|||
125366681|NCT02195583|450977179|FG000|Overall Study|Other Reason|2|||
125366682|NCT01709513|450977180|FG000|Overall Study|Randomized but not treated|0|||
125366683|NCT01709513|450977181|FG001|Overall Study|Randomized but not treated|1|||
125366684|NCT01709513|450977182|FG002|Overall Study|Randomized but not treated|0|||
125366685|NCT01709513|450977180|FG000|Overall Study|Adverse Event|16|||
125366686|NCT01709513|450977181|FG001|Overall Study|Adverse Event|31|||
125366687|NCT01709513|450977182|FG002|Overall Study|Adverse Event|23|||
125366688|NCT01709513|450977180|FG000|Overall Study|Poor compliance to protocol|2|||
125366689|NCT01709513|450977181|FG001|Overall Study|Poor compliance to protocol|0|||
125366690|NCT01709513|450977182|FG002|Overall Study|Poor compliance to protocol|0|||
125366691|NCT01709513|450977180|FG000|Overall Study|Other|3|||
125366692|NCT01709513|450977181|FG001|Overall Study|Other|11|||
125366693|NCT01709513|450977182|FG002|Overall Study|Other|7|||
125366694|NCT02165215|450977183|FG000|Induction Phase|Adverse Event|1|||
125366695|NCT02165215|450977184|FG001|Induction Phase|Adverse Event|0|||
125366696|NCT02165215|450977185|FG002|Induction Phase|Adverse Event|0|||
125366697|NCT02165215|450977183|FG000|Induction Phase|Withdrawal by Subject|10|||
125366698|NCT02165215|450977184|FG001|Induction Phase|Withdrawal by Subject|0|||
125366699|NCT02165215|450977185|FG002|Induction Phase|Withdrawal by Subject|0|||
125366700|NCT02165215|450977183|FG000|Induction Phase|Protocol Violation|1|||
125366701|NCT02165215|450977184|FG001|Induction Phase|Protocol Violation|0|||
125366702|NCT02165215|450977185|FG002|Induction Phase|Protocol Violation|0|||
125366703|NCT02165215|450977183|FG000|Induction Phase|Physician Decision|1|||
125366704|NCT02165215|450977184|FG001|Induction Phase|Physician Decision|0|||
125366705|NCT02165215|450977185|FG002|Induction Phase|Physician Decision|0|||
125366706|NCT02165215|450977183|FG000|Induction Phase|Lack of Efficacy|2|||
125366707|NCT02165215|450977184|FG001|Induction Phase|Lack of Efficacy|0|||
125366708|NCT02165215|450977185|FG002|Induction Phase|Lack of Efficacy|0|||
125366709|NCT02165215|450977183|FG000|Induction Phase|Non-Compliance|2|||
125366710|NCT02165215|450977184|FG001|Induction Phase|Non-Compliance|0|||
125366711|NCT02165215|450977185|FG002|Induction Phase|Non-Compliance|0|||
125595899|NCT05635838|451806310|FG002|16-Week DBVC Period|Protocol Violation|0|||
125595900|NCT05635838|451806311|FG003|16-Week DBVC Period|Protocol Violation|0|||
125595901|NCT05635838|451806308|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
125595902|NCT05635838|451806309|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
125595903|NCT05635838|451806310|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
125595904|NCT05635838|451806311|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
125595905|NCT05635838|451806308|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
125595906|NCT05635838|451806309|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
125595907|NCT05635838|451806310|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
125595908|NCT05635838|451806311|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
125595909|NCT05635838|451806308|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
125595910|NCT05635838|451806309|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
125595911|NCT05635838|451806310|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
125595912|NCT05635838|451806311|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
125595913|NCT05635838|451806308|FG000|16-Week OLE Period|Adverse Event|0|||
125595914|NCT05635838|451806309|FG001|16-Week OLE Period|Adverse Event|0|||
125595915|NCT05635838|451806310|FG002|16-Week OLE Period|Adverse Event|0|||
125595916|NCT05635838|451806311|FG003|16-Week OLE Period|Adverse Event|2|||
125595917|NCT05635838|451806308|FG000|16-Week OLE Period|Lost to Follow-up|0|||
125595918|NCT05635838|451806309|FG001|16-Week OLE Period|Lost to Follow-up|0|||
125595919|NCT05635838|451806310|FG002|16-Week OLE Period|Lost to Follow-up|1|||
125595920|NCT05635838|451806311|FG003|16-Week OLE Period|Lost to Follow-up|3|||
125595921|NCT05635838|451806308|FG000|16-Week OLE Period|Physician Decision|0|||
125595922|NCT05635838|451806309|FG001|16-Week OLE Period|Physician Decision|0|||
125595923|NCT05635838|451806310|FG002|16-Week OLE Period|Physician Decision|0|||
125595924|NCT05635838|451806311|FG003|16-Week OLE Period|Physician Decision|1|||
125366712|NCT02165215|450977183|FG000|Induction Phase|Lost to Follow-up|6|||
125366713|NCT02165215|450977184|FG001|Induction Phase|Lost to Follow-up|0|||
125366714|NCT02165215|450977185|FG002|Induction Phase|Lost to Follow-up|0|||
125366715|NCT02165215|450977183|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125366716|NCT02165215|450977184|FG001|Maintenance Phase|Withdrawal by Subject|7|||
125366717|NCT02165215|450977185|FG002|Maintenance Phase|Withdrawal by Subject|3|||
125595925|NCT05635838|451806308|FG000|16-Week OLE Period|Protocol Violation|0|||
125595926|NCT05635838|451806309|FG001|16-Week OLE Period|Protocol Violation|0|||
125430070|NCT01191840|451201467|FG001|Overall Study|Non Staph Infection|3|||
125430071|NCT01191840|451201466|FG000|Overall Study|ineligible at enrollment|1|||
125430072|NCT01191840|451201467|FG001|Overall Study|ineligible at enrollment|0|||
125430073|NCT01191840|451201466|FG000|Overall Study|IRB approval lapse|0|||
125430074|NCT01191840|451201467|FG001|Overall Study|IRB approval lapse|2|||
125430075|NCT01191840|451201466|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
125430076|NCT01191840|451201467|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
125430077|NCT01191840|451201466|FG000|Overall Study|Withdrawal by Subject|2|||
125430078|NCT01191840|451201467|FG001|Overall Study|Withdrawal by Subject|0|||
125430079|NCT01392300|451201468|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
125430080|NCT01392300|451201469|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
125430081|NCT01392300|451201470|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
125430082|NCT01392300|451201468|FG000|Main Period (MP)|Withdrawal by Subject|5|||
125430083|NCT01392300|451201469|FG001|Main Period (MP)|Withdrawal by Subject|1|||
125430084|NCT01392300|451201470|FG002|Main Period (MP)|Withdrawal by Subject|0|||
125430085|NCT01392300|451201468|FG000|Main Period (MP)|Lost to Follow-up|3|||
125430086|NCT01392300|451201469|FG001|Main Period (MP)|Lost to Follow-up|3|||
125430087|NCT01392300|451201470|FG002|Main Period (MP)|Lost to Follow-up|0|||
125430088|NCT01392300|451201468|FG000|Main Period (MP)|Non-compliance|1|||
125430089|NCT01392300|451201469|FG001|Main Period (MP)|Non-compliance|0|||
125430090|NCT01392300|451201470|FG002|Main Period (MP)|Non-compliance|0|||
125430091|NCT01392300|451201468|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
125430092|NCT01392300|451201469|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
125430093|NCT01392300|451201470|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
125430094|NCT01392300|451201468|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
125430095|NCT01392300|451201469|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
125430096|NCT01392300|451201470|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
125430097|NCT01392300|451201468|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
125430098|NCT01392300|451201469|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
125430099|NCT01392300|451201470|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
125430100|NCT01392300|451201468|FG000|Open Label Extension (OLEX) Period|Death|0|||
125430101|NCT01392300|451201469|FG001|Open Label Extension (OLEX) Period|Death|0|||
125430102|NCT01392300|451201470|FG002|Open Label Extension (OLEX) Period|Death|4|||
125430103|NCT01392300|451201468|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
125430104|NCT01392300|451201469|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
125430105|NCT01392300|451201470|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
125430106|NCT01392300|451201468|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
125430107|NCT01392300|451201469|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
125430108|NCT01392300|451201470|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
125430109|NCT01392300|451201468|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
125430110|NCT01392300|451201469|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
125430111|NCT01392300|451201470|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
125430112|NCT01802437|451201475|FG000|Overall Study|Lost to Follow-up|1|||
125430113|NCT01802437|451201476|FG001|Overall Study|Lost to Follow-up|0|||
125430114|NCT01802437|451201475|FG000|Overall Study|Withdrawal by Subject|3|||
125430115|NCT01802437|451201476|FG001|Overall Study|Withdrawal by Subject|4|||
125430116|NCT01682213|451201484|FG000|Overall Study|Withdrawal by Subject|2|||
125430117|NCT00742079|451201485|FG000|Overall Study|Lost to Follow-up|0|||
125430118|NCT00742079|451201486|FG001|Overall Study|Lost to Follow-up|1|||
125430119|NCT01181726|451201487|FG000|First Intervention|Adverse Event|1|||
125430120|NCT01181726|451201488|FG001|First Intervention|Adverse Event|0|||
125430121|NCT01264380|451201489|FG000|Period C|Disease Progression|0|||
125430122|NCT01264380|451201490|FG001|Period C|Disease Progression|0|||
125430123|NCT01264380|451201491|FG002|Period C|Disease Progression|4|||
125430124|NCT01264380|451201489|FG000|Period C|Death|0|||
125430125|NCT01264380|451201490|FG001|Period C|Death|0|||
125430126|NCT01264380|451201491|FG002|Period C|Death|2|||
125430127|NCT01264380|451201489|FG000|Period C|Follow-up for survival status|0|||
125430128|NCT01264380|451201490|FG001|Period C|Follow-up for survival status|0|||
125430129|NCT01264380|451201491|FG002|Period C|Follow-up for survival status|6|||
125430130|NCT01264380|451201489|FG000|Period C|Withdrawal by Subject|0|||
125430131|NCT01264380|451201490|FG001|Period C|Withdrawal by Subject|0|||
125430132|NCT01264380|451201491|FG002|Period C|Withdrawal by Subject|1|||
125430133|NCT01264380|451201489|FG000|Period C|Adverse Event|0|||
125430134|NCT01264380|451201490|FG001|Period C|Adverse Event|0|||
125430135|NCT01264380|451201491|FG002|Period C|Adverse Event|1|||
125430136|NCT01147822|451201492|FG000|Overall Study|Lost to Follow-up|14|||
125430137|NCT01147822|451201493|FG001|Overall Study|Lost to Follow-up|6|||
125430138|NCT01147822|451201492|FG000|Overall Study|Withdrawal by Subject|10|||
125430139|NCT01147822|451201493|FG001|Overall Study|Withdrawal by Subject|16|||
125430140|NCT01147822|451201492|FG000|Overall Study|Physician Decision|9|||
125430141|NCT01147822|451201493|FG001|Overall Study|Physician Decision|8|||
125430142|NCT01147822|451201492|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
125430143|NCT01147822|451201493|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
125430144|NCT01147822|451201492|FG000|Overall Study|Protocol Violation|1|||
125430145|NCT01147822|451201493|FG001|Overall Study|Protocol Violation|1|||
125430146|NCT04382924|451201495|FG000|Overall Study|Death|2|||
125430147|NCT04382924|451201496|FG001|Overall Study|Death|5|||
125430148|NCT04382924|451201497|FG002|Overall Study|Death|4|||
125430149|NCT04382924|451201495|FG000|Overall Study|Protocol Violation|0|||
125595927|NCT05635838|451806310|FG002|16-Week OLE Period|Protocol Violation|1|||
125430150|NCT04382924|451201496|FG001|Overall Study|Protocol Violation|1|||
125430151|NCT04382924|451201497|FG002|Overall Study|Protocol Violation|1|||
125595928|NCT05635838|451806311|FG003|16-Week OLE Period|Protocol Violation|1|||
125595929|NCT05635838|451806308|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
125595930|NCT05635838|451806309|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
125595931|NCT05635838|451806310|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
125595932|NCT05635838|451806311|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
125595933|NCT05635838|451806308|FG000|16-Week OLE Period|Pregnancy|0|||
125595934|NCT05635838|451806309|FG001|16-Week OLE Period|Pregnancy|0|||
125595935|NCT05635838|451806310|FG002|16-Week OLE Period|Pregnancy|1|||
125595936|NCT05635838|451806311|FG003|16-Week OLE Period|Pregnancy|0|||
125595937|NCT03518840|451806317|FG000|Overall Study|Lost to Follow-up|6|||
125595938|NCT00875420|451806319|FG000|Overall Study|Adverse Event|0|||
125595939|NCT00875420|451806320|FG001|Overall Study|Adverse Event|1|||
125595940|NCT00875420|451806321|FG002|Overall Study|Adverse Event|1|||
125595941|NCT00875420|451806322|FG003|Overall Study|Adverse Event|0|||
125595942|NCT00875420|451806323|FG004|Overall Study|Adverse Event|0|||
125595943|NCT00875420|451806319|FG000|Overall Study|Inability to complete study procedures|1|||
125595944|NCT00875420|451806320|FG001|Overall Study|Inability to complete study procedures|0|||
125595945|NCT00875420|451806321|FG002|Overall Study|Inability to complete study procedures|1|||
125595946|NCT00875420|451806322|FG003|Overall Study|Inability to complete study procedures|1|||
125595947|NCT00875420|451806323|FG004|Overall Study|Inability to complete study procedures|1|||
125595948|NCT00875420|451806319|FG000|Overall Study|Lost to Follow-up|1|||
125595949|NCT00875420|451806320|FG001|Overall Study|Lost to Follow-up|0|||
125595950|NCT00875420|451806321|FG002|Overall Study|Lost to Follow-up|0|||
125595951|NCT00875420|451806322|FG003|Overall Study|Lost to Follow-up|0|||
125595952|NCT00875420|451806323|FG004|Overall Study|Lost to Follow-up|0|||
125595953|NCT00875420|451806319|FG000|Overall Study|Personal reason|0|||
125595954|NCT00875420|451806320|FG001|Overall Study|Personal reason|0|||
125595955|NCT00875420|451806321|FG002|Overall Study|Personal reason|0|||
125595956|NCT00875420|451806322|FG003|Overall Study|Personal reason|0|||
125595957|NCT00875420|451806323|FG004|Overall Study|Personal reason|1|||
125595958|NCT00875420|451806319|FG000|Overall Study|Prohibited medication|0|||
125595959|NCT00875420|451806320|FG001|Overall Study|Prohibited medication|0|||
125595960|NCT00875420|451806321|FG002|Overall Study|Prohibited medication|0|||
125595961|NCT00875420|451806322|FG003|Overall Study|Prohibited medication|1|||
125595962|NCT00875420|451806323|FG004|Overall Study|Prohibited medication|0|||
125595963|NCT00875420|451806319|FG000|Overall Study|Sponsor decision|0|||
125595964|NCT00875420|451806320|FG001|Overall Study|Sponsor decision|1|||
125595965|NCT00875420|451806321|FG002|Overall Study|Sponsor decision|0|||
125595966|NCT00875420|451806322|FG003|Overall Study|Sponsor decision|0|||
125595967|NCT00875420|451806323|FG004|Overall Study|Sponsor decision|0|||
125595968|NCT00875420|451806319|FG000|Overall Study|Withdrawal by Subject|0|||
125595969|NCT00875420|451806320|FG001|Overall Study|Withdrawal by Subject|0|||
125595970|NCT00875420|451806321|FG002|Overall Study|Withdrawal by Subject|1|||
125595971|NCT00875420|451806322|FG003|Overall Study|Withdrawal by Subject|0|||
125595972|NCT00875420|451806323|FG004|Overall Study|Withdrawal by Subject|0|||
125595973|NCT00001259|451806324|FG000|Study 2|Adverse Event|0|||
125595974|NCT00001259|451806325|FG001|Study 2|Adverse Event|0|||
125595975|NCT00001259|451806326|FG002|Study 2|Adverse Event|0|||
125595976|NCT00001259|451806327|FG003|Study 2|Adverse Event|0|||
125595977|NCT00001259|451806328|FG004|Study 2|Adverse Event|2|||
125595978|NCT00001259|451806329|FG005|Study 2|Adverse Event|0|||
125595979|NCT00001259|451806330|FG006|Study 2|Adverse Event|0|||
125595980|NCT03716726|451806333|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
125595981|NCT03716726|451806334|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
125595982|NCT03716726|451806333|FG000|12 Months Followup|Lost to Follow-up|10|||
125595983|NCT03716726|451806334|FG001|12 Months Followup|Lost to Follow-up|17|||
125595984|NCT01416181|451806335|FG000|Part 1|Other|10|||
125595985|NCT01416181|451806336|FG001|Part 1|Other|24|||
125595986|NCT01416181|451806335|FG000|Part 1|Death|0|||
125595987|NCT01416181|451806336|FG001|Part 1|Death|1|||
125595988|NCT01416181|451806335|FG000|Part 1|Investigator Decision|7|||
125595989|NCT01416181|451806336|FG001|Part 1|Investigator Decision|6|||
125595990|NCT01416181|451806335|FG000|Part 1|Withdrawal by Subject|74|||
125595991|NCT01416181|451806336|FG001|Part 1|Withdrawal by Subject|48|||
125595992|NCT01416181|451806335|FG000|Part 1|Lack of Efficacy|16|||
125595993|NCT01416181|451806336|FG001|Part 1|Lack of Efficacy|8|||
125595994|NCT01416181|451806335|FG000|Part 1|Lost to Follow-up|1|||
125595995|NCT01416181|451806336|FG001|Part 1|Lost to Follow-up|1|||
125595996|NCT01416181|451806335|FG000|Part 1|Adverse Event|15|||
125595997|NCT01416181|451806336|FG001|Part 1|Adverse Event|18|||
125595998|NCT01416181|451806335|FG000|Part 1|Ongoing in Follow-Up|14|||
125595999|NCT01416181|451806336|FG001|Part 1|Ongoing in Follow-Up|8|||
125596000|NCT01416181|451806335|FG000|Part 2|Adverse Event|11|||
125596001|NCT01416181|451806336|FG001|Part 2|Adverse Event|4|||
125596002|NCT01416181|451806335|FG000|Part 2|Other|234|||
125596003|NCT01416181|451806336|FG001|Part 2|Other|267|||
125596004|NCT01416181|451806335|FG000|Part 2|Investigator Decision|6|||
125596005|NCT01416181|451806336|FG001|Part 2|Investigator Decision|7|||
125596006|NCT01416181|451806335|FG000|Part 2|Withdrawal by Subject|14|||
125596007|NCT01416181|451806336|FG001|Part 2|Withdrawal by Subject|5|||
125596008|NCT01416181|451806335|FG000|Part 2|Lack of Efficacy|4|||
125596009|NCT01416181|451806336|FG001|Part 2|Lack of Efficacy|1|||
125596010|NCT01416181|451806335|FG000|Part 2|Lost to Follow-up|2|||
125596011|NCT01416181|451806336|FG001|Part 2|Lost to Follow-up|2|||
125596012|NCT03199911|451806337|FG000|Overall Study|Lost to Follow-up|5|||
125596013|NCT03199911|451806338|FG001|Overall Study|Lost to Follow-up|5|||
125596014|NCT03199911|451806337|FG000|Overall Study|Did not proceed with surgery|2|||
125596015|NCT03199911|451806338|FG001|Overall Study|Did not proceed with surgery|1|||
125596016|NCT03126227|451806348|FG000|Overall Study|Adverse Event|43|||
125596017|NCT03126227|451806349|FG001|Overall Study|Adverse Event|4|||
125596018|NCT03126227|451806348|FG000|Overall Study|Death|0|||
125596019|NCT03126227|451806349|FG001|Overall Study|Death|1|||
125596020|NCT03126227|451806348|FG000|Overall Study|Lost to Follow-up|0|||
125596021|NCT03126227|451806349|FG001|Overall Study|Lost to Follow-up|1|||
125596022|NCT03126227|451806348|FG000|Overall Study|Physician Decision|2|||
125596023|NCT03126227|451806349|FG001|Overall Study|Physician Decision|0|||
125596024|NCT03126227|451806348|FG000|Overall Study|Protocol Violation|1|||
125596025|NCT03126227|451806349|FG001|Overall Study|Protocol Violation|0|||
125596026|NCT03126227|451806348|FG000|Overall Study|Withdrawal by Subject|19|||
125596027|NCT03126227|451806349|FG001|Overall Study|Withdrawal by Subject|3|||
125596028|NCT03126227|451806348|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
125596029|NCT03126227|451806349|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
125596030|NCT03126227|451806348|FG000|Overall Study|Lack of dosing compliance|2|||
125596031|NCT03126227|451806349|FG001|Overall Study|Lack of dosing compliance|0|||
125596032|NCT03126227|451806348|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
125596033|NCT03126227|451806349|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
125596034|NCT03126227|451806348|FG000|Overall Study|Scheduling conflict|1|||
125596035|NCT03126227|451806349|FG001|Overall Study|Scheduling conflict|0|||
125596036|NCT00900796|451806352|FG000|Phase 1|Lacked sufficient information|4|||
125596037|NCT00900796|451806352|FG000|Phase 1|Missing information at Week 16|7|||
125596038|NCT00900796|451806352|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
125596039|NCT00900796|451806352|FG000|Phase 2|Lost to Follow-up|5|||
125596040|NCT01121406|451806353|FG000|Overall Study|Progressive disease RECIST|44|||
125596041|NCT01121406|451806354|FG001|Overall Study|Progressive disease RECIST|28|||
125596042|NCT01121406|451806353|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
125596043|NCT01121406|451806354|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
125596044|NCT01121406|451806353|FG000|Overall Study|Other AE|3|||
125596045|NCT01121406|451806354|FG001|Overall Study|Other AE|10|||
125596046|NCT01121406|451806353|FG000|Overall Study|Non-compliant with protocol|0|||
125596047|NCT01121406|451806354|FG001|Overall Study|Non-compliant with protocol|2|||
125596048|NCT01121406|451806353|FG000|Overall Study|Lost to Follow-up|0|||
125596049|NCT01121406|451806354|FG001|Overall Study|Lost to Follow-up|1|||
125596050|NCT01121406|451806353|FG000|Overall Study|Refused continuation of study med.|1|||
125596051|NCT01121406|451806354|FG001|Overall Study|Refused continuation of study med.|2|||
125596052|NCT01121406|451806353|FG000|Overall Study|Reason other than specified above|2|||
125596053|NCT01121406|451806354|FG001|Overall Study|Reason other than specified above|6|||
125596054|NCT01121406|451806353|FG000|Overall Study|Not treated|1|||
125596055|NCT01121406|451806354|FG001|Overall Study|Not treated|0|||
125596056|NCT03185130|451806355|FG000|Overall Study|Withdrawal by Subject|0|||
125596057|NCT03185130|451806356|FG001|Overall Study|Withdrawal by Subject|2|||
125596058|NCT01925703|451806357|FG000|Overall Study|Physician Decision|1|||
125596059|NCT01925703|451806357|FG000|Overall Study|Lost to Follow-up|2|||
125596060|NCT01925703|451806357|FG000|Overall Study|Discharge prior to full iron repletion|1|||
125596061|NCT03215277|451806359|FG000|Overall Study|Adverse Event|2|||
125596062|NCT03215277|451806360|FG001|Overall Study|Adverse Event|3|||
125596063|NCT03215277|451806359|FG000|Overall Study|Death|1|||
125596064|NCT03215277|451806360|FG001|Overall Study|Death|0|||
125596065|NCT03215277|451806359|FG000|Overall Study|Lost to Follow-up|0|||
125596066|NCT03215277|451806360|FG001|Overall Study|Lost to Follow-up|1|||
125596067|NCT03215277|451806359|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
125596068|NCT03215277|451806360|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
125596069|NCT03794986|451806361|FG000|Overall Study|0 Sessions Attended|34|||
125596070|NCT03794986|451806362|FG001|Overall Study|0 Sessions Attended|37|||
125596071|NCT03794986|451806361|FG000|Overall Study|Withdrawal by Subject|4|||
125596072|NCT03794986|451806362|FG001|Overall Study|Withdrawal by Subject|6|||
125596073|NCT03794986|451806361|FG000|Overall Study|Protocol Violation|1|||
125596074|NCT03794986|451806362|FG001|Overall Study|Protocol Violation|0|||
125596075|NCT01238120|451806365|FG000|Overall Study|Withdrawal by Subject|4|||
125596076|NCT01238120|451806366|FG001|Overall Study|Withdrawal by Subject|1|||
125596077|NCT01238120|451806367|FG002|Overall Study|Withdrawal by Subject|2|||
125596078|NCT01238120|451806368|FG003|Overall Study|Withdrawal by Subject|5|||
125596079|NCT01238120|451806365|FG000|Overall Study|Lost to Follow-up|2|||
125596080|NCT01238120|451806366|FG001|Overall Study|Lost to Follow-up|0|||
125596081|NCT01238120|451806367|FG002|Overall Study|Lost to Follow-up|1|||
125596082|NCT01238120|451806368|FG003|Overall Study|Lost to Follow-up|1|||
125596083|NCT01238120|451806365|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
125596084|NCT01238120|451806366|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
125596085|NCT01238120|451806367|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
125596086|NCT01238120|451806368|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
125596087|NCT02498652|451806371|FG000|Overall Study|Protocol Violation|0|||
125596088|NCT02498652|451806372|FG001|Overall Study|Protocol Violation|1|||
125596089|NCT00465569|451806374|FG000|Overall Study|persistent eczema during dose escalation|1|||
125596090|NCT00465569|451806375|FG001|Overall Study|persistent eczema during dose escalation|0|||
125596091|NCT00922935|451806376|FG000|Overall Study|Protocol Violation|0|||
125596092|NCT00922935|451806377|FG001|Overall Study|Protocol Violation|3|||
125596093|NCT00922935|451806378|FG002|Overall Study|Protocol Violation|0|||
125596094|NCT00922935|451806376|FG000|Overall Study|Physician Decision|1|||
125596095|NCT00922935|451806377|FG001|Overall Study|Physician Decision|1|||
125596096|NCT00922935|451806378|FG002|Overall Study|Physician Decision|0|||
125596097|NCT00922935|451806376|FG000|Overall Study|Lost to Follow-up|0|||
125596098|NCT00922935|451806377|FG001|Overall Study|Lost to Follow-up|1|||
125596099|NCT00922935|451806378|FG002|Overall Study|Lost to Follow-up|0|||
125596100|NCT00849212|451806379|FG000|Overall Study|Lack of Efficacy|1|||
125596101|NCT00849212|451806379|FG000|Overall Study|Withdrawal by Subject|3|||
125596102|NCT00849212|451806379|FG000|Overall Study|Adverse Event|2|||
125596103|NCT00849212|451806379|FG000|Overall Study|Miscellaneous|1|||
125596104|NCT00095303|451806380|FG000|Main Study|Lost to Follow-up|91|||
125596105|NCT00095303|451806381|FG001|Main Study|Lost to Follow-up|87|||
125596106|NCT00095303|451806380|FG000|Follow Up Study|Lost to Follow-up|59|||
125596107|NCT00095303|451806381|FG001|Follow Up Study|Lost to Follow-up|58|||
125596108|NCT01499576|451806382|FG000|Overall Study|Physician Decision|12|||
125596109|NCT01499576|451806382|FG000|Overall Study|Withdrawal by Subject|9|||
125596110|NCT04283461|451806383|FG000|Overall Study|Enrolled in separate trial|0|||
125596111|NCT04283461|451806384|FG001|Overall Study|Enrolled in separate trial|0|||
125596112|NCT04283461|451806385|FG002|Overall Study|Enrolled in separate trial|8|||
125596113|NCT04283461|451806386|FG003|Overall Study|Enrolled in separate trial|13|||
125596114|NCT04283461|451806387|FG004|Overall Study|Enrolled in separate trial|12|||
125596115|NCT04283461|451806388|FG005|Overall Study|Enrolled in separate trial|0|||
125596116|NCT04283461|451806389|FG006|Overall Study|Enrolled in separate trial|0|||
125596117|NCT04283461|451806390|FG007|Overall Study|Enrolled in separate trial|8|||
125596118|NCT04283461|451806391|FG008|Overall Study|Enrolled in separate trial|0|||
125596119|NCT04283461|451806392|FG009|Overall Study|Enrolled in separate trial|0|||
125596120|NCT04283461|451806393|FG010|Overall Study|Enrolled in separate trial|0|||
125596121|NCT04283461|451806394|FG011|Overall Study|Enrolled in separate trial|7|||
125596122|NCT04283461|451806395|FG012|Overall Study|Enrolled in separate trial|0|||
125596123|NCT04375878|451806402|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
125596124|NCT04375878|451806403|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
125596125|NCT04375878|451806404|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
125596126|NCT04375878|451806405|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
125596127|NCT04375878|451806406|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
125596128|NCT04375878|451806407|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
125596129|NCT04375878|451806402|FG000|Crossover First and Second Interventions|Adverse Event|0|||
125596130|NCT04375878|451806403|FG001|Crossover First and Second Interventions|Adverse Event|0|||
125596131|NCT04375878|451806404|FG002|Crossover First and Second Interventions|Adverse Event|1|||
125596132|NCT04375878|451806405|FG003|Crossover First and Second Interventions|Adverse Event|0|||
125596133|NCT04375878|451806406|FG004|Crossover First and Second Interventions|Adverse Event|0|||
125596134|NCT04375878|451806407|FG005|Crossover First and Second Interventions|Adverse Event|0|||
125596135|NCT04375878|451806402|FG000|Extension Phase|Withdrawal by Subject|0|||
125596136|NCT04375878|451806403|FG001|Extension Phase|Withdrawal by Subject|0|||
125596137|NCT04375878|451806404|FG002|Extension Phase|Withdrawal by Subject|0|||
125596138|NCT04375878|451806405|FG003|Extension Phase|Withdrawal by Subject|0|||
125596139|NCT04375878|451806406|FG004|Extension Phase|Withdrawal by Subject|1|||
125596140|NCT04375878|451806407|FG005|Extension Phase|Withdrawal by Subject|0|||
125596141|NCT00195351|451806408|FG000|Overall Study|Lost to Follow-up|9|||
125596142|NCT00195351|451806409|FG001|Overall Study|Lost to Follow-up|9|||
125596143|NCT00195351|451806408|FG000|Overall Study|Withdrawal by Subject|6|||
125596144|NCT00195351|451806409|FG001|Overall Study|Withdrawal by Subject|3|||
125596145|NCT00195351|451806408|FG000|Overall Study|Protocol Deviation|3|||
125596146|NCT00195351|451806409|FG001|Overall Study|Protocol Deviation|2|||
125596147|NCT00195351|451806408|FG000|Overall Study|Death|3|||
125596148|NCT00195351|451806409|FG001|Overall Study|Death|1|||
125430152|NCT04382924|451201495|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
125430153|NCT04382924|451201496|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
125430154|NCT04382924|451201497|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
125430155|NCT04382924|451201495|FG000|Overall Study|Withdrawal by Subject|6|||
125430156|NCT04382924|451201496|FG001|Overall Study|Withdrawal by Subject|3|||
125430157|NCT04382924|451201497|FG002|Overall Study|Withdrawal by Subject|6|||
125430158|NCT02013388|451201500|FG000|Overall Study|work emergency|1|||
125430159|NCT02013388|451201501|FG001|Overall Study|work emergency|0|||
125430160|NCT02013388|451201502|FG002|Overall Study|work emergency|0|||
125430161|NCT02013388|451201503|FG003|Overall Study|work emergency|0|||
125430162|NCT02013388|451201504|FG004|Overall Study|work emergency|1|||
125430163|NCT02013388|451201505|FG005|Overall Study|work emergency|0|||
125430164|NCT02013388|451201506|FG006|Overall Study|work emergency|0|||
125430165|NCT02013388|451201507|FG007|Overall Study|work emergency|0|||
125430166|NCT00429663|451201508|FG000|Overall Study|Lost to Follow-up|24|||
125430167|NCT00429663|451201509|FG001|Overall Study|Lost to Follow-up|31|||
125430168|NCT00429663|451201508|FG000|Overall Study|Physician Decision|6|||
125430169|NCT00429663|451201509|FG001|Overall Study|Physician Decision|3|||
125430170|NCT00429663|451201508|FG000|Overall Study|Withdrawal by Subject|2|||
125430171|NCT00429663|451201509|FG001|Overall Study|Withdrawal by Subject|5|||
125430172|NCT00429663|451201508|FG000|Overall Study|Death|4|||
125430173|NCT00429663|451201509|FG001|Overall Study|Death|0|||
125430174|NCT04207840|451201510|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
125430175|NCT04207840|451201511|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
125430176|NCT04207840|451201512|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
125430177|NCT04207840|451201510|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
125430178|NCT04207840|451201511|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
125430179|NCT04207840|451201512|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
125430180|NCT03243422|451201513|FG000|Overall Study|Death|20|||
125430181|NCT03243422|451201514|FG001|Overall Study|Death|21|||
125430182|NCT03243422|451201513|FG000|Overall Study|Lost to Follow-up|9|||
125430183|NCT03243422|451201514|FG001|Overall Study|Lost to Follow-up|21|||
125430184|NCT03243422|451201513|FG000|Overall Study|Withdrawal by Subject|22|||
125430185|NCT03243422|451201514|FG001|Overall Study|Withdrawal by Subject|8|||
125430186|NCT03261271|451201518|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
125596149|NCT00195351|451806408|FG000|Overall Study|Lack of Efficacy|0|||
125596150|NCT00195351|451806409|FG001|Overall Study|Lack of Efficacy|1|||
125596151|NCT02111369|451806410|FG000|Overall Study|Lost to Follow-up|2|||
125596152|NCT02111369|451806410|FG000|Overall Study|Withdrawal by Subject|1|||
125596153|NCT01259466|451806411|FG000|Overall Study|Withdrawal by Subject|1|||
125596154|NCT01259466|451806412|FG001|Overall Study|Withdrawal by Subject|9|||
125596155|NCT00519623|451806415|FG000|Overall Study|Adverse Event|1|||
125596156|NCT02296840|451806417|FG000|Overall Study|Adverse Event|1|||
125596157|NCT02296840|451806418|FG001|Overall Study|Adverse Event|1|||
125596158|NCT02296840|451806417|FG000|Overall Study|Protocol Violation|2|||
125430187|NCT03261271|451201519|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
125430188|NCT02173054|451201520|FG000|Overall Study|lack of compliance|1|||
125430189|NCT02173054|451201521|FG001|Overall Study|lack of compliance|0|||
125596159|NCT02296840|451806418|FG001|Overall Study|Protocol Violation|1|||
125596160|NCT02296840|451806417|FG000|Overall Study|Lost to Follow-up|6|||
125596161|NCT02296840|451806418|FG001|Overall Study|Lost to Follow-up|17|||
125596162|NCT00104871|451806419|FG000|Overall Study|Not evaluable|1|||
125596163|NCT00761215|451806422|FG000|Overall Study|Randomized but didn't receive drug|1|||
125596164|NCT00761215|451806423|FG001|Overall Study|Randomized but didn't receive drug|1|||
125596165|NCT00761215|451806424|FG002|Overall Study|Randomized but didn't receive drug|2|||
125596166|NCT00761215|451806422|FG000|Overall Study|Lost to Follow-up|6|||
125596167|NCT00761215|451806423|FG001|Overall Study|Lost to Follow-up|3|||
125596168|NCT00761215|451806424|FG002|Overall Study|Lost to Follow-up|6|||
125596169|NCT00761215|451806422|FG000|Overall Study|Withdrawal by Subject|1|||
125596170|NCT00761215|451806423|FG001|Overall Study|Withdrawal by Subject|0|||
125596171|NCT00761215|451806424|FG002|Overall Study|Withdrawal by Subject|0|||
125596172|NCT00761215|451806422|FG000|Overall Study|Bacteremia|1|||
125596173|NCT00761215|451806423|FG001|Overall Study|Bacteremia|0|||
125596174|NCT00761215|451806424|FG002|Overall Study|Bacteremia|0|||
125596175|NCT05121103|451806425|FG000|Overall Study|Progressive disease|2|||
125596176|NCT05121103|451806426|FG001|Overall Study|Progressive disease|1|||
125596177|NCT05121103|451806427|FG002|Overall Study|Progressive disease|6|||
125596178|NCT05121103|451806425|FG000|Overall Study|Physician Decision|2|||
125596179|NCT05121103|451806426|FG001|Overall Study|Physician Decision|1|||
125596180|NCT05121103|451806427|FG002|Overall Study|Physician Decision|0|||
125596181|NCT05121103|451806425|FG000|Overall Study|Withdrawal by Subject|0|||
125596182|NCT05121103|451806426|FG001|Overall Study|Withdrawal by Subject|1|||
125596183|NCT05121103|451806427|FG002|Overall Study|Withdrawal by Subject|0|||
125596184|NCT01687673|451806432|FG000|Overall Study|Physician Decision|1|||
125596185|NCT02234622|451806433|FG000|Overall Study|Withdrawal by Subject|16|||
125596186|NCT02234622|451806434|FG001|Overall Study|Withdrawal by Subject|22|||
125596187|NCT02234622|451806433|FG000|Overall Study|Lost to Follow-up|27|||
125212561|NCT01483599|450403415|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
125212562|NCT01483599|450403416|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
125212563|NCT01483599|450403417|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
125212564|NCT01483599|450403418|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
125212565|NCT01483599|450403419|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
125212566|NCT01483599|450403420|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
125212567|NCT01483599|450403421|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
125212568|NCT01483599|450403422|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
125212569|NCT01483599|450403423|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
125212570|NCT01483599|450403424|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
125212571|NCT01483599|450403411|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212572|NCT01483599|450403412|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212573|NCT01483599|450403413|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212574|NCT01483599|450403414|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212575|NCT01483599|450403415|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212576|NCT01483599|450403416|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212577|NCT01483599|450403417|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212578|NCT01483599|450403418|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
125212579|NCT01483599|450403419|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
125212580|NCT01483599|450403420|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212581|NCT01483599|450403421|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212582|NCT01483599|450403422|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
125212583|NCT01483599|450403423|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
125366718|NCT02165215|450977183|FG000|Maintenance Phase|Multiple reasons|0|||
125366719|NCT02165215|450977184|FG001|Maintenance Phase|Multiple reasons|2|||
125596188|NCT02234622|451806434|FG001|Overall Study|Lost to Follow-up|14|||
125596189|NCT02453841|451806435|FG000|Overall Study|Protocol Violation|1|||
125596190|NCT02453841|451806435|FG000|Overall Study|Unable to obtain blood samples|2|||
125596191|NCT00618956|451806436|FG000|Overall Study|Adverse Event|10|||
125596192|NCT00618956|451806437|FG001|Overall Study|Adverse Event|34|||
125596193|NCT00618956|451806436|FG000|Overall Study|Lack of Efficacy|2|||
125596194|NCT00618956|451806437|FG001|Overall Study|Lack of Efficacy|1|||
125596195|NCT00618956|451806436|FG000|Overall Study|Withdrawal by Subject|5|||
125596196|NCT00618956|451806437|FG001|Overall Study|Withdrawal by Subject|7|||
125596197|NCT00618956|451806436|FG000|Overall Study|Lost to Follow-up|4|||
125596198|NCT00618956|451806437|FG001|Overall Study|Lost to Follow-up|5|||
125596199|NCT00618956|451806436|FG000|Overall Study|Protocol Violation|2|||
125596200|NCT00618956|451806437|FG001|Overall Study|Protocol Violation|2|||
125596201|NCT00618956|451806436|FG000|Overall Study|did not meet criteria, non-compliance|2|||
125596202|NCT00618956|451806437|FG001|Overall Study|did not meet criteria, non-compliance|1|||
125596203|NCT02006576|451806438|FG000|Overall Study|Withdrawal by Subject|4|||
125596204|NCT02006576|451806439|FG001|Overall Study|Withdrawal by Subject|6|||
125596205|NCT02006576|451806440|FG002|Overall Study|Withdrawal by Subject|2|||
125596206|NCT02006576|451806438|FG000|Overall Study|Death|0|||
125596207|NCT02006576|451806439|FG001|Overall Study|Death|0|||
125596208|NCT02006576|451806440|FG002|Overall Study|Death|1|||
125596209|NCT02006576|451806438|FG000|Overall Study|Lost to Follow-up|1|||
125596210|NCT02006576|451806439|FG001|Overall Study|Lost to Follow-up|0|||
125596211|NCT02006576|451806440|FG002|Overall Study|Lost to Follow-up|1|||
125596212|NCT02006576|451806438|FG000|Overall Study|Screen Failure, too sick, other|13|||
125596213|NCT02006576|451806439|FG001|Overall Study|Screen Failure, too sick, other|1|||
125596214|NCT02006576|451806440|FG002|Overall Study|Screen Failure, too sick, other|13|||
125596215|NCT04090164|451806443|FG000|Overall Study|incomplete data on file|245|||
125596216|NCT04090164|451806444|FG001|Overall Study|incomplete data on file|0|||
125596217|NCT01650805|451806445|FG000|Overall Study|Withdrawal by Subject|1|||
125596218|NCT01650805|451806446|FG001|Overall Study|Withdrawal by Subject|0|||
125596219|NCT01877655|451806449|FG000|Overall Study|Death|57|||
125212584|NCT01483599|450403424|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
125212585|NCT01483599|450403411|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212586|NCT01483599|450403412|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212587|NCT01483599|450403413|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212588|NCT01483599|450403414|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212589|NCT01483599|450403415|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212590|NCT01483599|450403416|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212591|NCT01483599|450403417|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212592|NCT01483599|450403418|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212593|NCT01483599|450403419|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
125212594|NCT01483599|450403420|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212595|NCT01483599|450403421|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212596|NCT01483599|450403422|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
125212597|NCT01483599|450403423|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
125212598|NCT01483599|450403424|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
125212599|NCT01483599|450403411|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212600|NCT01483599|450403412|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212601|NCT01483599|450403413|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212602|NCT01483599|450403414|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212603|NCT01483599|450403415|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212604|NCT01483599|450403416|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212605|NCT01483599|450403417|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212606|NCT01483599|450403418|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212607|NCT01483599|450403419|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
125212608|NCT01483599|450403420|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212609|NCT01483599|450403421|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
125212610|NCT01483599|450403422|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212611|NCT01483599|450403423|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
125212612|NCT01483599|450403424|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
125212613|NCT01483599|450403411|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212614|NCT01483599|450403412|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212615|NCT01483599|450403413|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212616|NCT01483599|450403414|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125430190|NCT02173054|451201522|FG002|Overall Study|lack of compliance|0|||
125596220|NCT01877655|451806450|FG001|Overall Study|Death|52|||
125596221|NCT01877655|451806449|FG000|Overall Study|Withdrawal by Subject|18|||
125596222|NCT01877655|451806450|FG001|Overall Study|Withdrawal by Subject|26|||
125596223|NCT01877655|451806449|FG000|Overall Study|Physician Decision|11|||
125596224|NCT01877655|451806450|FG001|Overall Study|Physician Decision|10|||
125596225|NCT01877655|451806449|FG000|Overall Study|Miscellaneous|4|||
125596226|NCT01877655|451806450|FG001|Overall Study|Miscellaneous|4|||
125596227|NCT01877655|451806449|FG000|Overall Study|Randomized but Never Received Drug|8|||
125596228|NCT01877655|451806450|FG001|Overall Study|Randomized but Never Received Drug|5|||
125596229|NCT05847881|451806451|FG000|Overall Study|Principal Investigator Decision|8|||
125596230|NCT05847881|451806451|FG000|Overall Study|Withdrawal by Subject|2|||
125596231|NCT04513158|451806454|FG000|Overall Study|Screen Failure|1|||
125596232|NCT03439345|451808230|FG000|Overall Study|Lost to Follow-up|0|||
125596233|NCT03439345|451808231|FG001|Overall Study|Lost to Follow-up|1|||
125596234|NCT03439345|451808230|FG000|Overall Study|Consent withdrawn|0|||
125596235|NCT03439345|451808231|FG001|Overall Study|Consent withdrawn|1|||
125596236|NCT04493619|451808234|FG000|Overall Study|Death|4|||
125596237|NCT04493619|451808235|FG001|Overall Study|Death|3|||
125596238|NCT04493619|451808236|FG002|Overall Study|Death|3|||
125596239|NCT04493619|451808237|FG003|Overall Study|Death|4|||
125596240|NCT04493619|451808234|FG000|Overall Study|Study discontinued early|10|||
125596241|NCT04493619|451808235|FG001|Overall Study|Study discontinued early|0|||
125596242|NCT04493619|451808236|FG002|Overall Study|Study discontinued early|4|||
125596243|NCT04493619|451808237|FG003|Overall Study|Study discontinued early|8|||
125596244|NCT04493619|451808234|FG000|Overall Study|Lost to Follow-up|0|||
125596245|NCT04493619|451808235|FG001|Overall Study|Lost to Follow-up|0|||
125596246|NCT04493619|451808236|FG002|Overall Study|Lost to Follow-up|0|||
125212617|NCT01483599|450403415|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212618|NCT01483599|450403416|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212619|NCT01483599|450403417|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212620|NCT01483599|450403418|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212621|NCT01483599|450403419|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
125212622|NCT01483599|450403420|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212623|NCT01483599|450403421|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212624|NCT01483599|450403422|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
125212625|NCT01483599|450403423|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
125212626|NCT01483599|450403424|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
125212627|NCT01483599|450403411|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
125212628|NCT01483599|450403412|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
125212629|NCT01483599|450403413|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
125212630|NCT01483599|450403414|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
125212631|NCT01483599|450403415|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
125212632|NCT01483599|450403416|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
125212633|NCT01483599|450403417|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
125212634|NCT01483599|450403418|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
125212635|NCT01483599|450403419|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
125212636|NCT01483599|450403420|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
125212637|NCT01483599|450403421|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
125212638|NCT01483599|450403422|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
125212639|NCT01483599|450403423|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
125212640|NCT01483599|450403424|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
125212641|NCT02510820|450405413|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
125212642|NCT02510820|450405414|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125212643|NCT02510820|450405413|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125212644|NCT02510820|450405414|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
125212645|NCT03046056|450405415|FG000|Overall Study|Non-responder at Week 10|6|||
125212646|NCT03046056|450405416|FG001|Overall Study|Non-responder at Week 10|6|||
125212647|NCT03046056|450405417|FG002|Overall Study|Non-responder at Week 10|4|||
125212648|NCT03046056|450405415|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
125212649|NCT03046056|450405416|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
125212650|NCT03046056|450405417|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
125212651|NCT03046056|450405415|FG000|Overall Study|Adverse Event|1|||
125212652|NCT03046056|450405416|FG001|Overall Study|Adverse Event|5|||
125212653|NCT03046056|450405417|FG002|Overall Study|Adverse Event|0|||
125212654|NCT03046056|450405415|FG000|Overall Study|Non-compliance With Study Drug|0|||
125212655|NCT03046056|450405416|FG001|Overall Study|Non-compliance With Study Drug|0|||
125212656|NCT03046056|450405417|FG002|Overall Study|Non-compliance With Study Drug|2|||
125212657|NCT03046056|450405415|FG000|Overall Study|Protocol Violation|1|||
125212658|NCT03046056|450405416|FG001|Overall Study|Protocol Violation|1|||
125212659|NCT03046056|450405417|FG002|Overall Study|Protocol Violation|0|||
125212660|NCT03046056|450405415|FG000|Overall Study|Investigator's Discretion|0|||
125212661|NCT03046056|450405416|FG001|Overall Study|Investigator's Discretion|1|||
125212662|NCT03046056|450405417|FG002|Overall Study|Investigator's Discretion|0|||
125212663|NCT03046056|450405415|FG000|Overall Study|Withdrew Consent|1|||
125212664|NCT03046056|450405416|FG001|Overall Study|Withdrew Consent|0|||
125212665|NCT03046056|450405417|FG002|Overall Study|Withdrew Consent|0|||
125212666|NCT02913105|450405418|FG000|Overall Study|Adverse Event|11|||
125366720|NCT02165215|450977185|FG002|Maintenance Phase|Multiple reasons|1|||
125366721|NCT02165215|450977183|FG000|Maintenance Phase|Lost to Follow-up|0|||
125366722|NCT02165215|450977184|FG001|Maintenance Phase|Lost to Follow-up|2|||
125366723|NCT02165215|450977185|FG002|Maintenance Phase|Lost to Follow-up|0|||
125596247|NCT04493619|451808237|FG003|Overall Study|Lost to Follow-up|1|||
125596248|NCT02128490|451808240|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
125596249|NCT02128490|451808241|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
125596250|NCT02128490|451808242|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
125596251|NCT02128490|451808243|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
125366724|NCT02165215|450977183|FG000|Maintenance Phase|Adverse Event|0|||
125366725|NCT02165215|450977184|FG001|Maintenance Phase|Adverse Event|1|||
125596252|NCT02128490|451808244|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
125596253|NCT02128490|451808240|FG000|Overall Study|Major Protocol Deviation|1|||
125596254|NCT02128490|451808241|FG001|Overall Study|Major Protocol Deviation|2|||
125596255|NCT02128490|451808242|FG002|Overall Study|Major Protocol Deviation|0|||
125212667|NCT02913105|450405419|FG001|Overall Study|Adverse Event|0|||
125212668|NCT02913105|450405420|FG002|Overall Study|Adverse Event|4|||
125366726|NCT02165215|450977185|FG002|Maintenance Phase|Adverse Event|1|||
125366727|NCT04678661|450977186|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
125596256|NCT02128490|451808243|FG003|Overall Study|Major Protocol Deviation|2|||
125596257|NCT02128490|451808244|FG004|Overall Study|Major Protocol Deviation|2|||
125596258|NCT02128490|451808240|FG000|Overall Study|Lost to Follow-up|0|||
125596259|NCT02128490|451808241|FG001|Overall Study|Lost to Follow-up|0|||
125596260|NCT02128490|451808242|FG002|Overall Study|Lost to Follow-up|1|||
125596261|NCT02128490|451808243|FG003|Overall Study|Lost to Follow-up|1|||
125596262|NCT02128490|451808244|FG004|Overall Study|Lost to Follow-up|1|||
125596263|NCT02128490|451808240|FG000|Overall Study|Voluntary Withdrawal|3|||
125596264|NCT02128490|451808241|FG001|Overall Study|Voluntary Withdrawal|3|||
125596265|NCT02128490|451808242|FG002|Overall Study|Voluntary Withdrawal|1|||
125596266|NCT02128490|451808243|FG003|Overall Study|Voluntary Withdrawal|1|||
125596267|NCT02128490|451808244|FG004|Overall Study|Voluntary Withdrawal|2|||
125596268|NCT02128490|451808240|FG000|Overall Study|Lack of Efficacy|0|||
125596269|NCT02128490|451808241|FG001|Overall Study|Lack of Efficacy|1|||
125596270|NCT02128490|451808242|FG002|Overall Study|Lack of Efficacy|0|||
125596271|NCT02128490|451808243|FG003|Overall Study|Lack of Efficacy|0|||
125596272|NCT02128490|451808244|FG004|Overall Study|Lack of Efficacy|0|||
125596273|NCT02128490|451808240|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
125596274|NCT02128490|451808241|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
125596275|NCT02128490|451808242|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
125596276|NCT02128490|451808243|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
125596277|NCT02128490|451808244|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
125596278|NCT02128490|451808240|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125596279|NCT02128490|451808241|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125596280|NCT02128490|451808242|FG002|Overall Study|Other Miscellaneous Reasons|2|||
125596281|NCT02128490|451808243|FG003|Overall Study|Other Miscellaneous Reasons|1|||
125596282|NCT02128490|451808244|FG004|Overall Study|Other Miscellaneous Reasons|1|||
125596283|NCT02243176|451808245|FG000|Overall Study|Other reason|1|||
125596284|NCT02243176|451808246|FG001|Overall Study|Other reason|2|||
125596285|NCT02243176|451808245|FG000|Overall Study|protocol specified withdrawal critera|1|||
125596286|NCT02243176|451808246|FG001|Overall Study|protocol specified withdrawal critera|3|||
125596287|NCT02243176|451808245|FG000|Overall Study|Protocol Violation|2|||
125596288|NCT02243176|451808246|FG001|Overall Study|Protocol Violation|1|||
125596289|NCT02243176|451808245|FG000|Overall Study|Withdrawal by Subject|8|||
125596290|NCT02243176|451808246|FG001|Overall Study|Withdrawal by Subject|7|||
125596291|NCT02243176|451808245|FG000|Overall Study|Adverse Event|2|||
125596292|NCT02243176|451808246|FG001|Overall Study|Adverse Event|2|||
125596293|NCT03705494|451808249|FG000|Overall Study|Lost to Follow-up|2|||
125596294|NCT03705494|451808250|FG001|Overall Study|Lost to Follow-up|1|||
125596295|NCT03705494|451808249|FG000|Overall Study|Withdrawal by Subject|5|||
125596296|NCT03705494|451808250|FG001|Overall Study|Withdrawal by Subject|2|||
125596297|NCT03704051|451808251|FG000|Overall Study|Withdrawal by Subject|4|||
125596298|NCT03704051|451808252|FG001|Overall Study|Withdrawal by Subject|0|||
125212669|NCT02913105|450405418|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125212670|NCT02913105|450405419|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125366728|NCT04678661|450977187|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
125366729|NCT04678661|450977186|FG000|Overall Study|Protocol Violation|2|||
125596299|NCT02629393|451808253|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
125596300|NCT02629393|451808253|FG000|Overall Study|Physician Decision|1|||
125596301|NCT01981187|451808257|FG000|Overall Study|Participant/guardian decision|2|||
125596302|NCT01981187|451808257|FG000|Overall Study|Physician Decision|1|||
125596303|NCT01981187|451808257|FG000|Overall Study|Disease progression|2|||
125596304|NCT01981187|451808257|FG000|Overall Study|Adverse Event|7|||
125596305|NCT01943539|451808261|FG000|Overall Study|Non-compliance with at-home intervention|4|||
125596306|NCT01943539|451808262|FG001|Overall Study|Non-compliance with at-home intervention|0|||
125596307|NCT02413255|451808263|FG000|Overall Study|Voluntary Withdrawal|0|||
125596308|NCT02413255|451808264|FG001|Overall Study|Voluntary Withdrawal|0|||
125596309|NCT02413255|451808265|FG002|Overall Study|Voluntary Withdrawal|0|||
125596310|NCT02413255|451808266|FG003|Overall Study|Voluntary Withdrawal|0|||
125596311|NCT02413255|451808267|FG004|Overall Study|Voluntary Withdrawal|0|||
125596312|NCT02413255|451808268|FG005|Overall Study|Voluntary Withdrawal|0|||
125596313|NCT02413255|451808269|FG006|Overall Study|Voluntary Withdrawal|0|||
125596314|NCT02413255|451808270|FG007|Overall Study|Voluntary Withdrawal|0|||
125596315|NCT02413255|451808271|FG008|Overall Study|Voluntary Withdrawal|0|||
125596316|NCT02413255|451808272|FG009|Overall Study|Voluntary Withdrawal|0|||
125596317|NCT02413255|451808273|FG010|Overall Study|Voluntary Withdrawal|0|||
125596318|NCT02413255|451808274|FG011|Overall Study|Voluntary Withdrawal|0|||
125596319|NCT02413255|451808275|FG012|Overall Study|Voluntary Withdrawal|0|||
125596320|NCT02413255|451808276|FG013|Overall Study|Voluntary Withdrawal|0|||
125596321|NCT02413255|451808277|FG014|Overall Study|Voluntary Withdrawal|1|||
125596322|NCT02413255|451808278|FG015|Overall Study|Voluntary Withdrawal|0|||
125596323|NCT02413255|451808279|FG016|Overall Study|Voluntary Withdrawal|0|||
125596324|NCT02333331|451808280|FG000|Overall Study|Adverse Event|1|||
125596325|NCT02333331|451808281|FG001|Overall Study|Adverse Event|0|||
125596326|NCT02333331|451808282|FG002|Overall Study|Adverse Event|4|||
125596327|NCT02333331|451808283|FG003|Overall Study|Adverse Event|1|||
125596328|NCT02333331|451808280|FG000|Overall Study|Death|0|||
125596329|NCT02333331|451808281|FG001|Overall Study|Death|0|||
125596330|NCT02333331|451808282|FG002|Overall Study|Death|2|||
125596331|NCT02333331|451808283|FG003|Overall Study|Death|0|||
125596332|NCT02333331|451808280|FG000|Overall Study|Lost to Follow-up|0|||
125596333|NCT02333331|451808281|FG001|Overall Study|Lost to Follow-up|0|||
125596334|NCT02333331|451808282|FG002|Overall Study|Lost to Follow-up|1|||
125596335|NCT02333331|451808283|FG003|Overall Study|Lost to Follow-up|0|||
125596336|NCT02333331|451808280|FG000|Overall Study|Physician Decision|0|||
125596337|NCT02333331|451808281|FG001|Overall Study|Physician Decision|1|||
125596338|NCT02333331|451808282|FG002|Overall Study|Physician Decision|0|||
125596339|NCT02333331|451808283|FG003|Overall Study|Physician Decision|0|||
125596340|NCT02333331|451808280|FG000|Overall Study|Protocol Deviation|0|||
125596341|NCT02333331|451808281|FG001|Overall Study|Protocol Deviation|3|||
125596342|NCT02333331|451808282|FG002|Overall Study|Protocol Deviation|2|||
125596343|NCT02333331|451808283|FG003|Overall Study|Protocol Deviation|1|||
125596344|NCT02333331|451808280|FG000|Overall Study|Patient/Guardian Decision|1|||
125596345|NCT02333331|451808281|FG001|Overall Study|Patient/Guardian Decision|2|||
125596346|NCT02333331|451808282|FG002|Overall Study|Patient/Guardian Decision|9|||
125596347|NCT02333331|451808283|FG003|Overall Study|Patient/Guardian Decision|1|||
125596348|NCT05309668|451808284|FG000|Overall Study|Ongoing at data cut-off|14|||
125596349|NCT05309668|451808285|FG001|Overall Study|Ongoing at data cut-off|17|||
125596350|NCT05309668|451808286|FG002|Overall Study|Ongoing at data cut-off|4|||
125596351|NCT01451515|451808294|FG000|Overall Study|Death|0|||
125596352|NCT01451515|451808295|FG001|Overall Study|Death|1|||
125596353|NCT01451515|451808296|FG002|Overall Study|Death|0|||
125596354|NCT01451515|451808294|FG000|Overall Study|Withdrawal by Subject|0|||
125596355|NCT01451515|451808295|FG001|Overall Study|Withdrawal by Subject|1|||
125596356|NCT01451515|451808296|FG002|Overall Study|Withdrawal by Subject|0|||
125596357|NCT01451515|451808294|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
125596358|NCT01451515|451808295|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
125596359|NCT01451515|451808296|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
125596360|NCT01451515|451808294|FG000|Overall Study|Relapse (except CNS)|1|||
125596361|NCT01451515|451808295|FG001|Overall Study|Relapse (except CNS)|1|||
125596362|NCT01451515|451808296|FG002|Overall Study|Relapse (except CNS)|0|||
125596363|NCT00174941|451808297|FG000|Overall Study|Adverse Event|1|||
125596364|NCT00174941|451808298|FG001|Overall Study|Adverse Event|10|||
125430191|NCT02173054|451201520|FG000|Overall Study|Withdrawal by Subject|0|||
125430192|NCT02173054|451201521|FG001|Overall Study|Withdrawal by Subject|0|||
125430193|NCT02173054|451201522|FG002|Overall Study|Withdrawal by Subject|1|||
125596365|NCT00174941|451808299|FG002|Overall Study|Adverse Event|2|||
125596366|NCT00174941|451808300|FG003|Overall Study|Adverse Event|13|||
125596367|NCT00174941|451808297|FG000|Overall Study|Protocol Violation|0|||
125596368|NCT00174941|451808298|FG001|Overall Study|Protocol Violation|1|||
125596369|NCT00174941|451808299|FG002|Overall Study|Protocol Violation|0|||
125596370|NCT00174941|451808300|FG003|Overall Study|Protocol Violation|1|||
125596371|NCT00174941|451808297|FG000|Overall Study|Lost to Follow-up|0|||
125596372|NCT00174941|451808298|FG001|Overall Study|Lost to Follow-up|3|||
125596373|NCT00174941|451808299|FG002|Overall Study|Lost to Follow-up|2|||
125430194|NCT01559454|451201525|FG000|Overall Study|Lost to Follow-up|3|||
125596374|NCT00174941|451808300|FG003|Overall Study|Lost to Follow-up|5|||
125596375|NCT00174941|451808297|FG000|Overall Study|Personal Reason(s)|0|||
125596376|NCT00174941|451808298|FG001|Overall Study|Personal Reason(s)|14|||
125596377|NCT00174941|451808299|FG002|Overall Study|Personal Reason(s)|8|||
125596378|NCT00174941|451808300|FG003|Overall Study|Personal Reason(s)|22|||
125596379|NCT00174941|451808297|FG000|Overall Study|Gout Flare|0|||
125596380|NCT00174941|451808298|FG001|Overall Study|Gout Flare|4|||
125596381|NCT00174941|451808299|FG002|Overall Study|Gout Flare|4|||
125596382|NCT00174941|451808300|FG003|Overall Study|Gout Flare|8|||
125596383|NCT00174941|451808297|FG000|Overall Study|Reason Not Specified|1|||
125596384|NCT00174941|451808298|FG001|Overall Study|Reason Not Specified|6|||
125596385|NCT00174941|451808299|FG002|Overall Study|Reason Not Specified|2|||
125596386|NCT00174941|451808300|FG003|Overall Study|Reason Not Specified|9|||
125596387|NCT03230097|451808304|FG000|Overall Study|Adverse Event|2|||
125596388|NCT03230097|451808305|FG001|Overall Study|Adverse Event|1|||
125596389|NCT03230097|451808304|FG000|Overall Study|non-compliance|0|||
125596390|NCT03230097|451808305|FG001|Overall Study|non-compliance|1|||
125596391|NCT03230097|451808304|FG000|Overall Study|Lost to Follow-up|2|||
125596392|NCT03230097|451808305|FG001|Overall Study|Lost to Follow-up|4|||
125596393|NCT03230097|451808304|FG000|Overall Study|Withdrawal by Subject|7|||
125596394|NCT03230097|451808305|FG001|Overall Study|Withdrawal by Subject|3|||
125596395|NCT03230097|451808304|FG000|Overall Study|Trial termination|4|||
125596396|NCT03230097|451808305|FG001|Overall Study|Trial termination|5|||
125596397|NCT03230097|451808304|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
125430195|NCT01559454|451201526|FG001|Overall Study|Lost to Follow-up|2|||
125430196|NCT01559454|451201525|FG000|Overall Study|Withdrawal by Subject|0|||
125430197|NCT01559454|451201526|FG001|Overall Study|Withdrawal by Subject|1|||
125430198|NCT01559454|451201525|FG000|Overall Study|Physician Decision|0|||
125430199|NCT01559454|451201526|FG001|Overall Study|Physician Decision|1|||
125430200|NCT01559454|451201525|FG000|Overall Study|Protocol Violation|0|||
125430201|NCT01559454|451201526|FG001|Overall Study|Protocol Violation|1|||
125430202|NCT01559454|451201525|FG000|Overall Study|Lack of Efficacy|0|||
125430203|NCT01559454|451201526|FG001|Overall Study|Lack of Efficacy|1|||
125596398|NCT03230097|451808305|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
125596399|NCT03230097|451808304|FG000|Overall Study|outcome event|0|||
125596400|NCT03230097|451808305|FG001|Overall Study|outcome event|1|||
125596401|NCT05370157|451808308|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
125596402|NCT05370157|451808309|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
125596403|NCT05370157|451808308|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
125596404|NCT05370157|451808309|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
125596405|NCT01364467|451808319|FG000|Overall Study|Lost to Follow-up|1|||
125596406|NCT01364467|451808320|FG001|Overall Study|Lost to Follow-up|2|||
125596407|NCT00587223|451808328|FG000|Overall Study|Adverse Event|1|||
125596408|NCT00883753|451808329|FG000|Overall Study|Adverse Event|37|||
125596409|NCT00883753|451808329|FG000|Overall Study|Death|2|||
125596410|NCT00883753|451808329|FG000|Overall Study|Insufficient therapeutic response|16|||
125596411|NCT00883753|451808329|FG000|Overall Study|Lost to Follow-up|4|||
125596412|NCT00883753|451808329|FG000|Overall Study|Violation of selection criteria at entry|7|||
125596413|NCT00883753|451808329|FG000|Overall Study|Protocol Violation|2|||
125596414|NCT00883753|451808329|FG000|Overall Study|Refused treatment|4|||
125596415|NCT00883753|451808329|FG000|Overall Study|Withdrew consent|10|||
125596416|NCT00883753|451808329|FG000|Overall Study|Investigator's decision|17|||
125596417|NCT00883753|451808329|FG000|Overall Study|Administrative/Other|8|||
125596418|NCT00971321|451808334|FG000|Up to Month 7|Withdrawal by Subject|1|||
125596419|NCT00971321|451808335|FG001|Up to Month 7|Withdrawal by Subject|0|||
125596420|NCT00971321|451808334|FG000|Up to Month 7|Migrated/moved from study area|3|||
125596421|NCT00971321|451808335|FG001|Up to Month 7|Migrated/moved from study area|2|||
125596422|NCT00971321|451808334|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
125596423|NCT00971321|451808335|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
125596424|NCT00971321|451808334|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
125596425|NCT00971321|451808335|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
125596426|NCT00971321|451808334|FG000|Up to Month 11-12|Lost to Follow-up|1|||
125596427|NCT00971321|451808335|FG001|Up to Month 11-12|Lost to Follow-up|0|||
125596428|NCT03885284|451808338|FG000|Overall Study|Disease Progression|1|||
125596429|NCT03885284|451808339|FG001|Overall Study|Disease Progression|3|||
125596430|NCT03885284|451808338|FG000|Overall Study|Physician Decision|0|||
125596431|NCT03885284|451808339|FG001|Overall Study|Physician Decision|1|||
125596432|NCT01476787|451808344|FG000|Treatment|Progression|64|||
125596433|NCT01476787|451808345|FG001|Treatment|Progression|71|||
125596434|NCT01476787|451808344|FG000|Treatment|Toxicity|44|||
125596435|NCT01476787|451808345|FG001|Treatment|Toxicity|16|||
125596436|NCT01476787|451808344|FG000|Treatment|Death|0|||
125596437|NCT01476787|451808345|FG001|Treatment|Death|1|||
125596438|NCT01476787|451808344|FG000|Treatment|Withdrawal by Subject|3|||
125596439|NCT01476787|451808345|FG001|Treatment|Withdrawal by Subject|14|||
125596440|NCT01476787|451808344|FG000|Treatment|Major protocol violation|1|||
125596441|NCT01476787|451808345|FG001|Treatment|Major protocol violation|6|||
125596442|NCT01476787|451808344|FG000|Treatment|Other reasons|10|||
125596443|NCT01476787|451808345|FG001|Treatment|Other reasons|22|||
125596444|NCT01476787|451808344|FG000|Treatment|Concurrent illness|12|||
125596445|NCT01476787|451808345|FG001|Treatment|Concurrent illness|9|||
125596446|NCT01476787|451808344|FG000|Treatment|Insufficient response|15|||
125596447|NCT01476787|451808345|FG001|Treatment|Insufficient response|3|||
125596448|NCT01476787|451808344|FG000|Treatment|Voluntary treatment discontinuation|8|||
125596449|NCT01476787|451808345|FG001|Treatment|Voluntary treatment discontinuation|4|||
125596450|NCT01591330|451808346|FG000|Period 1|Adverse Event|1|||
125596451|NCT01591330|451808347|FG001|Period 1|Adverse Event|0|||
125596452|NCT01591330|451808348|FG002|Period 1|Adverse Event|0|||
125596453|NCT01591330|451808349|FG003|Period 1|Adverse Event|0|||
125596454|NCT01591330|451808346|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
125596455|NCT01591330|451808347|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
125596456|NCT01591330|451808348|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
125596457|NCT01591330|451808349|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
125596458|NCT01591330|451808346|FG000|Period 2|Adverse Event|1|||
125596459|NCT01591330|451808347|FG001|Period 2|Adverse Event|0|||
125596460|NCT01591330|451808348|FG002|Period 2|Adverse Event|0|||
125596461|NCT01591330|451808349|FG003|Period 2|Adverse Event|0|||
125596462|NCT01450137|451808350|FG000|Up to Week 12|Adverse Event|2|||
125596463|NCT01450137|451808351|FG001|Up to Week 12|Adverse Event|1|||
125596464|NCT01450137|451808350|FG000|Up to Week 12|Withdrawal by Subject|0|||
125596465|NCT01450137|451808351|FG001|Up to Week 12|Withdrawal by Subject|2|||
125596466|NCT01450137|451808350|FG000|Week 12 to Study End|Death|0|||
125596467|NCT01450137|451808351|FG001|Week 12 to Study End|Death|1|||
125596468|NCT01450137|451808350|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
125596469|NCT01450137|451808351|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
125596470|NCT01450540|451808352|FG000|Overall Study|Withdrawal by Subject|19|||
125596471|NCT01450540|451808353|FG001|Overall Study|Withdrawal by Subject|13|||
125596472|NCT01450540|451808352|FG000|Overall Study|protocol deviation|3|||
125596473|NCT01450540|451808353|FG001|Overall Study|protocol deviation|23|||
125596474|NCT01926886|451808354|FG000|Overall Study|Administrative/other|1|||
125596475|NCT01926886|451808355|FG001|Overall Study|Administrative/other|0|||
125596476|NCT01926886|451808354|FG000|Overall Study|Adverse event/intercurrent illness|4|||
125596477|NCT01926886|451808355|FG001|Overall Study|Adverse event/intercurrent illness|0|||
125596478|NCT01926886|451808354|FG000|Overall Study|Disease progression/recurrence|4|||
125596479|NCT01926886|451808355|FG001|Overall Study|Disease progression/recurrence|0|||
125596480|NCT01926886|451808354|FG000|Overall Study|Withdrawal by Subject|15|||
125596481|NCT01926886|451808355|FG001|Overall Study|Withdrawal by Subject|0|||
125596482|NCT01926886|451808354|FG000|Overall Study|Failure to return|3|||
125596483|NCT01926886|451808355|FG001|Overall Study|Failure to return|0|||
125596484|NCT01926886|451808354|FG000|Overall Study|Recurrence of disease|1|||
125596485|NCT01926886|451808355|FG001|Overall Study|Recurrence of disease|0|||
125596486|NCT01926886|451808354|FG000|Overall Study|Progression of disease|2|||
125596487|NCT01926886|451808355|FG001|Overall Study|Progression of disease|0|||
125596488|NCT01926886|451808354|FG000|Overall Study|Death|1|||
125596489|NCT01926886|451808355|FG001|Overall Study|Death|0|||
125596490|NCT01926886|451808354|FG000|Overall Study|Did not cooperate|1|||
125596491|NCT01926886|451808355|FG001|Overall Study|Did not cooperate|0|||
125596492|NCT01662999|451808370|FG000|Period 3|Withdrawal by Subject|0|||
125596493|NCT01662999|451808371|FG001|Period 3|Withdrawal by Subject|1|||
125596494|NCT01662999|451808372|FG002|Period 3|Withdrawal by Subject|0|||
125596495|NCT01662999|451808373|FG003|Period 3|Withdrawal by Subject|0|||
125596496|NCT01662999|451808374|FG004|Period 3|Withdrawal by Subject|0|||
125596497|NCT01662999|451808375|FG005|Period 3|Withdrawal by Subject|0|||
125596498|NCT02932267|451808381|FG000|Overall Study|Withdrawal by Subject|3|||
125596499|NCT02932267|451808381|FG000|Overall Study|Lost to Follow-up|4|||
125596500|NCT02932267|451808381|FG000|Overall Study|Pregnancy|1|||
125596501|NCT03875235|451808382|FG000|Overall Study|Ongoing study treatment|63|||
125596502|NCT03875235|451808383|FG001|Overall Study|Ongoing study treatment|20|||
125596503|NCT03875235|451808382|FG000|Overall Study|Off treatment|77|||
125596504|NCT03875235|451808383|FG001|Overall Study|Off treatment|91|||
125596505|NCT03875235|451808382|FG000|Overall Study|Withdrawal by Subject|3|||
125596506|NCT03875235|451808383|FG001|Overall Study|Withdrawal by Subject|10|||
125596507|NCT03875235|451808382|FG000|Overall Study|Death|198|||
125366730|NCT04678661|450977187|FG001|Overall Study|Protocol Violation|0|||
125366731|NCT04678661|450977186|FG000|Overall Study|Withdrawal by Subject|1|||
125366732|NCT04678661|450977187|FG001|Overall Study|Withdrawal by Subject|0|||
125366733|NCT04678661|450977186|FG000|Overall Study|Lost to Follow-up|2|||
125366734|NCT04678661|450977187|FG001|Overall Study|Lost to Follow-up|0|||
125366735|NCT04678661|450977186|FG000|Overall Study|Death|2|||
125366736|NCT04678661|450977187|FG001|Overall Study|Death|0|||
125366737|NCT01397890|450977188|FG000|Overall Study|Withdrawal by Subject|7|||
125596508|NCT03875235|451808383|FG001|Overall Study|Death|223|||
125596509|NCT03851510|451808386|FG000|Overall Study|Screen Fail|1|||
125596510|NCT03851510|451808386|FG000|Overall Study|Adverse Event|1|||
125596511|NCT03851510|451808386|FG000|Overall Study|Withdrawal by Subject|1|||
125596512|NCT01151137|451808387|FG000|Overall Study|Death|15|||
125596513|NCT01151137|451808388|FG001|Overall Study|Death|27|||
125596514|NCT01151137|451808387|FG000|Overall Study|Lost to Follow-up|1|||
125596515|NCT01151137|451808388|FG001|Overall Study|Lost to Follow-up|1|||
125366738|NCT01397890|450977189|FG001|Overall Study|Withdrawal by Subject|11|||
125596516|NCT03478683|451808389|FG000|Overall Study|Adverse Event|5|||
125596517|NCT03478683|451808390|FG001|Overall Study|Adverse Event|3|||
125596518|NCT03478683|451808389|FG000|Overall Study|Lost to Follow-up|0|||
125596519|NCT03478683|451808390|FG001|Overall Study|Lost to Follow-up|5|||
125596520|NCT03478683|451808389|FG000|Overall Study|Physician Decision|1|||
125596521|NCT03478683|451808390|FG001|Overall Study|Physician Decision|3|||
125596522|NCT03478683|451808389|FG000|Overall Study|Withdrawal by Subject|7|||
125596523|NCT03478683|451808390|FG001|Overall Study|Withdrawal by Subject|7|||
125596524|NCT01887210|451808391|FG000|Overall Study|Withdrawal by Subject|1|||
125596525|NCT01887210|451808392|FG001|Overall Study|Withdrawal by Subject|3|||
125596526|NCT01887210|451808391|FG000|Overall Study|Lost to Follow-up|0|||
125596527|NCT01887210|451808392|FG001|Overall Study|Lost to Follow-up|1|||
125596528|NCT01287117|451808399|FG000|Overall Study|Adverse Event|2|||
125596529|NCT01287117|451808400|FG001|Overall Study|Adverse Event|1|||
125596530|NCT01287117|451808401|FG002|Overall Study|Adverse Event|1|||
125596531|NCT01287117|451808402|FG003|Overall Study|Adverse Event|1|||
125596532|NCT01287117|451808399|FG000|Overall Study|Lost to Follow-up|1|||
125596533|NCT01287117|451808400|FG001|Overall Study|Lost to Follow-up|1|||
125596534|NCT01287117|451808401|FG002|Overall Study|Lost to Follow-up|0|||
125596535|NCT01287117|451808402|FG003|Overall Study|Lost to Follow-up|0|||
125596536|NCT01287117|451808399|FG000|Overall Study|Physician Decision|0|||
125596537|NCT01287117|451808400|FG001|Overall Study|Physician Decision|1|||
125596538|NCT01287117|451808401|FG002|Overall Study|Physician Decision|1|||
125596539|NCT01287117|451808402|FG003|Overall Study|Physician Decision|1|||
125596540|NCT01287117|451808399|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
125596541|NCT01287117|451808400|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
125596542|NCT01287117|451808401|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
125596543|NCT01287117|451808402|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
125596544|NCT01287117|451808399|FG000|Overall Study|Disease Progression|10|||
125596545|NCT01287117|451808400|FG001|Overall Study|Disease Progression|5|||
125596546|NCT01287117|451808401|FG002|Overall Study|Disease Progression|6|||
125596547|NCT01287117|451808402|FG003|Overall Study|Disease Progression|5|||
125596548|NCT00630032|451808403|FG000|Overall Study|Death|55|||
125596549|NCT00630032|451808404|FG001|Overall Study|Death|49|||
125596550|NCT00630032|451808403|FG000|Overall Study|Withdrawal by Subject|3|||
125596551|NCT00630032|451808404|FG001|Overall Study|Withdrawal by Subject|2|||
125596552|NCT00630032|451808403|FG000|Overall Study|Lost to Follow-up|18|||
125596553|NCT00630032|451808404|FG001|Overall Study|Lost to Follow-up|31|||
125596554|NCT00630032|451808403|FG000|Overall Study|Protocol Violation|1|||
125596555|NCT00630032|451808404|FG001|Overall Study|Protocol Violation|0|||
125596556|NCT00630032|451808403|FG000|Overall Study|Patient has moved|1|||
125596557|NCT00630032|451808404|FG001|Overall Study|Patient has moved|1|||
125596558|NCT00630032|451808403|FG000|Overall Study|Disease progression|1|||
125596559|NCT00630032|451808404|FG001|Overall Study|Disease progression|1|||
125596560|NCT00630032|451808403|FG000|Overall Study|End of monitoring in US centers|11|||
125596561|NCT00630032|451808404|FG001|Overall Study|End of monitoring in US centers|11|||
125596562|NCT02332915|451808405|FG000|Overall Study|Moved out of region|3|||
125596563|NCT02332915|451808406|FG001|Overall Study|Moved out of region|0|||
125596564|NCT02332915|451808405|FG000|Overall Study|Unrelated illness|1|||
125596565|NCT02332915|451808406|FG001|Overall Study|Unrelated illness|1|||
125596566|NCT02332915|451808405|FG000|Overall Study|Travel distance prohibitive|0|||
125596567|NCT02332915|451808406|FG001|Overall Study|Travel distance prohibitive|1|||
125596568|NCT02332915|451808405|FG000|Overall Study|did not meet inclusion criteria|2|||
125596569|NCT02332915|451808406|FG001|Overall Study|did not meet inclusion criteria|4|||
125596570|NCT02342171|451810308|FG000|Overall Study|Death|4|||
125596571|NCT02342171|451810309|FG001|Overall Study|Death|87|||
125596572|NCT02342171|451810308|FG000|Overall Study|Received favipiravir|10|||
125596573|NCT02342171|451810309|FG001|Overall Study|Received favipiravir|0|||
125596574|NCT02342171|451810308|FG000|Overall Study|Missing cycle treshold value|1|||
125596575|NCT02342171|451810309|FG001|Overall Study|Missing cycle treshold value|0|||
125596576|NCT02342171|451810308|FG000|Overall Study|Unknown outcome|0|||
125596577|NCT02342171|451810309|FG001|Overall Study|Unknown outcome|1|||
125596578|NCT02342171|451810308|FG000|Overall Study|Missing age data|0|||
125596579|NCT02342171|451810309|FG001|Overall Study|Missing age data|1|||
125212671|NCT02913105|450405420|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125596580|NCT05165394|451810310|FG000|Overall Study|Withdrawal by Subject|5|||
125596581|NCT05165394|451810311|FG001|Overall Study|Withdrawal by Subject|1|||
125596582|NCT05165394|451810310|FG000|Overall Study|Lost to Follow-up|1|||
125596583|NCT05165394|451810311|FG001|Overall Study|Lost to Follow-up|2|||
125596584|NCT05165394|451810310|FG000|Overall Study|Other Than Specified|0|||
125596585|NCT05165394|451810311|FG001|Overall Study|Other Than Specified|1|||
125596586|NCT02517515|451810317|FG000|Overall Study|Adverse Event|0|||
125596587|NCT02517515|451810318|FG001|Overall Study|Adverse Event|1|||
125596588|NCT02517515|451810317|FG000|Overall Study|Withdrew Consent|0|||
125596589|NCT02517515|451810318|FG001|Overall Study|Withdrew Consent|1|||
125596590|NCT02517515|451810317|FG000|Overall Study|Lost to Follow-up|1|||
125596591|NCT02517515|451810318|FG001|Overall Study|Lost to Follow-up|0|||
125596592|NCT02517515|451810317|FG000|Overall Study|Other|1|||
125596593|NCT02517515|451810318|FG001|Overall Study|Other|0|||
125596594|NCT02786537|451810319|FG000|As Randomized|Adverse Event|0|||
125596595|NCT02786537|451810320|FG001|As Randomized|Adverse Event|11|||
125430204|NCT01114204|451201527|FG000|Overall Study|Adverse Event|3|||
125430205|NCT01114204|451201528|FG001|Overall Study|Adverse Event|2|||
125430206|NCT01114204|451201527|FG000|Overall Study|Lost to Follow-up|1|||
125430207|NCT01114204|451201528|FG001|Overall Study|Lost to Follow-up|0|||
125430208|NCT01114204|451201527|FG000|Overall Study|Withdrawal by Subject|10|||
125430209|NCT01114204|451201528|FG001|Overall Study|Withdrawal by Subject|6|||
125430210|NCT01114204|451201527|FG000|Overall Study|Death|1|||
125430211|NCT01114204|451201528|FG001|Overall Study|Death|0|||
125430212|NCT01114204|451201527|FG000|Overall Study|Other-Personal reasons|2|||
125430213|NCT01114204|451201528|FG001|Overall Study|Other-Personal reasons|0|||
125430214|NCT01114204|451201527|FG000|Overall Study|Other-Medical monitor request|1|||
125430215|NCT01114204|451201528|FG001|Overall Study|Other-Medical monitor request|0|||
125430216|NCT01114204|451201527|FG000|Overall Study|Other-Participant request|2|||
125430217|NCT01114204|451201528|FG001|Overall Study|Other-Participant request|0|||
125430218|NCT01114204|451201527|FG000|Overall Study|Other-Protocol Violation|1|||
125430219|NCT01114204|451201528|FG001|Overall Study|Other-Protocol Violation|0|||
125430220|NCT03420781|451201536|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
125430221|NCT03420781|451201537|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
125430222|NCT03420781|451201538|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
125430223|NCT03420781|451201539|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
125430224|NCT03420781|451201540|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
125430225|NCT03420781|451201536|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
125430226|NCT03420781|451201537|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
125430227|NCT03420781|451201538|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
125430228|NCT03420781|451201539|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
125430229|NCT03420781|451201540|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
125430230|NCT03420781|451201536|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
125430231|NCT03420781|451201537|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
125430232|NCT03420781|451201538|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
125430233|NCT03420781|451201539|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
125430234|NCT03420781|451201540|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
125430235|NCT03420781|451201536|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
125430236|NCT03420781|451201537|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
125430237|NCT03420781|451201538|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
125430238|NCT03420781|451201539|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
125430239|NCT03420781|451201540|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
125430240|NCT03420781|451201536|FG000|Treatment Period (40 Weeks)|Death|2|||
125430241|NCT03420781|451201537|FG001|Treatment Period (40 Weeks)|Death|2|||
125430242|NCT03420781|451201538|FG002|Treatment Period (40 Weeks)|Death|0|||
125430243|NCT03420781|451201539|FG003|Treatment Period (40 Weeks)|Death|0|||
125430244|NCT03420781|451201540|FG004|Treatment Period (40 Weeks)|Death|0|||
125430245|NCT03420781|451201536|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
125430246|NCT03420781|451201537|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
125430247|NCT03420781|451201538|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
125596596|NCT02786537|451810321|FG002|As Randomized|Adverse Event|0|||
125596597|NCT02786537|451810322|FG003|As Randomized|Adverse Event|4|||
125596598|NCT02786537|451810323|FG004|As Randomized|Adverse Event|6|||
125596599|NCT02786537|451810324|FG005|As Randomized|Adverse Event|2|||
125596600|NCT02786537|451810319|FG000|As Randomized|Lack of Efficacy|0|||
125596601|NCT02786537|451810320|FG001|As Randomized|Lack of Efficacy|0|||
125596602|NCT02786537|451810321|FG002|As Randomized|Lack of Efficacy|0|||
125596603|NCT02786537|451810322|FG003|As Randomized|Lack of Efficacy|1|||
125596604|NCT02786537|451810323|FG004|As Randomized|Lack of Efficacy|0|||
125596605|NCT02786537|451810324|FG005|As Randomized|Lack of Efficacy|0|||
125596606|NCT02786537|451810319|FG000|As Randomized|Withdrawal by Subject|1|||
125596607|NCT02786537|451810320|FG001|As Randomized|Withdrawal by Subject|2|||
125596608|NCT02786537|451810321|FG002|As Randomized|Withdrawal by Subject|0|||
125596609|NCT02786537|451810322|FG003|As Randomized|Withdrawal by Subject|1|||
125596610|NCT02786537|451810323|FG004|As Randomized|Withdrawal by Subject|1|||
125596611|NCT02786537|451810324|FG005|As Randomized|Withdrawal by Subject|0|||
125430248|NCT03420781|451201539|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
125430249|NCT03420781|451201540|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
125430250|NCT03420781|451201536|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
125430251|NCT03420781|451201537|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
125430252|NCT03420781|451201538|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
125596612|NCT02786537|451810319|FG000|As Randomized|Death|0|||
125596613|NCT02786537|451810320|FG001|As Randomized|Death|2|||
125366739|NCT01397890|450977188|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
125366740|NCT01397890|450977189|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
125366741|NCT01397890|450977188|FG000|Overall Study|Death|2|||
125366742|NCT01397890|450977189|FG001|Overall Study|Death|3|||
125366743|NCT01397890|450977188|FG000|Overall Study|Lost to Follow-up|1|||
125366744|NCT01397890|450977189|FG001|Overall Study|Lost to Follow-up|4|||
125366745|NCT01397890|450977188|FG000|Overall Study|Condition under Investigation Worsened|1|||
125366746|NCT01397890|450977189|FG001|Overall Study|Condition under Investigation Worsened|3|||
125366747|NCT01397890|450977188|FG000|Overall Study|Adverse Event|1|||
125366748|NCT01397890|450977189|FG001|Overall Study|Adverse Event|2|||
125366749|NCT01397890|450977188|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
125366750|NCT01397890|450977189|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
125366751|NCT01397890|450977188|FG000|Overall Study|Others|2|||
125366752|NCT01397890|450977189|FG001|Overall Study|Others|1|||
125366753|NCT03094169|450977190|FG000|Overall Study|Lack of Efficacy|0|||
125366754|NCT03094169|450977191|FG001|Overall Study|Lack of Efficacy|0|||
125366755|NCT03094169|450977192|FG002|Overall Study|Lack of Efficacy|0|||
125366756|NCT03094169|450977193|FG003|Overall Study|Lack of Efficacy|0|||
125366757|NCT03094169|450977194|FG004|Overall Study|Lack of Efficacy|0|||
125366758|NCT03094169|450977195|FG005|Overall Study|Lack of Efficacy|0|||
125366759|NCT03094169|450977196|FG006|Overall Study|Lack of Efficacy|0|||
125366760|NCT03094169|450977197|FG007|Overall Study|Lack of Efficacy|21|||
125366761|NCT03094169|450977190|FG000|Overall Study|Adverse Event|0|||
125366762|NCT03094169|450977191|FG001|Overall Study|Adverse Event|0|||
125366763|NCT03094169|450977192|FG002|Overall Study|Adverse Event|0|||
125366764|NCT03094169|450977193|FG003|Overall Study|Adverse Event|0|||
125366765|NCT03094169|450977194|FG004|Overall Study|Adverse Event|0|||
125366766|NCT03094169|450977195|FG005|Overall Study|Adverse Event|0|||
125366767|NCT03094169|450977196|FG006|Overall Study|Adverse Event|0|||
125366768|NCT03094169|450977197|FG007|Overall Study|Adverse Event|2|||
125366769|NCT03094169|450977190|FG000|Overall Study|Withdrawal by Subject|0|||
125366770|NCT03094169|450977191|FG001|Overall Study|Withdrawal by Subject|0|||
125366771|NCT03094169|450977192|FG002|Overall Study|Withdrawal by Subject|0|||
125366772|NCT03094169|450977193|FG003|Overall Study|Withdrawal by Subject|0|||
125212672|NCT02913105|450405418|FG000|Overall Study|Reason Not Specified|3|||
125212673|NCT02913105|450405419|FG001|Overall Study|Reason Not Specified|1|||
125212674|NCT02913105|450405420|FG002|Overall Study|Reason Not Specified|1|||
125430253|NCT03420781|451201539|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
125430254|NCT03420781|451201540|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
125596614|NCT02786537|451810321|FG002|As Randomized|Death|0|||
125596615|NCT02786537|451810322|FG003|As Randomized|Death|3|||
125596616|NCT02786537|451810323|FG004|As Randomized|Death|1|||
125596617|NCT02786537|451810324|FG005|As Randomized|Death|0|||
125596618|NCT02786537|451810319|FG000|As Randomized|Non-compliance with study drug|1|||
125596619|NCT02786537|451810320|FG001|As Randomized|Non-compliance with study drug|11|||
125596620|NCT02786537|451810321|FG002|As Randomized|Non-compliance with study drug|0|||
125596621|NCT02786537|451810322|FG003|As Randomized|Non-compliance with study drug|1|||
125596622|NCT02786537|451810323|FG004|As Randomized|Non-compliance with study drug|0|||
125596623|NCT02786537|451810324|FG005|As Randomized|Non-compliance with study drug|1|||
125596624|NCT02786537|451810319|FG000|As Randomized|Lost to treatment follow-up|4|||
125596625|NCT02786537|451810320|FG001|As Randomized|Lost to treatment follow-up|32|||
125596626|NCT02786537|451810321|FG002|As Randomized|Lost to treatment follow-up|0|||
125596627|NCT02786537|451810322|FG003|As Randomized|Lost to treatment follow-up|24|||
125596628|NCT02786537|451810323|FG004|As Randomized|Lost to treatment follow-up|4|||
125596629|NCT02786537|451810324|FG005|As Randomized|Lost to treatment follow-up|4|||
125596630|NCT02786537|451810319|FG000|As Randomized|Incarceration|0|||
125596631|NCT02786537|451810320|FG001|As Randomized|Incarceration|1|||
125596632|NCT02786537|451810321|FG002|As Randomized|Incarceration|0|||
125596633|NCT02786537|451810322|FG003|As Randomized|Incarceration|0|||
125596634|NCT02786537|451810323|FG004|As Randomized|Incarceration|0|||
125596635|NCT02786537|451810324|FG005|As Randomized|Incarceration|0|||
125596636|NCT02786537|451810319|FG000|As Randomized|Opiate Dependency Relapse|0|||
125596637|NCT02786537|451810320|FG001|As Randomized|Opiate Dependency Relapse|1|||
125596638|NCT02786537|451810321|FG002|As Randomized|Opiate Dependency Relapse|0|||
125596639|NCT02786537|451810322|FG003|As Randomized|Opiate Dependency Relapse|0|||
125596640|NCT02786537|451810323|FG004|As Randomized|Opiate Dependency Relapse|0|||
125596641|NCT02786537|451810324|FG005|As Randomized|Opiate Dependency Relapse|0|||
125596642|NCT02786537|451810319|FG000|As Randomized|HCV drugs stolen from pt|0|||
125596643|NCT02786537|451810320|FG001|As Randomized|HCV drugs stolen from pt|1|||
125596644|NCT02786537|451810321|FG002|As Randomized|HCV drugs stolen from pt|0|||
125596645|NCT02786537|451810322|FG003|As Randomized|HCV drugs stolen from pt|0|||
125596646|NCT02786537|451810323|FG004|As Randomized|HCV drugs stolen from pt|0|||
125596647|NCT02786537|451810324|FG005|As Randomized|HCV drugs stolen from pt|0|||
125596648|NCT02786537|451810319|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
125596649|NCT02786537|451810320|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
125596650|NCT02786537|451810321|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
125596651|NCT02786537|451810322|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
125596652|NCT02786537|451810323|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
125596653|NCT02786537|451810324|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
125596654|NCT02786537|451810319|FG000|As Randomized|Subject lost insurance|0|||
125596655|NCT02786537|451810320|FG001|As Randomized|Subject lost insurance|0|||
125596656|NCT02786537|451810321|FG002|As Randomized|Subject lost insurance|0|||
125596657|NCT02786537|451810322|FG003|As Randomized|Subject lost insurance|1|||
125596658|NCT02786537|451810323|FG004|As Randomized|Subject lost insurance|0|||
125596659|NCT02786537|451810324|FG005|As Randomized|Subject lost insurance|0|||
125596660|NCT02786537|451810319|FG000|As Treated|Adverse Event|0|||
125430255|NCT03420781|451201536|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
125430256|NCT03420781|451201537|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
125430257|NCT03420781|451201538|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
125430258|NCT03420781|451201539|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
125596661|NCT02786537|451810320|FG001|As Treated|Adverse Event|11|||
125596662|NCT02786537|451810321|FG002|As Treated|Adverse Event|0|||
125596663|NCT02786537|451810322|FG003|As Treated|Adverse Event|4|||
125596664|NCT02786537|451810323|FG004|As Treated|Adverse Event|6|||
125596665|NCT02786537|451810324|FG005|As Treated|Adverse Event|2|||
125596666|NCT02786537|451810319|FG000|As Treated|Death|0|||
125596667|NCT02786537|451810320|FG001|As Treated|Death|2|||
125596668|NCT02786537|451810321|FG002|As Treated|Death|0|||
125596669|NCT02786537|451810322|FG003|As Treated|Death|3|||
125596670|NCT02786537|451810323|FG004|As Treated|Death|1|||
125596671|NCT02786537|451810324|FG005|As Treated|Death|0|||
125596672|NCT02786537|451810319|FG000|As Treated|Lack of Efficacy|0|||
125596673|NCT02786537|451810320|FG001|As Treated|Lack of Efficacy|0|||
125596674|NCT02786537|451810321|FG002|As Treated|Lack of Efficacy|0|||
125596675|NCT02786537|451810322|FG003|As Treated|Lack of Efficacy|1|||
125596676|NCT02786537|451810323|FG004|As Treated|Lack of Efficacy|0|||
125596677|NCT02786537|451810324|FG005|As Treated|Lack of Efficacy|0|||
125366773|NCT03094169|450977194|FG004|Overall Study|Withdrawal by Subject|0|||
125366774|NCT03094169|450977195|FG005|Overall Study|Withdrawal by Subject|0|||
125366775|NCT03094169|450977196|FG006|Overall Study|Withdrawal by Subject|1|||
125366776|NCT03094169|450977197|FG007|Overall Study|Withdrawal by Subject|1|||
125366777|NCT03094169|450977190|FG000|Overall Study|Trial Termination|0|||
125366778|NCT03094169|450977191|FG001|Overall Study|Trial Termination|0|||
125366779|NCT03094169|450977192|FG002|Overall Study|Trial Termination|0|||
125366780|NCT03094169|450977193|FG003|Overall Study|Trial Termination|0|||
125366781|NCT03094169|450977194|FG004|Overall Study|Trial Termination|0|||
125366782|NCT03094169|450977195|FG005|Overall Study|Trial Termination|0|||
125366783|NCT03094169|450977196|FG006|Overall Study|Trial Termination|0|||
125366784|NCT03094169|450977197|FG007|Overall Study|Trial Termination|1|||
125366785|NCT04645953|450977198|FG000|Overall Study|Lost to Follow-up|2|||
125366786|NCT04645953|450977199|FG001|Overall Study|Lost to Follow-up|1|||
125366787|NCT04645953|450977200|FG002|Overall Study|Lost to Follow-up|1|||
125366788|NCT04645953|450977198|FG000|Overall Study|Withdrawal by Subject|0|||
125366789|NCT04645953|450977199|FG001|Overall Study|Withdrawal by Subject|1|||
125366790|NCT04645953|450977200|FG002|Overall Study|Withdrawal by Subject|0|||
125366791|NCT04645953|450977198|FG000|Overall Study|Physician Decision|0|||
125366792|NCT04645953|450977199|FG001|Overall Study|Physician Decision|1|||
125366793|NCT04645953|450977200|FG002|Overall Study|Physician Decision|0|||
125366794|NCT04645953|450977198|FG000|Overall Study|Discontinued Prior to Dosing|0|||
125366795|NCT04645953|450977199|FG001|Overall Study|Discontinued Prior to Dosing|0|||
125366796|NCT04645953|450977200|FG002|Overall Study|Discontinued Prior to Dosing|2|||
125366797|NCT00002651|450977201|FG000|Induction|Adverse Event|44|||
125366798|NCT00002651|450977202|FG001|Induction|Adverse Event|0|||
125366799|NCT00002651|450977203|FG002|Induction|Adverse Event|0|||
125366800|NCT00002651|450977201|FG000|Induction|Refusal unrelated to adverse event|50|||
125366801|NCT00002651|450977202|FG001|Induction|Refusal unrelated to adverse event|0|||
125596678|NCT02786537|451810319|FG000|As Treated|Lost to Follow-up|4|||
125596679|NCT02786537|451810320|FG001|As Treated|Lost to Follow-up|32|||
125596680|NCT02786537|451810321|FG002|As Treated|Lost to Follow-up|0|||
125596681|NCT02786537|451810322|FG003|As Treated|Lost to Follow-up|25|||
125596682|NCT02786537|451810323|FG004|As Treated|Lost to Follow-up|4|||
125596683|NCT02786537|451810324|FG005|As Treated|Lost to Follow-up|4|||
125596684|NCT02786537|451810319|FG000|As Treated|Non-compliance with study drug|1|||
125596685|NCT02786537|451810320|FG001|As Treated|Non-compliance with study drug|11|||
125596686|NCT02786537|451810321|FG002|As Treated|Non-compliance with study drug|0|||
125596687|NCT02786537|451810322|FG003|As Treated|Non-compliance with study drug|1|||
125596688|NCT02786537|451810323|FG004|As Treated|Non-compliance with study drug|0|||
125596689|NCT02786537|451810324|FG005|As Treated|Non-compliance with study drug|1|||
125596690|NCT02786537|451810319|FG000|As Treated|Lost insurance|0|||
125596691|NCT02786537|451810320|FG001|As Treated|Lost insurance|0|||
125596692|NCT02786537|451810321|FG002|As Treated|Lost insurance|0|||
125596693|NCT02786537|451810322|FG003|As Treated|Lost insurance|1|||
125596694|NCT02786537|451810323|FG004|As Treated|Lost insurance|0|||
125596695|NCT02786537|451810324|FG005|As Treated|Lost insurance|0|||
125596696|NCT02786537|451810319|FG000|As Treated|Withdrawal by Subject|1|||
125596697|NCT02786537|451810320|FG001|As Treated|Withdrawal by Subject|2|||
125596698|NCT02786537|451810321|FG002|As Treated|Withdrawal by Subject|0|||
125596699|NCT02786537|451810322|FG003|As Treated|Withdrawal by Subject|0|||
125596700|NCT02786537|451810323|FG004|As Treated|Withdrawal by Subject|1|||
125596701|NCT02786537|451810324|FG005|As Treated|Withdrawal by Subject|0|||
125596702|NCT02786537|451810319|FG000|As Treated|Incarceration|0|||
125596703|NCT02786537|451810320|FG001|As Treated|Incarceration|1|||
125596704|NCT02786537|451810321|FG002|As Treated|Incarceration|0|||
125596705|NCT02786537|451810322|FG003|As Treated|Incarceration|0|||
125596706|NCT02786537|451810323|FG004|As Treated|Incarceration|0|||
125596707|NCT02786537|451810324|FG005|As Treated|Incarceration|0|||
125366802|NCT00002651|450977203|FG002|Induction|Refusal unrelated to adverse event|0|||
125366803|NCT00002651|450977201|FG000|Induction|Progression/relapse|274|||
125366804|NCT00002651|450977202|FG001|Induction|Progression/relapse|0|||
125430259|NCT03420781|451201540|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
125212675|NCT02913105|450405418|FG000|Overall Study|Physician Decision|1|||
125212676|NCT02913105|450405419|FG001|Overall Study|Physician Decision|1|||
125366805|NCT00002651|450977203|FG002|Induction|Progression/relapse|0|||
125366806|NCT00002651|450977201|FG000|Induction|Death|62|||
125366807|NCT00002651|450977202|FG001|Induction|Death|0|||
125366808|NCT00002651|450977203|FG002|Induction|Death|0|||
125366809|NCT00002651|450977201|FG000|Induction|Other|823|||
125366810|NCT00002651|450977202|FG001|Induction|Other|0|||
125366811|NCT00002651|450977203|FG002|Induction|Other|0|||
125596708|NCT02786537|451810319|FG000|As Treated|Opiate dependency relapse|0|||
125596709|NCT02786537|451810320|FG001|As Treated|Opiate dependency relapse|1|||
125596710|NCT02786537|451810321|FG002|As Treated|Opiate dependency relapse|0|||
125596711|NCT02786537|451810322|FG003|As Treated|Opiate dependency relapse|0|||
125596712|NCT02786537|451810323|FG004|As Treated|Opiate dependency relapse|0|||
125366812|NCT00002651|450977201|FG000|Induction|not eligible|90|||
125596713|NCT02786537|451810324|FG005|As Treated|Opiate dependency relapse|0|||
125596714|NCT02786537|451810319|FG000|As Treated|Drugs stolen from patient|0|||
125596715|NCT02786537|451810320|FG001|As Treated|Drugs stolen from patient|1|||
125596716|NCT02786537|451810321|FG002|As Treated|Drugs stolen from patient|0|||
125596717|NCT02786537|451810322|FG003|As Treated|Drugs stolen from patient|0|||
125596718|NCT02786537|451810323|FG004|As Treated|Drugs stolen from patient|0|||
125596719|NCT02786537|451810324|FG005|As Treated|Drugs stolen from patient|0|||
125596720|NCT02786537|451810319|FG000|As Treated|Advised to stop tx after loss of meds|0|||
125596721|NCT02786537|451810320|FG001|As Treated|Advised to stop tx after loss of meds|1|||
125596722|NCT02786537|451810321|FG002|As Treated|Advised to stop tx after loss of meds|0|||
125596723|NCT02786537|451810322|FG003|As Treated|Advised to stop tx after loss of meds|0|||
125596724|NCT02786537|451810323|FG004|As Treated|Advised to stop tx after loss of meds|0|||
125596725|NCT02786537|451810324|FG005|As Treated|Advised to stop tx after loss of meds|0|||
125596726|NCT02638012|451810325|FG000|Overall Study|Lost to Follow-up|1|||
125596727|NCT00443560|451810326|FG000|Overall Study|No intrathecal dose|58|||
125596728|NCT00443560|451810327|FG001|Overall Study|No intrathecal dose|26|||
125596729|NCT00443560|451810326|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
125596730|NCT00443560|451810327|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
125596731|NCT04329949|451810328|FG000|Overall Study|Death|36|||
125596732|NCT04329949|451810328|FG000|Overall Study|Withdrawal by Subject|4|||
125596733|NCT04329949|451810328|FG000|Overall Study|Termination of study by sponsor|3|||
125596734|NCT03180736|451810329|FG000|Overall Study|Adverse Event|3|||
125596735|NCT03180736|451810330|FG001|Overall Study|Adverse Event|4|||
125596736|NCT03180736|451810329|FG000|Overall Study|Death|10|||
125596737|NCT03180736|451810330|FG001|Overall Study|Death|7|||
125596738|NCT03180736|451810329|FG000|Overall Study|Withdrawal by Subject|5|||
125596739|NCT03180736|451810330|FG001|Overall Study|Withdrawal by Subject|12|||
125596740|NCT03180736|451810329|FG000|Overall Study|Lost to Follow-up|1|||
125596741|NCT03180736|451810330|FG001|Overall Study|Lost to Follow-up|0|||
125596742|NCT03180736|451810329|FG000|Overall Study|Lack of Efficacy|66|||
125596743|NCT03180736|451810330|FG001|Overall Study|Lack of Efficacy|87|||
125596744|NCT03180736|451810329|FG000|Overall Study|Physician Decision|4|||
125212677|NCT02913105|450405420|FG002|Overall Study|Physician Decision|0|||
125212678|NCT02913105|450405418|FG000|Overall Study|Withdrawal by Subject|0|||
125212679|NCT02913105|450405419|FG001|Overall Study|Withdrawal by Subject|3|||
125212680|NCT02913105|450405420|FG002|Overall Study|Withdrawal by Subject|1|||
125212681|NCT01317004|450405421|FG000|Overall Study|Withdrawal by Subject|1|||
125212682|NCT01317004|450405422|FG001|Overall Study|Withdrawal by Subject|4|||
125366813|NCT00002651|450977202|FG001|Induction|not eligible|0|||
125366814|NCT00002651|450977203|FG002|Induction|not eligible|0|||
125366815|NCT00002651|450977201|FG000|Consolidation and Randomization|Adverse Event|0|||
125366816|NCT00002651|450977202|FG001|Consolidation and Randomization|Adverse Event|36|||
125366817|NCT00002651|450977203|FG002|Consolidation and Randomization|Adverse Event|14|||
125366818|NCT00002651|450977201|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
125366819|NCT00002651|450977202|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
125366820|NCT00002651|450977203|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
125366821|NCT00002651|450977201|FG000|Consolidation and Randomization|Progression/relapse|0|||
125366822|NCT00002651|450977202|FG001|Consolidation and Randomization|Progression/relapse|295|||
125366823|NCT00002651|450977203|FG002|Consolidation and Randomization|Progression/relapse|298|||
125366824|NCT00002651|450977201|FG000|Consolidation and Randomization|Death|0|||
125430260|NCT03420781|451201536|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
125596745|NCT03180736|451810330|FG001|Overall Study|Physician Decision|7|||
125596746|NCT03180736|451810329|FG000|Overall Study|randomized but not treated|2|||
125596747|NCT03180736|451810330|FG001|Overall Study|randomized but not treated|3|||
125596748|NCT05299892|451810331|FG000|Overall Study|Withdrawal by Subject|2|||
125596749|NCT01458340|451810332|FG000|Overall Study|Adverse Event|5|||
125596750|NCT01458340|451810333|FG001|Overall Study|Adverse Event|4|||
125596751|NCT01458340|451810334|FG002|Overall Study|Adverse Event|2|||
125596752|NCT01458340|451810332|FG000|Overall Study|Lost to Follow-up|3|||
125366825|NCT00002651|450977202|FG001|Consolidation and Randomization|Death|38|||
125366826|NCT00002651|450977203|FG002|Consolidation and Randomization|Death|48|||
125366827|NCT00002651|450977201|FG000|Consolidation and Randomization|Other|0|||
125366828|NCT00002651|450977202|FG001|Consolidation and Randomization|Other|314|||
125366829|NCT00002651|450977203|FG002|Consolidation and Randomization|Other|313|||
125366830|NCT00002651|450977201|FG000|Consolidation and Randomization|not eligible|0|||
125366831|NCT00002651|450977202|FG001|Consolidation and Randomization|not eligible|102|||
125366832|NCT00002651|450977203|FG002|Consolidation and Randomization|not eligible|112|||
125366833|NCT03741062|450977204|FG000|Overall Study|Protocol Violation|1|||
125366834|NCT03741062|450977205|FG001|Overall Study|Protocol Violation|0|||
125366835|NCT02763462|450977209|FG000|Overall Study|Protocol Violation|6|||
125366836|NCT03417219|450977210|FG000|Overall Study|Lost to Follow-up|0|||
125366837|NCT03417219|450977211|FG001|Overall Study|Lost to Follow-up|3|||
125366838|NCT00261807|450977212|FG000|Overall Study|Lost to Follow-up|2|||
125366839|NCT00261807|450977212|FG000|Overall Study|Adverse Event|2|||
125366840|NCT00261807|450977212|FG000|Overall Study|Death|1|||
125366841|NCT00261807|450977212|FG000|Overall Study|Protocol Violation|2|||
125366842|NCT00675948|450977215|FG000|Overall Study|Adverse Event|23|||
125366843|NCT00675948|450977216|FG001|Overall Study|Adverse Event|1|||
125366844|NCT00675948|450977215|FG000|Overall Study|Lack of Efficacy|3|||
125366845|NCT00675948|450977216|FG001|Overall Study|Lack of Efficacy|0|||
125366846|NCT00675948|450977215|FG000|Overall Study|Withdrawal by Subject|7|||
125366847|NCT00675948|450977216|FG001|Overall Study|Withdrawal by Subject|0|||
125366848|NCT00675948|450977215|FG000|Overall Study|Lost to Follow-up|2|||
125366849|NCT00675948|450977216|FG001|Overall Study|Lost to Follow-up|0|||
125596753|NCT01458340|451810333|FG001|Overall Study|Lost to Follow-up|3|||
125596754|NCT01458340|451810334|FG002|Overall Study|Lost to Follow-up|10|||
125366850|NCT00675948|450977215|FG000|Overall Study|Protocol Violation|1|||
125366851|NCT00675948|450977216|FG001|Overall Study|Protocol Violation|0|||
125366852|NCT00675948|450977215|FG000|Overall Study|Pain under control|1|||
125366853|NCT00675948|450977216|FG001|Overall Study|Pain under control|0|||
125366854|NCT00675948|450977215|FG000|Overall Study|Sponsor decision|0|||
125366855|NCT00675948|450977216|FG001|Overall Study|Sponsor decision|1|||
125366856|NCT00675948|450977215|FG000|Overall Study|Patient died|1|||
125596755|NCT01458340|451810332|FG000|Overall Study|Miscellaneous|0|||
125596756|NCT01458340|451810333|FG001|Overall Study|Miscellaneous|1|||
125596757|NCT01458340|451810334|FG002|Overall Study|Miscellaneous|0|||
125596758|NCT01458340|451810332|FG000|Overall Study|Physician Decision|1|||
125596759|NCT01458340|451810333|FG001|Overall Study|Physician Decision|1|||
125596760|NCT01458340|451810334|FG002|Overall Study|Physician Decision|2|||
125596761|NCT01458340|451810332|FG000|Overall Study|Protocol Violation|6|||
125596762|NCT01458340|451810333|FG001|Overall Study|Protocol Violation|6|||
125596763|NCT01458340|451810334|FG002|Overall Study|Protocol Violation|5|||
125596764|NCT01458340|451810332|FG000|Overall Study|Withdrawal by Subject|12|||
125366857|NCT00675948|450977216|FG001|Overall Study|Patient died|0|||
125366858|NCT00675948|450977215|FG000|Overall Study|Patient unable to comply with diaries|1|||
125366859|NCT00675948|450977216|FG001|Overall Study|Patient unable to comply with diaries|0|||
125366860|NCT00675948|450977215|FG000|Overall Study|Patient feels unable to take medication|0|||
125366861|NCT00675948|450977216|FG001|Overall Study|Patient feels unable to take medication|1|||
125366862|NCT02527161|450977217|FG000|Overall Study|Failed MRI|52|||
125366863|NCT02527161|450977217|FG000|Overall Study|Withdrawal by Subject|19|||
125366864|NCT02527161|450977217|FG000|Overall Study|Delay in or unfit for surgery|16|||
125366865|NCT02527161|450977217|FG000|Overall Study|MRI contraindication|6|||
125366866|NCT02527161|450977217|FG000|Overall Study|Consent violation|4|||
125366867|NCT02527161|450977217|FG000|Overall Study|Only Recruited to Part A|27|||
125366868|NCT02527161|450977217|FG000|Overall Study|Physician Decision|1|||
125366869|NCT02527161|450977217|FG000|Overall Study|Adverse Event|1|||
125366870|NCT02527161|450977217|FG000|Overall Study|Lost to Follow-up|6|||
125366871|NCT05209360|450977218|FG000|Overall Study|Withdrawal by Subject|0|||
125366872|NCT05209360|450977219|FG001|Overall Study|Withdrawal by Subject|0|||
125366873|NCT05209360|450977220|FG002|Overall Study|Withdrawal by Subject|1|||
125366874|NCT05209360|450977221|FG003|Overall Study|Withdrawal by Subject|0|||
125366875|NCT05209360|450977222|FG004|Overall Study|Withdrawal by Subject|0|||
125366876|NCT05209360|450977223|FG005|Overall Study|Withdrawal by Subject|0|||
125366877|NCT02100514|450977224|FG000|Treatment Period|Adverse Event|0|||
125366878|NCT02100514|450977225|FG001|Treatment Period|Adverse Event|5|||
125366879|NCT02100514|450977226|FG002|Treatment Period|Adverse Event|0|||
125366880|NCT02100514|450977227|FG003|Treatment Period|Adverse Event|0|||
125366881|NCT02100514|450977228|FG004|Treatment Period|Adverse Event|0|||
125366882|NCT02100514|450977224|FG000|Treatment Period|Death|2|||
125366883|NCT02100514|450977225|FG001|Treatment Period|Death|2|||
125366884|NCT02100514|450977226|FG002|Treatment Period|Death|0|||
125366885|NCT02100514|450977227|FG003|Treatment Period|Death|0|||
125366886|NCT02100514|450977228|FG004|Treatment Period|Death|0|||
125366887|NCT02100514|450977224|FG000|Treatment Period|Lost to Follow-up|5|||
125596765|NCT01458340|451810333|FG001|Overall Study|Withdrawal by Subject|6|||
125596766|NCT01458340|451810334|FG002|Overall Study|Withdrawal by Subject|4|||
125596767|NCT01126619|451810337|FG000|Overall Study|Not eligible for the study|2|||
125430261|NCT03420781|451201537|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
125430262|NCT03420781|451201538|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
125430263|NCT03420781|451201539|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
125212683|NCT01317004|450405421|FG000|Overall Study|Protocol Violation|0|||
125212684|NCT01317004|450405422|FG001|Overall Study|Protocol Violation|2|||
125212685|NCT01317004|450405421|FG000|Overall Study|Adverse Event|3|||
125212686|NCT01317004|450405422|FG001|Overall Study|Adverse Event|3|||
125212687|NCT01344759|450405426|FG000|Overall Study|Patients failed to reach sedation level|0|||
125212688|NCT01344759|450405427|FG001|Overall Study|Patients failed to reach sedation level|2|||
125212689|NCT01153009|450405428|FG000|Overall Study|Adverse Event|4|||
125212690|NCT01153009|450405429|FG001|Overall Study|Adverse Event|14|||
125212691|NCT01153009|450405430|FG002|Overall Study|Adverse Event|14|||
125212692|NCT01153009|450405431|FG003|Overall Study|Adverse Event|10|||
125212693|NCT01153009|450405428|FG000|Overall Study|Lack of Efficacy|9|||
125212694|NCT01153009|450405429|FG001|Overall Study|Lack of Efficacy|0|||
125212695|NCT01153009|450405430|FG002|Overall Study|Lack of Efficacy|2|||
125212696|NCT01153009|450405431|FG003|Overall Study|Lack of Efficacy|1|||
125212697|NCT01153009|450405428|FG000|Overall Study|Noncompliance with Study Medication|1|||
125212698|NCT01153009|450405429|FG001|Overall Study|Noncompliance with Study Medication|3|||
125212699|NCT01153009|450405430|FG002|Overall Study|Noncompliance with Study Medication|4|||
125212700|NCT01153009|450405431|FG003|Overall Study|Noncompliance with Study Medication|1|||
125212701|NCT01153009|450405428|FG000|Overall Study|Protocol Deviations|4|||
125212702|NCT01153009|450405429|FG001|Overall Study|Protocol Deviations|3|||
125212703|NCT01153009|450405430|FG002|Overall Study|Protocol Deviations|3|||
125212704|NCT01153009|450405431|FG003|Overall Study|Protocol Deviations|2|||
125212705|NCT01153009|450405428|FG000|Overall Study|Withdrawal of Consent|5|||
125212706|NCT01153009|450405429|FG001|Overall Study|Withdrawal of Consent|5|||
125212707|NCT01153009|450405430|FG002|Overall Study|Withdrawal of Consent|4|||
125212708|NCT01153009|450405431|FG003|Overall Study|Withdrawal of Consent|6|||
125212709|NCT01153009|450405428|FG000|Overall Study|Lost to Follow-up|8|||
125212710|NCT01153009|450405429|FG001|Overall Study|Lost to Follow-up|8|||
125430264|NCT03420781|451201540|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
125430265|NCT03420781|451201536|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
125430266|NCT03420781|451201537|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
125212711|NCT01153009|450405430|FG002|Overall Study|Lost to Follow-up|11|||
125212712|NCT01153009|450405431|FG003|Overall Study|Lost to Follow-up|15|||
125212713|NCT01153009|450405428|FG000|Overall Study|Other|1|||
125212714|NCT01153009|450405429|FG001|Overall Study|Other|1|||
125212715|NCT01153009|450405430|FG002|Overall Study|Other|3|||
125366888|NCT02100514|450977225|FG001|Treatment Period|Lost to Follow-up|17|||
125366889|NCT02100514|450977226|FG002|Treatment Period|Lost to Follow-up|0|||
125366890|NCT02100514|450977227|FG003|Treatment Period|Lost to Follow-up|0|||
125366891|NCT02100514|450977228|FG004|Treatment Period|Lost to Follow-up|0|||
125366892|NCT02100514|450977224|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
125366893|NCT02100514|450977225|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
125366894|NCT02100514|450977226|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
125366895|NCT02100514|450977227|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
125366896|NCT02100514|450977228|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
125366897|NCT02100514|450977224|FG000|Treatment Period|Protocol Violation|1|||
125366898|NCT02100514|450977225|FG001|Treatment Period|Protocol Violation|1|||
125366899|NCT02100514|450977226|FG002|Treatment Period|Protocol Violation|0|||
125366900|NCT02100514|450977227|FG003|Treatment Period|Protocol Violation|0|||
125366901|NCT02100514|450977228|FG004|Treatment Period|Protocol Violation|0|||
125366902|NCT02100514|450977224|FG000|Treatment Period|Withdrawal by Subject|12|||
125366903|NCT02100514|450977225|FG001|Treatment Period|Withdrawal by Subject|37|||
125366904|NCT02100514|450977226|FG002|Treatment Period|Withdrawal by Subject|0|||
125366905|NCT02100514|450977227|FG003|Treatment Period|Withdrawal by Subject|0|||
125366906|NCT02100514|450977228|FG004|Treatment Period|Withdrawal by Subject|0|||
125366907|NCT02100514|450977224|FG000|Treatment Period|Other|9|||
125366908|NCT02100514|450977225|FG001|Treatment Period|Other|11|||
125366909|NCT02100514|450977226|FG002|Treatment Period|Other|0|||
125366910|NCT02100514|450977227|FG003|Treatment Period|Other|0|||
125366911|NCT02100514|450977228|FG004|Treatment Period|Other|0|||
125366912|NCT02100514|450977224|FG000|Extension Period|Withdrew consent|0|||
125366913|NCT02100514|450977225|FG001|Extension Period|Withdrew consent|0|||
125366914|NCT02100514|450977226|FG002|Extension Period|Withdrew consent|2|||
125366915|NCT02100514|450977227|FG003|Extension Period|Withdrew consent|0|||
125366916|NCT02100514|450977228|FG004|Extension Period|Withdrew consent|0|||
125366917|NCT00724932|450977229|FG000|Overall Study|Lost to Follow-up|1|||
125366918|NCT00724932|450977230|FG001|Overall Study|Lost to Follow-up|0|||
125366919|NCT00724932|450977229|FG000|Overall Study|Not treated|4|||
125366920|NCT00724932|450977230|FG001|Overall Study|Not treated|3|||
125366921|NCT02021331|450977231|FG000|Overall Study|Adverse Event|0|||
125366922|NCT02021331|450977232|FG001|Overall Study|Adverse Event|2|||
125596768|NCT01126619|451810337|FG000|Overall Study|Investigator decision|4|||
125596769|NCT01126619|451810337|FG000|Overall Study|Serious adverse event|1|||
125596770|NCT01126619|451810337|FG000|Overall Study|Withdrawal by Subject|9|||
125596771|NCT01126619|451810337|FG000|Overall Study|Non-compliance|1|||
125596772|NCT03351244|451810338|FG000|Overall Study|Adverse Event|7|||
125596773|NCT03351244|451810339|FG001|Overall Study|Adverse Event|11|||
125596774|NCT03351244|451810340|FG002|Overall Study|Adverse Event|12|||
125212716|NCT01153009|450405431|FG003|Overall Study|Other|2|||
125212717|NCT04003623|450405435|FG000|Overall Study|Withdrawal by Subject|1|||
125212718|NCT04003623|450405436|FG001|Overall Study|Withdrawal by Subject|0|||
125212719|NCT00703326|450405438|FG000|Overall Study|Lost to Follow-up|47|||
125212720|NCT00703326|450405439|FG001|Overall Study|Lost to Follow-up|18|||
125212721|NCT00703326|450405438|FG000|Overall Study|Withdrawal by Subject|54|||
125212722|NCT00703326|450405439|FG001|Overall Study|Withdrawal by Subject|20|||
125212723|NCT00703326|450405438|FG000|Overall Study|Adverse Event|1|||
125212724|NCT00703326|450405439|FG001|Overall Study|Adverse Event|0|||
125212725|NCT01190189|450405443|FG000|Overall Study|Lost to Follow-up|4|||
125212726|NCT01190189|450405443|FG000|Overall Study|Withdrawal by Subject|1|||
125212727|NCT01190189|450405443|FG000|Overall Study|Migrated/moved from study area|1|||
125212728|NCT03214679|450405445|FG000|Overall Study|Lost to Follow-up|12|||
125212729|NCT03214679|450405446|FG001|Overall Study|Lost to Follow-up|14|||
125212730|NCT03214679|450405445|FG000|Overall Study|not eligible|2|||
125212731|NCT03214679|450405446|FG001|Overall Study|not eligible|0|||
125212732|NCT04571385|450405461|FG000|Overall Study|Participant non-compliance|1|||
125212733|NCT04571385|450405462|FG001|Overall Study|Participant non-compliance|0|||
125212734|NCT04571385|450405463|FG002|Overall Study|Participant non-compliance|0|||
125212735|NCT04571385|450405461|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
125212736|NCT04571385|450405462|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
125366923|NCT00762229|450977233|FG000|Overall Study|Lost to Follow-up|1|||
125366924|NCT00762229|450977234|FG001|Overall Study|Lost to Follow-up|1|||
125366925|NCT00762229|450977233|FG000|Overall Study|did not recveive intervention|0|||
125366926|NCT00762229|450977234|FG001|Overall Study|did not recveive intervention|1|||
125366927|NCT00319553|450977239|FG000|Overall Study|Protocol Violation|1|||
125366928|NCT00319553|450977240|FG001|Overall Study|Protocol Violation|2|||
125212737|NCT04571385|450405463|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
125366929|NCT00319553|450977239|FG000|Overall Study|Lost to Follow-up|2|||
125596775|NCT03351244|451810338|FG000|Overall Study|Investigator's decision|0|||
125366930|NCT00319553|450977240|FG001|Overall Study|Lost to Follow-up|1|||
125366931|NCT00319553|450977239|FG000|Overall Study|Withdrawal by Subject|1|||
125366932|NCT00319553|450977240|FG001|Overall Study|Withdrawal by Subject|1|||
125366933|NCT00885846|450977242|FG000|Overall Study|Withdrawal by Subject|2|||
125366934|NCT00885846|450977243|FG001|Overall Study|Withdrawal by Subject|5|||
125366935|NCT00885846|450977244|FG002|Overall Study|Withdrawal by Subject|2|||
125366936|NCT01081678|450977246|FG000|Overall Study|Ineligibility Determined|0|||
125366937|NCT01081678|450977247|FG001|Overall Study|Ineligibility Determined|0|||
125366938|NCT01081678|450977248|FG002|Overall Study|Ineligibility Determined|1|||
125366939|NCT01081678|450977249|FG003|Overall Study|Ineligibility Determined|1|||
125366940|NCT01081678|450977246|FG000|Overall Study|Noncompliance|3|||
125366941|NCT01081678|450977247|FG001|Overall Study|Noncompliance|4|||
125366942|NCT01081678|450977248|FG002|Overall Study|Noncompliance|5|||
125366943|NCT01081678|450977249|FG003|Overall Study|Noncompliance|2|||
125366944|NCT01081678|450977246|FG000|Overall Study|Adverse Event|2|||
125366945|NCT01081678|450977247|FG001|Overall Study|Adverse Event|1|||
125366946|NCT01081678|450977248|FG002|Overall Study|Adverse Event|2|||
125366947|NCT01081678|450977249|FG003|Overall Study|Adverse Event|2|||
125366948|NCT01081678|450977246|FG000|Overall Study|Withdrawal by Subject|15|||
125366949|NCT01081678|450977247|FG001|Overall Study|Withdrawal by Subject|7|||
125366950|NCT01081678|450977248|FG002|Overall Study|Withdrawal by Subject|17|||
125366951|NCT01081678|450977249|FG003|Overall Study|Withdrawal by Subject|14|||
125366952|NCT01081678|450977246|FG000|Overall Study|Administrative Decision|1|||
125366953|NCT01081678|450977247|FG001|Overall Study|Administrative Decision|0|||
125366954|NCT01081678|450977248|FG002|Overall Study|Administrative Decision|0|||
125366955|NCT01081678|450977249|FG003|Overall Study|Administrative Decision|1|||
125366956|NCT01081678|450977246|FG000|Overall Study|Lost to Follow-up|4|||
125366957|NCT01081678|450977247|FG001|Overall Study|Lost to Follow-up|1|||
125366958|NCT01081678|450977248|FG002|Overall Study|Lost to Follow-up|4|||
125366959|NCT01081678|450977249|FG003|Overall Study|Lost to Follow-up|3|||
125366960|NCT01081678|450977246|FG000|Overall Study|Death|2|||
125366961|NCT01081678|450977247|FG001|Overall Study|Death|2|||
125366962|NCT01081678|450977248|FG002|Overall Study|Death|2|||
125366963|NCT01081678|450977249|FG003|Overall Study|Death|6|||
125366964|NCT01081678|450977246|FG000|Overall Study|Other|0|||
125366965|NCT01081678|450977247|FG001|Overall Study|Other|1|||
125366966|NCT01081678|450977248|FG002|Overall Study|Other|0|||
125366967|NCT01081678|450977249|FG003|Overall Study|Other|0|||
125366968|NCT00444912|450977252|FG000|Overall Study|Death|1|||
125366969|NCT00444912|450977253|FG001|Overall Study|Death|2|||
125366970|NCT00444912|450977252|FG000|Overall Study|Lost to Follow-up|1|||
125366971|NCT00444912|450977253|FG001|Overall Study|Lost to Follow-up|0|||
125366972|NCT00444912|450977252|FG000|Overall Study|Participant Failed Mobilization|1|||
125366973|NCT00444912|450977253|FG001|Overall Study|Participant Failed Mobilization|0|||
125366974|NCT01281865|450977254|FG000|Overall Study|Adverse Event|1|||
125366975|NCT01281865|450977255|FG001|Overall Study|Adverse Event|1|||
125366976|NCT01281865|450977254|FG000|Overall Study|Withdrawal by Subject|1|||
125366977|NCT01281865|450977255|FG001|Overall Study|Withdrawal by Subject|0|||
125366978|NCT01281865|450977254|FG000|Overall Study|Lack of Efficacy|1|||
125366979|NCT01281865|450977255|FG001|Overall Study|Lack of Efficacy|0|||
125366980|NCT02747875|450977256|FG000|Overall Study|Physician Decision|1|||
125366981|NCT02747875|450977257|FG001|Overall Study|Physician Decision|0|||
125366982|NCT02747875|450977256|FG000|Overall Study|Adverse Event|0|||
125366983|NCT02747875|450977257|FG001|Overall Study|Adverse Event|1|||
125366984|NCT01702805|450977259|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
125366985|NCT01702805|450977260|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
125366986|NCT01702805|450977259|FG000|Overall Study|Incomplete Follow-up|18|||
125366987|NCT01702805|450977260|FG001|Overall Study|Incomplete Follow-up|15|||
125366988|NCT01702805|450977259|FG000|Overall Study|Vital Status Assessment Only|40|||
125366989|NCT01702805|450977260|FG001|Overall Study|Vital Status Assessment Only|39|||
125596776|NCT03351244|451810339|FG001|Overall Study|Investigator's decision|0|||
125596777|NCT03351244|451810340|FG002|Overall Study|Investigator's decision|2|||
125596778|NCT03351244|451810338|FG000|Overall Study|System error|0|||
125596779|NCT03351244|451810339|FG001|Overall Study|System error|0|||
125366990|NCT01702805|450977259|FG000|Overall Study|Lost to Follow-up|5|||
125366991|NCT01702805|450977260|FG001|Overall Study|Lost to Follow-up|5|||
125366992|NCT02499783|450977261|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
125366993|NCT02499783|450977262|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
125366994|NCT02499783|450977263|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
125366995|NCT02499783|450977261|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
125366996|NCT02499783|450977262|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
125366997|NCT02499783|450977263|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
125366998|NCT02499783|450977261|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
125366999|NCT02499783|450977262|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
125212738|NCT04571385|450405461|FG000|Overall Study|Screen failure|0|||
125212739|NCT04571385|450405462|FG001|Overall Study|Screen failure|0|||
125212740|NCT04571385|450405463|FG002|Overall Study|Screen failure|1|||
125212741|NCT02263729|450405465|FG000|Overall Study|Lost to Follow-up|1|||
125212742|NCT02263729|450405466|FG001|Overall Study|Lost to Follow-up|1|||
125212743|NCT01212159|450405467|FG000|Overall Study|Withdrawal by Subject|12|||
125212744|NCT01212159|450405468|FG001|Overall Study|Withdrawal by Subject|12|||
125212745|NCT01502956|450405476|FG000|Overall Study|Death|0|||
125212746|NCT01502956|450405477|FG001|Overall Study|Death|2|||
125212747|NCT01502956|450405476|FG000|Overall Study|Lost to Follow-up|14|||
125212748|NCT01502956|450405477|FG001|Overall Study|Lost to Follow-up|11|||
125596780|NCT03351244|451810340|FG002|Overall Study|System error|2|||
125596781|NCT03351244|451810338|FG000|Overall Study|COVID-19 restrictions|3|||
125596782|NCT03351244|451810339|FG001|Overall Study|COVID-19 restrictions|0|||
125596783|NCT03351244|451810340|FG002|Overall Study|COVID-19 restrictions|1|||
125596784|NCT03351244|451810338|FG000|Overall Study|Non-compliance|2|||
125596785|NCT03351244|451810339|FG001|Overall Study|Non-compliance|5|||
125596786|NCT03351244|451810340|FG002|Overall Study|Non-compliance|0|||
125596787|NCT03351244|451810338|FG000|Overall Study|Withdrawal by Subject|11|||
125596788|NCT03351244|451810339|FG001|Overall Study|Withdrawal by Subject|16|||
125596789|NCT03351244|451810340|FG002|Overall Study|Withdrawal by Subject|13|||
125596790|NCT03351244|451810338|FG000|Overall Study|Lost to Follow-up|2|||
125596791|NCT03351244|451810339|FG001|Overall Study|Lost to Follow-up|6|||
125596792|NCT03351244|451810340|FG002|Overall Study|Lost to Follow-up|4|||
125596793|NCT03351244|451810338|FG000|Overall Study|Protocol Violation|2|||
125212749|NCT01502956|450405476|FG000|Overall Study|Physician Decision|2|||
125212750|NCT01502956|450405477|FG001|Overall Study|Physician Decision|3|||
125212751|NCT01502956|450405476|FG000|Overall Study|Withdrawal by Subject|8|||
125596794|NCT03351244|451810339|FG001|Overall Study|Protocol Violation|2|||
125212752|NCT01502956|450405477|FG001|Overall Study|Withdrawal by Subject|10|||
125212753|NCT01026818|450405478|FG000|Screening Period|Entry Criteria Not Met|105|||
125212754|NCT01026818|450405479|FG001|Screening Period|Entry Criteria Not Met|0|||
125212755|NCT01026818|450405480|FG002|Screening Period|Entry Criteria Not Met|0|||
125212756|NCT01026818|450405481|FG003|Screening Period|Entry Criteria Not Met|0|||
125212757|NCT01026818|450405478|FG000|Screening Period|Withdrawal by Subject|49|||
125212758|NCT01026818|450405479|FG001|Screening Period|Withdrawal by Subject|0|||
125212759|NCT01026818|450405480|FG002|Screening Period|Withdrawal by Subject|0|||
125212760|NCT01026818|450405481|FG003|Screening Period|Withdrawal by Subject|0|||
125212761|NCT01026818|450405478|FG000|Screening Period|Protocol Deviation|3|||
125367000|NCT02499783|450977263|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
125367001|NCT02499783|450977261|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
125367002|NCT02499783|450977262|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
125367003|NCT02499783|450977263|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
125367004|NCT02499783|450977261|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
125367005|NCT02499783|450977262|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
125367006|NCT02499783|450977263|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
125367007|NCT02499783|450977261|FG000|DB Period: Weeks 0-8|Other|1|||
125367008|NCT02499783|450977262|FG001|DB Period: Weeks 0-8|Other|1|||
125367009|NCT02499783|450977263|FG002|DB Period: Weeks 0-8|Other|0|||
125367010|NCT02499783|450977261|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
125367011|NCT02499783|450977262|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
125367012|NCT02499783|450977263|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
125367013|NCT02499783|450977261|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
125367014|NCT02499783|450977262|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
125367015|NCT02499783|450977263|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
125367016|NCT02499783|450977261|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
125367017|NCT02499783|450977262|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
125367018|NCT02499783|450977263|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
125367019|NCT02499783|450977261|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
125367020|NCT02499783|450977262|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
125367021|NCT02499783|450977263|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
125367022|NCT01866293|450977264|FG000|Overall Study|Adverse Event|2|||
125596795|NCT03351244|451810340|FG002|Overall Study|Protocol Violation|0|||
125596796|NCT00091793|451810342|FG000|Overall Study|Adverse Event|1|||
125596797|NCT00091793|451810343|FG001|Overall Study|Adverse Event|2|||
125212762|NCT01026818|450405479|FG001|Screening Period|Protocol Deviation|0|||
125212763|NCT01026818|450405480|FG002|Screening Period|Protocol Deviation|0|||
125212764|NCT01026818|450405481|FG003|Screening Period|Protocol Deviation|0|||
125367023|NCT04457336|450977265|FG000|Period 2: Part A|Withdrawal by Subject|0|||
125367024|NCT04457336|450977266|FG001|Period 2: Part A|Withdrawal by Subject|1|||
125596798|NCT00091793|451810342|FG000|Overall Study|Withdrawal by Subject|10|||
125596799|NCT00091793|451810343|FG001|Overall Study|Withdrawal by Subject|15|||
125596800|NCT00091793|451810342|FG000|Overall Study|Ineligibility determined|2|||
125596801|NCT00091793|451810343|FG001|Overall Study|Ineligibility determined|0|||
125596802|NCT00091793|451810342|FG000|Overall Study|Lost to Follow-up|7|||
125596803|NCT00091793|451810343|FG001|Overall Study|Lost to Follow-up|5|||
125596804|NCT00091793|451810342|FG000|Overall Study|Noncompliance|2|||
125596805|NCT00091793|451810343|FG001|Overall Study|Noncompliance|0|||
125596806|NCT00091793|451810342|FG000|Overall Study|Other|2|||
125596807|NCT00091793|451810343|FG001|Overall Study|Other|0|||
125596808|NCT05309083|451810345|FG000|Overall Study|Withdrawal by Subject|2|||
125596809|NCT01165229|451810346|FG000|Overall Study|Serious Adverse Event|456|||
125596810|NCT01165229|451810347|FG001|Overall Study|Serious Adverse Event|487|||
125596811|NCT01165229|451810346|FG000|Overall Study|Non-Serious Adverse Event|47|||
125596812|NCT01165229|451810347|FG001|Overall Study|Non-Serious Adverse Event|15|||
125596813|NCT01165229|451810346|FG000|Overall Study|Protocol Violation|6|||
125596814|NCT01165229|451810347|FG001|Overall Study|Protocol Violation|8|||
125596815|NCT01165229|451810346|FG000|Overall Study|Withdrawal by Subject|387|||
125596816|NCT01165229|451810347|FG001|Overall Study|Withdrawal by Subject|396|||
125596817|NCT01165229|451810346|FG000|Overall Study|Migrated/moved from study area|51|||
125596818|NCT01165229|451810347|FG001|Overall Study|Migrated/moved from study area|46|||
125596819|NCT01165229|451810346|FG000|Overall Study|Lost to Follow-up|123|||
125596820|NCT01165229|451810347|FG001|Overall Study|Lost to Follow-up|133|||
125596821|NCT01165229|451810346|FG000|Overall Study|Suspected HZ Episode|2|||
125596822|NCT01165229|451810347|FG001|Overall Study|Suspected HZ Episode|2|||
125596823|NCT01165229|451810346|FG000|Overall Study|No reason from the subject|108|||
125596824|NCT01165229|451810347|FG001|Overall Study|No reason from the subject|102|||
125596825|NCT01165229|451810346|FG000|Overall Study|Unknown completion status|0|||
125596826|NCT01165229|451810347|FG001|Overall Study|Unknown completion status|1|||
125596827|NCT00881205|451810351|FG000|Overall Study|Adverse Event|8|||
125596828|NCT00881205|451810352|FG001|Overall Study|Adverse Event|3|||
125596829|NCT00881205|451810351|FG000|Overall Study|Withdrawal by Subject|1|||
125596830|NCT00881205|451810352|FG001|Overall Study|Withdrawal by Subject|2|||
125596831|NCT00881205|451810351|FG000|Overall Study|Lost to Follow-up|0|||
125596832|NCT00881205|451810352|FG001|Overall Study|Lost to Follow-up|1|||
125596833|NCT00881205|451810351|FG000|Overall Study|Administrative problems|1|||
125596834|NCT00881205|451810352|FG001|Overall Study|Administrative problems|1|||
125596835|NCT00881205|451810351|FG000|Overall Study|Condition no longer requires drug|1|||
125596836|NCT00881205|451810352|FG001|Overall Study|Condition no longer requires drug|0|||
125596837|NCT00550238|451810353|FG000|Overall Study|Adverse Event|88|||
125596838|NCT00550238|451810353|FG000|Overall Study|Death|34|||
125367025|NCT04457336|450977267|FG002|Period 2: Part A|Withdrawal by Subject|1|||
125367026|NCT04457336|450977268|FG003|Period 2: Part A|Withdrawal by Subject|1|||
125367027|NCT04457336|450977269|FG004|Period 2: Part A|Withdrawal by Subject|0|||
125367028|NCT04457336|450977270|FG005|Period 2: Part A|Withdrawal by Subject|0|||
125367029|NCT04457336|450977271|FG006|Period 2: Part A|Withdrawal by Subject|0|||
125367030|NCT04457336|450977272|FG007|Period 2: Part A|Withdrawal by Subject|0|||
125367031|NCT04457336|450977265|FG000|Period 2: Part A|Adverse Event|0|||
125367032|NCT04457336|450977266|FG001|Period 2: Part A|Adverse Event|0|||
125367033|NCT04457336|450977267|FG002|Period 2: Part A|Adverse Event|1|||
125367034|NCT04457336|450977268|FG003|Period 2: Part A|Adverse Event|1|||
125367035|NCT04457336|450977269|FG004|Period 2: Part A|Adverse Event|0|||
125367036|NCT04457336|450977270|FG005|Period 2: Part A|Adverse Event|0|||
125367037|NCT04457336|450977271|FG006|Period 2: Part A|Adverse Event|0|||
125367038|NCT04457336|450977272|FG007|Period 2: Part A|Adverse Event|0|||
125367039|NCT04457336|450977265|FG000|Period 2: Part A|Study Terminated|0|||
125367040|NCT04457336|450977266|FG001|Period 2: Part A|Study Terminated|0|||
125367041|NCT04457336|450977267|FG002|Period 2: Part A|Study Terminated|1|||
125367042|NCT04457336|450977268|FG003|Period 2: Part A|Study Terminated|0|||
125367043|NCT04457336|450977269|FG004|Period 2: Part A|Study Terminated|0|||
125367044|NCT04457336|450977270|FG005|Period 2: Part A|Study Terminated|0|||
125596839|NCT00550238|451810353|FG000|Overall Study|Disease progression|46|||
125596840|NCT00550238|451810353|FG000|Overall Study|Withdrawal by Subject|167|||
125596841|NCT00550238|451810353|FG000|Overall Study|Physician Decision|31|||
125596842|NCT00550238|451810353|FG000|Overall Study|Patient noncompliance|25|||
125596843|NCT00550238|451810353|FG000|Overall Study|Lost to Follow-up|13|||
125596844|NCT00550238|451810353|FG000|Overall Study|Sponsor decision|55|||
125596845|NCT00779038|451810354|FG000|Overall Study|Study Prematurely Terminated|13|||
125596846|NCT00537745|451810355|FG000|Overall Study|Did not meet eligibility criteria|2|||
125430267|NCT03420781|451201538|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
125430268|NCT03420781|451201539|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
125430269|NCT03420781|451201540|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
125430270|NCT03420781|451201536|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
125430271|NCT03420781|451201537|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
125430272|NCT03420781|451201538|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
125430273|NCT03420781|451201539|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
125430274|NCT03420781|451201540|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
125430275|NCT03420781|451201536|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
125430276|NCT03420781|451201537|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
125430277|NCT03420781|451201538|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
125430278|NCT03420781|451201539|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
125430279|NCT03420781|451201540|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
125430280|NCT03420781|451201536|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
125430281|NCT03420781|451201537|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
125430282|NCT03420781|451201538|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
125430283|NCT03420781|451201539|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
125430284|NCT03420781|451201540|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
125430285|NCT00215540|451201551|FG000|Overall Study|Withdrew from study medication|1|||
125430286|NCT00215540|451201552|FG001|Overall Study|Withdrew from study medication|0|||
125430287|NCT00215540|451201553|FG002|Overall Study|Withdrew from study medication|0|||
125430288|NCT02799472|451201560|FG000|Overall Study|Withdrawal by Subject|2|||
125430289|NCT02799472|451201561|FG001|Overall Study|Withdrawal by Subject|4|||
125430290|NCT02799472|451201560|FG000|Overall Study|Lack of Efficacy|2|||
125430291|NCT02799472|451201561|FG001|Overall Study|Lack of Efficacy|0|||
125430292|NCT02799472|451201560|FG000|Overall Study|Lost to Follow-up|0|||
125430293|NCT02799472|451201561|FG001|Overall Study|Lost to Follow-up|1|||
125430294|NCT01226511|451201562|FG000|Acute Treatment Period|Adverse Event|7|||
125430295|NCT01226511|451201563|FG001|Acute Treatment Period|Adverse Event|6|||
125430296|NCT01226511|451201562|FG000|Acute Treatment Period|Lack of Efficacy|2|||
125430297|NCT01226511|451201563|FG001|Acute Treatment Period|Lack of Efficacy|1|||
125430298|NCT01226511|451201562|FG000|Acute Treatment Period|Lost to Follow-up|3|||
125430299|NCT01226511|451201563|FG001|Acute Treatment Period|Lost to Follow-up|6|||
125430300|NCT01226511|451201562|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
125430301|NCT01226511|451201563|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
125430302|NCT01226511|451201562|FG000|Acute Treatment Period|Protocol Violation|5|||
125430303|NCT01226511|451201563|FG001|Acute Treatment Period|Protocol Violation|5|||
125430304|NCT01226511|451201562|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
125430305|NCT01226511|451201563|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
125430306|NCT01226511|451201562|FG000|Extension Treatment Period|Adverse Event|8|||
125430307|NCT01226511|451201563|FG001|Extension Treatment Period|Adverse Event|8|||
125430308|NCT01226511|451201562|FG000|Extension Treatment Period|Lack of Efficacy|3|||
125430309|NCT01226511|451201563|FG001|Extension Treatment Period|Lack of Efficacy|2|||
125430310|NCT01226511|451201562|FG000|Extension Treatment Period|Lost to Follow-up|4|||
125430311|NCT01226511|451201563|FG001|Extension Treatment Period|Lost to Follow-up|3|||
125430312|NCT01226511|451201562|FG000|Extension Treatment Period|Protocol Violation|2|||
125596847|NCT00537745|451810355|FG000|Overall Study|Withdrawal by Subject|2|||
125596848|NCT00537745|451810355|FG000|Overall Study|Subject unable to provide Interlock info|1|||
125596849|NCT04786210|451810356|FG000|Overall Study|Lost to Follow-up|2|||
125596850|NCT04786210|451810356|FG000|Overall Study|Withdrawal by Subject|4|||
125596851|NCT03700892|451810357|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
125596852|NCT03700892|451810358|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
125596853|NCT03700892|451810359|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
125596854|NCT01634243|451810360|FG000|Overall Study|Adverse Event|5|||
125596855|NCT01634243|451810361|FG001|Overall Study|Adverse Event|5|||
125596856|NCT01634243|451810360|FG000|Overall Study|Lack of Efficacy|1|||
125596857|NCT01634243|451810361|FG001|Overall Study|Lack of Efficacy|0|||
125596858|NCT00845429|451810364|FG000|Overall Study|Protocol Violation|5|||
125596859|NCT00845429|451810365|FG001|Overall Study|Protocol Violation|4|||
125596860|NCT00845429|451810366|FG002|Overall Study|Protocol Violation|7|||
125596861|NCT00845429|451810364|FG000|Overall Study|Lost to Follow-up|7|||
125596862|NCT00845429|451810365|FG001|Overall Study|Lost to Follow-up|9|||
125596863|NCT00845429|451810366|FG002|Overall Study|Lost to Follow-up|10|||
125596864|NCT00845429|451810364|FG000|Overall Study|Withdrawal by Subject|2|||
125596865|NCT00845429|451810365|FG001|Overall Study|Withdrawal by Subject|2|||
125596866|NCT00845429|451810366|FG002|Overall Study|Withdrawal by Subject|2|||
125596867|NCT00845429|451810364|FG000|Overall Study|Serious adverse event|0|||
125596868|NCT00845429|451810365|FG001|Overall Study|Serious adverse event|0|||
125596869|NCT00845429|451810366|FG002|Overall Study|Serious adverse event|1|||
125596870|NCT03240081|451810373|FG000|Overall Study|Withdrawal by Subject|0|||
125596871|NCT03240081|451810374|FG001|Overall Study|Withdrawal by Subject|2|||
125596872|NCT03240081|451810373|FG000|Overall Study|Lost to Follow-up|0|||
125596873|NCT03240081|451810374|FG001|Overall Study|Lost to Follow-up|1|||
125596874|NCT01480180|451810375|FG000|Main Phase|Withdrawal criteria|12|||
125367045|NCT04457336|450977271|FG006|Period 2: Part A|Study Terminated|0|||
125367046|NCT04457336|450977272|FG007|Period 2: Part A|Study Terminated|0|||
125596875|NCT01480180|451810376|FG001|Main Phase|Withdrawal criteria|1|||
125596876|NCT01480180|451810377|FG002|Main Phase|Withdrawal criteria|0|||
125596877|NCT01480180|451810378|FG003|Main Phase|Withdrawal criteria|0|||
125596878|NCT01480180|451810379|FG004|Main Phase|Withdrawal criteria|0|||
125596879|NCT01480180|451810380|FG005|Main Phase|Withdrawal criteria|0|||
125596880|NCT01480180|451810375|FG000|Main Phase|Lack of Efficacy|1|||
125596881|NCT01480180|451810376|FG001|Main Phase|Lack of Efficacy|0|||
125596882|NCT01480180|451810377|FG002|Main Phase|Lack of Efficacy|0|||
125596883|NCT01480180|451810378|FG003|Main Phase|Lack of Efficacy|0|||
125596884|NCT01480180|451810379|FG004|Main Phase|Lack of Efficacy|0|||
125596885|NCT01480180|451810380|FG005|Main Phase|Lack of Efficacy|0|||
125596886|NCT01480180|451810375|FG000|Main Phase|Non-compliance|3|||
125596887|NCT01480180|451810376|FG001|Main Phase|Non-compliance|0|||
125596888|NCT01480180|451810377|FG002|Main Phase|Non-compliance|0|||
125596889|NCT01480180|451810378|FG003|Main Phase|Non-compliance|0|||
125596890|NCT01480180|451810379|FG004|Main Phase|Non-compliance|0|||
125596891|NCT01480180|451810380|FG005|Main Phase|Non-compliance|0|||
125596892|NCT01480180|451810375|FG000|Main Phase|Unclassified|3|||
125596893|NCT01480180|451810376|FG001|Main Phase|Unclassified|0|||
125596894|NCT01480180|451810377|FG002|Main Phase|Unclassified|0|||
125596895|NCT01480180|451810378|FG003|Main Phase|Unclassified|0|||
125596896|NCT01480180|451810379|FG004|Main Phase|Unclassified|0|||
125596897|NCT01480180|451810380|FG005|Main Phase|Unclassified|0|||
125596898|NCT01480180|451810375|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
125596899|NCT01480180|451810376|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
125596900|NCT01480180|451810377|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
125596901|NCT01480180|451810378|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
125596902|NCT01480180|451810379|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
125596903|NCT01480180|451810380|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
125596904|NCT01480180|451810375|FG000|Extension Phase, Part 1|Unclassified|0|||
125596905|NCT01480180|451810376|FG001|Extension Phase, Part 1|Unclassified|0|||
125596906|NCT01480180|451810377|FG002|Extension Phase, Part 1|Unclassified|1|||
125596907|NCT01480180|451810378|FG003|Extension Phase, Part 1|Unclassified|0|||
125596908|NCT01480180|451810379|FG004|Extension Phase, Part 1|Unclassified|0|||
125596909|NCT01480180|451810380|FG005|Extension Phase, Part 1|Unclassified|0|||
125596910|NCT01480180|451810375|FG000|Extension Phase, Part 1|Adverse Event|0|||
125596911|NCT01480180|451810376|FG001|Extension Phase, Part 1|Adverse Event|0|||
125596912|NCT01480180|451810377|FG002|Extension Phase, Part 1|Adverse Event|4|||
125596913|NCT01480180|451810378|FG003|Extension Phase, Part 1|Adverse Event|1|||
125596914|NCT01480180|451810379|FG004|Extension Phase, Part 1|Adverse Event|0|||
125596915|NCT01480180|451810380|FG005|Extension Phase, Part 1|Adverse Event|0|||
125596916|NCT01480180|451810375|FG000|Extension Phase, Part 1|Change of treatment|0|||
125596917|NCT01480180|451810376|FG001|Extension Phase, Part 1|Change of treatment|0|||
125367047|NCT04457336|450977265|FG000|Period 2: Part A|Protocol Violation|0|||
125367048|NCT04457336|450977266|FG001|Period 2: Part A|Protocol Violation|1|||
125367049|NCT04457336|450977267|FG002|Period 2: Part A|Protocol Violation|0|||
125367050|NCT04457336|450977268|FG003|Period 2: Part A|Protocol Violation|0|||
125367051|NCT04457336|450977269|FG004|Period 2: Part A|Protocol Violation|0|||
125367052|NCT04457336|450977270|FG005|Period 2: Part A|Protocol Violation|0|||
125367053|NCT04457336|450977271|FG006|Period 2: Part A|Protocol Violation|0|||
125367054|NCT04457336|450977272|FG007|Period 2: Part A|Protocol Violation|0|||
125367055|NCT04457336|450977265|FG000|Period 2: Part A|Lost to Follow-up|0|||
125367056|NCT04457336|450977266|FG001|Period 2: Part A|Lost to Follow-up|1|||
125367057|NCT04457336|450977267|FG002|Period 2: Part A|Lost to Follow-up|0|||
125367058|NCT04457336|450977268|FG003|Period 2: Part A|Lost to Follow-up|0|||
125367059|NCT04457336|450977269|FG004|Period 2: Part A|Lost to Follow-up|0|||
125367060|NCT04457336|450977270|FG005|Period 2: Part A|Lost to Follow-up|0|||
125367061|NCT04457336|450977271|FG006|Period 2: Part A|Lost to Follow-up|0|||
125367062|NCT04457336|450977272|FG007|Period 2: Part A|Lost to Follow-up|0|||
125367063|NCT04457336|450977265|FG000|Period 2: Part A|Other|0|||
125367064|NCT04457336|450977266|FG001|Period 2: Part A|Other|1|||
125367065|NCT04457336|450977267|FG002|Period 2: Part A|Other|0|||
125367066|NCT04457336|450977268|FG003|Period 2: Part A|Other|0|||
125367067|NCT04457336|450977269|FG004|Period 2: Part A|Other|0|||
125367068|NCT04457336|450977270|FG005|Period 2: Part A|Other|0|||
125367069|NCT04457336|450977271|FG006|Period 2: Part A|Other|0|||
125367070|NCT04457336|450977272|FG007|Period 2: Part A|Other|0|||
125367071|NCT04457336|450977265|FG000|Period 2: Part A|Physician Decision|0|||
125367072|NCT04457336|450977266|FG001|Period 2: Part A|Physician Decision|0|||
125367073|NCT04457336|450977267|FG002|Period 2: Part A|Physician Decision|0|||
125367074|NCT04457336|450977268|FG003|Period 2: Part A|Physician Decision|1|||
125367075|NCT04457336|450977269|FG004|Period 2: Part A|Physician Decision|0|||
125367076|NCT04457336|450977270|FG005|Period 2: Part A|Physician Decision|0|||
125367077|NCT04457336|450977271|FG006|Period 2: Part A|Physician Decision|0|||
125367078|NCT04457336|450977272|FG007|Period 2: Part A|Physician Decision|0|||
125367079|NCT04457336|450977265|FG000|Period 3: Part B|Study Terminated|0|||
125367080|NCT04457336|450977266|FG001|Period 3: Part B|Study Terminated|0|||
125367081|NCT04457336|450977267|FG002|Period 3: Part B|Study Terminated|0|||
125367082|NCT04457336|450977268|FG003|Period 3: Part B|Study Terminated|0|||
125367083|NCT04457336|450977269|FG004|Period 3: Part B|Study Terminated|1|||
125367084|NCT04457336|450977270|FG005|Period 3: Part B|Study Terminated|10|||
125367085|NCT04457336|450977271|FG006|Period 3: Part B|Study Terminated|13|||
125367086|NCT04457336|450977272|FG007|Period 3: Part B|Study Terminated|0|||
125367087|NCT04457336|450977265|FG000|Period 3: Part B|Withdrawal by Subject|0|||
125367088|NCT04457336|450977266|FG001|Period 3: Part B|Withdrawal by Subject|0|||
125367089|NCT04457336|450977267|FG002|Period 3: Part B|Withdrawal by Subject|0|||
125367090|NCT04457336|450977268|FG003|Period 3: Part B|Withdrawal by Subject|0|||
125367091|NCT04457336|450977269|FG004|Period 3: Part B|Withdrawal by Subject|0|||
125367092|NCT04457336|450977270|FG005|Period 3: Part B|Withdrawal by Subject|1|||
125367093|NCT04457336|450977271|FG006|Period 3: Part B|Withdrawal by Subject|2|||
125596918|NCT01480180|451810377|FG002|Extension Phase, Part 1|Change of treatment|0|||
125596919|NCT01480180|451810378|FG003|Extension Phase, Part 1|Change of treatment|9|||
125596920|NCT01480180|451810379|FG004|Extension Phase, Part 1|Change of treatment|0|||
125212765|NCT01026818|450405478|FG000|Screening Period|Adverse Event|2|||
125367094|NCT04457336|450977272|FG007|Period 3: Part B|Withdrawal by Subject|0|||
125367095|NCT04457336|450977265|FG000|Period 4: Part C|Study Terminated|0|||
125367096|NCT04457336|450977266|FG001|Period 4: Part C|Study Terminated|0|||
125367097|NCT04457336|450977267|FG002|Period 4: Part C|Study Terminated|0|||
125367098|NCT04457336|450977268|FG003|Period 4: Part C|Study Terminated|0|||
125367099|NCT04457336|450977269|FG004|Period 4: Part C|Study Terminated|0|||
125367100|NCT04457336|450977270|FG005|Period 4: Part C|Study Terminated|0|||
125367101|NCT04457336|450977271|FG006|Period 4: Part C|Study Terminated|0|||
125367102|NCT04457336|450977272|FG007|Period 4: Part C|Study Terminated|30|||
125367103|NCT04457336|450977265|FG000|Period 4: Part C|Adverse Event|0|||
125367104|NCT04457336|450977266|FG001|Period 4: Part C|Adverse Event|0|||
125367105|NCT04457336|450977267|FG002|Period 4: Part C|Adverse Event|0|||
125367106|NCT04457336|450977268|FG003|Period 4: Part C|Adverse Event|0|||
125367107|NCT04457336|450977269|FG004|Period 4: Part C|Adverse Event|0|||
125367108|NCT04457336|450977270|FG005|Period 4: Part C|Adverse Event|0|||
125367109|NCT04457336|450977271|FG006|Period 4: Part C|Adverse Event|0|||
125367110|NCT04457336|450977272|FG007|Period 4: Part C|Adverse Event|2|||
125367111|NCT04457336|450977265|FG000|Period 4: Part C|Site Terminated|0|||
125367112|NCT04457336|450977266|FG001|Period 4: Part C|Site Terminated|0|||
125367113|NCT04457336|450977267|FG002|Period 4: Part C|Site Terminated|0|||
125367114|NCT04457336|450977268|FG003|Period 4: Part C|Site Terminated|0|||
125367115|NCT04457336|450977269|FG004|Period 4: Part C|Site Terminated|0|||
125367116|NCT04457336|450977270|FG005|Period 4: Part C|Site Terminated|0|||
125367117|NCT04457336|450977271|FG006|Period 4: Part C|Site Terminated|0|||
125367118|NCT04457336|450977272|FG007|Period 4: Part C|Site Terminated|1|||
125367119|NCT04457336|450977265|FG000|Period 4: Part C|Other|0|||
125367120|NCT04457336|450977266|FG001|Period 4: Part C|Other|0|||
125367121|NCT04457336|450977267|FG002|Period 4: Part C|Other|0|||
125367122|NCT04457336|450977268|FG003|Period 4: Part C|Other|0|||
125367123|NCT04457336|450977269|FG004|Period 4: Part C|Other|0|||
125367124|NCT04457336|450977270|FG005|Period 4: Part C|Other|0|||
125367125|NCT04457336|450977271|FG006|Period 4: Part C|Other|0|||
125367126|NCT04457336|450977272|FG007|Period 4: Part C|Other|2|||
125367127|NCT04457336|450977265|FG000|Period 4: Part C|Withdrawal by Subject|0|||
125367128|NCT04457336|450977266|FG001|Period 4: Part C|Withdrawal by Subject|0|||
125367129|NCT04457336|450977267|FG002|Period 4: Part C|Withdrawal by Subject|0|||
125367130|NCT04457336|450977268|FG003|Period 4: Part C|Withdrawal by Subject|0|||
125367131|NCT04457336|450977269|FG004|Period 4: Part C|Withdrawal by Subject|0|||
125367132|NCT04457336|450977270|FG005|Period 4: Part C|Withdrawal by Subject|0|||
125367133|NCT04457336|450977271|FG006|Period 4: Part C|Withdrawal by Subject|0|||
125367134|NCT04457336|450977272|FG007|Period 4: Part C|Withdrawal by Subject|3|||
125367135|NCT02693119|450977275|FG000|Open-Label Period|Withdrawal by Subject|0|||
125367136|NCT02693119|450977276|FG001|Open-Label Period|Withdrawal by Subject|1|||
125367137|NCT02571075|450977277|FG000|Overall Study|Lost to Follow-up|20|||
125367138|NCT02571075|450977278|FG001|Overall Study|Lost to Follow-up|24|||
125367139|NCT04203498|450977281|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
125367140|NCT04203498|450977282|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
125367141|NCT04203498|450977281|FG000|Overall Study|Withdrawal of patient consent|7|||
125367142|NCT04203498|450977282|FG001|Overall Study|Withdrawal of patient consent|2|||
125367143|NCT04203498|450977281|FG000|Overall Study|Adverse Event|4|||
125367144|NCT04203498|450977282|FG001|Overall Study|Adverse Event|1|||
125367145|NCT04203498|450977281|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
125367146|NCT04203498|450977282|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
125367147|NCT04203498|450977281|FG000|Overall Study|Did not receive IMP|2|||
125367148|NCT04203498|450977282|FG001|Overall Study|Did not receive IMP|0|||
125367149|NCT02106975|450977283|FG000|Overall Study|Death|25|||
125367150|NCT02106975|450977284|FG001|Overall Study|Death|39|||
125367151|NCT02935842|450977286|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
125367152|NCT02935842|450977287|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
125367153|NCT02935842|450977288|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
125367154|NCT02935842|450977289|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
125367155|NCT02935842|450977286|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
125367156|NCT02935842|450977287|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
125430313|NCT01226511|451201563|FG001|Extension Treatment Period|Protocol Violation|2|||
125430314|NCT01226511|451201562|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
125430315|NCT01226511|451201563|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
125430316|NCT01226511|451201562|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
125430317|NCT01226511|451201563|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
125430318|NCT01226511|451201562|FG000|Extension Treatment Period|Sponsor Decision|1|||
125430319|NCT01226511|451201563|FG001|Extension Treatment Period|Sponsor Decision|1|||
125430320|NCT01226511|451201562|FG000|Taper Period|Adverse Event|1|||
125430321|NCT01226511|451201563|FG001|Taper Period|Adverse Event|0|||
125430322|NCT01226511|451201562|FG000|Taper Period|Lost to Follow-up|2|||
125430323|NCT01226511|451201563|FG001|Taper Period|Lost to Follow-up|2|||
125430324|NCT01226511|451201562|FG000|Taper Period|Protocol Violation|1|||
125430325|NCT01226511|451201563|FG001|Taper Period|Protocol Violation|0|||
125430326|NCT01226511|451201562|FG000|Taper Period|Parent/Caregiver Decision|1|||
125430327|NCT01226511|451201563|FG001|Taper Period|Parent/Caregiver Decision|1|||
125430328|NCT00674570|451201565|FG000|Overall Study|Withdrawal by Subject|0|||
125430329|NCT00674570|451201566|FG001|Overall Study|Withdrawal by Subject|2|||
125430330|NCT00674570|451201567|FG002|Overall Study|Withdrawal by Subject|0|||
125430331|NCT01337986|451201568|FG000|Overall Study|Adverse Event|2|||
125430332|NCT01337986|451201569|FG001|Overall Study|Adverse Event|2|||
125430333|NCT01337986|451201568|FG000|Overall Study|Lost to Follow-up|1|||
125430334|NCT01337986|451201569|FG001|Overall Study|Lost to Follow-up|0|||
125430335|NCT01337986|451201568|FG000|Overall Study|Protocol Violation|0|||
125430336|NCT01337986|451201569|FG001|Overall Study|Protocol Violation|3|||
125430337|NCT04461795|451201571|FG000|Overall Study|Lost to Follow-up|2|||
125430338|NCT04461795|451201571|FG000|Overall Study|Withdrawal by Subject|2|||
125430339|NCT04461795|451201571|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
125430340|NCT00185640|451201572|FG000|Overall Study|Not Eligible|4|||
125430341|NCT00185640|451201572|FG000|Overall Study|Withdrawal by Subject|3|||
125430342|NCT00185640|451201572|FG000|Overall Study|Death|138|||
125430343|NCT00058422|451201573|FG000|Overall Study|Not treated|2|||
125430344|NCT01520402|451201576|FG000|Overall Study|Withdrawal by Subject|2|||
125430345|NCT01520402|451201576|FG000|Overall Study|Physician Decision|3|||
125430346|NCT01722162|451201578|FG000|Overall Study|Withdrawal by Subject|1|||
125430347|NCT01722162|451201579|FG001|Overall Study|Withdrawal by Subject|1|||
125430348|NCT01722162|451201578|FG000|Overall Study|Found ineligible|1|||
125430349|NCT01722162|451201579|FG001|Overall Study|Found ineligible|0|||
125430350|NCT01722162|451201578|FG000|Overall Study|Unrelated to study adverse event|2|||
125430351|NCT01722162|451201579|FG001|Overall Study|Unrelated to study adverse event|2|||
125430352|NCT01722162|451201578|FG000|Overall Study|Adverse Event|1|||
125430353|NCT01722162|451201579|FG001|Overall Study|Adverse Event|1|||
125430354|NCT01722162|451201578|FG000|Overall Study|Insurance denial post enrollment|0|||
125430355|NCT01722162|451201579|FG001|Overall Study|Insurance denial post enrollment|1|||
125430356|NCT01722162|451201578|FG000|Overall Study|Noncompliance|0|||
125430357|NCT01722162|451201579|FG001|Overall Study|Noncompliance|1|||
125430358|NCT03124199|451201580|FG000|Overall Study|Lost to Follow-up|4|||
125430359|NCT04074590|451201581|FG000|Overall Study|Adverse Event|1|||
125430360|NCT04074590|451201582|FG001|Overall Study|Adverse Event|0|||
125430361|NCT04074590|451201581|FG000|Overall Study|Physician Decision|1|||
125430362|NCT04074590|451201582|FG001|Overall Study|Physician Decision|0|||
125430363|NCT04074590|451201581|FG000|Overall Study|Withdrawal by Subject|2|||
125430364|NCT04074590|451201582|FG001|Overall Study|Withdrawal by Subject|0|||
125430365|NCT02709005|451201586|FG000|Overall Study|Lost to Follow-up|1|||
125430366|NCT02709005|451201587|FG001|Overall Study|Lost to Follow-up|1|||
125430367|NCT02709005|451201586|FG000|Overall Study|Withdrawal by Subject|3|||
125430368|NCT02709005|451201587|FG001|Overall Study|Withdrawal by Subject|0|||
125430369|NCT00691132|451201590|FG000|Overall Study|Adverse Event|2|||
125430370|NCT00691132|451201591|FG001|Overall Study|Adverse Event|3|||
125430371|NCT00691132|451201590|FG000|Overall Study|Withdrawal by Subject|10|||
125430372|NCT00691132|451201591|FG001|Overall Study|Withdrawal by Subject|10|||
125430373|NCT00532155|451201592|FG000|Overall Study|Adverse Event|66|||
125430374|NCT00532155|451201593|FG001|Overall Study|Adverse Event|123|||
125430375|NCT00532155|451201592|FG000|Overall Study|Lack of Efficacy|332|||
125430376|NCT00532155|451201593|FG001|Overall Study|Lack of Efficacy|255|||
125430377|NCT00532155|451201592|FG000|Overall Study|Protocol Violation|1|||
125430378|NCT00532155|451201593|FG001|Overall Study|Protocol Violation|3|||
125430379|NCT00532155|451201592|FG000|Overall Study|Lost to Follow-up|2|||
125430380|NCT00532155|451201593|FG001|Overall Study|Lost to Follow-up|0|||
125430381|NCT00532155|451201592|FG000|Overall Study|Physician Decision|16|||
125430382|NCT00532155|451201593|FG001|Overall Study|Physician Decision|15|||
125430383|NCT00532155|451201592|FG000|Overall Study|Withdrawal by Subject|23|||
125430384|NCT00532155|451201593|FG001|Overall Study|Withdrawal by Subject|44|||
125430385|NCT00532155|451201592|FG000|Overall Study|Consent withdrawn|5|||
125430386|NCT00532155|451201593|FG001|Overall Study|Consent withdrawn|7|||
125430387|NCT00532155|451201592|FG000|Overall Study|Moved|1|||
125430388|NCT00532155|451201593|FG001|Overall Study|Moved|0|||
125430389|NCT00532155|451201592|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
125430390|NCT00532155|451201593|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
125430391|NCT00532155|451201592|FG000|Overall Study|Occurence of a second cancer|0|||
125430392|NCT00532155|451201593|FG001|Overall Study|Occurence of a second cancer|1|||
125430393|NCT00532155|451201592|FG000|Overall Study|Occurence of a secondary cancer|0|||
125430394|NCT00532155|451201593|FG001|Overall Study|Occurence of a secondary cancer|1|||
125430395|NCT00532155|451201592|FG000|Overall Study|Promotor ended study|1|||
125430396|NCT00532155|451201593|FG001|Overall Study|Promotor ended study|0|||
125596921|NCT01480180|451810380|FG005|Extension Phase, Part 1|Change of treatment|0|||
125596922|NCT01480180|451810375|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
125596923|NCT01480180|451810376|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
125596924|NCT01480180|451810377|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
125596925|NCT01480180|451810378|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
125596926|NCT01480180|451810379|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
125596927|NCT01480180|451810380|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
125596928|NCT01480180|451810375|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
125596929|NCT01480180|451810376|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
125596930|NCT01480180|451810377|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
125596931|NCT01480180|451810378|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
125596932|NCT01480180|451810379|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
125596933|NCT01480180|451810380|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
125596934|NCT01480180|451810375|FG000|Extension Phase, Part 2|Unclassified|0|||
125596935|NCT01480180|451810376|FG001|Extension Phase, Part 2|Unclassified|0|||
125596936|NCT01480180|451810377|FG002|Extension Phase, Part 2|Unclassified|3|||
125596937|NCT01480180|451810378|FG003|Extension Phase, Part 2|Unclassified|1|||
125596938|NCT01480180|451810379|FG004|Extension Phase, Part 2|Unclassified|1|||
125596939|NCT01480180|451810380|FG005|Extension Phase, Part 2|Unclassified|0|||
125596940|NCT00184054|451810382|FG000|Overall Study|Adverse Event|1|||
125596941|NCT04925570|451810383|FG000|Overall Study|Protocol Violation|24|||
125596942|NCT04925570|451810384|FG001|Overall Study|Protocol Violation|30|||
125596943|NCT04925570|451810383|FG000|Overall Study|Withdrawal by Subject|0|||
125596944|NCT04925570|451810384|FG001|Overall Study|Withdrawal by Subject|2|||
125596945|NCT00828451|451810385|FG000|Overall Study|Death|2|||
125596946|NCT00828451|451810385|FG000|Overall Study|Lack of intravenous line|7|||
125596947|NCT00828451|451810385|FG000|Overall Study|Withdrawal by Subject|1|||
125596948|NCT00828451|451810385|FG000|Overall Study|Deterioration in clinical status|1|||
125596949|NCT00667277|451810387|FG000|Overall Study|Withdrawal by Subject|2|||
125596950|NCT00814710|451810390|FG000|Overall Study|Adverse Event|1|||
125596951|NCT00814710|451810391|FG001|Overall Study|Adverse Event|0|||
125596952|NCT00814710|451810390|FG000|Overall Study|Lost to Follow-up|7|||
125596953|NCT00814710|451810391|FG001|Overall Study|Lost to Follow-up|3|||
125596954|NCT02609399|451810400|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
125596955|NCT02609399|451810401|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
125596956|NCT02609399|451810400|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
125596957|NCT02609399|451810401|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
125596958|NCT02609399|451810400|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
125596959|NCT02609399|451810401|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
125596960|NCT00840463|451810408|FG000|Overall Study|Adverse Event|1|||
125596961|NCT00840463|451810409|FG001|Overall Study|Adverse Event|0|||
125596962|NCT02515669|451810413|FG000|228 Week Open-Label Phase|Other|0|||
125596963|NCT02515669|451810414|FG001|228 Week Open-Label Phase|Other|0|||
125596964|NCT02515669|451810415|FG002|228 Week Open-Label Phase|Other|1|||
125596965|NCT02515669|451810416|FG003|228 Week Open-Label Phase|Other|4|||
125596966|NCT02515669|451810413|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
125596967|NCT02515669|451810414|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
125596968|NCT02515669|451810415|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
125596969|NCT02515669|451810416|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
125596970|NCT02515669|451810413|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
125596971|NCT02515669|451810414|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
125596972|NCT02515669|451810415|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
125596973|NCT02515669|451810416|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
125596974|NCT02515669|451810413|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
125596975|NCT02515669|451810414|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
125596976|NCT02515669|451810415|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
125596977|NCT02515669|451810416|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
125596978|NCT02515669|451810413|FG000|228 Week Open-Label Phase|Missing|0|||
125596979|NCT02515669|451810414|FG001|228 Week Open-Label Phase|Missing|2|||
125596980|NCT02515669|451810415|FG002|228 Week Open-Label Phase|Missing|2|||
125596981|NCT02515669|451810416|FG003|228 Week Open-Label Phase|Missing|2|||
125596982|NCT01739595|451810417|FG000|Overall Study|Adverse Event|3|||
125596983|NCT01739595|451810418|FG001|Overall Study|Adverse Event|0|||
125596984|NCT01739595|451810419|FG002|Overall Study|Adverse Event|0|||
125596985|NCT01739595|451810417|FG000|Overall Study|Lost to Follow-up|2|||
125596986|NCT01739595|451810418|FG001|Overall Study|Lost to Follow-up|0|||
125367157|NCT02935842|450977288|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
125367158|NCT02935842|450977289|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
125367159|NCT02935842|450977286|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
125367160|NCT02935842|450977287|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
125367161|NCT02935842|450977288|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
125367162|NCT02935842|450977289|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
125367163|NCT02935842|450977286|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
125367164|NCT02935842|450977287|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
125212766|NCT01026818|450405479|FG001|Screening Period|Adverse Event|0|||
125367165|NCT02935842|450977288|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
125367166|NCT02935842|450977289|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
125367167|NCT02935842|450977286|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
125367168|NCT02935842|450977287|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
125367169|NCT02935842|450977288|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
125367170|NCT02935842|450977289|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
125367171|NCT01201785|450977290|FG000|Overall Study|Lost to Follow-up|16|||
125367172|NCT04545385|450977291|FG000|Overall Study|Withdrawal by Subject|2|||
125367173|NCT04545385|450977292|FG001|Overall Study|Withdrawal by Subject|0|||
125367174|NCT04545385|450977291|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
125367175|NCT04545385|450977292|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
125367176|NCT04545385|450977291|FG000|Overall Study|Study termination|10|||
125367177|NCT04545385|450977292|FG001|Overall Study|Study termination|10|||
125367178|NCT04545385|450977291|FG000|Overall Study|Sponsor decision|2|||
125367179|NCT04545385|450977292|FG001|Overall Study|Sponsor decision|2|||
125367180|NCT04545385|450977291|FG000|Overall Study|Other than specified|1|||
125367181|NCT04545385|450977292|FG001|Overall Study|Other than specified|0|||
125367182|NCT00939770|450977293|FG000|Overall Study|Adverse Event|1|||
125367183|NCT00939770|450977294|FG001|Overall Study|Adverse Event|1|||
125367184|NCT00939770|450977295|FG002|Overall Study|Adverse Event|0|||
125367185|NCT00939770|450977296|FG003|Overall Study|Adverse Event|0|||
125367186|NCT00939770|450977297|FG004|Overall Study|Adverse Event|6|||
125212767|NCT01026818|450405480|FG002|Screening Period|Adverse Event|0|||
125430397|NCT00532155|451201592|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
125430398|NCT00532155|451201593|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
125430399|NCT00532155|451201592|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
125430400|NCT00532155|451201593|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
125430401|NCT00532155|451201592|FG000|Overall Study|Study stopped|1|||
125430402|NCT00532155|451201593|FG001|Overall Study|Study stopped|0|||
125430403|NCT00532155|451201592|FG000|Overall Study|Study terminated by sponsor|1|||
125430404|NCT00532155|451201593|FG001|Overall Study|Study terminated by sponsor|0|||
125430405|NCT00532155|451201592|FG000|Overall Study|Study termination stop further treatment|4|||
125430406|NCT00532155|451201593|FG001|Overall Study|Study termination stop further treatment|0|||
125430407|NCT00532155|451201592|FG000|Overall Study|Did not receive study medication|2|||
125430408|NCT00532155|451201593|FG001|Overall Study|Did not receive study medication|6|||
125430409|NCT02158884|451201598|FG000|Baseline Assessment|Missed performance assessment|3|||
125430410|NCT02158884|451201598|FG000|Baseline Assessment|Missed SMFA|1|||
125430411|NCT02158884|451201598|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
125430412|NCT02158884|451201598|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
125430413|NCT02158884|451201598|FG000|6 Month Assessment|Missed SMFA|20|||
125430414|NCT02158884|451201598|FG000|12 Month Assessment|Missed SMFA|17|||
125430415|NCT01313286|451201601|FG000|Period 1|Withdrawal by Subject|2|||
125430416|NCT01313286|451201602|FG001|Period 1|Withdrawal by Subject|0|||
125430417|NCT02034708|451201603|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
125430418|NCT02034708|451201604|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
125430419|NCT02034708|451201603|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
125430420|NCT02034708|451201604|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
125430421|NCT02034708|451201603|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
125430422|NCT02034708|451201604|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
125430423|NCT02034708|451201603|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
125430424|NCT02034708|451201604|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
125430425|NCT04241094|451201613|FG000|Overall Study|Dropped out of treatment|4|||
125430426|NCT04241094|451201613|FG000|Overall Study|Ineligible after clinical assessment|2|||
125430427|NCT04241094|451201613|FG000|Overall Study|Lost to Follow-up|2|||
125430428|NCT02044848|451203238|FG000|Overall Study|Administrative Problems|2|||
125430429|NCT02044848|451203239|FG001|Overall Study|Administrative Problems|3|||
125430430|NCT00045708|451203240|FG000|Phase 1|early progressive disease|0|||
125430431|NCT00045708|451203241|FG001|Phase 1|early progressive disease|1|||
125430432|NCT00045708|451203242|FG002|Phase 1|early progressive disease|0|||
125430433|NCT01679236|451203243|FG000|Overall Study|Lost to Follow-up|15|||
125430434|NCT01679236|451203244|FG001|Overall Study|Lost to Follow-up|15|||
125430435|NCT03237858|451203248|FG000|Overall Study|Death|19|||
125430436|NCT03237858|451203248|FG000|Overall Study|Withdrawal by Subject|37|||
125430437|NCT04858802|451203251|FG000|Overall Study|Lost to Follow-up|1|||
125430438|NCT04858802|451203252|FG001|Overall Study|Lost to Follow-up|1|||
125430439|NCT04858802|451203251|FG000|Overall Study|Withdrawal by Subject|1|||
125430440|NCT04858802|451203252|FG001|Overall Study|Withdrawal by Subject|1|||
125430441|NCT03086018|451203254|FG000|Final Testing for End of Trial|Adverse Event|1|||
125430442|NCT03086018|451203254|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
125430443|NCT02748694|451203255|FG000|Overall Study|Voluntary Withdrawal|0|||
125430444|NCT02748694|451203256|FG001|Overall Study|Voluntary Withdrawal|0|||
125430445|NCT02748694|451203257|FG002|Overall Study|Voluntary Withdrawal|0|||
125430446|NCT02748694|451203258|FG003|Overall Study|Voluntary Withdrawal|0|||
125430447|NCT02748694|451203259|FG004|Overall Study|Voluntary Withdrawal|0|||
125430448|NCT02748694|451203260|FG005|Overall Study|Voluntary Withdrawal|0|||
125430449|NCT02748694|451203261|FG006|Overall Study|Voluntary Withdrawal|0|||
125430450|NCT02748694|451203262|FG007|Overall Study|Voluntary Withdrawal|0|||
125430451|NCT02748694|451203263|FG008|Overall Study|Voluntary Withdrawal|0|||
125596987|NCT01739595|451810419|FG002|Overall Study|Lost to Follow-up|0|||
125596988|NCT01739595|451810417|FG000|Overall Study|Withdrawal by Subject|2|||
125596989|NCT01739595|451810418|FG001|Overall Study|Withdrawal by Subject|1|||
125596990|NCT01739595|451810419|FG002|Overall Study|Withdrawal by Subject|2|||
125596991|NCT01739595|451810417|FG000|Overall Study|Eligibility issue|3|||
125596992|NCT01739595|451810418|FG001|Overall Study|Eligibility issue|0|||
125430452|NCT02748694|451203264|FG009|Overall Study|Voluntary Withdrawal|0|||
125430453|NCT02748694|451203265|FG010|Overall Study|Voluntary Withdrawal|0|||
125430454|NCT02748694|451203266|FG011|Overall Study|Voluntary Withdrawal|0|||
125596993|NCT01739595|451810419|FG002|Overall Study|Eligibility issue|0|||
125596994|NCT01739595|451810417|FG000|Overall Study|Protocol Violation|1|||
125430455|NCT02748694|451203267|FG012|Overall Study|Voluntary Withdrawal|0|||
125430456|NCT02748694|451203268|FG013|Overall Study|Voluntary Withdrawal|0|||
125430457|NCT02748694|451203269|FG014|Overall Study|Voluntary Withdrawal|2|||
125430458|NCT02487810|451203273|FG000|Overall Study|Withdrawal by Subject|1|||
125596995|NCT01739595|451810418|FG001|Overall Study|Protocol Violation|0|||
125596996|NCT01739595|451810419|FG002|Overall Study|Protocol Violation|0|||
125596997|NCT01739595|451810417|FG000|Overall Study|Lab assessment|1|||
125212768|NCT01026818|450405481|FG003|Screening Period|Adverse Event|0|||
125367187|NCT00939770|450977298|FG005|Overall Study|Adverse Event|2|||
125367188|NCT00939770|450977299|FG006|Overall Study|Adverse Event|1|||
125367189|NCT00939770|450977300|FG007|Overall Study|Adverse Event|1|||
125367190|NCT00939770|450977293|FG000|Overall Study|Lack of Efficacy|4|||
125367191|NCT00939770|450977294|FG001|Overall Study|Lack of Efficacy|6|||
125367192|NCT00939770|450977295|FG002|Overall Study|Lack of Efficacy|13|||
125367193|NCT00939770|450977296|FG003|Overall Study|Lack of Efficacy|9|||
125367194|NCT00939770|450977297|FG004|Overall Study|Lack of Efficacy|16|||
125367195|NCT00939770|450977298|FG005|Overall Study|Lack of Efficacy|8|||
125367196|NCT00939770|450977299|FG006|Overall Study|Lack of Efficacy|11|||
125367197|NCT00939770|450977300|FG007|Overall Study|Lack of Efficacy|1|||
125367198|NCT00939770|450977293|FG000|Overall Study|Lost to Follow-up|0|||
125367199|NCT00939770|450977294|FG001|Overall Study|Lost to Follow-up|0|||
125367200|NCT00939770|450977295|FG002|Overall Study|Lost to Follow-up|0|||
125367201|NCT00939770|450977296|FG003|Overall Study|Lost to Follow-up|0|||
125367202|NCT00939770|450977297|FG004|Overall Study|Lost to Follow-up|1|||
125367203|NCT00939770|450977298|FG005|Overall Study|Lost to Follow-up|0|||
125367204|NCT00939770|450977299|FG006|Overall Study|Lost to Follow-up|0|||
125367205|NCT00939770|450977300|FG007|Overall Study|Lost to Follow-up|0|||
125367206|NCT00939770|450977293|FG000|Overall Study|Physician Decision|0|||
125367207|NCT00939770|450977294|FG001|Overall Study|Physician Decision|0|||
125367208|NCT00939770|450977295|FG002|Overall Study|Physician Decision|2|||
125367209|NCT00939770|450977296|FG003|Overall Study|Physician Decision|0|||
125367210|NCT00939770|450977297|FG004|Overall Study|Physician Decision|7|||
125367211|NCT00939770|450977298|FG005|Overall Study|Physician Decision|1|||
125367212|NCT00939770|450977299|FG006|Overall Study|Physician Decision|0|||
125367213|NCT00939770|450977300|FG007|Overall Study|Physician Decision|6|||
125367214|NCT00939770|450977293|FG000|Overall Study|Protocol Violation|0|||
125367215|NCT00939770|450977294|FG001|Overall Study|Protocol Violation|0|||
125367216|NCT00939770|450977295|FG002|Overall Study|Protocol Violation|0|||
125367217|NCT00939770|450977296|FG003|Overall Study|Protocol Violation|0|||
125367218|NCT00939770|450977297|FG004|Overall Study|Protocol Violation|1|||
125367219|NCT00939770|450977298|FG005|Overall Study|Protocol Violation|0|||
125367220|NCT00939770|450977299|FG006|Overall Study|Protocol Violation|0|||
125367221|NCT00939770|450977300|FG007|Overall Study|Protocol Violation|0|||
125367222|NCT00939770|450977293|FG000|Overall Study|Withdrawal by Subject|0|||
125367223|NCT00939770|450977294|FG001|Overall Study|Withdrawal by Subject|1|||
125367224|NCT00939770|450977295|FG002|Overall Study|Withdrawal by Subject|5|||
125367225|NCT00939770|450977296|FG003|Overall Study|Withdrawal by Subject|2|||
125367226|NCT00939770|450977297|FG004|Overall Study|Withdrawal by Subject|6|||
125367227|NCT00939770|450977298|FG005|Overall Study|Withdrawal by Subject|0|||
125367228|NCT00939770|450977299|FG006|Overall Study|Withdrawal by Subject|2|||
125367229|NCT00939770|450977300|FG007|Overall Study|Withdrawal by Subject|2|||
125367230|NCT00191139|450977301|FG000|Overall Study|Adverse Event|2|||
125367231|NCT00191139|450977302|FG001|Overall Study|Adverse Event|6|||
125367232|NCT00191139|450977301|FG000|Overall Study|Death|2|||
125367233|NCT00191139|450977302|FG001|Overall Study|Death|0|||
125367234|NCT00191139|450977301|FG000|Overall Study|Withdrawal by Subject|0|||
125367235|NCT00191139|450977302|FG001|Overall Study|Withdrawal by Subject|3|||
125367236|NCT00191139|450977301|FG000|Overall Study|Disease Progression|0|||
125367237|NCT00191139|450977302|FG001|Overall Study|Disease Progression|1|||
125367238|NCT00191139|450977301|FG000|Overall Study|Other|1|||
125367239|NCT00191139|450977302|FG001|Overall Study|Other|2|||
125367240|NCT03128411|450977309|FG000|Treatment Phase|Adverse Event|21|||
125367241|NCT03128411|450977309|FG000|Treatment Phase|Physician Decision|1|||
125367242|NCT03128411|450977309|FG000|Treatment Phase|Other|2|||
125367243|NCT03128411|450977309|FG000|Long Term Follow-up Phase|Death|2|||
125367244|NCT00926328|450978774|FG000|Overall Study|Lost to Follow-up|12|||
125367245|NCT00926328|450978775|FG001|Overall Study|Lost to Follow-up|14|||
125367246|NCT00289133|450978776|FG000|Overall Study|Non-study device implanted|12|||
125367247|NCT00289133|450978777|FG001|Overall Study|Non-study device implanted|0|||
125367248|NCT00289133|450978776|FG000|Overall Study|Protocol Violation|32|||
125367249|NCT00289133|450978777|FG001|Overall Study|Protocol Violation|38|||
125367250|NCT00289133|450978776|FG000|Overall Study|Withdrawal by Subject|9|||
125367251|NCT00289133|450978777|FG001|Overall Study|Withdrawal by Subject|10|||
125367252|NCT00289133|450978776|FG000|Overall Study|Death|5|||
125367253|NCT00289133|450978777|FG001|Overall Study|Death|10|||
125367254|NCT00289133|450978776|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
125367255|NCT00289133|450978777|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
125367256|NCT00289133|450978776|FG000|Overall Study|Physician Decision|41|||
125367257|NCT00289133|450978777|FG001|Overall Study|Physician Decision|45|||
125367258|NCT00289133|450978776|FG000|Overall Study|Revision|8|||
125367259|NCT00289133|450978777|FG001|Overall Study|Revision|6|||
125367260|NCT00289133|450978776|FG000|Overall Study|Lost to Follow-up|92|||
125367261|NCT00289133|450978777|FG001|Overall Study|Lost to Follow-up|115|||
125367262|NCT04613375|450978781|FG000|Overall Study|Death|198|||
125367263|NCT04613375|450978781|FG000|Overall Study|Withdrawal by Subject|3|||
125367264|NCT01921387|450978784|FG000|Overall Study|Adverse Event|1|||
125367265|NCT02582983|450978786|FG000|Overall Study|Death|3|||
125367266|NCT02582983|450978786|FG000|Overall Study|Withdrawal by Subject|2|||
125367267|NCT02582983|450978786|FG000|Overall Study|Adverse Event|1|||
125367268|NCT03095612|450978789|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
125367269|NCT03095612|450978790|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
125367270|NCT03095612|450978791|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
125367271|NCT03095612|450978792|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
125367272|NCT03095612|450978793|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
125367273|NCT03095612|450978794|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
125367274|NCT03095612|450978795|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
125367275|NCT04447794|450978798|FG000|Overall Study|Lost to Follow-up|2|||
125430459|NCT02487810|451203274|FG001|Overall Study|Withdrawal by Subject|0|||
125430460|NCT01889186|451203275|FG000|Overall Study|Adverse event- not related to progression|18|||
125430461|NCT01889186|451203276|FG001|Overall Study|Adverse event- not related to progression|5|||
125430462|NCT01889186|451203275|FG000|Overall Study|Adverse event- related to progression|7|||
125430463|NCT01889186|451203276|FG001|Overall Study|Adverse event- related to progression|2|||
125430464|NCT01889186|451203275|FG000|Overall Study|COVID-19 logistical restrictions|1|||
125430465|NCT01889186|451203276|FG001|Overall Study|COVID-19 logistical restrictions|0|||
125430466|NCT01889186|451203275|FG000|Overall Study|Investigator request|1|||
125430467|NCT01889186|451203276|FG001|Overall Study|Investigator request|1|||
125430468|NCT01889186|451203275|FG000|Overall Study|Progressive disease- Richter's|12|||
125430469|NCT01889186|451203276|FG001|Overall Study|Progressive disease- Richter's|7|||
125430470|NCT01889186|451203275|FG000|Overall Study|Progressive disease per protocol|46|||
125430471|NCT01889186|451203276|FG001|Overall Study|Progressive disease per protocol|17|||
125430472|NCT01889186|451203275|FG000|Overall Study|Stem cell transplant|2|||
125430473|NCT01889186|451203276|FG001|Overall Study|Stem cell transplant|1|||
125430474|NCT01889186|451203275|FG000|Overall Study|Withdrew consent|2|||
125430475|NCT01889186|451203276|FG001|Overall Study|Withdrew consent|3|||
125430476|NCT01889186|451203275|FG000|Overall Study|Other, not specified|18|||
125430477|NCT01889186|451203276|FG001|Overall Study|Other, not specified|15|||
125430478|NCT02569437|451203281|FG000|Overall Study|Lost to Follow-up|12|||
125430479|NCT02569437|451203282|FG001|Overall Study|Lost to Follow-up|14|||
125430480|NCT00441701|451203283|FG000|Overall Study|Adverse Event|3|||
125430481|NCT00441701|451203284|FG001|Overall Study|Adverse Event|2|||
125430482|NCT00441701|451203285|FG002|Overall Study|Adverse Event|1|||
125430483|NCT00441701|451203286|FG003|Overall Study|Adverse Event|0|||
125430484|NCT00441701|451203287|FG004|Overall Study|Adverse Event|2|||
125430485|NCT00441701|451203288|FG005|Overall Study|Adverse Event|2|||
125430486|NCT00441701|451203289|FG006|Overall Study|Adverse Event|0|||
125430487|NCT00441701|451203290|FG007|Overall Study|Adverse Event|0|||
125430488|NCT00441701|451203291|FG008|Overall Study|Adverse Event|0|||
125430489|NCT00441701|451203292|FG009|Overall Study|Adverse Event|0|||
125430490|NCT00441701|451203283|FG000|Overall Study|Lack of Efficacy|2|||
125430491|NCT00441701|451203284|FG001|Overall Study|Lack of Efficacy|0|||
125430492|NCT00441701|451203285|FG002|Overall Study|Lack of Efficacy|2|||
125430493|NCT00441701|451203286|FG003|Overall Study|Lack of Efficacy|2|||
125430494|NCT00441701|451203287|FG004|Overall Study|Lack of Efficacy|0|||
125430495|NCT00441701|451203288|FG005|Overall Study|Lack of Efficacy|1|||
125430496|NCT00441701|451203289|FG006|Overall Study|Lack of Efficacy|0|||
125430497|NCT00441701|451203290|FG007|Overall Study|Lack of Efficacy|0|||
125430498|NCT00441701|451203291|FG008|Overall Study|Lack of Efficacy|0|||
125430499|NCT00441701|451203292|FG009|Overall Study|Lack of Efficacy|0|||
125430500|NCT00441701|451203283|FG000|Overall Study|Withdrawal by Subject|0|||
125430501|NCT00441701|451203284|FG001|Overall Study|Withdrawal by Subject|2|||
125430502|NCT00441701|451203285|FG002|Overall Study|Withdrawal by Subject|1|||
125430503|NCT00441701|451203286|FG003|Overall Study|Withdrawal by Subject|1|||
125430504|NCT00441701|451203287|FG004|Overall Study|Withdrawal by Subject|0|||
125430505|NCT00441701|451203288|FG005|Overall Study|Withdrawal by Subject|0|||
125596998|NCT01739595|451810418|FG001|Overall Study|Lab assessment|0|||
125367276|NCT04447794|450978799|FG001|Overall Study|Lost to Follow-up|3|||
125367277|NCT04447794|450978800|FG002|Overall Study|Lost to Follow-up|8|||
125367278|NCT04447794|450978798|FG000|Overall Study|Withdrawal by Subject|1|||
125367279|NCT04447794|450978799|FG001|Overall Study|Withdrawal by Subject|1|||
125367280|NCT04447794|450978800|FG002|Overall Study|Withdrawal by Subject|0|||
125367281|NCT00621582|450978801|FG000|Overall Study|Adverse Event|7|||
125367282|NCT00621582|450978801|FG000|Overall Study|Protocol Violation|57|||
125596999|NCT01739595|451810419|FG002|Overall Study|Lab assessment|0|||
125367283|NCT00621582|450978801|FG000|Overall Study|Lost to Follow-up|24|||
125367284|NCT00621582|450978801|FG000|Overall Study|issues not identified by investigators|18|||
125367285|NCT01387932|450978803|FG000|Randomized and Treated|Physician Decision|3|||
125367286|NCT01387932|450978804|FG001|Randomized and Treated|Physician Decision|2|||
125367287|NCT01387932|450978803|FG000|Randomized and Treated|Withdrawal by Subject|4|||
125367288|NCT01387932|450978804|FG001|Randomized and Treated|Withdrawal by Subject|2|||
125367289|NCT01387932|450978803|FG000|Survival Follow-up|Liver Transplant|24|||
125367290|NCT01387932|450978804|FG001|Survival Follow-up|Liver Transplant|28|||
125367291|NCT01387932|450978803|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
125367292|NCT01387932|450978804|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
125367293|NCT01387932|450978803|FG000|Survival Follow-up|Withdrawal by Subject|2|||
125367294|NCT01387932|450978804|FG001|Survival Follow-up|Withdrawal by Subject|4|||
125367295|NCT01387932|450978803|FG000|Survival Follow-up|Lost to Follow-up|6|||
125367296|NCT01387932|450978804|FG001|Survival Follow-up|Lost to Follow-up|5|||
125367297|NCT00963937|450978807|FG000|Overall Study|Protocol Violation|1|||
125367298|NCT00963937|450978808|FG001|Overall Study|Protocol Violation|1|||
125367299|NCT00963937|450978809|FG002|Overall Study|Protocol Violation|0|||
125367300|NCT00963937|450978807|FG000|Overall Study|Physician Decision|18|||
125367301|NCT00963937|450978808|FG001|Overall Study|Physician Decision|10|||
125367302|NCT00963937|450978809|FG002|Overall Study|Physician Decision|4|||
125367303|NCT01350492|450978810|FG000|Intervention|Lost to Follow-up|2|||
125367304|NCT01350492|450978811|FG001|Intervention|Lost to Follow-up|5|||
125367305|NCT01350492|450978810|FG000|Intervention|Withdrawal by Subject|3|||
125367306|NCT01350492|450978811|FG001|Intervention|Withdrawal by Subject|1|||
125367307|NCT01350492|450978810|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
125367308|NCT01350492|450978811|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
125367309|NCT01350492|450978810|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
125367310|NCT01350492|450978811|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
125367311|NCT00939640|450978814|FG000|Overall Study|Physician Decision|1|||
125367312|NCT01235689|450978820|FG000|Overall Study|Adverse Event|12|||
125367313|NCT01235689|450978821|FG001|Overall Study|Adverse Event|16|||
125367314|NCT01235689|450978820|FG000|Overall Study|Lack of Efficacy|12|||
125367315|NCT01235689|450978821|FG001|Overall Study|Lack of Efficacy|5|||
125367316|NCT01235689|450978820|FG000|Overall Study|Withdrawal by Subject|3|||
125367317|NCT01235689|450978821|FG001|Overall Study|Withdrawal by Subject|4|||
125367318|NCT01235689|450978820|FG000|Overall Study|Lost to Follow-up|1|||
125367319|NCT01235689|450978821|FG001|Overall Study|Lost to Follow-up|2|||
125367320|NCT01235689|450978820|FG000|Overall Study|Miscellaneous|1|||
125367321|NCT01235689|450978821|FG001|Overall Study|Miscellaneous|5|||
125367322|NCT00389597|450978822|FG000|Overall Study|Lost to Follow-up|8|||
125367323|NCT00389597|450978823|FG001|Overall Study|Lost to Follow-up|6|||
125367324|NCT00389597|450978824|FG002|Overall Study|Lost to Follow-up|4|||
125367325|NCT00389597|450978825|FG003|Overall Study|Lost to Follow-up|6|||
125367326|NCT00005044|450978826|FG000|Overall Study|Protocol Violation|37|||
125367327|NCT00005044|450978827|FG001|Overall Study|Protocol Violation|46|||
125367328|NCT00005044|450978826|FG000|Overall Study|Withdrawal by Subject|1|||
125367329|NCT00005044|450978827|FG001|Overall Study|Withdrawal by Subject|5|||
125367330|NCT00005044|450978826|FG000|Overall Study|No protocol treatment|0|||
125597000|NCT01739595|451810417|FG000|Overall Study|Drug discrepancy|1|||
125430506|NCT00441701|451203289|FG006|Overall Study|Withdrawal by Subject|0|||
125430507|NCT00441701|451203290|FG007|Overall Study|Withdrawal by Subject|0|||
125430508|NCT00441701|451203291|FG008|Overall Study|Withdrawal by Subject|0|||
125430509|NCT00441701|451203292|FG009|Overall Study|Withdrawal by Subject|0|||
125430510|NCT00077064|451203293|FG000|Overall Study|Adverse Event|0|||
125430511|NCT00077064|451203294|FG001|Overall Study|Adverse Event|4|||
125430512|NCT00077064|451203293|FG000|Overall Study|Patient refusal|0|||
125430513|NCT00077064|451203294|FG001|Overall Study|Patient refusal|2|||
125430514|NCT04710927|451203298|FG000|Overall Study|Lost to Follow-up|7|||
125430515|NCT04710927|451203299|FG001|Overall Study|Lost to Follow-up|6|||
125430516|NCT04710927|451203300|FG002|Overall Study|Lost to Follow-up|5|||
125430517|NCT02007434|451203303|FG000|Overall Study|Lost to Follow-up|0|||
125430518|NCT02007434|451203304|FG001|Overall Study|Lost to Follow-up|1|||
125430519|NCT02007434|451203305|FG002|Overall Study|Lost to Follow-up|0|||
125367331|NCT00005044|450978827|FG001|Overall Study|No protocol treatment|1|||
125367332|NCT04431453|450978828|FG000|Overall Study|Withdrew Consent|0|||
125367333|NCT04431453|450978829|FG001|Overall Study|Withdrew Consent|1|||
125367334|NCT04431453|450978830|FG002|Overall Study|Withdrew Consent|0|||
125367335|NCT04431453|450978831|FG003|Overall Study|Withdrew Consent|2|||
125367336|NCT04431453|450978832|FG004|Overall Study|Withdrew Consent|0|||
125367337|NCT04431453|450978833|FG005|Overall Study|Withdrew Consent|0|||
125367338|NCT04431453|450978834|FG006|Overall Study|Withdrew Consent|0|||
125367339|NCT04431453|450978835|FG007|Overall Study|Withdrew Consent|0|||
125367340|NCT04431453|450978828|FG000|Overall Study|Death|1|||
125367341|NCT04431453|450978829|FG001|Overall Study|Death|0|||
125367342|NCT04431453|450978830|FG002|Overall Study|Death|0|||
125367343|NCT04431453|450978831|FG003|Overall Study|Death|0|||
125367344|NCT04431453|450978832|FG004|Overall Study|Death|0|||
125367345|NCT04431453|450978833|FG005|Overall Study|Death|0|||
125367346|NCT04431453|450978834|FG006|Overall Study|Death|0|||
125367347|NCT04431453|450978835|FG007|Overall Study|Death|1|||
125367348|NCT04431453|450978828|FG000|Overall Study|Lost to Follow-up|0|||
125367349|NCT04431453|450978829|FG001|Overall Study|Lost to Follow-up|0|||
125367350|NCT04431453|450978830|FG002|Overall Study|Lost to Follow-up|1|||
125367351|NCT04431453|450978831|FG003|Overall Study|Lost to Follow-up|1|||
125367352|NCT04431453|450978832|FG004|Overall Study|Lost to Follow-up|0|||
125367353|NCT04431453|450978833|FG005|Overall Study|Lost to Follow-up|0|||
125367354|NCT04431453|450978834|FG006|Overall Study|Lost to Follow-up|0|||
125367355|NCT04431453|450978835|FG007|Overall Study|Lost to Follow-up|0|||
125367356|NCT04431453|450978828|FG000|Overall Study|Enrolled but Never Treated|0|||
125367357|NCT04431453|450978829|FG001|Overall Study|Enrolled but Never Treated|0|||
125367358|NCT04431453|450978830|FG002|Overall Study|Enrolled but Never Treated|0|||
125367359|NCT04431453|450978831|FG003|Overall Study|Enrolled but Never Treated|0|||
125367360|NCT04431453|450978832|FG004|Overall Study|Enrolled but Never Treated|1|||
125367361|NCT04431453|450978833|FG005|Overall Study|Enrolled but Never Treated|0|||
125367362|NCT04431453|450978834|FG006|Overall Study|Enrolled but Never Treated|0|||
125367363|NCT04431453|450978835|FG007|Overall Study|Enrolled but Never Treated|0|||
125367364|NCT03546062|450978836|FG000|Overall Study|Adverse Event|6|||
125430520|NCT02007434|451203306|FG003|Overall Study|Lost to Follow-up|0|||
125430521|NCT02007434|451203307|FG004|Overall Study|Lost to Follow-up|0|||
125367365|NCT03546062|450978837|FG001|Overall Study|Adverse Event|5|||
125367366|NCT03546062|450978838|FG002|Overall Study|Adverse Event|8|||
125367367|NCT02083965|450978840|FG000|Treatment Period|Other|1|||
125367368|NCT02083965|450978841|FG001|Treatment Period|Other|0|||
125367369|NCT04502433|450978842|FG000|Overall Study|Death|2|||
125367370|NCT04502433|450978843|FG001|Overall Study|Death|4|||
125367371|NCT04502433|450978842|FG000|Overall Study|Lost to Follow-up|1|||
125367372|NCT04502433|450978843|FG001|Overall Study|Lost to Follow-up|0|||
125367373|NCT04502433|450978842|FG000|Overall Study|Physician Decision|0|||
125367374|NCT04502433|450978843|FG001|Overall Study|Physician Decision|1|||
125367375|NCT01702961|450978846|FG000|Overall Study|Additional treatment|3|||
125367376|NCT01702961|450978846|FG000|Overall Study|Progressive disease|5|||
125367377|NCT01702961|450978846|FG000|Overall Study|Relapse|20|||
125367378|NCT01702961|450978846|FG000|Overall Study|Death|6|||
125367379|NCT01702961|450978846|FG000|Overall Study|Lost to Follow-up|2|||
125367380|NCT01702961|450978846|FG000|Overall Study|Ongoing|11|||
125367381|NCT02229383|450978847|FG000|Overall Study|Adverse Event|7|||
125367382|NCT02229383|450978848|FG001|Overall Study|Adverse Event|4|||
125367383|NCT02229383|450978847|FG000|Overall Study|Death|0|||
125367384|NCT02229383|450978848|FG001|Overall Study|Death|1|||
125367385|NCT02229383|450978847|FG000|Overall Study|Lost to Follow-up|5|||
125367386|NCT02229383|450978848|FG001|Overall Study|Lost to Follow-up|3|||
125367387|NCT02229383|450978847|FG000|Overall Study|Withdrawal by Subject|4|||
125367388|NCT02229383|450978848|FG001|Overall Study|Withdrawal by Subject|6|||
125367389|NCT02229383|450978847|FG000|Overall Study|Did not receive treatment|1|||
125367390|NCT02229383|450978848|FG001|Overall Study|Did not receive treatment|0|||
125367391|NCT02229383|450978847|FG000|Overall Study|Other|3|||
125367392|NCT02229383|450978848|FG001|Overall Study|Other|8|||
125367393|NCT00674362|450978851|FG000|Double Blind|Adverse Event|6|||
125367394|NCT00674362|450978852|FG001|Double Blind|Adverse Event|6|||
125367395|NCT00674362|450978851|FG000|Double Blind|Lack of Efficacy|2|||
125367396|NCT00674362|450978852|FG001|Double Blind|Lack of Efficacy|6|||
125367397|NCT00674362|450978851|FG000|Double Blind|Loss of efficacy|0|||
125367398|NCT00674362|450978852|FG001|Double Blind|Loss of efficacy|1|||
125367399|NCT00674362|450978851|FG000|Double Blind|Withdrawal by Subject|4|||
125367400|NCT00674362|450978852|FG001|Double Blind|Withdrawal by Subject|3|||
125367401|NCT00674362|450978851|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
125367402|NCT00674362|450978852|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
125367403|NCT00674362|450978851|FG000|Double Blind|Other: Surgery|0|||
125367404|NCT00674362|450978852|FG001|Double Blind|Other: Surgery|1|||
125367405|NCT00674362|450978851|FG000|Open Label|Adverse Event|1|||
125367406|NCT00674362|450978852|FG001|Open Label|Adverse Event|0|||
125367407|NCT00674362|450978851|FG000|Open Label|Other: Subject moved to extension study|1|||
125367408|NCT00674362|450978852|FG001|Open Label|Other: Subject moved to extension study|0|||
125367409|NCT00923156|450978853|FG000|Overall Study|Adverse Event|0|||
125367410|NCT00923156|450978854|FG001|Overall Study|Adverse Event|2|||
125367411|NCT00923156|450978855|FG002|Overall Study|Adverse Event|1|||
125367412|NCT00923156|450978853|FG000|Overall Study|Abnormal laboratory values|0|||
125367413|NCT00923156|450978854|FG001|Overall Study|Abnormal laboratory values|0|||
125367414|NCT00923156|450978855|FG002|Overall Study|Abnormal laboratory values|1|||
125367415|NCT00923156|450978853|FG000|Overall Study|Withdrawal by Subject|0|||
125367416|NCT00923156|450978854|FG001|Overall Study|Withdrawal by Subject|1|||
125212769|NCT01026818|450405478|FG000|Screening Period|Physician Decision|1|||
125430522|NCT02007434|451203308|FG005|Overall Study|Lost to Follow-up|0|||
125430523|NCT02007434|451203309|FG006|Overall Study|Lost to Follow-up|0|||
125430524|NCT02007434|451203310|FG007|Overall Study|Lost to Follow-up|0|||
125430525|NCT02007434|451203303|FG000|Overall Study|Non-compliance|1|||
125430526|NCT02007434|451203304|FG001|Overall Study|Non-compliance|0|||
125430527|NCT02007434|451203305|FG002|Overall Study|Non-compliance|1|||
125430528|NCT02007434|451203306|FG003|Overall Study|Non-compliance|0|||
125430529|NCT02007434|451203307|FG004|Overall Study|Non-compliance|0|||
125430530|NCT02007434|451203308|FG005|Overall Study|Non-compliance|0|||
125430531|NCT02007434|451203309|FG006|Overall Study|Non-compliance|0|||
125430532|NCT02007434|451203310|FG007|Overall Study|Non-compliance|0|||
125430533|NCT01287611|451203311|FG000|Overall Study|Lost to Follow-up|29|||
125430534|NCT01287611|451203312|FG001|Overall Study|Lost to Follow-up|16|||
125430535|NCT01287611|451203311|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
125430536|NCT01287611|451203312|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
125430537|NCT02192970|451203317|FG000|Overall Study|Lost to Follow-up|6|||
125430538|NCT02192970|451203318|FG001|Overall Study|Lost to Follow-up|0|||
125430539|NCT03299686|451203329|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
125430540|NCT03299686|451203330|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
125430541|NCT03299686|451203329|FG000|Treatment Epoch|Physician Decision|1|||
125430542|NCT03299686|451203330|FG001|Treatment Epoch|Physician Decision|0|||
125430543|NCT03299686|451203329|FG000|Treatment Epoch|Adverse Event|8|||
125430544|NCT03299686|451203330|FG001|Treatment Epoch|Adverse Event|4|||
125430545|NCT03299686|451203329|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
125430546|NCT03299686|451203330|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
125430547|NCT03745222|451203331|FG000|Overall Study|Withdrawal by Subject|0|||
125430548|NCT03745222|451203332|FG001|Overall Study|Withdrawal by Subject|1|||
125430549|NCT03745222|451203333|FG002|Overall Study|Withdrawal by Subject|0|||
125430550|NCT01959347|451203334|FG000|Overall Study|Protocol Violation|9|||
125430551|NCT01959347|451203335|FG001|Overall Study|Protocol Violation|7|||
125430552|NCT03954743|451203336|FG000|Overall Study|Adverse Event|1|||
125430553|NCT03954743|451203337|FG001|Overall Study|Adverse Event|0|||
125430554|NCT03954743|451203336|FG000|Overall Study|Lost to Follow-up|6|||
125430555|NCT03954743|451203337|FG001|Overall Study|Lost to Follow-up|4|||
125430556|NCT03954743|451203336|FG000|Overall Study|Protocol Violation|1|||
125430557|NCT03954743|451203337|FG001|Overall Study|Protocol Violation|0|||
125430558|NCT03954743|451203336|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
125430559|NCT03954743|451203337|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
125430560|NCT03954743|451203336|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
125430561|NCT03954743|451203337|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125430562|NCT00860067|451203340|FG000|Overall Study|Lost to Follow-up|46|||
125430563|NCT00860067|451203341|FG001|Overall Study|Lost to Follow-up|9|||
125430564|NCT00860067|451203342|FG002|Overall Study|Lost to Follow-up|9|||
125430565|NCT00860067|451203340|FG000|Overall Study|Withdrawal by Subject|4|||
125430566|NCT00860067|451203341|FG001|Overall Study|Withdrawal by Subject|0|||
125430567|NCT00860067|451203342|FG002|Overall Study|Withdrawal by Subject|0|||
125430568|NCT00860067|451203340|FG000|Overall Study|Pregnancy|1|||
125430569|NCT00860067|451203341|FG001|Overall Study|Pregnancy|0|||
125430570|NCT00860067|451203342|FG002|Overall Study|Pregnancy|0|||
125430571|NCT01282801|451203343|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
125212770|NCT01026818|450405479|FG001|Screening Period|Physician Decision|0|||
125430572|NCT01282801|451203344|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
125430573|NCT02387996|451203347|FG000|Overall Study|Disease Progression|167|||
125430574|NCT02387996|451203347|FG000|Overall Study|Study Drug Toxicity|31|||
125430575|NCT02387996|451203347|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
125430576|NCT02387996|451203347|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
125430577|NCT02387996|451203347|FG000|Overall Study|Subject Withdrew Consent|5|||
125430578|NCT02387996|451203347|FG000|Overall Study|Lost to Follow-up|1|||
125430579|NCT02387996|451203347|FG000|Overall Study|Poor/Non-Compliance|1|||
125430580|NCT02387996|451203347|FG000|Overall Study|Other Reasons|5|||
125212771|NCT01026818|450405480|FG002|Screening Period|Physician Decision|0|||
125367417|NCT00923156|450978855|FG002|Overall Study|Withdrawal by Subject|0|||
125367418|NCT00923156|450978853|FG000|Overall Study|Death|0|||
125367419|NCT00923156|450978854|FG001|Overall Study|Death|1|||
125367420|NCT00923156|450978855|FG002|Overall Study|Death|0|||
125367421|NCT00923156|450978853|FG000|Overall Study|Lack of Efficacy|0|||
125367422|NCT00923156|450978854|FG001|Overall Study|Lack of Efficacy|0|||
125367423|NCT00923156|450978855|FG002|Overall Study|Lack of Efficacy|1|||
125367424|NCT01201850|450978858|FG000|Overall Study|Tumor progression|4|||
125367425|NCT03137537|450978859|FG000|Overall Study|Adverse Event|0|||
125367426|NCT03137537|450978860|FG001|Overall Study|Adverse Event|1|||
125367427|NCT03386448|450978861|FG000|Overall Study|Adverse Event|0|||
125367428|NCT03386448|450978862|FG001|Overall Study|Adverse Event|2|||
125367429|NCT03338010|450978865|FG000|Overall Study|Withdrawal by Subject|14|||
125367430|NCT03338010|450978866|FG001|Overall Study|Withdrawal by Subject|8|||
125367431|NCT03338010|450978865|FG000|Overall Study|Lost to Follow-up|4|||
125367432|NCT03338010|450978866|FG001|Overall Study|Lost to Follow-up|2|||
125367433|NCT03338010|450978865|FG000|Overall Study|Adverse Event|3|||
125367434|NCT03338010|450978866|FG001|Overall Study|Adverse Event|2|||
125367435|NCT03338010|450978865|FG000|Overall Study|Physician Decision|2|||
125367436|NCT03338010|450978866|FG001|Overall Study|Physician Decision|2|||
125367437|NCT03338010|450978865|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125367438|NCT03338010|450978866|FG001|Overall Study|Non-Compliance with Study Drug|3|||
125367439|NCT03338010|450978865|FG000|Overall Study|Protocol Violation|0|||
125597001|NCT01739595|451810418|FG001|Overall Study|Drug discrepancy|0|||
125597002|NCT01739595|451810419|FG002|Overall Study|Drug discrepancy|0|||
125367440|NCT03338010|450978866|FG001|Overall Study|Protocol Violation|1|||
125367441|NCT01146665|450978867|FG000|Overall Study|Withdrawal by Subject|10|||
125367442|NCT01146665|450978868|FG001|Overall Study|Withdrawal by Subject|16|||
125367443|NCT02465515|450978869|FG000|Overall Study|Investigator site closed|4|||
125367444|NCT02465515|450978870|FG001|Overall Study|Investigator site closed|5|||
125367445|NCT02465515|450978869|FG000|Overall Study|Withdrawal by Subject|74|||
125367446|NCT02465515|450978870|FG001|Overall Study|Withdrawal by Subject|43|||
125367447|NCT02465515|450978869|FG000|Overall Study|Physician Decision|8|||
125367448|NCT02465515|450978870|FG001|Overall Study|Physician Decision|12|||
125367449|NCT02465515|450978869|FG000|Overall Study|Lost to Follow-up|68|||
125367450|NCT02465515|450978870|FG001|Overall Study|Lost to Follow-up|51|||
125367451|NCT00816595|450978871|FG000|Overall Study|Withdrawal by Subject|2|||
125367452|NCT00816595|450978872|FG001|Overall Study|Withdrawal by Subject|0|||
125367453|NCT00293033|450978873|FG000|Open-label Titration Period|Adverse Event|10|||
125367454|NCT00293033|450978873|FG000|Open-label Titration Period|Death|3|||
125367455|NCT00293033|450978873|FG000|Open-label Titration Period|Lack of Efficacy|5|||
125367456|NCT00293033|450978873|FG000|Open-label Titration Period|Protocol Violation|2|||
125367457|NCT00293033|450978873|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
125367458|NCT00293033|450978873|FG000|Open-label Titration Period|Noncompliance and other|27|||
125367459|NCT00293033|450978873|FG000|Double-blind Treatment Period|Adverse Event|3|||
125367460|NCT00293033|450978873|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
125367461|NCT00293033|450978873|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
125367462|NCT00293033|450978873|FG000|Double-blind Treatment Period|Noncompliance|4|||
125367463|NCT01817530|450978875|FG000|Overall Study|Exclusionary Medication Received|0|||
125367464|NCT01817530|450978876|FG001|Overall Study|Exclusionary Medication Received|0|||
125367465|NCT01817530|450978877|FG002|Overall Study|Exclusionary Medication Received|0|||
125367466|NCT01817530|450978878|FG003|Overall Study|Exclusionary Medication Received|0|||
125367467|NCT01817530|450978879|FG004|Overall Study|Exclusionary Medication Received|1|||
125367468|NCT01817530|450978880|FG005|Overall Study|Exclusionary Medication Received|0|||
125367469|NCT01817530|450978881|FG006|Overall Study|Exclusionary Medication Received|0|||
125367470|NCT01817530|450978882|FG007|Overall Study|Exclusionary Medication Received|0|||
125367471|NCT01817530|450978875|FG000|Overall Study|Adverse Event|6|||
125367472|NCT01817530|450978876|FG001|Overall Study|Adverse Event|3|||
125367473|NCT01817530|450978877|FG002|Overall Study|Adverse Event|2|||
125367474|NCT01817530|450978878|FG003|Overall Study|Adverse Event|5|||
125367475|NCT01817530|450978879|FG004|Overall Study|Adverse Event|0|||
125367476|NCT01817530|450978880|FG005|Overall Study|Adverse Event|10|||
125597003|NCT01676116|451810423|FG000|Overall Study|Withdrawal criteria|2|||
125597004|NCT01676116|451810424|FG001|Overall Study|Withdrawal criteria|14|||
125367477|NCT01817530|450978881|FG006|Overall Study|Adverse Event|5|||
125367478|NCT01817530|450978882|FG007|Overall Study|Adverse Event|8|||
125367479|NCT01817530|450978875|FG000|Overall Study|Subject Noncompliant|3|||
125367480|NCT01817530|450978876|FG001|Overall Study|Subject Noncompliant|1|||
125367481|NCT01817530|450978877|FG002|Overall Study|Subject Noncompliant|0|||
125367482|NCT01817530|450978878|FG003|Overall Study|Subject Noncompliant|4|||
125367483|NCT01817530|450978879|FG004|Overall Study|Subject Noncompliant|0|||
125597005|NCT01676116|451810423|FG000|Overall Study|Adverse Event|1|||
125597006|NCT01676116|451810424|FG001|Overall Study|Adverse Event|2|||
125597007|NCT01676116|451810423|FG000|Overall Study|Unclassified|4|||
125597008|NCT01676116|451810424|FG001|Overall Study|Unclassified|10|||
125597009|NCT01676116|451810423|FG000|Overall Study|Protocol Violation|9|||
125367484|NCT01817530|450978880|FG005|Overall Study|Subject Noncompliant|1|||
125367485|NCT01817530|450978881|FG006|Overall Study|Subject Noncompliant|1|||
125367486|NCT01817530|450978882|FG007|Overall Study|Subject Noncompliant|1|||
125367487|NCT01817530|450978875|FG000|Overall Study|Lack of Efficacy|1|||
125367488|NCT01817530|450978876|FG001|Overall Study|Lack of Efficacy|0|||
125367489|NCT01817530|450978877|FG002|Overall Study|Lack of Efficacy|0|||
125367490|NCT01817530|450978878|FG003|Overall Study|Lack of Efficacy|0|||
125367491|NCT01817530|450978879|FG004|Overall Study|Lack of Efficacy|0|||
125367492|NCT01817530|450978880|FG005|Overall Study|Lack of Efficacy|1|||
125367493|NCT01817530|450978881|FG006|Overall Study|Lack of Efficacy|0|||
125367494|NCT01817530|450978882|FG007|Overall Study|Lack of Efficacy|1|||
125367495|NCT01817530|450978875|FG000|Overall Study|Pregnancy|0|||
125367496|NCT01817530|450978876|FG001|Overall Study|Pregnancy|0|||
125367497|NCT01817530|450978877|FG002|Overall Study|Pregnancy|0|||
125367498|NCT01817530|450978878|FG003|Overall Study|Pregnancy|0|||
125367499|NCT01817530|450978879|FG004|Overall Study|Pregnancy|0|||
125367500|NCT01817530|450978880|FG005|Overall Study|Pregnancy|1|||
125367501|NCT01817530|450978881|FG006|Overall Study|Pregnancy|0|||
125367502|NCT01817530|450978882|FG007|Overall Study|Pregnancy|0|||
125367503|NCT01817530|450978875|FG000|Overall Study|Other|0|||
125367504|NCT01817530|450978876|FG001|Overall Study|Other|1|||
125367505|NCT01817530|450978877|FG002|Overall Study|Other|0|||
125367506|NCT01817530|450978878|FG003|Overall Study|Other|0|||
125367507|NCT01817530|450978879|FG004|Overall Study|Other|1|||
125367508|NCT01817530|450978880|FG005|Overall Study|Other|0|||
125367509|NCT01817530|450978881|FG006|Overall Study|Other|5|||
125367510|NCT01817530|450978882|FG007|Overall Study|Other|0|||
125367511|NCT01817530|450978875|FG000|Overall Study|Surgery or Invasive Intervention|1|||
125367512|NCT01817530|450978876|FG001|Overall Study|Surgery or Invasive Intervention|0|||
125367513|NCT01817530|450978877|FG002|Overall Study|Surgery or Invasive Intervention|0|||
125367514|NCT01817530|450978878|FG003|Overall Study|Surgery or Invasive Intervention|0|||
125367515|NCT01817530|450978879|FG004|Overall Study|Surgery or Invasive Intervention|1|||
125367516|NCT01817530|450978880|FG005|Overall Study|Surgery or Invasive Intervention|1|||
125367517|NCT01817530|450978881|FG006|Overall Study|Surgery or Invasive Intervention|1|||
125367518|NCT01817530|450978882|FG007|Overall Study|Surgery or Invasive Intervention|0|||
125367519|NCT01817530|450978875|FG000|Overall Study|Consent Withdrawn by Subject|3|||
125367520|NCT01817530|450978876|FG001|Overall Study|Consent Withdrawn by Subject|4|||
125367521|NCT01817530|450978877|FG002|Overall Study|Consent Withdrawn by Subject|7|||
125367522|NCT01817530|450978878|FG003|Overall Study|Consent Withdrawn by Subject|3|||
125367523|NCT01817530|450978879|FG004|Overall Study|Consent Withdrawn by Subject|5|||
125367524|NCT01817530|450978880|FG005|Overall Study|Consent Withdrawn by Subject|3|||
125367525|NCT01817530|450978881|FG006|Overall Study|Consent Withdrawn by Subject|3|||
125367526|NCT01817530|450978882|FG007|Overall Study|Consent Withdrawn by Subject|10|||
125367527|NCT01817530|450978875|FG000|Overall Study|Lost to Follow-up|1|||
125367528|NCT01817530|450978876|FG001|Overall Study|Lost to Follow-up|4|||
125367529|NCT01817530|450978877|FG002|Overall Study|Lost to Follow-up|2|||
125367530|NCT01817530|450978878|FG003|Overall Study|Lost to Follow-up|1|||
125367531|NCT01817530|450978879|FG004|Overall Study|Lost to Follow-up|3|||
125367532|NCT01817530|450978880|FG005|Overall Study|Lost to Follow-up|2|||
125367533|NCT01817530|450978881|FG006|Overall Study|Lost to Follow-up|8|||
125367534|NCT01817530|450978882|FG007|Overall Study|Lost to Follow-up|4|||
125212772|NCT01026818|450405481|FG003|Screening Period|Physician Decision|0|||
125212773|NCT01026818|450405478|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
125367535|NCT03846804|450978883|FG000|Overall Study|Refused blood draw|1|||
125367536|NCT03846804|450978883|FG000|Overall Study|Protocol Violation|1|||
125367537|NCT00404235|450978884|FG000|Overall Study|Withdrawal by Subject|1|||
125367538|NCT00404235|450978885|FG001|Overall Study|Withdrawal by Subject|2|||
125430581|NCT02387996|451203347|FG000|Overall Study|Death|1|||
125367539|NCT00345839|450978886|FG000|Overall Study|Withdrawal by Subject|91|||
125367540|NCT00345839|450978887|FG001|Overall Study|Withdrawal by Subject|98|||
125367541|NCT00345839|450978886|FG000|Overall Study|Lost to Follow-up|58|||
125430582|NCT01060553|451203348|FG000|Overall Study|Lost to Follow-up|3|||
125367542|NCT00345839|450978887|FG001|Overall Study|Lost to Follow-up|61|||
125430583|NCT01060553|451203349|FG001|Overall Study|Lost to Follow-up|5|||
125367543|NCT03298867|450978890|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
125367544|NCT03298867|450978891|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
125367545|NCT03298867|450978890|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
125367546|NCT03298867|450978891|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
125367547|NCT03298867|450978890|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
125367548|NCT03298867|450978891|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
125367549|NCT03298867|450978890|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
125367550|NCT03298867|450978891|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
125367551|NCT03298867|450978890|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
125367552|NCT03298867|450978891|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
125367553|NCT03298867|450978890|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
125367554|NCT03298867|450978891|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
125367555|NCT03298867|450978890|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
125367556|NCT03298867|450978891|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
125367557|NCT03298867|450978890|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
125430584|NCT01060553|451203348|FG000|Overall Study|Withdrawal by Subject|5|||
125430585|NCT01060553|451203349|FG001|Overall Study|Withdrawal by Subject|5|||
125430586|NCT01060553|451203348|FG000|Overall Study|Lack of Efficacy|1|||
125430587|NCT01060553|451203349|FG001|Overall Study|Lack of Efficacy|0|||
125430588|NCT04707196|451203352|FG000|Overall Study|Withdrawal by Subject|9|||
125430589|NCT04707196|451203353|FG001|Overall Study|Withdrawal by Subject|6|||
125430590|NCT04707196|451203352|FG000|Overall Study|Lost to Follow-up|1|||
125597010|NCT01676116|451810424|FG001|Overall Study|Protocol Violation|3|||
125597011|NCT00778999|451810427|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
125597012|NCT00778999|451810428|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
125597013|NCT00778999|451810427|FG000|Overall Study|Did not receive recFSH|14|||
125597014|NCT00778999|451810428|FG001|Overall Study|Did not receive recFSH|20|||
125597015|NCT02032524|451810429|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
125597016|NCT02032524|451810430|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
125597017|NCT02032524|451810431|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
125597018|NCT02032524|451810432|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
125597019|NCT02032524|451810433|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
125597020|NCT02032524|451810434|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
125597021|NCT02032524|451810429|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
125597022|NCT02032524|451810430|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
125597023|NCT02032524|451810431|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
125597024|NCT02032524|451810432|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
125597025|NCT02032524|451810433|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
125597026|NCT02032524|451810434|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
125597027|NCT02032524|451810429|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
125597028|NCT02032524|451810430|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
125597029|NCT02032524|451810431|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
125597030|NCT02032524|451810432|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
125597031|NCT02032524|451810433|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
125597032|NCT02032524|451810434|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
125597033|NCT02032524|451810429|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
125597034|NCT02032524|451810430|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
125597035|NCT02032524|451810431|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
125597036|NCT02032524|451810432|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
125597037|NCT02032524|451810433|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
125597038|NCT02032524|451810434|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
125597039|NCT02032524|451810429|FG000|Period 2: LTS13769 Study|Other|0|||
125430591|NCT04707196|451203353|FG001|Overall Study|Lost to Follow-up|0|||
125430592|NCT04707196|451203352|FG000|Overall Study|Protocol Violation|4|||
125430593|NCT04707196|451203353|FG001|Overall Study|Protocol Violation|1|||
125430594|NCT04707196|451203352|FG000|Overall Study|Adverse Event|2|||
125430595|NCT04707196|451203353|FG001|Overall Study|Adverse Event|2|||
125430596|NCT04707196|451203352|FG000|Overall Study|Death|3|||
125430597|NCT04707196|451203353|FG001|Overall Study|Death|1|||
125430598|NCT04707196|451203352|FG000|Overall Study|Non-compliance with study drug|1|||
125430599|NCT04707196|451203353|FG001|Overall Study|Non-compliance with study drug|0|||
125430600|NCT04707196|451203352|FG000|Overall Study|Progressive disease|9|||
125430601|NCT04707196|451203353|FG001|Overall Study|Progressive disease|10|||
125430602|NCT01862796|451203354|FG000|Overall Study|Prohibited medications|0|||
125430603|NCT01862796|451203355|FG001|Overall Study|Prohibited medications|0|||
125430604|NCT01862796|451203356|FG002|Overall Study|Prohibited medications|1|||
125430605|NCT05375955|451203374|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
125430606|NCT05375955|451203375|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
125430607|NCT05375955|451203376|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
125430608|NCT05375955|451203377|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
125430609|NCT05375955|451203378|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
125430610|NCT05375955|451203379|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
125430611|NCT05375955|451203380|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
125430612|NCT05375955|451203374|FG000|Treatment (12 Weeks)|Physician Decision|4|||
125430613|NCT05375955|451203375|FG001|Treatment (12 Weeks)|Physician Decision|1|||
125430614|NCT05375955|451203376|FG002|Treatment (12 Weeks)|Physician Decision|3|||
125430615|NCT05375955|451203377|FG003|Treatment (12 Weeks)|Physician Decision|0|||
125430616|NCT05375955|451203378|FG004|Treatment (12 Weeks)|Physician Decision|0|||
125430617|NCT05375955|451203379|FG005|Treatment (12 Weeks)|Physician Decision|1|||
125430618|NCT05375955|451203380|FG006|Treatment (12 Weeks)|Physician Decision|0|||
125430619|NCT05375955|451203374|FG000|Treatment (12 Weeks)|Other|0|||
125430620|NCT05375955|451203375|FG001|Treatment (12 Weeks)|Other|1|||
125430621|NCT05375955|451203376|FG002|Treatment (12 Weeks)|Other|0|||
125430622|NCT05375955|451203377|FG003|Treatment (12 Weeks)|Other|0|||
125430623|NCT05375955|451203378|FG004|Treatment (12 Weeks)|Other|0|||
125430624|NCT05375955|451203379|FG005|Treatment (12 Weeks)|Other|0|||
125430625|NCT05375955|451203380|FG006|Treatment (12 Weeks)|Other|0|||
125430626|NCT05375955|451203374|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
125430627|NCT05375955|451203375|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
125430628|NCT05375955|451203376|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
125430629|NCT05375955|451203377|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
125212774|NCT01026818|450405479|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
125212775|NCT01026818|450405480|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
125430630|NCT05375955|451203378|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
125430631|NCT05375955|451203379|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
125430632|NCT05375955|451203380|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
125430633|NCT05375955|451203374|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
125430634|NCT05375955|451203375|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
125430635|NCT05375955|451203376|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
125430636|NCT05375955|451203377|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
125430637|NCT05375955|451203378|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
125430638|NCT05375955|451203379|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
125430639|NCT05375955|451203380|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
125430640|NCT05375955|451203374|FG000|Treatment (12 Weeks)|Pregnancy|0|||
125430641|NCT05375955|451203375|FG001|Treatment (12 Weeks)|Pregnancy|0|||
125430642|NCT05375955|451203376|FG002|Treatment (12 Weeks)|Pregnancy|1|||
125212776|NCT01026818|450405481|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
125430643|NCT05375955|451203377|FG003|Treatment (12 Weeks)|Pregnancy|0|||
125430644|NCT05375955|451203378|FG004|Treatment (12 Weeks)|Pregnancy|0|||
125430645|NCT05375955|451203379|FG005|Treatment (12 Weeks)|Pregnancy|0|||
125430646|NCT05375955|451203380|FG006|Treatment (12 Weeks)|Pregnancy|0|||
125367558|NCT03298867|450978891|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
125367559|NCT03298867|450978890|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
125367560|NCT03298867|450978891|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
125367561|NCT00743483|450978892|FG000|Baseline Period|Physician Decision|1|||
125367562|NCT00743483|450978892|FG000|Treatment Period|Adverse Event|1|||
125367563|NCT01466153|450978893|FG000|Overall Study|Disease Progression|2|||
125367564|NCT01466153|450978894|FG001|Overall Study|Disease Progression|2|||
125367565|NCT01466153|450978895|FG002|Overall Study|Disease Progression|0|||
125367566|NCT01466153|450978893|FG000|Overall Study|Adverse Event|14|||
125367567|NCT01466153|450978894|FG001|Overall Study|Adverse Event|13|||
125367568|NCT01466153|450978895|FG002|Overall Study|Adverse Event|17|||
125367569|NCT01466153|450978893|FG000|Overall Study|Withdrawal of Consent|2|||
125367570|NCT01466153|450978894|FG001|Overall Study|Withdrawal of Consent|0|||
125367571|NCT01466153|450978895|FG002|Overall Study|Withdrawal of Consent|0|||
125367572|NCT01466153|450978893|FG000|Overall Study|Investigator Discretion|3|||
125367573|NCT01466153|450978894|FG001|Overall Study|Investigator Discretion|2|||
125367574|NCT01466153|450978895|FG002|Overall Study|Investigator Discretion|2|||
125367575|NCT01466153|450978893|FG000|Overall Study|Randomized-Not Treated|2|||
125367576|NCT01466153|450978894|FG001|Overall Study|Randomized-Not Treated|3|||
125367577|NCT01466153|450978895|FG002|Overall Study|Randomized-Not Treated|4|||
125367578|NCT01466153|450978893|FG000|Overall Study|Other-Unspecified|6|||
125367579|NCT01466153|450978894|FG001|Overall Study|Other-Unspecified|4|||
125367580|NCT01466153|450978895|FG002|Overall Study|Other-Unspecified|2|||
125367581|NCT03281577|450980786|FG000|Overall Study|Adverse Event|0|||
125367582|NCT03281577|450980787|FG001|Overall Study|Adverse Event|0|||
125367583|NCT03281577|450980788|FG002|Overall Study|Adverse Event|0|||
125367584|NCT03281577|450980789|FG003|Overall Study|Adverse Event|1|||
125367585|NCT03281577|450980786|FG000|Overall Study|Withdrawal by Subject|1|||
125367586|NCT03281577|450980787|FG001|Overall Study|Withdrawal by Subject|0|||
125367587|NCT03281577|450980788|FG002|Overall Study|Withdrawal by Subject|0|||
125367588|NCT03281577|450980789|FG003|Overall Study|Withdrawal by Subject|0|||
125367589|NCT02323113|450980790|FG000|Overall Study|Adverse Event|3|||
125367590|NCT02323113|450980791|FG001|Overall Study|Adverse Event|3|||
125367591|NCT02323113|450980792|FG002|Overall Study|Adverse Event|2|||
125367592|NCT02323113|450980793|FG003|Overall Study|Adverse Event|5|||
125367593|NCT02323113|450980794|FG004|Overall Study|Adverse Event|8|||
125367594|NCT02323113|450980795|FG005|Overall Study|Adverse Event|3|||
125367595|NCT02323113|450980796|FG006|Overall Study|Adverse Event|6|||
125367596|NCT02323113|450980797|FG007|Overall Study|Adverse Event|0|||
125367597|NCT02323113|450980790|FG000|Overall Study|Progressive Disease|0|||
125367598|NCT02323113|450980791|FG001|Overall Study|Progressive Disease|1|||
125367599|NCT02323113|450980792|FG002|Overall Study|Progressive Disease|1|||
125367600|NCT02323113|450980793|FG003|Overall Study|Progressive Disease|0|||
125367601|NCT02323113|450980794|FG004|Overall Study|Progressive Disease|0|||
125430647|NCT05375955|451203374|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
125430648|NCT05375955|451203375|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
125430649|NCT05375955|451203376|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
125430650|NCT05375955|451203377|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
125430651|NCT05375955|451203378|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
125430652|NCT05375955|451203379|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
125430653|NCT05375955|451203380|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
125430654|NCT05375955|451203374|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
125430655|NCT05375955|451203375|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
125430656|NCT05375955|451203376|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
125430657|NCT05375955|451203377|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
125430658|NCT05375955|451203378|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
125430659|NCT05375955|451203379|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
125597040|NCT02032524|451810430|FG001|Period 2: LTS13769 Study|Other|0|||
125597041|NCT02032524|451810431|FG002|Period 2: LTS13769 Study|Other|0|||
125597042|NCT02032524|451810432|FG003|Period 2: LTS13769 Study|Other|0|||
125597043|NCT02032524|451810433|FG004|Period 2: LTS13769 Study|Other|0|||
125367602|NCT02323113|450980795|FG005|Overall Study|Progressive Disease|3|||
125367603|NCT02323113|450980796|FG006|Overall Study|Progressive Disease|0|||
125367604|NCT02323113|450980797|FG007|Overall Study|Progressive Disease|0|||
125367605|NCT02323113|450980790|FG000|Overall Study|Symptomatic Deterioration|0|||
125430660|NCT05375955|451203380|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
125597044|NCT02032524|451810434|FG005|Period 2: LTS13769 Study|Other|1|||
125430661|NCT05375955|451203374|FG000|Follow-up (up to 5 Weeks)|Other|0|||
125430662|NCT05375955|451203375|FG001|Follow-up (up to 5 Weeks)|Other|1|||
125597045|NCT02975349|451810437|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125367606|NCT02323113|450980791|FG001|Overall Study|Symptomatic Deterioration|0|||
125367607|NCT02323113|450980792|FG002|Overall Study|Symptomatic Deterioration|1|||
125367608|NCT02323113|450980793|FG003|Overall Study|Symptomatic Deterioration|0|||
125367609|NCT02323113|450980794|FG004|Overall Study|Symptomatic Deterioration|1|||
125367610|NCT02323113|450980795|FG005|Overall Study|Symptomatic Deterioration|0|||
125367611|NCT02323113|450980796|FG006|Overall Study|Symptomatic Deterioration|0|||
125430663|NCT05375955|451203376|FG002|Follow-up (up to 5 Weeks)|Other|0|||
125430664|NCT05375955|451203377|FG003|Follow-up (up to 5 Weeks)|Other|0|||
125430665|NCT05375955|451203378|FG004|Follow-up (up to 5 Weeks)|Other|0|||
125430666|NCT05375955|451203379|FG005|Follow-up (up to 5 Weeks)|Other|0|||
125430667|NCT05375955|451203380|FG006|Follow-up (up to 5 Weeks)|Other|0|||
125430668|NCT05375955|451203374|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
125430669|NCT05375955|451203375|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
125430670|NCT05375955|451203376|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
125430671|NCT05375955|451203377|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
125430672|NCT05375955|451203378|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
125430673|NCT05375955|451203379|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
125430674|NCT05375955|451203380|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
125430675|NCT05375955|451203374|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
125430676|NCT05375955|451203375|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
125430677|NCT05375955|451203376|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
125430678|NCT05375955|451203377|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
125430679|NCT05375955|451203378|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
125430680|NCT05375955|451203379|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
125430681|NCT05375955|451203380|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
125430682|NCT01320943|451203381|FG000|Overall Study|Lost to Follow-up|1|||
125430683|NCT01320943|451203382|FG001|Overall Study|Lost to Follow-up|0|||
125430684|NCT01320943|451203381|FG000|Overall Study|Physician Decision|0|||
125430685|NCT01320943|451203382|FG001|Overall Study|Physician Decision|1|||
125430686|NCT01320943|451203381|FG000|Overall Study|Randomized but not Treated|0|||
125430687|NCT01320943|451203382|FG001|Overall Study|Randomized but not Treated|1|||
125430688|NCT00733980|451203389|FG000|Overall Study|Adverse Event|5|||
125430689|NCT00733980|451203390|FG001|Overall Study|Adverse Event|2|||
125430690|NCT00733980|451203389|FG000|Overall Study|Lack of Efficacy|0|||
125597046|NCT02975349|451810438|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125597047|NCT02975349|451810439|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125597048|NCT02975349|451810440|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
125597049|NCT02975349|451810441|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
125597050|NCT02975349|451810442|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125597051|NCT02975349|451810443|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125597052|NCT02975349|451810437|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125597053|NCT02975349|451810438|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125597054|NCT02975349|451810439|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125597055|NCT02975349|451810440|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125597056|NCT02975349|451810441|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125597057|NCT02975349|451810442|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125597058|NCT02975349|451810443|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125597059|NCT02975349|451810437|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
125597060|NCT02975349|451810438|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
125597061|NCT02975349|451810439|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
125597062|NCT02975349|451810440|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
125597063|NCT02975349|451810441|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
125597064|NCT02975349|451810442|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
125597065|NCT02975349|451810443|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
125597066|NCT02975349|451810437|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
125597067|NCT02975349|451810438|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
125367612|NCT02323113|450980797|FG007|Overall Study|Symptomatic Deterioration|0|||
125367613|NCT02323113|450980790|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
125367614|NCT02323113|450980791|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
125367615|NCT02323113|450980792|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
125367616|NCT02323113|450980793|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
125367617|NCT02323113|450980794|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
125367618|NCT02323113|450980795|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
125367619|NCT02323113|450980796|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
125367620|NCT02323113|450980797|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
125367621|NCT02323113|450980790|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125367622|NCT02323113|450980791|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
125367623|NCT02323113|450980792|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125367624|NCT02323113|450980793|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125367625|NCT02323113|450980794|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125367626|NCT02323113|450980795|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125367627|NCT02323113|450980796|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125367628|NCT02323113|450980797|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
125367629|NCT00443261|450980798|FG000|Overall Study|Death|1|||
125367630|NCT01663532|450980799|FG000|Overall Study|Lost to Follow-up|9|||
125367631|NCT01663532|450980800|FG001|Overall Study|Lost to Follow-up|10|||
125367632|NCT01663532|450980799|FG000|Overall Study|Adverse Event|7|||
125597068|NCT02975349|451810439|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
125597069|NCT02975349|451810440|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
125597070|NCT02975349|451810441|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
125597071|NCT02975349|451810442|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
125597072|NCT02975349|451810443|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
125597073|NCT02975349|451810437|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
125597074|NCT02975349|451810438|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
125597075|NCT02975349|451810439|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
125597076|NCT02975349|451810440|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
125597077|NCT02975349|451810441|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
125597078|NCT02975349|451810442|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
125597079|NCT02975349|451810443|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
125597080|NCT02975349|451810437|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
125597081|NCT02975349|451810438|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
125597082|NCT02975349|451810439|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
125597083|NCT02975349|451810440|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
125597084|NCT02975349|451810441|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
125597085|NCT02975349|451810442|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
125597086|NCT02975349|451810443|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
125597087|NCT02975349|451810437|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
125597088|NCT02975349|451810438|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
125597089|NCT02975349|451810439|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
125597090|NCT02975349|451810440|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
125597091|NCT02975349|451810441|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
125367633|NCT01663532|450980800|FG001|Overall Study|Adverse Event|13|||
125367634|NCT01663532|450980799|FG000|Overall Study|Met Withdrawal Criteria|7|||
125367635|NCT01663532|450980800|FG001|Overall Study|Met Withdrawal Criteria|6|||
125367636|NCT01663532|450980799|FG000|Overall Study|Physician Decision|1|||
125367637|NCT01663532|450980800|FG001|Overall Study|Physician Decision|1|||
125367638|NCT01663532|450980799|FG000|Overall Study|Withdrawal by Subject|35|||
125367639|NCT01663532|450980800|FG001|Overall Study|Withdrawal by Subject|17|||
125367640|NCT01663532|450980799|FG000|Overall Study|Lack of Efficacy|15|||
125367641|NCT01663532|450980800|FG001|Overall Study|Lack of Efficacy|60|||
125597092|NCT02975349|451810442|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
125597093|NCT02975349|451810443|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
125597094|NCT02975349|451810437|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
125597095|NCT02975349|451810438|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
125367642|NCT01433991|450980802|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
125430691|NCT00733980|451203390|FG001|Overall Study|Lack of Efficacy|1|||
125597096|NCT02975349|451810439|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
125597097|NCT02975349|451810440|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
125597098|NCT02975349|451810441|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
125597099|NCT02975349|451810442|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
125597100|NCT02975349|451810443|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
125367643|NCT01433991|450980803|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
125367644|NCT01433991|450980804|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
125367645|NCT01433991|450980805|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
125367646|NCT01433991|450980802|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
125367647|NCT01433991|450980803|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
125367648|NCT01433991|450980804|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
125367649|NCT01433991|450980805|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
125367650|NCT01433991|450980802|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
125367651|NCT01433991|450980803|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
125430692|NCT00733980|451203389|FG000|Overall Study|Protocol Violation|2|||
125430693|NCT00733980|451203390|FG001|Overall Study|Protocol Violation|1|||
125430694|NCT00733980|451203389|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
125430695|NCT00733980|451203390|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
125430696|NCT00733980|451203389|FG000|Overall Study|Lost to Follow-up|6|||
125430697|NCT00733980|451203390|FG001|Overall Study|Lost to Follow-up|11|||
125430698|NCT00733980|451203389|FG000|Overall Study|Physician Decision|2|||
125430699|NCT00733980|451203390|FG001|Overall Study|Physician Decision|3|||
125430700|NCT00733980|451203389|FG000|Overall Study|Withdrawal by Subject|6|||
125430701|NCT00733980|451203390|FG001|Overall Study|Withdrawal by Subject|2|||
125430702|NCT00779779|451203391|FG000|Overall Study|Adverse Event|1|||
125430703|NCT00779779|451203391|FG000|Overall Study|Protocol Violation|14|||
125430704|NCT00779779|451203391|FG000|Overall Study|Withdrawal by Subject|4|||
125430705|NCT00779779|451203391|FG000|Overall Study|Lost to Follow-up|5|||
125430706|NCT02719990|451203392|FG000|Overall Study|Physician Decision|2|||
125430707|NCT02719990|451203392|FG000|Overall Study|Withdrawal by Subject|2|||
125430708|NCT02719990|451203392|FG000|Overall Study|Study Terminated By Sponsor|32|||
125430709|NCT02010632|451203393|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
125597101|NCT02975349|451810437|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
125597102|NCT02975349|451810438|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
125430710|NCT02010632|451203394|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
125430711|NCT06387472|451203398|FG000|Overall Study|Withdrawal by Subject|1|||
125430712|NCT06387472|451203398|FG000|Overall Study|Lost to Follow-up|2|||
125430713|NCT06387472|451203398|FG000|Overall Study|Physician Decision|1|||
125430714|NCT00404495|451203400|FG000|Overall Study|Death|37|||
125430715|NCT00404495|451203401|FG001|Overall Study|Death|11|||
125430716|NCT00404495|451203400|FG000|Overall Study|Lost to Follow-up|5|||
125430717|NCT00404495|451203401|FG001|Overall Study|Lost to Follow-up|0|||
125430718|NCT00404495|451203400|FG000|Overall Study|Other|1|||
125430719|NCT00404495|451203401|FG001|Overall Study|Other|0|||
125430720|NCT00404495|451203400|FG000|Overall Study|Withdrawal by Subject|1|||
125430721|NCT00404495|451203401|FG001|Overall Study|Withdrawal by Subject|0|||
125430722|NCT01061333|451203402|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
125430723|NCT01061333|451203403|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
125430724|NCT01160484|451205496|FG000|Overall Study|Lack of Efficacy|9|||
125430725|NCT01160484|451205496|FG000|Overall Study|Adverse Event|6|||
125597103|NCT02975349|451810439|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
125597104|NCT02975349|451810440|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
125597105|NCT02975349|451810441|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
125597106|NCT02975349|451810442|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
125597107|NCT02975349|451810443|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
125597108|NCT02975349|451810437|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
125597109|NCT02975349|451810438|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
125430726|NCT01160484|451205496|FG000|Overall Study|Withdrawal by Subject|2|||
125430727|NCT01160484|451205496|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
125430728|NCT01782742|451205497|FG000|Double-blind Treatment Phase|Adverse Event|1|||
125430729|NCT01782742|451205498|FG001|Double-blind Treatment Phase|Adverse Event|0|||
125430730|NCT00803101|451205499|FG000|Overall Study|Death / Serious Adverse Event|4|||
125430731|NCT00803101|451205500|FG001|Overall Study|Death / Serious Adverse Event|6|||
125597110|NCT02975349|451810439|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
125597111|NCT02975349|451810440|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
125597112|NCT02975349|451810441|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
125597113|NCT02975349|451810442|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
125597114|NCT02975349|451810443|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
125597115|NCT02975349|451810437|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
125597116|NCT02975349|451810438|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
125597117|NCT02975349|451810439|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
125597118|NCT02975349|451810440|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
125597119|NCT02975349|451810441|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
125597120|NCT02975349|451810442|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
125597121|NCT02975349|451810443|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
125597122|NCT02975349|451810437|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
125597123|NCT02975349|451810438|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
125597124|NCT02975349|451810439|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
125597125|NCT02975349|451810440|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
125597126|NCT02975349|451810441|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
125367652|NCT01433991|450980804|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
125367653|NCT01433991|450980805|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
125367654|NCT01433991|450980802|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
125367655|NCT01433991|450980803|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
125367656|NCT01433991|450980804|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
125367657|NCT01433991|450980805|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
125367658|NCT01433991|450980802|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
125367659|NCT01433991|450980803|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
125367660|NCT01433991|450980804|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
125367661|NCT01433991|450980805|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
125367662|NCT01433991|450980802|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
125367663|NCT01433991|450980803|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
125367664|NCT01433991|450980804|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
125367665|NCT01433991|450980805|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
125367666|NCT01433991|450980802|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
125367667|NCT01433991|450980803|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
125367668|NCT01433991|450980804|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
125367669|NCT01433991|450980805|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
125367670|NCT00844831|450980806|FG000|Overall Study|Withdrawal by Subject|4|||
125367671|NCT00844831|450980806|FG000|Overall Study|Adverse Event|1|||
125367672|NCT00844831|450980806|FG000|Overall Study|Physician Decision|1|||
125367673|NCT00354744|450980809|FG000|Overall Study|Adverse Event|2|||
125367674|NCT00354744|450980809|FG000|Overall Study|Death|2|||
125367675|NCT00354744|450980809|FG000|Overall Study|Lack of Efficacy|11|||
125367676|NCT00354744|450980809|FG000|Overall Study|Lost to Follow-up|2|||
125367677|NCT00354744|450980809|FG000|Overall Study|Physician Decision|11|||
125367678|NCT00354744|450980809|FG000|Overall Study|Withdrawal by Subject|14|||
125367679|NCT01193530|450980810|FG000|Overall Study|Withdrawal by Subject|2|||
125367680|NCT01193530|450980811|FG001|Overall Study|Withdrawal by Subject|2|||
125367681|NCT01193530|450980810|FG000|Overall Study|Began Contraindicated Therapy|1|||
125367682|NCT01193530|450980811|FG001|Overall Study|Began Contraindicated Therapy|0|||
125367683|NCT01193530|450980810|FG000|Overall Study|Lost Light Box|0|||
125367684|NCT01193530|450980811|FG001|Overall Study|Lost Light Box|1|||
125367685|NCT01193530|450980810|FG000|Overall Study|Returned home - out of state|0|||
125367686|NCT01193530|450980811|FG001|Overall Study|Returned home - out of state|1|||
125367687|NCT01193530|450980810|FG000|Overall Study|Non-Compliance|0|||
125367688|NCT01193530|450980811|FG001|Overall Study|Non-Compliance|1|||
125367689|NCT01513343|450980812|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
125367690|NCT01513343|450980813|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
125367691|NCT01513343|450980812|FG000|Post Data Collection|Dropped/withdrew from study|7|||
125367692|NCT01513343|450980813|FG001|Post Data Collection|Dropped/withdrew from study|1|||
125367693|NCT01513343|450980812|FG000|Post Data Collection|Lost to Follow-up|10|||
125367694|NCT01513343|450980813|FG001|Post Data Collection|Lost to Follow-up|23|||
125367695|NCT01513343|450980812|FG000|6-month Follow-up|Lost to Follow-up|28|||
125597127|NCT02975349|451810442|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
125212777|NCT01026818|450405478|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
125367696|NCT01513343|450980813|FG001|6-month Follow-up|Lost to Follow-up|17|||
125367697|NCT01513343|450980812|FG000|12-month Follow-up|Lost to Follow-up|10|||
125367698|NCT01513343|450980813|FG001|12-month Follow-up|Lost to Follow-up|3|||
125367699|NCT01749137|450980814|FG000|Overall Study|Adverse Event|4|||
125367700|NCT01749137|450980815|FG001|Overall Study|Adverse Event|4|||
125597128|NCT02975349|451810443|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
125367701|NCT01749137|450980814|FG000|Overall Study|Lost to Follow-up|2|||
125367702|NCT01749137|450980815|FG001|Overall Study|Lost to Follow-up|3|||
125367703|NCT01749137|450980814|FG000|Overall Study|Physician Decision|1|||
125367704|NCT01749137|450980815|FG001|Overall Study|Physician Decision|0|||
125367705|NCT01749137|450980814|FG000|Overall Study|Withdrawal by Subject|8|||
125367706|NCT01749137|450980815|FG001|Overall Study|Withdrawal by Subject|4|||
125367707|NCT02587234|450980816|FG000|Overall Study|Withdrawal by Subject|1|||
125367708|NCT02587234|450980817|FG001|Overall Study|Withdrawal by Subject|1|||
125367709|NCT02587234|450980816|FG000|Overall Study|Lost to Follow-up|0|||
125367710|NCT02587234|450980817|FG001|Overall Study|Lost to Follow-up|2|||
125367711|NCT01153347|450980818|FG000|Overall Study|Withdrawal by Subject|7|||
125367712|NCT01153347|450980819|FG001|Overall Study|Withdrawal by Subject|7|||
125367713|NCT01153347|450980820|FG002|Overall Study|Withdrawal by Subject|7|||
125367714|NCT01153347|450980821|FG003|Overall Study|Withdrawal by Subject|7|||
125367715|NCT01153347|450980818|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125367716|NCT01153347|450980819|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125367717|NCT01153347|450980820|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
125367718|NCT01153347|450980821|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
125367719|NCT01153347|450980818|FG000|Overall Study|Adverse Event|3|||
125367720|NCT01153347|450980819|FG001|Overall Study|Adverse Event|9|||
125367721|NCT01153347|450980820|FG002|Overall Study|Adverse Event|21|||
125367722|NCT01153347|450980821|FG003|Overall Study|Adverse Event|7|||
125367723|NCT01153347|450980818|FG000|Overall Study|Severe non-compliance to protocol|6|||
125367724|NCT01153347|450980819|FG001|Overall Study|Severe non-compliance to protocol|7|||
125367725|NCT01153347|450980820|FG002|Overall Study|Severe non-compliance to protocol|4|||
125367726|NCT01153347|450980821|FG003|Overall Study|Severe non-compliance to protocol|3|||
125367727|NCT01153347|450980818|FG000|Overall Study|Condition under investigation worsened|1|||
125367728|NCT01153347|450980819|FG001|Overall Study|Condition under investigation worsened|1|||
125367729|NCT01153347|450980820|FG002|Overall Study|Condition under investigation worsened|0|||
125367730|NCT01153347|450980821|FG003|Overall Study|Condition under investigation worsened|0|||
125367731|NCT01153347|450980818|FG000|Overall Study|Lack of Efficacy|2|||
125367732|NCT01153347|450980819|FG001|Overall Study|Lack of Efficacy|2|||
125367733|NCT01153347|450980820|FG002|Overall Study|Lack of Efficacy|0|||
125367734|NCT01153347|450980821|FG003|Overall Study|Lack of Efficacy|4|||
125367735|NCT01153347|450980818|FG000|Overall Study|Study-specific withdrawal criteria|4|||
125367736|NCT01153347|450980819|FG001|Overall Study|Study-specific withdrawal criteria|3|||
125367737|NCT01153347|450980820|FG002|Overall Study|Study-specific withdrawal criteria|1|||
125367738|NCT01153347|450980821|FG003|Overall Study|Study-specific withdrawal criteria|2|||
125367739|NCT01153347|450980818|FG000|Overall Study|Lost to Follow-up|4|||
125367740|NCT01153347|450980819|FG001|Overall Study|Lost to Follow-up|9|||
125367741|NCT01153347|450980820|FG002|Overall Study|Lost to Follow-up|11|||
125367742|NCT01153347|450980821|FG003|Overall Study|Lost to Follow-up|8|||
125367743|NCT01153347|450980818|FG000|Overall Study|Other|5|||
125367744|NCT01153347|450980819|FG001|Overall Study|Other|5|||
125367745|NCT01153347|450980820|FG002|Overall Study|Other|4|||
125367746|NCT01153347|450980821|FG003|Overall Study|Other|0|||
125367747|NCT01153347|450980818|FG000|Overall Study|Death|1|||
125367748|NCT01153347|450980819|FG001|Overall Study|Death|0|||
125367749|NCT01153347|450980820|FG002|Overall Study|Death|0|||
125367750|NCT01153347|450980821|FG003|Overall Study|Death|0|||
125367751|NCT01706146|450980822|FG000|Overall Study|Withdrawal by Subject|1|||
125367752|NCT01706146|450980822|FG000|Overall Study|Adverse Event|3|||
125367753|NCT01706146|450980822|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
125367754|NCT01751178|450980823|FG000|Overall Study|Adverse Event|2|||
125367755|NCT01751178|450980824|FG001|Overall Study|Adverse Event|0|||
125367756|NCT01751178|450980825|FG002|Overall Study|Adverse Event|0|||
125367757|NCT01751178|450980823|FG000|Overall Study|Other Reason (unknown)|1|||
125367758|NCT01751178|450980824|FG001|Overall Study|Other Reason (unknown)|0|||
125367759|NCT01751178|450980825|FG002|Overall Study|Other Reason (unknown)|2|||
125367760|NCT00289991|450980826|FG000|Overall Study|Death|35|||
125367761|NCT00289991|450980827|FG001|Overall Study|Death|38|||
125367762|NCT00289991|450980826|FG000|Overall Study|Adverse Event|15|||
125367763|NCT00289991|450980827|FG001|Overall Study|Adverse Event|13|||
125367764|NCT00289991|450980826|FG000|Overall Study|Failure of prophylaxis|1|||
125367765|NCT00289991|450980827|FG001|Overall Study|Failure of prophylaxis|1|||
125367766|NCT00289991|450980826|FG000|Overall Study|Fungal breakthrough infection|0|||
125367767|NCT00289991|450980827|FG001|Overall Study|Fungal breakthrough infection|1|||
125367768|NCT00289991|450980826|FG000|Overall Study|Lost to Follow-up|0|||
125367769|NCT00289991|450980827|FG001|Overall Study|Lost to Follow-up|1|||
125367770|NCT00289991|450980826|FG000|Overall Study|Withdrawal by Subject|2|||
125367771|NCT00289991|450980827|FG001|Overall Study|Withdrawal by Subject|12|||
125367772|NCT00289991|450980826|FG000|Overall Study|Other|5|||
125367773|NCT00289991|450980827|FG001|Overall Study|Other|14|||
125367774|NCT01606007|450980836|FG000|Overall Study|Reason 'Other' in the protocol|0|||
125597129|NCT02975349|451810437|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
125367775|NCT01606007|450980837|FG001|Overall Study|Reason 'Other' in the protocol|1|||
125367776|NCT01606007|450980838|FG002|Overall Study|Reason 'Other' in the protocol|1|||
125367777|NCT01606007|450980836|FG000|Overall Study|Pregnancy|0|||
125367778|NCT01606007|450980837|FG001|Overall Study|Pregnancy|1|||
125367779|NCT01606007|450980838|FG002|Overall Study|Pregnancy|1|||
125367780|NCT01606007|450980836|FG000|Overall Study|Withdrawal by Subject|8|||
125367781|NCT01606007|450980837|FG001|Overall Study|Withdrawal by Subject|6|||
125367782|NCT01606007|450980838|FG002|Overall Study|Withdrawal by Subject|1|||
125367783|NCT01606007|450980836|FG000|Overall Study|Adverse Event|0|||
125367784|NCT01606007|450980837|FG001|Overall Study|Adverse Event|1|||
125367785|NCT01606007|450980838|FG002|Overall Study|Adverse Event|1|||
125367786|NCT01606007|450980836|FG000|Overall Study|discontinue study treatment|0|||
125367787|NCT01606007|450980837|FG001|Overall Study|discontinue study treatment|2|||
125367788|NCT01606007|450980838|FG002|Overall Study|discontinue study treatment|1|||
125367789|NCT01606007|450980836|FG000|Overall Study|Lost to Follow-up|6|||
125367790|NCT01606007|450980837|FG001|Overall Study|Lost to Follow-up|8|||
125367791|NCT01606007|450980838|FG002|Overall Study|Lost to Follow-up|5|||
125367792|NCT01606007|450980836|FG000|Overall Study|Poor/Non-compliance|1|||
125367793|NCT01606007|450980837|FG001|Overall Study|Poor/Non-compliance|0|||
125367794|NCT01606007|450980838|FG002|Overall Study|Poor/Non-compliance|0|||
125367795|NCT01007812|450980843|FG000|Period 1, One Week|Lost to Follow-up|0|||
125367796|NCT01007812|450980844|FG001|Period 1, One Week|Lost to Follow-up|1|||
125367797|NCT01007812|450980843|FG000|Period 1, One Week|Discomfort|1|||
125367798|NCT01007812|450980844|FG001|Period 1, One Week|Discomfort|0|||
125367799|NCT01091974|450980845|FG000|Overall Study|Did not start intervention|3|||
125367800|NCT01091974|450980846|FG001|Overall Study|Did not start intervention|1|||
125367801|NCT01091974|450980847|FG002|Overall Study|Did not start intervention|3|||
125367802|NCT01091974|450980848|FG003|Overall Study|Did not start intervention|1|||
125367803|NCT01091974|450980845|FG000|Overall Study|resumed sleep medication|0|||
125367804|NCT01091974|450980846|FG001|Overall Study|resumed sleep medication|0|||
125367805|NCT01091974|450980847|FG002|Overall Study|resumed sleep medication|1|||
125367806|NCT01091974|450980848|FG003|Overall Study|resumed sleep medication|2|||
125367807|NCT01091974|450980845|FG000|Overall Study|Withdrawal by Subject|1|||
125367808|NCT01091974|450980846|FG001|Overall Study|Withdrawal by Subject|3|||
125367809|NCT01091974|450980847|FG002|Overall Study|Withdrawal by Subject|2|||
125367810|NCT01091974|450980848|FG003|Overall Study|Withdrawal by Subject|2|||
125367811|NCT01091974|450980845|FG000|Overall Study|side-effects|1|||
125367812|NCT01091974|450980846|FG001|Overall Study|side-effects|1|||
125367813|NCT01091974|450980847|FG002|Overall Study|side-effects|0|||
125367814|NCT01091974|450980848|FG003|Overall Study|side-effects|2|||
125367815|NCT00555971|450980850|FG000|Overall Study|Adverse Event|1|||
125367816|NCT00555971|450980851|FG001|Overall Study|Adverse Event|1|||
125367817|NCT00518284|450980852|FG000|Overall Study|Adverse Event|0|||
125367818|NCT00518284|450980853|FG001|Overall Study|Adverse Event|1|||
125367819|NCT00518284|450980854|FG002|Overall Study|Adverse Event|0|||
125367820|NCT00518284|450980855|FG003|Overall Study|Adverse Event|0|||
125367821|NCT00518284|450980852|FG000|Overall Study|Study Termination|0|||
125367822|NCT00518284|450980853|FG001|Overall Study|Study Termination|2|||
125367823|NCT00518284|450980854|FG002|Overall Study|Study Termination|1|||
125367824|NCT00518284|450980855|FG003|Overall Study|Study Termination|2|||
125367825|NCT02571777|450980856|FG000|Overall Study|Subject/guardian decision|34|||
125367826|NCT02571777|450980857|FG001|Overall Study|Subject/guardian decision|26|||
125367827|NCT02571777|450980858|FG002|Overall Study|Subject/guardian decision|26|||
125367828|NCT02571777|450980859|FG003|Overall Study|Subject/guardian decision|25|||
125367829|NCT02571777|450980860|FG004|Overall Study|Subject/guardian decision|27|||
125367830|NCT02571777|450980856|FG000|Overall Study|Protocol Deviation|2|||
125367831|NCT02571777|450980857|FG001|Overall Study|Protocol Deviation|3|||
125367832|NCT02571777|450980858|FG002|Overall Study|Protocol Deviation|4|||
125367833|NCT02571777|450980859|FG003|Overall Study|Protocol Deviation|8|||
125367834|NCT02571777|450980860|FG004|Overall Study|Protocol Deviation|4|||
125367835|NCT02571777|450980856|FG000|Overall Study|Death|1|||
125367836|NCT02571777|450980857|FG001|Overall Study|Death|1|||
125367837|NCT02571777|450980858|FG002|Overall Study|Death|4|||
125367838|NCT02571777|450980859|FG003|Overall Study|Death|0|||
125430732|NCT00803101|451205499|FG000|Overall Study|Withdrawal by Subject|6|||
125367839|NCT02571777|450980860|FG004|Overall Study|Death|0|||
125367840|NCT02571777|450980856|FG000|Overall Study|Lost to Follow-up|1|||
125367841|NCT02571777|450980857|FG001|Overall Study|Lost to Follow-up|1|||
125367842|NCT02571777|450980858|FG002|Overall Study|Lost to Follow-up|2|||
125597130|NCT02975349|451810438|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
125367843|NCT02571777|450980859|FG003|Overall Study|Lost to Follow-up|0|||
125367844|NCT02571777|450980860|FG004|Overall Study|Lost to Follow-up|1|||
125367845|NCT02571777|450980856|FG000|Overall Study|Physician Decision|1|||
125367846|NCT02571777|450980857|FG001|Overall Study|Physician Decision|7|||
125367847|NCT02571777|450980858|FG002|Overall Study|Physician Decision|5|||
125367848|NCT02571777|450980859|FG003|Overall Study|Physician Decision|2|||
125367849|NCT02571777|450980860|FG004|Overall Study|Physician Decision|4|||
125367850|NCT02571777|450980856|FG000|Overall Study|Pregnancy|0|||
125367851|NCT02571777|450980857|FG001|Overall Study|Pregnancy|0|||
125367852|NCT02571777|450980858|FG002|Overall Study|Pregnancy|0|||
125367853|NCT02571777|450980859|FG003|Overall Study|Pregnancy|2|||
125367854|NCT02571777|450980860|FG004|Overall Study|Pregnancy|0|||
125367855|NCT00801632|450980861|FG000|Overall Study|Re-transplant|1|||
125367856|NCT00205881|450980862|FG000|Overall Study|Withdrawal by Subject|16|||
125367857|NCT00781274|450980871|FG000|Overall Study|Withdrawal by Subject|2|||
125367858|NCT01534962|450980872|FG000|Overall Study|Randomized but did not start treatment|2|||
125367859|NCT01534962|450980873|FG001|Overall Study|Randomized but did not start treatment|0|||
125367860|NCT01534962|450980874|FG002|Overall Study|Randomized but did not start treatment|0|||
125367861|NCT01534962|450980875|FG003|Overall Study|Randomized but did not start treatment|1|||
125367862|NCT01534962|450980872|FG000|Overall Study|Discontinued at AF recurrence|35|||
125367863|NCT01534962|450980873|FG001|Overall Study|Discontinued at AF recurrence|26|||
125367864|NCT01534962|450980874|FG002|Overall Study|Discontinued at AF recurrence|24|||
125430733|NCT00803101|451205500|FG001|Overall Study|Withdrawal by Subject|4|||
125430734|NCT00803101|451205499|FG000|Overall Study|Lost to Follow-up|2|||
125597131|NCT02975349|451810439|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
125597132|NCT02975349|451810440|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
125597133|NCT02975349|451810441|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
125597134|NCT02975349|451810442|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
125597135|NCT02975349|451810443|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
125597136|NCT02975349|451810437|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
125597137|NCT02975349|451810438|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
125597138|NCT02975349|451810439|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
125597139|NCT02975349|451810440|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
125367865|NCT01534962|450980875|FG003|Overall Study|Discontinued at AF recurrence|31|||
125367866|NCT00282984|450980876|FG000|Overall Study|Death|2|||
125367867|NCT00282984|450980877|FG001|Overall Study|Death|5|||
125367868|NCT00282984|450980876|FG000|Overall Study|Adverse Event|8|||
125367869|NCT00282984|450980877|FG001|Overall Study|Adverse Event|5|||
125430735|NCT00803101|451205500|FG001|Overall Study|Lost to Follow-up|2|||
125430736|NCT00803101|451205499|FG000|Overall Study|Protocol Violation|1|||
125430737|NCT00803101|451205500|FG001|Overall Study|Protocol Violation|7|||
125430738|NCT00803101|451205499|FG000|Overall Study|Surgery finished outside protocol window|1|||
125430739|NCT00803101|451205500|FG001|Overall Study|Surgery finished outside protocol window|1|||
125430740|NCT00803101|451205499|FG000|Overall Study|Patient died outside SAE report period|1|||
125430741|NCT00803101|451205500|FG001|Overall Study|Patient died outside SAE report period|0|||
125430742|NCT00803101|451205499|FG000|Overall Study|Patient did not attend scheduled visit|2|||
125430743|NCT00803101|451205500|FG001|Overall Study|Patient did not attend scheduled visit|1|||
125430744|NCT00803101|451205499|FG000|Overall Study|Patient did not have surgery|1|||
125430745|NCT00803101|451205500|FG001|Overall Study|Patient did not have surgery|1|||
125430746|NCT01679301|451205501|FG000|Screening Period|screen failure|3|||
125430747|NCT01679301|451205502|FG001|Screening Period|screen failure|0|||
125430748|NCT01679301|451205503|FG002|Screening Period|screen failure|0|||
125430749|NCT02026232|451205504|FG000|Overall Study|incomplete visit/missing data|3|||
125430750|NCT02026232|451205505|FG001|Overall Study|incomplete visit/missing data|2|||
125430751|NCT01529008|451205506|FG000|Bone Marrow Harvesting|Physician Decision|1|||
125430752|NCT01529008|451205507|FG001|Bone Marrow Harvesting|Physician Decision|1|||
125430753|NCT01529008|451205506|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
125367870|NCT00282984|450980876|FG000|Overall Study|Lack of Efficacy|0|||
125367871|NCT00282984|450980877|FG001|Overall Study|Lack of Efficacy|2|||
125367872|NCT00282984|450980876|FG000|Overall Study|Lost to Follow-up|14|||
125367873|NCT00282984|450980877|FG001|Overall Study|Lost to Follow-up|10|||
125367874|NCT00282984|450980876|FG000|Overall Study|Withdrawal by Participant|22|||
125367875|NCT00282984|450980877|FG001|Overall Study|Withdrawal by Participant|34|||
125367876|NCT00282984|450980876|FG000|Overall Study|Participant stopped study medication|2|||
125367877|NCT00282984|450980877|FG001|Overall Study|Participant stopped study medication|2|||
125367878|NCT00282984|450980876|FG000|Overall Study|Participant only allowed phone follow-up|0|||
125367879|NCT00282984|450980877|FG001|Overall Study|Participant only allowed phone follow-up|1|||
125367880|NCT00282984|450980876|FG000|Overall Study|Participant used antipsychosis meds|0|||
125367881|NCT00282984|450980877|FG001|Overall Study|Participant used antipsychosis meds|1|||
125430754|NCT01529008|451205507|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
125430755|NCT01529008|451205506|FG000|Treatment|Adverse Event|6|||
125430756|NCT01529008|451205507|FG001|Treatment|Adverse Event|0|||
125430757|NCT01529008|451205506|FG000|Treatment|Other|3|||
125367882|NCT00282984|450980876|FG000|Overall Study|lack of motivation|1|||
125367883|NCT00282984|450980877|FG001|Overall Study|lack of motivation|0|||
125367884|NCT00282984|450980876|FG000|Overall Study|in prison|0|||
125367885|NCT00282984|450980877|FG001|Overall Study|in prison|1|||
125367886|NCT00282984|450980876|FG000|Overall Study|Protocol Violation|2|||
125367887|NCT00282984|450980877|FG001|Overall Study|Protocol Violation|0|||
125367888|NCT00191269|450980878|FG000|Overall Study|Protocol Violation|0|||
125367889|NCT00191269|450980879|FG001|Overall Study|Protocol Violation|2|||
125367890|NCT00191269|450980878|FG000|Overall Study|Adverse Event|1|||
125367891|NCT00191269|450980879|FG001|Overall Study|Adverse Event|4|||
125367892|NCT00191269|450980878|FG000|Overall Study|Progression of Disease|4|||
125367893|NCT00191269|450980879|FG001|Overall Study|Progression of Disease|42|||
125367894|NCT00191269|450980878|FG000|Overall Study|Lack of Efficacy|1|||
125367895|NCT00191269|450980879|FG001|Overall Study|Lack of Efficacy|5|||
125367896|NCT00191269|450980878|FG000|Overall Study|Withdrawal by Subject|0|||
125367897|NCT00191269|450980879|FG001|Overall Study|Withdrawal by Subject|1|||
125367898|NCT00191269|450980878|FG000|Overall Study|Pathologic Aggrevation|0|||
125367899|NCT00191269|450980879|FG001|Overall Study|Pathologic Aggrevation|1|||
125367900|NCT00191269|450980878|FG000|Overall Study|Physician Decision|0|||
125367901|NCT00191269|450980879|FG001|Overall Study|Physician Decision|3|||
125367902|NCT02151110|450980885|FG000|Overall Study|Withdrawal by Subject|0|||
125367903|NCT02151110|450980886|FG001|Overall Study|Withdrawal by Subject|0|||
125367904|NCT02151110|450980887|FG002|Overall Study|Withdrawal by Subject|0|||
125367905|NCT02151110|450980888|FG003|Overall Study|Withdrawal by Subject|0|||
125367906|NCT02151110|450980889|FG004|Overall Study|Withdrawal by Subject|0|||
125367907|NCT02151110|450980890|FG005|Overall Study|Withdrawal by Subject|0|||
125367908|NCT02151110|450980891|FG006|Overall Study|Withdrawal by Subject|0|||
125367909|NCT02151110|450980892|FG007|Overall Study|Withdrawal by Subject|1|||
125367910|NCT02151110|450980885|FG000|Overall Study|Lost to Follow-up|0|||
125367911|NCT02151110|450980886|FG001|Overall Study|Lost to Follow-up|0|||
125367912|NCT02151110|450980887|FG002|Overall Study|Lost to Follow-up|0|||
125367913|NCT02151110|450980888|FG003|Overall Study|Lost to Follow-up|0|||
125367914|NCT02151110|450980889|FG004|Overall Study|Lost to Follow-up|0|||
125367915|NCT02151110|450980890|FG005|Overall Study|Lost to Follow-up|0|||
125367916|NCT02151110|450980891|FG006|Overall Study|Lost to Follow-up|0|||
125367917|NCT02151110|450980892|FG007|Overall Study|Lost to Follow-up|2|||
125367918|NCT02015754|450980893|FG000|Overall Study|Disease progression|5|||
125367919|NCT02015754|450980893|FG000|Overall Study|Change in treatment modality|5|||
125367920|NCT02015754|450980893|FG000|Overall Study|Lost to Follow-up|1|||
125367921|NCT01128842|450980894|FG000|Overall Study|Adverse Event|1|||
125367922|NCT01128842|450980894|FG000|Overall Study|Disease Progression|6|||
125367923|NCT04528732|450980901|FG000|Overall Study|Death|1|||
125367924|NCT04528732|450980902|FG001|Overall Study|Death|0|||
125367925|NCT04528732|450980903|FG002|Overall Study|Death|1|||
125367926|NCT04528732|450980901|FG000|Overall Study|Lost to Follow-up|0|||
125367927|NCT04528732|450980902|FG001|Overall Study|Lost to Follow-up|1|||
125367928|NCT04528732|450980903|FG002|Overall Study|Lost to Follow-up|2|||
125367929|NCT01300650|450980904|FG000|Overall Study|Adverse Event|1|||
125367930|NCT02369016|450980905|FG000|Overall Study|AE associated with clinical disease progression|2|||
125367931|NCT02369016|450980906|FG001|Overall Study|AE associated with clinical disease progression|1|||
125367932|NCT02369016|450980905|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
125367933|NCT02369016|450980906|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
125367934|NCT02369016|450980905|FG000|Overall Study|Progressive disease - clinical progression|1|||
125367935|NCT02369016|450980906|FG001|Overall Study|Progressive disease - clinical progression|4|||
125367936|NCT02369016|450980905|FG000|Overall Study|withdrawal by patient|4|||
125367937|NCT02369016|450980906|FG001|Overall Study|withdrawal by patient|0|||
125597140|NCT02975349|451810441|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
125597141|NCT02975349|451810442|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
125597142|NCT02975349|451810443|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
125597143|NCT02975349|451810437|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
125597144|NCT02975349|451810438|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
125597145|NCT02975349|451810439|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
125597146|NCT02975349|451810440|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
125597147|NCT02975349|451810441|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
125597148|NCT02975349|451810442|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
125597149|NCT02975349|451810443|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
125367938|NCT02369016|450980905|FG000|Overall Study|Progressive disease - radiological progression|6|||
125367939|NCT02369016|450980906|FG001|Overall Study|Progressive disease - radiological progression|2|||
125367940|NCT00668707|450980907|FG000|Overall Study|Cancer Recurrence|58|||
125367941|NCT00668707|450980908|FG001|Overall Study|Cancer Recurrence|58|||
125367942|NCT00668707|450980907|FG000|Overall Study|Withdrawal by Subject|117|||
125367943|NCT00668707|450980908|FG001|Overall Study|Withdrawal by Subject|100|||
125367944|NCT00668707|450980907|FG000|Overall Study|Lost to Follow-up|3|||
125597150|NCT03497689|451810449|FG000|Overall Study|Adverse Event|2|||
125597151|NCT03497689|451810449|FG000|Overall Study|Death|1|||
125367945|NCT00668707|450980908|FG001|Overall Study|Lost to Follow-up|6|||
125367946|NCT00668707|450980907|FG000|Overall Study|Protocol Violation|10|||
125367947|NCT00668707|450980908|FG001|Overall Study|Protocol Violation|12|||
125367948|NCT00668707|450980907|FG000|Overall Study|Death|11|||
125367949|NCT00668707|450980908|FG001|Overall Study|Death|4|||
125367950|NCT03583697|450980909|FG000|Overall Study|Withdrawal by Subject|0|||
125367951|NCT03583697|450980910|FG001|Overall Study|Withdrawal by Subject|0|||
125367952|NCT03583697|450980911|FG002|Overall Study|Withdrawal by Subject|1|||
125367953|NCT03583697|450980909|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
125367954|NCT03583697|450980910|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
125367955|NCT03583697|450980911|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
125367956|NCT00114530|450980912|FG000|Overall Study|Death|3|||
125367957|NCT00114530|450980913|FG001|Overall Study|Death|11|||
125367958|NCT00114530|450980912|FG000|Overall Study|Lost to Follow-up|1|||
125367959|NCT00114530|450980913|FG001|Overall Study|Lost to Follow-up|1|||
125367960|NCT00114530|450980912|FG000|Overall Study|Physician Decision|1|||
125367961|NCT00114530|450980913|FG001|Overall Study|Physician Decision|1|||
125367962|NCT00114530|450980912|FG000|Overall Study|Withdrawal by Subject|2|||
125367963|NCT00114530|450980913|FG001|Overall Study|Withdrawal by Subject|6|||
125367964|NCT00114530|450980912|FG000|Overall Study|Breast Cancer|1|||
125367965|NCT00114530|450980913|FG001|Overall Study|Breast Cancer|0|||
125367966|NCT00114530|450980912|FG000|Overall Study|Subject decision after endpoint failure|0|||
125367967|NCT00114530|450980913|FG001|Overall Study|Subject decision after endpoint failure|1|||
125367968|NCT00114530|450980912|FG000|Overall Study|Ineligible|1|||
125367969|NCT00114530|450980913|FG001|Overall Study|Ineligible|0|||
125367970|NCT00365508|450980917|FG000|Overall Study|Lost to Follow-up|139|||
125367971|NCT00365508|450980918|FG001|Overall Study|Lost to Follow-up|154|||
125367972|NCT01064310|450980920|FG000|Period 1|Adverse Event|7|||
125367973|NCT01064310|450980921|FG001|Period 1|Adverse Event|10|||
125367974|NCT01064310|450980922|FG002|Period 1|Adverse Event|0|||
125367975|NCT01064310|450980920|FG000|Period 1|Physician Decision|1|||
125367976|NCT01064310|450980921|FG001|Period 1|Physician Decision|0|||
125367977|NCT01064310|450980922|FG002|Period 1|Physician Decision|0|||
125367978|NCT01064310|450980920|FG000|Period 1|Withdrawal by Subject|2|||
125367979|NCT01064310|450980921|FG001|Period 1|Withdrawal by Subject|2|||
125367980|NCT01064310|450980922|FG002|Period 1|Withdrawal by Subject|0|||
125367981|NCT01064310|450980920|FG000|Period 1|Lack of Efficacy|3|||
125367982|NCT01064310|450980921|FG001|Period 1|Lack of Efficacy|5|||
125367983|NCT01064310|450980922|FG002|Period 1|Lack of Efficacy|0|||
125367984|NCT01064310|450980920|FG000|Period 1|Entered Open-label Period|1|||
125367985|NCT01064310|450980921|FG001|Period 1|Entered Open-label Period|1|||
125367986|NCT01064310|450980922|FG002|Period 1|Entered Open-label Period|0|||
125367987|NCT01064310|450980920|FG000|Period 2|Adverse Event|2|||
125367988|NCT01064310|450980921|FG001|Period 2|Adverse Event|1|||
125367989|NCT01064310|450980922|FG002|Period 2|Adverse Event|0|||
125367990|NCT01064310|450980920|FG000|Period 2|Physician Decision|0|||
125367991|NCT01064310|450980921|FG001|Period 2|Physician Decision|1|||
125367992|NCT01064310|450980922|FG002|Period 2|Physician Decision|0|||
125367993|NCT01064310|450980920|FG000|Period 2|Entered Open-label Period|1|||
125367994|NCT01064310|450980921|FG001|Period 2|Entered Open-label Period|0|||
125367995|NCT01064310|450980922|FG002|Period 2|Entered Open-label Period|0|||
125367996|NCT01064310|450980920|FG000|Period 2|Lack of Efficacy|1|||
125367997|NCT01064310|450980921|FG001|Period 2|Lack of Efficacy|4|||
125367998|NCT01064310|450980922|FG002|Period 2|Lack of Efficacy|0|||
125367999|NCT01064310|450980920|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
125368000|NCT01064310|450980921|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
125368001|NCT01064310|450980922|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
125368002|NCT01064310|450980920|FG000|Open Label Pazopinib|Adverse Event|0|||
125368003|NCT01064310|450980921|FG001|Open Label Pazopinib|Adverse Event|0|||
125368004|NCT01064310|450980922|FG002|Open Label Pazopinib|Adverse Event|12|||
125368005|NCT01064310|450980920|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
125368006|NCT01064310|450980921|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
125368007|NCT01064310|450980922|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
125368008|NCT01064310|450980920|FG000|Open Label Pazopinib|Physician Decision|0|||
125368009|NCT01064310|450980921|FG001|Open Label Pazopinib|Physician Decision|0|||
125368010|NCT01064310|450980922|FG002|Open Label Pazopinib|Physician Decision|20|||
125368011|NCT00679432|450980923|FG000|Overall Study|Adverse Event|5|||
125368012|NCT00679432|450980924|FG001|Overall Study|Adverse Event|6|||
125368013|NCT00679432|450980925|FG002|Overall Study|Adverse Event|10|||
125368014|NCT00679432|450980926|FG003|Overall Study|Adverse Event|7|||
125368015|NCT00679432|450980923|FG000|Overall Study|Protocol Violation|1|||
125368016|NCT00679432|450980924|FG001|Overall Study|Protocol Violation|1|||
125368017|NCT00679432|450980925|FG002|Overall Study|Protocol Violation|2|||
125368018|NCT00679432|450980926|FG003|Overall Study|Protocol Violation|1|||
125368019|NCT00679432|450980923|FG000|Overall Study|Withdrawal by Subject|8|||
125368020|NCT00679432|450980924|FG001|Overall Study|Withdrawal by Subject|11|||
125368021|NCT00679432|450980925|FG002|Overall Study|Withdrawal by Subject|10|||
125368022|NCT00679432|450980926|FG003|Overall Study|Withdrawal by Subject|9|||
125368023|NCT00679432|450980923|FG000|Overall Study|Lost to Follow-up|1|||
125368024|NCT00679432|450980924|FG001|Overall Study|Lost to Follow-up|5|||
125368025|NCT00679432|450980925|FG002|Overall Study|Lost to Follow-up|4|||
125368026|NCT00679432|450980926|FG003|Overall Study|Lost to Follow-up|2|||
125368027|NCT00679432|450980923|FG000|Overall Study|Physician Decision|3|||
125368028|NCT00679432|450980924|FG001|Overall Study|Physician Decision|2|||
125368029|NCT00679432|450980925|FG002|Overall Study|Physician Decision|2|||
125368030|NCT00679432|450980926|FG003|Overall Study|Physician Decision|2|||
125368031|NCT00679432|450980923|FG000|Overall Study|Sponsor decision|1|||
125368032|NCT00679432|450980924|FG001|Overall Study|Sponsor decision|0|||
125368033|NCT00679432|450980925|FG002|Overall Study|Sponsor decision|0|||
125368034|NCT00679432|450980926|FG003|Overall Study|Sponsor decision|0|||
125368035|NCT00679432|450980923|FG000|Overall Study|Lack of Efficacy|13|||
125368036|NCT00679432|450980924|FG001|Overall Study|Lack of Efficacy|9|||
125368037|NCT00679432|450980925|FG002|Overall Study|Lack of Efficacy|14|||
125368038|NCT00679432|450980926|FG003|Overall Study|Lack of Efficacy|8|||
125368039|NCT00679432|450980923|FG000|Overall Study|Infectious colitis, normal histology|5|||
125368040|NCT00679432|450980924|FG001|Overall Study|Infectious colitis, normal histology|4|||
125368041|NCT00679432|450980925|FG002|Overall Study|Infectious colitis, normal histology|8|||
125368042|NCT00679432|450980926|FG003|Overall Study|Infectious colitis, normal histology|3|||
125368043|NCT00679432|450980923|FG000|Overall Study|Randomization error, return to prior Rx|0|||
125368044|NCT00679432|450980924|FG001|Overall Study|Randomization error, return to prior Rx|0|||
125368045|NCT00679432|450980925|FG002|Overall Study|Randomization error, return to prior Rx|3|||
125368046|NCT00679432|450980926|FG003|Overall Study|Randomization error, return to prior Rx|0|||
125368047|NCT00873015|450980928|FG000|Overall Study|Withdrawal by Subject|0|||
125368048|NCT00873015|450980929|FG001|Overall Study|Withdrawal by Subject|1|||
125368049|NCT00873015|450980930|FG002|Overall Study|Withdrawal by Subject|0|||
125368050|NCT00873015|450980931|FG003|Overall Study|Withdrawal by Subject|0|||
125368051|NCT02339584|450980932|FG000|Overall Study|Adverse Event|11|||
125368052|NCT02339584|450980933|FG001|Overall Study|Adverse Event|7|||
125368053|NCT02339584|450980932|FG000|Overall Study|Lack of Efficacy|0|||
125368054|NCT02339584|450980933|FG001|Overall Study|Lack of Efficacy|1|||
125368055|NCT02339584|450980932|FG000|Overall Study|Physician Decision|1|||
125368056|NCT02339584|450980933|FG001|Overall Study|Physician Decision|2|||
125368057|NCT02339584|450980932|FG000|Overall Study|Protocol Violation|1|||
125368058|NCT02339584|450980933|FG001|Overall Study|Protocol Violation|1|||
125368059|NCT02339584|450980932|FG000|Overall Study|Withdrawal by Subject|2|||
125368060|NCT02339584|450980933|FG001|Overall Study|Withdrawal by Subject|4|||
125368061|NCT01382212|450980934|FG000|Overall Study|Kidney transplant|1|||
125368062|NCT01382212|450980934|FG000|Overall Study|Withdrew consent|1|||
125368063|NCT00873912|450980936|FG000|Overall Study|Withdrawal by Subject|1|||
125368064|NCT00873912|450980937|FG001|Overall Study|Withdrawal by Subject|0|||
125368065|NCT00873912|450980936|FG000|Overall Study|Lost to Follow-up|2|||
125368066|NCT00873912|450980937|FG001|Overall Study|Lost to Follow-up|0|||
125368067|NCT01980940|450980939|FG000|Overall Study|Protocol Violation|0|||
125368068|NCT01980940|450980940|FG001|Overall Study|Protocol Violation|0|||
125368069|NCT01980940|450980941|FG002|Overall Study|Protocol Violation|0|||
125368070|NCT01980940|450980942|FG003|Overall Study|Protocol Violation|0|||
125368071|NCT01980940|450980943|FG004|Overall Study|Protocol Violation|0|||
125368072|NCT01980940|450980944|FG005|Overall Study|Protocol Violation|2|||
125368073|NCT01980940|450980945|FG006|Overall Study|Protocol Violation|0|||
125368074|NCT01980940|450980946|FG007|Overall Study|Protocol Violation|0|||
125368075|NCT00709761|450982347|FG000|Overall Study|Withdrawal by Subject|8|||
125368076|NCT00709761|450982347|FG000|Overall Study|study closed/terminated|17|||
125368077|NCT00709761|450982347|FG000|Overall Study|Lost to Follow-up|2|||
125368078|NCT00259649|450982348|FG000|Overall Study|Lost to Follow-up|7|||
125368079|NCT00259649|450982348|FG000|Overall Study|irregular menses|3|||
125368080|NCT03311724|450982349|FG000|Overall Study|Physician Decision|0|||
125368081|NCT03311724|450982350|FG001|Overall Study|Physician Decision|0|||
125368082|NCT03311724|450982351|FG002|Overall Study|Physician Decision|0|||
125368083|NCT03311724|450982352|FG003|Overall Study|Physician Decision|1|||
125368084|NCT03311724|450982349|FG000|Overall Study|Protocol Violation|1|||
125368085|NCT03311724|450982350|FG001|Overall Study|Protocol Violation|0|||
125368086|NCT03311724|450982351|FG002|Overall Study|Protocol Violation|1|||
125368087|NCT03311724|450982352|FG003|Overall Study|Protocol Violation|0|||
125368088|NCT03311724|450982349|FG000|Overall Study|Withdrawal by Subject|1|||
125368089|NCT03311724|450982350|FG001|Overall Study|Withdrawal by Subject|1|||
125368090|NCT03311724|450982351|FG002|Overall Study|Withdrawal by Subject|0|||
125368091|NCT03311724|450982352|FG003|Overall Study|Withdrawal by Subject|0|||
125368092|NCT03311724|450982349|FG000|Overall Study|Lost to Follow-up|1|||
125368093|NCT03311724|450982350|FG001|Overall Study|Lost to Follow-up|0|||
125368094|NCT03311724|450982351|FG002|Overall Study|Lost to Follow-up|0|||
125368095|NCT03311724|450982352|FG003|Overall Study|Lost to Follow-up|0|||
125368096|NCT03311724|450982349|FG000|Overall Study|Sponsor Decision|0|||
125368097|NCT03311724|450982350|FG001|Overall Study|Sponsor Decision|0|||
125368098|NCT03311724|450982351|FG002|Overall Study|Sponsor Decision|1|||
125368099|NCT03311724|450982352|FG003|Overall Study|Sponsor Decision|0|||
125368100|NCT03305575|450982359|FG000|Overall Study|Physician Decision|1|||
125430758|NCT01529008|451205507|FG001|Treatment|Other|1|||
125430759|NCT01529008|451205506|FG000|Efficacy Analysis|Protocol Violation|2|||
125430760|NCT01529008|451205507|FG001|Efficacy Analysis|Protocol Violation|0|||
125430761|NCT01529008|451205506|FG000|Efficacy Analysis|Physician Decision|0|||
125430762|NCT01529008|451205507|FG001|Efficacy Analysis|Physician Decision|1|||
125430763|NCT01529008|451205506|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
125430764|NCT01529008|451205507|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
125430765|NCT02305381|451205508|FG000|Overall Study|Unclassified|5|||
125430766|NCT02305381|451205509|FG001|Overall Study|Unclassified|5|||
125430767|NCT02305381|451205510|FG002|Overall Study|Unclassified|7|||
125430768|NCT02487498|451205516|FG000|Period: Period 1|Adverse Event|2|||
125430769|NCT02487498|451205517|FG001|Period: Period 1|Adverse Event|4|||
125430770|NCT02487498|451205516|FG000|Period: Period 1|Subject/guardian decision|2|||
125430771|NCT02487498|451205517|FG001|Period: Period 1|Subject/guardian decision|4|||
125430772|NCT02487498|451205516|FG000|Period: Period 1|Lost to Follow-up|0|||
125430773|NCT02487498|451205517|FG001|Period: Period 1|Lost to Follow-up|2|||
125430774|NCT02487498|451205516|FG000|Period: Period 1|Lack of Efficacy|1|||
125430775|NCT02487498|451205517|FG001|Period: Period 1|Lack of Efficacy|0|||
125430776|NCT02487498|451205516|FG000|Period: Period 1|Physician Decision|0|||
125430777|NCT02487498|451205517|FG001|Period: Period 1|Physician Decision|1|||
125430778|NCT02487498|451205516|FG000|Period: Period 1|Protocol deviation|1|||
125430779|NCT02487498|451205517|FG001|Period: Period 1|Protocol deviation|0|||
125430780|NCT02487498|451205516|FG000|Period: Washout|Subject/guardian decision|0|||
125430781|NCT02487498|451205517|FG001|Period: Washout|Subject/guardian decision|5|||
125430782|NCT02487498|451205516|FG000|Period: Washout|Lack of Efficacy|1|||
125430783|NCT02487498|451205517|FG001|Period: Washout|Lack of Efficacy|1|||
125430784|NCT02487498|451205516|FG000|Period: Washout|Physician Decision|1|||
125430785|NCT02487498|451205517|FG001|Period: Washout|Physician Decision|0|||
125430786|NCT02487498|451205516|FG000|Period: Washout|Non-compliance with study treatment|0|||
125430787|NCT02487498|451205517|FG001|Period: Washout|Non-compliance with study treatment|1|||
125430788|NCT02487498|451205516|FG000|Period: Period 2|Adverse Event|2|||
125430789|NCT02487498|451205517|FG001|Period: Period 2|Adverse Event|2|||
125430790|NCT02487498|451205516|FG000|Period: Period 2|Subject/guardian decision|2|||
125430791|NCT02487498|451205517|FG001|Period: Period 2|Subject/guardian decision|1|||
125430792|NCT02487498|451205516|FG000|Period: Period 2|Lost to Follow-up|1|||
125430793|NCT02487498|451205517|FG001|Period: Period 2|Lost to Follow-up|1|||
125430794|NCT02487498|451205516|FG000|Period: Period 2|Death|0|||
125430795|NCT02487498|451205517|FG001|Period: Period 2|Death|1|||
125430796|NCT02487498|451205516|FG000|Period: Period 2|Physician Decision|1|||
125430797|NCT02487498|451205517|FG001|Period: Period 2|Physician Decision|0|||
125430798|NCT05056870|451205518|FG000|Period 1|Site COVID-19 Related|3|||
125430799|NCT05056870|451205519|FG001|Period 1|Site COVID-19 Related|3|||
125430800|NCT05056870|451205518|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125430801|NCT05056870|451205519|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
125430802|NCT05056870|451205518|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
125430803|NCT05056870|451205519|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
125430804|NCT05056870|451205518|FG000|Period 2|COVID-19 Related|1|||
125430805|NCT05056870|451205519|FG001|Period 2|COVID-19 Related|0|||
125430806|NCT05056870|451205518|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
125430807|NCT05056870|451205519|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
125597152|NCT03497689|451810449|FG000|Overall Study|Physician Decision|1|||
125597153|NCT03497689|451810449|FG000|Overall Study|Withdrawal by Subject|1|||
125597154|NCT03497689|451810449|FG000|Overall Study|Protocol Violation|2|||
125597155|NCT03191786|451810450|FG000|Overall Study|Death|236|||
125597156|NCT03191786|451810451|FG001|Overall Study|Death|127|||
125597157|NCT03191786|451810450|FG000|Overall Study|Lost to Follow-up|9|||
125597158|NCT03191786|451810451|FG001|Overall Study|Lost to Follow-up|3|||
125597159|NCT03191786|451810450|FG000|Overall Study|Physician Decision|1|||
125597160|NCT03191786|451810451|FG001|Overall Study|Physician Decision|0|||
125430808|NCT00676130|451205522|FG000|Overall Study|Lost to Follow-up|0|||
125597161|NCT03191786|451810450|FG000|Overall Study|Moved to Post Trial Access Program|30|||
125430809|NCT00676130|451205523|FG001|Overall Study|Lost to Follow-up|1|||
125430810|NCT00676130|451205522|FG000|Overall Study|Found ineligible|3|||
125430811|NCT00676130|451205523|FG001|Overall Study|Found ineligible|2|||
125430812|NCT00676130|451205522|FG000|Overall Study|Withdrawal by Subject|0|||
125430813|NCT00676130|451205523|FG001|Overall Study|Withdrawal by Subject|1|||
125430814|NCT05044325|451205524|FG000|Part A:Treatment Period 1|Adverse Event|0|||
125430815|NCT05044325|451205525|FG001|Part A:Treatment Period 1|Adverse Event|0|||
125430816|NCT05044325|451205526|FG002|Part A:Treatment Period 1|Adverse Event|0|||
125597162|NCT03191786|451810451|FG001|Overall Study|Moved to Post Trial Access Program|5|||
125597163|NCT03191786|451810450|FG000|Overall Study|Withdrawal by Subject|26|||
125597164|NCT03191786|451810451|FG001|Overall Study|Withdrawal by Subject|16|||
125597165|NCT01362322|451812241|FG000|Overall Study|Withdrawal by Subject|3|||
125597166|NCT01362322|451812242|FG001|Overall Study|Withdrawal by Subject|1|||
125597167|NCT01362322|451812241|FG000|Overall Study|Lost to Follow-up|2|||
125597168|NCT01362322|451812242|FG001|Overall Study|Lost to Follow-up|6|||
125597169|NCT01009463|451812243|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
125597170|NCT01009463|451812244|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125597171|NCT01009463|451812245|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125597172|NCT01009463|451812246|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125597173|NCT01009463|451812247|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
125597174|NCT01009463|451812243|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
125597175|NCT01009463|451812244|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
125597176|NCT01009463|451812245|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
125597177|NCT01009463|451812246|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
125597178|NCT01009463|451812247|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
125597179|NCT01009463|451812243|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
125597180|NCT01009463|451812244|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125597181|NCT01009463|451812245|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125597182|NCT01009463|451812246|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125597183|NCT01009463|451812247|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
125597184|NCT01009463|451812243|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
125597185|NCT01009463|451812244|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
125597186|NCT01009463|451812245|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
125597187|NCT01009463|451812246|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
125597188|NCT01009463|451812247|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
125597189|NCT01009463|451812243|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
125597190|NCT01009463|451812244|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125597191|NCT01009463|451812245|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125597192|NCT01009463|451812246|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125368101|NCT03305575|450982360|FG001|Overall Study|Physician Decision|0|||
125368102|NCT03486223|450982373|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
125368103|NCT03486223|450982374|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
125368104|NCT01819831|450982375|FG000|Overall Study|Withdrawal by Subject|1|||
125368105|NCT03068130|450982391|FG000|Overall Study|Adverse Event|19|||
125368106|NCT03068130|450982391|FG000|Overall Study|Death|14|||
125368107|NCT03068130|450982391|FG000|Overall Study|Lost to Follow-up|4|||
125368108|NCT03068130|450982391|FG000|Overall Study|Withdrawal by Subject|26|||
125368109|NCT03068130|450982391|FG000|Overall Study|Administrative Reasons|3|||
125368110|NCT03068130|450982391|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
125368111|NCT03068130|450982391|FG000|Overall Study|Study terminated by sponsor|194|||
125368112|NCT03130257|450982396|FG000|Overall Study|Withdrawal by Subject|1|||
125368113|NCT03130257|450982397|FG001|Overall Study|Withdrawal by Subject|0|||
125368114|NCT03130257|450982398|FG002|Overall Study|Withdrawal by Subject|2|||
125368115|NCT00297830|450982399|FG000|6 Month Visit|Death|1|||
125368116|NCT00297830|450982400|FG001|6 Month Visit|Death|0|||
125368117|NCT00297830|450982401|FG002|6 Month Visit|Death|2|||
125368118|NCT00297830|450982399|FG000|6 Month Visit|Withdrawal by Subject|2|||
125368119|NCT00297830|450982400|FG001|6 Month Visit|Withdrawal by Subject|1|||
125368120|NCT00297830|450982401|FG002|6 Month Visit|Withdrawal by Subject|1|||
125368121|NCT00297830|450982399|FG000|6 Month Visit|Adverse Event|0|||
125368122|NCT00297830|450982400|FG001|6 Month Visit|Adverse Event|1|||
125368123|NCT00297830|450982401|FG002|6 Month Visit|Adverse Event|0|||
125368124|NCT00297830|450982399|FG000|12 Month Visit|Lost to Follow-up|1|||
125368125|NCT00297830|450982400|FG001|12 Month Visit|Lost to Follow-up|0|||
125368126|NCT00297830|450982401|FG002|12 Month Visit|Lost to Follow-up|0|||
125368127|NCT00297830|450982399|FG000|12 Month Visit|Adverse Event|0|||
125368128|NCT00297830|450982400|FG001|12 Month Visit|Adverse Event|3|||
125368129|NCT00297830|450982401|FG002|12 Month Visit|Adverse Event|0|||
125368130|NCT00297830|450982399|FG000|12 Month Visit|Withdrawal by Subject|0|||
125368131|NCT00297830|450982400|FG001|12 Month Visit|Withdrawal by Subject|3|||
125368132|NCT00297830|450982401|FG002|12 Month Visit|Withdrawal by Subject|0|||
125368133|NCT03727230|450982404|FG000|Overall Study|Lost to Follow-up|12|||
125368134|NCT04377620|450982405|FG000|Overall Study|Death|42|||
125368135|NCT04377620|450982406|FG001|Overall Study|Death|48|||
125368136|NCT04377620|450982407|FG002|Overall Study|Death|36|||
125368137|NCT04377620|450982405|FG000|Overall Study|Withdrawal by Subject|0|||
125368138|NCT04377620|450982406|FG001|Overall Study|Withdrawal by Subject|2|||
125597193|NCT01009463|451812247|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
125368139|NCT04377620|450982407|FG002|Overall Study|Withdrawal by Subject|0|||
125368140|NCT00288054|450982411|FG000|Overall Study|Protocol Violation|2|||
125368141|NCT00288054|450982411|FG000|Overall Study|Lack of Efficacy|16|||
125368142|NCT00288054|450982411|FG000|Overall Study|Adverse Event|3|||
125368143|NCT00288054|450982411|FG000|Overall Study|Withdrawal by Subject|1|||
125368144|NCT00288054|450982411|FG000|Overall Study|Not protocol specified|2|||
125368145|NCT03733470|450982416|FG000|Overall Study|PI Decision|1|||
125368146|NCT03733470|450982417|FG001|Overall Study|PI Decision|1|||
125368147|NCT01010061|450982418|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
125368148|NCT01010061|450982419|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
125430817|NCT05044325|451205527|FG003|Part A:Treatment Period 1|Adverse Event|0|||
125430818|NCT05044325|451205528|FG004|Part A:Treatment Period 1|Adverse Event|0|||
125597194|NCT01009463|451812243|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
125597195|NCT01009463|451812244|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
125597196|NCT01009463|451812245|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
125597197|NCT01009463|451812246|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
125597198|NCT01009463|451812247|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
125597199|NCT01009463|451812243|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125597200|NCT01009463|451812244|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
125597201|NCT01009463|451812245|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
125597202|NCT01009463|451812246|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
125597203|NCT01009463|451812247|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
125597204|NCT01009463|451812243|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
125597205|NCT01009463|451812244|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
125597206|NCT01009463|451812245|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
125597207|NCT01009463|451812246|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
125597208|NCT01009463|451812247|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
125597209|NCT01009463|451812243|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
125597210|NCT01009463|451812244|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
125597211|NCT01009463|451812245|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
125597212|NCT01009463|451812246|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
125597213|NCT01009463|451812247|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
125597214|NCT01009463|451812243|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
125597215|NCT01009463|451812244|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
125597216|NCT01009463|451812245|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
125597217|NCT01009463|451812246|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
125597218|NCT01009463|451812247|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
125597219|NCT01009463|451812243|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
125597220|NCT01009463|451812244|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
125597221|NCT01009463|451812245|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
125597222|NCT01009463|451812246|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
125597223|NCT01009463|451812247|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
125597224|NCT01009463|451812243|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125368149|NCT01010061|450982418|FG000|Overall Study|Disease Progression|2|||
125368150|NCT01010061|450982419|FG001|Overall Study|Disease Progression|8|||
125368151|NCT01010061|450982418|FG000|Overall Study|Withdrew Consent|5|||
125368152|NCT01010061|450982419|FG001|Overall Study|Withdrew Consent|1|||
125368153|NCT01010061|450982418|FG000|Overall Study|Death|3|||
125368154|NCT01010061|450982419|FG001|Overall Study|Death|6|||
125368155|NCT01010061|450982418|FG000|Overall Study|Administrative/Other|0|||
125368156|NCT01010061|450982419|FG001|Overall Study|Administrative/Other|1|||
125368157|NCT01010061|450982418|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
125368158|NCT01010061|450982419|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
125368159|NCT01010061|450982418|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125368160|NCT01010061|450982419|FG001|Overall Study|Insufficient Therapeutic Response|5|||
125368161|NCT01010061|450982418|FG000|Overall Study|Violation of Selection Criteria|0|||
125368162|NCT01010061|450982419|FG001|Overall Study|Violation of Selection Criteria|1|||
125368163|NCT01010061|450982418|FG000|Overall Study|Did Not Receive Treatment|2|||
125368164|NCT01010061|450982419|FG001|Overall Study|Did Not Receive Treatment|2|||
125368165|NCT03470441|450982420|FG000|Overall Study|Death|0|||
125368166|NCT03470441|450982421|FG001|Overall Study|Death|1|||
125368167|NCT03470441|450982422|FG002|Overall Study|Death|1|||
125368168|NCT03470441|450982423|FG003|Overall Study|Death|0|||
125430819|NCT05044325|451205529|FG005|Part A:Treatment Period 1|Adverse Event|1|||
125368169|NCT03470441|450982420|FG000|Overall Study|Adverse Event|0|||
125368170|NCT03470441|450982421|FG001|Overall Study|Adverse Event|0|||
125368171|NCT03470441|450982422|FG002|Overall Study|Adverse Event|0|||
125368172|NCT03470441|450982423|FG003|Overall Study|Adverse Event|1|||
125368173|NCT03470441|450982420|FG000|Overall Study|Withdrawal by Subject|1|||
125368174|NCT03470441|450982421|FG001|Overall Study|Withdrawal by Subject|4|||
125368175|NCT03470441|450982422|FG002|Overall Study|Withdrawal by Subject|1|||
125368176|NCT03470441|450982423|FG003|Overall Study|Withdrawal by Subject|3|||
125368177|NCT03768414|450982424|FG000|Overall Study|Adverse Event or side effects|72|||
125368178|NCT03768414|450982425|FG001|Overall Study|Adverse Event or side effects|28|||
125368179|NCT03768414|450982424|FG000|Overall Study|Refusal unrelated to adverse event|33|||
125368180|NCT03768414|450982425|FG001|Overall Study|Refusal unrelated to adverse event|33|||
125368181|NCT03768414|450982424|FG000|Overall Study|Progression/relapse|132|||
125368182|NCT03768414|450982425|FG001|Overall Study|Progression/relapse|60|||
125368183|NCT03768414|450982424|FG000|Overall Study|Death|9|||
125368184|NCT03768414|450982425|FG001|Overall Study|Death|6|||
125368185|NCT03768414|450982424|FG000|Overall Study|Other - not protocol specified|45|||
125368186|NCT03768414|450982425|FG001|Overall Study|Other - not protocol specified|18|||
125368187|NCT03768414|450982424|FG000|Overall Study|Reason under review|3|||
125368188|NCT03768414|450982425|FG001|Overall Study|Reason under review|2|||
125368189|NCT02197520|450982432|FG000|Period 1|Withdrawal by Subject|1|||
125368190|NCT02197520|450982433|FG001|Period 1|Withdrawal by Subject|0|||
125368191|NCT02197520|450982432|FG000|Period 2|Adverse Event|0|||
125368192|NCT02197520|450982433|FG001|Period 2|Adverse Event|2|||
125368193|NCT02197520|450982432|FG000|Period 2|Withdrawal by Subject|1|||
125368194|NCT02197520|450982433|FG001|Period 2|Withdrawal by Subject|0|||
125368195|NCT01306942|450982434|FG000|Phase I|Adverse Event|2|||
125368196|NCT01306942|450982435|FG001|Phase I|Adverse Event|2|||
125368197|NCT01306942|450982436|FG002|Phase I|Adverse Event|0|||
125368198|NCT01306942|450982437|FG003|Phase I|Adverse Event|0|||
125368199|NCT01306942|450982434|FG000|Phase I|Physician Decision|3|||
125368200|NCT01306942|450982435|FG001|Phase I|Physician Decision|1|||
125368201|NCT01306942|450982436|FG002|Phase I|Physician Decision|0|||
125368202|NCT01306942|450982437|FG003|Phase I|Physician Decision|0|||
125368203|NCT01306942|450982434|FG000|Phase II|Adverse Event|0|||
125368204|NCT01306942|450982435|FG001|Phase II|Adverse Event|0|||
125368205|NCT01306942|450982436|FG002|Phase II|Adverse Event|0|||
125368206|NCT01306942|450982437|FG003|Phase II|Adverse Event|6|||
125368207|NCT01306942|450982434|FG000|Phase II|Physician Decision|2|||
125368208|NCT01306942|450982435|FG001|Phase II|Physician Decision|0|||
125368209|NCT01306942|450982436|FG002|Phase II|Physician Decision|0|||
125368210|NCT01306942|450982437|FG003|Phase II|Physician Decision|5|||
125368211|NCT01306942|450982434|FG000|Phase II|Withdrawal by Subject|0|||
125368212|NCT01306942|450982435|FG001|Phase II|Withdrawal by Subject|0|||
125368213|NCT01306942|450982436|FG002|Phase II|Withdrawal by Subject|0|||
125368214|NCT01306942|450982437|FG003|Phase II|Withdrawal by Subject|2|||
125368215|NCT01306942|450982434|FG000|Phase II|Death|0|||
125368216|NCT01306942|450982435|FG001|Phase II|Death|0|||
125368217|NCT01306942|450982436|FG002|Phase II|Death|0|||
125368218|NCT01306942|450982437|FG003|Phase II|Death|1|||
125368219|NCT01306942|450982434|FG000|Phase II|Not finished treatment|0|||
125368220|NCT01306942|450982435|FG001|Phase II|Not finished treatment|0|||
125597225|NCT01009463|451812244|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
125597226|NCT01009463|451812245|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
125597227|NCT01009463|451812246|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
125597228|NCT01009463|451812247|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
125597229|NCT01009463|451812243|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
125597230|NCT01009463|451812244|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
125597231|NCT01009463|451812245|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
125597232|NCT01009463|451812246|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
125597233|NCT01009463|451812247|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
125597234|NCT01494038|451812250|FG000|Overall Study|Protocol Violation|1|||
125368221|NCT01306942|450982436|FG002|Phase II|Not finished treatment|0|||
125368222|NCT01306942|450982437|FG003|Phase II|Not finished treatment|1|||
125368223|NCT01306942|450982434|FG000|Phase II|Protocol Violation|0|||
125368224|NCT01306942|450982435|FG001|Phase II|Protocol Violation|0|||
125368225|NCT01306942|450982436|FG002|Phase II|Protocol Violation|0|||
125368226|NCT01306942|450982437|FG003|Phase II|Protocol Violation|1|||
125368227|NCT02021773|450982441|FG000|Overall Study|Adverse Event|1|||
125368228|NCT02021773|450982442|FG001|Overall Study|Adverse Event|4|||
125368229|NCT02021773|450982443|FG002|Overall Study|Adverse Event|3|||
125368230|NCT02021773|450982441|FG000|Overall Study|Lack of Efficacy|2|||
125368231|NCT02021773|450982442|FG001|Overall Study|Lack of Efficacy|2|||
125368232|NCT02021773|450982443|FG002|Overall Study|Lack of Efficacy|2|||
125368233|NCT02021773|450982441|FG000|Overall Study|Protocol Violation|2|||
125597235|NCT01494038|451812251|FG001|Overall Study|Protocol Violation|1|||
125368234|NCT02021773|450982442|FG001|Overall Study|Protocol Violation|3|||
125368235|NCT02021773|450982443|FG002|Overall Study|Protocol Violation|1|||
125368236|NCT02021773|450982441|FG000|Overall Study|Withdrawal by Subject|3|||
125368237|NCT02021773|450982442|FG001|Overall Study|Withdrawal by Subject|4|||
125597236|NCT01494038|451812250|FG000|Overall Study|Lost to Follow-up|18|||
125368238|NCT02021773|450982443|FG002|Overall Study|Withdrawal by Subject|5|||
125597237|NCT01494038|451812251|FG001|Overall Study|Lost to Follow-up|20|||
125597238|NCT01494038|451812250|FG000|Overall Study|Withdrawal by Subject|44|||
125597239|NCT01494038|451812251|FG001|Overall Study|Withdrawal by Subject|34|||
125597240|NCT01494038|451812250|FG000|Overall Study|Not able to get to clinic|21|||
125597241|NCT01494038|451812251|FG001|Overall Study|Not able to get to clinic|15|||
125597242|NCT01494038|451812250|FG000|Overall Study|Not willing to adhere to reqs|2|||
125597243|NCT01494038|451812251|FG001|Overall Study|Not willing to adhere to reqs|9|||
125597244|NCT01494038|451812250|FG000|Overall Study|Death|2|||
125597245|NCT01494038|451812251|FG001|Overall Study|Death|4|||
125597246|NCT02401256|451812252|FG000|Overall Study|Adverse Event|5|||
125597247|NCT02401256|451812252|FG000|Overall Study|Withdrawal by Subject|12|||
125597248|NCT00430781|451812253|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
125597249|NCT00430781|451812254|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
125597250|NCT00430781|451812255|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
125597251|NCT00430781|451812253|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
125597252|NCT00430781|451812254|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
125597253|NCT00430781|451812255|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
125597254|NCT00430781|451812253|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
125597255|NCT00430781|451812254|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
125597256|NCT00430781|451812255|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
125597257|NCT00430781|451812253|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
125597258|NCT00430781|451812254|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
125597259|NCT00430781|451812255|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
125597260|NCT00430781|451812253|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
125597261|NCT00430781|451812254|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
125597262|NCT00430781|451812255|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
125597263|NCT00430781|451812253|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
125597264|NCT00430781|451812254|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
125597265|NCT00430781|451812255|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
125597266|NCT00430781|451812253|FG000|Interim Analysis; 11 February 2008|Death|0|||
125597267|NCT00430781|451812254|FG001|Interim Analysis; 11 February 2008|Death|1|||
125597268|NCT00430781|451812255|FG002|Interim Analysis; 11 February 2008|Death|0|||
125597269|NCT00430781|451812253|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
125597270|NCT00430781|451812254|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
125597271|NCT00430781|451812255|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
125597272|NCT00430781|451812253|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
125597273|NCT00430781|451812254|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
125597274|NCT00430781|451812255|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
125597275|NCT00430781|451812253|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
125597276|NCT00430781|451812254|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
125597277|NCT00430781|451812255|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
125597278|NCT00430781|451812253|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
125597279|NCT00430781|451812254|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
125597280|NCT00430781|451812255|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
125597281|NCT00430781|451812253|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
125597282|NCT00430781|451812254|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
125597283|NCT00430781|451812255|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
125597284|NCT00430781|451812253|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
125597285|NCT00430781|451812254|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
125597286|NCT00430781|451812255|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
125597287|NCT00430781|451812253|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
125597288|NCT00430781|451812254|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
125597289|NCT00430781|451812255|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
125212778|NCT01026818|450405479|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
125368239|NCT02021773|450982441|FG000|Overall Study|Lost to Follow-up|1|||
125368240|NCT02021773|450982442|FG001|Overall Study|Lost to Follow-up|3|||
125368241|NCT02021773|450982443|FG002|Overall Study|Lost to Follow-up|0|||
125368242|NCT02021773|450982441|FG000|Overall Study|Reason not specified|3|||
125368243|NCT02021773|450982442|FG001|Overall Study|Reason not specified|0|||
125368244|NCT02021773|450982443|FG002|Overall Study|Reason not specified|0|||
125368245|NCT02243696|450982444|FG000|Overall Study|Death|282|||
125597290|NCT00430781|451812253|FG000|Final Analysis; 31 July 2008|Other|0|||
125597291|NCT00430781|451812254|FG001|Final Analysis; 31 July 2008|Other|1|||
125597292|NCT00430781|451812255|FG002|Final Analysis; 31 July 2008|Other|0|||
125597293|NCT00430781|451812253|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
125597294|NCT00430781|451812254|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
125368246|NCT02243696|450982444|FG000|Overall Study|Withdrawal by Subject|79|||
125368247|NCT02243696|450982444|FG000|Overall Study|Lost to Follow-up|57|||
125430820|NCT05044325|451205530|FG006|Part A:Treatment Period 1|Adverse Event|0|||
125430821|NCT05044325|451205531|FG007|Part A:Treatment Period 1|Adverse Event|1|||
125430822|NCT05044325|451205532|FG008|Part A:Treatment Period 1|Adverse Event|0|||
125430823|NCT05044325|451205533|FG009|Part A:Treatment Period 1|Adverse Event|0|||
125430824|NCT05044325|451205524|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125430825|NCT05044325|451205525|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125430826|NCT05044325|451205526|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125430827|NCT05044325|451205527|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
125430828|NCT05044325|451205528|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
125430829|NCT05044325|451205529|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
125430830|NCT05044325|451205530|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125430831|NCT05044325|451205531|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125430832|NCT05044325|451205532|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125430833|NCT05044325|451205533|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
125430834|NCT05044325|451205524|FG000|Part A:Treatment Period 1|Physician Decision|0|||
125430835|NCT05044325|451205525|FG001|Part A:Treatment Period 1|Physician Decision|0|||
125430836|NCT05044325|451205526|FG002|Part A:Treatment Period 1|Physician Decision|0|||
125430837|NCT05044325|451205527|FG003|Part A:Treatment Period 1|Physician Decision|0|||
125430838|NCT05044325|451205528|FG004|Part A:Treatment Period 1|Physician Decision|0|||
125430839|NCT05044325|451205529|FG005|Part A:Treatment Period 1|Physician Decision|0|||
125430840|NCT05044325|451205530|FG006|Part A:Treatment Period 1|Physician Decision|1|||
125430841|NCT05044325|451205531|FG007|Part A:Treatment Period 1|Physician Decision|0|||
125430842|NCT05044325|451205532|FG008|Part A:Treatment Period 1|Physician Decision|0|||
125430843|NCT05044325|451205533|FG009|Part A:Treatment Period 1|Physician Decision|0|||
125430844|NCT05044325|451205524|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125430845|NCT05044325|451205525|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125430846|NCT05044325|451205526|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
125430847|NCT05044325|451205527|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125430848|NCT05044325|451205528|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125430849|NCT05044325|451205529|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125430850|NCT05044325|451205530|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125430851|NCT05044325|451205531|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125430852|NCT05044325|451205532|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125430853|NCT05044325|451205533|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
125430854|NCT05044325|451205524|FG000|Part A:Treatment Period 2|Adverse Event|0|||
125430855|NCT05044325|451205525|FG001|Part A:Treatment Period 2|Adverse Event|1|||
125430856|NCT05044325|451205526|FG002|Part A:Treatment Period 2|Adverse Event|0|||
125430857|NCT05044325|451205527|FG003|Part A:Treatment Period 2|Adverse Event|0|||
125430858|NCT05044325|451205528|FG004|Part A:Treatment Period 2|Adverse Event|1|||
125430859|NCT05044325|451205529|FG005|Part A:Treatment Period 2|Adverse Event|1|||
125430860|NCT05044325|451205530|FG006|Part A:Treatment Period 2|Adverse Event|0|||
125430861|NCT05044325|451205531|FG007|Part A:Treatment Period 2|Adverse Event|0|||
125430862|NCT05044325|451205532|FG008|Part A:Treatment Period 2|Adverse Event|0|||
125430863|NCT05044325|451205533|FG009|Part A:Treatment Period 2|Adverse Event|0|||
125430864|NCT05044325|451205524|FG000|Part A:Treatment Period 2|Physician Decision|0|||
125430865|NCT05044325|451205525|FG001|Part A:Treatment Period 2|Physician Decision|0|||
125430866|NCT05044325|451205526|FG002|Part A:Treatment Period 2|Physician Decision|0|||
125368248|NCT02243696|450982444|FG000|Overall Study|Subject No Longer has Study System|42|||
125368249|NCT02243696|450982444|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
125368250|NCT02243696|450982444|FG000|Overall Study|Study Terminated for EP PASSION|961|||
125368251|NCT00190671|450982445|FG000|Overall Study|Satisfactory Response|4|||
125368252|NCT00190671|450982446|FG001|Overall Study|Satisfactory Response|7|||
125368253|NCT00190671|450982445|FG000|Overall Study|Lack of Efficacy|19|||
125368254|NCT00190671|450982446|FG001|Overall Study|Lack of Efficacy|24|||
125368255|NCT00190671|450982445|FG000|Overall Study|Death from Study Disease|1|||
125368256|NCT00190671|450982446|FG001|Overall Study|Death from Study Disease|1|||
125368257|NCT00190671|450982445|FG000|Overall Study|Adverse Event|3|||
125368258|NCT00190671|450982446|FG001|Overall Study|Adverse Event|2|||
125368259|NCT00190671|450982445|FG000|Overall Study|Clinical Relapse|0|||
125597295|NCT00430781|451812255|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
125597296|NCT00430781|451812253|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
125597297|NCT00430781|451812254|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
125597298|NCT00430781|451812255|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
125597299|NCT00430781|451812253|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
125597300|NCT00430781|451812254|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
125597301|NCT00430781|451812255|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
125597302|NCT00430781|451812253|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
125597303|NCT00430781|451812254|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
125597304|NCT00430781|451812255|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
125597305|NCT00430781|451812253|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
125597306|NCT00430781|451812254|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
125597307|NCT00430781|451812255|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
125597308|NCT00430781|451812253|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
125597309|NCT00430781|451812254|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
125597310|NCT00430781|451812255|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
125597311|NCT00430781|451812253|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
125597312|NCT00430781|451812254|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
125597313|NCT00430781|451812255|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
125368260|NCT00190671|450982446|FG001|Overall Study|Clinical Relapse|1|||
125368261|NCT00190671|450982445|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
125368262|NCT00190671|450982446|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
125368263|NCT00190671|450982445|FG000|Overall Study|Death from Other Causes|0|||
125368264|NCT00190671|450982446|FG001|Overall Study|Death from Other Causes|2|||
125368265|NCT00190671|450982445|FG000|Overall Study|Protocol Violation|0|||
125368266|NCT00190671|450982446|FG001|Overall Study|Protocol Violation|1|||
125368267|NCT00190671|450982445|FG000|Overall Study|Withdrawal by Subject|0|||
125368268|NCT00190671|450982446|FG001|Overall Study|Withdrawal by Subject|2|||
125368269|NCT00087607|450982447|FG000|Overall Study|Adverse Event|14|||
125368270|NCT00087607|450982448|FG001|Overall Study|Adverse Event|24|||
125368271|NCT00087607|450982447|FG000|Overall Study|Death|0|||
125368272|NCT00087607|450982448|FG001|Overall Study|Death|1|||
125368273|NCT00087607|450982447|FG000|Overall Study|Insufficient Therapeutic Response|53|||
125368274|NCT00087607|450982448|FG001|Overall Study|Insufficient Therapeutic Response|42|||
125368275|NCT00087607|450982447|FG000|Overall Study|Failure to return|21|||
125368276|NCT00087607|450982448|FG001|Overall Study|Failure to return|17|||
125368277|NCT00087607|450982447|FG000|Overall Study|Withdrew Consent|12|||
125368278|NCT00087607|450982448|FG001|Overall Study|Withdrew Consent|16|||
125368279|NCT00087607|450982447|FG000|Overall Study|Administrative|12|||
125368280|NCT00087607|450982448|FG001|Overall Study|Administrative|12|||
125368281|NCT00087607|450982447|FG000|Overall Study|Refused Treatment|5|||
125368282|NCT00087607|450982448|FG001|Overall Study|Refused Treatment|7|||
125368283|NCT00087607|450982447|FG000|Overall Study|Other Protocol Violation|5|||
125368284|NCT00087607|450982448|FG001|Overall Study|Other Protocol Violation|2|||
125368285|NCT00087607|450982447|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
125368286|NCT00087607|450982448|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
125368287|NCT05399641|450982449|FG000|Overall Study|Adverse Event|0|||
125368288|NCT05399641|450982450|FG001|Overall Study|Adverse Event|1|||
125368289|NCT05399641|450982451|FG002|Overall Study|Adverse Event|1|||
125368290|NCT05399641|450982449|FG000|Overall Study|Lost to Follow-up|1|||
125368291|NCT05399641|450982450|FG001|Overall Study|Lost to Follow-up|2|||
125368292|NCT05399641|450982451|FG002|Overall Study|Lost to Follow-up|2|||
125368293|NCT05399641|450982449|FG000|Overall Study|Physician Decision|1|||
125368294|NCT05399641|450982450|FG001|Overall Study|Physician Decision|3|||
125368295|NCT05399641|450982451|FG002|Overall Study|Physician Decision|3|||
125368296|NCT05399641|450982449|FG000|Overall Study|Withdrawal by Subject|4|||
125368297|NCT05399641|450982450|FG001|Overall Study|Withdrawal by Subject|11|||
125368298|NCT05399641|450982451|FG002|Overall Study|Withdrawal by Subject|7|||
125368299|NCT05399641|450982449|FG000|Overall Study|Reason not defined|3|||
125368300|NCT05399641|450982450|FG001|Overall Study|Reason not defined|5|||
125368301|NCT05399641|450982451|FG002|Overall Study|Reason not defined|6|||
125368302|NCT03408483|450982452|FG000|Overall Study|Physician Decision|3|||
125368303|NCT03408483|450982453|FG001|Overall Study|Physician Decision|3|||
125368304|NCT03408483|450982452|FG000|Overall Study|Lost to Follow-up|3|||
125368305|NCT03408483|450982453|FG001|Overall Study|Lost to Follow-up|0|||
125368306|NCT02094677|450982454|FG000|Overall Study|Screening|3|||
125368307|NCT02094677|450982455|FG001|Overall Study|Screening|1|||
125368308|NCT00478231|450982456|FG000|Overall Study|Death|7|||
125368309|NCT00478231|450982456|FG000|Overall Study|Lack of Efficacy|47|||
125368310|NCT00478231|450982456|FG000|Overall Study|Lost to Follow-up|7|||
125368311|NCT00478231|450982456|FG000|Overall Study|Withdrawal by Subject|6|||
125368312|NCT00478231|450982456|FG000|Overall Study|Other|9|||
125368313|NCT00478231|450982456|FG000|Overall Study|Adverse Event|5|||
125368314|NCT00478231|450982456|FG000|Overall Study|Randomized, not treated|3|||
125368315|NCT04066023|450982464|FG000|Overall Study|Adverse Event|0|||
125368316|NCT04066023|450982465|FG001|Overall Study|Adverse Event|0|||
125368317|NCT04066023|450982466|FG002|Overall Study|Adverse Event|1|||
125368318|NCT04066023|450982464|FG000|Overall Study|Sponsor decision|3|||
125368319|NCT04066023|450982465|FG001|Overall Study|Sponsor decision|6|||
125368320|NCT04066023|450982466|FG002|Overall Study|Sponsor decision|2|||
125368321|NCT04066023|450982464|FG000|Overall Study|Physician Decision|0|||
125368322|NCT04066023|450982465|FG001|Overall Study|Physician Decision|0|||
125368323|NCT04066023|450982466|FG002|Overall Study|Physician Decision|1|||
125368324|NCT04066023|450982464|FG000|Overall Study|Lost to Follow-up|0|||
125368325|NCT04066023|450982465|FG001|Overall Study|Lost to Follow-up|1|||
125368326|NCT04066023|450982466|FG002|Overall Study|Lost to Follow-up|1|||
125368327|NCT04066023|450982464|FG000|Overall Study|Noncompliance|0|||
125368328|NCT04066023|450982465|FG001|Overall Study|Noncompliance|1|||
125368329|NCT04066023|450982466|FG002|Overall Study|Noncompliance|1|||
125368330|NCT00751933|450982467|FG000|Overall Study|Withdrawal by Subject|0|||
125368331|NCT00751933|450982468|FG001|Overall Study|Withdrawal by Subject|1|||
125368332|NCT00751933|450982469|FG002|Overall Study|Withdrawal by Subject|0|||
125368333|NCT00751933|450982470|FG003|Overall Study|Withdrawal by Subject|0|||
125368334|NCT00751933|450982467|FG000|Overall Study|Physician Decision|0|||
125368335|NCT00751933|450982468|FG001|Overall Study|Physician Decision|0|||
125368336|NCT00751933|450982469|FG002|Overall Study|Physician Decision|1|||
125368337|NCT00751933|450982470|FG003|Overall Study|Physician Decision|1|||
125368338|NCT02538029|450982471|FG000|Overall Study|unable to complete cognitive assessments|1|||
125368339|NCT02538029|450982472|FG001|Overall Study|unable to complete cognitive assessments|0|||
125368340|NCT02538029|450982473|FG002|Overall Study|unable to complete cognitive assessments|1|||
125368341|NCT05248867|450982475|FG000|Double-blind Period|Lost to Follow-up|0|||
125368342|NCT05248867|450982476|FG001|Double-blind Period|Lost to Follow-up|3|||
125368343|NCT05248867|450982477|FG002|Double-blind Period|Lost to Follow-up|0|||
125368344|NCT05248867|450982478|FG003|Double-blind Period|Lost to Follow-up|0|||
125368345|NCT05248867|450982479|FG004|Double-blind Period|Lost to Follow-up|0|||
125368346|NCT05248867|450982480|FG005|Double-blind Period|Lost to Follow-up|0|||
125430867|NCT05044325|451205527|FG003|Part A:Treatment Period 2|Physician Decision|0|||
125430868|NCT05044325|451205528|FG004|Part A:Treatment Period 2|Physician Decision|0|||
125430869|NCT05044325|451205529|FG005|Part A:Treatment Period 2|Physician Decision|1|||
125430870|NCT05044325|451205530|FG006|Part A:Treatment Period 2|Physician Decision|0|||
125430871|NCT05044325|451205531|FG007|Part A:Treatment Period 2|Physician Decision|0|||
125430872|NCT05044325|451205532|FG008|Part A:Treatment Period 2|Physician Decision|0|||
125430873|NCT05044325|451205533|FG009|Part A:Treatment Period 2|Physician Decision|0|||
125430874|NCT05044325|451205524|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125430875|NCT05044325|451205525|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125430876|NCT05044325|451205526|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125430877|NCT05044325|451205527|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
125430878|NCT05044325|451205528|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
125430879|NCT05044325|451205529|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125430880|NCT05044325|451205530|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125430881|NCT05044325|451205531|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125430882|NCT05044325|451205532|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125430883|NCT05044325|451205533|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
125430884|NCT00755222|451205534|FG000|Overall Study|Withdrawal by Subject|4|||
125430885|NCT00755222|451205535|FG001|Overall Study|Withdrawal by Subject|2|||
125430886|NCT00755222|451205534|FG000|Overall Study|Adverse Event|2|||
125430887|NCT00755222|451205535|FG001|Overall Study|Adverse Event|0|||
125430888|NCT00755222|451205534|FG000|Overall Study|Protocol Violation|2|||
125430889|NCT00755222|451205535|FG001|Overall Study|Protocol Violation|0|||
125430890|NCT02243202|451205541|FG000|Overall Study|Adverse Event|5|||
125430891|NCT02243202|451205542|FG001|Overall Study|Adverse Event|6|||
125430892|NCT02243202|451205543|FG002|Overall Study|Adverse Event|10|||
125430893|NCT02243202|451205544|FG003|Overall Study|Adverse Event|4|||
125430894|NCT02243202|451205541|FG000|Overall Study|Lost to Follow-up|9|||
125368347|NCT05248867|450982475|FG000|Double-blind Period|Withdrawal by Subject|5|||
125430895|NCT02243202|451205542|FG001|Overall Study|Lost to Follow-up|9|||
125430896|NCT02243202|451205543|FG002|Overall Study|Lost to Follow-up|14|||
125368348|NCT05248867|450982476|FG001|Double-blind Period|Withdrawal by Subject|14|||
125368349|NCT05248867|450982477|FG002|Double-blind Period|Withdrawal by Subject|0|||
125368350|NCT05248867|450982478|FG003|Double-blind Period|Withdrawal by Subject|0|||
125368351|NCT05248867|450982479|FG004|Double-blind Period|Withdrawal by Subject|0|||
125368352|NCT05248867|450982480|FG005|Double-blind Period|Withdrawal by Subject|0|||
125368353|NCT05248867|450982475|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
125368354|NCT05248867|450982476|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
125430897|NCT02243202|451205544|FG003|Overall Study|Lost to Follow-up|11|||
125430898|NCT02243202|451205541|FG000|Overall Study|Protocol Violation|3|||
125430899|NCT02243202|451205542|FG001|Overall Study|Protocol Violation|1|||
125430900|NCT02243202|451205543|FG002|Overall Study|Protocol Violation|2|||
125430901|NCT02243202|451205544|FG003|Overall Study|Protocol Violation|1|||
125430902|NCT02243202|451205541|FG000|Overall Study|Withdrawal by Subject|7|||
125430903|NCT02243202|451205542|FG001|Overall Study|Withdrawal by Subject|6|||
125430904|NCT02243202|451205543|FG002|Overall Study|Withdrawal by Subject|4|||
125430905|NCT02243202|451205544|FG003|Overall Study|Withdrawal by Subject|4|||
125430906|NCT02243202|451205541|FG000|Overall Study|Other|1|||
125430907|NCT02243202|451205542|FG001|Overall Study|Other|3|||
125430908|NCT02243202|451205543|FG002|Overall Study|Other|1|||
125430909|NCT02243202|451205544|FG003|Overall Study|Other|2|||
125597314|NCT01059812|451812258|FG000|Overall Study|Adverse Event|9|||
125597315|NCT01059812|451812259|FG001|Overall Study|Adverse Event|5|||
125597316|NCT01059812|451812258|FG000|Overall Study|Lack of Efficacy|2|||
125597317|NCT01059812|451812259|FG001|Overall Study|Lack of Efficacy|2|||
125597318|NCT01059812|451812258|FG000|Overall Study|Protocol Violation|3|||
125597319|NCT01059812|451812259|FG001|Overall Study|Protocol Violation|1|||
125597320|NCT01059812|451812258|FG000|Overall Study|Withdrawal Criteria|9|||
125597321|NCT01059812|451812259|FG001|Overall Study|Withdrawal Criteria|4|||
125597322|NCT01059812|451812258|FG000|Overall Study|Unclassified|14|||
125597323|NCT01059812|451812259|FG001|Overall Study|Unclassified|4|||
125597324|NCT01389128|451812260|FG000|Overall Study|Fetal distress|1|||
125597325|NCT01389128|451812261|FG001|Overall Study|Fetal distress|0|||
125597326|NCT01389128|451812260|FG000|Overall Study|Cervix dilation stop|1|||
125597327|NCT01389128|451812261|FG001|Overall Study|Cervix dilation stop|2|||
125597328|NCT01389128|451812260|FG000|Overall Study|Rapid labor evolution|3|||
125597329|NCT01389128|451812261|FG001|Overall Study|Rapid labor evolution|2|||
125597330|NCT01389128|451812260|FG000|Overall Study|Intolerance to procedure|0|||
125597331|NCT01389128|451812261|FG001|Overall Study|Intolerance to procedure|2|||
125597332|NCT03056287|451812266|FG000|Overall Study|Withdrawal by Subject|0|||
125597333|NCT03056287|451812267|FG001|Overall Study|Withdrawal by Subject|1|||
125597334|NCT03056287|451812268|FG002|Overall Study|Withdrawal by Subject|0|||
125597335|NCT03056287|451812269|FG003|Overall Study|Withdrawal by Subject|0|||
125597336|NCT03056287|451812266|FG000|Overall Study|move out of area|0|||
125597337|NCT03056287|451812267|FG001|Overall Study|move out of area|0|||
125597338|NCT03056287|451812268|FG002|Overall Study|move out of area|1|||
125597339|NCT03056287|451812269|FG003|Overall Study|move out of area|1|||
125597340|NCT00947154|451812273|FG000|Overall Study|Lost to Follow-up|1|||
125597341|NCT01588197|451812276|FG000|Overall Study|Lack of Efficacy|0|||
125597342|NCT01588197|451812277|FG001|Overall Study|Lack of Efficacy|1|||
125597343|NCT01588197|451812276|FG000|Overall Study|No MRI|1|||
125597344|NCT01588197|451812277|FG001|Overall Study|No MRI|0|||
125597345|NCT01844076|451812280|FG000|Overall Study|Adverse Event|1|||
125597346|NCT01844076|451812281|FG001|Overall Study|Adverse Event|0|||
125597347|NCT01844076|451812282|FG002|Overall Study|Adverse Event|0|||
125597348|NCT01844076|451812283|FG003|Overall Study|Adverse Event|0|||
125597349|NCT01844076|451812280|FG000|Overall Study|Withdrawal by Subject|1|||
125597350|NCT01844076|451812281|FG001|Overall Study|Withdrawal by Subject|0|||
125597351|NCT01844076|451812282|FG002|Overall Study|Withdrawal by Subject|0|||
125597352|NCT01844076|451812283|FG003|Overall Study|Withdrawal by Subject|0|||
125597353|NCT00440401|451812292|FG000|Overall Study|Adverse Event|2|||
125597354|NCT00440401|451812293|FG001|Overall Study|Adverse Event|1|||
125597355|NCT00440401|451812292|FG000|Overall Study|Other|2|||
125597356|NCT00440401|451812293|FG001|Overall Study|Other|5|||
125597357|NCT02286960|451812294|FG000|Overall Study|Lost to Follow-up|3|||
125597358|NCT02286960|451812295|FG001|Overall Study|Lost to Follow-up|3|||
125597359|NCT01937312|451812296|FG000|Overall Study|Adverse Event|10|||
125597360|NCT01937312|451812297|FG001|Overall Study|Adverse Event|1|||
125597361|NCT01937312|451812296|FG000|Overall Study|Lack of Efficacy|0|||
125597362|NCT01937312|451812297|FG001|Overall Study|Lack of Efficacy|1|||
125597363|NCT01937312|451812296|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
125597364|NCT01937312|451812297|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
125597365|NCT00474253|451812298|FG000|Overall Study|Withdrew consent|2|||
125430910|NCT02243202|451205541|FG000|Overall Study|Randomized but not received treatment|0|||
125430911|NCT02243202|451205542|FG001|Overall Study|Randomized but not received treatment|0|||
125430912|NCT02243202|451205543|FG002|Overall Study|Randomized but not received treatment|0|||
125430913|NCT02243202|451205544|FG003|Overall Study|Randomized but not received treatment|1|||
125597366|NCT00474253|451812299|FG001|Overall Study|Withdrew consent|0|||
125597367|NCT00474253|451812298|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
125597368|NCT00474253|451812299|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
125597369|NCT00474253|451812298|FG000|Overall Study|Lost to Follow-up|1|||
125597370|NCT00474253|451812299|FG001|Overall Study|Lost to Follow-up|0|||
125597371|NCT00474253|451812298|FG000|Overall Study|Discharged prior to study completion|0|||
125597372|NCT00474253|451812299|FG001|Overall Study|Discharged prior to study completion|1|||
125597373|NCT00593112|451812307|FG000|Overall Study|Scan Anxiety|3|||
125597374|NCT00593112|451812308|FG001|Overall Study|Scan Anxiety|0|||
125430914|NCT00991341|451205550|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
125430915|NCT00991341|451205551|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
125430916|NCT00991341|451205550|FG000|Overall Study|Death|3|||
125430917|NCT00991341|451205551|FG001|Overall Study|Death|0|||
125430918|NCT00991341|451205550|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
125430919|NCT00991341|451205551|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
125430920|NCT00991341|451205550|FG000|Overall Study|Physician Decision|1|||
125430921|NCT00991341|451205551|FG001|Overall Study|Physician Decision|2|||
125430922|NCT00991341|451205550|FG000|Overall Study|Withdrawal by Subject|3|||
125430923|NCT00991341|451205551|FG001|Overall Study|Withdrawal by Subject|4|||
125430924|NCT01330316|451205557|FG000|Overall Study|Adverse Event|2|||
125430925|NCT01330316|451205558|FG001|Overall Study|Adverse Event|2|||
125430926|NCT01330316|451205557|FG000|Overall Study|Lack of Efficacy|0|||
125430927|NCT01330316|451205558|FG001|Overall Study|Lack of Efficacy|10|||
125430928|NCT01330316|451205557|FG000|Overall Study|Lost to Follow-up|0|||
125430929|NCT01330316|451205558|FG001|Overall Study|Lost to Follow-up|1|||
125430930|NCT01330316|451205557|FG000|Overall Study|Withdrawal by Subject|0|||
125430931|NCT01330316|451205558|FG001|Overall Study|Withdrawal by Subject|1|||
125430932|NCT01330316|451205557|FG000|Overall Study|other than above|0|||
125430933|NCT01330316|451205558|FG001|Overall Study|other than above|1|||
125212779|NCT01026818|450405480|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
125212780|NCT01026818|450405481|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
125212781|NCT01026818|450405478|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
125212782|NCT01026818|450405479|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
125430934|NCT03010462|451205559|FG000|Overall Study|Withdrawal by Subject|3|||
125430935|NCT03010462|451205560|FG001|Overall Study|Withdrawal by Subject|1|||
125430936|NCT02207725|451205561|FG000|Overall Study|Did Not Receive Treatment|0|||
125430937|NCT02207725|451205562|FG001|Overall Study|Did Not Receive Treatment|1|||
125430938|NCT02207725|451205563|FG002|Overall Study|Did Not Receive Treatment|1|||
125430939|NCT02207725|451205564|FG003|Overall Study|Did Not Receive Treatment|1|||
125430940|NCT03145766|451205565|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
125430941|NCT03145766|451205566|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
125430942|NCT03145766|451205567|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
125430943|NCT03145766|451205568|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
125430944|NCT03145766|451205569|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
125430945|NCT03145766|451205565|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
125430946|NCT03145766|451205566|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
125430947|NCT03145766|451205567|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
125430948|NCT03145766|451205568|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
125597375|NCT00593112|451812307|FG000|Overall Study|Abnormal Scan|1|||
125597376|NCT00593112|451812308|FG001|Overall Study|Abnormal Scan|0|||
125597377|NCT00593112|451812307|FG000|Overall Study|Unreadable Scan|1|||
125597378|NCT00593112|451812308|FG001|Overall Study|Unreadable Scan|0|||
125597379|NCT00593112|451812307|FG000|Overall Study|Withdrawal by Subject|5|||
125597380|NCT00593112|451812308|FG001|Overall Study|Withdrawal by Subject|0|||
125597381|NCT00482001|451812309|FG000|Overall Study|Protocol Violation|1|||
125597382|NCT00482001|451812310|FG001|Overall Study|Protocol Violation|1|||
125597383|NCT00258154|451812311|FG000|Overall Study|Adverse Event|1|||
125597384|NCT00258154|451812312|FG001|Overall Study|Adverse Event|0|||
125597385|NCT00258154|451812311|FG000|Overall Study|Lost to Follow-up|0|||
125597386|NCT00258154|451812312|FG001|Overall Study|Lost to Follow-up|1|||
125597387|NCT00258154|451812311|FG000|Overall Study|Protocol Violation|2|||
125597388|NCT00258154|451812312|FG001|Overall Study|Protocol Violation|1|||
125597389|NCT00258154|451812311|FG000|Overall Study|Withdrawal by Subject|3|||
125597390|NCT00258154|451812312|FG001|Overall Study|Withdrawal by Subject|4|||
125597391|NCT00258154|451812311|FG000|Overall Study|Patient Moved|3|||
125597392|NCT00258154|451812312|FG001|Overall Study|Patient Moved|1|||
125597393|NCT00754390|451812317|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
125597394|NCT00754390|451812317|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
125597395|NCT00754390|451812317|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
125597396|NCT00754390|451812317|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
125597397|NCT00847613|451812318|FG000|Overall Study|Ongoing at cut-off date|250|||
125597398|NCT00847613|451812319|FG001|Overall Study|Ongoing at cut-off date|265|||
125597399|NCT00847613|451812320|FG002|Overall Study|Ongoing at cut-off date|64|||
125597400|NCT00847613|451812321|FG003|Overall Study|Ongoing at cut-off date|64|||
125597401|NCT00847613|451812318|FG000|Overall Study|Death|1|||
125597402|NCT00847613|451812319|FG001|Overall Study|Death|1|||
125597403|NCT00847613|451812320|FG002|Overall Study|Death|0|||
125597404|NCT00847613|451812321|FG003|Overall Study|Death|0|||
125597405|NCT00847613|451812318|FG000|Overall Study|Adverse Event|36|||
125597406|NCT00847613|451812319|FG001|Overall Study|Adverse Event|26|||
125597407|NCT00847613|451812320|FG002|Overall Study|Adverse Event|5|||
125597408|NCT00847613|451812321|FG003|Overall Study|Adverse Event|6|||
125597409|NCT00847613|451812318|FG000|Overall Study|Lack of Efficacy|7|||
125430949|NCT03145766|451205569|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
125430950|NCT03145766|451205565|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
125430951|NCT03145766|451205566|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
125430952|NCT03145766|451205567|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
125430953|NCT03145766|451205568|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
125430954|NCT03145766|451205569|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
125430955|NCT03145766|451205565|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
125430956|NCT03145766|451205566|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
125430957|NCT03145766|451205567|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
125430958|NCT03145766|451205568|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
125430959|NCT03145766|451205569|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
125430960|NCT03145766|451205565|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
125430961|NCT03145766|451205566|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
125430962|NCT03145766|451205567|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
125430963|NCT03145766|451205568|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
125430964|NCT03145766|451205569|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
125430965|NCT03145766|451205565|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
125430966|NCT03145766|451205566|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
125430967|NCT03145766|451205567|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
125430968|NCT03145766|451205568|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
125430969|NCT03145766|451205569|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
125430970|NCT03145766|451205565|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
125430971|NCT03145766|451205566|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
125430972|NCT03145766|451205567|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
125430973|NCT03145766|451205568|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
125430974|NCT03145766|451205569|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
125430975|NCT00246337|451205570|FG000|Overall Study|Lost to Follow-up|3|||
125430976|NCT00246337|451205571|FG001|Overall Study|Lost to Follow-up|0|||
125430977|NCT00246337|451205572|FG002|Overall Study|Lost to Follow-up|0|||
125430978|NCT00246337|451205573|FG003|Overall Study|Lost to Follow-up|0|||
125430979|NCT00246337|451205574|FG004|Overall Study|Lost to Follow-up|2|||
125430980|NCT00246337|451205575|FG005|Overall Study|Lost to Follow-up|2|||
125430981|NCT00246337|451205576|FG006|Overall Study|Lost to Follow-up|1|||
125430982|NCT00246337|451205577|FG007|Overall Study|Lost to Follow-up|2|||
125430983|NCT00246337|451205578|FG008|Overall Study|Lost to Follow-up|0|||
125430984|NCT00246337|451205570|FG000|Overall Study|Protocol Violation|1|||
125430985|NCT00246337|451205571|FG001|Overall Study|Protocol Violation|0|||
125430986|NCT00246337|451205572|FG002|Overall Study|Protocol Violation|0|||
125430987|NCT00246337|451205573|FG003|Overall Study|Protocol Violation|0|||
125430988|NCT00246337|451205574|FG004|Overall Study|Protocol Violation|1|||
125430989|NCT00246337|451205575|FG005|Overall Study|Protocol Violation|0|||
125430990|NCT00246337|451205576|FG006|Overall Study|Protocol Violation|1|||
125430991|NCT00246337|451205577|FG007|Overall Study|Protocol Violation|1|||
125430992|NCT00246337|451205578|FG008|Overall Study|Protocol Violation|0|||
125430993|NCT00246337|451205570|FG000|Overall Study|Withdrawal by Subject|2|||
125430994|NCT00246337|451205571|FG001|Overall Study|Withdrawal by Subject|0|||
125430995|NCT00246337|451205572|FG002|Overall Study|Withdrawal by Subject|0|||
125430996|NCT00246337|451205573|FG003|Overall Study|Withdrawal by Subject|0|||
125430997|NCT00246337|451205574|FG004|Overall Study|Withdrawal by Subject|0|||
125430998|NCT00246337|451205575|FG005|Overall Study|Withdrawal by Subject|0|||
125430999|NCT00246337|451205576|FG006|Overall Study|Withdrawal by Subject|1|||
125431000|NCT00246337|451205577|FG007|Overall Study|Withdrawal by Subject|1|||
125597410|NCT00847613|451812319|FG001|Overall Study|Lack of Efficacy|3|||
125597411|NCT00847613|451812320|FG002|Overall Study|Lack of Efficacy|3|||
125597412|NCT00847613|451812321|FG003|Overall Study|Lack of Efficacy|1|||
125597413|NCT00847613|451812318|FG000|Overall Study|Study terminated by Sponsor|1|||
125597414|NCT00847613|451812319|FG001|Overall Study|Study terminated by Sponsor|0|||
125597415|NCT00847613|451812320|FG002|Overall Study|Study terminated by Sponsor|2|||
125597416|NCT00847613|451812321|FG003|Overall Study|Study terminated by Sponsor|1|||
125597417|NCT00847613|451812318|FG000|Overall Study|Lost to Follow-up|5|||
125597418|NCT00847613|451812319|FG001|Overall Study|Lost to Follow-up|0|||
125597419|NCT00847613|451812320|FG002|Overall Study|Lost to Follow-up|0|||
125597420|NCT00847613|451812321|FG003|Overall Study|Lost to Follow-up|3|||
125597421|NCT00847613|451812318|FG000|Overall Study|Protocol Violation|6|||
125597422|NCT00847613|451812319|FG001|Overall Study|Protocol Violation|6|||
125431001|NCT00246337|451205578|FG008|Overall Study|Withdrawal by Subject|0|||
125431002|NCT00246337|451205570|FG000|Overall Study|Lack of Qualifying Event|8|||
125597423|NCT00847613|451812320|FG002|Overall Study|Protocol Violation|3|||
125597424|NCT00847613|451812321|FG003|Overall Study|Protocol Violation|1|||
125597425|NCT00847613|451812318|FG000|Overall Study|Pregnancy|1|||
125597426|NCT00847613|451812319|FG001|Overall Study|Pregnancy|1|||
125597427|NCT00847613|451812320|FG002|Overall Study|Pregnancy|0|||
125597428|NCT00847613|451812321|FG003|Overall Study|Pregnancy|0|||
125597429|NCT00847613|451812318|FG000|Overall Study|Site closure|1|||
125597430|NCT00847613|451812319|FG001|Overall Study|Site closure|0|||
125597431|NCT00847613|451812320|FG002|Overall Study|Site closure|0|||
125597432|NCT00847613|451812321|FG003|Overall Study|Site closure|1|||
125597433|NCT00847613|451812318|FG000|Overall Study|Withdrawal by Subject|8|||
125597434|NCT00847613|451812319|FG001|Overall Study|Withdrawal by Subject|11|||
125597435|NCT00847613|451812320|FG002|Overall Study|Withdrawal by Subject|2|||
125597436|NCT00847613|451812321|FG003|Overall Study|Withdrawal by Subject|2|||
125597437|NCT00847613|451812318|FG000|Overall Study|Participant moved|4|||
125597438|NCT00847613|451812319|FG001|Overall Study|Participant moved|1|||
125597439|NCT00847613|451812320|FG002|Overall Study|Participant moved|0|||
125597440|NCT00847613|451812321|FG003|Overall Study|Participant moved|0|||
125597441|NCT00847613|451812318|FG000|Overall Study|Sponsor request|0|||
125597442|NCT00847613|451812319|FG001|Overall Study|Sponsor request|1|||
125597443|NCT00847613|451812320|FG002|Overall Study|Sponsor request|0|||
125597444|NCT00847613|451812321|FG003|Overall Study|Sponsor request|0|||
125597445|NCT00847613|451812318|FG000|Overall Study|Randomized, but not treated|0|||
125597446|NCT00847613|451812319|FG001|Overall Study|Randomized, but not treated|3|||
125597447|NCT00847613|451812320|FG002|Overall Study|Randomized, but not treated|0|||
125597448|NCT00847613|451812321|FG003|Overall Study|Randomized, but not treated|0|||
125597449|NCT00847613|451812318|FG000|Overall Study|Other|1|||
125597450|NCT00847613|451812319|FG001|Overall Study|Other|1|||
125597451|NCT00847613|451812320|FG002|Overall Study|Other|2|||
125597452|NCT00847613|451812321|FG003|Overall Study|Other|0|||
125597453|NCT01009294|451812322|FG000|Overall Study|Study discontinued by Sponsor|6|||
125597454|NCT01856673|451812323|FG000|Overall Study|Withdrawal by Subject|44|||
125597455|NCT01856673|451812324|FG001|Overall Study|Withdrawal by Subject|50|||
125597456|NCT01856673|451812325|FG002|Overall Study|Withdrawal by Subject|33|||
125597457|NCT01856673|451812323|FG000|Overall Study|Lost to Follow-up|31|||
125597458|NCT01856673|451812324|FG001|Overall Study|Lost to Follow-up|34|||
125597459|NCT01856673|451812325|FG002|Overall Study|Lost to Follow-up|0|||
125597460|NCT01856673|451812323|FG000|Overall Study|Unknown reasons|9|||
125597461|NCT01856673|451812324|FG001|Overall Study|Unknown reasons|0|||
125597462|NCT01856673|451812325|FG002|Overall Study|Unknown reasons|0|||
125597463|NCT01856673|451812323|FG000|Overall Study|Psychologist decision|1|||
125597464|NCT01856673|451812324|FG001|Overall Study|Psychologist decision|0|||
125597465|NCT01856673|451812325|FG002|Overall Study|Psychologist decision|0|||
125597466|NCT01856673|451812323|FG000|Overall Study|Paperwork errors|8|||
125597467|NCT01856673|451812324|FG001|Overall Study|Paperwork errors|0|||
125597468|NCT01856673|451812325|FG002|Overall Study|Paperwork errors|0|||
125597469|NCT01856673|451812323|FG000|Overall Study|Death|1|||
125431003|NCT00246337|451205571|FG001|Overall Study|Lack of Qualifying Event|2|||
125431004|NCT00246337|451205572|FG002|Overall Study|Lack of Qualifying Event|1|||
125431005|NCT00246337|451205573|FG003|Overall Study|Lack of Qualifying Event|1|||
125431006|NCT00246337|451205574|FG004|Overall Study|Lack of Qualifying Event|1|||
125431007|NCT00246337|451205575|FG005|Overall Study|Lack of Qualifying Event|3|||
125431008|NCT00246337|451205576|FG006|Overall Study|Lack of Qualifying Event|3|||
125431009|NCT00246337|451205577|FG007|Overall Study|Lack of Qualifying Event|2|||
125431010|NCT00246337|451205578|FG008|Overall Study|Lack of Qualifying Event|5|||
125431011|NCT00246337|451205570|FG000|Overall Study|Site Terminated|10|||
125431012|NCT00246337|451205571|FG001|Overall Study|Site Terminated|0|||
125431013|NCT00246337|451205572|FG002|Overall Study|Site Terminated|0|||
125431014|NCT00246337|451205573|FG003|Overall Study|Site Terminated|0|||
125431015|NCT00246337|451205574|FG004|Overall Study|Site Terminated|0|||
125431016|NCT00246337|451205575|FG005|Overall Study|Site Terminated|7|||
125431017|NCT00246337|451205576|FG006|Overall Study|Site Terminated|1|||
125431018|NCT00246337|451205577|FG007|Overall Study|Site Terminated|6|||
125431019|NCT00246337|451205578|FG008|Overall Study|Site Terminated|2|||
125431020|NCT00246337|451205570|FG000|Overall Study|Abnormal baseline lab values|7|||
125597470|NCT01856673|451812324|FG001|Overall Study|Death|1|||
125597471|NCT01856673|451812325|FG002|Overall Study|Death|0|||
125597472|NCT01856673|451812323|FG000|Overall Study|Protocol Violation|1|||
125597473|NCT01856673|451812324|FG001|Overall Study|Protocol Violation|0|||
125597474|NCT01856673|451812325|FG002|Overall Study|Protocol Violation|1|||
125597475|NCT04332419|451812326|FG000|Overall Study|Withdrawal by Subject|1|||
125597476|NCT02436239|451812327|FG000|Open-Lable Treatment Period|Adverse Event|12|||
125597477|NCT02436239|451812328|FG001|Open-Lable Treatment Period|Adverse Event|3|||
125597478|NCT02436239|451812329|FG002|Open-Lable Treatment Period|Adverse Event|4|||
125597479|NCT02436239|451812330|FG003|Open-Lable Treatment Period|Adverse Event|2|||
125597480|NCT02436239|451812327|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
125597481|NCT02436239|451812328|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
125597482|NCT02436239|451812329|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
125597483|NCT02436239|451812330|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
125431021|NCT00246337|451205571|FG001|Overall Study|Abnormal baseline lab values|0|||
125431022|NCT00246337|451205572|FG002|Overall Study|Abnormal baseline lab values|2|||
125431023|NCT00246337|451205573|FG003|Overall Study|Abnormal baseline lab values|0|||
125597484|NCT02436239|451812327|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
125597485|NCT02436239|451812328|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
125597486|NCT02436239|451812329|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
125597487|NCT02436239|451812330|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
125597488|NCT02436239|451812327|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
125597489|NCT02436239|451812328|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
125597490|NCT02436239|451812329|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
125597491|NCT02436239|451812330|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
125597492|NCT02436239|451812327|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
125431024|NCT00246337|451205574|FG004|Overall Study|Abnormal baseline lab values|0|||
125431025|NCT00246337|451205575|FG005|Overall Study|Abnormal baseline lab values|2|||
125431026|NCT00246337|451205576|FG006|Overall Study|Abnormal baseline lab values|2|||
125431027|NCT00246337|451205577|FG007|Overall Study|Abnormal baseline lab values|0|||
125431028|NCT00246337|451205578|FG008|Overall Study|Abnormal baseline lab values|4|||
125431029|NCT00246337|451205570|FG000|Overall Study|Overwhelmed|0|||
125431030|NCT00246337|451205571|FG001|Overall Study|Overwhelmed|0|||
125431031|NCT00246337|451205572|FG002|Overall Study|Overwhelmed|0|||
125431032|NCT00246337|451205573|FG003|Overall Study|Overwhelmed|0|||
125431033|NCT00246337|451205574|FG004|Overall Study|Overwhelmed|0|||
125431034|NCT00246337|451205575|FG005|Overall Study|Overwhelmed|1|||
125431035|NCT00246337|451205576|FG006|Overall Study|Overwhelmed|0|||
125431036|NCT00246337|451205577|FG007|Overall Study|Overwhelmed|0|||
125431037|NCT00246337|451205578|FG008|Overall Study|Overwhelmed|0|||
125431038|NCT00246337|451205570|FG000|Overall Study|Protocol Violator|1|||
125431039|NCT00246337|451205571|FG001|Overall Study|Protocol Violator|0|||
125431040|NCT00246337|451205572|FG002|Overall Study|Protocol Violator|0|||
125597493|NCT02436239|451812328|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
125597494|NCT02436239|451812329|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
125597495|NCT02436239|451812330|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
125597496|NCT02436239|451812327|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
125597497|NCT02436239|451812328|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
125597498|NCT02436239|451812329|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
125597499|NCT02436239|451812330|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
125597500|NCT02436239|451812327|FG000|Open-Lable Treatment Period|Other Reason|1|||
125597501|NCT02436239|451812328|FG001|Open-Lable Treatment Period|Other Reason|1|||
125597502|NCT02436239|451812329|FG002|Open-Lable Treatment Period|Other Reason|0|||
125597503|NCT02436239|451812330|FG003|Open-Lable Treatment Period|Other Reason|0|||
125597504|NCT02436239|451812327|FG000|Down-Taper Period|Withdrawal by Subject|4|||
125597505|NCT02436239|451812328|FG001|Down-Taper Period|Withdrawal by Subject|4|||
125597506|NCT02436239|451812329|FG002|Down-Taper Period|Withdrawal by Subject|1|||
125597507|NCT02436239|451812330|FG003|Down-Taper Period|Withdrawal by Subject|2|||
125431041|NCT00246337|451205573|FG003|Overall Study|Protocol Violator|0|||
125431042|NCT00246337|451205574|FG004|Overall Study|Protocol Violator|0|||
125431043|NCT00246337|451205575|FG005|Overall Study|Protocol Violator|0|||
125431044|NCT00246337|451205576|FG006|Overall Study|Protocol Violator|0|||
125431045|NCT00246337|451205577|FG007|Overall Study|Protocol Violator|0|||
125431046|NCT00246337|451205578|FG008|Overall Study|Protocol Violator|0|||
125431047|NCT00246337|451205570|FG000|Overall Study|Reported as completing trial in error|0|||
125431048|NCT00246337|451205571|FG001|Overall Study|Reported as completing trial in error|0|||
125431049|NCT00246337|451205572|FG002|Overall Study|Reported as completing trial in error|0|||
125431050|NCT00246337|451205573|FG003|Overall Study|Reported as completing trial in error|0|||
125431051|NCT00246337|451205574|FG004|Overall Study|Reported as completing trial in error|0|||
125431052|NCT00246337|451205575|FG005|Overall Study|Reported as completing trial in error|0|||
125431053|NCT00246337|451205576|FG006|Overall Study|Reported as completing trial in error|0|||
125431054|NCT00246337|451205577|FG007|Overall Study|Reported as completing trial in error|1|||
125431055|NCT00246337|451205578|FG008|Overall Study|Reported as completing trial in error|0|||
125431056|NCT01966003|451205582|FG000|Overall Study|Death|43|||
125431057|NCT01966003|451205583|FG001|Overall Study|Death|36|||
125431058|NCT01966003|451205582|FG000|Overall Study|Protocol Violation|6|||
125431059|NCT01966003|451205583|FG001|Overall Study|Protocol Violation|4|||
125431060|NCT01966003|451205582|FG000|Overall Study|Lost to Follow-up|4|||
125431061|NCT01966003|451205583|FG001|Overall Study|Lost to Follow-up|3|||
125431062|NCT01966003|451205582|FG000|Overall Study|Physician Decision|12|||
125431063|NCT01966003|451205583|FG001|Overall Study|Physician Decision|13|||
125431064|NCT01966003|451205582|FG000|Overall Study|Withdrawal by Subject|29|||
125431065|NCT01966003|451205583|FG001|Overall Study|Withdrawal by Subject|19|||
125431066|NCT01966003|451205582|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
125431067|NCT01966003|451205583|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
125597508|NCT00658333|451812331|FG000|Overall Study|Adverse Event|2|||
125597509|NCT00658333|451812332|FG001|Overall Study|Adverse Event|1|||
125597510|NCT00519532|451812337|FG000|Overall Study|Adverse Event|11|||
125431068|NCT01966003|451205582|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
125431069|NCT01966003|451205583|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
125597511|NCT00519532|451812337|FG000|Overall Study|Withdrawal by Subject|5|||
125597512|NCT00519532|451812337|FG000|Overall Study|Lost to Follow-up|2|||
125597513|NCT03138564|451812338|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
125597514|NCT03138564|451812339|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
125597515|NCT03138564|451812338|FG000|Overall Study|Lost to Follow-up|16|||
125597516|NCT03138564|451812339|FG001|Overall Study|Lost to Follow-up|2|||
125597517|NCT03138564|451812338|FG000|Overall Study|Withdrawal by Subject|48|||
125597518|NCT03138564|451812339|FG001|Overall Study|Withdrawal by Subject|4|||
125597519|NCT03138564|451812338|FG000|Overall Study|No longer met eligibility criteria|2|||
125597520|NCT03138564|451812339|FG001|Overall Study|No longer met eligibility criteria|0|||
125597521|NCT03138564|451812338|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
125597522|NCT03138564|451812339|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
125597523|NCT03138564|451812338|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
125597524|NCT03138564|451812339|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
125597525|NCT03138564|451812338|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
125597526|NCT03138564|451812339|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
125597527|NCT03138564|451812338|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
125597528|NCT03138564|451812339|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
125597529|NCT03443024|451812343|FG000|Overall Study|Adverse Event|2|||
125368355|NCT05248867|450982477|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
125368356|NCT05248867|450982478|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
125368357|NCT05248867|450982479|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
125368358|NCT05248867|450982480|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
125368359|NCT05248867|450982475|FG000|Double-blind Period|Other, not specified|3|||
125368360|NCT05248867|450982476|FG001|Double-blind Period|Other, not specified|8|||
125368361|NCT05248867|450982477|FG002|Double-blind Period|Other, not specified|0|||
125368362|NCT05248867|450982478|FG003|Double-blind Period|Other, not specified|0|||
125368363|NCT05248867|450982479|FG004|Double-blind Period|Other, not specified|0|||
125368364|NCT05248867|450982480|FG005|Double-blind Period|Other, not specified|0|||
125368365|NCT05248867|450982475|FG000|Open-label Period|Withdrawal by Subject|0|||
125368366|NCT05248867|450982476|FG001|Open-label Period|Withdrawal by Subject|0|||
125368367|NCT05248867|450982477|FG002|Open-label Period|Withdrawal by Subject|3|||
125368368|NCT05248867|450982478|FG003|Open-label Period|Withdrawal by Subject|1|||
125368369|NCT05248867|450982479|FG004|Open-label Period|Withdrawal by Subject|7|||
125368370|NCT05248867|450982480|FG005|Open-label Period|Withdrawal by Subject|9|||
125368371|NCT05248867|450982475|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
125368372|NCT05248867|450982476|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
125368373|NCT05248867|450982477|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
125368374|NCT05248867|450982478|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
125368375|NCT05248867|450982479|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
125368376|NCT05248867|450982480|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
125368377|NCT05248867|450982475|FG000|Open-label Period|Lost to Follow-up|0|||
125368378|NCT05248867|450982476|FG001|Open-label Period|Lost to Follow-up|0|||
125597530|NCT03443024|451812344|FG001|Overall Study|Adverse Event|4|||
125597531|NCT03443024|451812345|FG002|Overall Study|Adverse Event|3|||
125597532|NCT03443024|451812346|FG003|Overall Study|Adverse Event|1|||
125368379|NCT05248867|450982477|FG002|Open-label Period|Lost to Follow-up|0|||
125368380|NCT05248867|450982478|FG003|Open-label Period|Lost to Follow-up|0|||
125368381|NCT05248867|450982479|FG004|Open-label Period|Lost to Follow-up|5|||
125431070|NCT01966003|451205582|FG000|Overall Study|Other|1|||
125431071|NCT01966003|451205583|FG001|Overall Study|Other|1|||
125431072|NCT03633929|451205585|FG000|Overall Study|Lost to Follow-up|1|||
125431073|NCT03633929|451205585|FG000|Overall Study|Did not login to software. Did not participate|3|||
125431074|NCT02287584|451205589|FG000|the Double-blind Phase|Adverse Event|17|||
125431075|NCT02287584|451205590|FG001|the Double-blind Phase|Adverse Event|17|||
125597533|NCT03443024|451812343|FG000|Overall Study|Lost to Follow-up|9|||
125597534|NCT03443024|451812344|FG001|Overall Study|Lost to Follow-up|9|||
125597535|NCT03443024|451812345|FG002|Overall Study|Lost to Follow-up|7|||
125597536|NCT03443024|451812346|FG003|Overall Study|Lost to Follow-up|5|||
125597537|NCT03443024|451812343|FG000|Overall Study|Withdrawal by Subject|8|||
125597538|NCT03443024|451812344|FG001|Overall Study|Withdrawal by Subject|15|||
125597539|NCT03443024|451812345|FG002|Overall Study|Withdrawal by Subject|9|||
125597540|NCT03443024|451812346|FG003|Overall Study|Withdrawal by Subject|23|||
125597541|NCT03443024|451812343|FG000|Overall Study|Physician Decision|1|||
125597542|NCT03443024|451812344|FG001|Overall Study|Physician Decision|2|||
125597543|NCT03443024|451812345|FG002|Overall Study|Physician Decision|0|||
125597544|NCT03443024|451812346|FG003|Overall Study|Physician Decision|1|||
125597545|NCT03443024|451812343|FG000|Overall Study|Sponsor Decision|1|||
125597546|NCT03443024|451812344|FG001|Overall Study|Sponsor Decision|1|||
125597547|NCT03443024|451812345|FG002|Overall Study|Sponsor Decision|0|||
125597548|NCT03443024|451812346|FG003|Overall Study|Sponsor Decision|0|||
125597549|NCT03443024|451812343|FG000|Overall Study|Protocol Deviation|0|||
125597550|NCT03443024|451812344|FG001|Overall Study|Protocol Deviation|0|||
125597551|NCT03443024|451812345|FG002|Overall Study|Protocol Deviation|0|||
125597552|NCT03443024|451812346|FG003|Overall Study|Protocol Deviation|2|||
125597553|NCT00624338|451812347|FG000|Overall Study|Adverse Event|14|||
125597554|NCT00624338|451812348|FG001|Overall Study|Adverse Event|14|||
125597555|NCT00624338|451812349|FG002|Overall Study|Adverse Event|18|||
125597556|NCT00624338|451812347|FG000|Overall Study|Lost to Follow-up|1|||
125597557|NCT00624338|451812348|FG001|Overall Study|Lost to Follow-up|0|||
125597558|NCT00624338|451812349|FG002|Overall Study|Lost to Follow-up|0|||
125597559|NCT00624338|451812347|FG000|Overall Study|Lack of Efficacy|11|||
125597560|NCT00624338|451812348|FG001|Overall Study|Lack of Efficacy|3|||
125597561|NCT00624338|451812349|FG002|Overall Study|Lack of Efficacy|14|||
125597562|NCT00624338|451812347|FG000|Overall Study|Protocol Violation|3|||
125597563|NCT00624338|451812348|FG001|Overall Study|Protocol Violation|3|||
125597564|NCT00624338|451812349|FG002|Overall Study|Protocol Violation|2|||
125597565|NCT00624338|451812347|FG000|Overall Study|Death|0|||
125597566|NCT00624338|451812348|FG001|Overall Study|Death|2|||
125597567|NCT00624338|451812349|FG002|Overall Study|Death|0|||
125597568|NCT00624338|451812347|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
125597569|NCT00624338|451812348|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
125597570|NCT00624338|451812349|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
125597571|NCT00624338|451812347|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
125597572|NCT00624338|451812348|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
125597573|NCT00624338|451812349|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
125597574|NCT00624338|451812347|FG000|Overall Study|Other|15|||
125597575|NCT00624338|451812348|FG001|Overall Study|Other|5|||
125597576|NCT00624338|451812349|FG002|Overall Study|Other|9|||
125597577|NCT00624338|451812347|FG000|Overall Study|Randomized but not treated|2|||
125597578|NCT00624338|451812348|FG001|Overall Study|Randomized but not treated|1|||
125597579|NCT00624338|451812349|FG002|Overall Study|Randomized but not treated|3|||
125597580|NCT01548638|451812350|FG000|Overall Study|Protocol Violation|3|||
125597581|NCT01548638|451812350|FG000|Overall Study|Withdrawal by Subject|1|||
125597582|NCT05593432|451812351|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
125597583|NCT05593432|451812352|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
125597584|NCT05593432|451812353|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
125597585|NCT05593432|451812354|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
125597586|NCT05593432|451812351|FG000|16-Week OLE Period|Lack of Efficacy|0|||
125597587|NCT05593432|451812352|FG001|16-Week OLE Period|Lack of Efficacy|0|||
125597588|NCT05593432|451812353|FG002|16-Week OLE Period|Lack of Efficacy|0|||
125597589|NCT05593432|451812354|FG003|16-Week OLE Period|Lack of Efficacy|1|||
125597590|NCT05593432|451812351|FG000|16-Week OLE Period|Lost to Follow-up|0|||
125431076|NCT02287584|451205591|FG002|the Double-blind Phase|Adverse Event|12|||
125431077|NCT02287584|451205592|FG003|the Double-blind Phase|Adverse Event|0|||
125431078|NCT02287584|451205593|FG004|the Double-blind Phase|Adverse Event|0|||
125597591|NCT05593432|451812352|FG001|16-Week OLE Period|Lost to Follow-up|0|||
125597592|NCT05593432|451812353|FG002|16-Week OLE Period|Lost to Follow-up|1|||
125431079|NCT02287584|451205594|FG005|the Double-blind Phase|Adverse Event|0|||
125597593|NCT05593432|451812354|FG003|16-Week OLE Period|Lost to Follow-up|2|||
125597594|NCT05593432|451812351|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
125597595|NCT05593432|451812352|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
125597596|NCT05593432|451812353|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
125597597|NCT05593432|451812354|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
125597598|NCT04800315|451812359|FG000|Randomization|Did not receive study treatment|1|||
125597599|NCT04800315|451812360|FG001|Randomization|Did not receive study treatment|0|||
125597600|NCT04800315|451812361|FG002|Randomization|Did not receive study treatment|0|||
125597601|NCT04800315|451812362|FG003|Randomization|Did not receive study treatment|0|||
125597602|NCT04800315|451812359|FG000|Treatment Period|Adverse Event|4|||
125597603|NCT04800315|451812360|FG001|Treatment Period|Adverse Event|2|||
125597604|NCT04800315|451812361|FG002|Treatment Period|Adverse Event|1|||
125597605|NCT04800315|451812362|FG003|Treatment Period|Adverse Event|2|||
125597606|NCT04800315|451812359|FG000|Treatment Period|Lack of Efficacy|1|||
125368382|NCT05248867|450982480|FG005|Open-label Period|Lost to Follow-up|2|||
125368383|NCT05248867|450982475|FG000|Open-label Period|COVID-19 Infection|0|||
125368384|NCT05248867|450982476|FG001|Open-label Period|COVID-19 Infection|0|||
125368385|NCT05248867|450982477|FG002|Open-label Period|COVID-19 Infection|0|||
125368386|NCT05248867|450982478|FG003|Open-label Period|COVID-19 Infection|0|||
125368387|NCT05248867|450982479|FG004|Open-label Period|COVID-19 Infection|1|||
125368388|NCT05248867|450982480|FG005|Open-label Period|COVID-19 Infection|0|||
125368389|NCT05248867|450982475|FG000|Open-label Period|Other, not specified|0|||
125368390|NCT05248867|450982476|FG001|Open-label Period|Other, not specified|0|||
125368391|NCT05248867|450982477|FG002|Open-label Period|Other, not specified|0|||
125368392|NCT05248867|450982478|FG003|Open-label Period|Other, not specified|0|||
125368393|NCT05248867|450982479|FG004|Open-label Period|Other, not specified|4|||
125368394|NCT05248867|450982480|FG005|Open-label Period|Other, not specified|0|||
125368395|NCT01084083|450982483|FG000|Overall Study|Adverse Event|5|||
125368396|NCT01084083|450982483|FG000|Overall Study|Death|1|||
125368397|NCT01084083|450982483|FG000|Overall Study|Withdrawal by Subject|2|||
125368398|NCT01084083|450982483|FG000|Overall Study|Complicating disease|1|||
125368399|NCT01084083|450982483|FG000|Overall Study|Other|2|||
125368400|NCT01084083|450982483|FG000|Overall Study|Never started assigned therapy|1|||
125368401|NCT01273597|450982484|FG000|Overall Study|Adverse Event|5|||
125368402|NCT01273597|450982484|FG000|Overall Study|Underwent Kidney Transplantation|2|||
125368403|NCT01273597|450982484|FG000|Overall Study|Reason Not Reported|1|||
125368404|NCT01088997|450982485|FG000|Overall Study|Physician Decision|1|||
125368405|NCT01088997|450982486|FG001|Overall Study|Physician Decision|1|||
125368406|NCT01088997|450982485|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
125368407|NCT01088997|450982486|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
125368408|NCT01088997|450982485|FG000|Overall Study|Excluded prior to receiving drug|1|||
125368409|NCT01088997|450982486|FG001|Overall Study|Excluded prior to receiving drug|1|||
125368410|NCT05695209|450982489|FG000|3-months|Withdrawal by Subject|2|||
125368411|NCT05695209|450982490|FG001|3-months|Withdrawal by Subject|0|||
125368412|NCT05695209|450982489|FG000|3-months|Unable to contact for 3-month data collection|0|||
125368413|NCT05695209|450982490|FG001|3-months|Unable to contact for 3-month data collection|1|||
125368414|NCT05695209|450982489|FG000|6-months|Lost to Follow-up|1|||
125368415|NCT05695209|450982490|FG001|6-months|Lost to Follow-up|1|||
125368416|NCT04731363|450982494|FG000|Overall Study|Could not obtain samples|0|||
125368417|NCT04731363|450982495|FG001|Overall Study|Could not obtain samples|1|||
125368418|NCT04731363|450982496|FG002|Overall Study|Could not obtain samples|0|||
125368419|NCT04731363|450982497|FG003|Overall Study|Could not obtain samples|0|||
125368420|NCT04731363|450982494|FG000|Overall Study|Physician Decision|0|||
125368421|NCT04731363|450982495|FG001|Overall Study|Physician Decision|1|||
125368422|NCT04731363|450982496|FG002|Overall Study|Physician Decision|0|||
125368423|NCT04731363|450982497|FG003|Overall Study|Physician Decision|0|||
125368424|NCT02513394|450982498|FG000|Overall Study|Withdrawal by Subject|11|||
125368425|NCT02513394|450982499|FG001|Overall Study|Withdrawal by Subject|23|||
125368426|NCT02513394|450982498|FG000|Overall Study|Ineligible|1|||
125368427|NCT02513394|450982499|FG001|Overall Study|Ineligible|0|||
125368428|NCT04292743|450982500|FG000|Overall Study|Physician Decision|1|||
125368429|NCT04292743|450982501|FG001|Overall Study|Physician Decision|3|||
125368430|NCT04292743|450982502|FG002|Overall Study|Physician Decision|0|||
125368431|NCT04292743|450982503|FG003|Overall Study|Physician Decision|0|||
125368432|NCT04292743|450982500|FG000|Overall Study|Withdrawal by Subject|0|||
125368433|NCT04292743|450982501|FG001|Overall Study|Withdrawal by Subject|5|||
125368434|NCT04292743|450982502|FG002|Overall Study|Withdrawal by Subject|0|||
125368435|NCT04292743|450982503|FG003|Overall Study|Withdrawal by Subject|0|||
125368436|NCT04292743|450982500|FG000|Overall Study|Death|0|||
125368437|NCT04292743|450982501|FG001|Overall Study|Death|1|||
125368438|NCT04292743|450982502|FG002|Overall Study|Death|0|||
125368439|NCT04292743|450982503|FG003|Overall Study|Death|0|||
125368440|NCT04292743|450982500|FG000|Overall Study|Progression of Disease|2|||
125368441|NCT04292743|450982501|FG001|Overall Study|Progression of Disease|5|||
125368442|NCT04292743|450982502|FG002|Overall Study|Progression of Disease|0|||
125368443|NCT04292743|450982503|FG003|Overall Study|Progression of Disease|0|||
125368444|NCT04292743|450982500|FG000|Overall Study|No Treatment per protocol|0|||
125368445|NCT04292743|450982501|FG001|Overall Study|No Treatment per protocol|2|||
125368446|NCT04292743|450982502|FG002|Overall Study|No Treatment per protocol|0|||
125368447|NCT04292743|450982503|FG003|Overall Study|No Treatment per protocol|0|||
125368448|NCT05766423|450982504|FG000|Overall Study|Withdrawal by Subject|1|||
125368449|NCT05766423|450982505|FG001|Overall Study|Withdrawal by Subject|0|||
125597607|NCT04800315|451812360|FG001|Treatment Period|Lack of Efficacy|0|||
125368450|NCT05766423|450982504|FG000|Overall Study|Consented, not scheduled|3|||
125597608|NCT04800315|451812361|FG002|Treatment Period|Lack of Efficacy|0|||
125431080|NCT02287584|451205589|FG000|the Double-blind Phase|Lack of Efficacy|18|||
125431081|NCT02287584|451205590|FG001|the Double-blind Phase|Lack of Efficacy|8|||
125431082|NCT02287584|451205591|FG002|the Double-blind Phase|Lack of Efficacy|8|||
125431083|NCT02287584|451205592|FG003|the Double-blind Phase|Lack of Efficacy|0|||
125431084|NCT02287584|451205593|FG004|the Double-blind Phase|Lack of Efficacy|0|||
125431085|NCT02287584|451205594|FG005|the Double-blind Phase|Lack of Efficacy|0|||
125431086|NCT02287584|451205589|FG000|the Double-blind Phase|Lost to Follow-up|0|||
125431087|NCT02287584|451205590|FG001|the Double-blind Phase|Lost to Follow-up|1|||
125431088|NCT02287584|451205591|FG002|the Double-blind Phase|Lost to Follow-up|1|||
125431089|NCT02287584|451205592|FG003|the Double-blind Phase|Lost to Follow-up|0|||
125431090|NCT02287584|451205593|FG004|the Double-blind Phase|Lost to Follow-up|0|||
125431091|NCT02287584|451205594|FG005|the Double-blind Phase|Lost to Follow-up|0|||
125431092|NCT02287584|451205589|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
125431093|NCT02287584|451205590|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
125431094|NCT02287584|451205591|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
125431095|NCT02287584|451205592|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
125431096|NCT02287584|451205593|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
125431097|NCT02287584|451205594|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
125431098|NCT02287584|451205589|FG000|the Double-blind Phase|Pregnancy|0|||
125431099|NCT02287584|451205590|FG001|the Double-blind Phase|Pregnancy|1|||
125431100|NCT02287584|451205591|FG002|the Double-blind Phase|Pregnancy|0|||
125431101|NCT02287584|451205592|FG003|the Double-blind Phase|Pregnancy|0|||
125431102|NCT02287584|451205593|FG004|the Double-blind Phase|Pregnancy|0|||
125431103|NCT02287584|451205594|FG005|the Double-blind Phase|Pregnancy|0|||
125431104|NCT02287584|451205589|FG000|the Double-blind Phase|Protocol Violation|0|||
125431105|NCT02287584|451205590|FG001|the Double-blind Phase|Protocol Violation|3|||
125431106|NCT02287584|451205591|FG002|the Double-blind Phase|Protocol Violation|0|||
125431107|NCT02287584|451205592|FG003|the Double-blind Phase|Protocol Violation|0|||
125431108|NCT02287584|451205593|FG004|the Double-blind Phase|Protocol Violation|0|||
125431109|NCT02287584|451205594|FG005|the Double-blind Phase|Protocol Violation|0|||
125431110|NCT02287584|451205589|FG000|the Double-blind Phase|other reasons|0|||
125431111|NCT02287584|451205590|FG001|the Double-blind Phase|other reasons|0|||
125431112|NCT02287584|451205591|FG002|the Double-blind Phase|other reasons|1|||
125431113|NCT02287584|451205592|FG003|the Double-blind Phase|other reasons|0|||
125431114|NCT02287584|451205593|FG004|the Double-blind Phase|other reasons|0|||
125431115|NCT02287584|451205594|FG005|the Double-blind Phase|other reasons|0|||
125431116|NCT02287584|451205589|FG000|the Open-label Phase|Did not receive drug|0|||
125431117|NCT02287584|451205590|FG001|the Open-label Phase|Did not receive drug|0|||
125431118|NCT02287584|451205591|FG002|the Open-label Phase|Did not receive drug|0|||
125431119|NCT02287584|451205592|FG003|the Open-label Phase|Did not receive drug|7|||
125431120|NCT02287584|451205593|FG004|the Open-label Phase|Did not receive drug|6|||
125431121|NCT02287584|451205594|FG005|the Open-label Phase|Did not receive drug|4|||
125431122|NCT02287584|451205589|FG000|the Open-label Phase|Adverse Event|0|||
125431123|NCT02287584|451205590|FG001|the Open-label Phase|Adverse Event|0|||
125431124|NCT02287584|451205591|FG002|the Open-label Phase|Adverse Event|0|||
125431125|NCT02287584|451205592|FG003|the Open-label Phase|Adverse Event|15|||
125431126|NCT02287584|451205593|FG004|the Open-label Phase|Adverse Event|12|||
125431127|NCT02287584|451205594|FG005|the Open-label Phase|Adverse Event|16|||
125431128|NCT02287584|451205589|FG000|the Open-label Phase|Lack of Efficacy|0|||
125431129|NCT02287584|451205590|FG001|the Open-label Phase|Lack of Efficacy|0|||
125431130|NCT02287584|451205591|FG002|the Open-label Phase|Lack of Efficacy|0|||
125431131|NCT02287584|451205592|FG003|the Open-label Phase|Lack of Efficacy|8|||
125431132|NCT02287584|451205593|FG004|the Open-label Phase|Lack of Efficacy|3|||
125431133|NCT02287584|451205594|FG005|the Open-label Phase|Lack of Efficacy|7|||
125431134|NCT02287584|451205589|FG000|the Open-label Phase|Lost to Follow-up|0|||
125431135|NCT02287584|451205590|FG001|the Open-label Phase|Lost to Follow-up|0|||
125431136|NCT02287584|451205591|FG002|the Open-label Phase|Lost to Follow-up|0|||
125431137|NCT02287584|451205592|FG003|the Open-label Phase|Lost to Follow-up|4|||
125431138|NCT02287584|451205593|FG004|the Open-label Phase|Lost to Follow-up|1|||
125431139|NCT02287584|451205594|FG005|the Open-label Phase|Lost to Follow-up|2|||
125431140|NCT02287584|451205589|FG000|the Open-label Phase|Withdrawal by Subject|0|||
125597609|NCT04800315|451812362|FG003|Treatment Period|Lack of Efficacy|3|||
125597610|NCT04800315|451812359|FG000|Treatment Period|Lost to Follow-up|0|||
125597611|NCT04800315|451812360|FG001|Treatment Period|Lost to Follow-up|1|||
125368451|NCT05766423|450982505|FG001|Overall Study|Consented, not scheduled|5|||
125368452|NCT00688753|450984691|FG000|Overall Study|Disease progression|55|||
125597612|NCT04800315|451812361|FG002|Treatment Period|Lost to Follow-up|2|||
125597613|NCT04800315|451812362|FG003|Treatment Period|Lost to Follow-up|2|||
125597614|NCT04800315|451812359|FG000|Treatment Period|Withdrawal by participant|0|||
125597615|NCT04800315|451812360|FG001|Treatment Period|Withdrawal by participant|0|||
125597616|NCT04800315|451812361|FG002|Treatment Period|Withdrawal by participant|0|||
125597617|NCT04800315|451812362|FG003|Treatment Period|Withdrawal by participant|4|||
125597618|NCT04800315|451812359|FG000|Treatment Period|Other Reasons|0|||
125597619|NCT04800315|451812360|FG001|Treatment Period|Other Reasons|2|||
125597620|NCT04800315|451812361|FG002|Treatment Period|Other Reasons|0|||
125597621|NCT04800315|451812362|FG003|Treatment Period|Other Reasons|1|||
125597622|NCT00753922|451812363|FG000|Overall Study|Lost to Follow-up|155|||
125597623|NCT00753922|451812364|FG001|Overall Study|Lost to Follow-up|24|||
125597624|NCT00753922|451812365|FG002|Overall Study|Lost to Follow-up|28|||
125597625|NCT00753922|451812366|FG003|Overall Study|Lost to Follow-up|5|||
125597626|NCT00753922|451812363|FG000|Overall Study|Withdrawal by Subject|9|||
125597627|NCT00753922|451812364|FG001|Overall Study|Withdrawal by Subject|11|||
125597628|NCT00753922|451812365|FG002|Overall Study|Withdrawal by Subject|4|||
125597629|NCT00753922|451812366|FG003|Overall Study|Withdrawal by Subject|2|||
125597630|NCT00753922|451812363|FG000|Overall Study|Patient Non-compliance|55|||
125597631|NCT00753922|451812364|FG001|Overall Study|Patient Non-compliance|22|||
125597632|NCT00753922|451812365|FG002|Overall Study|Patient Non-compliance|14|||
125597633|NCT00753922|451812366|FG003|Overall Study|Patient Non-compliance|11|||
125597634|NCT00753922|451812363|FG000|Overall Study|Patients Not Completing Visit|11|||
125597635|NCT00753922|451812364|FG001|Overall Study|Patients Not Completing Visit|0|||
125597636|NCT00753922|451812365|FG002|Overall Study|Patients Not Completing Visit|1|||
125597637|NCT00753922|451812366|FG003|Overall Study|Patients Not Completing Visit|0|||
125597638|NCT00753922|451812363|FG000|Overall Study|Death|2|||
125597639|NCT00753922|451812364|FG001|Overall Study|Death|23|||
125597640|NCT00753922|451812365|FG002|Overall Study|Death|2|||
125597641|NCT00753922|451812366|FG003|Overall Study|Death|1|||
125597642|NCT00753922|451812363|FG000|Overall Study|Discontinuation Due to Explantation|14|||
125597643|NCT00753922|451812364|FG001|Overall Study|Discontinuation Due to Explantation|14|||
125597644|NCT00753922|451812365|FG002|Overall Study|Discontinuation Due to Explantation|14|||
125597645|NCT00753922|451812366|FG003|Overall Study|Discontinuation Due to Explantation|4|||
125597646|NCT03598777|451812367|FG000|Overall Study|Study Terminated by Sponsor|3|||
125597647|NCT03598777|451812368|FG001|Overall Study|Study Terminated by Sponsor|0|||
125597648|NCT03598777|451812369|FG002|Overall Study|Study Terminated by Sponsor|0|||
125597649|NCT03598777|451812370|FG003|Overall Study|Study Terminated by Sponsor|0|||
125597650|NCT03598777|451812371|FG004|Overall Study|Study Terminated by Sponsor|15|||
125597651|NCT03598777|451812367|FG000|Overall Study|Withdrawal by Subject|1|||
125597652|NCT03598777|451812368|FG001|Overall Study|Withdrawal by Subject|1|||
125597653|NCT03598777|451812369|FG002|Overall Study|Withdrawal by Subject|0|||
125368453|NCT00688753|450984691|FG000|Overall Study|Missing|1|||
125368454|NCT00688753|450984691|FG000|Overall Study|Death|9|||
125368455|NCT00688753|450984691|FG000|Overall Study|Withdrawal by Subject|3|||
125368456|NCT00688753|450984691|FG000|Overall Study|Adverse Event|20|||
125368457|NCT00688753|450984691|FG000|Overall Study|Protocol Violation|1|||
125368458|NCT00688753|450984691|FG000|Overall Study|Lost to Follow-up|3|||
125368459|NCT03749447|450984692|FG000|Overall Study|Adverse Event|11|||
125368460|NCT03749447|450984693|FG001|Overall Study|Adverse Event|3|||
125368461|NCT03749447|450984692|FG000|Overall Study|Death|1|||
125368462|NCT03749447|450984693|FG001|Overall Study|Death|1|||
125368463|NCT03749447|450984692|FG000|Overall Study|Lost to Follow-up|2|||
125368464|NCT03749447|450984693|FG001|Overall Study|Lost to Follow-up|2|||
125368465|NCT03749447|450984692|FG000|Overall Study|Reason Not Specified|0|||
125368466|NCT03749447|450984693|FG001|Overall Study|Reason Not Specified|3|||
125368467|NCT03749447|450984692|FG000|Overall Study|Physician Decision|4|||
125597654|NCT03598777|451812370|FG003|Overall Study|Withdrawal by Subject|0|||
125597655|NCT03598777|451812371|FG004|Overall Study|Withdrawal by Subject|0|||
125597656|NCT03598777|451812367|FG000|Overall Study|Adverse Event|1|||
125368468|NCT03749447|450984693|FG001|Overall Study|Physician Decision|3|||
125368469|NCT03749447|450984692|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
125368470|NCT03749447|450984693|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
125597657|NCT03598777|451812368|FG001|Overall Study|Adverse Event|0|||
125597658|NCT03598777|451812369|FG002|Overall Study|Adverse Event|0|||
125597659|NCT03598777|451812370|FG003|Overall Study|Adverse Event|0|||
125597660|NCT03598777|451812371|FG004|Overall Study|Adverse Event|0|||
125597661|NCT03598777|451812367|FG000|Overall Study|Lost to Follow-up|1|||
125368471|NCT03749447|450984692|FG000|Overall Study|Study Terminated By Sponsor|112|||
125368472|NCT03749447|450984693|FG001|Overall Study|Study Terminated By Sponsor|105|||
125431141|NCT02287584|451205590|FG001|the Open-label Phase|Withdrawal by Subject|0|||
125431142|NCT02287584|451205591|FG002|the Open-label Phase|Withdrawal by Subject|0|||
125431143|NCT02287584|451205592|FG003|the Open-label Phase|Withdrawal by Subject|18|||
125431144|NCT02287584|451205593|FG004|the Open-label Phase|Withdrawal by Subject|29|||
125431145|NCT02287584|451205594|FG005|the Open-label Phase|Withdrawal by Subject|21|||
125431146|NCT02287584|451205589|FG000|the Open-label Phase|non-compliance|0|||
125431147|NCT02287584|451205590|FG001|the Open-label Phase|non-compliance|0|||
125431148|NCT02287584|451205591|FG002|the Open-label Phase|non-compliance|0|||
125431149|NCT02287584|451205592|FG003|the Open-label Phase|non-compliance|2|||
125431150|NCT02287584|451205593|FG004|the Open-label Phase|non-compliance|5|||
125431151|NCT02287584|451205594|FG005|the Open-label Phase|non-compliance|1|||
125431152|NCT02287584|451205589|FG000|the Open-label Phase|other reasons|0|||
125431153|NCT02287584|451205590|FG001|the Open-label Phase|other reasons|0|||
125431154|NCT02287584|451205591|FG002|the Open-label Phase|other reasons|0|||
125431155|NCT02287584|451205592|FG003|the Open-label Phase|other reasons|3|||
125431156|NCT02287584|451205593|FG004|the Open-label Phase|other reasons|6|||
125431157|NCT02287584|451205594|FG005|the Open-label Phase|other reasons|6|||
125431158|NCT01492686|451205598|FG000|Double-blind Phase|Adverse Event|0|||
125431159|NCT01492686|451205599|FG001|Double-blind Phase|Adverse Event|2|||
125431160|NCT01492686|451205598|FG000|Double-blind Phase|Physician Decision|0|||
125431161|NCT01492686|451205599|FG001|Double-blind Phase|Physician Decision|1|||
125431162|NCT01492686|451205598|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125431163|NCT01492686|451205599|FG001|Double-blind Phase|Withdrawal by Subject|2|||
125431164|NCT01492686|451205598|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
125431165|NCT01492686|451205599|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
125431166|NCT01492686|451205598|FG000|Open-label Phase|Adverse Event|1|||
125431167|NCT01492686|451205599|FG001|Open-label Phase|Adverse Event|2|||
125431168|NCT01492686|451205598|FG000|Open-label Phase|Physician Decision|1|||
125431169|NCT01492686|451205599|FG001|Open-label Phase|Physician Decision|0|||
125431170|NCT01492686|451205598|FG000|Open-label Phase|Withdrawal by Subject|6|||
125431171|NCT01492686|451205599|FG001|Open-label Phase|Withdrawal by Subject|7|||
125431172|NCT01492686|451205598|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
125431173|NCT01492686|451205599|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
125431174|NCT02798211|451205609|FG000|Period 1|Adverse Event|1|||
125431175|NCT02798211|451205610|FG001|Period 1|Adverse Event|1|||
125431176|NCT02798211|451205611|FG002|Period 1|Adverse Event|0|||
125431177|NCT02798211|451205612|FG003|Period 1|Adverse Event|0|||
125431178|NCT02798211|451205613|FG004|Period 1|Adverse Event|0|||
125431179|NCT02798211|451205614|FG005|Period 1|Adverse Event|0|||
125431180|NCT02798211|451205609|FG000|Period 1|Lost to Follow-up|2|||
125431181|NCT02798211|451205610|FG001|Period 1|Lost to Follow-up|1|||
125431182|NCT02798211|451205611|FG002|Period 1|Lost to Follow-up|0|||
125431183|NCT02798211|451205612|FG003|Period 1|Lost to Follow-up|0|||
125431184|NCT02798211|451205613|FG004|Period 1|Lost to Follow-up|0|||
125431185|NCT02798211|451205614|FG005|Period 1|Lost to Follow-up|0|||
125431186|NCT02798211|451205609|FG000|Period 1|Protocol Violation|0|||
125431187|NCT02798211|451205610|FG001|Period 1|Protocol Violation|0|||
125431188|NCT02798211|451205611|FG002|Period 1|Protocol Violation|2|||
125431189|NCT02798211|451205612|FG003|Period 1|Protocol Violation|0|||
125431190|NCT02798211|451205613|FG004|Period 1|Protocol Violation|0|||
125431191|NCT02798211|451205614|FG005|Period 1|Protocol Violation|0|||
125431192|NCT02798211|451205609|FG000|Period 1|Withdrawal by Subject|1|||
125597662|NCT03598777|451812368|FG001|Overall Study|Lost to Follow-up|0|||
125597663|NCT03598777|451812369|FG002|Overall Study|Lost to Follow-up|0|||
125597664|NCT03598777|451812370|FG003|Overall Study|Lost to Follow-up|0|||
125597665|NCT03598777|451812371|FG004|Overall Study|Lost to Follow-up|0|||
125597666|NCT00072189|451812372|FG000|Overall Study|Withdrawal by Subject|1|||
125597667|NCT01919411|451812373|FG000|Overall Study|Lost to Follow-up|2|||
125597668|NCT01919411|451812374|FG001|Overall Study|Lost to Follow-up|4|||
125597669|NCT01919411|451812373|FG000|Overall Study|Physician Decision|1|||
125597670|NCT01919411|451812374|FG001|Overall Study|Physician Decision|0|||
125597671|NCT01919411|451812373|FG000|Overall Study|Protocol Violation|2|||
125597672|NCT01919411|451812374|FG001|Overall Study|Protocol Violation|1|||
125597673|NCT01933672|451812375|FG000|Metformin Run-in Period|Adverse Event|1|||
125597674|NCT01933672|451812376|FG001|Metformin Run-in Period|Adverse Event|0|||
125597675|NCT01933672|451812377|FG002|Metformin Run-in Period|Adverse Event|0|||
125597676|NCT01933672|451812378|FG003|Metformin Run-in Period|Adverse Event|0|||
125597677|NCT01933672|451812379|FG004|Metformin Run-in Period|Adverse Event|0|||
125597678|NCT01933672|451812380|FG005|Metformin Run-in Period|Adverse Event|0|||
125597679|NCT01933672|451812381|FG006|Metformin Run-in Period|Adverse Event|0|||
125597680|NCT01933672|451812375|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
125597681|NCT01933672|451812376|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
125597682|NCT01933672|451812377|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
125597683|NCT01933672|451812378|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
125597684|NCT01933672|451812379|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
125597685|NCT01933672|451812380|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
125597686|NCT01933672|451812381|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
125597687|NCT01933672|451812375|FG000|Metformin Run-in Period|Other|5|||
125597688|NCT01933672|451812376|FG001|Metformin Run-in Period|Other|0|||
125597689|NCT01933672|451812377|FG002|Metformin Run-in Period|Other|0|||
125597690|NCT01933672|451812378|FG003|Metformin Run-in Period|Other|0|||
125597691|NCT01933672|451812379|FG004|Metformin Run-in Period|Other|0|||
125212783|NCT01026818|450405480|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
125212784|NCT01026818|450405481|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
125368473|NCT03749447|450984692|FG000|Overall Study|Withdrawal by Subject|12|||
125368474|NCT03749447|450984693|FG001|Overall Study|Withdrawal by Subject|6|||
125368475|NCT03749447|450984692|FG000|Overall Study|Non-compliance With Study Drug|0|||
125368476|NCT03749447|450984693|FG001|Overall Study|Non-compliance With Study Drug|1|||
125368477|NCT05996718|450984694|FG000|Overall Study|Lost to Follow-up|3|||
125368478|NCT01218113|450984695|FG000|Overall Study|Withdrawal by Subject|1|||
125368479|NCT01218113|450984696|FG001|Overall Study|Withdrawal by Subject|0|||
125368480|NCT01218113|450984697|FG002|Overall Study|Withdrawal by Subject|1|||
125368481|NCT01218113|450984695|FG000|Overall Study|Lost to Follow-up|4|||
125368482|NCT01218113|450984696|FG001|Overall Study|Lost to Follow-up|1|||
125368483|NCT01218113|450984697|FG002|Overall Study|Lost to Follow-up|4|||
125368484|NCT01218113|450984695|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
125368485|NCT01218113|450984696|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
125368486|NCT01218113|450984697|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
125368487|NCT01713686|450984698|FG000|Overall Study|Lost to Follow-up|9|||
125368488|NCT01713686|450984698|FG000|Overall Study|Withdrawal by Subject|6|||
125368489|NCT04840615|450984699|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
125368490|NCT04840615|450984700|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
125368491|NCT04840615|450984701|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
125368492|NCT00967668|450984702|FG000|Overall Study|Withdrawal by Subject|13|||
125368493|NCT00967668|450984703|FG001|Overall Study|Withdrawal by Subject|8|||
125368494|NCT00967668|450984704|FG002|Overall Study|Withdrawal by Subject|8|||
125368495|NCT00967668|450984702|FG000|Overall Study|Death|0|||
125368496|NCT00967668|450984703|FG001|Overall Study|Death|2|||
125368497|NCT00967668|450984704|FG002|Overall Study|Death|4|||
125368498|NCT00967668|450984702|FG000|Overall Study|Removed due to behavior|1|||
125368499|NCT00967668|450984703|FG001|Overall Study|Removed due to behavior|1|||
125368500|NCT00967668|450984704|FG002|Overall Study|Removed due to behavior|2|||
125368501|NCT00967668|450984702|FG000|Overall Study|Refused Year 2|11|||
125368502|NCT00967668|450984703|FG001|Overall Study|Refused Year 2|6|||
125368503|NCT00967668|450984704|FG002|Overall Study|Refused Year 2|4|||
125368504|NCT00967668|450984702|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
125368505|NCT00967668|450984703|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
125368506|NCT00967668|450984704|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
125368507|NCT00967668|450984702|FG000|Overall Study|Lost to Follow-up|15|||
125368508|NCT00967668|450984703|FG001|Overall Study|Lost to Follow-up|9|||
125368509|NCT00967668|450984704|FG002|Overall Study|Lost to Follow-up|16|||
125368510|NCT00967668|450984702|FG000|Overall Study|Refused 12-mo assessment|3|||
125368511|NCT00967668|450984703|FG001|Overall Study|Refused 12-mo assessment|1|||
125368512|NCT00967668|450984704|FG002|Overall Study|Refused 12-mo assessment|9|||
125368513|NCT00967668|450984702|FG000|Overall Study|Pregnancy|1|||
125368514|NCT00967668|450984703|FG001|Overall Study|Pregnancy|0|||
125368515|NCT00967668|450984704|FG002|Overall Study|Pregnancy|0|||
125368516|NCT00115739|450984705|FG000|Overall Study|Lost to Follow-up|3|||
125368517|NCT02200211|450984708|FG000|Overall Study|Lost to Follow-up|7|||
125368518|NCT02200211|450984709|FG001|Overall Study|Lost to Follow-up|7|||
125368519|NCT02200211|450984710|FG002|Overall Study|Lost to Follow-up|1|||
125368520|NCT02200211|450984711|FG003|Overall Study|Lost to Follow-up|2|||
125368521|NCT02200211|450984708|FG000|Overall Study|Withdrawal by Subject|1|||
125368522|NCT02200211|450984709|FG001|Overall Study|Withdrawal by Subject|0|||
125368523|NCT02200211|450984710|FG002|Overall Study|Withdrawal by Subject|0|||
125368524|NCT02200211|450984711|FG003|Overall Study|Withdrawal by Subject|0|||
125368525|NCT01918774|450984712|FG000|Overall Study|Lost prior to first CBTw session|4|||
125368526|NCT01918774|450984712|FG000|Overall Study|Lost to Follow-up|1|||
125368527|NCT01606800|450984713|FG000|Overall Study|Adverse Event|3|||
125368528|NCT01606800|450984714|FG001|Overall Study|Adverse Event|1|||
125368529|NCT01606800|450984713|FG000|Overall Study|Participant withdrew consent|0|||
125368530|NCT01606800|450984714|FG001|Overall Study|Participant withdrew consent|1|||
125368531|NCT01606800|450984713|FG000|Overall Study|Missing completion status|2|||
125368532|NCT01606800|450984714|FG001|Overall Study|Missing completion status|0|||
125368533|NCT00042289|450984715|FG000|Overall Study|Lost to Follow-up|3|||
125368534|NCT00042289|450984716|FG001|Overall Study|Lost to Follow-up|0|||
125368535|NCT00042289|450984717|FG002|Overall Study|Lost to Follow-up|0|||
125368536|NCT00042289|450984718|FG003|Overall Study|Lost to Follow-up|1|||
125368537|NCT00042289|450984719|FG004|Overall Study|Lost to Follow-up|3|||
125368538|NCT00042289|450984720|FG005|Overall Study|Lost to Follow-up|3|||
125368539|NCT00042289|450984721|FG006|Overall Study|Lost to Follow-up|6|||
125597692|NCT01933672|451812380|FG005|Metformin Run-in Period|Other|0|||
125431193|NCT02798211|451205610|FG001|Period 1|Withdrawal by Subject|1|||
125431194|NCT02798211|451205611|FG002|Period 1|Withdrawal by Subject|0|||
125431195|NCT02798211|451205612|FG003|Period 1|Withdrawal by Subject|0|||
125431196|NCT02798211|451205613|FG004|Period 1|Withdrawal by Subject|0|||
125431197|NCT02798211|451205614|FG005|Period 1|Withdrawal by Subject|0|||
125431198|NCT02798211|451205609|FG000|Period 1|Death|0|||
125431199|NCT02798211|451205610|FG001|Period 1|Death|0|||
125431200|NCT02798211|451205611|FG002|Period 1|Death|1|||
125431201|NCT02798211|451205612|FG003|Period 1|Death|0|||
125431202|NCT02798211|451205613|FG004|Period 1|Death|0|||
125431203|NCT02798211|451205614|FG005|Period 1|Death|0|||
125431204|NCT02798211|451205609|FG000|Period 1|Withdrawal of Informed Consent|2|||
125431205|NCT02798211|451205610|FG001|Period 1|Withdrawal of Informed Consent|7|||
125431206|NCT02798211|451205611|FG002|Period 1|Withdrawal of Informed Consent|3|||
125431207|NCT02798211|451205612|FG003|Period 1|Withdrawal of Informed Consent|0|||
125431208|NCT02798211|451205613|FG004|Period 1|Withdrawal of Informed Consent|0|||
125431209|NCT02798211|451205614|FG005|Period 1|Withdrawal of Informed Consent|0|||
125431210|NCT02798211|451205609|FG000|Period 2|Withdrawal by Subject|2|||
125431211|NCT02798211|451205610|FG001|Period 2|Withdrawal by Subject|0|||
125431212|NCT02798211|451205611|FG002|Period 2|Withdrawal by Subject|0|||
125431213|NCT02798211|451205612|FG003|Period 2|Withdrawal by Subject|0|||
125431214|NCT02798211|451205613|FG004|Period 2|Withdrawal by Subject|2|||
125431215|NCT02798211|451205614|FG005|Period 2|Withdrawal by Subject|2|||
125431216|NCT02798211|451205609|FG000|Period 2|Adverse Event|5|||
125431217|NCT02798211|451205610|FG001|Period 2|Adverse Event|0|||
125431218|NCT02798211|451205611|FG002|Period 2|Adverse Event|0|||
125431219|NCT02798211|451205612|FG003|Period 2|Adverse Event|0|||
125431220|NCT02798211|451205613|FG004|Period 2|Adverse Event|1|||
125431221|NCT02798211|451205614|FG005|Period 2|Adverse Event|0|||
125431222|NCT02798211|451205609|FG000|Period 2|Lack of Efficacy|1|||
125431223|NCT02798211|451205610|FG001|Period 2|Lack of Efficacy|0|||
125431224|NCT02798211|451205611|FG002|Period 2|Lack of Efficacy|0|||
125431225|NCT02798211|451205612|FG003|Period 2|Lack of Efficacy|1|||
125431226|NCT02798211|451205613|FG004|Period 2|Lack of Efficacy|0|||
125431227|NCT02798211|451205614|FG005|Period 2|Lack of Efficacy|1|||
125431228|NCT02798211|451205609|FG000|Period 2|Lost to Follow-up|3|||
125431229|NCT02798211|451205610|FG001|Period 2|Lost to Follow-up|0|||
125431230|NCT02798211|451205611|FG002|Period 2|Lost to Follow-up|0|||
125431231|NCT02798211|451205612|FG003|Period 2|Lost to Follow-up|0|||
125431232|NCT02798211|451205613|FG004|Period 2|Lost to Follow-up|2|||
125431233|NCT02798211|451205614|FG005|Period 2|Lost to Follow-up|0|||
125431234|NCT02798211|451205609|FG000|Period 2|Physician Decision|1|||
125431235|NCT02798211|451205610|FG001|Period 2|Physician Decision|0|||
125431236|NCT02798211|451205611|FG002|Period 2|Physician Decision|0|||
125431237|NCT02798211|451205612|FG003|Period 2|Physician Decision|1|||
125431238|NCT02798211|451205613|FG004|Period 2|Physician Decision|1|||
125431239|NCT02798211|451205614|FG005|Period 2|Physician Decision|0|||
125431240|NCT02798211|451205609|FG000|Period 2|Pregnancy|0|||
125431241|NCT02798211|451205610|FG001|Period 2|Pregnancy|0|||
125431242|NCT02798211|451205611|FG002|Period 2|Pregnancy|0|||
125431243|NCT02798211|451205612|FG003|Period 2|Pregnancy|2|||
125431244|NCT02798211|451205613|FG004|Period 2|Pregnancy|0|||
125431245|NCT02798211|451205614|FG005|Period 2|Pregnancy|0|||
125431246|NCT02798211|451205609|FG000|Period 2|Technical problems|1|||
125431247|NCT02798211|451205610|FG001|Period 2|Technical problems|0|||
125431248|NCT02798211|451205611|FG002|Period 2|Technical problems|0|||
125431249|NCT02798211|451205612|FG003|Period 2|Technical problems|1|||
125597693|NCT01933672|451812381|FG006|Metformin Run-in Period|Other|0|||
125597694|NCT01933672|451812375|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125597695|NCT01933672|451812376|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125597696|NCT01933672|451812377|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125597697|NCT01933672|451812378|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125597698|NCT01933672|451812379|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
125597699|NCT01933672|451812380|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125597700|NCT01933672|451812381|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125431250|NCT02798211|451205613|FG004|Period 2|Technical problems|0|||
125431251|NCT02798211|451205614|FG005|Period 2|Technical problems|0|||
125431252|NCT02798211|451205609|FG000|Period 2|Withdrawal of Informed Consent|1|||
125431253|NCT02798211|451205610|FG001|Period 2|Withdrawal of Informed Consent|0|||
125431254|NCT02798211|451205611|FG002|Period 2|Withdrawal of Informed Consent|0|||
125431255|NCT02798211|451205612|FG003|Period 2|Withdrawal of Informed Consent|2|||
125431256|NCT02798211|451205613|FG004|Period 2|Withdrawal of Informed Consent|2|||
125431257|NCT02798211|451205614|FG005|Period 2|Withdrawal of Informed Consent|3|||
125431258|NCT01982435|451205615|FG000|Overall Study|Adverse Event|1|||
125431259|NCT01982435|451205616|FG001|Overall Study|Adverse Event|0|||
125431260|NCT05292534|451205617|FG000|Overall Study|Protocol Violation|3|||
125431261|NCT05292534|451205618|FG001|Overall Study|Protocol Violation|4|||
125431262|NCT05292534|451205617|FG000|Overall Study|Withdrawal by Subject|0|||
125431263|NCT05292534|451205618|FG001|Overall Study|Withdrawal by Subject|1|||
125431264|NCT04887948|451205619|FG000|Overall Study|Death|1|||
125431265|NCT04887948|451205620|FG001|Overall Study|Death|0|||
125368540|NCT00042289|450984722|FG007|Overall Study|Lost to Follow-up|1|||
125368541|NCT00042289|450984723|FG008|Overall Study|Lost to Follow-up|1|||
125597701|NCT01933672|451812375|FG000|First Intervention Period (12-16 Days)|Other|0|||
125597702|NCT01933672|451812376|FG001|First Intervention Period (12-16 Days)|Other|0|||
125597703|NCT01933672|451812377|FG002|First Intervention Period (12-16 Days)|Other|1|||
125597704|NCT01933672|451812378|FG003|First Intervention Period (12-16 Days)|Other|0|||
125597705|NCT01933672|451812379|FG004|First Intervention Period (12-16 Days)|Other|0|||
125597706|NCT01933672|451812380|FG005|First Intervention Period (12-16 Days)|Other|1|||
125368542|NCT00042289|450984724|FG009|Overall Study|Lost to Follow-up|0|||
125368543|NCT00042289|450984725|FG010|Overall Study|Lost to Follow-up|0|||
125368544|NCT00042289|450984726|FG011|Overall Study|Lost to Follow-up|0|||
125368545|NCT00042289|450984727|FG012|Overall Study|Lost to Follow-up|0|||
125368546|NCT00042289|450984728|FG013|Overall Study|Lost to Follow-up|0|||
125368547|NCT00042289|450984729|FG014|Overall Study|Lost to Follow-up|0|||
125368548|NCT00042289|450984730|FG015|Overall Study|Lost to Follow-up|1|||
125368549|NCT00042289|450984731|FG016|Overall Study|Lost to Follow-up|1|||
125368550|NCT00042289|450984732|FG017|Overall Study|Lost to Follow-up|0|||
125368551|NCT00042289|450984733|FG018|Overall Study|Lost to Follow-up|3|||
125368552|NCT00042289|450984734|FG019|Overall Study|Lost to Follow-up|2|||
125597707|NCT01933672|451812381|FG006|First Intervention Period (12-16 Days)|Other|0|||
125597708|NCT01933672|451812375|FG000|Second Intervention Period (12-16 Days)|Other|0|||
125597709|NCT01933672|451812376|FG001|Second Intervention Period (12-16 Days)|Other|1|||
125597710|NCT01933672|451812377|FG002|Second Intervention Period (12-16 Days)|Other|1|||
125597711|NCT01933672|451812378|FG003|Second Intervention Period (12-16 Days)|Other|0|||
125368553|NCT00042289|450984735|FG020|Overall Study|Lost to Follow-up|0|||
125368554|NCT00042289|450984736|FG021|Overall Study|Lost to Follow-up|0|||
125368555|NCT00042289|450984737|FG022|Overall Study|Lost to Follow-up|0|||
125368556|NCT00042289|450984738|FG023|Overall Study|Lost to Follow-up|0|||
125368557|NCT00042289|450984739|FG024|Overall Study|Lost to Follow-up|0|||
125368558|NCT00042289|450984740|FG025|Overall Study|Lost to Follow-up|0|||
125368559|NCT00042289|450984741|FG026|Overall Study|Lost to Follow-up|2|||
125368560|NCT00042289|450984742|FG027|Overall Study|Lost to Follow-up|2|||
125368561|NCT00042289|450984743|FG028|Overall Study|Lost to Follow-up|2|||
125368562|NCT00042289|450984744|FG029|Overall Study|Lost to Follow-up|0|||
125368563|NCT00042289|450984745|FG030|Overall Study|Lost to Follow-up|0|||
125368564|NCT00042289|450984746|FG031|Overall Study|Lost to Follow-up|2|||
125368565|NCT00042289|450984747|FG032|Overall Study|Lost to Follow-up|1|||
125368566|NCT00042289|450984748|FG033|Overall Study|Lost to Follow-up|1|||
125368567|NCT00042289|450984749|FG034|Overall Study|Lost to Follow-up|1|||
125368568|NCT00042289|450984750|FG035|Overall Study|Lost to Follow-up|2|||
125368569|NCT00042289|450984751|FG036|Overall Study|Lost to Follow-up|1|||
125368570|NCT00042289|450984752|FG037|Overall Study|Lost to Follow-up|1|||
125368571|NCT00042289|450984753|FG038|Overall Study|Lost to Follow-up|0|||
125368572|NCT00042289|450984754|FG039|Overall Study|Lost to Follow-up|5|||
125368573|NCT00042289|450984755|FG040|Overall Study|Lost to Follow-up|0|||
125368574|NCT00042289|450984756|FG041|Overall Study|Lost to Follow-up|2|||
125368575|NCT00042289|450984757|FG042|Overall Study|Lost to Follow-up|2|||
125368576|NCT00042289|450984758|FG043|Overall Study|Lost to Follow-up|0|||
125368577|NCT00042289|450984759|FG044|Overall Study|Lost to Follow-up|0|||
125368578|NCT00042289|450984760|FG045|Overall Study|Lost to Follow-up|1|||
125368579|NCT00042289|450984761|FG046|Overall Study|Lost to Follow-up|0|||
125368580|NCT00042289|450984715|FG000|Overall Study|Other reason|0|||
125368581|NCT00042289|450984716|FG001|Overall Study|Other reason|0|||
125368582|NCT00042289|450984717|FG002|Overall Study|Other reason|0|||
125597712|NCT01933672|451812379|FG004|Second Intervention Period (12-16 Days)|Other|0|||
125368583|NCT00042289|450984718|FG003|Overall Study|Other reason|2|||
125368584|NCT00042289|450984719|FG004|Overall Study|Other reason|0|||
125368585|NCT00042289|450984720|FG005|Overall Study|Other reason|0|||
125368586|NCT00042289|450984721|FG006|Overall Study|Other reason|0|||
125368587|NCT00042289|450984722|FG007|Overall Study|Other reason|0|||
125368588|NCT00042289|450984723|FG008|Overall Study|Other reason|0|||
125368589|NCT00042289|450984724|FG009|Overall Study|Other reason|0|||
125368590|NCT00042289|450984725|FG010|Overall Study|Other reason|0|||
125368591|NCT00042289|450984726|FG011|Overall Study|Other reason|0|||
125368592|NCT00042289|450984727|FG012|Overall Study|Other reason|0|||
125368593|NCT00042289|450984728|FG013|Overall Study|Other reason|0|||
125368594|NCT00042289|450984729|FG014|Overall Study|Other reason|0|||
125368595|NCT00042289|450984730|FG015|Overall Study|Other reason|0|||
125368596|NCT00042289|450984731|FG016|Overall Study|Other reason|0|||
125597713|NCT01933672|451812380|FG005|Second Intervention Period (12-16 Days)|Other|0|||
125597714|NCT01933672|451812381|FG006|Second Intervention Period (12-16 Days)|Other|0|||
125597715|NCT01933672|451812375|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125597716|NCT01933672|451812376|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125597717|NCT01933672|451812377|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125597718|NCT01933672|451812378|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
125597719|NCT01933672|451812379|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125597720|NCT01933672|451812380|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125597721|NCT01933672|451812381|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
125597722|NCT01933672|451812375|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
125597723|NCT01933672|451812376|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
125597724|NCT01933672|451812377|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
125597725|NCT01933672|451812378|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
125597726|NCT01933672|451812379|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
125597727|NCT01933672|451812380|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
125597728|NCT01933672|451812381|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
125597729|NCT02426086|451812382|FG000|Overall Study|Death|33|||
125597730|NCT02426086|451812383|FG001|Overall Study|Death|36|||
125597731|NCT02426086|451812382|FG000|Overall Study|Lost to Follow-up|2|||
125597732|NCT02426086|451812383|FG001|Overall Study|Lost to Follow-up|0|||
125597733|NCT02426086|451812382|FG000|Overall Study|Study Terminated by Sponsor|5|||
125597734|NCT02426086|451812383|FG001|Overall Study|Study Terminated by Sponsor|14|||
125597735|NCT02426086|451812382|FG000|Overall Study|Withdrawal by Subject|8|||
125597736|NCT02426086|451812383|FG001|Overall Study|Withdrawal by Subject|9|||
125597737|NCT00524303|451812384|FG000|Overall Study|Lost to Follow-up|6|||
125597738|NCT00524303|451812385|FG001|Overall Study|Lost to Follow-up|0|||
125597739|NCT00524303|451812386|FG002|Overall Study|Lost to Follow-up|3|||
125597740|NCT00524303|451812384|FG000|Overall Study|Protocol Violation|0|||
125597741|NCT00524303|451812385|FG001|Overall Study|Protocol Violation|1|||
125597742|NCT00524303|451812386|FG002|Overall Study|Protocol Violation|1|||
125597743|NCT00524303|451812384|FG000|Overall Study|Withdrawal by Subject|3|||
125597744|NCT00524303|451812385|FG001|Overall Study|Withdrawal by Subject|0|||
125597745|NCT00524303|451812386|FG002|Overall Study|Withdrawal by Subject|4|||
125597746|NCT00524303|451812384|FG000|Overall Study|Death|0|||
125368597|NCT00042289|450984732|FG017|Overall Study|Other reason|0|||
125368598|NCT00042289|450984733|FG018|Overall Study|Other reason|1|||
125368599|NCT00042289|450984734|FG019|Overall Study|Other reason|0|||
125368600|NCT00042289|450984735|FG020|Overall Study|Other reason|0|||
125368601|NCT00042289|450984736|FG021|Overall Study|Other reason|0|||
125368602|NCT00042289|450984737|FG022|Overall Study|Other reason|0|||
125368603|NCT00042289|450984738|FG023|Overall Study|Other reason|1|||
125368604|NCT00042289|450984739|FG024|Overall Study|Other reason|0|||
125368605|NCT00042289|450984740|FG025|Overall Study|Other reason|0|||
125368606|NCT00042289|450984741|FG026|Overall Study|Other reason|1|||
125368607|NCT00042289|450984742|FG027|Overall Study|Other reason|0|||
125597747|NCT00524303|451812385|FG001|Overall Study|Death|2|||
125597748|NCT00524303|451812386|FG002|Overall Study|Death|3|||
125597749|NCT00524303|451812384|FG000|Overall Study|Adverse Event|1|||
125597750|NCT00524303|451812385|FG001|Overall Study|Adverse Event|2|||
125597751|NCT00524303|451812386|FG002|Overall Study|Adverse Event|3|||
125597752|NCT00524303|451812384|FG000|Overall Study|Did not Complete Study Dosing|1|||
125597753|NCT00524303|451812385|FG001|Overall Study|Did not Complete Study Dosing|0|||
125368608|NCT00042289|450984743|FG028|Overall Study|Other reason|3|||
125368609|NCT00042289|450984744|FG029|Overall Study|Other reason|0|||
125368610|NCT00042289|450984745|FG030|Overall Study|Other reason|0|||
125368611|NCT00042289|450984746|FG031|Overall Study|Other reason|1|||
125368612|NCT00042289|450984747|FG032|Overall Study|Other reason|0|||
125368613|NCT00042289|450984748|FG033|Overall Study|Other reason|1|||
125368614|NCT00042289|450984749|FG034|Overall Study|Other reason|0|||
125597754|NCT00524303|451812386|FG002|Overall Study|Did not Complete Study Dosing|0|||
125597755|NCT00524303|451812384|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
125597756|NCT00524303|451812385|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
125597757|NCT00524303|451812386|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
125597758|NCT00524303|451812384|FG000|Overall Study|Disease Progression|0|||
125597759|NCT00524303|451812385|FG001|Overall Study|Disease Progression|4|||
125368615|NCT00042289|450984750|FG035|Overall Study|Other reason|2|||
125368616|NCT00042289|450984751|FG036|Overall Study|Other reason|0|||
125368617|NCT00042289|450984752|FG037|Overall Study|Other reason|0|||
125368618|NCT00042289|450984753|FG038|Overall Study|Other reason|0|||
125368619|NCT00042289|450984754|FG039|Overall Study|Other reason|0|||
125368620|NCT00042289|450984755|FG040|Overall Study|Other reason|0|||
125368621|NCT00042289|450984756|FG041|Overall Study|Other reason|0|||
125597760|NCT00524303|451812386|FG002|Overall Study|Disease Progression|1|||
125597761|NCT00524303|451812384|FG000|Overall Study|Disease Recurrence|0|||
125597762|NCT00524303|451812385|FG001|Overall Study|Disease Recurrence|1|||
125597763|NCT00524303|451812386|FG002|Overall Study|Disease Recurrence|0|||
125597764|NCT00524303|451812384|FG000|Overall Study|Sponsor Request|0|||
125597765|NCT00524303|451812385|FG001|Overall Study|Sponsor Request|0|||
125597766|NCT00524303|451812386|FG002|Overall Study|Sponsor Request|1|||
125597767|NCT00524303|451812384|FG000|Overall Study|Physician Decision|0|||
125597768|NCT00524303|451812385|FG001|Overall Study|Physician Decision|0|||
125597769|NCT00524303|451812386|FG002|Overall Study|Physician Decision|1|||
125597770|NCT00524303|451812384|FG000|Overall Study|Completed 5 years|0|||
125597771|NCT00524303|451812385|FG001|Overall Study|Completed 5 years|0|||
125431266|NCT04887948|451205621|FG002|Overall Study|Death|0|||
125431267|NCT04887948|451205619|FG000|Overall Study|Lost to Follow-up|1|||
125431268|NCT04887948|451205620|FG001|Overall Study|Lost to Follow-up|0|||
125431269|NCT04887948|451205621|FG002|Overall Study|Lost to Follow-up|3|||
125431270|NCT04887948|451205619|FG000|Overall Study|Physician Decision|0|||
125431271|NCT04887948|451205620|FG001|Overall Study|Physician Decision|4|||
125431272|NCT04887948|451205621|FG002|Overall Study|Physician Decision|1|||
125431273|NCT04887948|451205619|FG000|Overall Study|Protocol Violation|1|||
125431274|NCT04887948|451205620|FG001|Overall Study|Protocol Violation|1|||
125431275|NCT04887948|451205621|FG002|Overall Study|Protocol Violation|0|||
125431276|NCT04887948|451205619|FG000|Overall Study|Withdrawal by Subject|0|||
125431277|NCT04887948|451205620|FG001|Overall Study|Withdrawal by Subject|6|||
125431278|NCT04887948|451205621|FG002|Overall Study|Withdrawal by Subject|1|||
125431279|NCT04887948|451205619|FG000|Overall Study|No longer met eligibility criteria|1|||
125431280|NCT04887948|451205620|FG001|Overall Study|No longer met eligibility criteria|2|||
125431281|NCT04887948|451205621|FG002|Overall Study|No longer met eligibility criteria|1|||
125431282|NCT04887948|451205619|FG000|Overall Study|Other|2|||
125431283|NCT04887948|451205620|FG001|Overall Study|Other|1|||
125431284|NCT04887948|451205621|FG002|Overall Study|Other|1|||
125431285|NCT01782872|451205626|FG000|Overall Study|Protocol Violation|0|||
125431286|NCT01782872|451205627|FG001|Overall Study|Protocol Violation|0|||
125431287|NCT01782872|451205628|FG002|Overall Study|Protocol Violation|0|||
125431288|NCT01782872|451205629|FG003|Overall Study|Protocol Violation|1|||
125431289|NCT01782872|451205626|FG000|Overall Study|Withdrawal by Subject|0|||
125431290|NCT01782872|451205627|FG001|Overall Study|Withdrawal by Subject|1|||
125431291|NCT01782872|451205628|FG002|Overall Study|Withdrawal by Subject|0|||
125431292|NCT01782872|451205629|FG003|Overall Study|Withdrawal by Subject|0|||
125431293|NCT01892345|451205630|FG000|Overall Study|Adverse Event|0|||
125431294|NCT01892345|451205631|FG001|Overall Study|Adverse Event|2|||
125431295|NCT01892345|451205630|FG000|Overall Study|Death|1|||
125431296|NCT01892345|451205631|FG001|Overall Study|Death|0|||
125431297|NCT01892345|451205630|FG000|Overall Study|Lost to Follow-up|3|||
125431298|NCT01892345|451205631|FG001|Overall Study|Lost to Follow-up|0|||
125431299|NCT01892345|451205630|FG000|Overall Study|Withdrawal by Subject|12|||
125597772|NCT00524303|451812386|FG002|Overall Study|Completed 5 years|1|||
125597773|NCT04358458|451812387|FG000|Overall Study|Death|1|||
125597774|NCT04358458|451812388|FG001|Overall Study|Death|1|||
125597775|NCT04358458|451812389|FG002|Overall Study|Death|3|||
125597776|NCT04358458|451812390|FG003|Overall Study|Death|8|||
125597777|NCT04358458|451812391|FG004|Overall Study|Death|1|||
125597778|NCT04358458|451812392|FG005|Overall Study|Death|6|||
125597779|NCT04358458|451812393|FG006|Overall Study|Death|2|||
125431300|NCT01892345|451205631|FG001|Overall Study|Withdrawal by Subject|1|||
125431301|NCT00638235|451205632|FG000|Overall Study|Lost to Follow-up|31|||
125431302|NCT00638235|451205633|FG001|Overall Study|Lost to Follow-up|3|||
125431303|NCT00638235|451205634|FG002|Overall Study|Lost to Follow-up|18|||
125431304|NCT00638235|451205635|FG003|Overall Study|Lost to Follow-up|10|||
125431305|NCT00638235|451205636|FG004|Overall Study|Lost to Follow-up|13|||
125431306|NCT00638235|451205637|FG005|Overall Study|Lost to Follow-up|26|||
125431307|NCT00638235|451205638|FG006|Overall Study|Lost to Follow-up|0|||
125597780|NCT04358458|451812394|FG007|Overall Study|Death|3|||
125597781|NCT04358458|451812387|FG000|Overall Study|Lost to Follow-up|0|||
125597782|NCT04358458|451812388|FG001|Overall Study|Lost to Follow-up|0|||
125597783|NCT04358458|451812389|FG002|Overall Study|Lost to Follow-up|0|||
125597784|NCT04358458|451812390|FG003|Overall Study|Lost to Follow-up|0|||
125431308|NCT00638235|451205639|FG007|Overall Study|Lost to Follow-up|1|||
125431309|NCT00638235|451205640|FG008|Overall Study|Lost to Follow-up|18|||
125431310|NCT01473381|451205641|FG000|Overall Study|Adverse Event|8|||
125431311|NCT01473381|451205642|FG001|Overall Study|Adverse Event|20|||
125431312|NCT01473381|451205643|FG002|Overall Study|Adverse Event|25|||
125431313|NCT01473381|451205644|FG003|Overall Study|Adverse Event|17|||
125431314|NCT01473381|451205641|FG000|Overall Study|Insufficient Therapeutic Response|10|||
125431315|NCT01473381|451205642|FG001|Overall Study|Insufficient Therapeutic Response|1|||
125431316|NCT01473381|451205643|FG002|Overall Study|Insufficient Therapeutic Response|2|||
125431317|NCT01473381|451205644|FG003|Overall Study|Insufficient Therapeutic Response|3|||
125597785|NCT04358458|451812391|FG004|Overall Study|Lost to Follow-up|0|||
125597786|NCT04358458|451812392|FG005|Overall Study|Lost to Follow-up|0|||
125597787|NCT04358458|451812393|FG006|Overall Study|Lost to Follow-up|0|||
125597788|NCT04358458|451812394|FG007|Overall Study|Lost to Follow-up|1|||
125597789|NCT04358458|451812387|FG000|Overall Study|Site is closing study participation|0|||
125431318|NCT01473381|451205641|FG000|Overall Study|Protocol Violation|17|||
125431319|NCT01473381|451205642|FG001|Overall Study|Protocol Violation|23|||
125431320|NCT01473381|451205643|FG002|Overall Study|Protocol Violation|19|||
125431321|NCT01473381|451205644|FG003|Overall Study|Protocol Violation|17|||
125431322|NCT01473381|451205641|FG000|Overall Study|Withdrawal of Consent|20|||
125431323|NCT01473381|451205642|FG001|Overall Study|Withdrawal of Consent|21|||
125431324|NCT01473381|451205643|FG002|Overall Study|Withdrawal of Consent|20|||
125431325|NCT01473381|451205644|FG003|Overall Study|Withdrawal of Consent|26|||
125431326|NCT01473381|451205641|FG000|Overall Study|Lost to Follow-up|25|||
125431327|NCT01473381|451205642|FG001|Overall Study|Lost to Follow-up|28|||
125431328|NCT01473381|451205643|FG002|Overall Study|Lost to Follow-up|35|||
125431329|NCT01473381|451205644|FG003|Overall Study|Lost to Follow-up|23|||
125431330|NCT01473381|451205641|FG000|Overall Study|Other Reasons|0|||
125431331|NCT01473381|451205642|FG001|Overall Study|Other Reasons|0|||
125431332|NCT01473381|451205643|FG002|Overall Study|Other Reasons|1|||
125431333|NCT01473381|451205644|FG003|Overall Study|Other Reasons|3|||
125431334|NCT04026165|451205645|FG000|Run-in Placebo Period|Enrollment Error|13|||
125597790|NCT04358458|451812388|FG001|Overall Study|Site is closing study participation|0|||
125597791|NCT04358458|451812389|FG002|Overall Study|Site is closing study participation|0|||
125597792|NCT04358458|451812390|FG003|Overall Study|Site is closing study participation|1|||
125597793|NCT04358458|451812391|FG004|Overall Study|Site is closing study participation|0|||
125597794|NCT04358458|451812392|FG005|Overall Study|Site is closing study participation|0|||
125597795|NCT04358458|451812393|FG006|Overall Study|Site is closing study participation|0|||
125597796|NCT04358458|451812394|FG007|Overall Study|Site is closing study participation|0|||
125597797|NCT04358458|451812387|FG000|Overall Study|Sponsor request|2|||
125597798|NCT04358458|451812388|FG001|Overall Study|Sponsor request|3|||
125597799|NCT04358458|451812389|FG002|Overall Study|Sponsor request|3|||
125597800|NCT04358458|451812390|FG003|Overall Study|Sponsor request|0|||
125597801|NCT04358458|451812391|FG004|Overall Study|Sponsor request|2|||
125597802|NCT04358458|451812392|FG005|Overall Study|Sponsor request|3|||
125597803|NCT04358458|451812393|FG006|Overall Study|Sponsor request|1|||
125597804|NCT04358458|451812394|FG007|Overall Study|Sponsor request|1|||
125597805|NCT04358458|451812387|FG000|Overall Study|Withdrawal by Subject|0|||
125597806|NCT04358458|451812388|FG001|Overall Study|Withdrawal by Subject|0|||
125597807|NCT04358458|451812389|FG002|Overall Study|Withdrawal by Subject|1|||
125597808|NCT04358458|451812390|FG003|Overall Study|Withdrawal by Subject|1|||
125597809|NCT04358458|451812391|FG004|Overall Study|Withdrawal by Subject|0|||
125597810|NCT04358458|451812392|FG005|Overall Study|Withdrawal by Subject|1|||
125597811|NCT04358458|451812393|FG006|Overall Study|Withdrawal by Subject|0|||
125597812|NCT04358458|451812394|FG007|Overall Study|Withdrawal by Subject|1|||
125597813|NCT02031146|451813725|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
125597814|NCT02031146|451813726|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
125597815|NCT02031146|451813727|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
125597816|NCT02031146|451813728|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
125597817|NCT02031146|451813729|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
125597818|NCT02031146|451813730|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
125597819|NCT02031146|451813731|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
125597820|NCT01266148|451813736|FG000|Overall Study|Adverse Event|2|||
125597821|NCT01266148|451813737|FG001|Overall Study|Adverse Event|0|||
125597822|NCT01266148|451813736|FG000|Overall Study|Ongoing rejection|1|||
125597823|NCT01266148|451813737|FG001|Overall Study|Ongoing rejection|0|||
125597824|NCT01266148|451813736|FG000|Overall Study|2 2R rejections|1|||
125597825|NCT01266148|451813737|FG001|Overall Study|2 2R rejections|0|||
125597826|NCT01266148|451813736|FG000|Overall Study|Death|2|||
125597827|NCT01266148|451813737|FG001|Overall Study|Death|3|||
125597828|NCT01266148|451813736|FG000|Overall Study|missing mGFR value + AE|1|||
125597829|NCT01266148|451813737|FG001|Overall Study|missing mGFR value + AE|0|||
125597830|NCT03937986|451813740|FG000|Overall Study|COVID-19 Pandemic|1|||
125597831|NCT01853228|451813743|FG000|Phase 1|Lack of Efficacy|8|||
125597832|NCT01853228|451813744|FG001|Phase 1|Lack of Efficacy|0|||
125431335|NCT04026165|451205646|FG001|Run-in Placebo Period|Enrollment Error|0|||
125431336|NCT04026165|451205647|FG002|Run-in Placebo Period|Enrollment Error|0|||
125431337|NCT04026165|451205648|FG003|Run-in Placebo Period|Enrollment Error|0|||
125431338|NCT04026165|451205645|FG000|Run-in Placebo Period|Run-in Failure|4|||
125597833|NCT01853228|451813743|FG000|Phase 1|Other|1|||
125597834|NCT01853228|451813744|FG001|Phase 1|Other|0|||
125597835|NCT01853228|451813743|FG000|Phase 2|Physician Decision|0|||
125597836|NCT01853228|451813744|FG001|Phase 2|Physician Decision|1|||
125597837|NCT01853228|451813743|FG000|Phase 2|Proceed To Transplant|0|||
125597838|NCT01853228|451813744|FG001|Phase 2|Proceed To Transplant|3|||
125597839|NCT01853228|451813743|FG000|Phase 2|Lack of Efficacy|0|||
125597840|NCT01853228|451813744|FG001|Phase 2|Lack of Efficacy|4|||
125597841|NCT03167619|451813747|FG000|Overall Study|Death|11|||
125597842|NCT03167619|451813748|FG001|Overall Study|Death|8|||
125597843|NCT03167619|451813747|FG000|Overall Study|Withdrawal by Subject|1|||
125597844|NCT03167619|451813748|FG001|Overall Study|Withdrawal by Subject|2|||
125597845|NCT03167619|451813747|FG000|Overall Study|Physician Decision|0|||
125597846|NCT03167619|451813748|FG001|Overall Study|Physician Decision|1|||
125368622|NCT00042289|450984757|FG042|Overall Study|Other reason|0|||
125368623|NCT00042289|450984758|FG043|Overall Study|Other reason|1|||
125368624|NCT00042289|450984759|FG044|Overall Study|Other reason|0|||
125368625|NCT00042289|450984760|FG045|Overall Study|Other reason|0|||
125368626|NCT00042289|450984761|FG046|Overall Study|Other reason|0|||
125368627|NCT00042289|450984715|FG000|Overall Study|Severe debilitation, unable to continue|0|||
125368628|NCT00042289|450984716|FG001|Overall Study|Severe debilitation, unable to continue|0|||
125368629|NCT00042289|450984717|FG002|Overall Study|Severe debilitation, unable to continue|0|||
125368630|NCT00042289|450984718|FG003|Overall Study|Severe debilitation, unable to continue|0|||
125368631|NCT00042289|450984719|FG004|Overall Study|Severe debilitation, unable to continue|0|||
125368632|NCT00042289|450984720|FG005|Overall Study|Severe debilitation, unable to continue|0|||
125368633|NCT00042289|450984721|FG006|Overall Study|Severe debilitation, unable to continue|0|||
125368634|NCT00042289|450984722|FG007|Overall Study|Severe debilitation, unable to continue|0|||
125368635|NCT00042289|450984723|FG008|Overall Study|Severe debilitation, unable to continue|0|||
125368636|NCT00042289|450984724|FG009|Overall Study|Severe debilitation, unable to continue|0|||
125368637|NCT00042289|450984725|FG010|Overall Study|Severe debilitation, unable to continue|0|||
125368638|NCT00042289|450984726|FG011|Overall Study|Severe debilitation, unable to continue|0|||
125368639|NCT00042289|450984727|FG012|Overall Study|Severe debilitation, unable to continue|0|||
125368640|NCT00042289|450984728|FG013|Overall Study|Severe debilitation, unable to continue|0|||
125368641|NCT00042289|450984729|FG014|Overall Study|Severe debilitation, unable to continue|0|||
125368642|NCT00042289|450984730|FG015|Overall Study|Severe debilitation, unable to continue|0|||
125368643|NCT00042289|450984731|FG016|Overall Study|Severe debilitation, unable to continue|0|||
125368644|NCT00042289|450984732|FG017|Overall Study|Severe debilitation, unable to continue|0|||
125368645|NCT00042289|450984733|FG018|Overall Study|Severe debilitation, unable to continue|0|||
125368646|NCT00042289|450984734|FG019|Overall Study|Severe debilitation, unable to continue|0|||
125368647|NCT00042289|450984735|FG020|Overall Study|Severe debilitation, unable to continue|0|||
125368648|NCT00042289|450984736|FG021|Overall Study|Severe debilitation, unable to continue|1|||
125368649|NCT00042289|450984737|FG022|Overall Study|Severe debilitation, unable to continue|0|||
125368650|NCT00042289|450984738|FG023|Overall Study|Severe debilitation, unable to continue|1|||
125368651|NCT00042289|450984739|FG024|Overall Study|Severe debilitation, unable to continue|0|||
125368652|NCT00042289|450984740|FG025|Overall Study|Severe debilitation, unable to continue|0|||
125368653|NCT00042289|450984741|FG026|Overall Study|Severe debilitation, unable to continue|0|||
125368654|NCT00042289|450984742|FG027|Overall Study|Severe debilitation, unable to continue|1|||
125368655|NCT00042289|450984743|FG028|Overall Study|Severe debilitation, unable to continue|0|||
125368656|NCT00042289|450984744|FG029|Overall Study|Severe debilitation, unable to continue|0|||
125368657|NCT00042289|450984745|FG030|Overall Study|Severe debilitation, unable to continue|0|||
125368658|NCT00042289|450984746|FG031|Overall Study|Severe debilitation, unable to continue|1|||
125368659|NCT00042289|450984747|FG032|Overall Study|Severe debilitation, unable to continue|1|||
125368660|NCT00042289|450984748|FG033|Overall Study|Severe debilitation, unable to continue|0|||
125368661|NCT00042289|450984749|FG034|Overall Study|Severe debilitation, unable to continue|0|||
125368662|NCT00042289|450984750|FG035|Overall Study|Severe debilitation, unable to continue|0|||
125368663|NCT00042289|450984751|FG036|Overall Study|Severe debilitation, unable to continue|0|||
125368664|NCT00042289|450984752|FG037|Overall Study|Severe debilitation, unable to continue|0|||
125368665|NCT00042289|450984753|FG038|Overall Study|Severe debilitation, unable to continue|0|||
125368666|NCT00042289|450984754|FG039|Overall Study|Severe debilitation, unable to continue|0|||
125368667|NCT00042289|450984755|FG040|Overall Study|Severe debilitation, unable to continue|0|||
125368668|NCT00042289|450984756|FG041|Overall Study|Severe debilitation, unable to continue|0|||
125368669|NCT00042289|450984757|FG042|Overall Study|Severe debilitation, unable to continue|0|||
125368670|NCT00042289|450984758|FG043|Overall Study|Severe debilitation, unable to continue|0|||
125368671|NCT00042289|450984759|FG044|Overall Study|Severe debilitation, unable to continue|0|||
125368672|NCT00042289|450984760|FG045|Overall Study|Severe debilitation, unable to continue|0|||
125368673|NCT00042289|450984761|FG046|Overall Study|Severe debilitation, unable to continue|0|||
125368674|NCT00042289|450984715|FG000|Overall Study|Site closed|0|||
125368675|NCT00042289|450984716|FG001|Overall Study|Site closed|0|||
125597847|NCT01348919|451813750|FG000|Overall Study|Adverse Event|3|||
125368676|NCT00042289|450984717|FG002|Overall Study|Site closed|0|||
125368677|NCT00042289|450984718|FG003|Overall Study|Site closed|0|||
125368678|NCT00042289|450984719|FG004|Overall Study|Site closed|0|||
125368679|NCT00042289|450984720|FG005|Overall Study|Site closed|0|||
125368680|NCT00042289|450984721|FG006|Overall Study|Site closed|0|||
125368681|NCT00042289|450984722|FG007|Overall Study|Site closed|0|||
125597848|NCT01348919|451813751|FG001|Overall Study|Adverse Event|1|||
125597849|NCT01348919|451813752|FG002|Overall Study|Adverse Event|0|||
125368682|NCT00042289|450984723|FG008|Overall Study|Site closed|0|||
125368683|NCT00042289|450984724|FG009|Overall Study|Site closed|0|||
125368684|NCT00042289|450984725|FG010|Overall Study|Site closed|0|||
125368685|NCT00042289|450984726|FG011|Overall Study|Site closed|0|||
125368686|NCT00042289|450984727|FG012|Overall Study|Site closed|0|||
125368687|NCT00042289|450984728|FG013|Overall Study|Site closed|0|||
125368688|NCT00042289|450984729|FG014|Overall Study|Site closed|0|||
125368689|NCT00042289|450984730|FG015|Overall Study|Site closed|0|||
125368690|NCT00042289|450984731|FG016|Overall Study|Site closed|0|||
125368691|NCT00042289|450984732|FG017|Overall Study|Site closed|0|||
125368692|NCT00042289|450984733|FG018|Overall Study|Site closed|0|||
125368693|NCT00042289|450984734|FG019|Overall Study|Site closed|0|||
125368694|NCT00042289|450984735|FG020|Overall Study|Site closed|0|||
125368695|NCT00042289|450984736|FG021|Overall Study|Site closed|0|||
125368696|NCT00042289|450984737|FG022|Overall Study|Site closed|0|||
125368697|NCT00042289|450984738|FG023|Overall Study|Site closed|0|||
125368698|NCT00042289|450984739|FG024|Overall Study|Site closed|0|||
125368699|NCT00042289|450984740|FG025|Overall Study|Site closed|0|||
125368700|NCT00042289|450984741|FG026|Overall Study|Site closed|0|||
125368701|NCT00042289|450984742|FG027|Overall Study|Site closed|0|||
125368702|NCT00042289|450984743|FG028|Overall Study|Site closed|0|||
125368703|NCT00042289|450984744|FG029|Overall Study|Site closed|0|||
125368704|NCT00042289|450984745|FG030|Overall Study|Site closed|0|||
125368705|NCT00042289|450984746|FG031|Overall Study|Site closed|3|||
125368706|NCT00042289|450984747|FG032|Overall Study|Site closed|0|||
125368707|NCT00042289|450984748|FG033|Overall Study|Site closed|0|||
125368708|NCT00042289|450984749|FG034|Overall Study|Site closed|0|||
125368709|NCT00042289|450984750|FG035|Overall Study|Site closed|0|||
125368710|NCT00042289|450984751|FG036|Overall Study|Site closed|1|||
125368711|NCT00042289|450984752|FG037|Overall Study|Site closed|0|||
125368712|NCT00042289|450984753|FG038|Overall Study|Site closed|0|||
125368713|NCT00042289|450984754|FG039|Overall Study|Site closed|0|||
125368714|NCT00042289|450984755|FG040|Overall Study|Site closed|0|||
125368715|NCT00042289|450984756|FG041|Overall Study|Site closed|0|||
125368716|NCT00042289|450984757|FG042|Overall Study|Site closed|1|||
125368717|NCT00042289|450984758|FG043|Overall Study|Site closed|0|||
125368718|NCT00042289|450984759|FG044|Overall Study|Site closed|0|||
125368719|NCT00042289|450984760|FG045|Overall Study|Site closed|0|||
125368720|NCT00042289|450984761|FG046|Overall Study|Site closed|0|||
125368721|NCT00042289|450984715|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
125368722|NCT00042289|450984716|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
125368723|NCT00042289|450984717|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
125368724|NCT00042289|450984718|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
125368725|NCT00042289|450984719|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
125368726|NCT00042289|450984720|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
125368727|NCT00042289|450984721|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
125368728|NCT00042289|450984722|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
125368729|NCT00042289|450984723|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
125368730|NCT00042289|450984724|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
125368731|NCT00042289|450984725|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
125368732|NCT00042289|450984726|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
125368733|NCT00042289|450984727|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
125368734|NCT00042289|450984728|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
125368735|NCT00042289|450984729|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
125368736|NCT00042289|450984730|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
125368737|NCT00042289|450984731|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
125368738|NCT00042289|450984732|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
125368739|NCT00042289|450984733|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
125368740|NCT00042289|450984734|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
125368741|NCT00042289|450984735|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
125368742|NCT00042289|450984736|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
125368743|NCT00042289|450984737|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
125368744|NCT00042289|450984738|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
125368745|NCT00042289|450984739|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
125597850|NCT01348919|451813750|FG000|Overall Study|Withdrawal by Subject|0|||
125597851|NCT01348919|451813751|FG001|Overall Study|Withdrawal by Subject|1|||
125368746|NCT00042289|450984740|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
125368747|NCT00042289|450984741|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
125368748|NCT00042289|450984742|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
125597852|NCT01348919|451813752|FG002|Overall Study|Withdrawal by Subject|0|||
125368749|NCT00042289|450984743|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
125368750|NCT00042289|450984744|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
125368751|NCT00042289|450984745|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
125368752|NCT00042289|450984746|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
125597853|NCT01348919|451813750|FG000|Overall Study|Disease progression|0|||
125597854|NCT01348919|451813751|FG001|Overall Study|Disease progression|1|||
125597855|NCT01348919|451813752|FG002|Overall Study|Disease progression|1|||
125431339|NCT04026165|451205646|FG001|Run-in Placebo Period|Run-in Failure|0|||
125431340|NCT04026165|451205647|FG002|Run-in Placebo Period|Run-in Failure|0|||
125431341|NCT04026165|451205648|FG003|Run-in Placebo Period|Run-in Failure|0|||
125431342|NCT04026165|451205645|FG000|Run-in Placebo Period|Protocol Violation|2|||
125431343|NCT04026165|451205646|FG001|Run-in Placebo Period|Protocol Violation|0|||
125431344|NCT04026165|451205647|FG002|Run-in Placebo Period|Protocol Violation|0|||
125431345|NCT04026165|451205648|FG003|Run-in Placebo Period|Protocol Violation|0|||
125431346|NCT04026165|451205645|FG000|Run-in Placebo Period|Withdrew Consent|2|||
125431347|NCT04026165|451205646|FG001|Run-in Placebo Period|Withdrew Consent|0|||
125431348|NCT04026165|451205647|FG002|Run-in Placebo Period|Withdrew Consent|0|||
125431349|NCT04026165|451205648|FG003|Run-in Placebo Period|Withdrew Consent|0|||
125431350|NCT04026165|451205645|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
125597856|NCT02114203|451813753|FG000|Overall Study|Adverse Event|0|||
125597857|NCT02114203|451813754|FG001|Overall Study|Adverse Event|1|||
125597858|NCT02114203|451813755|FG002|Overall Study|Adverse Event|0|||
125597859|NCT02114203|451813753|FG000|Overall Study|Withdrawal by Subject|0|||
125597860|NCT02114203|451813754|FG001|Overall Study|Withdrawal by Subject|1|||
125431351|NCT04026165|451205646|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
125431352|NCT04026165|451205647|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
125431353|NCT04026165|451205648|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
125431354|NCT04026165|451205645|FG000|Run-in SEL Period|Run-in Failure|0|||
125431355|NCT04026165|451205646|FG001|Run-in SEL Period|Run-in Failure|26|||
125431356|NCT04026165|451205647|FG002|Run-in SEL Period|Run-in Failure|0|||
125431357|NCT04026165|451205648|FG003|Run-in SEL Period|Run-in Failure|0|||
125431358|NCT04026165|451205645|FG000|Run-in SEL Period|Withdrew Consent|0|||
125431359|NCT04026165|451205646|FG001|Run-in SEL Period|Withdrew Consent|10|||
125431360|NCT04026165|451205647|FG002|Run-in SEL Period|Withdrew Consent|0|||
125431361|NCT04026165|451205648|FG003|Run-in SEL Period|Withdrew Consent|0|||
125431362|NCT04026165|451205645|FG000|Run-in SEL Period|Enrollment Error|0|||
125431363|NCT04026165|451205646|FG001|Run-in SEL Period|Enrollment Error|4|||
125431364|NCT04026165|451205647|FG002|Run-in SEL Period|Enrollment Error|0|||
125431365|NCT04026165|451205648|FG003|Run-in SEL Period|Enrollment Error|0|||
125431366|NCT04026165|451205645|FG000|Run-in SEL Period|Protocol Violation|0|||
125431367|NCT04026165|451205646|FG001|Run-in SEL Period|Protocol Violation|3|||
125431368|NCT04026165|451205647|FG002|Run-in SEL Period|Protocol Violation|0|||
125431369|NCT04026165|451205648|FG003|Run-in SEL Period|Protocol Violation|0|||
125431370|NCT04026165|451205645|FG000|Run-in SEL Period|Investigator's Discretion|0|||
125431371|NCT04026165|451205646|FG001|Run-in SEL Period|Investigator's Discretion|2|||
125431372|NCT04026165|451205647|FG002|Run-in SEL Period|Investigator's Discretion|0|||
125431373|NCT04026165|451205648|FG003|Run-in SEL Period|Investigator's Discretion|0|||
125431374|NCT04026165|451205645|FG000|Run-in SEL Period|Death|0|||
125431375|NCT04026165|451205646|FG001|Run-in SEL Period|Death|1|||
125431376|NCT04026165|451205647|FG002|Run-in SEL Period|Death|0|||
125431377|NCT04026165|451205648|FG003|Run-in SEL Period|Death|0|||
125431378|NCT04026165|451205645|FG000|Randomized Period|Withdrew Consent|0|||
125431379|NCT04026165|451205646|FG001|Randomized Period|Withdrew Consent|0|||
125431380|NCT04026165|451205647|FG002|Randomized Period|Withdrew Consent|5|||
125597861|NCT02114203|451813755|FG002|Overall Study|Withdrawal by Subject|0|||
125597862|NCT01518699|451813756|FG000|Period 2|Protocol Violation|1|||
125597863|NCT01518699|451813757|FG001|Period 2|Protocol Violation|1|||
125597864|NCT01518699|451813758|FG002|Period 2|Protocol Violation|0|||
125597865|NCT01518699|451813759|FG003|Period 2|Protocol Violation|0|||
125597866|NCT01518699|451813760|FG004|Period 2|Protocol Violation|0|||
125431381|NCT04026165|451205648|FG003|Randomized Period|Withdrew Consent|8|||
125431382|NCT04026165|451205645|FG000|Randomized Period|Death|0|||
125431383|NCT04026165|451205646|FG001|Randomized Period|Death|0|||
125431384|NCT04026165|451205647|FG002|Randomized Period|Death|5|||
125431385|NCT04026165|451205648|FG003|Randomized Period|Death|7|||
125597867|NCT01518699|451813761|FG005|Period 2|Protocol Violation|0|||
125597868|NCT01518699|451813756|FG000|Period 2|Lost to Follow-up|0|||
125597869|NCT01518699|451813757|FG001|Period 2|Lost to Follow-up|1|||
125431386|NCT04026165|451205645|FG000|Randomized Period|Investigator's Discretion|0|||
125431387|NCT04026165|451205646|FG001|Randomized Period|Investigator's Discretion|0|||
125431388|NCT04026165|451205647|FG002|Randomized Period|Investigator's Discretion|2|||
125431389|NCT04026165|451205648|FG003|Randomized Period|Investigator's Discretion|2|||
125431390|NCT04026165|451205645|FG000|Randomized Period|Lost to Follow-up|0|||
125431391|NCT04026165|451205646|FG001|Randomized Period|Lost to Follow-up|0|||
125431392|NCT04026165|451205647|FG002|Randomized Period|Lost to Follow-up|2|||
125431393|NCT04026165|451205648|FG003|Randomized Period|Lost to Follow-up|2|||
125431394|NCT02255357|451205649|FG000|Overall Study|Physician Decision|10|||
125431395|NCT02255357|451205650|FG001|Overall Study|Physician Decision|24|||
125431396|NCT05061537|451205651|FG000|Treatment Phase|Progressive disease|0|||
125431397|NCT05061537|451205652|FG001|Treatment Phase|Progressive disease|1|||
125431398|NCT05061537|451205653|FG002|Treatment Phase|Progressive disease|2|||
125431399|NCT05061537|451205654|FG003|Treatment Phase|Progressive disease|0|||
125431400|NCT05061537|451205655|FG004|Treatment Phase|Progressive disease|0|||
125431401|NCT05061537|451205651|FG000|Treatment Phase|Adverse Event|0|||
125431402|NCT05061537|451205652|FG001|Treatment Phase|Adverse Event|0|||
125431403|NCT05061537|451205653|FG002|Treatment Phase|Adverse Event|2|||
125431404|NCT05061537|451205654|FG003|Treatment Phase|Adverse Event|0|||
125431405|NCT05061537|451205655|FG004|Treatment Phase|Adverse Event|0|||
125431406|NCT05061537|451205651|FG000|Treatment Phase|Global deterioration of health status|0|||
125431407|NCT05061537|451205652|FG001|Treatment Phase|Global deterioration of health status|1|||
125431408|NCT05061537|451205653|FG002|Treatment Phase|Global deterioration of health status|0|||
125431409|NCT05061537|451205654|FG003|Treatment Phase|Global deterioration of health status|0|||
125431410|NCT05061537|451205655|FG004|Treatment Phase|Global deterioration of health status|0|||
125431411|NCT05061537|451205651|FG000|Follow up|Other|2|||
125431412|NCT05061537|451205652|FG001|Follow up|Other|0|||
125431413|NCT05061537|451205653|FG002|Follow up|Other|2|||
125431414|NCT05061537|451205654|FG003|Follow up|Other|0|||
125431415|NCT05061537|451205655|FG004|Follow up|Other|0|||
125431416|NCT05061537|451205651|FG000|Follow up|Study terminated by sponsor|0|||
125431417|NCT05061537|451205652|FG001|Follow up|Study terminated by sponsor|0|||
125431418|NCT05061537|451205653|FG002|Follow up|Study terminated by sponsor|2|||
125431419|NCT05061537|451205654|FG003|Follow up|Study terminated by sponsor|0|||
125431420|NCT05061537|451205655|FG004|Follow up|Study terminated by sponsor|0|||
125431421|NCT05061537|451205651|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
125431422|NCT05061537|451205652|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
125431423|NCT05061537|451205653|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
125431424|NCT05061537|451205654|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
125431425|NCT05061537|451205655|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
125431426|NCT05061537|451205651|FG000|Long-term Follow-up|Death|0|||
125431427|NCT05061537|451205652|FG001|Long-term Follow-up|Death|1|||
125431428|NCT05061537|451205653|FG002|Long-term Follow-up|Death|0|||
125431429|NCT05061537|451205654|FG003|Long-term Follow-up|Death|0|||
125431430|NCT05061537|451205655|FG004|Long-term Follow-up|Death|0|||
125431431|NCT01674621|451205666|FG000|Overall Study|Adverse Event|3|||
125431432|NCT01674621|451205667|FG001|Overall Study|Adverse Event|2|||
125431433|NCT01674621|451205668|FG002|Overall Study|Adverse Event|5|||
125431434|NCT01674621|451205669|FG003|Overall Study|Adverse Event|5|||
125431435|NCT01674621|451205670|FG004|Overall Study|Adverse Event|1|||
125431436|NCT01674621|451205666|FG000|Overall Study|Inability to Complete Study Procedures|0|||
125431437|NCT01674621|451205667|FG001|Overall Study|Inability to Complete Study Procedures|0|||
125431438|NCT01674621|451205668|FG002|Overall Study|Inability to Complete Study Procedures|0|||
125431439|NCT01674621|451205669|FG003|Overall Study|Inability to Complete Study Procedures|0|||
125431440|NCT01674621|451205670|FG004|Overall Study|Inability to Complete Study Procedures|2|||
125431441|NCT01674621|451205666|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
125431442|NCT01674621|451205667|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
125431443|NCT01674621|451205668|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
125431444|NCT01674621|451205669|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
125431445|NCT01674621|451205670|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
125431446|NCT01674621|451205666|FG000|Overall Study|Withdrawal by Subject|2|||
125431447|NCT01674621|451205667|FG001|Overall Study|Withdrawal by Subject|5|||
125431448|NCT01674621|451205668|FG002|Overall Study|Withdrawal by Subject|2|||
125431449|NCT01674621|451205669|FG003|Overall Study|Withdrawal by Subject|0|||
125431450|NCT01674621|451205670|FG004|Overall Study|Withdrawal by Subject|1|||
125431451|NCT01674621|451205666|FG000|Overall Study|Other than specified|0|||
125431452|NCT01674621|451205667|FG001|Overall Study|Other than specified|1|||
125431453|NCT01674621|451205668|FG002|Overall Study|Other than specified|0|||
125431454|NCT01674621|451205669|FG003|Overall Study|Other than specified|0|||
125431455|NCT01674621|451205670|FG004|Overall Study|Other than specified|2|||
125597870|NCT01518699|451813758|FG002|Period 2|Lost to Follow-up|0|||
125597871|NCT01518699|451813759|FG003|Period 2|Lost to Follow-up|0|||
125597872|NCT01518699|451813760|FG004|Period 2|Lost to Follow-up|0|||
125597873|NCT01518699|451813761|FG005|Period 2|Lost to Follow-up|0|||
125597874|NCT01518699|451813756|FG000|Period 2|Adverse Event|1|||
125597875|NCT01518699|451813757|FG001|Period 2|Adverse Event|0|||
125597876|NCT01518699|451813758|FG002|Period 2|Adverse Event|0|||
125597877|NCT01518699|451813759|FG003|Period 2|Adverse Event|0|||
125597878|NCT01518699|451813760|FG004|Period 2|Adverse Event|0|||
125597879|NCT01518699|451813761|FG005|Period 2|Adverse Event|0|||
125597880|NCT02839746|451813763|FG000|Overall Study|Not met selection criteria|12|||
125597881|NCT00744055|451813764|FG000|Overall Study|Withdrawal by Subject|6|||
125597882|NCT00744055|451813765|FG001|Overall Study|Withdrawal by Subject|9|||
125597883|NCT00744055|451813764|FG000|Overall Study|Lack of Efficacy|0|||
125597884|NCT00744055|451813765|FG001|Overall Study|Lack of Efficacy|1|||
125368753|NCT00042289|450984747|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
125368754|NCT00042289|450984748|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
125368755|NCT00042289|450984749|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
125368756|NCT00042289|450984750|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
125368757|NCT00042289|450984751|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
125368758|NCT00042289|450984752|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
125368759|NCT00042289|450984753|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
125368760|NCT00042289|450984754|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
125368761|NCT00042289|450984755|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
125368762|NCT00042289|450984756|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
125368763|NCT00042289|450984757|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
125368764|NCT00042289|450984758|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
125368765|NCT00042289|450984759|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
125368766|NCT00042289|450984760|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
125368767|NCT00042289|450984761|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
125368768|NCT00042289|450984715|FG000|Overall Study|Protocol Violation|0|||
125368769|NCT00042289|450984716|FG001|Overall Study|Protocol Violation|0|||
125368770|NCT00042289|450984717|FG002|Overall Study|Protocol Violation|0|||
125368771|NCT00042289|450984718|FG003|Overall Study|Protocol Violation|0|||
125368772|NCT00042289|450984719|FG004|Overall Study|Protocol Violation|0|||
125368773|NCT00042289|450984720|FG005|Overall Study|Protocol Violation|1|||
125368774|NCT00042289|450984721|FG006|Overall Study|Protocol Violation|0|||
125368775|NCT00042289|450984722|FG007|Overall Study|Protocol Violation|1|||
125368776|NCT00042289|450984723|FG008|Overall Study|Protocol Violation|0|||
125368777|NCT00042289|450984724|FG009|Overall Study|Protocol Violation|0|||
125368778|NCT00042289|450984725|FG010|Overall Study|Protocol Violation|0|||
125368779|NCT00042289|450984726|FG011|Overall Study|Protocol Violation|0|||
125368780|NCT00042289|450984727|FG012|Overall Study|Protocol Violation|0|||
125368781|NCT00042289|450984728|FG013|Overall Study|Protocol Violation|0|||
125368782|NCT00042289|450984729|FG014|Overall Study|Protocol Violation|0|||
125368783|NCT00042289|450984730|FG015|Overall Study|Protocol Violation|0|||
125368784|NCT00042289|450984731|FG016|Overall Study|Protocol Violation|0|||
125368785|NCT00042289|450984732|FG017|Overall Study|Protocol Violation|0|||
125368786|NCT00042289|450984733|FG018|Overall Study|Protocol Violation|0|||
125368787|NCT00042289|450984734|FG019|Overall Study|Protocol Violation|0|||
125368788|NCT00042289|450984735|FG020|Overall Study|Protocol Violation|0|||
125368789|NCT00042289|450984736|FG021|Overall Study|Protocol Violation|0|||
125368790|NCT00042289|450984737|FG022|Overall Study|Protocol Violation|0|||
125368791|NCT00042289|450984738|FG023|Overall Study|Protocol Violation|1|||
125368792|NCT00042289|450984739|FG024|Overall Study|Protocol Violation|1|||
125368793|NCT00042289|450984740|FG025|Overall Study|Protocol Violation|0|||
125368794|NCT00042289|450984741|FG026|Overall Study|Protocol Violation|2|||
125368795|NCT00042289|450984742|FG027|Overall Study|Protocol Violation|0|||
125368796|NCT00042289|450984743|FG028|Overall Study|Protocol Violation|0|||
125368797|NCT00042289|450984744|FG029|Overall Study|Protocol Violation|0|||
125368798|NCT00042289|450984745|FG030|Overall Study|Protocol Violation|1|||
125368799|NCT00042289|450984746|FG031|Overall Study|Protocol Violation|0|||
125368800|NCT00042289|450984747|FG032|Overall Study|Protocol Violation|0|||
125368801|NCT00042289|450984748|FG033|Overall Study|Protocol Violation|0|||
125431456|NCT01859793|451205671|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
125597885|NCT00744055|451813764|FG000|Overall Study|Physician Decision|0|||
125368802|NCT00042289|450984749|FG034|Overall Study|Protocol Violation|0|||
125368803|NCT00042289|450984750|FG035|Overall Study|Protocol Violation|0|||
125368804|NCT00042289|450984751|FG036|Overall Study|Protocol Violation|0|||
125368805|NCT00042289|450984752|FG037|Overall Study|Protocol Violation|0|||
125368806|NCT00042289|450984753|FG038|Overall Study|Protocol Violation|0|||
125368807|NCT00042289|450984754|FG039|Overall Study|Protocol Violation|0|||
125597886|NCT00744055|451813765|FG001|Overall Study|Physician Decision|2|||
125597887|NCT00744055|451813764|FG000|Overall Study|Protocol Violation|1|||
125597888|NCT00744055|451813765|FG001|Overall Study|Protocol Violation|1|||
125431457|NCT01859793|451205672|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
125431458|NCT01859793|451205671|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
125431459|NCT01859793|451205672|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
125431460|NCT01859793|451205671|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
125431461|NCT01859793|451205672|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
125431462|NCT01859793|451205671|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
125431463|NCT01859793|451205672|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
125431464|NCT01735396|451205673|FG000|Overall Study|not evaluable|1|||
125431465|NCT01148862|451205674|FG000|Second Intervention|Withdrawal by Subject|0|||
125431466|NCT01148862|451205675|FG001|Second Intervention|Withdrawal by Subject|2|||
125431467|NCT03724396|451205677|FG000|Overall Study|Lost to Follow-up|1|||
125431468|NCT03724396|451205678|FG001|Overall Study|Lost to Follow-up|1|||
125431469|NCT03724396|451205677|FG000|Overall Study|Withdrawal by Subject|1|||
125431470|NCT03724396|451205678|FG001|Overall Study|Withdrawal by Subject|0|||
125431471|NCT00652938|451205682|FG000|Overall Study|Adverse Event|1|||
125431472|NCT00652938|451205683|FG001|Overall Study|Adverse Event|0|||
125431473|NCT00652938|451205684|FG002|Overall Study|Adverse Event|2|||
125431474|NCT00652938|451205682|FG000|Overall Study|Withdrawal by Subject|0|||
125431475|NCT00652938|451205683|FG001|Overall Study|Withdrawal by Subject|6|||
125431476|NCT00652938|451205684|FG002|Overall Study|Withdrawal by Subject|1|||
125431477|NCT00652938|451205682|FG000|Overall Study|Lost to Follow-up|0|||
125431478|NCT00652938|451205683|FG001|Overall Study|Lost to Follow-up|0|||
125431479|NCT00652938|451205684|FG002|Overall Study|Lost to Follow-up|2|||
125431480|NCT00652938|451205682|FG000|Overall Study|fear of blood sampling|0|||
125431481|NCT00652938|451205683|FG001|Overall Study|fear of blood sampling|1|||
125431482|NCT00652938|451205684|FG002|Overall Study|fear of blood sampling|0|||
125431483|NCT01547299|451205685|FG000|Overall Study|Withdrawal by Subject|2|||
125431484|NCT01547299|451205686|FG001|Overall Study|Withdrawal by Subject|2|||
125431485|NCT01833143|451205691|FG000|Overall Study|Not Treated|1|||
125431486|NCT03995784|451205692|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
125431487|NCT01493960|451207667|FG000|Overall Study|Adverse Event|0|||
125431488|NCT01493960|451207668|FG001|Overall Study|Adverse Event|1|||
125431489|NCT01493960|451207667|FG000|Overall Study|Lack of Efficacy|15|||
125431490|NCT01493960|451207668|FG001|Overall Study|Lack of Efficacy|9|||
125431491|NCT01493960|451207667|FG000|Overall Study|Protocol Violation|3|||
125431492|NCT01493960|451207668|FG001|Overall Study|Protocol Violation|0|||
125431493|NCT01493960|451207667|FG000|Overall Study|Withdrawal by Subject|10|||
125431494|NCT01493960|451207668|FG001|Overall Study|Withdrawal by Subject|4|||
125431495|NCT01493960|451207667|FG000|Overall Study|Non-specified|4|||
125431496|NCT01493960|451207668|FG001|Overall Study|Non-specified|4|||
125431497|NCT00284141|451207673|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
125431498|NCT00284141|451207673|FG000|Overall Study|Adverse Event|19|||
125431499|NCT00284141|451207673|FG000|Overall Study|Participant's request|9|||
125431500|NCT00284141|451207673|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
125431501|NCT00284141|451207673|FG000|Overall Study|Clinical deterioration / death|2|||
125431502|NCT00284141|451207673|FG000|Overall Study|General decline|1|||
125431503|NCT00284141|451207673|FG000|Overall Study|Pneumonia|1|||
125431504|NCT00284141|451207673|FG000|Overall Study|Did not take study medication|2|||
125431505|NCT00284141|451207673|FG000|Overall Study|Ongoing treatment|2|||
125431506|NCT00975221|451207674|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
125431507|NCT00975221|451207675|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
125431508|NCT00975221|451207674|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
125431509|NCT00975221|451207675|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
125597889|NCT00744055|451813764|FG000|Overall Study|Lost to Follow-up|0|||
125597890|NCT00744055|451813765|FG001|Overall Study|Lost to Follow-up|1|||
125597891|NCT02767570|451813766|FG000|Overall Study|Lost to Follow-up|3|||
125431510|NCT00975221|451207674|FG000|Titration Phase (Weeks 1-12)|Other|0|||
125597892|NCT02767570|451813767|FG001|Overall Study|Lost to Follow-up|0|||
125431511|NCT00975221|451207675|FG001|Titration Phase (Weeks 1-12)|Other|1|||
125431512|NCT00975221|451207674|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
125431513|NCT00975221|451207675|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
125431514|NCT00975221|451207674|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
125431515|NCT00975221|451207675|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
125431516|NCT00975221|451207674|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
125431517|NCT00975221|451207675|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
125431518|NCT03935217|451207678|FG000|Overall Study|Adverse Event|1|||
125431519|NCT03935217|451207679|FG001|Overall Study|Adverse Event|0|||
125597893|NCT02767570|451813766|FG000|Overall Study|COVID shutdown|2|||
125431520|NCT03935217|451207678|FG000|Overall Study|Lost to Follow-up|0|||
125597894|NCT02767570|451813767|FG001|Overall Study|COVID shutdown|5|||
125597895|NCT02767570|451813766|FG000|Overall Study|Increased pain|2|||
125597896|NCT02767570|451813767|FG001|Overall Study|Increased pain|0|||
125597897|NCT02767570|451813766|FG000|Overall Study|Withdrawal by Subject|1|||
125597898|NCT02767570|451813767|FG001|Overall Study|Withdrawal by Subject|3|||
125597899|NCT02767570|451813766|FG000|Overall Study|Unrelated medical issue|1|||
125597900|NCT02767570|451813767|FG001|Overall Study|Unrelated medical issue|1|||
125597901|NCT02767570|451813766|FG000|Overall Study|Received intra-articular injection|0|||
125597902|NCT02767570|451813767|FG001|Overall Study|Received intra-articular injection|1|||
125597903|NCT00151411|451813768|FG000|Overall Study|Lost to Follow-up|15|||
125597904|NCT00151411|451813769|FG001|Overall Study|Lost to Follow-up|19|||
125597905|NCT00151411|451813768|FG000|Overall Study|Withdrawal by Subject|12|||
125597906|NCT00151411|451813769|FG001|Overall Study|Withdrawal by Subject|20|||
125597907|NCT00151411|451813768|FG000|Overall Study|Adverse Event|6|||
125597908|NCT00151411|451813769|FG001|Overall Study|Adverse Event|0|||
125597909|NCT00151411|451813768|FG000|Overall Study|Pregnancy|0|||
125597910|NCT00151411|451813769|FG001|Overall Study|Pregnancy|4|||
125597911|NCT01712438|451813770|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
125597912|NCT01712438|451813770|FG000|Overall Study|Ongoing ITI treatment|6|||
125597913|NCT01712438|451813770|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
125597914|NCT01712438|451813770|FG000|Overall Study|Prematurely Discontinued|25|||
125597915|NCT03846947|451813777|FG000|Overall Study|technical issues with imaging sequence|2|||
125212785|NCT01026818|450405478|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
125597916|NCT02082184|451813779|FG000|Overall Study|Adverse Event|1|||
125597917|NCT02082184|451813780|FG001|Overall Study|Adverse Event|0|||
125597918|NCT02082184|451813779|FG000|Overall Study|Medical diagnosis|1|||
125597919|NCT02082184|451813780|FG001|Overall Study|Medical diagnosis|2|||
125597920|NCT02082184|451813779|FG000|Overall Study|Device associated symptoms|5|||
125597921|NCT02082184|451813780|FG001|Overall Study|Device associated symptoms|0|||
125597922|NCT02082184|451813779|FG000|Overall Study|Withdrawal by Subject|3|||
125597923|NCT02082184|451813780|FG001|Overall Study|Withdrawal by Subject|2|||
125597924|NCT02082184|451813779|FG000|Overall Study|Protocol Violation|0|||
125368808|NCT00042289|450984755|FG040|Overall Study|Protocol Violation|0|||
125368809|NCT00042289|450984756|FG041|Overall Study|Protocol Violation|1|||
125368810|NCT00042289|450984757|FG042|Overall Study|Protocol Violation|1|||
125368811|NCT00042289|450984758|FG043|Overall Study|Protocol Violation|1|||
125368812|NCT00042289|450984759|FG044|Overall Study|Protocol Violation|0|||
125368813|NCT00042289|450984760|FG045|Overall Study|Protocol Violation|0|||
125368814|NCT00042289|450984761|FG046|Overall Study|Protocol Violation|0|||
125368815|NCT00042289|450984715|FG000|Overall Study|Withdrawal by Subject|4|||
125368816|NCT00042289|450984716|FG001|Overall Study|Withdrawal by Subject|1|||
125368817|NCT00042289|450984717|FG002|Overall Study|Withdrawal by Subject|0|||
125368818|NCT00042289|450984718|FG003|Overall Study|Withdrawal by Subject|2|||
125368819|NCT00042289|450984719|FG004|Overall Study|Withdrawal by Subject|0|||
125368820|NCT00042289|450984720|FG005|Overall Study|Withdrawal by Subject|2|||
125368821|NCT00042289|450984721|FG006|Overall Study|Withdrawal by Subject|0|||
125368822|NCT00042289|450984722|FG007|Overall Study|Withdrawal by Subject|0|||
125368823|NCT00042289|450984723|FG008|Overall Study|Withdrawal by Subject|0|||
125368824|NCT00042289|450984724|FG009|Overall Study|Withdrawal by Subject|1|||
125368825|NCT00042289|450984725|FG010|Overall Study|Withdrawal by Subject|0|||
125431521|NCT03935217|451207679|FG001|Overall Study|Lost to Follow-up|1|||
125431522|NCT03935217|451207678|FG000|Overall Study|Withdrawal by Subject|0|||
125431523|NCT03935217|451207679|FG001|Overall Study|Withdrawal by Subject|2|||
125368826|NCT00042289|450984726|FG011|Overall Study|Withdrawal by Subject|0|||
125368827|NCT00042289|450984727|FG012|Overall Study|Withdrawal by Subject|2|||
125597925|NCT02082184|451813780|FG001|Overall Study|Protocol Violation|6|||
125597926|NCT02082184|451813779|FG000|Overall Study|Lost to Follow-up|0|||
125597927|NCT02082184|451813780|FG001|Overall Study|Lost to Follow-up|2|||
125597928|NCT02082184|451813779|FG000|Overall Study|Subject non-compliance|0|||
125597929|NCT02082184|451813780|FG001|Overall Study|Subject non-compliance|1|||
125368828|NCT00042289|450984728|FG013|Overall Study|Withdrawal by Subject|0|||
125368829|NCT00042289|450984729|FG014|Overall Study|Withdrawal by Subject|0|||
125368830|NCT00042289|450984730|FG015|Overall Study|Withdrawal by Subject|0|||
125368831|NCT00042289|450984731|FG016|Overall Study|Withdrawal by Subject|0|||
125368832|NCT00042289|450984732|FG017|Overall Study|Withdrawal by Subject|0|||
125368833|NCT00042289|450984733|FG018|Overall Study|Withdrawal by Subject|0|||
125368834|NCT00042289|450984734|FG019|Overall Study|Withdrawal by Subject|0|||
125368835|NCT00042289|450984735|FG020|Overall Study|Withdrawal by Subject|0|||
125368836|NCT00042289|450984736|FG021|Overall Study|Withdrawal by Subject|1|||
125368837|NCT00042289|450984737|FG022|Overall Study|Withdrawal by Subject|1|||
125368838|NCT00042289|450984738|FG023|Overall Study|Withdrawal by Subject|1|||
125368839|NCT00042289|450984739|FG024|Overall Study|Withdrawal by Subject|0|||
125368840|NCT00042289|450984740|FG025|Overall Study|Withdrawal by Subject|0|||
125368841|NCT00042289|450984741|FG026|Overall Study|Withdrawal by Subject|1|||
125368842|NCT00042289|450984742|FG027|Overall Study|Withdrawal by Subject|0|||
125368843|NCT00042289|450984743|FG028|Overall Study|Withdrawal by Subject|2|||
125368844|NCT00042289|450984744|FG029|Overall Study|Withdrawal by Subject|0|||
125368845|NCT00042289|450984745|FG030|Overall Study|Withdrawal by Subject|0|||
125368846|NCT00042289|450984746|FG031|Overall Study|Withdrawal by Subject|1|||
125368847|NCT00042289|450984747|FG032|Overall Study|Withdrawal by Subject|2|||
125368848|NCT00042289|450984748|FG033|Overall Study|Withdrawal by Subject|1|||
125368849|NCT00042289|450984749|FG034|Overall Study|Withdrawal by Subject|0|||
125368850|NCT00042289|450984750|FG035|Overall Study|Withdrawal by Subject|0|||
125368851|NCT00042289|450984751|FG036|Overall Study|Withdrawal by Subject|0|||
125368852|NCT00042289|450984752|FG037|Overall Study|Withdrawal by Subject|1|||
125368853|NCT00042289|450984753|FG038|Overall Study|Withdrawal by Subject|0|||
125368854|NCT00042289|450984754|FG039|Overall Study|Withdrawal by Subject|0|||
125368855|NCT00042289|450984755|FG040|Overall Study|Withdrawal by Subject|0|||
125368856|NCT00042289|450984756|FG041|Overall Study|Withdrawal by Subject|0|||
125368857|NCT00042289|450984757|FG042|Overall Study|Withdrawal by Subject|1|||
125368858|NCT00042289|450984758|FG043|Overall Study|Withdrawal by Subject|0|||
125368859|NCT00042289|450984759|FG044|Overall Study|Withdrawal by Subject|0|||
125368860|NCT00042289|450984760|FG045|Overall Study|Withdrawal by Subject|0|||
125368861|NCT00042289|450984761|FG046|Overall Study|Withdrawal by Subject|0|||
125368862|NCT00745823|450984762|FG000|Overall Study|Adverse Event|5|||
125368863|NCT00745823|450984763|FG001|Overall Study|Adverse Event|3|||
125368864|NCT00745823|450984762|FG000|Overall Study|Lack of Efficacy|20|||
125368865|NCT00745823|450984763|FG001|Overall Study|Lack of Efficacy|6|||
125368866|NCT00745823|450984762|FG000|Overall Study|Lost to Follow-up|10|||
125368867|NCT00745823|450984763|FG001|Overall Study|Lost to Follow-up|11|||
125368868|NCT00745823|450984762|FG000|Overall Study|Physician Decision|10|||
125368869|NCT00745823|450984763|FG001|Overall Study|Physician Decision|5|||
125368870|NCT00745823|450984762|FG000|Overall Study|Pregnancy|0|||
125368871|NCT00745823|450984763|FG001|Overall Study|Pregnancy|4|||
125368872|NCT00745823|450984762|FG000|Overall Study|Withdrawal by Subject|14|||
125368873|NCT00745823|450984763|FG001|Overall Study|Withdrawal by Subject|8|||
125368874|NCT00745823|450984762|FG000|Overall Study|Study Terminated by Sponsor|326|||
125368875|NCT00745823|450984763|FG001|Overall Study|Study Terminated by Sponsor|349|||
125368876|NCT01687998|450984764|FG000|Overall Study|Withdrawal by Subject|49|||
125368877|NCT01687998|450984765|FG001|Overall Study|Withdrawal by Subject|51|||
125368878|NCT01687998|450984764|FG000|Overall Study|Known to be Alive at Study End|54|||
125368879|NCT01687998|450984765|FG001|Overall Study|Known to be Alive at Study End|62|||
125368880|NCT01687998|450984764|FG000|Overall Study|Lost to Follow-up|9|||
125368881|NCT01687998|450984765|FG001|Overall Study|Lost to Follow-up|7|||
125368882|NCT00717197|450984772|FG000|Overall Study|Unable to purchase study drug|5|||
125368883|NCT00717197|450984772|FG000|Overall Study|Tumor Progression|1|||
125368884|NCT00717197|450984772|FG000|Overall Study|Physician Decision|1|||
125368885|NCT00982137|450984773|FG000|Overall Study|Lost to Follow-up|0|||
125368886|NCT00982137|450984774|FG001|Overall Study|Lost to Follow-up|0|||
125368887|NCT00982137|450984775|FG002|Overall Study|Lost to Follow-up|0|||
125368888|NCT00982137|450984776|FG003|Overall Study|Lost to Follow-up|1|||
125368889|NCT00982137|450984773|FG000|Overall Study|Withdrawal by Subject|0|||
125368890|NCT00982137|450984774|FG001|Overall Study|Withdrawal by Subject|1|||
125368891|NCT00982137|450984775|FG002|Overall Study|Withdrawal by Subject|0|||
125368892|NCT00982137|450984776|FG003|Overall Study|Withdrawal by Subject|0|||
125368893|NCT00612690|450984785|FG000|Overall Study|Lost to Follow-up|72|||
125368894|NCT00612690|450984786|FG001|Overall Study|Lost to Follow-up|98|||
125368895|NCT00612690|450984785|FG000|Overall Study|Withdrawal by Subject|32|||
125368896|NCT00612690|450984786|FG001|Overall Study|Withdrawal by Subject|20|||
125368897|NCT00612690|450984785|FG000|Overall Study|Withdrawal by Site|11|||
125368898|NCT00612690|450984786|FG001|Overall Study|Withdrawal by Site|0|||
125368899|NCT00787891|450984788|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
125368900|NCT00787891|450984789|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
125368901|NCT00787891|450984788|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
125368902|NCT00787891|450984789|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
125368903|NCT00787891|450984788|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
125368904|NCT00787891|450984789|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
125368905|NCT00787891|450984788|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
125368906|NCT00787891|450984789|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
125368907|NCT00787891|450984788|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
125368908|NCT00787891|450984789|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
125368909|NCT00787891|450984788|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
125368910|NCT00787891|450984789|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
125368911|NCT00787891|450984788|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
125368912|NCT00787891|450984789|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
125368913|NCT00787891|450984788|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
125368914|NCT00787891|450984789|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
125368915|NCT00787891|450984788|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
125368916|NCT00787891|450984789|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
125368917|NCT00787891|450984788|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
125368918|NCT00787891|450984789|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
125368919|NCT02955602|450984790|FG000|Overall Study|Adverse Event|0|||
125368920|NCT02955602|450984791|FG001|Overall Study|Adverse Event|3|||
125368921|NCT02955602|450984792|FG002|Overall Study|Adverse Event|0|||
125368922|NCT02955602|450984790|FG000|Overall Study|Withdrawal of informed consent|1|||
125368923|NCT02955602|450984791|FG001|Overall Study|Withdrawal of informed consent|3|||
125368924|NCT02955602|450984792|FG002|Overall Study|Withdrawal of informed consent|2|||
125368925|NCT02955602|450984790|FG000|Overall Study|Lost to Follow-up|0|||
125368926|NCT02955602|450984791|FG001|Overall Study|Lost to Follow-up|0|||
125368927|NCT02955602|450984792|FG002|Overall Study|Lost to Follow-up|1|||
125368928|NCT02955602|450984790|FG000|Overall Study|Other|0|||
125368929|NCT02955602|450984791|FG001|Overall Study|Other|1|||
125368930|NCT02955602|450984792|FG002|Overall Study|Other|3|||
125368931|NCT02980601|450984795|FG000|Overall Study|Lost to Follow-up|2|||
125368932|NCT02980601|450984796|FG001|Overall Study|Lost to Follow-up|2|||
125368933|NCT02980601|450984795|FG000|Overall Study|Death|0|||
125368934|NCT02980601|450984796|FG001|Overall Study|Death|1|||
125368935|NCT02980601|450984795|FG000|Overall Study|Graft loss|1|||
125368936|NCT02980601|450984796|FG001|Overall Study|Graft loss|0|||
125368937|NCT02980601|450984795|FG000|Overall Study|Failed to sign consent|2|||
125368938|NCT02980601|450984796|FG001|Overall Study|Failed to sign consent|0|||
125368939|NCT01575769|450984797|FG000|Overall Study|Adverse Event|1|||
125368940|NCT01575769|450984797|FG000|Overall Study|Study terminated by sponsor|40|||
125368941|NCT03156543|450984800|FG000|Overall Study|Withdrawal by Subject|1|||
125368942|NCT03156543|450984801|FG001|Overall Study|Withdrawal by Subject|0|||
125368943|NCT00674700|450984802|FG000|Year 1|Adverse Event|17|||
125368944|NCT00674700|450984803|FG001|Year 1|Adverse Event|20|||
125368945|NCT00674700|450984804|FG002|Year 1|Adverse Event|5|||
125368946|NCT00674700|450984802|FG000|Year 1|Withdrawal by Subject|7|||
125368947|NCT00674700|450984803|FG001|Year 1|Withdrawal by Subject|7|||
125368948|NCT00674700|450984804|FG002|Year 1|Withdrawal by Subject|6|||
125368949|NCT00674700|450984802|FG000|Year 1|Any other reason not above-mentioned|7|||
125368950|NCT00674700|450984803|FG001|Year 1|Any other reason not above-mentioned|7|||
125368951|NCT00674700|450984804|FG002|Year 1|Any other reason not above-mentioned|6|||
125368952|NCT00674700|450984802|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
125368953|NCT00674700|450984803|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
125368954|NCT00674700|450984804|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
125368955|NCT00674700|450984802|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
125368956|NCT00674700|450984803|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
125368957|NCT00674700|450984804|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
125368958|NCT00674700|450984802|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
125368959|NCT00674700|450984803|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
125368960|NCT00674700|450984804|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
125368961|NCT00395304|450984805|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125368962|NCT00395304|450984806|FG001|Treatment Period 1|Withdrawal by Subject|3|||
125368963|NCT00395304|450984807|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125368964|NCT00395304|450984808|FG003|Treatment Period 1|Withdrawal by Subject|2|||
125368965|NCT00395304|450984809|FG004|Treatment Period 1|Withdrawal by Subject|1|||
125368966|NCT00395304|450984810|FG005|Treatment Period 1|Withdrawal by Subject|1|||
125368967|NCT00395304|450984805|FG000|Treatment Period 1|Lost to Follow-up|1|||
125368968|NCT00395304|450984806|FG001|Treatment Period 1|Lost to Follow-up|0|||
125368969|NCT00395304|450984807|FG002|Treatment Period 1|Lost to Follow-up|0|||
125368970|NCT00395304|450984808|FG003|Treatment Period 1|Lost to Follow-up|1|||
125368971|NCT00395304|450984809|FG004|Treatment Period 1|Lost to Follow-up|0|||
125368972|NCT00395304|450984810|FG005|Treatment Period 1|Lost to Follow-up|1|||
125368973|NCT00395304|450984805|FG000|Treatment Period 1|Physician Decision|0|||
125368974|NCT00395304|450984806|FG001|Treatment Period 1|Physician Decision|1|||
125368975|NCT00395304|450984807|FG002|Treatment Period 1|Physician Decision|0|||
125368976|NCT00395304|450984808|FG003|Treatment Period 1|Physician Decision|0|||
125368977|NCT00395304|450984809|FG004|Treatment Period 1|Physician Decision|0|||
125368978|NCT00395304|450984810|FG005|Treatment Period 1|Physician Decision|0|||
125368979|NCT00395304|450984805|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125368980|NCT00395304|450984806|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125368981|NCT00395304|450984807|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125368982|NCT00395304|450984808|FG003|Treatment Period 2|Withdrawal by Subject|1|||
125368983|NCT00395304|450984809|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125368984|NCT00395304|450984810|FG005|Treatment Period 2|Withdrawal by Subject|2|||
125368985|NCT00395304|450984805|FG000|Treatment Period 2|Lost to Follow-up|0|||
125368986|NCT00395304|450984806|FG001|Treatment Period 2|Lost to Follow-up|3|||
125368987|NCT00395304|450984807|FG002|Treatment Period 2|Lost to Follow-up|0|||
125431524|NCT03559218|451207680|FG000|Overall Study|Withdrawal by Subject|1|||
125431525|NCT03559218|451207681|FG001|Overall Study|Withdrawal by Subject|0|||
125431526|NCT00332332|451207683|FG000|Overall Study|Adverse Event|13|||
125431527|NCT00332332|451207683|FG000|Overall Study|Death|1|||
125431528|NCT00332332|451207683|FG000|Overall Study|Withdrawal by Subject|8|||
125431529|NCT00332332|451207683|FG000|Overall Study|Physician Decision|1|||
125431530|NCT00332332|451207683|FG000|Overall Study|Lost to Follow-up|3|||
125431531|NCT00332332|451207683|FG000|Overall Study|Protocol deviation|4|||
125431532|NCT00332332|451207683|FG000|Overall Study|Noncompliance|2|||
125431533|NCT00332332|451207683|FG000|Overall Study|Disease progression|2|||
125431534|NCT00332332|451207683|FG000|Overall Study|Other|18|||
125431535|NCT00332332|451207683|FG000|Overall Study|Did not receive study treatment|16|||
125431536|NCT01108458|451207684|FG000|Overall Study|Withdrawal by Subject|1|||
125431537|NCT01382602|451207685|FG000|Overall Study|Protocol Violation|0|||
125431538|NCT01382602|451207686|FG001|Overall Study|Protocol Violation|3|||
125431539|NCT01382602|451207685|FG000|Overall Study|Withdrawal by Subject|0|||
125431540|NCT01382602|451207686|FG001|Overall Study|Withdrawal by Subject|1|||
125431541|NCT02790073|451207687|FG000|Overall Study|Death|1|||
125431542|NCT02790073|451207687|FG000|Overall Study|Withdrawal from HD|1|||
125212786|NCT01026818|450405479|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
125212787|NCT01026818|450405480|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
125212788|NCT01026818|450405481|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
125212789|NCT01026818|450405478|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
125212790|NCT01026818|450405479|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
125212791|NCT01026818|450405480|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
125212792|NCT01026818|450405481|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
125212793|NCT01026818|450405478|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
125368988|NCT00395304|450984808|FG003|Treatment Period 2|Lost to Follow-up|0|||
125368989|NCT00395304|450984809|FG004|Treatment Period 2|Lost to Follow-up|0|||
125368990|NCT00395304|450984810|FG005|Treatment Period 2|Lost to Follow-up|0|||
125368991|NCT00395304|450984805|FG000|Treatment Period 2|Physician Decision|0|||
125431543|NCT02790073|451207687|FG000|Overall Study|Withdrawal by Subject|1|||
125431544|NCT04170686|451207688|FG000|Screening|Physician Decision|12|||
125431545|NCT04170686|451207689|FG001|Screening|Physician Decision|13|||
125431546|NCT04170686|451207688|FG000|Randomization and Treatment|Lost to Follow-up|26|||
125431547|NCT04170686|451207689|FG001|Randomization and Treatment|Lost to Follow-up|15|||
125431548|NCT03328143|451207690|FG000|Overall Study|Declined|3|||
125431549|NCT03328143|451207690|FG000|Overall Study|Required increased sedation|4|||
125431550|NCT03328143|451207690|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
125431551|NCT03328143|451207690|FG000|Overall Study|Surgery cancelled|1|||
125431552|NCT02801669|451207691|FG000|Overall Study|Death|66|||
125431553|NCT02801669|451207692|FG001|Overall Study|Death|69|||
125368992|NCT00395304|450984806|FG001|Treatment Period 2|Physician Decision|0|||
125368993|NCT00395304|450984807|FG002|Treatment Period 2|Physician Decision|1|||
125368994|NCT00395304|450984808|FG003|Treatment Period 2|Physician Decision|0|||
125368995|NCT00395304|450984809|FG004|Treatment Period 2|Physician Decision|0|||
125431554|NCT02801669|451207691|FG000|Overall Study|Withdrawal by Subject|81|||
125431555|NCT02801669|451207692|FG001|Overall Study|Withdrawal by Subject|77|||
125431556|NCT02801669|451207691|FG000|Overall Study|Other|4|||
125431557|NCT02801669|451207692|FG001|Overall Study|Other|6|||
125431558|NCT02696564|451207693|FG000|Overall Study|Death|1|||
125431559|NCT02696564|451207694|FG001|Overall Study|Death|2|||
125431560|NCT02696564|451207693|FG000|Overall Study|Withdrawal by Subject|3|||
125431561|NCT02696564|451207694|FG001|Overall Study|Withdrawal by Subject|2|||
125431562|NCT02696564|451207693|FG000|Overall Study|Lost to Follow-up|3|||
125431563|NCT02696564|451207694|FG001|Overall Study|Lost to Follow-up|3|||
125597930|NCT02413398|451813783|FG000|Overall Study|Lost to Follow-up|2|||
125368996|NCT00395304|450984810|FG005|Treatment Period 2|Physician Decision|0|||
125431564|NCT02696564|451207693|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
125431565|NCT02696564|451207694|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
125431566|NCT02696564|451207693|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
125368997|NCT00395304|450984805|FG000|Treatment Period 2|Other|0|||
125368998|NCT00395304|450984806|FG001|Treatment Period 2|Other|1|||
125431567|NCT02696564|451207694|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
125431568|NCT02696564|451207693|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
125431569|NCT02696564|451207694|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
125431570|NCT02696564|451207693|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
125597931|NCT02413398|451813784|FG001|Overall Study|Lost to Follow-up|4|||
125597932|NCT02413398|451813783|FG000|Overall Study|Withdrawal by Subject|1|||
125597933|NCT02413398|451813784|FG001|Overall Study|Withdrawal by Subject|1|||
125597934|NCT02413398|451813783|FG000|Overall Study|Other Eligibility criteria|1|||
125597935|NCT02413398|451813784|FG001|Overall Study|Other Eligibility criteria|2|||
125597936|NCT02874794|451813785|FG000|Overall Study|Physician Decision|3|||
125597937|NCT02874794|451813786|FG001|Overall Study|Physician Decision|2|||
125597938|NCT02874794|451813785|FG000|Overall Study|Withdrawal by Subject|2|||
125597939|NCT02874794|451813786|FG001|Overall Study|Withdrawal by Subject|8|||
125597940|NCT02874794|451813785|FG000|Overall Study|Death|2|||
125597941|NCT02874794|451813786|FG001|Overall Study|Death|1|||
125597942|NCT00537940|451813787|FG000|Overall Study|Adverse Event|20|||
125597943|NCT00537940|451813788|FG001|Overall Study|Adverse Event|19|||
125597944|NCT00537940|451813787|FG000|Overall Study|Lack of Efficacy|8|||
125597945|NCT00537940|451813788|FG001|Overall Study|Lack of Efficacy|16|||
125368999|NCT00395304|450984807|FG002|Treatment Period 2|Other|0|||
125369000|NCT00395304|450984808|FG003|Treatment Period 2|Other|0|||
125369001|NCT00395304|450984809|FG004|Treatment Period 2|Other|0|||
125369002|NCT00395304|450984810|FG005|Treatment Period 2|Other|0|||
125431571|NCT02696564|451207694|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
125369003|NCT00395304|450984805|FG000|Treatment Period 3|Withdrawal by Subject|0|||
125369004|NCT00395304|450984806|FG001|Treatment Period 3|Withdrawal by Subject|0|||
125369005|NCT00395304|450984807|FG002|Treatment Period 3|Withdrawal by Subject|0|||
125369006|NCT00395304|450984808|FG003|Treatment Period 3|Withdrawal by Subject|1|||
125369007|NCT00395304|450984809|FG004|Treatment Period 3|Withdrawal by Subject|0|||
125369008|NCT00395304|450984810|FG005|Treatment Period 3|Withdrawal by Subject|1|||
125369009|NCT00395304|450984805|FG000|Treatment Period 3|Lost to Follow-up|1|||
125369010|NCT00395304|450984806|FG001|Treatment Period 3|Lost to Follow-up|1|||
125369011|NCT00395304|450984807|FG002|Treatment Period 3|Lost to Follow-up|0|||
125369012|NCT00395304|450984808|FG003|Treatment Period 3|Lost to Follow-up|0|||
125369013|NCT00395304|450984809|FG004|Treatment Period 3|Lost to Follow-up|0|||
125369014|NCT00395304|450984810|FG005|Treatment Period 3|Lost to Follow-up|0|||
125369015|NCT00395304|450984805|FG000|Treatment Period 3|Physician Decision|0|||
125369016|NCT00395304|450984806|FG001|Treatment Period 3|Physician Decision|1|||
125369017|NCT00395304|450984807|FG002|Treatment Period 3|Physician Decision|0|||
125369018|NCT00395304|450984808|FG003|Treatment Period 3|Physician Decision|0|||
125369019|NCT00395304|450984809|FG004|Treatment Period 3|Physician Decision|0|||
125369020|NCT00395304|450984810|FG005|Treatment Period 3|Physician Decision|0|||
125369021|NCT00395304|450984805|FG000|Treatment Period 3|Other|0|||
125369022|NCT00395304|450984806|FG001|Treatment Period 3|Other|0|||
125369023|NCT00395304|450984807|FG002|Treatment Period 3|Other|0|||
125369024|NCT00395304|450984808|FG003|Treatment Period 3|Other|1|||
125369025|NCT00395304|450984809|FG004|Treatment Period 3|Other|0|||
125369026|NCT00395304|450984810|FG005|Treatment Period 3|Other|0|||
125369027|NCT03797014|450984812|FG000|Overall Study|Withdrawal by Subject|1|||
125369028|NCT03797014|450984812|FG000|Overall Study|Lost to Follow-up|1|||
125369029|NCT03797014|450984812|FG000|Overall Study|Protocol Violation|1|||
125369030|NCT01970397|450984813|FG000|Overall Study|Adverse Event|0|||
125369031|NCT01970397|450984814|FG001|Overall Study|Adverse Event|1|||
125369032|NCT01970397|450984813|FG000|Overall Study|Lost to Follow-up|0|||
125369033|NCT01970397|450984814|FG001|Overall Study|Lost to Follow-up|1|||
125369034|NCT01970397|450984813|FG000|Overall Study|Personal Reasons|1|||
125369035|NCT01970397|450984814|FG001|Overall Study|Personal Reasons|2|||
125369036|NCT01970397|450984813|FG000|Overall Study|Protocol Violation|1|||
125369037|NCT01970397|450984814|FG001|Overall Study|Protocol Violation|1|||
125369038|NCT01389817|450984817|FG000|Overall Study|Physician Decision|1|||
125369039|NCT01389817|450984818|FG001|Overall Study|Physician Decision|0|||
125369040|NCT01389817|450984817|FG000|Overall Study|Lost to Follow-up|1|||
125369041|NCT01389817|450984818|FG001|Overall Study|Lost to Follow-up|0|||
125369042|NCT01389817|450984817|FG000|Overall Study|Withdrawal by Subject|2|||
125369043|NCT01389817|450984818|FG001|Overall Study|Withdrawal by Subject|0|||
125369044|NCT01434667|450984824|FG000|Overall Study|Lost to Follow-up|5|||
125369045|NCT01434667|450984825|FG001|Overall Study|Lost to Follow-up|10|||
125369046|NCT02966028|450984826|FG000|Overall Study|Adverse Event|7|||
125597946|NCT00537940|451813787|FG000|Overall Study|Lost to Follow-up|23|||
125369047|NCT02966028|450984827|FG001|Overall Study|Adverse Event|13|||
125369048|NCT02966028|450984828|FG002|Overall Study|Adverse Event|10|||
125369049|NCT02966028|450984826|FG000|Overall Study|Physician Decision|1|||
125597947|NCT00537940|451813788|FG001|Overall Study|Lost to Follow-up|29|||
125597948|NCT00537940|451813787|FG000|Overall Study|Withdrawal by Subject|113|||
125369050|NCT02966028|450984827|FG001|Overall Study|Physician Decision|0|||
125369051|NCT02966028|450984828|FG002|Overall Study|Physician Decision|2|||
125597949|NCT00537940|451813788|FG001|Overall Study|Withdrawal by Subject|95|||
125369052|NCT02966028|450984826|FG000|Overall Study|Withdrawal by Subject|7|||
125369053|NCT02966028|450984827|FG001|Overall Study|Withdrawal by Subject|5|||
125369054|NCT02966028|450984828|FG002|Overall Study|Withdrawal by Subject|5|||
125597950|NCT00537940|451813787|FG000|Overall Study|Protocol Violation|6|||
125597951|NCT00537940|451813788|FG001|Overall Study|Protocol Violation|4|||
125597952|NCT00537940|451813787|FG000|Overall Study|Pregnancy|1|||
125597953|NCT00537940|451813788|FG001|Overall Study|Pregnancy|1|||
125597954|NCT00537940|451813787|FG000|Overall Study|Study terminated by sponsor|2|||
125597955|NCT00537940|451813788|FG001|Overall Study|Study terminated by sponsor|3|||
125597956|NCT00537940|451813787|FG000|Overall Study|Other|10|||
125597957|NCT00537940|451813788|FG001|Overall Study|Other|12|||
125597958|NCT00634543|451813791|FG000|Overall Study|Other|1|||
125597959|NCT00634543|451813792|FG001|Overall Study|Other|2|||
125597960|NCT00634543|451813791|FG000|Overall Study|Protocol Violation|3|||
125597961|NCT00634543|451813792|FG001|Overall Study|Protocol Violation|3|||
125597962|NCT00634543|451813791|FG000|Overall Study|Adverse Event|11|||
125597963|NCT00634543|451813792|FG001|Overall Study|Adverse Event|11|||
125597964|NCT00634543|451813791|FG000|Overall Study|Withdrawal by Subject|4|||
125597965|NCT00634543|451813792|FG001|Overall Study|Withdrawal by Subject|4|||
125597966|NCT00634543|451813791|FG000|Overall Study|Lost to Follow-up|0|||
125597967|NCT00634543|451813792|FG001|Overall Study|Lost to Follow-up|1|||
125597968|NCT02465034|451813793|FG000|Overall Study|Withdrawal by Subject|1|||
125597969|NCT02465034|451813794|FG001|Overall Study|Withdrawal by Subject|1|||
125597970|NCT02465034|451813793|FG000|Overall Study|Screen fail|2|||
125597971|NCT02465034|451813794|FG001|Overall Study|Screen fail|0|||
125597972|NCT02465034|451813793|FG000|Overall Study|Could not be scheduled for study visit|0|||
125597973|NCT02465034|451813794|FG001|Overall Study|Could not be scheduled for study visit|5|||
125597974|NCT02397655|451813800|FG000|Overall Study|data not completed|1301|||
125597975|NCT01736683|451813801|FG000|Overall Study|Disease Relapse|0|||
125597976|NCT01736683|451813802|FG001|Overall Study|Disease Relapse|0|||
125597977|NCT01736683|451813803|FG002|Overall Study|Disease Relapse|2|||
125597978|NCT01736683|451813804|FG003|Overall Study|Disease Relapse|1|||
125597979|NCT01736683|451813805|FG004|Overall Study|Disease Relapse|0|||
125597980|NCT01736683|451813801|FG000|Overall Study|Adverse Event|0|||
125597981|NCT01736683|451813802|FG001|Overall Study|Adverse Event|2|||
125597982|NCT01736683|451813803|FG002|Overall Study|Adverse Event|2|||
125597983|NCT01736683|451813804|FG003|Overall Study|Adverse Event|3|||
125597984|NCT01736683|451813805|FG004|Overall Study|Adverse Event|2|||
125597985|NCT01736683|451813801|FG000|Overall Study|Withdrawal by Subject|0|||
125597986|NCT01736683|451813802|FG001|Overall Study|Withdrawal by Subject|0|||
125597987|NCT01736683|451813803|FG002|Overall Study|Withdrawal by Subject|3|||
125597988|NCT01736683|451813804|FG003|Overall Study|Withdrawal by Subject|1|||
125597989|NCT01736683|451813805|FG004|Overall Study|Withdrawal by Subject|1|||
125597990|NCT01736683|451813801|FG000|Overall Study|Lack of Therapeutic Effect|7|||
125597991|NCT01736683|451813802|FG001|Overall Study|Lack of Therapeutic Effect|4|||
125597992|NCT01736683|451813803|FG002|Overall Study|Lack of Therapeutic Effect|13|||
125597993|NCT01736683|451813804|FG003|Overall Study|Lack of Therapeutic Effect|20|||
125597994|NCT01736683|451813805|FG004|Overall Study|Lack of Therapeutic Effect|1|||
125597995|NCT01736683|451813801|FG000|Overall Study|Progressive Disease|0|||
125597996|NCT01736683|451813802|FG001|Overall Study|Progressive Disease|0|||
125597997|NCT01736683|451813803|FG002|Overall Study|Progressive Disease|0|||
125597998|NCT01736683|451813804|FG003|Overall Study|Progressive Disease|1|||
125597999|NCT01736683|451813805|FG004|Overall Study|Progressive Disease|0|||
125598000|NCT01736683|451813801|FG000|Overall Study|Other|0|||
125598001|NCT01736683|451813802|FG001|Overall Study|Other|0|||
125598002|NCT01736683|451813803|FG002|Overall Study|Other|1|||
125598003|NCT01736683|451813804|FG003|Overall Study|Other|9|||
125598004|NCT01736683|451813805|FG004|Overall Study|Other|1|||
125598005|NCT03633331|451813810|FG000|Overall Study|Withdrawal by Subject|1|||
125598006|NCT02986373|451813811|FG000|Overall Study|Adverse Event|4|||
125369055|NCT02966028|450984826|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
125369056|NCT02966028|450984827|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
125369057|NCT02966028|450984828|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
125369058|NCT04115839|450984829|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
125369059|NCT04115839|450984830|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
125369060|NCT04115839|450984831|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
125369061|NCT04115839|450984832|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
125598007|NCT02986373|451813811|FG000|Overall Study|Lost to Follow-up|1|||
125598008|NCT02986373|451813811|FG000|Overall Study|Withdrawal by Subject|10|||
125598009|NCT02986373|451813811|FG000|Overall Study|Other|24|||
125598010|NCT00995371|451813817|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
125598011|NCT00995371|451813818|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
125598012|NCT04725682|451813819|FG000|Overall Study|Withdrawal by Subject|7|||
125598013|NCT04725682|451813820|FG001|Overall Study|Withdrawal by Subject|5|||
125598014|NCT04725682|451813819|FG000|Overall Study|Failed to comply with the requirements|2|||
125598015|NCT04725682|451813820|FG001|Overall Study|Failed to comply with the requirements|1|||
125598016|NCT04725682|451813819|FG000|Overall Study|Adverse Event|1|||
125598017|NCT04725682|451813820|FG001|Overall Study|Adverse Event|1|||
125598018|NCT04725682|451813819|FG000|Overall Study|Death|0|||
125598019|NCT04725682|451813820|FG001|Overall Study|Death|1|||
125598020|NCT02190591|451813821|FG000|Overall Study|Withdrawal by Subject|1|||
125369062|NCT04115839|450984833|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
125369063|NCT04115839|450984834|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
125369064|NCT04115839|450984835|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
125598021|NCT02190591|451813822|FG001|Overall Study|Withdrawal by Subject|8|||
125598022|NCT02190591|451813821|FG000|Overall Study|Protocol Violation|1|||
125598023|NCT02190591|451813822|FG001|Overall Study|Protocol Violation|0|||
125598024|NCT02190591|451813821|FG000|Overall Study|did not use peanut ball as instructed|0|||
125598025|NCT02190591|451813822|FG001|Overall Study|did not use peanut ball as instructed|2|||
125598026|NCT02190591|451813821|FG000|Overall Study|face presentation so she was ineligible|0|||
125598027|NCT02190591|451813822|FG001|Overall Study|face presentation so she was ineligible|1|||
125598028|NCT00144300|451813823|FG000|Overall Study|Adverse Event|18|||
125598029|NCT00144300|451813824|FG001|Overall Study|Adverse Event|16|||
125598030|NCT00144300|451813823|FG000|Overall Study|Protocol Violation|1|||
125598031|NCT00144300|451813824|FG001|Overall Study|Protocol Violation|3|||
125598032|NCT00144300|451813823|FG000|Overall Study|Lost to Follow-up|3|||
125598033|NCT00144300|451813824|FG001|Overall Study|Lost to Follow-up|0|||
125598034|NCT00144300|451813823|FG000|Overall Study|Withdrawal by Subject|6|||
125598035|NCT00144300|451813824|FG001|Overall Study|Withdrawal by Subject|6|||
125598036|NCT00144300|451813823|FG000|Overall Study|Other reason (not specified)|1|||
125598037|NCT00144300|451813824|FG001|Overall Study|Other reason (not specified)|3|||
125598038|NCT01607892|451813825|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
125598039|NCT01607892|451813826|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
125598040|NCT01607892|451813827|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
125598041|NCT01607892|451813828|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
125598042|NCT01607892|451813829|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
125598043|NCT01607892|451813825|FG000|Overall Study|Death|4|||
125598044|NCT01607892|451813826|FG001|Overall Study|Death|2|||
125598045|NCT01607892|451813827|FG002|Overall Study|Death|8|||
125598046|NCT01607892|451813828|FG003|Overall Study|Death|10|||
125598047|NCT01607892|451813829|FG004|Overall Study|Death|3|||
125598048|NCT01607892|451813825|FG000|Overall Study|Investigator discretion|2|||
125598049|NCT01607892|451813826|FG001|Overall Study|Investigator discretion|4|||
125598050|NCT01607892|451813827|FG002|Overall Study|Investigator discretion|4|||
125598051|NCT01607892|451813828|FG003|Overall Study|Investigator discretion|8|||
125598052|NCT01607892|451813829|FG004|Overall Study|Investigator discretion|0|||
125598053|NCT01607892|451813825|FG000|Overall Study|Other treatments became available|1|||
125598054|NCT01607892|451813826|FG001|Overall Study|Other treatments became available|1|||
125598055|NCT01607892|451813827|FG002|Overall Study|Other treatments became available|0|||
125598056|NCT01607892|451813828|FG003|Overall Study|Other treatments became available|0|||
125598057|NCT01607892|451813829|FG004|Overall Study|Other treatments became available|2|||
125598058|NCT01607892|451813825|FG000|Overall Study|Intercurrent illness|1|||
125598059|NCT01607892|451813826|FG001|Overall Study|Intercurrent illness|0|||
125598060|NCT01607892|451813827|FG002|Overall Study|Intercurrent illness|0|||
125598061|NCT01607892|451813828|FG003|Overall Study|Intercurrent illness|3|||
125598062|NCT01607892|451813829|FG004|Overall Study|Intercurrent illness|0|||
125598063|NCT01607892|451813825|FG000|Overall Study|Non-Compliance with study procedures|0|||
125598064|NCT01607892|451813826|FG001|Overall Study|Non-Compliance with study procedures|0|||
125598065|NCT01607892|451813827|FG002|Overall Study|Non-Compliance with study procedures|1|||
125598066|NCT01607892|451813828|FG003|Overall Study|Non-Compliance with study procedures|0|||
125598067|NCT01607892|451813829|FG004|Overall Study|Non-Compliance with study procedures|0|||
125598068|NCT01607892|451813825|FG000|Overall Study|Consent withdrawn by participant|9|||
125598069|NCT01607892|451813826|FG001|Overall Study|Consent withdrawn by participant|4|||
125598070|NCT01607892|451813827|FG002|Overall Study|Consent withdrawn by participant|24|||
125598071|NCT01607892|451813828|FG003|Overall Study|Consent withdrawn by participant|14|||
125598072|NCT01607892|451813829|FG004|Overall Study|Consent withdrawn by participant|4|||
125598073|NCT01607892|451813825|FG000|Overall Study|Disease progression|38|||
125598074|NCT01607892|451813826|FG001|Overall Study|Disease progression|13|||
125598075|NCT01607892|451813827|FG002|Overall Study|Disease progression|37|||
125598076|NCT01607892|451813828|FG003|Overall Study|Disease progression|57|||
125598077|NCT01607892|451813829|FG004|Overall Study|Disease progression|9|||
125598078|NCT01607892|451813825|FG000|Overall Study|Incidence or severity of Adverse events|3|||
125598079|NCT01607892|451813826|FG001|Overall Study|Incidence or severity of Adverse events|3|||
125369065|NCT04115839|450984829|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
125369066|NCT04115839|450984830|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
125598080|NCT01607892|451813827|FG002|Overall Study|Incidence or severity of Adverse events|7|||
125598081|NCT01607892|451813828|FG003|Overall Study|Incidence or severity of Adverse events|2|||
125598082|NCT01607892|451813829|FG004|Overall Study|Incidence or severity of Adverse events|6|||
125598083|NCT03414359|451813833|FG000|Overall Study|Lack of Efficacy|1|||
125598084|NCT03414359|451813834|FG001|Overall Study|Lack of Efficacy|1|||
125598085|NCT03414359|451813833|FG000|Overall Study|Protocol Violation|0|||
125598086|NCT03414359|451813834|FG001|Overall Study|Protocol Violation|1|||
125598087|NCT02273973|451813835|FG000|Overall Study|Adverse Event|4|||
125598088|NCT02273973|451813836|FG001|Overall Study|Adverse Event|0|||
125369067|NCT04115839|450984831|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
125369068|NCT04115839|450984832|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
125369069|NCT04115839|450984833|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
125369070|NCT04115839|450984834|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
125369071|NCT04115839|450984835|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
125369072|NCT04115839|450984829|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
125369073|NCT04115839|450984830|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
125369074|NCT04115839|450984831|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
125598089|NCT02273973|451813835|FG000|Overall Study|Withdrawal by Subject|2|||
125598090|NCT02273973|451813836|FG001|Overall Study|Withdrawal by Subject|3|||
125598091|NCT02273973|451813835|FG000|Overall Study|Death|1|||
125598092|NCT02273973|451813836|FG001|Overall Study|Death|0|||
125598093|NCT02273973|451813835|FG000|Overall Study|Non-compliance|1|||
125598094|NCT02273973|451813836|FG001|Overall Study|Non-compliance|0|||
125598095|NCT02273973|451813835|FG000|Overall Study|Protocol Violation|1|||
125598096|NCT02273973|451813836|FG001|Overall Study|Protocol Violation|0|||
125598097|NCT02273973|451813835|FG000|Overall Study|Progression of disease|0|||
125598098|NCT02273973|451813836|FG001|Overall Study|Progression of disease|2|||
125598099|NCT02273973|451813835|FG000|Overall Study|Lost to Follow-up|0|||
125598100|NCT02273973|451813836|FG001|Overall Study|Lost to Follow-up|1|||
125598101|NCT02273973|451813835|FG000|Overall Study|Physician Decision|0|||
125598102|NCT02273973|451813836|FG001|Overall Study|Physician Decision|1|||
125598103|NCT02273973|451813835|FG000|Overall Study|Reason not specified|0|||
125598104|NCT02273973|451813836|FG001|Overall Study|Reason not specified|1|||
125598105|NCT02403206|451813838|FG000|Overall Study|Lost to Follow-up|4|||
125598106|NCT02403206|451813839|FG001|Overall Study|Lost to Follow-up|3|||
125598107|NCT02403206|451813838|FG000|Overall Study|Physician Decision|2|||
125598108|NCT02403206|451813839|FG001|Overall Study|Physician Decision|0|||
125598109|NCT02403206|451813838|FG000|Overall Study|Withdrawal by Subject|3|||
125598110|NCT02403206|451813839|FG001|Overall Study|Withdrawal by Subject|3|||
125598111|NCT02403206|451813838|FG000|Overall Study|Reason not given|2|||
125598112|NCT02403206|451813839|FG001|Overall Study|Reason not given|4|||
125598113|NCT03750838|451813840|FG000|Overall Study|Lost to Follow-up|10|||
125598114|NCT03750838|451813841|FG001|Overall Study|Lost to Follow-up|6|||
125598115|NCT01769404|451813846|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
125598116|NCT01769404|451813847|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
125598117|NCT01769404|451813846|FG000|Treatment Period 1|Withdrawal by Subject|3|||
125598118|NCT01769404|451813847|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125598119|NCT01769404|451813846|FG000|Treatment Period 1|Sponsor decision|1|||
125598120|NCT01769404|451813847|FG001|Treatment Period 1|Sponsor decision|0|||
125598121|NCT01769404|451813846|FG000|Treatment Period 2|Sponsor decision|7|||
125598122|NCT01769404|451813847|FG001|Treatment Period 2|Sponsor decision|0|||
125598123|NCT00538733|451813848|FG000|Overall Study|Adverse Event|8|||
125598124|NCT00538733|451813848|FG000|Overall Study|Death|1|||
125598125|NCT00538733|451813848|FG000|Overall Study|declined to participate|2|||
125598126|NCT00538733|451813848|FG000|Overall Study|still on therapy|1|||
125598127|NCT00095121|451813853|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
125598128|NCT00095121|451813854|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
125598129|NCT00095121|451813853|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
125598130|NCT00095121|451813854|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
125598131|NCT02209597|451813855|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
125598132|NCT02209597|451813855|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
125598133|NCT02209597|451813855|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
125598134|NCT02209597|451813855|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
125431572|NCT02696564|451207693|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
125431573|NCT02696564|451207694|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
125431574|NCT00615264|451207696|FG000|Overall Study|Withdrawal by Subject|17|||
125369075|NCT04115839|450984832|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
125369076|NCT04115839|450984833|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
125431575|NCT00615264|451207697|FG001|Overall Study|Withdrawal by Subject|19|||
125369077|NCT04115839|450984834|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
125369078|NCT04115839|450984835|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
125431576|NCT00615264|451207696|FG000|Overall Study|Lost to Follow-up|6|||
125431577|NCT00615264|451207697|FG001|Overall Study|Lost to Follow-up|13|||
125431578|NCT00615264|451207696|FG000|Overall Study|Adverse Event|8|||
125598135|NCT03567187|451813860|FG000|Overall Study|Lost to Follow-up|18|||
125369079|NCT04115839|450984829|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
125369080|NCT04115839|450984830|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
125431579|NCT00615264|451207697|FG001|Overall Study|Adverse Event|5|||
125598136|NCT02032875|451813863|FG000|Treatment Period|Adverse Event|1|||
125598137|NCT02032875|451813864|FG001|Treatment Period|Adverse Event|0|||
125598138|NCT02032875|451813863|FG000|Treatment Period|Liver transplant, No extension needed|0|||
125598139|NCT02032875|451813864|FG001|Treatment Period|Liver transplant, No extension needed|1|||
125598140|NCT02032875|451813863|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
125431580|NCT00615264|451207696|FG000|Overall Study|Death|1|||
125431581|NCT00615264|451207697|FG001|Overall Study|Death|1|||
125431582|NCT00615264|451207696|FG000|Overall Study|Protocol Violation|11|||
125431583|NCT00615264|451207697|FG001|Overall Study|Protocol Violation|7|||
125431584|NCT00615264|451207696|FG000|Overall Study|Not defined|7|||
125369081|NCT04115839|450984831|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
125369082|NCT04115839|450984832|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
125369083|NCT04115839|450984833|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
125369084|NCT04115839|450984834|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
125369085|NCT04115839|450984835|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
125369086|NCT04115839|450984829|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
125369087|NCT04115839|450984830|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
125369088|NCT04115839|450984831|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
125369089|NCT04115839|450984832|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
125369090|NCT04115839|450984833|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
125369091|NCT04115839|450984834|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
125369092|NCT04115839|450984835|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
125369093|NCT04115839|450984829|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
125369094|NCT04115839|450984830|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
125369095|NCT04115839|450984831|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
125369096|NCT04115839|450984832|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
125431585|NCT00615264|451207697|FG001|Overall Study|Not defined|4|||
125431586|NCT00615264|451207696|FG000|Overall Study|Dermal Hypersensitivity|0|||
125598141|NCT02032875|451813864|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
125598142|NCT02032875|451813863|FG000|Follow-up Period|Death|0|||
125598143|NCT02032875|451813864|FG001|Follow-up Period|Death|1|||
125598144|NCT02032875|451813863|FG000|Follow-up Period|Virologic Relapse|3|||
125598145|NCT02032875|451813864|FG001|Follow-up Period|Virologic Relapse|10|||
125598146|NCT02089737|451815265|FG000|Overall Study|Survey form not completed|5|||
125598147|NCT02089737|451815265|FG000|Overall Study|Not treated|1|||
125598148|NCT04426630|451815266|FG000|Overall Study|Death|4|||
125598149|NCT04426630|451815266|FG000|Overall Study|Lost to Follow-up|2|||
125598150|NCT01157169|451815267|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
125598151|NCT01157169|451815268|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
125598152|NCT01157169|451815267|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
125598153|NCT01157169|451815268|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
125598154|NCT01123889|451815269|FG000|Overall Study|Lost to Follow-up|3|||
125598155|NCT01123889|451815270|FG001|Overall Study|Lost to Follow-up|1|||
125598156|NCT00849693|451815277|FG000|Acute Treatment Phase|Adverse Event|12|||
125598157|NCT00849693|451815278|FG001|Acute Treatment Phase|Adverse Event|7|||
125598158|NCT00849693|451815279|FG002|Acute Treatment Phase|Adverse Event|6|||
125598159|NCT00849693|451815280|FG003|Acute Treatment Phase|Adverse Event|4|||
125598160|NCT00849693|451815277|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
125598161|NCT00849693|451815278|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
125598162|NCT00849693|451815279|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
125598163|NCT00849693|451815280|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
125598164|NCT00849693|451815277|FG000|Acute Treatment Phase|Protocol Violation|1|||
125598165|NCT00849693|451815278|FG001|Acute Treatment Phase|Protocol Violation|5|||
125598166|NCT00849693|451815279|FG002|Acute Treatment Phase|Protocol Violation|2|||
125598167|NCT00849693|451815280|FG003|Acute Treatment Phase|Protocol Violation|6|||
125598168|NCT00849693|451815277|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
125598169|NCT00849693|451815278|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
125598170|NCT00849693|451815279|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
125598171|NCT00849693|451815280|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
125598172|NCT00849693|451815277|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
125598173|NCT00849693|451815278|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
125598174|NCT00849693|451815279|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
125598175|NCT00849693|451815280|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
125598176|NCT00849693|451815277|FG000|Acute Treatment Phase|Physician Decision|2|||
125598177|NCT00849693|451815278|FG001|Acute Treatment Phase|Physician Decision|1|||
125598178|NCT00849693|451815279|FG002|Acute Treatment Phase|Physician Decision|2|||
125598179|NCT00849693|451815280|FG003|Acute Treatment Phase|Physician Decision|1|||
125598180|NCT00849693|451815277|FG000|Acute Treatment Phase|Sponsor decision|0|||
125598181|NCT00849693|451815278|FG001|Acute Treatment Phase|Sponsor decision|0|||
125598182|NCT00849693|451815279|FG002|Acute Treatment Phase|Sponsor decision|1|||
125598183|NCT00849693|451815280|FG003|Acute Treatment Phase|Sponsor decision|0|||
125598184|NCT00849693|451815277|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
125369097|NCT04115839|450984833|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
125369098|NCT04115839|450984834|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
125431587|NCT00615264|451207697|FG001|Overall Study|Dermal Hypersensitivity|3|||
125431588|NCT03430063|451207698|FG000|Overall Study|Adverse Event|0|||
125598185|NCT00849693|451815278|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
125598186|NCT00849693|451815279|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
125598187|NCT00849693|451815280|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
125598188|NCT00849693|451815277|FG000|Extension Phase|Adverse Event|4|||
125598189|NCT00849693|451815278|FG001|Extension Phase|Adverse Event|6|||
125598190|NCT00849693|451815279|FG002|Extension Phase|Adverse Event|3|||
125598191|NCT00849693|451815280|FG003|Extension Phase|Adverse Event|7|||
125598192|NCT00849693|451815277|FG000|Extension Phase|Lost to Follow-up|7|||
125598193|NCT00849693|451815278|FG001|Extension Phase|Lost to Follow-up|5|||
125598194|NCT00849693|451815279|FG002|Extension Phase|Lost to Follow-up|6|||
125598195|NCT00849693|451815280|FG003|Extension Phase|Lost to Follow-up|6|||
125598196|NCT00849693|451815277|FG000|Extension Phase|Protocol Violation|0|||
125598197|NCT00849693|451815278|FG001|Extension Phase|Protocol Violation|3|||
125598198|NCT00849693|451815279|FG002|Extension Phase|Protocol Violation|2|||
125598199|NCT00849693|451815280|FG003|Extension Phase|Protocol Violation|3|||
125598200|NCT00849693|451815277|FG000|Extension Phase|Withdrawal by Subject|6|||
125598201|NCT00849693|451815278|FG001|Extension Phase|Withdrawal by Subject|9|||
125598202|NCT00849693|451815279|FG002|Extension Phase|Withdrawal by Subject|10|||
125598203|NCT00849693|451815280|FG003|Extension Phase|Withdrawal by Subject|15|||
125598204|NCT00849693|451815277|FG000|Extension Phase|Parent or caregiver decision|9|||
125598205|NCT00849693|451815278|FG001|Extension Phase|Parent or caregiver decision|4|||
125598206|NCT00849693|451815279|FG002|Extension Phase|Parent or caregiver decision|10|||
125598207|NCT00849693|451815280|FG003|Extension Phase|Parent or caregiver decision|5|||
125598208|NCT00849693|451815277|FG000|Extension Phase|Physician Decision|1|||
125598209|NCT00849693|451815278|FG001|Extension Phase|Physician Decision|1|||
125598210|NCT00849693|451815279|FG002|Extension Phase|Physician Decision|2|||
125598211|NCT00849693|451815280|FG003|Extension Phase|Physician Decision|0|||
125598212|NCT00849693|451815277|FG000|Extension Phase|Sponsor decision|1|||
125598213|NCT00849693|451815278|FG001|Extension Phase|Sponsor decision|0|||
125598214|NCT00849693|451815279|FG002|Extension Phase|Sponsor decision|0|||
125598215|NCT00849693|451815280|FG003|Extension Phase|Sponsor decision|1|||
125598216|NCT00849693|451815277|FG000|Extension Phase|Lack of Efficacy|2|||
125598217|NCT00849693|451815278|FG001|Extension Phase|Lack of Efficacy|2|||
125598218|NCT00849693|451815279|FG002|Extension Phase|Lack of Efficacy|2|||
125598219|NCT00849693|451815280|FG003|Extension Phase|Lack of Efficacy|1|||
125598220|NCT01062399|451815281|FG000|Overall Study|Protocol Violation|0|||
125598221|NCT01062399|451815282|FG001|Overall Study|Protocol Violation|1|||
125598222|NCT01062399|451815283|FG002|Overall Study|Protocol Violation|0|||
125598223|NCT01062399|451815284|FG003|Overall Study|Protocol Violation|6|||
125598224|NCT01062399|451815285|FG004|Overall Study|Protocol Violation|4|||
125598225|NCT03334214|451815293|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
125598226|NCT03334214|451815294|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
125598227|NCT03334214|451815293|FG000|Overall Study|Withdrawal by Subject|0|||
125598228|NCT03334214|451815294|FG001|Overall Study|Withdrawal by Subject|1|||
125598229|NCT03334214|451815293|FG000|Overall Study|Other|1|||
125598230|NCT03334214|451815294|FG001|Overall Study|Other|0|||
125598231|NCT01260181|451815297|FG000|Overall Study|Decision of Investigator|1|||
125598232|NCT00984659|451815300|FG000|2-week Run-in Period|Adverse Event|8|||
125598233|NCT00984659|451815301|FG001|2-week Run-in Period|Adverse Event|0|||
125598234|NCT00984659|451815302|FG002|2-week Run-in Period|Adverse Event|0|||
125598235|NCT00984659|451815303|FG003|2-week Run-in Period|Adverse Event|0|||
125598236|NCT00984659|451815300|FG000|2-week Run-in Period|Protocol Violation|5|||
125598237|NCT00984659|451815301|FG001|2-week Run-in Period|Protocol Violation|0|||
125598238|NCT00984659|451815302|FG002|2-week Run-in Period|Protocol Violation|0|||
125598239|NCT00984659|451815303|FG003|2-week Run-in Period|Protocol Violation|0|||
125598240|NCT00984659|451815300|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
125598241|NCT00984659|451815301|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
125598242|NCT00984659|451815302|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
125598243|NCT00984659|451815303|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
125598244|NCT00984659|451815300|FG000|2-week Run-in Period|Lost to Follow-up|3|||
125598245|NCT00984659|451815301|FG001|2-week Run-in Period|Lost to Follow-up|0|||
125369099|NCT04115839|450984835|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
125598246|NCT00984659|451815302|FG002|2-week Run-in Period|Lost to Follow-up|0|||
125598247|NCT00984659|451815303|FG003|2-week Run-in Period|Lost to Follow-up|0|||
125598248|NCT00984659|451815300|FG000|2-week Run-in Period|Physician Decision|10|||
125598249|NCT00984659|451815301|FG001|2-week Run-in Period|Physician Decision|0|||
125598250|NCT00984659|451815302|FG002|2-week Run-in Period|Physician Decision|0|||
125369100|NCT03535844|450984842|FG000|Overall Study|Withdrawal by Subject|0|||
125598251|NCT00984659|451815303|FG003|2-week Run-in Period|Physician Decision|0|||
125598252|NCT00984659|451815300|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
125598253|NCT00984659|451815301|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
125598254|NCT00984659|451815302|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
125598255|NCT00984659|451815303|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
125598256|NCT00984659|451815300|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
125598257|NCT00984659|451815301|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
125598258|NCT00984659|451815302|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
125598259|NCT00984659|451815303|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
125598260|NCT00984659|451815300|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
125598261|NCT00984659|451815301|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
125598262|NCT00984659|451815302|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
125598263|NCT00984659|451815303|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
125598264|NCT00984659|451815300|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
125598265|NCT00984659|451815301|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
125598266|NCT00984659|451815302|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
125598267|NCT00984659|451815303|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
125598268|NCT00984659|451815300|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
125598269|NCT00984659|451815301|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
125598270|NCT00984659|451815302|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
125598271|NCT00984659|451815303|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
125598272|NCT00984659|451815300|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
125598273|NCT00984659|451815301|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
125598274|NCT00984659|451815302|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
125598275|NCT00984659|451815303|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
125598276|NCT00984659|451815300|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125598277|NCT00984659|451815301|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
125598278|NCT00984659|451815302|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
125598279|NCT00984659|451815303|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
125598280|NCT02424149|451815306|FG000|Overall Study|surgery cancelled|2|||
125598281|NCT02424149|451815307|FG001|Overall Study|surgery cancelled|0|||
125598282|NCT02424149|451815306|FG000|Overall Study|Withdrawal by Subject|0|||
125598283|NCT02424149|451815307|FG001|Overall Study|Withdrawal by Subject|1|||
125598284|NCT01025336|451815310|FG000|Overall Study|Protocol Violation|0|||
125598285|NCT01025336|451815311|FG001|Overall Study|Protocol Violation|0|||
125598286|NCT01025336|451815312|FG002|Overall Study|Protocol Violation|0|||
125598287|NCT01025336|451815313|FG003|Overall Study|Protocol Violation|2|||
125598288|NCT01025336|451815314|FG004|Overall Study|Protocol Violation|0|||
125598289|NCT00592683|451815315|FG000|Overall Study|Found ineligible|0|||
125598290|NCT00592683|451815316|FG001|Overall Study|Found ineligible|1|||
125598291|NCT00592683|451815315|FG000|Overall Study|Withdrawal by Subject|1|||
125598292|NCT00592683|451815316|FG001|Overall Study|Withdrawal by Subject|0|||
125598293|NCT00592683|451815315|FG000|Overall Study|Adverse Event|0|||
125598294|NCT00592683|451815316|FG001|Overall Study|Adverse Event|2|||
125598295|NCT00592683|451815315|FG000|Overall Study|Protocol Violation|1|||
125598296|NCT00592683|451815316|FG001|Overall Study|Protocol Violation|0|||
125598297|NCT00592683|451815315|FG000|Overall Study|Study drug expired|1|||
125598298|NCT00592683|451815316|FG001|Overall Study|Study drug expired|0|||
125598299|NCT00592683|451815315|FG000|Overall Study|Other|1|||
125598300|NCT00592683|451815316|FG001|Overall Study|Other|0|||
125598301|NCT00592683|451815315|FG000|Overall Study|Lost to Follow-up|0|||
125598302|NCT00592683|451815316|FG001|Overall Study|Lost to Follow-up|1|||
125598303|NCT00545818|451815319|FG000|Overall Study|Protocol Violation|1|||
125598304|NCT00545818|451815320|FG001|Overall Study|Protocol Violation|0|||
125598305|NCT00545818|451815319|FG000|Overall Study|Adverse Event|1|||
125598306|NCT00545818|451815320|FG001|Overall Study|Adverse Event|1|||
125598307|NCT00545818|451815319|FG000|Overall Study|Lost to Follow-up|1|||
125598308|NCT00545818|451815320|FG001|Overall Study|Lost to Follow-up|6|||
125598309|NCT02723630|451815321|FG000|Intervention Period 1|Adverse Event|1|||
125598310|NCT02723630|451815322|FG001|Intervention Period 1|Adverse Event|0|||
125598311|NCT02723630|451815323|FG002|Intervention Period 1|Adverse Event|0|||
125598312|NCT02723630|451815324|FG003|Intervention Period 1|Adverse Event|0|||
125598313|NCT02723630|451815325|FG004|Intervention Period 1|Adverse Event|0|||
125598314|NCT02723630|451815326|FG005|Intervention Period 1|Adverse Event|0|||
125598315|NCT02723630|451815321|FG000|Intervention Period 3|consumption of restricted item|0|||
125598316|NCT02723630|451815322|FG001|Intervention Period 3|consumption of restricted item|1|||
125598317|NCT02723630|451815323|FG002|Intervention Period 3|consumption of restricted item|0|||
125598318|NCT02723630|451815324|FG003|Intervention Period 3|consumption of restricted item|0|||
125598319|NCT02723630|451815325|FG004|Intervention Period 3|consumption of restricted item|0|||
125598320|NCT02723630|451815326|FG005|Intervention Period 3|consumption of restricted item|0|||
125598321|NCT00479466|451815329|FG000|Overall Study|Adverse Event|5|||
125598322|NCT00479466|451815330|FG001|Overall Study|Adverse Event|1|||
125598323|NCT00479466|451815331|FG002|Overall Study|Adverse Event|0|||
125598324|NCT00479466|451815332|FG003|Overall Study|Adverse Event|1|||
125598325|NCT00479466|451815333|FG004|Overall Study|Adverse Event|2|||
125598326|NCT00479466|451815334|FG005|Overall Study|Adverse Event|0|||
125598327|NCT00479466|451815329|FG000|Overall Study|Hyperglycemia|0|||
125598328|NCT00479466|451815330|FG001|Overall Study|Hyperglycemia|0|||
125598329|NCT00479466|451815331|FG002|Overall Study|Hyperglycemia|0|||
125598330|NCT00479466|451815332|FG003|Overall Study|Hyperglycemia|0|||
125598331|NCT00479466|451815333|FG004|Overall Study|Hyperglycemia|0|||
125598332|NCT00479466|451815334|FG005|Overall Study|Hyperglycemia|1|||
125598333|NCT00479466|451815329|FG000|Overall Study|Lack of Efficacy|2|||
125598334|NCT00479466|451815330|FG001|Overall Study|Lack of Efficacy|0|||
125598335|NCT00479466|451815331|FG002|Overall Study|Lack of Efficacy|1|||
125598336|NCT00479466|451815332|FG003|Overall Study|Lack of Efficacy|0|||
125598337|NCT00479466|451815333|FG004|Overall Study|Lack of Efficacy|0|||
125598338|NCT00479466|451815334|FG005|Overall Study|Lack of Efficacy|0|||
125598339|NCT00479466|451815329|FG000|Overall Study|Lost to Follow-up|0|||
125598340|NCT00479466|451815330|FG001|Overall Study|Lost to Follow-up|1|||
125598341|NCT00479466|451815331|FG002|Overall Study|Lost to Follow-up|1|||
125598342|NCT00479466|451815332|FG003|Overall Study|Lost to Follow-up|0|||
125598343|NCT00479466|451815333|FG004|Overall Study|Lost to Follow-up|2|||
125598344|NCT00479466|451815334|FG005|Overall Study|Lost to Follow-up|2|||
125598345|NCT00479466|451815329|FG000|Overall Study|Physician Decision|2|||
125598346|NCT00479466|451815330|FG001|Overall Study|Physician Decision|1|||
125598347|NCT00479466|451815331|FG002|Overall Study|Physician Decision|1|||
125598348|NCT00479466|451815332|FG003|Overall Study|Physician Decision|0|||
125598349|NCT00479466|451815333|FG004|Overall Study|Physician Decision|0|||
125598350|NCT00479466|451815334|FG005|Overall Study|Physician Decision|0|||
125598351|NCT00479466|451815329|FG000|Overall Study|Pregnancy|0|||
125598352|NCT00479466|451815330|FG001|Overall Study|Pregnancy|0|||
125598353|NCT00479466|451815331|FG002|Overall Study|Pregnancy|0|||
125598354|NCT00479466|451815332|FG003|Overall Study|Pregnancy|0|||
125598355|NCT00479466|451815333|FG004|Overall Study|Pregnancy|1|||
125598356|NCT00479466|451815334|FG005|Overall Study|Pregnancy|0|||
125598357|NCT00479466|451815329|FG000|Overall Study|Protocol Violation|1|||
125598358|NCT00479466|451815330|FG001|Overall Study|Protocol Violation|0|||
125598359|NCT00479466|451815331|FG002|Overall Study|Protocol Violation|0|||
125598360|NCT00479466|451815332|FG003|Overall Study|Protocol Violation|0|||
125598361|NCT00479466|451815333|FG004|Overall Study|Protocol Violation|0|||
125598362|NCT00479466|451815334|FG005|Overall Study|Protocol Violation|0|||
125598363|NCT00479466|451815329|FG000|Overall Study|Withdrawal by Subject|3|||
125598364|NCT00479466|451815330|FG001|Overall Study|Withdrawal by Subject|5|||
125598365|NCT00479466|451815331|FG002|Overall Study|Withdrawal by Subject|0|||
125598366|NCT00479466|451815332|FG003|Overall Study|Withdrawal by Subject|2|||
125598367|NCT00479466|451815333|FG004|Overall Study|Withdrawal by Subject|3|||
125598368|NCT00479466|451815334|FG005|Overall Study|Withdrawal by Subject|1|||
125598369|NCT01325493|451815335|FG000|Overall Study|Protocol Violation|0|||
125598370|NCT01325493|451815336|FG001|Overall Study|Protocol Violation|1|||
125598371|NCT01325493|451815335|FG000|Overall Study|loss of neuromonitoring signals|0|||
125598372|NCT01325493|451815336|FG001|Overall Study|loss of neuromonitoring signals|2|||
125598373|NCT01325493|451815335|FG000|Overall Study|Allergy|1|||
125598374|NCT01325493|451815336|FG001|Overall Study|Allergy|0|||
125369101|NCT03535844|450984843|FG001|Overall Study|Withdrawal by Subject|1|||
125369102|NCT02835820|450984846|FG000|Overall Study|Baseline Screen Failure|0|||
125369103|NCT02835820|450984847|FG001|Overall Study|Baseline Screen Failure|3|||
125369104|NCT00160693|450984851|FG000|Overall Study|Adverse Event|97|||
125598375|NCT05372315|451815339|FG000|Overall Study|Withdrawal by Subject|1|||
125598376|NCT05372315|451815340|FG001|Overall Study|Withdrawal by Subject|0|||
125598377|NCT01184989|451815341|FG000|Overall Study|Adverse Event|11|||
125598378|NCT01184989|451815341|FG000|Overall Study|Withdrawal by Subject|1|||
125598379|NCT01570491|451815342|FG000|Overall Study|Lost to Follow-up|3|||
125598380|NCT01570491|451815343|FG001|Overall Study|Lost to Follow-up|1|||
125598381|NCT01570491|451815342|FG000|Overall Study|treatment: not given or discontinued|2|||
125598382|NCT01570491|451815343|FG001|Overall Study|treatment: not given or discontinued|0|||
125598383|NCT03047213|451815344|FG000|Overall Study|Withdrawal by Subject|2|||
125598384|NCT03047213|451815345|FG001|Overall Study|Withdrawal by Subject|0|||
125598385|NCT03047213|451815344|FG000|Overall Study|Adverse Event|2|||
125598386|NCT03047213|451815345|FG001|Overall Study|Adverse Event|0|||
125598387|NCT00650585|451815351|FG000|Overall Study|Lost to Follow-up|505|||
125598388|NCT00650585|451815352|FG001|Overall Study|Lost to Follow-up|482|||
125598389|NCT00650585|451815351|FG000|Overall Study|No parental consent|935|||
125598390|NCT00650585|451815352|FG001|Overall Study|No parental consent|866|||
125598391|NCT00650585|451815351|FG000|Overall Study|Excluded/ruled ineligible|357|||
125598392|NCT00650585|451815352|FG001|Overall Study|Excluded/ruled ineligible|129|||
125598393|NCT04407507|451815353|FG000|Overall Study|Withdrawal by Subject|0|||
125598394|NCT04407507|451815354|FG001|Overall Study|Withdrawal by Subject|1|||
125598395|NCT00923091|451815355|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
125598396|NCT00923091|451815356|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
125598397|NCT00923091|451815357|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
125598398|NCT00923091|451815358|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
125598399|NCT00923091|451815359|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
125598400|NCT00923091|451815360|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
125598401|NCT00923091|451815361|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
125598402|NCT00923091|451815362|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
125598403|NCT00923091|451815363|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
125598404|NCT00923091|451815364|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
125598405|NCT00923091|451815365|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
125598406|NCT00923091|451815366|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
125598407|NCT00923091|451815367|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
125598408|NCT00923091|451815355|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
125598409|NCT00923091|451815356|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
125598410|NCT00923091|451815357|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
125598411|NCT00923091|451815358|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
125598412|NCT00923091|451815359|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
125598413|NCT00923091|451815360|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
125598414|NCT00923091|451815361|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
125598415|NCT00923091|451815362|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
125598416|NCT00923091|451815363|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
125598417|NCT00923091|451815364|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
125598418|NCT00923091|451815365|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
125598419|NCT00923091|451815366|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
125598420|NCT00923091|451815367|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
125598421|NCT00923091|451815355|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
125598422|NCT00923091|451815356|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
125598423|NCT00923091|451815357|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
125598424|NCT00923091|451815358|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
125598425|NCT00923091|451815359|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
125598426|NCT00923091|451815360|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
125598427|NCT00923091|451815361|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
125598428|NCT00923091|451815362|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
125598429|NCT00923091|451815363|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
125598430|NCT00923091|451815364|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
125598431|NCT00923091|451815365|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
125598432|NCT00923091|451815366|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
125598433|NCT00923091|451815367|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
125598434|NCT00923091|451815355|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125598435|NCT00923091|451815356|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125598436|NCT00923091|451815357|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125598437|NCT00923091|451815358|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125598438|NCT00923091|451815359|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125598439|NCT00923091|451815360|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
125598440|NCT00923091|451815361|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125598441|NCT00923091|451815362|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125598442|NCT00923091|451815363|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125598443|NCT00923091|451815364|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125598444|NCT00923091|451815365|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125598445|NCT00923091|451815366|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125598446|NCT00923091|451815367|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
125598447|NCT00923091|451815355|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125598448|NCT00923091|451815356|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
125598449|NCT00923091|451815357|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125598450|NCT00923091|451815358|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
125212794|NCT01026818|450405479|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
125212795|NCT01026818|450405480|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
125598451|NCT00923091|451815359|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125598452|NCT00923091|451815360|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
125598453|NCT00923091|451815361|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125598454|NCT00923091|451815362|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125598455|NCT00923091|451815363|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125598456|NCT00923091|451815364|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125598457|NCT00923091|451815365|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125598458|NCT00923091|451815366|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125598459|NCT00923091|451815367|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
125598460|NCT00923091|451815355|FG000|Period III (Single-Blind)|Adverse Event|5|||
125598461|NCT00923091|451815356|FG001|Period III (Single-Blind)|Adverse Event|0|||
125598462|NCT00923091|451815357|FG002|Period III (Single-Blind)|Adverse Event|0|||
125598463|NCT00923091|451815358|FG003|Period III (Single-Blind)|Adverse Event|0|||
125598464|NCT00923091|451815359|FG004|Period III (Single-Blind)|Adverse Event|0|||
125598465|NCT00923091|451815360|FG005|Period III (Single-Blind)|Adverse Event|0|||
125598466|NCT00923091|451815361|FG006|Period III (Single-Blind)|Adverse Event|0|||
125598467|NCT00923091|451815362|FG007|Period III (Single-Blind)|Adverse Event|0|||
125598468|NCT00923091|451815363|FG008|Period III (Single-Blind)|Adverse Event|0|||
125598469|NCT00923091|451815364|FG009|Period III (Single-Blind)|Adverse Event|0|||
125598470|NCT00923091|451815365|FG010|Period III (Single-Blind)|Adverse Event|0|||
125598471|NCT00923091|451815366|FG011|Period III (Single-Blind)|Adverse Event|0|||
125598472|NCT00923091|451815367|FG012|Period III (Single-Blind)|Adverse Event|0|||
125598473|NCT00923091|451815355|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
125598474|NCT00923091|451815356|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
125598475|NCT00923091|451815357|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
125598476|NCT00923091|451815358|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
125598477|NCT00923091|451815359|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
125598478|NCT00923091|451815360|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
125598479|NCT00923091|451815361|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
125598480|NCT00923091|451815362|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
125598481|NCT00923091|451815363|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
125598482|NCT00923091|451815364|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
125598483|NCT00923091|451815365|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
125598484|NCT00923091|451815366|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
125598485|NCT00923091|451815367|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
125598486|NCT00923091|451815355|FG000|Period III (Single-Blind)|Protocol Violation|3|||
125598487|NCT00923091|451815356|FG001|Period III (Single-Blind)|Protocol Violation|0|||
125598488|NCT00923091|451815357|FG002|Period III (Single-Blind)|Protocol Violation|0|||
125598489|NCT00923091|451815358|FG003|Period III (Single-Blind)|Protocol Violation|0|||
125598490|NCT00923091|451815359|FG004|Period III (Single-Blind)|Protocol Violation|0|||
125598491|NCT00923091|451815360|FG005|Period III (Single-Blind)|Protocol Violation|0|||
125598492|NCT00923091|451815361|FG006|Period III (Single-Blind)|Protocol Violation|0|||
125598493|NCT00923091|451815362|FG007|Period III (Single-Blind)|Protocol Violation|0|||
125598494|NCT00923091|451815363|FG008|Period III (Single-Blind)|Protocol Violation|0|||
125598495|NCT00923091|451815364|FG009|Period III (Single-Blind)|Protocol Violation|0|||
125598496|NCT00923091|451815365|FG010|Period III (Single-Blind)|Protocol Violation|0|||
125598497|NCT00923091|451815366|FG011|Period III (Single-Blind)|Protocol Violation|0|||
125598498|NCT00923091|451815367|FG012|Period III (Single-Blind)|Protocol Violation|0|||
125598499|NCT00923091|451815355|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
125598500|NCT00923091|451815356|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
125598501|NCT00923091|451815357|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
125598502|NCT00923091|451815358|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
125598503|NCT00923091|451815359|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
125598504|NCT00923091|451815360|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
125598505|NCT00923091|451815361|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
125598506|NCT00923091|451815362|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
125598507|NCT00923091|451815363|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
125598508|NCT00923091|451815364|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
125598509|NCT00923091|451815365|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
125598510|NCT00923091|451815366|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
125598511|NCT00923091|451815367|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
125598512|NCT00923091|451815355|FG000|Period IV (Double-Blind)|Adverse Event|2|||
125598513|NCT00923091|451815356|FG001|Period IV (Double-Blind)|Adverse Event|0|||
125598514|NCT00923091|451815357|FG002|Period IV (Double-Blind)|Adverse Event|0|||
125598515|NCT00923091|451815358|FG003|Period IV (Double-Blind)|Adverse Event|0|||
125598516|NCT00923091|451815359|FG004|Period IV (Double-Blind)|Adverse Event|0|||
125598517|NCT00923091|451815360|FG005|Period IV (Double-Blind)|Adverse Event|0|||
125598518|NCT00923091|451815361|FG006|Period IV (Double-Blind)|Adverse Event|0|||
125598519|NCT00923091|451815362|FG007|Period IV (Double-Blind)|Adverse Event|0|||
125598520|NCT00923091|451815363|FG008|Period IV (Double-Blind)|Adverse Event|0|||
125598521|NCT00923091|451815364|FG009|Period IV (Double-Blind)|Adverse Event|0|||
125598522|NCT00923091|451815365|FG010|Period IV (Double-Blind)|Adverse Event|0|||
125598523|NCT00923091|451815366|FG011|Period IV (Double-Blind)|Adverse Event|0|||
125598524|NCT00923091|451815367|FG012|Period IV (Double-Blind)|Adverse Event|0|||
125598525|NCT00923091|451815355|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125598526|NCT00923091|451815356|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
125598527|NCT00923091|451815357|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125598528|NCT00923091|451815358|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125598529|NCT00923091|451815359|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125598530|NCT00923091|451815360|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125598531|NCT00923091|451815361|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125598532|NCT00923091|451815362|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125598533|NCT00923091|451815363|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125598534|NCT00923091|451815364|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125598535|NCT00923091|451815365|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125598536|NCT00923091|451815366|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125598537|NCT00923091|451815367|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
125598538|NCT00923091|451815355|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
125598539|NCT00923091|451815356|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
125598540|NCT00923091|451815357|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
125598541|NCT00923091|451815358|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
125598542|NCT00923091|451815359|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
125598543|NCT00923091|451815360|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
125598544|NCT00923091|451815361|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
125598545|NCT00923091|451815362|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
125598546|NCT00923091|451815363|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
125598547|NCT00923091|451815364|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
125598548|NCT00923091|451815365|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
125598549|NCT00923091|451815366|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
125598550|NCT00923091|451815367|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
125598551|NCT00923091|451815355|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
125598552|NCT00923091|451815356|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
125598553|NCT00923091|451815357|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
125598554|NCT00923091|451815358|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
125598555|NCT00923091|451815359|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
125598556|NCT00923091|451815360|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
125598557|NCT00923091|451815361|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
125598558|NCT00923091|451815362|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
125598559|NCT00923091|451815363|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
125598560|NCT00923091|451815364|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
125598561|NCT00923091|451815365|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
125598562|NCT00923091|451815366|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
125598563|NCT00923091|451815367|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
125598564|NCT00923091|451815355|FG000|Period V (Double -Blind)|Protocol Violation|0|||
125598565|NCT00923091|451815356|FG001|Period V (Double -Blind)|Protocol Violation|0|||
125598566|NCT00923091|451815357|FG002|Period V (Double -Blind)|Protocol Violation|0|||
125598567|NCT00923091|451815358|FG003|Period V (Double -Blind)|Protocol Violation|0|||
125598568|NCT00923091|451815359|FG004|Period V (Double -Blind)|Protocol Violation|0|||
125598569|NCT00923091|451815360|FG005|Period V (Double -Blind)|Protocol Violation|0|||
125598570|NCT00923091|451815361|FG006|Period V (Double -Blind)|Protocol Violation|0|||
125598571|NCT00923091|451815362|FG007|Period V (Double -Blind)|Protocol Violation|0|||
125598572|NCT00923091|451815363|FG008|Period V (Double -Blind)|Protocol Violation|0|||
125598573|NCT00923091|451815364|FG009|Period V (Double -Blind)|Protocol Violation|0|||
125598574|NCT00923091|451815365|FG010|Period V (Double -Blind)|Protocol Violation|0|||
125598575|NCT00923091|451815366|FG011|Period V (Double -Blind)|Protocol Violation|0|||
125598576|NCT00923091|451815367|FG012|Period V (Double -Blind)|Protocol Violation|1|||
125598577|NCT00923091|451815355|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
125598578|NCT00923091|451815356|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
125598579|NCT00923091|451815357|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
125598580|NCT00923091|451815358|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
125598581|NCT00923091|451815359|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
125598582|NCT00923091|451815360|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
125598583|NCT00923091|451815361|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
125598584|NCT00923091|451815362|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
125598585|NCT00923091|451815363|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
125431589|NCT03430063|451207699|FG001|Overall Study|Adverse Event|1|||
125431590|NCT03430063|451207700|FG002|Overall Study|Adverse Event|0|||
125431591|NCT03430063|451207698|FG000|Overall Study|Death|3|||
125431592|NCT03430063|451207699|FG001|Overall Study|Death|2|||
125431593|NCT03430063|451207700|FG002|Overall Study|Death|3|||
125431594|NCT03430063|451207698|FG000|Overall Study|Lost to Follow-up|0|||
125431595|NCT03430063|451207699|FG001|Overall Study|Lost to Follow-up|1|||
125431596|NCT03430063|451207700|FG002|Overall Study|Lost to Follow-up|0|||
125431597|NCT03430063|451207698|FG000|Overall Study|Withdrawal by Subject|0|||
125431598|NCT03430063|451207699|FG001|Overall Study|Withdrawal by Subject|0|||
125431599|NCT03430063|451207700|FG002|Overall Study|Withdrawal by Subject|1|||
125431600|NCT03430063|451207698|FG000|Overall Study|Withdrawal of consent|3|||
125431601|NCT03430063|451207699|FG001|Overall Study|Withdrawal of consent|1|||
125431602|NCT03430063|451207700|FG002|Overall Study|Withdrawal of consent|2|||
125431603|NCT03430063|451207698|FG000|Overall Study|Progressive disease|1|||
125431604|NCT03430063|451207699|FG001|Overall Study|Progressive disease|2|||
125431605|NCT03430063|451207700|FG002|Overall Study|Progressive disease|1|||
125598586|NCT00923091|451815364|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
125598587|NCT00923091|451815365|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
125598588|NCT00923091|451815366|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
125598589|NCT00923091|451815367|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
125598590|NCT00923091|451815355|FG000|Period VI (Open-Label)|Adverse Event|17|||
125598591|NCT00923091|451815356|FG001|Period VI (Open-Label)|Adverse Event|0|||
125598592|NCT00923091|451815357|FG002|Period VI (Open-Label)|Adverse Event|4|||
125598593|NCT00923091|451815358|FG003|Period VI (Open-Label)|Adverse Event|1|||
125598594|NCT00923091|451815359|FG004|Period VI (Open-Label)|Adverse Event|1|||
125598595|NCT00923091|451815360|FG005|Period VI (Open-Label)|Adverse Event|0|||
125598596|NCT00923091|451815361|FG006|Period VI (Open-Label)|Adverse Event|0|||
125598597|NCT00923091|451815362|FG007|Period VI (Open-Label)|Adverse Event|0|||
125598598|NCT00923091|451815363|FG008|Period VI (Open-Label)|Adverse Event|0|||
125598599|NCT00923091|451815364|FG009|Period VI (Open-Label)|Adverse Event|0|||
125598600|NCT00923091|451815365|FG010|Period VI (Open-Label)|Adverse Event|0|||
125598601|NCT00923091|451815366|FG011|Period VI (Open-Label)|Adverse Event|0|||
125598602|NCT00923091|451815367|FG012|Period VI (Open-Label)|Adverse Event|0|||
125598603|NCT00923091|451815355|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
125598604|NCT00923091|451815356|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
125598605|NCT00923091|451815357|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
125431606|NCT03430063|451207698|FG000|Overall Study|Other un-specified|1|||
125431607|NCT03430063|451207699|FG001|Overall Study|Other un-specified|1|||
125431608|NCT03430063|451207700|FG002|Overall Study|Other un-specified|0|||
125598606|NCT00923091|451815358|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
125598607|NCT00923091|451815359|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
125212796|NCT01026818|450405481|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
125431609|NCT03430063|451207698|FG000|Overall Study|Randomized, but never treated|0|||
125598608|NCT00923091|451815360|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
125598609|NCT00923091|451815361|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
125369105|NCT00160693|450984851|FG000|Overall Study|Lack of Efficacy|30|||
125369106|NCT00160693|450984851|FG000|Overall Study|Protocol Violation|24|||
125369107|NCT00160693|450984851|FG000|Overall Study|Lost to Follow-up|15|||
125369108|NCT00160693|450984851|FG000|Overall Study|Withdrawal by Subject|54|||
125369109|NCT00160693|450984851|FG000|Overall Study|Study terminated by sponsor|15|||
125369110|NCT03039283|450984854|FG000|Overall Study|Protocol Violation|2|||
125369111|NCT01867424|450984855|FG000|Overall Study|Patient noncompliance|2|||
125369112|NCT01867424|450984856|FG001|Overall Study|Patient noncompliance|1|||
125369113|NCT01056653|450984857|FG000|Overall Study|Lost to Follow-up|0|||
125369114|NCT01056653|450984858|FG001|Overall Study|Lost to Follow-up|0|||
125369115|NCT01056653|450984859|FG002|Overall Study|Lost to Follow-up|2|||
125369116|NCT05386680|450984860|FG000|Overall Study|Guardian decision|2|||
125369117|NCT01847274|450984861|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
125369118|NCT01847274|450984862|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
125369119|NCT01847274|450984863|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
125369120|NCT01847274|450984864|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
125369121|NCT01847274|450984865|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125369122|NCT01847274|450984866|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125369123|NCT01847274|450984867|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125369124|NCT01847274|450984868|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125369125|NCT01847274|450984869|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125369126|NCT01847274|450984870|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125369127|NCT01847274|450984871|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
125369128|NCT01847274|450984861|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
125369129|NCT01847274|450984862|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
125369130|NCT01847274|450984863|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
125369131|NCT01847274|450984864|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
125369132|NCT01847274|450984865|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125369133|NCT01847274|450984866|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125369134|NCT01847274|450984867|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125369135|NCT01847274|450984868|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125369136|NCT01847274|450984869|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125369137|NCT01847274|450984870|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125369138|NCT01847274|450984871|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
125369139|NCT01847274|450984861|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
125369140|NCT01847274|450984862|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
125369141|NCT01847274|450984863|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
125369142|NCT01847274|450984864|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
125369143|NCT01847274|450984865|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125369144|NCT01847274|450984866|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125369145|NCT01847274|450984867|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125369146|NCT01847274|450984868|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125369147|NCT01847274|450984869|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125598610|NCT00923091|451815362|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
125598611|NCT00923091|451815363|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
125598612|NCT00923091|451815364|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
125598613|NCT00923091|451815365|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
125598614|NCT00923091|451815366|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
125598615|NCT00923091|451815367|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
125598616|NCT00923091|451815355|FG000|Period VI (Open-Label)|Protocol Violation|6|||
125598617|NCT00923091|451815356|FG001|Period VI (Open-Label)|Protocol Violation|1|||
125598618|NCT00923091|451815357|FG002|Period VI (Open-Label)|Protocol Violation|3|||
125598619|NCT00923091|451815358|FG003|Period VI (Open-Label)|Protocol Violation|1|||
125598620|NCT00923091|451815359|FG004|Period VI (Open-Label)|Protocol Violation|4|||
125598621|NCT00923091|451815360|FG005|Period VI (Open-Label)|Protocol Violation|0|||
125598622|NCT00923091|451815361|FG006|Period VI (Open-Label)|Protocol Violation|0|||
125598623|NCT00923091|451815362|FG007|Period VI (Open-Label)|Protocol Violation|0|||
125598624|NCT00923091|451815363|FG008|Period VI (Open-Label)|Protocol Violation|0|||
125598625|NCT00923091|451815364|FG009|Period VI (Open-Label)|Protocol Violation|0|||
125598626|NCT00923091|451815365|FG010|Period VI (Open-Label)|Protocol Violation|0|||
125598627|NCT00923091|451815366|FG011|Period VI (Open-Label)|Protocol Violation|0|||
125598628|NCT00923091|451815367|FG012|Period VI (Open-Label)|Protocol Violation|0|||
125598629|NCT00923091|451815355|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
125598630|NCT00923091|451815356|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
125598631|NCT00923091|451815357|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
125598632|NCT00923091|451815358|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
125598633|NCT00923091|451815359|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
125598634|NCT00923091|451815360|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
125598635|NCT00923091|451815361|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
125598636|NCT00923091|451815362|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
125598637|NCT00923091|451815363|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
125598638|NCT00923091|451815364|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
125598639|NCT00923091|451815365|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
125598640|NCT00923091|451815366|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
125598641|NCT00923091|451815367|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
125598642|NCT00923091|451815355|FG000|Period VI (Open-Label)|Other Reason|0|||
125598643|NCT00923091|451815356|FG001|Period VI (Open-Label)|Other Reason|0|||
125598644|NCT00923091|451815357|FG002|Period VI (Open-Label)|Other Reason|0|||
125598645|NCT00923091|451815358|FG003|Period VI (Open-Label)|Other Reason|1|||
125598646|NCT00923091|451815359|FG004|Period VI (Open-Label)|Other Reason|1|||
125598647|NCT00923091|451815360|FG005|Period VI (Open-Label)|Other Reason|0|||
125598648|NCT00923091|451815361|FG006|Period VI (Open-Label)|Other Reason|0|||
125598649|NCT00923091|451815362|FG007|Period VI (Open-Label)|Other Reason|0|||
125598650|NCT00923091|451815363|FG008|Period VI (Open-Label)|Other Reason|0|||
125598651|NCT00923091|451815364|FG009|Period VI (Open-Label)|Other Reason|0|||
125598652|NCT00923091|451815365|FG010|Period VI (Open-Label)|Other Reason|0|||
125598653|NCT00923091|451815366|FG011|Period VI (Open-Label)|Other Reason|0|||
125598654|NCT00923091|451815367|FG012|Period VI (Open-Label)|Other Reason|0|||
125598655|NCT00467649|451815368|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
125598656|NCT00467649|451815369|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
125598657|NCT00467649|451815370|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
125598658|NCT00467649|451815371|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
125598659|NCT00467649|451815372|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
125598660|NCT00467649|451815373|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
125598661|NCT00467649|451815368|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
125598662|NCT00467649|451815369|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
125598663|NCT00467649|451815370|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
125598664|NCT00467649|451815371|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
125598665|NCT00467649|451815372|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
125598666|NCT00467649|451815373|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
125598667|NCT00467649|451815368|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
125598668|NCT00467649|451815369|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
125598669|NCT00467649|451815370|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
125598670|NCT00467649|451815371|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
125598671|NCT00467649|451815372|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
125598672|NCT00467649|451815373|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
125598673|NCT00467649|451815368|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
125598674|NCT00467649|451815369|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
125598675|NCT00467649|451815370|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
125598676|NCT00467649|451815371|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
125598677|NCT00467649|451815372|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
125598678|NCT00467649|451815373|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
125598679|NCT00467649|451815368|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
125598680|NCT00467649|451815369|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
125598681|NCT00467649|451815370|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
125598682|NCT00467649|451815371|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
125598683|NCT00467649|451815372|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
125598684|NCT00467649|451815373|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
125598685|NCT00467649|451815368|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
125598686|NCT00467649|451815369|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
125598687|NCT00467649|451815370|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
125598688|NCT00467649|451815371|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
125598689|NCT00467649|451815372|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
125598690|NCT00467649|451815373|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
125598691|NCT00467649|451815368|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
125598692|NCT00467649|451815369|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
125598693|NCT00467649|451815370|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
125598694|NCT00467649|451815371|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
125598695|NCT00467649|451815372|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
125598696|NCT00467649|451815373|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
125598697|NCT03233048|451815376|FG000|Overall Study|Withdrawal by Subject|1|||
125598698|NCT05897853|451815386|FG000|Overall Study|Lost to Follow-up|2|||
125598699|NCT05897853|451815387|FG001|Overall Study|Lost to Follow-up|0|||
125598700|NCT05897853|451815386|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
125598701|NCT05897853|451815387|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
125598702|NCT02782715|451815392|FG000|Overall Study|Withdrawal by Subject|1|||
125598703|NCT04458857|451815393|FG000|Overall Study|Adverse Event|0|||
125598704|NCT04458857|451815394|FG001|Overall Study|Adverse Event|1|||
125598705|NCT04458857|451815395|FG002|Overall Study|Adverse Event|0|||
125598706|NCT04458857|451815393|FG000|Overall Study|Withdrawal by Subject|2|||
125598707|NCT04458857|451815394|FG001|Overall Study|Withdrawal by Subject|0|||
125598708|NCT04458857|451815395|FG002|Overall Study|Withdrawal by Subject|0|||
125598709|NCT04458857|451815393|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125598710|NCT04458857|451815394|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125598711|NCT04458857|451815395|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125598712|NCT04458857|451815393|FG000|Overall Study|Non-compliance with study drug|0|||
125598713|NCT04458857|451815394|FG001|Overall Study|Non-compliance with study drug|1|||
125598714|NCT04458857|451815395|FG002|Overall Study|Non-compliance with study drug|0|||
125598715|NCT04458857|451815393|FG000|Overall Study|Lost to Follow-up|4|||
125598716|NCT04458857|451815394|FG001|Overall Study|Lost to Follow-up|1|||
125598717|NCT04458857|451815395|FG002|Overall Study|Lost to Follow-up|0|||
125598718|NCT03368404|451815398|FG000|Overall Study|Adverse Event|2|||
125598719|NCT03368404|451815399|FG001|Overall Study|Adverse Event|1|||
125598720|NCT03368404|451815398|FG000|Overall Study|Withdrawal by Subject|1|||
125598721|NCT03368404|451815399|FG001|Overall Study|Withdrawal by Subject|1|||
125598722|NCT02983292|451815400|FG000|Overall Study|Participant unwell & cannot travel|2|||
125598723|NCT02983292|451815400|FG000|Overall Study|Lost to Follow-up|3|||
125598724|NCT02983292|451815400|FG000|Overall Study|Participant withdrew consent|2|||
125598725|NCT02983292|451815400|FG000|Overall Study|Revision|7|||
125598726|NCT02983292|451815400|FG000|Overall Study|Death|1|||
125598727|NCT02983292|451815400|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
125598728|NCT02983292|451815400|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
125598729|NCT02983292|451815400|FG000|Overall Study|Participant relocation|1|||
125598730|NCT00964795|451815401|FG000|Overall Study|Withdrawal by Subject|79|||
125598731|NCT00964795|451815401|FG000|Overall Study|Adverse Event|12|||
125598732|NCT00964795|451815401|FG000|Overall Study|Death|14|||
125598733|NCT00964795|451815401|FG000|Overall Study|Lost to Follow-up|7|||
125598734|NCT00964795|451815401|FG000|Overall Study|Termination of Study by Sponsor|169|||
125598735|NCT00964795|451815401|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
125598736|NCT00964795|451815401|FG000|Overall Study|Other|23|||
125598737|NCT00586690|451815406|FG000|Overall Study|Death|2|||
125598738|NCT00586690|451815407|FG001|Overall Study|Death|0|||
125598739|NCT00586690|451815406|FG000|Overall Study|Disease Progression|10|||
125598740|NCT00586690|451815407|FG001|Overall Study|Disease Progression|0|||
125598741|NCT00586690|451815406|FG000|Overall Study|Adverse Event|1|||
125598742|NCT00586690|451815407|FG001|Overall Study|Adverse Event|0|||
125598743|NCT00586690|451815406|FG000|Overall Study|Lack of Efficacy|2|||
125598744|NCT00586690|451815407|FG001|Overall Study|Lack of Efficacy|0|||
125598745|NCT00586690|451815406|FG000|Overall Study|Lab can't accommodate|1|||
125598746|NCT00586690|451815407|FG001|Overall Study|Lab can't accommodate|0|||
125598747|NCT00857246|451815408|FG000|Induction Regimen|Adverse Event|1|||
125598748|NCT00857246|451815408|FG000|Induction Regimen|disease-related complications|1|||
125598749|NCT00857246|451815408|FG000|Induction Regimen|Withdrawal by Subject|1|||
125598750|NCT00857246|451815408|FG000|Surgery (Curative)|disease progression|6|||
125598751|NCT00857246|451815408|FG000|ChemoRT|Withdrawal by Subject|1|||
125598752|NCT00857246|451815408|FG000|ChemoRT|Adverse Event|2|||
125598753|NCT03022422|451815414|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
125598754|NCT03022422|451815415|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
125598755|NCT03022422|451815416|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
125598756|NCT03022422|451815417|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
125598757|NCT03022422|451815418|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
125598758|NCT03022422|451815419|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
125598759|NCT00957372|451815420|FG000|PART I|Lost to Follow-up|0|||
125598760|NCT00957372|451815421|FG001|PART I|Lost to Follow-up|0|||
125598761|NCT00957372|451815422|FG002|PART I|Lost to Follow-up|1|||
125598762|NCT00957372|451815423|FG003|PART I|Lost to Follow-up|0|||
125598763|NCT00957372|451815420|FG000|PART II|Withdrawal by Subject|0|||
125598764|NCT00957372|451815421|FG001|PART II|Withdrawal by Subject|0|||
125598765|NCT00957372|451815422|FG002|PART II|Withdrawal by Subject|0|||
125598766|NCT00957372|451815423|FG003|PART II|Withdrawal by Subject|8|||
125598767|NCT00957372|451815420|FG000|PART II|Physician Decision|0|||
125598768|NCT00957372|451815421|FG001|PART II|Physician Decision|0|||
125598769|NCT00957372|451815422|FG002|PART II|Physician Decision|0|||
125598770|NCT00957372|451815423|FG003|PART II|Physician Decision|1|||
125598771|NCT00957372|451815420|FG000|PART II|Pregnancy|0|||
125598772|NCT00957372|451815421|FG001|PART II|Pregnancy|0|||
125598773|NCT00957372|451815422|FG002|PART II|Pregnancy|0|||
125598774|NCT00957372|451815423|FG003|PART II|Pregnancy|1|||
125598775|NCT00957372|451815420|FG000|PART II|Not Know|0|||
125598776|NCT00957372|451815421|FG001|PART II|Not Know|0|||
125598777|NCT00957372|451815422|FG002|PART II|Not Know|0|||
125598778|NCT00957372|451815423|FG003|PART II|Not Know|20|||
125598779|NCT00957372|451815420|FG000|PART II|Adverse Event|0|||
125598780|NCT00957372|451815421|FG001|PART II|Adverse Event|0|||
125598781|NCT00957372|451815422|FG002|PART II|Adverse Event|0|||
125598782|NCT00957372|451815423|FG003|PART II|Adverse Event|10|||
125598783|NCT00957372|451815420|FG000|PART II|Patient non-compliance|0|||
125598784|NCT00957372|451815421|FG001|PART II|Patient non-compliance|0|||
125598785|NCT00957372|451815422|FG002|PART II|Patient non-compliance|0|||
125598786|NCT00957372|451815423|FG003|PART II|Patient non-compliance|4|||
125598787|NCT01282814|451815424|FG000|First Intervention|Emesis During Dosing Interval|0|||
125598788|NCT01282814|451815425|FG001|First Intervention|Emesis During Dosing Interval|3|||
125598789|NCT01282814|451815424|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
125598790|NCT01282814|451815425|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125598791|NCT01524289|451815426|FG000|Overall Study|Lost to Follow-up|0|||
125598792|NCT01524289|451815427|FG001|Overall Study|Lost to Follow-up|1|||
125598793|NCT01524289|451815426|FG000|Overall Study|Physician Decision|1|||
125598794|NCT01524289|451815427|FG001|Overall Study|Physician Decision|0|||
125598795|NCT01524289|451815426|FG000|Overall Study|Protocol Violation|5|||
125598796|NCT01524289|451815427|FG001|Overall Study|Protocol Violation|1|||
125598797|NCT01524289|451815426|FG000|Overall Study|Withdrawal by Subject|11|||
125598798|NCT01524289|451815427|FG001|Overall Study|Withdrawal by Subject|7|||
125598799|NCT01524289|451815426|FG000|Overall Study|Adverse Event|12|||
125598800|NCT01524289|451815427|FG001|Overall Study|Adverse Event|5|||
125598801|NCT01524289|451815426|FG000|Overall Study|Did not take study medication|1|||
125598802|NCT01524289|451815427|FG001|Overall Study|Did not take study medication|0|||
125598803|NCT02104180|451815428|FG000|Overall Study|Protocol Violation|1|||
125598804|NCT02104180|451815429|FG001|Overall Study|Protocol Violation|0|||
125598805|NCT00907738|451815436|FG000|Overall Study|Adverse Event|2|||
125598806|NCT00907738|451815437|FG001|Overall Study|Adverse Event|0|||
125598807|NCT00907738|451815438|FG002|Overall Study|Adverse Event|1|||
125598808|NCT00907738|451815439|FG003|Overall Study|Adverse Event|0|||
125598809|NCT00907738|451815440|FG004|Overall Study|Adverse Event|0|||
125598810|NCT00907738|451815436|FG000|Overall Study|not specified or withdrew consent|3|||
125598811|NCT00907738|451815437|FG001|Overall Study|not specified or withdrew consent|0|||
125598812|NCT00907738|451815438|FG002|Overall Study|not specified or withdrew consent|0|||
125598813|NCT00907738|451815439|FG003|Overall Study|not specified or withdrew consent|0|||
125598814|NCT00907738|451815440|FG004|Overall Study|not specified or withdrew consent|0|||
125598815|NCT00907738|451815436|FG000|Overall Study|Disease progression|8|||
125598816|NCT00907738|451815437|FG001|Overall Study|Disease progression|1|||
125598817|NCT00907738|451815438|FG002|Overall Study|Disease progression|6|||
125598818|NCT00907738|451815439|FG003|Overall Study|Disease progression|4|||
125431610|NCT03430063|451207699|FG001|Overall Study|Randomized, but never treated|0|||
125431611|NCT03430063|451207700|FG002|Overall Study|Randomized, but never treated|1|||
125431612|NCT00985985|451207703|FG000|Overall Study|Adverse Event|4|||
125598819|NCT00907738|451815440|FG004|Overall Study|Disease progression|2|||
125598820|NCT01089725|451815441|FG000|Overall Study|Adverse Event|1|||
125598821|NCT01089725|451815442|FG001|Overall Study|Adverse Event|1|||
125598822|NCT01089725|451815443|FG002|Overall Study|Adverse Event|0|||
125598823|NCT01089725|451815444|FG003|Overall Study|Adverse Event|0|||
125598824|NCT01089725|451815445|FG004|Overall Study|Adverse Event|2|||
125598825|NCT01089725|451815441|FG000|Overall Study|Lack of Efficacy|4|||
125598826|NCT01089725|451815442|FG001|Overall Study|Lack of Efficacy|3|||
125598827|NCT01089725|451815443|FG002|Overall Study|Lack of Efficacy|1|||
125598828|NCT01089725|451815444|FG003|Overall Study|Lack of Efficacy|0|||
125598829|NCT01089725|451815445|FG004|Overall Study|Lack of Efficacy|4|||
125598830|NCT01089725|451815441|FG000|Overall Study|Lost to Follow-up|2|||
125598831|NCT01089725|451815442|FG001|Overall Study|Lost to Follow-up|2|||
125598832|NCT01089725|451815443|FG002|Overall Study|Lost to Follow-up|0|||
125598833|NCT01089725|451815444|FG003|Overall Study|Lost to Follow-up|3|||
125598834|NCT01089725|451815445|FG004|Overall Study|Lost to Follow-up|0|||
125598835|NCT01089725|451815441|FG000|Overall Study|Protocol Violation|0|||
125598836|NCT01089725|451815442|FG001|Overall Study|Protocol Violation|0|||
125598837|NCT01089725|451815443|FG002|Overall Study|Protocol Violation|1|||
125598838|NCT01089725|451815444|FG003|Overall Study|Protocol Violation|1|||
125598839|NCT01089725|451815445|FG004|Overall Study|Protocol Violation|0|||
125598840|NCT01089725|451815441|FG000|Overall Study|Withdrawal by Subject|5|||
125598841|NCT01089725|451815442|FG001|Overall Study|Withdrawal by Subject|5|||
125598842|NCT01089725|451815443|FG002|Overall Study|Withdrawal by Subject|4|||
125598843|NCT01089725|451815444|FG003|Overall Study|Withdrawal by Subject|5|||
125598844|NCT01089725|451815445|FG004|Overall Study|Withdrawal by Subject|4|||
125598845|NCT01089725|451815441|FG000|Overall Study|Study Terminated by Sponsor|51|||
125598846|NCT01089725|451815442|FG001|Overall Study|Study Terminated by Sponsor|56|||
125598847|NCT01089725|451815443|FG002|Overall Study|Study Terminated by Sponsor|53|||
125598848|NCT01089725|451815444|FG003|Overall Study|Study Terminated by Sponsor|68|||
125598849|NCT01089725|451815445|FG004|Overall Study|Study Terminated by Sponsor|68|||
125598850|NCT01089725|451815441|FG000|Overall Study|Randomized, but not treated|0|||
125598851|NCT01089725|451815442|FG001|Overall Study|Randomized, but not treated|1|||
125598852|NCT01089725|451815443|FG002|Overall Study|Randomized, but not treated|2|||
125598853|NCT01089725|451815444|FG003|Overall Study|Randomized, but not treated|1|||
125598854|NCT01089725|451815445|FG004|Overall Study|Randomized, but not treated|2|||
125598855|NCT01089725|451815441|FG000|Overall Study|Other|3|||
125598856|NCT01089725|451815442|FG001|Overall Study|Other|0|||
125598857|NCT01089725|451815443|FG002|Overall Study|Other|0|||
125598858|NCT01089725|451815444|FG003|Overall Study|Other|1|||
125598859|NCT01089725|451815445|FG004|Overall Study|Other|0|||
125598860|NCT02495077|451817351|FG000|Overall Study|Adverse Event|0|||
125598861|NCT02495077|451817352|FG001|Overall Study|Adverse Event|1|||
125598862|NCT02495077|451817353|FG002|Overall Study|Adverse Event|1|||
125598863|NCT02495077|451817354|FG003|Overall Study|Adverse Event|0|||
125598864|NCT02495077|451817351|FG000|Overall Study|Death|3|||
125598865|NCT02495077|451817352|FG001|Overall Study|Death|5|||
125431613|NCT00985985|451207704|FG001|Overall Study|Adverse Event|2|||
125431614|NCT00985985|451207705|FG002|Overall Study|Adverse Event|2|||
125598866|NCT02495077|451817353|FG002|Overall Study|Death|0|||
125598867|NCT02495077|451817354|FG003|Overall Study|Death|0|||
125598868|NCT02495077|451817351|FG000|Overall Study|Lost to Follow-up|6|||
125598869|NCT02495077|451817352|FG001|Overall Study|Lost to Follow-up|4|||
125598870|NCT02495077|451817353|FG002|Overall Study|Lost to Follow-up|0|||
125598871|NCT02495077|451817354|FG003|Overall Study|Lost to Follow-up|0|||
125598872|NCT02495077|451817351|FG000|Overall Study|Physician Decision|2|||
125598873|NCT02495077|451817352|FG001|Overall Study|Physician Decision|1|||
125598874|NCT02495077|451817353|FG002|Overall Study|Physician Decision|4|||
125598875|NCT02495077|451817354|FG003|Overall Study|Physician Decision|0|||
125598876|NCT02495077|451817351|FG000|Overall Study|Protocol Violation|0|||
125598877|NCT02495077|451817352|FG001|Overall Study|Protocol Violation|1|||
125598878|NCT02495077|451817353|FG002|Overall Study|Protocol Violation|0|||
125598879|NCT02495077|451817354|FG003|Overall Study|Protocol Violation|0|||
125598880|NCT02495077|451817351|FG000|Overall Study|Screen Failure|0|||
125598881|NCT02495077|451817352|FG001|Overall Study|Screen Failure|0|||
125598882|NCT02495077|451817353|FG002|Overall Study|Screen Failure|0|||
125598883|NCT02495077|451817354|FG003|Overall Study|Screen Failure|48|||
125598884|NCT02495077|451817351|FG000|Overall Study|Withdrawal by Subject|7|||
125598885|NCT02495077|451817352|FG001|Overall Study|Withdrawal by Subject|7|||
125598886|NCT02495077|451817353|FG002|Overall Study|Withdrawal by Subject|7|||
125598887|NCT02495077|451817354|FG003|Overall Study|Withdrawal by Subject|0|||
125598888|NCT02495077|451817351|FG000|Overall Study|Covid-19 research restrictions|1|||
125598889|NCT02495077|451817352|FG001|Overall Study|Covid-19 research restrictions|0|||
125598890|NCT02495077|451817353|FG002|Overall Study|Covid-19 research restrictions|0|||
125598891|NCT02495077|451817354|FG003|Overall Study|Covid-19 research restrictions|0|||
125598892|NCT02495077|451817351|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
125598893|NCT02495077|451817352|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
125598894|NCT02495077|451817353|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
125598895|NCT02495077|451817354|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
125598896|NCT02495077|451817351|FG000|Overall Study|Incarcerated|0|||
125598897|NCT02495077|451817352|FG001|Overall Study|Incarcerated|1|||
125598898|NCT02495077|451817353|FG002|Overall Study|Incarcerated|0|||
125598899|NCT02495077|451817354|FG003|Overall Study|Incarcerated|0|||
125598900|NCT02495077|451817351|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
125598901|NCT02495077|451817352|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
125598902|NCT02495077|451817353|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
125598903|NCT02495077|451817354|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
125598904|NCT02495077|451817351|FG000|Overall Study|Timing of transplant and randomization|0|||
125598905|NCT02495077|451817352|FG001|Overall Study|Timing of transplant and randomization|0|||
125598906|NCT02495077|451817353|FG002|Overall Study|Timing of transplant and randomization|5|||
125598907|NCT02495077|451817354|FG003|Overall Study|Timing of transplant and randomization|0|||
125598908|NCT02742649|451817361|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
125598909|NCT02742649|451817362|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
125598910|NCT02742649|451817363|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
125598911|NCT02742649|451817364|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
125598912|NCT02742649|451817365|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
125598913|NCT02742649|451817361|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125598914|NCT02742649|451817362|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125598915|NCT02742649|451817363|FG002|Double-Blind Treatment Period|Adverse Event|0|||
125598916|NCT02742649|451817364|FG003|Double-Blind Treatment Period|Adverse Event|0|||
125598917|NCT02742649|451817365|FG004|Double-Blind Treatment Period|Adverse Event|0|||
125598918|NCT02742649|451817361|FG000|Open-Label Period|Lost to Follow-up|0|||
125598919|NCT02742649|451817362|FG001|Open-Label Period|Lost to Follow-up|0|||
125598920|NCT02742649|451817363|FG002|Open-Label Period|Lost to Follow-up|0|||
125598921|NCT02742649|451817364|FG003|Open-Label Period|Lost to Follow-up|0|||
125598922|NCT02742649|451817365|FG004|Open-Label Period|Lost to Follow-up|1|||
125598923|NCT01978912|451817374|FG000|Overall Study|Adverse Event|0|||
125598924|NCT01978912|451817375|FG001|Overall Study|Adverse Event|1|||
125598925|NCT01978912|451817376|FG002|Overall Study|Adverse Event|0|||
125598926|NCT01978912|451817377|FG003|Overall Study|Adverse Event|0|||
125598927|NCT01978912|451817374|FG000|Overall Study|Lost to Follow-up|1|||
125598928|NCT01978912|451817375|FG001|Overall Study|Lost to Follow-up|1|||
125598929|NCT01978912|451817376|FG002|Overall Study|Lost to Follow-up|0|||
125598930|NCT01978912|451817377|FG003|Overall Study|Lost to Follow-up|1|||
125598931|NCT01978912|451817374|FG000|Overall Study|Withdrawal by Subject|1|||
125598932|NCT01978912|451817375|FG001|Overall Study|Withdrawal by Subject|0|||
125598933|NCT01978912|451817376|FG002|Overall Study|Withdrawal by Subject|2|||
125598934|NCT01978912|451817377|FG003|Overall Study|Withdrawal by Subject|2|||
125598935|NCT01978912|451817374|FG000|Overall Study|Lumbar Surgery|1|||
125598936|NCT01978912|451817375|FG001|Overall Study|Lumbar Surgery|0|||
125598937|NCT01978912|451817376|FG002|Overall Study|Lumbar Surgery|1|||
125598938|NCT01978912|451817377|FG003|Overall Study|Lumbar Surgery|0|||
125598939|NCT01978912|451817374|FG000|Overall Study|Intradiscal Steroid Injection|0|||
125598940|NCT01978912|451817375|FG001|Overall Study|Intradiscal Steroid Injection|1|||
125598941|NCT01978912|451817376|FG002|Overall Study|Intradiscal Steroid Injection|0|||
125598942|NCT01978912|451817377|FG003|Overall Study|Intradiscal Steroid Injection|0|||
125598943|NCT04220866|451817378|FG000|Overall Study|Death|4|||
125598944|NCT04220866|451817379|FG001|Overall Study|Death|5|||
125598945|NCT04220866|451817378|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
125598946|NCT04220866|451817379|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
125598947|NCT04220866|451817378|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
125598948|NCT04220866|451817379|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
125598949|NCT04220866|451817378|FG000|Overall Study|Withdrawal by Subject|0|||
125598950|NCT04220866|451817379|FG001|Overall Study|Withdrawal by Subject|1|||
125598951|NCT00791128|451817381|FG000|Overall Study|Adverse Event|4|||
125598952|NCT00791128|451817381|FG000|Overall Study|Device migration|2|||
125598953|NCT00791128|451817381|FG000|Overall Study|non-compliance by subject|2|||
125598954|NCT00791128|451817381|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
125598955|NCT00635102|451817384|FG000|Overall Study|Withdrawal by Subject|7|||
125598956|NCT00635102|451817385|FG001|Overall Study|Withdrawal by Subject|8|||
125598957|NCT01938625|451817386|FG000|Overall Study|Withdrawal by Subject|0|||
125598958|NCT01938625|451817387|FG001|Overall Study|Withdrawal by Subject|1|||
125598959|NCT01938625|451817386|FG000|Overall Study|Adverse Event|0|||
125598960|NCT01938625|451817387|FG001|Overall Study|Adverse Event|1|||
125598961|NCT02088034|451817388|FG000|Overall Study|Lost to Follow-up|1|||
125598962|NCT02088034|451817389|FG001|Overall Study|Lost to Follow-up|1|||
125598963|NCT02088034|451817390|FG002|Overall Study|Lost to Follow-up|0|||
125598964|NCT02088034|451817388|FG000|Overall Study|Pregnancy|2|||
125598965|NCT02088034|451817389|FG001|Overall Study|Pregnancy|1|||
125598966|NCT02088034|451817390|FG002|Overall Study|Pregnancy|2|||
125598967|NCT00308620|451817391|FG000|Overall Study|Death|1|||
125598968|NCT00308620|451817392|FG001|Overall Study|Death|1|||
125598969|NCT00308620|451817393|FG002|Overall Study|Death|0|||
125598970|NCT00308620|451817391|FG000|Overall Study|Lost to Follow-up|0|||
125598971|NCT00308620|451817392|FG001|Overall Study|Lost to Follow-up|0|||
125598972|NCT00308620|451817393|FG002|Overall Study|Lost to Follow-up|1|||
125598973|NCT00546351|451817394|FG000|Overall Study|Adverse Event|76|||
125598974|NCT00546351|451817394|FG000|Overall Study|Lack of Efficacy|15|||
125598975|NCT00546351|451817394|FG000|Overall Study|Withdrawal by Subject|109|||
125598976|NCT00546351|451817394|FG000|Overall Study|Lost to Follow-up|9|||
125598977|NCT00546351|451817394|FG000|Overall Study|Protocol Deviation|1|||
125598978|NCT00546351|451817394|FG000|Overall Study|Unsatisfactory compliance|9|||
125598979|NCT00546351|451817394|FG000|Overall Study|Other reasons for premature termination|17|||
125598980|NCT03952650|451817395|FG000|Overall Study|TRAVEL|0|||
125598981|NCT03952650|451817396|FG001|Overall Study|TRAVEL|4|||
125598982|NCT03952650|451817397|FG002|Overall Study|TRAVEL|0|||
125598983|NCT03952650|451817398|FG003|Overall Study|TRAVEL|4|||
125598984|NCT03952650|451817399|FG004|Overall Study|TRAVEL|0|||
125598985|NCT03952650|451817400|FG005|Overall Study|TRAVEL|3|||
125598986|NCT03952650|451817401|FG006|Overall Study|TRAVEL|2|||
125598987|NCT03952650|451817395|FG000|Overall Study|Withdrawal by Subject|0|||
125598988|NCT03952650|451817396|FG001|Overall Study|Withdrawal by Subject|2|||
125598989|NCT03952650|451817397|FG002|Overall Study|Withdrawal by Subject|0|||
125598990|NCT03952650|451817398|FG003|Overall Study|Withdrawal by Subject|3|||
125598991|NCT03952650|451817399|FG004|Overall Study|Withdrawal by Subject|0|||
125598992|NCT03952650|451817400|FG005|Overall Study|Withdrawal by Subject|1|||
125598993|NCT03952650|451817401|FG006|Overall Study|Withdrawal by Subject|1|||
125598994|NCT03952650|451817395|FG000|Overall Study|Lost to Follow-up|0|||
125598995|NCT03952650|451817396|FG001|Overall Study|Lost to Follow-up|1|||
125598996|NCT03952650|451817397|FG002|Overall Study|Lost to Follow-up|0|||
125598997|NCT03952650|451817398|FG003|Overall Study|Lost to Follow-up|0|||
125598998|NCT03952650|451817399|FG004|Overall Study|Lost to Follow-up|0|||
125598999|NCT03952650|451817400|FG005|Overall Study|Lost to Follow-up|1|||
125599000|NCT03952650|451817401|FG006|Overall Study|Lost to Follow-up|1|||
125599001|NCT03952650|451817395|FG000|Overall Study|Received wrong vaccine and travelled|0|||
125599002|NCT03952650|451817396|FG001|Overall Study|Received wrong vaccine and travelled|0|||
125599003|NCT03952650|451817397|FG002|Overall Study|Received wrong vaccine and travelled|0|||
125599004|NCT03952650|451817398|FG003|Overall Study|Received wrong vaccine and travelled|0|||
125599005|NCT03952650|451817399|FG004|Overall Study|Received wrong vaccine and travelled|0|||
125599006|NCT03952650|451817400|FG005|Overall Study|Received wrong vaccine and travelled|1|||
125599007|NCT03952650|451817401|FG006|Overall Study|Received wrong vaccine and travelled|0|||
125599008|NCT03952650|451817395|FG000|Overall Study|Unable to make study visit|0|||
125599009|NCT03952650|451817396|FG001|Overall Study|Unable to make study visit|0|||
125599010|NCT03952650|451817397|FG002|Overall Study|Unable to make study visit|0|||
125599011|NCT03952650|451817398|FG003|Overall Study|Unable to make study visit|0|||
125599012|NCT03952650|451817399|FG004|Overall Study|Unable to make study visit|0|||
125599013|NCT03952650|451817400|FG005|Overall Study|Unable to make study visit|1|||
125599014|NCT03952650|451817401|FG006|Overall Study|Unable to make study visit|0|||
125599015|NCT01357239|451817403|FG000|Stratum: All Patients|Adverse Event|0|||
125599016|NCT01357239|451817404|FG001|Stratum: All Patients|Adverse Event|0|||
125599017|NCT01357239|451817405|FG002|Stratum: All Patients|Adverse Event|1|||
125599018|NCT01357239|451817406|FG003|Stratum: All Patients|Adverse Event|1|||
125599019|NCT01357239|451817403|FG000|Stratum: All Patients|Subject withdrew consent|0|||
125599020|NCT01357239|451817404|FG001|Stratum: All Patients|Subject withdrew consent|0|||
125599021|NCT01357239|451817405|FG002|Stratum: All Patients|Subject withdrew consent|1|||
125599022|NCT01357239|451817406|FG003|Stratum: All Patients|Subject withdrew consent|1|||
125599023|NCT01357239|451817403|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
125599024|NCT01357239|451817404|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
125599025|NCT01357239|451817405|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
125599026|NCT01357239|451817406|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
125599027|NCT01357239|451817403|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
125599028|NCT01357239|451817404|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
125599029|NCT01357239|451817405|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
125599030|NCT01357239|451817406|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
125599031|NCT01357239|451817403|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
125599032|NCT01357239|451817404|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
125599033|NCT01357239|451817405|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
125599034|NCT01357239|451817406|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
125599035|NCT03133481|451817410|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
125599036|NCT03133481|451817411|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
125599037|NCT00637728|451817415|FG000|Double-blind Phase|Adverse Event|1|||
125599038|NCT00637728|451817416|FG001|Double-blind Phase|Adverse Event|0|||
125599039|NCT00637728|451817417|FG002|Double-blind Phase|Adverse Event|0|||
125599040|NCT00637728|451817415|FG000|Double-blind Phase|Non-compliance|2|||
125599041|NCT00637728|451817416|FG001|Double-blind Phase|Non-compliance|0|||
125599042|NCT00637728|451817417|FG002|Double-blind Phase|Non-compliance|0|||
125599043|NCT00637728|451817415|FG000|Double-blind Phase|Study Discontinued|1|||
125599044|NCT00637728|451817416|FG001|Double-blind Phase|Study Discontinued|1|||
125599045|NCT00637728|451817417|FG002|Double-blind Phase|Study Discontinued|0|||
125599046|NCT01050062|451817418|FG000|Overall Study|Adverse Event|75|||
125599047|NCT01050062|451817419|FG001|Overall Study|Adverse Event|22|||
125599048|NCT01050062|451817418|FG000|Overall Study|Lost to Follow-up|83|||
125599049|NCT01050062|451817419|FG001|Overall Study|Lost to Follow-up|35|||
125599050|NCT01050062|451817418|FG000|Overall Study|Lack of Efficacy|22|||
125599051|NCT01050062|451817419|FG001|Overall Study|Lack of Efficacy|35|||
125599052|NCT01050062|451817418|FG000|Overall Study|Physician Decision|74|||
125599053|NCT01050062|451817419|FG001|Overall Study|Physician Decision|9|||
125599054|NCT01050062|451817418|FG000|Overall Study|Others|17|||
125599055|NCT01050062|451817419|FG001|Overall Study|Others|11|||
125599077|NCT00670111|451817427|FG000|Enrollment to One Month|Testing Failure|0|||
125599078|NCT00670111|451817428|FG001|Enrollment to One Month|Testing Failure|0|||
125599079|NCT00670111|451817429|FG002|Enrollment to One Month|Testing Failure|13|||
125599080|NCT00670111|451817427|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
125599081|NCT00670111|451817428|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
125599082|NCT00670111|451817429|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
125599083|NCT00670111|451817427|FG000|Enrollment to One Month|Physician Decision|1|||
125599084|NCT00670111|451817428|FG001|Enrollment to One Month|Physician Decision|0|||
125599085|NCT00670111|451817429|FG002|Enrollment to One Month|Physician Decision|0|||
125599086|NCT03988751|451817430|FG000|Overall Study|Withdrawal by Subject|1|||
125599087|NCT03988751|451817431|FG001|Overall Study|Withdrawal by Subject|0|||
125599088|NCT03988751|451817430|FG000|Overall Study|Protocol Violation|0|||
125599089|NCT03988751|451817431|FG001|Overall Study|Protocol Violation|1|||
125599090|NCT02623361|451817432|FG000|Overall Study|Protocol Violation|0|||
125599091|NCT02623361|451817433|FG001|Overall Study|Protocol Violation|1|||
125599092|NCT02623361|451817432|FG000|Overall Study|Withdrawal by Subject|0|||
125599093|NCT02623361|451817433|FG001|Overall Study|Withdrawal by Subject|1|||
125599094|NCT00844883|451817436|FG000|Overall Study|Bridged to liver transplant|3|||
125599095|NCT00844883|451817436|FG000|Overall Study|Bridged to resection|1|||
125599096|NCT03894540|451817438|FG000|Overall Study|Adverse Event|0|||
125599097|NCT03894540|451817439|FG001|Overall Study|Adverse Event|0|||
125599098|NCT03894540|451817440|FG002|Overall Study|Adverse Event|0|||
125599099|NCT03894540|451817441|FG003|Overall Study|Adverse Event|0|||
125599100|NCT03894540|451817442|FG004|Overall Study|Adverse Event|1|||
125599101|NCT03894540|451817443|FG005|Overall Study|Adverse Event|0|||
125599102|NCT03894540|451817438|FG000|Overall Study|Withdrawal by Subject|0|||
125599103|NCT03894540|451817439|FG001|Overall Study|Withdrawal by Subject|0|||
125599104|NCT03894540|451817440|FG002|Overall Study|Withdrawal by Subject|0|||
125599105|NCT03894540|451817441|FG003|Overall Study|Withdrawal by Subject|0|||
125599106|NCT03894540|451817442|FG004|Overall Study|Withdrawal by Subject|1|||
125599107|NCT03894540|451817443|FG005|Overall Study|Withdrawal by Subject|0|||
125599108|NCT03894540|451817438|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
125599109|NCT03894540|451817439|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
125599110|NCT03894540|451817440|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
125599111|NCT03894540|451817441|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
125599112|NCT03894540|451817442|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
125599113|NCT03894540|451817443|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
125599114|NCT03894540|451817438|FG000|Overall Study|Progressive Disease Clinical|1|||
125599115|NCT03894540|451817439|FG001|Overall Study|Progressive Disease Clinical|1|||
125599116|NCT03894540|451817440|FG002|Overall Study|Progressive Disease Clinical|0|||
125599117|NCT03894540|451817441|FG003|Overall Study|Progressive Disease Clinical|1|||
125599118|NCT03894540|451817442|FG004|Overall Study|Progressive Disease Clinical|5|||
125599119|NCT03894540|451817443|FG005|Overall Study|Progressive Disease Clinical|1|||
125599120|NCT03894540|451817438|FG000|Overall Study|Study termination by sponsor|0|||
125599121|NCT03894540|451817439|FG001|Overall Study|Study termination by sponsor|0|||
125599122|NCT03894540|451817440|FG002|Overall Study|Study termination by sponsor|0|||
125599123|NCT03894540|451817441|FG003|Overall Study|Study termination by sponsor|0|||
125599124|NCT03894540|451817442|FG004|Overall Study|Study termination by sponsor|2|||
125599125|NCT03894540|451817443|FG005|Overall Study|Study termination by sponsor|0|||
125599126|NCT03000452|451817445|FG000|Treatment Period|Death|1|||
125599127|NCT03000452|451817445|FG000|Treatment Period|Progressive Disease (PD)|14|||
125599128|NCT03000452|451817445|FG000|Treatment Period|Physician Decision|1|||
125599129|NCT03000452|451817445|FG000|Treatment Period|Miscellaneous|2|||
125599130|NCT03000452|451817445|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
125599131|NCT03000452|451817445|FG000|Follow-Up Period|Death|3|||
125599132|NCT03000452|451817445|FG000|Follow-Up Period|Withdrawal by Subject|3|||
125599133|NCT03043365|451817446|FG000|Weeks 0 to Week 8|Adverse Event|1|||
125599134|NCT03043365|451817447|FG001|Weeks 0 to Week 8|Adverse Event|3|||
125599135|NCT03043365|451817446|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
125599136|NCT03043365|451817447|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
125599137|NCT03043365|451817446|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
125599138|NCT03043365|451817447|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
125599139|NCT03455543|451817448|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
125599140|NCT03455543|451817449|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
125599141|NCT03455543|451817450|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
125599142|NCT03455543|451817448|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
125599143|NCT03455543|451817449|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
125599144|NCT03455543|451817450|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
125599145|NCT03455543|451817448|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
125599146|NCT03455543|451817449|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
125599147|NCT03455543|451817450|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
125599148|NCT03455543|451817448|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
125599149|NCT03455543|451817449|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
125599150|NCT03455543|451817450|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
125599151|NCT03455543|451817448|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
125599152|NCT03455543|451817449|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
125599153|NCT03455543|451817450|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
125599154|NCT03455543|451817448|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
125599155|NCT03455543|451817449|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
125599156|NCT03455543|451817450|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
125599157|NCT03455543|451817448|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
125599158|NCT03455543|451817449|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
125599159|NCT03455543|451817450|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
125599160|NCT03455543|451817448|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
125599161|NCT03455543|451817449|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
125599162|NCT03455543|451817450|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
125599163|NCT03455543|451817448|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
125599164|NCT03455543|451817449|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
125599165|NCT03455543|451817450|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
125599166|NCT02873221|451817451|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
125599167|NCT02873221|451817452|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
125599168|NCT02873221|451817453|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
125599169|NCT02873221|451817451|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
125599170|NCT02873221|451817452|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
125599171|NCT02873221|451817453|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
125599172|NCT02873221|451817451|FG000|Treatment Period|Protocol Violation|2|||
125599173|NCT02873221|451817452|FG001|Treatment Period|Protocol Violation|5|||
125599174|NCT02873221|451817453|FG002|Treatment Period|Protocol Violation|8|||
125599175|NCT02873221|451817451|FG000|Treatment Period|Pregnancy|4|||
125599176|NCT02873221|451817452|FG001|Treatment Period|Pregnancy|6|||
125599177|NCT02873221|451817453|FG002|Treatment Period|Pregnancy|3|||
125599178|NCT02873221|451817451|FG000|Treatment Period|Lack of Qualifying Event|0|||
125599179|NCT02873221|451817452|FG001|Treatment Period|Lack of Qualifying Event|3|||
125599180|NCT02873221|451817453|FG002|Treatment Period|Lack of Qualifying Event|1|||
125599181|NCT02873221|451817451|FG000|Treatment Period|Withdrawal of Consent|52|||
125599182|NCT02873221|451817452|FG001|Treatment Period|Withdrawal of Consent|51|||
125599183|NCT02873221|451817453|FG002|Treatment Period|Withdrawal of Consent|41|||
125599184|NCT02873221|451817451|FG000|Treatment Period|Lack of Efficacy|0|||
125599185|NCT02873221|451817452|FG001|Treatment Period|Lack of Efficacy|17|||
125599186|NCT02873221|451817453|FG002|Treatment Period|Lack of Efficacy|12|||
125599187|NCT02873221|451817451|FG000|Treatment Period|Adverse Event|4|||
125599188|NCT02873221|451817452|FG001|Treatment Period|Adverse Event|9|||
125599189|NCT02873221|451817453|FG002|Treatment Period|Adverse Event|11|||
125599190|NCT02873221|451817451|FG000|Treatment Period|Lost to Follow-up|26|||
125599191|NCT02873221|451817452|FG001|Treatment Period|Lost to Follow-up|30|||
125599192|NCT02873221|451817453|FG002|Treatment Period|Lost to Follow-up|26|||
125599193|NCT02873221|451817451|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
125599194|NCT02873221|451817452|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
125599195|NCT02873221|451817453|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
125599196|NCT02873221|451817451|FG000|Safety Follow-up Period|Protocol Violation|0|||
125599197|NCT02873221|451817452|FG001|Safety Follow-up Period|Protocol Violation|0|||
125599198|NCT02873221|451817453|FG002|Safety Follow-up Period|Protocol Violation|1|||
125599199|NCT02873221|451817451|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
125599200|NCT02873221|451817452|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
125599201|NCT02873221|451817453|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
125599202|NCT02873221|451817451|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
125599203|NCT02873221|451817452|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
125599204|NCT02873221|451817453|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
125599205|NCT01508676|451817454|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
125599206|NCT01508676|451817455|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
125599207|NCT01508676|451817454|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
125431615|NCT00985985|451207706|FG003|Overall Study|Adverse Event|2|||
125212797|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
125599208|NCT01508676|451817455|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
125599209|NCT01508676|451817454|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
125599210|NCT01508676|451817455|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
125599211|NCT01508676|451817454|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
125599212|NCT01508676|451817455|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
125599213|NCT01508676|451817454|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
125599214|NCT01508676|451817455|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
125599215|NCT02532543|451817456|FG000|Overall Study|Lost to Follow-up|0|||
125599216|NCT02532543|451817457|FG001|Overall Study|Lost to Follow-up|0|||
125599217|NCT02532543|451817458|FG002|Overall Study|Lost to Follow-up|1|||
125599218|NCT02532543|451817459|FG003|Overall Study|Lost to Follow-up|0|||
125599219|NCT02614794|451817462|FG000|Overall Study|Death|258|||
125599220|NCT02614794|451817463|FG001|Overall Study|Death|151|||
125599221|NCT02614794|451817462|FG000|Overall Study|Study closure by Sponsor|119|||
125599222|NCT02614794|451817463|FG001|Overall Study|Study closure by Sponsor|45|||
125599223|NCT02614794|451817462|FG000|Overall Study|Withdrawal by Subject|24|||
125599224|NCT02614794|451817463|FG001|Overall Study|Withdrawal by Subject|5|||
125599225|NCT02614794|451817462|FG000|Overall Study|Lost to Follow-up|7|||
125599226|NCT02614794|451817463|FG001|Overall Study|Lost to Follow-up|0|||
125599227|NCT02614794|451817462|FG000|Overall Study|Physician Decision|1|||
125599228|NCT02614794|451817463|FG001|Overall Study|Physician Decision|1|||
125599229|NCT02614794|451817462|FG000|Overall Study|Hospital closure|1|||
125599230|NCT02614794|451817463|FG001|Overall Study|Hospital closure|0|||
125599231|NCT01633060|451817473|FG000|Randomization Phase|Protocol deviation|1|||
125599232|NCT01633060|451817474|FG001|Randomization Phase|Protocol deviation|2|||
125599233|NCT01633060|451817473|FG000|Randomization Phase|Technical problem|0|||
125599234|NCT01633060|451817474|FG001|Randomization Phase|Technical problem|1|||
125599235|NCT01633060|451817473|FG000|Treatment Phase|Adverse Event|24|||
125599236|NCT01633060|451817474|FG001|Treatment Phase|Adverse Event|3|||
125599237|NCT01633060|451817473|FG000|Treatment Phase|Lost to Follow-up|1|||
125599238|NCT01633060|451817474|FG001|Treatment Phase|Lost to Follow-up|0|||
125599239|NCT01633060|451817473|FG000|Treatment Phase|Physician Decision|16|||
125599240|NCT01633060|451817474|FG001|Treatment Phase|Physician Decision|7|||
125599241|NCT01633060|451817473|FG000|Treatment Phase|Progressive Disease|210|||
125599242|NCT01633060|451817474|FG001|Treatment Phase|Progressive Disease|120|||
125599243|NCT01633060|451817473|FG000|Treatment Phase|Protocol Deviation|1|||
125599244|NCT01633060|451817474|FG001|Treatment Phase|Protocol Deviation|0|||
125599245|NCT01633060|451817473|FG000|Treatment Phase|Study Terminated by sponsor|7|||
125599246|NCT01633060|451817474|FG001|Treatment Phase|Study Terminated by sponsor|3|||
125599247|NCT01633060|451817473|FG000|Treatment Phase|Subject/guardian decision|25|||
125599248|NCT01633060|451817474|FG001|Treatment Phase|Subject/guardian decision|4|||
125599249|NCT01633060|451817473|FG000|Treatment Phase|Death|4|||
125599250|NCT01633060|451817474|FG001|Treatment Phase|Death|3|||
125599251|NCT01633060|451817473|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
125599252|NCT01633060|451817474|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125599253|NCT01633060|451817473|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
125599254|NCT01633060|451817474|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
125599255|NCT01633060|451817473|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
125599256|NCT01633060|451817474|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
125599257|NCT01633060|451817473|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
125599258|NCT01633060|451817474|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
125599259|NCT01633060|451817473|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
125599260|NCT01633060|451817474|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
125599261|NCT01633060|451817473|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
125599262|NCT01633060|451817474|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
125599263|NCT01396525|451817479|FG000|Overall Study|Withdrawal by Subject|8|||
125599264|NCT01396525|451817479|FG000|Overall Study|Death|14|||
125431616|NCT00985985|451207703|FG000|Overall Study|Lost to Follow-up|4|||
125431617|NCT00985985|451207704|FG001|Overall Study|Lost to Follow-up|11|||
125431618|NCT00985985|451207705|FG002|Overall Study|Lost to Follow-up|2|||
125431619|NCT00985985|451207706|FG003|Overall Study|Lost to Follow-up|3|||
125431620|NCT00985985|451207703|FG000|Overall Study|Protocol Violation|1|||
125431621|NCT00985985|451207704|FG001|Overall Study|Protocol Violation|2|||
125431622|NCT00985985|451207705|FG002|Overall Study|Protocol Violation|0|||
125431623|NCT00985985|451207706|FG003|Overall Study|Protocol Violation|1|||
125431624|NCT00985985|451207703|FG000|Overall Study|Lack of Efficacy|5|||
125431625|NCT00985985|451207704|FG001|Overall Study|Lack of Efficacy|6|||
125431626|NCT00985985|451207705|FG002|Overall Study|Lack of Efficacy|1|||
125431627|NCT00985985|451207706|FG003|Overall Study|Lack of Efficacy|3|||
125431628|NCT00985985|451207703|FG000|Overall Study|Withdrawal by Subject|4|||
125431629|NCT00985985|451207704|FG001|Overall Study|Withdrawal by Subject|2|||
125431630|NCT00985985|451207705|FG002|Overall Study|Withdrawal by Subject|2|||
125431631|NCT00985985|451207706|FG003|Overall Study|Withdrawal by Subject|2|||
125431632|NCT00985985|451207703|FG000|Overall Study|Other Reason|6|||
125431633|NCT00985985|451207704|FG001|Overall Study|Other Reason|1|||
125431634|NCT00985985|451207705|FG002|Overall Study|Other Reason|4|||
125431635|NCT00985985|451207706|FG003|Overall Study|Other Reason|2|||
125431636|NCT00895622|451207707|FG000|Overall Study|Protocol Violation|5|||
125599265|NCT01396525|451817479|FG000|Overall Study|Lost to Follow-up|4|||
125599266|NCT03114969|451817480|FG000|Overall Study|Lost to Follow-up|0|||
125599267|NCT03114969|451817481|FG001|Overall Study|Lost to Follow-up|0|||
125599268|NCT03114969|451817482|FG002|Overall Study|Lost to Follow-up|3|||
125599269|NCT03114969|451817483|FG003|Overall Study|Lost to Follow-up|2|||
125599270|NCT03114969|451817484|FG004|Overall Study|Lost to Follow-up|0|||
125599271|NCT03114969|451817485|FG005|Overall Study|Lost to Follow-up|0|||
125599272|NCT03114969|451817486|FG006|Overall Study|Lost to Follow-up|0|||
125599273|NCT03114969|451817487|FG007|Overall Study|Lost to Follow-up|0|||
125599274|NCT03114969|451817488|FG008|Overall Study|Lost to Follow-up|0|||
125599275|NCT03114969|451817480|FG000|Overall Study|Adverse Event|0|||
125599276|NCT03114969|451817481|FG001|Overall Study|Adverse Event|0|||
125599277|NCT03114969|451817482|FG002|Overall Study|Adverse Event|1|||
125599278|NCT03114969|451817483|FG003|Overall Study|Adverse Event|0|||
125599279|NCT03114969|451817484|FG004|Overall Study|Adverse Event|0|||
125599280|NCT03114969|451817485|FG005|Overall Study|Adverse Event|1|||
125599281|NCT03114969|451817486|FG006|Overall Study|Adverse Event|1|||
125599282|NCT03114969|451817487|FG007|Overall Study|Adverse Event|0|||
125599283|NCT03114969|451817488|FG008|Overall Study|Adverse Event|2|||
125599284|NCT00949650|451817489|FG000|Overall Study|Progressive disease|188|||
125599285|NCT00949650|451817490|FG001|Overall Study|Progressive disease|19|||
125599286|NCT00949650|451817489|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
125599287|NCT00949650|451817490|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
125599288|NCT00949650|451817489|FG000|Overall Study|Other Adverse Event (AE)|28|||
125599289|NCT00949650|451817490|FG001|Overall Study|Other Adverse Event (AE)|17|||
125599290|NCT00949650|451817489|FG000|Overall Study|Protocol Violation|1|||
125599291|NCT00949650|451817490|FG001|Overall Study|Protocol Violation|4|||
125599292|NCT00949650|451817489|FG000|Overall Study|Refusal to continue medication|7|||
125599293|NCT00949650|451817490|FG001|Overall Study|Refusal to continue medication|11|||
125599294|NCT00949650|451817489|FG000|Overall Study|Not treated|1|||
125599295|NCT00949650|451817490|FG001|Overall Study|Not treated|4|||
125599296|NCT00949650|451817489|FG000|Overall Study|Other not specified above|5|||
125599297|NCT00949650|451817490|FG001|Overall Study|Other not specified above|0|||
125599298|NCT04601272|451817491|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
125599299|NCT04601272|451817492|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
125599300|NCT04601272|451817493|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
125599301|NCT00414440|451817494|FG000|Core Period|Withdrawal by Subject|70|||
125599302|NCT00414440|451817495|FG001|Core Period|Withdrawal by Subject|32|||
125431637|NCT00895622|451207708|FG001|Overall Study|Protocol Violation|4|||
125431638|NCT00895622|451207709|FG002|Overall Study|Protocol Violation|4|||
125431639|NCT01490125|451207710|FG000|Period I|Adverse Event|4|||
125431640|NCT01490125|451207711|FG001|Period I|Adverse Event|1|||
125431641|NCT01490125|451207712|FG002|Period I|Adverse Event|1|||
125431642|NCT01490125|451207713|FG003|Period I|Adverse Event|3|||
125599303|NCT00414440|451817494|FG000|Extension Period|Lost to Follow-up|44|||
125599304|NCT00414440|451817495|FG001|Extension Period|Lost to Follow-up|52|||
125599305|NCT00414440|451817494|FG000|Extension Period|Did not consent to continue follow up|61|||
125599306|NCT00414440|451817495|FG001|Extension Period|Did not consent to continue follow up|54|||
125431643|NCT01490125|451207714|FG004|Period I|Adverse Event|2|||
125599307|NCT00414440|451817494|FG000|Extension Period|Other|1|||
125599308|NCT00414440|451817495|FG001|Extension Period|Other|1|||
125431644|NCT01490125|451207715|FG005|Period I|Adverse Event|4|||
125599309|NCT00414440|451817494|FG000|Extension Period|Administrative|16|||
125599310|NCT00414440|451817495|FG001|Extension Period|Administrative|16|||
125599311|NCT00414440|451817494|FG000|Extension Period|Death|1|||
125599312|NCT00414440|451817495|FG001|Extension Period|Death|2|||
125599313|NCT00414440|451817494|FG000|Extension Period|Withdrawal by Subject|9|||
125599314|NCT00414440|451817495|FG001|Extension Period|Withdrawal by Subject|7|||
125599315|NCT00414440|451817494|FG000|Extension Period|Not included in follow up period|18|||
125599316|NCT00414440|451817495|FG001|Extension Period|Not included in follow up period|8|||
125599317|NCT02168946|451817496|FG000|Overall Study|Adverse Event|8|||
125599318|NCT02168946|451817497|FG001|Overall Study|Adverse Event|5|||
125599319|NCT02168946|451817496|FG000|Overall Study|Lost to Follow-up|3|||
125599320|NCT02168946|451817497|FG001|Overall Study|Lost to Follow-up|0|||
125599321|NCT02168946|451817496|FG000|Overall Study|Subject unable to come back for visits|1|||
125599322|NCT02168946|451817497|FG001|Overall Study|Subject unable to come back for visits|0|||
125599323|NCT04222725|451817501|FG000|Overall Study|Adverse Event|0|||
125599324|NCT04222725|451817502|FG001|Overall Study|Adverse Event|1|||
125599325|NCT04222725|451817503|FG002|Overall Study|Adverse Event|0|||
125599326|NCT04222725|451817504|FG003|Overall Study|Adverse Event|0|||
125599327|NCT01743027|451817509|FG000|Overall Study|Adverse Event|2|||
125599328|NCT01743027|451817510|FG001|Overall Study|Adverse Event|0|||
125599329|NCT01743027|451817511|FG002|Overall Study|Adverse Event|0|||
125599330|NCT01743027|451817512|FG003|Overall Study|Adverse Event|0|||
125599331|NCT01743027|451817509|FG000|Overall Study|Lost to Follow-up|0|||
125599332|NCT01743027|451817510|FG001|Overall Study|Lost to Follow-up|0|||
125599333|NCT01743027|451817511|FG002|Overall Study|Lost to Follow-up|2|||
125599334|NCT01743027|451817512|FG003|Overall Study|Lost to Follow-up|0|||
125599335|NCT01743027|451817509|FG000|Overall Study|Progressive Disease|1|||
125599336|NCT01743027|451817510|FG001|Overall Study|Progressive Disease|4|||
125599337|NCT01743027|451817511|FG002|Overall Study|Progressive Disease|3|||
125599338|NCT01743027|451817512|FG003|Overall Study|Progressive Disease|0|||
125599339|NCT01743027|451817509|FG000|Overall Study|Protocol Violation|1|||
125599340|NCT01743027|451817510|FG001|Overall Study|Protocol Violation|1|||
125599341|NCT01743027|451817511|FG002|Overall Study|Protocol Violation|1|||
125599342|NCT01743027|451817512|FG003|Overall Study|Protocol Violation|0|||
125599343|NCT01743027|451817509|FG000|Overall Study|Withdrawal by Subject|1|||
125599344|NCT01743027|451817510|FG001|Overall Study|Withdrawal by Subject|0|||
125599345|NCT01743027|451817511|FG002|Overall Study|Withdrawal by Subject|3|||
125599346|NCT01743027|451817512|FG003|Overall Study|Withdrawal by Subject|1|||
125599347|NCT00069121|451817516|FG000|Overall Study|Death|286|||
125599348|NCT00069121|451817517|FG001|Overall Study|Death|242|||
125599349|NCT00069121|451817516|FG000|Overall Study|Withdrawal by Subject|18|||
125599350|NCT00069121|451817517|FG001|Overall Study|Withdrawal by Subject|20|||
125599351|NCT00069121|451817516|FG000|Overall Study|Lost to Follow-up|63|||
125599352|NCT00069121|451817517|FG001|Overall Study|Lost to Follow-up|63|||
125599353|NCT00231478|451817523|FG000|Overall Study|Protocol Violation|3|||
125599354|NCT00231478|451817524|FG001|Overall Study|Protocol Violation|2|||
125599355|NCT00231478|451817523|FG000|Overall Study|Refused Treatment|1|||
125599356|NCT00231478|451817524|FG001|Overall Study|Refused Treatment|1|||
125599357|NCT00231478|451817523|FG000|Overall Study|Withdrawal by Subject|1|||
125599358|NCT00231478|451817524|FG001|Overall Study|Withdrawal by Subject|0|||
125599359|NCT00231478|451817523|FG000|Overall Study|Adverse Event|0|||
125599360|NCT00231478|451817524|FG001|Overall Study|Adverse Event|1|||
125599361|NCT00231478|451817523|FG000|Overall Study|Administrative|3|||
125599362|NCT00231478|451817524|FG001|Overall Study|Administrative|2|||
125599363|NCT00393458|451817531|FG000|Overall Study|Adverse Event|35|||
125599364|NCT00393458|451817532|FG001|Overall Study|Adverse Event|24|||
125599365|NCT00393458|451817533|FG002|Overall Study|Adverse Event|40|||
125599366|NCT00393458|451817534|FG003|Overall Study|Adverse Event|35|||
125599367|NCT00393458|451817531|FG000|Overall Study|Subject withdrew consent|27|||
125599368|NCT00393458|451817532|FG001|Overall Study|Subject withdrew consent|40|||
125599369|NCT00393458|451817533|FG002|Overall Study|Subject withdrew consent|33|||
125599370|NCT00393458|451817534|FG003|Overall Study|Subject withdrew consent|50|||
125599371|NCT00393458|451817531|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
125599372|NCT00393458|451817532|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
125599373|NCT00393458|451817533|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
125599374|NCT00393458|451817534|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
125599375|NCT00393458|451817531|FG000|Overall Study|Protocol deviation|11|||
125599376|NCT00393458|451817532|FG001|Overall Study|Protocol deviation|11|||
125599377|NCT00393458|451817533|FG002|Overall Study|Protocol deviation|11|||
125599378|NCT00393458|451817534|FG003|Overall Study|Protocol deviation|10|||
125599379|NCT00393458|451817531|FG000|Overall Study|Administrative problems|7|||
125599380|NCT00393458|451817532|FG001|Overall Study|Administrative problems|8|||
125599381|NCT00393458|451817533|FG002|Overall Study|Administrative problems|5|||
125599382|NCT00393458|451817534|FG003|Overall Study|Administrative problems|2|||
125599383|NCT00393458|451817531|FG000|Overall Study|Lost to Follow-up|5|||
125599384|NCT00393458|451817532|FG001|Overall Study|Lost to Follow-up|6|||
125599385|NCT00393458|451817533|FG002|Overall Study|Lost to Follow-up|5|||
125599386|NCT00393458|451817534|FG003|Overall Study|Lost to Follow-up|3|||
125599387|NCT00393458|451817531|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125599388|NCT00393458|451817532|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125599389|NCT00393458|451817533|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125599390|NCT00393458|451817534|FG003|Overall Study|Abnormal laboratory value(s)|0|||
125599391|NCT00393458|451817531|FG000|Overall Study|Death|1|||
125599392|NCT00393458|451817532|FG001|Overall Study|Death|1|||
125599393|NCT00393458|451817533|FG002|Overall Study|Death|5|||
125599394|NCT00393458|451817534|FG003|Overall Study|Death|5|||
125599395|NCT00393458|451817531|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125599396|NCT00393458|451817532|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125599397|NCT00393458|451817533|FG002|Overall Study|Abnormal test procedure result(s)|1|||
125599398|NCT00393458|451817534|FG003|Overall Study|Abnormal test procedure result(s)|2|||
125599399|NCT00393458|451817531|FG000|Overall Study|Subject no longer requires study drug|0|||
125599400|NCT00393458|451817532|FG001|Overall Study|Subject no longer requires study drug|1|||
125599401|NCT00393458|451817533|FG002|Overall Study|Subject no longer requires study drug|0|||
125599402|NCT00393458|451817534|FG003|Overall Study|Subject no longer requires study drug|0|||
125599403|NCT01444391|451817541|FG000|Overall Study|Death|1|||
125599404|NCT02704429|451817544|FG000|Part A: 24 Weeks|Adverse Event|3|||
125599405|NCT02704429|451817545|FG001|Part A: 24 Weeks|Adverse Event|0|||
125599406|NCT02704429|451817544|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
125599407|NCT02704429|451817545|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
125599408|NCT00104104|451817546|FG000|Overall Study|Adverse Event|8|||
125599409|NCT00104104|451817547|FG001|Overall Study|Adverse Event|8|||
125599410|NCT00104104|451817546|FG000|Overall Study|Abnormal laboratory value(s)|20|||
125599411|NCT00104104|451817547|FG001|Overall Study|Abnormal laboratory value(s)|14|||
125599412|NCT00104104|451817546|FG000|Overall Study|Lack of Efficacy|0|||
125599413|NCT00104104|451817547|FG001|Overall Study|Lack of Efficacy|3|||
125599414|NCT00104104|451817546|FG000|Overall Study|Condition no longer requires study drug|7|||
125599415|NCT00104104|451817547|FG001|Overall Study|Condition no longer requires study drug|4|||
125599416|NCT00104104|451817546|FG000|Overall Study|Protocol Violation|5|||
125599417|NCT00104104|451817547|FG001|Overall Study|Protocol Violation|2|||
125599418|NCT00104104|451817546|FG000|Overall Study|Withdrawal by Subject|11|||
125599419|NCT00104104|451817547|FG001|Overall Study|Withdrawal by Subject|15|||
125599420|NCT00104104|451817546|FG000|Overall Study|Lost to Follow-up|3|||
125599421|NCT00104104|451817547|FG001|Overall Study|Lost to Follow-up|7|||
125599422|NCT00104104|451817546|FG000|Overall Study|Administrative problems|12|||
125599423|NCT00104104|451817547|FG001|Overall Study|Administrative problems|13|||
125599424|NCT00104104|451817546|FG000|Overall Study|Death|9|||
125599425|NCT00104104|451817547|FG001|Overall Study|Death|6|||
125599426|NCT01821677|451817550|FG000|Overall Study|Adverse Event|4|||
125599427|NCT01821677|451817551|FG001|Overall Study|Adverse Event|6|||
125599428|NCT01821677|451817552|FG002|Overall Study|Adverse Event|5|||
125599429|NCT01821677|451817550|FG000|Overall Study|Physician Decision|1|||
125599430|NCT01821677|451817551|FG001|Overall Study|Physician Decision|4|||
125599431|NCT01821677|451817552|FG002|Overall Study|Physician Decision|1|||
125599432|NCT01821677|451817550|FG000|Overall Study|Non-compliance|0|||
125599433|NCT01821677|451817551|FG001|Overall Study|Non-compliance|1|||
125599434|NCT01821677|451817552|FG002|Overall Study|Non-compliance|2|||
125599435|NCT01821677|451817550|FG000|Overall Study|Lost to Follow-up|2|||
125599436|NCT01821677|451817551|FG001|Overall Study|Lost to Follow-up|1|||
125599437|NCT01821677|451817552|FG002|Overall Study|Lost to Follow-up|3|||
125599438|NCT01821677|451817550|FG000|Overall Study|Protocol Violation|0|||
125599439|NCT01821677|451817551|FG001|Overall Study|Protocol Violation|0|||
125599440|NCT01821677|451817552|FG002|Overall Study|Protocol Violation|2|||
125599441|NCT01821677|451817550|FG000|Overall Study|Withdrawal by Subject|7|||
125599442|NCT01821677|451817551|FG001|Overall Study|Withdrawal by Subject|3|||
125599443|NCT01821677|451817552|FG002|Overall Study|Withdrawal by Subject|2|||
125599444|NCT01821677|451817550|FG000|Overall Study|Other|9|||
125599445|NCT01821677|451817551|FG001|Overall Study|Other|0|||
125599446|NCT01821677|451817552|FG002|Overall Study|Other|0|||
125599447|NCT01855789|451817553|FG000|1) Baseline up to Week 24|Adverse Event|37|||
125599448|NCT01855789|451817554|FG001|1) Baseline up to Week 24|Adverse Event|0|||
125599449|NCT01855789|451817555|FG002|1) Baseline up to Week 24|Adverse Event|0|||
125599450|NCT01855789|451817556|FG003|1) Baseline up to Week 24|Adverse Event|0|||
125599451|NCT01855789|451817553|FG000|1) Baseline up to Week 24|Death|2|||
125599452|NCT01855789|451817554|FG001|1) Baseline up to Week 24|Death|0|||
125599453|NCT01855789|451817555|FG002|1) Baseline up to Week 24|Death|0|||
125599454|NCT01855789|451817556|FG003|1) Baseline up to Week 24|Death|0|||
125369148|NCT01847274|450984870|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125369149|NCT01847274|450984871|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
125369150|NCT01847274|450984861|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125599455|NCT01855789|451817553|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
125599456|NCT01855789|451817554|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
125599457|NCT01855789|451817555|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
125599458|NCT01855789|451817556|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
125599459|NCT01855789|451817553|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
125599460|NCT01855789|451817554|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
125599461|NCT01855789|451817555|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
125599462|NCT01855789|451817556|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
125599463|NCT01855789|451817553|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
125599464|NCT01855789|451817554|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
125599465|NCT01855789|451817555|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
125599466|NCT01855789|451817556|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
125599467|NCT01855789|451817553|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
125599468|NCT01855789|451817554|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
125599469|NCT01855789|451817555|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
125599470|NCT01855789|451817556|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
125599471|NCT01855789|451817553|FG000|1) Baseline up to Week 24|Physician Decision|4|||
125599472|NCT01855789|451817554|FG001|1) Baseline up to Week 24|Physician Decision|0|||
125599473|NCT01855789|451817555|FG002|1) Baseline up to Week 24|Physician Decision|0|||
125599474|NCT01855789|451817556|FG003|1) Baseline up to Week 24|Physician Decision|0|||
125599475|NCT01855789|451817553|FG000|1) Baseline up to Week 24|Pregnancy|1|||
125599476|NCT01855789|451817554|FG001|1) Baseline up to Week 24|Pregnancy|0|||
125599477|NCT01855789|451817555|FG002|1) Baseline up to Week 24|Pregnancy|0|||
125599478|NCT01855789|451817556|FG003|1) Baseline up to Week 24|Pregnancy|0|||
125599479|NCT01855789|451817553|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
125599480|NCT01855789|451817554|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
125599481|NCT01855789|451817555|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
125599482|NCT01855789|451817556|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
125599483|NCT01855789|451817553|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
125599484|NCT01855789|451817554|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
125599485|NCT01855789|451817555|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
125599486|NCT01855789|451817556|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
125599487|NCT01855789|451817553|FG000|1) Baseline up to Week 24|Other|4|||
125599488|NCT01855789|451817554|FG001|1) Baseline up to Week 24|Other|0|||
125599489|NCT01855789|451817555|FG002|1) Baseline up to Week 24|Other|0|||
125599490|NCT01855789|451817556|FG003|1) Baseline up to Week 24|Other|0|||
125599491|NCT01855789|451817553|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
125599492|NCT01855789|451817554|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
125599493|NCT01855789|451817555|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
125599494|NCT01855789|451817556|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
125599495|NCT01855789|451817553|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
125599496|NCT01855789|451817554|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
125599497|NCT01855789|451817555|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
125599498|NCT01855789|451817556|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
125599499|NCT01855789|451817553|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
125599500|NCT01855789|451817554|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
125599501|NCT01855789|451817555|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
125599502|NCT01855789|451817556|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
125599503|NCT01855789|451817553|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
125599504|NCT01855789|451817554|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
125599505|NCT01855789|451817555|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
125599506|NCT01855789|451817556|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
125599507|NCT01855789|451817553|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
125599508|NCT01855789|451817554|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
125599509|NCT01855789|451817555|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
125599510|NCT01855789|451817556|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
125599511|NCT01855789|451817553|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
125599512|NCT01855789|451817554|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
125599513|NCT01855789|451817555|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
125599514|NCT01855789|451817556|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
125599515|NCT01855789|451817553|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
125599516|NCT01855789|451817554|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
125599517|NCT01855789|451817555|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
125369151|NCT01847274|450984862|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125369152|NCT01847274|450984863|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125599518|NCT01855789|451817556|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
125599519|NCT01855789|451817553|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
125599520|NCT01855789|451817554|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
125599521|NCT01855789|451817555|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
125599522|NCT01855789|451817556|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
125599523|NCT01855789|451817553|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
125599524|NCT01855789|451817554|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
125599525|NCT01855789|451817555|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
125599526|NCT01855789|451817556|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
125599527|NCT01855789|451817553|FG000|2) Week 24 up to End of Study|Other|0|||
125599528|NCT01855789|451817554|FG001|2) Week 24 up to End of Study|Other|0|||
125599529|NCT01855789|451817555|FG002|2) Week 24 up to End of Study|Other|0|||
125599530|NCT01855789|451817556|FG003|2) Week 24 up to End of Study|Other|1|||
125599531|NCT03067311|451817557|FG000|Overall Study|Lost to Follow-up|1|||
125599532|NCT03067311|451817558|FG001|Overall Study|Lost to Follow-up|1|||
125599533|NCT03067311|451817557|FG000|Overall Study|Moved away|1|||
125599534|NCT03067311|451817558|FG001|Overall Study|Moved away|1|||
125599535|NCT01582282|451818873|FG000|Overall Study|Adverse Event|1|||
125599536|NCT01582282|451818874|FG001|Overall Study|Adverse Event|1|||
125212798|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
125212799|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
125431645|NCT01490125|451207710|FG000|Period I|Protocol Violation|1|||
125431646|NCT01490125|451207711|FG001|Period I|Protocol Violation|1|||
125599537|NCT01582282|451818875|FG002|Overall Study|Adverse Event|0|||
125599538|NCT01582282|451818873|FG000|Overall Study|Lost to Follow-up|1|||
125599539|NCT01582282|451818874|FG001|Overall Study|Lost to Follow-up|0|||
125599540|NCT01582282|451818875|FG002|Overall Study|Lost to Follow-up|0|||
125599541|NCT01582282|451818873|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
125599542|NCT01582282|451818874|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
125599543|NCT01582282|451818875|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
125599544|NCT01486316|451818876|FG000|Overall Study|Device explanted with/without re-implant|3|||
125599545|NCT01486316|451818877|FG001|Overall Study|Device explanted with/without re-implant|2|||
125599546|NCT01486316|451818878|FG002|Overall Study|Device explanted with/without re-implant|0|||
125599547|NCT01486316|451818879|FG003|Overall Study|Device explanted with/without re-implant|2|||
125599548|NCT01486316|451818876|FG000|Overall Study|Not meeting eligibility criteria|0|||
125599549|NCT01486316|451818877|FG001|Overall Study|Not meeting eligibility criteria|0|||
125599550|NCT01486316|451818878|FG002|Overall Study|Not meeting eligibility criteria|1|||
125599551|NCT01486316|451818879|FG003|Overall Study|Not meeting eligibility criteria|0|||
125599552|NCT01486316|451818876|FG000|Overall Study|Withdrawal by Subject|1|||
125599553|NCT01486316|451818877|FG001|Overall Study|Withdrawal by Subject|0|||
125599554|NCT01486316|451818878|FG002|Overall Study|Withdrawal by Subject|3|||
125599555|NCT01486316|451818879|FG003|Overall Study|Withdrawal by Subject|0|||
125599556|NCT01486316|451818876|FG000|Overall Study|Physician Decision|0|||
125599557|NCT01486316|451818877|FG001|Overall Study|Physician Decision|0|||
125599558|NCT01486316|451818878|FG002|Overall Study|Physician Decision|1|||
125599559|NCT01486316|451818879|FG003|Overall Study|Physician Decision|0|||
125599560|NCT01486316|451818876|FG000|Overall Study|Death|0|||
125599561|NCT01486316|451818877|FG001|Overall Study|Death|1|||
125599562|NCT01486316|451818878|FG002|Overall Study|Death|0|||
125599563|NCT01486316|451818879|FG003|Overall Study|Death|0|||
125599564|NCT03635190|451818887|FG000|Overall Study|Lost to Follow-up|4|||
125599565|NCT03635190|451818887|FG000|Overall Study|Death|3|||
125599566|NCT03635190|451818887|FG000|Overall Study|Withdrawal by Subject|1|||
125599567|NCT03635190|451818887|FG000|Overall Study|Patient moved and did not return for follow up|1|||
125599568|NCT03692910|451818890|FG000|Overall Study|Lost to Follow-up|4|||
125599569|NCT03692910|451818891|FG001|Overall Study|Lost to Follow-up|0|||
125599570|NCT03692910|451818892|FG002|Overall Study|Lost to Follow-up|0|||
125599571|NCT03692910|451818890|FG000|Overall Study|Withdrawal by Subject|2|||
125599572|NCT03692910|451818891|FG001|Overall Study|Withdrawal by Subject|0|||
125599573|NCT03692910|451818892|FG002|Overall Study|Withdrawal by Subject|0|||
125599574|NCT01981122|451818897|FG000|Overall Study|Withdrawal by Subject|0|||
125599575|NCT01981122|451818898|FG001|Overall Study|Withdrawal by Subject|2|||
125599576|NCT01981122|451818897|FG000|Overall Study|Protocol Violation|0|||
125599577|NCT01981122|451818898|FG001|Overall Study|Protocol Violation|1|||
125599578|NCT01981122|451818897|FG000|Overall Study|Lost to Follow-up|0|||
125431647|NCT01490125|451207712|FG002|Period I|Protocol Violation|1|||
125431648|NCT01490125|451207713|FG003|Period I|Protocol Violation|1|||
125431649|NCT01490125|451207714|FG004|Period I|Protocol Violation|0|||
125431650|NCT01490125|451207715|FG005|Period I|Protocol Violation|0|||
125431651|NCT01490125|451207710|FG000|Period I|Withdrawal by Subject|1|||
125431652|NCT01490125|451207711|FG001|Period I|Withdrawal by Subject|3|||
125599579|NCT01981122|451818898|FG001|Overall Study|Lost to Follow-up|1|||
125599580|NCT01981122|451818897|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
125599581|NCT01981122|451818898|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
125599582|NCT01981122|451818897|FG000|Overall Study|Death|14|||
125599583|NCT01981122|451818898|FG001|Overall Study|Death|15|||
125431653|NCT01490125|451207712|FG002|Period I|Withdrawal by Subject|2|||
125431654|NCT01490125|451207713|FG003|Period I|Withdrawal by Subject|1|||
125431655|NCT01490125|451207714|FG004|Period I|Withdrawal by Subject|2|||
125431656|NCT01490125|451207715|FG005|Period I|Withdrawal by Subject|1|||
125431657|NCT01490125|451207710|FG000|Period II|Adverse Event|2|||
125431658|NCT01490125|451207711|FG001|Period II|Adverse Event|3|||
125431659|NCT01490125|451207712|FG002|Period II|Adverse Event|2|||
125431660|NCT01490125|451207713|FG003|Period II|Adverse Event|2|||
125599584|NCT00092547|451818900|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
125599585|NCT00092547|451818901|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
125599586|NCT00092547|451818902|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
125599587|NCT00092547|451818900|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
125599588|NCT00092547|451818901|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
125599589|NCT00092547|451818902|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
125599590|NCT00092547|451818900|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
125599591|NCT00092547|451818901|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
125599592|NCT00092547|451818902|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
125599593|NCT00092547|451818900|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
125599594|NCT00092547|451818901|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
125599595|NCT00092547|451818902|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
125599596|NCT00092547|451818900|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
125599597|NCT00092547|451818901|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
125599598|NCT00092547|451818902|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
125599599|NCT00092547|451818900|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
125599600|NCT00092547|451818901|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
125599601|NCT00092547|451818902|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
125599602|NCT00092547|451818900|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
125599603|NCT00092547|451818901|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
125599604|NCT00092547|451818902|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
125599605|NCT00092547|451818900|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
125599606|NCT00092547|451818901|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
125599607|NCT00092547|451818902|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
125431661|NCT01490125|451207714|FG004|Period II|Adverse Event|4|||
125431662|NCT01490125|451207715|FG005|Period II|Adverse Event|2|||
125599608|NCT00092547|451818900|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
125599609|NCT00092547|451818901|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
125599610|NCT00092547|451818902|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
125599611|NCT00092547|451818900|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
125599612|NCT00092547|451818901|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
125599613|NCT00092547|451818902|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
125599614|NCT00092547|451818900|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
125599615|NCT00092547|451818901|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
125599616|NCT00092547|451818902|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
125599617|NCT00092547|451818900|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
125599618|NCT00092547|451818901|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
125599619|NCT00092547|451818902|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
125599620|NCT00092547|451818900|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
125599621|NCT00092547|451818901|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
125599622|NCT00092547|451818902|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
125599623|NCT00092547|451818900|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
125599624|NCT00092547|451818901|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
125599625|NCT00092547|451818902|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
125599626|NCT00092547|451818900|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
125599627|NCT00092547|451818901|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
125599628|NCT00092547|451818902|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
125599629|NCT00092547|451818900|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
125431663|NCT01490125|451207710|FG000|Period II|Protocol Violation|0|||
125431664|NCT01490125|451207711|FG001|Period II|Protocol Violation|0|||
125431665|NCT01490125|451207712|FG002|Period II|Protocol Violation|1|||
125431666|NCT01490125|451207713|FG003|Period II|Protocol Violation|1|||
125599630|NCT00092547|451818901|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
125431667|NCT01490125|451207714|FG004|Period II|Protocol Violation|0|||
125369153|NCT01847274|450984864|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
125369154|NCT01847274|450984865|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125599631|NCT00092547|451818902|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
125599632|NCT00092547|451818900|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
125599633|NCT00092547|451818901|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
125599634|NCT00092547|451818902|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
125599635|NCT00092547|451818900|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
125599636|NCT00092547|451818901|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
125599637|NCT00092547|451818902|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
125599638|NCT00092547|451818900|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
125599639|NCT00092547|451818901|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
125599640|NCT00092547|451818902|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
125599641|NCT00092547|451818900|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
125599642|NCT00092547|451818901|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
125599643|NCT00092547|451818902|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
125599644|NCT00092547|451818900|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
125599645|NCT00092547|451818901|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
125599646|NCT00092547|451818902|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
125599647|NCT04328623|451818903|FG000|Overall Study|Protocol Violation|0|||
125599648|NCT04328623|451818904|FG001|Overall Study|Protocol Violation|1|||
125599649|NCT01539837|451818905|FG000|Overall Study|reduce neutrophil level|0|||
125599650|NCT01539837|451818906|FG001|Overall Study|reduce neutrophil level|1|||
125599651|NCT01539837|451818907|FG002|Overall Study|reduce neutrophil level|1|||
125599652|NCT01539837|451818905|FG000|Overall Study|bad compliance|0|||
125599653|NCT01539837|451818906|FG001|Overall Study|bad compliance|0|||
125599654|NCT01539837|451818907|FG002|Overall Study|bad compliance|1|||
125599655|NCT02138110|451818908|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
125599656|NCT02138110|451818908|FG000|Overall Scaffold Implantation|Death|3|||
125599657|NCT01408537|451818911|FG000|Overall Study|Withdrawal by Subject|2|||
125599658|NCT01408537|451818911|FG000|Overall Study|Protocol Violation|3|||
125369155|NCT01847274|450984866|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125369156|NCT01847274|450984867|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125599659|NCT01408537|451818911|FG000|Overall Study|Lost to Follow-up|3|||
125599660|NCT02760602|451818914|FG000|Overall Study|Withdrawal by Subject|1|||
125599661|NCT02760602|451818915|FG001|Overall Study|Withdrawal by Subject|0|||
125599662|NCT02760602|451818914|FG000|Overall Study|Terminated by sponsor|12|||
125599663|NCT02760602|451818915|FG001|Overall Study|Terminated by sponsor|13|||
125599664|NCT02046564|451818921|FG000|Overall Study|Adverse Event|6|||
125599665|NCT02046564|451818922|FG001|Overall Study|Adverse Event|3|||
125599666|NCT02046564|451818921|FG000|Overall Study|Physician Decision|0|||
125599667|NCT02046564|451818922|FG001|Overall Study|Physician Decision|1|||
125599668|NCT02046564|451818921|FG000|Overall Study|Protocol Violation|3|||
125599669|NCT02046564|451818922|FG001|Overall Study|Protocol Violation|1|||
125599670|NCT02046564|451818921|FG000|Overall Study|Withdrawal by Subject|4|||
125599671|NCT02046564|451818922|FG001|Overall Study|Withdrawal by Subject|10|||
125599672|NCT02046564|451818921|FG000|Overall Study|Subject met withdrawal criteria|2|||
125599673|NCT02046564|451818922|FG001|Overall Study|Subject met withdrawal criteria|5|||
125599674|NCT01295905|451818925|FG000|Overall Study|Did not meet inclusion criteria|1|||
125599675|NCT01295905|451818926|FG001|Overall Study|Did not meet inclusion criteria|0|||
125599676|NCT01295905|451818925|FG000|Overall Study|Met exclusion criteria|1|||
125599677|NCT01295905|451818926|FG001|Overall Study|Met exclusion criteria|0|||
125599678|NCT03707977|451818930|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
125599679|NCT03707977|451818931|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
125599680|NCT03707977|451818932|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
125369157|NCT01847274|450984868|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125599681|NCT03707977|451818930|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
125599682|NCT03707977|451818931|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
125599683|NCT03707977|451818932|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
125431668|NCT01490125|451207715|FG005|Period II|Protocol Violation|0|||
125599684|NCT02564120|451818933|FG000|Overall Study|Did not return release forms|160|||
125599685|NCT02564120|451818933|FG000|Overall Study|Death|58|||
125599686|NCT02564120|451818933|FG000|Overall Study|Withdrawal by Subject|204|||
125599687|NCT02564120|451818933|FG000|Overall Study|Other medical condition|24|||
125599688|NCT03842709|451818934|FG000|Overall Study|Withdrawal by Subject|3|||
125599689|NCT03842709|451818935|FG001|Overall Study|Withdrawal by Subject|3|||
125599690|NCT03842709|451818934|FG000|Overall Study|Lost to Follow-up|1|||
125599691|NCT03842709|451818935|FG001|Overall Study|Lost to Follow-up|0|||
125599692|NCT00609609|451818940|FG000|Overall Study|Withdrawal by Subject|2|||
125599693|NCT00609609|451818941|FG001|Overall Study|Withdrawal by Subject|0|||
125599694|NCT00609609|451818940|FG000|Overall Study|Progression|4|||
125599695|NCT00609609|451818941|FG001|Overall Study|Progression|2|||
125599696|NCT02441803|451818943|FG000|Overall Study|Physician Decision|0|||
125599697|NCT02441803|451818944|FG001|Overall Study|Physician Decision|2|||
125431669|NCT01490125|451207710|FG000|Period II|Lost to Follow-up|0|||
125599698|NCT02441803|451818945|FG002|Overall Study|Physician Decision|2|||
125599699|NCT00537823|451818948|FG000|Overall Study|Adverse Event|2|||
125599700|NCT00537823|451818949|FG001|Overall Study|Adverse Event|0|||
125599701|NCT03065530|451818950|FG000|Overall Study|Lack of Efficacy|1|||
125599702|NCT03065530|451818951|FG001|Overall Study|Lack of Efficacy|1|||
125599703|NCT03065530|451818952|FG002|Overall Study|Lack of Efficacy|0|||
125599704|NCT03065530|451818953|FG003|Overall Study|Lack of Efficacy|1|||
125599705|NCT03065530|451818950|FG000|Overall Study|Protocol Violation|1|||
125599706|NCT03065530|451818951|FG001|Overall Study|Protocol Violation|0|||
125599707|NCT03065530|451818952|FG002|Overall Study|Protocol Violation|1|||
125599708|NCT03065530|451818953|FG003|Overall Study|Protocol Violation|1|||
125599709|NCT00852930|451818954|FG000|Overall Study|Withdrawal by Subject|1|||
125599710|NCT00852930|451818955|FG001|Overall Study|Withdrawal by Subject|1|||
125599711|NCT00852930|451818956|FG002|Overall Study|Withdrawal by Subject|1|||
125599712|NCT00852930|451818954|FG000|Overall Study|Physician Decision|0|||
125599713|NCT00852930|451818955|FG001|Overall Study|Physician Decision|0|||
125599714|NCT00852930|451818956|FG002|Overall Study|Physician Decision|1|||
125599715|NCT01512368|451818960|FG000|Overall Study|Protocol Violation|3|||
125599716|NCT02717546|451818965|FG000|Overall Study|Lost to Follow-up|12|||
125599717|NCT02460822|451818972|FG000|Overall Study|Withdrawal by Subject|1|||
125599718|NCT02498821|451818973|FG000|Overall Study|Screen failure|3|||
125599719|NCT02498821|451818974|FG001|Overall Study|Screen failure|5|||
125599720|NCT05258058|451818989|FG000|Overall Study|Withdrawal by Subject|2|||
125599721|NCT01333189|451818994|FG000|Overall Study|Time constraints|1|||
125599722|NCT01333189|451818995|FG001|Overall Study|Time constraints|0|||
125599723|NCT01333189|451818994|FG000|Overall Study|Adverse Event|1|||
125599724|NCT01333189|451818995|FG001|Overall Study|Adverse Event|0|||
125599725|NCT01333189|451818994|FG000|Overall Study|Transportation difficulties|0|||
125599726|NCT01333189|451818995|FG001|Overall Study|Transportation difficulties|1|||
125599727|NCT01333189|451818994|FG000|Overall Study|Moved from region|0|||
125599728|NCT01333189|451818995|FG001|Overall Study|Moved from region|1|||
125599729|NCT01787591|451819000|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
125599730|NCT01787591|451819001|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
125599731|NCT01787591|451819002|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
125599732|NCT01787591|451819003|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
125599733|NCT02725177|451819007|FG000|Overall Study|Physician Decision|4|||
125599734|NCT02725177|451819007|FG000|Overall Study|Adverse Event|1|||
125599735|NCT00793585|451819010|FG000|Overall Study|Adverse Event|1|||
125599736|NCT00793585|451819011|FG001|Overall Study|Adverse Event|1|||
125599737|NCT00793585|451819010|FG000|Overall Study|Protocol Violation|1|||
125599738|NCT00793585|451819011|FG001|Overall Study|Protocol Violation|2|||
125599739|NCT00377299|451819012|FG000|Overall Study|Lost to Follow-up|14|||
125599740|NCT00377299|451819013|FG001|Overall Study|Lost to Follow-up|19|||
125599741|NCT00377299|451819012|FG000|Overall Study|Adverse Event|0|||
125599742|NCT00377299|451819013|FG001|Overall Study|Adverse Event|1|||
125599743|NCT00377299|451819012|FG000|Overall Study|Withdrawal by Subject|5|||
125599744|NCT00377299|451819013|FG001|Overall Study|Withdrawal by Subject|4|||
125599745|NCT00035815|451819015|FG000|Overall Study|Withdrawal by Subject|17|||
125599746|NCT00035815|451819016|FG001|Overall Study|Withdrawal by Subject|11|||
125599747|NCT01894516|451820800|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
125599748|NCT01894516|451820801|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
125599749|NCT01894516|451820802|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
125599750|NCT01894516|451820803|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
125599751|NCT01894516|451820800|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
125599752|NCT01894516|451820801|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
125599753|NCT01894516|451820802|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
125599754|NCT01894516|451820803|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
125599755|NCT01894516|451820800|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
125599756|NCT01894516|451820801|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
125599757|NCT01894516|451820802|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
125599758|NCT01894516|451820803|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
125599759|NCT01894516|451820800|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
125599760|NCT01894516|451820801|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
125599761|NCT01894516|451820802|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
125599762|NCT01894516|451820803|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
125599763|NCT01894516|451820800|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
125599764|NCT01894516|451820801|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
125599765|NCT01894516|451820802|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
125599766|NCT01894516|451820803|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
125599767|NCT01894516|451820800|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
125599768|NCT01894516|451820801|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
125599769|NCT01894516|451820802|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
125599770|NCT01894516|451820803|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
125599771|NCT01894516|451820800|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
125599772|NCT01894516|451820801|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
125599773|NCT01894516|451820802|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
125599774|NCT01894516|451820803|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
125599775|NCT01894516|451820800|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
125599776|NCT01894516|451820801|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
125599777|NCT01894516|451820802|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
125599778|NCT01894516|451820803|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
125599779|NCT03191396|451820805|FG000|Overall Study|Lost to Follow-up|0|||
125599780|NCT03191396|451820806|FG001|Overall Study|Lost to Follow-up|3|||
125599781|NCT03191396|451820805|FG000|Overall Study|Withdrawal by Subject|3|||
125599782|NCT03191396|451820806|FG001|Overall Study|Withdrawal by Subject|2|||
125599783|NCT01300286|451820807|FG000|Overall Study|did not get dosed|1|||
125599784|NCT00417612|451820808|FG000|Overall Study|Errant diagnosis|0|||
125599785|NCT00417612|451820809|FG001|Overall Study|Errant diagnosis|1|||
125599786|NCT00417612|451820808|FG000|Overall Study|Adverse Event|2|||
125599787|NCT00417612|451820809|FG001|Overall Study|Adverse Event|0|||
125599788|NCT00417612|451820808|FG000|Overall Study|Protocol Violation|0|||
125599789|NCT00417612|451820809|FG001|Overall Study|Protocol Violation|2|||
125599790|NCT00417612|451820808|FG000|Overall Study|Lost to Follow-up|1|||
125599791|NCT00417612|451820809|FG001|Overall Study|Lost to Follow-up|0|||
125599792|NCT01330381|451820810|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
125599793|NCT01330381|451820811|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
125599794|NCT01330381|451820812|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
125599795|NCT01330381|451820810|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
125599796|NCT01330381|451820811|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
125599797|NCT01330381|451820812|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
125599798|NCT01330381|451820810|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
125599799|NCT01330381|451820811|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
125599800|NCT01330381|451820812|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
125599801|NCT01330381|451820810|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
125599802|NCT01330381|451820811|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
125599803|NCT01330381|451820812|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
125599804|NCT01330381|451820810|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
125599805|NCT01330381|451820811|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
125599806|NCT01330381|451820812|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
125599807|NCT01330381|451820810|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
125599808|NCT01330381|451820811|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
125599809|NCT01330381|451820812|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
125599810|NCT01330381|451820810|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
125599811|NCT01330381|451820811|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
125599812|NCT01330381|451820812|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
125599813|NCT01330381|451820810|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
125599814|NCT01330381|451820811|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
125599815|NCT01330381|451820812|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
125599816|NCT01330381|451820810|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
125599817|NCT01330381|451820811|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
125599818|NCT01330381|451820812|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
125599819|NCT01330381|451820810|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
125599820|NCT01330381|451820811|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
125599821|NCT01330381|451820812|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
125599822|NCT03060577|451820813|FG000|Overall Study|Withdrawal by Subject|25|||
125599823|NCT03060577|451820814|FG001|Overall Study|Withdrawal by Subject|5|||
125599824|NCT03060577|451820813|FG000|Overall Study|Physician Decision|4|||
125599825|NCT03060577|451820814|FG001|Overall Study|Physician Decision|3|||
125599826|NCT03060577|451820813|FG000|Overall Study|Lost to Follow-up|3|||
125599827|NCT03060577|451820814|FG001|Overall Study|Lost to Follow-up|0|||
125599828|NCT03060577|451820813|FG000|Overall Study|Death|7|||
125599829|NCT03060577|451820814|FG001|Overall Study|Death|1|||
125599830|NCT03060577|451820813|FG000|Overall Study|Adverse Event|9|||
125599831|NCT03060577|451820814|FG001|Overall Study|Adverse Event|1|||
125599832|NCT03060577|451820813|FG000|Overall Study|Inclusion/Exclusion|1|||
125599833|NCT03060577|451820814|FG001|Overall Study|Inclusion/Exclusion|0|||
125599834|NCT03060577|451820813|FG000|Overall Study|Other|8|||
125599835|NCT03060577|451820814|FG001|Overall Study|Other|2|||
125599836|NCT03216265|451820818|FG000|Overall Study|Adverse Event|2|||
125599837|NCT03216265|451820819|FG001|Overall Study|Adverse Event|0|||
125599838|NCT03216265|451820820|FG002|Overall Study|Adverse Event|2|||
125599839|NCT03216265|451820818|FG000|Overall Study|Lost to Follow-up|0|||
125599840|NCT03216265|451820819|FG001|Overall Study|Lost to Follow-up|1|||
125599841|NCT03216265|451820820|FG002|Overall Study|Lost to Follow-up|0|||
125599842|NCT03216265|451820818|FG000|Overall Study|Withdrawal by Subject|0|||
125599843|NCT03216265|451820819|FG001|Overall Study|Withdrawal by Subject|0|||
125599844|NCT03216265|451820820|FG002|Overall Study|Withdrawal by Subject|1|||
125599845|NCT01277289|451820821|FG000|Overall Study|fragile vein|1|||
125599846|NCT01277289|451820822|FG001|Overall Study|fragile vein|0|||
125599847|NCT01277289|451820821|FG000|Overall Study|Physician Decision|1|||
125599848|NCT01277289|451820822|FG001|Overall Study|Physician Decision|0|||
125599849|NCT01277289|451820821|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
125599850|NCT01277289|451820822|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
125599851|NCT01277289|451820821|FG000|Overall Study|Protocol Violation|1|||
125599852|NCT01277289|451820822|FG001|Overall Study|Protocol Violation|1|||
125599853|NCT01277289|451820821|FG000|Overall Study|Adverse Event|2|||
125599854|NCT01277289|451820822|FG001|Overall Study|Adverse Event|1|||
125599855|NCT01277289|451820821|FG000|Overall Study|consent withdrawn|1|||
125599856|NCT01277289|451820822|FG001|Overall Study|consent withdrawn|1|||
125599857|NCT01277289|451820821|FG000|Overall Study|premature closure of the study|4|||
125599858|NCT01277289|451820822|FG001|Overall Study|premature closure of the study|2|||
125599859|NCT00224107|451820824|FG000|Overall Study|Adverse Event|20|||
125599860|NCT00224107|451820825|FG001|Overall Study|Adverse Event|6|||
125599861|NCT00224107|451820824|FG000|Overall Study|Protocol Violation|2|||
125599862|NCT00224107|451820825|FG001|Overall Study|Protocol Violation|3|||
125599863|NCT00224107|451820824|FG000|Overall Study|Withdrawal by Subject|1|||
125599864|NCT00224107|451820825|FG001|Overall Study|Withdrawal by Subject|4|||
125599865|NCT00224107|451820824|FG000|Overall Study|Lack of Efficacy|2|||
125599866|NCT00224107|451820825|FG001|Overall Study|Lack of Efficacy|0|||
125599867|NCT00224107|451820824|FG000|Overall Study|Lost to Follow-up|4|||
125599868|NCT00224107|451820825|FG001|Overall Study|Lost to Follow-up|0|||
125599869|NCT00224107|451820824|FG000|Overall Study|Physician Decision|1|||
125599870|NCT00224107|451820825|FG001|Overall Study|Physician Decision|0|||
125599871|NCT00224107|451820824|FG000|Overall Study|Other|1|||
125599872|NCT00224107|451820825|FG001|Overall Study|Other|1|||
125369158|NCT01847274|450984869|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125369159|NCT01847274|450984870|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125369160|NCT01847274|450984871|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
125369161|NCT01847274|450984861|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
125369162|NCT01847274|450984862|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
125369163|NCT01847274|450984863|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
125369164|NCT01847274|450984864|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
125369165|NCT01847274|450984865|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125369166|NCT01847274|450984866|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125599873|NCT00685178|451820826|FG000|Overall Study|Adverse Event|1|||
125599874|NCT00685178|451820827|FG001|Overall Study|Adverse Event|5|||
125599875|NCT00685178|451820828|FG002|Overall Study|Adverse Event|2|||
125599876|NCT00685178|451820829|FG003|Overall Study|Adverse Event|4|||
125599877|NCT00685178|451820826|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
125599878|NCT00685178|451820827|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
125369167|NCT01847274|450984867|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125599879|NCT00685178|451820828|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
125599880|NCT00685178|451820829|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
125599881|NCT00685178|451820826|FG000|Overall Study|voluntary study discharge|4|||
125599882|NCT00685178|451820827|FG001|Overall Study|voluntary study discharge|5|||
125599883|NCT00685178|451820828|FG002|Overall Study|voluntary study discharge|1|||
125599884|NCT00685178|451820829|FG003|Overall Study|voluntary study discharge|1|||
125599885|NCT00685178|451820826|FG000|Overall Study|incarcerated|1|||
125599886|NCT00685178|451820827|FG001|Overall Study|incarcerated|3|||
125599887|NCT00685178|451820828|FG002|Overall Study|incarcerated|7|||
125599888|NCT00685178|451820829|FG003|Overall Study|incarcerated|0|||
125599889|NCT00685178|451820826|FG000|Overall Study|administrative (disciplinary) discharge|0|||
125599890|NCT00685178|451820827|FG001|Overall Study|administrative (disciplinary) discharge|1|||
125599891|NCT00685178|451820828|FG002|Overall Study|administrative (disciplinary) discharge|0|||
125599892|NCT00685178|451820829|FG003|Overall Study|administrative (disciplinary) discharge|2|||
125599893|NCT00685178|451820826|FG000|Overall Study|Pregnancy|0|||
125599894|NCT00685178|451820827|FG001|Overall Study|Pregnancy|0|||
125599895|NCT00685178|451820828|FG002|Overall Study|Pregnancy|0|||
125599896|NCT00685178|451820829|FG003|Overall Study|Pregnancy|1|||
125599897|NCT00077623|451820830|FG000|Overall Study|Adverse Event|1|||
125599898|NCT00077623|451820831|FG001|Overall Study|Adverse Event|0|||
125599899|NCT00077623|451820832|FG002|Overall Study|Adverse Event|1|||
125599900|NCT00077623|451820830|FG000|Overall Study|Withdrawal by Subject|2|||
125599901|NCT00077623|451820831|FG001|Overall Study|Withdrawal by Subject|10|||
125599902|NCT00077623|451820832|FG002|Overall Study|Withdrawal by Subject|1|||
125369168|NCT01847274|450984868|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125599903|NCT00077623|451820830|FG000|Overall Study|Other-Non safety reason|18|||
125599904|NCT00077623|451820831|FG001|Overall Study|Other-Non safety reason|15|||
125599905|NCT00077623|451820832|FG002|Overall Study|Other-Non safety reason|19|||
125599906|NCT00077623|451820830|FG000|Overall Study|Insufficient therapeutic response|2|||
125599907|NCT00077623|451820831|FG001|Overall Study|Insufficient therapeutic response|0|||
125599908|NCT00077623|451820832|FG002|Overall Study|Insufficient therapeutic response|0|||
125599909|NCT00077623|451820830|FG000|Overall Study|Death|12|||
125599910|NCT00077623|451820831|FG001|Overall Study|Death|18|||
125599911|NCT00077623|451820832|FG002|Overall Study|Death|11|||
125599912|NCT00077623|451820830|FG000|Overall Study|Failure to return|1|||
125599913|NCT00077623|451820831|FG001|Overall Study|Failure to return|0|||
125599914|NCT00077623|451820832|FG002|Overall Study|Failure to return|0|||
125599915|NCT00882713|451820835|FG000|Overall Study|Adverse Event|2|||
125599916|NCT00882713|451820835|FG000|Overall Study|Death|3|||
125599917|NCT00882713|451820835|FG000|Overall Study|Administrative reasons|4|||
125599918|NCT00882713|451820835|FG000|Overall Study|refused treatment/withdrew consent|4|||
125599919|NCT00882713|451820835|FG000|Overall Study|Blood transfusion|2|||
125599920|NCT00882713|451820835|FG000|Overall Study|Insufficient therapeutic response|3|||
125599921|NCT00882713|451820835|FG000|Overall Study|Failure to return|2|||
125599922|NCT00882713|451820835|FG000|Overall Study|Other - Reasons|2|||
125599923|NCT00401973|451820836|FG000|Overall Study|Adverse Event|2|||
125599924|NCT00401973|451820837|FG001|Overall Study|Adverse Event|8|||
125599925|NCT00401973|451820838|FG002|Overall Study|Adverse Event|4|||
125599926|NCT00401973|451820836|FG000|Overall Study|Clinical Relapse|0|||
125599927|NCT00401973|451820837|FG001|Overall Study|Clinical Relapse|1|||
125599928|NCT00401973|451820838|FG002|Overall Study|Clinical Relapse|1|||
125599929|NCT00401973|451820836|FG000|Overall Study|Lack of Efficacy|0|||
125599930|NCT00401973|451820837|FG001|Overall Study|Lack of Efficacy|0|||
125599931|NCT00401973|451820838|FG002|Overall Study|Lack of Efficacy|3|||
125599932|NCT00401973|451820836|FG000|Overall Study|Lost to Follow-up|2|||
125599933|NCT00401973|451820837|FG001|Overall Study|Lost to Follow-up|2|||
125599934|NCT00401973|451820838|FG002|Overall Study|Lost to Follow-up|2|||
125599935|NCT00401973|451820836|FG000|Overall Study|Physician Decision|2|||
125599936|NCT00401973|451820837|FG001|Overall Study|Physician Decision|0|||
125599937|NCT00401973|451820838|FG002|Overall Study|Physician Decision|1|||
125599938|NCT00401973|451820836|FG000|Overall Study|Protocol Violation|1|||
125599939|NCT00401973|451820837|FG001|Overall Study|Protocol Violation|2|||
125599940|NCT00401973|451820838|FG002|Overall Study|Protocol Violation|3|||
125599941|NCT00401973|451820836|FG000|Overall Study|Sponsor Decision|0|||
125599942|NCT00401973|451820837|FG001|Overall Study|Sponsor Decision|1|||
125599943|NCT00401973|451820838|FG002|Overall Study|Sponsor Decision|0|||
125599944|NCT00401973|451820836|FG000|Overall Study|Withdrawal by Subject|4|||
125599945|NCT00401973|451820837|FG001|Overall Study|Withdrawal by Subject|12|||
125599946|NCT00401973|451820838|FG002|Overall Study|Withdrawal by Subject|9|||
125599947|NCT05523362|451820839|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
125599948|NCT05523362|451820839|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
125599949|NCT05523362|451820839|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
125599950|NCT05523362|451820839|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
125599951|NCT03515538|451820840|FG000|Overall Study|Lack of Efficacy|2|||
125599952|NCT03515538|451820841|FG001|Overall Study|Lack of Efficacy|0|||
125599953|NCT03515538|451820842|FG002|Overall Study|Lack of Efficacy|2|||
125599954|NCT03515538|451820843|FG003|Overall Study|Lack of Efficacy|0|||
125599955|NCT03515538|451820840|FG000|Overall Study|Death|0|||
125599956|NCT03515538|451820841|FG001|Overall Study|Death|0|||
125369169|NCT01847274|450984869|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125599957|NCT03515538|451820842|FG002|Overall Study|Death|1|||
125599958|NCT03515538|451820843|FG003|Overall Study|Death|0|||
125599959|NCT03515538|451820840|FG000|Overall Study|Protocol Violation|0|||
125599960|NCT03515538|451820841|FG001|Overall Study|Protocol Violation|0|||
125599961|NCT03515538|451820842|FG002|Overall Study|Protocol Violation|0|||
125599962|NCT03515538|451820843|FG003|Overall Study|Protocol Violation|1|||
125599963|NCT03515538|451820840|FG000|Overall Study|Screen failure (baseline dropout)|0|||
125599964|NCT03515538|451820841|FG001|Overall Study|Screen failure (baseline dropout)|1|||
125599965|NCT03515538|451820842|FG002|Overall Study|Screen failure (baseline dropout)|0|||
125599966|NCT03515538|451820843|FG003|Overall Study|Screen failure (baseline dropout)|0|||
125599967|NCT03515538|451820840|FG000|Overall Study|Withdrawal by Subject|2|||
125599968|NCT03515538|451820841|FG001|Overall Study|Withdrawal by Subject|2|||
125599969|NCT03515538|451820842|FG002|Overall Study|Withdrawal by Subject|1|||
125599970|NCT03515538|451820843|FG003|Overall Study|Withdrawal by Subject|3|||
125599971|NCT03515538|451820840|FG000|Overall Study|Physician Decision|1|||
125599972|NCT03515538|451820841|FG001|Overall Study|Physician Decision|0|||
125599973|NCT03515538|451820842|FG002|Overall Study|Physician Decision|0|||
125599974|NCT03515538|451820843|FG003|Overall Study|Physician Decision|1|||
125599975|NCT04075604|451820844|FG000|Overall Study|Adverse Event|0|||
125599976|NCT04075604|451820845|FG001|Overall Study|Adverse Event|0|||
125599977|NCT04075604|451820846|FG002|Overall Study|Adverse Event|3|||
125599978|NCT04075604|451820844|FG000|Overall Study|Participant request to discontinue study treatment|0|||
125599979|NCT04075604|451820845|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125599980|NCT04075604|451820846|FG002|Overall Study|Participant request to discontinue study treatment|1|||
125599981|NCT04075604|451820844|FG000|Overall Study|Participant withdrew consent|0|||
125599982|NCT04075604|451820845|FG001|Overall Study|Participant withdrew consent|0|||
125599983|NCT04075604|451820846|FG002|Overall Study|Participant withdrew consent|1|||
125599984|NCT04075604|451820844|FG000|Overall Study|Other reasons|1|||
125599985|NCT04075604|451820845|FG001|Overall Study|Other reasons|0|||
125599986|NCT04075604|451820846|FG002|Overall Study|Other reasons|0|||
125599987|NCT04075604|451820844|FG000|Overall Study|Disease progression|0|||
125599988|NCT04075604|451820845|FG001|Overall Study|Disease progression|1|||
125599989|NCT04075604|451820846|FG002|Overall Study|Disease progression|0|||
125599990|NCT04075604|451820844|FG000|Overall Study|Study drug toxicity|0|||
125599991|NCT04075604|451820845|FG001|Overall Study|Study drug toxicity|5|||
125599992|NCT04075604|451820846|FG002|Overall Study|Study drug toxicity|1|||
125599993|NCT01650779|451820853|FG000|Overall Study|Withdrawal by Subject|1|||
125599994|NCT03666143|451820854|FG000|Overall Study|Death|158|||
125599995|NCT03666143|451820854|FG000|Overall Study|Sponsor Decision|31|||
125599996|NCT03666143|451820854|FG000|Overall Study|Withdrawal by Subject|11|||
125599997|NCT03666143|451820854|FG000|Overall Study|Lost to Follow-up|5|||
125599998|NCT03666143|451820854|FG000|Overall Study|Physician Decision|1|||
125599999|NCT03666143|451820854|FG000|Overall Study|Rolled into extension study|9|||
125600000|NCT03666143|451820854|FG000|Overall Study|Progressive Disease|1|||
125600001|NCT00283712|451820857|FG000|Overall Study|Death|0|||
125600002|NCT00283712|451820858|FG001|Overall Study|Death|1|||
125600003|NCT04329923|451820859|FG000|Overall Study|Withdrawal by Subject|1|||
125600004|NCT04329923|451820860|FG001|Overall Study|Withdrawal by Subject|4|||
125600005|NCT04329923|451820861|FG002|Overall Study|Withdrawal by Subject|1|||
125600006|NCT04329923|451820862|FG003|Overall Study|Withdrawal by Subject|1|||
125600007|NCT04329923|451820863|FG004|Overall Study|Withdrawal by Subject|1|||
125600008|NCT04329923|451820864|FG005|Overall Study|Withdrawal by Subject|1|||
125600009|NCT04329923|451820859|FG000|Overall Study|early termination of study|0|||
125600010|NCT04329923|451820860|FG001|Overall Study|early termination of study|0|||
125600011|NCT04329923|451820861|FG002|Overall Study|early termination of study|0|||
125600012|NCT04329923|451820862|FG003|Overall Study|early termination of study|0|||
125600013|NCT04329923|451820863|FG004|Overall Study|early termination of study|1|||
125600014|NCT04329923|451820864|FG005|Overall Study|early termination of study|2|||
125600015|NCT04329923|451820859|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
125600016|NCT04329923|451820860|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
125600017|NCT04329923|451820861|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
125600018|NCT04329923|451820862|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
125600019|NCT04329923|451820863|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
125600020|NCT04329923|451820864|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
125600021|NCT01272180|451820865|FG000|Overall Study|Adverse Event|0|||
125369170|NCT01847274|450984870|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125369171|NCT01847274|450984871|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
125369172|NCT01847274|450984861|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
125600022|NCT01272180|451820866|FG001|Overall Study|Adverse Event|0|||
125600023|NCT01272180|451820867|FG002|Overall Study|Adverse Event|1|||
125600024|NCT01272180|451820868|FG003|Overall Study|Adverse Event|0|||
125600025|NCT01272180|451820865|FG000|Overall Study|Withdrawal by Subject|2|||
125600026|NCT01272180|451820866|FG001|Overall Study|Withdrawal by Subject|6|||
125600027|NCT01272180|451820867|FG002|Overall Study|Withdrawal by Subject|3|||
125600028|NCT01272180|451820868|FG003|Overall Study|Withdrawal by Subject|2|||
125600029|NCT01272180|451820865|FG000|Overall Study|Lost to Follow-up|15|||
125600030|NCT01272180|451820866|FG001|Overall Study|Lost to Follow-up|14|||
125600031|NCT01272180|451820867|FG002|Overall Study|Lost to Follow-up|8|||
125600032|NCT01272180|451820868|FG003|Overall Study|Lost to Follow-up|10|||
125600033|NCT01272180|451820865|FG000|Overall Study|Inappropriate enrollment|0|||
125600034|NCT01272180|451820866|FG001|Overall Study|Inappropriate enrollment|0|||
125600035|NCT01272180|451820867|FG002|Overall Study|Inappropriate enrollment|1|||
125600036|NCT01272180|451820868|FG003|Overall Study|Inappropriate enrollment|1|||
125600037|NCT01272180|451820865|FG000|Overall Study|Protocol Violation|0|||
125600038|NCT01272180|451820866|FG001|Overall Study|Protocol Violation|1|||
125600039|NCT01272180|451820867|FG002|Overall Study|Protocol Violation|0|||
125600040|NCT01272180|451820868|FG003|Overall Study|Protocol Violation|1|||
125600041|NCT01183858|451820869|FG000|Overall Study|Death not related to Progressive Disease|5|||
125600042|NCT01183858|451820870|FG001|Overall Study|Death not related to Progressive Disease|6|||
125600043|NCT01183858|451820869|FG000|Overall Study|Adverse Event|14|||
125600044|NCT01183858|451820870|FG001|Overall Study|Adverse Event|11|||
125600045|NCT01183858|451820869|FG000|Overall Study|Investigator's Decision|0|||
125600046|NCT01183858|451820870|FG001|Overall Study|Investigator's Decision|3|||
125600047|NCT01183858|451820869|FG000|Overall Study|Insufficient Therapeutic Response|2|||
125600048|NCT01183858|451820870|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125600049|NCT01183858|451820869|FG000|Overall Study|Refused Treatment|1|||
125600050|NCT01183858|451820870|FG001|Overall Study|Refused Treatment|4|||
125600051|NCT01183858|451820869|FG000|Overall Study|Withdrew Consent|4|||
125600052|NCT01183858|451820870|FG001|Overall Study|Withdrew Consent|4|||
125600053|NCT01183858|451820869|FG000|Overall Study|Discontinued Smoking|3|||
125600054|NCT01183858|451820870|FG001|Overall Study|Discontinued Smoking|1|||
125600055|NCT01183858|451820869|FG000|Overall Study|Protocol Violation|1|||
125600056|NCT01183858|451820870|FG001|Overall Study|Protocol Violation|0|||
125600057|NCT01183858|451820869|FG000|Overall Study|Administrative/Other|6|||
125600058|NCT01183858|451820870|FG001|Overall Study|Administrative/Other|6|||
125600059|NCT01183858|451820869|FG000|Overall Study|Progressive Disease|112|||
125600060|NCT01183858|451820870|FG001|Overall Study|Progressive Disease|115|||
125600061|NCT01183858|451820869|FG000|Overall Study|Death related to Progressive Disease|4|||
125600062|NCT01183858|451820870|FG001|Overall Study|Death related to Progressive Disease|5|||
125600063|NCT01183858|451820869|FG000|Overall Study|Lost to Follow-up|1|||
125600064|NCT01183858|451820870|FG001|Overall Study|Lost to Follow-up|1|||
125600065|NCT02747043|451820873|FG000|Overall Study|Other|1|||
125600066|NCT02747043|451820874|FG001|Overall Study|Other|1|||
125600067|NCT02747043|451820873|FG000|Overall Study|Adverse Event|3|||
125600068|NCT02747043|451820874|FG001|Overall Study|Adverse Event|1|||
125600069|NCT02747043|451820873|FG000|Overall Study|Withdrawal by Subject|1|||
125600070|NCT02747043|451820874|FG001|Overall Study|Withdrawal by Subject|1|||
125600071|NCT02747043|451820873|FG000|Overall Study|Physician Decision|1|||
125600072|NCT02747043|451820874|FG001|Overall Study|Physician Decision|1|||
125600073|NCT02747043|451820873|FG000|Overall Study|Protocol Violation|0|||
125600074|NCT02747043|451820874|FG001|Overall Study|Protocol Violation|1|||
125600075|NCT02747043|451820873|FG000|Overall Study|Disease progression|4|||
125600076|NCT02747043|451820874|FG001|Overall Study|Disease progression|0|||
125600077|NCT00641147|451820879|FG000|Completed 4 Months.|Physician Decision|1|||
125600078|NCT00641147|451820880|FG001|Completed 4 Months.|Physician Decision|0|||
125600079|NCT00641147|451820879|FG000|Completed 4 Months.|Adverse Event|1|||
125600080|NCT00641147|451820880|FG001|Completed 4 Months.|Adverse Event|0|||
125600081|NCT00641147|451820879|FG000|Completed 8 Months.|Physician Decision|2|||
125600082|NCT00641147|451820880|FG001|Completed 8 Months.|Physician Decision|1|||
125600083|NCT00641147|451820879|FG000|Completed 8 Months.|non compliance|1|||
125600084|NCT00641147|451820880|FG001|Completed 8 Months.|non compliance|0|||
125600085|NCT00641147|451820879|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
125600086|NCT00641147|451820880|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
125600087|NCT00641147|451820879|FG000|Completed 12 Months.|Physician Decision|1|||
125600088|NCT00641147|451820880|FG001|Completed 12 Months.|Physician Decision|1|||
125369173|NCT01847274|450984862|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
125369174|NCT01847274|450984863|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
125600089|NCT00641147|451820879|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
125600090|NCT00641147|451820880|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
125600091|NCT00641147|451820879|FG000|Completed 16 Months.|Physician Decision|1|||
125600092|NCT00641147|451820880|FG001|Completed 16 Months.|Physician Decision|0|||
125600093|NCT00641147|451820879|FG000|Completed 16 Months.|Lost to Follow-up|1|||
125600094|NCT00641147|451820880|FG001|Completed 16 Months.|Lost to Follow-up|0|||
125600095|NCT01629667|451820881|FG000|Overall Study|Lost to Follow-up|0|||
125600096|NCT01629667|451820882|FG001|Overall Study|Lost to Follow-up|1|||
125600097|NCT01629667|451820883|FG002|Overall Study|Lost to Follow-up|1|||
125600098|NCT01629667|451820881|FG000|Overall Study|Withdrawal by Subject|31|||
125600099|NCT01629667|451820882|FG001|Overall Study|Withdrawal by Subject|20|||
125369175|NCT01847274|450984864|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
125600100|NCT01629667|451820883|FG002|Overall Study|Withdrawal by Subject|28|||
125600101|NCT01629667|451820881|FG000|Overall Study|Death|1|||
125600102|NCT01629667|451820882|FG001|Overall Study|Death|5|||
125600103|NCT01629667|451820883|FG002|Overall Study|Death|3|||
125600104|NCT01629667|451820881|FG000|Overall Study|Randomized, not treated|2|||
125600105|NCT01629667|451820882|FG001|Overall Study|Randomized, not treated|1|||
125600106|NCT01629667|451820883|FG002|Overall Study|Randomized, not treated|0|||
125600107|NCT01629667|451820881|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
125600108|NCT01629667|451820882|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
125600109|NCT01629667|451820883|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
125600110|NCT01629667|451820881|FG000|Overall Study|Requiring lung transplant|2|||
125600111|NCT01629667|451820882|FG001|Overall Study|Requiring lung transplant|1|||
125600112|NCT01629667|451820883|FG002|Overall Study|Requiring lung transplant|3|||
125600113|NCT01629667|451820881|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
125600114|NCT01629667|451820882|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
125600115|NCT01629667|451820883|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
125600116|NCT01629667|451820881|FG000|Overall Study|Started other medicine|1|||
125600117|NCT01629667|451820882|FG001|Overall Study|Started other medicine|0|||
125600118|NCT01629667|451820883|FG002|Overall Study|Started other medicine|1|||
125600119|NCT01629667|451820881|FG000|Overall Study|Site error in safety follow-up|0|||
125600120|NCT01629667|451820882|FG001|Overall Study|Site error in safety follow-up|0|||
125600121|NCT01629667|451820883|FG002|Overall Study|Site error in safety follow-up|1|||
125600122|NCT01629667|451820881|FG000|Overall Study|Enrolled in another clinical study|0|||
125600123|NCT01629667|451820882|FG001|Overall Study|Enrolled in another clinical study|1|||
125600124|NCT01629667|451820883|FG002|Overall Study|Enrolled in another clinical study|0|||
125600125|NCT01629667|451820881|FG000|Overall Study|Code break|1|||
125600126|NCT01629667|451820882|FG001|Overall Study|Code break|0|||
125600127|NCT01629667|451820883|FG002|Overall Study|Code break|0|||
125600128|NCT01966731|451820884|FG000|Overall Study|Death|2|||
125600129|NCT01966731|451820884|FG000|Overall Study|Lost to Follow-up|1|||
125600130|NCT01966731|451820884|FG000|Overall Study|Physician Decision|2|||
125600131|NCT01966731|451820884|FG000|Overall Study|Follow up is not complete|600|||
125600132|NCT01966731|451820884|FG000|Overall Study|Screening Failure|29|||
125600133|NCT01966731|451820884|FG000|Overall Study|Found to be ineligible|1|||
125600134|NCT01380093|451820886|FG000|Naloxone Challenge Phase|Screen failures|21|||
125600135|NCT01380093|451820887|FG001|Naloxone Challenge Phase|Screen failures|0|||
125600136|NCT01380093|451820888|FG002|Naloxone Challenge Phase|Screen failures|0|||
125600137|NCT01380093|451820889|FG003|Naloxone Challenge Phase|Screen failures|0|||
125600138|NCT01380093|451820890|FG004|Naloxone Challenge Phase|Screen failures|0|||
125600139|NCT01380093|451820891|FG005|Naloxone Challenge Phase|Screen failures|0|||
125600140|NCT01380093|451820892|FG006|Naloxone Challenge Phase|Screen failures|0|||
125600141|NCT01380093|451820893|FG007|Naloxone Challenge Phase|Screen failures|0|||
125600142|NCT01380093|451820894|FG008|Naloxone Challenge Phase|Screen failures|0|||
125600143|NCT01380093|451820886|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125600144|NCT01380093|451820887|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
125600145|NCT01380093|451820888|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125600146|NCT01380093|451820889|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125600147|NCT01380093|451820890|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125600148|NCT01380093|451820891|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125600149|NCT01380093|451820892|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125600150|NCT01380093|451820893|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125600151|NCT01380093|451820894|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
125600152|NCT01380093|451820886|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125600153|NCT01380093|451820887|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
125600154|NCT01380093|451820888|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
125600155|NCT01380093|451820889|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125600156|NCT01380093|451820890|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125600157|NCT01380093|451820891|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125600158|NCT01380093|451820892|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125600159|NCT01380093|451820893|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125600160|NCT01380093|451820894|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
125600161|NCT01380093|451820886|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125600162|NCT01380093|451820887|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
125600163|NCT01380093|451820888|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125600164|NCT01380093|451820889|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125600165|NCT01380093|451820890|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125600166|NCT01380093|451820891|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125600167|NCT01380093|451820892|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125600168|NCT01380093|451820893|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125600169|NCT01380093|451820894|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
125600170|NCT01380093|451820886|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125600171|NCT01380093|451820887|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
125600172|NCT01380093|451820888|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
125369176|NCT01847274|450984865|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
125369177|NCT01847274|450984866|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
125369178|NCT01847274|450984867|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
125369179|NCT01847274|450984868|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
125369180|NCT01847274|450984869|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
125369181|NCT01847274|450984870|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
125369182|NCT01847274|450984871|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
125369183|NCT01847274|450984861|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
125369184|NCT01847274|450984862|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
125369185|NCT01847274|450984863|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
125600173|NCT01380093|451820889|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125600174|NCT01380093|451820890|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125600175|NCT01380093|451820891|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125600176|NCT01380093|451820892|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125600177|NCT01380093|451820893|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125600178|NCT01380093|451820894|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
125600179|NCT01380093|451820886|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125600180|NCT01380093|451820887|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
125600181|NCT01380093|451820888|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
125600182|NCT01380093|451820889|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125600183|NCT01380093|451820890|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125600184|NCT01380093|451820891|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125600185|NCT01380093|451820892|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125600186|NCT01380093|451820893|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125600187|NCT01380093|451820894|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
125600188|NCT01380093|451820886|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
125600189|NCT01380093|451820887|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
125600190|NCT01380093|451820888|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
125600191|NCT01380093|451820889|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
125600192|NCT01380093|451820890|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
125600193|NCT01380093|451820891|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
125600194|NCT01380093|451820892|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
125600195|NCT01380093|451820893|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
125600196|NCT01380093|451820894|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
125600197|NCT01380093|451820886|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125600198|NCT01380093|451820887|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125600199|NCT01380093|451820888|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
125600200|NCT01380093|451820889|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125600201|NCT01380093|451820890|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125600202|NCT01380093|451820891|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125600203|NCT01380093|451820892|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125600204|NCT01380093|451820893|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125600205|NCT01380093|451820894|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
125600206|NCT01380093|451820886|FG000|Treatment Phase: Second Intervention|Other|0|||
125600207|NCT01380093|451820887|FG001|Treatment Phase: Second Intervention|Other|0|||
125600208|NCT01380093|451820888|FG002|Treatment Phase: Second Intervention|Other|0|||
125600209|NCT01380093|451820889|FG003|Treatment Phase: Second Intervention|Other|1|||
125600210|NCT01380093|451820890|FG004|Treatment Phase: Second Intervention|Other|0|||
125600211|NCT01380093|451820891|FG005|Treatment Phase: Second Intervention|Other|0|||
125600212|NCT01380093|451820892|FG006|Treatment Phase: Second Intervention|Other|0|||
125600213|NCT01380093|451820893|FG007|Treatment Phase: Second Intervention|Other|0|||
125600214|NCT01380093|451820894|FG008|Treatment Phase: Second Intervention|Other|0|||
125600215|NCT01380093|451820886|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
125600216|NCT01380093|451820887|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
125600217|NCT01380093|451820888|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
125600218|NCT01380093|451820889|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
125600219|NCT01380093|451820890|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
125600220|NCT01380093|451820891|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
125600221|NCT01380093|451820892|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
125600222|NCT01380093|451820893|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
125600223|NCT01380093|451820894|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
125600224|NCT01380093|451820886|FG000|Treatment Phase: Third Intervention|Other|0|||
125600225|NCT01380093|451820887|FG001|Treatment Phase: Third Intervention|Other|0|||
125600226|NCT01380093|451820888|FG002|Treatment Phase: Third Intervention|Other|0|||
125600227|NCT01380093|451820889|FG003|Treatment Phase: Third Intervention|Other|0|||
125600228|NCT01380093|451820890|FG004|Treatment Phase: Third Intervention|Other|0|||
125431670|NCT01490125|451207711|FG001|Period II|Lost to Follow-up|1|||
125600229|NCT01380093|451820891|FG005|Treatment Phase: Third Intervention|Other|0|||
125600230|NCT01380093|451820892|FG006|Treatment Phase: Third Intervention|Other|0|||
125600231|NCT01380093|451820893|FG007|Treatment Phase: Third Intervention|Other|0|||
125600232|NCT01380093|451820894|FG008|Treatment Phase: Third Intervention|Other|1|||
125600233|NCT04734873|451820895|FG000|Overall Study|Lost to Follow-up|1|||
125600234|NCT04734873|451820896|FG001|Overall Study|Lost to Follow-up|3|||
125600235|NCT04734873|451820897|FG002|Overall Study|Lost to Follow-up|2|||
125600236|NCT04734873|451820895|FG000|Overall Study|Randomized but not dosed|1|||
125600237|NCT04734873|451820896|FG001|Overall Study|Randomized but not dosed|0|||
125600238|NCT04734873|451820897|FG002|Overall Study|Randomized but not dosed|1|||
125600239|NCT00328198|451820901|FG000|Treatment|Adverse Event|21|||
125600240|NCT00328198|451820901|FG000|Treatment|Death|1|||
125600241|NCT00328198|451820901|FG000|Treatment|Physician Decision|5|||
125600242|NCT00328198|451820901|FG000|Treatment|Withdrawal by Subject|5|||
125600243|NCT00328198|451820901|FG000|Treatment|Evidence of disease progression|2|||
125600244|NCT00328198|451820901|FG000|Treatment|Non-compliance|1|||
125600245|NCT00328198|451820901|FG000|Treatment|Confirmed complete response, MRD -|3|||
125600246|NCT00328198|451820901|FG000|Follow-up|Lost to Follow-up|4|||
125600247|NCT00328198|451820901|FG000|Follow-up|Death|31|||
125600248|NCT03396471|451820902|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
125600249|NCT03396471|451820902|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
125600250|NCT03396471|451820902|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
125600251|NCT03396471|451820902|FG000|Study Treatment - Up to 22 Months|Death|2|||
125600252|NCT03396471|451820902|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
125600253|NCT03396471|451820902|FG000|Follow up - Up to 2 Years|Death|9|||
125600254|NCT03396471|451820902|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
125600255|NCT03396471|451820902|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
125600256|NCT03396471|451820902|FG000|Follow up - Up to 2 Years|study terminated|1|||
125600257|NCT03396471|451820902|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
125600258|NCT03396471|451820902|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
125600259|NCT00718861|451820903|FG000|Overall Study|Withdrawal by Subject|15|||
125600260|NCT00718861|451820904|FG001|Overall Study|Withdrawal by Subject|10|||
125600261|NCT00718861|451820903|FG000|Overall Study|Adverse Event|2|||
125600262|NCT00718861|451820904|FG001|Overall Study|Adverse Event|1|||
125600263|NCT00718861|451820903|FG000|Overall Study|Lost to Follow-up|2|||
125600264|NCT00718861|451820904|FG001|Overall Study|Lost to Follow-up|1|||
125600265|NCT00718861|451820903|FG000|Overall Study|Administrative Problems|1|||
125600266|NCT00718861|451820904|FG001|Overall Study|Administrative Problems|1|||
125600267|NCT00718861|451820903|FG000|Overall Study|Death|1|||
125600268|NCT00718861|451820904|FG001|Overall Study|Death|5|||
125600269|NCT03237845|451820905|FG000|Overall Study|Adverse Event|0|||
125600270|NCT03237845|451820906|FG001|Overall Study|Adverse Event|1|||
125600271|NCT03237845|451820905|FG000|Overall Study|Lost to Follow-up|13|||
125600272|NCT03237845|451820906|FG001|Overall Study|Lost to Follow-up|10|||
125600273|NCT03237845|451820905|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
125600274|NCT03237845|451820906|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
125600275|NCT03237845|451820905|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
125600276|NCT03237845|451820906|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
125600277|NCT03237845|451820905|FG000|Overall Study|Physician Decision|1|||
125600278|NCT03237845|451820906|FG001|Overall Study|Physician Decision|2|||
125600279|NCT03237845|451820905|FG000|Overall Study|Pregnancy|1|||
125600280|NCT03237845|451820906|FG001|Overall Study|Pregnancy|0|||
125600281|NCT03237845|451820905|FG000|Overall Study|Protocol Deviation|0|||
125600282|NCT03237845|451820906|FG001|Overall Study|Protocol Deviation|1|||
125600283|NCT03237845|451820905|FG000|Overall Study|Technical Problems|8|||
125600284|NCT03237845|451820906|FG001|Overall Study|Technical Problems|1|||
125600285|NCT03237845|451820905|FG000|Overall Study|Withdrawal by Subject|3|||
125600286|NCT03237845|451820906|FG001|Overall Study|Withdrawal by Subject|3|||
125600287|NCT03237845|451820905|FG000|Overall Study|Other Reasons|4|||
125600288|NCT03237845|451820906|FG001|Overall Study|Other Reasons|0|||
125600289|NCT03865407|451820910|FG000|Overall Study|Adverse Event|1|||
125600290|NCT03865407|451820911|FG001|Overall Study|Adverse Event|0|||
125600291|NCT03865407|451820910|FG000|Overall Study|Withdrawal by Subject|1|||
125600292|NCT03865407|451820911|FG001|Overall Study|Withdrawal by Subject|0|||
125600293|NCT03865407|451820910|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
125600294|NCT03865407|451820911|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
125600295|NCT02117050|451820912|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
125600296|NCT01645280|451820913|FG000|Overall Study|Death|0|||
125600297|NCT01645280|451820914|FG001|Overall Study|Death|1|||
125600298|NCT01645280|451820915|FG002|Overall Study|Death|0|||
125600299|NCT01645280|451820916|FG003|Overall Study|Death|0|||
125600300|NCT01645280|451820917|FG004|Overall Study|Death|0|||
125600301|NCT01645280|451820913|FG000|Overall Study|Withdrawal by Subject|4|||
125600302|NCT01645280|451820914|FG001|Overall Study|Withdrawal by Subject|0|||
125600303|NCT01645280|451820915|FG002|Overall Study|Withdrawal by Subject|2|||
125600304|NCT01645280|451820916|FG003|Overall Study|Withdrawal by Subject|4|||
125600305|NCT01645280|451820917|FG004|Overall Study|Withdrawal by Subject|5|||
125600306|NCT01645280|451820913|FG000|Overall Study|Lost to Follow-up|0|||
125600307|NCT01645280|451820914|FG001|Overall Study|Lost to Follow-up|0|||
125600308|NCT01645280|451820915|FG002|Overall Study|Lost to Follow-up|0|||
125600309|NCT01645280|451820916|FG003|Overall Study|Lost to Follow-up|2|||
125600310|NCT01645280|451820917|FG004|Overall Study|Lost to Follow-up|1|||
125600311|NCT01645280|451820913|FG000|Overall Study|Other|1|||
125600312|NCT01645280|451820914|FG001|Overall Study|Other|1|||
125600313|NCT01645280|451820915|FG002|Overall Study|Other|2|||
125600314|NCT01645280|451820916|FG003|Overall Study|Other|0|||
125600315|NCT01645280|451820917|FG004|Overall Study|Other|0|||
125600316|NCT01645280|451820913|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
125600317|NCT01645280|451820914|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
125600318|NCT01645280|451820915|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
125600319|NCT01645280|451820916|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
125600320|NCT01645280|451820917|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
125131402|NCT03818581|450109961|FG001|Overall Study|Withdrawal by Subject|0|||
125369186|NCT01847274|450984864|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
125369187|NCT01847274|450984865|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125369188|NCT01847274|450984866|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125369189|NCT01847274|450984867|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125369190|NCT01847274|450984868|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125369191|NCT01847274|450984869|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125369192|NCT01847274|450984870|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125369193|NCT01847274|450984871|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
125369194|NCT01847274|450984861|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125369195|NCT01847274|450984862|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125369196|NCT01847274|450984863|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125369197|NCT01847274|450984864|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125600321|NCT00234104|451820922|FG000|Overall Study|Adverse Event|4|||
125600322|NCT00234104|451820923|FG001|Overall Study|Adverse Event|0|||
125600323|NCT00234104|451820924|FG002|Overall Study|Adverse Event|3|||
125600324|NCT00234104|451820925|FG003|Overall Study|Adverse Event|5|||
125600325|NCT00234104|451820922|FG000|Overall Study|Protocol Violation|0|||
125600326|NCT00234104|451820923|FG001|Overall Study|Protocol Violation|0|||
125600327|NCT00234104|451820924|FG002|Overall Study|Protocol Violation|0|||
125600328|NCT00234104|451820925|FG003|Overall Study|Protocol Violation|1|||
125600329|NCT00234104|451820922|FG000|Overall Study|Physician Decision|0|||
125600330|NCT00234104|451820923|FG001|Overall Study|Physician Decision|1|||
125600331|NCT00234104|451820924|FG002|Overall Study|Physician Decision|2|||
125600332|NCT00234104|451820925|FG003|Overall Study|Physician Decision|2|||
125600333|NCT01716169|451820927|FG000|Overall Study|Adverse Event|1|||
125600334|NCT01716169|451820927|FG000|Overall Study|Lost to Follow-up|1|||
125600335|NCT01716169|451820927|FG000|Overall Study|Withdrawal by Subject|1|||
125600336|NCT01716169|451820927|FG000|Overall Study|inconsistent dressing application|1|||
125600337|NCT01088412|451820928|FG000|Overall Study|Adverse Event|38|||
125600338|NCT01088412|451820929|FG001|Overall Study|Adverse Event|0|||
125600339|NCT01088412|451820930|FG002|Overall Study|Adverse Event|0|||
125600340|NCT01088412|451820928|FG000|Overall Study|Death|42|||
125600341|NCT01088412|451820929|FG001|Overall Study|Death|6|||
125600342|NCT01088412|451820930|FG002|Overall Study|Death|0|||
125600343|NCT01088412|451820928|FG000|Overall Study|Other Reason per Case Report Form|2089|||
125600344|NCT01088412|451820929|FG001|Overall Study|Other Reason per Case Report Form|103|||
125600345|NCT01088412|451820930|FG002|Overall Study|Other Reason per Case Report Form|9|||
125600346|NCT01088412|451820928|FG000|Overall Study|Withdrawal by Subject|1761|||
125600347|NCT01088412|451820929|FG001|Overall Study|Withdrawal by Subject|25|||
125600348|NCT01088412|451820930|FG002|Overall Study|Withdrawal by Subject|1|||
125600349|NCT01088412|451820928|FG000|Overall Study|Received Another GH Product|79|||
125600350|NCT01088412|451820929|FG001|Overall Study|Received Another GH Product|0|||
125600351|NCT01088412|451820930|FG002|Overall Study|Received Another GH Product|0|||
125600352|NCT01088412|451820928|FG000|Overall Study|Participant Moved|601|||
125600353|NCT01088412|451820929|FG001|Overall Study|Participant Moved|21|||
125600354|NCT01088412|451820930|FG002|Overall Study|Participant Moved|2|||
125600355|NCT01088412|451820928|FG000|Overall Study|Physician Decision|1041|||
125600356|NCT01088412|451820929|FG001|Overall Study|Physician Decision|8|||
125600357|NCT01088412|451820930|FG002|Overall Study|Physician Decision|4|||
125600358|NCT01088412|451820928|FG000|Overall Study|Sponsor Decision|4467|||
125600359|NCT01088412|451820929|FG001|Overall Study|Sponsor Decision|79|||
125600360|NCT01088412|451820930|FG002|Overall Study|Sponsor Decision|23|||
125600361|NCT01088412|451820928|FG000|Overall Study|Third Party Required to Change Brand|487|||
125600362|NCT01088412|451820929|FG001|Overall Study|Third Party Required to Change Brand|0|||
125600363|NCT01088412|451820930|FG002|Overall Study|Third Party Required to Change Brand|0|||
125600364|NCT01088412|451820928|FG000|Overall Study|Lost to Follow-up|3052|||
125600365|NCT01088412|451820929|FG001|Overall Study|Lost to Follow-up|130|||
125600366|NCT01088412|451820930|FG002|Overall Study|Lost to Follow-up|11|||
125600367|NCT01088412|451820928|FG000|Overall Study|Study Summary Not Completed|4360|||
125600368|NCT01088412|451820929|FG001|Overall Study|Study Summary Not Completed|64|||
125600369|NCT01088412|451820930|FG002|Overall Study|Study Summary Not Completed|22|||
125600384|NCT02111811|451820933|FG000|Treatment Phase|Lost to Follow-up|22|||
125600385|NCT02111811|451820934|FG001|Treatment Phase|Lost to Follow-up|18|||
125600386|NCT02111811|451820933|FG000|Treatment Phase|Death|2|||
125600387|NCT02111811|451820934|FG001|Treatment Phase|Death|0|||
125600388|NCT02111811|451820933|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
125600389|NCT02111811|451820934|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
125600390|NCT02111811|451820933|FG000|Follow up Period (Aim 2)|Death|2|||
125600391|NCT02111811|451820934|FG001|Follow up Period (Aim 2)|Death|0|||
125600392|NCT01478347|451820939|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
125600393|NCT01478347|451820939|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
125600394|NCT01478347|451820939|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
125600395|NCT04579393|451820940|FG000|Overall Study|Withdrawal by Subject|2|||
125600396|NCT04579393|451820941|FG001|Overall Study|Withdrawal by Subject|2|||
125600397|NCT04579393|451820940|FG000|Overall Study|Death|1|||
125600398|NCT04579393|451820941|FG001|Overall Study|Death|3|||
125600399|NCT01326962|451820942|FG000|Overall Study|Adverse Event|1|||
125600400|NCT01326962|451820942|FG000|Overall Study|Withdrawal by Subject|1|||
125600401|NCT01326962|451820942|FG000|Overall Study|Lost to Follow-up|3|||
125600402|NCT01326962|451820942|FG000|Overall Study|Other|2|||
125600403|NCT02369510|451820945|FG000|Overall Study|Spilled Medication|1|||
125600404|NCT02369510|451820946|FG001|Overall Study|Spilled Medication|2|||
125600405|NCT02369510|451820947|FG002|Overall Study|Spilled Medication|1|||
125600406|NCT02369510|451820945|FG000|Overall Study|Epidural Activation|1|||
125600407|NCT02369510|451820946|FG001|Overall Study|Epidural Activation|1|||
125600408|NCT02369510|451820947|FG002|Overall Study|Epidural Activation|5|||
125600409|NCT01507246|451820949|FG000|Overall Study|Required different surgical procedures|2|||
125600410|NCT01507246|451820950|FG001|Overall Study|Required different surgical procedures|1|||
125600411|NCT02903511|451820954|FG000|Overall Study|Withdrawal by Subject|1|||
125600412|NCT02903511|451820955|FG001|Overall Study|Withdrawal by Subject|0|||
125600413|NCT02903511|451820954|FG000|Overall Study|Lost to Follow-up|3|||
125600414|NCT02903511|451820955|FG001|Overall Study|Lost to Follow-up|2|||
125600415|NCT00969618|451820956|FG000|Overall Study|Adverse Event|29|||
125600416|NCT00969618|451820956|FG000|Overall Study|Entry Criteria Not Met|3|||
125600417|NCT00969618|451820956|FG000|Overall Study|Lack of Efficacy|2|||
125600418|NCT00969618|451820956|FG000|Overall Study|Lost to Follow-up|7|||
125600419|NCT00969618|451820956|FG000|Overall Study|Physician Decision|1|||
125600420|NCT00969618|451820956|FG000|Overall Study|Protocol Violation|9|||
125600421|NCT00969618|451820956|FG000|Overall Study|Withdrawal by Subject|27|||
125600422|NCT05363293|451820959|FG000|Overall Study|Withdrawal by Subject|1|||
125600423|NCT05363293|451820960|FG001|Overall Study|Withdrawal by Subject|0|||
125600424|NCT05363293|451820961|FG002|Overall Study|Withdrawal by Subject|0|||
125600425|NCT05363293|451820962|FG003|Overall Study|Withdrawal by Subject|0|||
125600426|NCT05363293|451820963|FG004|Overall Study|Withdrawal by Subject|0|||
125600427|NCT05363293|451820964|FG005|Overall Study|Withdrawal by Subject|0|||
125600428|NCT05363293|451820965|FG006|Overall Study|Withdrawal by Subject|0|||
125600429|NCT05363293|451820966|FG007|Overall Study|Withdrawal by Subject|0|||
125600430|NCT05363293|451820967|FG008|Overall Study|Withdrawal by Subject|0|||
125600431|NCT05363293|451820968|FG009|Overall Study|Withdrawal by Subject|0|||
125600432|NCT05243550|451822575|FG000|Overall Study|Ongoing in the Study|171|||
125600433|NCT05243550|451822575|FG000|Overall Study|Withdrawal by Subject|10|||
125600434|NCT05243550|451822575|FG000|Overall Study|Lost to Follow-up|7|||
125600435|NCT05243550|451822575|FG000|Overall Study|Adverse Event|3|||
125600436|NCT05243550|451822575|FG000|Overall Study|Noncompliance|1|||
125600437|NCT05243550|451822575|FG000|Overall Study|Physician Decision|1|||
125600438|NCT05243550|451822575|FG000|Overall Study|Other Reason|4|||
125600439|NCT02452970|451822582|FG000|Overall Study|Adverse Event|1|||
125600440|NCT00128206|451822585|FG000|Overall Study|Lost to Follow-up|137|||
125600441|NCT00128206|451822586|FG001|Overall Study|Lost to Follow-up|118|||
125600442|NCT00128206|451822585|FG000|Overall Study|Adverse Event|0|||
125600443|NCT00128206|451822586|FG001|Overall Study|Adverse Event|2|||
125600444|NCT03270085|451822587|FG000|Overall Study|Withdrawal by Subject|1|||
125600445|NCT03270085|451822588|FG001|Overall Study|Withdrawal by Subject|0|||
125600446|NCT00663858|451822591|FG000|Overall Study|Adverse Event|9|||
125600447|NCT00663858|451822592|FG001|Overall Study|Adverse Event|1|||
125600448|NCT00663858|451822593|FG002|Overall Study|Adverse Event|6|||
125600449|NCT00663858|451822591|FG000|Overall Study|Lack of Efficacy|5|||
125600450|NCT00663858|451822592|FG001|Overall Study|Lack of Efficacy|1|||
125600451|NCT00663858|451822593|FG002|Overall Study|Lack of Efficacy|3|||
125600452|NCT00663858|451822591|FG000|Overall Study|Withdrawal by Subject|7|||
125600453|NCT00663858|451822592|FG001|Overall Study|Withdrawal by Subject|3|||
125600454|NCT00663858|451822593|FG002|Overall Study|Withdrawal by Subject|3|||
125600455|NCT00663858|451822591|FG000|Overall Study|Protocol Violation|5|||
125600456|NCT00663858|451822592|FG001|Overall Study|Protocol Violation|3|||
125600457|NCT00663858|451822593|FG002|Overall Study|Protocol Violation|4|||
125600458|NCT00663858|451822591|FG000|Overall Study|Other|8|||
125600459|NCT00663858|451822592|FG001|Overall Study|Other|2|||
125600460|NCT00663858|451822593|FG002|Overall Study|Other|4|||
125600461|NCT00098345|451822600|FG000|Overall Study|Adverse Event|7|||
125600462|NCT00098345|451822600|FG000|Overall Study|Withdrawal by Subject|2|||
125600463|NCT00098345|451822600|FG000|Overall Study|progression|4|||
125600464|NCT01936649|451822601|FG000|Overall Study|Withdrawal by Subject|4|||
125600465|NCT01936649|451822601|FG000|Overall Study|Physician Decision|2|||
125600466|NCT01936649|451822601|FG000|Overall Study|Protocol Violation|2|||
125600467|NCT01936649|451822601|FG000|Overall Study|Other than specified above|5|||
125600468|NCT04655586|451822604|FG000|Overall Study|Physician Decision|1|||
125600469|NCT04655586|451822605|FG001|Overall Study|Physician Decision|3|||
125600470|NCT04655586|451822606|FG002|Overall Study|Physician Decision|4|||
125600471|NCT04655586|451822604|FG000|Overall Study|Withdrawal by Subject|1|||
125600472|NCT04655586|451822605|FG001|Overall Study|Withdrawal by Subject|3|||
125600473|NCT04655586|451822606|FG002|Overall Study|Withdrawal by Subject|1|||
125369198|NCT01847274|450984865|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125369199|NCT01847274|450984866|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
125369200|NCT01847274|450984867|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125369201|NCT01847274|450984868|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125369202|NCT01847274|450984869|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125369203|NCT01847274|450984870|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125369204|NCT01847274|450984871|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
125369205|NCT01847274|450984861|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125369206|NCT01847274|450984862|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125369207|NCT01847274|450984863|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125369208|NCT01847274|450984864|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125369209|NCT01847274|450984865|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
125431671|NCT01490125|451207712|FG002|Period II|Lost to Follow-up|0|||
125369210|NCT01847274|450984866|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125369211|NCT01847274|450984867|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125369212|NCT01847274|450984868|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125369213|NCT01847274|450984869|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125369214|NCT01847274|450984870|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125369215|NCT01847274|450984871|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
125369216|NCT01847274|450984861|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125600474|NCT00201201|451822609|FG000|Overall Study|Death|0|||
125600475|NCT00201201|451822610|FG001|Overall Study|Death|2|||
125600476|NCT00201201|451822609|FG000|Overall Study|Withdrawal by Subject|5|||
125600477|NCT00201201|451822610|FG001|Overall Study|Withdrawal by Subject|5|||
125600478|NCT01342640|451822612|FG000|Overall Study|Adverse Event|3|||
125600479|NCT01342640|451822612|FG000|Overall Study|Protocol Violation|16|||
125600480|NCT01342640|451822612|FG000|Overall Study|Lost to Follow-up|21|||
125600481|NCT01342640|451822612|FG000|Overall Study|Other|1|||
125600482|NCT04101422|451822614|FG000|Overall Study|Ineligible|1|||
125600483|NCT04101422|451822615|FG001|Overall Study|Ineligible|0|||
125600484|NCT04101422|451822616|FG002|Overall Study|Ineligible|9|||
125600485|NCT04101422|451822617|FG003|Overall Study|Ineligible|0|||
125600486|NCT04101422|451822614|FG000|Overall Study|Withdrawal by Subject|0|||
125600487|NCT04101422|451822615|FG001|Overall Study|Withdrawal by Subject|0|||
125600488|NCT04101422|451822616|FG002|Overall Study|Withdrawal by Subject|1|||
125600489|NCT04101422|451822617|FG003|Overall Study|Withdrawal by Subject|0|||
125600490|NCT04101422|451822614|FG000|Overall Study|Not attending to the stimuli|0|||
125600491|NCT04101422|451822615|FG001|Overall Study|Not attending to the stimuli|0|||
125600492|NCT04101422|451822616|FG002|Overall Study|Not attending to the stimuli|4|||
125600493|NCT04101422|451822617|FG003|Overall Study|Not attending to the stimuli|0|||
125600494|NCT04101422|451822614|FG000|Overall Study|Did not download app|0|||
125600495|NCT04101422|451822615|FG001|Overall Study|Did not download app|0|||
125600496|NCT04101422|451822616|FG002|Overall Study|Did not download app|0|||
125600497|NCT04101422|451822617|FG003|Overall Study|Did not download app|17|||
125600498|NCT04101422|451822614|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
125600499|NCT04101422|451822615|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
125600500|NCT04101422|451822616|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
125600501|NCT04101422|451822617|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
125600502|NCT02640612|451822618|FG000|Overall Study|Adverse Event|6|||
125600503|NCT02640612|451822619|FG001|Overall Study|Adverse Event|7|||
125600504|NCT02640612|451822620|FG002|Overall Study|Adverse Event|2|||
125600505|NCT02640612|451822618|FG000|Overall Study|Death|1|||
125600506|NCT02640612|451822619|FG001|Overall Study|Death|0|||
125600507|NCT02640612|451822620|FG002|Overall Study|Death|0|||
125600508|NCT02640612|451822618|FG000|Overall Study|Withdrawal by Subject|10|||
125600509|NCT02640612|451822619|FG001|Overall Study|Withdrawal by Subject|3|||
125600510|NCT02640612|451822620|FG002|Overall Study|Withdrawal by Subject|3|||
125600511|NCT02640612|451822618|FG000|Overall Study|Lost to Follow-up|4|||
125600512|NCT02640612|451822619|FG001|Overall Study|Lost to Follow-up|1|||
125600513|NCT02640612|451822620|FG002|Overall Study|Lost to Follow-up|1|||
125600514|NCT02640612|451822618|FG000|Overall Study|Protocol Violation|0|||
125600515|NCT02640612|451822619|FG001|Overall Study|Protocol Violation|2|||
125600516|NCT02640612|451822620|FG002|Overall Study|Protocol Violation|0|||
125600517|NCT02640612|451822618|FG000|Overall Study|Lack of Efficacy|1|||
125600518|NCT02640612|451822619|FG001|Overall Study|Lack of Efficacy|1|||
125600519|NCT02640612|451822620|FG002|Overall Study|Lack of Efficacy|0|||
125600520|NCT03472534|451822621|FG000|Overall Study|Withdrawal by Subject|9|||
125600521|NCT03472534|451822621|FG000|Overall Study|Adverse Event|2|||
125600522|NCT00552305|451822622|FG000|Overall Study|Adverse Event|43|||
125600523|NCT00552305|451822622|FG000|Overall Study|Lack of Efficacy|120|||
125600524|NCT00552305|451822622|FG000|Overall Study|Lost to Follow-up|4|||
125600525|NCT00552305|451822622|FG000|Overall Study|Protocol Violation|3|||
125600526|NCT00552305|451822622|FG000|Overall Study|Withdrawal by Subject|44|||
125600527|NCT00552305|451822622|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
125600528|NCT00552305|451822622|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
125369217|NCT01847274|450984862|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125600529|NCT00552305|451822622|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
125600530|NCT00552305|451822622|FG000|Overall Study|Unsatisfactory compliance|11|||
125600531|NCT00552305|451822622|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
125600532|NCT00552305|451822622|FG000|Overall Study|AE/Other: prohibited drug required|1|||
125600533|NCT00552305|451822622|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
125600534|NCT00552305|451822622|FG000|Overall Study|Other: Site closed|4|||
125600535|NCT00552305|451822622|FG000|Overall Study|Other: Personal problems|1|||
125600536|NCT00552305|451822622|FG000|Overall Study|Other: Unable to attend visits|1|||
125600537|NCT00552305|451822622|FG000|Overall Study|Other: Subject underwent surgery|4|||
125600538|NCT00552305|451822622|FG000|Overall Study|Other: Subject became pregnant|1|||
125600539|NCT00552305|451822622|FG000|Overall Study|Other: Health problems, not drug related|1|||
125600540|NCT00552305|451822622|FG000|Overall Study|Other: Subject moved from area|2|||
125600541|NCT00552305|451822622|FG000|Overall Study|Other: Subject incarcerated|1|||
125600542|NCT00552305|451822622|FG000|Overall Study|Other: Subject went to rehab|1|||
125600543|NCT00546819|451822625|FG000|Overall Study|Adverse Event|2|||
125600544|NCT00546819|451822626|FG001|Overall Study|Adverse Event|3|||
125600545|NCT00546819|451822625|FG000|Overall Study|Lost to Follow-up|2|||
125600546|NCT00546819|451822626|FG001|Overall Study|Lost to Follow-up|1|||
125600547|NCT00546819|451822625|FG000|Overall Study|Withdrawal by Subject|4|||
125600548|NCT00546819|451822626|FG001|Overall Study|Withdrawal by Subject|2|||
125600549|NCT02052960|451822628|FG000|Overall Study|Adverse Event|19|||
125600550|NCT02052960|451822629|FG001|Overall Study|Adverse Event|17|||
125600551|NCT02052960|451822628|FG000|Overall Study|Protocol Violation|4|||
125600552|NCT02052960|451822629|FG001|Overall Study|Protocol Violation|3|||
125600553|NCT02052960|451822628|FG000|Overall Study|Withdrawal by Subject|6|||
125600554|NCT02052960|451822629|FG001|Overall Study|Withdrawal by Subject|11|||
125600555|NCT02052960|451822628|FG000|Overall Study|Other|25|||
125600556|NCT02052960|451822629|FG001|Overall Study|Other|15|||
125600557|NCT03849560|451822630|FG000|Overall Study|Withdrawal by Subject|1|||
125600558|NCT03849560|451822631|FG001|Overall Study|Withdrawal by Subject|0|||
125600559|NCT03849560|451822632|FG002|Overall Study|Withdrawal by Subject|0|||
125600560|NCT04045613|451822633|FG000|Overall Study|Adverse Event|2|||
125600561|NCT04045613|451822634|FG001|Overall Study|Adverse Event|2|||
125600562|NCT04045613|451822635|FG002|Overall Study|Adverse Event|1|||
125600563|NCT04045613|451822636|FG003|Overall Study|Adverse Event|1|||
125600564|NCT04045613|451822637|FG004|Overall Study|Adverse Event|0|||
125600565|NCT04045613|451822638|FG005|Overall Study|Adverse Event|0|||
125600566|NCT04045613|451822639|FG006|Overall Study|Adverse Event|1|||
125600567|NCT04045613|451822633|FG000|Overall Study|Withdrawal by Subject|0|||
125600568|NCT04045613|451822634|FG001|Overall Study|Withdrawal by Subject|5|||
125600569|NCT04045613|451822635|FG002|Overall Study|Withdrawal by Subject|0|||
125600570|NCT04045613|451822636|FG003|Overall Study|Withdrawal by Subject|0|||
125600571|NCT04045613|451822637|FG004|Overall Study|Withdrawal by Subject|0|||
125600572|NCT04045613|451822638|FG005|Overall Study|Withdrawal by Subject|1|||
125600573|NCT04045613|451822639|FG006|Overall Study|Withdrawal by Subject|0|||
125600574|NCT04045613|451822633|FG000|Overall Study|Physician Decision|2|||
125600575|NCT04045613|451822634|FG001|Overall Study|Physician Decision|0|||
125600576|NCT04045613|451822635|FG002|Overall Study|Physician Decision|0|||
125600577|NCT04045613|451822636|FG003|Overall Study|Physician Decision|0|||
125600578|NCT04045613|451822637|FG004|Overall Study|Physician Decision|1|||
125600579|NCT04045613|451822638|FG005|Overall Study|Physician Decision|0|||
125600580|NCT04045613|451822639|FG006|Overall Study|Physician Decision|0|||
125600581|NCT04045613|451822633|FG000|Overall Study|Death|3|||
125600582|NCT04045613|451822634|FG001|Overall Study|Death|0|||
125600583|NCT04045613|451822635|FG002|Overall Study|Death|0|||
125600584|NCT04045613|451822636|FG003|Overall Study|Death|0|||
125600585|NCT04045613|451822637|FG004|Overall Study|Death|0|||
125600586|NCT04045613|451822638|FG005|Overall Study|Death|0|||
125600587|NCT04045613|451822639|FG006|Overall Study|Death|1|||
125600588|NCT04045613|451822633|FG000|Overall Study|Other reasons|0|||
125600589|NCT04045613|451822634|FG001|Overall Study|Other reasons|1|||
125600590|NCT04045613|451822635|FG002|Overall Study|Other reasons|0|||
125600591|NCT04045613|451822636|FG003|Overall Study|Other reasons|0|||
125431672|NCT01490125|451207713|FG003|Period II|Lost to Follow-up|0|||
125600592|NCT04045613|451822637|FG004|Overall Study|Other reasons|0|||
125600593|NCT04045613|451822638|FG005|Overall Study|Other reasons|0|||
125600594|NCT04045613|451822639|FG006|Overall Study|Other reasons|1|||
125600595|NCT04045613|451822633|FG000|Overall Study|Progressive disease: Clinical progression|1|||
125600596|NCT04045613|451822634|FG001|Overall Study|Progressive disease: Clinical progression|0|||
125600597|NCT04045613|451822635|FG002|Overall Study|Progressive disease: Clinical progression|3|||
125600598|NCT04045613|451822636|FG003|Overall Study|Progressive disease: Clinical progression|1|||
125600599|NCT04045613|451822637|FG004|Overall Study|Progressive disease: Clinical progression|1|||
125600600|NCT04045613|451822638|FG005|Overall Study|Progressive disease: Clinical progression|3|||
125600601|NCT04045613|451822639|FG006|Overall Study|Progressive disease: Clinical progression|3|||
125600602|NCT04045613|451822633|FG000|Overall Study|Progressive disease: Radiological progression|24|||
125600603|NCT04045613|451822634|FG001|Overall Study|Progressive disease: Radiological progression|6|||
125600604|NCT04045613|451822635|FG002|Overall Study|Progressive disease: Radiological progression|8|||
125600605|NCT04045613|451822636|FG003|Overall Study|Progressive disease: Radiological progression|0|||
125600606|NCT04045613|451822637|FG004|Overall Study|Progressive disease: Radiological progression|6|||
125369218|NCT01847274|450984863|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125600607|NCT04045613|451822638|FG005|Overall Study|Progressive disease: Radiological progression|6|||
125600608|NCT04045613|451822639|FG006|Overall Study|Progressive disease: Radiological progression|11|||
125600609|NCT04983901|451822640|FG000|Overall Study|Death|1|||
125600610|NCT04983901|451822641|FG001|Overall Study|Death|4|||
125369219|NCT01847274|450984864|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125369220|NCT01847274|450984865|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125369221|NCT01847274|450984866|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125369222|NCT01847274|450984867|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
125369223|NCT01847274|450984868|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125369224|NCT01847274|450984869|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125369225|NCT01847274|450984870|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125369226|NCT01847274|450984871|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
125369227|NCT01847274|450984861|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125369228|NCT01847274|450984862|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125369229|NCT01847274|450984863|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125369230|NCT01847274|450984864|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125369231|NCT01847274|450984865|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125369232|NCT01847274|450984866|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125369233|NCT01847274|450984867|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
125369234|NCT01847274|450984868|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125369235|NCT01847274|450984869|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125369236|NCT01847274|450984870|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125369237|NCT01847274|450984871|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
125369238|NCT01847274|450984861|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125369239|NCT01847274|450984862|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125369240|NCT01847274|450984863|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125369241|NCT01847274|450984864|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125369242|NCT01847274|450984865|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125369243|NCT01847274|450984866|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125600611|NCT04983901|451822640|FG000|Overall Study|Lost to Follow-up|3|||
125600612|NCT04983901|451822641|FG001|Overall Study|Lost to Follow-up|0|||
125600613|NCT04983901|451822640|FG000|Overall Study|Protocol Violation|1|||
125600614|NCT04983901|451822641|FG001|Overall Study|Protocol Violation|0|||
125600615|NCT04983901|451822640|FG000|Overall Study|Withdrawal by Subject|1|||
125600616|NCT04983901|451822641|FG001|Overall Study|Withdrawal by Subject|2|||
125600617|NCT02859415|451822649|FG000|Overall Study|Physician Decision|1|||
125600618|NCT02859415|451822650|FG001|Overall Study|Physician Decision|0|||
125600619|NCT02859415|451822649|FG000|Overall Study|Off treatment due to cardiac event|0|||
125600620|NCT02859415|451822650|FG001|Overall Study|Off treatment due to cardiac event|1|||
125600621|NCT01174784|451822651|FG000|Overall Study|Screen fails|4|||
125600622|NCT01507545|451822656|FG000|Overall Study|Withdrawal by Subject|6|||
125600623|NCT01507545|451822657|FG001|Overall Study|Withdrawal by Subject|2|||
125600624|NCT01507545|451822656|FG000|Overall Study|Lost to Follow-up|1|||
125600625|NCT01507545|451822657|FG001|Overall Study|Lost to Follow-up|0|||
125600626|NCT01507545|451822656|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
125600627|NCT01507545|451822657|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
125600628|NCT01507545|451822656|FG000|Overall Study|Progressive disease|60|||
125600629|NCT01507545|451822657|FG001|Overall Study|Progressive disease|27|||
125600630|NCT01507545|451822656|FG000|Overall Study|Other|6|||
125600631|NCT01507545|451822657|FG001|Overall Study|Other|4|||
125600632|NCT00450866|451822658|FG000|Overall Study|Adverse Event|0|||
125600633|NCT00450866|451822659|FG001|Overall Study|Adverse Event|1|||
125600634|NCT00450866|451822658|FG000|Overall Study|Withdrawal by Subject|5|||
125600635|NCT00450866|451822659|FG001|Overall Study|Withdrawal by Subject|2|||
125600636|NCT00450866|451822658|FG000|Overall Study|Death|1|||
125600637|NCT00450866|451822659|FG001|Overall Study|Death|0|||
125600638|NCT00450866|451822658|FG000|Overall Study|Physician Decision|1|||
125600639|NCT00450866|451822659|FG001|Overall Study|Physician Decision|0|||
125600640|NCT00553787|451822660|FG000|Overall Study|Adverse Event|34|||
125600641|NCT00553787|451822661|FG001|Overall Study|Adverse Event|21|||
125600642|NCT00553787|451822662|FG002|Overall Study|Adverse Event|67|||
125600643|NCT00553787|451822660|FG000|Overall Study|Lost to Follow-up|132|||
125600644|NCT00553787|451822661|FG001|Overall Study|Lost to Follow-up|44|||
125600645|NCT00553787|451822662|FG002|Overall Study|Lost to Follow-up|78|||
125600646|NCT00553787|451822660|FG000|Overall Study|Withdrawal by Subject|151|||
125600647|NCT00553787|451822661|FG001|Overall Study|Withdrawal by Subject|40|||
125600648|NCT00553787|451822662|FG002|Overall Study|Withdrawal by Subject|83|||
125369244|NCT01847274|450984867|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
125369245|NCT01847274|450984868|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125369246|NCT01847274|450984869|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125369247|NCT01847274|450984870|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125212800|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
125600649|NCT00553787|451822660|FG000|Overall Study|Lack of Efficacy|31|||
125600650|NCT00553787|451822661|FG001|Overall Study|Lack of Efficacy|1|||
125600651|NCT00553787|451822662|FG002|Overall Study|Lack of Efficacy|3|||
125600652|NCT00553787|451822660|FG000|Overall Study|Pregnancy|0|||
125600653|NCT00553787|451822661|FG001|Overall Study|Pregnancy|1|||
125600654|NCT00553787|451822662|FG002|Overall Study|Pregnancy|2|||
125600655|NCT00553787|451822660|FG000|Overall Study|non compliance|4|||
125600656|NCT00553787|451822661|FG001|Overall Study|non compliance|0|||
125600657|NCT00553787|451822662|FG002|Overall Study|non compliance|11|||
125600658|NCT00553787|451822660|FG000|Overall Study|Requirement for restricted medication|8|||
125600659|NCT00553787|451822661|FG001|Overall Study|Requirement for restricted medication|7|||
125600660|NCT00553787|451822662|FG002|Overall Study|Requirement for restricted medication|5|||
125600661|NCT00553787|451822660|FG000|Overall Study|Other|18|||
125600662|NCT00553787|451822661|FG001|Overall Study|Other|10|||
125600663|NCT00553787|451822662|FG002|Overall Study|Other|13|||
125600664|NCT02285010|451822663|FG000|Overall Study|not abdominal hysterectomy|2|||
125600665|NCT02285010|451822664|FG001|Overall Study|not abdominal hysterectomy|0|||
125600666|NCT02285010|451822663|FG000|Overall Study|Not spinal anesthesia|3|||
125600667|NCT02285010|451822664|FG001|Overall Study|Not spinal anesthesia|1|||
125600668|NCT01426386|451822668|FG000|Overall Study|Adverse Event|0|||
125600669|NCT01426386|451822669|FG001|Overall Study|Adverse Event|1|||
125600670|NCT01426386|451822670|FG002|Overall Study|Adverse Event|0|||
125600671|NCT01426386|451822671|FG003|Overall Study|Adverse Event|0|||
125600672|NCT01426386|451822672|FG004|Overall Study|Adverse Event|0|||
125600673|NCT01426386|451822673|FG005|Overall Study|Adverse Event|0|||
125600674|NCT01426386|451822668|FG000|Overall Study|Did not attend scheduled visit|1|||
125600675|NCT01426386|451822669|FG001|Overall Study|Did not attend scheduled visit|4|||
125600676|NCT01426386|451822670|FG002|Overall Study|Did not attend scheduled visit|0|||
125600677|NCT01426386|451822671|FG003|Overall Study|Did not attend scheduled visit|0|||
125600678|NCT01426386|451822672|FG004|Overall Study|Did not attend scheduled visit|2|||
125600679|NCT01426386|451822673|FG005|Overall Study|Did not attend scheduled visit|1|||
125600680|NCT01426386|451822668|FG000|Overall Study|Poor response|2|||
125600681|NCT01426386|451822669|FG001|Overall Study|Poor response|1|||
125600682|NCT01426386|451822670|FG002|Overall Study|Poor response|2|||
125600683|NCT01426386|451822671|FG003|Overall Study|Poor response|0|||
125600684|NCT01426386|451822672|FG004|Overall Study|Poor response|1|||
125600685|NCT01426386|451822673|FG005|Overall Study|Poor response|0|||
125600686|NCT01426386|451822668|FG000|Overall Study|Personal reasons|0|||
125600687|NCT01426386|451822669|FG001|Overall Study|Personal reasons|0|||
125600688|NCT01426386|451822670|FG002|Overall Study|Personal reasons|0|||
125600689|NCT01426386|451822671|FG003|Overall Study|Personal reasons|0|||
125600690|NCT01426386|451822672|FG004|Overall Study|Personal reasons|1|||
125600691|NCT01426386|451822673|FG005|Overall Study|Personal reasons|0|||
125600692|NCT00196937|451822674|FG000|Overall Study|Serious Adverse Event|1|||
125600693|NCT00196937|451822675|FG001|Overall Study|Serious Adverse Event|0|||
125600694|NCT00196937|451822676|FG002|Overall Study|Serious Adverse Event|0|||
125600695|NCT00196937|451822674|FG000|Overall Study|Non-serious adverse event|1|||
125600696|NCT00196937|451822675|FG001|Overall Study|Non-serious adverse event|1|||
125600697|NCT00196937|451822676|FG002|Overall Study|Non-serious adverse event|1|||
125600698|NCT00196937|451822674|FG000|Overall Study|Withdrawal by Subject|0|||
125600699|NCT00196937|451822675|FG001|Overall Study|Withdrawal by Subject|0|||
125600700|NCT00196937|451822676|FG002|Overall Study|Withdrawal by Subject|2|||
125600701|NCT00196937|451822674|FG000|Overall Study|Lost to Follow-up|4|||
125600702|NCT00196937|451822675|FG001|Overall Study|Lost to Follow-up|3|||
125600703|NCT00196937|451822676|FG002|Overall Study|Lost to Follow-up|3|||
125600704|NCT00196937|451822674|FG000|Overall Study|Other|3|||
125600705|NCT00196937|451822675|FG001|Overall Study|Other|1|||
125600706|NCT00196937|451822676|FG002|Overall Study|Other|1|||
125600707|NCT01096667|451822677|FG000|Overall Study|Lost to Follow-up|1|||
125600708|NCT01096667|451822678|FG001|Overall Study|Lost to Follow-up|1|||
125600709|NCT01096667|451822679|FG002|Overall Study|Lost to Follow-up|1|||
125600710|NCT01096667|451822680|FG003|Overall Study|Lost to Follow-up|0|||
125600711|NCT01096667|451822681|FG004|Overall Study|Lost to Follow-up|0|||
125600712|NCT01096667|451822677|FG000|Overall Study|Withdrawal by Subject|1|||
125600713|NCT01096667|451822678|FG001|Overall Study|Withdrawal by Subject|0|||
125600714|NCT01096667|451822679|FG002|Overall Study|Withdrawal by Subject|0|||
125600715|NCT01096667|451822680|FG003|Overall Study|Withdrawal by Subject|1|||
125600716|NCT01096667|451822681|FG004|Overall Study|Withdrawal by Subject|0|||
125600717|NCT01096667|451822677|FG000|Overall Study|Reason not available|0|||
125600718|NCT01096667|451822678|FG001|Overall Study|Reason not available|1|||
125600719|NCT01096667|451822679|FG002|Overall Study|Reason not available|1|||
125600720|NCT01096667|451822680|FG003|Overall Study|Reason not available|1|||
125600721|NCT01096667|451822681|FG004|Overall Study|Reason not available|0|||
125600722|NCT01096667|451822677|FG000|Overall Study|Protocol Violation|0|||
125600723|NCT01096667|451822678|FG001|Overall Study|Protocol Violation|0|||
125600724|NCT01096667|451822679|FG002|Overall Study|Protocol Violation|0|||
125600725|NCT01096667|451822680|FG003|Overall Study|Protocol Violation|1|||
125369248|NCT01847274|450984871|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
125369249|NCT01847274|450984861|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125600726|NCT01096667|451822681|FG004|Overall Study|Protocol Violation|0|||
125600727|NCT01096667|451822677|FG000|Overall Study|Not treated|1|||
125600728|NCT01096667|451822678|FG001|Overall Study|Not treated|0|||
125600729|NCT01096667|451822679|FG002|Overall Study|Not treated|0|||
125600730|NCT01096667|451822680|FG003|Overall Study|Not treated|0|||
125600731|NCT01096667|451822681|FG004|Overall Study|Not treated|0|||
125600732|NCT02973815|451822685|FG000|Post Intervention|Death|1|||
125600733|NCT02973815|451822686|FG001|Post Intervention|Death|0|||
125600734|NCT02973815|451822685|FG000|Post Intervention|Lost to Follow-up|7|||
125600735|NCT02973815|451822686|FG001|Post Intervention|Lost to Follow-up|24|||
125600736|NCT02973815|451822685|FG000|Follow-up|Lost to Follow-up|2|||
125600737|NCT02973815|451822686|FG001|Follow-up|Lost to Follow-up|0|||
125600738|NCT00853905|451822691|FG000|Overall Study|Lost to Follow-up|1|||
125600739|NCT00853905|451822692|FG001|Overall Study|Lost to Follow-up|3|||
125600740|NCT00853905|451822691|FG000|Overall Study|Withdrawal by Subject|0|||
125600741|NCT00853905|451822692|FG001|Overall Study|Withdrawal by Subject|1|||
125600742|NCT00853905|451822691|FG000|Overall Study|never had surgery|1|||
125600743|NCT00853905|451822692|FG001|Overall Study|never had surgery|0|||
125600744|NCT00465738|451822697|FG000|Overall Study|Lost to Follow-up|2|||
125600745|NCT00465738|451822698|FG001|Overall Study|Lost to Follow-up|0|||
125600746|NCT00465738|451822697|FG000|Overall Study|Adverse Event|0|||
125600747|NCT00465738|451822698|FG001|Overall Study|Adverse Event|1|||
125600748|NCT00465738|451822697|FG000|Overall Study|Withdrawal by Subject|2|||
125600749|NCT00465738|451822698|FG001|Overall Study|Withdrawal by Subject|0|||
125600750|NCT00465738|451822697|FG000|Overall Study|Other|2|||
125600751|NCT00465738|451822698|FG001|Overall Study|Other|5|||
125600752|NCT02489630|451822700|FG000|Overall Study|Oversedation|1|||
125600753|NCT02489630|451822701|FG001|Overall Study|Oversedation|1|||
125600754|NCT02489630|451822700|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
125600755|NCT02489630|451822701|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
125600756|NCT01056523|451822702|FG000|Overall Study|Death|1|||
125600757|NCT01056523|451822703|FG001|Overall Study|Death|0|||
125600758|NCT01056523|451822704|FG002|Overall Study|Death|2|||
125600759|NCT01056523|451822705|FG003|Overall Study|Death|3|||
125600760|NCT01056523|451822706|FG004|Overall Study|Death|0|||
125600761|NCT01056523|451822707|FG005|Overall Study|Death|0|||
125600762|NCT01056523|451822708|FG006|Overall Study|Death|1|||
125600763|NCT03429556|451822709|FG000|Overall Study|Lost to Follow-up|0|||
125600764|NCT03429556|451822710|FG001|Overall Study|Lost to Follow-up|1|||
125600765|NCT03429556|451822711|FG002|Overall Study|Lost to Follow-up|0|||
125600766|NCT03429556|451822712|FG003|Overall Study|Lost to Follow-up|0|||
125600767|NCT01863758|451822717|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
125600768|NCT01863758|451822717|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
125600769|NCT04952389|451822718|FG000|Overall Study|Withdrawal by Subject|8|||
125600770|NCT04952389|451822719|FG001|Overall Study|Withdrawal by Subject|4|||
125600771|NCT02050048|451822720|FG000|Overall Study|Lost to Follow-up|0|||
125600772|NCT02050048|451822721|FG001|Overall Study|Lost to Follow-up|1|||
125600773|NCT02050048|451822720|FG000|Overall Study|Death|1|||
125600774|NCT02050048|451822721|FG001|Overall Study|Death|0|||
125600775|NCT02050048|451822720|FG000|Overall Study|Ineligible after ERCP|4|||
125600776|NCT02050048|451822721|FG001|Overall Study|Ineligible after ERCP|1|||
125600777|NCT04285723|451822725|FG000|Overall Study|Subject decision|1|||
125600778|NCT04285723|451822726|FG001|Overall Study|Subject decision|2|||
125600779|NCT04285723|451822725|FG000|Overall Study|Physician Decision|1|||
125600780|NCT04285723|451822726|FG001|Overall Study|Physician Decision|0|||
125600781|NCT04285723|451822725|FG000|Overall Study|No efficiency|1|||
125600782|NCT04285723|451822726|FG001|Overall Study|No efficiency|0|||
125600783|NCT01318902|451822731|FG000|Overall Study|Symptomatic Deterioration|0|||
125600784|NCT01318902|451822732|FG001|Overall Study|Symptomatic Deterioration|1|||
125212801|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
125369250|NCT01847274|450984862|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125600785|NCT01318902|451822733|FG002|Overall Study|Symptomatic Deterioration|1|||
125600786|NCT01318902|451822734|FG003|Overall Study|Symptomatic Deterioration|2|||
125600787|NCT01318902|451822731|FG000|Overall Study|Withdrawal by Patient|0|||
125600788|NCT01318902|451822732|FG001|Overall Study|Withdrawal by Patient|1|||
125600789|NCT01318902|451822733|FG002|Overall Study|Withdrawal by Patient|0|||
125600790|NCT01318902|451822734|FG003|Overall Study|Withdrawal by Patient|3|||
125600791|NCT01318902|451822731|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
125600792|NCT01318902|451822732|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
125600793|NCT01318902|451822733|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
125600794|NCT01318902|451822734|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
125600795|NCT01318902|451822731|FG000|Overall Study|Adverse Event|0|||
125600796|NCT01318902|451822732|FG001|Overall Study|Adverse Event|1|||
125600797|NCT01318902|451822733|FG002|Overall Study|Adverse Event|0|||
125600798|NCT01318902|451822734|FG003|Overall Study|Adverse Event|0|||
125600799|NCT01318902|451822731|FG000|Overall Study|Terminated by Sponsor|0|||
125600800|NCT01318902|451822732|FG001|Overall Study|Terminated by Sponsor|0|||
125600801|NCT01318902|451822733|FG002|Overall Study|Terminated by Sponsor|1|||
125600802|NCT01318902|451822734|FG003|Overall Study|Terminated by Sponsor|0|||
125600803|NCT02699515|451824798|FG000|Overall Study|Death|3|||
125600804|NCT02699515|451824799|FG001|Overall Study|Death|3|||
125600805|NCT02699515|451824800|FG002|Overall Study|Death|3|||
125600806|NCT02699515|451824801|FG003|Overall Study|Death|23|||
125600807|NCT02699515|451824802|FG004|Overall Study|Death|22|||
125600808|NCT02699515|451824803|FG005|Overall Study|Death|23|||
125600809|NCT02699515|451824804|FG006|Overall Study|Death|3|||
125600810|NCT02699515|451824805|FG007|Overall Study|Death|5|||
125600811|NCT02699515|451824798|FG000|Overall Study|Withdrawal by Subject|0|||
125600812|NCT02699515|451824799|FG001|Overall Study|Withdrawal by Subject|0|||
125600813|NCT02699515|451824800|FG002|Overall Study|Withdrawal by Subject|3|||
125600814|NCT02699515|451824801|FG003|Overall Study|Withdrawal by Subject|1|||
125600815|NCT02699515|451824802|FG004|Overall Study|Withdrawal by Subject|5|||
125600816|NCT02699515|451824803|FG005|Overall Study|Withdrawal by Subject|3|||
125600817|NCT02699515|451824804|FG006|Overall Study|Withdrawal by Subject|0|||
125600818|NCT02699515|451824805|FG007|Overall Study|Withdrawal by Subject|1|||
125600819|NCT02699515|451824798|FG000|Overall Study|Other|1|||
125600820|NCT02699515|451824799|FG001|Overall Study|Other|0|||
125600821|NCT02699515|451824800|FG002|Overall Study|Other|1|||
125600822|NCT02699515|451824801|FG003|Overall Study|Other|6|||
125600823|NCT02699515|451824802|FG004|Overall Study|Other|4|||
125600824|NCT02699515|451824803|FG005|Overall Study|Other|3|||
125600825|NCT02699515|451824804|FG006|Overall Study|Other|0|||
125600826|NCT02699515|451824805|FG007|Overall Study|Other|0|||
125600827|NCT00375934|451824808|FG000|Overall Study|Adverse Event|1|||
125600828|NCT00375934|451824809|FG001|Overall Study|Adverse Event|1|||
125600829|NCT00375934|451824808|FG000|Overall Study|Withdrawal by Subject|2|||
125600830|NCT00375934|451824809|FG001|Overall Study|Withdrawal by Subject|2|||
125600831|NCT00375934|451824808|FG000|Overall Study|Lack of Efficacy|0|||
125600832|NCT00375934|451824809|FG001|Overall Study|Lack of Efficacy|2|||
125600833|NCT00375934|451824808|FG000|Overall Study|Physician Decision|0|||
125600834|NCT00375934|451824809|FG001|Overall Study|Physician Decision|1|||
125600835|NCT00893113|451824810|FG000|Overall Study|Lost to Follow-up|4|||
125600836|NCT00893113|451824811|FG001|Overall Study|Lost to Follow-up|8|||
125600837|NCT00893113|451824810|FG000|Overall Study|Early Termination|1|||
125600838|NCT00893113|451824811|FG001|Overall Study|Early Termination|1|||
125600839|NCT00893113|451824810|FG000|Overall Study|Withdrew Consent|8|||
125600840|NCT00893113|451824811|FG001|Overall Study|Withdrew Consent|7|||
125600841|NCT02400346|451824818|FG000|Overall Study|Adverse Event|24|||
125600842|NCT02400346|451824818|FG000|Overall Study|Lack of Efficacy|9|||
125600843|NCT02400346|451824818|FG000|Overall Study|Non-compliance with IMP|1|||
125600844|NCT02400346|451824818|FG000|Overall Study|Withdrawal by Subject|7|||
125600845|NCT02400346|451824818|FG000|Overall Study|Administrative or other reason(s)|2|||
125600846|NCT02400346|451824818|FG000|Overall Study|Lost to Follow-up|1|||
125600847|NCT01269125|451824819|FG000|Overall Study|Adverse Event|3|||
125600848|NCT01269125|451824820|FG001|Overall Study|Adverse Event|5|||
125600849|NCT01269125|451824821|FG002|Overall Study|Adverse Event|0|||
125600850|NCT01269125|451824819|FG000|Overall Study|Lost to Follow-up|4|||
125600851|NCT01269125|451824820|FG001|Overall Study|Lost to Follow-up|0|||
125600852|NCT01269125|451824821|FG002|Overall Study|Lost to Follow-up|0|||
125600853|NCT01283581|451824822|FG000|Overall Study|Lost to Follow-up|8|||
125600854|NCT01283581|451824823|FG001|Overall Study|Lost to Follow-up|6|||
125600855|NCT01283581|451824824|FG002|Overall Study|Lost to Follow-up|8|||
125600856|NCT01283581|451824822|FG000|Overall Study|Withdrawal by Subject|2|||
125600857|NCT01283581|451824823|FG001|Overall Study|Withdrawal by Subject|5|||
125600858|NCT01283581|451824824|FG002|Overall Study|Withdrawal by Subject|2|||
125600859|NCT01283581|451824822|FG000|Overall Study|Adverse Event|1|||
125600860|NCT01283581|451824823|FG001|Overall Study|Adverse Event|1|||
125600861|NCT01283581|451824824|FG002|Overall Study|Adverse Event|4|||
125600862|NCT01283581|451824822|FG000|Overall Study|Physician Decision|0|||
125600863|NCT01283581|451824823|FG001|Overall Study|Physician Decision|1|||
125600864|NCT01283581|451824824|FG002|Overall Study|Physician Decision|2|||
125600865|NCT01283581|451824822|FG000|Overall Study|Protocol Violation|0|||
125600866|NCT01283581|451824823|FG001|Overall Study|Protocol Violation|1|||
125600867|NCT01283581|451824824|FG002|Overall Study|Protocol Violation|2|||
125600868|NCT01283581|451824822|FG000|Overall Study|Noncompliance|1|||
125600869|NCT01283581|451824823|FG001|Overall Study|Noncompliance|0|||
125600870|NCT01283581|451824824|FG002|Overall Study|Noncompliance|0|||
125600871|NCT01283581|451824822|FG000|Overall Study|Investigator unblinded|0|||
125600872|NCT01283581|451824823|FG001|Overall Study|Investigator unblinded|0|||
125600873|NCT01283581|451824824|FG002|Overall Study|Investigator unblinded|1|||
125600874|NCT01283581|451824822|FG000|Overall Study|"Early termination"|0|||
125600875|NCT01283581|451824823|FG001|Overall Study|"Early termination"|0|||
125600876|NCT01283581|451824824|FG002|Overall Study|"Early termination"|1|||
125600877|NCT00486226|451824825|FG000|Overall Study|Death|3|||
125600878|NCT00486226|451824825|FG000|Overall Study|Adverse Event|1|||
125600879|NCT00486226|451824825|FG000|Overall Study|Withdrawal by Subject|1|||
125600880|NCT00486226|451824825|FG000|Overall Study|Lost to Follow-up|8|||
125600881|NCT01259492|451824826|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
125600882|NCT01259492|451824827|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
125600883|NCT01259492|451824828|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
125600884|NCT01259492|451824829|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
125600885|NCT01259492|451824826|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
125600886|NCT01259492|451824827|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
125600887|NCT01259492|451824828|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
125600888|NCT01259492|451824829|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
125600889|NCT01259492|451824826|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
125600890|NCT01259492|451824827|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
125600891|NCT01259492|451824828|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
125600892|NCT01259492|451824829|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
125600893|NCT01259492|451824826|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
125600894|NCT01259492|451824827|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
125600895|NCT01259492|451824828|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
125369251|NCT01847274|450984863|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125369252|NCT01847274|450984864|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125369253|NCT01847274|450984865|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125369254|NCT01847274|450984866|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125369255|NCT01847274|450984867|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
125600896|NCT01259492|451824829|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
125600897|NCT01259492|451824826|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
125600898|NCT01259492|451824827|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
125600899|NCT01259492|451824828|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
125600900|NCT01259492|451824829|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
125600901|NCT01259492|451824826|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
125600902|NCT01259492|451824827|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
125600903|NCT01259492|451824828|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
125600904|NCT01259492|451824829|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
125600905|NCT01259492|451824826|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
125600906|NCT01259492|451824827|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
125600907|NCT01259492|451824828|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
125600908|NCT01259492|451824829|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
125600909|NCT01259492|451824826|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
125600910|NCT01259492|451824827|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
125600911|NCT01259492|451824828|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
125600912|NCT01259492|451824829|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
125600913|NCT01259492|451824826|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
125600914|NCT01259492|451824827|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
125600915|NCT01259492|451824828|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
125600916|NCT01259492|451824829|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
125600917|NCT01259492|451824826|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
125600918|NCT01259492|451824827|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
125600919|NCT01259492|451824828|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
125600920|NCT01259492|451824829|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
125600921|NCT01259492|451824826|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
125600922|NCT01259492|451824827|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
125600923|NCT01259492|451824828|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
125600924|NCT01259492|451824829|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
125600925|NCT01259492|451824826|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
125600926|NCT01259492|451824827|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
125600927|NCT01259492|451824828|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
125600928|NCT01259492|451824829|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
125600929|NCT01259492|451824826|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
125600930|NCT01259492|451824827|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
125600931|NCT01259492|451824828|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
125600932|NCT01259492|451824829|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
125600933|NCT01259492|451824826|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
125600934|NCT01259492|451824827|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
125600935|NCT01259492|451824828|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
125600936|NCT01259492|451824829|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
125600937|NCT01259492|451824826|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
125600938|NCT01259492|451824827|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
125600939|NCT01259492|451824828|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
125600940|NCT01259492|451824829|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
125600941|NCT01259492|451824826|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
125600942|NCT01259492|451824827|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
125600943|NCT01259492|451824828|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
125600944|NCT01259492|451824829|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
125600945|NCT01259492|451824826|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
125600946|NCT01259492|451824827|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
125600947|NCT01259492|451824828|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
125600948|NCT01259492|451824829|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
125600949|NCT01259492|451824826|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
125600950|NCT01259492|451824827|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
125600951|NCT01259492|451824828|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
125600952|NCT01259492|451824829|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
125600953|NCT01259492|451824826|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
125600954|NCT01259492|451824827|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
125600955|NCT01259492|451824828|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
125600956|NCT01259492|451824829|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
125600957|NCT01259492|451824826|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
125600958|NCT01259492|451824827|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
125600959|NCT01259492|451824828|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
125600960|NCT01259492|451824829|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
125600961|NCT01166659|451824838|FG000|Overall Study|Subject Decision|8|||
125600962|NCT01166659|451824838|FG000|Overall Study|Investigator Decision|2|||
125600963|NCT01166659|451824838|FG000|Overall Study|Death|1|||
125600964|NCT01166659|451824838|FG000|Overall Study|Lost to Follow-up|1|||
125600965|NCT01166659|451824838|FG000|Overall Study|Study Closed at Site|1|||
125600966|NCT01371838|451824857|FG000|Overall Study|Withdrawal by Subject|27|||
125600967|NCT01371838|451824858|FG001|Overall Study|Withdrawal by Subject|33|||
125600968|NCT01371838|451824857|FG000|Overall Study|Lost to Follow-up|10|||
125600969|NCT01371838|451824858|FG001|Overall Study|Lost to Follow-up|20|||
125600970|NCT01371838|451824857|FG000|Overall Study|Death|3|||
125600971|NCT01371838|451824858|FG001|Overall Study|Death|4|||
125600972|NCT01371838|451824857|FG000|Overall Study|Protocol Violation|3|||
125600973|NCT01371838|451824858|FG001|Overall Study|Protocol Violation|0|||
125600974|NCT01371838|451824857|FG000|Overall Study|Investigator Decision|3|||
125600975|NCT01371838|451824858|FG001|Overall Study|Investigator Decision|8|||
125600976|NCT01371838|451824857|FG000|Overall Study|Last follow-up visit not conducted|2|||
125600977|NCT01371838|451824858|FG001|Overall Study|Last follow-up visit not conducted|0|||
125369256|NCT01847274|450984868|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
125369257|NCT01847274|450984869|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
125369258|NCT01847274|450984870|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
125369259|NCT01847274|450984871|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
125369260|NCT01847274|450984861|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125369261|NCT01847274|450984862|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125369262|NCT01847274|450984863|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125369263|NCT01847274|450984864|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125369264|NCT01847274|450984865|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125600978|NCT01371838|451824857|FG000|Overall Study|Lack of therapeutic response|0|||
125600979|NCT01371838|451824858|FG001|Overall Study|Lack of therapeutic response|1|||
125600980|NCT01371838|451824857|FG000|Overall Study|Surgery|1|||
125600981|NCT01371838|451824858|FG001|Overall Study|Surgery|0|||
125600982|NCT01334125|451824859|FG000|Overall Study|Lost to Follow-up|3|||
125600983|NCT01334125|451824860|FG001|Overall Study|Lost to Follow-up|3|||
125600984|NCT00641043|451824867|FG000|Overall Study|Adverse Event|6|||
125600985|NCT00641043|451824868|FG001|Overall Study|Adverse Event|4|||
125600986|NCT00641043|451824867|FG000|Overall Study|Protocol Violation|2|||
125600987|NCT00641043|451824868|FG001|Overall Study|Protocol Violation|3|||
125600988|NCT00641043|451824867|FG000|Overall Study|Lost to Follow-up|3|||
125600989|NCT00641043|451824868|FG001|Overall Study|Lost to Follow-up|2|||
125600990|NCT00641043|451824867|FG000|Overall Study|Withdrawal by Subject|4|||
125600991|NCT00641043|451824868|FG001|Overall Study|Withdrawal by Subject|4|||
125600992|NCT00641043|451824867|FG000|Overall Study|Other incl. lack of efficacy|4|||
125600993|NCT00641043|451824868|FG001|Overall Study|Other incl. lack of efficacy|2|||
125600994|NCT02584634|451824869|FG000|Overall Study|Adverse Event|3|||
125600995|NCT02584634|451824870|FG001|Overall Study|Adverse Event|5|||
125600996|NCT02584634|451824869|FG000|Overall Study|Death|0|||
125600997|NCT02584634|451824870|FG001|Overall Study|Death|1|||
125600998|NCT02584634|451824869|FG000|Overall Study|Lost to Follow-up|0|||
125600999|NCT02584634|451824870|FG001|Overall Study|Lost to Follow-up|1|||
125601000|NCT02584634|451824869|FG000|Overall Study|Physician Decision|1|||
125601001|NCT02584634|451824870|FG001|Overall Study|Physician Decision|2|||
125601002|NCT02584634|451824869|FG000|Overall Study|Progressive disease|7|||
125601003|NCT02584634|451824870|FG001|Overall Study|Progressive disease|15|||
125601004|NCT02584634|451824869|FG000|Overall Study|Withdrawal by Subject|1|||
125601005|NCT02584634|451824870|FG001|Overall Study|Withdrawal by Subject|1|||
125601006|NCT02584634|451824869|FG000|Overall Study|Other|0|||
125601007|NCT02584634|451824870|FG001|Overall Study|Other|6|||
125601008|NCT04275310|451824871|FG000|Overall Study|Non-randomized due to running out of funding|4|||
125601009|NCT04275310|451824872|FG001|Overall Study|Non-randomized due to running out of funding|0|||
125601010|NCT03088605|451824873|FG000|Overall Study|Withdrawal by Subject|1|||
125601011|NCT03088605|451824874|FG001|Overall Study|Withdrawal by Subject|0|||
125601012|NCT00891657|451824884|FG000|Overall Study|Withdrawal by Subject|1|||
125601013|NCT00891657|451824885|FG001|Overall Study|Withdrawal by Subject|1|||
125601014|NCT02927171|451824888|FG000|Overall Study|Lost to Follow-up|0|||
125601015|NCT02927171|451824889|FG001|Overall Study|Lost to Follow-up|1|||
125601016|NCT04530825|451824892|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
125601017|NCT04530825|451824893|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
125431673|NCT01490125|451207714|FG004|Period II|Lost to Follow-up|0|||
125601018|NCT04530825|451824894|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
125601019|NCT04530825|451824895|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
125601020|NCT04530825|451824892|FG000|Overall Study|Did not complete follow-up|3|||
125601021|NCT04530825|451824893|FG001|Overall Study|Did not complete follow-up|0|||
125601022|NCT04530825|451824894|FG002|Overall Study|Did not complete follow-up|0|||
125601023|NCT04530825|451824895|FG003|Overall Study|Did not complete follow-up|0|||
125601024|NCT01720667|451824897|FG000|Overall Study|Adverse Event|1|||
125601025|NCT01720667|451824898|FG001|Overall Study|Adverse Event|1|||
125601026|NCT01720667|451824897|FG000|Overall Study|Withdrawal by Subject|3|||
125601027|NCT01720667|451824898|FG001|Overall Study|Withdrawal by Subject|0|||
125601028|NCT01319929|451824899|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
125601029|NCT01319929|451824900|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
125601030|NCT01319929|451824899|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
125601031|NCT01319929|451824900|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
125601032|NCT01319929|451824899|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
125601033|NCT01319929|451824900|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
125601034|NCT01319929|451824899|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
125601035|NCT01319929|451824900|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
125601036|NCT01319929|451824899|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
125601037|NCT01319929|451824900|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
125601038|NCT01749735|451824902|FG000|Overall Study|Withdrawal by Subject|1|||
125601039|NCT01749735|451824903|FG001|Overall Study|Withdrawal by Subject|0|||
125601040|NCT01221233|451824904|FG000|Overall Study|Withdrawal by Subject|3|||
125601041|NCT01221233|451824905|FG001|Overall Study|Withdrawal by Subject|1|||
125601042|NCT00611455|451824908|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
125601043|NCT00611455|451824909|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
125601044|NCT00611455|451824910|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125601045|NCT00611455|451824908|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
125601046|NCT00611455|451824909|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
125601047|NCT00611455|451824910|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
125601048|NCT00611455|451824908|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
125601049|NCT00611455|451824909|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
125601050|NCT00611455|451824910|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125601051|NCT00611455|451824908|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
125601052|NCT00611455|451824909|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
125601053|NCT00611455|451824910|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125601054|NCT00611455|451824908|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
125601055|NCT00611455|451824909|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
125601056|NCT00611455|451824910|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
125601057|NCT00611455|451824908|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
125601058|NCT00611455|451824909|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
125601059|NCT00611455|451824910|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
125601060|NCT00611455|451824908|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
125601061|NCT00611455|451824909|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
125601062|NCT00611455|451824910|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
125601063|NCT00611455|451824908|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
125601064|NCT00611455|451824909|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
125601065|NCT00611455|451824910|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
125601066|NCT00611455|451824908|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
125601067|NCT00611455|451824909|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
125601068|NCT00611455|451824910|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
125601069|NCT00611455|451824908|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
125601070|NCT00611455|451824909|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
125601071|NCT00611455|451824910|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
125601072|NCT00611455|451824908|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
125601073|NCT00611455|451824909|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
125601074|NCT00611455|451824910|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
125601075|NCT00611455|451824908|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
125601076|NCT00611455|451824909|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
125601077|NCT00611455|451824910|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
125601078|NCT00611455|451824908|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
125601079|NCT00611455|451824909|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
125601080|NCT00611455|451824910|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
125601081|NCT00611455|451824908|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
125601082|NCT00611455|451824909|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
125601083|NCT00611455|451824910|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
125601084|NCT00611455|451824908|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
125601085|NCT00611455|451824909|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
125601086|NCT00611455|451824910|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
125601087|NCT00611455|451824908|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
125369265|NCT01847274|450984866|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125369266|NCT01847274|450984867|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125369267|NCT01847274|450984868|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
125369268|NCT01847274|450984869|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125369269|NCT01847274|450984870|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
125601088|NCT00611455|451824909|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
125601089|NCT00611455|451824910|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
125601090|NCT00611455|451824908|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
125601091|NCT00611455|451824909|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
125601092|NCT00611455|451824910|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
125601093|NCT00611455|451824908|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
125601094|NCT00611455|451824909|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
125601095|NCT00611455|451824910|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
125601096|NCT00611455|451824908|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
125601097|NCT00611455|451824909|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
125601098|NCT00611455|451824910|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
125601099|NCT00611455|451824908|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
125601100|NCT00611455|451824909|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
125601101|NCT00611455|451824910|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
125601102|NCT00611455|451824908|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
125601103|NCT00611455|451824909|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
125601104|NCT00611455|451824910|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
125601105|NCT00858702|451824913|FG000|Overall Study|Lack of Efficacy|1|||
125601106|NCT00858702|451824914|FG001|Overall Study|Lack of Efficacy|0|||
125601107|NCT00858702|451824913|FG000|Overall Study|Protocol Violation|1|||
125601108|NCT00858702|451824914|FG001|Overall Study|Protocol Violation|1|||
125601109|NCT00858702|451824913|FG000|Overall Study|Other|2|||
125601110|NCT00858702|451824914|FG001|Overall Study|Other|1|||
125601111|NCT00858702|451824913|FG000|Overall Study|Withdrawal by Subject|1|||
125601112|NCT00858702|451824914|FG001|Overall Study|Withdrawal by Subject|0|||
125601113|NCT00491530|451824915|FG000|Overall Study|Adverse Event|6|||
125601114|NCT00491530|451824916|FG001|Overall Study|Adverse Event|1|||
125601115|NCT00491530|451824917|FG002|Overall Study|Adverse Event|2|||
125601116|NCT00491530|451824915|FG000|Overall Study|Withdrawal by Subject|3|||
125601117|NCT00491530|451824916|FG001|Overall Study|Withdrawal by Subject|0|||
125601118|NCT00491530|451824917|FG002|Overall Study|Withdrawal by Subject|0|||
125601119|NCT00491530|451824915|FG000|Overall Study|Lost to Follow-up|3|||
125601120|NCT00491530|451824916|FG001|Overall Study|Lost to Follow-up|2|||
125601121|NCT00491530|451824917|FG002|Overall Study|Lost to Follow-up|2|||
125601122|NCT00491530|451824915|FG000|Overall Study|Lack of Efficacy|0|||
125601123|NCT00491530|451824916|FG001|Overall Study|Lack of Efficacy|1|||
125601124|NCT00491530|451824917|FG002|Overall Study|Lack of Efficacy|0|||
125601125|NCT00491530|451824915|FG000|Overall Study|Investigator Discretion|0|||
125601126|NCT00491530|451824916|FG001|Overall Study|Investigator Discretion|1|||
125601127|NCT00491530|451824917|FG002|Overall Study|Investigator Discretion|0|||
125601128|NCT00491530|451824915|FG000|Overall Study|Patient Request|0|||
125601129|NCT00491530|451824916|FG001|Overall Study|Patient Request|1|||
125601130|NCT00491530|451824917|FG002|Overall Study|Patient Request|0|||
125601131|NCT00491530|451824915|FG000|Overall Study|Use of Prohibited Medication|0|||
125601132|NCT00491530|451824916|FG001|Overall Study|Use of Prohibited Medication|0|||
125601133|NCT00491530|451824917|FG002|Overall Study|Use of Prohibited Medication|1|||
125601134|NCT03671369|451824920|FG000|Overall Study|Other|1|||
125601135|NCT03671369|451824920|FG000|Overall Study|Withdrawal by Subject|289|||
125601136|NCT03671369|451824920|FG000|Overall Study|Not willing to be vaccinated|1|||
125601137|NCT02732912|451824921|FG000|Overall Study|Discharged before night|2|||
125601138|NCT02732912|451824922|FG001|Overall Study|Discharged before night|6|||
125601139|NCT02732912|451824921|FG000|Overall Study|Incomplete completion of questionnaire|2|||
125601140|NCT02732912|451824922|FG001|Overall Study|Incomplete completion of questionnaire|3|||
125601141|NCT02732912|451824921|FG000|Overall Study|No outcome; discharged or refused|6|||
125601142|NCT02732912|451824922|FG001|Overall Study|No outcome; discharged or refused|9|||
125601143|NCT04382651|451824923|FG000|Overall Study|Death|26|||
125601144|NCT04382651|451824924|FG001|Overall Study|Death|23|||
125601145|NCT04382651|451824923|FG000|Overall Study|Lost to Follow-up|3|||
125601146|NCT04382651|451824924|FG001|Overall Study|Lost to Follow-up|4|||
125601147|NCT04382651|451824923|FG000|Overall Study|Withdrawal by Subject|2|||
125601148|NCT04382651|451824924|FG001|Overall Study|Withdrawal by Subject|0|||
125601149|NCT04382651|451824923|FG000|Overall Study|Physician Decision|0|||
125601150|NCT04382651|451824924|FG001|Overall Study|Physician Decision|1|||
125601151|NCT01873742|451824925|FG000|Overall Study|Lost to Follow-up|68|||
125601152|NCT01873742|451824926|FG001|Overall Study|Lost to Follow-up|76|||
125601153|NCT00790296|451824928|FG000|Overall Study|Did not meet study eligibility criteria|1|||
125601154|NCT00790296|451824929|FG001|Overall Study|Did not meet study eligibility criteria|1|||
125601155|NCT00790296|451824928|FG000|Overall Study|Adverse Event|0|||
125601156|NCT00790296|451824929|FG001|Overall Study|Adverse Event|1|||
125601157|NCT01671488|451824930|FG000|Overall Study|Withdrawal by Subject|1|||
125601158|NCT02612077|451824931|FG000|Overall Study|Adverse Event|3|||
125601159|NCT02612077|451824931|FG000|Overall Study|Withdrawal by Subject|9|||
125601160|NCT02612077|451824931|FG000|Overall Study|Protocol Violation|28|||
125601161|NCT02612077|451824931|FG000|Overall Study|Lost to Follow-up|20|||
125601162|NCT02612077|451824931|FG000|Overall Study|Death|377|||
125601163|NCT02612077|451824931|FG000|Overall Study|Moved or Changed Medical Team|23|||
125601164|NCT02612077|451824931|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
125601165|NCT02612077|451824931|FG000|Overall Study|Disease Progression|3|||
125601166|NCT02612077|451824931|FG000|Overall Study|Unknown reason|2|||
125601167|NCT01022853|451824932|FG000|Overall Study|Progressive disease|2|||
125601168|NCT01022853|451824933|FG001|Overall Study|Progressive disease|3|||
125601169|NCT01022853|451824934|FG002|Overall Study|Progressive disease|11|||
125601170|NCT01022853|451824935|FG003|Overall Study|Progressive disease|7|||
125601171|NCT01022853|451824936|FG004|Overall Study|Progressive disease|1|||
125601172|NCT01022853|451824932|FG000|Overall Study|Dose-limiting toxicity|0|||
125601173|NCT01022853|451824933|FG001|Overall Study|Dose-limiting toxicity|0|||
125601174|NCT01022853|451824934|FG002|Overall Study|Dose-limiting toxicity|0|||
125601175|NCT01022853|451824935|FG003|Overall Study|Dose-limiting toxicity|0|||
125601176|NCT01022853|451824936|FG004|Overall Study|Dose-limiting toxicity|1|||
125431674|NCT01490125|451207715|FG005|Period II|Lost to Follow-up|0|||
125431675|NCT01490125|451207710|FG000|Period II|Withdrawal by Subject|1|||
125431676|NCT01490125|451207711|FG001|Period II|Withdrawal by Subject|0|||
125431677|NCT01490125|451207712|FG002|Period II|Withdrawal by Subject|0|||
125431678|NCT01490125|451207713|FG003|Period II|Withdrawal by Subject|0|||
125431679|NCT01490125|451207714|FG004|Period II|Withdrawal by Subject|0|||
125431680|NCT01490125|451207715|FG005|Period II|Withdrawal by Subject|0|||
125431681|NCT01490125|451207710|FG000|Period III|Adverse Event|3|||
125431682|NCT01490125|451207711|FG001|Period III|Adverse Event|1|||
125601177|NCT01022853|451824932|FG000|Overall Study|Withdrawal by Subject|0|||
125601178|NCT01022853|451824933|FG001|Overall Study|Withdrawal by Subject|1|||
125601179|NCT01022853|451824934|FG002|Overall Study|Withdrawal by Subject|1|||
125601180|NCT01022853|451824935|FG003|Overall Study|Withdrawal by Subject|1|||
125601181|NCT01022853|451824936|FG004|Overall Study|Withdrawal by Subject|0|||
125601182|NCT01022853|451824932|FG000|Overall Study|Other not stated above|1|||
125601183|NCT01022853|451824933|FG001|Overall Study|Other not stated above|0|||
125601184|NCT01022853|451824934|FG002|Overall Study|Other not stated above|1|||
125601185|NCT01022853|451824935|FG003|Overall Study|Other not stated above|0|||
125601186|NCT01022853|451824936|FG004|Overall Study|Other not stated above|0|||
125601187|NCT01753518|451824937|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
125601188|NCT01753518|451824938|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
125601189|NCT01753518|451824937|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
125601190|NCT01753518|451824938|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
125601191|NCT01753518|451824937|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
125601192|NCT01753518|451824938|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
125601193|NCT01753518|451824937|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
125601194|NCT01753518|451824938|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
125601195|NCT01971476|451824939|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
125601196|NCT01971476|451824940|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
125601197|NCT01971476|451824941|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
125601198|NCT01971476|451824939|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
125601199|NCT01971476|451824940|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
125601200|NCT01971476|451824941|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
125601201|NCT01971476|451824939|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
125601202|NCT01971476|451824940|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
125601203|NCT01971476|451824941|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
125601204|NCT02075255|451824942|FG000|Overall Study|Study specific withdrawal criteria|0|||
125601205|NCT02075255|451824943|FG001|Overall Study|Study specific withdrawal criteria|1|||
125601206|NCT02075255|451824944|FG002|Overall Study|Study specific withdrawal criteria|1|||
125601207|NCT02075255|451824942|FG000|Overall Study|Withdrawal by Subject|4|||
125601208|NCT02075255|451824943|FG001|Overall Study|Withdrawal by Subject|1|||
125601209|NCT02075255|451824944|FG002|Overall Study|Withdrawal by Subject|0|||
125431683|NCT01490125|451207712|FG002|Period III|Adverse Event|0|||
125431684|NCT01490125|451207713|FG003|Period III|Adverse Event|1|||
125431685|NCT01490125|451207714|FG004|Period III|Adverse Event|0|||
125369270|NCT01847274|450984871|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
125369271|NCT01847274|450984861|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125601210|NCT02075255|451824942|FG000|Overall Study|Lost to Follow-up|0|||
125601211|NCT02075255|451824943|FG001|Overall Study|Lost to Follow-up|0|||
125601212|NCT02075255|451824944|FG002|Overall Study|Lost to Follow-up|1|||
125601213|NCT02075255|451824942|FG000|Overall Study|Adverse Event|0|||
125601214|NCT02075255|451824943|FG001|Overall Study|Adverse Event|0|||
125601215|NCT02075255|451824944|FG002|Overall Study|Adverse Event|1|||
125601216|NCT02075255|451824942|FG000|Overall Study|Death|0|||
125601217|NCT02075255|451824943|FG001|Overall Study|Death|2|||
125601218|NCT02075255|451824944|FG002|Overall Study|Death|0|||
125601219|NCT03503773|451824945|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
125601220|NCT03503773|451824946|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
125601221|NCT03503773|451824945|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
125601222|NCT03503773|451824946|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
125601223|NCT03503773|451824945|FG000|Overall Study|Not completing the primary ABPM|3|||
125601224|NCT03503773|451824946|FG001|Overall Study|Not completing the primary ABPM|1|||
125601225|NCT03503773|451824945|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
125601226|NCT03503773|451824946|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
125601227|NCT02675517|451824949|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
125601228|NCT02675517|451824949|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
125601229|NCT00425438|451824950|FG000|Overall Study|Termination by Sponsor|25|||
125601230|NCT00425438|451824951|FG001|Overall Study|Termination by Sponsor|27|||
125601231|NCT02619253|451824952|FG000|Overall Study|Adverse Event|0|||
125601232|NCT02619253|451824953|FG001|Overall Study|Adverse Event|0|||
125601233|NCT02619253|451824954|FG002|Overall Study|Adverse Event|1|||
125601234|NCT02619253|451824955|FG003|Overall Study|Adverse Event|1|||
125601235|NCT02619253|451824956|FG004|Overall Study|Adverse Event|3|||
125601236|NCT02619253|451824952|FG000|Overall Study|Alternative Therapy|0|||
125601237|NCT02619253|451824953|FG001|Overall Study|Alternative Therapy|0|||
125601238|NCT02619253|451824954|FG002|Overall Study|Alternative Therapy|1|||
125601239|NCT02619253|451824955|FG003|Overall Study|Alternative Therapy|0|||
125601240|NCT02619253|451824956|FG004|Overall Study|Alternative Therapy|0|||
125601241|NCT02619253|451824952|FG000|Overall Study|Death|0|||
125601242|NCT02619253|451824953|FG001|Overall Study|Death|0|||
125601243|NCT02619253|451824954|FG002|Overall Study|Death|0|||
125601244|NCT02619253|451824955|FG003|Overall Study|Death|1|||
125601245|NCT02619253|451824956|FG004|Overall Study|Death|0|||
125601246|NCT02619253|451824952|FG000|Overall Study|Disease Progression|4|||
125601247|NCT02619253|451824953|FG001|Overall Study|Disease Progression|2|||
125601248|NCT02619253|451824954|FG002|Overall Study|Disease Progression|8|||
125601249|NCT02619253|451824955|FG003|Overall Study|Disease Progression|9|||
125601250|NCT02619253|451824956|FG004|Overall Study|Disease Progression|10|||
125601251|NCT02619253|451824952|FG000|Overall Study|Needed a disqualifying therapy|0|||
125601252|NCT02619253|451824953|FG001|Overall Study|Needed a disqualifying therapy|0|||
125601253|NCT02619253|451824954|FG002|Overall Study|Needed a disqualifying therapy|1|||
125601254|NCT02619253|451824955|FG003|Overall Study|Needed a disqualifying therapy|0|||
125601255|NCT02619253|451824956|FG004|Overall Study|Needed a disqualifying therapy|0|||
125601256|NCT02619253|451824952|FG000|Overall Study|Transferred to hospice|0|||
125601257|NCT02619253|451824953|FG001|Overall Study|Transferred to hospice|0|||
125601258|NCT02619253|451824954|FG002|Overall Study|Transferred to hospice|1|||
125601259|NCT02619253|451824955|FG003|Overall Study|Transferred to hospice|0|||
125601260|NCT02619253|451824956|FG004|Overall Study|Transferred to hospice|0|||
125601261|NCT02619253|451824952|FG000|Overall Study|Physician Decision|0|||
125601262|NCT02619253|451824953|FG001|Overall Study|Physician Decision|1|||
125601263|NCT02619253|451824954|FG002|Overall Study|Physician Decision|2|||
125601264|NCT02619253|451824955|FG003|Overall Study|Physician Decision|3|||
125601265|NCT02619253|451824956|FG004|Overall Study|Physician Decision|0|||
125601266|NCT02619253|451824952|FG000|Overall Study|Withdrawal by Subject|0|||
125601267|NCT02619253|451824953|FG001|Overall Study|Withdrawal by Subject|1|||
125601268|NCT02619253|451824954|FG002|Overall Study|Withdrawal by Subject|0|||
125601269|NCT02619253|451824955|FG003|Overall Study|Withdrawal by Subject|0|||
125601270|NCT02619253|451824956|FG004|Overall Study|Withdrawal by Subject|2|||
125601271|NCT01208181|451824959|FG000|Part 1|Withdrawal by Subject|11|||
125601272|NCT01208181|451824960|FG001|Part 1|Withdrawal by Subject|10|||
125601273|NCT01208181|451824961|FG002|Part 1|Withdrawal by Subject|0|||
125601274|NCT01208181|451824962|FG003|Part 1|Withdrawal by Subject|0|||
125601275|NCT01208181|451824963|FG004|Part 1|Withdrawal by Subject|0|||
125601276|NCT01208181|451824959|FG000|Part 1|Technical problem|5|||
125601277|NCT01208181|451824960|FG001|Part 1|Technical problem|0|||
125601278|NCT01208181|451824961|FG002|Part 1|Technical problem|0|||
125601279|NCT01208181|451824962|FG003|Part 1|Technical problem|0|||
125369272|NCT01847274|450984862|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125369273|NCT01847274|450984863|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125369274|NCT01847274|450984864|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125369275|NCT01847274|450984865|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125369276|NCT01847274|450984866|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125601280|NCT01208181|451824963|FG004|Part 1|Technical problem|0|||
125601281|NCT01208181|451824959|FG000|Part 1|Protocol Violation|10|||
125601282|NCT01208181|451824960|FG001|Part 1|Protocol Violation|5|||
125601283|NCT01208181|451824961|FG002|Part 1|Protocol Violation|0|||
125601284|NCT01208181|451824962|FG003|Part 1|Protocol Violation|0|||
125601285|NCT01208181|451824963|FG004|Part 1|Protocol Violation|0|||
125601286|NCT01208181|451824959|FG000|Part 1|Physician Decision|4|||
125601287|NCT01208181|451824960|FG001|Part 1|Physician Decision|0|||
125601288|NCT01208181|451824961|FG002|Part 1|Physician Decision|0|||
125601289|NCT01208181|451824962|FG003|Part 1|Physician Decision|0|||
125601290|NCT01208181|451824963|FG004|Part 1|Physician Decision|0|||
125601291|NCT01208181|451824959|FG000|Part 1|Non-compliance with study drug|1|||
125601292|NCT01208181|451824960|FG001|Part 1|Non-compliance with study drug|1|||
125601293|NCT01208181|451824961|FG002|Part 1|Non-compliance with study drug|0|||
125601294|NCT01208181|451824962|FG003|Part 1|Non-compliance with study drug|0|||
125601295|NCT01208181|451824963|FG004|Part 1|Non-compliance with study drug|0|||
125601296|NCT01208181|451824959|FG000|Part 1|Lost to Follow-up|5|||
125601297|NCT01208181|451824960|FG001|Part 1|Lost to Follow-up|3|||
125601298|NCT01208181|451824961|FG002|Part 1|Lost to Follow-up|0|||
125601299|NCT01208181|451824962|FG003|Part 1|Lost to Follow-up|0|||
125601300|NCT01208181|451824963|FG004|Part 1|Lost to Follow-up|1|||
125601301|NCT01208181|451824959|FG000|Part 1|Lack of Efficacy|37|||
125601302|NCT01208181|451824960|FG001|Part 1|Lack of Efficacy|12|||
125601303|NCT01208181|451824961|FG002|Part 1|Lack of Efficacy|0|||
125601304|NCT01208181|451824962|FG003|Part 1|Lack of Efficacy|0|||
125601305|NCT01208181|451824963|FG004|Part 1|Lack of Efficacy|17|||
125601306|NCT01208181|451824959|FG000|Part 1|Adverse Event|26|||
125601307|NCT01208181|451824960|FG001|Part 1|Adverse Event|24|||
125601308|NCT01208181|451824961|FG002|Part 1|Adverse Event|0|||
125601309|NCT01208181|451824962|FG003|Part 1|Adverse Event|0|||
125601310|NCT01208181|451824963|FG004|Part 1|Adverse Event|4|||
125601311|NCT01208181|451824959|FG000|Part 2|Adverse Event|0|||
125601312|NCT01208181|451824960|FG001|Part 2|Adverse Event|0|||
125601313|NCT01208181|451824961|FG002|Part 2|Adverse Event|6|||
125601314|NCT01208181|451824962|FG003|Part 2|Adverse Event|7|||
125601315|NCT01208181|451824963|FG004|Part 2|Adverse Event|0|||
125601316|NCT01208181|451824959|FG000|Part 2|Withdrawal by Subject|0|||
125601317|NCT01208181|451824960|FG001|Part 2|Withdrawal by Subject|0|||
125601318|NCT01208181|451824961|FG002|Part 2|Withdrawal by Subject|1|||
125601319|NCT01208181|451824962|FG003|Part 2|Withdrawal by Subject|1|||
125601320|NCT01208181|451824963|FG004|Part 2|Withdrawal by Subject|0|||
125601321|NCT01208181|451824959|FG000|Part 2|Protocol Violation|0|||
125601322|NCT01208181|451824960|FG001|Part 2|Protocol Violation|0|||
125601323|NCT01208181|451824961|FG002|Part 2|Protocol Violation|1|||
125601324|NCT01208181|451824962|FG003|Part 2|Protocol Violation|0|||
125601325|NCT01208181|451824963|FG004|Part 2|Protocol Violation|0|||
125601326|NCT01208181|451824959|FG000|Part 2|Physician Decision|0|||
125601327|NCT01208181|451824960|FG001|Part 2|Physician Decision|0|||
125601328|NCT01208181|451824961|FG002|Part 2|Physician Decision|1|||
125601329|NCT01208181|451824962|FG003|Part 2|Physician Decision|2|||
125601330|NCT01208181|451824963|FG004|Part 2|Physician Decision|0|||
125601331|NCT01208181|451824959|FG000|Part 2|Non-compliance with study drug|0|||
125601332|NCT01208181|451824960|FG001|Part 2|Non-compliance with study drug|0|||
125601333|NCT01208181|451824961|FG002|Part 2|Non-compliance with study drug|1|||
125601334|NCT01208181|451824962|FG003|Part 2|Non-compliance with study drug|1|||
125601335|NCT01208181|451824963|FG004|Part 2|Non-compliance with study drug|0|||
125601336|NCT01208181|451824959|FG000|Part 2|Lost to Follow-up|0|||
125601337|NCT01208181|451824960|FG001|Part 2|Lost to Follow-up|0|||
125601338|NCT01208181|451824961|FG002|Part 2|Lost to Follow-up|1|||
125601339|NCT01208181|451824962|FG003|Part 2|Lost to Follow-up|2|||
125601340|NCT01208181|451824963|FG004|Part 2|Lost to Follow-up|0|||
125601341|NCT01208181|451824959|FG000|Part 2|Lack of Efficacy|0|||
125601342|NCT01208181|451824960|FG001|Part 2|Lack of Efficacy|0|||
125601343|NCT01208181|451824961|FG002|Part 2|Lack of Efficacy|5|||
125601344|NCT01208181|451824962|FG003|Part 2|Lack of Efficacy|7|||
125601345|NCT01208181|451824963|FG004|Part 2|Lack of Efficacy|0|||
125601346|NCT03694522|451824969|FG000|Overall Study|Withdrawal by Subject|8|||
125601347|NCT03694522|451824970|FG001|Overall Study|Withdrawal by Subject|10|||
125601348|NCT03694522|451824969|FG000|Overall Study|Physician Decision|53|||
125601349|NCT03694522|451824970|FG001|Overall Study|Physician Decision|54|||
125601350|NCT03694522|451824969|FG000|Overall Study|Other|1|||
125601351|NCT03694522|451824970|FG001|Overall Study|Other|1|||
125601352|NCT03694522|451824969|FG000|Overall Study|Lost to Follow-up|0|||
125601353|NCT03694522|451824970|FG001|Overall Study|Lost to Follow-up|1|||
125601354|NCT01748760|451824971|FG000|Overall Study|Withdrawal by Subject|1|||
125601355|NCT01748760|451824972|FG001|Overall Study|Withdrawal by Subject|1|||
125601356|NCT01748760|451824971|FG000|Overall Study|Lost to Follow-up|5|||
125601357|NCT01748760|451824972|FG001|Overall Study|Lost to Follow-up|1|||
125601358|NCT01164501|451824973|FG000|Overall Study|Not treated|2|||
125601359|NCT01164501|451824974|FG001|Overall Study|Not treated|0|||
125601360|NCT01164501|451824975|FG002|Overall Study|Not treated|1|||
125601361|NCT01164501|451824973|FG000|Overall Study|Adverse Event|18|||
125601362|NCT01164501|451824974|FG001|Overall Study|Adverse Event|4|||
125601363|NCT01164501|451824975|FG002|Overall Study|Adverse Event|21|||
125601364|NCT01164501|451824973|FG000|Overall Study|Lack of Efficacy|0|||
125601365|NCT01164501|451824974|FG001|Overall Study|Lack of Efficacy|0|||
125601366|NCT01164501|451824975|FG002|Overall Study|Lack of Efficacy|1|||
125601367|NCT01164501|451824973|FG000|Overall Study|Non compliant with protocol|1|||
125601368|NCT01164501|451824974|FG001|Overall Study|Non compliant with protocol|1|||
125601369|NCT01164501|451824975|FG002|Overall Study|Non compliant with protocol|4|||
125601370|NCT01164501|451824973|FG000|Overall Study|Lost to Follow-up|3|||
125601371|NCT01164501|451824974|FG001|Overall Study|Lost to Follow-up|0|||
125601372|NCT01164501|451824975|FG002|Overall Study|Lost to Follow-up|3|||
125601373|NCT01164501|451824973|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
125601374|NCT01164501|451824974|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
125601375|NCT01164501|451824975|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
125601376|NCT01164501|451824973|FG000|Overall Study|Other reason not defined above|9|||
125601377|NCT01164501|451824974|FG001|Overall Study|Other reason not defined above|1|||
125601378|NCT01164501|451824975|FG002|Overall Study|Other reason not defined above|4|||
125601379|NCT00306891|451824976|FG000|Part A|Withdrawal by Subject|1|||
125601380|NCT00306891|451824977|FG001|Part A|Withdrawal by Subject|1|||
125601381|NCT00306891|451824978|FG002|Part A|Withdrawal by Subject|0|||
125601382|NCT00306891|451824979|FG003|Part A|Withdrawal by Subject|0|||
125601383|NCT00306891|451824976|FG000|Part A|Condition under investigation worsened|2|||
125601384|NCT00306891|451824977|FG001|Part A|Condition under investigation worsened|2|||
125601385|NCT00306891|451824978|FG002|Part A|Condition under investigation worsened|0|||
125601386|NCT00306891|451824979|FG003|Part A|Condition under investigation worsened|0|||
125601387|NCT00306891|451824976|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
125601388|NCT00306891|451824977|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
125601389|NCT00306891|451824978|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
125601390|NCT00306891|451824979|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
125601391|NCT00306891|451824976|FG000|Part A|Partial bowel obstruction|1|||
125601392|NCT00306891|451824977|FG001|Part A|Partial bowel obstruction|0|||
125601393|NCT00306891|451824978|FG002|Part A|Partial bowel obstruction|0|||
125601394|NCT00306891|451824979|FG003|Part A|Partial bowel obstruction|0|||
125601395|NCT00306891|451824976|FG000|Part A|Reaccumul. of ascites following drainage|0|||
125601396|NCT00306891|451824977|FG001|Part A|Reaccumul. of ascites following drainage|1|||
125601397|NCT00306891|451824978|FG002|Part A|Reaccumul. of ascites following drainage|0|||
125601398|NCT00306891|451824979|FG003|Part A|Reaccumul. of ascites following drainage|0|||
125601399|NCT00306891|451824976|FG000|Part A|Suspicion of second malignancy|0|||
125601400|NCT00306891|451824977|FG001|Part A|Suspicion of second malignancy|1|||
125601401|NCT00306891|451824978|FG002|Part A|Suspicion of second malignancy|0|||
125601402|NCT00306891|451824979|FG003|Part A|Suspicion of second malignancy|0|||
125601403|NCT00306891|451824976|FG000|Part A|QTC interval outwith elig. criteria|1|||
125601404|NCT00306891|451824977|FG001|Part A|QTC interval outwith elig. criteria|0|||
125601405|NCT00306891|451824978|FG002|Part A|QTC interval outwith elig. criteria|0|||
125601406|NCT00306891|451824979|FG003|Part A|QTC interval outwith elig. criteria|0|||
125601407|NCT00306891|451824976|FG000|Part B|Death|0|||
125601408|NCT00306891|451824977|FG001|Part B|Death|0|||
125601409|NCT00306891|451824978|FG002|Part B|Death|1|||
125601410|NCT00306891|451824979|FG003|Part B|Death|2|||
125601411|NCT00306891|451824976|FG000|Part B|Adverse Event|0|||
125601412|NCT00306891|451824977|FG001|Part B|Adverse Event|0|||
125601413|NCT00306891|451824978|FG002|Part B|Adverse Event|5|||
125601414|NCT00306891|451824979|FG003|Part B|Adverse Event|5|||
125601415|NCT00306891|451824976|FG000|Part B|Withdrawal by Subject|0|||
125601416|NCT00306891|451824977|FG001|Part B|Withdrawal by Subject|0|||
125601417|NCT00306891|451824978|FG002|Part B|Withdrawal by Subject|3|||
125601418|NCT00306891|451824979|FG003|Part B|Withdrawal by Subject|1|||
125601419|NCT00306891|451824976|FG000|Part B|Condition under investigation worsened|0|||
125601420|NCT00306891|451824977|FG001|Part B|Condition under investigation worsened|0|||
125601421|NCT00306891|451824978|FG002|Part B|Condition under investigation worsened|2|||
125601422|NCT00306891|451824979|FG003|Part B|Condition under investigation worsened|8|||
125601423|NCT00306891|451824976|FG000|Part B|Development of study specific disc crit.|0|||
125601424|NCT00306891|451824977|FG001|Part B|Development of study specific disc crit.|0|||
125601425|NCT00306891|451824978|FG002|Part B|Development of study specific disc crit.|0|||
125601426|NCT00306891|451824979|FG003|Part B|Development of study specific disc crit.|1|||
125601427|NCT00673673|451824980|FG000|Overall Study|Progressive disease|27|||
125601428|NCT00673673|451824980|FG000|Overall Study|Adverse Event|4|||
125601429|NCT00673673|451824980|FG000|Overall Study|Withdrawal by Subject|3|||
125601430|NCT00673673|451824980|FG000|Overall Study|Investigators' discretion|2|||
125212802|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
125601431|NCT01751646|451824981|FG000|Overall Study|Lost to Follow-up|5|||
125601432|NCT01751646|451824982|FG001|Overall Study|Lost to Follow-up|1|||
125601433|NCT01751646|451824981|FG000|Overall Study|Withdrawal by Subject|0|||
125601434|NCT01751646|451824982|FG001|Overall Study|Withdrawal by Subject|4|||
125212803|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
125212804|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
125212805|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
125212806|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
125212807|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
125212808|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
125212809|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
125212810|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
125212811|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
125212812|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
125212813|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
125212814|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
125212815|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
125212816|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
125212817|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
125212818|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
125212819|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
125212820|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
125212821|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
125212822|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
125212823|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
125212824|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
125212825|NCT01026818|450405478|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
125212826|NCT01026818|450405479|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
125212827|NCT01026818|450405480|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
125212828|NCT01026818|450405481|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
125212829|NCT01026818|450405478|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
125212830|NCT01026818|450405479|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
125212831|NCT01026818|450405480|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
125212832|NCT01026818|450405481|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
125212833|NCT01026818|450405478|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
125212834|NCT01026818|450405479|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
125601435|NCT01751646|451824981|FG000|Overall Study|Starting hormone therapy|1|||
125601436|NCT01751646|451824982|FG001|Overall Study|Starting hormone therapy|0|||
125601437|NCT01751646|451824981|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
125601438|NCT01751646|451824982|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
125601439|NCT01751646|451824981|FG000|Overall Study|Inadvertent enrollment|1|||
125601440|NCT01751646|451824982|FG001|Overall Study|Inadvertent enrollment|1|||
125601441|NCT01751646|451824981|FG000|Overall Study|Moved out of the area|1|||
125601442|NCT01751646|451824982|FG001|Overall Study|Moved out of the area|5|||
125601443|NCT01751646|451824981|FG000|Overall Study|Inability to attend required visits|0|||
125601444|NCT01751646|451824982|FG001|Overall Study|Inability to attend required visits|1|||
125601445|NCT01751646|451824981|FG000|Overall Study|Off study due to multiple obligations|0|||
125601446|NCT01751646|451824982|FG001|Overall Study|Off study due to multiple obligations|1|||
125212835|NCT01026818|450405480|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
125212836|NCT01026818|450405481|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
125212837|NCT01026818|450405478|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
125601447|NCT01751646|451824981|FG000|Overall Study|Fails to comply with study requirements|0|||
125601448|NCT01751646|451824982|FG001|Overall Study|Fails to comply with study requirements|1|||
125601449|NCT01751646|451824981|FG000|Overall Study|Childcare issues|1|||
125601450|NCT01751646|451824982|FG001|Overall Study|Childcare issues|1|||
125601451|NCT02335450|451824983|FG000|Overall Study|Pregnancy|1|||
125601452|NCT02613572|451824984|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
125601453|NCT02613572|451824985|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
125601454|NCT02613572|451824986|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
125601455|NCT02613572|451824984|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
125601456|NCT02613572|451824985|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
125601457|NCT02613572|451824986|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
125601458|NCT04542291|451824987|FG000|Overall Study|Adverse Event|1|||
125601459|NCT04542291|451824987|FG000|Overall Study|Physician Decision|2|||
125601460|NCT04538950|451824988|FG000|Overall Study|Pulmonary Issues|2|||
125601461|NCT04538950|451824988|FG000|Overall Study|illness|2|||
125601462|NCT01004146|451824989|FG000|Overall Study|Withdrawal by Subject|4|||
125601463|NCT01004146|451824990|FG001|Overall Study|Withdrawal by Subject|5|||
125601464|NCT00970294|451824993|FG000|Overall Study|Physician Decision|4|||
125601465|NCT00970294|451824993|FG000|Overall Study|Withdrawal by Subject|1|||
125601466|NCT00847561|451824994|FG000|Overall Study|Withdrawal by Subject|4|||
125601467|NCT00847561|451824995|FG001|Overall Study|Withdrawal by Subject|3|||
125601468|NCT00847561|451824994|FG000|Overall Study|Unable to schedule|9|||
125601469|NCT00847561|451824995|FG001|Overall Study|Unable to schedule|1|||
125601470|NCT00408681|451824996|FG000|Overall Study|Lack of Efficacy|2|||
125601471|NCT00408681|451824996|FG000|Overall Study|Adverse Event|7|||
125601472|NCT00447421|451824997|FG000|Overall Study|Lack of Efficacy|1|||
125601473|NCT00447421|451824997|FG000|Overall Study|Adverse Event|3|||
125601474|NCT00447421|451824997|FG000|Overall Study|Sponsor Decision|2|||
125601475|NCT02792777|451824998|FG000|Overall Study|Withdrawal by Subject|2|||
125601476|NCT02792777|451824999|FG001|Overall Study|Withdrawal by Subject|0|||
125601477|NCT02792777|451824998|FG000|Overall Study|Recording malfunction|2|||
125601478|NCT02792777|451824999|FG001|Overall Study|Recording malfunction|0|||
125601479|NCT02792777|451824998|FG000|Overall Study|Later determined to be ineligible|2|||
125601480|NCT02792777|451824999|FG001|Overall Study|Later determined to be ineligible|0|||
125601481|NCT02792777|451824998|FG000|Overall Study|Participant interviewed twice|1|||
125601482|NCT02792777|451824999|FG001|Overall Study|Participant interviewed twice|0|||
125601483|NCT01707147|451825000|FG000|Overall Study|Administered Trajenta prior to contract|5|||
125601484|NCT01707147|451825000|FG000|Overall Study|Patients who have not taken Trajenta|1|||
125601485|NCT01707147|451825000|FG000|Overall Study|Follow-up failure|17|||
125601486|NCT01707147|451825000|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
125601487|NCT01040832|451826499|FG000|Overall Study|Adverse Event|4|||
125601488|NCT01040832|451826500|FG001|Overall Study|Adverse Event|5|||
125601489|NCT01040832|451826499|FG000|Overall Study|Death|4|||
125601490|NCT01040832|451826500|FG001|Overall Study|Death|6|||
125601491|NCT01040832|451826499|FG000|Overall Study|Withdrawal by Subject|2|||
125601492|NCT01040832|451826500|FG001|Overall Study|Withdrawal by Subject|3|||
125601493|NCT01040832|451826499|FG000|Overall Study|Progressive disease|32|||
125601494|NCT01040832|451826500|FG001|Overall Study|Progressive disease|17|||
125601495|NCT01040832|451826499|FG000|Overall Study|Symptomatic deterioration|2|||
125601496|NCT01040832|451826500|FG001|Overall Study|Symptomatic deterioration|5|||
125601497|NCT01040832|451826499|FG000|Overall Study|Other|2|||
125601498|NCT01040832|451826500|FG001|Overall Study|Other|1|||
125601499|NCT01058369|451826506|FG000|Overall Study|Adverse Event|1|||
125601500|NCT01058369|451826506|FG000|Overall Study|Early termination study|1|||
125601501|NCT02940886|451826507|FG000|Overall Study|Adverse Event|7|||
125601502|NCT02940886|451826508|FG001|Overall Study|Adverse Event|3|||
125601503|NCT02940886|451826507|FG000|Overall Study|Protocol Violation|0|||
125601504|NCT02940886|451826508|FG001|Overall Study|Protocol Violation|2|||
125601505|NCT02940886|451826507|FG000|Overall Study|Withdrawal by Subject|28|||
125601506|NCT02940886|451826508|FG001|Overall Study|Withdrawal by Subject|20|||
125601507|NCT02940886|451826507|FG000|Overall Study|Death|1|||
125601508|NCT02940886|451826508|FG001|Overall Study|Death|0|||
125601509|NCT02940886|451826507|FG000|Overall Study|Lack of Efficacy|1|||
125601510|NCT02940886|451826508|FG001|Overall Study|Lack of Efficacy|0|||
125601511|NCT02940886|451826507|FG000|Overall Study|Lost to Follow-up|49|||
125601512|NCT02940886|451826508|FG001|Overall Study|Lost to Follow-up|21|||
125601513|NCT02940886|451826507|FG000|Overall Study|Physician Decision|9|||
125601514|NCT02940886|451826508|FG001|Overall Study|Physician Decision|4|||
125601515|NCT02940886|451826507|FG000|Overall Study|Sponsor decision|0|||
125601516|NCT02940886|451826508|FG001|Overall Study|Sponsor decision|1|||
125601517|NCT02940886|451826507|FG000|Overall Study|No treatment|7|||
125601518|NCT02940886|451826508|FG001|Overall Study|No treatment|2|||
125601519|NCT02940886|451826507|FG000|Overall Study|Enrolment error|0|||
125601520|NCT02940886|451826508|FG001|Overall Study|Enrolment error|1|||
125601521|NCT01306058|451826510|FG000|Overall Study|Death|1|||
125601522|NCT01306058|451826510|FG000|Overall Study|Enrolled but did not get treatment|1|||
125601523|NCT01666444|451826511|FG000|Overall Study|Did not initiate treatment|2|||
125601524|NCT01666444|451826512|FG001|Overall Study|Did not initiate treatment|1|||
125601525|NCT00592358|451826515|FG000|Overall Study|Withdrawal by Subject|2|||
125601526|NCT00592358|451826515|FG000|Overall Study|Adverse Event|1|||
125601527|NCT00592358|451826515|FG000|Overall Study|Lack of Efficacy|2|||
125601528|NCT00592358|451826515|FG000|Overall Study|Inability to swallow pills|1|||
125601529|NCT00084682|451826516|FG000|Overall Study|Withdrawal by Subject|1|||
125601530|NCT03238248|451826524|FG000|Overall Study|Death|5|||
125601531|NCT03238248|451826524|FG000|Overall Study|Withdrawal by Subject|7|||
125601532|NCT03238248|451826524|FG000|Overall Study|Participant proceeding to transplant|10|||
125601533|NCT03238248|451826524|FG000|Overall Study|Lack of Efficacy|4|||
125601534|NCT03238248|451826524|FG000|Overall Study|Physician Decision|3|||
125601535|NCT03238248|451826524|FG000|Overall Study|Transitioning to another study|1|||
125601536|NCT03238248|451826524|FG000|Overall Study|No longer benefiting|1|||
125601537|NCT03238248|451826524|FG000|Overall Study|Other complicating disease|1|||
125601538|NCT03238248|451826524|FG000|Overall Study|Adverse Event|5|||
125601539|NCT03238248|451826524|FG000|Overall Study|Disease progression|26|||
125601540|NCT03238248|451826524|FG000|Overall Study|N/A participant is still on treatment|1|||
125601541|NCT03238248|451826524|FG000|Overall Study|Decline in condition|1|||
125601542|NCT03238248|451826524|FG000|Overall Study|Alternative therapy|2|||
125601543|NCT01013883|451826525|FG000|Overall Study|Lost to Follow-up|2|||
125601544|NCT01013883|451826526|FG001|Overall Study|Lost to Follow-up|2|||
125601545|NCT02241512|451826527|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
125601546|NCT02241512|451826528|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
125601547|NCT00474630|451826529|FG000|Overall Study|Adverse Event|98|||
125601548|NCT00474630|451826530|FG001|Overall Study|Adverse Event|26|||
125601549|NCT00474630|451826529|FG000|Overall Study|Lost to Follow-up|22|||
125601550|NCT00474630|451826530|FG001|Overall Study|Lost to Follow-up|15|||
125601551|NCT00474630|451826529|FG000|Overall Study|Withdrawal by Subject|21|||
125601552|NCT00474630|451826530|FG001|Overall Study|Withdrawal by Subject|15|||
125601553|NCT00474630|451826529|FG000|Overall Study|Protocol Violation|3|||
125601554|NCT00474630|451826530|FG001|Overall Study|Protocol Violation|4|||
125601555|NCT00474630|451826529|FG000|Overall Study|Lack of Efficacy|5|||
125601556|NCT00474630|451826530|FG001|Overall Study|Lack of Efficacy|6|||
125601557|NCT00474630|451826529|FG000|Overall Study|Drug noncompliance, other|11|||
125601558|NCT00474630|451826530|FG001|Overall Study|Drug noncompliance, other|4|||
125601559|NCT02225223|451826531|FG000|Overall Study|Death|10|||
125601560|NCT02225223|451826532|FG001|Overall Study|Death|1|||
125601561|NCT02225223|451826531|FG000|Overall Study|Lost to Follow-up|5|||
125601562|NCT02225223|451826532|FG001|Overall Study|Lost to Follow-up|0|||
125601563|NCT02225223|451826531|FG000|Overall Study|Other|1|||
125601564|NCT02225223|451826532|FG001|Overall Study|Other|2|||
125601565|NCT02225223|451826531|FG000|Overall Study|Physician Decision|1|||
125601566|NCT02225223|451826532|FG001|Overall Study|Physician Decision|0|||
125601567|NCT02225223|451826531|FG000|Overall Study|Withdrawal by Subject|2|||
125601568|NCT02225223|451826532|FG001|Overall Study|Withdrawal by Subject|2|||
125601569|NCT00958568|451826534|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
125601570|NCT00958568|451826535|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
125601571|NCT00958568|451826536|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
125601572|NCT00958568|451826537|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
125601573|NCT00958568|451826534|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
125601574|NCT00958568|451826535|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
125601575|NCT00958568|451826536|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
125601576|NCT00958568|451826537|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
125601577|NCT00958568|451826534|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
125601578|NCT00958568|451826535|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
125601579|NCT00958568|451826536|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
125601580|NCT00958568|451826537|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
125601581|NCT00958568|451826534|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
125601582|NCT00958568|451826535|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
125601583|NCT00958568|451826536|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
125601584|NCT00958568|451826537|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
125601585|NCT00958568|451826534|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
125601586|NCT00958568|451826535|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
125601587|NCT00958568|451826536|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
125601588|NCT00958568|451826537|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
125601589|NCT00958568|451826534|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
125601590|NCT00958568|451826535|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
125601591|NCT00958568|451826536|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
125601592|NCT00958568|451826537|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
125601593|NCT00958568|451826534|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
125601594|NCT00958568|451826535|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
125601595|NCT00958568|451826536|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
125601596|NCT00958568|451826537|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
125601597|NCT00958568|451826534|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
125601598|NCT00958568|451826535|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
125601599|NCT00958568|451826536|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
125601600|NCT00958568|451826537|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
125601601|NCT00958568|451826534|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
125601602|NCT00958568|451826535|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
125601603|NCT00958568|451826536|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
125601604|NCT00958568|451826537|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
125601605|NCT00958568|451826534|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
125601606|NCT00958568|451826535|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
125601607|NCT00958568|451826536|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
125601608|NCT00958568|451826537|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
125601609|NCT00958568|451826534|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
125601610|NCT00958568|451826535|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
125601611|NCT00958568|451826536|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
125601612|NCT00958568|451826537|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
125601613|NCT00958568|451826534|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
125601614|NCT00958568|451826535|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
125601615|NCT00958568|451826536|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
125601616|NCT00958568|451826537|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
125601617|NCT00958568|451826534|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
125601618|NCT00958568|451826535|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
125601619|NCT00958568|451826536|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
125601620|NCT00958568|451826537|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
125601621|NCT00958568|451826534|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
125601622|NCT00958568|451826535|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
125601623|NCT00958568|451826536|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
125369277|NCT01847274|450984867|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125369278|NCT01847274|450984868|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
125369279|NCT01847274|450984869|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
125601624|NCT00958568|451826537|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
125601625|NCT00958568|451826534|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
125601626|NCT00958568|451826535|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
125601627|NCT00958568|451826536|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
125601628|NCT00958568|451826537|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
125601629|NCT00958568|451826534|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
125601630|NCT00958568|451826535|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
125601631|NCT00958568|451826536|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
125601632|NCT00958568|451826537|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
125601633|NCT00958568|451826534|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
125601634|NCT00958568|451826535|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
125601635|NCT00958568|451826536|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
125601636|NCT00958568|451826537|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
125601637|NCT00958568|451826534|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
125601638|NCT00958568|451826535|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
125601639|NCT00958568|451826536|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
125601640|NCT00958568|451826537|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
125601641|NCT00958568|451826534|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
125601642|NCT00958568|451826535|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
125601643|NCT00958568|451826536|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
125601644|NCT00958568|451826537|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
125601645|NCT00958568|451826534|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
125601646|NCT00958568|451826535|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
125601647|NCT00958568|451826536|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
125601648|NCT00958568|451826537|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
125601649|NCT00958568|451826534|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
125601650|NCT00958568|451826535|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
125601651|NCT00958568|451826536|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
125601652|NCT00958568|451826537|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
125601653|NCT00958568|451826534|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
125601654|NCT00958568|451826535|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
125601655|NCT00958568|451826536|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
125601656|NCT00958568|451826537|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
125601657|NCT00958568|451826534|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
125601658|NCT00958568|451826535|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
125601659|NCT00958568|451826536|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
125601660|NCT00958568|451826537|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
125601661|NCT00958568|451826534|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
125601662|NCT00958568|451826535|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
125601663|NCT00958568|451826536|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
125601664|NCT00958568|451826537|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
125601665|NCT00958568|451826534|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
125601666|NCT00958568|451826535|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
125431686|NCT01490125|451207715|FG005|Period III|Adverse Event|0|||
125431687|NCT01490125|451207710|FG000|Period III|Death|0|||
125601667|NCT00958568|451826536|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
125601668|NCT00958568|451826537|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
125601669|NCT00958568|451826534|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
125601670|NCT00958568|451826535|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
125601671|NCT00958568|451826536|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
125601672|NCT00958568|451826537|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
125601673|NCT00958568|451826534|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
125601674|NCT00958568|451826535|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
125601675|NCT00958568|451826536|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
125601676|NCT00958568|451826537|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
125601677|NCT00958568|451826534|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
125601678|NCT00958568|451826535|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
125601679|NCT00958568|451826536|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
125601680|NCT00958568|451826537|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
125601681|NCT00958568|451826534|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
125601682|NCT00958568|451826535|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
125601683|NCT00958568|451826536|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
125601684|NCT00958568|451826537|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
125601685|NCT03268746|451826548|FG000|Overall Study|Withdrawal by Subject|1|||
125601686|NCT00850499|451826551|FG000|Overall Study|Adverse Event|3|||
125601687|NCT00850499|451826552|FG001|Overall Study|Adverse Event|1|||
125601688|NCT00850499|451826551|FG000|Overall Study|Lack of Efficacy|0|||
125601689|NCT00850499|451826552|FG001|Overall Study|Lack of Efficacy|1|||
125601690|NCT00909090|451826558|FG000|Overall Study|Lost to Follow-up|17|||
125601691|NCT00909090|451826559|FG001|Overall Study|Lost to Follow-up|17|||
125601692|NCT02345434|451826561|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
125601693|NCT02345434|451826562|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
125601694|NCT01214434|451826569|FG000|Overall Study|Withdrawal by Subject|1|||
125601695|NCT01214434|451826570|FG001|Overall Study|Withdrawal by Subject|0|||
125601696|NCT01214434|451826569|FG000|Overall Study|Lost to Follow-up|2|||
125601697|NCT01214434|451826570|FG001|Overall Study|Lost to Follow-up|2|||
125601698|NCT01214434|451826569|FG000|Overall Study|Site error|1|||
125601699|NCT01214434|451826570|FG001|Overall Study|Site error|0|||
125601700|NCT03792750|451826572|FG000|Overall Study|Death|3|||
125601701|NCT00138151|451826573|FG000|Overall Study|Withdrawal by Subject|3|||
125601702|NCT00138151|451826573|FG000|Overall Study|Physician Decision|1|||
125601703|NCT02902809|451826577|FG000|Overall Study|Discontinuation of asthma program|28|||
125601704|NCT00532259|451826578|FG000|Overall Study|Withdrawal by Subject|2|||
125601705|NCT00532259|451826578|FG000|Overall Study|Adverse Event|1|||
125601706|NCT00532259|451826578|FG000|Overall Study|Death|1|||
125601707|NCT00532259|451826578|FG000|Overall Study|Lack of Efficacy|21|||
125601708|NCT00532259|451826578|FG000|Overall Study|Lost to Follow-up|3|||
125601709|NCT00532259|451826578|FG000|Overall Study|Physician Decision|3|||
125601710|NCT00532259|451826578|FG000|Overall Study|Protocol Violation|1|||
125601711|NCT00793104|451826579|FG000|Overall Study|Lost to Follow-up|1|||
125601712|NCT03494725|451826580|FG000|Overall Study|Withdrawal by Subject|0|||
125601713|NCT03494725|451826581|FG001|Overall Study|Withdrawal by Subject|2|||
125601714|NCT03494725|451826580|FG000|Overall Study|Antibiotic use|1|||
125601715|NCT03494725|451826581|FG001|Overall Study|Antibiotic use|0|||
125601716|NCT04983940|451826582|FG000|Overall Study|Lost to Follow-up|14|||
125601717|NCT04983940|451826582|FG000|Overall Study|Lack of Efficacy|2|||
125601718|NCT00514449|451826583|FG000|Overall Study|Withdrawal by Subject|1|||
125601719|NCT00514449|451826584|FG001|Overall Study|Withdrawal by Subject|2|||
125601720|NCT00514449|451826583|FG000|Overall Study|Protocol Violation|1|||
125601721|NCT00514449|451826584|FG001|Overall Study|Protocol Violation|2|||
125601722|NCT00514449|451826583|FG000|Overall Study|Lost to Follow-up|1|||
125601723|NCT00514449|451826584|FG001|Overall Study|Lost to Follow-up|0|||
125601724|NCT00301067|451826586|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
125601725|NCT00301067|451826587|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
125601726|NCT00301067|451826588|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
125601727|NCT00301067|451826589|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
125601728|NCT00301067|451826586|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
125601729|NCT00301067|451826587|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
125601730|NCT00301067|451826588|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
125601731|NCT00301067|451826589|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
125601732|NCT00301067|451826586|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
125601733|NCT00301067|451826587|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
125601734|NCT00301067|451826588|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
125601735|NCT00301067|451826589|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
125431688|NCT01490125|451207711|FG001|Period III|Death|0|||
125431689|NCT01490125|451207712|FG002|Period III|Death|0|||
125431690|NCT01490125|451207713|FG003|Period III|Death|1|||
125601736|NCT00301067|451826586|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
125601737|NCT00301067|451826587|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
125601738|NCT00301067|451826588|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
125601739|NCT00301067|451826589|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
125601740|NCT00301067|451826586|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
125601741|NCT00301067|451826587|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
125601742|NCT00301067|451826588|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
125601743|NCT00301067|451826589|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
125601744|NCT00301067|451826586|FG000|Follow up Until Death|Alive at last data cut point|1|||
125601745|NCT00301067|451826587|FG001|Follow up Until Death|Alive at last data cut point|0|||
125601746|NCT00301067|451826588|FG002|Follow up Until Death|Alive at last data cut point|0|||
125601747|NCT00301067|451826589|FG003|Follow up Until Death|Alive at last data cut point|1|||
125601748|NCT00149825|451826590|FG000|Overall Study|Intolerance to medication side effects|1|||
125601749|NCT00149825|451826591|FG001|Overall Study|Intolerance to medication side effects|2|||
125601750|NCT00149825|451826590|FG000|Overall Study|Time commitments|2|||
125601751|NCT00149825|451826591|FG001|Overall Study|Time commitments|1|||
125601752|NCT00149825|451826590|FG000|Overall Study|Not liking insomnia therapy|1|||
125601753|NCT00149825|451826591|FG001|Overall Study|Not liking insomnia therapy|0|||
125601754|NCT00149825|451826590|FG000|Overall Study|Other|1|||
125601755|NCT00149825|451826591|FG001|Overall Study|Other|0|||
125601756|NCT01359982|451826592|FG000|Overall Study|Adverse Event|2|||
125601757|NCT01359982|451826593|FG001|Overall Study|Adverse Event|0|||
125601758|NCT01359982|451826594|FG002|Overall Study|Adverse Event|0|||
125601759|NCT01359982|451826595|FG003|Overall Study|Adverse Event|1|||
125601760|NCT01359982|451826596|FG004|Overall Study|Adverse Event|0|||
125601761|NCT01359982|451826597|FG005|Overall Study|Adverse Event|0|||
125601762|NCT01359982|451826592|FG000|Overall Study|Death|1|||
125601763|NCT01359982|451826593|FG001|Overall Study|Death|0|||
125601764|NCT01359982|451826594|FG002|Overall Study|Death|0|||
125601765|NCT01359982|451826595|FG003|Overall Study|Death|0|||
125601766|NCT01359982|451826596|FG004|Overall Study|Death|0|||
125601767|NCT01359982|451826597|FG005|Overall Study|Death|0|||
125601768|NCT00942708|451826598|FG000|Overall Study|Withdrawal by Subject|1|||
125601769|NCT01457339|451826599|FG000|Period 3 (100 mg)|Adverse Event|0|||
125601770|NCT01457339|451826600|FG001|Period 3 (100 mg)|Adverse Event|1|||
125601771|NCT01457339|451826599|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
125601772|NCT01457339|451826600|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
125601773|NCT01457339|451826599|FG000|Period 6 (250 mg)|Family Emergency|1|||
125601774|NCT01457339|451826600|FG001|Period 6 (250 mg)|Family Emergency|0|||
125601775|NCT01457339|451826599|FG000|Period 6 (250 mg)|Personal appointment|0|||
125601776|NCT01457339|451826600|FG001|Period 6 (250 mg)|Personal appointment|1|||
125601777|NCT02760407|451826601|FG000|Overall Study|Death|2|||
125601778|NCT02760407|451826602|FG001|Overall Study|Death|3|||
125601779|NCT02760407|451826603|FG002|Overall Study|Death|1|||
125601780|NCT02760407|451826604|FG003|Overall Study|Death|1|||
125601781|NCT02760407|451826601|FG000|Overall Study|Lost to Follow-up|1|||
125601782|NCT02760407|451826602|FG001|Overall Study|Lost to Follow-up|7|||
125601783|NCT02760407|451826603|FG002|Overall Study|Lost to Follow-up|4|||
125601784|NCT02760407|451826604|FG003|Overall Study|Lost to Follow-up|6|||
125601785|NCT02760407|451826601|FG000|Overall Study|Withdrawal by Subject|25|||
125601786|NCT02760407|451826602|FG001|Overall Study|Withdrawal by Subject|31|||
125601787|NCT02760407|451826603|FG002|Overall Study|Withdrawal by Subject|37|||
125601788|NCT02760407|451826604|FG003|Overall Study|Withdrawal by Subject|25|||
125601789|NCT02760407|451826601|FG000|Overall Study|Violation of Eligibility criteria|0|||
125601790|NCT02760407|451826602|FG001|Overall Study|Violation of Eligibility criteria|0|||
125601791|NCT02760407|451826603|FG002|Overall Study|Violation of Eligibility criteria|1|||
125601792|NCT02760407|451826604|FG003|Overall Study|Violation of Eligibility criteria|1|||
125601793|NCT02760407|451826601|FG000|Overall Study|Personal reasons|0|||
125601794|NCT02760407|451826602|FG001|Overall Study|Personal reasons|0|||
125601795|NCT02760407|451826603|FG002|Overall Study|Personal reasons|0|||
125601796|NCT02760407|451826604|FG003|Overall Study|Personal reasons|1|||
125601797|NCT02760407|451826601|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
125601798|NCT02760407|451826602|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
125601799|NCT02760407|451826603|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
125601800|NCT02760407|451826604|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
125601801|NCT02760407|451826601|FG000|Overall Study|Use of prohibited Medication|0|||
125601802|NCT02760407|451826602|FG001|Overall Study|Use of prohibited Medication|0|||
125601803|NCT02760407|451826603|FG002|Overall Study|Use of prohibited Medication|1|||
125601804|NCT02760407|451826604|FG003|Overall Study|Use of prohibited Medication|0|||
125601805|NCT02760407|451826601|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
125601806|NCT02760407|451826602|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
125601807|NCT02760407|451826603|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
125601808|NCT02760407|451826604|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
125601809|NCT02760407|451826601|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
125601810|NCT02760407|451826602|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
125601811|NCT02760407|451826603|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
125601812|NCT02760407|451826604|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
125601813|NCT02760407|451826601|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
125601814|NCT02760407|451826602|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
125601815|NCT02760407|451826603|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
125601816|NCT02760407|451826604|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
125601817|NCT02760407|451826601|FG000|Overall Study|Inadequately Enrolled|0|||
125601818|NCT02760407|451826602|FG001|Overall Study|Inadequately Enrolled|0|||
125601819|NCT02760407|451826603|FG002|Overall Study|Inadequately Enrolled|0|||
125601820|NCT02760407|451826604|FG003|Overall Study|Inadequately Enrolled|1|||
125601821|NCT02760407|451826601|FG000|Overall Study|Withdrawal By PI's Decision|0|||
125601822|NCT02760407|451826602|FG001|Overall Study|Withdrawal By PI's Decision|1|||
125601823|NCT02760407|451826603|FG002|Overall Study|Withdrawal By PI's Decision|0|||
125601824|NCT02760407|451826604|FG003|Overall Study|Withdrawal By PI's Decision|0|||
125601825|NCT02760407|451826601|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
125601826|NCT02760407|451826602|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
125601827|NCT02760407|451826603|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
125601828|NCT02760407|451826604|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
125601829|NCT02760407|451826601|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
125601830|NCT02760407|451826602|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
125601831|NCT02760407|451826603|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
125601832|NCT02760407|451826604|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
125601833|NCT02760407|451826601|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
125601834|NCT02760407|451826602|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
125601835|NCT02760407|451826603|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
125601836|NCT02760407|451826604|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
125601837|NCT02760407|451826601|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
125601838|NCT02760407|451826602|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
125601839|NCT02760407|451826603|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
125601840|NCT02760407|451826604|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
125601841|NCT02760407|451826601|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
125601842|NCT02760407|451826602|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
125601843|NCT02760407|451826603|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
125601844|NCT02760407|451826604|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
125601845|NCT02760407|451826601|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
125601846|NCT02760407|451826602|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
125601847|NCT02760407|451826603|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
125601848|NCT02760407|451826604|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
125601849|NCT02760407|451826601|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
125601850|NCT02760407|451826602|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
125601851|NCT02760407|451826603|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
125601852|NCT02760407|451826604|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
125601853|NCT02760407|451826601|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
125601854|NCT02760407|451826602|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
125601855|NCT02760407|451826603|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
125601856|NCT02760407|451826604|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
125601857|NCT02760407|451826601|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
125601858|NCT02760407|451826602|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
125601859|NCT02760407|451826603|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
125601860|NCT02760407|451826604|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
125601861|NCT01645930|451826605|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
125601862|NCT01645930|451826605|FG000|Overall Study|Progressive Disease|12|||
125601863|NCT01645930|451826605|FG000|Overall Study|Adverse Event|4|||
125601864|NCT01645930|451826605|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
125601865|NCT01645930|451826605|FG000|Overall Study|Withdrawal by Participant|2|||
125601866|NCT01645930|451826605|FG000|Overall Study|Reason not Defined|1|||
125601867|NCT03245814|451826606|FG000|Overall Study|Lost to Follow-up|5|||
125601868|NCT03245814|451826607|FG001|Overall Study|Lost to Follow-up|8|||
125601869|NCT03245814|451826606|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
125601870|NCT03245814|451826607|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
125601871|NCT02522377|451826608|FG000|Overall Study|Withdrawal by Subject|1|||
125601872|NCT02522377|451826609|FG001|Overall Study|Withdrawal by Subject|0|||
125601873|NCT02522377|451826608|FG000|Overall Study|Remission Achieved|3|||
125601874|NCT02522377|451826609|FG001|Overall Study|Remission Achieved|0|||
125601875|NCT01158950|451826610|FG000|1st Intervention (1 Day)|Physician Decision|1|||
125601876|NCT01158950|451826611|FG001|1st Intervention (1 Day)|Physician Decision|2|||
125601877|NCT02263365|451826612|FG000|Overall Study|Physician Decision|22|||
125601878|NCT02263365|451826613|FG001|Overall Study|Physician Decision|18|||
125601879|NCT00945191|451826614|FG000|Overall Study|Did not achieve a complete response|18|||
125601880|NCT00945191|451826614|FG000|Overall Study|Participant relocated to another state|1|||
125601881|NCT00945191|451826614|FG000|Overall Study|Disease progression|3|||
125601882|NCT00945191|451826614|FG000|Overall Study|Serious adverse event or adverse event|1|||
125601883|NCT00945191|451826614|FG000|Overall Study|Investigator's discretion|1|||
125601884|NCT00206518|451826615|FG000|Overall Study|Lack of Efficacy|6|||
125601885|NCT00206518|451826616|FG001|Overall Study|Lack of Efficacy|4|||
125601886|NCT00206518|451826615|FG000|Overall Study|Adverse Event|2|||
125601887|NCT00206518|451826616|FG001|Overall Study|Adverse Event|1|||
125601888|NCT00206518|451826615|FG000|Overall Study|Physician Decision|1|||
125601889|NCT00206518|451826616|FG001|Overall Study|Physician Decision|0|||
125601890|NCT00206518|451826615|FG000|Overall Study|Protocol Violation|1|||
125601891|NCT00206518|451826616|FG001|Overall Study|Protocol Violation|1|||
125601892|NCT02053246|451826628|FG000|Overall Study|Withdrawal by Subject|3|||
125601893|NCT02053246|451826628|FG000|Overall Study|Physician Decision|1|||
125601894|NCT02707757|451826629|FG000|Overall Study|Protocol Violation|3|||
125601895|NCT02707757|451826630|FG001|Overall Study|Protocol Violation|2|||
125601896|NCT02707757|451826629|FG000|Overall Study|Withdrawal by Subject|2|||
125601897|NCT02707757|451826630|FG001|Overall Study|Withdrawal by Subject|0|||
125601898|NCT02707757|451826629|FG000|Overall Study|Death|0|||
125601899|NCT02707757|451826630|FG001|Overall Study|Death|1|||
125601900|NCT02707757|451826629|FG000|Overall Study|Adverse Event|6|||
125601901|NCT02707757|451826630|FG001|Overall Study|Adverse Event|4|||
125601902|NCT02707757|451826629|FG000|Overall Study|Renal transplant/elective operation|1|||
125601903|NCT02707757|451826630|FG001|Overall Study|Renal transplant/elective operation|5|||
125601904|NCT00638846|451826634|FG000|Overall Study|Adverse Event|0|||
125601905|NCT00638846|451826635|FG001|Overall Study|Adverse Event|1|||
125601906|NCT00638846|451826634|FG000|Overall Study|Lost to Follow-up|3|||
125601907|NCT00638846|451826635|FG001|Overall Study|Lost to Follow-up|2|||
125601908|NCT00638846|451826634|FG000|Overall Study|lens issue|1|||
125601909|NCT00638846|451826635|FG001|Overall Study|lens issue|3|||
125601910|NCT01589094|451826636|FG000|Overall Study|Did not receive treatment|2|||
125601911|NCT03575468|451826637|FG000|Overall Study|Withdrawal by Subject|3|||
125601912|NCT03575468|451826638|FG001|Overall Study|Withdrawal by Subject|0|||
125601913|NCT03575468|451826637|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
125601914|NCT03575468|451826638|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
125601915|NCT03575468|451826637|FG000|Overall Study|Lost to Follow-up|13|||
125601916|NCT03575468|451826638|FG001|Overall Study|Lost to Follow-up|17|||
125601917|NCT03123939|451826639|FG000|Overall Study|Lack of Efficacy|6|||
125601918|NCT03123939|451826639|FG000|Overall Study|Death|5|||
125601919|NCT03123939|451826639|FG000|Overall Study|Physician Decision|2|||
125601920|NCT03123939|451826639|FG000|Overall Study|Subject/guardian decision|2|||
125601921|NCT03123939|451826639|FG000|Overall Study|Lost to Follow-up|1|||
125601922|NCT03123939|451826639|FG000|Overall Study|New therapy for study indication|1|||
125601923|NCT03123939|451826639|FG000|Overall Study|Protocol deviation|1|||
125601924|NCT03123939|451826639|FG000|Overall Study|Progressive disease|18|||
125601925|NCT03123939|451826639|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
125601926|NCT03123939|451826639|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
125601927|NCT02112448|451826640|FG000|Overall Study|lab values precluding use of ketorolac|2|||
125601928|NCT02112448|451826641|FG001|Overall Study|lab values precluding use of ketorolac|2|||
125601929|NCT02112448|451826640|FG000|Overall Study|Protocol Violation|1|||
125601930|NCT02112448|451826641|FG001|Overall Study|Protocol Violation|2|||
125601931|NCT02112448|451826640|FG000|Overall Study|Physician Decision|4|||
125601932|NCT02112448|451826641|FG001|Overall Study|Physician Decision|6|||
125601933|NCT02112448|451826640|FG000|Overall Study|required heparin so could not use ketoro|1|||
125601934|NCT02112448|451826641|FG001|Overall Study|required heparin so could not use ketoro|0|||
125601935|NCT05270694|451827806|FG000|Overall Study|Death|1|||
125601936|NCT05270694|451827806|FG000|Overall Study|Medical issues impacted ability to participate|2|||
125601937|NCT05270694|451827806|FG000|Overall Study|Lost to Follow-up|3|||
125601938|NCT05270694|451827806|FG000|Overall Study|Withdrawal by Subject|3|||
125601939|NCT01991977|451827809|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
125601940|NCT01991977|451827809|FG000|Overall Study|Withdrew after start of treatment|5|||
125601941|NCT02531035|451827816|FG000|Overall Study|Death|0|||
125601942|NCT02531035|451827817|FG001|Overall Study|Death|1|||
125601943|NCT02531035|451827816|FG000|Overall Study|Protocol Violation|1|||
125601944|NCT02531035|451827817|FG001|Overall Study|Protocol Violation|1|||
125601945|NCT02531035|451827816|FG000|Overall Study|Noncompliance with study drug|8|||
125601946|NCT02531035|451827817|FG001|Overall Study|Noncompliance with study drug|3|||
125601947|NCT02531035|451827816|FG000|Overall Study|Physician Decision|1|||
125601948|NCT02531035|451827817|FG001|Overall Study|Physician Decision|0|||
125601949|NCT02531035|451827816|FG000|Overall Study|Adverse Event|16|||
125601950|NCT02531035|451827817|FG001|Overall Study|Adverse Event|45|||
125601951|NCT02531035|451827816|FG000|Overall Study|Other|3|||
125601952|NCT02531035|451827817|FG001|Overall Study|Other|2|||
125601953|NCT02531035|451827816|FG000|Overall Study|Withdrawal by Subject|42|||
125601954|NCT02531035|451827817|FG001|Overall Study|Withdrawal by Subject|32|||
125601955|NCT02531035|451827816|FG000|Overall Study|Lost to Follow-up|8|||
125601956|NCT02531035|451827817|FG001|Overall Study|Lost to Follow-up|10|||
125601957|NCT02531035|451827816|FG000|Overall Study|Randomized, not treated|2|||
125601958|NCT02531035|451827817|FG001|Overall Study|Randomized, not treated|1|||
125601959|NCT03032068|451827827|FG000|Overall Study|Adverse Event|1|||
125601960|NCT01597622|451827828|FG000|Overall Study|Adverse Event|7|||
125601961|NCT01597622|451827828|FG000|Overall Study|Lack of Efficacy|3|||
125601962|NCT01597622|451827828|FG000|Overall Study|Protocol Violation|1|||
125601963|NCT01597622|451827828|FG000|Overall Study|Lost to Follow-up|1|||
125601964|NCT01597622|451827828|FG000|Overall Study|Investigator Discretion|5|||
125601965|NCT01597622|451827828|FG000|Overall Study|Withdrawal by Subject|20|||
125601966|NCT01597622|451827828|FG000|Overall Study|Death|1|||
125601967|NCT03567291|451827833|FG000|Period I|Adverse Event|14|||
125601968|NCT03567291|451827834|FG001|Period I|Adverse Event|0|||
125601969|NCT03567291|451827835|FG002|Period I|Adverse Event|0|||
125601970|NCT03567291|451827836|FG003|Period I|Adverse Event|0|||
125601971|NCT03567291|451827833|FG000|Period I|Protocol Violation|1|||
125601972|NCT03567291|451827834|FG001|Period I|Protocol Violation|0|||
125601973|NCT03567291|451827835|FG002|Period I|Protocol Violation|0|||
125369280|NCT01847274|450984870|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
125369281|NCT01847274|450984871|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
125601974|NCT03567291|451827836|FG003|Period I|Protocol Violation|0|||
125601975|NCT03567291|451827833|FG000|Period I|Withdrawal by Subject|23|||
125601976|NCT03567291|451827834|FG001|Period I|Withdrawal by Subject|0|||
125601977|NCT03567291|451827835|FG002|Period I|Withdrawal by Subject|0|||
125601978|NCT03567291|451827836|FG003|Period I|Withdrawal by Subject|0|||
125601979|NCT03567291|451827833|FG000|Period I|Lost to Follow-up|2|||
125601980|NCT03567291|451827834|FG001|Period I|Lost to Follow-up|0|||
125601981|NCT03567291|451827835|FG002|Period I|Lost to Follow-up|0|||
125601982|NCT03567291|451827836|FG003|Period I|Lost to Follow-up|0|||
125601983|NCT03567291|451827833|FG000|Period I|Terminated by sponsor|44|||
125601984|NCT03567291|451827834|FG001|Period I|Terminated by sponsor|0|||
125601985|NCT03567291|451827835|FG002|Period I|Terminated by sponsor|0|||
125601986|NCT03567291|451827836|FG003|Period I|Terminated by sponsor|0|||
125601987|NCT03567291|451827833|FG000|Period I|Missing or unknown|7|||
125601988|NCT03567291|451827834|FG001|Period I|Missing or unknown|0|||
125212838|NCT01026818|450405479|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
125601989|NCT03567291|451827835|FG002|Period I|Missing or unknown|0|||
125601990|NCT03567291|451827836|FG003|Period I|Missing or unknown|0|||
125601991|NCT03567291|451827833|FG000|Period II|Adverse Event|0|||
125601992|NCT03567291|451827834|FG001|Period II|Adverse Event|1|||
125601993|NCT03567291|451827835|FG002|Period II|Adverse Event|0|||
125601994|NCT03567291|451827836|FG003|Period II|Adverse Event|0|||
125601995|NCT03567291|451827833|FG000|Period II|Missing or unknown|0|||
125601996|NCT03567291|451827834|FG001|Period II|Missing or unknown|2|||
125601997|NCT03567291|451827835|FG002|Period II|Missing or unknown|1|||
125601998|NCT03567291|451827836|FG003|Period II|Missing or unknown|0|||
125601999|NCT03567291|451827833|FG000|Period III|Adverse Event|0|||
125602000|NCT03567291|451827834|FG001|Period III|Adverse Event|0|||
125602001|NCT03567291|451827835|FG002|Period III|Adverse Event|0|||
125602002|NCT03567291|451827836|FG003|Period III|Adverse Event|4|||
125602003|NCT03567291|451827833|FG000|Period III|Withdrawal by Subject|0|||
125602004|NCT03567291|451827834|FG001|Period III|Withdrawal by Subject|0|||
125602005|NCT03567291|451827835|FG002|Period III|Withdrawal by Subject|0|||
125602006|NCT03567291|451827836|FG003|Period III|Withdrawal by Subject|4|||
125602007|NCT03567291|451827833|FG000|Period III|Lost to Follow-up|0|||
125602008|NCT03567291|451827834|FG001|Period III|Lost to Follow-up|0|||
125602009|NCT03567291|451827835|FG002|Period III|Lost to Follow-up|0|||
125602010|NCT03567291|451827836|FG003|Period III|Lost to Follow-up|1|||
125602011|NCT03567291|451827833|FG000|Period III|Terminated by sponsor|0|||
125602012|NCT03567291|451827834|FG001|Period III|Terminated by sponsor|0|||
125602013|NCT03567291|451827835|FG002|Period III|Terminated by sponsor|0|||
125602014|NCT03567291|451827836|FG003|Period III|Terminated by sponsor|68|||
125602015|NCT03567291|451827833|FG000|Period III|Missing or unknown|0|||
125602016|NCT03567291|451827834|FG001|Period III|Missing or unknown|0|||
125602017|NCT03567291|451827835|FG002|Period III|Missing or unknown|0|||
125602018|NCT03567291|451827836|FG003|Period III|Missing or unknown|8|||
125602019|NCT01103349|451827837|FG000|Overall Study|Adverse Event|8|||
125602020|NCT01103349|451827838|FG001|Overall Study|Adverse Event|5|||
125602021|NCT01103349|451827839|FG002|Overall Study|Adverse Event|3|||
125602022|NCT01103349|451827837|FG000|Overall Study|Consent withdrawn|1|||
125602023|NCT01103349|451827838|FG001|Overall Study|Consent withdrawn|0|||
125602024|NCT01103349|451827839|FG002|Overall Study|Consent withdrawn|0|||
125602025|NCT01103349|451827837|FG000|Overall Study|Incorrectly included in the trial|1|||
125602026|NCT01103349|451827838|FG001|Overall Study|Incorrectly included in the trial|0|||
125602027|NCT01103349|451827839|FG002|Overall Study|Incorrectly included in the trial|0|||
125602028|NCT01103349|451827837|FG000|Overall Study|Withdrawal by Subject|1|||
125602029|NCT01103349|451827838|FG001|Overall Study|Withdrawal by Subject|1|||
125602030|NCT01103349|451827839|FG002|Overall Study|Withdrawal by Subject|0|||
125602031|NCT01103349|451827837|FG000|Overall Study|did not want to take trial medication|0|||
125602032|NCT01103349|451827838|FG001|Overall Study|did not want to take trial medication|1|||
125602033|NCT01103349|451827839|FG002|Overall Study|did not want to take trial medication|0|||
125602034|NCT01103349|451827837|FG000|Overall Study|forgot to take medication|0|||
125602035|NCT01103349|451827838|FG001|Overall Study|forgot to take medication|0|||
125602036|NCT01103349|451827839|FG002|Overall Study|forgot to take medication|1|||
125602037|NCT00090285|451827840|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
125602038|NCT00090285|451827841|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
125602039|NCT00090285|451827842|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
125602040|NCT00090285|451827843|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
125602041|NCT00090285|451827844|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
125602042|NCT00090285|451827845|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
125602043|NCT00090285|451827840|FG000|Base Study Vaccination Period|Adverse Event|2|||
125602044|NCT00090285|451827841|FG001|Base Study Vaccination Period|Adverse Event|4|||
125602045|NCT00090285|451827842|FG002|Base Study Vaccination Period|Adverse Event|0|||
125602046|NCT00090285|451827843|FG003|Base Study Vaccination Period|Adverse Event|0|||
125602047|NCT00090285|451827844|FG004|Base Study Vaccination Period|Adverse Event|0|||
125212839|NCT01026818|450405480|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
125212840|NCT01026818|450405481|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
125212841|NCT01026818|450405478|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
125602048|NCT00090285|451827845|FG005|Base Study Vaccination Period|Adverse Event|0|||
125602049|NCT00090285|451827840|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
125602050|NCT00090285|451827841|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
125602051|NCT00090285|451827842|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
125602052|NCT00090285|451827843|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
125602053|NCT00090285|451827844|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
125602054|NCT00090285|451827845|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
125602055|NCT00090285|451827840|FG000|Base Study Vaccination Period|Protocol Violation|2|||
125602056|NCT00090285|451827841|FG001|Base Study Vaccination Period|Protocol Violation|3|||
125602057|NCT00090285|451827842|FG002|Base Study Vaccination Period|Protocol Violation|0|||
125602058|NCT00090285|451827843|FG003|Base Study Vaccination Period|Protocol Violation|0|||
125602059|NCT00090285|451827844|FG004|Base Study Vaccination Period|Protocol Violation|0|||
125602060|NCT00090285|451827845|FG005|Base Study Vaccination Period|Protocol Violation|0|||
125602061|NCT00090285|451827840|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
125602062|NCT00090285|451827841|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
125602063|NCT00090285|451827842|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
125602064|NCT00090285|451827843|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
125602065|NCT00090285|451827844|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
125602066|NCT00090285|451827845|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
125369282|NCT01847274|450984861|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125369283|NCT01847274|450984862|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125369284|NCT01847274|450984863|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125602067|NCT00090285|451827840|FG000|Base Study Vaccination Period|Uncooperative|2|||
125602068|NCT00090285|451827841|FG001|Base Study Vaccination Period|Uncooperative|2|||
125602069|NCT00090285|451827842|FG002|Base Study Vaccination Period|Uncooperative|0|||
125602070|NCT00090285|451827843|FG003|Base Study Vaccination Period|Uncooperative|0|||
125602071|NCT00090285|451827844|FG004|Base Study Vaccination Period|Uncooperative|0|||
125602072|NCT00090285|451827845|FG005|Base Study Vaccination Period|Uncooperative|0|||
125602073|NCT00090285|451827840|FG000|Base Study Vaccination Period|Moved|20|||
125602074|NCT00090285|451827841|FG001|Base Study Vaccination Period|Moved|21|||
125602075|NCT00090285|451827842|FG002|Base Study Vaccination Period|Moved|0|||
125602076|NCT00090285|451827843|FG003|Base Study Vaccination Period|Moved|0|||
125602077|NCT00090285|451827844|FG004|Base Study Vaccination Period|Moved|0|||
125602078|NCT00090285|451827845|FG005|Base Study Vaccination Period|Moved|0|||
125602079|NCT00090285|451827840|FG000|Base Study Vaccination Period|Site Terminated|1|||
125602080|NCT00090285|451827841|FG001|Base Study Vaccination Period|Site Terminated|0|||
125602081|NCT00090285|451827842|FG002|Base Study Vaccination Period|Site Terminated|0|||
125602082|NCT00090285|451827843|FG003|Base Study Vaccination Period|Site Terminated|0|||
125602083|NCT00090285|451827844|FG004|Base Study Vaccination Period|Site Terminated|0|||
125602084|NCT00090285|451827845|FG005|Base Study Vaccination Period|Site Terminated|0|||
125602085|NCT00090285|451827840|FG000|Base Study Vaccination Period|Other|2|||
125602086|NCT00090285|451827841|FG001|Base Study Vaccination Period|Other|2|||
125602087|NCT00090285|451827842|FG002|Base Study Vaccination Period|Other|0|||
125602088|NCT00090285|451827843|FG003|Base Study Vaccination Period|Other|0|||
125602089|NCT00090285|451827844|FG004|Base Study Vaccination Period|Other|0|||
125602090|NCT00090285|451827845|FG005|Base Study Vaccination Period|Other|0|||
125602091|NCT00090285|451827840|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
125602092|NCT00090285|451827841|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
125602093|NCT00090285|451827842|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
125602094|NCT00090285|451827843|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
125602095|NCT00090285|451827844|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
125602096|NCT00090285|451827845|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
125602097|NCT00090285|451827840|FG000|Base Study Vaccination Period|HIV positive|1|||
125602098|NCT00090285|451827841|FG001|Base Study Vaccination Period|HIV positive|1|||
125602099|NCT00090285|451827842|FG002|Base Study Vaccination Period|HIV positive|0|||
125602100|NCT00090285|451827843|FG003|Base Study Vaccination Period|HIV positive|0|||
125602101|NCT00090285|451827844|FG004|Base Study Vaccination Period|HIV positive|0|||
125602102|NCT00090285|451827845|FG005|Base Study Vaccination Period|HIV positive|0|||
125602103|NCT00090285|451827840|FG000|Base Study Follow-up Period|Adverse Event|3|||
125602104|NCT00090285|451827841|FG001|Base Study Follow-up Period|Adverse Event|10|||
125602105|NCT00090285|451827842|FG002|Base Study Follow-up Period|Adverse Event|0|||
125602106|NCT00090285|451827843|FG003|Base Study Follow-up Period|Adverse Event|0|||
125602107|NCT00090285|451827844|FG004|Base Study Follow-up Period|Adverse Event|0|||
125602108|NCT00090285|451827845|FG005|Base Study Follow-up Period|Adverse Event|0|||
125602109|NCT00090285|451827840|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
125602110|NCT00090285|451827841|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
125602111|NCT00090285|451827842|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
125602112|NCT00090285|451827843|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
125602113|NCT00090285|451827844|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
125602114|NCT00090285|451827845|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
125602115|NCT00090285|451827840|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
125602116|NCT00090285|451827841|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
125602117|NCT00090285|451827842|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
125602118|NCT00090285|451827843|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
125602119|NCT00090285|451827844|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
125602120|NCT00090285|451827845|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
125602121|NCT00090285|451827840|FG000|Base Study Follow-up Period|Moved|41|||
125602122|NCT00090285|451827841|FG001|Base Study Follow-up Period|Moved|36|||
125602123|NCT00090285|451827842|FG002|Base Study Follow-up Period|Moved|0|||
125602124|NCT00090285|451827843|FG003|Base Study Follow-up Period|Moved|0|||
125602125|NCT00090285|451827844|FG004|Base Study Follow-up Period|Moved|0|||
125602126|NCT00090285|451827845|FG005|Base Study Follow-up Period|Moved|0|||
125602127|NCT00090285|451827840|FG000|Base Study Follow-up Period|Other|2|||
125602128|NCT00090285|451827841|FG001|Base Study Follow-up Period|Other|0|||
125369285|NCT01847274|450984864|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125602129|NCT00090285|451827842|FG002|Base Study Follow-up Period|Other|0|||
125602130|NCT00090285|451827843|FG003|Base Study Follow-up Period|Other|0|||
125602131|NCT00090285|451827844|FG004|Base Study Follow-up Period|Other|0|||
125602132|NCT00090285|451827845|FG005|Base Study Follow-up Period|Other|0|||
125602133|NCT00090285|451827840|FG000|Base Study Follow-up Period|Protocol Violation|1|||
125602134|NCT00090285|451827841|FG001|Base Study Follow-up Period|Protocol Violation|0|||
125369286|NCT01847274|450984865|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125602135|NCT00090285|451827842|FG002|Base Study Follow-up Period|Protocol Violation|0|||
125602136|NCT00090285|451827843|FG003|Base Study Follow-up Period|Protocol Violation|0|||
125602137|NCT00090285|451827844|FG004|Base Study Follow-up Period|Protocol Violation|0|||
125602138|NCT00090285|451827845|FG005|Base Study Follow-up Period|Protocol Violation|0|||
125602139|NCT00090285|451827840|FG000|Base Study Follow-up Period|Uncooperative|3|||
125602140|NCT00090285|451827841|FG001|Base Study Follow-up Period|Uncooperative|4|||
125602141|NCT00090285|451827842|FG002|Base Study Follow-up Period|Uncooperative|0|||
125602142|NCT00090285|451827843|FG003|Base Study Follow-up Period|Uncooperative|0|||
125602143|NCT00090285|451827844|FG004|Base Study Follow-up Period|Uncooperative|0|||
125602144|NCT00090285|451827845|FG005|Base Study Follow-up Period|Uncooperative|0|||
125602145|NCT00090285|451827840|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
125602146|NCT00090285|451827841|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
125602147|NCT00090285|451827842|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
125602148|NCT00090285|451827843|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
125602149|NCT00090285|451827844|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
125602150|NCT00090285|451827845|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
125602151|NCT00090285|451827840|FG000|Extension 1|Adverse Event|0|||
125602152|NCT00090285|451827841|FG001|Extension 1|Adverse Event|0|||
125602153|NCT00090285|451827842|FG002|Extension 1|Adverse Event|2|||
125602154|NCT00090285|451827843|FG003|Extension 1|Adverse Event|0|||
125602155|NCT00090285|451827844|FG004|Extension 1|Adverse Event|0|||
125602156|NCT00090285|451827845|FG005|Extension 1|Adverse Event|0|||
125602157|NCT00090285|451827840|FG000|Extension 1|Lost to Follow-up|0|||
125602158|NCT00090285|451827841|FG001|Extension 1|Lost to Follow-up|0|||
125602159|NCT00090285|451827842|FG002|Extension 1|Lost to Follow-up|35|||
125602160|NCT00090285|451827843|FG003|Extension 1|Lost to Follow-up|0|||
125602161|NCT00090285|451827844|FG004|Extension 1|Lost to Follow-up|0|||
125602162|NCT00090285|451827845|FG005|Extension 1|Lost to Follow-up|0|||
125602163|NCT00090285|451827840|FG000|Extension 1|Withdrawal by Subject|0|||
125602164|NCT00090285|451827841|FG001|Extension 1|Withdrawal by Subject|0|||
125602165|NCT00090285|451827842|FG002|Extension 1|Withdrawal by Subject|13|||
125602166|NCT00090285|451827843|FG003|Extension 1|Withdrawal by Subject|1|||
125602167|NCT00090285|451827844|FG004|Extension 1|Withdrawal by Subject|0|||
125602168|NCT00090285|451827845|FG005|Extension 1|Withdrawal by Subject|0|||
125602169|NCT00090285|451827840|FG000|Extension 1|Other|0|||
125602170|NCT00090285|451827841|FG001|Extension 1|Other|0|||
125602171|NCT00090285|451827842|FG002|Extension 1|Other|4|||
125602172|NCT00090285|451827843|FG003|Extension 1|Other|0|||
125602173|NCT00090285|451827844|FG004|Extension 1|Other|0|||
125602174|NCT00090285|451827845|FG005|Extension 1|Other|0|||
125602175|NCT00090285|451827840|FG000|Extension 1|Moved|0|||
125602176|NCT00090285|451827841|FG001|Extension 1|Moved|0|||
125602177|NCT00090285|451827842|FG002|Extension 1|Moved|3|||
125602178|NCT00090285|451827843|FG003|Extension 1|Moved|0|||
125602179|NCT00090285|451827844|FG004|Extension 1|Moved|0|||
125602180|NCT00090285|451827845|FG005|Extension 1|Moved|0|||
125602181|NCT00090285|451827840|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
125602182|NCT00090285|451827841|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
125602183|NCT00090285|451827842|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
125602184|NCT00090285|451827843|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
125602185|NCT00090285|451827844|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
125602186|NCT00090285|451827845|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
125602187|NCT00090285|451827840|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125602188|NCT00090285|451827841|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125602189|NCT00090285|451827842|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125602190|NCT00090285|451827843|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125602191|NCT00090285|451827844|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
125602192|NCT00090285|451827845|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
125602193|NCT00090285|451827840|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125602194|NCT00090285|451827841|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125602195|NCT00090285|451827842|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125602196|NCT00090285|451827843|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125602197|NCT00090285|451827844|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
125602198|NCT00090285|451827845|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
125602199|NCT00090285|451827840|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
125602200|NCT00090285|451827841|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
125602201|NCT00090285|451827842|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
125602202|NCT00090285|451827843|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
125602203|NCT00090285|451827844|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
125602204|NCT00090285|451827845|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
125602205|NCT04498910|451827846|FG000|Overall Study|Lost to Follow-up|0|||
125602206|NCT04498910|451827847|FG001|Overall Study|Lost to Follow-up|1|||
125602207|NCT04498910|451827846|FG000|Overall Study|Withdrawal by Subject|2|||
125602208|NCT04498910|451827847|FG001|Overall Study|Withdrawal by Subject|1|||
125602209|NCT04498910|451827846|FG000|Overall Study|Adverse Event|1|||
125602210|NCT04498910|451827847|FG001|Overall Study|Adverse Event|0|||
125602211|NCT01849848|451827848|FG000|Overall Study|Physician Decision|1|||
125602212|NCT01849848|451827848|FG000|Overall Study|Progression of the primary disease|3|||
125602213|NCT01070303|451827849|FG000|Overall Study|Adverse Event|39|||
125602214|NCT01070303|451827849|FG000|Overall Study|Withdrawal by Subject|20|||
125602215|NCT01070303|451827849|FG000|Overall Study|Lost to Follow-up|9|||
125602216|NCT01070303|451827849|FG000|Overall Study|Protocol Violation|0|||
125602217|NCT01070303|451827849|FG000|Overall Study|Lack of Efficacy|2|||
125602218|NCT01070303|451827849|FG000|Overall Study|Administrative Reason|1|||
125602219|NCT01070303|451827849|FG000|Overall Study|Other|18|||
125602220|NCT02926573|451827851|FG000|Overall Study|Nausea|1|||
125602221|NCT02926573|451827852|FG001|Overall Study|Nausea|0|||
125602222|NCT02926573|451827851|FG000|Overall Study|Remain intubated|2|||
125602223|NCT02926573|451827852|FG001|Overall Study|Remain intubated|2|||
125602224|NCT02926573|451827851|FG000|Overall Study|Change in surgery plan|3|||
125602225|NCT02926573|451827852|FG001|Overall Study|Change in surgery plan|1|||
125602226|NCT02926573|451827851|FG000|Overall Study|Change to outpatient status|5|||
125602227|NCT02926573|451827852|FG001|Overall Study|Change to outpatient status|1|||
125602228|NCT02926573|451827851|FG000|Overall Study|Withdrawal by Subject|0|||
125602229|NCT02926573|451827852|FG001|Overall Study|Withdrawal by Subject|2|||
125602230|NCT02926573|451827851|FG000|Overall Study|Return to operating room|0|||
125602231|NCT02926573|451827852|FG001|Overall Study|Return to operating room|2|||
125602232|NCT02926573|451827851|FG000|Overall Study|Delirium|0|||
125602233|NCT02926573|451827852|FG001|Overall Study|Delirium|1|||
125602234|NCT00510692|451827862|FG000|Overall Study|Adverse Event|1|||
125602235|NCT00510692|451827863|FG001|Overall Study|Adverse Event|3|||
125602236|NCT00510692|451827862|FG000|Overall Study|Withdrawal by Subject|1|||
125602237|NCT00510692|451827863|FG001|Overall Study|Withdrawal by Subject|0|||
125602238|NCT01001494|451827872|FG000|Overall Study|Adverse Event|8|||
125602239|NCT01001494|451827873|FG001|Overall Study|Adverse Event|4|||
125602240|NCT01001494|451827874|FG002|Overall Study|Adverse Event|6|||
125602241|NCT01001494|451827872|FG000|Overall Study|Protocol Violation|0|||
125602242|NCT01001494|451827873|FG001|Overall Study|Protocol Violation|1|||
125602243|NCT01001494|451827874|FG002|Overall Study|Protocol Violation|1|||
125602244|NCT01001494|451827872|FG000|Overall Study|Lost to Follow-up|2|||
125602245|NCT01001494|451827873|FG001|Overall Study|Lost to Follow-up|0|||
125602246|NCT01001494|451827874|FG002|Overall Study|Lost to Follow-up|1|||
125602247|NCT01001494|451827872|FG000|Overall Study|Withdrawal by Subject|9|||
125602248|NCT01001494|451827873|FG001|Overall Study|Withdrawal by Subject|7|||
125602249|NCT01001494|451827874|FG002|Overall Study|Withdrawal by Subject|17|||
125602250|NCT01001494|451827872|FG000|Overall Study|COPD exacerbation|3|||
125602251|NCT01001494|451827873|FG001|Overall Study|COPD exacerbation|4|||
125602252|NCT01001494|451827874|FG002|Overall Study|COPD exacerbation|5|||
125602253|NCT01001494|451827872|FG000|Overall Study|Lack of Efficacy|2|||
125602254|NCT01001494|451827873|FG001|Overall Study|Lack of Efficacy|0|||
125602255|NCT01001494|451827874|FG002|Overall Study|Lack of Efficacy|8|||
125602256|NCT01001494|451827872|FG000|Overall Study|Other|0|||
125602257|NCT01001494|451827873|FG001|Overall Study|Other|1|||
125602258|NCT01001494|451827874|FG002|Overall Study|Other|3|||
125602259|NCT02519231|451827878|FG000|Overall Study|Lost to Follow-up|2|||
125602260|NCT02519231|451827879|FG001|Overall Study|Lost to Follow-up|5|||
125602261|NCT02519231|451827878|FG000|Overall Study|Withdrawal by Subject|0|||
125602262|NCT02519231|451827879|FG001|Overall Study|Withdrawal by Subject|1|||
125602263|NCT02124798|451827880|FG000|Overall Study|Adverse Event|3|||
125602264|NCT02124798|451827880|FG000|Overall Study|Lost to Follow-up|1|||
125602265|NCT01797432|451827884|FG000|Overall Study|Lost to Follow-up|1|||
125602266|NCT01797432|451827884|FG000|Overall Study|Adverse Event|1|||
125602267|NCT01797432|451827884|FG000|Overall Study|Withdrawal by Subject|1|||
125602268|NCT01797432|451827884|FG000|Overall Study|lived too far from study site|1|||
125602269|NCT02795156|451827886|FG000|Overall Study|Progressive Disease|22|||
125602270|NCT02795156|451827887|FG001|Overall Study|Progressive Disease|7|||
125602271|NCT02795156|451827888|FG002|Overall Study|Progressive Disease|34|||
125602272|NCT02795156|451827889|FG003|Overall Study|Progressive Disease|7|||
125602273|NCT02795156|451827886|FG000|Overall Study|Adverse Event|13|||
125602274|NCT02795156|451827887|FG001|Overall Study|Adverse Event|2|||
125602275|NCT02795156|451827888|FG002|Overall Study|Adverse Event|3|||
125602276|NCT02795156|451827889|FG003|Overall Study|Adverse Event|2|||
125602277|NCT02795156|451827886|FG000|Overall Study|Death|1|||
125602278|NCT02795156|451827887|FG001|Overall Study|Death|1|||
125602279|NCT02795156|451827888|FG002|Overall Study|Death|1|||
125602280|NCT02795156|451827889|FG003|Overall Study|Death|0|||
125602281|NCT02795156|451827886|FG000|Overall Study|Physician Decision|1|||
125602282|NCT02795156|451827887|FG001|Overall Study|Physician Decision|0|||
125602283|NCT02795156|451827888|FG002|Overall Study|Physician Decision|1|||
125602284|NCT02795156|451827889|FG003|Overall Study|Physician Decision|0|||
125602285|NCT02795156|451827886|FG000|Overall Study|Withdrawal by Subject|2|||
125602286|NCT02795156|451827887|FG001|Overall Study|Withdrawal by Subject|0|||
125602287|NCT02795156|451827888|FG002|Overall Study|Withdrawal by Subject|3|||
125602288|NCT02795156|451827889|FG003|Overall Study|Withdrawal by Subject|0|||
125602289|NCT00815308|451827890|FG000|Overall Study|Adverse Event|4|||
125602290|NCT00815308|451827890|FG000|Overall Study|Withdrawal by Subject|0|||
125602291|NCT00815308|451827890|FG000|Overall Study|Protocol Violation|6|||
125602292|NCT02746679|451827894|FG000|Overall Study|Lost to Follow-up|4|||
125602293|NCT02746679|451827895|FG001|Overall Study|Lost to Follow-up|6|||
125602294|NCT01171521|451827897|FG000|Overall Study|Lost to Follow-up|5|||
125602295|NCT01171521|451827897|FG000|Overall Study|screen failure|1|||
125602296|NCT00734929|451827902|FG000|Overall Study|Lost to Follow-up|1|||
125602297|NCT00734929|451827903|FG001|Overall Study|Lost to Follow-up|2|||
125602298|NCT00734929|451827902|FG000|Overall Study|No intervention/ screen fail|5|||
125602299|NCT00734929|451827903|FG001|Overall Study|No intervention/ screen fail|3|||
125602300|NCT02955186|451827904|FG000|Overall Study|Withdrawal by Subject|6|||
125602301|NCT02955186|451827905|FG001|Overall Study|Withdrawal by Subject|2|||
125602302|NCT02955186|451827904|FG000|Overall Study|Protocol Violation|1|||
125602303|NCT02955186|451827905|FG001|Overall Study|Protocol Violation|0|||
125602304|NCT01422304|451827906|FG000|Overall Study|Adverse Event|0|||
125602305|NCT01422304|451827907|FG001|Overall Study|Adverse Event|1|||
125602306|NCT01422304|451827906|FG000|Overall Study|Lost to Follow-up|14|||
125602307|NCT01422304|451827907|FG001|Overall Study|Lost to Follow-up|20|||
125602308|NCT01422304|451827906|FG000|Overall Study|Never Entered Follow-up|2|||
125602309|NCT01422304|451827907|FG001|Overall Study|Never Entered Follow-up|1|||
125602310|NCT01422304|451827906|FG000|Overall Study|Protocol Violation|1|||
125602311|NCT01422304|451827907|FG001|Overall Study|Protocol Violation|0|||
125602312|NCT01422304|451827906|FG000|Overall Study|Withdrawal by Subject|4|||
125602313|NCT01422304|451827907|FG001|Overall Study|Withdrawal by Subject|2|||
125602314|NCT01422304|451827906|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
125602315|NCT01422304|451827907|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
125602316|NCT01422304|451827906|FG000|Overall Study|Not Treated|3|||
125602317|NCT01422304|451827907|FG001|Overall Study|Not Treated|11|||
125602318|NCT00866294|451827908|FG000|Overall Study|Adverse Event|12|||
125602319|NCT00866294|451827909|FG001|Overall Study|Adverse Event|13|||
125602320|NCT00866294|451827910|FG002|Overall Study|Adverse Event|9|||
125602321|NCT00866294|451827908|FG000|Overall Study|Lack of Efficacy|7|||
125602322|NCT00866294|451827909|FG001|Overall Study|Lack of Efficacy|1|||
125602323|NCT00866294|451827910|FG002|Overall Study|Lack of Efficacy|0|||
125602324|NCT00866294|451827908|FG000|Overall Study|Protocol Violation|2|||
125602325|NCT00866294|451827909|FG001|Overall Study|Protocol Violation|0|||
125602326|NCT00866294|451827910|FG002|Overall Study|Protocol Violation|0|||
125602327|NCT00866294|451827908|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
125602328|NCT00866294|451827909|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125602329|NCT00866294|451827910|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125602330|NCT00866294|451827908|FG000|Overall Study|Lost to Follow-up|1|||
125602331|NCT00866294|451827909|FG001|Overall Study|Lost to Follow-up|3|||
125602332|NCT00866294|451827910|FG002|Overall Study|Lost to Follow-up|0|||
125602333|NCT00866294|451827908|FG000|Overall Study|Physician Decision|6|||
125602334|NCT00866294|451827909|FG001|Overall Study|Physician Decision|2|||
125602335|NCT00866294|451827910|FG002|Overall Study|Physician Decision|1|||
125602336|NCT04799782|451827911|FG000|Washout|Physician Decision|2|||
125602337|NCT04799782|451827912|FG001|Washout|Physician Decision|0|||
125602338|NCT04799782|451827911|FG000|Washout|Withdrawal by Subject|0|||
125602339|NCT04799782|451827912|FG001|Washout|Withdrawal by Subject|2|||
125602340|NCT04799782|451827911|FG000|Washout|Lost to Follow-up|0|||
125602341|NCT04799782|451827912|FG001|Washout|Lost to Follow-up|1|||
125602342|NCT02606877|451827913|FG000|Overall Study|Adverse Event|3|||
125602343|NCT02606877|451827914|FG001|Overall Study|Adverse Event|0|||
125602344|NCT02606877|451827913|FG000|Overall Study|Non-compliance with protocol|0|||
125602345|NCT02606877|451827914|FG001|Overall Study|Non-compliance with protocol|1|||
125602346|NCT02606877|451827913|FG000|Overall Study|Other than listed above|1|||
125602347|NCT02606877|451827914|FG001|Overall Study|Other than listed above|0|||
125602348|NCT00515463|451827926|FG000|Overall Study|Physician Decision|4|||
125602349|NCT00515463|451827927|FG001|Overall Study|Physician Decision|2|||
125602350|NCT00515463|451827926|FG000|Overall Study|Adverse Event|1|||
125602351|NCT00515463|451827927|FG001|Overall Study|Adverse Event|2|||
125602352|NCT00515463|451827926|FG000|Overall Study|Withdrawal by Subject|3|||
125602353|NCT00515463|451827927|FG001|Overall Study|Withdrawal by Subject|4|||
125602354|NCT00515463|451827926|FG000|Overall Study|Lost to Follow-up|6|||
125602355|NCT00515463|451827927|FG001|Overall Study|Lost to Follow-up|5|||
125602356|NCT00515463|451827926|FG000|Overall Study|Other|0|||
125602357|NCT00515463|451827927|FG001|Overall Study|Other|1|||
125602358|NCT01558089|451827928|FG000|Overall Study|Adverse Event|1|||
125602359|NCT01558089|451827928|FG000|Overall Study|Lack of Efficacy|1|||
125602360|NCT01558089|451827928|FG000|Overall Study|Lost to Follow-up|5|||
125602361|NCT01558089|451827928|FG000|Overall Study|Withdrawal by Subject|6|||
125602362|NCT01903434|451827929|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
125602363|NCT01903434|451827930|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
125602364|NCT01903434|451827929|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
125602365|NCT01903434|451827930|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
125602366|NCT02190435|451827933|FG000|Overall Study|First 12 patients were lead-ins|12|||
125602367|NCT02190435|451827934|FG001|Overall Study|First 12 patients were lead-ins|0|||
125602368|NCT02190435|451827933|FG000|Overall Study|3 consented screen fails|3|||
125602369|NCT02190435|451827934|FG001|Overall Study|3 consented screen fails|0|||
125602370|NCT01781026|451827935|FG000|Overall Study|Lack of Efficacy|2|||
125602371|NCT02269319|451827936|FG000|Overall Study|Lost to Follow-up|4|||
125602372|NCT02269319|451827937|FG001|Overall Study|Lost to Follow-up|3|||
125602373|NCT02269319|451827936|FG000|Overall Study|Adverse Event|0|||
125602374|NCT02269319|451827937|FG001|Overall Study|Adverse Event|1|||
125602375|NCT02269319|451827936|FG000|Overall Study|Instructions not followed|1|||
125602376|NCT02269319|451827937|FG001|Overall Study|Instructions not followed|0|||
125602377|NCT01118143|451827940|FG000|Overall Study|Withdrawal by Subject|2|||
125602378|NCT01118143|451827941|FG001|Overall Study|Withdrawal by Subject|5|||
125602379|NCT01937130|451829350|FG000|Overall Study|Withdrawal by Subject|0|||
125602380|NCT01937130|451829351|FG001|Overall Study|Withdrawal by Subject|0|||
125602381|NCT01937130|451829352|FG002|Overall Study|Withdrawal by Subject|0|||
125602382|NCT01937130|451829353|FG003|Overall Study|Withdrawal by Subject|1|||
125602383|NCT01937130|451829350|FG000|Overall Study|Adverse Event|0|||
125602384|NCT01937130|451829351|FG001|Overall Study|Adverse Event|1|||
125602385|NCT01937130|451829352|FG002|Overall Study|Adverse Event|0|||
125602386|NCT01937130|451829353|FG003|Overall Study|Adverse Event|1|||
125602387|NCT01937130|451829350|FG000|Overall Study|Death|1|||
125602388|NCT01937130|451829351|FG001|Overall Study|Death|1|||
125602389|NCT01937130|451829352|FG002|Overall Study|Death|1|||
125602390|NCT01937130|451829353|FG003|Overall Study|Death|0|||
125602391|NCT01937130|451829350|FG000|Overall Study|Lost to Follow-up|2|||
125602392|NCT01937130|451829351|FG001|Overall Study|Lost to Follow-up|0|||
125602393|NCT01937130|451829352|FG002|Overall Study|Lost to Follow-up|2|||
125602394|NCT01937130|451829353|FG003|Overall Study|Lost to Follow-up|0|||
125602395|NCT01937130|451829350|FG000|Overall Study|Physician Decision|0|||
125602396|NCT01937130|451829351|FG001|Overall Study|Physician Decision|1|||
125602397|NCT01937130|451829352|FG002|Overall Study|Physician Decision|0|||
125602398|NCT01937130|451829353|FG003|Overall Study|Physician Decision|0|||
125602399|NCT01937130|451829350|FG000|Overall Study|Patients unable to swallow|0|||
125602400|NCT01937130|451829351|FG001|Overall Study|Patients unable to swallow|1|||
125602401|NCT01937130|451829352|FG002|Overall Study|Patients unable to swallow|0|||
125602402|NCT01937130|451829353|FG003|Overall Study|Patients unable to swallow|0|||
125602403|NCT01937130|451829350|FG000|Overall Study|Patient lost to FU due to death|2|||
125602404|NCT01937130|451829351|FG001|Overall Study|Patient lost to FU due to death|0|||
125602405|NCT01937130|451829352|FG002|Overall Study|Patient lost to FU due to death|0|||
125602406|NCT01937130|451829353|FG003|Overall Study|Patient lost to FU due to death|0|||
125602407|NCT03825042|451829356|FG000|Overall Study|Adverse Event|1|||
125602408|NCT03825042|451829357|FG001|Overall Study|Adverse Event|0|||
125602409|NCT03825042|451829356|FG000|Overall Study|Withdrawal by Subject|1|||
125602410|NCT03825042|451829357|FG001|Overall Study|Withdrawal by Subject|0|||
125602411|NCT01988012|451829364|FG000|Overall Study|Adverse Event|5|||
125602412|NCT01988012|451829364|FG000|Overall Study|Insufficient Therapeutic Response|3|||
125602413|NCT01988012|451829364|FG000|Overall Study|Patient Withdrawal of Consent|4|||
125602414|NCT01988012|451829364|FG000|Overall Study|Lost to Follow-up|1|||
125602415|NCT01988012|451829364|FG000|Overall Study|Physician Decision|1|||
125602416|NCT01988012|451829364|FG000|Overall Study|Protocol Violation|1|||
125602417|NCT00089843|451829365|FG000|Overall Study|Withdrawal by Subject|1|||
125602418|NCT00089843|451829366|FG001|Overall Study|Withdrawal by Subject|4|||
125602419|NCT00089843|451829367|FG002|Overall Study|Withdrawal by Subject|5|||
125602420|NCT00089843|451829368|FG003|Overall Study|Withdrawal by Subject|6|||
125602421|NCT00089843|451829365|FG000|Overall Study|Physician Decision|1|||
125602422|NCT00089843|451829366|FG001|Overall Study|Physician Decision|0|||
125602423|NCT00089843|451829367|FG002|Overall Study|Physician Decision|0|||
125602424|NCT00089843|451829368|FG003|Overall Study|Physician Decision|1|||
125602425|NCT03042611|451829369|FG000|Core Phase|Withdrawal by Subject|13|||
125602426|NCT03042611|451829370|FG001|Core Phase|Withdrawal by Subject|4|||
125602427|NCT03042611|451829371|FG002|Core Phase|Withdrawal by Subject|0|||
125602428|NCT03042611|451829372|FG003|Core Phase|Withdrawal by Subject|0|||
125602429|NCT03042611|451829369|FG000|Core Phase|Death|232|||
125602430|NCT03042611|451829370|FG001|Core Phase|Death|110|||
125602431|NCT03042611|451829371|FG002|Core Phase|Death|0|||
125602432|NCT03042611|451829372|FG003|Core Phase|Death|0|||
125602433|NCT03042611|451829369|FG000|Core Phase|Lost to Follow-up|4|||
125602434|NCT03042611|451829370|FG001|Core Phase|Lost to Follow-up|7|||
125602435|NCT03042611|451829371|FG002|Core Phase|Lost to Follow-up|0|||
125602436|NCT03042611|451829372|FG003|Core Phase|Lost to Follow-up|0|||
125602437|NCT03042611|451829369|FG000|Core Phase|Physician Decision|7|||
125602438|NCT03042611|451829370|FG001|Core Phase|Physician Decision|2|||
125602439|NCT03042611|451829371|FG002|Core Phase|Physician Decision|0|||
125602440|NCT03042611|451829372|FG003|Core Phase|Physician Decision|0|||
125602441|NCT03042611|451829369|FG000|Core Phase|Study Closed|0|||
125602442|NCT03042611|451829370|FG001|Core Phase|Study Closed|1|||
125602443|NCT03042611|451829371|FG002|Core Phase|Study Closed|0|||
125602444|NCT03042611|451829372|FG003|Core Phase|Study Closed|0|||
125602445|NCT03042611|451829369|FG000|Extension Phase|Death|0|||
125602446|NCT03042611|451829370|FG001|Extension Phase|Death|0|||
125602447|NCT03042611|451829371|FG002|Extension Phase|Death|34|||
125602448|NCT03042611|451829372|FG003|Extension Phase|Death|16|||
125602449|NCT03042611|451829369|FG000|Extension Phase|Lost to Follow-up|0|||
125602450|NCT03042611|451829370|FG001|Extension Phase|Lost to Follow-up|0|||
125602451|NCT03042611|451829371|FG002|Extension Phase|Lost to Follow-up|1|||
125602452|NCT03042611|451829372|FG003|Extension Phase|Lost to Follow-up|1|||
125602453|NCT03042611|451829369|FG000|Extension Phase|Study Closed|0|||
125602454|NCT03042611|451829370|FG001|Extension Phase|Study Closed|0|||
125602455|NCT03042611|451829371|FG002|Extension Phase|Study Closed|17|||
125602456|NCT03042611|451829372|FG003|Extension Phase|Study Closed|11|||
125602457|NCT00907478|451829377|FG000|Overall Study|Ineligibility determined|0|||
125602458|NCT00907478|451829378|FG001|Overall Study|Ineligibility determined|0|||
125602459|NCT00907478|451829379|FG002|Overall Study|Ineligibility determined|1|||
125602460|NCT00907478|451829377|FG000|Overall Study|Noncompliance|0|||
125602461|NCT00907478|451829378|FG001|Overall Study|Noncompliance|0|||
125602462|NCT00907478|451829379|FG002|Overall Study|Noncompliance|1|||
125602463|NCT00907478|451829377|FG000|Overall Study|Adverse Event|3|||
125602464|NCT00907478|451829378|FG001|Overall Study|Adverse Event|1|||
125602465|NCT00907478|451829379|FG002|Overall Study|Adverse Event|2|||
125602466|NCT00907478|451829377|FG000|Overall Study|Withdrawal by Subject|8|||
125602467|NCT00907478|451829378|FG001|Overall Study|Withdrawal by Subject|9|||
125602468|NCT00907478|451829379|FG002|Overall Study|Withdrawal by Subject|6|||
125602469|NCT00907478|451829377|FG000|Overall Study|Requirement for alternative therapy|1|||
125602470|NCT00907478|451829378|FG001|Overall Study|Requirement for alternative therapy|2|||
125602471|NCT00907478|451829379|FG002|Overall Study|Requirement for alternative therapy|3|||
125602472|NCT00907478|451829377|FG000|Overall Study|Physician Decision|2|||
125602473|NCT00907478|451829378|FG001|Overall Study|Physician Decision|0|||
125602474|NCT00907478|451829379|FG002|Overall Study|Physician Decision|3|||
125602475|NCT00907478|451829377|FG000|Overall Study|Death|4|||
125602476|NCT00907478|451829378|FG001|Overall Study|Death|2|||
125602477|NCT00907478|451829379|FG002|Overall Study|Death|1|||
125602478|NCT00907478|451829377|FG000|Overall Study|Protocol-specified criteria|5|||
125602479|NCT00907478|451829378|FG001|Overall Study|Protocol-specified criteria|2|||
125602480|NCT00907478|451829379|FG002|Overall Study|Protocol-specified criteria|3|||
125602481|NCT00907478|451829377|FG000|Overall Study|Pregnancy|0|||
125602482|NCT00907478|451829378|FG001|Overall Study|Pregnancy|1|||
125602483|NCT00907478|451829379|FG002|Overall Study|Pregnancy|1|||
125602484|NCT00907478|451829377|FG000|Overall Study|Lost to Follow-up|1|||
125602485|NCT00907478|451829378|FG001|Overall Study|Lost to Follow-up|0|||
125602486|NCT00907478|451829379|FG002|Overall Study|Lost to Follow-up|0|||
125602487|NCT00907478|451829377|FG000|Overall Study|Other|3|||
125602488|NCT00907478|451829378|FG001|Overall Study|Other|0|||
125602489|NCT00907478|451829379|FG002|Overall Study|Other|1|||
125602490|NCT02639182|451829380|FG000|Overall Study|Disease Progression|50|||
125602491|NCT02639182|451829381|FG001|Overall Study|Disease Progression|49|||
125602492|NCT02639182|451829380|FG000|Overall Study|Adverse Event|7|||
125602493|NCT02639182|451829381|FG001|Overall Study|Adverse Event|5|||
125602494|NCT02639182|451829380|FG000|Overall Study|Physician Decision|3|||
125602495|NCT02639182|451829381|FG001|Overall Study|Physician Decision|3|||
125602496|NCT02639182|451829380|FG000|Overall Study|Withdrew Consent|5|||
125602497|NCT02639182|451829381|FG001|Overall Study|Withdrew Consent|4|||
125602498|NCT02639182|451829380|FG000|Overall Study|Lost to Follow-up|0|||
125602499|NCT02639182|451829381|FG001|Overall Study|Lost to Follow-up|1|||
125602500|NCT02639182|451829380|FG000|Overall Study|Study Closure|1|||
125602501|NCT02639182|451829381|FG001|Overall Study|Study Closure|2|||
125602502|NCT02639182|451829380|FG000|Overall Study|Sponsor Ended Study|0|||
125602503|NCT02639182|451829381|FG001|Overall Study|Sponsor Ended Study|1|||
125602504|NCT02639182|451829380|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
125602505|NCT02639182|451829381|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
125602506|NCT03069690|451829382|FG000|Pregnancy Intervention|Pregnancy loss|9|||
125602507|NCT03069690|451829383|FG001|Pregnancy Intervention|Pregnancy loss|4|||
125602508|NCT03069690|451829384|FG002|Pregnancy Intervention|Pregnancy loss|0|||
125602509|NCT03069690|451829385|FG003|Pregnancy Intervention|Pregnancy loss|0|||
125602510|NCT03069690|451829386|FG004|Pregnancy Intervention|Pregnancy loss|0|||
125602511|NCT03069690|451829387|FG005|Pregnancy Intervention|Pregnancy loss|0|||
125602512|NCT03069690|451829382|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
125602513|NCT03069690|451829383|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
125602514|NCT03069690|451829384|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
125602515|NCT03069690|451829385|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
125602516|NCT03069690|451829386|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
125602517|NCT03069690|451829387|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
125602518|NCT03069690|451829382|FG000|Postpartum Intervention|Lost to Follow-up|0|||
125602519|NCT03069690|451829383|FG001|Postpartum Intervention|Lost to Follow-up|0|||
125602520|NCT03069690|451829384|FG002|Postpartum Intervention|Lost to Follow-up|5|||
125602521|NCT03069690|451829385|FG003|Postpartum Intervention|Lost to Follow-up|5|||
125602522|NCT03069690|451829386|FG004|Postpartum Intervention|Lost to Follow-up|2|||
125602523|NCT03069690|451829387|FG005|Postpartum Intervention|Lost to Follow-up|4|||
125602524|NCT01372878|451829388|FG000|Overall Study|Withdrawal by Subject|63|||
125602525|NCT01372878|451829388|FG000|Overall Study|Protocol Violation|17|||
125602526|NCT01372878|451829388|FG000|Overall Study|incomplete study procedure|104|||
125602527|NCT02385123|451829389|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
125602528|NCT01302769|451829402|FG000|Overall Study|Lost to Follow-up|1|||
125602529|NCT01302769|451829403|FG001|Overall Study|Lost to Follow-up|1|||
125602530|NCT01845077|451829404|FG000|Washout Period|Lost to Follow-up|0|||
125602531|NCT01845077|451829405|FG001|Washout Period|Lost to Follow-up|1|||
125602532|NCT01845077|451829406|FG002|Washout Period|Lost to Follow-up|0|||
125602533|NCT01845077|451829407|FG003|Washout Period|Lost to Follow-up|1|||
125602534|NCT01845077|451829408|FG004|Washout Period|Lost to Follow-up|0|||
125602535|NCT01845077|451829409|FG005|Washout Period|Lost to Follow-up|1|||
125602536|NCT01845077|451829404|FG000|Washout Period|Adverse Event|1|||
125602537|NCT01845077|451829405|FG001|Washout Period|Adverse Event|0|||
125602538|NCT01845077|451829406|FG002|Washout Period|Adverse Event|0|||
125602539|NCT01845077|451829407|FG003|Washout Period|Adverse Event|0|||
125602540|NCT01845077|451829408|FG004|Washout Period|Adverse Event|0|||
125602541|NCT01845077|451829409|FG005|Washout Period|Adverse Event|0|||
125602542|NCT01845077|451829404|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
125602543|NCT01845077|451829405|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
125602544|NCT01845077|451829406|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
125602545|NCT01845077|451829407|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
125602546|NCT01845077|451829408|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
125602547|NCT01845077|451829409|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
125602548|NCT01845077|451829404|FG000|Washout Period|Protocol Violation|0|||
125602549|NCT01845077|451829405|FG001|Washout Period|Protocol Violation|0|||
125602550|NCT01845077|451829406|FG002|Washout Period|Protocol Violation|0|||
125602551|NCT01845077|451829407|FG003|Washout Period|Protocol Violation|1|||
125602552|NCT01845077|451829408|FG004|Washout Period|Protocol Violation|1|||
125602553|NCT01845077|451829409|FG005|Washout Period|Protocol Violation|0|||
125602554|NCT00394914|451829410|FG000|Treatment Period|Adverse Event|0|||
125602555|NCT00394914|451829411|FG001|Treatment Period|Adverse Event|3|||
125602556|NCT00394914|451829412|FG002|Treatment Period|Adverse Event|1|||
125602557|NCT00394914|451829410|FG000|Treatment Period|Lost to Follow-up|0|||
125602558|NCT00394914|451829411|FG001|Treatment Period|Lost to Follow-up|1|||
125602559|NCT00394914|451829412|FG002|Treatment Period|Lost to Follow-up|0|||
125602560|NCT00394914|451829410|FG000|Treatment Period|Withdrawal by Subject|0|||
125602561|NCT00394914|451829411|FG001|Treatment Period|Withdrawal by Subject|2|||
125602562|NCT00394914|451829412|FG002|Treatment Period|Withdrawal by Subject|2|||
125602563|NCT00394914|451829410|FG000|Treatment Period|Noncompliance with protocol|0|||
125602564|NCT00394914|451829411|FG001|Treatment Period|Noncompliance with protocol|3|||
125602565|NCT00394914|451829412|FG002|Treatment Period|Noncompliance with protocol|2|||
125602566|NCT00394914|451829410|FG000|Treatment Period|Did not meet protocol eligibility|0|||
125602567|NCT00394914|451829411|FG001|Treatment Period|Did not meet protocol eligibility|1|||
125602568|NCT00394914|451829412|FG002|Treatment Period|Did not meet protocol eligibility|1|||
125602569|NCT00312377|451829417|FG000|Overall Study|Death|403|||
125602570|NCT00312377|451829418|FG001|Overall Study|Death|418|||
125602571|NCT00312377|451829417|FG000|Overall Study|Withdrawal by Subject|23|||
125602572|NCT00312377|451829418|FG001|Overall Study|Withdrawal by Subject|30|||
125602573|NCT00312377|451829417|FG000|Overall Study|Lost to Follow-up|9|||
125602574|NCT00312377|451829418|FG001|Overall Study|Lost to Follow-up|12|||
125602575|NCT00312377|451829417|FG000|Overall Study|Non-compliance|0|||
125602576|NCT00312377|451829418|FG001|Overall Study|Non-compliance|2|||
125602577|NCT00312377|451829417|FG000|Overall Study|Randomised but never received treatment|6|||
125602578|NCT00312377|451829418|FG001|Overall Study|Randomised but never received treatment|6|||
125602579|NCT00312377|451829417|FG000|Overall Study|Discontinue treatment survival follow up|202|||
125602580|NCT00312377|451829418|FG001|Overall Study|Discontinue treatment survival follow up|200|||
125602581|NCT00312377|451829417|FG000|Overall Study|Site ended participation in study|1|||
125602582|NCT00312377|451829418|FG001|Overall Study|Site ended participation in study|0|||
125602583|NCT00872898|451829419|FG000|Part Two - Double Blind|Adverse Event|4|||
125602584|NCT00872898|451829420|FG001|Part Two - Double Blind|Adverse Event|3|||
125602585|NCT00872898|451829419|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
125602586|NCT00872898|451829420|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
125602587|NCT00872898|451829419|FG000|Part Two - Double Blind|Protocol Violation|1|||
125602588|NCT00872898|451829420|FG001|Part Two - Double Blind|Protocol Violation|0|||
125602589|NCT00872898|451829419|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
125602590|NCT00872898|451829420|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
125602591|NCT00872898|451829419|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
125602592|NCT00872898|451829420|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
125602593|NCT00872898|451829419|FG000|Part Two - Double Blind|Other reasons|2|||
125602594|NCT00872898|451829420|FG001|Part Two - Double Blind|Other reasons|0|||
125602595|NCT02179398|451829426|FG000|Overall Study|Lack of obligatory data|3|||
125602596|NCT02179398|451829427|FG001|Overall Study|Lack of obligatory data|3|||
125602597|NCT02179398|451829426|FG000|Overall Study|Lost to Follow-up|0|||
125602598|NCT02179398|451829427|FG001|Overall Study|Lost to Follow-up|1|||
125602599|NCT01137435|451829428|FG000|Overall Study|Lost to Follow-up|24|||
125602600|NCT01137435|451829428|FG000|Overall Study|Off label usage|4|||
125602601|NCT00487279|451829436|FG000|Overall Study|Death|1|||
125602602|NCT00487279|451829437|FG001|Overall Study|Death|0|||
125602603|NCT00487279|451829436|FG000|Overall Study|Withdrawal by Subject|0|||
125602604|NCT00487279|451829437|FG001|Overall Study|Withdrawal by Subject|2|||
125602605|NCT00501852|451829438|FG000|Overall Study|Adverse Event|3|||
125602606|NCT00501852|451829438|FG000|Overall Study|Withdrawal by Subject|2|||
125602607|NCT01416610|451829440|FG000|Overall Study|Adverse Event|4|||
125602608|NCT01416610|451829440|FG000|Overall Study|Adverse Event -Patient decision|3|||
125602609|NCT01416610|451829440|FG000|Overall Study|Lack of Efficacy|4|||
125602610|NCT01416610|451829440|FG000|Overall Study|No reason given|5|||
125602611|NCT01416610|451829440|FG000|Overall Study|Withdrawal by Subject|13|||
125602612|NCT01416610|451829440|FG000|Overall Study|Lost to Follow-up|7|||
125602613|NCT01416610|451829440|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
125602614|NCT01927562|451829441|FG000|Overall Study|Lost to Follow-up|30|||
125602615|NCT01927562|451829441|FG000|Overall Study|Withdrawal by Subject|3|||
125602616|NCT01927562|451829441|FG000|Overall Study|Physician Decision|5|||
125602617|NCT00642616|451829442|FG000|Overall Study|Adverse Event|2|||
125602618|NCT00642616|451829443|FG001|Overall Study|Adverse Event|0|||
125602619|NCT00642616|451829444|FG002|Overall Study|Adverse Event|1|||
125602620|NCT00642616|451829445|FG003|Overall Study|Adverse Event|0|||
125602621|NCT00642616|451829442|FG000|Overall Study|Study Terminated by Sponsor|7|||
125602622|NCT00642616|451829443|FG001|Overall Study|Study Terminated by Sponsor|6|||
125602623|NCT00642616|451829444|FG002|Overall Study|Study Terminated by Sponsor|4|||
125602624|NCT00642616|451829445|FG003|Overall Study|Study Terminated by Sponsor|5|||
125602625|NCT00642616|451829442|FG000|Overall Study|Withdrawal by Subject|0|||
125602626|NCT00642616|451829443|FG001|Overall Study|Withdrawal by Subject|1|||
125602627|NCT00642616|451829444|FG002|Overall Study|Withdrawal by Subject|1|||
125602628|NCT00642616|451829445|FG003|Overall Study|Withdrawal by Subject|1|||
125602629|NCT00642616|451829442|FG000|Overall Study|Protocol Violation|0|||
125602630|NCT00642616|451829443|FG001|Overall Study|Protocol Violation|0|||
125602631|NCT00642616|451829444|FG002|Overall Study|Protocol Violation|2|||
125602632|NCT00642616|451829445|FG003|Overall Study|Protocol Violation|0|||
125602633|NCT00642616|451829442|FG000|Overall Study|Physician Decision|0|||
125602634|NCT00642616|451829443|FG001|Overall Study|Physician Decision|0|||
125602635|NCT00642616|451829444|FG002|Overall Study|Physician Decision|1|||
125602636|NCT00642616|451829445|FG003|Overall Study|Physician Decision|1|||
125602637|NCT00399802|451829446|FG000|Overall Study|Adverse Event|0|||
125602638|NCT00399802|451829447|FG001|Overall Study|Adverse Event|2|||
125602639|NCT00399802|451829446|FG000|Overall Study|Participant discontinued by mistake|0|||
125602640|NCT00399802|451829447|FG001|Overall Study|Participant discontinued by mistake|1|||
125602641|NCT00492921|451829448|FG000|Overall Study|Death|1|||
125602642|NCT00492921|451829449|FG001|Overall Study|Death|0|||
125602643|NCT00492921|451829450|FG002|Overall Study|Death|1|||
125602644|NCT00652093|451829451|FG000|Overall Study|Withdrawal by Subject|0|||
125602645|NCT00652093|451829452|FG001|Overall Study|Withdrawal by Subject|0|||
125602646|NCT00652093|451829453|FG002|Overall Study|Withdrawal by Subject|1|||
125602647|NCT00652093|451829454|FG003|Overall Study|Withdrawal by Subject|0|||
125602648|NCT00652093|451829455|FG004|Overall Study|Withdrawal by Subject|1|||
125602649|NCT00652093|451829456|FG005|Overall Study|Withdrawal by Subject|0|||
125602650|NCT00652093|451829451|FG000|Overall Study|Physician Decision|0|||
125602651|NCT00652093|451829452|FG001|Overall Study|Physician Decision|0|||
125602652|NCT00652093|451829453|FG002|Overall Study|Physician Decision|0|||
125602653|NCT00652093|451829454|FG003|Overall Study|Physician Decision|0|||
125602654|NCT00652093|451829455|FG004|Overall Study|Physician Decision|1|||
125602655|NCT00652093|451829456|FG005|Overall Study|Physician Decision|0|||
125602656|NCT00542815|451829457|FG000|Overall Study|Adverse Event|19|||
125602657|NCT00542815|451829458|FG001|Overall Study|Adverse Event|6|||
125602658|NCT00542815|451829459|FG002|Overall Study|Adverse Event|9|||
125602659|NCT00542815|451829457|FG000|Overall Study|Death|10|||
125602660|NCT00542815|451829458|FG001|Overall Study|Death|7|||
125602661|NCT00542815|451829459|FG002|Overall Study|Death|3|||
125602662|NCT00542815|451829457|FG000|Overall Study|Lack of Efficacy|9|||
125602663|NCT00542815|451829458|FG001|Overall Study|Lack of Efficacy|2|||
125602664|NCT00542815|451829459|FG002|Overall Study|Lack of Efficacy|0|||
125602665|NCT00542815|451829457|FG000|Overall Study|Physician Decision|2|||
125602666|NCT00542815|451829458|FG001|Overall Study|Physician Decision|1|||
125602667|NCT00542815|451829459|FG002|Overall Study|Physician Decision|0|||
125602668|NCT00542815|451829457|FG000|Overall Study|Protocol Violation|1|||
125602669|NCT00542815|451829458|FG001|Overall Study|Protocol Violation|1|||
125602670|NCT00542815|451829459|FG002|Overall Study|Protocol Violation|2|||
125602671|NCT00542815|451829457|FG000|Overall Study|Withdrawal by Subject|41|||
125369287|NCT01847274|450984866|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125369288|NCT01847274|450984867|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125369289|NCT01847274|450984868|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125369290|NCT01847274|450984869|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125369291|NCT01847274|450984870|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
125369292|NCT01847274|450984871|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
125369293|NCT02217878|450984873|FG000|Overall Study|required morphine due to chest pain|1|||
125369294|NCT02217878|450984874|FG001|Overall Study|required morphine due to chest pain|2|||
125369295|NCT02217878|450984873|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
125369296|NCT02217878|450984874|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
125369297|NCT00334958|450984875|FG000|Overall Study|Medication Noncompliance|0|||
125369298|NCT00334958|450984876|FG001|Overall Study|Medication Noncompliance|3|||
125369299|NCT00334958|450984875|FG000|Overall Study|Protocol Violation|2|||
125369300|NCT00334958|450984876|FG001|Overall Study|Protocol Violation|2|||
125602672|NCT00542815|451829458|FG001|Overall Study|Withdrawal by Subject|5|||
125369301|NCT00334958|450984875|FG000|Overall Study|Request of the investigator or sponsor|0|||
125602673|NCT00542815|451829459|FG002|Overall Study|Withdrawal by Subject|8|||
125602674|NCT00542815|451829457|FG000|Overall Study|Other reasons|24|||
125602675|NCT00542815|451829458|FG001|Overall Study|Other reasons|10|||
125602676|NCT00542815|451829459|FG002|Overall Study|Other reasons|10|||
125602677|NCT03176966|451829460|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
125602678|NCT03176966|451829461|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
125602679|NCT03176966|451829460|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
125369302|NCT00334958|450984876|FG001|Overall Study|Request of the investigator or sponsor|1|||
125369303|NCT00334958|450984875|FG000|Overall Study|Withdrawal by Subject|7|||
125369304|NCT00334958|450984876|FG001|Overall Study|Withdrawal by Subject|4|||
125602680|NCT03176966|451829461|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
125602681|NCT03176966|451829460|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
125602682|NCT03176966|451829461|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
125602683|NCT03176966|451829460|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
125602684|NCT03176966|451829461|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
125602685|NCT03176966|451829460|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
125602686|NCT03176966|451829461|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
125602687|NCT03176966|451829460|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
125602688|NCT03176966|451829461|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
125602689|NCT03176966|451829460|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
125602690|NCT03176966|451829461|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
125602691|NCT01520922|451829465|FG000|Treatment Phase|Physician Decision|2|||
125602692|NCT01520922|451829466|FG001|Treatment Phase|Physician Decision|1|||
125602693|NCT01520922|451829465|FG000|Treatment Phase|Progression|0|||
125602694|NCT01520922|451829466|FG001|Treatment Phase|Progression|2|||
125602695|NCT01520922|451829465|FG000|Treatment Phase|Adverse Event|3|||
125602696|NCT01520922|451829466|FG001|Treatment Phase|Adverse Event|5|||
125602697|NCT01520922|451829465|FG000|Follow up|Lost to Follow-up|0|||
125602698|NCT01520922|451829466|FG001|Follow up|Lost to Follow-up|1|||
125602699|NCT01520922|451829465|FG000|Survival Follow-up|Withdrawal by Subject|1|||
125602700|NCT01520922|451829466|FG001|Survival Follow-up|Withdrawal by Subject|0|||
125602701|NCT01696877|451829469|FG000|Overall Study|Adverse Event|0|||
125602702|NCT01696877|451829470|FG001|Overall Study|Adverse Event|1|||
125602703|NCT01618656|451829471|FG000|Overall Study|Withdrawal by Subject|7|||
125602704|NCT01618656|451829472|FG001|Overall Study|Withdrawal by Subject|3|||
125602705|NCT01618656|451829471|FG000|Overall Study|Physician Decision|1|||
125602706|NCT01618656|451829472|FG001|Overall Study|Physician Decision|1|||
125602707|NCT02961764|451829475|FG000|Overall Study|Protocol Violation|0|||
125602708|NCT02961764|451829476|FG001|Overall Study|Protocol Violation|1|||
125602709|NCT02961764|451829475|FG000|Overall Study|Death|2|||
125602710|NCT02961764|451829476|FG001|Overall Study|Death|0|||
125602711|NCT02961764|451829475|FG000|Overall Study|Lost to Follow-up|35|||
125602712|NCT02961764|451829476|FG001|Overall Study|Lost to Follow-up|24|||
125602713|NCT02961764|451829475|FG000|Overall Study|Withdrawal by Subject|2|||
125602714|NCT02961764|451829476|FG001|Overall Study|Withdrawal by Subject|0|||
125602715|NCT04770155|451829477|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125602716|NCT04770155|451829478|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125602717|NCT04770155|451829479|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125602718|NCT04770155|451829480|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125602719|NCT04770155|451829481|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125602720|NCT04770155|451829482|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125602721|NCT04770155|451829483|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125602722|NCT04770155|451829484|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
125602723|NCT00469014|451829487|FG000|Initial Phase Randomization|Disease Progression|0|||
125602724|NCT00469014|451829488|FG001|Initial Phase Randomization|Disease Progression|1|||
125602725|NCT00469014|451829489|FG002|Initial Phase Randomization|Disease Progression|1|||
125602726|NCT00469014|451829490|FG003|Initial Phase Randomization|Disease Progression|0|||
125602727|NCT00469014|451829487|FG000|Initial Phase Randomization|No Response|1|||
125602728|NCT00469014|451829488|FG001|Initial Phase Randomization|No Response|0|||
125602729|NCT00469014|451829489|FG002|Initial Phase Randomization|No Response|0|||
125602730|NCT00469014|451829490|FG003|Initial Phase Randomization|No Response|1|||
125602731|NCT00469014|451829487|FG000|Adaptive Randomization|Not Evaluable|1|||
125602732|NCT00469014|451829488|FG001|Adaptive Randomization|Not Evaluable|0|||
125602733|NCT00469014|451829489|FG002|Adaptive Randomization|Not Evaluable|0|||
125602734|NCT00469014|451829490|FG003|Adaptive Randomization|Not Evaluable|1|||
125602735|NCT00469014|451829487|FG000|Adaptive Randomization|No Response|0|||
125369305|NCT00334958|450984875|FG000|Overall Study|Adverse Event|27|||
125369306|NCT00334958|450984876|FG001|Overall Study|Adverse Event|12|||
125369307|NCT00334958|450984875|FG000|Overall Study|Other|1|||
125602736|NCT00469014|451829488|FG001|Adaptive Randomization|No Response|1|||
125602737|NCT00469014|451829489|FG002|Adaptive Randomization|No Response|0|||
125602738|NCT00469014|451829490|FG003|Adaptive Randomization|No Response|0|||
125369308|NCT00334958|450984876|FG001|Overall Study|Other|2|||
125369309|NCT00824720|450984879|FG000|Overall Study|failed plug insertion|3|||
125602739|NCT00469014|451829487|FG000|Adaptive Randomization|Death|0|||
125369310|NCT00824720|450984880|FG001|Overall Study|failed plug insertion|1|||
125431691|NCT01490125|451207714|FG004|Period III|Death|0|||
125602740|NCT00469014|451829488|FG001|Adaptive Randomization|Death|0|||
125602741|NCT00469014|451829489|FG002|Adaptive Randomization|Death|1|||
125602742|NCT00469014|451829490|FG003|Adaptive Randomization|Death|0|||
125602743|NCT03321929|451829491|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
125602744|NCT01632878|451829492|FG000|Screening|Physician Decision|268|||
125602745|NCT01632878|451829492|FG000|Treatment|Lost to Follow-up|41|||
125602746|NCT01632878|451829492|FG000|Treatment|Withdrawal by Subject|36|||
125602747|NCT01632878|451829492|FG000|Treatment|Physician Decision|34|||
125602748|NCT01632878|451829492|FG000|Treatment|missing information|4|||
125602749|NCT01632878|451829492|FG000|Treatment|no information on study completion|43|||
125602750|NCT00336492|451829507|FG000|Overall Study|Adverse Event|4|||
125602751|NCT00336492|451829508|FG001|Overall Study|Adverse Event|3|||
125602752|NCT00336492|451829509|FG002|Overall Study|Adverse Event|6|||
125602753|NCT00336492|451829507|FG000|Overall Study|Lack of Efficacy|6|||
125602754|NCT00336492|451829508|FG001|Overall Study|Lack of Efficacy|1|||
125602755|NCT00336492|451829509|FG002|Overall Study|Lack of Efficacy|4|||
125602756|NCT00336492|451829507|FG000|Overall Study|Other|5|||
125602757|NCT00336492|451829508|FG001|Overall Study|Other|0|||
125602758|NCT00336492|451829509|FG002|Overall Study|Other|1|||
125602759|NCT00227877|451829510|FG000|Pre-visit Assessment|Technical difficulties|7|||
125602760|NCT00227877|451829511|FG001|Pre-visit Assessment|Technical difficulties|3|||
125602761|NCT00227877|451829512|FG002|Pre-visit Assessment|Technical difficulties|0|||
125602762|NCT00227877|451829513|FG003|Pre-visit Assessment|Technical difficulties|0|||
125602763|NCT00227877|451829510|FG000|Post-visit Checklist|Lost to Follow-up|24|||
125602764|NCT00227877|451829511|FG001|Post-visit Checklist|Lost to Follow-up|13|||
125602765|NCT00227877|451829512|FG002|Post-visit Checklist|Lost to Follow-up|1|||
125602766|NCT00227877|451829513|FG003|Post-visit Checklist|Lost to Follow-up|0|||
125602767|NCT00227877|451829510|FG000|3-months Follow-up|Completed late|135|||
125602768|NCT00227877|451829511|FG001|3-months Follow-up|Completed late|128|||
125602769|NCT00227877|451829512|FG002|3-months Follow-up|Completed late|34|||
125602770|NCT00227877|451829513|FG003|3-months Follow-up|Completed late|8|||
125602771|NCT00227877|451829510|FG000|3-months Follow-up|Lost to Follow-up|178|||
125602772|NCT00227877|451829511|FG001|3-months Follow-up|Lost to Follow-up|139|||
125602773|NCT00227877|451829512|FG002|3-months Follow-up|Lost to Follow-up|18|||
125602774|NCT00227877|451829513|FG003|3-months Follow-up|Lost to Follow-up|13|||
125602775|NCT00227877|451829510|FG000|12-months Follow-up|Completed late|78|||
125602776|NCT00227877|451829511|FG001|12-months Follow-up|Completed late|74|||
125602777|NCT00227877|451829512|FG002|12-months Follow-up|Completed late|1|||
125602778|NCT00227877|451829513|FG003|12-months Follow-up|Completed late|0|||
125602779|NCT00227877|451829510|FG000|12-months Follow-up|Lost to Follow-up|232|||
125602780|NCT00227877|451829511|FG001|12-months Follow-up|Lost to Follow-up|189|||
125602781|NCT00227877|451829512|FG002|12-months Follow-up|Lost to Follow-up|30|||
125602782|NCT00227877|451829513|FG003|12-months Follow-up|Lost to Follow-up|26|||
125602783|NCT05094154|451831242|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
125602784|NCT05094154|451831243|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
125602785|NCT05094154|451831242|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
125602786|NCT05094154|451831243|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
125602787|NCT01543490|451831246|FG000|Overall Study|Adverse Event|4|||
125602788|NCT01543490|451831247|FG001|Overall Study|Adverse Event|0|||
125602789|NCT01543490|451831246|FG000|Overall Study|Physician Decision|1|||
125602790|NCT01543490|451831247|FG001|Overall Study|Physician Decision|0|||
125602791|NCT01543490|451831246|FG000|Overall Study|Lack of Efficacy|3|||
125602792|NCT01543490|451831247|FG001|Overall Study|Lack of Efficacy|3|||
125602793|NCT01543490|451831246|FG000|Overall Study|Lost to Follow-up|5|||
125602794|NCT01543490|451831247|FG001|Overall Study|Lost to Follow-up|0|||
125602795|NCT01543490|451831246|FG000|Overall Study|Withdrawal by Subject|2|||
125602796|NCT01543490|451831247|FG001|Overall Study|Withdrawal by Subject|0|||
125602797|NCT01543490|451831246|FG000|Overall Study|Other-Various Administrative Reasons|1|||
125602798|NCT01543490|451831247|FG001|Overall Study|Other-Various Administrative Reasons|2|||
125602799|NCT04168645|451831250|FG000|Overall Study|Lost to Follow-up|23|||
125602800|NCT04168645|451831251|FG001|Overall Study|Lost to Follow-up|28|||
125602801|NCT04168645|451831252|FG002|Overall Study|Lost to Follow-up|15|||
125602802|NCT04168645|451831253|FG003|Overall Study|Lost to Follow-up|12|||
125602803|NCT04168645|451831250|FG000|Overall Study|Death|1|||
125602804|NCT04168645|451831251|FG001|Overall Study|Death|1|||
125602805|NCT04168645|451831252|FG002|Overall Study|Death|0|||
125369311|NCT00824720|450984881|FG002|Overall Study|failed plug insertion|0|||
125369312|NCT00824720|450984879|FG000|Overall Study|Protocol Violation|0|||
125369313|NCT00824720|450984880|FG001|Overall Study|Protocol Violation|0|||
125602806|NCT04168645|451831253|FG003|Overall Study|Death|0|||
125602807|NCT04168645|451831250|FG000|Overall Study|Withdrawal by Subject|5|||
125602808|NCT04168645|451831251|FG001|Overall Study|Withdrawal by Subject|2|||
125602809|NCT04168645|451831252|FG002|Overall Study|Withdrawal by Subject|2|||
125602810|NCT04168645|451831253|FG003|Overall Study|Withdrawal by Subject|2|||
125602811|NCT04168645|451831250|FG000|Overall Study|Administrative Withdrawal|3|||
125602812|NCT04168645|451831251|FG001|Overall Study|Administrative Withdrawal|1|||
125602813|NCT04168645|451831252|FG002|Overall Study|Administrative Withdrawal|1|||
125602814|NCT04168645|451831253|FG003|Overall Study|Administrative Withdrawal|3|||
125602815|NCT03918642|451831254|FG000|Overall Study|Lost to Follow-up|12|||
125602816|NCT03918642|451831255|FG001|Overall Study|Lost to Follow-up|10|||
125602817|NCT02601001|451831256|FG000|Dosing Period 2|Adverse Event|0|||
125602818|NCT02601001|451831257|FG001|Dosing Period 2|Adverse Event|0|||
125602819|NCT02601001|451831258|FG002|Dosing Period 2|Adverse Event|0|||
125602820|NCT02601001|451831259|FG003|Dosing Period 2|Adverse Event|0|||
125602821|NCT02601001|451831260|FG004|Dosing Period 2|Adverse Event|0|||
125602822|NCT02601001|451831261|FG005|Dosing Period 2|Adverse Event|0|||
125602823|NCT02601001|451831262|FG006|Dosing Period 2|Adverse Event|1|||
125602824|NCT02115815|451831263|FG000|Overall Study|Withdrawal by Subject|2|||
125602825|NCT02115815|451831264|FG001|Overall Study|Withdrawal by Subject|0|||
125602826|NCT02115815|451831265|FG002|Overall Study|Withdrawal by Subject|0|||
125602827|NCT02115815|451831266|FG003|Overall Study|Withdrawal by Subject|0|||
125602828|NCT02115815|451831267|FG004|Overall Study|Withdrawal by Subject|0|||
125602829|NCT02115815|451831268|FG005|Overall Study|Withdrawal by Subject|0|||
125602830|NCT02115815|451831269|FG006|Overall Study|Withdrawal by Subject|0|||
125602831|NCT02115815|451831263|FG000|Overall Study|Not enough drug to dose participant|0|||
125602832|NCT02115815|451831264|FG001|Overall Study|Not enough drug to dose participant|0|||
125602833|NCT02115815|451831265|FG002|Overall Study|Not enough drug to dose participant|0|||
125602834|NCT02115815|451831266|FG003|Overall Study|Not enough drug to dose participant|0|||
125602835|NCT02115815|451831267|FG004|Overall Study|Not enough drug to dose participant|0|||
125602836|NCT02115815|451831268|FG005|Overall Study|Not enough drug to dose participant|1|||
125602837|NCT02115815|451831269|FG006|Overall Study|Not enough drug to dose participant|0|||
125602838|NCT02115815|451831263|FG000|Overall Study|Missed appointment, randomized in error|0|||
125602839|NCT02115815|451831264|FG001|Overall Study|Missed appointment, randomized in error|0|||
125602840|NCT02115815|451831265|FG002|Overall Study|Missed appointment, randomized in error|0|||
125602841|NCT02115815|451831266|FG003|Overall Study|Missed appointment, randomized in error|0|||
125602842|NCT02115815|451831267|FG004|Overall Study|Missed appointment, randomized in error|0|||
125602843|NCT02115815|451831268|FG005|Overall Study|Missed appointment, randomized in error|1|||
125602844|NCT02115815|451831269|FG006|Overall Study|Missed appointment, randomized in error|0|||
125602845|NCT01228071|451831270|FG000|Overall Study|Protocol Violation|1|||
125602846|NCT01228071|451831270|FG000|Overall Study|Withdrawal by Subject|1|||
125602847|NCT03314519|451831271|FG000|Overall Study|Protocol Violation|3|||
125602848|NCT03314519|451831272|FG001|Overall Study|Protocol Violation|2|||
125602849|NCT04003155|451831273|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
125602850|NCT04003155|451831274|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
125602851|NCT04003155|451831275|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
125602852|NCT04003155|451831276|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
125602853|NCT04003155|451831277|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
125602854|NCT04003155|451831273|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
125602855|NCT04003155|451831274|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
125602856|NCT04003155|451831275|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
125602857|NCT04003155|451831276|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
125602858|NCT04003155|451831277|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
125602859|NCT04003155|451831273|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
125602860|NCT04003155|451831274|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
125602861|NCT04003155|451831275|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
125602862|NCT04003155|451831276|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
125602863|NCT04003155|451831277|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
125602864|NCT04003155|451831273|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
125602865|NCT04003155|451831274|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
125602866|NCT04003155|451831275|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
125602867|NCT04003155|451831276|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
125602868|NCT04003155|451831277|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
125602869|NCT04003155|451831273|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
125602870|NCT04003155|451831274|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
125602871|NCT04003155|451831275|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
125602872|NCT04003155|451831276|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
125602873|NCT04003155|451831277|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
125602874|NCT04003155|451831273|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
125602875|NCT04003155|451831274|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
125602876|NCT04003155|451831275|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
125602877|NCT04003155|451831276|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
125602878|NCT04003155|451831277|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
125602879|NCT04003155|451831273|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
125602880|NCT04003155|451831274|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
125602881|NCT04003155|451831275|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
125602882|NCT04003155|451831276|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
125602883|NCT04003155|451831277|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
125602884|NCT04003155|451831273|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
125602885|NCT04003155|451831274|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
125602886|NCT04003155|451831275|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
125602887|NCT04003155|451831276|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
125602888|NCT04003155|451831277|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
125602889|NCT04003155|451831273|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
125602890|NCT04003155|451831274|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
125602891|NCT04003155|451831275|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
125602892|NCT04003155|451831276|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
125602893|NCT04003155|451831277|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
125602894|NCT01912872|451831278|FG000|Overall Study|Lost to Follow-up|2|||
125602895|NCT01912872|451831279|FG001|Overall Study|Lost to Follow-up|3|||
125602896|NCT01912872|451831280|FG002|Overall Study|Lost to Follow-up|5|||
125602897|NCT01912872|451831281|FG003|Overall Study|Lost to Follow-up|5|||
125602898|NCT01912872|451831278|FG000|Overall Study|Other unspecified|3|||
125602899|NCT01912872|451831279|FG001|Overall Study|Other unspecified|1|||
125602900|NCT01912872|451831280|FG002|Overall Study|Other unspecified|3|||
125602901|NCT01912872|451831281|FG003|Overall Study|Other unspecified|0|||
125602902|NCT01912872|451831278|FG000|Overall Study|Informed consent withdrawn|0|||
125602903|NCT01912872|451831279|FG001|Overall Study|Informed consent withdrawn|0|||
125602904|NCT01912872|451831280|FG002|Overall Study|Informed consent withdrawn|1|||
125602905|NCT01912872|451831281|FG003|Overall Study|Informed consent withdrawn|1|||
125602906|NCT01912872|451831278|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
125602907|NCT01912872|451831279|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
125602908|NCT01912872|451831280|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
125602909|NCT01912872|451831281|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
125602910|NCT01912872|451831278|FG000|Overall Study|Protocol Violation|0|||
125602911|NCT01912872|451831279|FG001|Overall Study|Protocol Violation|0|||
125602912|NCT01912872|451831280|FG002|Overall Study|Protocol Violation|1|||
125602913|NCT01912872|451831281|FG003|Overall Study|Protocol Violation|0|||
125602914|NCT01912872|451831278|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125602915|NCT01912872|451831279|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125602916|NCT01912872|451831280|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125602917|NCT01912872|451831281|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
125602918|NCT01912872|451831278|FG000|Overall Study|Withdrawal of study medication|0|||
125602919|NCT01912872|451831279|FG001|Overall Study|Withdrawal of study medication|0|||
125602920|NCT01912872|451831280|FG002|Overall Study|Withdrawal of study medication|0|||
125602921|NCT01912872|451831281|FG003|Overall Study|Withdrawal of study medication|2|||
125602922|NCT01912872|451831278|FG000|Overall Study|Missing|0|||
125602923|NCT01912872|451831279|FG001|Overall Study|Missing|0|||
125602924|NCT01912872|451831280|FG002|Overall Study|Missing|0|||
125602925|NCT01912872|451831281|FG003|Overall Study|Missing|1|||
125602926|NCT01713036|451831282|FG000|Overall Study|Death|1|||
125602927|NCT02778867|451831283|FG000|Phase 1|Withdrawal by Subject|2|||
125602928|NCT02778867|451831284|FG001|Phase 1|Withdrawal by Subject|3|||
125602929|NCT02778867|451831285|FG002|Phase 1|Withdrawal by Subject|0|||
125602930|NCT02778867|451831286|FG003|Phase 1|Withdrawal by Subject|0|||
125602931|NCT02778867|451831283|FG000|Phase 2|Withdrawal by Subject|0|||
125602932|NCT02778867|451831284|FG001|Phase 2|Withdrawal by Subject|0|||
125602933|NCT02778867|451831285|FG002|Phase 2|Withdrawal by Subject|1|||
125602934|NCT02778867|451831286|FG003|Phase 2|Withdrawal by Subject|0|||
125602935|NCT02778867|451831283|FG000|Phase 2|Physician Decision|0|||
125602936|NCT02778867|451831284|FG001|Phase 2|Physician Decision|0|||
125602937|NCT02778867|451831285|FG002|Phase 2|Physician Decision|0|||
125602938|NCT02778867|451831286|FG003|Phase 2|Physician Decision|1|||
125602939|NCT02778867|451831283|FG000|Phase 2|Adverse Event|0|||
125602940|NCT02778867|451831284|FG001|Phase 2|Adverse Event|0|||
125369314|NCT00824720|450984881|FG002|Overall Study|Protocol Violation|1|||
125369315|NCT02777333|450984887|FG000|Overall Study|Withdrawal by Subject|0|||
125369316|NCT02777333|450984888|FG001|Overall Study|Withdrawal by Subject|1|||
125369317|NCT02777333|450984887|FG000|Overall Study|Lost to Follow-up|0|||
125369318|NCT02777333|450984888|FG001|Overall Study|Lost to Follow-up|1|||
125602941|NCT02778867|451831285|FG002|Phase 2|Adverse Event|0|||
125602942|NCT02778867|451831286|FG003|Phase 2|Adverse Event|1|||
125602943|NCT03504774|451831287|FG000|Overall Study|Adverse Event|2|||
125602944|NCT03504774|451831288|FG001|Overall Study|Adverse Event|0|||
125602945|NCT03504774|451831287|FG000|Overall Study|Lost to Follow-up|0|||
125602946|NCT03504774|451831288|FG001|Overall Study|Lost to Follow-up|1|||
125602947|NCT03504774|451831287|FG000|Overall Study|Protocol Violation|11|||
125602948|NCT03504774|451831288|FG001|Overall Study|Protocol Violation|3|||
125602949|NCT03504774|451831287|FG000|Overall Study|failed wk 52 DBPCFC|1|||
125602950|NCT03504774|451831288|FG001|Overall Study|failed wk 52 DBPCFC|0|||
125602951|NCT00915005|451831294|FG000|Overall Study|Withdrawal by Subject|4|||
125369319|NCT00837811|450984889|FG000|Overall Study|Adverse Event|4|||
125369320|NCT00837811|450984890|FG001|Overall Study|Adverse Event|6|||
125602952|NCT00915005|451831295|FG001|Overall Study|Withdrawal by Subject|4|||
125602953|NCT00915005|451831294|FG000|Overall Study|Patient preferred protons therapy|6|||
125602954|NCT00915005|451831295|FG001|Overall Study|Patient preferred protons therapy|0|||
125602955|NCT00915005|451831294|FG000|Overall Study|Insurance denial|3|||
125602956|NCT00915005|451831295|FG001|Overall Study|Insurance denial|15|||
125602957|NCT03648476|451831300|FG000|Overall Study|Withdrawal by Subject|2|||
125602958|NCT03648476|451831301|FG001|Overall Study|Withdrawal by Subject|1|||
125602959|NCT02546856|451831306|FG000|4 Months Evaluation|Death|2|||
125602960|NCT02546856|451831307|FG001|4 Months Evaluation|Death|3|||
125602961|NCT02546856|451831306|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
125602962|NCT02546856|451831307|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
125602963|NCT02546856|451831306|FG000|4 Months Evaluation|Lost to Follow-up|3|||
125602964|NCT02546856|451831307|FG001|4 Months Evaluation|Lost to Follow-up|3|||
125602965|NCT02546856|451831306|FG000|4 Months Evaluation|Physician Decision|3|||
125602966|NCT02546856|451831307|FG001|4 Months Evaluation|Physician Decision|0|||
125602967|NCT02546856|451831306|FG000|4 Months Evaluation|Working or living abroad|5|||
125602968|NCT02546856|451831307|FG001|4 Months Evaluation|Working or living abroad|1|||
125602969|NCT02546856|451831306|FG000|4 Months Evaluation|reasons not due to titration|4|||
125602970|NCT02546856|451831307|FG001|4 Months Evaluation|reasons not due to titration|1|||
125602971|NCT02546856|451831306|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
125602972|NCT02546856|451831307|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
125602973|NCT02546856|451831306|FG000|6 Months Evaluation|Death|1|||
125602974|NCT02546856|451831307|FG001|6 Months Evaluation|Death|1|||
125602975|NCT02546856|451831306|FG000|6 Months Evaluation|Lost to Follow-up|1|||
125602976|NCT02546856|451831307|FG001|6 Months Evaluation|Lost to Follow-up|1|||
125602977|NCT02546856|451831306|FG000|6 Months Evaluation|Working or living abroad|6|||
125602978|NCT02546856|451831307|FG001|6 Months Evaluation|Working or living abroad|4|||
125602979|NCT02546856|451831306|FG000|6 Months Evaluation|reasons not due to titration|0|||
125602980|NCT02546856|451831307|FG001|6 Months Evaluation|reasons not due to titration|1|||
125602981|NCT01097616|451831308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
125602982|NCT01097616|451831309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
125602983|NCT01097616|451831310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
125602984|NCT01097616|451831311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125602985|NCT01097616|451831312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125602986|NCT01097616|451831313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125602987|NCT01097616|451831314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125602988|NCT01097616|451831315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
125602989|NCT01097616|451831308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
125602990|NCT01097616|451831309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
125602991|NCT01097616|451831310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
125602992|NCT01097616|451831311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125602993|NCT01097616|451831312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125602994|NCT01097616|451831313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125602995|NCT01097616|451831314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125602996|NCT01097616|451831315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
125602997|NCT01097616|451831308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
125602998|NCT01097616|451831309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
125602999|NCT01097616|451831310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
125603000|NCT01097616|451831311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125603001|NCT01097616|451831312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125603002|NCT01097616|451831313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125603003|NCT01097616|451831314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125369321|NCT00837811|450984891|FG002|Overall Study|Adverse Event|0|||
125369322|NCT00837811|450984889|FG000|Overall Study|Death|1|||
125369323|NCT00837811|450984890|FG001|Overall Study|Death|1|||
125369324|NCT00837811|450984891|FG002|Overall Study|Death|0|||
125369325|NCT00837811|450984889|FG000|Overall Study|Lack of Efficacy|0|||
125369326|NCT00837811|450984890|FG001|Overall Study|Lack of Efficacy|11|||
125369327|NCT00837811|450984891|FG002|Overall Study|Lack of Efficacy|0|||
125369328|NCT00837811|450984889|FG000|Overall Study|Lost to Follow-up|1|||
125369329|NCT00837811|450984890|FG001|Overall Study|Lost to Follow-up|3|||
125369330|NCT00837811|450984891|FG002|Overall Study|Lost to Follow-up|0|||
125369331|NCT00837811|450984889|FG000|Overall Study|Physician Decision|0|||
125369332|NCT00837811|450984890|FG001|Overall Study|Physician Decision|2|||
125369333|NCT00837811|450984891|FG002|Overall Study|Physician Decision|1|||
125369334|NCT00837811|450984889|FG000|Overall Study|Withdrawal by Subject|1|||
125369335|NCT00837811|450984890|FG001|Overall Study|Withdrawal by Subject|9|||
125369336|NCT00837811|450984891|FG002|Overall Study|Withdrawal by Subject|0|||
125369337|NCT00837811|450984889|FG000|Overall Study|Sponsor Decision|0|||
125369338|NCT00837811|450984890|FG001|Overall Study|Sponsor Decision|2|||
125369339|NCT00837811|450984891|FG002|Overall Study|Sponsor Decision|0|||
125369340|NCT03187197|450986961|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
125369341|NCT03187197|450986962|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
125369342|NCT03187197|450986963|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
125369343|NCT03187197|450986961|FG000|Overall Study|Withdrawal by Subject|8|||
125369344|NCT03187197|450986962|FG001|Overall Study|Withdrawal by Subject|63|||
125603004|NCT01097616|451831315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
125603005|NCT01097616|451831308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
125603006|NCT01097616|451831309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
125603007|NCT01097616|451831310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125603008|NCT01097616|451831311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125603009|NCT01097616|451831312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125603010|NCT01097616|451831313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125603011|NCT01097616|451831314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125603012|NCT01097616|451831315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
125603013|NCT01097616|451831308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
125603014|NCT01097616|451831309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
125603015|NCT01097616|451831310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
125603016|NCT01097616|451831311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125603017|NCT01097616|451831312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125603018|NCT01097616|451831313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125603019|NCT01097616|451831314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125603020|NCT01097616|451831315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
125603021|NCT01097616|451831308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
125603022|NCT01097616|451831309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
125603023|NCT01097616|451831310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
125603024|NCT01097616|451831311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
125603025|NCT01097616|451831312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
125603026|NCT01097616|451831313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
125603027|NCT01097616|451831314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
125603028|NCT01097616|451831315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
125603029|NCT01097616|451831308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
125603030|NCT01097616|451831309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
125603031|NCT01097616|451831310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125603032|NCT01097616|451831311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125603033|NCT01097616|451831312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125603034|NCT01097616|451831313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125369345|NCT03187197|450986963|FG002|Overall Study|Withdrawal by Subject|4|||
125369346|NCT03187197|450986961|FG000|Overall Study|Lost to Follow-up|1|||
125369347|NCT03187197|450986962|FG001|Overall Study|Lost to Follow-up|60|||
125369348|NCT03187197|450986963|FG002|Overall Study|Lost to Follow-up|7|||
125369349|NCT03187197|450986961|FG000|Overall Study|Adverse Event|6|||
125369350|NCT03187197|450986962|FG001|Overall Study|Adverse Event|29|||
125369351|NCT03187197|450986963|FG002|Overall Study|Adverse Event|0|||
125369352|NCT03187197|450986961|FG000|Overall Study|Death|0|||
125369353|NCT03187197|450986962|FG001|Overall Study|Death|11|||
125369354|NCT03187197|450986963|FG002|Overall Study|Death|0|||
125369355|NCT03187197|450986961|FG000|Overall Study|Administrative problem|1|||
125369356|NCT03187197|450986962|FG001|Overall Study|Administrative problem|1|||
125369357|NCT03187197|450986963|FG002|Overall Study|Administrative problem|0|||
125369358|NCT03187197|450986961|FG000|Overall Study|Reason not listed|2|||
125369359|NCT03187197|450986962|FG001|Overall Study|Reason not listed|54|||
125369360|NCT03187197|450986963|FG002|Overall Study|Reason not listed|1|||
125369361|NCT03187197|450986961|FG000|Overall Study|Missing|1|||
125369362|NCT03187197|450986962|FG001|Overall Study|Missing|32|||
125369363|NCT03187197|450986963|FG002|Overall Study|Missing|3|||
125369364|NCT03187197|450986961|FG000|Overall Study|Status missing|2|||
125369365|NCT03187197|450986962|FG001|Overall Study|Status missing|33|||
125369366|NCT03187197|450986963|FG002|Overall Study|Status missing|3|||
125369367|NCT03187197|450986961|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
125369368|NCT03187197|450986962|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
125369369|NCT03187197|450986963|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
125603035|NCT01097616|451831314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125603036|NCT01097616|451831315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
125603037|NCT01097616|451831308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125603038|NCT01097616|451831309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125603039|NCT01097616|451831310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
125603040|NCT01097616|451831311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125603041|NCT01097616|451831312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125603042|NCT01097616|451831313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125603043|NCT01097616|451831314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125603044|NCT01097616|451831315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
125603045|NCT01097616|451831308|FG000|Optional DB EXT Phase|Adverse Event|0|||
125603046|NCT01097616|451831309|FG001|Optional DB EXT Phase|Adverse Event|7|||
125603047|NCT01097616|451831310|FG002|Optional DB EXT Phase|Adverse Event|2|||
125603048|NCT01097616|451831311|FG003|Optional DB EXT Phase|Adverse Event|0|||
125603049|NCT01097616|451831312|FG004|Optional DB EXT Phase|Adverse Event|0|||
125603050|NCT01097616|451831313|FG005|Optional DB EXT Phase|Adverse Event|0|||
125603051|NCT01097616|451831314|FG006|Optional DB EXT Phase|Adverse Event|0|||
125603052|NCT01097616|451831315|FG007|Optional DB EXT Phase|Adverse Event|0|||
125603053|NCT01097616|451831308|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
125603054|NCT01097616|451831309|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
125603055|NCT01097616|451831310|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
125603056|NCT01097616|451831311|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
125603057|NCT01097616|451831312|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
125603058|NCT01097616|451831313|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
125603059|NCT01097616|451831314|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
125603060|NCT01097616|451831315|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
125603061|NCT01097616|451831308|FG000|Optional DB EXT Phase|Protocol Violation|0|||
125603062|NCT01097616|451831309|FG001|Optional DB EXT Phase|Protocol Violation|2|||
125603063|NCT01097616|451831310|FG002|Optional DB EXT Phase|Protocol Violation|3|||
125603064|NCT01097616|451831311|FG003|Optional DB EXT Phase|Protocol Violation|0|||
125603065|NCT01097616|451831312|FG004|Optional DB EXT Phase|Protocol Violation|0|||
125603066|NCT01097616|451831313|FG005|Optional DB EXT Phase|Protocol Violation|0|||
125603067|NCT01097616|451831314|FG006|Optional DB EXT Phase|Protocol Violation|0|||
125603068|NCT01097616|451831315|FG007|Optional DB EXT Phase|Protocol Violation|0|||
125603069|NCT01097616|451831308|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
125603070|NCT01097616|451831309|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
125603071|NCT01097616|451831310|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
125431692|NCT01490125|451207715|FG005|Period III|Death|0|||
125431693|NCT01490125|451207710|FG000|Period III|Lack of Efficacy|0|||
125431694|NCT01490125|451207711|FG001|Period III|Lack of Efficacy|0|||
125431695|NCT01490125|451207712|FG002|Period III|Lack of Efficacy|0|||
125603072|NCT01097616|451831311|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
125603073|NCT01097616|451831312|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
125603074|NCT01097616|451831313|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
125603075|NCT01097616|451831314|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
125603076|NCT01097616|451831315|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
125603077|NCT01097616|451831308|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
125603078|NCT01097616|451831309|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
125369370|NCT02385045|450986964|FG000|Overall Study|Endoscopy could not be completed|4|||
125369371|NCT02871297|450986965|FG000|Overall Study|Adverse Event|34|||
125431696|NCT01490125|451207713|FG003|Period III|Lack of Efficacy|0|||
125603079|NCT01097616|451831310|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
125603080|NCT01097616|451831311|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
125603081|NCT01097616|451831312|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
125603082|NCT01097616|451831313|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
125431697|NCT01490125|451207714|FG004|Period III|Lack of Efficacy|1|||
125603083|NCT01097616|451831314|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
125603084|NCT01097616|451831315|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
125603085|NCT01097616|451831308|FG000|Optional DB EXT Phase|Physician Decision|1|||
125603086|NCT01097616|451831309|FG001|Optional DB EXT Phase|Physician Decision|0|||
125603087|NCT01097616|451831310|FG002|Optional DB EXT Phase|Physician Decision|0|||
125369372|NCT02871297|450986965|FG000|Overall Study|Lack of Efficacy|10|||
125369373|NCT02871297|450986965|FG000|Overall Study|Non-compliance with study drug|15|||
125369374|NCT02871297|450986965|FG000|Overall Study|Protocol Violation|3|||
125431698|NCT01490125|451207715|FG005|Period III|Lack of Efficacy|0|||
125369375|NCT02871297|450986965|FG000|Overall Study|Withdrawal by Subject|20|||
125369376|NCT02871297|450986965|FG000|Overall Study|Lost to Follow-up|13|||
125369377|NCT02871297|450986965|FG000|Overall Study|Rolled over to 13546A|2|||
125369378|NCT02871297|450986965|FG000|Overall Study|Other than specified|39|||
125369379|NCT02034110|450986966|FG000|Overall Study|Physician Decision|0|||
125369380|NCT02034110|450986967|FG001|Overall Study|Physician Decision|0|||
125369381|NCT02034110|450986968|FG002|Overall Study|Physician Decision|0|||
125369382|NCT02034110|450986969|FG003|Overall Study|Physician Decision|0|||
125369383|NCT02034110|450986970|FG004|Overall Study|Physician Decision|2|||
125369384|NCT02034110|450986971|FG005|Overall Study|Physician Decision|0|||
125369385|NCT02034110|450986972|FG006|Overall Study|Physician Decision|1|||
125369386|NCT02034110|450986973|FG007|Overall Study|Physician Decision|0|||
125369387|NCT02034110|450986966|FG000|Overall Study|Lost to Follow-up|1|||
125369388|NCT02034110|450986967|FG001|Overall Study|Lost to Follow-up|0|||
125369389|NCT02034110|450986968|FG002|Overall Study|Lost to Follow-up|0|||
125369390|NCT02034110|450986969|FG003|Overall Study|Lost to Follow-up|0|||
125369391|NCT02034110|450986970|FG004|Overall Study|Lost to Follow-up|1|||
125603088|NCT01097616|451831311|FG003|Optional DB EXT Phase|Physician Decision|0|||
125603089|NCT01097616|451831312|FG004|Optional DB EXT Phase|Physician Decision|0|||
125603090|NCT01097616|451831313|FG005|Optional DB EXT Phase|Physician Decision|0|||
125603091|NCT01097616|451831314|FG006|Optional DB EXT Phase|Physician Decision|0|||
125603092|NCT01097616|451831315|FG007|Optional DB EXT Phase|Physician Decision|0|||
125603093|NCT01097616|451831308|FG000|DB RO Phase|Adverse Event|0|||
125603094|NCT01097616|451831309|FG001|DB RO Phase|Adverse Event|0|||
125603095|NCT01097616|451831310|FG002|DB RO Phase|Adverse Event|0|||
125603096|NCT01097616|451831311|FG003|DB RO Phase|Adverse Event|0|||
125603097|NCT01097616|451831312|FG004|DB RO Phase|Adverse Event|0|||
125603098|NCT01097616|451831313|FG005|DB RO Phase|Adverse Event|0|||
125603099|NCT01097616|451831314|FG006|DB RO Phase|Adverse Event|1|||
125603100|NCT01097616|451831315|FG007|DB RO Phase|Adverse Event|0|||
125603101|NCT01097616|451831308|FG000|DB RO Phase|Withdrawal by Subject|0|||
125603102|NCT01097616|451831309|FG001|DB RO Phase|Withdrawal by Subject|0|||
125603103|NCT01097616|451831310|FG002|DB RO Phase|Withdrawal by Subject|0|||
125603104|NCT01097616|451831311|FG003|DB RO Phase|Withdrawal by Subject|0|||
125603105|NCT01097616|451831312|FG004|DB RO Phase|Withdrawal by Subject|0|||
125603106|NCT01097616|451831313|FG005|DB RO Phase|Withdrawal by Subject|1|||
125603107|NCT01097616|451831314|FG006|DB RO Phase|Withdrawal by Subject|0|||
125603108|NCT01097616|451831315|FG007|DB RO Phase|Withdrawal by Subject|0|||
125603109|NCT01097616|451831308|FG000|DB RO Phase|Lost to Follow-up|0|||
125603110|NCT01097616|451831309|FG001|DB RO Phase|Lost to Follow-up|0|||
125603111|NCT01097616|451831310|FG002|DB RO Phase|Lost to Follow-up|0|||
125603112|NCT01097616|451831311|FG003|DB RO Phase|Lost to Follow-up|1|||
125603113|NCT01097616|451831312|FG004|DB RO Phase|Lost to Follow-up|1|||
125603114|NCT01097616|451831313|FG005|DB RO Phase|Lost to Follow-up|0|||
125603115|NCT01097616|451831314|FG006|DB RO Phase|Lost to Follow-up|0|||
125603116|NCT01097616|451831315|FG007|DB RO Phase|Lost to Follow-up|1|||
125603117|NCT01097616|451831308|FG000|DB RO Phase|Not Treated in RO|0|||
125603118|NCT01097616|451831309|FG001|DB RO Phase|Not Treated in RO|0|||
125603119|NCT01097616|451831310|FG002|DB RO Phase|Not Treated in RO|0|||
125603120|NCT01097616|451831311|FG003|DB RO Phase|Not Treated in RO|0|||
125603121|NCT01097616|451831312|FG004|DB RO Phase|Not Treated in RO|0|||
125603122|NCT01097616|451831313|FG005|DB RO Phase|Not Treated in RO|1|||
125603123|NCT01097616|451831314|FG006|DB RO Phase|Not Treated in RO|0|||
125603124|NCT01097616|451831315|FG007|DB RO Phase|Not Treated in RO|0|||
125603125|NCT02240628|451831317|FG000|Overall Study|Physician Decision|6|||
125603126|NCT02240628|451831318|FG001|Overall Study|Physician Decision|5|||
125603127|NCT01703819|451831322|FG000|Overall Study|Adverse Event|0|||
125603128|NCT01703819|451831323|FG001|Overall Study|Adverse Event|1|||
125603129|NCT01703819|451831322|FG000|Overall Study|Withdrawal by Subject|0|||
125603130|NCT01703819|451831323|FG001|Overall Study|Withdrawal by Subject|1|||
125603131|NCT00859898|451831324|FG000|Overall Study|Lack of Efficacy|0|||
125603132|NCT00859898|451831325|FG001|Overall Study|Lack of Efficacy|1|||
125603133|NCT00859898|451831326|FG002|Overall Study|Lack of Efficacy|1|||
125603134|NCT00859898|451831324|FG000|Overall Study|Adverse Event|4|||
125603135|NCT00859898|451831325|FG001|Overall Study|Adverse Event|9|||
125603136|NCT00859898|451831326|FG002|Overall Study|Adverse Event|8|||
125603137|NCT00859898|451831324|FG000|Overall Study|Withdrawal by Subject|11|||
125603138|NCT00859898|451831325|FG001|Overall Study|Withdrawal by Subject|8|||
125603139|NCT00859898|451831326|FG002|Overall Study|Withdrawal by Subject|11|||
125603140|NCT00859898|451831324|FG000|Overall Study|Death|0|||
125369392|NCT02034110|450986971|FG005|Overall Study|Lost to Follow-up|0|||
125369393|NCT02034110|450986972|FG006|Overall Study|Lost to Follow-up|1|||
125369394|NCT02034110|450986973|FG007|Overall Study|Lost to Follow-up|0|||
125369395|NCT02034110|450986966|FG000|Overall Study|Withdrawal by Subject|5|||
125369396|NCT02034110|450986967|FG001|Overall Study|Withdrawal by Subject|7|||
125369397|NCT02034110|450986968|FG002|Overall Study|Withdrawal by Subject|0|||
125369398|NCT02034110|450986969|FG003|Overall Study|Withdrawal by Subject|3|||
125369399|NCT02034110|450986970|FG004|Overall Study|Withdrawal by Subject|7|||
125369400|NCT02034110|450986971|FG005|Overall Study|Withdrawal by Subject|0|||
125603141|NCT00859898|451831325|FG001|Overall Study|Death|0|||
125603142|NCT00859898|451831326|FG002|Overall Study|Death|1|||
125369401|NCT02034110|450986972|FG006|Overall Study|Withdrawal by Subject|3|||
125369402|NCT02034110|450986973|FG007|Overall Study|Withdrawal by Subject|1|||
125369403|NCT02034110|450986966|FG000|Overall Study|Study closed by sponsor|6|||
125369404|NCT02034110|450986967|FG001|Overall Study|Study closed by sponsor|2|||
125369405|NCT02034110|450986968|FG002|Overall Study|Study closed by sponsor|0|||
125369406|NCT02034110|450986969|FG003|Overall Study|Study closed by sponsor|6|||
125369407|NCT02034110|450986970|FG004|Overall Study|Study closed by sponsor|7|||
125369408|NCT02034110|450986971|FG005|Overall Study|Study closed by sponsor|0|||
125369409|NCT02034110|450986972|FG006|Overall Study|Study closed by sponsor|42|||
125369410|NCT02034110|450986973|FG007|Overall Study|Study closed by sponsor|0|||
125369411|NCT00621985|450986974|FG000|Dexamethasone Admission|Adverse Event|1|||
125369412|NCT01877265|450986976|FG000|Treatment Period 1|Sponsor Decision|0|||
125369413|NCT01877265|450986977|FG001|Treatment Period 1|Sponsor Decision|0|||
125369414|NCT01877265|450986978|FG002|Treatment Period 1|Sponsor Decision|1|||
125369415|NCT01877265|450986979|FG003|Treatment Period 1|Sponsor Decision|0|||
125369416|NCT01877265|450986980|FG004|Treatment Period 1|Sponsor Decision|0|||
125369417|NCT01877265|450986981|FG005|Treatment Period 1|Sponsor Decision|0|||
125369418|NCT01877265|450986976|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
125369419|NCT01877265|450986977|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
125369420|NCT01877265|450986978|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
125369421|NCT01877265|450986979|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
125369422|NCT01877265|450986980|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
125369423|NCT01877265|450986981|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
125369424|NCT01877265|450986976|FG000|Treatment Period 3|Lost to Follow-up|1|||
125369425|NCT01877265|450986977|FG001|Treatment Period 3|Lost to Follow-up|0|||
125369426|NCT01877265|450986978|FG002|Treatment Period 3|Lost to Follow-up|0|||
125369427|NCT01877265|450986979|FG003|Treatment Period 3|Lost to Follow-up|0|||
125369428|NCT01877265|450986980|FG004|Treatment Period 3|Lost to Follow-up|0|||
125369429|NCT01877265|450986981|FG005|Treatment Period 3|Lost to Follow-up|0|||
125369430|NCT00691015|450986982|FG000|Overall Study|Refused further treatment|1|||
125369431|NCT04160195|450986983|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
125369432|NCT04160195|450986984|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
125369433|NCT00684593|450986988|FG000|Overall Study|Adverse Event|0|||
125369434|NCT00684593|450986989|FG001|Overall Study|Adverse Event|2|||
125369435|NCT00590720|450986992|FG000|Overall Study|Lost to Follow-up|1|||
125369436|NCT00590720|450986993|FG001|Overall Study|Lost to Follow-up|0|||
125369437|NCT00590720|450986992|FG000|Overall Study|Withdrawal by Subject|0|||
125369438|NCT00590720|450986993|FG001|Overall Study|Withdrawal by Subject|1|||
125369439|NCT01001377|450986994|FG000|Overall Study|Ineligibility determined|2|||
125369440|NCT01001377|450986995|FG001|Overall Study|Ineligibility determined|0|||
125369441|NCT01001377|450986994|FG000|Overall Study|Withdrawal by Subject|19|||
125369442|NCT01001377|450986995|FG001|Overall Study|Withdrawal by Subject|20|||
125369443|NCT01001377|450986994|FG000|Overall Study|Lost to Follow-up|14|||
125369444|NCT01001377|450986995|FG001|Overall Study|Lost to Follow-up|17|||
125369445|NCT01001377|450986994|FG000|Overall Study|Death|391|||
125369446|NCT01001377|450986995|FG001|Overall Study|Death|384|||
125369447|NCT02193867|450986998|FG000|Overall Study|Death|2|||
125369448|NCT02193867|450986998|FG000|Overall Study|Sponsor Study Termination|2|||
125369449|NCT03616600|450986999|FG000|Overall Study|Withdrawal by Subject|1|||
125369450|NCT03616600|450987000|FG001|Overall Study|Withdrawal by Subject|0|||
125369451|NCT03600818|450987001|FG000|Overall Study|Adverse Event|4|||
125369452|NCT03600818|450987002|FG001|Overall Study|Adverse Event|7|||
125369453|NCT03600818|450987001|FG000|Overall Study|Lack of Efficacy|9|||
125603143|NCT00859898|451831324|FG000|Overall Study|Lost to Follow-up|10|||
125603144|NCT00859898|451831325|FG001|Overall Study|Lost to Follow-up|11|||
125603145|NCT00859898|451831326|FG002|Overall Study|Lost to Follow-up|5|||
125603146|NCT00859898|451831324|FG000|Overall Study|poor/non-compliance|2|||
125603147|NCT00859898|451831325|FG001|Overall Study|poor/non-compliance|0|||
125603148|NCT00859898|451831326|FG002|Overall Study|poor/non-compliance|0|||
125603149|NCT00859898|451831324|FG000|Overall Study|No longer meets criteria|0|||
125603150|NCT00859898|451831325|FG001|Overall Study|No longer meets criteria|1|||
125603151|NCT00859898|451831326|FG002|Overall Study|No longer meets criteria|0|||
125603152|NCT00859898|451831324|FG000|Overall Study|non-specified|1|||
125603153|NCT00859898|451831325|FG001|Overall Study|non-specified|1|||
125369454|NCT03600818|450987002|FG001|Overall Study|Lack of Efficacy|4|||
125369455|NCT03600818|450987001|FG000|Overall Study|Withdrawal by Subject|4|||
125369456|NCT03600818|450987002|FG001|Overall Study|Withdrawal by Subject|3|||
125369457|NCT03600818|450987001|FG000|Overall Study|Other-unspecified|5|||
125369458|NCT03600818|450987002|FG001|Overall Study|Other-unspecified|3|||
125369459|NCT03600818|450987001|FG000|Overall Study|Randomized and not treated|0|||
125603154|NCT00859898|451831326|FG002|Overall Study|non-specified|1|||
125369460|NCT03600818|450987002|FG001|Overall Study|Randomized and not treated|1|||
125369461|NCT01488370|450987006|FG000|Overall Study|Protocol Violation|0|||
125369462|NCT01488370|450987007|FG001|Overall Study|Protocol Violation|1|||
125369463|NCT01488370|450987008|FG002|Overall Study|Protocol Violation|1|||
125369464|NCT01471171|450987009|FG000|Treatment Period 1|Adverse Event|4|||
125369465|NCT01471171|450987010|FG001|Treatment Period 1|Adverse Event|1|||
125369466|NCT01471171|450987009|FG000|Treatment Period 2|Adverse Event|1|||
125369467|NCT01471171|450987010|FG001|Treatment Period 2|Adverse Event|0|||
125369468|NCT03478930|450987012|FG000|Overall Study|Adverse Event|0|||
125369469|NCT03478930|450987013|FG001|Overall Study|Adverse Event|1|||
125369470|NCT03478930|450987012|FG000|Overall Study|Lack of Efficacy|3|||
125369471|NCT03478930|450987013|FG001|Overall Study|Lack of Efficacy|3|||
125369472|NCT03478930|450987012|FG000|Overall Study|Withdrawal by Subject|6|||
125369473|NCT03478930|450987013|FG001|Overall Study|Withdrawal by Subject|5|||
125369474|NCT04189081|450987014|FG000|Overall Study|Lost to Follow-up|1|||
125369475|NCT04189081|450987015|FG001|Overall Study|Lost to Follow-up|0|||
125369476|NCT04189081|450987016|FG002|Overall Study|Lost to Follow-up|0|||
125369477|NCT04189081|450987014|FG000|Overall Study|Withdrawal by Subject|0|||
125369478|NCT04189081|450987015|FG001|Overall Study|Withdrawal by Subject|0|||
125369479|NCT04189081|450987016|FG002|Overall Study|Withdrawal by Subject|1|||
125369480|NCT00705484|450987019|FG000|Overall Study|Adverse Event|28|||
125369481|NCT00705484|450987020|FG001|Overall Study|Adverse Event|27|||
125369482|NCT00705484|450987019|FG000|Overall Study|Lost to Follow-up|169|||
125369483|NCT00705484|450987020|FG001|Overall Study|Lost to Follow-up|250|||
125369484|NCT00705484|450987019|FG000|Overall Study|Withdrawal by Subject|96|||
125369485|NCT00705484|450987020|FG001|Overall Study|Withdrawal by Subject|72|||
125369486|NCT00705484|450987019|FG000|Overall Study|Administrative|89|||
125369487|NCT00705484|450987020|FG001|Overall Study|Administrative|59|||
125369488|NCT03982368|450987028|FG000|Overall Study|Adverse Event|6|||
125369489|NCT03982368|450987029|FG001|Overall Study|Adverse Event|4|||
125369490|NCT03982368|450987030|FG002|Overall Study|Adverse Event|3|||
125369491|NCT03982368|450987028|FG000|Overall Study|Lost to Follow-up|2|||
125369492|NCT03982368|450987029|FG001|Overall Study|Lost to Follow-up|1|||
125369493|NCT03982368|450987030|FG002|Overall Study|Lost to Follow-up|0|||
125369494|NCT03982368|450987028|FG000|Overall Study|Withdrawal by Subject|1|||
125369495|NCT03982368|450987029|FG001|Overall Study|Withdrawal by Subject|2|||
125369496|NCT03982368|450987030|FG002|Overall Study|Withdrawal by Subject|0|||
125369497|NCT03982368|450987028|FG000|Overall Study|unknow|4|||
125369498|NCT03982368|450987029|FG001|Overall Study|unknow|0|||
125369499|NCT03982368|450987030|FG002|Overall Study|unknow|2|||
125369500|NCT03706079|450987031|FG000|Predecessor Study|Death|0|||
125369501|NCT03706079|450987032|FG001|Predecessor Study|Death|2|||
125369502|NCT03706079|450987033|FG002|Predecessor Study|Death|0|||
125369503|NCT03706079|450987034|FG003|Predecessor Study|Death|1|||
125369504|NCT03706079|450987035|FG004|Predecessor Study|Death|0|||
125369505|NCT03706079|450987036|FG005|Predecessor Study|Death|0|||
125369506|NCT03706079|450987031|FG000|Predecessor Study|Lost to Follow-up|5|||
125369507|NCT03706079|450987032|FG001|Predecessor Study|Lost to Follow-up|2|||
125369508|NCT03706079|450987033|FG002|Predecessor Study|Lost to Follow-up|0|||
125369509|NCT03706079|450987034|FG003|Predecessor Study|Lost to Follow-up|0|||
125603155|NCT02145156|451831327|FG000|Overall Study|No match to vaccination records|60|||
125603156|NCT02145156|451831328|FG001|Overall Study|No match to vaccination records|52|||
125603157|NCT02145156|451831329|FG002|Overall Study|No match to vaccination records|41|||
125603158|NCT01302041|451831330|FG000|Overall Study|Death|5|||
125603159|NCT01302041|451831330|FG000|Overall Study|Withdrawal by Subject|4|||
125603160|NCT01302041|451831330|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
125603161|NCT01302041|451831330|FG000|Overall Study|Other-Miscellaneous Reason|2|||
125603162|NCT04504032|451831333|FG000|Overall Study|Adverse Event|1|||
125603163|NCT04504032|451831334|FG001|Overall Study|Adverse Event|2|||
125603164|NCT04504032|451831333|FG000|Overall Study|Lost to Follow-up|6|||
125603165|NCT04504032|451831334|FG001|Overall Study|Lost to Follow-up|9|||
125603166|NCT04504032|451831333|FG000|Overall Study|Protocol Violation|2|||
125369510|NCT03706079|450987035|FG004|Predecessor Study|Lost to Follow-up|1|||
125369511|NCT03706079|450987036|FG005|Predecessor Study|Lost to Follow-up|0|||
125369512|NCT03706079|450987031|FG000|Predecessor Study|Withdrawal by Subject|8|||
125369513|NCT03706079|450987032|FG001|Predecessor Study|Withdrawal by Subject|15|||
125603167|NCT04504032|451831334|FG001|Overall Study|Protocol Violation|0|||
125603168|NCT04504032|451831333|FG000|Overall Study|Study terminated by sponsor|1|||
125369514|NCT03706079|450987033|FG002|Predecessor Study|Withdrawal by Subject|0|||
125369515|NCT03706079|450987034|FG003|Predecessor Study|Withdrawal by Subject|5|||
125369516|NCT03706079|450987035|FG004|Predecessor Study|Withdrawal by Subject|2|||
125369517|NCT03706079|450987036|FG005|Predecessor Study|Withdrawal by Subject|0|||
125369518|NCT03706079|450987031|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
125369519|NCT03706079|450987032|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
125369520|NCT03706079|450987033|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
125603169|NCT04504032|451831334|FG001|Overall Study|Study terminated by sponsor|2|||
125603170|NCT04504032|451831333|FG000|Overall Study|Withdrawal by Subject|9|||
125603171|NCT04504032|451831334|FG001|Overall Study|Withdrawal by Subject|11|||
125369521|NCT03706079|450987034|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
125369522|NCT03706079|450987035|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
125369523|NCT03706079|450987036|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
125369524|NCT03706079|450987031|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
125369525|NCT03706079|450987032|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
125369526|NCT03706079|450987033|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
125369527|NCT03706079|450987034|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
125369528|NCT03706079|450987035|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
125369529|NCT03706079|450987036|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
125603172|NCT04504032|451831333|FG000|Overall Study|Disease progression prior to dosing|15|||
125603173|NCT04504032|451831334|FG001|Overall Study|Disease progression prior to dosing|3|||
125603174|NCT04504032|451831333|FG000|Overall Study|Drug supply issues|1|||
125603175|NCT04504032|451831334|FG001|Overall Study|Drug supply issues|1|||
125603176|NCT04504032|451831333|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
125603177|NCT04504032|451831334|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
125603178|NCT00771030|451831335|FG000|Overall Study|Adverse Event|0|||
125603179|NCT00771030|451831336|FG001|Overall Study|Adverse Event|1|||
125603180|NCT00771030|451831337|FG002|Overall Study|Adverse Event|0|||
125603181|NCT00771030|451831338|FG003|Overall Study|Adverse Event|0|||
125603182|NCT00771030|451831339|FG004|Overall Study|Adverse Event|0|||
125603183|NCT00771030|451831340|FG005|Overall Study|Adverse Event|0|||
125603184|NCT00771030|451831341|FG006|Overall Study|Adverse Event|0|||
125603185|NCT01839188|451831342|FG000|Overall Study|Withdrawal by Subject|1|||
125603186|NCT02416908|451831343|FG000|Dose Escalation Phase|Adverse Event|0|||
125603187|NCT02416908|451831344|FG001|Dose Escalation Phase|Adverse Event|0|||
125603188|NCT02416908|451831345|FG002|Dose Escalation Phase|Adverse Event|3|||
125603189|NCT02416908|451831346|FG003|Dose Escalation Phase|Adverse Event|0|||
125603190|NCT02416908|451831343|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
125603191|NCT02416908|451831344|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
125603192|NCT02416908|451831345|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
125603193|NCT02416908|451831346|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
125603194|NCT01797783|451831347|FG000|Overall Study|Adverse Event|1|||
125603195|NCT01797783|451831348|FG001|Overall Study|Adverse Event|1|||
125603196|NCT01797783|451831347|FG000|Overall Study|Withdrawal by Subject|1|||
125603197|NCT01797783|451831348|FG001|Overall Study|Withdrawal by Subject|0|||
125603198|NCT00940342|451831349|FG000|Overall Study|Adverse Event|0|||
125603199|NCT00940342|451831350|FG001|Overall Study|Adverse Event|2|||
125603200|NCT00940342|451831351|FG002|Overall Study|Adverse Event|1|||
125603201|NCT05232097|451831352|FG000|Overall Study|Physician Decision|1|||
125603202|NCT01327339|451831353|FG000|Overall Study|Protocol Violation|8|||
125603203|NCT00700752|451831358|FG000|First Intervention|Withdrawal by Subject|0|||
125603204|NCT00700752|451831359|FG001|First Intervention|Withdrawal by Subject|2|||
125603205|NCT03662334|451831360|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
125603206|NCT03662334|451831361|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
125603207|NCT01097330|451831364|FG000|Overall Study|Study terminated early|7|||
125603208|NCT01097330|451831365|FG001|Overall Study|Study terminated early|5|||
125603209|NCT00864227|451831370|FG000|Overall Study|Withdrawal by Subject|1|||
125603210|NCT00864227|451831370|FG000|Overall Study|Disease Relapse/Progression|3|||
125603211|NCT03461289|451831373|FG000|Overall Study|Death|1|||
125603212|NCT00081289|451831374|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
125603213|NCT00081289|451831375|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
125603214|NCT00081289|451831374|FG000|Overall Study|Ineligible / no protocol treatment|3|||
125603215|NCT00081289|451831375|FG001|Overall Study|Ineligible / no protocol treatment|4|||
125603216|NCT00916721|451831376|FG000|Overall Study|Lost to Follow-up|0|||
125603217|NCT00916721|451831377|FG001|Overall Study|Lost to Follow-up|1|||
125603218|NCT00916721|451831376|FG000|Overall Study|Adverse Event|6|||
125603219|NCT00916721|451831377|FG001|Overall Study|Adverse Event|3|||
125603220|NCT00916721|451831376|FG000|Overall Study|Withdrawal by Subject|2|||
125369530|NCT03706079|450987031|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
125369531|NCT03706079|450987032|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
125369532|NCT03706079|450987033|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
125369533|NCT03706079|450987034|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
125369534|NCT03706079|450987035|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
125369535|NCT03706079|450987036|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
125369536|NCT03706079|450987031|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
125603221|NCT00916721|451831377|FG001|Overall Study|Withdrawal by Subject|2|||
125603222|NCT00916721|451831376|FG000|Overall Study|Protocol Violation|2|||
125603223|NCT00916721|451831377|FG001|Overall Study|Protocol Violation|4|||
125603224|NCT01469052|451831382|FG000|Overall Study|Adverse Event|2|||
125603225|NCT01469052|451831383|FG001|Overall Study|Adverse Event|3|||
125603226|NCT01469052|451831384|FG002|Overall Study|Adverse Event|0|||
125603227|NCT01469052|451831385|FG003|Overall Study|Adverse Event|2|||
125603228|NCT01469052|451831386|FG004|Overall Study|Adverse Event|0|||
125603229|NCT01469052|451831387|FG005|Overall Study|Adverse Event|1|||
125603230|NCT01469052|451831382|FG000|Overall Study|Progressive disease|3|||
125603231|NCT01469052|451831383|FG001|Overall Study|Progressive disease|0|||
125603232|NCT01469052|451831384|FG002|Overall Study|Progressive disease|5|||
125603233|NCT01469052|451831385|FG003|Overall Study|Progressive disease|3|||
125603234|NCT01469052|451831386|FG004|Overall Study|Progressive disease|7|||
125603235|NCT01469052|451831387|FG005|Overall Study|Progressive disease|2|||
125603236|NCT01469052|451831382|FG000|Overall Study|Lack of Efficacy|0|||
125603237|NCT01469052|451831383|FG001|Overall Study|Lack of Efficacy|0|||
125603238|NCT01469052|451831384|FG002|Overall Study|Lack of Efficacy|0|||
125603239|NCT01469052|451831385|FG003|Overall Study|Lack of Efficacy|0|||
125603240|NCT01469052|451831386|FG004|Overall Study|Lack of Efficacy|0|||
125603241|NCT01469052|451831387|FG005|Overall Study|Lack of Efficacy|2|||
125603242|NCT01469052|451831382|FG000|Overall Study|Moved to rollover protocol|1|||
125603243|NCT01469052|451831383|FG001|Overall Study|Moved to rollover protocol|0|||
125603244|NCT01469052|451831384|FG002|Overall Study|Moved to rollover protocol|1|||
125603245|NCT01469052|451831385|FG003|Overall Study|Moved to rollover protocol|0|||
125603246|NCT01469052|451831386|FG004|Overall Study|Moved to rollover protocol|0|||
125603247|NCT01469052|451831387|FG005|Overall Study|Moved to rollover protocol|1|||
125603248|NCT01469052|451831382|FG000|Overall Study|Other|0|||
125603249|NCT01469052|451831383|FG001|Overall Study|Other|1|||
125603250|NCT01469052|451831384|FG002|Overall Study|Other|0|||
125603251|NCT01469052|451831385|FG003|Overall Study|Other|0|||
125603252|NCT01469052|451831386|FG004|Overall Study|Other|1|||
125603253|NCT01469052|451831387|FG005|Overall Study|Other|0|||
125603254|NCT02749370|451831391|FG000|Overall Study|Withdrawal by Subject|11|||
125603255|NCT02749370|451831391|FG000|Overall Study|Lost to Follow-up|3|||
125603256|NCT01519427|451831395|FG000|Overall Study|disease progression|2|||
125603257|NCT03894904|451831396|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
125603258|NCT03894904|451831397|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
125603259|NCT03894904|451831396|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
125603260|NCT03894904|451831397|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
125603261|NCT03242759|451831398|FG000|Overall Study|Adverse Event|5|||
125603262|NCT03242759|451831399|FG001|Overall Study|Adverse Event|1|||
125603263|NCT03242759|451831398|FG000|Overall Study|Withdrawal by Subject|4|||
125603264|NCT03242759|451831399|FG001|Overall Study|Withdrawal by Subject|3|||
125603265|NCT03242759|451831398|FG000|Overall Study|Lost to Follow-up|3|||
125603266|NCT03242759|451831399|FG001|Overall Study|Lost to Follow-up|1|||
125603267|NCT03242759|451831398|FG000|Overall Study|Administrative problems|1|||
125603268|NCT03242759|451831399|FG001|Overall Study|Administrative problems|1|||
125603269|NCT03242759|451831398|FG000|Overall Study|Death|22|||
125603270|NCT03242759|451831399|FG001|Overall Study|Death|0|||
125603271|NCT03242759|451831398|FG000|Overall Study|Change visit schedule|0|||
125603272|NCT03242759|451831399|FG001|Overall Study|Change visit schedule|1|||
125603273|NCT02522481|451831403|FG000|Overall Study|discontinued|1|||
125603274|NCT02522481|451831403|FG000|Overall Study|Not dosed|2|||
125369537|NCT03706079|450987032|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
125603275|NCT00404768|451831406|FG000|Part A and B|Withdrawn due to labor progression|1|||
125603276|NCT00404768|451831407|FG001|Part A and B|Withdrawn due to labor progression|0|||
125603277|NCT00404768|451831408|FG002|Part A and B|Withdrawn due to labor progression|0|||
125603278|NCT00404768|451831409|FG003|Part A and B|Withdrawn due to labor progression|0|||
125603279|NCT00404768|451831406|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
125603280|NCT00404768|451831407|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
125603281|NCT00404768|451831408|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
125603282|NCT00404768|451831409|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
125603283|NCT00404768|451831406|FG000|Part C|Adverse Event|0|||
125603284|NCT00404768|451831407|FG001|Part C|Adverse Event|0|||
125603285|NCT00404768|451831408|FG002|Part C|Adverse Event|0|||
125603286|NCT00404768|451831409|FG003|Part C|Adverse Event|3|||
125603287|NCT00404768|451831406|FG000|Part C|Lost to Follow-up|0|||
125603288|NCT00404768|451831407|FG001|Part C|Lost to Follow-up|0|||
125603289|NCT00404768|451831408|FG002|Part C|Lost to Follow-up|3|||
125603290|NCT00404768|451831409|FG003|Part C|Lost to Follow-up|1|||
125603291|NCT00404768|451831406|FG000|Part C|Withdrawal by Subject|0|||
125603292|NCT00404768|451831407|FG001|Part C|Withdrawal by Subject|0|||
125603293|NCT00404768|451831408|FG002|Part C|Withdrawal by Subject|2|||
125603294|NCT00404768|451831409|FG003|Part C|Withdrawal by Subject|1|||
125603295|NCT00404768|451831406|FG000|Part C|Early withdrawal from study medication|0|||
125603296|NCT00404768|451831407|FG001|Part C|Early withdrawal from study medication|0|||
125603297|NCT00404768|451831408|FG002|Part C|Early withdrawal from study medication|1|||
125603298|NCT00404768|451831409|FG003|Part C|Early withdrawal from study medication|0|||
125603299|NCT00404768|451831406|FG000|Part C|Participant did not respond to therapy|0|||
125603300|NCT00404768|451831407|FG001|Part C|Participant did not respond to therapy|0|||
125603301|NCT00404768|451831408|FG002|Part C|Participant did not respond to therapy|1|||
125603302|NCT00404768|451831409|FG003|Part C|Participant did not respond to therapy|1|||
125603303|NCT00404768|451831406|FG000|Part C|Physician withdrew the study medication|0|||
125603304|NCT00404768|451831407|FG001|Part C|Physician withdrew the study medication|0|||
125603305|NCT00404768|451831408|FG002|Part C|Physician withdrew the study medication|1|||
125603306|NCT00404768|451831409|FG003|Part C|Physician withdrew the study medication|0|||
125603307|NCT00404768|451831406|FG000|Part C|Participant delivered baby|0|||
125603308|NCT00404768|451831407|FG001|Part C|Participant delivered baby|0|||
125603309|NCT00404768|451831408|FG002|Part C|Participant delivered baby|0|||
125603310|NCT00404768|451831409|FG003|Part C|Participant delivered baby|1|||
125603311|NCT00404768|451831406|FG000|Part C|Unsatisfactory uterine response to IP|0|||
125603312|NCT00404768|451831407|FG001|Part C|Unsatisfactory uterine response to IP|0|||
125603313|NCT00404768|451831408|FG002|Part C|Unsatisfactory uterine response to IP|0|||
125603314|NCT00404768|451831409|FG003|Part C|Unsatisfactory uterine response to IP|1|||
125603315|NCT00404768|451831406|FG000|Part C|Active labor|0|||
125603316|NCT00404768|451831407|FG001|Part C|Active labor|0|||
125603317|NCT00404768|451831408|FG002|Part C|Active labor|0|||
125603318|NCT00404768|451831409|FG003|Part C|Active labor|1|||
125603319|NCT00404768|451831406|FG000|Part C|Lack of Efficacy|0|||
125603320|NCT00404768|451831407|FG001|Part C|Lack of Efficacy|0|||
125603321|NCT00404768|451831408|FG002|Part C|Lack of Efficacy|0|||
125603322|NCT00404768|451831409|FG003|Part C|Lack of Efficacy|2|||
125603323|NCT00404768|451831406|FG000|Part C|Treatment failure|0|||
125603324|NCT00404768|451831407|FG001|Part C|Treatment failure|0|||
125603325|NCT00404768|451831408|FG002|Part C|Treatment failure|0|||
125603326|NCT00404768|451831409|FG003|Part C|Treatment failure|1|||
125603327|NCT00404768|451831406|FG000|Part C|Investigator discretion|0|||
125603328|NCT00404768|451831407|FG001|Part C|Investigator discretion|0|||
125603329|NCT00404768|451831408|FG002|Part C|Investigator discretion|0|||
125603330|NCT00404768|451831409|FG003|Part C|Investigator discretion|1|||
125603331|NCT00404768|451831406|FG000|Part C|Researcher suspended study medication|0|||
125603332|NCT00404768|451831407|FG001|Part C|Researcher suspended study medication|0|||
125603333|NCT00404768|451831408|FG002|Part C|Researcher suspended study medication|0|||
125603334|NCT00404768|451831409|FG003|Part C|Researcher suspended study medication|1|||
125603335|NCT04773041|451831410|FG000|Overall Study|Unable to data match|1|||
125603336|NCT04773041|451831411|FG001|Overall Study|Unable to data match|0|||
125603337|NCT04773041|451831412|FG002|Overall Study|Unable to data match|0|||
125603338|NCT01240811|451832646|FG000|Overall Study|Physician Decision|0|||
125603339|NCT01240811|451832647|FG001|Overall Study|Physician Decision|1|||
125603340|NCT01240811|451832648|FG002|Overall Study|Physician Decision|0|||
125603341|NCT01240811|451832646|FG000|Overall Study|Withdrawal by Subject|0|||
125603342|NCT01240811|451832647|FG001|Overall Study|Withdrawal by Subject|0|||
125603343|NCT01240811|451832648|FG002|Overall Study|Withdrawal by Subject|1|||
125603344|NCT03132805|451832651|FG000|Overall Study|Lost to Follow-up|142|||
125603345|NCT03132805|451832652|FG001|Overall Study|Lost to Follow-up|141|||
125603346|NCT03132805|451832653|FG002|Overall Study|Lost to Follow-up|113|||
125603347|NCT00710034|451832654|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
125603348|NCT00710034|451832655|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
125603349|NCT00710034|451832654|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
125603350|NCT00710034|451832655|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
125603351|NCT00710034|451832654|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
125603352|NCT00710034|451832655|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
125603353|NCT00710034|451832654|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
125603354|NCT00710034|451832655|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
125603355|NCT00710034|451832654|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
125603356|NCT00710034|451832655|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
125603357|NCT00710034|451832654|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
125603358|NCT00710034|451832655|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
125603359|NCT00710034|451832654|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
125603360|NCT00710034|451832655|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
125369538|NCT03706079|450987033|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
125369539|NCT03706079|450987034|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
125369540|NCT03706079|450987035|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
125369541|NCT03706079|450987036|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
125369542|NCT03706079|450987031|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
125369543|NCT03706079|450987032|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
125369544|NCT03706079|450987033|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
125369545|NCT03706079|450987034|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
125369546|NCT03706079|450987035|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
125369547|NCT03706079|450987036|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
125369548|NCT03706079|450987031|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
125369549|NCT03706079|450987032|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
125369550|NCT03706079|450987033|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
125603361|NCT00710034|451832654|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
125603362|NCT00710034|451832655|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
125603363|NCT00710034|451832654|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
125603364|NCT00710034|451832655|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
125603365|NCT00710034|451832654|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
125603366|NCT00710034|451832655|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
125603367|NCT00710034|451832654|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
125603368|NCT00710034|451832655|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
125603369|NCT00500149|451832656|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
125603370|NCT00500149|451832657|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
125603371|NCT00500149|451832656|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
125603372|NCT00500149|451832657|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
125603373|NCT00500149|451832656|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
125603374|NCT00500149|451832657|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
125603375|NCT00500149|451832656|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
125603376|NCT00500149|451832657|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
125603377|NCT00500149|451832656|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
125603378|NCT00500149|451832657|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
125603379|NCT00500149|451832656|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
125603380|NCT00500149|451832657|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
125603381|NCT00500149|451832656|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
125603382|NCT00500149|451832657|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
125603383|NCT01158534|451832658|FG000|Overall Study|Withdrawal by Subject|1|||
125603384|NCT01158534|451832658|FG000|Overall Study|Death|1|||
125603385|NCT01158534|451832658|FG000|Overall Study|Other|1|||
125603386|NCT00521339|451832659|FG000|Treatment Phase|Adverse Event|2|||
125603387|NCT00521339|451832660|FG001|Treatment Phase|Adverse Event|0|||
125603388|NCT00521339|451832661|FG002|Treatment Phase|Adverse Event|0|||
125603389|NCT00521339|451832659|FG000|Treatment Phase|Intolerability to study drug|2|||
125603390|NCT00521339|451832660|FG001|Treatment Phase|Intolerability to study drug|0|||
125603391|NCT00521339|451832661|FG002|Treatment Phase|Intolerability to study drug|0|||
125603392|NCT00521339|451832659|FG000|Treatment Phase|Lack of Efficacy|3|||
125603393|NCT00521339|451832660|FG001|Treatment Phase|Lack of Efficacy|0|||
125603394|NCT00521339|451832661|FG002|Treatment Phase|Lack of Efficacy|0|||
125603395|NCT00521339|451832659|FG000|Treatment Phase|Withdrawal by Subject|3|||
125603396|NCT00521339|451832660|FG001|Treatment Phase|Withdrawal by Subject|0|||
125603397|NCT00521339|451832661|FG002|Treatment Phase|Withdrawal by Subject|0|||
125603398|NCT00521339|451832659|FG000|Treatment Phase|Lost to Follow-up|1|||
125603399|NCT00521339|451832660|FG001|Treatment Phase|Lost to Follow-up|0|||
125603400|NCT00521339|451832661|FG002|Treatment Phase|Lost to Follow-up|0|||
125603401|NCT00521339|451832659|FG000|Treatment Phase|Protocol Violation|1|||
125603402|NCT00521339|451832660|FG001|Treatment Phase|Protocol Violation|0|||
125603403|NCT00521339|451832661|FG002|Treatment Phase|Protocol Violation|0|||
125603404|NCT00521339|451832659|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
125603405|NCT00521339|451832660|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
125603406|NCT00521339|451832661|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
125603407|NCT00521339|451832659|FG000|Treatment Extension Phase|Death|0|||
125603408|NCT00521339|451832660|FG001|Treatment Extension Phase|Death|0|||
125369551|NCT03706079|450987034|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
125431699|NCT02237508|451207717|FG000|Overall Study|Withdrawal by Subject|0|||
125431700|NCT02237508|451207718|FG001|Overall Study|Withdrawal by Subject|2|||
125431701|NCT02237508|451207719|FG002|Overall Study|Withdrawal by Subject|0|||
125431702|NCT02237508|451207720|FG003|Overall Study|Withdrawal by Subject|1|||
125603409|NCT00521339|451832661|FG002|Treatment Extension Phase|Death|1|||
125603410|NCT00950690|451832662|FG000|Overall Study|Death|4|||
125603411|NCT00950690|451832662|FG000|Overall Study|Adverse Event|15|||
125431703|NCT02237508|451207721|FG004|Overall Study|Withdrawal by Subject|0|||
125431704|NCT02237508|451207722|FG005|Overall Study|Withdrawal by Subject|1|||
125603412|NCT00950690|451832662|FG000|Overall Study|Lack of Efficacy|22|||
125603413|NCT00950690|451832662|FG000|Overall Study|Lost to Follow-up|40|||
125603414|NCT00950690|451832662|FG000|Overall Study|Other|163|||
125603415|NCT00305006|451832663|FG000|Overall Study|Withdrawal by Subject|1|||
125603416|NCT00305006|451832664|FG001|Overall Study|Withdrawal by Subject|0|||
125603417|NCT00305006|451832663|FG000|Overall Study|Failure to complete pretest|0|||
125603418|NCT00305006|451832664|FG001|Overall Study|Failure to complete pretest|1|||
125603419|NCT00631488|451832665|FG000|Overall Study|Adverse Event|1|||
125603420|NCT00631488|451832666|FG001|Overall Study|Adverse Event|0|||
125603421|NCT00631488|451832667|FG002|Overall Study|Adverse Event|0|||
125603422|NCT00631488|451832665|FG000|Overall Study|Lost to Follow-up|2|||
125603423|NCT00631488|451832666|FG001|Overall Study|Lost to Follow-up|2|||
125603424|NCT00631488|451832667|FG002|Overall Study|Lost to Follow-up|0|||
125603425|NCT00631488|451832665|FG000|Overall Study|Physician Decision|1|||
125603426|NCT00631488|451832666|FG001|Overall Study|Physician Decision|0|||
125603427|NCT00631488|451832667|FG002|Overall Study|Physician Decision|1|||
125603428|NCT00631488|451832665|FG000|Overall Study|Protocol Violation|0|||
125603429|NCT00631488|451832666|FG001|Overall Study|Protocol Violation|0|||
125603430|NCT00631488|451832667|FG002|Overall Study|Protocol Violation|1|||
125603431|NCT01996319|451832670|FG000|Overall Study|Protocol Violation|1|||
125603432|NCT01996319|451832671|FG001|Overall Study|Protocol Violation|0|||
125603433|NCT01996319|451832670|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
125603434|NCT01996319|451832671|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
125603435|NCT01996319|451832670|FG000|Overall Study|Adverse Event|2|||
125603436|NCT01996319|451832671|FG001|Overall Study|Adverse Event|2|||
125603437|NCT00130208|451832674|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
125603438|NCT00130208|451832675|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
125603439|NCT00130208|451832674|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
125603440|NCT00130208|451832675|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
125603441|NCT00130208|451832674|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
125603442|NCT00130208|451832675|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
125603443|NCT00130208|451832674|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
125603444|NCT00130208|451832675|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
125603445|NCT00130208|451832674|FG000|Maintenance Period (26 Weeks)|Other|1|||
125603446|NCT00130208|451832675|FG001|Maintenance Period (26 Weeks)|Other|1|||
125603447|NCT00130208|451832674|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
125603448|NCT00130208|451832675|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
125603449|NCT00130208|451832674|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
125603450|NCT00130208|451832675|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
125603451|NCT00130208|451832674|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
125603452|NCT00130208|451832675|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
125603453|NCT00130208|451832674|FG000|Washout Period (8 Weeks)|Other|1|||
125603454|NCT00130208|451832675|FG001|Washout Period (8 Weeks)|Other|1|||
125603455|NCT00589472|451832677|FG000|Overall Study|Adverse Event|1|||
125603456|NCT00553059|451832678|FG000|Overall Study|Deemed ineligible|1|||
125603457|NCT00553059|451832679|FG001|Overall Study|Deemed ineligible|1|||
125603458|NCT00553059|451832678|FG000|Overall Study|Drug supply not available|0|||
125603459|NCT00553059|451832679|FG001|Overall Study|Drug supply not available|1|||
125603460|NCT00117338|451832680|FG000|Overall Study|Adverse Event|0|||
125603461|NCT00117338|451832681|FG001|Overall Study|Adverse Event|1|||
125603462|NCT00117338|451832680|FG000|Overall Study|Protocol Violation|3|||
125603463|NCT00117338|451832681|FG001|Overall Study|Protocol Violation|2|||
125603464|NCT00117338|451832680|FG000|Overall Study|Withdrawal by Subject|1|||
125603465|NCT00117338|451832681|FG001|Overall Study|Withdrawal by Subject|0|||
125603466|NCT00117338|451832680|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
125603467|NCT00117338|451832681|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
125603468|NCT00117338|451832680|FG000|Overall Study|Lack of Efficacy|0|||
125603469|NCT00117338|451832681|FG001|Overall Study|Lack of Efficacy|1|||
125603470|NCT02805907|451832684|FG000|Overall Study|Lost to Follow-up|3|||
125603471|NCT02805907|451832685|FG001|Overall Study|Lost to Follow-up|3|||
125603472|NCT01264965|451832686|FG000|Overall Study|Withdrawal by Subject|10|||
125603473|NCT02202031|451832687|FG000|Overall Study|Lost to Follow-up|1|||
125603474|NCT02202031|451832688|FG001|Overall Study|Lost to Follow-up|0|||
125603475|NCT02202031|451832687|FG000|Overall Study|Too Busy|1|||
125603476|NCT02202031|451832688|FG001|Overall Study|Too Busy|3|||
125603477|NCT02202031|451832687|FG000|Overall Study|Illness/Medical Reason|0|||
125603478|NCT02202031|451832688|FG001|Overall Study|Illness/Medical Reason|2|||
125603479|NCT02202031|451832687|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
125603480|NCT02202031|451832688|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
125603481|NCT00871858|451832691|FG000|Overall Study|Protocol Violation|3|||
125603482|NCT00871858|451832692|FG001|Overall Study|Protocol Violation|4|||
125603483|NCT00871858|451832691|FG000|Overall Study|Adverse Event|1|||
125369552|NCT03706079|450987035|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
125369553|NCT03706079|450987036|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
125369554|NCT03706079|450987031|FG000|Long Term Extension (DESTINATION)|Death|8|||
125369555|NCT03706079|450987032|FG001|Long Term Extension (DESTINATION)|Death|2|||
125603484|NCT00871858|451832692|FG001|Overall Study|Adverse Event|1|||
125603485|NCT00871858|451832691|FG000|Overall Study|Withdrawal by Subject|1|||
125603486|NCT00871858|451832692|FG001|Overall Study|Withdrawal by Subject|1|||
125603487|NCT00871858|451832691|FG000|Overall Study|Lost to Follow-up|0|||
125603488|NCT00871858|451832692|FG001|Overall Study|Lost to Follow-up|1|||
125603489|NCT02853331|451832703|FG000|Overall Study|Death|59|||
125603490|NCT02853331|451832704|FG001|Overall Study|Death|95|||
125603491|NCT02853331|451832703|FG000|Overall Study|Withdrawal by Subject|5|||
125603492|NCT02853331|451832704|FG001|Overall Study|Withdrawal by Subject|9|||
125603493|NCT02853331|451832703|FG000|Overall Study|Ongoing in study|368|||
125603494|NCT02853331|451832704|FG001|Overall Study|Ongoing in study|325|||
125603495|NCT03290300|451832711|FG000|Overall Study|Lost to Follow-up|3|||
125603496|NCT01276847|451832715|FG000|Overall Study|Withdrawal by Subject|1|||
125603497|NCT01276847|451832716|FG001|Overall Study|Withdrawal by Subject|0|||
125603498|NCT01276847|451832717|FG002|Overall Study|Withdrawal by Subject|0|||
125603499|NCT01899144|451832718|FG000|Treatment Period 2|Other|1|||
125603500|NCT01899144|451832718|FG000|Treatment Period 3|Other|2|||
125603501|NCT01899144|451832718|FG000|Treatment Period 5|Other|1|||
125603502|NCT00751881|451832721|FG000|Core Treatment Period|Not treated|1|||
125603503|NCT00751881|451832722|FG001|Core Treatment Period|Not treated|1|||
125603504|NCT00751881|451832723|FG002|Core Treatment Period|Not treated|2|||
125603505|NCT00751881|451832721|FG000|Core Treatment Period|Adverse Event|26|||
125603506|NCT00751881|451832722|FG001|Core Treatment Period|Adverse Event|54|||
125603507|NCT00751881|451832723|FG002|Core Treatment Period|Adverse Event|58|||
125603508|NCT00751881|451832721|FG000|Core Treatment Period|Lack of Efficacy|37|||
125603509|NCT00751881|451832722|FG001|Core Treatment Period|Lack of Efficacy|30|||
125603510|NCT00751881|451832723|FG002|Core Treatment Period|Lack of Efficacy|20|||
125603511|NCT00751881|451832721|FG000|Core Treatment Period|Poor compliance to protocol|15|||
125603512|NCT00751881|451832722|FG001|Core Treatment Period|Poor compliance to protocol|3|||
125603513|NCT00751881|451832723|FG002|Core Treatment Period|Poor compliance to protocol|4|||
125603514|NCT00751881|451832721|FG000|Core Treatment Period|Lost to Follow-up|6|||
125603515|NCT00751881|451832722|FG001|Core Treatment Period|Lost to Follow-up|4|||
125603516|NCT00751881|451832723|FG002|Core Treatment Period|Lost to Follow-up|3|||
125603517|NCT00751881|451832721|FG000|Core Treatment Period|Other: protocol deviation|3|||
125603518|NCT00751881|451832722|FG001|Core Treatment Period|Other: protocol deviation|3|||
125603519|NCT00751881|451832723|FG002|Core Treatment Period|Other: protocol deviation|7|||
125603520|NCT00751881|451832721|FG000|Core Treatment Period|Other: wish to parent|5|||
125603521|NCT00751881|451832722|FG001|Core Treatment Period|Other: wish to parent|7|||
125603522|NCT00751881|451832723|FG002|Core Treatment Period|Other: wish to parent|4|||
125603523|NCT00751881|451832721|FG000|Core Treatment Period|Other: personal/family constraints|6|||
125603524|NCT00751881|451832722|FG001|Core Treatment Period|Other: personal/family constraints|7|||
125603525|NCT00751881|451832723|FG002|Core Treatment Period|Other: personal/family constraints|10|||
125603526|NCT00751881|451832721|FG000|Core Treatment Period|Other: MS treatment change|6|||
125603527|NCT00751881|451832722|FG001|Core Treatment Period|Other: MS treatment change|4|||
125603528|NCT00751881|451832723|FG002|Core Treatment Period|Other: MS treatment change|4|||
125603529|NCT00751881|451832721|FG000|Core Treatment Period|Other: tolerability complaints|2|||
125603530|NCT00751881|451832722|FG001|Core Treatment Period|Other: tolerability complaints|0|||
125603531|NCT00751881|451832723|FG002|Core Treatment Period|Other: tolerability complaints|0|||
125603532|NCT00751881|451832721|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
125603533|NCT00751881|451832722|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
125603534|NCT00751881|451832723|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
125603535|NCT00751881|451832721|FG000|Extension Study Period|Adverse Event|18|||
125603536|NCT00751881|451832722|FG001|Extension Study Period|Adverse Event|20|||
125603537|NCT00751881|451832723|FG002|Extension Study Period|Adverse Event|21|||
125603538|NCT00751881|451832721|FG000|Extension Study Period|Lack of Efficacy|14|||
125603539|NCT00751881|451832722|FG001|Extension Study Period|Lack of Efficacy|10|||
125603540|NCT00751881|451832723|FG002|Extension Study Period|Lack of Efficacy|20|||
125603541|NCT00751881|451832721|FG000|Extension Study Period|Lost to Follow-up|4|||
125603542|NCT00751881|451832722|FG001|Extension Study Period|Lost to Follow-up|9|||
125603543|NCT00751881|451832723|FG002|Extension Study Period|Lost to Follow-up|6|||
125603544|NCT00751881|451832721|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
125603545|NCT00751881|451832722|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
125603546|NCT00751881|451832723|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
125369556|NCT03706079|450987033|FG002|Long Term Extension (DESTINATION)|Death|2|||
125369557|NCT03706079|450987034|FG003|Long Term Extension (DESTINATION)|Death|1|||
125603547|NCT00751881|451832721|FG000|Extension Study Period|Other than specified above|26|||
125603548|NCT00751881|451832722|FG001|Extension Study Period|Other than specified above|30|||
125603549|NCT00751881|451832723|FG002|Extension Study Period|Other than specified above|18|||
125603550|NCT02119104|451832724|FG000|Overall Study|Protocol Violation|16|||
125603551|NCT00530712|451832727|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
125603552|NCT00530712|451832727|FG000|30 Day Follow-up Visit|Missed Visit|5|||
125603553|NCT00530712|451832727|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
125603554|NCT00530712|451832727|FG000|6 Month Follow-up Visit|Missed Visit|3|||
125603555|NCT00530712|451832727|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
125603556|NCT00530712|451832727|FG000|6 Month Follow-up Visit|Death|2|||
125603557|NCT00530712|451832727|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
125603558|NCT00530712|451832727|FG000|12 Month Follow-up Visit|Missed Visit|3|||
125603559|NCT00530712|451832727|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
125603560|NCT00530712|451832727|FG000|12 Month Follow-up Visit|Death|9|||
125603561|NCT00651118|451832735|FG000|Overall Study|Adverse Event|4|||
125603562|NCT00651118|451832736|FG001|Overall Study|Adverse Event|0|||
125603563|NCT00651118|451832737|FG002|Overall Study|Adverse Event|1|||
125603564|NCT00651118|451832738|FG003|Overall Study|Adverse Event|1|||
125603565|NCT00651118|451832735|FG000|Overall Study|Protocol Violation|2|||
125603566|NCT00651118|451832736|FG001|Overall Study|Protocol Violation|2|||
125603567|NCT00651118|451832737|FG002|Overall Study|Protocol Violation|6|||
125603568|NCT00651118|451832738|FG003|Overall Study|Protocol Violation|2|||
125603569|NCT00651118|451832735|FG000|Overall Study|Lost to Follow-up|2|||
125603570|NCT00651118|451832736|FG001|Overall Study|Lost to Follow-up|0|||
125603571|NCT00651118|451832737|FG002|Overall Study|Lost to Follow-up|1|||
125603572|NCT00651118|451832738|FG003|Overall Study|Lost to Follow-up|2|||
125603573|NCT00651118|451832735|FG000|Overall Study|administrative|1|||
125603574|NCT00651118|451832736|FG001|Overall Study|administrative|4|||
125603575|NCT00651118|451832737|FG002|Overall Study|administrative|2|||
125603576|NCT00651118|451832738|FG003|Overall Study|administrative|1|||
125603577|NCT00651118|451832735|FG000|Overall Study|Withdrawal by Subject|0|||
125603578|NCT00651118|451832736|FG001|Overall Study|Withdrawal by Subject|1|||
125603579|NCT00651118|451832737|FG002|Overall Study|Withdrawal by Subject|1|||
125603580|NCT00651118|451832738|FG003|Overall Study|Withdrawal by Subject|1|||
125603581|NCT03117049|451832739|FG000|Overall Study|Continued the follow-up period|109|||
125603582|NCT03117049|451832740|FG001|Overall Study|Continued the follow-up period|129|||
125603583|NCT03117049|451832739|FG000|Overall Study|Died|82|||
125603584|NCT03117049|451832740|FG001|Overall Study|Died|93|||
125603585|NCT03117049|451832739|FG000|Overall Study|Consent withdrawal|7|||
125603586|NCT03117049|451832740|FG001|Overall Study|Consent withdrawal|6|||
125603587|NCT03117049|451832739|FG000|Overall Study|Missing contact|3|||
125603588|NCT03117049|451832740|FG001|Overall Study|Missing contact|3|||
125603589|NCT00839098|451832741|FG000|Overall Study|Withdrawal by Subject|2|||
125603590|NCT00839098|451832742|FG001|Overall Study|Withdrawal by Subject|1|||
125603591|NCT00839098|451832743|FG002|Overall Study|Withdrawal by Subject|7|||
125603592|NCT00365976|451832746|FG000|Overall Study|Withdrawal by Subject|1|||
125603593|NCT00365976|451832747|FG001|Overall Study|Withdrawal by Subject|5|||
125603594|NCT02260193|451832748|FG000|Overall Study|Lack of Efficacy|0|||
125603595|NCT02260193|451832749|FG001|Overall Study|Lack of Efficacy|1|||
125603596|NCT02260193|451832750|FG002|Overall Study|Lack of Efficacy|6|||
125603597|NCT02260193|451832748|FG000|Overall Study|Adverse Event|3|||
125603598|NCT02260193|451832749|FG001|Overall Study|Adverse Event|4|||
125369558|NCT03706079|450987035|FG004|Long Term Extension (DESTINATION)|Death|0|||
125369559|NCT03706079|450987036|FG005|Long Term Extension (DESTINATION)|Death|0|||
125369560|NCT00329238|450987037|FG000|Overall Study|Adverse Event|147|||
125369561|NCT00329238|450987038|FG001|Overall Study|Adverse Event|129|||
125369562|NCT00329238|450987037|FG000|Overall Study|Protocol Violation|23|||
125369563|NCT00329238|450987038|FG001|Overall Study|Protocol Violation|34|||
125369564|NCT00329238|450987037|FG000|Overall Study|Lost to Follow-up|2|||
125369565|NCT00329238|450987038|FG001|Overall Study|Lost to Follow-up|6|||
125369566|NCT00329238|450987037|FG000|Overall Study|Withdrawal by Subject|64|||
125369567|NCT00329238|450987038|FG001|Overall Study|Withdrawal by Subject|58|||
125369568|NCT00329238|450987037|FG000|Overall Study|Other reason (not specified)|40|||
125369569|NCT00329238|450987038|FG001|Overall Study|Other reason (not specified)|54|||
125369570|NCT05393895|450987041|FG000|Overall Study|Adverse Event|2|||
125369571|NCT05393895|450987042|FG001|Overall Study|Adverse Event|3|||
125369572|NCT05393895|450987041|FG000|Overall Study|Lost to Follow-up|4|||
125369573|NCT05393895|450987042|FG001|Overall Study|Lost to Follow-up|3|||
125369574|NCT05393895|450987041|FG000|Overall Study|Protocol Violation|1|||
125369575|NCT05393895|450987042|FG001|Overall Study|Protocol Violation|0|||
125369576|NCT05393895|450987041|FG000|Overall Study|Withdrawal by Subject|1|||
125369577|NCT05393895|450987042|FG001|Overall Study|Withdrawal by Subject|4|||
125369578|NCT00968513|450987045|FG000|Overall Study|Death|4|||
125369579|NCT00968513|450987046|FG001|Overall Study|Death|10|||
125369580|NCT00968513|450987047|FG002|Overall Study|Death|15|||
125369581|NCT05537883|450987048|FG000|Overall Study|revisional surgery|4|||
125369582|NCT05537883|450987049|FG001|Overall Study|revisional surgery|2|||
125369583|NCT05537883|450987048|FG000|Overall Study|surgeries were cancelled|0|||
125369584|NCT05537883|450987049|FG001|Overall Study|surgeries were cancelled|2|||
125369585|NCT05537883|450987048|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
125369586|NCT05537883|450987049|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
125369587|NCT01302834|450987050|FG000|Overall Study|Protocol Violation|17|||
125369588|NCT01302834|450987051|FG001|Overall Study|Protocol Violation|23|||
125369589|NCT01302834|450987050|FG000|Overall Study|HIV positive|1|||
125369590|NCT01302834|450987051|FG001|Overall Study|HIV positive|3|||
125369591|NCT01328431|450987052|FG000|Baseline|Protocol Violation|0|||
125369592|NCT01328431|450987053|FG001|Baseline|Protocol Violation|2|||
125369593|NCT01328431|450987052|FG000|1 Month (1M)|Lost to Follow-up|55|||
125369594|NCT01328431|450987053|FG001|1 Month (1M)|Lost to Follow-up|58|||
125369595|NCT01328431|450987052|FG000|3 Month (3M)|Death|2|||
125369596|NCT01328431|450987053|FG001|3 Month (3M)|Death|2|||
125369597|NCT01328431|450987052|FG000|3 Month (3M)|Lost to Follow-up|75|||
125369598|NCT01328431|450987053|FG001|3 Month (3M)|Lost to Follow-up|70|||
125369599|NCT01328431|450987052|FG000|12 Month (12M)|Death|2|||
125369600|NCT01328431|450987053|FG001|12 Month (12M)|Death|6|||
125369601|NCT01328431|450987052|FG000|12 Month (12M)|Lost to Follow-up|82|||
125369602|NCT01328431|450987053|FG001|12 Month (12M)|Lost to Follow-up|91|||
125369603|NCT05379231|450987054|FG000|Home Visit|Withdrawal by Subject|2|||
125369604|NCT05379231|450987054|FG000|In-lab Visit|Withdrawal by Subject|2|||
125369605|NCT02296320|450987061|FG000|Overall Study|Withdrawal by Subject|4|||
125369606|NCT02296320|450987062|FG001|Overall Study|Withdrawal by Subject|0|||
125369607|NCT02296320|450987063|FG002|Overall Study|Withdrawal by Subject|2|||
125369608|NCT02296320|450987061|FG000|Overall Study|Death|24|||
125369609|NCT02296320|450987062|FG001|Overall Study|Death|3|||
125369610|NCT02296320|450987063|FG002|Overall Study|Death|27|||
125369611|NCT02296320|450987061|FG000|Overall Study|Lost to Follow-up|5|||
125369612|NCT02296320|450987062|FG001|Overall Study|Lost to Follow-up|2|||
125369613|NCT02296320|450987063|FG002|Overall Study|Lost to Follow-up|7|||
125369614|NCT02296320|450987061|FG000|Overall Study|Not treated|2|||
125369615|NCT02296320|450987062|FG001|Overall Study|Not treated|0|||
125369616|NCT02296320|450987063|FG002|Overall Study|Not treated|0|||
125369617|NCT02296320|450987061|FG000|Overall Study|Not - specified|0|||
125369618|NCT02296320|450987062|FG001|Overall Study|Not - specified|0|||
125369619|NCT02296320|450987063|FG002|Overall Study|Not - specified|1|||
125369620|NCT01203098|450987070|FG000|Overall Study|Adverse Event|3|||
125369621|NCT01203098|450987071|FG001|Overall Study|Adverse Event|1|||
125369622|NCT01203098|450987072|FG002|Overall Study|Adverse Event|7|||
125369623|NCT01203098|450987070|FG000|Overall Study|Lost to Follow-up|0|||
125369624|NCT01203098|450987071|FG001|Overall Study|Lost to Follow-up|0|||
125369625|NCT01203098|450987072|FG002|Overall Study|Lost to Follow-up|1|||
125369626|NCT01203098|450987070|FG000|Overall Study|Physician Decision|2|||
125369627|NCT01203098|450987071|FG001|Overall Study|Physician Decision|2|||
125369628|NCT01203098|450987072|FG002|Overall Study|Physician Decision|0|||
125369629|NCT01203098|450987070|FG000|Overall Study|Withdrawal by Subject|1|||
125369630|NCT01203098|450987071|FG001|Overall Study|Withdrawal by Subject|1|||
125369631|NCT01203098|450987072|FG002|Overall Study|Withdrawal by Subject|3|||
125369632|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
125603599|NCT02260193|451832750|FG002|Overall Study|Adverse Event|1|||
125369633|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
125369634|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
125369635|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
125369636|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
125369637|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
125369638|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
125369639|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
125603600|NCT02260193|451832748|FG000|Overall Study|Protocol Violation|0|||
125603601|NCT02260193|451832749|FG001|Overall Study|Protocol Violation|4|||
125603602|NCT02260193|451832750|FG002|Overall Study|Protocol Violation|0|||
125603603|NCT02260193|451832748|FG000|Overall Study|Withdrawal by Subject|3|||
125603604|NCT02260193|451832749|FG001|Overall Study|Withdrawal by Subject|0|||
125603605|NCT02260193|451832750|FG002|Overall Study|Withdrawal by Subject|2|||
125603606|NCT02260193|451832748|FG000|Overall Study|Kidney Transplantation|0|||
125603607|NCT02260193|451832749|FG001|Overall Study|Kidney Transplantation|0|||
125603608|NCT02260193|451832750|FG002|Overall Study|Kidney Transplantation|1|||
125603609|NCT00633139|451832757|FG000|Overall Study|Non compliance|0|||
125603610|NCT00633139|451832758|FG001|Overall Study|Non compliance|0|||
125603611|NCT00633139|451832759|FG002|Overall Study|Non compliance|1|||
125603612|NCT00633139|451832757|FG000|Overall Study|Withdrawal by Subject|0|||
125603613|NCT00633139|451832758|FG001|Overall Study|Withdrawal by Subject|1|||
125603614|NCT00633139|451832759|FG002|Overall Study|Withdrawal by Subject|0|||
125603615|NCT04430582|451832760|FG000|Overall Study|Found to meet exclusionary criteria|1|||
125603616|NCT04430582|451832761|FG001|Overall Study|Found to meet exclusionary criteria|0|||
125603617|NCT04430582|451832760|FG000|Overall Study|Withdrawal by Subject|0|||
125603618|NCT04430582|451832761|FG001|Overall Study|Withdrawal by Subject|1|||
125603619|NCT01522651|451832764|FG000|Overall Study|Adverse Event|3|||
125603620|NCT01522651|451832765|FG001|Overall Study|Adverse Event|4|||
125603621|NCT01522651|451832766|FG002|Overall Study|Adverse Event|4|||
125603622|NCT01522651|451832767|FG003|Overall Study|Adverse Event|5|||
125603623|NCT01522651|451832768|FG004|Overall Study|Adverse Event|4|||
125603624|NCT01522651|451832764|FG000|Overall Study|Cardioversion|1|||
125603625|NCT01522651|451832765|FG001|Overall Study|Cardioversion|0|||
125603626|NCT01522651|451832766|FG002|Overall Study|Cardioversion|0|||
125603627|NCT01522651|451832767|FG003|Overall Study|Cardioversion|0|||
125603628|NCT01522651|451832768|FG004|Overall Study|Cardioversion|0|||
125603629|NCT01522651|451832764|FG000|Overall Study|Device Malfunction|0|||
125603630|NCT01522651|451832765|FG001|Overall Study|Device Malfunction|1|||
125603631|NCT01522651|451832766|FG002|Overall Study|Device Malfunction|0|||
125603632|NCT01522651|451832767|FG003|Overall Study|Device Malfunction|0|||
125603633|NCT01522651|451832768|FG004|Overall Study|Device Malfunction|0|||
125603634|NCT01522651|451832764|FG000|Overall Study|Investigator's Discretion|0|||
125603635|NCT01522651|451832765|FG001|Overall Study|Investigator's Discretion|1|||
125603636|NCT01522651|451832766|FG002|Overall Study|Investigator's Discretion|0|||
125603637|NCT01522651|451832767|FG003|Overall Study|Investigator's Discretion|0|||
125603638|NCT01522651|451832768|FG004|Overall Study|Investigator's Discretion|0|||
125603639|NCT01522651|451832764|FG000|Overall Study|Protocol Violation|3|||
125603640|NCT01522651|451832765|FG001|Overall Study|Protocol Violation|0|||
125603641|NCT01522651|451832766|FG002|Overall Study|Protocol Violation|0|||
125603642|NCT01522651|451832767|FG003|Overall Study|Protocol Violation|0|||
125603643|NCT01522651|451832768|FG004|Overall Study|Protocol Violation|0|||
125603644|NCT01522651|451832764|FG000|Overall Study|Reason Not Specified|0|||
125603645|NCT01522651|451832765|FG001|Overall Study|Reason Not Specified|0|||
125603646|NCT01522651|451832766|FG002|Overall Study|Reason Not Specified|0|||
125603647|NCT01522651|451832767|FG003|Overall Study|Reason Not Specified|1|||
125603648|NCT01522651|451832768|FG004|Overall Study|Reason Not Specified|0|||
125603649|NCT01522651|451832764|FG000|Overall Study|Participant Non-Compliance|1|||
125603650|NCT01522651|451832765|FG001|Overall Study|Participant Non-Compliance|0|||
125603651|NCT01522651|451832766|FG002|Overall Study|Participant Non-Compliance|0|||
125603652|NCT01522651|451832767|FG003|Overall Study|Participant Non-Compliance|0|||
125603653|NCT01522651|451832768|FG004|Overall Study|Participant Non-Compliance|0|||
125603654|NCT01522651|451832764|FG000|Overall Study|Withdrew Consent|1|||
125603655|NCT01522651|451832765|FG001|Overall Study|Withdrew Consent|1|||
125603656|NCT01522651|451832766|FG002|Overall Study|Withdrew Consent|0|||
125603657|NCT01522651|451832767|FG003|Overall Study|Withdrew Consent|1|||
125603658|NCT01522651|451832768|FG004|Overall Study|Withdrew Consent|1|||
125603659|NCT01522651|451832764|FG000|Overall Study|Randomized but Never Treated|0|||
125603660|NCT01522651|451832765|FG001|Overall Study|Randomized but Never Treated|1|||
125603661|NCT01522651|451832766|FG002|Overall Study|Randomized but Never Treated|0|||
125603662|NCT01522651|451832767|FG003|Overall Study|Randomized but Never Treated|1|||
125603663|NCT01522651|451832768|FG004|Overall Study|Randomized but Never Treated|1|||
125603664|NCT02658656|451832769|FG000|Screening|Failed eligibility criteria|0|||
125603665|NCT02658656|451832770|FG001|Screening|Failed eligibility criteria|0|||
125603666|NCT02658656|451832771|FG002|Screening|Failed eligibility criteria|263|||
125369640|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
125369641|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
125369642|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
125369643|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
125369644|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
125369645|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
125369646|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
125369647|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
125369648|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
125369649|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
125369650|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
125369651|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
125369652|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
125369653|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
125369654|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
125431705|NCT02237508|451207723|FG006|Overall Study|Withdrawal by Subject|1|||
125431706|NCT02237508|451207724|FG007|Overall Study|Withdrawal by Subject|0|||
125603667|NCT02658656|451832769|FG000|Randomization|Withdrawal by Subject|8|||
125603668|NCT02658656|451832770|FG001|Randomization|Withdrawal by Subject|7|||
125603669|NCT02658656|451832771|FG002|Randomization|Withdrawal by Subject|0|||
125603670|NCT02658656|451832769|FG000|Randomization|Lost to Follow-up|1|||
125603671|NCT02658656|451832770|FG001|Randomization|Lost to Follow-up|3|||
125603672|NCT02658656|451832771|FG002|Randomization|Lost to Follow-up|0|||
125603673|NCT02658656|451832769|FG000|Randomization|Adverse Event|4|||
125603674|NCT02658656|451832770|FG001|Randomization|Adverse Event|0|||
125603675|NCT02658656|451832771|FG002|Randomization|Adverse Event|0|||
125603676|NCT02658656|451832769|FG000|Randomization|Administrative Termination|3|||
125603677|NCT02658656|451832770|FG001|Randomization|Administrative Termination|1|||
125603678|NCT02658656|451832771|FG002|Randomization|Administrative Termination|0|||
125603679|NCT02658656|451832769|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
125603680|NCT02658656|451832770|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
125603681|NCT02658656|451832771|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
125603682|NCT02658656|451832769|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
125603683|NCT02658656|451832770|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
125603684|NCT02658656|451832771|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
125603685|NCT02658656|451832769|FG000|Randomization|Not eligible for Randomization|1|||
125603686|NCT02658656|451832770|FG001|Randomization|Not eligible for Randomization|0|||
125603687|NCT02658656|451832771|FG002|Randomization|Not eligible for Randomization|0|||
125603688|NCT02658656|451832769|FG000|Randomization|Protocol Violation|1|||
125603689|NCT02658656|451832770|FG001|Randomization|Protocol Violation|0|||
125603690|NCT02658656|451832771|FG002|Randomization|Protocol Violation|0|||
125603691|NCT02100657|451834101|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
125603692|NCT02100657|451834102|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
125603693|NCT02100657|451834103|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
125603694|NCT02100657|451834101|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
125603695|NCT02100657|451834102|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
125603696|NCT02100657|451834103|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
125603697|NCT02100657|451834101|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
125603698|NCT02100657|451834102|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
125603699|NCT02100657|451834103|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
125603700|NCT02100657|451834101|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
125603701|NCT02100657|451834102|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
125603702|NCT02100657|451834103|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
125603703|NCT02100657|451834101|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
125603704|NCT02100657|451834102|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
125603705|NCT02100657|451834103|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
125369655|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
125369656|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
125369657|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
125369658|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
125369659|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
125431707|NCT02237508|451207725|FG008|Overall Study|Withdrawal by Subject|1|||
125603706|NCT02100657|451834101|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
125603707|NCT02100657|451834102|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
125603708|NCT02100657|451834103|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
125603709|NCT02100657|451834101|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
125603710|NCT02100657|451834102|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
125603711|NCT02100657|451834103|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
125603712|NCT02100657|451834101|FG000|Cohort 3: Dose Level 3|Death|0|||
125369660|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
125369661|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
125369662|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
125369663|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
125369664|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
125369665|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
125369666|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
125369667|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
125369668|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
125369669|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
125369670|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
125369671|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
125369672|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
125369673|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
125369674|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
125369675|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
125369676|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
125369677|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
125369678|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
125369679|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
125369680|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
125369681|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
125369682|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
125369683|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
125369684|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
125369685|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
125369686|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
125369687|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
125369688|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
125369689|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
125369690|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
125369691|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
125369692|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
125369693|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
125369694|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
125603713|NCT02100657|451834102|FG001|Cohort 3: Dose Level 3|Death|0|||
125603714|NCT02100657|451834103|FG002|Cohort 3: Dose Level 3|Death|1|||
125603715|NCT02100657|451834101|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
125603716|NCT02100657|451834102|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
125603717|NCT02100657|451834103|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
125603718|NCT02100657|451834101|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
125603719|NCT02100657|451834102|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
125603720|NCT02100657|451834103|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
125603721|NCT02100657|451834101|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
125603722|NCT02100657|451834102|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
125603723|NCT02100657|451834103|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
125603724|NCT02100657|451834101|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
125603725|NCT02100657|451834102|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
125603726|NCT02100657|451834103|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
125603727|NCT02100657|451834101|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
125603728|NCT02100657|451834102|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
125603729|NCT02100657|451834103|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
125603730|NCT02322892|451834107|FG000|Overall Study|Surgery cancelled|1|||
125603731|NCT02322892|451834108|FG001|Overall Study|Surgery cancelled|2|||
125603732|NCT02322892|451834107|FG000|Overall Study|Met exclusion criteria|0|||
125603733|NCT02322892|451834108|FG001|Overall Study|Met exclusion criteria|1|||
125603734|NCT02322892|451834107|FG000|Overall Study|Protocol Violation|1|||
125603735|NCT02322892|451834108|FG001|Overall Study|Protocol Violation|0|||
125369695|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
125369696|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
125369697|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
125369698|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
125369699|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
125603736|NCT02125331|451834111|FG000|Overall Study|Protocol Violation|1|||
125603737|NCT02125331|451834112|FG001|Overall Study|Protocol Violation|0|||
125603738|NCT02125331|451834111|FG000|Overall Study|technical problem|2|||
125603739|NCT02125331|451834112|FG001|Overall Study|technical problem|0|||
125603740|NCT02125331|451834111|FG000|Overall Study|screen failure|2|||
125603741|NCT02125331|451834112|FG001|Overall Study|screen failure|0|||
125603742|NCT03123354|451834113|FG000|Overall Study|Physician Decision|6|||
125603743|NCT04230486|451834123|FG000|Overall Study|Screen Failure|1|||
125603744|NCT03215264|451834124|FG000|Dose Level 2|Adverse Event|0|||
125603745|NCT03215264|451834125|FG001|Dose Level 2|Adverse Event|1|||
125603746|NCT03215264|451834126|FG002|Dose Level 2|Adverse Event|0|||
125603747|NCT03215264|451834124|FG000|Dose Level 3|Withdrawal by Subject|0|||
125603748|NCT03215264|451834125|FG001|Dose Level 3|Withdrawal by Subject|0|||
125603749|NCT03215264|451834126|FG002|Dose Level 3|Withdrawal by Subject|1|||
125603750|NCT02234583|451834129|FG000|Overall Study|Adverse Event|172|||
125603751|NCT02234583|451834130|FG001|Overall Study|Adverse Event|156|||
125603752|NCT02234583|451834129|FG000|Overall Study|Withdrawal by Subject|109|||
125603753|NCT02234583|451834130|FG001|Overall Study|Withdrawal by Subject|157|||
125603754|NCT02234583|451834129|FG000|Overall Study|Lost to Follow-up|0|||
125603755|NCT02234583|451834130|FG001|Overall Study|Lost to Follow-up|1|||
125603756|NCT02234583|451834129|FG000|Overall Study|Lack of Efficacy|58|||
125603757|NCT02234583|451834130|FG001|Overall Study|Lack of Efficacy|103|||
125603758|NCT02234583|451834129|FG000|Overall Study|Protocol Violation|35|||
125603759|NCT02234583|451834130|FG001|Overall Study|Protocol Violation|42|||
125603760|NCT02234583|451834129|FG000|Overall Study|Other|39|||
125603761|NCT02234583|451834130|FG001|Overall Study|Other|97|||
125603762|NCT01740440|451834131|FG000|Overall Study|Lost to Follow-up|3|||
125603763|NCT00532883|451834132|FG000|Overall Study|Adverse Event|1|||
125603764|NCT00532883|451834133|FG001|Overall Study|Adverse Event|0|||
125603765|NCT00532883|451834134|FG002|Overall Study|Adverse Event|0|||
125603766|NCT00532883|451834135|FG003|Overall Study|Adverse Event|1|||
125603767|NCT00532883|451834132|FG000|Overall Study|Lost to Follow-up|1|||
125603768|NCT00532883|451834133|FG001|Overall Study|Lost to Follow-up|1|||
125603769|NCT00532883|451834134|FG002|Overall Study|Lost to Follow-up|1|||
125603770|NCT00532883|451834135|FG003|Overall Study|Lost to Follow-up|0|||
125603771|NCT00532883|451834132|FG000|Overall Study|Withdrawal by Subject|0|||
125603772|NCT00532883|451834133|FG001|Overall Study|Withdrawal by Subject|1|||
125603773|NCT00532883|451834134|FG002|Overall Study|Withdrawal by Subject|1|||
125603774|NCT00532883|451834135|FG003|Overall Study|Withdrawal by Subject|0|||
125603775|NCT00532883|451834132|FG000|Overall Study|Subject was Nonadherent|0|||
125603776|NCT00532883|451834133|FG001|Overall Study|Subject was Nonadherent|1|||
125603777|NCT00532883|451834134|FG002|Overall Study|Subject was Nonadherent|1|||
125603778|NCT00532883|451834135|FG003|Overall Study|Subject was Nonadherent|0|||
125603779|NCT00532883|451834132|FG000|Overall Study|Early Study Termination|4|||
125603780|NCT00532883|451834133|FG001|Overall Study|Early Study Termination|4|||
125603781|NCT00532883|451834134|FG002|Overall Study|Early Study Termination|1|||
125603782|NCT00532883|451834135|FG003|Overall Study|Early Study Termination|4|||
125603783|NCT01172288|451834138|FG000|Overall Study|Adverse Event|1|||
125603784|NCT01172288|451834139|FG001|Overall Study|Adverse Event|0|||
125603785|NCT01172288|451834138|FG000|Overall Study|Protocol Violation|0|||
125603786|NCT01172288|451834139|FG001|Overall Study|Protocol Violation|1|||
125603787|NCT01188798|451834142|FG000|Overall Study|Death|0|||
125603788|NCT01188798|451834143|FG001|Overall Study|Death|1|||
125603789|NCT01188798|451834142|FG000|Overall Study|Required additional transplant|1|||
125603790|NCT01188798|451834143|FG001|Overall Study|Required additional transplant|1|||
125603791|NCT01188798|451834142|FG000|Overall Study|Protocol closure|1|||
125212842|NCT01026818|450405479|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
125603792|NCT01188798|451834143|FG001|Overall Study|Protocol closure|1|||
125603793|NCT02795767|451834144|FG000|Overall Study|Received Commercial Emicizumab|1|||
125603794|NCT02795767|451834145|FG001|Overall Study|Received Commercial Emicizumab|0|||
125369700|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
125369701|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
125603795|NCT02795767|451834146|FG002|Overall Study|Received Commercial Emicizumab|0|||
125603796|NCT03078608|451834156|FG000|Overall Study|Death|1|||
125603797|NCT03078608|451834157|FG001|Overall Study|Death|2|||
125603798|NCT03078608|451834158|FG002|Overall Study|Death|0|||
125603799|NCT03078608|451834159|FG003|Overall Study|Death|0|||
125603800|NCT03078608|451834156|FG000|Overall Study|Withdrawal by Subject|8|||
125603801|NCT03078608|451834157|FG001|Overall Study|Withdrawal by Subject|1|||
125603802|NCT03078608|451834158|FG002|Overall Study|Withdrawal by Subject|0|||
125603803|NCT03078608|451834159|FG003|Overall Study|Withdrawal by Subject|0|||
125603804|NCT03078608|451834156|FG000|Overall Study|Lost to Follow-up|5|||
125603805|NCT03078608|451834157|FG001|Overall Study|Lost to Follow-up|8|||
125603806|NCT03078608|451834158|FG002|Overall Study|Lost to Follow-up|4|||
125603807|NCT03078608|451834159|FG003|Overall Study|Lost to Follow-up|1|||
125603808|NCT00723840|451834160|FG000|Overall Study|Lost to Follow-up|2|||
125603809|NCT00723840|451834160|FG000|Overall Study|Failure to return|18|||
125603810|NCT00723840|451834160|FG000|Overall Study|Withdrawal by Subject|55|||
125603811|NCT00723840|451834160|FG000|Overall Study|Serious Adverse Events|3|||
125603812|NCT00723840|451834160|FG000|Overall Study|Other Medical Event|2|||
125603813|NCT00723840|451834160|FG000|Overall Study|Unspecified reason|2|||
125603814|NCT04156646|451834161|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
125603815|NCT04156646|451834162|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
125603816|NCT00751101|451834163|FG000|Overall Study|Withdrawal by Subject|1|||
125603817|NCT00751101|451834164|FG001|Overall Study|Withdrawal by Subject|0|||
125603818|NCT00751101|451834163|FG000|Overall Study|No HFS / Never Started Patch/|0|||
125603819|NCT00751101|451834164|FG001|Overall Study|No HFS / Never Started Patch/|4|||
125603820|NCT00751101|451834163|FG000|Overall Study|Never began capecitabine|1|||
125603821|NCT00751101|451834164|FG001|Overall Study|Never began capecitabine|0|||
125603822|NCT00751101|451834163|FG000|Overall Study|Physician Decision|0|||
125603823|NCT00751101|451834164|FG001|Overall Study|Physician Decision|1|||
125603824|NCT00784784|451834165|FG000|Overall Study|Withdrawal by Subject|2|||
125603825|NCT00784784|451834166|FG001|Overall Study|Withdrawal by Subject|2|||
125603826|NCT01905397|451834167|FG000|Overall Study|Death|0|||
125603827|NCT01905397|451834168|FG001|Overall Study|Death|1|||
125603828|NCT01905397|451834167|FG000|Overall Study|Withdrawal by Subject|2|||
125603829|NCT01905397|451834168|FG001|Overall Study|Withdrawal by Subject|0|||
125603830|NCT01905397|451834167|FG000|Overall Study|Surgery canceled/aborted|9|||
125603831|NCT01905397|451834168|FG001|Overall Study|Surgery canceled/aborted|5|||
125603832|NCT01905397|451834167|FG000|Overall Study|Incision < 7 cm|2|||
125603833|NCT01905397|451834168|FG001|Overall Study|Incision < 7 cm|0|||
125603834|NCT01905397|451834167|FG000|Overall Study|Wrong treatment|1|||
125603835|NCT01905397|451834168|FG001|Overall Study|Wrong treatment|1|||
125603836|NCT01905397|451834167|FG000|Overall Study|Device not applied|3|||
125603837|NCT01905397|451834168|FG001|Overall Study|Device not applied|0|||
125603838|NCT01905397|451834167|FG000|Overall Study|Dressing not applied in operating room|1|||
125603839|NCT01905397|451834168|FG001|Overall Study|Dressing not applied in operating room|0|||
125603840|NCT01905397|451834167|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
125603841|NCT01905397|451834168|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
125603842|NCT00844428|451834169|FG000|Screening Period|Screen Failure|3|||
125603843|NCT00844428|451834169|FG000|Extension Treatment Period|Death|1|||
125603844|NCT00844428|451834169|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
125603845|NCT00863928|451834172|FG000|Overall Study|Protocol Violation|26|||
125603846|NCT00863928|451834173|FG001|Overall Study|Protocol Violation|0|||
125603847|NCT00863928|451834172|FG000|Overall Study|Withdrawal by Subject|3|||
125603848|NCT00863928|451834173|FG001|Overall Study|Withdrawal by Subject|0|||
125603849|NCT00863928|451834172|FG000|Overall Study|surgery cancellation|4|||
125603850|NCT00863928|451834173|FG001|Overall Study|surgery cancellation|0|||
125603851|NCT00863928|451834172|FG000|Overall Study|medication allergy|3|||
125603852|NCT00863928|451834173|FG001|Overall Study|medication allergy|0|||
125603853|NCT00772967|451834174|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
125603854|NCT00772967|451834175|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
125603855|NCT00772967|451834176|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
125369702|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Change of location|0|||
125369703|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Change of location|0|||
125369704|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Change of location|0|||
125369705|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Change of location|1|||
125603856|NCT00772967|451834177|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
125603857|NCT00772967|451834178|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
125603858|NCT00772967|451834179|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
125603859|NCT00772967|451834174|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
125603860|NCT00772967|451834175|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
125603861|NCT00772967|451834176|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
125603862|NCT00772967|451834177|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
125369706|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Change of location|0|||
125603863|NCT00772967|451834178|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
125603864|NCT00772967|451834179|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
125603865|NCT00772967|451834174|FG000|Crossover Treatment 3|Adverse Event|0|||
125603866|NCT00772967|451834175|FG001|Crossover Treatment 3|Adverse Event|0|||
125603867|NCT00772967|451834176|FG002|Crossover Treatment 3|Adverse Event|0|||
125603868|NCT00772967|451834177|FG003|Crossover Treatment 3|Adverse Event|0|||
125603869|NCT00772967|451834178|FG004|Crossover Treatment 3|Adverse Event|1|||
125603870|NCT00772967|451834179|FG005|Crossover Treatment 3|Adverse Event|0|||
125603871|NCT04172831|451834181|FG000|Overall Study|Adverse Event|21|||
125603872|NCT04172831|451834182|FG001|Overall Study|Adverse Event|9|||
125603873|NCT04172831|451834181|FG000|Overall Study|Lack of Efficacy|2|||
125603874|NCT04172831|451834182|FG001|Overall Study|Lack of Efficacy|8|||
125603875|NCT04172831|451834181|FG000|Overall Study|Physician Decision|0|||
125603876|NCT04172831|451834182|FG001|Overall Study|Physician Decision|1|||
125603877|NCT04172831|451834181|FG000|Overall Study|Withdrawal by Subject|12|||
125603878|NCT04172831|451834182|FG001|Overall Study|Withdrawal by Subject|11|||
125603879|NCT04172831|451834181|FG000|Overall Study|Lost to Follow-up|4|||
125603880|NCT04172831|451834182|FG001|Overall Study|Lost to Follow-up|9|||
125603881|NCT04172831|451834181|FG000|Overall Study|COVID-19 related crisis|3|||
125603882|NCT04172831|451834182|FG001|Overall Study|COVID-19 related crisis|3|||
125603883|NCT04172831|451834181|FG000|Overall Study|Subject non-compliance|1|||
125603884|NCT04172831|451834182|FG001|Overall Study|Subject non-compliance|1|||
125603885|NCT04172831|451834181|FG000|Overall Study|Family emergency|1|||
125603886|NCT04172831|451834182|FG001|Overall Study|Family emergency|0|||
125603887|NCT01041573|451834183|FG000|Overall Study|Withdrawal by Subject|2|||
125603888|NCT01041573|451834184|FG001|Overall Study|Withdrawal by Subject|5|||
125603889|NCT01041573|451834185|FG002|Overall Study|Withdrawal by Subject|2|||
125603890|NCT01041573|451834186|FG003|Overall Study|Withdrawal by Subject|0|||
125603891|NCT01041573|451834183|FG000|Overall Study|Death|1|||
125603892|NCT01041573|451834184|FG001|Overall Study|Death|0|||
125603893|NCT01041573|451834185|FG002|Overall Study|Death|0|||
125603894|NCT01041573|451834186|FG003|Overall Study|Death|0|||
125603895|NCT01041573|451834183|FG000|Overall Study|Lost to Follow-up|0|||
125603896|NCT01041573|451834184|FG001|Overall Study|Lost to Follow-up|1|||
125603897|NCT01041573|451834185|FG002|Overall Study|Lost to Follow-up|2|||
125603898|NCT01041573|451834186|FG003|Overall Study|Lost to Follow-up|1|||
125603899|NCT01041573|451834183|FG000|Overall Study|Adverse Event|0|||
125603900|NCT01041573|451834184|FG001|Overall Study|Adverse Event|2|||
125603901|NCT01041573|451834185|FG002|Overall Study|Adverse Event|0|||
125369707|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
125369708|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
125369709|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
125369710|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
125603902|NCT01041573|451834186|FG003|Overall Study|Adverse Event|0|||
125603903|NCT01041573|451834183|FG000|Overall Study|relocation|1|||
125603904|NCT01041573|451834184|FG001|Overall Study|relocation|4|||
125603905|NCT01041573|451834185|FG002|Overall Study|relocation|3|||
125603906|NCT01041573|451834186|FG003|Overall Study|relocation|1|||
125603907|NCT01041573|451834183|FG000|Overall Study|further blood extraction|0|||
125431708|NCT02237508|451207726|FG009|Overall Study|Withdrawal by Subject|0|||
125431709|NCT02237508|451207717|FG000|Overall Study|Physician Decision|0|||
125431710|NCT02237508|451207718|FG001|Overall Study|Physician Decision|1|||
125431711|NCT02237508|451207719|FG002|Overall Study|Physician Decision|0|||
125431712|NCT02237508|451207720|FG003|Overall Study|Physician Decision|0|||
125431713|NCT02237508|451207721|FG004|Overall Study|Physician Decision|0|||
125431714|NCT02237508|451207722|FG005|Overall Study|Physician Decision|0|||
125431715|NCT02237508|451207723|FG006|Overall Study|Physician Decision|0|||
125603908|NCT01041573|451834184|FG001|Overall Study|further blood extraction|1|||
125603909|NCT01041573|451834185|FG002|Overall Study|further blood extraction|0|||
125603910|NCT01041573|451834186|FG003|Overall Study|further blood extraction|0|||
125603911|NCT01041573|451834183|FG000|Overall Study|positive to anti-HCV|1|||
125603912|NCT01041573|451834184|FG001|Overall Study|positive to anti-HCV|0|||
125603913|NCT01041573|451834185|FG002|Overall Study|positive to anti-HCV|0|||
125603914|NCT01041573|451834186|FG003|Overall Study|positive to anti-HCV|0|||
125603915|NCT01765764|451834191|FG000|Treatment Period|Adverse Event|1|||
125603916|NCT01765764|451834192|FG001|Treatment Period|Adverse Event|2|||
125603917|NCT01765764|451834193|FG002|Treatment Period|Adverse Event|1|||
125603918|NCT01765764|451834191|FG000|Treatment Period|Lost to Follow-up|0|||
125603919|NCT01765764|451834192|FG001|Treatment Period|Lost to Follow-up|3|||
125603920|NCT01765764|451834193|FG002|Treatment Period|Lost to Follow-up|2|||
125603921|NCT01765764|451834191|FG000|Treatment Period|Personal Reasons|1|||
125603922|NCT01765764|451834192|FG001|Treatment Period|Personal Reasons|2|||
125603923|NCT01765764|451834193|FG002|Treatment Period|Personal Reasons|1|||
125603924|NCT01765764|451834191|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
125603925|NCT01765764|451834192|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
125603926|NCT01765764|451834193|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
125603927|NCT01597193|451834195|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
125603928|NCT01597193|451834196|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
125603929|NCT01597193|451834197|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
125603930|NCT01597193|451834198|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
125603931|NCT01597193|451834199|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
125603932|NCT01597193|451834200|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
125603933|NCT01597193|451834201|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
125603934|NCT01597193|451834195|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
125603935|NCT01597193|451834196|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
125603936|NCT01597193|451834197|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
125603937|NCT01597193|451834198|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
125603938|NCT01597193|451834199|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
125603939|NCT01597193|451834200|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
125603940|NCT01597193|451834201|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
125603941|NCT01597193|451834195|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
125603942|NCT01597193|451834196|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
125603943|NCT01597193|451834197|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
125603944|NCT01597193|451834198|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
125603945|NCT01597193|451834199|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
125603946|NCT01597193|451834200|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
125603947|NCT01597193|451834201|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
125603948|NCT01597193|451834195|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
125603949|NCT01597193|451834196|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
125603950|NCT01597193|451834197|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
125603951|NCT01597193|451834198|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
125603952|NCT01597193|451834199|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
125603953|NCT01597193|451834200|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
125603954|NCT01597193|451834201|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
125603955|NCT01597193|451834195|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
125603956|NCT01597193|451834196|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
125603957|NCT01597193|451834197|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
125603958|NCT01597193|451834198|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
125603959|NCT01597193|451834199|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
125603960|NCT01597193|451834200|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
125603961|NCT01597193|451834201|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
125603962|NCT03184701|451834202|FG000|Overall Study|Death|3|||
125603963|NCT03184701|451834202|FG000|Overall Study|Physician Decision|3|||
125603964|NCT03184701|451834202|FG000|Overall Study|Withdrawal by Subject|6|||
125603965|NCT03184701|451834202|FG000|Overall Study|Lost to Follow-up|5|||
125603966|NCT00935220|451834213|FG000|Overall Study|Adverse Event|1|||
125603967|NCT00935220|451834213|FG000|Overall Study|Other reason (not specified)|1|||
125603968|NCT01000064|451834214|FG000|Overall Study|Withdrawal by Subject|1|||
125431716|NCT02237508|451207724|FG007|Overall Study|Physician Decision|0|||
125369711|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
125369712|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
125378962|NCT00799487|451019223|FG001|Dose Adjustment Period|Investigator Discretion|0|||
125603969|NCT01000064|451834215|FG001|Overall Study|Withdrawal by Subject|1|||
125603970|NCT01518192|451834216|FG000|Overall Study|Lost to Follow-up|29|||
125603971|NCT01518192|451834217|FG001|Overall Study|Lost to Follow-up|26|||
125603972|NCT01518192|451834218|FG002|Overall Study|Lost to Follow-up|35|||
125603973|NCT00798967|451834219|FG000|Overall Study|Adverse Event|2|||
125603974|NCT00798967|451834220|FG001|Overall Study|Adverse Event|3|||
125603975|NCT00798967|451834219|FG000|Overall Study|Withdrawal by Subject|0|||
125603976|NCT00798967|451834220|FG001|Overall Study|Withdrawal by Subject|1|||
125603977|NCT00798967|451834219|FG000|Overall Study|Physician Decision|1|||
125603978|NCT00798967|451834220|FG001|Overall Study|Physician Decision|0|||
125603979|NCT00798967|451834219|FG000|Overall Study|Randomized in error by site|1|||
125603980|NCT00798967|451834220|FG001|Overall Study|Randomized in error by site|0|||
125603981|NCT01415440|451834221|FG000|Overall Study|Lost to Follow-up|0|||
125603982|NCT01415440|451834222|FG001|Overall Study|Lost to Follow-up|1|||
125603983|NCT01415440|451834223|FG002|Overall Study|Lost to Follow-up|2|||
125603984|NCT01415440|451834221|FG000|Overall Study|Physician Decision|3|||
125603985|NCT01415440|451834222|FG001|Overall Study|Physician Decision|0|||
125603986|NCT01415440|451834223|FG002|Overall Study|Physician Decision|0|||
125603987|NCT01415440|451834221|FG000|Overall Study|Withdrawal by Subject|1|||
125603988|NCT01415440|451834222|FG001|Overall Study|Withdrawal by Subject|0|||
125603989|NCT01415440|451834223|FG002|Overall Study|Withdrawal by Subject|0|||
125603990|NCT03141307|451834224|FG000|In-Hospital|Withdrawal by Subject|0|||
125603991|NCT03141307|451834225|FG001|In-Hospital|Withdrawal by Subject|2|||
125603992|NCT03141307|451834224|FG000|In-Hospital|Protocol Violation|4|||
125603993|NCT03141307|451834225|FG001|In-Hospital|Protocol Violation|0|||
125603994|NCT03141307|451834224|FG000|Follow-Up|Lost to Follow-up|97|||
125603995|NCT03141307|451834225|FG001|Follow-Up|Lost to Follow-up|54|||
125603996|NCT03090737|451834226|FG000|Overall Study|Other reasons|1|||
125603997|NCT03090737|451834226|FG000|Overall Study|Completed treatment as per protocol|17|||
125603998|NCT03090737|451834226|FG000|Overall Study|Maximum clinical benefit|2|||
125603999|NCT03090737|451834226|FG000|Overall Study|Adverse event unrelated to study drug|7|||
125604000|NCT03090737|451834226|FG000|Overall Study|Study drug toxicity|4|||
125604001|NCT03090737|451834226|FG000|Overall Study|Disease progression|98|||
125604002|NCT02160977|451834229|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
125604003|NCT02160977|451834230|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
125604004|NCT02160977|451834229|FG000|Three Months After Surgery|Lost to Follow-up|0|||
125604005|NCT02160977|451834230|FG001|Three Months After Surgery|Lost to Follow-up|2|||
125604006|NCT02160977|451834229|FG000|Six Months After Surgery|Lost to Follow-up|2|||
125604007|NCT02160977|451834230|FG001|Six Months After Surgery|Lost to Follow-up|1|||
125604008|NCT01850563|451836015|FG000|Overall Study|Not eligible|3|||
125604009|NCT01850563|451836016|FG001|Overall Study|Not eligible|0|||
125604010|NCT04359823|451836017|FG000|Overall Study|Lost to Follow-up|0|||
125604011|NCT04359823|451836018|FG001|Overall Study|Lost to Follow-up|1|||
125604012|NCT04359823|451836017|FG000|Overall Study|Withdrawal by Subject|0|||
125604013|NCT04359823|451836018|FG001|Overall Study|Withdrawal by Subject|1|||
125604014|NCT00408421|451836021|FG000|Treatment Initial Randomization|Adverse Event|5|||
125604015|NCT00408421|451836022|FG001|Treatment Initial Randomization|Adverse Event|9|||
125604016|NCT00408421|451836023|FG002|Treatment Initial Randomization|Adverse Event|0|||
125604017|NCT00408421|451836021|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
125604018|NCT00408421|451836022|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
125604019|NCT00408421|451836023|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
125604020|NCT00408421|451836021|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
125604021|NCT00408421|451836022|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
125604022|NCT00408421|451836023|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
125604023|NCT00408421|451836021|FG000|Treatment Initial Randomization|Physician Decision|1|||
125604024|NCT00408421|451836022|FG001|Treatment Initial Randomization|Physician Decision|0|||
125604025|NCT00408421|451836023|FG002|Treatment Initial Randomization|Physician Decision|0|||
125604026|NCT00408421|451836021|FG000|Treatment Initial Randomization|Protocol Violation|0|||
125604027|NCT00408421|451836022|FG001|Treatment Initial Randomization|Protocol Violation|1|||
125604028|NCT00408421|451836023|FG002|Treatment Initial Randomization|Protocol Violation|0|||
125604029|NCT00408421|451836021|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
125604030|NCT00408421|451836022|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
125604031|NCT00408421|451836023|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
125604032|NCT00408421|451836021|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
125604033|NCT00408421|451836022|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
125604034|NCT00408421|451836023|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
125604035|NCT00408421|451836021|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
125604036|NCT00408421|451836022|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
125604037|NCT00408421|451836023|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
125604038|NCT00408421|451836021|FG000|Treatment Re-Randomization|Adverse Event|2|||
125604039|NCT00408421|451836022|FG001|Treatment Re-Randomization|Adverse Event|2|||
125604040|NCT00408421|451836023|FG002|Treatment Re-Randomization|Adverse Event|4|||
125604041|NCT00408421|451836021|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
125604042|NCT00408421|451836022|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
125369713|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
125369714|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
125369715|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
125369716|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
125369717|NCT00730405|450987073|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
125604043|NCT00408421|451836023|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
125604044|NCT00408421|451836021|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
125604045|NCT00408421|451836022|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
125604046|NCT00408421|451836023|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
125604047|NCT00408421|451836021|FG000|Treatment Re-Randomization|Physician Decision|1|||
125604048|NCT00408421|451836022|FG001|Treatment Re-Randomization|Physician Decision|3|||
125604049|NCT00408421|451836023|FG002|Treatment Re-Randomization|Physician Decision|0|||
125604050|NCT00408421|451836021|FG000|Treatment Re-Randomization|Protocol Violation|1|||
125604051|NCT00408421|451836022|FG001|Treatment Re-Randomization|Protocol Violation|1|||
125604052|NCT00408421|451836023|FG002|Treatment Re-Randomization|Protocol Violation|0|||
125604053|NCT00408421|451836021|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
125604054|NCT00408421|451836022|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
125604055|NCT00408421|451836023|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
125604056|NCT01790438|451836028|FG000|Overall Study|Adverse Event|3|||
125604057|NCT01790438|451836029|FG001|Overall Study|Adverse Event|2|||
125604058|NCT01790438|451836028|FG000|Overall Study|Death|4|||
125604059|NCT01790438|451836029|FG001|Overall Study|Death|0|||
125604060|NCT01790438|451836028|FG000|Overall Study|Lost to Follow-up|5|||
125604061|NCT01790438|451836029|FG001|Overall Study|Lost to Follow-up|2|||
125604062|NCT01790438|451836028|FG000|Overall Study|Withdrawal by Subject|13|||
125604063|NCT01790438|451836029|FG001|Overall Study|Withdrawal by Subject|2|||
125604064|NCT01790438|451836028|FG000|Overall Study|Physician Decision|3|||
125604065|NCT01790438|451836029|FG001|Overall Study|Physician Decision|1|||
125604066|NCT01790438|451836028|FG000|Overall Study|Sponsor Decision|0|||
125604067|NCT01790438|451836029|FG001|Overall Study|Sponsor Decision|3|||
125604068|NCT01790438|451836028|FG000|Overall Study|Protocol Required Discontinuation|7|||
125604069|NCT01790438|451836029|FG001|Overall Study|Protocol Required Discontinuation|1|||
125604070|NCT01614769|451836035|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
125604071|NCT01614769|451836036|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
125604072|NCT01614769|451836037|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
125604073|NCT01614769|451836038|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
125604074|NCT01614769|451836039|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
125604075|NCT01614769|451836040|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
125604076|NCT01614769|451836035|FG000|Period 1|Protocol Violation|0|||
125604077|NCT01614769|451836036|FG001|Period 1|Protocol Violation|0|||
125604078|NCT01614769|451836037|FG002|Period 1|Protocol Violation|0|||
125604079|NCT01614769|451836038|FG003|Period 1|Protocol Violation|1|||
125604080|NCT01614769|451836039|FG004|Period 1|Protocol Violation|0|||
125604081|NCT01614769|451836040|FG005|Period 1|Protocol Violation|0|||
125604082|NCT01614769|451836035|FG000|Period 1|Withdrawal by Subject|1|||
125604083|NCT01614769|451836036|FG001|Period 1|Withdrawal by Subject|0|||
125604084|NCT01614769|451836037|FG002|Period 1|Withdrawal by Subject|0|||
125604085|NCT01614769|451836038|FG003|Period 1|Withdrawal by Subject|0|||
125604086|NCT01614769|451836039|FG004|Period 1|Withdrawal by Subject|0|||
125604087|NCT01614769|451836040|FG005|Period 1|Withdrawal by Subject|0|||
125604088|NCT01614769|451836035|FG000|Period 3|Withdrawal by Subject|0|||
125604089|NCT01614769|451836036|FG001|Period 3|Withdrawal by Subject|0|||
125604090|NCT01614769|451836037|FG002|Period 3|Withdrawal by Subject|1|||
125604091|NCT01614769|451836038|FG003|Period 3|Withdrawal by Subject|0|||
125604092|NCT01614769|451836039|FG004|Period 3|Withdrawal by Subject|0|||
125604093|NCT01614769|451836040|FG005|Period 3|Withdrawal by Subject|0|||
125604094|NCT04760314|451836043|FG000|Induction Period|Withdrawal by Subject|0|||
125604095|NCT04760314|451836044|FG001|Induction Period|Withdrawal by Subject|1|||
125604096|NCT04760314|451836045|FG002|Induction Period|Withdrawal by Subject|1|||
125369718|NCT00730405|450987074|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
125369719|NCT00730405|450987075|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
125369720|NCT00730405|450987076|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
125369721|NCT00730405|450987077|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
125604097|NCT04760314|451836046|FG003|Induction Period|Withdrawal by Subject|0|||
125604098|NCT04760314|451836047|FG004|Induction Period|Withdrawal by Subject|0|||
125604099|NCT04760314|451836048|FG005|Induction Period|Withdrawal by Subject|0|||
125604100|NCT04760314|451836049|FG006|Induction Period|Withdrawal by Subject|0|||
125604101|NCT04760314|451836050|FG007|Induction Period|Withdrawal by Subject|0|||
125604102|NCT04760314|451836051|FG008|Induction Period|Withdrawal by Subject|0|||
125604103|NCT04760314|451836052|FG009|Induction Period|Withdrawal by Subject|0|||
125604104|NCT04760314|451836053|FG010|Induction Period|Withdrawal by Subject|0|||
125604105|NCT04760314|451836043|FG000|Induction Period|Adverse Event|0|||
125604106|NCT04760314|451836044|FG001|Induction Period|Adverse Event|0|||
125604107|NCT04760314|451836045|FG002|Induction Period|Adverse Event|2|||
125604108|NCT04760314|451836046|FG003|Induction Period|Adverse Event|0|||
125604109|NCT04760314|451836047|FG004|Induction Period|Adverse Event|0|||
125604110|NCT04760314|451836048|FG005|Induction Period|Adverse Event|0|||
125604111|NCT04760314|451836049|FG006|Induction Period|Adverse Event|0|||
125604112|NCT04760314|451836050|FG007|Induction Period|Adverse Event|0|||
125604113|NCT04760314|451836051|FG008|Induction Period|Adverse Event|0|||
125604114|NCT04760314|451836052|FG009|Induction Period|Adverse Event|0|||
125604115|NCT04760314|451836053|FG010|Induction Period|Adverse Event|0|||
125604116|NCT04760314|451836043|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
125604117|NCT04760314|451836044|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
125604118|NCT04760314|451836045|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
125604119|NCT04760314|451836046|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
125604120|NCT04760314|451836047|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
125604121|NCT04760314|451836048|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
125604122|NCT04760314|451836049|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
125604123|NCT04760314|451836050|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
125604124|NCT04760314|451836051|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
125604125|NCT04760314|451836052|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
125604126|NCT04760314|451836053|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
125604127|NCT04760314|451836043|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125604128|NCT04760314|451836044|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125604129|NCT04760314|451836045|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125604130|NCT04760314|451836046|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
125604131|NCT04760314|451836047|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125604132|NCT04760314|451836048|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
125604133|NCT04760314|451836049|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
125604134|NCT04760314|451836050|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125604135|NCT04760314|451836051|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125604136|NCT04760314|451836052|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125604137|NCT04760314|451836053|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
125604138|NCT04760314|451836043|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125604139|NCT04760314|451836044|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125604140|NCT04760314|451836045|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125604141|NCT04760314|451836046|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125604142|NCT04760314|451836047|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
125604143|NCT04760314|451836048|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125604144|NCT04760314|451836049|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125604145|NCT04760314|451836050|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125604146|NCT04760314|451836051|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125604147|NCT04760314|451836052|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125604148|NCT04760314|451836053|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
125604149|NCT04760314|451836043|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
125604150|NCT04760314|451836044|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
125604151|NCT04760314|451836045|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
125604152|NCT04760314|451836046|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
125604153|NCT04760314|451836047|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
125604154|NCT04760314|451836048|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
125604155|NCT04760314|451836049|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
125604156|NCT04760314|451836050|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
125604157|NCT04760314|451836051|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
125604158|NCT04760314|451836052|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
125604159|NCT04760314|451836053|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
125604160|NCT04760314|451836043|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125604161|NCT04760314|451836044|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125604162|NCT04760314|451836045|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125604163|NCT04760314|451836046|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125604164|NCT04760314|451836047|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125604165|NCT04760314|451836048|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125604166|NCT04760314|451836049|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125604167|NCT04760314|451836050|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
125604168|NCT04760314|451836051|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125604169|NCT04760314|451836052|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
125604170|NCT04760314|451836053|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
125604171|NCT04760314|451836043|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125604172|NCT04760314|451836044|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125604173|NCT04760314|451836045|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125604174|NCT04760314|451836046|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125604175|NCT04760314|451836047|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125604176|NCT04760314|451836048|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125604177|NCT04760314|451836049|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125604178|NCT04760314|451836050|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
125604179|NCT04760314|451836051|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
125604180|NCT04760314|451836052|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
125604181|NCT04760314|451836053|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125604182|NCT04760314|451836043|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125604183|NCT04760314|451836044|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125604184|NCT04760314|451836045|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125604185|NCT04760314|451836046|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125604186|NCT04760314|451836047|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125604187|NCT04760314|451836048|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125604188|NCT04760314|451836049|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125604189|NCT04760314|451836050|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
125604190|NCT04760314|451836051|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125604191|NCT04760314|451836052|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125604192|NCT04760314|451836053|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125604193|NCT04760314|451836043|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
125604194|NCT04760314|451836044|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
125604195|NCT04760314|451836045|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
125604196|NCT04760314|451836046|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
125604197|NCT04760314|451836047|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
125604198|NCT04760314|451836048|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
125604199|NCT04760314|451836049|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
125604200|NCT04760314|451836050|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
125604201|NCT04760314|451836051|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
125604202|NCT04760314|451836052|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
125604203|NCT04760314|451836053|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
125604204|NCT00960440|451836055|FG000|Overall Study|Death|0|||
125604205|NCT00960440|451836056|FG001|Overall Study|Death|0|||
125604206|NCT00960440|451836057|FG002|Overall Study|Death|0|||
125604207|NCT00960440|451836058|FG003|Overall Study|Death|1|||
125604208|NCT00960440|451836055|FG000|Overall Study|Adverse Event|12|||
125604209|NCT00960440|451836056|FG001|Overall Study|Adverse Event|12|||
125604210|NCT00960440|451836057|FG002|Overall Study|Adverse Event|4|||
125604211|NCT00960440|451836058|FG003|Overall Study|Adverse Event|4|||
125604212|NCT00960440|451836055|FG000|Overall Study|Lack of Efficacy|2|||
125604213|NCT00960440|451836056|FG001|Overall Study|Lack of Efficacy|5|||
125604214|NCT00960440|451836057|FG002|Overall Study|Lack of Efficacy|3|||
125604215|NCT00960440|451836058|FG003|Overall Study|Lack of Efficacy|8|||
125604216|NCT00960440|451836055|FG000|Overall Study|Protocol Violation|2|||
125604217|NCT00960440|451836056|FG001|Overall Study|Protocol Violation|8|||
125604218|NCT00960440|451836057|FG002|Overall Study|Protocol Violation|3|||
125604219|NCT00960440|451836058|FG003|Overall Study|Protocol Violation|4|||
125604220|NCT00960440|451836055|FG000|Overall Study|Withdrawal by Subject|9|||
125604221|NCT00960440|451836056|FG001|Overall Study|Withdrawal by Subject|5|||
125604222|NCT00960440|451836057|FG002|Overall Study|Withdrawal by Subject|2|||
125604223|NCT00960440|451836058|FG003|Overall Study|Withdrawal by Subject|1|||
125604224|NCT00960440|451836055|FG000|Overall Study|Other|1|||
125604225|NCT00960440|451836056|FG001|Overall Study|Other|1|||
125604226|NCT00960440|451836057|FG002|Overall Study|Other|1|||
125604227|NCT00960440|451836058|FG003|Overall Study|Other|0|||
125604228|NCT02421120|451836059|FG000|Overall Study|Adverse Event|1|||
125604229|NCT02207530|451836060|FG000|Overall Study|Worsening condition under investigation|78|||
125604230|NCT02207530|451836060|FG000|Overall Study|Patient decision to stop study treatment|5|||
125604231|NCT02207530|451836060|FG000|Overall Study|Adverse Event|8|||
125604232|NCT02345161|451836061|FG000|Overall Study|Withdrawal by Subject|25|||
125604233|NCT02345161|451836062|FG001|Overall Study|Withdrawal by Subject|33|||
125604234|NCT02345161|451836061|FG000|Overall Study|Adverse Event|16|||
125604235|NCT02345161|451836062|FG001|Overall Study|Adverse Event|19|||
125604236|NCT02345161|451836061|FG000|Overall Study|Physician Decision|4|||
125604237|NCT02345161|451836062|FG001|Overall Study|Physician Decision|4|||
125604238|NCT02345161|451836061|FG000|Overall Study|Lost to Follow-up|0|||
125604239|NCT02345161|451836062|FG001|Overall Study|Lost to Follow-up|1|||
125604240|NCT03554005|451836069|FG000|Overall Study|Not in participant's best interest|0|||
125604241|NCT03554005|451836070|FG001|Overall Study|Not in participant's best interest|0|||
125604242|NCT03554005|451836071|FG002|Overall Study|Not in participant's best interest|0|||
125604243|NCT03554005|451836072|FG003|Overall Study|Not in participant's best interest|0|||
125604244|NCT03554005|451836073|FG004|Overall Study|Not in participant's best interest|0|||
125604245|NCT03554005|451836074|FG005|Overall Study|Not in participant's best interest|1|||
125604246|NCT03554005|451836069|FG000|Overall Study|Disease Progression|1|||
125604247|NCT03554005|451836070|FG001|Overall Study|Disease Progression|1|||
125604248|NCT03554005|451836071|FG002|Overall Study|Disease Progression|1|||
125604249|NCT03554005|451836072|FG003|Overall Study|Disease Progression|1|||
125604250|NCT03554005|451836073|FG004|Overall Study|Disease Progression|5|||
125604251|NCT03554005|451836074|FG005|Overall Study|Disease Progression|6|||
125604252|NCT03554005|451836069|FG000|Overall Study|Adverse Event|0|||
125604253|NCT03554005|451836070|FG001|Overall Study|Adverse Event|0|||
125604254|NCT03554005|451836071|FG002|Overall Study|Adverse Event|0|||
125604255|NCT03554005|451836072|FG003|Overall Study|Adverse Event|0|||
125604256|NCT03554005|451836073|FG004|Overall Study|Adverse Event|0|||
125604257|NCT03554005|451836074|FG005|Overall Study|Adverse Event|3|||
125604258|NCT03554005|451836069|FG000|Overall Study|Physician Decision|0|||
125604259|NCT03554005|451836070|FG001|Overall Study|Physician Decision|0|||
125604260|NCT03554005|451836071|FG002|Overall Study|Physician Decision|0|||
125604261|NCT03554005|451836072|FG003|Overall Study|Physician Decision|0|||
125604262|NCT03554005|451836073|FG004|Overall Study|Physician Decision|1|||
125604263|NCT03554005|451836074|FG005|Overall Study|Physician Decision|0|||
125604264|NCT03554005|451836069|FG000|Overall Study|Other|0|||
125604265|NCT03554005|451836070|FG001|Overall Study|Other|0|||
125604266|NCT03554005|451836071|FG002|Overall Study|Other|0|||
125604267|NCT03554005|451836072|FG003|Overall Study|Other|0|||
125604268|NCT03554005|451836073|FG004|Overall Study|Other|0|||
125604269|NCT03554005|451836074|FG005|Overall Study|Other|1|||
125604270|NCT02855411|451836078|FG000|Overall Study|Study terminated by sponsor|21|||
125604271|NCT02855411|451836078|FG000|Overall Study|Does not meet entrance criteria|14|||
125604272|NCT02606045|451836079|FG000|Overall Study|Study closed before treament could begin|1|||
125604273|NCT02606045|451836080|FG001|Overall Study|Study closed before treament could begin|2|||
125604274|NCT00907881|451836081|FG000|Overall Study|Lost to Follow-up|59|||
125604275|NCT00907881|451836081|FG000|Overall Study|Noncompliance|5|||
125604276|NCT00907881|451836081|FG000|Overall Study|Withdrawal by Subject|5|||
125604277|NCT00907881|451836081|FG000|Overall Study|Protocol Violation|1|||
125604278|NCT00907881|451836081|FG000|Overall Study|Missing discontinuation information|15|||
125604279|NCT01671085|451836082|FG000|Overall Study|Withdrawal by Subject|1|||
125604280|NCT01671085|451836083|FG001|Overall Study|Withdrawal by Subject|0|||
125604281|NCT00637273|451836084|FG000|Overall Study|Adverse Event|11|||
125604282|NCT00637273|451836085|FG001|Overall Study|Adverse Event|5|||
125604283|NCT00637273|451836086|FG002|Overall Study|Adverse Event|7|||
125604284|NCT00637273|451836084|FG000|Overall Study|Lost to Follow-up|8|||
125604285|NCT00637273|451836085|FG001|Overall Study|Lost to Follow-up|9|||
125604286|NCT00637273|451836086|FG002|Overall Study|Lost to Follow-up|13|||
125604287|NCT00637273|451836084|FG000|Overall Study|Protocol Violation|2|||
125604288|NCT00637273|451836085|FG001|Overall Study|Protocol Violation|4|||
125604289|NCT00637273|451836086|FG002|Overall Study|Protocol Violation|1|||
125604290|NCT00637273|451836084|FG000|Overall Study|Withdrawal of Consent|18|||
125604291|NCT00637273|451836085|FG001|Overall Study|Withdrawal of Consent|6|||
125604292|NCT00637273|451836086|FG002|Overall Study|Withdrawal of Consent|18|||
125604293|NCT00637273|451836084|FG000|Overall Study|Investigator Decision|1|||
125604294|NCT00637273|451836085|FG001|Overall Study|Investigator Decision|3|||
125604295|NCT00637273|451836086|FG002|Overall Study|Investigator Decision|1|||
125604296|NCT00637273|451836084|FG000|Overall Study|Administrative|2|||
125604297|NCT00637273|451836085|FG001|Overall Study|Administrative|0|||
125604298|NCT00637273|451836086|FG002|Overall Study|Administrative|0|||
125604299|NCT00637273|451836084|FG000|Overall Study|Loss of Glucose Control|1|||
125604300|NCT00637273|451836085|FG001|Overall Study|Loss of Glucose Control|1|||
125604301|NCT00637273|451836086|FG002|Overall Study|Loss of Glucose Control|1|||
125604302|NCT00986258|451836087|FG000|Observation Period|Not eligible to be dosed|11|||
125604303|NCT00986258|451836087|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
125604304|NCT00986258|451836087|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
125604305|NCT00986258|451836087|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
125604306|NCT00986258|451836087|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
125604307|NCT00986258|451836087|FG000|Titration and Optimal Dose Period|Other|1|||
125604308|NCT00986258|451836087|FG000|Maintenance Period|Adverse Event|5|||
125604309|NCT00986258|451836087|FG000|Maintenance Period|Lack of Efficacy|2|||
125604310|NCT00986258|451836087|FG000|Maintenance Period|Withdrawal by Subject|2|||
125604311|NCT02616029|451836089|FG000|Overall Study|Adverse Event|1|||
125604312|NCT02616029|451836090|FG001|Overall Study|Adverse Event|0|||
125604313|NCT02616029|451836089|FG000|Overall Study|Death|0|||
125369722|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
125604314|NCT02616029|451836090|FG001|Overall Study|Death|1|||
125604315|NCT02616029|451836089|FG000|Overall Study|Protocol Violation|1|||
125604316|NCT02616029|451836090|FG001|Overall Study|Protocol Violation|0|||
125604317|NCT02616029|451836089|FG000|Overall Study|Withdrew Consent|1|||
125604318|NCT02616029|451836090|FG001|Overall Study|Withdrew Consent|0|||
125604319|NCT02616029|451836089|FG000|Overall Study|Enrolled and Never Treated|1|||
125604320|NCT02616029|451836090|FG001|Overall Study|Enrolled and Never Treated|1|||
125604321|NCT01505491|451836091|FG000|Overall Study|Other reason not listed|1|||
125604322|NCT01505491|451836092|FG001|Overall Study|Other reason not listed|0|||
125604323|NCT01505491|451836093|FG002|Overall Study|Other reason not listed|0|||
125604324|NCT01505491|451836091|FG000|Overall Study|Withdrawal by Subject|1|||
125604325|NCT01505491|451836092|FG001|Overall Study|Withdrawal by Subject|1|||
125604326|NCT01505491|451836093|FG002|Overall Study|Withdrawal by Subject|4|||
125604327|NCT01505491|451836091|FG000|Overall Study|Lost to Follow-up|0|||
125604328|NCT01505491|451836092|FG001|Overall Study|Lost to Follow-up|0|||
125604329|NCT01505491|451836093|FG002|Overall Study|Lost to Follow-up|1|||
125604330|NCT01063751|451836102|FG000|Overall Study|Censored from analyses|42|||
125604331|NCT01063751|451836102|FG000|Overall Study|Withdrawal by Subject|34|||
125604332|NCT01063751|451836102|FG000|Overall Study|Lost to Follow-up|30|||
125604333|NCT01063751|451836102|FG000|Overall Study|Death|13|||
125604334|NCT01063751|451836102|FG000|Overall Study|Sponsored Terminated Study|60|||
125604335|NCT01063751|451836102|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
125604336|NCT01063751|451836102|FG000|Overall Study|Investigator site closed|10|||
125604337|NCT01063751|451836102|FG000|Overall Study|Revision|6|||
125604338|NCT01063751|451836102|FG000|Overall Study|Physician Decision|4|||
125604339|NCT03408873|451836108|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
125604340|NCT03408873|451836108|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
125604341|NCT03408873|451836108|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
125604342|NCT03408873|451836108|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
125604343|NCT03408873|451836108|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
125604344|NCT03408873|451836108|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
125604345|NCT01312428|451836112|FG000|Overall Study|Study Termination|3|||
125604346|NCT01312428|451836113|FG001|Overall Study|Study Termination|4|||
125604347|NCT03799718|451836114|FG000|Overall Study|Adverse Event|2|||
125604348|NCT02214186|451836116|FG000|Overall Study|Lost to Follow-up|1|||
125604349|NCT02214186|451836117|FG001|Overall Study|Lost to Follow-up|1|||
125604350|NCT02214186|451836116|FG000|Overall Study|Protocol Violation|1|||
125604351|NCT02214186|451836117|FG001|Overall Study|Protocol Violation|1|||
125604352|NCT01651052|451836118|FG000|Overall Study|Death|21|||
125604353|NCT01651052|451836118|FG000|Overall Study|Explant|1|||
125604354|NCT01651052|451836118|FG000|Overall Study|Withdrawal by Subject|1|||
125604355|NCT01651052|451836118|FG000|Overall Study|Lost to Follow-up|3|||
125604356|NCT00611130|451836125|FG000|Overall Study|Lost to Follow-up|25|||
125604357|NCT00611130|451836126|FG001|Overall Study|Lost to Follow-up|29|||
125604358|NCT00611130|451836125|FG000|Overall Study|Protocol noncompliance|7|||
125604359|NCT00611130|451836126|FG001|Overall Study|Protocol noncompliance|6|||
125604360|NCT00611130|451836125|FG000|Overall Study|Withdrawal by Subject|6|||
125604361|NCT00611130|451836126|FG001|Overall Study|Withdrawal by Subject|5|||
125604362|NCT00611130|451836125|FG000|Overall Study|Other|5|||
125604363|NCT00611130|451836126|FG001|Overall Study|Other|4|||
125604364|NCT00611130|451836125|FG000|Overall Study|Incarceration|3|||
125604365|NCT00611130|451836126|FG001|Overall Study|Incarceration|2|||
125604366|NCT00611130|451836125|FG000|Overall Study|Administrative|1|||
125604367|NCT00611130|451836126|FG001|Overall Study|Administrative|1|||
125604368|NCT00611130|451836125|FG000|Overall Study|Adverse Event|1|||
125604369|NCT00611130|451836126|FG001|Overall Study|Adverse Event|0|||
125604370|NCT00611130|451836125|FG000|Overall Study|Death|1|||
125604371|NCT00611130|451836126|FG001|Overall Study|Death|0|||
125604372|NCT03964415|451836127|FG000|Overall Study|Sponsor's decision|1563|||
125604373|NCT03964415|451836128|FG001|Overall Study|Sponsor's decision|1528|||
125604374|NCT03964415|451836127|FG000|Overall Study|Lost to Follow-up|139|||
125604375|NCT03964415|451836128|FG001|Overall Study|Lost to Follow-up|146|||
125604376|NCT03964415|451836127|FG000|Overall Study|Withdrawal by Subject|68|||
125604377|NCT03964415|451836128|FG001|Overall Study|Withdrawal by Subject|72|||
125604378|NCT03964415|451836127|FG000|Overall Study|Physician Decision|34|||
125604379|NCT03964415|451836128|FG001|Overall Study|Physician Decision|48|||
125604380|NCT03964415|451836127|FG000|Overall Study|Adverse Event|3|||
125604381|NCT03964415|451836128|FG001|Overall Study|Adverse Event|0|||
125604382|NCT03964415|451836127|FG000|Overall Study|Death|4|||
125604383|NCT03964415|451836128|FG001|Overall Study|Death|6|||
125604384|NCT03964415|451836127|FG000|Overall Study|Protocol Violation|1|||
125604385|NCT03964415|451836128|FG001|Overall Study|Protocol Violation|4|||
125604386|NCT03964415|451836127|FG000|Overall Study|Other|35|||
125604387|NCT03964415|451836128|FG001|Overall Study|Other|38|||
125604388|NCT03964415|451836127|FG000|Overall Study|Randomized but not treated|6|||
125604389|NCT03964415|451836128|FG001|Overall Study|Randomized but not treated|7|||
125604390|NCT01024465|451836129|FG000|Overall Study|Adverse Event|2|||
125604391|NCT01024465|451836129|FG000|Overall Study|Physician Decision|1|||
125369723|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
125369724|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
125369725|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
125369726|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
125369727|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
125604392|NCT01734993|451836130|FG000|Overall Study|Adverse Event|1|||
125604393|NCT01734993|451836130|FG000|Overall Study|Lack of Efficacy|1|||
125604394|NCT02062151|451836133|FG000|Overall Study|screen failure|1|||
125604395|NCT02086565|451836134|FG000|Overall Study|Lost to Follow-up|9|||
125604396|NCT02086565|451836135|FG001|Overall Study|Lost to Follow-up|7|||
125604397|NCT02086565|451836134|FG000|Overall Study|Withdrawal by Subject|2|||
125604398|NCT02086565|451836135|FG001|Overall Study|Withdrawal by Subject|1|||
125604399|NCT02086565|451836134|FG000|Overall Study|Death|3|||
125604400|NCT02086565|451836135|FG001|Overall Study|Death|2|||
125604401|NCT02086565|451836134|FG000|Overall Study|withdrawn by research team|2|||
125604402|NCT02086565|451836135|FG001|Overall Study|withdrawn by research team|2|||
125604403|NCT02116972|451836136|FG000|Overall Study|Adverse Event|4|||
125604404|NCT02116972|451836137|FG001|Overall Study|Adverse Event|4|||
125604405|NCT02116972|451836138|FG002|Overall Study|Adverse Event|1|||
125604406|NCT02116972|451836136|FG000|Overall Study|Withdrawal by Subject|1|||
125604407|NCT02116972|451836137|FG001|Overall Study|Withdrawal by Subject|1|||
125604408|NCT02116972|451836138|FG002|Overall Study|Withdrawal by Subject|5|||
125604409|NCT02116972|451836136|FG000|Overall Study|Protocol Violation|1|||
125604410|NCT02116972|451836137|FG001|Overall Study|Protocol Violation|0|||
125604411|NCT02116972|451836138|FG002|Overall Study|Protocol Violation|1|||
125604412|NCT02116972|451836136|FG000|Overall Study|Lost to Follow-up|4|||
125604413|NCT02116972|451836137|FG001|Overall Study|Lost to Follow-up|3|||
125604414|NCT02116972|451836138|FG002|Overall Study|Lost to Follow-up|1|||
125604415|NCT02116972|451836136|FG000|Overall Study|Lack of Efficacy|6|||
125604416|NCT02116972|451836137|FG001|Overall Study|Lack of Efficacy|6|||
125604417|NCT02116972|451836138|FG002|Overall Study|Lack of Efficacy|5|||
125604418|NCT02116972|451836136|FG000|Overall Study|scheduling conflicts and relocation|3|||
125604419|NCT02116972|451836137|FG001|Overall Study|scheduling conflicts and relocation|3|||
125604420|NCT02116972|451836138|FG002|Overall Study|scheduling conflicts and relocation|6|||
125604421|NCT00789477|451836143|FG000|Overall Study|Withdrawal by Subject|2|||
125604422|NCT00789477|451836144|FG001|Overall Study|Withdrawal by Subject|1|||
125604423|NCT00789477|451836145|FG002|Overall Study|Withdrawal by Subject|3|||
125604424|NCT00789477|451836146|FG003|Overall Study|Withdrawal by Subject|2|||
125604425|NCT00789477|451836147|FG004|Overall Study|Withdrawal by Subject|3|||
125604426|NCT00789477|451836143|FG000|Overall Study|Protocol Violation|1|||
125604427|NCT00789477|451836144|FG001|Overall Study|Protocol Violation|0|||
125604428|NCT00789477|451836145|FG002|Overall Study|Protocol Violation|0|||
125604429|NCT00789477|451836146|FG003|Overall Study|Protocol Violation|1|||
125604430|NCT00789477|451836147|FG004|Overall Study|Protocol Violation|0|||
125604431|NCT00789477|451836143|FG000|Overall Study|Adverse Event|3|||
125604432|NCT00789477|451836144|FG001|Overall Study|Adverse Event|3|||
125604433|NCT00789477|451836145|FG002|Overall Study|Adverse Event|1|||
125604434|NCT00789477|451836146|FG003|Overall Study|Adverse Event|0|||
125604435|NCT00789477|451836147|FG004|Overall Study|Adverse Event|0|||
125604436|NCT00789477|451836143|FG000|Overall Study|Death|1|||
125604437|NCT00789477|451836144|FG001|Overall Study|Death|1|||
125604438|NCT00789477|451836145|FG002|Overall Study|Death|2|||
125604439|NCT00789477|451836146|FG003|Overall Study|Death|2|||
125604440|NCT00789477|451836147|FG004|Overall Study|Death|0|||
125604441|NCT00789477|451836143|FG000|Overall Study|Lost to Follow-up|0|||
125604442|NCT00789477|451836144|FG001|Overall Study|Lost to Follow-up|1|||
125604443|NCT00789477|451836145|FG002|Overall Study|Lost to Follow-up|4|||
125604444|NCT00789477|451836146|FG003|Overall Study|Lost to Follow-up|2|||
125604445|NCT00789477|451836147|FG004|Overall Study|Lost to Follow-up|4|||
125604446|NCT00789477|451836143|FG000|Overall Study|Lack of Efficacy|2|||
125604447|NCT00789477|451836144|FG001|Overall Study|Lack of Efficacy|0|||
125604448|NCT00789477|451836145|FG002|Overall Study|Lack of Efficacy|0|||
125604449|NCT00789477|451836146|FG003|Overall Study|Lack of Efficacy|0|||
125369728|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
125369729|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
125369730|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
125604450|NCT00789477|451836147|FG004|Overall Study|Lack of Efficacy|0|||
125369731|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
125431717|NCT02237508|451207725|FG008|Overall Study|Physician Decision|0|||
125604451|NCT00789477|451836143|FG000|Overall Study|Other|2|||
125604452|NCT00789477|451836144|FG001|Overall Study|Other|0|||
125604453|NCT00789477|451836145|FG002|Overall Study|Other|1|||
125604454|NCT00789477|451836146|FG003|Overall Study|Other|3|||
125604455|NCT00789477|451836147|FG004|Overall Study|Other|0|||
125604456|NCT02092389|451836149|FG000|Overall Study|Adverse Event|1|||
125604457|NCT02092389|451836149|FG000|Overall Study|Other|5|||
125369732|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
125369733|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
125369734|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
125369735|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
125369736|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
125369737|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Death|0|||
125369738|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Death|1|||
125369739|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Death|0|||
125369740|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Death|1|||
125369741|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Death|0|||
125369742|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Change of location|1|||
125369743|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Change of location|1|||
125369744|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Change of location|0|||
125369745|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Change of location|1|||
125369746|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Change of location|0|||
125369747|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
125369748|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
125369749|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
125369750|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
125369751|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
125369752|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
125369753|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
125369754|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
125369755|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
125369756|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
125369757|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
125369758|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
125369759|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
125369760|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
125369761|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
125369762|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
125369763|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
125369764|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
125369765|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
125369766|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
125369767|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
125369768|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
125369769|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
125369770|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
125369771|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
125369772|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
125369773|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
125369774|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
125604458|NCT01242020|451836150|FG000|Overall Study|Withdrawal by Subject|2|||
125604459|NCT01242020|451836151|FG001|Overall Study|Withdrawal by Subject|0|||
125604460|NCT01242020|451836150|FG000|Overall Study|Failed screening|1|||
125604461|NCT01242020|451836151|FG001|Overall Study|Failed screening|0|||
125604462|NCT01052012|451836156|FG000|Overall Study|Not treated|2|||
125604463|NCT01052012|451836157|FG001|Overall Study|Not treated|5|||
125604464|NCT01052012|451836158|FG002|Overall Study|Not treated|0|||
125604465|NCT01052012|451836159|FG003|Overall Study|Not treated|0|||
125604466|NCT01052012|451836160|FG004|Overall Study|Not treated|11|||
125604467|NCT01052012|451836161|FG005|Overall Study|Not treated|8|||
125604468|NCT01052012|451836156|FG000|Overall Study|Adverse Event|1|||
125604469|NCT01052012|451836157|FG001|Overall Study|Adverse Event|0|||
125604470|NCT01052012|451836158|FG002|Overall Study|Adverse Event|0|||
125604471|NCT01052012|451836159|FG003|Overall Study|Adverse Event|1|||
125369775|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
125369776|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
125369777|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
125369778|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
125604472|NCT01052012|451836160|FG004|Overall Study|Adverse Event|0|||
125604473|NCT01052012|451836161|FG005|Overall Study|Adverse Event|0|||
125604474|NCT01052012|451836156|FG000|Overall Study|Lost to Follow-up|0|||
125604475|NCT01052012|451836157|FG001|Overall Study|Lost to Follow-up|0|||
125604476|NCT01052012|451836158|FG002|Overall Study|Lost to Follow-up|0|||
125604477|NCT01052012|451836159|FG003|Overall Study|Lost to Follow-up|0|||
125604478|NCT01052012|451836160|FG004|Overall Study|Lost to Follow-up|1|||
125604479|NCT01052012|451836161|FG005|Overall Study|Lost to Follow-up|0|||
125604480|NCT01052012|451836156|FG000|Overall Study|Withdrawal by Subject|1|||
125212843|NCT01026818|450405480|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
125212844|NCT01026818|450405481|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
125212845|NCT01026818|450405478|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
125212846|NCT01026818|450405479|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
125212847|NCT01026818|450405480|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
125604481|NCT01052012|451836157|FG001|Overall Study|Withdrawal by Subject|1|||
125604482|NCT01052012|451836158|FG002|Overall Study|Withdrawal by Subject|0|||
125604483|NCT01052012|451836159|FG003|Overall Study|Withdrawal by Subject|0|||
125604484|NCT01052012|451836160|FG004|Overall Study|Withdrawal by Subject|3|||
125604485|NCT01052012|451836161|FG005|Overall Study|Withdrawal by Subject|1|||
125604486|NCT01052012|451836156|FG000|Overall Study|Physician Decision|0|||
125604487|NCT01052012|451836157|FG001|Overall Study|Physician Decision|0|||
125604488|NCT01052012|451836158|FG002|Overall Study|Physician Decision|0|||
125604489|NCT01052012|451836159|FG003|Overall Study|Physician Decision|0|||
125604490|NCT01052012|451836160|FG004|Overall Study|Physician Decision|0|||
125604491|NCT01052012|451836161|FG005|Overall Study|Physician Decision|1|||
125604492|NCT01052012|451836156|FG000|Overall Study|Other|0|||
125604493|NCT01052012|451836157|FG001|Overall Study|Other|0|||
125604494|NCT01052012|451836158|FG002|Overall Study|Other|0|||
125604495|NCT01052012|451836159|FG003|Overall Study|Other|0|||
125369779|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
125604496|NCT01052012|451836160|FG004|Overall Study|Other|1|||
125604497|NCT01052012|451836161|FG005|Overall Study|Other|0|||
125604498|NCT02239094|451836169|FG000|Overall Study|Withdrawal by Subject|1|||
125604499|NCT02239094|451836169|FG000|Overall Study|Remitted before started|1|||
125604500|NCT02508701|451836170|FG000|Overall Study|Lost to Follow-up|9|||
125604501|NCT02508701|451836171|FG001|Overall Study|Lost to Follow-up|5|||
125604502|NCT02508701|451836172|FG002|Overall Study|Lost to Follow-up|5|||
125604503|NCT02508701|451836173|FG003|Overall Study|Lost to Follow-up|3|||
125604504|NCT00592501|451836174|FG000|Overall Study|Withdrawal by Subject|1|||
125604505|NCT00592501|451836174|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
125604506|NCT03880227|451836178|FG000|First Visit|Withdrawal by Subject|1|||
125604507|NCT03880227|451836179|FG001|First Visit|Withdrawal by Subject|0|||
125604508|NCT03880227|451836180|FG002|First Visit|Withdrawal by Subject|0|||
125604509|NCT03880227|451836181|FG003|First Visit|Withdrawal by Subject|0|||
125431718|NCT02237508|451207726|FG009|Overall Study|Physician Decision|0|||
125604510|NCT03880227|451836178|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
125604511|NCT03880227|451836179|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
125604512|NCT03880227|451836180|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
125604513|NCT03880227|451836181|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
125604514|NCT03880227|451836178|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
125604515|NCT03880227|451836179|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
125604516|NCT03880227|451836180|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
125604517|NCT03880227|451836181|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
125604518|NCT03880227|451836178|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
125604519|NCT03880227|451836179|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
125604520|NCT03880227|451836180|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
125604521|NCT03880227|451836181|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
125604522|NCT02399475|451836184|FG000|Overall Study|Physician Decision|1|||
125604523|NCT02399475|451836185|FG001|Overall Study|Physician Decision|0|||
125604524|NCT01963117|451836186|FG000|Overall Study|Death|1|||
125604525|NCT01605396|451836187|FG000|Overall Study|Adverse Event|5|||
125604526|NCT01605396|451836188|FG001|Overall Study|Adverse Event|3|||
125604527|NCT01605396|451836187|FG000|Overall Study|Lost to Follow-up|1|||
125604528|NCT01605396|451836188|FG001|Overall Study|Lost to Follow-up|0|||
125604529|NCT01605396|451836187|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125604530|NCT01605396|451836188|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125604531|NCT01605396|451836187|FG000|Overall Study|Physician Decision|2|||
125604532|NCT01605396|451836188|FG001|Overall Study|Physician Decision|2|||
125604533|NCT01605396|451836187|FG000|Overall Study|Progressive Disease|23|||
125604534|NCT01605396|451836188|FG001|Overall Study|Progressive Disease|27|||
125604535|NCT01605396|451836187|FG000|Overall Study|Withdrawal by Subject|4|||
125604536|NCT01605396|451836188|FG001|Overall Study|Withdrawal by Subject|2|||
125604537|NCT01605396|451836187|FG000|Overall Study|Transfer Off Study|4|||
125604538|NCT01605396|451836188|FG001|Overall Study|Transfer Off Study|5|||
125604539|NCT00109733|451837868|FG000|Overall Study|Protocol Violation|0|||
125604540|NCT00109733|451837869|FG001|Overall Study|Protocol Violation|1|||
125604541|NCT00109733|451837868|FG000|Overall Study|Stopped taking study drug|1|||
125604542|NCT00109733|451837869|FG001|Overall Study|Stopped taking study drug|1|||
125604543|NCT00109733|451837868|FG000|Overall Study|Non-compliant|0|||
125604544|NCT00109733|451837869|FG001|Overall Study|Non-compliant|1|||
125604545|NCT00109733|451837868|FG000|Overall Study|Could not commit time for study|1|||
125604546|NCT00109733|451837869|FG001|Overall Study|Could not commit time for study|1|||
125604547|NCT02433288|451837876|FG000|Overall Study|Severe non-compliance to protocol|13|||
125604548|NCT02433288|451837877|FG001|Overall Study|Severe non-compliance to protocol|7|||
125604549|NCT02433288|451837876|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
125604550|NCT02433288|451837877|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
125604551|NCT02433288|451837876|FG000|Overall Study|Withdrawal by Subject|101|||
125604552|NCT02433288|451837877|FG001|Overall Study|Withdrawal by Subject|99|||
125604553|NCT02433288|451837876|FG000|Overall Study|Lost to Follow-up|2|||
125604554|NCT02433288|451837877|FG001|Overall Study|Lost to Follow-up|14|||
125604555|NCT02433288|451837876|FG000|Overall Study|Death|0|||
125604556|NCT02433288|451837877|FG001|Overall Study|Death|3|||
125604557|NCT00367640|451837878|FG000|Overall Study|Adverse Event|3|||
125604558|NCT00367640|451837879|FG001|Overall Study|Adverse Event|6|||
125604559|NCT00367640|451837880|FG002|Overall Study|Adverse Event|8|||
125604560|NCT00367640|451837881|FG003|Overall Study|Adverse Event|0|||
125604561|NCT00367640|451837878|FG000|Overall Study|Withdrawal by Subject|8|||
125604562|NCT00367640|451837879|FG001|Overall Study|Withdrawal by Subject|11|||
125604563|NCT00367640|451837880|FG002|Overall Study|Withdrawal by Subject|8|||
125604564|NCT00367640|451837881|FG003|Overall Study|Withdrawal by Subject|6|||
125604565|NCT00367640|451837878|FG000|Overall Study|Any other reason not above-mentioned|7|||
125604566|NCT00367640|451837879|FG001|Overall Study|Any other reason not above-mentioned|5|||
125604567|NCT00367640|451837880|FG002|Overall Study|Any other reason not above-mentioned|3|||
125604568|NCT00367640|451837881|FG003|Overall Study|Any other reason not above-mentioned|4|||
125604569|NCT00406315|451837883|FG000|Overall Study|Death|1|||
125604570|NCT00406315|451837883|FG000|Overall Study|Adverse Event|39|||
125604571|NCT00406315|451837883|FG000|Overall Study|Laboratory Abnormality|4|||
125604572|NCT00406315|451837883|FG000|Overall Study|Lack of Efficacy|13|||
125604573|NCT00406315|451837883|FG000|Overall Study|Other|33|||
125604574|NCT00406315|451837883|FG000|Overall Study|Lost to Follow-up|21|||
125604575|NCT00406315|451837883|FG000|Overall Study|Withdrawal by Subject|30|||
125604576|NCT02142894|451837887|FG000|Overall Study|Protocol Violation|8|||
125604577|NCT01455428|451837894|FG000|Overall Study|Protocol Violation|2|||
125604578|NCT01455428|451837895|FG001|Overall Study|Protocol Violation|1|||
125604579|NCT01455428|451837894|FG000|Overall Study|Adverse Event|6|||
125604580|NCT01455428|451837895|FG001|Overall Study|Adverse Event|2|||
125604581|NCT01455428|451837894|FG000|Overall Study|Lost to Follow-up|1|||
125604582|NCT01455428|451837895|FG001|Overall Study|Lost to Follow-up|1|||
125604583|NCT01455428|451837894|FG000|Overall Study|Withdrawal by Subject|2|||
125604584|NCT01455428|451837895|FG001|Overall Study|Withdrawal by Subject|5|||
125604585|NCT01455428|451837894|FG000|Overall Study|Did not meet entrance criteria|0|||
125604586|NCT01455428|451837895|FG001|Overall Study|Did not meet entrance criteria|2|||
125369780|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
125604587|NCT01455428|451837894|FG000|Overall Study|Insufficient clinical response|0|||
125604588|NCT01455428|451837895|FG001|Overall Study|Insufficient clinical response|2|||
125604589|NCT01455428|451837894|FG000|Overall Study|Did not receive treatment|1|||
125604590|NCT01455428|451837895|FG001|Overall Study|Did not receive treatment|1|||
125604591|NCT01455428|451837894|FG000|Overall Study|Other|2|||
125604592|NCT01455428|451837895|FG001|Overall Study|Other|4|||
125604593|NCT03303339|451837896|FG000|Overall Study|Death|2|||
125604594|NCT03303339|451837897|FG001|Overall Study|Death|2|||
125604595|NCT03303339|451837898|FG002|Overall Study|Death|2|||
125604596|NCT03303339|451837899|FG003|Overall Study|Death|1|||
125604597|NCT03303339|451837900|FG004|Overall Study|Death|4|||
125604598|NCT03303339|451837901|FG005|Overall Study|Death|2|||
125604599|NCT03303339|451837902|FG006|Overall Study|Death|2|||
125604600|NCT03303339|451837903|FG007|Overall Study|Death|2|||
125604601|NCT03303339|451837904|FG008|Overall Study|Death|3|||
125604602|NCT03303339|451837905|FG009|Overall Study|Death|3|||
125604603|NCT03303339|451837906|FG010|Overall Study|Death|4|||
125604604|NCT03303339|451837907|FG011|Overall Study|Death|24|||
125604605|NCT03303339|451837896|FG000|Overall Study|Study Terminated by Sponsor|0|||
125604606|NCT03303339|451837897|FG001|Overall Study|Study Terminated by Sponsor|0|||
125604607|NCT03303339|451837898|FG002|Overall Study|Study Terminated by Sponsor|0|||
125604608|NCT03303339|451837899|FG003|Overall Study|Study Terminated by Sponsor|0|||
125604609|NCT03303339|451837900|FG004|Overall Study|Study Terminated by Sponsor|0|||
125604610|NCT03303339|451837901|FG005|Overall Study|Study Terminated by Sponsor|0|||
125604611|NCT03303339|451837902|FG006|Overall Study|Study Terminated by Sponsor|0|||
125604612|NCT03303339|451837903|FG007|Overall Study|Study Terminated by Sponsor|0|||
125604613|NCT03303339|451837904|FG008|Overall Study|Study Terminated by Sponsor|1|||
125604614|NCT03303339|451837905|FG009|Overall Study|Study Terminated by Sponsor|0|||
125604615|NCT03303339|451837906|FG010|Overall Study|Study Terminated by Sponsor|1|||
125604616|NCT03303339|451837907|FG011|Overall Study|Study Terminated by Sponsor|1|||
125604617|NCT03303339|451837896|FG000|Overall Study|Withdrawal by Subject|1|||
125604618|NCT03303339|451837897|FG001|Overall Study|Withdrawal by Subject|0|||
125604619|NCT03303339|451837898|FG002|Overall Study|Withdrawal by Subject|0|||
125604620|NCT03303339|451837899|FG003|Overall Study|Withdrawal by Subject|0|||
125604621|NCT03303339|451837900|FG004|Overall Study|Withdrawal by Subject|0|||
125604622|NCT03303339|451837901|FG005|Overall Study|Withdrawal by Subject|1|||
125604623|NCT03303339|451837902|FG006|Overall Study|Withdrawal by Subject|1|||
125604624|NCT03303339|451837903|FG007|Overall Study|Withdrawal by Subject|0|||
125604625|NCT03303339|451837904|FG008|Overall Study|Withdrawal by Subject|0|||
125604626|NCT03303339|451837905|FG009|Overall Study|Withdrawal by Subject|0|||
125604627|NCT03303339|451837906|FG010|Overall Study|Withdrawal by Subject|0|||
125604628|NCT03303339|451837907|FG011|Overall Study|Withdrawal by Subject|2|||
125604629|NCT03303339|451837896|FG000|Overall Study|Physician Decision|0|||
125604630|NCT03303339|451837897|FG001|Overall Study|Physician Decision|0|||
125604631|NCT03303339|451837898|FG002|Overall Study|Physician Decision|0|||
125604632|NCT03303339|451837899|FG003|Overall Study|Physician Decision|0|||
125604633|NCT03303339|451837900|FG004|Overall Study|Physician Decision|1|||
125604634|NCT03303339|451837901|FG005|Overall Study|Physician Decision|0|||
125604635|NCT03303339|451837902|FG006|Overall Study|Physician Decision|0|||
125604636|NCT03303339|451837903|FG007|Overall Study|Physician Decision|0|||
125604637|NCT03303339|451837904|FG008|Overall Study|Physician Decision|0|||
125604638|NCT03303339|451837905|FG009|Overall Study|Physician Decision|0|||
125604639|NCT03303339|451837906|FG010|Overall Study|Physician Decision|0|||
125604640|NCT03303339|451837907|FG011|Overall Study|Physician Decision|0|||
125604641|NCT03303339|451837896|FG000|Overall Study|Safety/Non-compliance|0|||
125604642|NCT03303339|451837897|FG001|Overall Study|Safety/Non-compliance|0|||
125604643|NCT03303339|451837898|FG002|Overall Study|Safety/Non-compliance|0|||
125604644|NCT03303339|451837899|FG003|Overall Study|Safety/Non-compliance|0|||
125369781|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
125369782|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
125604645|NCT03303339|451837900|FG004|Overall Study|Safety/Non-compliance|0|||
125604646|NCT03303339|451837901|FG005|Overall Study|Safety/Non-compliance|0|||
125604647|NCT03303339|451837902|FG006|Overall Study|Safety/Non-compliance|0|||
125604648|NCT03303339|451837903|FG007|Overall Study|Safety/Non-compliance|0|||
125604649|NCT03303339|451837904|FG008|Overall Study|Safety/Non-compliance|0|||
125604650|NCT03303339|451837905|FG009|Overall Study|Safety/Non-compliance|0|||
125604651|NCT03303339|451837906|FG010|Overall Study|Safety/Non-compliance|0|||
125604652|NCT03303339|451837907|FG011|Overall Study|Safety/Non-compliance|1|||
125604653|NCT00257192|451837910|FG000|Overall Study|Adverse Event|21|||
125604654|NCT00257192|451837911|FG001|Overall Study|Adverse Event|10|||
125604655|NCT00257192|451837910|FG000|Overall Study|Laboratory abnormality|1|||
125604656|NCT00257192|451837911|FG001|Overall Study|Laboratory abnormality|1|||
125604657|NCT00257192|451837910|FG000|Overall Study|Lost to Follow-up|3|||
125369783|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
125369784|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
125369785|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
125369786|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
125369787|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
125369788|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
125431719|NCT02237508|451207717|FG000|Overall Study|Protocol Violation|0|||
125431720|NCT02237508|451207718|FG001|Overall Study|Protocol Violation|0|||
125431721|NCT02237508|451207719|FG002|Overall Study|Protocol Violation|1|||
125369789|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
125369790|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
125369791|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
125369792|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
125369793|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
125369794|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
125369795|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
125369796|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
125369797|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Missing|0|||
125369798|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Missing|0|||
125369799|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Missing|2|||
125369800|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Missing|0|||
125369801|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Missing|0|||
125369802|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
125369803|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
125431722|NCT02237508|451207720|FG003|Overall Study|Protocol Violation|0|||
125431723|NCT02237508|451207721|FG004|Overall Study|Protocol Violation|0|||
125431724|NCT02237508|451207722|FG005|Overall Study|Protocol Violation|0|||
125431725|NCT02237508|451207723|FG006|Overall Study|Protocol Violation|0|||
125431726|NCT02237508|451207724|FG007|Overall Study|Protocol Violation|0|||
125369804|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
125369805|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
125369806|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
125369807|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
125369808|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
125369809|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
125369810|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
125604658|NCT00257192|451837911|FG001|Overall Study|Lost to Follow-up|3|||
125604659|NCT00257192|451837910|FG000|Overall Study|Insufficient clinical response|18|||
125604660|NCT00257192|451837911|FG001|Overall Study|Insufficient clinical response|18|||
125604661|NCT00257192|451837910|FG000|Overall Study|Withdrawal by Subject|14|||
125369811|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
125604662|NCT00257192|451837911|FG001|Overall Study|Withdrawal by Subject|2|||
125604663|NCT00257192|451837910|FG000|Overall Study|Randomized but not treated|0|||
125604664|NCT00257192|451837911|FG001|Overall Study|Randomized but not treated|1|||
125604665|NCT00257192|451837910|FG000|Overall Study|Study terminated by sponsor|1|||
125604666|NCT00257192|451837911|FG001|Overall Study|Study terminated by sponsor|0|||
125604667|NCT00257192|451837910|FG000|Overall Study|Miscellaneous|0|||
125604668|NCT00257192|451837911|FG001|Overall Study|Miscellaneous|4|||
125604669|NCT00570739|451837912|FG000|Overall Study|Adverse Event|8|||
125604670|NCT00570739|451837913|FG001|Overall Study|Adverse Event|6|||
125604671|NCT00570739|451837914|FG002|Overall Study|Adverse Event|2|||
125604672|NCT00570739|451837915|FG003|Overall Study|Adverse Event|2|||
125604673|NCT00570739|451837912|FG000|Overall Study|Lost to Follow-up|4|||
125604674|NCT00570739|451837913|FG001|Overall Study|Lost to Follow-up|5|||
125604675|NCT00570739|451837914|FG002|Overall Study|Lost to Follow-up|4|||
125604676|NCT00570739|451837915|FG003|Overall Study|Lost to Follow-up|1|||
125604677|NCT00570739|451837912|FG000|Overall Study|Physician Decision|1|||
125604678|NCT00570739|451837913|FG001|Overall Study|Physician Decision|1|||
125604679|NCT00570739|451837914|FG002|Overall Study|Physician Decision|0|||
125604680|NCT00570739|451837915|FG003|Overall Study|Physician Decision|0|||
125604681|NCT00570739|451837912|FG000|Overall Study|Withdrawal by Subject|7|||
125604682|NCT00570739|451837913|FG001|Overall Study|Withdrawal by Subject|7|||
125604683|NCT00570739|451837914|FG002|Overall Study|Withdrawal by Subject|3|||
125604684|NCT00570739|451837915|FG003|Overall Study|Withdrawal by Subject|5|||
125604685|NCT00570739|451837912|FG000|Overall Study|Required restricted medication|0|||
125604686|NCT00570739|451837913|FG001|Overall Study|Required restricted medication|0|||
125604687|NCT00570739|451837914|FG002|Overall Study|Required restricted medication|1|||
125604688|NCT00570739|451837915|FG003|Overall Study|Required restricted medication|0|||
125604689|NCT00570739|451837912|FG000|Overall Study|Met discontinuation criteria|1|||
125604690|NCT00570739|451837913|FG001|Overall Study|Met discontinuation criteria|0|||
125604691|NCT00570739|451837914|FG002|Overall Study|Met discontinuation criteria|1|||
125604692|NCT00570739|451837915|FG003|Overall Study|Met discontinuation criteria|1|||
125604693|NCT00570739|451837912|FG000|Overall Study|Other|0|||
125604694|NCT00570739|451837913|FG001|Overall Study|Other|2|||
125604695|NCT00570739|451837914|FG002|Overall Study|Other|5|||
125604696|NCT00570739|451837915|FG003|Overall Study|Other|3|||
125604697|NCT01400971|451837919|FG000|Overall Study|Death|82|||
125604698|NCT01400971|451837919|FG000|Overall Study|Lost to Follow-up|196|||
125604699|NCT01400971|451837919|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
125604700|NCT01400971|451837919|FG000|Overall Study|Physician Decision|57|||
125604701|NCT01400971|451837919|FG000|Overall Study|Withdrawal by Subject|158|||
125604702|NCT01400971|451837919|FG000|Overall Study|Other|422|||
125604703|NCT01921270|451837923|FG000|Overall Study|Withdrawal by Subject|1|||
125604704|NCT00455858|451837924|FG000|Overall Study|Lost to Follow-up|2|||
125604705|NCT00455858|451837924|FG000|Overall Study|Protocol Violation|1|||
125604706|NCT00455858|451837924|FG000|Overall Study|Lack of Efficacy|1|||
125604707|NCT00455858|451837924|FG000|Overall Study|Well controlled FPG without insulin|1|||
125604708|NCT00455858|451837924|FG000|Overall Study|Withdrawal|1|||
125604709|NCT02375698|451837925|FG000|Overall Study|Withdrawal by Subject|0|||
125604710|NCT02375698|451837926|FG001|Overall Study|Withdrawal by Subject|2|||
125604711|NCT02375698|451837925|FG000|Overall Study|Physician Decision|2|||
125604712|NCT02375698|451837926|FG001|Overall Study|Physician Decision|0|||
125604713|NCT01595646|451837929|FG000|Overall Study|Withdrawal by Subject|1|||
125604714|NCT01595646|451837930|FG001|Overall Study|Withdrawal by Subject|0|||
125604715|NCT01595646|451837931|FG002|Overall Study|Withdrawal by Subject|0|||
125604716|NCT01161524|451837933|FG000|Core Study (23 Weeks)|Adverse Event|3|||
125604717|NCT01161524|451837934|FG001|Core Study (23 Weeks)|Adverse Event|0|||
125369812|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
125369813|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
125369814|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
125369815|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
125369816|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
125604718|NCT01161524|451837935|FG002|Core Study (23 Weeks)|Adverse Event|0|||
125604719|NCT01161524|451837933|FG000|Core Study (23 Weeks)|Other|1|||
125604720|NCT01161524|451837934|FG001|Core Study (23 Weeks)|Other|0|||
125604721|NCT01161524|451837935|FG002|Core Study (23 Weeks)|Other|0|||
125604722|NCT01161524|451837933|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
125604723|NCT01161524|451837934|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
125604724|NCT01161524|451837935|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
125604725|NCT01161524|451837933|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
125604726|NCT01161524|451837934|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
125604727|NCT01161524|451837935|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
125604728|NCT01161524|451837933|FG000|Core Study (23 Weeks)|Subject Choice|3|||
125604729|NCT01161524|451837934|FG001|Core Study (23 Weeks)|Subject Choice|2|||
125604730|NCT01161524|451837935|FG002|Core Study (23 Weeks)|Subject Choice|0|||
125604731|NCT01161524|451837933|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
125604732|NCT01161524|451837934|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
125604733|NCT01161524|451837935|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
125369817|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
125604734|NCT01161524|451837933|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
125604735|NCT01161524|451837934|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
125604736|NCT01161524|451837935|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
125604737|NCT01161524|451837933|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
125604738|NCT01161524|451837934|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
125604739|NCT01161524|451837935|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
125604740|NCT01161524|451837933|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
125604741|NCT01161524|451837934|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
125604742|NCT01161524|451837935|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
125604743|NCT01161524|451837933|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
125604744|NCT01161524|451837934|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
125604745|NCT01161524|451837935|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
125604746|NCT00231062|451837940|FG000|Overall Study|Physician Decision|6|||
125604747|NCT00803244|451837941|FG000|Overall Study|Adverse Event|1|||
125604748|NCT00803244|451837942|FG001|Overall Study|Adverse Event|2|||
125604749|NCT00803244|451837941|FG000|Overall Study|Withdrawal by Subject|2|||
125604750|NCT00803244|451837942|FG001|Overall Study|Withdrawal by Subject|3|||
125604751|NCT00803244|451837941|FG000|Overall Study|Any other reason not above-mentioned|4|||
125604752|NCT00803244|451837942|FG001|Overall Study|Any other reason not above-mentioned|10|||
125604753|NCT00616239|451837943|FG000|Overall Study|Withdrawal by Subject|2|||
125604754|NCT02873715|451837944|FG000|Overall Study|Lost to Follow-up|84|||
125604755|NCT02873715|451837945|FG001|Overall Study|Lost to Follow-up|94|||
125604756|NCT02873715|451837944|FG000|Overall Study|Withdrawal by Subject|7|||
125604757|NCT02873715|451837945|FG001|Overall Study|Withdrawal by Subject|26|||
125604758|NCT02021812|451837946|FG000|Overall Study|Death|8|||
125604759|NCT02021812|451837946|FG000|Overall Study|Withdrawal by Subject|3|||
125604760|NCT02021812|451837946|FG000|Overall Study|Lost to Follow-up|2|||
125604761|NCT02021812|451837946|FG000|Overall Study|Refuse to return, COVD 19|2|||
125604762|NCT03241173|451837947|FG000|Overall Study|Death|3|||
125604763|NCT03241173|451837948|FG001|Overall Study|Death|2|||
125604764|NCT03241173|451837949|FG002|Overall Study|Death|4|||
125604765|NCT03241173|451837950|FG003|Overall Study|Death|4|||
125604766|NCT03241173|451837951|FG004|Overall Study|Death|2|||
125604767|NCT03241173|451837952|FG005|Overall Study|Death|2|||
125604768|NCT03241173|451837953|FG006|Overall Study|Death|3|||
125604769|NCT03241173|451837954|FG007|Overall Study|Death|1|||
125604770|NCT03241173|451837955|FG008|Overall Study|Death|0|||
125604771|NCT03241173|451837956|FG009|Overall Study|Death|5|||
125604772|NCT03241173|451837957|FG010|Overall Study|Death|4|||
125604773|NCT03241173|451837958|FG011|Overall Study|Death|3|||
125604774|NCT03241173|451837959|FG012|Overall Study|Death|0|||
125604775|NCT03241173|451837960|FG013|Overall Study|Death|0|||
125604776|NCT03241173|451837961|FG014|Overall Study|Death|0|||
125604777|NCT03241173|451837947|FG000|Overall Study|Withdrawal by Subject|0|||
125604778|NCT03241173|451837948|FG001|Overall Study|Withdrawal by Subject|0|||
125604779|NCT03241173|451837949|FG002|Overall Study|Withdrawal by Subject|1|||
125604780|NCT03241173|451837950|FG003|Overall Study|Withdrawal by Subject|0|||
125604781|NCT03241173|451837951|FG004|Overall Study|Withdrawal by Subject|0|||
125604782|NCT03241173|451837952|FG005|Overall Study|Withdrawal by Subject|1|||
125604783|NCT03241173|451837953|FG006|Overall Study|Withdrawal by Subject|0|||
125604784|NCT03241173|451837954|FG007|Overall Study|Withdrawal by Subject|0|||
125604785|NCT03241173|451837955|FG008|Overall Study|Withdrawal by Subject|0|||
125604786|NCT03241173|451837956|FG009|Overall Study|Withdrawal by Subject|0|||
125604787|NCT03241173|451837957|FG010|Overall Study|Withdrawal by Subject|0|||
125604788|NCT03241173|451837958|FG011|Overall Study|Withdrawal by Subject|0|||
125604789|NCT03241173|451837959|FG012|Overall Study|Withdrawal by Subject|0|||
125604790|NCT03241173|451837960|FG013|Overall Study|Withdrawal by Subject|0|||
125604791|NCT03241173|451837961|FG014|Overall Study|Withdrawal by Subject|0|||
125604792|NCT03241173|451837947|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
125604793|NCT03241173|451837948|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
125604794|NCT03241173|451837949|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
125604795|NCT03241173|451837950|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
125604796|NCT03241173|451837951|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
125604797|NCT03241173|451837952|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
125604798|NCT03241173|451837953|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
125604799|NCT03241173|451837954|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
125604800|NCT03241173|451837955|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
125369818|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
125369819|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
125604801|NCT03241173|451837956|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
125604802|NCT03241173|451837957|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
125604803|NCT03241173|451837958|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
125604804|NCT03241173|451837959|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
125604805|NCT03241173|451837960|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
125604806|NCT03241173|451837961|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
125604807|NCT03241173|451837947|FG000|Overall Study|Lost to Follow-up|0|||
125604808|NCT03241173|451837948|FG001|Overall Study|Lost to Follow-up|0|||
125604809|NCT03241173|451837949|FG002|Overall Study|Lost to Follow-up|0|||
125604810|NCT03241173|451837950|FG003|Overall Study|Lost to Follow-up|0|||
125604811|NCT03241173|451837951|FG004|Overall Study|Lost to Follow-up|1|||
125604812|NCT03241173|451837952|FG005|Overall Study|Lost to Follow-up|0|||
125604813|NCT03241173|451837953|FG006|Overall Study|Lost to Follow-up|0|||
125604814|NCT03241173|451837954|FG007|Overall Study|Lost to Follow-up|0|||
125604815|NCT03241173|451837955|FG008|Overall Study|Lost to Follow-up|0|||
125604816|NCT03241173|451837956|FG009|Overall Study|Lost to Follow-up|1|||
125604817|NCT03241173|451837957|FG010|Overall Study|Lost to Follow-up|0|||
125604818|NCT03241173|451837958|FG011|Overall Study|Lost to Follow-up|0|||
125604819|NCT03241173|451837959|FG012|Overall Study|Lost to Follow-up|0|||
125604820|NCT03241173|451837960|FG013|Overall Study|Lost to Follow-up|0|||
125604821|NCT03241173|451837961|FG014|Overall Study|Lost to Follow-up|0|||
125604822|NCT00564629|451837962|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
125604823|NCT00564629|451837963|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
125604824|NCT02698423|451837964|FG000|Overall Study|Lost to Follow-up|19|||
125604825|NCT02698423|451837965|FG001|Overall Study|Lost to Follow-up|24|||
125604826|NCT03634072|451837966|FG000|Overall Study|Early termination of overall study|1|||
125604827|NCT03634072|451837967|FG001|Overall Study|Early termination of overall study|0|||
125604828|NCT01651260|451837969|FG000|Overall Study|unable to apply product|3|||
125604829|NCT01952015|451837970|FG000|Induction|Protocol Violation|1|||
125604830|NCT01952015|451837970|FG000|Maintenance|Adverse Event|2|||
125604831|NCT01952015|451837970|FG000|Treatment Period 3|Physician Decision|9|||
125604832|NCT01259297|451837974|FG000|Double Blind Randomized Period|Death|1|||
125604833|NCT01259297|451837975|FG001|Double Blind Randomized Period|Death|1|||
125604834|NCT01259297|451837976|FG002|Double Blind Randomized Period|Death|1|||
125604835|NCT01259297|451837977|FG003|Double Blind Randomized Period|Death|2|||
125604836|NCT01259297|451837978|FG004|Double Blind Randomized Period|Death|1|||
125604837|NCT01259297|451837979|FG005|Double Blind Randomized Period|Death|5|||
125604838|NCT01259297|451837980|FG006|Double Blind Randomized Period|Death|2|||
125604839|NCT01259297|451837981|FG007|Double Blind Randomized Period|Death|1|||
125604840|NCT01259297|451837974|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
125604841|NCT01259297|451837975|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
125604842|NCT01259297|451837976|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
125604843|NCT01259297|451837977|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
125604844|NCT01259297|451837978|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
125604845|NCT01259297|451837979|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
125604846|NCT01259297|451837980|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
125604847|NCT01259297|451837981|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
125604848|NCT01259297|451837974|FG000|Double Blind Randomized Period|Other reasons|0|||
125604849|NCT01259297|451837975|FG001|Double Blind Randomized Period|Other reasons|1|||
125604850|NCT01259297|451837976|FG002|Double Blind Randomized Period|Other reasons|0|||
125212848|NCT01026818|450405481|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
125212849|NCT03300050|450405491|FG000|Overall Study|Lost to Follow-up|2|||
125369820|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
125369821|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
125369822|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
125369823|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
125604851|NCT01259297|451837977|FG003|Double Blind Randomized Period|Other reasons|0|||
125604852|NCT01259297|451837978|FG004|Double Blind Randomized Period|Other reasons|1|||
125604853|NCT01259297|451837979|FG005|Double Blind Randomized Period|Other reasons|2|||
125604854|NCT01259297|451837980|FG006|Double Blind Randomized Period|Other reasons|3|||
125604855|NCT01259297|451837981|FG007|Double Blind Randomized Period|Other reasons|1|||
125604856|NCT00053846|451837984|FG000|Overall Study|Changed mind|8|||
125604857|NCT00053846|451837985|FG001|Overall Study|Changed mind|13|||
125604858|NCT00053846|451837984|FG000|Overall Study|Became too ill|8|||
125604859|NCT00053846|451837985|FG001|Overall Study|Became too ill|7|||
125604860|NCT00053846|451837984|FG000|Overall Study|Expired|5|||
125604861|NCT00053846|451837985|FG001|Overall Study|Expired|0|||
125604862|NCT00053846|451837984|FG000|Overall Study|Became ineligible|3|||
125431727|NCT02237508|451207725|FG008|Overall Study|Protocol Violation|0|||
125431728|NCT02237508|451207726|FG009|Overall Study|Protocol Violation|0|||
125604863|NCT00053846|451837985|FG001|Overall Study|Became ineligible|1|||
125604864|NCT00053846|451837984|FG000|Overall Study|Did not return data|1|||
125604865|NCT00053846|451837985|FG001|Overall Study|Did not return data|2|||
125604866|NCT00053846|451837984|FG000|Overall Study|Quit due to side effects|1|||
125604867|NCT00053846|451837985|FG001|Overall Study|Quit due to side effects|3|||
125604868|NCT00053846|451837984|FG000|Overall Study|Pills too large|0|||
125604869|NCT00053846|451837985|FG001|Overall Study|Pills too large|1|||
125604870|NCT00064662|451837986|FG000|Overall Study|Death|1|||
125604871|NCT00064662|451837987|FG001|Overall Study|Death|1|||
125604872|NCT00064662|451837986|FG000|Overall Study|Lost to Follow-up|57|||
125604873|NCT00064662|451837987|FG001|Overall Study|Lost to Follow-up|44|||
125604874|NCT00064662|451837986|FG000|Overall Study|Withdrawal by Subject|14|||
125604875|NCT00064662|451837987|FG001|Overall Study|Withdrawal by Subject|14|||
125604876|NCT00064662|451837986|FG000|Overall Study|Administratively withdrawn|2|||
125604877|NCT00064662|451837987|FG001|Overall Study|Administratively withdrawn|2|||
125604878|NCT01345786|451837997|FG000|Overall Study|Adverse Event|0|||
125604879|NCT01345786|451837998|FG001|Overall Study|Adverse Event|1|||
125604880|NCT01345786|451837999|FG002|Overall Study|Adverse Event|3|||
125604881|NCT01345786|451838000|FG003|Overall Study|Adverse Event|1|||
125604882|NCT01345786|451837997|FG000|Overall Study|Subject withdrew consent|2|||
125604883|NCT01345786|451837998|FG001|Overall Study|Subject withdrew consent|2|||
125604884|NCT01345786|451837999|FG002|Overall Study|Subject withdrew consent|1|||
125604885|NCT01345786|451838000|FG003|Overall Study|Subject withdrew consent|0|||
125604886|NCT01345786|451837997|FG000|Overall Study|Noncompliance with protocol|1|||
125604887|NCT01345786|451837998|FG001|Overall Study|Noncompliance with protocol|0|||
125604888|NCT01345786|451837999|FG002|Overall Study|Noncompliance with protocol|1|||
125604889|NCT01345786|451838000|FG003|Overall Study|Noncompliance with protocol|0|||
125604890|NCT01345786|451837997|FG000|Overall Study|Administrative|3|||
125604891|NCT01345786|451837998|FG001|Overall Study|Administrative|5|||
125604892|NCT01345786|451837999|FG002|Overall Study|Administrative|0|||
125604893|NCT01345786|451838000|FG003|Overall Study|Administrative|0|||
125604894|NCT01345786|451837997|FG000|Overall Study|Lost to Follow-up|0|||
125604895|NCT01345786|451837998|FG001|Overall Study|Lost to Follow-up|0|||
125604896|NCT01345786|451837999|FG002|Overall Study|Lost to Follow-up|0|||
125604897|NCT01345786|451838000|FG003|Overall Study|Lost to Follow-up|2|||
125604898|NCT01929044|451838001|FG000|Overall Study|Adverse Event|1|||
125604899|NCT01929044|451838002|FG001|Overall Study|Adverse Event|0|||
125604900|NCT01929044|451838001|FG000|Overall Study|Protocol Violation|9|||
125604901|NCT01929044|451838002|FG001|Overall Study|Protocol Violation|14|||
125604902|NCT01929044|451838001|FG000|Overall Study|Not Treated|1|||
125604903|NCT01929044|451838002|FG001|Overall Study|Not Treated|3|||
125604904|NCT02807454|451838005|FG000|Overall Study|Adverse Event|1|||
125604905|NCT02807454|451838006|FG001|Overall Study|Adverse Event|0|||
125604906|NCT02807454|451838005|FG000|Overall Study|Withdrawal by Subject|0|||
125604907|NCT02807454|451838006|FG001|Overall Study|Withdrawal by Subject|1|||
125604908|NCT02807454|451838005|FG000|Overall Study|Progressive Disease|30|||
125604909|NCT02807454|451838006|FG001|Overall Study|Progressive Disease|3|||
125604910|NCT02807454|451838005|FG000|Overall Study|Other Reasons|1|||
125604911|NCT02807454|451838006|FG001|Overall Study|Other Reasons|1|||
125604912|NCT01165203|451838007|FG000|Active Phase|Serious Adverse Event|1|||
125604913|NCT01165203|451838008|FG001|Active Phase|Serious Adverse Event|0|||
125604914|NCT01165203|451838007|FG000|Active Phase|Withdrawal by Subject|2|||
125604915|NCT01165203|451838008|FG001|Active Phase|Withdrawal by Subject|1|||
125604916|NCT01165203|451838007|FG000|Active Phase|Migrated/moved from study area|0|||
125604917|NCT01165203|451838008|FG001|Active Phase|Migrated/moved from study area|1|||
125604918|NCT01165203|451838007|FG000|Active Phase|Lost to Follow-up|2|||
125604919|NCT01165203|451838008|FG001|Active Phase|Lost to Follow-up|0|||
125604920|NCT01165203|451838007|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
125604921|NCT01165203|451838008|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
125604922|NCT01165203|451838007|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
125604923|NCT01165203|451838008|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
125431729|NCT04954586|451207727|FG000|Overall Study|Withdrawal by Subject|5|||
125604924|NCT01165203|451838007|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
125604925|NCT01165203|451838008|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
125604926|NCT01165203|451838007|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
125604927|NCT01165203|451838008|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
125604928|NCT01165203|451838007|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
125604929|NCT01165203|451838008|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
125604930|NCT01070784|451838009|FG000|Overall Study|Withdrawal by Subject|6|||
125604931|NCT01070784|451838010|FG001|Overall Study|Withdrawal by Subject|9|||
125604932|NCT01070784|451838009|FG000|Overall Study|Adverse Event|14|||
125604933|NCT01070784|451838010|FG001|Overall Study|Adverse Event|9|||
125604934|NCT02582749|451838011|FG000|Overall Study|Study terminated by funder|5|||
125604935|NCT02582749|451838012|FG001|Overall Study|Study terminated by funder|10|||
125604936|NCT02582749|451838011|FG000|Overall Study|Withdrawal by Subject|0|||
125604937|NCT02582749|451838012|FG001|Overall Study|Withdrawal by Subject|1|||
125604938|NCT02815397|451838013|FG000|Overall Study|Physician Decision|2|||
125604939|NCT02518620|451838014|FG000|Overall Study|Adverse Event|23|||
125604940|NCT02518620|451838015|FG001|Overall Study|Adverse Event|11|||
125604941|NCT02518620|451838014|FG000|Overall Study|Lack of Efficacy|2|||
125604942|NCT02518620|451838015|FG001|Overall Study|Lack of Efficacy|0|||
125604943|NCT02518620|451838014|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125604944|NCT02518620|451838015|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125604945|NCT02518620|451838014|FG000|Overall Study|Physician Decision|1|||
125604946|NCT02518620|451838015|FG001|Overall Study|Physician Decision|1|||
125604947|NCT02518620|451838014|FG000|Overall Study|Sponsor's Decision|0|||
125604948|NCT02518620|451838015|FG001|Overall Study|Sponsor's Decision|3|||
125604949|NCT02518620|451838014|FG000|Overall Study|Lost to Follow-up|1|||
125604950|NCT02518620|451838015|FG001|Overall Study|Lost to Follow-up|1|||
125604951|NCT02518620|451838014|FG000|Overall Study|Withdrawal by Subject|17|||
125604952|NCT02518620|451838015|FG001|Overall Study|Withdrawal by Subject|9|||
125604953|NCT02518620|451838014|FG000|Overall Study|Death|1|||
125604954|NCT02518620|451838015|FG001|Overall Study|Death|0|||
125604955|NCT02518620|451838014|FG000|Overall Study|Pregnancy Wish|3|||
125604956|NCT02518620|451838015|FG001|Overall Study|Pregnancy Wish|0|||
125604957|NCT02518620|451838014|FG000|Overall Study|Pregnancy|1|||
125604958|NCT02518620|451838015|FG001|Overall Study|Pregnancy|0|||
125604959|NCT02518620|451838014|FG000|Overall Study|Relocation|2|||
125604960|NCT02518620|451838015|FG001|Overall Study|Relocation|1|||
125604961|NCT00085540|451838016|FG000|Overall Study|Withdrawal by Subject|0|||
125604962|NCT00085540|451838017|FG001|Overall Study|Withdrawal by Subject|1|||
125604963|NCT00085540|451838016|FG000|Overall Study|Protocol Violation|0|||
125604964|NCT00085540|451838017|FG001|Overall Study|Protocol Violation|1|||
125604965|NCT01663740|451838020|FG000|Overall Study|Lost to Follow-up|1|||
125604966|NCT01663740|451838021|FG001|Overall Study|Lost to Follow-up|4|||
125604967|NCT01663740|451838020|FG000|Overall Study|Other|9|||
125604968|NCT01663740|451838021|FG001|Overall Study|Other|2|||
125604969|NCT01663740|451838020|FG000|Overall Study|Inclusion/Exclusion not met|1|||
125604970|NCT01663740|451838021|FG001|Overall Study|Inclusion/Exclusion not met|0|||
125604971|NCT01663740|451838020|FG000|Overall Study|Death|0|||
125604972|NCT01663740|451838021|FG001|Overall Study|Death|1|||
125604973|NCT01663740|451838020|FG000|Overall Study|Withdrawal by Subject|2|||
125604974|NCT01663740|451838021|FG001|Overall Study|Withdrawal by Subject|1|||
125604975|NCT01663740|451838020|FG000|Overall Study|No end of study status|3|||
125604976|NCT01663740|451838021|FG001|Overall Study|No end of study status|0|||
125604977|NCT03607682|451838022|FG000|Overall Study|Withdrawal by Subject|1|||
125604978|NCT03607682|451838022|FG000|Overall Study|Disease progression|1|||
125604979|NCT01770353|451838023|FG000|Overall Study|Progressive disease|2|||
125604980|NCT01770353|451838024|FG001|Overall Study|Progressive disease|1|||
125604981|NCT01770353|451838023|FG000|Overall Study|Adverse Event|0|||
125604982|NCT01770353|451838024|FG001|Overall Study|Adverse Event|1|||
125604983|NCT01770353|451838023|FG000|Overall Study|Protocol Violation|1|||
125604984|NCT01770353|451838024|FG001|Overall Study|Protocol Violation|0|||
125604985|NCT01770353|451838023|FG000|Overall Study|Physician Decision|0|||
125604986|NCT01770353|451838024|FG001|Overall Study|Physician Decision|3|||
125604987|NCT01770353|451838023|FG000|Overall Study|Clinical deterioration|3|||
125604988|NCT01770353|451838024|FG001|Overall Study|Clinical deterioration|6|||
125604989|NCT01770353|451838023|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
125604990|NCT01770353|451838024|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
125604991|NCT00376688|451838025|FG000|Overall Study|Adverse Event|3|||
125604992|NCT00376688|451838025|FG000|Overall Study|Death|1|||
125604993|NCT02574312|451838026|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
125604994|NCT02574312|451838027|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
125604995|NCT03009539|451839754|FG000|Overall Study|Lost to Follow-up|132|||
125604996|NCT03009539|451839755|FG001|Overall Study|Lost to Follow-up|113|||
125604997|NCT03009539|451839756|FG002|Overall Study|Lost to Follow-up|132|||
125604998|NCT03009539|451839757|FG003|Overall Study|Lost to Follow-up|113|||
125604999|NCT03151148|451839758|FG000|Overall Study|Lost to Follow-up|1|||
125605000|NCT03151148|451839759|FG001|Overall Study|Lost to Follow-up|0|||
125605001|NCT03151148|451839758|FG000|Overall Study|Withdrawal by Subject|1|||
125605002|NCT03151148|451839759|FG001|Overall Study|Withdrawal by Subject|0|||
125605003|NCT00494871|451839760|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
125605004|NCT00494871|451839761|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
125605005|NCT00494871|451839760|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
125605006|NCT00494871|451839761|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
125605007|NCT00494871|451839760|FG000|Double-blind (DB) Treatment Period|Death|8|||
125605008|NCT00494871|451839761|FG001|Double-blind (DB) Treatment Period|Death|3|||
125605009|NCT00494871|451839760|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
125605010|NCT00494871|451839761|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
125605011|NCT00494871|451839760|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
125605012|NCT00494871|451839761|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
125605013|NCT00494871|451839760|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
125605014|NCT00494871|451839761|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
125605015|NCT00494871|451839760|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
125605016|NCT00494871|451839761|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
125605017|NCT00494871|451839760|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
125605018|NCT00494871|451839761|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
125605019|NCT00494871|451839760|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
125605020|NCT00494871|451839761|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
125605021|NCT00494871|451839760|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
125605022|NCT00494871|451839761|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
125605023|NCT00494871|451839760|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
125605024|NCT00494871|451839761|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
125605025|NCT00494871|451839760|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
125605026|NCT00494871|451839761|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
125605027|NCT00494871|451839760|FG000|Follow-up (FU) Period|Adverse Event|1|||
125605028|NCT00494871|451839761|FG001|Follow-up (FU) Period|Adverse Event|1|||
125605029|NCT00494871|451839760|FG000|Follow-up (FU) Period|Death|13|||
125605030|NCT00494871|451839761|FG001|Follow-up (FU) Period|Death|12|||
125605031|NCT00494871|451839760|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
125605032|NCT00494871|451839761|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
125605033|NCT00494871|451839760|FG000|Follow-up (FU) Period|Physician Decision|0|||
125605034|NCT00494871|451839761|FG001|Follow-up (FU) Period|Physician Decision|1|||
125605035|NCT00494871|451839760|FG000|Follow-up (FU) Period|Protocol Violation|1|||
125605036|NCT00494871|451839761|FG001|Follow-up (FU) Period|Protocol Violation|0|||
125605037|NCT00494871|451839760|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
125605038|NCT00494871|451839761|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
125605039|NCT00494871|451839760|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
125605040|NCT00494871|451839761|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
125605041|NCT04543955|451839762|FG000|Overall Study|Company cancelled study|1|||
125605042|NCT04543955|451839763|FG001|Overall Study|Company cancelled study|0|||
125605043|NCT02433210|451839767|FG000|Overall Study|Physician Decision|1|||
125605044|NCT02433210|451839768|FG001|Overall Study|Physician Decision|0|||
125605045|NCT02433210|451839769|FG002|Overall Study|Physician Decision|0|||
125605046|NCT02090114|451839770|FG000|Overall Study|Withdrawal by Subject|3|||
125605047|NCT02090114|451839771|FG001|Overall Study|Withdrawal by Subject|6|||
125605048|NCT02090114|451839772|FG002|Overall Study|Withdrawal by Subject|2|||
125605049|NCT02090114|451839773|FG003|Overall Study|Withdrawal by Subject|1|||
125605050|NCT02090114|451839770|FG000|Overall Study|Physician Decision|5|||
125605051|NCT02090114|451839771|FG001|Overall Study|Physician Decision|0|||
125605052|NCT02090114|451839772|FG002|Overall Study|Physician Decision|1|||
125605053|NCT02090114|451839773|FG003|Overall Study|Physician Decision|1|||
125605054|NCT02090114|451839770|FG000|Overall Study|Adverse Event|1|||
125605055|NCT02090114|451839771|FG001|Overall Study|Adverse Event|2|||
125605056|NCT02090114|451839772|FG002|Overall Study|Adverse Event|2|||
125605057|NCT02090114|451839773|FG003|Overall Study|Adverse Event|0|||
125605058|NCT02090114|451839770|FG000|Overall Study|Progressive Disease|20|||
125605059|NCT02090114|451839771|FG001|Overall Study|Progressive Disease|21|||
125605060|NCT02090114|451839772|FG002|Overall Study|Progressive Disease|23|||
125605061|NCT02090114|451839773|FG003|Overall Study|Progressive Disease|6|||
125605062|NCT02090114|451839770|FG000|Overall Study|Death|1|||
125605063|NCT02090114|451839771|FG001|Overall Study|Death|0|||
125605064|NCT02090114|451839772|FG002|Overall Study|Death|1|||
125605065|NCT02090114|451839773|FG003|Overall Study|Death|0|||
125605066|NCT01989546|451839778|FG000|Overall Study|Clinical Progression|1|||
125605067|NCT01989546|451839778|FG000|Overall Study|Disease progression on study|8|||
125605068|NCT01958671|451839779|FG000|Overall Study|Adverse Event|1|||
125605069|NCT01958671|451839780|FG001|Overall Study|Adverse Event|1|||
125605070|NCT01958671|451839781|FG002|Overall Study|Adverse Event|5|||
125605071|NCT01958671|451839779|FG000|Overall Study|Death|1|||
125605072|NCT01958671|451839780|FG001|Overall Study|Death|0|||
125605073|NCT01958671|451839781|FG002|Overall Study|Death|0|||
125605074|NCT01958671|451839779|FG000|Overall Study|Excluded medication|0|||
125605075|NCT01958671|451839780|FG001|Overall Study|Excluded medication|0|||
125369824|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
125369825|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
125369826|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
125369827|NCT00730405|450987073|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
125369828|NCT00730405|450987074|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
125369829|NCT00730405|450987075|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
125369830|NCT00730405|450987076|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
125369831|NCT00730405|450987077|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
125369832|NCT03851705|450987080|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
125369833|NCT03851705|450987081|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
125369834|NCT03851705|450987082|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
125369835|NCT03851705|450987083|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
125369836|NCT03851705|450987080|FG000|Part 1: Double-Blind Period|Other reason|1|||
125369837|NCT03851705|450987081|FG001|Part 1: Double-Blind Period|Other reason|0|||
125369838|NCT03851705|450987082|FG002|Part 1: Double-Blind Period|Other reason|0|||
125369839|NCT03851705|450987083|FG003|Part 1: Double-Blind Period|Other reason|0|||
125369840|NCT03851705|450987080|FG000|Part 2: Open-Label Period|Other reason|0|||
125369841|NCT03851705|450987081|FG001|Part 2: Open-Label Period|Other reason|0|||
125369842|NCT03851705|450987082|FG002|Part 2: Open-Label Period|Other reason|0|||
125369843|NCT03851705|450987083|FG003|Part 2: Open-Label Period|Other reason|1|||
125369844|NCT03851705|450987080|FG000|Part 2: Open-Label Period|Death|0|||
125369845|NCT03851705|450987081|FG001|Part 2: Open-Label Period|Death|0|||
125605076|NCT01958671|451839781|FG002|Overall Study|Excluded medication|1|||
125212850|NCT03300050|450405492|FG001|Overall Study|Lost to Follow-up|1|||
125369846|NCT03851705|450987082|FG002|Part 2: Open-Label Period|Death|3|||
125369847|NCT03851705|450987083|FG003|Part 2: Open-Label Period|Death|0|||
125369848|NCT03851705|450987080|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
125369849|NCT03851705|450987081|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
125605077|NCT01958671|451839779|FG000|Overall Study|Hyperglycemia|0|||
125605078|NCT01958671|451839780|FG001|Overall Study|Hyperglycemia|0|||
125605079|NCT01958671|451839781|FG002|Overall Study|Hyperglycemia|2|||
125605080|NCT01958671|451839779|FG000|Overall Study|Lost to Follow-up|7|||
125605081|NCT01958671|451839780|FG001|Overall Study|Lost to Follow-up|11|||
125605082|NCT01958671|451839781|FG002|Overall Study|Lost to Follow-up|7|||
125605083|NCT01958671|451839779|FG000|Overall Study|Non-compliance with study drug|1|||
125605084|NCT01958671|451839780|FG001|Overall Study|Non-compliance with study drug|1|||
125605085|NCT01958671|451839781|FG002|Overall Study|Non-compliance with study drug|1|||
125605086|NCT01958671|451839779|FG000|Overall Study|Pregnancy|0|||
125605087|NCT01958671|451839780|FG001|Overall Study|Pregnancy|0|||
125605088|NCT01958671|451839781|FG002|Overall Study|Pregnancy|1|||
125605089|NCT01958671|451839779|FG000|Overall Study|Protocol Violation|0|||
125605090|NCT01958671|451839780|FG001|Overall Study|Protocol Violation|1|||
125605091|NCT01958671|451839781|FG002|Overall Study|Protocol Violation|0|||
125605092|NCT01958671|451839779|FG000|Overall Study|Study site terminated by sponsor|1|||
125605093|NCT01958671|451839780|FG001|Overall Study|Study site terminated by sponsor|0|||
125605094|NCT01958671|451839781|FG002|Overall Study|Study site terminated by sponsor|1|||
125605095|NCT01958671|451839779|FG000|Overall Study|Participant moved|0|||
125605096|NCT01958671|451839780|FG001|Overall Study|Participant moved|0|||
125369850|NCT03851705|450987082|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
125369851|NCT03851705|450987083|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
125605097|NCT01958671|451839781|FG002|Overall Study|Participant moved|1|||
125605098|NCT01958671|451839779|FG000|Overall Study|Withdrawal by Subject|8|||
125605099|NCT01958671|451839780|FG001|Overall Study|Withdrawal by Subject|10|||
125605100|NCT01958671|451839781|FG002|Overall Study|Withdrawal by Subject|13|||
125605101|NCT01993329|451839782|FG000|Period 2|Adverse Event|0|||
125605102|NCT01993329|451839783|FG001|Period 2|Adverse Event|0|||
125605103|NCT01993329|451839784|FG002|Period 2|Adverse Event|0|||
125369852|NCT01496807|450987087|FG000|Overall Study|Progressive Disease|21|||
125369853|NCT01496807|450987087|FG000|Overall Study|Participant preference/toxicity|8|||
125605104|NCT01993329|451839785|FG003|Period 2|Adverse Event|0|||
125605105|NCT01993329|451839786|FG004|Period 2|Adverse Event|0|||
125605106|NCT01993329|451839787|FG005|Period 2|Adverse Event|1|||
125605107|NCT01993329|451839782|FG000|Wash-out|Personal reasons|0|||
125605108|NCT01993329|451839783|FG001|Wash-out|Personal reasons|1|||
125605109|NCT01993329|451839784|FG002|Wash-out|Personal reasons|0|||
125605110|NCT01993329|451839785|FG003|Wash-out|Personal reasons|0|||
125605111|NCT01993329|451839786|FG004|Wash-out|Personal reasons|0|||
125605112|NCT01993329|451839787|FG005|Wash-out|Personal reasons|0|||
125605113|NCT02948777|451839788|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
125605114|NCT02311478|451839789|FG000|Overall Study|Withdrawal by Subject|1|||
125605115|NCT02311478|451839789|FG000|Overall Study|Lost to Follow-up|5|||
125605116|NCT02311478|451839789|FG000|Overall Study|Failed IUD Insertion|1|||
125605117|NCT03242928|451839790|FG000|Overall Study|Adverse Event|2|||
125605118|NCT03242928|451839791|FG001|Overall Study|Adverse Event|1|||
125605119|NCT03242928|451839790|FG000|Overall Study|Lost to Follow-up|2|||
125605120|NCT03242928|451839791|FG001|Overall Study|Lost to Follow-up|0|||
125605121|NCT03242928|451839790|FG000|Overall Study|Physician Decision|0|||
125605122|NCT03242928|451839791|FG001|Overall Study|Physician Decision|1|||
125605123|NCT03242928|451839790|FG000|Overall Study|Withdrawal by Subject|5|||
125605124|NCT03242928|451839791|FG001|Overall Study|Withdrawal by Subject|3|||
125605125|NCT02795988|451839796|FG000|Phase 1b|Withdrawal by Subject|0|||
125605126|NCT02795988|451839797|FG001|Phase 1b|Withdrawal by Subject|1|||
125605127|NCT02795988|451839798|FG002|Phase 1b|Withdrawal by Subject|0|||
125605128|NCT02795988|451839799|FG003|Phase 1b|Withdrawal by Subject|0|||
125605129|NCT02795988|451839800|FG004|Phase 1b|Withdrawal by Subject|0|||
125605130|NCT02795988|451839801|FG005|Phase 1b|Withdrawal by Subject|0|||
125605131|NCT02795988|451839802|FG006|Phase 1b|Withdrawal by Subject|0|||
125605132|NCT02795988|451839796|FG000|Phase 1b|Death|1|||
125605133|NCT02795988|451839797|FG001|Phase 1b|Death|2|||
125605134|NCT02795988|451839798|FG002|Phase 1b|Death|1|||
125605135|NCT02795988|451839799|FG003|Phase 1b|Death|0|||
125605136|NCT02795988|451839800|FG004|Phase 1b|Death|0|||
125605137|NCT02795988|451839801|FG005|Phase 1b|Death|0|||
125605138|NCT02795988|451839802|FG006|Phase 1b|Death|0|||
125605139|NCT02795988|451839796|FG000|Phase 1b|Physician Decision|0|||
125605140|NCT02795988|451839797|FG001|Phase 1b|Physician Decision|0|||
125605141|NCT02795988|451839798|FG002|Phase 1b|Physician Decision|1|||
125605142|NCT02795988|451839799|FG003|Phase 1b|Physician Decision|0|||
125605143|NCT02795988|451839800|FG004|Phase 1b|Physician Decision|0|||
125605144|NCT02795988|451839801|FG005|Phase 1b|Physician Decision|0|||
125605145|NCT02795988|451839802|FG006|Phase 1b|Physician Decision|0|||
125605146|NCT02795988|451839796|FG000|Phase 1b|Progressive Disease|2|||
125605147|NCT02795988|451839797|FG001|Phase 1b|Progressive Disease|2|||
125605148|NCT02795988|451839798|FG002|Phase 1b|Progressive Disease|0|||
125605149|NCT02795988|451839799|FG003|Phase 1b|Progressive Disease|0|||
125605150|NCT02795988|451839800|FG004|Phase 1b|Progressive Disease|0|||
125605151|NCT02795988|451839801|FG005|Phase 1b|Progressive Disease|0|||
125605152|NCT02795988|451839802|FG006|Phase 1b|Progressive Disease|0|||
125605153|NCT02795988|451839796|FG000|Phase 2|Withdrawal by Subject|0|||
125605154|NCT02795988|451839797|FG001|Phase 2|Withdrawal by Subject|0|||
125605155|NCT02795988|451839798|FG002|Phase 2|Withdrawal by Subject|0|||
125605156|NCT02795988|451839799|FG003|Phase 2|Withdrawal by Subject|1|||
125605157|NCT02795988|451839800|FG004|Phase 2|Withdrawal by Subject|0|||
125605158|NCT02795988|451839801|FG005|Phase 2|Withdrawal by Subject|0|||
125605159|NCT02795988|451839802|FG006|Phase 2|Withdrawal by Subject|0|||
125605160|NCT02795988|451839796|FG000|Phase 2|Death|0|||
125605161|NCT02795988|451839797|FG001|Phase 2|Death|0|||
125605162|NCT02795988|451839798|FG002|Phase 2|Death|0|||
125605163|NCT02795988|451839799|FG003|Phase 2|Death|17|||
125605164|NCT02795988|451839800|FG004|Phase 2|Death|17|||
125605165|NCT02795988|451839801|FG005|Phase 2|Death|0|||
125605166|NCT02795988|451839802|FG006|Phase 2|Death|0|||
125605167|NCT02795988|451839796|FG000|Phase 2|Other|0|||
125605168|NCT02795988|451839797|FG001|Phase 2|Other|0|||
125605169|NCT02795988|451839798|FG002|Phase 2|Other|0|||
125605170|NCT02795988|451839799|FG003|Phase 2|Other|1|||
125605171|NCT02795988|451839800|FG004|Phase 2|Other|0|||
125212851|NCT03300050|450405493|FG002|Overall Study|Lost to Follow-up|0|||
125605172|NCT02795988|451839801|FG005|Phase 2|Other|0|||
125605173|NCT02795988|451839802|FG006|Phase 2|Other|0|||
125605174|NCT02795988|451839796|FG000|Phase 2 Extension|Death|0|||
125605175|NCT02795988|451839797|FG001|Phase 2 Extension|Death|0|||
125605176|NCT02795988|451839798|FG002|Phase 2 Extension|Death|0|||
125605177|NCT02795988|451839799|FG003|Phase 2 Extension|Death|0|||
125605178|NCT02795988|451839800|FG004|Phase 2 Extension|Death|0|||
125212852|NCT03300050|450405494|FG003|Overall Study|Lost to Follow-up|0|||
125369854|NCT01496807|450987087|FG000|Overall Study|Change in diagnosis|1|||
125605179|NCT02795988|451839801|FG005|Phase 2 Extension|Death|5|||
125605180|NCT02795988|451839802|FG006|Phase 2 Extension|Death|6|||
125605181|NCT02795988|451839796|FG000|Phase 2 Extension|Other reasons|0|||
125605182|NCT02795988|451839797|FG001|Phase 2 Extension|Other reasons|0|||
125605183|NCT02795988|451839798|FG002|Phase 2 Extension|Other reasons|0|||
125605184|NCT02795988|451839799|FG003|Phase 2 Extension|Other reasons|0|||
125605185|NCT02795988|451839800|FG004|Phase 2 Extension|Other reasons|0|||
125605186|NCT02795988|451839801|FG005|Phase 2 Extension|Other reasons|2|||
125605187|NCT02795988|451839802|FG006|Phase 2 Extension|Other reasons|1|||
125605188|NCT02834403|451839803|FG000|Overall Study|Physician Decision|2|||
125605189|NCT02834403|451839804|FG001|Overall Study|Physician Decision|1|||
125605190|NCT02834403|451839805|FG002|Overall Study|Physician Decision|2|||
125369855|NCT02591290|450987094|FG000|Overall Study|Withdrawal by Subject|2|||
125369856|NCT00913497|450987095|FG000|Overall Study|Adverse Event|1|||
125369857|NCT00913497|450987095|FG000|Overall Study|Withdrawal by Subject|2|||
125369858|NCT02002091|450987102|FG000|Screening|Lost to Follow-up|10|||
125369859|NCT02002091|450987103|FG001|Screening|Lost to Follow-up|12|||
125369860|NCT02002091|450987102|FG000|Screening|Death|3|||
125605191|NCT02834403|451839806|FG003|Overall Study|Physician Decision|1|||
125605192|NCT02834403|451839807|FG004|Overall Study|Physician Decision|1|||
125605193|NCT02834403|451839808|FG005|Overall Study|Physician Decision|2|||
125605194|NCT02834403|451839809|FG006|Overall Study|Physician Decision|12|||
125605195|NCT02834403|451839803|FG000|Overall Study|Adverse Event|0|||
125605196|NCT02834403|451839804|FG001|Overall Study|Adverse Event|0|||
125605197|NCT02834403|451839805|FG002|Overall Study|Adverse Event|0|||
125605198|NCT02834403|451839806|FG003|Overall Study|Adverse Event|0|||
125605199|NCT02834403|451839807|FG004|Overall Study|Adverse Event|1|||
125605200|NCT02834403|451839808|FG005|Overall Study|Adverse Event|1|||
125605201|NCT02834403|451839809|FG006|Overall Study|Adverse Event|3|||
125605202|NCT02834403|451839803|FG000|Overall Study|Withdrawal by Subject|0|||
125605203|NCT02834403|451839804|FG001|Overall Study|Withdrawal by Subject|1|||
125605204|NCT02834403|451839805|FG002|Overall Study|Withdrawal by Subject|0|||
125605205|NCT02834403|451839806|FG003|Overall Study|Withdrawal by Subject|0|||
125605206|NCT02834403|451839807|FG004|Overall Study|Withdrawal by Subject|1|||
125605207|NCT02834403|451839808|FG005|Overall Study|Withdrawal by Subject|0|||
125605208|NCT02834403|451839809|FG006|Overall Study|Withdrawal by Subject|0|||
125605209|NCT02834403|451839803|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
125605210|NCT02834403|451839804|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
125605211|NCT02834403|451839805|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
125605212|NCT02834403|451839806|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
125605213|NCT02834403|451839807|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
125605214|NCT02834403|451839808|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
125605215|NCT02834403|451839809|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
125605216|NCT02341014|451839810|FG000|Overall Study|Adverse Event|0|||
125605217|NCT02341014|451839811|FG001|Overall Study|Adverse Event|1|||
125605218|NCT02341014|451839812|FG002|Overall Study|Adverse Event|0|||
125605219|NCT02341014|451839813|FG003|Overall Study|Adverse Event|0|||
125605220|NCT02341014|451839814|FG004|Overall Study|Adverse Event|2|||
125605221|NCT00273858|451839824|FG000|Overall Study|Not completed 24 month observation time|334|||
125605222|NCT00273858|451839824|FG000|Overall Study|Lost to Follow-up|101|||
125605223|NCT00273858|451839824|FG000|Overall Study|Withdrawal by Subject|21|||
125605224|NCT00273858|451839824|FG000|Overall Study|Adverse Event|81|||
125605225|NCT00390780|451839825|FG000|Overall Study|Not completed|10|||
125605226|NCT00390780|451839826|FG001|Overall Study|Not completed|4|||
125605227|NCT00390780|451839825|FG000|Overall Study|Protocol Violation|6|||
125605228|NCT00390780|451839826|FG001|Overall Study|Protocol Violation|4|||
125605229|NCT00390780|451839825|FG000|Overall Study|Lost to Follow-up|3|||
125605230|NCT00390780|451839826|FG001|Overall Study|Lost to Follow-up|6|||
125605231|NCT00390780|451839825|FG000|Overall Study|Adverse Event|2|||
125605232|NCT00390780|451839826|FG001|Overall Study|Adverse Event|3|||
125605233|NCT00390780|451839825|FG000|Overall Study|Death|1|||
125605234|NCT00390780|451839826|FG001|Overall Study|Death|3|||
125605235|NCT00390780|451839825|FG000|Overall Study|Withdrawal by Subject|1|||
125605236|NCT00390780|451839826|FG001|Overall Study|Withdrawal by Subject|2|||
125605237|NCT00390780|451839825|FG000|Overall Study|Inclusion criteria not satisfied|0|||
125605238|NCT00390780|451839826|FG001|Overall Study|Inclusion criteria not satisfied|2|||
125605239|NCT00390780|451839825|FG000|Overall Study|Lost to follow up and other reasons|0|||
125369861|NCT02002091|450987103|FG001|Screening|Death|2|||
125605240|NCT00390780|451839826|FG001|Overall Study|Lost to follow up and other reasons|1|||
125605241|NCT00390780|451839825|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
125605242|NCT00390780|451839826|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
125605243|NCT00390780|451839825|FG000|Overall Study|SAE, death|0|||
125605244|NCT00390780|451839826|FG001|Overall Study|SAE, death|1|||
125605245|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
125605246|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
125212853|NCT03300050|450405495|FG004|Overall Study|Lost to Follow-up|1|||
125605247|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
125369862|NCT00369824|450987104|FG000|Overall Study|Adverse Event|0|||
125369863|NCT00369824|450987105|FG001|Overall Study|Adverse Event|2|||
125605248|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
125605249|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
125605250|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
125605251|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
125605252|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
125605253|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
125605254|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
125605255|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
125605256|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
125605257|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
125605258|NCT02232516|451839827|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
125605259|NCT02232516|451839827|FG000|Survival Follow-up|Death|15|||
125605260|NCT02232516|451839827|FG000|Survival Follow-up|Withdrawal by Subject|3|||
125605261|NCT02232516|451839827|FG000|Survival Follow-up|Lost to Follow-up|1|||
125605262|NCT02232516|451839827|FG000|Survival Follow-up|Still in follow-up|5|||
125605263|NCT01070550|451839828|FG000|Overall Study|Adverse Event|43|||
125605264|NCT01070550|451839829|FG001|Overall Study|Adverse Event|1|||
125605265|NCT01070550|451839830|FG002|Overall Study|Adverse Event|3|||
125605266|NCT01070550|451839831|FG003|Overall Study|Adverse Event|0|||
125605267|NCT01070550|451839832|FG004|Overall Study|Adverse Event|0|||
125605268|NCT01070550|451839833|FG005|Overall Study|Adverse Event|0|||
125605269|NCT01070550|451839828|FG000|Overall Study|Death|20|||
125605270|NCT01070550|451839829|FG001|Overall Study|Death|4|||
125605271|NCT01070550|451839830|FG002|Overall Study|Death|3|||
125605272|NCT01070550|451839831|FG003|Overall Study|Death|0|||
125605273|NCT01070550|451839832|FG004|Overall Study|Death|0|||
125605274|NCT01070550|451839833|FG005|Overall Study|Death|0|||
125605275|NCT01070550|451839828|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
125605276|NCT01070550|451839829|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
125605277|NCT01070550|451839830|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
125605278|NCT01070550|451839831|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
125605279|NCT01070550|451839832|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
125605280|NCT01070550|451839833|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
125605281|NCT01070550|451839828|FG000|Overall Study|Early termination|3|||
125605282|NCT01070550|451839829|FG001|Overall Study|Early termination|0|||
125605283|NCT01070550|451839830|FG002|Overall Study|Early termination|0|||
125605284|NCT01070550|451839831|FG003|Overall Study|Early termination|0|||
125605285|NCT01070550|451839832|FG004|Overall Study|Early termination|0|||
125605286|NCT01070550|451839833|FG005|Overall Study|Early termination|0|||
125605287|NCT01070550|451839828|FG000|Overall Study|Failed to return|450|||
125605288|NCT01070550|451839829|FG001|Overall Study|Failed to return|33|||
125605289|NCT01070550|451839830|FG002|Overall Study|Failed to return|144|||
125605290|NCT01070550|451839831|FG003|Overall Study|Failed to return|40|||
125605291|NCT01070550|451839832|FG004|Overall Study|Failed to return|1|||
125605292|NCT01070550|451839833|FG005|Overall Study|Failed to return|2|||
125605293|NCT01070550|451839828|FG000|Overall Study|Incomplete treatment|2|||
125605294|NCT01070550|451839829|FG001|Overall Study|Incomplete treatment|0|||
125605295|NCT01070550|451839830|FG002|Overall Study|Incomplete treatment|0|||
125605296|NCT01070550|451839831|FG003|Overall Study|Incomplete treatment|0|||
125605297|NCT01070550|451839832|FG004|Overall Study|Incomplete treatment|0|||
125605298|NCT01070550|451839833|FG005|Overall Study|Incomplete treatment|0|||
125605299|NCT01070550|451839828|FG000|Overall Study|Lab test not done|22|||
125605300|NCT01070550|451839829|FG001|Overall Study|Lab test not done|3|||
125605301|NCT01070550|451839830|FG002|Overall Study|Lab test not done|4|||
125605302|NCT01070550|451839831|FG003|Overall Study|Lab test not done|1|||
125605303|NCT01070550|451839832|FG004|Overall Study|Lab test not done|0|||
125605304|NCT01070550|451839833|FG005|Overall Study|Lab test not done|1|||
125605305|NCT01070550|451839828|FG000|Overall Study|Lack of Efficacy|65|||
125605306|NCT01070550|451839829|FG001|Overall Study|Lack of Efficacy|1|||
125605307|NCT01070550|451839830|FG002|Overall Study|Lack of Efficacy|5|||
125369864|NCT00369824|450987106|FG002|Overall Study|Adverse Event|0|||
125369865|NCT00369824|450987107|FG003|Overall Study|Adverse Event|0|||
125369866|NCT00369824|450987108|FG004|Overall Study|Adverse Event|1|||
125369867|NCT00369824|450987109|FG005|Overall Study|Adverse Event|0|||
125369868|NCT00369824|450987104|FG000|Overall Study|Protocol Violation|0|||
125369869|NCT00369824|450987105|FG001|Overall Study|Protocol Violation|1|||
125605308|NCT01070550|451839831|FG003|Overall Study|Lack of Efficacy|5|||
125605309|NCT01070550|451839832|FG004|Overall Study|Lack of Efficacy|0|||
125605310|NCT01070550|451839833|FG005|Overall Study|Lack of Efficacy|1|||
125605311|NCT01070550|451839828|FG000|Overall Study|Miscellaneous|12|||
125605312|NCT01070550|451839829|FG001|Overall Study|Miscellaneous|2|||
125605313|NCT01070550|451839830|FG002|Overall Study|Miscellaneous|3|||
125605314|NCT01070550|451839831|FG003|Overall Study|Miscellaneous|1|||
125605315|NCT01070550|451839832|FG004|Overall Study|Miscellaneous|0|||
125605316|NCT01070550|451839833|FG005|Overall Study|Miscellaneous|0|||
125605317|NCT01070550|451839828|FG000|Overall Study|New treatment started|3|||
125605318|NCT01070550|451839829|FG001|Overall Study|New treatment started|1|||
125605319|NCT01070550|451839830|FG002|Overall Study|New treatment started|0|||
125605320|NCT01070550|451839831|FG003|Overall Study|New treatment started|2|||
125605321|NCT01070550|451839832|FG004|Overall Study|New treatment started|0|||
125605322|NCT01070550|451839833|FG005|Overall Study|New treatment started|0|||
125605323|NCT01070550|451839828|FG000|Overall Study|Non-responders|493|||
125605324|NCT01070550|451839829|FG001|Overall Study|Non-responders|4|||
125605325|NCT01070550|451839830|FG002|Overall Study|Non-responders|21|||
125605326|NCT01070550|451839831|FG003|Overall Study|Non-responders|20|||
125605327|NCT01070550|451839832|FG004|Overall Study|Non-responders|0|||
125605328|NCT01070550|451839833|FG005|Overall Study|Non-responders|2|||
125605329|NCT01070550|451839828|FG000|Overall Study|Not categorized|33|||
125605330|NCT01070550|451839829|FG001|Overall Study|Not categorized|2|||
125605331|NCT01070550|451839830|FG002|Overall Study|Not categorized|6|||
125605332|NCT01070550|451839831|FG003|Overall Study|Not categorized|1|||
125605333|NCT01070550|451839832|FG004|Overall Study|Not categorized|0|||
125605334|NCT01070550|451839833|FG005|Overall Study|Not categorized|1|||
125605335|NCT01070550|451839828|FG000|Overall Study|Protocol Violation|15|||
125605336|NCT01070550|451839829|FG001|Overall Study|Protocol Violation|1|||
125605337|NCT01070550|451839830|FG002|Overall Study|Protocol Violation|1|||
125605338|NCT01070550|451839831|FG003|Overall Study|Protocol Violation|1|||
125605339|NCT01070550|451839832|FG004|Overall Study|Protocol Violation|0|||
125605340|NCT01070550|451839833|FG005|Overall Study|Protocol Violation|0|||
125605341|NCT01070550|451839828|FG000|Overall Study|Relapse|44|||
125605342|NCT01070550|451839829|FG001|Overall Study|Relapse|5|||
125605343|NCT01070550|451839830|FG002|Overall Study|Relapse|14|||
125605344|NCT01070550|451839831|FG003|Overall Study|Relapse|4|||
125605345|NCT01070550|451839832|FG004|Overall Study|Relapse|0|||
125605346|NCT01070550|451839833|FG005|Overall Study|Relapse|0|||
125605347|NCT01070550|451839828|FG000|Overall Study|Result not available|3|||
125605348|NCT01070550|451839829|FG001|Overall Study|Result not available|1|||
125605349|NCT01070550|451839830|FG002|Overall Study|Result not available|3|||
125605350|NCT01070550|451839831|FG003|Overall Study|Result not available|0|||
125605351|NCT01070550|451839832|FG004|Overall Study|Result not available|0|||
125605352|NCT01070550|451839833|FG005|Overall Study|Result not available|0|||
125605353|NCT01070550|451839828|FG000|Overall Study|Screen failure|1|||
125605354|NCT01070550|451839829|FG001|Overall Study|Screen failure|0|||
125605355|NCT01070550|451839830|FG002|Overall Study|Screen failure|0|||
125605356|NCT01070550|451839831|FG003|Overall Study|Screen failure|0|||
125605357|NCT01070550|451839832|FG004|Overall Study|Screen failure|0|||
125605358|NCT01070550|451839833|FG005|Overall Study|Screen failure|0|||
125605359|NCT01070550|451839828|FG000|Overall Study|Sponsor decision|1|||
125605360|NCT01070550|451839829|FG001|Overall Study|Sponsor decision|0|||
125605361|NCT01070550|451839830|FG002|Overall Study|Sponsor decision|0|||
125605362|NCT01070550|451839831|FG003|Overall Study|Sponsor decision|0|||
125605363|NCT01070550|451839832|FG004|Overall Study|Sponsor decision|0|||
125605364|NCT01070550|451839833|FG005|Overall Study|Sponsor decision|0|||
125605365|NCT01070550|451839828|FG000|Overall Study|Treatment duration shortened|1|||
125605366|NCT01070550|451839829|FG001|Overall Study|Treatment duration shortened|0|||
125605367|NCT01070550|451839830|FG002|Overall Study|Treatment duration shortened|0|||
125605368|NCT01070550|451839831|FG003|Overall Study|Treatment duration shortened|0|||
125605369|NCT01070550|451839832|FG004|Overall Study|Treatment duration shortened|0|||
125605370|NCT01070550|451839833|FG005|Overall Study|Treatment duration shortened|0|||
125605371|NCT01070550|451839828|FG000|Overall Study|Treatment interrupted|7|||
125605372|NCT01070550|451839829|FG001|Overall Study|Treatment interrupted|0|||
125605373|NCT01070550|451839830|FG002|Overall Study|Treatment interrupted|1|||
125605374|NCT01070550|451839831|FG003|Overall Study|Treatment interrupted|1|||
125605375|NCT01070550|451839832|FG004|Overall Study|Treatment interrupted|0|||
125605376|NCT01070550|451839833|FG005|Overall Study|Treatment interrupted|0|||
125605377|NCT01070550|451839828|FG000|Overall Study|Treatment not started|14|||
125605378|NCT01070550|451839829|FG001|Overall Study|Treatment not started|2|||
125605379|NCT01070550|451839830|FG002|Overall Study|Treatment not started|4|||
125605380|NCT01070550|451839831|FG003|Overall Study|Treatment not started|0|||
125605381|NCT01070550|451839832|FG004|Overall Study|Treatment not started|0|||
125605382|NCT01070550|451839833|FG005|Overall Study|Treatment not started|0|||
125605383|NCT01070550|451839828|FG000|Overall Study|Treatment restarted|0|||
125605384|NCT01070550|451839829|FG001|Overall Study|Treatment restarted|1|||
125605385|NCT01070550|451839830|FG002|Overall Study|Treatment restarted|0|||
125605386|NCT01070550|451839831|FG003|Overall Study|Treatment restarted|0|||
125605387|NCT01070550|451839832|FG004|Overall Study|Treatment restarted|0|||
125605388|NCT01070550|451839833|FG005|Overall Study|Treatment restarted|0|||
125605389|NCT01070550|451839828|FG000|Overall Study|Treatment stopped|3|||
125605390|NCT01070550|451839829|FG001|Overall Study|Treatment stopped|0|||
125605391|NCT01070550|451839830|FG002|Overall Study|Treatment stopped|0|||
125605392|NCT01070550|451839831|FG003|Overall Study|Treatment stopped|0|||
125605393|NCT01070550|451839832|FG004|Overall Study|Treatment stopped|0|||
125605394|NCT01070550|451839833|FG005|Overall Study|Treatment stopped|0|||
125605395|NCT01070550|451839828|FG000|Overall Study|Treatment unavailable|1|||
125605396|NCT01070550|451839829|FG001|Overall Study|Treatment unavailable|0|||
125605397|NCT01070550|451839830|FG002|Overall Study|Treatment unavailable|0|||
125605398|NCT01070550|451839831|FG003|Overall Study|Treatment unavailable|0|||
125605399|NCT01070550|451839832|FG004|Overall Study|Treatment unavailable|0|||
125605400|NCT01070550|451839833|FG005|Overall Study|Treatment unavailable|0|||
125605401|NCT01070550|451839828|FG000|Overall Study|Treatment was stopped early|7|||
125605402|NCT01070550|451839829|FG001|Overall Study|Treatment was stopped early|0|||
125605403|NCT01070550|451839830|FG002|Overall Study|Treatment was stopped early|0|||
125605404|NCT01070550|451839831|FG003|Overall Study|Treatment was stopped early|0|||
125605405|NCT01070550|451839832|FG004|Overall Study|Treatment was stopped early|0|||
125605406|NCT01070550|451839833|FG005|Overall Study|Treatment was stopped early|0|||
125605407|NCT01070550|451839828|FG000|Overall Study|Other|5|||
125605408|NCT01070550|451839829|FG001|Overall Study|Other|0|||
125605409|NCT01070550|451839830|FG002|Overall Study|Other|0|||
125605410|NCT01070550|451839831|FG003|Overall Study|Other|1|||
125605411|NCT01070550|451839832|FG004|Overall Study|Other|0|||
125605412|NCT01070550|451839833|FG005|Overall Study|Other|0|||
125605413|NCT01070550|451839828|FG000|Overall Study|Withdrawal by Subject|35|||
125605414|NCT01070550|451839829|FG001|Overall Study|Withdrawal by Subject|0|||
125605415|NCT01070550|451839830|FG002|Overall Study|Withdrawal by Subject|3|||
125605416|NCT01070550|451839831|FG003|Overall Study|Withdrawal by Subject|0|||
125605417|NCT01070550|451839832|FG004|Overall Study|Withdrawal by Subject|0|||
125605418|NCT01070550|451839833|FG005|Overall Study|Withdrawal by Subject|0|||
125605419|NCT01585961|451839834|FG000|Overall Study|Death|6|||
125605420|NCT01585961|451839834|FG000|Overall Study|Physician Decision|1|||
125605421|NCT01585961|451839834|FG000|Overall Study|Decision to use non-study catheter|1|||
125605422|NCT01585961|451839834|FG000|Overall Study|Withdrawal by Subject|1|||
125605423|NCT01585961|451839834|FG000|Overall Study|Lost to Follow-up|23|||
125605424|NCT01585961|451839834|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
125605425|NCT01258348|451839835|FG000|Overall Study|Adverse Event|1|||
125605426|NCT01258348|451839836|FG001|Overall Study|Adverse Event|1|||
125605427|NCT01258348|451839837|FG002|Overall Study|Adverse Event|3|||
125605428|NCT01258348|451839838|FG003|Overall Study|Adverse Event|2|||
125605429|NCT01258348|451839839|FG004|Overall Study|Adverse Event|4|||
125605430|NCT01258348|451839835|FG000|Overall Study|Progressive Disease|0|||
125605431|NCT01258348|451839836|FG001|Overall Study|Progressive Disease|3|||
125605432|NCT01258348|451839837|FG002|Overall Study|Progressive Disease|0|||
125605433|NCT01258348|451839838|FG003|Overall Study|Progressive Disease|2|||
125605434|NCT01258348|451839839|FG004|Overall Study|Progressive Disease|2|||
125605435|NCT01258348|451839835|FG000|Overall Study|Physician Decision|0|||
125605436|NCT01258348|451839836|FG001|Overall Study|Physician Decision|0|||
125605437|NCT01258348|451839837|FG002|Overall Study|Physician Decision|0|||
125605438|NCT01258348|451839838|FG003|Overall Study|Physician Decision|2|||
125605439|NCT01258348|451839839|FG004|Overall Study|Physician Decision|0|||
125605440|NCT01258348|451839835|FG000|Overall Study|Withdrawal by Subject|0|||
125605441|NCT01258348|451839836|FG001|Overall Study|Withdrawal by Subject|1|||
125605442|NCT01258348|451839837|FG002|Overall Study|Withdrawal by Subject|0|||
125369870|NCT00369824|450987106|FG002|Overall Study|Protocol Violation|0|||
125369871|NCT00369824|450987107|FG003|Overall Study|Protocol Violation|1|||
125369872|NCT00369824|450987108|FG004|Overall Study|Protocol Violation|1|||
125369873|NCT00369824|450987109|FG005|Overall Study|Protocol Violation|0|||
125605443|NCT01258348|451839838|FG003|Overall Study|Withdrawal by Subject|0|||
125605444|NCT01258348|451839839|FG004|Overall Study|Withdrawal by Subject|0|||
125605445|NCT04964063|451839840|FG000|Overall Study|Adverse Event|4|||
125605446|NCT04964063|451839840|FG000|Overall Study|Lost to Follow-up|47|||
125605447|NCT04964063|451839840|FG000|Overall Study|Withdrawal by Subject|5|||
125605448|NCT04964063|451839840|FG000|Overall Study|Baseline Tasks Expired|41|||
125605449|NCT04964063|451839840|FG000|Overall Study|Participant withdrawn in error|1|||
125605450|NCT03350750|451839841|FG000|Overall Study|Death|1|||
125605451|NCT03350750|451839842|FG001|Overall Study|Death|1|||
125605452|NCT01849250|451839843|FG000|Overall Study|Withdrawal by Subject|1|||
125369874|NCT00369824|450987104|FG000|Overall Study|Withdrawal by Subject|9|||
125369875|NCT00369824|450987105|FG001|Overall Study|Withdrawal by Subject|5|||
125605453|NCT01849250|451839844|FG001|Overall Study|Withdrawal by Subject|0|||
125605454|NCT01849250|451839843|FG000|Overall Study|Not Evaluable|5|||
125605455|NCT01849250|451839844|FG001|Overall Study|Not Evaluable|3|||
125605456|NCT01849250|451839843|FG000|Overall Study|Screen Failure|1|||
125605457|NCT01849250|451839844|FG001|Overall Study|Screen Failure|0|||
125605458|NCT01525849|451839848|FG000|Overall Study|Lost to Follow-up|3|||
125605459|NCT01525849|451839849|FG001|Overall Study|Lost to Follow-up|2|||
125605460|NCT01525849|451839848|FG000|Overall Study|Withdrawal by Subject|1|||
125605461|NCT01525849|451839849|FG001|Overall Study|Withdrawal by Subject|9|||
125605462|NCT01525849|451839848|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
125605463|NCT01525849|451839849|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
125605464|NCT01525849|451839848|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
125605465|NCT01525849|451839849|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
125605466|NCT00339183|451839850|FG000|Overall Study|Adverse Event|5|||
125605467|NCT00339183|451839851|FG001|Overall Study|Adverse Event|3|||
125605468|NCT00339183|451839850|FG000|Overall Study|Withdrawal by Subject|16|||
125605469|NCT00339183|451839851|FG001|Overall Study|Withdrawal by Subject|19|||
125605470|NCT00339183|451839850|FG000|Overall Study|Physician Decision|2|||
125605471|NCT00339183|451839851|FG001|Overall Study|Physician Decision|4|||
125605472|NCT00339183|451839850|FG000|Overall Study|Lost to Follow-up|17|||
125605473|NCT00339183|451839851|FG001|Overall Study|Lost to Follow-up|17|||
125605474|NCT00339183|451839850|FG000|Overall Study|Protocol-specified criteria|12|||
125605475|NCT00339183|451839851|FG001|Overall Study|Protocol-specified criteria|8|||
125605476|NCT00339183|451839850|FG000|Overall Study|Missing reason|3|||
125605477|NCT00339183|451839851|FG001|Overall Study|Missing reason|1|||
125605478|NCT00339183|451839850|FG000|Overall Study|Other|46|||
125605479|NCT00339183|451839851|FG001|Overall Study|Other|40|||
125605480|NCT00339183|451839850|FG000|Overall Study|Ongoing|20|||
125605481|NCT00339183|451839851|FG001|Overall Study|Ongoing|13|||
125605482|NCT00793819|451839852|FG000|Overall Study|Adverse Event|8|||
125605483|NCT00793819|451839853|FG001|Overall Study|Adverse Event|4|||
125605484|NCT00793819|451839852|FG000|Overall Study|Lack of Efficacy|1|||
125605485|NCT00793819|451839853|FG001|Overall Study|Lack of Efficacy|1|||
125605486|NCT00793819|451839852|FG000|Overall Study|Withdrawal by Subject|4|||
125605487|NCT00793819|451839853|FG001|Overall Study|Withdrawal by Subject|3|||
125605488|NCT00793819|451839852|FG000|Overall Study|Lost to Follow-up|1|||
125605489|NCT00793819|451839853|FG001|Overall Study|Lost to Follow-up|1|||
125605490|NCT00446446|451839854|FG000|Overall Study|Death|10|||
125605491|NCT00446446|451839854|FG000|Overall Study|Withdrawal by Subject|6|||
125605492|NCT00446446|451839854|FG000|Overall Study|Other|4|||
125605493|NCT00446446|451839854|FG000|Overall Study|Disease Progession|2|||
125605494|NCT00446446|451839854|FG000|Overall Study|Adverse Event|1|||
125605495|NCT00446446|451839854|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
125605496|NCT01844700|451839860|FG000|Overall Study|Lack of Efficacy|1|||
125605497|NCT01844700|451839861|FG001|Overall Study|Lack of Efficacy|0|||
125605498|NCT01844700|451839860|FG000|Overall Study|refused medication switch|1|||
125605499|NCT01844700|451839861|FG001|Overall Study|refused medication switch|0|||
125605500|NCT01844700|451839860|FG000|Overall Study|Withdrawal by Subject|1|||
125605501|NCT01844700|451839861|FG001|Overall Study|Withdrawal by Subject|0|||
125605502|NCT01844700|451839860|FG000|Overall Study|stopped taking meds|0|||
125605503|NCT01844700|451839861|FG001|Overall Study|stopped taking meds|1|||
125605504|NCT02680847|451839862|FG000|Overall Study|Other|2|||
125605505|NCT02680847|451839863|FG001|Overall Study|Other|0|||
125605506|NCT02680847|451839864|FG002|Overall Study|Other|0|||
125605507|NCT02680847|451839862|FG000|Overall Study|No longer met eligibility criteria|2|||
125605508|NCT02680847|451839863|FG001|Overall Study|No longer met eligibility criteria|2|||
125605509|NCT02680847|451839864|FG002|Overall Study|No longer met eligibility criteria|0|||
125605510|NCT02680847|451839862|FG000|Overall Study|Unwilling to participate in study|1|||
125605511|NCT02680847|451839863|FG001|Overall Study|Unwilling to participate in study|1|||
125605512|NCT02680847|451839864|FG002|Overall Study|Unwilling to participate in study|0|||
125605513|NCT02680847|451839862|FG000|Overall Study|Lack of Efficacy|0|||
125605514|NCT02680847|451839863|FG001|Overall Study|Lack of Efficacy|0|||
125605515|NCT02680847|451839864|FG002|Overall Study|Lack of Efficacy|2|||
125605516|NCT02680847|451839862|FG000|Overall Study|Adverse Event|0|||
125605517|NCT02680847|451839863|FG001|Overall Study|Adverse Event|0|||
125605518|NCT02680847|451839864|FG002|Overall Study|Adverse Event|1|||
125605519|NCT02144220|451839865|FG000|Overall Study|technology incompatibility|9|||
125605520|NCT02144220|451839865|FG000|Overall Study|Lack of Efficacy|4|||
125605521|NCT02144220|451839865|FG000|Overall Study|Physician Decision|3|||
125605522|NCT02144220|451839865|FG000|Overall Study|Withdrawal by Subject|2|||
125605523|NCT02144220|451839865|FG000|Overall Study|Protocol Violation|1|||
125605524|NCT03648996|451839866|FG000|Overall Study|Withdrawal by Subject|0|||
125605525|NCT03648996|451839867|FG001|Overall Study|Withdrawal by Subject|2|||
125605526|NCT03648996|451839868|FG002|Overall Study|Withdrawal by Subject|2|||
125605527|NCT03648996|451839866|FG000|Overall Study|Physician Decision|2|||
125605528|NCT03648996|451839867|FG001|Overall Study|Physician Decision|0|||
125605529|NCT03648996|451839868|FG002|Overall Study|Physician Decision|0|||
125605530|NCT00590681|451839869|FG000|Overall Study|Withdrawal by Subject|7|||
125605531|NCT00590681|451839869|FG000|Overall Study|Adverse Event|8|||
125605532|NCT00590681|451839869|FG000|Overall Study|Death|3|||
125605533|NCT00590681|451839869|FG000|Overall Study|Lost to Follow-up|1|||
125605534|NCT00590681|451839869|FG000|Overall Study|disease progression|1|||
125605535|NCT00504166|451839870|FG000|Overall Study|Adverse Event|1|||
125605536|NCT00504166|451839871|FG001|Overall Study|Adverse Event|4|||
125605537|NCT00504166|451839870|FG000|Overall Study|Withdrawal by Subject|3|||
125605538|NCT00504166|451839871|FG001|Overall Study|Withdrawal by Subject|6|||
125605539|NCT00504166|451839870|FG000|Overall Study|Physician Decision|1|||
125605540|NCT00504166|451839871|FG001|Overall Study|Physician Decision|1|||
125605541|NCT00504166|451839870|FG000|Overall Study|Lost to Follow-up|1|||
125605542|NCT00504166|451839871|FG001|Overall Study|Lost to Follow-up|3|||
125605543|NCT02229864|451839872|FG000|Overall Study|Death|2|||
125605544|NCT02229864|451839872|FG000|Overall Study|Lost to Follow-up|1|||
125605545|NCT02650284|451839873|FG000|Overall Study|Lost to Follow-up|3|||
125605546|NCT02650284|451839874|FG001|Overall Study|Lost to Follow-up|3|||
125605547|NCT02650284|451839873|FG000|Overall Study|Consent incorrectly taken|0|||
125605548|NCT02650284|451839874|FG001|Overall Study|Consent incorrectly taken|1|||
125605549|NCT01780389|451839880|FG000|Overall Study|Adverse Event|1|||
125605550|NCT02566525|451839885|FG000|Overall Study|Protocol Violation|3|||
125605551|NCT02566525|451839886|FG001|Overall Study|Protocol Violation|5|||
125605552|NCT00337467|451839887|FG000|Overall Study|Adverse Event|3|||
125605553|NCT00337467|451839887|FG000|Overall Study|Subject Withdrew Consent|2|||
125605554|NCT00337467|451839887|FG000|Overall Study|Pregnancy|1|||
125605555|NCT00337467|451839887|FG000|Overall Study|Lost to Follow-up|2|||
125605556|NCT00337467|451839887|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
125605557|NCT02488759|451839888|FG000|Overall Study|Disease progression|73|||
125605558|NCT02488759|451839889|FG001|Overall Study|Disease progression|111|||
125605559|NCT02488759|451839890|FG002|Overall Study|Disease progression|62|||
125605560|NCT02488759|451839891|FG003|Overall Study|Disease progression|7|||
125605561|NCT02488759|451839892|FG004|Overall Study|Disease progression|4|||
125605562|NCT02488759|451839893|FG005|Overall Study|Disease progression|2|||
125605563|NCT02488759|451839888|FG000|Overall Study|Study drug toxicity|11|||
125605564|NCT02488759|451839889|FG001|Overall Study|Study drug toxicity|33|||
125605565|NCT02488759|451839890|FG002|Overall Study|Study drug toxicity|31|||
125605566|NCT02488759|451839891|FG003|Overall Study|Study drug toxicity|0|||
125605567|NCT02488759|451839892|FG004|Overall Study|Study drug toxicity|0|||
125605568|NCT02488759|451839893|FG005|Overall Study|Study drug toxicity|2|||
125605569|NCT02488759|451839888|FG000|Overall Study|Adverse event unrelated to study drug|9|||
125605570|NCT02488759|451839889|FG001|Overall Study|Adverse event unrelated to study drug|11|||
125605571|NCT02488759|451839890|FG002|Overall Study|Adverse event unrelated to study drug|7|||
125605572|NCT02488759|451839891|FG003|Overall Study|Adverse event unrelated to study drug|0|||
125605573|NCT02488759|451839892|FG004|Overall Study|Adverse event unrelated to study drug|1|||
125605574|NCT02488759|451839893|FG005|Overall Study|Adverse event unrelated to study drug|0|||
125605575|NCT02488759|451839888|FG000|Overall Study|Participant request to discontinue study treatment|6|||
125605576|NCT02488759|451839889|FG001|Overall Study|Participant request to discontinue study treatment|8|||
125605577|NCT02488759|451839890|FG002|Overall Study|Participant request to discontinue study treatment|4|||
125605578|NCT02488759|451839891|FG003|Overall Study|Participant request to discontinue study treatment|0|||
125605579|NCT02488759|451839892|FG004|Overall Study|Participant request to discontinue study treatment|0|||
125605580|NCT02488759|451839893|FG005|Overall Study|Participant request to discontinue study treatment|0|||
125605581|NCT02488759|451839888|FG000|Overall Study|Withdrawal by Subject|4|||
125605582|NCT02488759|451839889|FG001|Overall Study|Withdrawal by Subject|0|||
125605583|NCT02488759|451839890|FG002|Overall Study|Withdrawal by Subject|3|||
125605584|NCT02488759|451839891|FG003|Overall Study|Withdrawal by Subject|0|||
125605585|NCT02488759|451839892|FG004|Overall Study|Withdrawal by Subject|0|||
125605586|NCT02488759|451839893|FG005|Overall Study|Withdrawal by Subject|2|||
125605587|NCT02488759|451839888|FG000|Overall Study|Lost to Follow-up|0|||
125605588|NCT02488759|451839889|FG001|Overall Study|Lost to Follow-up|0|||
125605589|NCT02488759|451839890|FG002|Overall Study|Lost to Follow-up|2|||
125605590|NCT02488759|451839891|FG003|Overall Study|Lost to Follow-up|0|||
125605591|NCT02488759|451839892|FG004|Overall Study|Lost to Follow-up|0|||
125605592|NCT02488759|451839893|FG005|Overall Study|Lost to Follow-up|0|||
125605593|NCT02488759|451839888|FG000|Overall Study|Maximum clinical benefit|3|||
125369876|NCT00369824|450987106|FG002|Overall Study|Withdrawal by Subject|5|||
125369877|NCT00369824|450987107|FG003|Overall Study|Withdrawal by Subject|4|||
125605594|NCT02488759|451839889|FG001|Overall Study|Maximum clinical benefit|0|||
125605595|NCT02488759|451839890|FG002|Overall Study|Maximum clinical benefit|1|||
125605596|NCT02488759|451839891|FG003|Overall Study|Maximum clinical benefit|0|||
125605597|NCT02488759|451839892|FG004|Overall Study|Maximum clinical benefit|0|||
125605598|NCT02488759|451839893|FG005|Overall Study|Maximum clinical benefit|0|||
125605599|NCT02488759|451839888|FG000|Overall Study|Other reasons|7|||
125605600|NCT02488759|451839889|FG001|Overall Study|Other reasons|32|||
125605601|NCT02488759|451839890|FG002|Overall Study|Other reasons|23|||
125605602|NCT02488759|451839891|FG003|Overall Study|Other reasons|1|||
125605603|NCT02488759|451839892|FG004|Overall Study|Other reasons|1|||
125605604|NCT02488759|451839893|FG005|Overall Study|Other reasons|1|||
125605605|NCT04083222|451839894|FG000|Overall Study|Voluntary Withdrawal|0|||
125605606|NCT04083222|451839895|FG001|Overall Study|Voluntary Withdrawal|1|||
125605607|NCT04083222|451839894|FG000|Overall Study|Reason not Specified|0|||
125605608|NCT04083222|451839895|FG001|Overall Study|Reason not Specified|1|||
125605609|NCT03103750|451839896|FG000|Overall Study|Adverse Event|1|||
125605610|NCT03103750|451839897|FG001|Overall Study|Adverse Event|0|||
125605611|NCT03103750|451839896|FG000|Overall Study|Lost to Follow-up|1|||
125605612|NCT03103750|451839897|FG001|Overall Study|Lost to Follow-up|0|||
125605613|NCT03103750|451839896|FG000|Overall Study|PET Equipment Related|2|||
125605614|NCT03103750|451839897|FG001|Overall Study|PET Equipment Related|2|||
125605615|NCT02429427|451839905|FG000|Overall Study|Adverse Event|220|||
125605616|NCT02429427|451839906|FG001|Overall Study|Adverse Event|92|||
125605617|NCT02429427|451839905|FG000|Overall Study|Protocol Violation|10|||
125605618|NCT02429427|451839906|FG001|Overall Study|Protocol Violation|6|||
125605619|NCT02429427|451839905|FG000|Overall Study|Lost to Follow-up|15|||
125605620|NCT02429427|451839906|FG001|Overall Study|Lost to Follow-up|6|||
125605621|NCT02429427|451839905|FG000|Overall Study|Withdrawal by Subject|64|||
125605622|NCT02429427|451839906|FG001|Overall Study|Withdrawal by Subject|34|||
125605623|NCT02429427|451839905|FG000|Overall Study|Other|62|||
125605624|NCT02429427|451839906|FG001|Overall Study|Other|41|||
125605625|NCT04267562|451842162|FG000|Assessed for Eligibility|Screen Failure|64|||
125605626|NCT04267562|451842162|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
125605627|NCT04267562|451842162|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
125605628|NCT04267562|451842162|FG000|Assessed for Eligibility|Site closure|6|||
125605629|NCT04267562|451842162|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
125605630|NCT04267562|451842162|FG000|Assessed for Eligibility|Physician Decision|1|||
125605631|NCT04267562|451842162|FG000|Month 24|Elective hysterectomy|1|||
125605632|NCT04267562|451842162|FG000|Month 24|Lost to Follow-up|1|||
125605633|NCT04267562|451842162|FG000|Month 36|Elective hysterectomy|2|||
125605634|NCT04267562|451842162|FG000|Month 36|Lost to Follow-up|3|||
125605635|NCT02078713|451842163|FG000|Overall Study|Lost to Follow-up|49|||
125605636|NCT02078713|451842164|FG001|Overall Study|Lost to Follow-up|55|||
125605637|NCT02078713|451842165|FG002|Overall Study|Lost to Follow-up|0|||
125605638|NCT02078713|451842166|FG003|Overall Study|Lost to Follow-up|0|||
125605639|NCT02078713|451842163|FG000|Overall Study|Pregnant at baseline|3|||
125605640|NCT02078713|451842164|FG001|Overall Study|Pregnant at baseline|5|||
125605641|NCT02078713|451842165|FG002|Overall Study|Pregnant at baseline|0|||
125605642|NCT02078713|451842166|FG003|Overall Study|Pregnant at baseline|0|||
125605643|NCT02078713|451842163|FG000|Overall Study|Enrolled twice|0|||
125605644|NCT02078713|451842164|FG001|Overall Study|Enrolled twice|1|||
125605645|NCT02078713|451842165|FG002|Overall Study|Enrolled twice|0|||
125605646|NCT02078713|451842166|FG003|Overall Study|Enrolled twice|0|||
125605647|NCT00696657|451842171|FG000|Overall Study|Protocol Violation|0|||
125605648|NCT00696657|451842172|FG001|Overall Study|Protocol Violation|0|||
125605649|NCT00696657|451842173|FG002|Overall Study|Protocol Violation|0|||
125605650|NCT00696657|451842174|FG003|Overall Study|Protocol Violation|0|||
125605651|NCT00696657|451842175|FG004|Overall Study|Protocol Violation|0|||
125605652|NCT00696657|451842176|FG005|Overall Study|Protocol Violation|1|||
125605653|NCT00696657|451842177|FG006|Overall Study|Protocol Violation|0|||
125605654|NCT00696657|451842178|FG007|Overall Study|Protocol Violation|0|||
125605655|NCT00696657|451842179|FG008|Overall Study|Protocol Violation|1|||
125605656|NCT00696657|451842171|FG000|Overall Study|Lack of Efficacy|0|||
125605657|NCT00696657|451842172|FG001|Overall Study|Lack of Efficacy|1|||
125605658|NCT00696657|451842173|FG002|Overall Study|Lack of Efficacy|0|||
125605659|NCT00696657|451842174|FG003|Overall Study|Lack of Efficacy|0|||
125605660|NCT00696657|451842175|FG004|Overall Study|Lack of Efficacy|0|||
125605661|NCT00696657|451842176|FG005|Overall Study|Lack of Efficacy|0|||
125605662|NCT00696657|451842177|FG006|Overall Study|Lack of Efficacy|0|||
125605663|NCT00696657|451842178|FG007|Overall Study|Lack of Efficacy|0|||
125605664|NCT00696657|451842179|FG008|Overall Study|Lack of Efficacy|0|||
125605665|NCT00696657|451842171|FG000|Overall Study|Withdrawal criteria|1|||
125605666|NCT00696657|451842172|FG001|Overall Study|Withdrawal criteria|3|||
125605667|NCT00696657|451842173|FG002|Overall Study|Withdrawal criteria|2|||
125605668|NCT00696657|451842174|FG003|Overall Study|Withdrawal criteria|2|||
125605669|NCT00696657|451842175|FG004|Overall Study|Withdrawal criteria|0|||
125605670|NCT00696657|451842176|FG005|Overall Study|Withdrawal criteria|0|||
125605671|NCT00696657|451842177|FG006|Overall Study|Withdrawal criteria|1|||
125605672|NCT00696657|451842178|FG007|Overall Study|Withdrawal criteria|1|||
125605673|NCT00696657|451842179|FG008|Overall Study|Withdrawal criteria|2|||
125605674|NCT00696657|451842171|FG000|Overall Study|Unclassified|0|||
125605675|NCT00696657|451842172|FG001|Overall Study|Unclassified|1|||
125605676|NCT00696657|451842173|FG002|Overall Study|Unclassified|3|||
125605677|NCT00696657|451842174|FG003|Overall Study|Unclassified|2|||
125369878|NCT00369824|450987108|FG004|Overall Study|Withdrawal by Subject|6|||
125605678|NCT00696657|451842175|FG004|Overall Study|Unclassified|4|||
125605679|NCT00696657|451842176|FG005|Overall Study|Unclassified|2|||
125605680|NCT00696657|451842177|FG006|Overall Study|Unclassified|0|||
125605681|NCT00696657|451842178|FG007|Overall Study|Unclassified|0|||
125605682|NCT00696657|451842179|FG008|Overall Study|Unclassified|1|||
125605683|NCT00696657|451842171|FG000|Overall Study|Adverse Event|0|||
125605684|NCT00696657|451842172|FG001|Overall Study|Adverse Event|0|||
125605685|NCT00696657|451842173|FG002|Overall Study|Adverse Event|3|||
125605686|NCT00696657|451842174|FG003|Overall Study|Adverse Event|7|||
125605687|NCT00696657|451842175|FG004|Overall Study|Adverse Event|6|||
125605688|NCT00696657|451842176|FG005|Overall Study|Adverse Event|9|||
125605689|NCT00696657|451842177|FG006|Overall Study|Adverse Event|14|||
125605690|NCT00696657|451842178|FG007|Overall Study|Adverse Event|2|||
125605691|NCT00696657|451842179|FG008|Overall Study|Adverse Event|5|||
125605692|NCT00059215|451842183|FG000|Overall Study|Adverse Event|5|||
125605693|NCT00059215|451842184|FG001|Overall Study|Adverse Event|5|||
125605694|NCT00059215|451842185|FG002|Overall Study|Adverse Event|9|||
125605695|NCT00059215|451842186|FG003|Overall Study|Adverse Event|9|||
125605696|NCT00059215|451842183|FG000|Overall Study|Death|0|||
125605697|NCT00059215|451842184|FG001|Overall Study|Death|0|||
125605698|NCT00059215|451842185|FG002|Overall Study|Death|3|||
125605699|NCT00059215|451842186|FG003|Overall Study|Death|0|||
125605700|NCT00059215|451842183|FG000|Overall Study|Lost to Follow-up|1|||
125605701|NCT00059215|451842184|FG001|Overall Study|Lost to Follow-up|2|||
125605702|NCT00059215|451842185|FG002|Overall Study|Lost to Follow-up|0|||
125605703|NCT00059215|451842186|FG003|Overall Study|Lost to Follow-up|0|||
125605704|NCT00059215|451842183|FG000|Overall Study|Withdrawal by Subject|4|||
125605705|NCT00059215|451842184|FG001|Overall Study|Withdrawal by Subject|4|||
125605706|NCT00059215|451842185|FG002|Overall Study|Withdrawal by Subject|1|||
125605707|NCT00059215|451842186|FG003|Overall Study|Withdrawal by Subject|3|||
125605708|NCT00059215|451842183|FG000|Overall Study|Protocol Violation|1|||
125605709|NCT00059215|451842184|FG001|Overall Study|Protocol Violation|0|||
125605710|NCT00059215|451842185|FG002|Overall Study|Protocol Violation|1|||
125605711|NCT00059215|451842186|FG003|Overall Study|Protocol Violation|0|||
125605712|NCT00059215|451842183|FG000|Overall Study|Protocol entry criteria not met|1|||
125605713|NCT00059215|451842184|FG001|Overall Study|Protocol entry criteria not met|1|||
125605714|NCT00059215|451842185|FG002|Overall Study|Protocol entry criteria not met|0|||
125605715|NCT00059215|451842186|FG003|Overall Study|Protocol entry criteria not met|2|||
125605716|NCT00059215|451842183|FG000|Overall Study|Physician Decision|1|||
125605717|NCT00059215|451842184|FG001|Overall Study|Physician Decision|2|||
125605718|NCT00059215|451842185|FG002|Overall Study|Physician Decision|1|||
125605719|NCT00059215|451842186|FG003|Overall Study|Physician Decision|1|||
125605720|NCT04439838|451842187|FG000|Overall Study|Withdrawal by Subject|0|||
125605721|NCT04439838|451842188|FG001|Overall Study|Withdrawal by Subject|0|||
125605722|NCT04439838|451842189|FG002|Overall Study|Withdrawal by Subject|0|||
125605723|NCT04439838|451842190|FG003|Overall Study|Withdrawal by Subject|0|||
125605724|NCT04439838|451842191|FG004|Overall Study|Withdrawal by Subject|0|||
125605725|NCT04439838|451842192|FG005|Overall Study|Withdrawal by Subject|0|||
125605726|NCT04439838|451842193|FG006|Overall Study|Withdrawal by Subject|0|||
125605727|NCT04439838|451842194|FG007|Overall Study|Withdrawal by Subject|0|||
125605728|NCT04439838|451842195|FG008|Overall Study|Withdrawal by Subject|1|||
125605729|NCT04494633|451842198|FG000|Overall Study|Lost to Follow-up|5|||
125605730|NCT04494633|451842199|FG001|Overall Study|Lost to Follow-up|3|||
125605731|NCT04494633|451842198|FG000|Overall Study|Protocol Violation|1|||
125605732|NCT04494633|451842199|FG001|Overall Study|Protocol Violation|1|||
125605733|NCT00414310|451842200|FG000|Overall Study|Not treated|1|||
125605734|NCT00414310|451842201|FG001|Overall Study|Not treated|0|||
125605735|NCT01254604|451842202|FG000|Overall Study|Lost to Follow-up|1|||
125605736|NCT01254604|451842203|FG001|Overall Study|Lost to Follow-up|1|||
125605737|NCT01254604|451842202|FG000|Overall Study|Protocol Violation|2|||
125605738|NCT01254604|451842203|FG001|Overall Study|Protocol Violation|2|||
125605739|NCT01254604|451842202|FG000|Overall Study|Withdrawal by Subject|2|||
125369879|NCT00369824|450987109|FG005|Overall Study|Withdrawal by Subject|2|||
125369880|NCT00369824|450987104|FG000|Overall Study|Lost to Follow-up|6|||
125605740|NCT01254604|451842203|FG001|Overall Study|Withdrawal by Subject|4|||
125605741|NCT01254604|451842202|FG000|Overall Study|Adverse Event|3|||
125605742|NCT01254604|451842203|FG001|Overall Study|Adverse Event|2|||
125605743|NCT03074162|451842204|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
125605744|NCT03074162|451842205|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
125605745|NCT03074162|451842206|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
125605746|NCT03074162|451842207|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
125605747|NCT03074162|451842208|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
125605748|NCT03074162|451842209|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
125605749|NCT03074162|451842204|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
125605750|NCT03074162|451842205|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
125605751|NCT03074162|451842206|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
125605752|NCT03074162|451842207|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
125605753|NCT03074162|451842208|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
125605754|NCT03074162|451842209|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
125605755|NCT03074162|451842204|FG000|Period 3|Withdrawal by Subject|1|||
125605756|NCT03074162|451842205|FG001|Period 3|Withdrawal by Subject|0|||
125605757|NCT03074162|451842206|FG002|Period 3|Withdrawal by Subject|0|||
125605758|NCT03074162|451842207|FG003|Period 3|Withdrawal by Subject|0|||
125605759|NCT03074162|451842208|FG004|Period 3|Withdrawal by Subject|1|||
125605760|NCT03074162|451842209|FG005|Period 3|Withdrawal by Subject|0|||
125605761|NCT03041116|451842210|FG000|Double-blind|Death|0|||
125605762|NCT03041116|451842211|FG001|Double-blind|Death|2|||
125605763|NCT03041116|451842210|FG000|Double-blind|Withdrawal by Subject|0|||
125605764|NCT03041116|451842211|FG001|Double-blind|Withdrawal by Subject|4|||
125605765|NCT03041116|451842210|FG000|Open-label|Death|1|||
125605766|NCT03041116|451842211|FG001|Open-label|Death|0|||
125605767|NCT03041116|451842210|FG000|Open-label|Termination of the study by Sponsor|39|||
125605768|NCT03041116|451842211|FG001|Open-label|Termination of the study by Sponsor|37|||
125605769|NCT03041116|451842210|FG000|Open-label|Withdrawal by Subject|1|||
125605770|NCT03041116|451842211|FG001|Open-label|Withdrawal by Subject|0|||
125605771|NCT03097328|451842212|FG000|Overall Study|Still on Therapy|2|||
125605772|NCT03097328|451842212|FG000|Overall Study|Progressive Disease|29|||
125605773|NCT03097328|451842212|FG000|Overall Study|Adverse Event|4|||
125605774|NCT03097328|451842212|FG000|Overall Study|Withdrawal by Subject|1|||
125605775|NCT03097328|451842212|FG000|Overall Study|Physician Decision|1|||
125605776|NCT03097328|451842212|FG000|Overall Study|Patient Decision|1|||
125605777|NCT03097328|451842212|FG000|Overall Study|Ineligible for Study Drug|1|||
125605778|NCT02436577|451842213|FG000|Overall Study|Protocol Deviation|0|||
125605779|NCT02436577|451842214|FG001|Overall Study|Protocol Deviation|1|||
125605780|NCT02436577|451842215|FG002|Overall Study|Protocol Deviation|0|||
125605781|NCT02436577|451842216|FG003|Overall Study|Protocol Deviation|0|||
125605782|NCT02436577|451842217|FG004|Overall Study|Protocol Deviation|0|||
125605783|NCT02436577|451842218|FG005|Overall Study|Protocol Deviation|0|||
125605784|NCT01675011|451842222|FG000|Overall Study|Trial terminated by Sponsor|3|||
125605785|NCT01675011|451842223|FG001|Overall Study|Trial terminated by Sponsor|1|||
125605786|NCT00931892|451842227|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
125605787|NCT00931892|451842228|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
125605788|NCT01876732|451842229|FG000|Overall Study|MMA was not over 800mg/dL|75|||
125605789|NCT02531373|451842232|FG000|Overall Study|Lack of Efficacy|0|||
125605790|NCT02531373|451842233|FG001|Overall Study|Lack of Efficacy|0|||
125605791|NCT02531373|451842234|FG002|Overall Study|Lack of Efficacy|0|||
125605792|NCT02531373|451842235|FG003|Overall Study|Lack of Efficacy|0|||
125605793|NCT02531373|451842236|FG004|Overall Study|Lack of Efficacy|3|||
125605794|NCT02531373|451842237|FG005|Overall Study|Lack of Efficacy|2|||
125605795|NCT02531373|451842238|FG006|Overall Study|Lack of Efficacy|4|||
125605796|NCT02531373|451842239|FG007|Overall Study|Lack of Efficacy|8|||
125605797|NCT02531373|451842240|FG008|Overall Study|Lack of Efficacy|5|||
125605798|NCT02531373|451842232|FG000|Overall Study|Lost to Follow-up|0|||
125605799|NCT02531373|451842233|FG001|Overall Study|Lost to Follow-up|0|||
125605800|NCT02531373|451842234|FG002|Overall Study|Lost to Follow-up|0|||
125605801|NCT02531373|451842235|FG003|Overall Study|Lost to Follow-up|0|||
125605802|NCT02531373|451842236|FG004|Overall Study|Lost to Follow-up|0|||
125605803|NCT02531373|451842237|FG005|Overall Study|Lost to Follow-up|2|||
125605804|NCT02531373|451842238|FG006|Overall Study|Lost to Follow-up|2|||
125605805|NCT02531373|451842239|FG007|Overall Study|Lost to Follow-up|0|||
125605806|NCT02531373|451842240|FG008|Overall Study|Lost to Follow-up|0|||
125605807|NCT02531373|451842232|FG000|Overall Study|Physician Decision|0|||
125605808|NCT02531373|451842233|FG001|Overall Study|Physician Decision|0|||
125605809|NCT02531373|451842234|FG002|Overall Study|Physician Decision|0|||
125605810|NCT02531373|451842235|FG003|Overall Study|Physician Decision|0|||
125605811|NCT02531373|451842236|FG004|Overall Study|Physician Decision|2|||
125605812|NCT02531373|451842237|FG005|Overall Study|Physician Decision|1|||
125605813|NCT02531373|451842238|FG006|Overall Study|Physician Decision|0|||
125605814|NCT02531373|451842239|FG007|Overall Study|Physician Decision|0|||
125605815|NCT02531373|451842240|FG008|Overall Study|Physician Decision|0|||
125369881|NCT00369824|450987105|FG001|Overall Study|Lost to Follow-up|11|||
125605816|NCT02531373|451842232|FG000|Overall Study|Protocol Violation|0|||
125605817|NCT02531373|451842233|FG001|Overall Study|Protocol Violation|0|||
125605818|NCT02531373|451842234|FG002|Overall Study|Protocol Violation|0|||
125605819|NCT02531373|451842235|FG003|Overall Study|Protocol Violation|0|||
125605820|NCT02531373|451842236|FG004|Overall Study|Protocol Violation|0|||
125605821|NCT02531373|451842237|FG005|Overall Study|Protocol Violation|1|||
125605822|NCT02531373|451842238|FG006|Overall Study|Protocol Violation|1|||
125605823|NCT02531373|451842239|FG007|Overall Study|Protocol Violation|0|||
125605824|NCT02531373|451842240|FG008|Overall Study|Protocol Violation|1|||
125605825|NCT02531373|451842232|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125431730|NCT04000594|451207728|FG000|Overall Study|Withdrawal by Subject|1|||
125431731|NCT04000594|451207729|FG001|Overall Study|Withdrawal by Subject|0|||
125431732|NCT04000594|451207730|FG002|Overall Study|Withdrawal by Subject|0|||
125605826|NCT02531373|451842233|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125605827|NCT02531373|451842234|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125605828|NCT02531373|451842235|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125605829|NCT02531373|451842236|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125605830|NCT02531373|451842237|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
125605831|NCT02531373|451842238|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
125605832|NCT02531373|451842239|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
125605833|NCT02531373|451842240|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
125605834|NCT02531373|451842232|FG000|Overall Study|Withdrawal by Subject|0|||
125605835|NCT02531373|451842233|FG001|Overall Study|Withdrawal by Subject|0|||
125605836|NCT02531373|451842234|FG002|Overall Study|Withdrawal by Subject|0|||
125605837|NCT02531373|451842235|FG003|Overall Study|Withdrawal by Subject|0|||
125605838|NCT02531373|451842236|FG004|Overall Study|Withdrawal by Subject|3|||
125605839|NCT02531373|451842237|FG005|Overall Study|Withdrawal by Subject|0|||
125605840|NCT02531373|451842238|FG006|Overall Study|Withdrawal by Subject|0|||
125605841|NCT02531373|451842239|FG007|Overall Study|Withdrawal by Subject|0|||
125605842|NCT02531373|451842240|FG008|Overall Study|Withdrawal by Subject|0|||
125605843|NCT00536731|451842241|FG000|Overall Study|Adverse Event|3|||
125605844|NCT00536731|451842242|FG001|Overall Study|Adverse Event|2|||
125605845|NCT00536731|451842243|FG002|Overall Study|Adverse Event|3|||
125605846|NCT00536731|451842241|FG000|Overall Study|Withdrawal by Subject|0|||
125605847|NCT00536731|451842242|FG001|Overall Study|Withdrawal by Subject|2|||
125605848|NCT00536731|451842243|FG002|Overall Study|Withdrawal by Subject|0|||
125605849|NCT00536731|451842241|FG000|Overall Study|Intake of prohibited conc. medication|0|||
125605850|NCT00536731|451842242|FG001|Overall Study|Intake of prohibited conc. medication|0|||
125605851|NCT00536731|451842243|FG002|Overall Study|Intake of prohibited conc. medication|1|||
125605852|NCT00536731|451842241|FG000|Overall Study|Safety reasons|0|||
125605853|NCT00536731|451842242|FG001|Overall Study|Safety reasons|0|||
125605854|NCT00536731|451842243|FG002|Overall Study|Safety reasons|1|||
125605855|NCT00536731|451842241|FG000|Overall Study|Other|1|||
125605856|NCT00536731|451842242|FG001|Overall Study|Other|1|||
125605857|NCT00536731|451842243|FG002|Overall Study|Other|0|||
125605858|NCT01675531|451842244|FG000|Overall Study|Adverse Event|9|||
125605859|NCT01675531|451842244|FG000|Overall Study|Withdrawal by Subject|7|||
125605860|NCT01675531|451842244|FG000|Overall Study|Lack of Efficacy|1|||
125605861|NCT01675531|451842244|FG000|Overall Study|Protocol Violation|8|||
125605862|NCT00623467|451842245|FG000|Overall Study|Lost to Follow-up|1|||
125605863|NCT00623467|451842245|FG000|Overall Study|Protocol Violation|4|||
125605864|NCT00623467|451842245|FG000|Overall Study|Withdrawal by Subject|2|||
125605865|NCT04705597|451842250|FG000|Overall Study|Death|16|||
125605866|NCT04705597|451842251|FG001|Overall Study|Death|9|||
125605867|NCT04705597|451842250|FG000|Overall Study|Lost to Follow-up|1|||
125605868|NCT04705597|451842251|FG001|Overall Study|Lost to Follow-up|0|||
125605869|NCT04705597|451842250|FG000|Overall Study|Withdrawal by Subject|1|||
125605870|NCT04705597|451842251|FG001|Overall Study|Withdrawal by Subject|2|||
125605871|NCT06094296|451842254|FG000|Overall Study|Progressive Disease|1|||
125605872|NCT06094296|451842255|FG001|Overall Study|Progressive Disease|0|||
125431733|NCT04522180|451207731|FG000|Overall Study|Investigator judgement|3|||
125431734|NCT04522180|451207732|FG001|Overall Study|Investigator judgement|4|||
125431735|NCT04522180|451207731|FG000|Overall Study|Voluntary withdrawal|1|||
125431736|NCT04522180|451207732|FG001|Overall Study|Voluntary withdrawal|0|||
125431737|NCT04522180|451207731|FG000|Overall Study|Pregnancy|0|||
125431738|NCT04522180|451207732|FG001|Overall Study|Pregnancy|1|||
125431739|NCT04522180|451207731|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
125431740|NCT04522180|451207732|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
125431741|NCT04522180|451207731|FG000|Overall Study|Reason not specified|8|||
125605873|NCT06094296|451842256|FG002|Overall Study|Progressive Disease|0|||
125431742|NCT04522180|451207732|FG001|Overall Study|Reason not specified|5|||
125431743|NCT01905046|451207733|FG000|Months 13-24|Withdrawal by Subject|10|||
125431744|NCT01905046|451207734|FG001|Months 13-24|Withdrawal by Subject|10|||
125605874|NCT06094296|451842257|FG003|Overall Study|Progressive Disease|0|||
125605875|NCT03332667|451842258|FG000|Overall Study|Adverse Event|0|||
125605876|NCT03332667|451842259|FG001|Overall Study|Adverse Event|0|||
125605877|NCT03332667|451842260|FG002|Overall Study|Adverse Event|2|||
125605878|NCT03332667|451842261|FG003|Overall Study|Adverse Event|1|||
125605879|NCT03332667|451842258|FG000|Overall Study|Withdrawal by Subject|2|||
125605880|NCT03332667|451842259|FG001|Overall Study|Withdrawal by Subject|1|||
125605881|NCT03332667|451842260|FG002|Overall Study|Withdrawal by Subject|5|||
125605882|NCT03332667|451842261|FG003|Overall Study|Withdrawal by Subject|1|||
125605883|NCT03332667|451842258|FG000|Overall Study|Disease Progression or Relapse|2|||
125605884|NCT03332667|451842259|FG001|Overall Study|Disease Progression or Relapse|1|||
125605885|NCT03332667|451842260|FG002|Overall Study|Disease Progression or Relapse|3|||
125605886|NCT03332667|451842261|FG003|Overall Study|Disease Progression or Relapse|0|||
125605887|NCT03332667|451842258|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
125605888|NCT03332667|451842259|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
125605889|NCT03332667|451842260|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
125605890|NCT03332667|451842261|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
125605891|NCT03332667|451842258|FG000|Overall Study|No Treatment Received|0|||
125605892|NCT03332667|451842259|FG001|Overall Study|No Treatment Received|0|||
125605893|NCT03332667|451842260|FG002|Overall Study|No Treatment Received|1|||
125605894|NCT03332667|451842261|FG003|Overall Study|No Treatment Received|0|||
125605895|NCT01035606|451842262|FG000|Overall Study|change in health, job demands,family|3|||
125605896|NCT01035606|451842263|FG001|Overall Study|change in health, job demands,family|3|||
125605897|NCT01035606|451842264|FG002|Overall Study|change in health, job demands,family|4|||
125605898|NCT01809262|451842265|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
125605899|NCT01809262|451842266|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
125605900|NCT01809262|451842267|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
125605901|NCT01809262|451842268|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
125605902|NCT01809262|451842269|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
125605903|NCT01809262|451842270|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
125605904|NCT01809262|451842271|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
125605905|NCT01809262|451842272|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
125605906|NCT01809262|451842273|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
125605907|NCT01809262|451842274|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
125605908|NCT01809262|451842265|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125605909|NCT01809262|451842266|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
125605910|NCT01809262|451842267|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125605911|NCT01809262|451842268|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125605912|NCT01809262|451842269|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125605913|NCT01809262|451842270|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125605914|NCT01809262|451842271|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125605915|NCT01809262|451842272|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125605916|NCT01809262|451842273|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125605917|NCT01809262|451842274|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
125605918|NCT02064439|451842276|FG000|Overall Study|Adverse Event|51|||
125605919|NCT02064439|451842277|FG001|Overall Study|Adverse Event|47|||
125605920|NCT02064439|451842278|FG002|Overall Study|Adverse Event|46|||
125605921|NCT02064439|451842276|FG000|Overall Study|Death|0|||
125605922|NCT02064439|451842277|FG001|Overall Study|Death|2|||
125605923|NCT02064439|451842278|FG002|Overall Study|Death|3|||
125605924|NCT02064439|451842276|FG000|Overall Study|Withdrawal by Subject|29|||
125605925|NCT02064439|451842277|FG001|Overall Study|Withdrawal by Subject|18|||
125605926|NCT02064439|451842278|FG002|Overall Study|Withdrawal by Subject|26|||
125605927|NCT02064439|451842276|FG000|Overall Study|Protocol Violation|3|||
125605928|NCT02064439|451842277|FG001|Overall Study|Protocol Violation|5|||
125605929|NCT02064439|451842278|FG002|Overall Study|Protocol Violation|3|||
125605930|NCT02064439|451842276|FG000|Overall Study|Lost to Follow-up|1|||
125605931|NCT02064439|451842277|FG001|Overall Study|Lost to Follow-up|3|||
125605932|NCT02064439|451842278|FG002|Overall Study|Lost to Follow-up|4|||
125605933|NCT02064439|451842276|FG000|Overall Study|Non-compliance with study medication|21|||
125605934|NCT02064439|451842277|FG001|Overall Study|Non-compliance with study medication|19|||
125605935|NCT02064439|451842278|FG002|Overall Study|Non-compliance with study medication|23|||
125605936|NCT02064439|451842276|FG000|Overall Study|Physician Decision|0|||
125605937|NCT02064439|451842277|FG001|Overall Study|Physician Decision|1|||
125605938|NCT02064439|451842278|FG002|Overall Study|Physician Decision|1|||
125605939|NCT02064439|451842276|FG000|Overall Study|Logistical difficulties|6|||
125605940|NCT02064439|451842277|FG001|Overall Study|Logistical difficulties|5|||
125605941|NCT02064439|451842278|FG002|Overall Study|Logistical difficulties|2|||
125605942|NCT02064439|451842276|FG000|Overall Study|Efficacy outcome reached|18|||
125605943|NCT02064439|451842277|FG001|Overall Study|Efficacy outcome reached|16|||
125605944|NCT02064439|451842278|FG002|Overall Study|Efficacy outcome reached|57|||
125605945|NCT02064439|451842276|FG000|Overall Study|Safety outcome reached|12|||
125605946|NCT02064439|451842277|FG001|Overall Study|Safety outcome reached|20|||
125605947|NCT02064439|451842278|FG002|Overall Study|Safety outcome reached|10|||
125605948|NCT02064439|451842276|FG000|Overall Study|Other|2|||
125605949|NCT02064439|451842277|FG001|Overall Study|Other|2|||
125605950|NCT02064439|451842278|FG002|Overall Study|Other|7|||
125605951|NCT01120093|451842283|FG000|Treatment Period 1|Adverse Event|0|||
125605952|NCT01120093|451842284|FG001|Treatment Period 1|Adverse Event|0|||
125605953|NCT01120093|451842285|FG002|Treatment Period 1|Adverse Event|1|||
125605954|NCT01120093|451842286|FG003|Treatment Period 1|Adverse Event|0|||
125605955|NCT01120093|451842287|FG004|Treatment Period 1|Adverse Event|1|||
125605956|NCT01120093|451842283|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125605957|NCT01120093|451842284|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125605958|NCT01120093|451842285|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125605959|NCT01120093|451842286|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125605960|NCT01120093|451842287|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125605961|NCT01120093|451842283|FG000|Treatment Period 2|Adverse Event|0|||
125605962|NCT01120093|451842284|FG001|Treatment Period 2|Adverse Event|0|||
125605963|NCT01120093|451842285|FG002|Treatment Period 2|Adverse Event|0|||
125605964|NCT01120093|451842286|FG003|Treatment Period 2|Adverse Event|1|||
125605965|NCT01120093|451842287|FG004|Treatment Period 2|Adverse Event|0|||
125605966|NCT01120093|451842283|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125605967|NCT01120093|451842284|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125605968|NCT01120093|451842285|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125605969|NCT01120093|451842286|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125605970|NCT01120093|451842287|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125605971|NCT01120093|451842283|FG000|Treatment Period 3|Lack of Efficacy|0|||
125605972|NCT01120093|451842284|FG001|Treatment Period 3|Lack of Efficacy|0|||
125605973|NCT01120093|451842285|FG002|Treatment Period 3|Lack of Efficacy|0|||
125605974|NCT01120093|451842286|FG003|Treatment Period 3|Lack of Efficacy|1|||
125605975|NCT01120093|451842287|FG004|Treatment Period 3|Lack of Efficacy|0|||
125605976|NCT01120093|451842283|FG000|Treatment Period 3|Adverse Event|0|||
125605977|NCT01120093|451842284|FG001|Treatment Period 3|Adverse Event|0|||
125605978|NCT01120093|451842285|FG002|Treatment Period 3|Adverse Event|0|||
125605979|NCT01120093|451842286|FG003|Treatment Period 3|Adverse Event|0|||
125605980|NCT01120093|451842287|FG004|Treatment Period 3|Adverse Event|1|||
125605981|NCT01120093|451842283|FG000|Treatment Period 3|Withdrawal by Subject|0|||
125605982|NCT01120093|451842284|FG001|Treatment Period 3|Withdrawal by Subject|0|||
125605983|NCT01120093|451842285|FG002|Treatment Period 3|Withdrawal by Subject|1|||
125605984|NCT01120093|451842286|FG003|Treatment Period 3|Withdrawal by Subject|0|||
125605985|NCT01120093|451842287|FG004|Treatment Period 3|Withdrawal by Subject|0|||
125605986|NCT01120093|451842283|FG000|Treatment Period 4|Adverse Event|1|||
125605987|NCT01120093|451842284|FG001|Treatment Period 4|Adverse Event|0|||
125605988|NCT01120093|451842285|FG002|Treatment Period 4|Adverse Event|0|||
125605989|NCT01120093|451842286|FG003|Treatment Period 4|Adverse Event|0|||
125605990|NCT01120093|451842287|FG004|Treatment Period 4|Adverse Event|0|||
125605991|NCT01120093|451842283|FG000|Treatment Period 5|Adverse Event|0|||
125605992|NCT01120093|451842284|FG001|Treatment Period 5|Adverse Event|1|||
125605993|NCT01120093|451842285|FG002|Treatment Period 5|Adverse Event|0|||
125605994|NCT01120093|451842286|FG003|Treatment Period 5|Adverse Event|1|||
125605995|NCT01120093|451842287|FG004|Treatment Period 5|Adverse Event|0|||
125369882|NCT00369824|450987106|FG002|Overall Study|Lost to Follow-up|7|||
125369883|NCT00369824|450987107|FG003|Overall Study|Lost to Follow-up|8|||
125369884|NCT00369824|450987108|FG004|Overall Study|Lost to Follow-up|9|||
125369885|NCT00369824|450987109|FG005|Overall Study|Lost to Follow-up|6|||
125369886|NCT00369824|450987104|FG000|Overall Study|Other|0|||
125369887|NCT00369824|450987105|FG001|Overall Study|Other|0|||
125369888|NCT00369824|450987106|FG002|Overall Study|Other|0|||
125605996|NCT02389816|451842292|FG000|Overall Study|Randomized but Not Treated|1|||
125605997|NCT02389816|451842293|FG001|Overall Study|Randomized but Not Treated|0|||
125605998|NCT02389816|451842294|FG002|Overall Study|Randomized but Not Treated|0|||
125605999|NCT02389816|451842292|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
125606000|NCT02389816|451842293|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
125606001|NCT02389816|451842294|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
125606002|NCT02389816|451842292|FG000|Overall Study|Major Protocol Deviation|1|||
125606003|NCT02389816|451842293|FG001|Overall Study|Major Protocol Deviation|0|||
125606004|NCT02389816|451842294|FG002|Overall Study|Major Protocol Deviation|0|||
125606005|NCT02389816|451842292|FG000|Overall Study|Lost to Follow-up|1|||
125606006|NCT02389816|451842293|FG001|Overall Study|Lost to Follow-up|0|||
125606007|NCT02389816|451842294|FG002|Overall Study|Lost to Follow-up|0|||
125606008|NCT02389816|451842292|FG000|Overall Study|Withdrawal of Consent|6|||
125606009|NCT02389816|451842293|FG001|Overall Study|Withdrawal of Consent|4|||
125606010|NCT02389816|451842294|FG002|Overall Study|Withdrawal of Consent|4|||
125606011|NCT02389816|451842292|FG000|Overall Study|Lack of Efficacy|1|||
125606012|NCT02389816|451842293|FG001|Overall Study|Lack of Efficacy|0|||
125606013|NCT02389816|451842294|FG002|Overall Study|Lack of Efficacy|0|||
125606014|NCT02389816|451842292|FG000|Overall Study|Non Compliance with Study Drug|1|||
125606015|NCT02389816|451842293|FG001|Overall Study|Non Compliance with Study Drug|1|||
125606016|NCT02389816|451842294|FG002|Overall Study|Non Compliance with Study Drug|1|||
125606017|NCT02389816|451842292|FG000|Overall Study|Reason not Specified|0|||
125606018|NCT02389816|451842293|FG001|Overall Study|Reason not Specified|2|||
125606019|NCT02389816|451842294|FG002|Overall Study|Reason not Specified|0|||
125606020|NCT02417233|451842295|FG000|Overall Study|Death|4|||
125606021|NCT02417233|451842296|FG001|Overall Study|Death|10|||
125606022|NCT02417233|451842297|FG002|Overall Study|Death|14|||
125606023|NCT02417233|451842295|FG000|Overall Study|Lost to Follow-up|27|||
125606024|NCT02417233|451842296|FG001|Overall Study|Lost to Follow-up|39|||
125606025|NCT02417233|451842297|FG002|Overall Study|Lost to Follow-up|34|||
125606026|NCT02417233|451842295|FG000|Overall Study|Protocol Violation|2|||
125369889|NCT00369824|450987107|FG003|Overall Study|Other|2|||
125369890|NCT00369824|450987108|FG004|Overall Study|Other|1|||
125369891|NCT00369824|450987109|FG005|Overall Study|Other|3|||
125369892|NCT01390649|450987110|FG000|Overall Study|Physician Decision|1|||
125606027|NCT02417233|451842296|FG001|Overall Study|Protocol Violation|0|||
125606028|NCT02417233|451842297|FG002|Overall Study|Protocol Violation|2|||
125369893|NCT03385564|450987112|FG000|Overall Study|Adverse Event|0|||
125369894|NCT03385564|450987113|FG001|Overall Study|Adverse Event|0|||
125369895|NCT03385564|450987114|FG002|Overall Study|Adverse Event|3|||
125369896|NCT03385564|450987115|FG003|Overall Study|Adverse Event|3|||
125369897|NCT03385564|450987112|FG000|Overall Study|Other than listed|0|||
125369898|NCT03385564|450987113|FG001|Overall Study|Other than listed|0|||
125369899|NCT03385564|450987114|FG002|Overall Study|Other than listed|0|||
125369900|NCT03385564|450987115|FG003|Overall Study|Other than listed|5|||
125369901|NCT03385564|450987112|FG000|Overall Study|Withdrawal by Subject|0|||
125369902|NCT03385564|450987113|FG001|Overall Study|Withdrawal by Subject|1|||
125369903|NCT03385564|450987114|FG002|Overall Study|Withdrawal by Subject|1|||
125369904|NCT03385564|450987115|FG003|Overall Study|Withdrawal by Subject|0|||
125369905|NCT03385564|450987112|FG000|Overall Study|Lack of Efficacy|0|||
125369906|NCT03385564|450987113|FG001|Overall Study|Lack of Efficacy|0|||
125369907|NCT03385564|450987114|FG002|Overall Study|Lack of Efficacy|0|||
125606029|NCT02417233|451842295|FG000|Overall Study|Withdrawal by Subject|2|||
125606030|NCT02417233|451842296|FG001|Overall Study|Withdrawal by Subject|1|||
125606031|NCT02417233|451842297|FG002|Overall Study|Withdrawal by Subject|8|||
125606032|NCT02417233|451842295|FG000|Overall Study|Relocation out of study area|1|||
125606033|NCT02417233|451842296|FG001|Overall Study|Relocation out of study area|0|||
125606034|NCT02417233|451842297|FG002|Overall Study|Relocation out of study area|1|||
125606035|NCT02417233|451842295|FG000|Overall Study|Mentally unstable|0|||
125606036|NCT02417233|451842296|FG001|Overall Study|Mentally unstable|1|||
125606037|NCT02417233|451842297|FG002|Overall Study|Mentally unstable|0|||
125606038|NCT03649321|451842298|FG000|Overall Study|Withdrawal by Subject|1|||
125606039|NCT03649321|451842299|FG001|Overall Study|Withdrawal by Subject|0|||
125606040|NCT03649321|451842298|FG000|Overall Study|Death|1|||
125606041|NCT03649321|451842299|FG001|Overall Study|Death|0|||
125606042|NCT01702363|451842300|FG000|Overall Study|Adverse Event|14|||
125606043|NCT01702363|451842300|FG000|Overall Study|Lack of Efficacy|4|||
125606044|NCT01702363|451842300|FG000|Overall Study|Withdrawal by Subject|2|||
125606045|NCT01293032|451842301|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
125606046|NCT01293032|451842302|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
125606047|NCT01293032|451842303|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
125606048|NCT01293032|451842304|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
125606049|NCT01293032|451842301|FG000|Treatment|Adverse Event|0|||
125606050|NCT01293032|451842302|FG001|Treatment|Adverse Event|0|||
125606051|NCT01293032|451842303|FG002|Treatment|Adverse Event|1|||
125606052|NCT01293032|451842304|FG003|Treatment|Adverse Event|1|||
125606053|NCT01293032|451842301|FG000|Treatment|Withdrawal by Subject|2|||
125606054|NCT01293032|451842302|FG001|Treatment|Withdrawal by Subject|4|||
125606055|NCT01293032|451842303|FG002|Treatment|Withdrawal by Subject|0|||
125606056|NCT01293032|451842304|FG003|Treatment|Withdrawal by Subject|0|||
125606057|NCT01293032|451842301|FG000|Treatment|Disease Progression, relapse|0|||
125606058|NCT01293032|451842302|FG001|Treatment|Disease Progression, relapse|1|||
125606059|NCT01293032|451842303|FG002|Treatment|Disease Progression, relapse|0|||
125606060|NCT01293032|451842304|FG003|Treatment|Disease Progression, relapse|0|||
125606061|NCT02184143|451842311|FG000|Overall Study|Withdrawal by Subject|4|||
125606062|NCT02184143|451842312|FG001|Overall Study|Withdrawal by Subject|4|||
125606063|NCT02184143|451842311|FG000|Overall Study|Lost to Follow-up|5|||
125606064|NCT02184143|451842312|FG001|Overall Study|Lost to Follow-up|3|||
125606065|NCT02184143|451842311|FG000|Overall Study|Death|1|||
125606066|NCT02184143|451842312|FG001|Overall Study|Death|0|||
125606067|NCT00321984|451842313|FG000|Overall Study|Adverse Event|9|||
125606068|NCT00321984|451842314|FG001|Overall Study|Adverse Event|6|||
125606069|NCT00321984|451842315|FG002|Overall Study|Adverse Event|8|||
125606070|NCT00321984|451842313|FG000|Overall Study|Protocol Violation|0|||
125606071|NCT00321984|451842314|FG001|Overall Study|Protocol Violation|1|||
125606072|NCT00321984|451842315|FG002|Overall Study|Protocol Violation|1|||
125606073|NCT00321984|451842313|FG000|Overall Study|Lost to Follow-up|2|||
125606074|NCT00321984|451842314|FG001|Overall Study|Lost to Follow-up|4|||
125606075|NCT00321984|451842315|FG002|Overall Study|Lost to Follow-up|2|||
125606076|NCT00321984|451842313|FG000|Overall Study|Withdrawal by Subject|8|||
125606077|NCT00321984|451842314|FG001|Overall Study|Withdrawal by Subject|6|||
125606078|NCT00321984|451842315|FG002|Overall Study|Withdrawal by Subject|5|||
125369908|NCT03385564|450987115|FG003|Overall Study|Lack of Efficacy|1|||
125369909|NCT03385564|450987112|FG000|Overall Study|Death|0|||
125369910|NCT03385564|450987113|FG001|Overall Study|Death|0|||
125369911|NCT03385564|450987114|FG002|Overall Study|Death|1|||
125606079|NCT00321984|451842313|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
125606080|NCT00321984|451842314|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
125606081|NCT00321984|451842315|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
125606082|NCT00321984|451842313|FG000|Overall Study|Lack of Efficacy|3|||
125606083|NCT00321984|451842314|FG001|Overall Study|Lack of Efficacy|1|||
125606084|NCT00321984|451842315|FG002|Overall Study|Lack of Efficacy|3|||
125606085|NCT00321984|451842313|FG000|Overall Study|Noncompliant|0|||
125606086|NCT00321984|451842314|FG001|Overall Study|Noncompliant|0|||
125606087|NCT00321984|451842315|FG002|Overall Study|Noncompliant|2|||
125369912|NCT03385564|450987115|FG003|Overall Study|Death|0|||
125369913|NCT00622401|450987116|FG000|Overall Study|Disease progression prior to treatment|3|||
125369914|NCT00622401|450987117|FG001|Overall Study|Disease progression prior to treatment|2|||
125369915|NCT00622401|450987118|FG002|Overall Study|Disease progression prior to treatment|0|||
125369916|NCT03087643|450987126|FG000|Overall Study|Withdrawal by Subject|2|||
125369917|NCT03087643|450987127|FG001|Overall Study|Withdrawal by Subject|4|||
125369918|NCT03087643|450987126|FG000|Overall Study|Death|2|||
125369919|NCT03087643|450987127|FG001|Overall Study|Death|2|||
125369920|NCT02083783|450987131|FG000|Overall Study|Withdrawal by Subject|1|||
125369921|NCT02083783|450987132|FG001|Overall Study|Withdrawal by Subject|0|||
125369922|NCT01546883|450987135|FG000|Overall Study|Withdrawal by Subject|3|||
125369923|NCT01546883|450987135|FG000|Overall Study|Adverse Event|4|||
125369924|NCT01546883|450987135|FG000|Overall Study|Lost to Follow-up|2|||
125369925|NCT01546883|450987135|FG000|Overall Study|early closure of study|2|||
125369926|NCT01546883|450987135|FG000|Overall Study|other unrelated illness|1|||
125369927|NCT02256631|450987139|FG000|Overall Study|Lost to Follow-up|1|||
125369928|NCT02256631|450987140|FG001|Overall Study|Lost to Follow-up|1|||
125369929|NCT02256631|450987141|FG002|Overall Study|Lost to Follow-up|0|||
125606088|NCT00321984|451842313|FG000|Overall Study|Pregnancy|0|||
125606089|NCT00321984|451842314|FG001|Overall Study|Pregnancy|1|||
125606090|NCT00321984|451842315|FG002|Overall Study|Pregnancy|0|||
125606091|NCT00321984|451842313|FG000|Overall Study|Per Subject Request|1|||
125606092|NCT00321984|451842314|FG001|Overall Study|Per Subject Request|0|||
125606093|NCT00321984|451842315|FG002|Overall Study|Per Subject Request|0|||
125606094|NCT00321984|451842313|FG000|Overall Study|Per Investigator Request|1|||
125606095|NCT00321984|451842314|FG001|Overall Study|Per Investigator Request|0|||
125606096|NCT00321984|451842315|FG002|Overall Study|Per Investigator Request|0|||
125606097|NCT00321984|451842313|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
125606098|NCT00321984|451842314|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
125606099|NCT00321984|451842315|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
125606100|NCT02985450|451842322|FG000|Overall Study|Lost to Follow-up|7|||
125606101|NCT00431847|451842325|FG000|Overall Study|completion of less than two study visits|6|||
125606102|NCT00431847|451842326|FG001|Overall Study|completion of less than two study visits|3|||
125606103|NCT00431847|451842327|FG002|Overall Study|completion of less than two study visits|4|||
125606104|NCT00431847|451842328|FG003|Overall Study|completion of less than two study visits|14|||
125606105|NCT00431847|451842329|FG004|Overall Study|completion of less than two study visits|0|||
125606106|NCT00431847|451842325|FG000|Overall Study|Protocol Violation|0|||
125606107|NCT00431847|451842326|FG001|Overall Study|Protocol Violation|0|||
125606108|NCT00431847|451842327|FG002|Overall Study|Protocol Violation|0|||
125606109|NCT00431847|451842328|FG003|Overall Study|Protocol Violation|0|||
125606110|NCT00431847|451842329|FG004|Overall Study|Protocol Violation|1|||
125606111|NCT01469013|451842330|FG000|Part A (Treatment Period)|Adverse Event|1|||
125606112|NCT01469013|451842331|FG001|Part A (Treatment Period)|Adverse Event|0|||
125606113|NCT01469013|451842332|FG002|Part A (Treatment Period)|Adverse Event|0|||
125606114|NCT01469013|451842333|FG003|Part A (Treatment Period)|Adverse Event|0|||
125606115|NCT01469013|451842334|FG004|Part A (Treatment Period)|Adverse Event|1|||
125606116|NCT01469013|451842335|FG005|Part A (Treatment Period)|Adverse Event|0|||
125606117|NCT01469013|451842336|FG006|Part A (Treatment Period)|Adverse Event|0|||
125606118|NCT01469013|451842337|FG007|Part A (Treatment Period)|Adverse Event|0|||
125606119|NCT01469013|451842338|FG008|Part A (Treatment Period)|Adverse Event|0|||
125606120|NCT01469013|451842339|FG009|Part A (Treatment Period)|Adverse Event|0|||
125606121|NCT01469013|451842340|FG010|Part A (Treatment Period)|Adverse Event|0|||
125606122|NCT01469013|451842341|FG011|Part A (Treatment Period)|Adverse Event|0|||
125606123|NCT01469013|451842342|FG012|Part A (Treatment Period)|Adverse Event|0|||
125606124|NCT01469013|451842330|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
125606125|NCT01469013|451842331|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
125606126|NCT01469013|451842332|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
125606127|NCT01469013|451842333|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
125606128|NCT01469013|451842334|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
125606129|NCT01469013|451842335|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
125606130|NCT01469013|451842336|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
125606131|NCT01469013|451842337|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
125606132|NCT01469013|451842338|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
125606133|NCT01469013|451842339|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
125606134|NCT01469013|451842340|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
125606135|NCT01469013|451842341|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
125606136|NCT01469013|451842342|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
125606137|NCT01469013|451842330|FG000|Part B (Extension Period)|Adverse Event|0|||
125606138|NCT01469013|451842331|FG001|Part B (Extension Period)|Adverse Event|0|||
125606139|NCT01469013|451842332|FG002|Part B (Extension Period)|Adverse Event|0|||
125369930|NCT02256631|450987142|FG003|Overall Study|Lost to Follow-up|2|||
125369931|NCT02256631|450987143|FG004|Overall Study|Lost to Follow-up|0|||
125606140|NCT01469013|451842333|FG003|Part B (Extension Period)|Adverse Event|0|||
125606141|NCT01469013|451842334|FG004|Part B (Extension Period)|Adverse Event|0|||
125606142|NCT01469013|451842335|FG005|Part B (Extension Period)|Adverse Event|2|||
125606143|NCT01469013|451842336|FG006|Part B (Extension Period)|Adverse Event|5|||
125606144|NCT01469013|451842337|FG007|Part B (Extension Period)|Adverse Event|5|||
125606145|NCT01469013|451842338|FG008|Part B (Extension Period)|Adverse Event|3|||
125606146|NCT01469013|451842339|FG009|Part B (Extension Period)|Adverse Event|3|||
125606147|NCT01469013|451842340|FG010|Part B (Extension Period)|Adverse Event|1|||
125606148|NCT01469013|451842341|FG011|Part B (Extension Period)|Adverse Event|6|||
125606149|NCT01469013|451842342|FG012|Part B (Extension Period)|Adverse Event|3|||
125606150|NCT01469013|451842330|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
125606151|NCT01469013|451842331|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
125606152|NCT01469013|451842332|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
125606153|NCT01469013|451842333|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
125606154|NCT01469013|451842334|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
125606155|NCT01469013|451842335|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
125606156|NCT01469013|451842336|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
125606157|NCT01469013|451842337|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
125606158|NCT01469013|451842338|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
125606159|NCT01469013|451842339|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
125606160|NCT01469013|451842340|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
125606161|NCT01469013|451842341|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
125606162|NCT01469013|451842342|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
125606163|NCT00002663|451842343|FG000|Overall Study|Death|4|||
125606164|NCT00002663|451842344|FG001|Overall Study|Death|1|||
125606165|NCT00002663|451842345|FG002|Overall Study|Death|1|||
125606166|NCT00002663|451842346|FG003|Overall Study|Death|0|||
125606167|NCT00002663|451842347|FG004|Overall Study|Death|0|||
125606168|NCT00002663|451842348|FG005|Overall Study|Death|13|||
125606169|NCT00002663|451842349|FG006|Overall Study|Death|0|||
125606170|NCT00002663|451842350|FG007|Overall Study|Death|1|||
125606171|NCT00002663|451842351|FG008|Overall Study|Death|1|||
125606172|NCT00002663|451842352|FG009|Overall Study|Death|1|||
125606173|NCT00002663|451842343|FG000|Overall Study|Lost to Follow-up|3|||
125606174|NCT00002663|451842344|FG001|Overall Study|Lost to Follow-up|0|||
125606175|NCT00002663|451842345|FG002|Overall Study|Lost to Follow-up|0|||
125606176|NCT00002663|451842346|FG003|Overall Study|Lost to Follow-up|1|||
125606177|NCT00002663|451842347|FG004|Overall Study|Lost to Follow-up|0|||
125606178|NCT00002663|451842348|FG005|Overall Study|Lost to Follow-up|1|||
125606179|NCT00002663|451842349|FG006|Overall Study|Lost to Follow-up|0|||
125606180|NCT00002663|451842350|FG007|Overall Study|Lost to Follow-up|0|||
125606181|NCT00002663|451842351|FG008|Overall Study|Lost to Follow-up|0|||
125606182|NCT00002663|451842352|FG009|Overall Study|Lost to Follow-up|0|||
125606183|NCT00002663|451842343|FG000|Overall Study|Other|0|||
125606184|NCT00002663|451842344|FG001|Overall Study|Other|1|||
125606185|NCT00002663|451842345|FG002|Overall Study|Other|0|||
125606186|NCT00002663|451842346|FG003|Overall Study|Other|0|||
125606187|NCT00002663|451842347|FG004|Overall Study|Other|0|||
125606188|NCT00002663|451842348|FG005|Overall Study|Other|1|||
125606189|NCT00002663|451842349|FG006|Overall Study|Other|1|||
125606190|NCT00002663|451842350|FG007|Overall Study|Other|0|||
125606191|NCT00002663|451842351|FG008|Overall Study|Other|0|||
125369932|NCT02256631|450987144|FG005|Overall Study|Lost to Follow-up|4|||
125369933|NCT02256631|450987145|FG006|Overall Study|Lost to Follow-up|1|||
125369934|NCT02256631|450987139|FG000|Overall Study|Withdrawal by Subject|0|||
125369935|NCT02256631|450987140|FG001|Overall Study|Withdrawal by Subject|0|||
125369936|NCT02256631|450987141|FG002|Overall Study|Withdrawal by Subject|0|||
125369937|NCT02256631|450987142|FG003|Overall Study|Withdrawal by Subject|1|||
125369938|NCT02256631|450987143|FG004|Overall Study|Withdrawal by Subject|1|||
125369939|NCT02256631|450987144|FG005|Overall Study|Withdrawal by Subject|0|||
125369940|NCT02256631|450987145|FG006|Overall Study|Withdrawal by Subject|1|||
125369941|NCT02256631|450987139|FG000|Overall Study|Unable to get to clinic|0|||
125369942|NCT02256631|450987140|FG001|Overall Study|Unable to get to clinic|2|||
125369943|NCT02256631|450987141|FG002|Overall Study|Unable to get to clinic|0|||
125431745|NCT01905046|451207733|FG000|Months 13-24|Adverse Event|3|||
125606192|NCT00002663|451842352|FG009|Overall Study|Other|0|||
125606193|NCT00002663|451842343|FG000|Overall Study|Physician Decision|0|||
125606194|NCT00002663|451842344|FG001|Overall Study|Physician Decision|0|||
125606195|NCT00002663|451842345|FG002|Overall Study|Physician Decision|0|||
125606196|NCT00002663|451842346|FG003|Overall Study|Physician Decision|0|||
125369944|NCT02256631|450987142|FG003|Overall Study|Unable to get to clinic|1|||
125369945|NCT02256631|450987143|FG004|Overall Study|Unable to get to clinic|0|||
125606197|NCT00002663|451842347|FG004|Overall Study|Physician Decision|1|||
125606198|NCT00002663|451842348|FG005|Overall Study|Physician Decision|0|||
125369946|NCT02256631|450987144|FG005|Overall Study|Unable to get to clinic|1|||
125606199|NCT00002663|451842349|FG006|Overall Study|Physician Decision|0|||
125606200|NCT00002663|451842350|FG007|Overall Study|Physician Decision|0|||
125606201|NCT00002663|451842351|FG008|Overall Study|Physician Decision|1|||
125606202|NCT00002663|451842352|FG009|Overall Study|Physician Decision|1|||
125606203|NCT00002663|451842343|FG000|Overall Study|Adverse Event|0|||
125606204|NCT00002663|451842344|FG001|Overall Study|Adverse Event|0|||
125606205|NCT00002663|451842345|FG002|Overall Study|Adverse Event|0|||
125606206|NCT00002663|451842346|FG003|Overall Study|Adverse Event|1|||
125606207|NCT00002663|451842347|FG004|Overall Study|Adverse Event|0|||
125606208|NCT00002663|451842348|FG005|Overall Study|Adverse Event|0|||
125606209|NCT00002663|451842349|FG006|Overall Study|Adverse Event|0|||
125606210|NCT00002663|451842350|FG007|Overall Study|Adverse Event|1|||
125606211|NCT00002663|451842351|FG008|Overall Study|Adverse Event|0|||
125606212|NCT00002663|451842352|FG009|Overall Study|Adverse Event|0|||
125606213|NCT01603641|451842356|FG000|Overall Study|Did not Receive Treatment|3|||
125606214|NCT01603641|451842356|FG000|Overall Study|Adverse Event|1|||
125606215|NCT01603641|451842356|FG000|Overall Study|Lack of Efficacy|1|||
125606216|NCT01603641|451842356|FG000|Overall Study|Lost to Follow-up|6|||
125606217|NCT01603641|451842356|FG000|Overall Study|Personal Reasons|18|||
125606218|NCT01603641|451842356|FG000|Overall Study|Other Miscellaneous Reasons|6|||
125606219|NCT03161678|451842357|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
125606220|NCT03161678|451842358|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
125606221|NCT03161678|451842359|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
125606222|NCT03161678|451842360|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
125606223|NCT03161678|451842361|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
125606224|NCT03161678|451842362|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
125606225|NCT03161678|451842357|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
125606226|NCT03161678|451842358|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
125606227|NCT03161678|451842359|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
125606228|NCT03161678|451842360|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
125606229|NCT03161678|451842361|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
125606230|NCT03161678|451842362|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
125606231|NCT03161678|451842357|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
125606232|NCT03161678|451842358|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
125606233|NCT03161678|451842359|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
125606234|NCT03161678|451842360|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
125606235|NCT03161678|451842361|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
125606236|NCT03161678|451842362|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
125606237|NCT03161678|451842357|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
125606238|NCT03161678|451842358|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
125606239|NCT03161678|451842359|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
125606240|NCT03161678|451842360|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
125606241|NCT03161678|451842361|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
125606242|NCT03161678|451842362|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
125606243|NCT00739297|451842363|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
125606244|NCT00739297|451842364|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
125606245|NCT00739297|451842365|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
125606246|NCT00739297|451842366|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
125606247|NCT00739297|451842367|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
125606248|NCT00739297|451842368|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
125606249|NCT00739297|451842369|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
125606250|NCT00739297|451842363|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
125606251|NCT00739297|451842364|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
125606252|NCT00739297|451842365|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
125606253|NCT00739297|451842366|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
125606254|NCT00739297|451842367|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
125606255|NCT00739297|451842368|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
125606256|NCT00739297|451842369|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
125606257|NCT01757704|451842370|FG000|Overall Study|Protocol Violation|1|||
125606258|NCT01757704|451842371|FG001|Overall Study|Protocol Violation|3|||
125606259|NCT02749721|451842377|FG000|Screening|Withdrawal by Subject|1|||
125606260|NCT02749721|451842377|FG000|Screening|Lost to Follow-up|2|||
125606261|NCT02749721|451842377|FG000|Screening|Protocol Violation|3|||
125606262|NCT02749721|451842377|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
125606263|NCT02749721|451842377|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
125369947|NCT02256631|450987145|FG006|Overall Study|Unable to get to clinic|2|||
125369948|NCT01427972|450987146|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125369949|NCT01427972|450987147|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125369950|NCT01427972|450987148|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125369951|NCT01427972|450987149|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125369952|NCT01427972|450987150|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125369953|NCT01427972|450987151|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125369954|NCT01427972|450987152|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125606264|NCT02137772|451842378|FG000|Overall Study|Adverse Event|6|||
125606265|NCT02137772|451842379|FG001|Overall Study|Adverse Event|3|||
125606266|NCT02137772|451842378|FG000|Overall Study|Death|71|||
125606267|NCT02137772|451842379|FG001|Overall Study|Death|44|||
125431746|NCT01905046|451207734|FG001|Months 13-24|Adverse Event|2|||
125606268|NCT02137772|451842378|FG000|Overall Study|Lost to Follow-up|8|||
125606269|NCT02137772|451842379|FG001|Overall Study|Lost to Follow-up|4|||
125606270|NCT02137772|451842378|FG000|Overall Study|Physician Decision|15|||
125606271|NCT02137772|451842379|FG001|Overall Study|Physician Decision|5|||
125606272|NCT02137772|451842378|FG000|Overall Study|Withdrawal by Subject|28|||
125606273|NCT02137772|451842379|FG001|Overall Study|Withdrawal by Subject|17|||
125606274|NCT02137772|451842378|FG000|Overall Study|Non-compliance with study drug|1|||
125606275|NCT02137772|451842379|FG001|Overall Study|Non-compliance with study drug|0|||
125606276|NCT02137772|451842378|FG000|Overall Study|Not treated|3|||
125606277|NCT02137772|451842379|FG001|Overall Study|Not treated|2|||
125431747|NCT01905046|451207733|FG000|Months 13-24|Protocol Violation|3|||
125431748|NCT01905046|451207734|FG001|Months 13-24|Protocol Violation|3|||
125431749|NCT01905046|451207733|FG000|Months 13-24|Physician Decision|1|||
125431750|NCT01905046|451207734|FG001|Months 13-24|Physician Decision|0|||
125431751|NCT03489057|451207739|FG000|Overall Study|Lost to Follow-up|16|||
125431752|NCT03489057|451207740|FG001|Overall Study|Lost to Follow-up|16|||
125431753|NCT03489057|451207741|FG002|Overall Study|Lost to Follow-up|14|||
125431754|NCT03489057|451207742|FG003|Overall Study|Lost to Follow-up|14|||
125431755|NCT03489057|451207739|FG000|Overall Study|Withdrawal by Subject|12|||
125431756|NCT03489057|451207740|FG001|Overall Study|Withdrawal by Subject|12|||
125431757|NCT03489057|451207741|FG002|Overall Study|Withdrawal by Subject|8|||
125431758|NCT03489057|451207742|FG003|Overall Study|Withdrawal by Subject|8|||
125431759|NCT03489057|451207739|FG000|Overall Study|Protocol Violation|7|||
125431760|NCT03489057|451207740|FG001|Overall Study|Protocol Violation|7|||
125431761|NCT03489057|451207741|FG002|Overall Study|Protocol Violation|2|||
125431762|NCT03489057|451207742|FG003|Overall Study|Protocol Violation|2|||
125431763|NCT01368900|451207745|FG000|Overall Study|Lost to Follow-up|7|||
125606278|NCT02691247|451842380|FG000|Overall Study|Withdrawal by Subject|1|||
125606279|NCT02691247|451842381|FG001|Overall Study|Withdrawal by Subject|2|||
125606280|NCT02691247|451842382|FG002|Overall Study|Withdrawal by Subject|2|||
125606281|NCT02691247|451842380|FG000|Overall Study|Lost to Follow-up|2|||
125606282|NCT02691247|451842381|FG001|Overall Study|Lost to Follow-up|0|||
125606283|NCT02691247|451842382|FG002|Overall Study|Lost to Follow-up|1|||
125606284|NCT00443430|451842384|FG000|Overall Study|Lack of Efficacy|3|||
125606285|NCT00443430|451842385|FG001|Overall Study|Lack of Efficacy|3|||
125606286|NCT00443430|451842384|FG000|Overall Study|Adverse Event|1|||
125606287|NCT00443430|451842385|FG001|Overall Study|Adverse Event|1|||
125606288|NCT00933335|451842389|FG000|Overall Study|Lost to Follow-up|1|||
125606289|NCT00933335|451842390|FG001|Overall Study|Lost to Follow-up|3|||
125606290|NCT00933335|451842389|FG000|Overall Study|Withdrawal by Subject|0|||
125606291|NCT00933335|451842390|FG001|Overall Study|Withdrawal by Subject|1|||
125606292|NCT00933335|451842389|FG000|Overall Study|Progressive Disease|0|||
125606293|NCT00933335|451842390|FG001|Overall Study|Progressive Disease|11|||
125606294|NCT00933335|451842389|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
125606295|NCT00933335|451842390|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
125606296|NCT00933335|451842389|FG000|Overall Study|Co-morbid Illness|1|||
125606297|NCT00933335|451842390|FG001|Overall Study|Co-morbid Illness|0|||
125606298|NCT02084134|451842395|FG000|Overall Study|Protocol Violation|4|||
125606299|NCT02084134|451842396|FG001|Overall Study|Protocol Violation|2|||
125606300|NCT02084134|451842395|FG000|Overall Study|Death|0|||
125606301|NCT02084134|451842396|FG001|Overall Study|Death|1|||
125606302|NCT01095250|451842402|FG000|Overall Study|administrative reasons|8|||
125606303|NCT01095250|451842403|FG001|Overall Study|administrative reasons|10|||
125606304|NCT01095250|451842404|FG002|Overall Study|administrative reasons|7|||
125606305|NCT01095250|451842405|FG003|Overall Study|administrative reasons|5|||
125606306|NCT01095250|451842402|FG000|Overall Study|Withdrawal by Subject|0|||
125606307|NCT01095250|451842403|FG001|Overall Study|Withdrawal by Subject|0|||
125606308|NCT01095250|451842404|FG002|Overall Study|Withdrawal by Subject|1|||
125606309|NCT01095250|451842405|FG003|Overall Study|Withdrawal by Subject|0|||
125606310|NCT04598165|451842406|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
125606311|NCT04598165|451842407|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
125606312|NCT04598165|451842406|FG000|Completed 6-week Follow-up|Death|2|||
125606313|NCT04598165|451842407|FG001|Completed 6-week Follow-up|Death|1|||
125606314|NCT04598165|451842406|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
125606315|NCT04598165|451842407|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
125606316|NCT04598165|451842406|FG000|Completed 6-week Follow-up|Ineligible|4|||
125606317|NCT04598165|451842407|FG001|Completed 6-week Follow-up|Ineligible|3|||
125606318|NCT04598165|451842406|FG000|Completed 6-week Follow-up|Partner refusal|0|||
125606319|NCT04598165|451842407|FG001|Completed 6-week Follow-up|Partner refusal|1|||
125606320|NCT04598165|451842406|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
125606321|NCT04598165|451842407|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
125606322|NCT01323673|451842408|FG000|Overall Study|Adverse Event|0|||
125606323|NCT01323673|451842409|FG001|Overall Study|Adverse Event|1|||
125606324|NCT01323673|451842408|FG000|Overall Study|Lost to Follow-up|0|||
125606325|NCT01323673|451842409|FG001|Overall Study|Lost to Follow-up|1|||
125606326|NCT01323673|451842408|FG000|Overall Study|Protocol Violation|1|||
125606327|NCT01323673|451842409|FG001|Overall Study|Protocol Violation|0|||
125606328|NCT01323673|451842408|FG000|Overall Study|Withdrawal by Subject|2|||
125606329|NCT01323673|451842409|FG001|Overall Study|Withdrawal by Subject|3|||
125606330|NCT00426751|451842410|FG000|Overall Study|Adverse Event|8|||
125606331|NCT00426751|451842411|FG001|Overall Study|Adverse Event|1|||
125606332|NCT00426751|451842410|FG000|Overall Study|Lost to Follow-up|7|||
125431764|NCT04027348|451207748|FG000|Overall Study|Adverse Event|2|||
125431765|NCT02487472|451207749|FG000|Overall Study|Did not complete telephonic interviews|9|||
125431766|NCT02487472|451207749|FG000|Overall Study|Other|2|||
125431767|NCT02277743|451207750|FG000|Overall Study|Protocol Violation|1|||
125431768|NCT02277743|451207751|FG001|Overall Study|Protocol Violation|1|||
125431769|NCT02277743|451207752|FG002|Overall Study|Protocol Violation|1|||
125606333|NCT00426751|451842411|FG001|Overall Study|Lost to Follow-up|6|||
125606334|NCT00426751|451842410|FG000|Overall Study|Consent Withdrawn|0|||
125606335|NCT00426751|451842411|FG001|Overall Study|Consent Withdrawn|1|||
125606336|NCT00426751|451842410|FG000|Overall Study|Other Reasons|7|||
125606337|NCT00426751|451842411|FG001|Overall Study|Other Reasons|12|||
125606338|NCT00747617|451843658|FG000|Overall Study|Lost to Follow-up|3|||
125606339|NCT00747617|451843659|FG001|Overall Study|Lost to Follow-up|1|||
125606340|NCT01746732|451843660|FG000|Lead-In Period|Withdrawal by Subject|1|||
125606341|NCT01746732|451843661|FG001|Lead-In Period|Withdrawal by Subject|0|||
125606342|NCT01746732|451843662|FG002|Lead-In Period|Withdrawal by Subject|0|||
125606343|NCT01746732|451843660|FG000|Period 1|Physician Decision|0|||
125606344|NCT01746732|451843661|FG001|Period 1|Physician Decision|1|||
125606345|NCT01746732|451843662|FG002|Period 1|Physician Decision|0|||
125606346|NCT01746732|451843660|FG000|Period 2|Withdrawal by Subject|0|||
125606347|NCT01746732|451843661|FG001|Period 2|Withdrawal by Subject|0|||
125606348|NCT01746732|451843662|FG002|Period 2|Withdrawal by Subject|2|||
125606349|NCT01746732|451843660|FG000|Period 2|Adverse Event|0|||
125606350|NCT01746732|451843661|FG001|Period 2|Adverse Event|0|||
125606351|NCT01746732|451843662|FG002|Period 2|Adverse Event|1|||
125606352|NCT01746732|451843660|FG000|Period 2|Lost to Follow-up|0|||
125606353|NCT01746732|451843661|FG001|Period 2|Lost to Follow-up|0|||
125606354|NCT01746732|451843662|FG002|Period 2|Lost to Follow-up|1|||
125606355|NCT02279524|451843663|FG000|Overall Study|Withdrawal by Subject|3|||
125606356|NCT02279524|451843664|FG001|Overall Study|Withdrawal by Subject|6|||
125606357|NCT02279524|451843665|FG002|Overall Study|Withdrawal by Subject|3|||
125606358|NCT02279524|451843663|FG000|Overall Study|Adverse Event|4|||
125606359|NCT02279524|451843664|FG001|Overall Study|Adverse Event|3|||
125606360|NCT02279524|451843665|FG002|Overall Study|Adverse Event|2|||
125606361|NCT02279524|451843663|FG000|Overall Study|Lost to Follow-up|1|||
125606362|NCT02279524|451843664|FG001|Overall Study|Lost to Follow-up|1|||
125606363|NCT02279524|451843665|FG002|Overall Study|Lost to Follow-up|0|||
125606364|NCT02279524|451843663|FG000|Overall Study|Disallowed medication|1|||
125606365|NCT02279524|451843664|FG001|Overall Study|Disallowed medication|1|||
125606366|NCT02279524|451843665|FG002|Overall Study|Disallowed medication|2|||
125606367|NCT02279524|451843663|FG000|Overall Study|Bariatric surgery|1|||
125606368|NCT02279524|451843664|FG001|Overall Study|Bariatric surgery|0|||
125606369|NCT02279524|451843665|FG002|Overall Study|Bariatric surgery|0|||
125606370|NCT03509207|451843666|FG000|Overall Study|Death|2|||
125606371|NCT02817555|451843667|FG000|Overall Study|Death|1|||
125606372|NCT02817555|451843668|FG001|Overall Study|Death|3|||
125606373|NCT02817555|451843667|FG000|Overall Study|moved away|1|||
125606374|NCT02817555|451843668|FG001|Overall Study|moved away|0|||
125606375|NCT02817555|451843667|FG000|Overall Study|transplant|1|||
125606376|NCT02817555|451843668|FG001|Overall Study|transplant|1|||
125606377|NCT02817555|451843667|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
125606378|NCT02817555|451843668|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
125606379|NCT00137436|451843669|FG000|Overall Study|Adverse Event|13|||
125606380|NCT00137436|451843669|FG000|Overall Study|Death|2|||
125606381|NCT00137436|451843669|FG000|Overall Study|Lack of Efficacy|17|||
125606382|NCT00137436|451843669|FG000|Overall Study|Withdrawal by Subject|6|||
125606383|NCT00137436|451843669|FG000|Overall Study|Other|5|||
125606384|NCT00165646|451843670|FG000|Overall Study|Adverse Event|1|||
125606385|NCT00165646|451843671|FG001|Overall Study|Adverse Event|1|||
125606386|NCT00165646|451843672|FG002|Overall Study|Adverse Event|1|||
125606387|NCT00165646|451843670|FG000|Overall Study|Lack of Efficacy|1|||
125606388|NCT00165646|451843671|FG001|Overall Study|Lack of Efficacy|2|||
125606389|NCT00165646|451843672|FG002|Overall Study|Lack of Efficacy|0|||
125606390|NCT00165646|451843670|FG000|Overall Study|Withdrawal by Subject|0|||
125606391|NCT00165646|451843671|FG001|Overall Study|Withdrawal by Subject|2|||
125606392|NCT00165646|451843672|FG002|Overall Study|Withdrawal by Subject|1|||
125606393|NCT00165646|451843670|FG000|Overall Study|Physician Decision|2|||
125606394|NCT00165646|451843671|FG001|Overall Study|Physician Decision|0|||
125606395|NCT00165646|451843672|FG002|Overall Study|Physician Decision|2|||
125606396|NCT00165646|451843670|FG000|Overall Study|Protocol Violation|1|||
125606397|NCT00165646|451843671|FG001|Overall Study|Protocol Violation|0|||
125606398|NCT00165646|451843672|FG002|Overall Study|Protocol Violation|0|||
125606399|NCT00912015|451843676|FG000|Overall Study|Lack of Efficacy|1|||
125606400|NCT00912015|451843677|FG001|Overall Study|Lack of Efficacy|0|||
125606401|NCT00912015|451843678|FG002|Overall Study|Lack of Efficacy|0|||
125606402|NCT00912015|451843679|FG003|Overall Study|Lack of Efficacy|0|||
125606403|NCT00912015|451843676|FG000|Overall Study|Withdrawal by Subject|8|||
125369955|NCT01427972|450987153|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
125369956|NCT01427972|450987154|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125369957|NCT01427972|450987155|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125369958|NCT01427972|450987156|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125369959|NCT01427972|450987157|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
125369960|NCT01427972|450987146|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125606404|NCT00912015|451843677|FG001|Overall Study|Withdrawal by Subject|8|||
125369961|NCT01427972|450987147|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125606405|NCT00912015|451843678|FG002|Overall Study|Withdrawal by Subject|3|||
125606406|NCT00912015|451843679|FG003|Overall Study|Withdrawal by Subject|0|||
125606407|NCT00912015|451843676|FG000|Overall Study|Protocol Violation|1|||
125606408|NCT00912015|451843677|FG001|Overall Study|Protocol Violation|0|||
125606409|NCT00912015|451843678|FG002|Overall Study|Protocol Violation|0|||
125606410|NCT00912015|451843679|FG003|Overall Study|Protocol Violation|1|||
125606411|NCT00912015|451843676|FG000|Overall Study|Adverse Event|6|||
125606412|NCT00912015|451843677|FG001|Overall Study|Adverse Event|0|||
125606413|NCT00912015|451843678|FG002|Overall Study|Adverse Event|0|||
125606414|NCT00912015|451843679|FG003|Overall Study|Adverse Event|1|||
125606415|NCT01356602|451843680|FG000|Overall Study|Protocol Deviation|0|||
125606416|NCT01356602|451843681|FG001|Overall Study|Protocol Deviation|1|||
125606417|NCT01356602|451843682|FG002|Overall Study|Protocol Deviation|1|||
125606418|NCT01356602|451843680|FG000|Overall Study|Administrative Problems|1|||
125606419|NCT01356602|451843681|FG001|Overall Study|Administrative Problems|4|||
125606420|NCT01356602|451843682|FG002|Overall Study|Administrative Problems|5|||
125606421|NCT01356602|451843680|FG000|Overall Study|Lost to Follow-up|4|||
125606422|NCT01356602|451843681|FG001|Overall Study|Lost to Follow-up|5|||
125606423|NCT01356602|451843682|FG002|Overall Study|Lost to Follow-up|6|||
125606424|NCT01356602|451843680|FG000|Overall Study|Withdrawal by Subject|4|||
125606425|NCT01356602|451843681|FG001|Overall Study|Withdrawal by Subject|3|||
125606426|NCT01356602|451843682|FG002|Overall Study|Withdrawal by Subject|7|||
125606427|NCT01356602|451843680|FG000|Overall Study|Lack of Efficacy|0|||
125606428|NCT01356602|451843681|FG001|Overall Study|Lack of Efficacy|1|||
125606429|NCT01356602|451843682|FG002|Overall Study|Lack of Efficacy|4|||
125606430|NCT01356602|451843680|FG000|Overall Study|Adverse Event|0|||
125606431|NCT01356602|451843681|FG001|Overall Study|Adverse Event|1|||
125606432|NCT01356602|451843682|FG002|Overall Study|Adverse Event|1|||
125606433|NCT01115569|451843683|FG000|Conversion/Titration Phase|Adverse Event|59|||
125606434|NCT01115569|451843684|FG001|Conversion/Titration Phase|Adverse Event|0|||
125606435|NCT01115569|451843683|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
125606436|NCT01115569|451843684|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
125606437|NCT01115569|451843683|FG000|Conversion/Titration Phase|Physician Decision|5|||
125606438|NCT01115569|451843684|FG001|Conversion/Titration Phase|Physician Decision|0|||
125606439|NCT01115569|451843683|FG000|Conversion/Titration Phase|Protocol Violation|68|||
125606440|NCT01115569|451843684|FG001|Conversion/Titration Phase|Protocol Violation|0|||
125606441|NCT01115569|451843683|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
125606442|NCT01115569|451843684|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
125606443|NCT01115569|451843683|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
125606444|NCT01115569|451843684|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
125606445|NCT01115569|451843683|FG000|Maintenance Phase|Adverse Event|0|||
125606446|NCT01115569|451843684|FG001|Maintenance Phase|Adverse Event|43|||
125606447|NCT01115569|451843683|FG000|Maintenance Phase|Lost to Follow-up|0|||
125606448|NCT01115569|451843684|FG001|Maintenance Phase|Lost to Follow-up|8|||
125606449|NCT01115569|451843683|FG000|Maintenance Phase|Physician Decision|0|||
125606450|NCT01115569|451843684|FG001|Maintenance Phase|Physician Decision|3|||
125606451|NCT01115569|451843683|FG000|Maintenance Phase|Protocol Violation|0|||
125606452|NCT01115569|451843684|FG001|Maintenance Phase|Protocol Violation|9|||
125606453|NCT01115569|451843683|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125606454|NCT01115569|451843684|FG001|Maintenance Phase|Withdrawal by Subject|27|||
125606455|NCT01115569|451843683|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
125606456|NCT01115569|451843684|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
125606457|NCT01115569|451843683|FG000|Maintenance Phase|Administrative|0|||
125606458|NCT01115569|451843684|FG001|Maintenance Phase|Administrative|1|||
125606459|NCT01931462|451843685|FG000|Overall Study|Withdrawal by Subject|1|||
125606460|NCT02819310|451843686|FG000|Overall Study|Withdrawal by Subject|37|||
125606461|NCT02819310|451843686|FG000|Overall Study|Lost to Follow-up|16|||
125606462|NCT02819310|451843686|FG000|Overall Study|Adverse Event|13|||
125606463|NCT02819310|451843686|FG000|Overall Study|Lack of Efficacy|5|||
125606464|NCT02819310|451843686|FG000|Overall Study|Physician Decision|8|||
125606465|NCT02819310|451843686|FG000|Overall Study|Protocol Violation|30|||
125606466|NCT05070429|451843692|FG000|Overall Study|Death|0|||
125606467|NCT05070429|451843693|FG001|Overall Study|Death|4|||
125606468|NCT05070429|451843692|FG000|Overall Study|Withdrawal by Subject|2|||
125606469|NCT05070429|451843693|FG001|Overall Study|Withdrawal by Subject|1|||
125606470|NCT05070429|451843692|FG000|Overall Study|Other|15|||
125606471|NCT05070429|451843693|FG001|Overall Study|Other|5|||
125606472|NCT00943319|451843694|FG000|Overall Study|Death|1|||
125606473|NCT02043301|451843695|FG000|Overall Study|Discontinued|0|||
125606474|NCT02043301|451843696|FG001|Overall Study|Discontinued|1|||
125606475|NCT02043301|451843697|FG002|Overall Study|Discontinued|0|||
125606476|NCT02023164|451843698|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
125606477|NCT02023164|451843699|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
125606478|NCT02653976|451843700|FG000|Overall Study|Withdrawal by Subject|5|||
125606479|NCT02653976|451843700|FG000|Overall Study|Death|4|||
125606480|NCT00883558|451843701|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
125606481|NCT00883558|451843702|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
125606482|NCT00883558|451843703|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
125606483|NCT00883558|451843701|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
125606484|NCT00883558|451843702|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
125606485|NCT00883558|451843703|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
125606486|NCT00883558|451843701|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
125606487|NCT00883558|451843702|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
125606488|NCT00883558|451843703|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
125606489|NCT00883558|451843701|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
125606490|NCT00883558|451843702|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
125369962|NCT01427972|450987148|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125369963|NCT01427972|450987149|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125606491|NCT00883558|451843703|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
125606492|NCT00883558|451843701|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
125606493|NCT00883558|451843702|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
125606494|NCT00883558|451843703|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
125606495|NCT03703375|451843704|FG000|Randomization Period|Withdrawal by Subject|0|||
125606496|NCT03703375|451843705|FG001|Randomization Period|Withdrawal by Subject|0|||
125606497|NCT03703375|451843706|FG002|Randomization Period|Withdrawal by Subject|0|||
125606498|NCT03703375|451843707|FG003|Randomization Period|Withdrawal by Subject|1|||
125606499|NCT03703375|451843704|FG000|Randomization Period|Completed safety run-in treatment|7|||
125606500|NCT03703375|451843705|FG001|Randomization Period|Completed safety run-in treatment|0|||
125606501|NCT03703375|451843706|FG002|Randomization Period|Completed safety run-in treatment|0|||
125606502|NCT03703375|451843707|FG003|Randomization Period|Completed safety run-in treatment|0|||
125606503|NCT03703375|451843704|FG000|Treatment Period|Other Reasons|0|||
125606504|NCT03703375|451843705|FG001|Treatment Period|Other Reasons|1|||
125606505|NCT03703375|451843706|FG002|Treatment Period|Other Reasons|0|||
125606506|NCT03703375|451843707|FG003|Treatment Period|Other Reasons|3|||
125606507|NCT03703375|451843704|FG000|Treatment Period|Consent Withdrawal|0|||
125212854|NCT03300050|450405491|FG000|Overall Study|Withdrawal by Subject|1|||
125606508|NCT03703375|451843705|FG001|Treatment Period|Consent Withdrawal|0|||
125606509|NCT03703375|451843706|FG002|Treatment Period|Consent Withdrawal|0|||
125606510|NCT03703375|451843707|FG003|Treatment Period|Consent Withdrawal|1|||
125212855|NCT03300050|450405492|FG001|Overall Study|Withdrawal by Subject|1|||
125369964|NCT01427972|450987150|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125369965|NCT01427972|450987151|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
125369966|NCT01427972|450987152|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125369967|NCT01427972|450987153|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125369968|NCT01427972|450987154|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125369969|NCT01427972|450987155|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125369970|NCT01427972|450987156|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125369971|NCT01427972|450987157|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
125369972|NCT01427972|450987146|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125369973|NCT01427972|450987147|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
125369974|NCT01427972|450987148|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125369975|NCT01427972|450987149|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125606511|NCT03703375|451843704|FG000|Treatment Period|Death|1|||
125606512|NCT03703375|451843705|FG001|Treatment Period|Death|0|||
125606513|NCT03703375|451843706|FG002|Treatment Period|Death|1|||
125606514|NCT03703375|451843707|FG003|Treatment Period|Death|2|||
125606515|NCT03703375|451843704|FG000|Treatment Period|Toxicity of Study Treatment|2|||
125606516|NCT03703375|451843705|FG001|Treatment Period|Toxicity of Study Treatment|0|||
125369976|NCT01427972|450987150|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125606517|NCT03703375|451843706|FG002|Treatment Period|Toxicity of Study Treatment|4|||
125606518|NCT03703375|451843707|FG003|Treatment Period|Toxicity of Study Treatment|1|||
125606519|NCT03703375|451843704|FG000|Treatment Period|Progression|32|||
125606520|NCT03703375|451843705|FG001|Treatment Period|Progression|1|||
125606521|NCT03703375|451843706|FG002|Treatment Period|Progression|7|||
125369977|NCT01427972|450987151|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125369978|NCT01427972|450987152|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125369979|NCT01427972|450987153|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125369980|NCT01427972|450987154|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125606522|NCT03703375|451843707|FG003|Treatment Period|Progression|11|||
125606523|NCT03703375|451843704|FG000|Treatment Period|Completed treatment|7|||
125606524|NCT03703375|451843705|FG001|Treatment Period|Completed treatment|2|||
125606525|NCT03703375|451843706|FG002|Treatment Period|Completed treatment|0|||
125606526|NCT03703375|451843707|FG003|Treatment Period|Completed treatment|0|||
125606527|NCT01781429|451843709|FG000|Overall Study|Death|0|||
125606528|NCT01781429|451843710|FG001|Overall Study|Death|0|||
125606529|NCT01781429|451843711|FG002|Overall Study|Death|0|||
125606530|NCT01781429|451843712|FG003|Overall Study|Death|0|||
125606531|NCT01781429|451843713|FG004|Overall Study|Death|0|||
125606532|NCT01781429|451843714|FG005|Overall Study|Death|0|||
125606533|NCT01781429|451843715|FG006|Overall Study|Death|0|||
125606534|NCT01781429|451843716|FG007|Overall Study|Death|0|||
125606535|NCT01781429|451843717|FG008|Overall Study|Death|0|||
125606536|NCT01781429|451843718|FG009|Overall Study|Death|1|||
125606537|NCT01781429|451843719|FG010|Overall Study|Death|0|||
125606538|NCT01781429|451843720|FG011|Overall Study|Death|0|||
125606539|NCT01781429|451843721|FG012|Overall Study|Death|1|||
125606540|NCT01781429|451843722|FG013|Overall Study|Death|0|||
125606541|NCT01781429|451843723|FG014|Overall Study|Death|1|||
125606542|NCT01781429|451843724|FG015|Overall Study|Death|0|||
125606543|NCT01781429|451843709|FG000|Overall Study|Withdrawal by Subject|0|||
125606544|NCT01781429|451843710|FG001|Overall Study|Withdrawal by Subject|0|||
125606545|NCT01781429|451843711|FG002|Overall Study|Withdrawal by Subject|0|||
125606546|NCT01781429|451843712|FG003|Overall Study|Withdrawal by Subject|0|||
125606547|NCT01781429|451843713|FG004|Overall Study|Withdrawal by Subject|0|||
125606548|NCT01781429|451843714|FG005|Overall Study|Withdrawal by Subject|0|||
125606549|NCT01781429|451843715|FG006|Overall Study|Withdrawal by Subject|0|||
125606550|NCT01781429|451843716|FG007|Overall Study|Withdrawal by Subject|0|||
125606551|NCT01781429|451843717|FG008|Overall Study|Withdrawal by Subject|1|||
125606552|NCT01781429|451843718|FG009|Overall Study|Withdrawal by Subject|3|||
125606553|NCT01781429|451843719|FG010|Overall Study|Withdrawal by Subject|1|||
125606554|NCT01781429|451843720|FG011|Overall Study|Withdrawal by Subject|1|||
125606555|NCT01781429|451843721|FG012|Overall Study|Withdrawal by Subject|5|||
125606556|NCT01781429|451843722|FG013|Overall Study|Withdrawal by Subject|2|||
125606557|NCT01781429|451843723|FG014|Overall Study|Withdrawal by Subject|3|||
125606558|NCT01781429|451843724|FG015|Overall Study|Withdrawal by Subject|0|||
125606559|NCT01781429|451843709|FG000|Overall Study|Disease Progression|1|||
125606560|NCT01781429|451843710|FG001|Overall Study|Disease Progression|0|||
125606561|NCT01781429|451843711|FG002|Overall Study|Disease Progression|1|||
125606562|NCT01781429|451843712|FG003|Overall Study|Disease Progression|1|||
125606563|NCT01781429|451843713|FG004|Overall Study|Disease Progression|1|||
125606564|NCT01781429|451843714|FG005|Overall Study|Disease Progression|4|||
125606565|NCT01781429|451843715|FG006|Overall Study|Disease Progression|7|||
125606566|NCT01781429|451843716|FG007|Overall Study|Disease Progression|4|||
125606567|NCT01781429|451843717|FG008|Overall Study|Disease Progression|6|||
125606568|NCT01781429|451843718|FG009|Overall Study|Disease Progression|15|||
125606569|NCT01781429|451843719|FG010|Overall Study|Disease Progression|15|||
125606570|NCT01781429|451843720|FG011|Overall Study|Disease Progression|15|||
125606571|NCT01781429|451843721|FG012|Overall Study|Disease Progression|15|||
125606572|NCT01781429|451843722|FG013|Overall Study|Disease Progression|4|||
125606573|NCT01781429|451843723|FG014|Overall Study|Disease Progression|11|||
125606574|NCT01781429|451843724|FG015|Overall Study|Disease Progression|0|||
125606575|NCT01781429|451843709|FG000|Overall Study|Unacceptable Toxicity|0|||
125606576|NCT01781429|451843710|FG001|Overall Study|Unacceptable Toxicity|0|||
125606577|NCT01781429|451843711|FG002|Overall Study|Unacceptable Toxicity|0|||
125606578|NCT01781429|451843712|FG003|Overall Study|Unacceptable Toxicity|0|||
125606579|NCT01781429|451843713|FG004|Overall Study|Unacceptable Toxicity|0|||
125606580|NCT01781429|451843714|FG005|Overall Study|Unacceptable Toxicity|0|||
125606581|NCT01781429|451843715|FG006|Overall Study|Unacceptable Toxicity|0|||
125606582|NCT01781429|451843716|FG007|Overall Study|Unacceptable Toxicity|0|||
125606583|NCT01781429|451843717|FG008|Overall Study|Unacceptable Toxicity|0|||
125606584|NCT01781429|451843718|FG009|Overall Study|Unacceptable Toxicity|0|||
125369981|NCT01427972|450987155|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125369982|NCT01427972|450987156|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125606585|NCT01781429|451843719|FG010|Overall Study|Unacceptable Toxicity|0|||
125606586|NCT01781429|451843720|FG011|Overall Study|Unacceptable Toxicity|2|||
125431770|NCT02277743|451207750|FG000|Overall Study|Adverse Event|10|||
125606587|NCT01781429|451843721|FG012|Overall Study|Unacceptable Toxicity|0|||
125606588|NCT01781429|451843722|FG013|Overall Study|Unacceptable Toxicity|0|||
125606589|NCT01781429|451843723|FG014|Overall Study|Unacceptable Toxicity|0|||
125606590|NCT01781429|451843724|FG015|Overall Study|Unacceptable Toxicity|0|||
125606591|NCT01781429|451843709|FG000|Overall Study|Patient Condition Changed|0|||
125606592|NCT01781429|451843710|FG001|Overall Study|Patient Condition Changed|0|||
125606593|NCT01781429|451843711|FG002|Overall Study|Patient Condition Changed|0|||
125606594|NCT01781429|451843712|FG003|Overall Study|Patient Condition Changed|0|||
125606595|NCT01781429|451843713|FG004|Overall Study|Patient Condition Changed|0|||
125606596|NCT01781429|451843714|FG005|Overall Study|Patient Condition Changed|0|||
125606597|NCT01781429|451843715|FG006|Overall Study|Patient Condition Changed|0|||
125606598|NCT01781429|451843716|FG007|Overall Study|Patient Condition Changed|0|||
125606599|NCT01781429|451843717|FG008|Overall Study|Patient Condition Changed|0|||
125606600|NCT01781429|451843718|FG009|Overall Study|Patient Condition Changed|4|||
125606601|NCT01781429|451843719|FG010|Overall Study|Patient Condition Changed|0|||
125606602|NCT01781429|451843720|FG011|Overall Study|Patient Condition Changed|1|||
125606603|NCT01781429|451843721|FG012|Overall Study|Patient Condition Changed|0|||
125606604|NCT01781429|451843722|FG013|Overall Study|Patient Condition Changed|1|||
125606605|NCT01781429|451843723|FG014|Overall Study|Patient Condition Changed|0|||
125606606|NCT01781429|451843724|FG015|Overall Study|Patient Condition Changed|0|||
125606607|NCT01781429|451843709|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
125606608|NCT01781429|451843710|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
125606609|NCT01781429|451843711|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
125606610|NCT01781429|451843712|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
125606611|NCT01781429|451843713|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
125606612|NCT01781429|451843714|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
125606613|NCT01781429|451843715|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
125606614|NCT01781429|451843716|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
125606615|NCT01781429|451843717|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
125606616|NCT01781429|451843718|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
125606617|NCT01781429|451843719|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
125606618|NCT01781429|451843720|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
125606619|NCT01781429|451843721|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
125606620|NCT01781429|451843722|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
125606621|NCT01781429|451843723|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
125606622|NCT01781429|451843724|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
125606623|NCT01781429|451843709|FG000|Overall Study|Enrolled, but not treated|0|||
125606624|NCT01781429|451843710|FG001|Overall Study|Enrolled, but not treated|0|||
125606625|NCT01781429|451843711|FG002|Overall Study|Enrolled, but not treated|0|||
125606626|NCT01781429|451843712|FG003|Overall Study|Enrolled, but not treated|0|||
125606627|NCT01781429|451843713|FG004|Overall Study|Enrolled, but not treated|0|||
125606628|NCT01781429|451843714|FG005|Overall Study|Enrolled, but not treated|0|||
125606629|NCT01781429|451843715|FG006|Overall Study|Enrolled, but not treated|0|||
125606630|NCT01781429|451843716|FG007|Overall Study|Enrolled, but not treated|0|||
125606631|NCT01781429|451843717|FG008|Overall Study|Enrolled, but not treated|0|||
125606632|NCT01781429|451843718|FG009|Overall Study|Enrolled, but not treated|0|||
125606633|NCT01781429|451843719|FG010|Overall Study|Enrolled, but not treated|1|||
125606634|NCT01781429|451843720|FG011|Overall Study|Enrolled, but not treated|0|||
125606635|NCT01781429|451843721|FG012|Overall Study|Enrolled, but not treated|0|||
125606636|NCT01781429|451843722|FG013|Overall Study|Enrolled, but not treated|0|||
125606637|NCT01781429|451843723|FG014|Overall Study|Enrolled, but not treated|0|||
125606638|NCT01781429|451843724|FG015|Overall Study|Enrolled, but not treated|0|||
125606639|NCT02678741|451843725|FG000|Overall Study|Death|4|||
125606640|NCT02678741|451843725|FG000|Overall Study|Withdrawal by Subject|1|||
125606641|NCT02678741|451843725|FG000|Overall Study|ineligible|3|||
125606642|NCT02678741|451843725|FG000|Overall Study|Not RECIST Measurable|2|||
125606643|NCT02678741|451843725|FG000|Overall Study|Lack of Efficacy|10|||
125606644|NCT00903032|451843726|FG000|Overall Study|Withdrawal by Subject|5|||
125606645|NCT00903032|451843727|FG001|Overall Study|Withdrawal by Subject|3|||
125606646|NCT00903032|451843726|FG000|Overall Study|Lost to Follow-up|2|||
125606647|NCT00903032|451843727|FG001|Overall Study|Lost to Follow-up|2|||
125369983|NCT01427972|450987157|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
125369984|NCT00530946|450987158|FG000|Overall Study|Adverse Event|1|||
125606648|NCT01703286|451843740|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
125606649|NCT01703286|451843741|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
125606650|NCT01703286|451843742|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
125606651|NCT01703286|451843743|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
125606652|NCT01703286|451843744|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
125606653|NCT01703286|451843745|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
125606654|NCT01703286|451843740|FG000|Period 2 Including Washout|Adverse Event|0|||
125606655|NCT01703286|451843741|FG001|Period 2 Including Washout|Adverse Event|0|||
125606656|NCT01703286|451843742|FG002|Period 2 Including Washout|Adverse Event|0|||
125606657|NCT01703286|451843743|FG003|Period 2 Including Washout|Adverse Event|1|||
125369985|NCT00530946|450987159|FG001|Overall Study|Adverse Event|2|||
125369986|NCT00530946|450987160|FG002|Overall Study|Adverse Event|1|||
125212856|NCT03300050|450405493|FG002|Overall Study|Withdrawal by Subject|1|||
125212857|NCT03300050|450405494|FG003|Overall Study|Withdrawal by Subject|0|||
125212858|NCT03300050|450405495|FG004|Overall Study|Withdrawal by Subject|0|||
125212859|NCT03300050|450405491|FG000|Overall Study|Death|0|||
125212860|NCT03300050|450405492|FG001|Overall Study|Death|0|||
125212861|NCT03300050|450405493|FG002|Overall Study|Death|1|||
125212862|NCT03300050|450405494|FG003|Overall Study|Death|0|||
125212863|NCT03300050|450405495|FG004|Overall Study|Death|0|||
125212864|NCT03300050|450405491|FG000|Overall Study|Not Eligible at Randomization|0|||
125212865|NCT03300050|450405492|FG001|Overall Study|Not Eligible at Randomization|0|||
125212866|NCT03300050|450405493|FG002|Overall Study|Not Eligible at Randomization|1|||
125606658|NCT01703286|451843744|FG004|Period 2 Including Washout|Adverse Event|0|||
125606659|NCT01703286|451843745|FG005|Period 2 Including Washout|Adverse Event|0|||
125606660|NCT01984346|451843746|FG000|Overall Study|Physician Decision|4|||
125606661|NCT01984346|451843747|FG001|Overall Study|Physician Decision|2|||
125606662|NCT01984346|451843746|FG000|Overall Study|Withdrawal by Subject|2|||
125606663|NCT01984346|451843747|FG001|Overall Study|Withdrawal by Subject|2|||
125606664|NCT01984346|451843746|FG000|Overall Study|Enrollment Closed|8|||
125606665|NCT01984346|451843747|FG001|Overall Study|Enrollment Closed|1|||
125606666|NCT01984346|451843746|FG000|Overall Study|Insurance Coverage|1|||
125212867|NCT03300050|450405494|FG003|Overall Study|Not Eligible at Randomization|1|||
125212868|NCT03300050|450405495|FG004|Overall Study|Not Eligible at Randomization|0|||
125212869|NCT00631163|450405496|FG000|Number of Participants in Year 1|Adverse Event|12|||
125212870|NCT00631163|450405496|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
125606667|NCT01984346|451843747|FG001|Overall Study|Insurance Coverage|0|||
125606668|NCT01984346|451843746|FG000|Overall Study|Intra-operative Exclusion|2|||
125212871|NCT00631163|450405496|FG000|Number of Participants in Year 1|Death|6|||
125212872|NCT00631163|450405496|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
125212873|NCT00631163|450405496|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
125212874|NCT00631163|450405496|FG000|Number of Participants in Year 1|Administrative problems|6|||
125212875|NCT00631163|450405496|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
125212876|NCT00631163|450405496|FG000|Number of Participants in Year 2|Adverse Event|1|||
125212877|NCT00631163|450405496|FG000|Number of Participants in Year 2|Protocol Violation|1|||
125212878|NCT00631163|450405496|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
125212879|NCT02714036|450405497|FG000|Overall Study|Adverse Event|9|||
125212880|NCT02714036|450405498|FG001|Overall Study|Adverse Event|2|||
125212881|NCT02714036|450405497|FG000|Overall Study|Withdrawal by Subject|3|||
125212882|NCT02714036|450405498|FG001|Overall Study|Withdrawal by Subject|2|||
125212883|NCT01597492|450405499|FG000|Overall Study|Withdrawal by Subject|1|||
125212884|NCT01597492|450405500|FG001|Overall Study|Withdrawal by Subject|2|||
125606669|NCT01984346|451843747|FG001|Overall Study|Intra-operative Exclusion|0|||
125606670|NCT01234402|451843749|FG000|Overall Study|Lost to Follow-up|0|||
125606671|NCT01234402|451843750|FG001|Overall Study|Lost to Follow-up|1|||
125606672|NCT01234402|451843751|FG002|Overall Study|Lost to Follow-up|3|||
125606673|NCT01234402|451843749|FG000|Overall Study|Withdrawal by Subject|1|||
125606674|NCT01234402|451843750|FG001|Overall Study|Withdrawal by Subject|3|||
125606675|NCT01234402|451843751|FG002|Overall Study|Withdrawal by Subject|4|||
125606676|NCT01234402|451843749|FG000|Overall Study|Never treated: Death|0|||
125606677|NCT01234402|451843750|FG001|Overall Study|Never treated: Death|0|||
125606678|NCT01234402|451843751|FG002|Overall Study|Never treated: Death|1|||
125606679|NCT01234402|451843749|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
125606680|NCT01234402|451843750|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
125606681|NCT01234402|451843751|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
125606682|NCT01234402|451843749|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
125606683|NCT01234402|451843750|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
125606684|NCT01234402|451843751|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
125606685|NCT01594476|451843752|FG000|Overall Study|Protocol Violation|1|||
125606686|NCT01594476|451843753|FG001|Overall Study|Protocol Violation|3|||
125606687|NCT05468086|451843754|FG000|Overall Study|Withdrawal by Subject|3|||
125606688|NCT05468086|451843754|FG000|Overall Study|Subject was found ineligible after consent|1|||
125606689|NCT00374907|451843755|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
125606690|NCT00374907|451843756|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
125606691|NCT00374907|451843755|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
125606692|NCT00374907|451843756|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
125606693|NCT00374907|451843755|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
125606694|NCT00374907|451843756|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
125606695|NCT00374907|451843755|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
125606696|NCT00374907|451843756|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
125606697|NCT00374907|451843755|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
125606698|NCT00374907|451843756|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
125606699|NCT01108809|451843757|FG000|Overall Study|Adverse Event|3|||
125606700|NCT01108809|451843757|FG000|Overall Study|Lost to Follow-up|1|||
125606701|NCT00783705|451843760|FG000|Overall Study|Adverse Event|2|||
125606702|NCT00783705|451843761|FG001|Overall Study|Adverse Event|0|||
125606703|NCT00783705|451843760|FG000|Overall Study|Withdrawal by Subject|3|||
125606704|NCT00783705|451843761|FG001|Overall Study|Withdrawal by Subject|2|||
125606705|NCT00783705|451843760|FG000|Overall Study|Lost to Follow-up|1|||
125212885|NCT01597492|450405499|FG000|Overall Study|Adverse Event|3|||
125212886|NCT01597492|450405500|FG001|Overall Study|Adverse Event|0|||
125212887|NCT01597492|450405499|FG000|Overall Study|Lost to Follow-up|0|||
125606706|NCT00783705|451843761|FG001|Overall Study|Lost to Follow-up|3|||
125606707|NCT02379923|451843762|FG000|Overall Study|Death|5|||
125606708|NCT01200511|451843764|FG000|Overall Study|Lost to Follow-up|3|||
125606709|NCT01200511|451843764|FG000|Overall Study|Withdrawal by Subject|1|||
125606710|NCT01200511|451843764|FG000|Overall Study|Adverse Event|1|||
125606711|NCT02504892|451843771|FG000|Overall Study|Adverse event-pneumonitis|2|||
125606712|NCT04229446|451843772|FG000|Overall Study|Death|12|||
125606713|NCT04229446|451843773|FG001|Overall Study|Death|10|||
125606714|NCT04229446|451843772|FG000|Overall Study|Lost to Follow-up|5|||
125606715|NCT04229446|451843773|FG001|Overall Study|Lost to Follow-up|8|||
125606716|NCT00576693|451843774|FG000|Overall Study|Lost to Follow-up|7|||
125606717|NCT00576693|451843775|FG001|Overall Study|Lost to Follow-up|11|||
125606718|NCT00576693|451843774|FG000|Overall Study|Withdrawal by Subject|3|||
125606719|NCT00576693|451843775|FG001|Overall Study|Withdrawal by Subject|13|||
125606720|NCT00804193|451843776|FG000|Overall Study|Lack of baseline fungus|32|||
125606721|NCT00804193|451843777|FG001|Overall Study|Lack of baseline fungus|31|||
125606722|NCT00804193|451843778|FG002|Overall Study|Lack of baseline fungus|19|||
125606723|NCT00804193|451843776|FG000|Overall Study|Adverse Event|0|||
125606724|NCT00804193|451843777|FG001|Overall Study|Adverse Event|0|||
125606725|NCT00804193|451843778|FG002|Overall Study|Adverse Event|2|||
125606726|NCT00804193|451843776|FG000|Overall Study|Lack of Efficacy|1|||
125606727|NCT00804193|451843777|FG001|Overall Study|Lack of Efficacy|1|||
125606728|NCT00804193|451843778|FG002|Overall Study|Lack of Efficacy|3|||
125606729|NCT00804193|451843776|FG000|Overall Study|Protocol Violation|0|||
125606730|NCT00804193|451843777|FG001|Overall Study|Protocol Violation|8|||
125606731|NCT00804193|451843778|FG002|Overall Study|Protocol Violation|2|||
125606732|NCT00804193|451843776|FG000|Overall Study|Lost to Follow-up|3|||
125606733|NCT00804193|451843777|FG001|Overall Study|Lost to Follow-up|3|||
125606734|NCT00804193|451843778|FG002|Overall Study|Lost to Follow-up|4|||
125606735|NCT00804193|451843776|FG000|Overall Study|Withdrawal by Subject|3|||
125606736|NCT00804193|451843777|FG001|Overall Study|Withdrawal by Subject|1|||
125606737|NCT00804193|451843778|FG002|Overall Study|Withdrawal by Subject|2|||
125606738|NCT00705224|451843779|FG000|Overall Study|Adverse Event|1|||
125212888|NCT01597492|450405500|FG001|Overall Study|Lost to Follow-up|2|||
125606739|NCT00705224|451843779|FG000|Overall Study|Lack of Efficacy|2|||
125606740|NCT00705224|451843779|FG000|Overall Study|Withdrawal by Subject|3|||
125606741|NCT00705224|451843779|FG000|Overall Study|Lost to Follow-up|5|||
125606742|NCT01617434|451843780|FG000|Overall Study|Adverse Event|12|||
125606743|NCT01617434|451843781|FG001|Overall Study|Adverse Event|3|||
125606744|NCT01617434|451843780|FG000|Overall Study|Protocol Violation|8|||
125606745|NCT01617434|451843781|FG001|Overall Study|Protocol Violation|7|||
125606746|NCT01617434|451843780|FG000|Overall Study|Withdrawal Criteria|12|||
125606747|NCT01617434|451843781|FG001|Overall Study|Withdrawal Criteria|37|||
125606748|NCT01617434|451843780|FG000|Overall Study|Unclassified|3|||
125606749|NCT01617434|451843781|FG001|Overall Study|Unclassified|4|||
125606750|NCT01987986|451843782|FG000|Overall Study|Lost to Follow-up|1|||
125606751|NCT01987986|451843783|FG001|Overall Study|Lost to Follow-up|0|||
125606752|NCT01987986|451843784|FG002|Overall Study|Lost to Follow-up|0|||
125606753|NCT01987986|451843785|FG003|Overall Study|Lost to Follow-up|0|||
125606754|NCT01987986|451843782|FG000|Overall Study|Adverse Event|1|||
125606755|NCT01987986|451843783|FG001|Overall Study|Adverse Event|0|||
125606756|NCT01987986|451843784|FG002|Overall Study|Adverse Event|2|||
125606757|NCT01987986|451843785|FG003|Overall Study|Adverse Event|0|||
125606758|NCT03283163|451843786|FG000|Overall Study|Lost to Follow-up|1|||
125606759|NCT03283163|451843786|FG000|Overall Study|other life commitments|6|||
125606760|NCT03283163|451843786|FG000|Overall Study|COVID-19 institution wide halting|1|||
125606761|NCT03283163|451843786|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
125606762|NCT03283163|451843786|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
125606763|NCT04238663|451843787|FG000|Overall Study|Lost to Follow-up|0|||
125606764|NCT04238663|451843788|FG001|Overall Study|Lost to Follow-up|1|||
125606765|NCT04238663|451843789|FG002|Overall Study|Lost to Follow-up|0|||
125606766|NCT03596177|451843790|FG000|Single Blind Period|Withdrawal by Subject|1|||
125606767|NCT03596177|451843791|FG001|Single Blind Period|Withdrawal by Subject|1|||
125606768|NCT03596177|451843790|FG000|Single Blind Period|Other|1|||
125606769|NCT03596177|451843791|FG001|Single Blind Period|Other|0|||
125606770|NCT03596177|451843790|FG000|Double Blind Period|Withdrawal by Subject|0|||
125606771|NCT03596177|451843791|FG001|Double Blind Period|Withdrawal by Subject|1|||
125606772|NCT03596177|451843790|FG000|Double Blind Period|Other|0|||
125606773|NCT03596177|451843791|FG001|Double Blind Period|Other|4|||
125606774|NCT03596177|451843790|FG000|Double Blind Period|Death during safety follow-up|0|||
125606775|NCT03596177|451843791|FG001|Double Blind Period|Death during safety follow-up|1|||
125606776|NCT00968253|451843792|FG000|Overall Study|Death|0|||
125606777|NCT00968253|451843793|FG001|Overall Study|Death|0|||
125606778|NCT00968253|451843794|FG002|Overall Study|Death|2|||
125606779|NCT00968253|451843792|FG000|Overall Study|Withdrawal by Subject|0|||
125606780|NCT00968253|451843793|FG001|Overall Study|Withdrawal by Subject|0|||
125606781|NCT00968253|451843794|FG002|Overall Study|Withdrawal by Subject|1|||
125606782|NCT00968253|451843792|FG000|Overall Study|Disease Progression|0|||
125606783|NCT00968253|451843793|FG001|Overall Study|Disease Progression|3|||
125606784|NCT00968253|451843794|FG002|Overall Study|Disease Progression|3|||
125606785|NCT00968253|451843792|FG000|Overall Study|Adverse Event|0|||
125606786|NCT00968253|451843793|FG001|Overall Study|Adverse Event|0|||
125606787|NCT00968253|451843794|FG002|Overall Study|Adverse Event|1|||
125606788|NCT01432262|451845171|FG000|Overall Study|Withdrawal by Subject|2|||
125606789|NCT01432262|451845172|FG001|Overall Study|Withdrawal by Subject|1|||
125212889|NCT01597492|450405499|FG000|Overall Study|Other Reason|2|||
125212890|NCT01597492|450405500|FG001|Overall Study|Other Reason|0|||
125606790|NCT04657016|451845173|FG000|Overall Study|Adverse Event|2|||
125606791|NCT04657016|451845174|FG001|Overall Study|Adverse Event|4|||
125606792|NCT04657016|451845173|FG000|Overall Study|Death|1|||
125606793|NCT04657016|451845174|FG001|Overall Study|Death|1|||
125606794|NCT04657016|451845173|FG000|Overall Study|Lost to Follow-up|24|||
125606795|NCT04657016|451845174|FG001|Overall Study|Lost to Follow-up|12|||
125606796|NCT04657016|451845173|FG000|Overall Study|Physician Decision|1|||
125606797|NCT04657016|451845174|FG001|Overall Study|Physician Decision|2|||
125606798|NCT04657016|451845173|FG000|Overall Study|Pregnancy|2|||
125606799|NCT04657016|451845174|FG001|Overall Study|Pregnancy|2|||
125606800|NCT04657016|451845173|FG000|Overall Study|Protocol Deviation|1|||
125212891|NCT03624569|450405501|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
125606801|NCT04657016|451845174|FG001|Overall Study|Protocol Deviation|0|||
125606802|NCT04657016|451845173|FG000|Overall Study|Withdrawal by Subject|28|||
125606803|NCT04657016|451845174|FG001|Overall Study|Withdrawal by Subject|14|||
125606804|NCT04657016|451845173|FG000|Overall Study|Other - as reported by the investigator|6|||
125606805|NCT04657016|451845174|FG001|Overall Study|Other - as reported by the investigator|0|||
125606806|NCT01755195|451845175|FG000|Overall Study|Participant noncompliance|2|||
125606807|NCT01755195|451845175|FG000|Overall Study|Switched to alternative treatment|4|||
125212892|NCT03624569|450405502|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
125212893|NCT03624569|450405501|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
125212894|NCT03624569|450405502|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
125212895|NCT03517449|450405513|FG000|Overall Study|Death|184|||
125212896|NCT03517449|450405514|FG001|Overall Study|Death|236|||
125212897|NCT03517449|450405513|FG000|Overall Study|Lost to Follow-up|0|||
125212898|NCT03517449|450405514|FG001|Overall Study|Lost to Follow-up|2|||
125212899|NCT03517449|450405513|FG000|Overall Study|Withdrawal by Subject|7|||
125212900|NCT03517449|450405514|FG001|Overall Study|Withdrawal by Subject|26|||
125212901|NCT03517449|450405513|FG000|Overall Study|Participants Ongoing|220|||
125212902|NCT03517449|450405514|FG001|Overall Study|Participants Ongoing|152|||
125212903|NCT01119846|450405515|FG000|Overall Study|Adverse Event|1|||
125212904|NCT01119846|450405516|FG001|Overall Study|Adverse Event|0|||
125212905|NCT01119846|450405517|FG002|Overall Study|Adverse Event|6|||
125212906|NCT01119846|450405515|FG000|Overall Study|Physician Decision|1|||
125212907|NCT01119846|450405516|FG001|Overall Study|Physician Decision|0|||
125606808|NCT01755195|451845175|FG000|Overall Study|Withdrawal by Subject|1|||
125212908|NCT01119846|450405517|FG002|Overall Study|Physician Decision|0|||
125212909|NCT01119846|450405515|FG000|Overall Study|Protocol Violation|0|||
125212910|NCT01119846|450405516|FG001|Overall Study|Protocol Violation|0|||
125212911|NCT01119846|450405517|FG002|Overall Study|Protocol Violation|1|||
125212912|NCT01119846|450405515|FG000|Overall Study|Withdrawal by Subject|0|||
125212913|NCT01119846|450405516|FG001|Overall Study|Withdrawal by Subject|0|||
125606809|NCT01755195|451845175|FG000|Overall Study|Participant refused to start treatment|1|||
125606810|NCT01755195|451845175|FG000|Overall Study|Participant has been consented for another trial|1|||
125606811|NCT01755195|451845175|FG000|Overall Study|Refused further treatment|3|||
125606812|NCT01755195|451845175|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
125606813|NCT03470922|451845176|FG000|Overall Study|Death|107|||
125606814|NCT03470922|451845177|FG001|Overall Study|Death|118|||
125606815|NCT03470922|451845176|FG000|Overall Study|Lost to Follow-up|5|||
125606816|NCT03470922|451845177|FG001|Overall Study|Lost to Follow-up|5|||
125606817|NCT03470922|451845176|FG000|Overall Study|Participant Withdrew Consent|4|||
125606818|NCT03470922|451845177|FG001|Overall Study|Participant Withdrew Consent|9|||
125606819|NCT03470922|451845176|FG000|Overall Study|Other reasons|1|||
125606820|NCT03470922|451845177|FG001|Overall Study|Other reasons|0|||
125606821|NCT03470922|451845176|FG000|Overall Study|Not reported|1|||
125606822|NCT03470922|451845177|FG001|Overall Study|Not reported|0|||
125606823|NCT02340819|451845178|FG000|Overall Study|Adverse Event|1|||
125606824|NCT02340819|451845178|FG000|Overall Study|Withdrawal by Subject|2|||
125606825|NCT02340819|451845178|FG000|Overall Study|Discontinued with other reason|1|||
125606826|NCT02361762|451845179|FG000|Overall Study|Withdrawal by Subject|0|||
125606827|NCT02361762|451845180|FG001|Overall Study|Withdrawal by Subject|1|||
125606828|NCT02361762|451845179|FG000|Overall Study|Lost to Follow-up|0|||
125606829|NCT02361762|451845180|FG001|Overall Study|Lost to Follow-up|1|||
125606830|NCT00028002|451845181|FG000|Overall Study|Withdrawal by Subject|3|||
125606831|NCT00028002|451845181|FG000|Overall Study|Ineligible|8|||
125606832|NCT01793051|451845182|FG000|Overall Study|Withdrawal by Subject|6|||
125606833|NCT01793051|451845183|FG001|Overall Study|Withdrawal by Subject|4|||
125212914|NCT01119846|450405517|FG002|Overall Study|Withdrawal by Subject|4|||
125212915|NCT01370616|450405522|FG000|Overall Study|Adverse Event|11|||
125212916|NCT01370616|450405523|FG001|Overall Study|Adverse Event|16|||
125606834|NCT01793051|451845182|FG000|Overall Study|Adverse Event|0|||
125606835|NCT01793051|451845183|FG001|Overall Study|Adverse Event|2|||
125606836|NCT01793051|451845182|FG000|Overall Study|Too ill to continue|1|||
125606837|NCT01793051|451845183|FG001|Overall Study|Too ill to continue|0|||
125606838|NCT01793051|451845182|FG000|Overall Study|Switched chemo|1|||
125606839|NCT01793051|451845183|FG001|Overall Study|Switched chemo|1|||
125212917|NCT01370616|450405522|FG000|Overall Study|Death|1|||
125212918|NCT01370616|450405523|FG001|Overall Study|Death|0|||
125369987|NCT00530946|450987161|FG003|Overall Study|Adverse Event|1|||
125369988|NCT00530946|450987158|FG000|Overall Study|Protocol Violation|0|||
125369989|NCT00530946|450987159|FG001|Overall Study|Protocol Violation|0|||
125369990|NCT00530946|450987160|FG002|Overall Study|Protocol Violation|0|||
125369991|NCT00530946|450987161|FG003|Overall Study|Protocol Violation|1|||
125369992|NCT00530946|450987158|FG000|Overall Study|Noncompliance|1|||
125369993|NCT00530946|450987159|FG001|Overall Study|Noncompliance|0|||
125369994|NCT00530946|450987160|FG002|Overall Study|Noncompliance|0|||
125369995|NCT00530946|450987161|FG003|Overall Study|Noncompliance|0|||
125369996|NCT00457301|450987162|FG000|Overall Study|Withdrawal by Subject|3|||
125369997|NCT00457301|450987163|FG001|Overall Study|Withdrawal by Subject|3|||
125369998|NCT00457301|450987162|FG000|Overall Study|Censored out of the study|15|||
125369999|NCT00457301|450987163|FG001|Overall Study|Censored out of the study|14|||
125370000|NCT00457301|450987162|FG000|Overall Study|Death|5|||
125370001|NCT00457301|450987163|FG001|Overall Study|Death|7|||
125370002|NCT00880009|450987164|FG000|Overall Study|Study terminated by sponsor|14|||
125370003|NCT00880009|450987164|FG000|Overall Study|Withdrawal by Subject|1|||
125370004|NCT00880009|450987164|FG000|Overall Study|Protocol Violation|1|||
125370005|NCT02378961|450987165|FG000|Overall Study|Lack of Efficacy|4|||
125370006|NCT02378961|450987166|FG001|Overall Study|Lack of Efficacy|2|||
125370007|NCT02378961|450987167|FG002|Overall Study|Lack of Efficacy|0|||
125370008|NCT02378961|450987168|FG003|Overall Study|Lack of Efficacy|1|||
125370009|NCT02378961|450987165|FG000|Overall Study|Death|0|||
125370010|NCT02378961|450987166|FG001|Overall Study|Death|0|||
125370011|NCT02378961|450987167|FG002|Overall Study|Death|1|||
125370012|NCT02378961|450987168|FG003|Overall Study|Death|0|||
125370013|NCT01253408|450987169|FG000|Overall Study|Adverse Event|0|||
125370014|NCT01253408|450987170|FG001|Overall Study|Adverse Event|1|||
125370015|NCT01253408|450987171|FG002|Overall Study|Adverse Event|0|||
125370016|NCT03035409|450987173|FG000|Overall Study|Adverse Event|5|||
125370017|NCT03035409|450987173|FG000|Overall Study|Death|2|||
125370018|NCT03035409|450987173|FG000|Overall Study|Withdrawal by Subject|2|||
125370019|NCT03035409|450987173|FG000|Overall Study|Non compliance|4|||
125370020|NCT03035409|450987173|FG000|Overall Study|Patient was jittery|1|||
125370021|NCT03035409|450987173|FG000|Overall Study|Did not like Questionnaire|1|||
125370022|NCT03035409|450987173|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
125370023|NCT03035409|450987173|FG000|Overall Study|Did not like taking drugs|1|||
125606840|NCT01793051|451845182|FG000|Overall Study|Lack of compliance|1|||
125606841|NCT01793051|451845183|FG001|Overall Study|Lack of compliance|0|||
125606842|NCT01793051|451845182|FG000|Overall Study|Requested to be removed from the study|1|||
125606843|NCT01793051|451845183|FG001|Overall Study|Requested to be removed from the study|1|||
125606844|NCT04467164|451845187|FG000|Washout (1 Week)|Lost to Follow-up|2|||
125606845|NCT04467164|451845188|FG001|Washout (1 Week)|Lost to Follow-up|0|||
125606846|NCT03276936|451845191|FG000|Overall Study|Adverse Event|4|||
125370024|NCT01552694|450987174|FG000|Overall Study|Lost to Follow-up|0|||
125370025|NCT01552694|450987175|FG001|Overall Study|Lost to Follow-up|1|||
125370026|NCT01552694|450987174|FG000|Overall Study|Protocol Violation|0|||
125370027|NCT01552694|450987175|FG001|Overall Study|Protocol Violation|1|||
125370028|NCT02166905|450987177|FG000|Overall Study|Withdrawal by Subject|1|||
125370029|NCT02166905|450987178|FG001|Overall Study|Withdrawal by Subject|0|||
125370030|NCT02166905|450987179|FG002|Overall Study|Withdrawal by Subject|0|||
125370031|NCT02166905|450987180|FG003|Overall Study|Withdrawal by Subject|0|||
125370032|NCT02617628|450987181|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
125606847|NCT03276936|451845192|FG001|Overall Study|Adverse Event|2|||
125606848|NCT03276936|451845191|FG000|Overall Study|Lost to Follow-up|16|||
125606849|NCT03276936|451845192|FG001|Overall Study|Lost to Follow-up|13|||
125606850|NCT03276936|451845191|FG000|Overall Study|Withdrawal by Subject|30|||
125606851|NCT03276936|451845192|FG001|Overall Study|Withdrawal by Subject|20|||
125606852|NCT03276936|451845191|FG000|Overall Study|Not mentioned|6|||
125606853|NCT03276936|451845192|FG001|Overall Study|Not mentioned|3|||
125606854|NCT01798134|451845193|FG000|Overall Study|Lost to Follow-up|1|||
125606855|NCT01798134|451845193|FG000|Overall Study|Withdrawal by Subject|3|||
125606856|NCT01798134|451845193|FG000|Overall Study|Death|2|||
125606857|NCT01798134|451845193|FG000|Overall Study|Adverse Event|3|||
125606858|NCT01798134|451845193|FG000|Overall Study|Physician Decision|3|||
125606859|NCT01798134|451845193|FG000|Overall Study|Liver transplant/surgery|4|||
125606860|NCT00625365|451845194|FG000|Overall Study|Withdrawal by Subject|1|||
125606861|NCT00625365|451845194|FG000|Overall Study|No IV access|5|||
125606862|NCT00625365|451845194|FG000|Overall Study|VSD|1|||
125606863|NCT02245568|451845195|FG000|Overall Study|Study terminated by Sponsor|346|||
125606864|NCT02245568|451845195|FG000|Overall Study|Adverse Event|144|||
125606865|NCT02245568|451845195|FG000|Overall Study|Lack of Efficacy|98|||
125606866|NCT02245568|451845195|FG000|Overall Study|Withdrawal by Caregiver|85|||
125606867|NCT02245568|451845195|FG000|Overall Study|Withdrawal by Subject|77|||
125606868|NCT02245568|451845195|FG000|Overall Study|Withdrawal by Legal Representative|31|||
125606869|NCT02245568|451845195|FG000|Overall Study|Missing (Site closure)|16|||
125606870|NCT02245568|451845195|FG000|Overall Study|Physician Decision|14|||
125606871|NCT02245568|451845195|FG000|Overall Study|Non-compliance with study drug|11|||
125606872|NCT02245568|451845195|FG000|Overall Study|Death|9|||
125606873|NCT02245568|451845195|FG000|Overall Study|Blue staining|6|||
125606874|NCT02245568|451845195|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
125606875|NCT02245568|451845195|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
125606876|NCT02245568|451845195|FG000|Overall Study|Lost to Follow-up|5|||
125606877|NCT00366548|451845196|FG000|Infant Series|Adverse Event|1|||
125606878|NCT00366548|451845197|FG001|Infant Series|Adverse Event|3|||
125606879|NCT00366548|451845196|FG000|Infant Series|Protocol Violation|0|||
125606880|NCT00366548|451845197|FG001|Infant Series|Protocol Violation|1|||
125606881|NCT00366548|451845196|FG000|Infant Series|Withdrawal by Subject|3|||
125606882|NCT00366548|451845197|FG001|Infant Series|Withdrawal by Subject|1|||
125606883|NCT00366548|451845196|FG000|After Infant Series|Withdrawal by Subject|3|||
125606884|NCT00366548|451845197|FG001|After Infant Series|Withdrawal by Subject|1|||
125606885|NCT00366548|451845196|FG000|After Infant Series|Adverse Event|2|||
125606886|NCT00366548|451845197|FG001|After Infant Series|Adverse Event|0|||
125606887|NCT00366548|451845196|FG000|After Infant Series|Lost to Follow-up|1|||
125606888|NCT00366548|451845197|FG001|After Infant Series|Lost to Follow-up|0|||
125606889|NCT01252134|451845198|FG000|Period 1, 8 Hours|Personal Reasons|0|||
125606890|NCT01252134|451845199|FG001|Period 1, 8 Hours|Personal Reasons|1|||
125606891|NCT01252134|451845200|FG002|Period 1, 8 Hours|Personal Reasons|1|||
125606892|NCT01252134|451845201|FG003|Period 1, 8 Hours|Personal Reasons|0|||
125606893|NCT01252134|451845202|FG004|Period 1, 8 Hours|Personal Reasons|0|||
125606894|NCT01252134|451845203|FG005|Period 1, 8 Hours|Personal Reasons|0|||
125606895|NCT03650452|451845205|FG000|Overall Study|Physician Decision|1|||
125606896|NCT03650452|451845206|FG001|Overall Study|Physician Decision|0|||
125606897|NCT03650452|451845205|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
125606898|NCT03650452|451845206|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125606899|NCT03650452|451845205|FG000|Overall Study|Adverse Event|3|||
125606900|NCT03650452|451845206|FG001|Overall Study|Adverse Event|4|||
125606901|NCT03650452|451845205|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
125606902|NCT03650452|451845206|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
125606903|NCT02273050|451845207|FG000|Overall Study|Adverse Event|4|||
125606904|NCT02273050|451845208|FG001|Overall Study|Adverse Event|3|||
125606905|NCT02273050|451845209|FG002|Overall Study|Adverse Event|3|||
125606906|NCT02273050|451845207|FG000|Overall Study|Death|0|||
125606907|NCT02273050|451845208|FG001|Overall Study|Death|0|||
125606908|NCT02273050|451845209|FG002|Overall Study|Death|1|||
125606909|NCT02273050|451845207|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
125606910|NCT02273050|451845208|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
125606911|NCT02273050|451845209|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
125606912|NCT02273050|451845207|FG000|Overall Study|Lack of Efficacy|0|||
125606913|NCT02273050|451845208|FG001|Overall Study|Lack of Efficacy|1|||
125370033|NCT02617628|450987182|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
125370034|NCT05243641|450987186|FG000|Overall Study|Adverse Event|3|||
125370035|NCT05243641|450987187|FG001|Overall Study|Adverse Event|0|||
125370036|NCT05243641|450987188|FG002|Overall Study|Adverse Event|0|||
125370037|NCT05243641|450987189|FG003|Overall Study|Adverse Event|1|||
125370038|NCT05243641|450987190|FG004|Overall Study|Adverse Event|0|||
125370039|NCT05243641|450987191|FG005|Overall Study|Adverse Event|0|||
125370040|NCT05243641|450987186|FG000|Overall Study|Disease progression|4|||
125370041|NCT05243641|450987187|FG001|Overall Study|Disease progression|0|||
125370042|NCT05243641|450987188|FG002|Overall Study|Disease progression|0|||
125370043|NCT05243641|450987189|FG003|Overall Study|Disease progression|2|||
125370044|NCT05243641|450987190|FG004|Overall Study|Disease progression|0|||
125370045|NCT05243641|450987191|FG005|Overall Study|Disease progression|0|||
125370046|NCT04518306|450987192|FG000|Double-Blind Period|Run in failure|0|||
125370047|NCT04518306|450987193|FG001|Double-Blind Period|Run in failure|0|||
125370048|NCT04518306|450987194|FG002|Double-Blind Period|Run in failure|1|||
125370049|NCT04518306|450987192|FG000|Double-Blind Period|Adverse Event|0|||
125370050|NCT04518306|450987193|FG001|Double-Blind Period|Adverse Event|2|||
125370051|NCT04518306|450987194|FG002|Double-Blind Period|Adverse Event|2|||
125370052|NCT04518306|450987192|FG000|Double-Blind Period|Lost to Follow-up|1|||
125370053|NCT04518306|450987193|FG001|Double-Blind Period|Lost to Follow-up|2|||
125370054|NCT04518306|450987194|FG002|Double-Blind Period|Lost to Follow-up|2|||
125370055|NCT04518306|450987192|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
125370056|NCT04518306|450987193|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
125370057|NCT04518306|450987194|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
125370058|NCT04518306|450987192|FG000|Double-Blind Period|Other|0|||
125212919|NCT01370616|450405522|FG000|Overall Study|Lack of Efficacy|6|||
125212920|NCT01370616|450405523|FG001|Overall Study|Lack of Efficacy|2|||
125212921|NCT01370616|450405522|FG000|Overall Study|Lost to Follow-up|0|||
125212922|NCT01370616|450405523|FG001|Overall Study|Lost to Follow-up|3|||
125370059|NCT04518306|450987193|FG001|Double-Blind Period|Other|2|||
125370060|NCT04518306|450987194|FG002|Double-Blind Period|Other|0|||
125370061|NCT04518306|450987192|FG000|Double-Blind Period|Missing|0|||
125370062|NCT04518306|450987193|FG001|Double-Blind Period|Missing|1|||
125370063|NCT04518306|450987194|FG002|Double-Blind Period|Missing|0|||
125370064|NCT03904043|450987195|FG000|Overall Study|Adverse Event|1|||
125370065|NCT03904043|450987196|FG001|Overall Study|Adverse Event|1|||
125370066|NCT03904043|450987195|FG000|Overall Study|Withdrawal by Subject|1|||
125370067|NCT03904043|450987196|FG001|Overall Study|Withdrawal by Subject|0|||
125370068|NCT03904043|450987195|FG000|Overall Study|Non-compliance|1|||
125370069|NCT03904043|450987196|FG001|Overall Study|Non-compliance|0|||
125370070|NCT03904043|450987195|FG000|Overall Study|Did not start treatment|1|||
125370071|NCT03904043|450987196|FG001|Overall Study|Did not start treatment|0|||
125370072|NCT02849678|450989143|FG000|Overall Study|Protocol Violation|3|||
125370073|NCT02849678|450989144|FG001|Overall Study|Protocol Violation|6|||
125370074|NCT02228460|450989150|FG000|Overall Study|Adverse Event|1|||
125370075|NCT02228460|450989150|FG000|Overall Study|Lost to Follow-up|1|||
125606914|NCT02273050|451845209|FG002|Overall Study|Lack of Efficacy|1|||
125606915|NCT02273050|451845207|FG000|Overall Study|Withdrawal by Subject|17|||
125606916|NCT02273050|451845208|FG001|Overall Study|Withdrawal by Subject|14|||
125606917|NCT02273050|451845209|FG002|Overall Study|Withdrawal by Subject|16|||
125606918|NCT02273050|451845207|FG000|Overall Study|Lost to Follow-up|0|||
125606919|NCT02273050|451845208|FG001|Overall Study|Lost to Follow-up|2|||
125212923|NCT01370616|450405522|FG000|Overall Study|Physician Decision|6|||
125370076|NCT01243892|450989151|FG000|Overall Study|Did not meet eligibility criteria|2|||
125370077|NCT01243892|450989152|FG001|Overall Study|Did not meet eligibility criteria|0|||
125370078|NCT00119106|450989153|FG000|Overall Study|HIV infected at baseline|179|||
125370079|NCT00119106|450989154|FG001|Overall Study|HIV infected at baseline|178|||
125370080|NCT03066804|450989155|FG000|Overall Study|Physician Decision|0|||
125370081|NCT03066804|450989156|FG001|Overall Study|Physician Decision|4|||
125370082|NCT03066804|450989155|FG000|Overall Study|Death|23|||
125606920|NCT02273050|451845209|FG002|Overall Study|Lost to Follow-up|3|||
125212924|NCT01370616|450405523|FG001|Overall Study|Physician Decision|6|||
125212925|NCT01370616|450405522|FG000|Overall Study|Progressive Disease|0|||
125212926|NCT01370616|450405523|FG001|Overall Study|Progressive Disease|1|||
125212927|NCT01370616|450405522|FG000|Overall Study|Recovery|1|||
125212928|NCT01370616|450405523|FG001|Overall Study|Recovery|0|||
125212929|NCT01370616|450405522|FG000|Overall Study|Technical Problems|3|||
125212930|NCT01370616|450405523|FG001|Overall Study|Technical Problems|5|||
125212931|NCT01370616|450405522|FG000|Overall Study|Withdrawal by Subject|34|||
125212932|NCT01370616|450405523|FG001|Overall Study|Withdrawal by Subject|34|||
125212933|NCT02324699|450405524|FG000|Overall Study|study terminated|1|||
125212934|NCT01605825|450405529|FG000|Overall Study|Adverse Event|4|||
125212935|NCT01605825|450405530|FG001|Overall Study|Adverse Event|2|||
125212936|NCT01605825|450405529|FG000|Overall Study|Withdrawal by Subject|0|||
125212937|NCT01605825|450405530|FG001|Overall Study|Withdrawal by Subject|1|||
125212938|NCT01605825|450405529|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
125212939|NCT01605825|450405530|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
125212940|NCT01605825|450405529|FG000|Overall Study|Non-Compliance with Protocol|3|||
125212941|NCT01605825|450405530|FG001|Overall Study|Non-Compliance with Protocol|0|||
125212942|NCT03469999|450405537|FG000|Overall Study|Lost to Follow-up|2|||
125212943|NCT00394771|450405541|FG000|Overall Study|Did not meet protocol requirements|1|||
125212944|NCT00394771|450405542|FG001|Overall Study|Did not meet protocol requirements|0|||
125212945|NCT00394771|450405543|FG002|Overall Study|Did not meet protocol requirements|2|||
125212946|NCT00394771|450405544|FG003|Overall Study|Did not meet protocol requirements|0|||
125212947|NCT00394771|450405541|FG000|Overall Study|Protocol Violation|2|||
125212948|NCT00394771|450405542|FG001|Overall Study|Protocol Violation|4|||
125606921|NCT02273050|451845207|FG000|Overall Study|Protocol Violation|3|||
125606922|NCT02273050|451845208|FG001|Overall Study|Protocol Violation|1|||
125606923|NCT02273050|451845209|FG002|Overall Study|Protocol Violation|4|||
125606924|NCT02297438|451845210|FG000|Overall Study|Death|79|||
125606925|NCT02297438|451845211|FG001|Overall Study|Death|86|||
125606926|NCT02297438|451845210|FG000|Overall Study|Lost to Follow-up|9|||
125606927|NCT02297438|451845211|FG001|Overall Study|Lost to Follow-up|7|||
125606928|NCT02297438|451845210|FG000|Overall Study|Withdrawal by Subject|7|||
125606929|NCT02297438|451845211|FG001|Overall Study|Withdrawal by Subject|0|||
125606930|NCT02297438|451845210|FG000|Overall Study|Other|9|||
125606931|NCT02297438|451845211|FG001|Overall Study|Other|5|||
125606932|NCT02297438|451845210|FG000|Overall Study|Ongoing|65|||
125606933|NCT02297438|451845211|FG001|Overall Study|Ongoing|73|||
125606934|NCT02042404|451845212|FG000|Overall Study|Death|1|||
125606935|NCT02042404|451845213|FG001|Overall Study|Death|0|||
125606936|NCT02042404|451845212|FG000|Overall Study|Unrelated Adverse Event|3|||
125606937|NCT02042404|451845213|FG001|Overall Study|Unrelated Adverse Event|0|||
125606938|NCT02042404|451845212|FG000|Overall Study|Inability to meet time requirements|1|||
125606939|NCT02042404|451845213|FG001|Overall Study|Inability to meet time requirements|0|||
125606940|NCT05058664|451845216|FG000|Overall Study|No follow-up data provided|4|||
125606941|NCT05058664|451845217|FG001|Overall Study|No follow-up data provided|0|||
125606942|NCT05058664|451845218|FG002|Overall Study|No follow-up data provided|2|||
125212949|NCT00394771|450405543|FG002|Overall Study|Protocol Violation|9|||
125212950|NCT00394771|450405544|FG003|Overall Study|Protocol Violation|7|||
125212951|NCT00394771|450405541|FG000|Overall Study|Withdrawal by Subject|10|||
125212952|NCT00394771|450405542|FG001|Overall Study|Withdrawal by Subject|6|||
125606943|NCT05058664|451845216|FG000|Overall Study|Withdrawal by Subject|0|||
125606944|NCT05058664|451845217|FG001|Overall Study|Withdrawal by Subject|0|||
125606945|NCT05058664|451845218|FG002|Overall Study|Withdrawal by Subject|1|||
125606946|NCT00972244|451845219|FG000|Overall Study|Incorrect Enrolment|1|||
125212953|NCT00394771|450405543|FG002|Overall Study|Withdrawal by Subject|8|||
125212954|NCT00394771|450405544|FG003|Overall Study|Withdrawal by Subject|12|||
125212955|NCT00394771|450405541|FG000|Overall Study|Adverse Event|10|||
125212956|NCT00394771|450405542|FG001|Overall Study|Adverse Event|5|||
125212957|NCT00394771|450405543|FG002|Overall Study|Adverse Event|12|||
125212958|NCT00394771|450405544|FG003|Overall Study|Adverse Event|8|||
125212959|NCT00394771|450405541|FG000|Overall Study|Participant pregnant|0|||
125212960|NCT00394771|450405542|FG001|Overall Study|Participant pregnant|1|||
125212961|NCT00394771|450405543|FG002|Overall Study|Participant pregnant|2|||
125212962|NCT00394771|450405544|FG003|Overall Study|Participant pregnant|2|||
125212963|NCT00394771|450405541|FG000|Overall Study|Lost to Follow-up|15|||
125212964|NCT00394771|450405542|FG001|Overall Study|Lost to Follow-up|15|||
125212965|NCT00394771|450405543|FG002|Overall Study|Lost to Follow-up|13|||
125212966|NCT00394771|450405544|FG003|Overall Study|Lost to Follow-up|10|||
125212967|NCT00394771|450405541|FG000|Overall Study|Other|3|||
125212968|NCT00394771|450405542|FG001|Overall Study|Other|3|||
125212969|NCT00394771|450405543|FG002|Overall Study|Other|1|||
125212970|NCT00394771|450405544|FG003|Overall Study|Other|0|||
125212971|NCT00520767|450405545|FG000|Overall Study|Death|2|||
125212972|NCT03597139|450405546|FG000|Overall Study|Adverse Event|3|||
125212973|NCT03597139|450405547|FG001|Overall Study|Adverse Event|0|||
125212974|NCT03597139|450405546|FG000|Overall Study|Protocol Non-compliance|1|||
125212975|NCT03597139|450405547|FG001|Overall Study|Protocol Non-compliance|0|||
125212976|NCT00382109|450405549|FG000|Overall Study|Adverse Event|3|||
125212977|NCT00382109|450405550|FG001|Overall Study|Adverse Event|0|||
125212978|NCT00382109|450405549|FG000|Overall Study|Physician Decision|6|||
125212979|NCT00382109|450405550|FG001|Overall Study|Physician Decision|1|||
125212980|NCT00382109|450405549|FG000|Overall Study|Withdrawal by Subject|1|||
125212981|NCT00382109|450405550|FG001|Overall Study|Withdrawal by Subject|0|||
125370083|NCT03066804|450989156|FG001|Overall Study|Death|17|||
125370084|NCT03066804|450989155|FG000|Overall Study|Withdrawal by Subject|19|||
125370085|NCT03066804|450989156|FG001|Overall Study|Withdrawal by Subject|25|||
125606947|NCT00972244|451845220|FG001|Overall Study|Incorrect Enrolment|0|||
125606948|NCT00972244|451845221|FG002|Overall Study|Incorrect Enrolment|0|||
125606949|NCT00972244|451845222|FG003|Overall Study|Incorrect Enrolment|0|||
125606950|NCT00972244|451845223|FG004|Overall Study|Incorrect Enrolment|0|||
125606951|NCT00972244|451845219|FG000|Overall Study|Adverse Event|0|||
125606952|NCT00972244|451845220|FG001|Overall Study|Adverse Event|1|||
125606953|NCT00972244|451845221|FG002|Overall Study|Adverse Event|1|||
125606954|NCT00972244|451845222|FG003|Overall Study|Adverse Event|0|||
125606955|NCT00972244|451845223|FG004|Overall Study|Adverse Event|0|||
125606956|NCT00972244|451845219|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
125606957|NCT00972244|451845220|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
125606958|NCT00972244|451845221|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
125606959|NCT00972244|451845222|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
125606960|NCT00972244|451845223|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
125606961|NCT00972244|451845219|FG000|Overall Study|Withdrawal by Subject|1|||
125606962|NCT00972244|451845220|FG001|Overall Study|Withdrawal by Subject|2|||
125606963|NCT00972244|451845221|FG002|Overall Study|Withdrawal by Subject|1|||
125606964|NCT00972244|451845222|FG003|Overall Study|Withdrawal by Subject|0|||
125606965|NCT00972244|451845223|FG004|Overall Study|Withdrawal by Subject|1|||
125606966|NCT00972244|451845219|FG000|Overall Study|Safety|0|||
125606967|NCT00972244|451845220|FG001|Overall Study|Safety|0|||
125606968|NCT00972244|451845221|FG002|Overall Study|Safety|0|||
125606969|NCT00972244|451845222|FG003|Overall Study|Safety|0|||
125212982|NCT00382109|450405549|FG000|Overall Study|ineligible|2|||
125212983|NCT00382109|450405550|FG001|Overall Study|ineligible|0|||
125212984|NCT00382109|450405549|FG000|Overall Study|Other|0|||
125212985|NCT00382109|450405550|FG001|Overall Study|Other|2|||
125212986|NCT00382109|450405549|FG000|Overall Study|consent withdrawal|0|||
125212987|NCT00382109|450405550|FG001|Overall Study|consent withdrawal|1|||
125212988|NCT00248833|450405553|FG000|Overall Study|Adverse Event|2|||
125606970|NCT00972244|451845223|FG004|Overall Study|Safety|1|||
125606971|NCT00972244|451845219|FG000|Overall Study|Death|1|||
125606972|NCT00972244|451845220|FG001|Overall Study|Death|0|||
125606973|NCT00972244|451845221|FG002|Overall Study|Death|0|||
125606974|NCT00972244|451845222|FG003|Overall Study|Death|0|||
125606975|NCT00972244|451845223|FG004|Overall Study|Death|0|||
125606976|NCT00972244|451845219|FG000|Overall Study|Various|0|||
125606977|NCT00972244|451845220|FG001|Overall Study|Various|0|||
125606978|NCT00972244|451845221|FG002|Overall Study|Various|0|||
125606979|NCT00972244|451845222|FG003|Overall Study|Various|0|||
125606980|NCT00972244|451845223|FG004|Overall Study|Various|2|||
125606981|NCT01597557|451845224|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
125606982|NCT01597557|451845225|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
125606983|NCT02561000|451845228|FG000|Overall Study|Withdrawal by Subject|2|||
125606984|NCT02561000|451845229|FG001|Overall Study|Withdrawal by Subject|3|||
125606985|NCT02561000|451845230|FG002|Overall Study|Withdrawal by Subject|0|||
125606986|NCT02561000|451845228|FG000|Overall Study|Adverse Event|0|||
125606987|NCT02561000|451845229|FG001|Overall Study|Adverse Event|1|||
125606988|NCT02561000|451845230|FG002|Overall Study|Adverse Event|0|||
125606989|NCT03952468|451845231|FG000|Overall Study|Death|0|||
125606990|NCT03952468|451845232|FG001|Overall Study|Death|1|||
125606991|NCT03952468|451845231|FG000|Overall Study|Adverse Event|0|||
125606992|NCT03952468|451845232|FG001|Overall Study|Adverse Event|1|||
125606993|NCT03952468|451845231|FG000|Overall Study|Physician Decision|1|||
125606994|NCT03952468|451845232|FG001|Overall Study|Physician Decision|0|||
125606995|NCT03952468|451845231|FG000|Overall Study|Lost to Follow-up|3|||
125606996|NCT03952468|451845232|FG001|Overall Study|Lost to Follow-up|4|||
125606997|NCT03952468|451845231|FG000|Overall Study|Withdrawal by Subject|2|||
125606998|NCT03952468|451845232|FG001|Overall Study|Withdrawal by Subject|1|||
125606999|NCT05761444|451845234|FG000|Overall Study|Protocol Violation|2|||
125607000|NCT05761444|451845235|FG001|Overall Study|Protocol Violation|1|||
125607001|NCT05761444|451845234|FG000|Overall Study|Adverse Event|2|||
125607002|NCT05761444|451845235|FG001|Overall Study|Adverse Event|2|||
125607003|NCT05761444|451845234|FG000|Overall Study|Withdrawal by Subject|3|||
125607004|NCT05761444|451845235|FG001|Overall Study|Withdrawal by Subject|2|||
125607005|NCT05761444|451845234|FG000|Overall Study|Other|1|||
125607006|NCT05761444|451845235|FG001|Overall Study|Other|0|||
125607007|NCT04716933|451845236|FG000|Overall Study|Sponsor Decision|36|||
125607008|NCT04716933|451845237|FG001|Overall Study|Sponsor Decision|33|||
125607009|NCT04716933|451845236|FG000|Overall Study|Death|65|||
125607010|NCT04716933|451845237|FG001|Overall Study|Death|67|||
125607011|NCT01005719|451845240|FG000|Period 1|Adverse Event|0|||
125607012|NCT01005719|451845241|FG001|Period 1|Adverse Event|0|||
125607013|NCT01005719|451845242|FG002|Period 1|Adverse Event|0|||
125607014|NCT01005719|451845243|FG003|Period 1|Adverse Event|1|||
125607015|NCT01005719|451845244|FG004|Period 1|Adverse Event|0|||
125607016|NCT01005719|451845245|FG005|Period 1|Adverse Event|0|||
125607017|NCT01005719|451845240|FG000|Period 1|Delay in completing study procedures|0|||
125607018|NCT01005719|451845241|FG001|Period 1|Delay in completing study procedures|0|||
125607019|NCT01005719|451845242|FG002|Period 1|Delay in completing study procedures|0|||
125607020|NCT01005719|451845243|FG003|Period 1|Delay in completing study procedures|0|||
125607021|NCT01005719|451845244|FG004|Period 1|Delay in completing study procedures|0|||
125607022|NCT01005719|451845245|FG005|Period 1|Delay in completing study procedures|1|||
125607023|NCT01005719|451845240|FG000|Period 2|Adverse Event|0|||
125607024|NCT01005719|451845241|FG001|Period 2|Adverse Event|0|||
125607025|NCT01005719|451845242|FG002|Period 2|Adverse Event|0|||
125607026|NCT01005719|451845243|FG003|Period 2|Adverse Event|0|||
125607027|NCT01005719|451845244|FG004|Period 2|Adverse Event|1|||
125607028|NCT01005719|451845245|FG005|Period 2|Adverse Event|1|||
125607029|NCT01106534|451845246|FG000|Overall Study|Withdrawal by Subject|18|||
125607030|NCT01106534|451845246|FG000|Overall Study|Lost to Follow-up|2|||
125607031|NCT01106534|451845246|FG000|Overall Study|Death|16|||
125607032|NCT01106534|451845246|FG000|Overall Study|Physician Decision|1|||
125607033|NCT04430738|451845247|FG000|Phase 1: Dose Escalation|Death|1|||
125607034|NCT04430738|451845248|FG001|Phase 1: Dose Escalation|Death|4|||
125607035|NCT04430738|451845249|FG002|Phase 1: Dose Escalation|Death|4|||
125607036|NCT04430738|451845250|FG003|Phase 1: Dose Escalation|Death|1|||
125607037|NCT04430738|451845251|FG004|Phase 1: Dose Escalation|Death|6|||
125607038|NCT04430738|451845252|FG005|Phase 1: Dose Escalation|Death|0|||
125607039|NCT04430738|451845247|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
125607040|NCT04430738|451845248|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
125607041|NCT04430738|451845249|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
125607042|NCT04430738|451845250|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
125607043|NCT04430738|451845251|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
125607044|NCT04430738|451845252|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
125607045|NCT04430738|451845247|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
125607046|NCT04430738|451845248|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
125607047|NCT04430738|451845249|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
125607048|NCT04430738|451845250|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
125637233|NCT03073200|451952839|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
125212989|NCT00248833|450405554|FG001|Overall Study|Adverse Event|0|||
125212990|NCT00248833|450405555|FG002|Overall Study|Adverse Event|0|||
125212991|NCT00248833|450405553|FG000|Overall Study|Withdrawal by Subject|0|||
125212992|NCT00248833|450405554|FG001|Overall Study|Withdrawal by Subject|1|||
125212993|NCT00248833|450405555|FG002|Overall Study|Withdrawal by Subject|1|||
125212994|NCT00248833|450405553|FG000|Overall Study|Lost to Follow-up|1|||
125212995|NCT00248833|450405554|FG001|Overall Study|Lost to Follow-up|1|||
125212996|NCT00248833|450405555|FG002|Overall Study|Lost to Follow-up|1|||
125212997|NCT00248833|450405553|FG000|Overall Study|Other|0|||
125212998|NCT00248833|450405554|FG001|Overall Study|Other|1|||
125212999|NCT00248833|450405555|FG002|Overall Study|Other|0|||
125213000|NCT01900899|450405556|FG000|Overall Study|Withdrawal by Subject|7|||
125213001|NCT01900899|450405557|FG001|Overall Study|Withdrawal by Subject|1|||
125213002|NCT01900899|450405556|FG000|Overall Study|Migrated from study area|2|||
125213003|NCT01900899|450405557|FG001|Overall Study|Migrated from study area|0|||
125213004|NCT00723697|450405560|FG000|Overall Study|Physician questionnaires not received|2|||
125213005|NCT00723697|450405560|FG000|Overall Study|Missing Informed Consent Form|10|||
125213006|NCT00723697|450405560|FG000|Overall Study|Other exclusion criteria applied|6|||
125213007|NCT00385827|450407170|FG000|Part 1|Adverse Event|1|||
125213008|NCT00385827|450407171|FG001|Part 1|Adverse Event|0|||
125213009|NCT00385827|450407172|FG002|Part 1|Adverse Event|0|||
125213010|NCT00385827|450407170|FG000|Part 1|Death|2|||
125213011|NCT00385827|450407171|FG001|Part 1|Death|0|||
125213012|NCT00385827|450407172|FG002|Part 1|Death|0|||
125213013|NCT00385827|450407170|FG000|Part 1|Lack of Efficacy|5|||
125213014|NCT00385827|450407171|FG001|Part 1|Lack of Efficacy|0|||
125213015|NCT00385827|450407172|FG002|Part 1|Lack of Efficacy|0|||
125607049|NCT04430738|451845251|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
125607050|NCT04430738|451845252|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
125607051|NCT04430738|451845247|FG000|Phase 1: Dose Escalation|Other|1|||
125607052|NCT04430738|451845248|FG001|Phase 1: Dose Escalation|Other|0|||
125607053|NCT04430738|451845249|FG002|Phase 1: Dose Escalation|Other|0|||
125607054|NCT04430738|451845250|FG003|Phase 1: Dose Escalation|Other|0|||
125607055|NCT04430738|451845251|FG004|Phase 1: Dose Escalation|Other|0|||
125607056|NCT04430738|451845252|FG005|Phase 1: Dose Escalation|Other|0|||
125607057|NCT04430738|451845247|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
125607058|NCT04430738|451845248|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
125607059|NCT04430738|451845249|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
125607060|NCT04430738|451845250|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
125607061|NCT04430738|451845251|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
125607062|NCT04430738|451845252|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
125607063|NCT04430738|451845247|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
125607064|NCT04430738|451845248|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
125607065|NCT04430738|451845249|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
125607066|NCT04430738|451845250|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
125607067|NCT04430738|451845251|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
125607068|NCT04430738|451845252|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
125607069|NCT05187013|451845253|FG000|Overall Study|Withdrawal by Subject|1|||
125607070|NCT05187013|451845254|FG001|Overall Study|Withdrawal by Subject|1|||
125607071|NCT05187013|451845255|FG002|Overall Study|Withdrawal by Subject|0|||
125607072|NCT05187013|451845253|FG000|Overall Study|Death|0|||
125607073|NCT05187013|451845254|FG001|Overall Study|Death|1|||
125607074|NCT05187013|451845255|FG002|Overall Study|Death|0|||
125607075|NCT05187013|451845253|FG000|Overall Study|Lost to Follow-up|20|||
125607076|NCT05187013|451845254|FG001|Overall Study|Lost to Follow-up|17|||
125607077|NCT05187013|451845255|FG002|Overall Study|Lost to Follow-up|0|||
125607078|NCT05187013|451845253|FG000|Overall Study|Ongoing Participants|3|||
125607079|NCT05187013|451845254|FG001|Overall Study|Ongoing Participants|5|||
125213016|NCT00385827|450407170|FG000|Part 1|Other|1|||
125213017|NCT00385827|450407171|FG001|Part 1|Other|0|||
125213018|NCT00385827|450407172|FG002|Part 1|Other|0|||
125213019|NCT00385827|450407170|FG000|Part 2|Adverse Event|0|||
125213020|NCT00385827|450407171|FG001|Part 2|Adverse Event|6|||
125213021|NCT00385827|450407172|FG002|Part 2|Adverse Event|10|||
125607080|NCT05187013|451845255|FG002|Overall Study|Ongoing Participants|0|||
125213022|NCT00385827|450407170|FG000|Part 2|Death|0|||
125213023|NCT00385827|450407171|FG001|Part 2|Death|0|||
125607081|NCT04488822|451845256|FG000|Overall Study|Adverse Event|8|||
125607082|NCT04488822|451845256|FG000|Overall Study|Withdrawal by Subject|1|||
125213024|NCT00385827|450407172|FG002|Part 2|Death|2|||
125213025|NCT00385827|450407170|FG000|Part 2|Lack of Efficacy|0|||
125213026|NCT00385827|450407171|FG001|Part 2|Lack of Efficacy|14|||
125431771|NCT02277743|451207751|FG001|Overall Study|Adverse Event|6|||
125213027|NCT00385827|450407172|FG002|Part 2|Lack of Efficacy|13|||
125213028|NCT00385827|450407170|FG000|Part 2|Randomized but not treated|0|||
125213029|NCT00385827|450407171|FG001|Part 2|Randomized but not treated|2|||
125213030|NCT00385827|450407172|FG002|Part 2|Randomized but not treated|2|||
125213031|NCT00385827|450407170|FG000|Part 2|Other|0|||
125213032|NCT00385827|450407171|FG001|Part 2|Other|11|||
125370086|NCT03066804|450989155|FG000|Overall Study|Lost to Follow-up|2|||
125370087|NCT03066804|450989156|FG001|Overall Study|Lost to Follow-up|0|||
125370088|NCT03066804|450989155|FG000|Overall Study|Adverse Event|2|||
125370089|NCT03066804|450989156|FG001|Overall Study|Adverse Event|3|||
125370090|NCT03066804|450989155|FG000|Overall Study|Technical problems|5|||
125370091|NCT03066804|450989156|FG001|Overall Study|Technical problems|1|||
125370092|NCT03310021|450989160|FG000|Overall Study|Withdrawal by Subject|0|||
125370093|NCT03310021|450989161|FG001|Overall Study|Withdrawal by Subject|0|||
125370094|NCT03310021|450989162|FG002|Overall Study|Withdrawal by Subject|0|||
125370095|NCT03310021|450989163|FG003|Overall Study|Withdrawal by Subject|0|||
125370096|NCT03310021|450989164|FG004|Overall Study|Withdrawal by Subject|0|||
125370097|NCT03310021|450989165|FG005|Overall Study|Withdrawal by Subject|0|||
125607083|NCT03838367|451845257|FG000|Overall Study|Early termination of study|3|||
125607084|NCT03838367|451845258|FG001|Overall Study|Early termination of study|4|||
125607085|NCT03838367|451845259|FG002|Overall Study|Early termination of study|3|||
125607086|NCT03838367|451845260|FG003|Overall Study|Early termination of study|0|||
125607087|NCT03406104|451845261|FG000|Overall Study|Lost to Follow-up|2|||
125607088|NCT03406104|451845261|FG000|Overall Study|Withdrawal by Subject|2|||
125607089|NCT03406104|451845261|FG000|Overall Study|due to Covid patient did not want to travel|1|||
125607090|NCT03406104|451845261|FG000|Overall Study|Death|2|||
125607091|NCT02499146|451845275|FG000|Overall Study|Lost to Follow-up|1|||
125607092|NCT02499146|451845275|FG000|Overall Study|Withdrawal by Subject|1|||
125607093|NCT02499146|451845275|FG000|Overall Study|Other|2|||
125607094|NCT02499146|451845275|FG000|Overall Study|Ongoing at date of cut-off|9|||
125607095|NCT02499146|451845275|FG000|Overall Study|Began other treatment/therapy|13|||
125607096|NCT01879618|451845276|FG000|Overall Study|Does not meet entrance criteria|1|||
125607097|NCT01879618|451845276|FG000|Overall Study|Withdrawal by Subject|1|||
125607098|NCT01879618|451845276|FG000|Overall Study|Surgery;changed schedule; not available|8|||
125607099|NCT01879618|451845276|FG000|Overall Study|Protocol Violation|6|||
125607100|NCT01879618|451845276|FG000|Overall Study|Adverse Event|5|||
125607101|NCT02890329|451845277|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
125607102|NCT02890329|451845278|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
125607103|NCT02890329|451845279|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
125607104|NCT02890329|451845280|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
125607105|NCT02890329|451845281|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
125607106|NCT02890329|451845282|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
125607107|NCT02890329|451845277|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
125607108|NCT02890329|451845278|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
125607109|NCT02890329|451845279|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
125607110|NCT02890329|451845280|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
125607111|NCT02890329|451845281|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
125607112|NCT02890329|451845282|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
125607113|NCT02890329|451845277|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
125607114|NCT02890329|451845278|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
125607115|NCT02890329|451845279|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
125607116|NCT02890329|451845280|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
125607117|NCT02890329|451845281|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
125607118|NCT02890329|451845282|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
125607119|NCT02890329|451845277|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
125607120|NCT02890329|451845278|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
125607121|NCT02890329|451845279|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
125607122|NCT02890329|451845280|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
125607123|NCT02890329|451845281|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
125607124|NCT02890329|451845282|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
125370098|NCT03310021|450989166|FG006|Overall Study|Withdrawal by Subject|1|||
125370099|NCT03310021|450989167|FG007|Overall Study|Withdrawal by Subject|0|||
125370100|NCT03310021|450989168|FG008|Overall Study|Withdrawal by Subject|0|||
125607125|NCT02275026|451845283|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
125607126|NCT02275026|451845283|FG000|Overall Study|Withdrawal by Subject|4|||
125607127|NCT02275026|451845283|FG000|Overall Study|Ineligible due to medical history|13|||
125607128|NCT02275026|451845283|FG000|Overall Study|MRI malfunction precluded testing|1|||
125607129|NCT02275026|451845283|FG000|Overall Study|Ineligible after MRI findings|1|||
125607130|NCT02275026|451845283|FG000|Overall Study|Lost to Follow-up|2|||
125607131|NCT02275026|451845283|FG000|Overall Study|Scanner failure|1|||
125607132|NCT00001262|451845286|FG000|Overall Study|Death|10|||
125607133|NCT00001262|451845287|FG001|Overall Study|Death|11|||
125607134|NCT00001262|451845288|FG002|Overall Study|Death|0|||
125607135|NCT00001262|451845286|FG000|Overall Study|Withdrawal by Subject|0|||
125607136|NCT00001262|451845287|FG001|Overall Study|Withdrawal by Subject|3|||
125607137|NCT00001262|451845288|FG002|Overall Study|Withdrawal by Subject|0|||
125607138|NCT00878072|451845289|FG000|Overall Study|Withdrew consent|2|||
125607139|NCT01954121|451845290|FG000|Overall Study|Lack of Efficacy|94|||
125607140|NCT01954121|451845291|FG001|Overall Study|Lack of Efficacy|41|||
125607141|NCT01954121|451845290|FG000|Overall Study|Protocol Violation|0|||
125607142|NCT01954121|451845291|FG001|Overall Study|Protocol Violation|2|||
125607143|NCT01954121|451845290|FG000|Overall Study|Lost to Follow-up|5|||
125607144|NCT01954121|451845291|FG001|Overall Study|Lost to Follow-up|6|||
125607145|NCT01954121|451845290|FG000|Overall Study|Withdrawal by Subject|18|||
125607146|NCT01954121|451845291|FG001|Overall Study|Withdrawal by Subject|12|||
125607147|NCT01954121|451845290|FG000|Overall Study|Pregnancy|1|||
125607148|NCT01954121|451845291|FG001|Overall Study|Pregnancy|1|||
125607149|NCT01954121|451845290|FG000|Overall Study|AE, serious fatal|1|||
125607150|NCT01954121|451845291|FG001|Overall Study|AE, serious fatal|0|||
125607151|NCT01954121|451845290|FG000|Overall Study|AE, non-serious non-fatal|5|||
125607152|NCT01954121|451845291|FG001|Overall Study|AE, non-serious non-fatal|22|||
125607153|NCT01954121|451845290|FG000|Overall Study|SAE, non-fatal|1|||
125607154|NCT01954121|451845291|FG001|Overall Study|SAE, non-fatal|4|||
125607155|NCT01954121|451845290|FG000|Overall Study|Non-compliant with study procedures|1|||
125607156|NCT01954121|451845291|FG001|Overall Study|Non-compliant with study procedures|0|||
125607157|NCT01954121|451845290|FG000|Overall Study|Non-compliant patient|1|||
125607158|NCT01954121|451845291|FG001|Overall Study|Non-compliant patient|1|||
125607159|NCT01954121|451845290|FG000|Overall Study|Subject did not follow instructions|0|||
125607160|NCT01954121|451845291|FG001|Overall Study|Subject did not follow instructions|2|||
125607161|NCT03844633|451845292|FG000|1 Week FU|Lost to Follow-up|0|||
125607162|NCT03844633|451845293|FG001|1 Week FU|Lost to Follow-up|1|||
125607163|NCT03844633|451845294|FG002|1 Week FU|Lost to Follow-up|4|||
125607164|NCT03844633|451845292|FG000|12-month Follow-up|Lost to Follow-up|7|||
125213033|NCT00385827|450407172|FG002|Part 2|Other|21|||
125213034|NCT00410072|450407173|FG000|Day 1 to Week 48|Adverse Event|1|||
125213035|NCT00410072|450407174|FG001|Day 1 to Week 48|Adverse Event|2|||
125213036|NCT00410072|450407173|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
125213037|NCT00410072|450407174|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
125213038|NCT00410072|450407173|FG000|Day 1 to Week 48|Other|0|||
125213039|NCT00410072|450407174|FG001|Day 1 to Week 48|Other|1|||
125213040|NCT00410072|450407173|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
125213041|NCT00410072|450407174|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
125213042|NCT00410072|450407173|FG000|Day 1 to Week 48|Pregnancy|0|||
125213043|NCT00410072|450407174|FG001|Day 1 to Week 48|Pregnancy|2|||
125213044|NCT00410072|450407173|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
125213045|NCT00410072|450407174|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
125213046|NCT00410072|450407173|FG000|After Week 48 to Week 96|Adverse Event|1|||
125213047|NCT00410072|450407174|FG001|After Week 48 to Week 96|Adverse Event|2|||
125213048|NCT00410072|450407173|FG000|After Week 48 to Week 96|Death|0|||
125213049|NCT00410072|450407174|FG001|After Week 48 to Week 96|Death|1|||
125213050|NCT00410072|450407173|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
125213051|NCT00410072|450407174|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
125213052|NCT00410072|450407173|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
125213053|NCT00410072|450407174|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
125213054|NCT00410072|450407173|FG000|After Week 48 to Week 96|Other|2|||
125213055|NCT00410072|450407174|FG001|After Week 48 to Week 96|Other|0|||
125213056|NCT00410072|450407173|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
125213057|NCT00410072|450407174|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
125213058|NCT00410072|450407173|FG000|After Week 48 to Week 96|Pregnancy|0|||
125213059|NCT00410072|450407174|FG001|After Week 48 to Week 96|Pregnancy|2|||
125213060|NCT00410072|450407173|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
125213061|NCT00410072|450407174|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
125213062|NCT01421147|450407179|FG000|Treatment Period|Adverse Event|2|||
125213063|NCT01421147|450407180|FG001|Treatment Period|Adverse Event|3|||
125213064|NCT01421147|450407179|FG000|Treatment Period|Lost to Follow-up|2|||
125213065|NCT01421147|450407180|FG001|Treatment Period|Lost to Follow-up|1|||
125607165|NCT03844633|451845293|FG001|12-month Follow-up|Lost to Follow-up|5|||
125607166|NCT03844633|451845294|FG002|12-month Follow-up|Lost to Follow-up|8|||
125607167|NCT02588248|451845295|FG000|Overall Study|Physician Decision|4|||
125607168|NCT02588248|451845296|FG001|Overall Study|Physician Decision|3|||
125607169|NCT01413178|451845297|FG000|Overall Study|Toxicity|1|||
125607170|NCT01413178|451845298|FG001|Overall Study|Toxicity|0|||
125607171|NCT01413178|451845297|FG000|Overall Study|Ineligible|0|||
125607172|NCT01413178|451845298|FG001|Overall Study|Ineligible|2|||
125607173|NCT00237796|451845299|FG000|Overall Study|Baseline and one other ILSS required|10|||
125607174|NCT00237796|451845300|FG001|Overall Study|Baseline and one other ILSS required|5|||
125607175|NCT03860844|451845301|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
125607176|NCT03860844|451845302|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
125607177|NCT03860844|451845303|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
125607178|NCT03860844|451845301|FG000|Overall Study|Progressive disease|5|||
125607179|NCT03860844|451845302|FG001|Overall Study|Progressive disease|3|||
125213066|NCT01421147|450407179|FG000|Treatment Period|Physician Decision|2|||
125213067|NCT01421147|450407180|FG001|Treatment Period|Physician Decision|2|||
125213068|NCT01421147|450407179|FG000|Treatment Period|Withdrawal by Subject|10|||
125213069|NCT01421147|450407180|FG001|Treatment Period|Withdrawal by Subject|5|||
125213070|NCT01421147|450407179|FG000|Extension Period|Adverse Event|0|||
125213071|NCT01421147|450407180|FG001|Extension Period|Adverse Event|2|||
125370101|NCT03310021|450989169|FG009|Overall Study|Withdrawal by Subject|0|||
125607180|NCT03860844|451845303|FG002|Overall Study|Progressive disease|4|||
125607181|NCT03860844|451845301|FG000|Overall Study|Other, Not related to COVID-19|0|||
125607182|NCT03860844|451845302|FG001|Overall Study|Other, Not related to COVID-19|1|||
125607183|NCT03860844|451845303|FG002|Overall Study|Other, Not related to COVID-19|0|||
125607184|NCT01678807|451845304|FG000|Overall Study|Adverse Event|4|||
125607185|NCT01678807|451845305|FG001|Overall Study|Adverse Event|4|||
125607186|NCT01678807|451845306|FG002|Overall Study|Adverse Event|0|||
125607187|NCT01678807|451845304|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
125607188|NCT01678807|451845305|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
125607189|NCT01678807|451845306|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
125607190|NCT00370149|451845307|FG000|Overall Study|Physician Decision|16|||
125607191|NCT00370149|451845308|FG001|Overall Study|Physician Decision|16|||
125607192|NCT00370149|451845307|FG000|Overall Study|Protocol Violation|1|||
125607193|NCT00370149|451845308|FG001|Overall Study|Protocol Violation|0|||
125607194|NCT00370149|451845307|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
125607195|NCT00370149|451845308|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
125607196|NCT00370149|451845307|FG000|Overall Study|Pre-existing infection|0|||
125607197|NCT00370149|451845308|FG001|Overall Study|Pre-existing infection|1|||
125607198|NCT00370149|451845307|FG000|Overall Study|Antibiotic coated dressing placed|0|||
125607199|NCT00370149|451845308|FG001|Overall Study|Antibiotic coated dressing placed|1|||
125213072|NCT01421147|450407179|FG000|Extension Period|Death|0|||
125213073|NCT01421147|450407180|FG001|Extension Period|Death|1|||
125213074|NCT01421147|450407179|FG000|Extension Period|Lost to Follow-up|2|||
125213075|NCT01421147|450407180|FG001|Extension Period|Lost to Follow-up|5|||
125213076|NCT01421147|450407179|FG000|Extension Period|Physician Decision|1|||
125213077|NCT01421147|450407180|FG001|Extension Period|Physician Decision|0|||
125213078|NCT01421147|450407179|FG000|Extension Period|Withdrawal by Subject|5|||
125213079|NCT01421147|450407180|FG001|Extension Period|Withdrawal by Subject|3|||
125213080|NCT01270321|450407181|FG000|Overall Study|Death|3|||
125213081|NCT01270321|450407182|FG001|Overall Study|Death|1|||
125370102|NCT03310021|450989170|FG010|Overall Study|Withdrawal by Subject|0|||
125370103|NCT03310021|450989171|FG011|Overall Study|Withdrawal by Subject|0|||
125370104|NCT03310021|450989172|FG012|Overall Study|Withdrawal by Subject|0|||
125370105|NCT03310021|450989173|FG013|Overall Study|Withdrawal by Subject|0|||
125607200|NCT04400318|451846446|FG000|Overall Study|Adverse Event|1|||
125607201|NCT04400318|451846447|FG001|Overall Study|Adverse Event|0|||
125607202|NCT04400318|451846446|FG000|Overall Study|Withdrawal by Subject|1|||
125607203|NCT04400318|451846447|FG001|Overall Study|Withdrawal by Subject|1|||
125607204|NCT04400318|451846446|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
125607205|NCT04400318|451846447|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
125607206|NCT01096446|451846448|FG000|Overall Study|Death|1|||
125607207|NCT01096446|451846449|FG001|Overall Study|Death|0|||
125607208|NCT01096446|451846448|FG000|Overall Study|Protocol Violation|2|||
125607209|NCT01096446|451846449|FG001|Overall Study|Protocol Violation|0|||
125607210|NCT01043185|451846450|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
125607211|NCT01043185|451846451|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
125607212|NCT01043185|451846452|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
125607213|NCT01043185|451846453|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
125607214|NCT01043185|451846454|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
125607215|NCT01043185|451846455|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
125607216|NCT01043185|451846456|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
125607217|NCT01043185|451846457|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
125607218|NCT01043185|451846458|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
125607219|NCT01043185|451846459|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
125607220|NCT01104558|451846460|FG000|Overall Study|Protocol Violation|6|||
125607221|NCT01104558|451846460|FG000|Overall Study|Missing of primary efficacy assessment|10|||
125607222|NCT01104558|451846460|FG000|Overall Study|Missing of genetic analysis results|1|||
125607223|NCT03395197|451846463|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
125607224|NCT03395197|451846464|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
125607225|NCT03395197|451846465|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
125607226|NCT03395197|451846466|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
125607227|NCT03395197|451846467|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
125607228|NCT03395197|451846468|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
125607229|NCT03395197|451846463|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
125607230|NCT03395197|451846464|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
125607231|NCT03395197|451846465|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
125607232|NCT03395197|451846466|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
125607233|NCT03395197|451846467|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
125607234|NCT03395197|451846468|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
125607235|NCT03395197|451846463|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
125607236|NCT03395197|451846464|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
125607237|NCT03395197|451846465|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
125607238|NCT03395197|451846466|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
125607239|NCT03395197|451846467|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
125607240|NCT03395197|451846468|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
125607241|NCT03395197|451846463|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
125607242|NCT03395197|451846464|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
125607243|NCT03395197|451846465|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
125607244|NCT03395197|451846466|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
125607245|NCT03395197|451846467|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
125607246|NCT03395197|451846468|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
125607247|NCT03395197|451846463|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
125607248|NCT03395197|451846464|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
125213082|NCT01270321|450407183|FG002|Overall Study|Death|4|||
125213083|NCT01270321|450407181|FG000|Overall Study|Adverse Event|7|||
125370106|NCT03310021|450989174|FG014|Overall Study|Withdrawal by Subject|0|||
125370107|NCT03310021|450989175|FG015|Overall Study|Withdrawal by Subject|0|||
125370108|NCT03310021|450989176|FG016|Overall Study|Withdrawal by Subject|0|||
125213084|NCT01270321|450407182|FG001|Overall Study|Adverse Event|9|||
125431772|NCT02277743|451207752|FG002|Overall Study|Adverse Event|6|||
125431773|NCT02277743|451207750|FG000|Overall Study|Lack of Efficacy|11|||
125431774|NCT02277743|451207751|FG001|Overall Study|Lack of Efficacy|4|||
125431775|NCT02277743|451207752|FG002|Overall Study|Lack of Efficacy|3|||
125431776|NCT02277743|451207750|FG000|Overall Study|Other than specified above|18|||
125431777|NCT02277743|451207751|FG001|Overall Study|Other than specified above|5|||
125431778|NCT02277743|451207752|FG002|Overall Study|Other than specified above|16|||
125431779|NCT01224158|451207753|FG000|Overall Study|Withdrawal by Subject|1|||
125431780|NCT01224158|451207754|FG001|Overall Study|Withdrawal by Subject|0|||
125213085|NCT01270321|450407183|FG002|Overall Study|Adverse Event|5|||
125213086|NCT01393106|450407186|FG000|Overall Study|Adverse Event|3|||
125213087|NCT01393106|450407186|FG000|Overall Study|Withdrawal by Subject|1|||
125213088|NCT01393106|450407186|FG000|Overall Study|Lack of Efficacy|1|||
125213089|NCT03307837|450407187|FG000|Overall Study|Withdrawal by Subject|0|||
125213090|NCT03307837|450407188|FG001|Overall Study|Withdrawal by Subject|0|||
125213091|NCT03307837|450407189|FG002|Overall Study|Withdrawal by Subject|1|||
125213092|NCT03307837|450407190|FG003|Overall Study|Withdrawal by Subject|0|||
125213093|NCT03307837|450407191|FG004|Overall Study|Withdrawal by Subject|0|||
125213094|NCT03307837|450407192|FG005|Overall Study|Withdrawal by Subject|1|||
125213095|NCT03307837|450407187|FG000|Overall Study|Lost to Follow-up|1|||
125213096|NCT03307837|450407188|FG001|Overall Study|Lost to Follow-up|1|||
125213097|NCT03307837|450407189|FG002|Overall Study|Lost to Follow-up|0|||
125213098|NCT03307837|450407190|FG003|Overall Study|Lost to Follow-up|0|||
125213099|NCT03307837|450407191|FG004|Overall Study|Lost to Follow-up|0|||
125213100|NCT03307837|450407192|FG005|Overall Study|Lost to Follow-up|1|||
125213101|NCT05437640|450407193|FG000|Washout (1 Week)|Adverse Event|1|||
125213102|NCT05437640|450407194|FG001|Washout (1 Week)|Adverse Event|0|||
125213103|NCT00904917|450407195|FG000|Overall Study|Lost to Follow-up|2|||
125213104|NCT00904917|450407196|FG001|Overall Study|Lost to Follow-up|2|||
125213105|NCT00904917|450407197|FG002|Overall Study|Lost to Follow-up|2|||
125213106|NCT00904917|450407198|FG003|Overall Study|Lost to Follow-up|2|||
125213107|NCT04228965|450407201|FG000|Overall Study|Lost to Follow-up|26|||
125431781|NCT02055157|451207757|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
125213108|NCT04228965|450407202|FG001|Overall Study|Lost to Follow-up|11|||
125213109|NCT04228965|450407201|FG000|Overall Study|Withdrawal by Subject|18|||
125213110|NCT04228965|450407202|FG001|Overall Study|Withdrawal by Subject|5|||
125431782|NCT02055157|451207758|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
125607249|NCT03395197|451846465|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
125607250|NCT03395197|451846466|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
125607251|NCT03395197|451846467|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
125607252|NCT03395197|451846468|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
125607253|NCT03395197|451846463|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
125607254|NCT03395197|451846464|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
125607255|NCT03395197|451846465|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
125607256|NCT03395197|451846466|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
125607257|NCT03395197|451846467|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
125607258|NCT03395197|451846468|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
125607259|NCT03395197|451846463|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
125607260|NCT03395197|451846464|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
125607261|NCT03395197|451846465|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
125607262|NCT03395197|451846466|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
125607263|NCT03395197|451846467|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
125607264|NCT03395197|451846468|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
125607265|NCT03395197|451846463|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
125607266|NCT03395197|451846464|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
125607267|NCT03395197|451846465|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
125607268|NCT03395197|451846466|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
125607269|NCT03395197|451846467|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
125607270|NCT03395197|451846468|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
125607271|NCT03395197|451846463|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
125607272|NCT03395197|451846464|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
125607273|NCT03395197|451846465|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
125607274|NCT03395197|451846466|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
125607275|NCT03395197|451846467|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
125607276|NCT03395197|451846468|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
125607277|NCT03395197|451846463|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
125607278|NCT03395197|451846464|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
125607279|NCT03395197|451846465|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
125607280|NCT03395197|451846466|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
125607281|NCT03395197|451846467|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
125607282|NCT03395197|451846468|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
125607283|NCT03395197|451846463|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
125607284|NCT03395197|451846464|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
125607285|NCT03395197|451846465|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
125607286|NCT03395197|451846466|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
125607287|NCT03395197|451846467|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
125607288|NCT03395197|451846468|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
125607289|NCT03395197|451846463|FG000|Analysis for DDR-Deficient Participants|Death|0|||
125607290|NCT03395197|451846464|FG001|Analysis for DDR-Deficient Participants|Death|0|||
125607291|NCT03395197|451846465|FG002|Analysis for DDR-Deficient Participants|Death|0|||
125607292|NCT03395197|451846466|FG003|Analysis for DDR-Deficient Participants|Death|0|||
125607293|NCT03395197|451846467|FG004|Analysis for DDR-Deficient Participants|Death|1|||
125607294|NCT03395197|451846468|FG005|Analysis for DDR-Deficient Participants|Death|4|||
125607295|NCT03395197|451846463|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
125607296|NCT03395197|451846464|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
125607297|NCT03395197|451846465|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
125607298|NCT03395197|451846466|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
125607299|NCT03395197|451846467|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
125607300|NCT03395197|451846468|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
125607301|NCT03395197|451846463|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
125607302|NCT03395197|451846464|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
125607303|NCT03395197|451846465|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
125607304|NCT03395197|451846466|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
125607305|NCT03395197|451846467|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
125607306|NCT03395197|451846468|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
125607307|NCT03395197|451846463|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
125607308|NCT03395197|451846464|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
125607309|NCT03395197|451846465|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
125607310|NCT03395197|451846466|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
125213111|NCT00734656|450407205|FG000|Lab Session 1|Withdrawal by Subject|2|||
125213112|NCT00734656|450407206|FG001|Lab Session 1|Withdrawal by Subject|0|||
125370109|NCT03310021|450989177|FG017|Overall Study|Withdrawal by Subject|0|||
125370110|NCT03310021|450989178|FG018|Overall Study|Withdrawal by Subject|0|||
125370111|NCT03310021|450989179|FG019|Overall Study|Withdrawal by Subject|0|||
125370112|NCT03310021|450989160|FG000|Overall Study|Lost to Follow-up|0|||
125370113|NCT03310021|450989161|FG001|Overall Study|Lost to Follow-up|0|||
125370114|NCT03310021|450989162|FG002|Overall Study|Lost to Follow-up|0|||
125370115|NCT03310021|450989163|FG003|Overall Study|Lost to Follow-up|0|||
125370116|NCT03310021|450989164|FG004|Overall Study|Lost to Follow-up|0|||
125370117|NCT03310021|450989165|FG005|Overall Study|Lost to Follow-up|0|||
125370118|NCT03310021|450989166|FG006|Overall Study|Lost to Follow-up|0|||
125370119|NCT03310021|450989167|FG007|Overall Study|Lost to Follow-up|0|||
125370120|NCT03310021|450989168|FG008|Overall Study|Lost to Follow-up|0|||
125370121|NCT03310021|450989169|FG009|Overall Study|Lost to Follow-up|0|||
125370122|NCT03310021|450989170|FG010|Overall Study|Lost to Follow-up|1|||
125370123|NCT03310021|450989171|FG011|Overall Study|Lost to Follow-up|0|||
125370124|NCT03310021|450989172|FG012|Overall Study|Lost to Follow-up|0|||
125213113|NCT00734656|450407207|FG002|Lab Session 1|Withdrawal by Subject|0|||
125213114|NCT00734656|450407208|FG003|Lab Session 1|Withdrawal by Subject|0|||
125213115|NCT00734656|450407205|FG000|Washout 1|Withdrawal by Subject|1|||
125213116|NCT00734656|450407206|FG001|Washout 1|Withdrawal by Subject|5|||
125370125|NCT03310021|450989173|FG013|Overall Study|Lost to Follow-up|0|||
125370126|NCT03310021|450989174|FG014|Overall Study|Lost to Follow-up|0|||
125370127|NCT03310021|450989175|FG015|Overall Study|Lost to Follow-up|0|||
125370128|NCT03310021|450989176|FG016|Overall Study|Lost to Follow-up|0|||
125370129|NCT03310021|450989177|FG017|Overall Study|Lost to Follow-up|0|||
125370130|NCT03310021|450989178|FG018|Overall Study|Lost to Follow-up|0|||
125370131|NCT03310021|450989179|FG019|Overall Study|Lost to Follow-up|0|||
125370132|NCT01874054|450989180|FG000|Overall Study|Withdrawal by Subject|3|||
125370133|NCT01874054|450989180|FG000|Overall Study|Study Termination by Sponsor|42|||
125370134|NCT01874054|450989180|FG000|Overall Study|Lost to Follow-up|5|||
125370135|NCT01874054|450989180|FG000|Overall Study|Death|5|||
125370136|NCT00702923|450989181|FG000|Overall Study|Adverse Event|1|||
125370137|NCT03953820|450989187|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
125370138|NCT03953820|450989188|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
125370139|NCT03953820|450989189|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
125370140|NCT03953820|450989187|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
125370141|NCT03953820|450989188|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
125370142|NCT03953820|450989189|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
125370143|NCT00799422|450989190|FG000|First Week of Wear|Lost to Follow-up|0|||
125370144|NCT00799422|450989191|FG001|First Week of Wear|Lost to Follow-up|0|||
125370145|NCT00799422|450989192|FG002|First Week of Wear|Lost to Follow-up|1|||
125370146|NCT00799422|450989193|FG003|First Week of Wear|Lost to Follow-up|0|||
125370147|NCT00799422|450989194|FG004|First Week of Wear|Lost to Follow-up|0|||
125607311|NCT03395197|451846467|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
125607312|NCT03395197|451846468|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
125607313|NCT03395197|451846463|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
125607314|NCT03395197|451846464|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
125607315|NCT03395197|451846465|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
125607316|NCT03395197|451846466|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
125607317|NCT03395197|451846467|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
125607318|NCT03395197|451846468|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
125607319|NCT03395197|451846463|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
125607320|NCT03395197|451846464|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
125607321|NCT03395197|451846465|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
125607322|NCT03395197|451846466|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
125607323|NCT03395197|451846467|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
125607324|NCT03395197|451846468|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
125607325|NCT03395197|451846463|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
125607326|NCT03395197|451846464|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
125607327|NCT03395197|451846465|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
125607328|NCT03395197|451846466|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
125607329|NCT03395197|451846467|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
125607330|NCT03395197|451846468|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
125607331|NCT03395197|451846463|FG000|Analysis for DDR-Deficient Participants|Other|0|||
125607332|NCT03395197|451846464|FG001|Analysis for DDR-Deficient Participants|Other|0|||
125607333|NCT03395197|451846465|FG002|Analysis for DDR-Deficient Participants|Other|0|||
125607334|NCT03395197|451846466|FG003|Analysis for DDR-Deficient Participants|Other|0|||
125607335|NCT03395197|451846467|FG004|Analysis for DDR-Deficient Participants|Other|3|||
125607336|NCT03395197|451846468|FG005|Analysis for DDR-Deficient Participants|Other|3|||
125607337|NCT03395197|451846463|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
125607338|NCT03395197|451846464|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
125607339|NCT03395197|451846465|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
125607340|NCT03395197|451846466|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
125607341|NCT03395197|451846467|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
125607342|NCT03395197|451846468|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
125607343|NCT05137041|451846469|FG000|Overall Study|Lost to Follow-up|1|||
125607344|NCT05137041|451846470|FG001|Overall Study|Lost to Follow-up|1|||
125607345|NCT05137041|451846469|FG000|Overall Study|Withdrawal by Subject|0|||
125607346|NCT05137041|451846470|FG001|Overall Study|Withdrawal by Subject|2|||
125370148|NCT00799422|450989195|FG005|First Week of Wear|Lost to Follow-up|0|||
125370149|NCT00799422|450989190|FG000|First Week of Wear|Adverse Event|0|||
125370150|NCT00799422|450989191|FG001|First Week of Wear|Adverse Event|0|||
125370151|NCT00799422|450989192|FG002|First Week of Wear|Adverse Event|0|||
125370152|NCT00799422|450989193|FG003|First Week of Wear|Adverse Event|1|||
125607347|NCT05137041|451846469|FG000|Overall Study|Reason not Specified|0|||
125607348|NCT05137041|451846470|FG001|Overall Study|Reason not Specified|1|||
125607349|NCT01605071|451846471|FG000|Overall Study|Withdrawal by Subject|3|||
125370153|NCT00799422|450989194|FG004|First Week of Wear|Adverse Event|0|||
125370154|NCT00799422|450989195|FG005|First Week of Wear|Adverse Event|0|||
125370155|NCT00622284|450989197|FG000|Overall Study|Lack of Efficacy|45|||
125370156|NCT00622284|450989198|FG001|Overall Study|Lack of Efficacy|15|||
125607350|NCT01605071|451846472|FG001|Overall Study|Withdrawal by Subject|2|||
125607351|NCT00392171|451846473|FG000|Overall Study|Did not meet inclusion criteria|4|||
125607352|NCT00392171|451846473|FG000|Overall Study|Disease progression|101|||
125607353|NCT04907539|451846479|FG000|Overall Study|Consent withdrawn|1|||
125607354|NCT04907539|451846480|FG001|Overall Study|Consent withdrawn|0|||
125607355|NCT04907539|451846479|FG000|Overall Study|Death|14|||
125607356|NCT04907539|451846480|FG001|Overall Study|Death|3|||
125607357|NCT01881620|451846482|FG000|Overall Study|Protocol Violation|4|||
125607358|NCT01808118|451846483|FG000|Period 1|Adverse Event|15|||
125607359|NCT01808118|451846484|FG001|Period 1|Adverse Event|0|||
125607360|NCT01808118|451846485|FG002|Period 1|Adverse Event|0|||
125607361|NCT01808118|451846483|FG000|Period 1|Withdrew consent|24|||
125607362|NCT01808118|451846484|FG001|Period 1|Withdrew consent|0|||
125607363|NCT01808118|451846485|FG002|Period 1|Withdrew consent|0|||
125607364|NCT01808118|451846483|FG000|Period 1|Lost to Follow-up|9|||
125607365|NCT01808118|451846484|FG001|Period 1|Lost to Follow-up|0|||
125607366|NCT01808118|451846485|FG002|Period 1|Lost to Follow-up|0|||
125607367|NCT01808118|451846483|FG000|Period 1|Did not meet criteria for remission|303|||
125607368|NCT01808118|451846484|FG001|Period 1|Did not meet criteria for remission|0|||
125607369|NCT01808118|451846485|FG002|Period 1|Did not meet criteria for remission|0|||
125607370|NCT01808118|451846483|FG000|Period 1|Enrolled in error|7|||
125607371|NCT01808118|451846484|FG001|Period 1|Enrolled in error|0|||
125607372|NCT01808118|451846485|FG002|Period 1|Enrolled in error|0|||
125607373|NCT01808118|451846483|FG000|Period 1|Did not meet inclusion criteria|3|||
125607374|NCT01808118|451846484|FG001|Period 1|Did not meet inclusion criteria|0|||
125607375|NCT01808118|451846485|FG002|Period 1|Did not meet inclusion criteria|0|||
125607376|NCT01808118|451846483|FG000|Period 1|Non-conformance with inclusion criteria|3|||
125607377|NCT01808118|451846484|FG001|Period 1|Non-conformance with inclusion criteria|0|||
125607378|NCT01808118|451846485|FG002|Period 1|Non-conformance with inclusion criteria|0|||
125607379|NCT01808118|451846483|FG000|Period 1|Investigator decision: site closure|2|||
125607380|NCT01808118|451846484|FG001|Period 1|Investigator decision: site closure|0|||
125607381|NCT01808118|451846485|FG002|Period 1|Investigator decision: site closure|0|||
125607382|NCT01808118|451846483|FG000|Period 1|Non-compliance per sponsor|1|||
125607383|NCT01808118|451846484|FG001|Period 1|Non-compliance per sponsor|0|||
125607384|NCT01808118|451846485|FG002|Period 1|Non-compliance per sponsor|0|||
125607385|NCT01808118|451846483|FG000|Period 1|Lack of Efficacy|1|||
125607386|NCT01808118|451846484|FG001|Period 1|Lack of Efficacy|0|||
125607387|NCT01808118|451846485|FG002|Period 1|Lack of Efficacy|0|||
125607388|NCT01808118|451846483|FG000|Period 2|Adverse Event|0|||
125607389|NCT01808118|451846484|FG001|Period 2|Adverse Event|4|||
125607390|NCT01808118|451846485|FG002|Period 2|Adverse Event|0|||
125607391|NCT01808118|451846483|FG000|Period 2|Withdrew consent|0|||
125607392|NCT01808118|451846484|FG001|Period 2|Withdrew consent|7|||
125607393|NCT01808118|451846485|FG002|Period 2|Withdrew consent|6|||
125607394|NCT01808118|451846483|FG000|Period 2|Lost to Follow-up|0|||
125607395|NCT01808118|451846484|FG001|Period 2|Lost to Follow-up|0|||
125607396|NCT01808118|451846485|FG002|Period 2|Lost to Follow-up|2|||
125607397|NCT01808118|451846483|FG000|Period 2|Investigator no longer conducting trials|0|||
125607398|NCT01808118|451846484|FG001|Period 2|Investigator no longer conducting trials|1|||
125607399|NCT01808118|451846485|FG002|Period 2|Investigator no longer conducting trials|0|||
125607400|NCT01808118|451846483|FG000|Period 2|Switched to other therapy|0|||
125607401|NCT01808118|451846484|FG001|Period 2|Switched to other therapy|1|||
125607402|NCT01808118|451846485|FG002|Period 2|Switched to other therapy|0|||
125607403|NCT01701583|451846486|FG000|Overall Study|Withdrawal by Subject|2|||
125607404|NCT01701583|451846487|FG001|Overall Study|Withdrawal by Subject|0|||
125607405|NCT01441440|451846488|FG000|Overall Study|Death|1|||
125607406|NCT01441440|451846489|FG001|Overall Study|Death|0|||
125607407|NCT01441440|451846490|FG002|Overall Study|Death|1|||
125607408|NCT01441440|451846488|FG000|Overall Study|Adverse Event|2|||
125607409|NCT01441440|451846489|FG001|Overall Study|Adverse Event|9|||
125607410|NCT01441440|451846490|FG002|Overall Study|Adverse Event|9|||
125607411|NCT01441440|451846488|FG000|Overall Study|Lost to Follow-up|0|||
125607412|NCT01441440|451846489|FG001|Overall Study|Lost to Follow-up|2|||
125607413|NCT01441440|451846490|FG002|Overall Study|Lost to Follow-up|1|||
125607414|NCT01441440|451846488|FG000|Overall Study|Withdrawal by Subject|11|||
125607415|NCT01441440|451846489|FG001|Overall Study|Withdrawal by Subject|9|||
125607416|NCT01441440|451846490|FG002|Overall Study|Withdrawal by Subject|9|||
125607417|NCT01441440|451846488|FG000|Overall Study|Pregnancy|1|||
125607418|NCT01441440|451846489|FG001|Overall Study|Pregnancy|0|||
125607419|NCT01441440|451846490|FG002|Overall Study|Pregnancy|0|||
125607420|NCT01441440|451846488|FG000|Overall Study|Lack of Efficacy|1|||
125607421|NCT01441440|451846489|FG001|Overall Study|Lack of Efficacy|0|||
125607422|NCT01441440|451846490|FG002|Overall Study|Lack of Efficacy|1|||
125213117|NCT00734656|450407207|FG002|Washout 1|Withdrawal by Subject|2|||
125213118|NCT00734656|450407208|FG003|Washout 1|Withdrawal by Subject|3|||
125607423|NCT01441440|451846488|FG000|Overall Study|Moving|0|||
125607424|NCT01441440|451846489|FG001|Overall Study|Moving|1|||
125607425|NCT01441440|451846490|FG002|Overall Study|Moving|1|||
125607426|NCT01441440|451846488|FG000|Overall Study|Work-related matter|0|||
125607427|NCT01441440|451846489|FG001|Overall Study|Work-related matter|1|||
125607428|NCT01441440|451846490|FG002|Overall Study|Work-related matter|0|||
125607429|NCT01441440|451846488|FG000|Overall Study|Difficllty in keeping the schedule|1|||
125370157|NCT00622284|450989197|FG000|Overall Study|Adverse Event|61|||
125370158|NCT00622284|450989198|FG001|Overall Study|Adverse Event|90|||
125370159|NCT00622284|450989197|FG000|Overall Study|Protocol Violation|12|||
125370160|NCT00622284|450989198|FG001|Overall Study|Protocol Violation|5|||
125370161|NCT00622284|450989197|FG000|Overall Study|Lost to Follow-up|11|||
125370162|NCT00622284|450989198|FG001|Overall Study|Lost to Follow-up|13|||
125370163|NCT00622284|450989197|FG000|Overall Study|Withdrawal by Subject|27|||
125370164|NCT00622284|450989198|FG001|Overall Study|Withdrawal by Subject|24|||
125370165|NCT00622284|450989197|FG000|Overall Study|Other reason (not specified)|33|||
125370166|NCT00622284|450989198|FG001|Overall Study|Other reason (not specified)|24|||
125370167|NCT03322631|450989203|FG000|Overall Study|Withdrawal by Subject|0|||
125370168|NCT03322631|450989204|FG001|Overall Study|Withdrawal by Subject|1|||
125370169|NCT03322631|450989205|FG002|Overall Study|Withdrawal by Subject|0|||
125370170|NCT03322631|450989206|FG003|Overall Study|Withdrawal by Subject|0|||
125370171|NCT03322631|450989203|FG000|Overall Study|Adverse Event|0|||
125370172|NCT03322631|450989204|FG001|Overall Study|Adverse Event|0|||
125370173|NCT03322631|450989205|FG002|Overall Study|Adverse Event|1|||
125370174|NCT03322631|450989206|FG003|Overall Study|Adverse Event|0|||
125370175|NCT02412618|450989208|FG000|Overall Study|Withdrawal by Subject|1|||
125370176|NCT02412618|450989209|FG001|Overall Study|Withdrawal by Subject|1|||
125370177|NCT02412618|450989208|FG000|Overall Study|Expulsion|1|||
125370178|NCT02412618|450989209|FG001|Overall Study|Expulsion|1|||
125370179|NCT01217801|450989210|FG000|Period 1|Protocol Violation|1|||
125370180|NCT01217801|450989211|FG001|Period 1|Protocol Violation|1|||
125370181|NCT01217801|450989210|FG000|Period 1|Withdrawal by Subject|0|||
125370182|NCT01217801|450989211|FG001|Period 1|Withdrawal by Subject|1|||
125370183|NCT00291577|450989216|FG000|Overall Study|Adverse Event|1|||
125370184|NCT00291577|450989216|FG000|Overall Study|Other|4|||
125370185|NCT00291577|450989216|FG000|Overall Study|Withdrawal by Subject|2|||
125370186|NCT00291577|450989216|FG000|Overall Study|Lack of Efficacy|14|||
125607430|NCT01441440|451846489|FG001|Overall Study|Difficllty in keeping the schedule|1|||
125607431|NCT01441440|451846490|FG002|Overall Study|Difficllty in keeping the schedule|0|||
125607432|NCT02750813|451846496|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
125607433|NCT02750813|451846497|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
125607434|NCT02750813|451846496|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
125607435|NCT02750813|451846497|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
125607436|NCT00615290|451846498|FG000|Overall Study|Adverse Event|2|||
125607437|NCT00615290|451846498|FG000|Overall Study|Lost to Follow-up|3|||
125607438|NCT00615290|451846498|FG000|Overall Study|Withdrawal by Subject|1|||
125607439|NCT00615290|451846498|FG000|Overall Study|Other|2|||
125607440|NCT00972478|451846514|FG000|Overall Study|Adverse Event|3|||
125607441|NCT00972478|451846515|FG001|Overall Study|Adverse Event|16|||
125607442|NCT00972478|451846514|FG000|Overall Study|Withdrawal by Subject|1|||
125607443|NCT00972478|451846515|FG001|Overall Study|Withdrawal by Subject|8|||
125607444|NCT00972478|451846514|FG000|Overall Study|Progression/Relapse|0|||
125607445|NCT00972478|451846515|FG001|Overall Study|Progression/Relapse|2|||
125607446|NCT00972478|451846514|FG000|Overall Study|Death|0|||
125607447|NCT00972478|451846515|FG001|Overall Study|Death|2|||
125607448|NCT00972478|451846514|FG000|Overall Study|Not protocol specified|1|||
125607449|NCT00972478|451846515|FG001|Overall Study|Not protocol specified|1|||
125607450|NCT00972478|451846514|FG000|Overall Study|Ineligible|1|||
125607451|NCT00972478|451846515|FG001|Overall Study|Ineligible|7|||
125607452|NCT00972478|451846514|FG000|Overall Study|Not start protocol treatment|1|||
125607453|NCT00972478|451846515|FG001|Overall Study|Not start protocol treatment|2|||
125607454|NCT01522976|451846516|FG000|Overall Study|Ineligible|4|||
125607455|NCT01522976|451846517|FG001|Overall Study|Ineligible|0|||
125607456|NCT01522976|451846518|FG002|Overall Study|Ineligible|1|||
125607457|NCT01522976|451846516|FG000|Overall Study|Death|7|||
125607458|NCT01522976|451846517|FG001|Overall Study|Death|6|||
125607459|NCT01522976|451846518|FG002|Overall Study|Death|2|||
125607460|NCT01522976|451846516|FG000|Overall Study|Still on treatment|9|||
125607461|NCT01522976|451846517|FG001|Overall Study|Still on treatment|9|||
125370187|NCT04967443|450989219|FG000|Open Label Treatment|Death|1|||
125370188|NCT04967443|450989220|FG001|Open Label Treatment|Death|0|||
125370189|NCT04967443|450989221|FG002|Open Label Treatment|Death|0|||
125370190|NCT04967443|450989222|FG003|Open Label Treatment|Death|0|||
125370191|NCT04967443|450989223|FG004|Open Label Treatment|Death|0|||
125370192|NCT04967443|450989224|FG005|Open Label Treatment|Death|0|||
125370193|NCT04967443|450989225|FG006|Open Label Treatment|Death|0|||
125370194|NCT04967443|450989226|FG007|Open Label Treatment|Death|0|||
125370195|NCT04967443|450989219|FG000|Open Label Treatment|Lost to Follow-up|0|||
125607462|NCT01522976|451846518|FG002|Overall Study|Still on treatment|6|||
125607463|NCT01522976|451846516|FG000|Overall Study|Disease progression|28|||
125607464|NCT01522976|451846517|FG001|Overall Study|Disease progression|30|||
125607465|NCT01522976|451846518|FG002|Overall Study|Disease progression|25|||
125607466|NCT01522976|451846516|FG000|Overall Study|Adverse Event|17|||
125607467|NCT01522976|451846517|FG001|Overall Study|Adverse Event|7|||
125607468|NCT01522976|451846518|FG002|Overall Study|Adverse Event|18|||
125607469|NCT01522976|451846516|FG000|Overall Study|Refusal unrelated to adverse event|10|||
125607470|NCT01522976|451846517|FG001|Overall Study|Refusal unrelated to adverse event|13|||
125607471|NCT01522976|451846518|FG002|Overall Study|Refusal unrelated to adverse event|14|||
125607472|NCT01522976|451846516|FG000|Overall Study|Not protocol specified|22|||
125607473|NCT01522976|451846517|FG001|Overall Study|Not protocol specified|27|||
125607474|NCT01522976|451846518|FG002|Overall Study|Not protocol specified|27|||
125607475|NCT04075266|451846519|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
125607476|NCT04075266|451846520|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
125607477|NCT04075266|451846519|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
125607478|NCT04075266|451846520|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
125607479|NCT05132569|451846521|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
125607480|NCT05132569|451846522|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
125607481|NCT05132569|451846521|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
125607482|NCT05132569|451846522|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
125607483|NCT05132569|451846521|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
125607484|NCT05132569|451846522|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
125607485|NCT04102098|451846523|FG000|Main Study Period|Ongoing in study|302|||
125607486|NCT04102098|451846524|FG001|Main Study Period|Ongoing in study|291|||
125607487|NCT04102098|451846523|FG000|Main Study Period|Death|20|||
125607488|NCT04102098|451846524|FG001|Main Study Period|Death|27|||
125607489|NCT04102098|451846523|FG000|Main Study Period|Lost to Follow-up|1|||
125607490|NCT04102098|451846524|FG001|Main Study Period|Lost to Follow-up|1|||
125607491|NCT04102098|451846523|FG000|Main Study Period|Physician Decision|0|||
125607492|NCT04102098|451846524|FG001|Main Study Period|Physician Decision|1|||
125607493|NCT04102098|451846523|FG000|Main Study Period|Withdrawal by Subject|11|||
125607494|NCT04102098|451846524|FG001|Main Study Period|Withdrawal by Subject|14|||
125607495|NCT04102098|451846523|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
125607496|NCT04102098|451846524|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
125607497|NCT04102098|451846523|FG000|Crossover: AS Who Crossed Over|Death|11|||
125607498|NCT04102098|451846524|FG001|Crossover: AS Who Crossed Over|Death|0|||
125607499|NCT04102098|451846523|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
125607500|NCT04102098|451846524|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
125607501|NCT04742907|451846525|FG000|Overall Study|Adverse Event|1|||
125607502|NCT04742907|451846526|FG001|Overall Study|Adverse Event|0|||
125607503|NCT04742907|451846527|FG002|Overall Study|Adverse Event|1|||
125607504|NCT04742907|451846525|FG000|Overall Study|Lost to Follow-up|3|||
125431783|NCT02055157|451207759|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
125431784|NCT02055157|451207760|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
125431785|NCT02055157|451207757|FG000|Initial 6 Months|Adverse Event|0|||
125607505|NCT04742907|451846526|FG001|Overall Study|Lost to Follow-up|3|||
125607506|NCT04742907|451846527|FG002|Overall Study|Lost to Follow-up|2|||
125607507|NCT04742907|451846525|FG000|Overall Study|Physician Decision|0|||
125607508|NCT04742907|451846526|FG001|Overall Study|Physician Decision|1|||
125607509|NCT04742907|451846527|FG002|Overall Study|Physician Decision|0|||
125607510|NCT04742907|451846525|FG000|Overall Study|Protocol Violation|1|||
125607511|NCT04742907|451846526|FG001|Overall Study|Protocol Violation|1|||
125607512|NCT04742907|451846527|FG002|Overall Study|Protocol Violation|1|||
125607513|NCT04742907|451846525|FG000|Overall Study|Withdrawal by Subject|5|||
125607514|NCT04742907|451846526|FG001|Overall Study|Withdrawal by Subject|6|||
125607515|NCT04742907|451846527|FG002|Overall Study|Withdrawal by Subject|4|||
125607516|NCT04742907|451846525|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
125607517|NCT04742907|451846526|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
125607518|NCT04742907|451846527|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
125607519|NCT04742907|451846525|FG000|Overall Study|Did Not Receive the Study Drug|2|||
125607520|NCT04742907|451846526|FG001|Overall Study|Did Not Receive the Study Drug|4|||
125607521|NCT04742907|451846527|FG002|Overall Study|Did Not Receive the Study Drug|4|||
125607522|NCT02280291|451846528|FG000|Overall Study|Lost to Follow-up|2|||
125607523|NCT02280291|451846529|FG001|Overall Study|Lost to Follow-up|1|||
125607524|NCT02280291|451846530|FG002|Overall Study|Lost to Follow-up|3|||
125607525|NCT02280291|451846531|FG003|Overall Study|Lost to Follow-up|8|||
125607526|NCT02280291|451846528|FG000|Overall Study|Protocol Violation|1|||
125607527|NCT02280291|451846529|FG001|Overall Study|Protocol Violation|0|||
125607528|NCT02280291|451846530|FG002|Overall Study|Protocol Violation|0|||
125607529|NCT02280291|451846531|FG003|Overall Study|Protocol Violation|0|||
125607530|NCT02280291|451846528|FG000|Overall Study|Other|1|||
125607531|NCT02280291|451846529|FG001|Overall Study|Other|1|||
125607532|NCT02280291|451846530|FG002|Overall Study|Other|0|||
125607533|NCT02280291|451846531|FG003|Overall Study|Other|0|||
125607534|NCT03508622|451846532|FG000|Overall Study|Protocol Violation|1|||
125607535|NCT03508622|451846533|FG001|Overall Study|Protocol Violation|0|||
125607536|NCT03508622|451846532|FG000|Overall Study|Withdrawal by Subject|1|||
125607537|NCT03508622|451846533|FG001|Overall Study|Withdrawal by Subject|0|||
125607538|NCT03508622|451846532|FG000|Overall Study|Lost to Follow-up|16|||
125607539|NCT03508622|451846533|FG001|Overall Study|Lost to Follow-up|0|||
125607540|NCT03508622|451846532|FG000|Overall Study|Incomplete data|0|||
125607541|NCT03508622|451846533|FG001|Overall Study|Incomplete data|24|||
125607542|NCT00210158|451846535|FG000|Overall Study|Protocol Violation|0|||
125607543|NCT00210158|451846536|FG001|Overall Study|Protocol Violation|2|||
125607544|NCT03196505|451846538|FG000|Overall Study|Physician Decision|26|||
125607545|NCT03196505|451846539|FG001|Overall Study|Physician Decision|26|||
125607546|NCT05590793|451846541|FG000|Overall Study|Withdrawal by Subject|6|||
125607547|NCT05590793|451846541|FG000|Overall Study|Physician Decision|1|||
125607548|NCT03015610|451846546|FG000|Overall Study|Lost to Follow-up|1|||
125607549|NCT03015610|451846547|FG001|Overall Study|Lost to Follow-up|5|||
125607550|NCT05692154|451846549|FG000|Overall Study|Adverse Event|0|||
125607551|NCT05692154|451846550|FG001|Overall Study|Adverse Event|1|||
125607552|NCT00938327|451846556|FG000|Overall Study|Adverse Event|2|||
125607553|NCT00938327|451846556|FG000|Overall Study|Protocol Violation|1|||
125607554|NCT00938327|451846556|FG000|Overall Study|Withdrawal by Subject|4|||
125607555|NCT00938327|451846556|FG000|Overall Study|Lost to Follow-up|37|||
125607556|NCT00938327|451846556|FG000|Overall Study|2nd dose received outside of the study|7|||
125607557|NCT00938327|451846556|FG000|Overall Study|Vaccine not received as out of stock|9|||
125607558|NCT02552355|451846557|FG000|Overall Study|Adverse Event|0|||
125607559|NCT02552355|451846558|FG001|Overall Study|Adverse Event|2|||
125607560|NCT02552355|451846559|FG002|Overall Study|Adverse Event|2|||
125607561|NCT02552355|451846560|FG003|Overall Study|Adverse Event|0|||
125607562|NCT02552355|451846557|FG000|Overall Study|Withdrawal by Subject|0|||
125607563|NCT02552355|451846558|FG001|Overall Study|Withdrawal by Subject|0|||
125607564|NCT02552355|451846559|FG002|Overall Study|Withdrawal by Subject|0|||
125607565|NCT02552355|451846560|FG003|Overall Study|Withdrawal by Subject|1|||
125607566|NCT01519245|451846561|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
125607567|NCT01519245|451846562|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
125607568|NCT04072146|451846565|FG000|Overall Study|Adverse Event|0|||
125607569|NCT04072146|451846566|FG001|Overall Study|Adverse Event|1|||
125607570|NCT01193348|451846570|FG000|Screening Period|Screen Failure|5|||
125607571|NCT01193348|451846570|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
125607572|NCT01193348|451846570|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
125607573|NCT01193348|451846570|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
125607574|NCT01193348|451846570|FG000|Extension Treatment Period|Physician Decision|1|||
125607575|NCT01193348|451846570|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
125607576|NCT04070378|451846571|FG000|Overall Study|Withdrawal by Subject|2|||
125607577|NCT04070378|451846571|FG000|Overall Study|Screen Failure|6|||
125607578|NCT04070378|451846571|FG000|Overall Study|Physician Decision|1|||
125607579|NCT04070378|451846571|FG000|Overall Study|Adverse Event|1|||
125607580|NCT03259334|451846572|FG000|Overall Study|Adverse Event|3|||
125607581|NCT03259334|451846573|FG001|Overall Study|Adverse Event|8|||
125607582|NCT03259334|451846574|FG002|Overall Study|Adverse Event|5|||
125607583|NCT03259334|451846572|FG000|Overall Study|Withdrawal by Subject|4|||
125607584|NCT03259334|451846573|FG001|Overall Study|Withdrawal by Subject|2|||
125607585|NCT03259334|451846574|FG002|Overall Study|Withdrawal by Subject|4|||
125607586|NCT03259334|451846572|FG000|Overall Study|Physician Decision|1|||
125607587|NCT03259334|451846573|FG001|Overall Study|Physician Decision|0|||
125607588|NCT03259334|451846574|FG002|Overall Study|Physician Decision|0|||
125607589|NCT03259334|451846572|FG000|Overall Study|Lost to Follow-up|0|||
125607590|NCT03259334|451846573|FG001|Overall Study|Lost to Follow-up|2|||
125607591|NCT03259334|451846574|FG002|Overall Study|Lost to Follow-up|1|||
125607592|NCT03259334|451846572|FG000|Overall Study|Protocol Deviation|0|||
125607593|NCT03259334|451846573|FG001|Overall Study|Protocol Deviation|3|||
125607594|NCT03259334|451846574|FG002|Overall Study|Protocol Deviation|2|||
125607595|NCT03259334|451846572|FG000|Overall Study|Lack of Efficacy|2|||
125607596|NCT03259334|451846573|FG001|Overall Study|Lack of Efficacy|0|||
125607597|NCT03259334|451846574|FG002|Overall Study|Lack of Efficacy|1|||
125607598|NCT03259334|451846572|FG000|Overall Study|Randomized but never treated|0|||
125607599|NCT03259334|451846573|FG001|Overall Study|Randomized but never treated|2|||
125607600|NCT03259334|451846574|FG002|Overall Study|Randomized but never treated|0|||
125607601|NCT03141086|451846575|FG000|Overall Study|Study Terminated By Sponsor|1|||
125607602|NCT03141086|451846576|FG001|Overall Study|Study Terminated By Sponsor|1|||
125607603|NCT03141086|451846575|FG000|Overall Study|Withdrawal by Subject|0|||
125607604|NCT03141086|451846576|FG001|Overall Study|Withdrawal by Subject|1|||
125607605|NCT03141086|451846575|FG000|Overall Study|Protocol Violation|0|||
125607606|NCT03141086|451846576|FG001|Overall Study|Protocol Violation|1|||
125607607|NCT03141086|451846575|FG000|Overall Study|Adverse Event|0|||
125607608|NCT03141086|451846576|FG001|Overall Study|Adverse Event|2|||
125607609|NCT00719732|451846577|FG000|Overall Study|Lost to Follow-up|20|||
125607610|NCT00719732|451846577|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
125607611|NCT00719732|451846577|FG000|Overall Study|Illness not associated with device|1|||
125607612|NCT05306873|451847953|FG000|Stage 2|Study stopped|1|||
125607613|NCT05306873|451847954|FG001|Stage 2|Study stopped|1|||
125607614|NCT05306873|451847955|FG002|Stage 2|Study stopped|0|||
125607615|NCT05306873|451847956|FG003|Stage 2|Study stopped|0|||
125607616|NCT05306873|451847953|FG000|Stage 2|Stage 2 Treatment Failure|2|||
125607617|NCT05306873|451847954|FG001|Stage 2|Stage 2 Treatment Failure|3|||
125607618|NCT05306873|451847955|FG002|Stage 2|Stage 2 Treatment Failure|0|||
125607619|NCT05306873|451847956|FG003|Stage 2|Stage 2 Treatment Failure|0|||
125607620|NCT05306873|451847953|FG000|Stage 2|Logistical issues due to participant moving|1|||
125607621|NCT05306873|451847954|FG001|Stage 2|Logistical issues due to participant moving|0|||
125607622|NCT05306873|451847955|FG002|Stage 2|Logistical issues due to participant moving|0|||
125370196|NCT04967443|450989220|FG001|Open Label Treatment|Lost to Follow-up|0|||
125607623|NCT05306873|451847956|FG003|Stage 2|Logistical issues due to participant moving|0|||
125607624|NCT05306873|451847953|FG000|Stage 3|Stage 3 Treatment Failure|0|||
125607625|NCT05306873|451847954|FG001|Stage 3|Stage 3 Treatment Failure|0|||
125370197|NCT04967443|450989221|FG002|Open Label Treatment|Lost to Follow-up|1|||
125370198|NCT04967443|450989222|FG003|Open Label Treatment|Lost to Follow-up|0|||
125370199|NCT04967443|450989223|FG004|Open Label Treatment|Lost to Follow-up|0|||
125370200|NCT04967443|450989224|FG005|Open Label Treatment|Lost to Follow-up|0|||
125370201|NCT04967443|450989225|FG006|Open Label Treatment|Lost to Follow-up|0|||
125370202|NCT04967443|450989226|FG007|Open Label Treatment|Lost to Follow-up|0|||
125370203|NCT04967443|450989219|FG000|Open Label Treatment|Withdrawal by Subject|0|||
125370204|NCT04967443|450989220|FG001|Open Label Treatment|Withdrawal by Subject|1|||
125607626|NCT05306873|451847955|FG002|Stage 3|Stage 3 Treatment Failure|0|||
125607627|NCT05306873|451847956|FG003|Stage 3|Stage 3 Treatment Failure|1|||
125607628|NCT05306873|451847953|FG000|Stage 3|Study Stopped|0|||
125607629|NCT05306873|451847954|FG001|Stage 3|Study Stopped|0|||
125607630|NCT05306873|451847955|FG002|Stage 3|Study Stopped|1|||
125607631|NCT05306873|451847956|FG003|Stage 3|Study Stopped|0|||
125607632|NCT03625986|451847965|FG000|Randomization Period|Lost to Follow-up|7|||
125607633|NCT03625986|451847966|FG001|Randomization Period|Lost to Follow-up|12|||
125607634|NCT03625986|451847965|FG000|Randomization Period|Withdrawal by Subject|10|||
125607635|NCT03625986|451847966|FG001|Randomization Period|Withdrawal by Subject|6|||
125607636|NCT04920084|451847968|FG000|Overall Study|Adverse Event|1|||
125607637|NCT04920084|451847968|FG000|Overall Study|Lost to Follow-up|2|||
125607638|NCT04920084|451847968|FG000|Overall Study|Withdrawal by Subject|2|||
125607639|NCT00620321|451847969|FG000|Overall Study|Adverse Event|1|||
125607640|NCT00620321|451847970|FG001|Overall Study|Adverse Event|1|||
125607641|NCT00620321|451847969|FG000|Overall Study|Death|1|||
125607642|NCT00620321|451847970|FG001|Overall Study|Death|1|||
125607643|NCT00620321|451847969|FG000|Overall Study|Physician Decision|0|||
125607644|NCT00620321|451847970|FG001|Overall Study|Physician Decision|7|||
125607645|NCT00620321|451847969|FG000|Overall Study|Progressive Disease|5|||
125607646|NCT00620321|451847970|FG001|Overall Study|Progressive Disease|5|||
125607647|NCT00620321|451847969|FG000|Overall Study|Sponsor Decision|0|||
125607648|NCT00620321|451847970|FG001|Overall Study|Sponsor Decision|1|||
125607649|NCT00620321|451847969|FG000|Overall Study|Withdrawal by Subject|1|||
125607650|NCT00620321|451847970|FG001|Overall Study|Withdrawal by Subject|1|||
125607651|NCT04191967|451847971|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
125607652|NCT04191967|451847971|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
125607653|NCT01431144|451847972|FG000|Overall Study|Implant mobility and removal|2|||
125607654|NCT01431144|451847973|FG001|Overall Study|Implant mobility and removal|0|||
125607655|NCT02410902|451847982|FG000|Overall Study|Adverse Event|2|||
125607656|NCT02410902|451847983|FG001|Overall Study|Adverse Event|3|||
125607657|NCT02410902|451847982|FG000|Overall Study|Lost to Follow-up|4|||
125607658|NCT02410902|451847983|FG001|Overall Study|Lost to Follow-up|1|||
125607659|NCT02410902|451847982|FG000|Overall Study|Protocol Violation|1|||
125607660|NCT02410902|451847983|FG001|Overall Study|Protocol Violation|4|||
125607661|NCT02410902|451847982|FG000|Overall Study|Withdrawal by Subject|6|||
125607662|NCT02410902|451847983|FG001|Overall Study|Withdrawal by Subject|8|||
125607663|NCT02410902|451847982|FG000|Overall Study|Non-Compliance|8|||
125607664|NCT02410902|451847983|FG001|Overall Study|Non-Compliance|2|||
125607665|NCT00953043|451847984|FG000|Overall Study|Withdrawal by Subject|4|||
125607666|NCT00953043|451847985|FG001|Overall Study|Withdrawal by Subject|0|||
125607667|NCT00953043|451847984|FG000|Overall Study|Physician Decision|0|||
125607668|NCT00953043|451847985|FG001|Overall Study|Physician Decision|2|||
125607669|NCT00701727|451847987|FG000|First Treatment Period|Adverse Event|0|||
125607670|NCT00701727|451847988|FG001|First Treatment Period|Adverse Event|0|||
125607671|NCT00701727|451847987|FG000|First Treatment Period|Withdrawal by Subject|1|||
125607672|NCT00701727|451847988|FG001|First Treatment Period|Withdrawal by Subject|0|||
125607673|NCT00701727|451847987|FG000|First Treatment Period|sponsor decision|0|||
125607674|NCT00701727|451847988|FG001|First Treatment Period|sponsor decision|1|||
125607675|NCT00701727|451847987|FG000|First Treatment Period|Lost to Follow-up|0|||
125607676|NCT00701727|451847988|FG001|First Treatment Period|Lost to Follow-up|1|||
125607677|NCT00701727|451847987|FG000|Second Treatment Period|Withdrawal by Subject|2|||
125607678|NCT00701727|451847988|FG001|Second Treatment Period|Withdrawal by Subject|0|||
125607679|NCT05113953|451847991|FG000|Overall Study|Adverse Event|5|||
125607680|NCT05113953|451847992|FG001|Overall Study|Adverse Event|0|||
125607681|NCT05113953|451847993|FG002|Overall Study|Adverse Event|3|||
125607682|NCT05113953|451847991|FG000|Overall Study|Lost to Follow-up|3|||
125607683|NCT05113953|451847992|FG001|Overall Study|Lost to Follow-up|4|||
125607684|NCT05113953|451847993|FG002|Overall Study|Lost to Follow-up|2|||
125607685|NCT05113953|451847991|FG000|Overall Study|Non-compliance with Study Drug|1|||
125370205|NCT04967443|450989221|FG002|Open Label Treatment|Withdrawal by Subject|0|||
125370206|NCT04967443|450989222|FG003|Open Label Treatment|Withdrawal by Subject|1|||
125370207|NCT04967443|450989223|FG004|Open Label Treatment|Withdrawal by Subject|0|||
125370208|NCT04967443|450989224|FG005|Open Label Treatment|Withdrawal by Subject|1|||
125370209|NCT04967443|450989225|FG006|Open Label Treatment|Withdrawal by Subject|2|||
125370210|NCT04967443|450989226|FG007|Open Label Treatment|Withdrawal by Subject|3|||
125370211|NCT04967443|450989219|FG000|Follow-Up|Death|1|||
125370212|NCT04967443|450989220|FG001|Follow-Up|Death|0|||
125370213|NCT04967443|450989221|FG002|Follow-Up|Death|0|||
125370214|NCT04967443|450989222|FG003|Follow-Up|Death|0|||
125370215|NCT04967443|450989223|FG004|Follow-Up|Death|0|||
125607686|NCT05113953|451847992|FG001|Overall Study|Non-compliance with Study Drug|0|||
125607687|NCT05113953|451847993|FG002|Overall Study|Non-compliance with Study Drug|0|||
125607688|NCT05113953|451847991|FG000|Overall Study|Withdrawal by Subject|2|||
125370216|NCT04967443|450989224|FG005|Follow-Up|Death|0|||
125607689|NCT05113953|451847992|FG001|Overall Study|Withdrawal by Subject|6|||
125607690|NCT05113953|451847993|FG002|Overall Study|Withdrawal by Subject|4|||
125607691|NCT05113953|451847991|FG000|Overall Study|Reason not Specified|2|||
125607692|NCT05113953|451847992|FG001|Overall Study|Reason not Specified|0|||
125370217|NCT04967443|450989225|FG006|Follow-Up|Death|0|||
125370218|NCT04967443|450989226|FG007|Follow-Up|Death|0|||
125607693|NCT05113953|451847993|FG002|Overall Study|Reason not Specified|0|||
125607694|NCT00523341|451847994|FG000|Overall Study|Withdrawal by Subject|399|||
125607695|NCT00523341|451847995|FG001|Overall Study|Withdrawal by Subject|427|||
125607696|NCT00523341|451847994|FG000|Overall Study|Other|181|||
125607697|NCT00523341|451847995|FG001|Overall Study|Other|198|||
125607698|NCT00523341|451847994|FG000|Overall Study|Adverse Event|122|||
125607699|NCT00523341|451847995|FG001|Overall Study|Adverse Event|155|||
125607700|NCT00523341|451847994|FG000|Overall Study|Death|101|||
125607701|NCT00523341|451847995|FG001|Overall Study|Death|110|||
125607702|NCT00523341|451847994|FG000|Overall Study|Lost to Follow-up|73|||
125607703|NCT00523341|451847995|FG001|Overall Study|Lost to Follow-up|61|||
125607704|NCT00523341|451847994|FG000|Overall Study|Non-compliance|20|||
125607705|NCT00523341|451847995|FG001|Overall Study|Non-compliance|13|||
125607706|NCT00523341|451847994|FG000|Overall Study|Physician Decision|14|||
125607707|NCT00523341|451847995|FG001|Overall Study|Physician Decision|13|||
125607708|NCT00523341|451847994|FG000|Overall Study|Requirement for Alternative Therapy|4|||
125607709|NCT00523341|451847995|FG001|Overall Study|Requirement for Alternative Therapy|14|||
125607710|NCT00523341|451847994|FG000|Overall Study|Protocol Deviation|6|||
125607711|NCT00523341|451847995|FG001|Overall Study|Protocol Deviation|5|||
125607712|NCT00523341|451847994|FG000|Overall Study|Ineligibility Determined|3|||
125607713|NCT00523341|451847995|FG001|Overall Study|Ineligibility Determined|4|||
125607714|NCT00523341|451847994|FG000|Overall Study|Disease Progression|1|||
125607715|NCT00523341|451847995|FG001|Overall Study|Disease Progression|0|||
125607716|NCT02626819|451847996|FG000|Overall Study|Lost to Follow-up|3|||
125607717|NCT02626819|451847997|FG001|Overall Study|Lost to Follow-up|2|||
125607718|NCT02626819|451847996|FG000|Overall Study|Withdrawal by Subject|1|||
125607719|NCT02626819|451847997|FG001|Overall Study|Withdrawal by Subject|0|||
125607720|NCT02626819|451847996|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
125607721|NCT02626819|451847997|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
125607722|NCT00502307|451848000|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
125370219|NCT04967443|450989219|FG000|Follow-Up|Lost to Follow-up|0|||
125370220|NCT04967443|450989220|FG001|Follow-Up|Lost to Follow-up|0|||
125370221|NCT04967443|450989221|FG002|Follow-Up|Lost to Follow-up|1|||
125370222|NCT04967443|450989222|FG003|Follow-Up|Lost to Follow-up|1|||
125607723|NCT00502307|451848001|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
125607724|NCT00502307|451848002|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
125607725|NCT00502307|451848000|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
125607726|NCT00502307|451848001|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
125607727|NCT00502307|451848002|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
125607728|NCT00502307|451848000|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
125607729|NCT00502307|451848001|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
125607730|NCT00502307|451848002|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
125607731|NCT00502307|451848000|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
125607732|NCT00502307|451848001|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
125607733|NCT00502307|451848002|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
125607734|NCT00502307|451848000|FG000|Maintenance Period|Progressive disease|80|||
125607735|NCT00502307|451848001|FG001|Maintenance Period|Progressive disease|0|||
125607736|NCT00502307|451848002|FG002|Maintenance Period|Progressive disease|0|||
125607737|NCT00502307|451848000|FG000|Maintenance Period|Discontinued due to other reasons|68|||
125607738|NCT00502307|451848001|FG001|Maintenance Period|Discontinued due to other reasons|0|||
125607739|NCT00502307|451848002|FG002|Maintenance Period|Discontinued due to other reasons|0|||
125607740|NCT00051558|451848003|FG000|Overall Study|Adverse Event|30|||
125607741|NCT00051558|451848004|FG001|Overall Study|Adverse Event|18|||
125607742|NCT00051558|451848003|FG000|Overall Study|Withdrawal by Subject|29|||
125607743|NCT00051558|451848004|FG001|Overall Study|Withdrawal by Subject|42|||
125607744|NCT00051558|451848003|FG000|Overall Study|Death|9|||
125607745|NCT00051558|451848004|FG001|Overall Study|Death|15|||
125607746|NCT00051558|451848003|FG000|Overall Study|Lost to Follow-up|4|||
125607747|NCT00051558|451848004|FG001|Overall Study|Lost to Follow-up|13|||
125607748|NCT00051558|451848003|FG000|Overall Study|Protocol Violation|3|||
125607749|NCT00051558|451848004|FG001|Overall Study|Protocol Violation|4|||
125607750|NCT00051558|451848003|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
125607751|NCT00051558|451848004|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
125607752|NCT00051558|451848003|FG000|Overall Study|Sponsor Decision|6|||
125607753|NCT00051558|451848004|FG001|Overall Study|Sponsor Decision|1|||
125607754|NCT00051558|451848003|FG000|Overall Study|Other|2|||
125607755|NCT00051558|451848004|FG001|Overall Study|Other|1|||
125607756|NCT00051558|451848003|FG000|Overall Study|Significant Lab Value|2|||
125607757|NCT00051558|451848004|FG001|Overall Study|Significant Lab Value|0|||
125607758|NCT00051558|451848003|FG000|Overall Study|Physician Decision|5|||
125607759|NCT00051558|451848004|FG001|Overall Study|Physician Decision|0|||
125607760|NCT02849990|451848012|FG000|Overall Study|Adverse Event|1|||
125607761|NCT02849990|451848012|FG000|Overall Study|Withdrawal by Subject|1|||
125607762|NCT01051986|451848013|FG000|Overall Study|Death|1|||
125607763|NCT01051986|451848014|FG001|Overall Study|Death|0|||
125607764|NCT01051986|451848013|FG000|Overall Study|Withdrawal by Subject|2|||
125607765|NCT01051986|451848014|FG001|Overall Study|Withdrawal by Subject|1|||
125607766|NCT01051986|451848013|FG000|Overall Study|Protocol Violation|2|||
125607767|NCT01051986|451848014|FG001|Overall Study|Protocol Violation|3|||
125607768|NCT01725152|451848016|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
125607769|NCT01725152|451848017|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
125607770|NCT01725152|451848016|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
125607771|NCT01725152|451848017|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
125607772|NCT01725152|451848016|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
125607773|NCT01725152|451848017|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
125607774|NCT01725152|451848016|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
125607775|NCT01725152|451848017|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
125607776|NCT02044159|451848018|FG000|Overall Study|Consent declined (deferred consent)|2|||
125607777|NCT02044159|451848019|FG001|Overall Study|Consent declined (deferred consent)|4|||
125607778|NCT02044159|451848018|FG000|Overall Study|No longer eligible, drug not given|1|||
125607779|NCT02044159|451848019|FG001|Overall Study|No longer eligible, drug not given|0|||
125607780|NCT02044159|451848018|FG000|Overall Study|Nurse declined to give study drug|1|||
125607781|NCT02044159|451848019|FG001|Overall Study|Nurse declined to give study drug|0|||
125607782|NCT01111539|451848021|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
125607783|NCT01111539|451848022|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125607784|NCT01111539|451848023|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125607785|NCT01111539|451848024|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125607786|NCT01111539|451848025|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125370223|NCT04967443|450989223|FG004|Follow-Up|Lost to Follow-up|0|||
125370224|NCT04967443|450989224|FG005|Follow-Up|Lost to Follow-up|0|||
125370225|NCT04967443|450989225|FG006|Follow-Up|Lost to Follow-up|0|||
125607787|NCT01111539|451848021|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
125607788|NCT01111539|451848022|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125607789|NCT01111539|451848023|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125607790|NCT01111539|451848024|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125607791|NCT01111539|451848025|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125607792|NCT01111539|451848021|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
125607793|NCT01111539|451848022|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125607794|NCT01111539|451848023|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125607795|NCT01111539|451848024|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125607796|NCT01111539|451848025|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125607797|NCT01111539|451848021|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
125607798|NCT01111539|451848022|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
125607799|NCT01111539|451848023|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
125607800|NCT01111539|451848024|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
125607801|NCT01111539|451848025|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
125607802|NCT01111539|451848021|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
125607803|NCT01111539|451848022|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
125370226|NCT04967443|450989226|FG007|Follow-Up|Lost to Follow-up|0|||
125370227|NCT04967443|450989219|FG000|Follow-Up|Withdrawal by Subject|0|||
125370228|NCT04967443|450989220|FG001|Follow-Up|Withdrawal by Subject|1|||
125370229|NCT04967443|450989221|FG002|Follow-Up|Withdrawal by Subject|0|||
125370230|NCT04967443|450989222|FG003|Follow-Up|Withdrawal by Subject|1|||
125370231|NCT04967443|450989223|FG004|Follow-Up|Withdrawal by Subject|0|||
125370232|NCT04967443|450989224|FG005|Follow-Up|Withdrawal by Subject|1|||
125370233|NCT04967443|450989225|FG006|Follow-Up|Withdrawal by Subject|2|||
125370234|NCT04967443|450989226|FG007|Follow-Up|Withdrawal by Subject|3|||
125370235|NCT04502693|450989229|FG000|Overall Study|Adverse Event|7|||
125370236|NCT04502693|450989230|FG001|Overall Study|Adverse Event|6|||
125370237|NCT04502693|450989231|FG002|Overall Study|Adverse Event|11|||
125370238|NCT04502693|450989232|FG003|Overall Study|Adverse Event|1|||
125370239|NCT04502693|450989229|FG000|Overall Study|Lost to Follow-up|32|||
125370240|NCT04502693|450989230|FG001|Overall Study|Lost to Follow-up|36|||
125370241|NCT04502693|450989231|FG002|Overall Study|Lost to Follow-up|69|||
125370242|NCT04502693|450989232|FG003|Overall Study|Lost to Follow-up|4|||
125370243|NCT04502693|450989229|FG000|Overall Study|Protocol Violation|8|||
125370244|NCT04502693|450989230|FG001|Overall Study|Protocol Violation|8|||
125370245|NCT04502693|450989231|FG002|Overall Study|Protocol Violation|16|||
125370246|NCT04502693|450989232|FG003|Overall Study|Protocol Violation|1|||
125370247|NCT04502693|450989229|FG000|Overall Study|Withdrawal by Subject|46|||
125370248|NCT04502693|450989230|FG001|Overall Study|Withdrawal by Subject|38|||
125370249|NCT04502693|450989231|FG002|Overall Study|Withdrawal by Subject|54|||
125370250|NCT04502693|450989232|FG003|Overall Study|Withdrawal by Subject|7|||
125370251|NCT04502693|450989229|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
125431786|NCT02055157|451207758|FG001|Initial 6 Months|Adverse Event|0|||
125607804|NCT01111539|451848023|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
125607805|NCT01111539|451848024|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
125607806|NCT01111539|451848025|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
125607807|NCT01111539|451848021|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
125607808|NCT01111539|451848022|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125607809|NCT01111539|451848023|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125607810|NCT01111539|451848024|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125607811|NCT01111539|451848025|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125607812|NCT01111539|451848021|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
125607813|NCT01111539|451848022|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
125607814|NCT01111539|451848023|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
125370252|NCT04502693|450989230|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
125370253|NCT04502693|450989231|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
125370254|NCT04502693|450989232|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125431787|NCT02055157|451207759|FG002|Initial 6 Months|Adverse Event|0|||
125370255|NCT04502693|450989229|FG000|Overall Study|Other|1|||
125370256|NCT04502693|450989230|FG001|Overall Study|Other|0|||
125370257|NCT04502693|450989231|FG002|Overall Study|Other|1|||
125370258|NCT04502693|450989232|FG003|Overall Study|Other|1|||
125370259|NCT00602797|450989234|FG000|Overall Study|Adverse Event|1|||
125431788|NCT02055157|451207760|FG003|Initial 6 Months|Adverse Event|1|||
125213119|NCT00734656|450407205|FG000|Lab Session 2|Withdrawal by Subject|1|||
125213120|NCT00734656|450407206|FG001|Lab Session 2|Withdrawal by Subject|0|||
125213121|NCT00734656|450407207|FG002|Lab Session 2|Withdrawal by Subject|0|||
125213122|NCT00734656|450407208|FG003|Lab Session 2|Withdrawal by Subject|1|||
125213123|NCT00734656|450407205|FG000|Washout 2|Withdrawal by Subject|1|||
125213124|NCT00734656|450407206|FG001|Washout 2|Withdrawal by Subject|1|||
125213125|NCT00734656|450407207|FG002|Washout 2|Withdrawal by Subject|1|||
125213126|NCT00734656|450407208|FG003|Washout 2|Withdrawal by Subject|0|||
125213127|NCT00734656|450407205|FG000|Washout 3|Withdrawal by Subject|1|||
125213128|NCT00734656|450407206|FG001|Washout 3|Withdrawal by Subject|0|||
125213129|NCT00734656|450407207|FG002|Washout 3|Withdrawal by Subject|0|||
125213130|NCT00734656|450407208|FG003|Washout 3|Withdrawal by Subject|1|||
125213131|NCT00734656|450407205|FG000|Lab Session 4|Withdrawal by Subject|0|||
125213132|NCT00734656|450407206|FG001|Lab Session 4|Withdrawal by Subject|0|||
125213133|NCT00734656|450407207|FG002|Lab Session 4|Withdrawal by Subject|0|||
125213134|NCT00734656|450407208|FG003|Lab Session 4|Withdrawal by Subject|1|||
125213135|NCT03915626|450407209|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
125213136|NCT04676152|450407210|FG000|Overall Study|screen fail|9|||
125213137|NCT02626000|450407223|FG000|Overall Study|Decision by Sponsor|1|||
125213138|NCT02626000|450407223|FG000|Overall Study|Death|29|||
125213139|NCT02164318|450407224|FG000|Overall Study|Withdrawal by Subject|0|||
125213140|NCT02164318|450407225|FG001|Overall Study|Withdrawal by Subject|1|||
125213141|NCT02164318|450407226|FG002|Overall Study|Withdrawal by Subject|0|||
125213142|NCT02164318|450407227|FG003|Overall Study|Withdrawal by Subject|1|||
125213143|NCT02335346|450407248|FG000|Overall Study|Adverse Event|11|||
125213144|NCT02335346|450407248|FG000|Overall Study|Withdrawal by Subject|1|||
125213145|NCT02769312|450407252|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
125213146|NCT02769312|450407253|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
125213147|NCT02769312|450407252|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
125213148|NCT02769312|450407253|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
125213149|NCT02769312|450407252|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
125213150|NCT02769312|450407253|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
125213151|NCT02769312|450407252|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
125213152|NCT02769312|450407253|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
125213153|NCT02769312|450407252|FG000|Follow-up|Lost to Follow-up|1|||
125213154|NCT02769312|450407253|FG001|Follow-up|Lost to Follow-up|1|||
125213155|NCT02178358|450407254|FG000|Overall Study|Withdrawal by Subject|0|||
125213156|NCT02178358|450407255|FG001|Overall Study|Withdrawal by Subject|2|||
125213157|NCT02178358|450407256|FG002|Overall Study|Withdrawal by Subject|2|||
125213158|NCT02178358|450407254|FG000|Overall Study|Lost to Follow-up|1|||
125213159|NCT02178358|450407255|FG001|Overall Study|Lost to Follow-up|0|||
125213160|NCT02178358|450407256|FG002|Overall Study|Lost to Follow-up|0|||
125213161|NCT01066663|450407258|FG000|Overall Study|Adverse Event|0|||
125213162|NCT01066663|450407259|FG001|Overall Study|Adverse Event|0|||
125213163|NCT01066663|450407260|FG002|Overall Study|Adverse Event|1|||
125213164|NCT02985021|450407261|FG000|Overall Study|Inability to comply with study procedures|1|||
125213165|NCT02756819|450407262|FG000|Overall Study|Lost for observation|23|||
125213166|NCT02756819|450407262|FG000|Overall Study|Patient's unwillingness|16|||
125213167|NCT02756819|450407262|FG000|Overall Study|Insufficient efficacy|2|||
125213168|NCT02756819|450407262|FG000|Overall Study|Adverse Event|2|||
125213169|NCT02756819|450407262|FG000|Overall Study|Reason not Specified|9|||
125213170|NCT01090050|450407263|FG000|Overall Study|Lost to Follow-up|0|||
125213171|NCT01090050|450407264|FG001|Overall Study|Lost to Follow-up|1|||
125213172|NCT01090050|450407263|FG000|Overall Study|Lack of Efficacy|1|||
125213173|NCT01090050|450407264|FG001|Overall Study|Lack of Efficacy|5|||
125213174|NCT01090050|450407263|FG000|Overall Study|Physician Decision|0|||
125370260|NCT03943147|450989235|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
125213175|NCT01090050|450407264|FG001|Overall Study|Physician Decision|1|||
125213176|NCT03539484|450407265|FG000|Overall Study|Death|1|||
125213177|NCT03539484|450407266|FG001|Overall Study|Death|0|||
125213178|NCT03539484|450407267|FG002|Overall Study|Death|0|||
125213179|NCT03539484|450407268|FG003|Overall Study|Death|2|||
125213180|NCT03539484|450407269|FG004|Overall Study|Death|8|||
125370261|NCT03943147|450989236|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
125213181|NCT03539484|450407270|FG005|Overall Study|Death|3|||
125607815|NCT01111539|451848024|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
125607816|NCT01111539|451848025|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
125607817|NCT01111539|451848021|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125607818|NCT01111539|451848022|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125607819|NCT01111539|451848023|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
125607820|NCT01111539|451848024|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125607821|NCT01111539|451848025|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
125607822|NCT01111539|451848021|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125213182|NCT03539484|450407271|FG006|Overall Study|Death|0|||
125213183|NCT03539484|450407265|FG000|Overall Study|Lost to Follow-up|0|||
125213184|NCT03539484|450407266|FG001|Overall Study|Lost to Follow-up|1|||
125213185|NCT03539484|450407267|FG002|Overall Study|Lost to Follow-up|0|||
125213186|NCT03539484|450407268|FG003|Overall Study|Lost to Follow-up|0|||
125213187|NCT03539484|450407269|FG004|Overall Study|Lost to Follow-up|1|||
125213188|NCT03539484|450407270|FG005|Overall Study|Lost to Follow-up|0|||
125213189|NCT03539484|450407271|FG006|Overall Study|Lost to Follow-up|0|||
125213190|NCT03539484|450407265|FG000|Overall Study|Withdrawal by Subject|0|||
125213191|NCT03539484|450407266|FG001|Overall Study|Withdrawal by Subject|0|||
125213192|NCT03539484|450407267|FG002|Overall Study|Withdrawal by Subject|0|||
125213193|NCT03539484|450407268|FG003|Overall Study|Withdrawal by Subject|0|||
125213194|NCT03539484|450407269|FG004|Overall Study|Withdrawal by Subject|2|||
125213195|NCT03539484|450407270|FG005|Overall Study|Withdrawal by Subject|0|||
125213196|NCT03539484|450407271|FG006|Overall Study|Withdrawal by Subject|1|||
125213197|NCT03539484|450407265|FG000|Overall Study|Study Terminated by Sponsor|0|||
125213198|NCT03539484|450407266|FG001|Overall Study|Study Terminated by Sponsor|0|||
125213199|NCT03539484|450407267|FG002|Overall Study|Study Terminated by Sponsor|1|||
125213200|NCT03539484|450407268|FG003|Overall Study|Study Terminated by Sponsor|1|||
125213201|NCT03539484|450407269|FG004|Overall Study|Study Terminated by Sponsor|2|||
125213202|NCT03539484|450407270|FG005|Overall Study|Study Terminated by Sponsor|2|||
125213203|NCT03539484|450407271|FG006|Overall Study|Study Terminated by Sponsor|1|||
125213204|NCT02232061|450407272|FG000|Overall Study|Administrative problems|1|||
125213205|NCT02232061|450407272|FG000|Overall Study|Withdrawal by Subject|1|||
125213206|NCT00560703|450407274|FG000|Overall Study|Adverse Event|0|||
125213207|NCT00560703|450407275|FG001|Overall Study|Adverse Event|2|||
125213208|NCT00560703|450407274|FG000|Overall Study|Protocol Violation|0|||
125213209|NCT00560703|450407275|FG001|Overall Study|Protocol Violation|2|||
125213210|NCT00560703|450407274|FG000|Overall Study|Withdrawal by Subject|0|||
125213211|NCT00560703|450407275|FG001|Overall Study|Withdrawal by Subject|1|||
125213212|NCT00560703|450407274|FG000|Overall Study|non-compliance|0|||
125213213|NCT00560703|450407275|FG001|Overall Study|non-compliance|1|||
125607823|NCT01111539|451848022|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125607824|NCT01111539|451848023|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
125607825|NCT01111539|451848024|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125607826|NCT01111539|451848025|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
125607827|NCT01111539|451848021|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
125607828|NCT01111539|451848022|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
125607829|NCT01111539|451848023|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
125607830|NCT01111539|451848024|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
125607831|NCT01111539|451848025|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
125607832|NCT01111539|451848021|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
125607833|NCT01111539|451848022|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
125607834|NCT01111539|451848023|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
125607835|NCT01111539|451848024|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
125607836|NCT01111539|451848025|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
125607837|NCT01111539|451848021|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
125607838|NCT01111539|451848022|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
125607839|NCT01111539|451848023|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
125607840|NCT01111539|451848024|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
125607841|NCT01111539|451848025|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
125213214|NCT00339833|450407285|FG000|Overall Study|Withdrawal by Subject|1|||
125213215|NCT00339833|450407286|FG001|Overall Study|Withdrawal by Subject|2|||
125370262|NCT03943147|450989235|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
125370263|NCT03943147|450989236|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
125370264|NCT03943147|450989235|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
125370265|NCT03943147|450989236|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
125607842|NCT01111539|451848021|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
125607843|NCT01111539|451848022|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
125607844|NCT01111539|451848023|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
125607845|NCT01111539|451848024|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
125607846|NCT01111539|451848025|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
125370266|NCT03943147|450989235|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
125370267|NCT03943147|450989236|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
125370268|NCT03943147|450989235|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
125370269|NCT03943147|450989236|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
125370270|NCT03943147|450989235|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
125370271|NCT03943147|450989236|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
125370272|NCT01318993|450989237|FG000|Overall Study|Adverse Event|53|||
125370273|NCT01318993|450989237|FG000|Overall Study|Lack of Efficacy|121|||
125370274|NCT01318993|450989237|FG000|Overall Study|Protocol Violation|3|||
125370275|NCT01318993|450989237|FG000|Overall Study|Protocol based stopping criteria|6|||
125370276|NCT01318993|450989237|FG000|Overall Study|Study closed or terminated|174|||
125370277|NCT01318993|450989237|FG000|Overall Study|Lost to Follow-up|4|||
125370278|NCT01318993|450989237|FG000|Overall Study|Physician Decision|13|||
125370279|NCT01318993|450989237|FG000|Overall Study|Withdrawal by Subject|24|||
125607847|NCT01111539|451848021|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125607848|NCT01111539|451848022|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125607849|NCT01111539|451848023|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125607850|NCT01111539|451848024|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125607851|NCT01111539|451848025|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
125607852|NCT01795898|451848026|FG000|Overall Study|Adverse Event|27|||
125607853|NCT01795898|451848026|FG000|Overall Study|Lost to Follow-up|20|||
125607854|NCT01795898|451848026|FG000|Overall Study|Withdrawal of consent|6|||
125607855|NCT01795898|451848026|FG000|Overall Study|Diagnosed with metastasis|1|||
125607856|NCT01795898|451848026|FG000|Overall Study|No pain|1|||
125607857|NCT01795898|451848026|FG000|Overall Study|Death|1|||
125607858|NCT01795898|451848026|FG000|Overall Study|Withdrew consent & had adverse events|3|||
125607859|NCT01795898|451848026|FG000|Overall Study|Physician Decision|1|||
125607860|NCT03628417|451848027|FG000|Overall Study|Death|1|||
125607861|NCT03628417|451848028|FG001|Overall Study|Death|1|||
125607862|NCT03539458|451848029|FG000|Overall Study|Death|1|||
125607863|NCT00372190|451848030|FG000|Overall Study|Lost to Follow-up|3|||
125607864|NCT00372190|451848031|FG001|Overall Study|Lost to Follow-up|1|||
125607865|NCT00718419|451848032|FG000|Overall Study|Adverse Event|2|||
125607866|NCT00718419|451848033|FG001|Overall Study|Adverse Event|1|||
125607867|NCT00718419|451848032|FG000|Overall Study|Physician Decision|1|||
125607868|NCT00718419|451848033|FG001|Overall Study|Physician Decision|6|||
125607869|NCT00718419|451848032|FG000|Overall Study|Sponsor decision|0|||
125607870|NCT00718419|451848033|FG001|Overall Study|Sponsor decision|1|||
125607871|NCT00718419|451848032|FG000|Overall Study|Withdrawal by Subject|0|||
125607872|NCT00718419|451848033|FG001|Overall Study|Withdrawal by Subject|5|||
125607873|NCT00718419|451848032|FG000|Overall Study|Progressive Disease|7|||
125607874|NCT00718419|451848033|FG001|Overall Study|Progressive Disease|25|||
125607875|NCT00718419|451848032|FG000|Overall Study|Death Due to Progressive Disease|2|||
125607876|NCT00718419|451848033|FG001|Overall Study|Death Due to Progressive Disease|0|||
125607877|NCT00718419|451848032|FG000|Overall Study|Death Due to Study Drug Related|0|||
125607878|NCT00718419|451848033|FG001|Overall Study|Death Due to Study Drug Related|1|||
125607879|NCT00718419|451848032|FG000|Overall Study|Death Due to Adverse Events|1|||
125607880|NCT00718419|451848033|FG001|Overall Study|Death Due to Adverse Events|0|||
125607881|NCT00726323|451848036|FG000|Overall Study|Withdrawal by Subject|3|||
125607882|NCT00726323|451848037|FG001|Overall Study|Withdrawal by Subject|1|||
125607883|NCT00726323|451848036|FG000|Overall Study|Physician Decision|1|||
125607884|NCT00726323|451848037|FG001|Overall Study|Physician Decision|0|||
125607885|NCT00726323|451848036|FG000|Overall Study|Progressive disease|23|||
125607886|NCT00726323|451848037|FG001|Overall Study|Progressive disease|16|||
125607887|NCT00726323|451848036|FG000|Overall Study|Clinical progression|0|||
125607888|NCT00726323|451848037|FG001|Overall Study|Clinical progression|3|||
125607889|NCT00726323|451848036|FG000|Overall Study|Adverse Event|9|||
125607890|NCT00726323|451848037|FG001|Overall Study|Adverse Event|9|||
125607891|NCT00726323|451848036|FG000|Overall Study|Death|1|||
125607892|NCT00726323|451848037|FG001|Overall Study|Death|0|||
125607893|NCT00726323|451848036|FG000|Overall Study|Participant wished to discontinue|0|||
125607894|NCT00726323|451848037|FG001|Overall Study|Participant wished to discontinue|1|||
125213216|NCT00339833|450407285|FG000|Overall Study|toothache|0|||
125370280|NCT02756013|450989238|FG000|Overall Study|Adverse Event|1|||
125370281|NCT02756013|450989238|FG000|Overall Study|Hypersensitivity|1|||
125370282|NCT00629707|450989241|FG000|Overall Study|Withdrawal by Subject|0|||
125370283|NCT00629707|450989242|FG001|Overall Study|Withdrawal by Subject|1|||
125370284|NCT00629707|450989241|FG000|Overall Study|Physician Decision|0|||
125370285|NCT00629707|450989242|FG001|Overall Study|Physician Decision|1|||
125370286|NCT03724032|450989243|FG000|Overall Study|Physician Decision|1|||
125370287|NCT03724032|450989244|FG001|Overall Study|Physician Decision|0|||
125370288|NCT03724032|450989245|FG002|Overall Study|Physician Decision|0|||
125370289|NCT03724032|450989243|FG000|Overall Study|Protocol Violation|2|||
125370290|NCT03724032|450989244|FG001|Overall Study|Protocol Violation|2|||
125370291|NCT03724032|450989245|FG002|Overall Study|Protocol Violation|1|||
125370292|NCT00001880|450989249|FG000|Overall Study|Death|14|||
125370293|NCT02657369|450989250|FG000|Overall Study|Death|27|||
125370294|NCT02657369|450989250|FG000|Overall Study|Study terminated by sponsor|7|||
125370295|NCT00361569|450989251|FG000|Overall Study|Protocol Violation|3|||
125370296|NCT00361569|450989252|FG001|Overall Study|Protocol Violation|2|||
125370297|NCT00361569|450989253|FG002|Overall Study|Protocol Violation|4|||
125370298|NCT00361569|450989254|FG003|Overall Study|Protocol Violation|2|||
125370299|NCT00361569|450989251|FG000|Overall Study|Withdrawal by Subject|2|||
125370300|NCT00361569|450989252|FG001|Overall Study|Withdrawal by Subject|1|||
125370301|NCT00361569|450989253|FG002|Overall Study|Withdrawal by Subject|9|||
125370302|NCT00361569|450989254|FG003|Overall Study|Withdrawal by Subject|14|||
125370303|NCT00361569|450989251|FG000|Overall Study|Adverse Event|3|||
125370304|NCT00361569|450989252|FG001|Overall Study|Adverse Event|5|||
125370305|NCT00361569|450989253|FG002|Overall Study|Adverse Event|2|||
125607895|NCT00726323|451848036|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
125607896|NCT00726323|451848037|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
125607897|NCT03521154|451848045|FG000|Overall Study|Ongoing study at data cut-off|111|||
125607898|NCT03521154|451848046|FG001|Overall Study|Ongoing study at data cut-off|52|||
125607899|NCT00365716|451848049|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
125607900|NCT00365716|451848050|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
125607901|NCT00365716|451848051|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
125607902|NCT00365716|451848052|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
125607903|NCT00365716|451848053|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
125607904|NCT00365716|451848054|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
125607905|NCT00365716|451848055|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
125607906|NCT00365716|451848049|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
125607907|NCT00365716|451848050|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
125607908|NCT00365716|451848051|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
125607909|NCT00365716|451848052|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
125607910|NCT00365716|451848053|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
125607911|NCT00365716|451848054|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
125607912|NCT00365716|451848055|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
125607913|NCT00365716|451848049|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
125607914|NCT00365716|451848050|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
125607915|NCT00365716|451848051|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
125607916|NCT00365716|451848052|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
125607917|NCT00365716|451848053|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
125607918|NCT00365716|451848054|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
125607919|NCT00365716|451848055|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
125607920|NCT00365716|451848049|FG000|Base Study (Day 1 to Month 7)|Other|0|||
125607921|NCT00365716|451848050|FG001|Base Study (Day 1 to Month 7)|Other|1|||
125370306|NCT00361569|450989254|FG003|Overall Study|Adverse Event|2|||
125370307|NCT00361569|450989251|FG000|Overall Study|Lost to Follow-up|2|||
125370308|NCT00361569|450989252|FG001|Overall Study|Lost to Follow-up|3|||
125607922|NCT00365716|451848051|FG002|Base Study (Day 1 to Month 7)|Other|0|||
125607923|NCT00365716|451848052|FG003|Base Study (Day 1 to Month 7)|Other|0|||
125607924|NCT00365716|451848053|FG004|Base Study (Day 1 to Month 7)|Other|0|||
125607925|NCT00365716|451848054|FG005|Base Study (Day 1 to Month 7)|Other|0|||
125607926|NCT00365716|451848055|FG006|Base Study (Day 1 to Month 7)|Other|0|||
125607927|NCT00365716|451848049|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
125607928|NCT00365716|451848050|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
125213217|NCT00339833|450407286|FG001|Overall Study|toothache|1|||
125370309|NCT00361569|450989253|FG002|Overall Study|Lost to Follow-up|3|||
125370310|NCT00361569|450989254|FG003|Overall Study|Lost to Follow-up|2|||
125370311|NCT00361569|450989251|FG000|Overall Study|Not specified by investigator|2|||
125370312|NCT00361569|450989252|FG001|Overall Study|Not specified by investigator|0|||
125370313|NCT00361569|450989253|FG002|Overall Study|Not specified by investigator|0|||
125370314|NCT00361569|450989254|FG003|Overall Study|Not specified by investigator|1|||
125607929|NCT00365716|451848051|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
125370315|NCT02639065|450989255|FG000|Study Treatment|Disease Progression|13|||
125370316|NCT02639065|450989255|FG000|Study Treatment|Adverse Event|9|||
125370317|NCT02639065|450989255|FG000|Study Treatment|Withdrawal by Subject|1|||
125370318|NCT02639065|450989255|FG000|Follow up|Subject refused to follow up|1|||
125370319|NCT02639065|450989255|FG000|Follow up|Symptomatic Deterioration|2|||
125370320|NCT02639065|450989255|FG000|Follow up|Death|2|||
125370321|NCT02639065|450989255|FG000|Follow up|Study Terminated|1|||
125370322|NCT02639065|450989255|FG000|Follow up|Disease Progression|3|||
125370323|NCT00481078|450989256|FG000|Overall Study|Progression of disease|11|||
125370324|NCT00481078|450989257|FG001|Overall Study|Progression of disease|11|||
125370325|NCT00481078|450989256|FG000|Overall Study|Adverse Event|15|||
125607930|NCT00365716|451848052|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
125607931|NCT00365716|451848053|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
125607932|NCT00365716|451848054|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
125607933|NCT00365716|451848055|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
125607934|NCT00365716|451848049|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
125607935|NCT00365716|451848050|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
125607936|NCT00365716|451848051|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
125607937|NCT00365716|451848052|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
125607938|NCT00365716|451848053|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
125607939|NCT00365716|451848054|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
125607940|NCT00365716|451848055|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
125607941|NCT00365716|451848049|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
125607942|NCT00365716|451848050|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
125607943|NCT00365716|451848051|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
125607944|NCT00365716|451848052|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
125607945|NCT00365716|451848053|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
125607946|NCT00365716|451848054|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
125607947|NCT00365716|451848055|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
125607948|NCT00365716|451848049|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
125607949|NCT00365716|451848050|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
125607950|NCT00365716|451848051|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
125607951|NCT00365716|451848052|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
125607952|NCT00365716|451848053|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
125607953|NCT00365716|451848054|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
125607954|NCT00365716|451848055|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
125607955|NCT00365716|451848049|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
125607956|NCT00365716|451848050|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
125607957|NCT00365716|451848051|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
125607958|NCT00365716|451848052|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
125607959|NCT00365716|451848053|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
125213218|NCT00339833|450407285|FG000|Overall Study|indigestion|0|||
125213219|NCT00339833|450407286|FG001|Overall Study|indigestion|1|||
125370326|NCT00481078|450989257|FG001|Overall Study|Adverse Event|3|||
125370327|NCT00481078|450989256|FG000|Overall Study|Death|5|||
125607960|NCT00365716|451848054|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
125607961|NCT00365716|451848055|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
125607962|NCT00365716|451848049|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
125607963|NCT00365716|451848050|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
125607964|NCT00365716|451848051|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
125607965|NCT00365716|451848052|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
125607966|NCT00365716|451848053|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
125607967|NCT00365716|451848054|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
125607968|NCT00365716|451848055|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
125607969|NCT00365716|451848049|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
125607970|NCT00365716|451848050|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
125607971|NCT00365716|451848051|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
125607972|NCT00365716|451848052|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
125607973|NCT00365716|451848053|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
125607974|NCT00365716|451848054|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
125607975|NCT00365716|451848055|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
125607976|NCT00365716|451848049|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
125607977|NCT00365716|451848050|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
125607978|NCT00365716|451848051|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
125607979|NCT00365716|451848052|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
125607980|NCT00365716|451848053|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
125607981|NCT00365716|451848054|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
125607982|NCT00365716|451848055|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
125607983|NCT00365716|451848049|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
125607984|NCT00365716|451848050|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
125607985|NCT00365716|451848051|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
125607986|NCT00365716|451848052|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
125607987|NCT00365716|451848053|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
125607988|NCT00365716|451848054|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
125607989|NCT00365716|451848055|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
125607990|NCT00365716|451848049|FG000|Extension 1|Lost to Follow-up|0|||
125607991|NCT00365716|451848050|FG001|Extension 1|Lost to Follow-up|0|||
125607992|NCT00365716|451848051|FG002|Extension 1|Lost to Follow-up|0|||
125607993|NCT00365716|451848052|FG003|Extension 1|Lost to Follow-up|0|||
125607994|NCT00365716|451848053|FG004|Extension 1|Lost to Follow-up|0|||
125607995|NCT00365716|451848054|FG005|Extension 1|Lost to Follow-up|1|||
125607996|NCT00365716|451848055|FG006|Extension 1|Lost to Follow-up|0|||
125607997|NCT00365716|451848049|FG000|Extension 1|Other|0|||
125607998|NCT00365716|451848050|FG001|Extension 1|Other|0|||
125213220|NCT00339833|450407285|FG000|Overall Study|Chest pain|0|||
125607999|NCT00365716|451848051|FG002|Extension 1|Other|0|||
125608000|NCT00365716|451848052|FG003|Extension 1|Other|0|||
125608001|NCT00365716|451848053|FG004|Extension 1|Other|0|||
125608002|NCT00365716|451848054|FG005|Extension 1|Other|9|||
125608003|NCT00365716|451848055|FG006|Extension 1|Other|0|||
125608004|NCT00365716|451848049|FG000|Extension 1|Moved|0|||
125608005|NCT00365716|451848050|FG001|Extension 1|Moved|0|||
125608006|NCT00365716|451848051|FG002|Extension 1|Moved|0|||
125608007|NCT00365716|451848052|FG003|Extension 1|Moved|0|||
125608008|NCT00365716|451848053|FG004|Extension 1|Moved|0|||
125608009|NCT00365716|451848054|FG005|Extension 1|Moved|4|||
125370328|NCT00481078|450989257|FG001|Overall Study|Death|3|||
125370329|NCT00481078|450989256|FG000|Overall Study|Intercurrent illness|1|||
125370330|NCT00481078|450989257|FG001|Overall Study|Intercurrent illness|0|||
125370331|NCT00481078|450989256|FG000|Overall Study|Withdrawal by Subject|7|||
125370332|NCT00481078|450989257|FG001|Overall Study|Withdrawal by Subject|1|||
125370333|NCT00481078|450989256|FG000|Overall Study|Information not available|1|||
125370334|NCT00481078|450989257|FG001|Overall Study|Information not available|0|||
125370335|NCT00481078|450989256|FG000|Overall Study|Received other treatment|2|||
125370336|NCT00481078|450989257|FG001|Overall Study|Received other treatment|1|||
125370337|NCT00481078|450989256|FG000|Overall Study|Brain metastasis|0|||
125370338|NCT00481078|450989257|FG001|Overall Study|Brain metastasis|1|||
125370339|NCT01558271|450989258|FG000|Overall Study|Adverse Event|6|||
125370340|NCT01558271|450989259|FG001|Overall Study|Adverse Event|3|||
125370341|NCT01558271|450989260|FG002|Overall Study|Adverse Event|4|||
125370342|NCT01558271|450989258|FG000|Overall Study|Lost to Follow-up|1|||
125370343|NCT01558271|450989259|FG001|Overall Study|Lost to Follow-up|0|||
125370344|NCT01558271|450989260|FG002|Overall Study|Lost to Follow-up|0|||
125370345|NCT01558271|450989258|FG000|Overall Study|Protocol Violation|1|||
125370346|NCT01558271|450989259|FG001|Overall Study|Protocol Violation|0|||
125370347|NCT01558271|450989260|FG002|Overall Study|Protocol Violation|0|||
125370348|NCT01558271|450989258|FG000|Overall Study|Withdrawal by Subject|10|||
125370349|NCT01558271|450989259|FG001|Overall Study|Withdrawal by Subject|6|||
125370350|NCT01558271|450989260|FG002|Overall Study|Withdrawal by Subject|12|||
125608010|NCT00365716|451848055|FG006|Extension 1|Moved|0|||
125608011|NCT00365716|451848049|FG000|Extension 1|Withdrawal by Subject|0|||
125608012|NCT00365716|451848050|FG001|Extension 1|Withdrawal by Subject|0|||
125608013|NCT00365716|451848051|FG002|Extension 1|Withdrawal by Subject|0|||
125213221|NCT00339833|450407286|FG001|Overall Study|Chest pain|1|||
125213222|NCT00339833|450407285|FG000|Overall Study|minor infection|0|||
125213223|NCT00339833|450407286|FG001|Overall Study|minor infection|1|||
125370351|NCT01558271|450989258|FG000|Overall Study|Physician Decision|0|||
125370352|NCT01558271|450989259|FG001|Overall Study|Physician Decision|2|||
125370353|NCT01558271|450989260|FG002|Overall Study|Physician Decision|1|||
125370354|NCT01845831|450989261|FG000|Inpatient Phase|Withdrawal by Subject|1|||
125370355|NCT01845831|450989262|FG001|Inpatient Phase|Withdrawal by Subject|1|||
125370356|NCT01845831|450989263|FG002|Inpatient Phase|Withdrawal by Subject|0|||
125370357|NCT01845831|450989264|FG003|Inpatient Phase|Withdrawal by Subject|0|||
125370358|NCT01845831|450989265|FG004|Inpatient Phase|Withdrawal by Subject|0|||
125370359|NCT02610725|450989266|FG000|Overall Study|Lost to Follow-up|197|||
125370360|NCT02610725|450989266|FG000|Overall Study|self-reported contraindication|9|||
125370361|NCT04094883|450989267|FG000|Overall Study|Withdrawal by Subject|1|||
125370362|NCT00826943|450989268|FG000|Overall Study|Withdrawal by Subject|0|||
125370363|NCT00826943|450989269|FG001|Overall Study|Withdrawal by Subject|0|||
125370364|NCT00826943|450989270|FG002|Overall Study|Withdrawal by Subject|0|||
125370365|NCT00826943|450989271|FG003|Overall Study|Withdrawal by Subject|0|||
125370366|NCT00826943|450989272|FG004|Overall Study|Withdrawal by Subject|1|||
125370367|NCT00826943|450989273|FG005|Overall Study|Withdrawal by Subject|0|||
125370368|NCT01348165|450989274|FG000|Overall Study|Adverse Event|0|||
125370369|NCT01348165|450989275|FG001|Overall Study|Adverse Event|0|||
125370370|NCT01348165|450989276|FG002|Overall Study|Adverse Event|0|||
125370371|NCT01348165|450989277|FG003|Overall Study|Adverse Event|0|||
125370372|NCT01348165|450989278|FG004|Overall Study|Adverse Event|0|||
125370373|NCT01348165|450989279|FG005|Overall Study|Adverse Event|0|||
125370374|NCT01348165|450989280|FG006|Overall Study|Adverse Event|1|||
125370375|NCT01594762|450989281|FG000|Overall Study|Withdrawal by Subject|1|||
125370376|NCT01594762|450989282|FG001|Overall Study|Withdrawal by Subject|0|||
125370377|NCT01594762|450989281|FG000|Overall Study|Lost to Follow-up|10|||
125608014|NCT00365716|451848052|FG003|Extension 1|Withdrawal by Subject|0|||
125213224|NCT00339833|450407285|FG000|Overall Study|Poor venous access|2|||
125370378|NCT01594762|450989282|FG001|Overall Study|Lost to Follow-up|10|||
125370379|NCT03547583|450989283|FG000|Overall Study|Adverse Event|16|||
125370380|NCT03547583|450989284|FG001|Overall Study|Adverse Event|11|||
125370381|NCT03547583|450989285|FG002|Overall Study|Adverse Event|10|||
125370382|NCT03547583|450989283|FG000|Overall Study|Death|11|||
125370383|NCT03547583|450989284|FG001|Overall Study|Death|7|||
125370384|NCT03547583|450989285|FG002|Overall Study|Death|4|||
125370385|NCT03547583|450989283|FG000|Overall Study|Lost to Follow-up|1|||
125370386|NCT03547583|450989284|FG001|Overall Study|Lost to Follow-up|0|||
125370387|NCT03547583|450989285|FG002|Overall Study|Lost to Follow-up|0|||
125608015|NCT00365716|451848053|FG004|Extension 1|Withdrawal by Subject|0|||
125608016|NCT00365716|451848054|FG005|Extension 1|Withdrawal by Subject|3|||
125608017|NCT00365716|451848055|FG006|Extension 1|Withdrawal by Subject|0|||
125608018|NCT00365716|451848049|FG000|Extension 1|Pregnancy|0|||
125608019|NCT00365716|451848050|FG001|Extension 1|Pregnancy|0|||
125608020|NCT00365716|451848051|FG002|Extension 1|Pregnancy|0|||
125608021|NCT00365716|451848052|FG003|Extension 1|Pregnancy|0|||
125608022|NCT00365716|451848053|FG004|Extension 1|Pregnancy|0|||
125608023|NCT00365716|451848054|FG005|Extension 1|Pregnancy|4|||
125608024|NCT00365716|451848055|FG006|Extension 1|Pregnancy|0|||
125608025|NCT00365716|451848049|FG000|Extension 1|Protocol Violation|0|||
125608026|NCT00365716|451848050|FG001|Extension 1|Protocol Violation|0|||
125608027|NCT00365716|451848051|FG002|Extension 1|Protocol Violation|0|||
125608028|NCT00365716|451848052|FG003|Extension 1|Protocol Violation|0|||
125608029|NCT00365716|451848053|FG004|Extension 1|Protocol Violation|0|||
125608030|NCT00365716|451848054|FG005|Extension 1|Protocol Violation|1|||
125608031|NCT00365716|451848055|FG006|Extension 1|Protocol Violation|0|||
125608032|NCT00365716|451848049|FG000|Extension 2|Lost to Follow-up|0|||
125608033|NCT00365716|451848050|FG001|Extension 2|Lost to Follow-up|0|||
125608034|NCT00365716|451848051|FG002|Extension 2|Lost to Follow-up|0|||
125608035|NCT00365716|451848052|FG003|Extension 2|Lost to Follow-up|0|||
125608036|NCT00365716|451848053|FG004|Extension 2|Lost to Follow-up|0|||
125608037|NCT00365716|451848054|FG005|Extension 2|Lost to Follow-up|0|||
125608038|NCT00365716|451848055|FG006|Extension 2|Lost to Follow-up|2|||
125608039|NCT00365716|451848049|FG000|Extension 2|Other|0|||
125608040|NCT00365716|451848050|FG001|Extension 2|Other|0|||
125608041|NCT00365716|451848051|FG002|Extension 2|Other|0|||
125608042|NCT00365716|451848052|FG003|Extension 2|Other|0|||
125608043|NCT00365716|451848053|FG004|Extension 2|Other|0|||
125608044|NCT00365716|451848054|FG005|Extension 2|Other|0|||
125608045|NCT00365716|451848055|FG006|Extension 2|Other|3|||
125608046|NCT00365716|451848049|FG000|Extension 2|Withdrawal by Subject|0|||
125608047|NCT00365716|451848050|FG001|Extension 2|Withdrawal by Subject|0|||
125608048|NCT00365716|451848051|FG002|Extension 2|Withdrawal by Subject|0|||
125608049|NCT00365716|451848052|FG003|Extension 2|Withdrawal by Subject|0|||
125608050|NCT00365716|451848053|FG004|Extension 2|Withdrawal by Subject|0|||
125608051|NCT00365716|451848054|FG005|Extension 2|Withdrawal by Subject|0|||
125608052|NCT00365716|451848055|FG006|Extension 2|Withdrawal by Subject|5|||
125608053|NCT06150573|451848056|FG000|Overall Study|Did not meet study criteria|1|||
125608054|NCT06150573|451848057|FG001|Overall Study|Did not meet study criteria|0|||
125608055|NCT06150573|451848056|FG000|Overall Study|Adverse Event|1|||
125608056|NCT06150573|451848057|FG001|Overall Study|Adverse Event|0|||
125608057|NCT06150573|451848056|FG000|Overall Study|Lost to Follow-up|0|||
125608058|NCT06150573|451848057|FG001|Overall Study|Lost to Follow-up|1|||
125608059|NCT06150573|451848056|FG000|Overall Study|Protocol Violation|0|||
125608060|NCT06150573|451848057|FG001|Overall Study|Protocol Violation|1|||
125608061|NCT06150573|451848056|FG000|Overall Study|Withdrawal by Subject|2|||
125608062|NCT06150573|451848057|FG001|Overall Study|Withdrawal by Subject|0|||
125608063|NCT00069095|451848058|FG000|Primary Treatment Phase|Ongoing|0|||
125608064|NCT00069095|451848059|FG001|Primary Treatment Phase|Ongoing|0|||
125608065|NCT00069095|451848060|FG002|Primary Treatment Phase|Ongoing|5|||
125608066|NCT00069095|451848061|FG003|Primary Treatment Phase|Ongoing|7|||
125608067|NCT00069095|451848062|FG004|Primary Treatment Phase|Ongoing|7|||
125370388|NCT03547583|450989283|FG000|Overall Study|Non-compliance with study drug|0|||
125370389|NCT03547583|450989284|FG001|Overall Study|Non-compliance with study drug|0|||
125370390|NCT03547583|450989285|FG002|Overall Study|Non-compliance with study drug|1|||
125608068|NCT00069095|451848063|FG005|Primary Treatment Phase|Ongoing|4|||
125608069|NCT00069095|451848058|FG000|Primary Treatment Phase|Admin/Other|29|||
125608070|NCT00069095|451848059|FG001|Primary Treatment Phase|Admin/Other|38|||
125608071|NCT00069095|451848060|FG002|Primary Treatment Phase|Admin/Other|31|||
125608072|NCT00069095|451848061|FG003|Primary Treatment Phase|Admin/Other|45|||
125608073|NCT00069095|451848062|FG004|Primary Treatment Phase|Admin/Other|48|||
125608074|NCT00069095|451848063|FG005|Primary Treatment Phase|Admin/Other|42|||
125608075|NCT00069095|451848058|FG000|Primary Treatment Phase|Adverse Event|99|||
125608076|NCT00069095|451848059|FG001|Primary Treatment Phase|Adverse Event|92|||
125370391|NCT03547583|450989283|FG000|Overall Study|Physician Decision|1|||
125608077|NCT00069095|451848060|FG002|Primary Treatment Phase|Adverse Event|71|||
125370392|NCT03547583|450989284|FG001|Overall Study|Physician Decision|0|||
125370393|NCT03547583|450989285|FG002|Overall Study|Physician Decision|3|||
125370394|NCT03547583|450989283|FG000|Overall Study|Protocol Violation|2|||
125370395|NCT03547583|450989284|FG001|Overall Study|Protocol Violation|1|||
125608078|NCT00069095|451848061|FG003|Primary Treatment Phase|Adverse Event|72|||
125608079|NCT00069095|451848062|FG004|Primary Treatment Phase|Adverse Event|109|||
125608080|NCT00069095|451848063|FG005|Primary Treatment Phase|Adverse Event|101|||
125608081|NCT00069095|451848058|FG000|Primary Treatment Phase|Death|14|||
125608082|NCT00069095|451848059|FG001|Primary Treatment Phase|Death|8|||
125608083|NCT00069095|451848060|FG002|Primary Treatment Phase|Death|2|||
125608084|NCT00069095|451848061|FG003|Primary Treatment Phase|Death|5|||
125608085|NCT00069095|451848062|FG004|Primary Treatment Phase|Death|8|||
125608086|NCT00069095|451848063|FG005|Primary Treatment Phase|Death|8|||
125608087|NCT00069095|451848058|FG000|Primary Treatment Phase|Failure to return|5|||
125608088|NCT00069095|451848059|FG001|Primary Treatment Phase|Failure to return|5|||
125608089|NCT00069095|451848060|FG002|Primary Treatment Phase|Failure to return|0|||
125608090|NCT00069095|451848061|FG003|Primary Treatment Phase|Failure to return|0|||
125608091|NCT00069095|451848062|FG004|Primary Treatment Phase|Failure to return|0|||
125608092|NCT00069095|451848063|FG005|Primary Treatment Phase|Failure to return|2|||
125608093|NCT00069095|451848058|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
125608094|NCT00069095|451848059|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
125608095|NCT00069095|451848060|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
125608096|NCT00069095|451848061|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
125608097|NCT00069095|451848062|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
125608098|NCT00069095|451848063|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
125608099|NCT00069095|451848058|FG000|Primary Treatment Phase|Refused treatment|15|||
125608100|NCT00069095|451848059|FG001|Primary Treatment Phase|Refused treatment|26|||
125608101|NCT00069095|451848060|FG002|Primary Treatment Phase|Refused treatment|17|||
125608102|NCT00069095|451848061|FG003|Primary Treatment Phase|Refused treatment|31|||
125608103|NCT00069095|451848062|FG004|Primary Treatment Phase|Refused treatment|24|||
125608104|NCT00069095|451848063|FG005|Primary Treatment Phase|Refused treatment|27|||
125608105|NCT00069095|451848058|FG000|Primary Treatment Phase|Withdrew|2|||
125608106|NCT00069095|451848059|FG001|Primary Treatment Phase|Withdrew|3|||
125370396|NCT03547583|450989285|FG002|Overall Study|Protocol Violation|1|||
125608107|NCT00069095|451848060|FG002|Primary Treatment Phase|Withdrew|8|||
125370397|NCT03547583|450989283|FG000|Overall Study|Withdrawal by Subject|12|||
125608108|NCT00069095|451848061|FG003|Primary Treatment Phase|Withdrew|2|||
125370398|NCT03547583|450989284|FG001|Overall Study|Withdrawal by Subject|19|||
125608109|NCT00069095|451848062|FG004|Primary Treatment Phase|Withdrew|4|||
125608110|NCT00069095|451848063|FG005|Primary Treatment Phase|Withdrew|9|||
125608111|NCT00069095|451848058|FG000|Primary Treatment Phase|Other Violation|0|||
125608112|NCT00069095|451848059|FG001|Primary Treatment Phase|Other Violation|1|||
125608113|NCT00069095|451848060|FG002|Primary Treatment Phase|Other Violation|1|||
125608114|NCT00069095|451848061|FG003|Primary Treatment Phase|Other Violation|1|||
125608115|NCT00069095|451848062|FG004|Primary Treatment Phase|Other Violation|0|||
125608116|NCT00069095|451848063|FG005|Primary Treatment Phase|Other Violation|1|||
125608117|NCT00069095|451848058|FG000|Primary Treatment Phase|Violation criteria|0|||
125608118|NCT00069095|451848059|FG001|Primary Treatment Phase|Violation criteria|2|||
125608119|NCT00069095|451848060|FG002|Primary Treatment Phase|Violation criteria|4|||
125608120|NCT00069095|451848061|FG003|Primary Treatment Phase|Violation criteria|3|||
125608121|NCT00069095|451848062|FG004|Primary Treatment Phase|Violation criteria|1|||
125608122|NCT00069095|451848063|FG005|Primary Treatment Phase|Violation criteria|5|||
125608123|NCT00069095|451848058|FG000|Post-study Treatment Phase|Missing reason|1|||
125608124|NCT00069095|451848059|FG001|Post-study Treatment Phase|Missing reason|3|||
125608125|NCT00069095|451848060|FG002|Post-study Treatment Phase|Missing reason|12|||
125608126|NCT00069095|451848061|FG003|Post-study Treatment Phase|Missing reason|8|||
125608127|NCT00069095|451848062|FG004|Post-study Treatment Phase|Missing reason|18|||
125608128|NCT00069095|451848063|FG005|Post-study Treatment Phase|Missing reason|17|||
125608129|NCT00069095|451848058|FG000|Post-study Treatment Phase|Adverse Event|2|||
125608130|NCT00069095|451848059|FG001|Post-study Treatment Phase|Adverse Event|3|||
125608131|NCT00069095|451848060|FG002|Post-study Treatment Phase|Adverse Event|1|||
125608132|NCT00069095|451848061|FG003|Post-study Treatment Phase|Adverse Event|0|||
125608133|NCT00069095|451848062|FG004|Post-study Treatment Phase|Adverse Event|5|||
125608134|NCT00069095|451848063|FG005|Post-study Treatment Phase|Adverse Event|1|||
125608135|NCT00069095|451848058|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
125608136|NCT00069095|451848059|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
125608137|NCT00069095|451848060|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
125608138|NCT00069095|451848061|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
125608139|NCT00069095|451848062|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
125608140|NCT00069095|451848063|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
125608141|NCT00069095|451848058|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
125608142|NCT00069095|451848059|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
125608143|NCT00069095|451848060|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
125608144|NCT00069095|451848061|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
125608145|NCT00069095|451848062|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
125608146|NCT00069095|451848063|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
125608147|NCT00069095|451848058|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
125608148|NCT00069095|451848059|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
125608149|NCT00069095|451848060|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
125608150|NCT00069095|451848061|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
125608151|NCT00069095|451848062|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
125608152|NCT00069095|451848063|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
125608153|NCT00069095|451848058|FG000|Post-study Treatment Phase|Participant had complete response|1|||
125608154|NCT00069095|451848059|FG001|Post-study Treatment Phase|Participant had complete response|1|||
125608155|NCT00069095|451848060|FG002|Post-study Treatment Phase|Participant had complete response|0|||
125608156|NCT00069095|451848061|FG003|Post-study Treatment Phase|Participant had complete response|0|||
125608157|NCT00069095|451848062|FG004|Post-study Treatment Phase|Participant had complete response|0|||
125608158|NCT00069095|451848063|FG005|Post-study Treatment Phase|Participant had complete response|0|||
125608159|NCT00069095|451848058|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
125608160|NCT00069095|451848059|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
125608161|NCT00069095|451848060|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
125608162|NCT00069095|451848061|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
125608163|NCT00069095|451848062|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
125608164|NCT00069095|451848063|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
125608165|NCT00069095|451848058|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
125608166|NCT00069095|451848059|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
125608167|NCT00069095|451848060|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
125608168|NCT00069095|451848061|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
125608169|NCT00069095|451848062|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
125608170|NCT00069095|451848063|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
125608171|NCT00069095|451848058|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
125608172|NCT00069095|451848059|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
125608173|NCT00069095|451848060|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
125608174|NCT00069095|451848061|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
125608175|NCT00069095|451848062|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
125608176|NCT00069095|451848063|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
125608177|NCT00069095|451848058|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
125608178|NCT00069095|451848059|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
125608179|NCT00069095|451848060|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
125608180|NCT00069095|451848061|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
125608181|NCT00069095|451848062|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
125608182|NCT00069095|451848063|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
125608183|NCT00069095|451848058|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
125608184|NCT00069095|451848059|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
125608185|NCT00069095|451848060|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
125608186|NCT00069095|451848061|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
125608187|NCT00069095|451848062|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
125370399|NCT03547583|450989285|FG002|Overall Study|Withdrawal by Subject|10|||
125370400|NCT03547583|450989283|FG000|Overall Study|Other|2|||
125370401|NCT03547583|450989284|FG001|Overall Study|Other|2|||
125370402|NCT03547583|450989285|FG002|Overall Study|Other|3|||
125370403|NCT00382252|450989286|FG000|Overall Study|Death|4|||
125370404|NCT00382252|450989286|FG000|Overall Study|Protocol Violation|8|||
125370405|NCT00382252|450989286|FG000|Overall Study|Not treated by RFA|1|||
125608188|NCT00069095|451848063|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
125608189|NCT00069095|451848058|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
125608190|NCT00069095|451848059|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
125608191|NCT00069095|451848060|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
125608192|NCT00069095|451848061|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
125608193|NCT00069095|451848062|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
125608194|NCT00069095|451848063|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
125608195|NCT00069095|451848058|FG000|Post-study Treatment Phase|Surgery|0|||
125608196|NCT00069095|451848059|FG001|Post-study Treatment Phase|Surgery|0|||
125608197|NCT00069095|451848060|FG002|Post-study Treatment Phase|Surgery|0|||
125608198|NCT00069095|451848061|FG003|Post-study Treatment Phase|Surgery|1|||
125608199|NCT00069095|451848062|FG004|Post-study Treatment Phase|Surgery|1|||
125608200|NCT00069095|451848063|FG005|Post-study Treatment Phase|Surgery|0|||
125608201|NCT00069095|451848058|FG000|Post-study Treatment Phase|Death|0|||
125608202|NCT00069095|451848059|FG001|Post-study Treatment Phase|Death|0|||
125608203|NCT00069095|451848060|FG002|Post-study Treatment Phase|Death|0|||
125608204|NCT00069095|451848061|FG003|Post-study Treatment Phase|Death|0|||
125608205|NCT00069095|451848062|FG004|Post-study Treatment Phase|Death|1|||
125608206|NCT00069095|451848063|FG005|Post-study Treatment Phase|Death|0|||
125608207|NCT00069095|451848058|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
125608208|NCT00069095|451848059|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
125608209|NCT00069095|451848060|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
125608210|NCT00069095|451848061|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
125608211|NCT00069095|451848062|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
125608212|NCT00069095|451848063|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
125608213|NCT00069095|451848058|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
125608214|NCT00069095|451848059|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
125608215|NCT00069095|451848060|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
125608216|NCT00069095|451848061|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
125608217|NCT00069095|451848062|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
125608218|NCT00069095|451848063|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
125608219|NCT00069095|451848058|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
125608220|NCT00069095|451848059|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
125608221|NCT00069095|451848060|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
125608222|NCT00069095|451848061|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
125608223|NCT00069095|451848062|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
125608224|NCT00069095|451848063|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
125608225|NCT00069095|451848058|FG000|Post-study Treatment Phase|Investigator decision|0|||
125608226|NCT00069095|451848059|FG001|Post-study Treatment Phase|Investigator decision|0|||
125608227|NCT00069095|451848060|FG002|Post-study Treatment Phase|Investigator decision|0|||
125608228|NCT00069095|451848061|FG003|Post-study Treatment Phase|Investigator decision|0|||
125608229|NCT00069095|451848062|FG004|Post-study Treatment Phase|Investigator decision|0|||
125608230|NCT00069095|451848063|FG005|Post-study Treatment Phase|Investigator decision|1|||
125608231|NCT00069095|451848058|FG000|Follow-up Phase|Death|174|||
125608232|NCT00069095|451848059|FG001|Follow-up Phase|Death|206|||
125608233|NCT00069095|451848060|FG002|Follow-up Phase|Death|120|||
125608234|NCT00069095|451848061|FG003|Follow-up Phase|Death|112|||
125608235|NCT00069095|451848062|FG004|Follow-up Phase|Death|92|||
125608236|NCT00069095|451848063|FG005|Follow-up Phase|Death|101|||
125370406|NCT05570500|450989291|FG000|Overall Study|Lost to Follow-up|7|||
125370407|NCT05570500|450989292|FG001|Overall Study|Lost to Follow-up|5|||
125608237|NCT05114590|451848067|FG000|Overall Study|Adverse Event|1|||
125608238|NCT05114590|451848067|FG000|Overall Study|Investigator decision|1|||
125608239|NCT05114590|451848067|FG000|Overall Study|Lost to Follow-up|5|||
125608240|NCT05114590|451848067|FG000|Overall Study|Withdrawal by Subject|5|||
125608241|NCT05114590|451848067|FG000|Overall Study|Other|2|||
125608242|NCT00358917|451848070|FG000|Overall Study|Adverse Event|14|||
125608243|NCT00358917|451848071|FG001|Overall Study|Adverse Event|21|||
125608244|NCT00358917|451848070|FG000|Overall Study|Withdrawal by Subject|5|||
125608245|NCT00358917|451848071|FG001|Overall Study|Withdrawal by Subject|7|||
125608246|NCT00358917|451848070|FG000|Overall Study|Lost to Follow-up|20|||
125608247|NCT00358917|451848071|FG001|Overall Study|Lost to Follow-up|17|||
125608248|NCT00358917|451848070|FG000|Overall Study|Noncompliance|12|||
125608249|NCT00358917|451848071|FG001|Overall Study|Noncompliance|11|||
125608250|NCT00358917|451848070|FG000|Overall Study|Death|2|||
125608251|NCT00358917|451848071|FG001|Overall Study|Death|3|||
125608252|NCT00358917|451848070|FG000|Overall Study|Virologic failure|11|||
125608253|NCT00358917|451848071|FG001|Overall Study|Virologic failure|8|||
125608254|NCT00358917|451848070|FG000|Overall Study|Unable to Continue Participation|2|||
125608255|NCT00358917|451848071|FG001|Overall Study|Unable to Continue Participation|2|||
125608256|NCT01379534|451848072|FG000|Treatment Phase|Withdrawal by Subject|2|||
125608257|NCT01379534|451848073|FG001|Treatment Phase|Withdrawal by Subject|2|||
125608258|NCT01379534|451848072|FG000|Treatment Phase|Progressive disease|13|||
125608259|NCT01379534|451848073|FG001|Treatment Phase|Progressive disease|22|||
125608260|NCT01379534|451848072|FG000|Treatment Phase|Adverse Event|7|||
125608261|NCT01379534|451848073|FG001|Treatment Phase|Adverse Event|7|||
125608262|NCT01379534|451848072|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
125608263|NCT01379534|451848073|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
125608264|NCT01379534|451848072|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
125608265|NCT01379534|451848073|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
125213225|NCT00339833|450407286|FG001|Overall Study|Poor venous access|2|||
125213226|NCT00339833|450407285|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
125213227|NCT00339833|450407286|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
125213228|NCT00339833|450407285|FG000|Overall Study|Error in data records|1|||
125213229|NCT00339833|450407286|FG001|Overall Study|Error in data records|0|||
125213230|NCT03077607|450407287|FG000|Period 1 (15 Days)|Adverse Event|1|||
125213231|NCT03077607|450407288|FG001|Period 1 (15 Days)|Adverse Event|0|||
125213232|NCT03077607|450407287|FG000|Period 1 (15 Days)|Death|1|||
125213233|NCT03077607|450407288|FG001|Period 1 (15 Days)|Death|0|||
125213234|NCT03077607|450407287|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
125213235|NCT03077607|450407288|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
125213236|NCT03077607|450407287|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
125213237|NCT03077607|450407288|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
125213238|NCT02476916|450407289|FG000|Core Period|Adverse Event|2|||
125213239|NCT02476916|450407290|FG001|Core Period|Adverse Event|2|||
125213240|NCT02476916|450407289|FG000|Core Period|Investigator decision|1|||
125213241|NCT02476916|450407290|FG001|Core Period|Investigator decision|1|||
125213242|NCT02476916|450407289|FG000|Core Period|Withdrawal by Subject|3|||
125213243|NCT02476916|450407290|FG001|Core Period|Withdrawal by Subject|0|||
125213244|NCT02476916|450407289|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
125213245|NCT02476916|450407290|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
125213246|NCT02476916|450407289|FG000|Extension Period|On Treatment|12|||
125213247|NCT02476916|450407290|FG001|Extension Period|On Treatment|17|||
125213248|NCT06010732|450407291|FG000|Crossover Period 1|Protocol Violation|0|||
125213249|NCT06010732|450407292|FG001|Crossover Period 1|Protocol Violation|0|||
125213250|NCT06010732|450407293|FG002|Crossover Period 1|Protocol Violation|1|||
125213251|NCT06010732|450407294|FG003|Crossover Period 1|Protocol Violation|0|||
125213252|NCT06010732|450407295|FG004|Crossover Period 1|Protocol Violation|1|||
125213253|NCT06010732|450407296|FG005|Crossover Period 1|Protocol Violation|0|||
125370408|NCT04706091|450989293|FG000|Treatment 2|Withdrawal by Subject|1|||
125370409|NCT04706091|450989294|FG001|Treatment 2|Withdrawal by Subject|0|||
125370410|NCT02612727|450989295|FG000|Overall Study|Parent request|4|||
125608266|NCT01379534|451848072|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
125608267|NCT01379534|451848073|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
125608268|NCT01379534|451848072|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
125608269|NCT01379534|451848073|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
125213254|NCT06010732|450407291|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
125213255|NCT06010732|450407292|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
125213256|NCT06010732|450407293|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
125213257|NCT06010732|450407294|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
125213258|NCT06010732|450407295|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
125370411|NCT02612727|450989296|FG001|Overall Study|Parent request|1|||
125608270|NCT05372575|451848076|FG000|Overall Study|Protocol Violation|7|||
125608271|NCT05372575|451848077|FG001|Overall Study|Protocol Violation|16|||
125370412|NCT02612727|450989295|FG000|Overall Study|Needed treatment incompatible with PT|1|||
125370413|NCT02612727|450989296|FG001|Overall Study|Needed treatment incompatible with PT|1|||
125370414|NCT02612727|450989295|FG000|Overall Study|Direct hyperbilirubinemia|0|||
125370415|NCT02612727|450989296|FG001|Overall Study|Direct hyperbilirubinemia|2|||
125370416|NCT01063868|450989297|FG000|Overall Study|Adverse Event|9|||
125370417|NCT01063868|450989298|FG001|Overall Study|Adverse Event|7|||
125370418|NCT01063868|450989297|FG000|Overall Study|Withdrawal by Subject|3|||
125370419|NCT01063868|450989298|FG001|Overall Study|Withdrawal by Subject|1|||
125370420|NCT01063868|450989297|FG000|Overall Study|Study Terminated By Sponsor|23|||
125370421|NCT01063868|450989298|FG001|Overall Study|Study Terminated By Sponsor|4|||
125608272|NCT01544595|451848078|FG000|Status at Week 68|Adverse Event|3|||
125608273|NCT01544595|451848079|FG001|Status at Week 68|Adverse Event|2|||
125608274|NCT01544595|451848080|FG002|Status at Week 68|Adverse Event|1|||
125608275|NCT01544595|451848081|FG003|Status at Week 68|Adverse Event|0|||
125608276|NCT01544595|451848082|FG004|Status at Week 68|Adverse Event|0|||
125608277|NCT01544595|451848083|FG005|Status at Week 68|Adverse Event|0|||
125608278|NCT01544595|451848078|FG000|Status at Week 68|Lack of Efficacy|1|||
125608279|NCT01544595|451848079|FG001|Status at Week 68|Lack of Efficacy|0|||
125608280|NCT01544595|451848080|FG002|Status at Week 68|Lack of Efficacy|0|||
125608281|NCT01544595|451848081|FG003|Status at Week 68|Lack of Efficacy|0|||
125608282|NCT01544595|451848082|FG004|Status at Week 68|Lack of Efficacy|0|||
125608283|NCT01544595|451848083|FG005|Status at Week 68|Lack of Efficacy|0|||
125608284|NCT01544595|451848078|FG000|Status at Week 68|Lost to Follow-up|1|||
125608285|NCT01544595|451848079|FG001|Status at Week 68|Lost to Follow-up|1|||
125608286|NCT01544595|451848080|FG002|Status at Week 68|Lost to Follow-up|0|||
125608287|NCT01544595|451848081|FG003|Status at Week 68|Lost to Follow-up|0|||
125608288|NCT01544595|451848082|FG004|Status at Week 68|Lost to Follow-up|0|||
125608289|NCT01544595|451848083|FG005|Status at Week 68|Lost to Follow-up|0|||
125608290|NCT01544595|451848078|FG000|Status at Week 68|Non-compliance with study treatment|1|||
125608291|NCT01544595|451848079|FG001|Status at Week 68|Non-compliance with study treatment|0|||
125608292|NCT01544595|451848080|FG002|Status at Week 68|Non-compliance with study treatment|0|||
125608293|NCT01544595|451848081|FG003|Status at Week 68|Non-compliance with study treatment|1|||
125608294|NCT01544595|451848082|FG004|Status at Week 68|Non-compliance with study treatment|0|||
125608295|NCT01544595|451848083|FG005|Status at Week 68|Non-compliance with study treatment|0|||
125608296|NCT01544595|451848078|FG000|Status at Week 68|Protocol Violation|2|||
125608297|NCT01544595|451848079|FG001|Status at Week 68|Protocol Violation|0|||
125608298|NCT01544595|451848080|FG002|Status at Week 68|Protocol Violation|1|||
125608299|NCT01544595|451848081|FG003|Status at Week 68|Protocol Violation|1|||
125608300|NCT01544595|451848082|FG004|Status at Week 68|Protocol Violation|0|||
125608301|NCT01544595|451848083|FG005|Status at Week 68|Protocol Violation|0|||
125608302|NCT01544595|451848078|FG000|Status at Week 68|Technical problems|1|||
125608303|NCT01544595|451848079|FG001|Status at Week 68|Technical problems|0|||
125608304|NCT01544595|451848080|FG002|Status at Week 68|Technical problems|0|||
125608305|NCT01544595|451848081|FG003|Status at Week 68|Technical problems|1|||
125608306|NCT01544595|451848082|FG004|Status at Week 68|Technical problems|0|||
125608307|NCT01544595|451848083|FG005|Status at Week 68|Technical problems|0|||
125608308|NCT01544595|451848078|FG000|Status at Week 68|Withdrawal by Subject|0|||
125608309|NCT01544595|451848079|FG001|Status at Week 68|Withdrawal by Subject|1|||
125608310|NCT01544595|451848080|FG002|Status at Week 68|Withdrawal by Subject|1|||
125608311|NCT01544595|451848081|FG003|Status at Week 68|Withdrawal by Subject|2|||
125608312|NCT01544595|451848082|FG004|Status at Week 68|Withdrawal by Subject|0|||
125608313|NCT01544595|451848083|FG005|Status at Week 68|Withdrawal by Subject|0|||
125608314|NCT01544595|451848078|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
125608315|NCT01544595|451848079|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
125608316|NCT01544595|451848080|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
125608317|NCT01544595|451848081|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
125608318|NCT01544595|451848082|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
125608319|NCT01544595|451848083|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
125608320|NCT01544595|451848078|FG000|Status at Week 156|Withdrawal by Subject|9|||
125608321|NCT01544595|451848079|FG001|Status at Week 156|Withdrawal by Subject|10|||
125608322|NCT01544595|451848080|FG002|Status at Week 156|Withdrawal by Subject|4|||
125608323|NCT01544595|451848081|FG003|Status at Week 156|Withdrawal by Subject|9|||
125608324|NCT01544595|451848082|FG004|Status at Week 156|Withdrawal by Subject|20|||
125608325|NCT01544595|451848083|FG005|Status at Week 156|Withdrawal by Subject|6|||
125608326|NCT01544595|451848078|FG000|Status at Week 156|Adverse Event|9|||
125608327|NCT01544595|451848079|FG001|Status at Week 156|Adverse Event|11|||
125608328|NCT01544595|451848080|FG002|Status at Week 156|Adverse Event|1|||
125608329|NCT01544595|451848081|FG003|Status at Week 156|Adverse Event|3|||
125608330|NCT01544595|451848082|FG004|Status at Week 156|Adverse Event|4|||
125608331|NCT01544595|451848083|FG005|Status at Week 156|Adverse Event|2|||
125608332|NCT01544595|451848078|FG000|Status at Week 156|Lost to Follow-up|4|||
125608333|NCT01544595|451848079|FG001|Status at Week 156|Lost to Follow-up|4|||
125370422|NCT02302807|450989301|FG000|Overall Study|Withdrawal by Subject|28|||
125608334|NCT01544595|451848080|FG002|Status at Week 156|Lost to Follow-up|0|||
125608335|NCT01544595|451848081|FG003|Status at Week 156|Lost to Follow-up|1|||
125608336|NCT01544595|451848082|FG004|Status at Week 156|Lost to Follow-up|4|||
125608337|NCT01544595|451848083|FG005|Status at Week 156|Lost to Follow-up|1|||
125608338|NCT01544595|451848078|FG000|Status at Week 156|Non-compliance with study treatement|0|||
125608339|NCT01544595|451848079|FG001|Status at Week 156|Non-compliance with study treatement|1|||
125608340|NCT01544595|451848080|FG002|Status at Week 156|Non-compliance with study treatement|0|||
125608341|NCT01544595|451848081|FG003|Status at Week 156|Non-compliance with study treatement|1|||
125608342|NCT01544595|451848082|FG004|Status at Week 156|Non-compliance with study treatement|0|||
125608343|NCT01544595|451848083|FG005|Status at Week 156|Non-compliance with study treatement|1|||
125608344|NCT01544595|451848078|FG000|Status at Week 156|Physician Decision|0|||
125608345|NCT01544595|451848079|FG001|Status at Week 156|Physician Decision|3|||
125608346|NCT01544595|451848080|FG002|Status at Week 156|Physician Decision|1|||
125608347|NCT01544595|451848081|FG003|Status at Week 156|Physician Decision|0|||
125608348|NCT01544595|451848082|FG004|Status at Week 156|Physician Decision|0|||
125608349|NCT01544595|451848083|FG005|Status at Week 156|Physician Decision|0|||
125608350|NCT01544595|451848078|FG000|Status at Week 156|Pregnancy|2|||
125608351|NCT01544595|451848079|FG001|Status at Week 156|Pregnancy|3|||
125608352|NCT01544595|451848080|FG002|Status at Week 156|Pregnancy|0|||
125608353|NCT01544595|451848081|FG003|Status at Week 156|Pregnancy|0|||
125608354|NCT01544595|451848082|FG004|Status at Week 156|Pregnancy|0|||
125608355|NCT01544595|451848083|FG005|Status at Week 156|Pregnancy|0|||
125608356|NCT01544595|451848078|FG000|Status at Week 156|Protocol Violation|3|||
125608357|NCT01544595|451848079|FG001|Status at Week 156|Protocol Violation|1|||
125608358|NCT01544595|451848080|FG002|Status at Week 156|Protocol Violation|2|||
125608359|NCT01544595|451848081|FG003|Status at Week 156|Protocol Violation|2|||
125608360|NCT01544595|451848082|FG004|Status at Week 156|Protocol Violation|0|||
125608361|NCT01544595|451848083|FG005|Status at Week 156|Protocol Violation|0|||
125608362|NCT01544595|451848078|FG000|Status at Week 156|Technical problems|3|||
125608363|NCT01544595|451848079|FG001|Status at Week 156|Technical problems|1|||
125608364|NCT01544595|451848080|FG002|Status at Week 156|Technical problems|0|||
125608365|NCT01544595|451848081|FG003|Status at Week 156|Technical problems|1|||
125608366|NCT01544595|451848082|FG004|Status at Week 156|Technical problems|0|||
125608367|NCT01544595|451848083|FG005|Status at Week 156|Technical problems|0|||
125608368|NCT01544595|451848078|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
125608369|NCT01544595|451848079|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
125608370|NCT01544595|451848080|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
125608371|NCT01544595|451848081|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
125608372|NCT01544595|451848082|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
125608373|NCT01544595|451848083|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
125608374|NCT01544595|451848078|FG000|Status at Week 156|Lack of Efficacy|1|||
125608375|NCT01544595|451848079|FG001|Status at Week 156|Lack of Efficacy|0|||
125608376|NCT01544595|451848080|FG002|Status at Week 156|Lack of Efficacy|1|||
125608377|NCT01544595|451848081|FG003|Status at Week 156|Lack of Efficacy|4|||
125608378|NCT01544595|451848082|FG004|Status at Week 156|Lack of Efficacy|10|||
125608379|NCT01544595|451848083|FG005|Status at Week 156|Lack of Efficacy|5|||
125608380|NCT00601523|451848085|FG000|Overall Study|Adverse Event|42|||
125608381|NCT00601523|451848086|FG001|Overall Study|Adverse Event|14|||
125608382|NCT00601523|451848085|FG000|Overall Study|Lack of Efficacy|3|||
125213259|NCT06010732|450407296|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
125608383|NCT00601523|451848086|FG001|Overall Study|Lack of Efficacy|0|||
125213260|NCT06010732|450407291|FG000|Crossover Period 2|Adverse Event|0|||
125608384|NCT00601523|451848085|FG000|Overall Study|Protocol Violation|5|||
125431789|NCT02055157|451207757|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
125608385|NCT00601523|451848086|FG001|Overall Study|Protocol Violation|1|||
125608386|NCT00601523|451848085|FG000|Overall Study|Lost to Follow-up|0|||
125608387|NCT00601523|451848086|FG001|Overall Study|Lost to Follow-up|1|||
125370423|NCT02302807|450989302|FG001|Overall Study|Withdrawal by Subject|11|||
125608388|NCT00601523|451848085|FG000|Overall Study|Withdrawal by Subject|18|||
125608389|NCT00601523|451848086|FG001|Overall Study|Withdrawal by Subject|9|||
125608390|NCT00601523|451848085|FG000|Overall Study|Other|9|||
125608391|NCT00601523|451848086|FG001|Overall Study|Other|1|||
125608392|NCT03643432|451848087|FG000|Overall Study|Lost to Follow-up|1|||
125608393|NCT03643432|451848088|FG001|Overall Study|Lost to Follow-up|0|||
125608394|NCT01064648|451848095|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
125608395|NCT01064648|451848096|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
125608396|NCT01064648|451848097|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
125608397|NCT01064648|451848098|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
125608398|NCT01064648|451848095|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
125608399|NCT01064648|451848096|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
125608400|NCT01064648|451848097|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
125608401|NCT01064648|451848098|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
125608402|NCT01064648|451848095|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
125608403|NCT01064648|451848096|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
125608404|NCT01064648|451848097|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
125608405|NCT01064648|451848098|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
125608406|NCT01064648|451848095|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
125608407|NCT01064648|451848096|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
125608408|NCT01064648|451848097|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
125608409|NCT01064648|451848098|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
125608410|NCT01064648|451848095|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
125608411|NCT01064648|451848096|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
125608412|NCT01064648|451848097|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
125608413|NCT01064648|451848098|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
125608414|NCT01064648|451848095|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
125608415|NCT01064648|451848096|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
125608416|NCT01064648|451848097|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
125608417|NCT01064648|451848098|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
125608418|NCT01064648|451848095|FG000|Phase II|Adverse Event|0|||
125608419|NCT01064648|451848096|FG001|Phase II|Adverse Event|0|||
125608420|NCT01064648|451848097|FG002|Phase II|Adverse Event|15|||
125608421|NCT01064648|451848098|FG003|Phase II|Adverse Event|8|||
125608422|NCT01064648|451848095|FG000|Phase II|Death|0|||
125608423|NCT01064648|451848096|FG001|Phase II|Death|0|||
125608424|NCT01064648|451848097|FG002|Phase II|Death|4|||
125608425|NCT01064648|451848098|FG003|Phase II|Death|5|||
125608426|NCT01064648|451848095|FG000|Phase II|Withdrawal by Subject|0|||
125608427|NCT01064648|451848096|FG001|Phase II|Withdrawal by Subject|0|||
125608428|NCT01064648|451848097|FG002|Phase II|Withdrawal by Subject|2|||
125608429|NCT01064648|451848098|FG003|Phase II|Withdrawal by Subject|5|||
125608430|NCT01064648|451848095|FG000|Phase II|Progression|0|||
125608431|NCT01064648|451848096|FG001|Phase II|Progression|0|||
125608432|NCT01064648|451848097|FG002|Phase II|Progression|21|||
125608433|NCT01064648|451848098|FG003|Phase II|Progression|27|||
125608434|NCT01064648|451848095|FG000|Phase II|Non-protocol specified|0|||
125608435|NCT01064648|451848096|FG001|Phase II|Non-protocol specified|0|||
125608436|NCT01064648|451848097|FG002|Phase II|Non-protocol specified|5|||
125608437|NCT01064648|451848098|FG003|Phase II|Non-protocol specified|3|||
125370424|NCT02302807|450989301|FG000|Overall Study|Lost to Follow-up|4|||
125370425|NCT02302807|450989302|FG001|Overall Study|Lost to Follow-up|6|||
125608438|NCT01064648|451848095|FG000|Phase II|Under Review|0|||
125608439|NCT01064648|451848096|FG001|Phase II|Under Review|0|||
125608440|NCT01064648|451848097|FG002|Phase II|Under Review|2|||
125608441|NCT01064648|451848098|FG003|Phase II|Under Review|0|||
125608442|NCT00977574|451848099|FG000|Overall Study|Never Treated|4|||
125213261|NCT06010732|450407292|FG001|Crossover Period 2|Adverse Event|1|||
125370426|NCT02302807|450989301|FG000|Overall Study|Death|397|||
125608443|NCT00977574|451848100|FG001|Overall Study|Never Treated|2|||
125608444|NCT00977574|451848101|FG002|Overall Study|Never Treated|4|||
125608445|NCT04491877|451849747|FG000|Overall Study|Protocol Deviation|1|||
125608446|NCT04491877|451849748|FG001|Overall Study|Protocol Deviation|0|||
125608447|NCT04491877|451849749|FG002|Overall Study|Protocol Deviation|2|||
125608448|NCT04491877|451849750|FG003|Overall Study|Protocol Deviation|0|||
125370427|NCT02302807|450989302|FG001|Overall Study|Death|385|||
125370428|NCT02302807|450989301|FG000|Overall Study|Study Terminated By Sponsor|35|||
125370429|NCT02302807|450989302|FG001|Overall Study|Study Terminated By Sponsor|64|||
125370430|NCT02302807|450989301|FG000|Overall Study|Physician Decision|0|||
125370431|NCT02302807|450989302|FG001|Overall Study|Physician Decision|1|||
125370432|NCT01446289|450989303|FG000|Overall Study|Withdrawal by Subject|1|||
125370433|NCT01446289|450989304|FG001|Overall Study|Withdrawal by Subject|0|||
125370434|NCT01446289|450989305|FG002|Overall Study|Withdrawal by Subject|1|||
125608449|NCT04491877|451849751|FG004|Overall Study|Protocol Deviation|0|||
125608450|NCT04491877|451849752|FG005|Overall Study|Protocol Deviation|0|||
125608451|NCT04491877|451849753|FG006|Overall Study|Protocol Deviation|1|||
125608452|NCT04491877|451849754|FG007|Overall Study|Protocol Deviation|1|||
125608453|NCT04491877|451849755|FG008|Overall Study|Protocol Deviation|0|||
125608454|NCT04491877|451849747|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125608455|NCT04491877|451849748|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125608456|NCT04491877|451849749|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125608457|NCT04491877|451849750|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
125608458|NCT04491877|451849751|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125608459|NCT04491877|451849752|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
125608460|NCT04491877|451849753|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
125608461|NCT04491877|451849754|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
125608462|NCT04491877|451849755|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
125608463|NCT04491877|451849747|FG000|Overall Study|Lost to Follow-up|0|||
125608464|NCT04491877|451849748|FG001|Overall Study|Lost to Follow-up|2|||
125608465|NCT04491877|451849749|FG002|Overall Study|Lost to Follow-up|0|||
125608466|NCT04491877|451849750|FG003|Overall Study|Lost to Follow-up|0|||
125608467|NCT04491877|451849751|FG004|Overall Study|Lost to Follow-up|0|||
125608468|NCT04491877|451849752|FG005|Overall Study|Lost to Follow-up|0|||
125608469|NCT04491877|451849753|FG006|Overall Study|Lost to Follow-up|2|||
125608470|NCT04491877|451849754|FG007|Overall Study|Lost to Follow-up|1|||
125608471|NCT04491877|451849755|FG008|Overall Study|Lost to Follow-up|1|||
125608472|NCT01286272|451849759|FG000|Overall Study|Ineligible after beginning treatment|1|||
125608473|NCT01286272|451849760|FG001|Overall Study|Ineligible after beginning treatment|3|||
125608474|NCT00418834|451849765|FG000|Overall Study|Adverse Event|16|||
125608475|NCT00418834|451849766|FG001|Overall Study|Adverse Event|9|||
125608476|NCT00418834|451849765|FG000|Overall Study|Lost to Follow-up|0|||
125608477|NCT00418834|451849766|FG001|Overall Study|Lost to Follow-up|1|||
125608478|NCT00418834|451849765|FG000|Overall Study|Protocol Violation|4|||
125608479|NCT00418834|451849766|FG001|Overall Study|Protocol Violation|3|||
125608480|NCT00418834|451849765|FG000|Overall Study|Withdrawal by Subject|3|||
125608481|NCT00418834|451849766|FG001|Overall Study|Withdrawal by Subject|7|||
125608482|NCT01953328|451849767|FG000|Overall Study|Withdrawal by Subject|0|||
125608483|NCT01953328|451849768|FG001|Overall Study|Withdrawal by Subject|0|||
125608484|NCT01953328|451849769|FG002|Overall Study|Withdrawal by Subject|0|||
125370435|NCT01446289|450989306|FG003|Overall Study|Withdrawal by Subject|0|||
125608485|NCT01953328|451849770|FG003|Overall Study|Withdrawal by Subject|0|||
125608486|NCT01953328|451849771|FG004|Overall Study|Withdrawal by Subject|1|||
125370436|NCT03329573|450989307|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
125608487|NCT01953328|451849772|FG005|Overall Study|Withdrawal by Subject|0|||
125608488|NCT01953328|451849773|FG006|Overall Study|Withdrawal by Subject|0|||
125608489|NCT01953328|451849774|FG007|Overall Study|Withdrawal by Subject|0|||
125608490|NCT01953328|451849767|FG000|Overall Study|Lost to Follow-up|0|||
125370437|NCT03329573|450989308|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
125370438|NCT03329573|450989309|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
125370439|NCT03329573|450989310|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
125370440|NCT03329573|450989307|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
125370441|NCT03329573|450989308|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
125370442|NCT03329573|450989309|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125370443|NCT03329573|450989310|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
125370444|NCT03329573|450989307|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
125370445|NCT03329573|450989308|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
125370446|NCT03329573|450989309|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
125370447|NCT03329573|450989310|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
125370448|NCT03329573|450989307|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
125370449|NCT03329573|450989308|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
125370450|NCT03329573|450989309|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
125370451|NCT03329573|450989310|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
125370452|NCT03307967|450989313|FG000|Overall Study|Lost to Follow-up|4|||
125370453|NCT02578316|450989314|FG000|Extension Phase|Progression of disease|6|||
125370454|NCT03278873|450989315|FG000|Overall Study|Withdrawal by Subject|0|||
125370455|NCT03278873|450989316|FG001|Overall Study|Withdrawal by Subject|1|||
125370456|NCT03278873|450989317|FG002|Overall Study|Withdrawal by Subject|0|||
125370457|NCT03278873|450989318|FG003|Overall Study|Withdrawal by Subject|0|||
125370458|NCT03278873|450989315|FG000|Overall Study|Sponsor's decision|0|||
125370459|NCT03278873|450989316|FG001|Overall Study|Sponsor's decision|1|||
125370460|NCT03278873|450989317|FG002|Overall Study|Sponsor's decision|0|||
125370461|NCT03278873|450989318|FG003|Overall Study|Sponsor's decision|0|||
125370462|NCT03278873|450989315|FG000|Overall Study|Early Termination|2|||
125370463|NCT03278873|450989316|FG001|Overall Study|Early Termination|6|||
125370464|NCT03278873|450989317|FG002|Overall Study|Early Termination|0|||
125370465|NCT03278873|450989318|FG003|Overall Study|Early Termination|4|||
125370466|NCT03278873|450989315|FG000|Overall Study|Lost to Follow-up|0|||
125370467|NCT03278873|450989316|FG001|Overall Study|Lost to Follow-up|0|||
125370468|NCT03278873|450989317|FG002|Overall Study|Lost to Follow-up|2|||
125370469|NCT03278873|450989318|FG003|Overall Study|Lost to Follow-up|0|||
125370470|NCT03278873|450989315|FG000|Overall Study|The patient decided to withdraw via email|1|||
125370471|NCT03278873|450989316|FG001|Overall Study|The patient decided to withdraw via email|0|||
125370472|NCT03278873|450989317|FG002|Overall Study|The patient decided to withdraw via email|0|||
125370473|NCT03278873|450989318|FG003|Overall Study|The patient decided to withdraw via email|0|||
125370474|NCT03278873|450989315|FG000|Overall Study|The patient was unresponsive to contact|0|||
125370475|NCT03278873|450989316|FG001|Overall Study|The patient was unresponsive to contact|0|||
125370476|NCT03278873|450989317|FG002|Overall Study|The patient was unresponsive to contact|0|||
125370477|NCT03278873|450989318|FG003|Overall Study|The patient was unresponsive to contact|4|||
125370478|NCT03278873|450989315|FG000|Overall Study|The patient wished to participate no longer|0|||
125370479|NCT03278873|450989316|FG001|Overall Study|The patient wished to participate no longer|1|||
125370480|NCT03278873|450989317|FG002|Overall Study|The patient wished to participate no longer|0|||
125370481|NCT03278873|450989318|FG003|Overall Study|The patient wished to participate no longer|0|||
125370482|NCT03278873|450989315|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
125370483|NCT03278873|450989316|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
125370484|NCT03278873|450989317|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
125370485|NCT03278873|450989318|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
125608491|NCT01953328|451849768|FG001|Overall Study|Lost to Follow-up|0|||
125608492|NCT01953328|451849769|FG002|Overall Study|Lost to Follow-up|0|||
125608493|NCT01953328|451849770|FG003|Overall Study|Lost to Follow-up|0|||
125608494|NCT01953328|451849771|FG004|Overall Study|Lost to Follow-up|1|||
125608495|NCT01953328|451849772|FG005|Overall Study|Lost to Follow-up|0|||
125608496|NCT01953328|451849773|FG006|Overall Study|Lost to Follow-up|0|||
125608497|NCT01953328|451849774|FG007|Overall Study|Lost to Follow-up|0|||
125608498|NCT02364947|451849779|FG000|Overall Study|Withdrawal by Subject|10|||
125608499|NCT02364947|451849780|FG001|Overall Study|Withdrawal by Subject|8|||
125608500|NCT02364947|451849781|FG002|Overall Study|Withdrawal by Subject|9|||
125608501|NCT02364947|451849779|FG000|Overall Study|Adverse Event|45|||
125608502|NCT02364947|451849780|FG001|Overall Study|Adverse Event|33|||
125370486|NCT05372419|450989319|FG000|Overall Study|Protocol Deviation|1|||
125370487|NCT05372419|450989319|FG000|Overall Study|Withdrawal by Subject|5|||
125370488|NCT05372419|450989319|FG000|Overall Study|Lost to Follow-up|7|||
125608503|NCT02364947|451849781|FG002|Overall Study|Adverse Event|11|||
125370489|NCT02801331|450989320|FG000|Overall Study|Transferred to another hospital|8|||
125370490|NCT02801331|450989321|FG001|Overall Study|Transferred to another hospital|7|||
125370491|NCT02801331|450989320|FG000|Overall Study|Withdrawal by Subject|0|||
125608504|NCT02364947|451849779|FG000|Overall Study|Protocol Violation|1|||
125608505|NCT02364947|451849780|FG001|Overall Study|Protocol Violation|1|||
125608506|NCT02364947|451849781|FG002|Overall Study|Protocol Violation|1|||
125370492|NCT02801331|450989321|FG001|Overall Study|Withdrawal by Subject|4|||
125370493|NCT02801331|450989320|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
125608507|NCT02364947|451849779|FG000|Overall Study|Physician Decision|3|||
125370494|NCT02801331|450989321|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
125370495|NCT03253744|450989323|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
125370496|NCT03253744|450989324|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
125370497|NCT03253744|450989325|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
125370498|NCT03253744|450989326|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
125370499|NCT04698187|450989335|FG000|Overall Study|Withdrawal by Subject|7|||
125370500|NCT04698187|450989335|FG000|Overall Study|Death|21|||
125370501|NCT04698187|450989335|FG000|Overall Study|Sponsor Decision|15|||
125370502|NCT04698187|450989335|FG000|Overall Study|In-transit Disease|1|||
125370503|NCT04362072|450989336|FG000|Treatment|Adverse Event|1|||
125370504|NCT04362072|450989336|FG000|Treatment|Death|9|||
125370505|NCT04362072|450989336|FG000|Treatment|Physician Decision|2|||
125370506|NCT04362072|450989336|FG000|Treatment|Progressive disease|27|||
125370507|NCT04362072|450989336|FG000|Treatment|Withdrawal by Subject|4|||
125370508|NCT04362072|450989336|FG000|Treatment|Global deterioration of health status|1|||
125370509|NCT04362072|450989336|FG000|Treatment|Switched to commercial Lorlatinib|13|||
125370510|NCT04362072|450989336|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
125370511|NCT04362072|450989336|FG000|Treatment|Other|3|||
125370512|NCT04362072|450989336|FG000|Follow up|Death|2|||
125370513|NCT04362072|450989336|FG000|Follow up|Other|2|||
125370514|NCT01133522|450989337|FG000|Overall Study|Withdrawal by Subject|0|||
125370515|NCT01133522|450989338|FG001|Overall Study|Withdrawal by Subject|1|||
125608508|NCT02364947|451849780|FG001|Overall Study|Physician Decision|2|||
125608509|NCT02364947|451849781|FG002|Overall Study|Physician Decision|5|||
125608510|NCT02364947|451849779|FG000|Overall Study|Death|0|||
125608511|NCT02364947|451849780|FG001|Overall Study|Death|1|||
125608512|NCT02364947|451849781|FG002|Overall Study|Death|0|||
125608513|NCT05525975|451849782|FG000|Overall Study|Surgery cancellation|4|||
125608514|NCT05525975|451849783|FG001|Overall Study|Surgery cancellation|5|||
125608515|NCT05525975|451849782|FG000|Overall Study|didn't fill prescription|1|||
125608516|NCT05525975|451849783|FG001|Overall Study|didn't fill prescription|0|||
125608517|NCT05525975|451849782|FG000|Overall Study|Withdrawal by Subject|0|||
125608518|NCT05525975|451849783|FG001|Overall Study|Withdrawal by Subject|3|||
125608519|NCT04009096|451849784|FG000|Overall Study|Withdrawal by Subject|0|||
125608520|NCT04009096|451849785|FG001|Overall Study|Withdrawal by Subject|7|||
125608521|NCT04009096|451849786|FG002|Overall Study|Withdrawal by Subject|0|||
125608522|NCT04009096|451849784|FG000|Overall Study|Physician Decision|0|||
125608523|NCT04009096|451849785|FG001|Overall Study|Physician Decision|1|||
125608524|NCT04009096|451849786|FG002|Overall Study|Physician Decision|0|||
125608525|NCT05151471|451849787|FG000|Overall Study|Adverse Event|21|||
125608526|NCT05151471|451849788|FG001|Overall Study|Adverse Event|16|||
125608527|NCT05151471|451849787|FG000|Overall Study|Death|1|||
125608528|NCT05151471|451849788|FG001|Overall Study|Death|0|||
125608529|NCT05151471|451849787|FG000|Overall Study|Lost to Follow-up|0|||
125608530|NCT05151471|451849788|FG001|Overall Study|Lost to Follow-up|1|||
125608531|NCT05151471|451849787|FG000|Overall Study|Withdrawal by Subject|7|||
125608532|NCT05151471|451849788|FG001|Overall Study|Withdrawal by Subject|9|||
125608533|NCT05151471|451849787|FG000|Overall Study|Study terminated by sponsor|49|||
125608534|NCT05151471|451849788|FG001|Overall Study|Study terminated by sponsor|47|||
125608535|NCT05151471|451849787|FG000|Overall Study|Other|2|||
125608536|NCT05151471|451849788|FG001|Overall Study|Other|1|||
125608537|NCT01028651|451849794|FG000|Overall Study|Death|2|||
125608538|NCT01028651|451849794|FG000|Overall Study|Adverse Event|1|||
125608539|NCT01554956|451849797|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
125608540|NCT01554956|451849798|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
125608541|NCT01554956|451849799|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
125608542|NCT01554956|451849797|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
125608543|NCT01554956|451849798|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
125608544|NCT01554956|451849799|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
125370516|NCT01133522|450989339|FG002|Overall Study|Withdrawal by Subject|0|||
125370517|NCT01133522|450989340|FG003|Overall Study|Withdrawal by Subject|1|||
125370518|NCT01133522|450989341|FG004|Overall Study|Withdrawal by Subject|0|||
125370519|NCT01133522|450989342|FG005|Overall Study|Withdrawal by Subject|0|||
125370520|NCT01133522|450989343|FG006|Overall Study|Withdrawal by Subject|0|||
125370521|NCT01133522|450989344|FG007|Overall Study|Withdrawal by Subject|0|||
125608545|NCT01554956|451849797|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
125608546|NCT01554956|451849798|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
125608547|NCT01554956|451849799|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
125608548|NCT00913978|451849800|FG000|Overall Study|Surgeon choice|1|||
125608549|NCT00913978|451849801|FG001|Overall Study|Surgeon choice|3|||
125608550|NCT01327651|451849802|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
125608551|NCT01327651|451849803|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
125608552|NCT01327651|451849804|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
125608553|NCT01327651|451849805|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
125608554|NCT01327651|451849806|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
125608555|NCT01327651|451849807|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
125608556|NCT01327651|451849808|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
125608557|NCT01327651|451849809|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
125608558|NCT01327651|451849810|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
125608559|NCT01327651|451849802|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
125608560|NCT01327651|451849803|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125608561|NCT01327651|451849804|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125608562|NCT01327651|451849805|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125608563|NCT01327651|451849806|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125608564|NCT01327651|451849807|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125608565|NCT01327651|451849808|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125608566|NCT01327651|451849809|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125608567|NCT01327651|451849810|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
125608568|NCT01327651|451849802|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
125608569|NCT01327651|451849803|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
125608570|NCT01327651|451849804|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
125608571|NCT01327651|451849805|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
125608572|NCT01327651|451849806|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
125608573|NCT01327651|451849807|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
125608574|NCT01327651|451849808|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
125608575|NCT01327651|451849809|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
125608576|NCT01327651|451849810|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
125608577|NCT01327651|451849802|FG000|Post Study Follow-up|Lost to Follow-up|0|||
125608578|NCT01327651|451849803|FG001|Post Study Follow-up|Lost to Follow-up|1|||
125608579|NCT01327651|451849804|FG002|Post Study Follow-up|Lost to Follow-up|1|||
125608580|NCT01327651|451849805|FG003|Post Study Follow-up|Lost to Follow-up|0|||
125608581|NCT01327651|451849806|FG004|Post Study Follow-up|Lost to Follow-up|0|||
125608582|NCT01327651|451849807|FG005|Post Study Follow-up|Lost to Follow-up|0|||
125608583|NCT01327651|451849808|FG006|Post Study Follow-up|Lost to Follow-up|4|||
125608584|NCT01327651|451849809|FG007|Post Study Follow-up|Lost to Follow-up|1|||
125608585|NCT01327651|451849810|FG008|Post Study Follow-up|Lost to Follow-up|2|||
125608586|NCT03249792|451849815|FG000|Arms 1, 2, and 4|Death|1|||
125608587|NCT03249792|451849816|FG001|Arms 1, 2, and 4|Death|1|||
125608588|NCT03249792|451849817|FG002|Arms 1, 2, and 4|Death|0|||
125608589|NCT03249792|451849818|FG003|Arms 1, 2, and 4|Death|2|||
125608590|NCT03249792|451849819|FG004|Arms 1, 2, and 4|Death|3|||
125608591|NCT03249792|451849820|FG005|Arms 1, 2, and 4|Death|2|||
125608592|NCT03249792|451849821|FG006|Arms 1, 2, and 4|Death|2|||
125608593|NCT03249792|451849822|FG007|Arms 1, 2, and 4|Death|4|||
125608594|NCT03249792|451849823|FG008|Arms 1, 2, and 4|Death|2|||
125608595|NCT03249792|451849824|FG009|Arms 1, 2, and 4|Death|1|||
125608596|NCT03249792|451849825|FG010|Arms 1, 2, and 4|Death|7|||
125608597|NCT03249792|451849826|FG011|Arms 1, 2, and 4|Death|7|||
125608598|NCT03249792|451849827|FG012|Arms 1, 2, and 4|Death|12|||
125608599|NCT03249792|451849828|FG013|Arms 1, 2, and 4|Death|7|||
125608600|NCT03249792|451849829|FG014|Arms 1, 2, and 4|Death|0|||
125608601|NCT03249792|451849830|FG015|Arms 1, 2, and 4|Death|4|||
125608602|NCT03249792|451849831|FG016|Arms 1, 2, and 4|Death|4|||
125608603|NCT03249792|451849832|FG017|Arms 1, 2, and 4|Death|12|||
125608604|NCT03249792|451849833|FG018|Arms 1, 2, and 4|Death|6|||
125608605|NCT03249792|451849834|FG019|Arms 1, 2, and 4|Death|4|||
125608606|NCT03249792|451849835|FG020|Arms 1, 2, and 4|Death|2|||
125608607|NCT03249792|451849836|FG021|Arms 1, 2, and 4|Death|3|||
125608608|NCT03249792|451849837|FG022|Arms 1, 2, and 4|Death|1|||
125608609|NCT03249792|451849838|FG023|Arms 1, 2, and 4|Death|1|||
125608610|NCT03249792|451849839|FG024|Arms 1, 2, and 4|Death|4|||
125608611|NCT03249792|451849840|FG025|Arms 1, 2, and 4|Death|0|||
125608612|NCT03249792|451849841|FG026|Arms 1, 2, and 4|Death|0|||
125608613|NCT03249792|451849842|FG027|Arms 1, 2, and 4|Death|0|||
125608614|NCT03249792|451849843|FG028|Arms 1, 2, and 4|Death|0|||
125608615|NCT03249792|451849844|FG029|Arms 1, 2, and 4|Death|0|||
125608616|NCT03249792|451849845|FG030|Arms 1, 2, and 4|Death|0|||
125608617|NCT03249792|451849846|FG031|Arms 1, 2, and 4|Death|0|||
125608618|NCT03249792|451849847|FG032|Arms 1, 2, and 4|Death|0|||
125608619|NCT03249792|451849815|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608620|NCT03249792|451849816|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608621|NCT03249792|451849817|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
125608622|NCT03249792|451849818|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608623|NCT03249792|451849819|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608624|NCT03249792|451849820|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
125608625|NCT03249792|451849821|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
125608626|NCT03249792|451849822|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608627|NCT03249792|451849823|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
125608628|NCT03249792|451849824|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
125608629|NCT03249792|451849825|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
125608630|NCT03249792|451849826|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
125608631|NCT03249792|451849827|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
125608632|NCT03249792|451849828|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
125608633|NCT03249792|451849829|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608634|NCT03249792|451849830|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608635|NCT03249792|451849831|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
125608636|NCT03249792|451849832|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608637|NCT03249792|451849833|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
125608638|NCT03249792|451849834|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608639|NCT03249792|451849835|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608640|NCT03249792|451849836|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608641|NCT03249792|451849837|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
125608642|NCT03249792|451849838|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
125608643|NCT03249792|451849839|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608644|NCT03249792|451849840|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608645|NCT03249792|451849841|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608646|NCT03249792|451849842|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608647|NCT03249792|451849843|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608648|NCT03249792|451849844|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608649|NCT03249792|451849845|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608650|NCT03249792|451849846|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608651|NCT03249792|451849847|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
125608652|NCT03249792|451849815|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
125608653|NCT03249792|451849816|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
125608654|NCT03249792|451849817|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
125608655|NCT03249792|451849818|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
125608656|NCT03249792|451849819|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
125608657|NCT03249792|451849820|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
125608658|NCT03249792|451849821|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
125608659|NCT03249792|451849822|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
125608660|NCT03249792|451849823|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
125608661|NCT03249792|451849824|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
125608662|NCT03249792|451849825|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
125608663|NCT03249792|451849826|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
125608664|NCT03249792|451849827|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
125608665|NCT03249792|451849828|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
125608666|NCT03249792|451849829|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
125608667|NCT03249792|451849830|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
125608668|NCT03249792|451849831|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
125608669|NCT03249792|451849832|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
125608670|NCT03249792|451849833|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
125608671|NCT03249792|451849834|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
125608672|NCT03249792|451849835|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
125370522|NCT01133522|450989345|FG008|Overall Study|Withdrawal by Subject|0|||
125370523|NCT01133522|450989346|FG009|Overall Study|Withdrawal by Subject|0|||
125370524|NCT01133522|450989337|FG000|Overall Study|Physician Decision|0|||
125608673|NCT03249792|451849836|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
125608674|NCT03249792|451849837|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
125608675|NCT03249792|451849838|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
125608676|NCT03249792|451849839|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
125608677|NCT03249792|451849840|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
125608678|NCT03249792|451849841|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
125608679|NCT03249792|451849842|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
125608680|NCT03249792|451849843|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
125608681|NCT03249792|451849844|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
125608682|NCT03249792|451849845|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
125608683|NCT03249792|451849846|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
125608684|NCT03249792|451849847|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
125608685|NCT03249792|451849815|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608686|NCT03249792|451849816|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608687|NCT03249792|451849817|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608688|NCT03249792|451849818|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608689|NCT03249792|451849819|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608690|NCT03249792|451849820|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608691|NCT03249792|451849821|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608692|NCT03249792|451849822|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608693|NCT03249792|451849823|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
125608694|NCT03249792|451849824|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608695|NCT03249792|451849825|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608696|NCT03249792|451849826|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608697|NCT03249792|451849827|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608698|NCT03249792|451849828|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608699|NCT03249792|451849829|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608700|NCT03249792|451849830|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608701|NCT03249792|451849831|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
125608702|NCT03249792|451849832|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
125608703|NCT03249792|451849833|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608704|NCT03249792|451849834|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
125608705|NCT03249792|451849835|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608706|NCT03249792|451849836|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608707|NCT03249792|451849837|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
125370525|NCT01133522|450989338|FG001|Overall Study|Physician Decision|0|||
125370526|NCT01133522|450989339|FG002|Overall Study|Physician Decision|0|||
125370527|NCT01133522|450989340|FG003|Overall Study|Physician Decision|0|||
125608708|NCT03249792|451849838|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608709|NCT03249792|451849839|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608710|NCT03249792|451849840|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608711|NCT03249792|451849841|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608712|NCT03249792|451849842|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608713|NCT03249792|451849843|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
125370528|NCT01133522|450989341|FG004|Overall Study|Physician Decision|1|||
125370529|NCT01133522|450989342|FG005|Overall Study|Physician Decision|0|||
125370530|NCT01133522|450989343|FG006|Overall Study|Physician Decision|0|||
125608714|NCT03249792|451849844|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608715|NCT03249792|451849845|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608716|NCT03249792|451849846|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608717|NCT03249792|451849847|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
125608718|NCT03249792|451849815|FG000|Switch Over Period|Withdrawal by Subject|0|||
125608719|NCT03249792|451849816|FG001|Switch Over Period|Withdrawal by Subject|0|||
125608720|NCT03249792|451849817|FG002|Switch Over Period|Withdrawal by Subject|0|||
125608721|NCT03249792|451849818|FG003|Switch Over Period|Withdrawal by Subject|0|||
125608722|NCT03249792|451849819|FG004|Switch Over Period|Withdrawal by Subject|0|||
125608723|NCT03249792|451849820|FG005|Switch Over Period|Withdrawal by Subject|0|||
125608724|NCT03249792|451849821|FG006|Switch Over Period|Withdrawal by Subject|0|||
125608725|NCT03249792|451849822|FG007|Switch Over Period|Withdrawal by Subject|0|||
125608726|NCT03249792|451849823|FG008|Switch Over Period|Withdrawal by Subject|0|||
125608727|NCT03249792|451849824|FG009|Switch Over Period|Withdrawal by Subject|0|||
125608728|NCT03249792|451849825|FG010|Switch Over Period|Withdrawal by Subject|0|||
125608729|NCT03249792|451849826|FG011|Switch Over Period|Withdrawal by Subject|0|||
125608730|NCT03249792|451849827|FG012|Switch Over Period|Withdrawal by Subject|0|||
125608731|NCT03249792|451849828|FG013|Switch Over Period|Withdrawal by Subject|0|||
125608732|NCT03249792|451849829|FG014|Switch Over Period|Withdrawal by Subject|0|||
125608733|NCT03249792|451849830|FG015|Switch Over Period|Withdrawal by Subject|0|||
125608734|NCT03249792|451849831|FG016|Switch Over Period|Withdrawal by Subject|0|||
125608735|NCT03249792|451849832|FG017|Switch Over Period|Withdrawal by Subject|0|||
125608736|NCT03249792|451849833|FG018|Switch Over Period|Withdrawal by Subject|0|||
125608737|NCT03249792|451849834|FG019|Switch Over Period|Withdrawal by Subject|0|||
125608738|NCT03249792|451849835|FG020|Switch Over Period|Withdrawal by Subject|0|||
125608739|NCT03249792|451849836|FG021|Switch Over Period|Withdrawal by Subject|0|||
125608740|NCT03249792|451849837|FG022|Switch Over Period|Withdrawal by Subject|0|||
125608741|NCT03249792|451849838|FG023|Switch Over Period|Withdrawal by Subject|0|||
125608742|NCT03249792|451849839|FG024|Switch Over Period|Withdrawal by Subject|0|||
125608743|NCT03249792|451849840|FG025|Switch Over Period|Withdrawal by Subject|0|||
125608744|NCT03249792|451849841|FG026|Switch Over Period|Withdrawal by Subject|0|||
125608745|NCT03249792|451849842|FG027|Switch Over Period|Withdrawal by Subject|0|||
125608746|NCT03249792|451849843|FG028|Switch Over Period|Withdrawal by Subject|0|||
125608747|NCT03249792|451849844|FG029|Switch Over Period|Withdrawal by Subject|0|||
125608748|NCT03249792|451849845|FG030|Switch Over Period|Withdrawal by Subject|0|||
125608749|NCT03249792|451849846|FG031|Switch Over Period|Withdrawal by Subject|1|||
125608750|NCT03249792|451849847|FG032|Switch Over Period|Withdrawal by Subject|0|||
125608751|NCT03249792|451849815|FG000|Switch Over Period|Progressive Disease|0|||
125608752|NCT03249792|451849816|FG001|Switch Over Period|Progressive Disease|0|||
125608753|NCT03249792|451849817|FG002|Switch Over Period|Progressive Disease|0|||
125608754|NCT03249792|451849818|FG003|Switch Over Period|Progressive Disease|0|||
125608755|NCT03249792|451849819|FG004|Switch Over Period|Progressive Disease|0|||
125608756|NCT03249792|451849820|FG005|Switch Over Period|Progressive Disease|0|||
125608757|NCT03249792|451849821|FG006|Switch Over Period|Progressive Disease|0|||
125608758|NCT03249792|451849822|FG007|Switch Over Period|Progressive Disease|0|||
125608759|NCT03249792|451849823|FG008|Switch Over Period|Progressive Disease|0|||
125608760|NCT03249792|451849824|FG009|Switch Over Period|Progressive Disease|0|||
125608761|NCT03249792|451849825|FG010|Switch Over Period|Progressive Disease|0|||
125608762|NCT03249792|451849826|FG011|Switch Over Period|Progressive Disease|0|||
125608763|NCT03249792|451849827|FG012|Switch Over Period|Progressive Disease|0|||
125608764|NCT03249792|451849828|FG013|Switch Over Period|Progressive Disease|0|||
125608765|NCT03249792|451849829|FG014|Switch Over Period|Progressive Disease|0|||
125608766|NCT03249792|451849830|FG015|Switch Over Period|Progressive Disease|0|||
125608767|NCT03249792|451849831|FG016|Switch Over Period|Progressive Disease|0|||
125608768|NCT03249792|451849832|FG017|Switch Over Period|Progressive Disease|0|||
125608769|NCT03249792|451849833|FG018|Switch Over Period|Progressive Disease|0|||
125608770|NCT03249792|451849834|FG019|Switch Over Period|Progressive Disease|0|||
125608771|NCT03249792|451849835|FG020|Switch Over Period|Progressive Disease|0|||
125608772|NCT03249792|451849836|FG021|Switch Over Period|Progressive Disease|0|||
125608773|NCT03249792|451849837|FG022|Switch Over Period|Progressive Disease|0|||
125608774|NCT03249792|451849838|FG023|Switch Over Period|Progressive Disease|0|||
125608775|NCT03249792|451849839|FG024|Switch Over Period|Progressive Disease|0|||
125608776|NCT03249792|451849840|FG025|Switch Over Period|Progressive Disease|0|||
125608777|NCT03249792|451849841|FG026|Switch Over Period|Progressive Disease|1|||
125608778|NCT03249792|451849842|FG027|Switch Over Period|Progressive Disease|0|||
125608779|NCT03249792|451849843|FG028|Switch Over Period|Progressive Disease|1|||
125608780|NCT03249792|451849844|FG029|Switch Over Period|Progressive Disease|2|||
125608781|NCT03249792|451849845|FG030|Switch Over Period|Progressive Disease|1|||
125608782|NCT03249792|451849846|FG031|Switch Over Period|Progressive Disease|0|||
125608783|NCT03249792|451849847|FG032|Switch Over Period|Progressive Disease|1|||
125608784|NCT03249792|451849815|FG000|Switch Over Period|Adverse Event|0|||
125608785|NCT03249792|451849816|FG001|Switch Over Period|Adverse Event|0|||
125608786|NCT03249792|451849817|FG002|Switch Over Period|Adverse Event|0|||
125608787|NCT03249792|451849818|FG003|Switch Over Period|Adverse Event|0|||
125608788|NCT03249792|451849819|FG004|Switch Over Period|Adverse Event|0|||
125608789|NCT03249792|451849820|FG005|Switch Over Period|Adverse Event|0|||
125608790|NCT03249792|451849821|FG006|Switch Over Period|Adverse Event|0|||
125608791|NCT03249792|451849822|FG007|Switch Over Period|Adverse Event|0|||
125608792|NCT03249792|451849823|FG008|Switch Over Period|Adverse Event|0|||
125608793|NCT03249792|451849824|FG009|Switch Over Period|Adverse Event|0|||
125608794|NCT03249792|451849825|FG010|Switch Over Period|Adverse Event|0|||
125608795|NCT03249792|451849826|FG011|Switch Over Period|Adverse Event|0|||
125608796|NCT03249792|451849827|FG012|Switch Over Period|Adverse Event|0|||
125608797|NCT03249792|451849828|FG013|Switch Over Period|Adverse Event|0|||
125608798|NCT03249792|451849829|FG014|Switch Over Period|Adverse Event|0|||
125608799|NCT03249792|451849830|FG015|Switch Over Period|Adverse Event|0|||
125608800|NCT03249792|451849831|FG016|Switch Over Period|Adverse Event|0|||
125608801|NCT03249792|451849832|FG017|Switch Over Period|Adverse Event|0|||
125608802|NCT03249792|451849833|FG018|Switch Over Period|Adverse Event|0|||
125608803|NCT03249792|451849834|FG019|Switch Over Period|Adverse Event|0|||
125608804|NCT03249792|451849835|FG020|Switch Over Period|Adverse Event|0|||
125608805|NCT03249792|451849836|FG021|Switch Over Period|Adverse Event|0|||
125608806|NCT03249792|451849837|FG022|Switch Over Period|Adverse Event|0|||
125608807|NCT03249792|451849838|FG023|Switch Over Period|Adverse Event|0|||
125608808|NCT03249792|451849839|FG024|Switch Over Period|Adverse Event|0|||
125608809|NCT03249792|451849840|FG025|Switch Over Period|Adverse Event|1|||
125608810|NCT03249792|451849841|FG026|Switch Over Period|Adverse Event|0|||
125608811|NCT03249792|451849842|FG027|Switch Over Period|Adverse Event|1|||
125608812|NCT03249792|451849843|FG028|Switch Over Period|Adverse Event|0|||
125608813|NCT03249792|451849844|FG029|Switch Over Period|Adverse Event|0|||
125608814|NCT03249792|451849845|FG030|Switch Over Period|Adverse Event|0|||
125608815|NCT03249792|451849846|FG031|Switch Over Period|Adverse Event|0|||
125608816|NCT03249792|451849847|FG032|Switch Over Period|Adverse Event|0|||
125608817|NCT02284906|451849850|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125608818|NCT02284906|451849851|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
125608819|NCT02284906|451849852|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
125608820|NCT02284906|451849850|FG000|Overall Study|Major Protocol Deviation|0|||
125608821|NCT02284906|451849851|FG001|Overall Study|Major Protocol Deviation|1|||
125608822|NCT02284906|451849852|FG002|Overall Study|Major Protocol Deviation|0|||
125608823|NCT02284906|451849850|FG000|Overall Study|Voluntary Withdrawal|2|||
125608824|NCT02284906|451849851|FG001|Overall Study|Voluntary Withdrawal|4|||
125608825|NCT02284906|451849852|FG002|Overall Study|Voluntary Withdrawal|5|||
125608826|NCT02284906|451849850|FG000|Overall Study|Study Termination|0|||
125608827|NCT02284906|451849851|FG001|Overall Study|Study Termination|11|||
125608828|NCT02284906|451849852|FG002|Overall Study|Study Termination|14|||
125608829|NCT02284906|451849850|FG000|Overall Study|Reason not Specified|1|||
125608830|NCT02284906|451849851|FG001|Overall Study|Reason not Specified|1|||
125608831|NCT02284906|451849852|FG002|Overall Study|Reason not Specified|0|||
125608832|NCT00069576|451849854|FG000|Original Trial|Lost to Follow-up|25|||
125608833|NCT00069576|451849855|FG001|Original Trial|Lost to Follow-up|33|||
125608834|NCT00069576|451849854|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
125608835|NCT00069576|451849855|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
125608836|NCT04060667|451849856|FG000|Overall Study|Lost to Follow-up|75|||
125608837|NCT04060667|451849857|FG001|Overall Study|Lost to Follow-up|10|||
125608838|NCT00525148|451849858|FG000|Overall Study|Other Adverse Event|3|||
125608839|NCT00525148|451849859|FG001|Overall Study|Other Adverse Event|5|||
125608840|NCT00525148|451849860|FG002|Overall Study|Other Adverse Event|1|||
125608841|NCT00525148|451849861|FG003|Overall Study|Other Adverse Event|8|||
125608842|NCT00525148|451849858|FG000|Overall Study|Progressive disease|18|||
125608843|NCT00525148|451849859|FG001|Overall Study|Progressive disease|30|||
125608844|NCT00525148|451849860|FG002|Overall Study|Progressive disease|6|||
125608845|NCT00525148|451849861|FG003|Overall Study|Progressive disease|49|||
125608846|NCT00525148|451849858|FG000|Overall Study|Refused continuation of study medication|0|||
125608847|NCT00525148|451849859|FG001|Overall Study|Refused continuation of study medication|2|||
125608848|NCT00525148|451849860|FG002|Overall Study|Refused continuation of study medication|0|||
125213262|NCT06010732|450407293|FG002|Crossover Period 2|Adverse Event|0|||
125213263|NCT06010732|450407294|FG003|Crossover Period 2|Adverse Event|0|||
125213264|NCT06010732|450407295|FG004|Crossover Period 2|Adverse Event|0|||
125213265|NCT06010732|450407296|FG005|Crossover Period 2|Adverse Event|0|||
125213266|NCT06010732|450407291|FG000|Crossover Period 2|broken denture|0|||
125213267|NCT06010732|450407292|FG001|Crossover Period 2|broken denture|0|||
125213268|NCT06010732|450407293|FG002|Crossover Period 2|broken denture|1|||
125213269|NCT06010732|450407294|FG003|Crossover Period 2|broken denture|0|||
125213270|NCT06010732|450407295|FG004|Crossover Period 2|broken denture|0|||
125213271|NCT06010732|450407296|FG005|Crossover Period 2|broken denture|0|||
125213272|NCT04401202|450407297|FG000|Overall Study|Lost to Follow-up|2|||
125213273|NCT04401202|450407298|FG001|Overall Study|Lost to Follow-up|2|||
125431790|NCT02055157|451207758|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
125608849|NCT00525148|451849861|FG003|Overall Study|Refused continuation of study medication|1|||
125608850|NCT00525148|451849858|FG000|Overall Study|Other than stated|2|||
125608851|NCT00525148|451849859|FG001|Overall Study|Other than stated|1|||
125608852|NCT00525148|451849860|FG002|Overall Study|Other than stated|0|||
125608853|NCT00525148|451849861|FG003|Overall Study|Other than stated|3|||
125608854|NCT05100199|451849863|FG000|Overall Study|Lost to Follow-up|5|||
125608855|NCT05100199|451849864|FG001|Overall Study|Lost to Follow-up|8|||
125608856|NCT05100199|451849865|FG002|Overall Study|Lost to Follow-up|3|||
125608857|NCT05100199|451849866|FG003|Overall Study|Lost to Follow-up|6|||
125608858|NCT05100199|451849863|FG000|Overall Study|Withdrawal by Subject|3|||
125608859|NCT05100199|451849864|FG001|Overall Study|Withdrawal by Subject|3|||
125608860|NCT05100199|451849865|FG002|Overall Study|Withdrawal by Subject|9|||
125608861|NCT05100199|451849866|FG003|Overall Study|Withdrawal by Subject|7|||
125608862|NCT05100199|451849863|FG000|Overall Study|Other|0|||
125608863|NCT05100199|451849864|FG001|Overall Study|Other|0|||
125608864|NCT05100199|451849865|FG002|Overall Study|Other|1|||
125608865|NCT05100199|451849866|FG003|Overall Study|Other|1|||
125608866|NCT00830037|451849867|FG000|Overall Study|Withdrawal by Subject|2|||
125608867|NCT00830037|451849868|FG001|Overall Study|Withdrawal by Subject|3|||
125608868|NCT00830037|451849867|FG000|Overall Study|Lost to Follow-up|1|||
125608869|NCT00830037|451849868|FG001|Overall Study|Lost to Follow-up|2|||
125608870|NCT00830037|451849867|FG000|Overall Study|Active when terminated by DSMB|15|||
125608871|NCT00830037|451849868|FG001|Overall Study|Active when terminated by DSMB|14|||
125608872|NCT00752609|451849869|FG000|Overall Study|Adverse Event|2|||
125608873|NCT00752609|451849870|FG001|Overall Study|Adverse Event|2|||
125608874|NCT00752609|451849869|FG000|Overall Study|Withdrawal by Subject|3|||
125608875|NCT00752609|451849870|FG001|Overall Study|Withdrawal by Subject|0|||
125608876|NCT00752609|451849869|FG000|Overall Study|Physician Decision|1|||
125608877|NCT00752609|451849870|FG001|Overall Study|Physician Decision|0|||
125608878|NCT00752609|451849869|FG000|Overall Study|Death|1|||
125608879|NCT00752609|451849870|FG001|Overall Study|Death|0|||
125608880|NCT00752609|451849869|FG000|Overall Study|Met exclusion criteria|1|||
125608881|NCT00752609|451849870|FG001|Overall Study|Met exclusion criteria|0|||
125608882|NCT00752609|451849869|FG000|Overall Study|Received Aranesp in error|1|||
125608883|NCT00752609|451849870|FG001|Overall Study|Received Aranesp in error|0|||
125608884|NCT01096550|451849879|FG000|Overall Study|discontinued site|10|||
125608885|NCT01096550|451849880|FG001|Overall Study|discontinued site|11|||
125608886|NCT01096550|451849879|FG000|Overall Study|non-regular treatment track at clinic|1|||
125608887|NCT01096550|451849880|FG001|Overall Study|non-regular treatment track at clinic|1|||
125213274|NCT04401202|450407297|FG000|Overall Study|Adverse Event|0|||
125213275|NCT04401202|450407298|FG001|Overall Study|Adverse Event|1|||
125213276|NCT04401202|450407297|FG000|Overall Study|Hospitalized|4|||
125213277|NCT04401202|450407298|FG001|Overall Study|Hospitalized|1|||
125213278|NCT03004924|450407302|FG000|Overall Study|Adverse Event|6|||
125608888|NCT01096550|451849879|FG000|Overall Study|clinic readmission|1|||
125608889|NCT01096550|451849880|FG001|Overall Study|clinic readmission|1|||
125608890|NCT01096550|451849879|FG000|Overall Study|Withdrawal by Subject|0|||
125608891|NCT01096550|451849880|FG001|Overall Study|Withdrawal by Subject|1|||
125608892|NCT01096550|451849879|FG000|Overall Study|non-African American participant|13|||
125608893|NCT01096550|451849880|FG001|Overall Study|non-African American participant|6|||
125608894|NCT01096550|451849879|FG000|Overall Study|Lost to Follow-up|12|||
125608895|NCT01096550|451849880|FG001|Overall Study|Lost to Follow-up|9|||
125608896|NCT03288779|451849889|FG000|Overall Study|Withdrawal by Subject|3|||
125608897|NCT02928406|451849894|FG000|Overall Study|Death|780|||
125608898|NCT02928406|451849894|FG000|Overall Study|Progressive disease|3|||
125608899|NCT02928406|451849894|FG000|Overall Study|Lost to Follow-up|49|||
125608900|NCT02928406|451849894|FG000|Overall Study|Non-compliance|2|||
125608901|NCT02928406|451849894|FG000|Overall Study|Withdrawal by Subject|40|||
125608902|NCT02928406|451849894|FG000|Overall Study|Study terminated by sponsor|57|||
125608903|NCT02928406|451849894|FG000|Overall Study|Physician Decision|1|||
125608904|NCT02928406|451849894|FG000|Overall Study|Various reasons|72|||
125608905|NCT02149836|451849895|FG000|Overall Study|Withdrawal by Subject|1|||
125608906|NCT05281523|451849900|FG000|Overall Study|Adverse Event|1|||
125608907|NCT05281523|451849901|FG001|Overall Study|Adverse Event|1|||
125608908|NCT05281523|451849900|FG000|Overall Study|Physician Decision|1|||
125608909|NCT05281523|451849901|FG001|Overall Study|Physician Decision|1|||
125608910|NCT05281523|451849900|FG000|Overall Study|Withdrawal by Subject|5|||
125608911|NCT05281523|451849901|FG001|Overall Study|Withdrawal by Subject|15|||
125608912|NCT05281523|451849900|FG000|Overall Study|GCP violations|3|||
125608913|NCT05281523|451849901|FG001|Overall Study|GCP violations|4|||
125608914|NCT05513391|451849902|FG000|Overall Study|Adverse Event|1|||
125608915|NCT05513391|451849903|FG001|Overall Study|Adverse Event|0|||
125608916|NCT05513391|451849902|FG000|Overall Study|Protocol Deviation|0|||
125608917|NCT05513391|451849903|FG001|Overall Study|Protocol Deviation|1|||
125608918|NCT05513391|451849902|FG000|Overall Study|Withdrawal by Subject|3|||
125608919|NCT05513391|451849903|FG001|Overall Study|Withdrawal by Subject|1|||
125608920|NCT05513391|451849902|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
125608921|NCT05513391|451849903|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
125213279|NCT03004924|450407303|FG001|Overall Study|Adverse Event|5|||
125608922|NCT05513391|451849902|FG000|Overall Study|Lost to Follow-up|0|||
125608923|NCT05513391|451849903|FG001|Overall Study|Lost to Follow-up|2|||
125608924|NCT05128162|451849904|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
125608925|NCT05128162|451849904|FG000|Overall Study|Physician Decision|1|||
125608926|NCT05513053|451849905|FG000|Overall Study|Lost to Follow-up|9|||
125608927|NCT05513053|451849906|FG001|Overall Study|Lost to Follow-up|11|||
125608928|NCT05513053|451849905|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125608929|NCT05513053|451849906|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125608930|NCT05513053|451849905|FG000|Overall Study|Withdrawal by Subject|2|||
125608931|NCT05513053|451849906|FG001|Overall Study|Withdrawal by Subject|9|||
125608932|NCT05513053|451849905|FG000|Overall Study|Protocol Violation|6|||
125608933|NCT05513053|451849906|FG001|Overall Study|Protocol Violation|3|||
125608934|NCT05513053|451849905|FG000|Overall Study|Adverse Event|0|||
125608935|NCT05513053|451849906|FG001|Overall Study|Adverse Event|2|||
125608936|NCT04038255|451852209|FG000|Overall Study|Lost to Follow-up|0|||
125608937|NCT04038255|451852210|FG001|Overall Study|Lost to Follow-up|9|||
125608938|NCT04038255|451852211|FG002|Overall Study|Lost to Follow-up|5|||
125608939|NCT04038255|451852209|FG000|Overall Study|Withdrawal by Subject|0|||
125608940|NCT04038255|451852210|FG001|Overall Study|Withdrawal by Subject|0|||
125608941|NCT04038255|451852211|FG002|Overall Study|Withdrawal by Subject|1|||
125608942|NCT05183867|451852214|FG000|Overall Study|Withdrawal by Subject|3|||
125608943|NCT05183867|451852215|FG001|Overall Study|Withdrawal by Subject|2|||
125608944|NCT05183867|451852216|FG002|Overall Study|Withdrawal by Subject|0|||
125213280|NCT03004924|450407304|FG002|Overall Study|Adverse Event|10|||
125213281|NCT03004924|450407302|FG000|Overall Study|Protocol Violation|4|||
125213282|NCT03004924|450407303|FG001|Overall Study|Protocol Violation|0|||
125213283|NCT03004924|450407304|FG002|Overall Study|Protocol Violation|1|||
125213284|NCT03004924|450407302|FG000|Overall Study|Withdrawal by Subject|5|||
125370531|NCT01133522|450989344|FG007|Overall Study|Physician Decision|0|||
125370532|NCT01133522|450989345|FG008|Overall Study|Physician Decision|0|||
125608945|NCT00074412|451852217|FG000|Overall Study|Death|30|||
125608946|NCT00074412|451852218|FG001|Overall Study|Death|26|||
125608947|NCT00074412|451852217|FG000|Overall Study|Lost to Follow-up|52|||
125608948|NCT00074412|451852218|FG001|Overall Study|Lost to Follow-up|58|||
125608949|NCT01520324|451852222|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
125213285|NCT03004924|450407303|FG001|Overall Study|Withdrawal by Subject|3|||
125213286|NCT03004924|450407304|FG002|Overall Study|Withdrawal by Subject|5|||
125608950|NCT00423085|451852224|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
125608951|NCT00423085|451852225|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
125608952|NCT00423085|451852226|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
125213287|NCT03004924|450407302|FG000|Overall Study|Lost to Follow-up|6|||
125370533|NCT01133522|450989346|FG009|Overall Study|Physician Decision|0|||
125370534|NCT00381485|450991157|FG000|Open-Label Run-In Period|Adverse Event|9|||
125608953|NCT00423085|451852227|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
125608954|NCT00423085|451852224|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
125608955|NCT00423085|451852225|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
125608956|NCT00423085|451852226|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
125608957|NCT00423085|451852227|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
125608958|NCT00423085|451852224|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
125608959|NCT00423085|451852225|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
125608960|NCT00423085|451852226|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
125608961|NCT00423085|451852227|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
125608962|NCT00423085|451852224|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
125608963|NCT00423085|451852225|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
125608964|NCT00423085|451852226|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
125608965|NCT00423085|451852227|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
125608966|NCT00423085|451852224|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
125608967|NCT00423085|451852225|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
125608968|NCT00423085|451852226|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
125608969|NCT00423085|451852227|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
125608970|NCT00423085|451852224|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
125608971|NCT00423085|451852225|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
125608972|NCT00423085|451852226|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
125608973|NCT00423085|451852227|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
125608974|NCT00423085|451852224|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
125608975|NCT00423085|451852225|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
125608976|NCT00423085|451852226|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
125608977|NCT00423085|451852227|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
125608978|NCT00423085|451852224|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
125608979|NCT00423085|451852225|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
125608980|NCT00423085|451852226|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
125608981|NCT00423085|451852227|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
125608982|NCT00423085|451852224|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
125608983|NCT00423085|451852225|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
125608984|NCT00423085|451852226|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
125608985|NCT00423085|451852227|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
125608986|NCT00423085|451852224|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
125608987|NCT00423085|451852225|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
125608988|NCT00423085|451852226|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
125608989|NCT00423085|451852227|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
125608990|NCT00423085|451852224|FG000|52-Week Open-Label Extension Phase|Death|0|||
125608991|NCT00423085|451852225|FG001|52-Week Open-Label Extension Phase|Death|0|||
125608992|NCT00423085|451852226|FG002|52-Week Open-Label Extension Phase|Death|0|||
125608993|NCT00423085|451852227|FG003|52-Week Open-Label Extension Phase|Death|2|||
125608994|NCT02163993|451852228|FG000|Treatment Period|Adverse Event|0|||
125608995|NCT02163993|451852229|FG001|Treatment Period|Adverse Event|1|||
125608996|NCT02163993|451852230|FG002|Treatment Period|Adverse Event|0|||
125608997|NCT02163993|451852231|FG003|Treatment Period|Adverse Event|0|||
125213288|NCT03004924|450407303|FG001|Overall Study|Lost to Follow-up|1|||
125213289|NCT03004924|450407304|FG002|Overall Study|Lost to Follow-up|4|||
125370535|NCT00381485|450991158|FG001|Open-Label Run-In Period|Adverse Event|0|||
125370536|NCT00381485|450991159|FG002|Open-Label Run-In Period|Adverse Event|0|||
125608998|NCT02163993|451852232|FG004|Treatment Period|Adverse Event|1|||
125608999|NCT02163993|451852228|FG000|Treatment Period|Lost to Follow-up|2|||
125609000|NCT02163993|451852229|FG001|Treatment Period|Lost to Follow-up|3|||
125609001|NCT02163993|451852230|FG002|Treatment Period|Lost to Follow-up|1|||
125609002|NCT02163993|451852231|FG003|Treatment Period|Lost to Follow-up|3|||
125609003|NCT02163993|451852232|FG004|Treatment Period|Lost to Follow-up|1|||
125609004|NCT02163993|451852228|FG000|Treatment Period|Physician Decision|1|||
125609005|NCT02163993|451852229|FG001|Treatment Period|Physician Decision|0|||
125609006|NCT02163993|451852230|FG002|Treatment Period|Physician Decision|0|||
125609007|NCT02163993|451852231|FG003|Treatment Period|Physician Decision|0|||
125609008|NCT02163993|451852232|FG004|Treatment Period|Physician Decision|0|||
125609009|NCT02163993|451852228|FG000|Treatment Period|Protocol Violation|2|||
125609010|NCT02163993|451852229|FG001|Treatment Period|Protocol Violation|1|||
125609011|NCT02163993|451852230|FG002|Treatment Period|Protocol Violation|0|||
125609012|NCT02163993|451852231|FG003|Treatment Period|Protocol Violation|1|||
125609013|NCT02163993|451852232|FG004|Treatment Period|Protocol Violation|2|||
125609014|NCT02163993|451852228|FG000|Treatment Period|Withdrawal by Subject|6|||
125609015|NCT02163993|451852229|FG001|Treatment Period|Withdrawal by Subject|4|||
125609016|NCT02163993|451852230|FG002|Treatment Period|Withdrawal by Subject|1|||
125609017|NCT02163993|451852231|FG003|Treatment Period|Withdrawal by Subject|4|||
125609018|NCT02163993|451852232|FG004|Treatment Period|Withdrawal by Subject|1|||
125609019|NCT02163993|451852228|FG000|Treatment Period|Not treated|1|||
125609020|NCT02163993|451852229|FG001|Treatment Period|Not treated|0|||
125609021|NCT02163993|451852230|FG002|Treatment Period|Not treated|0|||
125609022|NCT02163993|451852231|FG003|Treatment Period|Not treated|1|||
125609023|NCT02163993|451852232|FG004|Treatment Period|Not treated|2|||
125609024|NCT02163993|451852228|FG000|Post-treatment Period|Adverse Event|0|||
125609025|NCT02163993|451852229|FG001|Post-treatment Period|Adverse Event|0|||
125609026|NCT02163993|451852230|FG002|Post-treatment Period|Adverse Event|1|||
125609027|NCT02163993|451852231|FG003|Post-treatment Period|Adverse Event|0|||
125609028|NCT02163993|451852232|FG004|Post-treatment Period|Adverse Event|0|||
125609029|NCT02163993|451852228|FG000|Post-treatment Period|Lost to Follow-up|2|||
125609030|NCT02163993|451852229|FG001|Post-treatment Period|Lost to Follow-up|2|||
125609031|NCT02163993|451852230|FG002|Post-treatment Period|Lost to Follow-up|3|||
125609032|NCT02163993|451852231|FG003|Post-treatment Period|Lost to Follow-up|1|||
125609033|NCT02163993|451852232|FG004|Post-treatment Period|Lost to Follow-up|0|||
125609034|NCT02163993|451852228|FG000|Post-treatment Period|Protocol Violation|0|||
125609035|NCT02163993|451852229|FG001|Post-treatment Period|Protocol Violation|0|||
125609036|NCT02163993|451852230|FG002|Post-treatment Period|Protocol Violation|0|||
125609037|NCT02163993|451852231|FG003|Post-treatment Period|Protocol Violation|0|||
125609038|NCT02163993|451852232|FG004|Post-treatment Period|Protocol Violation|1|||
125609039|NCT02163993|451852228|FG000|Post-treatment Period|Withdrawal by Subject|2|||
125609040|NCT02163993|451852229|FG001|Post-treatment Period|Withdrawal by Subject|4|||
125609041|NCT02163993|451852230|FG002|Post-treatment Period|Withdrawal by Subject|0|||
125609042|NCT02163993|451852231|FG003|Post-treatment Period|Withdrawal by Subject|1|||
125609043|NCT02163993|451852232|FG004|Post-treatment Period|Withdrawal by Subject|2|||
125609044|NCT00853489|451852233|FG000|Overall Study|Lost to Follow-up|5|||
125609045|NCT00853489|451852234|FG001|Overall Study|Lost to Follow-up|2|||
125609046|NCT00441441|451852239|FG000|Overall Study|Adverse Event|2|||
125609047|NCT00441441|451852240|FG001|Overall Study|Adverse Event|1|||
125609048|NCT00441441|451852239|FG000|Overall Study|Protocol Violation|4|||
125609049|NCT00441441|451852240|FG001|Overall Study|Protocol Violation|6|||
125609050|NCT00441441|451852239|FG000|Overall Study|Exacerbation of asthma|1|||
125609051|NCT00441441|451852240|FG001|Overall Study|Exacerbation of asthma|2|||
125609052|NCT00441441|451852239|FG000|Overall Study|Withdrawal by Subject|1|||
125609053|NCT00441441|451852240|FG001|Overall Study|Withdrawal by Subject|2|||
125609054|NCT00441441|451852239|FG000|Overall Study|Other|3|||
125609055|NCT00441441|451852240|FG001|Overall Study|Other|3|||
125609056|NCT00262080|451852241|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
125609057|NCT00262080|451852242|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
125609058|NCT00262080|451852243|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
125609059|NCT00262080|451852241|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
125609060|NCT00262080|451852242|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
125609061|NCT00262080|451852243|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
125609062|NCT00262080|451852241|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
125609063|NCT00262080|451852242|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
125609064|NCT00262080|451852243|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
125609065|NCT00262080|451852241|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
125609066|NCT00262080|451852242|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
125609067|NCT00262080|451852243|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
125609068|NCT00262080|451852241|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
125370537|NCT00381485|450991160|FG003|Open-Label Run-In Period|Adverse Event|0|||
125370538|NCT00381485|450991157|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
125370539|NCT00381485|450991158|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
125370540|NCT00381485|450991159|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
125370541|NCT00381485|450991160|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
125370542|NCT00381485|450991157|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
125370543|NCT00381485|450991158|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
125370544|NCT00381485|450991159|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
125370545|NCT00381485|450991160|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
125370546|NCT00381485|450991157|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
125370547|NCT00381485|450991158|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
125370548|NCT00381485|450991159|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
125370549|NCT00381485|450991160|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
125370550|NCT00381485|450991157|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
125370551|NCT00381485|450991158|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
125370552|NCT00381485|450991159|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
125370553|NCT00381485|450991160|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
125370554|NCT00381485|450991157|FG000|Open-Label Run-In Period|Treatment failure|1|||
125370555|NCT00381485|450991158|FG001|Open-Label Run-In Period|Treatment failure|0|||
125370556|NCT00381485|450991159|FG002|Open-Label Run-In Period|Treatment failure|0|||
125370557|NCT00381485|450991160|FG003|Open-Label Run-In Period|Treatment failure|0|||
125370558|NCT00381485|450991157|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125370559|NCT00381485|450991158|FG001|Double-Blind Treatment Period|Adverse Event|2|||
125370560|NCT00381485|450991159|FG002|Double-Blind Treatment Period|Adverse Event|2|||
125370561|NCT00381485|450991160|FG003|Double-Blind Treatment Period|Adverse Event|5|||
125370562|NCT00381485|450991157|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
125370563|NCT00381485|450991158|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
125370564|NCT00381485|450991159|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
125370565|NCT00381485|450991160|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
125370566|NCT00381485|450991157|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125609069|NCT00262080|451852242|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
125609070|NCT00262080|451852243|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
125609071|NCT00262080|451852241|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
125609072|NCT00262080|451852242|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
125609073|NCT00262080|451852243|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
125609074|NCT02273752|451852244|FG000|Overall Study|Trial was terminated early|2|||
125609075|NCT02808312|451852245|FG000|Overall Study|Enrolled but Never Treated|0|||
125609076|NCT02808312|451852246|FG001|Overall Study|Enrolled but Never Treated|0|||
125609077|NCT02808312|451852247|FG002|Overall Study|Enrolled but Never Treated|1|||
125609078|NCT02808312|451852248|FG003|Overall Study|Enrolled but Never Treated|0|||
125609079|NCT02808312|451852249|FG004|Overall Study|Enrolled but Never Treated|0|||
125609080|NCT03100942|451852253|FG000|Randomized Treatment Period|Withdrew Consent|4|||
125609081|NCT03100942|451852254|FG001|Randomized Treatment Period|Withdrew Consent|5|||
125609082|NCT03100942|451852255|FG002|Randomized Treatment Period|Withdrew Consent|3|||
125609083|NCT03100942|451852256|FG003|Randomized Treatment Period|Withdrew Consent|3|||
125609084|NCT03100942|451852257|FG004|Randomized Treatment Period|Withdrew Consent|0|||
125609085|NCT03100942|451852258|FG005|Randomized Treatment Period|Withdrew Consent|0|||
125609086|NCT03100942|451852259|FG006|Randomized Treatment Period|Withdrew Consent|0|||
125609087|NCT03100942|451852253|FG000|Randomized Treatment Period|Adverse Event|5|||
125609088|NCT03100942|451852254|FG001|Randomized Treatment Period|Adverse Event|2|||
125370567|NCT00381485|450991158|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
125370568|NCT00381485|450991159|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
125370569|NCT00381485|450991160|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
125370570|NCT00381485|450991157|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
125370571|NCT00381485|450991158|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
125370572|NCT00381485|450991159|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
125213290|NCT03004924|450407302|FG000|Overall Study|Lack of Efficacy|2|||
125609089|NCT03100942|451852255|FG002|Randomized Treatment Period|Adverse Event|1|||
125609090|NCT03100942|451852256|FG003|Randomized Treatment Period|Adverse Event|0|||
125609091|NCT03100942|451852257|FG004|Randomized Treatment Period|Adverse Event|0|||
125609092|NCT03100942|451852258|FG005|Randomized Treatment Period|Adverse Event|0|||
125609093|NCT03100942|451852259|FG006|Randomized Treatment Period|Adverse Event|0|||
125609094|NCT03100942|451852253|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
125609095|NCT03100942|451852254|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
125609096|NCT03100942|451852255|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
125609097|NCT03100942|451852256|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
125609098|NCT03100942|451852257|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
125609099|NCT03100942|451852258|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
125609100|NCT03100942|451852259|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
125609101|NCT03100942|451852253|FG000|Randomized Treatment Period|Protocol Violation|0|||
125609102|NCT03100942|451852254|FG001|Randomized Treatment Period|Protocol Violation|1|||
125609103|NCT03100942|451852255|FG002|Randomized Treatment Period|Protocol Violation|1|||
125609104|NCT03100942|451852256|FG003|Randomized Treatment Period|Protocol Violation|1|||
125609105|NCT03100942|451852257|FG004|Randomized Treatment Period|Protocol Violation|0|||
125609106|NCT03100942|451852258|FG005|Randomized Treatment Period|Protocol Violation|0|||
125609107|NCT03100942|451852259|FG006|Randomized Treatment Period|Protocol Violation|0|||
125609108|NCT03100942|451852253|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
125609109|NCT03100942|451852254|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
125609110|NCT03100942|451852255|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
125609111|NCT03100942|451852256|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
125609112|NCT03100942|451852257|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
125609113|NCT03100942|451852258|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
125609114|NCT03100942|451852259|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
125609115|NCT03100942|451852253|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
125609116|NCT03100942|451852254|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
125609117|NCT03100942|451852255|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
125609118|NCT03100942|451852256|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
125609119|NCT03100942|451852257|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
125609120|NCT03100942|451852258|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
125609121|NCT03100942|451852259|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
125609122|NCT03100942|451852253|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
125609123|NCT03100942|451852254|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
125609124|NCT03100942|451852255|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
125609125|NCT03100942|451852256|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
125609126|NCT03100942|451852257|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
125609127|NCT03100942|451852258|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
125609128|NCT03100942|451852259|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
125609129|NCT04263142|451852260|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
125609130|NCT04263142|451852261|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
125609131|NCT04263142|451852262|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
125609132|NCT04263142|451852263|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
125609133|NCT04263142|451852264|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
125609134|NCT04263142|451852260|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
125609135|NCT04263142|451852261|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
125609136|NCT04263142|451852262|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
125609137|NCT04263142|451852263|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
125609138|NCT04263142|451852264|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
125609139|NCT01623531|451852265|FG000|Overall Study|Death|1|||
125609140|NCT01623531|451852266|FG001|Overall Study|Death|0|||
125609141|NCT01623531|451852265|FG000|Overall Study|Protocol Violation|2|||
125609142|NCT01623531|451852266|FG001|Overall Study|Protocol Violation|1|||
125609143|NCT01623531|451852265|FG000|Overall Study|Missing data at primary outcome time poi|1|||
125609144|NCT01623531|451852266|FG001|Overall Study|Missing data at primary outcome time poi|1|||
125609145|NCT01429792|451852267|FG000|Overall Study|Other Reasons|67|||
125609146|NCT01429792|451852267|FG000|Overall Study|Unknown Disposition|94|||
125609147|NCT01429792|451852267|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
125609148|NCT01429792|451852267|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
125609149|NCT01429792|451852267|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
125609150|NCT01429792|451852267|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
125609151|NCT01429792|451852267|FG000|Overall Study|Withdrawal by Subject|70|||
125213291|NCT03004924|450407303|FG001|Overall Study|Lack of Efficacy|4|||
125213292|NCT03004924|450407304|FG002|Overall Study|Lack of Efficacy|2|||
125213293|NCT03004924|450407302|FG000|Overall Study|Physician Decision|1|||
125609152|NCT01429792|451852267|FG000|Overall Study|Lost to Follow-up|88|||
125609153|NCT04184622|451852269|FG000|Primary Treatment Period|Adverse Event|6|||
125213294|NCT03004924|450407303|FG001|Overall Study|Physician Decision|0|||
125213295|NCT03004924|450407304|FG002|Overall Study|Physician Decision|1|||
125609154|NCT04184622|451852270|FG001|Primary Treatment Period|Adverse Event|4|||
125609155|NCT04184622|451852271|FG002|Primary Treatment Period|Adverse Event|8|||
125609156|NCT04184622|451852272|FG003|Primary Treatment Period|Adverse Event|6|||
125609157|NCT04184622|451852269|FG000|Primary Treatment Period|Death|4|||
125609158|NCT04184622|451852270|FG001|Primary Treatment Period|Death|4|||
125609159|NCT04184622|451852271|FG002|Primary Treatment Period|Death|2|||
125609160|NCT04184622|451852272|FG003|Primary Treatment Period|Death|1|||
125609161|NCT04184622|451852269|FG000|Primary Treatment Period|Lost to Follow-up|41|||
125609162|NCT04184622|451852270|FG001|Primary Treatment Period|Lost to Follow-up|17|||
125609163|NCT04184622|451852271|FG002|Primary Treatment Period|Lost to Follow-up|15|||
125609164|NCT04184622|451852272|FG003|Primary Treatment Period|Lost to Follow-up|13|||
125609165|NCT04184622|451852269|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
125609166|NCT04184622|451852270|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
125609167|NCT04184622|451852271|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
125609168|NCT04184622|451852272|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
125609169|NCT04184622|451852269|FG000|Primary Treatment Period|Physician Decision|0|||
125609170|NCT04184622|451852270|FG001|Primary Treatment Period|Physician Decision|0|||
125609171|NCT04184622|451852271|FG002|Primary Treatment Period|Physician Decision|3|||
125609172|NCT04184622|451852272|FG003|Primary Treatment Period|Physician Decision|1|||
125609173|NCT04184622|451852269|FG000|Primary Treatment Period|Pregnancy|4|||
125609174|NCT04184622|451852270|FG001|Primary Treatment Period|Pregnancy|3|||
125609175|NCT04184622|451852271|FG002|Primary Treatment Period|Pregnancy|4|||
125609176|NCT04184622|451852272|FG003|Primary Treatment Period|Pregnancy|1|||
125609177|NCT04184622|451852269|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
125609178|NCT04184622|451852270|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
125609179|NCT04184622|451852271|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
125609180|NCT04184622|451852272|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
125609181|NCT04184622|451852269|FG000|Additional Treatment Period|Adverse Event|1|||
125609182|NCT04184622|451852270|FG001|Additional Treatment Period|Adverse Event|2|||
125609183|NCT04184622|451852271|FG002|Additional Treatment Period|Adverse Event|1|||
125609184|NCT04184622|451852272|FG003|Additional Treatment Period|Adverse Event|0|||
125609185|NCT04184622|451852269|FG000|Additional Treatment Period|Death|0|||
125609186|NCT04184622|451852270|FG001|Additional Treatment Period|Death|0|||
125609187|NCT04184622|451852271|FG002|Additional Treatment Period|Death|1|||
125609188|NCT04184622|451852272|FG003|Additional Treatment Period|Death|1|||
125609189|NCT04184622|451852269|FG000|Additional Treatment Period|Lost to Follow-up|6|||
125609190|NCT04184622|451852270|FG001|Additional Treatment Period|Lost to Follow-up|4|||
125609191|NCT04184622|451852271|FG002|Additional Treatment Period|Lost to Follow-up|8|||
125609192|NCT04184622|451852272|FG003|Additional Treatment Period|Lost to Follow-up|6|||
125609193|NCT04184622|451852269|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
125609194|NCT04184622|451852270|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
125609195|NCT04184622|451852271|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
125609196|NCT04184622|451852272|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
125609197|NCT04184622|451852269|FG000|Additional Treatment Period|Physician Decision|0|||
125609198|NCT04184622|451852270|FG001|Additional Treatment Period|Physician Decision|0|||
125609199|NCT04184622|451852271|FG002|Additional Treatment Period|Physician Decision|1|||
125370573|NCT00381485|450991160|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
125370574|NCT00381485|450991157|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
125370575|NCT00381485|450991158|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
125370576|NCT00381485|450991159|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
125370577|NCT00381485|450991160|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
125370578|NCT00381485|450991157|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
125370579|NCT00381485|450991158|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
125370580|NCT00381485|450991159|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
125370581|NCT00381485|450991160|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
125370582|NCT00381485|450991157|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
125370583|NCT00381485|450991158|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
125370584|NCT00381485|450991159|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
125370585|NCT00381485|450991160|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
125370586|NCT00381485|450991157|FG000|Double-Blind Treatment Period|Administrative|0|||
125370587|NCT00381485|450991158|FG001|Double-Blind Treatment Period|Administrative|1|||
125370588|NCT00381485|450991159|FG002|Double-Blind Treatment Period|Administrative|0|||
125370589|NCT00381485|450991160|FG003|Double-Blind Treatment Period|Administrative|1|||
125370590|NCT01898806|450991163|FG000|Overall Study|Withdrawal by Subject|2|||
125370591|NCT01898806|450991163|FG000|Overall Study|Physician Decision|1|||
125370592|NCT00126191|450991164|FG000|Overall Study|Physician Decision|0|||
125370593|NCT00126191|450991165|FG001|Overall Study|Physician Decision|1|||
125370594|NCT00126191|450991164|FG000|Overall Study|Death|0|||
125370595|NCT00126191|450991165|FG001|Overall Study|Death|1|||
125370596|NCT01648101|450991166|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
125370597|NCT01648101|450991167|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
125370598|NCT01648101|450991168|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
125370599|NCT01648101|450991166|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
125370600|NCT01648101|450991167|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
125370601|NCT01648101|450991168|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
125370602|NCT01648101|450991166|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
125370603|NCT01648101|450991167|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
125370604|NCT01648101|450991168|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
125370605|NCT01648101|450991166|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
125370606|NCT01648101|450991167|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
125370607|NCT01648101|450991168|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
125370608|NCT01648101|450991166|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
125370609|NCT01648101|450991167|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
125370610|NCT01648101|450991168|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
125370611|NCT01648101|450991166|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
125370612|NCT01648101|450991167|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
125370613|NCT01648101|450991168|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
125370614|NCT01648101|450991166|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
125370615|NCT01648101|450991167|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
125370616|NCT01648101|450991168|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
125370617|NCT01648101|450991166|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
125370618|NCT01648101|450991167|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
125370619|NCT01648101|450991168|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
125370620|NCT01648101|450991166|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
125370621|NCT01648101|450991167|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
125431791|NCT02055157|451207759|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
125609200|NCT04184622|451852272|FG003|Additional Treatment Period|Physician Decision|0|||
125609201|NCT04184622|451852269|FG000|Additional Treatment Period|Pregnancy|0|||
125609202|NCT04184622|451852270|FG001|Additional Treatment Period|Pregnancy|0|||
125609203|NCT04184622|451852271|FG002|Additional Treatment Period|Pregnancy|0|||
125609204|NCT04184622|451852272|FG003|Additional Treatment Period|Pregnancy|1|||
125609205|NCT04184622|451852269|FG000|Additional Treatment Period|Protocol deviation|0|||
125609206|NCT04184622|451852270|FG001|Additional Treatment Period|Protocol deviation|0|||
125609207|NCT04184622|451852271|FG002|Additional Treatment Period|Protocol deviation|1|||
125609208|NCT04184622|451852272|FG003|Additional Treatment Period|Protocol deviation|0|||
125609209|NCT04184622|451852269|FG000|Additional Treatment Period|Site closed|1|||
125609210|NCT04184622|451852270|FG001|Additional Treatment Period|Site closed|0|||
125431792|NCT02055157|451207760|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
125609211|NCT04184622|451852271|FG002|Additional Treatment Period|Site closed|1|||
125609212|NCT04184622|451852272|FG003|Additional Treatment Period|Site closed|0|||
125370622|NCT01648101|450991168|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
125370623|NCT01648101|450991166|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
125370624|NCT01648101|450991167|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
125370625|NCT01648101|450991168|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
125609213|NCT04184622|451852269|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
125370626|NCT01648101|450991166|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
125370627|NCT01648101|450991167|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
125370628|NCT01648101|450991168|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
125370629|NCT02469298|450991182|FG000|Overall Study|Protocol Violation|0|||
125370630|NCT02469298|450991183|FG001|Overall Study|Protocol Violation|1|||
125370631|NCT02469298|450991184|FG002|Overall Study|Protocol Violation|1|||
125370632|NCT02469298|450991185|FG003|Overall Study|Protocol Violation|0|||
125609214|NCT04184622|451852270|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
125609215|NCT04184622|451852271|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
125609216|NCT04184622|451852272|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
125609217|NCT04184622|451852269|FG000|Safety Follow-up Period|Adverse Event|6|||
125609218|NCT04184622|451852270|FG001|Safety Follow-up Period|Adverse Event|8|||
125609219|NCT04184622|451852271|FG002|Safety Follow-up Period|Adverse Event|9|||
125609220|NCT04184622|451852272|FG003|Safety Follow-up Period|Adverse Event|16|||
125609221|NCT04184622|451852269|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
125609222|NCT04184622|451852270|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
125609223|NCT04184622|451852271|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
125609224|NCT04184622|451852272|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
125609225|NCT04184622|451852269|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
125609226|NCT04184622|451852270|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
125609227|NCT04184622|451852271|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
125609228|NCT04184622|451852272|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
125370633|NCT02469298|450991182|FG000|Overall Study|Lost to Follow-up|1|||
125370634|NCT02469298|450991183|FG001|Overall Study|Lost to Follow-up|0|||
125370635|NCT02469298|450991184|FG002|Overall Study|Lost to Follow-up|1|||
125609229|NCT04184622|451852269|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
125609230|NCT04184622|451852270|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
125609231|NCT04184622|451852271|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
125370636|NCT02469298|450991185|FG003|Overall Study|Lost to Follow-up|0|||
125370637|NCT02469298|450991182|FG000|Overall Study|Physician Decision|0|||
125370638|NCT02469298|450991183|FG001|Overall Study|Physician Decision|0|||
125609232|NCT04184622|451852272|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
125609233|NCT04184622|451852269|FG000|Safety Follow-up Period|Physician Decision|1|||
125609234|NCT04184622|451852270|FG001|Safety Follow-up Period|Physician Decision|0|||
125609235|NCT04184622|451852271|FG002|Safety Follow-up Period|Physician Decision|0|||
125609236|NCT04184622|451852272|FG003|Safety Follow-up Period|Physician Decision|1|||
125609237|NCT04184622|451852269|FG000|Safety Follow-up Period|Pregnancy|1|||
125213296|NCT03004924|450407302|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125609238|NCT04184622|451852270|FG001|Safety Follow-up Period|Pregnancy|3|||
125609239|NCT04184622|451852271|FG002|Safety Follow-up Period|Pregnancy|0|||
125213297|NCT03004924|450407303|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125213298|NCT03004924|450407304|FG002|Overall Study|Withdrawal by parent/guardian|2|||
125213299|NCT03004924|450407302|FG000|Overall Study|Screen Failure|1|||
125213300|NCT03004924|450407303|FG001|Overall Study|Screen Failure|0|||
125213301|NCT03004924|450407304|FG002|Overall Study|Screen Failure|0|||
125213302|NCT03004924|450407302|FG000|Overall Study|Pregnancy|0|||
125213303|NCT03004924|450407303|FG001|Overall Study|Pregnancy|1|||
125213304|NCT03004924|450407304|FG002|Overall Study|Pregnancy|0|||
125213305|NCT03004924|450407302|FG000|Overall Study|Terminated by Sponsor|0|||
125213306|NCT03004924|450407303|FG001|Overall Study|Terminated by Sponsor|0|||
125213307|NCT03004924|450407304|FG002|Overall Study|Terminated by Sponsor|1|||
125213308|NCT03004924|450407302|FG000|Overall Study|Missed Study Visit|0|||
125213309|NCT03004924|450407303|FG001|Overall Study|Missed Study Visit|0|||
125213310|NCT03004924|450407304|FG002|Overall Study|Missed Study Visit|2|||
125213311|NCT03004924|450407302|FG000|Overall Study|HSV1 Positive|1|||
125213312|NCT03004924|450407303|FG001|Overall Study|HSV1 Positive|0|||
125213313|NCT03004924|450407304|FG002|Overall Study|HSV1 Positive|0|||
125213314|NCT00269477|450407305|FG000|Overall Study|Protocol Violation|5|||
125213315|NCT00269477|450407306|FG001|Overall Study|Protocol Violation|5|||
125213316|NCT00269477|450407307|FG002|Overall Study|Protocol Violation|1|||
125213317|NCT00269477|450407308|FG003|Overall Study|Protocol Violation|0|||
125213318|NCT00269477|450407305|FG000|Overall Study|Missed post-vaccination blood draw|0|||
125213319|NCT00269477|450407306|FG001|Overall Study|Missed post-vaccination blood draw|1|||
125213320|NCT00269477|450407307|FG002|Overall Study|Missed post-vaccination blood draw|0|||
125213321|NCT00269477|450407308|FG003|Overall Study|Missed post-vaccination blood draw|0|||
125213322|NCT02670382|450407311|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
125213323|NCT02670382|450407312|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
125213324|NCT03244618|450407313|FG000|Overall Study|Lost to Follow-up|3|||
125213325|NCT03244618|450407314|FG001|Overall Study|Lost to Follow-up|4|||
125213326|NCT03244618|450407313|FG000|Overall Study|Protocol Violation|4|||
125213327|NCT03244618|450407314|FG001|Overall Study|Protocol Violation|3|||
125213328|NCT03244618|450407313|FG000|Overall Study|Withdrawal by Subject|0|||
125213329|NCT03244618|450407314|FG001|Overall Study|Withdrawal by Subject|2|||
125213330|NCT01863732|450407315|FG000|Overall Study|Adverse Event|2|||
125213331|NCT01863732|450407316|FG001|Overall Study|Adverse Event|0|||
125213332|NCT01863732|450407317|FG002|Overall Study|Adverse Event|3|||
125213333|NCT01863732|450407318|FG003|Overall Study|Adverse Event|3|||
125213334|NCT01863732|450407315|FG000|Overall Study|Lack of Efficacy|1|||
125213335|NCT01863732|450407316|FG001|Overall Study|Lack of Efficacy|0|||
125213336|NCT01863732|450407317|FG002|Overall Study|Lack of Efficacy|2|||
125213337|NCT01863732|450407318|FG003|Overall Study|Lack of Efficacy|1|||
125213338|NCT01863732|450407315|FG000|Overall Study|Lost to Follow-up|2|||
125213339|NCT01863732|450407316|FG001|Overall Study|Lost to Follow-up|2|||
125213340|NCT01863732|450407317|FG002|Overall Study|Lost to Follow-up|1|||
125213341|NCT01863732|450407318|FG003|Overall Study|Lost to Follow-up|1|||
125213342|NCT01863732|450407315|FG000|Overall Study|Physician Decision|1|||
125213343|NCT01863732|450407316|FG001|Overall Study|Physician Decision|0|||
125213344|NCT01863732|450407317|FG002|Overall Study|Physician Decision|1|||
125213345|NCT01863732|450407318|FG003|Overall Study|Physician Decision|0|||
125213346|NCT01863732|450407315|FG000|Overall Study|Pregnancy|0|||
125213347|NCT01863732|450407316|FG001|Overall Study|Pregnancy|0|||
125213348|NCT01863732|450407317|FG002|Overall Study|Pregnancy|0|||
125213349|NCT01863732|450407318|FG003|Overall Study|Pregnancy|1|||
125213350|NCT01863732|450407315|FG000|Overall Study|Technical problems|0|||
125213351|NCT01863732|450407316|FG001|Overall Study|Technical problems|1|||
125213352|NCT01863732|450407317|FG002|Overall Study|Technical problems|1|||
125213353|NCT01863732|450407318|FG003|Overall Study|Technical problems|0|||
125213354|NCT01863732|450407315|FG000|Overall Study|Subject/guardian decision|6|||
125213355|NCT01863732|450407316|FG001|Overall Study|Subject/guardian decision|9|||
125213356|NCT01863732|450407317|FG002|Overall Study|Subject/guardian decision|3|||
125213357|NCT01863732|450407318|FG003|Overall Study|Subject/guardian decision|1|||
125213358|NCT01863732|450407315|FG000|Overall Study|Death|1|||
125609240|NCT04184622|451852272|FG003|Safety Follow-up Period|Pregnancy|6|||
125609241|NCT04184622|451852269|FG000|Safety Follow-up Period|Protocol deviation|1|||
125213359|NCT01863732|450407316|FG001|Overall Study|Death|0|||
125213360|NCT01863732|450407317|FG002|Overall Study|Death|0|||
125213361|NCT01863732|450407318|FG003|Overall Study|Death|1|||
125609242|NCT04184622|451852270|FG001|Safety Follow-up Period|Protocol deviation|0|||
125213362|NCT01603394|450407323|FG000|Overall Study|Adverse Event|1|||
125213363|NCT00840034|450407325|FG000|Acute Treatment Phase|Adverse Event|6|||
125213364|NCT00840034|450407326|FG001|Acute Treatment Phase|Adverse Event|8|||
125213365|NCT00840034|450407325|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
125213366|NCT00840034|450407326|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
125213367|NCT00840034|450407325|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
125213368|NCT00840034|450407326|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
125213369|NCT00840034|450407325|FG000|Acute Treatment Phase|Physician Decision|0|||
125213370|NCT00840034|450407326|FG001|Acute Treatment Phase|Physician Decision|1|||
125213371|NCT00840034|450407325|FG000|Acute Treatment Phase|Protocol Violation|2|||
125213372|NCT00840034|450407326|FG001|Acute Treatment Phase|Protocol Violation|4|||
125370639|NCT02469298|450991184|FG002|Overall Study|Physician Decision|0|||
125213373|NCT00840034|450407325|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
125213374|NCT00840034|450407326|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
125213375|NCT00840034|450407325|FG000|Taper Phase|Adverse Event|1|||
125213376|NCT00840034|450407326|FG001|Taper Phase|Adverse Event|0|||
125213377|NCT00840034|450407325|FG000|Taper Phase|Lost to Follow-up|1|||
125213378|NCT00840034|450407326|FG001|Taper Phase|Lost to Follow-up|1|||
125213379|NCT00840034|450407325|FG000|Taper Phase|Withdrawal by Subject|1|||
125213380|NCT00840034|450407326|FG001|Taper Phase|Withdrawal by Subject|1|||
125213381|NCT01215435|450407327|FG000|Overall Study|Adverse Event|1|||
125213382|NCT01215435|450407328|FG001|Overall Study|Adverse Event|0|||
125370640|NCT02469298|450991185|FG003|Overall Study|Physician Decision|1|||
125370641|NCT02469298|450991182|FG000|Overall Study|Withdrawal by Subject|0|||
125370642|NCT02469298|450991183|FG001|Overall Study|Withdrawal by Subject|0|||
125370643|NCT02469298|450991184|FG002|Overall Study|Withdrawal by Subject|0|||
125370644|NCT02469298|450991185|FG003|Overall Study|Withdrawal by Subject|1|||
125370645|NCT03000439|450991188|FG000|Open Label Part 1|Adverse Event|6|||
125370646|NCT03000439|450991189|FG001|Open Label Part 1|Adverse Event|0|||
125370647|NCT03000439|450991190|FG002|Open Label Part 1|Adverse Event|0|||
125370648|NCT03000439|450991191|FG003|Open Label Part 1|Adverse Event|0|||
125370649|NCT03000439|450991188|FG000|Open Label Part 1|Other|2|||
125370650|NCT03000439|450991189|FG001|Open Label Part 1|Other|0|||
125370651|NCT03000439|450991190|FG002|Open Label Part 1|Other|0|||
125370652|NCT03000439|450991191|FG003|Open Label Part 1|Other|0|||
125370653|NCT03000439|450991188|FG000|Open Label Part 1|Insufficient clinical response|16|||
125370654|NCT03000439|450991189|FG001|Open Label Part 1|Insufficient clinical response|0|||
125370655|NCT03000439|450991190|FG002|Open Label Part 1|Insufficient clinical response|0|||
125370656|NCT03000439|450991191|FG003|Open Label Part 1|Insufficient clinical response|0|||
125370657|NCT03000439|450991188|FG000|Open Label Part 2|Other|0|||
125370658|NCT03000439|450991189|FG001|Open Label Part 2|Other|5|||
125370659|NCT03000439|450991190|FG002|Open Label Part 2|Other|0|||
125370660|NCT03000439|450991191|FG003|Open Label Part 2|Other|0|||
125370661|NCT03000439|450991188|FG000|Open Label Part 2|Insufficient clinical response|0|||
125370662|NCT03000439|450991189|FG001|Open Label Part 2|Insufficient clinical response|12|||
125370663|NCT03000439|450991190|FG002|Open Label Part 2|Insufficient clinical response|0|||
125370664|NCT03000439|450991191|FG003|Open Label Part 2|Insufficient clinical response|0|||
125370665|NCT03000439|450991188|FG000|Double Blind Phase|Adverse Event|0|||
125370666|NCT03000439|450991189|FG001|Double Blind Phase|Adverse Event|0|||
125370667|NCT03000439|450991190|FG002|Double Blind Phase|Adverse Event|2|||
125370668|NCT03000439|450991191|FG003|Double Blind Phase|Adverse Event|1|||
125370669|NCT03000439|450991188|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
125370670|NCT03000439|450991189|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
125370671|NCT03000439|450991190|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
125370672|NCT03000439|450991191|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
125370673|NCT03000439|450991188|FG000|Double Blind Phase|Other|0|||
125370674|NCT03000439|450991189|FG001|Double Blind Phase|Other|0|||
125370675|NCT03000439|450991190|FG002|Double Blind Phase|Other|10|||
125370676|NCT03000439|450991191|FG003|Double Blind Phase|Other|11|||
125370677|NCT03000439|450991188|FG000|Double Blind Phase|Insufficient clinical response|0|||
125370678|NCT03000439|450991189|FG001|Double Blind Phase|Insufficient clinical response|0|||
125370679|NCT03000439|450991190|FG002|Double Blind Phase|Insufficient clinical response|0|||
125370680|NCT03000439|450991191|FG003|Double Blind Phase|Insufficient clinical response|2|||
125370681|NCT02954237|450991194|FG000|Overall Study|Withdrawal by Subject|25|||
125370682|NCT02954237|450991194|FG000|Overall Study|Missed visit|16|||
125370683|NCT02954237|450991194|FG000|Overall Study|Death|2|||
125370684|NCT03292588|450991195|FG000|Overall Study|Death|1|||
125370685|NCT03292588|450991196|FG001|Overall Study|Death|0|||
125370686|NCT03292588|450991195|FG000|Overall Study|Lost to Follow-up|12|||
125370687|NCT03292588|450991196|FG001|Overall Study|Lost to Follow-up|16|||
125370688|NCT03292588|450991195|FG000|Overall Study|Physician Decision|0|||
125370689|NCT03292588|450991196|FG001|Overall Study|Physician Decision|1|||
125609243|NCT04184622|451852271|FG002|Safety Follow-up Period|Protocol deviation|0|||
125609244|NCT04184622|451852272|FG003|Safety Follow-up Period|Protocol deviation|0|||
125609245|NCT04184622|451852269|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
125609246|NCT04184622|451852270|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
125213383|NCT01215435|450407327|FG000|Overall Study|Protocol Violation|2|||
125370690|NCT03292588|450991195|FG000|Overall Study|Withdrawal by Subject|4|||
125370691|NCT03292588|450991196|FG001|Overall Study|Withdrawal by Subject|4|||
125370692|NCT03292588|450991195|FG000|Overall Study|Move out of town|1|||
125370693|NCT03292588|450991196|FG001|Overall Study|Move out of town|0|||
125370694|NCT03292588|450991195|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
125370695|NCT03292588|450991196|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
125370696|NCT02151591|450991197|FG000|Overall Study|Lost to Follow-up|6|||
125370697|NCT02151591|450991198|FG001|Overall Study|Lost to Follow-up|3|||
125370698|NCT03633695|450991201|FG000|Overall Study|Lost to Follow-up|4|||
125609247|NCT04184622|451852271|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
125213384|NCT01215435|450407328|FG001|Overall Study|Protocol Violation|0|||
125609248|NCT04184622|451852272|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
125609249|NCT00769704|451852273|FG000|Overall Study|Lost to Follow-up|3|||
125609250|NCT00769704|451852274|FG001|Overall Study|Lost to Follow-up|2|||
125609251|NCT00769704|451852273|FG000|Overall Study|Death|95|||
125609252|NCT00769704|451852274|FG001|Overall Study|Death|190|||
125609253|NCT00769704|451852273|FG000|Overall Study|Withdrawal by Subject|12|||
125609254|NCT00769704|451852274|FG001|Overall Study|Withdrawal by Subject|5|||
125609255|NCT00769704|451852273|FG000|Overall Study|Other|1|||
125609256|NCT00769704|451852274|FG001|Overall Study|Other|2|||
125609257|NCT01617681|451852277|FG000|Period 1 Double Blind|Adverse Event|2|||
125609258|NCT01617681|451852278|FG001|Period 1 Double Blind|Adverse Event|0|||
125609259|NCT01617681|451852279|FG002|Period 1 Double Blind|Adverse Event|0|||
125609260|NCT01617681|451852280|FG003|Period 1 Double Blind|Adverse Event|2|||
125609261|NCT01617681|451852281|FG004|Period 1 Double Blind|Adverse Event|0|||
125609262|NCT01617681|451852277|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
125609263|NCT01617681|451852278|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
125609264|NCT01617681|451852279|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
125609265|NCT01617681|451852280|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
125609266|NCT01617681|451852281|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
125609267|NCT01617681|451852277|FG000|Period 2 Open Label|Adverse Event|0|||
125609268|NCT01617681|451852278|FG001|Period 2 Open Label|Adverse Event|0|||
125609269|NCT01617681|451852279|FG002|Period 2 Open Label|Adverse Event|0|||
125609270|NCT01617681|451852280|FG003|Period 2 Open Label|Adverse Event|0|||
125609271|NCT01617681|451852281|FG004|Period 2 Open Label|Adverse Event|3|||
125609272|NCT01617681|451852277|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
125609273|NCT01617681|451852278|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
125213385|NCT01215435|450407327|FG000|Overall Study|Withdrawal Criteria|8|||
125213386|NCT01215435|450407328|FG001|Overall Study|Withdrawal Criteria|11|||
125213387|NCT01215435|450407327|FG000|Overall Study|Lost to Follow-up|3|||
125213388|NCT01215435|450407328|FG001|Overall Study|Lost to Follow-up|0|||
125213389|NCT01215435|450407327|FG000|Overall Study|Unclassified|5|||
125213390|NCT01215435|450407328|FG001|Overall Study|Unclassified|5|||
125213391|NCT00586898|450407337|FG000|Overall Study|Adverse Event|1|||
125213392|NCT00586898|450407337|FG000|Overall Study|Patiemt Non-compliance|1|||
125213393|NCT00586898|450407337|FG000|Overall Study|Evaluable for Toxicity Only|5|||
125213394|NCT03816007|450407338|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
125213395|NCT03816007|450407339|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
125213396|NCT03816007|450407338|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
125213397|NCT03816007|450407339|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
125213398|NCT03816007|450407338|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
125213399|NCT03816007|450407339|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
125213400|NCT01249833|450407340|FG000|Overall Study|Lost to Follow-up|0|||
125213401|NCT01249833|450407341|FG001|Overall Study|Lost to Follow-up|1|||
125213402|NCT03796676|450407342|FG000|Overall Study|Adverse Event|2|||
125213403|NCT03796676|450407343|FG001|Overall Study|Adverse Event|1|||
125213404|NCT03796676|450407344|FG002|Overall Study|Adverse Event|2|||
125213405|NCT03796676|450407342|FG000|Overall Study|Lost to Follow-up|2|||
125213406|NCT03796676|450407343|FG001|Overall Study|Lost to Follow-up|1|||
125213407|NCT03796676|450407344|FG002|Overall Study|Lost to Follow-up|0|||
125213408|NCT03796676|450407342|FG000|Overall Study|Protocol Violation|0|||
125213409|NCT03796676|450407343|FG001|Overall Study|Protocol Violation|0|||
125213410|NCT03796676|450407344|FG002|Overall Study|Protocol Violation|1|||
125213411|NCT03796676|450407342|FG000|Overall Study|Withdrawal by Subject|1|||
125213412|NCT03796676|450407343|FG001|Overall Study|Withdrawal by Subject|1|||
125213413|NCT03796676|450407344|FG002|Overall Study|Withdrawal by Subject|0|||
125213414|NCT03796676|450407342|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
125213415|NCT03796676|450407343|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
125213416|NCT03796676|450407344|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
125213417|NCT02432144|450407346|FG000|Overall Study|Participant Non-Compliance|1|||
125213418|NCT00448812|450407347|FG000|Year 2|Missed visit but remained in study|4|||
125213419|NCT00448812|450407348|FG001|Year 2|Missed visit but remained in study|1|||
125213420|NCT00448812|450407347|FG000|Year 3|Withdrawal by Subject|1|||
125213421|NCT00448812|450407348|FG001|Year 3|Withdrawal by Subject|3|||
125213422|NCT00448812|450407347|FG000|Year 3|Lost to Follow-up|1|||
125213423|NCT00448812|450407348|FG001|Year 3|Lost to Follow-up|0|||
125213424|NCT00448812|450407347|FG000|Year 3|Missed visit but remained in study|2|||
125213425|NCT00448812|450407348|FG001|Year 3|Missed visit but remained in study|0|||
125213426|NCT00448812|450407347|FG000|Year 5|Missed visit but remained in study|1|||
125370699|NCT03633695|450991202|FG001|Overall Study|Lost to Follow-up|5|||
125370700|NCT03633695|450991201|FG000|Overall Study|Discontinued|8|||
125370701|NCT03633695|450991202|FG001|Overall Study|Discontinued|4|||
125370702|NCT02853604|450991211|FG000|Overall Study|Withdrawal by Subject|12|||
125213427|NCT00448812|450407348|FG001|Year 5|Missed visit but remained in study|0|||
125213428|NCT01859949|450409640|FG000|Overall Study|Family Matters|0|||
125213429|NCT01859949|450409641|FG001|Overall Study|Family Matters|1|||
125213430|NCT01859949|450409640|FG000|Overall Study|Physician Decision|2|||
125213431|NCT01859949|450409641|FG001|Overall Study|Physician Decision|4|||
125213432|NCT01859949|450409640|FG000|Overall Study|Withdrawal by Subject|11|||
125213433|NCT01859949|450409641|FG001|Overall Study|Withdrawal by Subject|10|||
125213434|NCT01859949|450409640|FG000|Overall Study|Protocol Violation|1|||
125213435|NCT01859949|450409641|FG001|Overall Study|Protocol Violation|1|||
125213436|NCT01859949|450409640|FG000|Overall Study|Adverse Event|0|||
125370703|NCT02853604|450991212|FG001|Overall Study|Withdrawal by Subject|35|||
125370704|NCT02853604|450991211|FG000|Overall Study|Lost to Follow-up|4|||
125213437|NCT01859949|450409641|FG001|Overall Study|Adverse Event|1|||
125213438|NCT01890759|450409642|FG000|Overall Study|Protocol Violation|0|||
125370705|NCT02853604|450991212|FG001|Overall Study|Lost to Follow-up|8|||
125370706|NCT02853604|450991211|FG000|Overall Study|Death|1|||
125370707|NCT02853604|450991212|FG001|Overall Study|Death|5|||
125370708|NCT02853604|450991211|FG000|Overall Study|Miscellaneous|11|||
125370709|NCT02853604|450991212|FG001|Overall Study|Miscellaneous|2|||
125370710|NCT02853604|450991211|FG000|Overall Study|Progressive Disease|0|||
125370711|NCT02853604|450991212|FG001|Overall Study|Progressive Disease|2|||
125370712|NCT02732119|450991213|FG000|Phase I|Adverse Event|1|||
125370713|NCT02732119|450991214|FG001|Phase I|Adverse Event|3|||
125370714|NCT02732119|450991215|FG002|Phase I|Adverse Event|1|||
125370715|NCT02732119|450991216|FG003|Phase I|Adverse Event|0|||
125370716|NCT02732119|450991217|FG004|Phase I|Adverse Event|0|||
125370717|NCT02732119|450991213|FG000|Phase I|Progressive disease|7|||
125370718|NCT02732119|450991214|FG001|Phase I|Progressive disease|3|||
125370719|NCT02732119|450991215|FG002|Phase I|Progressive disease|2|||
125370720|NCT02732119|450991216|FG003|Phase I|Progressive disease|0|||
125370721|NCT02732119|450991217|FG004|Phase I|Progressive disease|0|||
125370722|NCT02732119|450991213|FG000|Phase I|Protocol deviation|0|||
125370723|NCT02732119|450991214|FG001|Phase I|Protocol deviation|1|||
125370724|NCT02732119|450991215|FG002|Phase I|Protocol deviation|0|||
125370725|NCT02732119|450991216|FG003|Phase I|Protocol deviation|0|||
125370726|NCT02732119|450991217|FG004|Phase I|Protocol deviation|0|||
125370727|NCT02732119|450991213|FG000|Phase I|Physician Decision|0|||
125370728|NCT02732119|450991214|FG001|Phase I|Physician Decision|3|||
125370729|NCT02732119|450991215|FG002|Phase I|Physician Decision|4|||
125370730|NCT02732119|450991216|FG003|Phase I|Physician Decision|0|||
125370731|NCT02732119|450991217|FG004|Phase I|Physician Decision|0|||
125370732|NCT02732119|450991213|FG000|Phase II|Adverse Event|0|||
125370733|NCT02732119|450991214|FG001|Phase II|Adverse Event|0|||
125370734|NCT02732119|450991215|FG002|Phase II|Adverse Event|0|||
125370735|NCT02732119|450991216|FG003|Phase II|Adverse Event|3|||
125370736|NCT02732119|450991217|FG004|Phase II|Adverse Event|3|||
125370737|NCT02732119|450991213|FG000|Phase II|Death|0|||
125370738|NCT02732119|450991214|FG001|Phase II|Death|0|||
125370739|NCT02732119|450991215|FG002|Phase II|Death|0|||
125370740|NCT02732119|450991216|FG003|Phase II|Death|1|||
125370741|NCT02732119|450991217|FG004|Phase II|Death|0|||
125370742|NCT02732119|450991213|FG000|Phase II|Progressive dissease|0|||
125370743|NCT02732119|450991214|FG001|Phase II|Progressive dissease|0|||
125370744|NCT02732119|450991215|FG002|Phase II|Progressive dissease|0|||
125370745|NCT02732119|450991216|FG003|Phase II|Progressive dissease|30|||
125370746|NCT02732119|450991217|FG004|Phase II|Progressive dissease|23|||
125370747|NCT02732119|450991213|FG000|Phase II|Study terminated by sponsor|0|||
125370748|NCT02732119|450991214|FG001|Phase II|Study terminated by sponsor|0|||
125370749|NCT02732119|450991215|FG002|Phase II|Study terminated by sponsor|0|||
125370750|NCT02732119|450991216|FG003|Phase II|Study terminated by sponsor|2|||
125370751|NCT02732119|450991217|FG004|Phase II|Study terminated by sponsor|2|||
125370752|NCT02732119|450991213|FG000|Phase II|Other|0|||
125370753|NCT02732119|450991214|FG001|Phase II|Other|0|||
125370754|NCT02732119|450991215|FG002|Phase II|Other|0|||
125370755|NCT02732119|450991216|FG003|Phase II|Other|2|||
125370756|NCT02732119|450991217|FG004|Phase II|Other|0|||
125370757|NCT02732119|450991213|FG000|Phase II|Physician Decision|0|||
125370758|NCT02732119|450991214|FG001|Phase II|Physician Decision|0|||
125370759|NCT02732119|450991215|FG002|Phase II|Physician Decision|0|||
125370760|NCT02732119|450991216|FG003|Phase II|Physician Decision|8|||
125609274|NCT01617681|451852279|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
125609275|NCT01617681|451852280|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
125609276|NCT01617681|451852281|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
125609277|NCT01856595|451852287|FG000|Overall Study|Withdrawal by Subject|0|||
125609278|NCT01856595|451852288|FG001|Overall Study|Withdrawal by Subject|1|||
125609279|NCT01856595|451852289|FG002|Overall Study|Withdrawal by Subject|0|||
125609280|NCT01856595|451852290|FG003|Overall Study|Withdrawal by Subject|0|||
125609281|NCT01856595|451852291|FG004|Overall Study|Withdrawal by Subject|0|||
125370761|NCT02732119|450991217|FG004|Phase II|Physician Decision|5|||
125370762|NCT00520936|450991218|FG000|Overall Study|Physician Decision|0|||
125370763|NCT00520936|450991219|FG001|Overall Study|Physician Decision|2|||
125370764|NCT00520936|450991220|FG002|Overall Study|Physician Decision|1|||
125370765|NCT00520936|450991221|FG003|Overall Study|Physician Decision|0|||
125370766|NCT00520936|450991222|FG004|Overall Study|Physician Decision|0|||
125370767|NCT00520936|450991223|FG005|Overall Study|Physician Decision|0|||
125370768|NCT00520936|450991224|FG006|Overall Study|Physician Decision|0|||
125370769|NCT00520936|450991225|FG007|Overall Study|Physician Decision|0|||
125370770|NCT00520936|450991218|FG000|Overall Study|Withdrawal by Subject|0|||
125370771|NCT00520936|450991219|FG001|Overall Study|Withdrawal by Subject|0|||
125370772|NCT00520936|450991220|FG002|Overall Study|Withdrawal by Subject|0|||
125370773|NCT00520936|450991221|FG003|Overall Study|Withdrawal by Subject|0|||
125370774|NCT00520936|450991222|FG004|Overall Study|Withdrawal by Subject|0|||
125370775|NCT00520936|450991223|FG005|Overall Study|Withdrawal by Subject|0|||
125370776|NCT00520936|450991224|FG006|Overall Study|Withdrawal by Subject|0|||
125609282|NCT01856595|451852292|FG005|Overall Study|Withdrawal by Subject|0|||
125609283|NCT01856595|451852293|FG006|Overall Study|Withdrawal by Subject|1|||
125609284|NCT01856595|451852294|FG007|Overall Study|Withdrawal by Subject|0|||
125609285|NCT01856595|451852295|FG008|Overall Study|Withdrawal by Subject|0|||
125609286|NCT04426825|451852297|FG000|Overall Study|Death|17|||
125609287|NCT04426825|451852297|FG000|Overall Study|Lost to Follow-up|1|||
125609288|NCT04426825|451852297|FG000|Overall Study|Study terminated by sponsor|5|||
125609289|NCT04346628|451852298|FG000|Overall Study|Lost to Follow-up|4|||
125609290|NCT04346628|451852299|FG001|Overall Study|Lost to Follow-up|4|||
125609291|NCT04346628|451852298|FG000|Overall Study|Withdrew (had personal reasons)|2|||
125609292|NCT04346628|451852299|FG001|Overall Study|Withdrew (had personal reasons)|5|||
125609293|NCT04346628|451852298|FG000|Overall Study|Withdrew (medication intolerant)|0|||
125609294|NCT04346628|451852299|FG001|Overall Study|Withdrew (medication intolerant)|3|||
125609295|NCT04346628|451852298|FG000|Overall Study|Withdrew (declined intervention)|0|||
125609296|NCT04346628|451852299|FG001|Overall Study|Withdrew (declined intervention)|1|||
125609297|NCT01763905|451852300|FG000|Overall Study|Withdrawal by Subject|1|||
125609298|NCT01763905|451852301|FG001|Overall Study|Withdrawal by Subject|1|||
125609299|NCT01763905|451852302|FG002|Overall Study|Withdrawal by Subject|0|||
125609300|NCT01763905|451852303|FG003|Overall Study|Withdrawal by Subject|1|||
125609301|NCT01763905|451852300|FG000|Overall Study|Decision by sponsor|5|||
125609302|NCT01763905|451852301|FG001|Overall Study|Decision by sponsor|0|||
125609303|NCT01763905|451852302|FG002|Overall Study|Decision by sponsor|8|||
125609304|NCT01763905|451852303|FG003|Overall Study|Decision by sponsor|0|||
125609305|NCT01763905|451852300|FG000|Overall Study|Lost to Follow-up|0|||
125609306|NCT01763905|451852301|FG001|Overall Study|Lost to Follow-up|0|||
125609307|NCT01763905|451852302|FG002|Overall Study|Lost to Follow-up|1|||
125609308|NCT01763905|451852303|FG003|Overall Study|Lost to Follow-up|0|||
125609309|NCT01428063|451852305|FG000|Overall Study|Lack of Efficacy|8|||
125609310|NCT01428063|451852306|FG001|Overall Study|Lack of Efficacy|4|||
125609311|NCT01428063|451852307|FG002|Overall Study|Lack of Efficacy|1|||
125609312|NCT01428063|451852305|FG000|Overall Study|Adverse Event|2|||
125609313|NCT01428063|451852306|FG001|Overall Study|Adverse Event|3|||
125609314|NCT01428063|451852307|FG002|Overall Study|Adverse Event|0|||
125609315|NCT01428063|451852305|FG000|Overall Study|Lost to Follow-up|0|||
125609316|NCT01428063|451852306|FG001|Overall Study|Lost to Follow-up|2|||
125609317|NCT01428063|451852307|FG002|Overall Study|Lost to Follow-up|0|||
125609318|NCT01428063|451852305|FG000|Overall Study|No longer meets study criteria|0|||
125609319|NCT01428063|451852306|FG001|Overall Study|No longer meets study criteria|1|||
125609320|NCT01428063|451852307|FG002|Overall Study|No longer meets study criteria|0|||
125609321|NCT00578864|451852308|FG000|Overall Study|Death|1|||
125609322|NCT00578864|451852309|FG001|Overall Study|Death|0|||
125609323|NCT01087528|451852310|FG000|Overall Study|Withdrawal by Subject|1|||
125609324|NCT01087528|451852310|FG000|Overall Study|Incomplete CE procedure|6|||
125609325|NCT02702193|451852315|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
125609326|NCT02702193|451852316|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
125609327|NCT02702193|451852315|FG000|4 Month Follow up|Withdrawal by Subject|1|||
125609328|NCT02702193|451852316|FG001|4 Month Follow up|Withdrawal by Subject|0|||
125609329|NCT02702193|451852315|FG000|4 Month Follow up|Lost to Follow-up|17|||
125609330|NCT02702193|451852316|FG001|4 Month Follow up|Lost to Follow-up|18|||
125609331|NCT02702193|451852315|FG000|8 Month Follow up|Withdrawal by Subject|1|||
125609332|NCT02702193|451852316|FG001|8 Month Follow up|Withdrawal by Subject|0|||
125609333|NCT02702193|451852315|FG000|8 Month Follow up|Lost to Follow-up|14|||
125213439|NCT01890759|450409643|FG001|Overall Study|Protocol Violation|2|||
125609334|NCT02702193|451852316|FG001|8 Month Follow up|Lost to Follow-up|18|||
125609335|NCT02702193|451852315|FG000|12 Month Follow up|Withdrawal by Subject|1|||
125609336|NCT02702193|451852316|FG001|12 Month Follow up|Withdrawal by Subject|0|||
125609337|NCT02702193|451852315|FG000|12 Month Follow up|Lost to Follow-up|16|||
125609338|NCT02702193|451852316|FG001|12 Month Follow up|Lost to Follow-up|18|||
125609339|NCT01201798|451852320|FG000|Overall Study|Adverse Event|2|||
125609340|NCT01201798|451852321|FG001|Overall Study|Adverse Event|0|||
125609341|NCT01201798|451852320|FG000|Overall Study|Lost to Follow-up|3|||
125609342|NCT01201798|451852321|FG001|Overall Study|Lost to Follow-up|5|||
125609343|NCT01201798|451852320|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
125609344|NCT01201798|451852321|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
125609345|NCT01201798|451852320|FG000|Overall Study|Noncompliance|1|||
125609346|NCT01201798|451852321|FG001|Overall Study|Noncompliance|0|||
125609347|NCT01201798|451852320|FG000|Overall Study|Protocol Violation|1|||
125609348|NCT01201798|451852321|FG001|Overall Study|Protocol Violation|1|||
125609349|NCT01201798|451852320|FG000|Overall Study|Treatment Failure|1|||
125609350|NCT01201798|451852321|FG001|Overall Study|Treatment Failure|8|||
125609351|NCT03609359|451852322|FG000|Overall Study|Progression of primary disease (PD)|25|||
125609352|NCT03609359|451852322|FG000|Overall Study|Patient's refusal|1|||
125609353|NCT03609359|451852322|FG000|Overall Study|Physician Decision|1|||
125609354|NCT03609359|451852322|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
125609355|NCT01035255|451852323|FG000|Overall Study|Death|724|||
125609356|NCT01035255|451852324|FG001|Overall Study|Death|844|||
125609357|NCT01035255|451852323|FG000|Overall Study|Lost to Follow-up|2|||
125609358|NCT01035255|451852324|FG001|Overall Study|Lost to Follow-up|5|||
125609359|NCT01035255|451852323|FG000|Overall Study|patient's request|15|||
125609360|NCT01035255|451852324|FG001|Overall Study|patient's request|13|||
125609361|NCT03007953|451852325|FG000|Overall Study|Withdrawal by Subject|5|||
125609362|NCT03007953|451852326|FG001|Overall Study|Withdrawal by Subject|2|||
125609363|NCT03007953|451852325|FG000|Overall Study|Death|5|||
125609364|NCT03007953|451852326|FG001|Overall Study|Death|7|||
125213440|NCT01890759|450409642|FG000|Overall Study|Lost to Follow-up|0|||
125213441|NCT01890759|450409643|FG001|Overall Study|Lost to Follow-up|2|||
125213442|NCT01890759|450409642|FG000|Overall Study|Withdrawal by Subject|2|||
125213443|NCT01890759|450409643|FG001|Overall Study|Withdrawal by Subject|8|||
125213444|NCT00171158|450409644|FG000|Core Study|Death|27|||
125213445|NCT00171158|450409644|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
125609365|NCT03007953|451852325|FG000|Overall Study|Lost to Follow-up|3|||
125609366|NCT03007953|451852326|FG001|Overall Study|Lost to Follow-up|2|||
125609367|NCT03007953|451852325|FG000|Overall Study|Enrolled in Hospice|3|||
125609368|NCT03007953|451852326|FG001|Overall Study|Enrolled in Hospice|2|||
125609369|NCT02203838|451852327|FG000|Overall Study|Lack of Efficacy|7|||
125213446|NCT00171158|450409644|FG000|Core Study|Protocol Violation|4|||
125213447|NCT00171158|450409644|FG000|Core Study|Administrative problems|1|||
125213448|NCT00171158|450409644|FG000|Core Study|Adverse event, non-fatal|21|||
125213449|NCT00171158|450409644|FG000|Core Study|Consent withdrawn by subject|6|||
125213450|NCT00171158|450409644|FG000|Core Study|No longer required drug (BMT)|14|||
125213451|NCT00171158|450409644|FG000|Core Study|Abnormal Laboratory Values|2|||
125213452|NCT00171158|450409644|FG000|Core Study|Lost to Follow-up|1|||
125213453|NCT00171158|450409644|FG000|E2 Extension|Other|7|||
125609370|NCT02203838|451852328|FG001|Overall Study|Lack of Efficacy|0|||
125609371|NCT02203838|451852329|FG002|Overall Study|Lack of Efficacy|1|||
125609372|NCT02203838|451852330|FG003|Overall Study|Lack of Efficacy|1|||
125609373|NCT02203838|451852327|FG000|Overall Study|Adverse Event|46|||
125609374|NCT02203838|451852328|FG001|Overall Study|Adverse Event|6|||
125609375|NCT02203838|451852329|FG002|Overall Study|Adverse Event|3|||
125609376|NCT02203838|451852330|FG003|Overall Study|Adverse Event|2|||
125609377|NCT02203838|451852327|FG000|Overall Study|Lost to Follow-up|39|||
125609378|NCT02203838|451852328|FG001|Overall Study|Lost to Follow-up|3|||
125609379|NCT02203838|451852329|FG002|Overall Study|Lost to Follow-up|2|||
125370777|NCT00520936|450991225|FG007|Overall Study|Withdrawal by Subject|1|||
125213454|NCT03536663|450409649|FG000|Endexo|Protocol Violation|1|||
125609380|NCT02203838|451852330|FG003|Overall Study|Lost to Follow-up|1|||
125609381|NCT02203838|451852327|FG000|Overall Study|Protocol Violation|7|||
125213455|NCT01471444|450409652|FG000|Overall Study|Physician Decision|3|||
125213456|NCT01471444|450409653|FG001|Overall Study|Physician Decision|2|||
125609382|NCT02203838|451852328|FG001|Overall Study|Protocol Violation|3|||
125609383|NCT02203838|451852329|FG002|Overall Study|Protocol Violation|0|||
125609384|NCT02203838|451852330|FG003|Overall Study|Protocol Violation|0|||
125609385|NCT02203838|451852327|FG000|Overall Study|Withdrawal by Subject|83|||
125609386|NCT02203838|451852328|FG001|Overall Study|Withdrawal by Subject|10|||
125609387|NCT02203838|451852329|FG002|Overall Study|Withdrawal by Subject|8|||
125609388|NCT02203838|451852330|FG003|Overall Study|Withdrawal by Subject|11|||
125609389|NCT02203838|451852327|FG000|Overall Study|Physician Decision|27|||
125609390|NCT02203838|451852328|FG001|Overall Study|Physician Decision|0|||
125609391|NCT02203838|451852329|FG002|Overall Study|Physician Decision|2|||
125213457|NCT01471444|450409652|FG000|Overall Study|Withdrawal by Subject|0|||
125213458|NCT01471444|450409653|FG001|Overall Study|Withdrawal by Subject|1|||
125213459|NCT01031004|450409654|FG000|Overall Study|Protocol Violation|0|||
125213460|NCT01031004|450409655|FG001|Overall Study|Protocol Violation|1|||
125213461|NCT01031004|450409654|FG000|Overall Study|Lost to Follow-up|1|||
125213462|NCT01031004|450409655|FG001|Overall Study|Lost to Follow-up|0|||
125213463|NCT02634801|450409656|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
125213464|NCT02634801|450409657|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
125213465|NCT02634801|450409658|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
125213466|NCT02634801|450409656|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
125213467|NCT02634801|450409657|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
125213468|NCT02634801|450409658|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
125213469|NCT02634801|450409656|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
125213470|NCT02634801|450409657|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
125213471|NCT02634801|450409658|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
125213472|NCT02634801|450409656|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
125213473|NCT02634801|450409657|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
125213474|NCT02634801|450409658|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
125213475|NCT02634801|450409656|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
125213476|NCT02634801|450409657|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
125213477|NCT02634801|450409658|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
125213478|NCT02634801|450409656|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
125213479|NCT02634801|450409657|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
125213480|NCT02634801|450409658|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
125213481|NCT02634801|450409656|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
125213482|NCT02634801|450409657|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
125213483|NCT02634801|450409658|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
125213484|NCT02634801|450409656|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
125213485|NCT02634801|450409657|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
125213486|NCT02634801|450409658|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
125213487|NCT02634801|450409656|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
125213488|NCT02634801|450409657|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
125213489|NCT02634801|450409658|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
125213490|NCT02634801|450409656|FG000|Follow-up Period|Lost to Follow-up|3|||
125213491|NCT02634801|450409657|FG001|Follow-up Period|Lost to Follow-up|1|||
125213492|NCT02634801|450409658|FG002|Follow-up Period|Lost to Follow-up|2|||
125213493|NCT02634801|450409656|FG000|Follow-up Period|Physician Decision|0|||
125213494|NCT02634801|450409657|FG001|Follow-up Period|Physician Decision|0|||
125213495|NCT02634801|450409658|FG002|Follow-up Period|Physician Decision|1|||
125213496|NCT02634801|450409656|FG000|Follow-up Period|Withdrawal by Subject|1|||
125213497|NCT02634801|450409657|FG001|Follow-up Period|Withdrawal by Subject|2|||
125213498|NCT02634801|450409658|FG002|Follow-up Period|Withdrawal by Subject|5|||
125213499|NCT02634801|450409656|FG000|Follow-up Period|Adverse Event|1|||
125213500|NCT02634801|450409657|FG001|Follow-up Period|Adverse Event|5|||
125213501|NCT02634801|450409658|FG002|Follow-up Period|Adverse Event|0|||
125213502|NCT00582426|450409659|FG000|Overall Study|Lost to Follow-up|0|||
125213503|NCT00582426|450409660|FG001|Overall Study|Lost to Follow-up|2|||
125213504|NCT00582426|450409659|FG000|Overall Study|Adverse Event|4|||
125213505|NCT00582426|450409660|FG001|Overall Study|Adverse Event|2|||
125213506|NCT00582426|450409659|FG000|Overall Study|Protocol Violation|6|||
125213507|NCT00582426|450409660|FG001|Overall Study|Protocol Violation|2|||
125213508|NCT00582426|450409659|FG000|Overall Study|Death|4|||
125213509|NCT00582426|450409660|FG001|Overall Study|Death|3|||
125213510|NCT00582426|450409659|FG000|Overall Study|Withdrawal by Subject|3|||
125213511|NCT00582426|450409660|FG001|Overall Study|Withdrawal by Subject|2|||
125213512|NCT00582426|450409659|FG000|Overall Study|Disease Progression|2|||
125213513|NCT00582426|450409660|FG001|Overall Study|Disease Progression|2|||
125213514|NCT00582426|450409659|FG000|Overall Study|Use of illicit drugs|1|||
125213515|NCT00582426|450409660|FG001|Overall Study|Use of illicit drugs|0|||
125213516|NCT00662311|450409661|FG000|Overall Study|Respiratory Infection|1|||
125213517|NCT00662311|450409662|FG001|Overall Study|Respiratory Infection|0|||
125213518|NCT00662311|450409663|FG002|Overall Study|Respiratory Infection|0|||
125213519|NCT01467271|450409666|FG000|Overall Study|Death|84|||
125213520|NCT01467271|450409666|FG000|Overall Study|Lost to Follow-up|83|||
125213521|NCT01467271|450409666|FG000|Overall Study|Retraction of patient's consent|21|||
125213522|NCT01467271|450409666|FG000|Overall Study|Other reason|14|||
125213523|NCT01548768|450409667|FG000|Overall Study|Withdrawal by Subject|0|||
125213524|NCT01548768|450409668|FG001|Overall Study|Withdrawal by Subject|2|||
125213525|NCT01548768|450409669|FG002|Overall Study|Withdrawal by Subject|1|||
125213526|NCT01548768|450409670|FG003|Overall Study|Withdrawal by Subject|0|||
125213527|NCT01548768|450409667|FG000|Overall Study|Physician Decision|1|||
125213528|NCT01548768|450409668|FG001|Overall Study|Physician Decision|0|||
125213529|NCT01548768|450409669|FG002|Overall Study|Physician Decision|0|||
125213530|NCT01548768|450409670|FG003|Overall Study|Physician Decision|0|||
125213531|NCT01548768|450409667|FG000|Overall Study|Adverse Event|0|||
125213532|NCT01548768|450409668|FG001|Overall Study|Adverse Event|0|||
125609392|NCT02203838|451852330|FG003|Overall Study|Physician Decision|3|||
125609393|NCT02203838|451852327|FG000|Overall Study|Other|1|||
125609394|NCT02203838|451852328|FG001|Overall Study|Other|0|||
125609395|NCT02203838|451852329|FG002|Overall Study|Other|0|||
125609396|NCT02203838|451852330|FG003|Overall Study|Other|0|||
125609397|NCT03196297|451852331|FG000|Main Period|Withdrawal by Subject|4|||
125609398|NCT03196297|451852331|FG000|Extension Period|Withdrawal by Subject|1|||
125609399|NCT03196297|451852331|FG000|Extension Period|Lack of Efficacy|2|||
125609400|NCT00829166|451852332|FG000|Overall Study|Death|305|||
125609401|NCT00829166|451852333|FG001|Overall Study|Death|333|||
125609402|NCT00829166|451852332|FG000|Overall Study|Lost to Follow-up|5|||
125213533|NCT01548768|450409669|FG002|Overall Study|Adverse Event|0|||
125213534|NCT01548768|450409670|FG003|Overall Study|Adverse Event|1|||
125213535|NCT01548768|450409667|FG000|Overall Study|Non-Compliance|0|||
125213536|NCT01548768|450409668|FG001|Overall Study|Non-Compliance|0|||
125213537|NCT01548768|450409669|FG002|Overall Study|Non-Compliance|0|||
125213538|NCT01548768|450409670|FG003|Overall Study|Non-Compliance|3|||
125213539|NCT04126317|450409687|FG000|Overall Study|Adverse Event|0|||
125213540|NCT04126317|450409688|FG001|Overall Study|Adverse Event|1|||
125213541|NCT04126317|450409687|FG000|Overall Study|Withdrawal by Subject|4|||
125213542|NCT04126317|450409688|FG001|Overall Study|Withdrawal by Subject|1|||
125213543|NCT01796301|450409689|FG000|Overall Study|Withdrawal by Subject|15|||
125213544|NCT01796301|450409690|FG001|Overall Study|Withdrawal by Subject|15|||
125213545|NCT01796301|450409689|FG000|Overall Study|Lost to Follow-up|3|||
125213546|NCT01796301|450409690|FG001|Overall Study|Lost to Follow-up|3|||
125213547|NCT01796301|450409689|FG000|Overall Study|Death|0|||
125213548|NCT01796301|450409690|FG001|Overall Study|Death|1|||
125213549|NCT01796301|450409689|FG000|Overall Study|Decision by Sponsor|0|||
125213550|NCT01796301|450409690|FG001|Overall Study|Decision by Sponsor|1|||
125213551|NCT00667563|450409691|FG000|Overall Study|Protocol Violation|24|||
125213552|NCT00264290|450409692|FG000|Intervention (8 Weeks)|Adverse Event|1|||
125213553|NCT00264290|450409693|FG001|Intervention (8 Weeks)|Adverse Event|0|||
125213554|NCT01939223|450409694|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
125213555|NCT01939223|450409695|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
125213556|NCT01939223|450409694|FG000|Overall Study|Disease recurrence (radiological)|1|||
125213557|NCT01939223|450409695|FG001|Overall Study|Disease recurrence (radiological)|3|||
125213558|NCT01939223|450409694|FG000|Overall Study|Study stopped by Sponsor|5|||
125213559|NCT01939223|450409695|FG001|Overall Study|Study stopped by Sponsor|7|||
125213560|NCT01939223|450409694|FG000|Overall Study|Withdrawal by Subject|6|||
125213561|NCT01939223|450409695|FG001|Overall Study|Withdrawal by Subject|0|||
125213562|NCT01557517|450409696|FG000|Overall Study|Death|1|||
125213563|NCT01557517|450409697|FG001|Overall Study|Death|0|||
125213564|NCT01557517|450409696|FG000|Overall Study|Refused further treatment|0|||
125213565|NCT01557517|450409697|FG001|Overall Study|Refused further treatment|2|||
125213566|NCT01557517|450409696|FG000|Overall Study|Adverse Event|0|||
125213567|NCT01557517|450409697|FG001|Overall Study|Adverse Event|2|||
125213568|NCT01557517|450409696|FG000|Overall Study|Pt declined before treatment started|1|||
125213569|NCT01557517|450409697|FG001|Overall Study|Pt declined before treatment started|0|||
125213570|NCT00162097|450409698|FG000|Overall Study|Participant no longer met study criteria|0|||
125213571|NCT00162097|450409699|FG001|Overall Study|Participant no longer met study criteria|0|||
125213572|NCT00162097|450409700|FG002|Overall Study|Participant no longer met study criteria|0|||
125213573|NCT00162097|450409701|FG003|Overall Study|Participant no longer met study criteria|1|||
125213574|NCT03585712|450409704|FG000|Treatment Period 1|Protocol Violation|1|||
125213575|NCT03585712|450409705|FG001|Treatment Period 1|Protocol Violation|0|||
125213576|NCT03585712|450409706|FG002|Treatment Period 1|Protocol Violation|0|||
125213577|NCT03585712|450409704|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
125213578|NCT03585712|450409705|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
125213579|NCT03585712|450409706|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
125213580|NCT03585712|450409704|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
125213581|NCT03585712|450409705|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
125213582|NCT03585712|450409706|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
125213583|NCT03585712|450409704|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
125213584|NCT03585712|450409705|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
125213585|NCT03585712|450409706|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
125213586|NCT01280682|450409713|FG000|Overall Study|Lost to Follow-up|0|||
125609403|NCT00829166|451852333|FG001|Overall Study|Lost to Follow-up|4|||
125609404|NCT00829166|451852332|FG000|Overall Study|Physician's Decision|4|||
125609405|NCT00829166|451852333|FG001|Overall Study|Physician's Decision|3|||
125213587|NCT01280682|450409714|FG001|Overall Study|Lost to Follow-up|6|||
125213588|NCT01280682|450409713|FG000|Overall Study|Withdrawal by Subject|0|||
125213589|NCT01280682|450409714|FG001|Overall Study|Withdrawal by Subject|7|||
125213590|NCT01964716|450409723|FG000|Overall Study|Withdrawal by Subject|2|||
125213591|NCT01964716|450409724|FG001|Overall Study|Withdrawal by Subject|3|||
125213592|NCT01964716|450409723|FG000|Overall Study|Lost to Follow-up|1|||
125213593|NCT01964716|450409724|FG001|Overall Study|Lost to Follow-up|2|||
125431793|NCT02055157|451207757|FG000|18-month Extension|Investigator decision|0|||
125431794|NCT02055157|451207758|FG001|18-month Extension|Investigator decision|1|||
125431795|NCT02055157|451207759|FG002|18-month Extension|Investigator decision|0|||
125431796|NCT02055157|451207760|FG003|18-month Extension|Investigator decision|0|||
125431797|NCT02055157|451207757|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
125431798|NCT02055157|451207758|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
125431799|NCT02055157|451207759|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
125431800|NCT02055157|451207760|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
125431801|NCT03976466|451207761|FG000|Overall Study|Lost to Follow-up|1|||
125370778|NCT00520936|450991218|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
125370779|NCT00520936|450991219|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
125609406|NCT00829166|451852332|FG000|Overall Study|Subject's Decision|41|||
125609407|NCT00829166|451852333|FG001|Overall Study|Subject's Decision|55|||
125609408|NCT00829166|451852332|FG000|Overall Study|Sponsor's Decision|137|||
125609409|NCT00829166|451852333|FG001|Overall Study|Sponsor's Decision|98|||
125609410|NCT00829166|451852332|FG000|Overall Study|Reason Not Specified|3|||
125609411|NCT00829166|451852333|FG001|Overall Study|Reason Not Specified|3|||
125609412|NCT04590937|451852334|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
125609413|NCT01635933|451852335|FG000|Overall Study|Adverse Event|1|||
125609414|NCT01635933|451852336|FG001|Overall Study|Adverse Event|0|||
125609415|NCT01635933|451852335|FG000|Overall Study|Lost to Follow-up|0|||
125609416|NCT01635933|451852336|FG001|Overall Study|Lost to Follow-up|5|||
125370780|NCT00520936|450991220|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
125370781|NCT00520936|450991221|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
125609417|NCT01635933|451852335|FG000|Overall Study|Subject decision|1|||
125609418|NCT01635933|451852336|FG001|Overall Study|Subject decision|1|||
125609419|NCT01635933|451852335|FG000|Overall Study|Noncompliance|0|||
125609420|NCT01635933|451852336|FG001|Overall Study|Noncompliance|1|||
125609421|NCT01635933|451852335|FG000|Overall Study|No longer had transportation|0|||
125609422|NCT01635933|451852336|FG001|Overall Study|No longer had transportation|1|||
125370782|NCT00520936|450991222|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
125370783|NCT00520936|450991223|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
125370784|NCT00520936|450991224|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
125370785|NCT00520936|450991225|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
125370786|NCT00520936|450991218|FG000|Overall Study|Death|0|||
125370787|NCT00520936|450991219|FG001|Overall Study|Death|0|||
125370788|NCT00520936|450991220|FG002|Overall Study|Death|0|||
125370789|NCT00520936|450991221|FG003|Overall Study|Death|0|||
125370790|NCT00520936|450991222|FG004|Overall Study|Death|0|||
125370791|NCT00520936|450991223|FG005|Overall Study|Death|0|||
125370792|NCT00520936|450991224|FG006|Overall Study|Death|1|||
125370793|NCT00520936|450991225|FG007|Overall Study|Death|0|||
125370794|NCT00520936|450991218|FG000|Overall Study|Protocol Violation|0|||
125370795|NCT00520936|450991219|FG001|Overall Study|Protocol Violation|1|||
125370796|NCT00520936|450991220|FG002|Overall Study|Protocol Violation|1|||
125370797|NCT00520936|450991221|FG003|Overall Study|Protocol Violation|0|||
125370798|NCT00520936|450991222|FG004|Overall Study|Protocol Violation|1|||
125370799|NCT00520936|450991223|FG005|Overall Study|Protocol Violation|0|||
125370800|NCT00520936|450991224|FG006|Overall Study|Protocol Violation|1|||
125370801|NCT00520936|450991225|FG007|Overall Study|Protocol Violation|0|||
125370802|NCT00964860|450991226|FG000|Overall Study|Withdrawal by Subject|0|||
125370803|NCT00964860|450991227|FG001|Overall Study|Withdrawal by Subject|1|||
125370804|NCT03716024|450991228|FG000|Overall Study|Randomized, not Treated|7|||
125370805|NCT03716024|450991229|FG001|Overall Study|Randomized, not Treated|8|||
125370806|NCT03716024|450991228|FG000|Overall Study|Adverse Event|1|||
125370807|NCT03716024|450991229|FG001|Overall Study|Adverse Event|2|||
125370808|NCT03716024|450991228|FG000|Overall Study|Treatment Failure|1|||
125370809|NCT03716024|450991229|FG001|Overall Study|Treatment Failure|0|||
125370810|NCT03716024|450991228|FG000|Overall Study|Lost to Follow-up|2|||
125370811|NCT03716024|450991229|FG001|Overall Study|Lost to Follow-up|6|||
125370812|NCT03716024|450991228|FG000|Overall Study|Withdrawal by Subject|0|||
125370813|NCT03716024|450991229|FG001|Overall Study|Withdrawal by Subject|1|||
125213594|NCT01964716|450409723|FG000|Overall Study|No longer met eligibility criteria|1|||
125370814|NCT03716024|450991228|FG000|Overall Study|Missing Reason|0|||
125370815|NCT03716024|450991229|FG001|Overall Study|Missing Reason|1|||
125213595|NCT01964716|450409724|FG001|Overall Study|No longer met eligibility criteria|1|||
125370816|NCT00867568|450991230|FG000|Overall Study|Lack of Efficacy|10|||
125370817|NCT00867568|450991230|FG000|Overall Study|Adverse Event|4|||
125370818|NCT00867568|450991230|FG000|Overall Study|Withdrawal by Subject|1|||
125370819|NCT04343261|450991231|FG000|Overall Study|Adverse Event|1|||
125213596|NCT01964716|450409723|FG000|Overall Study|Death|1|||
125370820|NCT04343261|450991231|FG000|Overall Study|received inadequate amount of antibodies|7|||
125370821|NCT05275400|450991239|FG000|Treatment Period|Adverse Event|7|||
125370822|NCT05275400|450991240|FG001|Treatment Period|Adverse Event|1|||
125370823|NCT05275400|450991239|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
125370824|NCT05275400|450991240|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
125370825|NCT05275400|450991239|FG000|Treatment Period|Death|5|||
125370826|NCT05275400|450991240|FG001|Treatment Period|Death|2|||
125370827|NCT05275400|450991239|FG000|Treatment Period|Protocol Violation|1|||
125370828|NCT05275400|450991240|FG001|Treatment Period|Protocol Violation|0|||
125370829|NCT05275400|450991239|FG000|Treatment Period|Physician Decision|5|||
125370830|NCT05275400|450991240|FG001|Treatment Period|Physician Decision|4|||
125370831|NCT05275400|450991239|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
125370832|NCT05275400|450991240|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
125370833|NCT05275400|450991239|FG000|Treatment Period|Withdrawal by Subject|30|||
125370834|NCT05275400|450991240|FG001|Treatment Period|Withdrawal by Subject|12|||
125370835|NCT05275400|450991239|FG000|Treatment Period|Lost to Follow-up|1|||
125370836|NCT05275400|450991240|FG001|Treatment Period|Lost to Follow-up|5|||
125370837|NCT05275400|450991239|FG000|Treatment Period|Lack of Efficacy|1|||
125370838|NCT05275400|450991240|FG001|Treatment Period|Lack of Efficacy|0|||
125370839|NCT05275400|450991239|FG000|Treatment Period|Sponsor Decision|1|||
125370840|NCT05275400|450991240|FG001|Treatment Period|Sponsor Decision|0|||
125370841|NCT05275400|450991239|FG000|Follow-Up Period|Death|2|||
125370842|NCT05275400|450991240|FG001|Follow-Up Period|Death|0|||
125370843|NCT05275400|450991239|FG000|Follow-Up Period|Protocol Violation|1|||
125370844|NCT05275400|450991240|FG001|Follow-Up Period|Protocol Violation|0|||
125370845|NCT05275400|450991239|FG000|Follow-Up Period|Withdrawal by Subject|3|||
125370846|NCT05275400|450991240|FG001|Follow-Up Period|Withdrawal by Subject|0|||
125370847|NCT02585960|450991241|FG000|PK/Safety Assessment Period|Physician Decision|0|||
125213597|NCT01964716|450409724|FG001|Overall Study|Death|0|||
125213598|NCT01464619|450409725|FG000|Overall Study|Lost to Follow-up|3|||
125213599|NCT01464619|450409726|FG001|Overall Study|Lost to Follow-up|4|||
125431802|NCT03976466|451207762|FG001|Overall Study|Lost to Follow-up|3|||
125370848|NCT02585960|450991242|FG001|PK/Safety Assessment Period|Physician Decision|1|||
125370849|NCT02585960|450991243|FG002|PK/Safety Assessment Period|Physician Decision|0|||
125213600|NCT02179749|450409732|FG000|Overall Study|Adverse Event|0|||
125213601|NCT02179749|450409733|FG001|Overall Study|Adverse Event|0|||
125213602|NCT02179749|450409734|FG002|Overall Study|Adverse Event|1|||
125213603|NCT02179749|450409732|FG000|Overall Study|Withdrawal by Subject|0|||
125213604|NCT02179749|450409733|FG001|Overall Study|Withdrawal by Subject|0|||
125213605|NCT02179749|450409734|FG002|Overall Study|Withdrawal by Subject|1|||
125213606|NCT02756364|450409735|FG000|Overall Study|Site Terminated by Sponsor|24|||
125213607|NCT02756364|450409736|FG001|Overall Study|Site Terminated by Sponsor|30|||
125213608|NCT02756364|450409737|FG002|Overall Study|Site Terminated by Sponsor|21|||
125213609|NCT02756364|450409735|FG000|Overall Study|Death|20|||
125213610|NCT02756364|450409736|FG001|Overall Study|Death|15|||
125213611|NCT02756364|450409737|FG002|Overall Study|Death|18|||
125213612|NCT02756364|450409735|FG000|Overall Study|Withdrawal by Patient|2|||
125213613|NCT02756364|450409736|FG001|Overall Study|Withdrawal by Patient|1|||
125213614|NCT02756364|450409737|FG002|Overall Study|Withdrawal by Patient|8|||
125213615|NCT02756364|450409735|FG000|Overall Study|Lost to Follow-up|0|||
125213616|NCT02756364|450409736|FG001|Overall Study|Lost to Follow-up|1|||
125213617|NCT02756364|450409737|FG002|Overall Study|Lost to Follow-up|1|||
125213618|NCT02655016|450409738|FG000|Overall Study|Disease progression|6|||
125213619|NCT02655016|450409739|FG001|Overall Study|Disease progression|4|||
125213620|NCT02655016|450409738|FG000|Overall Study|Site closed|0|||
125213621|NCT02655016|450409739|FG001|Overall Study|Site closed|1|||
125213622|NCT02655016|450409738|FG000|Overall Study|Death|30|||
125213623|NCT02655016|450409739|FG001|Overall Study|Death|48|||
125213624|NCT02655016|450409738|FG000|Overall Study|Lost to Follow-up|1|||
125213625|NCT02655016|450409739|FG001|Overall Study|Lost to Follow-up|1|||
125431803|NCT00733499|451207763|FG000|Pre-operative|Protocol Violation|0|||
125370850|NCT02585960|450991241|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
125213626|NCT02655016|450409738|FG000|Overall Study|Withdrawal by Subject|18|||
125213627|NCT02655016|450409739|FG001|Overall Study|Withdrawal by Subject|36|||
125370851|NCT02585960|450991242|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
125431804|NCT00733499|451207764|FG001|Pre-operative|Protocol Violation|1|||
125213628|NCT02223364|450409740|FG000|Overall Study|Protocol Violation|3|||
125213629|NCT02223364|450409741|FG001|Overall Study|Protocol Violation|0|||
125213630|NCT02223364|450409742|FG002|Overall Study|Protocol Violation|3|||
125213631|NCT02223364|450409740|FG000|Overall Study|subject expired before surgery|1|||
125213632|NCT02223364|450409741|FG001|Overall Study|subject expired before surgery|0|||
125213633|NCT02223364|450409742|FG002|Overall Study|subject expired before surgery|0|||
125213634|NCT02223364|450409740|FG000|Overall Study|Physician Decision|1|||
125213635|NCT02223364|450409741|FG001|Overall Study|Physician Decision|0|||
125370852|NCT02585960|450991243|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
125370853|NCT02585960|450991241|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
125370854|NCT02585960|450991242|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
125370855|NCT02585960|450991243|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
125370856|NCT02585960|450991241|FG000|PK/Safety Assessment Period|Other|4|||
125370857|NCT02585960|450991242|FG001|PK/Safety Assessment Period|Other|4|||
125370858|NCT02585960|450991243|FG002|PK/Safety Assessment Period|Other|0|||
125370859|NCT02585960|450991241|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
125370860|NCT02585960|450991242|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
125370861|NCT02585960|450991243|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
125370862|NCT02585960|450991241|FG000|PK/Safety Assessment Period|Screen Failure|0|||
125370863|NCT02585960|450991242|FG001|PK/Safety Assessment Period|Screen Failure|0|||
125370864|NCT02585960|450991243|FG002|PK/Safety Assessment Period|Screen Failure|1|||
125370865|NCT02585960|450991241|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
125370866|NCT02585960|450991242|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
125370867|NCT02585960|450991243|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
125370868|NCT02585960|450991241|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
125370869|NCT02585960|450991242|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
125370870|NCT02585960|450991243|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
125370871|NCT03639935|450991244|FG000|Overall Study|Death|3|||
125370872|NCT03639935|450991244|FG000|Overall Study|Adverse Event|1|||
125370873|NCT06333613|450991245|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
125370874|NCT03648541|450991250|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
125370875|NCT03648541|450991251|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
125370876|NCT03648541|450991250|FG000|Re-induction Period Only|Lack of Efficacy|7|||
125370877|NCT03648541|450991251|FG001|Re-induction Period Only|Lack of Efficacy|0|||
125370878|NCT03648541|450991250|FG000|Maintenance Period Only|Missing|0|||
125370879|NCT03648541|450991251|FG001|Maintenance Period Only|Missing|1|||
125370880|NCT03648541|450991250|FG000|Maintenance Period Only|Other not listed below|0|||
125370881|NCT03648541|450991251|FG001|Maintenance Period Only|Other not listed below|4|||
125370882|NCT03648541|450991250|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
125370883|NCT03648541|450991251|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
125370884|NCT03648541|450991250|FG000|Maintenance Period Only|Protocol Violation|0|||
125370885|NCT03648541|450991251|FG001|Maintenance Period Only|Protocol Violation|1|||
125370886|NCT03648541|450991250|FG000|Maintenance Period Only|Lack of Efficacy|0|||
125370887|NCT03648541|450991251|FG001|Maintenance Period Only|Lack of Efficacy|18|||
125370888|NCT03648541|450991250|FG000|Maintenance Period Only|Adverse Event|0|||
125431805|NCT00733499|451207763|FG000|3 Months Follow-up|Death|1|||
125370889|NCT03648541|450991251|FG001|Maintenance Period Only|Adverse Event|4|||
125370890|NCT03648541|450991250|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
125609423|NCT04333433|451852343|FG000|Overall Study|Withdrawal by Subject|6|||
125609424|NCT04333433|451852344|FG001|Overall Study|Withdrawal by Subject|3|||
125609425|NCT04333433|451852343|FG000|Overall Study|Death|3|||
125609426|NCT04333433|451852344|FG001|Overall Study|Death|0|||
125609427|NCT04333433|451852343|FG000|Overall Study|Lost to Follow-up|6|||
125609428|NCT04333433|451852344|FG001|Overall Study|Lost to Follow-up|1|||
125609429|NCT04333433|451852343|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
125609430|NCT04333433|451852344|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
125609431|NCT00320385|451852345|FG000|Overall Study|Lost to Follow-up|7|||
125609432|NCT00320385|451852346|FG001|Overall Study|Lost to Follow-up|10|||
125609433|NCT00320385|451852345|FG000|Overall Study|Withdrawal by Subject|6|||
125609434|NCT00320385|451852346|FG001|Overall Study|Withdrawal by Subject|7|||
125609435|NCT00320385|451852345|FG000|Overall Study|Sponsor Terminated Study|2|||
125609436|NCT00320385|451852346|FG001|Overall Study|Sponsor Terminated Study|1|||
125609437|NCT00320385|451852345|FG000|Overall Study|Investigator Decision|0|||
125609438|NCT00320385|451852346|FG001|Overall Study|Investigator Decision|1|||
125609439|NCT00320385|451852345|FG000|Overall Study|Death|1|||
125370891|NCT03648541|450991251|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
125370892|NCT04623216|450991252|FG000|Overall Study|Death|5|||
125370893|NCT04623216|450991253|FG001|Overall Study|Death|2|||
125370894|NCT04623216|450991254|FG002|Overall Study|Death|0|||
125370895|NCT04623216|450991255|FG003|Overall Study|Death|0|||
125370896|NCT04623216|450991252|FG000|Overall Study|Terminated by Sponsor|3|||
125370897|NCT04623216|450991253|FG001|Overall Study|Terminated by Sponsor|2|||
125370898|NCT04623216|450991254|FG002|Overall Study|Terminated by Sponsor|2|||
125370899|NCT04623216|450991255|FG003|Overall Study|Terminated by Sponsor|0|||
125370900|NCT04623216|450991252|FG000|Overall Study|Physician Decision|1|||
125370901|NCT04623216|450991253|FG001|Overall Study|Physician Decision|0|||
125370902|NCT04623216|450991254|FG002|Overall Study|Physician Decision|0|||
125370903|NCT04623216|450991255|FG003|Overall Study|Physician Decision|0|||
125370904|NCT01651039|450991256|FG000|Overall Study|Non-evaluables|5|||
125370905|NCT01651039|450991256|FG000|Overall Study|Physician Decision|2|||
125370906|NCT01651039|450991256|FG000|Overall Study|Withdrawal by Subject|1|||
125370907|NCT01651039|450991256|FG000|Overall Study|Progressive Disease|22|||
125370908|NCT04930965|450991259|FG000|Overall Study|Lost to Follow-up|7|||
125370909|NCT04930965|450991260|FG001|Overall Study|Lost to Follow-up|5|||
125370910|NCT02059395|450991261|FG000|Overall Study|Lost to Follow-up|2|||
125370911|NCT02059395|450991262|FG001|Overall Study|Lost to Follow-up|4|||
125370912|NCT00134082|450991263|FG000|Overall Study|Adverse Event|2|||
125370913|NCT00134082|450991263|FG000|Overall Study|Death|1|||
125370914|NCT00044083|450991264|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
125370915|NCT00044083|450991265|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
125370916|NCT00044083|450991264|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
125370917|NCT00044083|450991265|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
125370918|NCT00044083|450991264|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
125370919|NCT00044083|450991265|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
125431806|NCT00733499|451207764|FG001|3 Months Follow-up|Death|2|||
125370920|NCT00044083|450991264|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
125370921|NCT00044083|450991265|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
125370922|NCT00044083|450991264|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
125370923|NCT00044083|450991265|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
125370924|NCT00044083|450991264|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
125370925|NCT00044083|450991265|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
125370926|NCT00044083|450991264|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
125370927|NCT00044083|450991265|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
125370928|NCT00044083|450991264|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
125370929|NCT00044083|450991265|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
125370930|NCT00044083|450991264|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
125370931|NCT00044083|450991265|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
125370932|NCT00044083|450991264|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
125370933|NCT00044083|450991265|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
125370934|NCT02197247|450991266|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
125370935|NCT02197247|450991266|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
125370936|NCT02197247|450991266|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
125370937|NCT02197247|450991266|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
125370938|NCT02197247|450991266|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
125370939|NCT02197247|450991266|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
125370940|NCT02197247|450991266|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
125370941|NCT02197247|450991266|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
125370942|NCT01619423|450991267|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
125370943|NCT01619423|450991268|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
125370944|NCT01619423|450991269|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
125370945|NCT01619423|450991270|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
125370946|NCT02340975|450991280|FG000|Overall Study|Death|6|||
125370947|NCT02340975|450991281|FG001|Overall Study|Death|23|||
125370948|NCT02340975|450991282|FG002|Overall Study|Death|21|||
125370949|NCT02340975|450991283|FG003|Overall Study|Death|7|||
125370950|NCT02340975|450991284|FG004|Overall Study|Death|21|||
125370951|NCT02340975|450991285|FG005|Overall Study|Death|13|||
125370952|NCT02340975|450991280|FG000|Overall Study|Lost to Follow-up|0|||
125370953|NCT02340975|450991281|FG001|Overall Study|Lost to Follow-up|0|||
125370954|NCT02340975|450991282|FG002|Overall Study|Lost to Follow-up|0|||
125609440|NCT00320385|451852346|FG001|Overall Study|Death|2|||
125609441|NCT00320385|451852345|FG000|Overall Study|Serious Adverse Event|1|||
125609442|NCT00320385|451852346|FG001|Overall Study|Serious Adverse Event|0|||
125609443|NCT00320385|451852345|FG000|Overall Study|Withdrew Consent|1|||
125609444|NCT00320385|451852346|FG001|Overall Study|Withdrew Consent|0|||
125609445|NCT00320385|451852345|FG000|Overall Study|Adverse Event|0|||
125609446|NCT00320385|451852346|FG001|Overall Study|Adverse Event|1|||
125609447|NCT04743635|451852347|FG000|Overall Study|Lost to Follow-up|2|||
125609448|NCT04743635|451852348|FG001|Overall Study|Lost to Follow-up|0|||
125609449|NCT03382899|451852354|FG000|Overall Study|Ineligibility Determined|0|||
125370955|NCT02340975|450991283|FG003|Overall Study|Lost to Follow-up|0|||
125370956|NCT02340975|450991284|FG004|Overall Study|Lost to Follow-up|2|||
125370957|NCT02340975|450991285|FG005|Overall Study|Lost to Follow-up|0|||
125609450|NCT03382899|451852355|FG001|Overall Study|Ineligibility Determined|1|||
125609451|NCT03382899|451852354|FG000|Overall Study|Lost to Follow-up|0|||
125609452|NCT03382899|451852355|FG001|Overall Study|Lost to Follow-up|1|||
125609453|NCT03382899|451852354|FG000|Overall Study|Sponsor's decision|31|||
125213636|NCT02223364|450409742|FG002|Overall Study|Physician Decision|0|||
125370958|NCT02340975|450991280|FG000|Overall Study|Withdrawal by Subject|0|||
125370959|NCT02340975|450991281|FG001|Overall Study|Withdrawal by Subject|0|||
125370960|NCT02340975|450991282|FG002|Overall Study|Withdrawal by Subject|3|||
125370961|NCT02340975|450991283|FG003|Overall Study|Withdrawal by Subject|3|||
125370962|NCT02340975|450991284|FG004|Overall Study|Withdrawal by Subject|2|||
125370963|NCT02340975|450991285|FG005|Overall Study|Withdrawal by Subject|0|||
125370964|NCT02340975|450991280|FG000|Overall Study|Other|0|||
125370965|NCT02340975|450991281|FG001|Overall Study|Other|4|||
125370966|NCT02340975|450991282|FG002|Overall Study|Other|0|||
125370967|NCT02340975|450991283|FG003|Overall Study|Other|2|||
125370968|NCT02340975|450991284|FG004|Overall Study|Other|0|||
125370969|NCT02340975|450991285|FG005|Overall Study|Other|6|||
125370970|NCT02099708|450991292|FG000|Overall Study|Data Not Available|30|||
125370971|NCT02099708|450991292|FG000|Overall Study|Lost to Follow-up|141|||
125370972|NCT02099708|450991292|FG000|Overall Study|Other|29|||
125370973|NCT05466682|450991296|FG000|Overall Study|Withdrawal by Subject|0|||
125370974|NCT05466682|450991297|FG001|Overall Study|Withdrawal by Subject|2|||
125370975|NCT05466682|450991296|FG000|Overall Study|Lost to Follow-up|2|||
125370976|NCT05466682|450991297|FG001|Overall Study|Lost to Follow-up|1|||
125370977|NCT01930123|450991298|FG000|Overall Study|Adverse Event|1|||
125370978|NCT01930123|450991299|FG001|Overall Study|Adverse Event|0|||
125370979|NCT01930123|450991298|FG000|Overall Study|Physician Decision|21|||
125370980|NCT01930123|450991299|FG001|Overall Study|Physician Decision|8|||
125370981|NCT01930123|450991298|FG000|Overall Study|Withdrawal by Subject|1|||
125370982|NCT01930123|450991299|FG001|Overall Study|Withdrawal by Subject|0|||
125370983|NCT01447433|450991302|FG000|Overall Study|Lost to Follow-up|0|||
125370984|NCT01447433|450991303|FG001|Overall Study|Lost to Follow-up|2|||
125370985|NCT01447433|450991302|FG000|Overall Study|Withdrawal by Subject|3|||
125370986|NCT01447433|450991303|FG001|Overall Study|Withdrawal by Subject|3|||
125370987|NCT01447433|450991302|FG000|Overall Study|Protocol Violation|1|||
125370988|NCT01447433|450991303|FG001|Overall Study|Protocol Violation|1|||
125370989|NCT00036270|450991304|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
125370990|NCT00036270|450991305|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
125370991|NCT00036270|450991304|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
125370992|NCT00036270|450991305|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
125370993|NCT00036270|450991304|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
125370994|NCT00036270|450991305|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
125370995|NCT00036270|450991304|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
125370996|NCT00036270|450991305|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
125370997|NCT00036270|450991304|FG000|Study Treatment to 5 Year Report|Other|277|||
125370998|NCT00036270|450991305|FG001|Study Treatment to 5 Year Report|Other|288|||
125370999|NCT00036270|450991304|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
125609454|NCT03382899|451852355|FG001|Overall Study|Sponsor's decision|28|||
125609455|NCT03382899|451852354|FG000|Overall Study|Withdrawal by Subject|0|||
125609456|NCT03382899|451852355|FG001|Overall Study|Withdrawal by Subject|5|||
125609457|NCT01355068|451852356|FG000|First Intervention Period|Adverse Event|0|||
125609458|NCT01355068|451852357|FG001|First Intervention Period|Adverse Event|1|||
125609459|NCT01355068|451852356|FG000|First Intervention Period|Withdrawal by Subject|0|||
125609460|NCT01355068|451852357|FG001|First Intervention Period|Withdrawal by Subject|1|||
125609461|NCT00524745|451852358|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
125609462|NCT00524745|451852359|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
125609463|NCT00524745|451852360|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
125609464|NCT00524745|451852361|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
125371000|NCT00036270|450991305|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
125371001|NCT00036270|450991304|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
125371002|NCT00036270|450991305|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
125371003|NCT00036270|450991304|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
125371004|NCT00036270|450991305|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
125371005|NCT00036270|450991304|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
125371006|NCT00036270|450991305|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
125371007|NCT00036270|450991304|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
125371008|NCT00036270|450991305|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
125431807|NCT00733499|451207763|FG000|6 Months Follow-up|Death|0|||
125371009|NCT00036270|450991304|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
125371010|NCT00036270|450991305|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
125371011|NCT01578187|450991306|FG000|Usability Phase|Withdrawal by Subject|1|||
125431808|NCT00733499|451207764|FG001|6 Months Follow-up|Death|2|||
125431809|NCT00733499|451207763|FG000|6 Months Follow-up|Adverse Event|0|||
125431810|NCT00733499|451207764|FG001|6 Months Follow-up|Adverse Event|1|||
125431811|NCT00733499|451207763|FG000|12 Months Follow-up|Death|2|||
125431812|NCT00733499|451207764|FG001|12 Months Follow-up|Death|1|||
125431813|NCT00733499|451207763|FG000|24 Months Follow-up|Death|0|||
125431814|NCT00733499|451207764|FG001|24 Months Follow-up|Death|1|||
125431815|NCT00733499|451207763|FG000|5 Year Followup|Adverse Event|2|||
125431816|NCT00733499|451207764|FG001|5 Year Followup|Adverse Event|2|||
125431817|NCT00733499|451207763|FG000|5 Year Followup|Non device related AE|0|||
125431818|NCT00733499|451207764|FG001|5 Year Followup|Non device related AE|1|||
125431819|NCT00733499|451207763|FG000|5 Year Followup|Revision of Study Implant|0|||
125431820|NCT00733499|451207764|FG001|5 Year Followup|Revision of Study Implant|1|||
125431821|NCT00733499|451207763|FG000|5 Year Followup|Lost to Follow-up|2|||
125431822|NCT00733499|451207764|FG001|5 Year Followup|Lost to Follow-up|0|||
125431823|NCT00733499|451207763|FG000|5 Year Followup|Death|13|||
125431824|NCT00733499|451207764|FG001|5 Year Followup|Death|19|||
125431825|NCT00733499|451207763|FG000|5 Year Followup|missing, unable to locate|0|||
125431826|NCT00733499|451207764|FG001|5 Year Followup|missing, unable to locate|1|||
125431827|NCT00733499|451207763|FG000|5 Year Followup|Withdrawal by Subject|4|||
125431828|NCT00733499|451207764|FG001|5 Year Followup|Withdrawal by Subject|1|||
125431829|NCT00733499|451207763|FG000|10 Year Followup|Death|9|||
125431830|NCT00733499|451207764|FG001|10 Year Followup|Death|7|||
125431831|NCT00733499|451207763|FG000|10 Year Followup|Adverse Event|3|||
125431832|NCT00733499|451207764|FG001|10 Year Followup|Adverse Event|3|||
125431833|NCT00733499|451207763|FG000|10 Year Followup|Lost to Follow-up|3|||
125431834|NCT00733499|451207764|FG001|10 Year Followup|Lost to Follow-up|2|||
125431835|NCT00733499|451207763|FG000|10 Year Followup|Withdrawal by Subject|5|||
125431836|NCT00733499|451207764|FG001|10 Year Followup|Withdrawal by Subject|5|||
125431837|NCT00733499|451207763|FG000|10 Year Followup|missing, unable to locate|0|||
125431838|NCT00733499|451207764|FG001|10 Year Followup|missing, unable to locate|2|||
125431839|NCT01552954|451207765|FG000|Overall Study|Adverse Event|1|||
125431840|NCT01552954|451207766|FG001|Overall Study|Adverse Event|2|||
125431841|NCT01552954|451207765|FG000|Overall Study|Lost to Follow-up|1|||
125431842|NCT01552954|451207766|FG001|Overall Study|Lost to Follow-up|1|||
125431843|NCT01552954|451207765|FG000|Overall Study|Withdrawal by Subject|1|||
125431844|NCT01552954|451207766|FG001|Overall Study|Withdrawal by Subject|1|||
125431845|NCT01552954|451207765|FG000|Overall Study|Protocol Violation|1|||
125431846|NCT01552954|451207766|FG001|Overall Study|Protocol Violation|2|||
125431847|NCT01552954|451207765|FG000|Overall Study|diagnosed DM|1|||
125431848|NCT01552954|451207766|FG001|Overall Study|diagnosed DM|0|||
125431849|NCT03929562|451207767|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
125431850|NCT03929562|451207768|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
125431851|NCT03929562|451207767|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
125431852|NCT03929562|451207768|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
125431853|NCT03929562|451207767|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
125431854|NCT03929562|451207768|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
125431855|NCT04843930|451207769|FG000|Randomization|Withdrawal by Subject|6|||
125431856|NCT04843930|451207770|FG001|Randomization|Withdrawal by Subject|6|||
125431857|NCT04843930|451207771|FG002|Randomization|Withdrawal by Subject|0|||
125431858|NCT04843930|451207772|FG003|Randomization|Withdrawal by Subject|0|||
125431859|NCT04843930|451207769|FG000|Week 6 Assessment|Adverse Event|3|||
125431860|NCT04843930|451207770|FG001|Week 6 Assessment|Adverse Event|0|||
125371012|NCT01964430|450991307|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
125371013|NCT01964430|450991308|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
125371014|NCT01964430|450991307|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
125371015|NCT01964430|450991308|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
125431861|NCT04843930|451207771|FG002|Week 6 Assessment|Adverse Event|0|||
125431862|NCT04843930|451207772|FG003|Week 6 Assessment|Adverse Event|0|||
125371016|NCT01964430|450991307|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
125431863|NCT04843930|451207769|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
125431864|NCT04843930|451207770|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
125431865|NCT04843930|451207771|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
125431866|NCT04843930|451207772|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
125431867|NCT04843930|451207769|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
125431868|NCT04843930|451207770|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
125609465|NCT00540449|451852362|FG000|Overall Study|Adverse Event|12|||
125371017|NCT01964430|450991308|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
125371018|NCT01964430|450991307|FG000|Treatment Period|Adverse Event|71|||
125371019|NCT01964430|450991308|FG001|Treatment Period|Adverse Event|37|||
125371020|NCT01964430|450991307|FG000|Treatment Period|Withdrawal by Subject|36|||
125371021|NCT01964430|450991308|FG001|Treatment Period|Withdrawal by Subject|27|||
125371022|NCT01964430|450991307|FG000|Treatment Period|Death|1|||
125371023|NCT01964430|450991308|FG001|Treatment Period|Death|3|||
125371024|NCT01964430|450991307|FG000|Treatment Period|Protocol Deviation|0|||
125371025|NCT01964430|450991308|FG001|Treatment Period|Protocol Deviation|1|||
125371026|NCT01964430|450991307|FG000|Treatment Period|Physician Decision|5|||
125371027|NCT01964430|450991308|FG001|Treatment Period|Physician Decision|4|||
125371028|NCT01964430|450991307|FG000|Treatment Period|Disease Relapse|28|||
125371029|NCT01964430|450991308|FG001|Treatment Period|Disease Relapse|38|||
125371030|NCT01964430|450991307|FG000|Treatment Period|Other reasons|1|||
125371031|NCT01964430|450991308|FG001|Treatment Period|Other reasons|3|||
125371032|NCT02516163|450991309|FG000|Overall Study|Withdrawal by Subject|1|||
125371033|NCT02516163|450991309|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
125371034|NCT02516163|450991309|FG000|Overall Study|Unfit/delay in surgery|3|||
125371035|NCT02516163|450991309|FG000|Overall Study|Use of incorrect measurement technique|5|||
125371036|NCT02516163|450991309|FG000|Overall Study|Data not recorded|2|||
125371037|NCT02516163|450991309|FG000|Overall Study|MRI contraindication exclusion|6|||
125371038|NCT02801396|450991310|FG000|Period 1|Withdrawal by Subject|0|||
125371039|NCT02801396|450991311|FG001|Period 1|Withdrawal by Subject|0|||
125371040|NCT02801396|450991312|FG002|Period 1|Withdrawal by Subject|0|||
125371041|NCT02801396|450991313|FG003|Period 1|Withdrawal by Subject|0|||
125371042|NCT02801396|450991314|FG004|Period 1|Withdrawal by Subject|1|||
125371043|NCT02801396|450991315|FG005|Period 1|Withdrawal by Subject|0|||
125371044|NCT01658072|450991318|FG000|Overall Study|Protocol Violation|4|||
125371045|NCT01658072|450991319|FG001|Overall Study|Protocol Violation|2|||
125371046|NCT03208244|450991320|FG000|Overall Study|Death|1|||
125371047|NCT02405780|450991326|FG000|Period I|Adverse Event|8|||
125371048|NCT02405780|450991327|FG001|Period I|Adverse Event|0|||
125371049|NCT02405780|450991328|FG002|Period I|Adverse Event|3|||
125371050|NCT02405780|450991329|FG003|Period I|Adverse Event|7|||
125371051|NCT02405780|450991326|FG000|Period I|Medical reasons|1|||
125371052|NCT02405780|450991327|FG001|Period I|Medical reasons|1|||
125371053|NCT02405780|450991328|FG002|Period I|Medical reasons|0|||
125371054|NCT02405780|450991329|FG003|Period I|Medical reasons|1|||
125371055|NCT02405780|450991326|FG000|Period I|Screening Failure|1|||
125371056|NCT02405780|450991327|FG001|Period I|Screening Failure|0|||
125371057|NCT02405780|450991328|FG002|Period I|Screening Failure|1|||
125371058|NCT02405780|450991329|FG003|Period I|Screening Failure|0|||
125371059|NCT02405780|450991326|FG000|Period I|Withdrawal by Subject|9|||
125371060|NCT02405780|450991327|FG001|Period I|Withdrawal by Subject|1|||
125371061|NCT02405780|450991328|FG002|Period I|Withdrawal by Subject|3|||
125371062|NCT02405780|450991329|FG003|Period I|Withdrawal by Subject|4|||
125371063|NCT02405780|450991326|FG000|Period I|Non-compliance with study procedures|8|||
125609466|NCT00540449|451852363|FG001|Overall Study|Adverse Event|32|||
125609467|NCT00540449|451852362|FG000|Overall Study|Sponsor's Decision|1|||
125609468|NCT00540449|451852363|FG001|Overall Study|Sponsor's Decision|1|||
125609469|NCT00540449|451852362|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
125609470|NCT00540449|451852363|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
125371064|NCT02405780|450991327|FG001|Period I|Non-compliance with study procedures|6|||
125371065|NCT02405780|450991328|FG002|Period I|Non-compliance with study procedures|8|||
125371066|NCT02405780|450991329|FG003|Period I|Non-compliance with study procedures|11|||
125371067|NCT02405780|450991326|FG000|Period II|Adverse Event|3|||
125371068|NCT02405780|450991327|FG001|Period II|Adverse Event|5|||
125371069|NCT02405780|450991328|FG002|Period II|Adverse Event|4|||
125371070|NCT02405780|450991329|FG003|Period II|Adverse Event|11|||
125371071|NCT02405780|450991326|FG000|Period II|Medical reason|0|||
125371072|NCT02405780|450991327|FG001|Period II|Medical reason|1|||
125371073|NCT02405780|450991328|FG002|Period II|Medical reason|0|||
125371074|NCT02405780|450991329|FG003|Period II|Medical reason|0|||
125371075|NCT02405780|450991326|FG000|Period II|Pregnancy|0|||
125371076|NCT02405780|450991327|FG001|Period II|Pregnancy|0|||
125371077|NCT02405780|450991328|FG002|Period II|Pregnancy|1|||
125371078|NCT02405780|450991329|FG003|Period II|Pregnancy|0|||
125371079|NCT02405780|450991326|FG000|Period II|Withdrawal by Subject|7|||
125371080|NCT02405780|450991327|FG001|Period II|Withdrawal by Subject|4|||
125371081|NCT02405780|450991328|FG002|Period II|Withdrawal by Subject|0|||
125371082|NCT02405780|450991329|FG003|Period II|Withdrawal by Subject|3|||
125371083|NCT02405780|450991326|FG000|Period II|Non-compliance with study procedures|5|||
125371084|NCT02405780|450991327|FG001|Period II|Non-compliance with study procedures|2|||
125371085|NCT02405780|450991328|FG002|Period II|Non-compliance with study procedures|7|||
125371086|NCT02405780|450991329|FG003|Period II|Non-compliance with study procedures|4|||
125371087|NCT01654536|450991330|FG000|Overall Study|Lost to Follow-up|5|||
125371088|NCT01654536|450991331|FG001|Overall Study|Lost to Follow-up|5|||
125371089|NCT01654536|450991330|FG000|Overall Study|Physician Decision|12|||
125371090|NCT01654536|450991331|FG001|Overall Study|Physician Decision|8|||
125609471|NCT00540449|451852362|FG000|Overall Study|Lost to Follow-up|19|||
125371091|NCT01654536|450991330|FG000|Overall Study|Withdrawal by Subject|27|||
125371092|NCT01654536|450991331|FG001|Overall Study|Withdrawal by Subject|25|||
125371093|NCT00074152|450991337|FG000|Overall Study|Death|21|||
125371094|NCT00074152|450991338|FG001|Overall Study|Death|9|||
125371095|NCT00074152|450991337|FG000|Overall Study|Lack of Efficacy|34|||
125371096|NCT00074152|450991338|FG001|Overall Study|Lack of Efficacy|24|||
125371097|NCT01235351|450993096|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
125371098|NCT01235351|450993097|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
125371099|NCT03003390|450993101|FG000|Overall Study|Physician Decision|2|||
125371100|NCT03003390|450993102|FG001|Overall Study|Physician Decision|0|||
125371101|NCT03003390|450993101|FG000|Overall Study|Parent refused intervention|2|||
125371102|NCT03003390|450993102|FG001|Overall Study|Parent refused intervention|0|||
125609472|NCT00540449|451852363|FG001|Overall Study|Lost to Follow-up|17|||
125609473|NCT00540449|451852362|FG000|Overall Study|Subject Non-Compliant|7|||
125609474|NCT00540449|451852363|FG001|Overall Study|Subject Non-Compliant|5|||
125609475|NCT00540449|451852362|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
125609476|NCT00540449|451852363|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
125609477|NCT00540449|451852362|FG000|Overall Study|Withdrawal by Subject|10|||
125609478|NCT00540449|451852363|FG001|Overall Study|Withdrawal by Subject|10|||
125609479|NCT00540449|451852362|FG000|Overall Study|Other|1|||
125609480|NCT00540449|451852363|FG001|Overall Study|Other|4|||
125609481|NCT00872170|451852364|FG000|Overall Study|Adverse Event|1|||
125609482|NCT00872170|451852365|FG001|Overall Study|Adverse Event|0|||
125609483|NCT01721408|451852366|FG000|Overall Study|Adverse Event|6|||
125609484|NCT01721408|451852367|FG001|Overall Study|Adverse Event|1|||
125609485|NCT01721408|451852366|FG000|Overall Study|Death|1|||
125609486|NCT01721408|451852367|FG001|Overall Study|Death|0|||
125609487|NCT01721408|451852366|FG000|Overall Study|Insufficient clinical response|15|||
125609488|NCT01721408|451852367|FG001|Overall Study|Insufficient clinical response|6|||
125609489|NCT01721408|451852366|FG000|Overall Study|No longer willing to participate study|9|||
125609490|NCT01721408|451852367|FG001|Overall Study|No longer willing to participate study|10|||
125609491|NCT01721408|451852366|FG000|Overall Study|Protocol Violation|0|||
125609492|NCT01721408|451852367|FG001|Overall Study|Protocol Violation|2|||
125609493|NCT01721408|451852366|FG000|Overall Study|Other|3|||
125609494|NCT01721408|451852367|FG001|Overall Study|Other|3|||
125609495|NCT01721408|451852366|FG000|Overall Study|Lost to Follow-up|1|||
125609496|NCT01721408|451852367|FG001|Overall Study|Lost to Follow-up|2|||
125371103|NCT00307294|450993103|FG000|Overall Study|Withdrawal by Subject|1|||
125371104|NCT01664533|450993106|FG000|Overall Study|Death|42|||
125371105|NCT01664533|450993106|FG000|Overall Study|Lost to Follow-up|3|||
125371106|NCT01664533|450993106|FG000|Overall Study|Study termination|9|||
125371107|NCT01664533|450993106|FG000|Overall Study|Protocol Violation|3|||
125371108|NCT00290888|450993108|FG000|Overall Study|Physician Decision|3|||
125371109|NCT00290888|450993109|FG001|Overall Study|Physician Decision|1|||
125371110|NCT02370160|450993110|FG000|Overall Study|Death|3|||
125609497|NCT01721408|451852366|FG000|Overall Study|Does not meet entrance criteria|1|||
125609498|NCT01721408|451852367|FG001|Overall Study|Does not meet entrance criteria|0|||
125609499|NCT02426658|451852368|FG000|Overall Study|Withdrawal by Subject|1|||
125609500|NCT02426658|451852368|FG000|Overall Study|Patient expired before treatment|2|||
125609501|NCT00524316|451852369|FG000|Overall Study|Withdrawal by Subject|2|||
125609502|NCT00524316|451852369|FG000|Overall Study|Adverse Event|7|||
125609503|NCT00524316|451852369|FG000|Overall Study|Disease Progression|7|||
125609504|NCT01402284|451852370|FG000|Overall Study|Withdrawal consent|2|||
125609505|NCT01402284|451852370|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
125213637|NCT00793546|450409743|FG000|Overall Study|Death|3|||
125213638|NCT00793546|450409744|FG001|Overall Study|Death|0|||
125213639|NCT00793546|450409743|FG000|Overall Study|Lost to Follow-up|1|||
125213640|NCT00793546|450409744|FG001|Overall Study|Lost to Follow-up|0|||
125213641|NCT00793546|450409743|FG000|Overall Study|Withdrawal by Subject|1|||
125213642|NCT00793546|450409744|FG001|Overall Study|Withdrawal by Subject|1|||
125213643|NCT00793546|450409743|FG000|Overall Study|Study Terminated by Sponsor|8|||
125213644|NCT00793546|450409744|FG001|Overall Study|Study Terminated by Sponsor|27|||
125213645|NCT00793546|450409743|FG000|Overall Study|Other|1|||
125213646|NCT00793546|450409744|FG001|Overall Study|Other|0|||
125213647|NCT01841567|450409745|FG000|Overall Study|Adverse Event|3|||
125213648|NCT01416155|450409746|FG000|Overall Study|Adverse Event|8|||
125213649|NCT01416155|450409746|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
125213650|NCT01416155|450409746|FG000|Overall Study|Withdrawal by Subject|33|||
125213651|NCT01416155|450409746|FG000|Overall Study|Investigator decision|8|||
125213652|NCT01416155|450409746|FG000|Overall Study|Other|7|||
125213653|NCT01573754|450409751|FG000|Overall Study|Noncompliance or remission not achieved|3|||
125213654|NCT01573754|450409752|FG001|Overall Study|Noncompliance or remission not achieved|15|||
125213655|NCT00829829|450409754|FG000|Overall Study|Protocol Violation|0|||
125213656|NCT00829829|450409755|FG001|Overall Study|Protocol Violation|3|||
125213657|NCT00829829|450409756|FG002|Overall Study|Protocol Violation|0|||
125213658|NCT00829829|450409754|FG000|Overall Study|Adverse Event|4|||
125213659|NCT00829829|450409755|FG001|Overall Study|Adverse Event|4|||
125213660|NCT00829829|450409756|FG002|Overall Study|Adverse Event|3|||
125213661|NCT00829829|450409754|FG000|Overall Study|Withdrawal by Subject|8|||
125213662|NCT00829829|450409755|FG001|Overall Study|Withdrawal by Subject|4|||
125213663|NCT00829829|450409756|FG002|Overall Study|Withdrawal by Subject|2|||
125213664|NCT00829829|450409754|FG000|Overall Study|Decision by the Sponsor|1|||
125213665|NCT00829829|450409755|FG001|Overall Study|Decision by the Sponsor|0|||
125213666|NCT00829829|450409756|FG002|Overall Study|Decision by the Sponsor|2|||
125213667|NCT00829829|450409754|FG000|Overall Study|Lost to Follow-up|7|||
125213668|NCT00829829|450409755|FG001|Overall Study|Lost to Follow-up|3|||
125213669|NCT00829829|450409756|FG002|Overall Study|Lost to Follow-up|3|||
125213670|NCT00829829|450409754|FG000|Overall Study|Other than specified above|2|||
125213671|NCT00829829|450409755|FG001|Overall Study|Other than specified above|2|||
125213672|NCT00829829|450409756|FG002|Overall Study|Other than specified above|1|||
125213673|NCT02984267|450409757|FG000|Overall Study|Protocol Violation|1|||
125609506|NCT01402284|451852370|FG000|Overall Study|Physician Decision|1|||
125609507|NCT01402284|451852370|FG000|Overall Study|Disease progression on study|10|||
125609508|NCT01199263|451852371|FG000|Overall Study|Ineligible|0|||
125609509|NCT01199263|451852372|FG001|Overall Study|Ineligible|2|||
125609510|NCT01199263|451852371|FG000|Overall Study|Never Treated|6|||
125213674|NCT02984267|450409758|FG001|Overall Study|Protocol Violation|0|||
125213675|NCT02984267|450409757|FG000|Overall Study|Withdrawal by Subject|0|||
125213676|NCT02984267|450409758|FG001|Overall Study|Withdrawal by Subject|1|||
125371111|NCT02370160|450993111|FG001|Overall Study|Death|4|||
125371112|NCT02370160|450993112|FG002|Overall Study|Death|1|||
125371113|NCT04487730|450993115|FG000|Overall Study|Withdrawal by Subject|3|||
125609511|NCT01199263|451852372|FG001|Overall Study|Never Treated|0|||
125371114|NCT04487730|450993116|FG001|Overall Study|Withdrawal by Subject|1|||
125371115|NCT04487730|450993115|FG000|Overall Study|Lost to Follow-up|0|||
125431869|NCT04843930|451207771|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
125609512|NCT04937816|451852373|FG000|Overall Study|Study drug stopped, reason missing|5|||
125431870|NCT04843930|451207772|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
125609513|NCT04937816|451852374|FG001|Overall Study|Study drug stopped, reason missing|3|||
125213677|NCT02685072|450409759|FG000|Treatment Period|Lost to Follow-up|12|||
125213678|NCT02685072|450409760|FG001|Treatment Period|Lost to Follow-up|6|||
125213679|NCT02685072|450409759|FG000|Treatment Period|Withdrawal by Subject|1|||
125213680|NCT02685072|450409760|FG001|Treatment Period|Withdrawal by Subject|3|||
125213681|NCT02685072|450409759|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
125213682|NCT02685072|450409760|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
125213683|NCT00742027|450409761|FG000|Overall Study|Disease Progression|76|||
125431871|NCT01931735|451207773|FG000|Randomized Phase|Lost to Follow-up|2|||
125431872|NCT01931735|451207774|FG001|Randomized Phase|Lost to Follow-up|2|||
125431873|NCT01931735|451207775|FG002|Randomized Phase|Lost to Follow-up|5|||
125431874|NCT01931735|451207776|FG003|Randomized Phase|Lost to Follow-up|0|||
125431875|NCT01931735|451207773|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
125609514|NCT04937816|451852375|FG002|Overall Study|Study drug stopped, reason missing|4|||
125609515|NCT04937816|451852376|FG003|Overall Study|Study drug stopped, reason missing|6|||
125609516|NCT04937816|451852377|FG004|Overall Study|Study drug stopped, reason missing|1|||
125371116|NCT04487730|450993116|FG001|Overall Study|Lost to Follow-up|1|||
125371117|NCT04487730|450993115|FG000|Overall Study|Physician Decision|0|||
125371118|NCT04487730|450993116|FG001|Overall Study|Physician Decision|1|||
125371119|NCT01581931|450993117|FG000|Washout|Adverse Event|0|||
125371120|NCT01581931|450993118|FG001|Washout|Adverse Event|1|||
125371121|NCT03291808|450993123|FG000|Overall Study|Lost to Follow-up|6|||
125371122|NCT03291808|450993123|FG000|Overall Study|Research burden|4|||
125371123|NCT01892293|450993134|FG000|Overall Study|Apheresed but not treated|4|||
125371124|NCT03602482|450993139|FG000|Overall Study|Withdrawal by Subject|6|||
125371125|NCT03602482|450993140|FG001|Overall Study|Withdrawal by Subject|7|||
125371126|NCT03602482|450993141|FG002|Overall Study|Withdrawal by Subject|0|||
125371127|NCT03602482|450993142|FG003|Overall Study|Withdrawal by Subject|0|||
125371128|NCT02397278|450993143|FG000|Overall Study|Withdrawal by Subject|0|||
125371129|NCT02397278|450993144|FG001|Overall Study|Withdrawal by Subject|2|||
125371130|NCT02397278|450993143|FG000|Overall Study|Deemed ineligible following surgery|1|||
125609517|NCT04937816|451852378|FG005|Overall Study|Study drug stopped, reason missing|0|||
125609518|NCT04937816|451852379|FG006|Overall Study|Study drug stopped, reason missing|0|||
125609519|NCT04937816|451852373|FG000|Overall Study|Other than stated below|173|||
125609520|NCT04937816|451852374|FG001|Overall Study|Other than stated below|143|||
125609521|NCT04937816|451852375|FG002|Overall Study|Other than stated below|125|||
125609522|NCT04937816|451852376|FG003|Overall Study|Other than stated below|44|||
125609523|NCT04937816|451852377|FG004|Overall Study|Other than stated below|45|||
125609524|NCT04937816|451852378|FG005|Overall Study|Other than stated below|28|||
125609525|NCT04937816|451852379|FG006|Overall Study|Other than stated below|31|||
125609526|NCT04937816|451852373|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
125609527|NCT04937816|451852374|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
125609528|NCT04937816|451852375|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
125609529|NCT04937816|451852376|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
125609530|NCT04937816|451852377|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
125609531|NCT04937816|451852378|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
125609532|NCT04937816|451852379|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
125609533|NCT04937816|451852373|FG000|Overall Study|Lost to Follow-up|15|||
125609534|NCT04937816|451852374|FG001|Overall Study|Lost to Follow-up|9|||
125609535|NCT04937816|451852375|FG002|Overall Study|Lost to Follow-up|6|||
125609536|NCT04937816|451852376|FG003|Overall Study|Lost to Follow-up|6|||
125609537|NCT04937816|451852377|FG004|Overall Study|Lost to Follow-up|16|||
125609538|NCT04937816|451852378|FG005|Overall Study|Lost to Follow-up|11|||
125609539|NCT04937816|451852379|FG006|Overall Study|Lost to Follow-up|17|||
125609540|NCT04937816|451852373|FG000|Overall Study|Protocol Violation|15|||
125609541|NCT04937816|451852374|FG001|Overall Study|Protocol Violation|15|||
125609542|NCT04937816|451852375|FG002|Overall Study|Protocol Violation|12|||
125609543|NCT04937816|451852376|FG003|Overall Study|Protocol Violation|30|||
125609544|NCT04937816|451852377|FG004|Overall Study|Protocol Violation|24|||
125609545|NCT04937816|451852378|FG005|Overall Study|Protocol Violation|5|||
125609546|NCT04937816|451852379|FG006|Overall Study|Protocol Violation|5|||
125609547|NCT04937816|451852373|FG000|Overall Study|Adverse Event|303|||
125609548|NCT04937816|451852374|FG001|Overall Study|Adverse Event|267|||
125609549|NCT04937816|451852375|FG002|Overall Study|Adverse Event|273|||
125609550|NCT04937816|451852376|FG003|Overall Study|Adverse Event|553|||
125609551|NCT04937816|451852377|FG004|Overall Study|Adverse Event|575|||
125609552|NCT04937816|451852378|FG005|Overall Study|Adverse Event|343|||
125609553|NCT04937816|451852379|FG006|Overall Study|Adverse Event|337|||
125609554|NCT04937816|451852373|FG000|Overall Study|Not treated|4|||
125609555|NCT04937816|451852374|FG001|Overall Study|Not treated|2|||
125609556|NCT04937816|451852375|FG002|Overall Study|Not treated|2|||
125609557|NCT04937816|451852376|FG003|Overall Study|Not treated|2|||
125609558|NCT04937816|451852377|FG004|Overall Study|Not treated|1|||
125609559|NCT04937816|451852378|FG005|Overall Study|Not treated|4|||
125609560|NCT04937816|451852379|FG006|Overall Study|Not treated|0|||
125609561|NCT00436215|451852380|FG000|Overall Study|Refused further treatment|3|||
125609562|NCT00436215|451852380|FG000|Overall Study|Small bowel obstruction|1|||
125609563|NCT00309777|451852381|FG000|Overall Study|Adverse Event|13|||
125609564|NCT00309777|451852382|FG001|Overall Study|Adverse Event|2|||
125609565|NCT00309777|451852383|FG002|Overall Study|Adverse Event|8|||
125609566|NCT00309777|451852384|FG003|Overall Study|Adverse Event|1|||
125609567|NCT00309777|451852381|FG000|Overall Study|Protocol Violation|4|||
125371131|NCT02397278|450993144|FG001|Overall Study|Deemed ineligible following surgery|1|||
125371132|NCT02161731|450993145|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
125371133|NCT02161731|450993146|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
125371134|NCT02161731|450993145|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
125371135|NCT02161731|450993146|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
125371136|NCT01397084|450993151|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
125371137|NCT01397084|450993151|FG000|Overall Study|Protocol Violation|2|||
125371138|NCT01397084|450993151|FG000|Overall Study|Adverse Event|2|||
125371139|NCT01397084|450993151|FG000|Overall Study|Withdrawal by Subject|1|||
125371140|NCT01397084|450993151|FG000|Overall Study|Lost to Follow-up|1|||
125371141|NCT01397084|450993151|FG000|Overall Study|Used other proton pump inhibitor|1|||
125371142|NCT00618072|450993154|FG000|Overall Study|Lost to Follow-up|2|||
125371143|NCT00618072|450993155|FG001|Overall Study|Lost to Follow-up|0|||
125371144|NCT00618072|450993156|FG002|Overall Study|Lost to Follow-up|3|||
125371145|NCT00618072|450993154|FG000|Overall Study|Physician Decision|0|||
125371146|NCT00618072|450993155|FG001|Overall Study|Physician Decision|1|||
125371147|NCT00618072|450993156|FG002|Overall Study|Physician Decision|1|||
125371148|NCT00592384|450993157|FG000|Overall Study|Withdrawal by Subject|5|||
125371149|NCT00592384|450993158|FG001|Overall Study|Withdrawal by Subject|6|||
125371150|NCT02380677|450993162|FG000|Overall Study|Adverse Event|0|||
125371151|NCT02380677|450993163|FG001|Overall Study|Adverse Event|0|||
125371152|NCT02380677|450993164|FG002|Overall Study|Adverse Event|0|||
125371153|NCT02380677|450993165|FG003|Overall Study|Adverse Event|1|||
125371154|NCT02380677|450993166|FG004|Overall Study|Adverse Event|1|||
125371155|NCT02380677|450993167|FG005|Overall Study|Adverse Event|4|||
125371156|NCT02380677|450993168|FG006|Overall Study|Adverse Event|2|||
125371157|NCT02380677|450993169|FG007|Overall Study|Adverse Event|2|||
125371158|NCT02380677|450993170|FG008|Overall Study|Adverse Event|2|||
125371159|NCT02380677|450993171|FG009|Overall Study|Adverse Event|1|||
125371160|NCT02380677|450993172|FG010|Overall Study|Adverse Event|2|||
125371161|NCT02380677|450993173|FG011|Overall Study|Adverse Event|1|||
125371162|NCT02380677|450993162|FG000|Overall Study|Physician Decision|1|||
125371163|NCT02380677|450993163|FG001|Overall Study|Physician Decision|0|||
125371164|NCT02380677|450993164|FG002|Overall Study|Physician Decision|1|||
125371165|NCT02380677|450993165|FG003|Overall Study|Physician Decision|1|||
125371166|NCT02380677|450993166|FG004|Overall Study|Physician Decision|0|||
125371167|NCT02380677|450993167|FG005|Overall Study|Physician Decision|0|||
125371168|NCT02380677|450993168|FG006|Overall Study|Physician Decision|0|||
125371169|NCT02380677|450993169|FG007|Overall Study|Physician Decision|0|||
125371170|NCT02380677|450993170|FG008|Overall Study|Physician Decision|0|||
125371171|NCT02380677|450993171|FG009|Overall Study|Physician Decision|0|||
125371172|NCT02380677|450993172|FG010|Overall Study|Physician Decision|0|||
125371173|NCT02380677|450993173|FG011|Overall Study|Physician Decision|0|||
125371174|NCT02380677|450993162|FG000|Overall Study|Lack of Efficacy|0|||
125371175|NCT02380677|450993163|FG001|Overall Study|Lack of Efficacy|1|||
125371176|NCT02380677|450993164|FG002|Overall Study|Lack of Efficacy|2|||
125371177|NCT02380677|450993165|FG003|Overall Study|Lack of Efficacy|0|||
125371178|NCT02380677|450993166|FG004|Overall Study|Lack of Efficacy|4|||
125371179|NCT02380677|450993167|FG005|Overall Study|Lack of Efficacy|1|||
125371180|NCT02380677|450993168|FG006|Overall Study|Lack of Efficacy|1|||
125371181|NCT02380677|450993169|FG007|Overall Study|Lack of Efficacy|2|||
125371182|NCT02380677|450993170|FG008|Overall Study|Lack of Efficacy|2|||
125371183|NCT02380677|450993171|FG009|Overall Study|Lack of Efficacy|0|||
125371184|NCT02380677|450993172|FG010|Overall Study|Lack of Efficacy|2|||
125371185|NCT02380677|450993173|FG011|Overall Study|Lack of Efficacy|1|||
125371186|NCT02380677|450993162|FG000|Overall Study|Withdrawal by Subject|0|||
125371187|NCT02380677|450993163|FG001|Overall Study|Withdrawal by Subject|0|||
125371188|NCT02380677|450993164|FG002|Overall Study|Withdrawal by Subject|0|||
125371189|NCT02380677|450993165|FG003|Overall Study|Withdrawal by Subject|0|||
125371190|NCT02380677|450993166|FG004|Overall Study|Withdrawal by Subject|0|||
125371191|NCT02380677|450993167|FG005|Overall Study|Withdrawal by Subject|0|||
125371192|NCT02380677|450993168|FG006|Overall Study|Withdrawal by Subject|0|||
125371193|NCT02380677|450993169|FG007|Overall Study|Withdrawal by Subject|0|||
125371194|NCT02380677|450993170|FG008|Overall Study|Withdrawal by Subject|0|||
125371195|NCT02380677|450993171|FG009|Overall Study|Withdrawal by Subject|1|||
125371196|NCT02380677|450993172|FG010|Overall Study|Withdrawal by Subject|0|||
125371197|NCT02380677|450993173|FG011|Overall Study|Withdrawal by Subject|3|||
125213684|NCT00742027|450409761|FG000|Overall Study|New Cancer Therapy|19|||
125213685|NCT00742027|450409761|FG000|Overall Study|Withdrawal by Subject|18|||
125213686|NCT00742027|450409761|FG000|Overall Study|Death|7|||
125213687|NCT00742027|450409761|FG000|Overall Study|Lost to Follow-up|4|||
125213688|NCT00742027|450409761|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
125213689|NCT00742027|450409761|FG000|Overall Study|Missing|2|||
125213690|NCT00742027|450409761|FG000|Overall Study|Administrative Problems|1|||
125213691|NCT02634710|450409762|FG000|Overall Study|Death|4|||
125213692|NCT02717442|450409766|FG000|Overall Study|Study Terminated by Sponsor|31|||
125213693|NCT02717442|450409767|FG001|Overall Study|Study Terminated by Sponsor|29|||
125213694|NCT02717442|450409766|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
125213695|NCT02717442|450409767|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
125213696|NCT02717442|450409766|FG000|Overall Study|Other - Not Specified|2|||
125213697|NCT02717442|450409767|FG001|Overall Study|Other - Not Specified|0|||
125213698|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
125213699|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213700|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213701|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213702|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213703|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213704|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213705|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213706|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
125213707|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
125213708|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
125213709|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
125213710|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
125213711|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
125213712|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
125213713|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
125213714|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
125213715|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
125213716|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
125213717|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
125213718|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
125213719|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
125213720|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
125213721|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
125213722|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
125213723|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
125213724|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
125213725|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
125213726|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
125213727|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
125213728|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
125213729|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
125213730|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
125213731|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
125213732|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
125213733|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
125213734|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125213735|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125213736|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125371198|NCT02380677|450993162|FG000|Overall Study|Other|0|||
125371199|NCT02380677|450993163|FG001|Overall Study|Other|0|||
125371200|NCT02380677|450993164|FG002|Overall Study|Other|0|||
125371201|NCT02380677|450993165|FG003|Overall Study|Other|1|||
125371202|NCT02380677|450993166|FG004|Overall Study|Other|1|||
125371203|NCT02380677|450993167|FG005|Overall Study|Other|1|||
125371204|NCT02380677|450993168|FG006|Overall Study|Other|0|||
125371205|NCT02380677|450993169|FG007|Overall Study|Other|0|||
125371206|NCT02380677|450993170|FG008|Overall Study|Other|0|||
125371207|NCT02380677|450993171|FG009|Overall Study|Other|0|||
125609568|NCT00309777|451852382|FG001|Overall Study|Protocol Violation|1|||
125609569|NCT00309777|451852383|FG002|Overall Study|Protocol Violation|3|||
125609570|NCT00309777|451852384|FG003|Overall Study|Protocol Violation|1|||
125609571|NCT00309777|451852381|FG000|Overall Study|Withdrawal by Subject|6|||
125609572|NCT00309777|451852382|FG001|Overall Study|Withdrawal by Subject|5|||
125609573|NCT00309777|451852383|FG002|Overall Study|Withdrawal by Subject|7|||
125609574|NCT00309777|451852384|FG003|Overall Study|Withdrawal by Subject|2|||
125371208|NCT02380677|450993172|FG010|Overall Study|Other|0|||
125371209|NCT02380677|450993173|FG011|Overall Study|Other|0|||
125371210|NCT04932096|450993174|FG000|Overall Study|Withdrawal by Subject|1|||
125371211|NCT04932096|450993175|FG001|Overall Study|Withdrawal by Subject|1|||
125371212|NCT04932096|450993174|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
125371213|NCT04932096|450993175|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
125371214|NCT00133952|450993183|FG000|Overall Study|Adverse Event|1|||
125371215|NCT00133952|450993184|FG001|Overall Study|Adverse Event|2|||
125371216|NCT00133952|450993183|FG000|Overall Study|Death|3|||
125371217|NCT00133952|450993184|FG001|Overall Study|Death|2|||
125609575|NCT00309777|451852381|FG000|Overall Study|Lost to Follow-up|0|||
125609576|NCT00309777|451852382|FG001|Overall Study|Lost to Follow-up|0|||
125371218|NCT00133952|450993183|FG000|Overall Study|Lost to Follow-up|9|||
125371219|NCT00133952|450993184|FG001|Overall Study|Lost to Follow-up|14|||
125371220|NCT00133952|450993183|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
125371221|NCT00133952|450993184|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
125371222|NCT00133952|450993183|FG000|Overall Study|Protocol Violation|1|||
125371223|NCT00133952|450993184|FG001|Overall Study|Protocol Violation|1|||
125371224|NCT00133952|450993183|FG000|Overall Study|Withdrawal by Subject|20|||
125371225|NCT00133952|450993184|FG001|Overall Study|Withdrawal by Subject|4|||
125371226|NCT00133952|450993183|FG000|Overall Study|Physician Decision|4|||
125371227|NCT00133952|450993184|FG001|Overall Study|Physician Decision|3|||
125371228|NCT00133952|450993183|FG000|Overall Study|Sponsor Decision|0|||
125371229|NCT00133952|450993184|FG001|Overall Study|Sponsor Decision|1|||
125371230|NCT01976338|450993186|FG000|Overall Study|Physician Decision|0|||
125371231|NCT01976338|450993187|FG001|Overall Study|Physician Decision|1|||
125371232|NCT01976338|450993186|FG000|Overall Study|Lost to Follow-up|3|||
125371233|NCT01976338|450993187|FG001|Overall Study|Lost to Follow-up|0|||
125371234|NCT01976338|450993186|FG000|Overall Study|Withdrawal by Subject|5|||
125371235|NCT01976338|450993187|FG001|Overall Study|Withdrawal by Subject|2|||
125371236|NCT01976338|450993186|FG000|Overall Study|Adverse Event|5|||
125371237|NCT01976338|450993187|FG001|Overall Study|Adverse Event|1|||
125371238|NCT00777608|450993188|FG000|Overall Study|Lost to Follow-up|1|||
125371239|NCT00777608|450993189|FG001|Overall Study|Lost to Follow-up|1|||
125371240|NCT00777608|450993188|FG000|Overall Study|Withdrawal by Subject|1|||
125371241|NCT00777608|450993189|FG001|Overall Study|Withdrawal by Subject|3|||
125371242|NCT00777608|450993188|FG000|Overall Study|Protocol Violation|1|||
125371243|NCT00777608|450993189|FG001|Overall Study|Protocol Violation|0|||
125371244|NCT00777608|450993188|FG000|Overall Study|Investigator Decision|1|||
125371245|NCT00777608|450993189|FG001|Overall Study|Investigator Decision|2|||
125609577|NCT00309777|451852383|FG002|Overall Study|Lost to Follow-up|1|||
125609578|NCT00309777|451852384|FG003|Overall Study|Lost to Follow-up|0|||
125213737|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
125213738|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125213739|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
125213740|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125213741|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125213742|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
125213743|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
125213744|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
125213745|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
125213746|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
125213747|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
125213748|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
125213749|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
125213750|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
125213751|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
125213752|NCT00528372|450409771|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
125213753|NCT00528372|450409772|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
125213754|NCT00528372|450409773|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
125213755|NCT00528372|450409774|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
125371246|NCT04213079|450993190|FG000|Overall Study|Lost to Follow-up|0|||
125371247|NCT04213079|450993191|FG001|Overall Study|Lost to Follow-up|2|||
125371248|NCT03766581|450993194|FG000|Randomization|Other reasons|2|||
125609579|NCT00309777|451852381|FG000|Overall Study|Death|0|||
125609580|NCT00309777|451852382|FG001|Overall Study|Death|1|||
125609581|NCT00309777|451852383|FG002|Overall Study|Death|0|||
125609582|NCT00309777|451852384|FG003|Overall Study|Death|0|||
125609583|NCT00492856|451853962|FG000|Induction|Adverse Event|2|||
125371249|NCT03766581|450993195|FG001|Randomization|Other reasons|1|||
125371250|NCT03766581|450993196|FG002|Randomization|Other reasons|0|||
125609584|NCT00492856|451853963|FG001|Induction|Adverse Event|0|||
125609585|NCT00492856|451853964|FG002|Induction|Adverse Event|0|||
125609586|NCT00492856|451853965|FG003|Induction|Adverse Event|0|||
125609587|NCT00492856|451853962|FG000|Induction|Withdrawal by Subject|1|||
125609588|NCT00492856|451853963|FG001|Induction|Withdrawal by Subject|0|||
125609589|NCT00492856|451853964|FG002|Induction|Withdrawal by Subject|0|||
125609590|NCT00492856|451853965|FG003|Induction|Withdrawal by Subject|0|||
125371251|NCT03766581|450993197|FG003|Randomization|Other reasons|1|||
125371252|NCT03766581|450993198|FG004|Randomization|Other reasons|0|||
125371253|NCT03766581|450993199|FG005|Randomization|Other reasons|0|||
125371254|NCT03766581|450993200|FG006|Randomization|Other reasons|0|||
125371255|NCT03766581|450993201|FG007|Randomization|Other reasons|0|||
125371256|NCT03766581|450993194|FG000|Randomization|Participant no longer meets study criteria|5|||
125371257|NCT03766581|450993195|FG001|Randomization|Participant no longer meets study criteria|3|||
125371258|NCT03766581|450993196|FG002|Randomization|Participant no longer meets study criteria|4|||
125371259|NCT03766581|450993197|FG003|Randomization|Participant no longer meets study criteria|0|||
125371260|NCT03766581|450993198|FG004|Randomization|Participant no longer meets study criteria|2|||
125371261|NCT03766581|450993199|FG005|Randomization|Participant no longer meets study criteria|3|||
125371262|NCT03766581|450993200|FG006|Randomization|Participant no longer meets study criteria|0|||
125371263|NCT03766581|450993201|FG007|Randomization|Participant no longer meets study criteria|1|||
125371264|NCT03766581|450993194|FG000|Randomization|Participant request to discontinue study treatment|1|||
125371265|NCT03766581|450993195|FG001|Randomization|Participant request to discontinue study treatment|0|||
125371266|NCT03766581|450993196|FG002|Randomization|Participant request to discontinue study treatment|0|||
125371267|NCT03766581|450993197|FG003|Randomization|Participant request to discontinue study treatment|0|||
125371268|NCT03766581|450993198|FG004|Randomization|Participant request to discontinue study treatment|1|||
125371269|NCT03766581|450993199|FG005|Randomization|Participant request to discontinue study treatment|2|||
125371270|NCT03766581|450993200|FG006|Randomization|Participant request to discontinue study treatment|0|||
125371271|NCT03766581|450993201|FG007|Randomization|Participant request to discontinue study treatment|0|||
125371272|NCT03766581|450993194|FG000|Randomization|Participant withdrew consent|1|||
125371273|NCT03766581|450993195|FG001|Randomization|Participant withdrew consent|0|||
125371274|NCT03766581|450993196|FG002|Randomization|Participant withdrew consent|1|||
125371275|NCT03766581|450993197|FG003|Randomization|Participant withdrew consent|2|||
125371276|NCT03766581|450993198|FG004|Randomization|Participant withdrew consent|1|||
125371277|NCT03766581|450993199|FG005|Randomization|Participant withdrew consent|1|||
125371278|NCT03766581|450993200|FG006|Randomization|Participant withdrew consent|0|||
125609591|NCT00492856|451853962|FG000|Induction|Death|3|||
125609592|NCT00492856|451853963|FG001|Induction|Death|0|||
125371279|NCT03766581|450993201|FG007|Randomization|Participant withdrew consent|0|||
125371280|NCT03766581|450993194|FG000|Treatment|Adverse Event|82|||
125371281|NCT03766581|450993195|FG001|Treatment|Adverse Event|44|||
125371282|NCT03766581|450993196|FG002|Treatment|Adverse Event|47|||
125371283|NCT03766581|450993197|FG003|Treatment|Adverse Event|46|||
125371284|NCT03766581|450993198|FG004|Treatment|Adverse Event|50|||
125371285|NCT03766581|450993199|FG005|Treatment|Adverse Event|77|||
125371286|NCT03766581|450993200|FG006|Treatment|Adverse Event|5|||
125371287|NCT03766581|450993201|FG007|Treatment|Adverse Event|2|||
125371288|NCT03766581|450993194|FG000|Treatment|Participant request to discontinue treatment|34|||
125371289|NCT03766581|450993195|FG001|Treatment|Participant request to discontinue treatment|6|||
125371290|NCT03766581|450993196|FG002|Treatment|Participant request to discontinue treatment|10|||
125371291|NCT03766581|450993197|FG003|Treatment|Participant request to discontinue treatment|10|||
125371292|NCT03766581|450993198|FG004|Treatment|Participant request to discontinue treatment|14|||
125371293|NCT03766581|450993199|FG005|Treatment|Participant request to discontinue treatment|15|||
125371294|NCT03766581|450993200|FG006|Treatment|Participant request to discontinue treatment|0|||
125371295|NCT03766581|450993201|FG007|Treatment|Participant request to discontinue treatment|1|||
125371296|NCT03766581|450993194|FG000|Treatment|Participant withdrew consent|11|||
125371297|NCT03766581|450993195|FG001|Treatment|Participant withdrew consent|4|||
125371298|NCT03766581|450993196|FG002|Treatment|Participant withdrew consent|5|||
125371299|NCT03766581|450993197|FG003|Treatment|Participant withdrew consent|5|||
125371300|NCT03766581|450993198|FG004|Treatment|Participant withdrew consent|4|||
125371301|NCT03766581|450993199|FG005|Treatment|Participant withdrew consent|4|||
125371302|NCT03766581|450993200|FG006|Treatment|Participant withdrew consent|0|||
125371303|NCT03766581|450993201|FG007|Treatment|Participant withdrew consent|0|||
125371304|NCT03766581|450993194|FG000|Treatment|Death|1|||
125371305|NCT03766581|450993195|FG001|Treatment|Death|0|||
125371306|NCT03766581|450993196|FG002|Treatment|Death|0|||
125213756|NCT00528372|450409775|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
125371307|NCT03766581|450993197|FG003|Treatment|Death|0|||
125371308|NCT03766581|450993198|FG004|Treatment|Death|0|||
125371309|NCT03766581|450993199|FG005|Treatment|Death|0|||
125371310|NCT03766581|450993200|FG006|Treatment|Death|0|||
125371311|NCT03766581|450993201|FG007|Treatment|Death|0|||
125371312|NCT03766581|450993194|FG000|Treatment|Lost to Follow-up|1|||
125371313|NCT03766581|450993195|FG001|Treatment|Lost to Follow-up|0|||
125371314|NCT03766581|450993196|FG002|Treatment|Lost to Follow-up|0|||
125371315|NCT03766581|450993197|FG003|Treatment|Lost to Follow-up|1|||
125371316|NCT03766581|450993198|FG004|Treatment|Lost to Follow-up|0|||
125371317|NCT03766581|450993199|FG005|Treatment|Lost to Follow-up|0|||
125371318|NCT03766581|450993200|FG006|Treatment|Lost to Follow-up|0|||
125371319|NCT03766581|450993201|FG007|Treatment|Lost to Follow-up|0|||
125371320|NCT03766581|450993194|FG000|Treatment|Poor/Non compliance|2|||
125371321|NCT03766581|450993195|FG001|Treatment|Poor/Non compliance|2|||
125213757|NCT00528372|450409776|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
125371322|NCT03766581|450993196|FG002|Treatment|Poor/Non compliance|1|||
125371323|NCT03766581|450993197|FG003|Treatment|Poor/Non compliance|1|||
125371324|NCT03766581|450993198|FG004|Treatment|Poor/Non compliance|1|||
125371325|NCT03766581|450993199|FG005|Treatment|Poor/Non compliance|1|||
125371326|NCT03766581|450993200|FG006|Treatment|Poor/Non compliance|0|||
125371327|NCT03766581|450993201|FG007|Treatment|Poor/Non compliance|0|||
125371328|NCT03766581|450993194|FG000|Treatment|Participant no longer meets study criteria|9|||
125371329|NCT03766581|450993195|FG001|Treatment|Participant no longer meets study criteria|1|||
125371330|NCT03766581|450993196|FG002|Treatment|Participant no longer meets study criteria|5|||
125371331|NCT03766581|450993197|FG003|Treatment|Participant no longer meets study criteria|4|||
125371332|NCT03766581|450993198|FG004|Treatment|Participant no longer meets study criteria|4|||
125371333|NCT03766581|450993199|FG005|Treatment|Participant no longer meets study criteria|4|||
125371334|NCT03766581|450993200|FG006|Treatment|Participant no longer meets study criteria|2|||
125371335|NCT03766581|450993201|FG007|Treatment|Participant no longer meets study criteria|0|||
125371336|NCT03766581|450993194|FG000|Treatment|Other reasons|13|||
125371337|NCT03766581|450993195|FG001|Treatment|Other reasons|8|||
125371338|NCT03766581|450993196|FG002|Treatment|Other reasons|3|||
125371339|NCT03766581|450993197|FG003|Treatment|Other reasons|7|||
125371340|NCT03766581|450993198|FG004|Treatment|Other reasons|3|||
125371341|NCT03766581|450993199|FG005|Treatment|Other reasons|3|||
125371342|NCT03766581|450993200|FG006|Treatment|Other reasons|0|||
125371343|NCT03766581|450993201|FG007|Treatment|Other reasons|0|||
125371344|NCT00003479|450993203|FG000|Overall Study|Not evaluable|3|||
125371345|NCT01061177|450993204|FG000|Overall Study|Adverse Event|117|||
125371346|NCT01061177|450993204|FG000|Overall Study|Withdrawal by Subject|27|||
125371347|NCT01061177|450993204|FG000|Overall Study|Disease progression|17|||
125371348|NCT01061177|450993204|FG000|Overall Study|Protocol Violation|11|||
125371349|NCT01061177|450993204|FG000|Overall Study|Lost to Follow-up|9|||
125371350|NCT01061177|450993204|FG000|Overall Study|New cancer therapy|9|||
125371351|NCT01061177|450993204|FG000|Overall Study|Abnormal laboratory values|6|||
125371352|NCT01061177|450993204|FG000|Overall Study|Abnormal test procedure results|4|||
125371353|NCT01061177|450993204|FG000|Overall Study|Administratie problems|4|||
125371354|NCT01061177|450993204|FG000|Overall Study|Death|4|||
125371355|NCT00299104|450993205|FG000|Treatment Period|Adverse Event|14|||
125371356|NCT00299104|450993206|FG001|Treatment Period|Adverse Event|9|||
125371357|NCT00299104|450993207|FG002|Treatment Period|Adverse Event|7|||
125371358|NCT00299104|450993205|FG000|Treatment Period|Death|1|||
125371359|NCT00299104|450993206|FG001|Treatment Period|Death|1|||
125371360|NCT00299104|450993207|FG002|Treatment Period|Death|1|||
125371361|NCT00299104|450993205|FG000|Treatment Period|Insufficient therapeutic response|34|||
125371362|NCT00299104|450993206|FG001|Treatment Period|Insufficient therapeutic response|13|||
125371363|NCT00299104|450993207|FG002|Treatment Period|Insufficient therapeutic response|8|||
125371364|NCT00299104|450993205|FG000|Treatment Period|Failure to return|9|||
125371365|NCT00299104|450993206|FG001|Treatment Period|Failure to return|8|||
125371366|NCT00299104|450993207|FG002|Treatment Period|Failure to return|8|||
125371367|NCT00299104|450993205|FG000|Treatment Period|Violation of selection criteria|1|||
125371368|NCT00299104|450993206|FG001|Treatment Period|Violation of selection criteria|2|||
125371369|NCT00299104|450993207|FG002|Treatment Period|Violation of selection criteria|0|||
125371370|NCT00299104|450993205|FG000|Treatment Period|Protocol Violation|1|||
125371371|NCT00299104|450993206|FG001|Treatment Period|Protocol Violation|1|||
125371372|NCT00299104|450993207|FG002|Treatment Period|Protocol Violation|0|||
125371373|NCT00299104|450993205|FG000|Treatment Period|Refused treatment|9|||
125371374|NCT00299104|450993206|FG001|Treatment Period|Refused treatment|2|||
125371375|NCT00299104|450993207|FG002|Treatment Period|Refused treatment|2|||
125371376|NCT00299104|450993205|FG000|Treatment Period|Withdrew consent|14|||
125371377|NCT00299104|450993206|FG001|Treatment Period|Withdrew consent|19|||
125371378|NCT00299104|450993207|FG002|Treatment Period|Withdrew consent|9|||
125371379|NCT00299104|450993205|FG000|Treatment Period|Administrative reasons|106|||
125371380|NCT00299104|450993206|FG001|Treatment Period|Administrative reasons|120|||
125371381|NCT00299104|450993207|FG002|Treatment Period|Administrative reasons|137|||
125371382|NCT00299104|450993205|FG000|Safety Follow-Up (SFU) Period|Death|3|||
125371383|NCT00299104|450993206|FG001|Safety Follow-Up (SFU) Period|Death|2|||
125371384|NCT00299104|450993207|FG002|Safety Follow-Up (SFU) Period|Death|1|||
125371385|NCT00299104|450993205|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
125371386|NCT00299104|450993206|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
125609593|NCT00492856|451853964|FG002|Induction|Death|0|||
125609594|NCT00492856|451853965|FG003|Induction|Death|0|||
125609595|NCT00492856|451853962|FG000|Consolidation|Adverse Event|6|||
125609596|NCT00492856|451853963|FG001|Consolidation|Adverse Event|0|||
125609597|NCT00492856|451853964|FG002|Consolidation|Adverse Event|0|||
125609598|NCT00492856|451853965|FG003|Consolidation|Adverse Event|0|||
125609599|NCT00492856|451853962|FG000|Consolidation|Not protocol specified|2|||
125609600|NCT00492856|451853963|FG001|Consolidation|Not protocol specified|0|||
125371387|NCT00299104|450993207|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
125371388|NCT00299104|450993205|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
125371389|NCT00299104|450993206|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
125371390|NCT00299104|450993207|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
125371391|NCT00299104|450993205|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
125371392|NCT00299104|450993206|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
125371393|NCT00299104|450993207|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
125609601|NCT00492856|451853964|FG002|Consolidation|Not protocol specified|0|||
125213758|NCT00528372|450409777|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
125213759|NCT00528372|450409778|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
125213760|NCT00528372|450409779|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
125213761|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
125213762|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
125213763|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
125213764|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
125213765|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
125213766|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
125213767|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
125213768|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
125213769|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
125213770|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
125213771|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
125213772|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
125213773|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
125213774|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
125213775|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
125213776|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
125213777|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
125213778|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
125213779|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
125213780|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
125213781|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
125213782|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
125213783|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
125213784|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
125213785|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
125213786|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
125213787|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
125213788|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
125213789|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
125213790|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
125213791|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
125213792|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
125213793|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
125213794|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
125213795|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
125213796|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
125213797|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
125213798|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
125213799|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
125213800|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
125213801|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
125213802|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
125213803|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
125213804|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
125213805|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
125213806|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213807|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213808|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213809|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213810|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
125213811|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
125213812|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213813|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213814|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
125213815|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
125213816|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
125213817|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
125371394|NCT00299104|450993205|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
125371395|NCT00299104|450993206|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
125371396|NCT00299104|450993207|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
125213818|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
125213819|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
125213820|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
125371397|NCT00299104|450993205|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
125213821|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
125213822|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
125213823|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
125213824|NCT00528372|450409771|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
125213825|NCT00528372|450409772|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
125213826|NCT00528372|450409773|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
125213827|NCT00528372|450409774|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
125213828|NCT00528372|450409775|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
125213829|NCT00528372|450409776|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
125213830|NCT00528372|450409777|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
125213831|NCT00528372|450409778|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
125213832|NCT00528372|450409779|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
125213833|NCT02772809|450409780|FG000|Overall Study|not completed some tasks|6|||
125213834|NCT02774005|450409786|FG000|Overall Study|Adverse Event|8|||
125213835|NCT02774005|450409786|FG000|Overall Study|Withdrawal by Subject|23|||
125213836|NCT02774005|450409786|FG000|Overall Study|Lost to Follow-up|7|||
125213837|NCT02774005|450409786|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
125213838|NCT02774005|450409786|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
125213839|NCT02774005|450409786|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
125213840|NCT02774005|450409786|FG000|Overall Study|Death|1|||
125213841|NCT02774005|450409786|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
125213842|NCT02774005|450409786|FG000|Overall Study|Lack of compliance with study medication|4|||
125213843|NCT02774005|450409786|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
125213844|NCT02774005|450409786|FG000|Overall Study|another study|1|||
125213845|NCT02774005|450409786|FG000|Overall Study|cardiologist imposed travel restriction|1|||
125213846|NCT00534105|450409787|FG000|Overall Study|Lost to Follow-up|23|||
125213847|NCT00534105|450409788|FG001|Overall Study|Lost to Follow-up|39|||
125213848|NCT03275389|450409791|FG000|Overall Study|Lost to Follow-up|10|||
125213849|NCT03275389|450409792|FG001|Overall Study|Lost to Follow-up|10|||
125213850|NCT03275389|450409793|FG002|Overall Study|Lost to Follow-up|19|||
125213851|NCT03275389|450409794|FG003|Overall Study|Lost to Follow-up|12|||
125213852|NCT03275389|450409795|FG004|Overall Study|Lost to Follow-up|11|||
125213853|NCT03275389|450409796|FG005|Overall Study|Lost to Follow-up|12|||
125213854|NCT03275389|450409797|FG006|Overall Study|Lost to Follow-up|21|||
125213855|NCT03275389|450409798|FG007|Overall Study|Lost to Follow-up|15|||
125213856|NCT03275389|450409799|FG008|Overall Study|Lost to Follow-up|12|||
125213857|NCT03275389|450409800|FG009|Overall Study|Lost to Follow-up|14|||
125213858|NCT03275389|450409791|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213859|NCT03275389|450409792|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213860|NCT03275389|450409793|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213861|NCT03275389|450409794|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213862|NCT03275389|450409795|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213863|NCT03275389|450409796|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
125213864|NCT03275389|450409797|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213865|NCT03275389|450409798|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213866|NCT03275389|450409799|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
125213867|NCT03275389|450409800|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
125213868|NCT03275389|450409791|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
125213869|NCT03275389|450409792|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125213870|NCT03275389|450409793|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125213871|NCT03275389|450409794|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
125213872|NCT03275389|450409795|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
125213873|NCT03275389|450409796|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
125213874|NCT03275389|450409797|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
125213875|NCT03275389|450409798|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
125213876|NCT03275389|450409799|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
125213877|NCT03275389|450409800|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
125371398|NCT00299104|450993206|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
125371399|NCT00299104|450993207|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
125371400|NCT00299104|450993205|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
125371401|NCT00299104|450993206|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
125609602|NCT00492856|451853965|FG003|Consolidation|Not protocol specified|0|||
125609603|NCT00492856|451853962|FG000|Consolidation|Lost to Follow-up|1|||
125609604|NCT00492856|451853963|FG001|Consolidation|Lost to Follow-up|0|||
125609605|NCT00492856|451853964|FG002|Consolidation|Lost to Follow-up|0|||
125609606|NCT00492856|451853965|FG003|Consolidation|Lost to Follow-up|0|||
125609607|NCT00492856|451853962|FG000|Post-consolidation|Adverse Event|0|||
125609608|NCT00492856|451853963|FG001|Post-consolidation|Adverse Event|4|||
125609609|NCT00492856|451853964|FG002|Post-consolidation|Adverse Event|0|||
125609610|NCT00492856|451853965|FG003|Post-consolidation|Adverse Event|1|||
125371402|NCT00299104|450993207|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
125371403|NCT00299104|450993205|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
125371404|NCT00299104|450993206|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
125371405|NCT00299104|450993207|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
125371406|NCT00587054|450993217|FG000|Overall Study|Patient not treated|9|||
125371407|NCT00601458|450993221|FG000|Overall Study|Dosing Error|1|||
125371408|NCT00601458|450993222|FG001|Overall Study|Dosing Error|0|||
125371409|NCT00601458|450993223|FG002|Overall Study|Dosing Error|0|||
125371410|NCT00601458|450993221|FG000|Overall Study|Incomplete Data|0|||
125371411|NCT00601458|450993222|FG001|Overall Study|Incomplete Data|2|||
125371412|NCT00601458|450993223|FG002|Overall Study|Incomplete Data|0|||
125371413|NCT00601458|450993221|FG000|Overall Study|Protocol Violation|3|||
125371414|NCT00601458|450993222|FG001|Overall Study|Protocol Violation|2|||
125371415|NCT00601458|450993223|FG002|Overall Study|Protocol Violation|1|||
125371416|NCT00601458|450993221|FG000|Overall Study|Early Termination|0|||
125371417|NCT00601458|450993222|FG001|Overall Study|Early Termination|1|||
125371418|NCT00601458|450993223|FG002|Overall Study|Early Termination|1|||
125371419|NCT01697566|450993225|FG000|Overall Study|Withdrawal by Subject|0|||
125371420|NCT01697566|450993226|FG001|Overall Study|Withdrawal by Subject|0|||
125371421|NCT01697566|450993227|FG002|Overall Study|Withdrawal by Subject|1|||
125371422|NCT01697566|450993228|FG003|Overall Study|Withdrawal by Subject|1|||
125371423|NCT01697566|450993225|FG000|Overall Study|Final biopsy not obtained|0|||
125371424|NCT01697566|450993226|FG001|Overall Study|Final biopsy not obtained|0|||
125371425|NCT01697566|450993227|FG002|Overall Study|Final biopsy not obtained|1|||
125371426|NCT01697566|450993228|FG003|Overall Study|Final biopsy not obtained|0|||
125371427|NCT01709162|450993229|FG000|Overall Study|Disease progression|3|||
125371428|NCT01709162|450993230|FG001|Overall Study|Disease progression|3|||
125371429|NCT01709162|450993229|FG000|Overall Study|Study drug toxicity|2|||
125371430|NCT01709162|450993230|FG001|Overall Study|Study drug toxicity|0|||
125371431|NCT01709162|450993229|FG000|Overall Study|Administrative reason by sponsor|0|||
125371432|NCT01709162|450993230|FG001|Overall Study|Administrative reason by sponsor|1|||
125371433|NCT01709162|450993229|FG000|Overall Study|Other|1|||
125371434|NCT01709162|450993230|FG001|Overall Study|Other|0|||
125371435|NCT01709162|450993229|FG000|Overall Study|Withdrawal by Subject|0|||
125371436|NCT01709162|450993230|FG001|Overall Study|Withdrawal by Subject|1|||
125371437|NCT03129100|450993236|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
125371438|NCT03129100|450993237|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
125371439|NCT03129100|450993238|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
125371440|NCT03129100|450993239|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
125371441|NCT03129100|450993240|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
125371442|NCT03129100|450993241|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
125371443|NCT03129100|450993242|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
125609611|NCT00492856|451853962|FG000|Post-consolidation|Withdrawal by Subject|0|||
125609612|NCT00492856|451853963|FG001|Post-consolidation|Withdrawal by Subject|4|||
125609613|NCT00492856|451853964|FG002|Post-consolidation|Withdrawal by Subject|0|||
125609614|NCT00492856|451853965|FG003|Post-consolidation|Withdrawal by Subject|0|||
125609615|NCT00492856|451853962|FG000|Post-consolidation|Death|0|||
125609616|NCT00492856|451853963|FG001|Post-consolidation|Death|1|||
125609617|NCT00492856|451853964|FG002|Post-consolidation|Death|0|||
125609618|NCT00492856|451853965|FG003|Post-consolidation|Death|0|||
125371444|NCT03129100|450993243|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
125371445|NCT03129100|450993244|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
125371446|NCT03129100|450993245|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
125371447|NCT03129100|450993246|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
125371448|NCT03129100|450993247|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
125371449|NCT03129100|450993248|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
125371450|NCT03129100|450993249|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
125371451|NCT03129100|450993250|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
125371452|NCT03129100|450993251|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
125609619|NCT00492856|451853962|FG000|Post-consolidation|Not protocol specified|0|||
125371453|NCT03129100|450993252|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
125371454|NCT03129100|450993253|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
125371455|NCT03129100|450993254|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
125371456|NCT03129100|450993255|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
125609620|NCT00492856|451853963|FG001|Post-consolidation|Not protocol specified|1|||
125609621|NCT00492856|451853964|FG002|Post-consolidation|Not protocol specified|0|||
125609622|NCT00492856|451853965|FG003|Post-consolidation|Not protocol specified|0|||
125609623|NCT00492856|451853962|FG000|Post-consolidation|Lost to Follow-up|0|||
125609624|NCT00492856|451853963|FG001|Post-consolidation|Lost to Follow-up|2|||
125609625|NCT00492856|451853964|FG002|Post-consolidation|Lost to Follow-up|0|||
125609626|NCT00492856|451853965|FG003|Post-consolidation|Lost to Follow-up|0|||
125609627|NCT00492856|451853962|FG000|Post-consolidation|Observation Arm|0|||
125609628|NCT00492856|451853963|FG001|Post-consolidation|Observation Arm|0|||
125609629|NCT00492856|451853964|FG002|Post-consolidation|Observation Arm|27|||
125609630|NCT00492856|451853965|FG003|Post-consolidation|Observation Arm|0|||
125609631|NCT03488472|451853966|FG000|Overall Study|disease progression additional mets|1|||
125609632|NCT01998581|451853967|FG000|Overall Study|Refused repeat treatment|20|||
125609633|NCT01998581|451853968|FG001|Overall Study|Refused repeat treatment|4|||
125609634|NCT01998581|451853967|FG000|Overall Study|Protocol Violation|1|||
125609635|NCT01998581|451853968|FG001|Overall Study|Protocol Violation|0|||
125609636|NCT01998581|451853967|FG000|Overall Study|Withdrawal by Subject|8|||
125609637|NCT01998581|451853968|FG001|Overall Study|Withdrawal by Subject|1|||
125609638|NCT01998581|451853967|FG000|Overall Study|Lost to Follow-up|12|||
125609639|NCT01998581|451853968|FG001|Overall Study|Lost to Follow-up|4|||
125371457|NCT03129100|450993256|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
125371458|NCT03129100|450993257|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
125371459|NCT03129100|450993258|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
125371460|NCT03129100|450993259|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
125371461|NCT03129100|450993260|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
125371462|NCT03129100|450993261|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
125371463|NCT03129100|450993236|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
125371464|NCT03129100|450993237|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125213878|NCT03275389|450409791|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125371465|NCT03129100|450993238|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371466|NCT03129100|450993239|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371467|NCT03129100|450993240|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371468|NCT03129100|450993241|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125609640|NCT01998581|451853967|FG000|Overall Study|Adverse Event|1|||
125609641|NCT01998581|451853968|FG001|Overall Study|Adverse Event|1|||
125609642|NCT01998581|451853967|FG000|Overall Study|Other reasons|3|||
125371469|NCT03129100|450993242|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371470|NCT03129100|450993243|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371471|NCT03129100|450993244|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371472|NCT03129100|450993245|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371473|NCT03129100|450993246|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371474|NCT03129100|450993247|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371475|NCT03129100|450993248|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125609643|NCT01998581|451853968|FG001|Overall Study|Other reasons|2|||
125609644|NCT01998581|451853967|FG000|Overall Study|Randomized but withdrew before treatment|1|||
125609645|NCT01998581|451853968|FG001|Overall Study|Randomized but withdrew before treatment|0|||
125609646|NCT01251276|451853969|FG000|Overall Study|Protocol Violation|1|||
125609647|NCT01251276|451853970|FG001|Overall Study|Protocol Violation|0|||
125609648|NCT01251276|451853969|FG000|Overall Study|Lost to Follow-up|0|||
125609649|NCT01251276|451853970|FG001|Overall Study|Lost to Follow-up|1|||
125609650|NCT01345123|451853971|FG000|Overall Study|participants no longer with health plan|79|||
125609651|NCT01345123|451853972|FG001|Overall Study|participants no longer with health plan|85|||
125609652|NCT01345123|451853973|FG002|Overall Study|participants no longer with health plan|88|||
125609653|NCT03010423|451853977|FG000|Overall Study|Study termination|8|||
125609654|NCT03165721|451853983|FG000|Overall Study|Refused further treatment|3|||
125609655|NCT03165721|451853984|FG001|Overall Study|Refused further treatment|0|||
125609656|NCT03165721|451853985|FG002|Overall Study|Refused further treatment|0|||
125609657|NCT03165721|451853983|FG000|Overall Study|Physician Decision|1|||
125609658|NCT03165721|451853984|FG001|Overall Study|Physician Decision|0|||
125609659|NCT03165721|451853985|FG002|Overall Study|Physician Decision|0|||
125609660|NCT01863849|451853986|FG000|Overall Study|Lost to Follow-up|1|||
125609661|NCT01863849|451853987|FG001|Overall Study|Lost to Follow-up|0|||
125609662|NCT01457118|451853988|FG000|Overall Study|Adverse Event|1|||
125609663|NCT01457118|451853989|FG001|Overall Study|Adverse Event|0|||
125609664|NCT01457118|451853990|FG002|Overall Study|Adverse Event|0|||
125609665|NCT01457118|451853991|FG003|Overall Study|Adverse Event|1|||
125609666|NCT01457118|451853988|FG000|Overall Study|Clinical Progression|0|||
125609667|NCT01457118|451853989|FG001|Overall Study|Clinical Progression|1|||
125609668|NCT01457118|451853990|FG002|Overall Study|Clinical Progression|0|||
125609669|NCT01457118|451853991|FG003|Overall Study|Clinical Progression|1|||
125609670|NCT01457118|451853988|FG000|Overall Study|Physician Decision|2|||
125609671|NCT01457118|451853989|FG001|Overall Study|Physician Decision|0|||
125609672|NCT01457118|451853990|FG002|Overall Study|Physician Decision|0|||
125609673|NCT01457118|451853991|FG003|Overall Study|Physician Decision|0|||
125609674|NCT01457118|451853988|FG000|Overall Study|Progressive Disease by RECIST|12|||
125609675|NCT01457118|451853989|FG001|Overall Study|Progressive Disease by RECIST|3|||
125609676|NCT01457118|451853990|FG002|Overall Study|Progressive Disease by RECIST|1|||
125609677|NCT01457118|451853991|FG003|Overall Study|Progressive Disease by RECIST|0|||
125609678|NCT01457118|451853988|FG000|Overall Study|Withdrawal by Subject|5|||
125609679|NCT01457118|451853989|FG001|Overall Study|Withdrawal by Subject|0|||
125609680|NCT01457118|451853990|FG002|Overall Study|Withdrawal by Subject|0|||
125609681|NCT01457118|451853991|FG003|Overall Study|Withdrawal by Subject|0|||
125609682|NCT03456713|451853994|FG000|Overall Study|Lost to Follow-up|1|||
125609683|NCT03456713|451853995|FG001|Overall Study|Lost to Follow-up|0|||
125609684|NCT03456713|451853996|FG002|Overall Study|Lost to Follow-up|0|||
125609685|NCT03456713|451853997|FG003|Overall Study|Lost to Follow-up|0|||
125609686|NCT01263691|451853998|FG000|Overall Study|Lost to Follow-up|1|||
125609687|NCT01263691|451853999|FG001|Overall Study|Lost to Follow-up|0|||
125609688|NCT01263691|451854000|FG002|Overall Study|Lost to Follow-up|1|||
125609689|NCT01263691|451854001|FG003|Overall Study|Lost to Follow-up|1|||
125609690|NCT01263691|451854002|FG004|Overall Study|Lost to Follow-up|0|||
125609691|NCT01263691|451854003|FG005|Overall Study|Lost to Follow-up|0|||
125609692|NCT01263691|451853998|FG000|Overall Study|Withdrawal by Subject|1|||
125609693|NCT01263691|451853999|FG001|Overall Study|Withdrawal by Subject|0|||
125609694|NCT01263691|451854000|FG002|Overall Study|Withdrawal by Subject|0|||
125609695|NCT01263691|451854001|FG003|Overall Study|Withdrawal by Subject|0|||
125609696|NCT01263691|451854002|FG004|Overall Study|Withdrawal by Subject|0|||
125609697|NCT01263691|451854003|FG005|Overall Study|Withdrawal by Subject|0|||
125609698|NCT01263691|451853998|FG000|Overall Study|Adverse Event|1|||
125609699|NCT01263691|451853999|FG001|Overall Study|Adverse Event|0|||
125609700|NCT01263691|451854000|FG002|Overall Study|Adverse Event|0|||
125609701|NCT01263691|451854001|FG003|Overall Study|Adverse Event|0|||
125609702|NCT01263691|451854002|FG004|Overall Study|Adverse Event|0|||
125609703|NCT01263691|451854003|FG005|Overall Study|Adverse Event|0|||
125609704|NCT01202227|451854006|FG000|Overall Study|Adverse Event|16|||
125609705|NCT01202227|451854006|FG000|Overall Study|Withdrawal by Subject|2|||
125609706|NCT01202227|451854006|FG000|Overall Study|Lack of Efficacy|1|||
125609707|NCT04402008|451854009|FG000|Overall Study|Adverse Event|0|||
125609708|NCT04402008|451854010|FG001|Overall Study|Adverse Event|0|||
125609709|NCT04402008|451854011|FG002|Overall Study|Adverse Event|0|||
125609710|NCT04402008|451854012|FG003|Overall Study|Adverse Event|1|||
125609711|NCT04402008|451854013|FG004|Overall Study|Adverse Event|0|||
125609712|NCT04402008|451854014|FG005|Overall Study|Adverse Event|0|||
125609713|NCT04402008|451854015|FG006|Overall Study|Adverse Event|0|||
125609714|NCT04402008|451854009|FG000|Overall Study|Disease Progression|3|||
125609715|NCT04402008|451854010|FG001|Overall Study|Disease Progression|2|||
125609716|NCT04402008|451854011|FG002|Overall Study|Disease Progression|3|||
125609717|NCT04402008|451854012|FG003|Overall Study|Disease Progression|3|||
125371476|NCT03129100|450993249|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371477|NCT03129100|450993250|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371478|NCT03129100|450993251|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371479|NCT03129100|450993252|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371480|NCT03129100|450993253|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371481|NCT03129100|450993254|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371482|NCT03129100|450993255|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371483|NCT03129100|450993256|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371484|NCT03129100|450993257|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371485|NCT03129100|450993258|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371486|NCT03129100|450993259|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125609718|NCT04402008|451854013|FG004|Overall Study|Disease Progression|4|||
125609719|NCT04402008|451854014|FG005|Overall Study|Disease Progression|3|||
125609720|NCT04402008|451854015|FG006|Overall Study|Disease Progression|10|||
125609721|NCT04402008|451854009|FG000|Overall Study|Withdrawal by Subject|0|||
125609722|NCT04402008|451854010|FG001|Overall Study|Withdrawal by Subject|1|||
125609723|NCT04402008|451854011|FG002|Overall Study|Withdrawal by Subject|0|||
125609724|NCT04402008|451854012|FG003|Overall Study|Withdrawal by Subject|0|||
125609725|NCT04402008|451854013|FG004|Overall Study|Withdrawal by Subject|1|||
125609726|NCT04402008|451854014|FG005|Overall Study|Withdrawal by Subject|0|||
125609727|NCT04402008|451854015|FG006|Overall Study|Withdrawal by Subject|0|||
125609728|NCT04402008|451854009|FG000|Overall Study|Sponsor Decision|0|||
125609729|NCT04402008|451854010|FG001|Overall Study|Sponsor Decision|0|||
125609730|NCT04402008|451854011|FG002|Overall Study|Sponsor Decision|0|||
125609731|NCT04402008|451854012|FG003|Overall Study|Sponsor Decision|0|||
125609732|NCT04402008|451854013|FG004|Overall Study|Sponsor Decision|0|||
125609733|NCT04402008|451854014|FG005|Overall Study|Sponsor Decision|0|||
125609734|NCT04402008|451854015|FG006|Overall Study|Sponsor Decision|3|||
125609735|NCT04402008|451854009|FG000|Overall Study|Death|0|||
125609736|NCT04402008|451854010|FG001|Overall Study|Death|0|||
125609737|NCT04402008|451854011|FG002|Overall Study|Death|0|||
125609738|NCT04402008|451854012|FG003|Overall Study|Death|0|||
125609739|NCT04402008|451854013|FG004|Overall Study|Death|1|||
125609740|NCT04402008|451854014|FG005|Overall Study|Death|0|||
125609741|NCT04402008|451854015|FG006|Overall Study|Death|2|||
125609742|NCT04402008|451854009|FG000|Overall Study|Other|0|||
125609743|NCT04402008|451854010|FG001|Overall Study|Other|0|||
125609744|NCT04402008|451854011|FG002|Overall Study|Other|0|||
125609745|NCT04402008|451854012|FG003|Overall Study|Other|0|||
125609746|NCT04402008|451854013|FG004|Overall Study|Other|0|||
125609747|NCT04402008|451854014|FG005|Overall Study|Other|0|||
125609748|NCT04402008|451854015|FG006|Overall Study|Other|5|||
125609749|NCT00411788|451854016|FG000|Overall Study|Protocol Violation|1|||
125609750|NCT00411788|451854016|FG000|Overall Study|Adverse Event|1|||
125609751|NCT01533935|451854017|FG000|Overall Study|Adverse Event|5|||
125609752|NCT01533935|451854018|FG001|Overall Study|Adverse Event|7|||
125609753|NCT01533935|451854019|FG002|Overall Study|Adverse Event|1|||
125609754|NCT01533935|451854020|FG003|Overall Study|Adverse Event|5|||
125609755|NCT01533935|451854021|FG004|Overall Study|Adverse Event|3|||
125609756|NCT01533935|451854017|FG000|Overall Study|Protocol Violation|0|||
125609757|NCT01533935|451854018|FG001|Overall Study|Protocol Violation|2|||
125609758|NCT01533935|451854019|FG002|Overall Study|Protocol Violation|0|||
125609759|NCT01533935|451854020|FG003|Overall Study|Protocol Violation|0|||
125609760|NCT01533935|451854021|FG004|Overall Study|Protocol Violation|0|||
125609761|NCT01533935|451854017|FG000|Overall Study|Lost to Follow-up|0|||
125609762|NCT01533935|451854018|FG001|Overall Study|Lost to Follow-up|0|||
125609763|NCT01533935|451854019|FG002|Overall Study|Lost to Follow-up|1|||
125609764|NCT01533935|451854020|FG003|Overall Study|Lost to Follow-up|0|||
125609765|NCT01533935|451854021|FG004|Overall Study|Lost to Follow-up|0|||
125609766|NCT01533935|451854017|FG000|Overall Study|Withdrawal by Subject|0|||
125609767|NCT01533935|451854018|FG001|Overall Study|Withdrawal by Subject|4|||
125609768|NCT01533935|451854019|FG002|Overall Study|Withdrawal by Subject|5|||
125609769|NCT01533935|451854020|FG003|Overall Study|Withdrawal by Subject|2|||
125609770|NCT01533935|451854021|FG004|Overall Study|Withdrawal by Subject|4|||
125609771|NCT01533935|451854017|FG000|Overall Study|Other reason not defined above|1|||
125609772|NCT01533935|451854018|FG001|Overall Study|Other reason not defined above|0|||
125609773|NCT01533935|451854019|FG002|Overall Study|Other reason not defined above|1|||
125609774|NCT01533935|451854020|FG003|Overall Study|Other reason not defined above|0|||
125609775|NCT01533935|451854021|FG004|Overall Study|Other reason not defined above|1|||
125609776|NCT03430245|451854022|FG000|Overall Study|Withdrawal by Subject|6|||
125609777|NCT03430245|451854022|FG000|Overall Study|Lost to Follow-up|1|||
125609778|NCT00316303|451854023|FG000|Overall Study|Lost to Follow-up|11|||
125609779|NCT00316303|451854024|FG001|Overall Study|Lost to Follow-up|16|||
125609780|NCT00850759|451854025|FG000|Overall Study|Lost to Follow-up|7|||
125609781|NCT00850759|451854026|FG001|Overall Study|Lost to Follow-up|5|||
125371487|NCT03129100|450993260|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371488|NCT03129100|450993261|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
125371489|NCT03129100|450993236|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
125371490|NCT03129100|450993237|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
125371491|NCT03129100|450993238|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371492|NCT03129100|450993239|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371493|NCT03129100|450993240|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371494|NCT03129100|450993241|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371495|NCT03129100|450993242|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371496|NCT03129100|450993243|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371497|NCT03129100|450993244|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371498|NCT03129100|450993245|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371499|NCT03129100|450993246|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371500|NCT03129100|450993247|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371501|NCT03129100|450993248|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371502|NCT03129100|450993249|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371503|NCT03129100|450993250|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371504|NCT03129100|450993251|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371505|NCT03129100|450993252|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371506|NCT03129100|450993253|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371507|NCT03129100|450993254|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371508|NCT03129100|450993255|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371509|NCT03129100|450993256|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371510|NCT03129100|450993257|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371511|NCT03129100|450993258|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125609782|NCT00850759|451854027|FG002|Overall Study|Lost to Follow-up|5|||
125609783|NCT00850759|451854028|FG003|Overall Study|Lost to Follow-up|3|||
125371512|NCT03129100|450993259|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371513|NCT03129100|450993260|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371514|NCT03129100|450993261|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
125371515|NCT03129100|450993236|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
125371516|NCT03129100|450993237|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
125371517|NCT03129100|450993238|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371518|NCT03129100|450993239|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125609784|NCT00532948|451854029|FG000|Overall Study|Protocol Violation|1|||
125609785|NCT00532948|451854030|FG001|Overall Study|Protocol Violation|0|||
125609786|NCT00532948|451854031|FG002|Overall Study|Protocol Violation|0|||
125609787|NCT00532948|451854029|FG000|Overall Study|Death|3|||
125609788|NCT00532948|451854030|FG001|Overall Study|Death|3|||
125609789|NCT00532948|451854031|FG002|Overall Study|Death|4|||
125609790|NCT00532948|451854029|FG000|Overall Study|Violation of selection criteria at entry|0|||
125609791|NCT00532948|451854030|FG001|Overall Study|Violation of selection criteria at entry|1|||
125609792|NCT00532948|451854031|FG002|Overall Study|Violation of selection criteria at entry|0|||
125609793|NCT00532948|451854029|FG000|Overall Study|Failure to return|0|||
125609794|NCT00532948|451854030|FG001|Overall Study|Failure to return|1|||
125213879|NCT03275389|450409792|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
125213880|NCT03275389|450409793|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125213881|NCT03275389|450409794|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
125213882|NCT03275389|450409795|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125213883|NCT03275389|450409796|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125213884|NCT03275389|450409797|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125213885|NCT03275389|450409798|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125371519|NCT03129100|450993240|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125609795|NCT00532948|451854031|FG002|Overall Study|Failure to return|0|||
125609796|NCT01753076|451854032|FG000|Overall Study|Adverse Event|17|||
125609797|NCT01753076|451854033|FG001|Overall Study|Adverse Event|18|||
125609798|NCT01753076|451854032|FG000|Overall Study|Lack of Efficacy|3|||
125609799|NCT01753076|451854033|FG001|Overall Study|Lack of Efficacy|1|||
125609800|NCT01753076|451854032|FG000|Overall Study|Lost to Follow-up|2|||
125609801|NCT01753076|451854033|FG001|Overall Study|Lost to Follow-up|1|||
125371520|NCT03129100|450993241|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371521|NCT03129100|450993242|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371522|NCT03129100|450993243|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371523|NCT03129100|450993244|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371524|NCT03129100|450993245|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371525|NCT03129100|450993246|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371526|NCT03129100|450993247|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371527|NCT03129100|450993248|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371528|NCT03129100|450993249|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371529|NCT03129100|450993250|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371530|NCT03129100|450993251|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371531|NCT03129100|450993252|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371532|NCT03129100|450993253|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371533|NCT03129100|450993254|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371534|NCT03129100|450993255|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371535|NCT03129100|450993256|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371536|NCT03129100|450993257|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371537|NCT03129100|450993258|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371538|NCT03129100|450993259|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371539|NCT03129100|450993260|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371540|NCT03129100|450993261|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
125371541|NCT03129100|450993236|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371542|NCT03129100|450993237|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
125609802|NCT01753076|451854032|FG000|Overall Study|Physician Decision|4|||
125609803|NCT01753076|451854033|FG001|Overall Study|Physician Decision|2|||
125609804|NCT01753076|451854032|FG000|Overall Study|Withdrawal by Subject|14|||
125609805|NCT01753076|451854033|FG001|Overall Study|Withdrawal by Subject|24|||
125609806|NCT01753076|451854032|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
125609807|NCT01753076|451854033|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
125609808|NCT02575079|451854034|FG000|Overall Study|Death|3|||
125609809|NCT02575079|451854035|FG001|Overall Study|Death|0|||
125609810|NCT02575079|451854034|FG000|Overall Study|Withdrawal by Subject|3|||
125609811|NCT02575079|451854035|FG001|Overall Study|Withdrawal by Subject|0|||
125609812|NCT02918266|451854036|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
125609813|NCT02918266|451854037|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125609814|NCT02918266|451854038|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125609815|NCT02918266|451854039|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125609816|NCT02918266|451854040|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125609817|NCT02918266|451854041|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125609818|NCT02918266|451854042|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
125609819|NCT02918266|451854043|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125609820|NCT02918266|451854044|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
125609821|NCT02918266|451854045|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125609822|NCT02918266|451854046|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
125609823|NCT01259856|451854053|FG000|Overall Study|Adverse Event|12|||
125609824|NCT01259856|451854054|FG001|Overall Study|Adverse Event|9|||
125609825|NCT01259856|451854053|FG000|Overall Study|Death|0|||
125609826|NCT01259856|451854054|FG001|Overall Study|Death|1|||
125609827|NCT01259856|451854053|FG000|Overall Study|Lack of Efficacy|3|||
125431876|NCT01931735|451207774|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
125431877|NCT01931735|451207775|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
125431878|NCT01931735|451207776|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
125431879|NCT01931735|451207773|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
125609828|NCT01259856|451854054|FG001|Overall Study|Lack of Efficacy|1|||
125609829|NCT01259856|451854053|FG000|Overall Study|Lost to Follow-up|1|||
125609830|NCT01259856|451854054|FG001|Overall Study|Lost to Follow-up|1|||
125609831|NCT01259856|451854053|FG000|Overall Study|Physician Decision|2|||
125609832|NCT01259856|451854054|FG001|Overall Study|Physician Decision|1|||
125609833|NCT01259856|451854053|FG000|Overall Study|Withdrawal by Subject|9|||
125609834|NCT01259856|451854054|FG001|Overall Study|Withdrawal by Subject|10|||
125609835|NCT01259856|451854053|FG000|Overall Study|Treatment never started|0|||
125609836|NCT01259856|451854054|FG001|Overall Study|Treatment never started|6|||
125609837|NCT01259856|451854053|FG000|Overall Study|Study closure by sponsor|40|||
125609838|NCT01259856|451854054|FG001|Overall Study|Study closure by sponsor|41|||
125609839|NCT01259856|451854053|FG000|Overall Study|Patient developed other disease|0|||
125609840|NCT01259856|451854054|FG001|Overall Study|Patient developed other disease|1|||
125609841|NCT01259856|451854053|FG000|Overall Study|Transfer to another study|0|||
125609842|NCT01259856|451854054|FG001|Overall Study|Transfer to another study|1|||
125609843|NCT01259856|451854053|FG000|Overall Study|Unknown/missing|2|||
125609844|NCT01259856|451854054|FG001|Overall Study|Unknown/missing|2|||
125609845|NCT00788775|451854055|FG000|Overall Study|Progressive Disease|8|||
125609846|NCT00788775|451854056|FG001|Overall Study|Progressive Disease|6|||
125609847|NCT00788775|451854055|FG000|Overall Study|Withdrawal by Subject|0|||
125609848|NCT00788775|451854056|FG001|Overall Study|Withdrawal by Subject|2|||
125609849|NCT00788775|451854055|FG000|Overall Study|Patient Non-Compliance|1|||
125609850|NCT00788775|451854056|FG001|Overall Study|Patient Non-Compliance|0|||
125609851|NCT00788775|451854055|FG000|Overall Study|Patient's measurable disease resected.|1|||
125609852|NCT00788775|451854056|FG001|Overall Study|Patient's measurable disease resected.|0|||
125609853|NCT00114972|451854063|FG000|Overall Study|Withdrawal by Subject|40|||
125609854|NCT00114972|451854064|FG001|Overall Study|Withdrawal by Subject|7|||
125609855|NCT00114972|451854063|FG000|Overall Study|Lost to Follow-up|8|||
125609856|NCT00114972|451854064|FG001|Overall Study|Lost to Follow-up|5|||
125609857|NCT01425190|451854066|FG000|Overall Study|Full dose not consumed.|1|||
125609858|NCT01425190|451854067|FG001|Overall Study|Full dose not consumed.|0|||
125609859|NCT01425190|451854068|FG002|Overall Study|Full dose not consumed.|0|||
125609860|NCT01912729|451854069|FG000|Overall Study|Withdrawal by Subject|0|||
125609861|NCT01912729|451854070|FG001|Overall Study|Withdrawal by Subject|1|||
125609862|NCT01952834|451854073|FG000|Overall Study|Adverse Event|1|||
125609863|NCT04285346|451854074|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
125609864|NCT04285346|451854075|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
125609865|NCT04285346|451854074|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
125609866|NCT04285346|451854075|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125609867|NCT04285346|451854074|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
125371543|NCT03129100|450993238|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371544|NCT03129100|450993239|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371545|NCT03129100|450993240|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371546|NCT03129100|450993241|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371547|NCT03129100|450993242|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
125431880|NCT01931735|451207774|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
125431881|NCT01931735|451207775|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
125431882|NCT01931735|451207776|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
125431883|NCT05158296|451207783|FG000|Overall Study|Sponsor Decision|2|||
125431884|NCT05158296|451207784|FG001|Overall Study|Sponsor Decision|3|||
125431885|NCT05158296|451207785|FG002|Overall Study|Sponsor Decision|2|||
125371548|NCT03129100|450993243|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371549|NCT03129100|450993244|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371550|NCT03129100|450993245|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371551|NCT03129100|450993246|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371552|NCT03129100|450993247|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371553|NCT03129100|450993248|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371554|NCT03129100|450993249|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
125431886|NCT02552238|451207786|FG000|Overall Study|Withdrawal by Subject|2|||
125431887|NCT02552238|451207786|FG000|Overall Study|Adverse Event|2|||
125431888|NCT02036645|451207787|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125371555|NCT03129100|450993250|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371556|NCT03129100|450993251|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371557|NCT03129100|450993252|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371558|NCT03129100|450993253|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371559|NCT03129100|450993254|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371560|NCT03129100|450993255|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371561|NCT03129100|450993256|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371562|NCT03129100|450993257|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
125431889|NCT02036645|451207788|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125431890|NCT02036645|451207789|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125431891|NCT02036645|451207790|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125431892|NCT02036645|451207791|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125431893|NCT02036645|451207792|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125431894|NCT02036645|451207793|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
125431895|NCT02036645|451207794|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125431896|NCT02036645|451207795|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125371563|NCT03129100|450993258|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371564|NCT03129100|450993259|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371565|NCT03129100|450993260|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371566|NCT03129100|450993261|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
125371567|NCT03129100|450993236|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371568|NCT03129100|450993237|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371569|NCT03129100|450993238|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
125371570|NCT03129100|450993239|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
125371571|NCT03129100|450993240|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371572|NCT03129100|450993241|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
125371573|NCT03129100|450993242|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371574|NCT03129100|450993243|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371575|NCT03129100|450993244|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371576|NCT03129100|450993245|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371577|NCT03129100|450993246|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371578|NCT03129100|450993247|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371579|NCT03129100|450993248|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371580|NCT03129100|450993249|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125431897|NCT02036645|451207796|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125431898|NCT02036645|451207797|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125431899|NCT02036645|451207798|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
125371581|NCT03129100|450993250|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371582|NCT03129100|450993251|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371583|NCT03129100|450993252|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371584|NCT03129100|450993253|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371585|NCT03129100|450993254|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371586|NCT03129100|450993255|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371587|NCT03129100|450993256|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371588|NCT03129100|450993257|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371589|NCT03129100|450993258|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371590|NCT03129100|450993259|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371591|NCT03129100|450993260|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371592|NCT03129100|450993261|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
125371593|NCT03129100|450993236|FG000|Period2 Extension Period (Group A and B)|Death|0|||
125371594|NCT03129100|450993237|FG001|Period2 Extension Period (Group A and B)|Death|0|||
125371595|NCT03129100|450993238|FG002|Period2 Extension Period (Group A and B)|Death|1|||
125371596|NCT03129100|450993239|FG003|Period2 Extension Period (Group A and B)|Death|0|||
125371597|NCT03129100|450993240|FG004|Period2 Extension Period (Group A and B)|Death|0|||
125371598|NCT03129100|450993241|FG005|Period2 Extension Period (Group A and B)|Death|0|||
125371599|NCT03129100|450993242|FG006|Period2 Extension Period (Group A and B)|Death|0|||
125371600|NCT03129100|450993243|FG007|Period2 Extension Period (Group A and B)|Death|0|||
125371601|NCT03129100|450993244|FG008|Period2 Extension Period (Group A and B)|Death|0|||
125371602|NCT03129100|450993245|FG009|Period2 Extension Period (Group A and B)|Death|0|||
125371603|NCT03129100|450993246|FG010|Period2 Extension Period (Group A and B)|Death|0|||
125371604|NCT03129100|450993247|FG011|Period2 Extension Period (Group A and B)|Death|0|||
125371605|NCT03129100|450993248|FG012|Period2 Extension Period (Group A and B)|Death|0|||
125371606|NCT03129100|450993249|FG013|Period2 Extension Period (Group A and B)|Death|0|||
125371607|NCT03129100|450993250|FG014|Period2 Extension Period (Group A and B)|Death|0|||
125371608|NCT03129100|450993251|FG015|Period2 Extension Period (Group A and B)|Death|0|||
125371609|NCT03129100|450993252|FG016|Period2 Extension Period (Group A and B)|Death|0|||
125431900|NCT02036645|451207787|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125609868|NCT04285346|451854075|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
125609869|NCT00610935|451854076|FG000|Overall Study|Lost to Follow-up|0|||
125431901|NCT02036645|451207788|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125431902|NCT02036645|451207789|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125431903|NCT02036645|451207790|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
125431904|NCT02036645|451207791|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125431905|NCT02036645|451207792|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125431906|NCT02036645|451207793|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125431907|NCT02036645|451207794|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125431908|NCT02036645|451207795|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125431909|NCT02036645|451207796|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125431910|NCT02036645|451207797|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125431911|NCT02036645|451207798|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
125431912|NCT01778556|451207799|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
125431913|NCT01778556|451207800|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
125431914|NCT01778556|451207799|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
125431915|NCT01778556|451207800|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
125431916|NCT01778556|451207799|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
125431917|NCT01778556|451207800|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
125431918|NCT01778556|451207799|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
125431919|NCT01778556|451207800|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
125431920|NCT02404389|451207801|FG000|Overall Study|Adverse Event|1|||
125431921|NCT02404389|451207802|FG001|Overall Study|Adverse Event|0|||
125431922|NCT02404389|451207803|FG002|Overall Study|Adverse Event|1|||
125431923|NCT02404389|451207804|FG003|Overall Study|Adverse Event|0|||
125431924|NCT02404389|451207805|FG004|Overall Study|Adverse Event|2|||
125431925|NCT02404389|451207801|FG000|Overall Study|Subject/guardian decision|1|||
125431926|NCT02404389|451207802|FG001|Overall Study|Subject/guardian decision|0|||
125431927|NCT02404389|451207803|FG002|Overall Study|Subject/guardian decision|0|||
125431928|NCT02404389|451207804|FG003|Overall Study|Subject/guardian decision|1|||
125431929|NCT02404389|451207805|FG004|Overall Study|Subject/guardian decision|1|||
125431930|NCT01412801|451207809|FG000|Overall Study|Death|0|||
125431931|NCT01412801|451207810|FG001|Overall Study|Death|1|||
125431932|NCT01412801|451207811|FG002|Overall Study|Death|0|||
125431933|NCT01412801|451207812|FG003|Overall Study|Death|4|||
125431934|NCT01412801|451207813|FG004|Overall Study|Death|2|||
125431935|NCT01412801|451207814|FG005|Overall Study|Death|2|||
125431936|NCT01412801|451207809|FG000|Overall Study|Lost to Follow-up|1|||
125431937|NCT01412801|451207810|FG001|Overall Study|Lost to Follow-up|2|||
125609870|NCT00610935|451854077|FG001|Overall Study|Lost to Follow-up|1|||
125609871|NCT00610935|451854076|FG000|Overall Study|Withdrawal by Subject|0|||
125609872|NCT00610935|451854077|FG001|Overall Study|Withdrawal by Subject|2|||
125609873|NCT00610935|451854076|FG000|Overall Study|Sponsor Discontinuation|1|||
125609874|NCT00610935|451854077|FG001|Overall Study|Sponsor Discontinuation|0|||
125609875|NCT00740779|451854078|FG000|Overall Study|Adverse Event|4|||
125609876|NCT00740779|451854079|FG001|Overall Study|Adverse Event|6|||
125609877|NCT00740779|451854080|FG002|Overall Study|Adverse Event|3|||
125609878|NCT00740779|451854078|FG000|Overall Study|Protocol Violation|1|||
125609879|NCT00740779|451854079|FG001|Overall Study|Protocol Violation|1|||
125609880|NCT00740779|451854080|FG002|Overall Study|Protocol Violation|1|||
125609881|NCT00740779|451854078|FG000|Overall Study|Lack of Efficacy|0|||
125609882|NCT00740779|451854079|FG001|Overall Study|Lack of Efficacy|0|||
125609883|NCT00740779|451854080|FG002|Overall Study|Lack of Efficacy|2|||
125609884|NCT00740779|451854078|FG000|Overall Study|Withdrawal by Subject|2|||
125609885|NCT00740779|451854079|FG001|Overall Study|Withdrawal by Subject|4|||
125609886|NCT00740779|451854080|FG002|Overall Study|Withdrawal by Subject|2|||
125609887|NCT00740779|451854078|FG000|Overall Study|Lost to Follow-up|2|||
125609888|NCT00740779|451854079|FG001|Overall Study|Lost to Follow-up|3|||
125609889|NCT00740779|451854080|FG002|Overall Study|Lost to Follow-up|5|||
125609890|NCT00850460|451854081|FG000|Overall Study|Lost to Follow-up|4|||
125609891|NCT00850460|451854082|FG001|Overall Study|Lost to Follow-up|4|||
125609892|NCT02399813|451854083|FG000|Overall Study|Progressive Disease-Radiographic|2|||
125609893|NCT02399813|451854083|FG000|Overall Study|Death|20|||
125609894|NCT02399813|451854083|FG000|Overall Study|Withdrawal by Subject|3|||
125609895|NCT02399813|451854083|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
125609896|NCT02399813|451854083|FG000|Overall Study|Lost to Follow-up|2|||
125609897|NCT02399813|451854083|FG000|Overall Study|Other than specified|5|||
125609898|NCT00988559|451854084|FG000|Overall Study|Withdrawal by Subject|1|||
125609899|NCT00988559|451854085|FG001|Overall Study|Withdrawal by Subject|1|||
125609900|NCT00988559|451854086|FG002|Overall Study|Withdrawal by Subject|0|||
125609901|NCT00988559|451854087|FG003|Overall Study|Withdrawal by Subject|1|||
125609902|NCT00988559|451854084|FG000|Overall Study|Pregnancy|0|||
125609903|NCT00988559|451854085|FG001|Overall Study|Pregnancy|1|||
125609904|NCT00988559|451854086|FG002|Overall Study|Pregnancy|1|||
125609905|NCT00988559|451854087|FG003|Overall Study|Pregnancy|0|||
125609906|NCT00988559|451854084|FG000|Overall Study|Lost to Follow-up|0|||
125609907|NCT00988559|451854085|FG001|Overall Study|Lost to Follow-up|0|||
125609908|NCT00988559|451854086|FG002|Overall Study|Lost to Follow-up|1|||
125609909|NCT00988559|451854087|FG003|Overall Study|Lost to Follow-up|0|||
125609910|NCT02224846|451854088|FG000|Period 1 (Month 3)|Adverse Event|2|||
125609911|NCT02224846|451854089|FG001|Period 1 (Month 3)|Adverse Event|1|||
125609912|NCT02224846|451854088|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
125609913|NCT02224846|451854089|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
125609914|NCT02224846|451854088|FG000|Period 1 (Month 3)|Protocol Violation|4|||
125609915|NCT02224846|451854089|FG001|Period 1 (Month 3)|Protocol Violation|8|||
125609916|NCT02224846|451854088|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
125609917|NCT02224846|451854089|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
125609918|NCT02224846|451854088|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
125609919|NCT02224846|451854089|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
125609920|NCT02224846|451854088|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
125609921|NCT02224846|451854089|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
125609922|NCT02224846|451854088|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
125609923|NCT02224846|451854089|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
125431938|NCT01412801|451207811|FG002|Overall Study|Lost to Follow-up|4|||
125431939|NCT01412801|451207812|FG003|Overall Study|Lost to Follow-up|0|||
125431940|NCT01412801|451207813|FG004|Overall Study|Lost to Follow-up|1|||
125431941|NCT01412801|451207814|FG005|Overall Study|Lost to Follow-up|1|||
125431942|NCT01412801|451207809|FG000|Overall Study|Withdrawal by Subject|3|||
125431943|NCT01412801|451207810|FG001|Overall Study|Withdrawal by Subject|2|||
125431944|NCT01412801|451207811|FG002|Overall Study|Withdrawal by Subject|1|||
125431945|NCT01412801|451207812|FG003|Overall Study|Withdrawal by Subject|0|||
125431946|NCT01412801|451207813|FG004|Overall Study|Withdrawal by Subject|0|||
125431947|NCT01412801|451207814|FG005|Overall Study|Withdrawal by Subject|0|||
125431948|NCT01412801|451207809|FG000|Overall Study|Relocated to another area|0|||
125431949|NCT01412801|451207810|FG001|Overall Study|Relocated to another area|0|||
125431950|NCT01412801|451207811|FG002|Overall Study|Relocated to another area|2|||
125431951|NCT01412801|451207812|FG003|Overall Study|Relocated to another area|0|||
125431952|NCT01412801|451207813|FG004|Overall Study|Relocated to another area|0|||
125431953|NCT01412801|451207814|FG005|Overall Study|Relocated to another area|0|||
125431954|NCT03188120|451207815|FG000|Overall Study|Adverse Event|4|||
125431955|NCT03188120|451207815|FG000|Overall Study|Insufficient Effectiveness|8|||
125431956|NCT03188120|451207815|FG000|Overall Study|Improved|12|||
125431957|NCT03188120|451207815|FG000|Overall Study|Lost to Follow-up|7|||
125431958|NCT03188120|451207815|FG000|Overall Study|Other than specified|3|||
125431959|NCT03188120|451207815|FG000|Overall Study|No visit after the first visit|13|||
125431960|NCT02978443|451207816|FG000|Overall Study|Withdrawal by Subject|1|||
125609924|NCT02224846|451854088|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
125609925|NCT02224846|451854089|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
125609926|NCT02224846|451854088|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
125609927|NCT02224846|451854089|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
125609928|NCT02224846|451854088|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
125609929|NCT02224846|451854089|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
125609930|NCT02224846|451854088|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
125609931|NCT02224846|451854089|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
125609932|NCT02224846|451854088|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
125609933|NCT02224846|451854089|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
125609934|NCT02224846|451854088|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
125609935|NCT02224846|451854089|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
125609936|NCT02224846|451854088|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
125609937|NCT02224846|451854089|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
125609938|NCT02224846|451854088|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
125609939|NCT02224846|451854089|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
125609940|NCT02224846|451854088|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
125609941|NCT02224846|451854089|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
125609942|NCT02224846|451854088|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
125609943|NCT02224846|451854089|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
125609944|NCT02538666|451854094|FG000|Pre-Treatment|Disease progression|1|||
125609945|NCT02538666|451854095|FG001|Pre-Treatment|Disease progression|0|||
125609946|NCT02538666|451854096|FG002|Pre-Treatment|Disease progression|0|||
125609947|NCT02538666|451854094|FG000|Pre-Treatment|no longer meets study criteria|1|||
125609948|NCT02538666|451854095|FG001|Pre-Treatment|no longer meets study criteria|0|||
125609949|NCT02538666|451854096|FG002|Pre-Treatment|no longer meets study criteria|0|||
125609950|NCT02538666|451854094|FG000|Pre-Treatment|Withdrew Consent|0|||
125609951|NCT02538666|451854095|FG001|Pre-Treatment|Withdrew Consent|1|||
125609952|NCT02538666|451854096|FG002|Pre-Treatment|Withdrew Consent|1|||
125609953|NCT02538666|451854094|FG000|Treatment|Disease progression|270|||
125609954|NCT02538666|451854095|FG001|Treatment|Disease progression|227|||
125609955|NCT02538666|451854096|FG002|Treatment|Disease progression|165|||
125609956|NCT02538666|451854094|FG000|Treatment|Study drug toxicity|1|||
125609957|NCT02538666|451854095|FG001|Treatment|Study drug toxicity|29|||
125609958|NCT02538666|451854096|FG002|Treatment|Study drug toxicity|92|||
125609959|NCT02538666|451854094|FG000|Treatment|Death|0|||
125431961|NCT02978443|451207816|FG000|Overall Study|Adverse Event|3|||
125431962|NCT02978443|451207816|FG000|Overall Study|Disease Progression on study|6|||
125431963|NCT02978443|451207816|FG000|Overall Study|Death|1|||
125431964|NCT02978443|451207816|FG000|Overall Study|Physician Decision|1|||
125609960|NCT02538666|451854095|FG001|Treatment|Death|2|||
125609961|NCT02538666|451854096|FG002|Treatment|Death|3|||
125431965|NCT02978443|451207816|FG000|Overall Study|Switch to alternative therapy|1|||
125609962|NCT02538666|451854094|FG000|Treatment|Adverse event unrelated to study drug|8|||
125213886|NCT03275389|450409799|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125213887|NCT03275389|450409800|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125213888|NCT03275389|450409791|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213889|NCT03275389|450409792|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213890|NCT03275389|450409793|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
125213891|NCT03275389|450409794|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213892|NCT03275389|450409795|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213893|NCT03275389|450409796|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213894|NCT03275389|450409797|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213895|NCT03275389|450409798|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213896|NCT03275389|450409799|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
125213897|NCT03275389|450409800|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
125213898|NCT03275389|450409791|FG000|Overall Study|Other|0|||
125213899|NCT03275389|450409792|FG001|Overall Study|Other|4|||
125213900|NCT03275389|450409793|FG002|Overall Study|Other|3|||
125213901|NCT03275389|450409794|FG003|Overall Study|Other|2|||
125213902|NCT03275389|450409795|FG004|Overall Study|Other|2|||
125213903|NCT03275389|450409796|FG005|Overall Study|Other|2|||
125213904|NCT03275389|450409797|FG006|Overall Study|Other|0|||
125213905|NCT03275389|450409798|FG007|Overall Study|Other|0|||
125213906|NCT03275389|450409799|FG008|Overall Study|Other|1|||
125213907|NCT03275389|450409800|FG009|Overall Study|Other|0|||
125213908|NCT00978341|450409802|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
125213909|NCT00978341|450409803|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
125213910|NCT03035916|450409804|FG000|Overall Study|Puncture failed|0|||
125213911|NCT03035916|450409805|FG001|Overall Study|Puncture failed|2|||
125213912|NCT03035916|450409806|FG002|Overall Study|Puncture failed|0|||
125213913|NCT03885999|450409807|FG000|Overall Study|Adverse Event|1|||
125609963|NCT02538666|451854095|FG001|Treatment|Adverse event unrelated to study drug|10|||
125609964|NCT02538666|451854096|FG002|Treatment|Adverse event unrelated to study drug|15|||
125609965|NCT02538666|451854094|FG000|Treatment|Participant request to discontinue study treatment|3|||
125609966|NCT02538666|451854095|FG001|Treatment|Participant request to discontinue study treatment|6|||
125609967|NCT02538666|451854096|FG002|Treatment|Participant request to discontinue study treatment|11|||
125609968|NCT02538666|451854094|FG000|Treatment|Participant withdrew consent|2|||
125609969|NCT02538666|451854095|FG001|Treatment|Participant withdrew consent|5|||
125609970|NCT02538666|451854096|FG002|Treatment|Participant withdrew consent|3|||
125609971|NCT02538666|451854094|FG000|Treatment|Lost to Follow-up|0|||
125609972|NCT02538666|451854095|FG001|Treatment|Lost to Follow-up|1|||
125609973|NCT02538666|451854096|FG002|Treatment|Lost to Follow-up|1|||
125609974|NCT02538666|451854094|FG000|Treatment|Maximum clinical benefit|4|||
125609975|NCT02538666|451854095|FG001|Treatment|Maximum clinical benefit|3|||
125609976|NCT02538666|451854096|FG002|Treatment|Maximum clinical benefit|4|||
125609977|NCT02538666|451854094|FG000|Treatment|Poor/non-compliance|0|||
125609978|NCT02538666|451854095|FG001|Treatment|Poor/non-compliance|1|||
125609979|NCT02538666|451854096|FG002|Treatment|Poor/non-compliance|0|||
125609980|NCT02538666|451854094|FG000|Treatment|Participant no longer meets study criteria|0|||
125609981|NCT02538666|451854095|FG001|Treatment|Participant no longer meets study criteria|2|||
125609982|NCT02538666|451854096|FG002|Treatment|Participant no longer meets study criteria|0|||
125609983|NCT02538666|451854094|FG000|Treatment|Administrative reason by sponsor|0|||
125609984|NCT02538666|451854095|FG001|Treatment|Administrative reason by sponsor|0|||
125609985|NCT02538666|451854096|FG002|Treatment|Administrative reason by sponsor|1|||
125609986|NCT02538666|451854094|FG000|Treatment|Other reasons|8|||
125609987|NCT02538666|451854095|FG001|Treatment|Other reasons|15|||
125609988|NCT02538666|451854096|FG002|Treatment|Other reasons|5|||
125609989|NCT02538666|451854094|FG000|Treatment|Not reported|2|||
125213914|NCT02452554|450409808|FG000|Overall Study|Death|2|||
125213915|NCT02452554|450409809|FG001|Overall Study|Death|1|||
125213916|NCT02452554|450409810|FG002|Overall Study|Death|0|||
125213917|NCT02452554|450409811|FG003|Overall Study|Death|0|||
125213918|NCT02452554|450409812|FG004|Overall Study|Death|0|||
125213919|NCT02452554|450409813|FG005|Overall Study|Death|0|||
125213920|NCT02452554|450409808|FG000|Overall Study|Lack of Efficacy|13|||
125213921|NCT02452554|450409809|FG001|Overall Study|Lack of Efficacy|14|||
125609990|NCT02538666|451854095|FG001|Treatment|Not reported|2|||
125609991|NCT02538666|451854096|FG002|Treatment|Not reported|2|||
125609992|NCT03510663|451854097|FG000|Overall Study|Withdrawal by Subject|0|||
125609993|NCT03510663|451854098|FG001|Overall Study|Withdrawal by Subject|1|||
125371610|NCT03129100|450993253|FG017|Period2 Extension Period (Group A and B)|Death|0|||
125371611|NCT03129100|450993254|FG018|Period2 Extension Period (Group A and B)|Death|0|||
125371612|NCT03129100|450993255|FG019|Period2 Extension Period (Group A and B)|Death|0|||
125371613|NCT03129100|450993256|FG020|Period2 Extension Period (Group A and B)|Death|0|||
125371614|NCT03129100|450993257|FG021|Period2 Extension Period (Group A and B)|Death|0|||
125371615|NCT03129100|450993258|FG022|Period2 Extension Period (Group A and B)|Death|0|||
125371616|NCT03129100|450993259|FG023|Period2 Extension Period (Group A and B)|Death|0|||
125371617|NCT03129100|450993260|FG024|Period2 Extension Period (Group A and B)|Death|0|||
125371618|NCT03129100|450993261|FG025|Period2 Extension Period (Group A and B)|Death|0|||
125371619|NCT03129100|450993236|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371620|NCT03129100|450993237|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371621|NCT03129100|450993238|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
125371622|NCT03129100|450993239|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
125371623|NCT03129100|450993240|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
125371624|NCT03129100|450993241|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
125371625|NCT03129100|450993242|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
125371626|NCT03129100|450993243|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371627|NCT03129100|450993244|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371628|NCT03129100|450993245|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371629|NCT03129100|450993246|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371630|NCT03129100|450993247|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371631|NCT03129100|450993248|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371632|NCT03129100|450993249|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371633|NCT03129100|450993250|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371634|NCT03129100|450993251|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371635|NCT03129100|450993252|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125431966|NCT02978443|451207816|FG000|Overall Study|Refused further treatment|1|||
125609994|NCT03510663|451854099|FG002|Overall Study|Withdrawal by Subject|0|||
125609995|NCT03510663|451854100|FG003|Overall Study|Withdrawal by Subject|0|||
125609996|NCT03510663|451854101|FG004|Overall Study|Withdrawal by Subject|0|||
125609997|NCT03510663|451854102|FG005|Overall Study|Withdrawal by Subject|0|||
125609998|NCT03510663|451854103|FG006|Overall Study|Withdrawal by Subject|0|||
125609999|NCT03510663|451854104|FG007|Overall Study|Withdrawal by Subject|0|||
125610000|NCT02026271|451854107|FG000|Overall Study|Adverse Event|2|||
125610001|NCT02026271|451854108|FG001|Overall Study|Adverse Event|3|||
125610002|NCT02026271|451854109|FG002|Overall Study|Adverse Event|2|||
125610003|NCT02026271|451854110|FG003|Overall Study|Adverse Event|3|||
125610004|NCT02026271|451854111|FG004|Overall Study|Adverse Event|0|||
125610005|NCT02026271|451854107|FG000|Overall Study|Withdrawal by Subject|0|||
125610006|NCT02026271|451854108|FG001|Overall Study|Withdrawal by Subject|0|||
125610007|NCT02026271|451854109|FG002|Overall Study|Withdrawal by Subject|0|||
125610008|NCT02026271|451854110|FG003|Overall Study|Withdrawal by Subject|0|||
125610009|NCT02026271|451854111|FG004|Overall Study|Withdrawal by Subject|1|||
125610010|NCT01921257|451854113|FG000|Overall Study|Adverse Event|1|||
125610011|NCT01921257|451854113|FG000|Overall Study|Protocol Violation|1|||
125610012|NCT01921257|451854113|FG000|Overall Study|Withdrawal by Subject|1|||
125610013|NCT00777491|451854114|FG000|Overall Study|Protocol Violation|0|||
125610014|NCT00777491|451854115|FG001|Overall Study|Protocol Violation|2|||
125610015|NCT00777491|451854114|FG000|Overall Study|Did not receive any protocol treatment|2|||
125610016|NCT00777491|451854115|FG001|Overall Study|Did not receive any protocol treatment|0|||
125610017|NCT03987620|451854116|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
125610018|NCT03987620|451854117|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
125371636|NCT03129100|450993253|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371637|NCT03129100|450993254|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371638|NCT03129100|450993255|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371639|NCT03129100|450993256|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371640|NCT03129100|450993257|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371641|NCT03129100|450993258|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371642|NCT03129100|450993259|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371643|NCT03129100|450993260|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371644|NCT03129100|450993261|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
125371645|NCT03129100|450993236|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125610019|NCT03987620|451854116|FG000|Overall Study|Adverse Event|3|||
125610020|NCT03987620|451854117|FG001|Overall Study|Adverse Event|0|||
125610021|NCT03987620|451854116|FG000|Overall Study|Lost to Follow-up|1|||
125610022|NCT03987620|451854117|FG001|Overall Study|Lost to Follow-up|2|||
125610023|NCT03987620|451854116|FG000|Overall Study|Physician Decision|0|||
125610024|NCT03987620|451854117|FG001|Overall Study|Physician Decision|1|||
125213922|NCT02452554|450409810|FG002|Overall Study|Lack of Efficacy|9|||
125213923|NCT02452554|450409811|FG003|Overall Study|Lack of Efficacy|1|||
125213924|NCT02452554|450409812|FG004|Overall Study|Lack of Efficacy|5|||
125213925|NCT02452554|450409813|FG005|Overall Study|Lack of Efficacy|8|||
125213926|NCT02452554|450409808|FG000|Overall Study|Physician Decision|0|||
125213927|NCT02452554|450409809|FG001|Overall Study|Physician Decision|1|||
125213928|NCT02452554|450409810|FG002|Overall Study|Physician Decision|0|||
125213929|NCT02452554|450409811|FG003|Overall Study|Physician Decision|0|||
125213930|NCT02452554|450409812|FG004|Overall Study|Physician Decision|0|||
125213931|NCT02452554|450409813|FG005|Overall Study|Physician Decision|0|||
125213932|NCT02452554|450409808|FG000|Overall Study|Withdrawal by Subject|1|||
125213933|NCT02452554|450409809|FG001|Overall Study|Withdrawal by Subject|0|||
125213934|NCT02452554|450409810|FG002|Overall Study|Withdrawal by Subject|2|||
125213935|NCT02452554|450409811|FG003|Overall Study|Withdrawal by Subject|0|||
125213936|NCT02452554|450409812|FG004|Overall Study|Withdrawal by Subject|0|||
125213937|NCT02452554|450409813|FG005|Overall Study|Withdrawal by Subject|1|||
125213938|NCT02452554|450409808|FG000|Overall Study|Ineligible|0|||
125213939|NCT02452554|450409809|FG001|Overall Study|Ineligible|1|||
125213940|NCT02452554|450409810|FG002|Overall Study|Ineligible|0|||
125213941|NCT02452554|450409811|FG003|Overall Study|Ineligible|0|||
125213942|NCT02452554|450409812|FG004|Overall Study|Ineligible|0|||
125213943|NCT02452554|450409813|FG005|Overall Study|Ineligible|0|||
125213944|NCT02452554|450409808|FG000|Overall Study|Never Received Treatment|1|||
125213945|NCT02452554|450409809|FG001|Overall Study|Never Received Treatment|0|||
125213946|NCT02452554|450409810|FG002|Overall Study|Never Received Treatment|0|||
125213947|NCT02452554|450409811|FG003|Overall Study|Never Received Treatment|0|||
125213948|NCT02452554|450409812|FG004|Overall Study|Never Received Treatment|0|||
125213949|NCT02452554|450409813|FG005|Overall Study|Never Received Treatment|0|||
125213950|NCT05188729|450409814|FG000|Overall Study|Withdrawal by Subject|0|||
125213951|NCT05188729|450409815|FG001|Overall Study|Withdrawal by Subject|0|||
125213952|NCT05188729|450409816|FG002|Overall Study|Withdrawal by Subject|0|||
125213953|NCT05188729|450409817|FG003|Overall Study|Withdrawal by Subject|0|||
125213954|NCT05188729|450409818|FG004|Overall Study|Withdrawal by Subject|0|||
125213955|NCT05188729|450409819|FG005|Overall Study|Withdrawal by Subject|0|||
125213956|NCT05188729|450409820|FG006|Overall Study|Withdrawal by Subject|0|||
125213957|NCT05188729|450409821|FG007|Overall Study|Withdrawal by Subject|0|||
125213958|NCT05188729|450409822|FG008|Overall Study|Withdrawal by Subject|0|||
125213959|NCT05188729|450409823|FG009|Overall Study|Withdrawal by Subject|1|||
125213960|NCT05188729|450409824|FG010|Overall Study|Withdrawal by Subject|0|||
125213961|NCT05188729|450409825|FG011|Overall Study|Withdrawal by Subject|0|||
125213962|NCT05188729|450409826|FG012|Overall Study|Withdrawal by Subject|0|||
125213963|NCT05188729|450409814|FG000|Overall Study|Lost to Follow-up|0|||
125213964|NCT05188729|450409815|FG001|Overall Study|Lost to Follow-up|0|||
125213965|NCT05188729|450409816|FG002|Overall Study|Lost to Follow-up|0|||
125213966|NCT05188729|450409817|FG003|Overall Study|Lost to Follow-up|0|||
125213967|NCT05188729|450409818|FG004|Overall Study|Lost to Follow-up|0|||
125213968|NCT05188729|450409819|FG005|Overall Study|Lost to Follow-up|0|||
125213969|NCT05188729|450409820|FG006|Overall Study|Lost to Follow-up|0|||
125213970|NCT05188729|450409821|FG007|Overall Study|Lost to Follow-up|0|||
125213971|NCT05188729|450409822|FG008|Overall Study|Lost to Follow-up|0|||
125213972|NCT05188729|450409823|FG009|Overall Study|Lost to Follow-up|0|||
125213973|NCT05188729|450409824|FG010|Overall Study|Lost to Follow-up|1|||
125213974|NCT05188729|450409825|FG011|Overall Study|Lost to Follow-up|1|||
125213975|NCT05188729|450409826|FG012|Overall Study|Lost to Follow-up|0|||
125213976|NCT02552888|450409827|FG000|Overall Study|Lost to Follow-up|1|||
125213977|NCT02552888|450409828|FG001|Overall Study|Lost to Follow-up|1|||
125213978|NCT02442206|450411201|FG000|Period 1|Adverse Event|1|||
125213979|NCT02442206|450411202|FG001|Period 1|Adverse Event|1|||
125213980|NCT02442206|450411201|FG000|Period 1|withdrew consent|0|||
125213981|NCT02442206|450411202|FG001|Period 1|withdrew consent|1|||
125213982|NCT02442206|450411201|FG000|Period 1|COPD exacerbation|0|||
125213983|NCT02442206|450411202|FG001|Period 1|COPD exacerbation|1|||
125213984|NCT02442206|450411201|FG000|Period 2|Adverse Event|1|||
125213985|NCT02442206|450411202|FG001|Period 2|Adverse Event|0|||
125213986|NCT00497146|450411203|FG000|Treatment Period|Adverse Event|6|||
125213987|NCT00497146|450411204|FG001|Treatment Period|Adverse Event|2|||
125610025|NCT03987620|451854116|FG000|Overall Study|Pregnancy|1|||
125213988|NCT00497146|450411203|FG000|Treatment Period|Withdrawal by Subject|5|||
125213989|NCT00497146|450411204|FG001|Treatment Period|Withdrawal by Subject|9|||
125213990|NCT00497146|450411203|FG000|Treatment Period|Lost to Follow-up|1|||
125213991|NCT00497146|450411204|FG001|Treatment Period|Lost to Follow-up|3|||
125213992|NCT00497146|450411203|FG000|Treatment Period|Required dialysis|4|||
125213993|NCT00497146|450411204|FG001|Treatment Period|Required dialysis|1|||
125213994|NCT00497146|450411203|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
125213995|NCT00497146|450411204|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
125213996|NCT00497146|450411203|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
125213997|NCT00497146|450411204|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
125213998|NCT00497146|450411203|FG000|Treatment Period|Other Reason|2|||
125213999|NCT00497146|450411204|FG001|Treatment Period|Other Reason|3|||
125610026|NCT03987620|451854117|FG001|Overall Study|Pregnancy|0|||
125610027|NCT03987620|451854116|FG000|Overall Study|Withdrawal by Subject|7|||
125610028|NCT03987620|451854117|FG001|Overall Study|Withdrawal by Subject|1|||
125610029|NCT03987620|451854116|FG000|Overall Study|Other|2|||
125610030|NCT03987620|451854117|FG001|Overall Study|Other|5|||
125610031|NCT01745393|451854119|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
125610032|NCT01745393|451854120|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
125610033|NCT01745393|451854119|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
125610034|NCT01745393|451854120|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
125610035|NCT01745393|451854119|FG000|12-month Follow-up|Lost to Follow-up|6|||
125610036|NCT01745393|451854120|FG001|12-month Follow-up|Lost to Follow-up|5|||
125610037|NCT00471445|451854121|FG000|Overall Study|Withdrawal by Subject|1|||
125610038|NCT00471445|451854122|FG001|Overall Study|Withdrawal by Subject|1|||
125610039|NCT00471445|451854121|FG000|Overall Study|Ineligible|1|||
125610040|NCT00471445|451854122|FG001|Overall Study|Ineligible|0|||
125610041|NCT00471445|451854121|FG000|Overall Study|Protocol Violation|0|||
125610042|NCT00471445|451854122|FG001|Overall Study|Protocol Violation|1|||
125610043|NCT03591146|451854125|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
125610044|NCT03591146|451854126|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
125610045|NCT03591146|451854127|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
125610046|NCT03591146|451854128|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
125610047|NCT03591146|451854129|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
125610048|NCT03591146|451854125|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
125610049|NCT03591146|451854126|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
125214000|NCT00497146|450411203|FG000|Long-term Follow-up Period|Adverse Event|2|||
125214001|NCT00497146|450411204|FG001|Long-term Follow-up Period|Adverse Event|2|||
125214002|NCT00497146|450411203|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
125214003|NCT00497146|450411204|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
125214004|NCT00497146|450411203|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
125214005|NCT00497146|450411204|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
125214006|NCT00497146|450411203|FG000|Long-term Follow-up Period|Other|0|||
125214007|NCT00497146|450411204|FG001|Long-term Follow-up Period|Other|1|||
125214008|NCT02155309|450411205|FG000|Overall Study|Protocol Violation|0|||
125214009|NCT02155309|450411206|FG001|Overall Study|Protocol Violation|0|||
125214010|NCT02155309|450411207|FG002|Overall Study|Protocol Violation|1|||
125214011|NCT03084302|450411208|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
125214012|NCT03084302|450411208|FG000|Overall Study|No valid objective monitor data|6|||
125214013|NCT00929994|450411209|FG000|Overall Study|Withdrawal by Subject|1|||
125214014|NCT00929994|450411209|FG000|Overall Study|medical issue unrelated to intervention|4|||
125610050|NCT03591146|451854127|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
125214015|NCT00929994|450411209|FG000|Overall Study|employment|1|||
125610051|NCT03591146|451854128|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
125610052|NCT03591146|451854129|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
125610053|NCT03591146|451854125|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
125610054|NCT03591146|451854126|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
125610055|NCT03591146|451854127|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
125610056|NCT03591146|451854128|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
125610057|NCT03591146|451854129|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
125610058|NCT03591146|451854125|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
125610059|NCT03591146|451854126|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
125610060|NCT03591146|451854127|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
125610061|NCT03591146|451854128|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
125610062|NCT03591146|451854129|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
125610063|NCT04737031|451854130|FG000|Overall Study|Patients who did not have a treatment visit|0|||
125610064|NCT04737031|451854131|FG001|Overall Study|Patients who did not have a treatment visit|31|||
125610065|NCT04737031|451854132|FG002|Overall Study|Patients who did not have a treatment visit|93|||
125610066|NCT04737031|451854133|FG003|Overall Study|Patients who did not have a treatment visit|227|||
125610067|NCT01468909|451854134|FG000|Overall Study|Never Treated|2|||
125610068|NCT01468909|451854135|FG001|Overall Study|Never Treated|2|||
125610069|NCT01204658|451854139|FG000|Primary Phase|Adverse Event|0|||
125214016|NCT01411319|450411210|FG000|Overall Study|Lost to Follow-up|1|||
125214017|NCT01214668|450411211|FG000|Overall Study|Adverse Event|0|||
125214018|NCT01214668|450411212|FG001|Overall Study|Adverse Event|1|||
125214019|NCT01214668|450411213|FG002|Overall Study|Adverse Event|0|||
125214020|NCT01214668|450411214|FG003|Overall Study|Adverse Event|2|||
125610070|NCT01204658|451854140|FG001|Primary Phase|Adverse Event|0|||
125610071|NCT01204658|451854141|FG002|Primary Phase|Adverse Event|1|||
125610072|NCT01204658|451854142|FG003|Primary Phase|Adverse Event|0|||
125610073|NCT00905021|451854143|FG000|Overall Study|Adverse Event|2|||
125610074|NCT01511419|451854144|FG000|Dose 2|Physician Decision|1|||
125610075|NCT01511419|451854145|FG001|Dose 2|Physician Decision|0|||
125610076|NCT00786838|451854146|FG000|Overall Study|Physician Decision|4|||
125610077|NCT00786838|451854146|FG000|Overall Study|Death|4|||
125610078|NCT00786838|451854146|FG000|Overall Study|Adverse Event|6|||
125610079|NCT00786838|451854146|FG000|Overall Study|Progressive disease|31|||
125610080|NCT00786838|451854146|FG000|Overall Study|Withdrawal by Subject|4|||
125610081|NCT04594239|451854147|FG000|Overall Study|Withdrawal by Subject|3|||
125610082|NCT04594239|451854148|FG001|Overall Study|Withdrawal by Subject|4|||
125610083|NCT04594239|451854149|FG002|Overall Study|Withdrawal by Subject|2|||
125610084|NCT04594239|451854150|FG003|Overall Study|Withdrawal by Subject|4|||
125610085|NCT04594239|451854147|FG000|Overall Study|Lost to Follow-up|8|||
125610086|NCT04594239|451854148|FG001|Overall Study|Lost to Follow-up|5|||
125610087|NCT04594239|451854149|FG002|Overall Study|Lost to Follow-up|4|||
125610088|NCT04594239|451854150|FG003|Overall Study|Lost to Follow-up|6|||
125610089|NCT04594239|451854147|FG000|Overall Study|Subject relocated|0|||
125610090|NCT04594239|451854148|FG001|Overall Study|Subject relocated|0|||
125610091|NCT04594239|451854149|FG002|Overall Study|Subject relocated|0|||
125610092|NCT04594239|451854150|FG003|Overall Study|Subject relocated|1|||
125610093|NCT03484923|451855459|FG000|Overall Study|Adverse Event|3|||
125610094|NCT03484923|451855460|FG001|Overall Study|Adverse Event|3|||
125610095|NCT03484923|451855461|FG002|Overall Study|Adverse Event|5|||
125610096|NCT03484923|451855462|FG003|Overall Study|Adverse Event|11|||
125610097|NCT03484923|451855463|FG004|Overall Study|Adverse Event|1|||
125610098|NCT03484923|451855459|FG000|Overall Study|Death|2|||
125610099|NCT03484923|451855460|FG001|Overall Study|Death|2|||
125610100|NCT03484923|451855461|FG002|Overall Study|Death|3|||
125610101|NCT03484923|451855462|FG003|Overall Study|Death|0|||
125610102|NCT03484923|451855463|FG004|Overall Study|Death|1|||
125610103|NCT03484923|451855459|FG000|Overall Study|Physician Decision|6|||
125610104|NCT03484923|451855460|FG001|Overall Study|Physician Decision|7|||
125610105|NCT03484923|451855461|FG002|Overall Study|Physician Decision|6|||
125610106|NCT03484923|451855462|FG003|Overall Study|Physician Decision|3|||
125610107|NCT03484923|451855463|FG004|Overall Study|Physician Decision|2|||
125610108|NCT03484923|451855459|FG000|Overall Study|Progressive disease|33|||
125610109|NCT03484923|451855460|FG001|Overall Study|Progressive disease|28|||
125610110|NCT03484923|451855461|FG002|Overall Study|Progressive disease|26|||
125610111|NCT03484923|451855462|FG003|Overall Study|Progressive disease|30|||
125610112|NCT03484923|451855463|FG004|Overall Study|Progressive disease|16|||
125610113|NCT03484923|451855459|FG000|Overall Study|Subject Decision|1|||
125610114|NCT03484923|451855460|FG001|Overall Study|Subject Decision|3|||
125610115|NCT03484923|451855461|FG002|Overall Study|Subject Decision|3|||
125610116|NCT03484923|451855462|FG003|Overall Study|Subject Decision|0|||
125610117|NCT03484923|451855463|FG004|Overall Study|Subject Decision|1|||
125610118|NCT00630812|451855469|FG000|Randomisation to First Dose|Adverse Event|1|||
125610119|NCT00630812|451855470|FG001|Randomisation to First Dose|Adverse Event|1|||
125610120|NCT00630812|451855469|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
125610121|NCT00630812|451855470|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
125610122|NCT00630812|451855469|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
125610123|NCT00630812|451855470|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
125610124|NCT00630812|451855469|FG000|Randomisation to First Dose|Protocol Violation|4|||
125610125|NCT00630812|451855470|FG001|Randomisation to First Dose|Protocol Violation|1|||
125610126|NCT00630812|451855469|FG000|Double Blind Treatment Period|Adverse Event|13|||
125610127|NCT00630812|451855470|FG001|Double Blind Treatment Period|Adverse Event|5|||
125610128|NCT00630812|451855469|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
125610129|NCT00630812|451855470|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
125610130|NCT00630812|451855469|FG000|Double Blind Treatment Period|Physician Decision|2|||
125610131|NCT00630812|451855470|FG001|Double Blind Treatment Period|Physician Decision|1|||
125610132|NCT00630812|451855469|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125610133|NCT00630812|451855470|FG001|Double Blind Treatment Period|Protocol Violation|0|||
125610134|NCT00630812|451855469|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
125610135|NCT00630812|451855470|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
125610136|NCT00630812|451855469|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
125610137|NCT00630812|451855470|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
125610138|NCT00630812|451855469|FG000|Double Blind Treatment Period|Non-compliance|0|||
125610139|NCT00630812|451855470|FG001|Double Blind Treatment Period|Non-compliance|1|||
125610140|NCT05628181|451855471|FG000|Overall Study|Death|2|||
125610141|NCT05628181|451855472|FG001|Overall Study|Death|4|||
125610142|NCT05628181|451855473|FG002|Overall Study|Death|0|||
125610143|NCT03656926|451855482|FG000|Overall Study|Adverse Event|5|||
125610144|NCT03656926|451855483|FG001|Overall Study|Adverse Event|4|||
125610145|NCT03656926|451855482|FG000|Overall Study|Withdrawal by Subject|7|||
125610146|NCT03656926|451855483|FG001|Overall Study|Withdrawal by Subject|2|||
125610147|NCT03656926|451855482|FG000|Overall Study|Screen fail after randomization|1|||
125610148|NCT03656926|451855483|FG001|Overall Study|Screen fail after randomization|0|||
125610149|NCT03656926|451855482|FG000|Overall Study|PI decision due to patient condition|1|||
125610150|NCT03656926|451855483|FG001|Overall Study|PI decision due to patient condition|0|||
125610151|NCT03656926|451855482|FG000|Overall Study|Patient unresponsiveness|1|||
125610152|NCT03656926|451855483|FG001|Overall Study|Patient unresponsiveness|0|||
125371646|NCT03129100|450993237|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371647|NCT03129100|450993238|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
125371648|NCT03129100|450993239|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371649|NCT03129100|450993240|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371650|NCT03129100|450993241|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371651|NCT03129100|450993242|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371652|NCT03129100|450993243|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371653|NCT03129100|450993244|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371654|NCT03129100|450993245|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371655|NCT03129100|450993246|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371656|NCT03129100|450993247|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371657|NCT03129100|450993248|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371658|NCT03129100|450993249|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371659|NCT03129100|450993250|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125610153|NCT05610176|451855484|FG000|Overall Study|Death|6|||
125610154|NCT00471536|451855485|FG000|Overall Study|Withdrawal by Subject|1|||
125610155|NCT01253044|451855490|FG000|Overall Study|Lost to Follow-up|38|||
125610156|NCT01253044|451855491|FG001|Overall Study|Lost to Follow-up|29|||
125610157|NCT00905307|451855492|FG000|Overall Study|Switched to Open Label Rescue|7|||
125610158|NCT00905307|451855493|FG001|Overall Study|Switched to Open Label Rescue|17|||
125610159|NCT00905307|451855494|FG002|Overall Study|Switched to Open Label Rescue|11|||
125610160|NCT00905307|451855495|FG003|Overall Study|Switched to Open Label Rescue|11|||
125610161|NCT00905307|451855496|FG004|Overall Study|Switched to Open Label Rescue|4|||
125610162|NCT00905307|451855497|FG005|Overall Study|Switched to Open Label Rescue|15|||
125610163|NCT00905307|451855492|FG000|Overall Study|Lost to Follow-up|0|||
125610164|NCT00905307|451855493|FG001|Overall Study|Lost to Follow-up|0|||
125610165|NCT00905307|451855494|FG002|Overall Study|Lost to Follow-up|0|||
125610166|NCT00905307|451855495|FG003|Overall Study|Lost to Follow-up|0|||
125610167|NCT00905307|451855496|FG004|Overall Study|Lost to Follow-up|1|||
125610168|NCT00905307|451855497|FG005|Overall Study|Lost to Follow-up|1|||
125610169|NCT00905307|451855492|FG000|Overall Study|Adverse Event|3|||
125610170|NCT00905307|451855493|FG001|Overall Study|Adverse Event|4|||
125610171|NCT00905307|451855494|FG002|Overall Study|Adverse Event|5|||
125610172|NCT00905307|451855495|FG003|Overall Study|Adverse Event|11|||
125610173|NCT00905307|451855496|FG004|Overall Study|Adverse Event|3|||
125610174|NCT00905307|451855497|FG005|Overall Study|Adverse Event|5|||
125610175|NCT00905307|451855492|FG000|Overall Study|Withdrawal by Subject|5|||
125610176|NCT00905307|451855493|FG001|Overall Study|Withdrawal by Subject|13|||
125610177|NCT00905307|451855494|FG002|Overall Study|Withdrawal by Subject|15|||
125610178|NCT00905307|451855495|FG003|Overall Study|Withdrawal by Subject|11|||
125610179|NCT00905307|451855496|FG004|Overall Study|Withdrawal by Subject|4|||
125610180|NCT00905307|451855497|FG005|Overall Study|Withdrawal by Subject|13|||
125610181|NCT00905307|451855492|FG000|Overall Study|Protocol Violation|1|||
125610182|NCT00905307|451855493|FG001|Overall Study|Protocol Violation|0|||
125610183|NCT00905307|451855494|FG002|Overall Study|Protocol Violation|1|||
125610184|NCT00905307|451855495|FG003|Overall Study|Protocol Violation|0|||
125610185|NCT00905307|451855496|FG004|Overall Study|Protocol Violation|0|||
125610186|NCT00905307|451855497|FG005|Overall Study|Protocol Violation|0|||
125610187|NCT00905307|451855492|FG000|Overall Study|Lack of Efficacy|6|||
125610188|NCT00905307|451855493|FG001|Overall Study|Lack of Efficacy|3|||
125610189|NCT00905307|451855494|FG002|Overall Study|Lack of Efficacy|5|||
125610190|NCT00905307|451855495|FG003|Overall Study|Lack of Efficacy|4|||
125610191|NCT00905307|451855496|FG004|Overall Study|Lack of Efficacy|4|||
125610192|NCT00905307|451855497|FG005|Overall Study|Lack of Efficacy|8|||
125610193|NCT01864018|451855498|FG000|Overall Study|Ineligible|3|||
125610194|NCT01864018|451855499|FG001|Overall Study|Ineligible|1|||
125371660|NCT03129100|450993251|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371661|NCT03129100|450993252|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371662|NCT03129100|450993253|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125610195|NCT03280550|451855506|FG000|Overall Study|Withdrawal by Subject|2|||
125610196|NCT03280550|451855507|FG001|Overall Study|Withdrawal by Subject|2|||
125610197|NCT03280550|451855506|FG000|Overall Study|Physician Decision|0|||
125610198|NCT03280550|451855507|FG001|Overall Study|Physician Decision|1|||
125610199|NCT03345836|451855508|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
125610200|NCT03345836|451855509|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
125610201|NCT03345836|451855510|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
125610202|NCT03345836|451855511|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
125610203|NCT03345836|451855512|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
125610204|NCT03345836|451855513|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
125610205|NCT03345836|451855508|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
125610206|NCT03345836|451855509|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
125610207|NCT03345836|451855510|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
125371663|NCT03129100|450993254|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371664|NCT03129100|450993255|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371665|NCT03129100|450993256|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371666|NCT03129100|450993257|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371667|NCT03129100|450993258|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371668|NCT03129100|450993259|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371669|NCT03129100|450993260|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371670|NCT03129100|450993261|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
125371671|NCT03129100|450993236|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371672|NCT03129100|450993237|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371673|NCT03129100|450993238|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
125371674|NCT03129100|450993239|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371675|NCT03129100|450993240|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371676|NCT03129100|450993241|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125431967|NCT01987817|451207819|FG000|Overall Study|Adverse Event|4|||
125610208|NCT03345836|451855511|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
125610209|NCT03345836|451855512|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
125610210|NCT03345836|451855513|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
125610211|NCT03345836|451855508|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
125610212|NCT03345836|451855509|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
125610213|NCT03345836|451855510|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
125610214|NCT03345836|451855511|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
125610215|NCT03345836|451855512|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
125610216|NCT03345836|451855513|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
125431968|NCT01987817|451207820|FG001|Overall Study|Adverse Event|0|||
125431969|NCT01987817|451207819|FG000|Overall Study|Withdrawal by Subject|1|||
125610217|NCT03345836|451855508|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
125610218|NCT03345836|451855509|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
125610219|NCT03345836|451855510|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
125610220|NCT03345836|451855511|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
125610221|NCT03345836|451855512|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
125610222|NCT03345836|451855513|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
125431970|NCT01987817|451207820|FG001|Overall Study|Withdrawal by Subject|1|||
125431971|NCT01987817|451207819|FG000|Overall Study|Physician Decision|1|||
125431972|NCT01987817|451207820|FG001|Overall Study|Physician Decision|0|||
125610223|NCT03345836|451855508|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
125610224|NCT03345836|451855509|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
125610225|NCT03345836|451855510|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
125610226|NCT03345836|451855511|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
125610227|NCT03345836|451855512|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
125431973|NCT01576718|451207821|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
125431974|NCT01576718|451207822|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125431975|NCT01576718|451207823|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125431976|NCT01576718|451207824|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125431977|NCT01576718|451207825|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125431978|NCT01576718|451207826|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125431979|NCT01576718|451207827|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125431980|NCT01576718|451207821|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
125431981|NCT01576718|451207822|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125431982|NCT01576718|451207823|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125431983|NCT01576718|451207824|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125431984|NCT01576718|451207825|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125431985|NCT01576718|451207826|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125431986|NCT01576718|451207827|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125431987|NCT01576718|451207821|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
125431988|NCT01576718|451207822|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125610228|NCT03345836|451855513|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
125371677|NCT03129100|450993242|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371678|NCT03129100|450993243|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125431989|NCT01576718|451207823|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125431990|NCT01576718|451207824|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125431991|NCT01576718|451207825|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125610229|NCT03345836|451855508|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
125610230|NCT03345836|451855509|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
125610231|NCT03345836|451855510|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
125610232|NCT03345836|451855511|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
125610233|NCT03345836|451855512|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
125610234|NCT03345836|451855513|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
125610235|NCT03345836|451855508|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
125610236|NCT03345836|451855509|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
125610237|NCT03345836|451855510|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
125610238|NCT03345836|451855511|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
125610239|NCT03345836|451855512|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
125610240|NCT03345836|451855513|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
125610241|NCT03345836|451855508|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
125610242|NCT03345836|451855509|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
125610243|NCT03345836|451855510|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
125610244|NCT03345836|451855511|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
125610245|NCT03345836|451855512|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
125610246|NCT03345836|451855513|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
125610247|NCT03345836|451855508|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
125610248|NCT03345836|451855509|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
125610249|NCT03345836|451855510|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
125610250|NCT03345836|451855511|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
125610251|NCT03345836|451855512|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
125610252|NCT03345836|451855513|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
125610253|NCT03345836|451855508|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
125610254|NCT03345836|451855509|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
125610255|NCT03345836|451855510|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
125610256|NCT03345836|451855511|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
125610257|NCT03345836|451855512|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
125610258|NCT03345836|451855513|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
125610259|NCT03345836|451855508|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
125610260|NCT03345836|451855509|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
125610261|NCT03345836|451855510|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
125610262|NCT03345836|451855511|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
125610263|NCT03345836|451855512|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
125610264|NCT03345836|451855513|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
125610265|NCT01555463|451855514|FG000|Treatment|Adverse Event|6|||
125610266|NCT01555463|451855515|FG001|Treatment|Adverse Event|12|||
125610267|NCT01555463|451855514|FG000|Treatment|Withdrawal by Subject|24|||
125610268|NCT01555463|451855515|FG001|Treatment|Withdrawal by Subject|36|||
125610269|NCT01555463|451855514|FG000|Treatment|Lost to Follow-up|28|||
125610270|NCT01555463|451855515|FG001|Treatment|Lost to Follow-up|23|||
125610271|NCT01555463|451855514|FG000|Treatment|Protocol Violation|4|||
125610272|NCT01555463|451855515|FG001|Treatment|Protocol Violation|5|||
125610273|NCT01555463|451855514|FG000|Treatment|Other reason|2|||
125610274|NCT01555463|451855515|FG001|Treatment|Other reason|3|||
125610275|NCT01555463|451855514|FG000|Follow up|Adverse Event|2|||
125610276|NCT01555463|451855515|FG001|Follow up|Adverse Event|5|||
125610277|NCT01555463|451855514|FG000|Follow up|Death|0|||
125610278|NCT01555463|451855515|FG001|Follow up|Death|1|||
125610279|NCT01555463|451855514|FG000|Follow up|Withdrawal by Subject|22|||
125610280|NCT01555463|451855515|FG001|Follow up|Withdrawal by Subject|22|||
125610281|NCT01555463|451855514|FG000|Follow up|Lost to Follow-up|9|||
125610282|NCT01555463|451855515|FG001|Follow up|Lost to Follow-up|10|||
125610283|NCT01555463|451855514|FG000|Follow up|Protocol Violation|2|||
125610284|NCT01555463|451855515|FG001|Follow up|Protocol Violation|4|||
125610285|NCT01555463|451855514|FG000|Follow up|Other reason|3|||
125610286|NCT01555463|451855515|FG001|Follow up|Other reason|3|||
125436541|NCT02597933|451224422|FG000|Overall Study|Other than stated above|7|||
125610287|NCT04370028|451855517|FG000|Overall Study|Withdrawal by Subject|695|||
125610288|NCT04370028|451855517|FG000|Overall Study|Protocol Violation|9|||
125610289|NCT04370028|451855517|FG000|Overall Study|Adverse Event|3|||
125610290|NCT02213198|451855520|FG000|Baseline|No show for intake|7|||
125610291|NCT02213198|451855521|FG001|Baseline|No show for intake|9|||
125610292|NCT02213198|451855520|FG000|Baseline|Withdrawal by Subject|34|||
125610293|NCT02213198|451855521|FG001|Baseline|Withdrawal by Subject|11|||
125214021|NCT01214668|450411215|FG004|Overall Study|Adverse Event|1|||
125214022|NCT01214668|450411216|FG005|Overall Study|Adverse Event|1|||
125214023|NCT01214668|450411211|FG000|Overall Study|Death|0|||
125214024|NCT01214668|450411212|FG001|Overall Study|Death|0|||
125214025|NCT01214668|450411213|FG002|Overall Study|Death|1|||
125214026|NCT01214668|450411214|FG003|Overall Study|Death|0|||
125214027|NCT01214668|450411215|FG004|Overall Study|Death|0|||
125214028|NCT01214668|450411216|FG005|Overall Study|Death|0|||
125214029|NCT01214668|450411211|FG000|Overall Study|Progressive Disease|4|||
125214030|NCT01214668|450411212|FG001|Overall Study|Progressive Disease|2|||
125214031|NCT01214668|450411213|FG002|Overall Study|Progressive Disease|5|||
125214032|NCT01214668|450411214|FG003|Overall Study|Progressive Disease|4|||
125214033|NCT01214668|450411215|FG004|Overall Study|Progressive Disease|4|||
125214034|NCT01214668|450411216|FG005|Overall Study|Progressive Disease|5|||
125214035|NCT01214668|450411211|FG000|Overall Study|Withdrawal by Subject|0|||
125214036|NCT01214668|450411212|FG001|Overall Study|Withdrawal by Subject|0|||
125610294|NCT02213198|451855520|FG000|Baseline|transferred out of clinic|7|||
125610295|NCT02213198|451855521|FG001|Baseline|transferred out of clinic|9|||
125610296|NCT02213198|451855520|FG000|Baseline|Lost to Follow-up|40|||
125610297|NCT02213198|451855521|FG001|Baseline|Lost to Follow-up|21|||
125610298|NCT02213198|451855520|FG000|Baseline|incarcerated,violent|0|||
125610299|NCT02213198|451855521|FG001|Baseline|incarcerated,violent|1|||
125610300|NCT02213198|451855520|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
125610301|NCT02213198|451855521|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
125610302|NCT02213198|451855520|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
125610303|NCT02213198|451855521|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
125610304|NCT02213198|451855520|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
125610305|NCT02213198|451855521|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
125610306|NCT02213198|451855520|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
125371679|NCT03129100|450993244|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371680|NCT03129100|450993245|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371681|NCT03129100|450993246|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371682|NCT03129100|450993247|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371683|NCT03129100|450993248|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371684|NCT03129100|450993249|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371685|NCT03129100|450993250|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371686|NCT03129100|450993251|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371687|NCT03129100|450993252|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371688|NCT03129100|450993253|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371689|NCT03129100|450993254|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371690|NCT03129100|450993255|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371691|NCT03129100|450993256|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371692|NCT03129100|450993257|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371693|NCT03129100|450993258|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371694|NCT03129100|450993259|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371695|NCT03129100|450993260|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371696|NCT03129100|450993261|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
125371697|NCT03129100|450993236|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371698|NCT03129100|450993237|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371699|NCT03129100|450993238|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
125371700|NCT03129100|450993239|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371701|NCT03129100|450993240|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371702|NCT03129100|450993241|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371703|NCT03129100|450993242|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371704|NCT03129100|450993243|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371705|NCT03129100|450993244|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371706|NCT03129100|450993245|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371707|NCT03129100|450993246|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371708|NCT03129100|450993247|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371709|NCT03129100|450993248|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371710|NCT03129100|450993249|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125610307|NCT02213198|451855521|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
125610308|NCT02213198|451855520|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
125610309|NCT02213198|451855521|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
125214037|NCT01214668|450411213|FG002|Overall Study|Withdrawal by Subject|0|||
125214038|NCT01214668|450411214|FG003|Overall Study|Withdrawal by Subject|0|||
125214039|NCT01214668|450411215|FG004|Overall Study|Withdrawal by Subject|1|||
125214040|NCT01214668|450411216|FG005|Overall Study|Withdrawal by Subject|0|||
125371711|NCT03129100|450993250|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371712|NCT03129100|450993251|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371713|NCT03129100|450993252|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371714|NCT03129100|450993253|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371715|NCT03129100|450993254|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371716|NCT03129100|450993255|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371717|NCT03129100|450993256|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371718|NCT03129100|450993257|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371719|NCT03129100|450993258|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371720|NCT03129100|450993259|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371721|NCT03129100|450993260|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371722|NCT03129100|450993261|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
125371723|NCT03129100|450993236|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371724|NCT03129100|450993237|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371725|NCT03129100|450993238|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371726|NCT03129100|450993239|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371727|NCT03129100|450993240|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
125371728|NCT03129100|450993241|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
125371729|NCT03129100|450993242|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
125371730|NCT03129100|450993243|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371731|NCT03129100|450993244|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371732|NCT03129100|450993245|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371733|NCT03129100|450993246|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371734|NCT03129100|450993247|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371735|NCT03129100|450993248|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371736|NCT03129100|450993249|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371737|NCT03129100|450993250|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371738|NCT03129100|450993251|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371739|NCT03129100|450993252|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371740|NCT03129100|450993253|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371741|NCT03129100|450993254|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371742|NCT03129100|450993255|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371743|NCT03129100|450993256|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371744|NCT03129100|450993257|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371745|NCT03129100|450993258|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371746|NCT03129100|450993259|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371747|NCT03129100|450993260|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371748|NCT03129100|450993261|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
125371749|NCT03129100|450993236|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371750|NCT03129100|450993237|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371751|NCT03129100|450993238|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371752|NCT03129100|450993239|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371753|NCT03129100|450993240|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371754|NCT03129100|450993241|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371755|NCT03129100|450993242|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371756|NCT03129100|450993243|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371757|NCT03129100|450993244|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371758|NCT03129100|450993245|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
125371759|NCT03129100|450993246|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371760|NCT03129100|450993247|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371761|NCT03129100|450993248|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371762|NCT03129100|450993249|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371763|NCT03129100|450993250|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371764|NCT03129100|450993251|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371765|NCT03129100|450993252|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371766|NCT03129100|450993253|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371767|NCT03129100|450993254|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371768|NCT03129100|450993255|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371769|NCT03129100|450993256|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371770|NCT03129100|450993257|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125610310|NCT02213198|451855520|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
125610311|NCT02213198|451855521|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
125610312|NCT05091060|451855522|FG000|Overall Study|Lost to Follow-up|1|||
125610313|NCT01798706|451855523|FG000|Overall Study|Adverse Event|15|||
125610314|NCT01798706|451855524|FG001|Overall Study|Adverse Event|10|||
125610315|NCT01798706|451855523|FG000|Overall Study|Lack of Efficacy|0|||
125610316|NCT01798706|451855524|FG001|Overall Study|Lack of Efficacy|2|||
125610317|NCT01798706|451855523|FG000|Overall Study|Poor compliance to protocol|1|||
125610318|NCT01798706|451855524|FG001|Overall Study|Poor compliance to protocol|0|||
125610319|NCT01798706|451855523|FG000|Overall Study|Other than specified above|5|||
125610320|NCT01798706|451855524|FG001|Overall Study|Other than specified above|9|||
125610321|NCT00496873|451855525|FG000|Overall Study|Ineligible|2|||
125610322|NCT00496873|451855525|FG000|Overall Study|Death|2|||
125610323|NCT00496873|451855525|FG000|Overall Study|Withdrawal by Subject|3|||
125610324|NCT05896761|451855528|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
125610325|NCT05896761|451855529|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
125610326|NCT05896761|451855528|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
125610327|NCT05896761|451855529|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
125610328|NCT03552549|451855531|FG000|Overall Study|Disease progression|25|||
125610329|NCT03552549|451855532|FG001|Overall Study|Disease progression|17|||
125610330|NCT03552549|451855531|FG000|Overall Study|Adverse event in first 12 months|12|||
125610331|NCT03552549|451855532|FG001|Overall Study|Adverse event in first 12 months|8|||
125610332|NCT03552549|451855531|FG000|Overall Study|Withdrawal by Subject|7|||
125610333|NCT03552549|451855532|FG001|Overall Study|Withdrawal by Subject|7|||
125610334|NCT03552549|451855531|FG000|Overall Study|Unknown (no reason provided)|4|||
125610335|NCT03552549|451855532|FG001|Overall Study|Unknown (no reason provided)|2|||
125610336|NCT03552549|451855531|FG000|Overall Study|Not in participant's best interest|2|||
125610337|NCT03552549|451855532|FG001|Overall Study|Not in participant's best interest|1|||
125610338|NCT03552549|451855531|FG000|Overall Study|Did not complete study treatment|2|||
125610339|NCT03552549|451855532|FG001|Overall Study|Did not complete study treatment|3|||
125610340|NCT03552549|451855531|FG000|Overall Study|Did not meet eligibility criteria|1|||
125610341|NCT03552549|451855532|FG001|Overall Study|Did not meet eligibility criteria|0|||
125610342|NCT03552549|451855531|FG000|Overall Study|Administrative|0|||
125610343|NCT03552549|451855532|FG001|Overall Study|Administrative|14|||
125610344|NCT02739594|451855538|FG000|Overall Study|Undesired Event|3|||
125610345|NCT02739594|451855539|FG001|Overall Study|Undesired Event|4|||
125610346|NCT02739594|451855538|FG000|Overall Study|Violation of Eligibility Criteria|1|||
125610347|NCT02739594|451855539|FG001|Overall Study|Violation of Eligibility Criteria|2|||
125610348|NCT02739594|451855538|FG000|Overall Study|Protocol Violation|5|||
125610349|NCT02739594|451855539|FG001|Overall Study|Protocol Violation|6|||
125610350|NCT02739594|451855538|FG000|Overall Study|Death|4|||
125610351|NCT02739594|451855539|FG001|Overall Study|Death|2|||
125610352|NCT02739594|451855538|FG000|Overall Study|Renal Insufficiency|4|||
125610353|NCT02739594|451855539|FG001|Overall Study|Renal Insufficiency|6|||
125610354|NCT02739594|451855538|FG000|Overall Study|Administrative Reasons|1|||
125610355|NCT02739594|451855539|FG001|Overall Study|Administrative Reasons|3|||
125610356|NCT02739594|451855538|FG000|Overall Study|Withdrawal by Subject|1|||
125610357|NCT02739594|451855539|FG001|Overall Study|Withdrawal by Subject|1|||
125610358|NCT02739594|451855538|FG000|Overall Study|Lost to Follow-up|0|||
125610359|NCT02739594|451855539|FG001|Overall Study|Lost to Follow-up|1|||
125610360|NCT02739594|451855538|FG000|Overall Study|Elevated Serum Creatinine|0|||
125610361|NCT02739594|451855539|FG001|Overall Study|Elevated Serum Creatinine|1|||
125610362|NCT02739594|451855538|FG000|Overall Study|Other|6|||
125610363|NCT02739594|451855539|FG001|Overall Study|Other|2|||
125610364|NCT01465178|451855540|FG000|Overall Study|Withdrawal by Subject|1|||
125610365|NCT01465178|451855541|FG001|Overall Study|Withdrawal by Subject|0|||
125610366|NCT00527111|451855544|FG000|Overall Study|Adverse Event|14|||
125610367|NCT00527111|451855545|FG001|Overall Study|Adverse Event|13|||
125610368|NCT00527111|451855544|FG000|Overall Study|Death|0|||
125610369|NCT00527111|451855545|FG001|Overall Study|Death|1|||
125214041|NCT01964989|450411217|FG000|Overall Study|Protocol Violation|3|||
125214042|NCT01964989|450411218|FG001|Overall Study|Protocol Violation|4|||
125610370|NCT00527111|451855544|FG000|Overall Study|Investigator Request|2|||
125610371|NCT00527111|451855545|FG001|Overall Study|Investigator Request|1|||
125610372|NCT00527111|451855544|FG000|Overall Study|Patient Request|2|||
125214043|NCT01964989|450411217|FG000|Overall Study|Administrative Reason|103|||
125214044|NCT01964989|450411218|FG001|Overall Study|Administrative Reason|95|||
125214045|NCT01964989|450411217|FG000|Overall Study|Adverse Event|0|||
125610373|NCT00527111|451855545|FG001|Overall Study|Patient Request|5|||
125610374|NCT00527111|451855544|FG000|Overall Study|Other|2|||
125610375|NCT00527111|451855545|FG001|Overall Study|Other|2|||
125610376|NCT03827473|451855548|FG000|Overall Study|Withdrawal by Subject|1|||
125610377|NCT03827473|451855549|FG001|Overall Study|Withdrawal by Subject|0|||
125610378|NCT00875017|451855550|FG000|First Intervention|Withdrawal by Subject|1|||
125610379|NCT00875017|451855551|FG001|First Intervention|Withdrawal by Subject|0|||
125371771|NCT03129100|450993258|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371772|NCT03129100|450993259|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371773|NCT03129100|450993260|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125371774|NCT03129100|450993261|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
125610380|NCT00875017|451855552|FG002|First Intervention|Withdrawal by Subject|1|||
125610381|NCT00875017|451855553|FG003|First Intervention|Withdrawal by Subject|0|||
125610382|NCT00875017|451855554|FG004|First Intervention|Withdrawal by Subject|0|||
125610383|NCT00875017|451855555|FG005|First Intervention|Withdrawal by Subject|0|||
125610384|NCT00875017|451855550|FG000|First Intervention|Adverse Event|0|||
125610385|NCT00875017|451855551|FG001|First Intervention|Adverse Event|0|||
125610386|NCT00875017|451855552|FG002|First Intervention|Adverse Event|0|||
125610387|NCT00875017|451855553|FG003|First Intervention|Adverse Event|1|||
125610388|NCT00875017|451855554|FG004|First Intervention|Adverse Event|0|||
125610389|NCT00875017|451855555|FG005|First Intervention|Adverse Event|0|||
125610390|NCT00875017|451855550|FG000|First Intervention|Problems collecting rectal effluent|1|||
125610391|NCT00875017|451855551|FG001|First Intervention|Problems collecting rectal effluent|0|||
125610392|NCT00875017|451855552|FG002|First Intervention|Problems collecting rectal effluent|0|||
125610393|NCT00875017|451855553|FG003|First Intervention|Problems collecting rectal effluent|0|||
125610394|NCT00875017|451855554|FG004|First Intervention|Problems collecting rectal effluent|0|||
125610395|NCT00875017|451855555|FG005|First Intervention|Problems collecting rectal effluent|0|||
125610396|NCT00875017|451855550|FG000|First Intervention|Intolerance to nasogastric tube|0|||
125610397|NCT00875017|451855551|FG001|First Intervention|Intolerance to nasogastric tube|0|||
125610398|NCT00875017|451855552|FG002|First Intervention|Intolerance to nasogastric tube|0|||
125610399|NCT00875017|451855553|FG003|First Intervention|Intolerance to nasogastric tube|0|||
125610400|NCT00875017|451855554|FG004|First Intervention|Intolerance to nasogastric tube|1|||
125610401|NCT00875017|451855555|FG005|First Intervention|Intolerance to nasogastric tube|0|||
125610402|NCT00875017|451855550|FG000|Washout|Problem collecting rectal effluent|0|||
125610403|NCT00875017|451855551|FG001|Washout|Problem collecting rectal effluent|0|||
125610404|NCT00875017|451855552|FG002|Washout|Problem collecting rectal effluent|1|||
125610405|NCT00875017|451855553|FG003|Washout|Problem collecting rectal effluent|0|||
125610406|NCT00875017|451855554|FG004|Washout|Problem collecting rectal effluent|0|||
125610407|NCT00875017|451855555|FG005|Washout|Problem collecting rectal effluent|0|||
125610408|NCT00875017|451855550|FG000|Second Intervention|Adverse Event|0|||
125610409|NCT00875017|451855551|FG001|Second Intervention|Adverse Event|0|||
125610410|NCT00875017|451855552|FG002|Second Intervention|Adverse Event|0|||
125610411|NCT00875017|451855553|FG003|Second Intervention|Adverse Event|1|||
125610412|NCT00875017|451855554|FG004|Second Intervention|Adverse Event|0|||
125610413|NCT00875017|451855555|FG005|Second Intervention|Adverse Event|0|||
125610414|NCT00875017|451855550|FG000|Washout|Problems collecting rectal effluent|0|||
125610415|NCT00875017|451855551|FG001|Washout|Problems collecting rectal effluent|1|||
125610416|NCT00875017|451855552|FG002|Washout|Problems collecting rectal effluent|0|||
125610417|NCT00875017|451855553|FG003|Washout|Problems collecting rectal effluent|0|||
125610418|NCT00875017|451855554|FG004|Washout|Problems collecting rectal effluent|0|||
125610419|NCT00875017|451855555|FG005|Washout|Problems collecting rectal effluent|0|||
125610420|NCT00875017|451855550|FG000|Third Intervention|Adverse Event|0|||
125610421|NCT00875017|451855551|FG001|Third Intervention|Adverse Event|1|||
125610422|NCT00875017|451855552|FG002|Third Intervention|Adverse Event|1|||
125610423|NCT00875017|451855553|FG003|Third Intervention|Adverse Event|0|||
125610424|NCT00875017|451855554|FG004|Third Intervention|Adverse Event|0|||
125610425|NCT00875017|451855555|FG005|Third Intervention|Adverse Event|0|||
125610426|NCT00875017|451855550|FG000|Washout|Withdrawal by Subject|0|||
125610427|NCT00875017|451855551|FG001|Washout|Withdrawal by Subject|0|||
125610428|NCT00875017|451855552|FG002|Washout|Withdrawal by Subject|0|||
125610429|NCT00875017|451855553|FG003|Washout|Withdrawal by Subject|0|||
125610430|NCT00875017|451855554|FG004|Washout|Withdrawal by Subject|1|||
125610431|NCT00875017|451855555|FG005|Washout|Withdrawal by Subject|0|||
125610432|NCT00875017|451855550|FG000|Fourth Intervention|Inability to comply with fasting|0|||
125610433|NCT00875017|451855551|FG001|Fourth Intervention|Inability to comply with fasting|0|||
125610434|NCT00875017|451855552|FG002|Fourth Intervention|Inability to comply with fasting|0|||
125371775|NCT03129100|450993236|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371776|NCT03129100|450993237|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371777|NCT03129100|450993238|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125610435|NCT00875017|451855553|FG003|Fourth Intervention|Inability to comply with fasting|0|||
125610436|NCT00875017|451855554|FG004|Fourth Intervention|Inability to comply with fasting|0|||
125610437|NCT00875017|451855555|FG005|Fourth Intervention|Inability to comply with fasting|1|||
125610438|NCT02689219|451855556|FG000|Overall Study|Death|1|||
125610439|NCT02689219|451855557|FG001|Overall Study|Death|1|||
125610440|NCT02689219|451855556|FG000|Overall Study|Disease Progression|10|||
125610441|NCT02689219|451855557|FG001|Overall Study|Disease Progression|6|||
125610442|NCT01477892|451855558|FG000|Overall Study|Withdrawal by Subject|0|||
125610443|NCT01477892|451855559|FG001|Overall Study|Withdrawal by Subject|2|||
125610444|NCT05515601|451855563|FG000|Overall Study|Withdrawal by Subject|1|||
125610445|NCT05515601|451855564|FG001|Overall Study|Withdrawal by Subject|3|||
125610446|NCT05515601|451855565|FG002|Overall Study|Withdrawal by Subject|2|||
125610447|NCT05515601|451855566|FG003|Overall Study|Withdrawal by Subject|1|||
125610448|NCT05515601|451855567|FG004|Overall Study|Withdrawal by Subject|1|||
125610449|NCT05515601|451855568|FG005|Overall Study|Withdrawal by Subject|1|||
125610450|NCT05515601|451855563|FG000|Overall Study|Lost to Follow-up|0|||
125610451|NCT05515601|451855564|FG001|Overall Study|Lost to Follow-up|0|||
125610452|NCT05515601|451855565|FG002|Overall Study|Lost to Follow-up|0|||
125610453|NCT05515601|451855566|FG003|Overall Study|Lost to Follow-up|0|||
125610454|NCT05515601|451855567|FG004|Overall Study|Lost to Follow-up|1|||
125610455|NCT05515601|451855568|FG005|Overall Study|Lost to Follow-up|0|||
125610456|NCT00364845|451855569|FG000|Overall Study|Adverse Event|1|||
125610457|NCT00364845|451855570|FG001|Overall Study|Adverse Event|0|||
125610458|NCT00364845|451855569|FG000|Overall Study|Withdrawal by Subject|2|||
125214046|NCT01964989|450411218|FG001|Overall Study|Adverse Event|1|||
125214047|NCT01964989|450411217|FG000|Overall Study|Death|1|||
125214048|NCT01964989|450411218|FG001|Overall Study|Death|3|||
125214049|NCT01964989|450411217|FG000|Overall Study|Withdrawal by Subject|156|||
125214050|NCT01964989|450411218|FG001|Overall Study|Withdrawal by Subject|160|||
125214051|NCT01964989|450411217|FG000|Overall Study|Lost to Follow-up|254|||
125214052|NCT01964989|450411218|FG001|Overall Study|Lost to Follow-up|232|||
125214053|NCT01964989|450411217|FG000|Overall Study|Other|267|||
125214054|NCT01964989|450411218|FG001|Overall Study|Other|252|||
125214055|NCT00424593|450411219|FG000|Acute Double-Blind Period|Adverse Event|16|||
125214056|NCT00424593|450411220|FG001|Acute Double-Blind Period|Adverse Event|7|||
125214057|NCT00424593|450411219|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
125214058|NCT00424593|450411220|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
125214059|NCT00424593|450411219|FG000|Acute Double-Blind Period|Protocol Violation|2|||
125214060|NCT00424593|450411220|FG001|Acute Double-Blind Period|Protocol Violation|2|||
125214061|NCT00424593|450411219|FG000|Acute Double-Blind Period|Physician Decision|1|||
125214062|NCT00424593|450411220|FG001|Acute Double-Blind Period|Physician Decision|2|||
125214063|NCT00424593|450411219|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
125214064|NCT00424593|450411220|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
125214065|NCT00424593|450411219|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
125214066|NCT00424593|450411220|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
125214067|NCT00424593|450411219|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
125214068|NCT00424593|450411220|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
125214069|NCT00424593|450411219|FG000|Dose-Blind Extension Period|Adverse Event|18|||
125214070|NCT00424593|450411220|FG001|Dose-Blind Extension Period|Adverse Event|0|||
125214071|NCT00424593|450411219|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
125214072|NCT00424593|450411220|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
125214073|NCT00424593|450411219|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
125214074|NCT00424593|450411220|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
125214075|NCT00424593|450411219|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
125214076|NCT00424593|450411220|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
125214077|NCT00424593|450411219|FG000|Dose-Blind Extension Period|Physician Decision|3|||
125214078|NCT00424593|450411220|FG001|Dose-Blind Extension Period|Physician Decision|0|||
125214079|NCT03042910|450411221|FG000|Overall Study|Adverse Event|1|||
125214080|NCT03042910|450411221|FG000|Overall Study|Disease Progression|2|||
125214081|NCT03042910|450411221|FG000|Overall Study|Withdrawal by Subject|3|||
125214082|NCT03042910|450411221|FG000|Overall Study|Enrolled but not treated|1|||
125214083|NCT01491841|450411225|FG000|Overall Study|Screen Failure|10|||
125214084|NCT01491841|450411225|FG000|Overall Study|Withdrawal by Subject|1|||
125214085|NCT02933528|450411226|FG000|Overall Study|Lost to Follow-up|2|||
125214086|NCT02784288|450411228|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
125214087|NCT02734862|450411229|FG000|Part A|Death|3|||
125214088|NCT02734862|450411230|FG001|Part A|Death|4|||
125214089|NCT02734862|450411231|FG002|Part A|Death|6|||
125214090|NCT02734862|450411229|FG000|Part A|Lost to Follow-up|2|||
125214091|NCT02734862|450411230|FG001|Part A|Lost to Follow-up|1|||
125214092|NCT02734862|450411231|FG002|Part A|Lost to Follow-up|1|||
125214093|NCT02734862|450411229|FG000|Part A|Withdrawal by Subject|1|||
125214094|NCT02734862|450411230|FG001|Part A|Withdrawal by Subject|1|||
125214095|NCT02734862|450411231|FG002|Part A|Withdrawal by Subject|2|||
125214096|NCT02734862|450411229|FG000|Part A|Physician Decision|2|||
125214097|NCT02734862|450411230|FG001|Part A|Physician Decision|0|||
125214098|NCT02734862|450411231|FG002|Part A|Physician Decision|1|||
125610459|NCT00364845|451855570|FG001|Overall Study|Withdrawal by Subject|1|||
125610460|NCT00364845|451855569|FG000|Overall Study|Physician Decision|8|||
125610461|NCT00364845|451855570|FG001|Overall Study|Physician Decision|8|||
125610462|NCT00364845|451855569|FG000|Overall Study|Lost to Follow-up|0|||
125610463|NCT00364845|451855570|FG001|Overall Study|Lost to Follow-up|1|||
125610464|NCT00364845|451855569|FG000|Overall Study|Death|0|||
125610465|NCT00364845|451855570|FG001|Overall Study|Death|1|||
125610466|NCT01187901|451855571|FG000|Overall Study|Protocol Violation|1|||
125214099|NCT02734862|450411229|FG000|Part A|Adverse Event|2|||
125214100|NCT02734862|450411230|FG001|Part A|Adverse Event|0|||
125214101|NCT02734862|450411231|FG002|Part A|Adverse Event|1|||
125371778|NCT03129100|450993239|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371779|NCT03129100|450993240|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125610467|NCT01187901|451855572|FG001|Overall Study|Protocol Violation|0|||
125610468|NCT01187901|451855571|FG000|Overall Study|Lost to Follow-up|1|||
125610469|NCT01187901|451855572|FG001|Overall Study|Lost to Follow-up|2|||
125610470|NCT01187901|451855571|FG000|Overall Study|Unrelated Health Reasons|1|||
125610471|NCT01187901|451855572|FG001|Overall Study|Unrelated Health Reasons|2|||
125610472|NCT01187901|451855571|FG000|Overall Study|Suspected Allergic Reaction|1|||
125610473|NCT01187901|451855572|FG001|Overall Study|Suspected Allergic Reaction|1|||
125610474|NCT01187901|451855571|FG000|Overall Study|Adverse Event|3|||
125610475|NCT01187901|451855572|FG001|Overall Study|Adverse Event|0|||
125610476|NCT01187901|451855571|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
125610477|NCT01187901|451855572|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
125610478|NCT01187901|451855571|FG000|Overall Study|Pregnancy|0|||
125610479|NCT01187901|451855572|FG001|Overall Study|Pregnancy|2|||
125610480|NCT01912768|451855573|FG000|Overall Study|Adverse Event|2|||
125610481|NCT01912768|451855574|FG001|Overall Study|Adverse Event|0|||
125610482|NCT01912768|451855573|FG000|Overall Study|Lost to Follow-up|2|||
125610483|NCT01912768|451855574|FG001|Overall Study|Lost to Follow-up|1|||
125610484|NCT01912768|451855573|FG000|Overall Study|Withdrawal by Subject|5|||
125610485|NCT01912768|451855574|FG001|Overall Study|Withdrawal by Subject|3|||
125610486|NCT01912768|451855573|FG000|Overall Study|Randomized in error|1|||
125610487|NCT01912768|451855574|FG001|Overall Study|Randomized in error|0|||
125610488|NCT04160468|451855575|FG000|Overall Study|Lost to Follow-up|19|||
125610489|NCT04160468|451855576|FG001|Overall Study|Lost to Follow-up|4|||
125610490|NCT04160468|451855575|FG000|Overall Study|Randomized but not dosed|6|||
125610491|NCT04160468|451855576|FG001|Overall Study|Randomized but not dosed|0|||
125610492|NCT04160468|451855575|FG000|Overall Study|Withdrawal by Subject|4|||
125610493|NCT04160468|451855576|FG001|Overall Study|Withdrawal by Subject|1|||
125610494|NCT04160468|451855575|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
125610495|NCT04160468|451855576|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
125610496|NCT04160468|451855575|FG000|Overall Study|Participant incarcerated|1|||
125610497|NCT04160468|451855576|FG001|Overall Study|Participant incarcerated|0|||
125610498|NCT00540436|451855579|FG000|First 12-Week Treatment Period|Adverse Event|1|||
125610499|NCT00540436|451855579|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
125610500|NCT00540436|451855579|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
125610501|NCT00540436|451855579|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
125610502|NCT03255291|451855580|FG000|Overall Study|Determined to be ineligible|10|||
125610503|NCT03255291|451855581|FG001|Overall Study|Determined to be ineligible|12|||
125610504|NCT03255291|451855582|FG002|Overall Study|Determined to be ineligible|6|||
125610505|NCT03255291|451855583|FG003|Overall Study|Determined to be ineligible|6|||
125610506|NCT03255291|451855584|FG004|Overall Study|Determined to be ineligible|5|||
125610507|NCT03255291|451855585|FG005|Overall Study|Determined to be ineligible|10|||
125610508|NCT03255291|451855580|FG000|Overall Study|Baseline data collection issues|3|||
125610509|NCT03255291|451855581|FG001|Overall Study|Baseline data collection issues|0|||
125610510|NCT03255291|451855582|FG002|Overall Study|Baseline data collection issues|0|||
125610511|NCT03255291|451855583|FG003|Overall Study|Baseline data collection issues|0|||
125610512|NCT03255291|451855584|FG004|Overall Study|Baseline data collection issues|2|||
125610513|NCT03255291|451855585|FG005|Overall Study|Baseline data collection issues|0|||
125610514|NCT01067508|451855593|FG000|Overall Study|Physician Decision|0|||
125371780|NCT03129100|450993241|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371781|NCT03129100|450993242|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371782|NCT03129100|450993243|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371783|NCT03129100|450993244|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371784|NCT03129100|450993245|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371785|NCT03129100|450993246|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371786|NCT03129100|450993247|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
125371787|NCT03129100|450993248|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371788|NCT03129100|450993249|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125431992|NCT01576718|451207826|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125431993|NCT01576718|451207827|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125610515|NCT01067508|451855594|FG001|Overall Study|Physician Decision|1|||
125610516|NCT01067508|451855593|FG000|Overall Study|Withdrawal by Subject|0|||
125610517|NCT01067508|451855594|FG001|Overall Study|Withdrawal by Subject|1|||
125610518|NCT00444626|451855597|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
125610519|NCT00444626|451855597|FG000|Initial Treatment Period|Adverse Event|1|||
125610520|NCT00444626|451855597|FG000|Initial Treatment Period|Lost to Follow-up|9|||
125610521|NCT00091390|451855598|FG000|Overall Study|Protocol Violation|1|||
125610522|NCT00091390|451855598|FG000|Overall Study|No protocol treatment|3|||
125610523|NCT03229759|451855599|FG000|Overall Study|Screen Failure|30|||
125431994|NCT01576718|451207821|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
125610524|NCT00833248|451857104|FG000|Overall Study|Adverse Event|3|||
125610525|NCT00833248|451857105|FG001|Overall Study|Adverse Event|0|||
125610526|NCT00833248|451857104|FG000|Overall Study|Protocol Violation|1|||
125610527|NCT00833248|451857105|FG001|Overall Study|Protocol Violation|2|||
125610528|NCT00833248|451857104|FG000|Overall Study|Withdrawal by Subject|0|||
125610529|NCT00833248|451857105|FG001|Overall Study|Withdrawal by Subject|1|||
125610530|NCT03580382|451857106|FG000|Overall Study|Early Termination of Study|0|||
125610531|NCT03580382|451857107|FG001|Overall Study|Early Termination of Study|3|||
125610532|NCT05619172|451857111|FG000|Safety Cohort 1|Death|7|||
125610533|NCT05619172|451857112|FG001|Safety Cohort 1|Death|0|||
125610534|NCT05619172|451857111|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
125610535|NCT05619172|451857112|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
125610536|NCT05619172|451857111|FG000|Safety Cohort 2|Death|0|||
125610537|NCT05619172|451857112|FG001|Safety Cohort 2|Death|1|||
125610538|NCT05619172|451857111|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
125610539|NCT05619172|451857112|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
125610540|NCT00520676|451857116|FG000|Overall Study|Death|84|||
125610541|NCT00520676|451857117|FG001|Overall Study|Death|81|||
125610542|NCT00520676|451857116|FG000|Overall Study|Lost to Follow-up|6|||
125610543|NCT00520676|451857117|FG001|Overall Study|Lost to Follow-up|10|||
125610544|NCT00520676|451857116|FG000|Overall Study|Physician Decision|4|||
125610545|NCT00520676|451857117|FG001|Overall Study|Physician Decision|1|||
125610546|NCT00520676|451857116|FG000|Overall Study|Withdrawal by Subject|7|||
125610547|NCT00520676|451857117|FG001|Overall Study|Withdrawal by Subject|11|||
125610548|NCT02179515|451857118|FG000|Overall Study|switched to alternative treatment|0|||
125610549|NCT02179515|451857119|FG001|Overall Study|switched to alternative treatment|1|||
125610550|NCT02179515|451857120|FG002|Overall Study|switched to alternative treatment|1|||
125610551|NCT02179515|451857118|FG000|Overall Study|Death|0|||
125610552|NCT02179515|451857119|FG001|Overall Study|Death|1|||
125610553|NCT02179515|451857120|FG002|Overall Study|Death|1|||
125610554|NCT02179515|451857118|FG000|Overall Study|refused further treatment|0|||
125610555|NCT02179515|451857119|FG001|Overall Study|refused further treatment|3|||
125610556|NCT02179515|451857120|FG002|Overall Study|refused further treatment|4|||
125610557|NCT02179515|451857118|FG000|Overall Study|Disease progression on study|2|||
125431995|NCT01576718|451207822|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125431996|NCT01576718|451207823|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125431997|NCT01576718|451207824|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125431998|NCT01576718|451207825|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125431999|NCT01576718|451207826|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125610558|NCT02179515|451857119|FG001|Overall Study|Disease progression on study|11|||
125610559|NCT02179515|451857120|FG002|Overall Study|Disease progression on study|8|||
125610560|NCT03439748|451857121|FG000|Overall Study|Withdrawal by Subject|11|||
125610561|NCT03439748|451857122|FG001|Overall Study|Withdrawal by Subject|17|||
125610562|NCT05131451|451857123|FG000|Overall Study|Protocol Violation|1|||
125610563|NCT05131451|451857124|FG001|Overall Study|Protocol Violation|0|||
125610564|NCT00782418|451857125|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
125610565|NCT00782418|451857126|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
125610566|NCT00782418|451857127|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
125610567|NCT00782418|451857128|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
125610568|NCT00782418|451857129|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
125610569|NCT00782418|451857130|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
125610570|NCT00782418|451857131|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
125610571|NCT00782418|451857125|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
125610572|NCT00782418|451857126|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
125610573|NCT00782418|451857127|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
125610574|NCT00782418|451857128|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
125610575|NCT00782418|451857129|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
125610576|NCT00782418|451857130|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
125610577|NCT00782418|451857131|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
125610578|NCT01718509|451857132|FG000|Overall Study|Lost to Follow-up|18|||
125610579|NCT01718509|451857133|FG001|Overall Study|Lost to Follow-up|15|||
125214102|NCT02734862|450411229|FG000|Part A|Noncompliance|1|||
125214103|NCT02734862|450411230|FG001|Part A|Noncompliance|1|||
125610580|NCT01718509|451857132|FG000|Overall Study|Withdrawal by Subject|7|||
125610581|NCT01718509|451857133|FG001|Overall Study|Withdrawal by Subject|13|||
125610582|NCT01718509|451857132|FG000|Overall Study|Adverse Event|5|||
125610583|NCT01718509|451857133|FG001|Overall Study|Adverse Event|7|||
125610584|NCT01718509|451857132|FG000|Overall Study|Other|13|||
125610585|NCT01718509|451857133|FG001|Overall Study|Other|11|||
125214104|NCT02734862|450411231|FG002|Part A|Noncompliance|0|||
125214105|NCT02734862|450411229|FG000|Part A|Other|1|||
125214106|NCT02734862|450411230|FG001|Part A|Other|1|||
125214107|NCT02734862|450411231|FG002|Part A|Other|3|||
125214108|NCT02734862|450411229|FG000|Part B|Death|8|||
125214109|NCT02734862|450411230|FG001|Part B|Death|3|||
125214110|NCT02734862|450411231|FG002|Part B|Death|5|||
125214111|NCT02734862|450411229|FG000|Part B|Lost to Follow-up|2|||
125214112|NCT02734862|450411230|FG001|Part B|Lost to Follow-up|2|||
125214113|NCT02734862|450411231|FG002|Part B|Lost to Follow-up|0|||
125214114|NCT02734862|450411229|FG000|Part B|Withdrawal by Subject|3|||
125214115|NCT02734862|450411230|FG001|Part B|Withdrawal by Subject|1|||
125214116|NCT02734862|450411231|FG002|Part B|Withdrawal by Subject|0|||
125214117|NCT02734862|450411229|FG000|Part B|Other|0|||
125214118|NCT02734862|450411230|FG001|Part B|Other|1|||
125214119|NCT02734862|450411231|FG002|Part B|Other|0|||
125214120|NCT02757625|450411232|FG000|Overall Study|Investigator's discretion|0|||
125214121|NCT02757625|450411233|FG001|Overall Study|Investigator's discretion|0|||
125432000|NCT01576718|451207827|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125432001|NCT01576718|451207821|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
125610586|NCT01718509|451857132|FG000|Overall Study|Protocol Violation|4|||
125610587|NCT01718509|451857133|FG001|Overall Study|Protocol Violation|2|||
125610588|NCT01718509|451857132|FG000|Overall Study|Lack of Efficacy|1|||
125610589|NCT01718509|451857133|FG001|Overall Study|Lack of Efficacy|0|||
125610590|NCT00643487|451857139|FG000|Overall Study|Technical difficulty|3|||
125610591|NCT00879814|451857141|FG000|Overall Study|Adverse Event|0|||
125610592|NCT00879814|451857142|FG001|Overall Study|Adverse Event|1|||
125610593|NCT00879814|451857143|FG002|Overall Study|Adverse Event|0|||
125610594|NCT00879814|451857144|FG003|Overall Study|Adverse Event|0|||
125610595|NCT00879814|451857141|FG000|Overall Study|Lost to Follow-up|1|||
125610596|NCT00879814|451857142|FG001|Overall Study|Lost to Follow-up|0|||
125610597|NCT00879814|451857143|FG002|Overall Study|Lost to Follow-up|0|||
125610598|NCT00879814|451857144|FG003|Overall Study|Lost to Follow-up|2|||
125610599|NCT00879814|451857141|FG000|Overall Study|Participant Failed to Return|0|||
125610600|NCT00879814|451857142|FG001|Overall Study|Participant Failed to Return|0|||
125610601|NCT00879814|451857143|FG002|Overall Study|Participant Failed to Return|0|||
125610602|NCT00879814|451857144|FG003|Overall Study|Participant Failed to Return|1|||
125610603|NCT00879814|451857141|FG000|Overall Study|Withdrawal by Subject|3|||
125610604|NCT00879814|451857142|FG001|Overall Study|Withdrawal by Subject|1|||
125610605|NCT00879814|451857143|FG002|Overall Study|Withdrawal by Subject|1|||
125610606|NCT00879814|451857144|FG003|Overall Study|Withdrawal by Subject|2|||
125610607|NCT00879814|451857141|FG000|Overall Study|Physician Decision|0|||
125610608|NCT00879814|451857142|FG001|Overall Study|Physician Decision|0|||
125610609|NCT00879814|451857143|FG002|Overall Study|Physician Decision|1|||
125610610|NCT00879814|451857144|FG003|Overall Study|Physician Decision|0|||
125610611|NCT00879814|451857141|FG000|Overall Study|Other|0|||
125610612|NCT00879814|451857142|FG001|Overall Study|Other|0|||
125610613|NCT00879814|451857143|FG002|Overall Study|Other|1|||
125610614|NCT00879814|451857144|FG003|Overall Study|Other|0|||
125610615|NCT01219959|451857155|FG000|Overall Study|Adverse Event|6|||
125610616|NCT01219959|451857156|FG001|Overall Study|Adverse Event|14|||
125610617|NCT01219959|451857155|FG000|Overall Study|Physician Decision|0|||
125610618|NCT01219959|451857156|FG001|Overall Study|Physician Decision|4|||
125214122|NCT02757625|450411234|FG002|Overall Study|Investigator's discretion|1|||
125432002|NCT01576718|451207822|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125432003|NCT01576718|451207823|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125432004|NCT01576718|451207824|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125432005|NCT01576718|451207825|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125432006|NCT01576718|451207826|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125214123|NCT02757625|450411235|FG003|Overall Study|Investigator's discretion|0|||
125214124|NCT02757625|450411232|FG000|Overall Study|Adverse Event|0|||
125214125|NCT02757625|450411233|FG001|Overall Study|Adverse Event|0|||
125214126|NCT02757625|450411234|FG002|Overall Study|Adverse Event|1|||
125214127|NCT02757625|450411235|FG003|Overall Study|Adverse Event|0|||
125214128|NCT04854057|450411236|FG000|Overall Study|Adverse Event|0|||
125214129|NCT04854057|450411237|FG001|Overall Study|Adverse Event|1|||
125214130|NCT02131233|450411238|FG000|Overall Study|Not Treated|2|||
125610619|NCT01219959|451857155|FG000|Overall Study|Withdrawal by Subject|0|||
125610620|NCT01219959|451857156|FG001|Overall Study|Withdrawal by Subject|2|||
125610621|NCT01219959|451857155|FG000|Overall Study|Renal Transplantation|0|||
125610622|NCT01219959|451857156|FG001|Overall Study|Renal Transplantation|3|||
125610623|NCT01219959|451857155|FG000|Overall Study|Other|1|||
125214131|NCT02131233|450411239|FG001|Overall Study|Not Treated|3|||
125610624|NCT01219959|451857156|FG001|Overall Study|Other|0|||
125214132|NCT02131233|450411238|FG000|Overall Study|Adverse Event|7|||
125214133|NCT02131233|450411239|FG001|Overall Study|Adverse Event|6|||
125214134|NCT02131233|450411238|FG000|Overall Study|Death|0|||
125610625|NCT01728584|451857157|FG000|Overall Study|Adverse Event|1|||
125610626|NCT01728584|451857158|FG001|Overall Study|Adverse Event|0|||
125610627|NCT01728584|451857159|FG002|Overall Study|Adverse Event|0|||
125610628|NCT01728584|451857160|FG003|Overall Study|Adverse Event|0|||
125610629|NCT01728584|451857157|FG000|Overall Study|Physician Decision|4|||
125371789|NCT03129100|450993250|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371790|NCT03129100|450993251|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371791|NCT03129100|450993252|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371792|NCT03129100|450993253|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371793|NCT03129100|450993254|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371794|NCT03129100|450993255|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371795|NCT03129100|450993256|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371796|NCT03129100|450993257|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371797|NCT03129100|450993258|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371798|NCT03129100|450993259|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371799|NCT03129100|450993260|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371800|NCT03129100|450993261|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
125371801|NCT03129100|450993236|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371802|NCT03129100|450993237|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371803|NCT03129100|450993238|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371804|NCT03129100|450993239|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371805|NCT03129100|450993240|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371806|NCT03129100|450993241|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371807|NCT03129100|450993242|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371808|NCT03129100|450993243|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371809|NCT03129100|450993244|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371810|NCT03129100|450993245|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371811|NCT03129100|450993246|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125610630|NCT01728584|451857158|FG001|Overall Study|Physician Decision|0|||
125610631|NCT01728584|451857159|FG002|Overall Study|Physician Decision|1|||
125610632|NCT01728584|451857160|FG003|Overall Study|Physician Decision|0|||
125610633|NCT01728584|451857157|FG000|Overall Study|Withdrawal by Subject|1|||
125610634|NCT01728584|451857158|FG001|Overall Study|Withdrawal by Subject|0|||
125610635|NCT01728584|451857159|FG002|Overall Study|Withdrawal by Subject|0|||
125610636|NCT01728584|451857160|FG003|Overall Study|Withdrawal by Subject|0|||
125610637|NCT01728584|451857157|FG000|Overall Study|Screen failure|1|||
125610638|NCT01728584|451857158|FG001|Overall Study|Screen failure|0|||
125610639|NCT01728584|451857159|FG002|Overall Study|Screen failure|0|||
125610640|NCT01728584|451857160|FG003|Overall Study|Screen failure|0|||
125610641|NCT01728584|451857157|FG000|Overall Study|Other reason (not specified)|1|||
125610642|NCT01728584|451857158|FG001|Overall Study|Other reason (not specified)|0|||
125610643|NCT01728584|451857159|FG002|Overall Study|Other reason (not specified)|0|||
125610644|NCT01728584|451857160|FG003|Overall Study|Other reason (not specified)|1|||
125610645|NCT02935634|451857161|FG000|Randomization|Participant withdrew consent|0|||
125610646|NCT02935634|451857162|FG001|Randomization|Participant withdrew consent|1|||
125610647|NCT02935634|451857163|FG002|Randomization|Participant withdrew consent|0|||
125610648|NCT02935634|451857164|FG003|Randomization|Participant withdrew consent|0|||
125610649|NCT02935634|451857165|FG004|Randomization|Participant withdrew consent|0|||
125610650|NCT02935634|451857166|FG005|Randomization|Participant withdrew consent|0|||
125610651|NCT02935634|451857161|FG000|Randomization|Death|2|||
125610652|NCT02935634|451857162|FG001|Randomization|Death|1|||
125610653|NCT02935634|451857163|FG002|Randomization|Death|1|||
125610654|NCT02935634|451857164|FG003|Randomization|Death|0|||
125610655|NCT02935634|451857165|FG004|Randomization|Death|0|||
125610656|NCT02935634|451857166|FG005|Randomization|Death|0|||
125610657|NCT02935634|451857161|FG000|Randomization|Other reasons|0|||
125610658|NCT02935634|451857162|FG001|Randomization|Other reasons|2|||
125610659|NCT02935634|451857163|FG002|Randomization|Other reasons|2|||
125371812|NCT03129100|450993247|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
125371813|NCT03129100|450993248|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
125371814|NCT03129100|450993249|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
125610660|NCT02935634|451857164|FG003|Randomization|Other reasons|0|||
125610661|NCT02935634|451857165|FG004|Randomization|Other reasons|0|||
125371815|NCT03129100|450993250|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
125371816|NCT03129100|450993251|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125432007|NCT01576718|451207827|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125610662|NCT02935634|451857166|FG005|Randomization|Other reasons|0|||
125610663|NCT02935634|451857161|FG000|Treatment: Track 1|Disease progression|15|||
125610664|NCT02935634|451857162|FG001|Treatment: Track 1|Disease progression|17|||
125432008|NCT01576718|451207821|FG000|Treatment Period|Adverse Event|0|||
125610665|NCT02935634|451857163|FG002|Treatment: Track 1|Disease progression|28|||
125610666|NCT02935634|451857164|FG003|Treatment: Track 1|Disease progression|4|||
125610667|NCT02935634|451857165|FG004|Treatment: Track 1|Disease progression|6|||
125610668|NCT02935634|451857166|FG005|Treatment: Track 1|Disease progression|2|||
125610669|NCT02935634|451857161|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
125610670|NCT02935634|451857162|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
125610671|NCT02935634|451857163|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
125610672|NCT02935634|451857164|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
125610673|NCT02935634|451857165|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
125610674|NCT02935634|451857166|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
125610675|NCT02935634|451857161|FG000|Treatment: Track 1|Lost to Follow-up|1|||
125610676|NCT02935634|451857162|FG001|Treatment: Track 1|Lost to Follow-up|0|||
125610677|NCT02935634|451857163|FG002|Treatment: Track 1|Lost to Follow-up|0|||
125610678|NCT02935634|451857164|FG003|Treatment: Track 1|Lost to Follow-up|0|||
125610679|NCT02935634|451857165|FG004|Treatment: Track 1|Lost to Follow-up|0|||
125610680|NCT02935634|451857166|FG005|Treatment: Track 1|Lost to Follow-up|0|||
125610681|NCT02935634|451857161|FG000|Treatment: Track 1|Study drug toxicity|2|||
125610682|NCT02935634|451857162|FG001|Treatment: Track 1|Study drug toxicity|1|||
125610683|NCT02935634|451857163|FG002|Treatment: Track 1|Study drug toxicity|3|||
125610684|NCT02935634|451857164|FG003|Treatment: Track 1|Study drug toxicity|0|||
125610685|NCT02935634|451857165|FG004|Treatment: Track 1|Study drug toxicity|0|||
125610686|NCT02935634|451857166|FG005|Treatment: Track 1|Study drug toxicity|1|||
125610687|NCT02935634|451857161|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
125610688|NCT02935634|451857162|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
125610689|NCT02935634|451857163|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
125371817|NCT03129100|450993252|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371818|NCT03129100|450993253|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371819|NCT03129100|450993254|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371820|NCT03129100|450993255|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371821|NCT03129100|450993256|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371822|NCT03129100|450993257|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371823|NCT03129100|450993258|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371824|NCT03129100|450993259|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371825|NCT03129100|450993260|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371826|NCT03129100|450993261|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
125371827|NCT03129100|450993236|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371828|NCT03129100|450993237|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371829|NCT03129100|450993238|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371830|NCT03129100|450993239|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371831|NCT03129100|450993240|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371832|NCT03129100|450993241|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371833|NCT03129100|450993242|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371834|NCT03129100|450993243|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371835|NCT03129100|450993244|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371836|NCT03129100|450993245|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371837|NCT03129100|450993246|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371838|NCT03129100|450993247|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
125371839|NCT03129100|450993248|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371840|NCT03129100|450993249|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
125432009|NCT01576718|451207822|FG001|Treatment Period|Adverse Event|1|||
125432010|NCT01576718|451207823|FG002|Treatment Period|Adverse Event|1|||
125610690|NCT02935634|451857164|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
125610691|NCT02935634|451857165|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
125610692|NCT02935634|451857166|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
125610693|NCT02935634|451857161|FG000|Treatment: Track 1|Participant withdrew consent|2|||
125371841|NCT03129100|450993250|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
125371842|NCT03129100|450993251|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371843|NCT03129100|450993252|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125610694|NCT02935634|451857162|FG001|Treatment: Track 1|Participant withdrew consent|0|||
125610695|NCT02935634|451857163|FG002|Treatment: Track 1|Participant withdrew consent|1|||
125610696|NCT02935634|451857164|FG003|Treatment: Track 1|Participant withdrew consent|0|||
125610697|NCT02935634|451857165|FG004|Treatment: Track 1|Participant withdrew consent|1|||
125610698|NCT02935634|451857166|FG005|Treatment: Track 1|Participant withdrew consent|0|||
125610699|NCT02935634|451857161|FG000|Treatment: Track 1|Other reasons|0|||
125610700|NCT02935634|451857162|FG001|Treatment: Track 1|Other reasons|0|||
125610701|NCT02935634|451857163|FG002|Treatment: Track 1|Other reasons|2|||
125610702|NCT02935634|451857164|FG003|Treatment: Track 1|Other reasons|0|||
125610703|NCT02935634|451857165|FG004|Treatment: Track 1|Other reasons|0|||
125371844|NCT03129100|450993253|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125610704|NCT02935634|451857166|FG005|Treatment: Track 1|Other reasons|0|||
125610705|NCT02935634|451857161|FG000|Treatment: Track 2|Disease progression|13|||
125432011|NCT01576718|451207824|FG003|Treatment Period|Adverse Event|1|||
125610706|NCT02935634|451857162|FG001|Treatment: Track 2|Disease progression|26|||
125610707|NCT02935634|451857163|FG002|Treatment: Track 2|Disease progression|20|||
125610708|NCT02935634|451857164|FG003|Treatment: Track 2|Disease progression|5|||
125610709|NCT02935634|451857165|FG004|Treatment: Track 2|Disease progression|1|||
125610710|NCT02935634|451857166|FG005|Treatment: Track 2|Disease progression|4|||
125610711|NCT02935634|451857161|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
125610712|NCT02935634|451857162|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
125610713|NCT02935634|451857163|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
125610714|NCT02935634|451857164|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
125610715|NCT02935634|451857165|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
125610716|NCT02935634|451857166|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
125610717|NCT02935634|451857161|FG000|Treatment: Track 2|Study drug toxicity|7|||
125610718|NCT02935634|451857162|FG001|Treatment: Track 2|Study drug toxicity|3|||
125610719|NCT02935634|451857163|FG002|Treatment: Track 2|Study drug toxicity|0|||
125610720|NCT02935634|451857164|FG003|Treatment: Track 2|Study drug toxicity|0|||
125610721|NCT02935634|451857165|FG004|Treatment: Track 2|Study drug toxicity|0|||
125610722|NCT02935634|451857166|FG005|Treatment: Track 2|Study drug toxicity|0|||
125610723|NCT02935634|451857161|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
125610724|NCT02935634|451857162|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
125610725|NCT02935634|451857163|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
125610726|NCT02935634|451857164|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
125610727|NCT02935634|451857165|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
125610728|NCT02935634|451857166|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
125610729|NCT02935634|451857161|FG000|Treatment: Track 2|Participant withdrew consent|0|||
125371845|NCT03129100|450993254|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371846|NCT03129100|450993255|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371847|NCT03129100|450993256|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371848|NCT03129100|450993257|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371849|NCT03129100|450993258|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371850|NCT03129100|450993259|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371851|NCT03129100|450993260|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371852|NCT03129100|450993261|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
125371853|NCT03129100|450993236|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371854|NCT03129100|450993237|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371855|NCT03129100|450993238|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371856|NCT03129100|450993239|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371857|NCT03129100|450993240|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371858|NCT03129100|450993241|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371859|NCT03129100|450993242|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371860|NCT03129100|450993243|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371861|NCT03129100|450993244|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371862|NCT03129100|450993245|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371863|NCT03129100|450993246|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371864|NCT03129100|450993247|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371865|NCT03129100|450993248|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371866|NCT03129100|450993249|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371867|NCT03129100|450993250|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371868|NCT03129100|450993251|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
125371869|NCT03129100|450993252|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371870|NCT03129100|450993253|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371871|NCT03129100|450993254|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371872|NCT03129100|450993255|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371873|NCT03129100|450993256|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371874|NCT03129100|450993257|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371875|NCT03129100|450993258|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371876|NCT03129100|450993259|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371877|NCT03129100|450993260|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371878|NCT03129100|450993261|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
125371879|NCT03129100|450993236|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371880|NCT03129100|450993237|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371881|NCT03129100|450993238|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371882|NCT03129100|450993239|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371883|NCT03129100|450993240|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371884|NCT03129100|450993241|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371885|NCT03129100|450993242|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371886|NCT03129100|450993243|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371887|NCT03129100|450993244|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371888|NCT03129100|450993245|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371889|NCT03129100|450993246|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371890|NCT03129100|450993247|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371891|NCT03129100|450993248|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
125371892|NCT03129100|450993249|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371893|NCT03129100|450993250|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
125371894|NCT03129100|450993251|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
125371895|NCT03129100|450993252|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371896|NCT03129100|450993253|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371897|NCT03129100|450993254|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371898|NCT03129100|450993255|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371899|NCT03129100|450993256|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371900|NCT03129100|450993257|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371901|NCT03129100|450993258|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371902|NCT03129100|450993259|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371903|NCT03129100|450993260|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371904|NCT03129100|450993261|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
125371905|NCT03129100|450993236|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371906|NCT03129100|450993237|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371907|NCT03129100|450993238|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125214135|NCT02131233|450411239|FG001|Overall Study|Death|1|||
125610730|NCT02935634|451857162|FG001|Treatment: Track 2|Participant withdrew consent|1|||
125610731|NCT02935634|451857163|FG002|Treatment: Track 2|Participant withdrew consent|1|||
125610732|NCT02935634|451857164|FG003|Treatment: Track 2|Participant withdrew consent|0|||
125610733|NCT02935634|451857165|FG004|Treatment: Track 2|Participant withdrew consent|1|||
125610734|NCT02935634|451857166|FG005|Treatment: Track 2|Participant withdrew consent|0|||
125610735|NCT05906732|451857167|FG000|Overall Study|Withdrawal by Subject|1|||
125610736|NCT05906732|451857168|FG001|Overall Study|Withdrawal by Subject|0|||
125610737|NCT05906732|451857169|FG002|Overall Study|Withdrawal by Subject|0|||
125610738|NCT05906732|451857170|FG003|Overall Study|Withdrawal by Subject|0|||
125610739|NCT05906732|451857167|FG000|Overall Study|Physician Decision|2|||
125610740|NCT05906732|451857168|FG001|Overall Study|Physician Decision|4|||
125610741|NCT05906732|451857169|FG002|Overall Study|Physician Decision|0|||
125610742|NCT05906732|451857170|FG003|Overall Study|Physician Decision|0|||
125610743|NCT00506077|451857172|FG000|Treatment Period 1|Adverse Event|2|||
125610744|NCT00506077|451857173|FG001|Treatment Period 1|Adverse Event|1|||
125610745|NCT00506077|451857172|FG000|Treatment Period 1|Lost to Follow-up|0|||
125610746|NCT00506077|451857173|FG001|Treatment Period 1|Lost to Follow-up|2|||
125610747|NCT00506077|451857172|FG000|Treatment Period 1|Withdrawal by Subject|2|||
125610748|NCT00506077|451857173|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125610749|NCT00506077|451857172|FG000|Treatment Period 2|Adverse Event|0|||
125610750|NCT00506077|451857173|FG001|Treatment Period 2|Adverse Event|1|||
125610751|NCT00506077|451857172|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125610752|NCT00506077|451857173|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125610753|NCT01727713|451857177|FG000|Overall Study|Lost to Follow-up|5|||
125610754|NCT01727713|451857177|FG000|Overall Study|Adverse Event|10|||
125610755|NCT01727713|451857177|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
125610756|NCT01727713|451857177|FG000|Overall Study|Withdrawal by Subject|13|||
125610757|NCT01727713|451857177|FG000|Overall Study|Protocol Deviation|2|||
125610758|NCT02651194|451857178|FG000|Overall Study|Lost to Follow-up|3|||
125610759|NCT02651194|451857178|FG000|Overall Study|Other|2|||
125610760|NCT03885726|451857181|FG000|Overall Study|Staffing issues/lost interest|1|||
125610761|NCT03885726|451857181|FG000|Overall Study|Early discharge from hospital|3|||
125610762|NCT01217190|451857182|FG000|Second Dosing|Withdrawal by Subject|0|||
125610763|NCT01217190|451857183|FG001|Second Dosing|Withdrawal by Subject|2|||
125610764|NCT03116399|451857184|FG000|Overall Study|Death|8|||
125610765|NCT03116399|451857185|FG001|Overall Study|Death|3|||
125610766|NCT03116399|451857184|FG000|Overall Study|Lost to Follow-up|7|||
125610767|NCT03116399|451857185|FG001|Overall Study|Lost to Follow-up|11|||
125610768|NCT03116399|451857184|FG000|Overall Study|Investigator Decision|1|||
125610769|NCT03116399|451857185|FG001|Overall Study|Investigator Decision|1|||
125610770|NCT03116399|451857184|FG000|Overall Study|Withdrawal by Subject|24|||
125610771|NCT03116399|451857185|FG001|Overall Study|Withdrawal by Subject|9|||
125610772|NCT02868216|451857186|FG000|Overall Study|Death|0|||
125610773|NCT02868216|451857187|FG001|Overall Study|Death|1|||
125610774|NCT02868216|451857186|FG000|Overall Study|coronary artery bypass|1|||
125610775|NCT02868216|451857187|FG001|Overall Study|coronary artery bypass|0|||
125610776|NCT02868216|451857186|FG000|Overall Study|Withdrawal by Subject|7|||
125610777|NCT02868216|451857187|FG001|Overall Study|Withdrawal by Subject|5|||
125610778|NCT02496585|451857188|FG000|Overall Study|Death|3|||
125610779|NCT02496585|451857189|FG001|Overall Study|Death|0|||
125610780|NCT02496585|451857188|FG000|Overall Study|Lost to Follow-up|2|||
125610781|NCT02496585|451857189|FG001|Overall Study|Lost to Follow-up|0|||
125610782|NCT02496585|451857188|FG000|Overall Study|Withdrawal by Subject|1|||
125610783|NCT02496585|451857189|FG001|Overall Study|Withdrawal by Subject|2|||
125610784|NCT02496585|451857188|FG000|Overall Study|Progression of Malignancy|4|||
125610785|NCT02496585|451857189|FG001|Overall Study|Progression of Malignancy|1|||
125610786|NCT01401010|451857193|FG000|Overall Study|Could not interpret assay results|1|||
125610787|NCT01401010|451857194|FG001|Overall Study|Could not interpret assay results|0|||
125610788|NCT01975272|451857197|FG000|Overall Study|Excluded after protocol amendment|1|||
125610789|NCT01975272|451857198|FG001|Overall Study|Excluded after protocol amendment|1|||
125610790|NCT01975272|451857199|FG002|Overall Study|Excluded after protocol amendment|2|||
125610791|NCT00515008|451857202|FG000|Overall Study|Lost to Follow-up|1|||
125610792|NCT00515008|451857203|FG001|Overall Study|Lost to Follow-up|0|||
125610793|NCT00515008|451857202|FG000|Overall Study|Declined|0|||
125610794|NCT00515008|451857203|FG001|Overall Study|Declined|3|||
125610795|NCT00515008|451857202|FG000|Overall Study|Left the Boston Area|1|||
125610796|NCT00515008|451857203|FG001|Overall Study|Left the Boston Area|1|||
125610797|NCT00515008|451857202|FG000|Overall Study|Scheduling conflict|1|||
125610798|NCT00515008|451857203|FG001|Overall Study|Scheduling conflict|0|||
125610799|NCT01915849|451857206|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
125610800|NCT01915849|451857207|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
125610801|NCT01915849|451857208|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
125610802|NCT01915849|451857209|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
125610803|NCT01915849|451857206|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
125610804|NCT01915849|451857207|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
125610805|NCT01915849|451857208|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
125610806|NCT01915849|451857209|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
125610807|NCT02775864|451857210|FG000|Overall Study|Data ended end of 2010|1764|||
125610808|NCT02775864|451857211|FG001|Overall Study|Data ended end of 2010|2880|||
125610809|NCT02775864|451857212|FG002|Overall Study|Data ended end of 2010|1140|||
125610810|NCT02775864|451857213|FG003|Overall Study|Data ended end of 2010|1194|||
125610811|NCT02775864|451857210|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
125610812|NCT02775864|451857211|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
125610813|NCT02775864|451857212|FG002|Overall Study|Medicaid eligibility discontinued|720|||
125610814|NCT02775864|451857213|FG003|Overall Study|Medicaid eligibility discontinued|890|||
125610815|NCT03238235|451857214|FG000|Overall Study|Adverse Event|2|||
125610816|NCT03238235|451857215|FG001|Overall Study|Adverse Event|0|||
125610817|NCT03238235|451857214|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
125610818|NCT03238235|451857215|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
125610819|NCT02028338|451857217|FG000|Overall Study|Withdrawal by Subject|3|||
125610820|NCT02028338|451857218|FG001|Overall Study|Withdrawal by Subject|1|||
125610821|NCT02028338|451857217|FG000|Overall Study|Unable to contact participant|1|||
125610822|NCT02028338|451857218|FG001|Overall Study|Unable to contact participant|0|||
125610823|NCT02761993|451857223|FG000|Overall Study|Adverse Event|0|||
125610824|NCT02761993|451857224|FG001|Overall Study|Adverse Event|2|||
125610825|NCT02761993|451857225|FG002|Overall Study|Adverse Event|0|||
125610826|NCT02761993|451857223|FG000|Overall Study|Lost to Follow-up|1|||
125610827|NCT02761993|451857224|FG001|Overall Study|Lost to Follow-up|3|||
125610828|NCT02761993|451857225|FG002|Overall Study|Lost to Follow-up|2|||
125610829|NCT02761993|451857223|FG000|Overall Study|Withdrawal by Subject|1|||
125610830|NCT02761993|451857224|FG001|Overall Study|Withdrawal by Subject|1|||
125610831|NCT02761993|451857225|FG002|Overall Study|Withdrawal by Subject|2|||
125610832|NCT01842620|451857226|FG000|Period 1|Withdrawal by Subject|1|||
125610833|NCT01842620|451857227|FG001|Period 1|Withdrawal by Subject|0|||
125610834|NCT03342469|451857234|FG000|Overall Study|Withdrawal by Subject|0|||
125610835|NCT03342469|451857235|FG001|Overall Study|Withdrawal by Subject|1|||
125610836|NCT03342469|451857236|FG002|Overall Study|Withdrawal by Subject|0|||
125610837|NCT03342469|451857237|FG003|Overall Study|Withdrawal by Subject|0|||
125610838|NCT03050359|451858781|FG000|Overall Study|Randomized But Not Treated|2|||
125610839|NCT03050359|451858782|FG001|Overall Study|Randomized But Not Treated|0|||
125371908|NCT03129100|450993239|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371909|NCT03129100|450993240|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371910|NCT03129100|450993241|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371911|NCT03129100|450993242|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371912|NCT03129100|450993243|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371913|NCT03129100|450993244|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371914|NCT03129100|450993245|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371915|NCT03129100|450993246|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371916|NCT03129100|450993247|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371917|NCT03129100|450993248|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371918|NCT03129100|450993249|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371919|NCT03129100|450993250|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371920|NCT03129100|450993251|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371921|NCT03129100|450993252|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371922|NCT03129100|450993253|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
125371923|NCT03129100|450993254|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371924|NCT03129100|450993255|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
125371925|NCT03129100|450993256|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371926|NCT03129100|450993257|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371927|NCT03129100|450993258|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371928|NCT03129100|450993259|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371929|NCT03129100|450993260|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371930|NCT03129100|450993261|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
125371931|NCT03129100|450993236|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371932|NCT03129100|450993237|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371933|NCT03129100|450993238|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371934|NCT03129100|450993239|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371935|NCT03129100|450993240|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371936|NCT03129100|450993241|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371937|NCT03129100|450993242|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371938|NCT03129100|450993243|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371939|NCT03129100|450993244|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371940|NCT03129100|450993245|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371941|NCT03129100|450993246|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371942|NCT03129100|450993247|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371943|NCT03129100|450993248|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371944|NCT03129100|450993249|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125610840|NCT03050359|451858781|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
125610841|NCT03050359|451858782|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
125610842|NCT03050359|451858781|FG000|Overall Study|Significant Protocol Deviation|2|||
125610843|NCT03050359|451858782|FG001|Overall Study|Significant Protocol Deviation|3|||
125610844|NCT03050359|451858781|FG000|Overall Study|Lost to Follow-up|2|||
125610845|NCT03050359|451858782|FG001|Overall Study|Lost to Follow-up|1|||
125610846|NCT03050359|451858781|FG000|Overall Study|Voluntary Withdrawal|4|||
125610847|NCT03050359|451858782|FG001|Overall Study|Voluntary Withdrawal|6|||
125610848|NCT03050359|451858781|FG000|Overall Study|Pregnancy|1|||
125610849|NCT03050359|451858782|FG001|Overall Study|Pregnancy|0|||
125610850|NCT03050359|451858781|FG000|Overall Study|Reason Not Specified|1|||
125610851|NCT03050359|451858782|FG001|Overall Study|Reason Not Specified|0|||
125610852|NCT02614287|451858785|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
125610853|NCT02614287|451858786|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
125610854|NCT02614287|451858785|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
125610855|NCT02614287|451858786|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
125610856|NCT02614287|451858785|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
125610857|NCT02614287|451858786|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
125610858|NCT02614287|451858785|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
125610859|NCT02614287|451858786|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
125371945|NCT03129100|450993250|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371946|NCT03129100|450993251|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125610860|NCT02614287|451858785|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
125610861|NCT02614287|451858786|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
125610862|NCT02614287|451858785|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
125610863|NCT02614287|451858786|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
125610864|NCT02614287|451858785|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
125371947|NCT03129100|450993252|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371948|NCT03129100|450993253|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371949|NCT03129100|450993254|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371950|NCT03129100|450993255|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371951|NCT03129100|450993256|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
125371952|NCT03129100|450993257|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125610865|NCT02614287|451858786|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
125432012|NCT01576718|451207825|FG004|Treatment Period|Adverse Event|1|||
125610866|NCT02614287|451858785|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
125610867|NCT02614287|451858786|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
125610868|NCT02006667|451858792|FG000|Overall Study|Adverse Event|3|||
125610869|NCT02006667|451858792|FG000|Overall Study|Death|2|||
125610870|NCT02006667|451858792|FG000|Overall Study|Withdrawal by Subject|1|||
125610871|NCT02939937|451858793|FG000|Overall Study|Adverse Event|5|||
125610872|NCT02939937|451858794|FG001|Overall Study|Adverse Event|0|||
125610873|NCT02939937|451858793|FG000|Overall Study|Lost to Follow-up|1|||
125610874|NCT02939937|451858794|FG001|Overall Study|Lost to Follow-up|3|||
125610875|NCT04281030|451858803|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
125610876|NCT04281030|451858804|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
125610877|NCT04281030|451858803|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
125610878|NCT04281030|451858804|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
125610879|NCT01361009|451858805|FG000|Overall Study|Protocol Violation|116|||
125610880|NCT01826422|451858806|FG000|Overall Study|Withdrawal by Subject|1|||
125610881|NCT01826422|451858807|FG001|Overall Study|Withdrawal by Subject|3|||
125610882|NCT00450372|451858808|FG000|Overall Study|Physician Decision|1|||
125610883|NCT00115349|451858811|FG000|Overall Study|Study closed due to low enrollment.|11|||
125610884|NCT00115349|451858812|FG001|Overall Study|Study closed due to low enrollment.|9|||
125610885|NCT02116660|451858813|FG000|Overall Study|Deteriorating renal function|0|||
125610886|NCT02116660|451858814|FG001|Overall Study|Deteriorating renal function|1|||
125610887|NCT02116660|451858813|FG000|Overall Study|Adverse Event|1|||
125610888|NCT02116660|451858814|FG001|Overall Study|Adverse Event|1|||
125610889|NCT02116660|451858813|FG000|Overall Study|Withdrawal by Subject|0|||
125610890|NCT02116660|451858814|FG001|Overall Study|Withdrawal by Subject|2|||
125610891|NCT02116660|451858813|FG000|Overall Study|Organization reason|1|||
125610892|NCT02116660|451858814|FG001|Overall Study|Organization reason|0|||
125610893|NCT02750800|451858815|FG000|Overall Study|Adverse Event|18|||
125610894|NCT02750800|451858815|FG000|Overall Study|Lost to Follow-up|12|||
125610895|NCT02750800|451858815|FG000|Overall Study|Investigator decision|53|||
125610896|NCT02750800|451858815|FG000|Overall Study|Patient request|12|||
125610897|NCT02750800|451858815|FG000|Overall Study|Other, not specified|3|||
125610898|NCT03298412|451858816|FG000|Run-in Period|Other, Not Specified|1|||
125610899|NCT03298412|451858816|FG000|Run-in Period|Disease Progression|1|||
125610900|NCT03298412|451858816|FG000|Run-in Period|Ineligibility Determined|1|||
125610901|NCT03298412|451858816|FG000|Run-in Period|Decision by Sponsor|6|||
125610902|NCT05631548|451858817|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
125610903|NCT05631548|451858818|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
125610904|NCT00390416|451858819|FG000|Overall Study|Withdrawal by Subject|1|||
125610905|NCT00390416|451858819|FG000|Overall Study|Not treated|3|||
125610906|NCT01860534|451858828|FG000|ROP #1|Needed treatment for ROP|0|||
125610907|NCT01860534|451858829|FG001|ROP #1|Needed treatment for ROP|1|||
125610908|NCT01860534|451858828|FG000|ROP #2|discharged prior to ROP #2|1|||
125610909|NCT01860534|451858829|FG001|ROP #2|discharged prior to ROP #2|0|||
125610910|NCT04891770|451858830|FG000|Overall Study|Withdrew consent|1|||
125610911|NCT04891770|451858831|FG001|Overall Study|Withdrew consent|3|||
125610912|NCT04891770|451858832|FG002|Overall Study|Withdrew consent|0|||
125610913|NCT04891770|451858830|FG000|Overall Study|Enrolled but never treated|0|||
125610914|NCT04891770|451858831|FG001|Overall Study|Enrolled but never treated|0|||
125610915|NCT04891770|451858832|FG002|Overall Study|Enrolled but never treated|1|||
125610916|NCT04891770|451858830|FG000|Overall Study|Investigator's discretion|0|||
125610917|NCT04891770|451858831|FG001|Overall Study|Investigator's discretion|1|||
125610918|NCT04891770|451858832|FG002|Overall Study|Investigator's discretion|0|||
125610919|NCT00195260|451858837|FG000|Part 1: Dose Escalation|Adverse Event|0|||
125610920|NCT00195260|451858838|FG001|Part 1: Dose Escalation|Adverse Event|1|||
125610921|NCT00195260|451858839|FG002|Part 1: Dose Escalation|Adverse Event|0|||
125610922|NCT00195260|451858840|FG003|Part 1: Dose Escalation|Adverse Event|1|||
125610923|NCT00195260|451858841|FG004|Part 1: Dose Escalation|Adverse Event|1|||
125610924|NCT00195260|451858842|FG005|Part 1: Dose Escalation|Adverse Event|0|||
125610925|NCT00195260|451858843|FG006|Part 1: Dose Escalation|Adverse Event|3|||
125610926|NCT00195260|451858844|FG007|Part 1: Dose Escalation|Adverse Event|0|||
125610927|NCT00195260|451858845|FG008|Part 1: Dose Escalation|Adverse Event|0|||
125610928|NCT00195260|451858846|FG009|Part 1: Dose Escalation|Adverse Event|0|||
125610929|NCT00195260|451858847|FG010|Part 1: Dose Escalation|Adverse Event|0|||
125610930|NCT00195260|451858837|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125610931|NCT00195260|451858838|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125610932|NCT00195260|451858839|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125610933|NCT00195260|451858840|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125610934|NCT00195260|451858841|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
125610935|NCT00195260|451858842|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125610936|NCT00195260|451858843|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125610937|NCT00195260|451858844|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
125610938|NCT00195260|451858845|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125610939|NCT00195260|451858846|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125610940|NCT00195260|451858847|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125610941|NCT00195260|451858837|FG000|Part 1: Dose Escalation|Death|0|||
125610942|NCT00195260|451858838|FG001|Part 1: Dose Escalation|Death|0|||
125371953|NCT03129100|450993258|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371954|NCT03129100|450993259|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371955|NCT03129100|450993260|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125371956|NCT03129100|450993261|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
125610943|NCT00195260|451858839|FG002|Part 1: Dose Escalation|Death|0|||
125610944|NCT00195260|451858840|FG003|Part 1: Dose Escalation|Death|0|||
125610945|NCT00195260|451858841|FG004|Part 1: Dose Escalation|Death|0|||
125610946|NCT00195260|451858842|FG005|Part 1: Dose Escalation|Death|0|||
125610947|NCT00195260|451858843|FG006|Part 1: Dose Escalation|Death|0|||
125610948|NCT00195260|451858844|FG007|Part 1: Dose Escalation|Death|1|||
125610949|NCT00195260|451858845|FG008|Part 1: Dose Escalation|Death|0|||
125610950|NCT00195260|451858846|FG009|Part 1: Dose Escalation|Death|0|||
125610951|NCT00195260|451858847|FG010|Part 1: Dose Escalation|Death|0|||
125610952|NCT00195260|451858837|FG000|Part 1: Dose Escalation|Disease Progression|3|||
125610953|NCT00195260|451858838|FG001|Part 1: Dose Escalation|Disease Progression|2|||
125610954|NCT00195260|451858839|FG002|Part 1: Dose Escalation|Disease Progression|5|||
125610955|NCT00195260|451858840|FG003|Part 1: Dose Escalation|Disease Progression|6|||
125610956|NCT00195260|451858841|FG004|Part 1: Dose Escalation|Disease Progression|4|||
125432013|NCT01576718|451207826|FG005|Treatment Period|Adverse Event|1|||
125610957|NCT00195260|451858842|FG005|Part 1: Dose Escalation|Disease Progression|6|||
125610958|NCT00195260|451858843|FG006|Part 1: Dose Escalation|Disease Progression|7|||
125610959|NCT00195260|451858844|FG007|Part 1: Dose Escalation|Disease Progression|4|||
125610960|NCT00195260|451858845|FG008|Part 1: Dose Escalation|Disease Progression|0|||
125371957|NCT03129100|450993236|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
125371958|NCT03129100|450993237|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
125371959|NCT03129100|450993238|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
125610961|NCT00195260|451858846|FG009|Part 1: Dose Escalation|Disease Progression|0|||
125610962|NCT00195260|451858847|FG010|Part 1: Dose Escalation|Disease Progression|0|||
125610963|NCT00195260|451858837|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
125610964|NCT00195260|451858838|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
125610965|NCT00195260|451858839|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
125610966|NCT00195260|451858840|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125371960|NCT03129100|450993239|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
125371961|NCT03129100|450993240|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
125371962|NCT03129100|450993241|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
125371963|NCT03129100|450993242|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
125371964|NCT03129100|450993243|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
125371965|NCT03129100|450993244|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
125371966|NCT03129100|450993245|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
125371967|NCT03129100|450993246|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
125371968|NCT03129100|450993247|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
125371969|NCT03129100|450993248|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
125371970|NCT03129100|450993249|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
125371971|NCT03129100|450993250|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
125371972|NCT03129100|450993251|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
125371973|NCT03129100|450993252|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
125371974|NCT03129100|450993253|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
125371975|NCT03129100|450993254|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
125371976|NCT03129100|450993255|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
125371977|NCT03129100|450993256|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
125371978|NCT03129100|450993257|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
125371979|NCT03129100|450993258|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
125371980|NCT03129100|450993259|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
125371981|NCT03129100|450993260|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
125371982|NCT03129100|450993261|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
125371983|NCT03129100|450993236|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371984|NCT03129100|450993237|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371985|NCT03129100|450993238|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371986|NCT03129100|450993239|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371987|NCT03129100|450993240|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371988|NCT03129100|450993241|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371989|NCT03129100|450993242|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371990|NCT03129100|450993243|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371991|NCT03129100|450993244|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371992|NCT03129100|450993245|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371993|NCT03129100|450993246|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371994|NCT03129100|450993247|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371995|NCT03129100|450993248|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371996|NCT03129100|450993249|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371997|NCT03129100|450993250|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371998|NCT03129100|450993251|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125371999|NCT03129100|450993252|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125372000|NCT03129100|450993253|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125372001|NCT03129100|450993254|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125372002|NCT03129100|450993255|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125372003|NCT03129100|450993256|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
125372004|NCT03129100|450993257|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125372005|NCT03129100|450993258|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125372006|NCT03129100|450993259|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125372007|NCT03129100|450993260|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125372008|NCT03129100|450993261|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
125372009|NCT03129100|450993236|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
125372010|NCT03129100|450993237|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
125610967|NCT00195260|451858841|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125610968|NCT00195260|451858842|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
125610969|NCT00195260|451858843|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125610970|NCT00195260|451858844|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125372011|NCT03129100|450993238|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
125372012|NCT03129100|450993239|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
125372013|NCT03129100|450993240|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
125372014|NCT03129100|450993241|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
125372015|NCT03129100|450993242|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
125610971|NCT00195260|451858845|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125610972|NCT00195260|451858846|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125610973|NCT00195260|451858847|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
125610974|NCT00195260|451858837|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125610975|NCT00195260|451858838|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125372016|NCT03129100|450993243|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
125372017|NCT03129100|450993244|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
125372018|NCT03129100|450993245|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
125372019|NCT03129100|450993246|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
125372020|NCT03129100|450993247|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
125372021|NCT03129100|450993248|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
125372022|NCT03129100|450993249|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
125372023|NCT03129100|450993250|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
125372024|NCT03129100|450993251|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
125372025|NCT03129100|450993252|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
125372026|NCT03129100|450993253|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
125372027|NCT03129100|450993254|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
125372028|NCT03129100|450993255|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
125372029|NCT03129100|450993256|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
125372030|NCT03129100|450993257|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
125372031|NCT03129100|450993258|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
125372032|NCT03129100|450993259|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
125372033|NCT03129100|450993260|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
125372034|NCT03129100|450993261|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
125372035|NCT03129100|450993236|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372036|NCT03129100|450993237|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372037|NCT03129100|450993238|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372038|NCT03129100|450993239|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372039|NCT03129100|450993240|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372040|NCT03129100|450993241|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372041|NCT03129100|450993242|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372042|NCT03129100|450993243|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372043|NCT03129100|450993244|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372044|NCT03129100|450993245|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372045|NCT03129100|450993246|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372046|NCT03129100|450993247|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372047|NCT03129100|450993248|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372048|NCT03129100|450993249|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372049|NCT03129100|450993250|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372050|NCT03129100|450993251|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372051|NCT03129100|450993252|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372052|NCT03129100|450993253|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372053|NCT03129100|450993254|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372054|NCT03129100|450993255|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372055|NCT03129100|450993256|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372056|NCT03129100|450993257|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372057|NCT03129100|450993258|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372058|NCT03129100|450993259|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
125372059|NCT03129100|450993260|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
125372060|NCT03129100|450993261|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
125372061|NCT03129100|450993236|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372062|NCT03129100|450993237|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372063|NCT03129100|450993238|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372064|NCT03129100|450993239|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372065|NCT03129100|450993240|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372066|NCT03129100|450993241|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372067|NCT03129100|450993242|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372068|NCT03129100|450993243|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372069|NCT03129100|450993244|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372070|NCT03129100|450993245|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372071|NCT03129100|450993246|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372072|NCT03129100|450993247|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125610976|NCT00195260|451858839|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125610977|NCT00195260|451858840|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125372073|NCT03129100|450993248|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372074|NCT03129100|450993249|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372075|NCT03129100|450993250|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125432014|NCT01576718|451207827|FG006|Treatment Period|Adverse Event|0|||
125432015|NCT01576718|451207821|FG000|Treatment Period|Withdrawal by Subject|0|||
125610978|NCT00195260|451858841|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125610979|NCT00195260|451858842|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125610980|NCT00195260|451858843|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125610981|NCT00195260|451858844|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
125610982|NCT00195260|451858845|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
125610983|NCT00195260|451858846|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
125610984|NCT00195260|451858847|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
125610985|NCT00195260|451858837|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125610986|NCT00195260|451858838|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125610987|NCT00195260|451858839|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125610988|NCT00195260|451858840|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125610989|NCT00195260|451858841|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125610990|NCT00195260|451858842|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125610991|NCT00195260|451858843|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125610992|NCT00195260|451858844|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
125610993|NCT00195260|451858845|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
125610994|NCT00195260|451858846|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
125610995|NCT00195260|451858847|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
125610996|NCT00195260|451858837|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125610997|NCT00195260|451858838|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125610998|NCT00195260|451858839|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125610999|NCT00195260|451858840|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125372076|NCT03129100|450993251|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372077|NCT03129100|450993252|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372078|NCT03129100|450993253|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372079|NCT03129100|450993254|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372080|NCT03129100|450993255|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372081|NCT03129100|450993256|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372082|NCT03129100|450993257|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372083|NCT03129100|450993258|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
125372084|NCT03129100|450993259|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
125372085|NCT03129100|450993260|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
125372086|NCT03129100|450993261|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
125372087|NCT03129100|450993236|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372088|NCT03129100|450993237|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372089|NCT03129100|450993238|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372090|NCT03129100|450993239|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372091|NCT03129100|450993240|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372092|NCT03129100|450993241|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372093|NCT03129100|450993242|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372094|NCT03129100|450993243|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372095|NCT03129100|450993244|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372096|NCT03129100|450993245|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372097|NCT03129100|450993246|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372098|NCT03129100|450993247|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372099|NCT03129100|450993248|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372100|NCT03129100|450993249|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372101|NCT03129100|450993250|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372102|NCT03129100|450993251|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372103|NCT03129100|450993252|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372104|NCT03129100|450993253|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372105|NCT03129100|450993254|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372106|NCT03129100|450993255|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372107|NCT03129100|450993256|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372108|NCT03129100|450993257|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372109|NCT03129100|450993258|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125611000|NCT00195260|451858841|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125611001|NCT00195260|451858842|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125611002|NCT00195260|451858843|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125611003|NCT00195260|451858844|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
125611004|NCT00195260|451858845|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
125611005|NCT00195260|451858846|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
125611006|NCT00195260|451858847|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
125611007|NCT00195260|451858837|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125214136|NCT02131233|450411238|FG000|Overall Study|Lack of Efficacy|6|||
125611008|NCT00195260|451858838|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125611009|NCT00195260|451858839|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125611010|NCT00195260|451858840|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125611011|NCT00195260|451858841|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125372110|NCT03129100|450993259|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372111|NCT03129100|450993260|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
125372112|NCT03129100|450993261|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
125372113|NCT03129100|450993236|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372114|NCT03129100|450993237|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372115|NCT03129100|450993238|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372116|NCT03129100|450993239|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372117|NCT03129100|450993240|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372118|NCT03129100|450993241|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372119|NCT03129100|450993242|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372120|NCT03129100|450993243|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372121|NCT03129100|450993244|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372122|NCT03129100|450993245|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372123|NCT03129100|450993246|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372124|NCT03129100|450993247|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372125|NCT03129100|450993248|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372126|NCT03129100|450993249|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372127|NCT03129100|450993250|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372128|NCT03129100|450993251|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372129|NCT03129100|450993252|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372130|NCT03129100|450993253|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372131|NCT03129100|450993254|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372132|NCT03129100|450993255|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372133|NCT03129100|450993256|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372134|NCT03129100|450993257|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372135|NCT03129100|450993258|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372136|NCT03129100|450993259|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372137|NCT03129100|450993260|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
125372138|NCT03129100|450993261|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
125372139|NCT03129100|450993236|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
125372140|NCT03129100|450993237|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
125372141|NCT03129100|450993238|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
125372142|NCT03129100|450993239|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
125372143|NCT03129100|450993240|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
125372144|NCT03129100|450993241|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
125372145|NCT03129100|450993242|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
125372146|NCT03129100|450993243|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
125372147|NCT03129100|450993244|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
125372148|NCT03129100|450993245|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
125372149|NCT03129100|450993246|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
125372150|NCT03129100|450993247|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
125372151|NCT03129100|450993248|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
125372152|NCT03129100|450993249|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
125372153|NCT03129100|450993250|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
125372154|NCT03129100|450993251|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
125372155|NCT03129100|450993252|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
125372156|NCT03129100|450993253|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
125372157|NCT03129100|450993254|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
125372158|NCT03129100|450993255|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
125372159|NCT03129100|450993256|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
125372160|NCT03129100|450993257|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
125372161|NCT03129100|450993258|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
125372162|NCT03129100|450993259|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
125372163|NCT03129100|450993260|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
125372164|NCT03129100|450993261|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
125372165|NCT01587001|450993262|FG000|Overall Study|Lost to Follow-up|2|||
125372166|NCT01587001|450993263|FG001|Overall Study|Lost to Follow-up|0|||
125611012|NCT00195260|451858842|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125372167|NCT01587001|450993262|FG000|Overall Study|Insufficient samples to complete testing|4|||
125372168|NCT01587001|450993263|FG001|Overall Study|Insufficient samples to complete testing|1|||
125372169|NCT03845985|450993264|FG000|Overall Study|Lost to Follow-up|2|||
125372170|NCT03845985|450993265|FG001|Overall Study|Lost to Follow-up|1|||
125372171|NCT03845985|450993264|FG000|Overall Study|Physician Decision|1|||
125372172|NCT03845985|450993265|FG001|Overall Study|Physician Decision|0|||
125372173|NCT03845985|450993264|FG000|Overall Study|Withdrawal by Subject|4|||
125611013|NCT00195260|451858843|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125372174|NCT03845985|450993265|FG001|Overall Study|Withdrawal by Subject|1|||
125372175|NCT03334539|450993268|FG000|Overall Study|Adverse Event|3|||
125372176|NCT03334539|450993269|FG001|Overall Study|Adverse Event|5|||
125372177|NCT03334539|450993270|FG002|Overall Study|Adverse Event|0|||
125372178|NCT03334539|450993268|FG000|Overall Study|Withdrawal by Subject|0|||
125372179|NCT03334539|450993269|FG001|Overall Study|Withdrawal by Subject|1|||
125372180|NCT03334539|450993270|FG002|Overall Study|Withdrawal by Subject|1|||
125372181|NCT03334539|450993268|FG000|Overall Study|Administrative Reasons|1|||
125372182|NCT03334539|450993269|FG001|Overall Study|Administrative Reasons|0|||
125372183|NCT03334539|450993270|FG002|Overall Study|Administrative Reasons|0|||
125372184|NCT03334539|450993268|FG000|Overall Study|Hypertension Not Controlled|0|||
125372185|NCT03334539|450993269|FG001|Overall Study|Hypertension Not Controlled|1|||
125372186|NCT03334539|450993270|FG002|Overall Study|Hypertension Not Controlled|0|||
125372187|NCT03736447|450993271|FG000|Overall Study|Adverse Event|5|||
125372188|NCT03736447|450993272|FG001|Overall Study|Adverse Event|1|||
125372189|NCT03736447|450993271|FG000|Overall Study|Withdrawal by Subject|5|||
125372190|NCT03736447|450993272|FG001|Overall Study|Withdrawal by Subject|1|||
125372191|NCT03736447|450993271|FG000|Overall Study|Lost to Follow-up|1|||
125372192|NCT03736447|450993272|FG001|Overall Study|Lost to Follow-up|0|||
125372193|NCT03736447|450993271|FG000|Overall Study|Physician Decision|1|||
125372194|NCT03736447|450993272|FG001|Overall Study|Physician Decision|0|||
125372195|NCT03736447|450993271|FG000|Overall Study|Continued commitment to study treatment|3|||
125372196|NCT03736447|450993272|FG001|Overall Study|Continued commitment to study treatment|0|||
125372197|NCT03736447|450993271|FG000|Overall Study|Taste aversion to study product|0|||
125372198|NCT03736447|450993272|FG001|Overall Study|Taste aversion to study product|1|||
125372199|NCT02619175|450993274|FG000|Overall Study|Withdrawal by Subject|1|||
125372200|NCT02619175|450993275|FG001|Overall Study|Withdrawal by Subject|0|||
125372201|NCT02619175|450993274|FG000|Overall Study|foot pain|1|||
125611014|NCT00195260|451858844|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
125611015|NCT00195260|451858845|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
125611016|NCT00195260|451858846|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
125611017|NCT00195260|451858847|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
125611018|NCT04360187|451858849|FG000|Double-Blind Treatment|Adverse Event|9|||
125611019|NCT04360187|451858850|FG001|Double-Blind Treatment|Adverse Event|11|||
125611020|NCT04360187|451858849|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
125611021|NCT04360187|451858850|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
125611022|NCT04360187|451858849|FG000|Double-Blind Treatment|Physician Decision|1|||
125611023|NCT04360187|451858850|FG001|Double-Blind Treatment|Physician Decision|0|||
125611024|NCT04360187|451858849|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
125611025|NCT04360187|451858850|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
125611026|NCT04360187|451858849|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
125611027|NCT04360187|451858850|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
125611028|NCT04360187|451858849|FG000|Follow-Up|Lost to Follow-up|1|||
125611029|NCT04360187|451858850|FG001|Follow-Up|Lost to Follow-up|0|||
125611030|NCT00222729|451858859|FG000|Overall Study|Adverse Event|3|||
125611031|NCT01318083|451858860|FG000|Overall Study|Adverse Event|4|||
125611032|NCT01318083|451858861|FG001|Overall Study|Adverse Event|1|||
125611033|NCT01318083|451858862|FG002|Overall Study|Adverse Event|2|||
125611034|NCT01318083|451858860|FG000|Overall Study|Withdrawal by Subject|1|||
125611035|NCT01318083|451858861|FG001|Overall Study|Withdrawal by Subject|0|||
125611036|NCT01318083|451858862|FG002|Overall Study|Withdrawal by Subject|2|||
125611037|NCT01318083|451858860|FG000|Overall Study|Lack of Efficacy|0|||
125611038|NCT01318083|451858861|FG001|Overall Study|Lack of Efficacy|0|||
125611039|NCT01318083|451858862|FG002|Overall Study|Lack of Efficacy|1|||
125611040|NCT01318083|451858860|FG000|Overall Study|Treatment Complications|1|||
125611041|NCT01318083|451858861|FG001|Overall Study|Treatment Complications|0|||
125611042|NCT01318083|451858862|FG002|Overall Study|Treatment Complications|0|||
125611043|NCT01318083|451858860|FG000|Overall Study|Lack of Study Medication Compliance|0|||
125611044|NCT01318083|451858861|FG001|Overall Study|Lack of Study Medication Compliance|1|||
125611045|NCT01318083|451858862|FG002|Overall Study|Lack of Study Medication Compliance|0|||
125611046|NCT00256867|451858863|FG000|Overall Study|Adverse Event|0|||
125372202|NCT02619175|450993275|FG001|Overall Study|foot pain|0|||
125611047|NCT00256867|451858864|FG001|Overall Study|Adverse Event|1|||
125611048|NCT00256867|451858865|FG002|Overall Study|Adverse Event|1|||
125372203|NCT00256750|450993278|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
125611049|NCT00256867|451858866|FG003|Overall Study|Adverse Event|1|||
125611050|NCT00256867|451858867|FG004|Overall Study|Adverse Event|2|||
125611051|NCT00256867|451858868|FG005|Overall Study|Adverse Event|2|||
125611052|NCT00256867|451858869|FG006|Overall Study|Adverse Event|1|||
125611053|NCT00256867|451858870|FG007|Overall Study|Adverse Event|4|||
125611054|NCT00256867|451858863|FG000|Overall Study|Lost to Follow-up|2|||
125611055|NCT00256867|451858864|FG001|Overall Study|Lost to Follow-up|2|||
125611056|NCT00256867|451858865|FG002|Overall Study|Lost to Follow-up|2|||
125611057|NCT00256867|451858866|FG003|Overall Study|Lost to Follow-up|3|||
125372204|NCT00256750|450993279|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
125372205|NCT00256750|450993280|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
125611058|NCT00256867|451858867|FG004|Overall Study|Lost to Follow-up|2|||
125611059|NCT00256867|451858868|FG005|Overall Study|Lost to Follow-up|0|||
125611060|NCT00256867|451858869|FG006|Overall Study|Lost to Follow-up|1|||
125611061|NCT00256867|451858870|FG007|Overall Study|Lost to Follow-up|2|||
125611062|NCT00256867|451858863|FG000|Overall Study|Protocol Violation|0|||
125611063|NCT00256867|451858864|FG001|Overall Study|Protocol Violation|0|||
125611064|NCT00256867|451858865|FG002|Overall Study|Protocol Violation|0|||
125611065|NCT00256867|451858866|FG003|Overall Study|Protocol Violation|1|||
125611066|NCT00256867|451858867|FG004|Overall Study|Protocol Violation|0|||
125611067|NCT00256867|451858868|FG005|Overall Study|Protocol Violation|1|||
125611068|NCT00256867|451858869|FG006|Overall Study|Protocol Violation|0|||
125611069|NCT00256867|451858870|FG007|Overall Study|Protocol Violation|1|||
125611070|NCT00256867|451858863|FG000|Overall Study|Withdrawal by Subject|0|||
125611071|NCT00256867|451858864|FG001|Overall Study|Withdrawal by Subject|0|||
125611072|NCT00256867|451858865|FG002|Overall Study|Withdrawal by Subject|1|||
125611073|NCT00256867|451858866|FG003|Overall Study|Withdrawal by Subject|1|||
125611074|NCT00256867|451858867|FG004|Overall Study|Withdrawal by Subject|2|||
125611075|NCT00256867|451858868|FG005|Overall Study|Withdrawal by Subject|2|||
125611076|NCT00256867|451858869|FG006|Overall Study|Withdrawal by Subject|3|||
125611077|NCT00256867|451858870|FG007|Overall Study|Withdrawal by Subject|2|||
125611078|NCT00256867|451858863|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125611079|NCT00256867|451858864|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
125611080|NCT00256867|451858865|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125611081|NCT00256867|451858866|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125611082|NCT00256867|451858867|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125611083|NCT00256867|451858868|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125611084|NCT00256867|451858869|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125611085|NCT00256867|451858870|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
125611086|NCT00256867|451858863|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125611087|NCT00256867|451858864|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125611088|NCT00256867|451858865|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125611089|NCT00256867|451858866|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125611090|NCT00256867|451858867|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125611091|NCT00256867|451858868|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125611092|NCT00256867|451858869|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
125611093|NCT00256867|451858870|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
125611094|NCT00256867|451858863|FG000|Overall Study|Investigator's Decision|0|||
125611095|NCT00256867|451858864|FG001|Overall Study|Investigator's Decision|0|||
125611096|NCT00256867|451858865|FG002|Overall Study|Investigator's Decision|0|||
125611097|NCT00256867|451858866|FG003|Overall Study|Investigator's Decision|0|||
125611098|NCT00256867|451858867|FG004|Overall Study|Investigator's Decision|1|||
125611099|NCT00256867|451858868|FG005|Overall Study|Investigator's Decision|0|||
125611100|NCT00256867|451858869|FG006|Overall Study|Investigator's Decision|0|||
125611101|NCT00256867|451858870|FG007|Overall Study|Investigator's Decision|0|||
125611102|NCT00256867|451858863|FG000|Overall Study|Non-compliance with study medication|0|||
125611103|NCT00256867|451858864|FG001|Overall Study|Non-compliance with study medication|0|||
125611104|NCT00256867|451858865|FG002|Overall Study|Non-compliance with study medication|0|||
125611105|NCT00256867|451858866|FG003|Overall Study|Non-compliance with study medication|0|||
125611106|NCT00256867|451858867|FG004|Overall Study|Non-compliance with study medication|0|||
125611107|NCT00256867|451858868|FG005|Overall Study|Non-compliance with study medication|0|||
125611108|NCT00256867|451858869|FG006|Overall Study|Non-compliance with study medication|0|||
125611109|NCT00256867|451858870|FG007|Overall Study|Non-compliance with study medication|1|||
125611110|NCT00256867|451858863|FG000|Overall Study|Participant travelled Overseas|0|||
125611111|NCT00256867|451858864|FG001|Overall Study|Participant travelled Overseas|1|||
125611112|NCT00256867|451858865|FG002|Overall Study|Participant travelled Overseas|0|||
125611113|NCT00256867|451858866|FG003|Overall Study|Participant travelled Overseas|0|||
125611114|NCT00256867|451858867|FG004|Overall Study|Participant travelled Overseas|0|||
125611115|NCT00256867|451858868|FG005|Overall Study|Participant travelled Overseas|0|||
125611116|NCT00256867|451858869|FG006|Overall Study|Participant travelled Overseas|0|||
125611117|NCT00256867|451858870|FG007|Overall Study|Participant travelled Overseas|0|||
125432016|NCT01576718|451207822|FG001|Treatment Period|Withdrawal by Subject|1|||
125372206|NCT00256750|450993278|FG000|Transplanted Pre-Treatment|Other|2|||
125372207|NCT00256750|450993279|FG001|Transplanted Pre-Treatment|Other|0|||
125611118|NCT00256867|451858863|FG000|Overall Study|Participant out of assessment window|0|||
125611119|NCT00256867|451858864|FG001|Overall Study|Participant out of assessment window|0|||
125611120|NCT00256867|451858865|FG002|Overall Study|Participant out of assessment window|1|||
125611121|NCT00256867|451858866|FG003|Overall Study|Participant out of assessment window|0|||
125611122|NCT00256867|451858867|FG004|Overall Study|Participant out of assessment window|0|||
125611123|NCT00256867|451858868|FG005|Overall Study|Participant out of assessment window|0|||
125611124|NCT00256867|451858869|FG006|Overall Study|Participant out of assessment window|0|||
125611125|NCT00256867|451858870|FG007|Overall Study|Participant out of assessment window|0|||
125611126|NCT00256867|451858863|FG000|Overall Study|Withdrawal by participant|0|||
125611127|NCT00256867|451858864|FG001|Overall Study|Withdrawal by participant|0|||
125611128|NCT00256867|451858865|FG002|Overall Study|Withdrawal by participant|0|||
125611129|NCT00256867|451858866|FG003|Overall Study|Withdrawal by participant|0|||
125611130|NCT00256867|451858867|FG004|Overall Study|Withdrawal by participant|0|||
125611131|NCT00256867|451858868|FG005|Overall Study|Withdrawal by participant|1|||
125611132|NCT00256867|451858869|FG006|Overall Study|Withdrawal by participant|0|||
125611133|NCT00256867|451858870|FG007|Overall Study|Withdrawal by participant|0|||
125611134|NCT02993224|451858871|FG000|Core Phase - Period 1|Adverse Event|4|||
125611135|NCT02993224|451858871|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
125611136|NCT02993224|451858871|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
125611137|NCT02993224|451858871|FG000|Core Phase- Period 2|Adverse Event|1|||
125611138|NCT02993224|451858871|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
125611139|NCT02993224|451858871|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
125372208|NCT00256750|450993280|FG002|Transplanted Pre-Treatment|Other|0|||
125611140|NCT02993224|451858871|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
125611141|NCT02993224|451858871|FG000|Extension Phase|Adverse Event|3|||
125611142|NCT02993224|451858871|FG000|Extension Phase|Withdrawal by Subject|3|||
125611143|NCT02993224|451858871|FG000|Extension Phase|Lost to Follow-up|2|||
125611144|NCT02993224|451858871|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
125611145|NCT01930799|451858875|FG000|Overall Study|Withdrawal by Subject|3|||
125611146|NCT01930799|451858875|FG000|Overall Study|Lost to Follow-up|5|||
125611147|NCT00952289|451858877|FG000|All Participants|Death|9|||
125611148|NCT00952289|451858878|FG001|All Participants|Death|9|||
125611149|NCT00952289|451858877|FG000|All Participants|Adverse Event|8|||
125611150|NCT00952289|451858878|FG001|All Participants|Adverse Event|8|||
125611151|NCT00952289|451858877|FG000|All Participants|Disease progression|3|||
125611152|NCT00952289|451858878|FG001|All Participants|Disease progression|12|||
125611153|NCT00952289|451858877|FG000|All Participants|Withdrawal by Subject|1|||
125611154|NCT00952289|451858878|FG001|All Participants|Withdrawal by Subject|10|||
125611155|NCT00952289|451858877|FG000|All Participants|Data lost during site relocation|0|||
125611156|NCT00952289|451858878|FG001|All Participants|Data lost during site relocation|1|||
125611157|NCT00952289|451858877|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
125611158|NCT00952289|451858878|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
125611159|NCT00952289|451858877|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
125611160|NCT00952289|451858878|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
125611161|NCT00952289|451858877|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
125372209|NCT00256750|450993278|FG000|Transplanted Pre-Treatment|Death|1|||
125214137|NCT02131233|450411239|FG001|Overall Study|Lack of Efficacy|3|||
125611162|NCT00952289|451858878|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
125214138|NCT02131233|450411238|FG000|Overall Study|Lost to Follow-up|14|||
125214139|NCT02131233|450411239|FG001|Overall Study|Lost to Follow-up|13|||
125214140|NCT02131233|450411238|FG000|Overall Study|Non-Compliance With Study Drug|8|||
125214141|NCT02131233|450411239|FG001|Overall Study|Non-Compliance With Study Drug|5|||
125611163|NCT00952289|451858877|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
125611164|NCT00952289|451858878|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
125611165|NCT00952289|451858877|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
125611166|NCT00952289|451858878|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
125214142|NCT02131233|450411238|FG000|Overall Study|Physician Decision|7|||
125214143|NCT02131233|450411239|FG001|Overall Study|Physician Decision|0|||
125214144|NCT02131233|450411238|FG000|Overall Study|Pregnancy|4|||
125214145|NCT02131233|450411239|FG001|Overall Study|Pregnancy|0|||
125214146|NCT02131233|450411238|FG000|Overall Study|Withdrawal by Subject|18|||
125214147|NCT02131233|450411239|FG001|Overall Study|Withdrawal by Subject|11|||
125214148|NCT00790556|450411240|FG000|Treatment Period 1|Physician Decision|1|||
125214149|NCT00790556|450411241|FG001|Treatment Period 1|Physician Decision|0|||
125214150|NCT00790556|450411240|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125214151|NCT00790556|450411241|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125214152|NCT00217581|450411244|FG000|Overall Study|Withdrawal by Subject|1|||
125214153|NCT04399889|450411245|FG000|Overall Study|Death|5|||
125372210|NCT00256750|450993279|FG001|Transplanted Pre-Treatment|Death|0|||
125372211|NCT00256750|450993280|FG002|Transplanted Pre-Treatment|Death|0|||
125372212|NCT00256750|450993278|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
125372213|NCT00256750|450993279|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
125372214|NCT00256750|450993280|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
125372215|NCT00256750|450993278|FG000|Post-Transplant Treated (12 Months)|Death|3|||
125372216|NCT00256750|450993279|FG001|Post-Transplant Treated (12 Months)|Death|2|||
125372217|NCT00256750|450993280|FG002|Post-Transplant Treated (12 Months)|Death|4|||
125372218|NCT00256750|450993278|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
125372219|NCT00256750|450993279|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
125372220|NCT00256750|450993280|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
125372221|NCT00256750|450993278|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
125372222|NCT00256750|450993279|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
125372223|NCT00256750|450993280|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
125372224|NCT00256750|450993278|FG000|Post-Transplant Treated (12 Months)|Other|5|||
125372225|NCT00256750|450993279|FG001|Post-Transplant Treated (12 Months)|Other|4|||
125372226|NCT00256750|450993280|FG002|Post-Transplant Treated (12 Months)|Other|2|||
125372227|NCT00256750|450993278|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
125372228|NCT00256750|450993279|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
125372229|NCT00256750|450993280|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
125372230|NCT00256750|450993278|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
125372231|NCT00256750|450993279|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
125372232|NCT00256750|450993280|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
125372233|NCT00256750|450993278|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
125372234|NCT00256750|450993279|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
125372235|NCT00256750|450993280|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
125372236|NCT00256750|450993278|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
125372237|NCT00256750|450993279|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
125372238|NCT00256750|450993280|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
125372239|NCT00256750|450993278|FG000|Post-Transplant Treated (24 Months)|Death|3|||
125372240|NCT00256750|450993279|FG001|Post-Transplant Treated (24 Months)|Death|0|||
125372241|NCT00256750|450993280|FG002|Post-Transplant Treated (24 Months)|Death|0|||
125372242|NCT00256750|450993278|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
125372243|NCT00256750|450993279|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
125372244|NCT00256750|450993280|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
125372245|NCT00256750|450993278|FG000|Post-Transplant Treated (24 Months)|Other|2|||
125372246|NCT00256750|450993279|FG001|Post-Transplant Treated (24 Months)|Other|0|||
125372247|NCT00256750|450993280|FG002|Post-Transplant Treated (24 Months)|Other|1|||
125372248|NCT00256750|450993278|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
125372249|NCT00256750|450993279|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
125372250|NCT00256750|450993280|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
125372251|NCT00256750|450993278|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
125372252|NCT00256750|450993279|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
125372253|NCT00256750|450993280|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
125372254|NCT00256750|450993278|FG000|Post-Transplant Treated (36 Months)|Death|0|||
125372255|NCT00256750|450993279|FG001|Post-Transplant Treated (36 Months)|Death|2|||
125372256|NCT00256750|450993280|FG002|Post-Transplant Treated (36 Months)|Death|1|||
125372257|NCT00256750|450993278|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
125372258|NCT00256750|450993279|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
125372259|NCT00256750|450993280|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
125372260|NCT00256750|450993278|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
125372261|NCT00256750|450993279|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
125372262|NCT00256750|450993280|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
125372263|NCT00256750|450993278|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
125372264|NCT00256750|450993279|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
125372265|NCT00256750|450993280|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
125372266|NCT00256750|450993278|FG000|Post-Transplant Treated (36 Months)|Other|0|||
125372267|NCT00256750|450993279|FG001|Post-Transplant Treated (36 Months)|Other|1|||
125372268|NCT00256750|450993280|FG002|Post-Transplant Treated (36 Months)|Other|1|||
125372269|NCT00256750|450993278|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
125372270|NCT00256750|450993279|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
125372271|NCT00256750|450993280|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
125372272|NCT00256750|450993278|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
125372273|NCT00256750|450993279|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
125372274|NCT00256750|450993280|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
125372275|NCT00256750|450993278|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
125372276|NCT00256750|450993279|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
125372277|NCT00256750|450993280|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
125372278|NCT00256750|450993278|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
125372279|NCT00256750|450993279|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
125372280|NCT00256750|450993280|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
125372281|NCT00256750|450993278|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
125372282|NCT00256750|450993279|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
125372283|NCT00256750|450993280|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
125372284|NCT00256750|450993278|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
125372285|NCT00256750|450993279|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
125372286|NCT00256750|450993280|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
125372287|NCT00256750|450993278|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
125372288|NCT00256750|450993279|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
125372289|NCT00256750|450993280|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
125372290|NCT00256750|450993278|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
125372291|NCT00256750|450993279|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
125372292|NCT00256750|450993280|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
125372293|NCT00256750|450993278|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
125372294|NCT00256750|450993279|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
125372295|NCT00256750|450993280|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
125372296|NCT01197560|450993282|FG000|Overall Study|Adverse Event|6|||
125372297|NCT01197560|450993283|FG001|Overall Study|Adverse Event|8|||
125372298|NCT01197560|450993282|FG000|Overall Study|Death|3|||
125372299|NCT01197560|450993283|FG001|Overall Study|Death|5|||
125372300|NCT01197560|450993282|FG000|Overall Study|Withdrawal by Subject|1|||
125372301|NCT01197560|450993283|FG001|Overall Study|Withdrawal by Subject|1|||
125372302|NCT01197560|450993282|FG000|Overall Study|Disease progression|40|||
125372303|NCT01197560|450993283|FG001|Overall Study|Disease progression|35|||
125372304|NCT01197560|450993282|FG000|Overall Study|Miscellaneous|4|||
125372305|NCT01197560|450993283|FG001|Overall Study|Miscellaneous|3|||
125372306|NCT01197560|450993282|FG000|Overall Study|Missing|0|||
125372307|NCT01197560|450993283|FG001|Overall Study|Missing|1|||
125611167|NCT03136185|451858886|FG000|Overall Study|Adverse Event|0|||
125611168|NCT03136185|451858887|FG001|Overall Study|Adverse Event|1|||
125611169|NCT03136185|451858888|FG002|Overall Study|Adverse Event|3|||
125611170|NCT03136185|451858889|FG003|Overall Study|Adverse Event|1|||
125611171|NCT03136185|451858890|FG004|Overall Study|Adverse Event|2|||
125611172|NCT03136185|451858891|FG005|Overall Study|Adverse Event|2|||
125611173|NCT03136185|451858892|FG006|Overall Study|Adverse Event|5|||
125372308|NCT02006719|450993284|FG000|Overall Study|Withdrawal by Subject|10|||
125372309|NCT02006719|450993285|FG001|Overall Study|Withdrawal by Subject|2|||
125372310|NCT02006719|450993284|FG000|Overall Study|Lost to Follow-up|5|||
125372311|NCT02006719|450993285|FG001|Overall Study|Lost to Follow-up|1|||
125611174|NCT03136185|451858893|FG007|Overall Study|Adverse Event|1|||
125611175|NCT03136185|451858894|FG008|Overall Study|Adverse Event|1|||
125611176|NCT03136185|451858886|FG000|Overall Study|Death|0|||
125611177|NCT03136185|451858887|FG001|Overall Study|Death|0|||
125611178|NCT03136185|451858888|FG002|Overall Study|Death|0|||
125611179|NCT03136185|451858889|FG003|Overall Study|Death|1|||
125611180|NCT03136185|451858890|FG004|Overall Study|Death|1|||
125372312|NCT02006719|450993284|FG000|Overall Study|Protocol Violation|2|||
125432017|NCT01576718|451207823|FG002|Treatment Period|Withdrawal by Subject|1|||
125611181|NCT03136185|451858891|FG005|Overall Study|Death|0|||
125611182|NCT03136185|451858892|FG006|Overall Study|Death|1|||
125611183|NCT03136185|451858893|FG007|Overall Study|Death|0|||
125611184|NCT03136185|451858894|FG008|Overall Study|Death|0|||
125611185|NCT03136185|451858886|FG000|Overall Study|Physician Decision|3|||
125611186|NCT03136185|451858887|FG001|Overall Study|Physician Decision|1|||
125611187|NCT03136185|451858888|FG002|Overall Study|Physician Decision|1|||
125611188|NCT03136185|451858889|FG003|Overall Study|Physician Decision|2|||
125611189|NCT03136185|451858890|FG004|Overall Study|Physician Decision|1|||
125611190|NCT03136185|451858891|FG005|Overall Study|Physician Decision|2|||
125611191|NCT03136185|451858892|FG006|Overall Study|Physician Decision|1|||
125611192|NCT03136185|451858893|FG007|Overall Study|Physician Decision|0|||
125611193|NCT03136185|451858894|FG008|Overall Study|Physician Decision|1|||
125611194|NCT03136185|451858886|FG000|Overall Study|Protocol Defined Disease Progression|0|||
125611195|NCT03136185|451858887|FG001|Overall Study|Protocol Defined Disease Progression|0|||
125611196|NCT03136185|451858888|FG002|Overall Study|Protocol Defined Disease Progression|1|||
125611197|NCT03136185|451858889|FG003|Overall Study|Protocol Defined Disease Progression|0|||
125611198|NCT03136185|451858890|FG004|Overall Study|Protocol Defined Disease Progression|0|||
125611199|NCT03136185|451858891|FG005|Overall Study|Protocol Defined Disease Progression|1|||
125611200|NCT03136185|451858892|FG006|Overall Study|Protocol Defined Disease Progression|0|||
125611201|NCT03136185|451858893|FG007|Overall Study|Protocol Defined Disease Progression|1|||
125611202|NCT03136185|451858894|FG008|Overall Study|Protocol Defined Disease Progression|1|||
125611203|NCT03136185|451858886|FG000|Overall Study|Withdrawal by Subject|1|||
125611204|NCT03136185|451858887|FG001|Overall Study|Withdrawal by Subject|0|||
125611205|NCT03136185|451858888|FG002|Overall Study|Withdrawal by Subject|1|||
125611206|NCT03136185|451858889|FG003|Overall Study|Withdrawal by Subject|1|||
125611207|NCT03136185|451858890|FG004|Overall Study|Withdrawal by Subject|1|||
125611208|NCT03136185|451858891|FG005|Overall Study|Withdrawal by Subject|1|||
125611209|NCT03136185|451858892|FG006|Overall Study|Withdrawal by Subject|2|||
125611210|NCT03136185|451858893|FG007|Overall Study|Withdrawal by Subject|3|||
125611211|NCT03136185|451858894|FG008|Overall Study|Withdrawal by Subject|3|||
125611212|NCT03136185|451858886|FG000|Overall Study|Not Reported|4|||
125611213|NCT03136185|451858887|FG001|Overall Study|Not Reported|1|||
125611214|NCT03136185|451858888|FG002|Overall Study|Not Reported|0|||
125611215|NCT03136185|451858889|FG003|Overall Study|Not Reported|1|||
125611216|NCT03136185|451858890|FG004|Overall Study|Not Reported|0|||
125611217|NCT03136185|451858891|FG005|Overall Study|Not Reported|2|||
125611218|NCT03136185|451858892|FG006|Overall Study|Not Reported|1|||
125611219|NCT03136185|451858893|FG007|Overall Study|Not Reported|1|||
125611220|NCT03136185|451858894|FG008|Overall Study|Not Reported|0|||
125611221|NCT00488033|451858898|FG000|Overall Study|Withdrawal by Subject|1|||
125611222|NCT00488033|451858899|FG001|Overall Study|Withdrawal by Subject|0|||
125611223|NCT04715230|451858902|FG000|Overall Study|Withdrawal by Subject|1|||
125611224|NCT04715230|451858903|FG001|Overall Study|Withdrawal by Subject|0|||
125611225|NCT04715230|451858904|FG002|Overall Study|Withdrawal by Subject|0|||
125611226|NCT04715230|451858902|FG000|Overall Study|Lost to Follow-up|0|||
125611227|NCT04715230|451858903|FG001|Overall Study|Lost to Follow-up|5|||
125611228|NCT04715230|451858904|FG002|Overall Study|Lost to Follow-up|1|||
125611229|NCT03453151|451858905|FG000|Overall Study|Withdrawal by Subject|1|||
125611230|NCT03453151|451858905|FG000|Overall Study|Physician Decision|3|||
125611231|NCT02065622|451858909|FG000|Induction Study|Adverse Event|13|||
125611232|NCT02065622|451858910|FG001|Induction Study|Adverse Event|19|||
125611233|NCT02065622|451858911|FG002|Induction Study|Adverse Event|0|||
125611234|NCT02065622|451858912|FG003|Induction Study|Adverse Event|0|||
125611235|NCT02065622|451858913|FG004|Induction Study|Adverse Event|0|||
125611236|NCT02065622|451858909|FG000|Induction Study|Withdrawal by Subject|3|||
125611237|NCT02065622|451858910|FG001|Induction Study|Withdrawal by Subject|5|||
125611238|NCT02065622|451858911|FG002|Induction Study|Withdrawal by Subject|0|||
125611239|NCT02065622|451858912|FG003|Induction Study|Withdrawal by Subject|0|||
125611240|NCT02065622|451858913|FG004|Induction Study|Withdrawal by Subject|0|||
125611241|NCT02065622|451858909|FG000|Induction Study|Lost to Follow-up|1|||
125611242|NCT02065622|451858910|FG001|Induction Study|Lost to Follow-up|0|||
125611243|NCT02065622|451858911|FG002|Induction Study|Lost to Follow-up|0|||
125611244|NCT02065622|451858912|FG003|Induction Study|Lost to Follow-up|0|||
125611245|NCT02065622|451858913|FG004|Induction Study|Lost to Follow-up|0|||
125611246|NCT02065622|451858909|FG000|Induction Study|Lack of Efficacy|22|||
125611247|NCT02065622|451858910|FG001|Induction Study|Lack of Efficacy|27|||
125611248|NCT02065622|451858911|FG002|Induction Study|Lack of Efficacy|0|||
125611249|NCT02065622|451858912|FG003|Induction Study|Lack of Efficacy|0|||
125611250|NCT02065622|451858913|FG004|Induction Study|Lack of Efficacy|0|||
125372313|NCT02006719|450993285|FG001|Overall Study|Protocol Violation|0|||
125372314|NCT02006719|450993284|FG000|Overall Study|Adverse Event|1|||
125611251|NCT02065622|451858909|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
125611252|NCT02065622|451858910|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
125611253|NCT02065622|451858911|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
125611254|NCT02065622|451858912|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
125611255|NCT02065622|451858913|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
125611256|NCT02065622|451858909|FG000|Induction Study|Subject Noncompliance|1|||
125611257|NCT02065622|451858910|FG001|Induction Study|Subject Noncompliance|1|||
125372315|NCT02006719|450993285|FG001|Overall Study|Adverse Event|1|||
125611258|NCT02065622|451858911|FG002|Induction Study|Subject Noncompliance|0|||
125611259|NCT02065622|451858912|FG003|Induction Study|Subject Noncompliance|0|||
125611260|NCT02065622|451858913|FG004|Induction Study|Subject Noncompliance|0|||
125611261|NCT02065622|451858909|FG000|Induction Study|Other, Not Specified|3|||
125611262|NCT02065622|451858910|FG001|Induction Study|Other, Not Specified|2|||
125611263|NCT02065622|451858911|FG002|Induction Study|Other, Not Specified|0|||
125611264|NCT02065622|451858912|FG003|Induction Study|Other, Not Specified|0|||
125611265|NCT02065622|451858913|FG004|Induction Study|Other, Not Specified|0|||
125611266|NCT02065622|451858909|FG000|Maintenance Study|Adverse Event|0|||
125611267|NCT02065622|451858910|FG001|Maintenance Study|Adverse Event|0|||
125611268|NCT02065622|451858911|FG002|Maintenance Study|Adverse Event|25|||
125611269|NCT02065622|451858912|FG003|Maintenance Study|Adverse Event|22|||
125611270|NCT02065622|451858913|FG004|Maintenance Study|Adverse Event|11|||
125611271|NCT02065622|451858909|FG000|Maintenance Study|Withdrawal by Subject|0|||
125611272|NCT02065622|451858910|FG001|Maintenance Study|Withdrawal by Subject|0|||
125611273|NCT02065622|451858911|FG002|Maintenance Study|Withdrawal by Subject|11|||
125611274|NCT02065622|451858912|FG003|Maintenance Study|Withdrawal by Subject|5|||
125611275|NCT02065622|451858913|FG004|Maintenance Study|Withdrawal by Subject|7|||
125611276|NCT02065622|451858909|FG000|Maintenance Study|Lost to Follow-up|0|||
125611277|NCT02065622|451858910|FG001|Maintenance Study|Lost to Follow-up|0|||
125611278|NCT02065622|451858911|FG002|Maintenance Study|Lost to Follow-up|4|||
125611279|NCT02065622|451858912|FG003|Maintenance Study|Lost to Follow-up|1|||
125611280|NCT02065622|451858913|FG004|Maintenance Study|Lost to Follow-up|1|||
125611281|NCT02065622|451858909|FG000|Maintenance Study|Lack of Efficacy|0|||
125611282|NCT02065622|451858910|FG001|Maintenance Study|Lack of Efficacy|0|||
125611283|NCT02065622|451858911|FG002|Maintenance Study|Lack of Efficacy|70|||
125611284|NCT02065622|451858912|FG003|Maintenance Study|Lack of Efficacy|55|||
125611285|NCT02065622|451858913|FG004|Maintenance Study|Lack of Efficacy|19|||
125611286|NCT02065622|451858909|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
125611287|NCT02065622|451858910|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
125611288|NCT02065622|451858911|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
125611289|NCT02065622|451858912|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
125611290|NCT02065622|451858913|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
125611291|NCT02065622|451858909|FG000|Maintenance Study|Subject Non-Compliance|0|||
125611292|NCT02065622|451858910|FG001|Maintenance Study|Subject Non-Compliance|0|||
125611293|NCT02065622|451858911|FG002|Maintenance Study|Subject Non-Compliance|1|||
125611294|NCT02065622|451858912|FG003|Maintenance Study|Subject Non-Compliance|3|||
125611295|NCT02065622|451858913|FG004|Maintenance Study|Subject Non-Compliance|2|||
125611296|NCT02065622|451858909|FG000|Maintenance Study|Other, Not Specified|0|||
125611297|NCT02065622|451858910|FG001|Maintenance Study|Other, Not Specified|0|||
125432018|NCT01576718|451207824|FG003|Treatment Period|Withdrawal by Subject|0|||
125432019|NCT01576718|451207825|FG004|Treatment Period|Withdrawal by Subject|2|||
125432020|NCT01576718|451207826|FG005|Treatment Period|Withdrawal by Subject|4|||
125432021|NCT01576718|451207827|FG006|Treatment Period|Withdrawal by Subject|2|||
125432022|NCT01576718|451207821|FG000|Treatment Period|Physician Decision|0|||
125432023|NCT01576718|451207822|FG001|Treatment Period|Physician Decision|1|||
125432024|NCT01576718|451207823|FG002|Treatment Period|Physician Decision|1|||
125432025|NCT01576718|451207824|FG003|Treatment Period|Physician Decision|1|||
125432026|NCT01576718|451207825|FG004|Treatment Period|Physician Decision|1|||
125611298|NCT02065622|451858911|FG002|Maintenance Study|Other, Not Specified|6|||
125611299|NCT02065622|451858912|FG003|Maintenance Study|Other, Not Specified|14|||
125611300|NCT02065622|451858913|FG004|Maintenance Study|Other, Not Specified|2|||
125432027|NCT01576718|451207826|FG005|Treatment Period|Physician Decision|0|||
125611301|NCT02065622|451858909|FG000|Maintenance Study|Unknown Reason|0|||
125611302|NCT02065622|451858910|FG001|Maintenance Study|Unknown Reason|0|||
125611303|NCT02065622|451858911|FG002|Maintenance Study|Unknown Reason|0|||
125611304|NCT02065622|451858912|FG003|Maintenance Study|Unknown Reason|1|||
125432028|NCT01576718|451207827|FG006|Treatment Period|Physician Decision|0|||
125611305|NCT02065622|451858913|FG004|Maintenance Study|Unknown Reason|0|||
125611306|NCT02349789|451860180|FG000|Overall Study|Withdrawal by Subject|2|||
125611307|NCT00683475|451860183|FG000|Overall Study|Withdrawal by Subject|1|||
125611308|NCT00683475|451860184|FG001|Overall Study|Withdrawal by Subject|0|||
125611309|NCT00683475|451860183|FG000|Overall Study|Never Treated: Adverse Event|2|||
125372316|NCT02006719|450993284|FG000|Overall Study|Other/Unknown|0|||
125372317|NCT02006719|450993285|FG001|Overall Study|Other/Unknown|1|||
125372318|NCT04659161|450993286|FG000|Overall Study|Adverse Event|10|||
125372319|NCT04659161|450993287|FG001|Overall Study|Adverse Event|6|||
125372320|NCT04659161|450993286|FG000|Overall Study|Withdrawal by Subject|13|||
125372321|NCT04659161|450993287|FG001|Overall Study|Withdrawal by Subject|12|||
125372322|NCT04659161|450993286|FG000|Overall Study|Other|9|||
125372323|NCT04659161|450993287|FG001|Overall Study|Other|8|||
125372324|NCT02197130|450993288|FG000|Overall Study|Adverse Event|13|||
125372325|NCT02197130|450993289|FG001|Overall Study|Adverse Event|4|||
125372326|NCT02197130|450993290|FG002|Overall Study|Adverse Event|23|||
125372327|NCT02197130|450993288|FG000|Overall Study|Death|0|||
125372328|NCT02197130|450993289|FG001|Overall Study|Death|1|||
125611310|NCT00683475|451860184|FG001|Overall Study|Never Treated: Adverse Event|3|||
125611311|NCT00683475|451860183|FG000|Overall Study|Never Treated: Progressive Disease|1|||
125372329|NCT02197130|450993290|FG002|Overall Study|Death|0|||
125372330|NCT02197130|450993288|FG000|Overall Study|Lost to Follow-up|2|||
125372331|NCT02197130|450993289|FG001|Overall Study|Lost to Follow-up|0|||
125372332|NCT02197130|450993290|FG002|Overall Study|Lost to Follow-up|1|||
125372333|NCT02197130|450993288|FG000|Overall Study|Does not meet entrance criteria|0|||
125372334|NCT02197130|450993289|FG001|Overall Study|Does not meet entrance criteria|0|||
125372335|NCT02197130|450993290|FG002|Overall Study|Does not meet entrance criteria|1|||
125372336|NCT02197130|450993288|FG000|Overall Study|Withdrawal by Subject|0|||
125372337|NCT02197130|450993289|FG001|Overall Study|Withdrawal by Subject|3|||
125372338|NCT02197130|450993290|FG002|Overall Study|Withdrawal by Subject|4|||
125372339|NCT02197130|450993288|FG000|Overall Study|Other|1|||
125372340|NCT02197130|450993289|FG001|Overall Study|Other|0|||
125372341|NCT02197130|450993290|FG002|Overall Study|Other|3|||
125372342|NCT01473836|450994949|FG000|Overall Study|Adverse Event|4|||
125372343|NCT01473836|450994949|FG000|Overall Study|Lack of Efficacy|1|||
125372344|NCT01473836|450994949|FG000|Overall Study|Does not meet entrance criteria|1|||
125372345|NCT03364023|450994950|FG000|Overall Study|Lost to Follow-up|3|||
125372346|NCT03364023|450994950|FG000|Overall Study|Death|14|||
125372347|NCT00105469|450994953|FG000|Overall Study|Adverse Event|9|||
125372348|NCT00105469|450994954|FG001|Overall Study|Adverse Event|8|||
125611312|NCT00683475|451860184|FG001|Overall Study|Never Treated: Progressive Disease|0|||
125611313|NCT02922634|451860185|FG000|Overall Study|Withdrawal by Subject|5|||
125611314|NCT02922634|451860185|FG000|Overall Study|Did not have their surgery|5|||
125611315|NCT02723604|451860186|FG000|Overall Study|ineligible|1|||
125611316|NCT02723604|451860186|FG000|Overall Study|never received treatment|1|||
125611317|NCT00352755|451860189|FG000|Overall Study|Physician Decision|1|||
125611318|NCT00352755|451860189|FG000|Overall Study|Adverse Event|1|||
125214154|NCT04399889|450411246|FG001|Overall Study|Death|1|||
125611319|NCT01694420|451860191|FG000|Overall Study|Lost to Follow-up|3|||
125611320|NCT03987919|451860192|FG000|Overall Study|Adverse Event|1|||
125611321|NCT03987919|451860193|FG001|Overall Study|Adverse Event|4|||
125611322|NCT03987919|451860194|FG002|Overall Study|Adverse Event|1|||
125611323|NCT03987919|451860195|FG003|Overall Study|Adverse Event|3|||
125611324|NCT03987919|451860192|FG000|Overall Study|Death|4|||
125611325|NCT03987919|451860193|FG001|Overall Study|Death|4|||
125611326|NCT03987919|451860194|FG002|Overall Study|Death|4|||
125611327|NCT03987919|451860195|FG003|Overall Study|Death|1|||
125611328|NCT03987919|451860192|FG000|Overall Study|Lost to Follow-up|5|||
125611329|NCT03987919|451860193|FG001|Overall Study|Lost to Follow-up|6|||
125611330|NCT03987919|451860194|FG002|Overall Study|Lost to Follow-up|8|||
125611331|NCT03987919|451860195|FG003|Overall Study|Lost to Follow-up|12|||
125611332|NCT03987919|451860192|FG000|Overall Study|Physician Decision|0|||
125372349|NCT00105469|450994953|FG000|Overall Study|Protocol Violation|4|||
125372350|NCT00105469|450994954|FG001|Overall Study|Protocol Violation|0|||
125372351|NCT00105469|450994953|FG000|Overall Study|Withdrawal by Subject|2|||
125372352|NCT00105469|450994954|FG001|Overall Study|Withdrawal by Subject|3|||
125372353|NCT00105469|450994953|FG000|Overall Study|Lost to Follow-up|1|||
125372354|NCT00105469|450994954|FG001|Overall Study|Lost to Follow-up|0|||
125611333|NCT03987919|451860193|FG001|Overall Study|Physician Decision|2|||
125611334|NCT03987919|451860194|FG002|Overall Study|Physician Decision|0|||
125611335|NCT03987919|451860195|FG003|Overall Study|Physician Decision|4|||
125372355|NCT00105469|450994953|FG000|Overall Study|Lack of Efficacy|2|||
125372356|NCT00105469|450994954|FG001|Overall Study|Lack of Efficacy|0|||
125372357|NCT00105469|450994953|FG000|Overall Study|Other Reason|4|||
125372358|NCT00105469|450994954|FG001|Overall Study|Other Reason|0|||
125611336|NCT03987919|451860192|FG000|Overall Study|Pregnancy|1|||
125214155|NCT04399889|450411247|FG002|Overall Study|Death|1|||
125372359|NCT00599924|450994956|FG000|Overall Study|Lack of Efficacy|3|||
125611337|NCT03987919|451860193|FG001|Overall Study|Pregnancy|0|||
125611338|NCT03987919|451860194|FG002|Overall Study|Pregnancy|1|||
125611339|NCT03987919|451860195|FG003|Overall Study|Pregnancy|1|||
125611340|NCT03987919|451860192|FG000|Overall Study|Protocol Violation|0|||
125611341|NCT03987919|451860193|FG001|Overall Study|Protocol Violation|1|||
125611342|NCT03987919|451860194|FG002|Overall Study|Protocol Violation|0|||
125611343|NCT03987919|451860195|FG003|Overall Study|Protocol Violation|0|||
125611344|NCT03987919|451860192|FG000|Overall Study|Site terminated by Sponsor|0|||
125611345|NCT03987919|451860193|FG001|Overall Study|Site terminated by Sponsor|0|||
125611346|NCT03987919|451860194|FG002|Overall Study|Site terminated by Sponsor|0|||
125611347|NCT03987919|451860195|FG003|Overall Study|Site terminated by Sponsor|1|||
125611348|NCT03987919|451860192|FG000|Overall Study|Withdrawal by Subject|7|||
125611349|NCT03987919|451860193|FG001|Overall Study|Withdrawal by Subject|7|||
125611350|NCT03987919|451860194|FG002|Overall Study|Withdrawal by Subject|8|||
125611351|NCT03987919|451860195|FG003|Overall Study|Withdrawal by Subject|4|||
125611352|NCT03987919|451860192|FG000|Overall Study|Other - as reported by the investigator|1|||
125611353|NCT03987919|451860193|FG001|Overall Study|Other - as reported by the investigator|3|||
125611354|NCT03987919|451860194|FG002|Overall Study|Other - as reported by the investigator|2|||
125611355|NCT03987919|451860195|FG003|Overall Study|Other - as reported by the investigator|0|||
125611356|NCT01194804|451860196|FG000|Overall Study|Withdrawal by Subject|1|||
125611357|NCT03621943|451860197|FG000|First Randomized Intervention|Lost to Follow-up|51|||
125611358|NCT03621943|451860198|FG001|First Randomized Intervention|Lost to Follow-up|54|||
125611359|NCT03621943|451860197|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
125611360|NCT03621943|451860198|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
125611361|NCT03621943|451860197|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
125611362|NCT03621943|451860198|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
125611363|NCT03621943|451860197|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
125611364|NCT03621943|451860198|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
125611365|NCT00948818|451860199|FG000|Overall Study|Adverse Event|10|||
125611366|NCT00948818|451860200|FG001|Overall Study|Adverse Event|32|||
125611367|NCT00948818|451860199|FG000|Overall Study|Protocol Violation|9|||
125611368|NCT00948818|451860200|FG001|Overall Study|Protocol Violation|10|||
125611369|NCT00948818|451860199|FG000|Overall Study|Withdrawal by Subject|25|||
125611370|NCT00948818|451860200|FG001|Overall Study|Withdrawal by Subject|25|||
125611371|NCT00948818|451860199|FG000|Overall Study|Lost to Follow-up|10|||
125611372|NCT00948818|451860200|FG001|Overall Study|Lost to Follow-up|17|||
125611373|NCT00948818|451860199|FG000|Overall Study|Lack of Efficacy|4|||
125611374|NCT00948818|451860200|FG001|Overall Study|Lack of Efficacy|5|||
125611375|NCT00948818|451860199|FG000|Overall Study|Other Reason|4|||
125611376|NCT00948818|451860200|FG001|Overall Study|Other Reason|5|||
125611377|NCT02324842|451860205|FG000|Overall Study|Lost to Follow-up|1|||
125611378|NCT02324842|451860206|FG001|Overall Study|Lost to Follow-up|1|||
125611379|NCT02324842|451860207|FG002|Overall Study|Lost to Follow-up|2|||
125611380|NCT00995345|451860208|FG000|Overall Study|Withdrawal by Subject|4|||
125611381|NCT00995345|451860209|FG001|Overall Study|Withdrawal by Subject|2|||
125611382|NCT00995345|451860210|FG002|Overall Study|Withdrawal by Subject|1|||
125611383|NCT00995345|451860211|FG003|Overall Study|Withdrawal by Subject|3|||
125611384|NCT00995345|451860212|FG004|Overall Study|Withdrawal by Subject|1|||
125611385|NCT00995345|451860208|FG000|Overall Study|Adverse Event|3|||
125611386|NCT00995345|451860209|FG001|Overall Study|Adverse Event|1|||
125611387|NCT00995345|451860210|FG002|Overall Study|Adverse Event|2|||
125611388|NCT00995345|451860211|FG003|Overall Study|Adverse Event|0|||
125611389|NCT00995345|451860212|FG004|Overall Study|Adverse Event|1|||
125611390|NCT00995345|451860208|FG000|Overall Study|Lost to Follow-up|2|||
125611391|NCT00995345|451860209|FG001|Overall Study|Lost to Follow-up|2|||
125611392|NCT00995345|451860210|FG002|Overall Study|Lost to Follow-up|2|||
125611393|NCT00995345|451860211|FG003|Overall Study|Lost to Follow-up|1|||
125611394|NCT00995345|451860212|FG004|Overall Study|Lost to Follow-up|0|||
125611395|NCT00995345|451860208|FG000|Overall Study|all other reasons combined|2|||
125611396|NCT00995345|451860209|FG001|Overall Study|all other reasons combined|2|||
125611397|NCT00995345|451860210|FG002|Overall Study|all other reasons combined|2|||
125611398|NCT00995345|451860211|FG003|Overall Study|all other reasons combined|1|||
125611399|NCT00995345|451860212|FG004|Overall Study|all other reasons combined|3|||
125611400|NCT05122650|451860215|FG000|Overall Study|Adverse Event|4|||
125611401|NCT05122650|451860216|FG001|Overall Study|Adverse Event|16|||
125611402|NCT05122650|451860217|FG002|Overall Study|Adverse Event|11|||
125611403|NCT05122650|451860218|FG003|Overall Study|Adverse Event|12|||
125372360|NCT00599924|450994957|FG001|Overall Study|Lack of Efficacy|5|||
125611404|NCT05122650|451860215|FG000|Overall Study|Lack of Efficacy|0|||
125611405|NCT05122650|451860216|FG001|Overall Study|Lack of Efficacy|1|||
125611406|NCT05122650|451860217|FG002|Overall Study|Lack of Efficacy|1|||
125611407|NCT05122650|451860218|FG003|Overall Study|Lack of Efficacy|2|||
125611408|NCT05122650|451860215|FG000|Overall Study|Lost to Follow-up|1|||
125611409|NCT05122650|451860216|FG001|Overall Study|Lost to Follow-up|1|||
125611410|NCT05122650|451860217|FG002|Overall Study|Lost to Follow-up|3|||
125611411|NCT05122650|451860218|FG003|Overall Study|Lost to Follow-up|0|||
125611412|NCT05122650|451860215|FG000|Overall Study|Non-compliance with study intervention|0|||
125611413|NCT05122650|451860216|FG001|Overall Study|Non-compliance with study intervention|0|||
125611414|NCT05122650|451860217|FG002|Overall Study|Non-compliance with study intervention|0|||
125611415|NCT05122650|451860218|FG003|Overall Study|Non-compliance with study intervention|2|||
125611416|NCT05122650|451860215|FG000|Overall Study|Protocol Violation|0|||
125611417|NCT05122650|451860216|FG001|Overall Study|Protocol Violation|1|||
125611418|NCT05122650|451860217|FG002|Overall Study|Protocol Violation|0|||
125611419|NCT05122650|451860218|FG003|Overall Study|Protocol Violation|1|||
125611420|NCT05122650|451860215|FG000|Overall Study|Randomized by mistake|0|||
125611421|NCT05122650|451860216|FG001|Overall Study|Randomized by mistake|0|||
125611422|NCT05122650|451860217|FG002|Overall Study|Randomized by mistake|3|||
125611423|NCT05122650|451860218|FG003|Overall Study|Randomized by mistake|2|||
125611424|NCT05122650|451860215|FG000|Overall Study|Sponsor request|0|||
125611425|NCT05122650|451860216|FG001|Overall Study|Sponsor request|1|||
125611426|NCT05122650|451860217|FG002|Overall Study|Sponsor request|1|||
125611427|NCT05122650|451860218|FG003|Overall Study|Sponsor request|2|||
125611428|NCT05122650|451860215|FG000|Overall Study|Withdrawal by Subject|3|||
125611429|NCT05122650|451860216|FG001|Overall Study|Withdrawal by Subject|7|||
125611430|NCT05122650|451860217|FG002|Overall Study|Withdrawal by Subject|4|||
125611431|NCT05122650|451860218|FG003|Overall Study|Withdrawal by Subject|8|||
125611432|NCT05122650|451860215|FG000|Overall Study|Other|5|||
125611433|NCT05122650|451860216|FG001|Overall Study|Other|0|||
125611434|NCT05122650|451860217|FG002|Overall Study|Other|0|||
125611435|NCT05122650|451860218|FG003|Overall Study|Other|0|||
125611436|NCT02371759|451860225|FG000|Overall Study|Protocol Violation|3|||
125611437|NCT02371759|451860226|FG001|Overall Study|Protocol Violation|1|||
125611438|NCT02371759|451860227|FG002|Overall Study|Protocol Violation|1|||
125611439|NCT02371759|451860228|FG003|Overall Study|Protocol Violation|0|||
125611440|NCT02371759|451860229|FG004|Overall Study|Protocol Violation|3|||
125611441|NCT02371759|451860230|FG005|Overall Study|Protocol Violation|1|||
125611442|NCT02371759|451860231|FG006|Overall Study|Protocol Violation|0|||
125611443|NCT02371759|451860232|FG007|Overall Study|Protocol Violation|3|||
125611444|NCT02371759|451860225|FG000|Overall Study|Withdrawal by Subject|0|||
125611445|NCT02371759|451860226|FG001|Overall Study|Withdrawal by Subject|0|||
125611446|NCT02371759|451860227|FG002|Overall Study|Withdrawal by Subject|0|||
125611447|NCT02371759|451860228|FG003|Overall Study|Withdrawal by Subject|0|||
125611448|NCT02371759|451860229|FG004|Overall Study|Withdrawal by Subject|0|||
125611449|NCT02371759|451860230|FG005|Overall Study|Withdrawal by Subject|0|||
125611450|NCT02371759|451860231|FG006|Overall Study|Withdrawal by Subject|0|||
125611451|NCT02371759|451860232|FG007|Overall Study|Withdrawal by Subject|1|||
125611452|NCT01689207|451860233|FG000|Overall Study|Adverse Event|0|||
125611453|NCT01689207|451860234|FG001|Overall Study|Adverse Event|1|||
125611454|NCT01689207|451860235|FG002|Overall Study|Adverse Event|0|||
125611455|NCT01689207|451860236|FG003|Overall Study|Adverse Event|0|||
125611456|NCT01689207|451860237|FG004|Overall Study|Adverse Event|2|||
125611457|NCT01689207|451860238|FG005|Overall Study|Adverse Event|1|||
125611458|NCT01689207|451860239|FG006|Overall Study|Adverse Event|0|||
125611459|NCT01689207|451860240|FG007|Overall Study|Adverse Event|0|||
125611460|NCT01689207|451860241|FG008|Overall Study|Adverse Event|1|||
125611461|NCT01689207|451860242|FG009|Overall Study|Adverse Event|0|||
125611462|NCT01689207|451860243|FG010|Overall Study|Adverse Event|0|||
125611463|NCT01515306|451860247|FG000|Overall Study|Adverse Event|3|||
125611464|NCT01515306|451860248|FG001|Overall Study|Adverse Event|2|||
125611465|NCT01515306|451860247|FG000|Overall Study|Progressive Disease|19|||
125611466|NCT01515306|451860248|FG001|Overall Study|Progressive Disease|9|||
125611467|NCT01515306|451860247|FG000|Overall Study|Withdrawal by Subject|1|||
125611468|NCT01515306|451860248|FG001|Overall Study|Withdrawal by Subject|2|||
125611469|NCT01515306|451860247|FG000|Overall Study|Physician Decision|1|||
125611470|NCT01515306|451860248|FG001|Overall Study|Physician Decision|1|||
125611471|NCT00634244|451860252|FG000|Overall Study|Never started treatment|0|||
125611472|NCT00634244|451860253|FG001|Overall Study|Never started treatment|1|||
125611473|NCT00634244|451860254|FG002|Overall Study|Never started treatment|0|||
125611474|NCT00634244|451860252|FG000|Overall Study|Death|1|||
125611475|NCT00634244|451860253|FG001|Overall Study|Death|6|||
125611476|NCT00634244|451860254|FG002|Overall Study|Death|0|||
125611477|NCT00634244|451860252|FG000|Overall Study|Adverse Event|0|||
125611478|NCT00634244|451860253|FG001|Overall Study|Adverse Event|2|||
125611479|NCT00634244|451860254|FG002|Overall Study|Adverse Event|0|||
125611480|NCT00634244|451860252|FG000|Overall Study|Withdrawal by Subject|0|||
125611481|NCT00634244|451860253|FG001|Overall Study|Withdrawal by Subject|1|||
125611482|NCT00634244|451860254|FG002|Overall Study|Withdrawal by Subject|0|||
125611483|NCT00634244|451860252|FG000|Overall Study|Physician Decision|0|||
125611484|NCT00634244|451860253|FG001|Overall Study|Physician Decision|1|||
125611485|NCT00634244|451860254|FG002|Overall Study|Physician Decision|0|||
125611486|NCT00634244|451860252|FG000|Overall Study|Disease progression/relapse|0|||
125611487|NCT00634244|451860253|FG001|Overall Study|Disease progression/relapse|1|||
125611488|NCT00634244|451860254|FG002|Overall Study|Disease progression/relapse|0|||
125611489|NCT00634244|451860252|FG000|Overall Study|Other complicating disease|0|||
125611490|NCT00634244|451860253|FG001|Overall Study|Other complicating disease|1|||
125611491|NCT00634244|451860254|FG002|Overall Study|Other complicating disease|0|||
125611492|NCT02427477|451860256|FG000|Period 1|Adverse Event|1|||
125611493|NCT02427477|451860257|FG001|Period 1|Adverse Event|0|||
125611494|NCT04369430|451860258|FG000|Overall Study|Adverse Event|2|||
125611495|NCT04369430|451860259|FG001|Overall Study|Adverse Event|3|||
125611496|NCT04369430|451860258|FG000|Overall Study|Death|1|||
125611497|NCT04369430|451860259|FG001|Overall Study|Death|0|||
125611498|NCT04369430|451860258|FG000|Overall Study|Withdrawal by Subject|4|||
125611499|NCT04369430|451860259|FG001|Overall Study|Withdrawal by Subject|3|||
125611500|NCT04369430|451860258|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
125611501|NCT04369430|451860259|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
125611502|NCT04369430|451860258|FG000|Overall Study|Lost to Follow-up|0|||
125611503|NCT04369430|451860259|FG001|Overall Study|Lost to Follow-up|1|||
125611504|NCT02635737|451860266|FG000|Overall Study|Protocol Violation|1|||
125611505|NCT00937768|451860267|FG000|Overall Study|Refused Further Treatment|3|||
125611506|NCT00937768|451860268|FG001|Overall Study|Refused Further Treatment|2|||
125611507|NCT00937768|451860267|FG000|Overall Study|Disease Progression|1|||
125611508|NCT00937768|451860268|FG001|Overall Study|Disease Progression|1|||
125611509|NCT00937768|451860267|FG000|Overall Study|Alternate Treatment|0|||
125611510|NCT00937768|451860268|FG001|Overall Study|Alternate Treatment|1|||
125611511|NCT00937768|451860267|FG000|Overall Study|No Further Funding|4|||
125214156|NCT02829047|450411251|FG000|Overall Study|Withdrawal by Subject|1|||
125214157|NCT01909973|450411253|FG000|Overall Study|Lost to Follow-up|1|||
125214158|NCT01909973|450411254|FG001|Overall Study|Lost to Follow-up|0|||
125214159|NCT00460239|450411255|FG000|Overall Study|Physician Decision|0|||
125214160|NCT00460239|450411256|FG001|Overall Study|Physician Decision|1|||
125214161|NCT00460239|450411257|FG002|Overall Study|Physician Decision|0|||
125214162|NCT00460239|450411258|FG003|Overall Study|Physician Decision|0|||
125214163|NCT00460239|450411259|FG004|Overall Study|Physician Decision|0|||
125214164|NCT00460239|450411260|FG005|Overall Study|Physician Decision|2|||
125214165|NCT00460239|450411261|FG006|Overall Study|Physician Decision|0|||
125214166|NCT00460239|450411262|FG007|Overall Study|Physician Decision|0|||
125214167|NCT00460239|450411263|FG008|Overall Study|Physician Decision|0|||
125214168|NCT00460239|450411255|FG000|Overall Study|Withdrawal by Subject|0|||
125214169|NCT00460239|450411256|FG001|Overall Study|Withdrawal by Subject|0|||
125214170|NCT00460239|450411257|FG002|Overall Study|Withdrawal by Subject|0|||
125214171|NCT00460239|450411258|FG003|Overall Study|Withdrawal by Subject|0|||
125214172|NCT00460239|450411259|FG004|Overall Study|Withdrawal by Subject|0|||
125214173|NCT00460239|450411260|FG005|Overall Study|Withdrawal by Subject|1|||
125214174|NCT00460239|450411261|FG006|Overall Study|Withdrawal by Subject|0|||
125214175|NCT00460239|450411262|FG007|Overall Study|Withdrawal by Subject|0|||
125214176|NCT00460239|450411263|FG008|Overall Study|Withdrawal by Subject|0|||
125214177|NCT01005901|450411270|FG000|Overall Study|Withdrawal by Subject|38|||
125214178|NCT01005901|450411271|FG001|Overall Study|Withdrawal by Subject|14|||
125214179|NCT01005901|450411270|FG000|Overall Study|Adverse Event|30|||
125214180|NCT01005901|450411271|FG001|Overall Study|Adverse Event|16|||
125214181|NCT01005901|450411270|FG000|Overall Study|Administrative problems|21|||
125214182|NCT01005901|450411271|FG001|Overall Study|Administrative problems|13|||
125372361|NCT00599924|450994958|FG002|Overall Study|Lack of Efficacy|1|||
125372362|NCT00599924|450994959|FG003|Overall Study|Lack of Efficacy|2|||
125611512|NCT00937768|451860268|FG001|Overall Study|No Further Funding|4|||
125611513|NCT01687413|451860269|FG000|Overall Study|Withdrawal by Subject|0|||
125214183|NCT01005901|450411270|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
125214184|NCT01005901|450411271|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
125214185|NCT01005901|450411270|FG000|Overall Study|Protocol Violation|4|||
125214186|NCT01005901|450411271|FG001|Overall Study|Protocol Violation|3|||
125214187|NCT01005901|450411270|FG000|Overall Study|Death|2|||
125214188|NCT01005901|450411271|FG001|Overall Study|Death|3|||
125214189|NCT01005901|450411270|FG000|Overall Study|Lost to Follow-up|1|||
125372363|NCT00599924|450994960|FG004|Overall Study|Lack of Efficacy|3|||
125611514|NCT01687413|451860270|FG001|Overall Study|Withdrawal by Subject|2|||
125611515|NCT01687413|451860269|FG000|Overall Study|Not eligible|0|||
125214190|NCT01005901|450411271|FG001|Overall Study|Lost to Follow-up|2|||
125611516|NCT01687413|451860270|FG001|Overall Study|Not eligible|2|||
125214191|NCT01005901|450411270|FG000|Overall Study|Patient's inability to use the device|1|||
125214192|NCT01005901|450411271|FG001|Overall Study|Patient's inability to use the device|1|||
125214193|NCT01005901|450411270|FG000|Overall Study|No longer requires study drug|0|||
125214194|NCT01005901|450411271|FG001|Overall Study|No longer requires study drug|1|||
125214195|NCT00760487|450411272|FG000|Overall Study|Unilateral implantation|3|||
125214196|NCT06360588|450411274|FG000|Overall Study|Adverse Event|3|||
125214197|NCT06360588|450411274|FG000|Overall Study|Death|2|||
125214198|NCT06360588|450411274|FG000|Overall Study|Disease Progression|14|||
125214199|NCT06360588|450411274|FG000|Overall Study|Withdrawal by Subject|1|||
125214200|NCT06360588|450411274|FG000|Overall Study|Lack of Efficacy|1|||
125214201|NCT06360588|450411274|FG000|Overall Study|Ineligible|1|||
125214202|NCT02087943|450411276|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
125214203|NCT02087943|450411277|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
125214204|NCT02087943|450411278|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
125214205|NCT02087943|450411279|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
125214206|NCT02087943|450411280|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
125214207|NCT02087943|450411276|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
125214208|NCT02087943|450411277|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
125214209|NCT02087943|450411278|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
125214210|NCT02087943|450411279|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
125214211|NCT02087943|450411280|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
125214212|NCT02087943|450411276|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
125214213|NCT02087943|450411277|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
125214214|NCT02087943|450411278|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
125214215|NCT02087943|450411279|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
125214216|NCT02087943|450411280|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
125214217|NCT02087943|450411276|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
125214218|NCT02087943|450411277|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
125214219|NCT02087943|450411278|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
125214220|NCT02087943|450411279|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
125214221|NCT02087943|450411280|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
125214222|NCT02087943|450411276|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
125214223|NCT02087943|450411277|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
125214224|NCT02087943|450411278|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
125214225|NCT02087943|450411279|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
125372364|NCT00599924|450994961|FG005|Overall Study|Lack of Efficacy|2|||
125372365|NCT00599924|450994962|FG006|Overall Study|Lack of Efficacy|0|||
125214226|NCT02087943|450411280|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
125611517|NCT01687413|451860269|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
125611518|NCT01687413|451860270|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
125611519|NCT01767194|451860271|FG000|Overall Study|Adverse Event|1|||
125611520|NCT01767194|451860272|FG001|Overall Study|Adverse Event|1|||
125611521|NCT01767194|451860271|FG000|Overall Study|Death|0|||
125611522|NCT01767194|451860272|FG001|Overall Study|Death|1|||
125611523|NCT01767194|451860271|FG000|Overall Study|Lack of Efficacy|12|||
125611524|NCT01767194|451860272|FG001|Overall Study|Lack of Efficacy|11|||
125611525|NCT01767194|451860271|FG000|Overall Study|Physician Decision|2|||
125611526|NCT01767194|451860272|FG001|Overall Study|Physician Decision|23|||
125611527|NCT01767194|451860271|FG000|Overall Study|Withdrawal by Subject|0|||
125611528|NCT01767194|451860272|FG001|Overall Study|Withdrawal by Subject|1|||
125611529|NCT01767194|451860271|FG000|Overall Study|Ineligible|1|||
125611530|NCT01767194|451860272|FG001|Overall Study|Ineligible|1|||
125611531|NCT01767194|451860271|FG000|Overall Study|Refusal by patient/parent|2|||
125611532|NCT01767194|451860272|FG001|Overall Study|Refusal by patient/parent|4|||
125611533|NCT01767194|451860271|FG000|Overall Study|Criteria not met on time for next cycle|0|||
125611534|NCT01767194|451860272|FG001|Overall Study|Criteria not met on time for next cycle|1|||
125611535|NCT04973228|451860273|FG000|Overall Study|Adverse Event|2|||
125611536|NCT04973228|451860274|FG001|Overall Study|Adverse Event|3|||
125611537|NCT04973228|451860273|FG000|Overall Study|Lack of Efficacy|1|||
125611538|NCT04973228|451860274|FG001|Overall Study|Lack of Efficacy|3|||
125611539|NCT04973228|451860273|FG000|Overall Study|Lost to Follow-up|12|||
125611540|NCT04973228|451860274|FG001|Overall Study|Lost to Follow-up|4|||
125611541|NCT04973228|451860273|FG000|Overall Study|Withdrawal by Subject|11|||
125611542|NCT04973228|451860274|FG001|Overall Study|Withdrawal by Subject|4|||
125611543|NCT04973228|451860273|FG000|Overall Study|Did not tolerate application|1|||
125611544|NCT04973228|451860274|FG001|Overall Study|Did not tolerate application|0|||
125611545|NCT04973228|451860273|FG000|Overall Study|Wanted to early terminate and use own product|0|||
125611546|NCT04973228|451860274|FG001|Overall Study|Wanted to early terminate and use own product|1|||
125611547|NCT04973228|451860273|FG000|Overall Study|Missed visits due to new work schedule|1|||
125611548|NCT04973228|451860274|FG001|Overall Study|Missed visits due to new work schedule|0|||
125611549|NCT02678780|451860280|FG000|Overall Study|Adverse Event|11|||
125611550|NCT02678780|451860281|FG001|Overall Study|Adverse Event|14|||
125611551|NCT02678780|451860280|FG000|Overall Study|Withdrawal by Subject|2|||
125611552|NCT02678780|451860281|FG001|Overall Study|Withdrawal by Subject|1|||
125611553|NCT02678780|451860280|FG000|Overall Study|Sponsor discontinuation|7|||
125611554|NCT02678780|451860281|FG001|Overall Study|Sponsor discontinuation|4|||
125611555|NCT02678780|451860280|FG000|Overall Study|Death|1|||
125611556|NCT02678780|451860281|FG001|Overall Study|Death|1|||
125611557|NCT02678780|451860280|FG000|Overall Study|Other|6|||
125611558|NCT02678780|451860281|FG001|Overall Study|Other|8|||
125611559|NCT01454401|451860296|FG000|Overall Study|Death|1|||
125611560|NCT01454401|451860296|FG000|Overall Study|hospitalised|1|||
125611561|NCT01454401|451860296|FG000|Overall Study|osteomyelitis|2|||
125611562|NCT01454401|451860296|FG000|Overall Study|non-adherence|1|||
125611563|NCT00488618|451860302|FG000|Overall Study|Adverse Event|13|||
125611564|NCT00488618|451860303|FG001|Overall Study|Adverse Event|17|||
125611565|NCT00488618|451860302|FG000|Overall Study|Insufficient Therapeutic Response|18|||
125611566|NCT00488618|451860303|FG001|Overall Study|Insufficient Therapeutic Response|11|||
125611567|NCT00488618|451860302|FG000|Overall Study|Protocol Violation|0|||
125611568|NCT00488618|451860303|FG001|Overall Study|Protocol Violation|2|||
125611569|NCT00488618|451860302|FG000|Overall Study|Withdrawal of Consent|15|||
125611570|NCT00488618|451860303|FG001|Overall Study|Withdrawal of Consent|13|||
125611571|NCT00488618|451860302|FG000|Overall Study|Lost to Follow-up|1|||
125611572|NCT00488618|451860303|FG001|Overall Study|Lost to Follow-up|0|||
125611573|NCT00992446|451860304|FG000|Overall Study|Disease Progression|1|||
125611574|NCT00992446|451860304|FG000|Overall Study|Withdrawal by Subject|2|||
125611575|NCT00992446|451860304|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
125611576|NCT03675737|451860306|FG000|Overall Study|Death|593|||
125611577|NCT03675737|451860307|FG001|Overall Study|Death|660|||
125611578|NCT03675737|451860306|FG000|Overall Study|Lost to Follow-up|1|||
125611579|NCT03675737|451860307|FG001|Overall Study|Lost to Follow-up|5|||
125611580|NCT03675737|451860306|FG000|Overall Study|Physician Decision|1|||
125611581|NCT03675737|451860307|FG001|Overall Study|Physician Decision|0|||
125611582|NCT03675737|451860306|FG000|Overall Study|Withdrawal by Subject|14|||
125611583|NCT03675737|451860307|FG001|Overall Study|Withdrawal by Subject|12|||
125611584|NCT03675737|451860306|FG000|Overall Study|Ongoing in Study|181|||
125611585|NCT03675737|451860307|FG001|Overall Study|Ongoing in Study|112|||
125611586|NCT02294318|451861866|FG000|Overall Study|Worsening of drinking|3|||
125611587|NCT02294318|451861867|FG001|Overall Study|Worsening of drinking|0|||
125372366|NCT00599924|450994956|FG000|Overall Study|Adverse Event|0|||
125372367|NCT00599924|450994957|FG001|Overall Study|Adverse Event|0|||
125372368|NCT00599924|450994958|FG002|Overall Study|Adverse Event|0|||
125372369|NCT00599924|450994959|FG003|Overall Study|Adverse Event|2|||
125372370|NCT00599924|450994960|FG004|Overall Study|Adverse Event|0|||
125372371|NCT00599924|450994961|FG005|Overall Study|Adverse Event|0|||
125372372|NCT00599924|450994962|FG006|Overall Study|Adverse Event|2|||
125372373|NCT00599924|450994956|FG000|Overall Study|Death|0|||
125372374|NCT00599924|450994957|FG001|Overall Study|Death|0|||
125611588|NCT02294318|451861866|FG000|Overall Study|Not exposed to intervention|0|||
125611589|NCT02294318|451861867|FG001|Overall Study|Not exposed to intervention|2|||
125611590|NCT03725202|451861869|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
125611591|NCT03725202|451861870|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
125372375|NCT00599924|450994958|FG002|Overall Study|Death|0|||
125372376|NCT00599924|450994959|FG003|Overall Study|Death|2|||
125372377|NCT00599924|450994960|FG004|Overall Study|Death|0|||
125372378|NCT00599924|450994961|FG005|Overall Study|Death|2|||
125372379|NCT00599924|450994962|FG006|Overall Study|Death|1|||
125372380|NCT00599924|450994956|FG000|Overall Study|Protocol Violation|0|||
125372381|NCT00599924|450994957|FG001|Overall Study|Protocol Violation|0|||
125372382|NCT00599924|450994958|FG002|Overall Study|Protocol Violation|0|||
125372383|NCT00599924|450994959|FG003|Overall Study|Protocol Violation|1|||
125372384|NCT00599924|450994960|FG004|Overall Study|Protocol Violation|0|||
125372385|NCT00599924|450994961|FG005|Overall Study|Protocol Violation|0|||
125372386|NCT00599924|450994962|FG006|Overall Study|Protocol Violation|0|||
125372387|NCT00599924|450994956|FG000|Overall Study|Withdrawal by Subject|0|||
125372388|NCT00599924|450994957|FG001|Overall Study|Withdrawal by Subject|0|||
125372389|NCT00599924|450994958|FG002|Overall Study|Withdrawal by Subject|1|||
125372390|NCT00599924|450994959|FG003|Overall Study|Withdrawal by Subject|0|||
125372391|NCT00599924|450994960|FG004|Overall Study|Withdrawal by Subject|1|||
125372392|NCT00599924|450994961|FG005|Overall Study|Withdrawal by Subject|0|||
125372393|NCT00599924|450994962|FG006|Overall Study|Withdrawal by Subject|0|||
125214227|NCT02087943|450411276|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
125214228|NCT02087943|450411277|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
125214229|NCT02087943|450411278|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
125214230|NCT02087943|450411279|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
125214231|NCT02087943|450411280|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
125214232|NCT02087943|450411276|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
125214233|NCT02087943|450411277|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
125214234|NCT02087943|450411278|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
125214235|NCT02087943|450411279|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
125214236|NCT02087943|450411280|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
125214237|NCT02087943|450411276|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
125214238|NCT02087943|450411277|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
125214239|NCT02087943|450411278|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
125372394|NCT00599924|450994956|FG000|Overall Study|Other|0|||
125372395|NCT00599924|450994957|FG001|Overall Study|Other|0|||
125611592|NCT03725202|451861871|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
125611593|NCT03725202|451861872|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
125611594|NCT03725202|451861873|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
125611595|NCT03725202|451861874|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
125611596|NCT03725202|451861875|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
125611597|NCT03725202|451861876|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
125611598|NCT03725202|451861869|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
125611599|NCT03725202|451861870|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
125611600|NCT03725202|451861871|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
125611601|NCT03725202|451861872|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
125214240|NCT02087943|450411279|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
125214241|NCT02087943|450411280|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
125214242|NCT02087943|450411276|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
125372396|NCT00599924|450994958|FG002|Overall Study|Other|0|||
125611602|NCT03725202|451861873|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
125611603|NCT03725202|451861874|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
125611604|NCT03725202|451861875|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
125214243|NCT02087943|450411277|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
125214244|NCT02087943|450411278|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
125372397|NCT00599924|450994959|FG003|Overall Study|Other|1|||
125372398|NCT00599924|450994960|FG004|Overall Study|Other|2|||
125372399|NCT00599924|450994961|FG005|Overall Study|Other|0|||
125372400|NCT00599924|450994962|FG006|Overall Study|Other|2|||
125372401|NCT01806298|450994963|FG000|Overall Study|Adverse Event|3|||
125611605|NCT03725202|451861876|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
125372402|NCT01806298|450994963|FG000|Overall Study|Protocol Non-compliance|1|||
125372403|NCT01806298|450994963|FG000|Overall Study|Withdrawal by Subject|1|||
125372404|NCT01806298|450994963|FG000|Overall Study|Other|5|||
125611606|NCT03725202|451861869|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
125611607|NCT03725202|451861870|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125611608|NCT03725202|451861871|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125611609|NCT03725202|451861872|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125611610|NCT03725202|451861873|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125611611|NCT03725202|451861874|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125611612|NCT03725202|451861875|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125611613|NCT03725202|451861876|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
125611614|NCT03725202|451861869|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
125611615|NCT03725202|451861870|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125611616|NCT03725202|451861871|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125611617|NCT03725202|451861872|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125611618|NCT03725202|451861873|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125611619|NCT03725202|451861874|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125611620|NCT03725202|451861875|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125611621|NCT03725202|451861876|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
125611622|NCT03725202|451861869|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
125611623|NCT03725202|451861870|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
125611624|NCT03725202|451861871|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
125611625|NCT03725202|451861872|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
125372405|NCT02601469|450994964|FG000|Overall Study|Enrolled in Error|1|||
125372406|NCT02601469|450994965|FG001|Overall Study|Enrolled in Error|0|||
125372407|NCT03808545|450994966|FG000|Overall Study|Withdrawal by Subject|1|||
125372408|NCT03808545|450994967|FG001|Overall Study|Withdrawal by Subject|1|||
125372409|NCT00980057|450994972|FG000|Overall Study|Death|13|||
125372410|NCT00980057|450994973|FG001|Overall Study|Death|3|||
125372411|NCT00980057|450994972|FG000|Overall Study|Adverse Event|0|||
125372412|NCT00980057|450994973|FG001|Overall Study|Adverse Event|1|||
125372413|NCT00980057|450994972|FG000|Overall Study|Physician Decision|4|||
125372414|NCT00980057|450994973|FG001|Overall Study|Physician Decision|0|||
125372415|NCT00980057|450994972|FG000|Overall Study|Lost to Follow-up|1|||
125372416|NCT00980057|450994973|FG001|Overall Study|Lost to Follow-up|0|||
125372417|NCT00980057|450994972|FG000|Overall Study|Withdrawal by Subject|1|||
125372418|NCT00980057|450994973|FG001|Overall Study|Withdrawal by Subject|1|||
125372419|NCT04980040|450994974|FG000|Overall Study|Violated the Inclusion Criteria|260|||
125372420|NCT04980040|450994974|FG000|Overall Study|Violated the Administration & Dosage|225|||
125372421|NCT04980040|450994974|FG000|Overall Study|Lost to Safety-Follow-up|4|||
125372422|NCT04980040|450994974|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
125372423|NCT02820753|450994975|FG000|2 Month|Withdrawal by Subject|3|||
125372424|NCT02820753|450994976|FG001|2 Month|Withdrawal by Subject|3|||
125372425|NCT02820753|450994975|FG000|2 Month|Lost to Follow-up|24|||
125372426|NCT02820753|450994976|FG001|2 Month|Lost to Follow-up|26|||
125372427|NCT02820753|450994975|FG000|2 Month|Stopped per NIH Hold|51|||
125372428|NCT02820753|450994976|FG001|2 Month|Stopped per NIH Hold|13|||
125372429|NCT02820753|450994975|FG000|6 Month|Withdrawal by Subject|2|||
125372430|NCT02820753|450994976|FG001|6 Month|Withdrawal by Subject|2|||
125372431|NCT02820753|450994975|FG000|6 Month|Lost to Follow-up|20|||
125372432|NCT02820753|450994976|FG001|6 Month|Lost to Follow-up|27|||
125372433|NCT02820753|450994975|FG000|6 Month|Stopped per NIH Hold|81|||
125372434|NCT02820753|450994976|FG001|6 Month|Stopped per NIH Hold|81|||
125372435|NCT02820753|450994975|FG000|6 Month|Death|0|||
125372436|NCT02820753|450994976|FG001|6 Month|Death|1|||
125372437|NCT01408485|450994980|FG000|Overall Study|Withdrawal by Subject|21|||
125372438|NCT01315678|450994981|FG000|Overall Study|Withdrawal by Subject|7|||
125372439|NCT01315678|450994982|FG001|Overall Study|Withdrawal by Subject|3|||
125372440|NCT01315678|450994981|FG000|Overall Study|Adverse Event|3|||
125372441|NCT01315678|450994982|FG001|Overall Study|Adverse Event|1|||
125372442|NCT01315678|450994981|FG000|Overall Study|Lost to Follow-up|1|||
125372443|NCT01315678|450994982|FG001|Overall Study|Lost to Follow-up|0|||
125372444|NCT01315678|450994981|FG000|Overall Study|similar reason to those listed above|3|||
125372445|NCT01315678|450994982|FG001|Overall Study|similar reason to those listed above|2|||
125372446|NCT00062374|450994986|FG000|Overall Study|Not treated|12|||
125372447|NCT03555591|450994987|FG000|Overall Study|Protocol Violation|77|||
125372448|NCT00578812|450994991|FG000|Overall Study|Not treated|6|||
125372449|NCT00578812|450994992|FG001|Overall Study|Not treated|7|||
125372450|NCT05035550|450995004|FG000|Overall Study|Withdrawal by Subject|3|||
125372451|NCT05035550|450995005|FG001|Overall Study|Withdrawal by Subject|0|||
125611626|NCT03725202|451861873|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
125611627|NCT03725202|451861874|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
125611628|NCT03725202|451861875|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
125611629|NCT03725202|451861876|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
125611630|NCT03725202|451861869|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125611631|NCT03725202|451861870|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125611632|NCT03725202|451861871|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
125611633|NCT03725202|451861872|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125611634|NCT03725202|451861873|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125611635|NCT03725202|451861874|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125611636|NCT03725202|451861875|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125611637|NCT03725202|451861876|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
125611638|NCT03725202|451861869|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
125611639|NCT03725202|451861870|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
125372452|NCT01751867|450995006|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
125372453|NCT01751867|450995007|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
125372454|NCT01751867|450995006|FG000|Overall Study|Diease Progression|4|||
125372455|NCT01751867|450995007|FG001|Overall Study|Diease Progression|18|||
125372456|NCT01751867|450995006|FG000|Overall Study|Adverse Event|8|||
125372457|NCT01751867|450995007|FG001|Overall Study|Adverse Event|15|||
125372458|NCT01751867|450995006|FG000|Overall Study|Poor Compliance|0|||
125372459|NCT01751867|450995007|FG001|Overall Study|Poor Compliance|5|||
125372460|NCT01751867|450995006|FG000|Overall Study|Withdrawal by Subject|3|||
125372461|NCT01751867|450995007|FG001|Overall Study|Withdrawal by Subject|1|||
125372462|NCT01751867|450995006|FG000|Overall Study|Physician Decision|4|||
125372463|NCT01751867|450995007|FG001|Overall Study|Physician Decision|7|||
125214245|NCT02087943|450411279|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
125214246|NCT02087943|450411280|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
125214247|NCT02087943|450411276|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
125214248|NCT02087943|450411277|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
125214249|NCT02087943|450411278|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
125214250|NCT02087943|450411279|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
125214251|NCT02087943|450411280|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
125214252|NCT03836209|450411281|FG000|Overall Study|Adverse Event|5|||
125214253|NCT03836209|450411282|FG001|Overall Study|Adverse Event|2|||
125214254|NCT03836209|450411281|FG000|Overall Study|Death|4|||
125214255|NCT03836209|450411282|FG001|Overall Study|Death|1|||
125214256|NCT03836209|450411281|FG000|Overall Study|Lack of Efficacy|7|||
125214257|NCT03836209|450411282|FG001|Overall Study|Lack of Efficacy|10|||
125214258|NCT03836209|450411281|FG000|Overall Study|Physician Decision|7|||
125214259|NCT03836209|450411282|FG001|Overall Study|Physician Decision|11|||
125214260|NCT03836209|450411281|FG000|Overall Study|Protocol Violation|0|||
125214261|NCT03836209|450411282|FG001|Overall Study|Protocol Violation|3|||
125214262|NCT03836209|450411281|FG000|Overall Study|Withdrawal by Subject|2|||
125214263|NCT03836209|450411282|FG001|Overall Study|Withdrawal by Subject|10|||
125214264|NCT03836209|450411281|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
125214265|NCT03836209|450411282|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
125214266|NCT03739710|450411283|FG000|Overall Study|Screen Failed|81|||
125214267|NCT01753115|450411284|FG000|Overall Study|Lost to Follow-up|3|||
125214268|NCT01753115|450411285|FG001|Overall Study|Lost to Follow-up|6|||
125214269|NCT01753115|450411286|FG002|Overall Study|Lost to Follow-up|8|||
125214270|NCT01753115|450411284|FG000|Overall Study|Withdrawal by Subject|6|||
125214271|NCT01753115|450411285|FG001|Overall Study|Withdrawal by Subject|5|||
125214272|NCT01753115|450411286|FG002|Overall Study|Withdrawal by Subject|6|||
125214273|NCT01753115|450411284|FG000|Overall Study|Subject non-compliant|3|||
125214274|NCT01753115|450411285|FG001|Overall Study|Subject non-compliant|3|||
125214275|NCT01753115|450411286|FG002|Overall Study|Subject non-compliant|0|||
125214276|NCT01753115|450411284|FG000|Overall Study|Used excluded drug|0|||
125214277|NCT01753115|450411285|FG001|Overall Study|Used excluded drug|1|||
125214278|NCT01753115|450411286|FG002|Overall Study|Used excluded drug|0|||
125214279|NCT01424241|450411290|FG000|Overall Study|Withdrawal by Subject|1|||
125214280|NCT01424241|450411290|FG000|Overall Study|Time constraints|2|||
125214281|NCT05259917|450411291|FG000|Overall Study|Protocol Violation|0|||
125214282|NCT05259917|450411292|FG001|Overall Study|Protocol Violation|0|||
125214283|NCT05259917|450411293|FG002|Overall Study|Protocol Violation|1|||
125214284|NCT05259917|450411294|FG003|Overall Study|Protocol Violation|0|||
125372464|NCT01751867|450995006|FG000|Overall Study|Protocol Violation|0|||
125372465|NCT01751867|450995007|FG001|Overall Study|Protocol Violation|2|||
125372466|NCT01751867|450995006|FG000|Overall Study|Death|0|||
125372467|NCT01751867|450995007|FG001|Overall Study|Death|5|||
125611640|NCT03725202|451861871|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
125611641|NCT03725202|451861872|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
125611642|NCT03725202|451861873|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
125611643|NCT03725202|451861874|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
125611644|NCT03725202|451861875|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
125611645|NCT03725202|451861876|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
125611646|NCT03725202|451861869|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
125611647|NCT03725202|451861870|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
125611648|NCT03725202|451861871|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
125611649|NCT03725202|451861872|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
125611650|NCT03725202|451861873|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
125611651|NCT03725202|451861874|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
125611652|NCT03725202|451861875|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
125611653|NCT03725202|451861876|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
125611654|NCT03725202|451861869|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
125611655|NCT03725202|451861870|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
125611656|NCT03725202|451861871|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
125611657|NCT03725202|451861872|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
125611658|NCT03725202|451861873|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
125611659|NCT03725202|451861874|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
125611660|NCT03725202|451861875|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
125611661|NCT03725202|451861876|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
125611662|NCT03725202|451861869|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125611663|NCT03725202|451861870|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125214285|NCT05259917|450411295|FG004|Overall Study|Protocol Violation|0|||
125214286|NCT05259917|450411296|FG005|Overall Study|Protocol Violation|0|||
125214287|NCT05259917|450411291|FG000|Overall Study|Lost to Follow-up|0|||
125372468|NCT01751867|450995006|FG000|Overall Study|Other|11|||
125214288|NCT05259917|450411292|FG001|Overall Study|Lost to Follow-up|0|||
125372469|NCT01751867|450995007|FG001|Overall Study|Other|37|||
125611664|NCT03725202|451861871|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125611665|NCT03725202|451861872|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125611666|NCT03725202|451861873|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125611667|NCT03725202|451861874|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125611668|NCT03725202|451861875|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
125611669|NCT03725202|451861876|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
125611670|NCT03725202|451861869|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125611671|NCT03725202|451861870|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125611672|NCT03725202|451861871|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125611673|NCT03725202|451861872|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125611674|NCT03725202|451861873|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125372470|NCT01751867|450995006|FG000|Overall Study|Randomized but not treated.|2|||
125372471|NCT01751867|450995007|FG001|Overall Study|Randomized but not treated.|1|||
125372472|NCT00840450|450995008|FG000|Overall Study|Adverse Event|1|||
125372473|NCT00840450|450995008|FG000|Overall Study|Lack of Efficacy|2|||
125432029|NCT01576718|451207821|FG000|Treatment Period|Protocol Violation|0|||
125432030|NCT01576718|451207822|FG001|Treatment Period|Protocol Violation|5|||
125432031|NCT01576718|451207823|FG002|Treatment Period|Protocol Violation|4|||
125432032|NCT01576718|451207824|FG003|Treatment Period|Protocol Violation|10|||
125372474|NCT00617123|450995009|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
125372475|NCT00617123|450995010|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
125372476|NCT00617123|450995009|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
125372477|NCT00617123|450995010|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
125372478|NCT00617123|450995009|FG000|Referral Screening Period|Adverse Event|0|||
125372479|NCT00617123|450995010|FG001|Referral Screening Period|Adverse Event|1|||
125372480|NCT00617123|450995009|FG000|Study Treatment Period|Withdrawal by Subject|8|||
125372481|NCT00617123|450995010|FG001|Study Treatment Period|Withdrawal by Subject|12|||
125372482|NCT00617123|450995009|FG000|Study Treatment Period|Adverse Event|7|||
125372483|NCT00617123|450995010|FG001|Study Treatment Period|Adverse Event|3|||
125372484|NCT00617123|450995009|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
125372485|NCT00617123|450995010|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
125372486|NCT00617123|450995009|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
125372487|NCT00617123|450995010|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
125372488|NCT02170298|450995011|FG000|Overall Study|Withdrawal by Subject|0|||
125372489|NCT02170298|450995012|FG001|Overall Study|Withdrawal by Subject|1|||
125372490|NCT02170298|450995011|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
125372491|NCT02170298|450995012|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
125372492|NCT02128113|450995013|FG000|Overall Study|Withdrawal by Subject|3|||
125372493|NCT02128113|450995014|FG001|Overall Study|Withdrawal by Subject|1|||
125372494|NCT02128113|450995015|FG002|Overall Study|Withdrawal by Subject|0|||
125372495|NCT02128113|450995013|FG000|Overall Study|Protocol Violation|0|||
125372496|NCT02128113|450995014|FG001|Overall Study|Protocol Violation|1|||
125372497|NCT02128113|450995015|FG002|Overall Study|Protocol Violation|0|||
125372498|NCT02128113|450995013|FG000|Overall Study|Surgery cancelled|0|||
125372499|NCT02128113|450995014|FG001|Overall Study|Surgery cancelled|1|||
125372500|NCT02128113|450995015|FG002|Overall Study|Surgery cancelled|0|||
125372501|NCT02128113|450995013|FG000|Overall Study|Adverse Event|0|||
125372502|NCT02128113|450995014|FG001|Overall Study|Adverse Event|0|||
125372503|NCT02128113|450995015|FG002|Overall Study|Adverse Event|1|||
125372504|NCT00003499|450995019|FG000|Overall Study|Not evaluable|8|||
125372505|NCT01854710|450995026|FG000|Overall Study|Withdrawal by Subject|2|||
125372506|NCT01854710|450995027|FG001|Overall Study|Withdrawal by Subject|1|||
125372507|NCT01854710|450995028|FG002|Overall Study|Withdrawal by Subject|0|||
125372508|NCT01854710|450995029|FG003|Overall Study|Withdrawal by Subject|0|||
125372509|NCT01854710|450995030|FG004|Overall Study|Withdrawal by Subject|0|||
125372510|NCT01854710|450995031|FG005|Overall Study|Withdrawal by Subject|0|||
125372511|NCT01854710|450995026|FG000|Overall Study|CRI procedural error|2|||
125372512|NCT01854710|450995027|FG001|Overall Study|CRI procedural error|2|||
125372513|NCT01854710|450995028|FG002|Overall Study|CRI procedural error|2|||
125372514|NCT01854710|450995029|FG003|Overall Study|CRI procedural error|2|||
125372515|NCT01854710|450995030|FG004|Overall Study|CRI procedural error|2|||
125372516|NCT01854710|450995031|FG005|Overall Study|CRI procedural error|2|||
125372517|NCT00370032|450995032|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
125372518|NCT00370032|450995033|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
125372519|NCT00370032|450995032|FG000|Washout Period|Withdrawal by Subject|0|||
125372520|NCT00370032|450995033|FG001|Washout Period|Withdrawal by Subject|1|||
125372521|NCT00370032|450995032|FG000|Washout Period|Lost to Follow-up|0|||
125372522|NCT00370032|450995033|FG001|Washout Period|Lost to Follow-up|1|||
125372523|NCT00370032|450995032|FG000|Washout Period|Adverse Event|1|||
125432033|NCT01576718|451207825|FG004|Treatment Period|Protocol Violation|6|||
125432034|NCT01576718|451207826|FG005|Treatment Period|Protocol Violation|8|||
125432035|NCT01576718|451207827|FG006|Treatment Period|Protocol Violation|12|||
125432036|NCT01576718|451207821|FG000|Treatment Period|Sponsor request|0|||
125432037|NCT01576718|451207822|FG001|Treatment Period|Sponsor request|1|||
125432038|NCT01576718|451207823|FG002|Treatment Period|Sponsor request|0|||
125611675|NCT03725202|451861874|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
125611676|NCT03725202|451861875|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125611677|NCT03725202|451861876|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
125372524|NCT00370032|450995033|FG001|Washout Period|Adverse Event|0|||
125372525|NCT00370032|450995032|FG000|Follow-up Period|Withdrawal by Subject|1|||
125372526|NCT00370032|450995033|FG001|Follow-up Period|Withdrawal by Subject|0|||
125372527|NCT01844518|450995036|FG000|Overall Study|Adverse Event|7|||
125372528|NCT01844518|450995037|FG001|Overall Study|Adverse Event|1|||
125432039|NCT01576718|451207824|FG003|Treatment Period|Sponsor request|0|||
125432040|NCT01576718|451207825|FG004|Treatment Period|Sponsor request|0|||
125214289|NCT05259917|450411293|FG002|Overall Study|Lost to Follow-up|1|||
125214290|NCT05259917|450411294|FG003|Overall Study|Lost to Follow-up|0|||
125214291|NCT05259917|450411295|FG004|Overall Study|Lost to Follow-up|0|||
125214292|NCT05259917|450411296|FG005|Overall Study|Lost to Follow-up|1|||
125214293|NCT05259917|450411291|FG000|Overall Study|Physician Decision|0|||
125214294|NCT05259917|450411292|FG001|Overall Study|Physician Decision|1|||
125214295|NCT05259917|450411293|FG002|Overall Study|Physician Decision|0|||
125214296|NCT05259917|450411294|FG003|Overall Study|Physician Decision|0|||
125214297|NCT05259917|450411295|FG004|Overall Study|Physician Decision|0|||
125214298|NCT05259917|450411296|FG005|Overall Study|Physician Decision|0|||
125214299|NCT05259917|450411291|FG000|Overall Study|Withdrawal by Subject|0|||
125214300|NCT05259917|450411292|FG001|Overall Study|Withdrawal by Subject|1|||
125372529|NCT01844518|450995036|FG000|Overall Study|Lack of Efficacy|17|||
125372530|NCT01844518|450995037|FG001|Overall Study|Lack of Efficacy|5|||
125372531|NCT01844518|450995036|FG000|Overall Study|Participant's request to discontinue|4|||
125372532|NCT01844518|450995037|FG001|Overall Study|Participant's request to discontinue|1|||
125372533|NCT01844518|450995036|FG000|Overall Study|Poor/Non-compliance|1|||
125372534|NCT01844518|450995037|FG001|Overall Study|Poor/Non-compliance|0|||
125372535|NCT01844518|450995036|FG000|Overall Study|No Longer Met Study Criteria|2|||
125372536|NCT01844518|450995037|FG001|Overall Study|No Longer Met Study Criteria|0|||
125372537|NCT01844518|450995036|FG000|Overall Study|Withdrawal by Subject|9|||
125372538|NCT01844518|450995037|FG001|Overall Study|Withdrawal by Subject|0|||
125372539|NCT01844518|450995036|FG000|Overall Study|Pregnancy|1|||
125372540|NCT01844518|450995037|FG001|Overall Study|Pregnancy|0|||
125372541|NCT04584645|450995039|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
125372542|NCT04584645|450995040|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
125372543|NCT00390468|450995041|FG000|Overall Study|Protocol Violation|2|||
125372544|NCT00390468|450995041|FG000|Overall Study|Lack of Efficacy|1|||
125372545|NCT00968201|450995044|FG000|Base Study - (Period II)|Adverse Event|8|||
125372546|NCT00968201|450995045|FG001|Base Study - (Period II)|Adverse Event|0|||
125372547|NCT00968201|450995046|FG002|Base Study - (Period II)|Adverse Event|16|||
125214301|NCT05259917|450411293|FG002|Overall Study|Withdrawal by Subject|0|||
125611678|NCT03725202|451861869|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
125611679|NCT03725202|451861870|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
125611680|NCT03725202|451861871|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
125611681|NCT03725202|451861872|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
125611682|NCT03725202|451861873|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
125611683|NCT03725202|451861874|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
125611684|NCT03725202|451861875|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
125611685|NCT03725202|451861876|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
125611686|NCT01328249|451861879|FG000|Overall Study|Adverse Event|3|||
125611687|NCT01328249|451861880|FG001|Overall Study|Adverse Event|0|||
125372548|NCT00968201|450995044|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
125372549|NCT00968201|450995045|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
125611688|NCT01328249|451861879|FG000|Overall Study|Disease progression|1|||
125611689|NCT01328249|451861880|FG001|Overall Study|Disease progression|0|||
125611690|NCT01328249|451861879|FG000|Overall Study|Withdrawal by Subject|1|||
125611691|NCT01328249|451861880|FG001|Overall Study|Withdrawal by Subject|1|||
125611692|NCT01328249|451861879|FG000|Overall Study|Moved before end of treatment visit|1|||
125611693|NCT01328249|451861880|FG001|Overall Study|Moved before end of treatment visit|0|||
125611694|NCT01328249|451861879|FG000|Overall Study|Subject choice|1|||
125611695|NCT01328249|451861880|FG001|Overall Study|Subject choice|1|||
125611696|NCT01328249|451861879|FG000|Overall Study|Protocol Violation|0|||
125611697|NCT01328249|451861880|FG001|Overall Study|Protocol Violation|1|||
125611698|NCT01215734|451861881|FG000|Overall Study|Death|0|||
125611699|NCT01215734|451861882|FG001|Overall Study|Death|1|||
125611700|NCT00748553|451861883|FG000|Overall Study|Adverse Event|0|||
125611701|NCT00748553|451861884|FG001|Overall Study|Adverse Event|1|||
125611702|NCT00748553|451861883|FG000|Overall Study|disease progression|2|||
125611703|NCT00748553|451861884|FG001|Overall Study|disease progression|0|||
125611704|NCT00748553|451861883|FG000|Overall Study|noncompliance|1|||
125611705|NCT00748553|451861884|FG001|Overall Study|noncompliance|0|||
125611706|NCT00315705|451861885|FG000|Phase 1|Refused further treatment|1|||
125611707|NCT00315705|451861885|FG000|Phase 1|Failure to achieve response|8|||
125611708|NCT00315705|451861885|FG000|Phase 1|Disease relapse|4|||
125611709|NCT00315705|451861885|FG000|Phase 1|Scheduled for transplant|9|||
125372550|NCT00968201|450995046|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
125372551|NCT00968201|450995044|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
125611710|NCT00315705|451861885|FG000|Phase 1|Death|3|||
125611711|NCT00315705|451861885|FG000|Phase 2|Physician Decision|4|||
125611712|NCT00315705|451861885|FG000|Phase 2|Adverse Event|1|||
125611713|NCT00315705|451861885|FG000|Phase 2|Failure to achieve response|3|||
125611714|NCT00315705|451861885|FG000|Phase 2|Disease relapse|1|||
125611715|NCT00315705|451861885|FG000|Phase 2|Scheduled for transplant|8|||
125611716|NCT00315705|451861885|FG000|Phase 2|Other|1|||
125611717|NCT00315705|451861885|FG000|Phase 2|Death|7|||
125611718|NCT01716533|451861887|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
125611719|NCT01716533|451861888|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
125611720|NCT01716533|451861889|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
125611721|NCT01716533|451861890|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
125611722|NCT01716533|451861887|FG000|Overall Study|Withdrawal by Subject|0|||
125611723|NCT01716533|451861888|FG001|Overall Study|Withdrawal by Subject|0|||
125611724|NCT01716533|451861889|FG002|Overall Study|Withdrawal by Subject|0|||
125611725|NCT01716533|451861890|FG003|Overall Study|Withdrawal by Subject|5|||
125611726|NCT01716533|451861887|FG000|Overall Study|Death|0|||
125611727|NCT01716533|451861888|FG001|Overall Study|Death|0|||
125611728|NCT01716533|451861889|FG002|Overall Study|Death|0|||
125611729|NCT01716533|451861890|FG003|Overall Study|Death|2|||
125611730|NCT01716533|451861887|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
125611731|NCT01716533|451861888|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
125611732|NCT01716533|451861889|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
125611733|NCT01716533|451861890|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
125611734|NCT02330549|451861891|FG000|Overall Study|Adverse Event|1|||
125611735|NCT02330549|451861892|FG001|Overall Study|Adverse Event|0|||
125611736|NCT02330549|451861891|FG000|Overall Study|Subject withdrew consent|2|||
125611737|NCT02330549|451861892|FG001|Overall Study|Subject withdrew consent|1|||
125611738|NCT02330549|451861891|FG000|Overall Study|Failure to meet randomization criteria|1|||
125611739|NCT02330549|451861892|FG001|Overall Study|Failure to meet randomization criteria|0|||
125611740|NCT00495495|451861898|FG000|Overall Study|Protocol Violation|99|||
125611741|NCT00745368|451861899|FG000|Overall Study|Unable to provide sample|3|||
125611742|NCT03331666|451861903|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
125611743|NCT03331666|451861904|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
125611744|NCT02326467|451861905|FG000|Overall Study|Withdrawal by Subject|1|||
125611745|NCT00434512|451861906|FG000|Overall Study|Migrated/moved from study area|0|||
125611746|NCT00434512|451861907|FG001|Overall Study|Migrated/moved from study area|0|||
125611747|NCT00434512|451861908|FG002|Overall Study|Migrated/moved from study area|0|||
125611748|NCT00434512|451861909|FG003|Overall Study|Migrated/moved from study area|1|||
125611749|NCT00434512|451861910|FG004|Overall Study|Migrated/moved from study area|1|||
125611750|NCT00434512|451861911|FG005|Overall Study|Migrated/moved from study area|1|||
125611751|NCT00434512|451861906|FG000|Overall Study|Other|0|||
125611752|NCT00434512|451861907|FG001|Overall Study|Other|1|||
125611753|NCT00434512|451861908|FG002|Overall Study|Other|0|||
125611754|NCT00434512|451861909|FG003|Overall Study|Other|0|||
125611755|NCT00434512|451861910|FG004|Overall Study|Other|0|||
125372552|NCT00968201|450995045|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
125372553|NCT00968201|450995046|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
125372554|NCT00968201|450995044|FG000|Base Study - (Period II)|Protocol Violation|12|||
125372555|NCT00968201|450995045|FG001|Base Study - (Period II)|Protocol Violation|0|||
125372556|NCT00968201|450995046|FG002|Base Study - (Period II)|Protocol Violation|12|||
125372557|NCT00968201|450995044|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
125372558|NCT00968201|450995045|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
125372559|NCT00968201|450995046|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
125372560|NCT00968201|450995044|FG000|Base Study - (Period II)|Site Error|0|||
125432041|NCT01576718|451207826|FG005|Treatment Period|Sponsor request|1|||
125611756|NCT00434512|451861911|FG005|Overall Study|Other|0|||
125611757|NCT01575197|451861914|FG000|Overall Study|Migration out of study area|1|||
125611758|NCT01575197|451861915|FG001|Overall Study|Migration out of study area|5|||
125611759|NCT01575197|451861916|FG002|Overall Study|Migration out of study area|4|||
125611760|NCT01575197|451861914|FG000|Overall Study|SAE|0|||
125611761|NCT01575197|451861915|FG001|Overall Study|SAE|1|||
125611762|NCT01575197|451861916|FG002|Overall Study|SAE|0|||
125611763|NCT01575197|451861914|FG000|Overall Study|Lost to Follow-up|0|||
125611764|NCT01575197|451861915|FG001|Overall Study|Lost to Follow-up|1|||
125611765|NCT01575197|451861916|FG002|Overall Study|Lost to Follow-up|0|||
125611766|NCT01575197|451861914|FG000|Overall Study|Withdrawal by Subject|0|||
125611767|NCT01575197|451861915|FG001|Overall Study|Withdrawal by Subject|1|||
125611768|NCT01575197|451861916|FG002|Overall Study|Withdrawal by Subject|1|||
125611769|NCT01575197|451861914|FG000|Overall Study|Protocol Violation|2|||
125611770|NCT01575197|451861915|FG001|Overall Study|Protocol Violation|1|||
125611771|NCT01575197|451861916|FG002|Overall Study|Protocol Violation|1|||
125611772|NCT03137121|451861919|FG000|Overall Study|Withdrawal by Subject|0|||
125611773|NCT03137121|451861920|FG001|Overall Study|Withdrawal by Subject|1|||
125611774|NCT00111475|451861924|FG000|Overall Study|Lost to Follow-up|0|||
125611775|NCT00111475|451861925|FG001|Overall Study|Lost to Follow-up|0|||
125611776|NCT00111475|451861926|FG002|Overall Study|Lost to Follow-up|0|||
125611777|NCT00111475|451861927|FG003|Overall Study|Lost to Follow-up|0|||
125611778|NCT00111475|451861928|FG004|Overall Study|Lost to Follow-up|0|||
125611779|NCT00111475|451861929|FG005|Overall Study|Lost to Follow-up|1|||
125611780|NCT00111475|451861930|FG006|Overall Study|Lost to Follow-up|0|||
125611781|NCT00111475|451861931|FG007|Overall Study|Lost to Follow-up|0|||
125611782|NCT00111475|451861932|FG008|Overall Study|Lost to Follow-up|0|||
125611783|NCT00111475|451861933|FG009|Overall Study|Lost to Follow-up|0|||
125611784|NCT03303092|451861934|FG000|Overall Study|Adverse Event|1|||
125214302|NCT05259917|450411294|FG003|Overall Study|Withdrawal by Subject|0|||
125611785|NCT03303092|451861935|FG001|Overall Study|Adverse Event|0|||
125372561|NCT00968201|450995045|FG001|Base Study - (Period II)|Site Error|0|||
125611786|NCT03303092|451861936|FG002|Overall Study|Adverse Event|1|||
125611787|NCT03303092|451861934|FG000|Overall Study|Protocol Violation|1|||
125611788|NCT03303092|451861935|FG001|Overall Study|Protocol Violation|5|||
125611789|NCT03303092|451861936|FG002|Overall Study|Protocol Violation|1|||
125611790|NCT03303092|451861934|FG000|Overall Study|Withdrawal by Subject|1|||
125611791|NCT03303092|451861935|FG001|Overall Study|Withdrawal by Subject|1|||
125611792|NCT03303092|451861936|FG002|Overall Study|Withdrawal by Subject|3|||
125611793|NCT01026389|451861939|FG000|Overall Study|Withdrawal by Subject|1|||
125611794|NCT01026389|451861940|FG001|Overall Study|Withdrawal by Subject|3|||
125611795|NCT01026389|451861939|FG000|Overall Study|change of treatment, patient moved|4|||
125611796|NCT01026389|451861940|FG001|Overall Study|change of treatment, patient moved|2|||
125611797|NCT01995136|451861941|FG000|Overall Study|Change in residence|1|||
125611798|NCT00836277|451861942|FG000|Overall Study|Not evaluable for response|6|||
125611799|NCT04410198|451861943|FG000|Overall Study|Death|10|||
125611800|NCT04410198|451861943|FG000|Overall Study|Withdrawal by Subject|7|||
125611801|NCT04410198|451861943|FG000|Overall Study|Transferred/Relocation|4|||
125611802|NCT04410198|451861943|FG000|Overall Study|Kidney Transplant|9|||
125611803|NCT04410198|451861943|FG000|Overall Study|Adverse Event|4|||
125611804|NCT04410198|451861943|FG000|Overall Study|Physician Decision|2|||
125611805|NCT04410198|451861943|FG000|Overall Study|Other than specified|1|||
125611806|NCT01830543|451861949|FG000|Overall Study|Subject Decision|19|||
125611807|NCT01830543|451861950|FG001|Overall Study|Subject Decision|21|||
125611808|NCT01830543|451861951|FG002|Overall Study|Subject Decision|57|||
125611809|NCT01830543|451861949|FG000|Overall Study|Adverse Event|91|||
125611810|NCT01830543|451861950|FG001|Overall Study|Adverse Event|77|||
125611811|NCT01830543|451861951|FG002|Overall Study|Adverse Event|76|||
125611812|NCT01830543|451861949|FG000|Overall Study|Death|20|||
125611813|NCT01830543|451861950|FG001|Overall Study|Death|22|||
125611814|NCT01830543|451861951|FG002|Overall Study|Death|22|||
125611815|NCT01830543|451861949|FG000|Overall Study|Protocol Violation|3|||
125611816|NCT01830543|451861950|FG001|Overall Study|Protocol Violation|7|||
125611817|NCT01830543|451861951|FG002|Overall Study|Protocol Violation|7|||
125611818|NCT01830543|451861949|FG000|Overall Study|Physician Decision|11|||
125611819|NCT01830543|451861950|FG001|Overall Study|Physician Decision|5|||
125611820|NCT01830543|451861951|FG002|Overall Study|Physician Decision|12|||
125611821|NCT01830543|451861949|FG000|Overall Study|Withdrawal by consent|3|||
125611822|NCT01830543|451861950|FG001|Overall Study|Withdrawal by consent|3|||
125611823|NCT01830543|451861951|FG002|Overall Study|Withdrawal by consent|3|||
125611824|NCT01830543|451861949|FG000|Overall Study|Other|12|||
125611825|NCT01830543|451861950|FG001|Overall Study|Other|17|||
125611826|NCT01830543|451861951|FG002|Overall Study|Other|37|||
125611827|NCT03583372|451861956|FG000|Overall Study|Withdrawal by Subject|6|||
125611828|NCT03583372|451861957|FG001|Overall Study|Withdrawal by Subject|11|||
125611829|NCT03583372|451861958|FG002|Overall Study|Withdrawal by Subject|7|||
125611830|NCT03583372|451861959|FG003|Overall Study|Withdrawal by Subject|8|||
125611831|NCT03583372|451861956|FG000|Overall Study|Lost to Follow-up|4|||
125611832|NCT03583372|451861957|FG001|Overall Study|Lost to Follow-up|6|||
125611833|NCT03583372|451861958|FG002|Overall Study|Lost to Follow-up|3|||
125611834|NCT03583372|451861959|FG003|Overall Study|Lost to Follow-up|2|||
125611835|NCT03583372|451861956|FG000|Overall Study|Adverse Event|1|||
125611836|NCT03583372|451861957|FG001|Overall Study|Adverse Event|3|||
125611837|NCT03583372|451861958|FG002|Overall Study|Adverse Event|4|||
125611838|NCT03583372|451861959|FG003|Overall Study|Adverse Event|4|||
125611839|NCT03583372|451861956|FG000|Overall Study|Physician Decision|0|||
125611840|NCT03583372|451861957|FG001|Overall Study|Physician Decision|1|||
125611841|NCT03583372|451861958|FG002|Overall Study|Physician Decision|1|||
125611842|NCT03583372|451861959|FG003|Overall Study|Physician Decision|1|||
125611843|NCT03583372|451861956|FG000|Overall Study|Lack of Efficacy|0|||
125611844|NCT03583372|451861957|FG001|Overall Study|Lack of Efficacy|1|||
125611845|NCT03583372|451861958|FG002|Overall Study|Lack of Efficacy|0|||
125611846|NCT03583372|451861959|FG003|Overall Study|Lack of Efficacy|1|||
125611847|NCT03583372|451861956|FG000|Overall Study|Death|1|||
125611848|NCT03583372|451861957|FG001|Overall Study|Death|0|||
125611849|NCT03583372|451861958|FG002|Overall Study|Death|0|||
125611850|NCT03583372|451861959|FG003|Overall Study|Death|0|||
125611851|NCT03583372|451861956|FG000|Overall Study|Protocol Violation|0|||
125432042|NCT01576718|451207827|FG006|Treatment Period|Sponsor request|0|||
125611852|NCT03583372|451861957|FG001|Overall Study|Protocol Violation|1|||
125611853|NCT03583372|451861958|FG002|Overall Study|Protocol Violation|0|||
125611854|NCT03583372|451861959|FG003|Overall Study|Protocol Violation|0|||
125432043|NCT01576718|451207821|FG000|Treatment Period|Met stopping criteria|0|||
125611855|NCT03583372|451861956|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
125611856|NCT03583372|451861957|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
125611857|NCT03583372|451861958|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
125611858|NCT03583372|451861959|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
125611859|NCT03583372|451861956|FG000|Overall Study|Did Not Receive Study Drug|0|||
125611860|NCT03583372|451861957|FG001|Overall Study|Did Not Receive Study Drug|1|||
125611861|NCT03583372|451861958|FG002|Overall Study|Did Not Receive Study Drug|0|||
125611862|NCT03583372|451861959|FG003|Overall Study|Did Not Receive Study Drug|0|||
125611863|NCT03583372|451861956|FG000|Overall Study|Captured as Other in the Database|1|||
125611864|NCT03583372|451861957|FG001|Overall Study|Captured as Other in the Database|2|||
125611865|NCT03583372|451861958|FG002|Overall Study|Captured as Other in the Database|4|||
125611866|NCT03583372|451861959|FG003|Overall Study|Captured as Other in the Database|1|||
125611867|NCT03446651|451861967|FG000|Overall Study|Lost to Follow-up|4|||
125214303|NCT05259917|450411295|FG004|Overall Study|Withdrawal by Subject|1|||
125214304|NCT05259917|450411296|FG005|Overall Study|Withdrawal by Subject|1|||
125214305|NCT05259917|450411291|FG000|Overall Study|Trial Termination by Sponsor|7|||
125214306|NCT05259917|450411292|FG001|Overall Study|Trial Termination by Sponsor|2|||
125214307|NCT05259917|450411293|FG002|Overall Study|Trial Termination by Sponsor|3|||
125214308|NCT05259917|450411294|FG003|Overall Study|Trial Termination by Sponsor|5|||
125611868|NCT03446651|451861968|FG001|Overall Study|Lost to Follow-up|0|||
125611869|NCT03446651|451861967|FG000|Overall Study|Open Label Participants|5|||
125611870|NCT03446651|451861968|FG001|Overall Study|Open Label Participants|0|||
125611871|NCT02420223|451861969|FG000|Overall Study|Adverse Event|1|||
125611872|NCT02420223|451861970|FG001|Overall Study|Adverse Event|0|||
125214309|NCT05259917|450411295|FG004|Overall Study|Trial Termination by Sponsor|11|||
125214310|NCT05259917|450411296|FG005|Overall Study|Trial Termination by Sponsor|4|||
125214311|NCT05259917|450411291|FG000|Overall Study|Other|1|||
125214312|NCT05259917|450411292|FG001|Overall Study|Other|0|||
125611873|NCT02420223|451861969|FG000|Overall Study|Physician Decision|0|||
125611874|NCT02420223|451861970|FG001|Overall Study|Physician Decision|2|||
125611875|NCT05142332|451861971|FG000|Overall Study|Withdrawal by Subject|0|||
125611876|NCT05142332|451861972|FG001|Overall Study|Withdrawal by Subject|1|||
125214313|NCT05259917|450411293|FG002|Overall Study|Other|2|||
125611877|NCT05142332|451861973|FG002|Overall Study|Withdrawal by Subject|2|||
125611878|NCT05142332|451861974|FG003|Overall Study|Withdrawal by Subject|0|||
125611879|NCT05142332|451861975|FG004|Overall Study|Withdrawal by Subject|0|||
125611880|NCT05142332|451861976|FG005|Overall Study|Withdrawal by Subject|2|||
125611881|NCT05142332|451861977|FG006|Overall Study|Withdrawal by Subject|6|||
125611882|NCT05142332|451861971|FG000|Overall Study|Left ED|3|||
125611883|NCT05142332|451861972|FG001|Overall Study|Left ED|0|||
125611884|NCT05142332|451861973|FG002|Overall Study|Left ED|4|||
125611885|NCT05142332|451861974|FG003|Overall Study|Left ED|6|||
125611886|NCT05142332|451861975|FG004|Overall Study|Left ED|1|||
125214314|NCT05259917|450411294|FG003|Overall Study|Other|0|||
125611887|NCT05142332|451861976|FG005|Overall Study|Left ED|2|||
125611888|NCT05142332|451861977|FG006|Overall Study|Left ED|6|||
125611889|NCT05142332|451861971|FG000|Overall Study|Physician Decision|0|||
125611890|NCT05142332|451861972|FG001|Overall Study|Physician Decision|0|||
125611891|NCT05142332|451861973|FG002|Overall Study|Physician Decision|2|||
125611892|NCT05142332|451861974|FG003|Overall Study|Physician Decision|1|||
125611893|NCT05142332|451861975|FG004|Overall Study|Physician Decision|0|||
125611894|NCT05142332|451861976|FG005|Overall Study|Physician Decision|0|||
125611895|NCT05142332|451861977|FG006|Overall Study|Physician Decision|3|||
125611896|NCT05142332|451861971|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
125611897|NCT05142332|451861972|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
125611898|NCT05142332|451861973|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
125611899|NCT05142332|451861974|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
125611900|NCT05142332|451861975|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
125611901|NCT05142332|451861976|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
125611902|NCT05142332|451861977|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
125611903|NCT01894477|451861982|FG000|Overall Study|Protocol Violation|0|||
125611904|NCT01894477|451861983|FG001|Overall Study|Protocol Violation|1|||
125611905|NCT01894477|451861982|FG000|Overall Study|protocol changed due SC changed to cord|0|||
125611906|NCT01894477|451861983|FG001|Overall Study|protocol changed due SC changed to cord|1|||
125611907|NCT02052778|451861984|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
125611908|NCT02052778|451861985|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
125611909|NCT02052778|451861986|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
125611910|NCT02052778|451861987|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
125611911|NCT02052778|451861988|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
125611912|NCT02052778|451861989|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
125611913|NCT02052778|451861990|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125611914|NCT02052778|451861991|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
125611915|NCT02052778|451861992|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
125611916|NCT02052778|451861993|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
125611917|NCT02052778|451861994|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
125611918|NCT02052778|451861995|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
125611919|NCT02052778|451861996|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
125611920|NCT02052778|451861997|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
125611921|NCT02052778|451861998|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125611922|NCT02052778|451861999|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125611923|NCT02052778|451862000|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125611924|NCT02052778|451862001|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125611925|NCT02052778|451862002|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125611926|NCT02052778|451862003|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125611927|NCT02052778|451862004|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125611928|NCT02052778|451862005|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125611929|NCT02052778|451862006|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
125611930|NCT02052778|451861984|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
125611931|NCT02052778|451861985|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
125611932|NCT02052778|451861986|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
125611933|NCT02052778|451861987|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
125611934|NCT02052778|451861988|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
125611935|NCT02052778|451861989|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
125611936|NCT02052778|451861990|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
125611937|NCT02052778|451861991|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
125611938|NCT02052778|451861992|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
125611939|NCT02052778|451861993|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125611940|NCT02052778|451861994|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125611941|NCT02052778|451861995|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
125611942|NCT02052778|451861996|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
125611943|NCT02052778|451861997|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
125611944|NCT02052778|451861998|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125611945|NCT02052778|451861999|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125611946|NCT02052778|451862000|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125611947|NCT02052778|451862001|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125611948|NCT02052778|451862002|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125611949|NCT02052778|451862003|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125611950|NCT02052778|451862004|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125611951|NCT02052778|451862005|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125611952|NCT02052778|451862006|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
125611953|NCT02052778|451861984|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611954|NCT02052778|451861985|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611955|NCT02052778|451861986|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611956|NCT02052778|451861987|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611957|NCT02052778|451861988|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611958|NCT02052778|451861989|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125372562|NCT00968201|450995046|FG002|Base Study - (Period II)|Site Error|1|||
125432044|NCT01576718|451207822|FG001|Treatment Period|Met stopping criteria|16|||
125432045|NCT01576718|451207823|FG002|Treatment Period|Met stopping criteria|13|||
125432046|NCT01576718|451207824|FG003|Treatment Period|Met stopping criteria|19|||
125432047|NCT01576718|451207825|FG004|Treatment Period|Met stopping criteria|16|||
125432048|NCT01576718|451207826|FG005|Treatment Period|Met stopping criteria|33|||
125432049|NCT01576718|451207827|FG006|Treatment Period|Met stopping criteria|15|||
125432050|NCT01576718|451207821|FG000|Treatment Period|Lost to Follow-up|0|||
125432051|NCT01576718|451207822|FG001|Treatment Period|Lost to Follow-up|0|||
125432052|NCT01576718|451207823|FG002|Treatment Period|Lost to Follow-up|0|||
125432053|NCT01576718|451207824|FG003|Treatment Period|Lost to Follow-up|0|||
125432054|NCT01576718|451207825|FG004|Treatment Period|Lost to Follow-up|1|||
125611959|NCT02052778|451861990|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125372563|NCT00968201|450995044|FG000|Extension Study - (Period III)|Adverse Event|0|||
125372564|NCT00968201|450995045|FG001|Extension Study - (Period III)|Adverse Event|5|||
125372565|NCT00968201|450995046|FG002|Extension Study - (Period III)|Adverse Event|22|||
125372566|NCT00968201|450995044|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
125372567|NCT00968201|450995045|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
125372568|NCT00968201|450995046|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
125372569|NCT00968201|450995044|FG000|Extension Study - (Period III)|Protocol Violation|0|||
125372570|NCT00968201|450995045|FG001|Extension Study - (Period III)|Protocol Violation|17|||
125372571|NCT00968201|450995046|FG002|Extension Study - (Period III)|Protocol Violation|14|||
125372572|NCT00968201|450995044|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
125372573|NCT00968201|450995045|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
125372574|NCT00968201|450995046|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
125372575|NCT00968201|450995044|FG000|Extension Study - (Period III)|Patient Relocated|0|||
125372576|NCT00968201|450995045|FG001|Extension Study - (Period III)|Patient Relocated|1|||
125372577|NCT00968201|450995046|FG002|Extension Study - (Period III)|Patient Relocated|1|||
125372578|NCT00968201|450995044|FG000|Extension Study - (Period III)|Noncompliance|0|||
125372579|NCT00968201|450995045|FG001|Extension Study - (Period III)|Noncompliance|0|||
125372580|NCT00968201|450995046|FG002|Extension Study - (Period III)|Noncompliance|3|||
125372581|NCT00968201|450995044|FG000|Extension Study - (Period III)|Other|0|||
125372582|NCT00968201|450995045|FG001|Extension Study - (Period III)|Other|0|||
125372583|NCT00968201|450995046|FG002|Extension Study - (Period III)|Other|2|||
125372584|NCT00968201|450995044|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
125372585|NCT00968201|450995045|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
125372586|NCT00968201|450995046|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
125372587|NCT04974697|450995047|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
125372588|NCT04974697|450995047|FG000|Overall Study|Lens discomfort|1|||
125372589|NCT03706456|450995049|FG000|Overall Study|Adverse Event|1|||
125372590|NCT03706456|450995049|FG000|Overall Study|Lack of Efficacy|2|||
125372591|NCT02784431|450995050|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
125372592|NCT02784431|450995050|FG000|Overall Study|Early Study Termination|19|||
125372593|NCT03302234|450995051|FG000|Overall Study|Death|191|||
125372594|NCT03302234|450995052|FG001|Overall Study|Death|192|||
125372595|NCT03302234|450995051|FG000|Overall Study|Withdrawal by Subject|2|||
125372596|NCT03302234|450995052|FG001|Overall Study|Withdrawal by Subject|2|||
125372597|NCT03302234|450995051|FG000|Overall Study|Sponsor Decision|90|||
125372598|NCT03302234|450995052|FG001|Overall Study|Sponsor Decision|89|||
125372599|NCT03302234|450995051|FG000|Overall Study|Laryngeal carcinoma|0|||
125372600|NCT03302234|450995052|FG001|Overall Study|Laryngeal carcinoma|1|||
125611960|NCT02052778|451861991|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611961|NCT02052778|451861992|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611962|NCT02052778|451861993|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611963|NCT02052778|451861994|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611964|NCT02052778|451861995|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125372601|NCT03302234|450995051|FG000|Overall Study|Not Reported|1|||
125432055|NCT01576718|451207826|FG005|Treatment Period|Lost to Follow-up|0|||
125372602|NCT03302234|450995052|FG001|Overall Study|Not Reported|0|||
125372603|NCT02795832|450995055|FG000|Overall Study|Adverse Event|0|||
125372604|NCT02795832|450995056|FG001|Overall Study|Adverse Event|0|||
125372605|NCT02795832|450995057|FG002|Overall Study|Adverse Event|0|||
125372606|NCT02795832|450995058|FG003|Overall Study|Adverse Event|0|||
125372607|NCT02795832|450995059|FG004|Overall Study|Adverse Event|0|||
125372608|NCT02795832|450995060|FG005|Overall Study|Adverse Event|3|||
125432056|NCT01576718|451207827|FG006|Treatment Period|Lost to Follow-up|0|||
125432057|NCT01576718|451207821|FG000|Treatment Period|Noncompliance to study medication|0|||
125611965|NCT02052778|451861996|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125372609|NCT04523220|450995061|FG000|Main Treatment Period|Physician Decision|1|||
125372610|NCT04523220|450995062|FG001|Main Treatment Period|Physician Decision|1|||
125372611|NCT04523220|450995063|FG002|Main Treatment Period|Physician Decision|0|||
125372612|NCT04523220|450995061|FG000|Main Treatment Period|Other|5|||
125372613|NCT04523220|450995062|FG001|Main Treatment Period|Other|2|||
125611966|NCT02052778|451861997|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
125611967|NCT02052778|451861998|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611968|NCT02052778|451861999|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611969|NCT02052778|451862000|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611970|NCT02052778|451862001|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611971|NCT02052778|451862002|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611972|NCT02052778|451862003|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611973|NCT02052778|451862004|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611974|NCT02052778|451862005|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611975|NCT02052778|451862006|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
125611976|NCT02052778|451861984|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
125611977|NCT02052778|451861985|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
125611978|NCT02052778|451861986|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
125611979|NCT02052778|451861987|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
125611980|NCT02052778|451861988|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
125611981|NCT02052778|451861989|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
125611982|NCT02052778|451861990|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
125611983|NCT02052778|451861991|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
125611984|NCT02052778|451861992|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
125611985|NCT02052778|451861993|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
125611986|NCT02052778|451861994|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
125611987|NCT02052778|451861995|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
125611988|NCT02052778|451861996|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
125611989|NCT02052778|451861997|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
125611990|NCT02052778|451861998|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
125611991|NCT02052778|451861999|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
125611992|NCT02052778|451862000|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
125611993|NCT02052778|451862001|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
125611994|NCT02052778|451862002|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
125611995|NCT02052778|451862003|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
125611996|NCT02052778|451862004|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
125611997|NCT02052778|451862005|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
125611998|NCT02052778|451862006|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
125611999|NCT02052778|451861984|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612000|NCT02052778|451861985|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612001|NCT02052778|451861986|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125372614|NCT04523220|450995063|FG002|Main Treatment Period|Other|4|||
125372615|NCT04523220|450995061|FG000|Main Treatment Period|Subject Decision|5|||
125372616|NCT04523220|450995062|FG001|Main Treatment Period|Subject Decision|7|||
125372617|NCT04523220|450995063|FG002|Main Treatment Period|Subject Decision|3|||
125372618|NCT04523220|450995061|FG000|Main Treatment Period|Death|5|||
125372619|NCT04523220|450995062|FG001|Main Treatment Period|Death|11|||
125372620|NCT04523220|450995063|FG002|Main Treatment Period|Death|4|||
125372621|NCT04523220|450995061|FG000|Main Treatment Period|Adverse Event|11|||
125372622|NCT04523220|450995062|FG001|Main Treatment Period|Adverse Event|9|||
125372623|NCT04523220|450995063|FG002|Main Treatment Period|Adverse Event|9|||
125372624|NCT04523220|450995061|FG000|Main Treatment Period|Withdrawal by Subject|3|||
125372625|NCT04523220|450995062|FG001|Main Treatment Period|Withdrawal by Subject|3|||
125372626|NCT04523220|450995063|FG002|Main Treatment Period|Withdrawal by Subject|4|||
125372627|NCT04523220|450995061|FG000|Main Treatment Period|Study drug never adminstered|10|||
125372628|NCT04523220|450995062|FG001|Main Treatment Period|Study drug never adminstered|3|||
125372629|NCT04523220|450995063|FG002|Main Treatment Period|Study drug never adminstered|5|||
125372630|NCT04523220|450995061|FG000|Extension Treatment Period|Physician Decision|1|||
125372631|NCT04523220|450995062|FG001|Extension Treatment Period|Physician Decision|0|||
125432058|NCT01576718|451207822|FG001|Treatment Period|Noncompliance to study medication|0|||
125432059|NCT01576718|451207823|FG002|Treatment Period|Noncompliance to study medication|0|||
125612002|NCT02052778|451861987|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612003|NCT02052778|451861988|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612004|NCT02052778|451861989|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612005|NCT02052778|451861990|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612006|NCT02052778|451861991|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612007|NCT02052778|451861992|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
125612008|NCT02052778|451861993|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612009|NCT02052778|451861994|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612010|NCT02052778|451861995|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612011|NCT02052778|451861996|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612012|NCT02052778|451861997|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
125612013|NCT02052778|451861998|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612014|NCT02052778|451861999|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612015|NCT02052778|451862000|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612016|NCT02052778|451862001|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612017|NCT02052778|451862002|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612018|NCT02052778|451862003|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612019|NCT02052778|451862004|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612020|NCT02052778|451862005|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612021|NCT02052778|451862006|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
125612022|NCT02052778|451861984|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612023|NCT02052778|451861985|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612024|NCT02052778|451861986|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612025|NCT02052778|451861987|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612026|NCT02052778|451861988|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612027|NCT02052778|451861989|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
125612028|NCT02052778|451861990|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612029|NCT02052778|451861991|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612030|NCT02052778|451861992|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612031|NCT02052778|451861993|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612032|NCT02052778|451861994|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125372632|NCT04523220|450995063|FG002|Extension Treatment Period|Physician Decision|3|||
125372633|NCT04523220|450995061|FG000|Extension Treatment Period|Other|2|||
125372634|NCT04523220|450995062|FG001|Extension Treatment Period|Other|6|||
125612033|NCT02052778|451861995|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612034|NCT02052778|451861996|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
125612035|NCT02052778|451861997|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612036|NCT02052778|451861998|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612037|NCT02052778|451861999|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612038|NCT02052778|451862000|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612039|NCT02052778|451862001|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612040|NCT02052778|451862002|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612041|NCT02052778|451862003|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612042|NCT02052778|451862004|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612043|NCT02052778|451862005|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612044|NCT02052778|451862006|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
125612045|NCT02052778|451861984|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612046|NCT02052778|451861985|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125214315|NCT05259917|450411295|FG004|Overall Study|Other|0|||
125214316|NCT05259917|450411296|FG005|Overall Study|Other|0|||
125214317|NCT00482170|450411297|FG000|Overall Study|Adverse Event|5|||
125214318|NCT00482170|450411298|FG001|Overall Study|Adverse Event|14|||
125214319|NCT00482170|450411297|FG000|Overall Study|Withdrawal by Subject|6|||
125214320|NCT00482170|450411298|FG001|Overall Study|Withdrawal by Subject|1|||
125214321|NCT00482170|450411297|FG000|Overall Study|Protocol Violation|2|||
125214322|NCT00482170|450411298|FG001|Overall Study|Protocol Violation|3|||
125214323|NCT00482170|450411297|FG000|Overall Study|Lost to Follow-up|2|||
125214324|NCT00482170|450411298|FG001|Overall Study|Lost to Follow-up|0|||
125214325|NCT00482170|450411297|FG000|Overall Study|Unspecified reason|0|||
125214326|NCT00482170|450411298|FG001|Overall Study|Unspecified reason|2|||
125214327|NCT01658904|450411301|FG000|Overall Study|Principal Investigator discretion|2|||
125612047|NCT02052778|451861986|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612048|NCT02052778|451861987|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612049|NCT02052778|451861988|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612050|NCT02052778|451861989|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612051|NCT02052778|451861990|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612052|NCT02052778|451861991|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612053|NCT02052778|451861992|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612054|NCT02052778|451861993|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612055|NCT02052778|451861994|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612056|NCT02052778|451861995|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612057|NCT02052778|451861996|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612058|NCT02052778|451861997|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612059|NCT02052778|451861998|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
125612060|NCT02052778|451861999|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
125612061|NCT02052778|451862000|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
125612062|NCT02052778|451862001|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
125612063|NCT02052778|451862002|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
125612064|NCT02052778|451862003|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
125612065|NCT02052778|451862004|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
125612066|NCT02052778|451862005|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
125612067|NCT02052778|451862006|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
125612068|NCT02052778|451861984|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612069|NCT02052778|451861985|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612070|NCT02052778|451861986|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612071|NCT02052778|451861987|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612072|NCT02052778|451861988|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612073|NCT02052778|451861989|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612074|NCT02052778|451861990|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612075|NCT02052778|451861991|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612076|NCT02052778|451861992|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612077|NCT02052778|451861993|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612078|NCT02052778|451861994|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612079|NCT02052778|451861995|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612080|NCT02052778|451861996|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125214328|NCT01658904|450411302|FG001|Overall Study|Principal Investigator discretion|0|||
125214329|NCT01658904|450411303|FG002|Overall Study|Principal Investigator discretion|0|||
125214330|NCT00080483|450411304|FG000|Overall Study|Lost to Follow-up|1|||
125612081|NCT02052778|451861997|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612082|NCT02052778|451861998|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
125612083|NCT02052778|451861999|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
125612084|NCT02052778|451862000|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612085|NCT02052778|451862001|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
125612086|NCT02052778|451862002|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
125612087|NCT02052778|451862003|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
125612088|NCT02052778|451862004|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
125612089|NCT02052778|451862005|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
125612090|NCT02052778|451862006|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
125612091|NCT02052778|451861984|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612092|NCT02052778|451861985|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612093|NCT02052778|451861986|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612094|NCT02052778|451861987|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612095|NCT02052778|451861988|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612096|NCT02052778|451861989|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612097|NCT02052778|451861990|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612098|NCT02052778|451861991|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612099|NCT02052778|451861992|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612100|NCT02052778|451861993|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612101|NCT02052778|451861994|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612102|NCT02052778|451861995|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612103|NCT02052778|451861996|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612104|NCT02052778|451861997|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612105|NCT02052778|451861998|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
125214331|NCT00080483|450411305|FG001|Overall Study|Lost to Follow-up|1|||
125372635|NCT04523220|450995063|FG002|Extension Treatment Period|Other|6|||
125372636|NCT04523220|450995061|FG000|Extension Treatment Period|Subject Decision|5|||
125612106|NCT02052778|451861999|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
125372637|NCT04523220|450995062|FG001|Extension Treatment Period|Subject Decision|2|||
125372638|NCT04523220|450995063|FG002|Extension Treatment Period|Subject Decision|4|||
125372639|NCT04523220|450995061|FG000|Extension Treatment Period|Death|6|||
125372640|NCT04523220|450995062|FG001|Extension Treatment Period|Death|4|||
125612107|NCT02052778|451862000|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
125612108|NCT02052778|451862001|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612109|NCT02052778|451862002|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
125612110|NCT02052778|451862003|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
125612111|NCT02052778|451862004|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612112|NCT02052778|451862005|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612113|NCT02052778|451862006|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
125612114|NCT02052778|451861984|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612115|NCT02052778|451861985|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612116|NCT02052778|451861986|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612117|NCT02052778|451861987|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612118|NCT02052778|451861988|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612119|NCT02052778|451861989|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612120|NCT02052778|451861990|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612121|NCT02052778|451861991|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612122|NCT02052778|451861992|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612123|NCT02052778|451861993|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612124|NCT02052778|451861994|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612125|NCT02052778|451861995|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612126|NCT02052778|451861996|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612127|NCT02052778|451861997|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612128|NCT02052778|451861998|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
125612129|NCT02052778|451861999|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
125612130|NCT02052778|451862000|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612131|NCT02052778|451862001|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612132|NCT02052778|451862002|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612133|NCT02052778|451862003|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612134|NCT02052778|451862004|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612135|NCT02052778|451862005|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612136|NCT02052778|451862006|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
125612137|NCT02052778|451861984|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612138|NCT02052778|451861985|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612139|NCT02052778|451861986|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612140|NCT02052778|451861987|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612141|NCT02052778|451861988|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612142|NCT02052778|451861989|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612143|NCT02052778|451861990|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612144|NCT02052778|451861991|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612145|NCT02052778|451861992|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612146|NCT02052778|451861993|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612147|NCT02052778|451861994|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612148|NCT02052778|451861995|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612149|NCT02052778|451861996|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612150|NCT02052778|451861997|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125214332|NCT00080483|450411304|FG000|Overall Study|Physician Decision|1|||
125214333|NCT00080483|450411305|FG001|Overall Study|Physician Decision|1|||
125214334|NCT01808222|450411306|FG000|Overall Study|mpMR scan was not performed|1|||
125214335|NCT00460746|450411314|FG000|Overall Study|Adverse Event|1|||
125214336|NCT00460746|450411314|FG000|Overall Study|Lost to Follow-up|1|||
125214337|NCT04399538|450411319|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
125612151|NCT02052778|451861998|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
125612152|NCT02052778|451861999|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
125612153|NCT02052778|451862000|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612154|NCT02052778|451862001|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612155|NCT02052778|451862002|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612156|NCT02052778|451862003|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
125612157|NCT02052778|451862004|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612158|NCT02052778|451862005|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612159|NCT02052778|451862006|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
125612160|NCT02052778|451861984|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
125612161|NCT02052778|451861985|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
125612162|NCT02052778|451861986|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
125612163|NCT02052778|451861987|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
125612164|NCT02052778|451861988|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
125612165|NCT02052778|451861989|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
125612166|NCT02052778|451861990|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
125612167|NCT02052778|451861991|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
125612168|NCT02052778|451861992|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
125612169|NCT02052778|451861993|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
125612170|NCT02052778|451861994|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
125612171|NCT02052778|451861995|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
125612172|NCT02052778|451861996|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
125612173|NCT02052778|451861997|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
125612174|NCT02052778|451861998|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
125612175|NCT02052778|451861999|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
125612176|NCT02052778|451862000|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
125612177|NCT02052778|451862001|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
125612178|NCT02052778|451862002|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
125612179|NCT02052778|451862003|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
125612180|NCT02052778|451862004|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
125612181|NCT02052778|451862005|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
125612182|NCT02052778|451862006|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
125612183|NCT02052778|451861984|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612184|NCT02052778|451861985|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612185|NCT02052778|451861986|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612186|NCT02052778|451861987|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612187|NCT02052778|451861988|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612188|NCT02052778|451861989|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612189|NCT02052778|451861990|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612190|NCT02052778|451861991|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125372641|NCT04523220|450995063|FG002|Extension Treatment Period|Death|7|||
125372642|NCT04523220|450995061|FG000|Extension Treatment Period|Adverse Event|6|||
125372643|NCT04523220|450995062|FG001|Extension Treatment Period|Adverse Event|7|||
125372644|NCT04523220|450995063|FG002|Extension Treatment Period|Adverse Event|9|||
125372645|NCT04523220|450995061|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
125372646|NCT04523220|450995062|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
125612191|NCT02052778|451861992|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612192|NCT02052778|451861993|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612193|NCT02052778|451861994|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612194|NCT02052778|451861995|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612195|NCT02052778|451861996|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612196|NCT02052778|451861997|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612197|NCT02052778|451861998|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
125612198|NCT02052778|451861999|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
125612199|NCT02052778|451862000|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
125612200|NCT02052778|451862001|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612201|NCT02052778|451862002|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
125612202|NCT02052778|451862003|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612203|NCT02052778|451862004|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612204|NCT02052778|451862005|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612205|NCT02052778|451862006|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
125612206|NCT02052778|451861984|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612207|NCT02052778|451861985|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612208|NCT02052778|451861986|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612209|NCT02052778|451861987|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612210|NCT02052778|451861988|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612211|NCT02052778|451861989|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612212|NCT02052778|451861990|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612213|NCT02052778|451861991|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612214|NCT02052778|451861992|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612215|NCT02052778|451861993|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612216|NCT02052778|451861994|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612217|NCT02052778|451861995|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612218|NCT02052778|451861996|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612219|NCT02052778|451861997|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612220|NCT02052778|451861998|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612221|NCT02052778|451861999|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612222|NCT02052778|451862000|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612223|NCT02052778|451862001|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612224|NCT02052778|451862002|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612225|NCT02052778|451862003|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612226|NCT02052778|451862004|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612227|NCT02052778|451862005|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
125612228|NCT02052778|451862006|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
125612229|NCT02052778|451861984|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612230|NCT02052778|451861985|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612231|NCT02052778|451861986|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612232|NCT02052778|451861987|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612233|NCT02052778|451861988|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612234|NCT02052778|451861989|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612235|NCT02052778|451861990|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612236|NCT02052778|451861991|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612237|NCT02052778|451861992|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612238|NCT02052778|451861993|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612239|NCT02052778|451861994|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612240|NCT02052778|451861995|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612241|NCT02052778|451861996|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612242|NCT02052778|451861997|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612243|NCT02052778|451861998|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612244|NCT02052778|451861999|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612245|NCT02052778|451862000|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612246|NCT02052778|451862001|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612247|NCT02052778|451862002|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612248|NCT02052778|451862003|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612249|NCT02052778|451862004|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612250|NCT02052778|451862005|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
125612251|NCT02052778|451862006|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
125372647|NCT04523220|450995063|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
125612252|NCT02052778|451861984|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612253|NCT02052778|451861985|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612254|NCT02052778|451861986|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612255|NCT02052778|451861987|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612256|NCT02052778|451861988|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612257|NCT02052778|451861989|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612258|NCT02052778|451861990|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612259|NCT02052778|451861991|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612260|NCT02052778|451861992|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612261|NCT02052778|451861993|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612262|NCT02052778|451861994|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612263|NCT02052778|451861995|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612264|NCT02052778|451861996|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612265|NCT02052778|451861997|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612266|NCT02052778|451861998|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612267|NCT02052778|451861999|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612268|NCT02052778|451862000|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612269|NCT02052778|451862001|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612270|NCT02052778|451862002|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612271|NCT02052778|451862003|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612272|NCT02052778|451862004|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612273|NCT02052778|451862005|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
125612274|NCT02052778|451862006|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
125612275|NCT02052778|451861984|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612276|NCT02052778|451861985|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612277|NCT02052778|451861986|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612278|NCT02052778|451861987|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612279|NCT02052778|451861988|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612280|NCT02052778|451861989|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612281|NCT02052778|451861990|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612282|NCT02052778|451861991|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612283|NCT02052778|451861992|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612284|NCT02052778|451861993|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612285|NCT02052778|451861994|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612286|NCT02052778|451861995|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612287|NCT02052778|451861996|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612288|NCT02052778|451861997|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612289|NCT02052778|451861998|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612290|NCT02052778|451861999|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612291|NCT02052778|451862000|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612292|NCT02052778|451862001|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612293|NCT02052778|451862002|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612294|NCT02052778|451862003|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612295|NCT02052778|451862004|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612296|NCT02052778|451862005|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
125612297|NCT02052778|451862006|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
125612298|NCT02052778|451861984|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612299|NCT02052778|451861985|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612300|NCT02052778|451861986|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612301|NCT02052778|451861987|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612302|NCT02052778|451861988|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612303|NCT02052778|451861989|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612304|NCT02052778|451861990|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612305|NCT02052778|451861991|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612306|NCT02052778|451861992|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612307|NCT02052778|451861993|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612308|NCT02052778|451861994|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612309|NCT02052778|451861995|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612310|NCT02052778|451861996|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612311|NCT02052778|451861997|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612312|NCT02052778|451861998|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125432060|NCT01576718|451207824|FG003|Treatment Period|Noncompliance to study medication|0|||
125612313|NCT02052778|451861999|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612314|NCT02052778|451862000|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612315|NCT02052778|451862001|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612316|NCT02052778|451862002|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612317|NCT02052778|451862003|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612318|NCT02052778|451862004|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612319|NCT02052778|451862005|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
125612320|NCT02052778|451862006|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
125612321|NCT02052778|451861984|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
125612322|NCT02052778|451861985|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
125612323|NCT02052778|451861986|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
125612324|NCT02052778|451861987|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
125612325|NCT02052778|451861988|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
125612326|NCT02052778|451861989|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
125612327|NCT02052778|451861990|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
125612328|NCT02052778|451861991|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
125612329|NCT02052778|451861992|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
125612330|NCT02052778|451861993|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
125612331|NCT02052778|451861994|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
125612332|NCT02052778|451861995|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
125612333|NCT02052778|451861996|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
125612334|NCT02052778|451861997|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
125612335|NCT02052778|451861998|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
125612336|NCT02052778|451861999|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
125612337|NCT02052778|451862000|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
125612338|NCT02052778|451862001|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
125612339|NCT02052778|451862002|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
125612340|NCT02052778|451862003|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
125612341|NCT02052778|451862004|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
125612342|NCT02052778|451862005|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
125612343|NCT02052778|451862006|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
125612344|NCT02052778|451861984|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612345|NCT02052778|451861985|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612346|NCT02052778|451861986|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612347|NCT02052778|451861987|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612348|NCT02052778|451861988|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612349|NCT02052778|451861989|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612350|NCT02052778|451861990|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612351|NCT02052778|451861991|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612352|NCT02052778|451861992|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612353|NCT02052778|451861993|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612354|NCT02052778|451861994|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612355|NCT02052778|451861995|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612356|NCT02052778|451861996|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612357|NCT02052778|451861997|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612358|NCT02052778|451861998|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612359|NCT02052778|451861999|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612360|NCT02052778|451862000|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612361|NCT02052778|451862001|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612362|NCT02052778|451862002|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612363|NCT02052778|451862003|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612364|NCT02052778|451862004|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612365|NCT02052778|451862005|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
125612366|NCT02052778|451862006|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
125612367|NCT01409031|451862007|FG000|Overall Study|transferred to other hosp|1|||
125612368|NCT01409031|451862008|FG001|Overall Study|transferred to other hosp|0|||
125612369|NCT04171037|451862010|FG000|Overall Study|Lost to Follow-up|1|||
125612370|NCT04171037|451862011|FG001|Overall Study|Lost to Follow-up|0|||
125612371|NCT04171037|451862010|FG000|Overall Study|Physician Decision|3|||
125612372|NCT04171037|451862011|FG001|Overall Study|Physician Decision|3|||
125612373|NCT00748540|451862012|FG000|Overall Study|Physician Decision|1|||
125612374|NCT01814800|451862013|FG000|Overall Study|Adverse Event|2|||
125612375|NCT01814800|451862013|FG000|Overall Study|Pregnancy|1|||
125612376|NCT01814800|451862013|FG000|Overall Study|Sponsor decision|1|||
125612377|NCT01814800|451862013|FG000|Overall Study|Subject relocation|1|||
125612378|NCT00243230|451862016|FG000|Double-Blind Period|Adverse Event|0|||
125612379|NCT00243230|451862017|FG001|Double-Blind Period|Adverse Event|2|||
125612380|NCT00243230|451862018|FG002|Double-Blind Period|Adverse Event|2|||
125612381|NCT00243230|451862019|FG003|Double-Blind Period|Adverse Event|0|||
125612382|NCT00243230|451862016|FG000|Double-Blind Period|Withdrawal by Subject|1|||
125612383|NCT00243230|451862017|FG001|Double-Blind Period|Withdrawal by Subject|0|||
125214338|NCT04399538|450411320|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
125214339|NCT04399538|450411321|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
125214340|NCT04399538|450411322|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
125214341|NCT04399538|450411323|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
125214342|NCT04399538|450411319|FG000|Double-Blind Treatment|Adverse Event|0|||
125214343|NCT04399538|450411320|FG001|Double-Blind Treatment|Adverse Event|0|||
125214344|NCT04399538|450411321|FG002|Double-Blind Treatment|Adverse Event|0|||
125214345|NCT04399538|450411322|FG003|Double-Blind Treatment|Adverse Event|0|||
125372648|NCT04523220|450995061|FG000|Extension Treatment Period|Study drug never administered|0|||
125372649|NCT04523220|450995062|FG001|Extension Treatment Period|Study drug never administered|1|||
125372650|NCT04523220|450995063|FG002|Extension Treatment Period|Study drug never administered|0|||
125372651|NCT00571948|450995064|FG000|Overall Study|Lost to Follow-up|2|||
125372652|NCT00571948|450995065|FG001|Overall Study|Lost to Follow-up|0|||
125372653|NCT00571948|450995064|FG000|Overall Study|Withdrawal by Subject|1|||
125372654|NCT00571948|450995065|FG001|Overall Study|Withdrawal by Subject|2|||
125372655|NCT00571948|450995064|FG000|Overall Study|Protocol Violation|3|||
125372656|NCT00571948|450995065|FG001|Overall Study|Protocol Violation|3|||
125372657|NCT00571948|450995064|FG000|Overall Study|infant refused study meal|3|||
125372658|NCT00571948|450995065|FG001|Overall Study|infant refused study meal|4|||
125372659|NCT00571948|450995064|FG000|Overall Study|Parent were afraid of blood colection|2|||
125612384|NCT00243230|451862018|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125612385|NCT00243230|451862019|FG003|Double-Blind Period|Withdrawal by Subject|0|||
125612386|NCT00243230|451862016|FG000|Double-Blind Period|Protocol Violation|0|||
125612387|NCT00243230|451862017|FG001|Double-Blind Period|Protocol Violation|0|||
125612388|NCT00243230|451862018|FG002|Double-Blind Period|Protocol Violation|1|||
125612389|NCT00243230|451862019|FG003|Double-Blind Period|Protocol Violation|0|||
125612390|NCT00243230|451862016|FG000|Double-Blind Period|Randomized but Not Treated|0|||
125612391|NCT00243230|451862017|FG001|Double-Blind Period|Randomized but Not Treated|0|||
125612392|NCT00243230|451862018|FG002|Double-Blind Period|Randomized but Not Treated|2|||
125612393|NCT00243230|451862019|FG003|Double-Blind Period|Randomized but Not Treated|0|||
125612394|NCT00243230|451862016|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
125612395|NCT00243230|451862017|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
125612396|NCT00243230|451862018|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
125612397|NCT00243230|451862019|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
125612398|NCT00243230|451862016|FG000|Open Label Period|Adverse Event|0|||
125612399|NCT00243230|451862017|FG001|Open Label Period|Adverse Event|0|||
125612400|NCT00243230|451862018|FG002|Open Label Period|Adverse Event|0|||
125612401|NCT00243230|451862019|FG003|Open Label Period|Adverse Event|2|||
125612402|NCT00243230|451862016|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
125612403|NCT00243230|451862017|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
125612404|NCT00243230|451862018|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
125612405|NCT00243230|451862019|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
125612406|NCT00243230|451862016|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
125612407|NCT00243230|451862017|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
125612408|NCT00243230|451862018|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
125612409|NCT00243230|451862019|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
125612410|NCT00243230|451862016|FG000|Open Label Period|Lost to Follow-up|0|||
125612411|NCT00243230|451862017|FG001|Open Label Period|Lost to Follow-up|0|||
125612412|NCT00243230|451862018|FG002|Open Label Period|Lost to Follow-up|0|||
125612413|NCT00243230|451862019|FG003|Open Label Period|Lost to Follow-up|2|||
125612414|NCT00243230|451862016|FG000|Open Label Period|Withdrawal by Subject|0|||
125612415|NCT00243230|451862017|FG001|Open Label Period|Withdrawal by Subject|0|||
125612416|NCT00243230|451862018|FG002|Open Label Period|Withdrawal by Subject|0|||
125612417|NCT00243230|451862019|FG003|Open Label Period|Withdrawal by Subject|2|||
125612418|NCT00243230|451862016|FG000|Open Label Period|Protocol Violation|0|||
125612419|NCT00243230|451862017|FG001|Open Label Period|Protocol Violation|0|||
125612420|NCT00243230|451862018|FG002|Open Label Period|Protocol Violation|0|||
125372660|NCT00571948|450995065|FG001|Overall Study|Parent were afraid of blood colection|5|||
125372661|NCT04112784|450995066|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
125372662|NCT04112784|450995066|FG000|Overall Study|Screen Failures|4|||
125214346|NCT04399538|450411323|FG004|Double-Blind Treatment|Adverse Event|1|||
125214347|NCT04399538|450411319|FG000|Follow-Up|Adverse Event|0|||
125214348|NCT04399538|450411320|FG001|Follow-Up|Adverse Event|0|||
125214349|NCT04399538|450411321|FG002|Follow-Up|Adverse Event|0|||
125214350|NCT04399538|450411322|FG003|Follow-Up|Adverse Event|0|||
125214351|NCT04399538|450411323|FG004|Follow-Up|Adverse Event|1|||
125214352|NCT04399538|450411319|FG000|Follow-Up|Withdrawal by Subject|0|||
125214353|NCT04399538|450411320|FG001|Follow-Up|Withdrawal by Subject|0|||
125214354|NCT04399538|450411321|FG002|Follow-Up|Withdrawal by Subject|0|||
125214355|NCT04399538|450411322|FG003|Follow-Up|Withdrawal by Subject|2|||
125214356|NCT04399538|450411323|FG004|Follow-Up|Withdrawal by Subject|0|||
125214357|NCT00636961|450411330|FG000|Period 1|Administrative problems|1|||
125214358|NCT00636961|450411331|FG001|Period 1|Administrative problems|1|||
125214359|NCT00636961|450411330|FG000|Period 2|Adverse Event|1|||
125214360|NCT00636961|450411331|FG001|Period 2|Adverse Event|0|||
125214361|NCT01994902|450411333|FG000|Test Period 1|Withdrawal by Subject|3|||
125214362|NCT01994902|450411334|FG001|Test Period 1|Withdrawal by Subject|0|||
125214363|NCT01994902|450411333|FG000|Test Period 1|device deficiency with adverse event|0|||
125214364|NCT01994902|450411334|FG001|Test Period 1|device deficiency with adverse event|1|||
125214365|NCT01994902|450411333|FG000|Test Period 1|Adverse Event|2|||
125214366|NCT01994902|450411334|FG001|Test Period 1|Adverse Event|1|||
125214367|NCT01994902|450411333|FG000|Test Period 1|Lack of Efficacy|0|||
125214368|NCT01994902|450411334|FG001|Test Period 1|Lack of Efficacy|1|||
125214369|NCT01994902|450411333|FG000|Test Period 1|bag too small|1|||
125214370|NCT01994902|450411334|FG001|Test Period 1|bag too small|0|||
125214371|NCT01994902|450411333|FG000|Test Period 2|Withdrawal by Subject|0|||
125214372|NCT01994902|450411334|FG001|Test Period 2|Withdrawal by Subject|2|||
125214373|NCT01994902|450411333|FG000|Test Period 2|Lack of Efficacy|0|||
125214374|NCT01994902|450411334|FG001|Test Period 2|Lack of Efficacy|1|||
125214375|NCT01994902|450411333|FG000|Test Period 2|Other|0|||
125214376|NCT01994902|450411334|FG001|Test Period 2|Other|3|||
125214377|NCT00467558|450411335|FG000|Overall Study|Lost to Follow-up|2|||
125214378|NCT00467558|450411336|FG001|Overall Study|Lost to Follow-up|0|||
125214379|NCT02636439|450411338|FG000|Overall Study|Adverse Event|2|||
125214380|NCT02636439|450411339|FG001|Overall Study|Adverse Event|2|||
125612421|NCT00243230|451862019|FG003|Open Label Period|Protocol Violation|2|||
125612422|NCT00243230|451862016|FG000|Open Label Period|Administrative Reason|0|||
125612423|NCT00243230|451862017|FG001|Open Label Period|Administrative Reason|0|||
125612424|NCT00243230|451862018|FG002|Open Label Period|Administrative Reason|0|||
125612425|NCT00243230|451862019|FG003|Open Label Period|Administrative Reason|63|||
125612426|NCT05118386|451862020|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
125612427|NCT05118386|451862021|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
125612428|NCT05118386|451862022|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
125612429|NCT05118386|451862023|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
125612430|NCT05118386|451862024|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
125612431|NCT05118386|451862025|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
125612432|NCT05118386|451862020|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
125612433|NCT05118386|451862021|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
125612434|NCT05118386|451862022|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
125612435|NCT05118386|451862023|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
125612436|NCT05118386|451862024|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
125214381|NCT02636439|450411338|FG000|Overall Study|Lost to Follow-up|1|||
125432061|NCT01576718|451207825|FG004|Treatment Period|Noncompliance to study medication|0|||
125214382|NCT02636439|450411339|FG001|Overall Study|Lost to Follow-up|0|||
125214383|NCT02636439|450411338|FG000|Overall Study|Non-compliance|1|||
125372663|NCT00221403|450995067|FG000|Overall Study|Protocol Violation|1|||
125372664|NCT00221403|450995068|FG001|Overall Study|Protocol Violation|0|||
125372665|NCT00221403|450995069|FG002|Overall Study|Protocol Violation|0|||
125372666|NCT00221403|450995067|FG000|Overall Study|Physician Decision|1|||
125372667|NCT00221403|450995068|FG001|Overall Study|Physician Decision|0|||
125612437|NCT05118386|451862025|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
125612438|NCT01423617|451862026|FG000|Overall Study|Lost to Follow-up|0|||
125612439|NCT01423617|451862027|FG001|Overall Study|Lost to Follow-up|1|||
125612440|NCT00303108|451862028|FG000|Overall Study|Adverse Event|5|||
125612441|NCT00303108|451862029|FG001|Overall Study|Adverse Event|6|||
125612442|NCT00303108|451862030|FG002|Overall Study|Adverse Event|7|||
125612443|NCT00303108|451862028|FG000|Overall Study|Patient Request|4|||
125612444|NCT00303108|451862029|FG001|Overall Study|Patient Request|2|||
125612445|NCT00303108|451862030|FG002|Overall Study|Patient Request|8|||
125612446|NCT00303108|451862028|FG000|Overall Study|Failed Entry|1|||
125612447|NCT00303108|451862029|FG001|Overall Study|Failed Entry|0|||
125612448|NCT00303108|451862030|FG002|Overall Study|Failed Entry|1|||
125612449|NCT00303108|451862028|FG000|Overall Study|ineligible|2|||
125612450|NCT00303108|451862029|FG001|Overall Study|ineligible|1|||
125612451|NCT00303108|451862030|FG002|Overall Study|ineligible|0|||
125612452|NCT03201198|451862033|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
125612453|NCT03201198|451862034|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
125612454|NCT03201198|451862033|FG000|Overall Study|Withdrawal by Subject|2|||
125612455|NCT03201198|451862034|FG001|Overall Study|Withdrawal by Subject|3|||
125612456|NCT03855137|451862035|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
125612457|NCT03855137|451862036|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
125612458|NCT03855137|451862037|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
125612459|NCT03855137|451862035|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
125612460|NCT03855137|451862036|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
125612461|NCT03855137|451862037|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
125612462|NCT03855137|451862035|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
125612463|NCT03855137|451862036|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
125612464|NCT03855137|451862037|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
125612465|NCT03855137|451862035|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
125612466|NCT03855137|451862036|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
125612467|NCT03855137|451862037|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
125612468|NCT03855137|451862035|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
125612469|NCT03855137|451862036|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
125612470|NCT03855137|451862037|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
125612471|NCT03855137|451862035|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
125612472|NCT03855137|451862036|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
125612473|NCT03855137|451862037|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
125612474|NCT03855137|451862035|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
125612475|NCT03855137|451862036|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
125612476|NCT03855137|451862037|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
125612477|NCT03855137|451862035|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
125612478|NCT03855137|451862036|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
125612479|NCT03855137|451862037|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
125612480|NCT03855137|451862035|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
125612481|NCT03855137|451862036|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
125612482|NCT03855137|451862037|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
125612483|NCT03855137|451862035|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
125612484|NCT03855137|451862036|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
125612485|NCT03855137|451862037|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
125612486|NCT02435277|451862043|FG000|Overall Study|Adverse Event|1|||
125612487|NCT02435277|451862044|FG001|Overall Study|Adverse Event|1|||
125612488|NCT02435277|451862045|FG002|Overall Study|Adverse Event|0|||
125612489|NCT02435277|451862046|FG003|Overall Study|Adverse Event|0|||
125612490|NCT02435277|451862043|FG000|Overall Study|Withdrawal by Subject|1|||
125612491|NCT02435277|451862044|FG001|Overall Study|Withdrawal by Subject|0|||
125612492|NCT02435277|451862045|FG002|Overall Study|Withdrawal by Subject|0|||
125612493|NCT02435277|451862046|FG003|Overall Study|Withdrawal by Subject|0|||
125612494|NCT00008138|451862047|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
125612495|NCT00008138|451862047|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
125612496|NCT00008138|451862047|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
125612497|NCT00008138|451862047|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
125612498|NCT00008138|451862047|FG000|Interval Debulking|Withdrawal by Subject|2|||
125372668|NCT00221403|450995069|FG002|Overall Study|Physician Decision|0|||
125372669|NCT00221403|450995067|FG000|Overall Study|Withdrawal by Subject|0|||
125612499|NCT00008138|451862047|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
125612500|NCT00008138|451862047|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
125612501|NCT00008138|451862047|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
125612502|NCT00755846|451863495|FG000|Overall Study|Adverse Event|0|||
125612503|NCT00755846|451863496|FG001|Overall Study|Adverse Event|0|||
125612504|NCT00755846|451863497|FG002|Overall Study|Adverse Event|0|||
125612505|NCT00755846|451863498|FG003|Overall Study|Adverse Event|1|||
125612506|NCT00755846|451863499|FG004|Overall Study|Adverse Event|3|||
125612507|NCT00755846|451863500|FG005|Overall Study|Adverse Event|2|||
125612508|NCT00755846|451863495|FG000|Overall Study|Protocol Violation|1|||
125612509|NCT00755846|451863496|FG001|Overall Study|Protocol Violation|1|||
125214384|NCT02636439|450411339|FG001|Overall Study|Non-compliance|1|||
125214385|NCT02636439|450411338|FG000|Overall Study|Personal reasons|2|||
125214386|NCT02636439|450411339|FG001|Overall Study|Personal reasons|0|||
125214387|NCT00762034|450412798|FG000|Induction Period|Protocol Violation|1|||
125612510|NCT00755846|451863497|FG002|Overall Study|Protocol Violation|1|||
125612511|NCT00755846|451863498|FG003|Overall Study|Protocol Violation|1|||
125612512|NCT00755846|451863499|FG004|Overall Study|Protocol Violation|1|||
125612513|NCT00755846|451863500|FG005|Overall Study|Protocol Violation|1|||
125612514|NCT00755846|451863495|FG000|Overall Study|Lost to Follow-up|0|||
125612515|NCT00755846|451863496|FG001|Overall Study|Lost to Follow-up|2|||
125612516|NCT00755846|451863497|FG002|Overall Study|Lost to Follow-up|1|||
125612517|NCT00755846|451863498|FG003|Overall Study|Lost to Follow-up|0|||
125612518|NCT00755846|451863499|FG004|Overall Study|Lost to Follow-up|4|||
125612519|NCT00755846|451863500|FG005|Overall Study|Lost to Follow-up|2|||
125612520|NCT00755846|451863495|FG000|Overall Study|Withdrawal by Subject|2|||
125612521|NCT00755846|451863496|FG001|Overall Study|Withdrawal by Subject|3|||
125612522|NCT00755846|451863497|FG002|Overall Study|Withdrawal by Subject|5|||
125612523|NCT00755846|451863498|FG003|Overall Study|Withdrawal by Subject|2|||
125612524|NCT00755846|451863499|FG004|Overall Study|Withdrawal by Subject|0|||
125612525|NCT00755846|451863500|FG005|Overall Study|Withdrawal by Subject|1|||
125612526|NCT00755846|451863495|FG000|Overall Study|Hyperglycemic Rescue|21|||
125612527|NCT00755846|451863496|FG001|Overall Study|Hyperglycemic Rescue|7|||
125612528|NCT00755846|451863497|FG002|Overall Study|Hyperglycemic Rescue|5|||
125612529|NCT00755846|451863498|FG003|Overall Study|Hyperglycemic Rescue|8|||
125214388|NCT00762034|450412799|FG001|Induction Period|Protocol Violation|2|||
125612530|NCT00755846|451863499|FG004|Overall Study|Hyperglycemic Rescue|8|||
125612531|NCT00755846|451863500|FG005|Overall Study|Hyperglycemic Rescue|7|||
125612532|NCT00755846|451863495|FG000|Overall Study|Physician Decision|1|||
125612533|NCT00755846|451863496|FG001|Overall Study|Physician Decision|3|||
125214389|NCT00762034|450412798|FG000|Induction Period|Entry Criterion Not Met|12|||
125612534|NCT00755846|451863497|FG002|Overall Study|Physician Decision|0|||
125612535|NCT00755846|451863498|FG003|Overall Study|Physician Decision|1|||
125612536|NCT00755846|451863499|FG004|Overall Study|Physician Decision|0|||
125612537|NCT00755846|451863500|FG005|Overall Study|Physician Decision|1|||
125612538|NCT00755846|451863495|FG000|Overall Study|Administrative Error|0|||
125372670|NCT00221403|450995068|FG001|Overall Study|Withdrawal by Subject|3|||
125372671|NCT00221403|450995069|FG002|Overall Study|Withdrawal by Subject|0|||
125372672|NCT00221403|450995067|FG000|Overall Study|Lack of Efficacy|0|||
125372673|NCT00221403|450995068|FG001|Overall Study|Lack of Efficacy|1|||
125372674|NCT00221403|450995069|FG002|Overall Study|Lack of Efficacy|0|||
125372675|NCT00221403|450995067|FG000|Overall Study|Adverse Event|0|||
125372676|NCT00221403|450995068|FG001|Overall Study|Adverse Event|1|||
125372677|NCT00221403|450995069|FG002|Overall Study|Adverse Event|0|||
125372678|NCT02010775|450995070|FG000|Overall Study|Adverse Event|0|||
125372679|NCT02010775|450995071|FG001|Overall Study|Adverse Event|0|||
125372680|NCT02010775|450995072|FG002|Overall Study|Adverse Event|0|||
125372681|NCT02010775|450995073|FG003|Overall Study|Adverse Event|0|||
125372682|NCT02010775|450995074|FG004|Overall Study|Adverse Event|1|||
125372683|NCT02010775|450995070|FG000|Overall Study|Pregnancy|0|||
125372684|NCT02010775|450995071|FG001|Overall Study|Pregnancy|0|||
125372685|NCT02010775|450995072|FG002|Overall Study|Pregnancy|2|||
125372686|NCT02010775|450995073|FG003|Overall Study|Pregnancy|0|||
125372687|NCT02010775|450995074|FG004|Overall Study|Pregnancy|0|||
125372688|NCT02010775|450995070|FG000|Overall Study|Lost to Follow-up|2|||
125372689|NCT02010775|450995071|FG001|Overall Study|Lost to Follow-up|0|||
125372690|NCT02010775|450995072|FG002|Overall Study|Lost to Follow-up|0|||
125372691|NCT02010775|450995073|FG003|Overall Study|Lost to Follow-up|1|||
125372692|NCT02010775|450995074|FG004|Overall Study|Lost to Follow-up|1|||
125372693|NCT02010775|450995070|FG000|Overall Study|Personal Reasons|3|||
125372694|NCT02010775|450995071|FG001|Overall Study|Personal Reasons|3|||
125372695|NCT02010775|450995072|FG002|Overall Study|Personal Reasons|1|||
125372696|NCT02010775|450995073|FG003|Overall Study|Personal Reasons|2|||
125372697|NCT02010775|450995074|FG004|Overall Study|Personal Reasons|4|||
125372698|NCT02030041|450995075|FG000|Overall Study|Withdrawal by Subject|2|||
125372699|NCT02030041|450995076|FG001|Overall Study|Withdrawal by Subject|2|||
125372700|NCT02030041|450995077|FG002|Overall Study|Withdrawal by Subject|1|||
125372701|NCT01929343|450995078|FG000|Overall Study|Physician Decision|0|||
125612539|NCT00755846|451863496|FG001|Overall Study|Administrative Error|1|||
125612540|NCT00755846|451863497|FG002|Overall Study|Administrative Error|0|||
125612541|NCT00755846|451863498|FG003|Overall Study|Administrative Error|0|||
125612542|NCT00755846|451863499|FG004|Overall Study|Administrative Error|0|||
125612543|NCT00755846|451863500|FG005|Overall Study|Administrative Error|0|||
125612544|NCT00755846|451863495|FG000|Overall Study|Participant Non-compliance|0|||
125612545|NCT00755846|451863496|FG001|Overall Study|Participant Non-compliance|0|||
125612546|NCT00755846|451863497|FG002|Overall Study|Participant Non-compliance|0|||
125612547|NCT00755846|451863498|FG003|Overall Study|Participant Non-compliance|0|||
125612548|NCT00755846|451863499|FG004|Overall Study|Participant Non-compliance|1|||
125612549|NCT00755846|451863500|FG005|Overall Study|Participant Non-compliance|0|||
125612550|NCT00786032|451863501|FG000|Overall Study|Death|4|||
125612551|NCT00786032|451863501|FG000|Overall Study|Withdrawal by Subject|14|||
125612552|NCT00786032|451863501|FG000|Overall Study|Did not complete in the timeframe|6|||
125612553|NCT02669862|451863502|FG000|Overall Study|Lost to Follow-up|0|||
125612554|NCT02669862|451863503|FG001|Overall Study|Lost to Follow-up|2|||
125612555|NCT02669862|451863504|FG002|Overall Study|Lost to Follow-up|1|||
125612556|NCT02669862|451863502|FG000|Overall Study|Withdrawal by Subject|2|||
125612557|NCT02669862|451863503|FG001|Overall Study|Withdrawal by Subject|2|||
125612558|NCT02669862|451863504|FG002|Overall Study|Withdrawal by Subject|3|||
125612559|NCT02669862|451863502|FG000|Overall Study|moved|0|||
125612560|NCT02669862|451863503|FG001|Overall Study|moved|1|||
125612561|NCT02669862|451863504|FG002|Overall Study|moved|0|||
125612562|NCT02669862|451863502|FG000|Overall Study|Protocol Violation|0|||
125612563|NCT02669862|451863503|FG001|Overall Study|Protocol Violation|0|||
125372702|NCT01929343|450995079|FG001|Overall Study|Physician Decision|2|||
125612564|NCT02669862|451863504|FG002|Overall Study|Protocol Violation|1|||
125612565|NCT00311181|451863505|FG000|Overall Study|Final DFTs were not obtained|96|||
125612566|NCT02429258|451863506|FG000|Overall Study|Withdrawal by Subject|2|||
125612567|NCT02429258|451863507|FG001|Overall Study|Withdrawal by Subject|0|||
125372703|NCT01929343|450995080|FG002|Overall Study|Physician Decision|0|||
125372704|NCT01929343|450995078|FG000|Overall Study|Withdrawal by Subject|1|||
125372705|NCT01929343|450995079|FG001|Overall Study|Withdrawal by Subject|0|||
125372706|NCT01929343|450995080|FG002|Overall Study|Withdrawal by Subject|0|||
125372707|NCT01737697|450995088|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125372708|NCT01737697|450995089|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
125612568|NCT02429258|451863506|FG000|Overall Study|Protocol Violation|0|||
125372709|NCT01737697|450995090|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125372710|NCT01737697|450995091|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
125372711|NCT01737697|450995092|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
125372712|NCT01737697|450995093|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125372713|NCT01737697|450995094|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125612569|NCT02429258|451863507|FG001|Overall Study|Protocol Violation|1|||
125612570|NCT02397694|451863508|FG000|Double-Blinded Phase|Adverse Event|1|||
125612571|NCT02397694|451863509|FG001|Double-Blinded Phase|Adverse Event|0|||
125612572|NCT02397694|451863508|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
125612573|NCT02397694|451863509|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
125612574|NCT02397694|451863508|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
125612575|NCT02397694|451863509|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
125612576|NCT02397694|451863508|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
125612577|NCT02397694|451863509|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
125612578|NCT02397694|451863508|FG000|Open Label Extension Phase|Protocol Violation|1|||
125612579|NCT02397694|451863509|FG001|Open Label Extension Phase|Protocol Violation|0|||
125612580|NCT02397694|451863508|FG000|Open Label Extension Phase|Withdrew Consent|3|||
125612581|NCT02397694|451863509|FG001|Open Label Extension Phase|Withdrew Consent|1|||
125612582|NCT02397694|451863508|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
125612583|NCT02397694|451863509|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
125612584|NCT02616185|451863511|FG000|Overall Study|Death|0|||
125612585|NCT02616185|451863512|FG001|Overall Study|Death|0|||
125612586|NCT02616185|451863513|FG002|Overall Study|Death|0|||
125612587|NCT02616185|451863514|FG003|Overall Study|Death|1|||
125612588|NCT02616185|451863515|FG004|Overall Study|Death|2|||
125612589|NCT02616185|451863516|FG005|Overall Study|Death|0|||
125612590|NCT02616185|451863517|FG006|Overall Study|Death|0|||
125612591|NCT02616185|451863518|FG007|Overall Study|Death|2|||
125612592|NCT02616185|451863519|FG008|Overall Study|Death|1|||
125612593|NCT02616185|451863511|FG000|Overall Study|Study terminated by sponsor|0|||
125612594|NCT02616185|451863512|FG001|Overall Study|Study terminated by sponsor|0|||
125612595|NCT02616185|451863513|FG002|Overall Study|Study terminated by sponsor|1|||
125612596|NCT02616185|451863514|FG003|Overall Study|Study terminated by sponsor|0|||
125612597|NCT02616185|451863515|FG004|Overall Study|Study terminated by sponsor|0|||
125612598|NCT02616185|451863516|FG005|Overall Study|Study terminated by sponsor|0|||
125612599|NCT02616185|451863517|FG006|Overall Study|Study terminated by sponsor|5|||
125612600|NCT02616185|451863518|FG007|Overall Study|Study terminated by sponsor|2|||
125612601|NCT02616185|451863519|FG008|Overall Study|Study terminated by sponsor|0|||
125612602|NCT02616185|451863511|FG000|Overall Study|Participant refused further follow-up|1|||
125612603|NCT02616185|451863512|FG001|Overall Study|Participant refused further follow-up|1|||
125612604|NCT02616185|451863513|FG002|Overall Study|Participant refused further follow-up|2|||
125612605|NCT02616185|451863514|FG003|Overall Study|Participant refused further follow-up|3|||
125612606|NCT02616185|451863515|FG004|Overall Study|Participant refused further follow-up|4|||
125612607|NCT02616185|451863516|FG005|Overall Study|Participant refused further follow-up|0|||
125612608|NCT02616185|451863517|FG006|Overall Study|Participant refused further follow-up|3|||
125612609|NCT02616185|451863518|FG007|Overall Study|Participant refused further follow-up|4|||
125612610|NCT02616185|451863519|FG008|Overall Study|Participant refused further follow-up|3|||
125612611|NCT02616185|451863511|FG000|Overall Study|Not reported|0|||
125612612|NCT02616185|451863512|FG001|Overall Study|Not reported|0|||
125612613|NCT02616185|451863513|FG002|Overall Study|Not reported|0|||
125612614|NCT02616185|451863514|FG003|Overall Study|Not reported|1|||
125612615|NCT02616185|451863515|FG004|Overall Study|Not reported|3|||
125612616|NCT02616185|451863516|FG005|Overall Study|Not reported|1|||
125612617|NCT02616185|451863517|FG006|Overall Study|Not reported|0|||
125612618|NCT02616185|451863518|FG007|Overall Study|Not reported|5|||
125612619|NCT02616185|451863519|FG008|Overall Study|Not reported|2|||
125612620|NCT01346371|451863520|FG000|Overall Study|Lost to Follow-up|2|||
125612621|NCT01346371|451863521|FG001|Overall Study|Lost to Follow-up|0|||
125612622|NCT00568958|451863529|FG000|Allocation|Withdrawal by Subject|7|||
125612623|NCT00568958|451863530|FG001|Allocation|Withdrawal by Subject|3|||
125612624|NCT00568958|451863529|FG000|Allocation|Physician Decision|2|||
125612625|NCT00568958|451863530|FG001|Allocation|Physician Decision|0|||
125612626|NCT00568958|451863529|FG000|Follow-Up|Withdrawal by Subject|6|||
125612627|NCT00568958|451863530|FG001|Follow-Up|Withdrawal by Subject|6|||
125612628|NCT00568958|451863529|FG000|Follow-Up|Physician Decision|1|||
125612629|NCT00568958|451863530|FG001|Follow-Up|Physician Decision|1|||
125612630|NCT00568958|451863529|FG000|Follow-Up|Family Emergency|1|||
125612631|NCT00568958|451863530|FG001|Follow-Up|Family Emergency|0|||
125612632|NCT00568958|451863529|FG000|Follow-Up|Adverse Event|1|||
125612633|NCT00568958|451863530|FG001|Follow-Up|Adverse Event|0|||
125612634|NCT01354353|451863534|FG000|Overall Study|Adverse Event|1|||
125612635|NCT01354353|451863535|FG001|Overall Study|Adverse Event|0|||
125612636|NCT01354353|451863536|FG002|Overall Study|Adverse Event|0|||
125612637|NCT01354353|451863537|FG003|Overall Study|Adverse Event|4|||
125612638|NCT01354353|451863538|FG004|Overall Study|Adverse Event|0|||
125612639|NCT01354353|451863539|FG005|Overall Study|Adverse Event|5|||
125612640|NCT01354353|451863534|FG000|Overall Study|Entry Criteria Not Met|0|||
125612641|NCT01354353|451863535|FG001|Overall Study|Entry Criteria Not Met|0|||
125612642|NCT01354353|451863536|FG002|Overall Study|Entry Criteria Not Met|0|||
125612643|NCT01354353|451863537|FG003|Overall Study|Entry Criteria Not Met|1|||
125612644|NCT01354353|451863538|FG004|Overall Study|Entry Criteria Not Met|1|||
125612645|NCT01354353|451863539|FG005|Overall Study|Entry Criteria Not Met|0|||
125612646|NCT01354353|451863534|FG000|Overall Study|Physician Decision|0|||
125612647|NCT01354353|451863535|FG001|Overall Study|Physician Decision|1|||
125612648|NCT01354353|451863536|FG002|Overall Study|Physician Decision|1|||
125612649|NCT01354353|451863537|FG003|Overall Study|Physician Decision|0|||
125612650|NCT01354353|451863538|FG004|Overall Study|Physician Decision|0|||
125612651|NCT01354353|451863539|FG005|Overall Study|Physician Decision|0|||
125612652|NCT01354353|451863534|FG000|Overall Study|Withdrawal by Subject|2|||
125612653|NCT01354353|451863535|FG001|Overall Study|Withdrawal by Subject|0|||
125612654|NCT01354353|451863536|FG002|Overall Study|Withdrawal by Subject|1|||
125612655|NCT01354353|451863537|FG003|Overall Study|Withdrawal by Subject|0|||
125612656|NCT01354353|451863538|FG004|Overall Study|Withdrawal by Subject|0|||
125612657|NCT01354353|451863539|FG005|Overall Study|Withdrawal by Subject|1|||
125612658|NCT01640925|451863544|FG000|Overall Study|Withdrawal by Subject|1|||
125612659|NCT01640925|451863545|FG001|Overall Study|Withdrawal by Subject|0|||
125612660|NCT01640925|451863544|FG000|Overall Study|Previously enrolled in this trial|13|||
125612661|NCT01640925|451863545|FG001|Overall Study|Previously enrolled in this trial|11|||
125612662|NCT01592409|451863562|FG000|Overall Study|Withdrawal by Subject|0|||
125612663|NCT01592409|451863563|FG001|Overall Study|Withdrawal by Subject|1|||
125612664|NCT02345252|451863573|FG000|Double-Blind Phase|Adverse Event|2|||
125612665|NCT02345252|451863574|FG001|Double-Blind Phase|Adverse Event|3|||
125612666|NCT02345252|451863573|FG000|Double-Blind Phase|Death|1|||
125612667|NCT02345252|451863574|FG001|Double-Blind Phase|Death|2|||
125612668|NCT02345252|451863573|FG000|Double-Blind Phase|Lack of Efficacy|1|||
125612669|NCT02345252|451863574|FG001|Double-Blind Phase|Lack of Efficacy|0|||
125612670|NCT02345252|451863573|FG000|Double-Blind Phase|Investigator's Discretion|4|||
125612671|NCT02345252|451863574|FG001|Double-Blind Phase|Investigator's Discretion|6|||
125612672|NCT02345252|451863573|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
125612673|NCT02345252|451863574|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
125612674|NCT02345252|451863573|FG000|Double-Blind Phase|Protocol Violation|2|||
125612675|NCT02345252|451863574|FG001|Double-Blind Phase|Protocol Violation|1|||
125612676|NCT02345252|451863573|FG000|Double-Blind Phase|Withdrew Consent|21|||
125612677|NCT02345252|451863574|FG001|Double-Blind Phase|Withdrew Consent|23|||
125612678|NCT02345252|451863573|FG000|Double-Blind Phase|Lost to Follow-up|8|||
125612679|NCT02345252|451863574|FG001|Double-Blind Phase|Lost to Follow-up|10|||
125612680|NCT02345252|451863573|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
125612681|NCT02345252|451863574|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
125612682|NCT01094730|451863575|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
125612683|NCT01094730|451863576|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
125612684|NCT01094730|451863575|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
125612685|NCT01094730|451863576|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
125612686|NCT01094730|451863575|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
125612687|NCT01094730|451863576|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
125612688|NCT01094730|451863575|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
125612689|NCT01094730|451863576|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
125612690|NCT01094730|451863575|FG000|Period 2 (14 Days)|Protocol Violation|2|||
125612691|NCT01094730|451863576|FG001|Period 2 (14 Days)|Protocol Violation|0|||
125612692|NCT01094730|451863575|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
125612693|NCT01094730|451863576|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
125612694|NCT01094730|451863575|FG000|Period 2 (14 Days)|Adverse Event|0|||
125612695|NCT01094730|451863576|FG001|Period 2 (14 Days)|Adverse Event|1|||
125612696|NCT01094730|451863575|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
125612697|NCT01094730|451863576|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
125612698|NCT00779324|451863577|FG000|Overall Study|Lost to Follow-up|2|||
125612699|NCT00779324|451863578|FG001|Overall Study|Lost to Follow-up|1|||
125612700|NCT00779324|451863577|FG000|Overall Study|Withdrawal by Subject|4|||
125612701|NCT00779324|451863578|FG001|Overall Study|Withdrawal by Subject|2|||
125372714|NCT01737697|450995095|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125612702|NCT00779324|451863577|FG000|Overall Study|Missed visit|1|||
125612703|NCT00779324|451863578|FG001|Overall Study|Missed visit|1|||
125612704|NCT00617409|451863579|FG000|Overall Study|Withdrawal by Subject|4|||
125372715|NCT01737697|450995096|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125612705|NCT00617409|451863580|FG001|Overall Study|Withdrawal by Subject|1|||
125612706|NCT00617409|451863581|FG002|Overall Study|Withdrawal by Subject|2|||
125612707|NCT00617409|451863579|FG000|Overall Study|Adverse Event|0|||
125612708|NCT00617409|451863580|FG001|Overall Study|Adverse Event|2|||
125612709|NCT00617409|451863581|FG002|Overall Study|Adverse Event|3|||
125612710|NCT00617409|451863579|FG000|Overall Study|Disease Progression|8|||
125612711|NCT00617409|451863580|FG001|Overall Study|Disease Progression|8|||
125612712|NCT00617409|451863581|FG002|Overall Study|Disease Progression|18|||
125612713|NCT00617409|451863579|FG000|Overall Study|Death|3|||
125612714|NCT00617409|451863580|FG001|Overall Study|Death|5|||
125612715|NCT00617409|451863581|FG002|Overall Study|Death|4|||
125612716|NCT00617409|451863579|FG000|Overall Study|Alternative Therapy|1|||
125612717|NCT00617409|451863580|FG001|Overall Study|Alternative Therapy|2|||
125612718|NCT00617409|451863581|FG002|Overall Study|Alternative Therapy|0|||
125612719|NCT00987623|451863586|FG000|Overall Study|Lost to Follow-up|2|||
125612720|NCT00987623|451863587|FG001|Overall Study|Lost to Follow-up|1|||
125612721|NCT00987623|451863586|FG000|Overall Study|Time/job conflict|2|||
125612722|NCT00987623|451863587|FG001|Overall Study|Time/job conflict|0|||
125612723|NCT00987623|451863586|FG000|Overall Study|Discomfort|1|||
125612724|NCT00987623|451863587|FG001|Overall Study|Discomfort|0|||
125612725|NCT00987623|451863586|FG000|Overall Study|Biomicroscopy|0|||
125612726|NCT00987623|451863587|FG001|Overall Study|Biomicroscopy|1|||
125612727|NCT00987623|451863586|FG000|Overall Study|Influenza|0|||
125612728|NCT00987623|451863587|FG001|Overall Study|Influenza|1|||
125612729|NCT01100307|451863589|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
125612730|NCT01100307|451863590|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
125612731|NCT01100307|451863589|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
125612732|NCT01100307|451863590|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
125612733|NCT01100307|451863589|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
125612734|NCT01100307|451863590|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
125612735|NCT01100307|451863589|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
125612736|NCT01100307|451863590|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
125612737|NCT01100307|451863589|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
125612738|NCT01100307|451863590|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
125612739|NCT01100307|451863589|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
125612740|NCT01100307|451863590|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
125372716|NCT01737697|450995097|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125612741|NCT02509598|451863591|FG000|Overall Study|Withdrawal by Subject|1|||
125612742|NCT04056455|451863592|FG000|Overall Study|Adverse Event|1|||
125612743|NCT04056455|451863593|FG001|Overall Study|Adverse Event|0|||
125612744|NCT02196038|451863594|FG000|Overall Study|Death|16|||
125612745|NCT02196038|451863595|FG001|Overall Study|Death|21|||
125612746|NCT02196038|451863594|FG000|Overall Study|Withdrawal by Subject|0|||
125612747|NCT02196038|451863595|FG001|Overall Study|Withdrawal by Subject|1|||
125612748|NCT02196038|451863594|FG000|Overall Study|Lost to Follow-up|1|||
125612749|NCT02196038|451863595|FG001|Overall Study|Lost to Follow-up|0|||
125612750|NCT03135028|451863602|FG000|Overall Study|Death|6|||
125612751|NCT03135028|451863602|FG000|Overall Study|Study Terminated by Sponsor|2|||
125612752|NCT03135028|451863602|FG000|Overall Study|Withdrew Consent|1|||
125612753|NCT02065869|451863604|FG000|Overall Study|Death|7|||
125612754|NCT02065869|451863604|FG000|Overall Study|Disease relapse|16|||
125612755|NCT02065869|451863604|FG000|Overall Study|Lost to Follow-up|4|||
125612756|NCT02065869|451863604|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
125612757|NCT02065869|451863604|FG000|Overall Study|Withdrawal by Subject|1|||
125612758|NCT04436822|451863605|FG000|Overall Study|Physician Decision|2|||
125612759|NCT04436822|451863606|FG001|Overall Study|Physician Decision|0|||
125612760|NCT04436822|451863605|FG000|Overall Study|Sponsor request|1|||
125612761|NCT04436822|451863606|FG001|Overall Study|Sponsor request|0|||
125612762|NCT04436822|451863605|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125612763|NCT04436822|451863606|FG001|Overall Study|Withdrawal by parent/guardian|3|||
125612764|NCT04436822|451863605|FG000|Overall Study|Unsuccessful procedure|0|||
125612765|NCT04436822|451863606|FG001|Overall Study|Unsuccessful procedure|1|||
125612766|NCT04436822|451863605|FG000|Overall Study|Withdrawal due to Covid-19|8|||
125612767|NCT04436822|451863606|FG001|Overall Study|Withdrawal due to Covid-19|1|||
125612768|NCT04436822|451863605|FG000|Overall Study|Withdrawal by Subject|1|||
125612769|NCT04436822|451863606|FG001|Overall Study|Withdrawal by Subject|0|||
125612770|NCT04436822|451863605|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
125612771|NCT04436822|451863606|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
125612772|NCT03375112|451863607|FG000|Overall Study|Withdrawal by Subject|3|||
125612773|NCT03375112|451863608|FG001|Overall Study|Withdrawal by Subject|0|||
125612774|NCT00369668|451863609|FG000|Overall Study|Lack of Efficacy|4|||
125612775|NCT00369668|451863610|FG001|Overall Study|Lack of Efficacy|5|||
125612776|NCT00369668|451863611|FG002|Overall Study|Lack of Efficacy|7|||
125612777|NCT00894413|451863614|FG000|Overall Study|Physician Decision|0|||
125612778|NCT00894413|451863615|FG001|Overall Study|Physician Decision|2|||
125612779|NCT00894413|451863614|FG000|Overall Study|Adverse Event|0|||
125612780|NCT00894413|451863615|FG001|Overall Study|Adverse Event|2|||
125612781|NCT00894413|451863614|FG000|Overall Study|Withdrawal by Subject|0|||
125612782|NCT00894413|451863615|FG001|Overall Study|Withdrawal by Subject|4|||
125612783|NCT03213626|451863618|FG000|Overall Study|Adverse Event|1|||
125612784|NCT03213626|451863618|FG000|Overall Study|Progressive Disease|6|||
125612785|NCT01079962|451863631|FG000|Overall Study|Adverse Event|2|||
125612786|NCT01079962|451863632|FG001|Overall Study|Adverse Event|2|||
125612787|NCT01079962|451863631|FG000|Overall Study|Withdrawal by Subject|5|||
125612788|NCT01079962|451863632|FG001|Overall Study|Withdrawal by Subject|7|||
125612789|NCT01079962|451863631|FG000|Overall Study|Protocol Violation|2|||
125612790|NCT01079962|451863632|FG001|Overall Study|Protocol Violation|2|||
125612791|NCT01079962|451863631|FG000|Overall Study|No blood pressure (BP) control|3|||
125612792|NCT01079962|451863632|FG001|Overall Study|No blood pressure (BP) control|0|||
125612793|NCT01079962|451863631|FG000|Overall Study|Inclusion/exclusion criteria|1|||
125612794|NCT01079962|451863632|FG001|Overall Study|Inclusion/exclusion criteria|3|||
125372717|NCT01737697|450995098|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125612795|NCT01079962|451863631|FG000|Overall Study|Participant not returning for next visit|1|||
125612796|NCT01079962|451863632|FG001|Overall Study|Participant not returning for next visit|0|||
125612797|NCT01079962|451863631|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
125612798|NCT01079962|451863632|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
125372718|NCT01737697|450995099|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125612799|NCT01331239|451863633|FG000|Part II: Core Study|Adverse Event|0|||
125612800|NCT01331239|451863634|FG001|Part II: Core Study|Adverse Event|3|||
125612801|NCT01331239|451863635|FG002|Part II: Core Study|Adverse Event|0|||
125612802|NCT01331239|451863633|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
125612803|NCT01331239|451863634|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
125612804|NCT01331239|451863635|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
125612805|NCT01331239|451863633|FG000|Part II: Core Study|Withdrawal by Subject|0|||
125612806|NCT01331239|451863634|FG001|Part II: Core Study|Withdrawal by Subject|2|||
125612807|NCT01331239|451863635|FG002|Part II: Core Study|Withdrawal by Subject|0|||
125612808|NCT01331239|451863633|FG000|Part II: Core Study|Administrative problems|0|||
125612809|NCT01331239|451863634|FG001|Part II: Core Study|Administrative problems|1|||
125612810|NCT01331239|451863635|FG002|Part II: Core Study|Administrative problems|0|||
125612811|NCT00946530|451863638|FG000|Overall Study|Withdrawal by Subject|0|||
125612812|NCT00946530|451863639|FG001|Overall Study|Withdrawal by Subject|3|||
125612813|NCT00946530|451863640|FG002|Overall Study|Withdrawal by Subject|0|||
125612814|NCT00946530|451863641|FG003|Overall Study|Withdrawal by Subject|3|||
125612815|NCT00946530|451863638|FG000|Overall Study|Physician Decision|1|||
125612816|NCT00946530|451863639|FG001|Overall Study|Physician Decision|1|||
125612817|NCT00946530|451863640|FG002|Overall Study|Physician Decision|1|||
125612818|NCT00946530|451863641|FG003|Overall Study|Physician Decision|1|||
125612819|NCT01008995|451863642|FG000|Controlled Period|Adverse Event|1|||
125612820|NCT01008995|451863643|FG001|Controlled Period|Adverse Event|2|||
125612821|NCT01008995|451863644|FG002|Controlled Period|Adverse Event|0|||
125612822|NCT01008995|451863645|FG003|Controlled Period|Adverse Event|0|||
125612823|NCT01008995|451863642|FG000|Controlled Period|Other|2|||
125612824|NCT01008995|451863643|FG001|Controlled Period|Other|1|||
125612825|NCT01008995|451863644|FG002|Controlled Period|Other|0|||
125612826|NCT01008995|451863645|FG003|Controlled Period|Other|0|||
125612827|NCT01008995|451863642|FG000|After Controlled Period|Adverse Event|0|||
125612828|NCT01008995|451863643|FG001|After Controlled Period|Adverse Event|0|||
125612829|NCT01008995|451863644|FG002|After Controlled Period|Adverse Event|1|||
125612830|NCT01008995|451863645|FG003|After Controlled Period|Adverse Event|1|||
125612831|NCT01008995|451863642|FG000|After Controlled Period|Other|0|||
125612832|NCT01008995|451863643|FG001|After Controlled Period|Other|0|||
125612833|NCT01008995|451863644|FG002|After Controlled Period|Other|1|||
125612834|NCT01008995|451863645|FG003|After Controlled Period|Other|0|||
125612835|NCT00406640|451863646|FG000|Acute Phase|Adverse Event|18|||
125612836|NCT00406640|451863647|FG001|Acute Phase|Adverse Event|13|||
125612837|NCT00406640|451863646|FG000|Acute Phase|Failed to Return|5|||
125612838|NCT00406640|451863647|FG001|Acute Phase|Failed to Return|1|||
125612839|NCT00406640|451863646|FG000|Acute Phase|Physician Decision|0|||
125612840|NCT00406640|451863647|FG001|Acute Phase|Physician Decision|1|||
125612841|NCT00406640|451863646|FG000|Acute Phase|Lost to Follow-up|7|||
125612842|NCT00406640|451863647|FG001|Acute Phase|Lost to Follow-up|4|||
125612843|NCT00406640|451863646|FG000|Acute Phase|Protocol deviation|4|||
125612844|NCT00406640|451863647|FG001|Acute Phase|Protocol deviation|10|||
125612845|NCT00406640|451863646|FG000|Acute Phase|Protocol Violation|3|||
125612846|NCT00406640|451863647|FG001|Acute Phase|Protocol Violation|2|||
125612847|NCT00406640|451863646|FG000|Acute Phase|Withdrawal by Subject|11|||
125612848|NCT00406640|451863647|FG001|Acute Phase|Withdrawal by Subject|9|||
125612849|NCT00406640|451863646|FG000|Acute Phase|Lack of Efficacy|3|||
125612850|NCT00406640|451863647|FG001|Acute Phase|Lack of Efficacy|3|||
125612851|NCT00406640|451863646|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
125612852|NCT00406640|451863647|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
125612853|NCT00406640|451863646|FG000|DB Continuation Phase for Responders|Death|1|||
125612854|NCT00406640|451863647|FG001|DB Continuation Phase for Responders|Death|0|||
125612855|NCT00406640|451863646|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
125612856|NCT00406640|451863647|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
125612857|NCT00406640|451863646|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
125612858|NCT00406640|451863647|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
125612859|NCT00406640|451863646|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
125612860|NCT00406640|451863647|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
125612861|NCT00406640|451863646|FG000|DB Continuation Phase for Responders|non-compliance|7|||
125612862|NCT00406640|451863647|FG001|DB Continuation Phase for Responders|non-compliance|5|||
125612863|NCT00406640|451863646|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
125612864|NCT00406640|451863647|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
125612865|NCT00406640|451863646|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
125612866|NCT00406640|451863647|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
125612867|NCT00406640|451863646|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
125612868|NCT00406640|451863647|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
125612869|NCT00406640|451863646|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
125612870|NCT00406640|451863647|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
125612871|NCT00406640|451863646|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
125612872|NCT00406640|451863647|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
125612873|NCT00406640|451863646|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
125612874|NCT00406640|451863647|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
125612875|NCT00406640|451863646|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
125612876|NCT00406640|451863647|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
125612877|NCT00406640|451863646|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
125612878|NCT00406640|451863647|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
125612879|NCT00406640|451863646|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
125612880|NCT00406640|451863647|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
125612881|NCT00406640|451863646|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
125612882|NCT00406640|451863647|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
125372719|NCT01737697|450995100|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125612883|NCT01303380|451865109|FG000|Overall Study|Lack of compliance to study procedures|1|||
125612884|NCT01670656|451865110|FG000|Overall Study|Non-compliance with study drug|0|||
125372720|NCT01737697|450995101|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125372721|NCT01737697|450995102|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
125372722|NCT01737697|450995088|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
125372723|NCT01737697|450995089|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
125372724|NCT01737697|450995090|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
125372725|NCT01737697|450995091|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125612885|NCT01670656|451865111|FG001|Overall Study|Non-compliance with study drug|0|||
125612886|NCT01670656|451865112|FG002|Overall Study|Non-compliance with study drug|3|||
125612887|NCT01670656|451865113|FG003|Overall Study|Non-compliance with study drug|0|||
125612888|NCT01670656|451865114|FG004|Overall Study|Non-compliance with study drug|1|||
125612889|NCT01670656|451865110|FG000|Overall Study|Pregnancy|0|||
125612890|NCT01670656|451865111|FG001|Overall Study|Pregnancy|0|||
125612891|NCT01670656|451865112|FG002|Overall Study|Pregnancy|0|||
125612892|NCT01670656|451865113|FG003|Overall Study|Pregnancy|0|||
125612893|NCT01670656|451865114|FG004|Overall Study|Pregnancy|1|||
125612894|NCT01670656|451865110|FG000|Overall Study|Withdrawal by Subject|1|||
125612895|NCT01670656|451865111|FG001|Overall Study|Withdrawal by Subject|1|||
125612896|NCT01670656|451865112|FG002|Overall Study|Withdrawal by Subject|0|||
125612897|NCT01670656|451865113|FG003|Overall Study|Withdrawal by Subject|0|||
125612898|NCT01670656|451865114|FG004|Overall Study|Withdrawal by Subject|0|||
125612899|NCT01670656|451865110|FG000|Overall Study|Non-compliance with protocol|0|||
125612900|NCT01670656|451865111|FG001|Overall Study|Non-compliance with protocol|3|||
125612901|NCT01670656|451865112|FG002|Overall Study|Non-compliance with protocol|1|||
125612902|NCT01670656|451865113|FG003|Overall Study|Non-compliance with protocol|1|||
125612903|NCT01670656|451865114|FG004|Overall Study|Non-compliance with protocol|2|||
125612904|NCT01670656|451865110|FG000|Overall Study|Adverse Event|2|||
125612905|NCT01670656|451865111|FG001|Overall Study|Adverse Event|2|||
125612906|NCT01670656|451865112|FG002|Overall Study|Adverse Event|2|||
125612907|NCT01670656|451865113|FG003|Overall Study|Adverse Event|3|||
125612908|NCT01670656|451865114|FG004|Overall Study|Adverse Event|3|||
125612909|NCT01670656|451865110|FG000|Overall Study|Subject withdrew consent|0|||
125612910|NCT01670656|451865111|FG001|Overall Study|Subject withdrew consent|1|||
125612911|NCT01670656|451865112|FG002|Overall Study|Subject withdrew consent|2|||
125612912|NCT01670656|451865113|FG003|Overall Study|Subject withdrew consent|1|||
125612913|NCT01670656|451865114|FG004|Overall Study|Subject withdrew consent|1|||
125612914|NCT01670656|451865110|FG000|Overall Study|Lost to Follow-up|0|||
125612915|NCT01670656|451865111|FG001|Overall Study|Lost to Follow-up|0|||
125612916|NCT01670656|451865112|FG002|Overall Study|Lost to Follow-up|0|||
125612917|NCT01670656|451865113|FG003|Overall Study|Lost to Follow-up|0|||
125612918|NCT01670656|451865114|FG004|Overall Study|Lost to Follow-up|3|||
125612919|NCT01670656|451865110|FG000|Overall Study|Subject moved|0|||
125612920|NCT01670656|451865111|FG001|Overall Study|Subject moved|0|||
125612921|NCT01670656|451865112|FG002|Overall Study|Subject moved|0|||
125612922|NCT01670656|451865113|FG003|Overall Study|Subject moved|1|||
125612923|NCT01670656|451865114|FG004|Overall Study|Subject moved|0|||
125612924|NCT00789958|451865115|FG000|Overall Study|Adverse Event|3|||
125612925|NCT00789958|451865115|FG000|Overall Study|Withdrawal by Subject|4|||
125612926|NCT00789958|451865115|FG000|Overall Study|Progression|3|||
125612927|NCT00789958|451865115|FG000|Overall Study|not protocol specified|1|||
125612928|NCT00789958|451865115|FG000|Overall Study|Not eligible/not analyzable|26|||
125612929|NCT01000727|451865117|FG000|Overall Study|Lost to Follow-up|41|||
125612930|NCT01000727|451865118|FG001|Overall Study|Lost to Follow-up|43|||
125612931|NCT01000727|451865117|FG000|Overall Study|Withdrawal by Subject|111|||
125612932|NCT01000727|451865118|FG001|Overall Study|Withdrawal by Subject|109|||
125612933|NCT01000727|451865117|FG000|Overall Study|Study closed/terminated|23|||
125612934|NCT01000727|451865118|FG001|Overall Study|Study closed/terminated|24|||
125612935|NCT03544268|451865119|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
125612936|NCT03544268|451865120|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
125612937|NCT00377611|451865121|FG000|Overall Study|Adverse Event|2|||
125612938|NCT00377611|451865122|FG001|Overall Study|Adverse Event|9|||
125612939|NCT00377611|451865121|FG000|Overall Study|Protocol Violation|2|||
125612940|NCT00377611|451865122|FG001|Overall Study|Protocol Violation|0|||
125612941|NCT00377611|451865121|FG000|Overall Study|Withdrawal by Subject|0|||
125612942|NCT00377611|451865122|FG001|Overall Study|Withdrawal by Subject|5|||
125612943|NCT00377611|451865121|FG000|Overall Study|Lost to Follow-up|18|||
125612944|NCT00377611|451865122|FG001|Overall Study|Lost to Follow-up|16|||
125612945|NCT00377611|451865121|FG000|Overall Study|Other|0|||
125612946|NCT00377611|451865122|FG001|Overall Study|Other|3|||
125612947|NCT04831515|451865123|FG000|First Intervention|Adverse Event|0|||
125612948|NCT04831515|451865124|FG001|First Intervention|Adverse Event|1|||
125612949|NCT01030458|451865136|FG000|Overall Study|Lost to Follow-up|9|||
125612950|NCT01030458|451865137|FG001|Overall Study|Lost to Follow-up|10|||
125214390|NCT00762034|450412799|FG001|Induction Period|Entry Criterion Not Met|11|||
125214391|NCT00762034|450412798|FG000|Induction Period|Adverse Event|27|||
125214392|NCT00762034|450412799|FG001|Induction Period|Adverse Event|38|||
125214393|NCT00762034|450412798|FG000|Induction Period|Lost to Follow-up|1|||
125372726|NCT01737697|450995092|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125372727|NCT01737697|450995093|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125372728|NCT01737697|450995094|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125612951|NCT01030458|451865136|FG000|Overall Study|Withdrawal by Subject|2|||
125214394|NCT00762034|450412799|FG001|Induction Period|Lost to Follow-up|1|||
125214395|NCT00762034|450412798|FG000|Induction Period|Progressive Disease|73|||
125214396|NCT00762034|450412799|FG001|Induction Period|Progressive Disease|55|||
125214397|NCT00762034|450412798|FG000|Induction Period|Physician Decision|21|||
125214398|NCT00762034|450412799|FG001|Induction Period|Physician Decision|20|||
125214399|NCT00762034|450412798|FG000|Induction Period|Withdrawal by Subject|15|||
125214400|NCT00762034|450412799|FG001|Induction Period|Withdrawal by Subject|19|||
125214401|NCT00762034|450412798|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
125214402|NCT00762034|450412799|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
125214403|NCT00762034|450412798|FG000|Induction Period|Deaths Due to Study Disease|9|||
125214404|NCT00762034|450412799|FG001|Induction Period|Deaths Due to Study Disease|9|||
125214405|NCT00762034|450412798|FG000|Maintenance Period|Protocol Violation|1|||
125214406|NCT00762034|450412799|FG001|Maintenance Period|Protocol Violation|3|||
125214407|NCT00762034|450412798|FG000|Maintenance Period|Entry Criterion Not Met|0|||
125214408|NCT00762034|450412799|FG001|Maintenance Period|Entry Criterion Not Met|2|||
125214409|NCT00762034|450412798|FG000|Maintenance Period|Adverse Event|42|||
125214410|NCT00762034|450412799|FG001|Maintenance Period|Adverse Event|26|||
125214411|NCT00762034|450412798|FG000|Maintenance Period|Progressive Disease|186|||
125214412|NCT00762034|450412799|FG001|Maintenance Period|Progressive Disease|224|||
125214413|NCT00762034|450412798|FG000|Maintenance Period|Physician Decision|25|||
125214414|NCT00762034|450412799|FG001|Maintenance Period|Physician Decision|20|||
125214415|NCT00762034|450412798|FG000|Maintenance Period|Withdrawal by Subject|34|||
125214416|NCT00762034|450412799|FG001|Maintenance Period|Withdrawal by Subject|14|||
125214417|NCT00762034|450412798|FG000|Maintenance Period|Death not due to study disease|2|||
125372729|NCT01737697|450995095|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125372730|NCT01737697|450995096|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125372731|NCT01737697|450995097|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125372732|NCT01737697|450995098|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125372733|NCT01737697|450995099|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125612952|NCT01030458|451865137|FG001|Overall Study|Withdrawal by Subject|3|||
125612953|NCT01030458|451865136|FG000|Overall Study|Logistical reasons|9|||
125612954|NCT01030458|451865137|FG001|Overall Study|Logistical reasons|5|||
125612955|NCT01030458|451865136|FG000|Overall Study|Moved or changed job|6|||
125612956|NCT01030458|451865137|FG001|Overall Study|Moved or changed job|13|||
125612957|NCT01030458|451865136|FG000|Overall Study|Side effect of medication|1|||
125612958|NCT01030458|451865137|FG001|Overall Study|Side effect of medication|1|||
125612959|NCT01332019|451865138|FG000|Overall Study|Was Not Dosed|1|||
125612960|NCT01332019|451865139|FG001|Overall Study|Was Not Dosed|0|||
125612961|NCT01332019|451865138|FG000|Overall Study|Other|16|||
125612962|NCT01332019|451865139|FG001|Overall Study|Other|18|||
125612963|NCT01332019|451865138|FG000|Overall Study|Death|2|||
125612964|NCT01332019|451865139|FG001|Overall Study|Death|1|||
125612965|NCT01332019|451865138|FG000|Overall Study|Physician Decision|4|||
125612966|NCT01332019|451865139|FG001|Overall Study|Physician Decision|3|||
125612967|NCT01332019|451865138|FG000|Overall Study|Withdrawal by Subject|73|||
125612968|NCT01332019|451865139|FG001|Overall Study|Withdrawal by Subject|71|||
125372734|NCT01737697|450995100|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125372735|NCT01737697|450995101|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125372736|NCT01737697|450995102|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
125612969|NCT01332019|451865138|FG000|Overall Study|Lost to Follow-up|4|||
125612970|NCT01332019|451865139|FG001|Overall Study|Lost to Follow-up|7|||
125612971|NCT01332019|451865138|FG000|Overall Study|Adverse Event|13|||
125612972|NCT01332019|451865139|FG001|Overall Study|Adverse Event|22|||
125612973|NCT00871377|451865142|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
125612974|NCT00871377|451865143|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
125612975|NCT00871377|451865144|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
125612976|NCT00871377|451865145|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
125612977|NCT00871377|451865146|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
125612978|NCT00871377|451865147|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
125214418|NCT00762034|450412799|FG001|Maintenance Period|Death not due to study disease|5|||
125214419|NCT00762034|450412798|FG000|Maintenance Period|Death due to study disease|3|||
125214420|NCT00762034|450412799|FG001|Maintenance Period|Death due to study disease|3|||
125214421|NCT00762034|450412798|FG000|Maintenance Period|Other|1|||
125214422|NCT00762034|450412799|FG001|Maintenance Period|Other|1|||
125612979|NCT00871377|451865142|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
125612980|NCT00871377|451865143|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
125612981|NCT00871377|451865144|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
125612982|NCT00871377|451865145|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
125612983|NCT00871377|451865146|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
125612984|NCT00871377|451865147|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
125612985|NCT00871377|451865142|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
125612986|NCT00871377|451865143|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
125612987|NCT00871377|451865144|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
125214423|NCT01299896|450412802|FG000|Overall Study|Withdrawal by Subject|1|||
125214424|NCT01299896|450412803|FG001|Overall Study|Withdrawal by Subject|7|||
125214425|NCT01299896|450412802|FG000|Overall Study|Lost to Follow-up|0|||
125214426|NCT01299896|450412803|FG001|Overall Study|Lost to Follow-up|11|||
125214427|NCT02107313|450412804|FG000|Overall Study|One participant did not do the FED cohor|0|||
125214428|NCT02107313|450412805|FG001|Overall Study|One participant did not do the FED cohor|1|||
125214429|NCT02090283|450412810|FG000|Overall Study|Withdrawal by Subject|6|||
125214430|NCT02090283|450412811|FG001|Overall Study|Withdrawal by Subject|6|||
125214431|NCT02090283|450412812|FG002|Overall Study|Withdrawal by Subject|6|||
125214432|NCT02090283|450412810|FG000|Overall Study|Sponsor Terminated Study|6|||
125214433|NCT02090283|450412811|FG001|Overall Study|Sponsor Terminated Study|6|||
125214434|NCT02090283|450412812|FG002|Overall Study|Sponsor Terminated Study|1|||
125214435|NCT02090283|450412810|FG000|Overall Study|Lost to Follow-up|2|||
125214436|NCT02090283|450412811|FG001|Overall Study|Lost to Follow-up|2|||
125214437|NCT02090283|450412812|FG002|Overall Study|Lost to Follow-up|3|||
125214438|NCT02090283|450412810|FG000|Overall Study|Adverse Event|1|||
125214439|NCT02090283|450412811|FG001|Overall Study|Adverse Event|1|||
125214440|NCT02090283|450412812|FG002|Overall Study|Adverse Event|0|||
125214441|NCT02090283|450412810|FG000|Overall Study|Protocol Violation|2|||
125214442|NCT02090283|450412811|FG001|Overall Study|Protocol Violation|0|||
125214443|NCT02090283|450412812|FG002|Overall Study|Protocol Violation|0|||
125214444|NCT05205005|450412832|FG000|Overall Study|Withdrawal by Subject|1|||
125214445|NCT05205005|450412833|FG001|Overall Study|Withdrawal by Subject|0|||
125214446|NCT05205005|450412832|FG000|Overall Study|Adverse Event|1|||
125214447|NCT05205005|450412833|FG001|Overall Study|Adverse Event|0|||
125214448|NCT01148459|450412836|FG000|Overall Study|Serious Adverse Event|5|||
125214449|NCT01148459|450412837|FG001|Overall Study|Serious Adverse Event|4|||
125214450|NCT01148459|450412836|FG000|Overall Study|Withdrawal by Subject|1|||
125214451|NCT01148459|450412837|FG001|Overall Study|Withdrawal by Subject|0|||
125214452|NCT01148459|450412836|FG000|Overall Study|Migrated/moved from study area|3|||
125214453|NCT01148459|450412837|FG001|Overall Study|Migrated/moved from study area|6|||
125214454|NCT01148459|450412836|FG000|Overall Study|Lost to Follow-up|2|||
125372737|NCT01737697|450995088|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
125372738|NCT01737697|450995089|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
125372739|NCT01737697|450995090|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
125372740|NCT01737697|450995091|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
125372741|NCT01737697|450995092|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
125372742|NCT01737697|450995093|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
125372743|NCT01737697|450995094|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
125372744|NCT01737697|450995095|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
125372745|NCT01737697|450995096|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
125372746|NCT01737697|450995097|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
125372747|NCT01737697|450995098|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
125372748|NCT01737697|450995099|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
125372749|NCT01737697|450995100|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
125214455|NCT01148459|450412837|FG001|Overall Study|Lost to Follow-up|0|||
125214456|NCT01148459|450412836|FG000|Overall Study|Refusal|1|||
125214457|NCT01148459|450412837|FG001|Overall Study|Refusal|0|||
125214458|NCT01148459|450412836|FG000|Overall Study|Failure to comply with study procedures|0|||
125214459|NCT01148459|450412837|FG001|Overall Study|Failure to comply with study procedures|1|||
125214460|NCT02187029|450412838|FG000|Overall Study|Adverse Event|0|||
125612988|NCT00871377|451865145|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
125612989|NCT00871377|451865146|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
125612990|NCT00871377|451865147|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
125612991|NCT00871377|451865142|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
125612992|NCT00871377|451865143|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
125612993|NCT00871377|451865144|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
125612994|NCT00871377|451865145|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
125612995|NCT00871377|451865146|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
125612996|NCT00871377|451865147|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
125612997|NCT00871377|451865142|FG000|Third Intervention (10 Weeks)|Death|0|||
125612998|NCT00871377|451865143|FG001|Third Intervention (10 Weeks)|Death|0|||
125612999|NCT00871377|451865144|FG002|Third Intervention (10 Weeks)|Death|0|||
125613000|NCT00871377|451865145|FG003|Third Intervention (10 Weeks)|Death|1|||
125613001|NCT00871377|451865146|FG004|Third Intervention (10 Weeks)|Death|0|||
125613002|NCT00871377|451865147|FG005|Third Intervention (10 Weeks)|Death|0|||
125613003|NCT01395368|451865149|FG000|Overall Study|Physician Decision|14|||
125613004|NCT01395368|451865149|FG000|Overall Study|Withdrawal by Subject|2|||
125613005|NCT00288860|451865152|FG000|Overall Study|Did not complete intake|4|||
125613006|NCT00288860|451865153|FG001|Overall Study|Did not complete intake|8|||
125613007|NCT00288860|451865152|FG000|Overall Study|Death|4|||
125613008|NCT00288860|451865153|FG001|Overall Study|Death|3|||
125613009|NCT00288860|451865152|FG000|Overall Study|Withdrawal by Subject|20|||
125613010|NCT00288860|451865153|FG001|Overall Study|Withdrawal by Subject|15|||
125613011|NCT00288860|451865152|FG000|Overall Study|Lost to Follow-up|74|||
125613012|NCT00288860|451865153|FG001|Overall Study|Lost to Follow-up|71|||
125613013|NCT03072719|451865158|FG000|Overall Study|Adverse Event|1|||
125613014|NCT03072719|451865159|FG001|Overall Study|Adverse Event|1|||
125613015|NCT00882999|451865161|FG000|Overall Study|Adverse Event|0|||
125613016|NCT00882999|451865162|FG001|Overall Study|Adverse Event|0|||
125613017|NCT00882999|451865163|FG002|Overall Study|Adverse Event|0|||
125613018|NCT00882999|451865164|FG003|Overall Study|Adverse Event|0|||
125613019|NCT00882999|451865165|FG004|Overall Study|Adverse Event|1|||
125613020|NCT00882999|451865166|FG005|Overall Study|Adverse Event|0|||
125613021|NCT00882999|451865167|FG006|Overall Study|Adverse Event|0|||
125613022|NCT00882999|451865161|FG000|Overall Study|Death|0|||
125613023|NCT00882999|451865162|FG001|Overall Study|Death|1|||
125613024|NCT00882999|451865163|FG002|Overall Study|Death|0|||
125372750|NCT01737697|450995101|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
125372751|NCT01737697|450995102|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
125372752|NCT01737697|450995088|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125613025|NCT00882999|451865164|FG003|Overall Study|Death|0|||
125613026|NCT00882999|451865165|FG004|Overall Study|Death|0|||
125613027|NCT00882999|451865166|FG005|Overall Study|Death|0|||
125613028|NCT00882999|451865167|FG006|Overall Study|Death|0|||
125613029|NCT00882999|451865161|FG000|Overall Study|Withdrawal by Subject|7|||
125613030|NCT00882999|451865162|FG001|Overall Study|Withdrawal by Subject|6|||
125613031|NCT00882999|451865163|FG002|Overall Study|Withdrawal by Subject|3|||
125214461|NCT02187029|450412839|FG001|Overall Study|Adverse Event|1|||
125613032|NCT00882999|451865164|FG003|Overall Study|Withdrawal by Subject|3|||
125214462|NCT02187029|450412840|FG002|Overall Study|Adverse Event|1|||
125613033|NCT00882999|451865165|FG004|Overall Study|Withdrawal by Subject|6|||
125613034|NCT00882999|451865166|FG005|Overall Study|Withdrawal by Subject|5|||
125613035|NCT00882999|451865167|FG006|Overall Study|Withdrawal by Subject|5|||
125613036|NCT00882999|451865161|FG000|Overall Study|Lost to Follow-up|0|||
125613037|NCT00882999|451865162|FG001|Overall Study|Lost to Follow-up|1|||
125613038|NCT00882999|451865163|FG002|Overall Study|Lost to Follow-up|1|||
125613039|NCT00882999|451865164|FG003|Overall Study|Lost to Follow-up|2|||
125613040|NCT00882999|451865165|FG004|Overall Study|Lost to Follow-up|1|||
125613041|NCT00882999|451865166|FG005|Overall Study|Lost to Follow-up|1|||
125613042|NCT00882999|451865167|FG006|Overall Study|Lost to Follow-up|2|||
125613043|NCT00882999|451865161|FG000|Overall Study|Physician Decision|1|||
125613044|NCT00882999|451865162|FG001|Overall Study|Physician Decision|0|||
125613045|NCT00882999|451865163|FG002|Overall Study|Physician Decision|0|||
125613046|NCT00882999|451865164|FG003|Overall Study|Physician Decision|0|||
125613047|NCT00882999|451865165|FG004|Overall Study|Physician Decision|0|||
125613048|NCT00882999|451865166|FG005|Overall Study|Physician Decision|1|||
125613049|NCT00882999|451865167|FG006|Overall Study|Physician Decision|1|||
125613050|NCT01104584|451865168|FG000|Overall Study|Study drug never administered|21|||
125613051|NCT01104584|451865168|FG000|Overall Study|Study prematurely discontinued|2|||
125613052|NCT04017442|451865169|FG000|Overall Study|Withdrawal by Subject|0|||
125613053|NCT04017442|451865170|FG001|Overall Study|Withdrawal by Subject|3|||
125613054|NCT04017442|451865169|FG000|Overall Study|Lost to Follow-up|21|||
125613055|NCT04017442|451865170|FG001|Overall Study|Lost to Follow-up|19|||
125613056|NCT02586233|451865173|FG000|Overall Study|Randomized but did not receive treatment|0|||
125613057|NCT02586233|451865174|FG001|Overall Study|Randomized but did not receive treatment|1|||
125613058|NCT02586233|451865175|FG002|Overall Study|Randomized but did not receive treatment|0|||
125613059|NCT02586233|451865176|FG003|Overall Study|Randomized but did not receive treatment|0|||
125613060|NCT02586233|451865177|FG004|Overall Study|Randomized but did not receive treatment|0|||
125613061|NCT02586233|451865178|FG005|Overall Study|Randomized but did not receive treatment|2|||
125613062|NCT02586233|451865179|FG006|Overall Study|Randomized but did not receive treatment|2|||
125613063|NCT02586233|451865173|FG000|Overall Study|Death|0|||
125613064|NCT02586233|451865174|FG001|Overall Study|Death|1|||
125613065|NCT02586233|451865175|FG002|Overall Study|Death|0|||
125613066|NCT02586233|451865176|FG003|Overall Study|Death|0|||
125613067|NCT02586233|451865177|FG004|Overall Study|Death|2|||
125613068|NCT02586233|451865178|FG005|Overall Study|Death|0|||
125613069|NCT02586233|451865179|FG006|Overall Study|Death|0|||
125613070|NCT01757405|451865180|FG000|Overall Study|Lost to Follow-up|1|||
125613071|NCT01757405|451865181|FG001|Overall Study|Lost to Follow-up|1|||
125613072|NCT01757405|451865180|FG000|Overall Study|Withdrawal by Subject|0|||
125613073|NCT01757405|451865181|FG001|Overall Study|Withdrawal by Subject|1|||
125613074|NCT00082758|451865182|FG000|Overall Study|Adverse Event|0|||
125613075|NCT00082758|451865183|FG001|Overall Study|Adverse Event|2|||
125613076|NCT00082758|451865184|FG002|Overall Study|Adverse Event|0|||
125613077|NCT00082758|451865182|FG000|Overall Study|Lack of Efficacy|12|||
125613078|NCT00082758|451865183|FG001|Overall Study|Lack of Efficacy|13|||
125613079|NCT00082758|451865184|FG002|Overall Study|Lack of Efficacy|0|||
125613080|NCT00082758|451865182|FG000|Overall Study|Physician Decision|0|||
125613081|NCT00082758|451865183|FG001|Overall Study|Physician Decision|1|||
125613082|NCT00082758|451865184|FG002|Overall Study|Physician Decision|0|||
125613083|NCT00082758|451865182|FG000|Overall Study|Withdrawal by Subject|3|||
125613084|NCT00082758|451865183|FG001|Overall Study|Withdrawal by Subject|0|||
125613085|NCT00082758|451865184|FG002|Overall Study|Withdrawal by Subject|0|||
125613086|NCT00082758|451865182|FG000|Overall Study|Protocol Violation|0|||
125613087|NCT00082758|451865183|FG001|Overall Study|Protocol Violation|1|||
125613088|NCT00082758|451865184|FG002|Overall Study|Protocol Violation|0|||
125613089|NCT00238303|451865185|FG000|Overall Study|Withdrawal by Subject|11|||
125613090|NCT00238303|451865186|FG001|Overall Study|Withdrawal by Subject|1|||
125613091|NCT00238303|451865187|FG002|Overall Study|Withdrawal by Subject|2|||
125613092|NCT00238303|451865185|FG000|Overall Study|Death|1|||
125613093|NCT00238303|451865186|FG001|Overall Study|Death|0|||
125613094|NCT00238303|451865187|FG002|Overall Study|Death|1|||
125613095|NCT00238303|451865185|FG000|Overall Study|Other Medical Problems|2|||
125613096|NCT00238303|451865186|FG001|Overall Study|Other Medical Problems|0|||
125613097|NCT00238303|451865187|FG002|Overall Study|Other Medical Problems|2|||
125613098|NCT00238303|451865185|FG000|Overall Study|Poor tolerance of study treatment|1|||
125613099|NCT00238303|451865186|FG001|Overall Study|Poor tolerance of study treatment|0|||
125613100|NCT00238303|451865187|FG002|Overall Study|Poor tolerance of study treatment|1|||
125613101|NCT00238303|451865185|FG000|Overall Study|Adverse Event|0|||
125613102|NCT00238303|451865186|FG001|Overall Study|Adverse Event|1|||
125613103|NCT00238303|451865187|FG002|Overall Study|Adverse Event|3|||
125613104|NCT02561299|451865191|FG000|Overall Study|Death|2|||
125613105|NCT02561299|451865192|FG001|Overall Study|Death|4|||
125613106|NCT02561299|451865191|FG000|Overall Study|Lost to Follow-up|1|||
125613107|NCT02561299|451865192|FG001|Overall Study|Lost to Follow-up|0|||
125613108|NCT02561299|451865191|FG000|Overall Study|Withdrawal by Subject|2|||
125613109|NCT02561299|451865192|FG001|Overall Study|Withdrawal by Subject|2|||
125613110|NCT01358877|451865193|FG000|Overall Study|Death|80|||
125613111|NCT01358877|451865194|FG001|Overall Study|Death|89|||
125613112|NCT01358877|451865193|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
125613113|NCT01358877|451865194|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
125613114|NCT01358877|451865193|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
125613115|NCT01358877|451865194|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
125613116|NCT01358877|451865193|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
125613117|NCT01358877|451865194|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
125613118|NCT01358877|451865193|FG000|Overall Study|Other|142|||
125613119|NCT01358877|451865194|FG001|Overall Study|Other|129|||
125613120|NCT01911845|451865199|FG000|Overall Study|Adverse Event|2|||
125613121|NCT01911845|451865199|FG000|Overall Study|Lost to Follow-up|1|||
125613122|NCT01911845|451865199|FG000|Overall Study|Other (not specified)|3|||
125613123|NCT01994226|451865200|FG000|Overall Study|Protocol Violation|13|||
125613124|NCT01994226|451865201|FG001|Overall Study|Protocol Violation|10|||
125613125|NCT01994226|451865200|FG000|Overall Study|Early Cessation of treatment|6|||
125613126|NCT01994226|451865201|FG001|Overall Study|Early Cessation of treatment|11|||
125613127|NCT00501046|451865206|FG000|Overall Study|Adverse Event|21|||
125613128|NCT00501046|451865207|FG001|Overall Study|Adverse Event|25|||
125613129|NCT00501046|451865206|FG000|Overall Study|Death|23|||
125613130|NCT00501046|451865207|FG001|Overall Study|Death|30|||
125613131|NCT00501046|451865206|FG000|Overall Study|Lost to Follow-up|14|||
125613132|NCT00501046|451865207|FG001|Overall Study|Lost to Follow-up|13|||
125613133|NCT00501046|451865206|FG000|Overall Study|Physician Decision|7|||
125613134|NCT00501046|451865207|FG001|Overall Study|Physician Decision|2|||
125613135|NCT00501046|451865206|FG000|Overall Study|Pregnancy|0|||
125613136|NCT00501046|451865207|FG001|Overall Study|Pregnancy|3|||
125613137|NCT00501046|451865206|FG000|Overall Study|Protocol Violation|2|||
125613138|NCT00501046|451865207|FG001|Overall Study|Protocol Violation|1|||
125613139|NCT00501046|451865206|FG000|Overall Study|Withdrawal by Subject|84|||
125613140|NCT00501046|451865207|FG001|Overall Study|Withdrawal by Subject|83|||
125613141|NCT00501046|451865206|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
125613142|NCT00501046|451865207|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
125613143|NCT00436566|451865208|FG000|Overall Study|Withdrawal by Subject|2|||
125613144|NCT00436566|451865208|FG000|Overall Study|Protocol Violation|1|||
125613145|NCT01980706|451865209|FG000|Overall Study|Withdrawal by Subject|9|||
125613146|NCT01980706|451865210|FG001|Overall Study|Withdrawal by Subject|6|||
125613147|NCT01980706|451865211|FG002|Overall Study|Withdrawal by Subject|2|||
125613148|NCT01980706|451865209|FG000|Overall Study|Adverse Event|1|||
125613149|NCT01980706|451865210|FG001|Overall Study|Adverse Event|2|||
125613150|NCT01980706|451865211|FG002|Overall Study|Adverse Event|5|||
125613151|NCT01980706|451865209|FG000|Overall Study|Lost to Follow-up|3|||
125613152|NCT01980706|451865210|FG001|Overall Study|Lost to Follow-up|4|||
125613153|NCT01980706|451865211|FG002|Overall Study|Lost to Follow-up|3|||
125613154|NCT01980706|451865209|FG000|Overall Study|miscellaneous|4|||
125613155|NCT01980706|451865210|FG001|Overall Study|miscellaneous|5|||
125613156|NCT01980706|451865211|FG002|Overall Study|miscellaneous|3|||
125613157|NCT01934894|451865216|FG000|Overall Study|Adverse Event|1|||
125613158|NCT01934894|451865217|FG001|Overall Study|Adverse Event|2|||
125613159|NCT01934894|451865216|FG000|Overall Study|Death|2|||
125613160|NCT01934894|451865217|FG001|Overall Study|Death|0|||
125613161|NCT01934894|451865216|FG000|Overall Study|Withdrawal by Subject|0|||
125613162|NCT01934894|451865217|FG001|Overall Study|Withdrawal by Subject|1|||
125613163|NCT01934894|451865216|FG000|Overall Study|Progressive Disease|3|||
125613164|NCT01934894|451865217|FG001|Overall Study|Progressive Disease|2|||
125613165|NCT01842308|451865218|FG000|Overall Study|Withdrawal by Subject|0|||
125613166|NCT01842308|451865219|FG001|Overall Study|Withdrawal by Subject|0|||
125613167|NCT01842308|451865220|FG002|Overall Study|Withdrawal by Subject|0|||
125613168|NCT01842308|451865221|FG003|Overall Study|Withdrawal by Subject|0|||
125613169|NCT01842308|451865222|FG004|Overall Study|Withdrawal by Subject|1|||
125613170|NCT01106625|451865223|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
125613171|NCT01106625|451865224|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
125613172|NCT01106625|451865225|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
125613173|NCT01106625|451865223|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
125613174|NCT01106625|451865224|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
125613175|NCT01106625|451865225|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
125613176|NCT01106625|451865223|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
125613177|NCT01106625|451865224|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
125613178|NCT01106625|451865225|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
125613179|NCT01106625|451865223|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
125613180|NCT01106625|451865224|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
125613181|NCT01106625|451865225|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
125613182|NCT01106625|451865223|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
125613183|NCT01106625|451865224|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
125613184|NCT01106625|451865225|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
125613185|NCT01106625|451865223|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
125613186|NCT01106625|451865224|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
125613187|NCT01106625|451865225|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125613188|NCT01106625|451865223|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
125613189|NCT01106625|451865224|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
125613190|NCT01106625|451865225|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
125613191|NCT01106625|451865223|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
125613192|NCT01106625|451865224|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
125613193|NCT01106625|451865225|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125613194|NCT01106625|451865223|FG000|Core Period: Baseline to Week 26|Other|8|||
125613195|NCT01106625|451865224|FG001|Core Period: Baseline to Week 26|Other|7|||
125613196|NCT01106625|451865225|FG002|Core Period: Baseline to Week 26|Other|4|||
125613197|NCT01106625|451865223|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
125613198|NCT01106625|451865224|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
125613199|NCT01106625|451865225|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
125613200|NCT01106625|451865223|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
125613201|NCT01106625|451865224|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
125613202|NCT01106625|451865225|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
125613203|NCT01106625|451865223|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
125613204|NCT01106625|451865224|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125613205|NCT01106625|451865225|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
125613206|NCT01106625|451865223|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125613207|NCT01106625|451865224|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
125613208|NCT01106625|451865225|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125613209|NCT01106625|451865223|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
125613210|NCT01106625|451865224|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125613211|NCT01106625|451865225|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125613212|NCT01106625|451865223|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
125613213|NCT01106625|451865224|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
125613214|NCT01106625|451865225|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
125613215|NCT01106625|451865223|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
125613216|NCT01106625|451865224|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
125637234|NCT03073200|451952840|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
125637235|NCT03073200|451952841|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
125637236|NCT03073200|451952842|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
125613217|NCT01106625|451865225|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
125613218|NCT01106625|451865223|FG000|Extension Period: Week 26 to Week 52|Other|5|||
125613219|NCT01106625|451865224|FG001|Extension Period: Week 26 to Week 52|Other|5|||
125613220|NCT01106625|451865225|FG002|Extension Period: Week 26 to Week 52|Other|4|||
125613221|NCT00511342|451865234|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
125613222|NCT00511342|451865235|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
125613223|NCT00511342|451865234|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
125613224|NCT00511342|451865235|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
125613225|NCT00511342|451865234|FG000|Overall Study|Pregnancy|0|||
125613226|NCT00511342|451865235|FG001|Overall Study|Pregnancy|1|||
125613227|NCT00511342|451865234|FG000|Overall Study|Pregnancy wish|0|||
125613228|NCT00511342|451865235|FG001|Overall Study|Pregnancy wish|1|||
125613229|NCT00511342|451865234|FG000|Overall Study|Lost to Follow-up|1|||
125613230|NCT00511342|451865235|FG001|Overall Study|Lost to Follow-up|5|||
125613231|NCT00511342|451865234|FG000|Overall Study|Other Reason|2|||
125613232|NCT00511342|451865235|FG001|Overall Study|Other Reason|2|||
125613233|NCT01496430|451865236|FG000|Overall Study|Adverse Event|0|||
125613234|NCT01496430|451865237|FG001|Overall Study|Adverse Event|0|||
125613235|NCT01496430|451865238|FG002|Overall Study|Adverse Event|1|||
125613236|NCT01496430|451865236|FG000|Overall Study|Major Protocol Deviation|0|||
125613237|NCT01496430|451865237|FG001|Overall Study|Major Protocol Deviation|0|||
125613238|NCT01496430|451865238|FG002|Overall Study|Major Protocol Deviation|1|||
125613239|NCT01496430|451865236|FG000|Overall Study|Lost to Follow-up|2|||
125613240|NCT01496430|451865237|FG001|Overall Study|Lost to Follow-up|3|||
125613241|NCT01496430|451865238|FG002|Overall Study|Lost to Follow-up|1|||
125613242|NCT01496430|451865236|FG000|Overall Study|Voluntary Withdrawal|2|||
125613243|NCT01496430|451865237|FG001|Overall Study|Voluntary Withdrawal|1|||
125613244|NCT01496430|451865238|FG002|Overall Study|Voluntary Withdrawal|6|||
125613245|NCT01496430|451865236|FG000|Overall Study|Principal Investigator Discretion|0|||
125613246|NCT01496430|451865237|FG001|Overall Study|Principal Investigator Discretion|1|||
125613247|NCT01496430|451865238|FG002|Overall Study|Principal Investigator Discretion|1|||
125613248|NCT01496430|451865236|FG000|Overall Study|Other|2|||
125613249|NCT01496430|451865237|FG001|Overall Study|Other|0|||
125613250|NCT01496430|451865238|FG002|Overall Study|Other|0|||
125613251|NCT00997321|451865239|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
125613252|NCT00997321|451865240|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
125613253|NCT02402218|451865249|FG000|Overall Study|Did not pickup study medication|12|||
125613254|NCT02402218|451865250|FG001|Overall Study|Did not pickup study medication|9|||
125613255|NCT02402218|451865251|FG002|Overall Study|Did not pickup study medication|13|||
125613256|NCT02402218|451865249|FG000|Overall Study|Lack of Efficacy|0|||
125613257|NCT02402218|451865250|FG001|Overall Study|Lack of Efficacy|1|||
125613258|NCT02402218|451865251|FG002|Overall Study|Lack of Efficacy|1|||
125613259|NCT02402218|451865249|FG000|Overall Study|Death|1|||
125613260|NCT02402218|451865250|FG001|Overall Study|Death|0|||
125613261|NCT02402218|451865251|FG002|Overall Study|Death|0|||
125613262|NCT02402218|451865249|FG000|Overall Study|Reinfection|0|||
125613263|NCT02402218|451865250|FG001|Overall Study|Reinfection|0|||
125613264|NCT02402218|451865251|FG002|Overall Study|Reinfection|1|||
125613265|NCT02402218|451865249|FG000|Overall Study|Adverse Event|0|||
125613266|NCT02402218|451865250|FG001|Overall Study|Adverse Event|2|||
125613267|NCT02402218|451865251|FG002|Overall Study|Adverse Event|1|||
125613268|NCT02402218|451865249|FG000|Overall Study|Withdrawal by Subject|1|||
125613269|NCT02402218|451865250|FG001|Overall Study|Withdrawal by Subject|1|||
125613270|NCT02402218|451865251|FG002|Overall Study|Withdrawal by Subject|1|||
125613271|NCT03352414|451865259|FG000|Overall Study|Ineligible by operative criteria|12|||
125613272|NCT03352414|451865260|FG001|Overall Study|Ineligible by operative criteria|10|||
125613273|NCT00142519|451865261|FG000|Overall Study|Not Treated|7|||
125613274|NCT00142519|451865262|FG001|Overall Study|Not Treated|9|||
125613275|NCT00142519|451865261|FG000|Overall Study|Protocol Violation|1|||
125613276|NCT00142519|451865262|FG001|Overall Study|Protocol Violation|0|||
125613277|NCT00142519|451865261|FG000|Overall Study|Withdrawal by Subject|10|||
125613278|NCT00142519|451865262|FG001|Overall Study|Withdrawal by Subject|7|||
125613279|NCT02457182|451867462|FG000|Overall Study|Lost to Follow-up|1|||
125613280|NCT02457182|451867463|FG001|Overall Study|Lost to Follow-up|0|||
125613281|NCT00789191|451867468|FG000|Overall Study|Adverse Event|2|||
125613282|NCT00789191|451867469|FG001|Overall Study|Adverse Event|4|||
125613283|NCT00789191|451867468|FG000|Overall Study|Lack of Efficacy|0|||
125613284|NCT00789191|451867469|FG001|Overall Study|Lack of Efficacy|5|||
125613285|NCT00789191|451867468|FG000|Overall Study|Protocol Violation|5|||
125613286|NCT00789191|451867469|FG001|Overall Study|Protocol Violation|3|||
125613287|NCT00789191|451867468|FG000|Overall Study|Withdrawal Criteria|2|||
125613288|NCT00789191|451867469|FG001|Overall Study|Withdrawal Criteria|4|||
125613289|NCT00789191|451867468|FG000|Overall Study|Unclassified|5|||
125613290|NCT00789191|451867469|FG001|Overall Study|Unclassified|3|||
125613291|NCT03497429|451867470|FG000|Overall Study|Progressive disease|3|||
125613292|NCT03497429|451867471|FG001|Overall Study|Progressive disease|4|||
125214463|NCT02187029|450412841|FG003|Overall Study|Adverse Event|0|||
125214464|NCT02187029|450412838|FG000|Overall Study|Study Terminated by Sponsor|0|||
125613293|NCT03497429|451867470|FG000|Overall Study|Adverse Event|0|||
125613294|NCT03497429|451867471|FG001|Overall Study|Adverse Event|2|||
125613295|NCT01009983|451867472|FG000|Overall Study|necessary scans not completed|1|||
125613296|NCT00506948|451867473|FG000|Overall Study|Death|4|||
125613297|NCT00506948|451867473|FG000|Overall Study|Adverse Event|5|||
125613298|NCT00506948|451867473|FG000|Overall Study|Physician Decision|1|||
125613299|NCT00762372|451867475|FG000|Overall Study|Adverse Event|1|||
125613300|NCT00762372|451867476|FG001|Overall Study|Adverse Event|0|||
125613301|NCT00762372|451867477|FG002|Overall Study|Adverse Event|0|||
125613302|NCT03364335|451867478|FG000|Overall Study|Adverse Event|3|||
125613303|NCT03364335|451867479|FG001|Overall Study|Adverse Event|4|||
125613304|NCT03364335|451867480|FG002|Overall Study|Adverse Event|1|||
125613305|NCT03364335|451867481|FG003|Overall Study|Adverse Event|2|||
125613306|NCT03364335|451867482|FG004|Overall Study|Adverse Event|0|||
125613307|NCT03364335|451867478|FG000|Overall Study|Lost to Follow-up|7|||
125613308|NCT03364335|451867479|FG001|Overall Study|Lost to Follow-up|7|||
125613309|NCT03364335|451867480|FG002|Overall Study|Lost to Follow-up|10|||
125613310|NCT03364335|451867481|FG003|Overall Study|Lost to Follow-up|11|||
125613311|NCT03364335|451867482|FG004|Overall Study|Lost to Follow-up|11|||
125214465|NCT02187029|450412839|FG001|Overall Study|Study Terminated by Sponsor|0|||
125214466|NCT02187029|450412840|FG002|Overall Study|Study Terminated by Sponsor|10|||
125613312|NCT02670915|451867483|FG000|Overall Study|Withdrawal by Subject|0|||
125613313|NCT02670915|451867484|FG001|Overall Study|Withdrawal by Subject|1|||
125613314|NCT02670915|451867485|FG002|Overall Study|Withdrawal by Subject|4|||
125214467|NCT02187029|450412841|FG003|Overall Study|Study Terminated by Sponsor|3|||
125613315|NCT02670915|451867483|FG000|Overall Study|Withdrawal by parent/guardian|4|||
125613316|NCT02670915|451867484|FG001|Overall Study|Withdrawal by parent/guardian|4|||
125613317|NCT02670915|451867485|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125613318|NCT02670915|451867483|FG000|Overall Study|Unclassified|0|||
125613319|NCT02670915|451867484|FG001|Overall Study|Unclassified|3|||
125613320|NCT02670915|451867485|FG002|Overall Study|Unclassified|0|||
125613321|NCT00818207|451867486|FG000|Overall Study|Adverse Event|6|||
125613322|NCT00818207|451867487|FG001|Overall Study|Adverse Event|0|||
125613323|NCT00818207|451867486|FG000|Overall Study|Lost to Follow-up|160|||
125613324|NCT00818207|451867487|FG001|Overall Study|Lost to Follow-up|146|||
125613325|NCT00818207|451867486|FG000|Overall Study|Multiple reasons|11|||
125613326|NCT00818207|451867487|FG001|Overall Study|Multiple reasons|12|||
125613327|NCT00818207|451867486|FG000|Overall Study|Withdrawal by Subject|42|||
125613328|NCT00818207|451867487|FG001|Overall Study|Withdrawal by Subject|104|||
125613329|NCT00818207|451867486|FG000|Overall Study|Death|3|||
125613330|NCT00818207|451867487|FG001|Overall Study|Death|5|||
125613331|NCT02494778|451867488|FG000|Overall Study|Death|3|||
125613332|NCT02494778|451867488|FG000|Overall Study|Other|173|||
125613333|NCT02494778|451867488|FG000|Overall Study|Lack of Efficacy|4|||
125613334|NCT02494778|451867488|FG000|Overall Study|Adverse Event|18|||
125613335|NCT02494778|451867488|FG000|Overall Study|Withdrawal by Subject|20|||
125613336|NCT02494778|451867488|FG000|Overall Study|Lost to Follow-up|2|||
125613337|NCT02494778|451867488|FG000|Overall Study|Noncompliant with study drug admin.|1|||
125613338|NCT02174861|451867493|FG000|Overall Study|Decision by sponsor|8|||
125613339|NCT02174861|451867493|FG000|Overall Study|Withdrawal by Subject|124|||
125613340|NCT02174861|451867493|FG000|Overall Study|Lost to Follow-up|26|||
125613341|NCT03196193|451867503|FG000|Overall Study|Adverse Event|1|||
125613342|NCT03196193|451867504|FG001|Overall Study|Adverse Event|0|||
125613343|NCT03196193|451867503|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
125613344|NCT03196193|451867504|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
125613345|NCT02709083|451867505|FG000|Overall Study|Original PI left institution|7|||
125214468|NCT02187029|450412838|FG000|Overall Study|Withdrawal by Subject|1|||
125214469|NCT02187029|450412839|FG001|Overall Study|Withdrawal by Subject|0|||
125214470|NCT02187029|450412840|FG002|Overall Study|Withdrawal by Subject|0|||
125214471|NCT02187029|450412841|FG003|Overall Study|Withdrawal by Subject|0|||
125214472|NCT00694356|450412843|FG000|Overall Study|Adverse Event|1|||
125214473|NCT00694356|450412844|FG001|Overall Study|Adverse Event|0|||
125214474|NCT00694356|450412845|FG002|Overall Study|Adverse Event|0|||
125214475|NCT00694356|450412843|FG000|Overall Study|Progressive Disease|2|||
125214476|NCT00694356|450412844|FG001|Overall Study|Progressive Disease|6|||
125214477|NCT00694356|450412845|FG002|Overall Study|Progressive Disease|6|||
125214478|NCT01301079|450412855|FG000|Overall Study|Lost to Follow-up|2|||
125214479|NCT01301079|450412856|FG001|Overall Study|Lost to Follow-up|2|||
125214480|NCT02496039|450412857|FG000|Overall Study|Adverse Event|3|||
125214481|NCT02496039|450412857|FG000|Overall Study|Protocol Violation|1|||
125214482|NCT04472494|450412858|FG000|Pre-treatment|Other reasons|2|||
125214483|NCT04472494|450412859|FG001|Pre-treatment|Other reasons|0|||
125214484|NCT04472494|450412858|FG000|Treatment|Death|5|||
125613346|NCT01697267|451867506|FG000|Overall Study|Death|3|||
125613347|NCT01697267|451867507|FG001|Overall Study|Death|1|||
125613348|NCT01697267|451867506|FG000|Overall Study|Withdrawal by Subject|5|||
125613349|NCT01697267|451867507|FG001|Overall Study|Withdrawal by Subject|5|||
125613350|NCT01697267|451867506|FG000|Overall Study|Adverse Event|2|||
125613351|NCT01697267|451867507|FG001|Overall Study|Adverse Event|1|||
125613352|NCT01697267|451867506|FG000|Overall Study|Lost to Follow-up|2|||
125613353|NCT01697267|451867507|FG001|Overall Study|Lost to Follow-up|4|||
125613354|NCT01697267|451867506|FG000|Overall Study|Physician Decision|2|||
125613355|NCT01697267|451867507|FG001|Overall Study|Physician Decision|4|||
125613356|NCT00333619|451867508|FG000|Overall Study|Death|12|||
125613357|NCT00333619|451867509|FG001|Overall Study|Death|6|||
125613358|NCT00333619|451867508|FG000|Overall Study|Withdrawal by Subject|6|||
125613359|NCT00333619|451867509|FG001|Overall Study|Withdrawal by Subject|1|||
125613360|NCT00333619|451867508|FG000|Overall Study|Lost to Follow-up|3|||
125613361|NCT00333619|451867509|FG001|Overall Study|Lost to Follow-up|3|||
125613362|NCT02681055|451867512|FG000|Weeks 5-12|Adverse Event|1|||
125613363|NCT02695524|451867513|FG000|Overall Study|Lost to Follow-up|3|||
125613364|NCT02695524|451867514|FG001|Overall Study|Lost to Follow-up|2|||
125613365|NCT02695524|451867513|FG000|Overall Study|Death|0|||
125613366|NCT02695524|451867514|FG001|Overall Study|Death|1|||
125613367|NCT00831441|451867515|FG000|Randomized|Death|82|||
125613368|NCT00831441|451867516|FG001|Randomized|Death|81|||
125613369|NCT00831441|451867515|FG000|Randomized|Adverse Event|248|||
125613370|NCT00831441|451867516|FG001|Randomized|Adverse Event|321|||
125613371|NCT00831441|451867515|FG000|Randomized|Emergency procedure|2|||
125613372|NCT00831441|451867516|FG001|Randomized|Emergency procedure|2|||
125613373|NCT00831441|451867515|FG000|Randomized|Elective procedure|26|||
125613374|NCT00831441|451867516|FG001|Randomized|Elective procedure|25|||
125613375|NCT00831441|451867515|FG000|Randomized|Physician Decision|26|||
125613376|NCT00831441|451867516|FG001|Randomized|Physician Decision|35|||
125613377|NCT00831441|451867515|FG000|Randomized|No longer met criteria|13|||
125613378|NCT00831441|451867516|FG001|Randomized|No longer met criteria|19|||
125613379|NCT00831441|451867515|FG000|Randomized|Withdrawal by Subject|178|||
125613380|NCT00831441|451867516|FG001|Randomized|Withdrawal by Subject|212|||
125613381|NCT00831441|451867515|FG000|Randomized|Lost to Follow-up|26|||
125613382|NCT00831441|451867516|FG001|Randomized|Lost to Follow-up|35|||
125613383|NCT00831441|451867515|FG000|Randomized|Administrative reason by sponsor|2780|||
125613384|NCT00831441|451867516|FG001|Randomized|Administrative reason by sponsor|2671|||
125613385|NCT00831441|451867515|FG000|Randomized|poor/non-compliance|30|||
125613386|NCT00831441|451867516|FG001|Randomized|poor/non-compliance|38|||
125613387|NCT00831441|451867515|FG000|Randomized|non-specified|276|||
125613388|NCT00831441|451867516|FG001|Randomized|non-specified|266|||
125613389|NCT00831441|451867515|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
125613390|NCT00831441|451867516|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
125613391|NCT00831441|451867515|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
125613392|NCT00831441|451867516|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
125613393|NCT00831441|451867515|FG000|Follow Up (30 Days)|Death|63|||
125613394|NCT00831441|451867516|FG001|Follow Up (30 Days)|Death|86|||
125613395|NCT00831441|451867515|FG000|Follow Up (30 Days)|non-specified|16|||
125613396|NCT00831441|451867516|FG001|Follow Up (30 Days)|non-specified|26|||
125613397|NCT00831441|451867515|FG000|Follow Up (30 Days)|missing end of study status|0|||
125613398|NCT00831441|451867516|FG001|Follow Up (30 Days)|missing end of study status|1|||
125613399|NCT00111917|451867517|FG000|Overall Study|Withdrawal by Subject|1|||
125613400|NCT00111917|451867518|FG001|Overall Study|Withdrawal by Subject|1|||
125613401|NCT02338492|451867525|FG000|Overall Study|Death|32|||
125613402|NCT02338492|451867525|FG000|Overall Study|Adverse Event|3|||
125613403|NCT02338492|451867525|FG000|Overall Study|Lost to Follow-up|4|||
125613404|NCT02338492|451867525|FG000|Overall Study|Reason not captured above|6|||
125613405|NCT04507867|451867528|FG000|Overall Study|Death|7|||
125613406|NCT04507867|451867529|FG001|Overall Study|Death|1|||
125613407|NCT04096326|451867530|FG000|Overall Study|Withdrawal by Subject|0|||
125613408|NCT04096326|451867531|FG001|Overall Study|Withdrawal by Subject|0|||
125613409|NCT04096326|451867532|FG002|Overall Study|Withdrawal by Subject|0|||
125613410|NCT04096326|451867533|FG003|Overall Study|Withdrawal by Subject|0|||
125613411|NCT04096326|451867534|FG004|Overall Study|Withdrawal by Subject|0|||
125613412|NCT04096326|451867535|FG005|Overall Study|Withdrawal by Subject|0|||
125613413|NCT04096326|451867536|FG006|Overall Study|Withdrawal by Subject|1|||
125613414|NCT04096326|451867537|FG007|Overall Study|Withdrawal by Subject|0|||
125613415|NCT04096326|451867538|FG008|Overall Study|Withdrawal by Subject|0|||
125613416|NCT04096326|451867539|FG009|Overall Study|Withdrawal by Subject|0|||
125613417|NCT04096326|451867530|FG000|Overall Study|Lost to Follow-up|0|||
125613418|NCT04096326|451867531|FG001|Overall Study|Lost to Follow-up|1|||
125613419|NCT04096326|451867532|FG002|Overall Study|Lost to Follow-up|0|||
125613420|NCT04096326|451867533|FG003|Overall Study|Lost to Follow-up|0|||
125613421|NCT04096326|451867534|FG004|Overall Study|Lost to Follow-up|0|||
125613422|NCT04096326|451867535|FG005|Overall Study|Lost to Follow-up|0|||
125613423|NCT04096326|451867536|FG006|Overall Study|Lost to Follow-up|0|||
125613424|NCT04096326|451867537|FG007|Overall Study|Lost to Follow-up|0|||
125613425|NCT04096326|451867538|FG008|Overall Study|Lost to Follow-up|0|||
125613426|NCT04096326|451867539|FG009|Overall Study|Lost to Follow-up|0|||
125613427|NCT04096326|451867530|FG000|Overall Study|COVID-19-related reasons|0|||
125613428|NCT04096326|451867531|FG001|Overall Study|COVID-19-related reasons|0|||
125613429|NCT04096326|451867532|FG002|Overall Study|COVID-19-related reasons|0|||
125613430|NCT04096326|451867533|FG003|Overall Study|COVID-19-related reasons|0|||
125613431|NCT04096326|451867534|FG004|Overall Study|COVID-19-related reasons|1|||
125613432|NCT04096326|451867535|FG005|Overall Study|COVID-19-related reasons|5|||
125613433|NCT04096326|451867536|FG006|Overall Study|COVID-19-related reasons|0|||
125613434|NCT04096326|451867537|FG007|Overall Study|COVID-19-related reasons|0|||
125613435|NCT04096326|451867538|FG008|Overall Study|COVID-19-related reasons|0|||
125613436|NCT04096326|451867539|FG009|Overall Study|COVID-19-related reasons|0|||
125613437|NCT01088438|451867552|FG000|Overall Study|Withdrawal by Subject|11|||
125613438|NCT01088438|451867553|FG001|Overall Study|Withdrawal by Subject|6|||
125613439|NCT01088438|451867552|FG000|Overall Study|Lost to Follow-up|18|||
125613440|NCT01088438|451867553|FG001|Overall Study|Lost to Follow-up|30|||
125613441|NCT02512068|451867554|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
125613442|NCT02512068|451867555|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
125613443|NCT02512068|451867554|FG000|Overall Study|Major Protocol Deviation|1|||
125613444|NCT02512068|451867555|FG001|Overall Study|Major Protocol Deviation|0|||
125613445|NCT02512068|451867554|FG000|Overall Study|Voluntary Withdrawal|0|||
125613446|NCT02512068|451867555|FG001|Overall Study|Voluntary Withdrawal|1|||
125613447|NCT02512068|451867554|FG000|Overall Study|Lack of Efficacy|0|||
125613448|NCT02512068|451867555|FG001|Overall Study|Lack of Efficacy|1|||
125214485|NCT04472494|450412859|FG001|Treatment|Death|2|||
125613449|NCT02512068|451867554|FG000|Overall Study|Reason Not Specified|3|||
125613450|NCT02512068|451867555|FG001|Overall Study|Reason Not Specified|5|||
125613451|NCT03521687|451867558|FG000|Overall Study|Adverse Event|4|||
125613452|NCT03521687|451867558|FG000|Overall Study|Physician Decision|1|||
125613453|NCT01151579|451867564|FG000|Overall Study|Physician Decision|3|||
125613454|NCT01151579|451867565|FG001|Overall Study|Physician Decision|1|||
125613455|NCT01151579|451867564|FG000|Overall Study|Withdrawal by Subject|3|||
125613456|NCT01151579|451867565|FG001|Overall Study|Withdrawal by Subject|2|||
125613457|NCT01151579|451867564|FG000|Overall Study|Not meet inclusion criteria|6|||
125613458|NCT01151579|451867565|FG001|Overall Study|Not meet inclusion criteria|4|||
125613459|NCT01276457|451867566|FG000|Core Study|Adverse Event|6|||
125613460|NCT01276457|451867567|FG001|Core Study|Adverse Event|3|||
125613461|NCT01276457|451867566|FG000|Core Study|Lost to Follow-up|1|||
125613462|NCT01276457|451867567|FG001|Core Study|Lost to Follow-up|2|||
125613463|NCT01276457|451867566|FG000|Core Study|Administrative problems|1|||
125613464|NCT01276457|451867567|FG001|Core Study|Administrative problems|1|||
125613465|NCT01276457|451867566|FG000|Core Study|Death|2|||
125613466|NCT01276457|451867567|FG001|Core Study|Death|2|||
125613467|NCT01276457|451867566|FG000|Core Study|Lack of Efficacy|3|||
125613468|NCT01276457|451867567|FG001|Core Study|Lack of Efficacy|12|||
125613469|NCT01276457|451867566|FG000|Extension Study|Lost to Follow-up|3|||
125613470|NCT01276457|451867567|FG001|Extension Study|Lost to Follow-up|0|||
125613471|NCT01276457|451867566|FG000|Extension Study|Death|0|||
125613472|NCT01276457|451867567|FG001|Extension Study|Death|1|||
125613473|NCT01276457|451867566|FG000|Extension Study|Lack of Efficacy|3|||
125613474|NCT01276457|451867567|FG001|Extension Study|Lack of Efficacy|1|||
125613475|NCT01098461|451867572|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
125613476|NCT01098461|451867573|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
125613477|NCT01098461|451867574|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
125613478|NCT01098461|451867575|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
125613479|NCT01098461|451867572|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
125613480|NCT01098461|451867573|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
125613481|NCT01098461|451867574|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
125613482|NCT01098461|451867575|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
125613483|NCT01098461|451867572|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
125613484|NCT01098461|451867573|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
125613485|NCT01098461|451867574|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
125613486|NCT01098461|451867575|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
125613487|NCT01098461|451867572|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
125613488|NCT01098461|451867573|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
125613489|NCT01098461|451867574|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
125613490|NCT01098461|451867575|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
125613491|NCT01098461|451867572|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
125613492|NCT01098461|451867573|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
125613493|NCT01098461|451867574|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
125372753|NCT01737697|450995089|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
125613494|NCT01098461|451867575|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
125613495|NCT01098461|451867572|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
125613496|NCT01098461|451867573|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
125613497|NCT01098461|451867574|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
125613498|NCT01098461|451867575|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
125613499|NCT01098461|451867572|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
125613500|NCT01098461|451867573|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
125613501|NCT01098461|451867574|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
125613502|NCT01098461|451867575|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
125613503|NCT01153763|451867576|FG000|Overall Study|Study Closed|16|||
125613504|NCT01153763|451867576|FG000|Overall Study|Lost to Follow-up|1|||
125372754|NCT01737697|450995090|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125372755|NCT01737697|450995091|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125372756|NCT01737697|450995092|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125372757|NCT01737697|450995093|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125613505|NCT01153763|451867576|FG000|Overall Study|Physician Decision|2|||
125613506|NCT01153763|451867576|FG000|Overall Study|Withdrawal by Subject|2|||
125613507|NCT01474746|451867577|FG000|Overall Study|Lost to Follow-up|1|||
125613508|NCT01474746|451867578|FG001|Overall Study|Lost to Follow-up|1|||
125613509|NCT01474746|451867577|FG000|Overall Study|Withdrawal by Subject|2|||
125613510|NCT01474746|451867578|FG001|Overall Study|Withdrawal by Subject|1|||
125613511|NCT01766336|451867580|FG000|Overall Study|Adverse Event|11|||
125613512|NCT01766336|451867581|FG001|Overall Study|Adverse Event|8|||
125613513|NCT01766336|451867580|FG000|Overall Study|Death|4|||
125613514|NCT01766336|451867581|FG001|Overall Study|Death|3|||
125613515|NCT01766336|451867580|FG000|Overall Study|Lost to Follow-up|1|||
125613516|NCT01766336|451867581|FG001|Overall Study|Lost to Follow-up|3|||
125613517|NCT01766336|451867580|FG000|Overall Study|Physician Decision|4|||
125613518|NCT01766336|451867581|FG001|Overall Study|Physician Decision|2|||
125613519|NCT01766336|451867580|FG000|Overall Study|Protocol Violation|0|||
125613520|NCT01766336|451867581|FG001|Overall Study|Protocol Violation|1|||
125613521|NCT01766336|451867580|FG000|Overall Study|Sponsor Decision|52|||
125613522|NCT01766336|451867581|FG001|Overall Study|Sponsor Decision|43|||
125613523|NCT01766336|451867580|FG000|Overall Study|Withdrawal by Subject|18|||
125613524|NCT01766336|451867581|FG001|Overall Study|Withdrawal by Subject|15|||
125613525|NCT02605447|451867582|FG000|Overall Study|Death|66|||
125613526|NCT02605447|451867582|FG000|Overall Study|Physician Decision|1|||
125613527|NCT02605447|451867582|FG000|Overall Study|Lost to Follow-up|24|||
125613528|NCT02605447|451867582|FG000|Overall Study|Withdrawal by Subject|10|||
125613529|NCT02605447|451867582|FG000|Overall Study|Not disclosed|1|||
125613530|NCT04544709|451867586|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
125613531|NCT03628508|451867587|FG000|Overall Study|Lost to Follow-up|1|||
125613532|NCT02045212|451867588|FG000|Overall Study|Adverse Event|0|||
125613533|NCT02045212|451867589|FG001|Overall Study|Adverse Event|1|||
125613534|NCT02045212|451867588|FG000|Overall Study|Withdrawal by Subject|1|||
125372758|NCT01737697|450995094|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125613535|NCT02045212|451867589|FG001|Overall Study|Withdrawal by Subject|0|||
125214486|NCT04472494|450412858|FG000|Treatment|Hospital discharge|1|||
125613536|NCT02045212|451867588|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
125613537|NCT02045212|451867589|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
125613538|NCT03807739|451867593|FG000|Overall Study|Adverse Event|1|||
125613539|NCT03807739|451867594|FG001|Overall Study|Adverse Event|0|||
125613540|NCT03807739|451867595|FG002|Overall Study|Adverse Event|0|||
125372759|NCT01737697|450995095|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125372760|NCT01737697|450995096|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125372761|NCT01737697|450995097|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125372762|NCT01737697|450995098|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125372763|NCT01737697|450995099|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125372764|NCT01737697|450995100|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125372765|NCT01737697|450995101|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125372766|NCT01737697|450995102|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
125372767|NCT01737697|450995088|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372768|NCT01737697|450995089|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372769|NCT01737697|450995090|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372770|NCT01737697|450995091|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372771|NCT01737697|450995092|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
125372772|NCT01737697|450995093|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372773|NCT01737697|450995094|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372774|NCT01737697|450995095|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372775|NCT01737697|450995096|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372776|NCT01737697|450995097|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372777|NCT01737697|450995098|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372778|NCT01737697|450995099|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372779|NCT01737697|450995100|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372780|NCT01737697|450995101|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372781|NCT01737697|450995102|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
125372782|NCT01737697|450995088|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125372783|NCT01737697|450995089|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
125372784|NCT01737697|450995090|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
125372785|NCT01737697|450995091|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
125372786|NCT01737697|450995092|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
125372787|NCT01737697|450995093|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125372788|NCT01737697|450995094|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125372789|NCT01737697|450995095|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125372790|NCT01737697|450995096|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125372791|NCT01737697|450995097|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125372792|NCT01737697|450995098|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125372793|NCT01737697|450995099|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125372794|NCT01737697|450995100|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125372795|NCT01737697|450995101|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125372796|NCT01737697|450995102|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
125372797|NCT01737697|450995088|FG000|Subacute Phase|Adverse Event|0|||
125372798|NCT01737697|450995089|FG001|Subacute Phase|Adverse Event|0|||
125372799|NCT01737697|450995090|FG002|Subacute Phase|Adverse Event|0|||
125372800|NCT01737697|450995091|FG003|Subacute Phase|Adverse Event|0|||
125372801|NCT01737697|450995092|FG004|Subacute Phase|Adverse Event|0|||
125372802|NCT01737697|450995093|FG005|Subacute Phase|Adverse Event|1|||
125372803|NCT01737697|450995094|FG006|Subacute Phase|Adverse Event|1|||
125372804|NCT01737697|450995095|FG007|Subacute Phase|Adverse Event|1|||
125372805|NCT01737697|450995096|FG008|Subacute Phase|Adverse Event|1|||
125372806|NCT01737697|450995097|FG009|Subacute Phase|Adverse Event|1|||
125372807|NCT01737697|450995098|FG010|Subacute Phase|Adverse Event|4|||
125372808|NCT01737697|450995099|FG011|Subacute Phase|Adverse Event|1|||
125372809|NCT01737697|450995100|FG012|Subacute Phase|Adverse Event|1|||
125372810|NCT01737697|450995101|FG013|Subacute Phase|Adverse Event|0|||
125372811|NCT01737697|450995102|FG014|Subacute Phase|Adverse Event|0|||
125613541|NCT03807739|451867596|FG003|Overall Study|Adverse Event|0|||
125613542|NCT03807739|451867593|FG000|Overall Study|Withdrawal by Subject|1|||
125613543|NCT03807739|451867594|FG001|Overall Study|Withdrawal by Subject|0|||
125613544|NCT03807739|451867595|FG002|Overall Study|Withdrawal by Subject|0|||
125613545|NCT03807739|451867596|FG003|Overall Study|Withdrawal by Subject|0|||
125613546|NCT03126539|451867600|FG000|Overall Study|Lost to Follow-up|1|||
125613547|NCT03126539|451867601|FG001|Overall Study|Lost to Follow-up|1|||
125372812|NCT01737697|450995088|FG000|Subacute Phase|Withdrawal by Subject|0|||
125372813|NCT01737697|450995089|FG001|Subacute Phase|Withdrawal by Subject|0|||
125372814|NCT01737697|450995090|FG002|Subacute Phase|Withdrawal by Subject|0|||
125372815|NCT01737697|450995091|FG003|Subacute Phase|Withdrawal by Subject|0|||
125372816|NCT01737697|450995092|FG004|Subacute Phase|Withdrawal by Subject|0|||
125372817|NCT01737697|450995093|FG005|Subacute Phase|Withdrawal by Subject|1|||
125372818|NCT01737697|450995094|FG006|Subacute Phase|Withdrawal by Subject|0|||
125372819|NCT01737697|450995095|FG007|Subacute Phase|Withdrawal by Subject|2|||
125613548|NCT03126539|451867602|FG002|Overall Study|Lost to Follow-up|1|||
125613549|NCT03126539|451867603|FG003|Overall Study|Lost to Follow-up|0|||
125372820|NCT01737697|450995096|FG008|Subacute Phase|Withdrawal by Subject|0|||
125372821|NCT01737697|450995097|FG009|Subacute Phase|Withdrawal by Subject|1|||
125372822|NCT01737697|450995098|FG010|Subacute Phase|Withdrawal by Subject|0|||
125372823|NCT01737697|450995099|FG011|Subacute Phase|Withdrawal by Subject|1|||
125372824|NCT01737697|450995100|FG012|Subacute Phase|Withdrawal by Subject|1|||
125372825|NCT01737697|450995101|FG013|Subacute Phase|Withdrawal by Subject|1|||
125372826|NCT01737697|450995102|FG014|Subacute Phase|Withdrawal by Subject|0|||
125372827|NCT01737697|450995088|FG000|Subacute Phase|Lost to Follow-up|0|||
125372828|NCT01737697|450995089|FG001|Subacute Phase|Lost to Follow-up|0|||
125372829|NCT01737697|450995090|FG002|Subacute Phase|Lost to Follow-up|0|||
125372830|NCT01737697|450995091|FG003|Subacute Phase|Lost to Follow-up|0|||
125372831|NCT01737697|450995092|FG004|Subacute Phase|Lost to Follow-up|0|||
125372832|NCT01737697|450995093|FG005|Subacute Phase|Lost to Follow-up|0|||
125372833|NCT01737697|450995094|FG006|Subacute Phase|Lost to Follow-up|0|||
125372834|NCT01737697|450995095|FG007|Subacute Phase|Lost to Follow-up|0|||
125372835|NCT01737697|450995096|FG008|Subacute Phase|Lost to Follow-up|0|||
125372836|NCT01737697|450995097|FG009|Subacute Phase|Lost to Follow-up|0|||
125372837|NCT01737697|450995098|FG010|Subacute Phase|Lost to Follow-up|0|||
125372838|NCT01737697|450995099|FG011|Subacute Phase|Lost to Follow-up|0|||
125372839|NCT01737697|450995100|FG012|Subacute Phase|Lost to Follow-up|0|||
125372840|NCT01737697|450995101|FG013|Subacute Phase|Lost to Follow-up|0|||
125372841|NCT01737697|450995102|FG014|Subacute Phase|Lost to Follow-up|1|||
125613550|NCT03126539|451867604|FG004|Overall Study|Lost to Follow-up|0|||
125613551|NCT02632110|451867605|FG000|Overall Study|Withdrawal by Subject|1|||
125613552|NCT02632110|451867606|FG001|Overall Study|Withdrawal by Subject|1|||
125613553|NCT02632110|451867607|FG002|Overall Study|Withdrawal by Subject|0|||
125613554|NCT02632110|451867608|FG003|Overall Study|Withdrawal by Subject|0|||
125613555|NCT02632110|451867609|FG004|Overall Study|Withdrawal by Subject|1|||
125613556|NCT02632110|451867610|FG005|Overall Study|Withdrawal by Subject|1|||
125613557|NCT02632110|451867611|FG006|Overall Study|Withdrawal by Subject|3|||
125613558|NCT02632110|451867612|FG007|Overall Study|Withdrawal by Subject|3|||
125613559|NCT02632110|451867613|FG008|Overall Study|Withdrawal by Subject|1|||
125613560|NCT02632110|451867614|FG009|Overall Study|Withdrawal by Subject|1|||
125613561|NCT00516269|451867617|FG000|Overall Study|Adverse Event|2|||
125613562|NCT00516269|451867618|FG001|Overall Study|Adverse Event|1|||
125613563|NCT00516269|451867617|FG000|Overall Study|Lost to Follow-up|0|||
125613564|NCT00516269|451867618|FG001|Overall Study|Lost to Follow-up|1|||
125613565|NCT00516269|451867617|FG000|Overall Study|Protocol Violation|0|||
125613566|NCT00516269|451867618|FG001|Overall Study|Protocol Violation|1|||
125613567|NCT01005732|451867619|FG000|Overall Study|Lost to Follow-up|10|||
125613568|NCT01005732|451867619|FG000|Overall Study|Death|1|||
125613569|NCT02596711|451867620|FG000|Overall Study|Lost to Follow-up|1|||
125613570|NCT02596711|451867621|FG001|Overall Study|Lost to Follow-up|2|||
125613571|NCT02596711|451867622|FG002|Overall Study|Lost to Follow-up|3|||
125613572|NCT01552928|451867623|FG000|Period 3|Adverse Event|0|||
125613573|NCT01552928|451867624|FG001|Period 3|Adverse Event|0|||
125613574|NCT01552928|451867625|FG002|Period 3|Adverse Event|1|||
125613575|NCT01552928|451867626|FG003|Period 3|Adverse Event|0|||
125613576|NCT04570657|451867628|FG000|Overall Study|Adverse Event|0|||
125613577|NCT04570657|451867629|FG001|Overall Study|Adverse Event|0|||
125613578|NCT04570657|451867630|FG002|Overall Study|Adverse Event|1|||
125613579|NCT04570657|451867628|FG000|Overall Study|Lost to Follow-up|0|||
125613580|NCT04570657|451867629|FG001|Overall Study|Lost to Follow-up|0|||
125613581|NCT04570657|451867630|FG002|Overall Study|Lost to Follow-up|1|||
125613582|NCT04570657|451867628|FG000|Overall Study|Physician Decision|0|||
125613583|NCT04570657|451867629|FG001|Overall Study|Physician Decision|1|||
125613584|NCT04570657|451867630|FG002|Overall Study|Physician Decision|0|||
125613585|NCT04570657|451867628|FG000|Overall Study|Withdrawal by Subject|1|||
125613586|NCT04570657|451867629|FG001|Overall Study|Withdrawal by Subject|2|||
125613587|NCT04570657|451867630|FG002|Overall Study|Withdrawal by Subject|2|||
125613588|NCT01072539|451867631|FG000|Overall Study|Treated prior to the Site Initiation|1|||
125372842|NCT01737697|450995088|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
125372843|NCT01737697|450995089|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
125372844|NCT01737697|450995090|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
125613589|NCT01072539|451867631|FG000|Overall Study|Protocol Violation|2|||
125613590|NCT00115804|451867634|FG000|Overall Study|Adverse Event|2|||
125613591|NCT01752842|451867635|FG000|Overall Study|Adverse Event|3|||
125613592|NCT01752842|451867636|FG001|Overall Study|Adverse Event|0|||
125613593|NCT01752842|451867635|FG000|Overall Study|Withdrawal by Subject|0|||
125613594|NCT01752842|451867636|FG001|Overall Study|Withdrawal by Subject|2|||
125613595|NCT01683071|451867637|FG000|Part 1|Lack of Efficacy|1|||
125613596|NCT01683071|451867638|FG001|Part 1|Lack of Efficacy|0|||
125613597|NCT01683071|451867639|FG002|Part 1|Lack of Efficacy|0|||
125613598|NCT01683071|451867640|FG003|Part 1|Lack of Efficacy|3|||
125613599|NCT01683071|451867641|FG004|Part 1|Lack of Efficacy|0|||
125613600|NCT01683071|451867642|FG005|Part 1|Lack of Efficacy|0|||
125372845|NCT01737697|450995091|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
125372846|NCT01737697|450995092|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
125372847|NCT01737697|450995093|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
125372848|NCT01737697|450995094|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
125372849|NCT01737697|450995095|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
125613601|NCT01683071|451867637|FG000|Part 1|Withdrawal by Subject|1|||
125613602|NCT01683071|451867638|FG001|Part 1|Withdrawal by Subject|2|||
125613603|NCT01683071|451867639|FG002|Part 1|Withdrawal by Subject|2|||
125613604|NCT01683071|451867640|FG003|Part 1|Withdrawal by Subject|1|||
125613605|NCT01683071|451867641|FG004|Part 1|Withdrawal by Subject|0|||
125613606|NCT01683071|451867642|FG005|Part 1|Withdrawal by Subject|0|||
125613607|NCT01683071|451867637|FG000|Part 1|Surgery Cancelled|1|||
125613608|NCT01683071|451867638|FG001|Part 1|Surgery Cancelled|0|||
125613609|NCT01683071|451867639|FG002|Part 1|Surgery Cancelled|0|||
125613610|NCT01683071|451867640|FG003|Part 1|Surgery Cancelled|0|||
125613611|NCT01683071|451867641|FG004|Part 1|Surgery Cancelled|0|||
125613612|NCT01683071|451867642|FG005|Part 1|Surgery Cancelled|0|||
125613613|NCT01683071|451867637|FG000|Part 1|Did not receive study drug|1|||
125613614|NCT01683071|451867638|FG001|Part 1|Did not receive study drug|0|||
125613615|NCT01683071|451867639|FG002|Part 1|Did not receive study drug|0|||
125613616|NCT01683071|451867640|FG003|Part 1|Did not receive study drug|1|||
125613617|NCT01683071|451867641|FG004|Part 1|Did not receive study drug|0|||
125613618|NCT01683071|451867642|FG005|Part 1|Did not receive study drug|0|||
125613619|NCT01683071|451867637|FG000|Part 1|Early termination; met exclusion criteria|0|||
125613620|NCT01683071|451867638|FG001|Part 1|Early termination; met exclusion criteria|2|||
125613621|NCT01683071|451867639|FG002|Part 1|Early termination; met exclusion criteria|1|||
125613622|NCT01683071|451867640|FG003|Part 1|Early termination; met exclusion criteria|0|||
125613623|NCT01683071|451867641|FG004|Part 1|Early termination; met exclusion criteria|0|||
125613624|NCT01683071|451867642|FG005|Part 1|Early termination; met exclusion criteria|0|||
125613625|NCT01683071|451867637|FG000|Part 2|Lack of Efficacy|0|||
125613626|NCT01683071|451867638|FG001|Part 2|Lack of Efficacy|0|||
125613627|NCT01683071|451867639|FG002|Part 2|Lack of Efficacy|0|||
125613628|NCT01683071|451867640|FG003|Part 2|Lack of Efficacy|0|||
125613629|NCT01683071|451867641|FG004|Part 2|Lack of Efficacy|3|||
125613630|NCT01683071|451867642|FG005|Part 2|Lack of Efficacy|4|||
125613631|NCT01683071|451867637|FG000|Part 2|Lost to Follow-up|0|||
125613632|NCT01683071|451867638|FG001|Part 2|Lost to Follow-up|0|||
125613633|NCT01683071|451867639|FG002|Part 2|Lost to Follow-up|0|||
125613634|NCT01683071|451867640|FG003|Part 2|Lost to Follow-up|0|||
125613635|NCT01683071|451867641|FG004|Part 2|Lost to Follow-up|2|||
125613636|NCT01683071|451867642|FG005|Part 2|Lost to Follow-up|0|||
125613637|NCT01683071|451867637|FG000|Part 2|Withdrawal by Subject|0|||
125613638|NCT01683071|451867638|FG001|Part 2|Withdrawal by Subject|0|||
125613639|NCT01683071|451867639|FG002|Part 2|Withdrawal by Subject|0|||
125613640|NCT01683071|451867640|FG003|Part 2|Withdrawal by Subject|0|||
125613641|NCT01683071|451867641|FG004|Part 2|Withdrawal by Subject|3|||
125613642|NCT01683071|451867642|FG005|Part 2|Withdrawal by Subject|3|||
125613643|NCT01683071|451867637|FG000|Part 2|Surgery cancelled|0|||
125613644|NCT01683071|451867638|FG001|Part 2|Surgery cancelled|0|||
125613645|NCT01683071|451867639|FG002|Part 2|Surgery cancelled|0|||
125613646|NCT01683071|451867640|FG003|Part 2|Surgery cancelled|0|||
125613647|NCT01683071|451867641|FG004|Part 2|Surgery cancelled|4|||
125613648|NCT01683071|451867642|FG005|Part 2|Surgery cancelled|2|||
125613649|NCT01683071|451867637|FG000|Part 2|Did not receive study drug|0|||
125613650|NCT01683071|451867638|FG001|Part 2|Did not receive study drug|0|||
125613651|NCT01683071|451867639|FG002|Part 2|Did not receive study drug|0|||
125613652|NCT01683071|451867640|FG003|Part 2|Did not receive study drug|0|||
125613653|NCT01683071|451867641|FG004|Part 2|Did not receive study drug|2|||
125613654|NCT01683071|451867642|FG005|Part 2|Did not receive study drug|1|||
125613655|NCT01683071|451867637|FG000|Part 2|Met exclusion criterion|0|||
125613656|NCT01683071|451867638|FG001|Part 2|Met exclusion criterion|0|||
125613657|NCT01683071|451867639|FG002|Part 2|Met exclusion criterion|0|||
125613658|NCT01683071|451867640|FG003|Part 2|Met exclusion criterion|0|||
125613659|NCT01683071|451867641|FG004|Part 2|Met exclusion criterion|1|||
125613660|NCT01683071|451867642|FG005|Part 2|Met exclusion criterion|1|||
125613661|NCT01683071|451867637|FG000|Part 2|Protocol deviation|0|||
125613662|NCT01683071|451867638|FG001|Part 2|Protocol deviation|0|||
125613663|NCT01683071|451867639|FG002|Part 2|Protocol deviation|0|||
125613664|NCT01683071|451867640|FG003|Part 2|Protocol deviation|0|||
125613665|NCT01683071|451867641|FG004|Part 2|Protocol deviation|1|||
125613666|NCT01683071|451867642|FG005|Part 2|Protocol deviation|2|||
125613667|NCT01683071|451867637|FG000|Part 2|Withdrawal by investigator decision|0|||
125613668|NCT01683071|451867638|FG001|Part 2|Withdrawal by investigator decision|0|||
125613669|NCT01683071|451867639|FG002|Part 2|Withdrawal by investigator decision|0|||
125372850|NCT01737697|450995096|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
125613670|NCT01683071|451867640|FG003|Part 2|Withdrawal by investigator decision|0|||
125613671|NCT01683071|451867641|FG004|Part 2|Withdrawal by investigator decision|1|||
125613672|NCT01683071|451867642|FG005|Part 2|Withdrawal by investigator decision|2|||
125613673|NCT02020031|451869386|FG000|Overall Study|Physician Decision|1|||
125613674|NCT02020031|451869387|FG001|Overall Study|Physician Decision|1|||
125613675|NCT02625324|451869394|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
125613676|NCT02625324|451869394|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
125613677|NCT02625324|451869394|FG000|6-Month Follow-up Subject Accountability|Death|5|||
125613678|NCT02625324|451869394|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
125613679|NCT02625324|451869394|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
125613680|NCT02625324|451869394|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
125613681|NCT02625324|451869394|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
125372851|NCT01737697|450995097|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
125372852|NCT01737697|450995098|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
125372853|NCT01737697|450995099|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
125372854|NCT01737697|450995100|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
125372855|NCT01737697|450995101|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
125372856|NCT01737697|450995102|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
125372857|NCT01737697|450995088|FG000|Subacute Phase|Protocol Violation|0|||
125372858|NCT01737697|450995089|FG001|Subacute Phase|Protocol Violation|0|||
125613682|NCT02625324|451869394|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
125613683|NCT02625324|451869394|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
125613684|NCT02625324|451869394|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
125613685|NCT02625324|451869394|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
125613686|NCT02625324|451869394|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
125613687|NCT02625324|451869394|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
125613688|NCT02625324|451869394|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
125613689|NCT02625324|451869394|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
125613690|NCT02625324|451869394|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
125613691|NCT02625324|451869394|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
125613692|NCT01116687|451869395|FG000|Overall Study|Withdrawal by Subject|4|||
125613693|NCT00424528|451869396|FG000|Overall Study|Adverse Event|2|||
125613694|NCT00424528|451869397|FG001|Overall Study|Adverse Event|1|||
125613695|NCT00424528|451869398|FG002|Overall Study|Adverse Event|2|||
125613696|NCT00424528|451869396|FG000|Overall Study|Protocol Violation|1|||
125613697|NCT00424528|451869397|FG001|Overall Study|Protocol Violation|1|||
125613698|NCT00424528|451869398|FG002|Overall Study|Protocol Violation|0|||
125613699|NCT00424528|451869396|FG000|Overall Study|Lost to Follow-up|0|||
125613700|NCT00424528|451869397|FG001|Overall Study|Lost to Follow-up|1|||
125613701|NCT00424528|451869398|FG002|Overall Study|Lost to Follow-up|0|||
125613702|NCT00424528|451869396|FG000|Overall Study|noncompliance with study requirements|2|||
125613703|NCT00424528|451869397|FG001|Overall Study|noncompliance with study requirements|1|||
125613704|NCT00424528|451869398|FG002|Overall Study|noncompliance with study requirements|2|||
125613705|NCT02395653|451869399|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
125613706|NCT02395653|451869399|FG000|Overall Study|Consent Withdrawn at Screening|1|||
125613707|NCT02395653|451869399|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
125613708|NCT02395653|451869399|FG000|Overall Study|Investigator Decision at Screening|1|||
125613709|NCT02395653|451869399|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
125613710|NCT02395653|451869399|FG000|Overall Study|Withdrawal by Subject|1|||
125613711|NCT02395653|451869399|FG000|Overall Study|Lost to Follow-up|1|||
125613712|NCT00967226|451869403|FG000|Overall Study|Adverse Event|0|||
125613713|NCT00967226|451869404|FG001|Overall Study|Adverse Event|5|||
125613714|NCT00967226|451869403|FG000|Overall Study|Protocol Violation|2|||
125613715|NCT00967226|451869404|FG001|Overall Study|Protocol Violation|0|||
125613716|NCT00967226|451869403|FG000|Overall Study|Physician Decision|0|||
125613717|NCT00967226|451869404|FG001|Overall Study|Physician Decision|1|||
125613718|NCT00605722|451869405|FG000|Overall Study|Adverse Event|6|||
125613719|NCT00605722|451869405|FG000|Overall Study|Insufficient therapeutic response|44|||
125613720|NCT00605722|451869405|FG000|Overall Study|Failure to return|1|||
125613721|NCT02702518|451869408|FG000|Overall Study|Lost to Follow-up|3|||
125613722|NCT02702518|451869409|FG001|Overall Study|Lost to Follow-up|4|||
125613723|NCT00165841|451869410|FG000|Overall Study|Adverse Event|2|||
125613724|NCT00165841|451869411|FG001|Overall Study|Adverse Event|3|||
125613725|NCT00165841|451869410|FG000|Overall Study|Lack of Efficacy|6|||
125613726|NCT00165841|451869411|FG001|Overall Study|Lack of Efficacy|33|||
125613727|NCT00165841|451869410|FG000|Overall Study|Lost to Follow-up|4|||
125613728|NCT00165841|451869411|FG001|Overall Study|Lost to Follow-up|4|||
125613729|NCT00165841|451869410|FG000|Overall Study|Withdrawal by Subject|7|||
125613730|NCT00165841|451869411|FG001|Overall Study|Withdrawal by Subject|8|||
125613731|NCT00165841|451869410|FG000|Overall Study|Physician Decision|1|||
125613732|NCT00165841|451869411|FG001|Overall Study|Physician Decision|0|||
125613733|NCT00165841|451869410|FG000|Overall Study|Protocol Violation|6|||
125613734|NCT00165841|451869411|FG001|Overall Study|Protocol Violation|8|||
125613735|NCT00165841|451869410|FG000|Overall Study|Other|3|||
125214487|NCT04472494|450412859|FG001|Treatment|Hospital discharge|1|||
125372859|NCT01737697|450995090|FG002|Subacute Phase|Protocol Violation|0|||
125372860|NCT01737697|450995091|FG003|Subacute Phase|Protocol Violation|0|||
125613736|NCT00165841|451869411|FG001|Overall Study|Other|5|||
125613737|NCT00165841|451869410|FG000|Overall Study|Medication Noncompliance|1|||
125613738|NCT00165841|451869411|FG001|Overall Study|Medication Noncompliance|1|||
125613739|NCT04031404|451869412|FG000|Baseline|Lost to Follow-up|0|||
125613740|NCT04031404|451869413|FG001|Baseline|Lost to Follow-up|1|||
125613741|NCT04031404|451869412|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
125613742|NCT04031404|451869413|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
125613743|NCT04031404|451869412|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
125613744|NCT04031404|451869413|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
125613745|NCT04031404|451869412|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
125613746|NCT04031404|451869413|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
125613747|NCT04031404|451869412|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
125613748|NCT04031404|451869413|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
125613749|NCT02796391|451869414|FG000|Overall Study|Lost to Follow-up|2|||
125613750|NCT02796391|451869415|FG001|Overall Study|Lost to Follow-up|2|||
125613751|NCT02796391|451869416|FG002|Overall Study|Lost to Follow-up|13|||
125613752|NCT02796391|451869417|FG003|Overall Study|Lost to Follow-up|8|||
125613753|NCT02796391|451869418|FG004|Overall Study|Lost to Follow-up|14|||
125613754|NCT02796391|451869419|FG005|Overall Study|Lost to Follow-up|13|||
125613755|NCT02796391|451869414|FG000|Overall Study|COVID|0|||
125613756|NCT02796391|451869415|FG001|Overall Study|COVID|0|||
125613757|NCT02796391|451869416|FG002|Overall Study|COVID|5|||
125613758|NCT02796391|451869417|FG003|Overall Study|COVID|5|||
125613759|NCT02796391|451869418|FG004|Overall Study|COVID|2|||
125613760|NCT02796391|451869419|FG005|Overall Study|COVID|4|||
125613761|NCT02796391|451869414|FG000|Overall Study|Participant did not like study cigarettes|0|||
125613762|NCT02796391|451869415|FG001|Overall Study|Participant did not like study cigarettes|0|||
125613763|NCT02796391|451869416|FG002|Overall Study|Participant did not like study cigarettes|3|||
125613764|NCT02796391|451869417|FG003|Overall Study|Participant did not like study cigarettes|0|||
125613765|NCT02796391|451869418|FG004|Overall Study|Participant did not like study cigarettes|0|||
125613766|NCT02796391|451869419|FG005|Overall Study|Participant did not like study cigarettes|0|||
125613767|NCT02796391|451869414|FG000|Overall Study|Withdrawal by Subject|1|||
125613768|NCT02796391|451869415|FG001|Overall Study|Withdrawal by Subject|1|||
125613769|NCT02796391|451869416|FG002|Overall Study|Withdrawal by Subject|4|||
125613770|NCT02796391|451869417|FG003|Overall Study|Withdrawal by Subject|3|||
125613771|NCT02796391|451869418|FG004|Overall Study|Withdrawal by Subject|4|||
125613772|NCT02796391|451869419|FG005|Overall Study|Withdrawal by Subject|3|||
125613773|NCT02796391|451869414|FG000|Overall Study|Adverse Event|0|||
125613774|NCT02796391|451869415|FG001|Overall Study|Adverse Event|0|||
125613775|NCT02796391|451869416|FG002|Overall Study|Adverse Event|0|||
125613776|NCT02796391|451869417|FG003|Overall Study|Adverse Event|1|||
125613777|NCT02796391|451869418|FG004|Overall Study|Adverse Event|0|||
125613778|NCT02796391|451869419|FG005|Overall Study|Adverse Event|0|||
125613779|NCT02796391|451869414|FG000|Overall Study|Protocol Violation|0|||
125613780|NCT02796391|451869415|FG001|Overall Study|Protocol Violation|0|||
125613781|NCT02796391|451869416|FG002|Overall Study|Protocol Violation|0|||
125613782|NCT02796391|451869417|FG003|Overall Study|Protocol Violation|1|||
125613783|NCT02796391|451869418|FG004|Overall Study|Protocol Violation|0|||
125613784|NCT02796391|451869419|FG005|Overall Study|Protocol Violation|0|||
125613785|NCT05674344|451869420|FG000|Overall Study|Screen Fail|21|||
125613786|NCT05674344|451869420|FG000|Overall Study|Incomplete study procedures|3|||
125613787|NCT00798655|451869421|FG000|Overall Study|Did not receive at least one dose of pan|2|||
125613788|NCT00960934|451869422|FG000|Overall Study|Adverse Event|2|||
125613789|NCT00960934|451869423|FG001|Overall Study|Adverse Event|3|||
125613790|NCT00960934|451869424|FG002|Overall Study|Adverse Event|3|||
125613791|NCT00960934|451869425|FG003|Overall Study|Adverse Event|2|||
125613792|NCT00960934|451869426|FG004|Overall Study|Adverse Event|4|||
125613793|NCT00960934|451869427|FG005|Overall Study|Adverse Event|3|||
125613794|NCT00960934|451869422|FG000|Overall Study|Lack of Efficacy|1|||
125613795|NCT00960934|451869423|FG001|Overall Study|Lack of Efficacy|0|||
125613796|NCT00960934|451869424|FG002|Overall Study|Lack of Efficacy|0|||
125613797|NCT00960934|451869425|FG003|Overall Study|Lack of Efficacy|0|||
125613798|NCT00960934|451869426|FG004|Overall Study|Lack of Efficacy|0|||
125613799|NCT00960934|451869427|FG005|Overall Study|Lack of Efficacy|0|||
125613800|NCT00960934|451869422|FG000|Overall Study|Lost to Follow-up|0|||
125613801|NCT00960934|451869423|FG001|Overall Study|Lost to Follow-up|1|||
125613802|NCT00960934|451869424|FG002|Overall Study|Lost to Follow-up|0|||
125613803|NCT00960934|451869425|FG003|Overall Study|Lost to Follow-up|0|||
125613804|NCT00960934|451869426|FG004|Overall Study|Lost to Follow-up|0|||
125613805|NCT00960934|451869427|FG005|Overall Study|Lost to Follow-up|0|||
125613806|NCT00960934|451869422|FG000|Overall Study|Other|2|||
125613807|NCT00960934|451869423|FG001|Overall Study|Other|1|||
125613808|NCT00960934|451869424|FG002|Overall Study|Other|5|||
125613809|NCT00960934|451869425|FG003|Overall Study|Other|4|||
125613810|NCT00960934|451869426|FG004|Overall Study|Other|2|||
125613811|NCT00960934|451869427|FG005|Overall Study|Other|2|||
125613812|NCT00960934|451869422|FG000|Overall Study|Physician Decision|0|||
125613813|NCT00960934|451869423|FG001|Overall Study|Physician Decision|1|||
125613814|NCT00960934|451869424|FG002|Overall Study|Physician Decision|0|||
125613815|NCT00960934|451869425|FG003|Overall Study|Physician Decision|0|||
125613816|NCT00960934|451869426|FG004|Overall Study|Physician Decision|0|||
125613817|NCT00960934|451869427|FG005|Overall Study|Physician Decision|0|||
125613818|NCT00960934|451869422|FG000|Overall Study|Progressive Disease|1|||
125613819|NCT00960934|451869423|FG001|Overall Study|Progressive Disease|1|||
125613820|NCT00960934|451869424|FG002|Overall Study|Progressive Disease|0|||
125613821|NCT00960934|451869425|FG003|Overall Study|Progressive Disease|0|||
125613822|NCT00960934|451869426|FG004|Overall Study|Progressive Disease|1|||
125613823|NCT00960934|451869427|FG005|Overall Study|Progressive Disease|1|||
125613824|NCT00960934|451869422|FG000|Overall Study|Protocol Violation|3|||
125613825|NCT00960934|451869423|FG001|Overall Study|Protocol Violation|4|||
125613826|NCT00960934|451869424|FG002|Overall Study|Protocol Violation|0|||
125613827|NCT00960934|451869425|FG003|Overall Study|Protocol Violation|3|||
125613828|NCT00960934|451869426|FG004|Overall Study|Protocol Violation|3|||
125613829|NCT00960934|451869427|FG005|Overall Study|Protocol Violation|2|||
125613830|NCT00960934|451869422|FG000|Overall Study|Withdrawal by Subject|5|||
125613831|NCT00960934|451869423|FG001|Overall Study|Withdrawal by Subject|6|||
125613832|NCT00960934|451869424|FG002|Overall Study|Withdrawal by Subject|4|||
125613833|NCT00960934|451869425|FG003|Overall Study|Withdrawal by Subject|5|||
125613834|NCT00960934|451869426|FG004|Overall Study|Withdrawal by Subject|5|||
125613835|NCT00960934|451869427|FG005|Overall Study|Withdrawal by Subject|7|||
125613836|NCT00960934|451869422|FG000|Overall Study|Study Terminated by Sponsor|50|||
125613837|NCT00960934|451869423|FG001|Overall Study|Study Terminated by Sponsor|46|||
125613838|NCT00960934|451869424|FG002|Overall Study|Study Terminated by Sponsor|52|||
125613839|NCT00960934|451869425|FG003|Overall Study|Study Terminated by Sponsor|50|||
125613840|NCT00960934|451869426|FG004|Overall Study|Study Terminated by Sponsor|49|||
125613841|NCT00960934|451869427|FG005|Overall Study|Study Terminated by Sponsor|49|||
125613842|NCT02156492|451869428|FG000|Period 1|No Reason Given|0|||
125613843|NCT02156492|451869429|FG001|Period 1|No Reason Given|1|||
125613844|NCT02156492|451869430|FG002|Period 1|No Reason Given|0|||
125613845|NCT02156492|451869428|FG000|Period 3|Adverse Event|0|||
125613846|NCT02156492|451869429|FG001|Period 3|Adverse Event|1|||
125613847|NCT02156492|451869430|FG002|Period 3|Adverse Event|0|||
125613848|NCT05254613|451869431|FG000|Overall Study|Lost to Follow-up|0|||
125613849|NCT05254613|451869432|FG001|Overall Study|Lost to Follow-up|0|||
125613850|NCT05254613|451869433|FG002|Overall Study|Lost to Follow-up|1|||
125613851|NCT02387372|451869434|FG000|Overall Study|Not Treated|1|||
125613852|NCT02387372|451869435|FG001|Overall Study|Not Treated|0|||
125613853|NCT00848549|451869437|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
125613854|NCT00848549|451869438|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
125613855|NCT00848549|451869437|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
125613856|NCT00848549|451869438|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
125613857|NCT00848549|451869437|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
125613858|NCT00848549|451869438|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
125613859|NCT00848549|451869437|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
125613860|NCT00848549|451869438|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
125613861|NCT00848549|451869437|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
125613862|NCT00848549|451869438|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
125613863|NCT00848549|451869437|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
125613864|NCT00848549|451869438|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
125613865|NCT00848549|451869437|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
125432062|NCT01576718|451207826|FG005|Treatment Period|Noncompliance to study medication|1|||
125432063|NCT01576718|451207827|FG006|Treatment Period|Noncompliance to study medication|1|||
125432064|NCT01336621|451207828|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
125432065|NCT01336621|451207828|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
125613866|NCT00848549|451869438|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
125613867|NCT00848549|451869437|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
125613868|NCT00848549|451869438|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
125613869|NCT00848549|451869437|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
125613870|NCT00848549|451869438|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
125613871|NCT00848549|451869437|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
125613872|NCT00848549|451869438|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
125432066|NCT01336621|451207828|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
125613873|NCT00848549|451869437|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
125613874|NCT00848549|451869438|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
125613875|NCT00848549|451869437|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
125613876|NCT00848549|451869438|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
125613877|NCT00848549|451869437|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
125613878|NCT00848549|451869438|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
125613879|NCT00848549|451869437|FG000|E2090-E044-314 (Extension Study)|Other|5|||
125613880|NCT00848549|451869438|FG001|E2090-E044-314 (Extension Study)|Other|6|||
125613881|NCT01248130|451869441|FG000|Overall Study|Protocol Violation|1|||
125613882|NCT01248130|451869442|FG001|Overall Study|Protocol Violation|0|||
125613883|NCT01248130|451869441|FG000|Overall Study|Ineligible|1|||
125613884|NCT01248130|451869442|FG001|Overall Study|Ineligible|0|||
125613885|NCT00229203|451869447|FG000|Overall Study|Progressive disease|18|||
125613886|NCT00229203|451869448|FG001|Overall Study|Progressive disease|9|||
125613887|NCT00229203|451869447|FG000|Overall Study|Toxicity|6|||
125613888|NCT00229203|451869448|FG001|Overall Study|Toxicity|1|||
125613889|NCT00229203|451869447|FG000|Overall Study|Death|4|||
125613890|NCT00229203|451869448|FG001|Overall Study|Death|2|||
125613891|NCT00229203|451869447|FG000|Overall Study|Other|3|||
125613892|NCT00229203|451869448|FG001|Overall Study|Other|3|||
125613893|NCT00229203|451869447|FG000|Overall Study|Withdrawal by Subject|1|||
125613894|NCT00229203|451869448|FG001|Overall Study|Withdrawal by Subject|4|||
125613895|NCT02106455|451869449|FG000|Overall Study|Case Report Form Uncollected|6|||
125613896|NCT02106455|451869449|FG000|Overall Study|Protocol Deviation|2|||
125613897|NCT03607838|451869453|FG000|Overall Study|Lack of Efficacy|14|||
125613898|NCT03607838|451869454|FG001|Overall Study|Lack of Efficacy|20|||
125613899|NCT03607838|451869453|FG000|Overall Study|Withdrawal by Subject|13|||
125613900|NCT03607838|451869454|FG001|Overall Study|Withdrawal by Subject|8|||
125613901|NCT03607838|451869453|FG000|Overall Study|Lost to Follow-up|6|||
125613902|NCT03607838|451869454|FG001|Overall Study|Lost to Follow-up|11|||
125613903|NCT03607838|451869453|FG000|Overall Study|Adverse Event|2|||
125613904|NCT03607838|451869454|FG001|Overall Study|Adverse Event|2|||
125613905|NCT03607838|451869453|FG000|Overall Study|Physician Decision|2|||
125613906|NCT03607838|451869454|FG001|Overall Study|Physician Decision|0|||
125613907|NCT03607838|451869453|FG000|Overall Study|Failure to meet randomization criteria|1|||
125613908|NCT03607838|451869454|FG001|Overall Study|Failure to meet randomization criteria|2|||
125613909|NCT03607838|451869453|FG000|Overall Study|Pregnancy|1|||
125613910|NCT03607838|451869454|FG001|Overall Study|Pregnancy|0|||
125613911|NCT03607838|451869453|FG000|Overall Study|Protocol Violation|1|||
125613912|NCT03607838|451869454|FG001|Overall Study|Protocol Violation|0|||
125613913|NCT03607838|451869453|FG000|Overall Study|Due to work|1|||
125613914|NCT03607838|451869454|FG001|Overall Study|Due to work|0|||
125613915|NCT03607838|451869453|FG000|Overall Study|Litigation|0|||
125613916|NCT03607838|451869454|FG001|Overall Study|Litigation|1|||
125613917|NCT03607838|451869453|FG000|Overall Study|Temperature excursion for study drug|0|||
125613918|NCT03607838|451869454|FG001|Overall Study|Temperature excursion for study drug|1|||
125613919|NCT03607838|451869453|FG000|Overall Study|Change of mind|0|||
125613920|NCT03607838|451869454|FG001|Overall Study|Change of mind|1|||
125613921|NCT01576016|451869455|FG000|Lead Safety|Death|132|||
125613922|NCT01576016|451869456|FG001|Lead Safety|Death|0|||
125613923|NCT01576016|451869455|FG000|Lead Safety|Withdrawal by Subject|81|||
125613924|NCT01576016|451869456|FG001|Lead Safety|Withdrawal by Subject|0|||
125613925|NCT01576016|451869455|FG000|Lead Safety|System Explanted without Replacement|24|||
125613926|NCT01576016|451869456|FG001|Lead Safety|System Explanted without Replacement|0|||
125613927|NCT01576016|451869455|FG000|Lead Safety|Physician Decision|14|||
125613928|NCT01576016|451869456|FG001|Lead Safety|Physician Decision|0|||
125613929|NCT01576016|451869455|FG000|Lead Safety|Lost to Follow-up|13|||
125613930|NCT01576016|451869456|FG001|Lead Safety|Lost to Follow-up|0|||
125613931|NCT01576016|451869455|FG000|Lead Safety|Unsuccessful implant|2|||
125613932|NCT01576016|451869456|FG001|Lead Safety|Unsuccessful implant|0|||
125613933|NCT01576016|451869455|FG000|Lead Safety|Sponsor request|1|||
125613934|NCT01576016|451869456|FG001|Lead Safety|Sponsor request|0|||
125613935|NCT01576016|451869455|FG000|Lead Safety|Device replaced with CRT-D|1|||
125613936|NCT01576016|451869456|FG001|Lead Safety|Device replaced with CRT-D|0|||
125613937|NCT01576016|451869455|FG000|Lead Safety|Patient on Palliative Care|1|||
125613938|NCT01576016|451869456|FG001|Lead Safety|Patient on Palliative Care|0|||
125613939|NCT01576016|451869455|FG000|Lead Safety|Patient noncompliance|1|||
125613940|NCT01576016|451869456|FG001|Lead Safety|Patient noncompliance|0|||
125613941|NCT01576016|451869455|FG000|Lead Safety|Too far from study site|1|||
125613942|NCT01576016|451869456|FG001|Lead Safety|Too far from study site|0|||
125613943|NCT01576016|451869455|FG000|Lead Safety|System deactivated|1|||
125613944|NCT01576016|451869456|FG001|Lead Safety|System deactivated|0|||
125613945|NCT01576016|451869455|FG000|Lead Safety|Patient no longer followed by study PI|1|||
125613946|NCT01576016|451869456|FG001|Lead Safety|Patient no longer followed by study PI|0|||
125613947|NCT01576016|451869455|FG000|MRI Safety|Withdrawal by Subject|0|||
125613948|NCT01576016|451869456|FG001|MRI Safety|Withdrawal by Subject|10|||
125613949|NCT01576016|451869455|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
125613950|NCT01576016|451869456|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
125613951|NCT01576016|451869455|FG000|MRI Safety|Has not yet completed MRI scan|0|||
125613952|NCT01576016|451869456|FG001|MRI Safety|Has not yet completed MRI scan|56|||
125613953|NCT01576016|451869455|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
125613954|NCT01576016|451869456|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
125613955|NCT01163253|451869459|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
125613956|NCT01163253|451869460|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
125613957|NCT01163253|451869459|FG000|Overall Study|Study Terminated by Sponsor|978|||
125613958|NCT01163253|451869460|FG001|Overall Study|Study Terminated by Sponsor|349|||
125613959|NCT01163253|451869459|FG000|Overall Study|Protocol Violation|43|||
125613960|NCT01163253|451869460|FG001|Overall Study|Protocol Violation|12|||
125613961|NCT01163253|451869459|FG000|Overall Study|Withdrawal by Subject|199|||
125613962|NCT01163253|451869460|FG001|Overall Study|Withdrawal by Subject|50|||
125613963|NCT01163253|451869459|FG000|Overall Study|Medication Error|1|||
125613964|NCT01163253|451869460|FG001|Overall Study|Medication Error|0|||
125613965|NCT01163253|451869459|FG000|Overall Study|Lost to Follow-up|125|||
125613966|NCT01163253|451869460|FG001|Overall Study|Lost to Follow-up|23|||
125613967|NCT01163253|451869459|FG000|Overall Study|Insufficient Clinical Response|423|||
125613968|NCT01163253|451869460|FG001|Overall Study|Insufficient Clinical Response|29|||
125613969|NCT01163253|451869459|FG000|Overall Study|Adverse Event|300|||
125613970|NCT01163253|451869460|FG001|Overall Study|Adverse Event|78|||
125613971|NCT01163253|451869459|FG000|Overall Study|Death|17|||
125613972|NCT01163253|451869460|FG001|Overall Study|Death|5|||
125613973|NCT01163253|451869459|FG000|Overall Study|Ongoing|13|||
125613974|NCT01163253|451869460|FG001|Overall Study|Ongoing|4|||
125613975|NCT01163253|451869459|FG000|Overall Study|Other Unspecified|170|||
125613976|NCT01163253|451869460|FG001|Overall Study|Other Unspecified|34|||
125613977|NCT01188564|451869461|FG000|Double-blind Phase|randomized not treated|1|||
125613978|NCT01188564|451869462|FG001|Double-blind Phase|randomized not treated|0|||
125613979|NCT02492997|451869463|FG000|Overall Study|Withdrawal by Subject|1|||
125613980|NCT02492997|451869464|FG001|Overall Study|Withdrawal by Subject|0|||
125613981|NCT02492997|451869463|FG000|Overall Study|Gained Weight|1|||
125613982|NCT02492997|451869464|FG001|Overall Study|Gained Weight|0|||
125613983|NCT02492997|451869463|FG000|Overall Study|Lost to Follow-up|0|||
125613984|NCT02492997|451869464|FG001|Overall Study|Lost to Follow-up|1|||
125613985|NCT00579501|451869465|FG000|Overall Study|Death|1|||
125613986|NCT00579501|451869465|FG000|Overall Study|End of neoadjuvant therapy|25|||
125613987|NCT00579501|451869465|FG000|Overall Study|toxicity|1|||
125613988|NCT00579501|451869465|FG000|Overall Study|Secondary lesion|1|||
125613989|NCT00579501|451869465|FG000|Overall Study|Radiation therapy before surgery|1|||
125613990|NCT03025217|451869466|FG000|Overall Study|Pregnancy|1|||
125613991|NCT03025217|451869466|FG000|Overall Study|Lost to Follow-up|1|||
125613992|NCT03025217|451869466|FG000|Overall Study|Not eligible, poor English|2|||
125613993|NCT04069156|451869467|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
125613994|NCT04069156|451869468|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
125613995|NCT04069156|451869467|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
125613996|NCT04069156|451869468|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
125613997|NCT04069156|451869467|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
125613998|NCT04069156|451869468|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
125613999|NCT04069156|451869467|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
125614000|NCT04069156|451869468|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
125614001|NCT02208024|451869469|FG000|Overall Study|Withdrawal by Subject|1|||
125614002|NCT02207556|451869470|FG000|Overall Study|Physician Decision|1|||
125614003|NCT02207556|451869471|FG001|Overall Study|Physician Decision|0|||
125614004|NCT02207556|451869470|FG000|Overall Study|Withdrawal by Subject|1|||
125614005|NCT02207556|451869471|FG001|Overall Study|Withdrawal by Subject|0|||
125614006|NCT02207556|451869470|FG000|Overall Study|Death|0|||
125614007|NCT02207556|451869471|FG001|Overall Study|Death|5|||
125614008|NCT03558555|451869472|FG000|Overall Study|Lost to Follow-up|2|||
125614009|NCT03558555|451869473|FG001|Overall Study|Lost to Follow-up|1|||
125614010|NCT01958125|451869474|FG000|Overall Study|Missing diary data|2|||
125614011|NCT01958125|451869475|FG001|Overall Study|Missing diary data|6|||
125614012|NCT01958125|451869474|FG000|Overall Study|No headache attacks|0|||
125614013|NCT01958125|451869475|FG001|Overall Study|No headache attacks|2|||
125614014|NCT00194025|451869476|FG000|Overall Study|Adverse Event|1|||
125614015|NCT00194025|451869476|FG000|Overall Study|non-adherence with study medication|4|||
125614016|NCT04804033|451869478|FG000|Period 1: DBT Phase|Adverse Event|1|||
125614017|NCT04804033|451869479|FG001|Period 1: DBT Phase|Adverse Event|5|||
125614018|NCT04804033|451869480|FG002|Period 1: DBT Phase|Adverse Event|3|||
125614019|NCT04804033|451869481|FG003|Period 1: DBT Phase|Adverse Event|4|||
125614020|NCT04804033|451869478|FG000|Period 1: DBT Phase|Death|1|||
125614021|NCT04804033|451869479|FG001|Period 1: DBT Phase|Death|0|||
125614022|NCT04804033|451869480|FG002|Period 1: DBT Phase|Death|0|||
125614023|NCT04804033|451869481|FG003|Period 1: DBT Phase|Death|0|||
125614024|NCT04804033|451869478|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
125614025|NCT04804033|451869479|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
125614026|NCT04804033|451869480|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
125614027|NCT04804033|451869481|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
125614028|NCT04804033|451869478|FG000|Period 1: DBT Phase|Non-compliance|1|||
125614029|NCT04804033|451869479|FG001|Period 1: DBT Phase|Non-compliance|0|||
125614030|NCT04804033|451869480|FG002|Period 1: DBT Phase|Non-compliance|1|||
125614031|NCT04804033|451869481|FG003|Period 1: DBT Phase|Non-compliance|2|||
125614032|NCT04804033|451869478|FG000|Period 1: DBT Phase|Other|0|||
125614033|NCT04804033|451869479|FG001|Period 1: DBT Phase|Other|1|||
125614034|NCT04804033|451869480|FG002|Period 1: DBT Phase|Other|0|||
125614035|NCT04804033|451869481|FG003|Period 1: DBT Phase|Other|0|||
125614036|NCT04804033|451869478|FG000|Period 1: DBT Phase|Pregnancy|2|||
125614037|NCT04804033|451869479|FG001|Period 1: DBT Phase|Pregnancy|0|||
125614038|NCT04804033|451869480|FG002|Period 1: DBT Phase|Pregnancy|0|||
125614039|NCT04804033|451869481|FG003|Period 1: DBT Phase|Pregnancy|0|||
125614040|NCT04804033|451869478|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
125614041|NCT04804033|451869479|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
125614042|NCT04804033|451869480|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
125614043|NCT04804033|451869481|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
125614044|NCT04804033|451869478|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
125614045|NCT04804033|451869479|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
125614046|NCT04804033|451869480|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
125614047|NCT04804033|451869481|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
125614048|NCT04804033|451869478|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
125614049|NCT04804033|451869479|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
125614050|NCT04804033|451869480|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
125614051|NCT04804033|451869481|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
125614052|NCT04804033|451869478|FG000|Period 2: OLE Phase|Adverse Event|3|||
125614053|NCT04804033|451869479|FG001|Period 2: OLE Phase|Adverse Event|4|||
125614054|NCT04804033|451869480|FG002|Period 2: OLE Phase|Adverse Event|2|||
125614055|NCT04804033|451869481|FG003|Period 2: OLE Phase|Adverse Event|0|||
125614056|NCT04804033|451869478|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
125614057|NCT04804033|451869479|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
125614058|NCT04804033|451869480|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
125614059|NCT04804033|451869481|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
125614060|NCT04804033|451869478|FG000|Period 2: OLE Phase|Non-compliance|2|||
125614061|NCT04804033|451869479|FG001|Period 2: OLE Phase|Non-compliance|2|||
125614062|NCT04804033|451869480|FG002|Period 2: OLE Phase|Non-compliance|0|||
125614063|NCT04804033|451869481|FG003|Period 2: OLE Phase|Non-compliance|1|||
125614064|NCT04804033|451869478|FG000|Period 2: OLE Phase|Other|0|||
125614065|NCT04804033|451869479|FG001|Period 2: OLE Phase|Other|2|||
125614066|NCT04804033|451869480|FG002|Period 2: OLE Phase|Other|0|||
125614067|NCT04804033|451869481|FG003|Period 2: OLE Phase|Other|0|||
125614068|NCT04804033|451869478|FG000|Period 2: OLE Phase|Physician Decision|1|||
125614069|NCT04804033|451869479|FG001|Period 2: OLE Phase|Physician Decision|1|||
125614070|NCT04804033|451869480|FG002|Period 2: OLE Phase|Physician Decision|0|||
125614071|NCT04804033|451869481|FG003|Period 2: OLE Phase|Physician Decision|0|||
125614072|NCT04804033|451869478|FG000|Period 2: OLE Phase|Pregnancy|0|||
125614073|NCT04804033|451869479|FG001|Period 2: OLE Phase|Pregnancy|0|||
125614074|NCT04804033|451869480|FG002|Period 2: OLE Phase|Pregnancy|2|||
125614075|NCT04804033|451869481|FG003|Period 2: OLE Phase|Pregnancy|0|||
125614076|NCT04804033|451869478|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
125614077|NCT04804033|451869479|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
125614078|NCT04804033|451869480|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
125614079|NCT04804033|451869481|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
125614080|NCT04804033|451869478|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
125614081|NCT04804033|451869479|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
125614082|NCT04804033|451869480|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
125614083|NCT04804033|451869481|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
125614084|NCT04804033|451869478|FG000|Period 2: OLE Phase|Not reported|0|||
125614085|NCT04804033|451869479|FG001|Period 2: OLE Phase|Not reported|2|||
125614086|NCT04804033|451869480|FG002|Period 2: OLE Phase|Not reported|0|||
125614087|NCT04804033|451869481|FG003|Period 2: OLE Phase|Not reported|0|||
125614088|NCT04804033|451869478|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
125614089|NCT04804033|451869479|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
125614090|NCT04804033|451869480|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
125614091|NCT04804033|451869481|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
125614092|NCT04804033|451869478|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
125614093|NCT04804033|451869479|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
125614094|NCT04804033|451869480|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
125614095|NCT04804033|451869481|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
125614096|NCT04804033|451869478|FG000|Period 3: Follow-up Phase|Other|0|||
125614097|NCT04804033|451869479|FG001|Period 3: Follow-up Phase|Other|1|||
125614098|NCT04804033|451869480|FG002|Period 3: Follow-up Phase|Other|2|||
125614099|NCT04804033|451869481|FG003|Period 3: Follow-up Phase|Other|1|||
125614100|NCT04804033|451869478|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
125614101|NCT04804033|451869479|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
125614102|NCT04804033|451869480|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
125614103|NCT04804033|451869481|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
125214488|NCT00571103|450412860|FG000|Overall Study|Withdrawal by Subject|1|||
125214489|NCT00571103|450412860|FG000|Overall Study|Lost to Follow-up|1|||
125214490|NCT01308463|450412862|FG000|Overall Study|Study Discontinued|23|||
125214491|NCT01308463|450412862|FG000|Overall Study|Death|4|||
125214492|NCT01308463|450412862|FG000|Overall Study|Revision|2|||
125214493|NCT03297021|450412863|FG000|Overall Study|Incomplete/illegible data sheet|4|||
125214494|NCT03297021|450412864|FG001|Overall Study|Incomplete/illegible data sheet|2|||
125214495|NCT03297021|450412865|FG002|Overall Study|Incomplete/illegible data sheet|3|||
125214496|NCT03297021|450412863|FG000|Overall Study|Missing Post-Op Data|1|||
125214497|NCT03297021|450412864|FG001|Overall Study|Missing Post-Op Data|2|||
125214498|NCT03297021|450412865|FG002|Overall Study|Missing Post-Op Data|1|||
125214499|NCT00948922|450412867|FG000|Overall Study|Did not start study treatment|2|||
125214500|NCT00948922|450412868|FG001|Overall Study|Did not start study treatment|5|||
125214501|NCT00948922|450412869|FG002|Overall Study|Did not start study treatment|0|||
125214502|NCT00948922|450412867|FG000|Overall Study|Withdrawal by Subject|0|||
125214503|NCT00948922|450412868|FG001|Overall Study|Withdrawal by Subject|2|||
125214504|NCT00948922|450412869|FG002|Overall Study|Withdrawal by Subject|1|||
125214505|NCT00948922|450412867|FG000|Overall Study|Death|3|||
125214506|NCT00948922|450412868|FG001|Overall Study|Death|0|||
125214507|NCT00948922|450412869|FG002|Overall Study|Death|0|||
125214508|NCT00948922|450412867|FG000|Overall Study|Disease progression|0|||
125214509|NCT00948922|450412868|FG001|Overall Study|Disease progression|1|||
125214510|NCT00948922|450412869|FG002|Overall Study|Disease progression|0|||
125214511|NCT00948922|450412867|FG000|Overall Study|Insurance issues|1|||
125214512|NCT00948922|450412868|FG001|Overall Study|Insurance issues|0|||
125214513|NCT00948922|450412869|FG002|Overall Study|Insurance issues|0|||
125614104|NCT04804033|451869478|FG000|Period 3: Follow-up Phase|Not reported|18|||
125614105|NCT04804033|451869479|FG001|Period 3: Follow-up Phase|Not reported|15|||
125614106|NCT04804033|451869480|FG002|Period 3: Follow-up Phase|Not reported|1|||
125614107|NCT04804033|451869481|FG003|Period 3: Follow-up Phase|Not reported|4|||
125614108|NCT02130427|451869482|FG000|Overall Study|Imaging results not interpretable|30|||
125614109|NCT00543569|451869487|FG000|Overall Study|Death|2|||
125614110|NCT00543569|451869488|FG001|Overall Study|Death|2|||
125214514|NCT00948922|450412867|FG000|Overall Study|Transplant eligibility issues|2|||
125372861|NCT01737697|450995092|FG004|Subacute Phase|Protocol Violation|0|||
125372862|NCT01737697|450995093|FG005|Subacute Phase|Protocol Violation|1|||
125372863|NCT01737697|450995094|FG006|Subacute Phase|Protocol Violation|0|||
125614111|NCT00543569|451869489|FG002|Overall Study|Death|3|||
125214515|NCT00948922|450412868|FG001|Overall Study|Transplant eligibility issues|3|||
125372864|NCT01737697|450995095|FG007|Subacute Phase|Protocol Violation|0|||
125372865|NCT01737697|450995096|FG008|Subacute Phase|Protocol Violation|0|||
125372866|NCT01737697|450995097|FG009|Subacute Phase|Protocol Violation|0|||
125614112|NCT00543569|451869490|FG003|Overall Study|Death|1|||
125614113|NCT00543569|451869487|FG000|Overall Study|Lost to Follow-up|0|||
125614114|NCT00543569|451869488|FG001|Overall Study|Lost to Follow-up|0|||
125614115|NCT00543569|451869489|FG002|Overall Study|Lost to Follow-up|1|||
125614116|NCT00543569|451869490|FG003|Overall Study|Lost to Follow-up|1|||
125614117|NCT00543569|451869487|FG000|Overall Study|Miscellaneous Reasons|7|||
125614118|NCT00543569|451869488|FG001|Overall Study|Miscellaneous Reasons|3|||
125614119|NCT00543569|451869489|FG002|Overall Study|Miscellaneous Reasons|11|||
125614120|NCT00543569|451869490|FG003|Overall Study|Miscellaneous Reasons|4|||
125614121|NCT00543569|451869487|FG000|Overall Study|Randomized but never received study drug|3|||
125614122|NCT00543569|451869488|FG001|Overall Study|Randomized but never received study drug|3|||
125614123|NCT00543569|451869489|FG002|Overall Study|Randomized but never received study drug|5|||
125614124|NCT00543569|451869490|FG003|Overall Study|Randomized but never received study drug|3|||
125614125|NCT00781599|451869495|FG000|Overall Study|Lost to Follow-up|7|||
125614126|NCT00781599|451869496|FG001|Overall Study|Lost to Follow-up|4|||
125614127|NCT00089479|451869502|FG000|Overall Study|Death|108|||
125614128|NCT00089479|451869503|FG001|Overall Study|Death|75|||
125614129|NCT00089479|451869502|FG000|Overall Study|Withdrawal by Subject|86|||
125614130|NCT00089479|451869503|FG001|Overall Study|Withdrawal by Subject|107|||
125614131|NCT00089479|451869502|FG000|Overall Study|Lost to Follow-up|137|||
125614132|NCT00089479|451869503|FG001|Overall Study|Lost to Follow-up|107|||
125614133|NCT01124448|451869506|FG000|Overall Study|Lost to Follow-up|0|||
125614134|NCT01124448|451869507|FG001|Overall Study|Lost to Follow-up|3|||
125614135|NCT01124448|451869506|FG000|Overall Study|Protocol Violation|2|||
125614136|NCT01124448|451869507|FG001|Overall Study|Protocol Violation|0|||
125614137|NCT03198754|451869508|FG000|Overall Study|Withdrawal by Subject|5|||
125614138|NCT03198754|451869509|FG001|Overall Study|Withdrawal by Subject|4|||
125614139|NCT03198754|451869508|FG000|Overall Study|Lost to Follow-up|4|||
125614140|NCT03198754|451869509|FG001|Overall Study|Lost to Follow-up|3|||
125614141|NCT03198754|451869508|FG000|Overall Study|Ineligible|2|||
125614142|NCT03198754|451869509|FG001|Overall Study|Ineligible|1|||
125614143|NCT01968187|451869516|FG000|Overall Study|Adverse Event|0|||
125614144|NCT01968187|451869517|FG001|Overall Study|Adverse Event|1|||
125614145|NCT01968187|451869516|FG000|Overall Study|Randomized but not treated|1|||
125614146|NCT01968187|451869517|FG001|Overall Study|Randomized but not treated|0|||
125372867|NCT01737697|450995098|FG010|Subacute Phase|Protocol Violation|1|||
125372868|NCT01737697|450995099|FG011|Subacute Phase|Protocol Violation|0|||
125372869|NCT01737697|450995100|FG012|Subacute Phase|Protocol Violation|0|||
125372870|NCT01737697|450995101|FG013|Subacute Phase|Protocol Violation|0|||
125372871|NCT01737697|450995102|FG014|Subacute Phase|Protocol Violation|0|||
125372872|NCT01737697|450995088|FG000|Subacute Phase|Physician Decision|0|||
125372873|NCT01737697|450995089|FG001|Subacute Phase|Physician Decision|0|||
125372874|NCT01737697|450995090|FG002|Subacute Phase|Physician Decision|0|||
125372875|NCT01737697|450995091|FG003|Subacute Phase|Physician Decision|0|||
125372876|NCT01737697|450995092|FG004|Subacute Phase|Physician Decision|0|||
125372877|NCT01737697|450995093|FG005|Subacute Phase|Physician Decision|0|||
125372878|NCT01737697|450995094|FG006|Subacute Phase|Physician Decision|0|||
125372879|NCT01737697|450995095|FG007|Subacute Phase|Physician Decision|0|||
125372880|NCT01737697|450995096|FG008|Subacute Phase|Physician Decision|1|||
125372881|NCT01737697|450995097|FG009|Subacute Phase|Physician Decision|0|||
125372882|NCT01737697|450995098|FG010|Subacute Phase|Physician Decision|0|||
125372883|NCT01737697|450995099|FG011|Subacute Phase|Physician Decision|0|||
125372884|NCT01737697|450995100|FG012|Subacute Phase|Physician Decision|0|||
125372885|NCT01737697|450995101|FG013|Subacute Phase|Physician Decision|0|||
125372886|NCT01737697|450995102|FG014|Subacute Phase|Physician Decision|0|||
125372887|NCT01737697|450995088|FG000|Subacute Phase|Death|0|||
125372888|NCT01737697|450995089|FG001|Subacute Phase|Death|0|||
125372889|NCT01737697|450995090|FG002|Subacute Phase|Death|0|||
125372890|NCT01737697|450995091|FG003|Subacute Phase|Death|0|||
125372891|NCT01737697|450995092|FG004|Subacute Phase|Death|0|||
125372892|NCT01737697|450995093|FG005|Subacute Phase|Death|0|||
125372893|NCT01737697|450995094|FG006|Subacute Phase|Death|0|||
125372894|NCT01737697|450995095|FG007|Subacute Phase|Death|0|||
125372895|NCT01737697|450995096|FG008|Subacute Phase|Death|0|||
125372896|NCT01737697|450995097|FG009|Subacute Phase|Death|0|||
125372897|NCT01737697|450995098|FG010|Subacute Phase|Death|1|||
125372898|NCT01737697|450995099|FG011|Subacute Phase|Death|0|||
125372899|NCT01737697|450995100|FG012|Subacute Phase|Death|0|||
125372900|NCT01737697|450995101|FG013|Subacute Phase|Death|0|||
125372901|NCT01737697|450995102|FG014|Subacute Phase|Death|0|||
125372902|NCT03338998|450995104|FG000|Treatment Period|Withdrawal by Subject|1|||
125372903|NCT03338998|450995105|FG001|Treatment Period|Withdrawal by Subject|1|||
125372904|NCT03338998|450995104|FG000|Treatment Period|Adverse Event|0|||
125372905|NCT03338998|450995105|FG001|Treatment Period|Adverse Event|2|||
125372906|NCT03338998|450995104|FG000|Treatment Period|Protocol deviation|1|||
125372907|NCT03338998|450995105|FG001|Treatment Period|Protocol deviation|0|||
125372908|NCT03338998|450995104|FG000|Treatment Period|Physician Decision|2|||
125372909|NCT03338998|450995105|FG001|Treatment Period|Physician Decision|0|||
125372910|NCT03338998|450995104|FG000|Treatment Period|Subject failed swallow test|4|||
125372911|NCT03338998|450995105|FG001|Treatment Period|Subject failed swallow test|0|||
125372912|NCT03338998|450995104|FG000|Safety Follow-Up Period|Adverse Event|0|||
125614147|NCT04095286|451869518|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125614148|NCT04095286|451869519|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
125214516|NCT00948922|450412869|FG002|Overall Study|Transplant eligibility issues|0|||
125372913|NCT03338998|450995105|FG001|Safety Follow-Up Period|Adverse Event|1|||
125372914|NCT03338998|450995104|FG000|Safety Follow-Up Period|Protocol deviation|1|||
125372915|NCT03338998|450995105|FG001|Safety Follow-Up Period|Protocol deviation|0|||
125372916|NCT03338998|450995104|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
125372917|NCT03338998|450995105|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
125372918|NCT03288129|450995106|FG000|Overall Study|Adverse Event|10|||
125372919|NCT03288129|450995106|FG000|Overall Study|Lost to Follow-up|3|||
125372920|NCT03288129|450995106|FG000|Overall Study|Withdrawal by Subject|3|||
125372921|NCT03288129|450995106|FG000|Overall Study|Withdrawal of consent/assent|1|||
125614149|NCT04095286|451869520|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125614150|NCT04095286|451869521|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125614151|NCT04095286|451869522|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125614152|NCT04095286|451869523|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125614153|NCT04095286|451869518|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
125614154|NCT04095286|451869519|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
125614155|NCT04095286|451869520|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
125614156|NCT04095286|451869521|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
125614157|NCT04095286|451869522|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
125614158|NCT04095286|451869523|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
125372922|NCT03288129|450995106|FG000|Overall Study|Other|5|||
125372923|NCT04404361|450995111|FG000|Overall Study|Death|12|||
125614159|NCT04095286|451869518|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
125614160|NCT04095286|451869519|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
125614161|NCT04095286|451869520|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
125614162|NCT04095286|451869521|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
125372924|NCT04404361|450995112|FG001|Overall Study|Death|12|||
125372925|NCT04404361|450995111|FG000|Overall Study|Withdrawal by Subject|13|||
125614163|NCT04095286|451869522|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
125614164|NCT04095286|451869523|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
125614165|NCT04095286|451869518|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125614166|NCT04095286|451869519|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125614167|NCT04095286|451869520|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
125614168|NCT04095286|451869521|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125614169|NCT04095286|451869522|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125614170|NCT04095286|451869523|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
125614171|NCT04095286|451869518|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
125614172|NCT04095286|451869519|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
125614173|NCT04095286|451869520|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
125614174|NCT04095286|451869521|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
125614175|NCT04095286|451869522|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
125614176|NCT04095286|451869523|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
125614177|NCT04092816|451871637|FG000|Overall Study|Lost to Follow-up|1|||
125614178|NCT04092816|451871638|FG001|Overall Study|Lost to Follow-up|2|||
125614179|NCT00487084|451871644|FG000|Overall Study|Did not receive intervention|4|||
125614180|NCT00487084|451871645|FG001|Overall Study|Did not receive intervention|3|||
125614181|NCT00487084|451871646|FG002|Overall Study|Did not receive intervention|5|||
125614182|NCT00254293|451871647|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
125614183|NCT00254293|451871648|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
125614184|NCT00254293|451871649|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
125614185|NCT00254293|451871650|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
125614186|NCT00254293|451871651|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
125614187|NCT00254293|451871652|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
125614188|NCT00254293|451871653|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
125614189|NCT00254293|451871647|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
125614190|NCT00254293|451871648|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
125614191|NCT00254293|451871649|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
125614192|NCT00254293|451871650|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
125614193|NCT00254293|451871651|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
125614194|NCT00254293|451871652|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
125614195|NCT00254293|451871653|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
125614196|NCT00254293|451871647|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
125614197|NCT00254293|451871648|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
125614198|NCT00254293|451871649|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
125614199|NCT00254293|451871650|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
125614200|NCT00254293|451871651|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
125614201|NCT00254293|451871652|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
125614202|NCT00254293|451871653|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
125614203|NCT00254293|451871647|FG000|LTE Open Label Variable SC Dosing|Death|0|||
125614204|NCT00254293|451871648|FG001|LTE Open Label Variable SC Dosing|Death|0|||
125614205|NCT00254293|451871649|FG002|LTE Open Label Variable SC Dosing|Death|1|||
125614206|NCT00254293|451871650|FG003|LTE Open Label Variable SC Dosing|Death|0|||
125614207|NCT00254293|451871651|FG004|LTE Open Label Variable SC Dosing|Death|0|||
125614208|NCT00254293|451871652|FG005|LTE Open Label Variable SC Dosing|Death|0|||
125614209|NCT00254293|451871653|FG006|LTE Open Label Variable SC Dosing|Death|0|||
125614210|NCT00254293|451871647|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
125614211|NCT00254293|451871648|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
125614212|NCT00254293|451871649|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
125614213|NCT00254293|451871650|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
125614214|NCT00254293|451871651|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
125614215|NCT00254293|451871652|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
125614216|NCT00254293|451871653|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
125614217|NCT00254293|451871647|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
125614218|NCT00254293|451871648|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
125614219|NCT00254293|451871649|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
125614220|NCT00254293|451871650|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
125614221|NCT00254293|451871651|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
125614222|NCT00254293|451871652|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
125614223|NCT00254293|451871653|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
125614224|NCT00254293|451871647|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
125614225|NCT00254293|451871648|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
125614226|NCT00254293|451871649|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
125614227|NCT00254293|451871650|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
125614228|NCT00254293|451871651|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
125614229|NCT00254293|451871652|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
125614230|NCT00254293|451871653|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
125614231|NCT00254293|451871647|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
125614232|NCT00254293|451871648|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
125614233|NCT00254293|451871649|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
125614234|NCT00254293|451871650|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
125614235|NCT00254293|451871651|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
125614236|NCT00254293|451871652|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
125614237|NCT00254293|451871653|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
125614238|NCT00254293|451871647|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
125614239|NCT00254293|451871648|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
125614240|NCT00254293|451871649|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
125614241|NCT00254293|451871650|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
125614242|NCT00254293|451871651|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
125614243|NCT00254293|451871652|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
125614244|NCT00254293|451871653|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
125614245|NCT00254293|451871647|FG000|LTE Open Label Variable SC Dosing|Other|0|||
125614246|NCT00254293|451871648|FG001|LTE Open Label Variable SC Dosing|Other|0|||
125614247|NCT00254293|451871649|FG002|LTE Open Label Variable SC Dosing|Other|2|||
125614248|NCT00254293|451871650|FG003|LTE Open Label Variable SC Dosing|Other|0|||
125614249|NCT00254293|451871651|FG004|LTE Open Label Variable SC Dosing|Other|0|||
125614250|NCT00254293|451871652|FG005|LTE Open Label Variable SC Dosing|Other|0|||
125614251|NCT00254293|451871653|FG006|LTE Open Label Variable SC Dosing|Other|0|||
125614252|NCT00254293|451871647|FG000|LTE Open Label Fixed Dosing|Death|0|||
125614253|NCT00254293|451871648|FG001|LTE Open Label Fixed Dosing|Death|0|||
125614254|NCT00254293|451871649|FG002|LTE Open Label Fixed Dosing|Death|0|||
125614255|NCT00254293|451871650|FG003|LTE Open Label Fixed Dosing|Death|0|||
125614256|NCT00254293|451871651|FG004|LTE Open Label Fixed Dosing|Death|0|||
125614257|NCT00254293|451871652|FG005|LTE Open Label Fixed Dosing|Death|0|||
125614258|NCT00254293|451871653|FG006|LTE Open Label Fixed Dosing|Death|3|||
125614259|NCT00254293|451871647|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
125614260|NCT00254293|451871648|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
125614261|NCT00254293|451871649|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
125614262|NCT00254293|451871650|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
125614263|NCT00254293|451871651|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
125614264|NCT00254293|451871652|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
125614265|NCT00254293|451871653|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
125614266|NCT00254293|451871647|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
125614267|NCT00254293|451871648|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
125614268|NCT00254293|451871649|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
125614269|NCT00254293|451871650|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
125614270|NCT00254293|451871651|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
125614271|NCT00254293|451871652|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
125614272|NCT00254293|451871653|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
125614273|NCT00254293|451871647|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
125614274|NCT00254293|451871648|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
125614275|NCT00254293|451871649|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
125614276|NCT00254293|451871650|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
125614277|NCT00254293|451871651|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
125614278|NCT00254293|451871652|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
125614279|NCT00254293|451871653|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
125614280|NCT00254293|451871647|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
125614281|NCT00254293|451871648|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
125614282|NCT00254293|451871649|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
125614283|NCT00254293|451871650|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
125614284|NCT00254293|451871651|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
125614285|NCT00254293|451871652|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
125614286|NCT00254293|451871653|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
125614287|NCT00254293|451871647|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
125614288|NCT00254293|451871648|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
125614289|NCT00254293|451871649|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
125614290|NCT00254293|451871650|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
125614291|NCT00254293|451871651|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
125614292|NCT00254293|451871652|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
125614293|NCT00254293|451871653|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
125614294|NCT00254293|451871647|FG000|LTE Open Label Fixed Dosing|Other|0|||
125614295|NCT00254293|451871648|FG001|LTE Open Label Fixed Dosing|Other|0|||
125614296|NCT00254293|451871649|FG002|LTE Open Label Fixed Dosing|Other|0|||
125614297|NCT00254293|451871650|FG003|LTE Open Label Fixed Dosing|Other|0|||
125614298|NCT00254293|451871651|FG004|LTE Open Label Fixed Dosing|Other|0|||
125614299|NCT00254293|451871652|FG005|LTE Open Label Fixed Dosing|Other|0|||
125614300|NCT00254293|451871653|FG006|LTE Open Label Fixed Dosing|Other|1|||
125614301|NCT02690207|451871661|FG000|Overall Study|Lost to Follow-up|48|||
125614302|NCT02690207|451871661|FG000|Overall Study|Withdrawal by Subject|46|||
125614303|NCT02690207|451871661|FG000|Overall Study|Protocol Violation|2|||
125614304|NCT02690207|451871661|FG000|Overall Study|Serious adverse event|110|||
125614305|NCT02690207|451871661|FG000|Overall Study|Non-serious Adverse Event|18|||
125614306|NCT02690207|451871661|FG000|Overall Study|Migrated/moved from study area|5|||
125614307|NCT02690207|451871661|FG000|Overall Study|Suspected HZ Episode|1|||
125614308|NCT02690207|451871661|FG000|Overall Study|Other reasons for withdrawal|23|||
125614309|NCT01626352|451871662|FG000|Overall Study|Disease Progression|3|||
125614310|NCT01626352|451871662|FG000|Overall Study|Intercurrent Illness|2|||
125614311|NCT01626352|451871662|FG000|Overall Study|Death|2|||
125614312|NCT01626352|451871662|FG000|Overall Study|Withdrawal by Subject|1|||
125614313|NCT01626352|451871662|FG000|Overall Study|Non-Compliance|1|||
125614314|NCT01626352|451871662|FG000|Overall Study|Never Treated|1|||
125614315|NCT04348656|451871665|FG000|Overall Study|Withdrawal by Subject|2|||
125614316|NCT04348656|451871666|FG001|Overall Study|Withdrawal by Subject|0|||
125614317|NCT04348656|451871665|FG000|Overall Study|Lost to Follow-up|11|||
125614318|NCT04348656|451871666|FG001|Overall Study|Lost to Follow-up|6|||
125614319|NCT00937560|451871673|FG000|Initial Treatment|Death|6|||
125614320|NCT00937560|451871673|FG000|Initial Treatment|Withdraw consent|3|||
125614321|NCT00937560|451871673|FG000|Initial Treatment|Adverse Event|1|||
125614322|NCT00937560|451871673|FG000|Initial Treatment|Lost to Follow-up|1|||
125614323|NCT00937560|451871673|FG000|Initial Treatment|No end of study page|10|||
125614324|NCT00937560|451871673|FG000|Maintenance Treatment|Death|12|||
125614325|NCT00937560|451871673|FG000|Maintenance Treatment|Withdraw consent|5|||
125614326|NCT00937560|451871673|FG000|Maintenance Treatment|According to protocol|1|||
125614327|NCT02488551|451871678|FG000|Overall Study|Lost to Follow-up|4|||
125614328|NCT02488551|451871679|FG001|Overall Study|Lost to Follow-up|7|||
125614329|NCT02488551|451871680|FG002|Overall Study|Lost to Follow-up|0|||
125614330|NCT02488551|451871681|FG003|Overall Study|Lost to Follow-up|0|||
125614331|NCT02488551|451871678|FG000|Overall Study|Military Deployment|1|||
125614332|NCT02488551|451871679|FG001|Overall Study|Military Deployment|1|||
125614333|NCT02488551|451871680|FG002|Overall Study|Military Deployment|0|||
125614334|NCT02488551|451871681|FG003|Overall Study|Military Deployment|0|||
125614335|NCT03364608|451871682|FG000|Overall Study|Withdrawal by Subject|4|||
125614336|NCT03364608|451871682|FG000|Overall Study|Protocol Violation|2|||
125614337|NCT03364608|451871682|FG000|Overall Study|Lost to Follow-up|2|||
125614338|NCT02546674|451871689|FG000|Overall Study|Adverse Event|19|||
125614339|NCT02546674|451871689|FG000|Overall Study|Death|1|||
125614340|NCT02546674|451871689|FG000|Overall Study|Lost to Follow-up|1|||
125614341|NCT02546674|451871689|FG000|Overall Study|Physician Decision|13|||
125614342|NCT02546674|451871689|FG000|Overall Study|Pregnancy|1|||
125614343|NCT02546674|451871689|FG000|Overall Study|Progressive Disease|2|||
125614344|NCT02546674|451871689|FG000|Overall Study|Protocol Deviation|2|||
125614345|NCT02546674|451871689|FG000|Overall Study|Subject/Guardian Decision|6|||
125372926|NCT04404361|450995112|FG001|Overall Study|Withdrawal by Subject|5|||
125372927|NCT04404361|450995111|FG000|Overall Study|Lost to Follow-up|6|||
125372928|NCT04404361|450995112|FG001|Overall Study|Lost to Follow-up|3|||
125372929|NCT04404361|450995111|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
125372930|NCT04404361|450995112|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
125372931|NCT00558558|450995113|FG000|Overall Study|Unable to swallow|1|||
125372932|NCT00558558|450995113|FG000|Overall Study|Withdrawal by Subject|1|||
125372933|NCT00558558|450995113|FG000|Overall Study|Lack of Efficacy|4|||
125372934|NCT02144012|450995114|FG000|Overall Study|Adverse Event|1|||
125372935|NCT02144012|450995115|FG001|Overall Study|Adverse Event|0|||
125372936|NCT02144012|450995114|FG000|Overall Study|Death|1|||
125372937|NCT02144012|450995115|FG001|Overall Study|Death|0|||
125372938|NCT02144012|450995114|FG000|Overall Study|Withdrawal by Subject|11|||
125372939|NCT02144012|450995115|FG001|Overall Study|Withdrawal by Subject|3|||
125372940|NCT02144012|450995114|FG000|Overall Study|Study Terminated by Sponsor|18|||
125372941|NCT02144012|450995115|FG001|Overall Study|Study Terminated by Sponsor|12|||
125372942|NCT02144012|450995114|FG000|Overall Study|Other|3|||
125372943|NCT02144012|450995115|FG001|Overall Study|Other|0|||
125372944|NCT02915016|450995116|FG000|Overall Study|Lost to Follow-up|4|||
125372945|NCT02915016|450995117|FG001|Overall Study|Lost to Follow-up|2|||
125372946|NCT02915016|450995118|FG002|Overall Study|Lost to Follow-up|5|||
125372947|NCT02915016|450995119|FG003|Overall Study|Lost to Follow-up|3|||
125372948|NCT02915016|450995120|FG004|Overall Study|Lost to Follow-up|5|||
125372949|NCT02915016|450995121|FG005|Overall Study|Lost to Follow-up|2|||
125372950|NCT02915016|450995122|FG006|Overall Study|Lost to Follow-up|8|||
125372951|NCT02915016|450995123|FG007|Overall Study|Lost to Follow-up|2|||
125372952|NCT02915016|450995116|FG000|Overall Study|Physician Decision|0|||
125372953|NCT02915016|450995117|FG001|Overall Study|Physician Decision|0|||
125372954|NCT02915016|450995118|FG002|Overall Study|Physician Decision|1|||
125372955|NCT02915016|450995119|FG003|Overall Study|Physician Decision|0|||
125372956|NCT02915016|450995120|FG004|Overall Study|Physician Decision|0|||
125372957|NCT02915016|450995121|FG005|Overall Study|Physician Decision|1|||
125372958|NCT02915016|450995122|FG006|Overall Study|Physician Decision|2|||
125372959|NCT02915016|450995123|FG007|Overall Study|Physician Decision|0|||
125372960|NCT02915016|450995116|FG000|Overall Study|Withdrawal by Subject|2|||
125372961|NCT02915016|450995117|FG001|Overall Study|Withdrawal by Subject|0|||
125372962|NCT02915016|450995118|FG002|Overall Study|Withdrawal by Subject|1|||
125372963|NCT02915016|450995119|FG003|Overall Study|Withdrawal by Subject|0|||
125372964|NCT02915016|450995120|FG004|Overall Study|Withdrawal by Subject|1|||
125372965|NCT02915016|450995121|FG005|Overall Study|Withdrawal by Subject|3|||
125372966|NCT02915016|450995122|FG006|Overall Study|Withdrawal by Subject|1|||
125614346|NCT02546674|451871689|FG000|Overall Study|Withdrawal of Informed Consent|3|||
125614347|NCT03888391|451871696|FG000|Overall Study|Lost to Follow-up|15|||
125614348|NCT00423735|451871698|FG000|Overall Study|Ineligible / No protocol treatment|8|||
125614349|NCT00423735|451871699|FG001|Overall Study|Ineligible / No protocol treatment|6|||
125614350|NCT00423735|451871700|FG002|Overall Study|Ineligible / No protocol treatment|0|||
125614351|NCT01954251|451871703|FG000|Overall Study|Adverse Event|5|||
125614352|NCT01954251|451871704|FG001|Overall Study|Adverse Event|7|||
125614353|NCT01954251|451871703|FG000|Overall Study|Lost to Follow-up|6|||
125614354|NCT01954251|451871704|FG001|Overall Study|Lost to Follow-up|6|||
125614355|NCT01954251|451871703|FG000|Overall Study|Withdrawal by Subject|2|||
125614356|NCT01954251|451871704|FG001|Overall Study|Withdrawal by Subject|6|||
125614357|NCT02864940|451871705|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
125614358|NCT02864940|451871706|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
125372967|NCT02915016|450995123|FG007|Overall Study|Withdrawal by Subject|1|||
125372968|NCT02915016|450995116|FG000|Overall Study|Elected not to continue|0|||
125372969|NCT02915016|450995117|FG001|Overall Study|Elected not to continue|0|||
125372970|NCT02915016|450995118|FG002|Overall Study|Elected not to continue|0|||
125614359|NCT02175771|451871711|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
125614360|NCT02175771|451871712|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125614361|NCT02175771|451871713|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125614362|NCT02175771|451871714|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125614363|NCT02175771|451871715|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125372971|NCT02915016|450995119|FG003|Overall Study|Elected not to continue|1|||
125372972|NCT02915016|450995120|FG004|Overall Study|Elected not to continue|0|||
125372973|NCT02915016|450995121|FG005|Overall Study|Elected not to continue|0|||
125372974|NCT02915016|450995122|FG006|Overall Study|Elected not to continue|1|||
125614364|NCT02175771|451871716|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125614365|NCT02175771|451871717|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125614366|NCT02175771|451871718|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125614367|NCT02175771|451871719|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125614368|NCT02175771|451871711|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
125614369|NCT02175771|451871712|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125614370|NCT02175771|451871713|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125372975|NCT02915016|450995123|FG007|Overall Study|Elected not to continue|0|||
125614371|NCT02175771|451871714|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125372976|NCT02915016|450995116|FG000|Overall Study|HIV infection|1|||
125614372|NCT02175771|451871715|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125614373|NCT02175771|451871716|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125614374|NCT02175771|451871717|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125614375|NCT02175771|451871718|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125614376|NCT02175771|451871719|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125614377|NCT02175771|451871711|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
125614378|NCT02175771|451871712|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125614379|NCT02175771|451871713|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125614380|NCT02175771|451871714|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125614381|NCT02175771|451871715|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125614382|NCT02175771|451871716|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125614383|NCT02175771|451871717|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125614384|NCT02175771|451871718|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125614385|NCT02175771|451871719|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125614386|NCT02175771|451871711|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
125614387|NCT02175771|451871712|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
125614388|NCT02175771|451871713|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
125614389|NCT02175771|451871714|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
125614390|NCT02175771|451871715|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
125614391|NCT02175771|451871716|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
125614392|NCT02175771|451871717|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
125614393|NCT02175771|451871718|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
125614394|NCT02175771|451871719|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
125614395|NCT02175771|451871711|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
125614396|NCT02175771|451871712|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125614397|NCT02175771|451871713|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125614398|NCT02175771|451871714|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125614399|NCT02175771|451871715|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125614400|NCT02175771|451871716|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125614401|NCT02175771|451871717|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125614402|NCT02175771|451871718|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125614403|NCT02175771|451871719|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125614404|NCT02175771|451871711|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
125614405|NCT02175771|451871712|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125614406|NCT02175771|451871713|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125614407|NCT02175771|451871714|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125614408|NCT02175771|451871715|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125614409|NCT02175771|451871716|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125614410|NCT02175771|451871717|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125614411|NCT02175771|451871718|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125614412|NCT02175771|451871719|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125614413|NCT02175771|451871711|FG000|Run-In Period (Pre-assignment)|Other|8|||
125614414|NCT02175771|451871712|FG001|Run-In Period (Pre-assignment)|Other|0|||
125614415|NCT02175771|451871713|FG002|Run-In Period (Pre-assignment)|Other|0|||
125614416|NCT02175771|451871714|FG003|Run-In Period (Pre-assignment)|Other|0|||
125614417|NCT02175771|451871715|FG004|Run-In Period (Pre-assignment)|Other|0|||
125614418|NCT02175771|451871716|FG005|Run-In Period (Pre-assignment)|Other|0|||
125614419|NCT02175771|451871717|FG006|Run-In Period (Pre-assignment)|Other|0|||
125614420|NCT02175771|451871718|FG007|Run-In Period (Pre-assignment)|Other|0|||
125614421|NCT02175771|451871719|FG008|Run-In Period (Pre-assignment)|Other|0|||
125614422|NCT02175771|451871711|FG000|Treatment Period|Adverse Event|0|||
125614423|NCT02175771|451871712|FG001|Treatment Period|Adverse Event|2|||
125614424|NCT02175771|451871713|FG002|Treatment Period|Adverse Event|1|||
125614425|NCT02175771|451871714|FG003|Treatment Period|Adverse Event|1|||
125614426|NCT02175771|451871715|FG004|Treatment Period|Adverse Event|1|||
125432067|NCT01336621|451207828|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
125614427|NCT02175771|451871716|FG005|Treatment Period|Adverse Event|3|||
125614428|NCT02175771|451871717|FG006|Treatment Period|Adverse Event|2|||
125614429|NCT02175771|451871718|FG007|Treatment Period|Adverse Event|0|||
125614430|NCT02175771|451871719|FG008|Treatment Period|Adverse Event|1|||
125614431|NCT02175771|451871711|FG000|Treatment Period|Withdrawal by Subject|0|||
125372977|NCT02915016|450995117|FG001|Overall Study|HIV infection|1|||
125372978|NCT02915016|450995118|FG002|Overall Study|HIV infection|1|||
125372979|NCT02915016|450995119|FG003|Overall Study|HIV infection|0|||
125372980|NCT02915016|450995120|FG004|Overall Study|HIV infection|1|||
125372981|NCT02915016|450995121|FG005|Overall Study|HIV infection|0|||
125372982|NCT02915016|450995122|FG006|Overall Study|HIV infection|0|||
125372983|NCT02915016|450995123|FG007|Overall Study|HIV infection|0|||
125372984|NCT02915016|450995116|FG000|Overall Study|Participant unable to adhere|0|||
125372985|NCT02915016|450995117|FG001|Overall Study|Participant unable to adhere|0|||
125372986|NCT02915016|450995118|FG002|Overall Study|Participant unable to adhere|0|||
125372987|NCT02915016|450995119|FG003|Overall Study|Participant unable to adhere|0|||
125372988|NCT02915016|450995120|FG004|Overall Study|Participant unable to adhere|0|||
125372989|NCT02915016|450995121|FG005|Overall Study|Participant unable to adhere|0|||
125372990|NCT02915016|450995122|FG006|Overall Study|Participant unable to adhere|0|||
125372991|NCT02915016|450995123|FG007|Overall Study|Participant unable to adhere|1|||
125372992|NCT01532414|450996460|FG000|Overall Study|Lost to Follow-up|3|||
125372993|NCT01532414|450996461|FG001|Overall Study|Lost to Follow-up|0|||
125372994|NCT01532414|450996462|FG002|Overall Study|Lost to Follow-up|1|||
125372995|NCT01532414|450996460|FG000|Overall Study|Withdrawal by Subject|3|||
125372996|NCT01532414|450996461|FG001|Overall Study|Withdrawal by Subject|0|||
125372997|NCT01532414|450996462|FG002|Overall Study|Withdrawal by Subject|0|||
125372998|NCT01532414|450996460|FG000|Overall Study|No V6 semen sample|0|||
125372999|NCT01532414|450996461|FG001|Overall Study|No V6 semen sample|1|||
125373000|NCT01532414|450996462|FG002|Overall Study|No V6 semen sample|0|||
125373001|NCT01532414|450996460|FG000|Overall Study|Adverse Event|0|||
125373002|NCT01532414|450996461|FG001|Overall Study|Adverse Event|1|||
125373003|NCT01532414|450996462|FG002|Overall Study|Adverse Event|1|||
125373004|NCT01532414|450996460|FG000|Overall Study|Unable to complete 24 hour PK|0|||
125373005|NCT01532414|450996461|FG001|Overall Study|Unable to complete 24 hour PK|0|||
125214517|NCT00948922|450412867|FG000|Overall Study|Not evaluable at time of analysis|0|||
125214518|NCT00948922|450412868|FG001|Overall Study|Not evaluable at time of analysis|3|||
125214519|NCT00948922|450412869|FG002|Overall Study|Not evaluable at time of analysis|0|||
125214520|NCT03519919|450412870|FG000|Overall Study|Withdrawal by Subject|1|||
125214521|NCT03519919|450412870|FG000|Overall Study|Lack of Efficacy|1|||
125214522|NCT03519919|450412870|FG000|Overall Study|Screen Failure|1|||
125214523|NCT00645671|450412871|FG000|Overall Study|Protocol Violation|1|||
125214524|NCT00645671|450412872|FG001|Overall Study|Protocol Violation|0|||
125214525|NCT00645671|450412871|FG000|Overall Study|Withdrawal by Subject|0|||
125214526|NCT00645671|450412872|FG001|Overall Study|Withdrawal by Subject|4|||
125214527|NCT00645671|450412871|FG000|Overall Study|Adverse Event|0|||
125214528|NCT00645671|450412872|FG001|Overall Study|Adverse Event|1|||
125214529|NCT00645671|450412871|FG000|Overall Study|Physician Decision|0|||
125214530|NCT00645671|450412872|FG001|Overall Study|Physician Decision|1|||
125214531|NCT02095197|450412873|FG000|Overall Study|Lost to Follow-up|0|||
125214532|NCT02095197|450412874|FG001|Overall Study|Lost to Follow-up|3|||
125214533|NCT05114564|450412875|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
125373006|NCT01532414|450996462|FG002|Overall Study|Unable to complete 24 hour PK|1|||
125373007|NCT01532414|450996460|FG000|Overall Study|Withdrawn by sponsor|1|||
125373008|NCT01532414|450996461|FG001|Overall Study|Withdrawn by sponsor|0|||
125373009|NCT01532414|450996462|FG002|Overall Study|Withdrawn by sponsor|0|||
125373010|NCT00187486|450996463|FG000|Overall Study|Protocol Violation|1|||
125373011|NCT00617773|450996464|FG000|Overall Study|Physician Decision|1|||
125373012|NCT00617773|450996464|FG000|Overall Study|Lack of compliance with the protocol|1|||
125373013|NCT00617773|450996464|FG000|Overall Study|Withdrawal by Subject|1|||
125373014|NCT00617773|450996464|FG000|Overall Study|Death|1|||
125373015|NCT00617773|450996464|FG000|Overall Study|Progressive disease|19|||
125373016|NCT00617773|450996464|FG000|Overall Study|Protocol Violation|1|||
125373017|NCT03217175|450996467|FG000|Overall Study|Physician Decision|4|||
125373018|NCT03217175|450996468|FG001|Overall Study|Physician Decision|1|||
125373019|NCT01806545|450996469|FG000|Overall Study|Adverse Event|2|||
125373020|NCT01806545|450996470|FG001|Overall Study|Adverse Event|3|||
125373021|NCT01806545|450996469|FG000|Overall Study|Lost to Follow-up|1|||
125373022|NCT01806545|450996470|FG001|Overall Study|Lost to Follow-up|0|||
125214534|NCT05114564|450412876|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
125214535|NCT05114564|450412875|FG000|First Intervention|Adverse Event|0|||
125214536|NCT05114564|450412876|FG001|First Intervention|Adverse Event|1|||
125373023|NCT01806545|450996469|FG000|Overall Study|Withdrawal by Subject|3|||
125373024|NCT01806545|450996470|FG001|Overall Study|Withdrawal by Subject|2|||
125373025|NCT01396148|450996471|FG000|Overall Study|Patient Decision|1|||
125614432|NCT02175771|451871712|FG001|Treatment Period|Withdrawal by Subject|9|||
125614433|NCT02175771|451871713|FG002|Treatment Period|Withdrawal by Subject|3|||
125614434|NCT02175771|451871714|FG003|Treatment Period|Withdrawal by Subject|6|||
125614435|NCT02175771|451871715|FG004|Treatment Period|Withdrawal by Subject|2|||
125614436|NCT02175771|451871716|FG005|Treatment Period|Withdrawal by Subject|4|||
125614437|NCT02175771|451871717|FG006|Treatment Period|Withdrawal by Subject|2|||
125614438|NCT02175771|451871718|FG007|Treatment Period|Withdrawal by Subject|9|||
125614439|NCT02175771|451871719|FG008|Treatment Period|Withdrawal by Subject|2|||
125614440|NCT02175771|451871711|FG000|Treatment Period|Noncompliance|0|||
125614441|NCT02175771|451871712|FG001|Treatment Period|Noncompliance|1|||
125614442|NCT02175771|451871713|FG002|Treatment Period|Noncompliance|2|||
125614443|NCT02175771|451871714|FG003|Treatment Period|Noncompliance|0|||
125614444|NCT02175771|451871715|FG004|Treatment Period|Noncompliance|0|||
125614445|NCT02175771|451871716|FG005|Treatment Period|Noncompliance|0|||
125614446|NCT02175771|451871717|FG006|Treatment Period|Noncompliance|0|||
125614447|NCT02175771|451871718|FG007|Treatment Period|Noncompliance|0|||
125614448|NCT02175771|451871719|FG008|Treatment Period|Noncompliance|1|||
125614449|NCT02175771|451871711|FG000|Treatment Period|Protocol Violation|0|||
125614450|NCT02175771|451871712|FG001|Treatment Period|Protocol Violation|0|||
125614451|NCT02175771|451871713|FG002|Treatment Period|Protocol Violation|0|||
125614452|NCT02175771|451871714|FG003|Treatment Period|Protocol Violation|0|||
125614453|NCT02175771|451871715|FG004|Treatment Period|Protocol Violation|0|||
125614454|NCT02175771|451871716|FG005|Treatment Period|Protocol Violation|0|||
125614455|NCT02175771|451871717|FG006|Treatment Period|Protocol Violation|0|||
125614456|NCT02175771|451871718|FG007|Treatment Period|Protocol Violation|1|||
125614457|NCT02175771|451871719|FG008|Treatment Period|Protocol Violation|0|||
125614458|NCT02175771|451871711|FG000|Treatment Period|Disease progression|0|||
125614459|NCT02175771|451871712|FG001|Treatment Period|Disease progression|0|||
125614460|NCT02175771|451871713|FG002|Treatment Period|Disease progression|0|||
125614461|NCT02175771|451871714|FG003|Treatment Period|Disease progression|0|||
125614462|NCT02175771|451871715|FG004|Treatment Period|Disease progression|0|||
125614463|NCT02175771|451871716|FG005|Treatment Period|Disease progression|0|||
125614464|NCT02175771|451871717|FG006|Treatment Period|Disease progression|0|||
125614465|NCT02175771|451871718|FG007|Treatment Period|Disease progression|2|||
125614466|NCT02175771|451871719|FG008|Treatment Period|Disease progression|0|||
125614467|NCT02175771|451871711|FG000|Treatment Period|Lost to Follow-up|0|||
125614468|NCT02175771|451871712|FG001|Treatment Period|Lost to Follow-up|3|||
125614469|NCT02175771|451871713|FG002|Treatment Period|Lost to Follow-up|1|||
125614470|NCT02175771|451871714|FG003|Treatment Period|Lost to Follow-up|3|||
125614471|NCT02175771|451871715|FG004|Treatment Period|Lost to Follow-up|1|||
125614472|NCT02175771|451871716|FG005|Treatment Period|Lost to Follow-up|2|||
125614473|NCT02175771|451871717|FG006|Treatment Period|Lost to Follow-up|1|||
125614474|NCT02175771|451871718|FG007|Treatment Period|Lost to Follow-up|2|||
125614475|NCT02175771|451871719|FG008|Treatment Period|Lost to Follow-up|2|||
125614476|NCT02175771|451871711|FG000|Treatment Period|Lack of Efficacy|0|||
125614477|NCT02175771|451871712|FG001|Treatment Period|Lack of Efficacy|0|||
125614478|NCT02175771|451871713|FG002|Treatment Period|Lack of Efficacy|0|||
125614479|NCT02175771|451871714|FG003|Treatment Period|Lack of Efficacy|0|||
125614480|NCT02175771|451871715|FG004|Treatment Period|Lack of Efficacy|0|||
125614481|NCT02175771|451871716|FG005|Treatment Period|Lack of Efficacy|1|||
125614482|NCT02175771|451871717|FG006|Treatment Period|Lack of Efficacy|0|||
125614483|NCT02175771|451871718|FG007|Treatment Period|Lack of Efficacy|1|||
125614484|NCT02175771|451871719|FG008|Treatment Period|Lack of Efficacy|0|||
125614485|NCT02175771|451871711|FG000|Treatment Period|Other|0|||
125614486|NCT02175771|451871712|FG001|Treatment Period|Other|1|||
125614487|NCT02175771|451871713|FG002|Treatment Period|Other|0|||
125614488|NCT02175771|451871714|FG003|Treatment Period|Other|3|||
125614489|NCT02175771|451871715|FG004|Treatment Period|Other|1|||
125614490|NCT02175771|451871716|FG005|Treatment Period|Other|0|||
125614491|NCT02175771|451871717|FG006|Treatment Period|Other|0|||
125614492|NCT02175771|451871718|FG007|Treatment Period|Other|2|||
125614493|NCT02175771|451871719|FG008|Treatment Period|Other|0|||
125614494|NCT03364673|451871720|FG000|Overall Study|Withdrawal by Subject|2|||
125614495|NCT03364673|451871720|FG000|Overall Study|Injury unrelated to study|3|||
125614496|NCT02232087|451871721|FG000|Overall Study|Withdrawal by Subject|2|||
125614497|NCT02232087|451871722|FG001|Overall Study|Withdrawal by Subject|0|||
125614498|NCT02232087|451871723|FG002|Overall Study|Withdrawal by Subject|0|||
125614499|NCT02232087|451871724|FG003|Overall Study|Withdrawal by Subject|0|||
125614500|NCT02232087|451871725|FG004|Overall Study|Withdrawal by Subject|0|||
125614501|NCT02232087|451871726|FG005|Overall Study|Withdrawal by Subject|1|||
125614502|NCT02232087|451871721|FG000|Overall Study|poor inhalation technique|0|||
125614503|NCT02232087|451871722|FG001|Overall Study|poor inhalation technique|1|||
125614504|NCT02232087|451871723|FG002|Overall Study|poor inhalation technique|0|||
125614505|NCT02232087|451871724|FG003|Overall Study|poor inhalation technique|0|||
125614506|NCT02232087|451871725|FG004|Overall Study|poor inhalation technique|0|||
125614507|NCT02232087|451871726|FG005|Overall Study|poor inhalation technique|2|||
125614508|NCT02232087|451871721|FG000|Overall Study|protocol stop criteria|0|||
125214537|NCT01951573|450412877|FG000|Washout Period|Adverse Event|0|||
125214538|NCT01951573|450412878|FG001|Washout Period|Adverse Event|1|||
125214539|NCT02020889|450412897|FG000|Overall Study|Adverse Event|0|||
125214540|NCT02020889|450412898|FG001|Overall Study|Adverse Event|1|||
125214541|NCT02020889|450412897|FG000|Overall Study|Lack of Efficacy|1|||
125214542|NCT02020889|450412898|FG001|Overall Study|Lack of Efficacy|0|||
125214543|NCT02020889|450412897|FG000|Overall Study|Lost to Follow-up|1|||
125614509|NCT02232087|451871722|FG001|Overall Study|protocol stop criteria|1|||
125614510|NCT02232087|451871723|FG002|Overall Study|protocol stop criteria|0|||
125614511|NCT02232087|451871724|FG003|Overall Study|protocol stop criteria|1|||
125614512|NCT02232087|451871725|FG004|Overall Study|protocol stop criteria|0|||
125614513|NCT02232087|451871726|FG005|Overall Study|protocol stop criteria|0|||
125614514|NCT02232087|451871721|FG000|Overall Study|Adverse Event|0|||
125614515|NCT02232087|451871722|FG001|Overall Study|Adverse Event|0|||
125614516|NCT02232087|451871723|FG002|Overall Study|Adverse Event|0|||
125614517|NCT02232087|451871724|FG003|Overall Study|Adverse Event|0|||
125614518|NCT02232087|451871725|FG004|Overall Study|Adverse Event|1|||
125614519|NCT02232087|451871726|FG005|Overall Study|Adverse Event|0|||
125614520|NCT02504268|451871728|FG000|Overall Study|Adverse Event|18|||
125614521|NCT02504268|451871729|FG001|Overall Study|Adverse Event|8|||
125614522|NCT02504268|451871730|FG002|Overall Study|Adverse Event|14|||
125614523|NCT02504268|451871731|FG003|Overall Study|Adverse Event|0|||
125614524|NCT02504268|451871732|FG004|Overall Study|Adverse Event|0|||
125614525|NCT02504268|451871733|FG005|Overall Study|Adverse Event|0|||
125614526|NCT02504268|451871734|FG006|Overall Study|Adverse Event|0|||
125614527|NCT02504268|451871735|FG007|Overall Study|Adverse Event|0|||
125614528|NCT02504268|451871736|FG008|Overall Study|Adverse Event|0|||
125614529|NCT02504268|451871728|FG000|Overall Study|Withdrawal of Consent|11|||
125614530|NCT02504268|451871729|FG001|Overall Study|Withdrawal of Consent|10|||
125614531|NCT02504268|451871730|FG002|Overall Study|Withdrawal of Consent|3|||
125614532|NCT02504268|451871731|FG003|Overall Study|Withdrawal of Consent|0|||
125614533|NCT02504268|451871732|FG004|Overall Study|Withdrawal of Consent|0|||
125614534|NCT02504268|451871733|FG005|Overall Study|Withdrawal of Consent|0|||
125614535|NCT02504268|451871734|FG006|Overall Study|Withdrawal of Consent|0|||
125614536|NCT02504268|451871735|FG007|Overall Study|Withdrawal of Consent|0|||
125614537|NCT02504268|451871736|FG008|Overall Study|Withdrawal of Consent|0|||
125614538|NCT02504268|451871728|FG000|Overall Study|Pregnancy|2|||
125614539|NCT02504268|451871729|FG001|Overall Study|Pregnancy|0|||
125614540|NCT02504268|451871730|FG002|Overall Study|Pregnancy|0|||
125614541|NCT02504268|451871731|FG003|Overall Study|Pregnancy|0|||
125614542|NCT02504268|451871732|FG004|Overall Study|Pregnancy|0|||
125614543|NCT02504268|451871733|FG005|Overall Study|Pregnancy|0|||
125614544|NCT02504268|451871734|FG006|Overall Study|Pregnancy|0|||
125614545|NCT02504268|451871735|FG007|Overall Study|Pregnancy|0|||
125614546|NCT02504268|451871736|FG008|Overall Study|Pregnancy|0|||
125614547|NCT02504268|451871728|FG000|Overall Study|Lost to Follow-up|3|||
125614548|NCT02504268|451871729|FG001|Overall Study|Lost to Follow-up|6|||
125614549|NCT02504268|451871730|FG002|Overall Study|Lost to Follow-up|4|||
125614550|NCT02504268|451871731|FG003|Overall Study|Lost to Follow-up|0|||
125614551|NCT02504268|451871732|FG004|Overall Study|Lost to Follow-up|0|||
125614552|NCT02504268|451871733|FG005|Overall Study|Lost to Follow-up|0|||
125614553|NCT02504268|451871734|FG006|Overall Study|Lost to Follow-up|0|||
125614554|NCT02504268|451871735|FG007|Overall Study|Lost to Follow-up|0|||
125614555|NCT02504268|451871736|FG008|Overall Study|Lost to Follow-up|0|||
125614556|NCT02504268|451871728|FG000|Overall Study|Death|1|||
125614557|NCT02504268|451871729|FG001|Overall Study|Death|1|||
125614558|NCT02504268|451871730|FG002|Overall Study|Death|0|||
125614559|NCT02504268|451871731|FG003|Overall Study|Death|0|||
125614560|NCT02504268|451871732|FG004|Overall Study|Death|0|||
125373026|NCT00884312|450996474|FG000|Overall Study|Non-fatal Progressive Disease|0|||
125614561|NCT02504268|451871733|FG005|Overall Study|Death|0|||
125614562|NCT02504268|451871734|FG006|Overall Study|Death|0|||
125614563|NCT02504268|451871735|FG007|Overall Study|Death|0|||
125614564|NCT02504268|451871736|FG008|Overall Study|Death|0|||
125614565|NCT02504268|451871728|FG000|Overall Study|Subject Request to Discontinue|11|||
125614566|NCT02504268|451871729|FG001|Overall Study|Subject Request to Discontinue|3|||
125614567|NCT02504268|451871730|FG002|Overall Study|Subject Request to Discontinue|6|||
125614568|NCT02504268|451871731|FG003|Overall Study|Subject Request to Discontinue|0|||
125614569|NCT02504268|451871732|FG004|Overall Study|Subject Request to Discontinue|0|||
125614570|NCT02504268|451871733|FG005|Overall Study|Subject Request to Discontinue|0|||
125214544|NCT02020889|450412898|FG001|Overall Study|Lost to Follow-up|0|||
125214545|NCT02020889|450412897|FG000|Overall Study|Physician Decision|2|||
125614571|NCT02504268|451871734|FG006|Overall Study|Subject Request to Discontinue|0|||
125614572|NCT02504268|451871735|FG007|Overall Study|Subject Request to Discontinue|0|||
125614573|NCT02504268|451871736|FG008|Overall Study|Subject Request to Discontinue|0|||
125614574|NCT02504268|451871728|FG000|Overall Study|No Longer Meets Study Criteria|2|||
125614575|NCT02504268|451871729|FG001|Overall Study|No Longer Meets Study Criteria|3|||
125614576|NCT02504268|451871730|FG002|Overall Study|No Longer Meets Study Criteria|0|||
125614577|NCT02504268|451871731|FG003|Overall Study|No Longer Meets Study Criteria|0|||
125614578|NCT02504268|451871732|FG004|Overall Study|No Longer Meets Study Criteria|0|||
125614579|NCT02504268|451871733|FG005|Overall Study|No Longer Meets Study Criteria|0|||
125614580|NCT02504268|451871734|FG006|Overall Study|No Longer Meets Study Criteria|0|||
125614581|NCT02504268|451871735|FG007|Overall Study|No Longer Meets Study Criteria|0|||
125614582|NCT02504268|451871736|FG008|Overall Study|No Longer Meets Study Criteria|0|||
125614583|NCT02504268|451871728|FG000|Overall Study|Lack of Efficacy|11|||
125614584|NCT02504268|451871729|FG001|Overall Study|Lack of Efficacy|35|||
125614585|NCT02504268|451871730|FG002|Overall Study|Lack of Efficacy|9|||
125614586|NCT02504268|451871731|FG003|Overall Study|Lack of Efficacy|0|||
125614587|NCT02504268|451871732|FG004|Overall Study|Lack of Efficacy|0|||
125614588|NCT02504268|451871733|FG005|Overall Study|Lack of Efficacy|0|||
125614589|NCT02504268|451871734|FG006|Overall Study|Lack of Efficacy|0|||
125614590|NCT02504268|451871735|FG007|Overall Study|Lack of Efficacy|0|||
125614591|NCT02504268|451871736|FG008|Overall Study|Lack of Efficacy|0|||
125614592|NCT02504268|451871728|FG000|Overall Study|Poor/Non-Compliance|3|||
125614593|NCT02504268|451871729|FG001|Overall Study|Poor/Non-Compliance|2|||
125614594|NCT02504268|451871730|FG002|Overall Study|Poor/Non-Compliance|3|||
125614595|NCT02504268|451871731|FG003|Overall Study|Poor/Non-Compliance|0|||
125614596|NCT02504268|451871732|FG004|Overall Study|Poor/Non-Compliance|0|||
125614597|NCT02504268|451871733|FG005|Overall Study|Poor/Non-Compliance|0|||
125614598|NCT02504268|451871734|FG006|Overall Study|Poor/Non-Compliance|0|||
125614599|NCT02504268|451871735|FG007|Overall Study|Poor/Non-Compliance|0|||
125614600|NCT02504268|451871736|FG008|Overall Study|Poor/Non-Compliance|0|||
125614601|NCT02504268|451871728|FG000|Overall Study|Not Disclosed|1|||
125614602|NCT02504268|451871729|FG001|Overall Study|Not Disclosed|0|||
125614603|NCT02504268|451871730|FG002|Overall Study|Not Disclosed|2|||
125614604|NCT02504268|451871731|FG003|Overall Study|Not Disclosed|0|||
125614605|NCT02504268|451871732|FG004|Overall Study|Not Disclosed|0|||
125614606|NCT02504268|451871733|FG005|Overall Study|Not Disclosed|0|||
125614607|NCT02504268|451871734|FG006|Overall Study|Not Disclosed|0|||
125614608|NCT02504268|451871735|FG007|Overall Study|Not Disclosed|0|||
125614609|NCT02504268|451871736|FG008|Overall Study|Not Disclosed|0|||
125614610|NCT00209170|451871739|FG000|Overall Study|Adverse Event|0|||
125614611|NCT00209170|451871740|FG001|Overall Study|Adverse Event|1|||
125614612|NCT00209170|451871739|FG000|Overall Study|Withdrawal by Subject|2|||
125614613|NCT00209170|451871740|FG001|Overall Study|Withdrawal by Subject|1|||
125614614|NCT00209170|451871739|FG000|Overall Study|Lack of Efficacy|0|||
125614615|NCT00209170|451871740|FG001|Overall Study|Lack of Efficacy|1|||
125614616|NCT02108600|451871741|FG000|Overall Study|Withdrawal by Subject|2|||
125614617|NCT02108600|451871742|FG001|Overall Study|Withdrawal by Subject|0|||
125614618|NCT02108600|451871741|FG000|Overall Study|Lost to Follow-up|1|||
125614619|NCT02108600|451871742|FG001|Overall Study|Lost to Follow-up|1|||
125614620|NCT03150095|451871743|FG000|Overall Study|Death|0|||
125614621|NCT03150095|451871744|FG001|Overall Study|Death|1|||
125614622|NCT03150095|451871743|FG000|Overall Study|Lost to Follow-up|1|||
125614623|NCT03150095|451871744|FG001|Overall Study|Lost to Follow-up|1|||
125614624|NCT03150095|451871743|FG000|Overall Study|Withdrawal by Subject|4|||
125614625|NCT03150095|451871744|FG001|Overall Study|Withdrawal by Subject|0|||
125614626|NCT03150095|451871743|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
125614627|NCT03150095|451871744|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
125614628|NCT04032171|451871745|FG000|Overall Study|Study Termination|1|||
125614629|NCT04032171|451871746|FG001|Overall Study|Study Termination|0|||
125614630|NCT02124707|451871747|FG000|Overall Study|Adverse Event|5|||
125614631|NCT02124707|451871747|FG000|Overall Study|Physician Decision|1|||
125614632|NCT02124707|451871747|FG000|Overall Study|Death|1|||
125614633|NCT00668200|451871754|FG000|Overall Study|Withdrawal by Subject|2|||
125614634|NCT00668200|451871754|FG000|Overall Study|Lost to Follow-up|1|||
125614635|NCT02108951|451871758|FG000|Overall Study|Lost to Follow-up|1|||
125614636|NCT02108951|451871758|FG000|Overall Study|Patient's/guardian's decision|1|||
125614637|NCT02108951|451871758|FG000|Overall Study|Study Terminated by Sponsor|14|||
125614638|NCT00718666|451871759|FG000|Booster Phase Year 5|No active participation request|0|||
125614639|NCT00718666|451871760|FG001|Booster Phase Year 5|No active participation request|0|||
125614640|NCT00718666|451871761|FG002|Booster Phase Year 5|No active participation request|1|||
125614641|NCT00718666|451871759|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
125214546|NCT02020889|450412898|FG001|Overall Study|Physician Decision|0|||
125614642|NCT00718666|451871760|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
125614643|NCT00718666|451871761|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
125373027|NCT00884312|450996475|FG001|Overall Study|Non-fatal Progressive Disease|8|||
125373028|NCT00884312|450996474|FG000|Overall Study|Fatal Progressive Disease|0|||
125373029|NCT00884312|450996475|FG001|Overall Study|Fatal Progressive Disease|1|||
125373030|NCT00884312|450996474|FG000|Overall Study|Non-fatal Adverse Event|1|||
125373031|NCT00884312|450996475|FG001|Overall Study|Non-fatal Adverse Event|0|||
125373032|NCT00884312|450996474|FG000|Overall Study|Fatal Adverse Event|1|||
125373033|NCT00884312|450996475|FG001|Overall Study|Fatal Adverse Event|4|||
125614644|NCT00718666|451871759|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
125614645|NCT00718666|451871760|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
125614646|NCT00718666|451871761|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
125614647|NCT00718666|451871759|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
125614648|NCT00718666|451871760|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
125614649|NCT00718666|451871761|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
125614650|NCT00421343|451871764|FG000|Overall Study|Death|1|||
125614651|NCT00421343|451871764|FG000|Overall Study|Withdrawal by Subject|2|||
125614652|NCT00421343|451871764|FG000|Overall Study|Lost to Follow-up|3|||
125614653|NCT03471767|451871768|FG000|Overall Study|Withdrawal by Subject|3|||
125614654|NCT03471767|451871769|FG001|Overall Study|Withdrawal by Subject|1|||
125614655|NCT03471767|451871768|FG000|Overall Study|Adverse Event|1|||
125614656|NCT03471767|451871769|FG001|Overall Study|Adverse Event|0|||
125614657|NCT03471767|451871768|FG000|Overall Study|Lost to Follow-up|1|||
125614658|NCT03471767|451871769|FG001|Overall Study|Lost to Follow-up|0|||
125614659|NCT03471767|451871768|FG000|Overall Study|PI Withdrawal|1|||
125614660|NCT03471767|451871769|FG001|Overall Study|PI Withdrawal|3|||
125614661|NCT00678587|451871772|FG000|Overall Study|Adverse Event|3|||
125614662|NCT00678587|451871773|FG001|Overall Study|Adverse Event|3|||
125614663|NCT00678587|451871772|FG000|Overall Study|Lack of Efficacy|1|||
125614664|NCT00678587|451871773|FG001|Overall Study|Lack of Efficacy|0|||
125614665|NCT00678587|451871772|FG000|Overall Study|Protocol Violation|2|||
125614666|NCT00678587|451871773|FG001|Overall Study|Protocol Violation|1|||
125614667|NCT00678587|451871772|FG000|Overall Study|Study Closed/Terminated|1|||
125614668|NCT00678587|451871773|FG001|Overall Study|Study Closed/Terminated|0|||
125614669|NCT00678587|451871772|FG000|Overall Study|Lost to Follow-up|3|||
125614670|NCT00678587|451871773|FG001|Overall Study|Lost to Follow-up|5|||
125614671|NCT00678587|451871772|FG000|Overall Study|Investigator Discretion|2|||
125614672|NCT00678587|451871773|FG001|Overall Study|Investigator Discretion|6|||
125614673|NCT00678587|451871772|FG000|Overall Study|Withdrew Consent|8|||
125614674|NCT00678587|451871773|FG001|Overall Study|Withdrew Consent|3|||
125614675|NCT03806179|451871774|FG000|Overall Study|Progressive disease|0|||
125614676|NCT03806179|451871775|FG001|Overall Study|Progressive disease|2|||
125614677|NCT01952730|451871778|FG000|Overall Study|FDA shut down core lab used by study|1|||
125614678|NCT00305253|451871783|FG000|Overall Study|Withdrawal by Subject|0|||
125614679|NCT00305253|451871784|FG001|Overall Study|Withdrawal by Subject|1|||
125614680|NCT01357915|451871785|FG000|Overall Study|Lost to Follow-up|3|||
125614681|NCT01357915|451871786|FG001|Overall Study|Lost to Follow-up|0|||
125614682|NCT01479374|451871789|FG000|Overall Study|Adverse Event|2|||
125614683|NCT01479374|451871790|FG001|Overall Study|Adverse Event|1|||
125614684|NCT01479374|451871791|FG002|Overall Study|Adverse Event|0|||
125614685|NCT01479374|451871789|FG000|Overall Study|Lost to Follow-up|1|||
125614686|NCT01479374|451871790|FG001|Overall Study|Lost to Follow-up|2|||
125614687|NCT01479374|451871791|FG002|Overall Study|Lost to Follow-up|0|||
125614688|NCT01479374|451871789|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
125614689|NCT01479374|451871790|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
125614690|NCT01479374|451871791|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
125614691|NCT01479374|451871789|FG000|Overall Study|Other|0|||
125614692|NCT01479374|451871790|FG001|Overall Study|Other|4|||
125614693|NCT01479374|451871791|FG002|Overall Study|Other|5|||
125614694|NCT01606761|451871792|FG000|Prior to Week 24|Lost to Follow-up|0|||
125614695|NCT01606761|451871793|FG001|Prior to Week 24|Lost to Follow-up|3|||
125614696|NCT01606761|451871794|FG002|Prior to Week 24|Lost to Follow-up|2|||
125614697|NCT01606761|451871795|FG003|Prior to Week 24|Lost to Follow-up|0|||
125614698|NCT01606761|451871796|FG004|Prior to Week 24|Lost to Follow-up|0|||
125614699|NCT01606761|451871792|FG000|Prior to Week 24|Withdrawal by Subject|12|||
125614700|NCT01606761|451871793|FG001|Prior to Week 24|Withdrawal by Subject|10|||
125614701|NCT01606761|451871794|FG002|Prior to Week 24|Withdrawal by Subject|9|||
125614702|NCT01606761|451871795|FG003|Prior to Week 24|Withdrawal by Subject|0|||
125614703|NCT01606761|451871796|FG004|Prior to Week 24|Withdrawal by Subject|0|||
125614704|NCT01606761|451871792|FG000|Prior to Week 24|Adverse Event|11|||
125614705|NCT01606761|451871793|FG001|Prior to Week 24|Adverse Event|18|||
125614706|NCT01606761|451871794|FG002|Prior to Week 24|Adverse Event|22|||
125614707|NCT01606761|451871795|FG003|Prior to Week 24|Adverse Event|0|||
125614708|NCT01606761|451871796|FG004|Prior to Week 24|Adverse Event|0|||
125614709|NCT01606761|451871792|FG000|Prior to Week 24|Lack of Efficacy|15|||
125614710|NCT01606761|451871793|FG001|Prior to Week 24|Lack of Efficacy|14|||
125214547|NCT02020889|450412897|FG000|Overall Study|Withdrawal by Subject|3|||
125214548|NCT02020889|450412898|FG001|Overall Study|Withdrawal by Subject|2|||
125214549|NCT04217317|450412902|FG000|Overall Study|Lack of Efficacy|4|||
125214550|NCT04217317|450412902|FG000|Overall Study|Physician Decision|1|||
125214551|NCT01690299|450412903|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
125214552|NCT01690299|450412904|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
125214553|NCT01690299|450412905|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
125214554|NCT01690299|450412906|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
125214555|NCT01690299|450412907|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
125214556|NCT01690299|450412908|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
125214557|NCT01690299|450412903|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
125214558|NCT01690299|450412904|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125214559|NCT01690299|450412905|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125214560|NCT01690299|450412906|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125214561|NCT01690299|450412907|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125214562|NCT01690299|450412908|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125214563|NCT01690299|450412903|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
125214564|NCT01690299|450412904|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
125214565|NCT01690299|450412905|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125214566|NCT01690299|450412906|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125214567|NCT01690299|450412907|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125214568|NCT01690299|450412908|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125214569|NCT01690299|450412903|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
125214570|NCT01690299|450412904|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
125214571|NCT01690299|450412905|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
125214572|NCT01690299|450412906|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
125214573|NCT01690299|450412907|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
125214574|NCT01690299|450412908|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
125214575|NCT01690299|450412903|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
125214576|NCT01690299|450412904|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
125214577|NCT01690299|450412905|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
125214578|NCT01690299|450412906|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
125214579|NCT01690299|450412907|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
125214580|NCT01690299|450412908|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
125214581|NCT01690299|450412903|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
125214582|NCT01690299|450412904|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
125214583|NCT01690299|450412905|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
125214584|NCT01690299|450412906|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
125214585|NCT01690299|450412907|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
125214586|NCT01690299|450412908|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
125214587|NCT01690299|450412903|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
125214588|NCT01690299|450412904|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
125214589|NCT01690299|450412905|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
125373034|NCT00884312|450996474|FG000|Overall Study|Withdrawal by Subject|0|||
125614711|NCT01606761|451871794|FG002|Prior to Week 24|Lack of Efficacy|8|||
125614712|NCT01606761|451871795|FG003|Prior to Week 24|Lack of Efficacy|0|||
125614713|NCT01606761|451871796|FG004|Prior to Week 24|Lack of Efficacy|0|||
125614714|NCT01606761|451871792|FG000|Prior to Week 24|Physician Decision|0|||
125614715|NCT01606761|451871793|FG001|Prior to Week 24|Physician Decision|3|||
125614716|NCT01606761|451871794|FG002|Prior to Week 24|Physician Decision|1|||
125614717|NCT01606761|451871795|FG003|Prior to Week 24|Physician Decision|0|||
125614718|NCT01606761|451871796|FG004|Prior to Week 24|Physician Decision|0|||
125614719|NCT01606761|451871792|FG000|Prior to Week 24|Other|4|||
125614720|NCT01606761|451871793|FG001|Prior to Week 24|Other|7|||
125614721|NCT01606761|451871794|FG002|Prior to Week 24|Other|5|||
125614722|NCT01606761|451871795|FG003|Prior to Week 24|Other|0|||
125614723|NCT01606761|451871796|FG004|Prior to Week 24|Other|0|||
125614724|NCT01606761|451871792|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
125614725|NCT01606761|451871793|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
125614726|NCT01606761|451871794|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
125614727|NCT01606761|451871795|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
125614728|NCT01606761|451871796|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
125614729|NCT01606761|451871792|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
125614730|NCT01606761|451871793|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
125614731|NCT01606761|451871794|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
125614732|NCT01606761|451871795|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
125614733|NCT01606761|451871796|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
125614734|NCT01606761|451871792|FG000|Week 24 to Week 52|Adverse Event|0|||
125614735|NCT01606761|451871793|FG001|Week 24 to Week 52|Adverse Event|11|||
125614736|NCT01606761|451871794|FG002|Week 24 to Week 52|Adverse Event|14|||
125614737|NCT01606761|451871795|FG003|Week 24 to Week 52|Adverse Event|3|||
125614738|NCT01606761|451871796|FG004|Week 24 to Week 52|Adverse Event|15|||
125614739|NCT01606761|451871792|FG000|Week 24 to Week 52|Death|0|||
125614740|NCT01606761|451871793|FG001|Week 24 to Week 52|Death|0|||
125614741|NCT01606761|451871794|FG002|Week 24 to Week 52|Death|2|||
125614742|NCT01606761|451871795|FG003|Week 24 to Week 52|Death|1|||
125614743|NCT01606761|451871796|FG004|Week 24 to Week 52|Death|0|||
125614744|NCT01606761|451871792|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
125614745|NCT01606761|451871793|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
125614746|NCT01606761|451871794|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
125614747|NCT01606761|451871795|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
125614748|NCT01606761|451871796|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
125614749|NCT01606761|451871792|FG000|Week 24 to Week 52|Physician Decision|0|||
125614750|NCT01606761|451871793|FG001|Week 24 to Week 52|Physician Decision|1|||
125614751|NCT01606761|451871794|FG002|Week 24 to Week 52|Physician Decision|1|||
125614752|NCT01606761|451871795|FG003|Week 24 to Week 52|Physician Decision|0|||
125614753|NCT01606761|451871796|FG004|Week 24 to Week 52|Physician Decision|0|||
125614754|NCT01606761|451871792|FG000|Week 24 to Week 52|Other|0|||
125614755|NCT01606761|451871793|FG001|Week 24 to Week 52|Other|1|||
125614756|NCT01606761|451871794|FG002|Week 24 to Week 52|Other|5|||
125614757|NCT01606761|451871795|FG003|Week 24 to Week 52|Other|2|||
125614758|NCT01606761|451871796|FG004|Week 24 to Week 52|Other|2|||
125614759|NCT01606761|451871792|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
125614760|NCT01606761|451871793|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
125614761|NCT01606761|451871794|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
125614762|NCT01606761|451871795|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
125614763|NCT01606761|451871796|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
125614764|NCT01606761|451871792|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
125614765|NCT01606761|451871793|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
125614766|NCT01606761|451871794|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
125614767|NCT01606761|451871795|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
125614768|NCT01606761|451871796|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
125614769|NCT01606761|451871792|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
125614770|NCT01606761|451871793|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
125614771|NCT01606761|451871794|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
125614772|NCT01606761|451871795|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
125373035|NCT00884312|450996475|FG001|Overall Study|Withdrawal by Subject|6|||
125614773|NCT01606761|451871796|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
125614774|NCT01606761|451871792|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
125614775|NCT01606761|451871793|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
125614776|NCT01606761|451871794|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
125614777|NCT01606761|451871795|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
125614778|NCT01606761|451871796|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
125614779|NCT02237157|451871797|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
125614780|NCT02237157|451871798|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
125614781|NCT02237157|451871799|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
125614782|NCT02237157|451871800|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
125614783|NCT02237157|451871797|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
125614784|NCT02237157|451871798|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
125614785|NCT02237157|451871799|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
125614786|NCT02237157|451871800|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
125614787|NCT01996748|451871802|FG000|Overall Study|Personal reason|1|||
125614788|NCT01996748|451871803|FG001|Overall Study|Personal reason|0|||
125614789|NCT01996748|451871802|FG000|Overall Study|Physician Decision|2|||
125614790|NCT01996748|451871803|FG001|Overall Study|Physician Decision|0|||
125614791|NCT01996748|451871802|FG000|Overall Study|Adverse Event|1|||
125614792|NCT01996748|451871803|FG001|Overall Study|Adverse Event|4|||
125614793|NCT01996748|451871802|FG000|Overall Study|Withdrawal by Subject|0|||
125614794|NCT01996748|451871803|FG001|Overall Study|Withdrawal by Subject|1|||
125614795|NCT01996748|451871802|FG000|Overall Study|Lost to Follow-up|4|||
125614796|NCT01996748|451871803|FG001|Overall Study|Lost to Follow-up|1|||
125614797|NCT03599141|451871808|FG000|Overall Study|Lost to Follow-up|3|||
125614798|NCT03599141|451871809|FG001|Overall Study|Lost to Follow-up|1|||
125614799|NCT01081873|451871810|FG000|Overall Study|Death|86|||
125614800|NCT01081873|451871810|FG000|Overall Study|Withdrawal by Subject|10|||
125614801|NCT01081873|451871810|FG000|Overall Study|Lost to Follow-up|142|||
125614802|NCT01081873|451871810|FG000|Overall Study|Progression of prostate cancer|13|||
125614803|NCT01081873|451871810|FG000|Overall Study|Other|47|||
125614804|NCT03011840|451871812|FG000|Overall Study|Not received PIL in post PIL phase|0|||
125614805|NCT03011840|451871813|FG001|Overall Study|Not received PIL in post PIL phase|21|||
125614806|NCT02491073|451871814|FG000|Overall Study|screen failure|1|||
125614807|NCT02491073|451871815|FG001|Overall Study|screen failure|0|||
125614808|NCT01165021|451871816|FG000|Overall Study|Death|1|||
125614809|NCT01419665|451871817|FG000|Combination Treatment|Adverse Event|7|||
125614810|NCT01419665|451871818|FG001|Combination Treatment|Adverse Event|10|||
125614811|NCT01419665|451871817|FG000|Combination Treatment|Physician Decision|5|||
125614812|NCT01419665|451871818|FG001|Combination Treatment|Physician Decision|8|||
125614813|NCT01419665|451871817|FG000|Combination Treatment|Protocol Violation|6|||
125614814|NCT01419665|451871818|FG001|Combination Treatment|Protocol Violation|2|||
125614815|NCT01419665|451871817|FG000|Combination Treatment|disease progression|10|||
125614816|NCT01419665|451871818|FG001|Combination Treatment|disease progression|9|||
125614817|NCT01419665|451871817|FG000|Combination Treatment|Death|5|||
125614818|NCT01419665|451871818|FG001|Combination Treatment|Death|7|||
125614819|NCT01419665|451871817|FG000|Combination Treatment|administrative problems|0|||
125614820|NCT01419665|451871818|FG001|Combination Treatment|administrative problems|1|||
125614821|NCT01419665|451871817|FG000|Combination Treatment|Withdrawal by Subject|5|||
125614822|NCT01419665|451871818|FG001|Combination Treatment|Withdrawal by Subject|4|||
125614823|NCT01419665|451871817|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
125614824|NCT01419665|451871818|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
125614825|NCT01419665|451871817|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
125614826|NCT01419665|451871818|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
125614827|NCT01419665|451871817|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
125614828|NCT01419665|451871818|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
125614829|NCT01419665|451871817|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
125614830|NCT01419665|451871818|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
125614831|NCT01419665|451871817|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
125614832|NCT01419665|451871818|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
125614833|NCT01419665|451871817|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
125614834|NCT01419665|451871818|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
125614835|NCT01419665|451871817|FG000|Maintenance Treatment and/or Follow up|Death|1|||
125614836|NCT01419665|451871818|FG001|Maintenance Treatment and/or Follow up|Death|2|||
125614837|NCT01419665|451871817|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
125614838|NCT01419665|451871818|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
125614839|NCT01419665|451871817|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
125614840|NCT01419665|451871818|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
125614841|NCT01419665|451871817|FG000|Open Label Phase|Death|1|||
125614842|NCT01419665|451871818|FG001|Open Label Phase|Death|0|||
125614843|NCT01419665|451871817|FG000|Open Label Phase|disease progression|0|||
125614844|NCT01419665|451871818|FG001|Open Label Phase|disease progression|1|||
125614845|NCT03738566|451871819|FG000|Initial Study Phase|Withdrawal by Subject|1|||
125614846|NCT03738566|451871820|FG001|Initial Study Phase|Withdrawal by Subject|1|||
125214590|NCT01690299|450412906|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
125214591|NCT01690299|450412907|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
125214592|NCT01690299|450412908|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
125214593|NCT01690299|450412903|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
125214594|NCT01690299|450412904|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
125214595|NCT01690299|450412905|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
125214596|NCT01690299|450412906|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
125214597|NCT01690299|450412907|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
125214598|NCT01690299|450412908|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
125214599|NCT01690299|450412903|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
125214600|NCT01690299|450412904|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
125214601|NCT01690299|450412905|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
125214602|NCT01690299|450412906|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
125214603|NCT01690299|450412907|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
125214604|NCT01690299|450412908|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
125214605|NCT01690299|450412903|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
125214606|NCT01690299|450412904|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
125214607|NCT01690299|450412905|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
125214608|NCT01690299|450412906|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
125614847|NCT03738566|451871821|FG002|Initial Study Phase|Withdrawal by Subject|2|||
125614848|NCT03738566|451871822|FG003|Initial Study Phase|Withdrawal by Subject|0|||
125214609|NCT01690299|450412907|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
125214610|NCT01690299|450412908|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
125214611|NCT04313400|450412909|FG000|Overall Study|Withdrawal by Subject|0|||
125214612|NCT04313400|450412910|FG001|Overall Study|Withdrawal by Subject|0|||
125214613|NCT04313400|450412911|FG002|Overall Study|Withdrawal by Subject|0|||
125214614|NCT04313400|450412912|FG003|Overall Study|Withdrawal by Subject|0|||
125214615|NCT04313400|450412913|FG004|Overall Study|Withdrawal by Subject|0|||
125214616|NCT04313400|450412914|FG005|Overall Study|Withdrawal by Subject|4|||
125214617|NCT04313400|450412915|FG006|Overall Study|Withdrawal by Subject|1|||
125214618|NCT04313400|450412909|FG000|Overall Study|Adverse Event|0|||
125214619|NCT04313400|450412910|FG001|Overall Study|Adverse Event|0|||
125214620|NCT04313400|450412911|FG002|Overall Study|Adverse Event|0|||
125214621|NCT04313400|450412912|FG003|Overall Study|Adverse Event|0|||
125214622|NCT04313400|450412913|FG004|Overall Study|Adverse Event|0|||
125214623|NCT04313400|450412914|FG005|Overall Study|Adverse Event|1|||
125214624|NCT04313400|450412915|FG006|Overall Study|Adverse Event|0|||
125214625|NCT04313400|450412909|FG000|Overall Study|Lost to Follow-up|0|||
125214626|NCT04313400|450412910|FG001|Overall Study|Lost to Follow-up|0|||
125214627|NCT04313400|450412911|FG002|Overall Study|Lost to Follow-up|0|||
125214628|NCT04313400|450412912|FG003|Overall Study|Lost to Follow-up|0|||
125214629|NCT04313400|450412913|FG004|Overall Study|Lost to Follow-up|0|||
125214630|NCT04313400|450412914|FG005|Overall Study|Lost to Follow-up|1|||
125214631|NCT04313400|450412915|FG006|Overall Study|Lost to Follow-up|0|||
125214632|NCT00496587|450412920|FG000|Overall Study|Adverse Event|2|||
125214633|NCT00496587|450412920|FG000|Overall Study|Progressive Disease|24|||
125214634|NCT00496587|450412920|FG000|Overall Study|Withdrawal by Subject|2|||
125214635|NCT00496587|450412920|FG000|Overall Study|Death|1|||
125214636|NCT00496587|450412920|FG000|Overall Study|Complications unrelated|2|||
125214637|NCT02383355|450412922|FG000|Overall Study|Adverse Event|2|||
125214638|NCT02383355|450412923|FG001|Overall Study|Adverse Event|0|||
125214639|NCT01146561|450412924|FG000|Overall Study|Withdrawal by Subject|1|||
125214640|NCT01146561|450412924|FG000|Overall Study|Lost to Follow-up|1|||
125214641|NCT01778751|450412926|FG000|Overall Study|Lost to Follow-up|1|||
125214642|NCT01778751|450412927|FG001|Overall Study|Lost to Follow-up|0|||
125214643|NCT01778751|450412926|FG000|Overall Study|Withdrawal by Subject|0|||
125614849|NCT03738566|451871819|FG000|Initial Study Phase|Death|0|||
125614850|NCT03738566|451871820|FG001|Initial Study Phase|Death|1|||
125614851|NCT03738566|451871821|FG002|Initial Study Phase|Death|0|||
125614852|NCT03738566|451871822|FG003|Initial Study Phase|Death|0|||
125214644|NCT01778751|450412927|FG001|Overall Study|Withdrawal by Subject|2|||
125214645|NCT01778751|450412926|FG000|Overall Study|Transfered care|1|||
125214646|NCT01778751|450412927|FG001|Overall Study|Transfered care|0|||
125214647|NCT03628716|450412929|FG000|Overall Study|Adverse Event|1|||
125214648|NCT03628716|450412930|FG001|Overall Study|Adverse Event|1|||
125614853|NCT03738566|451871819|FG000|Initial Study Phase|Treatment failure|5|||
125614854|NCT03738566|451871820|FG001|Initial Study Phase|Treatment failure|0|||
125614855|NCT03738566|451871821|FG002|Initial Study Phase|Treatment failure|0|||
125614856|NCT03738566|451871822|FG003|Initial Study Phase|Treatment failure|0|||
125614857|NCT03738566|451871819|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
125614858|NCT03738566|451871820|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
125614859|NCT03738566|451871821|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
125614860|NCT03738566|451871822|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
125614861|NCT01655823|451871823|FG000|Overall Study|Lost to Follow-up|0|||
125614862|NCT01655823|451871824|FG001|Overall Study|Lost to Follow-up|1|||
125614863|NCT01655823|451871825|FG002|Overall Study|Lost to Follow-up|0|||
125614864|NCT01655823|451871826|FG003|Overall Study|Lost to Follow-up|0|||
125614865|NCT01655823|451871827|FG004|Overall Study|Lost to Follow-up|1|||
125614866|NCT01655823|451871823|FG000|Overall Study|Withdrawal by Subject|0|||
125614867|NCT01655823|451871824|FG001|Overall Study|Withdrawal by Subject|1|||
125614868|NCT01655823|451871825|FG002|Overall Study|Withdrawal by Subject|0|||
125614869|NCT01655823|451871826|FG003|Overall Study|Withdrawal by Subject|1|||
125614870|NCT01655823|451871827|FG004|Overall Study|Withdrawal by Subject|0|||
125614871|NCT04799405|451871830|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
125614872|NCT02998554|451871833|FG000|Overall Study|Adverse Event|8|||
125614873|NCT02998554|451871834|FG001|Overall Study|Adverse Event|3|||
125614874|NCT02998554|451871833|FG000|Overall Study|Protocol deviation|1|||
125614875|NCT02998554|451871834|FG001|Overall Study|Protocol deviation|0|||
125614876|NCT02998554|451871833|FG000|Overall Study|Withdrawal by Subject|2|||
125614877|NCT02998554|451871834|FG001|Overall Study|Withdrawal by Subject|6|||
125614878|NCT02998554|451871833|FG000|Overall Study|Lost to Follow-up|0|||
125614879|NCT02998554|451871834|FG001|Overall Study|Lost to Follow-up|1|||
125614880|NCT02998554|451871833|FG000|Overall Study|Lack of Efficacy|0|||
125614881|NCT02998554|451871834|FG001|Overall Study|Lack of Efficacy|1|||
125614882|NCT02953782|451871837|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
125614883|NCT02953782|451871838|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
125614884|NCT02953782|451871839|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
125614885|NCT02953782|451871840|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
125614886|NCT02953782|451871841|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
125614887|NCT02953782|451871842|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
125614888|NCT02953782|451871843|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
125614889|NCT02953782|451871844|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
125614890|NCT02953782|451871837|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
125614891|NCT02953782|451871838|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
125614892|NCT02953782|451871839|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
125614893|NCT02953782|451871840|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
125614894|NCT02953782|451871841|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
125614895|NCT02953782|451871842|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
125614896|NCT02953782|451871843|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
125614897|NCT02953782|451871844|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
125614898|NCT02953782|451871837|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
125614899|NCT02953782|451871838|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
125614900|NCT02953782|451871839|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
125614901|NCT02953782|451871840|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
125614902|NCT02953782|451871841|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
125614903|NCT02953782|451871842|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
125614904|NCT02953782|451871843|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
125614905|NCT02953782|451871844|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
125373036|NCT00884312|450996474|FG000|Overall Study|Physician Decision|0|||
125373037|NCT00884312|450996475|FG001|Overall Study|Physician Decision|1|||
125373038|NCT00884312|450996474|FG000|Overall Study|Other|0|||
125373039|NCT00884312|450996475|FG001|Overall Study|Other|4|||
125373040|NCT00884312|450996474|FG000|Overall Study|Did Not Receive Study Drug|0|||
125373041|NCT00884312|450996475|FG001|Overall Study|Did Not Receive Study Drug|1|||
125373042|NCT00224042|450996476|FG000|Overall Study|Adverse Event|2|||
125373043|NCT00224042|450996477|FG001|Overall Study|Adverse Event|1|||
125373044|NCT00224042|450996476|FG000|Overall Study|Protocol Violation|0|||
125373045|NCT00224042|450996477|FG001|Overall Study|Protocol Violation|1|||
125373046|NCT00224042|450996476|FG000|Overall Study|Physician Decision|0|||
125373047|NCT00224042|450996477|FG001|Overall Study|Physician Decision|1|||
125373048|NCT00224042|450996476|FG000|Overall Study|Did not meet lab incusion criteria|2|||
125373049|NCT00224042|450996477|FG001|Overall Study|Did not meet lab incusion criteria|3|||
125373050|NCT00224042|450996476|FG000|Overall Study|Other|2|||
125373051|NCT00224042|450996477|FG001|Overall Study|Other|0|||
125373052|NCT03052725|450996478|FG000|Overall Study|Adverse Event|2|||
125373053|NCT03052725|450996479|FG001|Overall Study|Adverse Event|0|||
125214649|NCT03628716|450412929|FG000|Overall Study|Death|1|||
125214650|NCT03628716|450412930|FG001|Overall Study|Death|0|||
125214651|NCT03628716|450412929|FG000|Overall Study|Lack of Efficacy|15|||
125214652|NCT03628716|450412930|FG001|Overall Study|Lack of Efficacy|20|||
125214653|NCT03628716|450412929|FG000|Overall Study|Withdrawal by Subject|1|||
125214654|NCT03628716|450412930|FG001|Overall Study|Withdrawal by Subject|2|||
125214655|NCT03628716|450412929|FG000|Overall Study|Study Terminated by Sponsor|1|||
125214656|NCT03628716|450412930|FG001|Overall Study|Study Terminated by Sponsor|0|||
125214657|NCT00856843|450412931|FG000|Overall Study|Withdrawal by Subject|1|||
125214658|NCT00856843|450412932|FG001|Overall Study|Withdrawal by Subject|5|||
125214659|NCT00856843|450412931|FG000|Overall Study|Lack of Efficacy|1|||
125214660|NCT00856843|450412932|FG001|Overall Study|Lack of Efficacy|0|||
125214661|NCT01366638|450412936|FG000|Overall Study|Withdrawal by Subject|0|||
125214662|NCT01366638|450412937|FG001|Overall Study|Withdrawal by Subject|0|||
125214663|NCT01366638|450412938|FG002|Overall Study|Withdrawal by Subject|6|||
125214664|NCT01366638|450412936|FG000|Overall Study|Other|1|||
125214665|NCT01366638|450412937|FG001|Overall Study|Other|0|||
125214666|NCT01366638|450412938|FG002|Overall Study|Other|0|||
125214667|NCT00401193|450414833|FG000|Overall Study|Adverse Event|1|||
125214668|NCT00401193|450414834|FG001|Overall Study|Adverse Event|3|||
125373054|NCT03052725|450996478|FG000|Overall Study|Withdrawal by Subject|3|||
125373055|NCT03052725|450996479|FG001|Overall Study|Withdrawal by Subject|4|||
125373056|NCT03052725|450996478|FG000|Overall Study|Pregnancy|0|||
125373057|NCT03052725|450996479|FG001|Overall Study|Pregnancy|1|||
125373058|NCT03052725|450996478|FG000|Overall Study|Site closure|0|||
125373059|NCT03052725|450996479|FG001|Overall Study|Site closure|1|||
125373060|NCT03052725|450996478|FG000|Overall Study|Study terminated by sponsor|143|||
125373061|NCT03052725|450996479|FG001|Overall Study|Study terminated by sponsor|144|||
125637237|NCT03073200|451952843|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
125614906|NCT02953782|451871837|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
125614907|NCT02953782|451871838|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
125614908|NCT02953782|451871839|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
125614909|NCT02953782|451871840|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
125614910|NCT02953782|451871841|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
125614911|NCT02953782|451871842|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
125614912|NCT02953782|451871843|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
125614913|NCT02953782|451871844|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
125614914|NCT02953782|451871837|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
125614915|NCT02953782|451871838|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
125614916|NCT02953782|451871839|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
125614917|NCT02953782|451871840|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
125614918|NCT02953782|451871841|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
125614919|NCT02953782|451871842|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
125614920|NCT02953782|451871843|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
125614921|NCT02953782|451871844|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
125614922|NCT02953782|451871837|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
125614923|NCT02953782|451871838|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
125614924|NCT02953782|451871839|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
125614925|NCT02953782|451871840|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
125614926|NCT02953782|451871841|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
125614927|NCT02953782|451871842|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
125614928|NCT02953782|451871843|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
125614929|NCT02953782|451871844|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
125432068|NCT01336621|451207828|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
125432069|NCT01336621|451207828|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
125432070|NCT01336621|451207828|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
125373062|NCT02548650|450996486|FG000|Triple Therapy|Adverse Event|1|||
125373063|NCT02548650|450996487|FG001|Triple Therapy|Adverse Event|0|||
125373064|NCT02548650|450996486|FG000|Triple Therapy|Withdrawal by Subject|0|||
125373065|NCT02548650|450996487|FG001|Triple Therapy|Withdrawal by Subject|4|||
125373066|NCT02548650|450996486|FG000|Double Therapy|Adverse Event|1|||
125373067|NCT02548650|450996487|FG001|Double Therapy|Adverse Event|1|||
125373068|NCT02548650|450996486|FG000|Double Therapy|Withdrawal by Subject|0|||
125614930|NCT02953782|451871837|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
125614931|NCT02953782|451871838|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
125614932|NCT02953782|451871839|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
125614933|NCT02953782|451871840|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
125614934|NCT02953782|451871841|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
125614935|NCT02953782|451871842|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
125373069|NCT02548650|450996487|FG001|Double Therapy|Withdrawal by Subject|1|||
125373070|NCT01539538|450996488|FG000|Overall Study|Adverse Event|13|||
125373071|NCT01539538|450996489|FG001|Overall Study|Adverse Event|18|||
125373072|NCT01539538|450996488|FG000|Overall Study|Lack of Efficacy|13|||
125373073|NCT01539538|450996489|FG001|Overall Study|Lack of Efficacy|16|||
125373074|NCT01539538|450996488|FG000|Overall Study|Withdrawal by Subject|2|||
125373075|NCT01539538|450996489|FG001|Overall Study|Withdrawal by Subject|3|||
125373076|NCT01539538|450996488|FG000|Overall Study|PCA no longer required or PCA problem|3|||
125373077|NCT01539538|450996489|FG001|Overall Study|PCA no longer required or PCA problem|7|||
125373078|NCT01909674|450996490|FG000|Overall Study|Withdrawal by Subject|5|||
125373079|NCT01909674|450996491|FG001|Overall Study|Withdrawal by Subject|2|||
125373080|NCT00847379|450996492|FG000|Overall Study|Study terminated by Sponsor|59|||
125614936|NCT02953782|451871843|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
125614937|NCT02953782|451871844|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
125614938|NCT02953782|451871837|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125614939|NCT02953782|451871838|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125614940|NCT02953782|451871839|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125614941|NCT02953782|451871840|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125614942|NCT02953782|451871841|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125614943|NCT02953782|451871842|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125614944|NCT02953782|451871843|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
125373081|NCT00847379|450996493|FG001|Overall Study|Study terminated by Sponsor|57|||
125373082|NCT00847379|450996494|FG002|Overall Study|Study terminated by Sponsor|57|||
125373083|NCT00521014|450996495|FG000|Overall Study|Inevaluable, not treated|1|||
125614945|NCT02953782|451871844|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
125614946|NCT02357849|451871845|FG000|Overall Study|Withdrawal by Subject|2|||
125614947|NCT02357849|451871846|FG001|Overall Study|Withdrawal by Subject|3|||
125614948|NCT01536119|451871847|FG000|Overall Study|Lost to Follow-up|17|||
125614949|NCT01536119|451871848|FG001|Overall Study|Lost to Follow-up|14|||
125614950|NCT00430521|451871857|FG000|Overall Study|Adverse Event|0|||
125614951|NCT00430521|451871858|FG001|Overall Study|Adverse Event|0|||
125614952|NCT00430521|451871859|FG002|Overall Study|Adverse Event|0|||
125373084|NCT02969369|450996496|FG000|Study|Adverse Event|1|||
125373085|NCT02969369|450996497|FG001|Study|Adverse Event|6|||
125373086|NCT02969369|450996496|FG000|Study|Lack of Efficacy|0|||
125373087|NCT02969369|450996497|FG001|Study|Lack of Efficacy|1|||
125373088|NCT02969369|450996496|FG000|Study|Lost to Follow-up|0|||
125614953|NCT00430521|451871860|FG003|Overall Study|Adverse Event|0|||
125614954|NCT00430521|451871861|FG004|Overall Study|Adverse Event|0|||
125614955|NCT00430521|451871862|FG005|Overall Study|Adverse Event|2|||
125614956|NCT00430521|451871863|FG006|Overall Study|Adverse Event|1|||
125614957|NCT00430521|451871864|FG007|Overall Study|Adverse Event|0|||
125614958|NCT00430521|451871857|FG000|Overall Study|Lost to Follow-up|7|||
125614959|NCT00430521|451871858|FG001|Overall Study|Lost to Follow-up|8|||
125614960|NCT00430521|451871859|FG002|Overall Study|Lost to Follow-up|3|||
125373089|NCT02969369|450996497|FG001|Study|Lost to Follow-up|1|||
125373090|NCT02969369|450996496|FG000|Study|Withdrawal by Subject|3|||
125614961|NCT00430521|451871860|FG003|Overall Study|Lost to Follow-up|5|||
125614962|NCT00430521|451871861|FG004|Overall Study|Lost to Follow-up|5|||
125614963|NCT00430521|451871862|FG005|Overall Study|Lost to Follow-up|2|||
125614964|NCT00430521|451871863|FG006|Overall Study|Lost to Follow-up|8|||
125614965|NCT00430521|451871864|FG007|Overall Study|Lost to Follow-up|10|||
125614966|NCT00430521|451871857|FG000|Overall Study|Pregnancy|0|||
125614967|NCT00430521|451871858|FG001|Overall Study|Pregnancy|0|||
125614968|NCT00430521|451871859|FG002|Overall Study|Pregnancy|0|||
125614969|NCT00430521|451871860|FG003|Overall Study|Pregnancy|0|||
125614970|NCT00430521|451871861|FG004|Overall Study|Pregnancy|0|||
125614971|NCT00430521|451871862|FG005|Overall Study|Pregnancy|0|||
125614972|NCT00430521|451871863|FG006|Overall Study|Pregnancy|1|||
125614973|NCT00430521|451871864|FG007|Overall Study|Pregnancy|0|||
125614974|NCT00430521|451871857|FG000|Overall Study|Vaccine Expired|0|||
125614975|NCT00430521|451871858|FG001|Overall Study|Vaccine Expired|0|||
125614976|NCT00430521|451871859|FG002|Overall Study|Vaccine Expired|0|||
125614977|NCT00430521|451871860|FG003|Overall Study|Vaccine Expired|0|||
125614978|NCT00430521|451871861|FG004|Overall Study|Vaccine Expired|0|||
125614979|NCT00430521|451871862|FG005|Overall Study|Vaccine Expired|1|||
125614980|NCT00430521|451871863|FG006|Overall Study|Vaccine Expired|0|||
125614981|NCT00430521|451871864|FG007|Overall Study|Vaccine Expired|0|||
125614982|NCT00430521|451871857|FG000|Overall Study|Protocol Violation|1|||
125614983|NCT00430521|451871858|FG001|Overall Study|Protocol Violation|0|||
125614984|NCT00430521|451871859|FG002|Overall Study|Protocol Violation|0|||
125614985|NCT00430521|451871860|FG003|Overall Study|Protocol Violation|0|||
125614986|NCT00430521|451871861|FG004|Overall Study|Protocol Violation|0|||
125614987|NCT00430521|451871862|FG005|Overall Study|Protocol Violation|0|||
125614988|NCT00430521|451871863|FG006|Overall Study|Protocol Violation|0|||
125614989|NCT00430521|451871864|FG007|Overall Study|Protocol Violation|0|||
125614990|NCT00430521|451871857|FG000|Overall Study|Withdrawal by Subject|3|||
125614991|NCT00430521|451871858|FG001|Overall Study|Withdrawal by Subject|1|||
125614992|NCT00430521|451871859|FG002|Overall Study|Withdrawal by Subject|0|||
125614993|NCT00430521|451871860|FG003|Overall Study|Withdrawal by Subject|3|||
125614994|NCT00430521|451871861|FG004|Overall Study|Withdrawal by Subject|0|||
125614995|NCT00430521|451871862|FG005|Overall Study|Withdrawal by Subject|0|||
125614996|NCT00430521|451871863|FG006|Overall Study|Withdrawal by Subject|0|||
125614997|NCT00430521|451871864|FG007|Overall Study|Withdrawal by Subject|2|||
125614998|NCT00839423|451873883|FG000|Overall Study|Adverse Event|4|||
125614999|NCT00839423|451873884|FG001|Overall Study|Adverse Event|3|||
125615000|NCT00839423|451873885|FG002|Overall Study|Adverse Event|7|||
125615001|NCT00839423|451873886|FG003|Overall Study|Adverse Event|16|||
125615002|NCT00839423|451873883|FG000|Overall Study|Lack of Efficacy|6|||
125373091|NCT02969369|450996497|FG001|Study|Withdrawal by Subject|5|||
125615003|NCT00839423|451873884|FG001|Overall Study|Lack of Efficacy|6|||
125615004|NCT00839423|451873885|FG002|Overall Study|Lack of Efficacy|3|||
125615005|NCT00839423|451873886|FG003|Overall Study|Lack of Efficacy|2|||
125615006|NCT00839423|451873883|FG000|Overall Study|Non-compliance|0|||
125615007|NCT00839423|451873884|FG001|Overall Study|Non-compliance|0|||
125615008|NCT00839423|451873885|FG002|Overall Study|Non-compliance|0|||
125615009|NCT00839423|451873886|FG003|Overall Study|Non-compliance|1|||
125615010|NCT00839423|451873883|FG000|Overall Study|Protocol Violation|0|||
125615011|NCT00839423|451873884|FG001|Overall Study|Protocol Violation|1|||
125615012|NCT00839423|451873885|FG002|Overall Study|Protocol Violation|2|||
125615013|NCT00839423|451873886|FG003|Overall Study|Protocol Violation|0|||
125615014|NCT00839423|451873883|FG000|Overall Study|Withdrawal of consent|4|||
125615015|NCT00839423|451873884|FG001|Overall Study|Withdrawal of consent|0|||
125615016|NCT00839423|451873885|FG002|Overall Study|Withdrawal of consent|4|||
125615017|NCT00839423|451873886|FG003|Overall Study|Withdrawal of consent|1|||
125615018|NCT00839423|451873883|FG000|Overall Study|Lost to Follow-up|1|||
125615019|NCT00839423|451873884|FG001|Overall Study|Lost to Follow-up|0|||
125615020|NCT00839423|451873885|FG002|Overall Study|Lost to Follow-up|1|||
125615021|NCT00839423|451873886|FG003|Overall Study|Lost to Follow-up|0|||
125615022|NCT00839423|451873883|FG000|Overall Study|Administrative or other reasons|3|||
125615023|NCT00839423|451873884|FG001|Overall Study|Administrative or other reasons|0|||
125615024|NCT00839423|451873885|FG002|Overall Study|Administrative or other reasons|1|||
125615025|NCT00839423|451873886|FG003|Overall Study|Administrative or other reasons|0|||
125615026|NCT01071096|451873887|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
125615027|NCT01071096|451873888|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
125615028|NCT00756886|451873892|FG000|Overall Study|Lost to Follow-up|1|||
125615029|NCT00756886|451873893|FG001|Overall Study|Lost to Follow-up|0|||
125615030|NCT00756886|451873892|FG000|Overall Study|Adverse Event|0|||
125615031|NCT00756886|451873893|FG001|Overall Study|Adverse Event|3|||
125615032|NCT00756886|451873892|FG000|Overall Study|Lack of Efficacy|1|||
125615033|NCT00756886|451873893|FG001|Overall Study|Lack of Efficacy|0|||
125615034|NCT00756886|451873892|FG000|Overall Study|Ineligible|9|||
125615035|NCT00756886|451873893|FG001|Overall Study|Ineligible|4|||
125615036|NCT03421964|451873896|FG000|Overall Study|Lost to Follow-up|11|||
125615037|NCT03421964|451873897|FG001|Overall Study|Lost to Follow-up|21|||
125615038|NCT03421964|451873896|FG000|Overall Study|Withdrawal by Subject|9|||
125615039|NCT03421964|451873897|FG001|Overall Study|Withdrawal by Subject|3|||
125615040|NCT03421964|451873896|FG000|Overall Study|Incarcerated|1|||
125615041|NCT03421964|451873897|FG001|Overall Study|Incarcerated|0|||
125615042|NCT03421964|451873896|FG000|Overall Study|Inpt Treatment Facility|1|||
125615043|NCT03421964|451873897|FG001|Overall Study|Inpt Treatment Facility|1|||
125214669|NCT00401193|450414835|FG002|Overall Study|Adverse Event|1|||
125615044|NCT03421964|451873896|FG000|Overall Study|Virtual Platform Issues|1|||
125615045|NCT03421964|451873897|FG001|Overall Study|Virtual Platform Issues|1|||
125615046|NCT02411201|451873898|FG000|Overall Study|Adverse Event|2|||
125615047|NCT02411201|451873898|FG000|Overall Study|Withdrawal by Subject|2|||
125615048|NCT02411201|451873898|FG000|Overall Study|Age group completed|2|||
125615049|NCT01260467|451873899|FG000|Overall Study|Withdrawal by Subject|2|||
125615050|NCT01774344|451873900|FG000|Overall Study|Withdrawal by Subject|3|||
125615051|NCT01774344|451873901|FG001|Overall Study|Withdrawal by Subject|10|||
125615052|NCT01774344|451873900|FG000|Overall Study|Protocol Violation|0|||
125615053|NCT01774344|451873901|FG001|Overall Study|Protocol Violation|1|||
125615054|NCT01774344|451873900|FG000|Overall Study|Lost to Follow-up|4|||
125615055|NCT01774344|451873901|FG001|Overall Study|Lost to Follow-up|10|||
125615056|NCT01774344|451873900|FG000|Overall Study|End of survival follow-up not available|2|||
125615057|NCT01774344|451873901|FG001|Overall Study|End of survival follow-up not available|2|||
125615058|NCT01774344|451873900|FG000|Overall Study|Data collection finished|4|||
125615059|NCT01774344|451873901|FG001|Overall Study|Data collection finished|14|||
125615060|NCT01774344|451873900|FG000|Overall Study|Other|0|||
125615061|NCT01774344|451873901|FG001|Overall Study|Other|1|||
125615062|NCT01774344|451873900|FG000|Overall Study|Did not enter Survival Follow up|49|||
125615063|NCT01774344|451873901|FG001|Overall Study|Did not enter Survival Follow up|83|||
125615064|NCT01397552|451873902|FG000|Overall Study|Adverse Event|1|||
125615065|NCT01397552|451873903|FG001|Overall Study|Adverse Event|0|||
125615066|NCT01397552|451873902|FG000|Overall Study|Withdrawal by Subject|2|||
125615067|NCT01397552|451873903|FG001|Overall Study|Withdrawal by Subject|1|||
125373092|NCT02969369|450996496|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
125615068|NCT00992784|451873910|FG000|Overall Study|Adverse Event|2|||
125615069|NCT00992784|451873911|FG001|Overall Study|Adverse Event|1|||
125615070|NCT00992784|451873912|FG002|Overall Study|Adverse Event|0|||
125615071|NCT00992784|451873910|FG000|Overall Study|Withdrawal by Subject|1|||
125615072|NCT00992784|451873911|FG001|Overall Study|Withdrawal by Subject|1|||
125615073|NCT00992784|451873912|FG002|Overall Study|Withdrawal by Subject|1|||
125615074|NCT01363713|451873913|FG000|Overall Study|Adverse Event|1|||
125615075|NCT01363713|451873913|FG000|Overall Study|Protocol Violation|3|||
125615076|NCT01363713|451873913|FG000|Overall Study|Withdrawal by Subject|2|||
125615077|NCT01658579|451873914|FG000|Treatment Period A|Other|0|||
125615078|NCT01658579|451873915|FG001|Treatment Period A|Other|0|||
125615079|NCT01658579|451873916|FG002|Treatment Period A|Other|1|||
125615080|NCT01658579|451873917|FG003|Treatment Period A|Other|1|||
125615081|NCT01658579|451873914|FG000|Treatment Period A|Adverse Event|1|||
125615082|NCT01658579|451873915|FG001|Treatment Period A|Adverse Event|0|||
125615083|NCT01658579|451873916|FG002|Treatment Period A|Adverse Event|0|||
125615084|NCT01658579|451873917|FG003|Treatment Period A|Adverse Event|0|||
125615085|NCT01658579|451873914|FG000|Treatment Period B|Other|0|||
125615086|NCT01658579|451873915|FG001|Treatment Period B|Other|0|||
125615087|NCT01658579|451873916|FG002|Treatment Period B|Other|0|||
125615088|NCT01658579|451873917|FG003|Treatment Period B|Other|1|||
125615089|NCT00608530|451873920|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
125615090|NCT00608530|451873921|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
125615091|NCT00608530|451873922|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
125615092|NCT00608530|451873923|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
125615093|NCT00608530|451873920|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
125615094|NCT00608530|451873921|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
125615095|NCT00608530|451873922|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
125615096|NCT00608530|451873923|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
125615097|NCT00608530|451873920|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
125615098|NCT00608530|451873921|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
125615099|NCT00608530|451873922|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
125615100|NCT00608530|451873923|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
125615101|NCT00608530|451873920|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
125615102|NCT00608530|451873921|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
125615103|NCT00608530|451873922|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
125615104|NCT00608530|451873923|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
125615105|NCT00608530|451873920|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
125615106|NCT00608530|451873921|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
125615107|NCT00608530|451873922|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
125615108|NCT00608530|451873923|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
125615109|NCT00608530|451873920|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
125615110|NCT00608530|451873921|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
125615111|NCT00608530|451873922|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
125615112|NCT00608530|451873923|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
125615113|NCT01514188|451873924|FG000|Overall Study|Adverse Event|3|||
125615114|NCT01514188|451873925|FG001|Overall Study|Adverse Event|5|||
125615115|NCT01514188|451873924|FG000|Overall Study|Withdrawal by Subject|2|||
125615116|NCT01514188|451873925|FG001|Overall Study|Withdrawal by Subject|4|||
125615117|NCT01514188|451873924|FG000|Overall Study|Protocol Violation|2|||
125615118|NCT01514188|451873925|FG001|Overall Study|Protocol Violation|4|||
125615119|NCT01514188|451873924|FG000|Overall Study|Physician Decision|0|||
125615120|NCT01514188|451873925|FG001|Overall Study|Physician Decision|2|||
125615121|NCT01514188|451873924|FG000|Overall Study|Disease Progression|13|||
125615122|NCT01514188|451873925|FG001|Overall Study|Disease Progression|14|||
125615123|NCT01514188|451873924|FG000|Overall Study|Death|1|||
125615124|NCT01514188|451873925|FG001|Overall Study|Death|3|||
125615125|NCT01514188|451873924|FG000|Overall Study|Other|2|||
125615126|NCT01514188|451873925|FG001|Overall Study|Other|1|||
125615127|NCT01019486|451873926|FG000|Overall Study|Withdrawal by Subject|1|||
125373093|NCT02969369|450996497|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
125615128|NCT01019486|451873927|FG001|Overall Study|Withdrawal by Subject|1|||
125615129|NCT01019486|451873928|FG002|Overall Study|Withdrawal by Subject|1|||
125615130|NCT02932332|451873933|FG000|Overall Study|Withdrawal by Subject|1|||
125615131|NCT02932332|451873934|FG001|Overall Study|Withdrawal by Subject|1|||
125373094|NCT02969369|450996496|FG000|Double-blind Period|Adverse Event|1|||
125615132|NCT02932332|451873935|FG002|Overall Study|Withdrawal by Subject|0|||
125615133|NCT02932332|451873936|FG003|Overall Study|Withdrawal by Subject|1|||
125615134|NCT02932332|451873933|FG000|Overall Study|Chest pain|0|||
125615135|NCT02932332|451873934|FG001|Overall Study|Chest pain|0|||
125373095|NCT02969369|450996497|FG001|Double-blind Period|Adverse Event|5|||
125615136|NCT02932332|451873935|FG002|Overall Study|Chest pain|0|||
125615137|NCT02932332|451873936|FG003|Overall Study|Chest pain|1|||
125615138|NCT02932332|451873933|FG000|Overall Study|Not Dyspneic cough|1|||
125214670|NCT00401193|450414833|FG000|Overall Study|Protocol Violation|3|||
125214671|NCT00401193|450414834|FG001|Overall Study|Protocol Violation|1|||
125214672|NCT00401193|450414835|FG002|Overall Study|Protocol Violation|1|||
125214673|NCT00401193|450414833|FG000|Overall Study|Lost to Follow-up|6|||
125214674|NCT00401193|450414834|FG001|Overall Study|Lost to Follow-up|5|||
125214675|NCT00401193|450414835|FG002|Overall Study|Lost to Follow-up|1|||
125214676|NCT00401193|450414833|FG000|Overall Study|Withdrawal by Subject|2|||
125214677|NCT00401193|450414834|FG001|Overall Study|Withdrawal by Subject|0|||
125373096|NCT02969369|450996496|FG000|Double-blind Period|Lost to Follow-up|0|||
125373097|NCT02969369|450996497|FG001|Double-blind Period|Lost to Follow-up|1|||
125214678|NCT00401193|450414835|FG002|Overall Study|Withdrawal by Subject|1|||
125214679|NCT00401193|450414833|FG000|Overall Study|Other Event|3|||
125373098|NCT02969369|450996496|FG000|Double-blind Period|Withdrawal by Subject|2|||
125373099|NCT02969369|450996497|FG001|Double-blind Period|Withdrawal by Subject|3|||
125373100|NCT02969369|450996496|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
125373101|NCT02969369|450996497|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
125373102|NCT02969369|450996496|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
125373103|NCT02969369|450996497|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
125373104|NCT02969369|450996496|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
125373105|NCT02969369|450996497|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
125373106|NCT02969369|450996496|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
125373107|NCT02969369|450996497|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
125373108|NCT02794883|450996498|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
125373109|NCT02794883|450996499|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
125373110|NCT02794883|450996500|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
125373111|NCT02794883|450996498|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
125373112|NCT02794883|450996499|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
125615139|NCT02932332|451873934|FG001|Overall Study|Not Dyspneic cough|2|||
125615140|NCT02932332|451873935|FG002|Overall Study|Not Dyspneic cough|1|||
125615141|NCT02932332|451873936|FG003|Overall Study|Not Dyspneic cough|0|||
125615142|NCT05373706|451873938|FG000|Overall Study|Lost to Follow-up|2|||
125615143|NCT05373706|451873939|FG001|Overall Study|Lost to Follow-up|2|||
125615144|NCT02841787|451873940|FG000|Overall Study|Lost to Follow-up|1|||
125615145|NCT02841787|451873941|FG001|Overall Study|Lost to Follow-up|0|||
125615146|NCT02841787|451873942|FG002|Overall Study|Lost to Follow-up|0|||
125615147|NCT02841787|451873940|FG000|Overall Study|Symptoms dropped below threshold|1|||
125615148|NCT02841787|451873941|FG001|Overall Study|Symptoms dropped below threshold|0|||
125615149|NCT02841787|451873942|FG002|Overall Study|Symptoms dropped below threshold|0|||
125615150|NCT02841787|451873940|FG000|Overall Study|Withdrawal by Subject|1|||
125615151|NCT02841787|451873941|FG001|Overall Study|Withdrawal by Subject|4|||
125615152|NCT02841787|451873942|FG002|Overall Study|Withdrawal by Subject|0|||
125615153|NCT03029650|451873946|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
125615154|NCT03029650|451873947|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
125615155|NCT03029650|451873946|FG000|Washout (1 Week)|Physician Decision|0|||
125615156|NCT03029650|451873947|FG001|Washout (1 Week)|Physician Decision|1|||
125615157|NCT01875367|451873949|FG000|Overall Study|Not complete at least 2 questionaries|4|||
125615158|NCT01875367|451873950|FG001|Overall Study|Not complete at least 2 questionaries|2|||
125615159|NCT01875367|451873949|FG000|Overall Study|Not receive study treatment|1|||
125615160|NCT01875367|451873950|FG001|Overall Study|Not receive study treatment|0|||
125615161|NCT05086289|451873961|FG000|Overall Study|Adverse Event|4|||
125615162|NCT05086289|451873962|FG001|Overall Study|Adverse Event|2|||
125615163|NCT05086289|451873961|FG000|Overall Study|Lost to Follow-up|2|||
125615164|NCT05086289|451873962|FG001|Overall Study|Lost to Follow-up|0|||
125615165|NCT05086289|451873961|FG000|Overall Study|Non-compliance with study drug|2|||
125615166|NCT05086289|451873962|FG001|Overall Study|Non-compliance with study drug|1|||
125615167|NCT05086289|451873961|FG000|Overall Study|Physician Decision|2|||
125615168|NCT05086289|451873962|FG001|Overall Study|Physician Decision|0|||
125615169|NCT05086289|451873961|FG000|Overall Study|Withdrawal by Subject|5|||
125615170|NCT05086289|451873962|FG001|Overall Study|Withdrawal by Subject|2|||
125373113|NCT02794883|450996500|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
125373114|NCT02794883|450996498|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
125373115|NCT02794883|450996499|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
125373116|NCT02794883|450996500|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
125615171|NCT04533815|451873963|FG000|Overall Study|Adverse Event|2|||
125615172|NCT04533815|451873963|FG000|Overall Study|Site withdrew|5|||
125615173|NCT02951988|451873966|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
125214680|NCT00401193|450414834|FG001|Overall Study|Other Event|2|||
125214681|NCT00401193|450414835|FG002|Overall Study|Other Event|2|||
125214682|NCT00398216|450414836|FG000|Overall Study|Adverse Event|4|||
125214683|NCT00398216|450414837|FG001|Overall Study|Adverse Event|2|||
125373117|NCT02794883|450996498|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
125373118|NCT02794883|450996499|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
125615174|NCT02951988|451873967|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
125214684|NCT00398216|450414838|FG002|Overall Study|Adverse Event|5|||
125373119|NCT02794883|450996500|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
125373120|NCT02794883|450996498|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
125373121|NCT02794883|450996499|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
125373122|NCT02794883|450996500|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
125373123|NCT02794883|450996498|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
125615175|NCT02951988|451873968|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
125615176|NCT02951988|451873969|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
125615177|NCT02951988|451873966|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
125615178|NCT02951988|451873967|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
125615179|NCT02951988|451873968|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
125615180|NCT02951988|451873969|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
125615181|NCT02951988|451873966|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
125615182|NCT02951988|451873967|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
125615183|NCT02951988|451873968|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
125615184|NCT02951988|451873969|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
125615185|NCT02951988|451873966|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
125615186|NCT02951988|451873967|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
125615187|NCT02951988|451873968|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
125615188|NCT02951988|451873969|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
125615189|NCT02951988|451873966|FG000|Open-Label Treatment Period|Protocol Violation|22|||
125615190|NCT02951988|451873967|FG001|Open-Label Treatment Period|Protocol Violation|0|||
125615191|NCT02951988|451873968|FG002|Open-Label Treatment Period|Protocol Violation|0|||
125615192|NCT02951988|451873969|FG003|Open-Label Treatment Period|Protocol Violation|0|||
125615193|NCT02951988|451873966|FG000|Open-Label Treatment Period|Pregnancy|2|||
125615194|NCT02951988|451873967|FG001|Open-Label Treatment Period|Pregnancy|0|||
125615195|NCT02951988|451873968|FG002|Open-Label Treatment Period|Pregnancy|0|||
125615196|NCT02951988|451873969|FG003|Open-Label Treatment Period|Pregnancy|0|||
125615197|NCT02951988|451873966|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
125615198|NCT02951988|451873967|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
125615199|NCT02951988|451873968|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
125615200|NCT02951988|451873969|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
125615201|NCT02951988|451873966|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
125615202|NCT02951988|451873967|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
125615203|NCT02951988|451873968|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
125615204|NCT02951988|451873969|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
125615205|NCT02951988|451873966|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
125615206|NCT02951988|451873967|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
125615207|NCT02951988|451873968|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
125615208|NCT02951988|451873969|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
125615209|NCT02951988|451873966|FG000|Open-Label Treatment Period|Adverse Event|45|||
125615210|NCT02951988|451873967|FG001|Open-Label Treatment Period|Adverse Event|0|||
125615211|NCT02951988|451873968|FG002|Open-Label Treatment Period|Adverse Event|0|||
125615212|NCT02951988|451873969|FG003|Open-Label Treatment Period|Adverse Event|0|||
125615213|NCT02951988|451873966|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
125615214|NCT02951988|451873967|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
125615215|NCT02951988|451873968|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
125615216|NCT02951988|451873969|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
125615217|NCT02951988|451873966|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
125615218|NCT02951988|451873967|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
125615219|NCT02951988|451873968|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
125615220|NCT02951988|451873969|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
125615221|NCT02951988|451873966|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
125615222|NCT02951988|451873967|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
125615223|NCT02951988|451873968|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
125615224|NCT02951988|451873969|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
125615225|NCT02951988|451873966|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
125615226|NCT02951988|451873967|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
125615227|NCT02951988|451873968|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
125615228|NCT02951988|451873969|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
125615229|NCT02951988|451873966|FG000|Double-Blind Treatment Period|Pregnancy|0|||
125615230|NCT02951988|451873967|FG001|Double-Blind Treatment Period|Pregnancy|1|||
125373124|NCT02794883|450996499|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
125615231|NCT02951988|451873968|FG002|Double-Blind Treatment Period|Pregnancy|1|||
125615232|NCT02951988|451873969|FG003|Double-Blind Treatment Period|Pregnancy|0|||
125615233|NCT02951988|451873966|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125615234|NCT02951988|451873967|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
125373125|NCT02794883|450996500|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
125615235|NCT02951988|451873968|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
125615236|NCT02951988|451873969|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
125615237|NCT02951988|451873966|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125615238|NCT02951988|451873967|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
125615239|NCT02951988|451873968|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
125214685|NCT00398216|450414839|FG003|Overall Study|Adverse Event|7|||
125214686|NCT00398216|450414840|FG004|Overall Study|Adverse Event|2|||
125214687|NCT00398216|450414836|FG000|Overall Study|Protocol Violation|2|||
125214688|NCT00398216|450414837|FG001|Overall Study|Protocol Violation|4|||
125214689|NCT00398216|450414838|FG002|Overall Study|Protocol Violation|5|||
125214690|NCT00398216|450414839|FG003|Overall Study|Protocol Violation|7|||
125214691|NCT00398216|450414840|FG004|Overall Study|Protocol Violation|5|||
125214692|NCT00398216|450414836|FG000|Overall Study|Lost to Follow-up|1|||
125214693|NCT00398216|450414837|FG001|Overall Study|Lost to Follow-up|6|||
125214694|NCT00398216|450414838|FG002|Overall Study|Lost to Follow-up|4|||
125615240|NCT02951988|451873969|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
125615241|NCT02951988|451873966|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125214695|NCT00398216|450414839|FG003|Overall Study|Lost to Follow-up|4|||
125615242|NCT02951988|451873967|FG001|Double-Blind Treatment Period|Adverse Event|8|||
125615243|NCT02951988|451873968|FG002|Double-Blind Treatment Period|Adverse Event|3|||
125615244|NCT02951988|451873969|FG003|Double-Blind Treatment Period|Adverse Event|6|||
125615245|NCT02951988|451873966|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
125615246|NCT02951988|451873967|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
125615247|NCT02951988|451873968|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
125615248|NCT02951988|451873969|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
125615249|NCT05836818|451873970|FG000|Overall Study|Physician Decision|1|||
125615250|NCT05836818|451873971|FG001|Overall Study|Physician Decision|1|||
125615251|NCT05836818|451873972|FG002|Overall Study|Physician Decision|0|||
125615252|NCT05836818|451873970|FG000|Overall Study|Withdrawal by Subject|0|||
125615253|NCT05836818|451873971|FG001|Overall Study|Withdrawal by Subject|0|||
125615254|NCT05836818|451873972|FG002|Overall Study|Withdrawal by Subject|1|||
125615255|NCT05836818|451873970|FG000|Overall Study|Later found to be previously vaccinated|0|||
125615256|NCT05836818|451873971|FG001|Overall Study|Later found to be previously vaccinated|1|||
125615257|NCT05836818|451873972|FG002|Overall Study|Later found to be previously vaccinated|3|||
125615258|NCT05836818|451873970|FG000|Overall Study|Pregnancy|0|||
125615259|NCT05836818|451873971|FG001|Overall Study|Pregnancy|1|||
125615260|NCT05836818|451873972|FG002|Overall Study|Pregnancy|0|||
125615261|NCT05836818|451873970|FG000|Overall Study|Allergic to vaccines|0|||
125214696|NCT00398216|450414840|FG004|Overall Study|Lost to Follow-up|1|||
125214697|NCT00398216|450414836|FG000|Overall Study|Death|0|||
125214698|NCT00398216|450414837|FG001|Overall Study|Death|3|||
125214699|NCT00398216|450414838|FG002|Overall Study|Death|0|||
125373126|NCT02794883|450996498|FG000|Follow-up Period (up to 2 Years)|Death|12|||
125373127|NCT02794883|450996499|FG001|Follow-up Period (up to 2 Years)|Death|10|||
125373128|NCT02794883|450996500|FG002|Follow-up Period (up to 2 Years)|Death|10|||
125615262|NCT05836818|451873971|FG001|Overall Study|Allergic to vaccines|1|||
125615263|NCT05836818|451873972|FG002|Overall Study|Allergic to vaccines|0|||
125615264|NCT00807846|451873973|FG000|Overall Study|Adverse Event|5|||
125615265|NCT00807846|451873974|FG001|Overall Study|Adverse Event|0|||
125615266|NCT00807846|451873973|FG000|Overall Study|Lack of Efficacy|2|||
125615267|NCT00807846|451873974|FG001|Overall Study|Lack of Efficacy|0|||
125615268|NCT00807846|451873973|FG000|Overall Study|Protocol Violation|2|||
125615269|NCT00807846|451873974|FG001|Overall Study|Protocol Violation|1|||
125615270|NCT00807846|451873973|FG000|Overall Study|Withdrawal by Subject|2|||
125615271|NCT00807846|451873974|FG001|Overall Study|Withdrawal by Subject|1|||
125615272|NCT00807846|451873973|FG000|Overall Study|Other|1|||
125615273|NCT00807846|451873974|FG001|Overall Study|Other|2|||
125615274|NCT03977727|451873975|FG000|Second Treatment|Lost to Follow-up|0|||
125214700|NCT00398216|450414839|FG003|Overall Study|Death|0|||
125214701|NCT00398216|450414840|FG004|Overall Study|Death|0|||
125615275|NCT03977727|451873976|FG001|Second Treatment|Lost to Follow-up|3|||
125214702|NCT00398216|450414836|FG000|Overall Study|Withdrawal by Subject|1|||
125214703|NCT00398216|450414837|FG001|Overall Study|Withdrawal by Subject|0|||
125214704|NCT00398216|450414838|FG002|Overall Study|Withdrawal by Subject|3|||
125615276|NCT00603980|451873982|FG000|Study Qualification|Protocol Violation|3|||
125615277|NCT00603980|451873982|FG000|Study Qualification|Inconsistent data reporting|13|||
125615278|NCT00603980|451873982|FG000|Main Study|14th subject completed trial|1|||
125615279|NCT02683525|451873983|FG000|Overall Study|Lost to Follow-up|1|||
125615280|NCT02683525|451873983|FG000|Overall Study|Physician Decision|1|||
125615281|NCT02683525|451873983|FG000|Overall Study|Disease Progression|6|||
125615282|NCT01627067|451873988|FG000|Overall Study|Screen Failure|1|||
125615283|NCT00926796|451873992|FG000|Overall Study|Did not receive randomized treatment|4|||
125214705|NCT00398216|450414839|FG003|Overall Study|Withdrawal by Subject|1|||
125214706|NCT00398216|450414840|FG004|Overall Study|Withdrawal by Subject|2|||
125214707|NCT00398216|450414836|FG000|Overall Study|administrative reasons|3|||
125214708|NCT00398216|450414837|FG001|Overall Study|administrative reasons|4|||
125615284|NCT00926796|451873993|FG001|Overall Study|Did not receive randomized treatment|7|||
125615285|NCT00926796|451873992|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
125615286|NCT00926796|451873993|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
125615287|NCT00926796|451873992|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
125615288|NCT00926796|451873993|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
125615289|NCT00926796|451873992|FG000|Overall Study|Adverse Event|7|||
125615290|NCT00926796|451873993|FG001|Overall Study|Adverse Event|14|||
125615291|NCT00926796|451873992|FG000|Overall Study|Lost to Follow-up|22|||
125615292|NCT00926796|451873993|FG001|Overall Study|Lost to Follow-up|13|||
125615293|NCT00926796|451873992|FG000|Overall Study|Protocol Violation|15|||
125615294|NCT00926796|451873993|FG001|Overall Study|Protocol Violation|11|||
125615295|NCT00926796|451873992|FG000|Overall Study|Withdrawal by Subject|1|||
125615296|NCT00926796|451873993|FG001|Overall Study|Withdrawal by Subject|0|||
125615297|NCT01341652|451873997|FG000|Overall Study|Incorrect Random Assignment|0|||
125615298|NCT01341652|451873998|FG001|Overall Study|Incorrect Random Assignment|1|||
125615299|NCT01341652|451873997|FG000|Overall Study|ineligible; presence metastatic disease|0|||
125615300|NCT01341652|451873998|FG001|Overall Study|ineligible; presence metastatic disease|1|||
125615301|NCT00632463|451874000|FG000|Overall Study|Adverse Event|0|||
125615302|NCT00632463|451874001|FG001|Overall Study|Adverse Event|1|||
125615303|NCT00632463|451874002|FG002|Overall Study|Adverse Event|0|||
125615304|NCT00586924|451874003|FG000|Overall Study|Adverse event/serious adverse event|0|||
125615305|NCT00586924|451874004|FG001|Overall Study|Adverse event/serious adverse event|0|||
125615306|NCT00586924|451874005|FG002|Overall Study|Adverse event/serious adverse event|0|||
125615307|NCT00586924|451874006|FG003|Overall Study|Adverse event/serious adverse event|1|||
125615308|NCT00586924|451874007|FG004|Overall Study|Adverse event/serious adverse event|0|||
125615309|NCT00586924|451874008|FG005|Overall Study|Adverse event/serious adverse event|2|||
125615310|NCT00586924|451874003|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
125615311|NCT00586924|451874004|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
125615312|NCT00586924|451874005|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
125615313|NCT00586924|451874006|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
125615314|NCT00586924|451874007|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
125615315|NCT00586924|451874008|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
125615316|NCT00586924|451874003|FG000|Overall Study|Disease progression|0|||
125615317|NCT00586924|451874004|FG001|Overall Study|Disease progression|0|||
125615318|NCT00586924|451874005|FG002|Overall Study|Disease progression|0|||
125615319|NCT00586924|451874006|FG003|Overall Study|Disease progression|1|||
125615320|NCT00586924|451874007|FG004|Overall Study|Disease progression|1|||
125615321|NCT00586924|451874008|FG005|Overall Study|Disease progression|0|||
125615322|NCT00586924|451874003|FG000|Overall Study|Development of neutralizing antibodies|2|||
125615323|NCT00586924|451874004|FG001|Overall Study|Development of neutralizing antibodies|2|||
125615324|NCT00586924|451874005|FG002|Overall Study|Development of neutralizing antibodies|2|||
125615325|NCT00586924|451874006|FG003|Overall Study|Development of neutralizing antibodies|0|||
125615326|NCT00586924|451874007|FG004|Overall Study|Development of neutralizing antibodies|0|||
125615327|NCT00586924|451874008|FG005|Overall Study|Development of neutralizing antibodies|22|||
125615328|NCT00586924|451874003|FG000|Overall Study|Complete response|0|||
125615329|NCT00586924|451874004|FG001|Overall Study|Complete response|1|||
125615330|NCT00586924|451874005|FG002|Overall Study|Complete response|0|||
125615331|NCT00586924|451874006|FG003|Overall Study|Complete response|0|||
125615332|NCT00586924|451874007|FG004|Overall Study|Complete response|2|||
125615333|NCT00586924|451874008|FG005|Overall Study|Complete response|2|||
125615334|NCT00586924|451874003|FG000|Overall Study|Other|1|||
125615335|NCT00586924|451874004|FG001|Overall Study|Other|0|||
125615336|NCT00586924|451874005|FG002|Overall Study|Other|1|||
125615337|NCT00586924|451874006|FG003|Overall Study|Other|1|||
125615338|NCT00586924|451874007|FG004|Overall Study|Other|1|||
125615339|NCT00586924|451874008|FG005|Overall Study|Other|6|||
125615340|NCT04146467|451874013|FG000|Overall Study|Adverse Event|0|||
125615341|NCT04146467|451874014|FG001|Overall Study|Adverse Event|1|||
125615342|NCT04146467|451874013|FG000|Overall Study|Lost to Follow-up|0|||
125615343|NCT04146467|451874014|FG001|Overall Study|Lost to Follow-up|2|||
125615344|NCT00621855|451874017|FG000|Overall Study|Adverse Event|32|||
125615345|NCT00621855|451874018|FG001|Overall Study|Adverse Event|31|||
125615346|NCT00621855|451874019|FG002|Overall Study|Adverse Event|48|||
125615347|NCT00621855|451874020|FG003|Overall Study|Adverse Event|34|||
125615348|NCT00621855|451874021|FG004|Overall Study|Adverse Event|31|||
125615349|NCT00621855|451874017|FG000|Overall Study|Lost to Follow-up|0|||
125615350|NCT00621855|451874018|FG001|Overall Study|Lost to Follow-up|1|||
125615351|NCT00621855|451874019|FG002|Overall Study|Lost to Follow-up|3|||
125615352|NCT00621855|451874020|FG003|Overall Study|Lost to Follow-up|4|||
125615353|NCT00621855|451874021|FG004|Overall Study|Lost to Follow-up|1|||
125615354|NCT00621855|451874017|FG000|Overall Study|Protocol Violation|16|||
125615355|NCT00621855|451874018|FG001|Overall Study|Protocol Violation|8|||
125615356|NCT00621855|451874019|FG002|Overall Study|Protocol Violation|6|||
125615357|NCT00621855|451874020|FG003|Overall Study|Protocol Violation|7|||
125615358|NCT00621855|451874021|FG004|Overall Study|Protocol Violation|8|||
125615359|NCT00621855|451874017|FG000|Overall Study|Withdrawal by Subject|16|||
125615360|NCT00621855|451874018|FG001|Overall Study|Withdrawal by Subject|11|||
125615361|NCT00621855|451874019|FG002|Overall Study|Withdrawal by Subject|13|||
125615362|NCT00621855|451874020|FG003|Overall Study|Withdrawal by Subject|13|||
125615363|NCT00621855|451874021|FG004|Overall Study|Withdrawal by Subject|9|||
125615364|NCT00621855|451874017|FG000|Overall Study|Other|9|||
125615365|NCT00621855|451874018|FG001|Overall Study|Other|7|||
125615366|NCT00621855|451874019|FG002|Overall Study|Other|6|||
125615367|NCT00621855|451874020|FG003|Overall Study|Other|5|||
125615368|NCT00621855|451874021|FG004|Overall Study|Other|4|||
125615369|NCT00621855|451874017|FG000|Overall Study|Patients did not receive study drug|3|||
125615370|NCT00621855|451874018|FG001|Overall Study|Patients did not receive study drug|3|||
125615371|NCT00621855|451874019|FG002|Overall Study|Patients did not receive study drug|5|||
125615372|NCT00621855|451874020|FG003|Overall Study|Patients did not receive study drug|4|||
125615373|NCT00621855|451874021|FG004|Overall Study|Patients did not receive study drug|2|||
125615374|NCT03731364|451874022|FG000|Overall Study|Adverse Event|0|||
125615375|NCT03731364|451874023|FG001|Overall Study|Adverse Event|0|||
125615376|NCT03731364|451874024|FG002|Overall Study|Adverse Event|1|||
125615377|NCT03731364|451874025|FG003|Overall Study|Adverse Event|2|||
125615378|NCT03731364|451874026|FG004|Overall Study|Adverse Event|1|||
125615379|NCT01934192|451874027|FG000|Overall Study|Protocol Violation|0|||
125615380|NCT01934192|451874028|FG001|Overall Study|Protocol Violation|0|||
125615381|NCT01934192|451874029|FG002|Overall Study|Protocol Violation|0|||
125615382|NCT01934192|451874030|FG003|Overall Study|Protocol Violation|1|||
125615383|NCT01934192|451874027|FG000|Overall Study|Other: reached stopping criteria|6|||
125615384|NCT01934192|451874028|FG001|Overall Study|Other: reached stopping criteria|5|||
125615385|NCT01934192|451874029|FG002|Overall Study|Other: reached stopping criteria|1|||
125615386|NCT01934192|451874030|FG003|Overall Study|Other: reached stopping criteria|0|||
125615387|NCT01934192|451874027|FG000|Overall Study|Physician Decision|3|||
125615388|NCT01934192|451874028|FG001|Overall Study|Physician Decision|2|||
125615389|NCT01934192|451874029|FG002|Overall Study|Physician Decision|0|||
125615390|NCT01934192|451874030|FG003|Overall Study|Physician Decision|0|||
125615391|NCT01189435|451874031|FG000|Overall Study|Withdrawal by Subject|1|||
125615392|NCT01189435|451874031|FG000|Overall Study|Physician Decision|1|||
125615393|NCT03259490|451874032|FG000|Period 1|Withdrawal by Subject|0|||
125615394|NCT03259490|451874033|FG001|Period 1|Withdrawal by Subject|1|||
125615395|NCT03259490|451874032|FG000|Period 2|Protocol Violation|1|||
125615396|NCT03259490|451874033|FG001|Period 2|Protocol Violation|0|||
125615397|NCT03095521|451874034|FG000|Overall Study|Withdrawal by Subject|0|||
125615398|NCT03095521|451874035|FG001|Overall Study|Withdrawal by Subject|1|||
125615399|NCT03095521|451874034|FG000|Overall Study|Lost to Follow-up|0|||
125615400|NCT03095521|451874035|FG001|Overall Study|Lost to Follow-up|1|||
125615401|NCT01963208|451874036|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
125615402|NCT01963208|451874037|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
125615403|NCT01963208|451874038|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
125615404|NCT01963208|451874039|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
125615405|NCT01963208|451874040|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
125615406|NCT01963208|451874041|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
125615407|NCT01963208|451874036|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
125615408|NCT01963208|451874037|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
125615409|NCT01963208|451874038|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
125615410|NCT01963208|451874039|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
125615411|NCT01963208|451874040|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
125615412|NCT01963208|451874041|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
125615413|NCT01963208|451874036|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
125615414|NCT01963208|451874037|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
125615415|NCT01963208|451874038|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
125615416|NCT01963208|451874039|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
125615417|NCT01963208|451874040|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
125615418|NCT01963208|451874041|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
125615419|NCT01963208|451874036|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
125615420|NCT01963208|451874037|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
125615421|NCT01963208|451874038|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
125615422|NCT01963208|451874039|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
125615423|NCT01963208|451874040|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
125615424|NCT01963208|451874041|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
125615425|NCT01963208|451874036|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
125615426|NCT01963208|451874037|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
125615427|NCT01963208|451874038|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
125615428|NCT01963208|451874039|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
125615429|NCT01963208|451874040|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
125615430|NCT01963208|451874041|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
125615431|NCT01963208|451874036|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
125373129|NCT02864498|450996505|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
125615432|NCT01963208|451874037|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
125615433|NCT01963208|451874038|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
125615434|NCT01963208|451874039|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
125615435|NCT01963208|451874040|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
125615436|NCT01963208|451874041|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
125615437|NCT01963208|451874036|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
125615438|NCT01963208|451874037|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
125615439|NCT01963208|451874038|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
125615440|NCT01963208|451874039|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
125615441|NCT01963208|451874040|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
125615442|NCT01963208|451874041|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
125615443|NCT01963208|451874036|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
125615444|NCT01963208|451874037|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
125615445|NCT01963208|451874038|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
125615446|NCT01963208|451874039|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
125615447|NCT01963208|451874040|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
125615448|NCT01963208|451874041|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
125615449|NCT01963208|451874036|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
125615450|NCT01963208|451874037|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
125615451|NCT01963208|451874038|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
125615452|NCT01963208|451874039|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
125615453|NCT01963208|451874040|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
125615454|NCT01963208|451874041|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
125615455|NCT01963208|451874036|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
125615456|NCT01963208|451874037|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
125615457|NCT01963208|451874038|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
125615458|NCT01963208|451874039|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
125615459|NCT01963208|451874040|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
125615460|NCT01963208|451874041|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
125615461|NCT01963208|451874036|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
125615462|NCT01963208|451874037|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
125615463|NCT01963208|451874038|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
125615464|NCT01963208|451874039|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
125615465|NCT01963208|451874040|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
125615466|NCT01963208|451874041|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
125615467|NCT01963208|451874036|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
125615468|NCT01963208|451874037|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
125615469|NCT01963208|451874038|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
125615470|NCT01963208|451874039|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
125615471|NCT01963208|451874040|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
125615472|NCT01963208|451874041|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
125615473|NCT01963208|451874036|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
125615474|NCT01963208|451874037|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
125615475|NCT01963208|451874038|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
125615476|NCT01963208|451874039|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
125615477|NCT01963208|451874040|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
125615478|NCT01963208|451874041|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
125214709|NCT00398216|450414838|FG002|Overall Study|administrative reasons|4|||
125615479|NCT01963208|451874036|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
125615480|NCT01963208|451874037|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
125214710|NCT00398216|450414839|FG003|Overall Study|administrative reasons|3|||
125615481|NCT01963208|451874038|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
125615482|NCT01963208|451874039|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
125615483|NCT01963208|451874040|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
125615484|NCT01963208|451874041|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
125615485|NCT00448916|451874042|FG000|Overall Study|Adverse Event|2|||
125615486|NCT00448916|451874043|FG001|Overall Study|Adverse Event|2|||
125615487|NCT00448916|451874044|FG002|Overall Study|Adverse Event|3|||
125615488|NCT00448916|451874045|FG003|Overall Study|Adverse Event|2|||
125615489|NCT00448916|451874042|FG000|Overall Study|Lack of Efficacy|1|||
125615490|NCT00448916|451874043|FG001|Overall Study|Lack of Efficacy|0|||
125615491|NCT00448916|451874044|FG002|Overall Study|Lack of Efficacy|2|||
125615492|NCT00448916|451874045|FG003|Overall Study|Lack of Efficacy|1|||
125615493|NCT00448916|451874042|FG000|Overall Study|Withdrawal by Subject|3|||
125615494|NCT00448916|451874043|FG001|Overall Study|Withdrawal by Subject|3|||
125615495|NCT00448916|451874044|FG002|Overall Study|Withdrawal by Subject|1|||
125615496|NCT00448916|451874045|FG003|Overall Study|Withdrawal by Subject|1|||
125615497|NCT00448916|451874042|FG000|Overall Study|Other|1|||
125615498|NCT00448916|451874043|FG001|Overall Study|Other|0|||
125615499|NCT00448916|451874044|FG002|Overall Study|Other|0|||
125615500|NCT00448916|451874045|FG003|Overall Study|Other|0|||
125615501|NCT00448916|451874042|FG000|Overall Study|Lost to Follow-up|0|||
125615502|NCT00448916|451874043|FG001|Overall Study|Lost to Follow-up|1|||
125615503|NCT00448916|451874044|FG002|Overall Study|Lost to Follow-up|0|||
125615504|NCT00448916|451874045|FG003|Overall Study|Lost to Follow-up|1|||
125615505|NCT00448916|451874042|FG000|Overall Study|Protocol Violation|0|||
125615506|NCT00448916|451874043|FG001|Overall Study|Protocol Violation|0|||
125615507|NCT00448916|451874044|FG002|Overall Study|Protocol Violation|0|||
125615508|NCT00448916|451874045|FG003|Overall Study|Protocol Violation|1|||
125615509|NCT03521193|451874046|FG000|Overall Study|Withdrawal by Subject|8|||
125615510|NCT03521193|451874047|FG001|Overall Study|Withdrawal by Subject|0|||
125615511|NCT03521193|451874046|FG000|Overall Study|non compliant to ASA treatment|8|||
125615512|NCT03521193|451874047|FG001|Overall Study|non compliant to ASA treatment|0|||
125615513|NCT01810042|451874048|FG000|Overall Study|Lost to Follow-up|10|||
125615514|NCT03707158|451874049|FG000|Midtreatment|Lost to Follow-up|16|||
125615515|NCT03707158|451874050|FG001|Midtreatment|Lost to Follow-up|7|||
125615516|NCT03707158|451874049|FG000|Midtreatment|Withdrawal by Subject|28|||
125615517|NCT03707158|451874050|FG001|Midtreatment|Withdrawal by Subject|19|||
125615518|NCT03707158|451874049|FG000|Posttreatment|Lost to Follow-up|0|||
125615519|NCT03707158|451874050|FG001|Posttreatment|Lost to Follow-up|5|||
125615520|NCT03707158|451874049|FG000|Follow-up|Lost to Follow-up|19|||
125615521|NCT03707158|451874050|FG001|Follow-up|Lost to Follow-up|18|||
125615522|NCT03707158|451874049|FG000|Follow-up|Withdrawal by Subject|13|||
125615523|NCT03707158|451874050|FG001|Follow-up|Withdrawal by Subject|6|||
125615524|NCT02773238|451874051|FG000|Overall Study|Lack of Efficacy|4|||
125615525|NCT05301322|451874052|FG000|Overall Study|Adverse Event|7|||
125615526|NCT05301322|451874053|FG001|Overall Study|Adverse Event|3|||
125615527|NCT05301322|451874052|FG000|Overall Study|Death|0|||
125615528|NCT05301322|451874053|FG001|Overall Study|Death|1|||
125615529|NCT05301322|451874052|FG000|Overall Study|Lost to Follow-up|2|||
125615530|NCT05301322|451874053|FG001|Overall Study|Lost to Follow-up|1|||
125615531|NCT05301322|451874052|FG000|Overall Study|Protocol Violation|3|||
125615532|NCT05301322|451874053|FG001|Overall Study|Protocol Violation|1|||
125615533|NCT05301322|451874052|FG000|Overall Study|Withdrawal by Subject|3|||
125615534|NCT05301322|451874053|FG001|Overall Study|Withdrawal by Subject|0|||
125615535|NCT05301322|451874052|FG000|Overall Study|Other|4|||
125615536|NCT05301322|451874053|FG001|Overall Study|Other|0|||
125615537|NCT01877382|451874054|FG000|Dose Escalation|Progressive disease|2|||
125615538|NCT01877382|451874055|FG001|Dose Escalation|Progressive disease|0|||
125615539|NCT01877382|451874056|FG002|Dose Escalation|Progressive disease|1|||
125615540|NCT01877382|451874057|FG003|Dose Escalation|Progressive disease|6|||
125615541|NCT01877382|451874058|FG004|Dose Escalation|Progressive disease|1|||
125615542|NCT01877382|451874059|FG005|Dose Escalation|Progressive disease|0|||
125615543|NCT01877382|451874060|FG006|Dose Escalation|Progressive disease|3|||
125615544|NCT01877382|451874061|FG007|Dose Escalation|Progressive disease|10|||
125615545|NCT01877382|451874062|FG008|Dose Escalation|Progressive disease|4|||
125615546|NCT01877382|451874063|FG009|Dose Escalation|Progressive disease|2|||
125615547|NCT01877382|451874064|FG010|Dose Escalation|Progressive disease|3|||
125615548|NCT01877382|451874065|FG011|Dose Escalation|Progressive disease|3|||
125615549|NCT01877382|451874066|FG012|Dose Escalation|Progressive disease|13|||
125615550|NCT01877382|451874067|FG013|Dose Escalation|Progressive disease|1|||
125615551|NCT01877382|451874068|FG014|Dose Escalation|Progressive disease|0|||
125615552|NCT01877382|451874054|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
125615553|NCT01877382|451874055|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615554|NCT01877382|451874056|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615555|NCT01877382|451874057|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
125615556|NCT01877382|451874058|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615557|NCT01877382|451874059|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615558|NCT01877382|451874060|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
125615559|NCT01877382|451874061|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615560|NCT01877382|451874062|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615561|NCT01877382|451874063|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615562|NCT01877382|451874064|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615563|NCT01877382|451874065|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615564|NCT01877382|451874066|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615565|NCT01877382|451874067|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615566|NCT01877382|451874068|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615567|NCT01877382|451874054|FG000|Dose Escalation|Clinical progression|0|||
125615568|NCT01877382|451874055|FG001|Dose Escalation|Clinical progression|1|||
125615569|NCT01877382|451874056|FG002|Dose Escalation|Clinical progression|0|||
125615570|NCT01877382|451874057|FG003|Dose Escalation|Clinical progression|2|||
125615571|NCT01877382|451874058|FG004|Dose Escalation|Clinical progression|0|||
125615572|NCT01877382|451874059|FG005|Dose Escalation|Clinical progression|0|||
125615573|NCT01877382|451874060|FG006|Dose Escalation|Clinical progression|1|||
125615574|NCT01877382|451874061|FG007|Dose Escalation|Clinical progression|0|||
125615575|NCT01877382|451874062|FG008|Dose Escalation|Clinical progression|0|||
125615576|NCT01877382|451874063|FG009|Dose Escalation|Clinical progression|1|||
125615577|NCT01877382|451874064|FG010|Dose Escalation|Clinical progression|0|||
125615578|NCT01877382|451874065|FG011|Dose Escalation|Clinical progression|0|||
125615579|NCT01877382|451874066|FG012|Dose Escalation|Clinical progression|2|||
125615580|NCT01877382|451874067|FG013|Dose Escalation|Clinical progression|1|||
125615581|NCT01877382|451874068|FG014|Dose Escalation|Clinical progression|0|||
125615582|NCT01877382|451874054|FG000|Dose Escalation|Adverse Event|0|||
125615583|NCT01877382|451874055|FG001|Dose Escalation|Adverse Event|0|||
125615584|NCT01877382|451874056|FG002|Dose Escalation|Adverse Event|0|||
125615585|NCT01877382|451874057|FG003|Dose Escalation|Adverse Event|4|||
125615586|NCT01877382|451874058|FG004|Dose Escalation|Adverse Event|1|||
125615587|NCT01877382|451874059|FG005|Dose Escalation|Adverse Event|2|||
125615588|NCT01877382|451874060|FG006|Dose Escalation|Adverse Event|1|||
125615589|NCT01877382|451874061|FG007|Dose Escalation|Adverse Event|2|||
125615590|NCT01877382|451874062|FG008|Dose Escalation|Adverse Event|0|||
125615591|NCT01877382|451874063|FG009|Dose Escalation|Adverse Event|0|||
125615592|NCT01877382|451874064|FG010|Dose Escalation|Adverse Event|0|||
125615593|NCT01877382|451874065|FG011|Dose Escalation|Adverse Event|0|||
125615594|NCT01877382|451874066|FG012|Dose Escalation|Adverse Event|1|||
125615595|NCT01877382|451874067|FG013|Dose Escalation|Adverse Event|0|||
125615596|NCT01877382|451874068|FG014|Dose Escalation|Adverse Event|0|||
125615597|NCT01877382|451874054|FG000|Dose Escalation|Withdrawal by Subject|0|||
125615598|NCT01877382|451874055|FG001|Dose Escalation|Withdrawal by Subject|0|||
125615599|NCT01877382|451874056|FG002|Dose Escalation|Withdrawal by Subject|0|||
125615600|NCT01877382|451874057|FG003|Dose Escalation|Withdrawal by Subject|0|||
125615601|NCT01877382|451874058|FG004|Dose Escalation|Withdrawal by Subject|0|||
125615602|NCT01877382|451874059|FG005|Dose Escalation|Withdrawal by Subject|3|||
125615603|NCT01877382|451874060|FG006|Dose Escalation|Withdrawal by Subject|2|||
125615604|NCT01877382|451874061|FG007|Dose Escalation|Withdrawal by Subject|1|||
125615605|NCT01877382|451874062|FG008|Dose Escalation|Withdrawal by Subject|1|||
125615606|NCT01877382|451874063|FG009|Dose Escalation|Withdrawal by Subject|0|||
125615607|NCT01877382|451874064|FG010|Dose Escalation|Withdrawal by Subject|0|||
125615608|NCT01877382|451874065|FG011|Dose Escalation|Withdrawal by Subject|0|||
125615609|NCT01877382|451874066|FG012|Dose Escalation|Withdrawal by Subject|0|||
125615610|NCT01877382|451874067|FG013|Dose Escalation|Withdrawal by Subject|0|||
125615611|NCT01877382|451874068|FG014|Dose Escalation|Withdrawal by Subject|0|||
125615612|NCT01877382|451874054|FG000|Dose Escalation|Protocol Violation|0|||
125615613|NCT01877382|451874055|FG001|Dose Escalation|Protocol Violation|0|||
125214711|NCT00398216|450414840|FG004|Overall Study|administrative reasons|3|||
125615614|NCT01877382|451874056|FG002|Dose Escalation|Protocol Violation|0|||
125615615|NCT01877382|451874057|FG003|Dose Escalation|Protocol Violation|0|||
125615616|NCT01877382|451874058|FG004|Dose Escalation|Protocol Violation|0|||
125615617|NCT01877382|451874059|FG005|Dose Escalation|Protocol Violation|0|||
125615618|NCT01877382|451874060|FG006|Dose Escalation|Protocol Violation|1|||
125615619|NCT01877382|451874061|FG007|Dose Escalation|Protocol Violation|0|||
125615620|NCT01877382|451874062|FG008|Dose Escalation|Protocol Violation|0|||
125615621|NCT01877382|451874063|FG009|Dose Escalation|Protocol Violation|0|||
125615622|NCT01877382|451874064|FG010|Dose Escalation|Protocol Violation|0|||
125615623|NCT01877382|451874065|FG011|Dose Escalation|Protocol Violation|0|||
125615624|NCT01877382|451874066|FG012|Dose Escalation|Protocol Violation|0|||
125615625|NCT01877382|451874067|FG013|Dose Escalation|Protocol Violation|0|||
125615626|NCT01877382|451874068|FG014|Dose Escalation|Protocol Violation|0|||
125615627|NCT01877382|451874054|FG000|Dose Escalation|Study terminated by sponsor|0|||
125615628|NCT01877382|451874055|FG001|Dose Escalation|Study terminated by sponsor|0|||
125615629|NCT01877382|451874056|FG002|Dose Escalation|Study terminated by sponsor|0|||
125615630|NCT01877382|451874057|FG003|Dose Escalation|Study terminated by sponsor|0|||
125615631|NCT01877382|451874058|FG004|Dose Escalation|Study terminated by sponsor|0|||
125615632|NCT01877382|451874059|FG005|Dose Escalation|Study terminated by sponsor|0|||
125615633|NCT01877382|451874060|FG006|Dose Escalation|Study terminated by sponsor|0|||
125615634|NCT01877382|451874061|FG007|Dose Escalation|Study terminated by sponsor|1|||
125615635|NCT01877382|451874062|FG008|Dose Escalation|Study terminated by sponsor|1|||
125615636|NCT01877382|451874063|FG009|Dose Escalation|Study terminated by sponsor|0|||
125615637|NCT01877382|451874064|FG010|Dose Escalation|Study terminated by sponsor|0|||
125615638|NCT01877382|451874065|FG011|Dose Escalation|Study terminated by sponsor|0|||
125615639|NCT01877382|451874066|FG012|Dose Escalation|Study terminated by sponsor|3|||
125615640|NCT01877382|451874067|FG013|Dose Escalation|Study terminated by sponsor|0|||
125615641|NCT01877382|451874068|FG014|Dose Escalation|Study terminated by sponsor|0|||
125615642|NCT01877382|451874054|FG000|Dose Escalation|Death|0|||
125615643|NCT01877382|451874055|FG001|Dose Escalation|Death|0|||
125615644|NCT01877382|451874056|FG002|Dose Escalation|Death|0|||
125615645|NCT01877382|451874057|FG003|Dose Escalation|Death|0|||
125615646|NCT01877382|451874058|FG004|Dose Escalation|Death|0|||
125615647|NCT01877382|451874059|FG005|Dose Escalation|Death|0|||
125615648|NCT01877382|451874060|FG006|Dose Escalation|Death|0|||
125615649|NCT01877382|451874061|FG007|Dose Escalation|Death|1|||
125615650|NCT01877382|451874062|FG008|Dose Escalation|Death|0|||
125615651|NCT01877382|451874063|FG009|Dose Escalation|Death|0|||
125615652|NCT01877382|451874064|FG010|Dose Escalation|Death|0|||
125615653|NCT01877382|451874065|FG011|Dose Escalation|Death|0|||
125615654|NCT01877382|451874066|FG012|Dose Escalation|Death|1|||
125615655|NCT01877382|451874067|FG013|Dose Escalation|Death|1|||
125615656|NCT01877382|451874068|FG014|Dose Escalation|Death|0|||
125615657|NCT01877382|451874054|FG000|Dose Expansion|Progressive disease|0|||
125615658|NCT01877382|451874055|FG001|Dose Expansion|Progressive disease|0|||
125615659|NCT01877382|451874056|FG002|Dose Expansion|Progressive disease|0|||
125615660|NCT01877382|451874057|FG003|Dose Expansion|Progressive disease|0|||
125615661|NCT01877382|451874058|FG004|Dose Expansion|Progressive disease|0|||
125615662|NCT01877382|451874059|FG005|Dose Expansion|Progressive disease|0|||
125615663|NCT01877382|451874060|FG006|Dose Expansion|Progressive disease|0|||
125615664|NCT01877382|451874061|FG007|Dose Expansion|Progressive disease|0|||
125615665|NCT01877382|451874062|FG008|Dose Expansion|Progressive disease|0|||
125615666|NCT01877382|451874063|FG009|Dose Expansion|Progressive disease|0|||
125615667|NCT01877382|451874064|FG010|Dose Expansion|Progressive disease|0|||
125615668|NCT01877382|451874065|FG011|Dose Expansion|Progressive disease|0|||
125615669|NCT01877382|451874066|FG012|Dose Expansion|Progressive disease|0|||
125615670|NCT01877382|451874067|FG013|Dose Expansion|Progressive disease|0|||
125615671|NCT01877382|451874068|FG014|Dose Expansion|Progressive disease|11|||
125615672|NCT01877382|451874054|FG000|Dose Expansion|Clinical progression|0|||
125615673|NCT01877382|451874055|FG001|Dose Expansion|Clinical progression|0|||
125615674|NCT01877382|451874056|FG002|Dose Expansion|Clinical progression|0|||
125615675|NCT01877382|451874057|FG003|Dose Expansion|Clinical progression|0|||
125615676|NCT01877382|451874058|FG004|Dose Expansion|Clinical progression|0|||
125615677|NCT01877382|451874059|FG005|Dose Expansion|Clinical progression|0|||
125615678|NCT01877382|451874060|FG006|Dose Expansion|Clinical progression|0|||
125615679|NCT01877382|451874061|FG007|Dose Expansion|Clinical progression|0|||
125615680|NCT01877382|451874062|FG008|Dose Expansion|Clinical progression|0|||
125615681|NCT01877382|451874063|FG009|Dose Expansion|Clinical progression|0|||
125615682|NCT01877382|451874064|FG010|Dose Expansion|Clinical progression|0|||
125615683|NCT01877382|451874065|FG011|Dose Expansion|Clinical progression|0|||
125615684|NCT01877382|451874066|FG012|Dose Expansion|Clinical progression|0|||
125615685|NCT01877382|451874067|FG013|Dose Expansion|Clinical progression|0|||
125615686|NCT01877382|451874068|FG014|Dose Expansion|Clinical progression|6|||
125615687|NCT01877382|451874054|FG000|Dose Expansion|Adverse Event|0|||
125615688|NCT01877382|451874055|FG001|Dose Expansion|Adverse Event|0|||
125615689|NCT01877382|451874056|FG002|Dose Expansion|Adverse Event|0|||
125615690|NCT01877382|451874057|FG003|Dose Expansion|Adverse Event|0|||
125615691|NCT01877382|451874058|FG004|Dose Expansion|Adverse Event|0|||
125615692|NCT01877382|451874059|FG005|Dose Expansion|Adverse Event|0|||
125373130|NCT02864498|450996506|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
125373131|NCT02864498|450996507|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
125615693|NCT01877382|451874060|FG006|Dose Expansion|Adverse Event|0|||
125615694|NCT01877382|451874061|FG007|Dose Expansion|Adverse Event|0|||
125615695|NCT01877382|451874062|FG008|Dose Expansion|Adverse Event|0|||
125615696|NCT01877382|451874063|FG009|Dose Expansion|Adverse Event|0|||
125615697|NCT01877382|451874064|FG010|Dose Expansion|Adverse Event|0|||
125615698|NCT01877382|451874065|FG011|Dose Expansion|Adverse Event|0|||
125615699|NCT01877382|451874066|FG012|Dose Expansion|Adverse Event|0|||
125615700|NCT01877382|451874067|FG013|Dose Expansion|Adverse Event|0|||
125615701|NCT01877382|451874068|FG014|Dose Expansion|Adverse Event|1|||
125615702|NCT01877382|451874054|FG000|Dose Expansion|Death|0|||
125615703|NCT01877382|451874055|FG001|Dose Expansion|Death|0|||
125615704|NCT01877382|451874056|FG002|Dose Expansion|Death|0|||
125615705|NCT01877382|451874057|FG003|Dose Expansion|Death|0|||
125615706|NCT01877382|451874058|FG004|Dose Expansion|Death|0|||
125615707|NCT01877382|451874059|FG005|Dose Expansion|Death|0|||
125615708|NCT01877382|451874060|FG006|Dose Expansion|Death|0|||
125615709|NCT01877382|451874061|FG007|Dose Expansion|Death|0|||
125615710|NCT01877382|451874062|FG008|Dose Expansion|Death|0|||
125615711|NCT01877382|451874063|FG009|Dose Expansion|Death|0|||
125615712|NCT01877382|451874064|FG010|Dose Expansion|Death|0|||
125615713|NCT01877382|451874065|FG011|Dose Expansion|Death|0|||
125615714|NCT01877382|451874066|FG012|Dose Expansion|Death|0|||
125615715|NCT01877382|451874067|FG013|Dose Expansion|Death|0|||
125615716|NCT01877382|451874068|FG014|Dose Expansion|Death|1|||
125615717|NCT01877382|451874054|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615718|NCT01877382|451874055|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615719|NCT01877382|451874056|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615720|NCT01877382|451874057|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615721|NCT01877382|451874058|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615722|NCT01877382|451874059|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615723|NCT01877382|451874060|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615724|NCT01877382|451874061|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615725|NCT01877382|451874062|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615726|NCT01877382|451874063|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615727|NCT01877382|451874064|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615728|NCT01877382|451874065|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615729|NCT01877382|451874066|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615730|NCT01877382|451874067|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
125615731|NCT01877382|451874068|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
125615732|NCT03829332|451874069|FG000|Overall Study|Death|225|||
125615733|NCT03829332|451874070|FG001|Overall Study|Death|230|||
125615734|NCT03829332|451874069|FG000|Overall Study|Lost to Follow-up|1|||
125615735|NCT03829332|451874070|FG001|Overall Study|Lost to Follow-up|3|||
125615736|NCT03829332|451874069|FG000|Overall Study|Physician Decision|1|||
125615737|NCT03829332|451874070|FG001|Overall Study|Physician Decision|0|||
125615738|NCT03829332|451874069|FG000|Overall Study|Sponsor Decision|71|||
125615739|NCT03829332|451874070|FG001|Overall Study|Sponsor Decision|72|||
125615740|NCT03829332|451874069|FG000|Overall Study|Withdrawal by Subject|11|||
125615741|NCT03829332|451874070|FG001|Overall Study|Withdrawal by Subject|9|||
125615742|NCT05108805|451874071|FG000|Overall Study|T-cell expansion was not successful.|5|||
125615743|NCT02198651|451876341|FG000|Lead-in Period|Withdrew consent|13|||
125615744|NCT02198651|451876342|FG001|Lead-in Period|Withdrew consent|0|||
125615745|NCT02198651|451876343|FG002|Lead-in Period|Withdrew consent|0|||
125615746|NCT02198651|451876344|FG003|Lead-in Period|Withdrew consent|0|||
125615747|NCT02198651|451876345|FG004|Lead-in Period|Withdrew consent|0|||
125615748|NCT02198651|451876341|FG000|Lead-in Period|Adverse Event|2|||
125615749|NCT02198651|451876342|FG001|Lead-in Period|Adverse Event|0|||
125615750|NCT02198651|451876343|FG002|Lead-in Period|Adverse Event|0|||
125615751|NCT02198651|451876344|FG003|Lead-in Period|Adverse Event|0|||
125615752|NCT02198651|451876345|FG004|Lead-in Period|Adverse Event|0|||
125214712|NCT00398216|450414836|FG000|Overall Study|entrance criteria|0|||
125615753|NCT02198651|451876341|FG000|Lead-in Period|Other, not specified|22|||
125615754|NCT02198651|451876342|FG001|Lead-in Period|Other, not specified|0|||
125373132|NCT02864498|450996505|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
125615755|NCT02198651|451876343|FG002|Lead-in Period|Other, not specified|0|||
125615756|NCT02198651|451876344|FG003|Lead-in Period|Other, not specified|0|||
125615757|NCT02198651|451876345|FG004|Lead-in Period|Other, not specified|0|||
125615758|NCT02198651|451876341|FG000|Double-blind Period|Withdrew consent|0|||
125615759|NCT02198651|451876342|FG001|Double-blind Period|Withdrew consent|4|||
125615760|NCT02198651|451876343|FG002|Double-blind Period|Withdrew consent|0|||
125615761|NCT02198651|451876344|FG003|Double-blind Period|Withdrew consent|0|||
125615762|NCT02198651|451876345|FG004|Double-blind Period|Withdrew consent|0|||
125615763|NCT02198651|451876341|FG000|Double-blind Period|Adverse Event|0|||
125615764|NCT02198651|451876342|FG001|Double-blind Period|Adverse Event|1|||
125615765|NCT02198651|451876343|FG002|Double-blind Period|Adverse Event|0|||
125615766|NCT02198651|451876344|FG003|Double-blind Period|Adverse Event|0|||
125615767|NCT02198651|451876345|FG004|Double-blind Period|Adverse Event|0|||
125615768|NCT02198651|451876341|FG000|Double-blind Period|Other, not specified|0|||
125615769|NCT02198651|451876342|FG001|Double-blind Period|Other, not specified|4|||
125615770|NCT02198651|451876343|FG002|Double-blind Period|Other, not specified|1|||
125615771|NCT02198651|451876344|FG003|Double-blind Period|Other, not specified|0|||
125615772|NCT02198651|451876345|FG004|Double-blind Period|Other, not specified|0|||
125615773|NCT02198651|451876341|FG000|Open-label Rescue Period|Withdrew consent|0|||
125615774|NCT02198651|451876342|FG001|Open-label Rescue Period|Withdrew consent|0|||
125615775|NCT02198651|451876343|FG002|Open-label Rescue Period|Withdrew consent|0|||
125615776|NCT02198651|451876344|FG003|Open-label Rescue Period|Withdrew consent|2|||
125615777|NCT02198651|451876345|FG004|Open-label Rescue Period|Withdrew consent|0|||
125615778|NCT02198651|451876341|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
125615779|NCT02198651|451876342|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
125615780|NCT02198651|451876343|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
125615781|NCT02198651|451876344|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
125615782|NCT02198651|451876345|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
125615783|NCT02115113|451876346|FG000|Participants in Run-in Period|Death|0|||
125615784|NCT02115113|451876347|FG001|Participants in Run-in Period|Death|0|||
125615785|NCT02115113|451876348|FG002|Participants in Run-in Period|Death|1|||
125615786|NCT02115113|451876346|FG000|Participants in Run-in Period|Administrative problems|0|||
125615787|NCT02115113|451876347|FG001|Participants in Run-in Period|Administrative problems|0|||
125615788|NCT02115113|451876348|FG002|Participants in Run-in Period|Administrative problems|1|||
125615789|NCT02115113|451876346|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
125615790|NCT02115113|451876347|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
125615791|NCT02115113|451876348|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
125615792|NCT02115113|451876346|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
125615793|NCT02115113|451876347|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
125615794|NCT02115113|451876348|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
125615795|NCT02115113|451876346|FG000|Participants Randomized|Lost to Follow-up|1|||
125615796|NCT02115113|451876347|FG001|Participants Randomized|Lost to Follow-up|0|||
125615797|NCT02115113|451876348|FG002|Participants Randomized|Lost to Follow-up|0|||
125615798|NCT02115113|451876346|FG000|Participants Randomized|Death|1|||
125615799|NCT02115113|451876347|FG001|Participants Randomized|Death|0|||
125615800|NCT02115113|451876348|FG002|Participants Randomized|Death|0|||
125615801|NCT02622724|451876349|FG000|Overall Study|Death|51|||
125615802|NCT02622724|451876350|FG001|Overall Study|Death|53|||
125615803|NCT02622724|451876349|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
125615804|NCT02622724|451876350|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
125615805|NCT02622724|451876349|FG000|Overall Study|Early termination of study|38|||
125615806|NCT02622724|451876350|FG001|Overall Study|Early termination of study|43|||
125615807|NCT00296725|451876351|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
125615808|NCT00296725|451876351|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
125615809|NCT00296725|451876351|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
125615810|NCT00356863|451876352|FG000|Overall Study|Death|16|||
125615811|NCT00356863|451876353|FG001|Overall Study|Death|32|||
125615812|NCT00356863|451876352|FG000|Overall Study|Lost to Follow-up|76|||
125615813|NCT00356863|451876353|FG001|Overall Study|Lost to Follow-up|43|||
125615814|NCT00343291|451876356|FG000|Overall Study|Adverse Event|13|||
125615815|NCT00343291|451876357|FG001|Overall Study|Adverse Event|13|||
125615816|NCT00343291|451876356|FG000|Overall Study|Death|3|||
125615817|NCT00343291|451876357|FG001|Overall Study|Death|2|||
125615818|NCT00343291|451876356|FG000|Overall Study|Progressive disease|33|||
125615819|NCT00343291|451876357|FG001|Overall Study|Progressive disease|34|||
125615820|NCT00343291|451876356|FG000|Overall Study|Withdrawal by Subject|0|||
125615821|NCT00343291|451876357|FG001|Overall Study|Withdrawal by Subject|2|||
125615822|NCT00343291|451876356|FG000|Overall Study|Other|8|||
125615823|NCT00343291|451876357|FG001|Overall Study|Other|5|||
125615824|NCT03712345|451876358|FG000|Overall Study|Failure to meet randomization criteria|0|||
125615825|NCT03712345|451876359|FG001|Overall Study|Failure to meet randomization criteria|0|||
125615826|NCT03712345|451876360|FG002|Overall Study|Failure to meet randomization criteria|1|||
125615827|NCT02585999|451876364|FG000|Overall Study|Lost to Follow-up|1|||
125615828|NCT02585999|451876364|FG000|Overall Study|Protocol Violation|1|||
125615829|NCT00485589|451876365|FG000|Overall Study|Death|2|||
125615830|NCT00485589|451876366|FG001|Overall Study|Death|2|||
125615831|NCT00485589|451876367|FG002|Overall Study|Death|0|||
125615832|NCT00485589|451876365|FG000|Overall Study|Failure to return|6|||
125615833|NCT00485589|451876366|FG001|Overall Study|Failure to return|5|||
125615834|NCT00485589|451876367|FG002|Overall Study|Failure to return|1|||
125615835|NCT00485589|451876365|FG000|Overall Study|Protocol Violation|1|||
125615836|NCT00485589|451876366|FG001|Overall Study|Protocol Violation|0|||
125615837|NCT00485589|451876367|FG002|Overall Study|Protocol Violation|0|||
125615838|NCT00485589|451876365|FG000|Overall Study|Violation of selection criteria at entry|0|||
125615839|NCT00485589|451876366|FG001|Overall Study|Violation of selection criteria at entry|3|||
125615840|NCT00485589|451876367|FG002|Overall Study|Violation of selection criteria at entry|1|||
125615841|NCT00485589|451876365|FG000|Overall Study|Administrative/Other|1|||
125615842|NCT00485589|451876366|FG001|Overall Study|Administrative/Other|2|||
125615843|NCT00485589|451876367|FG002|Overall Study|Administrative/Other|1|||
125615844|NCT00485589|451876365|FG000|Overall Study|Insufficient therapeutic response|10|||
125615845|NCT00485589|451876366|FG001|Overall Study|Insufficient therapeutic response|3|||
125615846|NCT00485589|451876367|FG002|Overall Study|Insufficient therapeutic response|1|||
125615847|NCT00485589|451876365|FG000|Overall Study|Refused treatment/did not cooperate|1|||
125615848|NCT00485589|451876366|FG001|Overall Study|Refused treatment/did not cooperate|0|||
125615849|NCT00485589|451876367|FG002|Overall Study|Refused treatment/did not cooperate|2|||
125615850|NCT00485589|451876365|FG000|Overall Study|Withdrawal by Subject|3|||
125615851|NCT00485589|451876366|FG001|Overall Study|Withdrawal by Subject|2|||
125615852|NCT00485589|451876367|FG002|Overall Study|Withdrawal by Subject|2|||
125615853|NCT00485589|451876365|FG000|Overall Study|Adverse Event|3|||
125615854|NCT00485589|451876366|FG001|Overall Study|Adverse Event|3|||
125615855|NCT00485589|451876367|FG002|Overall Study|Adverse Event|10|||
125615856|NCT01369849|451876368|FG000|Overall Study|Ineligible prior to treatment|0|||
125615857|NCT01369849|451876369|FG001|Overall Study|Ineligible prior to treatment|0|||
125615858|NCT01369849|451876370|FG002|Overall Study|Ineligible prior to treatment|1|||
125615859|NCT01369849|451876368|FG000|Overall Study|Ineligible after receiving treatment|0|||
125615860|NCT01369849|451876369|FG001|Overall Study|Ineligible after receiving treatment|1|||
125615861|NCT01369849|451876370|FG002|Overall Study|Ineligible after receiving treatment|0|||
125615862|NCT02924688|451876371|FG000|Overall Study|Adverse Event|9|||
125615863|NCT02924688|451876372|FG001|Overall Study|Adverse Event|3|||
125615864|NCT02924688|451876373|FG002|Overall Study|Adverse Event|2|||
125615865|NCT02924688|451876374|FG003|Overall Study|Adverse Event|2|||
125615866|NCT02924688|451876375|FG004|Overall Study|Adverse Event|3|||
125615867|NCT02924688|451876376|FG005|Overall Study|Adverse Event|2|||
125615868|NCT02924688|451876371|FG000|Overall Study|Lack of Efficacy|2|||
125615869|NCT02924688|451876372|FG001|Overall Study|Lack of Efficacy|3|||
125615870|NCT02924688|451876373|FG002|Overall Study|Lack of Efficacy|4|||
125615871|NCT02924688|451876374|FG003|Overall Study|Lack of Efficacy|2|||
125615872|NCT02924688|451876375|FG004|Overall Study|Lack of Efficacy|1|||
125615873|NCT02924688|451876376|FG005|Overall Study|Lack of Efficacy|1|||
125615874|NCT02924688|451876371|FG000|Overall Study|Protocol Violation|3|||
125615875|NCT02924688|451876372|FG001|Overall Study|Protocol Violation|7|||
125615876|NCT02924688|451876373|FG002|Overall Study|Protocol Violation|5|||
125615877|NCT02924688|451876374|FG003|Overall Study|Protocol Violation|6|||
125615878|NCT02924688|451876375|FG004|Overall Study|Protocol Violation|2|||
125615879|NCT02924688|451876376|FG005|Overall Study|Protocol Violation|2|||
125615880|NCT02924688|451876371|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
125615881|NCT02924688|451876372|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
125615882|NCT02924688|451876373|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
125615883|NCT02924688|451876374|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
125615884|NCT02924688|451876375|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
125615885|NCT02924688|451876376|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
125615886|NCT02924688|451876371|FG000|Overall Study|Lost to Follow-up|2|||
125615887|NCT02924688|451876372|FG001|Overall Study|Lost to Follow-up|4|||
125615888|NCT02924688|451876373|FG002|Overall Study|Lost to Follow-up|2|||
125615889|NCT02924688|451876374|FG003|Overall Study|Lost to Follow-up|4|||
125615890|NCT02924688|451876375|FG004|Overall Study|Lost to Follow-up|2|||
125615891|NCT02924688|451876376|FG005|Overall Study|Lost to Follow-up|4|||
125615892|NCT02924688|451876371|FG000|Overall Study|Physician Decision|2|||
125615893|NCT02924688|451876372|FG001|Overall Study|Physician Decision|1|||
125615894|NCT02924688|451876373|FG002|Overall Study|Physician Decision|0|||
125615895|NCT02924688|451876374|FG003|Overall Study|Physician Decision|1|||
125615896|NCT02924688|451876375|FG004|Overall Study|Physician Decision|1|||
125615897|NCT02924688|451876376|FG005|Overall Study|Physician Decision|1|||
125615898|NCT02924688|451876371|FG000|Overall Study|Withdrawal by Subject|14|||
125615899|NCT02924688|451876372|FG001|Overall Study|Withdrawal by Subject|13|||
125615900|NCT02924688|451876373|FG002|Overall Study|Withdrawal by Subject|9|||
125615901|NCT02924688|451876374|FG003|Overall Study|Withdrawal by Subject|12|||
125615902|NCT02924688|451876375|FG004|Overall Study|Withdrawal by Subject|13|||
125615903|NCT02924688|451876376|FG005|Overall Study|Withdrawal by Subject|14|||
125615904|NCT00174785|451876377|FG000|Overall Study|Adverse Event|293|||
125615905|NCT00174785|451876378|FG001|Overall Study|Adverse Event|191|||
125615906|NCT00174785|451876377|FG000|Overall Study|Protocol Violation|14|||
125615907|NCT00174785|451876378|FG001|Overall Study|Protocol Violation|14|||
125615908|NCT00174785|451876377|FG000|Overall Study|Withdrawal by Subject|173|||
125615909|NCT00174785|451876378|FG001|Overall Study|Withdrawal by Subject|175|||
125615910|NCT00174785|451876377|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
125615911|NCT00174785|451876378|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
125615912|NCT00174785|451876377|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
125615913|NCT00174785|451876378|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
125615914|NCT00174785|451876377|FG000|Overall Study|Other prohibited medication|5|||
125615915|NCT00174785|451876378|FG001|Overall Study|Other prohibited medication|3|||
125615916|NCT00174785|451876377|FG000|Overall Study|Family request|6|||
125615917|NCT00174785|451876378|FG001|Overall Study|Family request|8|||
125615918|NCT00174785|451876377|FG000|Overall Study|Not pre-specified/Not coded|56|||
125615919|NCT00174785|451876378|FG001|Overall Study|Not pre-specified/Not coded|70|||
125615920|NCT00120289|451876380|FG000|Overall Study|Death|96|||
125615921|NCT00120289|451876381|FG001|Overall Study|Death|82|||
125615922|NCT00120289|451876380|FG000|Overall Study|Lost to Follow-up|11|||
125615923|NCT00120289|451876381|FG001|Overall Study|Lost to Follow-up|14|||
125615924|NCT00120289|451876380|FG000|Overall Study|Withdrawal by Subject|14|||
125615925|NCT00120289|451876381|FG001|Overall Study|Withdrawal by Subject|13|||
125615926|NCT01754922|451876382|FG000|Overall Study|Adverse Event|0|||
125615927|NCT01754922|451876383|FG001|Overall Study|Adverse Event|1|||
125615928|NCT01944969|451876385|FG000|Overall Study|Adverse Event|1|||
125615929|NCT01944969|451876385|FG000|Overall Study|Lack of Efficacy|1|||
125615930|NCT01944969|451876385|FG000|Overall Study|Non-compliance with IMP|1|||
125615931|NCT01944969|451876385|FG000|Overall Study|Administrative or other reasons|23|||
125615932|NCT00310388|451876386|FG000|Primary Reporting Phase|Adverse Event|101|||
125615933|NCT00310388|451876387|FG001|Primary Reporting Phase|Adverse Event|0|||
125615934|NCT00310388|451876386|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
125615935|NCT00310388|451876387|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
125615936|NCT00310388|451876386|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
125615937|NCT00310388|451876387|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
125615938|NCT00310388|451876386|FG000|Primary Reporting Phase|Protocol Violation|10|||
125615939|NCT00310388|451876387|FG001|Primary Reporting Phase|Protocol Violation|0|||
125615940|NCT00310388|451876386|FG000|Primary Reporting Phase|Pregnancy|3|||
125615941|NCT00310388|451876387|FG001|Primary Reporting Phase|Pregnancy|0|||
125615942|NCT00310388|451876386|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
125615943|NCT00310388|451876387|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
125615944|NCT00310388|451876386|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
125615945|NCT00310388|451876387|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
125615946|NCT00310388|451876386|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
125615947|NCT00310388|451876387|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
125615948|NCT00310388|451876386|FG000|Primary Reporting Phase|Physician Decision|2|||
125615949|NCT00310388|451876387|FG001|Primary Reporting Phase|Physician Decision|0|||
125615950|NCT00310388|451876386|FG000|Primary Reporting Phase|Request of the sponsor|19|||
125615951|NCT00310388|451876387|FG001|Primary Reporting Phase|Request of the sponsor|0|||
125615952|NCT00310388|451876386|FG000|Primary Reporting Phase|Failed to return|8|||
125615953|NCT00310388|451876387|FG001|Primary Reporting Phase|Failed to return|0|||
125615954|NCT00310388|451876386|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
125615955|NCT00310388|451876387|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
125615956|NCT00310388|451876386|FG000|Primary Reporting Phase|Participant request|2|||
125615957|NCT00310388|451876387|FG001|Primary Reporting Phase|Participant request|0|||
125615958|NCT00310388|451876386|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
125615959|NCT00310388|451876387|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
125615960|NCT00310388|451876386|FG000|Primary Reporting Phase|Discontinuation of study|1|||
125615961|NCT00310388|451876387|FG001|Primary Reporting Phase|Discontinuation of study|0|||
125615962|NCT00310388|451876386|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
125615963|NCT00310388|451876387|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
125615964|NCT00310388|451876386|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
125615965|NCT00310388|451876387|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
125214713|NCT00398216|450414837|FG001|Overall Study|entrance criteria|0|||
125214714|NCT00398216|450414838|FG002|Overall Study|entrance criteria|0|||
125214715|NCT00398216|450414839|FG003|Overall Study|entrance criteria|0|||
125615966|NCT00310388|451876386|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
125615967|NCT00310388|451876387|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
125615968|NCT00310388|451876386|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
125615969|NCT00310388|451876387|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
125615970|NCT00310388|451876386|FG000|Primary Reporting Phase|Participant passed away|1|||
125615971|NCT00310388|451876387|FG001|Primary Reporting Phase|Participant passed away|0|||
125615972|NCT00310388|451876386|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
125615973|NCT00310388|451876387|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
125615974|NCT00310388|451876386|FG000|Primary Reporting Phase|Missing|1|||
125615975|NCT00310388|451876387|FG001|Primary Reporting Phase|Missing|0|||
125615976|NCT00310388|451876386|FG000|Primary Reporting Phase|Other|1|||
125615977|NCT00310388|451876387|FG001|Primary Reporting Phase|Other|0|||
125615978|NCT00310388|451876386|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
125615979|NCT00310388|451876387|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
125615980|NCT00310388|451876386|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
125615981|NCT00310388|451876387|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
125615982|NCT00310388|451876386|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
125615983|NCT00310388|451876387|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
125615984|NCT00310388|451876386|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
125615985|NCT00310388|451876387|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
125615986|NCT00848250|451876389|FG000|Overall Study|surgery was completed without cardiopulm|0|||
125615987|NCT00848250|451876390|FG001|Overall Study|surgery was completed without cardiopulm|1|||
125214716|NCT00398216|450414840|FG004|Overall Study|entrance criteria|2|||
125214717|NCT01048944|450414843|FG000|Overall Study|Protocol Violation|8|||
125373133|NCT02864498|450996506|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
125373134|NCT02864498|450996507|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
125373135|NCT02864498|450996505|FG000|Overall Study|Investigator Discretion|0|||
125373136|NCT02864498|450996506|FG001|Overall Study|Investigator Discretion|2|||
125373137|NCT02864498|450996507|FG002|Overall Study|Investigator Discretion|1|||
125373138|NCT02864498|450996505|FG000|Overall Study|Lost to Follow-up|8|||
125373139|NCT02864498|450996506|FG001|Overall Study|Lost to Follow-up|6|||
125373140|NCT02864498|450996507|FG002|Overall Study|Lost to Follow-up|3|||
125373141|NCT02864498|450996505|FG000|Overall Study|Lack of Efficacy|5|||
125373142|NCT02864498|450996506|FG001|Overall Study|Lack of Efficacy|3|||
125373143|NCT02864498|450996507|FG002|Overall Study|Lack of Efficacy|3|||
125373144|NCT02864498|450996505|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
125373145|NCT02864498|450996506|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
125373146|NCT02864498|450996507|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
125373147|NCT02864498|450996505|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
125373148|NCT02864498|450996506|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
125373149|NCT02864498|450996507|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
125373150|NCT02864498|450996505|FG000|Overall Study|Subject moved out of the country.|0|||
125373151|NCT02864498|450996506|FG001|Overall Study|Subject moved out of the country.|0|||
125373152|NCT02864498|450996507|FG002|Overall Study|Subject moved out of the country.|1|||
125615988|NCT02938585|451876394|FG000|Overall Study|Withdrawal by parent or guardian|0|||
125615989|NCT02938585|451876395|FG001|Overall Study|Withdrawal by parent or guardian|1|||
125373153|NCT01812174|450996508|FG000|Overall Study|Death|1|||
125615990|NCT02938585|451876396|FG002|Overall Study|Withdrawal by parent or guardian|0|||
125615991|NCT02938585|451876397|FG003|Overall Study|Withdrawal by parent or guardian|0|||
125615992|NCT02938585|451876394|FG000|Overall Study|Withdrawal by Subject|0|||
125615993|NCT02938585|451876395|FG001|Overall Study|Withdrawal by Subject|0|||
125615994|NCT02938585|451876396|FG002|Overall Study|Withdrawal by Subject|0|||
125615995|NCT02938585|451876397|FG003|Overall Study|Withdrawal by Subject|5|||
125615996|NCT03457103|451876401|FG000|Overall Study|illness/hospitalization|4|||
125615997|NCT03457103|451876402|FG001|Overall Study|illness/hospitalization|2|||
125615998|NCT03457103|451876401|FG000|Overall Study|Lost to Follow-up|2|||
125615999|NCT03457103|451876402|FG001|Overall Study|Lost to Follow-up|1|||
125616000|NCT03457103|451876401|FG000|Overall Study|Withdrawal by Subject|1|||
125616001|NCT03457103|451876402|FG001|Overall Study|Withdrawal by Subject|2|||
125373154|NCT01812174|450996509|FG001|Overall Study|Death|0|||
125616002|NCT03457103|451876401|FG000|Overall Study|financial/ insurance issues|1|||
125616003|NCT03457103|451876402|FG001|Overall Study|financial/ insurance issues|1|||
125616004|NCT00213980|451876403|FG000|Overall Study|Withdrawal by Subject|3|||
125616005|NCT00213980|451876404|FG001|Overall Study|Withdrawal by Subject|1|||
125616006|NCT00213980|451876403|FG000|Overall Study|Adverse Event|1|||
125616007|NCT00213980|451876404|FG001|Overall Study|Adverse Event|1|||
125616008|NCT00213980|451876403|FG000|Overall Study|Disease progression|0|||
125616009|NCT00213980|451876404|FG001|Overall Study|Disease progression|2|||
125616010|NCT00213980|451876403|FG000|Overall Study|Developed ovarian cancer|1|||
125616011|NCT00213980|451876404|FG001|Overall Study|Developed ovarian cancer|0|||
125616012|NCT00213980|451876403|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
125616013|NCT00213980|451876404|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
125616014|NCT00798694|451876405|FG000|Overall Study|Lost to Follow-up|1|||
125616015|NCT00798694|451876406|FG001|Overall Study|Lost to Follow-up|1|||
125373155|NCT01812174|450996508|FG000|Overall Study|Protocol Violation|2|||
125373156|NCT01812174|450996509|FG001|Overall Study|Protocol Violation|0|||
125373157|NCT00851747|450996513|FG000|Overall Study|Physician Decision|6|||
125373158|NCT00851747|450996514|FG001|Overall Study|Physician Decision|6|||
125373159|NCT00851747|450996515|FG002|Overall Study|Physician Decision|6|||
125373160|NCT01537393|450996516|FG000|Overall Study|Exclude prior to study|32|||
125373161|NCT01537393|450996517|FG001|Overall Study|Exclude prior to study|44|||
125373162|NCT01537393|450996516|FG000|Overall Study|Death|20|||
125373163|NCT01537393|450996517|FG001|Overall Study|Death|32|||
125373164|NCT01537393|450996516|FG000|Overall Study|Withdrawal by Subject|18|||
125373165|NCT01537393|450996517|FG001|Overall Study|Withdrawal by Subject|17|||
125373166|NCT01537393|450996516|FG000|Overall Study|Lost to Follow-up|53|||
125373167|NCT01537393|450996517|FG001|Overall Study|Lost to Follow-up|48|||
125373168|NCT01537393|450996516|FG000|Overall Study|Failure - Regrafted|28|||
125373169|NCT01537393|450996517|FG001|Overall Study|Failure - Regrafted|43|||
125373170|NCT01537393|450996516|FG000|Overall Study|Failure - Not regrafted|2|||
125373171|NCT01537393|450996517|FG001|Overall Study|Failure - Not regrafted|6|||
125373172|NCT01537393|450996516|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
125373173|NCT01537393|450996517|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
125373174|NCT05201703|450996528|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
125373175|NCT05201703|450996529|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
125373176|NCT05201703|450996528|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
125214718|NCT01048944|450414844|FG001|Overall Study|Protocol Violation|10|||
125214719|NCT01048944|450414845|FG002|Overall Study|Protocol Violation|10|||
125616016|NCT00798694|451876405|FG000|Overall Study|Physician Decision|1|||
125616017|NCT00798694|451876406|FG001|Overall Study|Physician Decision|0|||
125616018|NCT01089582|451876420|FG000|Overall Study|Death|2|||
125616019|NCT01089582|451876420|FG000|Overall Study|Adverse Event|15|||
125616020|NCT01089582|451876420|FG000|Overall Study|Lost to Follow-up|8|||
125616021|NCT01089582|451876420|FG000|Overall Study|Other|4|||
125616022|NCT01089582|451876420|FG000|Overall Study|Withdrawal by Subject|1|||
125616023|NCT00862849|451876421|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
125616024|NCT00862849|451876422|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
125616025|NCT00862849|451876423|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
125616026|NCT00862849|451876424|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
125616027|NCT00862849|451876425|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
125616028|NCT00862849|451876426|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
125616029|NCT00862849|451876421|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
125616030|NCT00862849|451876422|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
125616031|NCT00862849|451876423|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
125616032|NCT00862849|451876424|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
125616033|NCT00862849|451876425|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
125616034|NCT00862849|451876426|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
125616035|NCT03943953|451876429|FG000|Trial of ITG 1|Lost to Follow-up|19|||
125616036|NCT03943953|451876430|FG001|Trial of ITG 1|Lost to Follow-up|1|||
125616037|NCT03943953|451876429|FG000|Trial of ITG 2|Lost to Follow-up|8|||
125616038|NCT03943953|451876430|FG001|Trial of ITG 2|Lost to Follow-up|0|||
125616039|NCT03943953|451876429|FG000|Trial of ITG 3|Lost to Follow-up|2|||
125616040|NCT03943953|451876430|FG001|Trial of ITG 3|Lost to Follow-up|0|||
125616041|NCT03943953|451876429|FG000|Trial of ITG 4|Lost to Follow-up|2|||
125616042|NCT03943953|451876430|FG001|Trial of ITG 4|Lost to Follow-up|0|||
125616043|NCT01199055|451876435|FG000|Overall Study|Death|0|||
125616044|NCT01199055|451876436|FG001|Overall Study|Death|1|||
125616045|NCT01199055|451876437|FG002|Overall Study|Death|0|||
125616046|NCT01199055|451876435|FG000|Overall Study|Physician Decision|0|||
125616047|NCT01199055|451876436|FG001|Overall Study|Physician Decision|1|||
125616048|NCT01199055|451876437|FG002|Overall Study|Physician Decision|1|||
125616049|NCT01199055|451876435|FG000|Overall Study|Progressive disease|2|||
125616050|NCT01199055|451876436|FG001|Overall Study|Progressive disease|1|||
125616051|NCT01199055|451876437|FG002|Overall Study|Progressive disease|2|||
125616052|NCT01199055|451876435|FG000|Overall Study|Withdrawal by Subject|0|||
125616053|NCT01199055|451876436|FG001|Overall Study|Withdrawal by Subject|0|||
125616054|NCT01199055|451876437|FG002|Overall Study|Withdrawal by Subject|1|||
125616055|NCT00289185|451876438|FG000|Overall Study|Withdrawal by Subject|4|||
125616056|NCT00289185|451876439|FG001|Overall Study|Withdrawal by Subject|8|||
125616057|NCT00289185|451876438|FG000|Overall Study|Lost to Follow-up|23|||
125214720|NCT01048944|450414846|FG003|Overall Study|Protocol Violation|2|||
125214721|NCT00376532|450414847|FG000|Overall Study|Lack sufficient blood sample|6|||
125616058|NCT00289185|451876439|FG001|Overall Study|Lost to Follow-up|17|||
125616059|NCT00289185|451876438|FG000|Overall Study|Death|1|||
125616060|NCT00289185|451876439|FG001|Overall Study|Death|1|||
125616061|NCT02432040|451876440|FG000|Overall Study|Lack of Efficacy|3|||
125616062|NCT02432040|451876441|FG001|Overall Study|Lack of Efficacy|0|||
125616063|NCT02432040|451876440|FG000|Overall Study|Lost to Follow-up|4|||
125616064|NCT02432040|451876441|FG001|Overall Study|Lost to Follow-up|5|||
125616065|NCT02432040|451876440|FG000|Overall Study|Physician Decision|1|||
125616066|NCT02432040|451876441|FG001|Overall Study|Physician Decision|1|||
125616067|NCT03633227|451876442|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
125616068|NCT03633227|451876443|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
125616069|NCT03633227|451876442|FG000|Double Blind (DB), up to Week 48|Death|2|||
125616070|NCT03633227|451876443|FG001|Double Blind (DB), up to Week 48|Death|1|||
125616071|NCT03633227|451876442|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
125616072|NCT03633227|451876443|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
125616073|NCT03633227|451876442|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
125616074|NCT03633227|451876443|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
125616075|NCT03633227|451876442|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
125616076|NCT03633227|451876443|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
125214722|NCT00376532|450414848|FG001|Overall Study|Lack sufficient blood sample|6|||
125214723|NCT01844817|450414849|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
125214724|NCT01844817|450414850|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
125214725|NCT01844817|450414849|FG000|Treatment|Progressive Disease|27|||
125214726|NCT01844817|450414850|FG001|Treatment|Progressive Disease|36|||
125214727|NCT01844817|450414849|FG000|Treatment|Adverse Event|17|||
125214728|NCT01844817|450414850|FG001|Treatment|Adverse Event|9|||
125214729|NCT01844817|450414849|FG000|Treatment|Withdrawal by Subject|10|||
125214730|NCT01844817|450414850|FG001|Treatment|Withdrawal by Subject|6|||
125214731|NCT01844817|450414849|FG000|Treatment|Death|10|||
125214732|NCT01844817|450414850|FG001|Treatment|Death|8|||
125214733|NCT01844817|450414849|FG000|Treatment|Lost to Follow-up|0|||
125214734|NCT01844817|450414850|FG001|Treatment|Lost to Follow-up|1|||
125214735|NCT01844817|450414849|FG000|Treatment|Other|0|||
125214736|NCT01844817|450414850|FG001|Treatment|Other|3|||
125214737|NCT04227405|450414851|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
125214738|NCT04227405|450414852|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
125214739|NCT04227405|450414851|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
125214740|NCT04227405|450414852|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
125214741|NCT04227405|450414851|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
125214742|NCT04227405|450414852|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
125214743|NCT02207400|450414853|FG000|Overall Study|Adverse Event|1|||
125214744|NCT02207400|450414854|FG001|Overall Study|Adverse Event|1|||
125214745|NCT02207400|450414853|FG000|Overall Study|Lost to Follow-up|6|||
125214746|NCT02207400|450414854|FG001|Overall Study|Lost to Follow-up|7|||
125214747|NCT02207400|450414853|FG000|Overall Study|Protocol Violation|1|||
125616077|NCT03633227|451876442|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
125616078|NCT03633227|451876443|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
125616079|NCT03633227|451876442|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
125214748|NCT02207400|450414854|FG001|Overall Study|Protocol Violation|1|||
125214749|NCT02207400|450414853|FG000|Overall Study|Withdrawal by Subject|8|||
125214750|NCT02207400|450414854|FG001|Overall Study|Withdrawal by Subject|4|||
125214751|NCT02207400|450414853|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
125616080|NCT03633227|451876443|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
125616081|NCT03633227|451876442|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
125616082|NCT03633227|451876443|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
125616083|NCT03633227|451876442|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
125616084|NCT03633227|451876443|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
125616085|NCT03633227|451876442|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
125616086|NCT03633227|451876443|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
125616087|NCT03633227|451876442|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
125616088|NCT03633227|451876443|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
125616089|NCT03633227|451876442|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
125616090|NCT03633227|451876443|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
125616091|NCT01069523|451876444|FG000|Overall Study|Withdrawal by Subject|4|||
125616092|NCT01069523|451876445|FG001|Overall Study|Withdrawal by Subject|7|||
125616093|NCT04167306|451876453|FG000|Overall Study|Lost to Follow-up|2|||
125616094|NCT04167306|451876454|FG001|Overall Study|Lost to Follow-up|2|||
125616095|NCT04167306|451876455|FG002|Overall Study|Lost to Follow-up|5|||
125616096|NCT04167306|451876456|FG003|Overall Study|Lost to Follow-up|5|||
125616097|NCT04167306|451876453|FG000|Overall Study|Adverse Event|13|||
125616098|NCT04167306|451876454|FG001|Overall Study|Adverse Event|14|||
125616099|NCT04167306|451876455|FG002|Overall Study|Adverse Event|5|||
125616100|NCT04167306|451876456|FG003|Overall Study|Adverse Event|4|||
125616101|NCT04167306|451876453|FG000|Overall Study|Withdrawal by Subject|4|||
125616102|NCT04167306|451876454|FG001|Overall Study|Withdrawal by Subject|6|||
125616103|NCT04167306|451876455|FG002|Overall Study|Withdrawal by Subject|8|||
125616104|NCT04167306|451876456|FG003|Overall Study|Withdrawal by Subject|3|||
125616105|NCT04167306|451876453|FG000|Overall Study|covid|1|||
125616106|NCT04167306|451876454|FG001|Overall Study|covid|1|||
125616107|NCT04167306|451876455|FG002|Overall Study|covid|2|||
125616108|NCT04167306|451876456|FG003|Overall Study|covid|1|||
125214752|NCT02207400|450414854|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
125214753|NCT03396822|450414855|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
125214754|NCT03396822|450414855|FG000|Overall Study|Physician Decision|1|||
125214755|NCT02757352|450414858|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
125214756|NCT02757352|450414859|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125616109|NCT04167306|451876453|FG000|Overall Study|concomitant medication|0|||
125616110|NCT04167306|451876454|FG001|Overall Study|concomitant medication|0|||
125214757|NCT02757352|450414860|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
125214758|NCT02757352|450414861|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125214759|NCT02757352|450414862|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125214760|NCT02757352|450414863|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125214761|NCT02757352|450414864|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125214762|NCT02757352|450414865|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125214763|NCT02757352|450414866|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125214764|NCT02757352|450414867|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
125214765|NCT02757352|450414858|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214766|NCT02757352|450414859|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214767|NCT02757352|450414860|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
125214768|NCT02757352|450414861|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125373177|NCT05201703|450996529|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
125373178|NCT00393029|450996530|FG000|Overall Study|Not treated|0|||
125373179|NCT00393029|450996531|FG001|Overall Study|Not treated|1|||
125373180|NCT03715530|450996532|FG000|Overall Study|Lost to Follow-up|3|||
125373181|NCT03715530|450996533|FG001|Overall Study|Lost to Follow-up|1|||
125214769|NCT02757352|450414862|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125373182|NCT03715530|450996534|FG002|Overall Study|Lost to Follow-up|2|||
125616111|NCT04167306|451876455|FG002|Overall Study|concomitant medication|0|||
125616112|NCT04167306|451876456|FG003|Overall Study|concomitant medication|1|||
125616113|NCT04167306|451876453|FG000|Overall Study|Alcohol treatment|0|||
125616114|NCT04167306|451876454|FG001|Overall Study|Alcohol treatment|4|||
125616115|NCT04167306|451876455|FG002|Overall Study|Alcohol treatment|3|||
125616116|NCT04167306|451876456|FG003|Overall Study|Alcohol treatment|2|||
125616117|NCT04167306|451876453|FG000|Overall Study|non-compliance|0|||
125616118|NCT04167306|451876454|FG001|Overall Study|non-compliance|0|||
125616119|NCT04167306|451876455|FG002|Overall Study|non-compliance|1|||
125616120|NCT04167306|451876456|FG003|Overall Study|non-compliance|0|||
125616121|NCT04167306|451876453|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
125616122|NCT04167306|451876454|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
125616123|NCT04167306|451876455|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
125616124|NCT04167306|451876456|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
125616125|NCT01737840|451876457|FG000|Overall Study|Diagnosed with an other pathology|2|||
125616126|NCT01737840|451876458|FG001|Overall Study|Diagnosed with an other pathology|2|||
125616127|NCT00403559|451876461|FG000|Overall Study|Adverse Event|0|||
125616128|NCT00403559|451876462|FG001|Overall Study|Adverse Event|1|||
125616129|NCT00403559|451876461|FG000|Overall Study|Lost to Follow-up|3|||
125616130|NCT00403559|451876462|FG001|Overall Study|Lost to Follow-up|3|||
125616131|NCT00403559|451876461|FG000|Overall Study|Withdrawal by Subject|1|||
125616132|NCT00403559|451876462|FG001|Overall Study|Withdrawal by Subject|0|||
125616133|NCT03105700|451876463|FG000|Overall Study|screen fail|3|||
125616134|NCT03105700|451876463|FG000|Overall Study|Lost to Follow-up|4|||
125616135|NCT01253421|451876466|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
125616136|NCT01253421|451876467|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
125616137|NCT01253421|451876468|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
125616138|NCT01253421|451876469|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
125616139|NCT01253421|451876470|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
125616140|NCT01253421|451876466|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
125616141|NCT01253421|451876467|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
125616142|NCT01253421|451876468|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
125616143|NCT01253421|451876469|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
125616144|NCT01253421|451876470|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
125616145|NCT01253421|451876466|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
125616146|NCT01253421|451876467|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
125616147|NCT01253421|451876468|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
125616148|NCT01253421|451876469|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
125616149|NCT01253421|451876470|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
125616150|NCT01253421|451876466|FG000|Assessment and Scheduling|Physician Decision|1|||
125616151|NCT01253421|451876467|FG001|Assessment and Scheduling|Physician Decision|0|||
125616152|NCT01253421|451876468|FG002|Assessment and Scheduling|Physician Decision|0|||
125616153|NCT01253421|451876469|FG003|Assessment and Scheduling|Physician Decision|0|||
125616154|NCT01253421|451876470|FG004|Assessment and Scheduling|Physician Decision|0|||
125616155|NCT01253421|451876466|FG000|Drug+Scanning Visit|Physician Decision|0|||
125616156|NCT01253421|451876467|FG001|Drug+Scanning Visit|Physician Decision|0|||
125616157|NCT01253421|451876468|FG002|Drug+Scanning Visit|Physician Decision|0|||
125616158|NCT01253421|451876469|FG003|Drug+Scanning Visit|Physician Decision|0|||
125616159|NCT01253421|451876470|FG004|Drug+Scanning Visit|Physician Decision|1|||
125616160|NCT00121992|451876471|FG000|Overall Study|Treatment not received|2|||
125616161|NCT00121992|451876472|FG001|Overall Study|Treatment not received|11|||
125616162|NCT04387136|451876473|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
125616163|NCT04387136|451876474|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
125616164|NCT01029886|451876479|FG000|Overall Study|Adverse Event|12|||
125616165|NCT01029886|451876480|FG001|Overall Study|Adverse Event|25|||
125616166|NCT01029886|451876479|FG000|Overall Study|Lost to Follow-up|1|||
125616167|NCT01029886|451876480|FG001|Overall Study|Lost to Follow-up|0|||
125616168|NCT01029886|451876479|FG000|Overall Study|Physician Decision|2|||
125616169|NCT01029886|451876480|FG001|Overall Study|Physician Decision|6|||
125616170|NCT01029886|451876479|FG000|Overall Study|Protocol Violation|17|||
125616171|NCT01029886|451876480|FG001|Overall Study|Protocol Violation|5|||
125616172|NCT01029886|451876479|FG000|Overall Study|Withdrawal by Subject|8|||
125616173|NCT01029886|451876480|FG001|Overall Study|Withdrawal by Subject|18|||
125616174|NCT01029886|451876479|FG000|Overall Study|Entry Criteria Not Met|13|||
125616175|NCT01029886|451876480|FG001|Overall Study|Entry Criteria Not Met|5|||
125616176|NCT01029886|451876479|FG000|Overall Study|Sponsor Decision|1|||
125616177|NCT01029886|451876480|FG001|Overall Study|Sponsor Decision|0|||
125616178|NCT01029886|451876479|FG000|Overall Study|Loss Glucose Control|7|||
125616179|NCT01029886|451876480|FG001|Overall Study|Loss Glucose Control|1|||
125616180|NCT01553916|451876481|FG000|Overall Study|Withdrawal by Subject|2|||
125616181|NCT01553916|451876481|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
125616182|NCT03089216|451876482|FG000|Overall Study|Adverse Event|0|||
125616183|NCT03089216|451876483|FG001|Overall Study|Adverse Event|0|||
125616184|NCT03089216|451876484|FG002|Overall Study|Adverse Event|0|||
125616185|NCT03089216|451876485|FG003|Overall Study|Adverse Event|1|||
125616186|NCT01968954|451876489|FG000|Overall Study|Adverse Event|6|||
125616187|NCT01968954|451876490|FG001|Overall Study|Adverse Event|3|||
125616188|NCT01968954|451876489|FG000|Overall Study|Death|1|||
125616189|NCT01968954|451876490|FG001|Overall Study|Death|2|||
125616190|NCT01968954|451876489|FG000|Overall Study|Lost to Follow-up|6|||
125616191|NCT01968954|451876490|FG001|Overall Study|Lost to Follow-up|4|||
125616192|NCT01968954|451876489|FG000|Overall Study|Withdrawal by Subject|20|||
125616193|NCT01968954|451876490|FG001|Overall Study|Withdrawal by Subject|23|||
125616194|NCT01968954|451876489|FG000|Overall Study|Other|7|||
125616195|NCT01968954|451876490|FG001|Overall Study|Other|8|||
125616196|NCT01968954|451876489|FG000|Overall Study|Protocol Violation|0|||
125616197|NCT01968954|451876490|FG001|Overall Study|Protocol Violation|1|||
125616198|NCT01968954|451876489|FG000|Overall Study|Did not met inclusion criteria|0|||
125616199|NCT01968954|451876490|FG001|Overall Study|Did not met inclusion criteria|2|||
125616200|NCT00434122|451876491|FG000|Overall Study|Non-compliance with protocol|0|||
125616201|NCT00434122|451876492|FG001|Overall Study|Non-compliance with protocol|1|||
125616202|NCT00434122|451876491|FG000|Overall Study|loss of subject contact|1|||
125616203|NCT00434122|451876492|FG001|Overall Study|loss of subject contact|1|||
125616204|NCT00434122|451876491|FG000|Overall Study|Personal reasons|1|||
125616205|NCT00434122|451876492|FG001|Overall Study|Personal reasons|1|||
125616206|NCT00434122|451876491|FG000|Overall Study|Large follicle size|2|||
125616207|NCT00434122|451876492|FG001|Overall Study|Large follicle size|2|||
125616208|NCT00434122|451876491|FG000|Overall Study|Low follicular response.|1|||
125616209|NCT00434122|451876492|FG001|Overall Study|Low follicular response.|2|||
125616210|NCT00434122|451876491|FG000|Overall Study|Travelling of subject.|1|||
125616211|NCT00434122|451876492|FG001|Overall Study|Travelling of subject.|0|||
125616212|NCT04191577|451876493|FG000|Overall Study|Withdrawal by Subject|2|||
125616213|NCT04191577|451876494|FG001|Overall Study|Withdrawal by Subject|2|||
125616214|NCT04191577|451876495|FG002|Overall Study|Withdrawal by Subject|1|||
125616215|NCT04191577|451876493|FG000|Overall Study|Physician Decision|1|||
125616216|NCT04191577|451876494|FG001|Overall Study|Physician Decision|1|||
125616217|NCT04191577|451876495|FG002|Overall Study|Physician Decision|0|||
125616218|NCT04191577|451876493|FG000|Overall Study|Adverse Event|0|||
125616219|NCT04191577|451876494|FG001|Overall Study|Adverse Event|0|||
125616220|NCT04191577|451876495|FG002|Overall Study|Adverse Event|1|||
125616221|NCT04191577|451876493|FG000|Overall Study|Death|0|||
125616222|NCT04191577|451876494|FG001|Overall Study|Death|0|||
125616223|NCT04191577|451876495|FG002|Overall Study|Death|1|||
125616224|NCT03655717|451876496|FG000|Overall Study|Withdrawal by Subject|4|||
125616225|NCT03655717|451876497|FG001|Overall Study|Withdrawal by Subject|8|||
125616226|NCT03655717|451876498|FG002|Overall Study|Withdrawal by Subject|1|||
125616227|NCT03655717|451876499|FG003|Overall Study|Withdrawal by Subject|0|||
125214770|NCT02757352|450414863|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214771|NCT02757352|450414864|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214772|NCT02757352|450414865|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214773|NCT02757352|450414866|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214774|NCT02757352|450414867|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
125214775|NCT02757352|450414858|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
125214776|NCT02757352|450414859|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
125214777|NCT02757352|450414860|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
125214778|NCT02757352|450414861|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214779|NCT02757352|450414862|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214780|NCT02757352|450414863|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214781|NCT02757352|450414864|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214782|NCT02757352|450414865|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214783|NCT02757352|450414866|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214784|NCT02757352|450414867|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
125214785|NCT02757352|450414858|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125616228|NCT03655717|451876500|FG004|Overall Study|Withdrawal by Subject|0|||
125616229|NCT03655717|451876501|FG005|Overall Study|Withdrawal by Subject|1|||
125616230|NCT03655717|451876502|FG006|Overall Study|Withdrawal by Subject|3|||
125616231|NCT03655717|451876503|FG007|Overall Study|Withdrawal by Subject|1|||
125616232|NCT03655717|451876504|FG008|Overall Study|Withdrawal by Subject|2|||
125616233|NCT03655717|451876505|FG009|Overall Study|Withdrawal by Subject|0|||
125616234|NCT03655717|451876506|FG010|Overall Study|Withdrawal by Subject|0|||
125616235|NCT03655717|451876507|FG011|Overall Study|Withdrawal by Subject|1|||
125616236|NCT03655717|451876508|FG012|Overall Study|Withdrawal by Subject|0|||
125616237|NCT03655717|451876509|FG013|Overall Study|Withdrawal by Subject|3|||
125616238|NCT03655717|451876510|FG014|Overall Study|Withdrawal by Subject|0|||
125616239|NCT03655717|451876511|FG015|Overall Study|Withdrawal by Subject|1|||
125616240|NCT03655717|451876512|FG016|Overall Study|Withdrawal by Subject|0|||
125616241|NCT03655717|451876513|FG017|Overall Study|Withdrawal by Subject|0|||
125616242|NCT03655717|451876514|FG018|Overall Study|Withdrawal by Subject|1|||
125616243|NCT03655717|451876515|FG019|Overall Study|Withdrawal by Subject|0|||
125616244|NCT03655717|451876516|FG020|Overall Study|Withdrawal by Subject|0|||
125616245|NCT03655717|451876517|FG021|Overall Study|Withdrawal by Subject|1|||
125616246|NCT03655717|451876518|FG022|Overall Study|Withdrawal by Subject|2|||
125616247|NCT03655717|451876519|FG023|Overall Study|Withdrawal by Subject|1|||
125616248|NCT03655717|451876520|FG024|Overall Study|Withdrawal by Subject|1|||
125616249|NCT03655717|451876521|FG025|Overall Study|Withdrawal by Subject|0|||
125616250|NCT03655717|451876496|FG000|Overall Study|Physician Decision|3|||
125616251|NCT03655717|451876497|FG001|Overall Study|Physician Decision|3|||
125616252|NCT03655717|451876498|FG002|Overall Study|Physician Decision|0|||
125616253|NCT03655717|451876499|FG003|Overall Study|Physician Decision|0|||
125616254|NCT03655717|451876500|FG004|Overall Study|Physician Decision|0|||
125616255|NCT03655717|451876501|FG005|Overall Study|Physician Decision|0|||
125616256|NCT03655717|451876502|FG006|Overall Study|Physician Decision|0|||
125616257|NCT03655717|451876503|FG007|Overall Study|Physician Decision|0|||
125616258|NCT03655717|451876504|FG008|Overall Study|Physician Decision|0|||
125616259|NCT03655717|451876505|FG009|Overall Study|Physician Decision|1|||
125616260|NCT03655717|451876506|FG010|Overall Study|Physician Decision|0|||
125616261|NCT03655717|451876507|FG011|Overall Study|Physician Decision|0|||
125616262|NCT03655717|451876508|FG012|Overall Study|Physician Decision|0|||
125616263|NCT03655717|451876509|FG013|Overall Study|Physician Decision|0|||
125616264|NCT03655717|451876510|FG014|Overall Study|Physician Decision|0|||
125616265|NCT03655717|451876511|FG015|Overall Study|Physician Decision|0|||
125616266|NCT03655717|451876512|FG016|Overall Study|Physician Decision|0|||
125616267|NCT03655717|451876513|FG017|Overall Study|Physician Decision|0|||
125616268|NCT03655717|451876514|FG018|Overall Study|Physician Decision|0|||
125616269|NCT03655717|451876515|FG019|Overall Study|Physician Decision|1|||
125616270|NCT03655717|451876516|FG020|Overall Study|Physician Decision|0|||
125616271|NCT03655717|451876517|FG021|Overall Study|Physician Decision|0|||
125616272|NCT03655717|451876518|FG022|Overall Study|Physician Decision|0|||
125616273|NCT03655717|451876519|FG023|Overall Study|Physician Decision|1|||
125616274|NCT03655717|451876520|FG024|Overall Study|Physician Decision|0|||
125616275|NCT03655717|451876521|FG025|Overall Study|Physician Decision|0|||
125616276|NCT03655717|451876496|FG000|Overall Study|Lost to Follow-up|3|||
125373183|NCT00211510|450996538|FG000|Overall Study|Physician Decision|3|||
125616277|NCT03655717|451876497|FG001|Overall Study|Lost to Follow-up|1|||
125616278|NCT03655717|451876498|FG002|Overall Study|Lost to Follow-up|0|||
125373184|NCT00211510|450996539|FG001|Overall Study|Physician Decision|1|||
125373185|NCT00211510|450996538|FG000|Overall Study|Withdrawal by Subject|3|||
125616279|NCT03655717|451876499|FG003|Overall Study|Lost to Follow-up|1|||
125616280|NCT03655717|451876500|FG004|Overall Study|Lost to Follow-up|0|||
125616281|NCT03655717|451876501|FG005|Overall Study|Lost to Follow-up|1|||
125616282|NCT03655717|451876502|FG006|Overall Study|Lost to Follow-up|0|||
125616283|NCT03655717|451876503|FG007|Overall Study|Lost to Follow-up|0|||
125214786|NCT02757352|450414859|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
125214787|NCT02757352|450414860|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214788|NCT02757352|450414861|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214789|NCT02757352|450414862|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214790|NCT02757352|450414863|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214791|NCT02757352|450414864|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214792|NCT02757352|450414865|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214793|NCT02757352|450414866|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214794|NCT02757352|450414867|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
125214795|NCT02757352|450414858|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214796|NCT02757352|450414859|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
125214797|NCT02757352|450414860|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214798|NCT02757352|450414861|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214799|NCT02757352|450414862|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214800|NCT02757352|450414863|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214801|NCT02757352|450414864|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125616284|NCT03655717|451876504|FG008|Overall Study|Lost to Follow-up|0|||
125616285|NCT03655717|451876505|FG009|Overall Study|Lost to Follow-up|0|||
125616286|NCT03655717|451876506|FG010|Overall Study|Lost to Follow-up|0|||
125616287|NCT03655717|451876507|FG011|Overall Study|Lost to Follow-up|1|||
125616288|NCT03655717|451876508|FG012|Overall Study|Lost to Follow-up|0|||
125616289|NCT03655717|451876509|FG013|Overall Study|Lost to Follow-up|0|||
125616290|NCT03655717|451876510|FG014|Overall Study|Lost to Follow-up|0|||
125616291|NCT03655717|451876511|FG015|Overall Study|Lost to Follow-up|0|||
125616292|NCT03655717|451876512|FG016|Overall Study|Lost to Follow-up|0|||
125616293|NCT03655717|451876513|FG017|Overall Study|Lost to Follow-up|0|||
125616294|NCT03655717|451876514|FG018|Overall Study|Lost to Follow-up|0|||
125616295|NCT03655717|451876515|FG019|Overall Study|Lost to Follow-up|0|||
125616296|NCT03655717|451876516|FG020|Overall Study|Lost to Follow-up|0|||
125616297|NCT03655717|451876517|FG021|Overall Study|Lost to Follow-up|0|||
125616298|NCT03655717|451876518|FG022|Overall Study|Lost to Follow-up|0|||
125616299|NCT03655717|451876519|FG023|Overall Study|Lost to Follow-up|0|||
125616300|NCT03655717|451876520|FG024|Overall Study|Lost to Follow-up|0|||
125616301|NCT03655717|451876521|FG025|Overall Study|Lost to Follow-up|0|||
125616302|NCT01185249|451876522|FG000|Overall Study|Patients discharged or change in status|42|||
125616303|NCT01208038|451876525|FG000|Overall Study|Withdrawal by Subject|1|||
125616304|NCT03260205|451876529|FG000|Overall Study|Adverse Event|2|||
125616305|NCT03260205|451876530|FG001|Overall Study|Adverse Event|0|||
125616306|NCT03260205|451876531|FG002|Overall Study|Adverse Event|2|||
125616307|NCT03260205|451876532|FG003|Overall Study|Adverse Event|2|||
125616308|NCT03260205|451876533|FG004|Overall Study|Adverse Event|4|||
125616309|NCT03260205|451876529|FG000|Overall Study|Lost to Follow-up|2|||
125616310|NCT03260205|451876530|FG001|Overall Study|Lost to Follow-up|2|||
125616311|NCT03260205|451876531|FG002|Overall Study|Lost to Follow-up|1|||
125616312|NCT03260205|451876532|FG003|Overall Study|Lost to Follow-up|1|||
125616313|NCT03260205|451876533|FG004|Overall Study|Lost to Follow-up|5|||
125616314|NCT03260205|451876529|FG000|Overall Study|Protocol Violation|0|||
125616315|NCT03260205|451876530|FG001|Overall Study|Protocol Violation|0|||
125616316|NCT03260205|451876531|FG002|Overall Study|Protocol Violation|2|||
125616317|NCT03260205|451876532|FG003|Overall Study|Protocol Violation|0|||
125616318|NCT03260205|451876533|FG004|Overall Study|Protocol Violation|1|||
125616319|NCT03260205|451876529|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
125616320|NCT03260205|451876530|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
125616321|NCT03260205|451876531|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
125616322|NCT03260205|451876532|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
125616323|NCT03260205|451876533|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
125214802|NCT02757352|450414865|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214803|NCT02757352|450414866|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125616324|NCT03260205|451876529|FG000|Overall Study|Other: Unspecified|0|||
125616325|NCT03260205|451876530|FG001|Overall Study|Other: Unspecified|0|||
125616326|NCT03260205|451876531|FG002|Overall Study|Other: Unspecified|3|||
125616327|NCT03260205|451876532|FG003|Overall Study|Other: Unspecified|1|||
125616328|NCT03260205|451876533|FG004|Overall Study|Other: Unspecified|1|||
125616329|NCT03260205|451876529|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
125214804|NCT02757352|450414867|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125616330|NCT03260205|451876530|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
125616331|NCT03260205|451876531|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
125616332|NCT03260205|451876532|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
125616333|NCT03260205|451876533|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
125616334|NCT04752189|451876538|FG000|Overall Study|Withdrawal by Subject|0|||
125616335|NCT04752189|451876539|FG001|Overall Study|Withdrawal by Subject|150|||
125616336|NCT04752189|451876538|FG000|Overall Study|Lost to Follow-up|261|||
125616337|NCT04752189|451876539|FG001|Overall Study|Lost to Follow-up|126|||
125373186|NCT00211510|450996539|FG001|Overall Study|Withdrawal by Subject|1|||
125373187|NCT03648983|450996543|FG000|Overall Study|Study was terminated due to PI departure|95|||
125373188|NCT01269463|450996544|FG000|First Intervention|Withdrawal by Subject|1|||
125373189|NCT01269463|450996545|FG001|First Intervention|Withdrawal by Subject|0|||
125373190|NCT01269463|450996544|FG000|First Intervention|Adverse Event|1|||
125373191|NCT01269463|450996545|FG001|First Intervention|Adverse Event|0|||
125373192|NCT01269463|450996544|FG000|First Intervention|Lack of Efficacy|0|||
125373193|NCT01269463|450996545|FG001|First Intervention|Lack of Efficacy|1|||
125373194|NCT01269463|450996544|FG000|First Intervention|Physician Decision|0|||
125373195|NCT01269463|450996545|FG001|First Intervention|Physician Decision|1|||
125373196|NCT02862171|450996549|FG000|Overall Study|Death|1|||
125373197|NCT02862171|450996549|FG000|Overall Study|Lost to Follow-up|13|||
125373198|NCT02862171|450996549|FG000|Overall Study|Withdrawal by Subject|57|||
125373199|NCT02862171|450996549|FG000|Overall Study|Non-compliance|4|||
125373200|NCT02862171|450996549|FG000|Overall Study|HIV-1 seroconversion|18|||
125373201|NCT02549937|450996551|FG000|Overall Study|Death|0|||
125373202|NCT02549937|450996552|FG001|Overall Study|Death|1|||
125373203|NCT02549937|450996553|FG002|Overall Study|Death|0|||
125373204|NCT02549937|450996554|FG003|Overall Study|Death|1|||
125373205|NCT02549937|450996555|FG004|Overall Study|Death|0|||
125373206|NCT02549937|450996556|FG005|Overall Study|Death|8|||
125373207|NCT02549937|450996557|FG006|Overall Study|Death|0|||
125373208|NCT02549937|450996558|FG007|Overall Study|Death|0|||
125373209|NCT02549937|450996559|FG008|Overall Study|Death|19|||
125373210|NCT02549937|450996551|FG000|Overall Study|No follow up required|3|||
125373211|NCT02549937|450996552|FG001|Overall Study|No follow up required|6|||
125373212|NCT02549937|450996553|FG002|Overall Study|No follow up required|3|||
125373213|NCT02549937|450996554|FG003|Overall Study|No follow up required|8|||
125373214|NCT02549937|450996555|FG004|Overall Study|No follow up required|12|||
125373215|NCT02549937|450996556|FG005|Overall Study|No follow up required|21|||
125373216|NCT02549937|450996557|FG006|Overall Study|No follow up required|9|||
125373217|NCT02549937|450996558|FG007|Overall Study|No follow up required|11|||
125373218|NCT02549937|450996559|FG008|Overall Study|No follow up required|0|||
125373219|NCT02549937|450996551|FG000|Overall Study|Other|0|||
125373220|NCT02549937|450996552|FG001|Overall Study|Other|0|||
125373221|NCT02549937|450996553|FG002|Overall Study|Other|0|||
125373222|NCT02549937|450996554|FG003|Overall Study|Other|0|||
125373223|NCT02549937|450996555|FG004|Overall Study|Other|1|||
125373224|NCT02549937|450996556|FG005|Overall Study|Other|0|||
125373225|NCT02549937|450996557|FG006|Overall Study|Other|3|||
125373226|NCT02549937|450996558|FG007|Overall Study|Other|2|||
125373227|NCT02549937|450996559|FG008|Overall Study|Other|3|||
125616338|NCT03422133|451876540|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
125616339|NCT03422133|451876541|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
125616340|NCT04124692|451878343|FG000|Overall Study|Medical reason|0|||
125616341|NCT04124692|451878344|FG001|Overall Study|Medical reason|1|||
125616342|NCT04124692|451878343|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
125616343|NCT04124692|451878344|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
125616344|NCT04124692|451878343|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
125616345|NCT04124692|451878344|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
125616346|NCT04124692|451878343|FG000|Overall Study|Lost to Follow-up|2|||
125616347|NCT04124692|451878344|FG001|Overall Study|Lost to Follow-up|4|||
125616348|NCT04124692|451878343|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
125616349|NCT04124692|451878344|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
125616350|NCT02370498|451878345|FG000|Overall Study|Adverse Event|10|||
125616351|NCT02370498|451878346|FG001|Overall Study|Adverse Event|8|||
125616352|NCT02370498|451878345|FG000|Overall Study|Death|263|||
125616353|NCT02370498|451878346|FG001|Overall Study|Death|265|||
125616354|NCT02370498|451878345|FG000|Overall Study|Protocol Violation|1|||
125616355|NCT02370498|451878346|FG001|Overall Study|Protocol Violation|2|||
125616356|NCT02370498|451878345|FG000|Overall Study|Withdrawal by Subject|7|||
125616357|NCT02370498|451878346|FG001|Overall Study|Withdrawal by Subject|12|||
125616358|NCT02370498|451878345|FG000|Overall Study|Sponsor's decision|15|||
125616359|NCT02370498|451878346|FG001|Overall Study|Sponsor's decision|9|||
125616360|NCT01453998|451878357|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
125373228|NCT02549937|450996551|FG000|Overall Study|Lost to Follow-up|0|||
125373229|NCT02549937|450996552|FG001|Overall Study|Lost to Follow-up|0|||
125373230|NCT02549937|450996553|FG002|Overall Study|Lost to Follow-up|0|||
125373231|NCT02549937|450996554|FG003|Overall Study|Lost to Follow-up|0|||
125373232|NCT02549937|450996555|FG004|Overall Study|Lost to Follow-up|0|||
125373233|NCT02549937|450996556|FG005|Overall Study|Lost to Follow-up|0|||
125616361|NCT01453998|451878358|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
125373234|NCT02549937|450996557|FG006|Overall Study|Lost to Follow-up|0|||
125373235|NCT02549937|450996558|FG007|Overall Study|Lost to Follow-up|0|||
125373236|NCT02549937|450996559|FG008|Overall Study|Lost to Follow-up|3|||
125616362|NCT01453998|451878359|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
125616363|NCT01486784|451878360|FG000|Overall Study|Withdrawal by Subject|0|||
125616364|NCT01486784|451878361|FG001|Overall Study|Withdrawal by Subject|0|||
125616365|NCT01486784|451878362|FG002|Overall Study|Withdrawal by Subject|1|||
125616366|NCT01486784|451878363|FG003|Overall Study|Withdrawal by Subject|0|||
125616367|NCT01486784|451878364|FG004|Overall Study|Withdrawal by Subject|1|||
125616368|NCT01486784|451878365|FG005|Overall Study|Withdrawal by Subject|2|||
125616369|NCT01486784|451878360|FG000|Overall Study|Subject did not meet entry criteria|0|||
125616370|NCT01486784|451878361|FG001|Overall Study|Subject did not meet entry criteria|0|||
125616371|NCT01486784|451878362|FG002|Overall Study|Subject did not meet entry criteria|0|||
125616372|NCT01486784|451878363|FG003|Overall Study|Subject did not meet entry criteria|0|||
125616373|NCT01486784|451878364|FG004|Overall Study|Subject did not meet entry criteria|1|||
125616374|NCT01486784|451878365|FG005|Overall Study|Subject did not meet entry criteria|0|||
125616375|NCT01486784|451878360|FG000|Overall Study|Death|0|||
125616376|NCT01486784|451878361|FG001|Overall Study|Death|0|||
125616377|NCT01486784|451878362|FG002|Overall Study|Death|0|||
125616378|NCT01486784|451878363|FG003|Overall Study|Death|0|||
125616379|NCT01486784|451878364|FG004|Overall Study|Death|0|||
125616380|NCT01486784|451878365|FG005|Overall Study|Death|1|||
125616381|NCT03491553|451878366|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
125616382|NCT03491553|451878367|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
125616383|NCT03491553|451878368|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
125616384|NCT03491553|451878369|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
125616385|NCT03491553|451878370|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
125616386|NCT03491553|451878371|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
125616387|NCT03491553|451878366|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
125616388|NCT03491553|451878367|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
125616389|NCT03491553|451878368|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
125616390|NCT03491553|451878369|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
125616391|NCT03491553|451878370|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
125616392|NCT03491553|451878371|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
125616393|NCT00973921|451878374|FG000|Overall Study|IVUS results were not available|9|||
125616394|NCT00488592|451878375|FG000|Overall Study|Withdrawal by Subject|1|||
125616395|NCT00488592|451878375|FG000|Overall Study|Disease progression|1|||
125616396|NCT00488592|451878375|FG000|Overall Study|Enrolled but not treated|1|||
125616397|NCT01096849|451878380|FG000|Overall Study|Consent Withdrawn|1|||
125616398|NCT01096849|451878381|FG001|Overall Study|Consent Withdrawn|4|||
125616399|NCT01096849|451878382|FG002|Overall Study|Consent Withdrawn|2|||
125616400|NCT01096849|451878380|FG000|Overall Study|Lack of Efficacy|0|||
125616401|NCT01096849|451878381|FG001|Overall Study|Lack of Efficacy|2|||
125616402|NCT01096849|451878382|FG002|Overall Study|Lack of Efficacy|0|||
125616403|NCT01096849|451878380|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
125616404|NCT01096849|451878381|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
125616405|NCT01096849|451878382|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
125616406|NCT01096849|451878380|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
125616407|NCT01096849|451878381|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
125616408|NCT01096849|451878382|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
125616409|NCT01096849|451878380|FG000|Overall Study|Administrative Reasons|0|||
125616410|NCT01096849|451878381|FG001|Overall Study|Administrative Reasons|1|||
125616411|NCT01096849|451878382|FG002|Overall Study|Administrative Reasons|2|||
125616412|NCT01096849|451878380|FG000|Overall Study|Lost to Follow-up|1|||
125616413|NCT01096849|451878381|FG001|Overall Study|Lost to Follow-up|3|||
125616414|NCT01096849|451878382|FG002|Overall Study|Lost to Follow-up|1|||
125616415|NCT00242580|451878384|FG000|Overall Study|Adverse Event|3|||
125616416|NCT00242580|451878385|FG001|Overall Study|Adverse Event|0|||
125616417|NCT00242580|451878386|FG002|Overall Study|Adverse Event|2|||
125616418|NCT00242580|451878384|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125616419|NCT00242580|451878385|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
125373237|NCT02549937|450996551|FG000|Overall Study|Withdrawal by Subject|0|||
125373238|NCT02549937|450996552|FG001|Overall Study|Withdrawal by Subject|0|||
125616420|NCT00242580|451878386|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
125616421|NCT00242580|451878384|FG000|Overall Study|Protocol Violation|0|||
125616422|NCT00242580|451878385|FG001|Overall Study|Protocol Violation|0|||
125616423|NCT00242580|451878386|FG002|Overall Study|Protocol Violation|1|||
125616424|NCT00242580|451878384|FG000|Overall Study|Subject withdrew consent|2|||
125616425|NCT00242580|451878385|FG001|Overall Study|Subject withdrew consent|2|||
125214805|NCT02757352|450414858|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
125373239|NCT02549937|450996553|FG002|Overall Study|Withdrawal by Subject|0|||
125616426|NCT00242580|451878386|FG002|Overall Study|Subject withdrew consent|5|||
125616427|NCT00242580|451878384|FG000|Overall Study|Lost to Follow-up|0|||
125616428|NCT00242580|451878385|FG001|Overall Study|Lost to Follow-up|3|||
125616429|NCT00242580|451878386|FG002|Overall Study|Lost to Follow-up|0|||
125616430|NCT00242580|451878384|FG000|Overall Study|Death|1|||
125616431|NCT00242580|451878385|FG001|Overall Study|Death|2|||
125616432|NCT00242580|451878386|FG002|Overall Study|Death|1|||
125616433|NCT01232894|451878387|FG000|Overall Study|Lost to Follow-up|0|||
125616434|NCT01232894|451878388|FG001|Overall Study|Lost to Follow-up|1|||
125616435|NCT01232894|451878387|FG000|Overall Study|Death|1|||
125616436|NCT01232894|451878388|FG001|Overall Study|Death|0|||
125616437|NCT01232894|451878387|FG000|Overall Study|Protocol Violation|1|||
125616438|NCT01232894|451878388|FG001|Overall Study|Protocol Violation|1|||
125616439|NCT01232894|451878387|FG000|Overall Study|Withdrawal by Subject|8|||
125616440|NCT01232894|451878388|FG001|Overall Study|Withdrawal by Subject|5|||
125616441|NCT01232894|451878387|FG000|Overall Study|Physician Decision|2|||
125616442|NCT01232894|451878388|FG001|Overall Study|Physician Decision|1|||
125616443|NCT03970395|451878389|FG000|Overall Study|Withdrawal by Subject|3|||
125616444|NCT03970395|451878390|FG001|Overall Study|Withdrawal by Subject|4|||
125616445|NCT03970395|451878389|FG000|Overall Study|Lost to Follow-up|4|||
125616446|NCT03970395|451878390|FG001|Overall Study|Lost to Follow-up|8|||
125616447|NCT00125190|451878392|FG000|Overall Study|Subject/Parent Decision|7|||
125616448|NCT00125190|451878392|FG000|Overall Study|Non-compliance|2|||
125616449|NCT00125190|451878392|FG000|Overall Study|Adverse Event|1|||
125616450|NCT00125190|451878392|FG000|Overall Study|Other|1|||
125616451|NCT00125190|451878392|FG000|Overall Study|Lost to Follow-up|4|||
125616452|NCT00929734|451878393|FG000|Overall Study|Lost to Follow-up|2|||
125616453|NCT00929734|451878394|FG001|Overall Study|Lost to Follow-up|1|||
125616454|NCT00929734|451878393|FG000|Overall Study|Withdrawal by Subject|0|||
125616455|NCT00929734|451878394|FG001|Overall Study|Withdrawal by Subject|2|||
125616456|NCT00980980|451878395|FG000|Overall Study|Withdrawal by Hospital|0|||
125616457|NCT00980980|451878396|FG001|Overall Study|Withdrawal by Hospital|1|||
125616458|NCT00980980|451878397|FG002|Overall Study|Withdrawal by Hospital|0|||
125616459|NCT00414960|451878399|FG000|Overall Study|Adverse Event|4|||
125616460|NCT00414960|451878400|FG001|Overall Study|Adverse Event|0|||
125616461|NCT00414960|451878399|FG000|Overall Study|Withdrawal by Subject|3|||
125616462|NCT00414960|451878400|FG001|Overall Study|Withdrawal by Subject|0|||
125616463|NCT00414960|451878399|FG000|Overall Study|Physician Decision|0|||
125616464|NCT00414960|451878400|FG001|Overall Study|Physician Decision|1|||
125616465|NCT01449682|451878401|FG000|Overall Study|Death|0|||
125616466|NCT01449682|451878402|FG001|Overall Study|Death|1|||
125616467|NCT01449682|451878401|FG000|Overall Study|Adverse Event|1|||
125616468|NCT01449682|451878402|FG001|Overall Study|Adverse Event|0|||
125616469|NCT04863014|451878403|FG000|Overall Study|Lost to Follow-up|3|||
125616470|NCT04863014|451878404|FG001|Overall Study|Lost to Follow-up|2|||
125616471|NCT04863014|451878403|FG000|Overall Study|Subject Decision|0|||
125616472|NCT04863014|451878404|FG001|Overall Study|Subject Decision|4|||
125616473|NCT04633473|451878408|FG000|Overall Study|Withdrawal by Subject|6|||
125616474|NCT00264849|451878410|FG000|Overall Study|Adverse Event|7|||
125616475|NCT00264849|451878411|FG001|Overall Study|Adverse Event|2|||
125616476|NCT00264849|451878410|FG000|Overall Study|Withdrawal by Subject|7|||
125616477|NCT00264849|451878411|FG001|Overall Study|Withdrawal by Subject|11|||
125616478|NCT00264849|451878410|FG000|Overall Study|Protocol Violation|5|||
125616479|NCT00264849|451878411|FG001|Overall Study|Protocol Violation|3|||
125616480|NCT00264849|451878410|FG000|Overall Study|Lack of Efficacy|1|||
125616481|NCT00264849|451878411|FG001|Overall Study|Lack of Efficacy|6|||
125616482|NCT00264849|451878410|FG000|Overall Study|Lost to Follow-up|0|||
125616483|NCT00264849|451878411|FG001|Overall Study|Lost to Follow-up|2|||
125616484|NCT00264849|451878410|FG000|Overall Study|Death|0|||
125616485|NCT00264849|451878411|FG001|Overall Study|Death|1|||
125616486|NCT00264849|451878410|FG000|Overall Study|Administrative Problems|2|||
125616487|NCT00264849|451878411|FG001|Overall Study|Administrative Problems|0|||
125616488|NCT01982773|451878412|FG000|Overall Study|Withdrawal by Subject|1|||
125616489|NCT01982773|451878413|FG001|Overall Study|Withdrawal by Subject|3|||
125616490|NCT01982773|451878412|FG000|Overall Study|Lost to Follow-up|7|||
125616491|NCT01982773|451878413|FG001|Overall Study|Lost to Follow-up|1|||
125616492|NCT03294681|451878414|FG000|Overall Study|Withdrawal by Subject|1|||
125616493|NCT00417976|451878419|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
125616494|NCT00417976|451878419|FG000|Overall Study|Treatment -related toxicity|2|||
125616495|NCT04348591|451878420|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
125616496|NCT04348591|451878421|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
125214806|NCT02757352|450414859|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
125616497|NCT04348591|451878420|FG000|Imaging Session (120 Min)|Physician Decision|0|||
125616498|NCT04348591|451878421|FG001|Imaging Session (120 Min)|Physician Decision|1|||
125616499|NCT04348591|451878420|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
125616500|NCT04348591|451878421|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
125616501|NCT01778127|451878422|FG000|Overall Study|Lost to Follow-up|5|||
125616502|NCT01778127|451878423|FG001|Overall Study|Lost to Follow-up|1|||
125616503|NCT01778127|451878424|FG002|Overall Study|Lost to Follow-up|2|||
125616504|NCT01778127|451878422|FG000|Overall Study|Withdrawal by Subject|3|||
125616505|NCT01778127|451878423|FG001|Overall Study|Withdrawal by Subject|1|||
125616506|NCT01778127|451878424|FG002|Overall Study|Withdrawal by Subject|4|||
125616507|NCT01348425|451878425|FG000|Overall Study|Imaging was not taken.|1|||
125616508|NCT01348425|451878426|FG001|Overall Study|Imaging was not taken.|1|||
125616509|NCT02104804|451878427|FG000|Overall Study|Did not take study medication|0|||
125616510|NCT02104804|451878428|FG001|Overall Study|Did not take study medication|1|||
125616511|NCT02104804|451878427|FG000|Overall Study|Study specific discontinuation criteria|6|||
125616512|NCT02104804|451878428|FG001|Overall Study|Study specific discontinuation criteria|1|||
125616513|NCT02104804|451878427|FG000|Overall Study|Other listed|2|||
125616514|NCT02104804|451878428|FG001|Overall Study|Other listed|1|||
125616515|NCT02104804|451878427|FG000|Overall Study|Protocol Violation|0|||
125616516|NCT02104804|451878428|FG001|Overall Study|Protocol Violation|1|||
125616517|NCT02104804|451878427|FG000|Overall Study|Adverse Event|4|||
125616518|NCT02104804|451878428|FG001|Overall Study|Adverse Event|3|||
125616519|NCT02104804|451878427|FG000|Overall Study|Withdrawal by Subject|4|||
125616520|NCT02104804|451878428|FG001|Overall Study|Withdrawal by Subject|12|||
125616521|NCT03722784|451878431|FG000|Overall Study|Withdrawal by Subject|1|||
125616522|NCT03722784|451878432|FG001|Overall Study|Withdrawal by Subject|0|||
125616523|NCT03722784|451878431|FG000|Overall Study|Physician Decision|1|||
125616524|NCT03722784|451878432|FG001|Overall Study|Physician Decision|1|||
125616525|NCT03722784|451878431|FG000|Overall Study|Protocol Violation|0|||
125616526|NCT03722784|451878432|FG001|Overall Study|Protocol Violation|1|||
125616527|NCT00751114|451878436|FG000|Overall Study|Adverse Event|2|||
125616528|NCT00751114|451878437|FG001|Overall Study|Adverse Event|4|||
125616529|NCT00751114|451878436|FG000|Overall Study|Protocol Violation|8|||
125616530|NCT00751114|451878437|FG001|Overall Study|Protocol Violation|9|||
125616531|NCT00751114|451878436|FG000|Overall Study|Withdrawal by Subject|9|||
125616532|NCT00751114|451878437|FG001|Overall Study|Withdrawal by Subject|4|||
125616533|NCT00751114|451878436|FG000|Overall Study|Lost to Follow-up|4|||
125616534|NCT00751114|451878437|FG001|Overall Study|Lost to Follow-up|7|||
125616535|NCT00751114|451878436|FG000|Overall Study|Lack of Efficacy|0|||
125616536|NCT00751114|451878437|FG001|Overall Study|Lack of Efficacy|7|||
125616537|NCT00751114|451878436|FG000|Overall Study|Not Treated|13|||
125616538|NCT00751114|451878437|FG001|Overall Study|Not Treated|1|||
125616539|NCT00751114|451878436|FG000|Overall Study|Out of country for 2 months|1|||
125616540|NCT00751114|451878437|FG001|Overall Study|Out of country for 2 months|0|||
125616541|NCT00751114|451878436|FG000|Overall Study|Move to another city|1|||
125616542|NCT00751114|451878437|FG001|Overall Study|Move to another city|0|||
125616543|NCT05319080|451878438|FG000|Overall Study|Withdrawal by Subject|2|||
125616544|NCT05319080|451878438|FG000|Overall Study|Physician Decision|4|||
125616545|NCT02648724|451878441|FG000|Overall Study|Withdrawal by Subject|0|||
125616546|NCT02648724|451878442|FG001|Overall Study|Withdrawal by Subject|1|||
125616547|NCT02648724|451878443|FG002|Overall Study|Withdrawal by Subject|1|||
125616548|NCT02648724|451878444|FG003|Overall Study|Withdrawal by Subject|0|||
125616549|NCT02648724|451878445|FG004|Overall Study|Withdrawal by Subject|1|||
125616550|NCT02648724|451878446|FG005|Overall Study|Withdrawal by Subject|0|||
125616551|NCT02648724|451878447|FG006|Overall Study|Withdrawal by Subject|0|||
125616552|NCT02648724|451878441|FG000|Overall Study|Progressive disease|2|||
125616553|NCT02648724|451878442|FG001|Overall Study|Progressive disease|2|||
125616554|NCT02648724|451878443|FG002|Overall Study|Progressive disease|2|||
125616555|NCT02648724|451878444|FG003|Overall Study|Progressive disease|3|||
125616556|NCT02648724|451878445|FG004|Overall Study|Progressive disease|22|||
125616557|NCT02648724|451878446|FG005|Overall Study|Progressive disease|7|||
125616558|NCT02648724|451878447|FG006|Overall Study|Progressive disease|8|||
125616559|NCT02648724|451878441|FG000|Overall Study|Other reason (unknown)|1|||
125616560|NCT02648724|451878442|FG001|Overall Study|Other reason (unknown)|0|||
125616561|NCT02648724|451878443|FG002|Overall Study|Other reason (unknown)|0|||
125616562|NCT02648724|451878444|FG003|Overall Study|Other reason (unknown)|0|||
125616563|NCT02648724|451878445|FG004|Overall Study|Other reason (unknown)|0|||
125616564|NCT02648724|451878446|FG005|Overall Study|Other reason (unknown)|0|||
125616565|NCT02648724|451878447|FG006|Overall Study|Other reason (unknown)|0|||
125616566|NCT02648724|451878441|FG000|Overall Study|Protocol Violation|0|||
125616567|NCT02648724|451878442|FG001|Overall Study|Protocol Violation|0|||
125616568|NCT02648724|451878443|FG002|Overall Study|Protocol Violation|0|||
125616569|NCT02648724|451878444|FG003|Overall Study|Protocol Violation|0|||
125616570|NCT02648724|451878445|FG004|Overall Study|Protocol Violation|1|||
125616571|NCT02648724|451878446|FG005|Overall Study|Protocol Violation|0|||
125616572|NCT02648724|451878447|FG006|Overall Study|Protocol Violation|0|||
125616573|NCT02648724|451878441|FG000|Overall Study|Death|0|||
125616574|NCT02648724|451878442|FG001|Overall Study|Death|0|||
125616575|NCT02648724|451878443|FG002|Overall Study|Death|0|||
125616576|NCT02648724|451878444|FG003|Overall Study|Death|0|||
125616577|NCT02648724|451878445|FG004|Overall Study|Death|0|||
125616578|NCT02648724|451878446|FG005|Overall Study|Death|0|||
125616579|NCT02648724|451878447|FG006|Overall Study|Death|3|||
125616580|NCT02648724|451878441|FG000|Overall Study|Physician Decision|0|||
125616581|NCT02648724|451878442|FG001|Overall Study|Physician Decision|0|||
125616582|NCT02648724|451878443|FG002|Overall Study|Physician Decision|0|||
125616583|NCT02648724|451878444|FG003|Overall Study|Physician Decision|0|||
125616584|NCT02648724|451878445|FG004|Overall Study|Physician Decision|1|||
125616585|NCT02648724|451878446|FG005|Overall Study|Physician Decision|0|||
125616586|NCT02648724|451878447|FG006|Overall Study|Physician Decision|1|||
125616587|NCT02648724|451878441|FG000|Overall Study|Transferred to named patient program|0|||
125616588|NCT02648724|451878442|FG001|Overall Study|Transferred to named patient program|0|||
125616589|NCT02648724|451878443|FG002|Overall Study|Transferred to named patient program|0|||
125616590|NCT02648724|451878444|FG003|Overall Study|Transferred to named patient program|0|||
125616591|NCT02648724|451878445|FG004|Overall Study|Transferred to named patient program|0|||
125616592|NCT02648724|451878446|FG005|Overall Study|Transferred to named patient program|1|||
125616593|NCT02648724|451878447|FG006|Overall Study|Transferred to named patient program|0|||
125616594|NCT03076190|451878448|FG000|Overall Study|Lost to Follow-up|9|||
125616595|NCT03076190|451878449|FG001|Overall Study|Lost to Follow-up|34|||
125616596|NCT03076190|451878448|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
125616597|NCT03076190|451878449|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
125616598|NCT00406783|451878450|FG000|Overall Study|Adverse Event|4|||
125616599|NCT00406783|451878451|FG001|Overall Study|Adverse Event|4|||
125616600|NCT00406783|451878450|FG000|Overall Study|Treatment Failure|2|||
125616601|NCT00406783|451878451|FG001|Overall Study|Treatment Failure|3|||
125616602|NCT00406783|451878450|FG000|Overall Study|Lost to Follow-up|3|||
125616603|NCT00406783|451878451|FG001|Overall Study|Lost to Follow-up|0|||
125616604|NCT00406783|451878450|FG000|Overall Study|Withdrawal by Subject|1|||
125616605|NCT00406783|451878451|FG001|Overall Study|Withdrawal by Subject|4|||
125616606|NCT00406783|451878450|FG000|Overall Study|Protocol Violation|4|||
125616607|NCT00406783|451878451|FG001|Overall Study|Protocol Violation|4|||
125616608|NCT00012012|451878452|FG000|Overall Study|Protocol Violation|1|||
125616609|NCT00012012|451878453|FG001|Overall Study|Protocol Violation|1|||
125616610|NCT00012012|451878452|FG000|Overall Study|Withdrawal by Subject|0|||
125616611|NCT00012012|451878453|FG001|Overall Study|Withdrawal by Subject|2|||
125616612|NCT01391819|451878454|FG000|Overall Study|Withdrawal by Subject|56|||
125616613|NCT01391819|451878454|FG000|Overall Study|Migrated/moved from study area|82|||
125616614|NCT01391819|451878454|FG000|Overall Study|Lost to Follow-up|252|||
125616615|NCT01391819|451878454|FG000|Overall Study|Death|3|||
125616616|NCT01391819|451878454|FG000|Overall Study|Other|9|||
125616617|NCT00808249|451878457|FG000|Overall Study|Adverse Event|4|||
125616618|NCT00808249|451878458|FG001|Overall Study|Adverse Event|7|||
125616619|NCT00808249|451878459|FG002|Overall Study|Adverse Event|10|||
125616620|NCT00808249|451878460|FG003|Overall Study|Adverse Event|6|||
125616621|NCT00808249|451878457|FG000|Overall Study|Lost to Follow-up|2|||
125616622|NCT00808249|451878458|FG001|Overall Study|Lost to Follow-up|3|||
125616623|NCT00808249|451878459|FG002|Overall Study|Lost to Follow-up|3|||
125616624|NCT00808249|451878460|FG003|Overall Study|Lost to Follow-up|5|||
125616625|NCT00808249|451878457|FG000|Overall Study|Withdrawal by Subject|4|||
125616626|NCT00808249|451878458|FG001|Overall Study|Withdrawal by Subject|0|||
125616627|NCT00808249|451878459|FG002|Overall Study|Withdrawal by Subject|2|||
125616628|NCT00808249|451878460|FG003|Overall Study|Withdrawal by Subject|4|||
125616629|NCT00808249|451878457|FG000|Overall Study|Protocol Violation|3|||
125616630|NCT00808249|451878458|FG001|Overall Study|Protocol Violation|3|||
125616631|NCT00808249|451878459|FG002|Overall Study|Protocol Violation|3|||
125214807|NCT02757352|450414860|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
125616632|NCT00808249|451878460|FG003|Overall Study|Protocol Violation|0|||
125616633|NCT00808249|451878457|FG000|Overall Study|Lack of Efficacy|1|||
125616634|NCT00808249|451878458|FG001|Overall Study|Lack of Efficacy|1|||
125616635|NCT00808249|451878459|FG002|Overall Study|Lack of Efficacy|0|||
125616636|NCT00808249|451878460|FG003|Overall Study|Lack of Efficacy|0|||
125616637|NCT00808249|451878457|FG000|Overall Study|study specific discontinuation criteria|1|||
125616638|NCT00808249|451878458|FG001|Overall Study|study specific discontinuation criteria|0|||
125616639|NCT00808249|451878459|FG002|Overall Study|study specific discontinuation criteria|1|||
125214808|NCT02757352|450414861|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214809|NCT02757352|450414862|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214810|NCT02757352|450414863|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214811|NCT02757352|450414864|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214812|NCT02757352|450414865|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214813|NCT02757352|450414866|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214814|NCT02757352|450414867|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214815|NCT02757352|450414858|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
125214816|NCT02757352|450414859|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
125214817|NCT02757352|450414860|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
125214818|NCT02757352|450414861|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214819|NCT02757352|450414862|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214820|NCT02757352|450414863|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214821|NCT02757352|450414864|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214822|NCT02757352|450414865|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214823|NCT02757352|450414866|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214824|NCT02757352|450414867|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
125214825|NCT02757352|450414858|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214826|NCT02757352|450414859|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214827|NCT02757352|450414860|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214828|NCT02757352|450414861|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
125214829|NCT02757352|450414862|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214830|NCT02757352|450414863|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
125214831|NCT02757352|450414864|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214832|NCT02757352|450414865|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214833|NCT02757352|450414866|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214834|NCT02757352|450414867|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
125214835|NCT02757352|450414858|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214836|NCT02757352|450414859|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214837|NCT02757352|450414860|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214838|NCT02757352|450414861|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
125214839|NCT02757352|450414862|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
125214840|NCT02757352|450414863|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
125214841|NCT02757352|450414864|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214842|NCT02757352|450414865|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214843|NCT02757352|450414866|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214844|NCT02757352|450414867|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
125214845|NCT02757352|450414858|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214846|NCT02757352|450414859|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214847|NCT02757352|450414860|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214848|NCT02757352|450414861|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214849|NCT02757352|450414862|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
125214850|NCT02757352|450414863|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125616640|NCT00808249|451878460|FG003|Overall Study|study specific discontinuation criteria|0|||
125616641|NCT00808249|451878457|FG000|Overall Study|All other reasons|2|||
125616642|NCT00808249|451878458|FG001|Overall Study|All other reasons|1|||
125616643|NCT00808249|451878459|FG002|Overall Study|All other reasons|3|||
125616644|NCT00808249|451878460|FG003|Overall Study|All other reasons|1|||
125616645|NCT00479557|451878463|FG000|Overall Study|Death|0|||
125616646|NCT00479557|451878464|FG001|Overall Study|Death|0|||
125616647|NCT00479557|451878465|FG002|Overall Study|Death|0|||
125616648|NCT00479557|451878466|FG003|Overall Study|Death|0|||
125616649|NCT00479557|451878467|FG004|Overall Study|Death|0|||
125616650|NCT00479557|451878468|FG005|Overall Study|Death|1|||
125616651|NCT00479557|451878469|FG006|Overall Study|Death|0|||
125616652|NCT00479557|451878463|FG000|Overall Study|Lack of Efficacy|1|||
125616653|NCT00479557|451878464|FG001|Overall Study|Lack of Efficacy|0|||
125616654|NCT00479557|451878465|FG002|Overall Study|Lack of Efficacy|0|||
125616655|NCT00479557|451878466|FG003|Overall Study|Lack of Efficacy|0|||
125616656|NCT00479557|451878467|FG004|Overall Study|Lack of Efficacy|0|||
125616657|NCT00479557|451878468|FG005|Overall Study|Lack of Efficacy|0|||
125616658|NCT00479557|451878469|FG006|Overall Study|Lack of Efficacy|0|||
125616659|NCT00479557|451878463|FG000|Overall Study|Lost to Follow-up|0|||
125616660|NCT00479557|451878464|FG001|Overall Study|Lost to Follow-up|2|||
125616661|NCT00479557|451878465|FG002|Overall Study|Lost to Follow-up|0|||
125616662|NCT00479557|451878466|FG003|Overall Study|Lost to Follow-up|2|||
125616663|NCT00479557|451878467|FG004|Overall Study|Lost to Follow-up|0|||
125616664|NCT00479557|451878468|FG005|Overall Study|Lost to Follow-up|0|||
125373240|NCT02549937|450996554|FG003|Overall Study|Withdrawal by Subject|0|||
125373241|NCT02549937|450996555|FG004|Overall Study|Withdrawal by Subject|0|||
125616665|NCT00479557|451878469|FG006|Overall Study|Lost to Follow-up|0|||
125616666|NCT00479557|451878463|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
125616667|NCT00479557|451878464|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
125616668|NCT00479557|451878465|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
125616669|NCT00479557|451878466|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
125616670|NCT00479557|451878467|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
125616671|NCT00479557|451878468|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
125616672|NCT00479557|451878469|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
125616673|NCT00479557|451878463|FG000|Overall Study|AE not related to Study Drug|1|||
125616674|NCT00479557|451878464|FG001|Overall Study|AE not related to Study Drug|3|||
125616675|NCT00479557|451878465|FG002|Overall Study|AE not related to Study Drug|0|||
125616676|NCT00479557|451878466|FG003|Overall Study|AE not related to Study Drug|0|||
125616677|NCT00479557|451878467|FG004|Overall Study|AE not related to Study Drug|2|||
125616678|NCT00479557|451878468|FG005|Overall Study|AE not related to Study Drug|2|||
125616679|NCT00479557|451878469|FG006|Overall Study|AE not related to Study Drug|1|||
125616680|NCT00479557|451878463|FG000|Overall Study|Caregiver Request|2|||
125616681|NCT00479557|451878464|FG001|Overall Study|Caregiver Request|2|||
125616682|NCT00479557|451878465|FG002|Overall Study|Caregiver Request|2|||
125616683|NCT00479557|451878466|FG003|Overall Study|Caregiver Request|0|||
125616684|NCT00479557|451878467|FG004|Overall Study|Caregiver Request|1|||
125616685|NCT00479557|451878468|FG005|Overall Study|Caregiver Request|2|||
125616686|NCT00479557|451878469|FG006|Overall Study|Caregiver Request|0|||
125616687|NCT00479557|451878463|FG000|Overall Study|Investigator Request|0|||
125616688|NCT00479557|451878464|FG001|Overall Study|Investigator Request|0|||
125616689|NCT00479557|451878465|FG002|Overall Study|Investigator Request|1|||
125616690|NCT00479557|451878466|FG003|Overall Study|Investigator Request|0|||
125616691|NCT00479557|451878467|FG004|Overall Study|Investigator Request|0|||
125616692|NCT00479557|451878468|FG005|Overall Study|Investigator Request|0|||
125616693|NCT00479557|451878469|FG006|Overall Study|Investigator Request|0|||
125616694|NCT00479557|451878463|FG000|Overall Study|Subject Request|3|||
125616695|NCT00479557|451878464|FG001|Overall Study|Subject Request|0|||
125616696|NCT00479557|451878465|FG002|Overall Study|Subject Request|1|||
125616697|NCT00479557|451878466|FG003|Overall Study|Subject Request|1|||
125616698|NCT00479557|451878467|FG004|Overall Study|Subject Request|1|||
125616699|NCT00479557|451878468|FG005|Overall Study|Subject Request|4|||
125616700|NCT00479557|451878469|FG006|Overall Study|Subject Request|1|||
125616701|NCT00479557|451878463|FG000|Overall Study|Other|2|||
125616702|NCT00479557|451878464|FG001|Overall Study|Other|3|||
125616703|NCT00479557|451878465|FG002|Overall Study|Other|1|||
125616704|NCT00479557|451878466|FG003|Overall Study|Other|0|||
125616705|NCT00479557|451878467|FG004|Overall Study|Other|0|||
125616706|NCT00479557|451878468|FG005|Overall Study|Other|3|||
125616707|NCT00479557|451878469|FG006|Overall Study|Other|0|||
125616708|NCT02509494|451878472|FG000|Overall Study|Lost to Follow-up|8|||
125616709|NCT02509494|451878473|FG001|Overall Study|Lost to Follow-up|47|||
125616710|NCT02509494|451878474|FG002|Overall Study|Lost to Follow-up|19|||
125616711|NCT02509494|451878475|FG003|Overall Study|Lost to Follow-up|6|||
125616712|NCT02509494|451878476|FG004|Overall Study|Lost to Follow-up|3|||
125616713|NCT02509494|451878477|FG005|Overall Study|Lost to Follow-up|3|||
125616714|NCT02509494|451878478|FG006|Overall Study|Lost to Follow-up|1|||
125616715|NCT02509494|451878479|FG007|Overall Study|Lost to Follow-up|3|||
125616716|NCT02509494|451878480|FG008|Overall Study|Lost to Follow-up|1|||
125616717|NCT02509494|451878472|FG000|Overall Study|Physician Decision|2|||
125616718|NCT02509494|451878473|FG001|Overall Study|Physician Decision|1|||
125616719|NCT02509494|451878474|FG002|Overall Study|Physician Decision|0|||
125616720|NCT02509494|451878475|FG003|Overall Study|Physician Decision|0|||
125616721|NCT02509494|451878476|FG004|Overall Study|Physician Decision|0|||
125616722|NCT02509494|451878477|FG005|Overall Study|Physician Decision|0|||
125616723|NCT02509494|451878478|FG006|Overall Study|Physician Decision|0|||
125616724|NCT02509494|451878479|FG007|Overall Study|Physician Decision|0|||
125616725|NCT02509494|451878480|FG008|Overall Study|Physician Decision|0|||
125616726|NCT02509494|451878472|FG000|Overall Study|Withdrawal by Subject|4|||
125616727|NCT02509494|451878473|FG001|Overall Study|Withdrawal by Subject|17|||
125616728|NCT02509494|451878474|FG002|Overall Study|Withdrawal by Subject|7|||
125616729|NCT02509494|451878475|FG003|Overall Study|Withdrawal by Subject|5|||
125616730|NCT02509494|451878476|FG004|Overall Study|Withdrawal by Subject|0|||
125616731|NCT02509494|451878477|FG005|Overall Study|Withdrawal by Subject|6|||
125373242|NCT02549937|450996556|FG005|Overall Study|Withdrawal by Subject|1|||
125616732|NCT02509494|451878478|FG006|Overall Study|Withdrawal by Subject|1|||
125616733|NCT02509494|451878479|FG007|Overall Study|Withdrawal by Subject|2|||
125616734|NCT02509494|451878480|FG008|Overall Study|Withdrawal by Subject|1|||
125616735|NCT02509494|451878472|FG000|Overall Study|Death|0|||
125616736|NCT02509494|451878473|FG001|Overall Study|Death|1|||
125616737|NCT02509494|451878474|FG002|Overall Study|Death|0|||
125616738|NCT02509494|451878475|FG003|Overall Study|Death|0|||
125616739|NCT02509494|451878476|FG004|Overall Study|Death|1|||
125616740|NCT02509494|451878477|FG005|Overall Study|Death|0|||
125214851|NCT02757352|450414864|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214852|NCT02757352|450414865|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214853|NCT02757352|450414866|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214854|NCT02757352|450414867|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
125214855|NCT02757352|450414858|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214856|NCT02757352|450414859|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214857|NCT02757352|450414860|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214858|NCT02757352|450414861|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214859|NCT02757352|450414862|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214860|NCT02757352|450414863|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
125214861|NCT02757352|450414864|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214862|NCT02757352|450414865|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214863|NCT02757352|450414866|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125214864|NCT02757352|450414867|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
125616741|NCT02509494|451878478|FG006|Overall Study|Death|0|||
125616742|NCT02509494|451878479|FG007|Overall Study|Death|1|||
125616743|NCT02509494|451878480|FG008|Overall Study|Death|0|||
125616744|NCT02509494|451878472|FG000|Overall Study|Other|0|||
125616745|NCT02509494|451878473|FG001|Overall Study|Other|4|||
125616746|NCT02509494|451878474|FG002|Overall Study|Other|5|||
125616747|NCT02509494|451878475|FG003|Overall Study|Other|0|||
125616748|NCT02509494|451878476|FG004|Overall Study|Other|0|||
125616749|NCT02509494|451878477|FG005|Overall Study|Other|0|||
125616750|NCT02509494|451878478|FG006|Overall Study|Other|0|||
125616751|NCT02509494|451878479|FG007|Overall Study|Other|0|||
125616752|NCT02509494|451878480|FG008|Overall Study|Other|0|||
125616753|NCT02509494|451878472|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125616754|NCT02509494|451878473|FG001|Overall Study|Non-Compliance With Study Drug|11|||
125616755|NCT02509494|451878474|FG002|Overall Study|Non-Compliance With Study Drug|7|||
125616756|NCT02509494|451878475|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125616757|NCT02509494|451878476|FG004|Overall Study|Non-Compliance With Study Drug|1|||
125214865|NCT02757352|450414858|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214866|NCT02757352|450414859|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125373243|NCT02549937|450996557|FG006|Overall Study|Withdrawal by Subject|4|||
125373244|NCT02549937|450996558|FG007|Overall Study|Withdrawal by Subject|3|||
125373245|NCT02549937|450996559|FG008|Overall Study|Withdrawal by Subject|2|||
125373246|NCT02549937|450996551|FG000|Overall Study|Sponsor Decision|0|||
125373247|NCT02549937|450996552|FG001|Overall Study|Sponsor Decision|0|||
125373248|NCT02549937|450996553|FG002|Overall Study|Sponsor Decision|0|||
125373249|NCT02549937|450996554|FG003|Overall Study|Sponsor Decision|0|||
125373250|NCT02549937|450996555|FG004|Overall Study|Sponsor Decision|0|||
125373251|NCT02549937|450996556|FG005|Overall Study|Sponsor Decision|0|||
125373252|NCT02549937|450996557|FG006|Overall Study|Sponsor Decision|0|||
125373253|NCT02549937|450996558|FG007|Overall Study|Sponsor Decision|0|||
125373254|NCT02549937|450996559|FG008|Overall Study|Sponsor Decision|6|||
125373255|NCT03930797|450996560|FG000|Overall Study|Lost to Follow-up|3|||
125373256|NCT03930797|450996561|FG001|Overall Study|Lost to Follow-up|10|||
125373257|NCT00662012|450996562|FG000|Overall Study|Lost to Follow-up|85|||
125373258|NCT00662012|450996562|FG000|Overall Study|Death|1|||
125373259|NCT00662012|450996562|FG000|Overall Study|Withdrawal by Subject|1|||
125373260|NCT00317356|450996567|FG000|Overall Study|Adverse Event|0|||
125373261|NCT00317356|450996568|FG001|Overall Study|Adverse Event|0|||
125373262|NCT00317356|450996569|FG002|Overall Study|Adverse Event|1|||
125373263|NCT00317356|450996570|FG003|Overall Study|Adverse Event|0|||
125373264|NCT00317356|450996567|FG000|Overall Study|Lack of Efficacy|1|||
125373265|NCT00317356|450996568|FG001|Overall Study|Lack of Efficacy|1|||
125373266|NCT00317356|450996569|FG002|Overall Study|Lack of Efficacy|0|||
125373267|NCT00317356|450996570|FG003|Overall Study|Lack of Efficacy|3|||
125373268|NCT00317356|450996567|FG000|Overall Study|Physician Decision|0|||
125373269|NCT00317356|450996568|FG001|Overall Study|Physician Decision|1|||
125373270|NCT00317356|450996569|FG002|Overall Study|Physician Decision|0|||
125373271|NCT00317356|450996570|FG003|Overall Study|Physician Decision|0|||
125373272|NCT01949506|450996571|FG000|Overall Study|Physician Decision|1|||
125373273|NCT04212650|450996573|FG000|Overall Study|Withdrawal by Subject|1|||
125373274|NCT04212650|450996574|FG001|Overall Study|Withdrawal by Subject|0|||
125373275|NCT05475236|450996576|FG000|Overall Study|Withdrawal by Subject|0|||
125373276|NCT05475236|450996577|FG001|Overall Study|Withdrawal by Subject|1|||
125373277|NCT05425745|450996578|FG000|Overall Study|Withdrawal of Consent|3|||
125373278|NCT05425745|450996579|FG001|Overall Study|Withdrawal of Consent|3|||
125373279|NCT05425745|450996578|FG000|Overall Study|Death|2|||
125373280|NCT05425745|450996579|FG001|Overall Study|Death|3|||
125373281|NCT05425745|450996578|FG000|Overall Study|Lost to Follow-up|1|||
125616758|NCT02509494|451878477|FG005|Overall Study|Non-Compliance With Study Drug|2|||
125373282|NCT05425745|450996579|FG001|Overall Study|Lost to Follow-up|2|||
125616759|NCT02509494|451878478|FG006|Overall Study|Non-Compliance With Study Drug|1|||
125214867|NCT02757352|450414860|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214868|NCT02757352|450414861|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
125214869|NCT02757352|450414862|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
125214870|NCT02757352|450414863|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
125214871|NCT02757352|450414864|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214872|NCT02757352|450414865|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125373283|NCT05425745|450996578|FG000|Overall Study|Adverse Event|0|||
125373284|NCT05425745|450996579|FG001|Overall Study|Adverse Event|1|||
125616760|NCT02509494|451878479|FG007|Overall Study|Non-Compliance With Study Drug|1|||
125616761|NCT02509494|451878480|FG008|Overall Study|Non-Compliance With Study Drug|0|||
125616762|NCT03003403|451878481|FG000|Overall Study|Ineligible|8|||
125616763|NCT03003403|451878482|FG001|Overall Study|Ineligible|7|||
125616764|NCT03003403|451878481|FG000|Overall Study|Withdrawal by Subject|3|||
125616765|NCT03003403|451878482|FG001|Overall Study|Withdrawal by Subject|1|||
125616766|NCT02871401|451879897|FG000|Overall Study|Adverse Event|1|||
125616767|NCT02871401|451879898|FG001|Overall Study|Adverse Event|0|||
125616768|NCT01120379|451879899|FG000|One Year Timepoint|Withdrawal by Subject|41|||
125616769|NCT01120379|451879899|FG000|One Year Timepoint|Lost to Follow-up|115|||
125616770|NCT01120379|451879899|FG000|One Year Timepoint|Death|108|||
125616771|NCT01120379|451879899|FG000|One Year Timepoint|Physician Decision|9|||
125616772|NCT01120379|451879899|FG000|One Year Timepoint|Any other reason for early termination|5|||
125616773|NCT01120379|451879899|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
125616774|NCT01120379|451879899|FG000|Two Year Timepoint|Lost to Follow-up|87|||
125616775|NCT01120379|451879899|FG000|Two Year Timepoint|Death|123|||
125616776|NCT01120379|451879899|FG000|Two Year Timepoint|Physician Decision|12|||
125616777|NCT01120379|451879899|FG000|Two Year Timepoint|Any other reason for early termination|4|||
125616778|NCT01120379|451879899|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
125616779|NCT01120379|451879899|FG000|Three Year Timepoint|Lost to Follow-up|43|||
125616780|NCT01120379|451879899|FG000|Three Year Timepoint|Death|120|||
125616781|NCT01120379|451879899|FG000|Three Year Timepoint|Physician Decision|9|||
125616782|NCT01120379|451879899|FG000|Three Year Timepoint|Any other reason for early termination|17|||
125616783|NCT01120379|451879899|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
125616784|NCT01120379|451879899|FG000|Four Year Timepoint|Lost to Follow-up|10|||
125616785|NCT01120379|451879899|FG000|Four Year Timepoint|Death|131|||
125616786|NCT01120379|451879899|FG000|Four Year Timepoint|Physician Decision|5|||
125616787|NCT01120379|451879899|FG000|Four Year Timepoint|Any other reason for early termination|217|||
125616788|NCT03162055|451879900|FG000|Overall Study|Adverse Event|6|||
125616789|NCT03162055|451879901|FG001|Overall Study|Adverse Event|5|||
125616790|NCT03162055|451879900|FG000|Overall Study|Death|3|||
125616791|NCT03162055|451879901|FG001|Overall Study|Death|3|||
125616792|NCT03162055|451879900|FG000|Overall Study|Lost to Follow-up|0|||
125616793|NCT03162055|451879901|FG001|Overall Study|Lost to Follow-up|1|||
125616794|NCT03162055|451879900|FG000|Overall Study|Study-specific withdrawal criteria|22|||
125616795|NCT03162055|451879901|FG001|Overall Study|Study-specific withdrawal criteria|14|||
125616796|NCT03162055|451879900|FG000|Overall Study|Withdrawal by Subject|17|||
125616797|NCT03162055|451879901|FG001|Overall Study|Withdrawal by Subject|2|||
125373285|NCT05425745|450996578|FG000|Overall Study|Did not return for end of study visit|0|||
125373286|NCT05425745|450996579|FG001|Overall Study|Did not return for end of study visit|1|||
125373287|NCT05425745|450996578|FG000|Overall Study|End of study visit completed by phone|1|||
125373288|NCT05425745|450996579|FG001|Overall Study|End of study visit completed by phone|0|||
125373289|NCT05425745|450996578|FG000|Overall Study|Subject decision|1|||
125373290|NCT05425745|450996579|FG001|Overall Study|Subject decision|0|||
125373291|NCT05255068|450997968|FG000|Overall Study|Lost to Follow-up|0|||
125373292|NCT05255068|450997969|FG001|Overall Study|Lost to Follow-up|1|||
125373293|NCT00907777|450997972|FG000|Overall Study|Withdrawal by Subject|0|||
125373294|NCT00907777|450997973|FG001|Overall Study|Withdrawal by Subject|1|||
125373295|NCT02674529|450997974|FG000|Overall Study|Lost to Follow-up|1|||
125373296|NCT02674529|450997975|FG001|Overall Study|Lost to Follow-up|2|||
125616798|NCT03162055|451879900|FG000|Overall Study|Did not receive treatment|2|||
125616799|NCT03162055|451879901|FG001|Overall Study|Did not receive treatment|0|||
125616800|NCT03162055|451879900|FG000|Overall Study|Incorrect randomization|4|||
125373297|NCT02674529|450997974|FG000|Overall Study|Withdrawal by Subject|2|||
125373298|NCT02674529|450997975|FG001|Overall Study|Withdrawal by Subject|1|||
125373299|NCT02674529|450997974|FG000|Overall Study|Physician Decision|0|||
125616801|NCT03162055|451879901|FG001|Overall Study|Incorrect randomization|3|||
125616802|NCT03162055|451879900|FG000|Overall Study|Other|8|||
125616803|NCT03162055|451879901|FG001|Overall Study|Other|15|||
125616804|NCT01617655|451879902|FG000|Overall Study|Adverse Event|2|||
125616805|NCT01617655|451879903|FG001|Overall Study|Adverse Event|3|||
125616806|NCT01617655|451879902|FG000|Overall Study|Poor compliance to protocol|1|||
125616807|NCT01617655|451879903|FG001|Overall Study|Poor compliance to protocol|4|||
125432071|NCT01336621|451207828|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
125432072|NCT01336621|451207828|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
125432073|NCT01336621|451207828|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
125432074|NCT01336621|451207828|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
125432075|NCT01336621|451207828|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
125432076|NCT01336621|451207828|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
125432077|NCT01336621|451207828|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
125432078|NCT00682643|451207829|FG000|Overall Study|Adverse Event|12|||
125432079|NCT00682643|451207830|FG001|Overall Study|Adverse Event|23|||
125432080|NCT00682643|451207829|FG000|Overall Study|Lack of Efficacy|2|||
125432081|NCT00682643|451207830|FG001|Overall Study|Lack of Efficacy|0|||
125432082|NCT00682643|451207829|FG000|Overall Study|Protocol Violation|38|||
125432083|NCT00682643|451207830|FG001|Overall Study|Protocol Violation|76|||
125432084|NCT00682643|451207829|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
125432085|NCT00682643|451207830|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
125432086|NCT00682643|451207829|FG000|Overall Study|Lost to Follow-up|1|||
125432087|NCT00682643|451207830|FG001|Overall Study|Lost to Follow-up|6|||
125432088|NCT00682643|451207829|FG000|Overall Study|Physician Decision|2|||
125432089|NCT00682643|451207830|FG001|Overall Study|Physician Decision|6|||
125432090|NCT00682643|451207829|FG000|Overall Study|Withdrawal by Subject|19|||
125432091|NCT00682643|451207830|FG001|Overall Study|Withdrawal by Subject|53|||
125432092|NCT00682643|451207829|FG000|Overall Study|Did Not Receive Study Drug|1|||
125432093|NCT00682643|451207830|FG001|Overall Study|Did Not Receive Study Drug|1|||
125432094|NCT00263328|451207834|FG000|Overall Study|Death|0|||
125432095|NCT00263328|451207835|FG001|Overall Study|Death|0|||
125432096|NCT00263328|451207836|FG002|Overall Study|Death|1|||
125432097|NCT00263328|451207834|FG000|Overall Study|Lost to Follow-up|1|||
125432098|NCT00263328|451207835|FG001|Overall Study|Lost to Follow-up|1|||
125432099|NCT00263328|451207836|FG002|Overall Study|Lost to Follow-up|0|||
125432100|NCT00263328|451207834|FG000|Overall Study|Withdrawal by Subject|3|||
125432101|NCT00263328|451207835|FG001|Overall Study|Withdrawal by Subject|0|||
125432102|NCT00263328|451207836|FG002|Overall Study|Withdrawal by Subject|1|||
125432103|NCT00263328|451207834|FG000|Overall Study|Other|3|||
125432104|NCT00263328|451207835|FG001|Overall Study|Other|0|||
125432105|NCT00263328|451207836|FG002|Overall Study|Other|1|||
125432106|NCT00263328|451207834|FG000|Overall Study|Adverse Event|1|||
125432107|NCT00263328|451207835|FG001|Overall Study|Adverse Event|1|||
125432108|NCT00263328|451207836|FG002|Overall Study|Adverse Event|4|||
125432109|NCT00622180|451207837|FG000|Overall Study|Lost to Follow-up|1|||
125432110|NCT00622180|451207838|FG001|Overall Study|Lost to Follow-up|2|||
125432111|NCT04512066|451207841|FG000|Double-blind Treatment Period|Adverse Event|6|||
125432112|NCT04512066|451207842|FG001|Double-blind Treatment Period|Adverse Event|4|||
125432113|NCT04512066|451207843|FG002|Double-blind Treatment Period|Adverse Event|5|||
125432114|NCT04512066|451207844|FG003|Double-blind Treatment Period|Adverse Event|1|||
125432115|NCT04512066|451207845|FG004|Double-blind Treatment Period|Adverse Event|0|||
125432116|NCT04512066|451207846|FG005|Double-blind Treatment Period|Adverse Event|0|||
125432117|NCT04512066|451207841|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
125373300|NCT02674529|450997975|FG001|Overall Study|Physician Decision|1|||
125373301|NCT02674529|450997974|FG000|Overall Study|Protocol Violation|0|||
125373302|NCT02674529|450997975|FG001|Overall Study|Protocol Violation|1|||
125373303|NCT02891850|450997976|FG000|Overall Study|Adverse Event|3|||
125373304|NCT02891850|450997977|FG001|Overall Study|Adverse Event|0|||
125373305|NCT02891850|450997976|FG000|Overall Study|Death|0|||
125373306|NCT02891850|450997977|FG001|Overall Study|Death|4|||
125616808|NCT01617655|451879902|FG000|Overall Study|Participants moved|0|||
125432118|NCT04512066|451207842|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
125432119|NCT04512066|451207843|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
125432120|NCT04512066|451207844|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
125432121|NCT04512066|451207845|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
125432122|NCT04512066|451207846|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
125432123|NCT04512066|451207841|FG000|Double-blind Treatment Period|Physician Decision|1|||
125432124|NCT04512066|451207842|FG001|Double-blind Treatment Period|Physician Decision|0|||
125432125|NCT04512066|451207843|FG002|Double-blind Treatment Period|Physician Decision|1|||
125373307|NCT02891850|450997976|FG000|Overall Study|Physician Decision|1|||
125616809|NCT01617655|451879903|FG001|Overall Study|Participants moved|4|||
125616810|NCT01617655|451879902|FG000|Overall Study|Consent withdrawn by participant|1|||
125616811|NCT01617655|451879903|FG001|Overall Study|Consent withdrawn by participant|1|||
125616812|NCT01617655|451879902|FG000|Overall Study|Last visit outside protocol visit window|1|||
125616813|NCT01617655|451879903|FG001|Overall Study|Last visit outside protocol visit window|10|||
125616814|NCT01617655|451879902|FG000|Overall Study|Site closure|3|||
125616815|NCT01617655|451879903|FG001|Overall Study|Site closure|5|||
125616816|NCT01617655|451879902|FG000|Overall Study|Other than specified above|1|||
125616817|NCT01617655|451879903|FG001|Overall Study|Other than specified above|2|||
125616818|NCT02394808|451879912|FG000|Period 1|Unsatisfactory lens fitting|0|||
125616819|NCT02394808|451879913|FG001|Period 1|Unsatisfactory lens fitting|1|||
125214873|NCT02757352|450414866|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214874|NCT02757352|450414867|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
125214875|NCT02757352|450414858|FG000|Follow-Up Period|Adverse Event|0|||
125214876|NCT02757352|450414859|FG001|Follow-Up Period|Adverse Event|0|||
125214877|NCT02757352|450414860|FG002|Follow-Up Period|Adverse Event|0|||
125214878|NCT02757352|450414861|FG003|Follow-Up Period|Adverse Event|0|||
125214879|NCT02757352|450414862|FG004|Follow-Up Period|Adverse Event|0|||
125214880|NCT02757352|450414863|FG005|Follow-Up Period|Adverse Event|0|||
125214881|NCT02757352|450414864|FG006|Follow-Up Period|Adverse Event|1|||
125214882|NCT02757352|450414865|FG007|Follow-Up Period|Adverse Event|0|||
125214883|NCT02757352|450414866|FG008|Follow-Up Period|Adverse Event|2|||
125214884|NCT02757352|450414867|FG009|Follow-Up Period|Adverse Event|0|||
125214885|NCT02757352|450414858|FG000|Follow-Up Period|Lost to Follow-up|0|||
125214886|NCT02757352|450414859|FG001|Follow-Up Period|Lost to Follow-up|0|||
125214887|NCT02757352|450414860|FG002|Follow-Up Period|Lost to Follow-up|0|||
125214888|NCT02757352|450414861|FG003|Follow-Up Period|Lost to Follow-up|0|||
125214889|NCT02757352|450414862|FG004|Follow-Up Period|Lost to Follow-up|0|||
125214890|NCT02757352|450414863|FG005|Follow-Up Period|Lost to Follow-up|0|||
125214891|NCT02757352|450414864|FG006|Follow-Up Period|Lost to Follow-up|0|||
125214892|NCT02757352|450414865|FG007|Follow-Up Period|Lost to Follow-up|0|||
125214893|NCT02757352|450414866|FG008|Follow-Up Period|Lost to Follow-up|1|||
125214894|NCT02757352|450414867|FG009|Follow-Up Period|Lost to Follow-up|0|||
125214895|NCT02757352|450414858|FG000|Follow-Up Period|Lack of Efficacy|0|||
125214896|NCT02757352|450414859|FG001|Follow-Up Period|Lack of Efficacy|0|||
125214897|NCT02757352|450414860|FG002|Follow-Up Period|Lack of Efficacy|0|||
125214898|NCT02757352|450414861|FG003|Follow-Up Period|Lack of Efficacy|0|||
125214899|NCT02757352|450414862|FG004|Follow-Up Period|Lack of Efficacy|0|||
125214900|NCT02757352|450414863|FG005|Follow-Up Period|Lack of Efficacy|0|||
125214901|NCT02757352|450414864|FG006|Follow-Up Period|Lack of Efficacy|0|||
125214902|NCT02757352|450414865|FG007|Follow-Up Period|Lack of Efficacy|0|||
125214903|NCT02757352|450414866|FG008|Follow-Up Period|Lack of Efficacy|1|||
125214904|NCT02757352|450414867|FG009|Follow-Up Period|Lack of Efficacy|1|||
125214905|NCT02757352|450414858|FG000|Follow-Up Period|Withdrawal by Subject|0|||
125214906|NCT02757352|450414859|FG001|Follow-Up Period|Withdrawal by Subject|0|||
125214907|NCT02757352|450414860|FG002|Follow-Up Period|Withdrawal by Subject|0|||
125214908|NCT02757352|450414861|FG003|Follow-Up Period|Withdrawal by Subject|0|||
125214909|NCT02757352|450414862|FG004|Follow-Up Period|Withdrawal by Subject|0|||
125214910|NCT02757352|450414863|FG005|Follow-Up Period|Withdrawal by Subject|0|||
125373308|NCT02891850|450997977|FG001|Overall Study|Physician Decision|0|||
125373309|NCT02891850|450997976|FG000|Overall Study|Pregnancy|1|||
125373310|NCT02891850|450997977|FG001|Overall Study|Pregnancy|0|||
125373311|NCT02891850|450997976|FG000|Overall Study|Withdrawal by Subject|2|||
125373312|NCT02891850|450997977|FG001|Overall Study|Withdrawal by Subject|3|||
125373313|NCT00331682|450997980|FG000|Overall Study|Adverse Event|1|||
125373314|NCT00573469|450997981|FG000|Overall Study|Adverse Event|1|||
125373315|NCT00573469|450997982|FG001|Overall Study|Adverse Event|1|||
125373316|NCT00573469|450997983|FG002|Overall Study|Adverse Event|1|||
125373317|NCT00573469|450997981|FG000|Overall Study|Withdrawal by Subject|0|||
125373318|NCT00573469|450997982|FG001|Overall Study|Withdrawal by Subject|2|||
125373319|NCT00573469|450997983|FG002|Overall Study|Withdrawal by Subject|0|||
125373320|NCT00573469|450997981|FG000|Overall Study|Other|5|||
125373321|NCT00573469|450997982|FG001|Overall Study|Other|1|||
125373322|NCT00573469|450997983|FG002|Overall Study|Other|3|||
125373323|NCT00004978|450997984|FG000|Overall Study|Death|107|||
125373324|NCT00004978|450997985|FG001|Overall Study|Death|116|||
125373325|NCT00004978|450997984|FG000|Overall Study|Lost to Follow-up|101|||
125373326|NCT00004978|450997985|FG001|Overall Study|Lost to Follow-up|108|||
125373327|NCT00004978|450997984|FG000|Overall Study|Withdrawal by Subject|17|||
125373328|NCT00004978|450997985|FG001|Overall Study|Withdrawal by Subject|26|||
125373329|NCT00004978|450997984|FG000|Overall Study|site closure - not in analysis cohort|19|||
125373330|NCT00004978|450997985|FG001|Overall Study|site closure - not in analysis cohort|20|||
125373331|NCT03761277|450997986|FG000|Enrollment to Implant|Screen Failure|17|||
125373332|NCT03761277|450997986|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
125373333|NCT03761277|450997986|FG000|Enrollment to Implant|Physician Decision|2|||
125373334|NCT03761277|450997986|FG000|Enrollment to Implant|Site Closure|3|||
125373335|NCT03761277|450997986|FG000|Enrollment to Implant|Sponsor Request|2|||
125214911|NCT02757352|450414864|FG006|Follow-Up Period|Withdrawal by Subject|0|||
125214912|NCT02757352|450414865|FG007|Follow-Up Period|Withdrawal by Subject|1|||
125214913|NCT02757352|450414866|FG008|Follow-Up Period|Withdrawal by Subject|6|||
125214914|NCT02757352|450414867|FG009|Follow-Up Period|Withdrawal by Subject|2|||
125616820|NCT02394808|451879912|FG000|Period 2|Lost to Follow-up|1|||
125616821|NCT02394808|451879913|FG001|Period 2|Lost to Follow-up|0|||
125616822|NCT03341923|451879914|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
125616823|NCT03341923|451879915|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
125616824|NCT04580394|451879916|FG000|First Intervention|Incorrectly Randomized|1|||
125616825|NCT04580394|451879916|FG000|First Intervention|Physician Decision|1|||
125616826|NCT04580394|451879916|FG000|First Intervention|Lost to Follow-up|1|||
125616827|NCT04580394|451879916|FG000|Washout (One Week)|Withdrawal by Subject|1|||
125616828|NCT04580394|451879916|FG000|Washout (One Week)|Adverse Event|1|||
125616829|NCT04580394|451879916|FG000|Washout (One Week)|Withdrawal by Subject|2|||
125616830|NCT04580394|451879916|FG000|Third Intervention|Adverse Event|1|||
125616831|NCT04580394|451879916|FG000|Third Intervention|Withdrawal by Subject|1|||
125616832|NCT04580394|451879916|FG000|Washout (One Week)|Withdrawal by Subject|2|||
125616833|NCT03337152|451879919|FG000|Overall Study|Physician Decision|1|||
125616834|NCT03337152|451879920|FG001|Overall Study|Physician Decision|0|||
125616835|NCT03337152|451879919|FG000|Overall Study|Lost to Follow-up|1|||
125616836|NCT03337152|451879920|FG001|Overall Study|Lost to Follow-up|3|||
125616837|NCT03337152|451879919|FG000|Overall Study|Adverse Event|3|||
125616838|NCT03337152|451879920|FG001|Overall Study|Adverse Event|1|||
125616839|NCT03337152|451879919|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
125616840|NCT03337152|451879920|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
125616841|NCT02662985|451879921|FG000|Treatment Period 1|Adverse Event|0|||
125616842|NCT02662985|451879922|FG001|Treatment Period 1|Adverse Event|2|||
125616843|NCT02662985|451879921|FG000|Treatment Period 1|Protocol Violation|0|||
125616844|NCT02662985|451879922|FG001|Treatment Period 1|Protocol Violation|1|||
125616845|NCT02662985|451879921|FG000|Treatment Period 1|Physician Decision|1|||
125616846|NCT02662985|451879922|FG001|Treatment Period 1|Physician Decision|0|||
125616847|NCT02662985|451879921|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125616848|NCT02662985|451879922|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125616849|NCT02662985|451879921|FG000|Treatment Period 2|Lack of Efficacy|0|||
125616850|NCT02662985|451879922|FG001|Treatment Period 2|Lack of Efficacy|1|||
125616851|NCT02662985|451879921|FG000|Treatment Period 2|Lost to Follow-up|1|||
125616852|NCT02662985|451879922|FG001|Treatment Period 2|Lost to Follow-up|0|||
125616853|NCT02662985|451879921|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
125616854|NCT02662985|451879922|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
125616855|NCT02662985|451879921|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
125616856|NCT02662985|451879922|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
125616857|NCT02662985|451879921|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
125616858|NCT02662985|451879922|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
125616859|NCT02662985|451879921|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
125616860|NCT02662985|451879922|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
125616861|NCT02662985|451879921|FG000|Treatment Period 3 (Extension Period)|Death|0|||
125616862|NCT02662985|451879922|FG001|Treatment Period 3 (Extension Period)|Death|1|||
125616863|NCT02493426|451879923|FG000|Overall Study|Withdrawal by Subject|0|||
125616864|NCT02493426|451879924|FG001|Overall Study|Withdrawal by Subject|1|||
125616865|NCT01025817|451879927|FG000|Completed Study Medication|Adverse Event|66|||
125616866|NCT01025817|451879928|FG001|Completed Study Medication|Adverse Event|39|||
125616867|NCT01025817|451879927|FG000|Completed Study Medication|Protocol Deviation|9|||
125616868|NCT01025817|451879928|FG001|Completed Study Medication|Protocol Deviation|8|||
125616869|NCT01025817|451879927|FG000|Completed Study Medication|Withdrawal by Subject|8|||
125616870|NCT01025817|451879928|FG001|Completed Study Medication|Withdrawal by Subject|9|||
125616871|NCT01025817|451879927|FG000|Completed Study Medication|Administrative problems|7|||
125616872|NCT01025817|451879928|FG001|Completed Study Medication|Administrative problems|5|||
125616873|NCT01025817|451879927|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
125616874|NCT01025817|451879928|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
125214915|NCT03638466|450414868|FG000|Overall Study|Early Termination|0|||
125214916|NCT03638466|450414869|FG001|Overall Study|Early Termination|1|||
125214917|NCT03251482|450414870|FG000|Overall Study|Withdrawal by Subject|0|||
125616875|NCT01025817|451879927|FG000|Completed Study Medication|Abnormal test procedure|4|||
125616876|NCT01025817|451879928|FG001|Completed Study Medication|Abnormal test procedure|0|||
125616877|NCT01025817|451879927|FG000|Completed Study Medication|Graft loss|2|||
125616878|NCT01025817|451879928|FG001|Completed Study Medication|Graft loss|5|||
125616879|NCT01025817|451879927|FG000|Completed Study Medication|Death|2|||
125616880|NCT01025817|451879928|FG001|Completed Study Medication|Death|2|||
125616881|NCT01025817|451879927|FG000|Completed Study Medication|Abnormal lab values|0|||
125214918|NCT03251482|450414871|FG001|Overall Study|Withdrawal by Subject|1|||
125214919|NCT03251482|450414872|FG002|Overall Study|Withdrawal by Subject|0|||
125616882|NCT01025817|451879928|FG001|Completed Study Medication|Abnormal lab values|2|||
125616883|NCT01025817|451879927|FG000|Completed Study Medication|Subject no longer required study drug|0|||
125616884|NCT01025817|451879928|FG001|Completed Study Medication|Subject no longer required study drug|1|||
125616885|NCT01025817|451879927|FG000|Completed Study Medication|Lost to Follow-up|0|||
125616886|NCT01025817|451879928|FG001|Completed Study Medication|Lost to Follow-up|1|||
125616887|NCT01025817|451879927|FG000|Completed Study|Withdrawal by Subject|8|||
125616888|NCT01025817|451879928|FG001|Completed Study|Withdrawal by Subject|16|||
125616889|NCT01025817|451879927|FG000|Completed Study|Death|6|||
125616890|NCT01025817|451879928|FG001|Completed Study|Death|5|||
125616891|NCT01025817|451879927|FG000|Completed Study|Missing|2|||
125616892|NCT01025817|451879928|FG001|Completed Study|Missing|0|||
125616893|NCT01025817|451879927|FG000|Completed Study|Lost to Follow-up|0|||
125616894|NCT01025817|451879928|FG001|Completed Study|Lost to Follow-up|1|||
125616895|NCT01599754|451879930|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
125616896|NCT01599754|451879931|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
125616897|NCT01599754|451879930|FG000|Overall Study|Participant noncompliance|4|||
125616898|NCT01599754|451879931|FG001|Overall Study|Participant noncompliance|4|||
125616899|NCT01599754|451879930|FG000|Overall Study|Lost to Follow-up|13|||
125616900|NCT01599754|451879931|FG001|Overall Study|Lost to Follow-up|6|||
125616901|NCT01599754|451879930|FG000|Overall Study|Death|31|||
125616902|NCT01599754|451879931|FG001|Overall Study|Death|33|||
125616903|NCT01599754|451879930|FG000|Overall Study|Adverse Event|3|||
125616904|NCT01599754|451879931|FG001|Overall Study|Adverse Event|2|||
125616905|NCT01599754|451879930|FG000|Overall Study|Investigator decision|1|||
125616906|NCT01599754|451879931|FG001|Overall Study|Investigator decision|3|||
125616907|NCT01599754|451879930|FG000|Overall Study|Withdrawal by Subject|24|||
125616908|NCT01599754|451879931|FG001|Overall Study|Withdrawal by Subject|25|||
125373336|NCT03761277|450997986|FG000|Post-Implant to 6 Months|Adverse Event|2|||
125616909|NCT01599754|451879930|FG000|Overall Study|Study terminated by sponsor|282|||
125616910|NCT01599754|451879931|FG001|Overall Study|Study terminated by sponsor|285|||
125616911|NCT02618928|451879932|FG000|Overall Study|Failure to Return|28|||
125616912|NCT02618928|451879932|FG000|Overall Study|Insufficient Virological Response|1|||
125616913|NCT02618928|451879932|FG000|Overall Study|Withdrawal by Subject|2|||
125616914|NCT02618928|451879932|FG000|Overall Study|Death|3|||
125616915|NCT02618928|451879932|FG000|Overall Study|Other|11|||
125616916|NCT02618928|451879932|FG000|Overall Study|Missing|6|||
125616917|NCT02618928|451879932|FG000|Overall Study|Treatment Never Started|7|||
125616918|NCT03670641|451879933|FG000|Overall Study|Lost to Follow-up|3|||
125616919|NCT00118482|451879934|FG000|Overall Study|Lost to Follow-up|7|||
125616920|NCT00118482|451879935|FG001|Overall Study|Lost to Follow-up|7|||
125616921|NCT00118482|451879934|FG000|Overall Study|Withdrawal by Subject|23|||
125616922|NCT00118482|451879935|FG001|Overall Study|Withdrawal by Subject|22|||
125616923|NCT02128763|451879936|FG000|Overall Study|Death|1|||
125616924|NCT02128763|451879937|FG001|Overall Study|Death|0|||
125616925|NCT02128763|451879936|FG000|Overall Study|Lost to Follow-up|19|||
125616926|NCT02128763|451879937|FG001|Overall Study|Lost to Follow-up|16|||
125616927|NCT02921919|451879938|FG000|Overall Study|Other|5|||
125616928|NCT02921919|451879939|FG001|Overall Study|Other|6|||
125616929|NCT02921919|451879938|FG000|Overall Study|Lost to Follow-up|0|||
125616930|NCT02921919|451879939|FG001|Overall Study|Lost to Follow-up|1|||
125616931|NCT02921919|451879938|FG000|Overall Study|Withdrawal by Subject|5|||
125616932|NCT02921919|451879939|FG001|Overall Study|Withdrawal by Subject|1|||
125616933|NCT02921919|451879938|FG000|Overall Study|Disease Progression|47|||
125616934|NCT02921919|451879939|FG001|Overall Study|Disease Progression|38|||
125616935|NCT02921919|451879938|FG000|Overall Study|Physician Decision|3|||
125616936|NCT02921919|451879939|FG001|Overall Study|Physician Decision|2|||
125616937|NCT02921919|451879938|FG000|Overall Study|Adverse Event|6|||
125616938|NCT02921919|451879939|FG001|Overall Study|Adverse Event|4|||
125616939|NCT03666858|451879940|FG000|Cohort 1|Adverse Event|1|||
125616940|NCT03666858|451879941|FG001|Cohort 1|Adverse Event|0|||
125616941|NCT03666858|451879940|FG000|Cohort 2|Adverse Event|0|||
125616942|NCT03666858|451879941|FG001|Cohort 2|Adverse Event|1|||
125616943|NCT00547378|451879942|FG000|Randomized Cohort|Withdrawal by Subject|7|||
125616944|NCT00547378|451879943|FG001|Randomized Cohort|Withdrawal by Subject|5|||
125616945|NCT00547378|451879944|FG002|Randomized Cohort|Withdrawal by Subject|0|||
125616946|NCT00547378|451879942|FG000|Randomized Cohort|Death|0|||
125616947|NCT00547378|451879943|FG001|Randomized Cohort|Death|1|||
125616948|NCT00547378|451879944|FG002|Randomized Cohort|Death|0|||
125616949|NCT00547378|451879942|FG000|Randomized Cohort|Lost to Follow-up|1|||
125616950|NCT00547378|451879943|FG001|Randomized Cohort|Lost to Follow-up|0|||
125616951|NCT00547378|451879944|FG002|Randomized Cohort|Lost to Follow-up|0|||
125616952|NCT00547378|451879942|FG000|Randomized Cohort|Adverse Event|1|||
125616953|NCT00547378|451879943|FG001|Randomized Cohort|Adverse Event|0|||
125616954|NCT00547378|451879944|FG002|Randomized Cohort|Adverse Event|0|||
125616955|NCT00547378|451879942|FG000|Randomized Cohort|Other reasons|2|||
125616956|NCT00547378|451879943|FG001|Randomized Cohort|Other reasons|0|||
125616957|NCT00547378|451879944|FG002|Randomized Cohort|Other reasons|0|||
125616958|NCT00547378|451879942|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
125616959|NCT00547378|451879943|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
125373337|NCT03761277|450997986|FG000|Post-Implant to 6 Months|Death|1|||
125373338|NCT03761277|450997986|FG000|Post-Implant to 6 Months|Site Closure|2|||
125373339|NCT03761277|450997986|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
125373340|NCT03761277|450997986|FG000|6 Months to 12 Months|Physician Decision|2|||
125373341|NCT03761277|450997986|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
125616960|NCT00547378|451879944|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
125616961|NCT00547378|451879942|FG000|All Implanted Cohort|Adverse Event|4|||
125616962|NCT00547378|451879943|FG001|All Implanted Cohort|Adverse Event|10|||
125616963|NCT00547378|451879944|FG002|All Implanted Cohort|Adverse Event|17|||
125373342|NCT01508650|450997987|FG000|Overall Study|Lost to Follow-up|0|||
125616964|NCT00547378|451879942|FG000|All Implanted Cohort|Lost to Follow-up|0|||
125616965|NCT00547378|451879943|FG001|All Implanted Cohort|Lost to Follow-up|1|||
125616966|NCT00547378|451879944|FG002|All Implanted Cohort|Lost to Follow-up|14|||
125373343|NCT01508650|450997988|FG001|Overall Study|Lost to Follow-up|3|||
125373344|NCT02064894|450997989|FG000|Overall Study|Withdrawal by Subject|43|||
125373345|NCT02064894|450997990|FG001|Overall Study|Withdrawal by Subject|102|||
125373346|NCT02064894|450997991|FG002|Overall Study|Withdrawal by Subject|115|||
125373347|NCT00378378|450997992|FG000|Overall Study|Withdrawal by Subject|0|||
125373348|NCT00378378|450997993|FG001|Overall Study|Withdrawal by Subject|1|||
125373349|NCT00378378|450997994|FG002|Overall Study|Withdrawal by Subject|0|||
125616967|NCT00547378|451879942|FG000|All Implanted Cohort|Death|3|||
125616968|NCT00547378|451879943|FG001|All Implanted Cohort|Death|1|||
125616969|NCT00547378|451879944|FG002|All Implanted Cohort|Death|4|||
125616970|NCT00547378|451879942|FG000|All Implanted Cohort|Physician Decision|0|||
125616971|NCT00547378|451879943|FG001|All Implanted Cohort|Physician Decision|2|||
125616972|NCT00547378|451879944|FG002|All Implanted Cohort|Physician Decision|6|||
125616973|NCT00547378|451879942|FG000|All Implanted Cohort|Site closure|2|||
125616974|NCT00547378|451879943|FG001|All Implanted Cohort|Site closure|0|||
125616975|NCT00547378|451879944|FG002|All Implanted Cohort|Site closure|1|||
125616976|NCT00547378|451879942|FG000|All Implanted Cohort|Other reasons|1|||
125616977|NCT00547378|451879943|FG001|All Implanted Cohort|Other reasons|0|||
125616978|NCT00547378|451879944|FG002|All Implanted Cohort|Other reasons|1|||
125616979|NCT02112994|451879945|FG000|Overall Study|Progressive Disease|0|||
125616980|NCT02112994|451879946|FG001|Overall Study|Progressive Disease|0|||
125616981|NCT02112994|451879947|FG002|Overall Study|Progressive Disease|1|||
125616982|NCT02112994|451879945|FG000|Overall Study|Pregnancy|0|||
125616983|NCT02112994|451879946|FG001|Overall Study|Pregnancy|1|||
125616984|NCT02112994|451879947|FG002|Overall Study|Pregnancy|1|||
125616985|NCT02112994|451879945|FG000|Overall Study|Liver Transplant|0|||
125616986|NCT02112994|451879946|FG001|Overall Study|Liver Transplant|1|||
125616987|NCT02112994|451879947|FG002|Overall Study|Liver Transplant|0|||
125616988|NCT02112994|451879945|FG000|Overall Study|Withdrawal by Subject|0|||
125616989|NCT02112994|451879946|FG001|Overall Study|Withdrawal by Subject|0|||
125616990|NCT02112994|451879947|FG002|Overall Study|Withdrawal by Subject|1|||
125616991|NCT04105244|451879948|FG000|Overall Study|Withdrawal by Subject|10|||
125616992|NCT04105244|451879949|FG001|Overall Study|Withdrawal by Subject|12|||
125616993|NCT04105244|451879948|FG000|Overall Study|Lost to Follow-up|20|||
125616994|NCT04105244|451879949|FG001|Overall Study|Lost to Follow-up|15|||
125616995|NCT04105244|451879948|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
125616996|NCT04105244|451879949|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
125616997|NCT04105244|451879948|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
125616998|NCT04105244|451879949|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
125616999|NCT02768194|451879951|FG000|Period 1|Adverse Event|0|||
125617000|NCT02768194|451879952|FG001|Period 1|Adverse Event|0|||
125617001|NCT02768194|451879953|FG002|Period 1|Adverse Event|0|||
125617002|NCT02768194|451879954|FG003|Period 1|Adverse Event|1|||
125617003|NCT02768194|451879955|FG004|Period 1|Adverse Event|0|||
125617004|NCT02768194|451879956|FG005|Period 1|Adverse Event|0|||
125373350|NCT00378378|450997992|FG000|Overall Study|Treatment Failure|0|||
125373351|NCT00378378|450997993|FG001|Overall Study|Treatment Failure|0|||
125373352|NCT00378378|450997994|FG002|Overall Study|Treatment Failure|1|||
125373353|NCT00378378|450997992|FG000|Overall Study|Non-compliance with protocol|0|||
125373354|NCT00378378|450997993|FG001|Overall Study|Non-compliance with protocol|0|||
125373355|NCT00378378|450997994|FG002|Overall Study|Non-compliance with protocol|1|||
125373356|NCT00407797|450997995|FG000|Overall Study|Lost to Follow-up|2|||
125373357|NCT00407797|450997995|FG000|Overall Study|Adverse Event|6|||
125373358|NCT00407797|450997995|FG000|Overall Study|Other|7|||
125373359|NCT00407797|450997995|FG000|Overall Study|Withdrawal by Subject|3|||
125373360|NCT00553644|450997996|FG000|Overall Study|Adverse Event|17|||
125373361|NCT00553644|450997996|FG000|Overall Study|Withdrawal by Subject|4|||
125373362|NCT00553644|450997996|FG000|Overall Study|Physician Decision|1|||
125373363|NCT00553644|450997996|FG000|Overall Study|Alternative therapy|6|||
125373364|NCT01051323|450997997|FG000|Overall Study|Discontinuation of treatment|103|||
125373365|NCT01051323|450997997|FG000|Overall Study|Transplantation|28|||
125373366|NCT01051323|450997997|FG000|Overall Study|Dialysis dependency|22|||
125373367|NCT01051323|450997997|FG000|Overall Study|Withdrawal by Subject|13|||
125373368|NCT01051323|450997997|FG000|Overall Study|Lost to Follow-up|31|||
125373369|NCT01051323|450997997|FG000|Overall Study|Death|129|||
125373370|NCT01051323|450997997|FG000|Overall Study|Hospitalization|28|||
125373371|NCT01051323|450997997|FG000|Overall Study|Other|148|||
125373372|NCT01051323|450997997|FG000|Overall Study|Missing|37|||
125373373|NCT01233258|450998000|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
125373374|NCT01233258|450998001|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
125373375|NCT01233258|450998002|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
125373376|NCT01233258|450998003|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
125373377|NCT01233258|450998004|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
125373378|NCT01233258|450998005|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
125373379|NCT01233258|450998000|FG000|First Intervention (6 Months)|Protocol Violation|0|||
125373380|NCT01233258|450998001|FG001|First Intervention (6 Months)|Protocol Violation|0|||
125432126|NCT04512066|451207844|FG003|Double-blind Treatment Period|Physician Decision|0|||
125432127|NCT04512066|451207845|FG004|Double-blind Treatment Period|Physician Decision|0|||
125432128|NCT04512066|451207846|FG005|Double-blind Treatment Period|Physician Decision|0|||
125432129|NCT04512066|451207841|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
125432130|NCT04512066|451207842|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
125432131|NCT04512066|451207843|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
125432132|NCT04512066|451207844|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
125432133|NCT04512066|451207845|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
125432134|NCT04512066|451207846|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
125432135|NCT04512066|451207841|FG000|Extension Period|Adverse Event|0|||
125432136|NCT04512066|451207842|FG001|Extension Period|Adverse Event|1|||
125432137|NCT04512066|451207843|FG002|Extension Period|Adverse Event|4|||
125432138|NCT04512066|451207844|FG003|Extension Period|Adverse Event|3|||
125432139|NCT04512066|451207845|FG004|Extension Period|Adverse Event|1|||
125432140|NCT04512066|451207846|FG005|Extension Period|Adverse Event|3|||
125432141|NCT04512066|451207841|FG000|Extension Period|Death|0|||
125432142|NCT04512066|451207842|FG001|Extension Period|Death|0|||
125432143|NCT04512066|451207843|FG002|Extension Period|Death|0|||
125432144|NCT04512066|451207844|FG003|Extension Period|Death|0|||
125432145|NCT04512066|451207845|FG004|Extension Period|Death|0|||
125432146|NCT04512066|451207846|FG005|Extension Period|Death|1|||
125432147|NCT04512066|451207841|FG000|Extension Period|Lack of Efficacy|0|||
125432148|NCT04512066|451207842|FG001|Extension Period|Lack of Efficacy|4|||
125432149|NCT04512066|451207843|FG002|Extension Period|Lack of Efficacy|4|||
125432150|NCT04512066|451207844|FG003|Extension Period|Lack of Efficacy|1|||
125432151|NCT04512066|451207845|FG004|Extension Period|Lack of Efficacy|3|||
125432152|NCT04512066|451207846|FG005|Extension Period|Lack of Efficacy|3|||
125432153|NCT04512066|451207841|FG000|Extension Period|Lost to Follow-up|0|||
125432154|NCT04512066|451207842|FG001|Extension Period|Lost to Follow-up|1|||
125432155|NCT04512066|451207843|FG002|Extension Period|Lost to Follow-up|5|||
125432156|NCT04512066|451207844|FG003|Extension Period|Lost to Follow-up|2|||
125432157|NCT04512066|451207845|FG004|Extension Period|Lost to Follow-up|3|||
125432158|NCT04512066|451207846|FG005|Extension Period|Lost to Follow-up|2|||
125432159|NCT04512066|451207841|FG000|Extension Period|Non-compliance with study drug|0|||
125432160|NCT04512066|451207842|FG001|Extension Period|Non-compliance with study drug|1|||
125432161|NCT04512066|451207843|FG002|Extension Period|Non-compliance with study drug|0|||
125432162|NCT04512066|451207844|FG003|Extension Period|Non-compliance with study drug|0|||
125432163|NCT04512066|451207845|FG004|Extension Period|Non-compliance with study drug|0|||
125432164|NCT04512066|451207846|FG005|Extension Period|Non-compliance with study drug|1|||
125432165|NCT04512066|451207841|FG000|Extension Period|Other|0|||
125432166|NCT04512066|451207842|FG001|Extension Period|Other|2|||
125432167|NCT04512066|451207843|FG002|Extension Period|Other|0|||
125432168|NCT04512066|451207844|FG003|Extension Period|Other|0|||
125432169|NCT04512066|451207845|FG004|Extension Period|Other|0|||
125432170|NCT04512066|451207846|FG005|Extension Period|Other|0|||
125432171|NCT04512066|451207841|FG000|Extension Period|Physician Decision|0|||
125432172|NCT04512066|451207842|FG001|Extension Period|Physician Decision|2|||
125432173|NCT04512066|451207843|FG002|Extension Period|Physician Decision|0|||
125432174|NCT04512066|451207844|FG003|Extension Period|Physician Decision|1|||
125432175|NCT04512066|451207845|FG004|Extension Period|Physician Decision|1|||
125432176|NCT04512066|451207846|FG005|Extension Period|Physician Decision|0|||
125432177|NCT04512066|451207841|FG000|Extension Period|Withdrawal by Subject|0|||
125432178|NCT04512066|451207842|FG001|Extension Period|Withdrawal by Subject|3|||
125432179|NCT04512066|451207843|FG002|Extension Period|Withdrawal by Subject|7|||
125432180|NCT04512066|451207844|FG003|Extension Period|Withdrawal by Subject|11|||
125432181|NCT04512066|451207845|FG004|Extension Period|Withdrawal by Subject|8|||
125432182|NCT04512066|451207846|FG005|Extension Period|Withdrawal by Subject|4|||
125432183|NCT01862991|451210194|FG000|Overall Study|Lost to Follow-up|2|||
125432184|NCT01862991|451210195|FG001|Overall Study|Lost to Follow-up|1|||
125432185|NCT01862991|451210196|FG002|Overall Study|Lost to Follow-up|1|||
125432186|NCT01862991|451210194|FG000|Overall Study|Protocol Violation|1|||
125617005|NCT02768194|451879951|FG000|Period 2|Other (Reason not specified)|1|||
125617006|NCT02768194|451879952|FG001|Period 2|Other (Reason not specified)|0|||
125432187|NCT01862991|451210195|FG001|Overall Study|Protocol Violation|0|||
125432188|NCT01862991|451210196|FG002|Overall Study|Protocol Violation|0|||
125432189|NCT02228395|451210199|FG000|First Intervention Period|No longer willing to participate|1|||
125432190|NCT02228395|451210200|FG001|First Intervention Period|No longer willing to participate|0|||
125617007|NCT02768194|451879953|FG002|Period 2|Other (Reason not specified)|0|||
125432191|NCT02228395|451210201|FG002|First Intervention Period|No longer willing to participate|0|||
125432192|NCT02228395|451210199|FG000|First Intervention Period|Unable to comply with study dates|0|||
125214920|NCT03251482|450414873|FG003|Overall Study|Withdrawal by Subject|0|||
125432193|NCT02228395|451210200|FG001|First Intervention Period|Unable to comply with study dates|1|||
125432194|NCT02228395|451210201|FG002|First Intervention Period|Unable to comply with study dates|1|||
125432195|NCT00509236|451210202|FG000|Overall Study|Adverse Event|7|||
125432196|NCT00509236|451210203|FG001|Overall Study|Adverse Event|9|||
125617008|NCT02768194|451879954|FG003|Period 2|Other (Reason not specified)|0|||
125617009|NCT02768194|451879955|FG004|Period 2|Other (Reason not specified)|0|||
125617010|NCT02768194|451879956|FG005|Period 2|Other (Reason not specified)|0|||
125617011|NCT02768194|451879951|FG000|Period 3|Other (Reason not specified)|0|||
125617012|NCT02768194|451879952|FG001|Period 3|Other (Reason not specified)|1|||
125617013|NCT02768194|451879953|FG002|Period 3|Other (Reason not specified)|0|||
125617014|NCT02768194|451879954|FG003|Period 3|Other (Reason not specified)|0|||
125432197|NCT00509236|451210202|FG000|Overall Study|Withdrawal by Subject|5|||
125432198|NCT00509236|451210203|FG001|Overall Study|Withdrawal by Subject|10|||
125432199|NCT00509236|451210202|FG000|Overall Study|Protocol Violation|3|||
125432200|NCT00509236|451210203|FG001|Overall Study|Protocol Violation|0|||
125432201|NCT00509236|451210202|FG000|Overall Study|Excluded Medication|1|||
125432202|NCT00509236|451210203|FG001|Overall Study|Excluded Medication|1|||
125432203|NCT00509236|451210202|FG000|Overall Study|Scheduled Kidney Transplant|1|||
125432204|NCT00509236|451210203|FG001|Overall Study|Scheduled Kidney Transplant|0|||
125432205|NCT00792103|451210204|FG000|Overall Study|Enrolled, not treated|15|||
125432206|NCT00792103|451210204|FG000|Overall Study|Lost to Follow-up|17|||
125432207|NCT00792103|451210204|FG000|Overall Study|Adverse Event|25|||
125432208|NCT00792103|451210204|FG000|Overall Study|Withdrawal by Subject|52|||
125432209|NCT00792103|451210204|FG000|Overall Study|Protocol Violation|10|||
125432210|NCT00792103|451210204|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
125432211|NCT01572389|451210206|FG000|Overall Study|Death|1|||
125432212|NCT01572389|451210207|FG001|Overall Study|Death|3|||
125432213|NCT01572389|451210206|FG000|Overall Study|Withdrawal by Subject|14|||
125432214|NCT01572389|451210207|FG001|Overall Study|Withdrawal by Subject|2|||
125432215|NCT01572389|451210206|FG000|Overall Study|Lost to Follow-up|25|||
125432216|NCT01572389|451210207|FG001|Overall Study|Lost to Follow-up|14|||
125432217|NCT01572389|451210206|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
125432218|NCT01572389|451210207|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
125432219|NCT01287520|451210208|FG000|Overall Study|Adverse Event|2|||
125432220|NCT01287520|451210209|FG001|Overall Study|Adverse Event|2|||
125432221|NCT01287520|451210210|FG002|Overall Study|Adverse Event|2|||
125432222|NCT01287520|451210211|FG003|Overall Study|Adverse Event|1|||
125432223|NCT01287520|451210212|FG004|Overall Study|Adverse Event|1|||
125432224|NCT01287520|451210213|FG005|Overall Study|Adverse Event|2|||
125432225|NCT01287520|451210214|FG006|Overall Study|Adverse Event|0|||
125432226|NCT01287520|451210215|FG007|Overall Study|Adverse Event|2|||
125432227|NCT01287520|451210216|FG008|Overall Study|Adverse Event|0|||
125432228|NCT01287520|451210208|FG000|Overall Study|Physician Decision|1|||
125432229|NCT01287520|451210209|FG001|Overall Study|Physician Decision|1|||
125432230|NCT01287520|451210210|FG002|Overall Study|Physician Decision|2|||
125432231|NCT01287520|451210211|FG003|Overall Study|Physician Decision|0|||
125432232|NCT01287520|451210212|FG004|Overall Study|Physician Decision|1|||
125432233|NCT01287520|451210213|FG005|Overall Study|Physician Decision|1|||
125432234|NCT01287520|451210214|FG006|Overall Study|Physician Decision|0|||
125432235|NCT01287520|451210215|FG007|Overall Study|Physician Decision|1|||
125432236|NCT01287520|451210216|FG008|Overall Study|Physician Decision|0|||
125432237|NCT01287520|451210208|FG000|Overall Study|Progressive disease|0|||
125432238|NCT01287520|451210209|FG001|Overall Study|Progressive disease|4|||
125432239|NCT01287520|451210210|FG002|Overall Study|Progressive disease|1|||
125432240|NCT01287520|451210211|FG003|Overall Study|Progressive disease|6|||
125432241|NCT01287520|451210212|FG004|Overall Study|Progressive disease|1|||
125432242|NCT01287520|451210213|FG005|Overall Study|Progressive disease|0|||
125432243|NCT01287520|451210214|FG006|Overall Study|Progressive disease|2|||
125432244|NCT01287520|451210215|FG007|Overall Study|Progressive disease|2|||
125432245|NCT01287520|451210216|FG008|Overall Study|Progressive disease|4|||
125432246|NCT01287520|451210208|FG000|Overall Study|Withdrawal by Subject|0|||
125432247|NCT01287520|451210209|FG001|Overall Study|Withdrawal by Subject|0|||
125432248|NCT01287520|451210210|FG002|Overall Study|Withdrawal by Subject|0|||
125617015|NCT02768194|451879955|FG004|Period 3|Other (Reason not specified)|0|||
125432249|NCT01287520|451210211|FG003|Overall Study|Withdrawal by Subject|0|||
125432250|NCT01287520|451210212|FG004|Overall Study|Withdrawal by Subject|0|||
125432251|NCT01287520|451210213|FG005|Overall Study|Withdrawal by Subject|1|||
125432252|NCT01287520|451210214|FG006|Overall Study|Withdrawal by Subject|0|||
125432253|NCT01287520|451210215|FG007|Overall Study|Withdrawal by Subject|0|||
125432254|NCT01287520|451210216|FG008|Overall Study|Withdrawal by Subject|1|||
125432255|NCT03587142|451210217|FG000|Overall Study|Lost to Follow-up|5|||
125432256|NCT03587142|451210218|FG001|Overall Study|Lost to Follow-up|3|||
125432257|NCT03587142|451210217|FG000|Overall Study|Did not complete the f4 visit|3|||
125432258|NCT03587142|451210218|FG001|Overall Study|Did not complete the f4 visit|7|||
125432259|NCT02768662|451210219|FG000|Overall Study|Adverse Event|1|||
125432260|NCT02768662|451210219|FG000|Overall Study|Lost to Follow-up|4|||
125432261|NCT02768662|451210219|FG000|Overall Study|Withdrawal by Subject|3|||
125432262|NCT02768662|451210219|FG000|Overall Study|Study terminated by Sponsor|78|||
125432263|NCT03673462|451210220|FG000|Overall Study|Adverse Event|11|||
125432264|NCT03673462|451210221|FG001|Overall Study|Adverse Event|1|||
125432265|NCT03673462|451210220|FG000|Overall Study|Protocol Violation|25|||
125432266|NCT03673462|451210221|FG001|Overall Study|Protocol Violation|11|||
125432267|NCT03673462|451210220|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
125432268|NCT03673462|451210221|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
125432269|NCT03673462|451210220|FG000|Overall Study|Lost to Follow-up|102|||
125432270|NCT03673462|451210221|FG001|Overall Study|Lost to Follow-up|19|||
125432271|NCT00708435|451210222|FG000|Overall Study|Death / Serious Adverse Event|10|||
125432272|NCT00708435|451210223|FG001|Overall Study|Death / Serious Adverse Event|5|||
125432273|NCT00708435|451210222|FG000|Overall Study|Lost to Follow-up|9|||
125432274|NCT00708435|451210223|FG001|Overall Study|Lost to Follow-up|4|||
125432275|NCT00708435|451210222|FG000|Overall Study|Withdrawal by Subject|3|||
125432276|NCT00708435|451210223|FG001|Overall Study|Withdrawal by Subject|7|||
125432277|NCT00708435|451210222|FG000|Overall Study|Adverse Event|1|||
125432278|NCT00708435|451210223|FG001|Overall Study|Adverse Event|0|||
125432279|NCT00708435|451210222|FG000|Overall Study|Protocol Violation|0|||
125432280|NCT00708435|451210223|FG001|Overall Study|Protocol Violation|1|||
125432281|NCT00708435|451210222|FG000|Overall Study|Intervention by primary care physician|1|||
125432282|NCT00708435|451210223|FG001|Overall Study|Intervention by primary care physician|0|||
125432283|NCT00708435|451210222|FG000|Overall Study|Refused hospitalization|1|||
125432284|NCT00708435|451210223|FG001|Overall Study|Refused hospitalization|0|||
125432285|NCT03502616|451210226|FG000|Up to Week 16|Withdrawal by Subject|1|||
125432286|NCT03502616|451210227|FG001|Up to Week 16|Withdrawal by Subject|2|||
125432287|NCT03502616|451210226|FG000|Up to Week 16|Lost to Follow-up|0|||
125432288|NCT03502616|451210227|FG001|Up to Week 16|Lost to Follow-up|1|||
125432289|NCT03502616|451210226|FG000|Up to Week 16|Randomized, but not treated|1|||
125432290|NCT03502616|451210227|FG001|Up to Week 16|Randomized, but not treated|0|||
125432291|NCT03502616|451210226|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
125432292|NCT03502616|451210227|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
125432293|NCT03502616|451210226|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
125432294|NCT03502616|451210227|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
125432295|NCT00770432|451210234|FG000|Overall Study|Other|4|||
125214921|NCT03251482|450414874|FG004|Overall Study|Withdrawal by Subject|0|||
125214922|NCT02447328|450414875|FG000|Overall Study|Withdrawal by Subject|1|||
125432296|NCT00770432|451210235|FG001|Overall Study|Other|6|||
125432297|NCT00770432|451210234|FG000|Overall Study|Non-compliance|0|||
125432298|NCT00770432|451210235|FG001|Overall Study|Non-compliance|1|||
125432299|NCT00988221|451210236|FG000|Part I|Adverse Event|0|||
125432300|NCT00988221|451210237|FG001|Part I|Adverse Event|1|||
125432301|NCT00988221|451210238|FG002|Part I|Adverse Event|2|||
125432302|NCT00988221|451210239|FG003|Part I|Adverse Event|0|||
125432303|NCT00988221|451210236|FG000|Part I|Insufficient Therapeutic Response|4|||
125432304|NCT00988221|451210237|FG001|Part I|Insufficient Therapeutic Response|6|||
125373381|NCT01233258|450998002|FG002|First Intervention (6 Months)|Protocol Violation|1|||
125373382|NCT01233258|450998003|FG003|First Intervention (6 Months)|Protocol Violation|0|||
125373383|NCT01233258|450998004|FG004|First Intervention (6 Months)|Protocol Violation|0|||
125373384|NCT01233258|450998005|FG005|First Intervention (6 Months)|Protocol Violation|0|||
125373385|NCT01233258|450998000|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
125373386|NCT01233258|450998001|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
125373387|NCT01233258|450998002|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
125373388|NCT01233258|450998003|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
125373389|NCT01233258|450998004|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
125373390|NCT01233258|450998005|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
125373391|NCT01637272|450998006|FG000|Overall Study|Adverse Event|6|||
125373392|NCT01637272|450998006|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125432305|NCT00988221|451210238|FG002|Part I|Insufficient Therapeutic Response|5|||
125432306|NCT00988221|451210239|FG003|Part I|Insufficient Therapeutic Response|0|||
125432307|NCT00988221|451210236|FG000|Part I|Refused Treatment|0|||
125432308|NCT00988221|451210237|FG001|Part I|Refused Treatment|2|||
125432309|NCT00988221|451210238|FG002|Part I|Refused Treatment|1|||
125432310|NCT00988221|451210239|FG003|Part I|Refused Treatment|0|||
125432311|NCT00988221|451210236|FG000|Part I|Lost to Follow-up|0|||
125432312|NCT00988221|451210237|FG001|Part I|Lost to Follow-up|1|||
125432313|NCT00988221|451210238|FG002|Part I|Lost to Follow-up|0|||
125432314|NCT00988221|451210239|FG003|Part I|Lost to Follow-up|0|||
125432315|NCT00988221|451210236|FG000|Part II|Adverse Event|1|||
125432316|NCT00988221|451210237|FG001|Part II|Adverse Event|0|||
125432317|NCT00988221|451210238|FG002|Part II|Adverse Event|0|||
125432318|NCT00988221|451210239|FG003|Part II|Adverse Event|1|||
125432319|NCT00988221|451210236|FG000|Part II|Withdrawal by Subject|0|||
125432320|NCT00988221|451210237|FG001|Part II|Withdrawal by Subject|0|||
125432321|NCT00988221|451210238|FG002|Part II|Withdrawal by Subject|2|||
125432322|NCT00988221|451210239|FG003|Part II|Withdrawal by Subject|2|||
125432323|NCT00988221|451210236|FG000|Part II|Reason not Specified|0|||
125432324|NCT00988221|451210237|FG001|Part II|Reason not Specified|0|||
125432325|NCT00988221|451210238|FG002|Part II|Reason not Specified|1|||
125432326|NCT00988221|451210239|FG003|Part II|Reason not Specified|0|||
125432327|NCT00988221|451210236|FG000|Part III|Adverse Event|1|||
125432328|NCT00988221|451210237|FG001|Part III|Adverse Event|0|||
125432329|NCT00988221|451210238|FG002|Part III|Adverse Event|1|||
125432330|NCT00988221|451210239|FG003|Part III|Adverse Event|0|||
125432331|NCT00988221|451210236|FG000|Part III|Insufficient Therapeutic Response|0|||
125432332|NCT00988221|451210237|FG001|Part III|Insufficient Therapeutic Response|1|||
125432333|NCT00988221|451210238|FG002|Part III|Insufficient Therapeutic Response|1|||
125432334|NCT00988221|451210239|FG003|Part III|Insufficient Therapeutic Response|0|||
125432335|NCT00988221|451210236|FG000|Part III|Refused Treatment|0|||
125432336|NCT00988221|451210237|FG001|Part III|Refused Treatment|0|||
125432337|NCT00988221|451210238|FG002|Part III|Refused Treatment|1|||
125432338|NCT00988221|451210239|FG003|Part III|Refused Treatment|0|||
125432339|NCT02756832|451210242|FG000|Overall Study|Lost for Observation after Baseline|6|||
125432340|NCT02756832|451210242|FG000|Overall Study|Lost for Observation|13|||
125432341|NCT02756832|451210242|FG000|Overall Study|Patient's Unwillingness|12|||
125432342|NCT02756832|451210242|FG000|Overall Study|Insufficient Efficacy|2|||
125432343|NCT02756832|451210242|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
125432344|NCT02756832|451210242|FG000|Overall Study|Reason not Specified|9|||
125432345|NCT02756832|451210242|FG000|Overall Study|Protocol Deviation|10|||
125432346|NCT01364597|451210243|FG000|Overall Study|Adverse Event|4|||
125432347|NCT01364597|451210244|FG001|Overall Study|Adverse Event|5|||
125432348|NCT01364597|451210245|FG002|Overall Study|Adverse Event|16|||
125432349|NCT01364597|451210246|FG003|Overall Study|Adverse Event|7|||
125432350|NCT01364597|451210243|FG000|Overall Study|Lack of Efficacy|4|||
125432351|NCT01364597|451210244|FG001|Overall Study|Lack of Efficacy|4|||
125432352|NCT01364597|451210245|FG002|Overall Study|Lack of Efficacy|23|||
125432353|NCT01364597|451210246|FG003|Overall Study|Lack of Efficacy|8|||
125432354|NCT01364597|451210243|FG000|Overall Study|Protocol Violation|0|||
125432355|NCT01364597|451210244|FG001|Overall Study|Protocol Violation|0|||
125432356|NCT01364597|451210245|FG002|Overall Study|Protocol Violation|2|||
125432357|NCT01364597|451210246|FG003|Overall Study|Protocol Violation|0|||
125432358|NCT01364597|451210243|FG000|Overall Study|Lost to Follow-up|0|||
125432359|NCT01364597|451210244|FG001|Overall Study|Lost to Follow-up|0|||
125432360|NCT01364597|451210245|FG002|Overall Study|Lost to Follow-up|5|||
125432361|NCT01364597|451210246|FG003|Overall Study|Lost to Follow-up|3|||
125432362|NCT01364597|451210243|FG000|Overall Study|Withdrawal by Subject|4|||
125432363|NCT01364597|451210244|FG001|Overall Study|Withdrawal by Subject|1|||
125432364|NCT01364597|451210245|FG002|Overall Study|Withdrawal by Subject|18|||
125432365|NCT01364597|451210246|FG003|Overall Study|Withdrawal by Subject|6|||
125432366|NCT01364597|451210243|FG000|Overall Study|Non compliance|1|||
125432367|NCT01364597|451210244|FG001|Overall Study|Non compliance|0|||
125432368|NCT01364597|451210245|FG002|Overall Study|Non compliance|1|||
125432369|NCT01364597|451210246|FG003|Overall Study|Non compliance|0|||
125432370|NCT01364597|451210243|FG000|Overall Study|Lack of compliance|1|||
125432371|NCT01364597|451210244|FG001|Overall Study|Lack of compliance|0|||
125432372|NCT01364597|451210245|FG002|Overall Study|Lack of compliance|0|||
125432373|NCT01364597|451210246|FG003|Overall Study|Lack of compliance|0|||
125432374|NCT01364597|451210243|FG000|Overall Study|End of treatment epilepsy|1|||
125432375|NCT01364597|451210244|FG001|Overall Study|End of treatment epilepsy|0|||
125432376|NCT01364597|451210245|FG002|Overall Study|End of treatment epilepsy|0|||
125432377|NCT01364597|451210246|FG003|Overall Study|End of treatment epilepsy|0|||
125432378|NCT01364597|451210243|FG000|Overall Study|No Seizures|1|||
125432379|NCT01364597|451210244|FG001|Overall Study|No Seizures|0|||
125432380|NCT01364597|451210245|FG002|Overall Study|No Seizures|0|||
125432381|NCT01364597|451210246|FG003|Overall Study|No Seizures|0|||
125432382|NCT01364597|451210243|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
125617016|NCT02768194|451879956|FG005|Period 3|Other (Reason not specified)|0|||
125432383|NCT01364597|451210244|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
125432384|NCT01364597|451210245|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
125432385|NCT01364597|451210246|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
125432386|NCT01364597|451210243|FG000|Overall Study|Cure|1|||
125432387|NCT01364597|451210244|FG001|Overall Study|Cure|0|||
125432388|NCT01364597|451210245|FG002|Overall Study|Cure|0|||
125432389|NCT01364597|451210246|FG003|Overall Study|Cure|0|||
125432390|NCT01364597|451210243|FG000|Overall Study|Patient was moving|0|||
125432391|NCT01364597|451210244|FG001|Overall Study|Patient was moving|1|||
125432392|NCT01364597|451210245|FG002|Overall Study|Patient was moving|0|||
125432393|NCT01364597|451210246|FG003|Overall Study|Patient was moving|0|||
125432394|NCT01364597|451210243|FG000|Overall Study|Seizures resolved|0|||
125432395|NCT01364597|451210244|FG001|Overall Study|Seizures resolved|0|||
125432396|NCT01364597|451210245|FG002|Overall Study|Seizures resolved|1|||
125432397|NCT01364597|451210246|FG003|Overall Study|Seizures resolved|0|||
125432398|NCT01364597|451210243|FG000|Overall Study|Patient became seizure-free after surgery|0|||
125432399|NCT01364597|451210244|FG001|Overall Study|Patient became seizure-free after surgery|0|||
125432400|NCT01364597|451210245|FG002|Overall Study|Patient became seizure-free after surgery|1|||
125432401|NCT01364597|451210246|FG003|Overall Study|Patient became seizure-free after surgery|0|||
125432402|NCT01364597|451210243|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
125432403|NCT01364597|451210244|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
125432404|NCT01364597|451210245|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
125432405|NCT01364597|451210246|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
125432406|NCT01364597|451210243|FG000|Overall Study|Patient cured from Epilepsy|0|||
125432407|NCT01364597|451210244|FG001|Overall Study|Patient cured from Epilepsy|0|||
125432408|NCT01364597|451210245|FG002|Overall Study|Patient cured from Epilepsy|1|||
125432409|NCT01364597|451210246|FG003|Overall Study|Patient cured from Epilepsy|0|||
125617017|NCT00975195|451879957|FG000|Overall Study|Adverse Event|108|||
125432410|NCT01364597|451210243|FG000|Overall Study|Investigator decision|0|||
125432411|NCT01364597|451210244|FG001|Overall Study|Investigator decision|0|||
125432412|NCT01364597|451210245|FG002|Overall Study|Investigator decision|1|||
125432413|NCT01364597|451210246|FG003|Overall Study|Investigator decision|0|||
125432414|NCT01364597|451210243|FG000|Overall Study|Sponsor recommended discontinuation|0|||
125432415|NCT01364597|451210244|FG001|Overall Study|Sponsor recommended discontinuation|0|||
125432416|NCT01364597|451210245|FG002|Overall Study|Sponsor recommended discontinuation|0|||
125432417|NCT01364597|451210246|FG003|Overall Study|Sponsor recommended discontinuation|1|||
125432418|NCT01364597|451210243|FG000|Overall Study|Parents went abroad with the patient|0|||
125432419|NCT01364597|451210244|FG001|Overall Study|Parents went abroad with the patient|0|||
125432420|NCT01364597|451210245|FG002|Overall Study|Parents went abroad with the patient|1|||
125432421|NCT01364597|451210246|FG003|Overall Study|Parents went abroad with the patient|0|||
125432422|NCT01364597|451210243|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
125432423|NCT01364597|451210244|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
125214923|NCT02362425|450414876|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
125214924|NCT02362425|450414877|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
125373393|NCT01637272|450998006|FG000|Overall Study|Withdrawal by Subject|3|||
125373394|NCT01637272|450998006|FG000|Overall Study|Lost to Follow-up|2|||
125373395|NCT01637272|450998006|FG000|Overall Study|completed core, did not enter ext. phase|4|||
125373396|NCT01637272|450998006|FG000|Overall Study|Administrative problems|1|||
125373397|NCT01637272|450998006|FG000|Overall Study|Protocol Violation|2|||
125373398|NCT01496612|450998007|FG000|1st Intervention|Adverse Event|1|||
125373399|NCT01496612|450998008|FG001|1st Intervention|Adverse Event|0|||
125373400|NCT01496612|450998007|FG000|1st Intervention|Withdrawal by Subject|1|||
125373401|NCT01496612|450998008|FG001|1st Intervention|Withdrawal by Subject|0|||
125373402|NCT03708328|450998013|FG000|Overall Study|Death|3|||
125373403|NCT03708328|450998014|FG001|Overall Study|Death|3|||
125373404|NCT03708328|450998015|FG002|Overall Study|Death|4|||
125373405|NCT03708328|450998016|FG003|Overall Study|Death|2|||
125373406|NCT03708328|450998017|FG004|Overall Study|Death|2|||
125373407|NCT03708328|450998018|FG005|Overall Study|Death|13|||
125373408|NCT03708328|450998019|FG006|Overall Study|Death|26|||
125373409|NCT03708328|450998020|FG007|Overall Study|Death|18|||
125373410|NCT03708328|450998021|FG008|Overall Study|Death|13|||
125373411|NCT03708328|450998022|FG009|Overall Study|Death|8|||
125373412|NCT03708328|450998013|FG000|Overall Study|Lost to Follow-up|0|||
125373413|NCT03708328|450998014|FG001|Overall Study|Lost to Follow-up|1|||
125373414|NCT03708328|450998015|FG002|Overall Study|Lost to Follow-up|0|||
125373415|NCT03708328|450998016|FG003|Overall Study|Lost to Follow-up|1|||
125373416|NCT03708328|450998017|FG004|Overall Study|Lost to Follow-up|0|||
125373417|NCT03708328|450998018|FG005|Overall Study|Lost to Follow-up|3|||
125373418|NCT03708328|450998019|FG006|Overall Study|Lost to Follow-up|3|||
125373419|NCT03708328|450998020|FG007|Overall Study|Lost to Follow-up|0|||
125373420|NCT03708328|450998021|FG008|Overall Study|Lost to Follow-up|0|||
125373421|NCT03708328|450998022|FG009|Overall Study|Lost to Follow-up|1|||
125373422|NCT03708328|450998013|FG000|Overall Study|Physician Decision|0|||
125373423|NCT03708328|450998014|FG001|Overall Study|Physician Decision|0|||
125373424|NCT03708328|450998015|FG002|Overall Study|Physician Decision|0|||
125373425|NCT03708328|450998016|FG003|Overall Study|Physician Decision|0|||
125373426|NCT03708328|450998017|FG004|Overall Study|Physician Decision|0|||
125373427|NCT03708328|450998018|FG005|Overall Study|Physician Decision|1|||
125373428|NCT03708328|450998019|FG006|Overall Study|Physician Decision|0|||
125373429|NCT03708328|450998020|FG007|Overall Study|Physician Decision|0|||
125373430|NCT03708328|450998021|FG008|Overall Study|Physician Decision|0|||
125432424|NCT01364597|451210245|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
125373431|NCT03708328|450998022|FG009|Overall Study|Physician Decision|0|||
125373432|NCT03708328|450998013|FG000|Overall Study|Withdrawal by Subject|0|||
125373433|NCT03708328|450998014|FG001|Overall Study|Withdrawal by Subject|0|||
125373434|NCT03708328|450998015|FG002|Overall Study|Withdrawal by Subject|0|||
125373435|NCT03708328|450998016|FG003|Overall Study|Withdrawal by Subject|0|||
125373436|NCT03708328|450998017|FG004|Overall Study|Withdrawal by Subject|1|||
125373437|NCT03708328|450998018|FG005|Overall Study|Withdrawal by Subject|0|||
125373438|NCT03708328|450998019|FG006|Overall Study|Withdrawal by Subject|2|||
125373439|NCT03708328|450998020|FG007|Overall Study|Withdrawal by Subject|4|||
125373440|NCT03708328|450998021|FG008|Overall Study|Withdrawal by Subject|1|||
125373441|NCT03708328|450998022|FG009|Overall Study|Withdrawal by Subject|5|||
125373442|NCT03708328|450998013|FG000|Overall Study|Study Closed Locally|0|||
125373443|NCT03708328|450998014|FG001|Overall Study|Study Closed Locally|0|||
125373444|NCT03708328|450998015|FG002|Overall Study|Study Closed Locally|0|||
125373445|NCT03708328|450998016|FG003|Overall Study|Study Closed Locally|0|||
125373446|NCT03708328|450998017|FG004|Overall Study|Study Closed Locally|0|||
125373447|NCT03708328|450998018|FG005|Overall Study|Study Closed Locally|0|||
125373448|NCT03708328|450998019|FG006|Overall Study|Study Closed Locally|0|||
125373449|NCT03708328|450998020|FG007|Overall Study|Study Closed Locally|1|||
125373450|NCT03708328|450998021|FG008|Overall Study|Study Closed Locally|0|||
125373451|NCT03708328|450998022|FG009|Overall Study|Study Closed Locally|0|||
125373452|NCT03708328|450998013|FG000|Overall Study|Study Ended By Sponsor|0|||
125373453|NCT03708328|450998014|FG001|Overall Study|Study Ended By Sponsor|0|||
125373454|NCT03708328|450998015|FG002|Overall Study|Study Ended By Sponsor|0|||
125373455|NCT03708328|450998016|FG003|Overall Study|Study Ended By Sponsor|0|||
125373456|NCT03708328|450998017|FG004|Overall Study|Study Ended By Sponsor|0|||
125373457|NCT03708328|450998018|FG005|Overall Study|Study Ended By Sponsor|1|||
125373458|NCT03708328|450998019|FG006|Overall Study|Study Ended By Sponsor|0|||
125373459|NCT03708328|450998020|FG007|Overall Study|Study Ended By Sponsor|1|||
125373460|NCT03708328|450998021|FG008|Overall Study|Study Ended By Sponsor|0|||
125373461|NCT03708328|450998022|FG009|Overall Study|Study Ended By Sponsor|0|||
125373462|NCT03708328|450998013|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125373463|NCT03708328|450998014|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125373464|NCT03708328|450998015|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125373465|NCT03708328|450998016|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125373466|NCT03708328|450998017|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125373467|NCT03708328|450998018|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125373468|NCT03708328|450998019|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125373469|NCT03708328|450998020|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125373470|NCT03708328|450998021|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
125373471|NCT03708328|450998022|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
125373472|NCT02605824|450998023|FG000|Overall Study|Physician Decision|1|||
125373473|NCT02605824|450998024|FG001|Overall Study|Physician Decision|0|||
125373474|NCT02695329|450998027|FG000|Overall Study|Adverse Event|1|||
125373475|NCT02695329|450998028|FG001|Overall Study|Adverse Event|0|||
125373476|NCT02695329|450998027|FG000|Overall Study|Poor X-ray quality for measurement|4|||
125373477|NCT02695329|450998028|FG001|Overall Study|Poor X-ray quality for measurement|5|||
125373478|NCT01032837|450998030|FG000|Overall Study|Adverse event/internal illness|0|||
125373479|NCT01032837|450998031|FG001|Overall Study|Adverse event/internal illness|1|||
125373480|NCT01032837|450998032|FG002|Overall Study|Adverse event/internal illness|0|||
125373481|NCT01032837|450998033|FG003|Overall Study|Adverse event/internal illness|1|||
125214925|NCT02362425|450414878|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
125214926|NCT02362425|450414879|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
125214927|NCT02362425|450414876|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
125214928|NCT02362425|450414877|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
125432425|NCT01364597|451210246|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
125432426|NCT01364597|451210243|FG000|Overall Study|BRV administration dropout|0|||
125214929|NCT02362425|450414878|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
125432427|NCT01364597|451210244|FG001|Overall Study|BRV administration dropout|0|||
125432428|NCT01364597|451210245|FG002|Overall Study|BRV administration dropout|1|||
125432429|NCT01364597|451210246|FG003|Overall Study|BRV administration dropout|0|||
125432430|NCT01364597|451210243|FG000|Overall Study|Dropout|0|||
125432431|NCT01364597|451210244|FG001|Overall Study|Dropout|0|||
125432432|NCT01364597|451210245|FG002|Overall Study|Dropout|3|||
125432433|NCT01364597|451210246|FG003|Overall Study|Dropout|1|||
125432434|NCT01364597|451210243|FG000|Overall Study|Unreliable subject|0|||
125432435|NCT01364597|451210244|FG001|Overall Study|Unreliable subject|0|||
125432436|NCT01364597|451210245|FG002|Overall Study|Unreliable subject|0|||
125432437|NCT01364597|451210246|FG003|Overall Study|Unreliable subject|1|||
125432438|NCT01364597|451210243|FG000|Overall Study|Other|0|||
125432439|NCT01364597|451210244|FG001|Overall Study|Other|0|||
125432440|NCT01364597|451210245|FG002|Overall Study|Other|0|||
125617018|NCT00975195|451879958|FG001|Overall Study|Adverse Event|101|||
125617019|NCT00975195|451879957|FG000|Overall Study|Lack of Efficacy|6|||
125373482|NCT01032837|450998030|FG000|Overall Study|Withdrew consent|0|||
125373483|NCT01032837|450998031|FG001|Overall Study|Withdrew consent|2|||
125373484|NCT01032837|450998032|FG002|Overall Study|Withdrew consent|0|||
125373485|NCT01032837|450998033|FG003|Overall Study|Withdrew consent|1|||
125373486|NCT01032837|450998030|FG000|Overall Study|Failed to return|0|||
125373487|NCT01032837|450998031|FG001|Overall Study|Failed to return|0|||
125373488|NCT01032837|450998032|FG002|Overall Study|Failed to return|1|||
125373489|NCT01032837|450998033|FG003|Overall Study|Failed to return|0|||
125373490|NCT01032837|450998030|FG000|Overall Study|Refused treatment|0|||
125373491|NCT01032837|450998031|FG001|Overall Study|Refused treatment|0|||
125373492|NCT01032837|450998032|FG002|Overall Study|Refused treatment|0|||
125373493|NCT01032837|450998033|FG003|Overall Study|Refused treatment|1|||
125373494|NCT00843024|450998034|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
125373495|NCT00843024|450998035|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
125373496|NCT00843024|450998036|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
125373497|NCT00843024|450998037|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
125373498|NCT00843024|450998038|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
125373499|NCT00843024|450998039|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
125373500|NCT00843024|450998034|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
125373501|NCT00843024|450998035|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
125373502|NCT00843024|450998036|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
125373503|NCT00843024|450998037|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
125373504|NCT00843024|450998038|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
125373505|NCT00843024|450998039|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
125373506|NCT00843024|450998034|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
125373507|NCT00843024|450998035|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
125373508|NCT00843024|450998036|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
125373509|NCT00843024|450998037|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
125373510|NCT00843024|450998038|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
125373511|NCT00843024|450998039|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
125373512|NCT00843024|450998034|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
125373513|NCT00843024|450998035|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
125373514|NCT00843024|450998036|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
125373515|NCT00843024|450998037|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
125373516|NCT00843024|450998038|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
125373517|NCT00843024|450998039|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
125373518|NCT00843024|450998034|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
125373519|NCT00843024|450998035|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
125373520|NCT00843024|450998036|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
125373521|NCT00843024|450998037|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
125373522|NCT00843024|450998038|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
125432441|NCT01364597|451210246|FG003|Overall Study|Other|1|||
125432442|NCT01498822|451210247|FG000|Overall Study|Protocol Violation|8|||
125432443|NCT01498822|451210248|FG001|Overall Study|Protocol Violation|4|||
125432444|NCT01498822|451210247|FG000|Overall Study|Other Reason|5|||
125432445|NCT01498822|451210248|FG001|Overall Study|Other Reason|2|||
125432446|NCT01498822|451210247|FG000|Overall Study|Lack of Efficacy|7|||
125432447|NCT01498822|451210248|FG001|Overall Study|Lack of Efficacy|2|||
125432448|NCT01498822|451210247|FG000|Overall Study|AE, non-serious non-fatal|8|||
125432449|NCT01498822|451210248|FG001|Overall Study|AE, non-serious non-fatal|17|||
125432450|NCT01498822|451210247|FG000|Overall Study|SAE, non-fatal|2|||
125432451|NCT01498822|451210248|FG001|Overall Study|SAE, non-fatal|2|||
125432452|NCT01498822|451210247|FG000|Overall Study|Adverse Event, serious fatal|1|||
125432453|NCT01498822|451210248|FG001|Overall Study|Adverse Event, serious fatal|1|||
125432454|NCT01498822|451210247|FG000|Overall Study|Withdrawal by Subject|15|||
125432455|NCT01498822|451210248|FG001|Overall Study|Withdrawal by Subject|25|||
125432456|NCT01498822|451210247|FG000|Overall Study|Lost to Follow-up|8|||
125432457|NCT01498822|451210248|FG001|Overall Study|Lost to Follow-up|3|||
125432458|NCT03579290|451210256|FG000|Overall Study|Lost to Follow-up|9|||
125432459|NCT03131960|451210259|FG000|Overall Study|Adverse Event|0|||
125432460|NCT03131960|451210260|FG001|Overall Study|Adverse Event|1|||
125373523|NCT00843024|450998039|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
125373524|NCT00843024|450998034|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
125373525|NCT00843024|450998035|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
125373526|NCT00843024|450998036|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
125432461|NCT01781390|451210261|FG000|Overall Study|Withdrawal of Consent|0|||
125432462|NCT01781390|451210262|FG001|Overall Study|Withdrawal of Consent|3|||
125432463|NCT01781390|451210263|FG002|Overall Study|Withdrawal of Consent|1|||
125214930|NCT02362425|450414879|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
125432464|NCT01781390|451210261|FG000|Overall Study|Lost to Follow-up|1|||
125432465|NCT01781390|451210262|FG001|Overall Study|Lost to Follow-up|1|||
125432466|NCT01781390|451210263|FG002|Overall Study|Lost to Follow-up|1|||
125432467|NCT01781390|451210261|FG000|Overall Study|Adverse Event|1|||
125432468|NCT01781390|451210262|FG001|Overall Study|Adverse Event|2|||
125432469|NCT01781390|451210263|FG002|Overall Study|Adverse Event|1|||
125432470|NCT01781390|451210261|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
125432471|NCT01781390|451210262|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
125432472|NCT01781390|451210263|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
125432473|NCT04404478|451210265|FG000|Overall Study|Withdrawal by Subject|1|||
125432474|NCT04404478|451210266|FG001|Overall Study|Withdrawal by Subject|3|||
125432475|NCT02904902|451210267|FG000|Overall Study|Withdrawal by Subject|1|||
125432476|NCT01216163|451210271|FG000|Overall Study|Withdrawal by Subject|1|||
125432477|NCT01216163|451210272|FG001|Overall Study|Withdrawal by Subject|1|||
125432478|NCT01216163|451210273|FG002|Overall Study|Withdrawal by Subject|0|||
125432479|NCT02002182|451210276|FG000|Overall Study|Withdraw from study|3|||
125432480|NCT02002182|451210277|FG001|Overall Study|Withdraw from study|1|||
125432481|NCT02002182|451210276|FG000|Overall Study|Health Reasons|1|||
125432482|NCT02002182|451210277|FG001|Overall Study|Health Reasons|0|||
125432483|NCT02002182|451210276|FG000|Overall Study|Death|1|||
125432484|NCT02002182|451210277|FG001|Overall Study|Death|0|||
125432485|NCT01597505|451210280|FG000|Overall Study|Physician Decision|5|||
125432486|NCT01597505|451210281|FG001|Overall Study|Physician Decision|0|||
125432487|NCT01597505|451210280|FG000|Overall Study|Adverse Event|19|||
125432488|NCT01597505|451210281|FG001|Overall Study|Adverse Event|7|||
125432489|NCT01597505|451210280|FG000|Overall Study|Lost to Follow-up|4|||
125432490|NCT01597505|451210281|FG001|Overall Study|Lost to Follow-up|2|||
125432491|NCT01597505|451210280|FG000|Overall Study|Withdrawal by Subject|10|||
125432492|NCT01597505|451210281|FG001|Overall Study|Withdrawal by Subject|18|||
125432493|NCT01597505|451210280|FG000|Overall Study|Other|5|||
125432494|NCT01597505|451210281|FG001|Overall Study|Other|6|||
125432495|NCT01597505|451210280|FG000|Overall Study|Missing|1|||
125432496|NCT01597505|451210281|FG001|Overall Study|Missing|0|||
125432497|NCT03879408|451210291|FG000|Overall Study|Lost to Follow-up|0|||
125432498|NCT03879408|451210292|FG001|Overall Study|Lost to Follow-up|3|||
125432499|NCT03879408|451210293|FG002|Overall Study|Lost to Follow-up|2|||
125373527|NCT00843024|450998037|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
125373528|NCT00843024|450998038|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
125373529|NCT00843024|450998039|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
125373530|NCT00843024|450998034|FG000|Single-blind Placebo Run-In Phase|Other|0|||
125373531|NCT00843024|450998035|FG001|Single-blind Placebo Run-In Phase|Other|1|||
125373532|NCT00843024|450998036|FG002|Single-blind Placebo Run-In Phase|Other|0|||
125373533|NCT00843024|450998037|FG003|Single-blind Placebo Run-In Phase|Other|0|||
125373534|NCT00843024|450998038|FG004|Single-blind Placebo Run-In Phase|Other|0|||
125373535|NCT00843024|450998039|FG005|Single-blind Placebo Run-In Phase|Other|0|||
125373536|NCT00843024|450998034|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
125373537|NCT00843024|450998035|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
125432500|NCT03879408|451210294|FG003|Overall Study|Lost to Follow-up|1|||
125432501|NCT03879408|451210295|FG004|Overall Study|Lost to Follow-up|0|||
125432502|NCT03879408|451210291|FG000|Overall Study|Withdrawal by Subject|2|||
125432503|NCT03879408|451210292|FG001|Overall Study|Withdrawal by Subject|1|||
125432504|NCT03879408|451210293|FG002|Overall Study|Withdrawal by Subject|1|||
125432505|NCT03879408|451210294|FG003|Overall Study|Withdrawal by Subject|0|||
125432506|NCT03879408|451210295|FG004|Overall Study|Withdrawal by Subject|1|||
125432507|NCT00728962|451210296|FG000|Implant Placement Surgery|Adverse Event|8|||
125373538|NCT00843024|450998036|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
125373539|NCT00843024|450998037|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
125373540|NCT00843024|450998038|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
125373541|NCT00843024|450998039|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
125373542|NCT00843024|450998034|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
125373543|NCT00843024|450998035|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
125373544|NCT00843024|450998036|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
125373545|NCT00843024|450998037|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
125373546|NCT00843024|450998038|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
125373547|NCT00843024|450998039|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
125373548|NCT00843024|450998034|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125373549|NCT00843024|450998035|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125373550|NCT00843024|450998036|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125373551|NCT00843024|450998037|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
125373552|NCT00843024|450998038|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125373553|NCT00843024|450998039|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
125373554|NCT00843024|450998034|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
125373555|NCT00843024|450998035|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
125373556|NCT00843024|450998036|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
125373557|NCT00843024|450998037|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
125373558|NCT00843024|450998038|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
125373559|NCT00843024|450998039|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
125373560|NCT00843024|450998034|FG000|Double-blind Treatment Phase|Physician Decision|0|||
125373561|NCT00843024|450998035|FG001|Double-blind Treatment Phase|Physician Decision|0|||
125373562|NCT00843024|450998036|FG002|Double-blind Treatment Phase|Physician Decision|0|||
125373563|NCT00843024|450998037|FG003|Double-blind Treatment Phase|Physician Decision|3|||
125373564|NCT00843024|450998038|FG004|Double-blind Treatment Phase|Physician Decision|1|||
125373565|NCT00843024|450998039|FG005|Double-blind Treatment Phase|Physician Decision|1|||
125373566|NCT00843024|450998034|FG000|Double-blind Treatment Phase|Adverse Event|0|||
125373567|NCT00843024|450998035|FG001|Double-blind Treatment Phase|Adverse Event|0|||
125373568|NCT00843024|450998036|FG002|Double-blind Treatment Phase|Adverse Event|0|||
125373569|NCT00843024|450998037|FG003|Double-blind Treatment Phase|Adverse Event|0|||
125373570|NCT00843024|450998038|FG004|Double-blind Treatment Phase|Adverse Event|1|||
125373571|NCT00843024|450998039|FG005|Double-blind Treatment Phase|Adverse Event|1|||
125373572|NCT00843024|450998034|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
125373573|NCT00843024|450998035|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
125373574|NCT00843024|450998036|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
125373575|NCT00843024|450998037|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
125373576|NCT00843024|450998038|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
125373577|NCT00843024|450998039|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
125373578|NCT02439138|450998045|FG000|Overall Study|Adverse Event|1|||
125373579|NCT02439138|450998045|FG000|Overall Study|PI decision to terminate the study|2|||
125373580|NCT00006237|450998046|FG000|Overall Study|Adverse Event|39|||
125373581|NCT00006237|450998047|FG001|Overall Study|Adverse Event|29|||
125373582|NCT00006237|450998046|FG000|Overall Study|Death|1|||
125373583|NCT00006237|450998047|FG001|Overall Study|Death|0|||
125373584|NCT00006237|450998046|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
125373585|NCT00006237|450998047|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
125373586|NCT00006237|450998046|FG000|Overall Study|Progression/relapse|54|||
125373587|NCT00006237|450998047|FG001|Overall Study|Progression/relapse|2|||
125373588|NCT00006237|450998046|FG000|Overall Study|Not eligible|9|||
125373589|NCT00006237|450998047|FG001|Overall Study|Not eligible|20|||
125373590|NCT00006237|450998046|FG000|Overall Study|Withdrawal by Subject|0|||
125373591|NCT00006237|450998047|FG001|Overall Study|Withdrawal by Subject|1|||
125373592|NCT00006237|450998046|FG000|Overall Study|Not protocol specified|14|||
125373593|NCT00006237|450998047|FG001|Overall Study|Not protocol specified|5|||
125373594|NCT01846416|450998052|FG000|Treatment Phase|Death|2|||
125373595|NCT01846416|450998053|FG001|Treatment Phase|Death|9|||
125373596|NCT01846416|450998054|FG002|Treatment Phase|Death|1|||
125373597|NCT01846416|450998052|FG000|Treatment Phase|Withdrawal by Subject|2|||
125373598|NCT01846416|450998053|FG001|Treatment Phase|Withdrawal by Subject|4|||
125373599|NCT01846416|450998054|FG002|Treatment Phase|Withdrawal by Subject|2|||
125373600|NCT01846416|450998052|FG000|Treatment Phase|Other|1|||
125373601|NCT01846416|450998053|FG001|Treatment Phase|Other|5|||
125373602|NCT01846416|450998054|FG002|Treatment Phase|Other|1|||
125373603|NCT01846416|450998052|FG000|Treatment Phase|Physician Decision|1|||
125373604|NCT01846416|450998053|FG001|Treatment Phase|Physician Decision|2|||
125373605|NCT01846416|450998054|FG002|Treatment Phase|Physician Decision|0|||
125373606|NCT01846416|450998052|FG000|Treatment Phase|Adverse Event|3|||
125373607|NCT01846416|450998053|FG001|Treatment Phase|Adverse Event|4|||
125373608|NCT01846416|450998054|FG002|Treatment Phase|Adverse Event|0|||
125373609|NCT01846416|450998052|FG000|Treatment Phase|Non-compliance|0|||
125373610|NCT01846416|450998053|FG001|Treatment Phase|Non-compliance|2|||
125373611|NCT01846416|450998054|FG002|Treatment Phase|Non-compliance|0|||
125373612|NCT01846416|450998052|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
125373613|NCT01846416|450998053|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
125373614|NCT01846416|450998054|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
125373615|NCT01846416|450998052|FG000|Treatment Phase|Progressive Disease|21|||
125373616|NCT01846416|450998053|FG001|Treatment Phase|Progressive Disease|63|||
125373617|NCT01846416|450998054|FG002|Treatment Phase|Progressive Disease|9|||
125373618|NCT01846416|450998052|FG000|Survival Follow-up|Death|21|||
125373619|NCT01846416|450998053|FG001|Survival Follow-up|Death|62|||
125373620|NCT01846416|450998054|FG002|Survival Follow-up|Death|9|||
125373621|NCT01846416|450998052|FG000|Survival Follow-up|Lost to Follow-up|0|||
125373622|NCT01846416|450998053|FG001|Survival Follow-up|Lost to Follow-up|2|||
125373623|NCT01846416|450998054|FG002|Survival Follow-up|Lost to Follow-up|2|||
125373624|NCT01846416|450998052|FG000|Survival Follow-up|Withdrawal by Subject|2|||
125373625|NCT01846416|450998053|FG001|Survival Follow-up|Withdrawal by Subject|7|||
125373626|NCT01846416|450998054|FG002|Survival Follow-up|Withdrawal by Subject|0|||
125373627|NCT01846416|450998052|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
125373628|NCT01846416|450998053|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
125373629|NCT01846416|450998054|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
125373630|NCT01846416|450998052|FG000|Survival Follow-up|Other|3|||
125373631|NCT01846416|450998053|FG001|Survival Follow-up|Other|1|||
125373632|NCT01846416|450998054|FG002|Survival Follow-up|Other|1|||
125373633|NCT01487200|450998055|FG000|Overall Study|Withdrawal by Subject|0|||
125373634|NCT01487200|450998056|FG001|Overall Study|Withdrawal by Subject|1|||
125373635|NCT01487200|450998057|FG002|Overall Study|Withdrawal by Subject|0|||
125373636|NCT01487200|450998058|FG003|Overall Study|Withdrawal by Subject|0|||
125373637|NCT01962896|450998059|FG000|Overall Study|Lack of Efficacy|4|||
125373638|NCT02837783|450998060|FG000|Overall Study|Adverse Event|1|||
125373639|NCT02837783|450998061|FG001|Overall Study|Adverse Event|0|||
125373640|NCT02837783|450998060|FG000|Overall Study|Other, Not Specified|1|||
125373641|NCT02837783|450998061|FG001|Overall Study|Other, Not Specified|2|||
125373642|NCT02216591|450998062|FG000|Overall Study|Lost to Follow-up|0|||
125373643|NCT02216591|450998063|FG001|Overall Study|Lost to Follow-up|1|||
125373644|NCT02207244|450998064|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
125373645|NCT02207244|450998065|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
125373646|NCT02207244|450998066|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
125373647|NCT02207244|450998067|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125373648|NCT02207244|450998068|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125373649|NCT02207244|450998069|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125373650|NCT02207244|450998070|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125373651|NCT02207244|450998071|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125373652|NCT02207244|450998072|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125373653|NCT02207244|450998073|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125373654|NCT02207244|450998074|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
125617020|NCT00975195|451879958|FG001|Overall Study|Lack of Efficacy|6|||
125373655|NCT02207244|450998064|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
125373656|NCT02207244|450998065|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125373657|NCT02207244|450998066|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
125373658|NCT02207244|450998067|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125373659|NCT02207244|450998068|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125373660|NCT02207244|450998069|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125373661|NCT02207244|450998070|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125373662|NCT02207244|450998071|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125373663|NCT02207244|450998072|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125373664|NCT02207244|450998073|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125373665|NCT02207244|450998074|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
125373666|NCT02207244|450998064|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
125373667|NCT02207244|450998065|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
125373668|NCT02207244|450998066|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
125373669|NCT02207244|450998067|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125373670|NCT02207244|450998068|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125373671|NCT02207244|450998069|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125373672|NCT02207244|450998070|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125373673|NCT02207244|450998071|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125373674|NCT02207244|450998072|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125373675|NCT02207244|450998073|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125373676|NCT02207244|450998074|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
125373677|NCT02207244|450998064|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
125373678|NCT02207244|450998065|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
125373679|NCT02207244|450998066|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125373680|NCT02207244|450998067|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125373681|NCT02207244|450998068|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125373682|NCT02207244|450998069|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125373683|NCT02207244|450998070|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125373684|NCT02207244|450998071|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125373685|NCT02207244|450998072|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125432508|NCT00728962|451210296|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
125432509|NCT00728962|451210296|FG000|Implant Placement Surgery|Protocol Violation|1|||
125432510|NCT00728962|451210296|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
125432511|NCT00728962|451210296|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
125432512|NCT05807919|451210297|FG000|Overall Study|Received antibiotics - excluded|0|||
125432513|NCT05807919|451210298|FG001|Overall Study|Received antibiotics - excluded|1|||
125432514|NCT05807919|451210297|FG000|Overall Study|Withdrawal by Subject|0|||
125432515|NCT05807919|451210298|FG001|Overall Study|Withdrawal by Subject|3|||
125432516|NCT05807919|451210297|FG000|Overall Study|Adverse Event|1|||
125432517|NCT05807919|451210298|FG001|Overall Study|Adverse Event|1|||
125432518|NCT02739347|451210303|FG000|Overall Study|Adverse Event|3|||
125432519|NCT02739347|451210304|FG001|Overall Study|Adverse Event|0|||
125432520|NCT02739347|451210303|FG000|Overall Study|Protocol Violation|0|||
125432521|NCT02739347|451210304|FG001|Overall Study|Protocol Violation|1|||
125432522|NCT02739347|451210303|FG000|Overall Study|Lost to Follow-up|0|||
125432523|NCT02739347|451210304|FG001|Overall Study|Lost to Follow-up|2|||
125432524|NCT03324880|451210308|FG000|Overall Study|Adverse Event|0|||
125432525|NCT03324880|451210309|FG001|Overall Study|Adverse Event|2|||
125432526|NCT03324880|451210308|FG000|Overall Study|Withdrawal by Subject|2|||
125432527|NCT03324880|451210309|FG001|Overall Study|Withdrawal by Subject|2|||
125432528|NCT03324880|451210308|FG000|Overall Study|Lost to Follow-up|0|||
125432529|NCT03324880|451210309|FG001|Overall Study|Lost to Follow-up|1|||
125432530|NCT03324880|451210308|FG000|Overall Study|Product Recall|0|||
125432531|NCT03324880|451210309|FG001|Overall Study|Product Recall|1|||
125432532|NCT03300570|451210310|FG000|Overall Study|Adverse Event|0|||
125432533|NCT03300570|451210311|FG001|Overall Study|Adverse Event|1|||
125432534|NCT03300570|451210310|FG000|Overall Study|Withdrawal by Subject|1|||
125432535|NCT03300570|451210311|FG001|Overall Study|Withdrawal by Subject|0|||
125432536|NCT03300570|451210310|FG000|Overall Study|Inadequate bowel prep|1|||
125432537|NCT03300570|451210311|FG001|Overall Study|Inadequate bowel prep|0|||
125432538|NCT00116272|451210312|FG000|Overall Study|Lost to Follow-up|11|||
125432539|NCT00116272|451210313|FG001|Overall Study|Lost to Follow-up|6|||
125432540|NCT01235403|451210317|FG000|Overall Study|Adverse Event|14|||
125432541|NCT01235403|451210317|FG000|Overall Study|Lost to Follow-up|2|||
125432542|NCT01235403|451210317|FG000|Overall Study|Withdrawal by Subject|4|||
125432543|NCT01235403|451210317|FG000|Overall Study|Lack of Efficacy|2|||
125432544|NCT01235403|451210317|FG000|Overall Study|Other reasons for premature termination|4|||
125432545|NCT02296190|451210318|FG000|Overall Study|Lost to Follow-up|0|||
125432546|NCT02296190|451210319|FG001|Overall Study|Lost to Follow-up|0|||
125432547|NCT02296190|451210320|FG002|Overall Study|Lost to Follow-up|0|||
125432548|NCT02296190|451210321|FG003|Overall Study|Lost to Follow-up|0|||
125432549|NCT02296190|451210322|FG004|Overall Study|Lost to Follow-up|1|||
125432550|NCT02296190|451210323|FG005|Overall Study|Lost to Follow-up|0|||
125432551|NCT02296190|451210318|FG000|Overall Study|Failure to induce PSVT|6|||
125432552|NCT02296190|451210319|FG001|Overall Study|Failure to induce PSVT|10|||
125432553|NCT02296190|451210320|FG002|Overall Study|Failure to induce PSVT|5|||
125432554|NCT02296190|451210321|FG003|Overall Study|Failure to induce PSVT|13|||
125617021|NCT00975195|451879957|FG000|Overall Study|Protocol Violation|27|||
125617022|NCT00975195|451879958|FG001|Overall Study|Protocol Violation|23|||
125617023|NCT00975195|451879957|FG000|Overall Study|Lost to Follow-up|9|||
125617024|NCT00975195|451879958|FG001|Overall Study|Lost to Follow-up|7|||
125617025|NCT00975195|451879957|FG000|Overall Study|Withdrawal by Subject|48|||
125617026|NCT00975195|451879958|FG001|Overall Study|Withdrawal by Subject|61|||
125617027|NCT00975195|451879957|FG000|Overall Study|Other reason not defined above|29|||
125617028|NCT00975195|451879958|FG001|Overall Study|Other reason not defined above|33|||
125617029|NCT00975195|451879957|FG000|Overall Study|Not treated|1|||
125617030|NCT00975195|451879958|FG001|Overall Study|Not treated|2|||
125617031|NCT00363246|451879959|FG000|Overall Study|Death|40|||
125617032|NCT00363246|451879959|FG000|Overall Study|Withdrawal by Subject|19|||
125617033|NCT00363246|451879959|FG000|Overall Study|Lost to Follow-up|14|||
125617034|NCT00363246|451879959|FG000|Overall Study|Bad health|6|||
125617035|NCT00363246|451879959|FG000|Overall Study|Stopped using wheelchair|11|||
125617036|NCT00363246|451879959|FG000|Overall Study|Subject expressed security concerns|2|||
125617037|NCT00363246|451879959|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
125617038|NCT01608724|451879960|FG000|Overall Study|Withdrawal by Subject|131|||
125617039|NCT01608724|451879960|FG000|Overall Study|Lost to Follow-up|41|||
125617040|NCT01608724|451879960|FG000|Overall Study|Study-specific discontinuation criteria|32|||
125617041|NCT01608724|451879960|FG000|Overall Study|Adverse Event|29|||
125617042|NCT01608724|451879960|FG000|Overall Study|Protocol Violation|6|||
125617043|NCT01608724|451879960|FG000|Overall Study|bood sugar too high, etc.|3|||
125617044|NCT01608724|451879960|FG000|Overall Study|Safety reasons|1|||
125617045|NCT00099359|451879965|FG000|Overall Study|Death|11|||
125617046|NCT00099359|451879966|FG001|Overall Study|Death|15|||
125617047|NCT00099359|451879967|FG002|Overall Study|Death|17|||
125617048|NCT00099359|451879965|FG000|Overall Study|Withdrawal by Subject|19|||
125432555|NCT02296190|451210322|FG004|Overall Study|Failure to induce PSVT|8|||
125432556|NCT02296190|451210323|FG005|Overall Study|Failure to induce PSVT|0|||
125432557|NCT02296190|451210318|FG000|Overall Study|Physician Decision|1|||
125432558|NCT02296190|451210319|FG001|Overall Study|Physician Decision|1|||
125432559|NCT02296190|451210320|FG002|Overall Study|Physician Decision|0|||
125432560|NCT02296190|451210321|FG003|Overall Study|Physician Decision|1|||
125432561|NCT02296190|451210322|FG004|Overall Study|Physician Decision|2|||
125432562|NCT02296190|451210323|FG005|Overall Study|Physician Decision|0|||
125432563|NCT02296190|451210318|FG000|Overall Study|Withdrawal by Subject|0|||
125432564|NCT02296190|451210319|FG001|Overall Study|Withdrawal by Subject|1|||
125432565|NCT02296190|451210320|FG002|Overall Study|Withdrawal by Subject|0|||
125617049|NCT00099359|451879966|FG001|Overall Study|Withdrawal by Subject|19|||
125617050|NCT00099359|451879967|FG002|Overall Study|Withdrawal by Subject|23|||
125617051|NCT00099359|451879965|FG000|Overall Study|Lost to Follow-up|15|||
125617052|NCT00099359|451879966|FG001|Overall Study|Lost to Follow-up|24|||
125617053|NCT00099359|451879967|FG002|Overall Study|Lost to Follow-up|24|||
125617054|NCT00099359|451879965|FG000|Overall Study|moved out of area|9|||
125617055|NCT00099359|451879966|FG001|Overall Study|moved out of area|7|||
125617056|NCT00099359|451879967|FG002|Overall Study|moved out of area|4|||
125617057|NCT01822691|451879968|FG000|Overall Study|Withdrawal by Subject|2|||
125617058|NCT02756650|451879969|FG000|Overall Study|Physician Decision|1|||
125617059|NCT02756650|451879969|FG000|Overall Study|Adverse Event|1|||
125617060|NCT02720016|451879976|FG000|Overall Study|Separation of couple|6|||
125617061|NCT02720016|451879977|FG001|Overall Study|Separation of couple|8|||
125617062|NCT02720016|451879978|FG002|Overall Study|Separation of couple|2|||
125617063|NCT02720016|451879976|FG000|Overall Study|Withdrawal by Subject|6|||
125617064|NCT02720016|451879977|FG001|Overall Study|Withdrawal by Subject|6|||
125617065|NCT02720016|451879978|FG002|Overall Study|Withdrawal by Subject|4|||
125617066|NCT02720016|451879976|FG000|Overall Study|Scheduling issues|2|||
125617067|NCT02720016|451879977|FG001|Overall Study|Scheduling issues|4|||
125617068|NCT02720016|451879978|FG002|Overall Study|Scheduling issues|7|||
125617069|NCT02720016|451879976|FG000|Overall Study|Childcare|2|||
125617070|NCT02720016|451879977|FG001|Overall Study|Childcare|0|||
125617071|NCT02720016|451879978|FG002|Overall Study|Childcare|2|||
125617072|NCT02720016|451879976|FG000|Overall Study|Withdrawal by PI|2|||
125617073|NCT02720016|451879977|FG001|Overall Study|Withdrawal by PI|2|||
125617074|NCT02720016|451879978|FG002|Overall Study|Withdrawal by PI|0|||
125617075|NCT02720016|451879976|FG000|Overall Study|Moved away|2|||
125617076|NCT02720016|451879977|FG001|Overall Study|Moved away|0|||
125617077|NCT02720016|451879978|FG002|Overall Study|Moved away|0|||
125617078|NCT02720016|451879976|FG000|Overall Study|Not Primary Health Concern|0|||
125617079|NCT02720016|451879977|FG001|Overall Study|Not Primary Health Concern|0|||
125617080|NCT02720016|451879978|FG002|Overall Study|Not Primary Health Concern|2|||
125617081|NCT02720016|451879976|FG000|Overall Study|Transportation issues|0|||
125617082|NCT02720016|451879977|FG001|Overall Study|Transportation issues|0|||
125617083|NCT02720016|451879978|FG002|Overall Study|Transportation issues|1|||
125617084|NCT02720016|451879976|FG000|Overall Study|Other|0|||
125617085|NCT02720016|451879977|FG001|Overall Study|Other|0|||
125617086|NCT02720016|451879978|FG002|Overall Study|Other|2|||
125617087|NCT04501679|451879981|FG000|Overall Study|Pregnancy|0|||
125617088|NCT04501679|451879982|FG001|Overall Study|Pregnancy|1|||
125617089|NCT04501679|451879981|FG000|Overall Study|Adverse Event|4|||
125617090|NCT04501679|451879982|FG001|Overall Study|Adverse Event|2|||
125617091|NCT04501679|451879981|FG000|Overall Study|Withdrawal by Subject|2|||
125617092|NCT04501679|451879982|FG001|Overall Study|Withdrawal by Subject|0|||
125617093|NCT04501679|451879981|FG000|Overall Study|Physician Decision|1|||
125432566|NCT02296190|451210321|FG003|Overall Study|Withdrawal by Subject|0|||
125432567|NCT02296190|451210322|FG004|Overall Study|Withdrawal by Subject|0|||
125432568|NCT02296190|451210323|FG005|Overall Study|Withdrawal by Subject|0|||
125432569|NCT02296190|451210318|FG000|Overall Study|PSVT < 5 minutes|5|||
125432570|NCT02296190|451210319|FG001|Overall Study|PSVT < 5 minutes|6|||
125432571|NCT02296190|451210320|FG002|Overall Study|PSVT < 5 minutes|6|||
125432572|NCT02296190|451210321|FG003|Overall Study|PSVT < 5 minutes|6|||
125432573|NCT02296190|451210322|FG004|Overall Study|PSVT < 5 minutes|5|||
125432574|NCT02296190|451210323|FG005|Overall Study|PSVT < 5 minutes|0|||
125432575|NCT02296190|451210318|FG000|Overall Study|Patient was given Propofol|0|||
125432576|NCT02296190|451210319|FG001|Overall Study|Patient was given Propofol|1|||
125432577|NCT02296190|451210320|FG002|Overall Study|Patient was given Propofol|0|||
125432578|NCT02296190|451210321|FG003|Overall Study|Patient was given Propofol|1|||
125432579|NCT02296190|451210322|FG004|Overall Study|Patient was given Propofol|0|||
125617094|NCT04501679|451879982|FG001|Overall Study|Physician Decision|0|||
125432580|NCT02296190|451210323|FG005|Overall Study|Patient was given Propofol|0|||
125432581|NCT02296190|451210318|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
125432582|NCT02296190|451210319|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
125432583|NCT02296190|451210320|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
125617095|NCT04501679|451879981|FG000|Overall Study|Lost to Follow-up|2|||
125617096|NCT04501679|451879982|FG001|Overall Study|Lost to Follow-up|0|||
125617097|NCT00910429|451879985|FG000|Overall Study|Death|18|||
125617098|NCT00910429|451879986|FG001|Overall Study|Death|12|||
125617099|NCT00910429|451879985|FG000|Overall Study|Withdrawal by Subject|3|||
125617100|NCT00910429|451879986|FG001|Overall Study|Withdrawal by Subject|2|||
125617101|NCT00910429|451879985|FG000|Overall Study|Protocol Violation|1|||
125617102|NCT00910429|451879986|FG001|Overall Study|Protocol Violation|0|||
125617103|NCT00910429|451879985|FG000|Overall Study|Lost to Follow-up|2|||
125617104|NCT00910429|451879986|FG001|Overall Study|Lost to Follow-up|1|||
125373686|NCT02207244|450998073|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125373687|NCT02207244|450998074|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
125373688|NCT02207244|450998064|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
125373689|NCT02207244|450998065|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
125373690|NCT02207244|450998066|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
125373691|NCT02207244|450998067|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125373692|NCT02207244|450998068|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125373693|NCT02207244|450998069|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125373694|NCT02207244|450998070|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125373695|NCT02207244|450998071|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125373696|NCT02207244|450998072|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125373697|NCT02207244|450998073|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125373698|NCT02207244|450998074|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
125373699|NCT02207244|450998064|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125373700|NCT02207244|450998065|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
125373701|NCT02207244|450998066|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
125373702|NCT02207244|450998067|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125373703|NCT02207244|450998068|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125373704|NCT02207244|450998069|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125373705|NCT02207244|450998070|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125373706|NCT02207244|450998071|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125373707|NCT02207244|450998072|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125373708|NCT02207244|450998073|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125373709|NCT02207244|450998074|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
125373710|NCT02207244|450998064|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
125373711|NCT02207244|450998065|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
125373712|NCT02207244|450998066|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
125373713|NCT02207244|450998067|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
125373714|NCT02207244|450998068|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
125373715|NCT02207244|450998069|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
125373716|NCT02207244|450998070|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
125373717|NCT02207244|450998071|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
125373718|NCT02207244|450998072|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
125373719|NCT02207244|450998073|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
125373720|NCT02207244|450998074|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
125373721|NCT02207244|450998064|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125373722|NCT02207244|450998065|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125373723|NCT02207244|450998066|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125373724|NCT02207244|450998067|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125373725|NCT02207244|450998068|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
125373726|NCT02207244|450998069|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
125373727|NCT02207244|450998070|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125373728|NCT02207244|450998071|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125373729|NCT02207244|450998072|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125373730|NCT02207244|450998073|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125617105|NCT00910429|451879985|FG000|Overall Study|Adverse Event|10|||
125214931|NCT02362425|450414876|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
125373731|NCT02207244|450998074|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
125373732|NCT02207244|450998064|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125617106|NCT00910429|451879986|FG001|Overall Study|Adverse Event|5|||
125617107|NCT00910429|451879985|FG000|Overall Study|Drug non-compliance|1|||
125617108|NCT00910429|451879986|FG001|Overall Study|Drug non-compliance|0|||
125617109|NCT00910429|451879985|FG000|Overall Study|Lack of Efficacy|4|||
125617110|NCT00910429|451879986|FG001|Overall Study|Lack of Efficacy|1|||
125617111|NCT02358369|451879990|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
125617112|NCT02358369|451879991|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
125617113|NCT02358369|451879992|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
125617114|NCT02358369|451879993|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
125617115|NCT02358369|451879994|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
125617116|NCT02358369|451879990|FG000|Treatment Period A/B|Adverse Event|0|||
125617117|NCT02358369|451879991|FG001|Treatment Period A/B|Adverse Event|0|||
125617118|NCT02358369|451879992|FG002|Treatment Period A/B|Adverse Event|1|||
125373733|NCT02207244|450998065|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125373734|NCT02207244|450998066|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125373735|NCT02207244|450998067|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125373736|NCT02207244|450998068|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125373737|NCT02207244|450998069|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
125373738|NCT02207244|450998070|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125373739|NCT02207244|450998071|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125373740|NCT02207244|450998072|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125373741|NCT02207244|450998073|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125373742|NCT02207244|450998074|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
125373743|NCT02207244|450998064|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125373744|NCT02207244|450998065|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125373745|NCT02207244|450998066|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125373746|NCT02207244|450998067|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
125373747|NCT02207244|450998068|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
125373748|NCT02207244|450998069|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
125373749|NCT02207244|450998070|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125373750|NCT02207244|450998071|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125373751|NCT02207244|450998072|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125373752|NCT02207244|450998073|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125373753|NCT02207244|450998074|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
125373754|NCT02207244|450998064|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125373755|NCT02207244|450998065|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125373756|NCT02207244|450998066|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125373757|NCT02207244|450998067|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
125432584|NCT02296190|451210321|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
125432585|NCT02296190|451210322|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
125432586|NCT02296190|451210323|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
125432587|NCT02296190|451210318|FG000|Overall Study|Blood pressure <100 after sedation|0|||
125432588|NCT02296190|451210319|FG001|Overall Study|Blood pressure <100 after sedation|0|||
125432589|NCT02296190|451210320|FG002|Overall Study|Blood pressure <100 after sedation|0|||
125432590|NCT02296190|451210321|FG003|Overall Study|Blood pressure <100 after sedation|1|||
125617119|NCT02358369|451879993|FG003|Treatment Period A/B|Adverse Event|2|||
125617120|NCT02358369|451879994|FG004|Treatment Period A/B|Adverse Event|0|||
125617121|NCT02358369|451879990|FG000|Treatment Period A/B|Death|0|||
125617122|NCT02358369|451879991|FG001|Treatment Period A/B|Death|0|||
125617123|NCT02358369|451879992|FG002|Treatment Period A/B|Death|1|||
125617124|NCT02358369|451879993|FG003|Treatment Period A/B|Death|0|||
125617125|NCT02358369|451879994|FG004|Treatment Period A/B|Death|0|||
125617126|NCT02358369|451879990|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
125617127|NCT02358369|451879991|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
125617128|NCT02358369|451879992|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
125617129|NCT02358369|451879993|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
125617130|NCT02358369|451879994|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
125617131|NCT02358369|451879990|FG000|Treatment Period C|Adverse Event|0|||
125373758|NCT02207244|450998068|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
125373759|NCT02207244|450998069|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
125373760|NCT02207244|450998070|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125373761|NCT02207244|450998071|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125373762|NCT02207244|450998072|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125373763|NCT02207244|450998073|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125373764|NCT02207244|450998074|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
125373765|NCT02207244|450998064|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125617132|NCT02358369|451879991|FG001|Treatment Period C|Adverse Event|0|||
125617133|NCT02358369|451879992|FG002|Treatment Period C|Adverse Event|0|||
125617134|NCT02358369|451879993|FG003|Treatment Period C|Adverse Event|0|||
125617135|NCT02358369|451879994|FG004|Treatment Period C|Adverse Event|7|||
125617136|NCT04465396|451879995|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
125617137|NCT04465396|451879996|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
125617138|NCT04465396|451879997|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
125617139|NCT04465396|451879998|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
125617140|NCT02365584|451880006|FG000|Overall Study|Adverse Event|2|||
125617141|NCT02365584|451880007|FG001|Overall Study|Adverse Event|2|||
125432591|NCT02296190|451210322|FG004|Overall Study|Blood pressure <100 after sedation|0|||
125432592|NCT02296190|451210323|FG005|Overall Study|Blood pressure <100 after sedation|0|||
125432593|NCT02296190|451210318|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
125432594|NCT02296190|451210319|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
125432595|NCT02296190|451210320|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
125432596|NCT02296190|451210321|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
125432597|NCT02296190|451210322|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
125432598|NCT02296190|451210323|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
125432599|NCT02296190|451210318|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
125432600|NCT02296190|451210319|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
125432601|NCT02296190|451210320|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
125432602|NCT02296190|451210321|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
125432603|NCT02296190|451210322|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
125432604|NCT02296190|451210323|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
125432605|NCT02296190|451210318|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
125432606|NCT02296190|451210319|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
125432607|NCT02296190|451210320|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
125432608|NCT02296190|451210321|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
125432609|NCT02296190|451210322|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
125432610|NCT02296190|451210323|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
125432611|NCT02296190|451210318|FG000|Overall Study|Lab result not available in time|1|||
125432612|NCT02296190|451210319|FG001|Overall Study|Lab result not available in time|0|||
125432613|NCT02296190|451210320|FG002|Overall Study|Lab result not available in time|0|||
125432614|NCT02296190|451210321|FG003|Overall Study|Lab result not available in time|0|||
125432615|NCT02296190|451210322|FG004|Overall Study|Lab result not available in time|0|||
125432616|NCT02296190|451210323|FG005|Overall Study|Lab result not available in time|0|||
125432617|NCT00782496|451210324|FG000|Overall Study|Lost to Follow-up|14|||
125617142|NCT02365584|451880006|FG000|Overall Study|Withdrawal by Subject|1|||
125617143|NCT02365584|451880007|FG001|Overall Study|Withdrawal by Subject|0|||
125617144|NCT02365584|451880006|FG000|Overall Study|Disease Progression|9|||
125617145|NCT02365584|451880007|FG001|Overall Study|Disease Progression|12|||
125432618|NCT00782496|451210325|FG001|Overall Study|Lost to Follow-up|15|||
125432619|NCT00990340|451210327|FG000|First 14-day Treatment|Not Compliant|2|||
125432620|NCT00990340|451210328|FG001|First 14-day Treatment|Not Compliant|1|||
125432621|NCT00990340|451210327|FG000|First 14-day Treatment|Lost to Follow-up|2|||
125432622|NCT00990340|451210328|FG001|First 14-day Treatment|Lost to Follow-up|1|||
125432623|NCT00990340|451210327|FG000|First 14-day Treatment|Protocol Violation|2|||
125617146|NCT01973452|451880012|FG000|Overall Study|Lack of Efficacy|0|||
125617147|NCT01973452|451880013|FG001|Overall Study|Lack of Efficacy|1|||
125617148|NCT01973452|451880012|FG000|Overall Study|Lost to Follow-up|1|||
125617149|NCT01973452|451880013|FG001|Overall Study|Lost to Follow-up|0|||
125617150|NCT01973452|451880012|FG000|Overall Study|Withdrawal by Subject|10|||
125617151|NCT01973452|451880013|FG001|Overall Study|Withdrawal by Subject|9|||
125617152|NCT01973452|451880012|FG000|Overall Study|Ineligible|1|||
125617153|NCT01973452|451880013|FG001|Overall Study|Ineligible|1|||
125617154|NCT01973452|451880012|FG000|Overall Study|Surgery canceled by participant|5|||
125617155|NCT01973452|451880013|FG001|Overall Study|Surgery canceled by participant|3|||
125617156|NCT00349752|451880014|FG000|Overall Study|Adverse Event|8|||
125617157|NCT00349752|451880015|FG001|Overall Study|Adverse Event|12|||
125617158|NCT00349752|451880014|FG000|Overall Study|Lack of Efficacy|37|||
125617159|NCT00349752|451880015|FG001|Overall Study|Lack of Efficacy|42|||
125617160|NCT00349752|451880014|FG000|Overall Study|Lost to Follow-up|4|||
125617161|NCT00349752|451880015|FG001|Overall Study|Lost to Follow-up|2|||
125617162|NCT00349752|451880014|FG000|Overall Study|Personal reasons|6|||
125214932|NCT02362425|450414877|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
125214933|NCT02362425|450414878|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
125214934|NCT02362425|450414879|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
125432624|NCT00990340|451210328|FG001|First 14-day Treatment|Protocol Violation|2|||
125432625|NCT04615182|451210329|FG000|Overall Study|Re-transplanted|2|||
125432626|NCT04615182|451210329|FG000|Overall Study|Protocol Violation|6|||
125432627|NCT04615182|451210329|FG000|Overall Study|Death|6|||
125432628|NCT04615182|451210329|FG000|Overall Study|Death and protocol violation|1|||
125432629|NCT01874145|451210332|FG000|Core Period|Non-compliance|1|||
125432630|NCT01874145|451210333|FG001|Core Period|Non-compliance|0|||
125432631|NCT01874145|451210332|FG000|Core Period|Protocol Violation|1|||
125617163|NCT00349752|451880015|FG001|Overall Study|Personal reasons|5|||
125617164|NCT00349752|451880014|FG000|Overall Study|Other: Required exclusionary medication|0|||
125617165|NCT00349752|451880015|FG001|Overall Study|Other: Required exclusionary medication|1|||
125617166|NCT00349752|451880014|FG000|Overall Study|Other: Non compliance|0|||
125617167|NCT00349752|451880015|FG001|Overall Study|Other: Non compliance|1|||
125617168|NCT00349752|451880014|FG000|Overall Study|Other: Patient stopped steroids|0|||
125617169|NCT00349752|451880015|FG001|Overall Study|Other: Patient stopped steroids|1|||
125214935|NCT02362425|450414876|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
125214936|NCT02362425|450414877|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
125214937|NCT02362425|450414878|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
125214938|NCT02362425|450414879|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
125214939|NCT02362425|450414876|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
125214940|NCT02362425|450414877|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
125214941|NCT02362425|450414878|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
125214942|NCT02362425|450414879|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
125214943|NCT02362425|450414876|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
125214944|NCT02362425|450414877|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
125214945|NCT02362425|450414878|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
125214946|NCT02362425|450414879|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
125214947|NCT02362425|450414876|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
125214948|NCT02362425|450414877|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
125214949|NCT02362425|450414878|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
125214950|NCT02362425|450414879|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
125214951|NCT02362425|450414876|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
125214952|NCT02362425|450414877|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
125214953|NCT02362425|450414878|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
125214954|NCT02362425|450414879|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
125214955|NCT00802672|450414882|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
125214956|NCT00802672|450414883|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
125214957|NCT00802672|450414884|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
125214958|NCT00802672|450414882|FG000|Overall Study|Adverse Event|1|||
125214959|NCT00802672|450414883|FG001|Overall Study|Adverse Event|1|||
125214960|NCT00802672|450414884|FG002|Overall Study|Adverse Event|1|||
125214961|NCT00802672|450414882|FG000|Overall Study|Protocol Violation|2|||
125214962|NCT00802672|450414883|FG001|Overall Study|Protocol Violation|1|||
125214963|NCT00802672|450414884|FG002|Overall Study|Protocol Violation|1|||
125214964|NCT00802672|450414882|FG000|Overall Study|Lost to Follow-up|5|||
125214965|NCT00802672|450414883|FG001|Overall Study|Lost to Follow-up|5|||
125214966|NCT00802672|450414884|FG002|Overall Study|Lost to Follow-up|3|||
125214967|NCT00802672|450414882|FG000|Overall Study|Withdrawal by Subject|1|||
125214968|NCT00802672|450414883|FG001|Overall Study|Withdrawal by Subject|1|||
125214969|NCT00802672|450414884|FG002|Overall Study|Withdrawal by Subject|2|||
125214970|NCT00802672|450414882|FG000|Overall Study|other|3|||
125214971|NCT00802672|450414883|FG001|Overall Study|other|1|||
125214972|NCT00802672|450414884|FG002|Overall Study|other|2|||
125214973|NCT02579382|450414887|FG000|Main Study Phase|Lost to Follow-up|0|||
125214974|NCT02579382|450414888|FG001|Main Study Phase|Lost to Follow-up|0|||
125214975|NCT02579382|450414889|FG002|Main Study Phase|Lost to Follow-up|2|||
125214976|NCT02579382|450414890|FG003|Main Study Phase|Lost to Follow-up|0|||
125373766|NCT02207244|450998065|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125373767|NCT02207244|450998066|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125373768|NCT02207244|450998067|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
125373769|NCT02207244|450998068|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125373770|NCT02207244|450998069|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
125373771|NCT02207244|450998070|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125373772|NCT02207244|450998071|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125373773|NCT02207244|450998072|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125373774|NCT02207244|450998073|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125373775|NCT02207244|450998074|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
125373776|NCT02207244|450998064|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
125373777|NCT02207244|450998065|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
125373778|NCT02207244|450998066|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
125373779|NCT02207244|450998067|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
125373780|NCT02207244|450998068|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
125373781|NCT02207244|450998069|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
125373782|NCT02207244|450998070|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
125373783|NCT02207244|450998071|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
125373784|NCT02207244|450998072|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
125373785|NCT02207244|450998073|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
125373786|NCT02207244|450998074|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
125373787|NCT02207244|450998064|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125373788|NCT02207244|450998065|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125373789|NCT02207244|450998066|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125373790|NCT02207244|450998067|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125373791|NCT02207244|450998068|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125617170|NCT00349752|451880014|FG000|Overall Study|Other: Patient's steroid use|1|||
125373792|NCT02207244|450998069|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125432632|NCT01874145|451210333|FG001|Core Period|Protocol Violation|1|||
125432633|NCT01874145|451210332|FG000|Core Period|Physician Decision|1|||
125432634|NCT01874145|451210333|FG001|Core Period|Physician Decision|1|||
125432635|NCT01874145|451210332|FG000|Core Period|Adverse Event|0|||
125432636|NCT01874145|451210333|FG001|Core Period|Adverse Event|1|||
125432637|NCT01874145|451210332|FG000|Core Period|Withdrawal by Subject|0|||
125432638|NCT01874145|451210333|FG001|Core Period|Withdrawal by Subject|4|||
125432639|NCT01874145|451210332|FG000|Extension Period|Adverse Event|3|||
125432640|NCT01874145|451210333|FG001|Extension Period|Adverse Event|2|||
125432641|NCT01874145|451210332|FG000|Extension Period|Withdrawal by Subject|2|||
125432642|NCT01874145|451210333|FG001|Extension Period|Withdrawal by Subject|1|||
125432643|NCT01874145|451210332|FG000|Extension Period|Lost to Follow-up|1|||
125432644|NCT01874145|451210333|FG001|Extension Period|Lost to Follow-up|1|||
125617171|NCT00349752|451880015|FG001|Overall Study|Other: Patient's steroid use|0|||
125617172|NCT00349752|451880014|FG000|Overall Study|Other: Ineligible|1|||
125617173|NCT00349752|451880015|FG001|Overall Study|Other: Ineligible|0|||
125617174|NCT00349752|451880014|FG000|Overall Study|Other: Inadvertently unblinded|1|||
125617175|NCT00349752|451880015|FG001|Overall Study|Other: Inadvertently unblinded|0|||
125617176|NCT00349752|451880014|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
125214977|NCT02579382|450414887|FG000|Main Study Phase|Withdrew Consent|0|||
125373793|NCT02207244|450998070|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
125373794|NCT02207244|450998071|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
125373795|NCT02207244|450998072|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
125373796|NCT02207244|450998073|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
125373797|NCT02207244|450998074|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
125373798|NCT02207244|450998064|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125373799|NCT02207244|450998065|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125373800|NCT02207244|450998066|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125373801|NCT02207244|450998067|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125373802|NCT02207244|450998068|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125373803|NCT02207244|450998069|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125373804|NCT02207244|450998070|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125373805|NCT02207244|450998071|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
125373806|NCT02207244|450998072|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125373807|NCT02207244|450998073|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125373808|NCT02207244|450998074|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
125373809|NCT02207244|450998064|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125373810|NCT02207244|450998065|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125373811|NCT02207244|450998066|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125373812|NCT02207244|450998067|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125373813|NCT02207244|450998068|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125373814|NCT02207244|450998069|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125373815|NCT02207244|450998070|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
125373816|NCT02207244|450998071|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
125373817|NCT02207244|450998072|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
125373818|NCT02207244|450998073|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
125373819|NCT02207244|450998074|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
125373820|NCT02207244|450998064|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125373821|NCT02207244|450998065|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125373822|NCT02207244|450998066|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125373823|NCT02207244|450998067|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125373824|NCT02207244|450998068|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125373825|NCT02207244|450998069|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125373826|NCT02207244|450998070|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
125373827|NCT02207244|450998071|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
125373828|NCT02207244|450998072|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125373829|NCT02207244|450998073|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
125373830|NCT02207244|450998074|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
125373831|NCT02207244|450998064|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125373832|NCT02207244|450998065|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125373833|NCT02207244|450998066|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125373834|NCT02207244|450998067|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125373835|NCT02207244|450998068|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125373836|NCT02207244|450998069|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125373837|NCT02207244|450998070|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
125432645|NCT00402337|451210338|FG000|Overall Study|Adverse Event|0|||
125432646|NCT00402337|451210339|FG001|Overall Study|Adverse Event|2|||
125432647|NCT00402337|451210340|FG002|Overall Study|Adverse Event|2|||
125432648|NCT00402337|451210341|FG003|Overall Study|Adverse Event|3|||
125432649|NCT00402337|451210342|FG004|Overall Study|Adverse Event|2|||
125432650|NCT00402337|451210338|FG000|Overall Study|Noncompliance|0|||
125617177|NCT00349752|451880015|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
125617178|NCT05294211|451880017|FG000|Overall Study|Withdrawal by Subject|3|||
125432651|NCT00402337|451210339|FG001|Overall Study|Noncompliance|0|||
125432652|NCT00402337|451210340|FG002|Overall Study|Noncompliance|0|||
125617179|NCT05294211|451880017|FG000|Overall Study|Physician Decision|2|||
125617180|NCT05294211|451880017|FG000|Overall Study|Progressed to active labor|1|||
125617181|NCT05294211|451880017|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
125617182|NCT05294211|451880017|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
125617183|NCT00064350|451880018|FG000|Induction Treatment|Disease Progression|5|||
125617184|NCT00064350|451880019|FG001|Induction Treatment|Disease Progression|1|||
125432653|NCT00402337|451210341|FG003|Overall Study|Noncompliance|0|||
125432654|NCT00402337|451210342|FG004|Overall Study|Noncompliance|2|||
125432655|NCT00402337|451210338|FG000|Overall Study|Withdrawal by Subject|5|||
125432656|NCT00402337|451210339|FG001|Overall Study|Withdrawal by Subject|3|||
125432657|NCT00402337|451210340|FG002|Overall Study|Withdrawal by Subject|1|||
125432658|NCT00402337|451210341|FG003|Overall Study|Withdrawal by Subject|6|||
125432659|NCT00402337|451210342|FG004|Overall Study|Withdrawal by Subject|4|||
125432660|NCT00402337|451210338|FG000|Overall Study|Lost to Follow-up|0|||
125432661|NCT00402337|451210339|FG001|Overall Study|Lost to Follow-up|0|||
125432662|NCT00402337|451210340|FG002|Overall Study|Lost to Follow-up|1|||
125432663|NCT00402337|451210341|FG003|Overall Study|Lost to Follow-up|2|||
125617185|NCT00064350|451880020|FG002|Induction Treatment|Disease Progression|110|||
125617186|NCT00064350|451880018|FG000|Induction Treatment|Adverse Event|0|||
125432664|NCT00402337|451210342|FG004|Overall Study|Lost to Follow-up|0|||
125432665|NCT00402337|451210338|FG000|Overall Study|Physician Decision|0|||
125432666|NCT00402337|451210339|FG001|Overall Study|Physician Decision|0|||
125432667|NCT00402337|451210340|FG002|Overall Study|Physician Decision|0|||
125432668|NCT00402337|451210341|FG003|Overall Study|Physician Decision|1|||
125432669|NCT00402337|451210342|FG004|Overall Study|Physician Decision|0|||
125432670|NCT00402337|451210338|FG000|Overall Study|Other Reason|0|||
125432671|NCT00402337|451210339|FG001|Overall Study|Other Reason|1|||
125432672|NCT00402337|451210340|FG002|Overall Study|Other Reason|0|||
125432673|NCT00402337|451210341|FG003|Overall Study|Other Reason|0|||
125432674|NCT00402337|451210342|FG004|Overall Study|Other Reason|0|||
125432675|NCT02178566|451210343|FG000|Overall Study|patient did not complete due to noncompliance|0|||
125432676|NCT02178566|451210344|FG001|Overall Study|patient did not complete due to noncompliance|1|||
125432677|NCT02070484|451210349|FG000|Overall Study|Withdrawal by Subject|1|||
125432678|NCT02070484|451210350|FG001|Overall Study|Withdrawal by Subject|0|||
125617187|NCT00064350|451880019|FG001|Induction Treatment|Adverse Event|2|||
125617188|NCT00064350|451880020|FG002|Induction Treatment|Adverse Event|49|||
125617189|NCT00064350|451880018|FG000|Induction Treatment|Death|0|||
125617190|NCT00064350|451880019|FG001|Induction Treatment|Death|0|||
125617191|NCT00064350|451880020|FG002|Induction Treatment|Death|9|||
125617192|NCT00064350|451880018|FG000|Induction Treatment|Withdrawal by Subject|0|||
125617193|NCT00064350|451880019|FG001|Induction Treatment|Withdrawal by Subject|0|||
125617194|NCT00064350|451880020|FG002|Induction Treatment|Withdrawal by Subject|21|||
125617195|NCT00064350|451880018|FG000|Induction Treatment|Ineligible or never started treatment|3|||
125617196|NCT00064350|451880019|FG001|Induction Treatment|Ineligible or never started treatment|6|||
125617197|NCT00064350|451880020|FG002|Induction Treatment|Ineligible or never started treatment|34|||
125617198|NCT00064350|451880018|FG000|Induction Treatment|Other|0|||
125617199|NCT00064350|451880019|FG001|Induction Treatment|Other|0|||
125617200|NCT00064350|451880020|FG002|Induction Treatment|Other|13|||
125617201|NCT00064350|451880018|FG000|Randomization|Adverse Event|8|||
125617202|NCT00064350|451880019|FG001|Randomization|Adverse Event|3|||
125617203|NCT00064350|451880020|FG002|Randomization|Adverse Event|0|||
125617204|NCT00064350|451880018|FG000|Randomization|Death|3|||
125214978|NCT02579382|450414888|FG001|Main Study Phase|Withdrew Consent|0|||
125214979|NCT02579382|450414889|FG002|Main Study Phase|Withdrew Consent|0|||
125617205|NCT00064350|451880019|FG001|Randomization|Death|0|||
125617206|NCT00064350|451880020|FG002|Randomization|Death|0|||
125617207|NCT00064350|451880018|FG000|Randomization|Withdrawal by Subject|1|||
125617208|NCT00064350|451880019|FG001|Randomization|Withdrawal by Subject|0|||
125617209|NCT00064350|451880020|FG002|Randomization|Withdrawal by Subject|0|||
125432679|NCT02658630|451210353|FG000|Overall Study|Withdrawal by Subject|4|||
125432680|NCT02821819|451210354|FG000|Overall Study|Protocol Violation|1|||
125617210|NCT00064350|451880018|FG000|Randomization|Ineligible or never started treatment|9|||
125617211|NCT00064350|451880019|FG001|Randomization|Ineligible or never started treatment|15|||
125617212|NCT00064350|451880020|FG002|Randomization|Ineligible or never started treatment|0|||
125617213|NCT00064350|451880018|FG000|Randomization|Other|5|||
125617214|NCT00064350|451880019|FG001|Randomization|Other|0|||
125617215|NCT00064350|451880020|FG002|Randomization|Other|0|||
125214980|NCT02579382|450414890|FG003|Main Study Phase|Withdrew Consent|2|||
125617216|NCT00064350|451880018|FG000|Cross-Over|Adverse Event|0|||
125617217|NCT00064350|451880019|FG001|Cross-Over|Adverse Event|1|||
125617218|NCT00064350|451880020|FG002|Cross-Over|Adverse Event|0|||
125373838|NCT02207244|450998071|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
125373839|NCT02207244|450998072|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
125373840|NCT02207244|450998073|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
125617219|NCT00064350|451880018|FG000|Cross-Over|Death|1|||
125617220|NCT00064350|451880019|FG001|Cross-Over|Death|3|||
125617221|NCT00064350|451880020|FG002|Cross-Over|Death|0|||
125617222|NCT00064350|451880018|FG000|Cross-Over|Withdrawal by Subject|2|||
125617223|NCT00064350|451880019|FG001|Cross-Over|Withdrawal by Subject|2|||
125617224|NCT00064350|451880020|FG002|Cross-Over|Withdrawal by Subject|0|||
125617225|NCT00064350|451880018|FG000|Cross-Over|Ineligible or never started treatment|3|||
125617226|NCT00064350|451880019|FG001|Cross-Over|Ineligible or never started treatment|6|||
125617227|NCT00064350|451880020|FG002|Cross-Over|Ineligible or never started treatment|0|||
125617228|NCT00064350|451880018|FG000|Cross-Over|Other|0|||
125617229|NCT00064350|451880019|FG001|Cross-Over|Other|2|||
125617230|NCT00064350|451880020|FG002|Cross-Over|Other|0|||
125617231|NCT00838916|451880021|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
125617232|NCT00838916|451880022|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
125617233|NCT00838916|451880021|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
125617234|NCT00838916|451880022|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
125617235|NCT00838916|451880021|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
125617236|NCT00838916|451880022|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
125617237|NCT00838916|451880021|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
125617238|NCT00838916|451880022|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
125617239|NCT00838916|451880021|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
125617240|NCT00838916|451880022|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
125617241|NCT00838916|451880021|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
125617242|NCT00838916|451880022|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
125617243|NCT00838916|451880021|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
125617244|NCT00838916|451880022|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
125617245|NCT00838916|451880021|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
125617246|NCT00838916|451880022|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
125617247|NCT00838916|451880021|FG000|Treatment Period (156 Weeks)|Missing|3|||
125617248|NCT00838916|451880022|FG001|Treatment Period (156 Weeks)|Missing|1|||
125617249|NCT00838916|451880021|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
125617250|NCT00838916|451880022|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
125617251|NCT00838916|451880021|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
125617252|NCT00838916|451880022|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
125617253|NCT00838916|451880021|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
125373841|NCT02207244|450998074|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
125617254|NCT00838916|451880022|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
125617255|NCT00838916|451880021|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
125617256|NCT00838916|451880022|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
125617257|NCT00838916|451880021|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
125617258|NCT00838916|451880022|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
125617259|NCT00838916|451880021|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
125617260|NCT00838916|451880022|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
125617261|NCT00838916|451880021|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
125617262|NCT00838916|451880022|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
125617263|NCT00838916|451880021|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
125214981|NCT02579382|450414887|FG000|Main Study Phase|Lack of Efficacy|0|||
125214982|NCT02579382|450414888|FG001|Main Study Phase|Lack of Efficacy|0|||
125214983|NCT02579382|450414889|FG002|Main Study Phase|Lack of Efficacy|0|||
125617264|NCT00838916|451880022|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
125617265|NCT00838916|451880021|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
125617266|NCT00838916|451880022|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
125617267|NCT00838916|451880021|FG000|Follow-up Period (8 Weeks)|Missing|3|||
125617268|NCT00838916|451880022|FG001|Follow-up Period (8 Weeks)|Missing|0|||
125617269|NCT01842607|451880024|FG000|Overall Study|Adverse Event|11|||
125617270|NCT01842607|451880024|FG000|Overall Study|Lack of Efficacy|19|||
125617271|NCT01842607|451880024|FG000|Overall Study|Protocol Violation|8|||
125617272|NCT01842607|451880024|FG000|Overall Study|Protocol defined stopping criteria|2|||
125617273|NCT01842607|451880024|FG000|Overall Study|Lost to Follow-up|3|||
125617274|NCT01842607|451880024|FG000|Overall Study|Physician Decision|9|||
125617275|NCT01842607|451880024|FG000|Overall Study|Withdrawal by Subject|14|||
125617276|NCT02034474|451880025|FG000|Overall Study|Adverse Event|3|||
125617277|NCT02034474|451880026|FG001|Overall Study|Adverse Event|2|||
125617278|NCT02034474|451880025|FG000|Overall Study|Withdrawal by Subject|1|||
125617279|NCT02034474|451880026|FG001|Overall Study|Withdrawal by Subject|2|||
125617280|NCT00675103|451880027|FG000|Overall Study|Lack of Efficacy|2|||
125617281|NCT00675103|451880027|FG000|Overall Study|Adverse Event|1|||
125617282|NCT03600714|451880028|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
125617283|NCT02164513|451880031|FG000|Overall Study|Adverse Event|162|||
125617284|NCT02164513|451880032|FG001|Overall Study|Adverse Event|180|||
125617285|NCT02164513|451880033|FG002|Overall Study|Adverse Event|111|||
125617286|NCT02164513|451880031|FG000|Overall Study|Other: Study Closed or terminated|5|||
125617287|NCT02164513|451880032|FG001|Overall Study|Other: Study Closed or terminated|2|||
125617288|NCT02164513|451880033|FG002|Overall Study|Other: Study Closed or terminated|4|||
125617289|NCT02164513|451880031|FG000|Overall Study|Lost to Follow-up|30|||
125617290|NCT02164513|451880032|FG001|Overall Study|Lost to Follow-up|36|||
125617291|NCT02164513|451880033|FG002|Overall Study|Lost to Follow-up|22|||
125617292|NCT02164513|451880031|FG000|Overall Study|Physician Decision|47|||
125617293|NCT02164513|451880032|FG001|Overall Study|Physician Decision|57|||
125617294|NCT02164513|451880033|FG002|Overall Study|Physician Decision|28|||
125617295|NCT02164513|451880031|FG000|Overall Study|Withdrawal by Subject|192|||
125617296|NCT02164513|451880032|FG001|Overall Study|Withdrawal by Subject|261|||
125617297|NCT02164513|451880033|FG002|Overall Study|Withdrawal by Subject|130|||
125617298|NCT02164513|451880031|FG000|Overall Study|Other: Reason not provided by site|1|||
125617299|NCT02164513|451880032|FG001|Overall Study|Other: Reason not provided by site|0|||
125617300|NCT02164513|451880033|FG002|Overall Study|Other: Reason not provided by site|0|||
125637238|NCT03073200|451952844|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
125637239|NCT03073200|451952845|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
125637240|NCT03073200|451952846|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
125637241|NCT03073200|451952832|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125637242|NCT03073200|451952833|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125637243|NCT03073200|451952834|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125637244|NCT03073200|451952835|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125637245|NCT03073200|451952836|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125637246|NCT03073200|451952837|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125637247|NCT03073200|451952838|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125637248|NCT03073200|451952839|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125637249|NCT03073200|451952840|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125637250|NCT03073200|451952841|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125637251|NCT03073200|451952842|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125637252|NCT03073200|451952843|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
125637253|NCT03073200|451952844|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125637254|NCT03073200|451952845|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125214984|NCT02579382|450414890|FG003|Main Study Phase|Lack of Efficacy|1|||
125214985|NCT02579382|450414887|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
125214986|NCT02579382|450414888|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
125432681|NCT03238300|451210357|FG000|Baseline (Before Intervention)|Physician Decision|0|||
125637255|NCT03073200|451952846|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
125214987|NCT02579382|450414889|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
125637256|NCT03073200|451952832|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125637257|NCT03073200|451952833|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125637258|NCT03073200|451952834|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125214988|NCT02579382|450414890|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
125214989|NCT02579382|450414887|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
125637259|NCT03073200|451952835|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125637260|NCT03073200|451952836|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125617301|NCT03073213|451881820|FG000|Multiple Dose Period|Protocol Violation|0|||
125617302|NCT03073213|451881821|FG001|Multiple Dose Period|Protocol Violation|0|||
125617303|NCT03073213|451881822|FG002|Multiple Dose Period|Protocol Violation|1|||
125617304|NCT00280150|451881826|FG000|Overall Study|Adverse Event|0|||
125432682|NCT03238300|451210358|FG001|Baseline (Before Intervention)|Physician Decision|1|||
125432683|NCT03238300|451210357|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
125432684|NCT03238300|451210358|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
125432685|NCT03238300|451210357|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
125432686|NCT03238300|451210358|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
125432687|NCT03238300|451210357|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
125432688|NCT03238300|451210358|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
125432689|NCT00110890|451210360|FG000|Overall Study|Adverse Event|30|||
125432690|NCT00110890|451210361|FG001|Overall Study|Adverse Event|7|||
125432691|NCT00110890|451210360|FG000|Overall Study|Death|16|||
125432692|NCT00110890|451210361|FG001|Overall Study|Death|9|||
125432693|NCT00110890|451210360|FG000|Overall Study|Lost to Follow-up|3|||
125432694|NCT00110890|451210361|FG001|Overall Study|Lost to Follow-up|1|||
125432695|NCT00110890|451210360|FG000|Overall Study|Physician Decision|4|||
125432696|NCT00110890|451210361|FG001|Overall Study|Physician Decision|5|||
125432697|NCT00110890|451210360|FG000|Overall Study|Withdrawal by Subject|17|||
125432698|NCT00110890|451210361|FG001|Overall Study|Withdrawal by Subject|5|||
125432699|NCT00110890|451210360|FG000|Overall Study|Protocol Deviation|1|||
125432700|NCT00110890|451210361|FG001|Overall Study|Protocol Deviation|0|||
125432701|NCT00110890|451210360|FG000|Overall Study|Noncompliance|10|||
125432702|NCT00110890|451210361|FG001|Overall Study|Noncompliance|0|||
125432703|NCT00110890|451210360|FG000|Overall Study|Kidney Transplant|16|||
125432704|NCT00110890|451210361|FG001|Overall Study|Kidney Transplant|12|||
125432705|NCT00110890|451210360|FG000|Overall Study|Invest. Product Commercially Available|217|||
125432706|NCT00110890|451210361|FG001|Overall Study|Invest. Product Commercially Available|110|||
125432707|NCT00110890|451210360|FG000|Overall Study|Other|34|||
125432708|NCT00110890|451210361|FG001|Overall Study|Other|23|||
125432709|NCT00110890|451210360|FG000|Overall Study|Ineligibility determined|3|||
125432710|NCT00110890|451210361|FG001|Overall Study|Ineligibility determined|0|||
125432711|NCT00110890|451210360|FG000|Overall Study|Requirement for alternative therapy|0|||
125432712|NCT00110890|451210361|FG001|Overall Study|Requirement for alternative therapy|1|||
125432713|NCT00110890|451210360|FG000|Overall Study|Disease progression|0|||
125432714|NCT00110890|451210361|FG001|Overall Study|Disease progression|1|||
125432715|NCT00110890|451210360|FG000|Overall Study|Parathyroidectomy|0|||
125432716|NCT00110890|451210361|FG001|Overall Study|Parathyroidectomy|1|||
125432717|NCT00110890|451210360|FG000|Overall Study|Did not enter follow-up phase|10|||
125432718|NCT00110890|451210361|FG001|Overall Study|Did not enter follow-up phase|4|||
125432719|NCT01975220|451210362|FG000|Test Period 1|Not treated|0|||
125432720|NCT01975220|451210363|FG001|Test Period 1|Not treated|1|||
125432721|NCT01975220|451210364|FG002|Test Period 1|Not treated|0|||
125432722|NCT01975220|451210365|FG003|Test Period 1|Not treated|0|||
125432723|NCT01975220|451210366|FG004|Test Period 1|Not treated|0|||
125432724|NCT01975220|451210367|FG005|Test Period 1|Not treated|0|||
125432725|NCT02839343|451210368|FG000|Overall Study|Withdrawal by Subject|3|||
125432726|NCT02839343|451210369|FG001|Overall Study|Withdrawal by Subject|1|||
125432727|NCT02839343|451210368|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
125217430|NCT01348100|450423524|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125432728|NCT02839343|451210369|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
125432729|NCT02839343|451210368|FG000|Overall Study|Adverse Event|1|||
125432730|NCT02839343|451210369|FG001|Overall Study|Adverse Event|0|||
125432731|NCT01852058|451210370|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
125432732|NCT01852058|451210371|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125432733|NCT01852058|451210372|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125432734|NCT01852058|451210373|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125432735|NCT01852058|451210374|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125617305|NCT00280150|451881827|FG001|Overall Study|Adverse Event|1|||
125617306|NCT00280150|451881828|FG002|Overall Study|Adverse Event|2|||
125617307|NCT00280150|451881829|FG003|Overall Study|Adverse Event|3|||
125617308|NCT00280150|451881826|FG000|Overall Study|Lack of Efficacy|0|||
125617309|NCT00280150|451881827|FG001|Overall Study|Lack of Efficacy|0|||
125617310|NCT00280150|451881828|FG002|Overall Study|Lack of Efficacy|0|||
125617311|NCT00280150|451881829|FG003|Overall Study|Lack of Efficacy|3|||
125617312|NCT00280150|451881826|FG000|Overall Study|Physician Decision|0|||
125617313|NCT00280150|451881827|FG001|Overall Study|Physician Decision|0|||
125617314|NCT00280150|451881828|FG002|Overall Study|Physician Decision|0|||
125617315|NCT00280150|451881829|FG003|Overall Study|Physician Decision|1|||
125617316|NCT00280150|451881826|FG000|Overall Study|Protocol Violation|0|||
125617317|NCT00280150|451881827|FG001|Overall Study|Protocol Violation|0|||
125617318|NCT00280150|451881828|FG002|Overall Study|Protocol Violation|0|||
125617319|NCT00280150|451881829|FG003|Overall Study|Protocol Violation|1|||
125617320|NCT00280150|451881826|FG000|Overall Study|Withdrawal by Subject|0|||
125617321|NCT00280150|451881827|FG001|Overall Study|Withdrawal by Subject|0|||
125432736|NCT01852058|451210375|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125432737|NCT01852058|451210376|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125432738|NCT01852058|451210377|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125432739|NCT01852058|451210378|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125432740|NCT01852058|451210379|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125432741|NCT01852058|451210380|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125432742|NCT01852058|451210381|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
125432743|NCT01852058|451210370|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125432744|NCT01852058|451210371|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125432745|NCT01852058|451210372|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125432746|NCT01852058|451210373|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125432747|NCT01852058|451210374|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
125432748|NCT01852058|451210375|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125432749|NCT01852058|451210376|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125432750|NCT01852058|451210377|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125432751|NCT01852058|451210378|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125432752|NCT01852058|451210379|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125432753|NCT01852058|451210380|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125432754|NCT01852058|451210381|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
125432755|NCT01852058|451210370|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125432756|NCT01852058|451210371|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125432757|NCT01852058|451210372|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125432758|NCT01852058|451210373|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125432759|NCT01852058|451210374|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
125432760|NCT01852058|451210375|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
125432761|NCT01852058|451210376|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125432762|NCT01852058|451210377|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125432763|NCT01852058|451210378|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125432764|NCT01852058|451210379|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125432765|NCT01852058|451210380|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125432766|NCT01852058|451210381|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
125432767|NCT01852058|451210370|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125432768|NCT01852058|451210371|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125432769|NCT01852058|451210372|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125432770|NCT01852058|451210373|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125432771|NCT01852058|451210374|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
125432772|NCT01852058|451210375|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125432773|NCT01852058|451210376|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125432774|NCT01852058|451210377|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125373842|NCT02207244|450998064|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125373843|NCT02207244|450998065|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125373844|NCT02207244|450998066|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125373845|NCT02207244|450998067|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125373846|NCT02207244|450998068|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125373847|NCT02207244|450998069|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125373848|NCT02207244|450998070|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125373849|NCT02207244|450998071|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
125373850|NCT02207244|450998072|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
125432775|NCT01852058|451210378|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125432776|NCT01852058|451210379|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125432777|NCT01852058|451210380|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125432778|NCT01852058|451210381|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
125432779|NCT01852058|451210370|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125432780|NCT01852058|451210371|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125432781|NCT01852058|451210372|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125432782|NCT01852058|451210373|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125432783|NCT01852058|451210374|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
125432784|NCT01852058|451210375|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
125432785|NCT01852058|451210376|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125432786|NCT01852058|451210377|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125432787|NCT01852058|451210378|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125432788|NCT01852058|451210379|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125432789|NCT01852058|451210380|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125432790|NCT01852058|451210381|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
125432791|NCT01852058|451210370|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125432792|NCT01852058|451210371|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125432793|NCT01852058|451210372|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125432794|NCT01852058|451210373|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
125432795|NCT01852058|451210374|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125432796|NCT01852058|451210375|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125432797|NCT01852058|451210376|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125432798|NCT01852058|451210377|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125432799|NCT01852058|451210378|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125432800|NCT01852058|451210379|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125432801|NCT01852058|451210380|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125432802|NCT01852058|451210381|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
125432803|NCT01852058|451210370|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125432804|NCT01852058|451210371|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125432805|NCT01852058|451210372|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125432806|NCT01852058|451210373|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125432807|NCT01852058|451210374|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
125432808|NCT01852058|451210375|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
125432809|NCT01852058|451210376|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125432810|NCT01852058|451210377|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125432811|NCT01852058|451210378|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125432812|NCT01852058|451210379|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125432813|NCT01852058|451210380|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125432814|NCT01852058|451210381|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
125432815|NCT01852058|451210370|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125432816|NCT01852058|451210371|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125432817|NCT01852058|451210372|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125432818|NCT01852058|451210373|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125617322|NCT00280150|451881828|FG002|Overall Study|Withdrawal by Subject|0|||
125617323|NCT00280150|451881829|FG003|Overall Study|Withdrawal by Subject|1|||
125617324|NCT00280150|451881826|FG000|Overall Study|Did not get consolidation therapy|3|||
125617325|NCT00280150|451881827|FG001|Overall Study|Did not get consolidation therapy|0|||
125617326|NCT00280150|451881828|FG002|Overall Study|Did not get consolidation therapy|3|||
125617327|NCT00280150|451881829|FG003|Overall Study|Did not get consolidation therapy|0|||
125617328|NCT00280150|451881826|FG000|Overall Study|Declining Performance Status|0|||
125617329|NCT00280150|451881827|FG001|Overall Study|Declining Performance Status|0|||
125617330|NCT00280150|451881828|FG002|Overall Study|Declining Performance Status|0|||
125617331|NCT00280150|451881829|FG003|Overall Study|Declining Performance Status|1|||
125617332|NCT02586077|451881837|FG000|Overall Study|Withdrawal by Subject|1|||
125617333|NCT02586077|451881837|FG000|Overall Study|Physician Decision|4|||
125617334|NCT02586077|451881837|FG000|Overall Study|Lost to Follow-up|3|||
125617335|NCT01993615|451881841|FG000|Overall Study|Death|1|||
125617336|NCT01993615|451881842|FG001|Overall Study|Death|0|||
125617337|NCT01175213|451881843|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
125617338|NCT01175213|451881844|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
125617339|NCT01175213|451881843|FG000|IGSC, 10%/rHuPH20|Death|1|||
125617340|NCT01175213|451881844|FG001|IGSC, 10%/rHuPH20|Death|0|||
125617341|NCT01175213|451881843|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
125617342|NCT01175213|451881844|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
125617343|NCT01175213|451881843|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
125617344|NCT01175213|451881844|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
125617345|NCT01175213|451881843|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
125617346|NCT01175213|451881844|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
125617347|NCT01175213|451881843|FG000|Safety Follow-up|Adverse Event|1|||
125617348|NCT01175213|451881844|FG001|Safety Follow-up|Adverse Event|0|||
125617349|NCT01245764|451881851|FG000|Study Phase A|Other|3|||
125617350|NCT01245764|451881852|FG001|Study Phase A|Other|2|||
125617351|NCT01245764|451881853|FG002|Study Phase A|Other|3|||
125617352|NCT01245764|451881854|FG003|Study Phase A|Other|1|||
125617353|NCT01245764|451881851|FG000|Study Phase A|Protocol Violation|6|||
125617354|NCT01245764|451881852|FG001|Study Phase A|Protocol Violation|3|||
125432819|NCT01852058|451210374|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125617355|NCT01245764|451881853|FG002|Study Phase A|Protocol Violation|2|||
125617356|NCT01245764|451881854|FG003|Study Phase A|Protocol Violation|2|||
125617357|NCT01245764|451881851|FG000|Study Phase A|Lost to Follow-up|0|||
125617358|NCT01245764|451881852|FG001|Study Phase A|Lost to Follow-up|0|||
125617359|NCT01245764|451881853|FG002|Study Phase A|Lost to Follow-up|5|||
125617360|NCT01245764|451881854|FG003|Study Phase A|Lost to Follow-up|0|||
125617361|NCT00003476|451881855|FG000|Overall Study|Not evaluable|1|||
125617362|NCT00781963|451881860|FG000|Overall Study|Death|3|||
125617363|NCT00781963|451881861|FG001|Overall Study|Death|0|||
125373851|NCT02207244|450998073|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125373852|NCT02207244|450998074|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
125373853|NCT02207244|450998064|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125373854|NCT02207244|450998065|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125373855|NCT02207244|450998066|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125373856|NCT02207244|450998067|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125373857|NCT02207244|450998068|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125373858|NCT02207244|450998069|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125373859|NCT02207244|450998070|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125373860|NCT02207244|450998071|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125373861|NCT02207244|450998072|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
125373862|NCT02207244|450998073|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125373863|NCT02207244|450998074|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
125373864|NCT02207244|450998064|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125373865|NCT02207244|450998065|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125373866|NCT02207244|450998066|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125373867|NCT02207244|450998067|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125373868|NCT02207244|450998068|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125373869|NCT02207244|450998069|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125373870|NCT02207244|450998070|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125373871|NCT02207244|450998071|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
125373872|NCT02207244|450998072|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125373873|NCT02207244|450998073|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125373874|NCT02207244|450998074|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
125373875|NCT02207244|450998064|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125373876|NCT02207244|450998065|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125617364|NCT00781963|451881860|FG000|Overall Study|Lost to Follow-up|2|||
125617365|NCT00781963|451881861|FG001|Overall Study|Lost to Follow-up|1|||
125617366|NCT00781963|451881860|FG000|Overall Study|Withdrawal by Subject|3|||
125617367|NCT00781963|451881861|FG001|Overall Study|Withdrawal by Subject|1|||
125617368|NCT00781963|451881860|FG000|Overall Study|Refused follow-up|9|||
125617369|NCT00781963|451881861|FG001|Overall Study|Refused follow-up|0|||
125617370|NCT03057951|451881865|FG000|Overall Study|Adverse Event|553|||
125432820|NCT01852058|451210375|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125432821|NCT01852058|451210376|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125432822|NCT01852058|451210377|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
125432823|NCT01852058|451210378|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125432824|NCT01852058|451210379|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125432825|NCT01852058|451210380|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125432826|NCT01852058|451210381|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
125432827|NCT01852058|451210370|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125432828|NCT01852058|451210371|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125432829|NCT01852058|451210372|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125432830|NCT01852058|451210373|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125432831|NCT01852058|451210374|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125432832|NCT01852058|451210375|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125432833|NCT01852058|451210376|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125432834|NCT01852058|451210377|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125432835|NCT01852058|451210378|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
125432836|NCT01852058|451210379|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125432837|NCT01852058|451210380|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125432838|NCT01852058|451210381|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
125432839|NCT01301274|451210385|FG000|Overall Study|Physician Decision|2|||
125432840|NCT01301274|451210386|FG001|Overall Study|Physician Decision|1|||
125432841|NCT00661661|451210387|FG000|Overall Study|Adverse Event|99|||
125432842|NCT00661661|451210388|FG001|Overall Study|Adverse Event|24|||
125432843|NCT00661661|451210387|FG000|Overall Study|Lack of Efficacy|3|||
125617371|NCT03057951|451881866|FG001|Overall Study|Adverse Event|575|||
125617372|NCT03057951|451881865|FG000|Overall Study|Protocol Violation|30|||
125617373|NCT03057951|451881866|FG001|Overall Study|Protocol Violation|24|||
125617374|NCT03057951|451881865|FG000|Overall Study|Lost to Follow-up|6|||
125617375|NCT03057951|451881866|FG001|Overall Study|Lost to Follow-up|16|||
125617376|NCT03057951|451881865|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
125617377|NCT03057951|451881866|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
125617378|NCT03057951|451881865|FG000|Overall Study|Study drug stopped, reason missing|6|||
125617379|NCT03057951|451881866|FG001|Overall Study|Study drug stopped, reason missing|1|||
125617380|NCT03057951|451881865|FG000|Overall Study|Medical advice|6|||
125617381|NCT03057951|451881866|FG001|Overall Study|Medical advice|2|||
125617382|NCT03057951|451881865|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
125617383|NCT03057951|451881866|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
125617384|NCT03057951|451881865|FG000|Overall Study|Investigator decision|2|||
125432844|NCT00661661|451210388|FG001|Overall Study|Lack of Efficacy|2|||
125432845|NCT00661661|451210387|FG000|Overall Study|Lost to Follow-up|0|||
125432846|NCT00661661|451210388|FG001|Overall Study|Lost to Follow-up|1|||
125432847|NCT00661661|451210387|FG000|Overall Study|Withdrawal by Subject|15|||
125432848|NCT00661661|451210388|FG001|Overall Study|Withdrawal by Subject|5|||
125432849|NCT00661661|451210387|FG000|Overall Study|Other|22|||
125432850|NCT00661661|451210388|FG001|Overall Study|Other|7|||
125432851|NCT00661661|451210387|FG000|Overall Study|Not assigned treatment|1|||
125432852|NCT00661661|451210388|FG001|Overall Study|Not assigned treatment|0|||
125432853|NCT01893827|451210389|FG000|Overall Study|Lost to Follow-up|19|||
125432854|NCT01893827|451210390|FG001|Overall Study|Lost to Follow-up|26|||
125432855|NCT04182880|451210393|FG000|Overall Study|Pregnancy|1|||
125432856|NCT04182880|451210394|FG001|Overall Study|Pregnancy|0|||
125432857|NCT03389477|451210395|FG000|Step 1|Withdrawal by Subject|1|||
125432858|NCT03389477|451210396|FG001|Step 1|Withdrawal by Subject|0|||
125432859|NCT03389477|451210395|FG000|Step 2|Withdrawal by Subject|1|||
125432860|NCT03389477|451210396|FG001|Step 2|Withdrawal by Subject|2|||
125432861|NCT03389477|451210395|FG000|Step 2|Disease progression|1|||
125432862|NCT03389477|451210396|FG001|Step 2|Disease progression|0|||
125617385|NCT03057951|451881866|FG001|Overall Study|Investigator decision|0|||
125617386|NCT03057951|451881865|FG000|Overall Study|Patient decision|5|||
125617387|NCT03057951|451881866|FG001|Overall Study|Patient decision|2|||
125617388|NCT03057951|451881865|FG000|Overall Study|Not attending study visits|3|||
125617389|NCT03057951|451881866|FG001|Overall Study|Not attending study visits|0|||
125432863|NCT03389477|451210395|FG000|Step 2|Death|0|||
125432864|NCT03389477|451210396|FG001|Step 2|Death|1|||
125432865|NCT03389477|451210395|FG000|Step 2|Poor performance status and nutrition|0|||
125617390|NCT03057951|451881865|FG000|Overall Study|Patient moved away|3|||
125617391|NCT03057951|451881866|FG001|Overall Study|Patient moved away|4|||
125617392|NCT03057951|451881865|FG000|Overall Study|Other reason than stated above|23|||
125432866|NCT03389477|451210396|FG001|Step 2|Poor performance status and nutrition|1|||
125432867|NCT03389477|451210395|FG000|Step 3|Withdrawal after 3 cycles|0|||
125432868|NCT03389477|451210396|FG001|Step 3|Withdrawal after 3 cycles|1|||
125432869|NCT03389477|451210395|FG000|Step 3|Still receiving active treatment|4|||
125432870|NCT03389477|451210396|FG001|Step 3|Still receiving active treatment|0|||
125432871|NCT03389477|451210395|FG000|Step 3|Progressive disease after 2 cycles|1|||
125432872|NCT03389477|451210396|FG001|Step 3|Progressive disease after 2 cycles|0|||
125432873|NCT03403426|451210401|FG000|Overall Study|Death|1|||
125432874|NCT03403426|451210401|FG000|Overall Study|Lost to Follow-up|2|||
125432875|NCT03520400|451210402|FG000|Overall Study|Physician Decision|15|||
125432876|NCT03520400|451210403|FG001|Overall Study|Physician Decision|7|||
125432877|NCT01654601|451210404|FG000|1st Administration|Withdrawal by Subject|2|||
125432878|NCT01654601|451210405|FG001|1st Administration|Withdrawal by Subject|0|||
125432879|NCT01654601|451210404|FG000|1st Administration|Protocol Violation|0|||
125432880|NCT01654601|451210405|FG001|1st Administration|Protocol Violation|2|||
125432881|NCT01654601|451210404|FG000|2nd Administration|Adverse Event|1|||
125432882|NCT01654601|451210405|FG001|2nd Administration|Adverse Event|0|||
125432883|NCT01654601|451210404|FG000|2nd Administration|Protocol Violation|0|||
125373877|NCT02207244|450998066|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125373878|NCT02207244|450998067|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125373879|NCT02207244|450998068|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125373880|NCT02207244|450998069|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125373881|NCT02207244|450998070|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
125373882|NCT02207244|450998071|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125373883|NCT02207244|450998072|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125373884|NCT02207244|450998073|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125373885|NCT02207244|450998074|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
125373886|NCT02207244|450998064|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125432884|NCT01654601|451210405|FG001|2nd Administration|Protocol Violation|1|||
125432885|NCT04398537|451210406|FG000|Overall Study|Physician Decision|10|||
125432886|NCT04398537|451210407|FG001|Overall Study|Physician Decision|15|||
125432887|NCT03610737|451212342|FG000|Overall Study|Withdrawal by Subject|1|||
125432888|NCT03610737|451212343|FG001|Overall Study|Withdrawal by Subject|5|||
125432889|NCT03610737|451212342|FG000|Overall Study|Death|1|||
125432890|NCT03610737|451212343|FG001|Overall Study|Death|0|||
125432891|NCT03610737|451212342|FG000|Overall Study|Not treated|5|||
125432892|NCT03610737|451212343|FG001|Overall Study|Not treated|2|||
125432893|NCT03610737|451212342|FG000|Overall Study|Missed Visit|1|||
125617393|NCT03057951|451881866|FG001|Overall Study|Other reason than stated above|29|||
125617394|NCT03057951|451881865|FG000|Overall Study|Not treated|2|||
125617395|NCT03057951|451881866|FG001|Overall Study|Not treated|1|||
125617396|NCT02064205|451881867|FG000|Overall Study|Withdrawal by Subject|1|||
125617397|NCT00696436|451881868|FG000|Overall Study|Adverse Event|7|||
125617398|NCT00696436|451881869|FG001|Overall Study|Adverse Event|9|||
125617399|NCT00696436|451881870|FG002|Overall Study|Adverse Event|8|||
125617400|NCT00696436|451881871|FG003|Overall Study|Adverse Event|6|||
125617401|NCT00696436|451881872|FG004|Overall Study|Adverse Event|4|||
125617402|NCT00696436|451881868|FG000|Overall Study|Protocol Violation|3|||
125617403|NCT00696436|451881869|FG001|Overall Study|Protocol Violation|2|||
125617404|NCT00696436|451881870|FG002|Overall Study|Protocol Violation|2|||
125617405|NCT00696436|451881871|FG003|Overall Study|Protocol Violation|0|||
125617406|NCT00696436|451881872|FG004|Overall Study|Protocol Violation|1|||
125617407|NCT00696436|451881868|FG000|Overall Study|Lost to Follow-up|1|||
125617408|NCT00696436|451881869|FG001|Overall Study|Lost to Follow-up|6|||
125617409|NCT00696436|451881870|FG002|Overall Study|Lost to Follow-up|2|||
125432894|NCT03610737|451212343|FG001|Overall Study|Missed Visit|2|||
125432895|NCT02991482|451212344|FG000|Overall Study|Disease progression|56|||
125432896|NCT02991482|451212345|FG001|Overall Study|Disease progression|47|||
125432897|NCT02991482|451212344|FG000|Overall Study|Death|4|||
125432898|NCT02991482|451212345|FG001|Overall Study|Death|4|||
125432899|NCT02991482|451212344|FG000|Overall Study|Adverse Event|1|||
125432900|NCT02991482|451212345|FG001|Overall Study|Adverse Event|6|||
125617410|NCT00696436|451881871|FG003|Overall Study|Lost to Follow-up|4|||
125617411|NCT00696436|451881872|FG004|Overall Study|Lost to Follow-up|3|||
125432901|NCT02991482|451212344|FG000|Overall Study|Patient decision|1|||
125432902|NCT02991482|451212345|FG001|Overall Study|Patient decision|1|||
125432903|NCT02991482|451212344|FG000|Overall Study|Physician Decision|0|||
125432904|NCT02991482|451212345|FG001|Overall Study|Physician Decision|6|||
125432905|NCT02991482|451212344|FG000|Overall Study|Clinical deterioration|1|||
125432906|NCT02991482|451212345|FG001|Overall Study|Clinical deterioration|0|||
125617412|NCT00696436|451881868|FG000|Overall Study|Withdrawal by Subject|4|||
125617413|NCT00696436|451881869|FG001|Overall Study|Withdrawal by Subject|11|||
125214990|NCT02579382|450414888|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
125214991|NCT02579382|450414889|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
125617414|NCT00696436|451881870|FG002|Overall Study|Withdrawal by Subject|5|||
125617415|NCT00696436|451881871|FG003|Overall Study|Withdrawal by Subject|7|||
125617416|NCT00696436|451881872|FG004|Overall Study|Withdrawal by Subject|1|||
125617417|NCT00696436|451881868|FG000|Overall Study|Lack of Efficacy|3|||
125617418|NCT00696436|451881869|FG001|Overall Study|Lack of Efficacy|1|||
125617419|NCT00696436|451881870|FG002|Overall Study|Lack of Efficacy|5|||
125617420|NCT00696436|451881871|FG003|Overall Study|Lack of Efficacy|2|||
125617421|NCT00696436|451881872|FG004|Overall Study|Lack of Efficacy|4|||
125617422|NCT00696436|451881868|FG000|Overall Study|Participant Unavailability|2|||
125617423|NCT00696436|451881869|FG001|Overall Study|Participant Unavailability|0|||
125617424|NCT00696436|451881870|FG002|Overall Study|Participant Unavailability|2|||
125617425|NCT00696436|451881871|FG003|Overall Study|Participant Unavailability|1|||
125617426|NCT00696436|451881872|FG004|Overall Study|Participant Unavailability|0|||
125617427|NCT00696436|451881868|FG000|Overall Study|Administrative Error|2|||
125617428|NCT00696436|451881869|FG001|Overall Study|Administrative Error|0|||
125617429|NCT00696436|451881870|FG002|Overall Study|Administrative Error|2|||
125617430|NCT00696436|451881871|FG003|Overall Study|Administrative Error|0|||
125617431|NCT00696436|451881872|FG004|Overall Study|Administrative Error|0|||
125617432|NCT00696436|451881868|FG000|Overall Study|Participant Non-compliance|0|||
125617433|NCT00696436|451881869|FG001|Overall Study|Participant Non-compliance|0|||
125617434|NCT00696436|451881870|FG002|Overall Study|Participant Non-compliance|1|||
125617435|NCT00696436|451881871|FG003|Overall Study|Participant Non-compliance|2|||
125214992|NCT02579382|450414890|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
125432907|NCT02991482|451212344|FG000|Overall Study|Patient feeling too unwell|1|||
125432908|NCT02991482|451212345|FG001|Overall Study|Patient feeling too unwell|0|||
125432909|NCT02991482|451212344|FG000|Overall Study|Worsening of performance status|0|||
125432910|NCT02991482|451212345|FG001|Overall Study|Worsening of performance status|1|||
125617436|NCT00696436|451881872|FG004|Overall Study|Participant Non-compliance|0|||
125617437|NCT00696436|451881868|FG000|Overall Study|Administrative Decision|1|||
125617438|NCT00696436|451881869|FG001|Overall Study|Administrative Decision|0|||
125617439|NCT00696436|451881870|FG002|Overall Study|Administrative Decision|0|||
125617440|NCT00696436|451881871|FG003|Overall Study|Administrative Decision|0|||
125373887|NCT02207244|450998065|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125373888|NCT02207244|450998066|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125373889|NCT02207244|450998067|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125373890|NCT02207244|450998068|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125373891|NCT02207244|450998069|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125373892|NCT02207244|450998070|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125373893|NCT02207244|450998071|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125373894|NCT02207244|450998072|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
125373895|NCT02207244|450998073|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
125432911|NCT02991482|451212344|FG000|Overall Study|Death prior to study drug initiation|1|||
125432912|NCT02991482|451212345|FG001|Overall Study|Death prior to study drug initiation|0|||
125432913|NCT02991482|451212344|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
125432914|NCT02991482|451212345|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
125432915|NCT00871403|451212346|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
125432916|NCT00871403|451212347|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
125432917|NCT00871403|451212348|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
125432918|NCT00871403|451212346|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
125432919|NCT00871403|451212347|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
125432920|NCT00871403|451212348|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
125432921|NCT00871403|451212346|FG000|Combination Treatment Phase|Adverse Event|0|||
125432922|NCT00871403|451212347|FG001|Combination Treatment Phase|Adverse Event|17|||
125432923|NCT00871403|451212348|FG002|Combination Treatment Phase|Adverse Event|2|||
125432924|NCT00871403|451212346|FG000|Combination Treatment Phase|Disease Progression|0|||
125617441|NCT00696436|451881872|FG004|Overall Study|Administrative Decision|0|||
125617442|NCT00696436|451881868|FG000|Overall Study|Missing|0|||
125617443|NCT00696436|451881869|FG001|Overall Study|Missing|1|||
125617444|NCT00696436|451881870|FG002|Overall Study|Missing|1|||
125617445|NCT00696436|451881871|FG003|Overall Study|Missing|0|||
125432925|NCT00871403|451212347|FG001|Combination Treatment Phase|Disease Progression|8|||
125617446|NCT00696436|451881872|FG004|Overall Study|Missing|0|||
125617447|NCT02282982|451881873|FG000|Overall Study|Lost to Follow-up|15|||
125617448|NCT02282982|451881873|FG000|Overall Study|Withdrew consent|2|||
125617449|NCT02282982|451881873|FG000|Overall Study|Death|4|||
125617450|NCT02282982|451881873|FG000|Overall Study|Lack of product|156|||
125617451|NCT02282982|451881873|FG000|Overall Study|Palivizumab is ended|11|||
125617452|NCT02282982|451881873|FG000|Overall Study|Other, not specified|18|||
125617453|NCT02062463|451881874|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
125617454|NCT02062463|451881875|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
125617455|NCT02062463|451881876|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
125617456|NCT02062463|451881877|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
125617457|NCT02062463|451881874|FG000|Stage 2|Adverse Event|0|||
125617458|NCT02062463|451881875|FG001|Stage 2|Adverse Event|0|||
125214993|NCT02579382|450414887|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
125373896|NCT02207244|450998074|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
125373897|NCT02207244|450998064|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125373898|NCT02207244|450998065|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125373899|NCT02207244|450998066|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125373900|NCT02207244|450998067|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125373901|NCT02207244|450998068|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125373902|NCT02207244|450998069|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125373903|NCT02207244|450998070|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125373904|NCT02207244|450998071|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125373905|NCT02207244|450998072|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
125373906|NCT02207244|450998073|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
125373907|NCT02207244|450998074|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
125373908|NCT02207244|450998064|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125373909|NCT02207244|450998065|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125373910|NCT02207244|450998066|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125373911|NCT02207244|450998067|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125373912|NCT02207244|450998068|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125373913|NCT02207244|450998069|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125373914|NCT02207244|450998070|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125373915|NCT02207244|450998071|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125373916|NCT02207244|450998072|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
125373917|NCT02207244|450998073|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
125373918|NCT02207244|450998074|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
125373919|NCT02207244|450998064|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125373920|NCT02207244|450998065|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125373921|NCT02207244|450998066|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125373922|NCT02207244|450998067|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125373923|NCT02207244|450998068|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125373924|NCT02207244|450998069|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125373925|NCT02207244|450998070|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125373926|NCT02207244|450998071|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125373927|NCT02207244|450998072|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
125373928|NCT02207244|450998073|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
125373929|NCT02207244|450998074|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
125373930|NCT02207244|450998064|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
125373931|NCT02207244|450998065|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
125373932|NCT02207244|450998066|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
125373933|NCT02207244|450998067|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
125373934|NCT02207244|450998068|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
125373935|NCT02207244|450998069|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
125373936|NCT02207244|450998070|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
125373937|NCT02207244|450998071|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
125373938|NCT02207244|450998072|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
125373939|NCT02207244|450998073|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
125214994|NCT02579382|450414888|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
125373940|NCT02207244|450998074|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
125373941|NCT02207244|450998064|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
125373942|NCT02207244|450998065|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
125373943|NCT02207244|450998066|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
125373944|NCT02207244|450998067|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
125373945|NCT02207244|450998068|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
125373946|NCT02207244|450998069|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
125373947|NCT02207244|450998070|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
125373948|NCT02207244|450998071|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
125373949|NCT02207244|450998072|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
125373950|NCT02207244|450998073|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
125373951|NCT02207244|450998074|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
125373952|NCT02207244|450998064|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125373953|NCT02207244|450998065|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125432926|NCT00871403|451212348|FG002|Combination Treatment Phase|Disease Progression|5|||
125432927|NCT00871403|451212346|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
125432928|NCT00871403|451212347|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
125432929|NCT00871403|451212348|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
125432930|NCT00871403|451212346|FG000|Combination Treatment Phase|Physician Decision|0|||
125432931|NCT00871403|451212347|FG001|Combination Treatment Phase|Physician Decision|1|||
125432932|NCT00871403|451212348|FG002|Combination Treatment Phase|Physician Decision|3|||
125432933|NCT00871403|451212346|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
125432934|NCT00871403|451212347|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
125432935|NCT00871403|451212348|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
125432936|NCT00871403|451212346|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
125432937|NCT00871403|451212347|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
125432938|NCT00871403|451212348|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
125432939|NCT00787319|451212349|FG000|Overall Study|Lost to Follow-up|2|||
125432940|NCT00787319|451212349|FG000|Overall Study|Withdrawal by Subject|15|||
125432941|NCT00787319|451212349|FG000|Overall Study|Adverse Event|3|||
125432942|NCT00787319|451212349|FG000|Overall Study|Objective progression or relapse|30|||
125432943|NCT00787319|451212349|FG000|Overall Study|Lack of Efficacy|1|||
125432944|NCT00787319|451212349|FG000|Overall Study|Budget exhausted/exceeded|1|||
125617459|NCT02062463|451881876|FG002|Stage 2|Adverse Event|12|||
125617460|NCT02062463|451881877|FG003|Stage 2|Adverse Event|20|||
125617461|NCT02062463|451881874|FG000|Stage 2|Lack of Efficacy|0|||
125617462|NCT02062463|451881875|FG001|Stage 2|Lack of Efficacy|0|||
125617463|NCT02062463|451881876|FG002|Stage 2|Lack of Efficacy|3|||
125617464|NCT02062463|451881877|FG003|Stage 2|Lack of Efficacy|4|||
125617465|NCT02062463|451881874|FG000|Stage 2|Lost to Follow-up|0|||
125617466|NCT02062463|451881875|FG001|Stage 2|Lost to Follow-up|0|||
125617467|NCT02062463|451881876|FG002|Stage 2|Lost to Follow-up|20|||
125617468|NCT02062463|451881877|FG003|Stage 2|Lost to Follow-up|20|||
125617469|NCT02062463|451881874|FG000|Stage 2|Non-Compliance|0|||
125617470|NCT02062463|451881875|FG001|Stage 2|Non-Compliance|0|||
125617471|NCT02062463|451881876|FG002|Stage 2|Non-Compliance|0|||
125617472|NCT02062463|451881877|FG003|Stage 2|Non-Compliance|1|||
125617473|NCT02062463|451881874|FG000|Stage 2|Other than specified|0|||
125617474|NCT02062463|451881875|FG001|Stage 2|Other than specified|0|||
125373954|NCT02207244|450998066|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125432945|NCT00787319|451212349|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
125432946|NCT00787319|451212349|FG000|Overall Study|No health insurance reimbursement|2|||
125432947|NCT00787319|451212349|FG000|Overall Study|Stabilized disease findings|3|||
125432948|NCT00787319|451212349|FG000|Overall Study|Inactive disease|5|||
125432949|NCT02312856|451212350|FG000|Overall Study|Death|1|||
125432950|NCT02312856|451212350|FG000|Overall Study|Lost to Follow-up|3|||
125432951|NCT01932294|451212351|FG000|Overall Study|Death|43|||
125373955|NCT02207244|450998067|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125373956|NCT02207244|450998068|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125373957|NCT02207244|450998069|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125373958|NCT02207244|450998070|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125373959|NCT02207244|450998071|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125432952|NCT01932294|451212351|FG000|Overall Study|Lost to Follow-up|8|||
125432953|NCT01932294|451212351|FG000|Overall Study|VAD Implantation|20|||
125432954|NCT01932294|451212351|FG000|Overall Study|Heart Transplantation|16|||
125432955|NCT01932294|451212351|FG000|Overall Study|Transferred to other hospitals|12|||
125432956|NCT00659984|451212355|FG000|Overall Study|Adverse Event|1|||
125432957|NCT00927355|451212356|FG000|Overall Study|Adverse Event|1|||
125617475|NCT02062463|451881876|FG002|Stage 2|Other than specified|3|||
125617476|NCT02062463|451881877|FG003|Stage 2|Other than specified|1|||
125617477|NCT02062463|451881874|FG000|Stage 2|Withdrawal by Subject|0|||
125432958|NCT00927355|451212357|FG001|Overall Study|Adverse Event|1|||
125432959|NCT01800201|451212358|FG000|Overall Study|Withdrawal by Subject|2|||
125432960|NCT01800201|451212359|FG001|Overall Study|Withdrawal by Subject|0|||
125617478|NCT02062463|451881875|FG001|Stage 2|Withdrawal by Subject|0|||
125617479|NCT02062463|451881876|FG002|Stage 2|Withdrawal by Subject|15|||
125617480|NCT02062463|451881877|FG003|Stage 2|Withdrawal by Subject|10|||
125432961|NCT01800201|451212358|FG000|Overall Study|patient privacy concerns|1|||
125432962|NCT01800201|451212359|FG001|Overall Study|patient privacy concerns|1|||
125432963|NCT01800201|451212358|FG000|Overall Study|did not want to use device|0|||
125432964|NCT01800201|451212359|FG001|Overall Study|did not want to use device|1|||
125432965|NCT01800201|451212358|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
125432966|NCT01800201|451212359|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
125432967|NCT01691521|451212363|FG000|Overall Study|Adverse Event|4|||
125432968|NCT01691521|451212364|FG001|Overall Study|Adverse Event|0|||
125432969|NCT01691521|451212365|FG002|Overall Study|Adverse Event|1|||
125432970|NCT01691521|451212363|FG000|Overall Study|Lack of Efficacy|1|||
125432971|NCT01691521|451212364|FG001|Overall Study|Lack of Efficacy|1|||
125432972|NCT01691521|451212365|FG002|Overall Study|Lack of Efficacy|2|||
125432973|NCT01691521|451212363|FG000|Overall Study|Protocol Violation|0|||
125432974|NCT01691521|451212364|FG001|Overall Study|Protocol Violation|3|||
125432975|NCT01691521|451212365|FG002|Overall Study|Protocol Violation|0|||
125432976|NCT01691521|451212363|FG000|Overall Study|Lost to Follow-up|0|||
125432977|NCT01691521|451212364|FG001|Overall Study|Lost to Follow-up|2|||
125432978|NCT01691521|451212365|FG002|Overall Study|Lost to Follow-up|2|||
125617481|NCT00363051|451881884|FG000|Overall Study|Adminstrative problems|1|||
125432979|NCT01691521|451212363|FG000|Overall Study|Physician Decision|2|||
125432980|NCT01691521|451212364|FG001|Overall Study|Physician Decision|1|||
125432981|NCT01691521|451212365|FG002|Overall Study|Physician Decision|0|||
125214995|NCT02579382|450414889|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
125432982|NCT01691521|451212363|FG000|Overall Study|Withdrawal by Subject|5|||
125432983|NCT01691521|451212364|FG001|Overall Study|Withdrawal by Subject|9|||
125432984|NCT01691521|451212365|FG002|Overall Study|Withdrawal by Subject|4|||
125432985|NCT04503096|451212366|FG000|Overall Study|Withdrawal by Subject|3|||
125432986|NCT01480596|451212367|FG000|Overall Study|Adverse Event|3|||
125432987|NCT01480596|451212368|FG001|Overall Study|Adverse Event|0|||
125432988|NCT01480596|451212367|FG000|Overall Study|MG exacerbation or change in medication|2|||
125432989|NCT01480596|451212368|FG001|Overall Study|MG exacerbation or change in medication|2|||
125432990|NCT02343003|451212370|FG000|Overall Study|Withdrawal by Subject|9|||
125432991|NCT02343003|451212371|FG001|Overall Study|Withdrawal by Subject|4|||
125432992|NCT02343003|451212370|FG000|Overall Study|Lost to Follow-up|5|||
125432993|NCT02343003|451212371|FG001|Overall Study|Lost to Follow-up|1|||
125432994|NCT02343003|451212370|FG000|Overall Study|Protocol Violation|1|||
125432995|NCT02343003|451212371|FG001|Overall Study|Protocol Violation|0|||
125432996|NCT02343003|451212370|FG000|Overall Study|Death|0|||
125432997|NCT02343003|451212371|FG001|Overall Study|Death|1|||
125432998|NCT02343003|451212370|FG000|Overall Study|exclusion criteria met|1|||
125432999|NCT02343003|451212371|FG001|Overall Study|exclusion criteria met|1|||
125433000|NCT02343003|451212370|FG000|Overall Study|terminated by sponsor|2|||
125617482|NCT00363051|451881885|FG001|Overall Study|Adminstrative problems|1|||
125617483|NCT00363051|451881884|FG000|Overall Study|Adverse Event|21|||
125617484|NCT00363051|451881885|FG001|Overall Study|Adverse Event|12|||
125373960|NCT02207244|450998072|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125373961|NCT02207244|450998073|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
125373962|NCT02207244|450998074|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
125373963|NCT00039130|450998075|FG000|Overall Study|Adverse Event|11|||
125373964|NCT00039130|450998075|FG000|Overall Study|Death|9|||
125373965|NCT00039130|450998075|FG000|Overall Study|Withdrawal by Subject|3|||
125373966|NCT00039130|450998075|FG000|Overall Study|Progression|2|||
125373967|NCT00039130|450998075|FG000|Overall Study|Subsequent treatment|2|||
125373968|NCT00039130|450998075|FG000|Overall Study|Physician Decision|3|||
125373969|NCT01866930|450998076|FG000|Treatment Period|Other|1|||
125373970|NCT01866930|450998077|FG001|Treatment Period|Other|0|||
125373971|NCT01866930|450998076|FG000|Treatment Period|Death|0|||
125373972|NCT01866930|450998077|FG001|Treatment Period|Death|2|||
125373973|NCT01866930|450998076|FG000|Treatment Period|Poor/non compliance|0|||
125373974|NCT01866930|450998077|FG001|Treatment Period|Poor/non compliance|2|||
125373975|NCT01866930|450998076|FG000|Treatment Period|No longer meets study criteria|0|||
125373976|NCT01866930|450998077|FG001|Treatment Period|No longer meets study criteria|1|||
125373977|NCT01866930|450998076|FG000|Treatment Period|Withdrawal by Subject|2|||
125373978|NCT01866930|450998077|FG001|Treatment Period|Withdrawal by Subject|8|||
125373979|NCT01866930|450998076|FG000|Treatment Period|Lack of Efficacy|1|||
125373980|NCT01866930|450998077|FG001|Treatment Period|Lack of Efficacy|9|||
125373981|NCT01866930|450998076|FG000|Treatment Period|Adverse Event|4|||
125373982|NCT01866930|450998077|FG001|Treatment Period|Adverse Event|12|||
125373983|NCT01866930|450998076|FG000|Treatment Period|Lost to Follow-up|1|||
125373984|NCT01866930|450998077|FG001|Treatment Period|Lost to Follow-up|1|||
125373985|NCT01866930|450998076|FG000|Follow-up Period|Lost to Follow-up|1|||
125373986|NCT01866930|450998077|FG001|Follow-up Period|Lost to Follow-up|1|||
125373987|NCT01866930|450998076|FG000|Follow-up Period|Other|1|||
125373988|NCT01866930|450998077|FG001|Follow-up Period|Other|5|||
125373989|NCT01866930|450998076|FG000|Follow-up Period|No longer required per protocol|1|||
125373990|NCT01866930|450998077|FG001|Follow-up Period|No longer required per protocol|0|||
125373991|NCT01866930|450998076|FG000|Follow-up Period|Withdrawal by Subject|3|||
125373992|NCT01866930|450998077|FG001|Follow-up Period|Withdrawal by Subject|3|||
125373993|NCT00279305|450998080|FG000|Overall Study|Pregnancy|1|||
125373994|NCT00279305|450998081|FG001|Overall Study|Pregnancy|0|||
125373995|NCT00279305|450998080|FG000|Overall Study|Withdrawal by Subject|2|||
125373996|NCT00279305|450998081|FG001|Overall Study|Withdrawal by Subject|0|||
125373997|NCT00279305|450998080|FG000|Overall Study|Dificulting establishing IV|1|||
125373998|NCT00279305|450998081|FG001|Overall Study|Dificulting establishing IV|0|||
125373999|NCT00279305|450998080|FG000|Overall Study|FDA Safety Alert|4|||
125374000|NCT00279305|450998081|FG001|Overall Study|FDA Safety Alert|1|||
125374001|NCT00753415|450998090|FG000|Part A|Disease progression|1|||
125374002|NCT00753415|450998091|FG001|Part A|Disease progression|0|||
125374003|NCT00753415|450998092|FG002|Part A|Disease progression|1|||
125374004|NCT00753415|450998093|FG003|Part A|Disease progression|2|||
125374005|NCT00753415|450998094|FG004|Part A|Disease progression|0|||
125374006|NCT00753415|450998095|FG005|Part A|Disease progression|0|||
125374007|NCT00753415|450998096|FG006|Part A|Disease progression|0|||
125374008|NCT00753415|450998097|FG007|Part A|Disease progression|0|||
125374009|NCT00753415|450998098|FG008|Part A|Disease progression|0|||
125374010|NCT00753415|450998099|FG009|Part A|Disease progression|0|||
125374011|NCT00753415|450998090|FG000|Part A|Withdrawal by Subject|0|||
125374012|NCT00753415|450998091|FG001|Part A|Withdrawal by Subject|0|||
125374013|NCT00753415|450998092|FG002|Part A|Withdrawal by Subject|1|||
125374014|NCT00753415|450998093|FG003|Part A|Withdrawal by Subject|0|||
125374015|NCT00753415|450998094|FG004|Part A|Withdrawal by Subject|0|||
125374016|NCT00753415|450998095|FG005|Part A|Withdrawal by Subject|0|||
125374017|NCT00753415|450998096|FG006|Part A|Withdrawal by Subject|0|||
125374018|NCT00753415|450998097|FG007|Part A|Withdrawal by Subject|0|||
125374019|NCT00753415|450998098|FG008|Part A|Withdrawal by Subject|0|||
125374020|NCT00753415|450998099|FG009|Part A|Withdrawal by Subject|0|||
125374021|NCT00753415|450998090|FG000|Part B|Lost to Follow-up|0|||
125374022|NCT00753415|450998091|FG001|Part B|Lost to Follow-up|0|||
125374023|NCT00753415|450998092|FG002|Part B|Lost to Follow-up|0|||
125374024|NCT00753415|450998093|FG003|Part B|Lost to Follow-up|0|||
125374025|NCT00753415|450998094|FG004|Part B|Lost to Follow-up|0|||
125374026|NCT00753415|450998095|FG005|Part B|Lost to Follow-up|0|||
125374027|NCT00753415|450998096|FG006|Part B|Lost to Follow-up|0|||
125374028|NCT00753415|450998097|FG007|Part B|Lost to Follow-up|1|||
125374029|NCT00753415|450998098|FG008|Part B|Lost to Follow-up|1|||
125374030|NCT00753415|450998099|FG009|Part B|Lost to Follow-up|0|||
125374031|NCT00753415|450998090|FG000|Part B|Disease progression|0|||
125374032|NCT00753415|450998091|FG001|Part B|Disease progression|0|||
125374033|NCT00753415|450998092|FG002|Part B|Disease progression|0|||
125374034|NCT00753415|450998093|FG003|Part B|Disease progression|0|||
125433001|NCT02343003|451212371|FG001|Overall Study|terminated by sponsor|0|||
125433002|NCT03541044|451212373|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
125433003|NCT03541044|451212374|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
125433004|NCT03541044|451212373|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
125433005|NCT03541044|451212374|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
125433006|NCT01153269|451212375|FG000|Overall Study|Withdrawal by Subject|1|||
125433007|NCT01153269|451212375|FG000|Overall Study|Antiretroviral therapy break|1|||
125433008|NCT02635724|451212376|FG000|Overall Study|Withdrawal by Subject|0|||
125433009|NCT02635724|451212377|FG001|Overall Study|Withdrawal by Subject|1|||
125433010|NCT02635724|451212378|FG002|Overall Study|Withdrawal by Subject|0|||
125433011|NCT02424591|451212385|FG000|Overall Study|Protocol Violation|2|||
125433012|NCT02424591|451212386|FG001|Overall Study|Protocol Violation|3|||
125433013|NCT01446796|451212387|FG000|Overall Study|Withdrawal by Subject|1|||
125617485|NCT00363051|451881884|FG000|Overall Study|New Cancer Therapy|2|||
125617486|NCT00363051|451881885|FG001|Overall Study|New Cancer Therapy|1|||
125617487|NCT00363051|451881884|FG000|Overall Study|Withdrawal by Subject|11|||
125617488|NCT00363051|451881885|FG001|Overall Study|Withdrawal by Subject|3|||
125617489|NCT00363051|451881884|FG000|Overall Study|Lost to Follow-up|0|||
125617490|NCT00363051|451881885|FG001|Overall Study|Lost to Follow-up|1|||
125617491|NCT00363051|451881884|FG000|Overall Study|Protocol Violation|0|||
125617492|NCT00363051|451881885|FG001|Overall Study|Protocol Violation|2|||
125617493|NCT00363051|451881884|FG000|Overall Study|Death|3|||
125617494|NCT00363051|451881885|FG001|Overall Study|Death|2|||
125617495|NCT00205699|451881888|FG000|Overall Study|Lost to Follow-up|1|||
125617496|NCT00205699|451881889|FG001|Overall Study|Lost to Follow-up|3|||
125617497|NCT00205699|451881890|FG002|Overall Study|Lost to Follow-up|5|||
125617498|NCT00205699|451881888|FG000|Overall Study|Adverse Event|1|||
125617499|NCT00205699|451881889|FG001|Overall Study|Adverse Event|0|||
125617500|NCT00205699|451881890|FG002|Overall Study|Adverse Event|0|||
125617501|NCT00205699|451881888|FG000|Overall Study|Withdrawal by Subject|1|||
125617502|NCT00205699|451881889|FG001|Overall Study|Withdrawal by Subject|2|||
125617503|NCT00205699|451881890|FG002|Overall Study|Withdrawal by Subject|1|||
125617504|NCT00205699|451881888|FG000|Overall Study|Lack of Efficacy|0|||
125617505|NCT00205699|451881889|FG001|Overall Study|Lack of Efficacy|1|||
125617506|NCT00205699|451881890|FG002|Overall Study|Lack of Efficacy|0|||
125617507|NCT03225716|451881895|FG000|Overall Study|Withdrawal by Subject|2|||
125617508|NCT03225716|451881896|FG001|Overall Study|Withdrawal by Subject|2|||
125433014|NCT01446796|451212388|FG001|Overall Study|Withdrawal by Subject|0|||
125433015|NCT00312702|451212389|FG000|Immunization Phase|Lost to Follow-up|0|||
125433016|NCT00312702|451212390|FG001|Immunization Phase|Lost to Follow-up|1|||
125433017|NCT00312702|451212391|FG002|Immunization Phase|Lost to Follow-up|0|||
125433018|NCT04581200|451212394|FG000|Overall Study|Lost to Follow-up|6|||
125433019|NCT04581200|451212395|FG001|Overall Study|Lost to Follow-up|5|||
125433020|NCT04296890|451212403|FG000|Overall Study|Withdrawal by Subject|1|||
125433021|NCT04296890|451212403|FG000|Overall Study|Death|62|||
125433022|NCT04296890|451212403|FG000|Overall Study|Lost to Follow-up|3|||
125433023|NCT04296890|451212403|FG000|Overall Study|Other than specified|2|||
125433024|NCT05400746|451212404|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
125433025|NCT05400746|451212405|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
125433026|NCT05400746|451212406|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
125617509|NCT03225716|451881897|FG002|Overall Study|Withdrawal by Subject|0|||
125617510|NCT03225716|451881895|FG000|Overall Study|Lack of Efficacy|1|||
125617511|NCT03225716|451881896|FG001|Overall Study|Lack of Efficacy|0|||
125617512|NCT03225716|451881897|FG002|Overall Study|Lack of Efficacy|0|||
125617513|NCT03225716|451881895|FG000|Overall Study|Adverse Event|2|||
125617514|NCT03225716|451881896|FG001|Overall Study|Adverse Event|0|||
125617515|NCT03225716|451881897|FG002|Overall Study|Adverse Event|1|||
125433027|NCT05454410|451212407|FG000|Overall Study|Withdrawal by Subject|0|||
125433028|NCT05454410|451212408|FG001|Overall Study|Withdrawal by Subject|0|||
125433029|NCT05454410|451212409|FG002|Overall Study|Withdrawal by Subject|1|||
125433030|NCT05454410|451212410|FG003|Overall Study|Withdrawal by Subject|1|||
125433031|NCT05004688|451212412|FG000|Overall Study|Protocol Violation|7|||
125433032|NCT05004688|451212412|FG000|Overall Study|Physician Decision|2|||
125433033|NCT05004688|451212412|FG000|Overall Study|Withdrawal by Subject|2|||
125433034|NCT00717314|451212420|FG000|Overall Study|Adverse Event|3|||
125433035|NCT00717314|451212421|FG001|Overall Study|Adverse Event|2|||
125433036|NCT00717314|451212420|FG000|Overall Study|Protocol Violation|1|||
125433037|NCT00717314|451212421|FG001|Overall Study|Protocol Violation|0|||
125433038|NCT00717314|451212420|FG000|Overall Study|Lost to Follow-up|1|||
125433039|NCT00717314|451212421|FG001|Overall Study|Lost to Follow-up|5|||
125433040|NCT00717314|451212420|FG000|Overall Study|Withdrawal by Subject|1|||
125433041|NCT00717314|451212421|FG001|Overall Study|Withdrawal by Subject|3|||
125433042|NCT03682705|451212422|FG000|Overall Study|Adverse Event|1|||
125433043|NCT03682705|451212423|FG001|Overall Study|Adverse Event|1|||
125433044|NCT03682705|451212424|FG002|Overall Study|Adverse Event|1|||
125433045|NCT03682705|451212425|FG003|Overall Study|Adverse Event|0|||
125433046|NCT03682705|451212426|FG004|Overall Study|Adverse Event|1|||
125433047|NCT03682705|451212427|FG005|Overall Study|Adverse Event|1|||
125433048|NCT03682705|451212422|FG000|Overall Study|Withdrawal by Subject|1|||
125433049|NCT03682705|451212423|FG001|Overall Study|Withdrawal by Subject|3|||
125433050|NCT03682705|451212424|FG002|Overall Study|Withdrawal by Subject|2|||
125433051|NCT03682705|451212425|FG003|Overall Study|Withdrawal by Subject|4|||
125433052|NCT03682705|451212426|FG004|Overall Study|Withdrawal by Subject|0|||
125433053|NCT03682705|451212427|FG005|Overall Study|Withdrawal by Subject|1|||
125433054|NCT03682705|451212422|FG000|Overall Study|Other, not specified|0|||
125617516|NCT03225716|451881895|FG000|Overall Study|Study early termination by Sponsor|0|||
125617517|NCT03225716|451881896|FG001|Overall Study|Study early termination by Sponsor|0|||
125617518|NCT03225716|451881897|FG002|Overall Study|Study early termination by Sponsor|2|||
125617519|NCT01114373|451881898|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
125617520|NCT01114373|451881899|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
125617521|NCT01114373|451881898|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
125617522|NCT01114373|451881899|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
125617523|NCT01114373|451881898|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
125617524|NCT01114373|451881899|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
125617525|NCT01114373|451881898|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
125617526|NCT01114373|451881899|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
125617527|NCT01653158|451881903|FG000|Overall Study|Death|0|||
125617528|NCT01653158|451881904|FG001|Overall Study|Death|0|||
125617529|NCT01653158|451881905|FG002|Overall Study|Death|0|||
125617530|NCT01653158|451881906|FG003|Overall Study|Death|1|||
125617531|NCT01653158|451881907|FG004|Overall Study|Death|0|||
125617532|NCT01653158|451881908|FG005|Overall Study|Death|0|||
125617533|NCT01653158|451881909|FG006|Overall Study|Death|0|||
125617534|NCT01653158|451881910|FG007|Overall Study|Death|2|||
125617535|NCT01653158|451881903|FG000|Overall Study|Adverse Event|0|||
125617536|NCT01653158|451881904|FG001|Overall Study|Adverse Event|0|||
125617537|NCT01653158|451881905|FG002|Overall Study|Adverse Event|0|||
125617538|NCT01653158|451881906|FG003|Overall Study|Adverse Event|1|||
125617539|NCT01653158|451881907|FG004|Overall Study|Adverse Event|0|||
125617540|NCT01653158|451881908|FG005|Overall Study|Adverse Event|0|||
125617541|NCT01653158|451881909|FG006|Overall Study|Adverse Event|0|||
125617542|NCT01653158|451881910|FG007|Overall Study|Adverse Event|3|||
125617543|NCT01653158|451881903|FG000|Overall Study|Other|0|||
125617544|NCT01653158|451881904|FG001|Overall Study|Other|0|||
125617545|NCT01653158|451881905|FG002|Overall Study|Other|0|||
125617546|NCT01653158|451881906|FG003|Overall Study|Other|0|||
125617547|NCT01653158|451881907|FG004|Overall Study|Other|0|||
125617548|NCT01653158|451881908|FG005|Overall Study|Other|0|||
125617549|NCT01653158|451881909|FG006|Overall Study|Other|0|||
125617550|NCT01653158|451881910|FG007|Overall Study|Other|1|||
125433055|NCT03682705|451212423|FG001|Overall Study|Other, not specified|0|||
125617551|NCT01653158|451881903|FG000|Overall Study|Progressive disease|0|||
125617552|NCT01653158|451881904|FG001|Overall Study|Progressive disease|0|||
125617553|NCT01653158|451881905|FG002|Overall Study|Progressive disease|0|||
125617554|NCT01653158|451881906|FG003|Overall Study|Progressive disease|0|||
125617555|NCT01653158|451881907|FG004|Overall Study|Progressive disease|1|||
125617556|NCT01653158|451881908|FG005|Overall Study|Progressive disease|1|||
125617557|NCT01653158|451881909|FG006|Overall Study|Progressive disease|2|||
125617558|NCT01653158|451881910|FG007|Overall Study|Progressive disease|9|||
125433056|NCT03682705|451212424|FG002|Overall Study|Other, not specified|0|||
125433057|NCT03682705|451212425|FG003|Overall Study|Other, not specified|1|||
125433058|NCT03682705|451212426|FG004|Overall Study|Other, not specified|2|||
125617559|NCT01653158|451881903|FG000|Overall Study|Withdrawal by Subject|1|||
125617560|NCT01653158|451881904|FG001|Overall Study|Withdrawal by Subject|0|||
125617561|NCT01653158|451881905|FG002|Overall Study|Withdrawal by Subject|0|||
125617562|NCT01653158|451881906|FG003|Overall Study|Withdrawal by Subject|0|||
125617563|NCT01653158|451881907|FG004|Overall Study|Withdrawal by Subject|0|||
125617564|NCT01653158|451881908|FG005|Overall Study|Withdrawal by Subject|0|||
125617565|NCT01653158|451881909|FG006|Overall Study|Withdrawal by Subject|0|||
125617566|NCT01653158|451881910|FG007|Overall Study|Withdrawal by Subject|0|||
125617567|NCT03444870|451881913|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
125617568|NCT03444870|451881914|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
125617569|NCT03444870|451881915|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
125617570|NCT03444870|451881916|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
125617571|NCT03444870|451881917|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
125617572|NCT03444870|451881918|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
125617573|NCT03444870|451881913|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
125617574|NCT03444870|451881914|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
125617575|NCT03444870|451881915|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
125617576|NCT03444870|451881916|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
125617577|NCT03444870|451881917|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
125617578|NCT03444870|451881918|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
125214996|NCT02579382|450414890|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
125214997|NCT02579382|450414887|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
125214998|NCT02579382|450414888|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
125214999|NCT02579382|450414889|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
125215000|NCT02579382|450414890|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
125215001|NCT02579382|450414887|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
125215002|NCT02579382|450414888|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
125215003|NCT02579382|450414889|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
125215004|NCT02579382|450414890|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
125617579|NCT03444870|451881913|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
125617580|NCT03444870|451881914|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
125215005|NCT02579382|450414887|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
125374035|NCT00753415|450998094|FG004|Part B|Disease progression|0|||
125374036|NCT00753415|450998095|FG005|Part B|Disease progression|0|||
125374037|NCT00753415|450998096|FG006|Part B|Disease progression|0|||
125374038|NCT00753415|450998097|FG007|Part B|Disease progression|0|||
125374039|NCT00753415|450998098|FG008|Part B|Disease progression|2|||
125374040|NCT00753415|450998099|FG009|Part B|Disease progression|1|||
125374041|NCT00621153|450998100|FG000|Overall Study|Safety Reason|8|||
125374042|NCT00621153|450998101|FG001|Overall Study|Safety Reason|7|||
125374043|NCT00621153|450998100|FG000|Overall Study|Adverse Event|3|||
125374044|NCT00621153|450998101|FG001|Overall Study|Adverse Event|2|||
125374045|NCT00621153|450998100|FG000|Overall Study|Lost to Follow-up|5|||
125374046|NCT00621153|450998101|FG001|Overall Study|Lost to Follow-up|1|||
125374047|NCT00621153|450998100|FG000|Overall Study|Withdrawal by Subject|4|||
125374048|NCT00621153|450998101|FG001|Overall Study|Withdrawal by Subject|5|||
125374049|NCT03919799|450998102|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
125374050|NCT03919799|450998103|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
125374051|NCT03919799|450998104|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
125374052|NCT03919799|450998105|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
125374053|NCT03919799|450998106|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
125374054|NCT03919799|450998102|FG000|DB Period (28 Weeks)|Adverse Event|1|||
125374055|NCT03919799|450998103|FG001|DB Period (28 Weeks)|Adverse Event|1|||
125374056|NCT03919799|450998104|FG002|DB Period (28 Weeks)|Adverse Event|1|||
125374057|NCT03919799|450998105|FG003|DB Period (28 Weeks)|Adverse Event|0|||
125374058|NCT03919799|450998106|FG004|DB Period (28 Weeks)|Adverse Event|0|||
125374059|NCT03919799|450998102|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
125374060|NCT03919799|450998103|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
125374061|NCT03919799|450998104|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
125374062|NCT03919799|450998105|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
125374063|NCT03919799|450998106|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
125374064|NCT03919799|450998102|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
125374065|NCT03919799|450998103|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
125374066|NCT03919799|450998104|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
125374067|NCT03919799|450998105|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
125374068|NCT03919799|450998106|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
125374069|NCT03919799|450998102|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
125374070|NCT03919799|450998103|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
125374071|NCT03919799|450998104|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
125617581|NCT03444870|451881915|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
125374072|NCT03919799|450998105|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
125374073|NCT03919799|450998106|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
125617582|NCT03444870|451881916|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125617583|NCT03444870|451881917|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125617584|NCT03444870|451881918|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125617585|NCT03444870|451881913|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
125617586|NCT03444870|451881914|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
125617587|NCT03444870|451881915|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
125617588|NCT03444870|451881916|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
125617589|NCT03444870|451881917|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
125374074|NCT04023526|451000159|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
125374075|NCT04023526|451000160|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
125374076|NCT04023526|451000159|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
125374077|NCT04023526|451000160|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
125374078|NCT00540514|451000165|FG000|Overall Study|Still on treatment|3|||
125374079|NCT00540514|451000166|FG001|Overall Study|Still on treatment|0|||
125374080|NCT00540514|451000165|FG000|Overall Study|Unacceptable Toxicity|61|||
125374081|NCT00540514|451000166|FG001|Overall Study|Unacceptable Toxicity|62|||
125374082|NCT00540514|451000165|FG000|Overall Study|Adverse Event|20|||
125374083|NCT00540514|451000166|FG001|Overall Study|Adverse Event|24|||
125374084|NCT00540514|451000165|FG000|Overall Study|Physician Decision|86|||
125374085|NCT00540514|451000166|FG001|Overall Study|Physician Decision|99|||
125374086|NCT00540514|451000165|FG000|Overall Study|Protocol Deviation|3|||
125374087|NCT00540514|451000166|FG001|Overall Study|Protocol Deviation|4|||
125374088|NCT00540514|451000165|FG000|Overall Study|Lost to Follow-up|1|||
125374089|NCT00540514|451000166|FG001|Overall Study|Lost to Follow-up|1|||
125374090|NCT00540514|451000165|FG000|Overall Study|Withdrawal by Subject|65|||
125374091|NCT00540514|451000166|FG001|Overall Study|Withdrawal by Subject|67|||
125374092|NCT00540514|451000165|FG000|Overall Study|Excluded prior to treatment|7|||
125374093|NCT00540514|451000166|FG001|Overall Study|Excluded prior to treatment|7|||
125374094|NCT00540514|451000165|FG000|Overall Study|Paclitaxel not available|0|||
125374095|NCT00540514|451000166|FG001|Overall Study|Paclitaxel not available|2|||
125374096|NCT02501473|451000167|FG000|Overall Study|Study Terminated|2|||
125374097|NCT02501473|451000168|FG001|Overall Study|Study Terminated|3|||
125374098|NCT02501473|451000169|FG002|Overall Study|Study Terminated|7|||
125374099|NCT02501473|451000170|FG003|Overall Study|Study Terminated|9|||
125374100|NCT02501473|451000171|FG004|Overall Study|Study Terminated|2|||
125374101|NCT02501473|451000172|FG005|Overall Study|Study Terminated|10|||
125374102|NCT02501473|451000173|FG006|Overall Study|Study Terminated|1|||
125374103|NCT02501473|451000174|FG007|Overall Study|Study Terminated|0|||
125374104|NCT02501473|451000167|FG000|Overall Study|Withdrawal by Subject|0|||
125374105|NCT02501473|451000168|FG001|Overall Study|Withdrawal by Subject|0|||
125374106|NCT02501473|451000169|FG002|Overall Study|Withdrawal by Subject|3|||
125374107|NCT02501473|451000170|FG003|Overall Study|Withdrawal by Subject|3|||
125374108|NCT02501473|451000171|FG004|Overall Study|Withdrawal by Subject|2|||
125374109|NCT02501473|451000172|FG005|Overall Study|Withdrawal by Subject|2|||
125374110|NCT02501473|451000173|FG006|Overall Study|Withdrawal by Subject|0|||
125374111|NCT02501473|451000174|FG007|Overall Study|Withdrawal by Subject|0|||
125374112|NCT02501473|451000167|FG000|Overall Study|Death|0|||
125374113|NCT02501473|451000168|FG001|Overall Study|Death|0|||
125374114|NCT02501473|451000169|FG002|Overall Study|Death|1|||
125374115|NCT02501473|451000170|FG003|Overall Study|Death|1|||
125374116|NCT02501473|451000171|FG004|Overall Study|Death|0|||
125374117|NCT02501473|451000172|FG005|Overall Study|Death|1|||
125617590|NCT03444870|451881918|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
125374118|NCT02501473|451000173|FG006|Overall Study|Death|0|||
125374119|NCT02501473|451000174|FG007|Overall Study|Death|0|||
125617591|NCT03444870|451881913|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
125617592|NCT03444870|451881914|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
125617593|NCT03444870|451881915|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
125617594|NCT03444870|451881916|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
125617595|NCT03444870|451881917|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
125617596|NCT03444870|451881918|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
125617597|NCT03444870|451881913|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
125617598|NCT03444870|451881914|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
125374120|NCT02501473|451000167|FG000|Overall Study|Lost to Follow-up|1|||
125374121|NCT02501473|451000168|FG001|Overall Study|Lost to Follow-up|0|||
125374122|NCT02501473|451000169|FG002|Overall Study|Lost to Follow-up|1|||
125374123|NCT02501473|451000170|FG003|Overall Study|Lost to Follow-up|0|||
125374124|NCT02501473|451000171|FG004|Overall Study|Lost to Follow-up|0|||
125374125|NCT02501473|451000172|FG005|Overall Study|Lost to Follow-up|1|||
125374126|NCT02501473|451000173|FG006|Overall Study|Lost to Follow-up|0|||
125374127|NCT02501473|451000174|FG007|Overall Study|Lost to Follow-up|0|||
125374128|NCT02501473|451000167|FG000|Overall Study|Reason not specified|0|||
125374129|NCT02501473|451000168|FG001|Overall Study|Reason not specified|0|||
125374130|NCT02501473|451000169|FG002|Overall Study|Reason not specified|1|||
125374131|NCT02501473|451000170|FG003|Overall Study|Reason not specified|1|||
125374132|NCT02501473|451000171|FG004|Overall Study|Reason not specified|0|||
125374133|NCT02501473|451000172|FG005|Overall Study|Reason not specified|0|||
125374134|NCT02501473|451000173|FG006|Overall Study|Reason not specified|0|||
125374135|NCT02501473|451000174|FG007|Overall Study|Reason not specified|0|||
125374136|NCT00630396|451000178|FG000|Overall Study|Death|4|||
125374137|NCT00630396|451000178|FG000|Overall Study|Lost to Follow-up|3|||
125374138|NCT02990910|451000181|FG000|Overall Study|Lack of Efficacy|6|||
125374139|NCT02990910|451000182|FG001|Overall Study|Lack of Efficacy|10|||
125374140|NCT00790023|451000190|FG000|Overall Study|Adverse Event|2|||
125374141|NCT00790023|451000191|FG001|Overall Study|Adverse Event|1|||
125374142|NCT00790023|451000192|FG002|Overall Study|Adverse Event|4|||
125374143|NCT00790023|451000190|FG000|Overall Study|Protocol Violation|2|||
125374144|NCT00790023|451000191|FG001|Overall Study|Protocol Violation|4|||
125374145|NCT00790023|451000192|FG002|Overall Study|Protocol Violation|2|||
125374146|NCT00790023|451000190|FG000|Overall Study|Withdrawal by Subject|2|||
125374147|NCT00790023|451000191|FG001|Overall Study|Withdrawal by Subject|0|||
125374148|NCT00790023|451000192|FG002|Overall Study|Withdrawal by Subject|6|||
125374149|NCT00790023|451000190|FG000|Overall Study|Lost to Follow-up|0|||
125374150|NCT00790023|451000191|FG001|Overall Study|Lost to Follow-up|0|||
125374151|NCT00790023|451000192|FG002|Overall Study|Lost to Follow-up|1|||
125374152|NCT00790023|451000190|FG000|Overall Study|Other|5|||
125374153|NCT00790023|451000191|FG001|Overall Study|Other|5|||
125374154|NCT00790023|451000192|FG002|Overall Study|Other|8|||
125374155|NCT02468414|451000193|FG000|Overall Study|Early Study Termination by Sponsor|1|||
125374156|NCT02468414|451000194|FG001|Overall Study|Early Study Termination by Sponsor|0|||
125374157|NCT02468414|451000193|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
125374158|NCT02468414|451000194|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
125374159|NCT02468414|451000193|FG000|Overall Study|Screen Failure|1|||
125374160|NCT02468414|451000194|FG001|Overall Study|Screen Failure|0|||
125374161|NCT01338792|451000195|FG000|Overall Study|Adverse Event|2|||
125374162|NCT01338792|451000195|FG000|Overall Study|Death|1|||
125374163|NCT01338792|451000195|FG000|Overall Study|Withdrawal by Subject|1|||
125374164|NCT01652703|451000196|FG000|Overall Study|Withdrawal by Subject|0|||
125374165|NCT01652703|451000197|FG001|Overall Study|Withdrawal by Subject|1|||
125374166|NCT01652703|451000198|FG002|Overall Study|Withdrawal by Subject|3|||
125617599|NCT03444870|451881915|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
125617600|NCT03444870|451881916|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
125617601|NCT03444870|451881917|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
125617602|NCT03444870|451881918|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
125617603|NCT03444870|451881913|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
125617604|NCT03444870|451881914|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
125617605|NCT03444870|451881915|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
125617606|NCT03444870|451881916|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
125617607|NCT03444870|451881917|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
125617608|NCT03444870|451881918|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
125617609|NCT03444870|451881913|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
125617610|NCT03444870|451881914|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
125617611|NCT03444870|451881915|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
125617612|NCT03444870|451881916|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
125617613|NCT03444870|451881917|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
125617614|NCT03444870|451881918|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
125617615|NCT03444870|451881913|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
125617616|NCT03444870|451881914|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
125617617|NCT03444870|451881915|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
125617618|NCT03444870|451881916|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
125617619|NCT03444870|451881917|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
125617620|NCT03444870|451881918|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
125617621|NCT03444870|451881913|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125617622|NCT03444870|451881914|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125617623|NCT03444870|451881915|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125617624|NCT03444870|451881916|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125617625|NCT03444870|451881917|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
125617626|NCT03444870|451881918|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
125617627|NCT03444870|451881913|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
125617628|NCT03444870|451881914|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
125617629|NCT03444870|451881915|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
125617630|NCT03444870|451881916|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
125617631|NCT03444870|451881917|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
125617632|NCT03444870|451881918|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
125617633|NCT03444870|451881913|FG000|Open-Label Extension (OLE) Period|Death|0|||
125617634|NCT03444870|451881914|FG001|Open-Label Extension (OLE) Period|Death|0|||
125617635|NCT03444870|451881915|FG002|Open-Label Extension (OLE) Period|Death|0|||
125617636|NCT03444870|451881916|FG003|Open-Label Extension (OLE) Period|Death|0|||
125617637|NCT03444870|451881917|FG004|Open-Label Extension (OLE) Period|Death|1|||
125617638|NCT03444870|451881918|FG005|Open-Label Extension (OLE) Period|Death|0|||
125617639|NCT01170702|451881921|FG000|Overall Study|Exclusion criteria met after consent|1|||
125617640|NCT01170702|451881922|FG001|Overall Study|Exclusion criteria met after consent|2|||
125617641|NCT01170702|451881923|FG002|Overall Study|Exclusion criteria met after consent|0|||
125617642|NCT01170702|451881924|FG003|Overall Study|Exclusion criteria met after consent|2|||
125617643|NCT01677507|451881925|FG000|Initial Assignment|Adverse Event|0|||
125617644|NCT01677507|451881926|FG001|Initial Assignment|Adverse Event|1|||
125617645|NCT01677507|451881925|FG000|Initial Assignment|Protocol Violation|0|||
125617646|NCT01677507|451881926|FG001|Initial Assignment|Protocol Violation|1|||
125617647|NCT01677507|451881925|FG000|Second Assigment|Withdrawal by Subject|2|||
125617648|NCT01677507|451881926|FG001|Second Assigment|Withdrawal by Subject|2|||
125617649|NCT01677507|451881925|FG000|Second Assigment|Adverse Event|1|||
125617650|NCT01677507|451881926|FG001|Second Assigment|Adverse Event|3|||
125617651|NCT00571688|451881927|FG000|Overall Study|Lost to Follow-up|3|||
125617652|NCT00571688|451881928|FG001|Overall Study|Lost to Follow-up|6|||
125617653|NCT00571688|451881927|FG000|Overall Study|subject did not tolerate Consta|1|||
125617654|NCT00571688|451881928|FG001|Overall Study|subject did not tolerate Consta|0|||
125617655|NCT00571688|451881927|FG000|Overall Study|subject moved out of the area|1|||
125617656|NCT00571688|451881928|FG001|Overall Study|subject moved out of the area|0|||
125617657|NCT00190983|451881929|FG000|Overall Study|Inevaluable (never treated)|2|||
125617658|NCT02287402|451881930|FG000|Treatment Period|Adverse Event|17|||
125617659|NCT02287402|451881930|FG000|Treatment Period|Voluntary Withdrawal|10|||
125617660|NCT02287402|451881930|FG000|Follow-up|Lost to Follow-up|1|||
125617661|NCT02287402|451881930|FG000|Follow-up|Voluntary Withdrawal|2|||
125617662|NCT01844830|451881931|FG000|Overall Study|Withdrawal by Subject|1|||
125617663|NCT01844830|451881932|FG001|Overall Study|Withdrawal by Subject|0|||
125617664|NCT04247815|451881933|FG000|Overall Study|Adverse Event|1|||
125617665|NCT04247815|451881934|FG001|Overall Study|Adverse Event|0|||
125617666|NCT04247815|451881933|FG000|Overall Study|Withdrawal by Subject|1|||
125617667|NCT04247815|451881934|FG001|Overall Study|Withdrawal by Subject|0|||
125617668|NCT04247815|451881933|FG000|Overall Study|Protocol Violation|0|||
125617669|NCT04247815|451881934|FG001|Overall Study|Protocol Violation|1|||
125617670|NCT00502320|451881936|FG000|Overall Study|Lost to Follow-up|1|||
125617671|NCT00502320|451881937|FG001|Overall Study|Lost to Follow-up|1|||
125617672|NCT00502320|451881936|FG000|Overall Study|Withdrew Consent|1|||
125617673|NCT00502320|451881937|FG001|Overall Study|Withdrew Consent|0|||
125617674|NCT00502320|451881936|FG000|Overall Study|No longer met criteria|1|||
125617675|NCT00502320|451881937|FG001|Overall Study|No longer met criteria|0|||
125617676|NCT00502320|451881936|FG000|Overall Study|Screen Failure|0|||
125617677|NCT00502320|451881937|FG001|Overall Study|Screen Failure|1|||
125617678|NCT00502320|451881936|FG000|Overall Study|Adverse Event|3|||
125617679|NCT00502320|451881937|FG001|Overall Study|Adverse Event|5|||
125617680|NCT04724733|451881939|FG000|Overall Study|Lost to Follow-up|1|||
125617681|NCT04724733|451881940|FG001|Overall Study|Lost to Follow-up|1|||
125617682|NCT04724733|451881941|FG002|Overall Study|Lost to Follow-up|1|||
125617683|NCT01742078|451881942|FG000|Overall Study|Withdrawal by Subject|0|||
125617684|NCT01742078|451881943|FG001|Overall Study|Withdrawal by Subject|0|||
125617685|NCT01742078|451881944|FG002|Overall Study|Withdrawal by Subject|0|||
125617686|NCT01742078|451881945|FG003|Overall Study|Withdrawal by Subject|1|||
125617687|NCT01742078|451881946|FG004|Overall Study|Withdrawal by Subject|0|||
125617688|NCT01742078|451881947|FG005|Overall Study|Withdrawal by Subject|0|||
125617689|NCT01742078|451881948|FG006|Overall Study|Withdrawal by Subject|0|||
125617690|NCT01742078|451881949|FG007|Overall Study|Withdrawal by Subject|0|||
125617691|NCT01742078|451881950|FG008|Overall Study|Withdrawal by Subject|0|||
125617692|NCT00084929|451881951|FG000|Overall Study|ineligible - medical contraindication|1|||
125617693|NCT00084929|451881951|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
125617694|NCT00084929|451881951|FG000|Overall Study|Ineligible - Medical history|6|||
125617695|NCT00084929|451881951|FG000|Overall Study|Withdrawal by Subject|10|||
125617696|NCT00084929|451881951|FG000|Overall Study|Missing/incomplete CTC exam|9|||
125617697|NCT00084929|451881951|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
125617698|NCT00642746|451881953|FG000|Overall Study|Patient unevaluable|1|||
125617699|NCT00642746|451881954|FG001|Overall Study|Patient unevaluable|0|||
125617700|NCT00077610|451881955|FG000|Overall Study|Adverse Event|9|||
125617701|NCT00077610|451881956|FG001|Overall Study|Adverse Event|7|||
125617702|NCT00077610|451881957|FG002|Overall Study|Adverse Event|1|||
125617703|NCT00077610|451881955|FG000|Overall Study|Lost to Follow-up|0|||
125617704|NCT00077610|451881956|FG001|Overall Study|Lost to Follow-up|1|||
125617705|NCT00077610|451881957|FG002|Overall Study|Lost to Follow-up|2|||
125617706|NCT00077610|451881955|FG000|Overall Study|Withdrawal by Subject|4|||
125617707|NCT00077610|451881956|FG001|Overall Study|Withdrawal by Subject|10|||
125617708|NCT00077610|451881957|FG002|Overall Study|Withdrawal by Subject|6|||
125617709|NCT00077610|451881955|FG000|Overall Study|Death|17|||
125617710|NCT00077610|451881956|FG001|Overall Study|Death|13|||
125433059|NCT03682705|451212427|FG005|Overall Study|Other, not specified|0|||
125617711|NCT00077610|451881957|FG002|Overall Study|Death|13|||
125617712|NCT00077610|451881955|FG000|Overall Study|Renal transplant|12|||
125617713|NCT00077610|451881956|FG001|Overall Study|Renal transplant|15|||
125617714|NCT00077610|451881957|FG002|Overall Study|Renal transplant|11|||
125617715|NCT00077610|451881955|FG000|Overall Study|Withdrew from dialysis care|5|||
125617716|NCT00077610|451881956|FG001|Overall Study|Withdrew from dialysis care|0|||
125617717|NCT00077610|451881957|FG002|Overall Study|Withdrew from dialysis care|3|||
125617718|NCT00077610|451881955|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125617719|NCT00077610|451881956|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125617720|NCT00077610|451881957|FG002|Overall Study|Insufficient Therapeutic Response|0|||
125617721|NCT00077610|451881955|FG000|Overall Study|Multiple blood transfusions|0|||
125617722|NCT00077610|451881956|FG001|Overall Study|Multiple blood transfusions|0|||
125617723|NCT00077610|451881957|FG002|Overall Study|Multiple blood transfusions|1|||
125617724|NCT00077610|451881955|FG000|Overall Study|Principal Investigator's decision|1|||
125617725|NCT00077610|451881956|FG001|Overall Study|Principal Investigator's decision|0|||
125617726|NCT00077610|451881957|FG002|Overall Study|Principal Investigator's decision|1|||
125617727|NCT00077610|451881955|FG000|Overall Study|Worsening of health condition|1|||
125617728|NCT00077610|451881956|FG001|Overall Study|Worsening of health condition|1|||
125617729|NCT00077610|451881957|FG002|Overall Study|Worsening of health condition|0|||
125617730|NCT00077610|451881955|FG000|Overall Study|Given Epogen in hospital|1|||
125617731|NCT00077610|451881956|FG001|Overall Study|Given Epogen in hospital|0|||
125617732|NCT00077610|451881957|FG002|Overall Study|Given Epogen in hospital|0|||
125617733|NCT00077610|451881955|FG000|Overall Study|Transferred to other unit|0|||
125617734|NCT00077610|451881956|FG001|Overall Study|Transferred to other unit|0|||
125617735|NCT00077610|451881957|FG002|Overall Study|Transferred to other unit|1|||
125617736|NCT00077610|451881955|FG000|Overall Study|Transferred to nursing home|0|||
125617737|NCT00077610|451881956|FG001|Overall Study|Transferred to nursing home|0|||
125617738|NCT00077610|451881957|FG002|Overall Study|Transferred to nursing home|1|||
125617739|NCT00077610|451881955|FG000|Overall Study|Transfer to satellite unit|1|||
125617740|NCT00077610|451881956|FG001|Overall Study|Transfer to satellite unit|0|||
125617741|NCT00077610|451881957|FG002|Overall Study|Transfer to satellite unit|0|||
125617742|NCT00077610|451881955|FG000|Overall Study|Transfer to other center for surgery|1|||
125617743|NCT00077610|451881956|FG001|Overall Study|Transfer to other center for surgery|0|||
125617744|NCT00077610|451881957|FG002|Overall Study|Transfer to other center for surgery|0|||
125617745|NCT00077610|451881955|FG000|Overall Study|Change in dialysis modality|1|||
125617746|NCT00077610|451881956|FG001|Overall Study|Change in dialysis modality|0|||
125617747|NCT00077610|451881957|FG002|Overall Study|Change in dialysis modality|0|||
125617748|NCT00077610|451881955|FG000|Overall Study|Relocation|0|||
125617749|NCT00077610|451881956|FG001|Overall Study|Relocation|8|||
125617750|NCT00077610|451881957|FG002|Overall Study|Relocation|5|||
125617751|NCT00077610|451881955|FG000|Overall Study|Financial issues|0|||
125617752|NCT00077610|451881956|FG001|Overall Study|Financial issues|1|||
125617753|NCT00077610|451881957|FG002|Overall Study|Financial issues|0|||
125617754|NCT00077610|451881955|FG000|Overall Study|Sponsors decision to withdraw|0|||
125617755|NCT00077610|451881956|FG001|Overall Study|Sponsors decision to withdraw|0|||
125617756|NCT00077610|451881957|FG002|Overall Study|Sponsors decision to withdraw|1|||
125617757|NCT03442829|451881966|FG000|Overall Study|Scheduling clash|3|||
125617758|NCT03442829|451881967|FG001|Overall Study|Scheduling clash|1|||
125617759|NCT03442829|451881966|FG000|Overall Study|Illness unrelated to study|1|||
125617760|NCT03442829|451881967|FG001|Overall Study|Illness unrelated to study|1|||
125617761|NCT01029002|451881968|FG000|Overall Study|Lost to Follow-up|2|||
125617762|NCT01029002|451881969|FG001|Overall Study|Lost to Follow-up|4|||
125617763|NCT00702052|451881970|FG000|Overall Study|Adverse Event|23|||
125617764|NCT00702052|451881970|FG000|Overall Study|Disease Progression|30|||
125617765|NCT00702052|451881970|FG000|Overall Study|Withdrawal by Subject|5|||
125617766|NCT01577160|451881971|FG000|Overall Study|Adverse Event|9|||
125617767|NCT01577160|451881971|FG000|Overall Study|Lack of Efficacy|15|||
125617768|NCT01577160|451881971|FG000|Overall Study|Lost to Follow-up|40|||
125617769|NCT01577160|451881971|FG000|Overall Study|Withdrawal by Subject|18|||
125617770|NCT01577160|451881971|FG000|Overall Study|Subject Uncooperative|7|||
125617771|NCT01577160|451881971|FG000|Overall Study|Other|9|||
125617772|NCT01551758|451881972|FG000|Overall Study|Adverse Event|29|||
125617773|NCT01551758|451881973|FG001|Overall Study|Adverse Event|43|||
125617774|NCT01551758|451881972|FG000|Overall Study|Lack of Efficacy|0|||
125617775|NCT01551758|451881973|FG001|Overall Study|Lack of Efficacy|1|||
125617776|NCT01551758|451881972|FG000|Overall Study|Protocol Violation|5|||
125617777|NCT01551758|451881973|FG001|Overall Study|Protocol Violation|6|||
125617778|NCT01551758|451881972|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
125617779|NCT01551758|451881973|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
125433060|NCT03682705|451212422|FG000|Overall Study|Lost to Follow-up|0|||
125617780|NCT01551758|451881972|FG000|Overall Study|Lost to Follow-up|29|||
125617781|NCT01551758|451881973|FG001|Overall Study|Lost to Follow-up|25|||
125617782|NCT01551758|451881972|FG000|Overall Study|Physician Decision|9|||
125617783|NCT01551758|451881973|FG001|Overall Study|Physician Decision|3|||
125617784|NCT01551758|451881972|FG000|Overall Study|Withdrawal by Subject|14|||
125617785|NCT01551758|451881973|FG001|Overall Study|Withdrawal by Subject|17|||
125617786|NCT00101192|451881974|FG000|Overall Study|Ineligible|6|||
125617787|NCT00101192|451881974|FG000|Overall Study|Inevaluable|1|||
125617788|NCT03282357|451881981|FG000|Overall Study|Lost to Follow-up|3|||
125617789|NCT03282357|451881981|FG000|Overall Study|Withdrawal by Subject|4|||
125617790|NCT03282357|451881981|FG000|Overall Study|Adverse Event|1|||
125215006|NCT02579382|450414888|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
125215007|NCT02579382|450414889|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
125215008|NCT02579382|450414890|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
125617791|NCT03282357|451881981|FG000|Overall Study|Other|9|||
125617792|NCT01586156|451881982|FG000|Overall Study|Pregnancy|0|||
125617793|NCT01586156|451881983|FG001|Overall Study|Pregnancy|1|||
125617794|NCT01586156|451881984|FG002|Overall Study|Pregnancy|0|||
125617795|NCT02121756|451881987|FG000|Overall Study|Adverse Event|3|||
125617796|NCT02121756|451881988|FG001|Overall Study|Adverse Event|0|||
125617797|NCT02121756|451881987|FG000|Overall Study|Protocol Violation|1|||
125617798|NCT02121756|451881988|FG001|Overall Study|Protocol Violation|1|||
125617799|NCT02121756|451881987|FG000|Overall Study|Physician Decision|2|||
125617800|NCT02121756|451881988|FG001|Overall Study|Physician Decision|1|||
125617801|NCT00632541|451881989|FG000|Overall Study|Adverse Event|7|||
125617802|NCT01179347|451884034|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
125617803|NCT01179347|451884035|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
125617804|NCT01179347|451884034|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
125617805|NCT01179347|451884035|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
125617806|NCT01179347|451884034|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
125617807|NCT01179347|451884035|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
125617808|NCT01179347|451884034|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
125617809|NCT01179347|451884035|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
125617810|NCT01179347|451884034|FG000|Double-blind Period (12 Weeks)|Other|2|||
125617811|NCT01179347|451884035|FG001|Double-blind Period (12 Weeks)|Other|4|||
125617812|NCT01179347|451884034|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
125617813|NCT01179347|451884035|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
125617814|NCT01179347|451884034|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
125617815|NCT01179347|451884035|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
125617816|NCT01179347|451884034|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
125617817|NCT01179347|451884035|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
125617818|NCT01179347|451884034|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
125617819|NCT01179347|451884035|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
125617820|NCT01179347|451884034|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
125617821|NCT01179347|451884035|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
125617822|NCT01179347|451884034|FG000|Open-label Period (12 Weeks)|Other|7|||
125617823|NCT01179347|451884035|FG001|Open-label Period (12 Weeks)|Other|4|||
125617824|NCT00369967|451884037|FG000|Overall Study|Lost to Follow-up|23|||
125617825|NCT00369967|451884038|FG001|Overall Study|Lost to Follow-up|12|||
125617826|NCT01677624|451884039|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
125617827|NCT01830816|451884045|FG000|Overall Study|Progressive Disease|12|||
125617828|NCT01830816|451884046|FG001|Overall Study|Progressive Disease|7|||
125617829|NCT01830816|451884047|FG002|Overall Study|Progressive Disease|7|||
125617830|NCT01830816|451884045|FG000|Overall Study|Adverse Event|3|||
125617831|NCT01830816|451884046|FG001|Overall Study|Adverse Event|4|||
125617832|NCT01830816|451884047|FG002|Overall Study|Adverse Event|0|||
125215009|NCT03026283|450414892|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
125215010|NCT03026283|450414893|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
125215011|NCT03026283|450414894|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
125215012|NCT03026283|450414895|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
125215013|NCT03026283|450414896|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
125215014|NCT03026283|450414897|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
125215015|NCT03026283|450414898|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
125215016|NCT03026283|450414899|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
125215017|NCT03026283|450414892|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
125215018|NCT03026283|450414893|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
125617833|NCT01830816|451884045|FG000|Overall Study|Study Terminated by Sponsor|1|||
125617834|NCT01830816|451884046|FG001|Overall Study|Study Terminated by Sponsor|1|||
125617835|NCT01830816|451884047|FG002|Overall Study|Study Terminated by Sponsor|0|||
125617836|NCT01830816|451884045|FG000|Overall Study|Withdrawal by Subject|1|||
125617837|NCT01830816|451884046|FG001|Overall Study|Withdrawal by Subject|1|||
125617838|NCT01830816|451884047|FG002|Overall Study|Withdrawal by Subject|0|||
125617839|NCT01830816|451884045|FG000|Overall Study|Lost to Follow-up|0|||
125617840|NCT01830816|451884046|FG001|Overall Study|Lost to Follow-up|1|||
125617841|NCT01830816|451884047|FG002|Overall Study|Lost to Follow-up|0|||
125617842|NCT01830816|451884045|FG000|Overall Study|Symptomatic Deterioration|1|||
125617843|NCT01830816|451884046|FG001|Overall Study|Symptomatic Deterioration|0|||
125617844|NCT01830816|451884047|FG002|Overall Study|Symptomatic Deterioration|0|||
125374167|NCT01652703|451000199|FG003|Overall Study|Withdrawal by Subject|1|||
125374168|NCT01652703|451000200|FG004|Overall Study|Withdrawal by Subject|0|||
125617845|NCT01830816|451884045|FG000|Overall Study|Reason not Specified|2|||
125617846|NCT01830816|451884046|FG001|Overall Study|Reason not Specified|0|||
125617847|NCT01830816|451884047|FG002|Overall Study|Reason not Specified|0|||
125617848|NCT00830115|451884048|FG000|Overall Study|Adverse Event|2|||
125617849|NCT00830115|451884048|FG000|Overall Study|Improvement/recovery|1|||
125617850|NCT01207388|451884051|FG000|Overall Study|Death|67|||
125617851|NCT01207388|451884051|FG000|Overall Study|Withdrawal by Subject|1|||
125617852|NCT01885078|451884052|FG000|Treatment Period|Adverse Event|52|||
125617853|NCT01885078|451884053|FG001|Treatment Period|Adverse Event|136|||
125617854|NCT01885078|451884054|FG002|Treatment Period|Adverse Event|30|||
125617855|NCT01885078|451884055|FG003|Treatment Period|Adverse Event|73|||
125617856|NCT01885078|451884056|FG004|Treatment Period|Adverse Event|17|||
125617857|NCT01885078|451884057|FG005|Treatment Period|Adverse Event|72|||
125617858|NCT01885078|451884058|FG006|Treatment Period|Adverse Event|24|||
125617859|NCT01885078|451884059|FG007|Treatment Period|Adverse Event|5|||
125617860|NCT01885078|451884060|FG008|Treatment Period|Adverse Event|0|||
125617861|NCT01885078|451884061|FG009|Treatment Period|Adverse Event|0|||
125617862|NCT01885078|451884052|FG000|Treatment Period|Death|13|||
125617863|NCT01885078|451884053|FG001|Treatment Period|Death|33|||
125617864|NCT01885078|451884054|FG002|Treatment Period|Death|5|||
125617865|NCT01885078|451884055|FG003|Treatment Period|Death|9|||
125617866|NCT01885078|451884056|FG004|Treatment Period|Death|2|||
125617867|NCT01885078|451884057|FG005|Treatment Period|Death|10|||
125617868|NCT01885078|451884058|FG006|Treatment Period|Death|3|||
125617869|NCT01885078|451884059|FG007|Treatment Period|Death|2|||
125617870|NCT01885078|451884060|FG008|Treatment Period|Death|0|||
125617871|NCT01885078|451884061|FG009|Treatment Period|Death|0|||
125617872|NCT01885078|451884052|FG000|Treatment Period|Lack of Efficacy|12|||
125617873|NCT01885078|451884053|FG001|Treatment Period|Lack of Efficacy|33|||
125617874|NCT01885078|451884054|FG002|Treatment Period|Lack of Efficacy|10|||
125617875|NCT01885078|451884055|FG003|Treatment Period|Lack of Efficacy|23|||
125617876|NCT01885078|451884056|FG004|Treatment Period|Lack of Efficacy|24|||
125617877|NCT01885078|451884057|FG005|Treatment Period|Lack of Efficacy|58|||
125617878|NCT01885078|451884058|FG006|Treatment Period|Lack of Efficacy|9|||
125617879|NCT01885078|451884059|FG007|Treatment Period|Lack of Efficacy|5|||
125617880|NCT01885078|451884060|FG008|Treatment Period|Lack of Efficacy|0|||
125617881|NCT01885078|451884061|FG009|Treatment Period|Lack of Efficacy|0|||
125617882|NCT01885078|451884052|FG000|Treatment Period|Lost to Follow-up|16|||
125617883|NCT01885078|451884053|FG001|Treatment Period|Lost to Follow-up|19|||
125617884|NCT01885078|451884054|FG002|Treatment Period|Lost to Follow-up|7|||
125617885|NCT01885078|451884055|FG003|Treatment Period|Lost to Follow-up|9|||
125617886|NCT01885078|451884056|FG004|Treatment Period|Lost to Follow-up|2|||
125617887|NCT01885078|451884057|FG005|Treatment Period|Lost to Follow-up|8|||
125617888|NCT01885078|451884058|FG006|Treatment Period|Lost to Follow-up|2|||
125617889|NCT01885078|451884059|FG007|Treatment Period|Lost to Follow-up|0|||
125617890|NCT01885078|451884060|FG008|Treatment Period|Lost to Follow-up|0|||
125617891|NCT01885078|451884061|FG009|Treatment Period|Lost to Follow-up|0|||
125617892|NCT01885078|451884052|FG000|Treatment Period|Physician Decision|19|||
125617893|NCT01885078|451884053|FG001|Treatment Period|Physician Decision|21|||
125617894|NCT01885078|451884054|FG002|Treatment Period|Physician Decision|5|||
125617895|NCT01885078|451884055|FG003|Treatment Period|Physician Decision|12|||
125617896|NCT01885078|451884056|FG004|Treatment Period|Physician Decision|9|||
125617897|NCT01885078|451884057|FG005|Treatment Period|Physician Decision|24|||
125617898|NCT01885078|451884058|FG006|Treatment Period|Physician Decision|4|||
125617899|NCT01885078|451884059|FG007|Treatment Period|Physician Decision|3|||
125617900|NCT01885078|451884060|FG008|Treatment Period|Physician Decision|0|||
125617901|NCT01885078|451884061|FG009|Treatment Period|Physician Decision|0|||
125617902|NCT01885078|451884052|FG000|Treatment Period|Protocol Violation|3|||
125617903|NCT01885078|451884053|FG001|Treatment Period|Protocol Violation|5|||
125617904|NCT01885078|451884054|FG002|Treatment Period|Protocol Violation|0|||
125617905|NCT01885078|451884055|FG003|Treatment Period|Protocol Violation|3|||
125617906|NCT01885078|451884056|FG004|Treatment Period|Protocol Violation|1|||
125617907|NCT01885078|451884057|FG005|Treatment Period|Protocol Violation|6|||
125617908|NCT01885078|451884058|FG006|Treatment Period|Protocol Violation|0|||
125215019|NCT03026283|450414894|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
125617909|NCT01885078|451884059|FG007|Treatment Period|Protocol Violation|0|||
125617910|NCT01885078|451884060|FG008|Treatment Period|Protocol Violation|0|||
125617911|NCT01885078|451884061|FG009|Treatment Period|Protocol Violation|0|||
125617912|NCT01885078|451884052|FG000|Treatment Period|Sponsor Decision|245|||
125617913|NCT01885078|451884053|FG001|Treatment Period|Sponsor Decision|648|||
125617914|NCT01885078|451884054|FG002|Treatment Period|Sponsor Decision|49|||
125617915|NCT01885078|451884055|FG003|Treatment Period|Sponsor Decision|90|||
125617916|NCT01885078|451884056|FG004|Treatment Period|Sponsor Decision|20|||
125617917|NCT01885078|451884057|FG005|Treatment Period|Sponsor Decision|38|||
125617918|NCT01885078|451884058|FG006|Treatment Period|Sponsor Decision|162|||
125617919|NCT01885078|451884059|FG007|Treatment Period|Sponsor Decision|3|||
125617920|NCT01885078|451884060|FG008|Treatment Period|Sponsor Decision|0|||
125617921|NCT01885078|451884061|FG009|Treatment Period|Sponsor Decision|0|||
125617922|NCT01885078|451884052|FG000|Treatment Period|Withdrawal by Subject|72|||
125617923|NCT01885078|451884053|FG001|Treatment Period|Withdrawal by Subject|132|||
125617924|NCT01885078|451884054|FG002|Treatment Period|Withdrawal by Subject|25|||
125617925|NCT01885078|451884055|FG003|Treatment Period|Withdrawal by Subject|63|||
125617926|NCT01885078|451884056|FG004|Treatment Period|Withdrawal by Subject|15|||
125617927|NCT01885078|451884057|FG005|Treatment Period|Withdrawal by Subject|34|||
125617928|NCT01885078|451884058|FG006|Treatment Period|Withdrawal by Subject|17|||
125617929|NCT01885078|451884059|FG007|Treatment Period|Withdrawal by Subject|10|||
125617930|NCT01885078|451884060|FG008|Treatment Period|Withdrawal by Subject|0|||
125617931|NCT01885078|451884061|FG009|Treatment Period|Withdrawal by Subject|0|||
125617932|NCT01885078|451884052|FG000|Treatment Period|Other|0|||
125617933|NCT01885078|451884053|FG001|Treatment Period|Other|0|||
125617934|NCT01885078|451884054|FG002|Treatment Period|Other|0|||
125617935|NCT01885078|451884055|FG003|Treatment Period|Other|1|||
125617936|NCT01885078|451884056|FG004|Treatment Period|Other|0|||
125617937|NCT01885078|451884057|FG005|Treatment Period|Other|0|||
125617938|NCT01885078|451884058|FG006|Treatment Period|Other|0|||
125617939|NCT01885078|451884059|FG007|Treatment Period|Other|0|||
125617940|NCT01885078|451884060|FG008|Treatment Period|Other|0|||
125617941|NCT01885078|451884061|FG009|Treatment Period|Other|0|||
125617942|NCT01885078|451884052|FG000|Step-down Period|Sponsor Decision|0|||
125617943|NCT01885078|451884053|FG001|Step-down Period|Sponsor Decision|0|||
125617944|NCT01885078|451884054|FG002|Step-down Period|Sponsor Decision|0|||
125617945|NCT01885078|451884055|FG003|Step-down Period|Sponsor Decision|0|||
125617946|NCT01885078|451884056|FG004|Step-down Period|Sponsor Decision|0|||
125617947|NCT01885078|451884057|FG005|Step-down Period|Sponsor Decision|0|||
125617948|NCT01885078|451884058|FG006|Step-down Period|Sponsor Decision|0|||
125617949|NCT01885078|451884059|FG007|Step-down Period|Sponsor Decision|0|||
125617950|NCT01885078|451884060|FG008|Step-down Period|Sponsor Decision|1|||
125617951|NCT01885078|451884061|FG009|Step-down Period|Sponsor Decision|1|||
125617952|NCT01885078|451884052|FG000|Step-down Period|Adverse Event|0|||
125617953|NCT01885078|451884053|FG001|Step-down Period|Adverse Event|0|||
125617954|NCT01885078|451884054|FG002|Step-down Period|Adverse Event|0|||
125617955|NCT01885078|451884055|FG003|Step-down Period|Adverse Event|0|||
125617956|NCT01885078|451884056|FG004|Step-down Period|Adverse Event|0|||
125617957|NCT01885078|451884057|FG005|Step-down Period|Adverse Event|0|||
125617958|NCT01885078|451884058|FG006|Step-down Period|Adverse Event|0|||
125617959|NCT01885078|451884059|FG007|Step-down Period|Adverse Event|0|||
125617960|NCT01885078|451884060|FG008|Step-down Period|Adverse Event|29|||
125617961|NCT01885078|451884061|FG009|Step-down Period|Adverse Event|38|||
125617962|NCT01885078|451884052|FG000|Step-down Period|Withdrawal by Subject|0|||
125617963|NCT01885078|451884053|FG001|Step-down Period|Withdrawal by Subject|0|||
125617964|NCT01885078|451884054|FG002|Step-down Period|Withdrawal by Subject|0|||
125617965|NCT01885078|451884055|FG003|Step-down Period|Withdrawal by Subject|0|||
125617966|NCT01885078|451884056|FG004|Step-down Period|Withdrawal by Subject|0|||
125617967|NCT01885078|451884057|FG005|Step-down Period|Withdrawal by Subject|0|||
125617968|NCT01885078|451884058|FG006|Step-down Period|Withdrawal by Subject|0|||
125617969|NCT01885078|451884059|FG007|Step-down Period|Withdrawal by Subject|0|||
125617970|NCT01885078|451884060|FG008|Step-down Period|Withdrawal by Subject|25|||
125617971|NCT01885078|451884061|FG009|Step-down Period|Withdrawal by Subject|15|||
125617972|NCT01885078|451884052|FG000|Step-down Period|Physician Decision|0|||
125617973|NCT01885078|451884053|FG001|Step-down Period|Physician Decision|0|||
125617974|NCT01885078|451884054|FG002|Step-down Period|Physician Decision|0|||
125617975|NCT01885078|451884055|FG003|Step-down Period|Physician Decision|0|||
125617976|NCT01885078|451884056|FG004|Step-down Period|Physician Decision|0|||
125617977|NCT01885078|451884057|FG005|Step-down Period|Physician Decision|0|||
125617978|NCT01885078|451884058|FG006|Step-down Period|Physician Decision|0|||
125617979|NCT01885078|451884059|FG007|Step-down Period|Physician Decision|0|||
125617980|NCT01885078|451884060|FG008|Step-down Period|Physician Decision|7|||
125433061|NCT03682705|451212423|FG001|Overall Study|Lost to Follow-up|0|||
125617981|NCT01885078|451884061|FG009|Step-down Period|Physician Decision|2|||
125617982|NCT01885078|451884052|FG000|Step-down Period|Death|0|||
125617983|NCT01885078|451884053|FG001|Step-down Period|Death|0|||
125617984|NCT01885078|451884054|FG002|Step-down Period|Death|0|||
125617985|NCT01885078|451884055|FG003|Step-down Period|Death|0|||
125617986|NCT01885078|451884056|FG004|Step-down Period|Death|0|||
125617987|NCT01885078|451884057|FG005|Step-down Period|Death|0|||
125617988|NCT01885078|451884058|FG006|Step-down Period|Death|0|||
125617989|NCT01885078|451884059|FG007|Step-down Period|Death|0|||
125617990|NCT01885078|451884060|FG008|Step-down Period|Death|4|||
125617991|NCT01885078|451884061|FG009|Step-down Period|Death|3|||
125617992|NCT01885078|451884052|FG000|Step-down Period|Lost to Follow-up|0|||
125617993|NCT01885078|451884053|FG001|Step-down Period|Lost to Follow-up|0|||
125617994|NCT01885078|451884054|FG002|Step-down Period|Lost to Follow-up|0|||
125617995|NCT01885078|451884055|FG003|Step-down Period|Lost to Follow-up|0|||
125617996|NCT01885078|451884056|FG004|Step-down Period|Lost to Follow-up|0|||
125617997|NCT01885078|451884057|FG005|Step-down Period|Lost to Follow-up|0|||
125617998|NCT01885078|451884058|FG006|Step-down Period|Lost to Follow-up|0|||
125617999|NCT01885078|451884059|FG007|Step-down Period|Lost to Follow-up|0|||
125618000|NCT01885078|451884060|FG008|Step-down Period|Lost to Follow-up|1|||
125618001|NCT01885078|451884061|FG009|Step-down Period|Lost to Follow-up|1|||
125618002|NCT01885078|451884052|FG000|Step-down Period|Lack of Efficacy|0|||
125618003|NCT01885078|451884053|FG001|Step-down Period|Lack of Efficacy|0|||
125618004|NCT01885078|451884054|FG002|Step-down Period|Lack of Efficacy|0|||
125618005|NCT01885078|451884055|FG003|Step-down Period|Lack of Efficacy|0|||
125618006|NCT01885078|451884056|FG004|Step-down Period|Lack of Efficacy|0|||
125618007|NCT01885078|451884057|FG005|Step-down Period|Lack of Efficacy|0|||
125618008|NCT01885078|451884058|FG006|Step-down Period|Lack of Efficacy|0|||
125618009|NCT01885078|451884059|FG007|Step-down Period|Lack of Efficacy|0|||
125618010|NCT01885078|451884060|FG008|Step-down Period|Lack of Efficacy|1|||
125618011|NCT01885078|451884061|FG009|Step-down Period|Lack of Efficacy|0|||
125618012|NCT01885078|451884052|FG000|Step-down Period|Protocol Violation|0|||
125618013|NCT01885078|451884053|FG001|Step-down Period|Protocol Violation|0|||
125618014|NCT01885078|451884054|FG002|Step-down Period|Protocol Violation|0|||
125618015|NCT01885078|451884055|FG003|Step-down Period|Protocol Violation|0|||
125618016|NCT01885078|451884056|FG004|Step-down Period|Protocol Violation|0|||
125618017|NCT01885078|451884057|FG005|Step-down Period|Protocol Violation|0|||
125618018|NCT01885078|451884058|FG006|Step-down Period|Protocol Violation|0|||
125618019|NCT01885078|451884059|FG007|Step-down Period|Protocol Violation|0|||
125618020|NCT01885078|451884060|FG008|Step-down Period|Protocol Violation|1|||
125618021|NCT01885078|451884061|FG009|Step-down Period|Protocol Violation|1|||
125618022|NCT01895452|451884067|FG000|Overall Study|Adverse Event|1|||
125618023|NCT01895452|451884068|FG001|Overall Study|Adverse Event|4|||
125618024|NCT01895452|451884067|FG000|Overall Study|Lost to Follow-up|1|||
125618025|NCT01895452|451884068|FG001|Overall Study|Lost to Follow-up|5|||
125618026|NCT01895452|451884067|FG000|Overall Study|Pregnancy|0|||
125618027|NCT01895452|451884068|FG001|Overall Study|Pregnancy|1|||
125618028|NCT01895452|451884067|FG000|Overall Study|Withdrawal by Subject|2|||
125618029|NCT01895452|451884068|FG001|Overall Study|Withdrawal by Subject|14|||
125618030|NCT01895452|451884067|FG000|Overall Study|Underlying disease|0|||
125618031|NCT01895452|451884068|FG001|Overall Study|Underlying disease|3|||
125618032|NCT01895452|451884067|FG000|Overall Study|Noncompliance with study drug|0|||
125618033|NCT01895452|451884068|FG001|Overall Study|Noncompliance with study drug|1|||
125618034|NCT01204697|451884072|FG000|Overall Study|Death|26|||
125618035|NCT01204697|451884073|FG001|Overall Study|Death|27|||
125618036|NCT01204697|451884072|FG000|Overall Study|Lost to Follow-up|3|||
125618037|NCT01204697|451884073|FG001|Overall Study|Lost to Follow-up|4|||
125618038|NCT01204697|451884072|FG000|Overall Study|Withdrawal by Subject|2|||
125618039|NCT01204697|451884073|FG001|Overall Study|Withdrawal by Subject|4|||
125618040|NCT01204697|451884072|FG000|Overall Study|Randomized, but not treated|0|||
125618041|NCT01204697|451884073|FG001|Overall Study|Randomized, but not treated|1|||
125618042|NCT01205451|451884074|FG000|Overall Study|Lost to Follow-up|1|||
125618043|NCT01205451|451884075|FG001|Overall Study|Lost to Follow-up|1|||
125618044|NCT01205451|451884074|FG000|Overall Study|Withdrawal by Subject|5|||
125618045|NCT01205451|451884075|FG001|Overall Study|Withdrawal by Subject|9|||
125618046|NCT01194869|451884076|FG000|Overall Study|Disease Progression|2|||
125618047|NCT01194869|451884076|FG000|Overall Study|Toxicity|2|||
125618048|NCT04321252|451884079|FG000|Overall Study|Withdrawal by Subject|0|||
125618049|NCT04321252|451884080|FG001|Overall Study|Withdrawal by Subject|0|||
125618050|NCT04321252|451884081|FG002|Overall Study|Withdrawal by Subject|0|||
125618051|NCT04321252|451884082|FG003|Overall Study|Withdrawal by Subject|0|||
125618052|NCT04321252|451884083|FG004|Overall Study|Withdrawal by Subject|0|||
125618053|NCT04321252|451884084|FG005|Overall Study|Withdrawal by Subject|1|||
125215020|NCT03026283|450414895|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
125215021|NCT03026283|450414896|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
125618054|NCT04321252|451884085|FG006|Overall Study|Withdrawal by Subject|0|||
125618055|NCT04321252|451884086|FG007|Overall Study|Withdrawal by Subject|0|||
125618056|NCT04321252|451884087|FG008|Overall Study|Withdrawal by Subject|0|||
125618057|NCT03004469|451884088|FG000|Overall Study|Adverse Event|6|||
125618058|NCT03004469|451884089|FG001|Overall Study|Adverse Event|4|||
125618059|NCT03004469|451884090|FG002|Overall Study|Adverse Event|6|||
125618060|NCT03004469|451884088|FG000|Overall Study|Lack of Efficacy|1|||
125618061|NCT03004469|451884089|FG001|Overall Study|Lack of Efficacy|0|||
125618062|NCT03004469|451884090|FG002|Overall Study|Lack of Efficacy|1|||
125618063|NCT03004469|451884088|FG000|Overall Study|Lost to Follow-up|23|||
125618064|NCT03004469|451884089|FG001|Overall Study|Lost to Follow-up|14|||
125618065|NCT03004469|451884090|FG002|Overall Study|Lost to Follow-up|6|||
125618066|NCT03004469|451884088|FG000|Overall Study|Non-Compliance with Study Drug|2|||
125618067|NCT03004469|451884089|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125618068|NCT03004469|451884090|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125618069|NCT03004469|451884088|FG000|Overall Study|Protocol Violation|0|||
125618070|NCT03004469|451884089|FG001|Overall Study|Protocol Violation|0|||
125618071|NCT03004469|451884090|FG002|Overall Study|Protocol Violation|1|||
125618072|NCT03004469|451884088|FG000|Overall Study|Withdrawal by Subject|29|||
125618073|NCT03004469|451884089|FG001|Overall Study|Withdrawal by Subject|27|||
125618074|NCT03004469|451884090|FG002|Overall Study|Withdrawal by Subject|10|||
125618075|NCT03004469|451884088|FG000|Overall Study|Other unspecified reason|0|||
125618076|NCT03004469|451884089|FG001|Overall Study|Other unspecified reason|4|||
125618077|NCT03004469|451884090|FG002|Overall Study|Other unspecified reason|1|||
125618078|NCT00259740|451884091|FG000|Overall Study|Physician Decision|1|||
125618079|NCT00259740|451884092|FG001|Overall Study|Physician Decision|1|||
125618080|NCT00259740|451884091|FG000|Overall Study|Adverse Event|0|||
125618081|NCT00259740|451884092|FG001|Overall Study|Adverse Event|2|||
125618082|NCT00259740|451884091|FG000|Overall Study|Withdrawal by Subject|2|||
125618083|NCT00259740|451884092|FG001|Overall Study|Withdrawal by Subject|6|||
125618084|NCT00259740|451884091|FG000|Overall Study|Death|1|||
125618085|NCT00259740|451884092|FG001|Overall Study|Death|1|||
125618086|NCT00259740|451884091|FG000|Overall Study|Disease progression|19|||
125618087|NCT00259740|451884092|FG001|Overall Study|Disease progression|36|||
125618088|NCT00259740|451884091|FG000|Overall Study|Ongoing|17|||
125618089|NCT00259740|451884092|FG001|Overall Study|Ongoing|3|||
125618090|NCT00259740|451884091|FG000|Overall Study|Other|3|||
125618091|NCT00259740|451884092|FG001|Overall Study|Other|0|||
125618092|NCT00259740|451884091|FG000|Overall Study|Requirement for alternative therapy|0|||
125618093|NCT00259740|451884092|FG001|Overall Study|Requirement for alternative therapy|4|||
125618094|NCT03654755|451884096|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
125618095|NCT03654755|451884097|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
125618096|NCT03654755|451884098|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
125618097|NCT03654755|451884096|FG000|Overall Study|Withdrawal by Subject|2|||
125618098|NCT03654755|451884097|FG001|Overall Study|Withdrawal by Subject|4|||
125618099|NCT03654755|451884098|FG002|Overall Study|Withdrawal by Subject|8|||
125618100|NCT03654755|451884096|FG000|Overall Study|Lost to Follow-up|1|||
125618101|NCT03654755|451884097|FG001|Overall Study|Lost to Follow-up|3|||
125618102|NCT03654755|451884098|FG002|Overall Study|Lost to Follow-up|7|||
125618103|NCT03654755|451884096|FG000|Overall Study|Physician Decision|0|||
125618104|NCT03654755|451884097|FG001|Overall Study|Physician Decision|1|||
125618105|NCT03654755|451884098|FG002|Overall Study|Physician Decision|0|||
125618106|NCT03654755|451884096|FG000|Overall Study|Adverse Event|0|||
125618107|NCT03654755|451884097|FG001|Overall Study|Adverse Event|0|||
125618108|NCT03654755|451884098|FG002|Overall Study|Adverse Event|4|||
125618109|NCT03654755|451884096|FG000|Overall Study|Lack of Efficacy|0|||
125618110|NCT03654755|451884097|FG001|Overall Study|Lack of Efficacy|0|||
125618111|NCT03654755|451884098|FG002|Overall Study|Lack of Efficacy|1|||
125618112|NCT03495453|451884099|FG000|Overall Study|Withdrawal by Subject|0|||
125618113|NCT03495453|451884100|FG001|Overall Study|Withdrawal by Subject|1|||
125618114|NCT04511819|451884104|FG000|Overall Study|Non-compliance with study drug|5|||
125618115|NCT04511819|451884105|FG001|Overall Study|Non-compliance with study drug|1|||
125618116|NCT04511819|451884104|FG000|Overall Study|Withdrawal by Subject|0|||
125618117|NCT04511819|451884105|FG001|Overall Study|Withdrawal by Subject|3|||
125618118|NCT04511819|451884104|FG000|Overall Study|Adverse Event|0|||
125618119|NCT04511819|451884105|FG001|Overall Study|Adverse Event|1|||
125618120|NCT04511819|451884104|FG000|Overall Study|Protocol deviation|1|||
125618121|NCT04511819|451884105|FG001|Overall Study|Protocol deviation|0|||
125618122|NCT03247413|451884108|FG000|Overall Study|Lost to Follow-up|28|||
125618123|NCT00424294|451884109|FG000|Overall Study|Adverse Event|4|||
125618124|NCT00424294|451884110|FG001|Overall Study|Adverse Event|10|||
125618125|NCT00424294|451884109|FG000|Overall Study|Lack of Efficacy|2|||
125618126|NCT00424294|451884110|FG001|Overall Study|Lack of Efficacy|1|||
125618127|NCT00424294|451884109|FG000|Overall Study|Withdrawal by Subject|1|||
125618128|NCT00424294|451884110|FG001|Overall Study|Withdrawal by Subject|2|||
125618129|NCT00424294|451884109|FG000|Overall Study|Other|0|||
125618130|NCT00424294|451884110|FG001|Overall Study|Other|2|||
125618131|NCT00424294|451884109|FG000|Overall Study|Randomized but not Treated|1|||
125618132|NCT00424294|451884110|FG001|Overall Study|Randomized but not Treated|0|||
125618133|NCT04397718|451884111|FG000|Overall Study|Death|7|||
125618134|NCT04397718|451884112|FG001|Overall Study|Death|11|||
125618135|NCT04397718|451884111|FG000|Overall Study|Lost to Follow-up|0|||
125618136|NCT04397718|451884112|FG001|Overall Study|Lost to Follow-up|4|||
125618137|NCT01797965|451884113|FG000|Overall Study|Adverse Event|104|||
125618138|NCT01797965|451884114|FG001|Overall Study|Adverse Event|129|||
125618139|NCT01797965|451884115|FG002|Overall Study|Adverse Event|4|||
125618140|NCT01797965|451884116|FG003|Overall Study|Adverse Event|21|||
125618141|NCT01797965|451884113|FG000|Overall Study|Lost to Follow-up|9|||
125618142|NCT01797965|451884114|FG001|Overall Study|Lost to Follow-up|8|||
125618143|NCT01797965|451884115|FG002|Overall Study|Lost to Follow-up|1|||
125618144|NCT01797965|451884116|FG003|Overall Study|Lost to Follow-up|2|||
125618145|NCT01797965|451884113|FG000|Overall Study|Consent withdrawn|130|||
125618146|NCT01797965|451884114|FG001|Overall Study|Consent withdrawn|117|||
125618147|NCT01797965|451884115|FG002|Overall Study|Consent withdrawn|3|||
125618148|NCT01797965|451884116|FG003|Overall Study|Consent withdrawn|35|||
125618149|NCT01797965|451884113|FG000|Overall Study|Investigator decision|21|||
125618150|NCT01797965|451884114|FG001|Overall Study|Investigator decision|15|||
125618151|NCT01797965|451884115|FG002|Overall Study|Investigator decision|0|||
125618152|NCT01797965|451884116|FG003|Overall Study|Investigator decision|0|||
125618153|NCT01797965|451884113|FG000|Overall Study|Death|2|||
125618154|NCT01797965|451884114|FG001|Overall Study|Death|4|||
125618155|NCT01797965|451884115|FG002|Overall Study|Death|0|||
125618156|NCT01797965|451884116|FG003|Overall Study|Death|0|||
125618157|NCT01797965|451884113|FG000|Overall Study|Disease progression, defined by protocol|3|||
125618158|NCT01797965|451884114|FG001|Overall Study|Disease progression, defined by protocol|1|||
125618159|NCT01797965|451884115|FG002|Overall Study|Disease progression, defined by protocol|0|||
125618160|NCT01797965|451884116|FG003|Overall Study|Disease progression, defined by protocol|0|||
125618161|NCT01797965|451884113|FG000|Overall Study|Reason Not Specified|280|||
125618162|NCT01797965|451884114|FG001|Overall Study|Reason Not Specified|295|||
125618163|NCT01797965|451884115|FG002|Overall Study|Reason Not Specified|0|||
125618164|NCT01797965|451884116|FG003|Overall Study|Reason Not Specified|15|||
125618165|NCT00976950|451884117|FG000|Overall Study|Adverse Event|3|||
125618166|NCT00976950|451884117|FG000|Overall Study|Events with no relationship to Aptivus|3|||
125618167|NCT00304915|451884118|FG000|Overall Study|Lost to Follow-up|11|||
125618168|NCT00304915|451884119|FG001|Overall Study|Lost to Follow-up|11|||
125618169|NCT00304915|451884118|FG000|Overall Study|Death|4|||
125618170|NCT00304915|451884119|FG001|Overall Study|Death|5|||
125618171|NCT00304915|451884118|FG000|Overall Study|Withdrawal by Subject|3|||
125618172|NCT00304915|451884119|FG001|Overall Study|Withdrawal by Subject|0|||
125618173|NCT01021852|451884122|FG000|Treatment Period 1|Adverse Event|3|||
125618174|NCT01021852|451884123|FG001|Treatment Period 1|Adverse Event|1|||
125618175|NCT01021852|451884124|FG002|Treatment Period 1|Adverse Event|1|||
125618176|NCT01021852|451884125|FG003|Treatment Period 1|Adverse Event|0|||
125618177|NCT01021852|451884126|FG004|Treatment Period 1|Adverse Event|2|||
125618178|NCT01021852|451884127|FG005|Treatment Period 1|Adverse Event|2|||
125618179|NCT01021852|451884128|FG006|Treatment Period 1|Adverse Event|0|||
125618180|NCT01021852|451884129|FG007|Treatment Period 1|Adverse Event|0|||
125618181|NCT01021852|451884122|FG000|Treatment Period 1|Pregnancy|0|||
125618182|NCT01021852|451884123|FG001|Treatment Period 1|Pregnancy|0|||
125618183|NCT01021852|451884124|FG002|Treatment Period 1|Pregnancy|1|||
125618184|NCT01021852|451884125|FG003|Treatment Period 1|Pregnancy|0|||
125618185|NCT01021852|451884126|FG004|Treatment Period 1|Pregnancy|0|||
125618186|NCT01021852|451884127|FG005|Treatment Period 1|Pregnancy|0|||
125618187|NCT01021852|451884128|FG006|Treatment Period 1|Pregnancy|0|||
125618188|NCT01021852|451884129|FG007|Treatment Period 1|Pregnancy|0|||
125215022|NCT03026283|450414897|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
125374169|NCT01652703|451000201|FG005|Overall Study|Withdrawal by Subject|1|||
125374170|NCT01652703|451000196|FG000|Overall Study|Other|0|||
125374171|NCT01652703|451000197|FG001|Overall Study|Other|0|||
125374172|NCT01652703|451000198|FG002|Overall Study|Other|0|||
125618189|NCT01021852|451884122|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125618190|NCT01021852|451884123|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125618191|NCT01021852|451884124|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125618192|NCT01021852|451884125|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125618193|NCT01021852|451884126|FG004|Treatment Period 1|Withdrawal by Subject|1|||
125618194|NCT01021852|451884127|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125618195|NCT01021852|451884128|FG006|Treatment Period 1|Withdrawal by Subject|0|||
125618196|NCT01021852|451884129|FG007|Treatment Period 1|Withdrawal by Subject|1|||
125618197|NCT01021852|451884122|FG000|Treatment Period 1|Not Treated|0|||
125618198|NCT01021852|451884123|FG001|Treatment Period 1|Not Treated|0|||
125618199|NCT01021852|451884124|FG002|Treatment Period 1|Not Treated|0|||
125618200|NCT01021852|451884125|FG003|Treatment Period 1|Not Treated|2|||
125618201|NCT01021852|451884126|FG004|Treatment Period 1|Not Treated|0|||
125618202|NCT01021852|451884127|FG005|Treatment Period 1|Not Treated|0|||
125618203|NCT01021852|451884128|FG006|Treatment Period 1|Not Treated|0|||
125618204|NCT01021852|451884129|FG007|Treatment Period 1|Not Treated|0|||
125618205|NCT01021852|451884122|FG000|Washout Period-Placebo|Adverse Event|0|||
125618206|NCT01021852|451884123|FG001|Washout Period-Placebo|Adverse Event|0|||
125618207|NCT01021852|451884124|FG002|Washout Period-Placebo|Adverse Event|0|||
125618208|NCT01021852|451884125|FG003|Washout Period-Placebo|Adverse Event|1|||
125618209|NCT01021852|451884126|FG004|Washout Period-Placebo|Adverse Event|0|||
125618210|NCT01021852|451884127|FG005|Washout Period-Placebo|Adverse Event|1|||
125618211|NCT01021852|451884128|FG006|Washout Period-Placebo|Adverse Event|0|||
125618212|NCT01021852|451884129|FG007|Washout Period-Placebo|Adverse Event|0|||
125374173|NCT01652703|451000199|FG003|Overall Study|Other|1|||
125618213|NCT01021852|451884122|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
125618214|NCT01021852|451884123|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
125374174|NCT01652703|451000200|FG004|Overall Study|Other|1|||
125618215|NCT01021852|451884124|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
125433062|NCT03682705|451212424|FG002|Overall Study|Lost to Follow-up|0|||
125618216|NCT01021852|451884125|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
125618217|NCT01021852|451884126|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
125618218|NCT01021852|451884127|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
125618219|NCT01021852|451884128|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
125618220|NCT01021852|451884129|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
125618221|NCT01021852|451884122|FG000|Washout Period-Placebo|Protocol Violation|0|||
125618222|NCT01021852|451884123|FG001|Washout Period-Placebo|Protocol Violation|0|||
125618223|NCT01021852|451884124|FG002|Washout Period-Placebo|Protocol Violation|0|||
125618224|NCT01021852|451884125|FG003|Washout Period-Placebo|Protocol Violation|0|||
125618225|NCT01021852|451884126|FG004|Washout Period-Placebo|Protocol Violation|0|||
125618226|NCT01021852|451884127|FG005|Washout Period-Placebo|Protocol Violation|0|||
125618227|NCT01021852|451884128|FG006|Washout Period-Placebo|Protocol Violation|1|||
125618228|NCT01021852|451884129|FG007|Washout Period-Placebo|Protocol Violation|0|||
125618229|NCT01021852|451884122|FG000|Washout Period-No Drug|Adverse Event|1|||
125618230|NCT01021852|451884123|FG001|Washout Period-No Drug|Adverse Event|0|||
125618231|NCT01021852|451884124|FG002|Washout Period-No Drug|Adverse Event|0|||
125618232|NCT01021852|451884125|FG003|Washout Period-No Drug|Adverse Event|0|||
125618233|NCT01021852|451884126|FG004|Washout Period-No Drug|Adverse Event|0|||
125618234|NCT01021852|451884127|FG005|Washout Period-No Drug|Adverse Event|1|||
125618235|NCT01021852|451884128|FG006|Washout Period-No Drug|Adverse Event|0|||
125618236|NCT01021852|451884129|FG007|Washout Period-No Drug|Adverse Event|0|||
125618237|NCT01021852|451884122|FG000|Treatment Period 2|Adverse Event|0|||
125618238|NCT01021852|451884123|FG001|Treatment Period 2|Adverse Event|1|||
125618239|NCT01021852|451884124|FG002|Treatment Period 2|Adverse Event|0|||
125618240|NCT01021852|451884125|FG003|Treatment Period 2|Adverse Event|0|||
125618241|NCT01021852|451884126|FG004|Treatment Period 2|Adverse Event|1|||
125618242|NCT01021852|451884127|FG005|Treatment Period 2|Adverse Event|0|||
125618243|NCT01021852|451884128|FG006|Treatment Period 2|Adverse Event|1|||
125618244|NCT01021852|451884129|FG007|Treatment Period 2|Adverse Event|0|||
125618245|NCT01021852|451884122|FG000|Treatment Period 2|Lack of Efficacy|0|||
125618246|NCT01021852|451884123|FG001|Treatment Period 2|Lack of Efficacy|0|||
125618247|NCT01021852|451884124|FG002|Treatment Period 2|Lack of Efficacy|0|||
125618248|NCT01021852|451884125|FG003|Treatment Period 2|Lack of Efficacy|0|||
125618249|NCT01021852|451884126|FG004|Treatment Period 2|Lack of Efficacy|0|||
125618250|NCT01021852|451884127|FG005|Treatment Period 2|Lack of Efficacy|1|||
125618251|NCT01021852|451884128|FG006|Treatment Period 2|Lack of Efficacy|0|||
125618252|NCT01021852|451884129|FG007|Treatment Period 2|Lack of Efficacy|0|||
125618253|NCT01021852|451884122|FG000|Treatment Period 2|Physician Decision|0|||
125618254|NCT01021852|451884123|FG001|Treatment Period 2|Physician Decision|0|||
125618255|NCT01021852|451884124|FG002|Treatment Period 2|Physician Decision|1|||
125618256|NCT01021852|451884125|FG003|Treatment Period 2|Physician Decision|0|||
125618257|NCT01021852|451884126|FG004|Treatment Period 2|Physician Decision|0|||
125433063|NCT03682705|451212425|FG003|Overall Study|Lost to Follow-up|0|||
125618258|NCT01021852|451884127|FG005|Treatment Period 2|Physician Decision|0|||
125618259|NCT01021852|451884128|FG006|Treatment Period 2|Physician Decision|0|||
125618260|NCT01021852|451884129|FG007|Treatment Period 2|Physician Decision|0|||
125618261|NCT01021852|451884122|FG000|Treatment Period 2|Protocol Violation|0|||
125618262|NCT01021852|451884123|FG001|Treatment Period 2|Protocol Violation|0|||
125618263|NCT01021852|451884124|FG002|Treatment Period 2|Protocol Violation|0|||
125618264|NCT01021852|451884125|FG003|Treatment Period 2|Protocol Violation|0|||
125618265|NCT01021852|451884126|FG004|Treatment Period 2|Protocol Violation|1|||
125618266|NCT01021852|451884127|FG005|Treatment Period 2|Protocol Violation|0|||
125618267|NCT01021852|451884128|FG006|Treatment Period 2|Protocol Violation|1|||
125618268|NCT01021852|451884129|FG007|Treatment Period 2|Protocol Violation|0|||
125618269|NCT01021852|451884122|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125618270|NCT01021852|451884123|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125618271|NCT01021852|451884124|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125215023|NCT03026283|450414898|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
125215024|NCT03026283|450414899|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
125618272|NCT01021852|451884125|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125618273|NCT01021852|451884126|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125618274|NCT01021852|451884127|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125618275|NCT01021852|451884128|FG006|Treatment Period 2|Withdrawal by Subject|1|||
125618276|NCT01021852|451884129|FG007|Treatment Period 2|Withdrawal by Subject|2|||
125618277|NCT00712322|451884130|FG000|Overall Study|Protocol deviation|0|||
125215025|NCT03026283|450414892|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215026|NCT03026283|450414893|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
125215027|NCT03026283|450414894|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215028|NCT03026283|450414895|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215029|NCT03026283|450414896|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215030|NCT03026283|450414897|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215031|NCT03026283|450414898|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215032|NCT03026283|450414899|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
125215033|NCT03026283|450414892|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215034|NCT03026283|450414893|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215035|NCT03026283|450414894|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
125215036|NCT03026283|450414895|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215037|NCT03026283|450414896|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215038|NCT03026283|450414897|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215039|NCT03026283|450414898|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215040|NCT03026283|450414899|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
125215041|NCT03026283|450414892|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
125215042|NCT03026283|450414893|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
125215043|NCT03026283|450414894|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
125215044|NCT03026283|450414895|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
125215045|NCT03026283|450414896|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
125215046|NCT03026283|450414897|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
125215047|NCT03026283|450414898|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
125215048|NCT03026283|450414899|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
125215049|NCT03026283|450414892|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
125215050|NCT03026283|450414893|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
125215051|NCT03026283|450414894|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
125215052|NCT03026283|450414895|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
125215053|NCT03026283|450414896|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
125618278|NCT00712322|451884131|FG001|Overall Study|Protocol deviation|1|||
125618279|NCT00712322|451884132|FG002|Overall Study|Protocol deviation|0|||
125618280|NCT02802878|451884137|FG000|Overall Study|Withdrawal by Subject|3|||
125618281|NCT02802878|451884138|FG001|Overall Study|Withdrawal by Subject|3|||
125618282|NCT02802878|451884137|FG000|Overall Study|Protocol Violation|1|||
125618283|NCT02802878|451884138|FG001|Overall Study|Protocol Violation|0|||
125618284|NCT00536978|451884139|FG000|Overall Study|Not eligible for Adback Infusion|22|||
125618285|NCT00916370|451884142|FG000|Overall Study|Death|3|||
125618286|NCT00916370|451884143|FG001|Overall Study|Death|1|||
125618287|NCT00916370|451884142|FG000|Overall Study|Withdrawal by Subject|2|||
125618288|NCT00916370|451884143|FG001|Overall Study|Withdrawal by Subject|0|||
125618289|NCT00916370|451884142|FG000|Overall Study|Physician Decision|0|||
125618290|NCT00916370|451884143|FG001|Overall Study|Physician Decision|1|||
125618291|NCT03550131|451884144|FG000|Overall Study|Lost to Follow-up|16|||
125618292|NCT03550131|451884145|FG001|Overall Study|Lost to Follow-up|24|||
125618293|NCT03550131|451884144|FG000|Overall Study|Withdrawal by Subject|36|||
125618294|NCT03550131|451884145|FG001|Overall Study|Withdrawal by Subject|28|||
125618295|NCT03550131|451884144|FG000|Overall Study|Illness of dyad member|10|||
125618296|NCT03550131|451884145|FG001|Overall Study|Illness of dyad member|2|||
125618297|NCT03550131|451884144|FG000|Overall Study|Death of person with dementia|4|||
125618298|NCT03550131|451884145|FG001|Overall Study|Death of person with dementia|8|||
125618299|NCT01318512|451884146|FG000|Maintenance Period (6 Months)|Death|2|||
125618300|NCT01318512|451884146|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
125618301|NCT00717366|451884147|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
125618302|NCT00717366|451884148|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
125618303|NCT00717366|451884147|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
125618304|NCT00717366|451884148|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
125618305|NCT00717366|451884147|FG000|Core Study Period (20 Weeks)|Death|0|||
125618306|NCT00717366|451884148|FG001|Core Study Period (20 Weeks)|Death|1|||
125618307|NCT00717366|451884147|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
125618308|NCT00717366|451884148|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
125618309|NCT00717366|451884147|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
125215054|NCT03026283|450414897|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
125374175|NCT01652703|451000201|FG005|Overall Study|Other|1|||
125374176|NCT02155608|451000205|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
125618310|NCT00717366|451884148|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
125618311|NCT00717366|451884147|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
125618312|NCT00717366|451884148|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
125618313|NCT00717366|451884147|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
125215055|NCT03026283|450414898|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
125215056|NCT03026283|450414899|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
125215057|NCT03026283|450414892|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
125215058|NCT03026283|450414893|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
125215059|NCT03026283|450414894|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
125215060|NCT03026283|450414895|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
125215061|NCT03026283|450414896|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
125215062|NCT03026283|450414897|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
125618314|NCT00717366|451884148|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
125618315|NCT01317615|451884151|FG000|Overall Study|Disease progression|25|||
125618316|NCT01317615|451884151|FG000|Overall Study|New cancer therapy|5|||
125618317|NCT01317615|451884151|FG000|Overall Study|Death|6|||
125618318|NCT01317615|451884151|FG000|Overall Study|Withdrawal by Subject|5|||
125618319|NCT01317615|451884151|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125618320|NCT01317615|451884151|FG000|Overall Study|Adverse Event|7|||
125618321|NCT00255086|451884152|FG000|Overall Study|Adverse Event|1|||
125618322|NCT00255086|451884153|FG001|Overall Study|Adverse Event|1|||
125618323|NCT00255086|451884152|FG000|Overall Study|Protocol Violation|1|||
125618324|NCT00255086|451884153|FG001|Overall Study|Protocol Violation|1|||
125618325|NCT00438399|451884156|FG000|Overall Study|Lost to Follow-up|2|||
125618326|NCT00438399|451884157|FG001|Overall Study|Lost to Follow-up|2|||
125618327|NCT00438399|451884158|FG002|Overall Study|Lost to Follow-up|1|||
125618328|NCT00438399|451884159|FG003|Overall Study|Lost to Follow-up|1|||
125618329|NCT00438399|451884160|FG004|Overall Study|Lost to Follow-up|1|||
125618330|NCT00438399|451884161|FG005|Overall Study|Lost to Follow-up|1|||
125618331|NCT00438399|451884156|FG000|Overall Study|Adverse Event|0|||
125618332|NCT00438399|451884157|FG001|Overall Study|Adverse Event|0|||
125618333|NCT00438399|451884158|FG002|Overall Study|Adverse Event|1|||
125618334|NCT00438399|451884159|FG003|Overall Study|Adverse Event|1|||
125618335|NCT00438399|451884160|FG004|Overall Study|Adverse Event|0|||
125618336|NCT00438399|451884161|FG005|Overall Study|Adverse Event|1|||
125618337|NCT00438399|451884156|FG000|Overall Study|Withdrawal by Subject|5|||
125618338|NCT00438399|451884157|FG001|Overall Study|Withdrawal by Subject|6|||
125618339|NCT00438399|451884158|FG002|Overall Study|Withdrawal by Subject|3|||
125618340|NCT00438399|451884159|FG003|Overall Study|Withdrawal by Subject|2|||
125618341|NCT00438399|451884160|FG004|Overall Study|Withdrawal by Subject|2|||
125618342|NCT00438399|451884161|FG005|Overall Study|Withdrawal by Subject|2|||
125618343|NCT00438399|451884156|FG000|Overall Study|Protocol Violation|0|||
125618344|NCT00438399|451884157|FG001|Overall Study|Protocol Violation|0|||
125215063|NCT03026283|450414898|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
125374177|NCT02155608|451000206|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
125374178|NCT02155608|451000205|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
125374179|NCT02155608|451000206|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
125374180|NCT00543140|451000208|FG000|Overall Study|Lost to Follow-up|33|||
125374181|NCT00543140|451000208|FG000|Overall Study|Withdrawal by Subject|13|||
125374182|NCT00543140|451000208|FG000|Overall Study|Protocol Violation|10|||
125374183|NCT00543140|451000208|FG000|Overall Study|Insufficient weight loss|10|||
125374184|NCT00543140|451000208|FG000|Overall Study|SAE leading to explant of SAGB|3|||
125374185|NCT00543140|451000208|FG000|Overall Study|Death|1|||
125374186|NCT00543140|451000208|FG000|Overall Study|Subject moved|1|||
125374187|NCT00543140|451000208|FG000|Overall Study|Conversion to different procedure|1|||
125374188|NCT04532164|451000211|FG000|Overall Study|Adverse Event|1|||
125374189|NCT04532164|451000211|FG000|Overall Study|Protocol Violation|5|||
125374190|NCT04532164|451000211|FG000|Overall Study|Lost to Follow-up|1|||
125374191|NCT04532164|451000211|FG000|Overall Study|Found to be Ineligible|3|||
125374192|NCT04532164|451000211|FG000|Overall Study|Withdrawal by Subject|14|||
125618345|NCT00438399|451884158|FG002|Overall Study|Protocol Violation|1|||
125618346|NCT00438399|451884159|FG003|Overall Study|Protocol Violation|0|||
125618347|NCT00438399|451884160|FG004|Overall Study|Protocol Violation|0|||
125618348|NCT00438399|451884161|FG005|Overall Study|Protocol Violation|1|||
125618349|NCT00438399|451884156|FG000|Overall Study|Subje stopped study|0|||
125618350|NCT00438399|451884157|FG001|Overall Study|Subje stopped study|0|||
125618351|NCT00438399|451884158|FG002|Overall Study|Subje stopped study|1|||
125374193|NCT02599129|451000212|FG000|Overall Study|Lack of Efficacy|2|||
125374194|NCT02599129|451000213|FG001|Overall Study|Lack of Efficacy|2|||
125374195|NCT02599129|451000212|FG000|Overall Study|Lost to Follow-up|1|||
125374196|NCT02599129|451000213|FG001|Overall Study|Lost to Follow-up|0|||
125618352|NCT00438399|451884159|FG003|Overall Study|Subje stopped study|0|||
125618353|NCT00438399|451884160|FG004|Overall Study|Subje stopped study|0|||
125618354|NCT00438399|451884161|FG005|Overall Study|Subje stopped study|0|||
125618355|NCT00438399|451884156|FG000|Overall Study|Pregnancy|0|||
125618356|NCT00438399|451884157|FG001|Overall Study|Pregnancy|0|||
125618357|NCT00438399|451884158|FG002|Overall Study|Pregnancy|0|||
125618358|NCT00438399|451884159|FG003|Overall Study|Pregnancy|0|||
125618359|NCT00438399|451884160|FG004|Overall Study|Pregnancy|0|||
125618360|NCT00438399|451884161|FG005|Overall Study|Pregnancy|1|||
125618361|NCT00438399|451884156|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
125618362|NCT00438399|451884157|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
125618363|NCT00438399|451884158|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
125618364|NCT00438399|451884159|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
125618365|NCT00438399|451884160|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
125618366|NCT00438399|451884161|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
125618367|NCT03334396|451884164|FG000|Overall Study|Adverse Event|1|||
125618368|NCT03334396|451884165|FG001|Overall Study|Adverse Event|0|||
125618369|NCT03334396|451884166|FG002|Overall Study|Adverse Event|1|||
125618370|NCT03334396|451884167|FG003|Overall Study|Adverse Event|0|||
125618371|NCT03334396|451884168|FG004|Overall Study|Adverse Event|0|||
125618372|NCT03334396|451884169|FG005|Overall Study|Adverse Event|0|||
125618373|NCT03334396|451884170|FG006|Overall Study|Adverse Event|0|||
125618374|NCT03334396|451884171|FG007|Overall Study|Adverse Event|0|||
125618375|NCT03334396|451884164|FG000|Overall Study|Lack of Efficacy|10|||
125618376|NCT03334396|451884165|FG001|Overall Study|Lack of Efficacy|4|||
125618377|NCT03334396|451884166|FG002|Overall Study|Lack of Efficacy|1|||
125618378|NCT03334396|451884167|FG003|Overall Study|Lack of Efficacy|3|||
125618379|NCT03334396|451884168|FG004|Overall Study|Lack of Efficacy|1|||
125618380|NCT03334396|451884169|FG005|Overall Study|Lack of Efficacy|0|||
125618381|NCT03334396|451884170|FG006|Overall Study|Lack of Efficacy|0|||
125618382|NCT03334396|451884171|FG007|Overall Study|Lack of Efficacy|1|||
125618383|NCT03334396|451884164|FG000|Overall Study|Lost to Follow-up|0|||
125618384|NCT03334396|451884165|FG001|Overall Study|Lost to Follow-up|0|||
125618385|NCT03334396|451884166|FG002|Overall Study|Lost to Follow-up|1|||
125618386|NCT03334396|451884167|FG003|Overall Study|Lost to Follow-up|0|||
125618387|NCT03334396|451884168|FG004|Overall Study|Lost to Follow-up|0|||
125618388|NCT03334396|451884169|FG005|Overall Study|Lost to Follow-up|0|||
125618389|NCT03334396|451884170|FG006|Overall Study|Lost to Follow-up|1|||
125618390|NCT03334396|451884171|FG007|Overall Study|Lost to Follow-up|0|||
125618391|NCT03334396|451884164|FG000|Overall Study|Physician Decision|1|||
125618392|NCT03334396|451884165|FG001|Overall Study|Physician Decision|0|||
125618393|NCT03334396|451884166|FG002|Overall Study|Physician Decision|0|||
125618394|NCT03334396|451884167|FG003|Overall Study|Physician Decision|0|||
125618395|NCT03334396|451884168|FG004|Overall Study|Physician Decision|0|||
125618396|NCT03334396|451884169|FG005|Overall Study|Physician Decision|0|||
125433064|NCT03682705|451212426|FG004|Overall Study|Lost to Follow-up|3|||
125618397|NCT03334396|451884170|FG006|Overall Study|Physician Decision|0|||
125618398|NCT03334396|451884171|FG007|Overall Study|Physician Decision|0|||
125618399|NCT03334396|451884164|FG000|Overall Study|Withdrawal by Subject|10|||
125618400|NCT03334396|451884165|FG001|Overall Study|Withdrawal by Subject|5|||
125618401|NCT03334396|451884166|FG002|Overall Study|Withdrawal by Subject|7|||
125618402|NCT03334396|451884167|FG003|Overall Study|Withdrawal by Subject|2|||
125618403|NCT03334396|451884168|FG004|Overall Study|Withdrawal by Subject|2|||
125618404|NCT03334396|451884169|FG005|Overall Study|Withdrawal by Subject|1|||
125618405|NCT03334396|451884170|FG006|Overall Study|Withdrawal by Subject|2|||
125618406|NCT03334396|451884171|FG007|Overall Study|Withdrawal by Subject|0|||
125618407|NCT03334396|451884164|FG000|Overall Study|Pregnancy|0|||
125618408|NCT03334396|451884165|FG001|Overall Study|Pregnancy|1|||
125618409|NCT03334396|451884166|FG002|Overall Study|Pregnancy|0|||
125618410|NCT03334396|451884167|FG003|Overall Study|Pregnancy|0|||
125618411|NCT03334396|451884168|FG004|Overall Study|Pregnancy|0|||
125618412|NCT03334396|451884169|FG005|Overall Study|Pregnancy|0|||
125618413|NCT03334396|451884170|FG006|Overall Study|Pregnancy|0|||
125618414|NCT03334396|451884171|FG007|Overall Study|Pregnancy|0|||
125618415|NCT03334396|451884164|FG000|Overall Study|Ineligible|0|||
125618416|NCT03334396|451884165|FG001|Overall Study|Ineligible|1|||
125618417|NCT03334396|451884166|FG002|Overall Study|Ineligible|0|||
125618418|NCT03334396|451884167|FG003|Overall Study|Ineligible|0|||
125618419|NCT03334396|451884168|FG004|Overall Study|Ineligible|0|||
125618420|NCT03334396|451884169|FG005|Overall Study|Ineligible|0|||
125618421|NCT03334396|451884170|FG006|Overall Study|Ineligible|0|||
125618422|NCT03334396|451884171|FG007|Overall Study|Ineligible|0|||
125618423|NCT03334396|451884164|FG000|Overall Study|Started New Job|1|||
125618424|NCT03334396|451884165|FG001|Overall Study|Started New Job|0|||
125618425|NCT03334396|451884166|FG002|Overall Study|Started New Job|0|||
125618426|NCT03334396|451884167|FG003|Overall Study|Started New Job|0|||
125618427|NCT03334396|451884168|FG004|Overall Study|Started New Job|0|||
125618428|NCT03334396|451884169|FG005|Overall Study|Started New Job|0|||
125618429|NCT03334396|451884170|FG006|Overall Study|Started New Job|0|||
125618430|NCT03334396|451884171|FG007|Overall Study|Started New Job|0|||
125618431|NCT00592553|451884175|FG000|Overall Study|Protocol Noncompliance|1|||
125618432|NCT00592553|451884176|FG001|Overall Study|Protocol Noncompliance|0|||
125618433|NCT00592553|451884177|FG002|Overall Study|Protocol Noncompliance|0|||
125618434|NCT02379390|451884178|FG000|Overall Study|Adverse Event|1|||
125618435|NCT02379390|451884179|FG001|Overall Study|Adverse Event|1|||
125618436|NCT02379390|451884178|FG000|Overall Study|Investigator's decision|1|||
125618437|NCT02379390|451884179|FG001|Overall Study|Investigator's decision|0|||
125618438|NCT02379390|451884178|FG000|Overall Study|Study Termination|0|||
125618439|NCT02379390|451884179|FG001|Overall Study|Study Termination|1|||
125618440|NCT01255306|451885638|FG000|Overall Study|Physician Decision|1|||
125618441|NCT01255306|451885639|FG001|Overall Study|Physician Decision|1|||
125618442|NCT01283997|451885640|FG000|Overall Study|Physician Decision|8|||
125618443|NCT01283997|451885641|FG001|Overall Study|Physician Decision|10|||
125618444|NCT01283997|451885640|FG000|Overall Study|Withdrawal by Subject|3|||
125618445|NCT01283997|451885641|FG001|Overall Study|Withdrawal by Subject|2|||
125618446|NCT01283997|451885640|FG000|Overall Study|Physically unable to continue|0|||
125618447|NCT01283997|451885641|FG001|Overall Study|Physically unable to continue|1|||
125618448|NCT01283997|451885640|FG000|Overall Study|Progressive disease|1|||
125618449|NCT01283997|451885641|FG001|Overall Study|Progressive disease|0|||
125618450|NCT01283997|451885640|FG000|Overall Study|Other|4|||
125618451|NCT01283997|451885641|FG001|Overall Study|Other|4|||
125618452|NCT02017899|451885642|FG000|Overall Study|Withdrawal by Subject|0|||
125433065|NCT03682705|451212427|FG005|Overall Study|Lost to Follow-up|0|||
125433066|NCT03565068|451212428|FG000|Overall Study|Protocol Violation|0|||
125433067|NCT03565068|451212429|FG001|Overall Study|Protocol Violation|0|||
125618453|NCT02017899|451885643|FG001|Overall Study|Withdrawal by Subject|0|||
125618454|NCT02017899|451885644|FG002|Overall Study|Withdrawal by Subject|0|||
125618455|NCT02017899|451885645|FG003|Overall Study|Withdrawal by Subject|1|||
125618456|NCT02017899|451885646|FG004|Overall Study|Withdrawal by Subject|1|||
125618457|NCT02017899|451885647|FG005|Overall Study|Withdrawal by Subject|0|||
125618458|NCT01747811|451885651|FG000|Overall Study|Lack of Efficacy|2|||
125618459|NCT01747811|451885652|FG001|Overall Study|Lack of Efficacy|4|||
125618460|NCT01337167|451885653|FG000|Infant Series|Adverse Event|1|||
125618461|NCT01337167|451885654|FG001|Infant Series|Adverse Event|1|||
125618462|NCT01337167|451885653|FG000|Infant Series|Death|1|||
125618463|NCT01337167|451885654|FG001|Infant Series|Death|1|||
125618464|NCT01337167|451885653|FG000|Infant Series|Lost to Follow-up|13|||
125618465|NCT01337167|451885654|FG001|Infant Series|Lost to Follow-up|7|||
125618466|NCT01337167|451885653|FG000|Infant Series|Non-compliance with study drug|2|||
125618467|NCT01337167|451885654|FG001|Infant Series|Non-compliance with study drug|1|||
125433068|NCT03565068|451212430|FG002|Overall Study|Protocol Violation|0|||
125618468|NCT01337167|451885653|FG000|Infant Series|Physician Decision|3|||
125618469|NCT01337167|451885654|FG001|Infant Series|Physician Decision|1|||
125618470|NCT01337167|451885653|FG000|Infant Series|Protocol Violation|22|||
125618471|NCT01337167|451885654|FG001|Infant Series|Protocol Violation|9|||
125618472|NCT01337167|451885653|FG000|Infant Series|Withdrawal by Subject|15|||
125618473|NCT01337167|451885654|FG001|Infant Series|Withdrawal by Subject|4|||
125618474|NCT01337167|451885653|FG000|Infant Series|Randomized but not vaccinated|5|||
125618475|NCT01337167|451885654|FG001|Infant Series|Randomized but not vaccinated|3|||
125618476|NCT01337167|451885653|FG000|Interim Period|Lost to Follow-up|51|||
125618477|NCT01337167|451885654|FG001|Interim Period|Lost to Follow-up|23|||
125618478|NCT01337167|451885653|FG000|Interim Period|Non-compliance with study drug|1|||
125618479|NCT01337167|451885654|FG001|Interim Period|Non-compliance with study drug|0|||
125618480|NCT01337167|451885653|FG000|Interim Period|Physician Decision|6|||
125618481|NCT01337167|451885654|FG001|Interim Period|Physician Decision|3|||
125374197|NCT02599129|451000212|FG000|Overall Study|Withdrawal by Subject|2|||
125374198|NCT02599129|451000213|FG001|Overall Study|Withdrawal by Subject|1|||
125618482|NCT01337167|451885653|FG000|Interim Period|Protocol Violation|5|||
125618483|NCT01337167|451885654|FG001|Interim Period|Protocol Violation|3|||
125618484|NCT01337167|451885653|FG000|Interim Period|Withdrawal by Subject|18|||
125618485|NCT01337167|451885654|FG001|Interim Period|Withdrawal by Subject|10|||
125618486|NCT01337167|451885653|FG000|Interim Period|Other protocol criterion not met|0|||
125618487|NCT01337167|451885654|FG001|Interim Period|Other protocol criterion not met|1|||
125618488|NCT01337167|451885653|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
125618489|NCT01337167|451885654|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
125618490|NCT01337167|451885653|FG000|Toddler Vaccinations|Protocol Violation|0|||
125618491|NCT01337167|451885654|FG001|Toddler Vaccinations|Protocol Violation|1|||
125618492|NCT01337167|451885653|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
125618493|NCT01337167|451885654|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
125618494|NCT03833817|451885655|FG000|Overall Study|Withdrawal by Subject|3|||
125618495|NCT03833817|451885656|FG001|Overall Study|Withdrawal by Subject|3|||
125618496|NCT03833817|451885655|FG000|Overall Study|Lost to Follow-up|3|||
125618497|NCT03833817|451885656|FG001|Overall Study|Lost to Follow-up|3|||
125618498|NCT00884221|451885659|FG000|Overall Study|Withdrawal by Subject|0|||
125618499|NCT00884221|451885660|FG001|Overall Study|Withdrawal by Subject|3|||
125618500|NCT00884221|451885659|FG000|Overall Study|Adverse Event|6|||
125618501|NCT00884221|451885660|FG001|Overall Study|Adverse Event|3|||
125618502|NCT00884221|451885659|FG000|Overall Study|Protocol Violation|16|||
125618503|NCT00884221|451885660|FG001|Overall Study|Protocol Violation|13|||
125618504|NCT00884221|451885659|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
125618505|NCT00884221|451885660|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
125618506|NCT03363919|451885663|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
125618507|NCT03363919|451885664|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
125618508|NCT03363919|451885663|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
125618509|NCT03363919|451885664|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
125618510|NCT01646398|451885665|FG000|Overall Study|Withdrawal by Subject|1|||
125618511|NCT01646398|451885666|FG001|Overall Study|Withdrawal by Subject|0|||
125618512|NCT00255034|451885667|FG000|Overall Study|Withdrawal by Subject|15|||
125618513|NCT00255034|451885668|FG001|Overall Study|Withdrawal by Subject|38|||
125618514|NCT00574119|451885669|FG000|Overall Study|Adverse Event|1|||
125618515|NCT00574119|451885669|FG000|Overall Study|Protocol Violation|1|||
125618516|NCT00574119|451885669|FG000|Overall Study|Withdrawal by Subject|1|||
125618517|NCT00574119|451885669|FG000|Overall Study|Physician Decision|1|||
125215064|NCT03026283|450414899|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
125374199|NCT01029795|451000221|FG000|Overall Study|Entry Criteria Not Met|2|||
125374200|NCT01029795|451000222|FG001|Overall Study|Entry Criteria Not Met|1|||
125618518|NCT03434418|451885670|FG000|Overall Study|Disease Progression|11|||
125618519|NCT03434418|451885670|FG000|Overall Study|Adverse Event|2|||
125618520|NCT03434418|451885670|FG000|Overall Study|Physician Decision|1|||
125618521|NCT03434418|451885670|FG000|Overall Study|Decline in Performance Status (PS)|1|||
125618522|NCT01956240|451885671|FG000|Overall Study|Lost to Follow-up|6|||
125374201|NCT01029795|451000221|FG000|Overall Study|Physician Decision|2|||
125618523|NCT01956240|451885672|FG001|Overall Study|Lost to Follow-up|20|||
125618524|NCT01956240|451885671|FG000|Overall Study|Adverse Event|17|||
125215065|NCT03026283|450414892|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215066|NCT03026283|450414893|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215067|NCT03026283|450414894|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215068|NCT03026283|450414895|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
125215069|NCT03026283|450414896|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215070|NCT03026283|450414897|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215071|NCT03026283|450414898|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215072|NCT03026283|450414899|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
125215073|NCT03026283|450414892|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
125618525|NCT01956240|451885672|FG001|Overall Study|Adverse Event|4|||
125618526|NCT00600028|451885675|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
125618527|NCT00600028|451885676|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
125618528|NCT00600028|451885675|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
125618529|NCT00600028|451885676|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
125618530|NCT00600028|451885675|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
125618531|NCT00600028|451885676|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
125618532|NCT03172481|451885677|FG000|Double-blind|Withdrawal by Subject|1|||
125618533|NCT03172481|451885678|FG001|Double-blind|Withdrawal by Subject|0|||
125618534|NCT01957709|451885679|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
125618535|NCT01610076|451885689|FG000|Overall Study|Technical issue with video|0|||
125618536|NCT01610076|451885690|FG001|Overall Study|Technical issue with video|1|||
125618537|NCT01610076|451885689|FG000|Overall Study|Lost to Follow-up|3|||
125618538|NCT01610076|451885690|FG001|Overall Study|Lost to Follow-up|4|||
125618539|NCT01107405|451885691|FG000|Overall Study|Adverse Event|1|||
125618540|NCT01107405|451885692|FG001|Overall Study|Adverse Event|1|||
125618541|NCT01107405|451885693|FG002|Overall Study|Adverse Event|0|||
125618542|NCT01107405|451885694|FG003|Overall Study|Adverse Event|0|||
125618543|NCT01107405|451885695|FG004|Overall Study|Adverse Event|2|||
125618544|NCT01107405|451885691|FG000|Overall Study|Withdrawal by Subject|1|||
125618545|NCT01107405|451885692|FG001|Overall Study|Withdrawal by Subject|0|||
125618546|NCT01107405|451885693|FG002|Overall Study|Withdrawal by Subject|1|||
125618547|NCT01107405|451885694|FG003|Overall Study|Withdrawal by Subject|2|||
125618548|NCT01107405|451885695|FG004|Overall Study|Withdrawal by Subject|1|||
125618549|NCT01107405|451885691|FG000|Overall Study|Protocol Violation|0|||
125618550|NCT01107405|451885692|FG001|Overall Study|Protocol Violation|0|||
125618551|NCT01107405|451885693|FG002|Overall Study|Protocol Violation|1|||
125618552|NCT01107405|451885694|FG003|Overall Study|Protocol Violation|1|||
125618553|NCT01107405|451885695|FG004|Overall Study|Protocol Violation|0|||
125618554|NCT00098020|451885701|FG000|Overall Study|Adverse Event|2|||
125618555|NCT00098020|451885701|FG000|Overall Study|Lost to Follow-up|1|||
125618556|NCT00098020|451885701|FG000|Overall Study|elevated liver enzymes|1|||
125618557|NCT00098020|451885701|FG000|Overall Study|Low urine PCR|1|||
125618558|NCT00098020|451885701|FG000|Overall Study|Low epidermal growth factor receptor|1|||
125618559|NCT01840228|451885705|FG000|Overall Study|Lost to Follow-up|1|||
125618560|NCT01840228|451885706|FG001|Overall Study|Lost to Follow-up|1|||
125618561|NCT01879319|451885712|FG000|Overall Study|Withdrawal by Subject|1|||
125618562|NCT01879319|451885713|FG001|Overall Study|Withdrawal by Subject|0|||
125618563|NCT01879319|451885712|FG000|Overall Study|Lost to Follow-up|1|||
125618564|NCT01879319|451885713|FG001|Overall Study|Lost to Follow-up|5|||
125618565|NCT01360762|451885714|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
125618566|NCT01360762|451885714|FG000|Main Study Period (12-month Treatment)|Death|5|||
125618567|NCT01360762|451885714|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
125215074|NCT03026283|450414893|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
125215075|NCT03026283|450414894|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
125433069|NCT03565068|451212431|FG003|Overall Study|Protocol Violation|0|||
125433070|NCT03565068|451212432|FG004|Overall Study|Protocol Violation|1|||
125433071|NCT03565068|451212433|FG005|Overall Study|Protocol Violation|0|||
125618568|NCT01360762|451885714|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
125618569|NCT01360762|451885714|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
125618570|NCT01360762|451885714|FG000|Whole Study Period|Lost to Follow-up|10|||
125618571|NCT01360762|451885714|FG000|Whole Study Period|Death|7|||
125618572|NCT01360762|451885714|FG000|Whole Study Period|Patient relapsed|18|||
125618573|NCT01360762|451885714|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
125618574|NCT00844649|451885715|FG000|Overall Study|Progressive Disease|196|||
125618575|NCT00844649|451885716|FG001|Overall Study|Progressive Disease|245|||
125618576|NCT00844649|451885715|FG000|Overall Study|Adverse Event|128|||
125618577|NCT00844649|451885716|FG001|Overall Study|Adverse Event|73|||
125618578|NCT00844649|451885715|FG000|Overall Study|Physician Decision|25|||
125618579|NCT00844649|451885716|FG001|Overall Study|Physician Decision|18|||
125618580|NCT00844649|451885715|FG000|Overall Study|Protocol Violation|10|||
125618581|NCT00844649|451885716|FG001|Overall Study|Protocol Violation|6|||
125618582|NCT00844649|451885715|FG000|Overall Study|Withdrawal by Subject|28|||
125618583|NCT00844649|451885716|FG001|Overall Study|Withdrawal by Subject|39|||
125618584|NCT00844649|451885715|FG000|Overall Study|Other|7|||
125374202|NCT01029795|451000222|FG001|Overall Study|Physician Decision|1|||
125374203|NCT01029795|451000221|FG000|Overall Study|Sponsor Decision|11|||
125374204|NCT01029795|451000222|FG001|Overall Study|Sponsor Decision|17|||
125374205|NCT01029795|451000221|FG000|Overall Study|Withdrawal by Subject|1|||
125618585|NCT00844649|451885716|FG001|Overall Study|Other|10|||
125618586|NCT00844649|451885715|FG000|Overall Study|Withdrew prior to starting treatment|11|||
125618587|NCT00844649|451885716|FG001|Overall Study|Withdrew prior to starting treatment|27|||
125618588|NCT02670330|451885719|FG000|Overall Study|Protocol Deviation|1|||
125618589|NCT02670330|451885720|FG001|Overall Study|Protocol Deviation|0|||
125618590|NCT02670330|451885719|FG000|Overall Study|Study Terminated By Sponsor|36|||
125618591|NCT02670330|451885720|FG001|Overall Study|Study Terminated By Sponsor|43|||
125618592|NCT02670330|451885719|FG000|Overall Study|Adverse Event|1|||
125618593|NCT02670330|451885720|FG001|Overall Study|Adverse Event|3|||
125618594|NCT02670330|451885719|FG000|Overall Study|Withdrawal by Subject|34|||
125618595|NCT02670330|451885720|FG001|Overall Study|Withdrawal by Subject|29|||
125618596|NCT02670330|451885719|FG000|Overall Study|Lost to Follow-up|3|||
125374206|NCT01029795|451000222|FG001|Overall Study|Withdrawal by Subject|3|||
125374207|NCT00429273|451000232|FG000|Overall Study|Lost to Follow-up|1|||
125374208|NCT00429273|451000233|FG001|Overall Study|Lost to Follow-up|2|||
125374209|NCT00429273|451000234|FG002|Overall Study|Lost to Follow-up|2|||
125618597|NCT02670330|451885720|FG001|Overall Study|Lost to Follow-up|2|||
125637261|NCT03073200|451952837|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125374210|NCT00429273|451000232|FG000|Overall Study|Physician Decision|6|||
125618598|NCT04404010|451885723|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
125618599|NCT04404010|451885724|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
125618600|NCT02120157|451885725|FG000|Overall Study|Death|8|||
125618601|NCT00441103|451885729|FG000|Overall Study|Adverse Event|2|||
125618602|NCT00441103|451885730|FG001|Overall Study|Adverse Event|1|||
125618603|NCT00441103|451885729|FG000|Overall Study|Death|1|||
125618604|NCT00441103|451885730|FG001|Overall Study|Death|0|||
125618605|NCT00441103|451885729|FG000|Overall Study|Disease Progression|2|||
125618606|NCT00441103|451885730|FG001|Overall Study|Disease Progression|0|||
125618607|NCT00441103|451885729|FG000|Overall Study|Lost to Follow-up|1|||
125618608|NCT00441103|451885730|FG001|Overall Study|Lost to Follow-up|0|||
125618609|NCT00441103|451885729|FG000|Overall Study|Protocol Violation|1|||
125618610|NCT00441103|451885730|FG001|Overall Study|Protocol Violation|0|||
125618611|NCT00441103|451885729|FG000|Overall Study|Participant unable to use Rebiject II|1|||
125618612|NCT00441103|451885730|FG001|Overall Study|Participant unable to use Rebiject II|0|||
125618613|NCT00441103|451885729|FG000|Overall Study|Participant refused MRI|1|||
125618614|NCT00441103|451885730|FG001|Overall Study|Participant refused MRI|0|||
125618615|NCT00441103|451885729|FG000|Overall Study|Inclusion criteria absent|1|||
125618616|NCT00441103|451885730|FG001|Overall Study|Inclusion criteria absent|0|||
125618617|NCT00441103|451885729|FG000|Overall Study|Non-compliant|0|||
125618618|NCT00441103|451885730|FG001|Overall Study|Non-compliant|1|||
125618619|NCT00441103|451885729|FG000|Overall Study|Participant decided to withdraw|1|||
125618620|NCT00441103|451885730|FG001|Overall Study|Participant decided to withdraw|0|||
125618621|NCT00441103|451885729|FG000|Overall Study|Participant's reason|0|||
125618622|NCT00441103|451885730|FG001|Overall Study|Participant's reason|1|||
125618623|NCT00441103|451885729|FG000|Overall Study|Participant decided to stop|0|||
125215076|NCT03026283|450414895|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
125215077|NCT03026283|450414896|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
125217431|NCT01348100|450423525|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
125618624|NCT00441103|451885730|FG001|Overall Study|Participant decided to stop|1|||
125618625|NCT00239837|451885733|FG000|Overall Study|Lost to Follow-up|3|||
125618626|NCT00239837|451885734|FG001|Overall Study|Lost to Follow-up|7|||
125618627|NCT01153893|451885735|FG000|Overall Study|Adverse Event|1|||
125618628|NCT01153893|451885736|FG001|Overall Study|Adverse Event|0|||
125618629|NCT01838590|451885737|FG000|Overall Study|Lack of Efficacy|12|||
125618630|NCT01838590|451885738|FG001|Overall Study|Lack of Efficacy|4|||
125618631|NCT01838590|451885737|FG000|Overall Study|Lost to Follow-up|0|||
125618632|NCT01838590|451885738|FG001|Overall Study|Lost to Follow-up|1|||
125618633|NCT01354431|451885739|FG000|Pre-Treatment Period|Not reported|1|||
125618634|NCT01354431|451885740|FG001|Pre-Treatment Period|Not reported|0|||
125618635|NCT01354431|451885741|FG002|Pre-Treatment Period|Not reported|0|||
125618636|NCT01354431|451885739|FG000|Treatment Period|Disease Progression|50|||
125618637|NCT01354431|451885740|FG001|Treatment Period|Disease Progression|40|||
125618638|NCT01354431|451885741|FG002|Treatment Period|Disease Progression|44|||
125618639|NCT01354431|451885739|FG000|Treatment Period|Study Drug Toxicity|5|||
125618640|NCT01354431|451885740|FG001|Treatment Period|Study Drug Toxicity|8|||
125618641|NCT01354431|451885741|FG002|Treatment Period|Study Drug Toxicity|4|||
125618642|NCT01354431|451885739|FG000|Treatment Period|Death|0|||
125618643|NCT01354431|451885740|FG001|Treatment Period|Death|1|||
125618644|NCT01354431|451885741|FG002|Treatment Period|Death|0|||
125618645|NCT01354431|451885739|FG000|Treatment Period|AE unrelated to study drug|1|||
125618646|NCT01354431|451885740|FG001|Treatment Period|AE unrelated to study drug|2|||
125618647|NCT01354431|451885741|FG002|Treatment Period|AE unrelated to study drug|5|||
125618648|NCT01354431|451885739|FG000|Treatment Period|Participant request to discontinue|2|||
125618649|NCT01354431|451885740|FG001|Treatment Period|Participant request to discontinue|2|||
125618650|NCT01354431|451885741|FG002|Treatment Period|Participant request to discontinue|1|||
125618651|NCT01354431|451885739|FG000|Treatment Period|Participant withdrew consent|0|||
125618652|NCT01354431|451885740|FG001|Treatment Period|Participant withdrew consent|1|||
125618653|NCT01354431|451885741|FG002|Treatment Period|Participant withdrew consent|0|||
125618654|NCT01354431|451885739|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
125618655|NCT01354431|451885740|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
125618656|NCT01354431|451885741|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
125618657|NCT01364233|451885744|FG000|Overall Study|Lost to Follow-up|1|||
125618658|NCT00878215|451885745|FG000|Overall Study|Determined to be ineligible|0|||
125618659|NCT00878215|451885746|FG001|Overall Study|Determined to be ineligible|10|||
125618660|NCT00878215|451885747|FG002|Overall Study|Determined to be ineligible|0|||
125618661|NCT00878215|451885748|FG003|Overall Study|Determined to be ineligible|0|||
125618662|NCT00302718|451885750|FG000|Overall Study|Participant left the hospital|1|||
125618663|NCT00302718|451885751|FG001|Overall Study|Participant left the hospital|0|||
125618664|NCT00302718|451885752|FG002|Overall Study|Participant left the hospital|0|||
125618665|NCT00302718|451885753|FG003|Overall Study|Participant left the hospital|1|||
125618666|NCT00302718|451885750|FG000|Overall Study|Withdrawal by Subject|0|||
125618667|NCT00302718|451885751|FG001|Overall Study|Withdrawal by Subject|1|||
125618668|NCT00302718|451885752|FG002|Overall Study|Withdrawal by Subject|0|||
125618669|NCT00302718|451885753|FG003|Overall Study|Withdrawal by Subject|0|||
125618670|NCT00302718|451885750|FG000|Overall Study|Participant left primary care setting|0|||
125618671|NCT00302718|451885751|FG001|Overall Study|Participant left primary care setting|0|||
125618672|NCT00302718|451885752|FG002|Overall Study|Participant left primary care setting|2|||
125618673|NCT00302718|451885753|FG003|Overall Study|Participant left primary care setting|1|||
125618674|NCT00819585|451885754|FG000|Core Study|Adverse Event|2|||
125618675|NCT00819585|451885755|FG001|Core Study|Adverse Event|1|||
125618676|NCT00819585|451885756|FG002|Core Study|Adverse Event|1|||
125618677|NCT00819585|451885757|FG003|Core Study|Adverse Event|4|||
125618678|NCT00819585|451885758|FG004|Core Study|Adverse Event|1|||
125618679|NCT00819585|451885759|FG005|Core Study|Adverse Event|0|||
125618680|NCT00819585|451885760|FG006|Core Study|Adverse Event|2|||
125618681|NCT00819585|451885761|FG007|Core Study|Adverse Event|0|||
125618682|NCT00819585|451885762|FG008|Core Study|Adverse Event|0|||
125618683|NCT00819585|451885763|FG009|Core Study|Adverse Event|0|||
125618684|NCT00819585|451885764|FG010|Core Study|Adverse Event|0|||
125618685|NCT00819585|451885754|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
125618686|NCT00819585|451885755|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
125618687|NCT00819585|451885756|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
125618688|NCT00819585|451885757|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
125618689|NCT00819585|451885758|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
125618690|NCT00819585|451885759|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
125618691|NCT00819585|451885760|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
125433072|NCT03565068|451212434|FG006|Overall Study|Protocol Violation|0|||
125618692|NCT00819585|451885761|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
125618693|NCT00819585|451885762|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
125618694|NCT00819585|451885763|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
125618695|NCT00819585|451885764|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
125618696|NCT00819585|451885754|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
125618697|NCT00819585|451885755|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
125618698|NCT00819585|451885756|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
125618699|NCT00819585|451885757|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
125618700|NCT00819585|451885758|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
125618701|NCT00819585|451885759|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
125618702|NCT00819585|451885760|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
125433073|NCT03565068|451212435|FG007|Overall Study|Protocol Violation|1|||
125433074|NCT03565068|451212436|FG008|Overall Study|Protocol Violation|0|||
125618703|NCT00819585|451885761|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
125618704|NCT00819585|451885762|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
125618705|NCT00819585|451885763|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
125618706|NCT00819585|451885764|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
125618707|NCT00819585|451885754|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
125618708|NCT00819585|451885755|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
125618709|NCT00819585|451885756|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
125618710|NCT00819585|451885757|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
125618711|NCT00819585|451885758|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
125618712|NCT00819585|451885759|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
125618713|NCT00819585|451885760|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
125618714|NCT00819585|451885761|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
125618715|NCT00819585|451885762|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
125618716|NCT00819585|451885763|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
125618717|NCT00819585|451885764|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
125618718|NCT00819585|451885754|FG000|Core Study|Subject Withdrew Consent|0|||
125618719|NCT00819585|451885755|FG001|Core Study|Subject Withdrew Consent|3|||
125618720|NCT00819585|451885756|FG002|Core Study|Subject Withdrew Consent|2|||
125618721|NCT00819585|451885757|FG003|Core Study|Subject Withdrew Consent|1|||
125618722|NCT00819585|451885758|FG004|Core Study|Subject Withdrew Consent|0|||
125618723|NCT00819585|451885759|FG005|Core Study|Subject Withdrew Consent|0|||
125618724|NCT00819585|451885760|FG006|Core Study|Subject Withdrew Consent|3|||
125618725|NCT00819585|451885761|FG007|Core Study|Subject Withdrew Consent|0|||
125618726|NCT00819585|451885762|FG008|Core Study|Subject Withdrew Consent|0|||
125618727|NCT00819585|451885763|FG009|Core Study|Subject Withdrew Consent|0|||
125618728|NCT00819585|451885764|FG010|Core Study|Subject Withdrew Consent|0|||
125618729|NCT00819585|451885754|FG000|Core Study|Lost to Follow-up|2|||
125618730|NCT00819585|451885755|FG001|Core Study|Lost to Follow-up|1|||
125618731|NCT00819585|451885756|FG002|Core Study|Lost to Follow-up|2|||
125618732|NCT00819585|451885757|FG003|Core Study|Lost to Follow-up|0|||
125618733|NCT00819585|451885758|FG004|Core Study|Lost to Follow-up|1|||
125618734|NCT00819585|451885759|FG005|Core Study|Lost to Follow-up|1|||
125618735|NCT00819585|451885760|FG006|Core Study|Lost to Follow-up|1|||
125374211|NCT00429273|451000233|FG001|Overall Study|Physician Decision|5|||
125374212|NCT00429273|451000234|FG002|Overall Study|Physician Decision|5|||
125374213|NCT00429273|451000232|FG000|Overall Study|Adverse Event|1|||
125374214|NCT00429273|451000233|FG001|Overall Study|Adverse Event|1|||
125374215|NCT00429273|451000234|FG002|Overall Study|Adverse Event|2|||
125374216|NCT01438957|451000235|FG000|Overall Study|Physician Decision|1|||
125374217|NCT01438957|451000236|FG001|Overall Study|Physician Decision|1|||
125374218|NCT01438957|451000237|FG002|Overall Study|Physician Decision|0|||
125374219|NCT01438957|451000238|FG003|Overall Study|Physician Decision|1|||
125374220|NCT01438957|451000239|FG004|Overall Study|Physician Decision|0|||
125374221|NCT02495168|451000241|FG000|Overall Study|Other than Specified|18|||
125374222|NCT02495168|451000242|FG001|Overall Study|Other than Specified|22|||
125374223|NCT02495168|451000243|FG002|Overall Study|Other than Specified|5|||
125374224|NCT02495168|451000241|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
125374225|NCT02495168|451000242|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
125374226|NCT02495168|451000243|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
125374227|NCT02495168|451000241|FG000|Overall Study|Physician Decision|1|||
125374228|NCT02495168|451000242|FG001|Overall Study|Physician Decision|1|||
125374229|NCT02495168|451000243|FG002|Overall Study|Physician Decision|0|||
125374230|NCT02495168|451000241|FG000|Overall Study|Lost to Follow-up|10|||
125374231|NCT02495168|451000242|FG001|Overall Study|Lost to Follow-up|6|||
125374232|NCT02495168|451000243|FG002|Overall Study|Lost to Follow-up|1|||
125374233|NCT02495168|451000241|FG000|Overall Study|Withdrawal by Subject|1|||
125618736|NCT00819585|451885761|FG007|Core Study|Lost to Follow-up|0|||
125618737|NCT00819585|451885762|FG008|Core Study|Lost to Follow-up|0|||
125374234|NCT02495168|451000242|FG001|Overall Study|Withdrawal by Subject|4|||
125374235|NCT02495168|451000243|FG002|Overall Study|Withdrawal by Subject|2|||
125374236|NCT02495168|451000241|FG000|Overall Study|Protocol Violation|0|||
125374237|NCT02495168|451000242|FG001|Overall Study|Protocol Violation|10|||
125374238|NCT02495168|451000243|FG002|Overall Study|Protocol Violation|1|||
125374239|NCT02495168|451000241|FG000|Overall Study|Adverse Event|4|||
125374240|NCT02495168|451000242|FG001|Overall Study|Adverse Event|8|||
125618738|NCT00819585|451885763|FG009|Core Study|Lost to Follow-up|0|||
125618739|NCT00819585|451885764|FG010|Core Study|Lost to Follow-up|0|||
125618740|NCT00819585|451885754|FG000|Core Study|Administrative Problems|0|||
125618741|NCT00819585|451885755|FG001|Core Study|Administrative Problems|0|||
125618742|NCT00819585|451885756|FG002|Core Study|Administrative Problems|0|||
125618743|NCT00819585|451885757|FG003|Core Study|Administrative Problems|0|||
125618744|NCT00819585|451885758|FG004|Core Study|Administrative Problems|0|||
125618745|NCT00819585|451885759|FG005|Core Study|Administrative Problems|0|||
125618746|NCT00819585|451885760|FG006|Core Study|Administrative Problems|2|||
125618747|NCT00819585|451885761|FG007|Core Study|Administrative Problems|0|||
125618748|NCT00819585|451885762|FG008|Core Study|Administrative Problems|0|||
125618749|NCT00819585|451885763|FG009|Core Study|Administrative Problems|0|||
125618750|NCT00819585|451885764|FG010|Core Study|Administrative Problems|0|||
125618751|NCT00819585|451885754|FG000|Core Study|Death|0|||
125618752|NCT00819585|451885755|FG001|Core Study|Death|0|||
125618753|NCT00819585|451885756|FG002|Core Study|Death|0|||
125618754|NCT00819585|451885757|FG003|Core Study|Death|0|||
125618755|NCT00819585|451885758|FG004|Core Study|Death|0|||
125618756|NCT00819585|451885759|FG005|Core Study|Death|0|||
125618757|NCT00819585|451885760|FG006|Core Study|Death|1|||
125618758|NCT00819585|451885761|FG007|Core Study|Death|0|||
125618759|NCT00819585|451885762|FG008|Core Study|Death|0|||
125618760|NCT00819585|451885763|FG009|Core Study|Death|0|||
125618761|NCT00819585|451885764|FG010|Core Study|Death|0|||
125618762|NCT00819585|451885754|FG000|Core Study|Protocol Violation|0|||
125618763|NCT00819585|451885755|FG001|Core Study|Protocol Violation|0|||
125618764|NCT00819585|451885756|FG002|Core Study|Protocol Violation|1|||
125618765|NCT00819585|451885757|FG003|Core Study|Protocol Violation|0|||
125618766|NCT00819585|451885758|FG004|Core Study|Protocol Violation|0|||
125618767|NCT00819585|451885759|FG005|Core Study|Protocol Violation|1|||
125618768|NCT00819585|451885760|FG006|Core Study|Protocol Violation|3|||
125618769|NCT00819585|451885761|FG007|Core Study|Protocol Violation|0|||
125618770|NCT00819585|451885762|FG008|Core Study|Protocol Violation|0|||
125618771|NCT00819585|451885763|FG009|Core Study|Protocol Violation|0|||
125618772|NCT00819585|451885764|FG010|Core Study|Protocol Violation|0|||
125618773|NCT00819585|451885754|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
125618774|NCT00819585|451885755|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
125618775|NCT00819585|451885756|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
125618776|NCT00819585|451885757|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
125618777|NCT00819585|451885758|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
125618778|NCT00819585|451885759|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
125618779|NCT00819585|451885760|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
125618780|NCT00819585|451885761|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
125618781|NCT00819585|451885762|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
125618782|NCT00819585|451885763|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
125618783|NCT00819585|451885764|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
125618784|NCT00819585|451885754|FG000|Extension Study|Subject Withdrew Consent|0|||
125618785|NCT00819585|451885755|FG001|Extension Study|Subject Withdrew Consent|0|||
125618786|NCT00819585|451885756|FG002|Extension Study|Subject Withdrew Consent|0|||
125618787|NCT00819585|451885757|FG003|Extension Study|Subject Withdrew Consent|0|||
125618788|NCT00819585|451885758|FG004|Extension Study|Subject Withdrew Consent|0|||
125618789|NCT00819585|451885759|FG005|Extension Study|Subject Withdrew Consent|0|||
125618790|NCT00819585|451885760|FG006|Extension Study|Subject Withdrew Consent|0|||
125618791|NCT00819585|451885761|FG007|Extension Study|Subject Withdrew Consent|0|||
125618792|NCT00819585|451885762|FG008|Extension Study|Subject Withdrew Consent|3|||
125618793|NCT00819585|451885763|FG009|Extension Study|Subject Withdrew Consent|0|||
125618794|NCT00819585|451885764|FG010|Extension Study|Subject Withdrew Consent|1|||
125618795|NCT00819585|451885754|FG000|Extension Study|Lost to Follow-up|0|||
125618796|NCT00819585|451885755|FG001|Extension Study|Lost to Follow-up|0|||
125618797|NCT00819585|451885756|FG002|Extension Study|Lost to Follow-up|0|||
125618798|NCT00819585|451885757|FG003|Extension Study|Lost to Follow-up|0|||
125618799|NCT00819585|451885758|FG004|Extension Study|Lost to Follow-up|0|||
125618800|NCT00819585|451885759|FG005|Extension Study|Lost to Follow-up|0|||
125618801|NCT00819585|451885760|FG006|Extension Study|Lost to Follow-up|0|||
125618802|NCT00819585|451885761|FG007|Extension Study|Lost to Follow-up|0|||
125618803|NCT00819585|451885762|FG008|Extension Study|Lost to Follow-up|2|||
125618804|NCT00819585|451885763|FG009|Extension Study|Lost to Follow-up|1|||
125618805|NCT00819585|451885764|FG010|Extension Study|Lost to Follow-up|1|||
125433075|NCT03565068|451212428|FG000|Overall Study|Sponsor decision|0|||
125618806|NCT00819585|451885754|FG000|Extension Study|Death|0|||
125618807|NCT00819585|451885755|FG001|Extension Study|Death|0|||
125618808|NCT00819585|451885756|FG002|Extension Study|Death|0|||
125618809|NCT00819585|451885757|FG003|Extension Study|Death|0|||
125618810|NCT00819585|451885758|FG004|Extension Study|Death|0|||
125618811|NCT00819585|451885759|FG005|Extension Study|Death|0|||
125618812|NCT00819585|451885760|FG006|Extension Study|Death|0|||
125618813|NCT00819585|451885761|FG007|Extension Study|Death|0|||
125618814|NCT00819585|451885762|FG008|Extension Study|Death|2|||
125618815|NCT00819585|451885763|FG009|Extension Study|Death|0|||
125618816|NCT00819585|451885764|FG010|Extension Study|Death|0|||
125618817|NCT00738374|451885765|FG000|Induction Treatment Phase|Adverse Event|14|||
125618818|NCT00738374|451885766|FG001|Induction Treatment Phase|Adverse Event|0|||
125618819|NCT00738374|451885767|FG002|Induction Treatment Phase|Adverse Event|0|||
125618820|NCT00738374|451885768|FG003|Induction Treatment Phase|Adverse Event|0|||
125618821|NCT00738374|451885765|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
125618822|NCT00738374|451885766|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
125618823|NCT00738374|451885767|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
125618824|NCT00738374|451885768|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
125618825|NCT00738374|451885765|FG000|Induction Treatment Phase|Physician Decision|2|||
125618826|NCT00738374|451885766|FG001|Induction Treatment Phase|Physician Decision|0|||
125618827|NCT00738374|451885767|FG002|Induction Treatment Phase|Physician Decision|0|||
125618828|NCT00738374|451885768|FG003|Induction Treatment Phase|Physician Decision|0|||
125618829|NCT00738374|451885765|FG000|Induction Treatment Phase|Protocol Violation|2|||
125618830|NCT00738374|451885766|FG001|Induction Treatment Phase|Protocol Violation|0|||
125618831|NCT00738374|451885767|FG002|Induction Treatment Phase|Protocol Violation|0|||
125618832|NCT00738374|451885768|FG003|Induction Treatment Phase|Protocol Violation|0|||
125618833|NCT00738374|451885765|FG000|Induction Treatment Phase|Non-compliance|1|||
125618834|NCT00738374|451885766|FG001|Induction Treatment Phase|Non-compliance|0|||
125618835|NCT00738374|451885767|FG002|Induction Treatment Phase|Non-compliance|0|||
125618836|NCT00738374|451885768|FG003|Induction Treatment Phase|Non-compliance|0|||
125618837|NCT00738374|451885765|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
125618838|NCT00738374|451885766|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
125618839|NCT00738374|451885767|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
125618840|NCT00738374|451885768|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
125618841|NCT00738374|451885765|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
125618842|NCT00738374|451885766|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
125618843|NCT00738374|451885767|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
125618844|NCT00738374|451885768|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
125618845|NCT00738374|451885765|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
125618846|NCT00738374|451885766|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
125618847|NCT00738374|451885767|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
125618848|NCT00738374|451885768|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
125618849|NCT00738374|451885765|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
125618850|NCT00738374|451885766|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
125618851|NCT00738374|451885767|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
125618852|NCT00738374|451885768|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
125618853|NCT00738374|451885765|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
125618854|NCT00738374|451885766|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
125618855|NCT00738374|451885767|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
125618856|NCT00738374|451885768|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
125618857|NCT00738374|451885765|FG000|Maintenance Treatment/Observation Phase|Other|0|||
125618858|NCT00738374|451885766|FG001|Maintenance Treatment/Observation Phase|Other|1|||
125618859|NCT00738374|451885767|FG002|Maintenance Treatment/Observation Phase|Other|0|||
125618860|NCT00738374|451885768|FG003|Maintenance Treatment/Observation Phase|Other|0|||
125618861|NCT01969799|451885769|FG000|Overall Study|Adverse Event|0|||
125618862|NCT01969799|451885770|FG001|Overall Study|Adverse Event|1|||
125618863|NCT01969799|451885769|FG000|Overall Study|Death|16|||
125618864|NCT01969799|451885770|FG001|Overall Study|Death|11|||
125618865|NCT01969799|451885769|FG000|Overall Study|Lost to Follow-up|0|||
125618866|NCT01969799|451885770|FG001|Overall Study|Lost to Follow-up|2|||
125618867|NCT01969799|451885769|FG000|Overall Study|Physician Decision|1|||
125618868|NCT01969799|451885770|FG001|Overall Study|Physician Decision|0|||
125618869|NCT02927873|451885773|FG000|Overall Study|Lost to Follow-up|0|||
125618870|NCT02927873|451885774|FG001|Overall Study|Lost to Follow-up|1|||
125618871|NCT02927873|451885775|FG002|Overall Study|Lost to Follow-up|0|||
125618872|NCT02927873|451885776|FG003|Overall Study|Lost to Follow-up|0|||
125215078|NCT03026283|450414897|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
125215079|NCT03026283|450414898|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
125215080|NCT03026283|450414899|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
125215081|NCT03782571|450414900|FG000|Period 1|Withdrawal by Subject|1|||
125215082|NCT03782571|450414901|FG001|Period 1|Withdrawal by Subject|0|||
125215083|NCT03782571|450414902|FG002|Period 1|Withdrawal by Subject|0|||
125618873|NCT02927873|451885777|FG004|Overall Study|Lost to Follow-up|0|||
125215084|NCT03782571|450414903|FG003|Period 1|Withdrawal by Subject|0|||
125618874|NCT02927873|451885778|FG005|Overall Study|Lost to Follow-up|0|||
125618875|NCT02927873|451885773|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125618876|NCT02927873|451885774|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
125618877|NCT02927873|451885775|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125618878|NCT02927873|451885776|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125618879|NCT02927873|451885777|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125618880|NCT02927873|451885778|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125618881|NCT02927873|451885773|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125618882|NCT02927873|451885774|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125618883|NCT02927873|451885775|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125618884|NCT02927873|451885776|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125374241|NCT02495168|451000243|FG002|Overall Study|Adverse Event|3|||
125374242|NCT02495168|451000241|FG000|Overall Study|Lack of Efficacy|0|||
125374243|NCT02495168|451000242|FG001|Overall Study|Lack of Efficacy|0|||
125374244|NCT02495168|451000243|FG002|Overall Study|Lack of Efficacy|3|||
125374245|NCT00727025|451000244|FG000|Overall Study|Physician Decision|23|||
125374246|NCT02269241|451000245|FG000|Overall Study|Lost to Follow-up|269|||
125374247|NCT02269241|451000245|FG000|Overall Study|Withdrawal by Subject|155|||
125374248|NCT02269241|451000245|FG000|Overall Study|Protocol Violation|1|||
125374249|NCT02269241|451000245|FG000|Overall Study|Physician Decision|7|||
125374250|NCT02269241|451000245|FG000|Overall Study|Pregnancy|15|||
125374251|NCT02269241|451000245|FG000|Overall Study|Wish for pregnancy|5|||
125374252|NCT02269241|451000245|FG000|Overall Study|Development of an exclusion criteria|16|||
125374253|NCT02269241|451000245|FG000|Overall Study|Adverse Event|113|||
125374254|NCT02269241|451000245|FG000|Overall Study|At the specific request of the sponsor|20|||
125374255|NCT02269241|451000245|FG000|Overall Study|Several reasons not classified|53|||
125374256|NCT02269241|451000245|FG000|Overall Study|Screening failures|546|||
125374257|NCT02270957|451000246|FG000|Overall Study|Lack of Efficacy|2|||
125374258|NCT02270957|451000247|FG001|Overall Study|Lack of Efficacy|4|||
125374259|NCT02270957|451000246|FG000|Overall Study|Adverse Event|2|||
125374260|NCT02270957|451000247|FG001|Overall Study|Adverse Event|0|||
125374261|NCT00489541|451000252|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
125374262|NCT00489541|451000253|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
125374263|NCT00489541|451000252|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
125374264|NCT00489541|451000253|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
125618885|NCT02927873|451885777|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125618886|NCT02927873|451885778|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125618887|NCT02927873|451885773|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
125618888|NCT02927873|451885774|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
125618889|NCT02927873|451885775|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
125374265|NCT00489541|451000252|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
125374266|NCT00489541|451000253|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
125374267|NCT00489541|451000252|FG000|12-Month Clinical Follow-up|Death|3|||
125374268|NCT00489541|451000253|FG001|12-Month Clinical Follow-up|Death|2|||
125374269|NCT00489541|451000252|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
125374270|NCT00489541|451000253|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
125374271|NCT00489541|451000252|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
125433076|NCT03565068|451212429|FG001|Overall Study|Sponsor decision|0|||
125618890|NCT02927873|451885776|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
125618891|NCT02927873|451885777|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
125618892|NCT02927873|451885778|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
125618893|NCT02927873|451885773|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
125618894|NCT02927873|451885774|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
125618895|NCT02927873|451885775|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
125618896|NCT02927873|451885776|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
125618897|NCT02927873|451885777|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
125618898|NCT02927873|451885778|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
125618899|NCT02927873|451885773|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
125618900|NCT02927873|451885774|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
125618901|NCT02927873|451885775|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
125618902|NCT02927873|451885776|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
125618903|NCT02927873|451885777|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
125618904|NCT02927873|451885778|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
125618905|NCT03629041|451885784|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
125618906|NCT03629041|451885785|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
125618907|NCT03629041|451885786|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
125618908|NCT03629041|451885787|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
125618909|NCT00393913|451885789|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
125618910|NCT00393913|451885789|FG000|Initial Assessment|Withdrawal by Subject|16|||
125618911|NCT00393913|451885789|FG000|CPAP|Withdrawal by Subject|3|||
125618912|NCT00393913|451885789|FG000|CPAP|Physician Decision|1|||
125618913|NCT00393913|451885789|FG000|CPAP|TEchnical problem with CPAP|3|||
125618914|NCT01927419|451885790|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
125618915|NCT01927419|451885791|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
125618916|NCT01927419|451885790|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
125618917|NCT01927419|451885791|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
125618918|NCT01927419|451885790|FG000|Treatment Period|Disease progression|17|||
125618919|NCT01927419|451885791|FG001|Treatment Period|Disease progression|20|||
125618920|NCT01927419|451885790|FG000|Treatment Period|Study drug toxicity|48|||
125618921|NCT01927419|451885791|FG001|Treatment Period|Study drug toxicity|10|||
125618922|NCT01927419|451885790|FG000|Treatment Period|Death|0|||
125618923|NCT01927419|451885791|FG001|Treatment Period|Death|1|||
125618924|NCT01927419|451885790|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
125618925|NCT01927419|451885791|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
125618926|NCT01927419|451885790|FG000|Treatment Period|Participant request to discontinue|12|||
125618927|NCT01927419|451885791|FG001|Treatment Period|Participant request to discontinue|4|||
125618928|NCT01927419|451885790|FG000|Treatment Period|Withdrawal by Subject|1|||
125618929|NCT01927419|451885791|FG001|Treatment Period|Withdrawal by Subject|1|||
125618930|NCT01927419|451885790|FG000|Treatment Period|Maximum Clinical Benefit|6|||
125618931|NCT01927419|451885791|FG001|Treatment Period|Maximum Clinical Benefit|2|||
125618932|NCT01927419|451885790|FG000|Treatment Period|Other reasons|3|||
125618933|NCT01927419|451885791|FG001|Treatment Period|Other reasons|4|||
125618934|NCT01927419|451885790|FG000|Treatment Period|Not Reported|1|||
125618935|NCT01927419|451885791|FG001|Treatment Period|Not Reported|1|||
125618936|NCT03488251|451885792|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
125618937|NCT03488251|451885793|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
125618938|NCT03488251|451885794|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
125618939|NCT03488251|451885795|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
125618940|NCT03488251|451885792|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
125618941|NCT03488251|451885793|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
125618942|NCT03488251|451885794|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
125618943|NCT03488251|451885795|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
125618944|NCT03488251|451885792|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
125618945|NCT03488251|451885793|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
125618946|NCT03488251|451885794|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
125618947|NCT03488251|451885795|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
125618948|NCT03488251|451885792|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
125618949|NCT03488251|451885793|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
125374272|NCT00489541|451000253|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
125618950|NCT03488251|451885794|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
125618951|NCT03488251|451885795|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
125618952|NCT03488251|451885792|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
125618953|NCT03488251|451885793|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
125618954|NCT03488251|451885794|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
125618955|NCT03488251|451885795|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
125618956|NCT01244191|451885798|FG000|Overall Study|Progressive disease|295|||
125618957|NCT01244191|451885799|FG001|Overall Study|Progressive disease|350|||
125618958|NCT01244191|451885798|FG000|Overall Study|Clinical disease progression|54|||
125618959|NCT01244191|451885799|FG001|Overall Study|Clinical disease progression|36|||
125618960|NCT01244191|451885798|FG000|Overall Study|Adverse Event|65|||
125618961|NCT01244191|451885799|FG001|Overall Study|Adverse Event|48|||
125618962|NCT01244191|451885798|FG000|Overall Study|Death|22|||
125618963|NCT01244191|451885799|FG001|Overall Study|Death|29|||
125618964|NCT01244191|451885798|FG000|Overall Study|Lost to Follow-up|0|||
125618965|NCT01244191|451885799|FG001|Overall Study|Lost to Follow-up|2|||
125618966|NCT01244191|451885798|FG000|Overall Study|Protocol Violation|1|||
125618967|NCT01244191|451885799|FG001|Overall Study|Protocol Violation|2|||
125618968|NCT01244191|451885798|FG000|Overall Study|Withdrawal by Subject|31|||
125618969|NCT01244191|451885799|FG001|Overall Study|Withdrawal by Subject|23|||
125618970|NCT01244191|451885798|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
125618971|NCT01244191|451885799|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
125618972|NCT01511107|451885801|FG000|Overall Study|Ineligible|3|||
125618973|NCT01511107|451885802|FG001|Overall Study|Ineligible|2|||
125618974|NCT01511107|451885801|FG000|Overall Study|Lost to Follow-up|10|||
125618975|NCT01511107|451885802|FG001|Overall Study|Lost to Follow-up|19|||
125618976|NCT01511107|451885801|FG000|Overall Study|Withdrawal by Subject|9|||
125618977|NCT01511107|451885802|FG001|Overall Study|Withdrawal by Subject|20|||
125618978|NCT01146951|451887582|FG000|Overall Study|Adverse Event|4|||
125618979|NCT01146951|451887583|FG001|Overall Study|Adverse Event|1|||
125618980|NCT00804843|451887587|FG000|Overall Study|Protocol Violation|1|||
125618981|NCT00804843|451887588|FG001|Overall Study|Protocol Violation|0|||
125618982|NCT00804843|451887587|FG000|Overall Study|Adverse Event|8|||
125618983|NCT00804843|451887588|FG001|Overall Study|Adverse Event|5|||
125618984|NCT00804843|451887587|FG000|Overall Study|Withdrawal by Subject|1|||
125618985|NCT00804843|451887588|FG001|Overall Study|Withdrawal by Subject|2|||
125618986|NCT02126670|451887595|FG000|Overall Study|Withdrawal by Subject|1|||
125618987|NCT02126670|451887596|FG001|Overall Study|Withdrawal by Subject|0|||
125618988|NCT02126670|451887597|FG002|Overall Study|Withdrawal by Subject|0|||
125618989|NCT02126670|451887598|FG003|Overall Study|Withdrawal by Subject|1|||
125618990|NCT01975246|451887601|FG000|Overall Study|Adverse Event|2|||
125618991|NCT01975246|451887602|FG001|Overall Study|Adverse Event|1|||
125618992|NCT01975246|451887601|FG000|Overall Study|Lack of Efficacy|1|||
125618993|NCT01975246|451887602|FG001|Overall Study|Lack of Efficacy|0|||
125618994|NCT01975246|451887601|FG000|Overall Study|Protocol Violation|1|||
125618995|NCT01975246|451887602|FG001|Overall Study|Protocol Violation|0|||
125618996|NCT01975246|451887601|FG000|Overall Study|Other than stated|0|||
125618997|NCT01975246|451887602|FG001|Overall Study|Other than stated|1|||
125618998|NCT01263093|451887603|FG000|Washout|Physician Decision|1|||
125618999|NCT01263093|451887604|FG001|Washout|Physician Decision|0|||
125619000|NCT01263093|451887603|FG000|Period 2|Adverse Event|1|||
125619001|NCT01263093|451887604|FG001|Period 2|Adverse Event|0|||
125619002|NCT00424346|451887605|FG000|Core Study|Adverse Event|5|||
125619003|NCT00424346|451887606|FG001|Core Study|Adverse Event|3|||
125619004|NCT00424346|451887607|FG002|Core Study|Adverse Event|1|||
125619005|NCT00424346|451887608|FG003|Core Study|Adverse Event|1|||
125619006|NCT00424346|451887605|FG000|Core Study|Abnormal Laboratory Values|0|||
125619007|NCT00424346|451887606|FG001|Core Study|Abnormal Laboratory Values|1|||
125619008|NCT00424346|451887607|FG002|Core Study|Abnormal Laboratory Values|0|||
125619009|NCT00424346|451887608|FG003|Core Study|Abnormal Laboratory Values|0|||
125619010|NCT00424346|451887605|FG000|Core Study|Lack of Efficacy|1|||
125619011|NCT00424346|451887606|FG001|Core Study|Lack of Efficacy|3|||
125619012|NCT00424346|451887607|FG002|Core Study|Lack of Efficacy|0|||
125619013|NCT00424346|451887608|FG003|Core Study|Lack of Efficacy|4|||
125619014|NCT00424346|451887605|FG000|Core Study|Withdrawal by Subject|1|||
125619015|NCT00424346|451887606|FG001|Core Study|Withdrawal by Subject|0|||
125619016|NCT00424346|451887607|FG002|Core Study|Withdrawal by Subject|0|||
125619017|NCT00424346|451887608|FG003|Core Study|Withdrawal by Subject|2|||
125619018|NCT00424346|451887605|FG000|Core Study|Lost to Follow-up|1|||
125619019|NCT00424346|451887606|FG001|Core Study|Lost to Follow-up|1|||
125619020|NCT00424346|451887607|FG002|Core Study|Lost to Follow-up|0|||
125619021|NCT00424346|451887608|FG003|Core Study|Lost to Follow-up|0|||
125619022|NCT00424346|451887605|FG000|Core Study|Administrative Problems|1|||
125619023|NCT00424346|451887606|FG001|Core Study|Administrative Problems|0|||
125619024|NCT00424346|451887607|FG002|Core Study|Administrative Problems|1|||
125619025|NCT00424346|451887608|FG003|Core Study|Administrative Problems|0|||
125619026|NCT00424346|451887605|FG000|Core Study|Protocol Violation|0|||
125619027|NCT00424346|451887606|FG001|Core Study|Protocol Violation|0|||
125619028|NCT00424346|451887607|FG002|Core Study|Protocol Violation|2|||
125619029|NCT00424346|451887608|FG003|Core Study|Protocol Violation|0|||
125619030|NCT00424346|451887605|FG000|Extension Phase|Adverse Event|0|||
125619031|NCT00424346|451887606|FG001|Extension Phase|Adverse Event|9|||
125619032|NCT00424346|451887607|FG002|Extension Phase|Adverse Event|5|||
125619033|NCT00424346|451887608|FG003|Extension Phase|Adverse Event|4|||
125619034|NCT00424346|451887605|FG000|Extension Phase|Lack of Efficacy|0|||
125619035|NCT00424346|451887606|FG001|Extension Phase|Lack of Efficacy|16|||
125619036|NCT00424346|451887607|FG002|Extension Phase|Lack of Efficacy|14|||
125619037|NCT00424346|451887608|FG003|Extension Phase|Lack of Efficacy|11|||
125619038|NCT00424346|451887605|FG000|Extension Phase|Withdrawal by Subject|0|||
125619039|NCT00424346|451887606|FG001|Extension Phase|Withdrawal by Subject|5|||
125619040|NCT00424346|451887607|FG002|Extension Phase|Withdrawal by Subject|3|||
125619041|NCT00424346|451887608|FG003|Extension Phase|Withdrawal by Subject|4|||
125619042|NCT00424346|451887605|FG000|Extension Phase|Lost to Follow-up|0|||
125619043|NCT00424346|451887606|FG001|Extension Phase|Lost to Follow-up|2|||
125619044|NCT00424346|451887607|FG002|Extension Phase|Lost to Follow-up|0|||
125619045|NCT00424346|451887608|FG003|Extension Phase|Lost to Follow-up|0|||
125619046|NCT00424346|451887605|FG000|Extension Phase|Administrative Problems|0|||
125619047|NCT00424346|451887606|FG001|Extension Phase|Administrative Problems|69|||
125619048|NCT00424346|451887607|FG002|Extension Phase|Administrative Problems|32|||
125619049|NCT00424346|451887608|FG003|Extension Phase|Administrative Problems|35|||
125619050|NCT00424346|451887605|FG000|Extension Phase|Death|0|||
125619051|NCT00424346|451887606|FG001|Extension Phase|Death|0|||
125619052|NCT00424346|451887607|FG002|Extension Phase|Death|0|||
125619053|NCT00424346|451887608|FG003|Extension Phase|Death|1|||
125619054|NCT00424346|451887605|FG000|Extension Phase|Protocol Violation|0|||
125619055|NCT00424346|451887606|FG001|Extension Phase|Protocol Violation|1|||
125619056|NCT00424346|451887607|FG002|Extension Phase|Protocol Violation|1|||
125619057|NCT00424346|451887608|FG003|Extension Phase|Protocol Violation|0|||
125619058|NCT01827319|451887609|FG000|Overall Study|Lost to Follow-up|3|||
125619059|NCT00571519|451887610|FG000|Overall Study|Subject withdrew consent|0|||
125619060|NCT00571519|451887611|FG001|Overall Study|Subject withdrew consent|1|||
125619061|NCT00571519|451887612|FG002|Overall Study|Subject withdrew consent|0|||
125619062|NCT00571519|451887613|FG003|Overall Study|Subject withdrew consent|2|||
125619063|NCT00571519|451887614|FG004|Overall Study|Subject withdrew consent|1|||
125619064|NCT00571519|451887615|FG005|Overall Study|Subject withdrew consent|1|||
125619065|NCT00571519|451887616|FG006|Overall Study|Subject withdrew consent|2|||
125619066|NCT00571519|451887610|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
125619067|NCT00571519|451887611|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
125619068|NCT00571519|451887612|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
125619069|NCT00571519|451887613|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
125619070|NCT00571519|451887614|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
125619071|NCT00571519|451887615|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
125619072|NCT00571519|451887616|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
125619073|NCT00571519|451887610|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
125619074|NCT00571519|451887611|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
125619075|NCT00571519|451887612|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
125619076|NCT00571519|451887613|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
125619077|NCT00571519|451887614|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
125619078|NCT00571519|451887615|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
125619079|NCT00571519|451887616|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
125619080|NCT00571519|451887610|FG000|Overall Study|Termination of study by Sponsor|2|||
125619081|NCT00571519|451887611|FG001|Overall Study|Termination of study by Sponsor|7|||
125619082|NCT00571519|451887612|FG002|Overall Study|Termination of study by Sponsor|10|||
125619083|NCT00571519|451887613|FG003|Overall Study|Termination of study by Sponsor|24|||
125619084|NCT00571519|451887614|FG004|Overall Study|Termination of study by Sponsor|8|||
125619085|NCT00571519|451887615|FG005|Overall Study|Termination of study by Sponsor|9|||
125619086|NCT00571519|451887616|FG006|Overall Study|Termination of study by Sponsor|22|||
125433077|NCT03565068|451212430|FG002|Overall Study|Sponsor decision|0|||
125433078|NCT03565068|451212431|FG003|Overall Study|Sponsor decision|0|||
125433079|NCT03565068|451212432|FG004|Overall Study|Sponsor decision|1|||
125433080|NCT03565068|451212433|FG005|Overall Study|Sponsor decision|1|||
125619087|NCT00571519|451887610|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
125619088|NCT00571519|451887611|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
125619089|NCT00571519|451887612|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
125433081|NCT03565068|451212434|FG006|Overall Study|Sponsor decision|0|||
125619090|NCT00571519|451887613|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
125619091|NCT00571519|451887614|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
125619092|NCT00571519|451887615|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
125433082|NCT03565068|451212435|FG007|Overall Study|Sponsor decision|0|||
125433083|NCT03565068|451212436|FG008|Overall Study|Sponsor decision|0|||
125433084|NCT03565068|451212428|FG000|Overall Study|Withdrawal by Subject|0|||
125433085|NCT03565068|451212429|FG001|Overall Study|Withdrawal by Subject|0|||
125433086|NCT03565068|451212430|FG002|Overall Study|Withdrawal by Subject|1|||
125433087|NCT03565068|451212431|FG003|Overall Study|Withdrawal by Subject|0|||
125433088|NCT03565068|451212432|FG004|Overall Study|Withdrawal by Subject|2|||
125433089|NCT03565068|451212433|FG005|Overall Study|Withdrawal by Subject|0|||
125433090|NCT03565068|451212434|FG006|Overall Study|Withdrawal by Subject|1|||
125433091|NCT03565068|451212435|FG007|Overall Study|Withdrawal by Subject|5|||
125433092|NCT03565068|451212436|FG008|Overall Study|Withdrawal by Subject|1|||
125433093|NCT03565068|451212428|FG000|Overall Study|Physician Decision|0|||
125433094|NCT03565068|451212429|FG001|Overall Study|Physician Decision|0|||
125433095|NCT03565068|451212430|FG002|Overall Study|Physician Decision|0|||
125433096|NCT03565068|451212431|FG003|Overall Study|Physician Decision|0|||
125433097|NCT03565068|451212432|FG004|Overall Study|Physician Decision|0|||
125433098|NCT03565068|451212433|FG005|Overall Study|Physician Decision|0|||
125433099|NCT03565068|451212434|FG006|Overall Study|Physician Decision|0|||
125433100|NCT03565068|451212435|FG007|Overall Study|Physician Decision|1|||
125433101|NCT03565068|451212436|FG008|Overall Study|Physician Decision|0|||
125433102|NCT03565068|451212428|FG000|Overall Study|Lost to Follow-up|0|||
125619093|NCT00571519|451887616|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
125619094|NCT00562640|451887618|FG000|Overall Study|Death|0|||
125619095|NCT00562640|451887619|FG001|Overall Study|Death|1|||
125619096|NCT00562640|451887620|FG002|Overall Study|Death|1|||
125619097|NCT00562640|451887621|FG003|Overall Study|Death|0|||
125619098|NCT05263921|451887622|FG000|Overall Study|Other: family emergency.|0|||
125619099|NCT05263921|451887623|FG001|Overall Study|Other: family emergency.|0|||
125619100|NCT05263921|451887624|FG002|Overall Study|Other: family emergency.|1|||
125619101|NCT05263921|451887625|FG003|Overall Study|Other: family emergency.|0|||
125619102|NCT02499575|451887626|FG000|Overall Study|Protocol Violation|0|||
125619103|NCT02499575|451887627|FG001|Overall Study|Protocol Violation|1|||
125619104|NCT02658968|451887628|FG000|Received Rituximab|Adverse Event|0|||
125619105|NCT02658968|451887629|FG001|Received Rituximab|Adverse Event|0|||
125619106|NCT02658968|451887630|FG002|Received Rituximab|Adverse Event|0|||
125619107|NCT02658968|451887631|FG003|Received Rituximab|Adverse Event|0|||
125619108|NCT02658968|451887632|FG004|Received Rituximab|Adverse Event|1|||
125619109|NCT02658968|451887628|FG000|Received Rituximab|Progressive disease|0|||
125619110|NCT02658968|451887629|FG001|Received Rituximab|Progressive disease|0|||
125619111|NCT02658968|451887630|FG002|Received Rituximab|Progressive disease|0|||
125619112|NCT02658968|451887631|FG003|Received Rituximab|Progressive disease|0|||
125619113|NCT02658968|451887632|FG004|Received Rituximab|Progressive disease|1|||
125619114|NCT02658968|451887628|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
125619115|NCT02658968|451887629|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
125619116|NCT02658968|451887630|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
125619117|NCT02658968|451887631|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
125619118|NCT02658968|451887632|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
125619119|NCT02658968|451887628|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
125619120|NCT02658968|451887629|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
125619121|NCT02658968|451887630|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
125619122|NCT02658968|451887631|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
125619123|NCT02658968|451887632|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
125619124|NCT02658968|451887628|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
125619125|NCT02658968|451887629|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
125619126|NCT02658968|451887630|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
125619127|NCT02658968|451887631|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
125619128|NCT02658968|451887632|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
125619129|NCT02658968|451887628|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
125619130|NCT02658968|451887629|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
125619131|NCT02658968|451887630|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
125619132|NCT02658968|451887631|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
125619133|NCT02658968|451887632|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
125433103|NCT03565068|451212429|FG001|Overall Study|Lost to Follow-up|0|||
125433104|NCT03565068|451212430|FG002|Overall Study|Lost to Follow-up|0|||
125433105|NCT03565068|451212431|FG003|Overall Study|Lost to Follow-up|0|||
125433106|NCT03565068|451212432|FG004|Overall Study|Lost to Follow-up|0|||
125433107|NCT03565068|451212433|FG005|Overall Study|Lost to Follow-up|0|||
125619134|NCT02658968|451887628|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
125619135|NCT02658968|451887629|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
125619136|NCT02658968|451887630|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
125619137|NCT02658968|451887631|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
125619138|NCT02658968|451887632|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
125619139|NCT02667457|451887644|FG000|Overall Study|Withdrawal by Subject|1|||
125619140|NCT02667457|451887645|FG001|Overall Study|Withdrawal by Subject|0|||
125619141|NCT02667457|451887644|FG000|Overall Study|Other Reason|0|||
125619142|NCT02667457|451887645|FG001|Overall Study|Other Reason|2|||
125619143|NCT02475850|451887646|FG000|Overall Study|Death|155|||
125619144|NCT02475850|451887647|FG001|Overall Study|Death|141|||
125619145|NCT02475850|451887646|FG000|Overall Study|Lost to Follow-up|217|||
125619146|NCT02475850|451887647|FG001|Overall Study|Lost to Follow-up|188|||
125619147|NCT02475850|451887646|FG000|Overall Study|Withdrawal by Subject|221|||
125619148|NCT02475850|451887647|FG001|Overall Study|Withdrawal by Subject|155|||
125619149|NCT00603733|451887653|FG000|Active Phase ITT|Adverse Event|8|||
125619150|NCT00603733|451887654|FG001|Active Phase ITT|Adverse Event|7|||
125619151|NCT00603733|451887653|FG000|Active Phase ITT|Withdrawal by Subject|0|||
125619152|NCT00603733|451887654|FG001|Active Phase ITT|Withdrawal by Subject|3|||
125619153|NCT00603733|451887653|FG000|Active Phase ITT|Lost to Follow-up|0|||
125619154|NCT00603733|451887654|FG001|Active Phase ITT|Lost to Follow-up|1|||
125619155|NCT00603733|451887653|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
125619156|NCT00603733|451887654|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
125619157|NCT00603733|451887653|FG000|Active Phase ITT|Lack of Efficacy|1|||
125619158|NCT00603733|451887654|FG001|Active Phase ITT|Lack of Efficacy|2|||
125619159|NCT00603733|451887653|FG000|Active Phase ITT|Subject moved, site closed|1|||
125619160|NCT00603733|451887654|FG001|Active Phase ITT|Subject moved, site closed|1|||
125619161|NCT00603733|451887653|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
125619162|NCT00603733|451887654|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
125619163|NCT00603733|451887653|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
125619164|NCT00603733|451887654|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
125619165|NCT00603733|451887653|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
125619166|NCT00603733|451887654|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
125619167|NCT00603733|451887653|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
125619168|NCT00603733|451887654|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
125619169|NCT00603733|451887653|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
125619170|NCT00603733|451887654|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
125619171|NCT00603733|451887653|FG000|Maintenance Phase ITT|Adverse Event|3|||
125619172|NCT00603733|451887654|FG001|Maintenance Phase ITT|Adverse Event|6|||
125619173|NCT00603733|451887653|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
125619174|NCT00603733|451887654|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
125619175|NCT00603733|451887653|FG000|Maintenance Phase ITT|Protocol Violation|1|||
125619176|NCT00603733|451887654|FG001|Maintenance Phase ITT|Protocol Violation|1|||
125619177|NCT00603733|451887653|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
125619178|NCT00603733|451887654|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
125619179|NCT00603733|451887653|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
125619180|NCT00603733|451887654|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
125619181|NCT00603733|451887653|FG000|Maintenance Phase ITT|Physician Decision|0|||
125619182|NCT00603733|451887654|FG001|Maintenance Phase ITT|Physician Decision|1|||
125619183|NCT00603733|451887653|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
125619184|NCT00603733|451887654|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
125619185|NCT02700919|451887655|FG000|Overall Study|Physician Decision|1|||
125619186|NCT02700919|451887656|FG001|Overall Study|Physician Decision|0|||
125619187|NCT02700919|451887657|FG002|Overall Study|Physician Decision|0|||
125619188|NCT02700919|451887655|FG000|Overall Study|Protocol Violation|1|||
125619189|NCT02700919|451887656|FG001|Overall Study|Protocol Violation|0|||
125619190|NCT02700919|451887657|FG002|Overall Study|Protocol Violation|0|||
125619191|NCT02700919|451887655|FG000|Overall Study|Adverse Event|1|||
125619192|NCT02700919|451887656|FG001|Overall Study|Adverse Event|3|||
125619193|NCT02700919|451887657|FG002|Overall Study|Adverse Event|1|||
125619194|NCT02700919|451887655|FG000|Overall Study|Withdrawal by Subject|5|||
125619195|NCT02700919|451887656|FG001|Overall Study|Withdrawal by Subject|8|||
125619196|NCT02700919|451887657|FG002|Overall Study|Withdrawal by Subject|2|||
125215085|NCT03782571|450414900|FG000|Period 3|Subject Unable to Attend V5|1|||
125215086|NCT03782571|450414901|FG001|Period 3|Subject Unable to Attend V5|0|||
125215087|NCT03782571|450414902|FG002|Period 3|Subject Unable to Attend V5|0|||
125215088|NCT03782571|450414903|FG003|Period 3|Subject Unable to Attend V5|0|||
125215089|NCT03782571|450414900|FG000|Period 3|Adverse Event|1|||
125215090|NCT03782571|450414901|FG001|Period 3|Adverse Event|0|||
125215091|NCT03782571|450414902|FG002|Period 3|Adverse Event|0|||
125215092|NCT03782571|450414903|FG003|Period 3|Adverse Event|0|||
125215093|NCT02213380|450414906|FG000|Underwent Randomization|Withdrawal by Subject|2|||
125215094|NCT02213380|450414907|FG001|Underwent Randomization|Withdrawal by Subject|0|||
125374273|NCT04390191|451000258|FG000|Overall Study|Withdrawal by Subject|1|||
125619197|NCT02700919|451887655|FG000|Overall Study|Lost to Follow-up|2|||
125619198|NCT02700919|451887656|FG001|Overall Study|Lost to Follow-up|0|||
125619199|NCT02700919|451887657|FG002|Overall Study|Lost to Follow-up|0|||
125619200|NCT02700919|451887655|FG000|Overall Study|Other|2|||
125619201|NCT02700919|451887656|FG001|Overall Study|Other|1|||
125619202|NCT02700919|451887657|FG002|Overall Study|Other|1|||
125619203|NCT00912340|451887664|FG000|Overall Study|Adverse Event|2|||
125619204|NCT00912340|451887665|FG001|Overall Study|Adverse Event|4|||
125619205|NCT00912340|451887666|FG002|Overall Study|Adverse Event|0|||
125619206|NCT00912340|451887664|FG000|Overall Study|Protocol revised to remove arm|0|||
125619207|NCT00912340|451887665|FG001|Overall Study|Protocol revised to remove arm|0|||
125619208|NCT00912340|451887666|FG002|Overall Study|Protocol revised to remove arm|4|||
125619209|NCT01517412|451887667|FG000|Overall Study|Adverse Event|10|||
125619210|NCT01517412|451887668|FG001|Overall Study|Adverse Event|11|||
125619211|NCT01517412|451887667|FG000|Overall Study|Lack of Efficacy|10|||
125619212|NCT01517412|451887668|FG001|Overall Study|Lack of Efficacy|5|||
125619213|NCT01517412|451887667|FG000|Overall Study|Poor compliance to protocol|8|||
125619214|NCT01517412|451887668|FG001|Overall Study|Poor compliance to protocol|3|||
125619215|NCT01517412|451887667|FG000|Overall Study|Other than specified above|8|||
125619216|NCT01517412|451887668|FG001|Overall Study|Other than specified above|5|||
125619217|NCT01149343|451887674|FG000|Overall Study|Withdrawal by Subject|1|||
125619218|NCT01149343|451887675|FG001|Overall Study|Withdrawal by Subject|1|||
125619219|NCT01149343|451887676|FG002|Overall Study|Withdrawal by Subject|1|||
125619220|NCT01149343|451887677|FG003|Overall Study|Withdrawal by Subject|5|||
125619221|NCT01149343|451887674|FG000|Overall Study|Death|10|||
125619222|NCT01149343|451887675|FG001|Overall Study|Death|13|||
125374274|NCT04390191|451000259|FG001|Overall Study|Withdrawal by Subject|0|||
125374275|NCT03978832|451000264|FG000|Overall Study|Adverse Event|1|||
125374276|NCT03978832|451000264|FG000|Overall Study|Lost to Follow-up|1|||
125374277|NCT03978832|451000264|FG000|Overall Study|Withdrawal by Subject|6|||
125374278|NCT03978832|451000264|FG000|Overall Study|Physician Decision|2|||
125374279|NCT03978832|451000264|FG000|Overall Study|did not pass screening criteria|44|||
125374280|NCT02042183|451000265|FG000|Overall Study|Physician Decision|7|||
125619223|NCT01149343|451887676|FG002|Overall Study|Death|18|||
125619224|NCT01149343|451887677|FG003|Overall Study|Death|18|||
125619225|NCT01149343|451887674|FG000|Overall Study|Lost to Follow-up|1|||
125374281|NCT02042183|451000266|FG001|Overall Study|Physician Decision|2|||
125374282|NCT02042183|451000265|FG000|Overall Study|Lack of Efficacy|4|||
125619226|NCT01149343|451887675|FG001|Overall Study|Lost to Follow-up|0|||
125619227|NCT01149343|451887676|FG002|Overall Study|Lost to Follow-up|0|||
125619228|NCT01149343|451887677|FG003|Overall Study|Lost to Follow-up|1|||
125619229|NCT01149343|451887674|FG000|Overall Study|Other|8|||
125619230|NCT01149343|451887675|FG001|Overall Study|Other|10|||
125619231|NCT01149343|451887676|FG002|Overall Study|Other|2|||
125619232|NCT01149343|451887677|FG003|Overall Study|Other|14|||
125619233|NCT01149343|451887674|FG000|Overall Study|Sponsor study termination|0|||
125619234|NCT01149343|451887675|FG001|Overall Study|Sponsor study termination|0|||
125619235|NCT01149343|451887676|FG002|Overall Study|Sponsor study termination|0|||
125619236|NCT01149343|451887677|FG003|Overall Study|Sponsor study termination|2|||
125619237|NCT01149343|451887674|FG000|Overall Study|Recurrence / Progressive disease|0|||
125619238|NCT01149343|451887675|FG001|Overall Study|Recurrence / Progressive disease|0|||
125619239|NCT01149343|451887676|FG002|Overall Study|Recurrence / Progressive disease|1|||
125619240|NCT01149343|451887677|FG003|Overall Study|Recurrence / Progressive disease|0|||
125619241|NCT01061736|451887678|FG000|Overall Study|Dose regimen not selected|0|||
125619242|NCT01061736|451887679|FG001|Overall Study|Dose regimen not selected|0|||
125619243|NCT01061736|451887680|FG002|Overall Study|Dose regimen not selected|0|||
125619244|NCT01061736|451887681|FG003|Overall Study|Dose regimen not selected|0|||
125619245|NCT01061736|451887682|FG004|Overall Study|Dose regimen not selected|0|||
125619246|NCT01061736|451887683|FG005|Overall Study|Dose regimen not selected|0|||
125619247|NCT01061736|451887684|FG006|Overall Study|Dose regimen not selected|79|||
125619248|NCT01061736|451887685|FG007|Overall Study|Dose regimen not selected|0|||
125619249|NCT01061736|451887686|FG008|Overall Study|Dose regimen not selected|0|||
125619250|NCT01061736|451887687|FG009|Overall Study|Dose regimen not selected|0|||
125619251|NCT01061736|451887678|FG000|Overall Study|Adverse Event|13|||
125619252|NCT01061736|451887679|FG001|Overall Study|Adverse Event|1|||
125619253|NCT01061736|451887680|FG002|Overall Study|Adverse Event|3|||
125619254|NCT01061736|451887681|FG003|Overall Study|Adverse Event|2|||
125619255|NCT01061736|451887682|FG004|Overall Study|Adverse Event|4|||
125619256|NCT01061736|451887683|FG005|Overall Study|Adverse Event|1|||
125619257|NCT01061736|451887684|FG006|Overall Study|Adverse Event|4|||
125619258|NCT01061736|451887685|FG007|Overall Study|Adverse Event|63|||
125619259|NCT01061736|451887686|FG008|Overall Study|Adverse Event|67|||
125619260|NCT01061736|451887687|FG009|Overall Study|Adverse Event|34|||
125374283|NCT02042183|451000266|FG001|Overall Study|Lack of Efficacy|3|||
125619261|NCT01061736|451887678|FG000|Overall Study|Lack of Efficacy|0|||
125619262|NCT01061736|451887679|FG001|Overall Study|Lack of Efficacy|2|||
125619263|NCT01061736|451887680|FG002|Overall Study|Lack of Efficacy|1|||
125215095|NCT02213380|450414906|FG000|Underwent Randomization|Not treated|3|||
125215096|NCT02213380|450414907|FG001|Underwent Randomization|Not treated|3|||
125215097|NCT02213380|450414906|FG000|Per-protocol Analysis|Protocol Violation|32|||
125215098|NCT02213380|450414907|FG001|Per-protocol Analysis|Protocol Violation|36|||
125215099|NCT03498313|450414910|FG000|Experimental Period 1|Adverse Event|1|||
125215100|NCT03498313|450414911|FG001|Experimental Period 1|Adverse Event|0|||
125215101|NCT03498313|450414912|FG002|Experimental Period 1|Adverse Event|0|||
125215102|NCT03498313|450414913|FG003|Experimental Period 1|Adverse Event|1|||
125215103|NCT03498313|450414914|FG004|Experimental Period 1|Adverse Event|0|||
125215104|NCT03498313|450414915|FG005|Experimental Period 1|Adverse Event|0|||
125215105|NCT03498313|450414910|FG000|Experimental Period 1|Withdrawal by Subject|0|||
125215106|NCT03498313|450414911|FG001|Experimental Period 1|Withdrawal by Subject|1|||
125215107|NCT03498313|450414912|FG002|Experimental Period 1|Withdrawal by Subject|0|||
125215108|NCT03498313|450414913|FG003|Experimental Period 1|Withdrawal by Subject|0|||
125215109|NCT03498313|450414914|FG004|Experimental Period 1|Withdrawal by Subject|0|||
125433108|NCT03565068|451212434|FG006|Overall Study|Lost to Follow-up|0|||
125433109|NCT03565068|451212435|FG007|Overall Study|Lost to Follow-up|1|||
125215110|NCT03498313|450414915|FG005|Experimental Period 1|Withdrawal by Subject|0|||
125215111|NCT03498313|450414910|FG000|Washout Period 1|Anovulation|1|||
125215112|NCT03498313|450414911|FG001|Washout Period 1|Anovulation|0|||
125215113|NCT03498313|450414912|FG002|Washout Period 1|Anovulation|0|||
125215114|NCT03498313|450414913|FG003|Washout Period 1|Anovulation|0|||
125215115|NCT03498313|450414914|FG004|Washout Period 1|Anovulation|0|||
125215116|NCT03498313|450414915|FG005|Washout Period 1|Anovulation|0|||
125215117|NCT03498313|450414910|FG000|Washout Period 1|Withdrawal by Subject|0|||
125215118|NCT03498313|450414911|FG001|Washout Period 1|Withdrawal by Subject|3|||
125215119|NCT03498313|450414912|FG002|Washout Period 1|Withdrawal by Subject|0|||
125215120|NCT03498313|450414913|FG003|Washout Period 1|Withdrawal by Subject|1|||
125215121|NCT03498313|450414914|FG004|Washout Period 1|Withdrawal by Subject|0|||
125215122|NCT03498313|450414915|FG005|Washout Period 1|Withdrawal by Subject|1|||
125215123|NCT03498313|450414910|FG000|Experimental Period 2|Adverse Event|0|||
125215124|NCT03498313|450414911|FG001|Experimental Period 2|Adverse Event|0|||
125215125|NCT03498313|450414912|FG002|Experimental Period 2|Adverse Event|0|||
125215126|NCT03498313|450414913|FG003|Experimental Period 2|Adverse Event|0|||
125215127|NCT03498313|450414914|FG004|Experimental Period 2|Adverse Event|1|||
125215128|NCT03498313|450414915|FG005|Experimental Period 2|Adverse Event|2|||
125215129|NCT03498313|450414910|FG000|Washout Period 2|Physician Decision|1|||
125215130|NCT03498313|450414911|FG001|Washout Period 2|Physician Decision|0|||
125215131|NCT03498313|450414912|FG002|Washout Period 2|Physician Decision|0|||
125215132|NCT03498313|450414913|FG003|Washout Period 2|Physician Decision|1|||
125215133|NCT03498313|450414914|FG004|Washout Period 2|Physician Decision|0|||
125215134|NCT03498313|450414915|FG005|Washout Period 2|Physician Decision|1|||
125215135|NCT03498313|450414910|FG000|Washout Period 2|Withdrawal by Subject|3|||
125215136|NCT03498313|450414911|FG001|Washout Period 2|Withdrawal by Subject|2|||
125215137|NCT03498313|450414912|FG002|Washout Period 2|Withdrawal by Subject|0|||
125215138|NCT03498313|450414913|FG003|Washout Period 2|Withdrawal by Subject|0|||
125619264|NCT01061736|451887681|FG003|Overall Study|Lack of Efficacy|1|||
125619265|NCT01061736|451887682|FG004|Overall Study|Lack of Efficacy|1|||
125619266|NCT01061736|451887683|FG005|Overall Study|Lack of Efficacy|2|||
125619267|NCT01061736|451887684|FG006|Overall Study|Lack of Efficacy|1|||
125619268|NCT01061736|451887685|FG007|Overall Study|Lack of Efficacy|9|||
125619269|NCT01061736|451887686|FG008|Overall Study|Lack of Efficacy|9|||
125619270|NCT01061736|451887687|FG009|Overall Study|Lack of Efficacy|10|||
125619271|NCT01061736|451887678|FG000|Overall Study|Poor compliance to protocol|0|||
125619272|NCT01061736|451887679|FG001|Overall Study|Poor compliance to protocol|0|||
125619273|NCT01061736|451887680|FG002|Overall Study|Poor compliance to protocol|0|||
125619274|NCT01061736|451887681|FG003|Overall Study|Poor compliance to protocol|0|||
125619275|NCT01061736|451887682|FG004|Overall Study|Poor compliance to protocol|0|||
125619276|NCT01061736|451887683|FG005|Overall Study|Poor compliance to protocol|0|||
125619277|NCT01061736|451887684|FG006|Overall Study|Poor compliance to protocol|0|||
125619278|NCT01061736|451887685|FG007|Overall Study|Poor compliance to protocol|2|||
125619279|NCT01061736|451887686|FG008|Overall Study|Poor compliance to protocol|5|||
125619280|NCT01061736|451887687|FG009|Overall Study|Poor compliance to protocol|9|||
125619281|NCT01061736|451887678|FG000|Overall Study|Not treated|0|||
125619282|NCT01061736|451887679|FG001|Overall Study|Not treated|0|||
125619283|NCT01061736|451887680|FG002|Overall Study|Not treated|0|||
125619284|NCT01061736|451887681|FG003|Overall Study|Not treated|0|||
125619285|NCT01061736|451887682|FG004|Overall Study|Not treated|1|||
125619286|NCT01061736|451887683|FG005|Overall Study|Not treated|0|||
125619287|NCT01061736|451887684|FG006|Overall Study|Not treated|0|||
125619288|NCT01061736|451887685|FG007|Overall Study|Not treated|2|||
125619289|NCT01061736|451887686|FG008|Overall Study|Not treated|1|||
125619290|NCT01061736|451887687|FG009|Overall Study|Not treated|0|||
125619291|NCT01061736|451887678|FG000|Overall Study|Other than specified above|0|||
125619292|NCT01061736|451887679|FG001|Overall Study|Other than specified above|1|||
125619293|NCT01061736|451887680|FG002|Overall Study|Other than specified above|2|||
125619294|NCT01061736|451887681|FG003|Overall Study|Other than specified above|0|||
125619295|NCT01061736|451887682|FG004|Overall Study|Other than specified above|1|||
125619296|NCT01061736|451887683|FG005|Overall Study|Other than specified above|0|||
125619297|NCT01061736|451887684|FG006|Overall Study|Other than specified above|0|||
125619298|NCT01061736|451887685|FG007|Overall Study|Other than specified above|18|||
125215139|NCT03498313|450414914|FG004|Washout Period 2|Withdrawal by Subject|2|||
125215140|NCT03498313|450414915|FG005|Washout Period 2|Withdrawal by Subject|0|||
125215141|NCT03498313|450414910|FG000|Washout Period 2|Anovulation|0|||
125215142|NCT03498313|450414911|FG001|Washout Period 2|Anovulation|0|||
125215143|NCT03498313|450414912|FG002|Washout Period 2|Anovulation|0|||
125215144|NCT03498313|450414913|FG003|Washout Period 2|Anovulation|0|||
125215145|NCT03498313|450414914|FG004|Washout Period 2|Anovulation|0|||
125619299|NCT01061736|451887686|FG008|Overall Study|Other than specified above|15|||
125619300|NCT01061736|451887687|FG009|Overall Study|Other than specified above|21|||
125619301|NCT01093755|451887688|FG000|Overall Study|Withdrawal by Subject|3|||
125619302|NCT01093755|451887689|FG001|Overall Study|Withdrawal by Subject|4|||
125619303|NCT03115112|451887690|FG000|Overall Study|Adverse Event|5|||
125619304|NCT03115112|451887691|FG001|Overall Study|Adverse Event|1|||
125619305|NCT03115112|451887690|FG000|Overall Study|Withdrawal by Subject|4|||
125619306|NCT03115112|451887691|FG001|Overall Study|Withdrawal by Subject|2|||
125619307|NCT03115112|451887690|FG000|Overall Study|Lost to Follow-up|0|||
125619308|NCT03115112|451887691|FG001|Overall Study|Lost to Follow-up|1|||
125619309|NCT03115112|451887690|FG000|Overall Study|Death|1|||
125619310|NCT03115112|451887691|FG001|Overall Study|Death|0|||
125619311|NCT03115112|451887690|FG000|Overall Study|Pregnancy|1|||
125619312|NCT03115112|451887691|FG001|Overall Study|Pregnancy|0|||
125619313|NCT03115112|451887690|FG000|Overall Study|Site closure|1|||
125619314|NCT03115112|451887691|FG001|Overall Study|Site closure|1|||
125619315|NCT04019795|451887692|FG000|Overall Study|Withdrawal by Subject|1|||
125619316|NCT04019795|451887693|FG001|Overall Study|Withdrawal by Subject|2|||
125619317|NCT04019795|451887694|FG002|Overall Study|Withdrawal by Subject|2|||
125619318|NCT04019795|451887695|FG003|Overall Study|Withdrawal by Subject|1|||
125619319|NCT04019795|451887692|FG000|Overall Study|Lost to Follow-up|0|||
125619320|NCT04019795|451887693|FG001|Overall Study|Lost to Follow-up|1|||
125619321|NCT04019795|451887694|FG002|Overall Study|Lost to Follow-up|1|||
125619322|NCT04019795|451887695|FG003|Overall Study|Lost to Follow-up|2|||
125619323|NCT04019795|451887692|FG000|Overall Study|Treatment non-compliance|3|||
125619324|NCT04019795|451887693|FG001|Overall Study|Treatment non-compliance|1|||
125619325|NCT04019795|451887694|FG002|Overall Study|Treatment non-compliance|2|||
125619326|NCT04019795|451887695|FG003|Overall Study|Treatment non-compliance|0|||
125619327|NCT04019795|451887692|FG000|Overall Study|Physician Decision|0|||
125619328|NCT04019795|451887693|FG001|Overall Study|Physician Decision|0|||
125619329|NCT04019795|451887694|FG002|Overall Study|Physician Decision|1|||
125619330|NCT04019795|451887695|FG003|Overall Study|Physician Decision|0|||
125619331|NCT04019795|451887692|FG000|Overall Study|Adverse Event|1|||
125619332|NCT04019795|451887693|FG001|Overall Study|Adverse Event|0|||
125619333|NCT04019795|451887694|FG002|Overall Study|Adverse Event|0|||
125619334|NCT04019795|451887695|FG003|Overall Study|Adverse Event|0|||
125619335|NCT02168803|451887696|FG000|Overall Study|Lost to Follow-up|1|||
125619336|NCT02168803|451887697|FG001|Overall Study|Lost to Follow-up|0|||
125619337|NCT02168803|451887698|FG002|Overall Study|Lost to Follow-up|1|||
125619338|NCT02168803|451887696|FG000|Overall Study|Withdrawal by Subject|1|||
125619339|NCT02168803|451887697|FG001|Overall Study|Withdrawal by Subject|1|||
125433110|NCT03565068|451212436|FG008|Overall Study|Lost to Follow-up|0|||
125433111|NCT00085202|451212437|FG000|Overall Study|Still on therapy|2|||
125619340|NCT02168803|451887698|FG002|Overall Study|Withdrawal by Subject|2|||
125619341|NCT02168803|451887696|FG000|Overall Study|Physician Decision|0|||
125619342|NCT02168803|451887697|FG001|Overall Study|Physician Decision|1|||
125619343|NCT02168803|451887698|FG002|Overall Study|Physician Decision|0|||
125619344|NCT02168803|451887696|FG000|Overall Study|Adverse Event|0|||
125619345|NCT02168803|451887697|FG001|Overall Study|Adverse Event|1|||
125619346|NCT02168803|451887698|FG002|Overall Study|Adverse Event|1|||
125619347|NCT02168803|451887696|FG000|Overall Study|Death|0|||
125619348|NCT02168803|451887697|FG001|Overall Study|Death|0|||
125619349|NCT02168803|451887698|FG002|Overall Study|Death|1|||
125619350|NCT02168803|451887696|FG000|Overall Study|Sponsor Decision|0|||
125619351|NCT02168803|451887697|FG001|Overall Study|Sponsor Decision|0|||
125619352|NCT02168803|451887698|FG002|Overall Study|Sponsor Decision|1|||
125619353|NCT00980343|451887699|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
125619354|NCT00980343|451887700|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
125619355|NCT02310906|451887705|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
125619356|NCT02310906|451887706|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
125619357|NCT02310906|451887707|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
125619358|NCT02310906|451887708|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
125433112|NCT00085202|451212438|FG001|Overall Study|Still on therapy|0|||
125619359|NCT02310906|451887705|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
125619360|NCT02310906|451887706|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
125619361|NCT02310906|451887707|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
125619362|NCT02310906|451887708|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
125619363|NCT02310906|451887705|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
125619364|NCT02310906|451887706|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
125619365|NCT02310906|451887707|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
125619366|NCT02310906|451887708|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
125619367|NCT02310906|451887705|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
125619368|NCT02310906|451887706|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
125619369|NCT02310906|451887707|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
125619370|NCT02310906|451887708|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
125619371|NCT03084718|451887716|FG000|Overall Study|Withdrawal by Subject|4|||
125619372|NCT03084718|451887717|FG001|Overall Study|Withdrawal by Subject|3|||
125619373|NCT03084718|451887718|FG002|Overall Study|Withdrawal by Subject|4|||
125619374|NCT03084718|451887719|FG003|Overall Study|Withdrawal by Subject|0|||
125619375|NCT03084718|451887720|FG004|Overall Study|Withdrawal by Subject|0|||
125619376|NCT03084718|451887716|FG000|Overall Study|Physician Decision|1|||
125619377|NCT03084718|451887717|FG001|Overall Study|Physician Decision|0|||
125619378|NCT03084718|451887718|FG002|Overall Study|Physician Decision|0|||
125619379|NCT03084718|451887719|FG003|Overall Study|Physician Decision|0|||
125619380|NCT03084718|451887720|FG004|Overall Study|Physician Decision|0|||
125619381|NCT03084718|451887716|FG000|Overall Study|Adverse Event|3|||
125619382|NCT03084718|451887717|FG001|Overall Study|Adverse Event|5|||
125619383|NCT03084718|451887718|FG002|Overall Study|Adverse Event|5|||
125619384|NCT03084718|451887719|FG003|Overall Study|Adverse Event|8|||
125619385|NCT03084718|451887720|FG004|Overall Study|Adverse Event|2|||
125619386|NCT03084718|451887716|FG000|Overall Study|Lack of Efficacy|2|||
125619387|NCT03084718|451887717|FG001|Overall Study|Lack of Efficacy|0|||
125619388|NCT03084718|451887718|FG002|Overall Study|Lack of Efficacy|1|||
125619389|NCT03084718|451887719|FG003|Overall Study|Lack of Efficacy|4|||
125619390|NCT03084718|451887720|FG004|Overall Study|Lack of Efficacy|0|||
125619391|NCT03084718|451887716|FG000|Overall Study|Lost to Follow-up|0|||
125619392|NCT03084718|451887717|FG001|Overall Study|Lost to Follow-up|1|||
125619393|NCT03084718|451887718|FG002|Overall Study|Lost to Follow-up|0|||
125619394|NCT03084718|451887719|FG003|Overall Study|Lost to Follow-up|0|||
125619395|NCT03084718|451887720|FG004|Overall Study|Lost to Follow-up|2|||
125619396|NCT03084718|451887716|FG000|Overall Study|Protocol Violation|0|||
125619397|NCT03084718|451887717|FG001|Overall Study|Protocol Violation|0|||
125619398|NCT03084718|451887718|FG002|Overall Study|Protocol Violation|1|||
125619399|NCT03084718|451887719|FG003|Overall Study|Protocol Violation|0|||
125619400|NCT03084718|451887720|FG004|Overall Study|Protocol Violation|0|||
125619401|NCT03084718|451887716|FG000|Overall Study|Death|0|||
125619402|NCT03084718|451887717|FG001|Overall Study|Death|1|||
125619403|NCT03084718|451887718|FG002|Overall Study|Death|0|||
125619404|NCT03084718|451887719|FG003|Overall Study|Death|0|||
125619405|NCT03084718|451887720|FG004|Overall Study|Death|0|||
125619406|NCT03084718|451887716|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
125619407|NCT03084718|451887717|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
125619408|NCT03084718|451887718|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
125619409|NCT03084718|451887719|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
125619410|NCT03084718|451887720|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
125619411|NCT02767856|451887721|FG000|Overall Study|Lost to Follow-up|9|||
125619412|NCT02767856|451887722|FG001|Overall Study|Lost to Follow-up|1|||
125619413|NCT02767856|451887721|FG000|Overall Study|Withdrawal by Subject|2|||
125619414|NCT02767856|451887722|FG001|Overall Study|Withdrawal by Subject|1|||
125215146|NCT03498313|450414915|FG005|Washout Period 2|Anovulation|1|||
125619415|NCT00091026|451887723|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
125619416|NCT00091026|451887724|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
125374284|NCT02042183|451000265|FG000|Overall Study|Non-compliance with Study Drug|2|||
125374285|NCT02042183|451000266|FG001|Overall Study|Non-compliance with Study Drug|3|||
125374286|NCT02042183|451000265|FG000|Overall Study|Adverse Event|17|||
125374287|NCT02042183|451000266|FG001|Overall Study|Adverse Event|6|||
125619417|NCT00091026|451887723|FG000|Overall Study|Patient withdrew and never received trea|0|||
125619418|NCT00091026|451887724|FG001|Overall Study|Patient withdrew and never received trea|2|||
125619419|NCT00091026|451887723|FG000|Overall Study|Unknown-never received treatment|0|||
125619420|NCT00091026|451887724|FG001|Overall Study|Unknown-never received treatment|1|||
125619421|NCT00843843|451887725|FG000|Overall Study|Physician Decision|1|||
125619422|NCT00843843|451887726|FG001|Overall Study|Physician Decision|1|||
125619423|NCT00843843|451887725|FG000|Overall Study|Protocol Violation|1|||
125619424|NCT00843843|451887726|FG001|Overall Study|Protocol Violation|1|||
125619425|NCT00589979|451887727|FG000|Run-In Period|Adverse Event|5|||
125619426|NCT00589979|451887728|FG001|Run-In Period|Adverse Event|0|||
125619427|NCT00589979|451887729|FG002|Run-In Period|Adverse Event|0|||
125619428|NCT00589979|451887727|FG000|Run-In Period|Protocol Violation|3|||
125619429|NCT00589979|451887728|FG001|Run-In Period|Protocol Violation|0|||
125619430|NCT00589979|451887729|FG002|Run-In Period|Protocol Violation|0|||
125619431|NCT00589979|451887727|FG000|Run-In Period|Did not qualify for randomization|54|||
125619432|NCT00589979|451887728|FG001|Run-In Period|Did not qualify for randomization|0|||
125619433|NCT00589979|451887729|FG002|Run-In Period|Did not qualify for randomization|0|||
125619434|NCT00589979|451887727|FG000|Run-In Period|Withdrawal by Subject|10|||
125619435|NCT00589979|451887728|FG001|Run-In Period|Withdrawal by Subject|0|||
125619436|NCT00589979|451887729|FG002|Run-In Period|Withdrawal by Subject|0|||
125619437|NCT00589979|451887727|FG000|Run-In Period|Informed Consent Withdrawn|4|||
125619438|NCT00589979|451887728|FG001|Run-In Period|Informed Consent Withdrawn|0|||
125619439|NCT00589979|451887729|FG002|Run-In Period|Informed Consent Withdrawn|0|||
125619440|NCT00589979|451887727|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
125619441|NCT00589979|451887728|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
125619442|NCT00589979|451887729|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
125619443|NCT00589979|451887727|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
125619444|NCT00589979|451887728|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
125374288|NCT02042183|451000265|FG000|Overall Study|Other|3|||
125374289|NCT02042183|451000266|FG001|Overall Study|Other|3|||
125619445|NCT00589979|451887729|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
125619446|NCT00589979|451887727|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
125619447|NCT00589979|451887728|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
125619448|NCT00589979|451887729|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
125374290|NCT02042183|451000265|FG000|Overall Study|Withdrawal by Subject|21|||
125374291|NCT02042183|451000266|FG001|Overall Study|Withdrawal by Subject|16|||
125374292|NCT02042183|451000265|FG000|Overall Study|Site Terminated by Sponsor|2|||
125374293|NCT02042183|451000266|FG001|Overall Study|Site Terminated by Sponsor|1|||
125374294|NCT02042183|451000265|FG000|Overall Study|Lost to Follow-up|9|||
125619449|NCT00589979|451887727|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
125619450|NCT00589979|451887728|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
125619451|NCT00589979|451887729|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
125619452|NCT00589979|451887727|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
125619453|NCT00589979|451887728|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
125619454|NCT00589979|451887729|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
125619455|NCT00589979|451887727|FG000|Double-Blind Treatment Period 2|Other|0|||
125619456|NCT00589979|451887728|FG001|Double-Blind Treatment Period 2|Other|0|||
125619457|NCT00589979|451887729|FG002|Double-Blind Treatment Period 2|Other|1|||
125619458|NCT00589979|451887727|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
125619459|NCT00589979|451887728|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
125619460|NCT00589979|451887729|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
125619461|NCT00589979|451887727|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
125619462|NCT00589979|451887728|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
125619463|NCT00589979|451887729|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
125619464|NCT01397448|451887730|FG000|Overall Study|Adverse Event|4|||
125619465|NCT01397448|451887731|FG001|Overall Study|Adverse Event|4|||
125619466|NCT01397448|451887732|FG002|Overall Study|Adverse Event|6|||
125619467|NCT01397448|451887730|FG000|Overall Study|Withdrawal by Subject|4|||
125619468|NCT01397448|451887731|FG001|Overall Study|Withdrawal by Subject|4|||
125619469|NCT01397448|451887732|FG002|Overall Study|Withdrawal by Subject|3|||
125619470|NCT01397448|451887730|FG000|Overall Study|Lack of Efficacy|2|||
125619471|NCT01397448|451887731|FG001|Overall Study|Lack of Efficacy|0|||
125619472|NCT01397448|451887732|FG002|Overall Study|Lack of Efficacy|5|||
125619473|NCT01397448|451887730|FG000|Overall Study|Other|8|||
125619474|NCT01397448|451887731|FG001|Overall Study|Other|7|||
125619475|NCT01397448|451887732|FG002|Overall Study|Other|4|||
125619476|NCT02159469|451887741|FG000|Overall Study|Missing Completion status|1|||
125619477|NCT02159469|451887741|FG000|Overall Study|Adverse Event|5|||
125619478|NCT02159469|451887741|FG000|Overall Study|Non-compliance|2|||
125619479|NCT02159469|451887741|FG000|Overall Study|Withdrawal by Subject|9|||
125619480|NCT02159469|451887741|FG000|Overall Study|Lost to Follow-up|1|||
125619481|NCT02159469|451887741|FG000|Overall Study|Sponsor's request|2|||
125619482|NCT02159469|451887741|FG000|Overall Study|Met Stopping Criteria|3|||
125619483|NCT02159469|451887741|FG000|Overall Study|Other|1|||
125619484|NCT02159469|451887741|FG000|Overall Study|Multiple|29|||
125619485|NCT02475395|451887742|FG000|Overall Study|Protocol Violation|30|||
125619486|NCT02475395|451887743|FG001|Overall Study|Protocol Violation|3|||
125619487|NCT00995670|451887744|FG000|Overall Study|Failed arterial cannulation|1|||
125619488|NCT00995670|451887745|FG001|Overall Study|Failed arterial cannulation|0|||
125619489|NCT00995670|451887746|FG002|Overall Study|Failed arterial cannulation|3|||
125619490|NCT00383721|451887747|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
125619491|NCT00383721|451887748|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
125619492|NCT00383721|451887749|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
125619493|NCT00383721|451887750|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
125619494|NCT00383721|451887751|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
125619495|NCT00383721|451887747|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
125619496|NCT00383721|451887748|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
125619497|NCT00383721|451887749|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
125619498|NCT00383721|451887750|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
125619499|NCT00383721|451887751|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
125619500|NCT00383721|451887747|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
125619501|NCT00383721|451887748|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
125215147|NCT02499263|450414916|FG000|Overall Study|Lost to Follow-up|9|||
125619502|NCT00383721|451887749|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
125619503|NCT00383721|451887750|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
125619504|NCT00383721|451887751|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
125619505|NCT00383721|451887747|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
125619506|NCT00383721|451887748|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
125619507|NCT00383721|451887749|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
125619508|NCT00383721|451887750|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
125619509|NCT00383721|451887751|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
125619510|NCT00383721|451887747|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
125619511|NCT00383721|451887748|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
125619512|NCT00383721|451887749|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
125619513|NCT00383721|451887750|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
125619514|NCT00383721|451887751|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
125619515|NCT00383721|451887747|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
125619516|NCT00383721|451887748|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
125619517|NCT00383721|451887749|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
125619518|NCT00383721|451887750|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
125619519|NCT00383721|451887751|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
125619520|NCT00383721|451887747|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
125619521|NCT00383721|451887748|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
125619522|NCT00383721|451887749|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
125619523|NCT00383721|451887750|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
125619524|NCT00383721|451887751|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
125619525|NCT00383721|451887747|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
125619526|NCT00383721|451887748|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
125619527|NCT00383721|451887749|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
125619528|NCT00383721|451887750|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
125619529|NCT00383721|451887751|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
125619530|NCT00383721|451887747|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
125619531|NCT00383721|451887748|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
125619532|NCT00383721|451887749|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
125619533|NCT00383721|451887750|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
125619534|NCT00383721|451887751|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
125619535|NCT00383721|451887747|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
125619536|NCT00383721|451887748|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
125619537|NCT00383721|451887749|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
125619538|NCT00383721|451887750|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
125619539|NCT00383721|451887751|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
125619540|NCT00383721|451887747|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
125619541|NCT00383721|451887748|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
125619542|NCT00383721|451887749|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
125619543|NCT00383721|451887750|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
125619544|NCT00383721|451887751|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
125619545|NCT00383721|451887747|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
125619546|NCT00383721|451887748|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
125619547|NCT00383721|451887749|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
125619548|NCT00383721|451887750|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
125619549|NCT00383721|451887751|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
125619550|NCT00383721|451887747|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
125619551|NCT00383721|451887748|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
125619552|NCT00383721|451887749|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
125619553|NCT00383721|451887750|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
125619554|NCT00383721|451887751|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
125619555|NCT00383721|451887747|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
125619556|NCT00383721|451887748|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
125619557|NCT00383721|451887749|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
125619558|NCT00383721|451887750|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
125619559|NCT00383721|451887751|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
125619560|NCT00383721|451887747|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
125215148|NCT02499263|450414916|FG000|Overall Study|Participant's withdrawal of consent|4|||
125215149|NCT02499263|450414916|FG000|Overall Study|Lack of Efficacy|22|||
125215150|NCT02499263|450414916|FG000|Overall Study|investigator's judgment|12|||
125215151|NCT02499263|450414916|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
125215152|NCT02499263|450414916|FG000|Overall Study|Participant's decision|3|||
125215153|NCT02499263|450414916|FG000|Overall Study|Pregnancy|1|||
125215154|NCT00184002|450414917|FG000|Overall Study|Adverse Event|9|||
125215155|NCT00184002|450414917|FG000|Overall Study|Death|3|||
125215156|NCT00184002|450414917|FG000|Overall Study|Physician Decision|1|||
125215157|NCT00184002|450414917|FG000|Overall Study|Withdrawal by Subject|4|||
125215158|NCT02075008|450414922|FG000|Overall Study|Technical problems|1|||
125619561|NCT00383721|451887748|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
125619562|NCT00383721|451887749|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
125619563|NCT00383721|451887750|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
125619564|NCT00383721|451887751|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
125619565|NCT00383721|451887747|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
125619566|NCT00383721|451887748|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
125619567|NCT00383721|451887749|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
125619568|NCT00383721|451887750|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
125619569|NCT00383721|451887751|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
125619570|NCT00383721|451887747|FG000|26-Week Treatment Safety Extension|Administrative|1|||
125619571|NCT00383721|451887748|FG001|26-Week Treatment Safety Extension|Administrative|2|||
125619572|NCT00383721|451887749|FG002|26-Week Treatment Safety Extension|Administrative|3|||
125619573|NCT00383721|451887750|FG003|26-Week Treatment Safety Extension|Administrative|1|||
125619574|NCT00383721|451887751|FG004|26-Week Treatment Safety Extension|Administrative|0|||
125619575|NCT03784027|451887759|FG000|Period 1|Withdrawal by Subject|0|||
125619576|NCT03784027|451887760|FG001|Period 1|Withdrawal by Subject|1|||
125215159|NCT02075008|450414922|FG000|Overall Study|Pregnancy|1|||
125215160|NCT02075008|450414922|FG000|Overall Study|Physician Decision|1|||
125215161|NCT02075008|450414922|FG000|Overall Study|Lost to Follow-up|1|||
125215162|NCT02075008|450414922|FG000|Overall Study|Lack of Efficacy|1|||
125215163|NCT02075008|450414922|FG000|Overall Study|Death|1|||
125215164|NCT02075008|450414922|FG000|Overall Study|Adverse Event|5|||
125215165|NCT02075008|450414922|FG000|Overall Study|Withdrawal by Subject|6|||
125215166|NCT02075008|450414922|FG000|Overall Study|Study terminated by Sponsor|159|||
125215167|NCT00660595|450414923|FG000|Overall Study|Lost to Follow-up|0|||
125215168|NCT00660595|450414924|FG001|Overall Study|Lost to Follow-up|1|||
125215169|NCT00660595|450414923|FG000|Overall Study|Did not consent to participate in study|12|||
125215170|NCT00660595|450414924|FG001|Overall Study|Did not consent to participate in study|8|||
125215171|NCT00660595|450414923|FG000|Overall Study|Participant left hospital|1|||
125215172|NCT00660595|450414924|FG001|Overall Study|Participant left hospital|0|||
125215173|NCT00660595|450414923|FG000|Overall Study|Non Specified reasons|5|||
125374295|NCT02042183|451000266|FG001|Overall Study|Lost to Follow-up|2|||
125374296|NCT01727297|451000267|FG000|Overall Study|Death|13|||
125374297|NCT01727297|451000268|FG001|Overall Study|Death|0|||
125374298|NCT01727297|451000267|FG000|Overall Study|Protocol Violation|1|||
125374299|NCT01727297|451000268|FG001|Overall Study|Protocol Violation|10|||
125374300|NCT01727297|451000267|FG000|Overall Study|Adverse Event|3|||
125374301|NCT01727297|451000268|FG001|Overall Study|Adverse Event|1|||
125374302|NCT01727297|451000267|FG000|Overall Study|Lost to Follow-up|11|||
125374303|NCT01727297|451000268|FG001|Overall Study|Lost to Follow-up|0|||
125619577|NCT03297216|451890288|FG000|Overall Study|Death|0|||
125215174|NCT00660595|450414924|FG001|Overall Study|Non Specified reasons|0|||
125215175|NCT00493311|450414925|FG000|Overall Study|Need for rescue medication|2|||
125215176|NCT00493311|450414926|FG001|Overall Study|Need for rescue medication|2|||
125215177|NCT02779075|450414927|FG000|Overall Study|Withdrawal by Subject|1|||
125374304|NCT01727297|451000267|FG000|Overall Study|Withdrawal by Subject|26|||
125374305|NCT01727297|451000268|FG001|Overall Study|Withdrawal by Subject|27|||
125374306|NCT01727297|451000267|FG000|Overall Study|Physician Decision|19|||
125374307|NCT01727297|451000268|FG001|Overall Study|Physician Decision|5|||
125374308|NCT01727297|451000267|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
125374309|NCT01727297|451000268|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
125619578|NCT03297216|451890289|FG001|Overall Study|Death|1|||
125619579|NCT03297216|451890288|FG000|Overall Study|Miscarriage|0|||
125619580|NCT03297216|451890289|FG001|Overall Study|Miscarriage|2|||
125619581|NCT03297216|451890288|FG000|Overall Study|Lost to Follow-up|3|||
125619582|NCT03297216|451890289|FG001|Overall Study|Lost to Follow-up|2|||
125619583|NCT01253187|451890296|FG000|Period 2|Withdrawal by Subject|0|||
125619584|NCT01253187|451890297|FG001|Period 2|Withdrawal by Subject|0|||
125619585|NCT01253187|451890298|FG002|Period 2|Withdrawal by Subject|0|||
125619586|NCT01253187|451890299|FG003|Period 2|Withdrawal by Subject|0|||
125619587|NCT01253187|451890300|FG004|Period 2|Withdrawal by Subject|1|||
125619588|NCT01253187|451890301|FG005|Period 2|Withdrawal by Subject|0|||
125619589|NCT01253187|451890296|FG000|Period 3|Pregnancy|1|||
125619590|NCT01253187|451890297|FG001|Period 3|Pregnancy|0|||
125619591|NCT01253187|451890298|FG002|Period 3|Pregnancy|0|||
125619592|NCT01253187|451890299|FG003|Period 3|Pregnancy|0|||
125619593|NCT01253187|451890300|FG004|Period 3|Pregnancy|0|||
125619594|NCT01253187|451890301|FG005|Period 3|Pregnancy|0|||
125619595|NCT01253187|451890296|FG000|Period 3|difficulty with blood sampling|0|||
125619596|NCT01253187|451890297|FG001|Period 3|difficulty with blood sampling|1|||
125619597|NCT01253187|451890298|FG002|Period 3|difficulty with blood sampling|0|||
125619598|NCT01253187|451890299|FG003|Period 3|difficulty with blood sampling|0|||
125619599|NCT01253187|451890300|FG004|Period 3|difficulty with blood sampling|0|||
125619600|NCT01253187|451890301|FG005|Period 3|difficulty with blood sampling|0|||
125619601|NCT01253187|451890296|FG000|Period 3|non-compliance|0|||
125619602|NCT01253187|451890297|FG001|Period 3|non-compliance|0|||
125619603|NCT01253187|451890298|FG002|Period 3|non-compliance|0|||
125619604|NCT01253187|451890299|FG003|Period 3|non-compliance|0|||
125619605|NCT01253187|451890300|FG004|Period 3|non-compliance|1|||
125619606|NCT01253187|451890301|FG005|Period 3|non-compliance|0|||
125619607|NCT02680587|451890304|FG000|Overall Study|Withdrawal by Subject|1|||
125619608|NCT02680587|451890305|FG001|Overall Study|Withdrawal by Subject|0|||
125619609|NCT02899377|451890306|FG000|Overall Study|Adverse Event|1|||
125619610|NCT02899377|451890307|FG001|Overall Study|Adverse Event|0|||
125619611|NCT00469209|451890308|FG000|Overall Study|Adverse Event|1|||
125619612|NCT00469209|451890309|FG001|Overall Study|Adverse Event|0|||
125619613|NCT00469209|451890310|FG002|Overall Study|Adverse Event|1|||
125619614|NCT00712933|451890313|FG000|Overall Study|Adverse Event|69|||
125619615|NCT00712933|451890313|FG000|Overall Study|Lack of Efficacy|6|||
125619616|NCT00712933|451890313|FG000|Overall Study|Lost to Follow-up|22|||
125619617|NCT00712933|451890313|FG000|Overall Study|Non-compliance with study drug|13|||
125619618|NCT00712933|451890313|FG000|Overall Study|Other Pregnancy|37|||
125619619|NCT00712933|451890313|FG000|Overall Study|Sponsor decision|14|||
125619620|NCT00712933|451890313|FG000|Overall Study|Withdrew consent|4|||
125619621|NCT00712933|451890313|FG000|Overall Study|Hip replacement surgery|1|||
125619622|NCT00712933|451890313|FG000|Overall Study|Involved in Clinical research|3|||
125619623|NCT00712933|451890313|FG000|Overall Study|Participant hospitalized|1|||
125619624|NCT00712933|451890313|FG000|Overall Study|Participant travelled overseas|2|||
125374310|NCT01192516|451000269|FG000|Overall Study|Lost to Follow-up|7|||
125619625|NCT00712933|451890313|FG000|Overall Study|Death of patient|1|||
125619626|NCT00712933|451890313|FG000|Overall Study|Other Physician decision|1|||
125619627|NCT00712933|451890313|FG000|Overall Study|Not committed to contraception|1|||
125619628|NCT00712933|451890313|FG000|Overall Study|Participant received medication|1|||
125619629|NCT00712933|451890313|FG000|Overall Study|Physician Decision|36|||
125619630|NCT00712933|451890313|FG000|Overall Study|Protocol Violation|4|||
125619631|NCT00712933|451890313|FG000|Overall Study|Withdrawal by Subject|151|||
125619632|NCT01295580|451890314|FG000|Overall Study|Protocol Violation|4|||
125215178|NCT02779075|450414928|FG001|Overall Study|Withdrawal by Subject|3|||
125215179|NCT02779075|450414927|FG000|Overall Study|IV lost during 2nd study|1|||
125215180|NCT02779075|450414928|FG001|Overall Study|IV lost during 2nd study|0|||
125215181|NCT03959527|450414929|FG000|Overall Study|Withdrawal by Subject|8|||
125215182|NCT03959527|450414930|FG001|Overall Study|Withdrawal by Subject|3|||
125215183|NCT03959527|450414929|FG000|Overall Study|Lost to Follow-up|31|||
125215184|NCT03959527|450414930|FG001|Overall Study|Lost to Follow-up|15|||
125433113|NCT00085202|451212437|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
125215185|NCT03959527|450414929|FG000|Overall Study|Did not meet eligibility criteria|1|||
125619633|NCT01295580|451890315|FG001|Overall Study|Protocol Violation|2|||
125619634|NCT01295580|451890314|FG000|Overall Study|Withdrawal by Subject|1|||
125619635|NCT01295580|451890315|FG001|Overall Study|Withdrawal by Subject|4|||
125619636|NCT01295580|451890314|FG000|Overall Study|Adverse Event|2|||
125619637|NCT01295580|451890315|FG001|Overall Study|Adverse Event|1|||
125619638|NCT01295580|451890314|FG000|Overall Study|Lost to Follow-up|1|||
125619639|NCT01295580|451890315|FG001|Overall Study|Lost to Follow-up|0|||
125619640|NCT01295580|451890314|FG000|Overall Study|Lack of Efficacy|1|||
125619641|NCT01295580|451890315|FG001|Overall Study|Lack of Efficacy|0|||
125619642|NCT01295580|451890314|FG000|Overall Study|Other: inconvenience|1|||
125619643|NCT01295580|451890315|FG001|Overall Study|Other: inconvenience|0|||
125619644|NCT01295580|451890314|FG000|Overall Study|Other: family objection|0|||
125619645|NCT01295580|451890315|FG001|Overall Study|Other: family objection|1|||
125619646|NCT02022033|451890316|FG000|Overall Study|Physician Decision|1|||
125619647|NCT01103778|451890317|FG000|Overall Study|Lost to Follow-up|1|||
125619648|NCT01103778|451890317|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
125619649|NCT01103778|451890317|FG000|Overall Study|Screen failure|1|||
125619650|NCT03067129|451890318|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
125619651|NCT03067129|451890319|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
125619652|NCT03067129|451890320|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
125619653|NCT03067129|451890321|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
125619654|NCT03067129|451890318|FG000|Overall Study|Withdrawal by Subject|0|||
125619655|NCT03067129|451890319|FG001|Overall Study|Withdrawal by Subject|0|||
125619656|NCT03067129|451890320|FG002|Overall Study|Withdrawal by Subject|1|||
125619657|NCT03067129|451890321|FG003|Overall Study|Withdrawal by Subject|2|||
125619658|NCT03067129|451890318|FG000|Overall Study|Lost to Follow-up|5|||
125619659|NCT03067129|451890319|FG001|Overall Study|Lost to Follow-up|5|||
125619660|NCT03067129|451890320|FG002|Overall Study|Lost to Follow-up|4|||
125619661|NCT03067129|451890321|FG003|Overall Study|Lost to Follow-up|3|||
125619662|NCT03986190|451890322|FG000|Overall Study|Withdrawal by Subject|12|||
125619663|NCT03986190|451890323|FG001|Overall Study|Withdrawal by Subject|0|||
125619664|NCT04929613|451890324|FG000|Overall Study|Withdrawal by Subject|12|||
125619665|NCT00865189|451890325|FG000|Overall Study|Other|1|||
125619666|NCT00865189|451890326|FG001|Overall Study|Other|2|||
125619667|NCT00865189|451890325|FG000|Overall Study|Death|4|||
125619668|NCT00865189|451890326|FG001|Overall Study|Death|11|||
125619669|NCT00865189|451890325|FG000|Overall Study|Lost to Follow-up|6|||
125619670|NCT00865189|451890326|FG001|Overall Study|Lost to Follow-up|6|||
125619671|NCT00865189|451890325|FG000|Overall Study|Withdrawal by Subject|1|||
125374311|NCT01192516|451000270|FG001|Overall Study|Lost to Follow-up|10|||
125619672|NCT00865189|451890326|FG001|Overall Study|Withdrawal by Subject|0|||
125619673|NCT01464788|451890340|FG000|Overall Study|Lost to Follow-up|0|||
125374312|NCT01192516|451000271|FG002|Overall Study|Lost to Follow-up|7|||
125619674|NCT01464788|451890341|FG001|Overall Study|Lost to Follow-up|1|||
125619675|NCT01464788|451890342|FG002|Overall Study|Lost to Follow-up|0|||
125619676|NCT01464788|451890340|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
125619677|NCT01464788|451890341|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
125619678|NCT01464788|451890342|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
125619679|NCT00418379|451890345|FG000|Year 1|Adverse Event|9|||
125619680|NCT00418379|451890346|FG001|Year 1|Adverse Event|15|||
125619681|NCT00418379|451890347|FG002|Year 1|Adverse Event|3|||
125619682|NCT00418379|451890345|FG000|Year 1|Withdrawal by Subject|7|||
125619683|NCT00418379|451890346|FG001|Year 1|Withdrawal by Subject|8|||
125619684|NCT00418379|451890347|FG002|Year 1|Withdrawal by Subject|5|||
125619685|NCT00418379|451890345|FG000|Year 1|Any other reason not above-mentioned|2|||
125619686|NCT00418379|451890346|FG001|Year 1|Any other reason not above-mentioned|5|||
125619687|NCT00418379|451890347|FG002|Year 1|Any other reason not above-mentioned|7|||
125619688|NCT00418379|451890345|FG000|Year 2|Adverse Event|5|||
125619689|NCT00418379|451890346|FG001|Year 2|Adverse Event|2|||
125619690|NCT00418379|451890347|FG002|Year 2|Adverse Event|1|||
125619691|NCT00418379|451890345|FG000|Year 2|Withdrawal by Subject|1|||
125619692|NCT00418379|451890346|FG001|Year 2|Withdrawal by Subject|1|||
125619693|NCT00418379|451890347|FG002|Year 2|Withdrawal by Subject|3|||
125619694|NCT00418379|451890345|FG000|Year 2|Any other reason not above-mentioned|2|||
125619695|NCT00418379|451890346|FG001|Year 2|Any other reason not above-mentioned|1|||
125619696|NCT00418379|451890347|FG002|Year 2|Any other reason not above-mentioned|6|||
125619697|NCT00418379|451890345|FG000|Year 3|Withdrawal by Subject|1|||
125619698|NCT00418379|451890346|FG001|Year 3|Withdrawal by Subject|1|||
125619699|NCT00418379|451890347|FG002|Year 3|Withdrawal by Subject|2|||
125619700|NCT00418379|451890345|FG000|Year 3|Any other reason not above-mentioned|2|||
125619701|NCT00418379|451890346|FG001|Year 3|Any other reason not above-mentioned|1|||
125619702|NCT00418379|451890347|FG002|Year 3|Any other reason not above-mentioned|1|||
125619703|NCT00418379|451890345|FG000|Year 4|Adverse Event|0|||
125619704|NCT00418379|451890346|FG001|Year 4|Adverse Event|1|||
125619705|NCT00418379|451890347|FG002|Year 4|Adverse Event|0|||
125619706|NCT00418379|451890345|FG000|Year 4|Withdrawal by Subject|2|||
125619707|NCT00418379|451890346|FG001|Year 4|Withdrawal by Subject|3|||
125619708|NCT00418379|451890347|FG002|Year 4|Withdrawal by Subject|2|||
125619709|NCT00418379|451890345|FG000|Year 4|Any other reason not above-mentioned|1|||
125619710|NCT00418379|451890346|FG001|Year 4|Any other reason not above-mentioned|1|||
125619711|NCT00418379|451890347|FG002|Year 4|Any other reason not above-mentioned|0|||
125619712|NCT00418379|451890345|FG000|Year 5|Adverse Event|0|||
125619713|NCT00418379|451890346|FG001|Year 5|Adverse Event|1|||
125619714|NCT00418379|451890347|FG002|Year 5|Adverse Event|0|||
125619715|NCT00418379|451890345|FG000|Year 5|Any other reason not above-mentioned|2|||
125619716|NCT00418379|451890346|FG001|Year 5|Any other reason not above-mentioned|4|||
125619717|NCT00418379|451890347|FG002|Year 5|Any other reason not above-mentioned|3|||
125619718|NCT00565058|451890348|FG000|Overall Study|Adverse Event|1|||
125619719|NCT00565058|451890349|FG001|Overall Study|Adverse Event|0|||
125619720|NCT00830804|451890350|FG000|Overall Study|Lost to Follow-up|4|||
125619721|NCT00830804|451890350|FG000|Overall Study|Death|1|||
125619722|NCT00830804|451890350|FG000|Overall Study|Unable to get to clinic|7|||
125619723|NCT00830804|451890350|FG000|Overall Study|Consent withdrawn|2|||
125619724|NCT00830804|451890350|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
125619725|NCT00510068|451890351|FG000|Double-blind Period|Disease progression|98|||
125619726|NCT00510068|451890352|FG001|Double-blind Period|Disease progression|169|||
125619727|NCT00510068|451890351|FG000|Double-blind Period|Final primary analysis|52|||
125619728|NCT00510068|451890352|FG001|Double-blind Period|Final primary analysis|18|||
125619729|NCT00510068|451890351|FG000|Double-blind Period|Adverse Event|37|||
125619730|NCT00510068|451890352|FG001|Double-blind Period|Adverse Event|7|||
125619731|NCT00510068|451890351|FG000|Double-blind Period|Withdrawal by Subject|8|||
125619732|NCT00510068|451890352|FG001|Double-blind Period|Withdrawal by Subject|6|||
125619733|NCT00510068|451890351|FG000|Double-blind Period|Death|4|||
125619734|NCT00510068|451890352|FG001|Double-blind Period|Death|3|||
125619735|NCT00510068|451890351|FG000|Double-blind Period|Abnormal test result (s)|1|||
125619736|NCT00510068|451890352|FG001|Double-blind Period|Abnormal test result (s)|0|||
125619737|NCT00510068|451890351|FG000|Double-blind Period|Lost to Follow-up|1|||
125619738|NCT00510068|451890352|FG001|Double-blind Period|Lost to Follow-up|0|||
125619739|NCT00510068|451890351|FG000|Double-blind Period|Protocol Violation|6|||
125619740|NCT00510068|451890352|FG001|Double-blind Period|Protocol Violation|0|||
125215186|NCT03959527|450414930|FG001|Overall Study|Did not meet eligibility criteria|1|||
125215187|NCT03959527|450414929|FG000|Overall Study|Protocol Violation|10|||
125215188|NCT03959527|450414930|FG001|Overall Study|Protocol Violation|5|||
125215189|NCT00707980|450414931|FG000|Overall Study|Adverse Event|49|||
125215190|NCT00707980|450414931|FG000|Overall Study|Lack of Efficacy|35|||
125619741|NCT00510068|451890351|FG000|Open-label Period|Disease Progression|124|||
125619742|NCT00510068|451890352|FG001|Open-label Period|Disease Progression|0|||
125619743|NCT00510068|451890351|FG000|Open-label Period|Adverse Event|46|||
125619744|NCT00510068|451890352|FG001|Open-label Period|Adverse Event|0|||
125619745|NCT00510068|451890351|FG000|Open-label Period|Withdrawal by Subject|21|||
125619746|NCT00510068|451890352|FG001|Open-label Period|Withdrawal by Subject|0|||
125619747|NCT00510068|451890351|FG000|Open-label Period|Administrative problems|17|||
125619748|NCT00510068|451890352|FG001|Open-label Period|Administrative problems|0|||
125619749|NCT00510068|451890351|FG000|Open-label Period|Death|7|||
125619750|NCT00510068|451890352|FG001|Open-label Period|Death|0|||
125619751|NCT00510068|451890351|FG000|Open-label Period|New cancer therapy|7|||
125619752|NCT00510068|451890352|FG001|Open-label Period|New cancer therapy|0|||
125619753|NCT00510068|451890351|FG000|Open-label Period|Protocol Violation|2|||
125619754|NCT00510068|451890352|FG001|Open-label Period|Protocol Violation|0|||
125619755|NCT00510068|451890351|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
125619756|NCT00510068|451890352|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
125619757|NCT02180217|451890353|FG000|Overall Study|Adverse Event|3|||
125619758|NCT02180217|451890354|FG001|Overall Study|Adverse Event|2|||
125619759|NCT02180217|451890355|FG002|Overall Study|Adverse Event|22|||
125619760|NCT02180217|451890353|FG000|Overall Study|Death|1|||
125619761|NCT02180217|451890354|FG001|Overall Study|Death|1|||
125619762|NCT02180217|451890355|FG002|Overall Study|Death|0|||
125619763|NCT02180217|451890353|FG000|Overall Study|Withdrawal by Subject|1|||
125619764|NCT02180217|451890354|FG001|Overall Study|Withdrawal by Subject|1|||
125619765|NCT02180217|451890355|FG002|Overall Study|Withdrawal by Subject|4|||
125619766|NCT02180217|451890353|FG000|Overall Study|Subject/Guardian decision|5|||
125619767|NCT02180217|451890354|FG001|Overall Study|Subject/Guardian decision|3|||
125619768|NCT02180217|451890355|FG002|Overall Study|Subject/Guardian decision|6|||
125619769|NCT02180217|451890353|FG000|Overall Study|Physician Decision|1|||
125619770|NCT02180217|451890354|FG001|Overall Study|Physician Decision|1|||
125619771|NCT02180217|451890355|FG002|Overall Study|Physician Decision|6|||
125619772|NCT02180217|451890353|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125619773|NCT02180217|451890354|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125619774|NCT02180217|451890355|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125619775|NCT00645567|451890356|FG000|Overall Study|Adverse Event|1|||
125619776|NCT04664855|451890357|FG000|Overall Study|Withdrawal by Subject|0|||
125619777|NCT04664855|451890358|FG001|Overall Study|Withdrawal by Subject|2|||
125215191|NCT00707980|450414931|FG000|Overall Study|Non-Compliance with Study Drug|28|||
125215192|NCT00707980|450414931|FG000|Overall Study|Protocol Deviations|19|||
125619778|NCT02219087|451890359|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
125619779|NCT02219087|451890360|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
125619780|NCT03730194|451890366|FG000|First Stage Treatment|Withdrawal by Subject|1|||
125619781|NCT03730194|451890367|FG001|First Stage Treatment|Withdrawal by Subject|1|||
125619782|NCT03730194|451890368|FG002|First Stage Treatment|Withdrawal by Subject|0|||
125619783|NCT03730194|451890369|FG003|First Stage Treatment|Withdrawal by Subject|0|||
125215193|NCT00707980|450414931|FG000|Overall Study|Withdrawal of Consent|81|||
125215194|NCT00707980|450414931|FG000|Overall Study|Lost to Follow-up|59|||
125215195|NCT00707980|450414931|FG000|Overall Study|Other|39|||
125374313|NCT01192516|451000269|FG000|Overall Study|Withdrawal by Subject|4|||
125619784|NCT03730194|451890370|FG004|First Stage Treatment|Withdrawal by Subject|0|||
125619785|NCT03730194|451890371|FG005|First Stage Treatment|Withdrawal by Subject|0|||
125619786|NCT03730194|451890366|FG000|First Stage Treatment|Protocol Violation|3|||
125619787|NCT03730194|451890367|FG001|First Stage Treatment|Protocol Violation|3|||
125619788|NCT03730194|451890368|FG002|First Stage Treatment|Protocol Violation|0|||
125619789|NCT03730194|451890369|FG003|First Stage Treatment|Protocol Violation|0|||
125619790|NCT03730194|451890370|FG004|First Stage Treatment|Protocol Violation|0|||
125619791|NCT03730194|451890371|FG005|First Stage Treatment|Protocol Violation|0|||
125619792|NCT00870818|451890374|FG000|Overall Study|Lost to Follow-up|3|||
125619793|NCT00870818|451890375|FG001|Overall Study|Lost to Follow-up|2|||
125619794|NCT00870818|451890376|FG002|Overall Study|Lost to Follow-up|1|||
125619795|NCT00870818|451890377|FG003|Overall Study|Lost to Follow-up|0|||
125619796|NCT00870818|451890378|FG004|Overall Study|Lost to Follow-up|0|||
125619797|NCT00870818|451890374|FG000|Overall Study|Withdrawal by Subject|0|||
125619798|NCT00870818|451890375|FG001|Overall Study|Withdrawal by Subject|0|||
125619799|NCT00870818|451890376|FG002|Overall Study|Withdrawal by Subject|1|||
125619800|NCT00870818|451890377|FG003|Overall Study|Withdrawal by Subject|2|||
125619801|NCT00870818|451890378|FG004|Overall Study|Withdrawal by Subject|0|||
125619802|NCT00870818|451890374|FG000|Overall Study|Terminated by sponsor|29|||
125619803|NCT00870818|451890375|FG001|Overall Study|Terminated by sponsor|70|||
125619804|NCT00870818|451890376|FG002|Overall Study|Terminated by sponsor|36|||
125619805|NCT00870818|451890377|FG003|Overall Study|Terminated by sponsor|36|||
125619806|NCT00870818|451890378|FG004|Overall Study|Terminated by sponsor|38|||
125619807|NCT00870818|451890374|FG000|Overall Study|Other|0|||
125619808|NCT00870818|451890375|FG001|Overall Study|Other|1|||
125619809|NCT00870818|451890376|FG002|Overall Study|Other|0|||
125619810|NCT00870818|451890377|FG003|Overall Study|Other|0|||
125619811|NCT00870818|451890378|FG004|Overall Study|Other|0|||
125619812|NCT00178464|451890379|FG000|Overall Study|Withdrawal by Subject|1|||
125619813|NCT00178464|451890379|FG000|Overall Study|Physician Decision|1|||
125619814|NCT02227108|451890380|FG000|Overall Study|Did not receive treatment|2|||
125619815|NCT02227108|451890380|FG000|Overall Study|Other|3|||
125619816|NCT02227108|451890380|FG000|Overall Study|Progressive disease|17|||
125619817|NCT02227108|451890380|FG000|Overall Study|Initiation of alternative therapy|2|||
125619818|NCT02227108|451890380|FG000|Overall Study|Investigator discretion|1|||
125619819|NCT02227108|451890380|FG000|Overall Study|Adverse Event|6|||
125619820|NCT04900038|451890381|FG000|Overall Study|Adverse Event|1|||
125619821|NCT04900038|451890382|FG001|Overall Study|Adverse Event|0|||
125619822|NCT04900038|451890383|FG002|Overall Study|Adverse Event|1|||
125619823|NCT04900038|451890384|FG003|Overall Study|Adverse Event|1|||
125619824|NCT04900038|451890381|FG000|Overall Study|Withdrawal by Subject|0|||
125619825|NCT04900038|451890382|FG001|Overall Study|Withdrawal by Subject|1|||
125619826|NCT04900038|451890383|FG002|Overall Study|Withdrawal by Subject|0|||
125619827|NCT04900038|451890384|FG003|Overall Study|Withdrawal by Subject|0|||
125619828|NCT04900038|451890381|FG000|Overall Study|Study terminated by sponsor|18|||
125619829|NCT04900038|451890382|FG001|Overall Study|Study terminated by sponsor|15|||
125619830|NCT04900038|451890383|FG002|Overall Study|Study terminated by sponsor|17|||
125619831|NCT04900038|451890384|FG003|Overall Study|Study terminated by sponsor|14|||
125619832|NCT04900038|451890381|FG000|Overall Study|Protocol Deviation|1|||
125619833|NCT04900038|451890382|FG001|Overall Study|Protocol Deviation|1|||
125619834|NCT04900038|451890383|FG002|Overall Study|Protocol Deviation|0|||
125619835|NCT04900038|451890384|FG003|Overall Study|Protocol Deviation|0|||
125619836|NCT04900038|451890381|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
125619837|NCT04900038|451890382|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
125619838|NCT04900038|451890383|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
125619839|NCT04900038|451890384|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
125619840|NCT04900038|451890381|FG000|Overall Study|Lost to Follow-up|0|||
125619841|NCT04900038|451890382|FG001|Overall Study|Lost to Follow-up|0|||
125619842|NCT04900038|451890383|FG002|Overall Study|Lost to Follow-up|0|||
125619843|NCT04900038|451890384|FG003|Overall Study|Lost to Follow-up|1|||
125619844|NCT02486952|451890385|FG000|Overall Study|Not Started Induction Therapy|3|||
125619845|NCT02486952|451890385|FG000|Overall Study|Adverse Event|1|||
125619846|NCT02486952|451890385|FG000|Overall Study|Death|15|||
125619847|NCT02486952|451890385|FG000|Overall Study|Lack of Efficacy|3|||
125619848|NCT02486952|451890385|FG000|Overall Study|Lost to Follow-up|26|||
125619849|NCT02486952|451890385|FG000|Overall Study|Other|2|||
125619850|NCT04111107|451890386|FG000|Overall Study|Withdrawal by Subject|6|||
125619851|NCT04111107|451890386|FG000|Overall Study|Declining Health|5|||
125619852|NCT01928485|451890387|FG000|Overall Study|Physician Decision|0|||
125619853|NCT01928485|451890388|FG001|Overall Study|Physician Decision|1|||
125619854|NCT03814590|451890391|FG000|Overall Study|Adverse Event|0|||
125619855|NCT03814590|451890392|FG001|Overall Study|Adverse Event|0|||
125619856|NCT03814590|451890393|FG002|Overall Study|Adverse Event|0|||
125619857|NCT03814590|451890394|FG003|Overall Study|Adverse Event|0|||
125619858|NCT03814590|451890395|FG004|Overall Study|Adverse Event|0|||
125619859|NCT03814590|451890396|FG005|Overall Study|Adverse Event|1|||
125374314|NCT01192516|451000270|FG001|Overall Study|Withdrawal by Subject|4|||
125374315|NCT01192516|451000271|FG002|Overall Study|Withdrawal by Subject|1|||
125374316|NCT01192516|451000269|FG000|Overall Study|started new treatment|5|||
125619860|NCT03814590|451890397|FG006|Overall Study|Adverse Event|1|||
125619861|NCT03814590|451890398|FG007|Overall Study|Adverse Event|1|||
125619862|NCT03814590|451890399|FG008|Overall Study|Adverse Event|0|||
125619863|NCT03814590|451890400|FG009|Overall Study|Adverse Event|0|||
125619864|NCT03814590|451890401|FG010|Overall Study|Adverse Event|1|||
125619865|NCT03814590|451890402|FG011|Overall Study|Adverse Event|0|||
125619866|NCT03814590|451890403|FG012|Overall Study|Adverse Event|3|||
125619867|NCT03814590|451890404|FG013|Overall Study|Adverse Event|0|||
125619868|NCT03814590|451890391|FG000|Overall Study|Lost to Follow-up|0|||
125619869|NCT03814590|451890392|FG001|Overall Study|Lost to Follow-up|2|||
125619870|NCT03814590|451890393|FG002|Overall Study|Lost to Follow-up|1|||
125619871|NCT03814590|451890394|FG003|Overall Study|Lost to Follow-up|0|||
125619872|NCT03814590|451890395|FG004|Overall Study|Lost to Follow-up|1|||
125619873|NCT03814590|451890396|FG005|Overall Study|Lost to Follow-up|1|||
125619874|NCT03814590|451890397|FG006|Overall Study|Lost to Follow-up|1|||
125619875|NCT03814590|451890398|FG007|Overall Study|Lost to Follow-up|1|||
125619876|NCT03814590|451890399|FG008|Overall Study|Lost to Follow-up|0|||
125619877|NCT03814590|451890400|FG009|Overall Study|Lost to Follow-up|0|||
125619878|NCT03814590|451890401|FG010|Overall Study|Lost to Follow-up|1|||
125619879|NCT03814590|451890402|FG011|Overall Study|Lost to Follow-up|0|||
125619880|NCT03814590|451890403|FG012|Overall Study|Lost to Follow-up|0|||
125619881|NCT03814590|451890404|FG013|Overall Study|Lost to Follow-up|1|||
125619882|NCT03814590|451890391|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125619883|NCT03814590|451890392|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125619884|NCT03814590|451890393|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125619885|NCT03814590|451890394|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125619886|NCT03814590|451890395|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125619887|NCT03814590|451890396|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125619888|NCT03814590|451890397|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125619889|NCT03814590|451890398|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125619890|NCT03814590|451890399|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125619891|NCT03814590|451890400|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
125619892|NCT03814590|451890401|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125619893|NCT03814590|451890402|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125619894|NCT03814590|451890403|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125619895|NCT03814590|451890404|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
125215196|NCT01152996|450414932|FG000|Overall Study|Withdrawal by Subject|142|||
125619896|NCT03814590|451890391|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125619897|NCT03814590|451890392|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125215197|NCT01152996|450414932|FG000|Overall Study|Adverse Event|115|||
125374317|NCT01192516|451000270|FG001|Overall Study|started new treatment|1|||
125374318|NCT01192516|451000271|FG002|Overall Study|started new treatment|0|||
125637262|NCT03073200|451952838|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125619898|NCT03814590|451890393|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125619899|NCT03814590|451890394|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125619900|NCT03814590|451890395|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125619901|NCT03814590|451890396|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
125619902|NCT03814590|451890397|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
125619903|NCT03814590|451890398|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
125619904|NCT03814590|451890399|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125619905|NCT03814590|451890400|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
125619906|NCT03814590|451890401|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
125619907|NCT03814590|451890402|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
125619908|NCT03814590|451890403|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
125619909|NCT03814590|451890404|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
125619910|NCT03814590|451890391|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125619911|NCT03814590|451890392|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125619912|NCT03814590|451890393|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125619913|NCT03814590|451890394|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125619914|NCT03814590|451890395|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125619915|NCT03814590|451890396|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125619916|NCT03814590|451890397|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125619917|NCT03814590|451890398|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125619918|NCT03814590|451890399|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125619919|NCT03814590|451890400|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125619920|NCT03814590|451890401|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125619921|NCT03814590|451890402|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125619922|NCT03814590|451890403|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125619923|NCT03814590|451890404|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125619924|NCT03814590|451890391|FG000|Overall Study|UNKNOWN REASON|0|||
125619925|NCT03814590|451890392|FG001|Overall Study|UNKNOWN REASON|0|||
125619926|NCT03814590|451890393|FG002|Overall Study|UNKNOWN REASON|0|||
125619927|NCT03814590|451890394|FG003|Overall Study|UNKNOWN REASON|0|||
125619928|NCT03814590|451890395|FG004|Overall Study|UNKNOWN REASON|0|||
125619929|NCT03814590|451890396|FG005|Overall Study|UNKNOWN REASON|0|||
125619930|NCT03814590|451890397|FG006|Overall Study|UNKNOWN REASON|0|||
125619931|NCT03814590|451890398|FG007|Overall Study|UNKNOWN REASON|1|||
125619932|NCT03814590|451890399|FG008|Overall Study|UNKNOWN REASON|0|||
125619933|NCT03814590|451890400|FG009|Overall Study|UNKNOWN REASON|0|||
125619934|NCT03814590|451890401|FG010|Overall Study|UNKNOWN REASON|0|||
125619935|NCT03814590|451890402|FG011|Overall Study|UNKNOWN REASON|0|||
125619936|NCT03814590|451890403|FG012|Overall Study|UNKNOWN REASON|0|||
125619937|NCT03814590|451890404|FG013|Overall Study|UNKNOWN REASON|0|||
125619938|NCT00567541|451890406|FG000|Overall Study|Adverse Event|0|||
125619939|NCT00567541|451890407|FG001|Overall Study|Adverse Event|1|||
125619940|NCT01890512|451890410|FG000|Overall Study|Physician Decision|1|||
125619941|NCT01890512|451890410|FG000|Overall Study|Withdrawal by Subject|1|||
125619942|NCT01890512|451890410|FG000|Overall Study|Protocol Violation|1|||
125619943|NCT03519516|451890411|FG000|Overall Study|Adverse Event|0|||
125619944|NCT03519516|451890412|FG001|Overall Study|Adverse Event|1|||
125619945|NCT01935336|451890413|FG000|Overall Study|Adverse Event|1|||
125619946|NCT01935336|451890414|FG001|Overall Study|Adverse Event|0|||
125619947|NCT01935336|451890415|FG002|Overall Study|Adverse Event|0|||
125619948|NCT01935336|451890416|FG003|Overall Study|Adverse Event|0|||
125619949|NCT01935336|451890413|FG000|Overall Study|Progressive disease|5|||
125619950|NCT01935336|451890414|FG001|Overall Study|Progressive disease|3|||
125619951|NCT01935336|451890415|FG002|Overall Study|Progressive disease|47|||
125619952|NCT01935336|451890416|FG003|Overall Study|Progressive disease|66|||
125619953|NCT01529385|451890417|FG000|Overall Study|Lost to Follow-up|2|||
125619954|NCT01529385|451890418|FG001|Overall Study|Lost to Follow-up|1|||
125619955|NCT00964158|451890421|FG000|Overall Study|Lost to Follow-up|0|||
125619956|NCT00964158|451890422|FG001|Overall Study|Lost to Follow-up|1|||
125619957|NCT00964158|451890423|FG002|Overall Study|Lost to Follow-up|2|||
125619958|NCT00964158|451890421|FG000|Overall Study|Withdrawal by Subject|0|||
125619959|NCT00964158|451890422|FG001|Overall Study|Withdrawal by Subject|0|||
125619960|NCT00964158|451890423|FG002|Overall Study|Withdrawal by Subject|6|||
125619961|NCT01763866|451890430|FG000|Overall Study|Withdrawal by Subject|2|||
125619962|NCT01763866|451890431|FG001|Overall Study|Withdrawal by Subject|1|||
125619963|NCT01763866|451890432|FG002|Overall Study|Withdrawal by Subject|4|||
125619964|NCT01763866|451890433|FG003|Overall Study|Withdrawal by Subject|0|||
125619965|NCT01763866|451890434|FG004|Overall Study|Withdrawal by Subject|0|||
125619966|NCT01763866|451890435|FG005|Overall Study|Withdrawal by Subject|3|||
125619967|NCT01763866|451890436|FG006|Overall Study|Withdrawal by Subject|4|||
125619968|NCT01763866|451890437|FG007|Overall Study|Withdrawal by Subject|0|||
125619969|NCT01763866|451890438|FG008|Overall Study|Withdrawal by Subject|1|||
125619970|NCT01763866|451890439|FG009|Overall Study|Withdrawal by Subject|1|||
125619971|NCT01763866|451890440|FG010|Overall Study|Withdrawal by Subject|2|||
125619972|NCT01763866|451890441|FG011|Overall Study|Withdrawal by Subject|2|||
125619973|NCT01763866|451890442|FG012|Overall Study|Withdrawal by Subject|2|||
125619974|NCT01763866|451890443|FG013|Overall Study|Withdrawal by Subject|0|||
125619975|NCT01763866|451890444|FG014|Overall Study|Withdrawal by Subject|6|||
125619976|NCT01763866|451890445|FG015|Overall Study|Withdrawal by Subject|3|||
125619977|NCT01763866|451890446|FG016|Overall Study|Withdrawal by Subject|0|||
125619978|NCT01763866|451890447|FG017|Overall Study|Withdrawal by Subject|1|||
125619979|NCT01763866|451890448|FG018|Overall Study|Withdrawal by Subject|1|||
125619980|NCT01763866|451890449|FG019|Overall Study|Withdrawal by Subject|1|||
125619981|NCT01763866|451890450|FG020|Overall Study|Withdrawal by Subject|2|||
125619982|NCT01763866|451890451|FG021|Overall Study|Withdrawal by Subject|1|||
125619983|NCT01763866|451890452|FG022|Overall Study|Withdrawal by Subject|2|||
125619984|NCT01763866|451890453|FG023|Overall Study|Withdrawal by Subject|1|||
125619985|NCT01763866|451890430|FG000|Overall Study|Decision by sponsor|0|||
125619986|NCT01763866|451890431|FG001|Overall Study|Decision by sponsor|0|||
125619987|NCT01763866|451890432|FG002|Overall Study|Decision by sponsor|1|||
125619988|NCT01763866|451890433|FG003|Overall Study|Decision by sponsor|0|||
125619989|NCT01763866|451890434|FG004|Overall Study|Decision by sponsor|2|||
125619990|NCT01763866|451890435|FG005|Overall Study|Decision by sponsor|0|||
125619991|NCT01763866|451890436|FG006|Overall Study|Decision by sponsor|2|||
125619992|NCT01763866|451890437|FG007|Overall Study|Decision by sponsor|0|||
125619993|NCT01763866|451890438|FG008|Overall Study|Decision by sponsor|2|||
125619994|NCT01763866|451890439|FG009|Overall Study|Decision by sponsor|0|||
125619995|NCT01763866|451890440|FG010|Overall Study|Decision by sponsor|6|||
125619996|NCT01763866|451890441|FG011|Overall Study|Decision by sponsor|0|||
125619997|NCT01763866|451890442|FG012|Overall Study|Decision by sponsor|1|||
125619998|NCT01763866|451890443|FG013|Overall Study|Decision by sponsor|0|||
125619999|NCT01763866|451890444|FG014|Overall Study|Decision by sponsor|5|||
125620000|NCT01763866|451890445|FG015|Overall Study|Decision by sponsor|0|||
125620001|NCT01763866|451890446|FG016|Overall Study|Decision by sponsor|0|||
125620002|NCT01763866|451890447|FG017|Overall Study|Decision by sponsor|0|||
125620003|NCT01763866|451890448|FG018|Overall Study|Decision by sponsor|4|||
125620004|NCT01763866|451890449|FG019|Overall Study|Decision by sponsor|0|||
125620005|NCT01763866|451890450|FG020|Overall Study|Decision by sponsor|2|||
125620006|NCT01763866|451890451|FG021|Overall Study|Decision by sponsor|0|||
125620007|NCT01763866|451890452|FG022|Overall Study|Decision by sponsor|1|||
125620008|NCT01763866|451890453|FG023|Overall Study|Decision by sponsor|0|||
125374319|NCT01192516|451000269|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
125374320|NCT01192516|451000270|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
125374321|NCT01192516|451000271|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
125374322|NCT01256008|451000272|FG000|Overall Study|Lost to Follow-up|6|||
125620009|NCT01763866|451890430|FG000|Overall Study|Lost to Follow-up|0|||
125620010|NCT01763866|451890431|FG001|Overall Study|Lost to Follow-up|0|||
125620011|NCT01763866|451890432|FG002|Overall Study|Lost to Follow-up|0|||
125620012|NCT01763866|451890433|FG003|Overall Study|Lost to Follow-up|0|||
125620013|NCT01763866|451890434|FG004|Overall Study|Lost to Follow-up|0|||
125620014|NCT01763866|451890435|FG005|Overall Study|Lost to Follow-up|0|||
125620015|NCT01763866|451890436|FG006|Overall Study|Lost to Follow-up|1|||
125620016|NCT01763866|451890437|FG007|Overall Study|Lost to Follow-up|0|||
125620017|NCT01763866|451890438|FG008|Overall Study|Lost to Follow-up|0|||
125620018|NCT01763866|451890439|FG009|Overall Study|Lost to Follow-up|0|||
125620019|NCT01763866|451890440|FG010|Overall Study|Lost to Follow-up|0|||
125620020|NCT01763866|451890441|FG011|Overall Study|Lost to Follow-up|0|||
125620021|NCT01763866|451890442|FG012|Overall Study|Lost to Follow-up|1|||
125620022|NCT01763866|451890443|FG013|Overall Study|Lost to Follow-up|0|||
125620023|NCT01763866|451890444|FG014|Overall Study|Lost to Follow-up|1|||
125620024|NCT01763866|451890445|FG015|Overall Study|Lost to Follow-up|0|||
125620025|NCT01763866|451890446|FG016|Overall Study|Lost to Follow-up|0|||
125620026|NCT01763866|451890447|FG017|Overall Study|Lost to Follow-up|0|||
125620027|NCT01763866|451890448|FG018|Overall Study|Lost to Follow-up|1|||
125620028|NCT01763866|451890449|FG019|Overall Study|Lost to Follow-up|1|||
125620029|NCT01763866|451890450|FG020|Overall Study|Lost to Follow-up|0|||
125620030|NCT01763866|451890451|FG021|Overall Study|Lost to Follow-up|0|||
125620031|NCT01763866|451890452|FG022|Overall Study|Lost to Follow-up|0|||
125620032|NCT01763866|451890453|FG023|Overall Study|Lost to Follow-up|1|||
125620033|NCT01763866|451890430|FG000|Overall Study|Death|0|||
125620034|NCT01763866|451890431|FG001|Overall Study|Death|0|||
125620035|NCT01763866|451890432|FG002|Overall Study|Death|0|||
125620036|NCT01763866|451890433|FG003|Overall Study|Death|0|||
125620037|NCT01763866|451890434|FG004|Overall Study|Death|0|||
125620038|NCT01763866|451890435|FG005|Overall Study|Death|0|||
125620039|NCT01763866|451890436|FG006|Overall Study|Death|0|||
125620040|NCT01763866|451890437|FG007|Overall Study|Death|0|||
125620041|NCT01763866|451890438|FG008|Overall Study|Death|0|||
125620042|NCT01763866|451890439|FG009|Overall Study|Death|0|||
125620043|NCT01763866|451890440|FG010|Overall Study|Death|0|||
125620044|NCT01763866|451890441|FG011|Overall Study|Death|0|||
125620045|NCT01763866|451890442|FG012|Overall Study|Death|0|||
125620046|NCT01763866|451890443|FG013|Overall Study|Death|0|||
125620047|NCT01763866|451890444|FG014|Overall Study|Death|0|||
125620048|NCT01763866|451890445|FG015|Overall Study|Death|0|||
125620049|NCT01763866|451890446|FG016|Overall Study|Death|1|||
125620050|NCT01763866|451890447|FG017|Overall Study|Death|0|||
125620051|NCT01763866|451890448|FG018|Overall Study|Death|0|||
125620052|NCT01763866|451890449|FG019|Overall Study|Death|0|||
125620053|NCT01763866|451890450|FG020|Overall Study|Death|0|||
125620054|NCT01763866|451890451|FG021|Overall Study|Death|0|||
125620055|NCT01763866|451890452|FG022|Overall Study|Death|0|||
125620056|NCT01763866|451890453|FG023|Overall Study|Death|0|||
125620057|NCT03245723|451890456|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
125620058|NCT03245723|451890457|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
125620059|NCT03245723|451890456|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
125620060|NCT03245723|451890457|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
125620061|NCT03245723|451890456|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
125620062|NCT03245723|451890457|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
125620063|NCT03245723|451890456|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
125620064|NCT03245723|451890457|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
125620065|NCT03337139|451890458|FG000|Phase I|Withdrawal by Subject|10|||
125620066|NCT03337139|451890459|FG001|Phase I|Withdrawal by Subject|0|||
125620067|NCT02554253|451890460|FG000|Overall Study|ineligible after enrollment|1|||
125620068|NCT02554253|451890461|FG001|Overall Study|ineligible after enrollment|0|||
125620069|NCT02554253|451890460|FG000|Overall Study|converted to transcatheter procedure|0|||
125620070|NCT02554253|451890461|FG001|Overall Study|converted to transcatheter procedure|1|||
125620071|NCT02554253|451890460|FG000|Overall Study|received both drugs|0|||
125620072|NCT02554253|451890461|FG001|Overall Study|received both drugs|1|||
125620073|NCT03288493|451890462|FG000|Overall Study|Withdrawal by Subject|4|||
125620074|NCT03288493|451890463|FG001|Overall Study|Withdrawal by Subject|0|||
125620075|NCT03288493|451890464|FG002|Overall Study|Withdrawal by Subject|0|||
125620076|NCT03288493|451890465|FG003|Overall Study|Withdrawal by Subject|0|||
125620077|NCT03288493|451890466|FG004|Overall Study|Withdrawal by Subject|0|||
125620078|NCT03288493|451890467|FG005|Overall Study|Withdrawal by Subject|2|||
125620079|NCT03288493|451890468|FG006|Overall Study|Withdrawal by Subject|0|||
125620080|NCT03288493|451890462|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
125620081|NCT03288493|451890463|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
125620082|NCT03288493|451890464|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
125620083|NCT03288493|451890465|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
125620084|NCT03288493|451890466|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
125620085|NCT03288493|451890467|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
125620086|NCT03288493|451890468|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
125620087|NCT03288493|451890462|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
125620088|NCT03288493|451890463|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
125620089|NCT03288493|451890464|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
125620090|NCT03288493|451890465|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
125620091|NCT03288493|451890466|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
125637263|NCT03073200|451952839|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125637264|NCT03073200|451952840|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125637265|NCT03073200|451952841|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125637266|NCT03073200|451952842|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
125215198|NCT01152996|450414932|FG000|Overall Study|Lost to Follow-up|112|||
125637267|NCT03073200|451952843|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
125637268|NCT03073200|451952844|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125637269|NCT03073200|451952845|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125637270|NCT03073200|451952846|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125215199|NCT01152996|450414932|FG000|Overall Study|Lack of Efficacy|68|||
125215200|NCT01152996|450414932|FG000|Overall Study|Noncompliance|41|||
125215201|NCT01152996|450414932|FG000|Overall Study|Other|36|||
125215202|NCT01152996|450414932|FG000|Overall Study|Protocol Violation|22|||
125215203|NCT01152996|450414932|FG000|Overall Study|Elevated liver enzymes|1|||
125215204|NCT02072941|450414934|FG000|Overall Study|Withdrawal by Subject|29|||
125215205|NCT02072941|450414935|FG001|Overall Study|Withdrawal by Subject|21|||
125215206|NCT02072941|450414934|FG000|Overall Study|Lost to Follow-up|4|||
125215207|NCT02072941|450414935|FG001|Overall Study|Lost to Follow-up|4|||
125215208|NCT02072941|450414934|FG000|Overall Study|Death|3|||
125215209|NCT02072941|450414935|FG001|Overall Study|Death|2|||
125374323|NCT01256008|451000273|FG001|Overall Study|Lost to Follow-up|4|||
125374324|NCT01256008|451000274|FG002|Overall Study|Lost to Follow-up|11|||
125374325|NCT01256008|451000272|FG000|Overall Study|Withdrawal by Subject|2|||
125374326|NCT01256008|451000273|FG001|Overall Study|Withdrawal by Subject|3|||
125374327|NCT01256008|451000274|FG002|Overall Study|Withdrawal by Subject|10|||
125374328|NCT02244606|451000275|FG000|Overall Study|Adverse Event|0|||
125374329|NCT02244606|451000276|FG001|Overall Study|Adverse Event|1|||
125374330|NCT02244606|451000277|FG002|Overall Study|Adverse Event|1|||
125374331|NCT02244606|451000278|FG003|Overall Study|Adverse Event|0|||
125374332|NCT02244606|451000275|FG000|Overall Study|Lost to Follow-up|2|||
125374333|NCT02244606|451000276|FG001|Overall Study|Lost to Follow-up|2|||
125374334|NCT02244606|451000277|FG002|Overall Study|Lost to Follow-up|1|||
125374335|NCT02244606|451000278|FG003|Overall Study|Lost to Follow-up|0|||
125374336|NCT02244606|451000275|FG000|Overall Study|Protocol Violation|0|||
125374337|NCT02244606|451000276|FG001|Overall Study|Protocol Violation|0|||
125374338|NCT02244606|451000277|FG002|Overall Study|Protocol Violation|0|||
125374339|NCT02244606|451000278|FG003|Overall Study|Protocol Violation|1|||
125374340|NCT02244606|451000275|FG000|Overall Study|Withdrawal by Subject|1|||
125374341|NCT02244606|451000276|FG001|Overall Study|Withdrawal by Subject|1|||
125374342|NCT02244606|451000277|FG002|Overall Study|Withdrawal by Subject|0|||
125374343|NCT02244606|451000278|FG003|Overall Study|Withdrawal by Subject|0|||
125374344|NCT02244606|451000275|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
125374345|NCT02244606|451000276|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
125374346|NCT02244606|451000277|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
125374347|NCT02244606|451000278|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
125374348|NCT03782792|451000283|FG000|Overall Study|Patient left the country|0|||
125620092|NCT03288493|451890467|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
125620093|NCT03288493|451890468|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
125620094|NCT03288493|451890462|FG000|Overall Study|Death|2|||
125620095|NCT03288493|451890463|FG001|Overall Study|Death|0|||
125620096|NCT03288493|451890464|FG002|Overall Study|Death|0|||
125620097|NCT03288493|451890465|FG003|Overall Study|Death|0|||
125620098|NCT03288493|451890466|FG004|Overall Study|Death|0|||
125620099|NCT03288493|451890467|FG005|Overall Study|Death|0|||
125620100|NCT03288493|451890468|FG006|Overall Study|Death|0|||
125620101|NCT03288493|451890462|FG000|Overall Study|other reason not listed above|2|||
125620102|NCT03288493|451890463|FG001|Overall Study|other reason not listed above|0|||
125620103|NCT03288493|451890464|FG002|Overall Study|other reason not listed above|0|||
125620104|NCT03288493|451890465|FG003|Overall Study|other reason not listed above|0|||
125620105|NCT03288493|451890466|FG004|Overall Study|other reason not listed above|0|||
125620106|NCT03288493|451890467|FG005|Overall Study|other reason not listed above|0|||
125620107|NCT03288493|451890468|FG006|Overall Study|other reason not listed above|0|||
125620108|NCT01736254|451890470|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
125620109|NCT01736254|451890470|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
125620110|NCT02559206|451890471|FG000|Overall Study|Adverse Event|0|||
125374349|NCT03782792|451000284|FG001|Overall Study|Patient left the country|1|||
125374350|NCT03782792|451000283|FG000|Overall Study|Withdrawal by Subject|1|||
125620111|NCT02559206|451890472|FG001|Overall Study|Adverse Event|4|||
125620112|NCT02559206|451890473|FG002|Overall Study|Adverse Event|1|||
125620113|NCT02559206|451890474|FG003|Overall Study|Adverse Event|5|||
125620114|NCT02559206|451890475|FG004|Overall Study|Adverse Event|3|||
125620115|NCT02559206|451890476|FG005|Overall Study|Adverse Event|0|||
125620116|NCT02559206|451890477|FG006|Overall Study|Adverse Event|1|||
125620117|NCT02559206|451890478|FG007|Overall Study|Adverse Event|0|||
125620118|NCT02559206|451890471|FG000|Overall Study|Protocol Violation|1|||
125620119|NCT02559206|451890472|FG001|Overall Study|Protocol Violation|0|||
125215210|NCT02072941|450414934|FG000|Overall Study|Removed by Study Staff|2|||
125215211|NCT02072941|450414935|FG001|Overall Study|Removed by Study Staff|2|||
125215212|NCT03146741|450414936|FG000|Overall Study|Txp with non-HCV+ heart|4|||
125215213|NCT03146741|450414936|FG000|Overall Study|Listeted for MOT|2|||
125215214|NCT03146741|450414936|FG000|Overall Study|Physician Decision|2|||
125215215|NCT03146741|450414936|FG000|Overall Study|Awaiting txp|2|||
125374351|NCT03782792|451000284|FG001|Overall Study|Withdrawal by Subject|2|||
125374352|NCT00814164|451000286|FG000|Overall Study|Progression|7|||
125374353|NCT00814164|451000286|FG000|Overall Study|not stated|7|||
125620120|NCT02559206|451890473|FG002|Overall Study|Protocol Violation|1|||
125374354|NCT00814164|451000286|FG000|Overall Study|Death|5|||
125620121|NCT02559206|451890474|FG003|Overall Study|Protocol Violation|0|||
125620122|NCT02559206|451890475|FG004|Overall Study|Protocol Violation|0|||
125620123|NCT02559206|451890476|FG005|Overall Study|Protocol Violation|2|||
125620124|NCT02559206|451890477|FG006|Overall Study|Protocol Violation|0|||
125620125|NCT02559206|451890478|FG007|Overall Study|Protocol Violation|0|||
125620126|NCT02559206|451890471|FG000|Overall Study|Withdrawal by Subject|3|||
125620127|NCT02559206|451890472|FG001|Overall Study|Withdrawal by Subject|3|||
125620128|NCT02559206|451890473|FG002|Overall Study|Withdrawal by Subject|1|||
125620129|NCT02559206|451890474|FG003|Overall Study|Withdrawal by Subject|3|||
125620130|NCT02559206|451890475|FG004|Overall Study|Withdrawal by Subject|5|||
125620131|NCT02559206|451890476|FG005|Overall Study|Withdrawal by Subject|4|||
125620132|NCT02559206|451890477|FG006|Overall Study|Withdrawal by Subject|1|||
125620133|NCT02559206|451890478|FG007|Overall Study|Withdrawal by Subject|2|||
125620134|NCT02559206|451890471|FG000|Overall Study|Lost to Follow-up|3|||
125620135|NCT02559206|451890472|FG001|Overall Study|Lost to Follow-up|5|||
125620136|NCT02559206|451890473|FG002|Overall Study|Lost to Follow-up|3|||
125620137|NCT02559206|451890474|FG003|Overall Study|Lost to Follow-up|3|||
125620138|NCT02559206|451890475|FG004|Overall Study|Lost to Follow-up|2|||
125620139|NCT02559206|451890476|FG005|Overall Study|Lost to Follow-up|5|||
125620140|NCT02559206|451890477|FG006|Overall Study|Lost to Follow-up|1|||
125620141|NCT02559206|451890478|FG007|Overall Study|Lost to Follow-up|4|||
125620142|NCT02559206|451890471|FG000|Overall Study|Lack of Efficacy|1|||
125620143|NCT02559206|451890472|FG001|Overall Study|Lack of Efficacy|0|||
125620144|NCT02559206|451890473|FG002|Overall Study|Lack of Efficacy|3|||
125620145|NCT02559206|451890474|FG003|Overall Study|Lack of Efficacy|2|||
125620146|NCT02559206|451890475|FG004|Overall Study|Lack of Efficacy|2|||
125620147|NCT02559206|451890476|FG005|Overall Study|Lack of Efficacy|3|||
125620148|NCT02559206|451890477|FG006|Overall Study|Lack of Efficacy|3|||
125620149|NCT02559206|451890478|FG007|Overall Study|Lack of Efficacy|3|||
125620150|NCT02559206|451890471|FG000|Overall Study|Other Not Specified|0|||
125620151|NCT02559206|451890472|FG001|Overall Study|Other Not Specified|0|||
125620152|NCT02559206|451890473|FG002|Overall Study|Other Not Specified|0|||
125620153|NCT02559206|451890474|FG003|Overall Study|Other Not Specified|1|||
125620154|NCT02559206|451890475|FG004|Overall Study|Other Not Specified|0|||
125620155|NCT02559206|451890476|FG005|Overall Study|Other Not Specified|0|||
125620156|NCT02559206|451890477|FG006|Overall Study|Other Not Specified|0|||
125620157|NCT02559206|451890478|FG007|Overall Study|Other Not Specified|0|||
125620158|NCT01561560|451890479|FG000|First Two Weeks of Wear|Time/job conflict|0|||
125620159|NCT01561560|451890480|FG001|First Two Weeks of Wear|Time/job conflict|1|||
125620160|NCT01561560|451890479|FG000|First Two Weeks of Wear|Adverse Event|0|||
125620161|NCT01561560|451890480|FG001|First Two Weeks of Wear|Adverse Event|1|||
125620162|NCT01561560|451890479|FG000|Second Two Weeks of Wear|Adverse Event|0|||
125620163|NCT01561560|451890480|FG001|Second Two Weeks of Wear|Adverse Event|1|||
125620164|NCT00646113|451891952|FG000|Overall Study|Lost to Follow-up|5|||
125620165|NCT00646113|451891952|FG000|Overall Study|Adverse Event|3|||
125620166|NCT02109744|451891953|FG000|Overall Study|Death|1|||
125620167|NCT02109744|451891954|FG001|Overall Study|Death|1|||
125620168|NCT02109744|451891953|FG000|Overall Study|no marrow exam|1|||
125620169|NCT02109744|451891954|FG001|Overall Study|no marrow exam|0|||
125620170|NCT04656418|451891955|FG000|Overall Study|Withdrawal by Subject|1|||
125620171|NCT04656418|451891956|FG001|Overall Study|Withdrawal by Subject|3|||
125620172|NCT03287245|451891957|FG000|Overall Study|Study terminated by sponsor|3|||
125620173|NCT03287245|451891958|FG001|Overall Study|Study terminated by sponsor|0|||
125620174|NCT03287245|451891959|FG002|Overall Study|Study terminated by sponsor|3|||
125620175|NCT03287245|451891960|FG003|Overall Study|Study terminated by sponsor|1|||
125620176|NCT03287245|451891957|FG000|Overall Study|Adverse Event|1|||
125620177|NCT03287245|451891958|FG001|Overall Study|Adverse Event|0|||
125620178|NCT03287245|451891959|FG002|Overall Study|Adverse Event|0|||
125620179|NCT03287245|451891960|FG003|Overall Study|Adverse Event|0|||
125620180|NCT03287245|451891957|FG000|Overall Study|Withdrawal by Subject|8|||
125374355|NCT02321800|451000287|FG000|Overall Study|Withdrawal by Subject|3|||
125374356|NCT02321800|451000288|FG001|Overall Study|Withdrawal by Subject|3|||
125374357|NCT02321800|451000287|FG000|Overall Study|Death|1|||
125374358|NCT02321800|451000288|FG001|Overall Study|Death|0|||
125620181|NCT03287245|451891958|FG001|Overall Study|Withdrawal by Subject|3|||
125374359|NCT02321800|451000287|FG000|Overall Study|Protocol Violation|1|||
125374360|NCT02321800|451000288|FG001|Overall Study|Protocol Violation|0|||
125620182|NCT03287245|451891959|FG002|Overall Study|Withdrawal by Subject|3|||
125620183|NCT03287245|451891960|FG003|Overall Study|Withdrawal by Subject|0|||
125620184|NCT03287245|451891957|FG000|Overall Study|Physician Decision|3|||
125620185|NCT03287245|451891958|FG001|Overall Study|Physician Decision|2|||
125620186|NCT03287245|451891959|FG002|Overall Study|Physician Decision|0|||
125620187|NCT03287245|451891960|FG003|Overall Study|Physician Decision|0|||
125374361|NCT02321800|451000287|FG000|Overall Study|Lost to Follow-up|10|||
125620188|NCT02701192|451891961|FG000|Overall Study|Protocol Violation|2|||
125620189|NCT02701192|451891961|FG000|Overall Study|Lost to Follow-up|4|||
125620190|NCT02150213|451891963|FG000|Overall Study|Lost to Follow-up|1|||
125620191|NCT02150213|451891963|FG000|Overall Study|Withdrawal by Subject|1|||
125215216|NCT03224624|450414937|FG000|Overall Study|Lost to Follow-up|9|||
125215217|NCT03224624|450414938|FG001|Overall Study|Lost to Follow-up|4|||
125215218|NCT03224624|450414937|FG000|Overall Study|Death|1|||
125215219|NCT03224624|450414938|FG001|Overall Study|Death|0|||
125215220|NCT01884545|450414939|FG000|Overall Study|Lost to Follow-up|6|||
125215221|NCT01884545|450414940|FG001|Overall Study|Lost to Follow-up|4|||
125215222|NCT01884545|450414941|FG002|Overall Study|Lost to Follow-up|9|||
125215223|NCT01884545|450414942|FG003|Overall Study|Lost to Follow-up|4|||
125215224|NCT01884545|450414939|FG000|Overall Study|Patient withdrawn|7|||
125215225|NCT01884545|450414940|FG001|Overall Study|Patient withdrawn|12|||
125215226|NCT01884545|450414941|FG002|Overall Study|Patient withdrawn|5|||
125215227|NCT01884545|450414942|FG003|Overall Study|Patient withdrawn|5|||
125215228|NCT01884545|450414939|FG000|Overall Study|Non-adherence|0|||
125215229|NCT01884545|450414940|FG001|Overall Study|Non-adherence|2|||
125215230|NCT01884545|450414941|FG002|Overall Study|Non-adherence|0|||
125215231|NCT01884545|450414942|FG003|Overall Study|Non-adherence|0|||
125215232|NCT02521792|450414948|FG000|Overall Study|Study Terminated|6|||
125215233|NCT02937636|450414950|FG000|Overall Study|Other (Not specified)|3|||
125215234|NCT02937636|450414951|FG001|Overall Study|Other (Not specified)|2|||
125215235|NCT00770913|450414956|FG000|Overall Study|Adverse Event|1|||
125215236|NCT00770913|450414957|FG001|Overall Study|Adverse Event|3|||
125215237|NCT00770913|450414958|FG002|Overall Study|Adverse Event|6|||
125620192|NCT01297309|451891967|FG000|Overall Study|Eligibility failure|2|||
125620193|NCT01297309|451891967|FG000|Overall Study|Screen failure|2|||
125620194|NCT01297309|451891967|FG000|Overall Study|Withdrawal by Subject|5|||
125620195|NCT01297309|451891967|FG000|Overall Study|Adverse Event|1|||
125620196|NCT01297309|451891967|FG000|Overall Study|Investigator Decision|2|||
125620197|NCT01297309|451891967|FG000|Overall Study|Death|1|||
125620198|NCT01297309|451891967|FG000|Overall Study|Participant not entering extensionperiod|1|||
125620199|NCT03039738|451891968|FG000|Overall Study|Incomplete data sets|54|||
125620200|NCT03039738|451891969|FG001|Overall Study|Incomplete data sets|0|||
125620201|NCT02678312|451891970|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
125620202|NCT02678312|451891971|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
125620203|NCT02678312|451891972|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
125620204|NCT02678312|451891973|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
125620205|NCT02678312|451891974|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
125620206|NCT02678312|451891970|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
125620207|NCT02678312|451891971|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
125620208|NCT02678312|451891972|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
125620209|NCT02678312|451891973|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
125620210|NCT02678312|451891974|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
125620211|NCT02678312|451891970|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
125620212|NCT02678312|451891971|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
125620213|NCT02678312|451891972|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
125620214|NCT02678312|451891973|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
125620215|NCT02678312|451891974|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
125620216|NCT02678312|451891970|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
125620217|NCT02678312|451891971|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
125620218|NCT02678312|451891972|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
125620219|NCT02678312|451891973|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
125620220|NCT02678312|451891974|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
125620221|NCT02678312|451891970|FG000|Part 2 Double Blind Epoch|Death|0|||
125620222|NCT02678312|451891971|FG001|Part 2 Double Blind Epoch|Death|0|||
125620223|NCT02678312|451891972|FG002|Part 2 Double Blind Epoch|Death|0|||
125620224|NCT02678312|451891973|FG003|Part 2 Double Blind Epoch|Death|8|||
125620225|NCT02678312|451891974|FG004|Part 2 Double Blind Epoch|Death|12|||
125620226|NCT02678312|451891970|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
125620227|NCT02678312|451891971|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
125620228|NCT02678312|451891972|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
125215238|NCT00770913|450414956|FG000|Overall Study|Refusal to continue participation|6|||
125215239|NCT00770913|450414957|FG001|Overall Study|Refusal to continue participation|4|||
125620229|NCT02678312|451891973|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
125620230|NCT02678312|451891974|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
125620231|NCT02678312|451891970|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
125620232|NCT02678312|451891971|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
125620233|NCT02678312|451891972|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
125620234|NCT02678312|451891973|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
125620235|NCT02678312|451891974|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
125620236|NCT02678312|451891970|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
125215240|NCT00770913|450414958|FG002|Overall Study|Refusal to continue participation|5|||
125215241|NCT00770913|450414956|FG000|Overall Study|Physician Decision|0|||
125215242|NCT00770913|450414957|FG001|Overall Study|Physician Decision|1|||
125215243|NCT00770913|450414958|FG002|Overall Study|Physician Decision|1|||
125215244|NCT00770913|450414956|FG000|Overall Study|Protocol Violation|3|||
125620237|NCT02678312|451891971|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
125620238|NCT02678312|451891972|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
125620239|NCT02678312|451891973|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
125620240|NCT02678312|451891974|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
125620241|NCT02716194|451891977|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
125620242|NCT02716194|451891978|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
125620243|NCT02716194|451891979|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
125620244|NCT00971425|451891980|FG000|Overall Study|Adverse Event|1|||
125620245|NCT00971425|451891981|FG001|Overall Study|Adverse Event|1|||
125620246|NCT00971425|451891980|FG000|Overall Study|Withdrawal by Subject|0|||
125620247|NCT00971425|451891981|FG001|Overall Study|Withdrawal by Subject|1|||
125620248|NCT03587584|451891987|FG000|Overall Study|SOC deviations|4|||
125620249|NCT03587584|451891988|FG001|Overall Study|SOC deviations|6|||
125620250|NCT03587584|451891987|FG000|Overall Study|Incomplete data|0|||
125620251|NCT03587584|451891988|FG001|Overall Study|Incomplete data|3|||
125620252|NCT00225147|451891989|FG000|Open-label Phase|Lost to Follow-up|0|||
125620253|NCT00225147|451891990|FG001|Open-label Phase|Lost to Follow-up|0|||
125620254|NCT00225147|451891991|FG002|Open-label Phase|Lost to Follow-up|0|||
125620255|NCT00225147|451891992|FG003|Open-label Phase|Lost to Follow-up|4|||
125620256|NCT00225147|451891989|FG000|Open-label Phase|Withdrawal by Subject|0|||
125620257|NCT00225147|451891990|FG001|Open-label Phase|Withdrawal by Subject|0|||
125620258|NCT00225147|451891991|FG002|Open-label Phase|Withdrawal by Subject|0|||
125620259|NCT00225147|451891992|FG003|Open-label Phase|Withdrawal by Subject|6|||
125620260|NCT02685995|451891995|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
125620261|NCT02685995|451891996|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
125620262|NCT03625141|451891997|FG000|Overall Study|Adverse Event|0|||
125620263|NCT03625141|451891998|FG001|Overall Study|Adverse Event|2|||
125620264|NCT03625141|451891997|FG000|Overall Study|Study Terminated By Sponsor|1|||
125620265|NCT03625141|451891998|FG001|Overall Study|Study Terminated By Sponsor|13|||
125620266|NCT03625141|451891997|FG000|Overall Study|Withdrawal by Subject|3|||
125620267|NCT03625141|451891998|FG001|Overall Study|Withdrawal by Subject|0|||
125620268|NCT03625141|451891997|FG000|Overall Study|Withdrawal Of Consent|0|||
125620269|NCT03625141|451891998|FG001|Overall Study|Withdrawal Of Consent|1|||
125620270|NCT03625141|451891997|FG000|Overall Study|Death|11|||
125620271|NCT03625141|451891998|FG001|Overall Study|Death|47|||
125620272|NCT03625141|451891997|FG000|Overall Study|Progressive Disease|0|||
125620273|NCT03625141|451891998|FG001|Overall Study|Progressive Disease|2|||
125620274|NCT00868166|451892000|FG000|Overall Study|Death|58|||
125620275|NCT00868166|451892001|FG001|Overall Study|Death|65|||
125620276|NCT00868166|451892000|FG000|Overall Study|Withdrawal by Subject|33|||
125620277|NCT00868166|451892001|FG001|Overall Study|Withdrawal by Subject|25|||
125620278|NCT00868166|451892000|FG000|Overall Study|Protocol Violation|1|||
125620279|NCT00868166|451892001|FG001|Overall Study|Protocol Violation|0|||
125620280|NCT00868166|451892000|FG000|Overall Study|Lost to Follow-up|1|||
125620281|NCT00868166|451892001|FG001|Overall Study|Lost to Follow-up|3|||
125620282|NCT00868166|451892000|FG000|Overall Study|Adverse Event|9|||
125620283|NCT00868166|451892001|FG001|Overall Study|Adverse Event|10|||
125620284|NCT00868166|451892000|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
125620285|NCT00868166|451892001|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
125620286|NCT00868166|451892000|FG000|Overall Study|Non-compliance with IMP|1|||
125620287|NCT00868166|451892001|FG001|Overall Study|Non-compliance with IMP|1|||
125620288|NCT03819218|451892006|FG000|Overall Study|Protocol Violation|1|||
125620289|NCT02267278|451892007|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
125620290|NCT02267278|451892007|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
125620291|NCT02267278|451892007|FG000|Overall Study|Developed new cancer diagnoses|2|||
125620292|NCT02267278|451892007|FG000|Overall Study|prescribed prohibited medication|1|||
125620293|NCT00650091|451892008|FG000|Amended Study Design|Withdrawal by Subject|12|||
125620294|NCT00650091|451892009|FG001|Amended Study Design|Withdrawal by Subject|11|||
125620295|NCT00650091|451892010|FG002|Amended Study Design|Withdrawal by Subject|0|||
125620296|NCT00650091|451892008|FG000|Amended Study Design|Physician Decision|5|||
125620297|NCT00650091|451892009|FG001|Amended Study Design|Physician Decision|0|||
125620298|NCT00650091|451892010|FG002|Amended Study Design|Physician Decision|0|||
125620299|NCT00650091|451892008|FG000|Amended Study Design|Adverse Event|1|||
125620300|NCT00650091|451892009|FG001|Amended Study Design|Adverse Event|4|||
125620301|NCT00650091|451892010|FG002|Amended Study Design|Adverse Event|0|||
125620302|NCT00650091|451892008|FG000|Amended Study Design|Lung transplantation|4|||
125620303|NCT00650091|451892009|FG001|Amended Study Design|Lung transplantation|2|||
125620304|NCT00650091|451892010|FG002|Amended Study Design|Lung transplantation|0|||
125620305|NCT00650091|451892008|FG000|Amended Study Design|Other|1|||
125620306|NCT00650091|451892009|FG001|Amended Study Design|Other|3|||
125620307|NCT00650091|451892010|FG002|Amended Study Design|Other|0|||
125620308|NCT00085917|451892016|FG000|Overall Study|Adverse Event|4|||
125620309|NCT00085917|451892017|FG001|Overall Study|Adverse Event|3|||
125374362|NCT02321800|451000288|FG001|Overall Study|Lost to Follow-up|4|||
125620310|NCT01429077|451892018|FG000|Overall Study|Lost to Follow-up|0|||
125374363|NCT02321800|451000287|FG000|Overall Study|Adverse Event|2|||
125620311|NCT01429077|451892019|FG001|Overall Study|Lost to Follow-up|3|||
125620312|NCT03372603|451892021|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
125374364|NCT02321800|451000288|FG001|Overall Study|Adverse Event|3|||
125620313|NCT03372603|451892022|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
125620314|NCT03372603|451892021|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
125620315|NCT03372603|451892022|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
125620316|NCT02806947|451892023|FG000|Overall Study|Withdrawal by Subject|5|||
125620317|NCT02806947|451892024|FG001|Overall Study|Withdrawal by Subject|1|||
125620318|NCT00664209|451892031|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
125620319|NCT00664209|451892031|FG000|Study Treatment Period|Physician Decision|4|||
125620320|NCT00664209|451892031|FG000|Study Treatment Period|Withdrawal by Subject|2|||
125620321|NCT00065442|451892033|FG000|Overall Study|Lost to Follow-up|1|||
125620322|NCT00065442|451892034|FG001|Overall Study|Lost to Follow-up|1|||
125620323|NCT00065442|451892033|FG000|Overall Study|Death|121|||
125620324|NCT00065442|451892034|FG001|Overall Study|Death|210|||
125620325|NCT00065442|451892033|FG000|Overall Study|Withdrawal by Subject|3|||
125620326|NCT00065442|451892034|FG001|Overall Study|Withdrawal by Subject|9|||
125620327|NCT01594333|451892035|FG000|Overall Study|Death|96|||
125620328|NCT01594333|451892036|FG001|Overall Study|Death|83|||
125620329|NCT01594333|451892035|FG000|Overall Study|Lost to Follow-up|5|||
125620330|NCT01594333|451892036|FG001|Overall Study|Lost to Follow-up|5|||
125620331|NCT01594333|451892035|FG000|Overall Study|Withdrawal by Subject|60|||
125620332|NCT01594333|451892036|FG001|Overall Study|Withdrawal by Subject|63|||
125620333|NCT01764256|451892037|FG000|Received All Vaccinations|Adverse Event|1|||
125620334|NCT01764256|451892038|FG001|Received All Vaccinations|Adverse Event|1|||
125620335|NCT01764256|451892039|FG002|Received All Vaccinations|Adverse Event|0|||
125620336|NCT01764256|451892040|FG003|Received All Vaccinations|Adverse Event|0|||
125620337|NCT01764256|451892037|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
125620338|NCT01764256|451892038|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
125620339|NCT01764256|451892039|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
125620340|NCT01764256|451892040|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
125620341|NCT01764256|451892037|FG000|Received All Vaccinations|Lost to Follow-up|1|||
125620342|NCT01764256|451892038|FG001|Received All Vaccinations|Lost to Follow-up|0|||
125620343|NCT01764256|451892039|FG002|Received All Vaccinations|Lost to Follow-up|0|||
125620344|NCT01764256|451892040|FG003|Received All Vaccinations|Lost to Follow-up|0|||
125620345|NCT01764256|451892037|FG000|Completed Study|Lost to Follow-up|0|||
125620346|NCT01764256|451892038|FG001|Completed Study|Lost to Follow-up|0|||
125620347|NCT01764256|451892039|FG002|Completed Study|Lost to Follow-up|0|||
125620348|NCT01764256|451892040|FG003|Completed Study|Lost to Follow-up|1|||
125620349|NCT02029638|451892041|FG000|Overall Study|Death|0|||
125620350|NCT02029638|451892042|FG001|Overall Study|Death|0|||
125620351|NCT02029638|451892043|FG002|Overall Study|Death|1|||
125620352|NCT02029638|451892041|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
125620353|NCT02029638|451892042|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
125620354|NCT02029638|451892043|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
125620355|NCT01153841|451892044|FG000|Overall Study|Adverse Event|1|||
125620356|NCT01153841|451892045|FG001|Overall Study|Adverse Event|0|||
125620357|NCT01153841|451892044|FG000|Overall Study|Withdrawal by Subject|1|||
125620358|NCT01153841|451892045|FG001|Overall Study|Withdrawal by Subject|0|||
125620359|NCT01153841|451892044|FG000|Overall Study|Protocol Violation|2|||
125620360|NCT01153841|451892045|FG001|Overall Study|Protocol Violation|0|||
125620361|NCT01153841|451892044|FG000|Overall Study|Lost to Follow-up|2|||
125620362|NCT01153841|451892045|FG001|Overall Study|Lost to Follow-up|0|||
125620363|NCT03428997|451892055|FG000|Overall Study|Sponsor decision.|1|||
125620364|NCT03428997|451892055|FG000|Overall Study|Withdrawal by Subject|3|||
125620365|NCT03428997|451892055|FG000|Overall Study|Lost to Follow-up|4|||
125215245|NCT00770913|450414957|FG001|Overall Study|Protocol Violation|0|||
125215246|NCT00770913|450414958|FG002|Overall Study|Protocol Violation|1|||
125215247|NCT00770913|450414956|FG000|Overall Study|Incorrect drug was allocated|1|||
125215248|NCT00770913|450414957|FG001|Overall Study|Incorrect drug was allocated|0|||
125215249|NCT00770913|450414958|FG002|Overall Study|Incorrect drug was allocated|0|||
125215250|NCT00359294|450414962|FG000|Overall Study|Progressive disease|1|||
125215251|NCT00359294|450414963|FG001|Overall Study|Progressive disease|1|||
125215252|NCT00359294|450414964|FG002|Overall Study|Progressive disease|2|||
125215253|NCT00359294|450414965|FG003|Overall Study|Progressive disease|3|||
125215254|NCT00359294|450414966|FG004|Overall Study|Progressive disease|2|||
125215255|NCT00359294|450414962|FG000|Overall Study|Withdrawal by Subject|0|||
125215256|NCT00359294|450414963|FG001|Overall Study|Withdrawal by Subject|0|||
125215257|NCT00359294|450414964|FG002|Overall Study|Withdrawal by Subject|0|||
125215258|NCT00359294|450414965|FG003|Overall Study|Withdrawal by Subject|0|||
125374365|NCT02321800|451000287|FG000|Overall Study|Other, Miscellaneous|3|||
125374366|NCT02321800|451000288|FG001|Overall Study|Other, Miscellaneous|1|||
125374367|NCT00982878|451000289|FG000|Overall Study|Physician Decision|1|||
125374368|NCT01169493|451000295|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
125374369|NCT01169493|451000296|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
125374370|NCT01169493|451000297|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
125374371|NCT01169493|451000298|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
125374372|NCT01169493|451000299|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
125374373|NCT01169493|451000300|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
125374374|NCT01169493|451000295|FG000|Period 3 (6 Months)|Adverse Event|0|||
125215259|NCT00359294|450414966|FG004|Overall Study|Withdrawal by Subject|1|||
125215260|NCT00359294|450414962|FG000|Overall Study|Not treated|0|||
125215261|NCT00359294|450414963|FG001|Overall Study|Not treated|0|||
125374375|NCT01169493|451000296|FG001|Period 3 (6 Months)|Adverse Event|1|||
125374376|NCT01169493|451000297|FG002|Period 3 (6 Months)|Adverse Event|0|||
125374377|NCT01169493|451000298|FG003|Period 3 (6 Months)|Adverse Event|0|||
125374378|NCT01169493|451000299|FG004|Period 3 (6 Months)|Adverse Event|0|||
125374379|NCT01169493|451000300|FG005|Period 3 (6 Months)|Adverse Event|0|||
125374380|NCT01169493|451000295|FG000|Period 3 (6 Months)|Physician Decision|0|||
125374381|NCT01169493|451000296|FG001|Period 3 (6 Months)|Physician Decision|1|||
125374382|NCT01169493|451000297|FG002|Period 3 (6 Months)|Physician Decision|1|||
125374383|NCT01169493|451000298|FG003|Period 3 (6 Months)|Physician Decision|0|||
125374384|NCT01169493|451000299|FG004|Period 3 (6 Months)|Physician Decision|0|||
125374385|NCT01169493|451000300|FG005|Period 3 (6 Months)|Physician Decision|0|||
125374386|NCT03132220|451000301|FG000|Overall Study|Lost to Follow-up|17|||
125620366|NCT02563925|451892059|FG000|Overall Study|Withdrawal by Subject|2|||
125620367|NCT00400712|451892060|FG000|Overall Study|Death|1|||
125620368|NCT00400712|451892061|FG001|Overall Study|Death|0|||
125620369|NCT00400712|451892060|FG000|Overall Study|Withdrawal by Subject|11|||
125620370|NCT00400712|451892061|FG001|Overall Study|Withdrawal by Subject|12|||
125620371|NCT00400712|451892060|FG000|Overall Study|Physician Decision|5|||
125620372|NCT00400712|451892061|FG001|Overall Study|Physician Decision|4|||
125620373|NCT02553317|451892065|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
125620374|NCT02553317|451892066|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
125620375|NCT02553317|451892065|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
125620376|NCT02553317|451892066|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
125620377|NCT02553317|451892065|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
125620378|NCT02553317|451892066|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
125620379|NCT02553317|451892065|FG000|Overall Treatment Period + Follow-up|Death|1|||
125620380|NCT02553317|451892066|FG001|Overall Treatment Period + Follow-up|Death|3|||
125620381|NCT02553317|451892065|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
125620382|NCT02553317|451892066|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
125620383|NCT02553317|451892065|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
125620384|NCT02553317|451892066|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
125620385|NCT02553317|451892065|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
125620386|NCT02553317|451892066|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
125620387|NCT02553317|451892065|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
125620388|NCT02553317|451892066|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
125620389|NCT02553317|451892065|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
125620390|NCT02553317|451892066|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
125620391|NCT02553317|451892065|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
125620392|NCT02553317|451892066|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
125620393|NCT03691610|451892067|FG000|Overall Study|Adverse Event|0|||
125620394|NCT03691610|451892068|FG001|Overall Study|Adverse Event|1|||
125215262|NCT00359294|450414964|FG002|Overall Study|Not treated|0|||
125215263|NCT00359294|450414965|FG003|Overall Study|Not treated|1|||
125374387|NCT03132220|451000302|FG001|Overall Study|Lost to Follow-up|8|||
125374388|NCT03132220|451000301|FG000|Overall Study|Withdrawal by Subject|1|||
125374389|NCT03132220|451000302|FG001|Overall Study|Withdrawal by Subject|4|||
125620395|NCT03691610|451892069|FG002|Overall Study|Adverse Event|0|||
125620396|NCT03691610|451892070|FG003|Overall Study|Adverse Event|0|||
125620397|NCT03691610|451892067|FG000|Overall Study|Protocol Deviation|15|||
125620398|NCT03691610|451892068|FG001|Overall Study|Protocol Deviation|8|||
125620399|NCT03691610|451892069|FG002|Overall Study|Protocol Deviation|1|||
125620400|NCT03691610|451892070|FG003|Overall Study|Protocol Deviation|2|||
125620401|NCT03691610|451892067|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
125620402|NCT03691610|451892068|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
125620403|NCT03691610|451892069|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
125620404|NCT03691610|451892070|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
125620405|NCT03691610|451892067|FG000|Overall Study|Lost to Follow-up|20|||
125620406|NCT03691610|451892068|FG001|Overall Study|Lost to Follow-up|11|||
125620407|NCT03691610|451892069|FG002|Overall Study|Lost to Follow-up|5|||
125620408|NCT03691610|451892070|FG003|Overall Study|Lost to Follow-up|2|||
125620409|NCT00622869|451892072|FG000|Overall Study|Subject Withdrew Consent|13|||
125620410|NCT00622869|451892073|FG001|Overall Study|Subject Withdrew Consent|17|||
125620411|NCT00622869|451892074|FG002|Overall Study|Subject Withdrew Consent|11|||
125620412|NCT00622869|451892072|FG000|Overall Study|Administrative Problems|11|||
125620413|NCT00622869|451892073|FG001|Overall Study|Administrative Problems|17|||
125620414|NCT00622869|451892074|FG002|Overall Study|Administrative Problems|13|||
125620415|NCT00622869|451892072|FG000|Overall Study|Death|12|||
125620416|NCT00622869|451892073|FG001|Overall Study|Death|15|||
125620417|NCT00622869|451892074|FG002|Overall Study|Death|10|||
125620418|NCT00622869|451892072|FG000|Overall Study|Lost to Follow-up|2|||
125620419|NCT00622869|451892073|FG001|Overall Study|Lost to Follow-up|4|||
125620420|NCT00622869|451892074|FG002|Overall Study|Lost to Follow-up|2|||
125620421|NCT00622869|451892072|FG000|Overall Study|Graft Loss|5|||
125620422|NCT00622869|451892073|FG001|Overall Study|Graft Loss|3|||
125620423|NCT00622869|451892074|FG002|Overall Study|Graft Loss|2|||
125620424|NCT00622869|451892072|FG000|Overall Study|Missing|0|||
125620425|NCT00622869|451892073|FG001|Overall Study|Missing|1|||
125620426|NCT00622869|451892074|FG002|Overall Study|Missing|1|||
125620427|NCT03454412|451892075|FG000|Baseline Assesment|Physician Decision|12|||
125620428|NCT00115765|451892076|FG000|Overall Study|Withdrawal by Subject|22|||
125620429|NCT00115765|451892077|FG001|Overall Study|Withdrawal by Subject|53|||
125620430|NCT00115765|451892078|FG002|Overall Study|Withdrawal by Subject|76|||
125620431|NCT00115765|451892079|FG003|Overall Study|Withdrawal by Subject|15|||
125620432|NCT00115765|451892076|FG000|Overall Study|Physician Decision|4|||
125620433|NCT00115765|451892077|FG001|Overall Study|Physician Decision|15|||
125620434|NCT00115765|451892078|FG002|Overall Study|Physician Decision|18|||
125620435|NCT00115765|451892079|FG003|Overall Study|Physician Decision|13|||
125620436|NCT00115765|451892076|FG000|Overall Study|Lost to Follow-up|3|||
125620437|NCT00115765|451892077|FG001|Overall Study|Lost to Follow-up|20|||
125620438|NCT00115765|451892078|FG002|Overall Study|Lost to Follow-up|18|||
125620439|NCT00115765|451892079|FG003|Overall Study|Lost to Follow-up|1|||
125620440|NCT00115765|451892076|FG000|Overall Study|Other|6|||
125620441|NCT00115765|451892077|FG001|Overall Study|Other|12|||
125620442|NCT00115765|451892078|FG002|Overall Study|Other|9|||
125620443|NCT00115765|451892079|FG003|Overall Study|Other|2|||
125620444|NCT03543358|451892080|FG000|Overall Study|Death|1|||
125620445|NCT03543358|451892081|FG001|Overall Study|Death|0|||
125620446|NCT03543358|451892080|FG000|Overall Study|Disease Progression|1|||
125620447|NCT03543358|451892081|FG001|Overall Study|Disease Progression|0|||
125620448|NCT03543358|451892080|FG000|Overall Study|Parent Study Closure|1|||
125620449|NCT03543358|451892081|FG001|Overall Study|Parent Study Closure|0|||
125620450|NCT03956225|451892082|FG000|Overall Study|Lack of Efficacy|1|||
125620451|NCT03956225|451892083|FG001|Overall Study|Lack of Efficacy|1|||
125620452|NCT03956225|451892082|FG000|Overall Study|Lost to Follow-up|0|||
125215264|NCT00359294|450414966|FG004|Overall Study|Not treated|0|||
125620453|NCT03956225|451892083|FG001|Overall Study|Lost to Follow-up|1|||
125620454|NCT03956225|451892082|FG000|Overall Study|Withdrawal by Subject|2|||
125620455|NCT03956225|451892083|FG001|Overall Study|Withdrawal by Subject|1|||
125620456|NCT03956225|451892082|FG000|Overall Study|Other Reasons|2|||
125620457|NCT03956225|451892083|FG001|Overall Study|Other Reasons|1|||
125620458|NCT04093258|451892084|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
125620459|NCT04093258|451892085|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
125620460|NCT00594204|451892086|FG000|Overall Study|Adverse Event|15|||
125620461|NCT00594204|451892087|FG001|Overall Study|Adverse Event|3|||
125620462|NCT00594204|451892086|FG000|Overall Study|Lost to Follow-up|9|||
125620463|NCT00594204|451892087|FG001|Overall Study|Lost to Follow-up|5|||
125620464|NCT00594204|451892086|FG000|Overall Study|Withdrawal by Subject|23|||
125620465|NCT00594204|451892087|FG001|Overall Study|Withdrawal by Subject|29|||
125620466|NCT00594204|451892086|FG000|Overall Study|Other|4|||
125620467|NCT00594204|451892087|FG001|Overall Study|Other|3|||
125620468|NCT00594204|451892086|FG000|Overall Study|Lack of Efficacy|3|||
125620469|NCT00594204|451892087|FG001|Overall Study|Lack of Efficacy|4|||
125620470|NCT00594204|451892086|FG000|Overall Study|Randomized but not treated|4|||
125620471|NCT00594204|451892087|FG001|Overall Study|Randomized but not treated|1|||
125620472|NCT00986427|451892088|FG000|Overall Study|Lost to Follow-up|2|||
125620473|NCT00986427|451892089|FG001|Overall Study|Lost to Follow-up|0|||
125620474|NCT00986427|451892088|FG000|Overall Study|Lack of Efficacy|1|||
125620475|NCT00986427|451892089|FG001|Overall Study|Lack of Efficacy|0|||
125620476|NCT00986427|451892088|FG000|Overall Study|Withdrawal by Subject|1|||
125620477|NCT00986427|451892089|FG001|Overall Study|Withdrawal by Subject|0|||
125620478|NCT01115738|451892090|FG000|Overall Study|Death|1|||
125620479|NCT01115738|451892091|FG001|Overall Study|Death|0|||
125620480|NCT01115738|451892092|FG002|Overall Study|Death|0|||
125620481|NCT01115738|451892090|FG000|Overall Study|Lost to Follow-up|0|||
125620482|NCT01115738|451892091|FG001|Overall Study|Lost to Follow-up|0|||
125620483|NCT01115738|451892092|FG002|Overall Study|Lost to Follow-up|1|||
125620484|NCT01115738|451892090|FG000|Overall Study|Physician Decision|18|||
125620485|NCT01115738|451892091|FG001|Overall Study|Physician Decision|15|||
125620486|NCT01115738|451892092|FG002|Overall Study|Physician Decision|17|||
125620487|NCT01115738|451892090|FG000|Overall Study|Withdrawal by Subject|6|||
125620488|NCT01115738|451892091|FG001|Overall Study|Withdrawal by Subject|6|||
125620489|NCT01115738|451892092|FG002|Overall Study|Withdrawal by Subject|9|||
125620490|NCT01669811|451892101|FG000|Overall Study|Investigator decision|0|||
125620491|NCT01669811|451892102|FG001|Overall Study|Investigator decision|1|||
125620492|NCT01669811|451892101|FG000|Overall Study|Withdrawal by Subject|1|||
125620493|NCT01669811|451892102|FG001|Overall Study|Withdrawal by Subject|2|||
125620494|NCT01669811|451892101|FG000|Overall Study|Adverse Event|2|||
125620495|NCT01669811|451892102|FG001|Overall Study|Adverse Event|6|||
125620496|NCT01669811|451892101|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
125620497|NCT01669811|451892102|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
125620498|NCT04095442|451893360|FG000|Overall Study|Lost to Follow-up|0|||
125620499|NCT04095442|451893361|FG001|Overall Study|Lost to Follow-up|1|||
125620500|NCT04095442|451893360|FG000|Overall Study|Screen failure|1|||
125620501|NCT04095442|451893361|FG001|Overall Study|Screen failure|0|||
125620502|NCT03947255|451893364|FG000|Overall Study|Study Closure by Sponsor|2|||
125620503|NCT03947255|451893365|FG001|Overall Study|Study Closure by Sponsor|2|||
125620504|NCT03947255|451893364|FG000|Overall Study|Withdrawal by Subject|2|||
125620505|NCT03947255|451893365|FG001|Overall Study|Withdrawal by Subject|2|||
125620506|NCT03947255|451893364|FG000|Overall Study|Lost to Follow-up|2|||
125620507|NCT03947255|451893365|FG001|Overall Study|Lost to Follow-up|0|||
125620508|NCT03947255|451893364|FG000|Overall Study|Death|0|||
125620509|NCT03947255|451893365|FG001|Overall Study|Death|2|||
125620510|NCT00949910|451893366|FG000|Overall Study|Progressive Disease|3750|||
125620511|NCT00949910|451893366|FG000|Overall Study|Symptomatic Deterioration|1088|||
125620512|NCT00949910|451893366|FG000|Overall Study|Lost to Follow-up|100|||
125620513|NCT00949910|451893366|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
125620514|NCT00949910|451893366|FG000|Overall Study|Participant Refusal|390|||
125620515|NCT00949910|451893366|FG000|Overall Study|Death Due to Malignant Disease|456|||
125620516|NCT00949910|451893366|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
125620517|NCT00949910|451893366|FG000|Overall Study|Death Due to Adverse Event|115|||
125620518|NCT00949910|451893366|FG000|Overall Study|Death Due to Toxicity|3|||
125620519|NCT00949910|451893366|FG000|Overall Study|Death from Unknown Cause|5|||
125620520|NCT00949910|451893366|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
125620521|NCT00949910|451893366|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
125620522|NCT00949910|451893366|FG000|Overall Study|Switched to Commercial Treatment|4|||
125620523|NCT00949910|451893366|FG000|Overall Study|Violation of Eligibility|23|||
125620524|NCT00949910|451893366|FG000|Overall Study|Logistical Reasons|13|||
125620525|NCT00949910|451893366|FG000|Overall Study|Non-Compliance|10|||
125620526|NCT00949910|451893366|FG000|Overall Study|Prolonged Dosing Interruption|4|||
125620527|NCT00949910|451893366|FG000|Overall Study|Adverse Event|83|||
125620528|NCT00949910|451893366|FG000|Overall Study|Serious Adverse Event|6|||
125620529|NCT00949910|451893366|FG000|Overall Study|Physician/Participant Decision|7|||
125620530|NCT00949910|451893366|FG000|Overall Study|Other|4|||
125620531|NCT00949910|451893366|FG000|Overall Study|No Data|9|||
125620532|NCT03097614|451893367|FG000|Overall Study|Adverse Event|3|||
125620533|NCT02254551|451893371|FG000|Dose Escalation|Physician Decision|1|||
125620534|NCT02254551|451893371|FG000|Dose Escalation|Dose-limiting toxicity|2|||
125620535|NCT02759562|451893379|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
125620536|NCT02759562|451893380|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
125620537|NCT02759562|451893379|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
125620538|NCT02759562|451893380|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
125620539|NCT00387348|451893381|FG000|Overall Study|Death|1|||
125620540|NCT00387348|451893382|FG001|Overall Study|Death|1|||
125620541|NCT00387348|451893383|FG002|Overall Study|Death|0|||
125620542|NCT00387348|451893381|FG000|Overall Study|Physician Decision|1|||
125620543|NCT00387348|451893382|FG001|Overall Study|Physician Decision|0|||
125620544|NCT00387348|451893383|FG002|Overall Study|Physician Decision|1|||
125620545|NCT00387348|451893381|FG000|Overall Study|Withdrawal by Subject|0|||
125620546|NCT00387348|451893382|FG001|Overall Study|Withdrawal by Subject|2|||
125620547|NCT00387348|451893383|FG002|Overall Study|Withdrawal by Subject|2|||
125620548|NCT00387348|451893381|FG000|Overall Study|Adverse Event|1|||
125620549|NCT00387348|451893382|FG001|Overall Study|Adverse Event|0|||
125620550|NCT00387348|451893383|FG002|Overall Study|Adverse Event|1|||
125620551|NCT00505752|451893386|FG000|Overall Study|Adverse Event|1|||
125620552|NCT00505752|451893387|FG001|Overall Study|Adverse Event|0|||
125620553|NCT00505752|451893388|FG002|Overall Study|Adverse Event|1|||
125620554|NCT00505752|451893389|FG003|Overall Study|Adverse Event|0|||
125620555|NCT00505752|451893386|FG000|Overall Study|Lost to Follow-up|1|||
125620556|NCT00505752|451893387|FG001|Overall Study|Lost to Follow-up|0|||
125620557|NCT00505752|451893388|FG002|Overall Study|Lost to Follow-up|0|||
125620558|NCT00505752|451893389|FG003|Overall Study|Lost to Follow-up|0|||
125620559|NCT00505752|451893386|FG000|Overall Study|Lack of ovarian response|1|||
125620560|NCT00505752|451893387|FG001|Overall Study|Lack of ovarian response|3|||
125620561|NCT00505752|451893388|FG002|Overall Study|Lack of ovarian response|0|||
125620562|NCT00505752|451893389|FG003|Overall Study|Lack of ovarian response|0|||
125620563|NCT00505752|451893386|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
125620564|NCT00505752|451893387|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
125620565|NCT00505752|451893388|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
125620566|NCT00505752|451893389|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
125620567|NCT00505752|451893386|FG000|Overall Study|No oocytes retrieved|0|||
125620568|NCT00505752|451893387|FG001|Overall Study|No oocytes retrieved|2|||
125620569|NCT00505752|451893388|FG002|Overall Study|No oocytes retrieved|0|||
125620570|NCT00505752|451893389|FG003|Overall Study|No oocytes retrieved|1|||
125620571|NCT00505752|451893386|FG000|Overall Study|No Fertilization|1|||
125620572|NCT00505752|451893387|FG001|Overall Study|No Fertilization|1|||
125620573|NCT00505752|451893388|FG002|Overall Study|No Fertilization|2|||
125620574|NCT00505752|451893389|FG003|Overall Study|No Fertilization|1|||
125620575|NCT00505752|451893386|FG000|Overall Study|All embryos/blastocysts discarded|0|||
125620576|NCT00505752|451893387|FG001|Overall Study|All embryos/blastocysts discarded|0|||
125620577|NCT00505752|451893388|FG002|Overall Study|All embryos/blastocysts discarded|1|||
125620578|NCT00505752|451893389|FG003|Overall Study|All embryos/blastocysts discarded|1|||
125620579|NCT00505752|451893386|FG000|Overall Study|Other|1|||
125620580|NCT00505752|451893387|FG001|Overall Study|Other|2|||
125620581|NCT00505752|451893388|FG002|Overall Study|Other|1|||
125620582|NCT00505752|451893389|FG003|Overall Study|Other|2|||
125620583|NCT01925612|451893392|FG000|Overall Study|Progressive Disease|1|||
125620584|NCT01925612|451893393|FG001|Overall Study|Progressive Disease|1|||
125620585|NCT01925612|451893394|FG002|Overall Study|Progressive Disease|1|||
125620586|NCT01925612|451893395|FG003|Overall Study|Progressive Disease|0|||
125620587|NCT01925612|451893396|FG004|Overall Study|Progressive Disease|0|||
125620588|NCT01925612|451893392|FG000|Overall Study|Adverse Event|3|||
125620589|NCT01925612|451893393|FG001|Overall Study|Adverse Event|3|||
125620590|NCT01925612|451893394|FG002|Overall Study|Adverse Event|0|||
125620591|NCT01925612|451893395|FG003|Overall Study|Adverse Event|1|||
125620592|NCT01925612|451893396|FG004|Overall Study|Adverse Event|2|||
125620593|NCT04624672|451893402|FG000|Overall Study|Early Study Closure|2|||
125620594|NCT04624672|451893403|FG001|Overall Study|Early Study Closure|1|||
125620595|NCT03472040|451893404|FG000|Overall Study|Physician Decision|0|||
125620596|NCT03472040|451893405|FG001|Overall Study|Physician Decision|3|||
125620597|NCT03472040|451893404|FG000|Overall Study|Withdrawal by Subject|10|||
125620598|NCT03472040|451893405|FG001|Overall Study|Withdrawal by Subject|23|||
125620599|NCT03472040|451893404|FG000|Overall Study|Perceived Lack of Efficacy|29|||
125620600|NCT03472040|451893405|FG001|Overall Study|Perceived Lack of Efficacy|30|||
125620601|NCT03472040|451893404|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
125620602|NCT03472040|451893405|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
125620603|NCT03472040|451893404|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
125620604|NCT03472040|451893405|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
125620605|NCT03472040|451893404|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
125620606|NCT03472040|451893405|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
125620607|NCT03472040|451893404|FG000|Overall Study|Subject Non-compliance|2|||
125620608|NCT03472040|451893405|FG001|Overall Study|Subject Non-compliance|5|||
125620609|NCT03472040|451893404|FG000|Overall Study|Discontinuation due to Rash|0|||
125620610|NCT03472040|451893405|FG001|Overall Study|Discontinuation due to Rash|1|||
125620611|NCT03472040|451893404|FG000|Overall Study|Subsequent Ineligibility|0|||
125620612|NCT03472040|451893405|FG001|Overall Study|Subsequent Ineligibility|2|||
125620613|NCT03472040|451893404|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
125620614|NCT03472040|451893405|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
125620615|NCT02769832|451893406|FG000|Overall Study|Death|30|||
125620616|NCT00881361|451893431|FG000|Overall Study|Terminated prior to surgery|27|||
125620617|NCT00881361|451893432|FG001|Overall Study|Terminated prior to surgery|7|||
125620618|NCT00881361|451893433|FG002|Overall Study|Terminated prior to surgery|0|||
125620619|NCT00881361|451893431|FG000|Overall Study|Ineligible|17|||
125620620|NCT00881361|451893432|FG001|Overall Study|Ineligible|2|||
125620621|NCT00881361|451893433|FG002|Overall Study|Ineligible|2|||
125620622|NCT01413542|451893434|FG000|Overall Study|Physician Decision|1|||
125620623|NCT01413542|451893435|FG001|Overall Study|Physician Decision|0|||
125620624|NCT01413542|451893436|FG002|Overall Study|Physician Decision|3|||
125620625|NCT01413542|451893437|FG003|Overall Study|Physician Decision|0|||
125620626|NCT01413542|451893434|FG000|Overall Study|Adverse Event|0|||
125620627|NCT01413542|451893435|FG001|Overall Study|Adverse Event|0|||
125620628|NCT01413542|451893436|FG002|Overall Study|Adverse Event|0|||
125620629|NCT01413542|451893437|FG003|Overall Study|Adverse Event|1|||
125620630|NCT02505542|451893438|FG000|Part A: Open-Label Period|Adverse Event|31|||
125620631|NCT02505542|451893439|FG001|Part A: Open-Label Period|Adverse Event|0|||
125620632|NCT02505542|451893440|FG002|Part A: Open-Label Period|Adverse Event|0|||
125620633|NCT02505542|451893441|FG003|Part A: Open-Label Period|Adverse Event|0|||
125620634|NCT02505542|451893438|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
125620635|NCT02505542|451893439|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
125620636|NCT02505542|451893440|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
125620637|NCT02505542|451893441|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
125620638|NCT02505542|451893438|FG000|Part A: Open-Label Period|Protocol Violation|1|||
125620639|NCT02505542|451893439|FG001|Part A: Open-Label Period|Protocol Violation|0|||
125620640|NCT02505542|451893440|FG002|Part A: Open-Label Period|Protocol Violation|0|||
125620641|NCT02505542|451893441|FG003|Part A: Open-Label Period|Protocol Violation|0|||
125374390|NCT05228132|451000303|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
125620642|NCT02505542|451893438|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
125620643|NCT02505542|451893439|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
125620644|NCT02505542|451893440|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
125620645|NCT02505542|451893441|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
125620646|NCT02505542|451893438|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
125620647|NCT02505542|451893439|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
125620648|NCT02505542|451893440|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
125620649|NCT02505542|451893441|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
125620650|NCT02505542|451893438|FG000|Part A: Open-Label Period|New medical history available|1|||
125620651|NCT02505542|451893439|FG001|Part A: Open-Label Period|New medical history available|0|||
125620652|NCT02505542|451893440|FG002|Part A: Open-Label Period|New medical history available|0|||
125620653|NCT02505542|451893441|FG003|Part A: Open-Label Period|New medical history available|0|||
125620654|NCT02505542|451893438|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
125620655|NCT02505542|451893439|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
125620656|NCT02505542|451893440|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
125620657|NCT02505542|451893441|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
125620658|NCT02505542|451893438|FG000|Part A: Open-Label Period|Pregnancy|2|||
125620659|NCT02505542|451893439|FG001|Part A: Open-Label Period|Pregnancy|0|||
125620660|NCT02505542|451893440|FG002|Part A: Open-Label Period|Pregnancy|0|||
125620661|NCT02505542|451893441|FG003|Part A: Open-Label Period|Pregnancy|0|||
125620662|NCT02505542|451893438|FG000|Part A: Open-Label Period|Sponsor directive|1|||
125620663|NCT02505542|451893439|FG001|Part A: Open-Label Period|Sponsor directive|0|||
125620664|NCT02505542|451893440|FG002|Part A: Open-Label Period|Sponsor directive|0|||
125620665|NCT02505542|451893441|FG003|Part A: Open-Label Period|Sponsor directive|0|||
125620666|NCT02505542|451893438|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
125620667|NCT02505542|451893439|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
125620668|NCT02505542|451893440|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
125620669|NCT02505542|451893441|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
125620670|NCT02505542|451893438|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
125620671|NCT02505542|451893439|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
125620672|NCT02505542|451893440|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
125620673|NCT02505542|451893441|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
125620674|NCT02505542|451893438|FG000|Part A: Open-Label Period|Non-compliance|1|||
125620675|NCT02505542|451893439|FG001|Part A: Open-Label Period|Non-compliance|0|||
125620676|NCT02505542|451893440|FG002|Part A: Open-Label Period|Non-compliance|0|||
125620677|NCT02505542|451893441|FG003|Part A: Open-Label Period|Non-compliance|0|||
125620678|NCT02505542|451893438|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
125620679|NCT02505542|451893439|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
125620680|NCT02505542|451893440|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
125620681|NCT02505542|451893441|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
125620682|NCT02505542|451893438|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
125620683|NCT02505542|451893439|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
125620684|NCT02505542|451893440|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
125620685|NCT02505542|451893441|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
125620686|NCT02505542|451893438|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
125620687|NCT02505542|451893439|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
125620688|NCT02505542|451893440|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
125620689|NCT02505542|451893441|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
125620690|NCT02505542|451893438|FG000|Part B: Double-Blind Period|Adverse Event|0|||
125620691|NCT02505542|451893439|FG001|Part B: Double-Blind Period|Adverse Event|0|||
125620692|NCT02505542|451893440|FG002|Part B: Double-Blind Period|Adverse Event|1|||
125620693|NCT02505542|451893441|FG003|Part B: Double-Blind Period|Adverse Event|3|||
125620694|NCT02505542|451893438|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
125620695|NCT02505542|451893439|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
125620696|NCT02505542|451893440|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
125620697|NCT02505542|451893441|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
125620698|NCT02505542|451893438|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
125620699|NCT02505542|451893439|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
125374391|NCT05228132|451000303|FG000|Overall Study|Adverse Event|3|||
125374392|NCT05228132|451000303|FG000|Overall Study|Lost to Follow-up|1|||
125620700|NCT02505542|451893440|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
125620701|NCT02505542|451893441|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
125620702|NCT02505542|451893438|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
125374393|NCT05228132|451000303|FG000|Overall Study|Arteriovenous-fistula mature|1|||
125374394|NCT01336764|451000304|FG000|Overall Study|Withdrawal by Subject|5|||
125374395|NCT01336764|451000305|FG001|Overall Study|Withdrawal by Subject|5|||
125620703|NCT02505542|451893439|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
125620704|NCT02505542|451893440|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
125620705|NCT02505542|451893441|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
125620706|NCT02505542|451893438|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
125620707|NCT02505542|451893439|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
125620708|NCT02505542|451893440|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
125620709|NCT02505542|451893441|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
125620710|NCT02505542|451893438|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
125374396|NCT01906008|451000315|FG000|Overall Study|Lost to Follow-up|2|||
125374397|NCT01906008|451000316|FG001|Overall Study|Lost to Follow-up|0|||
125374398|NCT01906008|451000315|FG000|Overall Study|Oxaliplatin toxicity|2|||
125374399|NCT01906008|451000316|FG001|Overall Study|Oxaliplatin toxicity|0|||
125620711|NCT02505542|451893439|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
125620712|NCT02505542|451893440|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
125620713|NCT02505542|451893441|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
125620714|NCT02505542|451893438|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
125620715|NCT02505542|451893439|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
125620716|NCT02505542|451893440|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
125620717|NCT02505542|451893441|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
125620718|NCT02505542|451893438|FG000|Part B: Double-Blind Period|Miscalculation|0|||
125620719|NCT02505542|451893439|FG001|Part B: Double-Blind Period|Miscalculation|1|||
125374400|NCT01906008|451000315|FG000|Overall Study|Protocol Violation|0|||
125374401|NCT01906008|451000316|FG001|Overall Study|Protocol Violation|1|||
125374402|NCT01906008|451000315|FG000|Overall Study|Withdrawal by Subject|1|||
125374403|NCT01906008|451000316|FG001|Overall Study|Withdrawal by Subject|5|||
125620720|NCT02505542|451893440|FG002|Part B: Double-Blind Period|Miscalculation|0|||
125620721|NCT02505542|451893441|FG003|Part B: Double-Blind Period|Miscalculation|0|||
125620722|NCT02505542|451893438|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
125620723|NCT02505542|451893439|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
125620724|NCT02505542|451893440|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
125620725|NCT02505542|451893441|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
125620726|NCT02988219|451893442|FG000|Overall Study|Lack of Efficacy|1|||
125620727|NCT02988219|451893443|FG001|Overall Study|Lack of Efficacy|1|||
125620728|NCT02988219|451893442|FG000|Overall Study|Withdrawal by Subject|0|||
125620729|NCT02988219|451893443|FG001|Overall Study|Withdrawal by Subject|2|||
125620730|NCT01522443|451893444|FG000|Overall Study|No longer receiving clinical benefit|36|||
125620731|NCT01522443|451893445|FG001|Overall Study|No longer receiving clinical benefit|28|||
125620732|NCT01522443|451893444|FG000|Overall Study|Adverse Event|10|||
125620733|NCT01522443|451893445|FG001|Overall Study|Adverse Event|15|||
125620734|NCT01522443|451893444|FG000|Overall Study|Withdrawal by Subject|5|||
125620735|NCT01522443|451893445|FG001|Overall Study|Withdrawal by Subject|8|||
125620736|NCT01522443|451893444|FG000|Overall Study|No study treatment given|1|||
125620737|NCT01522443|451893445|FG001|Overall Study|No study treatment given|1|||
125620738|NCT01522443|451893444|FG000|Overall Study|Other|1|||
125620739|NCT01522443|451893445|FG001|Overall Study|Other|3|||
125620740|NCT00776555|451893446|FG000|Overall Study|Study terminated|3|||
125620741|NCT00776555|451893447|FG001|Overall Study|Study terminated|0|||
125620742|NCT04685499|451893448|FG000|Overall Study|Study Terminated Early|1|||
125620743|NCT03176277|451893449|FG000|Part A Dose Escalation Study|Adverse Event|1|||
125620744|NCT03176277|451893450|FG001|Part A Dose Escalation Study|Adverse Event|0|||
125620745|NCT03176277|451893451|FG002|Part A Dose Escalation Study|Adverse Event|1|||
125620746|NCT03176277|451893452|FG003|Part A Dose Escalation Study|Adverse Event|0|||
125620747|NCT03176277|451893449|FG000|Part A Dose Escalation Study|Physician Decision|1|||
125620748|NCT03176277|451893450|FG001|Part A Dose Escalation Study|Physician Decision|1|||
125620749|NCT03176277|451893451|FG002|Part A Dose Escalation Study|Physician Decision|2|||
125620750|NCT03176277|451893452|FG003|Part A Dose Escalation Study|Physician Decision|0|||
125620751|NCT03176277|451893449|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
125620752|NCT03176277|451893450|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
125620753|NCT03176277|451893451|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
125620754|NCT03176277|451893452|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
125620755|NCT03176277|451893449|FG000|Part A Dose Escalation Study|Progressive disease|3|||
125620756|NCT03176277|451893450|FG001|Part A Dose Escalation Study|Progressive disease|1|||
125620757|NCT03176277|451893451|FG002|Part A Dose Escalation Study|Progressive disease|3|||
125620758|NCT03176277|451893452|FG003|Part A Dose Escalation Study|Progressive disease|0|||
125374404|NCT01906008|451000315|FG000|Overall Study|Did not start study med|3|||
125374405|NCT01906008|451000316|FG001|Overall Study|Did not start study med|4|||
125374406|NCT01906008|451000315|FG000|Overall Study|Oxaliplatin stops|10|||
125620759|NCT00634114|451893453|FG000|Overall Study|Adverse Event|6|||
125620760|NCT00634114|451893454|FG001|Overall Study|Adverse Event|8|||
125620761|NCT00634114|451893455|FG002|Overall Study|Adverse Event|3|||
125620762|NCT00634114|451893453|FG000|Overall Study|Withdrawal by Subject|9|||
125620763|NCT00634114|451893454|FG001|Overall Study|Withdrawal by Subject|6|||
125374407|NCT01906008|451000316|FG001|Overall Study|Oxaliplatin stops|8|||
125374408|NCT01906008|451000315|FG000|Overall Study|Hospice|1|||
125374409|NCT01906008|451000316|FG001|Overall Study|Hospice|0|||
125374410|NCT01906008|451000315|FG000|Overall Study|Physician Decision|3|||
125374411|NCT01906008|451000316|FG001|Overall Study|Physician Decision|3|||
125374412|NCT01906008|451000315|FG000|Overall Study|Lack of compliance of study med|5|||
125374413|NCT01906008|451000316|FG001|Overall Study|Lack of compliance of study med|3|||
125374414|NCT01906008|451000315|FG000|Overall Study|Adverse Event|0|||
125374415|NCT01906008|451000316|FG001|Overall Study|Adverse Event|3|||
125374416|NCT00730132|451000317|FG000|Overall Study|Protocol Violation|154|||
125374417|NCT00730132|451000317|FG000|Overall Study|Death|1|||
125374418|NCT01626391|451000318|FG000|Overall Study|Physician Decision|1|||
125374419|NCT01626391|451000319|FG001|Overall Study|Physician Decision|0|||
125374420|NCT01626391|451000318|FG000|Overall Study|Withdrawal by Subject|1|||
125374421|NCT01626391|451000319|FG001|Overall Study|Withdrawal by Subject|0|||
125374422|NCT02220205|451000320|FG000|Overall Study|Withdrawal by Subject|1|||
125374423|NCT02220205|451000321|FG001|Overall Study|Withdrawal by Subject|0|||
125620764|NCT00634114|451893455|FG002|Overall Study|Withdrawal by Subject|11|||
125620765|NCT00634114|451893453|FG000|Overall Study|Lost to Follow-up|0|||
125620766|NCT00634114|451893454|FG001|Overall Study|Lost to Follow-up|0|||
125620767|NCT00634114|451893455|FG002|Overall Study|Lost to Follow-up|1|||
125620768|NCT00634114|451893453|FG000|Overall Study|Protocol Violation|3|||
125620769|NCT00634114|451893454|FG001|Overall Study|Protocol Violation|3|||
125620770|NCT00634114|451893455|FG002|Overall Study|Protocol Violation|1|||
125620771|NCT00634114|451893453|FG000|Overall Study|Pregnancy|1|||
125620772|NCT00634114|451893454|FG001|Overall Study|Pregnancy|0|||
125620773|NCT00634114|451893455|FG002|Overall Study|Pregnancy|0|||
125620774|NCT00634114|451893453|FG000|Overall Study|Incorrect enrolment|0|||
125620775|NCT00634114|451893454|FG001|Overall Study|Incorrect enrolment|1|||
125620776|NCT00634114|451893455|FG002|Overall Study|Incorrect enrolment|0|||
125620777|NCT00634114|451893453|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
125620778|NCT00634114|451893454|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
125620779|NCT00634114|451893455|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
125620780|NCT00634114|451893453|FG000|Overall Study|Difficult to continue|3|||
125620781|NCT00634114|451893454|FG001|Overall Study|Difficult to continue|1|||
125620782|NCT00634114|451893455|FG002|Overall Study|Difficult to continue|1|||
125620783|NCT00634114|451893453|FG000|Overall Study|Other reason|1|||
125620784|NCT00634114|451893454|FG001|Overall Study|Other reason|1|||
125620785|NCT00634114|451893455|FG002|Overall Study|Other reason|1|||
125620786|NCT03699631|451893456|FG000|Overall Study|Adverse Event|3|||
125620787|NCT02940626|451893457|FG000|Overall Study|Death|40|||
125620788|NCT02940626|451893458|FG001|Overall Study|Death|32|||
125620789|NCT02940626|451893457|FG000|Overall Study|Lost to Follow-up|5|||
125620790|NCT02940626|451893458|FG001|Overall Study|Lost to Follow-up|2|||
125620791|NCT02940626|451893457|FG000|Overall Study|Withdrawal by Subject|1|||
125620792|NCT02940626|451893458|FG001|Overall Study|Withdrawal by Subject|0|||
125620793|NCT02940626|451893457|FG000|Overall Study|Transfer to Hospice Care|1|||
125620794|NCT02940626|451893458|FG001|Overall Study|Transfer to Hospice Care|0|||
125620795|NCT02940626|451893457|FG000|Overall Study|Prohibited Concomitant Medication|0|||
125620796|NCT02940626|451893458|FG001|Overall Study|Prohibited Concomitant Medication|1|||
125620797|NCT01996904|451893459|FG000|Overall Study|Lost to Follow-up|38|||
125620798|NCT01996904|451893460|FG001|Overall Study|Lost to Follow-up|27|||
125620799|NCT00585923|451893461|FG000|Overall Study|Physician decided not to continue|31|||
125620800|NCT00585923|451893462|FG001|Overall Study|Physician decided not to continue|33|||
125620801|NCT01324622|451893463|FG000|Overall Study|Lost to Follow-up|7|||
125620802|NCT01324622|451893464|FG001|Overall Study|Lost to Follow-up|7|||
125620803|NCT01324622|451893463|FG000|Overall Study|Death|1|||
125620804|NCT01324622|451893464|FG001|Overall Study|Death|0|||
125620805|NCT01324622|451893463|FG000|Overall Study|Lack of Efficacy|1|||
125620806|NCT01324622|451893464|FG001|Overall Study|Lack of Efficacy|0|||
125620807|NCT00618449|451893465|FG000|Overall Study|Lost to Follow-up|98|||
125620808|NCT00618449|451893466|FG001|Overall Study|Lost to Follow-up|110|||
125374424|NCT00518986|451000323|FG000|Overall Study|Adverse Event|12|||
125620809|NCT05127421|451893467|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
125620810|NCT05127421|451893468|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
125620811|NCT05127421|451893469|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
125620812|NCT05127421|451893470|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
125620813|NCT05127421|451893467|FG000|4-Week Double-Blind Period|Physician Decision|1|||
125374425|NCT00518986|451000324|FG001|Overall Study|Adverse Event|7|||
125374426|NCT00518986|451000323|FG000|Overall Study|Lack of Efficacy|0|||
125374427|NCT00518986|451000324|FG001|Overall Study|Lack of Efficacy|2|||
125374428|NCT00518986|451000323|FG000|Overall Study|Lost to Follow-up|3|||
125620814|NCT05127421|451893468|FG001|4-Week Double-Blind Period|Physician Decision|0|||
125620815|NCT05127421|451893469|FG002|4-Week Double-Blind Period|Physician Decision|0|||
125620816|NCT05127421|451893470|FG003|4-Week Double-Blind Period|Physician Decision|0|||
125620817|NCT05127421|451893467|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
125620818|NCT05127421|451893468|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
125620819|NCT05127421|451893469|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
125620820|NCT05127421|451893470|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
125620821|NCT05127421|451893467|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
125620822|NCT05127421|451893468|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
125620823|NCT05127421|451893469|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
125620824|NCT05127421|451893470|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
125620825|NCT05127421|451893467|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
125620826|NCT05127421|451893468|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
125620827|NCT05127421|451893469|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
125620828|NCT05127421|451893470|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
125620829|NCT05127421|451893467|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
125620830|NCT05127421|451893468|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
125620831|NCT05127421|451893469|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
125620832|NCT05127421|451893470|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
125620833|NCT05127421|451893467|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
125374429|NCT00518986|451000324|FG001|Overall Study|Lost to Follow-up|2|||
125374430|NCT00518986|451000323|FG000|Overall Study|Physician Decision|0|||
125620834|NCT05127421|451893468|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
125620835|NCT05127421|451893469|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
125620836|NCT05127421|451893470|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
125620837|NCT05127421|451893467|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
125620838|NCT05127421|451893468|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
125620839|NCT05127421|451893469|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
125620840|NCT05127421|451893470|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
125620841|NCT01441115|451893471|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
125620842|NCT00138424|451893472|FG000|Overall Study|Physician Decision|0|||
125620843|NCT00138424|451893473|FG001|Overall Study|Physician Decision|1|||
125620844|NCT00138424|451893474|FG002|Overall Study|Physician Decision|0|||
125620845|NCT00138424|451893475|FG003|Overall Study|Physician Decision|0|||
125620846|NCT00574496|451893478|FG000|Overall Study|Withdrawal by Subject|1|||
125620847|NCT02176291|451893479|FG000|Overall Study|Death|1|||
125620848|NCT02176291|451893480|FG001|Overall Study|Death|0|||
125620849|NCT02176291|451893479|FG000|Overall Study|non compliance with protocol|2|||
125620850|NCT02176291|451893480|FG001|Overall Study|non compliance with protocol|0|||
125620851|NCT02176291|451893479|FG000|Overall Study|Withdrawal by Subject|2|||
125620852|NCT02176291|451893480|FG001|Overall Study|Withdrawal by Subject|0|||
125620853|NCT01167582|451893481|FG000|Overall Study|Lost to Follow-up|0|||
125620854|NCT01167582|451893482|FG001|Overall Study|Lost to Follow-up|1|||
125620855|NCT01518244|451893483|FG000|Overall Study|Adverse Event|3|||
125620856|NCT01766817|451893485|FG000|Overall Study|Drug-related adverse event|1|||
125620857|NCT01766817|451893486|FG001|Overall Study|Drug-related adverse event|2|||
125620858|NCT01766817|451893487|FG002|Overall Study|Drug-related adverse event|1|||
125620859|NCT01766817|451893485|FG000|Overall Study|Drug-unrelated adverse event|3|||
125374431|NCT00518986|451000324|FG001|Overall Study|Physician Decision|3|||
125374432|NCT00518986|451000323|FG000|Overall Study|Protocol Violation|5|||
125374433|NCT00518986|451000324|FG001|Overall Study|Protocol Violation|7|||
125374434|NCT00518986|451000323|FG000|Overall Study|Withdrawal by Subject|4|||
125374435|NCT00518986|451000324|FG001|Overall Study|Withdrawal by Subject|4|||
125374436|NCT00518986|451000323|FG000|Overall Study|Non-Specific|2|||
125374437|NCT00518986|451000324|FG001|Overall Study|Non-Specific|1|||
125374438|NCT02088047|451000325|FG000|Overall Study|Withdrawal by Subject|1|||
125374439|NCT02088047|451000326|FG001|Overall Study|Withdrawal by Subject|0|||
125374440|NCT04171531|451000329|FG000|Overall Study|Lost to Follow-up|4|||
125374441|NCT04171531|451000330|FG001|Overall Study|Lost to Follow-up|5|||
125374442|NCT04171531|451000329|FG000|Overall Study|Consent only through 6 months|1|||
125374443|NCT04171531|451000330|FG001|Overall Study|Consent only through 6 months|1|||
125374444|NCT04171531|451000329|FG000|Overall Study|Insurance did not cover procedure|0|||
125620860|NCT01766817|451893486|FG001|Overall Study|Drug-unrelated adverse event|3|||
125620861|NCT01766817|451893487|FG002|Overall Study|Drug-unrelated adverse event|3|||
125620862|NCT01766817|451893485|FG000|Overall Study|Death|1|||
125620863|NCT01766817|451893486|FG001|Overall Study|Death|1|||
125620864|NCT01766817|451893487|FG002|Overall Study|Death|0|||
125620865|NCT01766817|451893485|FG000|Overall Study|Unable to take study drug|0|||
125620866|NCT01766817|451893486|FG001|Overall Study|Unable to take study drug|1|||
125620867|NCT01766817|451893487|FG002|Overall Study|Unable to take study drug|0|||
125620868|NCT01766817|451893485|FG000|Overall Study|Withdrawal by Subject|2|||
125620869|NCT01766817|451893486|FG001|Overall Study|Withdrawal by Subject|0|||
125620870|NCT01766817|451893487|FG002|Overall Study|Withdrawal by Subject|3|||
125620871|NCT01766817|451893485|FG000|Overall Study|Subject non-compliance|0|||
125620872|NCT01766817|451893486|FG001|Overall Study|Subject non-compliance|1|||
125374445|NCT04171531|451000330|FG001|Overall Study|Insurance did not cover procedure|1|||
125374446|NCT04171531|451000329|FG000|Overall Study|Physician Decision|0|||
125374447|NCT04171531|451000330|FG001|Overall Study|Physician Decision|3|||
125433114|NCT00085202|451212438|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
125215265|NCT00359294|450414962|FG000|Overall Study|Physician Decision|0|||
125215266|NCT00359294|450414963|FG001|Overall Study|Physician Decision|0|||
125215267|NCT00359294|450414964|FG002|Overall Study|Physician Decision|1|||
125215268|NCT00359294|450414965|FG003|Overall Study|Physician Decision|0|||
125215269|NCT00359294|450414966|FG004|Overall Study|Physician Decision|0|||
125215270|NCT01398358|450414973|FG000|Overall Study|Lost to Follow-up|11|||
125215271|NCT01398358|450414974|FG001|Overall Study|Lost to Follow-up|21|||
125215272|NCT01398358|450414975|FG002|Overall Study|Lost to Follow-up|18|||
125620873|NCT01766817|451893487|FG002|Overall Study|Subject non-compliance|2|||
125620874|NCT01766817|451893485|FG000|Overall Study|Physician Decision|3|||
125620875|NCT01766817|451893486|FG001|Overall Study|Physician Decision|3|||
125620876|NCT01766817|451893487|FG002|Overall Study|Physician Decision|4|||
125620877|NCT01766817|451893485|FG000|Overall Study|Other|1|||
125620878|NCT01766817|451893486|FG001|Overall Study|Other|0|||
125620879|NCT01766817|451893487|FG002|Overall Study|Other|0|||
125620880|NCT02260648|451893491|FG000|Overall Study|Adverse Event|3|||
125620881|NCT02260648|451893492|FG001|Overall Study|Adverse Event|0|||
125620882|NCT02260648|451893493|FG002|Overall Study|Adverse Event|1|||
125620883|NCT02260648|451893491|FG000|Overall Study|Withdrawal by Subject|1|||
125620884|NCT02260648|451893492|FG001|Overall Study|Withdrawal by Subject|1|||
125620885|NCT02260648|451893493|FG002|Overall Study|Withdrawal by Subject|0|||
125620886|NCT02260648|451893491|FG000|Overall Study|Protocol Violation|1|||
125620887|NCT02260648|451893492|FG001|Overall Study|Protocol Violation|0|||
125620888|NCT02260648|451893493|FG002|Overall Study|Protocol Violation|0|||
125620889|NCT02260648|451893491|FG000|Overall Study|Discontinue Due to Study Termination|13|||
125620890|NCT02260648|451893492|FG001|Overall Study|Discontinue Due to Study Termination|12|||
125620891|NCT02260648|451893493|FG002|Overall Study|Discontinue Due to Study Termination|7|||
125620892|NCT01401465|451893494|FG000|Treatment Period 1|Adverse Event|4|||
125620893|NCT01401465|451893495|FG001|Treatment Period 1|Adverse Event|1|||
125620894|NCT01401465|451893494|FG000|Treatment Period 1|Pregnancy|0|||
125620895|NCT01401465|451893495|FG001|Treatment Period 1|Pregnancy|1|||
125620896|NCT01401465|451893494|FG000|Treatment Period 1|Protocol Violation|5|||
125620897|NCT01401465|451893495|FG001|Treatment Period 1|Protocol Violation|0|||
125620898|NCT01401465|451893494|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125620899|NCT01401465|451893495|FG001|Treatment Period 1|Withdrawal by Subject|4|||
125620900|NCT01401465|451893494|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
125620901|NCT01401465|451893495|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
125620902|NCT01401465|451893494|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
125620903|NCT01401465|451893495|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
125215273|NCT01398358|450414973|FG000|Overall Study|Withdrawal by Subject|3|||
125620904|NCT01401465|451893494|FG000|Treatment Period 1|Scheduling Difficulties|1|||
125215274|NCT01398358|450414974|FG001|Overall Study|Withdrawal by Subject|2|||
125374448|NCT04171531|451000329|FG000|Overall Study|Withdrawal by Subject|1|||
125374449|NCT04171531|451000330|FG001|Overall Study|Withdrawal by Subject|5|||
125374450|NCT04862585|451000331|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
125620905|NCT01401465|451893495|FG001|Treatment Period 1|Scheduling Difficulties|1|||
125620906|NCT01401465|451893494|FG000|Treatment Period 2|Lost to Follow-up|0|||
125620907|NCT01401465|451893495|FG001|Treatment Period 2|Lost to Follow-up|1|||
125620908|NCT01401465|451893494|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125620909|NCT01401465|451893495|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125620910|NCT04142216|451893496|FG000|Overall Study|Hospitalization|0|||
125620911|NCT04142216|451893497|FG001|Overall Study|Hospitalization|2|||
125620912|NCT04142216|451893496|FG000|Overall Study|Death|3|||
125620913|NCT04142216|451893497|FG001|Overall Study|Death|1|||
125620914|NCT04142216|451893496|FG000|Overall Study|Referral to another hemodialysis unit|3|||
125620915|NCT04142216|451893497|FG001|Overall Study|Referral to another hemodialysis unit|2|||
125620916|NCT04142216|451893496|FG000|Overall Study|Use of clove|0|||
125620917|NCT04142216|451893497|FG001|Overall Study|Use of clove|1|||
125620918|NCT01054976|451893500|FG000|Overall Study|Adverse Event|16|||
125620919|NCT01054976|451893500|FG000|Overall Study|Uncooperative participations to study|7|||
125620920|NCT01054976|451893500|FG000|Overall Study|Withdrawal by Subject|4|||
125620921|NCT01054976|451893500|FG000|Overall Study|Other|8|||
125620922|NCT01195363|451893501|FG000|Overall Study|Lost to Follow-up|7|||
125620923|NCT01195363|451893502|FG001|Overall Study|Lost to Follow-up|4|||
125620924|NCT01195363|451893501|FG000|Overall Study|Adverse Event|3|||
125620925|NCT01195363|451893502|FG001|Overall Study|Adverse Event|1|||
125620926|NCT01195363|451893501|FG000|Overall Study|Lack of Efficacy|0|||
125620927|NCT01195363|451893502|FG001|Overall Study|Lack of Efficacy|4|||
125620928|NCT01195363|451893501|FG000|Overall Study|incarceration|1|||
125620929|NCT01195363|451893502|FG001|Overall Study|incarceration|0|||
125620930|NCT00077376|451893505|FG000|Overall Study|Adverse Event|8|||
125620931|NCT00077376|451893505|FG000|Overall Study|Withdrawal by Subject|2|||
125620932|NCT00077376|451893505|FG000|Overall Study|Death|1|||
125620933|NCT00077376|451893505|FG000|Overall Study|Physician Decision|1|||
125620934|NCT00077376|451893505|FG000|Overall Study|Alternative therapy|5|||
125620935|NCT00077376|451893505|FG000|Overall Study|Complicating disease|1|||
125620936|NCT00077376|451893505|FG000|Overall Study|Still on treatment|1|||
125620937|NCT00077376|451893505|FG000|Overall Study|Symptomatic deterioration|1|||
125620938|NCT00077376|451893505|FG000|Overall Study|Surgery|1|||
125620939|NCT00077376|451893505|FG000|Overall Study|Insurance ran out|1|||
125620940|NCT05691829|451895620|FG000|Overall Study|Physician Decision|2|||
125620941|NCT05691829|451895620|FG000|Overall Study|Eligibility criteria not met|3|||
125620942|NCT00453180|451895625|FG000|Overall Study|Lost to Follow-up|2|||
125620943|NCT00453180|451895626|FG001|Overall Study|Lost to Follow-up|1|||
125620944|NCT00453180|451895625|FG000|Overall Study|Adverse Event|1|||
125620945|NCT00453180|451895626|FG001|Overall Study|Adverse Event|2|||
125620946|NCT01002742|451895633|FG000|Overall Study|Determined to be ineligible|0|||
125620947|NCT01002742|451895634|FG001|Overall Study|Determined to be ineligible|1|||
125620948|NCT02862548|451895646|FG000|Randomized Phase (Up to Week 48)|Death|0|||
125620949|NCT02862548|451895647|FG001|Randomized Phase (Up to Week 48)|Death|1|||
125620950|NCT02862548|451895646|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
125620951|NCT02862548|451895647|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
125620952|NCT02862548|451895646|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
125620953|NCT02862548|451895647|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
125620954|NCT02862548|451895646|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
125620955|NCT02862548|451895647|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
125620956|NCT00880763|451895648|FG000|Extension Period (Part 2)|Adverse Event|0|||
125620957|NCT00880763|451895649|FG001|Extension Period (Part 2)|Adverse Event|0|||
125620958|NCT00880763|451895650|FG002|Extension Period (Part 2)|Adverse Event|1|||
125620959|NCT00880763|451895651|FG003|Extension Period (Part 2)|Adverse Event|1|||
125620960|NCT00880763|451895648|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
125620961|NCT00880763|451895649|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
125620962|NCT00880763|451895650|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
125620963|NCT00880763|451895651|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
125620964|NCT00880763|451895648|FG000|Extension Period (Part 2)|Physician Decision|0|||
125620965|NCT00880763|451895649|FG001|Extension Period (Part 2)|Physician Decision|1|||
125620966|NCT00880763|451895650|FG002|Extension Period (Part 2)|Physician Decision|1|||
125620967|NCT00880763|451895651|FG003|Extension Period (Part 2)|Physician Decision|0|||
125620968|NCT00880763|451895648|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
125620969|NCT00880763|451895649|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
125620970|NCT00880763|451895650|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
125620971|NCT00880763|451895651|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
125620972|NCT02670928|451895652|FG000|Overall Study|Adverse Event|3|||
125620973|NCT02670928|451895653|FG001|Overall Study|Adverse Event|1|||
125620974|NCT02670928|451895652|FG000|Overall Study|Withdrawal by Subject|4|||
125620975|NCT02670928|451895653|FG001|Overall Study|Withdrawal by Subject|0|||
125620976|NCT02670928|451895652|FG000|Overall Study|Lost to Follow-up|1|||
125620977|NCT02670928|451895653|FG001|Overall Study|Lost to Follow-up|0|||
125620978|NCT02670928|451895652|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
125620979|NCT02670928|451895653|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
125620980|NCT01494987|451895654|FG000|Overall Study|Adverse Event|6|||
125620981|NCT01494987|451895655|FG001|Overall Study|Adverse Event|5|||
125620982|NCT01494987|451895654|FG000|Overall Study|Hyperglycemia|6|||
125620983|NCT01494987|451895655|FG001|Overall Study|Hyperglycemia|4|||
125620984|NCT01494987|451895654|FG000|Overall Study|Investigator's Discretion|1|||
125620985|NCT01494987|451895655|FG001|Overall Study|Investigator's Discretion|2|||
125620986|NCT01494987|451895654|FG000|Overall Study|Lost to Follow-up|1|||
125620987|NCT01494987|451895655|FG001|Overall Study|Lost to Follow-up|1|||
125620988|NCT01494987|451895654|FG000|Overall Study|Protocol Violation|3|||
125620989|NCT01494987|451895655|FG001|Overall Study|Protocol Violation|3|||
125620990|NCT01494987|451895654|FG000|Overall Study|Subject Non-Compliance|9|||
125620991|NCT01494987|451895655|FG001|Overall Study|Subject Non-Compliance|10|||
125620992|NCT01494987|451895654|FG000|Overall Study|Subject Withdrew Consent|2|||
125620993|NCT01494987|451895655|FG001|Overall Study|Subject Withdrew Consent|3|||
125620994|NCT00436982|451895656|FG000|Overall Study|Withdrawal by Subject|3|||
125620995|NCT00436982|451895657|FG001|Overall Study|Withdrawal by Subject|1|||
125620996|NCT00436982|451895656|FG000|Overall Study|Did not receive allocated intervention|0|||
125620997|NCT00436982|451895657|FG001|Overall Study|Did not receive allocated intervention|1|||
125620998|NCT00436982|451895656|FG000|Overall Study|no RSA data|1|||
125620999|NCT00436982|451895657|FG001|Overall Study|no RSA data|2|||
125621000|NCT02215616|451895661|FG000|Overall Study|Sponsor requested to stop study drug|0|||
125621001|NCT02215616|451895662|FG001|Overall Study|Sponsor requested to stop study drug|0|||
125621002|NCT02215616|451895663|FG002|Overall Study|Sponsor requested to stop study drug|1|||
125621003|NCT02215616|451895664|FG003|Overall Study|Sponsor requested to stop study drug|4|||
125621004|NCT02215616|451895661|FG000|Overall Study|Death|1|||
125621005|NCT02215616|451895662|FG001|Overall Study|Death|0|||
125621006|NCT02215616|451895663|FG002|Overall Study|Death|0|||
125621007|NCT02215616|451895664|FG003|Overall Study|Death|0|||
125621008|NCT02215616|451895661|FG000|Overall Study|Adverse Event|7|||
125621009|NCT02215616|451895662|FG001|Overall Study|Adverse Event|4|||
125621010|NCT02215616|451895663|FG002|Overall Study|Adverse Event|9|||
125621011|NCT02215616|451895664|FG003|Overall Study|Adverse Event|2|||
125621012|NCT02215616|451895661|FG000|Overall Study|Withdrawal by Subject|1|||
125621013|NCT02215616|451895662|FG001|Overall Study|Withdrawal by Subject|8|||
125621014|NCT02215616|451895663|FG002|Overall Study|Withdrawal by Subject|2|||
125621015|NCT02215616|451895664|FG003|Overall Study|Withdrawal by Subject|5|||
125621016|NCT02215616|451895661|FG000|Overall Study|Non-compliance|0|||
125621017|NCT02215616|451895662|FG001|Overall Study|Non-compliance|2|||
125621018|NCT02215616|451895663|FG002|Overall Study|Non-compliance|1|||
125621019|NCT02215616|451895664|FG003|Overall Study|Non-compliance|0|||
125621020|NCT02215616|451895661|FG000|Overall Study|Protocol Violation|0|||
125621021|NCT02215616|451895662|FG001|Overall Study|Protocol Violation|2|||
125621022|NCT02215616|451895663|FG002|Overall Study|Protocol Violation|0|||
125621023|NCT02215616|451895664|FG003|Overall Study|Protocol Violation|0|||
125621024|NCT02215616|451895661|FG000|Overall Study|Lost to Follow-up|1|||
125621025|NCT02215616|451895662|FG001|Overall Study|Lost to Follow-up|1|||
125621026|NCT02215616|451895663|FG002|Overall Study|Lost to Follow-up|0|||
125621027|NCT02215616|451895664|FG003|Overall Study|Lost to Follow-up|1|||
125621028|NCT02215616|451895661|FG000|Overall Study|Other than specified|1|||
125621029|NCT02215616|451895662|FG001|Overall Study|Other than specified|0|||
125621030|NCT02215616|451895663|FG002|Overall Study|Other than specified|1|||
125621031|NCT02215616|451895664|FG003|Overall Study|Other than specified|1|||
125621032|NCT01352845|451895667|FG000|Overall Study|Lost to Follow-up|313|||
125621033|NCT01352845|451895668|FG001|Overall Study|Lost to Follow-up|92|||
125621034|NCT01352845|451895667|FG000|Overall Study|No Longer Willing to Participate|205|||
125621035|NCT01352845|451895668|FG001|Overall Study|No Longer Willing to Participate|58|||
125621036|NCT01352845|451895667|FG000|Overall Study|Withdrawal by Subject|48|||
125621037|NCT01352845|451895668|FG001|Overall Study|Withdrawal by Subject|16|||
125621038|NCT01352845|451895667|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
125621039|NCT01352845|451895668|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
125621040|NCT01352845|451895667|FG000|Overall Study|Pregnancy|27|||
125621041|NCT01352845|451895668|FG001|Overall Study|Pregnancy|7|||
125621042|NCT01352845|451895667|FG000|Overall Study|Adverse Event|22|||
125621043|NCT01352845|451895668|FG001|Overall Study|Adverse Event|6|||
125621044|NCT01352845|451895667|FG000|Overall Study|Other|17|||
125621045|NCT01352845|451895668|FG001|Overall Study|Other|7|||
125621046|NCT01352845|451895667|FG000|Overall Study|Protocol Violation|12|||
125621047|NCT01352845|451895668|FG001|Overall Study|Protocol Violation|6|||
125621048|NCT01352845|451895667|FG000|Overall Study|Death|3|||
125621049|NCT01352845|451895668|FG001|Overall Study|Death|0|||
125621050|NCT00433446|451895674|FG000|Overall Study|Adverse Event|4|||
125621051|NCT00433446|451895674|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
125621052|NCT00433446|451895674|FG000|Overall Study|Progression|44|||
125621053|NCT00433446|451895674|FG000|Overall Study|Other - Not Protocol specified|3|||
125621054|NCT00433446|451895674|FG000|Overall Study|Ineligible|9|||
125621055|NCT01188538|451895675|FG000|Overall Study|Lost to Follow-up|0|||
125621056|NCT01188538|451895676|FG001|Overall Study|Lost to Follow-up|1|||
125621057|NCT01231607|451895680|FG000|Overall Study|Adverse Event|0|||
125621058|NCT01231607|451895681|FG001|Overall Study|Adverse Event|8|||
125621059|NCT01231607|451895682|FG002|Overall Study|Adverse Event|4|||
125621060|NCT01231607|451895683|FG003|Overall Study|Adverse Event|4|||
125621061|NCT01231607|451895684|FG004|Overall Study|Adverse Event|5|||
125621062|NCT01231607|451895680|FG000|Overall Study|Lost to Follow-up|13|||
125621063|NCT01231607|451895681|FG001|Overall Study|Lost to Follow-up|11|||
125621064|NCT01231607|451895682|FG002|Overall Study|Lost to Follow-up|10|||
125621065|NCT01231607|451895683|FG003|Overall Study|Lost to Follow-up|10|||
125621066|NCT01231607|451895684|FG004|Overall Study|Lost to Follow-up|4|||
125621067|NCT01231607|451895680|FG000|Overall Study|Physician Decision|4|||
125621068|NCT01231607|451895681|FG001|Overall Study|Physician Decision|4|||
125621069|NCT01231607|451895682|FG002|Overall Study|Physician Decision|3|||
125621070|NCT01231607|451895683|FG003|Overall Study|Physician Decision|5|||
125621071|NCT01231607|451895684|FG004|Overall Study|Physician Decision|4|||
125621072|NCT01231607|451895680|FG000|Overall Study|Protocol Violation|3|||
125621073|NCT01231607|451895681|FG001|Overall Study|Protocol Violation|2|||
125621074|NCT01231607|451895682|FG002|Overall Study|Protocol Violation|0|||
125621075|NCT01231607|451895683|FG003|Overall Study|Protocol Violation|2|||
125621076|NCT01231607|451895684|FG004|Overall Study|Protocol Violation|2|||
125621077|NCT01231607|451895680|FG000|Overall Study|Withdrawal by Subject|9|||
125621078|NCT01231607|451895681|FG001|Overall Study|Withdrawal by Subject|9|||
125621079|NCT01231607|451895682|FG002|Overall Study|Withdrawal by Subject|14|||
125621080|NCT01231607|451895683|FG003|Overall Study|Withdrawal by Subject|17|||
125621081|NCT01231607|451895684|FG004|Overall Study|Withdrawal by Subject|9|||
125621082|NCT02501902|451895685|FG000|Overall Study|Subject Refused Further Follow-up|0|||
125621083|NCT02501902|451895686|FG001|Overall Study|Subject Refused Further Follow-up|0|||
125621084|NCT02501902|451895687|FG002|Overall Study|Subject Refused Further Follow-up|0|||
125621085|NCT02501902|451895688|FG003|Overall Study|Subject Refused Further Follow-up|0|||
125621086|NCT02501902|451895689|FG004|Overall Study|Subject Refused Further Follow-up|0|||
125621087|NCT02501902|451895690|FG005|Overall Study|Subject Refused Further Follow-up|0|||
125621088|NCT02501902|451895691|FG006|Overall Study|Subject Refused Further Follow-up|0|||
125621089|NCT02501902|451895692|FG007|Overall Study|Subject Refused Further Follow-up|1|||
125621090|NCT02501902|451895685|FG000|Overall Study|Study Terminated by Sponsor|0|||
125621091|NCT02501902|451895686|FG001|Overall Study|Study Terminated by Sponsor|3|||
125621092|NCT02501902|451895687|FG002|Overall Study|Study Terminated by Sponsor|0|||
125621093|NCT02501902|451895688|FG003|Overall Study|Study Terminated by Sponsor|1|||
125621094|NCT02501902|451895689|FG004|Overall Study|Study Terminated by Sponsor|1|||
125621095|NCT02501902|451895690|FG005|Overall Study|Study Terminated by Sponsor|0|||
125621096|NCT02501902|451895691|FG006|Overall Study|Study Terminated by Sponsor|2|||
125621097|NCT02501902|451895692|FG007|Overall Study|Study Terminated by Sponsor|4|||
125621098|NCT02501902|451895685|FG000|Overall Study|Death|3|||
125621099|NCT02501902|451895686|FG001|Overall Study|Death|4|||
125621100|NCT02501902|451895687|FG002|Overall Study|Death|4|||
125621101|NCT02501902|451895688|FG003|Overall Study|Death|10|||
125621102|NCT02501902|451895689|FG004|Overall Study|Death|10|||
125621103|NCT02501902|451895690|FG005|Overall Study|Death|11|||
125621104|NCT02501902|451895691|FG006|Overall Study|Death|7|||
125621105|NCT02501902|451895692|FG007|Overall Study|Death|15|||
125621106|NCT02513771|451895693|FG000|Overall Study|Lost to Follow-up|1|||
125621107|NCT02513771|451895694|FG001|Overall Study|Lost to Follow-up|1|||
125621108|NCT02513771|451895693|FG000|Overall Study|Not being able to get to clinic|1|||
125621109|NCT02513771|451895694|FG001|Overall Study|Not being able to get to clinic|0|||
125621110|NCT01797445|451895695|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
125621111|NCT01797445|451895696|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
125621112|NCT01797445|451895695|FG000|Double-Blind Phase|Adverse Event|3|||
125433115|NCT00085202|451212437|FG000|Overall Study|Excessive toxicity|6|||
125621113|NCT01797445|451895696|FG001|Double-Blind Phase|Adverse Event|0|||
125621114|NCT01797445|451895695|FG000|Double-Blind Phase|Death|5|||
125621115|NCT01797445|451895696|FG001|Double-Blind Phase|Death|4|||
125374451|NCT04862585|451000332|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
125374452|NCT04862585|451000331|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
125621116|NCT01797445|451895695|FG000|Double-Blind Phase|Pregnancy|0|||
125621117|NCT01797445|451895696|FG001|Double-Blind Phase|Pregnancy|1|||
125621118|NCT01797445|451895695|FG000|Double-Blind Phase|Lack of Efficacy|1|||
125621119|NCT01797445|451895696|FG001|Double-Blind Phase|Lack of Efficacy|2|||
125621120|NCT01797445|451895695|FG000|Double-Blind Phase|Investigator's Discretion|15|||
125621121|NCT01797445|451895696|FG001|Double-Blind Phase|Investigator's Discretion|17|||
125621122|NCT01797445|451895695|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
125621123|NCT01797445|451895696|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
125621124|NCT01797445|451895695|FG000|Double-Blind Phase|Protocol Violation|0|||
125621125|NCT01797445|451895696|FG001|Double-Blind Phase|Protocol Violation|1|||
125621126|NCT01797445|451895695|FG000|Double-Blind Phase|Withdrew Consent|20|||
125621127|NCT01797445|451895696|FG001|Double-Blind Phase|Withdrew Consent|35|||
125621128|NCT01797445|451895695|FG000|Double-Blind Phase|Lost to Follow-up|34|||
125621129|NCT01797445|451895696|FG001|Double-Blind Phase|Lost to Follow-up|26|||
125621130|NCT01797445|451895695|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
125621131|NCT01797445|451895696|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
125621132|NCT01595438|451895697|FG000|Overall Study|Lost to Follow-up|20|||
125621133|NCT01595438|451895698|FG001|Overall Study|Lost to Follow-up|20|||
125621134|NCT01595438|451895697|FG000|Overall Study|Withdrawal by Subject|12|||
125621135|NCT01595438|451895698|FG001|Overall Study|Withdrawal by Subject|12|||
125621136|NCT01595438|451895697|FG000|Overall Study|Other Eligibility criteria|11|||
125621137|NCT01595438|451895698|FG001|Overall Study|Other Eligibility criteria|9|||
125621138|NCT01280266|451895699|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
125621139|NCT01280266|451895700|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
125621140|NCT01280266|451895699|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
125621141|NCT01280266|451895700|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
125621142|NCT04116073|451895703|FG000|Overall Study|Withdrawal by Subject|2|||
125621143|NCT04116073|451895703|FG000|Overall Study|failed to maintained eligibility|1|||
125621144|NCT00618995|451895712|FG000|Period 1|Adverse Event|0|||
125621145|NCT00618995|451895713|FG001|Period 1|Adverse Event|0|||
125621146|NCT00618995|451895714|FG002|Period 1|Adverse Event|1|||
125621147|NCT00618995|451895715|FG003|Period 1|Adverse Event|0|||
125621148|NCT00618995|451895712|FG000|Period 1|Protocol Violation|0|||
125621149|NCT00618995|451895713|FG001|Period 1|Protocol Violation|1|||
125621150|NCT00618995|451895714|FG002|Period 1|Protocol Violation|1|||
125621151|NCT00618995|451895715|FG003|Period 1|Protocol Violation|0|||
125621152|NCT00618995|451895712|FG000|Period 2|Protocol Violation|0|||
125621153|NCT00618995|451895713|FG001|Period 2|Protocol Violation|0|||
125621154|NCT00618995|451895714|FG002|Period 2|Protocol Violation|1|||
125621155|NCT00618995|451895715|FG003|Period 2|Protocol Violation|0|||
125621156|NCT00618995|451895712|FG000|Period 4|Adverse Event|1|||
125621157|NCT00618995|451895713|FG001|Period 4|Adverse Event|0|||
125621158|NCT00618995|451895714|FG002|Period 4|Adverse Event|0|||
125621159|NCT00618995|451895715|FG003|Period 4|Adverse Event|0|||
125621160|NCT05590767|451895718|FG000|Overall Study|Protocol Violation|1|||
125621161|NCT05590767|451895718|FG000|Overall Study|surgery canceled|1|||
125621162|NCT05590767|451895718|FG000|Overall Study|interscalene brachial block not performed|1|||
125621163|NCT02677220|451895726|FG000|Overall Study|Adverse Event|1|||
125621164|NCT00965146|451895727|FG000|Overall Study|Death|7|||
125621165|NCT00965146|451895727|FG000|Overall Study|Lost to Follow-up|22|||
125621166|NCT00965146|451895727|FG000|Overall Study|Withdrawal by Subject|17|||
125621167|NCT00965146|451895727|FG000|Overall Study|Unable to return|1|||
125621168|NCT00965146|451895727|FG000|Overall Study|Unwilling to return|11|||
125621169|NCT00965146|451895727|FG000|Overall Study|Intercurrent illness|1|||
125621170|NCT00965146|451895727|FG000|Overall Study|Revision / Removal of Study Implant|6|||
125621171|NCT00965146|451895727|FG000|Overall Study|Overall Study Termination|145|||
125621172|NCT01181102|451895730|FG000|Overall Study|Adverse Event|28|||
125621173|NCT01181102|451895731|FG001|Overall Study|Adverse Event|26|||
125621174|NCT01181102|451895730|FG000|Overall Study|Lack of Efficacy|3|||
125621175|NCT01181102|451895731|FG001|Overall Study|Lack of Efficacy|1|||
125621176|NCT01181102|451895730|FG000|Overall Study|Lost to Follow-up|2|||
125621177|NCT01181102|451895731|FG001|Overall Study|Lost to Follow-up|0|||
125621178|NCT01181102|451895730|FG000|Overall Study|Physician Decision|3|||
125621179|NCT01181102|451895731|FG001|Overall Study|Physician Decision|1|||
125621180|NCT01181102|451895730|FG000|Overall Study|Protocol Violation|5|||
125621181|NCT01181102|451895731|FG001|Overall Study|Protocol Violation|6|||
125621182|NCT01181102|451895730|FG000|Overall Study|Withdrawal by Subject|10|||
125621183|NCT01181102|451895731|FG001|Overall Study|Withdrawal by Subject|12|||
125621184|NCT00936117|451895732|FG000|Overall Study|Adverse Event|7|||
125621185|NCT00936117|451895732|FG000|Overall Study|Unable to continue oral medication|3|||
125621186|NCT01309841|451895741|FG000|Overall Study|Other|0|||
125621187|NCT01309841|451895742|FG001|Overall Study|Other|1|||
125621188|NCT01309841|451895743|FG002|Overall Study|Other|1|||
125621189|NCT01309841|451895741|FG000|Overall Study|Lost to Follow-up|7|||
125621190|NCT01309841|451895742|FG001|Overall Study|Lost to Follow-up|6|||
125621191|NCT01309841|451895743|FG002|Overall Study|Lost to Follow-up|4|||
125621192|NCT01309841|451895741|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
125621193|NCT01309841|451895742|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
125621194|NCT01309841|451895743|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
125621195|NCT01309841|451895741|FG000|Overall Study|Lack of Efficacy|0|||
125621196|NCT01309841|451895742|FG001|Overall Study|Lack of Efficacy|0|||
125621197|NCT01309841|451895743|FG002|Overall Study|Lack of Efficacy|2|||
125621198|NCT01309841|451895741|FG000|Overall Study|Adverse Event|9|||
125621199|NCT01309841|451895742|FG001|Overall Study|Adverse Event|22|||
125621200|NCT01309841|451895743|FG002|Overall Study|Adverse Event|11|||
125621201|NCT01309841|451895741|FG000|Overall Study|Death|1|||
125621202|NCT01309841|451895742|FG001|Overall Study|Death|0|||
125621203|NCT01309841|451895743|FG002|Overall Study|Death|0|||
125621204|NCT01309841|451895741|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
125621205|NCT01309841|451895742|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
125621206|NCT01309841|451895743|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
125621207|NCT01309841|451895741|FG000|Overall Study|Withdrawal by Subject|17|||
125621208|NCT01309841|451895742|FG001|Overall Study|Withdrawal by Subject|6|||
125621209|NCT01309841|451895743|FG002|Overall Study|Withdrawal by Subject|13|||
125621210|NCT01309841|451895741|FG000|Overall Study|Did Not Receive Treatment|2|||
125621211|NCT01309841|451895742|FG001|Overall Study|Did Not Receive Treatment|0|||
125621212|NCT01309841|451895743|FG002|Overall Study|Did Not Receive Treatment|1|||
125621213|NCT01309841|451895741|FG000|Overall Study|Severe non-compliance with protocol|0|||
125621214|NCT01309841|451895742|FG001|Overall Study|Severe non-compliance with protocol|5|||
125621215|NCT01309841|451895743|FG002|Overall Study|Severe non-compliance with protocol|2|||
125621216|NCT00050960|451895744|FG000|Overall Study|Progressive Disease|137|||
125621217|NCT00050960|451895745|FG001|Overall Study|Progressive Disease|93|||
125621218|NCT00050960|451895744|FG000|Overall Study|Stable Disease|19|||
125621219|NCT00050960|451895745|FG001|Overall Study|Stable Disease|48|||
125621220|NCT00050960|451895744|FG000|Overall Study|Partial Response|14|||
125621221|NCT00050960|451895745|FG001|Overall Study|Partial Response|19|||
125621222|NCT00050960|451895744|FG000|Overall Study|Complete Response|0|||
125621223|NCT00050960|451895745|FG001|Overall Study|Complete Response|2|||
125621224|NCT00050960|451895744|FG000|Overall Study|Adverse Event|62|||
125621225|NCT00050960|451895745|FG001|Overall Study|Adverse Event|61|||
125621226|NCT00050960|451895744|FG000|Overall Study|Lost to Follow-up|0|||
125621227|NCT00050960|451895745|FG001|Overall Study|Lost to Follow-up|1|||
125621228|NCT00050960|451895744|FG000|Overall Study|Withdrawal by Subject|23|||
125621229|NCT00050960|451895745|FG001|Overall Study|Withdrawal by Subject|18|||
125621230|NCT00050960|451895744|FG000|Overall Study|Administrative|31|||
125621231|NCT00050960|451895745|FG001|Overall Study|Administrative|46|||
125621232|NCT00050960|451895744|FG000|Overall Study|Non-compliance|3|||
125621233|NCT00050960|451895745|FG001|Overall Study|Non-compliance|1|||
125621234|NCT00050960|451895744|FG000|Overall Study|Death|13|||
125621235|NCT00050960|451895745|FG001|Overall Study|Death|15|||
125621236|NCT04311177|451895748|FG000|Overall Study|Adverse Event|3|||
125621237|NCT04311177|451895749|FG001|Overall Study|Adverse Event|1|||
125621238|NCT04311177|451895748|FG000|Overall Study|Physician Decision|4|||
125621239|NCT04311177|451895749|FG001|Overall Study|Physician Decision|3|||
125621240|NCT04311177|451895748|FG000|Overall Study|Withdrawal by Subject|1|||
125621241|NCT04311177|451895749|FG001|Overall Study|Withdrawal by Subject|0|||
125621242|NCT00413062|451895752|FG000|Overall Study|Adverse event/serious adverse event|289|||
125621243|NCT00413062|451895753|FG001|Overall Study|Adverse event/serious adverse event|56|||
125621244|NCT00413062|451895752|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
125621245|NCT00413062|451895753|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
125621246|NCT00413062|451895752|FG000|Overall Study|Withdrawal of informed consent|111|||
125621247|NCT00413062|451895753|FG001|Overall Study|Withdrawal of informed consent|36|||
125621248|NCT00413062|451895752|FG000|Overall Study|Pregnancy|15|||
125621249|NCT00413062|451895753|FG001|Overall Study|Pregnancy|5|||
125621250|NCT00413062|451895752|FG000|Overall Study|Pregnancy wish|17|||
125621251|NCT00413062|451895753|FG001|Overall Study|Pregnancy wish|6|||
125621252|NCT00413062|451895752|FG000|Overall Study|Lost to Follow-up|175|||
125621253|NCT00413062|451895753|FG001|Overall Study|Lost to Follow-up|73|||
125621254|NCT00413062|451895752|FG000|Overall Study|Other reason|70|||
125621255|NCT00413062|451895753|FG001|Overall Study|Other reason|34|||
125621256|NCT02815293|451895756|FG000|Overall Study|Study termination by sponsor|10|||
125621257|NCT02815293|451895757|FG001|Overall Study|Study termination by sponsor|7|||
125621258|NCT02815293|451895758|FG002|Overall Study|Study termination by sponsor|0|||
125621259|NCT02815293|451895756|FG000|Overall Study|Participants not randomized|0|||
125621260|NCT02815293|451895757|FG001|Overall Study|Participants not randomized|0|||
125621261|NCT02815293|451895758|FG002|Overall Study|Participants not randomized|18|||
125621262|NCT02815293|451895756|FG000|Overall Study|Adverse Event|0|||
125621263|NCT02815293|451895757|FG001|Overall Study|Adverse Event|1|||
125621264|NCT02815293|451895758|FG002|Overall Study|Adverse Event|0|||
125621265|NCT00006604|451895761|FG000|Overall Study|Met study objective - no further FU|1|||
125621266|NCT00006604|451895762|FG001|Overall Study|Met study objective - no further FU|0|||
125621267|NCT00006604|451895763|FG002|Overall Study|Met study objective - no further FU|0|||
125621268|NCT00006604|451895764|FG003|Overall Study|Met study objective - no further FU|0|||
125621269|NCT00006604|451895765|FG004|Overall Study|Met study objective - no further FU|0|||
125621270|NCT00006604|451895766|FG005|Overall Study|Met study objective - no further FU|0|||
125621271|NCT00006604|451895767|FG006|Overall Study|Met study objective - no further FU|0|||
125621272|NCT00006604|451895768|FG007|Overall Study|Met study objective - no further FU|0|||
125621273|NCT00006604|451895769|FG008|Overall Study|Met study objective - no further FU|0|||
125621274|NCT00006604|451895770|FG009|Overall Study|Met study objective - no further FU|0|||
125621275|NCT00006604|451895771|FG010|Overall Study|Met study objective - no further FU|0|||
125621276|NCT00006604|451895772|FG011|Overall Study|Met study objective - no further FU|0|||
125215275|NCT01398358|450414975|FG002|Overall Study|Withdrawal by Subject|2|||
125215276|NCT01398358|450414973|FG000|Overall Study|no longer eligible|1|||
125621277|NCT00006604|451895773|FG012|Overall Study|Met study objective - no further FU|0|||
125621278|NCT00006604|451895774|FG013|Overall Study|Met study objective - no further FU|0|||
125621279|NCT00006604|451895775|FG014|Overall Study|Met study objective - no further FU|1|||
125621280|NCT00006604|451895776|FG015|Overall Study|Met study objective - no further FU|1|||
125621281|NCT00006604|451895777|FG016|Overall Study|Met study objective - no further FU|0|||
125621282|NCT00006604|451895761|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
125621283|NCT00006604|451895762|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
125621284|NCT00006604|451895763|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
125621285|NCT00006604|451895764|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
125621286|NCT00006604|451895765|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
125621287|NCT00006604|451895766|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
125621288|NCT00006604|451895767|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
125621289|NCT00006604|451895768|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
125621290|NCT00006604|451895769|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
125621291|NCT00006604|451895770|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
125621292|NCT00006604|451895771|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
125621293|NCT00006604|451895772|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
125621294|NCT00006604|451895773|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
125621295|NCT00006604|451895774|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
125621296|NCT00006604|451895775|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
125621297|NCT00006604|451895776|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
125621298|NCT00006604|451895777|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
125621299|NCT00006604|451895761|FG000|Overall Study|Death|0|||
125621300|NCT00006604|451895762|FG001|Overall Study|Death|0|||
125621301|NCT00006604|451895763|FG002|Overall Study|Death|0|||
125621302|NCT00006604|451895764|FG003|Overall Study|Death|0|||
125621303|NCT00006604|451895765|FG004|Overall Study|Death|0|||
125621304|NCT00006604|451895766|FG005|Overall Study|Death|0|||
125621305|NCT00006604|451895767|FG006|Overall Study|Death|0|||
125621306|NCT00006604|451895768|FG007|Overall Study|Death|0|||
125621307|NCT00006604|451895769|FG008|Overall Study|Death|0|||
125621308|NCT00006604|451895770|FG009|Overall Study|Death|1|||
125621309|NCT00006604|451895771|FG010|Overall Study|Death|1|||
125621310|NCT00006604|451895772|FG011|Overall Study|Death|1|||
125621311|NCT00006604|451895773|FG012|Overall Study|Death|0|||
125621312|NCT00006604|451895774|FG013|Overall Study|Death|0|||
125621313|NCT00006604|451895775|FG014|Overall Study|Death|0|||
125621314|NCT00006604|451895776|FG015|Overall Study|Death|0|||
125621315|NCT00006604|451895777|FG016|Overall Study|Death|0|||
125621316|NCT00006604|451895761|FG000|Overall Study|Severe debilitation, unable to continue|0|||
125621317|NCT00006604|451895762|FG001|Overall Study|Severe debilitation, unable to continue|0|||
125621318|NCT00006604|451895763|FG002|Overall Study|Severe debilitation, unable to continue|0|||
125621319|NCT00006604|451895764|FG003|Overall Study|Severe debilitation, unable to continue|0|||
125621320|NCT00006604|451895765|FG004|Overall Study|Severe debilitation, unable to continue|0|||
125621321|NCT00006604|451895766|FG005|Overall Study|Severe debilitation, unable to continue|0|||
125215277|NCT01398358|450414974|FG001|Overall Study|no longer eligible|0|||
125374453|NCT04862585|451000332|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
125374454|NCT04862585|451000331|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
125374455|NCT04862585|451000332|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
125374456|NCT04862585|451000331|FG000|Overall Study|one withdrew without providing a reason|0|||
125374457|NCT04862585|451000332|FG001|Overall Study|one withdrew without providing a reason|1|||
125374458|NCT03366337|451000333|FG000|Overall Study|Lost to Follow-up|1|||
125374459|NCT03366337|451000334|FG001|Overall Study|Lost to Follow-up|0|||
125374460|NCT03366337|451000335|FG002|Overall Study|Lost to Follow-up|1|||
125374461|NCT03366337|451000336|FG003|Overall Study|Lost to Follow-up|0|||
125374462|NCT03366337|451000333|FG000|Overall Study|Withdrawal by Subject|2|||
125374463|NCT03366337|451000334|FG001|Overall Study|Withdrawal by Subject|0|||
125374464|NCT03366337|451000335|FG002|Overall Study|Withdrawal by Subject|1|||
125374465|NCT03366337|451000336|FG003|Overall Study|Withdrawal by Subject|1|||
125621322|NCT00006604|451895767|FG006|Overall Study|Severe debilitation, unable to continue|3|||
125621323|NCT00006604|451895768|FG007|Overall Study|Severe debilitation, unable to continue|0|||
125621324|NCT00006604|451895769|FG008|Overall Study|Severe debilitation, unable to continue|0|||
125621325|NCT00006604|451895770|FG009|Overall Study|Severe debilitation, unable to continue|5|||
125621326|NCT00006604|451895771|FG010|Overall Study|Severe debilitation, unable to continue|0|||
125621327|NCT00006604|451895772|FG011|Overall Study|Severe debilitation, unable to continue|2|||
125621328|NCT00006604|451895773|FG012|Overall Study|Severe debilitation, unable to continue|1|||
125621329|NCT00006604|451895774|FG013|Overall Study|Severe debilitation, unable to continue|0|||
125621330|NCT00006604|451895775|FG014|Overall Study|Severe debilitation, unable to continue|2|||
125621331|NCT00006604|451895776|FG015|Overall Study|Severe debilitation, unable to continue|0|||
125621332|NCT00006604|451895777|FG016|Overall Study|Severe debilitation, unable to continue|0|||
125621333|NCT00006604|451895761|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
125621334|NCT00006604|451895762|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
125621335|NCT00006604|451895763|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
125621336|NCT00006604|451895764|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
125621337|NCT00006604|451895765|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
125621338|NCT00006604|451895766|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
125621339|NCT00006604|451895767|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
125621340|NCT00006604|451895768|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
125621341|NCT00006604|451895769|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
125621342|NCT00006604|451895770|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
125621343|NCT00006604|451895771|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
125621344|NCT00006604|451895772|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
125621345|NCT00006604|451895773|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
125621346|NCT00006604|451895774|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
125621347|NCT00006604|451895775|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
125621348|NCT00006604|451895776|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
125621349|NCT00006604|451895777|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
125621350|NCT00006604|451895761|FG000|Overall Study|Site closing|0|||
125621351|NCT00006604|451895762|FG001|Overall Study|Site closing|0|||
125621352|NCT00006604|451895763|FG002|Overall Study|Site closing|1|||
125621353|NCT00006604|451895764|FG003|Overall Study|Site closing|1|||
125621354|NCT00006604|451895765|FG004|Overall Study|Site closing|0|||
125621355|NCT00006604|451895766|FG005|Overall Study|Site closing|0|||
125621356|NCT00006604|451895767|FG006|Overall Study|Site closing|0|||
125621357|NCT00006604|451895768|FG007|Overall Study|Site closing|1|||
125621358|NCT00006604|451895769|FG008|Overall Study|Site closing|0|||
125621359|NCT00006604|451895770|FG009|Overall Study|Site closing|0|||
125621360|NCT00006604|451895771|FG010|Overall Study|Site closing|0|||
125621361|NCT00006604|451895772|FG011|Overall Study|Site closing|1|||
125621362|NCT00006604|451895773|FG012|Overall Study|Site closing|1|||
125621363|NCT00006604|451895774|FG013|Overall Study|Site closing|1|||
125621364|NCT00006604|451895775|FG014|Overall Study|Site closing|0|||
125621365|NCT00006604|451895776|FG015|Overall Study|Site closing|0|||
125621366|NCT00006604|451895777|FG016|Overall Study|Site closing|1|||
125621367|NCT00006604|451895761|FG000|Overall Study|Withdrawal by Subject|1|||
125621368|NCT00006604|451895762|FG001|Overall Study|Withdrawal by Subject|0|||
125621369|NCT00006604|451895763|FG002|Overall Study|Withdrawal by Subject|2|||
125621370|NCT00006604|451895764|FG003|Overall Study|Withdrawal by Subject|0|||
125621371|NCT00006604|451895765|FG004|Overall Study|Withdrawal by Subject|1|||
125621372|NCT00006604|451895766|FG005|Overall Study|Withdrawal by Subject|2|||
125621373|NCT00006604|451895767|FG006|Overall Study|Withdrawal by Subject|2|||
125374466|NCT05229406|451000337|FG000|Overall Study|Withdrawal by Subject|1|||
125374467|NCT05229406|451000338|FG001|Overall Study|Withdrawal by Subject|2|||
125374468|NCT00459953|451000339|FG000|Overall Study|not analyzed-household member in study|1|||
125621374|NCT00006604|451895768|FG007|Overall Study|Withdrawal by Subject|0|||
125374469|NCT00459953|451000340|FG001|Overall Study|not analyzed-household member in study|1|||
125374470|NCT00496470|451000341|FG000|Overall Study|Adverse Event|8|||
125621375|NCT00006604|451895769|FG008|Overall Study|Withdrawal by Subject|1|||
125621376|NCT00006604|451895770|FG009|Overall Study|Withdrawal by Subject|3|||
125621377|NCT00006604|451895771|FG010|Overall Study|Withdrawal by Subject|2|||
125621378|NCT00006604|451895772|FG011|Overall Study|Withdrawal by Subject|0|||
125621379|NCT00006604|451895773|FG012|Overall Study|Withdrawal by Subject|1|||
125621380|NCT00006604|451895774|FG013|Overall Study|Withdrawal by Subject|2|||
125621381|NCT00006604|451895775|FG014|Overall Study|Withdrawal by Subject|1|||
125621382|NCT00006604|451895776|FG015|Overall Study|Withdrawal by Subject|0|||
125621383|NCT00006604|451895777|FG016|Overall Study|Withdrawal by Subject|1|||
125621384|NCT00006604|451895761|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
125621385|NCT00006604|451895762|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
125621386|NCT00006604|451895763|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
125621387|NCT00006604|451895764|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
125621388|NCT00006604|451895765|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
125621389|NCT00006604|451895766|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
125621390|NCT00006604|451895767|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
125621391|NCT00006604|451895768|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
125621392|NCT00006604|451895769|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
125621393|NCT00006604|451895770|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
125621394|NCT00006604|451895771|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
125621395|NCT00006604|451895772|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
125621396|NCT00006604|451895773|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
125621397|NCT00006604|451895774|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
125621398|NCT00006604|451895775|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
125621399|NCT00006604|451895776|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
125621400|NCT00006604|451895777|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
125621401|NCT00006604|451895761|FG000|Overall Study|Lost to Follow-up|0|||
125621402|NCT00006604|451895762|FG001|Overall Study|Lost to Follow-up|0|||
125621403|NCT00006604|451895763|FG002|Overall Study|Lost to Follow-up|0|||
125621404|NCT00006604|451895764|FG003|Overall Study|Lost to Follow-up|0|||
125621405|NCT00006604|451895765|FG004|Overall Study|Lost to Follow-up|0|||
125621406|NCT00006604|451895766|FG005|Overall Study|Lost to Follow-up|0|||
125621407|NCT00006604|451895767|FG006|Overall Study|Lost to Follow-up|0|||
125621408|NCT00006604|451895768|FG007|Overall Study|Lost to Follow-up|1|||
125621409|NCT00006604|451895769|FG008|Overall Study|Lost to Follow-up|0|||
125621410|NCT00006604|451895770|FG009|Overall Study|Lost to Follow-up|2|||
125621411|NCT00006604|451895771|FG010|Overall Study|Lost to Follow-up|0|||
125621412|NCT00006604|451895772|FG011|Overall Study|Lost to Follow-up|0|||
125621413|NCT00006604|451895773|FG012|Overall Study|Lost to Follow-up|0|||
125621414|NCT00006604|451895774|FG013|Overall Study|Lost to Follow-up|0|||
125621415|NCT00006604|451895775|FG014|Overall Study|Lost to Follow-up|0|||
125621416|NCT00006604|451895776|FG015|Overall Study|Lost to Follow-up|1|||
125621417|NCT00006604|451895777|FG016|Overall Study|Lost to Follow-up|3|||
125621418|NCT00006604|451895761|FG000|Overall Study|Other Reason|0|||
125621419|NCT00006604|451895762|FG001|Overall Study|Other Reason|0|||
125621420|NCT00006604|451895763|FG002|Overall Study|Other Reason|0|||
125621421|NCT00006604|451895764|FG003|Overall Study|Other Reason|0|||
125621422|NCT00006604|451895765|FG004|Overall Study|Other Reason|0|||
125621423|NCT00006604|451895766|FG005|Overall Study|Other Reason|1|||
125215278|NCT01398358|450414975|FG002|Overall Study|no longer eligible|1|||
125621424|NCT00006604|451895767|FG006|Overall Study|Other Reason|0|||
125621425|NCT00006604|451895768|FG007|Overall Study|Other Reason|0|||
125621426|NCT00006604|451895769|FG008|Overall Study|Other Reason|0|||
125621427|NCT00006604|451895770|FG009|Overall Study|Other Reason|1|||
125621428|NCT00006604|451895771|FG010|Overall Study|Other Reason|0|||
125621429|NCT00006604|451895772|FG011|Overall Study|Other Reason|0|||
125621430|NCT00006604|451895773|FG012|Overall Study|Other Reason|0|||
125621431|NCT00006604|451895774|FG013|Overall Study|Other Reason|0|||
125621432|NCT00006604|451895775|FG014|Overall Study|Other Reason|0|||
125621433|NCT00006604|451895776|FG015|Overall Study|Other Reason|0|||
125621434|NCT00006604|451895777|FG016|Overall Study|Other Reason|0|||
125621435|NCT01056341|451895778|FG000|Overall Study|Treatment Intolerance|0|||
125621436|NCT01056341|451895779|FG001|Overall Study|Treatment Intolerance|2|||
125621437|NCT01056341|451895780|FG002|Overall Study|Treatment Intolerance|0|||
125621438|NCT01056341|451895781|FG003|Overall Study|Treatment Intolerance|2|||
125621439|NCT01056341|451895782|FG004|Overall Study|Treatment Intolerance|0|||
125621440|NCT01056341|451895778|FG000|Overall Study|Lack of Efficacy|32|||
125621441|NCT01056341|451895779|FG001|Overall Study|Lack of Efficacy|30|||
125621442|NCT01056341|451895780|FG002|Overall Study|Lack of Efficacy|7|||
125621443|NCT01056341|451895781|FG003|Overall Study|Lack of Efficacy|25|||
125621444|NCT01056341|451895782|FG004|Overall Study|Lack of Efficacy|9|||
125621445|NCT01056341|451895778|FG000|Overall Study|Other reasons|4|||
125621446|NCT01056341|451895779|FG001|Overall Study|Other reasons|4|||
125621447|NCT01056341|451895780|FG002|Overall Study|Other reasons|8|||
125621448|NCT01056341|451895781|FG003|Overall Study|Other reasons|9|||
125621449|NCT01056341|451895782|FG004|Overall Study|Other reasons|5|||
125621450|NCT01086150|451895783|FG000|Overall Study|Withdrawal by Subject|0|||
125621451|NCT01086150|451895784|FG001|Overall Study|Withdrawal by Subject|4|||
125621452|NCT01086150|451895785|FG002|Overall Study|Withdrawal by Subject|1|||
125621453|NCT01086150|451895783|FG000|Overall Study|Lost to Follow-up|0|||
125621454|NCT01086150|451895784|FG001|Overall Study|Lost to Follow-up|1|||
125621455|NCT01086150|451895785|FG002|Overall Study|Lost to Follow-up|0|||
125621456|NCT01086150|451895783|FG000|Overall Study|Screen Failure|0|||
125621457|NCT01086150|451895784|FG001|Overall Study|Screen Failure|1|||
125621458|NCT01086150|451895785|FG002|Overall Study|Screen Failure|0|||
125621459|NCT01681576|451895788|FG000|Period 1|Adverse Event|1|||
125621460|NCT01681576|451895789|FG001|Period 1|Adverse Event|0|||
125621461|NCT01681576|451895788|FG000|Period 1|Protocol Deviation|1|||
125621462|NCT01681576|451895789|FG001|Period 1|Protocol Deviation|0|||
125621463|NCT01681576|451895788|FG000|Period 2|subject/guardian decision|3|||
125621464|NCT01681576|451895789|FG001|Period 2|subject/guardian decision|1|||
125621465|NCT01681576|451895788|FG000|Period 2|Non-compliance with study treatment|1|||
125621466|NCT01681576|451895789|FG001|Period 2|Non-compliance with study treatment|0|||
125621467|NCT02721251|451895790|FG000|Overall Study|Withdrawal by Subject|8|||
125621468|NCT02721251|451895791|FG001|Overall Study|Withdrawal by Subject|7|||
125621469|NCT02721251|451895792|FG002|Overall Study|Withdrawal by Subject|9|||
125621470|NCT02721251|451895790|FG000|Overall Study|poor adherence|2|||
125621471|NCT02721251|451895791|FG001|Overall Study|poor adherence|2|||
125621472|NCT02721251|451895792|FG002|Overall Study|poor adherence|2|||
125621473|NCT01714817|451895793|FG000|Year 1 Period|Lack of Efficacy|11|||
125621474|NCT01714817|451895794|FG001|Year 1 Period|Lack of Efficacy|9|||
125621475|NCT01714817|451895793|FG000|Year 1 Period|Adverse Event|20|||
125621476|NCT01714817|451895794|FG001|Year 1 Period|Adverse Event|17|||
125621477|NCT01714817|451895793|FG000|Year 1 Period|Withdrawal by Subject|6|||
125621478|NCT01714817|451895794|FG001|Year 1 Period|Withdrawal by Subject|7|||
125621479|NCT01714817|451895793|FG000|Year 1 Period|Death|1|||
125621480|NCT01714817|451895794|FG001|Year 1 Period|Death|1|||
125621481|NCT01714817|451895793|FG000|Year 1 Period|Lost to Follow-up|0|||
125621482|NCT01714817|451895794|FG001|Year 1 Period|Lost to Follow-up|2|||
125621483|NCT01714817|451895793|FG000|Year 1 Period|Poor / non-compliance|0|||
125621484|NCT01714817|451895794|FG001|Year 1 Period|Poor / non-compliance|1|||
125621485|NCT01714817|451895793|FG000|Year 1 Period|Pregnancy|2|||
125621486|NCT01714817|451895794|FG001|Year 1 Period|Pregnancy|0|||
125621487|NCT01714817|451895793|FG000|Year 1 Period|Participant no longer meets criteria|6|||
125621488|NCT01714817|451895794|FG001|Year 1 Period|Participant no longer meets criteria|2|||
125621489|NCT01714817|451895793|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
125621490|NCT01714817|451895794|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
125621491|NCT01714817|451895793|FG000|Year 1 Period|Change in Concomitant Medication|0|||
125621492|NCT01714817|451895794|FG001|Year 1 Period|Change in Concomitant Medication|1|||
125621493|NCT01714817|451895793|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
125621494|NCT01714817|451895794|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
125621495|NCT01714817|451895793|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
125621496|NCT01714817|451895794|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
125621497|NCT01714817|451895793|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
125621498|NCT01714817|451895794|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
125621499|NCT01714817|451895793|FG000|Year 2 Period|Lack of Efficacy|4|||
125621500|NCT01714817|451895794|FG001|Year 2 Period|Lack of Efficacy|12|||
125621501|NCT01714817|451895793|FG000|Year 2 Period|Adverse Event|7|||
125621502|NCT01714817|451895794|FG001|Year 2 Period|Adverse Event|6|||
125621503|NCT01714817|451895793|FG000|Year 2 Period|Participant request to stop treatment|4|||
125621504|NCT01714817|451895794|FG001|Year 2 Period|Participant request to stop treatment|4|||
125621505|NCT01714817|451895793|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
125621506|NCT01714817|451895794|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
125374471|NCT00496470|451000342|FG001|Overall Study|Adverse Event|10|||
125374472|NCT00496470|451000341|FG000|Overall Study|Withdrawal by Subject|5|||
125374473|NCT00496470|451000342|FG001|Overall Study|Withdrawal by Subject|12|||
125374474|NCT00496470|451000341|FG000|Overall Study|Incorrectly enrolled|13|||
125374475|NCT00496470|451000342|FG001|Overall Study|Incorrectly enrolled|5|||
125374476|NCT00496470|451000341|FG000|Overall Study|Other reason|0|||
125374477|NCT00496470|451000342|FG001|Overall Study|Other reason|2|||
125374478|NCT04419714|451000343|FG000|Overall Study|Technical Fault|5|||
125374479|NCT04419714|451000343|FG000|Overall Study|Protocol Deviation|2|||
125374480|NCT04419714|451000343|FG000|Overall Study|Withdrawal by Subject|1|||
125374481|NCT02324569|451002202|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
125374482|NCT02324569|451002203|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
125374483|NCT02324569|451002202|FG000|Overall Study|Voluntary Withdrawal|3|||
125374484|NCT02324569|451002203|FG001|Overall Study|Voluntary Withdrawal|6|||
125374485|NCT02324569|451002202|FG000|Overall Study|Lack of Efficacy|2|||
125621507|NCT01714817|451895793|FG000|Year 2 Period|Participant withdrew consent|1|||
125621508|NCT01714817|451895794|FG001|Year 2 Period|Participant withdrew consent|5|||
125621509|NCT01714817|451895793|FG000|Year 2 Period|Participant no longer meets criteria|1|||
125621510|NCT01714817|451895794|FG001|Year 2 Period|Participant no longer meets criteria|4|||
125621511|NCT01714817|451895793|FG000|Year 2 Period|Lost to Follow-up|2|||
125621512|NCT01714817|451895794|FG001|Year 2 Period|Lost to Follow-up|0|||
125621513|NCT01714817|451895793|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
125621514|NCT01714817|451895794|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
125621515|NCT01714817|451895793|FG000|Year 2 Period|Pregnancy|1|||
125621516|NCT01714817|451895794|FG001|Year 2 Period|Pregnancy|1|||
125621517|NCT01714817|451895793|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
125621518|NCT01714817|451895794|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
125621519|NCT01714817|451895793|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
125621520|NCT01714817|451895794|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
125621521|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
125621522|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
125621523|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
125621524|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
125621525|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
125621526|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
125621527|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
125621528|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
125621529|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
125621530|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
125621531|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
125621532|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
125621533|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
125621534|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
125621535|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
125621536|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
125621537|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
125621538|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
125621539|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
125621540|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
125621541|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
125621542|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
125621543|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
125621544|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
125621545|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
125621546|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
125621547|NCT01714817|451895793|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
125621548|NCT01714817|451895794|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
125621549|NCT02921763|451895795|FG000|Overall Study|Adverse Event|4|||
125374486|NCT02324569|451002203|FG001|Overall Study|Lack of Efficacy|3|||
125374487|NCT02324569|451002202|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
125374488|NCT02324569|451002203|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
125374489|NCT02324569|451002202|FG000|Overall Study|Inconvenient Schedule|2|||
125374490|NCT02324569|451002203|FG001|Overall Study|Inconvenient Schedule|0|||
125621550|NCT02921763|451895795|FG000|Overall Study|Lost to Follow-up|4|||
125215279|NCT03148067|450414976|FG000|Overall Study|Lost to Follow-up|3|||
125621551|NCT02921763|451895795|FG000|Overall Study|Lack of Efficacy|3|||
125215280|NCT03148067|450414976|FG000|Overall Study|Death|1|||
125374491|NCT00911820|451002204|FG000|Overall Study|RECIST progression|12|||
125374492|NCT00911820|451002205|FG001|Overall Study|RECIST progression|8|||
125374493|NCT00911820|451002204|FG000|Overall Study|Adverse Event|8|||
125374494|NCT00911820|451002205|FG001|Overall Study|Adverse Event|8|||
125621552|NCT02921763|451895795|FG000|Overall Study|Protocol Violation|2|||
125621553|NCT02921763|451895795|FG000|Overall Study|Withdrawal by Subject|2|||
125621554|NCT02921763|451895795|FG000|Overall Study|Physician Decision|1|||
125621555|NCT02921763|451895795|FG000|Overall Study|No data obtained|2|||
125621556|NCT01582971|451895796|FG000|Overall Study|Death|2|||
125621557|NCT01582971|451895797|FG001|Overall Study|Death|1|||
125621558|NCT01582971|451895796|FG000|Overall Study|Lost to Follow-up|18|||
125621559|NCT01582971|451895797|FG001|Overall Study|Lost to Follow-up|21|||
125621560|NCT01582971|451895796|FG000|Overall Study|Withdrawal by Subject|4|||
125621561|NCT01582971|451895797|FG001|Overall Study|Withdrawal by Subject|2|||
125621562|NCT01582971|451895796|FG000|Overall Study|Other|15|||
125621563|NCT01582971|451895797|FG001|Overall Study|Other|13|||
125621564|NCT02007954|451895798|FG000|Overall Study|Received liver transplant|3|||
125621565|NCT02007954|451895798|FG000|Overall Study|Switch in treatment modality|2|||
125621566|NCT02007954|451895798|FG000|Overall Study|Disease progression and unrelated AE|1|||
125621567|NCT02007954|451895798|FG000|Overall Study|Death|1|||
125621568|NCT01871896|451895807|FG000|Overall Study|Lost to Follow-up|1|||
125621569|NCT06025396|451897221|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
125621570|NCT06025396|451897222|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
125621571|NCT06025396|451897223|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
125621572|NCT06025396|451897224|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
125621573|NCT06025396|451897225|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
125621574|NCT06025396|451897221|FG000|Overall Study|Withdrawal by Subject|0|||
125621575|NCT06025396|451897222|FG001|Overall Study|Withdrawal by Subject|1|||
125621576|NCT06025396|451897223|FG002|Overall Study|Withdrawal by Subject|1|||
125621577|NCT06025396|451897224|FG003|Overall Study|Withdrawal by Subject|0|||
125621578|NCT06025396|451897225|FG004|Overall Study|Withdrawal by Subject|0|||
125621579|NCT06422377|451897231|FG000|Overall Study|Study Terminated by Sponsor|1|||
125621580|NCT02843178|451897232|FG000|Overall Study|Lost to Follow-up|8|||
125621581|NCT02843178|451897233|FG001|Overall Study|Lost to Follow-up|8|||
125621582|NCT02843178|451897234|FG002|Overall Study|Lost to Follow-up|6|||
125621583|NCT02843178|451897235|FG003|Overall Study|Lost to Follow-up|3|||
125621584|NCT02843178|451897232|FG000|Overall Study|Withdrawal by Subject|0|||
125621585|NCT02843178|451897233|FG001|Overall Study|Withdrawal by Subject|0|||
125621586|NCT02843178|451897234|FG002|Overall Study|Withdrawal by Subject|1|||
125621587|NCT02843178|451897235|FG003|Overall Study|Withdrawal by Subject|1|||
125621588|NCT02420795|451897239|FG000|Overall Study|Withdrawal by Subject|1|||
125621589|NCT02420795|451897240|FG001|Overall Study|Withdrawal by Subject|0|||
125621590|NCT02420795|451897241|FG002|Overall Study|Withdrawal by Subject|0|||
125621591|NCT02420795|451897239|FG000|Overall Study|Adverse Event|1|||
125621592|NCT02420795|451897240|FG001|Overall Study|Adverse Event|0|||
125621593|NCT02420795|451897241|FG002|Overall Study|Adverse Event|0|||
125621594|NCT02420795|451897239|FG000|Overall Study|Progressive disease|2|||
125621595|NCT02420795|451897240|FG001|Overall Study|Progressive disease|2|||
125621596|NCT02420795|451897241|FG002|Overall Study|Progressive disease|4|||
125621597|NCT02420795|451897239|FG000|Overall Study|Death|0|||
125621598|NCT02420795|451897240|FG001|Overall Study|Death|0|||
125621599|NCT02420795|451897241|FG002|Overall Study|Death|1|||
125621600|NCT01293006|451897245|FG000|Period 2|Lost to Follow-up|1|||
125621601|NCT01293006|451897246|FG001|Period 2|Lost to Follow-up|0|||
125621602|NCT01293006|451897247|FG002|Period 2|Lost to Follow-up|0|||
125621603|NCT01293006|451897248|FG003|Period 2|Lost to Follow-up|0|||
125621604|NCT00520299|451897251|FG000|Overall Study|Withdrawal by Subject|0|||
125621605|NCT00520299|451897252|FG001|Overall Study|Withdrawal by Subject|0|||
125621606|NCT00520299|451897253|FG002|Overall Study|Withdrawal by Subject|2|||
125621607|NCT00520299|451897251|FG000|Overall Study|Progressive disease|0|||
125621608|NCT00520299|451897252|FG001|Overall Study|Progressive disease|3|||
125621609|NCT00520299|451897253|FG002|Overall Study|Progressive disease|4|||
125374495|NCT00911820|451002204|FG000|Overall Study|Clinical Progression|7|||
125374496|NCT00911820|451002205|FG001|Overall Study|Clinical Progression|5|||
125374497|NCT00911820|451002204|FG000|Overall Study|Physician Decision|5|||
125374498|NCT00911820|451002205|FG001|Overall Study|Physician Decision|9|||
125374499|NCT00911820|451002204|FG000|Overall Study|Decline in Performance Status|4|||
125374500|NCT00911820|451002205|FG001|Overall Study|Decline in Performance Status|2|||
125621610|NCT05905601|451897257|FG000|Overall Study|Lost to Follow-up|1|||
125621611|NCT05905601|451897258|FG001|Overall Study|Lost to Follow-up|3|||
125621612|NCT03024255|451897259|FG000|Overall Study|Adverse Event|1|||
125374501|NCT00911820|451002204|FG000|Overall Study|Withdrawal by Subject|3|||
125374502|NCT00911820|451002205|FG001|Overall Study|Withdrawal by Subject|4|||
125433116|NCT00085202|451212438|FG001|Overall Study|Excessive toxicity|5|||
125621613|NCT03024255|451897260|FG001|Overall Study|Adverse Event|4|||
125621614|NCT03024255|451897261|FG002|Overall Study|Adverse Event|8|||
125621615|NCT03024255|451897262|FG003|Overall Study|Adverse Event|0|||
125621616|NCT03024255|451897259|FG000|Overall Study|Withdrawal by Subject|3|||
125621617|NCT03024255|451897260|FG001|Overall Study|Withdrawal by Subject|1|||
125621618|NCT03024255|451897261|FG002|Overall Study|Withdrawal by Subject|0|||
125621619|NCT03024255|451897262|FG003|Overall Study|Withdrawal by Subject|3|||
125621620|NCT03024255|451897259|FG000|Overall Study|Protocol Violation|0|||
125621621|NCT03024255|451897260|FG001|Overall Study|Protocol Violation|0|||
125621622|NCT03024255|451897261|FG002|Overall Study|Protocol Violation|2|||
125621623|NCT03024255|451897262|FG003|Overall Study|Protocol Violation|0|||
125621624|NCT03024255|451897259|FG000|Overall Study|Lost to Follow-up|1|||
125621625|NCT03024255|451897260|FG001|Overall Study|Lost to Follow-up|2|||
125621626|NCT03024255|451897261|FG002|Overall Study|Lost to Follow-up|1|||
125621627|NCT03024255|451897262|FG003|Overall Study|Lost to Follow-up|1|||
125621628|NCT03024255|451897259|FG000|Overall Study|Lack of Efficacy|1|||
125621629|NCT03024255|451897260|FG001|Overall Study|Lack of Efficacy|0|||
125621630|NCT03024255|451897261|FG002|Overall Study|Lack of Efficacy|0|||
125621631|NCT03024255|451897262|FG003|Overall Study|Lack of Efficacy|0|||
125621632|NCT03024255|451897259|FG000|Overall Study|Protocol Noncompliance|1|||
125621633|NCT03024255|451897260|FG001|Overall Study|Protocol Noncompliance|1|||
125621634|NCT03024255|451897261|FG002|Overall Study|Protocol Noncompliance|0|||
125621635|NCT03024255|451897262|FG003|Overall Study|Protocol Noncompliance|1|||
125621636|NCT03583606|451897263|FG000|Overall Study|Lost to Follow-up|0|||
125621637|NCT03583606|451897264|FG001|Overall Study|Lost to Follow-up|1|||
125621638|NCT03583606|451897265|FG002|Overall Study|Lost to Follow-up|0|||
125621639|NCT03583606|451897263|FG000|Overall Study|Ineligible at baseline|1|||
125621640|NCT03583606|451897264|FG001|Overall Study|Ineligible at baseline|0|||
125621641|NCT03583606|451897265|FG002|Overall Study|Ineligible at baseline|0|||
125621642|NCT00126581|451897270|FG000|Overall Study|Adverse Event|3|||
125621643|NCT00126581|451897271|FG001|Overall Study|Adverse Event|7|||
125621644|NCT00126581|451897270|FG000|Overall Study|Death|3|||
125621645|NCT00126581|451897271|FG001|Overall Study|Death|2|||
125621646|NCT00126581|451897270|FG000|Overall Study|Withdrawal by Subject|1|||
125621647|NCT00126581|451897271|FG001|Overall Study|Withdrawal by Subject|4|||
125621648|NCT00126581|451897270|FG000|Overall Study|Alternative therapy|3|||
125621649|NCT00126581|451897271|FG001|Overall Study|Alternative therapy|3|||
125621650|NCT00126581|451897270|FG000|Overall Study|Other illness/MD discretion|3|||
125621651|NCT00126581|451897271|FG001|Overall Study|Other illness/MD discretion|4|||
125621652|NCT03728140|451897273|FG000|Overall Study|Abnormal embryo transfer operation|10|||
125621653|NCT03728140|451897274|FG001|Overall Study|Abnormal embryo transfer operation|7|||
125621654|NCT03783442|451897279|FG000|Overall Study|Death|252|||
125621655|NCT03783442|451897280|FG001|Overall Study|Death|268|||
125621656|NCT03783442|451897279|FG000|Overall Study|Withdrawal by Subject|19|||
125621657|NCT03783442|451897280|FG001|Overall Study|Withdrawal by Subject|21|||
125621658|NCT03783442|451897279|FG000|Overall Study|Lost to Follow-up|7|||
125374503|NCT00911820|451002204|FG000|Overall Study|Death|1|||
125374504|NCT00911820|451002205|FG001|Overall Study|Death|2|||
125374505|NCT00911820|451002204|FG000|Overall Study|Pursue surgery|1|||
125621659|NCT03783442|451897280|FG001|Overall Study|Lost to Follow-up|6|||
125621660|NCT03783442|451897279|FG000|Overall Study|Sponsor Ended Study|48|||
125621661|NCT03783442|451897280|FG001|Overall Study|Sponsor Ended Study|28|||
125621662|NCT04190186|451897281|FG000|Overall Study|ILR is no longer functioning|0|||
125621663|NCT04190186|451897282|FG001|Overall Study|ILR is no longer functioning|1|||
125621664|NCT04190186|451897281|FG000|Overall Study|Lost to Follow-up|0|||
125621665|NCT04190186|451897282|FG001|Overall Study|Lost to Follow-up|1|||
125621666|NCT04190186|451897281|FG000|Overall Study|Withdrawal by Subject|2|||
125621667|NCT04190186|451897282|FG001|Overall Study|Withdrawal by Subject|0|||
125621668|NCT04190186|451897281|FG000|Overall Study|Subject choice to explant|1|||
125621669|NCT04190186|451897282|FG001|Overall Study|Subject choice to explant|0|||
125621670|NCT04190186|451897281|FG000|Overall Study|Physician Decision|0|||
125621671|NCT04190186|451897282|FG001|Overall Study|Physician Decision|1|||
125621672|NCT04190186|451897281|FG000|Overall Study|Study was stopped|4|||
125621673|NCT04190186|451897282|FG001|Overall Study|Study was stopped|5|||
125374506|NCT00911820|451002205|FG001|Overall Study|Pursue surgery|1|||
125621674|NCT01504971|451897287|FG000|Overall Study|Physician Decision|13|||
125621675|NCT03483116|451897288|FG000|Overall Study|Adverse Event|0|||
125621676|NCT03483116|451897289|FG001|Overall Study|Adverse Event|1|||
125621677|NCT03483116|451897290|FG002|Overall Study|Adverse Event|0|||
125621678|NCT03483116|451897291|FG003|Overall Study|Adverse Event|1|||
125621679|NCT03483116|451897288|FG000|Overall Study|Protocol Violation|1|||
125621680|NCT03483116|451897289|FG001|Overall Study|Protocol Violation|0|||
125621681|NCT03483116|451897290|FG002|Overall Study|Protocol Violation|0|||
125621682|NCT03483116|451897291|FG003|Overall Study|Protocol Violation|7|||
125374507|NCT00911820|451002204|FG000|Overall Study|Pursue Radiation|1|||
125621683|NCT03483116|451897288|FG000|Overall Study|Lost to Follow-up|9|||
125215281|NCT02559570|450414978|FG000|Overall Study|Adverse Event|0|||
125374508|NCT00911820|451002205|FG001|Overall Study|Pursue Radiation|0|||
125374509|NCT00911820|451002204|FG000|Overall Study|Still on Therapy|2|||
125621684|NCT03483116|451897289|FG001|Overall Study|Lost to Follow-up|4|||
125621685|NCT03483116|451897290|FG002|Overall Study|Lost to Follow-up|9|||
125621686|NCT03483116|451897291|FG003|Overall Study|Lost to Follow-up|5|||
125621687|NCT03483116|451897288|FG000|Overall Study|Death|1|||
125621688|NCT03483116|451897289|FG001|Overall Study|Death|0|||
125621689|NCT03483116|451897290|FG002|Overall Study|Death|2|||
125621690|NCT03483116|451897291|FG003|Overall Study|Death|1|||
125621691|NCT03483116|451897288|FG000|Overall Study|Withdrawal by Subject|14|||
125621692|NCT03483116|451897289|FG001|Overall Study|Withdrawal by Subject|16|||
125621693|NCT03483116|451897290|FG002|Overall Study|Withdrawal by Subject|14|||
125621694|NCT03483116|451897291|FG003|Overall Study|Withdrawal by Subject|16|||
125621695|NCT03483116|451897288|FG000|Overall Study|Unknown other reason|3|||
125621696|NCT03483116|451897289|FG001|Overall Study|Unknown other reason|2|||
125621697|NCT03483116|451897290|FG002|Overall Study|Unknown other reason|1|||
125621698|NCT03483116|451897291|FG003|Overall Study|Unknown other reason|1|||
125621699|NCT00426556|451897294|FG000|Phase I - Core Phase|Disease Progression|0|||
125621700|NCT00426556|451897295|FG001|Phase I - Core Phase|Disease Progression|6|||
125621701|NCT00426556|451897296|FG002|Phase I - Core Phase|Disease Progression|2|||
125621702|NCT00426556|451897297|FG003|Phase I - Core Phase|Disease Progression|0|||
125621703|NCT00426556|451897294|FG000|Phase I - Core Phase|Adverse Event|1|||
125621704|NCT00426556|451897295|FG001|Phase I - Core Phase|Adverse Event|3|||
125621705|NCT00426556|451897296|FG002|Phase I - Core Phase|Adverse Event|1|||
125621706|NCT00426556|451897297|FG003|Phase I - Core Phase|Adverse Event|0|||
125621707|NCT00426556|451897294|FG000|Phase I - Core Phase|Death|0|||
125621708|NCT00426556|451897295|FG001|Phase I - Core Phase|Death|1|||
125621709|NCT00426556|451897296|FG002|Phase I - Core Phase|Death|0|||
125621710|NCT00426556|451897297|FG003|Phase I - Core Phase|Death|0|||
125621711|NCT00426556|451897294|FG000|Phase I - Extension Phase|Adverse Event|0|||
125621712|NCT00426556|451897295|FG001|Phase I - Extension Phase|Adverse Event|1|||
125621713|NCT00426556|451897296|FG002|Phase I - Extension Phase|Adverse Event|1|||
125621714|NCT00426556|451897297|FG003|Phase I - Extension Phase|Adverse Event|0|||
125621715|NCT00426556|451897294|FG000|Phase I - Extension Phase|Disease Progression|5|||
125621716|NCT00426556|451897295|FG001|Phase I - Extension Phase|Disease Progression|5|||
125621717|NCT00426556|451897296|FG002|Phase I - Extension Phase|Disease Progression|6|||
125621718|NCT00426556|451897297|FG003|Phase I - Extension Phase|Disease Progression|0|||
125621719|NCT00426556|451897294|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
125621720|NCT00426556|451897295|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
125621721|NCT00426556|451897296|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
125621722|NCT00426556|451897297|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
125621723|NCT00426556|451897294|FG000|Phase II - Core Phase|Disease Progression|0|||
125621724|NCT00426556|451897295|FG001|Phase II - Core Phase|Disease Progression|0|||
125621725|NCT00426556|451897296|FG002|Phase II - Core Phase|Disease Progression|0|||
125621726|NCT00426556|451897297|FG003|Phase II - Core Phase|Disease Progression|16|||
125621727|NCT00426556|451897294|FG000|Phase II - Core Phase|Adverse Event|0|||
125621728|NCT00426556|451897295|FG001|Phase II - Core Phase|Adverse Event|0|||
125621729|NCT00426556|451897296|FG002|Phase II - Core Phase|Adverse Event|0|||
125621730|NCT00426556|451897297|FG003|Phase II - Core Phase|Adverse Event|8|||
125621731|NCT00426556|451897294|FG000|Phase II - Extension Phase|Disease Progression|0|||
125621732|NCT00426556|451897295|FG001|Phase II - Extension Phase|Disease Progression|0|||
125621733|NCT00426556|451897296|FG002|Phase II - Extension Phase|Disease Progression|0|||
125621734|NCT00426556|451897297|FG003|Phase II - Extension Phase|Disease Progression|21|||
125621735|NCT00426556|451897294|FG000|Phase II - Extension Phase|Adverse Event|0|||
125621736|NCT00426556|451897295|FG001|Phase II - Extension Phase|Adverse Event|0|||
125621737|NCT00426556|451897296|FG002|Phase II - Extension Phase|Adverse Event|0|||
125621738|NCT00426556|451897297|FG003|Phase II - Extension Phase|Adverse Event|2|||
125621739|NCT00225212|451897298|FG000|Overall Study|Disease progression|2|||
125621740|NCT00225212|451897298|FG000|Overall Study|Death|1|||
125621741|NCT00225212|451897298|FG000|Overall Study|Adverse Event|2|||
125621742|NCT00225212|451897298|FG000|Overall Study|Intercurrent illness|1|||
125621743|NCT01182337|451897305|FG000|Overall Study|Withdrawal by Subject|3|||
125621744|NCT01182337|451897306|FG001|Overall Study|Withdrawal by Subject|1|||
125374510|NCT00911820|451002205|FG001|Overall Study|Still on Therapy|2|||
125621745|NCT01182337|451897305|FG000|Overall Study|Lost to Follow-up|0|||
125621746|NCT01182337|451897306|FG001|Overall Study|Lost to Follow-up|1|||
125621747|NCT03448224|451897307|FG000|Overall Study|Provided same answer to every question|1|||
125621748|NCT03448224|451897308|FG001|Overall Study|Provided same answer to every question|0|||
125621749|NCT03103906|451897309|FG000|Overall Study|Adverse Event|2|||
125621750|NCT03103906|451897310|FG001|Overall Study|Adverse Event|3|||
125621751|NCT03103906|451897309|FG000|Overall Study|Other|2|||
125621752|NCT03103906|451897310|FG001|Overall Study|Other|0|||
125621753|NCT03571256|451897311|FG000|Overall Study|Adverse Event|3|||
125621754|NCT03571256|451897312|FG001|Overall Study|Adverse Event|0|||
125621755|NCT03571256|451897313|FG002|Overall Study|Adverse Event|1|||
125621756|NCT03571256|451897311|FG000|Overall Study|Withdrawal by Subject|3|||
125621757|NCT03571256|451897312|FG001|Overall Study|Withdrawal by Subject|1|||
125621758|NCT03571256|451897313|FG002|Overall Study|Withdrawal by Subject|1|||
125621759|NCT03571256|451897311|FG000|Overall Study|Other than specified|0|||
125621760|NCT03571256|451897312|FG001|Overall Study|Other than specified|1|||
125621761|NCT03571256|451897313|FG002|Overall Study|Other than specified|1|||
125621762|NCT03571256|451897311|FG000|Overall Study|Protocol Violation|0|||
125621763|NCT03571256|451897312|FG001|Overall Study|Protocol Violation|1|||
125621764|NCT03571256|451897313|FG002|Overall Study|Protocol Violation|1|||
125621765|NCT00575094|451897316|FG000|Overall Study|Adverse Event|2|||
125621766|NCT00575094|451897316|FG000|Overall Study|Withdrawal by Subject|1|||
125621767|NCT00772382|451897318|FG000|Overall Study|Adverse Event|19|||
125621768|NCT00772382|451897318|FG000|Overall Study|Death|6|||
125621769|NCT00772382|451897318|FG000|Overall Study|Lack of Efficacy|4|||
125621770|NCT00772382|451897318|FG000|Overall Study|Physician Decision|5|||
125621771|NCT00772382|451897318|FG000|Overall Study|Protocol Violation|1|||
125621772|NCT00772382|451897318|FG000|Overall Study|Withdrawal by Subject|10|||
125621773|NCT00772382|451897318|FG000|Overall Study|Other Reasons|10|||
125621774|NCT00643604|451897325|FG000|Overall Study|Death|1|||
125621775|NCT02702011|451897326|FG000|Overall Study|Withdrawal by Subject|0|||
125621776|NCT02702011|451897327|FG001|Overall Study|Withdrawal by Subject|1|||
125621777|NCT02702011|451897328|FG002|Overall Study|Withdrawal by Subject|0|||
125621778|NCT02702011|451897329|FG003|Overall Study|Withdrawal by Subject|0|||
125621779|NCT01374217|451897332|FG000|Overall Study|Lack of Efficacy|13|||
125621780|NCT01740388|451897333|FG000|Overall Study|Withdrawal by Subject|1|||
125621781|NCT01740388|451897334|FG001|Overall Study|Withdrawal by Subject|2|||
125621782|NCT01740388|451897333|FG000|Overall Study|Lost to Follow-up|2|||
125374511|NCT00911820|451002204|FG000|Overall Study|Pathology Not Confirmed|1|||
125374512|NCT00911820|451002205|FG001|Overall Study|Pathology Not Confirmed|0|||
125374513|NCT00911820|451002204|FG000|Overall Study|Withdraw before Receive Treatment|0|||
125621783|NCT01740388|451897334|FG001|Overall Study|Lost to Follow-up|0|||
125621784|NCT01740388|451897333|FG000|Overall Study|Physician Decision|2|||
125621785|NCT01740388|451897334|FG001|Overall Study|Physician Decision|6|||
125621786|NCT01740388|451897333|FG000|Overall Study|Subjects missing data, completed|41|||
125621787|NCT01740388|451897334|FG001|Overall Study|Subjects missing data, completed|36|||
125621788|NCT00862121|451897337|FG000|Overall Study|Adverse Event|1|||
125621789|NCT00862121|451897338|FG001|Overall Study|Adverse Event|2|||
125621790|NCT00862121|451897337|FG000|Overall Study|Lack of Efficacy|0|||
125621791|NCT00862121|451897338|FG001|Overall Study|Lack of Efficacy|3|||
125621792|NCT00862121|451897337|FG000|Overall Study|Protocol Violation|0|||
125621793|NCT00862121|451897338|FG001|Overall Study|Protocol Violation|1|||
125621794|NCT00862121|451897337|FG000|Overall Study|Exclusion criterion violation|0|||
125621795|NCT00862121|451897338|FG001|Overall Study|Exclusion criterion violation|1|||
125621796|NCT00862121|451897337|FG000|Overall Study|Incorrect randomisation|0|||
125621797|NCT00862121|451897338|FG001|Overall Study|Incorrect randomisation|1|||
125621798|NCT01641991|451897339|FG000|Overall Study|Physician Decision|0|||
125621799|NCT01641991|451897340|FG001|Overall Study|Physician Decision|1|||
125621800|NCT01641991|451897341|FG002|Overall Study|Physician Decision|7|||
125621801|NCT01641991|451897342|FG003|Overall Study|Physician Decision|5|||
125621802|NCT01641991|451897339|FG000|Overall Study|Withdrawal by Subject|4|||
125621803|NCT01641991|451897340|FG001|Overall Study|Withdrawal by Subject|2|||
125621804|NCT01641991|451897341|FG002|Overall Study|Withdrawal by Subject|1|||
125621805|NCT01641991|451897342|FG003|Overall Study|Withdrawal by Subject|5|||
125621806|NCT01641991|451897339|FG000|Overall Study|Adverse Event|2|||
125621807|NCT01641991|451897340|FG001|Overall Study|Adverse Event|1|||
125621808|NCT01641991|451897341|FG002|Overall Study|Adverse Event|2|||
125621809|NCT01641991|451897342|FG003|Overall Study|Adverse Event|1|||
125621810|NCT01641991|451897339|FG000|Overall Study|Lost to Follow-up|0|||
125621811|NCT01641991|451897340|FG001|Overall Study|Lost to Follow-up|2|||
125621812|NCT01641991|451897341|FG002|Overall Study|Lost to Follow-up|3|||
125621813|NCT01641991|451897342|FG003|Overall Study|Lost to Follow-up|1|||
125621814|NCT01641991|451897339|FG000|Overall Study|Protocol Violation|1|||
125621815|NCT01641991|451897340|FG001|Overall Study|Protocol Violation|1|||
125621816|NCT01641991|451897341|FG002|Overall Study|Protocol Violation|3|||
125621817|NCT01641991|451897342|FG003|Overall Study|Protocol Violation|0|||
125621818|NCT01641991|451897339|FG000|Overall Study|Pregnancy|0|||
125621819|NCT01641991|451897340|FG001|Overall Study|Pregnancy|0|||
125621820|NCT01641991|451897341|FG002|Overall Study|Pregnancy|1|||
125621821|NCT01641991|451897342|FG003|Overall Study|Pregnancy|0|||
125621822|NCT01641991|451897339|FG000|Overall Study|no longer eligible|2|||
125621823|NCT01641991|451897340|FG001|Overall Study|no longer eligible|1|||
125621824|NCT01641991|451897341|FG002|Overall Study|no longer eligible|0|||
125621825|NCT01641991|451897342|FG003|Overall Study|no longer eligible|4|||
125621826|NCT03371732|451897347|FG000|Overall Study|Withdrawal by Subject|9|||
125621827|NCT03371732|451897348|FG001|Overall Study|Withdrawal by Subject|3|||
125621828|NCT03371732|451897347|FG000|Overall Study|Refusal to continue|3|||
125621829|NCT03371732|451897348|FG001|Overall Study|Refusal to continue|4|||
125621830|NCT00171314|451897349|FG000|Overall Study|Adverse Event|44|||
125621831|NCT00171314|451897350|FG001|Overall Study|Adverse Event|41|||
125621832|NCT00171314|451897349|FG000|Overall Study|Lack of Efficacy|19|||
125621833|NCT00171314|451897350|FG001|Overall Study|Lack of Efficacy|14|||
125621834|NCT00171314|451897349|FG000|Overall Study|Withdrawal by Subject|9|||
125621835|NCT00171314|451897350|FG001|Overall Study|Withdrawal by Subject|6|||
125621836|NCT00171314|451897349|FG000|Overall Study|Abnormal Test Procedure Results|9|||
125621837|NCT00171314|451897350|FG001|Overall Study|Abnormal Test Procedure Results|3|||
125621838|NCT00171314|451897349|FG000|Overall Study|Protocol Violation|3|||
125621839|NCT00171314|451897350|FG001|Overall Study|Protocol Violation|7|||
125621840|NCT00171314|451897349|FG000|Overall Study|Administrative Problems|4|||
125374514|NCT00911820|451002205|FG001|Overall Study|Withdraw before Receive Treatment|2|||
125374515|NCT03098550|451002212|FG000|Overall Study|Disease Progression|30|||
125374516|NCT03098550|451002213|FG001|Overall Study|Disease Progression|19|||
125374517|NCT03098550|451002214|FG002|Overall Study|Disease Progression|41|||
125374518|NCT03098550|451002212|FG000|Overall Study|Study Drug Toxicity|2|||
125433117|NCT00085202|451212437|FG000|Overall Study|Non-specified|3|||
125621841|NCT00171314|451897350|FG001|Overall Study|Administrative Problems|3|||
125621842|NCT00171314|451897349|FG000|Overall Study|Lost to Follow-up|1|||
125621843|NCT00171314|451897350|FG001|Overall Study|Lost to Follow-up|3|||
125621844|NCT00171314|451897349|FG000|Overall Study|Death|2|||
125621845|NCT00171314|451897350|FG001|Overall Study|Death|1|||
125621846|NCT00475540|451897351|FG000|36 Months|Lost to Follow-up|4|||
125621847|NCT00475540|451897352|FG001|36 Months|Lost to Follow-up|4|||
125621848|NCT00475540|451897351|FG000|36 Months|Death|1|||
125621849|NCT00475540|451897352|FG001|36 Months|Death|2|||
125621850|NCT00475540|451897351|FG000|36 Months|Censored due to reoperation|3|||
125621851|NCT00475540|451897352|FG001|36 Months|Censored due to reoperation|0|||
125621852|NCT00377429|451897353|FG000|Overall Study|Withdrawal by Subject|5|||
125621853|NCT00377429|451897353|FG000|Overall Study|Adverse Event|8|||
125621854|NCT00377429|451897353|FG000|Overall Study|Physician Decision|1|||
125621855|NCT00377429|451897353|FG000|Overall Study|Patient non-compliance|1|||
125621856|NCT01033487|451897356|FG000|Fourth Intervention Period|Adverse Event|0|||
125621857|NCT01033487|451897357|FG001|Fourth Intervention Period|Adverse Event|0|||
125621858|NCT01033487|451897358|FG002|Fourth Intervention Period|Adverse Event|0|||
125621859|NCT01033487|451897359|FG003|Fourth Intervention Period|Adverse Event|0|||
125621860|NCT01033487|451897360|FG004|Fourth Intervention Period|Adverse Event|0|||
125621861|NCT01033487|451897361|FG005|Fourth Intervention Period|Adverse Event|0|||
125621862|NCT01033487|451897362|FG006|Fourth Intervention Period|Adverse Event|0|||
125621863|NCT01033487|451897363|FG007|Fourth Intervention Period|Adverse Event|0|||
125621864|NCT01033487|451897364|FG008|Fourth Intervention Period|Adverse Event|1|||
125621865|NCT01033487|451897365|FG009|Fourth Intervention Period|Adverse Event|0|||
125621866|NCT02939599|451897369|FG000|Overall Study|Adverse Event|1|||
125621867|NCT02939599|451897370|FG001|Overall Study|Adverse Event|0|||
125621868|NCT02939599|451897369|FG000|Overall Study|Study Terminated By Sponsor|2|||
125621869|NCT02939599|451897370|FG001|Overall Study|Study Terminated By Sponsor|2|||
125621870|NCT02148211|451897371|FG000|Overall Study|Lost to Follow-up|352|||
125621871|NCT02726113|451897372|FG000|Total Enrollment|Physician Decision|0|||
125621872|NCT02726113|451897373|FG001|Total Enrollment|Physician Decision|1|||
125621873|NCT02726113|451897372|FG000|Total Enrollment|Protocol Violation|1|||
125621874|NCT02726113|451897373|FG001|Total Enrollment|Protocol Violation|0|||
125621875|NCT02726113|451897372|FG000|Total Enrollment|Withdrawal by Subject|2|||
125621876|NCT02726113|451897373|FG001|Total Enrollment|Withdrawal by Subject|1|||
125621877|NCT02726113|451897372|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
125621878|NCT02726113|451897373|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
125621879|NCT02726113|451897372|FG000|Genomic Analysis|Protocol Violation|1|||
125621880|NCT02726113|451897373|FG001|Genomic Analysis|Protocol Violation|0|||
125621881|NCT02726113|451897372|FG000|Genomic Analysis|Withdrawal by Subject|2|||
125621882|NCT02726113|451897373|FG001|Genomic Analysis|Withdrawal by Subject|1|||
125621883|NCT02726113|451897372|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
125621884|NCT02726113|451897373|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
125621885|NCT01512108|451899448|FG000|Overall Study|Adverse Event|9|||
125621886|NCT01512108|451899449|FG001|Overall Study|Adverse Event|4|||
125621887|NCT01512108|451899448|FG000|Overall Study|Protocol Violation|1|||
125621888|NCT01512108|451899449|FG001|Overall Study|Protocol Violation|2|||
125621889|NCT01512108|451899448|FG000|Overall Study|Withdrawal Criteria|1|||
125621890|NCT01512108|451899449|FG001|Overall Study|Withdrawal Criteria|0|||
125621891|NCT01512108|451899448|FG000|Overall Study|Unclassified|11|||
125621892|NCT01512108|451899449|FG001|Overall Study|Unclassified|3|||
125621893|NCT01824693|451899450|FG000|Overall Study|Death|0|||
125621894|NCT01824693|451899451|FG001|Overall Study|Death|1|||
125621895|NCT01824693|451899452|FG002|Overall Study|Death|0|||
125621896|NCT01824693|451899450|FG000|Overall Study|Physician Decision|1|||
125621897|NCT01824693|451899451|FG001|Overall Study|Physician Decision|1|||
125621898|NCT01824693|451899452|FG002|Overall Study|Physician Decision|1|||
125621899|NCT01824693|451899450|FG000|Overall Study|Withdrawal by Subject|0|||
125621900|NCT01824693|451899451|FG001|Overall Study|Withdrawal by Subject|0|||
125621901|NCT01824693|451899452|FG002|Overall Study|Withdrawal by Subject|1|||
125621902|NCT01824693|451899450|FG000|Overall Study|Progressive Disease|0|||
125621903|NCT01824693|451899451|FG001|Overall Study|Progressive Disease|5|||
125621904|NCT01824693|451899452|FG002|Overall Study|Progressive Disease|0|||
125621905|NCT01824693|451899450|FG000|Overall Study|Ineligible|0|||
125621906|NCT01824693|451899451|FG001|Overall Study|Ineligible|0|||
125621907|NCT01824693|451899452|FG002|Overall Study|Ineligible|3|||
125621908|NCT01824693|451899450|FG000|Overall Study|No Transplant Planned|0|||
125621909|NCT01824693|451899451|FG001|Overall Study|No Transplant Planned|0|||
125621910|NCT01824693|451899452|FG002|Overall Study|No Transplant Planned|10|||
125621911|NCT03287869|451899455|FG000|Overall Study|Adverse Event|14|||
125621912|NCT03287869|451899456|FG001|Overall Study|Adverse Event|12|||
125621913|NCT03287869|451899455|FG000|Overall Study|Lack of Efficacy|1|||
125621914|NCT03287869|451899456|FG001|Overall Study|Lack of Efficacy|0|||
125621915|NCT03287869|451899455|FG000|Overall Study|Lost to Follow-up|13|||
125621916|NCT03287869|451899456|FG001|Overall Study|Lost to Follow-up|19|||
125621917|NCT03287869|451899455|FG000|Overall Study|Non-Compliance With Study Drug|5|||
125621918|NCT03287869|451899456|FG001|Overall Study|Non-Compliance With Study Drug|9|||
125621919|NCT03287869|451899455|FG000|Overall Study|Progressive Disease|1|||
125621920|NCT03287869|451899456|FG001|Overall Study|Progressive Disease|0|||
125621921|NCT03287869|451899455|FG000|Overall Study|Protocol Deviation|2|||
125621922|NCT03287869|451899456|FG001|Overall Study|Protocol Deviation|1|||
125621923|NCT03287869|451899455|FG000|Overall Study|Withdrawal by Subject|36|||
125621924|NCT03287869|451899456|FG001|Overall Study|Withdrawal by Subject|43|||
125621925|NCT03287869|451899455|FG000|Overall Study|Early Closure of the Site|0|||
125215282|NCT02559570|450414979|FG001|Overall Study|Adverse Event|2|||
125215283|NCT02559570|450414980|FG002|Overall Study|Adverse Event|0|||
125433118|NCT00085202|451212438|FG001|Overall Study|Non-specified|5|||
125621926|NCT03287869|451899456|FG001|Overall Study|Early Closure of the Site|1|||
125621927|NCT03287869|451899455|FG000|Overall Study|Physician Decision|5|||
125621928|NCT03287869|451899456|FG001|Overall Study|Physician Decision|5|||
125621929|NCT03287869|451899455|FG000|Overall Study|Reason not Specified|6|||
125621930|NCT03287869|451899456|FG001|Overall Study|Reason not Specified|3|||
125621931|NCT03488238|451899457|FG000|Overall Study|Equipment malfunction|1|||
125621932|NCT03488238|451899457|FG000|Overall Study|Adverse Event|1|||
125621933|NCT00656084|451899458|FG000|Overall Study|Adverse Event|4|||
125621934|NCT00656084|451899458|FG000|Overall Study|Withdrawal by Subject|1|||
125621935|NCT00656084|451899458|FG000|Overall Study|Patient Request|1|||
125621936|NCT00656084|451899458|FG000|Overall Study|Investigator Request|1|||
125621937|NCT02591238|451899459|FG000|Overall Study|Pregnancy|1|||
125621938|NCT02591238|451899460|FG001|Overall Study|Pregnancy|0|||
125621939|NCT02591238|451899461|FG002|Overall Study|Pregnancy|0|||
125621940|NCT02591238|451899462|FG003|Overall Study|Pregnancy|0|||
125621941|NCT02591238|451899459|FG000|Overall Study|Withdrawal by Subject|0|||
125621942|NCT02591238|451899460|FG001|Overall Study|Withdrawal by Subject|0|||
125621943|NCT02591238|451899461|FG002|Overall Study|Withdrawal by Subject|0|||
125621944|NCT02591238|451899462|FG003|Overall Study|Withdrawal by Subject|1|||
125621945|NCT02591238|451899459|FG000|Overall Study|influenza|0|||
125621946|NCT02591238|451899460|FG001|Overall Study|influenza|0|||
125621947|NCT02591238|451899461|FG002|Overall Study|influenza|0|||
125621948|NCT02591238|451899462|FG003|Overall Study|influenza|1|||
125621949|NCT02591238|451899459|FG000|Overall Study|personal circumstances|0|||
125621950|NCT02591238|451899460|FG001|Overall Study|personal circumstances|0|||
125621951|NCT02591238|451899461|FG002|Overall Study|personal circumstances|0|||
125621952|NCT02591238|451899462|FG003|Overall Study|personal circumstances|1|||
125621953|NCT02591238|451899459|FG000|Overall Study|personal circumstances|0|||
125621954|NCT02591238|451899460|FG001|Overall Study|personal circumstances|1|||
125621955|NCT02591238|451899461|FG002|Overall Study|personal circumstances|0|||
125621956|NCT02591238|451899462|FG003|Overall Study|personal circumstances|0|||
125621957|NCT00953225|451899466|FG000|Overall Study|Withdrawal by Subject|2|||
125621958|NCT00953225|451899467|FG001|Overall Study|Withdrawal by Subject|0|||
125621959|NCT00640146|451899468|FG000|Overall Study|Adverse Event|2|||
125621960|NCT00640146|451899469|FG001|Overall Study|Adverse Event|0|||
125621961|NCT00640146|451899468|FG000|Overall Study|Lost to Follow-up|0|||
125621962|NCT00640146|451899469|FG001|Overall Study|Lost to Follow-up|1|||
125621963|NCT00640146|451899468|FG000|Overall Study|Lack of Efficacy|0|||
125621964|NCT00640146|451899469|FG001|Overall Study|Lack of Efficacy|1|||
125621965|NCT00640146|451899468|FG000|Overall Study|Withdrawal by Subject|1|||
125621966|NCT00640146|451899469|FG001|Overall Study|Withdrawal by Subject|1|||
125621967|NCT00640146|451899468|FG000|Overall Study|Randomized but not treated|1|||
125621968|NCT00640146|451899469|FG001|Overall Study|Randomized but not treated|3|||
125621969|NCT01357980|451899472|FG000|Overall Study|Lack of Efficacy|0|||
125621970|NCT01357980|451899473|FG001|Overall Study|Lack of Efficacy|1|||
125621971|NCT01357980|451899474|FG002|Overall Study|Lack of Efficacy|0|||
125621972|NCT01357980|451899475|FG003|Overall Study|Lack of Efficacy|0|||
125621973|NCT01357980|451899472|FG000|Overall Study|Consent withdrawn|0|||
125621974|NCT01357980|451899473|FG001|Overall Study|Consent withdrawn|0|||
125621975|NCT01357980|451899474|FG002|Overall Study|Consent withdrawn|1|||
125621976|NCT01357980|451899475|FG003|Overall Study|Consent withdrawn|0|||
125621977|NCT02528253|451899476|FG000|Overall Study|Adverse Event|3|||
125621978|NCT02528253|451899477|FG001|Overall Study|Adverse Event|4|||
125621979|NCT02528253|451899478|FG002|Overall Study|Adverse Event|4|||
125621980|NCT02528253|451899479|FG003|Overall Study|Adverse Event|8|||
125621981|NCT02528253|451899480|FG004|Overall Study|Adverse Event|18|||
125621982|NCT02528253|451899476|FG000|Overall Study|Death|2|||
125621983|NCT02528253|451899477|FG001|Overall Study|Death|2|||
125621984|NCT02528253|451899478|FG002|Overall Study|Death|1|||
125621985|NCT02528253|451899479|FG003|Overall Study|Death|0|||
125621986|NCT02528253|451899480|FG004|Overall Study|Death|1|||
125621987|NCT02528253|451899476|FG000|Overall Study|Insufficient clinical response|7|||
125621988|NCT02528253|451899477|FG001|Overall Study|Insufficient clinical response|10|||
125621989|NCT02528253|451899478|FG002|Overall Study|Insufficient clinical response|13|||
125621990|NCT02528253|451899479|FG003|Overall Study|Insufficient clinical response|12|||
125621991|NCT02528253|451899480|FG004|Overall Study|Insufficient clinical response|16|||
125621992|NCT02528253|451899476|FG000|Overall Study|Lost to Follow-up|16|||
125621993|NCT02528253|451899477|FG001|Overall Study|Lost to Follow-up|9|||
125621994|NCT02528253|451899478|FG002|Overall Study|Lost to Follow-up|31|||
125621995|NCT02528253|451899479|FG003|Overall Study|Lost to Follow-up|16|||
125621996|NCT02528253|451899480|FG004|Overall Study|Lost to Follow-up|34|||
125621997|NCT02528253|451899476|FG000|Overall Study|Other|21|||
125621998|NCT02528253|451899477|FG001|Overall Study|Other|22|||
125621999|NCT02528253|451899478|FG002|Overall Study|Other|58|||
125622000|NCT02528253|451899479|FG003|Overall Study|Other|52|||
125622001|NCT02528253|451899480|FG004|Overall Study|Other|76|||
125622002|NCT02528253|451899476|FG000|Overall Study|Withdrawal by Subject|25|||
125622003|NCT02528253|451899477|FG001|Overall Study|Withdrawal by Subject|20|||
125622004|NCT02528253|451899478|FG002|Overall Study|Withdrawal by Subject|29|||
125622005|NCT02528253|451899479|FG003|Overall Study|Withdrawal by Subject|48|||
125622006|NCT02528253|451899480|FG004|Overall Study|Withdrawal by Subject|73|||
125622007|NCT02528253|451899476|FG000|Overall Study|Protocol Violation|1|||
125622008|NCT02528253|451899477|FG001|Overall Study|Protocol Violation|2|||
125622009|NCT02528253|451899478|FG002|Overall Study|Protocol Violation|4|||
125622010|NCT02528253|451899479|FG003|Overall Study|Protocol Violation|0|||
125622011|NCT02528253|451899480|FG004|Overall Study|Protocol Violation|4|||
125622012|NCT02528253|451899476|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
125622013|NCT02528253|451899477|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
125622014|NCT02528253|451899478|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
125622015|NCT02528253|451899479|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
125622016|NCT02528253|451899480|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
125622017|NCT02293993|451899482|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
125622018|NCT02293993|451899483|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
125622019|NCT02293993|451899484|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
125622020|NCT02293993|451899485|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
125622021|NCT02293993|451899482|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
125622022|NCT02293993|451899483|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
125622023|NCT02293993|451899484|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
125622024|NCT02293993|451899485|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
125622025|NCT02293993|451899482|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
125622026|NCT02293993|451899483|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
125622027|NCT02293993|451899484|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
125622028|NCT02293993|451899485|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
125622029|NCT02293993|451899482|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
125622030|NCT02293993|451899483|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
125622031|NCT02293993|451899484|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
125622032|NCT02293993|451899485|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
125622033|NCT02293993|451899482|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
125622034|NCT02293993|451899483|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
125622035|NCT02293993|451899484|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
125622036|NCT02293993|451899485|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
125622037|NCT00094835|451899486|FG000|Overall Study|Physician Decision|1|||
125622038|NCT00094835|451899487|FG001|Overall Study|Physician Decision|0|||
125622039|NCT00094835|451899488|FG002|Overall Study|Physician Decision|0|||
125622040|NCT00094835|451899489|FG003|Overall Study|Physician Decision|0|||
125622041|NCT00094835|451899490|FG004|Overall Study|Physician Decision|0|||
125622042|NCT00094835|451899491|FG005|Overall Study|Physician Decision|1|||
125622043|NCT00094835|451899492|FG006|Overall Study|Physician Decision|0|||
125622044|NCT00094835|451899486|FG000|Overall Study|Withdrawal by Subject|0|||
125622045|NCT00094835|451899487|FG001|Overall Study|Withdrawal by Subject|0|||
125622046|NCT00094835|451899488|FG002|Overall Study|Withdrawal by Subject|0|||
125622047|NCT00094835|451899489|FG003|Overall Study|Withdrawal by Subject|0|||
125622048|NCT00094835|451899490|FG004|Overall Study|Withdrawal by Subject|0|||
125622049|NCT00094835|451899491|FG005|Overall Study|Withdrawal by Subject|0|||
125622050|NCT00094835|451899492|FG006|Overall Study|Withdrawal by Subject|1|||
125622051|NCT00094835|451899486|FG000|Overall Study|Lost to Follow-up|0|||
125622052|NCT00094835|451899487|FG001|Overall Study|Lost to Follow-up|0|||
125622053|NCT00094835|451899488|FG002|Overall Study|Lost to Follow-up|0|||
125622054|NCT00094835|451899489|FG003|Overall Study|Lost to Follow-up|0|||
125622055|NCT00094835|451899490|FG004|Overall Study|Lost to Follow-up|1|||
125622056|NCT00094835|451899491|FG005|Overall Study|Lost to Follow-up|0|||
125622057|NCT00094835|451899492|FG006|Overall Study|Lost to Follow-up|0|||
125622058|NCT00094835|451899486|FG000|Overall Study|Death|1|||
125433119|NCT00085202|451212437|FG000|Overall Study|Withdrawal by Subject|2|||
125622059|NCT00094835|451899487|FG001|Overall Study|Death|0|||
125622060|NCT00094835|451899488|FG002|Overall Study|Death|0|||
125622061|NCT00094835|451899489|FG003|Overall Study|Death|0|||
125622062|NCT00094835|451899490|FG004|Overall Study|Death|1|||
125622063|NCT00094835|451899491|FG005|Overall Study|Death|0|||
125622064|NCT00094835|451899492|FG006|Overall Study|Death|0|||
125622065|NCT00094835|451899486|FG000|Overall Study|Non-compliance|1|||
125622066|NCT00094835|451899487|FG001|Overall Study|Non-compliance|2|||
125622067|NCT00094835|451899488|FG002|Overall Study|Non-compliance|2|||
125622068|NCT00094835|451899489|FG003|Overall Study|Non-compliance|0|||
125622069|NCT00094835|451899490|FG004|Overall Study|Non-compliance|2|||
125622070|NCT00094835|451899491|FG005|Overall Study|Non-compliance|2|||
125622071|NCT00094835|451899492|FG006|Overall Study|Non-compliance|1|||
125622072|NCT00094835|451899486|FG000|Overall Study|Other|1|||
125622073|NCT00094835|451899487|FG001|Overall Study|Other|1|||
125622074|NCT00094835|451899488|FG002|Overall Study|Other|1|||
125622075|NCT00094835|451899489|FG003|Overall Study|Other|1|||
125622076|NCT00094835|451899490|FG004|Overall Study|Other|0|||
125622077|NCT00094835|451899491|FG005|Overall Study|Other|0|||
125622078|NCT00094835|451899492|FG006|Overall Study|Other|0|||
125622079|NCT02514772|451899493|FG000|Overall Study|Adverse Event|1|||
125622080|NCT02514772|451899494|FG001|Overall Study|Adverse Event|0|||
125622081|NCT02514772|451899493|FG000|Overall Study|Death|0|||
125622082|NCT02514772|451899494|FG001|Overall Study|Death|1|||
125622083|NCT02514772|451899493|FG000|Overall Study|Withdrawal by Subject|2|||
125622084|NCT02514772|451899494|FG001|Overall Study|Withdrawal by Subject|1|||
125622085|NCT00817206|451899495|FG000|Overall Study|Adverse Event|10|||
125622086|NCT00817206|451899496|FG001|Overall Study|Adverse Event|3|||
125622087|NCT00817206|451899495|FG000|Overall Study|Protocol Violation|0|||
125622088|NCT00817206|451899496|FG001|Overall Study|Protocol Violation|2|||
125622089|NCT00817206|451899495|FG000|Overall Study|Lost to Follow-up|0|||
125622090|NCT00817206|451899496|FG001|Overall Study|Lost to Follow-up|1|||
125622091|NCT00817206|451899495|FG000|Overall Study|Death|2|||
125622092|NCT00817206|451899496|FG001|Overall Study|Death|0|||
125622093|NCT00817206|451899495|FG000|Overall Study|Withdrawal by Subject|7|||
125622094|NCT00817206|451899496|FG001|Overall Study|Withdrawal by Subject|3|||
125622095|NCT00817206|451899495|FG000|Overall Study|Physician Decision|2|||
125622096|NCT00817206|451899496|FG001|Overall Study|Physician Decision|0|||
125622097|NCT00793182|451899497|FG000|Overall Study|Adverse Event|0|||
125622098|NCT00793182|451899498|FG001|Overall Study|Adverse Event|1|||
125622099|NCT02197897|451899499|FG000|Overall Study|not eligible|1|||
125622100|NCT02384395|451899500|FG000|Overall Study|Physician Decision|4|||
125622101|NCT02384395|451899500|FG000|Overall Study|Withdrawal by Subject|3|||
125622102|NCT02384395|451899500|FG000|Overall Study|Lost to Follow-up|3|||
125622103|NCT04295356|451899502|FG000|Overall Study|Physician Decision|1|||
125622104|NCT04295356|451899503|FG001|Overall Study|Physician Decision|0|||
125622105|NCT04295356|451899502|FG000|Overall Study|Lost to Follow-up|0|||
125622106|NCT04295356|451899503|FG001|Overall Study|Lost to Follow-up|3|||
125622107|NCT04295356|451899502|FG000|Overall Study|Protocol Violation|0|||
125622108|NCT04295356|451899503|FG001|Overall Study|Protocol Violation|1|||
125622109|NCT01106391|451899504|FG000|Overall Study|Death|12|||
125374519|NCT03098550|451002213|FG001|Overall Study|Study Drug Toxicity|1|||
125374520|NCT03098550|451002214|FG002|Overall Study|Study Drug Toxicity|0|||
125374521|NCT03098550|451002212|FG000|Overall Study|Death|1|||
125374522|NCT03098550|451002213|FG001|Overall Study|Death|0|||
125622110|NCT01106391|451899504|FG000|Overall Study|Withdrawal by Subject|7|||
125622111|NCT04268004|451899505|FG000|Overall Study|Excluded from analyses|0|||
125622112|NCT04268004|451899506|FG001|Overall Study|Excluded from analyses|1|||
125622113|NCT01381718|451899507|FG000|Overall Study|Withdrawal by Subject|2|||
125622114|NCT01381718|451899508|FG001|Overall Study|Withdrawal by Subject|5|||
125622115|NCT01381718|451899507|FG000|Overall Study|Lost to Follow-up|3|||
125622116|NCT01381718|451899508|FG001|Overall Study|Lost to Follow-up|5|||
125622117|NCT01381718|451899507|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
125622118|NCT01381718|451899508|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
125622119|NCT02759861|451899509|FG000|Overall Study|Death|1|||
125622120|NCT00992186|451899512|FG000|Overall Study|Withdrawal by Subject|2|||
125374523|NCT03098550|451002214|FG002|Overall Study|Death|0|||
125622121|NCT00992186|451899512|FG000|Overall Study|Protocol Violation|1|||
125622122|NCT00992186|451899512|FG000|Overall Study|Physician Decision|1|||
125622123|NCT00992186|451899512|FG000|Overall Study|Adverse Event|9|||
125622124|NCT00992186|451899512|FG000|Overall Study|Progressive Disease|30|||
125622125|NCT00992186|451899512|FG000|Overall Study|Refusal To Receive Study Agent|3|||
125622126|NCT00830960|451899513|FG000|Overall Study|Death|5|||
125622127|NCT00830960|451899514|FG001|Overall Study|Death|4|||
125622128|NCT00830960|451899515|FG002|Overall Study|Death|3|||
125622129|NCT00830960|451899516|FG003|Overall Study|Death|2|||
125622130|NCT00830960|451899517|FG004|Overall Study|Death|6|||
125622131|NCT00830960|451899518|FG005|Overall Study|Death|1|||
125622132|NCT00830960|451899513|FG000|Overall Study|Lost to Follow-up|1|||
125622133|NCT00830960|451899514|FG001|Overall Study|Lost to Follow-up|1|||
125622134|NCT00830960|451899515|FG002|Overall Study|Lost to Follow-up|1|||
125622135|NCT00830960|451899516|FG003|Overall Study|Lost to Follow-up|0|||
125622136|NCT00830960|451899517|FG004|Overall Study|Lost to Follow-up|0|||
125622137|NCT00830960|451899518|FG005|Overall Study|Lost to Follow-up|1|||
125622138|NCT00830960|451899513|FG000|Overall Study|Withdrawal by Subject|19|||
125622139|NCT00830960|451899514|FG001|Overall Study|Withdrawal by Subject|19|||
125622140|NCT00830960|451899515|FG002|Overall Study|Withdrawal by Subject|18|||
125622141|NCT00830960|451899516|FG003|Overall Study|Withdrawal by Subject|23|||
125622142|NCT00830960|451899517|FG004|Overall Study|Withdrawal by Subject|16|||
125622143|NCT00830960|451899518|FG005|Overall Study|Withdrawal by Subject|21|||
125622144|NCT00830960|451899513|FG000|Overall Study|Sponsor Decision|1|||
125622145|NCT00830960|451899514|FG001|Overall Study|Sponsor Decision|2|||
125622146|NCT00830960|451899515|FG002|Overall Study|Sponsor Decision|3|||
125622147|NCT00830960|451899516|FG003|Overall Study|Sponsor Decision|4|||
125622148|NCT00830960|451899517|FG004|Overall Study|Sponsor Decision|5|||
125622149|NCT00830960|451899518|FG005|Overall Study|Sponsor Decision|7|||
125622150|NCT00830960|451899513|FG000|Overall Study|No study drug received|7|||
125622151|NCT00830960|451899514|FG001|Overall Study|No study drug received|2|||
125622152|NCT00830960|451899515|FG002|Overall Study|No study drug received|4|||
125622153|NCT00830960|451899516|FG003|Overall Study|No study drug received|3|||
125622154|NCT00830960|451899517|FG004|Overall Study|No study drug received|5|||
125622155|NCT00830960|451899518|FG005|Overall Study|No study drug received|7|||
125622156|NCT02855450|451899519|FG000|Overall Study|Adverse Event|1|||
125622157|NCT02855450|451899520|FG001|Overall Study|Adverse Event|0|||
125622158|NCT02855450|451899519|FG000|Overall Study|Lost to Follow-up|4|||
125622159|NCT02855450|451899520|FG001|Overall Study|Lost to Follow-up|0|||
125622160|NCT01376245|451899523|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
125622161|NCT01376245|451899524|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
125622162|NCT01376245|451899525|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
125622163|NCT01376245|451899526|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
125622164|NCT01376245|451899527|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
125622165|NCT01376245|451899523|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
125622166|NCT01376245|451899524|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
125622167|NCT01376245|451899525|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
125622168|NCT01376245|451899526|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
125622169|NCT01376245|451899527|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
125622170|NCT01376245|451899523|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
125622171|NCT01376245|451899524|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
125622172|NCT01376245|451899525|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
125622173|NCT01376245|451899526|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
125622174|NCT01376245|451899527|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
125622175|NCT01376245|451899523|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
125622176|NCT01376245|451899524|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
125622177|NCT01376245|451899525|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
125622178|NCT01376245|451899526|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
125622179|NCT01376245|451899527|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
125622180|NCT01376245|451899523|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
125622181|NCT01376245|451899524|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
125622182|NCT01376245|451899525|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
125622183|NCT01376245|451899526|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
125622184|NCT01376245|451899527|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
125622185|NCT01376245|451899523|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
125622186|NCT01376245|451899524|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
125622187|NCT01376245|451899525|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
125622188|NCT01376245|451899526|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
125433120|NCT00085202|451212438|FG001|Overall Study|Withdrawal by Subject|1|||
125433121|NCT00085202|451212437|FG000|Overall Study|Physician Decision|4|||
125433122|NCT00085202|451212438|FG001|Overall Study|Physician Decision|1|||
125433123|NCT00085202|451212437|FG000|Overall Study|Progressive disease|1|||
125433124|NCT00085202|451212438|FG001|Overall Study|Progressive disease|11|||
125433125|NCT01435655|451212444|FG000|Overall Study|Death|2|||
125433126|NCT01435655|451212444|FG000|Overall Study|Other|1|||
125433127|NCT01436201|451212445|FG000|Overall Study|Adverse Event|2|||
125433128|NCT01436201|451212445|FG000|Overall Study|Withdrawal by Subject|1|||
125433129|NCT01436201|451212445|FG000|Overall Study|Protocol Violation|1|||
125433130|NCT00445679|451212447|FG000|Overall Study|Adverse Event|22|||
125433131|NCT00445679|451212448|FG001|Overall Study|Adverse Event|12|||
125433132|NCT00445679|451212449|FG002|Overall Study|Adverse Event|30|||
125433133|NCT00445679|451212450|FG003|Overall Study|Adverse Event|19|||
125433134|NCT00445679|451212447|FG000|Overall Study|Failed to return|1|||
125433135|NCT00445679|451212448|FG001|Overall Study|Failed to return|3|||
125433136|NCT00445679|451212449|FG002|Overall Study|Failed to return|2|||
125433137|NCT00445679|451212450|FG003|Overall Study|Failed to return|2|||
125433138|NCT00445679|451212447|FG000|Overall Study|Physician Decision|0|||
125433139|NCT00445679|451212448|FG001|Overall Study|Physician Decision|0|||
125433140|NCT00445679|451212449|FG002|Overall Study|Physician Decision|1|||
125433141|NCT00445679|451212450|FG003|Overall Study|Physician Decision|0|||
125433142|NCT00445679|451212447|FG000|Overall Study|Lost to Follow-up|10|||
125622189|NCT01376245|451899527|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
125622190|NCT01376245|451899523|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
125622191|NCT01376245|451899524|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
125622192|NCT01376245|451899525|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
125622193|NCT01376245|451899526|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
125622194|NCT01376245|451899527|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
125622195|NCT01376245|451899523|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
125622196|NCT01376245|451899524|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
125622197|NCT01376245|451899525|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
125622198|NCT01376245|451899526|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
125622199|NCT01376245|451899527|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
125622200|NCT01376245|451899523|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
125622201|NCT01376245|451899524|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
125622202|NCT01376245|451899525|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
125622203|NCT01376245|451899526|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
125622204|NCT01376245|451899527|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
125622205|NCT01376245|451899523|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125622206|NCT01376245|451899524|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
125622207|NCT01376245|451899525|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125622208|NCT01376245|451899526|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
125622209|NCT01376245|451899527|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
125622210|NCT01376245|451899523|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
125622211|NCT01376245|451899524|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
125622212|NCT01376245|451899525|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
125622213|NCT01376245|451899526|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
125622214|NCT01376245|451899527|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
125622215|NCT01376245|451899523|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125622216|NCT01376245|451899524|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
125622217|NCT01376245|451899525|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
125622218|NCT01376245|451899526|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
125622219|NCT01376245|451899527|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
125622220|NCT05159362|451899528|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
125622221|NCT05159362|451899529|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
125622222|NCT05159362|451899530|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
125622223|NCT01357889|451899531|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
125622224|NCT01357889|451899532|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
125622225|NCT01357889|451899531|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
125622226|NCT01357889|451899532|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
125622227|NCT01357889|451899531|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
125622228|NCT01357889|451899532|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
125433143|NCT00445679|451212448|FG001|Overall Study|Lost to Follow-up|6|||
125433144|NCT00445679|451212449|FG002|Overall Study|Lost to Follow-up|6|||
125433145|NCT00445679|451212450|FG003|Overall Study|Lost to Follow-up|5|||
125433146|NCT00445679|451212447|FG000|Overall Study|Compliance|3|||
125433147|NCT00445679|451212448|FG001|Overall Study|Compliance|2|||
125433148|NCT00445679|451212449|FG002|Overall Study|Compliance|1|||
125433149|NCT00445679|451212450|FG003|Overall Study|Compliance|2|||
125622229|NCT01357889|451899531|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
125622230|NCT01357889|451899532|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
125622231|NCT01357889|451899531|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
125622232|NCT01357889|451899532|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
125622233|NCT01357889|451899531|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
125622234|NCT01357889|451899532|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
125622235|NCT01357889|451899531|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
125622236|NCT01357889|451899532|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
125622237|NCT01357889|451899531|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
125622238|NCT01357889|451899532|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
125622239|NCT01357889|451899531|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
125622240|NCT01357889|451899532|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
125622241|NCT01357889|451899531|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
125622242|NCT01357889|451899532|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
125622243|NCT01357889|451899531|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
125622244|NCT01357889|451899532|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
125622245|NCT01357889|451899531|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
125622246|NCT01357889|451899532|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
125622247|NCT01357889|451899531|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
125622248|NCT01357889|451899532|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
125622249|NCT01335698|451899533|FG000|Treatment Stage 1|Lack of Efficacy|3|||
125622250|NCT01335698|451899534|FG001|Treatment Stage 1|Lack of Efficacy|1|||
125622251|NCT01335698|451899535|FG002|Treatment Stage 1|Lack of Efficacy|3|||
125622252|NCT01335698|451899536|FG003|Treatment Stage 1|Lack of Efficacy|3|||
125622253|NCT01335698|451899537|FG004|Treatment Stage 1|Lack of Efficacy|1|||
125622254|NCT01335698|451899533|FG000|Treatment Stage 1|Adverse Event|1|||
125622255|NCT01335698|451899534|FG001|Treatment Stage 1|Adverse Event|2|||
125622256|NCT01335698|451899535|FG002|Treatment Stage 1|Adverse Event|2|||
125622257|NCT01335698|451899536|FG003|Treatment Stage 1|Adverse Event|1|||
125622258|NCT01335698|451899537|FG004|Treatment Stage 1|Adverse Event|1|||
125622259|NCT01335698|451899533|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
125622260|NCT01335698|451899534|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
125622261|NCT01335698|451899535|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
125622262|NCT01335698|451899536|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
125622263|NCT01335698|451899537|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
125622264|NCT01335698|451899533|FG000|Treatment Stage 1|Lost to Follow-up|1|||
125622265|NCT01335698|451899534|FG001|Treatment Stage 1|Lost to Follow-up|1|||
125622266|NCT01335698|451899535|FG002|Treatment Stage 1|Lost to Follow-up|0|||
125622267|NCT01335698|451899536|FG003|Treatment Stage 1|Lost to Follow-up|0|||
125622268|NCT01335698|451899537|FG004|Treatment Stage 1|Lost to Follow-up|0|||
125622269|NCT01335698|451899533|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
125622270|NCT01335698|451899534|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
125622271|NCT01335698|451899535|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
125622272|NCT01335698|451899536|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
125622273|NCT01335698|451899537|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
125622274|NCT01335698|451899533|FG000|Treatment Stage 1|No longer meets study criteria|1|||
125622275|NCT01335698|451899534|FG001|Treatment Stage 1|No longer meets study criteria|1|||
125622276|NCT01335698|451899535|FG002|Treatment Stage 1|No longer meets study criteria|0|||
125622277|NCT01335698|451899536|FG003|Treatment Stage 1|No longer meets study criteria|1|||
125622278|NCT01335698|451899537|FG004|Treatment Stage 1|No longer meets study criteria|0|||
125622279|NCT01335698|451899533|FG000|Treatment Stage 1|Other|1|||
125622280|NCT01335698|451899534|FG001|Treatment Stage 1|Other|0|||
125622281|NCT01335698|451899535|FG002|Treatment Stage 1|Other|0|||
125622282|NCT01335698|451899536|FG003|Treatment Stage 1|Other|1|||
125622283|NCT01335698|451899537|FG004|Treatment Stage 1|Other|0|||
125622284|NCT01335698|451899533|FG000|Treatment Stage 2|Lack of Efficacy|2|||
125622285|NCT01335698|451899534|FG001|Treatment Stage 2|Lack of Efficacy|1|||
125622286|NCT01335698|451899535|FG002|Treatment Stage 2|Lack of Efficacy|3|||
125622287|NCT01335698|451899536|FG003|Treatment Stage 2|Lack of Efficacy|1|||
125622288|NCT01335698|451899537|FG004|Treatment Stage 2|Lack of Efficacy|0|||
125622289|NCT01335698|451899533|FG000|Treatment Stage 2|Adverse Event|2|||
125622290|NCT01335698|451899534|FG001|Treatment Stage 2|Adverse Event|0|||
125622291|NCT01335698|451899535|FG002|Treatment Stage 2|Adverse Event|0|||
125622292|NCT01335698|451899536|FG003|Treatment Stage 2|Adverse Event|3|||
125622293|NCT01335698|451899537|FG004|Treatment Stage 2|Adverse Event|0|||
125622294|NCT01335698|451899533|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
125622295|NCT01335698|451899534|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
125622296|NCT01335698|451899535|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
125622297|NCT01335698|451899536|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
125622298|NCT01335698|451899537|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
125622299|NCT01335698|451899533|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
125622300|NCT01335698|451899534|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
125622301|NCT01335698|451899535|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
125622302|NCT01335698|451899536|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
125622303|NCT01335698|451899537|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
125622304|NCT01335698|451899533|FG000|Treatment Stage 2|Lost to Follow-up|1|||
125622305|NCT01335698|451899534|FG001|Treatment Stage 2|Lost to Follow-up|0|||
125622306|NCT01335698|451899535|FG002|Treatment Stage 2|Lost to Follow-up|0|||
125622307|NCT01335698|451899536|FG003|Treatment Stage 2|Lost to Follow-up|0|||
125622308|NCT01335698|451899537|FG004|Treatment Stage 2|Lost to Follow-up|0|||
125622309|NCT01335698|451899533|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
125622310|NCT01335698|451899534|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
125622311|NCT01335698|451899535|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
125622312|NCT01335698|451899536|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
125622313|NCT01335698|451899537|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
125622314|NCT01335698|451899533|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
125622315|NCT01335698|451899534|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
125622316|NCT01335698|451899535|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
125622317|NCT01335698|451899536|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
125622318|NCT01335698|451899537|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
125622319|NCT01335698|451899533|FG000|Treatment Stage 2|Switched to another formulation|1|||
125622320|NCT01335698|451899534|FG001|Treatment Stage 2|Switched to another formulation|1|||
125622321|NCT01335698|451899535|FG002|Treatment Stage 2|Switched to another formulation|0|||
125622322|NCT01335698|451899536|FG003|Treatment Stage 2|Switched to another formulation|0|||
125622323|NCT01335698|451899537|FG004|Treatment Stage 2|Switched to another formulation|0|||
125622324|NCT03970824|451899538|FG000|Overall Study|Withdrawal by Subject|1|||
125622325|NCT03970824|451899539|FG001|Overall Study|Withdrawal by Subject|1|||
125622326|NCT03970824|451899540|FG002|Overall Study|Withdrawal by Subject|3|||
125622327|NCT03970824|451899538|FG000|Overall Study|Lost to Follow-up|0|||
125622328|NCT03970824|451899539|FG001|Overall Study|Lost to Follow-up|2|||
125622329|NCT03970824|451899540|FG002|Overall Study|Lost to Follow-up|1|||
125622330|NCT03970824|451899538|FG000|Overall Study|Adverse Event|1|||
125622331|NCT03970824|451899539|FG001|Overall Study|Adverse Event|0|||
125622332|NCT03970824|451899540|FG002|Overall Study|Adverse Event|0|||
125622333|NCT00416312|451899541|FG000|Overall Study|tumors not visible on imaging|2|||
125622334|NCT02727660|451899544|FG000|Overall Study|Lack of Efficacy|40|||
125622335|NCT02727660|451899545|FG001|Overall Study|Lack of Efficacy|40|||
125622336|NCT02727660|451899546|FG002|Overall Study|Lack of Efficacy|70|||
125622337|NCT02727660|451899544|FG000|Overall Study|Adverse Event|28|||
125622338|NCT02727660|451899545|FG001|Overall Study|Adverse Event|21|||
125622339|NCT02727660|451899546|FG002|Overall Study|Adverse Event|32|||
125622340|NCT02727660|451899544|FG000|Overall Study|Withdrawal by Subject|26|||
125622341|NCT02727660|451899545|FG001|Overall Study|Withdrawal by Subject|25|||
125622342|NCT02727660|451899546|FG002|Overall Study|Withdrawal by Subject|30|||
125622343|NCT02727660|451899544|FG000|Overall Study|Physician Decision|3|||
125622344|NCT02727660|451899545|FG001|Overall Study|Physician Decision|8|||
125622345|NCT02727660|451899546|FG002|Overall Study|Physician Decision|14|||
125622346|NCT02727660|451899544|FG000|Overall Study|Lost to Follow-up|5|||
125622347|NCT02727660|451899545|FG001|Overall Study|Lost to Follow-up|9|||
125215284|NCT02559570|450414981|FG003|Overall Study|Adverse Event|1|||
125622348|NCT02727660|451899546|FG002|Overall Study|Lost to Follow-up|8|||
125622349|NCT02727660|451899544|FG000|Overall Study|Protocol Violation|7|||
125622350|NCT02727660|451899545|FG001|Overall Study|Protocol Violation|5|||
125622351|NCT02727660|451899546|FG002|Overall Study|Protocol Violation|5|||
125622352|NCT02727660|451899544|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
125622353|NCT02727660|451899545|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
125622354|NCT02727660|451899546|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
125622355|NCT02727660|451899544|FG000|Overall Study|Administrative Reasons|2|||
125622356|NCT02727660|451899545|FG001|Overall Study|Administrative Reasons|3|||
125622357|NCT02727660|451899546|FG002|Overall Study|Administrative Reasons|4|||
125622358|NCT00305604|451899547|FG000|Overall Study|Adverse Event|6|||
125622359|NCT00305604|451899548|FG001|Overall Study|Adverse Event|3|||
125622360|NCT00305604|451899547|FG000|Overall Study|Lack of Efficacy|11|||
125622361|NCT00305604|451899548|FG001|Overall Study|Lack of Efficacy|18|||
125622362|NCT00305604|451899547|FG000|Overall Study|Lost to Follow-up|0|||
125622363|NCT00305604|451899548|FG001|Overall Study|Lost to Follow-up|4|||
125622364|NCT00305604|451899547|FG000|Overall Study|Protocol Violation|2|||
125622365|NCT00305604|451899548|FG001|Overall Study|Protocol Violation|1|||
125622366|NCT00305604|451899547|FG000|Overall Study|Withdrawal by Subject|12|||
125622367|NCT00305604|451899548|FG001|Overall Study|Withdrawal by Subject|21|||
125622368|NCT00305604|451899547|FG000|Overall Study|Patient moved|1|||
125622369|NCT00305604|451899548|FG001|Overall Study|Patient moved|0|||
125622370|NCT00105560|451899549|FG000|Overall Study|Lost to Follow-up|1|||
125622371|NCT01248364|451899553|FG000|Overall Study|Adverse Event|0|||
125622372|NCT01248364|451899554|FG001|Overall Study|Adverse Event|1|||
125622373|NCT01248364|451899555|FG002|Overall Study|Adverse Event|0|||
125622374|NCT01248364|451899556|FG003|Overall Study|Adverse Event|0|||
125622375|NCT00764946|451899559|FG000|Overall Study|Lack of Efficacy|1|||
125622376|NCT00764946|451899560|FG001|Overall Study|Lack of Efficacy|0|||
125622377|NCT00764946|451899561|FG002|Overall Study|Lack of Efficacy|0|||
125622378|NCT00764946|451899559|FG000|Overall Study|Lost to Follow-up|3|||
125622379|NCT00764946|451899560|FG001|Overall Study|Lost to Follow-up|4|||
125622380|NCT00764946|451899561|FG002|Overall Study|Lost to Follow-up|0|||
125622381|NCT00764946|451899559|FG000|Overall Study|Physician Decision|2|||
125622382|NCT00764946|451899560|FG001|Overall Study|Physician Decision|4|||
125622383|NCT00764946|451899561|FG002|Overall Study|Physician Decision|0|||
125622384|NCT00764946|451899559|FG000|Overall Study|Adverse Event|3|||
125622385|NCT00764946|451899560|FG001|Overall Study|Adverse Event|2|||
125622386|NCT00764946|451899561|FG002|Overall Study|Adverse Event|1|||
125622387|NCT00764946|451899559|FG000|Overall Study|Withdrawal by Subject|3|||
125622388|NCT00764946|451899560|FG001|Overall Study|Withdrawal by Subject|6|||
125622389|NCT00764946|451899561|FG002|Overall Study|Withdrawal by Subject|2|||
125622390|NCT00764946|451899559|FG000|Overall Study|Never Treated|1|||
125622391|NCT00764946|451899560|FG001|Overall Study|Never Treated|1|||
125622392|NCT00764946|451899561|FG002|Overall Study|Never Treated|1|||
125622393|NCT02431468|451899565|FG000|Overall Study|Adverse Event|2|||
125622394|NCT02431468|451899566|FG001|Overall Study|Adverse Event|4|||
125622395|NCT02431468|451899567|FG002|Overall Study|Adverse Event|5|||
125622396|NCT02431468|451899565|FG000|Overall Study|Withdrawal by Subject|4|||
125622397|NCT02431468|451899566|FG001|Overall Study|Withdrawal by Subject|12|||
125622398|NCT02431468|451899567|FG002|Overall Study|Withdrawal by Subject|2|||
125622399|NCT02431468|451899565|FG000|Overall Study|noncompliance, investigator termination,|2|||
125622400|NCT02431468|451899566|FG001|Overall Study|noncompliance, investigator termination,|2|||
125622401|NCT02431468|451899567|FG002|Overall Study|noncompliance, investigator termination,|2|||
125622402|NCT01361919|451899568|FG000|Overall Study|technical issues|10|||
125622403|NCT01361919|451899569|FG001|Overall Study|technical issues|12|||
125622404|NCT01361919|451899570|FG002|Overall Study|technical issues|10|||
125622405|NCT00039741|451899574|FG000|Overall Study|Death|0|||
125622406|NCT00039741|451899575|FG001|Overall Study|Death|1|||
125622407|NCT00039741|451899576|FG002|Overall Study|Death|0|||
125622408|NCT00039741|451899577|FG003|Overall Study|Death|0|||
125622409|NCT00039741|451899574|FG000|Overall Study|Lost to Follow-up|3|||
125622410|NCT00039741|451899575|FG001|Overall Study|Lost to Follow-up|1|||
125622411|NCT00039741|451899576|FG002|Overall Study|Lost to Follow-up|5|||
125622412|NCT00039741|451899577|FG003|Overall Study|Lost to Follow-up|2|||
125622413|NCT00039741|451899574|FG000|Overall Study|Confounding medical condition|1|||
125622414|NCT00039741|451899575|FG001|Overall Study|Confounding medical condition|0|||
125622415|NCT00039741|451899576|FG002|Overall Study|Confounding medical condition|0|||
125622416|NCT00039741|451899577|FG003|Overall Study|Confounding medical condition|0|||
125622417|NCT00039741|451899574|FG000|Overall Study|Not able to get to clinic|5|||
125622418|NCT00039741|451899575|FG001|Overall Study|Not able to get to clinic|2|||
125622419|NCT00039741|451899576|FG002|Overall Study|Not able to get to clinic|0|||
125622420|NCT00039741|451899577|FG003|Overall Study|Not able to get to clinic|3|||
125622421|NCT00039741|451899574|FG000|Overall Study|Moved|3|||
125622422|NCT00039741|451899575|FG001|Overall Study|Moved|2|||
125622423|NCT00039741|451899576|FG002|Overall Study|Moved|3|||
125622424|NCT00039741|451899577|FG003|Overall Study|Moved|6|||
125622425|NCT00039741|451899574|FG000|Overall Study|Non-compliance with protocol|1|||
125622426|NCT00039741|451899575|FG001|Overall Study|Non-compliance with protocol|0|||
125622427|NCT00039741|451899576|FG002|Overall Study|Non-compliance with protocol|1|||
125622428|NCT00039741|451899577|FG003|Overall Study|Non-compliance with protocol|0|||
125622429|NCT00039741|451899574|FG000|Overall Study|Withdrew consent|0|||
125622430|NCT00039741|451899575|FG001|Overall Study|Withdrew consent|5|||
125622431|NCT00039741|451899576|FG002|Overall Study|Withdrew consent|0|||
125622432|NCT00039741|451899577|FG003|Overall Study|Withdrew consent|1|||
125622433|NCT00039741|451899574|FG000|Overall Study|Missed final visit|2|||
125622434|NCT00039741|451899575|FG001|Overall Study|Missed final visit|1|||
125622435|NCT00039741|451899576|FG002|Overall Study|Missed final visit|2|||
125622436|NCT00039741|451899577|FG003|Overall Study|Missed final visit|2|||
125622437|NCT01767519|451899578|FG000|Overall Study|Other Reasons|4|||
125622438|NCT01767519|451899579|FG001|Overall Study|Other Reasons|4|||
125622439|NCT01767519|451899580|FG002|Overall Study|Other Reasons|2|||
125622440|NCT01767519|451899578|FG000|Overall Study|Protocol Violation|0|||
125622441|NCT01767519|451899579|FG001|Overall Study|Protocol Violation|3|||
125622442|NCT01767519|451899580|FG002|Overall Study|Protocol Violation|0|||
125622443|NCT01767519|451899578|FG000|Overall Study|Personal Reasons|1|||
125622444|NCT01767519|451899579|FG001|Overall Study|Personal Reasons|0|||
125622445|NCT01767519|451899580|FG002|Overall Study|Personal Reasons|0|||
125622446|NCT01767519|451899578|FG000|Overall Study|Lost to Follow-up|3|||
125622447|NCT01767519|451899579|FG001|Overall Study|Lost to Follow-up|1|||
125622448|NCT01767519|451899580|FG002|Overall Study|Lost to Follow-up|2|||
125622449|NCT01767519|451899578|FG000|Overall Study|Lack of Efficacy|1|||
125622450|NCT01767519|451899579|FG001|Overall Study|Lack of Efficacy|0|||
125622451|NCT01767519|451899580|FG002|Overall Study|Lack of Efficacy|0|||
125622452|NCT01767519|451899578|FG000|Overall Study|Adverse Event|5|||
125622453|NCT01767519|451899579|FG001|Overall Study|Adverse Event|5|||
125622454|NCT01767519|451899580|FG002|Overall Study|Adverse Event|1|||
125622455|NCT00946881|451899581|FG000|First Treatment|Withdrawal by Subject|1|||
125622456|NCT00946881|451899581|FG000|First Treatment|Patient relocated to another state|1|||
125622457|NCT00946881|451899581|FG000|Retreatment|Withdrawal by Subject|1|||
125622458|NCT00293423|451899582|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
125622459|NCT00293423|451899583|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
125622460|NCT00293423|451899582|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
125622461|NCT00293423|451899583|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
125622462|NCT00293423|451899582|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
125622463|NCT00293423|451899583|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
125622464|NCT00293423|451899582|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
125622465|NCT00293423|451899583|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
125622466|NCT00293423|451899582|FG000|Surgical Resection|processing error during surgical resection|1|||
125622467|NCT00293423|451899583|FG001|Surgical Resection|processing error during surgical resection|0|||
125622468|NCT00293423|451899582|FG000|Surgical Resection|Withdrawal by Subject|4|||
125622469|NCT00293423|451899583|FG001|Surgical Resection|Withdrawal by Subject|0|||
125622470|NCT00293423|451899582|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
125622471|NCT00293423|451899583|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
125622472|NCT00805545|451899584|FG000|Overall Study|Protocol Violation|3|||
125622473|NCT00805545|451899585|FG001|Overall Study|Protocol Violation|2|||
125622474|NCT00805545|451899584|FG000|Overall Study|Protocol Violation|3|||
125622475|NCT00805545|451899585|FG001|Overall Study|Protocol Violation|1|||
125622476|NCT00507416|451899586|FG000|Overall Study|Adverse Event|58|||
125622477|NCT00507416|451899587|FG001|Overall Study|Adverse Event|67|||
125622478|NCT00507416|451899588|FG002|Overall Study|Adverse Event|65|||
125622479|NCT00507416|451899586|FG000|Overall Study|Protocol Violation|1|||
125622480|NCT00507416|451899587|FG001|Overall Study|Protocol Violation|2|||
125622481|NCT00507416|451899588|FG002|Overall Study|Protocol Violation|0|||
125622482|NCT00507416|451899586|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
125622483|NCT00507416|451899587|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
125622484|NCT00507416|451899588|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
125622485|NCT00507416|451899586|FG000|Overall Study|Progressive Disease|20|||
125622486|NCT00507416|451899587|FG001|Overall Study|Progressive Disease|10|||
125215285|NCT02559570|450414982|FG004|Overall Study|Adverse Event|0|||
125215286|NCT02559570|450414978|FG000|Overall Study|Withdrawal of Consent|0|||
125622487|NCT00507416|451899588|FG002|Overall Study|Progressive Disease|13|||
125622488|NCT00507416|451899586|FG000|Overall Study|Patient declined further treatment|18|||
125622489|NCT00507416|451899587|FG001|Overall Study|Patient declined further treatment|14|||
125622490|NCT00507416|451899588|FG002|Overall Study|Patient declined further treatment|11|||
125622491|NCT00507416|451899586|FG000|Overall Study|Other|11|||
125622492|NCT00507416|451899587|FG001|Overall Study|Other|16|||
125622493|NCT00507416|451899588|FG002|Overall Study|Other|13|||
125622494|NCT00507416|451899586|FG000|Overall Study|Did not Receive Study Treatment|3|||
125622495|NCT00507416|451899587|FG001|Overall Study|Did not Receive Study Treatment|9|||
125622496|NCT00507416|451899588|FG002|Overall Study|Did not Receive Study Treatment|4|||
125622497|NCT02157506|451899591|FG000|Overall Study|Adverse Event|0|||
125622498|NCT02157506|451899592|FG001|Overall Study|Adverse Event|1|||
125622499|NCT02157506|451899593|FG002|Overall Study|Adverse Event|0|||
125622500|NCT02157506|451899594|FG003|Overall Study|Adverse Event|0|||
125622501|NCT02157506|451899595|FG004|Overall Study|Adverse Event|0|||
125622502|NCT02157506|451899591|FG000|Overall Study|Lost to Follow-up|0|||
125622503|NCT02157506|451899592|FG001|Overall Study|Lost to Follow-up|0|||
125622504|NCT02157506|451899593|FG002|Overall Study|Lost to Follow-up|1|||
125622505|NCT02157506|451899594|FG003|Overall Study|Lost to Follow-up|0|||
125622506|NCT02157506|451899595|FG004|Overall Study|Lost to Follow-up|0|||
125622507|NCT03101514|451899596|FG000|Overall Study|Withdrawal by Subject|4|||
125622508|NCT03101514|451899596|FG000|Overall Study|Protocol Violation|2|||
125622509|NCT03101514|451899596|FG000|Overall Study|patient's information was incomplete|1|||
125622510|NCT01021813|451899597|FG000|DB Treatment Phase|Adverse Event|60|||
125622511|NCT01021813|451899598|FG001|DB Treatment Phase|Adverse Event|22|||
125622512|NCT01021813|451899599|FG002|DB Treatment Phase|Adverse Event|0|||
125622513|NCT01021813|451899600|FG003|DB Treatment Phase|Adverse Event|0|||
125622514|NCT01021813|451899601|FG004|DB Treatment Phase|Adverse Event|0|||
125622515|NCT01021813|451899597|FG000|DB Treatment Phase|Lack of Efficacy|44|||
125622516|NCT01021813|451899598|FG001|DB Treatment Phase|Lack of Efficacy|28|||
125622517|NCT01021813|451899599|FG002|DB Treatment Phase|Lack of Efficacy|0|||
125622518|NCT01021813|451899600|FG003|DB Treatment Phase|Lack of Efficacy|0|||
125622519|NCT01021813|451899601|FG004|DB Treatment Phase|Lack of Efficacy|0|||
125622520|NCT01021813|451899597|FG000|DB Treatment Phase|Lost to Follow-up|14|||
125622521|NCT01021813|451899598|FG001|DB Treatment Phase|Lost to Follow-up|12|||
125622522|NCT01021813|451899599|FG002|DB Treatment Phase|Lost to Follow-up|0|||
125622523|NCT01021813|451899600|FG003|DB Treatment Phase|Lost to Follow-up|0|||
125622524|NCT01021813|451899601|FG004|DB Treatment Phase|Lost to Follow-up|0|||
125622525|NCT01021813|451899597|FG000|DB Treatment Phase|Physician Decision|17|||
125622526|NCT01021813|451899598|FG001|DB Treatment Phase|Physician Decision|8|||
125622527|NCT01021813|451899599|FG002|DB Treatment Phase|Physician Decision|0|||
125622528|NCT01021813|451899600|FG003|DB Treatment Phase|Physician Decision|0|||
125622529|NCT01021813|451899601|FG004|DB Treatment Phase|Physician Decision|0|||
125622530|NCT01021813|451899597|FG000|DB Treatment Phase|Pregnancy|1|||
125622531|NCT01021813|451899598|FG001|DB Treatment Phase|Pregnancy|0|||
125622532|NCT01021813|451899599|FG002|DB Treatment Phase|Pregnancy|0|||
125622533|NCT01021813|451899600|FG003|DB Treatment Phase|Pregnancy|0|||
125622534|NCT01021813|451899601|FG004|DB Treatment Phase|Pregnancy|0|||
125622535|NCT01021813|451899597|FG000|DB Treatment Phase|Protocol Violation|4|||
125622536|NCT01021813|451899598|FG001|DB Treatment Phase|Protocol Violation|3|||
125622537|NCT01021813|451899599|FG002|DB Treatment Phase|Protocol Violation|0|||
125622538|NCT01021813|451899600|FG003|DB Treatment Phase|Protocol Violation|0|||
125622539|NCT01021813|451899601|FG004|DB Treatment Phase|Protocol Violation|0|||
125622540|NCT01021813|451899597|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
125622541|NCT01021813|451899598|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
125622542|NCT01021813|451899599|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
125622543|NCT01021813|451899600|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
125622544|NCT01021813|451899601|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
125622545|NCT01021813|451899597|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
125622546|NCT01021813|451899598|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
125622547|NCT01021813|451899599|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
125622548|NCT01021813|451899600|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
125622549|NCT01021813|451899601|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
125622550|NCT01021813|451899597|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
125622551|NCT01021813|451899598|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
125622552|NCT01021813|451899599|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
125622553|NCT01021813|451899600|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
125622554|NCT01021813|451899601|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
125622555|NCT01021813|451899597|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
125622556|NCT01021813|451899598|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
125622557|NCT01021813|451899599|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
125622558|NCT01021813|451899600|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
125622559|NCT01021813|451899601|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
125622560|NCT01021813|451899597|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
125622561|NCT01021813|451899598|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
125622562|NCT01021813|451899599|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
125622563|NCT01021813|451899600|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
125622564|NCT01021813|451899601|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
125622565|NCT01021813|451899597|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
125622566|NCT01021813|451899598|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
125215287|NCT02559570|450414979|FG001|Overall Study|Withdrawal of Consent|0|||
125215288|NCT02559570|450414980|FG002|Overall Study|Withdrawal of Consent|1|||
125622567|NCT01021813|451899599|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
125622568|NCT01021813|451899600|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
125374524|NCT03098550|451002212|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
125374525|NCT03098550|451002213|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
125374526|NCT03098550|451002214|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
125622569|NCT01021813|451899601|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
125622570|NCT00764478|451899602|FG000|Overall Study|Adverse Event|1|||
125622571|NCT00764478|451899603|FG001|Overall Study|Adverse Event|1|||
125622572|NCT00764478|451899604|FG002|Overall Study|Adverse Event|1|||
125622573|NCT00764478|451899602|FG000|Overall Study|Withdrawal by Subject|7|||
125622574|NCT00764478|451899603|FG001|Overall Study|Withdrawal by Subject|12|||
125622575|NCT00764478|451899604|FG002|Overall Study|Withdrawal by Subject|1|||
125622576|NCT00764478|451899602|FG000|Overall Study|Lost to Follow-up|7|||
125622577|NCT00764478|451899603|FG001|Overall Study|Lost to Follow-up|8|||
125622578|NCT00764478|451899604|FG002|Overall Study|Lost to Follow-up|5|||
125622579|NCT00764478|451899602|FG000|Overall Study|Protocol Violation|0|||
125622580|NCT00764478|451899603|FG001|Overall Study|Protocol Violation|1|||
125622581|NCT00764478|451899604|FG002|Overall Study|Protocol Violation|1|||
125622582|NCT02270684|451899605|FG000|Overall Study|Lost to Follow-up|0|||
125622583|NCT02270684|451899606|FG001|Overall Study|Lost to Follow-up|3|||
125622584|NCT02270684|451899605|FG000|Overall Study|Study terminated|1|||
125622585|NCT02270684|451899606|FG001|Overall Study|Study terminated|0|||
125622586|NCT03498287|451899613|FG000|Overall Study|Withdrawal by Subject|3|||
125622587|NCT03498287|451899614|FG001|Overall Study|Withdrawal by Subject|0|||
125622588|NCT03498287|451899613|FG000|Overall Study|Protocol Violation|0|||
125622589|NCT03498287|451899614|FG001|Overall Study|Protocol Violation|4|||
125622590|NCT03498287|451899613|FG000|Overall Study|Adverse Event|0|||
125622591|NCT03498287|451899614|FG001|Overall Study|Adverse Event|1|||
125622592|NCT02555657|451899617|FG000|Overall Study|Death|274|||
125622593|NCT02555657|451899618|FG001|Overall Study|Death|262|||
125622594|NCT02555657|451899617|FG000|Overall Study|Physician Decision|0|||
125622595|NCT02555657|451899618|FG001|Overall Study|Physician Decision|1|||
125622596|NCT02555657|451899617|FG000|Overall Study|Sponsor Decision|27|||
125622597|NCT02555657|451899618|FG001|Overall Study|Sponsor Decision|15|||
125622598|NCT02555657|451899617|FG000|Overall Study|Withdrawal by Subject|11|||
125622599|NCT02555657|451899618|FG001|Overall Study|Withdrawal by Subject|32|||
125622600|NCT00966693|451899619|FG000|Overall Study|Adverse Event|0|||
125622601|NCT00966693|451899620|FG001|Overall Study|Adverse Event|0|||
125622602|NCT00966693|451899621|FG002|Overall Study|Adverse Event|1|||
125622603|NCT00966693|451899622|FG003|Overall Study|Adverse Event|2|||
125622604|NCT00966693|451899619|FG000|Overall Study|Death|0|||
125622605|NCT00966693|451899620|FG001|Overall Study|Death|0|||
125622606|NCT00966693|451899621|FG002|Overall Study|Death|1|||
125622607|NCT00966693|451899622|FG003|Overall Study|Death|0|||
125622608|NCT00966693|451899619|FG000|Overall Study|Withdrawal by Subject|1|||
125622609|NCT00966693|451899620|FG001|Overall Study|Withdrawal by Subject|0|||
125622610|NCT00966693|451899621|FG002|Overall Study|Withdrawal by Subject|0|||
125622611|NCT00966693|451899622|FG003|Overall Study|Withdrawal by Subject|5|||
125622612|NCT00966693|451899619|FG000|Overall Study|Disease Progression|0|||
125622613|NCT00966693|451899620|FG001|Overall Study|Disease Progression|0|||
125622614|NCT00966693|451899621|FG002|Overall Study|Disease Progression|1|||
125622615|NCT00966693|451899622|FG003|Overall Study|Disease Progression|16|||
125622616|NCT01578785|451899623|FG000|Overall Study|Withdrawal by Subject|0|||
125622617|NCT01578785|451899624|FG001|Overall Study|Withdrawal by Subject|1|||
125622618|NCT01578785|451899623|FG000|Overall Study|Study terminated by sponsor|59|||
125622619|NCT01578785|451899624|FG001|Overall Study|Study terminated by sponsor|118|||
125622620|NCT02581982|451899625|FG000|Overall Study|Lack of Efficacy|12|||
125622621|NCT02581982|451899625|FG000|Overall Study|Adverse Event|3|||
125622622|NCT02581982|451899625|FG000|Overall Study|Physician Decision|1|||
125622623|NCT03479216|451899627|FG000|Overall Study|Withdrawal by Subject|3|||
125622624|NCT03479216|451899628|FG001|Overall Study|Withdrawal by Subject|2|||
125622625|NCT03479216|451899627|FG000|Overall Study|Physician Decision|2|||
125622626|NCT03479216|451899628|FG001|Overall Study|Physician Decision|3|||
125622627|NCT03326869|451900820|FG000|Overall Study|Study data has been lost to natural disa|1|||
125622628|NCT03326869|451900821|FG001|Overall Study|Study data has been lost to natural disa|1|||
125622629|NCT03788967|451900822|FG000|Overall Study|Lost to Follow-up|14|||
125622630|NCT03788967|451900823|FG001|Overall Study|Lost to Follow-up|10|||
125622631|NCT03788967|451900822|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
125622632|NCT03788967|451900823|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
125622633|NCT03788967|451900822|FG000|Overall Study|Participant Withdrawal of Consent|13|||
125622634|NCT03788967|451900823|FG001|Overall Study|Participant Withdrawal of Consent|5|||
125622635|NCT03788967|451900822|FG000|Overall Study|Adverse Event|1|||
125622636|NCT03788967|451900823|FG001|Overall Study|Adverse Event|1|||
125622637|NCT03788967|451900822|FG000|Overall Study|COVID-19|1|||
125622638|NCT03788967|451900823|FG001|Overall Study|COVID-19|2|||
125622639|NCT03927911|451900824|FG000|Overall Study|problems with eDiary|0|||
125622640|NCT03927911|451900825|FG001|Overall Study|problems with eDiary|1|||
125622641|NCT03927911|451900826|FG002|Overall Study|problems with eDiary|0|||
125622642|NCT03927911|451900827|FG003|Overall Study|problems with eDiary|1|||
125622643|NCT03927911|451900828|FG004|Overall Study|problems with eDiary|0|||
125622644|NCT03927911|451900829|FG005|Overall Study|problems with eDiary|4|||
125622645|NCT03927911|451900824|FG000|Overall Study|Adverse Event|0|||
125622646|NCT03927911|451900825|FG001|Overall Study|Adverse Event|0|||
125622647|NCT03927911|451900826|FG002|Overall Study|Adverse Event|0|||
125622648|NCT03927911|451900827|FG003|Overall Study|Adverse Event|0|||
125622649|NCT03927911|451900828|FG004|Overall Study|Adverse Event|0|||
125622650|NCT03927911|451900829|FG005|Overall Study|Adverse Event|1|||
125622651|NCT03927911|451900824|FG000|Overall Study|not treated -study terminated by sponsor|0|||
125622652|NCT03927911|451900825|FG001|Overall Study|not treated -study terminated by sponsor|1|||
125622653|NCT03927911|451900826|FG002|Overall Study|not treated -study terminated by sponsor|0|||
125622654|NCT03927911|451900827|FG003|Overall Study|not treated -study terminated by sponsor|0|||
125622655|NCT03927911|451900828|FG004|Overall Study|not treated -study terminated by sponsor|0|||
125622656|NCT03927911|451900829|FG005|Overall Study|not treated -study terminated by sponsor|0|||
125622657|NCT03927911|451900824|FG000|Overall Study|Surgery cancelled|0|||
125622658|NCT03927911|451900825|FG001|Overall Study|Surgery cancelled|0|||
125622659|NCT03927911|451900826|FG002|Overall Study|Surgery cancelled|0|||
125622660|NCT03927911|451900827|FG003|Overall Study|Surgery cancelled|1|||
125622661|NCT03927911|451900828|FG004|Overall Study|Surgery cancelled|0|||
125622662|NCT03927911|451900829|FG005|Overall Study|Surgery cancelled|1|||
125622663|NCT03927911|451900824|FG000|Overall Study|Protocol Violation|0|||
125622664|NCT03927911|451900825|FG001|Overall Study|Protocol Violation|0|||
125622665|NCT03927911|451900826|FG002|Overall Study|Protocol Violation|0|||
125622666|NCT03927911|451900827|FG003|Overall Study|Protocol Violation|0|||
125622667|NCT03927911|451900828|FG004|Overall Study|Protocol Violation|0|||
125622668|NCT03927911|451900829|FG005|Overall Study|Protocol Violation|1|||
125622669|NCT04432376|451900830|FG000|Double-blind Treatment Period|Adverse Event|2|||
125622670|NCT04432376|451900831|FG001|Double-blind Treatment Period|Adverse Event|6|||
125622671|NCT04432376|451900832|FG002|Double-blind Treatment Period|Adverse Event|0|||
125622672|NCT04432376|451900830|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
125622673|NCT04432376|451900831|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
125622674|NCT04432376|451900832|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
125622675|NCT04432376|451900830|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
125622676|NCT04432376|451900831|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
125622677|NCT04432376|451900832|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125622678|NCT04432376|451900830|FG000|Double-blind Treatment Period|Protocol Violation|0|||
125622679|NCT04432376|451900831|FG001|Double-blind Treatment Period|Protocol Violation|1|||
125622680|NCT04432376|451900832|FG002|Double-blind Treatment Period|Protocol Violation|0|||
125622681|NCT04432376|451900830|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
125622682|NCT04432376|451900831|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
125622683|NCT04432376|451900832|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
125622684|NCT04847141|451900833|FG000|Overall Study|Adverse Event|1|||
125622685|NCT04847141|451900834|FG001|Overall Study|Adverse Event|0|||
125622686|NCT04847141|451900835|FG002|Overall Study|Adverse Event|1|||
125622687|NCT04847141|451900833|FG000|Overall Study|Withdrawal by Subject|2|||
125622688|NCT04847141|451900834|FG001|Overall Study|Withdrawal by Subject|4|||
125622689|NCT04847141|451900835|FG002|Overall Study|Withdrawal by Subject|3|||
125622690|NCT04847141|451900833|FG000|Overall Study|Lost to Follow-up|7|||
125622691|NCT04847141|451900834|FG001|Overall Study|Lost to Follow-up|5|||
125622692|NCT04847141|451900835|FG002|Overall Study|Lost to Follow-up|7|||
125622693|NCT04847141|451900833|FG000|Overall Study|Reason not Specified|0|||
125622694|NCT04847141|451900834|FG001|Overall Study|Reason not Specified|1|||
125622695|NCT04847141|451900835|FG002|Overall Study|Reason not Specified|0|||
125622696|NCT04058158|451900836|FG000|Period 1|Death|1|||
125622697|NCT04058158|451900837|FG001|Period 1|Death|0|||
125622698|NCT04058158|451900836|FG000|Period 1|Adverse Event|1|||
125622699|NCT04058158|451900837|FG001|Period 1|Adverse Event|1|||
125622700|NCT04058158|451900836|FG000|Period 1|Pregnancy|0|||
125622701|NCT04058158|451900837|FG001|Period 1|Pregnancy|1|||
125622702|NCT01634113|451900838|FG000|Overall Study|Not treated|0|||
125622703|NCT01634113|451900839|FG001|Overall Study|Not treated|0|||
125622704|NCT01634113|451900840|FG002|Overall Study|Not treated|1|||
125622705|NCT00324740|451900841|FG000|Overall Study|Withdrawal by Subject|1|||
125622706|NCT00324740|451900842|FG001|Overall Study|Withdrawal by Subject|0|||
125622707|NCT00324740|451900843|FG002|Overall Study|Withdrawal by Subject|1|||
125622708|NCT04507776|451900844|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
125622709|NCT03628599|451900845|FG000|Overall Study|Adverse Event|0|||
125374527|NCT03098550|451002212|FG000|Overall Study|Administrative reason by sponsor|0|||
125622710|NCT03628599|451900846|FG001|Overall Study|Adverse Event|1|||
125622711|NCT01624506|451900847|FG000|Overall Study|Lost to Follow-up|29|||
125622712|NCT01624506|451900848|FG001|Overall Study|Lost to Follow-up|15|||
125622713|NCT01624506|451900847|FG000|Overall Study|Withdrawal by Subject|9|||
125622714|NCT01624506|451900848|FG001|Overall Study|Withdrawal by Subject|2|||
125374528|NCT03098550|451002213|FG001|Overall Study|Administrative reason by sponsor|0|||
125622715|NCT01624506|451900847|FG000|Overall Study|Death|1|||
125622716|NCT01624506|451900848|FG001|Overall Study|Death|0|||
125622717|NCT01624506|451900847|FG000|Overall Study|LINX explants|23|||
125622718|NCT01624506|451900848|FG001|Overall Study|LINX explants|0|||
125622719|NCT01624506|451900847|FG000|Overall Study|Adverse Event|3|||
125622720|NCT01624506|451900848|FG001|Overall Study|Adverse Event|0|||
125622721|NCT00132314|451900851|FG000|Overall Study|Lost to Follow-up|70|||
125622722|NCT00132314|451900852|FG001|Overall Study|Lost to Follow-up|62|||
125622723|NCT00132314|451900851|FG000|Overall Study|Lacked SSN|1|||
125622724|NCT00132314|451900852|FG001|Overall Study|Lacked SSN|3|||
125622725|NCT00132314|451900851|FG000|Overall Study|Refused intervention at baseline|2|||
125622726|NCT00132314|451900852|FG001|Overall Study|Refused intervention at baseline|7|||
125622727|NCT03250377|451900853|FG000|Overall Study|Adverse Event|2|||
125622728|NCT03250377|451900854|FG001|Overall Study|Adverse Event|4|||
125622729|NCT03250377|451900855|FG002|Overall Study|Adverse Event|0|||
125622730|NCT03250377|451900856|FG003|Overall Study|Adverse Event|4|||
125622731|NCT03250377|451900853|FG000|Overall Study|Lack of Efficacy|5|||
125622732|NCT03250377|451900854|FG001|Overall Study|Lack of Efficacy|14|||
125622733|NCT03250377|451900855|FG002|Overall Study|Lack of Efficacy|1|||
125622734|NCT03250377|451900856|FG003|Overall Study|Lack of Efficacy|3|||
125622735|NCT03250377|451900853|FG000|Overall Study|Protocol Violation|0|||
125622736|NCT03250377|451900854|FG001|Overall Study|Protocol Violation|2|||
125622737|NCT03250377|451900855|FG002|Overall Study|Protocol Violation|0|||
125622738|NCT03250377|451900856|FG003|Overall Study|Protocol Violation|1|||
125622739|NCT03250377|451900853|FG000|Overall Study|Lost to Follow-up|0|||
125622740|NCT03250377|451900854|FG001|Overall Study|Lost to Follow-up|1|||
125622741|NCT03250377|451900855|FG002|Overall Study|Lost to Follow-up|0|||
125622742|NCT03250377|451900856|FG003|Overall Study|Lost to Follow-up|0|||
125622743|NCT03250377|451900853|FG000|Overall Study|Withdrawal by Subject|7|||
125622744|NCT03250377|451900854|FG001|Overall Study|Withdrawal by Subject|7|||
125622745|NCT03250377|451900855|FG002|Overall Study|Withdrawal by Subject|0|||
125622746|NCT03250377|451900856|FG003|Overall Study|Withdrawal by Subject|4|||
125622747|NCT03250377|451900853|FG000|Overall Study|Investigator's Judgment|1|||
125622748|NCT03250377|451900854|FG001|Overall Study|Investigator's Judgment|0|||
125622749|NCT03250377|451900855|FG002|Overall Study|Investigator's Judgment|0|||
125622750|NCT03250377|451900856|FG003|Overall Study|Investigator's Judgment|0|||
125622751|NCT03250377|451900853|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
125622752|NCT03250377|451900854|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
125622753|NCT03250377|451900855|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
125622754|NCT03250377|451900856|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
125622755|NCT03250377|451900853|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
125622756|NCT03250377|451900854|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
125622757|NCT03250377|451900855|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
125622758|NCT03250377|451900856|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
125622759|NCT03250377|451900853|FG000|Overall Study|Epilepsy Surgery|0|||
125622760|NCT03250377|451900854|FG001|Overall Study|Epilepsy Surgery|1|||
125622761|NCT03250377|451900855|FG002|Overall Study|Epilepsy Surgery|2|||
125622762|NCT03250377|451900856|FG003|Overall Study|Epilepsy Surgery|0|||
125622763|NCT03250377|451900853|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
125622764|NCT03250377|451900854|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
125622765|NCT03250377|451900855|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
125622766|NCT03250377|451900856|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
125622767|NCT03250377|451900853|FG000|Overall Study|Request From The Sponsor|0|||
125622768|NCT03250377|451900854|FG001|Overall Study|Request From The Sponsor|1|||
125622769|NCT03250377|451900855|FG002|Overall Study|Request From The Sponsor|0|||
125622770|NCT03250377|451900856|FG003|Overall Study|Request From The Sponsor|0|||
125622771|NCT03250377|451900853|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
125622772|NCT03250377|451900854|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
125622773|NCT03250377|451900855|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
125622774|NCT03250377|451900856|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
125622775|NCT03250377|451900853|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
125622776|NCT03250377|451900854|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
125622777|NCT03250377|451900855|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
125622778|NCT03250377|451900856|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
125622779|NCT03250377|451900853|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
125622780|NCT03250377|451900854|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
125622781|NCT03250377|451900855|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
125622782|NCT03250377|451900856|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
125622783|NCT03250377|451900853|FG000|Overall Study|Pregnancy Event|0|||
125622784|NCT03250377|451900854|FG001|Overall Study|Pregnancy Event|1|||
125622785|NCT03250377|451900855|FG002|Overall Study|Pregnancy Event|0|||
125622786|NCT03250377|451900856|FG003|Overall Study|Pregnancy Event|0|||
125622787|NCT03250377|451900853|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
125622788|NCT03250377|451900854|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
125622789|NCT03250377|451900855|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
125622790|NCT03250377|451900856|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
125622791|NCT03250377|451900853|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
125622792|NCT03250377|451900854|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
125622793|NCT03250377|451900855|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
125622794|NCT03250377|451900856|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
125622795|NCT03250377|451900853|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
125622796|NCT03250377|451900854|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
125622797|NCT03250377|451900855|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
125622798|NCT03250377|451900856|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
125622799|NCT03250377|451900853|FG000|Overall Study|Patient requested to change hospital|0|||
125622800|NCT03250377|451900854|FG001|Overall Study|Patient requested to change hospital|0|||
125622801|NCT03250377|451900855|FG002|Overall Study|Patient requested to change hospital|0|||
125622802|NCT03250377|451900856|FG003|Overall Study|Patient requested to change hospital|1|||
125622803|NCT03250377|451900853|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
125622804|NCT03250377|451900854|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
125622805|NCT03250377|451900855|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
125622806|NCT03250377|451900856|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
125622807|NCT03657810|451900857|FG000|Overall Study|Adverse Event|0|||
125622808|NCT03657810|451900858|FG001|Overall Study|Adverse Event|1|||
125622809|NCT03657810|451900859|FG002|Overall Study|Adverse Event|0|||
125622810|NCT03657810|451900857|FG000|Overall Study|Lack of Efficacy|4|||
125622811|NCT03657810|451900858|FG001|Overall Study|Lack of Efficacy|1|||
125622812|NCT03657810|451900859|FG002|Overall Study|Lack of Efficacy|3|||
125622813|NCT03657810|451900857|FG000|Overall Study|Protocol Violation|1|||
125622814|NCT03657810|451900858|FG001|Overall Study|Protocol Violation|0|||
125622815|NCT03657810|451900859|FG002|Overall Study|Protocol Violation|0|||
125622816|NCT03657810|451900857|FG000|Overall Study|Lost to Follow-up|0|||
125622817|NCT03657810|451900858|FG001|Overall Study|Lost to Follow-up|1|||
125622818|NCT03657810|451900859|FG002|Overall Study|Lost to Follow-up|0|||
125622819|NCT03657810|451900857|FG000|Overall Study|Not provided|0|||
125622820|NCT03657810|451900858|FG001|Overall Study|Not provided|1|||
125622821|NCT03657810|451900859|FG002|Overall Study|Not provided|0|||
125622822|NCT03939637|451900868|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
125622823|NCT03939637|451900869|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
125622824|NCT03939637|451900868|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
125622825|NCT03939637|451900869|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
125622826|NCT05224076|451900870|FG000|Overall Study|Lost to Follow-up|24|||
125622827|NCT01082367|451900871|FG000|Double-blind Period|Administrative problems|0|||
125622828|NCT01082367|451900872|FG001|Double-blind Period|Administrative problems|1|||
125622829|NCT01082367|451900871|FG000|Double-blind Period|Lack of Efficacy|5|||
125622830|NCT01082367|451900872|FG001|Double-blind Period|Lack of Efficacy|11|||
125622831|NCT01082367|451900871|FG000|Double-blind Period|Adverse Event|0|||
125622832|NCT01082367|451900872|FG001|Double-blind Period|Adverse Event|1|||
125622833|NCT01082367|451900871|FG000|Follow-up (F-U) Period|Administrative problems|1|||
125622834|NCT01082367|451900872|FG001|Follow-up (F-U) Period|Administrative problems|0|||
125622835|NCT01082367|451900871|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
125622836|NCT01082367|451900872|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
125622837|NCT01082367|451900871|FG000|Follow-up (F-U) Period|Adverse Event|0|||
125622838|NCT01082367|451900872|FG001|Follow-up (F-U) Period|Adverse Event|1|||
125622839|NCT02016898|451900873|FG000|Overall Study|Death|1|||
125622840|NCT02016898|451900874|FG001|Overall Study|Death|1|||
125622841|NCT02016898|451900873|FG000|Overall Study|Lost to Follow-up|4|||
125622842|NCT02016898|451900874|FG001|Overall Study|Lost to Follow-up|4|||
125622843|NCT01665768|451900875|FG000|Overall Study|Adverse Event|3|||
125622844|NCT01665768|451900875|FG000|Overall Study|Lack of Efficacy|19|||
125622845|NCT01665768|451900875|FG000|Overall Study|Withdrawal by Subject|1|||
125622846|NCT01329341|451900876|FG000|Overall Study|Withdrawal by Subject|44|||
125622847|NCT03017846|451900877|FG000|Overall Study|Lost to Follow-up|3|||
125622848|NCT03017846|451900877|FG000|Overall Study|Adverse Event|2|||
125622849|NCT04603391|451900878|FG000|First Intervention (4 Days)|Adverse Event|1|||
125622850|NCT04603391|451900879|FG001|First Intervention (4 Days)|Adverse Event|0|||
125622851|NCT04603391|451900878|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
125622852|NCT04603391|451900879|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
125622853|NCT02151682|451900880|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
125622854|NCT02151682|451900881|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
125622855|NCT02151682|451900882|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
125374529|NCT03098550|451002214|FG002|Overall Study|Administrative reason by sponsor|1|||
125622856|NCT02151682|451900883|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
125622857|NCT02151682|451900884|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
125622858|NCT02151682|451900885|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
125622859|NCT02151682|451900880|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
125622860|NCT02151682|451900881|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
125622861|NCT02151682|451900882|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
125622862|NCT02151682|451900883|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
125622863|NCT02151682|451900884|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
125622864|NCT02151682|451900885|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
125622865|NCT02151682|451900880|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
125622866|NCT02151682|451900881|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
125622867|NCT02151682|451900882|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
125622868|NCT02151682|451900883|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
125622869|NCT02151682|451900884|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
125622870|NCT02151682|451900885|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
125622871|NCT02151682|451900880|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
125622872|NCT02151682|451900881|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
125622873|NCT02151682|451900882|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
125622874|NCT02151682|451900883|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
125622875|NCT02151682|451900884|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
125622876|NCT02151682|451900885|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
125622877|NCT02151682|451900880|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
125622878|NCT02151682|451900881|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
125622879|NCT02151682|451900882|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
125622880|NCT02151682|451900883|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
125622881|NCT02151682|451900884|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
125622882|NCT02151682|451900885|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
125622883|NCT02151682|451900880|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
125622884|NCT02151682|451900881|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
125622885|NCT02151682|451900882|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
125622886|NCT02151682|451900883|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
125622887|NCT02151682|451900884|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
125622888|NCT02151682|451900885|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
125622889|NCT02151682|451900880|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
125622890|NCT02151682|451900881|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
125622891|NCT02151682|451900882|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
125622892|NCT02151682|451900883|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
125622893|NCT02151682|451900884|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
125622894|NCT02151682|451900885|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
125622895|NCT02151682|451900880|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
125622896|NCT02151682|451900881|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
125622897|NCT02151682|451900882|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
125622898|NCT02151682|451900883|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
125622899|NCT02151682|451900884|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
125622900|NCT02151682|451900885|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
125622901|NCT02151682|451900880|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
125622902|NCT02151682|451900881|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
125622903|NCT02151682|451900882|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
125622904|NCT02151682|451900883|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
125622905|NCT02151682|451900884|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
125622906|NCT02151682|451900885|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
125622907|NCT02151682|451900880|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
125622908|NCT02151682|451900881|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
125622909|NCT02151682|451900882|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
125622910|NCT02151682|451900883|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
125622911|NCT02151682|451900884|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
125622912|NCT02151682|451900885|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
125622913|NCT02151682|451900880|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
125622914|NCT02151682|451900881|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
125622915|NCT02151682|451900882|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
125622916|NCT02151682|451900883|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
125622917|NCT02151682|451900884|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
125622918|NCT02151682|451900885|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
125622919|NCT02151682|451900880|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
125622920|NCT02151682|451900881|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
125374530|NCT03098550|451002212|FG000|Overall Study|Other reasons|2|||
125622921|NCT02151682|451900882|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
125622922|NCT02151682|451900883|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
125622923|NCT02151682|451900884|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
125622924|NCT02151682|451900885|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
125622925|NCT02151682|451900880|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
125622926|NCT02151682|451900881|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
125622927|NCT02151682|451900882|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
125622928|NCT02151682|451900883|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
125622929|NCT02151682|451900884|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
125622930|NCT02151682|451900885|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
125622931|NCT02151682|451900880|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
125622932|NCT02151682|451900881|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
125622933|NCT02151682|451900882|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
125622934|NCT02151682|451900883|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
125622935|NCT02151682|451900884|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
125622936|NCT02151682|451900885|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
125622937|NCT02151682|451900880|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
125374531|NCT03098550|451002213|FG001|Overall Study|Other reasons|0|||
125374532|NCT03098550|451002214|FG002|Overall Study|Other reasons|0|||
125374533|NCT01411774|451002229|FG000|Overall Study|Withdrawal by Subject|0|||
125374534|NCT01411774|451002230|FG001|Overall Study|Withdrawal by Subject|3|||
125374535|NCT00056316|451002231|FG000|Overall Study|Withdrawal by Subject|2|||
125374536|NCT00056316|451002232|FG001|Overall Study|Withdrawal by Subject|2|||
125374537|NCT00056316|451002231|FG000|Overall Study|Death/NH placement of pt|1|||
125622938|NCT02151682|451900881|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
125622939|NCT02151682|451900882|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
125622940|NCT02151682|451900883|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
125622941|NCT02151682|451900884|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
125622942|NCT02151682|451900885|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
125622943|NCT02151682|451900880|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
125622944|NCT02151682|451900881|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
125622945|NCT02151682|451900882|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
125622946|NCT02151682|451900883|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
125622947|NCT02151682|451900884|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
125622948|NCT02151682|451900885|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
125622949|NCT02151682|451900880|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
125622950|NCT02151682|451900881|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
125622951|NCT02151682|451900882|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
125622952|NCT02151682|451900883|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
125622953|NCT02151682|451900884|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
125622954|NCT02151682|451900885|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
125622955|NCT02151682|451900880|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
125622956|NCT02151682|451900881|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
125622957|NCT02151682|451900882|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
125622958|NCT02151682|451900883|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
125622959|NCT02151682|451900884|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
125622960|NCT02151682|451900885|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
125622961|NCT01306032|451900886|FG000|First Intervention|Adverse Event|1|||
125622962|NCT01306032|451900887|FG001|First Intervention|Adverse Event|0|||
125622963|NCT01306032|451900888|FG002|First Intervention|Adverse Event|1|||
125622964|NCT01306032|451900889|FG003|First Intervention|Adverse Event|0|||
125622965|NCT01306032|451900890|FG004|First Intervention|Adverse Event|0|||
125622966|NCT01306032|451900891|FG005|First Intervention|Adverse Event|1|||
125622967|NCT01306032|451900886|FG000|First Intervention|Withdrawal by Subject|0|||
125622968|NCT01306032|451900887|FG001|First Intervention|Withdrawal by Subject|2|||
125622969|NCT01306032|451900888|FG002|First Intervention|Withdrawal by Subject|0|||
125622970|NCT01306032|451900889|FG003|First Intervention|Withdrawal by Subject|1|||
125622971|NCT01306032|451900890|FG004|First Intervention|Withdrawal by Subject|0|||
125374538|NCT00056316|451002232|FG001|Overall Study|Death/NH placement of pt|1|||
125622972|NCT01306032|451900891|FG005|First Intervention|Withdrawal by Subject|0|||
125622973|NCT01306032|451900886|FG000|First Intervention|Death|0|||
125622974|NCT01306032|451900887|FG001|First Intervention|Death|0|||
125622975|NCT01306032|451900888|FG002|First Intervention|Death|1|||
125622976|NCT01306032|451900889|FG003|First Intervention|Death|0|||
125622977|NCT01306032|451900890|FG004|First Intervention|Death|0|||
125374539|NCT00903695|451002234|FG000|Overall Study|medical exclusion after 1st testing|1|||
125622978|NCT01306032|451900891|FG005|First Intervention|Death|0|||
125622979|NCT01306032|451900886|FG000|First Intervention|Ineligible|0|||
125622980|NCT01306032|451900887|FG001|First Intervention|Ineligible|0|||
125622981|NCT01306032|451900888|FG002|First Intervention|Ineligible|0|||
125622982|NCT01306032|451900889|FG003|First Intervention|Ineligible|0|||
125622983|NCT01306032|451900890|FG004|First Intervention|Ineligible|0|||
125622984|NCT01306032|451900891|FG005|First Intervention|Ineligible|1|||
125622985|NCT01306032|451900886|FG000|First Intervention|Progressive disease|0|||
125622986|NCT01306032|451900887|FG001|First Intervention|Progressive disease|0|||
125622987|NCT01306032|451900888|FG002|First Intervention|Progressive disease|0|||
125622988|NCT01306032|451900889|FG003|First Intervention|Progressive disease|0|||
125622989|NCT01306032|451900890|FG004|First Intervention|Progressive disease|2|||
125622990|NCT01306032|451900891|FG005|First Intervention|Progressive disease|0|||
125622991|NCT01306032|451900886|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
125622992|NCT01306032|451900887|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
125622993|NCT01306032|451900888|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
125622994|NCT01306032|451900889|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
125622995|NCT01306032|451900890|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
125622996|NCT01306032|451900891|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
125622997|NCT01306032|451900886|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
125622998|NCT01306032|451900887|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
125622999|NCT01306032|451900888|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
125623000|NCT01306032|451900889|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
125623001|NCT01306032|451900890|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
125623002|NCT01306032|451900891|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
125623003|NCT03260894|451900893|FG000|Overall Study|Death|6|||
125623004|NCT03260894|451900894|FG001|Overall Study|Death|8|||
125623005|NCT03260894|451900893|FG000|Overall Study|Withdrawal by Subject|4|||
125623006|NCT03260894|451900894|FG001|Overall Study|Withdrawal by Subject|11|||
125623007|NCT03260894|451900893|FG000|Overall Study|On-going at clinical cut off date|36|||
125623008|NCT03260894|451900894|FG001|Overall Study|On-going at clinical cut off date|31|||
125623009|NCT00168064|451900895|FG000|Overall Study|Adverse Event|26|||
125623010|NCT00168064|451900896|FG001|Overall Study|Adverse Event|22|||
125623011|NCT00168064|451900895|FG000|Overall Study|Withdrawal by Subject|3|||
125623012|NCT00168064|451900896|FG001|Overall Study|Withdrawal by Subject|4|||
125623013|NCT00168064|451900895|FG000|Overall Study|Lack of Efficacy|4|||
125623014|NCT00168064|451900896|FG001|Overall Study|Lack of Efficacy|4|||
125623015|NCT00168064|451900895|FG000|Overall Study|Lost to Follow-up|4|||
125623016|NCT00168064|451900896|FG001|Overall Study|Lost to Follow-up|3|||
125623017|NCT00168064|451900895|FG000|Overall Study|Non-compliance|2|||
125623018|NCT00168064|451900896|FG001|Overall Study|Non-compliance|3|||
125623019|NCT00168064|451900895|FG000|Overall Study|Concurrent Illness|4|||
125623020|NCT00168064|451900896|FG001|Overall Study|Concurrent Illness|3|||
125623021|NCT00168064|451900895|FG000|Overall Study|Subject's Best interest|2|||
125623022|NCT00168064|451900896|FG001|Overall Study|Subject's Best interest|2|||
125623023|NCT00168064|451900895|FG000|Overall Study|Various|4|||
125623024|NCT00168064|451900896|FG001|Overall Study|Various|3|||
125623025|NCT00290589|451900898|FG000|Overall Study|Lost to Follow-up|2|||
125623026|NCT00290589|451900899|FG001|Overall Study|Lost to Follow-up|2|||
125623027|NCT05014542|451900900|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
125623028|NCT05014542|451900901|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
125623029|NCT05014542|451900900|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
125623030|NCT05014542|451900901|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
125623031|NCT05014542|451900900|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
125623032|NCT05014542|451900901|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
125623033|NCT05014542|451900900|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
125623034|NCT05014542|451900901|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
125623035|NCT06000501|451900902|FG000|Overall Study|Screen failure|3|||
125623036|NCT06000501|451900902|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
125623037|NCT06000501|451900902|FG000|Overall Study|Physician Decision|4|||
125623038|NCT06000501|451900902|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
125623039|NCT06000501|451900902|FG000|Overall Study|Scheduling issues|2|||
125623040|NCT00318565|451900903|FG000|Overall Study|Excluded per protocol|24|||
125623041|NCT01896856|451900905|FG000|Overall Study|Transportation issues / Non-compliance|0|||
125623042|NCT01896856|451900906|FG001|Overall Study|Transportation issues / Non-compliance|0|||
125623043|NCT01896856|451900907|FG002|Overall Study|Transportation issues / Non-compliance|1|||
125623044|NCT01896856|451900908|FG003|Overall Study|Transportation issues / Non-compliance|0|||
125623045|NCT01896856|451900909|FG004|Overall Study|Transportation issues / Non-compliance|0|||
125623046|NCT01896856|451900910|FG005|Overall Study|Transportation issues / Non-compliance|0|||
125623047|NCT00282867|451900911|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
125623048|NCT00282867|451900912|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
125623049|NCT00282867|451900913|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
125623050|NCT03589885|451900915|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
125623051|NCT03589885|451900916|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
125623052|NCT03589885|451900917|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
125623053|NCT03589885|451900918|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
125623054|NCT03589885|451900919|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
125623055|NCT03589885|451900915|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
125623056|NCT03589885|451900916|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
125623057|NCT03589885|451900917|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
125623058|NCT03589885|451900918|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
125623059|NCT03589885|451900919|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
125623060|NCT03589885|451900915|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
125623061|NCT03589885|451900916|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
125623062|NCT03589885|451900917|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
125623063|NCT03589885|451900918|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
125623064|NCT03589885|451900919|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
125623065|NCT03589885|451900915|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
125623066|NCT03589885|451900916|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
125623067|NCT03589885|451900917|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
125623068|NCT03589885|451900918|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
125623069|NCT03589885|451900919|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
125623070|NCT03589885|451900915|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
125623071|NCT03589885|451900916|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
125623072|NCT03589885|451900917|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
125623073|NCT03589885|451900918|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
125623074|NCT03589885|451900919|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
125623075|NCT03589885|451900915|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
125623076|NCT03589885|451900916|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
125623077|NCT03589885|451900917|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
125623078|NCT03589885|451900918|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
125623079|NCT03589885|451900919|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
125623080|NCT03589885|451900915|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
125623081|NCT03589885|451900916|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
125623082|NCT03589885|451900917|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
125623083|NCT03589885|451900918|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
125623084|NCT03589885|451900919|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
125623085|NCT03589885|451900915|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
125623086|NCT03589885|451900916|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
125623087|NCT03589885|451900917|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
125623088|NCT03589885|451900918|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
125623089|NCT03589885|451900919|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
125623090|NCT00493974|451900922|FG000|Overall Study|Death|1|||
125623091|NCT00493974|451900923|FG001|Overall Study|Death|2|||
125623092|NCT00493974|451900922|FG000|Overall Study|Withdrawal by Subject|8|||
125623093|NCT00493974|451900923|FG001|Overall Study|Withdrawal by Subject|6|||
125623094|NCT00493974|451900922|FG000|Overall Study|Lost to Follow-up|4|||
125623095|NCT00493974|451900923|FG001|Overall Study|Lost to Follow-up|6|||
125623096|NCT02807363|451900924|FG000|Dosing Period|Adverse Event|0|||
125623097|NCT02807363|451900925|FG001|Dosing Period|Adverse Event|1|||
125623098|NCT02807363|451900926|FG002|Dosing Period|Adverse Event|0|||
125623099|NCT02807363|451900927|FG003|Dosing Period|Adverse Event|0|||
125623100|NCT02188719|451900928|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
125623101|NCT02188719|451900929|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
125623102|NCT02188719|451900930|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
125623103|NCT02188719|451900931|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
125623104|NCT00599027|451900932|FG000|Overall Study|Withdrawal by Subject|1|||
125623105|NCT00599027|451900933|FG001|Overall Study|Withdrawal by Subject|1|||
125374540|NCT00903695|451002235|FG001|Overall Study|medical exclusion after 1st testing|0|||
125374541|NCT00903695|451002234|FG000|Overall Study|lung cancer|1|||
125374542|NCT00903695|451002235|FG001|Overall Study|lung cancer|0|||
125623106|NCT00599027|451900932|FG000|Overall Study|Adverse Event|0|||
125623107|NCT00599027|451900933|FG001|Overall Study|Adverse Event|1|||
125623108|NCT00599027|451900932|FG000|Overall Study|Treatment Failure|0|||
125623109|NCT00599027|451900933|FG001|Overall Study|Treatment Failure|1|||
125623110|NCT00476996|451900934|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
125374543|NCT03902574|451002236|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
125623111|NCT00476996|451900935|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
125623112|NCT00476996|451900936|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
125623113|NCT00476996|451900937|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
125623114|NCT00476996|451900934|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
125623115|NCT00476996|451900935|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
125623116|NCT00476996|451900936|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
125623117|NCT00476996|451900937|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
125623118|NCT00476996|451900934|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
125623119|NCT00476996|451900935|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
125623120|NCT00476996|451900936|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
125623121|NCT00476996|451900937|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
125623122|NCT00476996|451900934|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
125623123|NCT00476996|451900935|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
125623124|NCT00476996|451900936|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
125623125|NCT00476996|451900937|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
125623126|NCT00476996|451900934|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
125623127|NCT00476996|451900935|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
125623128|NCT00476996|451900936|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
125623129|NCT00476996|451900937|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
125623130|NCT00476996|451900934|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
125623131|NCT00476996|451900935|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
125623132|NCT00476996|451900936|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
125623133|NCT00476996|451900937|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
125623134|NCT00476996|451900934|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
125623135|NCT00476996|451900935|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
125623136|NCT00476996|451900936|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
125623137|NCT00476996|451900937|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
125623138|NCT00476996|451900934|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
125623139|NCT00476996|451900935|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
125623140|NCT00476996|451900936|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
125623141|NCT00476996|451900937|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
125623142|NCT00476996|451900934|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
125623143|NCT00476996|451900935|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
125623144|NCT00476996|451900936|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
125623145|NCT00476996|451900937|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
125623146|NCT00476996|451900934|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
125623147|NCT00476996|451900935|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
125623148|NCT00476996|451900936|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
125623149|NCT00476996|451900937|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
125623150|NCT00476996|451900934|FG000|OLE Phase (From Week 48)|Death|0|||
125623151|NCT00476996|451900935|FG001|OLE Phase (From Week 48)|Death|0|||
125623152|NCT00476996|451900936|FG002|OLE Phase (From Week 48)|Death|0|||
125623153|NCT00476996|451900937|FG003|OLE Phase (From Week 48)|Death|7|||
125623154|NCT00476996|451900934|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
125623155|NCT00476996|451900935|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
125623156|NCT00476996|451900936|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
125623157|NCT00476996|451900937|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
125623158|NCT00476996|451900934|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
125623159|NCT00476996|451900935|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
125623160|NCT00476996|451900936|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
125623161|NCT00476996|451900937|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
125623162|NCT00476996|451900934|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
125623163|NCT00476996|451900935|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
125623164|NCT00476996|451900936|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
125623165|NCT00476996|451900937|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
125623166|NCT00476996|451900934|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
125623167|NCT00476996|451900935|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
125623168|NCT00476996|451900936|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
125623169|NCT00476996|451900937|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
125623170|NCT01181778|451900948|FG000|Overall Study|Physician Decision|48|||
125623171|NCT01265420|451900949|FG000|Overall Study|Lost to Follow-up|1|||
125623172|NCT02332798|451902825|FG000|Overall Study|Unwilling to Participate in Study|0|||
125623173|NCT02332798|451902826|FG001|Overall Study|Unwilling to Participate in Study|1|||
125623174|NCT02332798|451902827|FG002|Overall Study|Unwilling to Participate in Study|1|||
125623175|NCT02332798|451902825|FG000|Overall Study|Positive Urine Drug Test|0|||
125623176|NCT02332798|451902826|FG001|Overall Study|Positive Urine Drug Test|1|||
125623177|NCT02332798|451902827|FG002|Overall Study|Positive Urine Drug Test|0|||
125433150|NCT00445679|451212447|FG000|Overall Study|Withdrawal of Informed Consent|0|||
125215289|NCT02559570|450414981|FG003|Overall Study|Withdrawal of Consent|2|||
125215290|NCT02559570|450414982|FG004|Overall Study|Withdrawal of Consent|1|||
125215291|NCT02559570|450414978|FG000|Overall Study|Lost to Follow-up|1|||
125215292|NCT02559570|450414979|FG001|Overall Study|Lost to Follow-up|0|||
125215293|NCT02559570|450414980|FG002|Overall Study|Lost to Follow-up|0|||
125433151|NCT00445679|451212448|FG001|Overall Study|Withdrawal of Informed Consent|0|||
125433152|NCT00445679|451212449|FG002|Overall Study|Withdrawal of Informed Consent|1|||
125623178|NCT02332798|451902825|FG000|Overall Study|Abnormal Laboratory Findings|1|||
125623179|NCT02332798|451902826|FG001|Overall Study|Abnormal Laboratory Findings|0|||
125623180|NCT02332798|451902827|FG002|Overall Study|Abnormal Laboratory Findings|0|||
125623181|NCT05406440|451902828|FG000|Overall Study|Lost to Follow-up|0|||
125623182|NCT05406440|451902829|FG001|Overall Study|Lost to Follow-up|0|||
125623183|NCT05406440|451902830|FG002|Overall Study|Lost to Follow-up|0|||
125623184|NCT05406440|451902831|FG003|Overall Study|Lost to Follow-up|0|||
125623185|NCT05406440|451902832|FG004|Overall Study|Lost to Follow-up|2|||
125623186|NCT05406440|451902833|FG005|Overall Study|Lost to Follow-up|0|||
125623187|NCT05406440|451902834|FG006|Overall Study|Lost to Follow-up|0|||
125623188|NCT05406440|451902828|FG000|Overall Study|Physician Decision|0|||
125623189|NCT05406440|451902829|FG001|Overall Study|Physician Decision|0|||
125623190|NCT05406440|451902830|FG002|Overall Study|Physician Decision|0|||
125623191|NCT05406440|451902831|FG003|Overall Study|Physician Decision|0|||
125623192|NCT05406440|451902832|FG004|Overall Study|Physician Decision|1|||
125623193|NCT05406440|451902833|FG005|Overall Study|Physician Decision|0|||
125623194|NCT05406440|451902834|FG006|Overall Study|Physician Decision|0|||
125623195|NCT05406440|451902828|FG000|Overall Study|Withdrawal by Subject|0|||
125623196|NCT05406440|451902829|FG001|Overall Study|Withdrawal by Subject|0|||
125623197|NCT05406440|451902830|FG002|Overall Study|Withdrawal by Subject|0|||
125623198|NCT05406440|451902831|FG003|Overall Study|Withdrawal by Subject|0|||
125623199|NCT05406440|451902832|FG004|Overall Study|Withdrawal by Subject|0|||
125623200|NCT05406440|451902833|FG005|Overall Study|Withdrawal by Subject|2|||
125623201|NCT05406440|451902834|FG006|Overall Study|Withdrawal by Subject|0|||
125623202|NCT02455388|451902835|FG000|Overall Study|Protocol Violation|1|||
125623203|NCT02455388|451902836|FG001|Overall Study|Protocol Violation|0|||
125623204|NCT02455388|451902837|FG002|Overall Study|Protocol Violation|4|||
125623205|NCT02455388|451902835|FG000|Overall Study|Withdrawal by Subject|0|||
125623206|NCT02455388|451902836|FG001|Overall Study|Withdrawal by Subject|0|||
125623207|NCT02455388|451902837|FG002|Overall Study|Withdrawal by Subject|7|||
125623208|NCT00525785|451902838|FG000|Overall Study|Withdrawal by Subject|1|||
125623209|NCT00525785|451902838|FG000|Overall Study|Lack of Efficacy|1|||
125623210|NCT00525785|451902838|FG000|Overall Study|Physician Decision|1|||
125623211|NCT01316939|451902839|FG000|Overall Study|Study closed/terminated|26|||
125623212|NCT01316939|451902840|FG001|Overall Study|Study closed/terminated|25|||
125623213|NCT01316939|451902841|FG002|Overall Study|Study closed/terminated|23|||
125623214|NCT01316939|451902839|FG000|Overall Study|Lack of Efficacy|24|||
125623215|NCT01316939|451902840|FG001|Overall Study|Lack of Efficacy|25|||
125623216|NCT01316939|451902841|FG002|Overall Study|Lack of Efficacy|25|||
125623217|NCT01316939|451902839|FG000|Overall Study|Adverse Event|9|||
125623218|NCT01316939|451902840|FG001|Overall Study|Adverse Event|12|||
125623219|NCT01316939|451902841|FG002|Overall Study|Adverse Event|11|||
125623220|NCT01316939|451902839|FG000|Overall Study|Withdrawal by Subject|1|||
125623221|NCT01316939|451902840|FG001|Overall Study|Withdrawal by Subject|3|||
125623222|NCT01316939|451902841|FG002|Overall Study|Withdrawal by Subject|6|||
125623223|NCT01316939|451902839|FG000|Overall Study|Physician Decision|2|||
125623224|NCT01316939|451902840|FG001|Overall Study|Physician Decision|2|||
125623225|NCT01316939|451902841|FG002|Overall Study|Physician Decision|1|||
125623226|NCT01316939|451902839|FG000|Overall Study|Lost to Follow-up|0|||
125623227|NCT01316939|451902840|FG001|Overall Study|Lost to Follow-up|0|||
125623228|NCT01316939|451902841|FG002|Overall Study|Lost to Follow-up|2|||
125623229|NCT01316939|451902839|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
125623230|NCT01316939|451902840|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
125623231|NCT01316939|451902841|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
125623232|NCT01316939|451902839|FG000|Overall Study|Protocol Violation|0|||
125623233|NCT01316939|451902840|FG001|Overall Study|Protocol Violation|1|||
125623234|NCT01316939|451902841|FG002|Overall Study|Protocol Violation|0|||
125623235|NCT00801892|451902842|FG000|Main Study Period|Withdrawal by Subject|0|||
125623236|NCT00801892|451902843|FG001|Main Study Period|Withdrawal by Subject|1|||
125623237|NCT00801892|451902842|FG000|Sham Crossover Period|Lost to Follow-up|0|||
125623238|NCT00801892|451902843|FG001|Sham Crossover Period|Lost to Follow-up|2|||
125623239|NCT01711541|451902852|FG000|Overall Study|Cancel prior to treatment|0|||
125623240|NCT01711541|451902853|FG001|Overall Study|Cancel prior to treatment|0|||
125623241|NCT01711541|451902854|FG002|Overall Study|Cancel prior to treatment|0|||
125623242|NCT01711541|451902855|FG003|Overall Study|Cancel prior to treatment|1|||
125623243|NCT01711541|451902856|FG004|Overall Study|Cancel prior to treatment|0|||
125623244|NCT01711541|451902852|FG000|Overall Study|Ineligible|0|||
125623245|NCT01711541|451902853|FG001|Overall Study|Ineligible|1|||
125623246|NCT01711541|451902854|FG002|Overall Study|Ineligible|0|||
125623247|NCT01711541|451902855|FG003|Overall Study|Ineligible|0|||
125623248|NCT01711541|451902856|FG004|Overall Study|Ineligible|0|||
125623249|NCT00728936|451902857|FG000|Overall Study|Withdrawal by Subject|0|||
125623250|NCT00728936|451902858|FG001|Overall Study|Withdrawal by Subject|0|||
125623251|NCT00728936|451902859|FG002|Overall Study|Withdrawal by Subject|0|||
125623252|NCT00728936|451902860|FG003|Overall Study|Withdrawal by Subject|0|||
125623253|NCT00728936|451902861|FG004|Overall Study|Withdrawal by Subject|0|||
125623254|NCT00728936|451902862|FG005|Overall Study|Withdrawal by Subject|1|||
125623255|NCT00728936|451902863|FG006|Overall Study|Withdrawal by Subject|0|||
125623256|NCT02966353|451902872|FG000|Overall Study|Withdrawal by Subject|7|||
125623257|NCT02966353|451902872|FG000|Overall Study|Adverse Event|4|||
125623258|NCT02966353|451902872|FG000|Overall Study|Death|4|||
125623259|NCT02966353|451902872|FG000|Overall Study|Physician Decision|3|||
125623260|NCT02966353|451902872|FG000|Overall Study|Progressive disease|2|||
125623261|NCT02966353|451902872|FG000|Overall Study|Protocol deviation|2|||
125623262|NCT00093470|451902875|FG000|Overall Study|Disease progression|39|||
125623263|NCT00093470|451902876|FG001|Overall Study|Disease progression|0|||
125623264|NCT00093470|451902875|FG000|Overall Study|Adverse Event|15|||
125623265|NCT00093470|451902876|FG001|Overall Study|Adverse Event|0|||
125623266|NCT00093470|451902875|FG000|Overall Study|Death|2|||
125623267|NCT00093470|451902876|FG001|Overall Study|Death|0|||
125623268|NCT00093470|451902875|FG000|Overall Study|Withdrawal by Subject|8|||
125623269|NCT00093470|451902876|FG001|Overall Study|Withdrawal by Subject|0|||
125623270|NCT00093470|451902875|FG000|Overall Study|Alternative therapy|2|||
125623271|NCT00093470|451902876|FG001|Overall Study|Alternative therapy|0|||
125623272|NCT00093470|451902875|FG000|Overall Study|Other complicating disease|3|||
125623273|NCT00093470|451902876|FG001|Overall Study|Other complicating disease|0|||
125623274|NCT00093470|451902875|FG000|Overall Study|Physician Decision|2|||
125623275|NCT00093470|451902876|FG001|Overall Study|Physician Decision|0|||
125623276|NCT00093470|451902875|FG000|Overall Study|Never started treatment|1|||
125623277|NCT00093470|451902876|FG001|Overall Study|Never started treatment|0|||
125623278|NCT00093470|451902875|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
125623279|NCT00093470|451902876|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
125623280|NCT00877006|451902877|FG000|Treatment Period|Death|2|||
125623281|NCT00877006|451902878|FG001|Treatment Period|Death|1|||
125623282|NCT00877006|451902877|FG000|Treatment Period|Adverse Event|10|||
125623283|NCT00877006|451902878|FG001|Treatment Period|Adverse Event|3|||
125623284|NCT00877006|451902877|FG000|Treatment Period|Withdrawal by Subject|2|||
125623285|NCT00877006|451902878|FG001|Treatment Period|Withdrawal by Subject|3|||
125623286|NCT00877006|451902877|FG000|Treatment Period|Protocol Violation|1|||
125215294|NCT02559570|450414981|FG003|Overall Study|Lost to Follow-up|0|||
125623287|NCT00877006|451902878|FG001|Treatment Period|Protocol Violation|0|||
125623288|NCT00877006|451902877|FG000|Treatment Period|Lost to Follow-up|0|||
125623289|NCT00877006|451902878|FG001|Treatment Period|Lost to Follow-up|1|||
125623290|NCT00877006|451902877|FG000|Treatment Period|Disease Progression|1|||
125623291|NCT00877006|451902878|FG001|Treatment Period|Disease Progression|2|||
125623292|NCT00877006|451902877|FG000|Treatment Period|Started New Treatment Regimen|2|||
125623293|NCT00877006|451902878|FG001|Treatment Period|Started New Treatment Regimen|5|||
125623294|NCT00877006|451902877|FG000|Treatment Period|Other|4|||
125623295|NCT00877006|451902878|FG001|Treatment Period|Other|4|||
125623296|NCT00877006|451902877|FG000|Treatment Period|Randomized but Not Treated|3|||
125215295|NCT02559570|450414982|FG004|Overall Study|Lost to Follow-up|0|||
125623297|NCT00877006|451902878|FG001|Treatment Period|Randomized but Not Treated|8|||
125623298|NCT00877006|451902877|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
125623299|NCT00877006|451902878|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
125623300|NCT00877006|451902877|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
125623301|NCT00877006|451902878|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
125623302|NCT00877006|451902877|FG000|Long-Term Follow-up Period|Death|26|||
125623303|NCT00877006|451902878|FG001|Long-Term Follow-up Period|Death|18|||
125623304|NCT00877006|451902877|FG000|Long-Term Follow-up Period|Other|7|||
125623305|NCT00877006|451902878|FG001|Long-Term Follow-up Period|Other|9|||
125623306|NCT01415908|451902879|FG000|Overall Study|Withdrawal by Subject|1|||
125623307|NCT01415908|451902880|FG001|Overall Study|Withdrawal by Subject|0|||
125623308|NCT02034552|451902881|FG000|Overall Study|Never treated|3|||
125623309|NCT02034552|451902882|FG001|Overall Study|Never treated|2|||
125623310|NCT02034552|451902883|FG002|Overall Study|Never treated|0|||
125623311|NCT02034552|451902881|FG000|Overall Study|Radiological progression|3|||
125623312|NCT02034552|451902882|FG001|Overall Study|Radiological progression|5|||
125623313|NCT02034552|451902883|FG002|Overall Study|Radiological progression|4|||
125623314|NCT02034552|451902881|FG000|Overall Study|AE not assoc. with disease progression|1|||
125623315|NCT02034552|451902882|FG001|Overall Study|AE not assoc. with disease progression|4|||
125623316|NCT02034552|451902883|FG002|Overall Study|AE not assoc. with disease progression|2|||
125623317|NCT02034552|451902881|FG000|Overall Study|AE associated with disease progression|0|||
125623318|NCT02034552|451902882|FG001|Overall Study|AE associated with disease progression|1|||
125623319|NCT02034552|451902883|FG002|Overall Study|AE associated with disease progression|0|||
125623320|NCT02034552|451902881|FG000|Overall Study|Withdrawal by Subject|2|||
125623321|NCT02034552|451902882|FG001|Overall Study|Withdrawal by Subject|1|||
125623322|NCT02034552|451902883|FG002|Overall Study|Withdrawal by Subject|1|||
125623323|NCT02034552|451902881|FG000|Overall Study|Non-compliance with study drug|0|||
125623324|NCT02034552|451902882|FG001|Overall Study|Non-compliance with study drug|0|||
125623325|NCT02034552|451902883|FG002|Overall Study|Non-compliance with study drug|1|||
125623326|NCT02034552|451902881|FG000|Overall Study|Clinical progression|5|||
125623327|NCT02034552|451902882|FG001|Overall Study|Clinical progression|7|||
125623328|NCT02034552|451902883|FG002|Overall Study|Clinical progression|9|||
125623329|NCT01188096|451902885|FG000|Overall Study|progression of disease|4|||
125623330|NCT01188096|451902885|FG000|Overall Study|Withdrawal by Subject|2|||
125623331|NCT00851253|451902889|FG000|Overall Study|Disease Progression|1|||
125623332|NCT00851253|451902890|FG001|Overall Study|Disease Progression|0|||
125623333|NCT02062398|451902891|FG000|Overall Study|Implant removal|1|||
125623334|NCT01779648|451902892|FG000|Overall Study|Protocol Violation|1|||
125623335|NCT01779648|451902893|FG001|Overall Study|Protocol Violation|0|||
125623336|NCT00415519|451902894|FG000|Overall Study|Adverse Event|1|||
125623337|NCT00415519|451902895|FG001|Overall Study|Adverse Event|0|||
125623338|NCT00415519|451902894|FG000|Overall Study|Withdrawal by Subject|2|||
125623339|NCT00415519|451902895|FG001|Overall Study|Withdrawal by Subject|0|||
125623340|NCT00415519|451902894|FG000|Overall Study|Patient's convenience|1|||
125623341|NCT00415519|451902895|FG001|Overall Study|Patient's convenience|0|||
125623342|NCT03485222|451902900|FG000|Overall Study|Death|0|||
125623343|NCT03485222|451902901|FG001|Overall Study|Death|1|||
125623344|NCT03485222|451902900|FG000|Overall Study|Lost to Follow-up|2|||
125623345|NCT03485222|451902901|FG001|Overall Study|Lost to Follow-up|1|||
125623346|NCT03325556|451902905|FG000|Open-label Period|Lack of Response in OL period|70|||
125623347|NCT03325556|451902906|FG001|Open-label Period|Lack of Response in OL period|0|||
125623348|NCT03325556|451902907|FG002|Open-label Period|Lack of Response in OL period|0|||
125623349|NCT03325556|451902905|FG000|Open-label Period|Adverse Event|27|||
125623350|NCT03325556|451902906|FG001|Open-label Period|Adverse Event|0|||
125623351|NCT03325556|451902907|FG002|Open-label Period|Adverse Event|0|||
125623352|NCT03325556|451902905|FG000|Open-label Period|Death|1|||
125623353|NCT03325556|451902906|FG001|Open-label Period|Death|0|||
125623354|NCT03325556|451902907|FG002|Open-label Period|Death|0|||
125623355|NCT03325556|451902905|FG000|Open-label Period|Lost to Follow-up|1|||
125623356|NCT03325556|451902906|FG001|Open-label Period|Lost to Follow-up|0|||
125623357|NCT03325556|451902907|FG002|Open-label Period|Lost to Follow-up|0|||
125623358|NCT03325556|451902905|FG000|Open-label Period|Non-compliance with study drug|5|||
125623359|NCT03325556|451902906|FG001|Open-label Period|Non-compliance with study drug|0|||
125623360|NCT03325556|451902907|FG002|Open-label Period|Non-compliance with study drug|0|||
125623361|NCT03325556|451902905|FG000|Open-label Period|Use of prohibited medication|1|||
125623362|NCT03325556|451902906|FG001|Open-label Period|Use of prohibited medication|0|||
125623363|NCT03325556|451902907|FG002|Open-label Period|Use of prohibited medication|0|||
125623364|NCT03325556|451902905|FG000|Open-label Period|Protocol Violation|4|||
125623365|NCT03325556|451902906|FG001|Open-label Period|Protocol Violation|0|||
125623366|NCT03325556|451902907|FG002|Open-label Period|Protocol Violation|0|||
125623367|NCT03325556|451902905|FG000|Open-label Period|Withdrawal by Subject|17|||
125623368|NCT03325556|451902906|FG001|Open-label Period|Withdrawal by Subject|0|||
125623369|NCT03325556|451902907|FG002|Open-label Period|Withdrawal by Subject|0|||
125623370|NCT03325556|451902905|FG000|Open-label Period|Not otherwise specified|8|||
125623371|NCT03325556|451902906|FG001|Open-label Period|Not otherwise specified|0|||
125623372|NCT03325556|451902907|FG002|Open-label Period|Not otherwise specified|0|||
125623373|NCT03325556|451902905|FG000|Open-label Period|Administrative discont. at study termination|41|||
125623374|NCT03325556|451902906|FG001|Open-label Period|Administrative discont. at study termination|0|||
125623375|NCT03325556|451902907|FG002|Open-label Period|Administrative discont. at study termination|0|||
125623376|NCT03325556|451902905|FG000|Double-blind Period|Relapse|0|||
125623377|NCT03325556|451902906|FG001|Double-blind Period|Relapse|15|||
125623378|NCT03325556|451902907|FG002|Double-blind Period|Relapse|34|||
125623379|NCT03325556|451902905|FG000|Double-blind Period|Adverse Event|0|||
125623380|NCT03325556|451902906|FG001|Double-blind Period|Adverse Event|3|||
125623381|NCT03325556|451902907|FG002|Double-blind Period|Adverse Event|1|||
125623382|NCT03325556|451902905|FG000|Double-blind Period|Noncompliance with study drug|0|||
125623383|NCT03325556|451902906|FG001|Double-blind Period|Noncompliance with study drug|0|||
125623384|NCT03325556|451902907|FG002|Double-blind Period|Noncompliance with study drug|1|||
125623385|NCT03325556|451902905|FG000|Double-blind Period|Use of prohibited medication|0|||
125623386|NCT03325556|451902906|FG001|Double-blind Period|Use of prohibited medication|1|||
125623387|NCT03325556|451902907|FG002|Double-blind Period|Use of prohibited medication|0|||
125623388|NCT03325556|451902905|FG000|Double-blind Period|Physician Decision|0|||
125623389|NCT03325556|451902906|FG001|Double-blind Period|Physician Decision|0|||
125623390|NCT03325556|451902907|FG002|Double-blind Period|Physician Decision|1|||
125623391|NCT03325556|451902905|FG000|Double-blind Period|Withdrawal by Subject|0|||
125623392|NCT03325556|451902906|FG001|Double-blind Period|Withdrawal by Subject|6|||
125623393|NCT03325556|451902907|FG002|Double-blind Period|Withdrawal by Subject|4|||
125623394|NCT03325556|451902905|FG000|Double-blind Period|Not otherwise specified|0|||
125623395|NCT03325556|451902906|FG001|Double-blind Period|Not otherwise specified|1|||
125623396|NCT03325556|451902907|FG002|Double-blind Period|Not otherwise specified|5|||
125623397|NCT03325556|451902905|FG000|Double-blind Period|Administrative discont. at study termination|0|||
125623398|NCT03325556|451902906|FG001|Double-blind Period|Administrative discont. at study termination|35|||
125623399|NCT03325556|451902907|FG002|Double-blind Period|Administrative discont. at study termination|31|||
125623400|NCT01705587|451902910|FG000|Overall Study|Withdrawal by Subject|0|||
125623401|NCT01705587|451902911|FG001|Overall Study|Withdrawal by Subject|1|||
125623402|NCT02119026|451902912|FG000|1st-line Treatment|Adverse Event|9|||
125623403|NCT02119026|451902913|FG001|1st-line Treatment|Adverse Event|14|||
125623404|NCT02119026|451902912|FG000|1st-line Treatment|Physician Decision|3|||
125623405|NCT02119026|451902913|FG001|1st-line Treatment|Physician Decision|8|||
125623406|NCT02119026|451902912|FG000|1st-line Treatment|Withdrawal by Subject|4|||
125623407|NCT02119026|451902913|FG001|1st-line Treatment|Withdrawal by Subject|10|||
125623408|NCT02119026|451902912|FG000|1st-line Treatment|Patient condition or compliance|6|||
125623409|NCT02119026|451902913|FG001|1st-line Treatment|Patient condition or compliance|4|||
125623410|NCT02119026|451902912|FG000|1st-line Treatment|Surgery of metastases|2|||
125623411|NCT02119026|451902913|FG001|1st-line Treatment|Surgery of metastases|1|||
125623412|NCT02119026|451902912|FG000|1st-line Treatment|Death|2|||
125623413|NCT02119026|451902913|FG001|1st-line Treatment|Death|1|||
125623414|NCT02119026|451902912|FG000|2nd-line Treatment|Lost to Follow-up|2|||
125623415|NCT02119026|451902913|FG001|2nd-line Treatment|Lost to Follow-up|0|||
125623416|NCT02119026|451902912|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
125623417|NCT02119026|451902913|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
125623418|NCT02119026|451902912|FG000|2nd-line Treatment|Adverse Event|4|||
125623419|NCT02119026|451902913|FG001|2nd-line Treatment|Adverse Event|1|||
125623420|NCT01373918|451902914|FG000|Overall Study|Physician Decision|0|||
125623421|NCT01373918|451902915|FG001|Overall Study|Physician Decision|1|||
125623422|NCT00340834|451902917|FG000|Core Phase of Study|Adverse Event|26|||
125623423|NCT00340834|451902918|FG001|Core Phase of Study|Adverse Event|9|||
125623424|NCT00340834|451902919|FG002|Core Phase of Study|Adverse Event|9|||
125623425|NCT00340834|451902920|FG003|Core Phase of Study|Adverse Event|0|||
125623426|NCT00340834|451902921|FG004|Core Phase of Study|Adverse Event|0|||
125623427|NCT00340834|451902917|FG000|Core Phase of Study|Withdrawal by Subject|11|||
125623428|NCT00340834|451902918|FG001|Core Phase of Study|Withdrawal by Subject|9|||
125623429|NCT00340834|451902919|FG002|Core Phase of Study|Withdrawal by Subject|16|||
125623430|NCT00340834|451902920|FG003|Core Phase of Study|Withdrawal by Subject|0|||
125623431|NCT00340834|451902921|FG004|Core Phase of Study|Withdrawal by Subject|0|||
125623432|NCT00340834|451902917|FG000|Core Phase of Study|Administrative Problems|6|||
125623433|NCT00340834|451902918|FG001|Core Phase of Study|Administrative Problems|2|||
125623434|NCT00340834|451902919|FG002|Core Phase of Study|Administrative Problems|7|||
125623435|NCT00340834|451902920|FG003|Core Phase of Study|Administrative Problems|0|||
125623436|NCT00340834|451902921|FG004|Core Phase of Study|Administrative Problems|0|||
125623437|NCT00340834|451902917|FG000|Core Phase of Study|Lack of Efficacy|3|||
125623438|NCT00340834|451902918|FG001|Core Phase of Study|Lack of Efficacy|3|||
125623439|NCT00340834|451902919|FG002|Core Phase of Study|Lack of Efficacy|7|||
125623440|NCT00340834|451902920|FG003|Core Phase of Study|Lack of Efficacy|0|||
125623441|NCT00340834|451902921|FG004|Core Phase of Study|Lack of Efficacy|0|||
125623442|NCT00340834|451902917|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
125623443|NCT00340834|451902918|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
125623444|NCT00340834|451902919|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
125623445|NCT00340834|451902920|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
125623446|NCT00340834|451902921|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
125623447|NCT00340834|451902917|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
125623448|NCT00340834|451902918|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
125623449|NCT00340834|451902919|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
125623450|NCT00340834|451902920|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
125623451|NCT00340834|451902921|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
125623452|NCT00340834|451902917|FG000|Core Phase of Study|Lost to Follow-up|1|||
125623453|NCT00340834|451902918|FG001|Core Phase of Study|Lost to Follow-up|1|||
125623454|NCT00340834|451902919|FG002|Core Phase of Study|Lost to Follow-up|4|||
125623455|NCT00340834|451902920|FG003|Core Phase of Study|Lost to Follow-up|0|||
125623456|NCT00340834|451902921|FG004|Core Phase of Study|Lost to Follow-up|0|||
125623457|NCT00340834|451902917|FG000|Core Phase of Study|Death|2|||
125623458|NCT00340834|451902918|FG001|Core Phase of Study|Death|0|||
125623459|NCT00340834|451902919|FG002|Core Phase of Study|Death|0|||
125623460|NCT00340834|451902920|FG003|Core Phase of Study|Death|0|||
125623461|NCT00340834|451902921|FG004|Core Phase of Study|Death|0|||
125623462|NCT00340834|451902917|FG000|Core Phase of Study|Protocol Violation|0|||
125623463|NCT00340834|451902918|FG001|Core Phase of Study|Protocol Violation|0|||
125623464|NCT00340834|451902919|FG002|Core Phase of Study|Protocol Violation|2|||
125623465|NCT00340834|451902920|FG003|Core Phase of Study|Protocol Violation|0|||
125623466|NCT00340834|451902921|FG004|Core Phase of Study|Protocol Violation|0|||
125623467|NCT00340834|451902917|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
125623468|NCT00340834|451902918|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
125623469|NCT00340834|451902919|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
125623470|NCT00340834|451902920|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
125623471|NCT00340834|451902921|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
125623472|NCT00340834|451902917|FG000|Extension Phase of Study|Subject withdrew consent|26|||
125623473|NCT00340834|451902918|FG001|Extension Phase of Study|Subject withdrew consent|31|||
125623474|NCT00340834|451902919|FG002|Extension Phase of Study|Subject withdrew consent|0|||
125623475|NCT00340834|451902920|FG003|Extension Phase of Study|Subject withdrew consent|12|||
125623476|NCT00340834|451902921|FG004|Extension Phase of Study|Subject withdrew consent|15|||
125623477|NCT00340834|451902917|FG000|Extension Phase of Study|Adverse Event|21|||
125623478|NCT00340834|451902918|FG001|Extension Phase of Study|Adverse Event|22|||
125623479|NCT00340834|451902919|FG002|Extension Phase of Study|Adverse Event|0|||
125623480|NCT00340834|451902920|FG003|Extension Phase of Study|Adverse Event|19|||
125623481|NCT00340834|451902921|FG004|Extension Phase of Study|Adverse Event|7|||
125623482|NCT00340834|451902917|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
125623483|NCT00340834|451902918|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
125623484|NCT00340834|451902919|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
125623485|NCT00340834|451902920|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
125623486|NCT00340834|451902921|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
125623487|NCT00340834|451902917|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
125623488|NCT00340834|451902918|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
125623489|NCT00340834|451902919|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
125623490|NCT00340834|451902920|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
125623491|NCT00340834|451902921|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
125623492|NCT00340834|451902917|FG000|Extension Phase of Study|Lost to Follow-up|1|||
125623493|NCT00340834|451902918|FG001|Extension Phase of Study|Lost to Follow-up|1|||
125623494|NCT00340834|451902919|FG002|Extension Phase of Study|Lost to Follow-up|0|||
125623495|NCT00340834|451902920|FG003|Extension Phase of Study|Lost to Follow-up|2|||
125623496|NCT00340834|451902921|FG004|Extension Phase of Study|Lost to Follow-up|3|||
125623497|NCT00340834|451902917|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
125623498|NCT00340834|451902918|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
125623499|NCT00340834|451902919|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
125623500|NCT00340834|451902920|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
125623501|NCT00340834|451902921|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
125623502|NCT00340834|451902917|FG000|Extension Phase of Study|Administrative problems|3|||
125623503|NCT00340834|451902918|FG001|Extension Phase of Study|Administrative problems|0|||
125623504|NCT00340834|451902919|FG002|Extension Phase of Study|Administrative problems|0|||
125623505|NCT00340834|451902920|FG003|Extension Phase of Study|Administrative problems|1|||
125623506|NCT00340834|451902921|FG004|Extension Phase of Study|Administrative problems|1|||
125623507|NCT00340834|451902917|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
125623508|NCT00340834|451902918|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
125623509|NCT00340834|451902919|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
125623510|NCT00340834|451902920|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
125623511|NCT00340834|451902921|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
125623512|NCT00340834|451902917|FG000|Extension Phase of Study|Protocol Violation|3|||
125623513|NCT00340834|451902918|FG001|Extension Phase of Study|Protocol Violation|0|||
125623514|NCT00340834|451902919|FG002|Extension Phase of Study|Protocol Violation|0|||
125623515|NCT00340834|451902920|FG003|Extension Phase of Study|Protocol Violation|0|||
125623516|NCT00340834|451902921|FG004|Extension Phase of Study|Protocol Violation|0|||
125623517|NCT00340834|451902917|FG000|Extension Phase of Study|Death|0|||
125623518|NCT00340834|451902918|FG001|Extension Phase of Study|Death|0|||
125623519|NCT00340834|451902919|FG002|Extension Phase of Study|Death|0|||
125623520|NCT00340834|451902920|FG003|Extension Phase of Study|Death|0|||
125623521|NCT00340834|451902921|FG004|Extension Phase of Study|Death|1|||
125623522|NCT03004976|451902922|FG000|Overall Study|Lost to Follow-up|7|||
125623523|NCT03004976|451902923|FG001|Overall Study|Lost to Follow-up|5|||
125623524|NCT03004976|451902922|FG000|Overall Study|Physician Decision|1|||
125623525|NCT03004976|451902923|FG001|Overall Study|Physician Decision|0|||
125623526|NCT03004976|451902922|FG000|Overall Study|Withdrawal by Subject|1|||
125623527|NCT03004976|451902923|FG001|Overall Study|Withdrawal by Subject|0|||
125623528|NCT03004976|451902922|FG000|Overall Study|Death|4|||
125623529|NCT03004976|451902923|FG001|Overall Study|Death|1|||
125623530|NCT00291499|451902927|FG000|Overall Study|Adverse Event|3|||
125623531|NCT00291499|451902928|FG001|Overall Study|Adverse Event|8|||
125623532|NCT00291499|451902927|FG000|Overall Study|Change to other therapy|2|||
125623533|NCT00291499|451902928|FG001|Overall Study|Change to other therapy|1|||
125623534|NCT00291499|451902927|FG000|Overall Study|Intercurrent illness|1|||
125623535|NCT00291499|451902928|FG001|Overall Study|Intercurrent illness|0|||
125623536|NCT00291499|451902927|FG000|Overall Study|Protocol Violation|2|||
125623537|NCT00291499|451902928|FG001|Overall Study|Protocol Violation|2|||
125623538|NCT00291499|451902927|FG000|Overall Study|Other reasons|1|||
125623539|NCT00291499|451902928|FG001|Overall Study|Other reasons|4|||
125623540|NCT01532570|451902929|FG000|Overall Study|Lack of Efficacy|1|||
125623541|NCT01532570|451902930|FG001|Overall Study|Lack of Efficacy|0|||
125623542|NCT01532570|451902931|FG002|Overall Study|Lack of Efficacy|0|||
125623543|NCT01532570|451902932|FG003|Overall Study|Lack of Efficacy|0|||
125623544|NCT01532570|451902929|FG000|Overall Study|Withdrawal by Subject|0|||
125623545|NCT01532570|451902930|FG001|Overall Study|Withdrawal by Subject|1|||
125623546|NCT01532570|451902931|FG002|Overall Study|Withdrawal by Subject|0|||
125623547|NCT01532570|451902932|FG003|Overall Study|Withdrawal by Subject|0|||
125623548|NCT01807949|451902934|FG000|Overall Study|Adverse Event|1|||
125623549|NCT01807949|451902935|FG001|Overall Study|Adverse Event|2|||
125623550|NCT01807949|451902936|FG002|Overall Study|Adverse Event|2|||
125623551|NCT01807949|451902934|FG000|Overall Study|Withdrawal by Subject|1|||
125623552|NCT01807949|451902935|FG001|Overall Study|Withdrawal by Subject|2|||
125623553|NCT01807949|451902936|FG002|Overall Study|Withdrawal by Subject|2|||
125623554|NCT01807949|451902934|FG000|Overall Study|Non-Compliance|0|||
125623555|NCT01807949|451902935|FG001|Overall Study|Non-Compliance|0|||
125623556|NCT01807949|451902936|FG002|Overall Study|Non-Compliance|1|||
125623557|NCT01807949|451902934|FG000|Overall Study|Undefined|0|||
125623558|NCT01807949|451902935|FG001|Overall Study|Undefined|1|||
125623559|NCT01807949|451902936|FG002|Overall Study|Undefined|2|||
125623560|NCT01807949|451902934|FG000|Overall Study|Randomized But Not Treated|0|||
125623561|NCT01807949|451902935|FG001|Overall Study|Randomized But Not Treated|2|||
125623562|NCT01807949|451902936|FG002|Overall Study|Randomized But Not Treated|2|||
125623563|NCT04325906|451902937|FG000|Overall Study|Withdrawal by Subject|2|||
125623564|NCT04325906|451902938|FG001|Overall Study|Withdrawal by Subject|0|||
125623565|NCT01213264|451902943|FG000|Overall Study|Adverse Event|1|||
125623566|NCT01213264|451902944|FG001|Overall Study|Adverse Event|0|||
125623567|NCT01213264|451902945|FG002|Overall Study|Adverse Event|0|||
125623568|NCT01213264|451902943|FG000|Overall Study|Lost to Follow-up|1|||
125623569|NCT01213264|451902944|FG001|Overall Study|Lost to Follow-up|2|||
125623570|NCT01213264|451902945|FG002|Overall Study|Lost to Follow-up|6|||
125623571|NCT00118911|451902946|FG000|Overall Study|Withdrawal by Subject|2|||
125623572|NCT00118911|451902947|FG001|Overall Study|Withdrawal by Subject|5|||
125623573|NCT05507580|451902948|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125623574|NCT05507580|451902949|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
125623575|NCT05507580|451902950|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
125623576|NCT05507580|451902951|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
125623577|NCT05507580|451902952|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
125623578|NCT05507580|451902953|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
125623579|NCT05507580|451902948|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
125623580|NCT05507580|451902949|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125623581|NCT05507580|451902950|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125623582|NCT05507580|451902951|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125623583|NCT05507580|451902952|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125623584|NCT05507580|451902953|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125623585|NCT05507580|451902948|FG000|Double-Blind Treatment Period|Other, not specified|5|||
125623586|NCT05507580|451902949|FG001|Double-Blind Treatment Period|Other, not specified|4|||
125623587|NCT05507580|451902950|FG002|Double-Blind Treatment Period|Other, not specified|0|||
125623588|NCT05507580|451902951|FG003|Double-Blind Treatment Period|Other, not specified|0|||
125623589|NCT05507580|451902952|FG004|Double-Blind Treatment Period|Other, not specified|0|||
125623590|NCT05507580|451902953|FG005|Double-Blind Treatment Period|Other, not specified|0|||
125623591|NCT05507580|451902948|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
125623592|NCT05507580|451902949|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
125623593|NCT05507580|451902950|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
125623594|NCT05507580|451902951|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
125623595|NCT05507580|451902952|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
125623596|NCT05507580|451902953|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
125623597|NCT05507580|451902948|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
125623598|NCT05507580|451902949|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
125623599|NCT05507580|451902950|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
125623600|NCT05507580|451902951|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
125623601|NCT05507580|451902952|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
125623602|NCT05507580|451902953|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
125623603|NCT05507580|451902948|FG000|Single-Blind Treatment Period|Other, not specified|0|||
125623604|NCT05507580|451902949|FG001|Single-Blind Treatment Period|Other, not specified|0|||
125623605|NCT05507580|451902950|FG002|Single-Blind Treatment Period|Other, not specified|2|||
125623606|NCT05507580|451902951|FG003|Single-Blind Treatment Period|Other, not specified|7|||
125623607|NCT05507580|451902952|FG004|Single-Blind Treatment Period|Other, not specified|3|||
125623608|NCT05507580|451902953|FG005|Single-Blind Treatment Period|Other, not specified|5|||
125623609|NCT04702984|451902954|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
125623610|NCT03496662|451902955|FG000|Overall Study|Adverse Event|0|||
125623611|NCT03496662|451902956|FG001|Overall Study|Adverse Event|0|||
125623612|NCT03496662|451902957|FG002|Overall Study|Adverse Event|4|||
125623613|NCT03496662|451902955|FG000|Overall Study|Withdrawal by Subject|1|||
125623614|NCT03496662|451902956|FG001|Overall Study|Withdrawal by Subject|0|||
125623615|NCT03496662|451902957|FG002|Overall Study|Withdrawal by Subject|2|||
125623616|NCT03496662|451902955|FG000|Overall Study|Death|0|||
125623617|NCT03496662|451902956|FG001|Overall Study|Death|0|||
125623618|NCT03496662|451902957|FG002|Overall Study|Death|2|||
125623619|NCT03496662|451902955|FG000|Overall Study|Noncompliance|0|||
125623620|NCT03496662|451902956|FG001|Overall Study|Noncompliance|0|||
125623621|NCT03496662|451902957|FG002|Overall Study|Noncompliance|1|||
125623622|NCT03037307|451902958|FG000|Period 1|Did Not Meet Study Criteria|0|||
125623623|NCT03037307|451902959|FG001|Period 1|Did Not Meet Study Criteria|0|||
125623624|NCT03037307|451902960|FG002|Period 1|Did Not Meet Study Criteria|0|||
125623625|NCT03037307|451902961|FG003|Period 1|Did Not Meet Study Criteria|1|||
125623626|NCT03037307|451902962|FG004|Period 1|Did Not Meet Study Criteria|0|||
125623627|NCT03037307|451902963|FG005|Period 1|Did Not Meet Study Criteria|0|||
125623628|NCT00691093|451902964|FG000|Overall Study|Adverse Event|1|||
125623629|NCT00691093|451902964|FG000|Overall Study|Lost to Follow-up|1|||
125623630|NCT00691093|451902964|FG000|Overall Study|Lack of Efficacy|1|||
125623631|NCT00691093|451902964|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
125623632|NCT01588353|451902965|FG000|Step2|Withdrawal by Subject|0|||
125623633|NCT01588353|451902966|FG001|Step2|Withdrawal by Subject|1|||
125623634|NCT01588353|451902967|FG002|Step2|Withdrawal by Subject|0|||
125623635|NCT01588353|451902965|FG000|Step3|Adverse Event|0|||
125623636|NCT01588353|451902966|FG001|Step3|Adverse Event|0|||
125623637|NCT01588353|451902967|FG002|Step3|Adverse Event|2|||
125623638|NCT05489081|451902969|FG000|Overall Study|student left classroom|0|||
125623639|NCT05489081|451902970|FG001|Overall Study|student left classroom|1|||
125623640|NCT05489081|451902969|FG000|Overall Study|teacher left school|0|||
125623641|NCT05489081|451902970|FG001|Overall Study|teacher left school|2|||
125623642|NCT00810810|451902971|FG000|Overall Study|Withdrawal by Subject|0|||
125623643|NCT00810810|451902972|FG001|Overall Study|Withdrawal by Subject|8|||
125623644|NCT00810810|451902973|FG002|Overall Study|Withdrawal by Subject|10|||
125623645|NCT00810810|451902974|FG003|Overall Study|Withdrawal by Subject|8|||
125623646|NCT00810810|451902971|FG000|Overall Study|Physician Decision|0|||
125623647|NCT00810810|451902972|FG001|Overall Study|Physician Decision|3|||
125623648|NCT00810810|451902973|FG002|Overall Study|Physician Decision|1|||
125623649|NCT00810810|451902974|FG003|Overall Study|Physician Decision|5|||
125623650|NCT01409993|451902975|FG000|Overall Study|Adverse Event|4|||
125623651|NCT01409993|451902976|FG001|Overall Study|Adverse Event|4|||
125623652|NCT01409993|451902977|FG002|Overall Study|Adverse Event|3|||
125623653|NCT01409993|451902978|FG003|Overall Study|Adverse Event|1|||
125623654|NCT01409993|451902975|FG000|Overall Study|Withdrawal by Subject|0|||
125623655|NCT01409993|451902976|FG001|Overall Study|Withdrawal by Subject|0|||
125623656|NCT01409993|451902977|FG002|Overall Study|Withdrawal by Subject|0|||
125623657|NCT01409993|451902978|FG003|Overall Study|Withdrawal by Subject|4|||
125623658|NCT01409993|451902975|FG000|Overall Study|Lost to Follow-up|0|||
125623659|NCT01409993|451902976|FG001|Overall Study|Lost to Follow-up|1|||
125623660|NCT01409993|451902977|FG002|Overall Study|Lost to Follow-up|0|||
125623661|NCT01409993|451902978|FG003|Overall Study|Lost to Follow-up|0|||
125623662|NCT01700985|451902979|FG000|Overall Study|Incarcerated|0|||
125623663|NCT01700985|451902980|FG001|Overall Study|Incarcerated|1|||
125623664|NCT05067452|451902981|FG000|Overall Study|Lost to Follow-up|0|||
125623665|NCT05067452|451902982|FG001|Overall Study|Lost to Follow-up|4|||
125623666|NCT03074149|451902983|FG000|Overall Study|Reason unknown|22|||
125623667|NCT03074149|451902984|FG001|Overall Study|Reason unknown|35|||
125623668|NCT03074149|451902983|FG000|Overall Study|Death|10|||
125623669|NCT03074149|451902984|FG001|Overall Study|Death|45|||
125623670|NCT00067470|451902985|FG000|Overall Study|Withdrawal by Subject|0|||
125623671|NCT00067470|451902986|FG001|Overall Study|Withdrawal by Subject|1|||
125623672|NCT00050622|451902989|FG000|Overall Study|Adverse Event|1|||
125623673|NCT01192204|451902990|FG000|Overall Study|could not keep recall appointments|1|||
125623674|NCT01192204|451902991|FG001|Overall Study|could not keep recall appointments|0|||
125623675|NCT02146248|451902992|FG000|Overall Study|Withdrawal by Subject|2|||
125623676|NCT01315847|451902993|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
125623677|NCT01315847|451902994|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
125623678|NCT01315847|451902993|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
125623679|NCT01315847|451902994|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
125623680|NCT02247401|451902995|FG000|Overall Study|Adverse Event|1|||
125623681|NCT02247401|451902996|FG001|Overall Study|Adverse Event|0|||
125623682|NCT02247401|451902997|FG002|Overall Study|Adverse Event|0|||
125623683|NCT02247401|451902995|FG000|Overall Study|Withdrawal by Subject|4|||
125623684|NCT02247401|451902996|FG001|Overall Study|Withdrawal by Subject|1|||
125623685|NCT02247401|451902997|FG002|Overall Study|Withdrawal by Subject|1|||
125623686|NCT02247401|451902995|FG000|Overall Study|Lost to Follow-up|1|||
125623687|NCT02247401|451902996|FG001|Overall Study|Lost to Follow-up|1|||
125623688|NCT02247401|451902997|FG002|Overall Study|Lost to Follow-up|1|||
125623689|NCT01117012|451902999|FG000|Overall Study|Adverse Event|0|||
125623690|NCT01117012|451903000|FG001|Overall Study|Adverse Event|1|||
125623691|NCT01117012|451902999|FG000|Overall Study|Death|1|||
125623692|NCT01117012|451903000|FG001|Overall Study|Death|1|||
125623693|NCT01117012|451902999|FG000|Overall Study|Withdrawal by Subject|3|||
125623694|NCT01117012|451903000|FG001|Overall Study|Withdrawal by Subject|0|||
125623695|NCT01117012|451902999|FG000|Overall Study|Undefined|4|||
125623696|NCT01117012|451903000|FG001|Overall Study|Undefined|3|||
125623697|NCT03695393|451903001|FG000|Overall Study|Death|3|||
125623698|NCT03695393|451903002|FG001|Overall Study|Death|1|||
125623699|NCT03695393|451903001|FG000|Overall Study|Lost to Follow-up|0|||
125623700|NCT03695393|451903002|FG001|Overall Study|Lost to Follow-up|1|||
125623701|NCT00673894|451903003|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
125623702|NCT00673894|451903004|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
125623703|NCT00673894|451903003|FG000|First Intervention 4 Weeks|Adverse Event|1|||
125623704|NCT00673894|451903004|FG001|First Intervention 4 Weeks|Adverse Event|0|||
125623705|NCT01164865|451903005|FG000|Overall Study|Lost to Follow-up|2|||
125623706|NCT01164865|451903006|FG001|Overall Study|Lost to Follow-up|1|||
125623707|NCT00405821|451903011|FG000|Overall Study|Death|5|||
125623708|NCT00405821|451903012|FG001|Overall Study|Death|7|||
125623709|NCT00405821|451903011|FG000|Overall Study|Lost to Follow-up|7|||
125623710|NCT00405821|451903012|FG001|Overall Study|Lost to Follow-up|7|||
125623711|NCT00405821|451903011|FG000|Overall Study|Protocol Violation|1|||
125623712|NCT00405821|451903012|FG001|Overall Study|Protocol Violation|0|||
125623713|NCT00405821|451903011|FG000|Overall Study|initiated ART|9|||
125623714|NCT00405821|451903012|FG001|Overall Study|initiated ART|8|||
125623715|NCT01586806|451903014|FG000|Overall Study|Protocol Violation|0|||
125623716|NCT01586806|451903015|FG001|Overall Study|Protocol Violation|1|||
125623717|NCT01586806|451903016|FG002|Overall Study|Protocol Violation|0|||
125623718|NCT01586806|451903014|FG000|Overall Study|Withdrawal by Subject|1|||
125623719|NCT01586806|451903015|FG001|Overall Study|Withdrawal by Subject|0|||
125623720|NCT01586806|451903016|FG002|Overall Study|Withdrawal by Subject|0|||
125623721|NCT01586806|451903014|FG000|Overall Study|Lost to Follow-up|2|||
125623722|NCT01586806|451903015|FG001|Overall Study|Lost to Follow-up|3|||
125623723|NCT01586806|451903016|FG002|Overall Study|Lost to Follow-up|2|||
125623724|NCT01769469|451903018|FG000|Overall Study|Consent Withdrawn|5|||
125623725|NCT01769469|451903018|FG000|Overall Study|Moved Out Of Area|3|||
125623726|NCT01769469|451903018|FG000|Overall Study|Lost to Follow-up|17|||
125623727|NCT01769469|451903018|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
125623728|NCT01769469|451903018|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
125215296|NCT02559570|450414978|FG000|Overall Study|Protocol Violation|1|||
125215297|NCT02559570|450414979|FG001|Overall Study|Protocol Violation|0|||
125623729|NCT02031432|451903019|FG000|Overall Study|Protocol Violation|1|||
125623730|NCT02031432|451903019|FG000|Overall Study|Lack of Efficacy|5|||
125623731|NCT02031432|451903019|FG000|Overall Study|Cancer Progression|2|||
125623732|NCT02031432|451903019|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
125623733|NCT02031432|451903019|FG000|Overall Study|Adverse Event|8|||
125623734|NCT02031432|451903019|FG000|Overall Study|Withdrawal by Subject|5|||
125623735|NCT02031432|451903019|FG000|Overall Study|Lost to Follow-up|1|||
125623736|NCT02031432|451903019|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
125623737|NCT02031432|451903019|FG000|Overall Study|Death|10|||
125623738|NCT01617187|451903020|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
125623739|NCT01617187|451903021|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
125623740|NCT01617187|451903022|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
125623741|NCT01617187|451903023|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
125623742|NCT01617187|451903020|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
125623743|NCT01617187|451903021|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
125623744|NCT01617187|451903022|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
125623745|NCT01617187|451903023|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
125623746|NCT01617187|451903020|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
125623747|NCT01617187|451903021|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
125623748|NCT01617187|451903022|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
125623749|NCT01617187|451903023|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
125623750|NCT01617187|451903020|FG000|Treatment Through Study Completion|Adverse Event|1|||
125623751|NCT01617187|451903021|FG001|Treatment Through Study Completion|Adverse Event|1|||
125623752|NCT01617187|451903022|FG002|Treatment Through Study Completion|Adverse Event|0|||
125623753|NCT01617187|451903023|FG003|Treatment Through Study Completion|Adverse Event|1|||
125623754|NCT01617187|451903020|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
125623755|NCT01617187|451903021|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
125623756|NCT01617187|451903022|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
125623757|NCT01617187|451903023|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
125623758|NCT01617187|451903020|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
125623759|NCT01617187|451903021|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
125623760|NCT01617187|451903022|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
125623761|NCT01617187|451903023|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
125623762|NCT01617187|451903020|FG000|Treatment Through Study Completion|Protocol Violation|1|||
125623763|NCT01617187|451903021|FG001|Treatment Through Study Completion|Protocol Violation|0|||
125623764|NCT01617187|451903022|FG002|Treatment Through Study Completion|Protocol Violation|0|||
125623765|NCT01617187|451903023|FG003|Treatment Through Study Completion|Protocol Violation|1|||
125623766|NCT00595868|451904718|FG000|Overall Study|Lost to Follow-up|45|||
125623767|NCT00595868|451904719|FG001|Overall Study|Lost to Follow-up|50|||
125374544|NCT03902574|451002237|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
125374545|NCT03902574|451002238|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
125374546|NCT01218204|451002243|FG000|Part B Washout|Adverse Event|0|||
125623768|NCT04268303|451904721|FG000|Overall Study|Lost to Follow-up|1|||
125623769|NCT04268303|451904722|FG001|Overall Study|Lost to Follow-up|1|||
125623770|NCT04268303|451904723|FG002|Overall Study|Lost to Follow-up|2|||
125623771|NCT04268303|451904721|FG000|Overall Study|Withdrawal by Subject|0|||
125623772|NCT04268303|451904722|FG001|Overall Study|Withdrawal by Subject|1|||
125623773|NCT04268303|451904723|FG002|Overall Study|Withdrawal by Subject|1|||
125623774|NCT04268303|451904721|FG000|Overall Study|Adverse Event|2|||
125623775|NCT04268303|451904722|FG001|Overall Study|Adverse Event|0|||
125623776|NCT04268303|451904723|FG002|Overall Study|Adverse Event|0|||
125623777|NCT05742841|451904728|FG000|Overall Study|Withdrawal by Subject|1|||
125623778|NCT05742841|451904728|FG000|Overall Study|Lost to Follow-up|1|||
125623779|NCT01175590|451904734|FG000|Overall Study|Lost to Follow-up|1|||
125623780|NCT01175590|451904735|FG001|Overall Study|Lost to Follow-up|0|||
125623781|NCT01175590|451904734|FG000|Overall Study|Withdrawal by Subject|0|||
125623782|NCT01175590|451904735|FG001|Overall Study|Withdrawal by Subject|2|||
125623783|NCT01175590|451904734|FG000|Overall Study|Adverse Event|4|||
125623784|NCT01175590|451904735|FG001|Overall Study|Adverse Event|0|||
125623785|NCT01175590|451904734|FG000|Overall Study|Physician Decision|1|||
125623786|NCT01175590|451904735|FG001|Overall Study|Physician Decision|4|||
125623787|NCT01175590|451904734|FG000|Overall Study|Lack of Efficacy|1|||
125623788|NCT01175590|451904735|FG001|Overall Study|Lack of Efficacy|1|||
125623789|NCT01175590|451904734|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
125623790|NCT01175590|451904735|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
125623791|NCT01175590|451904734|FG000|Overall Study|Treated not as randomized|3|||
125623792|NCT01175590|451904735|FG001|Overall Study|Treated not as randomized|2|||
125623793|NCT01175590|451904734|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
125623794|NCT01175590|451904735|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
125623795|NCT01175590|451904734|FG000|Overall Study|Protocol Violation|0|||
125623796|NCT01175590|451904735|FG001|Overall Study|Protocol Violation|1|||
125623797|NCT03911869|451904738|FG000|Safety Lead-in Phase|Death|7|||
125623798|NCT03911869|451904739|FG001|Safety Lead-in Phase|Death|0|||
125623799|NCT03911869|451904740|FG002|Safety Lead-in Phase|Death|0|||
125623800|NCT03911869|451904738|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
125623801|NCT03911869|451904739|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
125623802|NCT03911869|451904740|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
125623803|NCT03911869|451904738|FG000|Safety Lead-in Phase|Other|1|||
125623804|NCT03911869|451904739|FG001|Safety Lead-in Phase|Other|0|||
125623805|NCT03911869|451904740|FG002|Safety Lead-in Phase|Other|0|||
125623806|NCT03911869|451904738|FG000|Phase 2|Death|0|||
125623807|NCT03911869|451904739|FG001|Phase 2|Death|3|||
125623808|NCT03911869|451904740|FG002|Phase 2|Death|0|||
125623809|NCT00688545|451904741|FG000|Overall Study|Lost to Follow-up|1|||
125623810|NCT00688545|451904742|FG001|Overall Study|Lost to Follow-up|4|||
125623811|NCT00688545|451904741|FG000|Overall Study|Insurance/cost of drug|0|||
125623812|NCT00688545|451904742|FG001|Overall Study|Insurance/cost of drug|1|||
125215298|NCT02559570|450414980|FG002|Overall Study|Protocol Violation|0|||
125215299|NCT02559570|450414981|FG003|Overall Study|Protocol Violation|0|||
125623813|NCT00688545|451904741|FG000|Overall Study|Withdrawal by Subject|2|||
125623814|NCT00688545|451904742|FG001|Overall Study|Withdrawal by Subject|3|||
125623815|NCT00688545|451904741|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
125623816|NCT00688545|451904742|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
125623817|NCT01878097|451904743|FG000|Baseline|Surveys not fully completed|2497|||
125623818|NCT01878097|451904744|FG001|Baseline|Surveys not fully completed|1800|||
125623819|NCT01878097|451904743|FG000|Implementation Year 1|Surveys not fully completed|3202|||
125623820|NCT01878097|451904744|FG001|Implementation Year 1|Surveys not fully completed|2549|||
125623821|NCT01878097|451904743|FG000|Implementation Year 2|Surveys not fully completed|3281|||
125623822|NCT01878097|451904744|FG001|Implementation Year 2|Surveys not fully completed|2841|||
125623823|NCT01878097|451904743|FG000|Implementation Year 3|Surveys not fully completed|3494|||
125623824|NCT01878097|451904744|FG001|Implementation Year 3|Surveys not fully completed|2980|||
125623825|NCT01878097|451904743|FG000|Implementation Year 4|Surveys not fully completed|3604|||
125623826|NCT01878097|451904744|FG001|Implementation Year 4|Surveys not fully completed|3007|||
125623827|NCT00367341|451904745|FG000|Overall Study|Physician Decision|1|||
125623828|NCT00367341|451904746|FG001|Overall Study|Physician Decision|0|||
125623829|NCT00367341|451904745|FG000|Overall Study|Protocol Violation|1|||
125623830|NCT00367341|451904746|FG001|Overall Study|Protocol Violation|0|||
125623831|NCT02786836|451904750|FG000|Overall Study|Death|1|||
125623832|NCT02786836|451904750|FG000|Overall Study|Lack of Efficacy|2|||
125623833|NCT02786836|451904750|FG000|Overall Study|Protocol Violation|3|||
125623834|NCT02786836|451904750|FG000|Overall Study|Withdrawal by Subject|3|||
125623835|NCT02786836|451904750|FG000|Overall Study|Liver Transplantation|2|||
125623836|NCT02786836|451904750|FG000|Overall Study|Device or Pharmacy Issues|3|||
125623837|NCT01143714|451904752|FG000|Overall Study|Adverse Event|4|||
125623838|NCT01143714|451904753|FG001|Overall Study|Adverse Event|2|||
125623839|NCT01143714|451904752|FG000|Overall Study|Withdrawal by Subject|1|||
125623840|NCT01143714|451904753|FG001|Overall Study|Withdrawal by Subject|0|||
125623841|NCT01143714|451904752|FG000|Overall Study|Subject non-compliance|0|||
125623842|NCT01143714|451904753|FG001|Overall Study|Subject non-compliance|1|||
125623843|NCT01143714|451904752|FG000|Overall Study|wound closed = deemed healed|1|||
125623844|NCT01143714|451904753|FG001|Overall Study|wound closed = deemed healed|0|||
125623845|NCT01143714|451904752|FG000|Overall Study|wound size increased|1|||
125623846|NCT01143714|451904753|FG001|Overall Study|wound size increased|0|||
125623847|NCT01387074|451904754|FG000|Overall Study|Lost to Follow-up|7|||
125623848|NCT01387074|451904754|FG000|Overall Study|Lack of Efficacy|1|||
125623849|NCT03892707|451904760|FG000|Overall Study|Screen failure|6|||
125623850|NCT03892707|451904761|FG001|Overall Study|Screen failure|0|||
125623851|NCT03892707|451904760|FG000|Overall Study|Pain resolution|0|||
125623852|NCT03892707|451904761|FG001|Overall Study|Pain resolution|4|||
125623853|NCT03892707|451904760|FG000|Overall Study|Withdrawal by Subject|0|||
125623854|NCT03892707|451904761|FG001|Overall Study|Withdrawal by Subject|1|||
125623855|NCT03892707|451904760|FG000|Overall Study|Other (long business trip)|0|||
125623856|NCT03892707|451904761|FG001|Overall Study|Other (long business trip)|1|||
125623857|NCT02137837|451904764|FG000|Overall Study|Adverse Event|0|||
125623858|NCT02137837|451904765|FG001|Overall Study|Adverse Event|2|||
125623859|NCT02137837|451904766|FG002|Overall Study|Adverse Event|1|||
125623860|NCT02137837|451904764|FG000|Overall Study|Refusal unrelated to adverse event|2|||
125623861|NCT02137837|451904765|FG001|Overall Study|Refusal unrelated to adverse event|2|||
125623862|NCT02137837|451904766|FG002|Overall Study|Refusal unrelated to adverse event|1|||
125623863|NCT02137837|451904764|FG000|Overall Study|Progression/relapse|9|||
125623864|NCT02137837|451904765|FG001|Overall Study|Progression/relapse|7|||
125623865|NCT02137837|451904766|FG002|Overall Study|Progression/relapse|7|||
125623866|NCT02137837|451904764|FG000|Overall Study|Not protocol specified|2|||
125215300|NCT02559570|450414982|FG004|Overall Study|Protocol Violation|1|||
125623867|NCT02137837|451904765|FG001|Overall Study|Not protocol specified|1|||
125623868|NCT02137837|451904766|FG002|Overall Study|Not protocol specified|3|||
125623869|NCT02141217|451904767|FG000|Overall Study|Adverse Event|1|||
125623870|NCT02141217|451904768|FG001|Overall Study|Adverse Event|2|||
125623871|NCT02141217|451904767|FG000|Overall Study|Protocol Violation|1|||
125623872|NCT02141217|451904768|FG001|Overall Study|Protocol Violation|4|||
125623873|NCT02141217|451904767|FG000|Overall Study|Withdrawal by Subject|6|||
125623874|NCT02141217|451904768|FG001|Overall Study|Withdrawal by Subject|0|||
125623875|NCT02141217|451904767|FG000|Overall Study|Lost to Follow-up|1|||
125623876|NCT02141217|451904768|FG001|Overall Study|Lost to Follow-up|1|||
125623877|NCT02141217|451904767|FG000|Overall Study|Physician Decision|1|||
125623878|NCT02141217|451904768|FG001|Overall Study|Physician Decision|0|||
125623879|NCT02141217|451904767|FG000|Overall Study|Surgical Intervention|1|||
125623880|NCT02141217|451904768|FG001|Overall Study|Surgical Intervention|1|||
125623881|NCT01181141|451904771|FG000|Overall Study|Adverse Event|2|||
125623882|NCT01181141|451904772|FG001|Overall Study|Adverse Event|1|||
125623883|NCT01181141|451904771|FG000|Overall Study|Lack of Efficacy|1|||
125623884|NCT01181141|451904772|FG001|Overall Study|Lack of Efficacy|0|||
125623885|NCT01181141|451904771|FG000|Overall Study|Lost to Follow-up|1|||
125623886|NCT01181141|451904772|FG001|Overall Study|Lost to Follow-up|1|||
125623887|NCT01181141|451904771|FG000|Overall Study|Physician Decision|2|||
125623888|NCT01181141|451904772|FG001|Overall Study|Physician Decision|0|||
125623889|NCT01181141|451904771|FG000|Overall Study|Protocol Violation|3|||
125623890|NCT01181141|451904772|FG001|Overall Study|Protocol Violation|1|||
125623891|NCT01181141|451904771|FG000|Overall Study|Withdrawal by Subject|3|||
125623892|NCT01181141|451904772|FG001|Overall Study|Withdrawal by Subject|1|||
125623893|NCT00448760|451904773|FG000|Overall Study|Death|3|||
125623894|NCT01438307|451904781|FG000|Overall Study|Death|1|||
125623895|NCT01438307|451904782|FG001|Overall Study|Death|1|||
125623896|NCT00555568|451904783|FG000|Overall Study|Lost to Follow-up|26|||
125623897|NCT00555568|451904784|FG001|Overall Study|Lost to Follow-up|16|||
125623898|NCT00555568|451904785|FG002|Overall Study|Lost to Follow-up|16|||
125623899|NCT02378883|451904788|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
125623900|NCT02378883|451904788|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
125623901|NCT02378883|451904788|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
125623902|NCT02378883|451904788|FG000|30 Day Follow-Up|Physician Decision|2|||
125623903|NCT02378883|451904788|FG000|30 Day Follow-Up|Missed Visit|2|||
125623904|NCT02378883|451904788|FG000|30 Day Follow-Up|Death|1|||
125623905|NCT02378883|451904788|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
125623906|NCT02378883|451904788|FG000|12 Months Follow-Up|Death|2|||
125623907|NCT03814005|451904792|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
125623908|NCT03814005|451904793|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
125623909|NCT03814005|451904794|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
125623910|NCT03814005|451904792|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
125623911|NCT03814005|451904793|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
125623912|NCT03814005|451904794|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
125623913|NCT03814005|451904792|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
125623914|NCT03814005|451904793|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
125623915|NCT03814005|451904794|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
125623916|NCT03814005|451904792|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
125623917|NCT03814005|451904793|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
125623918|NCT03814005|451904794|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
125623919|NCT03814005|451904792|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
125623920|NCT03814005|451904793|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
125623921|NCT03814005|451904794|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
125623922|NCT03814005|451904792|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
125623923|NCT03814005|451904793|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
125623924|NCT03814005|451904794|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
125623925|NCT01135017|451904798|FG000|Overall Study|Adverse Event|3|||
125623926|NCT01135017|451904799|FG001|Overall Study|Adverse Event|8|||
125623927|NCT01135017|451904798|FG000|Overall Study|Other than above|3|||
125623928|NCT01135017|451904799|FG001|Overall Study|Other than above|4|||
125623929|NCT01170221|451904801|FG000|Overall Study|Lost to Follow-up|22|||
125623930|NCT01170221|451904802|FG001|Overall Study|Lost to Follow-up|21|||
125623931|NCT01170221|451904801|FG000|Overall Study|Withdrawal by Subject|9|||
125623932|NCT01170221|451904802|FG001|Overall Study|Withdrawal by Subject|7|||
125623933|NCT01170221|451904801|FG000|Overall Study|Subject completed only screening and LFU|1|||
125623934|NCT01170221|451904802|FG001|Overall Study|Subject completed only screening and LFU|0|||
125623935|NCT01170221|451904801|FG000|Overall Study|Randomized but not treated|1|||
125623936|NCT01170221|451904802|FG001|Overall Study|Randomized but not treated|0|||
125623937|NCT04169061|451904803|FG000|Overall Study|Adverse Event|2|||
125623938|NCT04169061|451904803|FG000|Overall Study|Death|1|||
125623939|NCT04169061|451904803|FG000|Overall Study|Withdrawal by Subject|1|||
125623940|NCT04169061|451904803|FG000|Overall Study|Protocol Violation|1|||
125623941|NCT05425719|451904807|FG000|Overall Study|Lost to Follow-up|4|||
125623942|NCT05425719|451904808|FG001|Overall Study|Lost to Follow-up|0|||
125623943|NCT05425719|451904807|FG000|Overall Study|Withdrew consent|1|||
125623944|NCT05425719|451904808|FG001|Overall Study|Withdrew consent|1|||
125623945|NCT04682353|451904809|FG000|Overall Study|Lost to Follow-up|0|||
125623946|NCT04682353|451904810|FG001|Overall Study|Lost to Follow-up|1|||
125623947|NCT04682353|451904811|FG002|Overall Study|Lost to Follow-up|0|||
125623948|NCT04682353|451904812|FG003|Overall Study|Lost to Follow-up|1|||
125623949|NCT04682353|451904809|FG000|Overall Study|Personal reasons|0|||
125623950|NCT04682353|451904810|FG001|Overall Study|Personal reasons|1|||
125623951|NCT04682353|451904811|FG002|Overall Study|Personal reasons|0|||
125623952|NCT04682353|451904812|FG003|Overall Study|Personal reasons|0|||
125623953|NCT02394795|451904813|FG000|Overall Study|Adverse Event|92|||
125623954|NCT02394795|451904814|FG001|Overall Study|Adverse Event|70|||
125623955|NCT02394795|451904813|FG000|Overall Study|Lost to Follow-up|0|||
125623956|NCT02394795|451904814|FG001|Overall Study|Lost to Follow-up|1|||
125623957|NCT02394795|451904813|FG000|Overall Study|Withdrawal by Subject|17|||
125623958|NCT02394795|451904814|FG001|Overall Study|Withdrawal by Subject|26|||
125623959|NCT02394795|451904813|FG000|Overall Study|Lack of Efficacy|181|||
125623960|NCT02394795|451904814|FG001|Overall Study|Lack of Efficacy|211|||
125623961|NCT02394795|451904813|FG000|Overall Study|Death|4|||
125623962|NCT02394795|451904814|FG001|Overall Study|Death|5|||
125623963|NCT02394795|451904813|FG000|Overall Study|Physician Decision|109|||
125623964|NCT02394795|451904814|FG001|Overall Study|Physician Decision|93|||
125623965|NCT03505749|451904819|FG000|Overall Study|Lost to Follow-up|7|||
125623966|NCT03505749|451904820|FG001|Overall Study|Lost to Follow-up|11|||
125623967|NCT03505749|451904819|FG000|Overall Study|Withdrawal by Subject|6|||
125623968|NCT03505749|451904820|FG001|Overall Study|Withdrawal by Subject|0|||
125623969|NCT03505749|451904819|FG000|Overall Study|Discharged from treatment|3|||
125623970|NCT03505749|451904820|FG001|Overall Study|Discharged from treatment|6|||
125623971|NCT03846219|451904822|FG000|Overall Study|Withdrawal by Subject|3|||
125623972|NCT03846219|451904823|FG001|Overall Study|Withdrawal by Subject|2|||
125623973|NCT03846219|451904824|FG002|Overall Study|Withdrawal by Subject|2|||
125623974|NCT03846219|451904822|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
125623975|NCT03846219|451904823|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
125623976|NCT03846219|451904824|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
125623977|NCT03846219|451904822|FG000|Overall Study|Physician Decision|0|||
125623978|NCT03846219|451904823|FG001|Overall Study|Physician Decision|0|||
125623979|NCT03846219|451904824|FG002|Overall Study|Physician Decision|2|||
125623980|NCT01688635|451904825|FG000|Washout 1|Withdrawal by Subject|1|||
125623981|NCT01688635|451904826|FG001|Washout 1|Withdrawal by Subject|0|||
125623982|NCT01688635|451904825|FG000|Washout 1|Adverse Event|0|||
125623983|NCT01688635|451904826|FG001|Washout 1|Adverse Event|1|||
125623984|NCT01688635|451904825|FG000|Washout 1|Physician Decision|0|||
125623985|NCT01688635|451904826|FG001|Washout 1|Physician Decision|1|||
125623986|NCT01688635|451904825|FG000|Washout 2|Physician Decision|1|||
125623987|NCT01688635|451904826|FG001|Washout 2|Physician Decision|0|||
125623988|NCT01688635|451904825|FG000|Washout 2|Withdrawal by Subject|1|||
125623989|NCT01688635|451904826|FG001|Washout 2|Withdrawal by Subject|0|||
125623990|NCT01688635|451904825|FG000|Washout 2|Sponsor Decision|1|||
125623991|NCT01688635|451904826|FG001|Washout 2|Sponsor Decision|2|||
125623992|NCT01688635|451904825|FG000|Washout 3|Withdrawal by Subject|1|||
125623993|NCT01688635|451904826|FG001|Washout 3|Withdrawal by Subject|0|||
125623994|NCT00888615|451904827|FG000|Overall Study|No treatment|2|||
125623995|NCT03862131|451904828|FG000|Overall Study|Lost to Follow-up|1|||
125623996|NCT03862131|451904829|FG001|Overall Study|Lost to Follow-up|0|||
125623997|NCT03862131|451904830|FG002|Overall Study|Lost to Follow-up|1|||
125623998|NCT03862131|451904828|FG000|Overall Study|Determined to be ineligible|0|||
125623999|NCT03862131|451904829|FG001|Overall Study|Determined to be ineligible|0|||
125624000|NCT03862131|451904830|FG002|Overall Study|Determined to be ineligible|5|||
125624001|NCT03862131|451904828|FG000|Overall Study|Death|4|||
125624002|NCT03862131|451904829|FG001|Overall Study|Death|4|||
125624003|NCT03862131|451904830|FG002|Overall Study|Death|0|||
125624004|NCT03862131|451904828|FG000|Overall Study|Withdrawal by Subject|5|||
125624005|NCT03862131|451904829|FG001|Overall Study|Withdrawal by Subject|3|||
125624006|NCT03862131|451904830|FG002|Overall Study|Withdrawal by Subject|0|||
125624007|NCT03862131|451904828|FG000|Overall Study|Physician Decision|0|||
125624008|NCT03862131|451904829|FG001|Overall Study|Physician Decision|1|||
125624009|NCT03862131|451904830|FG002|Overall Study|Physician Decision|0|||
125624010|NCT02293902|451904831|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
125624011|NCT02293902|451904832|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
125624012|NCT02293902|451904833|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
125624013|NCT02293902|451904834|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
125624014|NCT02293902|451904835|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
125624015|NCT02293902|451904831|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
125624016|NCT02293902|451904832|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
125624017|NCT02293902|451904833|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
125624018|NCT02293902|451904834|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
125624019|NCT02293902|451904835|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
125624020|NCT02293902|451904831|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
125624021|NCT02293902|451904832|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
125624022|NCT02293902|451904833|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
125624023|NCT02293902|451904834|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
125624024|NCT02293902|451904835|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
125624025|NCT02293902|451904831|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
125624026|NCT02293902|451904832|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
125624027|NCT02293902|451904833|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
125624028|NCT02293902|451904834|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
125624029|NCT02293902|451904835|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
125624030|NCT02293902|451904831|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
125624031|NCT02293902|451904832|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
125624032|NCT02293902|451904833|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
125624033|NCT02293902|451904834|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
125624034|NCT02293902|451904835|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
125624035|NCT02947022|451904836|FG000|Overall Study|Study Stopped|1|||
125624036|NCT01770145|451906342|FG000|Baseline|Adverse Event|20|||
125624037|NCT01770145|451906342|FG000|Baseline|Withdrawal by Subject|1|||
125624038|NCT01770145|451906342|FG000|Baseline|Lost to Follow-up|1|||
125624039|NCT01770145|451906342|FG000|Baseline|Unable to define optimal dose|4|||
125624040|NCT01770145|451906342|FG000|Treatment|Adverse Event|3|||
125624041|NCT01770145|451906342|FG000|Treatment|Withdrawal by Subject|1|||
125624042|NCT04671342|451906346|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
125624043|NCT04671342|451906346|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
125624044|NCT04671342|451906346|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
125624045|NCT04671342|451906346|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
125624046|NCT04671342|451906346|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
125624047|NCT04671342|451906346|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
125624048|NCT03351478|451906349|FG000|Overall Study|At the subject's own request|11|||
125624049|NCT03351478|451906350|FG001|Overall Study|At the subject's own request|12|||
125624050|NCT03351478|451906351|FG002|Overall Study|At the subject's own request|5|||
125624051|NCT03351478|451906349|FG000|Overall Study|Adverse Event|1|||
125624052|NCT03351478|451906350|FG001|Overall Study|Adverse Event|2|||
125624053|NCT03351478|451906351|FG002|Overall Study|Adverse Event|1|||
125624054|NCT03351478|451906349|FG000|Overall Study|Poor compliance to protocol|1|||
125624055|NCT03351478|451906350|FG001|Overall Study|Poor compliance to protocol|0|||
125624056|NCT03351478|451906351|FG002|Overall Study|Poor compliance to protocol|0|||
125624057|NCT03351478|451906349|FG000|Overall Study|Reason not Specified|1|||
125624058|NCT03351478|451906350|FG001|Overall Study|Reason not Specified|3|||
125624059|NCT03351478|451906351|FG002|Overall Study|Reason not Specified|0|||
125624060|NCT03351478|451906349|FG000|Overall Study|Lost to Follow-up|0|||
125624061|NCT03351478|451906350|FG001|Overall Study|Lost to Follow-up|0|||
125624062|NCT03351478|451906351|FG002|Overall Study|Lost to Follow-up|1|||
125624063|NCT00510484|451906352|FG000|Wash-out Period|Adverse Event|0|||
125624064|NCT00510484|451906353|FG001|Wash-out Period|Adverse Event|1|||
125624065|NCT00762268|451906356|FG000|Overall Study|Withdrawal by Subject|3|||
125624066|NCT00762268|451906357|FG001|Overall Study|Withdrawal by Subject|3|||
125624067|NCT02533401|451906360|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
125624068|NCT02533401|451906360|FG000|Overall Study|Death|5|||
125624069|NCT02533401|451906360|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
125624070|NCT02533401|451906360|FG000|Overall Study|Lost to Follow-up|1|||
125624071|NCT02533401|451906360|FG000|Overall Study|Violation of Selection Criteria|1|||
125624072|NCT00973622|451906361|FG000|Overall Study|did not attend MRI|14|||
125624073|NCT00973622|451906362|FG001|Overall Study|did not attend MRI|3|||
125624074|NCT00973622|451906361|FG000|Overall Study|did not pass MRI screen|6|||
125624075|NCT00973622|451906362|FG001|Overall Study|did not pass MRI screen|0|||
125624076|NCT00973622|451906361|FG000|Overall Study|did not complete rTMS sessions|11|||
125624077|NCT00973622|451906362|FG001|Overall Study|did not complete rTMS sessions|2|||
125624078|NCT00493467|451906363|FG000|Overall Study|Death|1|||
125624079|NCT03395223|451906366|FG000|Overall Study|Lost to Follow-up|3|||
125624080|NCT03395223|451906366|FG000|Overall Study|Other|1|||
125624081|NCT01855945|451906369|FG000|Overall Study|Adverse Event|0|||
125624082|NCT01855945|451906370|FG001|Overall Study|Adverse Event|0|||
125624083|NCT01855945|451906371|FG002|Overall Study|Adverse Event|0|||
125624084|NCT01855945|451906372|FG003|Overall Study|Adverse Event|0|||
125624085|NCT01855945|451906373|FG004|Overall Study|Adverse Event|0|||
125624086|NCT01855945|451906374|FG005|Overall Study|Adverse Event|0|||
125624087|NCT01855945|451906375|FG006|Overall Study|Adverse Event|1|||
125624088|NCT01855945|451906376|FG007|Overall Study|Adverse Event|0|||
125624089|NCT01855945|451906377|FG008|Overall Study|Adverse Event|0|||
125624090|NCT01855945|451906378|FG009|Overall Study|Adverse Event|0|||
125624091|NCT01855945|451906379|FG010|Overall Study|Adverse Event|0|||
125624092|NCT01855945|451906380|FG011|Overall Study|Adverse Event|0|||
125624093|NCT01855945|451906369|FG000|Overall Study|Death|0|||
125624094|NCT01855945|451906370|FG001|Overall Study|Death|0|||
125624095|NCT01855945|451906371|FG002|Overall Study|Death|0|||
125624096|NCT01855945|451906372|FG003|Overall Study|Death|0|||
125624097|NCT01855945|451906373|FG004|Overall Study|Death|0|||
125624098|NCT01855945|451906374|FG005|Overall Study|Death|0|||
125624099|NCT01855945|451906375|FG006|Overall Study|Death|2|||
125624100|NCT01855945|451906376|FG007|Overall Study|Death|0|||
125624101|NCT01855945|451906377|FG008|Overall Study|Death|0|||
125624102|NCT01855945|451906378|FG009|Overall Study|Death|0|||
125624103|NCT01855945|451906379|FG010|Overall Study|Death|0|||
125624104|NCT01855945|451906380|FG011|Overall Study|Death|0|||
125624105|NCT01855945|451906369|FG000|Overall Study|Lost to Follow-up|11|||
125624106|NCT01855945|451906370|FG001|Overall Study|Lost to Follow-up|10|||
125624107|NCT01855945|451906371|FG002|Overall Study|Lost to Follow-up|7|||
125624108|NCT01855945|451906372|FG003|Overall Study|Lost to Follow-up|3|||
125624109|NCT01855945|451906373|FG004|Overall Study|Lost to Follow-up|0|||
125624110|NCT01855945|451906374|FG005|Overall Study|Lost to Follow-up|3|||
125624111|NCT01855945|451906375|FG006|Overall Study|Lost to Follow-up|4|||
125624112|NCT01855945|451906376|FG007|Overall Study|Lost to Follow-up|7|||
125624113|NCT01855945|451906377|FG008|Overall Study|Lost to Follow-up|2|||
125624114|NCT01855945|451906378|FG009|Overall Study|Lost to Follow-up|0|||
125624115|NCT01855945|451906379|FG010|Overall Study|Lost to Follow-up|0|||
125624116|NCT01855945|451906380|FG011|Overall Study|Lost to Follow-up|2|||
125215301|NCT02559570|450414978|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125215302|NCT02559570|450414979|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125215303|NCT02559570|450414980|FG002|Overall Study|Other Miscellaneous Reasons|1|||
125215304|NCT02559570|450414981|FG003|Overall Study|Other Miscellaneous Reasons|0|||
125215305|NCT02559570|450414982|FG004|Overall Study|Other Miscellaneous Reasons|0|||
125215306|NCT00524680|450414988|FG000|Overall Study|progression|0|||
125215307|NCT00524680|450414989|FG001|Overall Study|progression|0|||
125215308|NCT00524680|450414990|FG002|Overall Study|progression|0|||
125215309|NCT00524680|450414991|FG003|Overall Study|progression|1|||
125215310|NCT00524680|450414988|FG000|Overall Study|Adverse Event|2|||
125215311|NCT00524680|450414989|FG001|Overall Study|Adverse Event|0|||
125215312|NCT00524680|450414990|FG002|Overall Study|Adverse Event|0|||
125624117|NCT01855945|451906369|FG000|Overall Study|Other - Unclassified|1|||
125215313|NCT00524680|450414991|FG003|Overall Study|Adverse Event|1|||
125624118|NCT01855945|451906370|FG001|Overall Study|Other - Unclassified|1|||
125624119|NCT01855945|451906371|FG002|Overall Study|Other - Unclassified|1|||
125215314|NCT00524680|450414988|FG000|Overall Study|Other|0|||
125215315|NCT00524680|450414989|FG001|Overall Study|Other|1|||
125624120|NCT01855945|451906372|FG003|Overall Study|Other - Unclassified|0|||
125624121|NCT01855945|451906373|FG004|Overall Study|Other - Unclassified|0|||
125624122|NCT01855945|451906374|FG005|Overall Study|Other - Unclassified|0|||
125624123|NCT01855945|451906375|FG006|Overall Study|Other - Unclassified|2|||
125624124|NCT01855945|451906376|FG007|Overall Study|Other - Unclassified|1|||
125624125|NCT01855945|451906377|FG008|Overall Study|Other - Unclassified|0|||
125624126|NCT01855945|451906378|FG009|Overall Study|Other - Unclassified|0|||
125624127|NCT01855945|451906379|FG010|Overall Study|Other - Unclassified|1|||
125374547|NCT01218204|451002244|FG001|Part B Washout|Adverse Event|1|||
125374548|NCT01218204|451002245|FG002|Part B Washout|Adverse Event|0|||
125374549|NCT01218204|451002246|FG003|Part B Washout|Adverse Event|0|||
125374550|NCT01218204|451002243|FG000|Part B Washout|Lost to Follow-up|0|||
125374551|NCT01218204|451002244|FG001|Part B Washout|Lost to Follow-up|2|||
125374552|NCT01218204|451002245|FG002|Part B Washout|Lost to Follow-up|0|||
125374553|NCT01218204|451002246|FG003|Part B Washout|Lost to Follow-up|0|||
125374554|NCT01218204|451002243|FG000|Part B Washout|Physician Decision|0|||
125624128|NCT01855945|451906380|FG011|Overall Study|Other - Unclassified|0|||
125624129|NCT01855945|451906369|FG000|Overall Study|Withdrawal by Subject|4|||
125624130|NCT01855945|451906370|FG001|Overall Study|Withdrawal by Subject|0|||
125624131|NCT01855945|451906371|FG002|Overall Study|Withdrawal by Subject|4|||
125624132|NCT01855945|451906372|FG003|Overall Study|Withdrawal by Subject|1|||
125624133|NCT01855945|451906373|FG004|Overall Study|Withdrawal by Subject|1|||
125624134|NCT01855945|451906374|FG005|Overall Study|Withdrawal by Subject|0|||
125624135|NCT01855945|451906375|FG006|Overall Study|Withdrawal by Subject|1|||
125624136|NCT01855945|451906376|FG007|Overall Study|Withdrawal by Subject|0|||
125624137|NCT01855945|451906377|FG008|Overall Study|Withdrawal by Subject|0|||
125624138|NCT01855945|451906378|FG009|Overall Study|Withdrawal by Subject|2|||
125624139|NCT01855945|451906379|FG010|Overall Study|Withdrawal by Subject|4|||
125624140|NCT01855945|451906380|FG011|Overall Study|Withdrawal by Subject|1|||
125624141|NCT01148693|451906381|FG000|Overall Study|Attempts for cannulation were failed|13|||
125624142|NCT01148693|451906382|FG001|Overall Study|Attempts for cannulation were failed|10|||
125624143|NCT03228394|451906383|FG000|Overall Study|Lost to Follow-up|0|||
125624144|NCT03228394|451906384|FG001|Overall Study|Lost to Follow-up|0|||
125624145|NCT03228394|451906385|FG002|Overall Study|Lost to Follow-up|1|||
125624146|NCT03228394|451906386|FG003|Overall Study|Lost to Follow-up|1|||
125624147|NCT03228394|451906387|FG004|Overall Study|Lost to Follow-up|0|||
125624148|NCT03228394|451906388|FG005|Overall Study|Lost to Follow-up|0|||
125624149|NCT03228394|451906389|FG006|Overall Study|Lost to Follow-up|2|||
125624150|NCT03228394|451906390|FG007|Overall Study|Lost to Follow-up|0|||
125624151|NCT03228394|451906383|FG000|Overall Study|Withdrawal by Subject|0|||
125624152|NCT03228394|451906384|FG001|Overall Study|Withdrawal by Subject|0|||
125624153|NCT03228394|451906385|FG002|Overall Study|Withdrawal by Subject|1|||
125624154|NCT03228394|451906386|FG003|Overall Study|Withdrawal by Subject|0|||
125624155|NCT03228394|451906387|FG004|Overall Study|Withdrawal by Subject|0|||
125624156|NCT03228394|451906388|FG005|Overall Study|Withdrawal by Subject|0|||
125624157|NCT03228394|451906389|FG006|Overall Study|Withdrawal by Subject|1|||
125374555|NCT01218204|451002244|FG001|Part B Washout|Physician Decision|14|||
125624158|NCT03228394|451906390|FG007|Overall Study|Withdrawal by Subject|3|||
125624159|NCT03228394|451906383|FG000|Overall Study|Protocol Violation|0|||
125624160|NCT03228394|451906384|FG001|Overall Study|Protocol Violation|0|||
125624161|NCT03228394|451906385|FG002|Overall Study|Protocol Violation|0|||
125624162|NCT03228394|451906386|FG003|Overall Study|Protocol Violation|1|||
125624163|NCT03228394|451906387|FG004|Overall Study|Protocol Violation|0|||
125624164|NCT03228394|451906388|FG005|Overall Study|Protocol Violation|0|||
125624165|NCT03228394|451906389|FG006|Overall Study|Protocol Violation|0|||
125624166|NCT03228394|451906390|FG007|Overall Study|Protocol Violation|0|||
125624167|NCT03228394|451906383|FG000|Overall Study|Physician Decision|0|||
125374556|NCT01218204|451002245|FG002|Part B Washout|Physician Decision|0|||
125374557|NCT01218204|451002246|FG003|Part B Washout|Physician Decision|0|||
125374558|NCT01218204|451002243|FG000|Part B Washout|Withdrawal by Subject|0|||
125374559|NCT01218204|451002244|FG001|Part B Washout|Withdrawal by Subject|14|||
125374560|NCT01218204|451002245|FG002|Part B Washout|Withdrawal by Subject|0|||
125374561|NCT01218204|451002246|FG003|Part B Washout|Withdrawal by Subject|0|||
125374562|NCT01218204|451002243|FG000|Part B Washout|Reached defined stopping criteria|0|||
125374563|NCT01218204|451002244|FG001|Part B Washout|Reached defined stopping criteria|2|||
125374564|NCT01218204|451002245|FG002|Part B Washout|Reached defined stopping criteria|0|||
125374565|NCT01218204|451002246|FG003|Part B Washout|Reached defined stopping criteria|0|||
125624168|NCT03228394|451906384|FG001|Overall Study|Physician Decision|0|||
125624169|NCT03228394|451906385|FG002|Overall Study|Physician Decision|0|||
125374566|NCT01218204|451002243|FG000|Part B Washout|Did not meet continuation criteria|0|||
125624170|NCT03228394|451906386|FG003|Overall Study|Physician Decision|0|||
125624171|NCT03228394|451906387|FG004|Overall Study|Physician Decision|0|||
125624172|NCT03228394|451906388|FG005|Overall Study|Physician Decision|0|||
125624173|NCT03228394|451906389|FG006|Overall Study|Physician Decision|1|||
125215316|NCT00524680|450414990|FG002|Overall Study|Other|2|||
125215317|NCT00524680|450414991|FG003|Overall Study|Other|3|||
125215318|NCT00524680|450414988|FG000|Overall Study|Withdrawal by Subject|1|||
125215319|NCT00524680|450414989|FG001|Overall Study|Withdrawal by Subject|0|||
125215320|NCT00524680|450414990|FG002|Overall Study|Withdrawal by Subject|1|||
125215321|NCT00524680|450414991|FG003|Overall Study|Withdrawal by Subject|1|||
125215322|NCT01607346|450414992|FG000|Overall Study|Adverse Event|3|||
125215323|NCT01098162|450414993|FG000|Overall Study|Adverse Event|37|||
125215324|NCT01098162|450414993|FG000|Overall Study|Lack of Efficacy|4|||
125215325|NCT01098162|450414993|FG000|Overall Study|Wish of Patient|7|||
125215326|NCT01098162|450414993|FG000|Overall Study|Lost to Follow-up|9|||
125215327|NCT01098162|450414993|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
125215328|NCT01098162|450414993|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
125215329|NCT01098162|450414993|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
125215330|NCT01098162|450414993|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
125215331|NCT01098162|450414993|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
125215332|NCT01098162|450414993|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
125215333|NCT01098162|450414993|FG000|Overall Study|Other Reason|1|||
125215334|NCT01098162|450414993|FG000|Overall Study|Reason Unknown|26|||
125215335|NCT00625183|450414994|FG000|Overall Study|Disease Progression|1|||
125215336|NCT01451554|450414995|FG000|Overall Study|Withdrawal by Subject|14|||
125215337|NCT01451554|450414996|FG001|Overall Study|Withdrawal by Subject|9|||
125215338|NCT01402986|450414997|FG000|Overall Study|Withdrawal by Subject|7|||
125215339|NCT01402986|450414998|FG001|Overall Study|Withdrawal by Subject|10|||
125215340|NCT01402986|450414999|FG002|Overall Study|Withdrawal by Subject|7|||
125215341|NCT01402986|450415000|FG003|Overall Study|Withdrawal by Subject|13|||
125215342|NCT01402986|450414997|FG000|Overall Study|Death|0|||
125215343|NCT01402986|450414998|FG001|Overall Study|Death|0|||
125215344|NCT01402986|450414999|FG002|Overall Study|Death|0|||
125215345|NCT01402986|450415000|FG003|Overall Study|Death|2|||
125215346|NCT01402986|450414997|FG000|Overall Study|Lost to Follow-up|0|||
125624174|NCT03228394|451906390|FG007|Overall Study|Physician Decision|0|||
125624175|NCT03228394|451906383|FG000|Overall Study|Noncompliance|0|||
125624176|NCT03228394|451906384|FG001|Overall Study|Noncompliance|0|||
125624177|NCT03228394|451906385|FG002|Overall Study|Noncompliance|0|||
125624178|NCT03228394|451906386|FG003|Overall Study|Noncompliance|0|||
125624179|NCT03228394|451906387|FG004|Overall Study|Noncompliance|0|||
125624180|NCT03228394|451906388|FG005|Overall Study|Noncompliance|0|||
125624181|NCT03228394|451906389|FG006|Overall Study|Noncompliance|1|||
125624182|NCT03228394|451906390|FG007|Overall Study|Noncompliance|0|||
125624183|NCT00432562|451906398|FG000|Overall Study|Death|3|||
125624184|NCT00432562|451906399|FG001|Overall Study|Death|0|||
125624185|NCT02693691|451906400|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
125624186|NCT02693691|451906400|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
125624187|NCT02693691|451906400|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
125624188|NCT02693691|451906400|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
125624189|NCT02693691|451906400|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
125624190|NCT02693691|451906400|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
125624191|NCT02693691|451906400|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
125624192|NCT01162304|451906404|FG000|Overall Study|Beck scale to high|11|||
125624193|NCT00844285|451906406|FG000|Overall Study|Other|0|||
125624194|NCT00844285|451906407|FG001|Overall Study|Other|1|||
125624195|NCT00844285|451906408|FG002|Overall Study|Other|0|||
125624196|NCT00844285|451906406|FG000|Overall Study|Other than specified|95|||
125624197|NCT00844285|451906407|FG001|Overall Study|Other than specified|129|||
125624198|NCT00844285|451906408|FG002|Overall Study|Other than specified|12|||
125624199|NCT00844285|451906406|FG000|Overall Study|Site closure|256|||
125624200|NCT00844285|451906407|FG001|Overall Study|Site closure|450|||
125624201|NCT00844285|451906408|FG002|Overall Study|Site closure|50|||
125624202|NCT00844285|451906406|FG000|Overall Study|Follow-up < 8 years|16|||
125624203|NCT00844285|451906407|FG001|Overall Study|Follow-up < 8 years|23|||
125624204|NCT00844285|451906408|FG002|Overall Study|Follow-up < 8 years|4|||
125624205|NCT00844285|451906406|FG000|Overall Study|Protocol Violation|26|||
125624206|NCT00844285|451906407|FG001|Overall Study|Protocol Violation|28|||
125215347|NCT01402986|450414998|FG001|Overall Study|Lost to Follow-up|0|||
125215348|NCT01402986|450414999|FG002|Overall Study|Lost to Follow-up|0|||
125215349|NCT01402986|450415000|FG003|Overall Study|Lost to Follow-up|1|||
125624207|NCT00844285|451906408|FG002|Overall Study|Protocol Violation|54|||
125624208|NCT00844285|451906406|FG000|Overall Study|Death|22|||
125624209|NCT00844285|451906407|FG001|Overall Study|Death|21|||
125624210|NCT00844285|451906408|FG002|Overall Study|Death|8|||
125624211|NCT00844285|451906406|FG000|Overall Study|Withdrew Consent|344|||
125624212|NCT00844285|451906407|FG001|Overall Study|Withdrew Consent|466|||
125624213|NCT00844285|451906408|FG002|Overall Study|Withdrew Consent|70|||
125624214|NCT00844285|451906406|FG000|Overall Study|Lost to Follow-up|330|||
125624215|NCT00844285|451906407|FG001|Overall Study|Lost to Follow-up|486|||
125624216|NCT00844285|451906408|FG002|Overall Study|Lost to Follow-up|74|||
125624217|NCT00192036|451906409|FG000|Overall Study|Protocol Violation|3|||
125624218|NCT00192036|451906409|FG000|Overall Study|Adverse Event|6|||
125624219|NCT00192036|451906409|FG000|Overall Study|Patient/Physician Perception|1|||
125624220|NCT00192036|451906409|FG000|Overall Study|Objective Tumor Progression|4|||
125624221|NCT00192036|451906409|FG000|Overall Study|Clinical Disease Progression|1|||
125624222|NCT00192036|451906409|FG000|Overall Study|Death|1|||
125624223|NCT00192036|451906409|FG000|Overall Study|Unknown or Not Specified|5|||
125624224|NCT00862654|451906412|FG000|Overall Study|Lack of Efficacy|1|||
125624225|NCT00862654|451906413|FG001|Overall Study|Lack of Efficacy|0|||
125624226|NCT00862654|451906414|FG002|Overall Study|Lack of Efficacy|1|||
125624227|NCT00862654|451906415|FG003|Overall Study|Lack of Efficacy|0|||
125624228|NCT00862654|451906412|FG000|Overall Study|Lost to Follow-up|1|||
125624229|NCT00862654|451906413|FG001|Overall Study|Lost to Follow-up|2|||
125624230|NCT00862654|451906414|FG002|Overall Study|Lost to Follow-up|1|||
125624231|NCT00862654|451906415|FG003|Overall Study|Lost to Follow-up|3|||
125624232|NCT00862654|451906412|FG000|Overall Study|Adverse Event|0|||
125624233|NCT00862654|451906413|FG001|Overall Study|Adverse Event|1|||
125624234|NCT00862654|451906414|FG002|Overall Study|Adverse Event|1|||
125624235|NCT00862654|451906415|FG003|Overall Study|Adverse Event|0|||
125624236|NCT00862654|451906412|FG000|Overall Study|Pregnancy|1|||
125624237|NCT00862654|451906413|FG001|Overall Study|Pregnancy|1|||
125624238|NCT00862654|451906414|FG002|Overall Study|Pregnancy|0|||
125624239|NCT00862654|451906415|FG003|Overall Study|Pregnancy|0|||
125624240|NCT00862654|451906412|FG000|Overall Study|Withdrawal by Subject|2|||
125624241|NCT00862654|451906413|FG001|Overall Study|Withdrawal by Subject|2|||
125624242|NCT00862654|451906414|FG002|Overall Study|Withdrawal by Subject|2|||
125624243|NCT00862654|451906415|FG003|Overall Study|Withdrawal by Subject|3|||
125624244|NCT00862654|451906412|FG000|Overall Study|Subject mistake|0|||
125624245|NCT00862654|451906413|FG001|Overall Study|Subject mistake|1|||
125624246|NCT00862654|451906414|FG002|Overall Study|Subject mistake|0|||
125624247|NCT00862654|451906415|FG003|Overall Study|Subject mistake|0|||
125624248|NCT00862654|451906412|FG000|Overall Study|Familly constraint|0|||
125624249|NCT00862654|451906413|FG001|Overall Study|Familly constraint|1|||
125624250|NCT00862654|451906414|FG002|Overall Study|Familly constraint|0|||
125624251|NCT00862654|451906415|FG003|Overall Study|Familly constraint|0|||
125624252|NCT00862654|451906412|FG000|Overall Study|Never used study drugs|1|||
125624253|NCT00862654|451906413|FG001|Overall Study|Never used study drugs|0|||
125624254|NCT00862654|451906414|FG002|Overall Study|Never used study drugs|0|||
125624255|NCT00862654|451906415|FG003|Overall Study|Never used study drugs|0|||
125624256|NCT00862654|451906412|FG000|Overall Study|Included after end of inclusions|0|||
125624257|NCT00862654|451906413|FG001|Overall Study|Included after end of inclusions|0|||
125624258|NCT00862654|451906414|FG002|Overall Study|Included after end of inclusions|1|||
125624259|NCT00862654|451906415|FG003|Overall Study|Included after end of inclusions|0|||
125624260|NCT03219567|451906421|FG000|Overall Study|Withdrawal by Subject|0|||
125624261|NCT03219567|451906422|FG001|Overall Study|Withdrawal by Subject|1|||
125624262|NCT01654523|451906427|FG000|Overall Study|Withdrawal by Subject|1|||
125624263|NCT01313208|451906428|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
125624264|NCT01313208|451906429|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
125374567|NCT01218204|451002244|FG001|Part B Washout|Did not meet continuation criteria|112|||
125374568|NCT01218204|451002245|FG002|Part B Washout|Did not meet continuation criteria|0|||
125374569|NCT01218204|451002246|FG003|Part B Washout|Did not meet continuation criteria|0|||
125374570|NCT01218204|451002243|FG000|Part B Run-in|Adverse Event|0|||
125374571|NCT01218204|451002244|FG001|Part B Run-in|Adverse Event|0|||
125374572|NCT01218204|451002245|FG002|Part B Run-in|Adverse Event|1|||
125374573|NCT01218204|451002246|FG003|Part B Run-in|Adverse Event|0|||
125374574|NCT01218204|451002243|FG000|Part B Run-in|Protocol Violation|0|||
125374575|NCT01218204|451002244|FG001|Part B Run-in|Protocol Violation|0|||
125624265|NCT01313208|451906428|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
125624266|NCT01313208|451906429|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
125624267|NCT01313208|451906428|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
125624268|NCT01313208|451906429|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
125624269|NCT01313208|451906428|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
125624270|NCT01313208|451906429|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
125624271|NCT01313208|451906428|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
125624272|NCT01313208|451906429|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
125624273|NCT01313208|451906428|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
125624274|NCT01313208|451906429|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
125624275|NCT01313208|451906428|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
125624276|NCT01313208|451906429|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
125624277|NCT01313208|451906428|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
125624278|NCT01313208|451906429|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
125624279|NCT01313208|451906428|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
125624280|NCT01313208|451906429|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
125624281|NCT04377672|451906431|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
125624282|NCT03954444|451906432|FG000|Overall Study|Withdrawal by Subject|5|||
125624283|NCT03954444|451906433|FG001|Overall Study|Withdrawal by Subject|5|||
125624284|NCT03954444|451906434|FG002|Overall Study|Withdrawal by Subject|5|||
125624285|NCT03954444|451906432|FG000|Overall Study|Adverse Event|1|||
125624286|NCT03954444|451906433|FG001|Overall Study|Adverse Event|3|||
125624287|NCT03954444|451906434|FG002|Overall Study|Adverse Event|2|||
125624288|NCT03954444|451906432|FG000|Overall Study|Protocol Violation|0|||
125624289|NCT03954444|451906433|FG001|Overall Study|Protocol Violation|3|||
125624290|NCT03954444|451906434|FG002|Overall Study|Protocol Violation|5|||
125624291|NCT03954444|451906432|FG000|Overall Study|Use of prohibited therapy|1|||
125624292|NCT03954444|451906433|FG001|Overall Study|Use of prohibited therapy|1|||
125624293|NCT03954444|451906434|FG002|Overall Study|Use of prohibited therapy|2|||
125624294|NCT03954444|451906432|FG000|Overall Study|Lost to Follow-up|1|||
125624295|NCT03954444|451906433|FG001|Overall Study|Lost to Follow-up|0|||
125624296|NCT03954444|451906434|FG002|Overall Study|Lost to Follow-up|1|||
125624297|NCT03954444|451906432|FG000|Overall Study|Non-compliant with study drug application|2|||
125624298|NCT03954444|451906433|FG001|Overall Study|Non-compliant with study drug application|2|||
125624299|NCT03954444|451906434|FG002|Overall Study|Non-compliant with study drug application|0|||
125624300|NCT03954444|451906432|FG000|Overall Study|Administrative reasons|0|||
125624301|NCT03954444|451906433|FG001|Overall Study|Administrative reasons|0|||
125624302|NCT03954444|451906434|FG002|Overall Study|Administrative reasons|1|||
125624303|NCT03954444|451906432|FG000|Overall Study|Miscellaneous|3|||
125624304|NCT03954444|451906433|FG001|Overall Study|Miscellaneous|2|||
125624305|NCT03954444|451906434|FG002|Overall Study|Miscellaneous|1|||
125624306|NCT02447458|451906435|FG000|Overall Study|Other|0|||
125624307|NCT02447458|451906436|FG001|Overall Study|Other|0|||
125624308|NCT02447458|451906437|FG002|Overall Study|Other|1|||
125624309|NCT02447458|451906438|FG003|Overall Study|Other|0|||
125624310|NCT02447458|451906439|FG004|Overall Study|Other|0|||
125624311|NCT02447458|451906440|FG005|Overall Study|Other|0|||
125624312|NCT00405652|451906442|FG000|Overall Study|Adverse Event|4|||
125624313|NCT02133742|451906443|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
125624314|NCT02133742|451906443|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
125624315|NCT02133742|451906443|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
125624316|NCT02133742|451906443|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
125624317|NCT02133742|451906443|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
125624318|NCT00435994|451906444|FG000|Overall Study|Lost to Follow-up|7|||
125624319|NCT00435994|451906445|FG001|Overall Study|Lost to Follow-up|0|||
125433153|NCT00445679|451212450|FG003|Overall Study|Withdrawal of Informed Consent|0|||
125624320|NCT00435994|451906446|FG002|Overall Study|Lost to Follow-up|0|||
125624321|NCT02472795|451906450|FG000|Overall Study|Adverse Event|0|||
125624322|NCT02472795|451906451|FG001|Overall Study|Adverse Event|1|||
125624323|NCT02472795|451906452|FG002|Overall Study|Adverse Event|0|||
125624324|NCT02472795|451906453|FG003|Overall Study|Adverse Event|0|||
125624325|NCT02472795|451906454|FG004|Overall Study|Adverse Event|2|||
125624326|NCT02472795|451906450|FG000|Overall Study|Withdrawal by Subject|0|||
125624327|NCT02472795|451906451|FG001|Overall Study|Withdrawal by Subject|0|||
125624328|NCT02472795|451906452|FG002|Overall Study|Withdrawal by Subject|0|||
125624329|NCT02472795|451906453|FG003|Overall Study|Withdrawal by Subject|0|||
125624330|NCT02472795|451906454|FG004|Overall Study|Withdrawal by Subject|1|||
125624331|NCT05109702|451906455|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
125624332|NCT05109702|451906456|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
125374576|NCT01218204|451002245|FG002|Part B Run-in|Protocol Violation|2|||
125374577|NCT01218204|451002246|FG003|Part B Run-in|Protocol Violation|0|||
125374578|NCT01218204|451002243|FG000|Part B Run-in|Withdrawal by Subject|0|||
125374579|NCT01218204|451002244|FG001|Part B Run-in|Withdrawal by Subject|0|||
125624333|NCT05109702|451906457|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
125624334|NCT05109702|451906455|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
125624335|NCT05109702|451906456|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
125624336|NCT05109702|451906457|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
125624337|NCT05109702|451906455|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
125624338|NCT05109702|451906456|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
125624339|NCT05109702|451906457|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
125624340|NCT05109702|451906455|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
125624341|NCT05109702|451906456|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
125624342|NCT05109702|451906457|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
125624343|NCT05109702|451906455|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
125624344|NCT05109702|451906456|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
125624345|NCT05109702|451906457|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
125624346|NCT01392378|451906462|FG000|Infant Series|Adverse Event|0|||
125624347|NCT01392378|451906463|FG001|Infant Series|Adverse Event|0|||
125624348|NCT01392378|451906464|FG002|Infant Series|Adverse Event|0|||
125624349|NCT01392378|451906465|FG003|Infant Series|Adverse Event|1|||
125624350|NCT01392378|451906466|FG004|Infant Series|Adverse Event|0|||
125624351|NCT01392378|451906462|FG000|Infant Series|Lost to Follow-up|0|||
125624352|NCT01392378|451906463|FG001|Infant Series|Lost to Follow-up|0|||
125624353|NCT01392378|451906464|FG002|Infant Series|Lost to Follow-up|0|||
125624354|NCT01392378|451906465|FG003|Infant Series|Lost to Follow-up|1|||
125624355|NCT01392378|451906466|FG004|Infant Series|Lost to Follow-up|0|||
125624356|NCT01392378|451906462|FG000|Infant Series|Protocol Violation|0|||
125624357|NCT01392378|451906463|FG001|Infant Series|Protocol Violation|1|||
125624358|NCT01392378|451906464|FG002|Infant Series|Protocol Violation|0|||
125624359|NCT01392378|451906465|FG003|Infant Series|Protocol Violation|0|||
125624360|NCT01392378|451906466|FG004|Infant Series|Protocol Violation|0|||
125624361|NCT01392378|451906462|FG000|Infant Series|Withdrawal by Parent|4|||
125624362|NCT01392378|451906463|FG001|Infant Series|Withdrawal by Parent|1|||
125624363|NCT01392378|451906464|FG002|Infant Series|Withdrawal by Parent|0|||
125624364|NCT01392378|451906465|FG003|Infant Series|Withdrawal by Parent|0|||
125624365|NCT01392378|451906466|FG004|Infant Series|Withdrawal by Parent|0|||
125624366|NCT01392378|451906462|FG000|After Infant Series|Lost to Follow-up|0|||
125624367|NCT01392378|451906463|FG001|After Infant Series|Lost to Follow-up|0|||
125624368|NCT01392378|451906464|FG002|After Infant Series|Lost to Follow-up|1|||
125624369|NCT01392378|451906465|FG003|After Infant Series|Lost to Follow-up|0|||
125624370|NCT01392378|451906466|FG004|After Infant Series|Lost to Follow-up|0|||
125624371|NCT01392378|451906462|FG000|After Infant Series|Withdrawal by Parent|0|||
125624372|NCT01392378|451906463|FG001|After Infant Series|Withdrawal by Parent|1|||
125624373|NCT01392378|451906464|FG002|After Infant Series|Withdrawal by Parent|1|||
125624374|NCT01392378|451906465|FG003|After Infant Series|Withdrawal by Parent|0|||
125624375|NCT01392378|451906466|FG004|After Infant Series|Withdrawal by Parent|1|||
125624376|NCT01392378|451906462|FG000|Toddler Dose|Lost to Follow-up|0|||
125624377|NCT01392378|451906463|FG001|Toddler Dose|Lost to Follow-up|0|||
125624378|NCT01392378|451906464|FG002|Toddler Dose|Lost to Follow-up|0|||
125624379|NCT01392378|451906465|FG003|Toddler Dose|Lost to Follow-up|1|||
125624380|NCT01392378|451906466|FG004|Toddler Dose|Lost to Follow-up|0|||
125624381|NCT01392378|451906462|FG000|Toddler Dose|Withdrawal by Parent|0|||
125374580|NCT01218204|451002245|FG002|Part B Run-in|Withdrawal by Subject|3|||
125374581|NCT01218204|451002246|FG003|Part B Run-in|Withdrawal by Subject|0|||
125624382|NCT01392378|451906463|FG001|Toddler Dose|Withdrawal by Parent|1|||
125624383|NCT01392378|451906464|FG002|Toddler Dose|Withdrawal by Parent|0|||
125624384|NCT01392378|451906465|FG003|Toddler Dose|Withdrawal by Parent|1|||
125624385|NCT01392378|451906466|FG004|Toddler Dose|Withdrawal by Parent|1|||
125624386|NCT02322411|451906467|FG000|Overall Study|Lost to Follow-up|4|||
125624387|NCT02322411|451906468|FG001|Overall Study|Lost to Follow-up|7|||
125624388|NCT02322411|451906467|FG000|Overall Study|Withdrawal by Subject|1|||
125624389|NCT02322411|451906468|FG001|Overall Study|Withdrawal by Subject|0|||
125624390|NCT02261883|451906474|FG000|Overall Study|Death|3|||
125624391|NCT02261883|451906475|FG001|Overall Study|Death|2|||
125374582|NCT01218204|451002243|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
125374583|NCT01218204|451002244|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
125374584|NCT01218204|451002245|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
125374585|NCT01218204|451002246|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
125374586|NCT01218204|451002243|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
125374587|NCT01218204|451002244|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
125374588|NCT01218204|451002245|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
125374589|NCT01218204|451002246|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
125374590|NCT00127660|451002247|FG000|Overall Study|Protocol Violation|3|||
125374591|NCT00127660|451002248|FG001|Overall Study|Protocol Violation|3|||
125374592|NCT00127660|451002249|FG002|Overall Study|Protocol Violation|5|||
125374593|NCT00127660|451002250|FG003|Overall Study|Protocol Violation|0|||
125374594|NCT05147350|451002251|FG000|Overall Study|Death|2|||
125374595|NCT05147350|451002252|FG001|Overall Study|Death|3|||
125374596|NCT05147350|451002253|FG002|Overall Study|Death|3|||
125374597|NCT05147350|451002254|FG003|Overall Study|Death|2|||
125374598|NCT05147350|451002255|FG004|Overall Study|Death|2|||
125374599|NCT05147350|451002256|FG005|Overall Study|Death|1|||
125374600|NCT05147350|451002257|FG006|Overall Study|Death|1|||
125374601|NCT05147350|451002258|FG007|Overall Study|Death|3|||
125374602|NCT05147350|451002251|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
125374603|NCT05147350|451002252|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
125374604|NCT05147350|451002253|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
125374605|NCT05147350|451002254|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
125374606|NCT05147350|451002255|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
125374607|NCT05147350|451002256|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
125374608|NCT05147350|451002257|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
125374609|NCT05147350|451002258|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
125374610|NCT05147350|451002251|FG000|Overall Study|Withdrawal by Subject|0|||
125374611|NCT05147350|451002252|FG001|Overall Study|Withdrawal by Subject|0|||
125374612|NCT05147350|451002253|FG002|Overall Study|Withdrawal by Subject|3|||
125374613|NCT05147350|451002254|FG003|Overall Study|Withdrawal by Subject|1|||
125374614|NCT05147350|451002255|FG004|Overall Study|Withdrawal by Subject|1|||
125374615|NCT05147350|451002256|FG005|Overall Study|Withdrawal by Subject|0|||
125374616|NCT05147350|451002257|FG006|Overall Study|Withdrawal by Subject|1|||
125374617|NCT05147350|451002258|FG007|Overall Study|Withdrawal by Subject|0|||
125374618|NCT05147350|451002251|FG000|Overall Study|Other Reasons|0|||
125374619|NCT05147350|451002252|FG001|Overall Study|Other Reasons|0|||
125374620|NCT05147350|451002253|FG002|Overall Study|Other Reasons|2|||
125374621|NCT05147350|451002254|FG003|Overall Study|Other Reasons|0|||
125374622|NCT05147350|451002255|FG004|Overall Study|Other Reasons|0|||
125374623|NCT05147350|451002256|FG005|Overall Study|Other Reasons|2|||
125374624|NCT05147350|451002257|FG006|Overall Study|Other Reasons|1|||
125374625|NCT05147350|451002258|FG007|Overall Study|Other Reasons|1|||
125374626|NCT02627144|451002262|FG000|Overall Study|Serious adverse event|32|||
125374627|NCT02627144|451002262|FG000|Overall Study|Cancer progression|171|||
125374628|NCT02627144|451002262|FG000|Overall Study|Death from cancer|20|||
125374629|NCT02627144|451002262|FG000|Overall Study|Death from other cause|8|||
125374630|NCT02627144|451002262|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
125374631|NCT02627144|451002262|FG000|Overall Study|Administrative reasons|65|||
125374632|NCT02627144|451002262|FG000|Overall Study|Lost to Follow-up|8|||
125374633|NCT02627144|451002262|FG000|Overall Study|Enrolled, not treated|6|||
125374634|NCT02627144|451002262|FG000|Overall Study|Other|17|||
125374635|NCT00420927|451002265|FG000|Period 1|Adverse Event|19|||
125374636|NCT00420927|451002266|FG001|Period 1|Adverse Event|15|||
125374637|NCT00420927|451002267|FG002|Period 1|Adverse Event|0|||
125374638|NCT00420927|451002268|FG003|Period 1|Adverse Event|0|||
125374639|NCT00420927|451002269|FG004|Period 1|Adverse Event|0|||
125374640|NCT00420927|451002270|FG005|Period 1|Adverse Event|0|||
125374641|NCT00420927|451002271|FG006|Period 1|Adverse Event|0|||
125374642|NCT00420927|451002265|FG000|Period 1|Withdrawal by Subject|7|||
125374643|NCT00420927|451002266|FG001|Period 1|Withdrawal by Subject|12|||
125624392|NCT02261883|451906474|FG000|Overall Study|Physician Decision|1|||
125624393|NCT02261883|451906475|FG001|Overall Study|Physician Decision|0|||
125624394|NCT02261883|451906474|FG000|Overall Study|Protocol Violation|1|||
125624395|NCT02261883|451906475|FG001|Overall Study|Protocol Violation|0|||
125624396|NCT02261883|451906474|FG000|Overall Study|Withdrawal by Subject|0|||
125624397|NCT02261883|451906475|FG001|Overall Study|Withdrawal by Subject|1|||
125374644|NCT00420927|451002267|FG002|Period 1|Withdrawal by Subject|0|||
125624398|NCT02261883|451906474|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
125374645|NCT00420927|451002268|FG003|Period 1|Withdrawal by Subject|0|||
125374646|NCT00420927|451002269|FG004|Period 1|Withdrawal by Subject|0|||
125374647|NCT00420927|451002270|FG005|Period 1|Withdrawal by Subject|0|||
125374648|NCT00420927|451002271|FG006|Period 1|Withdrawal by Subject|0|||
125374649|NCT00420927|451002265|FG000|Period 1|Lost to Follow-up|8|||
125433154|NCT00445679|451212447|FG000|Overall Study|Protocol Violation|2|||
125624399|NCT02261883|451906475|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
125374650|NCT00420927|451002266|FG001|Period 1|Lost to Follow-up|6|||
125624400|NCT03549117|451906480|FG000|Overall Study|Withdrawal by Subject|1|||
125624401|NCT03549117|451906481|FG001|Overall Study|Withdrawal by Subject|0|||
125624402|NCT00367432|451906482|FG000|First Period (16 Weeks)|Adverse Event|6|||
125624403|NCT00367432|451906483|FG001|First Period (16 Weeks)|Adverse Event|0|||
125624404|NCT00367432|451906482|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
125624405|NCT00367432|451906483|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
125624406|NCT00367432|451906482|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
125624407|NCT00367432|451906483|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
125624408|NCT00367432|451906482|FG000|First Period (16 Weeks)|Other Reason|2|||
125624409|NCT00367432|451906483|FG001|First Period (16 Weeks)|Other Reason|0|||
125624410|NCT00367432|451906482|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
125624411|NCT00367432|451906483|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
125624412|NCT00367432|451906482|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
125624413|NCT00367432|451906483|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
125624414|NCT00367432|451906482|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
125624415|NCT00367432|451906483|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
125624416|NCT00367432|451906482|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
125624417|NCT00367432|451906483|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
125624418|NCT00367432|451906482|FG000|Second Period (up to 54 Months)|Other Reason|6|||
125624419|NCT00367432|451906483|FG001|Second Period (up to 54 Months)|Other Reason|2|||
125624420|NCT00903370|451906484|FG000|Overall Study|Death|13|||
125624421|NCT00903370|451906485|FG001|Overall Study|Death|10|||
125624422|NCT00903370|451906484|FG000|Overall Study|Withdrawal by Subject|9|||
125624423|NCT00903370|451906485|FG001|Overall Study|Withdrawal by Subject|6|||
125624424|NCT00903370|451906484|FG000|Overall Study|Lost to Follow-up|6|||
125624425|NCT00903370|451906485|FG001|Overall Study|Lost to Follow-up|8|||
125624426|NCT00014911|451906486|FG000|Overall Study|Adverse Event|1|||
125624427|NCT00014911|451906486|FG000|Overall Study|Lost to Follow-up|1|||
125624428|NCT00014911|451906486|FG000|Overall Study|Withdrawal by Subject|6|||
125624429|NCT00014911|451906486|FG000|Overall Study|Unknown Reasons|2|||
125624430|NCT00014911|451906486|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
125624431|NCT01924299|451906487|FG000|Period 2|Withdrawal by Subject|1|||
125624432|NCT01924299|451906488|FG001|Period 2|Withdrawal by Subject|0|||
125624433|NCT01924299|451906487|FG000|Period 2|Adverse Event|0|||
125624434|NCT01924299|451906488|FG001|Period 2|Adverse Event|1|||
125624435|NCT01999946|451906493|FG000|Overall Study|Participant not released from jail|2|||
125624436|NCT01999946|451906494|FG001|Overall Study|Participant not released from jail|2|||
125624437|NCT01999946|451906495|FG002|Overall Study|Participant not released from jail|0|||
125624438|NCT01999946|451906493|FG000|Overall Study|Not included in primary outcome analysis|0|||
125624439|NCT01999946|451906494|FG001|Overall Study|Not included in primary outcome analysis|0|||
125624440|NCT01999946|451906495|FG002|Overall Study|Not included in primary outcome analysis|79|||
125624441|NCT04021706|451908671|FG000|Overall Study|Adverse Event|2|||
125624442|NCT04021706|451908672|FG001|Overall Study|Adverse Event|0|||
125624443|NCT04021706|451908671|FG000|Overall Study|Withdrawal by Subject|1|||
125624444|NCT04021706|451908672|FG001|Overall Study|Withdrawal by Subject|2|||
125624445|NCT04021706|451908671|FG000|Overall Study|Physician Decision|1|||
125624446|NCT04021706|451908672|FG001|Overall Study|Physician Decision|0|||
125624447|NCT00355134|451908675|FG000|Core Phase|Withdrawal by Subject|35|||
125624448|NCT00355134|451908676|FG001|Core Phase|Withdrawal by Subject|24|||
125624449|NCT00355134|451908677|FG002|Core Phase|Withdrawal by Subject|35|||
125624450|NCT00355134|451908678|FG003|Core Phase|Withdrawal by Subject|0|||
125215350|NCT01402986|450414997|FG000|Overall Study|Other|2|||
125624451|NCT00355134|451908679|FG004|Core Phase|Withdrawal by Subject|0|||
125624452|NCT00355134|451908675|FG000|Core Phase|Adverse Event|28|||
125624453|NCT00355134|451908676|FG001|Core Phase|Adverse Event|22|||
125624454|NCT00355134|451908677|FG002|Core Phase|Adverse Event|16|||
125624455|NCT00355134|451908678|FG003|Core Phase|Adverse Event|0|||
125624456|NCT00355134|451908679|FG004|Core Phase|Adverse Event|0|||
125624457|NCT00355134|451908675|FG000|Core Phase|Lost to Follow-up|17|||
125624458|NCT00355134|451908676|FG001|Core Phase|Lost to Follow-up|13|||
125624459|NCT00355134|451908677|FG002|Core Phase|Lost to Follow-up|21|||
125624460|NCT00355134|451908678|FG003|Core Phase|Lost to Follow-up|0|||
125624461|NCT00355134|451908679|FG004|Core Phase|Lost to Follow-up|0|||
125624462|NCT00355134|451908675|FG000|Core Phase|Abnormal laboratory value(s)|19|||
125624463|NCT00355134|451908676|FG001|Core Phase|Abnormal laboratory value(s)|14|||
125624464|NCT00355134|451908677|FG002|Core Phase|Abnormal laboratory value(s)|2|||
125624465|NCT00355134|451908678|FG003|Core Phase|Abnormal laboratory value(s)|0|||
125624466|NCT00355134|451908679|FG004|Core Phase|Abnormal laboratory value(s)|0|||
125624467|NCT00355134|451908675|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
125624468|NCT00355134|451908676|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
125624469|NCT00355134|451908677|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
125624470|NCT00355134|451908678|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
125624471|NCT00355134|451908679|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
125624472|NCT00355134|451908675|FG000|Core Phase|Administrative problems|5|||
125624473|NCT00355134|451908676|FG001|Core Phase|Administrative problems|3|||
125624474|NCT00355134|451908677|FG002|Core Phase|Administrative problems|5|||
125624475|NCT00355134|451908678|FG003|Core Phase|Administrative problems|0|||
125624476|NCT00355134|451908679|FG004|Core Phase|Administrative problems|0|||
125624477|NCT00355134|451908675|FG000|Core Phase|Protocol Violation|3|||
125624478|NCT00355134|451908676|FG001|Core Phase|Protocol Violation|2|||
125624479|NCT00355134|451908677|FG002|Core Phase|Protocol Violation|2|||
125624480|NCT00355134|451908678|FG003|Core Phase|Protocol Violation|0|||
125624481|NCT00355134|451908679|FG004|Core Phase|Protocol Violation|0|||
125624482|NCT00355134|451908675|FG000|Core Phase|Abnormal test procedure result(s)|1|||
125624483|NCT00355134|451908676|FG001|Core Phase|Abnormal test procedure result(s)|2|||
125624484|NCT00355134|451908677|FG002|Core Phase|Abnormal test procedure result(s)|1|||
125624485|NCT00355134|451908678|FG003|Core Phase|Abnormal test procedure result(s)|0|||
125624486|NCT00355134|451908679|FG004|Core Phase|Abnormal test procedure result(s)|0|||
125624487|NCT00355134|451908675|FG000|Core Phase|Condition no longer requires study drug|1|||
125215351|NCT01402986|450414998|FG001|Overall Study|Other|5|||
125624488|NCT00355134|451908676|FG001|Core Phase|Condition no longer requires study drug|0|||
125624489|NCT00355134|451908677|FG002|Core Phase|Condition no longer requires study drug|1|||
125624490|NCT00355134|451908678|FG003|Core Phase|Condition no longer requires study drug|0|||
125215352|NCT01402986|450414999|FG002|Overall Study|Other|1|||
125215353|NCT01402986|450415000|FG003|Overall Study|Other|6|||
125374651|NCT00420927|451002267|FG002|Period 1|Lost to Follow-up|0|||
125374652|NCT00420927|451002268|FG003|Period 1|Lost to Follow-up|0|||
125374653|NCT00420927|451002269|FG004|Period 1|Lost to Follow-up|0|||
125374654|NCT00420927|451002270|FG005|Period 1|Lost to Follow-up|0|||
125374655|NCT00420927|451002271|FG006|Period 1|Lost to Follow-up|0|||
125374656|NCT00420927|451002265|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
125374657|NCT00420927|451002266|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
125374658|NCT00420927|451002267|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
125374659|NCT00420927|451002268|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
125374660|NCT00420927|451002269|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
125374661|NCT00420927|451002270|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
125374662|NCT00420927|451002271|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
125374663|NCT00420927|451002265|FG000|Period 1|Death|2|||
125374664|NCT00420927|451002266|FG001|Period 1|Death|0|||
125374665|NCT00420927|451002267|FG002|Period 1|Death|0|||
125374666|NCT00420927|451002268|FG003|Period 1|Death|0|||
125374667|NCT00420927|451002269|FG004|Period 1|Death|0|||
125374668|NCT00420927|451002270|FG005|Period 1|Death|0|||
125374669|NCT00420927|451002271|FG006|Period 1|Death|0|||
125374670|NCT00420927|451002265|FG000|Period 1|Subject moved/relocated|0|||
125624491|NCT00355134|451908679|FG004|Core Phase|Condition no longer requires study drug|0|||
125624492|NCT00355134|451908675|FG000|Extension Phase|Withdrawal by Subject|7|||
125624493|NCT00355134|451908676|FG001|Extension Phase|Withdrawal by Subject|11|||
125624494|NCT00355134|451908677|FG002|Extension Phase|Withdrawal by Subject|0|||
125624495|NCT00355134|451908678|FG003|Extension Phase|Withdrawal by Subject|7|||
125624496|NCT00355134|451908679|FG004|Extension Phase|Withdrawal by Subject|5|||
125624497|NCT00355134|451908675|FG000|Extension Phase|Adverse Event|13|||
125624498|NCT00355134|451908676|FG001|Extension Phase|Adverse Event|9|||
125624499|NCT00355134|451908677|FG002|Extension Phase|Adverse Event|0|||
125624500|NCT00355134|451908678|FG003|Extension Phase|Adverse Event|3|||
125624501|NCT00355134|451908679|FG004|Extension Phase|Adverse Event|5|||
125624502|NCT00355134|451908675|FG000|Extension Phase|Lost to Follow-up|2|||
125624503|NCT00355134|451908676|FG001|Extension Phase|Lost to Follow-up|6|||
125624504|NCT00355134|451908677|FG002|Extension Phase|Lost to Follow-up|0|||
125624505|NCT00355134|451908678|FG003|Extension Phase|Lost to Follow-up|2|||
125624506|NCT00355134|451908679|FG004|Extension Phase|Lost to Follow-up|4|||
125624507|NCT00355134|451908675|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
125624508|NCT00355134|451908676|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
125624509|NCT00355134|451908677|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
125624510|NCT00355134|451908678|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
125624511|NCT00355134|451908679|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
125624512|NCT00355134|451908675|FG000|Extension Phase|Administrative problems|2|||
125624513|NCT00355134|451908676|FG001|Extension Phase|Administrative problems|4|||
125624514|NCT00355134|451908677|FG002|Extension Phase|Administrative problems|0|||
125624515|NCT00355134|451908678|FG003|Extension Phase|Administrative problems|1|||
125624516|NCT00355134|451908679|FG004|Extension Phase|Administrative problems|1|||
125374671|NCT00420927|451002266|FG001|Period 1|Subject moved/relocated|2|||
125374672|NCT00420927|451002267|FG002|Period 1|Subject moved/relocated|0|||
125624517|NCT00355134|451908675|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
125624518|NCT00355134|451908676|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
125215354|NCT01085084|450415001|FG000|Overall Study|Withdrawal by Subject|1|||
125624519|NCT00355134|451908677|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
125624520|NCT00355134|451908678|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
125624521|NCT00355134|451908679|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
125624522|NCT00355134|451908675|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
125624523|NCT00355134|451908676|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
125624524|NCT00355134|451908677|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
125374673|NCT00420927|451002268|FG003|Period 1|Subject moved/relocated|0|||
125374674|NCT00420927|451002269|FG004|Period 1|Subject moved/relocated|0|||
125374675|NCT00420927|451002270|FG005|Period 1|Subject moved/relocated|0|||
125374676|NCT00420927|451002271|FG006|Period 1|Subject moved/relocated|0|||
125374677|NCT00420927|451002265|FG000|Period 1|Noncompliant with study drug|1|||
125374678|NCT00420927|451002266|FG001|Period 1|Noncompliant with study drug|1|||
125374679|NCT00420927|451002267|FG002|Period 1|Noncompliant with study drug|0|||
125624525|NCT00355134|451908678|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
125624526|NCT00355134|451908679|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
125624527|NCT00355134|451908675|FG000|Extension Phase|Protocol Violation|0|||
125624528|NCT00355134|451908676|FG001|Extension Phase|Protocol Violation|0|||
125624529|NCT00355134|451908677|FG002|Extension Phase|Protocol Violation|0|||
125624530|NCT00355134|451908678|FG003|Extension Phase|Protocol Violation|1|||
125624531|NCT00355134|451908679|FG004|Extension Phase|Protocol Violation|0|||
125624532|NCT01412151|451908680|FG000|Week 0 - 306 - Treatment Period|Death|1|||
125624533|NCT01412151|451908680|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
125624534|NCT01412151|451908680|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
125624535|NCT01412151|451908680|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
125624536|NCT03127852|451908682|FG000|Overall Study|Withdrawal by Subject|4|||
125624537|NCT03127852|451908683|FG001|Overall Study|Withdrawal by Subject|1|||
125624538|NCT03127852|451908682|FG000|Overall Study|Death|1|||
125624539|NCT03127852|451908683|FG001|Overall Study|Death|1|||
125624540|NCT00859573|451908685|FG000|Overall Study|Withdrawal by Subject|4|||
125624541|NCT00859573|451908686|FG001|Overall Study|Withdrawal by Subject|1|||
125624542|NCT00859573|451908685|FG000|Overall Study|Physician Decision|1|||
125624543|NCT00859573|451908686|FG001|Overall Study|Physician Decision|1|||
125624544|NCT01544478|451908687|FG000|Overall Study|Adverse Event|1|||
125624545|NCT01544478|451908687|FG000|Overall Study|Death|1|||
125624546|NCT01544478|451908687|FG000|Overall Study|Lost to Follow-up|48|||
125624547|NCT01544478|451908687|FG000|Overall Study|Physician Decision|15|||
125624548|NCT01544478|451908687|FG000|Overall Study|Pregnancy|1|||
125624549|NCT01544478|451908687|FG000|Overall Study|Withdrawal by Subject|52|||
125624550|NCT02574481|451908688|FG000|Overall Study|Withdrawal by Subject|29|||
125624551|NCT02574481|451908689|FG001|Overall Study|Withdrawal by Subject|15|||
125624552|NCT02574481|451908690|FG002|Overall Study|Withdrawal by Subject|4|||
125624553|NCT02574481|451908691|FG003|Overall Study|Withdrawal by Subject|1|||
125624554|NCT02574481|451908688|FG000|Overall Study|Adverse Event|5|||
125624555|NCT02574481|451908689|FG001|Overall Study|Adverse Event|1|||
125624556|NCT02574481|451908690|FG002|Overall Study|Adverse Event|1|||
125624557|NCT02574481|451908691|FG003|Overall Study|Adverse Event|0|||
125624558|NCT02574481|451908688|FG000|Overall Study|Visit Missed|15|||
125624559|NCT02574481|451908689|FG001|Overall Study|Visit Missed|7|||
125624560|NCT02574481|451908690|FG002|Overall Study|Visit Missed|5|||
125624561|NCT02574481|451908691|FG003|Overall Study|Visit Missed|0|||
125624562|NCT02574481|451908688|FG000|Overall Study|Other|7|||
125624563|NCT02574481|451908689|FG001|Overall Study|Other|2|||
125624564|NCT02574481|451908690|FG002|Overall Study|Other|0|||
125624565|NCT02574481|451908691|FG003|Overall Study|Other|0|||
125624566|NCT02574481|451908688|FG000|Overall Study|Death|48|||
125624567|NCT02574481|451908689|FG001|Overall Study|Death|26|||
125624568|NCT02574481|451908690|FG002|Overall Study|Death|12|||
125624569|NCT02574481|451908691|FG003|Overall Study|Death|4|||
125624570|NCT02574481|451908688|FG000|Overall Study|Physician Decision|5|||
125624571|NCT02574481|451908689|FG001|Overall Study|Physician Decision|2|||
125624572|NCT02574481|451908690|FG002|Overall Study|Physician Decision|0|||
125624573|NCT02574481|451908691|FG003|Overall Study|Physician Decision|0|||
125624574|NCT02574481|451908688|FG000|Overall Study|Lost to Follow-up|5|||
125624575|NCT02574481|451908689|FG001|Overall Study|Lost to Follow-up|1|||
125624576|NCT02574481|451908690|FG002|Overall Study|Lost to Follow-up|3|||
125624577|NCT02574481|451908691|FG003|Overall Study|Lost to Follow-up|0|||
125374680|NCT00420927|451002268|FG003|Period 1|Noncompliant with study drug|0|||
125374681|NCT00420927|451002269|FG004|Period 1|Noncompliant with study drug|0|||
125374682|NCT00420927|451002270|FG005|Period 1|Noncompliant with study drug|0|||
125374683|NCT00420927|451002271|FG006|Period 1|Noncompliant with study drug|0|||
125374684|NCT00420927|451002265|FG000|Period 1|Randomization error|1|||
125374685|NCT00420927|451002266|FG001|Period 1|Randomization error|0|||
125374686|NCT00420927|451002267|FG002|Period 1|Randomization error|0|||
125374687|NCT00420927|451002268|FG003|Period 1|Randomization error|0|||
125374688|NCT00420927|451002269|FG004|Period 1|Randomization error|0|||
125374689|NCT00420927|451002270|FG005|Period 1|Randomization error|0|||
125374690|NCT00420927|451002271|FG006|Period 1|Randomization error|0|||
125374691|NCT00420927|451002265|FG000|Period 1|Suspected tuberculosis/positive test|1|||
125374692|NCT00420927|451002266|FG001|Period 1|Suspected tuberculosis/positive test|1|||
125374693|NCT00420927|451002267|FG002|Period 1|Suspected tuberculosis/positive test|0|||
125374694|NCT00420927|451002268|FG003|Period 1|Suspected tuberculosis/positive test|0|||
125374695|NCT00420927|451002269|FG004|Period 1|Suspected tuberculosis/positive test|0|||
125374696|NCT00420927|451002270|FG005|Period 1|Suspected tuberculosis/positive test|0|||
125374697|NCT00420927|451002271|FG006|Period 1|Suspected tuberculosis/positive test|0|||
125374698|NCT00420927|451002265|FG000|Period 1|Study site closure|0|||
125374699|NCT00420927|451002266|FG001|Period 1|Study site closure|1|||
125374700|NCT00420927|451002267|FG002|Period 1|Study site closure|0|||
125374701|NCT00420927|451002268|FG003|Period 1|Study site closure|0|||
125624578|NCT04134728|451908695|FG000|Overall Study|Adverse Event|3|||
125624579|NCT04134728|451908696|FG001|Overall Study|Adverse Event|2|||
125374702|NCT00420927|451002269|FG004|Period 1|Study site closure|0|||
125374703|NCT00420927|451002270|FG005|Period 1|Study site closure|0|||
125374704|NCT00420927|451002271|FG006|Period 1|Study site closure|0|||
125374705|NCT00420927|451002265|FG000|Period 1|Subject received new diagnosis|0|||
125374706|NCT00420927|451002266|FG001|Period 1|Subject received new diagnosis|2|||
125374707|NCT00420927|451002267|FG002|Period 1|Subject received new diagnosis|0|||
125374708|NCT00420927|451002268|FG003|Period 1|Subject received new diagnosis|0|||
125624580|NCT04134728|451908697|FG002|Overall Study|Adverse Event|9|||
125374709|NCT00420927|451002269|FG004|Period 1|Subject received new diagnosis|0|||
125374710|NCT00420927|451002270|FG005|Period 1|Subject received new diagnosis|0|||
125374711|NCT00420927|451002271|FG006|Period 1|Subject received new diagnosis|0|||
125374712|NCT00420927|451002265|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
125215355|NCT01085084|450415002|FG001|Overall Study|Withdrawal by Subject|0|||
125215356|NCT01085084|450415003|FG002|Overall Study|Withdrawal by Subject|0|||
125215357|NCT01085084|450415001|FG000|Overall Study|Lost to Follow-up|2|||
125215358|NCT01085084|450415002|FG001|Overall Study|Lost to Follow-up|1|||
125215359|NCT01085084|450415003|FG002|Overall Study|Lost to Follow-up|1|||
125215360|NCT01085084|450415001|FG000|Overall Study|Adverse Event|4|||
125215361|NCT01085084|450415002|FG001|Overall Study|Adverse Event|3|||
125624581|NCT04134728|451908698|FG003|Overall Study|Adverse Event|0|||
125624582|NCT04134728|451908699|FG004|Overall Study|Adverse Event|0|||
125624583|NCT04134728|451908700|FG005|Overall Study|Adverse Event|0|||
125624584|NCT04134728|451908695|FG000|Overall Study|Lack of Efficacy|3|||
125624585|NCT04134728|451908696|FG001|Overall Study|Lack of Efficacy|3|||
125624586|NCT04134728|451908697|FG002|Overall Study|Lack of Efficacy|1|||
125624587|NCT04134728|451908698|FG003|Overall Study|Lack of Efficacy|2|||
125624588|NCT04134728|451908699|FG004|Overall Study|Lack of Efficacy|0|||
125624589|NCT04134728|451908700|FG005|Overall Study|Lack of Efficacy|0|||
125624590|NCT04134728|451908695|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
125624591|NCT04134728|451908696|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125624592|NCT04134728|451908697|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
125624593|NCT04134728|451908698|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125624594|NCT04134728|451908699|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125624595|NCT04134728|451908700|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125624596|NCT04134728|451908695|FG000|Overall Study|Protocol Deviation|0|||
125624597|NCT04134728|451908696|FG001|Overall Study|Protocol Deviation|0|||
125215362|NCT01085084|450415003|FG002|Overall Study|Adverse Event|6|||
125215363|NCT01085084|450415001|FG000|Overall Study|Treatment Failure|0|||
125215364|NCT01085084|450415002|FG001|Overall Study|Treatment Failure|1|||
125374713|NCT00420927|451002266|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
125215365|NCT01085084|450415003|FG002|Overall Study|Treatment Failure|2|||
125624598|NCT04134728|451908697|FG002|Overall Study|Protocol Deviation|1|||
125624599|NCT04134728|451908698|FG003|Overall Study|Protocol Deviation|0|||
125624600|NCT04134728|451908699|FG004|Overall Study|Protocol Deviation|0|||
125624601|NCT04134728|451908700|FG005|Overall Study|Protocol Deviation|0|||
125624602|NCT04134728|451908695|FG000|Overall Study|Informed Consent Withdrawn|3|||
125624603|NCT04134728|451908696|FG001|Overall Study|Informed Consent Withdrawn|6|||
125624604|NCT04134728|451908697|FG002|Overall Study|Informed Consent Withdrawn|8|||
125624605|NCT04134728|451908698|FG003|Overall Study|Informed Consent Withdrawn|1|||
125624606|NCT04134728|451908699|FG004|Overall Study|Informed Consent Withdrawn|1|||
125624607|NCT04134728|451908700|FG005|Overall Study|Informed Consent Withdrawn|0|||
125624608|NCT04134728|451908695|FG000|Overall Study|Physician Decision|2|||
125624609|NCT04134728|451908696|FG001|Overall Study|Physician Decision|0|||
125624610|NCT04134728|451908697|FG002|Overall Study|Physician Decision|0|||
125624611|NCT04134728|451908698|FG003|Overall Study|Physician Decision|0|||
125624612|NCT04134728|451908699|FG004|Overall Study|Physician Decision|0|||
125624613|NCT04134728|451908700|FG005|Overall Study|Physician Decision|0|||
125624614|NCT04134728|451908695|FG000|Overall Study|Lost to Follow-up|1|||
125433155|NCT00445679|451212448|FG001|Overall Study|Protocol Violation|3|||
125624615|NCT04134728|451908696|FG001|Overall Study|Lost to Follow-up|2|||
125624616|NCT04134728|451908697|FG002|Overall Study|Lost to Follow-up|1|||
125624617|NCT04134728|451908698|FG003|Overall Study|Lost to Follow-up|0|||
125624618|NCT04134728|451908699|FG004|Overall Study|Lost to Follow-up|0|||
125624619|NCT04134728|451908700|FG005|Overall Study|Lost to Follow-up|1|||
125624620|NCT04134728|451908695|FG000|Overall Study|Investigator Site Closed|0|||
125624621|NCT04134728|451908696|FG001|Overall Study|Investigator Site Closed|1|||
125624622|NCT04134728|451908697|FG002|Overall Study|Investigator Site Closed|1|||
125624623|NCT04134728|451908698|FG003|Overall Study|Investigator Site Closed|0|||
125624624|NCT04134728|451908699|FG004|Overall Study|Investigator Site Closed|0|||
125624625|NCT04134728|451908700|FG005|Overall Study|Investigator Site Closed|0|||
125624626|NCT03382262|451908701|FG000|Overall Study|Physician Decision|0|||
125215366|NCT02427802|450415004|FG000|Overall Study|Adverse Event|11|||
125215367|NCT02427802|450415005|FG001|Overall Study|Adverse Event|3|||
125215368|NCT02427802|450415006|FG002|Overall Study|Adverse Event|7|||
125215369|NCT02427802|450415004|FG000|Overall Study|Death|0|||
125215370|NCT02427802|450415005|FG001|Overall Study|Death|4|||
125215371|NCT02427802|450415006|FG002|Overall Study|Death|1|||
125215372|NCT02427802|450415004|FG000|Overall Study|Lost to Follow-up|13|||
125215373|NCT02427802|450415005|FG001|Overall Study|Lost to Follow-up|8|||
125215374|NCT02427802|450415006|FG002|Overall Study|Lost to Follow-up|8|||
125215375|NCT02427802|450415004|FG000|Overall Study|Physician Decision|4|||
125215376|NCT02427802|450415005|FG001|Overall Study|Physician Decision|2|||
125215377|NCT02427802|450415006|FG002|Overall Study|Physician Decision|4|||
125215378|NCT02427802|450415004|FG000|Overall Study|Withdrawal by Subject|10|||
125215379|NCT02427802|450415005|FG001|Overall Study|Withdrawal by Subject|5|||
125215380|NCT02427802|450415006|FG002|Overall Study|Withdrawal by Subject|11|||
125215381|NCT02427802|450415004|FG000|Overall Study|Protocol Violation|3|||
125215382|NCT02427802|450415005|FG001|Overall Study|Protocol Violation|1|||
125215383|NCT02427802|450415006|FG002|Overall Study|Protocol Violation|1|||
125215384|NCT02427802|450415004|FG000|Overall Study|protocol specific treatment unrelated|18|||
125215385|NCT02427802|450415005|FG001|Overall Study|protocol specific treatment unrelated|11|||
125215386|NCT02427802|450415006|FG002|Overall Study|protocol specific treatment unrelated|11|||
125215387|NCT02749799|450415007|FG000|Overall Study|Adverse Event|2|||
125215388|NCT02749799|450415007|FG000|Overall Study|Lost to Follow-up|4|||
125215389|NCT02749799|450415007|FG000|Overall Study|Protocol Violation|1|||
125215390|NCT02749799|450415007|FG000|Overall Study|Withdrawal by Subject|1|||
125215391|NCT02634983|450415008|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
125215392|NCT02634983|450415009|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
125215393|NCT02070978|450415010|FG000|Overall Study|Adverse Event|6|||
125374714|NCT00420927|451002267|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
125624627|NCT03382262|451908702|FG001|Overall Study|Physician Decision|0|||
125624628|NCT03382262|451908703|FG002|Overall Study|Physician Decision|1|||
125215394|NCT02070978|450415011|FG001|Overall Study|Adverse Event|2|||
125624629|NCT03382262|451908704|FG003|Overall Study|Physician Decision|0|||
125215395|NCT02070978|450415012|FG002|Overall Study|Adverse Event|0|||
125624630|NCT03382262|451908701|FG000|Overall Study|Withdrawal by Subject|0|||
125215396|NCT02070978|450415010|FG000|Overall Study|Lost to Follow-up|1|||
125215397|NCT02070978|450415011|FG001|Overall Study|Lost to Follow-up|3|||
125215398|NCT02070978|450415012|FG002|Overall Study|Lost to Follow-up|4|||
125624631|NCT03382262|451908702|FG001|Overall Study|Withdrawal by Subject|0|||
125624632|NCT03382262|451908703|FG002|Overall Study|Withdrawal by Subject|0|||
125624633|NCT03382262|451908704|FG003|Overall Study|Withdrawal by Subject|1|||
125624634|NCT02038790|451908706|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
125624635|NCT02038790|451908707|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
125624636|NCT00438464|451908715|FG000|Overall Study|Terminated Early|14|||
125624637|NCT00438464|451908716|FG001|Overall Study|Terminated Early|5|||
125624638|NCT00438464|451908715|FG000|Overall Study|Incomplete data submission|0|||
125624639|NCT00438464|451908716|FG001|Overall Study|Incomplete data submission|2|||
125624640|NCT03943446|451908718|FG000|Overall Study|Lost to Follow-up|0|||
125624641|NCT03943446|451908719|FG001|Overall Study|Lost to Follow-up|0|||
125624642|NCT03943446|451908720|FG002|Overall Study|Lost to Follow-up|1|||
125624643|NCT03943446|451908718|FG000|Overall Study|Withdrawal by Subject|1|||
125624644|NCT03943446|451908719|FG001|Overall Study|Withdrawal by Subject|1|||
125624645|NCT03943446|451908720|FG002|Overall Study|Withdrawal by Subject|2|||
125624646|NCT03943446|451908718|FG000|Overall Study|Study Terminated by Sponsor|1|||
125624647|NCT03943446|451908719|FG001|Overall Study|Study Terminated by Sponsor|2|||
125624648|NCT03943446|451908720|FG002|Overall Study|Study Terminated by Sponsor|1|||
125624649|NCT03943446|451908718|FG000|Overall Study|Reason not Specified|5|||
125624650|NCT03943446|451908719|FG001|Overall Study|Reason not Specified|1|||
125624651|NCT03943446|451908720|FG002|Overall Study|Reason not Specified|3|||
125624652|NCT02905825|451908727|FG000|Overall Study|Protocol Violation|11|||
125624653|NCT02905825|451908727|FG000|Overall Study|Device Malfunction|1|||
125624654|NCT01281189|451908728|FG000|Overall Study|Adverse Event|7|||
125624655|NCT01281189|451908729|FG001|Overall Study|Adverse Event|9|||
125624656|NCT01281189|451908728|FG000|Overall Study|Lost to Follow-up|6|||
125624657|NCT01281189|451908729|FG001|Overall Study|Lost to Follow-up|4|||
125624658|NCT01281189|451908728|FG000|Overall Study|Withdrawal by Subject|21|||
125624659|NCT01281189|451908729|FG001|Overall Study|Withdrawal by Subject|24|||
125624660|NCT01281189|451908728|FG000|Overall Study|Physician Decision|2|||
125624661|NCT01281189|451908729|FG001|Overall Study|Physician Decision|3|||
125624662|NCT01281189|451908728|FG000|Overall Study|Death|103|||
125624663|NCT01281189|451908729|FG001|Overall Study|Death|91|||
125624664|NCT01281189|451908728|FG000|Overall Study|Other|8|||
125624665|NCT01281189|451908729|FG001|Overall Study|Other|12|||
125624666|NCT05355818|451908730|FG000|Overall Study|Adverse Event|1|||
125624667|NCT05355818|451908731|FG001|Overall Study|Adverse Event|1|||
125624668|NCT05355818|451908730|FG000|Overall Study|Lack of Efficacy|2|||
125624669|NCT05355818|451908731|FG001|Overall Study|Lack of Efficacy|1|||
125624670|NCT05355818|451908730|FG000|Overall Study|Lost to Follow-up|0|||
125624671|NCT05355818|451908731|FG001|Overall Study|Lost to Follow-up|1|||
125624672|NCT01136746|451908736|FG000|Overall Study|Lost to Follow-up|0|||
125624673|NCT01136746|451908737|FG001|Overall Study|Lost to Follow-up|2|||
125624674|NCT01136746|451908736|FG000|Overall Study|Protocol Violation|2|||
125624675|NCT01136746|451908737|FG001|Overall Study|Protocol Violation|1|||
125374715|NCT00420927|451002268|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
125374716|NCT00420927|451002269|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
125624676|NCT01136746|451908736|FG000|Overall Study|Death|1|||
125624677|NCT01136746|451908737|FG001|Overall Study|Death|0|||
125624678|NCT00092677|451908742|FG000|Overall Study|Lost to Follow-up|0|||
125624679|NCT00092677|451908743|FG001|Overall Study|Lost to Follow-up|2|||
125624680|NCT00092677|451908742|FG000|Overall Study|Adminstrative|5|||
125624681|NCT00092677|451908743|FG001|Overall Study|Adminstrative|9|||
125624682|NCT01090102|451908744|FG000|First 12 Weeks|Withdrawal by Subject|1|||
125624683|NCT01090102|451908745|FG001|First 12 Weeks|Withdrawal by Subject|1|||
125624684|NCT01090102|451908744|FG000|First 12 Weeks|Adverse Event|2|||
125624685|NCT01090102|451908745|FG001|First 12 Weeks|Adverse Event|0|||
125624686|NCT01090102|451908744|FG000|First 12 Weeks|Death|1|||
125624687|NCT01090102|451908745|FG001|First 12 Weeks|Death|1|||
125624688|NCT01090102|451908744|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
125624689|NCT01090102|451908745|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
125624690|NCT01601704|451908746|FG000|Overall Study|Randomized but not dispensed study med|1|||
125374717|NCT00420927|451002270|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
125374718|NCT00420927|451002271|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
125374719|NCT00420927|451002265|FG000|Period 1|Failed to meet entry criteria|8|||
125374720|NCT00420927|451002266|FG001|Period 1|Failed to meet entry criteria|7|||
125374721|NCT00420927|451002267|FG002|Period 1|Failed to meet entry criteria|0|||
125374722|NCT00420927|451002268|FG003|Period 1|Failed to meet entry criteria|0|||
125374723|NCT00420927|451002269|FG004|Period 1|Failed to meet entry criteria|0|||
125374724|NCT00420927|451002270|FG005|Period 1|Failed to meet entry criteria|0|||
125374725|NCT00420927|451002271|FG006|Period 1|Failed to meet entry criteria|0|||
125374726|NCT00420927|451002265|FG000|Period 1|Took prohibited medication|1|||
125374727|NCT00420927|451002266|FG001|Period 1|Took prohibited medication|3|||
125374728|NCT00420927|451002267|FG002|Period 1|Took prohibited medication|0|||
125374729|NCT00420927|451002268|FG003|Period 1|Took prohibited medication|0|||
125374730|NCT00420927|451002269|FG004|Period 1|Took prohibited medication|0|||
125374731|NCT00420927|451002270|FG005|Period 1|Took prohibited medication|0|||
125374732|NCT00420927|451002271|FG006|Period 1|Took prohibited medication|0|||
125374733|NCT00420927|451002265|FG000|Period 2|Adverse Event|0|||
125374734|NCT00420927|451002266|FG001|Period 2|Adverse Event|0|||
125374735|NCT00420927|451002267|FG002|Period 2|Adverse Event|7|||
125374736|NCT00420927|451002268|FG003|Period 2|Adverse Event|3|||
125374737|NCT00420927|451002269|FG004|Period 2|Adverse Event|17|||
125374738|NCT00420927|451002270|FG005|Period 2|Adverse Event|6|||
125374739|NCT00420927|451002271|FG006|Period 2|Adverse Event|20|||
125374740|NCT00420927|451002265|FG000|Period 2|Withdrawal by Subject|0|||
125374741|NCT00420927|451002266|FG001|Period 2|Withdrawal by Subject|0|||
125374742|NCT00420927|451002267|FG002|Period 2|Withdrawal by Subject|1|||
125374743|NCT00420927|451002268|FG003|Period 2|Withdrawal by Subject|3|||
125374744|NCT00420927|451002269|FG004|Period 2|Withdrawal by Subject|11|||
125374745|NCT00420927|451002270|FG005|Period 2|Withdrawal by Subject|2|||
125374746|NCT00420927|451002271|FG006|Period 2|Withdrawal by Subject|12|||
125374747|NCT00420927|451002265|FG000|Period 2|Lost to Follow-up|0|||
125374748|NCT00420927|451002266|FG001|Period 2|Lost to Follow-up|0|||
125374749|NCT00420927|451002267|FG002|Period 2|Lost to Follow-up|2|||
125374750|NCT00420927|451002268|FG003|Period 2|Lost to Follow-up|2|||
125374751|NCT00420927|451002269|FG004|Period 2|Lost to Follow-up|6|||
125215399|NCT02070978|450415010|FG000|Overall Study|Withdrawal by Subject|3|||
125624691|NCT01601704|451908747|FG001|Overall Study|Randomized but not dispensed study med|4|||
125624692|NCT03518034|451908748|FG000|Overall Study|Not Treated|5|||
125624693|NCT03518034|451908749|FG001|Overall Study|Not Treated|1|||
125624694|NCT03518034|451908748|FG000|Overall Study|Withdrawal by Subject|309|||
125624695|NCT03518034|451908749|FG001|Overall Study|Withdrawal by Subject|351|||
125624696|NCT03518034|451908748|FG000|Overall Study|Lost to Follow-up|446|||
125624697|NCT03518034|451908749|FG001|Overall Study|Lost to Follow-up|458|||
125624698|NCT03518034|451908748|FG000|Overall Study|Adverse Event|138|||
125624699|NCT03518034|451908749|FG001|Overall Study|Adverse Event|130|||
125624700|NCT03518034|451908748|FG000|Overall Study|Lack of Efficacy|11|||
125624701|NCT03518034|451908749|FG001|Overall Study|Lack of Efficacy|23|||
125624702|NCT03518034|451908748|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
125624703|NCT03518034|451908749|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
125433156|NCT00445679|451212449|FG002|Overall Study|Protocol Violation|3|||
125433157|NCT00445679|451212450|FG003|Overall Study|Protocol Violation|1|||
125433158|NCT00445679|451212447|FG000|Overall Study|Withdrawal by Subject|8|||
125433159|NCT00445679|451212448|FG001|Overall Study|Withdrawal by Subject|14|||
125433160|NCT00445679|451212449|FG002|Overall Study|Withdrawal by Subject|20|||
125433161|NCT00445679|451212450|FG003|Overall Study|Withdrawal by Subject|18|||
125433162|NCT00445679|451212447|FG000|Overall Study|Lack of Efficacy|2|||
125624704|NCT03518034|451908748|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
125624705|NCT03518034|451908749|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
125624706|NCT03518034|451908748|FG000|Overall Study|Other, Not Specified|84|||
125624707|NCT03518034|451908749|FG001|Overall Study|Other, Not Specified|53|||
125433163|NCT00445679|451212448|FG001|Overall Study|Lack of Efficacy|6|||
125433164|NCT00445679|451212449|FG002|Overall Study|Lack of Efficacy|2|||
125433165|NCT00445679|451212450|FG003|Overall Study|Lack of Efficacy|0|||
125433166|NCT01353222|451212454|FG000|Overall Study|Death|30|||
125433167|NCT01353222|451212455|FG001|Overall Study|Death|30|||
125433168|NCT01353222|451212454|FG000|Overall Study|Withdrawal by Subject|8|||
125433169|NCT01353222|451212455|FG001|Overall Study|Withdrawal by Subject|5|||
125433170|NCT01353222|451212454|FG000|Overall Study|Study Terminated|31|||
125433171|NCT01353222|451212455|FG001|Overall Study|Study Terminated|37|||
125433172|NCT01353222|451212454|FG000|Overall Study|Site closed research department|1|||
125433173|NCT01353222|451212455|FG001|Overall Study|Site closed research department|0|||
125433174|NCT02636270|451212456|FG000|Overall Study|Adverse Event|1|||
125433175|NCT02636270|451212457|FG001|Overall Study|Adverse Event|0|||
125433176|NCT02636270|451212458|FG002|Overall Study|Adverse Event|0|||
125433177|NCT02636270|451212456|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
125433178|NCT02636270|451212457|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
125624708|NCT03518034|451908748|FG000|Overall Study|Reason Missing|2|||
125624709|NCT03518034|451908749|FG001|Overall Study|Reason Missing|3|||
125624710|NCT00010803|451908755|FG000|Overall Study|Withdrawal by Subject|97|||
125624711|NCT00010803|451908756|FG001|Overall Study|Withdrawal by Subject|98|||
125624712|NCT01019252|451908757|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
125215400|NCT02070978|450415011|FG001|Overall Study|Withdrawal by Subject|5|||
125624713|NCT01019252|451908758|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
125624714|NCT01019252|451908757|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
125624715|NCT01019252|451908758|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
125433179|NCT02636270|451212458|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
125624716|NCT01019252|451908757|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
125433180|NCT01119898|451212459|FG000|Overall Study|Adverse Event|4|||
125433181|NCT01119898|451212460|FG001|Overall Study|Adverse Event|5|||
125624717|NCT01019252|451908758|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
125624718|NCT01019252|451908757|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
125624719|NCT01019252|451908758|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
125624720|NCT02273037|451908759|FG000|Overall Study|Lost to Follow-up|1|||
125624721|NCT02273037|451908760|FG001|Overall Study|Lost to Follow-up|0|||
125624722|NCT02273037|451908759|FG000|Overall Study|Delivered before monitoring initiated|1|||
125624723|NCT02273037|451908760|FG001|Overall Study|Delivered before monitoring initiated|3|||
125624724|NCT02273037|451908759|FG000|Overall Study|Breech delivery|2|||
125624725|NCT02273037|451908760|FG001|Overall Study|Breech delivery|3|||
125624726|NCT02273037|451908759|FG000|Overall Study|Multiple delivery|2|||
125624727|NCT02273037|451908760|FG001|Overall Study|Multiple delivery|2|||
125624728|NCT02273037|451908759|FG000|Overall Study|Other complication|2|||
125624729|NCT02273037|451908760|FG001|Overall Study|Other complication|0|||
125624730|NCT00792701|451908767|FG000|Overall Study|Adverse Event|0|||
125624731|NCT00792701|451908768|FG001|Overall Study|Adverse Event|22|||
125624732|NCT00792701|451908767|FG000|Overall Study|Ineligible|1|||
125374752|NCT00420927|451002270|FG005|Period 2|Lost to Follow-up|3|||
125374753|NCT00420927|451002271|FG006|Period 2|Lost to Follow-up|9|||
125374754|NCT00420927|451002265|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
125374755|NCT00420927|451002266|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
125374756|NCT00420927|451002267|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
125374757|NCT00420927|451002268|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
125374758|NCT00420927|451002269|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
125374759|NCT00420927|451002270|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
125374760|NCT00420927|451002271|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
125374761|NCT00420927|451002265|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
125374762|NCT00420927|451002266|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
125374763|NCT00420927|451002267|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
125374764|NCT00420927|451002268|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
125374765|NCT00420927|451002269|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
125374766|NCT00420927|451002270|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
125374767|NCT00420927|451002271|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
125374768|NCT00420927|451002265|FG000|Period 2|Subject unable to find transportation|0|||
125374769|NCT00420927|451002266|FG001|Period 2|Subject unable to find transportation|0|||
125374770|NCT00420927|451002267|FG002|Period 2|Subject unable to find transportation|0|||
125374771|NCT00420927|451002268|FG003|Period 2|Subject unable to find transportation|0|||
125374772|NCT00420927|451002269|FG004|Period 2|Subject unable to find transportation|0|||
125374773|NCT00420927|451002270|FG005|Period 2|Subject unable to find transportation|0|||
125374774|NCT00420927|451002271|FG006|Period 2|Subject unable to find transportation|1|||
125374775|NCT00420927|451002265|FG000|Period 2|Physician Decision|0|||
125374776|NCT00420927|451002266|FG001|Period 2|Physician Decision|0|||
125374777|NCT00420927|451002267|FG002|Period 2|Physician Decision|0|||
125624733|NCT00792701|451908768|FG001|Overall Study|Ineligible|3|||
125624734|NCT00792701|451908767|FG000|Overall Study|Withdrawal by Subject|1|||
125624735|NCT00792701|451908768|FG001|Overall Study|Withdrawal by Subject|19|||
125624736|NCT00792701|451908767|FG000|Overall Study|Not protocol specified|17|||
125433182|NCT01119898|451212459|FG000|Overall Study|Withdrawal by Subject|1|||
125433183|NCT01119898|451212460|FG001|Overall Study|Withdrawal by Subject|4|||
125433184|NCT01119898|451212459|FG000|Overall Study|Lack of Efficacy|0|||
125433185|NCT01119898|451212460|FG001|Overall Study|Lack of Efficacy|2|||
125433186|NCT01119898|451212459|FG000|Overall Study|Protocol Violation|1|||
125433187|NCT01119898|451212460|FG001|Overall Study|Protocol Violation|1|||
125433188|NCT01119898|451212459|FG000|Overall Study|Medical procedure|1|||
125433189|NCT01119898|451212460|FG001|Overall Study|Medical procedure|0|||
125433190|NCT01119898|451212459|FG000|Overall Study|Randomized in error did not participate|1|||
125215401|NCT02070978|450415012|FG002|Overall Study|Withdrawal by Subject|3|||
125215402|NCT02070978|450415010|FG000|Overall Study|Protocol Violation|1|||
125215403|NCT02070978|450415011|FG001|Overall Study|Protocol Violation|0|||
125215404|NCT02070978|450415012|FG002|Overall Study|Protocol Violation|3|||
125433191|NCT01119898|451212460|FG001|Overall Study|Randomized in error did not participate|0|||
125433192|NCT01806584|451212461|FG000|Overall Study|Adverse Event|2|||
125433193|NCT01806584|451212462|FG001|Overall Study|Adverse Event|1|||
125215405|NCT02070978|450415010|FG000|Overall Study|Lack of Efficacy|0|||
125433194|NCT01806584|451212461|FG000|Overall Study|Death|1|||
125624737|NCT00792701|451908768|FG001|Overall Study|Not protocol specified|0|||
125624738|NCT03862495|451908774|FG000|Overall Study|Lost to Follow-up|37|||
125624739|NCT03862495|451908775|FG001|Overall Study|Lost to Follow-up|35|||
125624740|NCT01467661|451908776|FG000|Overall Study|Adverse Event|16|||
125624741|NCT01467661|451908776|FG000|Overall Study|Withdrawal by Subject|1|||
125624742|NCT01467661|451908776|FG000|Overall Study|Lack of Efficacy|3|||
125433195|NCT01806584|451212462|FG001|Overall Study|Death|0|||
125624743|NCT01467661|451908776|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
125624744|NCT03673956|451908777|FG000|Overall Study|Lost to Follow-up|1|||
125624745|NCT03673956|451908778|FG001|Overall Study|Lost to Follow-up|0|||
125624746|NCT03673956|451908779|FG002|Overall Study|Lost to Follow-up|0|||
125624747|NCT03673956|451908780|FG003|Overall Study|Lost to Follow-up|0|||
125624748|NCT03673956|451908777|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
125215406|NCT02070978|450415011|FG001|Overall Study|Lack of Efficacy|1|||
125215407|NCT02070978|450415012|FG002|Overall Study|Lack of Efficacy|0|||
125215408|NCT02070978|450415010|FG000|Overall Study|Death|0|||
125215409|NCT02070978|450415011|FG001|Overall Study|Death|0|||
125215410|NCT02070978|450415012|FG002|Overall Study|Death|2|||
125215411|NCT02070978|450415010|FG000|Overall Study|Un-specified|3|||
125215412|NCT02070978|450415011|FG001|Overall Study|Un-specified|2|||
125215413|NCT02070978|450415012|FG002|Overall Study|Un-specified|2|||
125215414|NCT02070978|450415010|FG000|Overall Study|Terminated by Sponsor|33|||
125215415|NCT02070978|450415011|FG001|Overall Study|Terminated by Sponsor|40|||
125215416|NCT02070978|450415012|FG002|Overall Study|Terminated by Sponsor|39|||
125215417|NCT03749109|450415013|FG000|Overall Study|Adverse Event|2|||
125215418|NCT03749109|450415014|FG001|Overall Study|Adverse Event|0|||
125215419|NCT03178851|450415015|FG000|Overall Study|Death|48|||
125215420|NCT03178851|450415016|FG001|Overall Study|Death|2|||
125215421|NCT03178851|450415017|FG002|Overall Study|Death|25|||
125215422|NCT03178851|450415015|FG000|Overall Study|Withdrawal by Subject|8|||
125215423|NCT03178851|450415016|FG001|Overall Study|Withdrawal by Subject|0|||
125215424|NCT03178851|450415017|FG002|Overall Study|Withdrawal by Subject|0|||
125215425|NCT03178851|450415015|FG000|Overall Study|Lost to Follow-up|5|||
125215426|NCT03178851|450415016|FG001|Overall Study|Lost to Follow-up|2|||
125215427|NCT03178851|450415017|FG002|Overall Study|Lost to Follow-up|0|||
125215428|NCT03178851|450415015|FG000|Overall Study|Adverse Event|0|||
125215429|NCT03178851|450415016|FG001|Overall Study|Adverse Event|0|||
125215430|NCT03178851|450415017|FG002|Overall Study|Adverse Event|1|||
125215431|NCT03178851|450415015|FG000|Overall Study|Study Termination by Sponsor|31|||
125215432|NCT03178851|450415016|FG001|Overall Study|Study Termination by Sponsor|7|||
125215433|NCT03178851|450415017|FG002|Overall Study|Study Termination by Sponsor|26|||
125215434|NCT03951753|450415018|FG000|Overall Study|Adverse Event|1|||
125215435|NCT03951753|450415019|FG001|Overall Study|Adverse Event|0|||
125624749|NCT03673956|451908778|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
125624750|NCT03673956|451908779|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
125624751|NCT03673956|451908780|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
125624752|NCT01074658|451908781|FG000|Overall Study|No implant attempted|19|||
125624753|NCT01342952|451908782|FG000|Overall Study|Adverse Event|0|||
125624754|NCT01342952|451908783|FG001|Overall Study|Adverse Event|5|||
125624755|NCT01342952|451908784|FG002|Overall Study|Adverse Event|1|||
125624756|NCT01342952|451908785|FG003|Overall Study|Adverse Event|0|||
125624757|NCT01342952|451908782|FG000|Overall Study|Lost to Follow-up|0|||
125374778|NCT00420927|451002268|FG003|Period 2|Physician Decision|0|||
125624758|NCT01342952|451908783|FG001|Overall Study|Lost to Follow-up|2|||
125624759|NCT01342952|451908784|FG002|Overall Study|Lost to Follow-up|0|||
125624760|NCT01342952|451908785|FG003|Overall Study|Lost to Follow-up|0|||
125624761|NCT01342952|451908782|FG000|Overall Study|Withdrawal by Subject|1|||
125624762|NCT01342952|451908783|FG001|Overall Study|Withdrawal by Subject|1|||
125624763|NCT01342952|451908784|FG002|Overall Study|Withdrawal by Subject|0|||
125374779|NCT00420927|451002269|FG004|Period 2|Physician Decision|1|||
125374780|NCT00420927|451002270|FG005|Period 2|Physician Decision|1|||
125215436|NCT03951753|450415020|FG002|Overall Study|Adverse Event|3|||
125215437|NCT03951753|450415018|FG000|Overall Study|Withdrawal by Subject|3|||
125215438|NCT03951753|450415019|FG001|Overall Study|Withdrawal by Subject|1|||
125374781|NCT00420927|451002271|FG006|Period 2|Physician Decision|0|||
125624764|NCT01342952|451908785|FG003|Overall Study|Withdrawal by Subject|0|||
125624765|NCT01342952|451908782|FG000|Overall Study|Physician Decision|3|||
125624766|NCT01342952|451908783|FG001|Overall Study|Physician Decision|3|||
125215439|NCT03951753|450415020|FG002|Overall Study|Withdrawal by Subject|0|||
125624767|NCT01342952|451908784|FG002|Overall Study|Physician Decision|1|||
125624768|NCT01342952|451908785|FG003|Overall Study|Physician Decision|0|||
125624769|NCT02156804|451908786|FG000|Overall Study|Withdrawal by Subject|1|||
125624770|NCT04581863|451908787|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
125624771|NCT04581863|451908788|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
125624772|NCT01803711|451908789|FG000|Overall Study|Adverse Event|1|||
125624773|NCT01803711|451908790|FG001|Overall Study|Adverse Event|1|||
125624774|NCT00636441|451908791|FG000|Overall Study|Adverse Event|0|||
125624775|NCT00636441|451908792|FG001|Overall Study|Adverse Event|1|||
125624776|NCT00636441|451908793|FG002|Overall Study|Adverse Event|1|||
125624777|NCT00636441|451908794|FG003|Overall Study|Adverse Event|0|||
125624778|NCT00636441|451908795|FG004|Overall Study|Adverse Event|0|||
125624779|NCT00636441|451908796|FG005|Overall Study|Adverse Event|1|||
125624780|NCT00636441|451908797|FG006|Overall Study|Adverse Event|0|||
125624781|NCT00636441|451908791|FG000|Overall Study|Late, ineligible|0|||
125624782|NCT00636441|451908792|FG001|Overall Study|Late, ineligible|0|||
125624783|NCT00636441|451908793|FG002|Overall Study|Late, ineligible|0|||
125624784|NCT00636441|451908794|FG003|Overall Study|Late, ineligible|0|||
125624785|NCT00636441|451908795|FG004|Overall Study|Late, ineligible|0|||
125624786|NCT00636441|451908796|FG005|Overall Study|Late, ineligible|0|||
125624787|NCT00636441|451908797|FG006|Overall Study|Late, ineligible|1|||
125624788|NCT00636441|451908791|FG000|Overall Study|Screen Failure|0|||
125624789|NCT00636441|451908792|FG001|Overall Study|Screen Failure|0|||
125624790|NCT00636441|451908793|FG002|Overall Study|Screen Failure|0|||
125624791|NCT00636441|451908794|FG003|Overall Study|Screen Failure|0|||
125433196|NCT01806584|451212461|FG000|Overall Study|Lost to Follow-up|0|||
125433197|NCT01806584|451212462|FG001|Overall Study|Lost to Follow-up|2|||
125433198|NCT01806584|451212461|FG000|Overall Study|Study terminated by sponsor|9|||
125624792|NCT00636441|451908795|FG004|Overall Study|Screen Failure|0|||
125624793|NCT00636441|451908796|FG005|Overall Study|Screen Failure|0|||
125624794|NCT00636441|451908797|FG006|Overall Study|Screen Failure|17|||
125624795|NCT03495817|451908802|FG000|26 Week Open Label|Adverse Event|3|||
125624796|NCT03495817|451908802|FG000|26 Week Open Label|Withdrawal by Subject|4|||
125624797|NCT03495817|451908802|FG000|26 Week Open Label|Lost to Follow-up|1|||
125624798|NCT03495817|451908802|FG000|26 Week Extension|Lost to Follow-up|2|||
125624799|NCT04585451|451908807|FG000|Overall Study|Withdrawal by Subject|26|||
125624800|NCT04585451|451908808|FG001|Overall Study|Withdrawal by Subject|0|||
125624801|NCT00326417|451908809|FG000|Overall Study|Withdrawal by Subject|0|||
125624802|NCT00326417|451908810|FG001|Overall Study|Withdrawal by Subject|0|||
125624803|NCT00326417|451908811|FG002|Overall Study|Withdrawal by Subject|1|||
125624804|NCT00326417|451908812|FG003|Overall Study|Withdrawal by Subject|0|||
125624805|NCT00326417|451908809|FG000|Overall Study|Arm Closed|7|||
125624806|NCT00326417|451908810|FG001|Overall Study|Arm Closed|0|||
125624807|NCT00326417|451908811|FG002|Overall Study|Arm Closed|0|||
125624808|NCT00326417|451908812|FG003|Overall Study|Arm Closed|3|||
125624809|NCT00326417|451908809|FG000|Overall Study|Death|7|||
125624810|NCT00326417|451908810|FG001|Overall Study|Death|0|||
125624811|NCT00326417|451908811|FG002|Overall Study|Death|0|||
125624812|NCT00326417|451908812|FG003|Overall Study|Death|0|||
125624813|NCT02849626|451908819|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
125624814|NCT02849626|451908820|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
125624815|NCT02849626|451908821|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
125624816|NCT02849626|451908822|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
125624817|NCT02849626|451908819|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
125624818|NCT02849626|451908820|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
125624819|NCT02849626|451908821|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
125624820|NCT02849626|451908822|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
125624821|NCT02849626|451908819|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
125624822|NCT02849626|451908820|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
125624823|NCT02849626|451908821|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
125624824|NCT02849626|451908822|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
125624825|NCT02849626|451908819|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
125624826|NCT02849626|451908820|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
125624827|NCT02849626|451908821|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
125624828|NCT02849626|451908822|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
125624829|NCT02849626|451908819|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
125624830|NCT02849626|451908820|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
125624831|NCT02849626|451908821|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
125215440|NCT03951753|450415018|FG000|Overall Study|Lost to Follow-up|0|||
125374782|NCT00420927|451002265|FG000|Period 2|Sponsor decision|0|||
125374783|NCT00420927|451002266|FG001|Period 2|Sponsor decision|0|||
125374784|NCT00420927|451002267|FG002|Period 2|Sponsor decision|1|||
125374785|NCT00420927|451002268|FG003|Period 2|Sponsor decision|0|||
125374786|NCT00420927|451002269|FG004|Period 2|Sponsor decision|0|||
125374787|NCT00420927|451002270|FG005|Period 2|Sponsor decision|0|||
125374788|NCT00420927|451002271|FG006|Period 2|Sponsor decision|1|||
125374789|NCT00420927|451002265|FG000|Period 2|Randomization error|0|||
125374790|NCT00420927|451002266|FG001|Period 2|Randomization error|0|||
125433199|NCT01806584|451212462|FG001|Overall Study|Study terminated by sponsor|14|||
125433200|NCT01806584|451212461|FG000|Overall Study|Withdrawal by Subject|1|||
125433201|NCT01806584|451212462|FG001|Overall Study|Withdrawal by Subject|1|||
125374791|NCT00420927|451002267|FG002|Period 2|Randomization error|0|||
125374792|NCT00420927|451002268|FG003|Period 2|Randomization error|0|||
125374793|NCT00420927|451002269|FG004|Period 2|Randomization error|1|||
125374794|NCT00420927|451002270|FG005|Period 2|Randomization error|1|||
125374795|NCT00420927|451002271|FG006|Period 2|Randomization error|0|||
125624832|NCT02849626|451908822|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
125624833|NCT02849626|451908819|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
125624834|NCT02849626|451908820|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
125433202|NCT01806584|451212461|FG000|Overall Study|Other unspecified|1|||
125215441|NCT03951753|450415019|FG001|Overall Study|Lost to Follow-up|0|||
125215442|NCT03951753|450415020|FG002|Overall Study|Lost to Follow-up|1|||
125215443|NCT02226120|450415023|FG000|Overall Study|Adverse Event|60|||
125215444|NCT02226120|450415023|FG000|Overall Study|Death|172|||
125215445|NCT02226120|450415023|FG000|Overall Study|Study terminated by sponsor|1|||
125215446|NCT02226120|450415023|FG000|Overall Study|Technical problems|4|||
125215447|NCT02226120|450415023|FG000|Overall Study|Lost to Follow-up|13|||
125215448|NCT02226120|450415023|FG000|Overall Study|Physician Decision|21|||
125215449|NCT02226120|450415023|FG000|Overall Study|Withdrawal by parent/guardian|36|||
125215450|NCT02226120|450415023|FG000|Overall Study|Non-compliance with study drug|10|||
125215451|NCT02226120|450415023|FG000|Overall Study|Protocol deviation|1|||
125215452|NCT02226120|450415023|FG000|Overall Study|missing treatment disposition pages|2|||
125215453|NCT02669043|450415024|FG000|Overall Study|Didn't meet I/E criteria|4|||
125215454|NCT01133704|450417377|FG000|Overall Study|Death|44|||
125215455|NCT01133704|450417378|FG001|Overall Study|Death|26|||
125215456|NCT01133704|450417377|FG000|Overall Study|Patient refused to continue|4|||
125215457|NCT01133704|450417378|FG001|Overall Study|Patient refused to continue|0|||
125215458|NCT01133704|450417377|FG000|Overall Study|Study Closure|1|||
125215459|NCT01133704|450417378|FG001|Overall Study|Study Closure|0|||
125215460|NCT04985942|450417381|FG000|Overall Study|Adverse Event|14|||
125215461|NCT04985942|450417382|FG001|Overall Study|Adverse Event|2|||
125215462|NCT04985942|450417381|FG000|Overall Study|Lack of Efficacy|0|||
125215463|NCT04985942|450417382|FG001|Overall Study|Lack of Efficacy|3|||
125215464|NCT04985942|450417381|FG000|Overall Study|Lost to Follow-up|1|||
125215465|NCT04985942|450417382|FG001|Overall Study|Lost to Follow-up|1|||
125215466|NCT04985942|450417381|FG000|Overall Study|Protocol Violation|1|||
125215467|NCT04985942|450417382|FG001|Overall Study|Protocol Violation|1|||
125215468|NCT04985942|450417381|FG000|Overall Study|Withdrawal by Subject|5|||
125215469|NCT04985942|450417382|FG001|Overall Study|Withdrawal by Subject|4|||
125215470|NCT02849704|450417384|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
125215471|NCT02849704|450417385|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
125215472|NCT02849704|450417384|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
125215473|NCT02849704|450417385|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
125215474|NCT02849704|450417384|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
125215475|NCT02849704|450417385|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
125215476|NCT01128400|450417388|FG000|Overall Study|Lost to Follow-up|1|||
125215477|NCT01128400|450417389|FG001|Overall Study|Lost to Follow-up|0|||
125215478|NCT01128400|450417390|FG002|Overall Study|Lost to Follow-up|1|||
125215479|NCT01128400|450417388|FG000|Overall Study|Screening failure|1|||
125215480|NCT01128400|450417389|FG001|Overall Study|Screening failure|0|||
125215481|NCT01128400|450417390|FG002|Overall Study|Screening failure|0|||
125215482|NCT01128400|450417388|FG000|Overall Study|were not invited to participate on taste|0|||
125215483|NCT01128400|450417389|FG001|Overall Study|were not invited to participate on taste|0|||
125215484|NCT01128400|450417390|FG002|Overall Study|were not invited to participate on taste|15|||
125215485|NCT01128400|450417388|FG000|Overall Study|Excluded due to sinus problems|0|||
125215486|NCT01128400|450417389|FG001|Overall Study|Excluded due to sinus problems|1|||
125215487|NCT01128400|450417390|FG002|Overall Study|Excluded due to sinus problems|0|||
125374796|NCT00420927|451002265|FG000|Period 2|Noncompliant with study drug|0|||
125374797|NCT00420927|451002266|FG001|Period 2|Noncompliant with study drug|0|||
125374798|NCT00420927|451002267|FG002|Period 2|Noncompliant with study drug|0|||
125374799|NCT00420927|451002268|FG003|Period 2|Noncompliant with study drug|1|||
125215488|NCT04076319|450417402|FG000|Overall Study|Withdrawal by Subject|2|||
125215489|NCT04076319|450417403|FG001|Overall Study|Withdrawal by Subject|0|||
125215490|NCT04076319|450417402|FG000|Overall Study|Death|1|||
125374800|NCT00420927|451002269|FG004|Period 2|Noncompliant with study drug|0|||
125374801|NCT00420927|451002270|FG005|Period 2|Noncompliant with study drug|0|||
125374802|NCT00420927|451002271|FG006|Period 2|Noncompliant with study drug|2|||
125374803|NCT00420927|451002265|FG000|Period 2|Methotrexate intolerance|0|||
125374804|NCT00420927|451002266|FG001|Period 2|Methotrexate intolerance|0|||
125374805|NCT00420927|451002267|FG002|Period 2|Methotrexate intolerance|0|||
125374806|NCT00420927|451002268|FG003|Period 2|Methotrexate intolerance|0|||
125127127|NCT04349917|450092173|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
125127128|NCT04349917|450092174|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
125127129|NCT04349917|450092173|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
125127130|NCT04349917|450092174|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
125127131|NCT00705536|450092175|FG000|Start Period 1|Withdrawal by Subject|0|||
125127132|NCT00705536|450092176|FG001|Start Period 1|Withdrawal by Subject|0|||
125127133|NCT00705536|450092177|FG002|Start Period 1|Withdrawal by Subject|0|||
125127134|NCT00705536|450092178|FG003|Start Period 1|Withdrawal by Subject|1|||
125127135|NCT04188106|450092179|FG000|Overall Study|Lost to Follow-up|5|||
125127136|NCT04188106|450092179|FG000|Overall Study|Non-Compliance|1|||
125127137|NCT00441467|450092180|FG000|Overall Study|Adverse Event|6|||
125127138|NCT00441467|450092180|FG000|Overall Study|Withdrawal by Subject|3|||
125374807|NCT00420927|451002269|FG004|Period 2|Methotrexate intolerance|0|||
125374808|NCT00420927|451002270|FG005|Period 2|Methotrexate intolerance|0|||
125374809|NCT00420927|451002271|FG006|Period 2|Methotrexate intolerance|1|||
125374810|NCT00420927|451002265|FG000|Period 2|Took prohibited medication|0|||
125374811|NCT00420927|451002266|FG001|Period 2|Took prohibited medication|0|||
125127139|NCT00441467|450092180|FG000|Overall Study|Progressive disease|9|||
125127140|NCT02289963|450092181|FG000|Overall Study|Adverse Event|1|||
125127141|NCT02289963|450092182|FG001|Overall Study|Adverse Event|2|||
125127142|NCT02289963|450092181|FG000|Overall Study|Poor compliance to protocol|1|||
125127143|NCT02289963|450092182|FG001|Overall Study|Poor compliance to protocol|0|||
125127144|NCT02289963|450092181|FG000|Overall Study|Withdrawal by Subject|1|||
125374812|NCT00420927|451002267|FG002|Period 2|Took prohibited medication|0|||
125127145|NCT02289963|450092182|FG001|Overall Study|Withdrawal by Subject|0|||
125127146|NCT02289963|450092181|FG000|Overall Study|Last injection missed|2|||
125127147|NCT02289963|450092182|FG001|Overall Study|Last injection missed|2|||
125374813|NCT00420927|451002268|FG003|Period 2|Took prohibited medication|0|||
125127148|NCT02289963|450092181|FG000|Overall Study|End treatment visit outside visit window|0|||
125127149|NCT02289963|450092182|FG001|Overall Study|End treatment visit outside visit window|4|||
125127150|NCT02289963|450092181|FG000|Overall Study|Other than specified above|0|||
125127151|NCT02289963|450092182|FG001|Overall Study|Other than specified above|2|||
125127152|NCT01042522|450092184|FG000|Overall Study|Adverse Event|1|||
125624835|NCT02849626|451908821|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
125624836|NCT02849626|451908822|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
125624837|NCT02849626|451908819|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
125624838|NCT02849626|451908820|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
125624839|NCT02849626|451908821|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
125624840|NCT02849626|451908822|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
125624841|NCT02849626|451908819|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
125624842|NCT02849626|451908820|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
125624843|NCT02849626|451908821|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
125624844|NCT02849626|451908822|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
125624845|NCT02849626|451908819|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
125624846|NCT02849626|451908820|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
125624847|NCT02849626|451908821|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
125624848|NCT02849626|451908822|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
125624849|NCT02849626|451908819|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
125624850|NCT02849626|451908820|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
125624851|NCT02849626|451908821|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
125624852|NCT02849626|451908822|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
125624853|NCT02849626|451908819|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
125624854|NCT02849626|451908820|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
125624855|NCT02849626|451908821|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
125624856|NCT02849626|451908822|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
125624857|NCT01957787|451908823|FG000|Overall Study|Death|18|||
125624858|NCT01957787|451908823|FG000|Overall Study|Lost to Follow-up|3|||
125624859|NCT01957787|451908823|FG000|Overall Study|Withdrawal by Subject|3|||
125624860|NCT01957787|451908823|FG000|Overall Study|Entered Hospice or Similar Program|2|||
125624861|NCT01957787|451908823|FG000|Overall Study|Index Tumor(s) Resected|2|||
125624862|NCT01957787|451908823|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
125624863|NCT01957787|451908823|FG000|Overall Study|Local therapy, not cryoablation|6|||
125624864|NCT04176445|451908824|FG000|Overall Study|Adverse Event|0|||
125624865|NCT04176445|451908825|FG001|Overall Study|Adverse Event|1|||
125127153|NCT01042522|450092185|FG001|Overall Study|Adverse Event|2|||
125127154|NCT01042522|450092184|FG000|Overall Study|Disease Progression|5|||
125127155|NCT01042522|450092185|FG001|Overall Study|Disease Progression|0|||
125127156|NCT01042522|450092184|FG000|Overall Study|Death|1|||
125127157|NCT01042522|450092185|FG001|Overall Study|Death|0|||
125127158|NCT01042522|450092184|FG000|Overall Study|Patient Refused|0|||
125127159|NCT01042522|450092185|FG001|Overall Study|Patient Refused|3|||
125127160|NCT01042522|450092184|FG000|Overall Study|Withdrawal by Subject|1|||
125127161|NCT01042522|450092185|FG001|Overall Study|Withdrawal by Subject|1|||
125127162|NCT00549718|450092186|FG000|Overall Study|Insufficient clinical response|20|||
125127163|NCT00549718|450092187|FG001|Overall Study|Insufficient clinical response|7|||
125127164|NCT00549718|450092188|FG002|Overall Study|Insufficient clinical response|18|||
125127165|NCT00549718|450092189|FG003|Overall Study|Insufficient clinical response|32|||
125127166|NCT00549718|450092186|FG000|Overall Study|Adverse Event|6|||
125127167|NCT00549718|450092187|FG001|Overall Study|Adverse Event|8|||
125127168|NCT00549718|450092188|FG002|Overall Study|Adverse Event|7|||
125127169|NCT00549718|450092189|FG003|Overall Study|Adverse Event|3|||
125127170|NCT00549718|450092186|FG000|Overall Study|Lost to Follow-up|4|||
125127171|NCT00549718|450092187|FG001|Overall Study|Lost to Follow-up|2|||
125127172|NCT00549718|450092188|FG002|Overall Study|Lost to Follow-up|0|||
125127173|NCT00549718|450092189|FG003|Overall Study|Lost to Follow-up|6|||
125127174|NCT00549718|450092186|FG000|Overall Study|Withdrawal by Subject|9|||
125127175|NCT00549718|450092187|FG001|Overall Study|Withdrawal by Subject|18|||
125127176|NCT00549718|450092188|FG002|Overall Study|Withdrawal by Subject|12|||
125127177|NCT00549718|450092189|FG003|Overall Study|Withdrawal by Subject|13|||
125127178|NCT00549718|450092186|FG000|Overall Study|Administrative|2|||
125624866|NCT04176445|451908824|FG000|Overall Study|change plans weaning after first intervention|0|||
125624867|NCT04176445|451908825|FG001|Overall Study|change plans weaning after first intervention|1|||
125624868|NCT02248857|451908826|FG000|3 Month|Withdrawal by Subject|9|||
125624869|NCT02248857|451908827|FG001|3 Month|Withdrawal by Subject|3|||
125624870|NCT02248857|451908828|FG002|3 Month|Withdrawal by Subject|4|||
125624871|NCT02248857|451908826|FG000|3 Month|Unable to reach for 3 month|35|||
125624872|NCT02248857|451908827|FG001|3 Month|Unable to reach for 3 month|29|||
125624873|NCT02248857|451908828|FG002|3 Month|Unable to reach for 3 month|26|||
125624874|NCT02248857|451908826|FG000|3 Month|Partially completed, unable to finish|2|||
125624875|NCT02248857|451908827|FG001|3 Month|Partially completed, unable to finish|2|||
125624876|NCT02248857|451908828|FG002|3 Month|Partially completed, unable to finish|1|||
125624877|NCT02248857|451908826|FG000|6 Month|Lost to Follow-up|27|||
125624878|NCT02248857|451908827|FG001|6 Month|Lost to Follow-up|26|||
125624879|NCT02248857|451908828|FG002|6 Month|Lost to Follow-up|15|||
125624880|NCT02248857|451908826|FG000|6 Month|Partially completed, unable to finish|0|||
125624881|NCT02248857|451908827|FG001|6 Month|Partially completed, unable to finish|1|||
125624882|NCT02248857|451908828|FG002|6 Month|Partially completed, unable to finish|0|||
125624883|NCT02248857|451908826|FG000|6 Month|Withdrawal by Subject|0|||
125624884|NCT02248857|451908827|FG001|6 Month|Withdrawal by Subject|2|||
125127179|NCT00549718|450092187|FG001|Overall Study|Administrative|2|||
125127180|NCT00549718|450092188|FG002|Overall Study|Administrative|2|||
125127181|NCT00549718|450092189|FG003|Overall Study|Administrative|1|||
125127182|NCT01507051|450092192|FG000|Overall Study|Withdrawal by Subject|1|||
125127183|NCT01507051|450092193|FG001|Overall Study|Withdrawal by Subject|3|||
125127184|NCT01507051|450092194|FG002|Overall Study|Withdrawal by Subject|1|||
125127185|NCT01507051|450092195|FG003|Overall Study|Withdrawal by Subject|6|||
125127186|NCT01507051|450092192|FG000|Overall Study|Physician Decision|0|||
125127187|NCT01507051|450092193|FG001|Overall Study|Physician Decision|0|||
125127188|NCT01507051|450092194|FG002|Overall Study|Physician Decision|0|||
125127189|NCT01507051|450092195|FG003|Overall Study|Physician Decision|1|||
125127190|NCT01507051|450092192|FG000|Overall Study|Adverse Event|1|||
125127191|NCT01507051|450092193|FG001|Overall Study|Adverse Event|0|||
125127192|NCT01507051|450092194|FG002|Overall Study|Adverse Event|0|||
125127193|NCT01507051|450092195|FG003|Overall Study|Adverse Event|0|||
125127194|NCT01675622|450092196|FG000|Overall Study|Withdrawal by Subject|2|||
125127195|NCT01675622|450092197|FG001|Overall Study|Withdrawal by Subject|2|||
125127196|NCT01675622|450092196|FG000|Overall Study|Adverse Event|12|||
125127197|NCT01675622|450092197|FG001|Overall Study|Adverse Event|10|||
125127198|NCT01675622|450092196|FG000|Overall Study|Protocol Violation|4|||
125127199|NCT01675622|450092197|FG001|Overall Study|Protocol Violation|1|||
125433203|NCT01806584|451212462|FG001|Overall Study|Other unspecified|0|||
125624885|NCT02248857|451908828|FG002|6 Month|Withdrawal by Subject|2|||
125624886|NCT02248857|451908826|FG000|6 Month|Death|1|||
125624887|NCT02248857|451908827|FG001|6 Month|Death|0|||
125624888|NCT02248857|451908828|FG002|6 Month|Death|0|||
125127200|NCT01675622|450092196|FG000|Overall Study|Lack of Efficacy|2|||
125127201|NCT01675622|450092197|FG001|Overall Study|Lack of Efficacy|4|||
125127202|NCT01675622|450092196|FG000|Overall Study|Lost to Follow-up|1|||
125127203|NCT01675622|450092197|FG001|Overall Study|Lost to Follow-up|3|||
125127204|NCT01675622|450092196|FG000|Overall Study|Other|5|||
125624889|NCT01412060|451908829|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
125624890|NCT01412060|451908830|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
125624891|NCT01412060|451908831|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
125127205|NCT01675622|450092197|FG001|Overall Study|Other|4|||
125127206|NCT04032977|450092198|FG000|Overall Study|Withdrawal by Subject|6|||
125127207|NCT04032977|450092199|FG001|Overall Study|Withdrawal by Subject|1|||
125127208|NCT04032977|450092198|FG000|Overall Study|Lost to Follow-up|2|||
125127209|NCT04032977|450092199|FG001|Overall Study|Lost to Follow-up|7|||
125127210|NCT04032977|450092198|FG000|Overall Study|Pregnancy|1|||
125127211|NCT04032977|450092199|FG001|Overall Study|Pregnancy|0|||
125127212|NCT02880761|450092200|FG000|Overall Study|Death|6|||
125127213|NCT02880761|450092201|FG001|Overall Study|Death|8|||
125127214|NCT02880761|450092200|FG000|Overall Study|Withdrawal by Subject|3|||
125127215|NCT02880761|450092201|FG001|Overall Study|Withdrawal by Subject|6|||
125127216|NCT02880761|450092200|FG000|Overall Study|Protocol Violation|4|||
125127217|NCT02880761|450092201|FG001|Overall Study|Protocol Violation|3|||
125127218|NCT02880761|450092200|FG000|Overall Study|Lost to Follow-up|3|||
125127219|NCT02880761|450092201|FG001|Overall Study|Lost to Follow-up|4|||
125127220|NCT03597256|450092202|FG000|Overall Study|Lost to Follow-up|3|||
125127221|NCT03597256|450092203|FG001|Overall Study|Lost to Follow-up|1|||
125127222|NCT03597256|450092202|FG000|Overall Study|Withdrawal by Subject|0|||
125127223|NCT03597256|450092203|FG001|Overall Study|Withdrawal by Subject|1|||
125127224|NCT03597256|450092202|FG000|Overall Study|Could not return for treatment|0|||
125127225|NCT03597256|450092203|FG001|Overall Study|Could not return for treatment|1|||
125127226|NCT03597256|450092202|FG000|Overall Study|Moved from location|0|||
125127227|NCT03597256|450092203|FG001|Overall Study|Moved from location|1|||
125127228|NCT03597256|450092202|FG000|Overall Study|Not accepted the treatment|0|||
125127229|NCT03597256|450092203|FG001|Overall Study|Not accepted the treatment|1|||
125374814|NCT00420927|451002269|FG004|Period 2|Took prohibited medication|1|||
125624892|NCT01412060|451908829|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
125127230|NCT02943447|450092204|FG000|Blinded Study Phase|Withdrew Consent|1|||
125127231|NCT02943447|450092205|FG001|Blinded Study Phase|Withdrew Consent|2|||
125127232|NCT02943447|450092206|FG002|Blinded Study Phase|Withdrew Consent|1|||
125127233|NCT02943447|450092204|FG000|Blinded Study Phase|Adverse Event|3|||
125127234|NCT02943447|450092205|FG001|Blinded Study Phase|Adverse Event|0|||
125127235|NCT02943447|450092206|FG002|Blinded Study Phase|Adverse Event|0|||
125127236|NCT02943447|450092204|FG000|Blinded Study Phase|Investigator's discretion|1|||
125127237|NCT02943447|450092205|FG001|Blinded Study Phase|Investigator's discretion|0|||
125127238|NCT02943447|450092206|FG002|Blinded Study Phase|Investigator's discretion|0|||
125127239|NCT02943447|450092204|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
125127240|NCT02943447|450092205|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
125127241|NCT02943447|450092206|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
125127242|NCT02943447|450092204|FG000|Open-Label Extension Phase|Adverse Event|4|||
125127243|NCT02943447|450092205|FG001|Open-Label Extension Phase|Adverse Event|7|||
125127244|NCT02943447|450092206|FG002|Open-Label Extension Phase|Adverse Event|3|||
125127245|NCT02943447|450092204|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
125127246|NCT02943447|450092205|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
125127247|NCT02943447|450092206|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
125127248|NCT02943447|450092204|FG000|Open-Label Extension Phase|Withdrew consent|1|||
125127249|NCT02943447|450092205|FG001|Open-Label Extension Phase|Withdrew consent|1|||
125127250|NCT02943447|450092206|FG002|Open-Label Extension Phase|Withdrew consent|1|||
125127251|NCT02943447|450092204|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
125127252|NCT02943447|450092205|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
125127253|NCT02943447|450092206|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
125127254|NCT02106156|450092207|FG000|Overall Study|Patient Died|19|||
125127255|NCT02106156|450092208|FG001|Overall Study|Patient Died|0|||
125374815|NCT00420927|451002270|FG005|Period 2|Took prohibited medication|0|||
125127256|NCT02106156|450092209|FG002|Overall Study|Patient Died|0|||
125127257|NCT02106156|450092207|FG000|Overall Study|Lack of Tolerability|305|||
125127258|NCT02106156|450092208|FG001|Overall Study|Lack of Tolerability|3|||
125127259|NCT02106156|450092209|FG002|Overall Study|Lack of Tolerability|0|||
125127260|NCT02106156|450092207|FG000|Overall Study|Lack of Virological Response|1044|||
125127261|NCT02106156|450092208|FG001|Overall Study|Lack of Virological Response|8|||
125127262|NCT02106156|450092209|FG002|Overall Study|Lack of Virological Response|0|||
125127263|NCT02106156|450092207|FG000|Overall Study|Concomitant Disease|74|||
125127264|NCT02106156|450092208|FG001|Overall Study|Concomitant Disease|2|||
125127265|NCT02106156|450092209|FG002|Overall Study|Concomitant Disease|0|||
125624893|NCT01412060|451908830|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
125127266|NCT02106156|450092207|FG000|Overall Study|Lack of Compliance|211|||
125127267|NCT02106156|450092208|FG001|Overall Study|Lack of Compliance|7|||
125127268|NCT02106156|450092209|FG002|Overall Study|Lack of Compliance|0|||
125127269|NCT02106156|450092207|FG000|Overall Study|Patients Request|307|||
125127270|NCT02106156|450092208|FG001|Overall Study|Patients Request|9|||
125127271|NCT02106156|450092209|FG002|Overall Study|Patients Request|0|||
125127272|NCT02106156|450092207|FG000|Overall Study|Lost to Follow-up|451|||
125127273|NCT02106156|450092208|FG001|Overall Study|Lost to Follow-up|8|||
125127274|NCT02106156|450092209|FG002|Overall Study|Lost to Follow-up|0|||
125127275|NCT02106156|450092207|FG000|Overall Study|Unplanned Event|82|||
125127276|NCT02106156|450092208|FG001|Overall Study|Unplanned Event|2|||
125127277|NCT02106156|450092209|FG002|Overall Study|Unplanned Event|0|||
125624894|NCT01412060|451908831|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
125624895|NCT01412060|451908829|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
125624896|NCT01412060|451908830|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
125624897|NCT01412060|451908831|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
125624898|NCT01412060|451908829|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
125624899|NCT01412060|451908830|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
125624900|NCT01412060|451908831|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
125624901|NCT01412060|451908829|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
125624902|NCT01412060|451908830|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
125624903|NCT01412060|451908831|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
125624904|NCT01412060|451908829|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
125624905|NCT01412060|451908830|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
125624906|NCT01412060|451908831|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
125624907|NCT01412060|451908829|FG000|Period Between RIP and SP|Adverse Event|4|||
125624908|NCT01412060|451908830|FG001|Period Between RIP and SP|Adverse Event|0|||
125624909|NCT01412060|451908831|FG002|Period Between RIP and SP|Adverse Event|0|||
125624910|NCT01412060|451908829|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
125624911|NCT01412060|451908830|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
125624912|NCT01412060|451908831|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
125624913|NCT01412060|451908829|FG000|Period Between RIP and SP|Protocol Violation|2|||
125624914|NCT01412060|451908830|FG001|Period Between RIP and SP|Protocol Violation|0|||
125624915|NCT01412060|451908831|FG002|Period Between RIP and SP|Protocol Violation|0|||
125624916|NCT01412060|451908829|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
125624917|NCT01412060|451908830|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
125624918|NCT01412060|451908831|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
125624919|NCT01412060|451908829|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
125624920|NCT01412060|451908830|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
125624921|NCT01412060|451908831|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
125624922|NCT01412060|451908829|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
125624923|NCT01412060|451908830|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
125624924|NCT01412060|451908831|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
125624925|NCT01412060|451908829|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
125127278|NCT02106156|450092207|FG000|Overall Study|Change of Laboratory Parameter|10|||
125624926|NCT01412060|451908830|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
125624927|NCT01412060|451908831|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
125624928|NCT01412060|451908829|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
125624929|NCT01412060|451908830|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
125624930|NCT01412060|451908831|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
125624931|NCT01412060|451908829|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
125624932|NCT01412060|451908830|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
125624933|NCT01412060|451908831|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
125624934|NCT01412060|451908829|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
125624935|NCT01412060|451908830|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
125624936|NCT01412060|451908831|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
125624937|NCT01412060|451908829|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
125624938|NCT01412060|451908830|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
125624939|NCT01412060|451908831|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
125624940|NCT01412060|451908829|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
125624941|NCT01412060|451908830|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
125624942|NCT01412060|451908831|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
125624943|NCT01412060|451908829|FG000|Period Between SP and DBP|Protocol Violation|2|||
125624944|NCT01412060|451908830|FG001|Period Between SP and DBP|Protocol Violation|0|||
125624945|NCT01412060|451908831|FG002|Period Between SP and DBP|Protocol Violation|0|||
125624946|NCT01412060|451908829|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
125624947|NCT01412060|451908830|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
125624948|NCT01412060|451908831|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
125624949|NCT01412060|451908829|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
125624950|NCT01412060|451908830|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
125624951|NCT01412060|451908831|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
125624952|NCT01412060|451908829|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
125624953|NCT01412060|451908830|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
125624954|NCT01412060|451908831|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
125624955|NCT01412060|451908829|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
125127279|NCT02106156|450092208|FG001|Overall Study|Change of Laboratory Parameter|0|||
125127280|NCT02106156|450092209|FG002|Overall Study|Change of Laboratory Parameter|0|||
125127281|NCT02106156|450092207|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
125127282|NCT02106156|450092208|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
125127283|NCT02106156|450092209|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
125127284|NCT02106156|450092207|FG000|Overall Study|Relocation/Change of Physician|40|||
125127285|NCT02106156|450092208|FG001|Overall Study|Relocation/Change of Physician|1|||
125127286|NCT02106156|450092209|FG002|Overall Study|Relocation/Change of Physician|0|||
125127287|NCT05017480|450092216|FG000|Stage 1 Study|Withdrawal by Subject|8|||
125127288|NCT05017480|450092217|FG001|Stage 1 Study|Withdrawal by Subject|6|||
125624956|NCT01412060|451908830|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
125624957|NCT01412060|451908831|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
125624958|NCT01412060|451908829|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
125624959|NCT01412060|451908830|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
125624960|NCT01412060|451908831|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
125127289|NCT05017480|450092218|FG002|Stage 1 Study|Withdrawal by Subject|0|||
125127290|NCT05017480|450092219|FG003|Stage 1 Study|Withdrawal by Subject|0|||
125127291|NCT05017480|450092220|FG004|Stage 1 Study|Withdrawal by Subject|0|||
125624961|NCT01412060|451908829|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
125624962|NCT01412060|451908830|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
125624963|NCT01412060|451908831|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
125624964|NCT01412060|451908829|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
125624965|NCT01412060|451908830|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
125624966|NCT01412060|451908831|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
125624967|NCT01412060|451908829|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
125624968|NCT01412060|451908830|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
125215491|NCT04076319|450417403|FG001|Overall Study|Death|0|||
125215492|NCT01054222|450417404|FG000|Overall Study|Lack of Efficacy|1|||
125215493|NCT01054222|450417404|FG000|Overall Study|Lost to Follow-up|4|||
125215494|NCT01054222|450417404|FG000|Overall Study|Withdrawal by Subject|6|||
125215495|NCT00824655|450417405|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
125215496|NCT00824655|450417406|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
125624969|NCT01412060|451908831|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
125624970|NCT01412060|451908829|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
125624971|NCT01412060|451908830|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
125624972|NCT01412060|451908831|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
125624973|NCT01412060|451908829|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
125624974|NCT01412060|451908830|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
125624975|NCT01412060|451908831|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
125624976|NCT00004732|451908832|FG000|Overall Study|Withdrawal by Subject|36|||
125127292|NCT05017480|450092216|FG000|Stage 1 Study|Adverse Event|1|||
125127293|NCT05017480|450092217|FG001|Stage 1 Study|Adverse Event|1|||
125127294|NCT05017480|450092218|FG002|Stage 1 Study|Adverse Event|0|||
125127295|NCT05017480|450092219|FG003|Stage 1 Study|Adverse Event|0|||
125127296|NCT05017480|450092220|FG004|Stage 1 Study|Adverse Event|0|||
125127297|NCT05017480|450092216|FG000|Stage 1 Study|Poor Compliance|1|||
125127298|NCT05017480|450092217|FG001|Stage 1 Study|Poor Compliance|1|||
125127299|NCT05017480|450092218|FG002|Stage 1 Study|Poor Compliance|0|||
125127300|NCT05017480|450092219|FG003|Stage 1 Study|Poor Compliance|0|||
125127301|NCT05017480|450092220|FG004|Stage 1 Study|Poor Compliance|0|||
125127302|NCT05017480|450092216|FG000|Stage 1 Study|Physician Decision|0|||
125127303|NCT05017480|450092217|FG001|Stage 1 Study|Physician Decision|1|||
125127304|NCT05017480|450092218|FG002|Stage 1 Study|Physician Decision|0|||
125127305|NCT05017480|450092219|FG003|Stage 1 Study|Physician Decision|0|||
125127306|NCT05017480|450092220|FG004|Stage 1 Study|Physician Decision|0|||
125127307|NCT05017480|450092216|FG000|Stage 2 Study|Withdrawal by Subject|0|||
125127308|NCT05017480|450092217|FG001|Stage 2 Study|Withdrawal by Subject|0|||
125127309|NCT05017480|450092218|FG002|Stage 2 Study|Withdrawal by Subject|6|||
125127310|NCT05017480|450092219|FG003|Stage 2 Study|Withdrawal by Subject|9|||
125215497|NCT00824655|450417405|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
125215498|NCT00824655|450417406|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
125624977|NCT00004732|451908833|FG001|Overall Study|Withdrawal by Subject|64|||
125624978|NCT00004732|451908832|FG000|Overall Study|Lost to Follow-up|33|||
125624979|NCT00004732|451908833|FG001|Overall Study|Lost to Follow-up|47|||
125624980|NCT02674685|451908837|FG000|Overall Study|Withdrawal by Subject|4|||
125215499|NCT03504189|450417407|FG000|Overall Study|Withdrawal by Subject|1|||
125624981|NCT02713789|451908838|FG000|Overall Study|Lost to Follow-up|0|||
125624982|NCT02713789|451908839|FG001|Overall Study|Lost to Follow-up|1|||
125127311|NCT05017480|450092220|FG004|Stage 2 Study|Withdrawal by Subject|11|||
125624983|NCT02713789|451908840|FG002|Overall Study|Lost to Follow-up|1|||
125127312|NCT05017480|450092216|FG000|Stage 2 Study|Lost to Follow-up|0|||
125127313|NCT05017480|450092217|FG001|Stage 2 Study|Lost to Follow-up|0|||
125127314|NCT05017480|450092218|FG002|Stage 2 Study|Lost to Follow-up|0|||
125624984|NCT02091921|451908841|FG000|Overall Study|Adverse Event|3|||
125624985|NCT03307629|451908842|FG000|Overall Study|Withdrawal by Subject|0|||
125624986|NCT03307629|451908843|FG001|Overall Study|Withdrawal by Subject|0|||
125624987|NCT03307629|451908844|FG002|Overall Study|Withdrawal by Subject|0|||
125624988|NCT03307629|451908845|FG003|Overall Study|Withdrawal by Subject|2|||
125624989|NCT03307629|451908842|FG000|Overall Study|Disease Progression|0|||
125624990|NCT03307629|451908843|FG001|Overall Study|Disease Progression|0|||
125624991|NCT03307629|451908844|FG002|Overall Study|Disease Progression|0|||
125624992|NCT03307629|451908845|FG003|Overall Study|Disease Progression|3|||
125624993|NCT03307629|451908842|FG000|Overall Study|Death|0|||
125624994|NCT03307629|451908843|FG001|Overall Study|Death|3|||
125624995|NCT03307629|451908844|FG002|Overall Study|Death|0|||
125624996|NCT03307629|451908845|FG003|Overall Study|Death|1|||
125624997|NCT00719953|451908850|FG000|Overall Study|Adverse Event|4|||
125624998|NCT01626989|451908851|FG000|Screening Period|Screen Failure|15|||
125624999|NCT01626989|451908852|FG001|Screening Period|Screen Failure|0|||
125625000|NCT01626989|451908853|FG002|Screening Period|Screen Failure|0|||
125625001|NCT01626989|451908851|FG000|Screening Period|Withdrawal by Subject|2|||
125625002|NCT01626989|451908852|FG001|Screening Period|Withdrawal by Subject|0|||
125625003|NCT01626989|451908853|FG002|Screening Period|Withdrawal by Subject|0|||
125625004|NCT00642018|451908856|FG000|Overall Study|Adverse Event|11|||
125625005|NCT00642018|451908857|FG001|Overall Study|Adverse Event|36|||
125625006|NCT00642018|451908856|FG000|Overall Study|Withdrawal by Subject|4|||
125625007|NCT00642018|451908857|FG001|Overall Study|Withdrawal by Subject|10|||
125625008|NCT00642018|451908856|FG000|Overall Study|Progressive Disease|13|||
125625009|NCT00642018|451908857|FG001|Overall Study|Progressive Disease|18|||
125625010|NCT00642018|451908856|FG000|Overall Study|Physician Decision|0|||
125625011|NCT00642018|451908857|FG001|Overall Study|Physician Decision|10|||
125625012|NCT00642018|451908856|FG000|Overall Study|Protocol Violation|0|||
125625013|NCT00642018|451908857|FG001|Overall Study|Protocol Violation|1|||
125625014|NCT00642018|451908856|FG000|Overall Study|Death|0|||
125625015|NCT00642018|451908857|FG001|Overall Study|Death|3|||
125625016|NCT00642018|451908856|FG000|Overall Study|Entry Criteria Not Met|0|||
125625017|NCT00642018|451908857|FG001|Overall Study|Entry Criteria Not Met|1|||
125625018|NCT01230749|451908858|FG000|Overall Study|Adverse Event|0|||
125625019|NCT01230749|451908859|FG001|Overall Study|Adverse Event|0|||
125625020|NCT01230749|451908860|FG002|Overall Study|Adverse Event|0|||
125625021|NCT01230749|451908861|FG003|Overall Study|Adverse Event|1|||
125625022|NCT01230749|451908858|FG000|Overall Study|Physician Decision|0|||
125625023|NCT01230749|451908859|FG001|Overall Study|Physician Decision|0|||
125625024|NCT01230749|451908860|FG002|Overall Study|Physician Decision|1|||
125625025|NCT01230749|451908861|FG003|Overall Study|Physician Decision|0|||
125625026|NCT01230749|451908858|FG000|Overall Study|Withdrawal by Subject|0|||
125625027|NCT01230749|451908859|FG001|Overall Study|Withdrawal by Subject|1|||
125625028|NCT01230749|451908860|FG002|Overall Study|Withdrawal by Subject|0|||
125625029|NCT01230749|451908861|FG003|Overall Study|Withdrawal by Subject|0|||
125625030|NCT01230749|451908858|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
125625031|NCT01230749|451908859|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
125625032|NCT01230749|451908860|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
125625033|NCT01230749|451908861|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
125625034|NCT02687711|451910593|FG000|Overall Study|Adverse Event|89|||
125625035|NCT02687711|451910593|FG000|Overall Study|Lack of Efficacy|70|||
125625036|NCT02687711|451910593|FG000|Overall Study|Lost to Follow-up|20|||
125625037|NCT02687711|451910593|FG000|Overall Study|Consent withdrawn|15|||
125625038|NCT02687711|451910593|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
125625039|NCT02687711|451910593|FG000|Overall Study|Too expensive|4|||
125625040|NCT02687711|451910593|FG000|Overall Study|Participant moved abroad|1|||
125625041|NCT02687711|451910593|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
125625042|NCT02687711|451910593|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
125625043|NCT02687711|451910593|FG000|Overall Study|Disliked taste|1|||
125625044|NCT02687711|451910593|FG000|Overall Study|Low mood|1|||
125625045|NCT02687711|451910593|FG000|Overall Study|Side effects|1|||
125625046|NCT02687711|451910593|FG000|Overall Study|Change of Hospital|1|||
125625047|NCT02687711|451910593|FG000|Overall Study|Liver Encephalopathy|1|||
125625048|NCT02687711|451910593|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
125625049|NCT02687711|451910593|FG000|Overall Study|Withdrawn due to intake interruption|1|||
125625050|NCT02687711|451910593|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
125625051|NCT02687711|451910593|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
125625052|NCT02687711|451910593|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
125625053|NCT03621189|451910594|FG000|Overall Study|Withdrawal by Subject|0|||
125625054|NCT03621189|451910595|FG001|Overall Study|Withdrawal by Subject|3|||
125625055|NCT03621189|451910594|FG000|Overall Study|Physician Decision|0|||
125625056|NCT03621189|451910595|FG001|Overall Study|Physician Decision|2|||
125625057|NCT03077243|451910596|FG000|Overall Study|Death|1|||
125625058|NCT03077243|451910597|FG001|Overall Study|Death|2|||
125625059|NCT03077243|451910598|FG002|Overall Study|Death|0|||
125625060|NCT03077243|451910599|FG003|Overall Study|Death|0|||
125625061|NCT03077243|451910596|FG000|Overall Study|Withdrawal by Subject|1|||
125625062|NCT03077243|451910597|FG001|Overall Study|Withdrawal by Subject|3|||
125625063|NCT03077243|451910598|FG002|Overall Study|Withdrawal by Subject|0|||
125625064|NCT03077243|451910599|FG003|Overall Study|Withdrawal by Subject|0|||
125625065|NCT03077243|451910596|FG000|Overall Study|Physician Decision|1|||
125625066|NCT03077243|451910597|FG001|Overall Study|Physician Decision|0|||
125625067|NCT03077243|451910598|FG002|Overall Study|Physician Decision|0|||
125625068|NCT03077243|451910599|FG003|Overall Study|Physician Decision|0|||
125625069|NCT03077243|451910596|FG000|Overall Study|Research at two study sites terminated early|0|||
125625070|NCT03077243|451910597|FG001|Overall Study|Research at two study sites terminated early|0|||
125625071|NCT03077243|451910598|FG002|Overall Study|Research at two study sites terminated early|0|||
125625072|NCT03077243|451910599|FG003|Overall Study|Research at two study sites terminated early|69|||
125625073|NCT01432457|451910600|FG000|Overall Study|Adverse Event|7|||
125625074|NCT01432457|451910601|FG001|Overall Study|Adverse Event|10|||
125625075|NCT01432457|451910602|FG002|Overall Study|Adverse Event|16|||
125625076|NCT01432457|451910600|FG000|Overall Study|Lack of Efficacy|2|||
125625077|NCT01432457|451910601|FG001|Overall Study|Lack of Efficacy|1|||
125127315|NCT05017480|450092219|FG003|Stage 2 Study|Lost to Follow-up|2|||
125127316|NCT05017480|450092220|FG004|Stage 2 Study|Lost to Follow-up|1|||
125625078|NCT01432457|451910602|FG002|Overall Study|Lack of Efficacy|1|||
125625079|NCT01432457|451910600|FG000|Overall Study|Lost to Follow-up|11|||
125625080|NCT01432457|451910601|FG001|Overall Study|Lost to Follow-up|15|||
125127317|NCT05017480|450092216|FG000|Stage 2 Study|Adverse Event|0|||
125127318|NCT05017480|450092217|FG001|Stage 2 Study|Adverse Event|0|||
125127319|NCT05017480|450092218|FG002|Stage 2 Study|Adverse Event|0|||
125127320|NCT05017480|450092219|FG003|Stage 2 Study|Adverse Event|1|||
125127321|NCT05017480|450092220|FG004|Stage 2 Study|Adverse Event|0|||
125127322|NCT05017480|450092216|FG000|Stage 2 Study|COVID-19|0|||
125127323|NCT05017480|450092217|FG001|Stage 2 Study|COVID-19|0|||
125127324|NCT05017480|450092218|FG002|Stage 2 Study|COVID-19|0|||
125127325|NCT05017480|450092219|FG003|Stage 2 Study|COVID-19|1|||
125127326|NCT05017480|450092220|FG004|Stage 2 Study|COVID-19|0|||
125127327|NCT05017480|450092216|FG000|Stage 2 Study|Pregnancy|0|||
125127328|NCT05017480|450092217|FG001|Stage 2 Study|Pregnancy|0|||
125127329|NCT05017480|450092218|FG002|Stage 2 Study|Pregnancy|0|||
125127330|NCT05017480|450092219|FG003|Stage 2 Study|Pregnancy|0|||
125127331|NCT05017480|450092220|FG004|Stage 2 Study|Pregnancy|1|||
125127332|NCT01136382|450092221|FG000|Overall Study|Other|8|||
125127333|NCT01136382|450092222|FG001|Overall Study|Other|3|||
125127334|NCT01136382|450092221|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
125127335|NCT01136382|450092222|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
125127336|NCT01136382|450092221|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
125127337|NCT01136382|450092222|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
125127338|NCT01136382|450092221|FG000|Overall Study|Withdrawal by Subject|4|||
125127339|NCT01136382|450092222|FG001|Overall Study|Withdrawal by Subject|1|||
125127340|NCT00485472|450092227|FG000|Overall Study|Adverse Event|8|||
125127341|NCT00485472|450092228|FG001|Overall Study|Adverse Event|5|||
125127342|NCT00485472|450092227|FG000|Overall Study|Lack of Efficacy|5|||
125127343|NCT00485472|450092228|FG001|Overall Study|Lack of Efficacy|4|||
125127344|NCT00485472|450092227|FG000|Overall Study|Withdrawal by Subject|1|||
125127345|NCT00485472|450092228|FG001|Overall Study|Withdrawal by Subject|0|||
125127346|NCT00485472|450092227|FG000|Overall Study|Protocol Violation|0|||
125127347|NCT00485472|450092228|FG001|Overall Study|Protocol Violation|1|||
125127348|NCT00485472|450092227|FG000|Overall Study|Other|2|||
125127349|NCT00485472|450092228|FG001|Overall Study|Other|1|||
125127350|NCT00485472|450092227|FG000|Overall Study|Lost to Follow-up|0|||
125127351|NCT00485472|450092228|FG001|Overall Study|Lost to Follow-up|1|||
125127352|NCT00088829|450092230|FG000|Overall Study|PI left institution and study was close|22|||
125625081|NCT01432457|451910602|FG002|Overall Study|Lost to Follow-up|20|||
125625082|NCT01432457|451910600|FG000|Overall Study|Protocol Violation|3|||
125625083|NCT01432457|451910601|FG001|Overall Study|Protocol Violation|2|||
125625084|NCT01432457|451910602|FG002|Overall Study|Protocol Violation|6|||
125625085|NCT01432457|451910600|FG000|Overall Study|Withdrawal by Subject|6|||
125625086|NCT01432457|451910601|FG001|Overall Study|Withdrawal by Subject|11|||
125625087|NCT01432457|451910602|FG002|Overall Study|Withdrawal by Subject|9|||
125625088|NCT01432457|451910600|FG000|Overall Study|Reasons not defined|2|||
125127353|NCT00633594|450092231|FG000|Overall Study|Adverse Event|0|||
125127354|NCT00633594|450092232|FG001|Overall Study|Adverse Event|4|||
125127355|NCT00633594|450092233|FG002|Overall Study|Adverse Event|7|||
125625089|NCT01432457|451910601|FG001|Overall Study|Reasons not defined|3|||
125625090|NCT01432457|451910602|FG002|Overall Study|Reasons not defined|4|||
125625091|NCT01432457|451910600|FG000|Overall Study|Did not take study drug|6|||
125625092|NCT01432457|451910601|FG001|Overall Study|Did not take study drug|6|||
125625093|NCT01432457|451910602|FG002|Overall Study|Did not take study drug|3|||
125625094|NCT02848313|451910603|FG000|Overall Study|Adverse Event|1|||
125625095|NCT02848313|451910604|FG001|Overall Study|Adverse Event|2|||
125625096|NCT02848313|451910603|FG000|Overall Study|Lack of Efficacy|0|||
125127356|NCT00633594|450092231|FG000|Overall Study|Death|0|||
125127357|NCT00633594|450092232|FG001|Overall Study|Death|1|||
125625097|NCT02848313|451910604|FG001|Overall Study|Lack of Efficacy|1|||
125127358|NCT00633594|450092233|FG002|Overall Study|Death|2|||
125127359|NCT00633594|450092231|FG000|Overall Study|Disease Progression|0|||
125127360|NCT00633594|450092232|FG001|Overall Study|Disease Progression|0|||
125127361|NCT00633594|450092233|FG002|Overall Study|Disease Progression|1|||
125127362|NCT00365300|450092238|FG000|Open-label Phase|Adverse Event|4|||
125127363|NCT00365300|450092239|FG001|Open-label Phase|Adverse Event|0|||
125127364|NCT00365300|450092238|FG000|Open-label Phase|Failed to Return|1|||
125127365|NCT00365300|450092239|FG001|Open-label Phase|Failed to Return|0|||
125127366|NCT00365300|450092238|FG000|Open-label Phase|Physician Decision|1|||
125127367|NCT00365300|450092239|FG001|Open-label Phase|Physician Decision|0|||
125127368|NCT00365300|450092238|FG000|Open-label Phase|Noncompliance|9|||
125127369|NCT00365300|450092239|FG001|Open-label Phase|Noncompliance|0|||
125127370|NCT00365300|450092238|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
125127371|NCT00365300|450092239|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
125127372|NCT00365300|450092238|FG000|Open-label Phase|Protocol Violation|1|||
125127373|NCT00365300|450092239|FG001|Open-label Phase|Protocol Violation|0|||
125625098|NCT02848313|451910603|FG000|Overall Study|Withdrawal by Subject|1|||
125625099|NCT02848313|451910604|FG001|Overall Study|Withdrawal by Subject|1|||
125127374|NCT00365300|450092238|FG000|Open-label Phase|Lack of Efficacy|1|||
125127375|NCT00365300|450092239|FG001|Open-label Phase|Lack of Efficacy|0|||
125625100|NCT02848313|451910603|FG000|Overall Study|Lost to follow up|1|||
125625101|NCT02848313|451910604|FG001|Overall Study|Lost to follow up|0|||
125127376|NCT00365300|450092238|FG000|Open-label Phase|Patient skipped open label phase|1|||
125127377|NCT00365300|450092239|FG001|Open-label Phase|Patient skipped open label phase|0|||
125127378|NCT00365300|450092238|FG000|Double-blind Phase|Failed to return|1|||
125127379|NCT00365300|450092239|FG001|Double-blind Phase|Failed to return|0|||
125127380|NCT00365300|450092238|FG000|Double-blind Phase|Noncompliance|1|||
125127381|NCT00365300|450092239|FG001|Double-blind Phase|Noncompliance|1|||
125127382|NCT00365300|450092238|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125127383|NCT00365300|450092239|FG001|Double-blind Phase|Withdrawal by Subject|1|||
125127384|NCT00365300|450092238|FG000|Double-blind Phase|Protocol Violation|3|||
125127385|NCT00365300|450092239|FG001|Double-blind Phase|Protocol Violation|1|||
125127386|NCT00365300|450092238|FG000|Double-blind Phase|Lack of Efficacy|6|||
125127387|NCT00365300|450092239|FG001|Double-blind Phase|Lack of Efficacy|6|||
125127388|NCT02896361|450092240|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
125127389|NCT02896361|450092241|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
125127390|NCT02896361|450092242|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
125127391|NCT02896361|450092240|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
125127392|NCT02896361|450092241|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
125127393|NCT02896361|450092242|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
125127394|NCT01287013|450092245|FG000|Overall Study|Non-evaluable|3|||
125127395|NCT01287013|450092246|FG001|Overall Study|Non-evaluable|5|||
125625102|NCT00247273|451910610|FG000|Overall Study|Adverse Event|85|||
125625103|NCT00247273|451910611|FG001|Overall Study|Adverse Event|80|||
125625104|NCT00247273|451910610|FG000|Overall Study|Physician Decision|6|||
125625105|NCT00247273|451910611|FG001|Overall Study|Physician Decision|3|||
125625106|NCT00247273|451910610|FG000|Overall Study|Lost to Follow-up|7|||
125625107|NCT00247273|451910611|FG001|Overall Study|Lost to Follow-up|7|||
125625108|NCT00247273|451910610|FG000|Overall Study|Withdrawal by Subject|46|||
125625109|NCT00247273|451910611|FG001|Overall Study|Withdrawal by Subject|47|||
125625110|NCT00247273|451910610|FG000|Overall Study|Did not take any study drug|2|||
125625111|NCT00247273|451910611|FG001|Overall Study|Did not take any study drug|0|||
125625112|NCT01419015|451910612|FG000|Overall Study|Death|2|||
125625113|NCT04209530|451910613|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
125625114|NCT04209530|451910614|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
125625115|NCT04209530|451910613|FG000|Overall Study|Withdrawal by Subject|0|||
125625116|NCT04209530|451910614|FG001|Overall Study|Withdrawal by Subject|1|||
125625117|NCT02580240|451910627|FG000|Overall Study|Physician Decision|2|||
125625118|NCT02580240|451910628|FG001|Overall Study|Physician Decision|0|||
125625119|NCT00607919|451910629|FG000|Acute Phase|Adverse Event|9|||
125625120|NCT00607919|451910630|FG001|Acute Phase|Adverse Event|2|||
125625121|NCT00607919|451910629|FG000|Acute Phase|Entry Criteria Not Met|1|||
125625122|NCT00607919|451910630|FG001|Acute Phase|Entry Criteria Not Met|1|||
125625123|NCT00607919|451910629|FG000|Acute Phase|Lack of Efficacy|1|||
125625124|NCT00607919|451910630|FG001|Acute Phase|Lack of Efficacy|2|||
125625125|NCT00607919|451910629|FG000|Acute Phase|Lost to Follow-up|9|||
125625126|NCT00607919|451910630|FG001|Acute Phase|Lost to Follow-up|3|||
125625127|NCT00607919|451910629|FG000|Acute Phase|Parent/Caregiver Decision|6|||
125625128|NCT00607919|451910630|FG001|Acute Phase|Parent/Caregiver Decision|4|||
125625129|NCT00607919|451910629|FG000|Acute Phase|Protocol Violation|5|||
125625130|NCT00607919|451910630|FG001|Acute Phase|Protocol Violation|1|||
125625131|NCT00607919|451910629|FG000|Acute Phase|Withdrawal by Subject|3|||
125625132|NCT00607919|451910630|FG001|Acute Phase|Withdrawal by Subject|3|||
125625133|NCT00607919|451910629|FG000|Open-Label Phase|Adverse Event|1|||
125625134|NCT00607919|451910630|FG001|Open-Label Phase|Adverse Event|5|||
125625135|NCT00607919|451910629|FG000|Open-Label Phase|Lost to Follow-up|4|||
125625136|NCT00607919|451910630|FG001|Open-Label Phase|Lost to Follow-up|1|||
125625137|NCT00607919|451910629|FG000|Open-Label Phase|Protocol Violation|2|||
125625138|NCT00607919|451910630|FG001|Open-Label Phase|Protocol Violation|2|||
125625139|NCT00607919|451910629|FG000|Open-Label Phase|Withdrawal by Subject|2|||
125625140|NCT00607919|451910630|FG001|Open-Label Phase|Withdrawal by Subject|2|||
125625141|NCT00607919|451910629|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
125127396|NCT01287013|450092247|FG002|Overall Study|Non-evaluable|21|||
125127397|NCT01045096|450092248|FG000|Overall Study|Withdrawal by Subject|2|||
125127398|NCT01045096|450092249|FG001|Overall Study|Withdrawal by Subject|0|||
125127399|NCT01045096|450092250|FG002|Overall Study|Withdrawal by Subject|0|||
125127400|NCT01045096|450092248|FG000|Overall Study|Other|1|||
125625142|NCT00607919|451910630|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
125625143|NCT01527110|451910631|FG000|Overall Study|Adverse Event|1|||
125625144|NCT02007252|451910634|FG000|Overall Study|Administrative problems|3|||
125625145|NCT02007252|451910635|FG001|Overall Study|Administrative problems|7|||
125625146|NCT02007252|451910634|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125625147|NCT02007252|451910635|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125625148|NCT02007252|451910634|FG000|Overall Study|Adverse Event|7|||
125625149|NCT02007252|451910635|FG001|Overall Study|Adverse Event|4|||
125625150|NCT00985738|451910638|FG000|Overall Study|Study closed prematurely|8|||
125625151|NCT00985738|451910639|FG001|Overall Study|Study closed prematurely|8|||
125433204|NCT00909428|451212463|FG000|Overall Study|Lost to Follow-up|13|||
125433205|NCT00909428|451212464|FG001|Overall Study|Lost to Follow-up|10|||
125433206|NCT00909428|451212465|FG002|Overall Study|Lost to Follow-up|9|||
125433207|NCT03021668|451212466|FG000|Overall Study|Physician Decision|0|||
125215500|NCT03504189|450417407|FG000|Overall Study|Screening Failure|1|||
125215501|NCT03504189|450417407|FG000|Overall Study|Device Failure|2|||
125215502|NCT04336475|450417408|FG000|Overall Study|pain|1|||
125215503|NCT04336475|450417409|FG001|Overall Study|pain|0|||
125215504|NCT04336475|450417408|FG000|Overall Study|upper respiratory infection|1|||
125215505|NCT04336475|450417409|FG001|Overall Study|upper respiratory infection|0|||
125215506|NCT04336475|450417408|FG000|Overall Study|Lost to Follow-up|0|||
125215507|NCT04336475|450417409|FG001|Overall Study|Lost to Follow-up|2|||
125433208|NCT03021668|451212467|FG001|Overall Study|Physician Decision|1|||
125433209|NCT01122381|451212468|FG000|Overall Study|study terminated early|0|||
125433210|NCT01122381|451212469|FG001|Overall Study|study terminated early|1|||
125433211|NCT00116844|451212470|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
125433212|NCT00116844|451212471|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
125625152|NCT02227849|451910641|FG000|Overall Study|Adverse Event|4|||
125625153|NCT02227849|451910641|FG000|Overall Study|Physician Decision|1|||
125625154|NCT02227849|451910641|FG000|Overall Study|Withdrawal by Subject|3|||
125625155|NCT01590212|451910644|FG000|Overall Study|Withdrawal by Subject|2|||
125625156|NCT01590212|451910645|FG001|Overall Study|Withdrawal by Subject|2|||
125625157|NCT01590212|451910646|FG002|Overall Study|Withdrawal by Subject|2|||
125625158|NCT01590212|451910644|FG000|Overall Study|Lost to Follow-up|1|||
125625159|NCT01590212|451910645|FG001|Overall Study|Lost to Follow-up|2|||
125625160|NCT01590212|451910646|FG002|Overall Study|Lost to Follow-up|3|||
125625161|NCT04897594|451910648|FG000|Overall Study|Lost to Follow-up|0|||
125625162|NCT04897594|451910649|FG001|Overall Study|Lost to Follow-up|1|||
125625163|NCT04897594|451910650|FG002|Overall Study|Lost to Follow-up|1|||
125433213|NCT00116844|451212470|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
125215508|NCT02171429|450417421|FG000|Overall Study|Other|0|||
125215509|NCT02171429|450417422|FG001|Overall Study|Other|1|||
125215510|NCT02171429|450417423|FG002|Overall Study|Other|1|||
125625164|NCT04897594|451910648|FG000|Overall Study|Sponsor Decision|0|||
125625165|NCT04897594|451910649|FG001|Overall Study|Sponsor Decision|0|||
125625166|NCT04897594|451910650|FG002|Overall Study|Sponsor Decision|1|||
125625167|NCT04897594|451910648|FG000|Overall Study|Withdrawal by Subject|1|||
125625168|NCT04897594|451910649|FG001|Overall Study|Withdrawal by Subject|0|||
125127401|NCT01045096|450092249|FG001|Overall Study|Other|0|||
125127402|NCT01045096|450092250|FG002|Overall Study|Other|0|||
125127403|NCT01179048|450092251|FG000|Overall Study|Withdrawn - does not allow contact|4|||
125127404|NCT01179048|450092252|FG001|Overall Study|Withdrawn - does not allow contact|8|||
125127405|NCT01179048|450092251|FG000|Overall Study|Lost to Follow-up|8|||
125127406|NCT01179048|450092252|FG001|Overall Study|Lost to Follow-up|9|||
125127407|NCT01179048|450092251|FG000|Overall Study|Alive|127|||
125127408|NCT01179048|450092252|FG001|Overall Study|Alive|142|||
125127409|NCT02109042|450092253|FG000|Overall Study|Sponsor Decision|15|||
125127410|NCT01511939|450092254|FG000|Overall Study|Withdrawal by Subject|2|||
125127411|NCT01511939|450092255|FG001|Overall Study|Withdrawal by Subject|1|||
125127412|NCT01511939|450092256|FG002|Overall Study|Withdrawal by Subject|0|||
125127413|NCT03203447|450092257|FG000|Overall Study|Withdrawal by Subject|2|||
125127414|NCT03203447|450092258|FG001|Overall Study|Withdrawal by Subject|1|||
125127415|NCT03203447|450092257|FG000|Overall Study|Lost to Follow-up|1|||
125127416|NCT03203447|450092258|FG001|Overall Study|Lost to Follow-up|10|||
125127417|NCT03203447|450092257|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
125127418|NCT03203447|450092258|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
125127419|NCT00324168|450092259|FG000|Overall Study|Lost to Follow-up|19|||
125127420|NCT00324168|450092260|FG001|Overall Study|Lost to Follow-up|18|||
125127421|NCT00324168|450092259|FG000|Overall Study|Death|3|||
125127422|NCT00324168|450092260|FG001|Overall Study|Death|3|||
125127423|NCT00324168|450092259|FG000|Overall Study|Patient did not visit in f/u window|6|||
125127424|NCT00324168|450092260|FG001|Overall Study|Patient did not visit in f/u window|9|||
125127425|NCT03497897|450092264|FG000|Overall Study|Adverse Event|1|||
125127426|NCT03497897|450092265|FG001|Overall Study|Adverse Event|1|||
125127427|NCT03497897|450092266|FG002|Overall Study|Adverse Event|1|||
125127428|NCT03497897|450092264|FG000|Overall Study|Lost to Follow-up|2|||
125127429|NCT03497897|450092265|FG001|Overall Study|Lost to Follow-up|0|||
125127430|NCT03497897|450092266|FG002|Overall Study|Lost to Follow-up|2|||
125127431|NCT03497897|450092264|FG000|Overall Study|Physician Decision|1|||
125127432|NCT03497897|450092265|FG001|Overall Study|Physician Decision|0|||
125127433|NCT03497897|450092266|FG002|Overall Study|Physician Decision|0|||
125127434|NCT03497897|450092264|FG000|Overall Study|Subject/Guardian Decision|2|||
125127435|NCT03497897|450092265|FG001|Overall Study|Subject/Guardian Decision|1|||
125127436|NCT03497897|450092266|FG002|Overall Study|Subject/Guardian Decision|3|||
125127437|NCT00528606|450092272|FG000|Overall Study|Withdrew consent|4|||
125127438|NCT00528606|450092273|FG001|Overall Study|Withdrew consent|3|||
125127439|NCT00528606|450092272|FG000|Overall Study|Lost to Follow-up|4|||
125127440|NCT00528606|450092273|FG001|Overall Study|Lost to Follow-up|1|||
125127441|NCT00528606|450092272|FG000|Overall Study|Adverse Event|3|||
125127442|NCT00528606|450092273|FG001|Overall Study|Adverse Event|0|||
125127443|NCT00528606|450092272|FG000|Overall Study|Other|2|||
125127444|NCT00528606|450092273|FG001|Overall Study|Other|0|||
125127445|NCT03478397|450092280|FG000|Overall Study|Refused to participate|31|||
125127446|NCT03478397|450092281|FG001|Overall Study|Refused to participate|7|||
125127447|NCT02188303|450092282|FG000|Overall Study|Adverse Event|0|||
125127448|NCT02188303|450092283|FG001|Overall Study|Adverse Event|0|||
125127449|NCT02188303|450092284|FG002|Overall Study|Adverse Event|0|||
125127450|NCT02188303|450092285|FG003|Overall Study|Adverse Event|0|||
125127451|NCT02188303|450092286|FG004|Overall Study|Adverse Event|0|||
125127452|NCT02188303|450092287|FG005|Overall Study|Adverse Event|2|||
125127453|NCT02188303|450092288|FG006|Overall Study|Adverse Event|0|||
125127454|NCT02188303|450092289|FG007|Overall Study|Adverse Event|2|||
125127455|NCT02188303|450092282|FG000|Overall Study|Dose Termination Criteria Met|0|||
125127456|NCT02188303|450092283|FG001|Overall Study|Dose Termination Criteria Met|0|||
125127457|NCT02188303|450092284|FG002|Overall Study|Dose Termination Criteria Met|0|||
125127458|NCT02188303|450092285|FG003|Overall Study|Dose Termination Criteria Met|0|||
125127459|NCT02188303|450092286|FG004|Overall Study|Dose Termination Criteria Met|0|||
125127460|NCT02188303|450092287|FG005|Overall Study|Dose Termination Criteria Met|0|||
125127461|NCT02188303|450092288|FG006|Overall Study|Dose Termination Criteria Met|2|||
125127462|NCT02188303|450092289|FG007|Overall Study|Dose Termination Criteria Met|4|||
125127463|NCT04206332|450092290|FG000|Part A|Lost to Follow-up|0|||
125215511|NCT02171429|450417421|FG000|Overall Study|Non-Compliance|0|||
125215512|NCT02171429|450417422|FG001|Overall Study|Non-Compliance|0|||
125127464|NCT04206332|450092291|FG001|Part A|Lost to Follow-up|1|||
125127465|NCT04206332|450092292|FG002|Part A|Lost to Follow-up|0|||
125127466|NCT04206332|450092293|FG003|Part A|Lost to Follow-up|0|||
125127467|NCT04206332|450092294|FG004|Part A|Lost to Follow-up|0|||
125127468|NCT04206332|450092295|FG005|Part A|Lost to Follow-up|0|||
125127469|NCT04206332|450092296|FG006|Part A|Lost to Follow-up|0|||
125127470|NCT04206332|450092297|FG007|Part A|Lost to Follow-up|0|||
125127471|NCT04206332|450092298|FG008|Part A|Lost to Follow-up|0|||
125127472|NCT04206332|450092299|FG009|Part A|Lost to Follow-up|0|||
125127473|NCT04206332|450092300|FG010|Part A|Lost to Follow-up|0|||
125127474|NCT04206332|450092301|FG011|Part A|Lost to Follow-up|0|||
125127475|NCT04206332|450092302|FG012|Part A|Lost to Follow-up|0|||
125215513|NCT02171429|450417423|FG002|Overall Study|Non-Compliance|1|||
125127476|NCT04206332|450092303|FG013|Part A|Lost to Follow-up|0|||
125625169|NCT04897594|451910650|FG002|Overall Study|Withdrawal by Subject|1|||
125625170|NCT00150345|451910653|FG000|Overall Study|Death|5|||
125625171|NCT00150345|451910654|FG001|Overall Study|Death|2|||
125625172|NCT00150345|451910653|FG000|Overall Study|Adverse Event|8|||
125625173|NCT00150345|451910654|FG001|Overall Study|Adverse Event|6|||
125625174|NCT00150345|451910653|FG000|Overall Study|Lack of Efficacy|5|||
125625175|NCT00150345|451910654|FG001|Overall Study|Lack of Efficacy|4|||
125625176|NCT00150345|451910653|FG000|Overall Study|Withdrawal by Subject|3|||
125625177|NCT00150345|451910654|FG001|Overall Study|Withdrawal by Subject|4|||
125625178|NCT00150345|451910653|FG000|Overall Study|Laboratory abnormality|1|||
125625179|NCT00150345|451910654|FG001|Overall Study|Laboratory abnormality|2|||
125625180|NCT00150345|451910653|FG000|Overall Study|Other|12|||
125625181|NCT00150345|451910654|FG001|Overall Study|Other|14|||
125625182|NCT01457924|451910657|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
125625183|NCT01457924|451910658|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
125625184|NCT01457924|451910659|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
125625185|NCT01457924|451910660|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
125127477|NCT04206332|450092304|FG014|Part A|Lost to Follow-up|0|||
125127478|NCT04206332|450092305|FG015|Part A|Lost to Follow-up|0|||
125127479|NCT04206332|450092306|FG016|Part A|Lost to Follow-up|0|||
125127480|NCT04206332|450092290|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127481|NCT04206332|450092291|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127482|NCT04206332|450092292|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127483|NCT04206332|450092293|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127484|NCT04206332|450092294|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127485|NCT04206332|450092295|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
125127486|NCT04206332|450092296|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127487|NCT04206332|450092297|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127488|NCT04206332|450092298|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127489|NCT04206332|450092299|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127490|NCT04206332|450092300|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127491|NCT04206332|450092301|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127492|NCT04206332|450092302|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127493|NCT04206332|450092303|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127494|NCT04206332|450092304|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127495|NCT04206332|450092305|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127496|NCT04206332|450092306|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
125127497|NCT04206332|450092290|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127498|NCT04206332|450092291|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127499|NCT04206332|450092292|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127500|NCT04206332|450092293|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127501|NCT04206332|450092294|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125215514|NCT02171429|450417421|FG000|Overall Study|Physician Decision|0|||
125215515|NCT02171429|450417422|FG001|Overall Study|Physician Decision|0|||
125215516|NCT02171429|450417423|FG002|Overall Study|Physician Decision|1|||
125215517|NCT02171429|450417421|FG000|Overall Study|Withdrawal by Subject|1|||
125215518|NCT02171429|450417422|FG001|Overall Study|Withdrawal by Subject|1|||
125215519|NCT02171429|450417423|FG002|Overall Study|Withdrawal by Subject|1|||
125215520|NCT02171429|450417421|FG000|Overall Study|Lost to Follow-up|0|||
125215521|NCT02171429|450417422|FG001|Overall Study|Lost to Follow-up|1|||
125215522|NCT02171429|450417423|FG002|Overall Study|Lost to Follow-up|0|||
125215523|NCT02171429|450417421|FG000|Overall Study|Death|0|||
125215524|NCT02171429|450417422|FG001|Overall Study|Death|0|||
125215525|NCT02171429|450417423|FG002|Overall Study|Death|1|||
125215526|NCT01763203|450417424|FG000|Overall Study|Death|4|||
125215527|NCT01763203|450417425|FG001|Overall Study|Death|7|||
125215528|NCT01763203|450417424|FG000|Overall Study|Lost to Follow-up|12|||
125215529|NCT01763203|450417425|FG001|Overall Study|Lost to Follow-up|12|||
125215530|NCT01763203|450417424|FG000|Overall Study|Withdrawal by Subject|8|||
125215531|NCT01763203|450417425|FG001|Overall Study|Withdrawal by Subject|12|||
125215532|NCT01763203|450417424|FG000|Overall Study|Moved out of study region|7|||
125215533|NCT01763203|450417425|FG001|Overall Study|Moved out of study region|10|||
125215534|NCT01763203|450417424|FG000|Overall Study|Physician Decision|2|||
125215535|NCT01763203|450417425|FG001|Overall Study|Physician Decision|1|||
125215536|NCT02187861|450417426|FG000|Overall Study|Adverse Event|2|||
125215537|NCT02187861|450417427|FG001|Overall Study|Adverse Event|1|||
125215538|NCT02187861|450417428|FG002|Overall Study|Adverse Event|2|||
125215539|NCT02187861|450417429|FG003|Overall Study|Adverse Event|1|||
125215540|NCT02187861|450417426|FG000|Overall Study|Death|0|||
125215541|NCT02187861|450417427|FG001|Overall Study|Death|3|||
125215542|NCT02187861|450417428|FG002|Overall Study|Death|1|||
125215543|NCT02187861|450417429|FG003|Overall Study|Death|2|||
125215544|NCT02187861|450417426|FG000|Overall Study|Physician Decision|0|||
125215545|NCT02187861|450417427|FG001|Overall Study|Physician Decision|1|||
125215546|NCT02187861|450417428|FG002|Overall Study|Physician Decision|0|||
125215547|NCT02187861|450417429|FG003|Overall Study|Physician Decision|3|||
125215548|NCT02187861|450417426|FG000|Overall Study|Progressive Disease|4|||
125215549|NCT02187861|450417427|FG001|Overall Study|Progressive Disease|42|||
125215550|NCT02187861|450417428|FG002|Overall Study|Progressive Disease|19|||
125215551|NCT02187861|450417429|FG003|Overall Study|Progressive Disease|22|||
125215552|NCT02187861|450417426|FG000|Overall Study|Withdrawal by Subject|0|||
125215553|NCT02187861|450417427|FG001|Overall Study|Withdrawal by Subject|0|||
125625186|NCT01457924|451910661|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
125215554|NCT02187861|450417428|FG002|Overall Study|Withdrawal by Subject|3|||
125127502|NCT04206332|450092295|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127503|NCT04206332|450092296|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127504|NCT04206332|450092297|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
125127505|NCT04206332|450092298|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127506|NCT04206332|450092299|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127507|NCT04206332|450092300|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
125127508|NCT04206332|450092301|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127509|NCT04206332|450092302|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127510|NCT04206332|450092303|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127511|NCT04206332|450092304|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127512|NCT04206332|450092305|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127513|NCT04206332|450092306|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127514|NCT04206332|450092290|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127515|NCT04206332|450092291|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127516|NCT04206332|450092292|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127517|NCT04206332|450092293|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127518|NCT04206332|450092294|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127519|NCT04206332|450092295|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127520|NCT04206332|450092296|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127521|NCT04206332|450092297|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127522|NCT04206332|450092298|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127523|NCT04206332|450092299|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127524|NCT04206332|450092300|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127525|NCT04206332|450092301|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127526|NCT04206332|450092302|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127527|NCT04206332|450092303|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127528|NCT04206332|450092304|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127529|NCT04206332|450092305|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
125127530|NCT04206332|450092306|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
125127531|NCT04206332|450092290|FG000|Part C|Withdrawal by Subject|0|||
125127532|NCT04206332|450092291|FG001|Part C|Withdrawal by Subject|0|||
125127533|NCT04206332|450092292|FG002|Part C|Withdrawal by Subject|0|||
125127534|NCT04206332|450092293|FG003|Part C|Withdrawal by Subject|0|||
125127535|NCT04206332|450092294|FG004|Part C|Withdrawal by Subject|0|||
125127536|NCT04206332|450092295|FG005|Part C|Withdrawal by Subject|0|||
125127537|NCT04206332|450092296|FG006|Part C|Withdrawal by Subject|0|||
125127538|NCT04206332|450092297|FG007|Part C|Withdrawal by Subject|0|||
125127539|NCT04206332|450092298|FG008|Part C|Withdrawal by Subject|0|||
125127540|NCT04206332|450092299|FG009|Part C|Withdrawal by Subject|0|||
125127541|NCT04206332|450092300|FG010|Part C|Withdrawal by Subject|0|||
125127542|NCT04206332|450092301|FG011|Part C|Withdrawal by Subject|0|||
125127543|NCT04206332|450092302|FG012|Part C|Withdrawal by Subject|0|||
125127544|NCT04206332|450092303|FG013|Part C|Withdrawal by Subject|0|||
125127545|NCT04206332|450092304|FG014|Part C|Withdrawal by Subject|2|||
125127546|NCT04206332|450092305|FG015|Part C|Withdrawal by Subject|0|||
125127547|NCT04206332|450092306|FG016|Part C|Withdrawal by Subject|0|||
125127548|NCT00912288|450092309|FG000|Overall Study|Death|0|||
125127549|NCT00912288|450092310|FG001|Overall Study|Death|1|||
125127550|NCT00912288|450092309|FG000|Overall Study|Adverse Event|1|||
125127551|NCT00912288|450092310|FG001|Overall Study|Adverse Event|1|||
125127552|NCT00912288|450092309|FG000|Overall Study|Lost to Follow-up|1|||
125127553|NCT00912288|450092310|FG001|Overall Study|Lost to Follow-up|0|||
125127554|NCT00912288|450092309|FG000|Overall Study|Protocol Violation|1|||
125127555|NCT00912288|450092310|FG001|Overall Study|Protocol Violation|0|||
125127556|NCT00912288|450092309|FG000|Overall Study|Withdrawal by Subject|3|||
125374816|NCT00420927|451002271|FG006|Period 2|Took prohibited medication|0|||
125374817|NCT01465997|451002272|FG000|Overall Study|Adverse Event|12|||
125374818|NCT01465997|451002273|FG001|Overall Study|Adverse Event|22|||
125374819|NCT01465997|451002272|FG000|Overall Study|Lack of Efficacy|13|||
125374820|NCT01465997|451002273|FG001|Overall Study|Lack of Efficacy|1|||
125374821|NCT01465997|451002272|FG000|Overall Study|Protocol Violation|1|||
125374822|NCT01465997|451002273|FG001|Overall Study|Protocol Violation|4|||
125374823|NCT01465997|451002272|FG000|Overall Study|Lost to Follow-up|6|||
125127557|NCT00912288|450092310|FG001|Overall Study|Withdrawal by Subject|3|||
125127558|NCT00912288|450092309|FG000|Overall Study|Study terminated by sponsor|34|||
125127559|NCT00912288|450092310|FG001|Overall Study|Study terminated by sponsor|35|||
125127560|NCT00912288|450092309|FG000|Overall Study|Other|1|||
125127561|NCT00912288|450092310|FG001|Overall Study|Other|0|||
125127562|NCT00893464|450092315|FG000|Overall Study|Did not complete therapy/experience PD|0|||
125127563|NCT00893464|450092316|FG001|Overall Study|Did not complete therapy/experience PD|0|||
125127564|NCT00893464|450092317|FG002|Overall Study|Did not complete therapy/experience PD|0|||
125127565|NCT00893464|450092318|FG003|Overall Study|Did not complete therapy/experience PD|0|||
125127566|NCT00893464|450092319|FG004|Overall Study|Did not complete therapy/experience PD|0|||
125127567|NCT00893464|450092320|FG005|Overall Study|Did not complete therapy/experience PD|0|||
125127568|NCT00893464|450092321|FG006|Overall Study|Did not complete therapy/experience PD|2|||
125127569|NCT00893464|450092322|FG007|Overall Study|Did not complete therapy/experience PD|2|||
125127570|NCT00050778|450092323|FG000|Overall Study|Adverse Event|13|||
125127571|NCT00050778|450092324|FG001|Overall Study|Adverse Event|3|||
125127572|NCT00050778|450092325|FG002|Overall Study|Adverse Event|2|||
125127573|NCT00050778|450092323|FG000|Overall Study|Death|0|||
125127574|NCT00050778|450092324|FG001|Overall Study|Death|1|||
125127575|NCT00050778|450092325|FG002|Overall Study|Death|1|||
125127576|NCT00050778|450092323|FG000|Overall Study|Lack of Efficacy|16|||
125127577|NCT00050778|450092324|FG001|Overall Study|Lack of Efficacy|2|||
125127578|NCT00050778|450092325|FG002|Overall Study|Lack of Efficacy|2|||
125127579|NCT00050778|450092323|FG000|Overall Study|Lost to Follow-up|0|||
125127580|NCT00050778|450092324|FG001|Overall Study|Lost to Follow-up|2|||
125127581|NCT00050778|450092325|FG002|Overall Study|Lost to Follow-up|4|||
125127582|NCT00050778|450092323|FG000|Overall Study|Physician Decision|3|||
125127583|NCT00050778|450092324|FG001|Overall Study|Physician Decision|0|||
125127584|NCT00050778|450092325|FG002|Overall Study|Physician Decision|2|||
125127585|NCT00050778|450092323|FG000|Overall Study|Protocol Violation|2|||
125127586|NCT00050778|450092324|FG001|Overall Study|Protocol Violation|0|||
125127587|NCT00050778|450092325|FG002|Overall Study|Protocol Violation|1|||
125127588|NCT00050778|450092323|FG000|Overall Study|Withdrawal by Subject|6|||
125127589|NCT00050778|450092324|FG001|Overall Study|Withdrawal by Subject|8|||
125127590|NCT00050778|450092325|FG002|Overall Study|Withdrawal by Subject|4|||
125127591|NCT00050778|450092323|FG000|Overall Study|Randomized but not treated|4|||
125127592|NCT00050778|450092324|FG001|Overall Study|Randomized but not treated|5|||
125127593|NCT00050778|450092325|FG002|Overall Study|Randomized but not treated|2|||
125127594|NCT00050778|450092323|FG000|Overall Study|Familial and personal reasons|1|||
125127595|NCT00050778|450092324|FG001|Overall Study|Familial and personal reasons|0|||
125127596|NCT00050778|450092325|FG002|Overall Study|Familial and personal reasons|0|||
125127597|NCT01126736|450092329|FG000|Overall Study|Death|2|||
125127598|NCT01126736|450092330|FG001|Overall Study|Death|2|||
125127599|NCT01126736|450092331|FG002|Overall Study|Death|1|||
125127600|NCT01126736|450092332|FG003|Overall Study|Death|19|||
125127601|NCT01126736|450092333|FG004|Overall Study|Death|19|||
125127602|NCT01126736|450092329|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
125127603|NCT01126736|450092330|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
125127604|NCT01126736|450092331|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
125127605|NCT01126736|450092332|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
125127606|NCT01126736|450092333|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
125127607|NCT01126736|450092329|FG000|Overall Study|Lost to Follow-up|0|||
125127608|NCT01126736|450092330|FG001|Overall Study|Lost to Follow-up|0|||
125127609|NCT01126736|450092331|FG002|Overall Study|Lost to Follow-up|0|||
125127610|NCT01126736|450092332|FG003|Overall Study|Lost to Follow-up|1|||
125127611|NCT01126736|450092333|FG004|Overall Study|Lost to Follow-up|1|||
125127612|NCT01126736|450092329|FG000|Overall Study|Administrative reasons|0|||
125127613|NCT01126736|450092330|FG001|Overall Study|Administrative reasons|0|||
125127614|NCT01126736|450092331|FG002|Overall Study|Administrative reasons|0|||
125127615|NCT01126736|450092332|FG003|Overall Study|Administrative reasons|0|||
125127616|NCT01126736|450092333|FG004|Overall Study|Administrative reasons|1|||
125127617|NCT01126736|450092329|FG000|Overall Study|Progressive disease|0|||
125625187|NCT01457924|451910657|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
125625188|NCT01457924|451910658|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
125625189|NCT01457924|451910659|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
125127618|NCT01126736|450092330|FG001|Overall Study|Progressive disease|0|||
125127619|NCT01126736|450092331|FG002|Overall Study|Progressive disease|0|||
125127620|NCT01126736|450092332|FG003|Overall Study|Progressive disease|2|||
125127621|NCT01126736|450092333|FG004|Overall Study|Progressive disease|1|||
125127622|NCT01126736|450092329|FG000|Overall Study|Withdrawal by Subject|0|||
125127623|NCT01126736|450092330|FG001|Overall Study|Withdrawal by Subject|0|||
125127624|NCT01126736|450092331|FG002|Overall Study|Withdrawal by Subject|0|||
125625190|NCT01457924|451910660|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
125127625|NCT01126736|450092332|FG003|Overall Study|Withdrawal by Subject|1|||
125127626|NCT01126736|450092333|FG004|Overall Study|Withdrawal by Subject|1|||
125127627|NCT01126736|450092329|FG000|Overall Study|Other|2|||
125625191|NCT01457924|451910661|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
125625192|NCT01457924|451910657|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
125625193|NCT01457924|451910658|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
125625194|NCT01457924|451910659|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
125127628|NCT01126736|450092330|FG001|Overall Study|Other|4|||
125625195|NCT01457924|451910660|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
125625196|NCT01457924|451910661|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
125625197|NCT01457924|451910657|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
125625198|NCT01457924|451910658|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
125625199|NCT01457924|451910659|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
125625200|NCT01457924|451910660|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
125625201|NCT01457924|451910661|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
125625202|NCT01457924|451910657|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
125625203|NCT01457924|451910658|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
125625204|NCT01457924|451910659|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
125625205|NCT01457924|451910660|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
125625206|NCT01457924|451910661|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
125625207|NCT01457924|451910657|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
125127629|NCT01126736|450092331|FG002|Overall Study|Other|4|||
125127630|NCT01126736|450092332|FG003|Overall Study|Other|16|||
125127631|NCT01126736|450092333|FG004|Overall Study|Other|15|||
125127632|NCT04869787|450092335|FG000|Screening|Physician Decision|1|||
125127633|NCT04869787|450092335|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
125127634|NCT00813293|450092336|FG000|Overall Study|Intercurrent illness|1|||
125127635|NCT00813293|450092337|FG001|Overall Study|Intercurrent illness|0|||
125127636|NCT00813293|450092336|FG000|Overall Study|Adverse Event|0|||
125127637|NCT00813293|450092337|FG001|Overall Study|Adverse Event|1|||
125127638|NCT00282048|450092339|FG000|Overall Study|Lack of Efficacy|30|||
125127639|NCT00282048|450092339|FG000|Overall Study|Adverse Event|22|||
125127640|NCT00282048|450092339|FG000|Overall Study|Withdrawal by Subject|1|||
125127641|NCT00282048|450092339|FG000|Overall Study|Other|8|||
125127642|NCT00282048|450092339|FG000|Overall Study|Ongoing|1|||
125127643|NCT01536405|450092340|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
125127644|NCT01536405|450092341|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
125127645|NCT01536405|450092340|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
125127646|NCT01536405|450092341|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
125127647|NCT01536405|450092340|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
125127648|NCT01536405|450092341|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
125127649|NCT01536405|450092340|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
125127650|NCT01536405|450092341|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
125127651|NCT01536405|450092340|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
125127652|NCT01536405|450092341|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
125127653|NCT01536405|450092340|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
125127654|NCT01536405|450092341|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
125127655|NCT01536405|450092340|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
125127656|NCT01536405|450092341|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
125127657|NCT01536405|450092340|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
125127658|NCT01536405|450092341|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
125127659|NCT01536405|450092340|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
125127660|NCT01536405|450092341|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
125127661|NCT01536405|450092340|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
125127662|NCT01536405|450092341|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
125127663|NCT01536405|450092340|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
125127664|NCT01536405|450092341|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
125127665|NCT01536405|450092340|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
125127666|NCT01536405|450092341|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
125127667|NCT01536405|450092340|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
125127668|NCT01536405|450092341|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
125127669|NCT00301366|450092342|FG000|Overall Study|Adverse Event|1|||
125625208|NCT01457924|451910658|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
125625209|NCT01457924|451910659|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
125127670|NCT04213326|450092343|FG000|Overall Study|Consent withdrawn|51|||
125127671|NCT04213326|450092344|FG001|Overall Study|Consent withdrawn|241|||
125127672|NCT04213326|450092343|FG000|Overall Study|Lost to Follow-up|50|||
125127673|NCT04213326|450092344|FG001|Overall Study|Lost to Follow-up|902|||
125625210|NCT01457924|451910660|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
125625211|NCT01457924|451910661|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
125625212|NCT01457924|451910657|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
125127674|NCT04213326|450092343|FG000|Overall Study|Protocol Violation|3|||
125127675|NCT04213326|450092344|FG001|Overall Study|Protocol Violation|25|||
125127676|NCT04213326|450092343|FG000|Overall Study|Participant eligibility changed|106|||
125625213|NCT01457924|451910658|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
125625214|NCT01457924|451910659|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
125127677|NCT04213326|450092344|FG001|Overall Study|Participant eligibility changed|19|||
125127678|NCT04213326|450092343|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
125127679|NCT04213326|450092344|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
125127680|NCT04213326|450092343|FG000|Overall Study|Incomplete study visit|0|||
125127681|NCT04213326|450092344|FG001|Overall Study|Incomplete study visit|367|||
125127682|NCT02549092|450092347|FG000|Treatment Period|Adverse Event|2|||
125127683|NCT02549092|450092348|FG001|Treatment Period|Adverse Event|2|||
125127684|NCT02549092|450092347|FG000|Treatment Period|Withdrawal by Subject|1|||
125127685|NCT02549092|450092348|FG001|Treatment Period|Withdrawal by Subject|3|||
125127686|NCT02549092|450092347|FG000|Treatment Period|Lack of Efficacy|0|||
125127687|NCT02549092|450092348|FG001|Treatment Period|Lack of Efficacy|2|||
125127688|NCT02549092|450092347|FG000|Extension/Transition Period|Adverse Event|1|||
125127689|NCT02549092|450092348|FG001|Extension/Transition Period|Adverse Event|1|||
125127690|NCT02549092|450092347|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
125127691|NCT02549092|450092348|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
125127692|NCT02549092|450092347|FG000|Extension/Transition Period|Other, Not Specified|4|||
125127693|NCT02549092|450092348|FG001|Extension/Transition Period|Other, Not Specified|2|||
125127694|NCT02511782|450092349|FG000|Overall Study|Withdrawal by Subject|1|||
125127695|NCT02511782|450092350|FG001|Overall Study|Withdrawal by Subject|0|||
125127696|NCT02511782|450092351|FG002|Overall Study|Withdrawal by Subject|0|||
125127697|NCT03627091|450092352|FG000|Overall Study|Adverse Event|0|||
125127698|NCT03627091|450092353|FG001|Overall Study|Adverse Event|0|||
125127699|NCT03627091|450092354|FG002|Overall Study|Adverse Event|2|||
125127700|NCT03627091|450092352|FG000|Overall Study|Withdrawal by Subject|2|||
125127701|NCT03627091|450092353|FG001|Overall Study|Withdrawal by Subject|0|||
125127702|NCT03627091|450092354|FG002|Overall Study|Withdrawal by Subject|2|||
125127703|NCT03627091|450092352|FG000|Overall Study|Physician Decision|2|||
125127704|NCT03627091|450092353|FG001|Overall Study|Physician Decision|0|||
125127705|NCT03627091|450092354|FG002|Overall Study|Physician Decision|0|||
125127706|NCT03627091|450092352|FG000|Overall Study|Site terminated by sponsor|0|||
125127707|NCT03627091|450092353|FG001|Overall Study|Site terminated by sponsor|1|||
125127708|NCT03627091|450092354|FG002|Overall Study|Site terminated by sponsor|0|||
125127709|NCT03627091|450092352|FG000|Overall Study|Disease relapse|7|||
125127710|NCT03627091|450092353|FG001|Overall Study|Disease relapse|5|||
125127711|NCT03627091|450092354|FG002|Overall Study|Disease relapse|1|||
125127712|NCT03627091|450092352|FG000|Overall Study|Other|1|||
125127713|NCT03627091|450092353|FG001|Overall Study|Other|0|||
125127714|NCT03627091|450092354|FG002|Overall Study|Other|0|||
125127715|NCT00450190|450092355|FG000|Overall Study|Withdrawal by Subject|2|||
125127716|NCT04149964|450092367|FG000|Overall Study|Lost to Follow-up|19|||
125215555|NCT02187861|450417429|FG003|Overall Study|Withdrawal by Subject|3|||
125215556|NCT02187861|450417426|FG000|Overall Study|Other|0|||
125374824|NCT01465997|451002273|FG001|Overall Study|Lost to Follow-up|9|||
125374825|NCT01465997|451002272|FG000|Overall Study|Withdrawal by Subject|32|||
125374826|NCT01465997|451002273|FG001|Overall Study|Withdrawal by Subject|35|||
125374827|NCT01465997|451002272|FG000|Overall Study|investigator's decision|1|||
125374828|NCT01465997|451002273|FG001|Overall Study|investigator's decision|1|||
125374829|NCT01465997|451002272|FG000|Overall Study|Death|0|||
125374830|NCT01465997|451002273|FG001|Overall Study|Death|1|||
125374831|NCT01465997|451002272|FG000|Overall Study|sponsor's decision|1|||
125374832|NCT01465997|451002273|FG001|Overall Study|sponsor's decision|1|||
125374833|NCT01465997|451002272|FG000|Overall Study|subject withdrew consent|1|||
125374834|NCT01465997|451002273|FG001|Overall Study|subject withdrew consent|0|||
125374835|NCT01465997|451002272|FG000|Overall Study|local lab unblinded site|1|||
125374836|NCT01465997|451002273|FG001|Overall Study|local lab unblinded site|0|||
125374837|NCT01465997|451002272|FG000|Overall Study|withdrew before follow-up|0|||
125374838|NCT01465997|451002273|FG001|Overall Study|withdrew before follow-up|13|||
125374839|NCT01465997|451002272|FG000|Overall Study|decision by site staff|0|||
125374840|NCT01465997|451002273|FG001|Overall Study|decision by site staff|1|||
125374841|NCT01465997|451002272|FG000|Overall Study|subject left participation SP0993|0|||
125374842|NCT01465997|451002273|FG001|Overall Study|subject left participation SP0993|1|||
125374843|NCT02246660|451002274|FG000|Overall Study|Withdrawal by Subject|0|||
125374844|NCT02246660|451002275|FG001|Overall Study|Withdrawal by Subject|1|||
125374845|NCT02246660|451002276|FG002|Overall Study|Withdrawal by Subject|0|||
125374846|NCT02246660|451002274|FG000|Overall Study|Death|0|||
125374847|NCT02246660|451002275|FG001|Overall Study|Death|0|||
125374848|NCT02246660|451002276|FG002|Overall Study|Death|1|||
125433214|NCT00116844|451212471|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
125127717|NCT04149964|450092368|FG001|Overall Study|Lost to Follow-up|18|||
125127718|NCT04753437|450092369|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125127719|NCT04753437|450092370|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
125374849|NCT03018704|451002277|FG000|Overall Study|Lost to Follow-up|1|||
125374850|NCT03018704|451002278|FG001|Overall Study|Lost to Follow-up|1|||
125374851|NCT00642460|451002281|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
125374852|NCT00642460|451002282|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
125127720|NCT04753437|450092369|FG000|Overall Study|Liver Function Test Abnormalities|2|||
125127721|NCT04753437|450092370|FG001|Overall Study|Liver Function Test Abnormalities|4|||
125127722|NCT02424097|450094005|FG000|Overall Study|Lost to Follow-up|1|||
125127723|NCT02424097|450094006|FG001|Overall Study|Lost to Follow-up|2|||
125127724|NCT02311361|450094007|FG000|Overall Study|Did not receive treatment|0|||
125127725|NCT02311361|450094008|FG001|Overall Study|Did not receive treatment|1|||
125127726|NCT02311361|450094009|FG002|Overall Study|Did not receive treatment|0|||
125127727|NCT02311361|450094010|FG003|Overall Study|Did not receive treatment|1|||
125127728|NCT00745420|450094012|FG000|Overall Study|Ineligible|1|||
125127729|NCT02653664|450094013|FG000|Post-Treatment|Withdrawal by Subject|6|||
125127730|NCT02653664|450094014|FG001|Post-Treatment|Withdrawal by Subject|5|||
125127731|NCT02653664|450094015|FG002|Post-Treatment|Withdrawal by Subject|7|||
125127732|NCT02653664|450094013|FG000|Post-Treatment|Lost to Follow-up|8|||
125127733|NCT02653664|450094014|FG001|Post-Treatment|Lost to Follow-up|1|||
125127734|NCT02653664|450094015|FG002|Post-Treatment|Lost to Follow-up|7|||
125127735|NCT02653664|450094013|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
125127736|NCT02653664|450094014|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
125127737|NCT02653664|450094015|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
125127738|NCT02653664|450094013|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
125127739|NCT02653664|450094014|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
125127740|NCT02653664|450094015|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
125127741|NCT02653664|450094013|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
125127742|NCT02653664|450094014|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
125127743|NCT02653664|450094015|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
125127744|NCT02653664|450094013|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
125127745|NCT02653664|450094014|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
125127746|NCT02653664|450094015|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
125127747|NCT02653664|450094013|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
125127748|NCT02653664|450094014|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
125127749|NCT02653664|450094015|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
125127750|NCT02653664|450094013|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
125127751|NCT02653664|450094014|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
125127752|NCT02653664|450094015|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
125127753|NCT02653664|450094013|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
125127754|NCT02653664|450094014|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
125127755|NCT02653664|450094015|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
125127756|NCT02653664|450094013|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
125127757|NCT02653664|450094014|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
125127758|NCT02653664|450094015|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
125127759|NCT04657770|450094016|FG000|Overall Study|Withdrawal by Subject|3|||
125127760|NCT04657770|450094016|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
125127761|NCT00746798|450094017|FG000|Overall Study|Protocol Violation|0|||
125127762|NCT00746798|450094018|FG001|Overall Study|Protocol Violation|1|||
125127763|NCT00746798|450094019|FG002|Overall Study|Protocol Violation|0|||
125127764|NCT00746798|450094020|FG003|Overall Study|Protocol Violation|0|||
125127765|NCT00746798|450094017|FG000|Overall Study|Withdrawal by Subject|0|||
125127766|NCT00746798|450094018|FG001|Overall Study|Withdrawal by Subject|1|||
125127767|NCT00746798|450094019|FG002|Overall Study|Withdrawal by Subject|1|||
125127768|NCT00746798|450094020|FG003|Overall Study|Withdrawal by Subject|0|||
125127769|NCT00746798|450094017|FG000|Overall Study|Death|0|||
125127770|NCT00746798|450094018|FG001|Overall Study|Death|0|||
125127771|NCT00746798|450094019|FG002|Overall Study|Death|2|||
125127772|NCT00746798|450094020|FG003|Overall Study|Death|0|||
125127773|NCT00746798|450094017|FG000|Overall Study|Participant unable to return for visit|1|||
125127774|NCT00746798|450094018|FG001|Overall Study|Participant unable to return for visit|0|||
125127775|NCT00746798|450094019|FG002|Overall Study|Participant unable to return for visit|0|||
125625215|NCT01457924|451910660|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
125625216|NCT01457924|451910661|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
125625217|NCT01457924|451910657|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
125127776|NCT00746798|450094020|FG003|Overall Study|Participant unable to return for visit|0|||
125127777|NCT03655106|450094021|FG000|Overall Study|Withdrawal by Subject|3|||
125625218|NCT01457924|451910658|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
125625219|NCT01457924|451910659|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
125625220|NCT01457924|451910660|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
125127778|NCT03655106|450094022|FG001|Overall Study|Withdrawal by Subject|2|||
125127779|NCT03655106|450094021|FG000|Overall Study|Lost to Follow-up|2|||
125127780|NCT03655106|450094022|FG001|Overall Study|Lost to Follow-up|1|||
125127781|NCT03655106|450094021|FG000|Overall Study|Duplicate Enrollment|1|||
125127782|NCT03655106|450094022|FG001|Overall Study|Duplicate Enrollment|1|||
125127783|NCT03655106|450094021|FG000|Overall Study|Protocol Violation|3|||
125625221|NCT01457924|451910661|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
125625222|NCT01457924|451910657|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
125625223|NCT01457924|451910658|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
125127784|NCT03655106|450094022|FG001|Overall Study|Protocol Violation|0|||
125127785|NCT01367457|450094032|FG000|Overall Study|Death|2|||
125127786|NCT01367457|450094033|FG001|Overall Study|Death|0|||
125127787|NCT01367457|450094034|FG002|Overall Study|Death|0|||
125127788|NCT01367457|450094032|FG000|Overall Study|Investigator's decision|2|||
125127789|NCT01367457|450094033|FG001|Overall Study|Investigator's decision|0|||
125127790|NCT01367457|450094034|FG002|Overall Study|Investigator's decision|0|||
125127791|NCT01367457|450094032|FG000|Overall Study|Clinical decline (CD)|2|||
125127792|NCT01367457|450094033|FG001|Overall Study|Clinical decline (CD)|0|||
125127793|NCT01367457|450094034|FG002|Overall Study|Clinical decline (CD)|0|||
125127794|NCT01367457|450094032|FG000|Overall Study|Progression and death|8|||
125127795|NCT01367457|450094033|FG001|Overall Study|Progression and death|0|||
125127796|NCT01367457|450094034|FG002|Overall Study|Progression and death|0|||
125127797|NCT01367457|450094032|FG000|Overall Study|Toxicity|16|||
125127798|NCT01367457|450094033|FG001|Overall Study|Toxicity|0|||
125127799|NCT01367457|450094034|FG002|Overall Study|Toxicity|0|||
125127800|NCT01367457|450094032|FG000|Overall Study|Progression|137|||
125433215|NCT00116844|451212470|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
125433216|NCT00116844|451212471|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
125433217|NCT00116844|451212470|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
125433218|NCT00116844|451212471|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
125433219|NCT00116844|451212470|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
125433220|NCT00116844|451212471|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
125433221|NCT00116844|451212470|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
125433222|NCT00116844|451212471|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
125433223|NCT00116844|451212470|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
125433224|NCT00116844|451212471|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
125433225|NCT00116844|451212470|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
125433226|NCT00116844|451212471|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
125433227|NCT00116844|451212470|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
125433228|NCT00116844|451212471|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
125433229|NCT03474549|451212472|FG000|Overall Study|Death|31|||
125433230|NCT03474549|451212472|FG000|Overall Study|Lost to Follow-up|4|||
125433231|NCT03474549|451212472|FG000|Overall Study|Withdrawal by Subject|2|||
125433232|NCT00738101|451212476|FG000|Overall Study|Physician Decision|5|||
125433233|NCT00738101|451212476|FG000|Overall Study|Death|1|||
125433234|NCT00738101|451212476|FG000|Overall Study|Repeat enrollment|1|||
125433235|NCT03445065|451212482|FG000|Overall Study|Withdrawal by Subject|3|||
125433236|NCT03445065|451212483|FG001|Overall Study|Withdrawal by Subject|6|||
125433237|NCT03445065|451212484|FG002|Overall Study|Withdrawal by Subject|2|||
125433238|NCT03445065|451212485|FG003|Overall Study|Withdrawal by Subject|2|||
125433239|NCT03445065|451212482|FG000|Overall Study|Other|4|||
125433240|NCT03445065|451212483|FG001|Overall Study|Other|3|||
125433241|NCT03445065|451212484|FG002|Overall Study|Other|3|||
125433242|NCT03445065|451212485|FG003|Overall Study|Other|1|||
125433243|NCT03315130|451212486|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
125433244|NCT03315130|451212487|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
125433245|NCT03315130|451212488|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
125433246|NCT03315130|451212489|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
125433247|NCT03315130|451212486|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
125433248|NCT03315130|451212487|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
125433249|NCT03315130|451212488|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
125625224|NCT01457924|451910659|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
125625225|NCT01457924|451910660|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
125625226|NCT01457924|451910661|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
125127801|NCT01367457|450094033|FG001|Overall Study|Progression|0|||
125127802|NCT01367457|450094034|FG002|Overall Study|Progression|0|||
125127803|NCT01367457|450094032|FG000|Overall Study|Patient asks for rest + slow progression|1|||
125127804|NCT01367457|450094033|FG001|Overall Study|Patient asks for rest + slow progression|0|||
125127805|NCT01367457|450094034|FG002|Overall Study|Patient asks for rest + slow progression|0|||
125127806|NCT01367457|450094032|FG000|Overall Study|Investigator's opinion, stable disease|1|||
125127807|NCT01367457|450094033|FG001|Overall Study|Investigator's opinion, stable disease|0|||
125127808|NCT01367457|450094034|FG002|Overall Study|Investigator's opinion, stable disease|0|||
125215557|NCT02187861|450417427|FG001|Overall Study|Other|1|||
125215558|NCT02187861|450417428|FG002|Overall Study|Other|7|||
125625227|NCT01457924|451910657|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
125127809|NCT01367457|450094032|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
125433250|NCT03315130|451212489|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
125433251|NCT03315130|451212486|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
125433252|NCT03315130|451212487|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
125625228|NCT01457924|451910658|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
125625229|NCT01457924|451910659|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
125127810|NCT01367457|450094033|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
125127811|NCT01367457|450094034|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
125374853|NCT00642460|451002283|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
125374854|NCT00642460|451002284|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
125374855|NCT00642460|451002285|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
125374856|NCT00642460|451002286|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
125374857|NCT00642460|451002281|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
125374858|NCT00642460|451002282|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
125625230|NCT01457924|451910660|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
125625231|NCT01457924|451910661|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
125625232|NCT01457924|451910657|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
125625233|NCT01457924|451910658|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
125625234|NCT01457924|451910659|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
125625235|NCT01457924|451910660|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
125625236|NCT01457924|451910661|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
125625237|NCT01457924|451910657|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
125625238|NCT01457924|451910658|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
125625239|NCT01457924|451910659|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
125127812|NCT01367457|450094032|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
125127813|NCT01367457|450094033|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
125127814|NCT01367457|450094034|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
125127815|NCT01367457|450094032|FG000|Overall Study|low grade toxicities + stable disease|1|||
125127816|NCT01367457|450094033|FG001|Overall Study|low grade toxicities + stable disease|0|||
125127817|NCT01367457|450094034|FG002|Overall Study|low grade toxicities + stable disease|0|||
125127818|NCT01367457|450094032|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
125127819|NCT01367457|450094033|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
125127820|NCT01367457|450094034|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
125127821|NCT01367457|450094032|FG000|Overall Study|Withdrawal by Subject|1|||
125127822|NCT01367457|450094033|FG001|Overall Study|Withdrawal by Subject|0|||
125127823|NCT01367457|450094034|FG002|Overall Study|Withdrawal by Subject|0|||
125127824|NCT01367457|450094032|FG000|Overall Study|CD, associated leukaemia|1|||
125127825|NCT01367457|450094033|FG001|Overall Study|CD, associated leukaemia|0|||
125127826|NCT01367457|450094034|FG002|Overall Study|CD, associated leukaemia|0|||
125127827|NCT01367457|450094032|FG000|Overall Study|Uncontrolled pain|1|||
125127828|NCT01367457|450094033|FG001|Overall Study|Uncontrolled pain|0|||
125127829|NCT01367457|450094034|FG002|Overall Study|Uncontrolled pain|0|||
125127830|NCT01367457|450094032|FG000|Overall Study|Overall status worsens to grade 4|1|||
125127831|NCT01367457|450094033|FG001|Overall Study|Overall status worsens to grade 4|0|||
125127832|NCT01367457|450094034|FG002|Overall Study|Overall status worsens to grade 4|0|||
125127833|NCT01367457|450094032|FG000|Overall Study|Stabilisation + frequent infections|1|||
125127834|NCT01367457|450094033|FG001|Overall Study|Stabilisation + frequent infections|0|||
125127835|NCT01367457|450094034|FG002|Overall Study|Stabilisation + frequent infections|0|||
125127836|NCT01367457|450094032|FG000|Overall Study|No clinical benefit|1|||
125127837|NCT01367457|450094033|FG001|Overall Study|No clinical benefit|0|||
125127838|NCT01367457|450094034|FG002|Overall Study|No clinical benefit|0|||
125127839|NCT01367457|450094032|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
125127840|NCT01367457|450094033|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
125127841|NCT01367457|450094034|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
125127842|NCT01367457|450094032|FG000|Overall Study|Overall decline|1|||
125127843|NCT01367457|450094033|FG001|Overall Study|Overall decline|0|||
125127844|NCT01367457|450094034|FG002|Overall Study|Overall decline|0|||
125127845|NCT01367457|450094032|FG000|Overall Study|Rejection of treatment|1|||
125127846|NCT01367457|450094033|FG001|Overall Study|Rejection of treatment|0|||
125127847|NCT01367457|450094034|FG002|Overall Study|Rejection of treatment|0|||
125127848|NCT01367457|450094032|FG000|Overall Study|Lost to Follow-up|1|||
125127849|NCT01367457|450094033|FG001|Overall Study|Lost to Follow-up|0|||
125127850|NCT01367457|450094034|FG002|Overall Study|Lost to Follow-up|0|||
125127851|NCT01367457|450094032|FG000|Overall Study|Death from septic shock|1|||
125127852|NCT01367457|450094033|FG001|Overall Study|Death from septic shock|0|||
125127853|NCT01367457|450094034|FG002|Overall Study|Death from septic shock|0|||
125127854|NCT01367457|450094032|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
125127855|NCT01367457|450094033|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
125127856|NCT01367457|450094034|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
125127857|NCT01367457|450094032|FG000|Overall Study|Patient's Wish|1|||
125127858|NCT01367457|450094033|FG001|Overall Study|Patient's Wish|0|||
125127859|NCT01367457|450094034|FG002|Overall Study|Patient's Wish|0|||
125127860|NCT01367457|450094032|FG000|Overall Study|Palliative. Overall decline|1|||
125127861|NCT01367457|450094033|FG001|Overall Study|Palliative. Overall decline|0|||
125127862|NCT01367457|450094034|FG002|Overall Study|Palliative. Overall decline|0|||
125127863|NCT01367457|450094032|FG000|Overall Study|Suspected DP/suspected active infection|1|||
125127864|NCT01367457|450094033|FG001|Overall Study|Suspected DP/suspected active infection|0|||
125215559|NCT02187861|450417429|FG003|Overall Study|Other|1|||
125374859|NCT00642460|451002283|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
125374860|NCT00642460|451002284|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
125374861|NCT00642460|451002285|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
125374862|NCT00642460|451002286|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
125374863|NCT00642460|451002281|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
125374864|NCT00642460|451002282|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
125374865|NCT00642460|451002283|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
125374866|NCT00642460|451002284|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
125374867|NCT00642460|451002285|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
125374868|NCT00642460|451002286|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
125374869|NCT00642460|451002281|FG000|Part II: Open-Label Up to Week 92|Death|0|||
125127865|NCT01367457|450094034|FG002|Overall Study|Suspected DP/suspected active infection|0|||
125374870|NCT00642460|451002282|FG001|Part II: Open-Label Up to Week 92|Death|1|||
125637271|NCT03073200|451952832|FG000|Randomized Withdrawal Period|Adverse Event|0|||
125127866|NCT01882257|450094037|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
125127867|NCT01882257|450094038|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
125127868|NCT01882257|450094039|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
125127869|NCT01882257|450094037|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
125127870|NCT01882257|450094038|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
125127871|NCT01882257|450094039|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
125127872|NCT02058498|450094040|FG000|Overall Study|Withdrawal by Subject|4|||
125127873|NCT01391793|450094044|FG000|Overall Study|Ineligible|3|||
125127874|NCT01391793|450094045|FG001|Overall Study|Ineligible|0|||
125127875|NCT01391793|450094044|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
125127876|NCT01391793|450094045|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
125127877|NCT01391793|450094044|FG000|Overall Study|No DMSA|73|||
125127878|NCT01391793|450094045|FG001|Overall Study|No DMSA|57|||
125127879|NCT01666730|450094046|FG000|Overall Study|Adverse Event|16|||
125127880|NCT01666730|450094046|FG000|Overall Study|Death|2|||
125127881|NCT01666730|450094046|FG000|Overall Study|Physician Decision|5|||
125127882|NCT01666730|450094046|FG000|Overall Study|Withdrawal by Subject|9|||
125127883|NCT01666730|450094046|FG000|Overall Study|Disease progression/relapse|18|||
125127884|NCT02087904|450094047|FG000|Overall Study|Did Not Receive Study Drug|0|||
125127885|NCT02087904|450094048|FG001|Overall Study|Did Not Receive Study Drug|0|||
125127886|NCT02087904|450094049|FG002|Overall Study|Did Not Receive Study Drug|2|||
125127887|NCT02087904|450094050|FG003|Overall Study|Did Not Receive Study Drug|1|||
125127888|NCT02087904|450094047|FG000|Overall Study|Adverse Event|8|||
125127889|NCT02087904|450094048|FG001|Overall Study|Adverse Event|4|||
125127890|NCT02087904|450094049|FG002|Overall Study|Adverse Event|4|||
125127891|NCT02087904|450094050|FG003|Overall Study|Adverse Event|12|||
125127892|NCT02087904|450094047|FG000|Overall Study|Lack of Efficacy|3|||
125127893|NCT02087904|450094048|FG001|Overall Study|Lack of Efficacy|6|||
125433253|NCT03315130|451212488|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
125127894|NCT02087904|450094049|FG002|Overall Study|Lack of Efficacy|3|||
125127895|NCT02087904|450094050|FG003|Overall Study|Lack of Efficacy|2|||
125127896|NCT02087904|450094047|FG000|Overall Study|Other|6|||
125433254|NCT03315130|451212489|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
125433255|NCT03315130|451212486|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
125433256|NCT03315130|451212487|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
125433257|NCT03315130|451212488|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
125433258|NCT03315130|451212489|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
125433259|NCT03315130|451212486|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
125433260|NCT03315130|451212487|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
125433261|NCT03315130|451212488|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
125127897|NCT02087904|450094048|FG001|Overall Study|Other|2|||
125127898|NCT02087904|450094049|FG002|Overall Study|Other|4|||
125127899|NCT02087904|450094050|FG003|Overall Study|Other|4|||
125127900|NCT02087904|450094047|FG000|Overall Study|Withdrawal by Subject|8|||
125127901|NCT02087904|450094048|FG001|Overall Study|Withdrawal by Subject|3|||
125127902|NCT02087904|450094049|FG002|Overall Study|Withdrawal by Subject|7|||
125127903|NCT02087904|450094050|FG003|Overall Study|Withdrawal by Subject|4|||
125127904|NCT02087904|450094047|FG000|Overall Study|Lost to Follow-up|0|||
125127905|NCT02087904|450094048|FG001|Overall Study|Lost to Follow-up|4|||
125127906|NCT02087904|450094049|FG002|Overall Study|Lost to Follow-up|2|||
125127907|NCT02087904|450094050|FG003|Overall Study|Lost to Follow-up|2|||
125127908|NCT01389102|450094052|FG000|Overall Study|Adverse Event|1|||
125127909|NCT01389102|450094053|FG001|Overall Study|Adverse Event|3|||
125127910|NCT01389102|450094054|FG002|Overall Study|Adverse Event|2|||
125127911|NCT01389102|450094055|FG003|Overall Study|Adverse Event|2|||
125127912|NCT01389102|450094056|FG004|Overall Study|Adverse Event|2|||
125127913|NCT01389102|450094057|FG005|Overall Study|Adverse Event|2|||
125127914|NCT01389102|450094052|FG000|Overall Study|Hurricane Katrina|4|||
125127915|NCT01389102|450094053|FG001|Overall Study|Hurricane Katrina|2|||
125127916|NCT01389102|450094054|FG002|Overall Study|Hurricane Katrina|3|||
125127917|NCT01389102|450094055|FG003|Overall Study|Hurricane Katrina|0|||
125127918|NCT01389102|450094056|FG004|Overall Study|Hurricane Katrina|3|||
125127919|NCT01389102|450094057|FG005|Overall Study|Hurricane Katrina|1|||
125127920|NCT01389102|450094052|FG000|Overall Study|Lost to Follow-up|4|||
125215560|NCT02768792|450417433|FG000|Overall Study|Adverse Event|1|||
125215561|NCT05980013|450417434|FG000|Overall Study|Withdrawal by Subject|0|||
125433262|NCT03315130|451212489|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
125625240|NCT01457924|451910660|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
125625241|NCT01457924|451910661|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
125127921|NCT01389102|450094053|FG001|Overall Study|Lost to Follow-up|1|||
125127922|NCT01389102|450094054|FG002|Overall Study|Lost to Follow-up|1|||
125215562|NCT05980013|450417435|FG001|Overall Study|Withdrawal by Subject|1|||
125127923|NCT01389102|450094055|FG003|Overall Study|Lost to Follow-up|2|||
125127924|NCT01389102|450094056|FG004|Overall Study|Lost to Follow-up|4|||
125215563|NCT05980013|450417434|FG000|Overall Study|Device Error|0|||
125127925|NCT01389102|450094057|FG005|Overall Study|Lost to Follow-up|1|||
125127926|NCT01389102|450094052|FG000|Overall Study|Protocol Violation|0|||
125215564|NCT05980013|450417435|FG001|Overall Study|Device Error|1|||
125625242|NCT01457924|451910657|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
125625243|NCT01457924|451910658|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
125625244|NCT01457924|451910659|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
125625245|NCT01457924|451910660|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
125625246|NCT01457924|451910661|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
125625247|NCT01628393|451910662|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
125625248|NCT01628393|451910663|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
125625249|NCT01628393|451910664|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
125625250|NCT01628393|451910665|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
125625251|NCT01628393|451910666|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
125625252|NCT01628393|451910662|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
125625253|NCT01628393|451910663|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
125625254|NCT01628393|451910664|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
125625255|NCT01628393|451910665|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
125625256|NCT01628393|451910666|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
125625257|NCT01628393|451910662|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
125625258|NCT01628393|451910663|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
125625259|NCT01628393|451910664|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
125625260|NCT01628393|451910665|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
125625261|NCT01628393|451910666|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
125625262|NCT01628393|451910662|FG000|Blinded Active Extension Period|Adverse Event|0|||
125625263|NCT01628393|451910663|FG001|Blinded Active Extension Period|Adverse Event|1|||
125625264|NCT01628393|451910664|FG002|Blinded Active Extension Period|Adverse Event|0|||
125625265|NCT01628393|451910665|FG003|Blinded Active Extension Period|Adverse Event|2|||
125625266|NCT01628393|451910666|FG004|Blinded Active Extension Period|Adverse Event|2|||
125625267|NCT01628393|451910662|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
125625268|NCT01628393|451910663|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
125625269|NCT01628393|451910664|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
125625270|NCT01628393|451910665|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
125625271|NCT01628393|451910666|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
125625272|NCT01628393|451910662|FG000|Blinded Active Extension Period|Physician Decision|0|||
125625273|NCT01628393|451910663|FG001|Blinded Active Extension Period|Physician Decision|3|||
125625274|NCT01628393|451910664|FG002|Blinded Active Extension Period|Physician Decision|0|||
125625275|NCT01628393|451910665|FG003|Blinded Active Extension Period|Physician Decision|1|||
125625276|NCT01628393|451910666|FG004|Blinded Active Extension Period|Physician Decision|0|||
125625277|NCT01628393|451910662|FG000|Blinded Active Extension Period|Protocol Violation|0|||
125127927|NCT01389102|450094053|FG001|Overall Study|Protocol Violation|0|||
125127928|NCT01389102|450094054|FG002|Overall Study|Protocol Violation|3|||
125127929|NCT01389102|450094055|FG003|Overall Study|Protocol Violation|0|||
125127930|NCT01389102|450094056|FG004|Overall Study|Protocol Violation|1|||
125127931|NCT01389102|450094057|FG005|Overall Study|Protocol Violation|1|||
125127932|NCT01389102|450094052|FG000|Overall Study|Withdrawal by Subject|7|||
125127933|NCT01389102|450094053|FG001|Overall Study|Withdrawal by Subject|4|||
125127934|NCT01389102|450094054|FG002|Overall Study|Withdrawal by Subject|9|||
125127935|NCT01389102|450094055|FG003|Overall Study|Withdrawal by Subject|2|||
125127936|NCT01389102|450094056|FG004|Overall Study|Withdrawal by Subject|3|||
125127937|NCT01389102|450094057|FG005|Overall Study|Withdrawal by Subject|3|||
125127938|NCT01389102|450094052|FG000|Overall Study|Subject Traveling Out of Country|0|||
125127939|NCT01389102|450094053|FG001|Overall Study|Subject Traveling Out of Country|0|||
125127940|NCT01389102|450094054|FG002|Overall Study|Subject Traveling Out of Country|0|||
125127941|NCT01389102|450094055|FG003|Overall Study|Subject Traveling Out of Country|1|||
125127942|NCT01389102|450094056|FG004|Overall Study|Subject Traveling Out of Country|0|||
125127943|NCT01389102|450094057|FG005|Overall Study|Subject Traveling Out of Country|0|||
125127944|NCT01389102|450094052|FG000|Overall Study|Subject Moved|2|||
125127945|NCT01389102|450094053|FG001|Overall Study|Subject Moved|0|||
125127946|NCT01389102|450094054|FG002|Overall Study|Subject Moved|1|||
125374871|NCT00642460|451002283|FG002|Part II: Open-Label Up to Week 92|Death|0|||
125374872|NCT00642460|451002284|FG003|Part II: Open-Label Up to Week 92|Death|2|||
125374873|NCT00642460|451002285|FG004|Part II: Open-Label Up to Week 92|Death|0|||
125625278|NCT01628393|451910663|FG001|Blinded Active Extension Period|Protocol Violation|0|||
125625279|NCT01628393|451910664|FG002|Blinded Active Extension Period|Protocol Violation|2|||
125625280|NCT01628393|451910665|FG003|Blinded Active Extension Period|Protocol Violation|1|||
125127947|NCT01389102|450094055|FG003|Overall Study|Subject Moved|0|||
125127948|NCT01389102|450094056|FG004|Overall Study|Subject Moved|0|||
125127949|NCT01389102|450094057|FG005|Overall Study|Subject Moved|0|||
125127950|NCT01389102|450094052|FG000|Overall Study|Unavailable due to husband's illness|0|||
125127951|NCT01389102|450094053|FG001|Overall Study|Unavailable due to husband's illness|1|||
125127952|NCT01389102|450094054|FG002|Overall Study|Unavailable due to husband's illness|0|||
125127953|NCT01389102|450094055|FG003|Overall Study|Unavailable due to husband's illness|0|||
125374874|NCT00642460|451002286|FG005|Part II: Open-Label Up to Week 92|Death|0|||
125625281|NCT01628393|451910666|FG004|Blinded Active Extension Period|Protocol Violation|0|||
125625282|NCT01628393|451910662|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
125625283|NCT01628393|451910663|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
125625284|NCT01628393|451910664|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
125625285|NCT01628393|451910665|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
125625286|NCT01628393|451910666|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
125625287|NCT02001688|451910667|FG000|Overall Study|Withdrawal by Subject|0|||
125625288|NCT02001688|451910668|FG001|Overall Study|Withdrawal by Subject|0|||
125625289|NCT02001688|451910669|FG002|Overall Study|Withdrawal by Subject|1|||
125625290|NCT02001688|451910667|FG000|Overall Study|Adverse Event|0|||
125625291|NCT02001688|451910668|FG001|Overall Study|Adverse Event|1|||
125625292|NCT02001688|451910669|FG002|Overall Study|Adverse Event|0|||
125625293|NCT00813917|451910673|FG000|Overall Study|Adverse Event|0|||
125625294|NCT00813917|451910674|FG001|Overall Study|Adverse Event|1|||
125625295|NCT00813917|451910673|FG000|Overall Study|Withdrawal by Subject|3|||
125625296|NCT00813917|451910674|FG001|Overall Study|Withdrawal by Subject|4|||
125625297|NCT00813917|451910673|FG000|Overall Study|Lost to Follow-up|3|||
125625298|NCT00813917|451910674|FG001|Overall Study|Lost to Follow-up|1|||
125625299|NCT05441540|451910675|FG000|Overall Study|Withdrawal by Subject|2|||
125625300|NCT02143141|451910682|FG000|Overall Study|pain scores at 24 hours not collected|1|||
125625301|NCT02143141|451910683|FG001|Overall Study|pain scores at 24 hours not collected|0|||
125625302|NCT00615914|451910684|FG000|Overall Study|Adverse Event|274|||
125625303|NCT00615914|451910684|FG000|Overall Study|Death|20|||
125625304|NCT00615914|451910684|FG000|Overall Study|Lack of Efficacy|59|||
125625305|NCT00615914|451910684|FG000|Overall Study|Lost to Follow-up|187|||
125625306|NCT00615914|451910684|FG000|Overall Study|Withdrawal by Subject|16|||
125625307|NCT00615914|451910684|FG000|Overall Study|Physician Decision|4|||
125625308|NCT00615914|451910684|FG000|Overall Study|No data was collected.|65|||
125625309|NCT00615914|451910684|FG000|Overall Study|No treatment|2|||
125625310|NCT00615914|451910684|FG000|Overall Study|Irregularly enrolled patients|10|||
125625311|NCT00270998|451910685|FG000|3 Month Follow-up|Adverse Event|1|||
125625312|NCT00270998|451910686|FG001|3 Month Follow-up|Adverse Event|0|||
125625313|NCT00270998|451910687|FG002|3 Month Follow-up|Adverse Event|0|||
125625314|NCT00270998|451910685|FG000|3 Month Follow-up|Lack of Efficacy|1|||
125625315|NCT00270998|451910686|FG001|3 Month Follow-up|Lack of Efficacy|2|||
125625316|NCT00270998|451910687|FG002|3 Month Follow-up|Lack of Efficacy|1|||
125625317|NCT00270998|451910685|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
125625318|NCT00270998|451910686|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
125625319|NCT00270998|451910687|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
125625320|NCT00270998|451910685|FG000|3 Month Follow-up|Pessary did not fit|12|||
125625321|NCT00270998|451910686|FG001|3 Month Follow-up|Pessary did not fit|0|||
125625322|NCT00270998|451910687|FG002|3 Month Follow-up|Pessary did not fit|0|||
125625323|NCT00270998|451910685|FG000|3 Month Follow-up|Personal/family health|1|||
125625324|NCT00270998|451910686|FG001|3 Month Follow-up|Personal/family health|1|||
125625325|NCT00270998|451910687|FG002|3 Month Follow-up|Personal/family health|0|||
125625326|NCT00270998|451910685|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
125625327|NCT00270998|451910686|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
125625328|NCT00270998|451910687|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
125625329|NCT00270998|451910685|FG000|12 Month Follow-up|Lack of Efficacy|5|||
125625330|NCT00270998|451910686|FG001|12 Month Follow-up|Lack of Efficacy|4|||
125625331|NCT00270998|451910687|FG002|12 Month Follow-up|Lack of Efficacy|3|||
125625332|NCT00270998|451910685|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
125625333|NCT00270998|451910686|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
125625334|NCT00270998|451910687|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
125625335|NCT00270998|451910685|FG000|12 Month Follow-up|Pessary did not fit|1|||
125625336|NCT00270998|451910686|FG001|12 Month Follow-up|Pessary did not fit|0|||
125625337|NCT00270998|451910687|FG002|12 Month Follow-up|Pessary did not fit|0|||
125625338|NCT00270998|451910685|FG000|12 Month Follow-up|Personal/family health|0|||
125625339|NCT00270998|451910686|FG001|12 Month Follow-up|Personal/family health|5|||
125625340|NCT00270998|451910687|FG002|12 Month Follow-up|Personal/family health|1|||
125625341|NCT00270998|451910685|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
125625342|NCT00270998|451910686|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
125625343|NCT00270998|451910687|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
125625344|NCT00563368|451910688|FG000|Overall Study|Lost to Follow-up|14|||
125625345|NCT00563368|451910689|FG001|Overall Study|Lost to Follow-up|14|||
125625346|NCT00563368|451910690|FG002|Overall Study|Lost to Follow-up|12|||
125625347|NCT00563368|451910691|FG003|Overall Study|Lost to Follow-up|6|||
125625348|NCT00563368|451910692|FG004|Overall Study|Lost to Follow-up|9|||
125625349|NCT00563368|451910693|FG005|Overall Study|Lost to Follow-up|8|||
125625350|NCT00563368|451910694|FG006|Overall Study|Lost to Follow-up|9|||
125625351|NCT00563368|451910688|FG000|Overall Study|Adverse Event|3|||
125625352|NCT00563368|451910689|FG001|Overall Study|Adverse Event|4|||
125625353|NCT00563368|451910690|FG002|Overall Study|Adverse Event|5|||
125625354|NCT00563368|451910691|FG003|Overall Study|Adverse Event|9|||
125625355|NCT00563368|451910692|FG004|Overall Study|Adverse Event|6|||
125127954|NCT01389102|450094056|FG004|Overall Study|Unavailable due to husband's illness|0|||
125127955|NCT01389102|450094057|FG005|Overall Study|Unavailable due to husband's illness|0|||
125127956|NCT01389102|450094052|FG000|Overall Study|Investigator Judgement|0|||
125127957|NCT01389102|450094053|FG001|Overall Study|Investigator Judgement|1|||
125127958|NCT01389102|450094054|FG002|Overall Study|Investigator Judgement|0|||
125127959|NCT01389102|450094055|FG003|Overall Study|Investigator Judgement|0|||
125625356|NCT00563368|451910693|FG005|Overall Study|Adverse Event|10|||
125625357|NCT00563368|451910694|FG006|Overall Study|Adverse Event|17|||
125625358|NCT00563368|451910688|FG000|Overall Study|Withdrawal by Subject|11|||
125625359|NCT00563368|451910689|FG001|Overall Study|Withdrawal by Subject|6|||
125625360|NCT00563368|451910690|FG002|Overall Study|Withdrawal by Subject|5|||
125625361|NCT00563368|451910691|FG003|Overall Study|Withdrawal by Subject|7|||
125625362|NCT00563368|451910692|FG004|Overall Study|Withdrawal by Subject|8|||
125625363|NCT00563368|451910693|FG005|Overall Study|Withdrawal by Subject|5|||
125625364|NCT00563368|451910694|FG006|Overall Study|Withdrawal by Subject|4|||
125625365|NCT00563368|451910688|FG000|Overall Study|protocol non-compliance|1|||
125625366|NCT00563368|451910689|FG001|Overall Study|protocol non-compliance|1|||
125625367|NCT00563368|451910690|FG002|Overall Study|protocol non-compliance|2|||
125625368|NCT00563368|451910691|FG003|Overall Study|protocol non-compliance|1|||
125625369|NCT00563368|451910692|FG004|Overall Study|protocol non-compliance|0|||
125625370|NCT00563368|451910693|FG005|Overall Study|protocol non-compliance|1|||
125625371|NCT00563368|451910694|FG006|Overall Study|protocol non-compliance|3|||
125625372|NCT00563368|451910688|FG000|Overall Study|Pregnancy|1|||
125625373|NCT00563368|451910689|FG001|Overall Study|Pregnancy|0|||
125625374|NCT00563368|451910690|FG002|Overall Study|Pregnancy|1|||
125127960|NCT01389102|450094056|FG004|Overall Study|Investigator Judgement|0|||
125127961|NCT01389102|450094057|FG005|Overall Study|Investigator Judgement|0|||
125127962|NCT02910037|450094058|FG000|Overall Study|Withdrawal by Subject|4|||
125127963|NCT02910037|450094058|FG000|Overall Study|Lost to Follow-up|6|||
125127964|NCT00436553|450094059|FG000|Overall Study|Adverse Event|4|||
125127965|NCT00436553|450094060|FG001|Overall Study|Adverse Event|3|||
125127966|NCT00436553|450094061|FG002|Overall Study|Adverse Event|4|||
125127967|NCT00436553|450094059|FG000|Overall Study|Death|3|||
125127968|NCT00436553|450094060|FG001|Overall Study|Death|1|||
125127969|NCT00436553|450094061|FG002|Overall Study|Death|3|||
125127970|NCT00436553|450094059|FG000|Overall Study|Lost to Follow-up|0|||
125127971|NCT00436553|450094060|FG001|Overall Study|Lost to Follow-up|2|||
125127972|NCT00436553|450094061|FG002|Overall Study|Lost to Follow-up|0|||
125127973|NCT00436553|450094059|FG000|Overall Study|Protocol Violation|1|||
125127974|NCT00436553|450094060|FG001|Overall Study|Protocol Violation|0|||
125127975|NCT00436553|450094061|FG002|Overall Study|Protocol Violation|0|||
125127976|NCT00436553|450094059|FG000|Overall Study|Withdrawal by Subject|5|||
125127977|NCT00436553|450094060|FG001|Overall Study|Withdrawal by Subject|6|||
125127978|NCT00436553|450094061|FG002|Overall Study|Withdrawal by Subject|3|||
125127979|NCT01661686|450094070|FG000|Overall Study|Lost to Follow-up|2|||
125127980|NCT01661686|450094071|FG001|Overall Study|Lost to Follow-up|1|||
125127981|NCT01661686|450094070|FG000|Overall Study|did not receive allocated intervention|0|||
125127982|NCT01661686|450094071|FG001|Overall Study|did not receive allocated intervention|1|||
125127983|NCT01873586|450094072|FG000|Overall Study|Lost to Follow-up|3|||
125127984|NCT00624065|450094073|FG000|Overall Study|Adverse Event|5|||
125127985|NCT00624065|450094074|FG001|Overall Study|Adverse Event|6|||
125127986|NCT00624065|450094073|FG000|Overall Study|Lost to Follow-up|4|||
125127987|NCT00624065|450094074|FG001|Overall Study|Lost to Follow-up|1|||
125127988|NCT00624065|450094073|FG000|Overall Study|Consent withdrawn|6|||
125127989|NCT00624065|450094074|FG001|Overall Study|Consent withdrawn|5|||
125127990|NCT00624065|450094073|FG000|Overall Study|Lack of Efficacy|0|||
125127991|NCT00624065|450094074|FG001|Overall Study|Lack of Efficacy|3|||
125127992|NCT00624065|450094073|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
125433263|NCT03315130|451212486|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
125433264|NCT03315130|451212487|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
125625375|NCT00563368|451910691|FG003|Overall Study|Pregnancy|2|||
125625376|NCT00563368|451910692|FG004|Overall Study|Pregnancy|1|||
125625377|NCT00563368|451910693|FG005|Overall Study|Pregnancy|2|||
125625378|NCT00563368|451910694|FG006|Overall Study|Pregnancy|0|||
125625379|NCT00563368|451910688|FG000|Overall Study|requirement for restricted medication|0|||
125625380|NCT00563368|451910689|FG001|Overall Study|requirement for restricted medication|0|||
125127993|NCT00624065|450094074|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
125127994|NCT00696020|450094075|FG000|Overall Study|Adverse Event|3|||
125127995|NCT00696020|450094076|FG001|Overall Study|Adverse Event|1|||
125127996|NCT00696020|450094077|FG002|Overall Study|Adverse Event|2|||
125127997|NCT00696020|450094078|FG003|Overall Study|Adverse Event|1|||
125127998|NCT00696020|450094075|FG000|Overall Study|Lack of Efficacy|1|||
125625381|NCT00563368|451910690|FG002|Overall Study|requirement for restricted medication|2|||
125127999|NCT00696020|450094076|FG001|Overall Study|Lack of Efficacy|0|||
125128000|NCT00696020|450094077|FG002|Overall Study|Lack of Efficacy|0|||
125128001|NCT00696020|450094078|FG003|Overall Study|Lack of Efficacy|0|||
125625382|NCT00563368|451910691|FG003|Overall Study|requirement for restricted medication|0|||
125128002|NCT00696020|450094075|FG000|Overall Study|Protocol Violation|0|||
125128003|NCT00696020|450094076|FG001|Overall Study|Protocol Violation|0|||
125128004|NCT00696020|450094077|FG002|Overall Study|Protocol Violation|0|||
125128005|NCT00696020|450094078|FG003|Overall Study|Protocol Violation|1|||
125128006|NCT00696020|450094075|FG000|Overall Study|Withdrawal by Subject|0|||
125128007|NCT00696020|450094076|FG001|Overall Study|Withdrawal by Subject|1|||
125128008|NCT00696020|450094077|FG002|Overall Study|Withdrawal by Subject|0|||
125128009|NCT00696020|450094078|FG003|Overall Study|Withdrawal by Subject|1|||
125128010|NCT00696020|450094075|FG000|Overall Study|Other not stated above|0|||
125128011|NCT00696020|450094076|FG001|Overall Study|Other not stated above|0|||
125128012|NCT00696020|450094077|FG002|Overall Study|Other not stated above|1|||
125128013|NCT00696020|450094078|FG003|Overall Study|Other not stated above|1|||
125128014|NCT01387022|450094079|FG000|Overall Study|Death|1|||
125128015|NCT01387022|450094080|FG001|Overall Study|Death|1|||
125128016|NCT01387022|450094079|FG000|Overall Study|Lost to Follow-up|0|||
125128017|NCT01387022|450094080|FG001|Overall Study|Lost to Follow-up|3|||
125128018|NCT01536574|450094090|FG000|Overall Study|Adverse Event|4|||
125128019|NCT01536574|450094091|FG001|Overall Study|Adverse Event|5|||
125128020|NCT01536574|450094090|FG000|Overall Study|Withdrawal by Subject|1|||
125128021|NCT01536574|450094091|FG001|Overall Study|Withdrawal by Subject|2|||
125128022|NCT01536574|450094090|FG000|Overall Study|Lack of Efficacy|1|||
125128023|NCT01536574|450094091|FG001|Overall Study|Lack of Efficacy|0|||
125128024|NCT02193165|450094094|FG000|4 Week Product Use|Lost to Follow-up|1|||
125128025|NCT02193165|450094095|FG001|4 Week Product Use|Lost to Follow-up|1|||
125128026|NCT02193165|450094096|FG002|4 Week Product Use|Lost to Follow-up|1|||
125128027|NCT02193165|450094094|FG000|6 Week Product Use|Lost to Follow-up|0|||
125128028|NCT02193165|450094095|FG001|6 Week Product Use|Lost to Follow-up|1|||
125128029|NCT02193165|450094096|FG002|6 Week Product Use|Lost to Follow-up|0|||
125128030|NCT01498120|450094097|FG000|Overall Study|Lost to Follow-up|1|||
125128031|NCT01498120|450094097|FG000|Overall Study|Withdrawal by Subject|5|||
125128032|NCT01498120|450094097|FG000|Overall Study|AE, non-serious non-fatal|3|||
125128033|NCT01498120|450094097|FG000|Overall Study|Other|4|||
125128034|NCT01173692|450094098|FG000|Overall Study|Adverse Event|1|||
125128035|NCT01173692|450094099|FG001|Overall Study|Adverse Event|2|||
125128036|NCT01173692|450094098|FG000|Overall Study|Withdrawal by Subject|1|||
125128037|NCT01173692|450094099|FG001|Overall Study|Withdrawal by Subject|3|||
125128038|NCT00678639|450094100|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
125128039|NCT00678639|450094101|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
125128040|NCT00986245|450094102|FG000|First Intervention|Poor compliance|8|||
125128041|NCT00986245|450094103|FG001|First Intervention|Poor compliance|4|||
125128042|NCT00986245|450094102|FG000|First Intervention|Lack of Efficacy|1|||
125128043|NCT00986245|450094103|FG001|First Intervention|Lack of Efficacy|2|||
125433265|NCT03315130|451212488|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
125433266|NCT03315130|451212489|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
125625383|NCT00563368|451910692|FG004|Overall Study|requirement for restricted medication|0|||
125128044|NCT00986245|450094102|FG000|First Intervention|Withdrawal by Subject|0|||
125128045|NCT00986245|450094103|FG001|First Intervention|Withdrawal by Subject|1|||
125128046|NCT00986245|450094102|FG000|First Intervention|Protocol Violation|0|||
125128047|NCT00986245|450094103|FG001|First Intervention|Protocol Violation|1|||
125128048|NCT00986245|450094102|FG000|First Intervention|Out of indication|1|||
125128049|NCT00986245|450094103|FG001|First Intervention|Out of indication|0|||
125128050|NCT00986245|450094102|FG000|Second Intervention|Poor compliance|1|||
125128051|NCT00986245|450094103|FG001|Second Intervention|Poor compliance|0|||
125128052|NCT00986245|450094102|FG000|Second Intervention|Lost to Follow-up|1|||
125625384|NCT00563368|451910693|FG005|Overall Study|requirement for restricted medication|0|||
125625385|NCT00563368|451910694|FG006|Overall Study|requirement for restricted medication|0|||
125625386|NCT00563368|451910688|FG000|Overall Study|Other|5|||
125625387|NCT00563368|451910689|FG001|Overall Study|Other|5|||
125625388|NCT00563368|451910690|FG002|Overall Study|Other|3|||
125625389|NCT00563368|451910691|FG003|Overall Study|Other|4|||
125625390|NCT00563368|451910692|FG004|Overall Study|Other|4|||
125625391|NCT00563368|451910693|FG005|Overall Study|Other|4|||
125625392|NCT00563368|451910694|FG006|Overall Study|Other|0|||
125128053|NCT00986245|450094103|FG001|Second Intervention|Lost to Follow-up|0|||
125625393|NCT00425113|451910695|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
125625394|NCT00425113|451910696|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
125625395|NCT00425113|451910695|FG000|Overall Study|diagnosis of abdominal TB|0|||
125625396|NCT00425113|451910696|FG001|Overall Study|diagnosis of abdominal TB|1|||
125215565|NCT01768559|450417438|FG000|Overall Study|Randomized but not treated|0|||
125433267|NCT03535337|451212498|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
125128054|NCT00986245|450094102|FG000|Second Intervention|Protocol Violation|0|||
125128055|NCT00986245|450094103|FG001|Second Intervention|Protocol Violation|1|||
125433268|NCT03535337|451212499|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
125625397|NCT00425113|451910695|FG000|Overall Study|missing study drug more than 14 days|0|||
125128056|NCT01629381|450094104|FG000|Overall Study|Withdrawal by Subject|2|||
125128057|NCT01629381|450094105|FG001|Overall Study|Withdrawal by Subject|5|||
125128058|NCT01214850|450094106|FG000|Overall Study|Withdrawal by Subject|38|||
125625398|NCT00425113|451910696|FG001|Overall Study|missing study drug more than 14 days|1|||
125128059|NCT01214850|450094107|FG001|Overall Study|Withdrawal by Subject|31|||
125128060|NCT01214850|450094108|FG002|Overall Study|Withdrawal by Subject|28|||
125128061|NCT01214850|450094106|FG000|Overall Study|Lost to Follow-up|124|||
125128062|NCT01214850|450094107|FG001|Overall Study|Lost to Follow-up|98|||
125128063|NCT01214850|450094108|FG002|Overall Study|Lost to Follow-up|123|||
125128064|NCT01214850|450094106|FG000|Overall Study|Protocol Violation|5|||
125128065|NCT01214850|450094107|FG001|Overall Study|Protocol Violation|5|||
125128066|NCT01214850|450094108|FG002|Overall Study|Protocol Violation|6|||
125128067|NCT01214850|450094106|FG000|Overall Study|Adverse event or death|11|||
125128068|NCT01214850|450094107|FG001|Overall Study|Adverse event or death|8|||
125128069|NCT01214850|450094108|FG002|Overall Study|Adverse event or death|3|||
125128070|NCT01214850|450094106|FG000|Overall Study|Inappropriate enrollment|2|||
125128071|NCT01214850|450094107|FG001|Overall Study|Inappropriate enrollment|1|||
125128072|NCT01214850|450094108|FG002|Overall Study|Inappropriate enrollment|0|||
125128073|NCT01214850|450094106|FG000|Overall Study|Administrative reason|1|||
125128074|NCT01214850|450094107|FG001|Overall Study|Administrative reason|0|||
125128075|NCT01214850|450094108|FG002|Overall Study|Administrative reason|0|||
125128076|NCT01214850|450094106|FG000|Overall Study|Unable to classify|2|||
125128077|NCT01214850|450094107|FG001|Overall Study|Unable to classify|1|||
125128078|NCT01214850|450094108|FG002|Overall Study|Unable to classify|1|||
125128079|NCT01863745|450094109|FG000|Overall Study|Disease Progression|9|||
125128080|NCT01863745|450094109|FG000|Overall Study|Adverse Event|2|||
125128081|NCT01863745|450094109|FG000|Overall Study|Death|1|||
125128082|NCT01863745|450094109|FG000|Overall Study|Withdrawal by Subject|1|||
125128083|NCT00193609|450094110|FG000|Overall Study|Lack of Efficacy|2|||
125128084|NCT00193609|450094110|FG000|Overall Study|Adverse Event|2|||
125128085|NCT00854308|450094111|FG000|Overall Study|Disease progression|42|||
125128086|NCT00854308|450094112|FG001|Overall Study|Disease progression|50|||
125128087|NCT00854308|450094111|FG000|Overall Study|Adverse Event|8|||
125128088|NCT00854308|450094112|FG001|Overall Study|Adverse Event|3|||
125128089|NCT00854308|450094111|FG000|Overall Study|Death|2|||
125128090|NCT00854308|450094112|FG001|Overall Study|Death|5|||
125128091|NCT00854308|450094111|FG000|Overall Study|Physician Decision|6|||
125128092|NCT00854308|450094112|FG001|Overall Study|Physician Decision|6|||
125128093|NCT00854308|450094111|FG000|Overall Study|Withdrawal by Subject|4|||
125128094|NCT00854308|450094112|FG001|Overall Study|Withdrawal by Subject|2|||
125128095|NCT00854308|450094111|FG000|Overall Study|Sponsor's decision to terminate study|0|||
125128096|NCT00854308|450094112|FG001|Overall Study|Sponsor's decision to terminate study|1|||
125128097|NCT00610363|450094115|FG000|Overall Study|Non-compliance with protocol|0|||
125128098|NCT00610363|450094116|FG001|Overall Study|Non-compliance with protocol|1|||
125128099|NCT00610363|450094115|FG000|Overall Study|Adverse Event|3|||
125128100|NCT00610363|450094116|FG001|Overall Study|Adverse Event|1|||
125128101|NCT00610363|450094115|FG000|Overall Study|Lack of Efficacy|2|||
125128102|NCT00610363|450094116|FG001|Overall Study|Lack of Efficacy|0|||
125128103|NCT00610363|450094115|FG000|Overall Study|Lost to Follow-up|4|||
125128104|NCT00610363|450094116|FG001|Overall Study|Lost to Follow-up|0|||
125128105|NCT00610363|450094115|FG000|Overall Study|Withdrawal by Subject|1|||
125128106|NCT00610363|450094116|FG001|Overall Study|Withdrawal by Subject|0|||
125128107|NCT00610363|450094115|FG000|Overall Study|Other than specified above|1|||
125128108|NCT00610363|450094116|FG001|Overall Study|Other than specified above|1|||
125128109|NCT03048500|450094117|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
125128110|NCT03048500|450094117|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
125128111|NCT03048500|450094117|FG000|Reached 1st Response/Continued Treatment|Death|1|||
125128112|NCT03048500|450094117|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
125128113|NCT03048500|450094117|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
125128114|NCT03048500|450094117|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
125128115|NCT03048500|450094117|FG000|Follow up for 3 Years|Death|12|||
125128116|NCT01171963|450094118|FG000|Overall Study|Adverse Event|10|||
125128117|NCT01171963|450094119|FG001|Overall Study|Adverse Event|15|||
125128118|NCT01171963|450094118|FG000|Overall Study|Lost to Follow-up|23|||
125128119|NCT01171963|450094119|FG001|Overall Study|Lost to Follow-up|24|||
125625399|NCT00425113|451910695|FG000|Overall Study|Withdrawal by Subject|1|||
125625400|NCT00425113|451910696|FG001|Overall Study|Withdrawal by Subject|0|||
125128120|NCT01171963|450094118|FG000|Overall Study|Other - diarrhoea|1|||
125128121|NCT01171963|450094119|FG001|Overall Study|Other - diarrhoea|0|||
125128122|NCT01171963|450094118|FG000|Overall Study|Withdrawal by Subject|114|||
125128123|NCT01171963|450094119|FG001|Overall Study|Withdrawal by Subject|129|||
125128124|NCT00626548|450094122|FG000|Overall Study|Adverse Event|164|||
125128125|NCT00626548|450094123|FG001|Overall Study|Adverse Event|44|||
125128126|NCT00626548|450094122|FG000|Overall Study|Withdrawal by Subject|42|||
125128127|NCT00626548|450094123|FG001|Overall Study|Withdrawal by Subject|46|||
125625401|NCT00879437|451910698|FG000|Overall Study|Protocol Violation|0|||
125128128|NCT00626548|450094122|FG000|Overall Study|Protocol Violation|4|||
125128129|NCT00626548|450094123|FG001|Overall Study|Protocol Violation|11|||
125128130|NCT00626548|450094122|FG000|Overall Study|Lost to Follow-up|2|||
125128131|NCT00626548|450094123|FG001|Overall Study|Lost to Follow-up|2|||
125625402|NCT00879437|451910699|FG001|Overall Study|Protocol Violation|1|||
125625403|NCT00879437|451910698|FG000|Overall Study|Death|1|||
125625404|NCT00879437|451910699|FG001|Overall Study|Death|0|||
125625405|NCT01611298|451910704|FG000|Overall Study|Relapsed|2|||
125625406|NCT00753623|451910705|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
125128132|NCT00626548|450094122|FG000|Overall Study|Other termination reason|493|||
125128133|NCT00626548|450094123|FG001|Overall Study|Other termination reason|613|||
125128134|NCT00048581|450094124|FG000|Double-Blind Period|Adverse Event|9|||
125128135|NCT00048581|450094125|FG001|Double-Blind Period|Adverse Event|5|||
125625407|NCT00753623|451910706|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
125625408|NCT00753623|451910705|FG000|Phase I (14 Days)|Physician Decision|1|||
125625409|NCT00753623|451910706|FG001|Phase I (14 Days)|Physician Decision|2|||
125625410|NCT00753623|451910705|FG000|Phase I (14 Days)|Adverse Event|0|||
125625411|NCT00753623|451910706|FG001|Phase I (14 Days)|Adverse Event|1|||
125625412|NCT00753623|451910705|FG000|Washout (7 Days)|Physician Decision|1|||
125625413|NCT00753623|451910706|FG001|Washout (7 Days)|Physician Decision|0|||
125625414|NCT00753623|451910705|FG000|Phase II (14 Days)|Physician Decision|0|||
125128136|NCT00048581|450094126|FG002|Double-Blind Period|Adverse Event|0|||
125128137|NCT00048581|450094124|FG000|Double-Blind Period|Lack of Efficacy|14|||
125128138|NCT00048581|450094125|FG001|Double-Blind Period|Lack of Efficacy|27|||
125128139|NCT00048581|450094126|FG002|Double-Blind Period|Lack of Efficacy|0|||
125625415|NCT00753623|451910706|FG001|Phase II (14 Days)|Physician Decision|1|||
125625416|NCT03332303|451910707|FG000|Overall Study|Participant did not dose|1|||
125625417|NCT03332303|451910708|FG001|Overall Study|Participant did not dose|2|||
125625418|NCT03332303|451910709|FG002|Overall Study|Participant did not dose|0|||
125625419|NCT03332303|451910707|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
125625420|NCT03332303|451910708|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
125625421|NCT03332303|451910709|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
125625422|NCT03332303|451910707|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
125625423|NCT03332303|451910708|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
125625424|NCT03332303|451910709|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
125625425|NCT03332303|451910707|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
125625426|NCT03332303|451910708|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
125128140|NCT00048581|450094124|FG000|Double-Blind Period|Lost to Follow-up|5|||
125128141|NCT00048581|450094125|FG001|Double-Blind Period|Lost to Follow-up|0|||
125128142|NCT00048581|450094126|FG002|Double-Blind Period|Lost to Follow-up|0|||
125128143|NCT00048581|450094124|FG000|Double-Blind Period|Withdrawal by Subject|5|||
125128144|NCT00048581|450094125|FG001|Double-Blind Period|Withdrawal by Subject|2|||
125625427|NCT03332303|451910709|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
125625428|NCT03332303|451910707|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
125625429|NCT03332303|451910708|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
125625430|NCT03332303|451910709|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
125625431|NCT03332303|451910707|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
125128145|NCT00048581|450094126|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125128146|NCT00048581|450094124|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
125128147|NCT00048581|450094125|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
125128148|NCT00048581|450094126|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
125128149|NCT00048581|450094124|FG000|Double-Blind Period|Investigator Decision|1|||
125128150|NCT00048581|450094125|FG001|Double-Blind Period|Investigator Decision|0|||
125128151|NCT00048581|450094126|FG002|Double-Blind Period|Investigator Decision|0|||
125128152|NCT00048581|450094124|FG000|Open-Label Period|Death|0|||
125128153|NCT00048581|450094125|FG001|Open-Label Period|Death|0|||
125128154|NCT00048581|450094126|FG002|Open-Label Period|Death|4|||
125128155|NCT00048581|450094124|FG000|Open-Label Period|Adverse Event|0|||
125128156|NCT00048581|450094125|FG001|Open-Label Period|Adverse Event|0|||
125128157|NCT00048581|450094126|FG002|Open-Label Period|Adverse Event|37|||
125128158|NCT00048581|450094124|FG000|Open-Label Period|Lack of Efficacy|0|||
125625432|NCT03332303|451910708|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
125625433|NCT03332303|451910709|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
125625434|NCT03332303|451910707|FG000|Overall Study|Participant had a significant protocol deviation|0|||
125128159|NCT00048581|450094125|FG001|Open-Label Period|Lack of Efficacy|0|||
125128160|NCT00048581|450094126|FG002|Open-Label Period|Lack of Efficacy|69|||
125128161|NCT00048581|450094124|FG000|Open-Label Period|Lost to Follow-up|0|||
125128162|NCT00048581|450094125|FG001|Open-Label Period|Lost to Follow-up|0|||
125128163|NCT00048581|450094126|FG002|Open-Label Period|Lost to Follow-up|14|||
125128164|NCT00048581|450094124|FG000|Open-Label Period|Withdrawal by Subject|0|||
125128165|NCT00048581|450094125|FG001|Open-Label Period|Withdrawal by Subject|0|||
125128166|NCT00048581|450094126|FG002|Open-Label Period|Withdrawal by Subject|20|||
125128167|NCT00048581|450094124|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
125128168|NCT00048581|450094125|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
125128169|NCT00048581|450094126|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
125128170|NCT00048581|450094124|FG000|Open-Label Period|Poor/Non-compliance|0|||
125128171|NCT00048581|450094125|FG001|Open-Label Period|Poor/Non-compliance|0|||
125128172|NCT00048581|450094126|FG002|Open-Label Period|Poor/Non-compliance|5|||
125128173|NCT00048581|450094124|FG000|Open-Label Period|Pregnancy|0|||
125128174|NCT00048581|450094125|FG001|Open-Label Period|Pregnancy|0|||
125128175|NCT00048581|450094126|FG002|Open-Label Period|Pregnancy|7|||
125128176|NCT00048581|450094124|FG000|Open-Label Period|Study Site Closure|0|||
125128177|NCT00048581|450094125|FG001|Open-Label Period|Study Site Closure|0|||
125128178|NCT00048581|450094126|FG002|Open-Label Period|Study Site Closure|2|||
125128179|NCT00048581|450094124|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
125128180|NCT00048581|450094125|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
125128181|NCT00048581|450094126|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
125128182|NCT00048581|450094124|FG000|Open-Label Period|Problem With Transportation To Site|0|||
125128183|NCT00048581|450094125|FG001|Open-Label Period|Problem With Transportation To Site|0|||
125128184|NCT00048581|450094126|FG002|Open-Label Period|Problem With Transportation To Site|1|||
125128185|NCT00048581|450094124|FG000|Open-Label Period|Primary Investigator Retired|0|||
125128186|NCT00048581|450094125|FG001|Open-Label Period|Primary Investigator Retired|0|||
125128187|NCT00048581|450094126|FG002|Open-Label Period|Primary Investigator Retired|2|||
125128188|NCT00048581|450094124|FG000|Open-Label Period|Study Ended By Sponsor|0|||
125128189|NCT00048581|450094125|FG001|Open-Label Period|Study Ended By Sponsor|0|||
125128190|NCT00048581|450094126|FG002|Open-Label Period|Study Ended By Sponsor|1|||
125128191|NCT01059903|450094127|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
125128192|NCT01059903|450094128|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
125128193|NCT00385593|450094129|FG000|Overall Study|Adverse Event|3|||
125128194|NCT00385593|450094130|FG001|Overall Study|Adverse Event|2|||
125128195|NCT00385593|450094129|FG000|Overall Study|Withdrawal by Subject|17|||
125128196|NCT00385593|450094130|FG001|Overall Study|Withdrawal by Subject|7|||
125128197|NCT00385593|450094129|FG000|Overall Study|Lost to Follow-up|12|||
125128198|NCT00385593|450094130|FG001|Overall Study|Lost to Follow-up|8|||
125128199|NCT00385593|450094129|FG000|Overall Study|Protocol Violation|7|||
125128200|NCT00385593|450094130|FG001|Overall Study|Protocol Violation|4|||
125128201|NCT00385593|450094129|FG000|Overall Study|Several reasons|17|||
125128202|NCT00385593|450094130|FG001|Overall Study|Several reasons|15|||
125128203|NCT00385593|450094129|FG000|Overall Study|Incorrect inclusion|2|||
125128204|NCT00385593|450094130|FG001|Overall Study|Incorrect inclusion|0|||
125128205|NCT00385593|450094129|FG000|Overall Study|Incorrect randomization|0|||
125128206|NCT00385593|450094130|FG001|Overall Study|Incorrect randomization|1|||
125128207|NCT00214422|450094131|FG000|Overall Study|Physician Decision|2|||
125128208|NCT00214422|450094132|FG001|Overall Study|Physician Decision|0|||
125128209|NCT00214422|450094133|FG002|Overall Study|Physician Decision|0|||
125128210|NCT00214422|450094131|FG000|Overall Study|Developed esophageal ca|1|||
125374875|NCT00642460|451002281|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
125374876|NCT00642460|451002282|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
125374877|NCT00642460|451002283|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
125374878|NCT00642460|451002284|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
125625435|NCT03332303|451910708|FG001|Overall Study|Participant had a significant protocol deviation|1|||
125625436|NCT03332303|451910709|FG002|Overall Study|Participant had a significant protocol deviation|0|||
125128211|NCT00214422|450094132|FG001|Overall Study|Developed esophageal ca|0|||
125128212|NCT00214422|450094133|FG002|Overall Study|Developed esophageal ca|0|||
125128213|NCT00214422|450094131|FG000|Overall Study|Pt taken off study|1|||
125128214|NCT00214422|450094132|FG001|Overall Study|Pt taken off study|1|||
125128215|NCT00214422|450094133|FG002|Overall Study|Pt taken off study|0|||
125128216|NCT00214422|450094131|FG000|Overall Study|Disease progression on study|1|||
125128217|NCT00214422|450094132|FG001|Overall Study|Disease progression on study|0|||
125128218|NCT00214422|450094133|FG002|Overall Study|Disease progression on study|0|||
125128219|NCT00214422|450094131|FG000|Overall Study|Unable to make a radiation treatment|0|||
125128220|NCT00214422|450094132|FG001|Overall Study|Unable to make a radiation treatment|0|||
125128221|NCT00214422|450094133|FG002|Overall Study|Unable to make a radiation treatment|1|||
125128222|NCT00319735|450094134|FG000|Overall Study|Death|2|||
125128223|NCT03929393|450094135|FG000|Overall Study|Death|1|||
125128224|NCT03929393|450094136|FG001|Overall Study|Death|0|||
125128225|NCT03929393|450094135|FG000|Overall Study|Time Commitment|2|||
125128226|NCT03929393|450094136|FG001|Overall Study|Time Commitment|5|||
125128227|NCT03929393|450094135|FG000|Overall Study|Motor Vehicle Accident|0|||
125128228|NCT03929393|450094136|FG001|Overall Study|Motor Vehicle Accident|1|||
125128229|NCT03929393|450094135|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
125128230|NCT03929393|450094136|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
125128231|NCT03929393|450094135|FG000|Overall Study|Other|1|||
125128232|NCT03929393|450094136|FG001|Overall Study|Other|3|||
125128233|NCT03420300|450094137|FG000|Overall Study|Death|2|||
125128234|NCT02421952|450094138|FG000|Overall Study|Diary Not Returned|93|||
125128235|NCT02421952|450094138|FG000|Overall Study|Failed seriation task|13|||
125433269|NCT03535337|451212500|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
125433270|NCT03535337|451212501|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
125433271|NCT03535337|451212502|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
125433272|NCT03535337|451212503|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
125433273|NCT03535337|451212504|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
125433274|NCT03535337|451212505|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
125433275|NCT03535337|451212506|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
125433276|NCT03535337|451212507|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
125433277|NCT02089230|451212508|FG000|Overall Study|Death|0|||
125433278|NCT02089230|451212509|FG001|Overall Study|Death|0|||
125433279|NCT02089230|451212510|FG002|Overall Study|Death|2|||
125433280|NCT02089230|451212508|FG000|Overall Study|Seeking Alternative Therapy|0|||
125433281|NCT02089230|451212509|FG001|Overall Study|Seeking Alternative Therapy|0|||
125433282|NCT02089230|451212510|FG002|Overall Study|Seeking Alternative Therapy|4|||
125433283|NCT02272725|451212511|FG000|Overall Study|equipment malfunction|2|||
125433284|NCT02272725|451212512|FG001|Overall Study|equipment malfunction|0|||
125433285|NCT02396537|451214427|FG000|Overall Study|Protocol Violation|0|||
125433286|NCT02396537|451214428|FG001|Overall Study|Protocol Violation|1|||
125433287|NCT04415151|451214429|FG000|Overall Study|Death|1|||
125433288|NCT04415151|451214430|FG001|Overall Study|Death|1|||
125433289|NCT04415151|451214429|FG000|Overall Study|Withdrawal by Subject|1|||
125433290|NCT04415151|451214430|FG001|Overall Study|Withdrawal by Subject|0|||
125433291|NCT03505476|451214436|FG000|Overall Study|Physician Decision|18|||
125433292|NCT03505476|451214436|FG000|Overall Study|Device Malfunctioned|101|||
125433293|NCT03505476|451214436|FG000|Overall Study|Data Corrupt|6|||
125433294|NCT03505476|451214436|FG000|Overall Study|Device application insufficiant|3|||
125433295|NCT03075904|451214437|FG000|Overall Study|Physician Decision|3|||
125433296|NCT03075904|451214437|FG000|Overall Study|Need for Medication not Permitted|1|||
125433297|NCT00539643|451214438|FG000|Overall Study|Adverse Event|1|||
125433298|NCT00539643|451214439|FG001|Overall Study|Adverse Event|0|||
125433299|NCT00539643|451214438|FG000|Overall Study|Death|2|||
125128236|NCT02421952|450094138|FG000|Overall Study|Subject uncooperative for baseline test|2|||
125128237|NCT02421952|450094138|FG000|Overall Study|Surgery cancelled|1|||
125128238|NCT02140060|450094139|FG000|Overall Study|Adverse Event|0|||
125128239|NCT02140060|450094140|FG001|Overall Study|Adverse Event|0|||
125128240|NCT02140060|450094141|FG002|Overall Study|Adverse Event|0|||
125128241|NCT02140060|450094142|FG003|Overall Study|Adverse Event|1|||
125128242|NCT02140060|450094143|FG004|Overall Study|Adverse Event|1|||
125128243|NCT02140060|450094144|FG005|Overall Study|Adverse Event|1|||
125128244|NCT02140060|450094139|FG000|Overall Study|Lack of Efficacy|0|||
125128245|NCT02140060|450094140|FG001|Overall Study|Lack of Efficacy|0|||
125433300|NCT00539643|451214439|FG001|Overall Study|Death|1|||
125433301|NCT00539643|451214438|FG000|Overall Study|Physician Decision|3|||
125433302|NCT00539643|451214439|FG001|Overall Study|Physician Decision|1|||
125128246|NCT02140060|450094141|FG002|Overall Study|Lack of Efficacy|0|||
125128247|NCT02140060|450094142|FG003|Overall Study|Lack of Efficacy|1|||
125128248|NCT02140060|450094143|FG004|Overall Study|Lack of Efficacy|0|||
125128249|NCT02140060|450094144|FG005|Overall Study|Lack of Efficacy|0|||
125128250|NCT01038856|450096013|FG000|Overall Study|Adverse Event|2|||
125128251|NCT04466111|450096015|FG000|Prior to Trial Phase|Physician Decision|1|||
125128252|NCT00105196|450096016|FG000|Overall Study|Lack of Efficacy|2|||
125128253|NCT00105196|450096017|FG001|Overall Study|Lack of Efficacy|3|||
125128254|NCT00105196|450096016|FG000|Overall Study|Adverse Event|11|||
125128255|NCT00105196|450096017|FG001|Overall Study|Adverse Event|3|||
125128256|NCT00105196|450096016|FG000|Overall Study|Withdrawal by Subject|6|||
125128257|NCT00105196|450096017|FG001|Overall Study|Withdrawal by Subject|6|||
125128258|NCT00105196|450096016|FG000|Overall Study|Lost to Follow-up|3|||
125128259|NCT00105196|450096017|FG001|Overall Study|Lost to Follow-up|2|||
125128260|NCT00105196|450096016|FG000|Overall Study|Poor/noncompliance|3|||
125128261|NCT00105196|450096017|FG001|Overall Study|Poor/noncompliance|4|||
125128262|NCT00105196|450096016|FG000|Overall Study|Protocol Violation|5|||
125128263|NCT00105196|450096017|FG001|Overall Study|Protocol Violation|2|||
125215566|NCT01768559|450417439|FG001|Overall Study|Randomized but not treated|0|||
125215567|NCT01768559|450417440|FG002|Overall Study|Randomized but not treated|1|||
125215568|NCT01768559|450417438|FG000|Overall Study|Adverse Event|15|||
125215569|NCT01768559|450417439|FG001|Overall Study|Adverse Event|2|||
125215570|NCT01768559|450417440|FG002|Overall Study|Adverse Event|5|||
125433303|NCT00539643|451214438|FG000|Overall Study|Withdrawal by Subject|0|||
125128264|NCT00105196|450096016|FG000|Overall Study|pending surgery|0|||
125215571|NCT01768559|450417438|FG000|Overall Study|Lack of Efficacy|6|||
125215572|NCT01768559|450417439|FG001|Overall Study|Lack of Efficacy|4|||
125215573|NCT01768559|450417440|FG002|Overall Study|Lack of Efficacy|0|||
125433304|NCT00539643|451214439|FG001|Overall Study|Withdrawal by Subject|1|||
125128265|NCT00105196|450096017|FG001|Overall Study|pending surgery|1|||
125128266|NCT00105196|450096016|FG000|Overall Study|marijuana use|0|||
125128267|NCT00105196|450096017|FG001|Overall Study|marijuana use|1|||
125128268|NCT00105196|450096016|FG000|Overall Study|Subject became unblinded|0|||
125128269|NCT00105196|450096017|FG001|Overall Study|Subject became unblinded|1|||
125215574|NCT01768559|450417438|FG000|Overall Study|Poor compliance to protocol|0|||
125128270|NCT03025880|450096018|FG000|Overall Study|Adverse Event|1|||
125128271|NCT03025880|450096019|FG001|Overall Study|Adverse Event|0|||
125128272|NCT03025880|450096018|FG000|Overall Study|Death|1|||
125128273|NCT03025880|450096019|FG001|Overall Study|Death|1|||
125128274|NCT03025880|450096018|FG000|Overall Study|Withdrawal by Subject|0|||
125128275|NCT03025880|450096019|FG001|Overall Study|Withdrawal by Subject|1|||
125128276|NCT03025880|450096018|FG000|Overall Study|Physician Decision|0|||
125128277|NCT03025880|450096019|FG001|Overall Study|Physician Decision|1|||
125128278|NCT03025880|450096018|FG000|Overall Study|Progressive Disease|12|||
125128279|NCT03025880|450096019|FG001|Overall Study|Progressive Disease|19|||
125128280|NCT01035060|450096020|FG000|Overall Study|Lost to Follow-up|0|||
125128281|NCT01035060|450096021|FG001|Overall Study|Lost to Follow-up|7|||
125128282|NCT01035060|450096020|FG000|Overall Study|Did not quality after 2nd screening|14|||
125128283|NCT01035060|450096021|FG001|Overall Study|Did not quality after 2nd screening|1|||
125128284|NCT01035060|450096020|FG000|Overall Study|Withdrawal by Subject|8|||
125128285|NCT01035060|450096021|FG001|Overall Study|Withdrawal by Subject|6|||
125128286|NCT01035060|450096020|FG000|Overall Study|Physician Decision|2|||
125128287|NCT01035060|450096021|FG001|Overall Study|Physician Decision|0|||
125128288|NCT02015390|450096026|FG000|Overall Study|Lost to Follow-up|1|||
125128289|NCT02015390|450096027|FG001|Overall Study|Lost to Follow-up|0|||
125128290|NCT02015390|450096026|FG000|Overall Study|Adverse Event|0|||
125128291|NCT02015390|450096027|FG001|Overall Study|Adverse Event|3|||
125128292|NCT02015390|450096026|FG000|Overall Study|Physician Decision|0|||
125128293|NCT02015390|450096027|FG001|Overall Study|Physician Decision|1|||
125128294|NCT02193880|450096028|FG000|Overall Study|patients did not collect enough HPC|3|||
125128295|NCT03136380|450096029|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125128296|NCT03136380|450096030|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
125128297|NCT03136380|450096031|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125128298|NCT03136380|450096032|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125128299|NCT03136380|450096033|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
125128300|NCT00553280|450096037|FG000|Overall Study|Adverse Event|19|||
125128301|NCT00553280|450096037|FG000|Overall Study|Lack of Efficacy|3|||
125128302|NCT00553280|450096037|FG000|Overall Study|Withdrawal by Subject|3|||
125128303|NCT00553280|450096037|FG000|Overall Study|Physician Decision|1|||
125128304|NCT02794974|450096038|FG000|Overall Study|Physician Decision|0|||
125128305|NCT02794974|450096039|FG001|Overall Study|Physician Decision|1|||
125128306|NCT02202850|450096040|FG000|Overall Study|Other|2|||
125128307|NCT02202850|450096041|FG001|Overall Study|Other|2|||
125128308|NCT02202850|450096040|FG000|Overall Study|Enbrel treatment discontinued|15|||
125128309|NCT02202850|450096041|FG001|Overall Study|Enbrel treatment discontinued|3|||
125128310|NCT02202850|450096040|FG000|Overall Study|Lost to Follow-up|7|||
125128311|NCT02202850|450096041|FG001|Overall Study|Lost to Follow-up|1|||
125128312|NCT02996682|450096042|FG000|Overall Study|Death|0|||
125128313|NCT02996682|450096043|FG001|Overall Study|Death|3|||
125128314|NCT02587962|450096044|FG000|Overall Study|Adverse Event|0|||
125128315|NCT02587962|450096045|FG001|Overall Study|Adverse Event|0|||
125128316|NCT02587962|450096046|FG002|Overall Study|Adverse Event|1|||
125128317|NCT02587962|450096047|FG003|Overall Study|Adverse Event|0|||
125128318|NCT02587962|450096048|FG004|Overall Study|Adverse Event|0|||
125128319|NCT02587962|450096044|FG000|Overall Study|Withdrawal by Subject|0|||
125128320|NCT02587962|450096045|FG001|Overall Study|Withdrawal by Subject|0|||
125374879|NCT00642460|451002285|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
125374880|NCT00642460|451002286|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
125625437|NCT03639987|451910710|FG000|Overall Study|Study terminated by sponsor|26|||
125625438|NCT03639987|451910711|FG001|Overall Study|Study terminated by sponsor|25|||
125625439|NCT03639987|451910710|FG000|Overall Study|Lost to Follow-up|0|||
125625440|NCT03639987|451910711|FG001|Overall Study|Lost to Follow-up|1|||
125128321|NCT02587962|450096046|FG002|Overall Study|Withdrawal by Subject|1|||
125128322|NCT02587962|450096047|FG003|Overall Study|Withdrawal by Subject|1|||
125128323|NCT02587962|450096048|FG004|Overall Study|Withdrawal by Subject|4|||
125128324|NCT02587962|450096044|FG000|Overall Study|Radiological progression|2|||
125128325|NCT02587962|450096045|FG001|Overall Study|Radiological progression|2|||
125128326|NCT02587962|450096046|FG002|Overall Study|Radiological progression|2|||
125128327|NCT02587962|450096047|FG003|Overall Study|Radiological progression|5|||
125128328|NCT02587962|450096048|FG004|Overall Study|Radiological progression|10|||
125128329|NCT02587962|450096044|FG000|Overall Study|Clinical progression|0|||
125128330|NCT02587962|450096045|FG001|Overall Study|Clinical progression|1|||
125128331|NCT02587962|450096046|FG002|Overall Study|Clinical progression|2|||
125128332|NCT02587962|450096047|FG003|Overall Study|Clinical progression|0|||
125128333|NCT02587962|450096048|FG004|Overall Study|Clinical progression|1|||
125128334|NCT00086996|450096050|FG000|Overall Study|Adverse Event|29|||
125128335|NCT00086996|450096050|FG000|Overall Study|Death|4|||
125128336|NCT00086996|450096050|FG000|Overall Study|progression/relapse|7|||
125128337|NCT00086996|450096050|FG000|Overall Study|Withdrawal by Subject|13|||
125128338|NCT00086996|450096050|FG000|Overall Study|Other|6|||
125128339|NCT00086996|450096050|FG000|Overall Study|not eligible|5|||
125128340|NCT00184600|450096051|FG000|Overall Study|Adverse Event|9|||
125625441|NCT00425100|451910712|FG000|Overall Study|Adverse Event|36|||
125625442|NCT00425100|451910712|FG000|Overall Study|Lack of Efficacy|4|||
125625443|NCT00425100|451910712|FG000|Overall Study|Lost to Follow-up|2|||
125625444|NCT00425100|451910712|FG000|Overall Study|Protocol Violation|4|||
125625445|NCT00425100|451910712|FG000|Overall Study|Withdrawal by Subject|7|||
125625446|NCT00555906|451910713|FG000|Phase 1|Objective Progression or Relapse|3|||
125128341|NCT00184600|450096052|FG001|Overall Study|Adverse Event|0|||
125128342|NCT00184600|450096053|FG002|Overall Study|Adverse Event|5|||
125128343|NCT00184600|450096051|FG000|Overall Study|Death|3|||
125128344|NCT00184600|450096052|FG001|Overall Study|Death|9|||
125128345|NCT00184600|450096053|FG002|Overall Study|Death|7|||
125128346|NCT00184600|450096051|FG000|Overall Study|Lack of Efficacy|3|||
125128347|NCT00184600|450096052|FG001|Overall Study|Lack of Efficacy|1|||
125128348|NCT00184600|450096053|FG002|Overall Study|Lack of Efficacy|3|||
125128349|NCT00184600|450096051|FG000|Overall Study|Lost to Follow-up|4|||
125128350|NCT00184600|450096052|FG001|Overall Study|Lost to Follow-up|6|||
125128351|NCT00184600|450096053|FG002|Overall Study|Lost to Follow-up|1|||
125128352|NCT00184600|450096051|FG000|Overall Study|Protocol Violation|2|||
125128353|NCT00184600|450096052|FG001|Overall Study|Protocol Violation|2|||
125128354|NCT00184600|450096053|FG002|Overall Study|Protocol Violation|3|||
125128355|NCT00184600|450096051|FG000|Overall Study|Withdrawal by Subject|20|||
125128356|NCT00184600|450096052|FG001|Overall Study|Withdrawal by Subject|28|||
125128357|NCT00184600|450096053|FG002|Overall Study|Withdrawal by Subject|12|||
125128358|NCT00184600|450096051|FG000|Overall Study|Unclassified|4|||
125128359|NCT00184600|450096052|FG001|Overall Study|Unclassified|5|||
125128360|NCT00184600|450096053|FG002|Overall Study|Unclassified|3|||
125128361|NCT04274686|450096055|FG000|Overall Study|Physician Decision|1|||
125128362|NCT04274686|450096056|FG001|Overall Study|Physician Decision|0|||
125128363|NCT00376623|450096057|FG000|Overall Study|Progressive disease|35|||
125128364|NCT00376623|450096058|FG001|Overall Study|Progressive disease|22|||
125128365|NCT00376623|450096059|FG002|Overall Study|Progressive disease|17|||
125128366|NCT00376623|450096057|FG000|Overall Study|Lost to Follow-up|0|||
125128367|NCT00376623|450096058|FG001|Overall Study|Lost to Follow-up|1|||
125128368|NCT00376623|450096059|FG002|Overall Study|Lost to Follow-up|0|||
125128369|NCT00376623|450096057|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
125128370|NCT00376623|450096058|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
125128371|NCT00376623|450096059|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
125128372|NCT00376623|450096057|FG000|Overall Study|Not treated with BI 2536|1|||
125128373|NCT00376623|450096058|FG001|Overall Study|Not treated with BI 2536|0|||
125128374|NCT00376623|450096059|FG002|Overall Study|Not treated with BI 2536|0|||
125128375|NCT00376623|450096057|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
125128376|NCT00376623|450096058|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
125128377|NCT00376623|450096059|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
125128378|NCT00376623|450096057|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
125128379|NCT00376623|450096058|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
125625447|NCT00555906|451910714|FG001|Phase 1|Objective Progression or Relapse|5|||
125625448|NCT00555906|451910715|FG002|Phase 1|Objective Progression or Relapse|3|||
125625449|NCT00555906|451910716|FG003|Phase 1|Objective Progression or Relapse|1|||
125625450|NCT00555906|451910717|FG004|Phase 1|Objective Progression or Relapse|0|||
125625451|NCT00555906|451910713|FG000|Phase 1|Global Deterioration of Health Status|0|||
125625452|NCT00555906|451910714|FG001|Phase 1|Global Deterioration of Health Status|1|||
125625453|NCT00555906|451910715|FG002|Phase 1|Global Deterioration of Health Status|1|||
125625454|NCT00555906|451910716|FG003|Phase 1|Global Deterioration of Health Status|1|||
125625455|NCT00555906|451910717|FG004|Phase 1|Global Deterioration of Health Status|0|||
125625456|NCT00555906|451910713|FG000|Phase 1|Adverse Event|0|||
125625457|NCT00555906|451910714|FG001|Phase 1|Adverse Event|0|||
125625458|NCT00555906|451910715|FG002|Phase 1|Adverse Event|3|||
125625459|NCT00555906|451910716|FG003|Phase 1|Adverse Event|2|||
125625460|NCT00555906|451910717|FG004|Phase 1|Adverse Event|0|||
125625461|NCT00555906|451910713|FG000|Phase 1|Withdrawal by Subject|0|||
125625462|NCT00555906|451910714|FG001|Phase 1|Withdrawal by Subject|0|||
125625463|NCT00555906|451910715|FG002|Phase 1|Withdrawal by Subject|0|||
125625464|NCT00555906|451910716|FG003|Phase 1|Withdrawal by Subject|1|||
125625465|NCT00555906|451910717|FG004|Phase 1|Withdrawal by Subject|0|||
125128380|NCT00376623|450096059|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
125128381|NCT00376623|450096057|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
125128382|NCT00376623|450096058|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
125128383|NCT00376623|450096059|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
125128384|NCT00376623|450096057|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
125625466|NCT00555906|451910713|FG000|Phase 2|Adverse Event|0|||
125625467|NCT00555906|451910714|FG001|Phase 2|Adverse Event|0|||
125625468|NCT00555906|451910715|FG002|Phase 2|Adverse Event|0|||
125625469|NCT00555906|451910716|FG003|Phase 2|Adverse Event|0|||
125625470|NCT00555906|451910717|FG004|Phase 2|Adverse Event|4|||
125625471|NCT00555906|451910713|FG000|Phase 2|Global Deterioration of Health Status|0|||
125625472|NCT00555906|451910714|FG001|Phase 2|Global Deterioration of Health Status|0|||
125625473|NCT00555906|451910715|FG002|Phase 2|Global Deterioration of Health Status|0|||
125625474|NCT00555906|451910716|FG003|Phase 2|Global Deterioration of Health Status|0|||
125625475|NCT00555906|451910717|FG004|Phase 2|Global Deterioration of Health Status|2|||
125625476|NCT00555906|451910713|FG000|Phase 2|Objective Progression or Relapse|0|||
125625477|NCT00555906|451910714|FG001|Phase 2|Objective Progression or Relapse|0|||
125625478|NCT00555906|451910715|FG002|Phase 2|Objective Progression or Relapse|0|||
125625479|NCT00555906|451910716|FG003|Phase 2|Objective Progression or Relapse|0|||
125625480|NCT00555906|451910717|FG004|Phase 2|Objective Progression or Relapse|16|||
125625481|NCT00555906|451910713|FG000|Phase 2|Withdrawal by Subject|0|||
125625482|NCT00555906|451910714|FG001|Phase 2|Withdrawal by Subject|0|||
125625483|NCT00555906|451910715|FG002|Phase 2|Withdrawal by Subject|0|||
125625484|NCT00555906|451910716|FG003|Phase 2|Withdrawal by Subject|0|||
125625485|NCT00555906|451910717|FG004|Phase 2|Withdrawal by Subject|2|||
125625486|NCT00555906|451910713|FG000|Phase 2|Other|0|||
125625487|NCT00555906|451910714|FG001|Phase 2|Other|0|||
125625488|NCT00555906|451910715|FG002|Phase 2|Other|0|||
125625489|NCT00555906|451910716|FG003|Phase 2|Other|0|||
125625490|NCT00555906|451910717|FG004|Phase 2|Other|6|||
125625491|NCT00555906|451910713|FG000|Phase 2|Randomized but not Treated|0|||
125625492|NCT00555906|451910714|FG001|Phase 2|Randomized but not Treated|0|||
125625493|NCT00555906|451910715|FG002|Phase 2|Randomized but not Treated|0|||
125625494|NCT00555906|451910716|FG003|Phase 2|Randomized but not Treated|0|||
125625495|NCT00555906|451910717|FG004|Phase 2|Randomized but not Treated|2|||
125625496|NCT00889681|451910718|FG000|Overall Study|Not meeting qualification Criteria|2|||
125625497|NCT00889681|451910718|FG000|Overall Study|Insurance disapproval|1|||
125625498|NCT00187889|451910721|FG000|Overall Study|Withdrawal by Subject|6|||
125625499|NCT00187889|451910722|FG001|Overall Study|Withdrawal by Subject|4|||
125625500|NCT04046341|451910723|FG000|Overall Study|Lost to Follow-up|2|||
125625501|NCT04046341|451910723|FG000|Overall Study|Withdrawal by Subject|1|||
125625502|NCT03094832|451910724|FG000|Overall Study|Lost to Follow-up|0|||
125625503|NCT03094832|451910725|FG001|Overall Study|Lost to Follow-up|0|||
125625504|NCT03094832|451910726|FG002|Overall Study|Lost to Follow-up|0|||
125625505|NCT03094832|451910727|FG003|Overall Study|Lost to Follow-up|1|||
125625506|NCT03094832|451910728|FG004|Overall Study|Lost to Follow-up|1|||
125625507|NCT03094832|451910724|FG000|Overall Study|Death|1|||
125625508|NCT03094832|451910725|FG001|Overall Study|Death|0|||
125625509|NCT03094832|451910726|FG002|Overall Study|Death|0|||
125625510|NCT03094832|451910727|FG003|Overall Study|Death|0|||
125625511|NCT03094832|451910728|FG004|Overall Study|Death|0|||
125625512|NCT03094832|451910724|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125625513|NCT03094832|451910725|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125625514|NCT03094832|451910726|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125625515|NCT03094832|451910727|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125625516|NCT03094832|451910728|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125625517|NCT03094832|451910724|FG000|Overall Study|Other|13|||
125625518|NCT03094832|451910725|FG001|Overall Study|Other|20|||
125625519|NCT03094832|451910726|FG002|Overall Study|Other|1|||
125625520|NCT03094832|451910727|FG003|Overall Study|Other|7|||
125625521|NCT03094832|451910728|FG004|Overall Study|Other|1|||
125625522|NCT01575899|451910729|FG000|Overall Study|Lost to Follow-up|3|||
125625523|NCT01575899|451910730|FG001|Overall Study|Lost to Follow-up|4|||
125625524|NCT01575899|451910731|FG002|Overall Study|Lost to Follow-up|2|||
125625525|NCT01575899|451910729|FG000|Overall Study|Protocol Violation|2|||
125625526|NCT01575899|451910730|FG001|Overall Study|Protocol Violation|1|||
125625527|NCT01575899|451910731|FG002|Overall Study|Protocol Violation|0|||
125625528|NCT05567393|451910732|FG000|Overall Study|Voluntary Withdrawal|0|||
125625529|NCT05567393|451910733|FG001|Overall Study|Voluntary Withdrawal|0|||
125625530|NCT05567393|451910734|FG002|Overall Study|Voluntary Withdrawal|0|||
125625531|NCT05567393|451910735|FG003|Overall Study|Voluntary Withdrawal|0|||
125625532|NCT05567393|451910736|FG004|Overall Study|Voluntary Withdrawal|0|||
125625533|NCT05567393|451910737|FG005|Overall Study|Voluntary Withdrawal|0|||
125625534|NCT05567393|451910738|FG006|Overall Study|Voluntary Withdrawal|0|||
125625535|NCT05567393|451910739|FG007|Overall Study|Voluntary Withdrawal|0|||
125625536|NCT05567393|451910740|FG008|Overall Study|Voluntary Withdrawal|0|||
125625537|NCT05567393|451910741|FG009|Overall Study|Voluntary Withdrawal|0|||
125625538|NCT05567393|451910742|FG010|Overall Study|Voluntary Withdrawal|0|||
125625539|NCT05567393|451910743|FG011|Overall Study|Voluntary Withdrawal|0|||
125625540|NCT05567393|451910744|FG012|Overall Study|Voluntary Withdrawal|0|||
125625541|NCT05567393|451910745|FG013|Overall Study|Voluntary Withdrawal|1|||
125625542|NCT05567393|451910746|FG014|Overall Study|Voluntary Withdrawal|0|||
125625543|NCT05567393|451910747|FG015|Overall Study|Voluntary Withdrawal|0|||
125625544|NCT05567393|451910748|FG016|Overall Study|Voluntary Withdrawal|0|||
125625545|NCT05567393|451910749|FG017|Overall Study|Voluntary Withdrawal|0|||
125625546|NCT04199793|451910750|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
125625547|NCT04199793|451910751|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
125625548|NCT04199793|451910750|FG000|Overall Study|Withdrawal by Subject|1|||
125625549|NCT04199793|451910751|FG001|Overall Study|Withdrawal by Subject|1|||
125625550|NCT04186663|451910758|FG000|Overall Study|Lost to Follow-up|1|||
125625551|NCT04186663|451910758|FG000|Overall Study|Unable to complete blood draw|3|||
125625552|NCT01602549|451910764|FG000|Overall Study|Protocol Violation|0|||
125625553|NCT01602549|451910765|FG001|Overall Study|Protocol Violation|1|||
125625554|NCT01602549|451910764|FG000|Overall Study|Withdrawal by Subject|1|||
125625555|NCT01602549|451910765|FG001|Overall Study|Withdrawal by Subject|0|||
125625556|NCT05200455|451910766|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
125625557|NCT00719862|451910767|FG000|Overall Study|Adverse Event|1|||
125625558|NCT00719862|451910768|FG001|Overall Study|Adverse Event|2|||
125625559|NCT00719862|451910767|FG000|Overall Study|Lack of Efficacy|3|||
125625560|NCT00719862|451910768|FG001|Overall Study|Lack of Efficacy|0|||
125625561|NCT00719862|451910767|FG000|Overall Study|Non-Compliance|1|||
125625562|NCT00719862|451910768|FG001|Overall Study|Non-Compliance|0|||
125625563|NCT00719862|451910767|FG000|Overall Study|Withdrawal by Subject|1|||
125625564|NCT00719862|451910768|FG001|Overall Study|Withdrawal by Subject|0|||
125625565|NCT00719862|451910767|FG000|Overall Study|Lost to Follow-up|0|||
125625566|NCT00719862|451910768|FG001|Overall Study|Lost to Follow-up|1|||
125625567|NCT00719862|451910767|FG000|Overall Study|Other|2|||
125625568|NCT00719862|451910768|FG001|Overall Study|Other|3|||
125625569|NCT01184846|451910770|FG000|Overall Study|Adverse Event|2|||
125625570|NCT01184846|451910770|FG000|Overall Study|Insufficient response|1|||
125625571|NCT03366844|451913315|FG000|Overall Study|Physician Decision|1|||
125625572|NCT03366844|451913315|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
125625573|NCT00107172|451913316|FG000|Overall Study|Withdrawal by Subject|1|||
125625574|NCT00107172|451913317|FG001|Overall Study|Withdrawal by Subject|0|||
125625575|NCT00107172|451913316|FG000|Overall Study|Death|0|||
125625576|NCT00107172|451913317|FG001|Overall Study|Death|2|||
125625577|NCT00107172|451913316|FG000|Overall Study|Other Reason|4|||
125625578|NCT00107172|451913317|FG001|Overall Study|Other Reason|3|||
125625579|NCT01102140|451913320|FG000|Overall Study|Lost to Follow-up|1|||
125625580|NCT01102140|451913321|FG001|Overall Study|Lost to Follow-up|0|||
125625581|NCT01102140|451913320|FG000|Overall Study|Investigator terminated study|2|||
125625582|NCT01102140|451913321|FG001|Overall Study|Investigator terminated study|2|||
125625583|NCT01673490|451913324|FG000|Overall Study|Lost to Follow-up|1|||
125625584|NCT01673490|451913324|FG000|Overall Study|Adverse Event|3|||
125625585|NCT01673490|451913324|FG000|Overall Study|Withdrawal by Subject|3|||
125625586|NCT00379236|451913325|FG000|Double-blind|Adverse Event|11|||
125625587|NCT00379236|451913326|FG001|Double-blind|Adverse Event|6|||
125625588|NCT00379236|451913327|FG002|Double-blind|Adverse Event|0|||
125625589|NCT00379236|451913325|FG000|Double-blind|Protocol Violation|3|||
125625590|NCT00379236|451913326|FG001|Double-blind|Protocol Violation|3|||
125625591|NCT00379236|451913327|FG002|Double-blind|Protocol Violation|0|||
125625592|NCT00379236|451913325|FG000|Double-blind|Withdrawal by Subject|12|||
125625593|NCT00379236|451913326|FG001|Double-blind|Withdrawal by Subject|13|||
125625594|NCT00379236|451913327|FG002|Double-blind|Withdrawal by Subject|0|||
125625595|NCT00379236|451913325|FG000|Double-blind|Lost to Follow-up|4|||
125625596|NCT00379236|451913326|FG001|Double-blind|Lost to Follow-up|3|||
125625597|NCT00379236|451913327|FG002|Double-blind|Lost to Follow-up|0|||
125625598|NCT00379236|451913325|FG000|Double-blind|Use of exclusionary medication|1|||
125625599|NCT00379236|451913326|FG001|Double-blind|Use of exclusionary medication|2|||
125625600|NCT00379236|451913327|FG002|Double-blind|Use of exclusionary medication|0|||
125625601|NCT00379236|451913325|FG000|Double-blind|Other|3|||
125625602|NCT00379236|451913326|FG001|Double-blind|Other|7|||
125625603|NCT00379236|451913327|FG002|Double-blind|Other|0|||
125625604|NCT00379236|451913325|FG000|Double-blind|Data could not be retrieved|2|||
125625605|NCT00379236|451913326|FG001|Double-blind|Data could not be retrieved|2|||
125625606|NCT00379236|451913327|FG002|Double-blind|Data could not be retrieved|0|||
125625607|NCT00379236|451913325|FG000|Open-label Extension|Adverse Event|0|||
125625608|NCT00379236|451913326|FG001|Open-label Extension|Adverse Event|0|||
125625609|NCT00379236|451913327|FG002|Open-label Extension|Adverse Event|13|||
125625610|NCT00379236|451913325|FG000|Open-label Extension|Protocol Violation|0|||
125625611|NCT00379236|451913326|FG001|Open-label Extension|Protocol Violation|0|||
125625612|NCT00379236|451913327|FG002|Open-label Extension|Protocol Violation|7|||
125625613|NCT00379236|451913325|FG000|Open-label Extension|Withdrawal by Subject|0|||
125625614|NCT00379236|451913326|FG001|Open-label Extension|Withdrawal by Subject|0|||
125625615|NCT00379236|451913327|FG002|Open-label Extension|Withdrawal by Subject|13|||
125625616|NCT00379236|451913325|FG000|Open-label Extension|Lost to Follow-up|0|||
125625617|NCT00379236|451913326|FG001|Open-label Extension|Lost to Follow-up|0|||
125625618|NCT00379236|451913327|FG002|Open-label Extension|Lost to Follow-up|12|||
125215575|NCT01768559|450417439|FG001|Overall Study|Poor compliance to protocol|3|||
125625619|NCT00379236|451913325|FG000|Open-label Extension|Use of exclusionary medication|0|||
125215576|NCT01768559|450417440|FG002|Overall Study|Poor compliance to protocol|2|||
125625620|NCT00379236|451913326|FG001|Open-label Extension|Use of exclusionary medication|0|||
125374881|NCT00642460|451002281|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
125625621|NCT00379236|451913327|FG002|Open-label Extension|Use of exclusionary medication|3|||
125625622|NCT00379236|451913325|FG000|Open-label Extension|Other|0|||
125625623|NCT00379236|451913326|FG001|Open-label Extension|Other|0|||
125625624|NCT00379236|451913327|FG002|Open-label Extension|Other|7|||
125625625|NCT03276572|451913333|FG000|Overall Study|In follow-up|0|||
125625626|NCT03276572|451913334|FG001|Overall Study|In follow-up|0|||
125625627|NCT03276572|451913335|FG002|Overall Study|In follow-up|0|||
125625628|NCT03276572|451913336|FG003|Overall Study|In follow-up|0|||
125625629|NCT03276572|451913337|FG004|Overall Study|In follow-up|0|||
125625630|NCT03276572|451913338|FG005|Overall Study|In follow-up|1|||
125625631|NCT03276572|451913339|FG006|Overall Study|In follow-up|1|||
125625632|NCT03276572|451913333|FG000|Overall Study|Lost to Follow-up|0|||
125625633|NCT03276572|451913334|FG001|Overall Study|Lost to Follow-up|0|||
125625634|NCT03276572|451913335|FG002|Overall Study|Lost to Follow-up|0|||
125625635|NCT03276572|451913336|FG003|Overall Study|Lost to Follow-up|0|||
125625636|NCT03276572|451913337|FG004|Overall Study|Lost to Follow-up|0|||
125625637|NCT03276572|451913338|FG005|Overall Study|Lost to Follow-up|0|||
125625638|NCT03276572|451913339|FG006|Overall Study|Lost to Follow-up|1|||
125625639|NCT01709708|451913340|FG000|Overall Study|Protocol Violation|1|||
125625640|NCT01709708|451913341|FG001|Overall Study|Protocol Violation|2|||
125625641|NCT00527072|451913342|FG000|Overall Study|Adverse Event|13|||
125625642|NCT00527072|451913342|FG000|Overall Study|Lack of Efficacy|11|||
125625643|NCT00527072|451913342|FG000|Overall Study|Lost to Follow-up|3|||
125625644|NCT00527072|451913342|FG000|Overall Study|Protocol Violation|2|||
125625645|NCT00527072|451913342|FG000|Overall Study|Withdrawal by Subject|7|||
125625646|NCT00810043|451913343|FG000|Overall Study|Withdrawal by Subject|1|||
125625647|NCT00810043|451913344|FG001|Overall Study|Withdrawal by Subject|0|||
125625648|NCT00810043|451913345|FG002|Overall Study|Withdrawal by Subject|2|||
125625649|NCT00810043|451913343|FG000|Overall Study|Lost to Follow-up|1|||
125625650|NCT00810043|451913344|FG001|Overall Study|Lost to Follow-up|0|||
125625651|NCT00810043|451913345|FG002|Overall Study|Lost to Follow-up|0|||
125625652|NCT00810043|451913343|FG000|Overall Study|Physician Decision|0|||
125625653|NCT00810043|451913344|FG001|Overall Study|Physician Decision|0|||
125625654|NCT00810043|451913345|FG002|Overall Study|Physician Decision|2|||
125625655|NCT00810043|451913343|FG000|Overall Study|Death|2|||
125625656|NCT00810043|451913344|FG001|Overall Study|Death|0|||
125625657|NCT00810043|451913345|FG002|Overall Study|Death|0|||
125625658|NCT00810043|451913343|FG000|Overall Study|Unrelated medical problem|0|||
125625659|NCT00810043|451913344|FG001|Overall Study|Unrelated medical problem|1|||
125625660|NCT00810043|451913345|FG002|Overall Study|Unrelated medical problem|0|||
125625661|NCT00810043|451913343|FG000|Overall Study|Non-medical problem|0|||
125625662|NCT00810043|451913344|FG001|Overall Study|Non-medical problem|0|||
125625663|NCT00810043|451913345|FG002|Overall Study|Non-medical problem|1|||
125625664|NCT00810043|451913343|FG000|Overall Study|No longer met enrollment criteria|0|||
125625665|NCT00810043|451913344|FG001|Overall Study|No longer met enrollment criteria|0|||
125625666|NCT00810043|451913345|FG002|Overall Study|No longer met enrollment criteria|3|||
125625667|NCT01989754|451913346|FG000|Overall Study|Withdrawal by Subject|10|||
125625668|NCT01989754|451913347|FG001|Overall Study|Withdrawal by Subject|14|||
125625669|NCT01989754|451913346|FG000|Overall Study|Lost to Follow-up|28|||
125625670|NCT01989754|451913347|FG001|Overall Study|Lost to Follow-up|20|||
125625671|NCT01989754|451913346|FG000|Overall Study|Closed Site|1|||
125625672|NCT01989754|451913347|FG001|Overall Study|Closed Site|1|||
125625673|NCT01369225|451913351|FG000|Overall Study|Withdrawal by Subject|1|||
125625674|NCT01369225|451913352|FG001|Overall Study|Withdrawal by Subject|0|||
125625675|NCT01369225|451913353|FG002|Overall Study|Withdrawal by Subject|2|||
125625676|NCT01369225|451913354|FG003|Overall Study|Withdrawal by Subject|1|||
125625677|NCT01369225|451913355|FG004|Overall Study|Withdrawal by Subject|0|||
125625678|NCT01369225|451913356|FG005|Overall Study|Withdrawal by Subject|0|||
125625679|NCT01369225|451913351|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
125625680|NCT01369225|451913352|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
125625681|NCT01369225|451913353|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
125625682|NCT01369225|451913354|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
125625683|NCT01369225|451913355|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
125625684|NCT01369225|451913356|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
125625685|NCT01369225|451913351|FG000|Overall Study|Other|1|||
125625686|NCT01369225|451913352|FG001|Overall Study|Other|0|||
125625687|NCT01369225|451913353|FG002|Overall Study|Other|0|||
125625688|NCT01369225|451913354|FG003|Overall Study|Other|0|||
125625689|NCT01369225|451913355|FG004|Overall Study|Other|1|||
125625690|NCT01369225|451913356|FG005|Overall Study|Other|0|||
125625691|NCT01369225|451913351|FG000|Overall Study|Adverse Event|0|||
125625692|NCT01369225|451913352|FG001|Overall Study|Adverse Event|0|||
125625693|NCT01369225|451913353|FG002|Overall Study|Adverse Event|0|||
125625694|NCT01369225|451913354|FG003|Overall Study|Adverse Event|1|||
125625695|NCT01369225|451913355|FG004|Overall Study|Adverse Event|1|||
125625696|NCT01369225|451913356|FG005|Overall Study|Adverse Event|0|||
125625697|NCT02980692|451913359|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
125625698|NCT02980692|451913360|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
125625699|NCT02980692|451913361|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
125625700|NCT02980692|451913362|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
125625701|NCT02980692|451913363|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
125625702|NCT02980692|451913359|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
125625703|NCT02980692|451913360|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
125625704|NCT02980692|451913361|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
125625705|NCT02980692|451913362|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
125625706|NCT02980692|451913363|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
125625707|NCT02980692|451913359|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
125625708|NCT02980692|451913360|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
125625709|NCT02980692|451913361|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
125625710|NCT02980692|451913362|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
125625711|NCT02980692|451913363|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
125625712|NCT02980692|451913359|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
125625713|NCT02980692|451913360|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
125625714|NCT02980692|451913361|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
125625715|NCT02980692|451913362|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
125625716|NCT02980692|451913363|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
125625717|NCT02980692|451913359|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
125625718|NCT02980692|451913360|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
125625719|NCT02980692|451913361|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
125625720|NCT02980692|451913362|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
125625721|NCT02980692|451913363|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
125625722|NCT02980692|451913359|FG000|Double Blind Placebo Controlled Period|Other|1|||
125625723|NCT02980692|451913360|FG001|Double Blind Placebo Controlled Period|Other|0|||
125625724|NCT02980692|451913361|FG002|Double Blind Placebo Controlled Period|Other|0|||
125625725|NCT02980692|451913362|FG003|Double Blind Placebo Controlled Period|Other|0|||
125625726|NCT02980692|451913363|FG004|Double Blind Placebo Controlled Period|Other|1|||
125625727|NCT02980692|451913359|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
125625728|NCT02980692|451913360|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
125625729|NCT02980692|451913361|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
125625730|NCT02980692|451913362|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
125625731|NCT02980692|451913363|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
125625732|NCT02980692|451913359|FG000|Double-blind Follow-up Period|Adverse Event|0|||
125625733|NCT02980692|451913360|FG001|Double-blind Follow-up Period|Adverse Event|0|||
125625734|NCT02980692|451913361|FG002|Double-blind Follow-up Period|Adverse Event|0|||
125625735|NCT02980692|451913362|FG003|Double-blind Follow-up Period|Adverse Event|1|||
125625736|NCT02980692|451913363|FG004|Double-blind Follow-up Period|Adverse Event|1|||
125625737|NCT02980692|451913359|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
125625738|NCT02980692|451913360|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
125625739|NCT02980692|451913361|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
125625740|NCT02980692|451913362|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
125625741|NCT02980692|451913363|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
125625742|NCT02980692|451913359|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
125625743|NCT02980692|451913360|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
125625744|NCT02980692|451913361|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
125625745|NCT02980692|451913362|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
125625746|NCT02980692|451913363|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
125625747|NCT02980692|451913359|FG000|Double-blind Follow-up Period|Pregnancy|0|||
125625748|NCT02980692|451913360|FG001|Double-blind Follow-up Period|Pregnancy|0|||
125625749|NCT02980692|451913361|FG002|Double-blind Follow-up Period|Pregnancy|1|||
125625750|NCT02980692|451913362|FG003|Double-blind Follow-up Period|Pregnancy|1|||
125625751|NCT02980692|451913363|FG004|Double-blind Follow-up Period|Pregnancy|0|||
125625752|NCT02980692|451913359|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
125625753|NCT02980692|451913360|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
125625754|NCT02980692|451913361|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
125625755|NCT02980692|451913362|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
125625756|NCT02980692|451913363|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
125625757|NCT02980692|451913359|FG000|Double-blind Follow-up Period|Other|0|||
125625758|NCT02980692|451913360|FG001|Double-blind Follow-up Period|Other|0|||
125625759|NCT02980692|451913361|FG002|Double-blind Follow-up Period|Other|1|||
125625760|NCT02980692|451913362|FG003|Double-blind Follow-up Period|Other|1|||
125625761|NCT02980692|451913363|FG004|Double-blind Follow-up Period|Other|3|||
125625762|NCT00064077|451913366|FG000|Overall Study|Improper prior treatment|1|||
125625763|NCT00064077|451913367|FG001|Overall Study|Improper prior treatment|0|||
125625764|NCT00064077|451913368|FG002|Overall Study|Improper prior treatment|0|||
125625765|NCT00064077|451913369|FG003|Overall Study|Improper prior treatment|0|||
125625766|NCT00064077|451913366|FG000|Overall Study|Poor risk|2|||
125625767|NCT00064077|451913367|FG001|Overall Study|Poor risk|0|||
125625768|NCT00064077|451913368|FG002|Overall Study|Poor risk|1|||
125625769|NCT00064077|451913369|FG003|Overall Study|Poor risk|1|||
125625770|NCT00064077|451913366|FG000|Overall Study|Pathology|10|||
125625771|NCT00064077|451913367|FG001|Overall Study|Pathology|7|||
125433305|NCT01576367|451214442|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125433306|NCT01576367|451214442|FG000|Overall Study|Moved to commercial use after 6 months|1|||
125433307|NCT01453348|451214443|FG000|Overall Study|Death|0|||
125433308|NCT01453348|451214444|FG001|Overall Study|Death|0|||
125433309|NCT01453348|451214445|FG002|Overall Study|Death|1|||
125433310|NCT01453348|451214443|FG000|Overall Study|Withdrawal by Subject|0|||
125433311|NCT01453348|451214444|FG001|Overall Study|Withdrawal by Subject|1|||
125433312|NCT01453348|451214445|FG002|Overall Study|Withdrawal by Subject|0|||
125625772|NCT00064077|451913368|FG002|Overall Study|Pathology|3|||
125625773|NCT00064077|451913369|FG003|Overall Study|Pathology|4|||
125625774|NCT00064077|451913366|FG000|Overall Study|No surgery|0|||
125625775|NCT00064077|451913367|FG001|Overall Study|No surgery|0|||
125625776|NCT00064077|451913368|FG002|Overall Study|No surgery|1|||
125625777|NCT00064077|451913369|FG003|Overall Study|No surgery|0|||
125433313|NCT01453348|451214443|FG000|Overall Study|Protocol Violation|1|||
125433314|NCT01453348|451214444|FG001|Overall Study|Protocol Violation|0|||
125433315|NCT01453348|451214445|FG002|Overall Study|Protocol Violation|0|||
125433316|NCT04359771|451214447|FG000|Overall Study|Lack of Efficacy|2|||
125433317|NCT04359771|451214448|FG001|Overall Study|Lack of Efficacy|2|||
125625778|NCT00064077|451913366|FG000|Overall Study|No tumor|0|||
125625779|NCT00064077|451913367|FG001|Overall Study|No tumor|0|||
125625780|NCT00064077|451913368|FG002|Overall Study|No tumor|1|||
125625781|NCT00064077|451913369|FG003|Overall Study|No tumor|0|||
125625782|NCT00064077|451913366|FG000|Overall Study|Other reasons|2|||
125625783|NCT00064077|451913367|FG001|Overall Study|Other reasons|2|||
125625784|NCT00064077|451913368|FG002|Overall Study|Other reasons|1|||
125625785|NCT00064077|451913369|FG003|Overall Study|Other reasons|2|||
125625786|NCT01112982|451913373|FG000|Overall Study|Withdrawal by Subject|1|||
125625787|NCT01112982|451913373|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
125625788|NCT01001234|451913378|FG000|Overall Study|Withdrawal by Subject|2|||
125625789|NCT01001234|451913379|FG001|Overall Study|Withdrawal by Subject|0|||
125625790|NCT01001234|451913380|FG002|Overall Study|Withdrawal by Subject|3|||
125625791|NCT01001234|451913381|FG003|Overall Study|Withdrawal by Subject|0|||
125625792|NCT01001234|451913382|FG004|Overall Study|Withdrawal by Subject|0|||
125625793|NCT01001234|451913378|FG000|Overall Study|Protocol Violation|34|||
125625794|NCT01001234|451913379|FG001|Overall Study|Protocol Violation|3|||
125625795|NCT01001234|451913380|FG002|Overall Study|Protocol Violation|19|||
125625796|NCT01001234|451913381|FG003|Overall Study|Protocol Violation|18|||
125625797|NCT01001234|451913382|FG004|Overall Study|Protocol Violation|0|||
125625798|NCT01001234|451913378|FG000|Overall Study|Lost to Follow-up|0|||
125625799|NCT01001234|451913379|FG001|Overall Study|Lost to Follow-up|0|||
125625800|NCT01001234|451913380|FG002|Overall Study|Lost to Follow-up|1|||
125625801|NCT01001234|451913381|FG003|Overall Study|Lost to Follow-up|2|||
125625802|NCT01001234|451913382|FG004|Overall Study|Lost to Follow-up|0|||
125625803|NCT01001234|451913378|FG000|Overall Study|Physician Decision|1|||
125625804|NCT01001234|451913379|FG001|Overall Study|Physician Decision|0|||
125625805|NCT01001234|451913380|FG002|Overall Study|Physician Decision|0|||
125625806|NCT01001234|451913381|FG003|Overall Study|Physician Decision|0|||
125625807|NCT01001234|451913382|FG004|Overall Study|Physician Decision|0|||
125625808|NCT01001234|451913378|FG000|Overall Study|Not Treated: Adverse Event|1|||
125625809|NCT01001234|451913379|FG001|Overall Study|Not Treated: Adverse Event|0|||
125625810|NCT01001234|451913380|FG002|Overall Study|Not Treated: Adverse Event|0|||
125625811|NCT01001234|451913381|FG003|Overall Study|Not Treated: Adverse Event|0|||
125625812|NCT01001234|451913382|FG004|Overall Study|Not Treated: Adverse Event|0|||
125625813|NCT01001234|451913378|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
125625814|NCT01001234|451913379|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
125625815|NCT01001234|451913380|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
125433318|NCT00954733|451214449|FG000|Overall Study|blood gas machine did not work|1|||
125433319|NCT03592277|451214450|FG000|Overall Study|Withdrawal by Subject|6|||
125433320|NCT03592277|451214451|FG001|Overall Study|Withdrawal by Subject|8|||
125433321|NCT00622713|451214452|FG000|Overall Study|Adverse Event|35|||
125433322|NCT00622713|451214452|FG000|Overall Study|Administrative problems|4|||
125433323|NCT00622713|451214452|FG000|Overall Study|Withdrawal by Subject|11|||
125625816|NCT01001234|451913381|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
125625817|NCT01001234|451913382|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
125625818|NCT01001234|451913378|FG000|Overall Study|Not Treated: Protocol Violation|3|||
125625819|NCT01001234|451913379|FG001|Overall Study|Not Treated: Protocol Violation|0|||
125625820|NCT01001234|451913380|FG002|Overall Study|Not Treated: Protocol Violation|0|||
125625821|NCT01001234|451913381|FG003|Overall Study|Not Treated: Protocol Violation|0|||
125625822|NCT01001234|451913382|FG004|Overall Study|Not Treated: Protocol Violation|0|||
125625823|NCT01001234|451913378|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
125625824|NCT01001234|451913379|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
125625825|NCT01001234|451913380|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
125625826|NCT01001234|451913381|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
125625827|NCT01001234|451913382|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
125625828|NCT01001234|451913378|FG000|Overall Study|Not Treated: Pregnancy|3|||
125625829|NCT01001234|451913379|FG001|Overall Study|Not Treated: Pregnancy|0|||
125625830|NCT01001234|451913380|FG002|Overall Study|Not Treated: Pregnancy|0|||
125625831|NCT01001234|451913381|FG003|Overall Study|Not Treated: Pregnancy|0|||
125625832|NCT01001234|451913382|FG004|Overall Study|Not Treated: Pregnancy|0|||
125625833|NCT01001234|451913378|FG000|Overall Study|Not Treated: Physician Decision|37|||
125625834|NCT01001234|451913379|FG001|Overall Study|Not Treated: Physician Decision|4|||
125625835|NCT01001234|451913380|FG002|Overall Study|Not Treated: Physician Decision|0|||
125625836|NCT01001234|451913381|FG003|Overall Study|Not Treated: Physician Decision|0|||
125625837|NCT01001234|451913382|FG004|Overall Study|Not Treated: Physician Decision|0|||
125625838|NCT01001234|451913378|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
125625839|NCT01001234|451913379|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
125625840|NCT01001234|451913380|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
125625841|NCT01001234|451913381|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
125625842|NCT01001234|451913382|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
125625843|NCT03379376|451913383|FG000|Overall Study|Lost to Follow-up|2|||
125625844|NCT03379376|451913383|FG000|Overall Study|Did not wish to complete follow up|1|||
125625845|NCT03379376|451913383|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
125625846|NCT03379376|451913383|FG000|Overall Study|Death|1|||
125625847|NCT00928512|451913384|FG000|Overall Study|Adverse Event|4|||
125625848|NCT00928512|451913385|FG001|Overall Study|Adverse Event|3|||
125625849|NCT00928512|451913386|FG002|Overall Study|Adverse Event|2|||
125625850|NCT00928512|451913387|FG003|Overall Study|Adverse Event|8|||
125625851|NCT00928512|451913388|FG004|Overall Study|Adverse Event|6|||
125625852|NCT00928512|451913384|FG000|Overall Study|Lack of Efficacy|2|||
125625853|NCT00928512|451913385|FG001|Overall Study|Lack of Efficacy|0|||
125625854|NCT00928512|451913386|FG002|Overall Study|Lack of Efficacy|4|||
125625855|NCT00928512|451913387|FG003|Overall Study|Lack of Efficacy|7|||
125625856|NCT00928512|451913388|FG004|Overall Study|Lack of Efficacy|3|||
125625857|NCT00928512|451913384|FG000|Overall Study|Protocol Violation|0|||
125625858|NCT00928512|451913385|FG001|Overall Study|Protocol Violation|1|||
125625859|NCT00928512|451913386|FG002|Overall Study|Protocol Violation|0|||
125625860|NCT00928512|451913387|FG003|Overall Study|Protocol Violation|1|||
125625861|NCT00928512|451913388|FG004|Overall Study|Protocol Violation|3|||
125625862|NCT00928512|451913384|FG000|Overall Study|Withdrawal by Subject|3|||
125625863|NCT00928512|451913385|FG001|Overall Study|Withdrawal by Subject|0|||
125625864|NCT00928512|451913386|FG002|Overall Study|Withdrawal by Subject|3|||
125625865|NCT00928512|451913387|FG003|Overall Study|Withdrawal by Subject|4|||
125625866|NCT00928512|451913388|FG004|Overall Study|Withdrawal by Subject|0|||
125625867|NCT00928512|451913384|FG000|Overall Study|Lost to Follow-up|1|||
125625868|NCT00928512|451913385|FG001|Overall Study|Lost to Follow-up|1|||
125625869|NCT00928512|451913386|FG002|Overall Study|Lost to Follow-up|2|||
125625870|NCT00928512|451913387|FG003|Overall Study|Lost to Follow-up|1|||
125625871|NCT00928512|451913388|FG004|Overall Study|Lost to Follow-up|3|||
125625872|NCT00928512|451913384|FG000|Overall Study|Administrative Problems|0|||
125625873|NCT00928512|451913385|FG001|Overall Study|Administrative Problems|1|||
125625874|NCT00928512|451913386|FG002|Overall Study|Administrative Problems|0|||
125625875|NCT00928512|451913387|FG003|Overall Study|Administrative Problems|0|||
125625876|NCT00928512|451913388|FG004|Overall Study|Administrative Problems|0|||
125625877|NCT01963780|451913389|FG000|Overall Study|Death|7|||
125215577|NCT01768559|450417438|FG000|Overall Study|Other than specified|9|||
125625878|NCT04153929|451913390|FG000|Overall Study|Other than listed|2|||
125625879|NCT04153929|451913391|FG001|Overall Study|Other than listed|2|||
125625880|NCT04153929|451913392|FG002|Overall Study|Other than listed|0|||
125625881|NCT04153929|451913393|FG003|Overall Study|Other than listed|1|||
125625882|NCT04153929|451913394|FG004|Overall Study|Other than listed|0|||
125625883|NCT04153929|451913395|FG005|Overall Study|Other than listed|2|||
125625884|NCT04153929|451913396|FG006|Overall Study|Other than listed|2|||
125625885|NCT04153929|451913397|FG007|Overall Study|Other than listed|1|||
125625886|NCT04153929|451913390|FG000|Overall Study|Lost to Follow-up|2|||
125374882|NCT00642460|451002282|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
125625887|NCT04153929|451913391|FG001|Overall Study|Lost to Follow-up|1|||
125433324|NCT00622713|451214452|FG000|Overall Study|Lost to Follow-up|5|||
125625888|NCT04153929|451913392|FG002|Overall Study|Lost to Follow-up|0|||
125625889|NCT04153929|451913393|FG003|Overall Study|Lost to Follow-up|1|||
125625890|NCT04153929|451913394|FG004|Overall Study|Lost to Follow-up|1|||
125625891|NCT04153929|451913395|FG005|Overall Study|Lost to Follow-up|0|||
125625892|NCT04153929|451913396|FG006|Overall Study|Lost to Follow-up|0|||
125625893|NCT04153929|451913397|FG007|Overall Study|Lost to Follow-up|0|||
125625894|NCT04153929|451913390|FG000|Overall Study|Withdrawal by Subject|3|||
125625895|NCT04153929|451913391|FG001|Overall Study|Withdrawal by Subject|1|||
125625896|NCT04153929|451913392|FG002|Overall Study|Withdrawal by Subject|0|||
125374883|NCT00642460|451002283|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
125374884|NCT00642460|451002284|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
125374885|NCT00642460|451002285|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
125625897|NCT04153929|451913393|FG003|Overall Study|Withdrawal by Subject|3|||
125625898|NCT04153929|451913394|FG004|Overall Study|Withdrawal by Subject|1|||
125625899|NCT04153929|451913395|FG005|Overall Study|Withdrawal by Subject|0|||
125625900|NCT04153929|451913396|FG006|Overall Study|Withdrawal by Subject|1|||
125625901|NCT04153929|451913397|FG007|Overall Study|Withdrawal by Subject|0|||
125625902|NCT04153929|451913390|FG000|Overall Study|Protocol Violation|0|||
125625903|NCT04153929|451913391|FG001|Overall Study|Protocol Violation|0|||
125625904|NCT04153929|451913392|FG002|Overall Study|Protocol Violation|0|||
125625905|NCT04153929|451913393|FG003|Overall Study|Protocol Violation|0|||
125625906|NCT04153929|451913394|FG004|Overall Study|Protocol Violation|0|||
125625907|NCT04153929|451913395|FG005|Overall Study|Protocol Violation|0|||
125625908|NCT04153929|451913396|FG006|Overall Study|Protocol Violation|1|||
125625909|NCT04153929|451913397|FG007|Overall Study|Protocol Violation|2|||
125625910|NCT04153929|451913390|FG000|Overall Study|Adverse Event|3|||
125374886|NCT00642460|451002286|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
125374887|NCT00642460|451002281|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
125374888|NCT00642460|451002282|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
125374889|NCT00642460|451002283|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
125374890|NCT00642460|451002284|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
125374891|NCT00642460|451002285|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
125374892|NCT00642460|451002286|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
125374893|NCT00642460|451002281|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
125374894|NCT00642460|451002282|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
125374895|NCT00642460|451002283|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
125374896|NCT00642460|451002284|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
125374897|NCT00642460|451002285|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
125374898|NCT00642460|451002286|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
125374899|NCT00642460|451002281|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
125374900|NCT00642460|451002282|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
125374901|NCT00642460|451002283|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
125374902|NCT00642460|451002284|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
125374903|NCT00642460|451002285|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
125433325|NCT00622713|451214452|FG000|Overall Study|Death|2|||
125433326|NCT00622713|451214452|FG000|Overall Study|Subject no longer required study drug|1|||
125433327|NCT00622713|451214452|FG000|Overall Study|Did not meet eligibility criteria|1|||
125433328|NCT01462162|451214453|FG000|Overall Study|Adverse Event|5|||
125433329|NCT01462162|451214453|FG000|Overall Study|Lack of Efficacy|4|||
125625911|NCT04153929|451913391|FG001|Overall Study|Adverse Event|5|||
125625912|NCT04153929|451913392|FG002|Overall Study|Adverse Event|5|||
125625913|NCT04153929|451913393|FG003|Overall Study|Adverse Event|11|||
125128385|NCT00376623|450096058|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
125128386|NCT00376623|450096059|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
125625914|NCT04153929|451913394|FG004|Overall Study|Adverse Event|15|||
125625915|NCT04153929|451913395|FG005|Overall Study|Adverse Event|4|||
125625916|NCT04153929|451913396|FG006|Overall Study|Adverse Event|8|||
125625917|NCT04153929|451913397|FG007|Overall Study|Adverse Event|2|||
125625918|NCT04153929|451913390|FG000|Overall Study|Not treated|1|||
125625919|NCT04153929|451913391|FG001|Overall Study|Not treated|0|||
125625920|NCT04153929|451913392|FG002|Overall Study|Not treated|0|||
125625921|NCT04153929|451913393|FG003|Overall Study|Not treated|0|||
125625922|NCT04153929|451913394|FG004|Overall Study|Not treated|0|||
125625923|NCT04153929|451913395|FG005|Overall Study|Not treated|0|||
125625924|NCT04153929|451913396|FG006|Overall Study|Not treated|1|||
125625925|NCT04153929|451913397|FG007|Overall Study|Not treated|0|||
125625926|NCT03383614|451913398|FG000|Overall Study|Withdrawal by Subject|0|||
125625927|NCT03383614|451913399|FG001|Overall Study|Withdrawal by Subject|1|||
125625928|NCT03383614|451913400|FG002|Overall Study|Withdrawal by Subject|0|||
125625929|NCT03383614|451913401|FG003|Overall Study|Withdrawal by Subject|0|||
125625930|NCT00729326|451913408|FG000|Overall Study|Lost to Follow-up|2|||
125128387|NCT00376623|450096057|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
125625931|NCT00729326|451913409|FG001|Overall Study|Lost to Follow-up|0|||
125625932|NCT00729326|451913408|FG000|Overall Study|Physician Decision|0|||
125625933|NCT00729326|451913409|FG001|Overall Study|Physician Decision|1|||
125625934|NCT00729326|451913408|FG000|Overall Study|Protocol Violation|3|||
125625935|NCT00729326|451913409|FG001|Overall Study|Protocol Violation|2|||
125625936|NCT00729326|451913408|FG000|Overall Study|Subject Decision|4|||
125625937|NCT00729326|451913409|FG001|Overall Study|Subject Decision|4|||
125625938|NCT00729326|451913408|FG000|Overall Study|Sponsor Decision|1|||
125625939|NCT00729326|451913409|FG001|Overall Study|Sponsor Decision|2|||
125625940|NCT01235728|451913410|FG000|Overall Study|Protocol Violation|0|||
125625941|NCT01235728|451913411|FG001|Overall Study|Protocol Violation|0|||
125625942|NCT01235728|451913412|FG002|Overall Study|Protocol Violation|0|||
125625943|NCT01235728|451913413|FG003|Overall Study|Protocol Violation|1|||
125625944|NCT01235728|451913414|FG004|Overall Study|Protocol Violation|0|||
125625945|NCT01235728|451913415|FG005|Overall Study|Protocol Violation|0|||
125625946|NCT01235728|451913416|FG006|Overall Study|Protocol Violation|0|||
125625947|NCT01235728|451913417|FG007|Overall Study|Protocol Violation|0|||
125625948|NCT02559713|451913418|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
125625949|NCT02193828|451913422|FG000|Overall Study|Withdrawal by Subject|0|||
125625950|NCT02193828|451913423|FG001|Overall Study|Withdrawal by Subject|0|||
125625951|NCT02193828|451913424|FG002|Overall Study|Withdrawal by Subject|1|||
125374904|NCT00642460|451002286|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
125374905|NCT00642460|451002281|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
125625952|NCT02193828|451913425|FG003|Overall Study|Withdrawal by Subject|1|||
125625953|NCT01185704|451913426|FG000|Overall Study|Randomized but not treated|3|||
125625954|NCT01185704|451913427|FG001|Overall Study|Randomized but not treated|3|||
125625955|NCT01185704|451913426|FG000|Overall Study|Lack of ovarian response|5|||
125625956|NCT01185704|451913427|FG001|Overall Study|Lack of ovarian response|1|||
125625957|NCT01185704|451913426|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
125625958|NCT01185704|451913427|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
125625959|NCT01185704|451913426|FG000|Overall Study|Ectopic pregnancy|0|||
125625960|NCT01185704|451913427|FG001|Overall Study|Ectopic pregnancy|1|||
125625961|NCT01686958|451913430|FG000|Overall Study|Withdrawal by Subject|1|||
125625962|NCT01151540|451913433|FG000|Overall Study|Other|2|||
125625963|NCT01151540|451913433|FG000|Overall Study|Adverse event, non-fatal|4|||
125625964|NCT01151540|451913433|FG000|Overall Study|Withdrawal by Subject|7|||
125625965|NCT00788697|451913436|FG000|Overall Study|No study drug administered|12|||
125625966|NCT00788697|451913436|FG000|Overall Study|Training Patients|74|||
125625967|NCT00788697|451913436|FG000|Overall Study|no truth standard procedure available|5|||
125625968|NCT00788697|451913436|FG000|Overall Study|Technically inadequate truth standard|1|||
125625969|NCT00788697|451913436|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
125625970|NCT01998880|451913440|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
125625971|NCT01998880|451913441|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
125625972|NCT01998880|451913440|FG000|Overall Study|Disease Progression|1|||
125625973|NCT01998880|451913441|FG001|Overall Study|Disease Progression|8|||
125625974|NCT01998880|451913440|FG000|Overall Study|Withdrew Consent|2|||
125625975|NCT01998880|451913441|FG001|Overall Study|Withdrew Consent|1|||
125625976|NCT01998880|451913440|FG000|Overall Study|Death|3|||
125625977|NCT01998880|451913441|FG001|Overall Study|Death|6|||
125625978|NCT01998880|451913440|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125625979|NCT01998880|451913441|FG001|Overall Study|Insufficient Therapeutic Response|5|||
125625980|NCT01998880|451913440|FG000|Overall Study|Administrative/Other|1|||
125625981|NCT01998880|451913441|FG001|Overall Study|Administrative/Other|1|||
125625982|NCT01998880|451913440|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
125625983|NCT01998880|451913441|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
125625984|NCT01998880|451913440|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
125625985|NCT01998880|451913441|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
125625986|NCT01998880|451913440|FG000|Overall Study|Did Not Receive Treatment|3|||
125625987|NCT01998880|451913441|FG001|Overall Study|Did Not Receive Treatment|2|||
125625988|NCT01419080|451913442|FG000|Overall Study|Withdrawal by Subject|75|||
125625989|NCT01419080|451913442|FG000|Overall Study|Death|30|||
125625990|NCT01419080|451913442|FG000|Overall Study|Lost to Follow-up|23|||
125625991|NCT01419080|451913442|FG000|Overall Study|Too Ill|3|||
125625992|NCT03199638|451913446|FG000|Overall Study|inability to drink glutamine during regularly|0|||
125625993|NCT03199638|451913447|FG001|Overall Study|inability to drink glutamine during regularly|2|||
125625994|NCT02671461|451913448|FG000|Treatment|Adverse Event|0|||
125625995|NCT02671461|451913449|FG001|Treatment|Adverse Event|0|||
125374906|NCT00642460|451002282|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
125374907|NCT00642460|451002283|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
125625996|NCT02671461|451913450|FG002|Treatment|Adverse Event|1|||
125625997|NCT02671461|451913448|FG000|Treatment|Administrative Reason by Sponsor|1|||
125625998|NCT02671461|451913449|FG001|Treatment|Administrative Reason by Sponsor|3|||
125625999|NCT02671461|451913450|FG002|Treatment|Administrative Reason by Sponsor|4|||
125626000|NCT02671461|451913448|FG000|Treatment|Randomized, not treated|1|||
125626001|NCT02671461|451913449|FG001|Treatment|Randomized, not treated|0|||
125626002|NCT02671461|451913450|FG002|Treatment|Randomized, not treated|0|||
125626003|NCT02671461|451913448|FG000|Follow-up|Withdrawal by Subject|1|||
125626004|NCT02671461|451913449|FG001|Follow-up|Withdrawal by Subject|0|||
125626005|NCT02671461|451913450|FG002|Follow-up|Withdrawal by Subject|0|||
125626006|NCT02671461|451913448|FG000|Follow-up|Lost to Follow-up|0|||
125626007|NCT02671461|451913449|FG001|Follow-up|Lost to Follow-up|0|||
125626008|NCT02671461|451913450|FG002|Follow-up|Lost to Follow-up|1|||
125626009|NCT02671461|451913448|FG000|Follow-up|Administrative Reason by Sponsor|0|||
125626010|NCT02671461|451913449|FG001|Follow-up|Administrative Reason by Sponsor|1|||
125626011|NCT02671461|451913450|FG002|Follow-up|Administrative Reason by Sponsor|0|||
125626012|NCT02807844|451913451|FG000|Overall Study|Physician Decision|0|||
125626013|NCT02807844|451913452|FG001|Overall Study|Physician Decision|0|||
125626014|NCT02807844|451913453|FG002|Overall Study|Physician Decision|0|||
125626015|NCT02807844|451913454|FG003|Overall Study|Physician Decision|0|||
125626016|NCT02807844|451913455|FG004|Overall Study|Physician Decision|0|||
125626017|NCT02807844|451913456|FG005|Overall Study|Physician Decision|0|||
125626018|NCT02807844|451913457|FG006|Overall Study|Physician Decision|3|||
125626019|NCT02807844|451913458|FG007|Overall Study|Physician Decision|0|||
125626020|NCT02807844|451913459|FG008|Overall Study|Physician Decision|1|||
125626021|NCT02807844|451913460|FG009|Overall Study|Physician Decision|2|||
125626022|NCT02807844|451913451|FG000|Overall Study|Death|0|||
125626023|NCT02807844|451913452|FG001|Overall Study|Death|0|||
125626024|NCT02807844|451913453|FG002|Overall Study|Death|2|||
125626025|NCT02807844|451913454|FG003|Overall Study|Death|4|||
125626026|NCT02807844|451913455|FG004|Overall Study|Death|1|||
125626027|NCT02807844|451913456|FG005|Overall Study|Death|2|||
125626028|NCT02807844|451913457|FG006|Overall Study|Death|1|||
125626029|NCT02807844|451913458|FG007|Overall Study|Death|2|||
125626030|NCT02807844|451913459|FG008|Overall Study|Death|0|||
125626031|NCT02807844|451913460|FG009|Overall Study|Death|1|||
125626032|NCT02807844|451913451|FG000|Overall Study|Withdrawal by Subject|0|||
125626033|NCT02807844|451913452|FG001|Overall Study|Withdrawal by Subject|0|||
125626034|NCT02807844|451913453|FG002|Overall Study|Withdrawal by Subject|2|||
125626035|NCT02807844|451913454|FG003|Overall Study|Withdrawal by Subject|1|||
125626036|NCT02807844|451913455|FG004|Overall Study|Withdrawal by Subject|1|||
125626037|NCT02807844|451913456|FG005|Overall Study|Withdrawal by Subject|0|||
125626038|NCT02807844|451913457|FG006|Overall Study|Withdrawal by Subject|1|||
125626039|NCT02807844|451913458|FG007|Overall Study|Withdrawal by Subject|0|||
125626040|NCT02807844|451913459|FG008|Overall Study|Withdrawal by Subject|0|||
125626041|NCT02807844|451913460|FG009|Overall Study|Withdrawal by Subject|0|||
125626042|NCT02807844|451913451|FG000|Overall Study|Progressive disease|5|||
125626043|NCT02807844|451913452|FG001|Overall Study|Progressive disease|12|||
125626044|NCT02807844|451913453|FG002|Overall Study|Progressive disease|8|||
125626045|NCT02807844|451913454|FG003|Overall Study|Progressive disease|8|||
125626046|NCT02807844|451913455|FG004|Overall Study|Progressive disease|3|||
125626047|NCT02807844|451913456|FG005|Overall Study|Progressive disease|8|||
125626048|NCT02807844|451913457|FG006|Overall Study|Progressive disease|14|||
125626049|NCT02807844|451913458|FG007|Overall Study|Progressive disease|17|||
125626050|NCT02807844|451913459|FG008|Overall Study|Progressive disease|19|||
125626051|NCT02807844|451913460|FG009|Overall Study|Progressive disease|15|||
125626052|NCT02807844|451913451|FG000|Overall Study|Adverse Event|1|||
125626053|NCT02807844|451913452|FG001|Overall Study|Adverse Event|0|||
125626054|NCT02807844|451913453|FG002|Overall Study|Adverse Event|0|||
125626055|NCT02807844|451913454|FG003|Overall Study|Adverse Event|0|||
125374908|NCT00642460|451002284|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
125374909|NCT00642460|451002285|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
125374910|NCT00642460|451002286|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
125374911|NCT00642460|451002281|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
125374912|NCT00642460|451002282|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
125374913|NCT00642460|451002283|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
125374914|NCT00642460|451002284|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
125626056|NCT02807844|451913455|FG004|Overall Study|Adverse Event|1|||
125626057|NCT02807844|451913456|FG005|Overall Study|Adverse Event|1|||
125626058|NCT02807844|451913457|FG006|Overall Study|Adverse Event|1|||
125626059|NCT02807844|451913458|FG007|Overall Study|Adverse Event|1|||
125626060|NCT02807844|451913459|FG008|Overall Study|Adverse Event|1|||
125626061|NCT02807844|451913460|FG009|Overall Study|Adverse Event|2|||
125626062|NCT00709124|451913461|FG000|Overall Study|Death|3|||
125626063|NCT00709124|451913462|FG001|Overall Study|Death|1|||
125626064|NCT00709124|451913461|FG000|Overall Study|encephalopathy; can't do assessment|1|||
125626065|NCT00709124|451913462|FG001|Overall Study|encephalopathy; can't do assessment|0|||
125626066|NCT00373490|451913463|FG000|Overall Study|Adverse Event|0|||
125626067|NCT00373490|451913464|FG001|Overall Study|Adverse Event|1|||
125626068|NCT00373490|451913463|FG000|Overall Study|Lack of Efficacy|9|||
125626069|NCT00373490|451913464|FG001|Overall Study|Lack of Efficacy|4|||
125626070|NCT00373490|451913463|FG000|Overall Study|Withdrawal by Subject|0|||
125626071|NCT00373490|451913464|FG001|Overall Study|Withdrawal by Subject|1|||
125626072|NCT04294095|451913465|FG000|Overall Study|Adverse Event|1|||
125626073|NCT04294095|451913466|FG001|Overall Study|Adverse Event|0|||
125626074|NCT00141037|451913474|FG000|Overall Study|Physician Decision|1|||
125626075|NCT00141037|451913475|FG001|Overall Study|Physician Decision|2|||
125626076|NCT00141037|451913474|FG000|Overall Study|Lost to Follow-up|3|||
125626077|NCT00141037|451913475|FG001|Overall Study|Lost to Follow-up|1|||
125626078|NCT00141037|451913474|FG000|Overall Study|Protocol Violation|0|||
125626079|NCT00141037|451913475|FG001|Overall Study|Protocol Violation|2|||
125626080|NCT00141037|451913474|FG000|Overall Study|Withdrawal by Subject|2|||
125626081|NCT00141037|451913475|FG001|Overall Study|Withdrawal by Subject|1|||
125626082|NCT00141037|451913474|FG000|Overall Study|Other|0|||
125626083|NCT00141037|451913475|FG001|Overall Study|Other|1|||
125626084|NCT00141037|451913474|FG000|Overall Study|Moved from area|1|||
125626085|NCT00141037|451913475|FG001|Overall Study|Moved from area|7|||
125626086|NCT00141037|451913474|FG000|Overall Study|Graft Failure|3|||
125626087|NCT00141037|451913475|FG001|Overall Study|Graft Failure|4|||
125626088|NCT00260429|451913476|FG000|Overall Study|failure to follow appointments|1|||
125626089|NCT00260429|451913477|FG001|Overall Study|failure to follow appointments|0|||
125626090|NCT00260429|451913476|FG000|Overall Study|scheduled hand surgery|1|||
125626091|NCT00260429|451913477|FG001|Overall Study|scheduled hand surgery|0|||
125626092|NCT00628758|451913478|FG000|Overall Study|Adverse Event|2|||
125626093|NCT00628758|451913479|FG001|Overall Study|Adverse Event|3|||
125626094|NCT00628758|451913478|FG000|Overall Study|Withdrawal by Subject|6|||
125626095|NCT00628758|451913479|FG001|Overall Study|Withdrawal by Subject|3|||
125626096|NCT00628758|451913478|FG000|Overall Study|Death|1|||
125626097|NCT00628758|451913479|FG001|Overall Study|Death|0|||
125626098|NCT00628758|451913478|FG000|Overall Study|Protocol Violation|5|||
125626099|NCT00628758|451913479|FG001|Overall Study|Protocol Violation|1|||
125626100|NCT00628758|451913478|FG000|Overall Study|Lost to Follow-up|25|||
125626101|NCT00628758|451913479|FG001|Overall Study|Lost to Follow-up|31|||
125626102|NCT00628758|451913478|FG000|Overall Study|Pregnancy|2|||
125626103|NCT00628758|451913479|FG001|Overall Study|Pregnancy|2|||
125626104|NCT00628758|451913478|FG000|Overall Study|Investigator Moved|3|||
125626105|NCT00628758|451913479|FG001|Overall Study|Investigator Moved|0|||
125626106|NCT00628758|451913478|FG000|Overall Study|Treatment Failure|0|||
125626107|NCT00628758|451913479|FG001|Overall Study|Treatment Failure|2|||
125626108|NCT04179786|451913480|FG000|Overall Study|Withdrawal by Subject|8|||
125626109|NCT01938001|451913481|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
125626110|NCT01938001|451913482|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
125626111|NCT01938001|451913481|FG000|Pre-Treatment|Death|1|||
125626112|NCT01938001|451913482|FG001|Pre-Treatment|Death|0|||
125626113|NCT01938001|451913481|FG000|Treatment|Death|2|||
125626114|NCT01938001|451913482|FG001|Treatment|Death|0|||
125626115|NCT01938001|451913481|FG000|Treatment|Adverse Event|14|||
125626116|NCT01938001|451913482|FG001|Treatment|Adverse Event|8|||
125626117|NCT01938001|451913481|FG000|Treatment|Progressive Disease|21|||
125626118|NCT01938001|451913482|FG001|Treatment|Progressive Disease|54|||
125626119|NCT01938001|451913481|FG000|Treatment|Withdrawal by Subject|13|||
125626120|NCT01938001|451913482|FG001|Treatment|Withdrawal by Subject|7|||
125626121|NCT01938001|451913481|FG000|Treatment|Other reasons|2|||
125626122|NCT01938001|451913482|FG001|Treatment|Other reasons|1|||
125626123|NCT03310580|451913483|FG000|Overall Study|Adverse Event|0|||
125626124|NCT03310580|451913484|FG001|Overall Study|Adverse Event|1|||
125626125|NCT03310580|451913485|FG002|Overall Study|Adverse Event|0|||
125626126|NCT02762708|451913490|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
125626127|NCT02762708|451913491|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
125626128|NCT02762708|451913492|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
125626129|NCT02762708|451913493|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
125626130|NCT01468701|451913498|FG000|Overall Study|Not eligible|91|||
125626131|NCT01468701|451913499|FG001|Overall Study|Not eligible|140|||
125626132|NCT01468701|451913500|FG002|Overall Study|Not eligible|29|||
125626133|NCT01468701|451913501|FG003|Overall Study|Not eligible|12|||
125626134|NCT01468701|451913502|FG004|Overall Study|Not eligible|22|||
125626135|NCT01468701|451913503|FG005|Overall Study|Not eligible|2|||
125626136|NCT01468701|451913504|FG006|Overall Study|Not eligible|39|||
125626137|NCT01468701|451913505|FG007|Overall Study|Not eligible|1|||
125626138|NCT01468701|451913506|FG008|Overall Study|Not eligible|40|||
125626139|NCT01468701|451913507|FG009|Overall Study|Not eligible|126|||
125626140|NCT01468701|451913508|FG010|Overall Study|Not eligible|39|||
125626141|NCT01468701|451913509|FG011|Overall Study|Not eligible|33|||
125626142|NCT01468701|451913510|FG012|Overall Study|Not eligible|1|||
125626143|NCT01468701|451913511|FG013|Overall Study|Not eligible|19|||
125626144|NCT01468701|451913512|FG014|Overall Study|Not eligible|1|||
125626145|NCT01468701|451913513|FG015|Overall Study|Not eligible|32|||
125626146|NCT01468701|451913514|FG016|Overall Study|Not eligible|0|||
125626147|NCT01468701|451913498|FG000|Overall Study|Lost to Follow-up|306|||
125626148|NCT01468701|451913499|FG001|Overall Study|Lost to Follow-up|0|||
125626149|NCT01468701|451913500|FG002|Overall Study|Lost to Follow-up|0|||
125626150|NCT01468701|451913501|FG003|Overall Study|Lost to Follow-up|0|||
125626151|NCT01468701|451913502|FG004|Overall Study|Lost to Follow-up|0|||
125626152|NCT01468701|451913503|FG005|Overall Study|Lost to Follow-up|0|||
125626153|NCT01468701|451913504|FG006|Overall Study|Lost to Follow-up|0|||
125626154|NCT01468701|451913505|FG007|Overall Study|Lost to Follow-up|0|||
125626155|NCT01468701|451913506|FG008|Overall Study|Lost to Follow-up|215|||
125626156|NCT01468701|451913507|FG009|Overall Study|Lost to Follow-up|309|||
125626157|NCT01468701|451913508|FG010|Overall Study|Lost to Follow-up|224|||
125626158|NCT01468701|451913509|FG011|Overall Study|Lost to Follow-up|212|||
125626159|NCT01468701|451913510|FG012|Overall Study|Lost to Follow-up|11|||
125626160|NCT01468701|451913511|FG013|Overall Study|Lost to Follow-up|164|||
125626161|NCT01468701|451913512|FG014|Overall Study|Lost to Follow-up|17|||
125626162|NCT01468701|451913513|FG015|Overall Study|Lost to Follow-up|127|||
125626163|NCT01468701|451913514|FG016|Overall Study|Lost to Follow-up|1|||
125626164|NCT01468701|451913498|FG000|Overall Study|Withdrawal by Subject|165|||
125626165|NCT01468701|451913499|FG001|Overall Study|Withdrawal by Subject|0|||
125626166|NCT01468701|451913500|FG002|Overall Study|Withdrawal by Subject|0|||
125626167|NCT01468701|451913501|FG003|Overall Study|Withdrawal by Subject|0|||
125626168|NCT01468701|451913502|FG004|Overall Study|Withdrawal by Subject|0|||
125626169|NCT01468701|451913503|FG005|Overall Study|Withdrawal by Subject|0|||
125626170|NCT01468701|451913504|FG006|Overall Study|Withdrawal by Subject|0|||
125626171|NCT01468701|451913505|FG007|Overall Study|Withdrawal by Subject|0|||
125626172|NCT01468701|451913506|FG008|Overall Study|Withdrawal by Subject|83|||
125626173|NCT01468701|451913507|FG009|Overall Study|Withdrawal by Subject|88|||
125626174|NCT01468701|451913508|FG010|Overall Study|Withdrawal by Subject|100|||
125626175|NCT01468701|451913509|FG011|Overall Study|Withdrawal by Subject|114|||
125626176|NCT01468701|451913510|FG012|Overall Study|Withdrawal by Subject|9|||
125626177|NCT01468701|451913511|FG013|Overall Study|Withdrawal by Subject|47|||
125626178|NCT01468701|451913512|FG014|Overall Study|Withdrawal by Subject|6|||
125626179|NCT01468701|451913513|FG015|Overall Study|Withdrawal by Subject|31|||
125626180|NCT01468701|451913514|FG016|Overall Study|Withdrawal by Subject|0|||
125626181|NCT01468701|451913498|FG000|Overall Study|Other reasons than listed|437|||
125626182|NCT01468701|451913499|FG001|Overall Study|Other reasons than listed|0|||
125626183|NCT01468701|451913500|FG002|Overall Study|Other reasons than listed|0|||
125626184|NCT01468701|451913501|FG003|Overall Study|Other reasons than listed|0|||
125626185|NCT01468701|451913502|FG004|Overall Study|Other reasons than listed|0|||
125626186|NCT01468701|451913503|FG005|Overall Study|Other reasons than listed|0|||
125626187|NCT01468701|451913504|FG006|Overall Study|Other reasons than listed|0|||
125626188|NCT01468701|451913505|FG007|Overall Study|Other reasons than listed|0|||
125626189|NCT01468701|451913506|FG008|Overall Study|Other reasons than listed|318|||
125626190|NCT01468701|451913507|FG009|Overall Study|Other reasons than listed|658|||
125626191|NCT01468701|451913508|FG010|Overall Study|Other reasons than listed|433|||
125626192|NCT01468701|451913509|FG011|Overall Study|Other reasons than listed|504|||
125626193|NCT01468701|451913510|FG012|Overall Study|Other reasons than listed|28|||
125626194|NCT01468701|451913511|FG013|Overall Study|Other reasons than listed|239|||
125626195|NCT01468701|451913512|FG014|Overall Study|Other reasons than listed|39|||
125626196|NCT01468701|451913513|FG015|Overall Study|Other reasons than listed|172|||
125626197|NCT01468701|451913514|FG016|Overall Study|Other reasons than listed|0|||
125626198|NCT01468701|451913498|FG000|Overall Study|No end of study case report form|0|||
125626199|NCT01468701|451913499|FG001|Overall Study|No end of study case report form|0|||
125626200|NCT01468701|451913500|FG002|Overall Study|No end of study case report form|0|||
125626201|NCT01468701|451913501|FG003|Overall Study|No end of study case report form|0|||
125626202|NCT01468701|451913502|FG004|Overall Study|No end of study case report form|0|||
125626203|NCT01468701|451913503|FG005|Overall Study|No end of study case report form|0|||
125626204|NCT01468701|451913504|FG006|Overall Study|No end of study case report form|0|||
125626205|NCT01468701|451913505|FG007|Overall Study|No end of study case report form|0|||
125626206|NCT01468701|451913506|FG008|Overall Study|No end of study case report form|4|||
125626207|NCT01468701|451913507|FG009|Overall Study|No end of study case report form|1|||
125626208|NCT01468701|451913508|FG010|Overall Study|No end of study case report form|2|||
125626209|NCT01468701|451913509|FG011|Overall Study|No end of study case report form|3|||
125626210|NCT01468701|451913510|FG012|Overall Study|No end of study case report form|0|||
125626211|NCT01468701|451913511|FG013|Overall Study|No end of study case report form|1|||
125626212|NCT01468701|451913512|FG014|Overall Study|No end of study case report form|0|||
125626213|NCT01468701|451913513|FG015|Overall Study|No end of study case report form|0|||
125626214|NCT01468701|451913514|FG016|Overall Study|No end of study case report form|0|||
125626215|NCT01468701|451913498|FG000|Overall Study|Not being followed up|0|||
125626216|NCT01468701|451913499|FG001|Overall Study|Not being followed up|4963|||
125626217|NCT01468701|451913500|FG002|Overall Study|Not being followed up|1755|||
125626218|NCT01468701|451913501|FG003|Overall Study|Not being followed up|703|||
125626219|NCT01468701|451913502|FG004|Overall Study|Not being followed up|1714|||
125626220|NCT01468701|451913503|FG005|Overall Study|Not being followed up|126|||
125626221|NCT01468701|451913504|FG006|Overall Study|Not being followed up|1170|||
125626222|NCT01468701|451913505|FG007|Overall Study|Not being followed up|4|||
125626223|NCT01468701|451913506|FG008|Overall Study|Not being followed up|0|||
125626224|NCT01468701|451913507|FG009|Overall Study|Not being followed up|0|||
125626225|NCT01468701|451913508|FG010|Overall Study|Not being followed up|0|||
125626226|NCT01468701|451913509|FG011|Overall Study|Not being followed up|0|||
125626227|NCT01468701|451913510|FG012|Overall Study|Not being followed up|0|||
125626228|NCT01468701|451913511|FG013|Overall Study|Not being followed up|0|||
125626229|NCT01468701|451913512|FG014|Overall Study|Not being followed up|0|||
125626230|NCT01468701|451913513|FG015|Overall Study|Not being followed up|0|||
125626231|NCT01468701|451913514|FG016|Overall Study|Not being followed up|0|||
125626232|NCT01068717|451913515|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
125626233|NCT01068717|451913516|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
125626234|NCT01068717|451913517|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
125626235|NCT01068717|451913518|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
125626236|NCT00892957|451913520|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
125626237|NCT00892957|451913521|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
125626238|NCT00892957|451913520|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
125626239|NCT00892957|451913521|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
125626240|NCT02483078|451913522|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
125626241|NCT02483078|451913523|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
125626242|NCT02483078|451913522|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
125626243|NCT02483078|451913523|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
125626244|NCT02483078|451913522|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
125626245|NCT02483078|451913523|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
125626246|NCT02483078|451913522|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
125626247|NCT02483078|451913523|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
125626248|NCT02483078|451913522|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
125626249|NCT02483078|451913523|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
125626250|NCT02483078|451913522|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
125626251|NCT02483078|451913523|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
125626252|NCT02853032|451913524|FG000|Overall Study|Adverse Event|4|||
125626253|NCT02853032|451913525|FG001|Overall Study|Adverse Event|0|||
125626254|NCT02853032|451913524|FG000|Overall Study|Withdrawal by Subject|3|||
125626255|NCT02853032|451913525|FG001|Overall Study|Withdrawal by Subject|1|||
125626256|NCT02853032|451913524|FG000|Overall Study|Requested to withdraw from all treatment|2|||
125626257|NCT02853032|451913525|FG001|Overall Study|Requested to withdraw from all treatment|2|||
125626258|NCT03700736|451913528|FG000|Overall Study|Pregnancy|1|||
125626259|NCT03700736|451913529|FG001|Overall Study|Pregnancy|1|||
125626260|NCT03700736|451913528|FG000|Overall Study|Withdrawal by Subject|2|||
125626261|NCT03700736|451913529|FG001|Overall Study|Withdrawal by Subject|6|||
125626262|NCT01410799|451913530|FG000|Overall Study|PI decision|13|||
125626263|NCT02688153|451915615|FG000|Overall Study|Death|7|||
125626264|NCT02688153|451915616|FG001|Overall Study|Death|5|||
125626265|NCT02688153|451915615|FG000|Overall Study|Withdrawal by Subject|4|||
125626266|NCT02688153|451915616|FG001|Overall Study|Withdrawal by Subject|2|||
125626267|NCT02688153|451915615|FG000|Overall Study|Valve Explant|1|||
125626268|NCT02688153|451915616|FG001|Overall Study|Valve Explant|0|||
125626269|NCT02688153|451915615|FG000|Overall Study|Conversion to Commercial Valve|3|||
125626270|NCT02688153|451915616|FG001|Overall Study|Conversion to Commercial Valve|0|||
125626271|NCT03682055|451915617|FG000|Overall Study|Lack of Efficacy|1|||
125626272|NCT03682055|451915618|FG001|Overall Study|Lack of Efficacy|2|||
125626273|NCT03682055|451915619|FG002|Overall Study|Lack of Efficacy|1|||
125626274|NCT03682055|451915620|FG003|Overall Study|Lack of Efficacy|2|||
125626275|NCT03682055|451915621|FG004|Overall Study|Lack of Efficacy|1|||
125626276|NCT03682055|451915622|FG005|Overall Study|Lack of Efficacy|3|||
125626277|NCT03682055|451915617|FG000|Overall Study|Withdrawal by Subject|0|||
125626278|NCT03682055|451915618|FG001|Overall Study|Withdrawal by Subject|0|||
125626279|NCT03682055|451915619|FG002|Overall Study|Withdrawal by Subject|0|||
125626280|NCT03682055|451915620|FG003|Overall Study|Withdrawal by Subject|0|||
125626281|NCT03682055|451915621|FG004|Overall Study|Withdrawal by Subject|0|||
125626282|NCT03682055|451915622|FG005|Overall Study|Withdrawal by Subject|1|||
125626283|NCT03682055|451915617|FG000|Overall Study|Termination of Study by Sponsor|0|||
125626284|NCT03682055|451915618|FG001|Overall Study|Termination of Study by Sponsor|0|||
125626285|NCT03682055|451915619|FG002|Overall Study|Termination of Study by Sponsor|0|||
125128388|NCT00376623|450096058|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
125128389|NCT00376623|450096059|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
125128390|NCT00376623|450096057|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
125128391|NCT00376623|450096058|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
125128392|NCT00376623|450096059|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
125128393|NCT00376623|450096057|FG000|Overall Study|Increase of tumour markers|0|||
125626286|NCT03682055|451915620|FG003|Overall Study|Termination of Study by Sponsor|0|||
125626287|NCT03682055|451915621|FG004|Overall Study|Termination of Study by Sponsor|0|||
125626288|NCT03682055|451915622|FG005|Overall Study|Termination of Study by Sponsor|3|||
125626289|NCT01135394|451915623|FG000|Screening|Lost to Follow-up|2|||
125626290|NCT01135394|451915623|FG000|Screening|Withdrawal by Subject|10|||
125626291|NCT01135394|451915623|FG000|Screening|Screening failure|16|||
125626292|NCT01135394|451915623|FG000|Screening|Physician Decision|5|||
125626293|NCT01135394|451915623|FG000|Baseline Assessment|Withdrawal by Subject|9|||
125626294|NCT01135394|451915623|FG000|Baseline Assessment|Physician Decision|3|||
125626295|NCT01135394|451915623|FG000|Baseline Assessment|Lost to Follow-up|2|||
125626296|NCT01135394|451915623|FG000|Baseline Assessment|Adverse Event|1|||
125626297|NCT01135394|451915623|FG000|Study Treatment|Withdrawal by Subject|1|||
125626298|NCT01135394|451915623|FG000|Study Treatment|Physician Decision|1|||
125626299|NCT01135394|451915623|FG000|Study Treatment|Adverse Event|2|||
125626300|NCT00191386|451915624|FG000|Overall Study|Adverse Event|16|||
125626301|NCT00191386|451915624|FG000|Overall Study|Lost to Follow-up|1|||
125626302|NCT00191386|451915624|FG000|Overall Study|Entry Criteria Exclusion|3|||
125626303|NCT00191386|451915624|FG000|Overall Study|Protocol Violation|18|||
125626304|NCT00191386|451915624|FG000|Overall Study|Withdrawal by Subject|96|||
125626305|NCT00191386|451915624|FG000|Overall Study|Physician Decision|11|||
125626306|NCT00191386|451915624|FG000|Overall Study|Lack of Efficacy|15|||
125626307|NCT00462488|451915625|FG000|Overall Study|Protocol Violation|1|||
125626308|NCT00462488|451915626|FG001|Overall Study|Protocol Violation|0|||
125626309|NCT00462488|451915625|FG000|Overall Study|Lack of Efficacy|19|||
125626310|NCT00462488|451915626|FG001|Overall Study|Lack of Efficacy|17|||
125626311|NCT01742091|451915631|FG000|Overall Study|Adverse Event|0|||
125626312|NCT01742091|451915632|FG001|Overall Study|Adverse Event|0|||
125626313|NCT01742091|451915633|FG002|Overall Study|Adverse Event|0|||
125626314|NCT01742091|451915634|FG003|Overall Study|Adverse Event|0|||
125626315|NCT01742091|451915635|FG004|Overall Study|Adverse Event|1|||
125626316|NCT01742091|451915636|FG005|Overall Study|Adverse Event|0|||
125626317|NCT01742091|451915631|FG000|Overall Study|Physician Decision|0|||
125626318|NCT01742091|451915632|FG001|Overall Study|Physician Decision|0|||
125626319|NCT01742091|451915633|FG002|Overall Study|Physician Decision|0|||
125626320|NCT01742091|451915634|FG003|Overall Study|Physician Decision|0|||
125626321|NCT01742091|451915635|FG004|Overall Study|Physician Decision|0|||
125626322|NCT01742091|451915636|FG005|Overall Study|Physician Decision|1|||
125626323|NCT01742091|451915631|FG000|Overall Study|Withdrawal by Subject|0|||
125626324|NCT01742091|451915632|FG001|Overall Study|Withdrawal by Subject|0|||
125626325|NCT01742091|451915633|FG002|Overall Study|Withdrawal by Subject|0|||
125626326|NCT01742091|451915634|FG003|Overall Study|Withdrawal by Subject|1|||
125626327|NCT01742091|451915635|FG004|Overall Study|Withdrawal by Subject|0|||
125626328|NCT01742091|451915636|FG005|Overall Study|Withdrawal by Subject|0|||
125626329|NCT01742091|451915631|FG000|Overall Study|Lost to Follow-up|0|||
125626330|NCT01742091|451915632|FG001|Overall Study|Lost to Follow-up|0|||
125626331|NCT01742091|451915633|FG002|Overall Study|Lost to Follow-up|0|||
125626332|NCT01742091|451915634|FG003|Overall Study|Lost to Follow-up|0|||
125626333|NCT01742091|451915635|FG004|Overall Study|Lost to Follow-up|0|||
125626334|NCT01742091|451915636|FG005|Overall Study|Lost to Follow-up|1|||
125626335|NCT03750240|451915637|FG000|Overall Study|Technical Difficulties|2|||
125626336|NCT03706040|451915638|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
125626337|NCT03706040|451915639|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
125626338|NCT03706040|451915640|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
125626339|NCT03706040|451915641|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
125626340|NCT03706040|451915642|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
125626341|NCT03706040|451915643|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
125626342|NCT03706040|451915644|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
125626343|NCT03706040|451915638|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
125626344|NCT03706040|451915639|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
125626345|NCT03706040|451915640|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
125626346|NCT03706040|451915641|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
125626347|NCT03706040|451915642|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
125626348|NCT03706040|451915643|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
125626349|NCT03706040|451915644|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
125626350|NCT03706040|451915638|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
125626351|NCT03706040|451915639|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
125626352|NCT03706040|451915640|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
125626353|NCT03706040|451915641|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
125626354|NCT03706040|451915642|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
125626355|NCT03706040|451915643|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
125626356|NCT03706040|451915644|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
125626357|NCT03706040|451915638|FG000|Period A (Week 0 to Week 16)|Other|2|||
125626358|NCT03706040|451915639|FG001|Period A (Week 0 to Week 16)|Other|0|||
125626359|NCT03706040|451915640|FG002|Period A (Week 0 to Week 16)|Other|2|||
125626360|NCT03706040|451915641|FG003|Period A (Week 0 to Week 16)|Other|0|||
125626361|NCT03706040|451915642|FG004|Period A (Week 0 to Week 16)|Other|0|||
125626362|NCT03706040|451915643|FG005|Period A (Week 0 to Week 16)|Other|0|||
125626363|NCT03706040|451915644|FG006|Period A (Week 0 to Week 16)|Other|0|||
125626364|NCT03706040|451915638|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
125626365|NCT03706040|451915639|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
125626366|NCT03706040|451915640|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
125626367|NCT03706040|451915641|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
125626368|NCT03706040|451915642|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
125626369|NCT03706040|451915643|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
125626370|NCT03706040|451915644|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
125626371|NCT03706040|451915638|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
125626372|NCT03706040|451915639|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
125626373|NCT03706040|451915640|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
125626374|NCT03706040|451915641|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
125626375|NCT03706040|451915642|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
125626376|NCT03706040|451915643|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
125626377|NCT03706040|451915644|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
125626378|NCT03706040|451915638|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125626379|NCT03706040|451915639|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125626380|NCT03706040|451915640|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125626381|NCT03706040|451915641|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125626382|NCT03706040|451915642|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
125626383|NCT03706040|451915643|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
125626384|NCT03706040|451915644|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
125626385|NCT03706040|451915638|FG000|Period B (Week 16 to Week 52)|Other|0|||
125626386|NCT03706040|451915639|FG001|Period B (Week 16 to Week 52)|Other|0|||
125626387|NCT03706040|451915640|FG002|Period B (Week 16 to Week 52)|Other|0|||
125626388|NCT03706040|451915641|FG003|Period B (Week 16 to Week 52)|Other|4|||
125626389|NCT03706040|451915642|FG004|Period B (Week 16 to Week 52)|Other|5|||
125626390|NCT03706040|451915643|FG005|Period B (Week 16 to Week 52)|Other|23|||
125626391|NCT03706040|451915644|FG006|Period B (Week 16 to Week 52)|Other|17|||
125626392|NCT00927758|451915645|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
125626393|NCT00927758|451915646|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
125215578|NCT01768559|450417439|FG001|Overall Study|Other than specified|8|||
125215579|NCT01768559|450417440|FG002|Overall Study|Other than specified|5|||
125374915|NCT00642460|451002285|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
125626394|NCT00927758|451915647|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
125626395|NCT00927758|451915648|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
125626396|NCT00927758|451915649|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
125626397|NCT00927758|451915650|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
125626398|NCT00927758|451915645|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
125626399|NCT00927758|451915646|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
125626400|NCT00927758|451915647|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
125626401|NCT00927758|451915648|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
125626402|NCT00927758|451915649|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
125626403|NCT00927758|451915650|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
125626404|NCT00439725|451915651|FG000|Treatment Period|Withdrawal by Subject|22|||
125626405|NCT00439725|451915652|FG001|Treatment Period|Withdrawal by Subject|19|||
125626406|NCT00439725|451915651|FG000|Treatment Period|Study terminated by sponsor|156|||
125626407|NCT00439725|451915652|FG001|Treatment Period|Study terminated by sponsor|148|||
125374916|NCT00642460|451002286|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
125374917|NCT00642460|451002281|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
125626408|NCT00439725|451915651|FG000|Treatment Period|Site closed by investigator|1|||
125626409|NCT00439725|451915652|FG001|Treatment Period|Site closed by investigator|2|||
125215580|NCT02782377|450417441|FG000|Overall Study|Physician Decision|5|||
125374918|NCT00642460|451002282|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
125626410|NCT00439725|451915651|FG000|Treatment Period|Adverse Event|39|||
125626411|NCT00439725|451915652|FG001|Treatment Period|Adverse Event|18|||
125626412|NCT00439725|451915651|FG000|Treatment Period|Physician Decision|1|||
125626413|NCT00439725|451915652|FG001|Treatment Period|Physician Decision|1|||
125626414|NCT00439725|451915651|FG000|Treatment Period|Protocol Violation|2|||
125626415|NCT00439725|451915652|FG001|Treatment Period|Protocol Violation|1|||
125626416|NCT00439725|451915651|FG000|Treatment Period|Clinical endpoint reached|6|||
125626417|NCT00439725|451915652|FG001|Treatment Period|Clinical endpoint reached|50|||
125626418|NCT00439725|451915651|FG000|Treatment Period|Technical problems|1|||
125626419|NCT00439725|451915652|FG001|Treatment Period|Technical problems|0|||
125626420|NCT00439725|451915651|FG000|Treatment Period|Lost to Follow-up|1|||
125626421|NCT00439725|451915652|FG001|Treatment Period|Lost to Follow-up|1|||
125626422|NCT00439725|451915651|FG000|Treatment Period|Participant convenience|1|||
125626423|NCT00439725|451915652|FG001|Treatment Period|Participant convenience|0|||
125626424|NCT00439725|451915651|FG000|Treatment Period|Protocol driven decision point|1|||
125626425|NCT00439725|451915652|FG001|Treatment Period|Protocol driven decision point|1|||
125626426|NCT00439725|451915651|FG000|Treatment Period|Death|1|||
125626427|NCT00439725|451915652|FG001|Treatment Period|Death|1|||
125626428|NCT00439725|451915651|FG000|Treatment Period|Participant did not receive treatment|4|||
125626429|NCT00439725|451915652|FG001|Treatment Period|Participant did not receive treatment|4|||
125626430|NCT00439725|451915651|FG000|Observational Period|Withdrawal by Subject|2|||
125626431|NCT00439725|451915652|FG001|Observational Period|Withdrawal by Subject|2|||
125626432|NCT00439725|451915651|FG000|Observational Period|Lost to Follow-up|0|||
125626433|NCT00439725|451915652|FG001|Observational Period|Lost to Follow-up|1|||
125626434|NCT00439725|451915651|FG000|Observational Period|Death|0|||
125626435|NCT00439725|451915652|FG001|Observational Period|Death|2|||
125626436|NCT00439725|451915651|FG000|Observational Period|Study termination by sponsor|1|||
125626437|NCT00439725|451915652|FG001|Observational Period|Study termination by sponsor|1|||
125626438|NCT00439725|451915651|FG000|Observational Period|Clinical endpoint reached|3|||
125626439|NCT00439725|451915652|FG001|Observational Period|Clinical endpoint reached|1|||
125626440|NCT00439725|451915651|FG000|Observational Period|Technical problems|1|||
125626441|NCT00439725|451915652|FG001|Observational Period|Technical problems|0|||
125626442|NCT00439725|451915651|FG000|Observational Period|Participant convenience|1|||
125626443|NCT00439725|451915652|FG001|Observational Period|Participant convenience|0|||
125626444|NCT00212758|451915655|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
125626445|NCT00212758|451915656|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
125626446|NCT00212758|451915655|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
125626447|NCT00212758|451915656|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
125626448|NCT03510910|451915657|FG000|Overall Study|Incomplete Survey|2|||
125626449|NCT03510910|451915658|FG001|Overall Study|Incomplete Survey|3|||
125626450|NCT02940860|451915664|FG000|Overall Study|Non-serious AE|1|||
125626451|NCT02940860|451915665|FG001|Overall Study|Non-serious AE|2|||
125626452|NCT02940860|451915664|FG000|Overall Study|Serious AE|7|||
125626453|NCT02940860|451915665|FG001|Overall Study|Serious AE|3|||
125626454|NCT02940860|451915664|FG000|Overall Study|Withdrawal by Subject|19|||
125626455|NCT02940860|451915665|FG001|Overall Study|Withdrawal by Subject|9|||
125626456|NCT02940860|451915664|FG000|Overall Study|Lost to Follow-up|13|||
125626457|NCT02940860|451915665|FG001|Overall Study|Lost to Follow-up|7|||
125626458|NCT02940860|451915664|FG000|Overall Study|Physician Decision|5|||
125626459|NCT02940860|451915665|FG001|Overall Study|Physician Decision|3|||
125626460|NCT02940860|451915664|FG000|Overall Study|Sponsor Decision|0|||
125626461|NCT02940860|451915665|FG001|Overall Study|Sponsor Decision|1|||
125626462|NCT02940860|451915664|FG000|Overall Study|Protocol Violation|0|||
125626463|NCT02940860|451915665|FG001|Overall Study|Protocol Violation|2|||
125626464|NCT02940860|451915664|FG000|Overall Study|Death|3|||
125626465|NCT02940860|451915665|FG001|Overall Study|Death|2|||
125626466|NCT02940860|451915664|FG000|Overall Study|Moved, poor venous access, transport|6|||
125626467|NCT02940860|451915665|FG001|Overall Study|Moved, poor venous access, transport|4|||
125626468|NCT02940860|451915664|FG000|Overall Study|Not treated|2|||
125626469|NCT02940860|451915665|FG001|Overall Study|Not treated|2|||
125626470|NCT04914819|451915666|FG000|Overall Study|Pregnancy|3|||
125626471|NCT04914819|451915667|FG001|Overall Study|Pregnancy|1|||
125626472|NCT04914819|451915666|FG000|Overall Study|Discontinued study|4|||
125626473|NCT04914819|451915667|FG001|Overall Study|Discontinued study|1|||
125626474|NCT04914819|451915666|FG000|Overall Study|Lost to Follow-up|7|||
125626475|NCT04914819|451915667|FG001|Overall Study|Lost to Follow-up|0|||
125626476|NCT02715804|451915668|FG000|Overall Study|Death|222|||
125626477|NCT02715804|451915669|FG001|Overall Study|Death|106|||
125626478|NCT02715804|451915668|FG000|Overall Study|Withdrawal by Subject|5|||
125626479|NCT02715804|451915669|FG001|Overall Study|Withdrawal by Subject|4|||
125626480|NCT02715804|451915668|FG000|Overall Study|Other than specified|2|||
125626481|NCT02715804|451915669|FG001|Overall Study|Other than specified|3|||
125626482|NCT04038385|451915670|FG000|Overall Study|Completed baseline assessment only|7|||
125626483|NCT04038385|451915671|FG001|Overall Study|Completed baseline assessment only|4|||
125626484|NCT04038385|451915670|FG000|Overall Study|Moved out of area|4|||
125626485|NCT04038385|451915671|FG001|Overall Study|Moved out of area|2|||
125433330|NCT01462162|451214453|FG000|Overall Study|Abnormal laboratory parameters|1|||
125433331|NCT01462162|451214453|FG000|Overall Study|Other|2|||
125433332|NCT03485911|451214454|FG000|Part 1|Perceived lack of efficacy|1|||
125626486|NCT04038385|451915670|FG000|Overall Study|Discontinued study involvement|6|||
125626487|NCT04038385|451915671|FG001|Overall Study|Discontinued study involvement|1|||
125626488|NCT00948194|451915674|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
125626489|NCT00948194|451915675|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
125626490|NCT00233324|451915676|FG000|Main Study|Death|68|||
125626491|NCT00233324|451915677|FG001|Main Study|Death|60|||
125626492|NCT00233324|451915678|FG002|Main Study|Death|62|||
125626493|NCT00233324|451915679|FG003|Main Study|Death|47|||
125626494|NCT00233324|451915676|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
125626495|NCT00233324|451915677|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
125626496|NCT00233324|451915678|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
125626497|NCT00233324|451915679|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
125626498|NCT00233324|451915676|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
125626499|NCT00233324|451915677|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
125626500|NCT00233324|451915678|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
125626501|NCT00233324|451915679|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
125626502|NCT00724815|451915689|FG000|Overall Study|Randomized, not treated|31|||
125626503|NCT00724815|451915690|FG001|Overall Study|Randomized, not treated|30|||
125626504|NCT00724815|451915689|FG000|Overall Study|Adverse Event|5|||
125626505|NCT00724815|451915690|FG001|Overall Study|Adverse Event|3|||
125626506|NCT00724815|451915689|FG000|Overall Study|Lost to Follow-up|4|||
125626507|NCT00724815|451915690|FG001|Overall Study|Lost to Follow-up|1|||
125626508|NCT00724815|451915689|FG000|Overall Study|Other Various|3|||
125626509|NCT00724815|451915690|FG001|Overall Study|Other Various|5|||
125626510|NCT00105183|451915695|FG000|Overall Study|Death|19|||
125626511|NCT00105183|451915696|FG001|Overall Study|Death|13|||
125626512|NCT00105183|451915697|FG002|Overall Study|Death|15|||
125626513|NCT00105183|451915695|FG000|Overall Study|Withdrawal by Subject|1|||
125626514|NCT00105183|451915696|FG001|Overall Study|Withdrawal by Subject|1|||
125626515|NCT00105183|451915697|FG002|Overall Study|Withdrawal by Subject|4|||
125626516|NCT00105183|451915695|FG000|Overall Study|Physician Decision|1|||
125626517|NCT00105183|451915696|FG001|Overall Study|Physician Decision|2|||
125626518|NCT00105183|451915697|FG002|Overall Study|Physician Decision|3|||
125626519|NCT00105183|451915695|FG000|Overall Study|Lost to Follow-up|0|||
125626520|NCT00105183|451915696|FG001|Overall Study|Lost to Follow-up|1|||
125626521|NCT00105183|451915697|FG002|Overall Study|Lost to Follow-up|1|||
125626522|NCT00105183|451915695|FG000|Overall Study|Other reason|1|||
125626523|NCT00105183|451915696|FG001|Overall Study|Other reason|2|||
125626524|NCT00105183|451915697|FG002|Overall Study|Other reason|0|||
125626525|NCT01819506|451915698|FG000|Overall Study|Physician Decision|5|||
125626526|NCT01819506|451915699|FG001|Overall Study|Physician Decision|2|||
125626527|NCT01819506|451915698|FG000|Overall Study|Withdrawal by Subject|3|||
125626528|NCT01819506|451915699|FG001|Overall Study|Withdrawal by Subject|3|||
125626529|NCT03000686|451915700|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
125626530|NCT03000686|451915701|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
125626531|NCT03000686|451915702|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
125626532|NCT03000686|451915703|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
125626533|NCT00294684|451915704|FG000|Overall Study|Lost to Follow-up|5|||
125626534|NCT00294684|451915705|FG001|Overall Study|Lost to Follow-up|8|||
125626535|NCT00389441|451915706|FG000|Overall Study|Adverse Event|7|||
125626536|NCT00389441|451915706|FG000|Overall Study|Death|4|||
125626537|NCT00389441|451915706|FG000|Overall Study|Lost to Follow-up|2|||
125626538|NCT00389441|451915706|FG000|Overall Study|Withdrawal by Subject|4|||
125626539|NCT00389441|451915706|FG000|Overall Study|Physician Decision|1|||
125626540|NCT00389441|451915706|FG000|Overall Study|Protocol Violation|1|||
125626541|NCT00389441|451915706|FG000|Overall Study|Global deterioration of health status|4|||
125626542|NCT00389441|451915706|FG000|Overall Study|Objective progression or relapse|26|||
125626543|NCT00389441|451915706|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
125626544|NCT00389441|451915706|FG000|Overall Study|Clinical progression|1|||
125626545|NCT01981109|451915707|FG000|Overall Study|Death|36|||
125626546|NCT01981109|451915707|FG000|Overall Study|Withdrawal by Subject|40|||
125626547|NCT01981109|451915707|FG000|Overall Study|Lost to Follow-up|9|||
125626548|NCT01981109|451915707|FG000|Overall Study|No Discontinuation Documentation|37|||
125626549|NCT01981109|451915707|FG000|Overall Study|Study Termination|100|||
125626550|NCT01981109|451915707|FG000|Overall Study|No data available|2|||
125626551|NCT00126672|451915709|FG000|Overall Study|Adverse Event|4|||
125626552|NCT00126672|451915709|FG000|Overall Study|Lost to Follow-up|4|||
125626553|NCT01851863|451915710|FG000|Overall Study|Did not receive study medication|2|||
125626554|NCT01851863|451915711|FG001|Overall Study|Did not receive study medication|5|||
125433333|NCT03485911|451214455|FG001|Part 1|Perceived lack of efficacy|1|||
125433334|NCT03485911|451214456|FG002|Part 1|Perceived lack of efficacy|2|||
125626555|NCT01851863|451915712|FG002|Overall Study|Did not receive study medication|3|||
125626556|NCT01851863|451915713|FG003|Overall Study|Did not receive study medication|0|||
125626557|NCT01851863|451915710|FG000|Overall Study|Lost to Follow-up|3|||
125626558|NCT01851863|451915711|FG001|Overall Study|Lost to Follow-up|4|||
125626559|NCT01851863|451915712|FG002|Overall Study|Lost to Follow-up|2|||
125626560|NCT01851863|451915713|FG003|Overall Study|Lost to Follow-up|3|||
125626561|NCT04083794|451915714|FG000|Overall Study|Lost to Follow-up|9|||
125626562|NCT03097029|451915717|FG000|Overall Study|Withdrawal by Subject|1|||
125626563|NCT02661464|451915727|FG000|Overall Study|Lost to Follow-up|28|||
125626564|NCT02661464|451915728|FG001|Overall Study|Lost to Follow-up|0|||
125626565|NCT02661464|451915729|FG002|Overall Study|Lost to Follow-up|0|||
125626566|NCT02661464|451915730|FG003|Overall Study|Lost to Follow-up|0|||
125626567|NCT02661464|451915727|FG000|Overall Study|Withdrawal by Subject|3|||
125626568|NCT02661464|451915728|FG001|Overall Study|Withdrawal by Subject|1|||
125626569|NCT02661464|451915729|FG002|Overall Study|Withdrawal by Subject|0|||
125626570|NCT02661464|451915730|FG003|Overall Study|Withdrawal by Subject|0|||
125626571|NCT02661464|451915727|FG000|Overall Study|Participants terminated prematurely|288|||
125626572|NCT02661464|451915728|FG001|Overall Study|Participants terminated prematurely|52|||
125626573|NCT02661464|451915729|FG002|Overall Study|Participants terminated prematurely|1|||
125626574|NCT02661464|451915730|FG003|Overall Study|Participants terminated prematurely|1|||
125626575|NCT02661464|451915727|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
125626576|NCT02661464|451915728|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
125626577|NCT02661464|451915729|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
125626578|NCT02661464|451915730|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
125626579|NCT03148756|451915731|FG000|Overall Study|Study Terminated|0|||
125626580|NCT03148756|451915732|FG001|Overall Study|Study Terminated|1|||
125626581|NCT02177175|451915733|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
125626582|NCT02177175|451915734|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
125626583|NCT03820726|451915739|FG000|Overall Study|Other than listed|23|||
125626584|NCT03820726|451915739|FG000|Overall Study|Withdrawal by Subject|37|||
125626585|NCT03820726|451915739|FG000|Overall Study|Lost to Follow-up|3|||
125626586|NCT03820726|451915739|FG000|Overall Study|Protocol deviation|1|||
125626587|NCT03820726|451915739|FG000|Overall Study|Adverse Event|146|||
125626588|NCT03820726|451915739|FG000|Overall Study|Not treated|1|||
125626589|NCT00345540|451915740|FG000|Overall Study|Withdrawal by Subject|1|||
125626590|NCT01406652|451915741|FG000|Overall Study|Lost-to-follow-up|3|||
125626591|NCT01406652|451915742|FG001|Overall Study|Lost-to-follow-up|4|||
125626592|NCT01406652|451915741|FG000|Overall Study|Withdrawal by Subject|2|||
125626593|NCT01406652|451915742|FG001|Overall Study|Withdrawal by Subject|2|||
125626594|NCT01406652|451915741|FG000|Overall Study|Insufficient follow-up|5|||
125626595|NCT01406652|451915742|FG001|Overall Study|Insufficient follow-up|4|||
125626596|NCT01406652|451915741|FG000|Overall Study|Infection not sure|10|||
125626597|NCT01406652|451915742|FG001|Overall Study|Infection not sure|10|||
125626598|NCT00861380|451915743|FG000|Overall Study|Withdrawal Information not recorded|8427|||
125626599|NCT00861380|451915744|FG001|Overall Study|Withdrawal Information not recorded|9112|||
125626600|NCT00861380|451915745|FG002|Overall Study|Withdrawal Information not recorded|8872|||
125626601|NCT00861380|451915746|FG003|Overall Study|Withdrawal Information not recorded|3689|||
125626602|NCT00861380|451915747|FG004|Overall Study|Withdrawal Information not recorded|1812|||
125626603|NCT00861380|451915748|FG005|Overall Study|Withdrawal Information not recorded|6249|||
125626604|NCT00861380|451915749|FG006|Overall Study|Withdrawal Information not recorded|3020|||
125626605|NCT00637377|451915750|FG000|Overall Study|Adverse Event|2|||
125626606|NCT00637377|451915751|FG001|Overall Study|Adverse Event|6|||
125626607|NCT00637377|451915752|FG002|Overall Study|Adverse Event|8|||
125626608|NCT00637377|451915753|FG003|Overall Study|Adverse Event|9|||
125626609|NCT00637377|451915750|FG000|Overall Study|Death|1|||
125626610|NCT00637377|451915751|FG001|Overall Study|Death|3|||
125626611|NCT00637377|451915752|FG002|Overall Study|Death|2|||
125626612|NCT00637377|451915753|FG003|Overall Study|Death|1|||
125626613|NCT00637377|451915750|FG000|Overall Study|Lack of Efficacy|0|||
125626614|NCT00637377|451915751|FG001|Overall Study|Lack of Efficacy|0|||
125626615|NCT00637377|451915752|FG002|Overall Study|Lack of Efficacy|1|||
125626616|NCT00637377|451915753|FG003|Overall Study|Lack of Efficacy|1|||
125626617|NCT00637377|451915750|FG000|Overall Study|Lost to Follow-up|4|||
125626618|NCT00637377|451915751|FG001|Overall Study|Lost to Follow-up|1|||
125626619|NCT00637377|451915752|FG002|Overall Study|Lost to Follow-up|2|||
125626620|NCT00637377|451915753|FG003|Overall Study|Lost to Follow-up|2|||
125626621|NCT00637377|451915750|FG000|Overall Study|Protocol Violation|2|||
125626622|NCT00637377|451915751|FG001|Overall Study|Protocol Violation|1|||
125626623|NCT00637377|451915752|FG002|Overall Study|Protocol Violation|1|||
125626624|NCT00637377|451915753|FG003|Overall Study|Protocol Violation|0|||
125626625|NCT00637377|451915750|FG000|Overall Study|Withdrawal by Subject|11|||
125626626|NCT00637377|451915751|FG001|Overall Study|Withdrawal by Subject|15|||
125626627|NCT00637377|451915752|FG002|Overall Study|Withdrawal by Subject|13|||
125626628|NCT00637377|451915753|FG003|Overall Study|Withdrawal by Subject|11|||
125626629|NCT00637377|451915750|FG000|Overall Study|Other (no further information available)|7|||
125626630|NCT00637377|451915751|FG001|Overall Study|Other (no further information available)|6|||
125626631|NCT00637377|451915752|FG002|Overall Study|Other (no further information available)|10|||
125626632|NCT00637377|451915753|FG003|Overall Study|Other (no further information available)|5|||
125626633|NCT01822223|451915754|FG000|Overall Study|Death|0|||
125626634|NCT01822223|451915755|FG001|Overall Study|Death|1|||
125626635|NCT00631540|451915760|FG000|Overall Study|Withdrawal by Subject|5|||
125626636|NCT00631540|451915760|FG000|Overall Study|Death|4|||
125626637|NCT00631540|451915760|FG000|Overall Study|Lost to Follow-up|2|||
125626638|NCT00631540|451915760|FG000|Overall Study|Core Lab Data Unavailable|3|||
125626639|NCT03136367|451915762|FG000|T1 Consultation|discontinued mistakenly included|2|||
125626640|NCT03136367|451915763|FG001|T1 Consultation|discontinued mistakenly included|6|||
125626641|NCT03136367|451915764|FG002|T1 Consultation|discontinued mistakenly included|1|||
125626642|NCT03136367|451915762|FG000|T1 Consultation|Discontinued other|0|||
125626643|NCT03136367|451915763|FG001|T1 Consultation|Discontinued other|1|||
125626644|NCT03136367|451915764|FG002|T1 Consultation|Discontinued other|0|||
125626645|NCT03136367|451915762|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
125626646|NCT03136367|451915763|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
125626647|NCT03136367|451915764|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
125626648|NCT03136367|451915762|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
125626649|NCT03136367|451915763|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
125626650|NCT03136367|451915764|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
125626651|NCT03136367|451915762|FG000|T2 Post-consultation|Discontinued other|0|||
125626652|NCT03136367|451915763|FG001|T2 Post-consultation|Discontinued other|2|||
125626653|NCT03136367|451915764|FG002|T2 Post-consultation|Discontinued other|6|||
125626654|NCT03136367|451915762|FG000|T2 Post-consultation|Discontinued transferred care|0|||
125626655|NCT03136367|451915763|FG001|T2 Post-consultation|Discontinued transferred care|0|||
125626656|NCT03136367|451915764|FG002|T2 Post-consultation|Discontinued transferred care|3|||
125626657|NCT03136367|451915762|FG000|T2 Post-consultation|Discontinued lost contact|0|||
125626658|NCT03136367|451915763|FG001|T2 Post-consultation|Discontinued lost contact|1|||
125626659|NCT03136367|451915764|FG002|T2 Post-consultation|Discontinued lost contact|0|||
125626660|NCT03136367|451915762|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
125626661|NCT03136367|451915763|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
125626662|NCT03136367|451915764|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
125626663|NCT03136367|451915762|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
125626664|NCT03136367|451915763|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
125626665|NCT03136367|451915764|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
125626666|NCT03136367|451915762|FG000|T3 1 Week After Surgery|other discontinued|2|||
125626667|NCT03136367|451915763|FG001|T3 1 Week After Surgery|other discontinued|4|||
125626668|NCT03136367|451915764|FG002|T3 1 Week After Surgery|other discontinued|3|||
125626669|NCT03136367|451915762|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
125626670|NCT03136367|451915763|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
125626671|NCT03136367|451915764|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
125626672|NCT03136367|451915762|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
125626673|NCT03136367|451915763|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
125626674|NCT03136367|451915764|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
125626675|NCT03136367|451915762|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
125626676|NCT03136367|451915763|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
125626677|NCT03136367|451915764|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
125626678|NCT03136367|451915762|FG000|T4 12 Weeks After Surgery|Death|0|||
125626679|NCT03136367|451915763|FG001|T4 12 Weeks After Surgery|Death|1|||
125626680|NCT03136367|451915764|FG002|T4 12 Weeks After Surgery|Death|3|||
125626681|NCT03136367|451915762|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
125626682|NCT03136367|451915763|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
125626683|NCT03136367|451915764|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
125626684|NCT03136367|451915762|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
125626685|NCT03136367|451915763|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
125626686|NCT03136367|451915764|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
125626687|NCT03136367|451915762|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
125626688|NCT03136367|451915763|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
125626689|NCT03136367|451915764|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
125626690|NCT03136367|451915762|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
125626691|NCT03136367|451915763|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
125626692|NCT03136367|451915764|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
125626693|NCT03136367|451915762|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
125374919|NCT00642460|451002283|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
125374920|NCT00642460|451002284|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
125626694|NCT03136367|451915763|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
125626695|NCT03136367|451915764|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
125626696|NCT03136367|451915762|FG000|T5 1 Year After Surgery|Death|0|||
125626697|NCT03136367|451915763|FG001|T5 1 Year After Surgery|Death|0|||
125374921|NCT00642460|451002285|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
125374922|NCT00642460|451002286|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
125626698|NCT03136367|451915764|FG002|T5 1 Year After Surgery|Death|1|||
125626699|NCT03136367|451915762|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
125626700|NCT03136367|451915763|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
125626701|NCT03136367|451915764|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
125626702|NCT03136367|451915762|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
125626703|NCT03136367|451915763|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
125626704|NCT03136367|451915764|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
125626705|NCT03136367|451915762|FG000|T5 1 Year After Surgery|study ended before due|31|||
125626706|NCT03136367|451915763|FG001|T5 1 Year After Surgery|study ended before due|103|||
125626707|NCT03136367|451915764|FG002|T5 1 Year After Surgery|study ended before due|110|||
125626708|NCT03136367|451915762|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
125626709|NCT03136367|451915763|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
125215581|NCT00398047|450417443|FG000|Overall Study|all patient progressed before completion|3|||
125626710|NCT03136367|451915764|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
125626711|NCT04876599|451915771|FG000|Overall Study|Missed|2|||
125626712|NCT04876599|451915772|FG001|Overall Study|Missed|0|||
125626713|NCT04876599|451915771|FG000|Overall Study|Declined|2|||
125626714|NCT04876599|451915772|FG001|Overall Study|Declined|3|||
125626715|NCT03175562|451915773|FG000|Overall Study|Adverse Event|1|||
125626716|NCT03175562|451915773|FG000|Overall Study|Lost to Follow-up|3|||
125626717|NCT03175562|451915773|FG000|Overall Study|Withdrawal by Subject|7|||
125626718|NCT03175562|451915773|FG000|Overall Study|Other (Not Specified)|5|||
125626719|NCT02146833|451915774|FG000|Overall Study|Death|10|||
125626720|NCT02146833|451915774|FG000|Overall Study|No longer consented to study treatment|1|||
125626721|NCT00676208|451915777|FG000|Overall Study|Lost to Follow-up|0|||
125626722|NCT00676208|451915778|FG001|Overall Study|Lost to Follow-up|2|||
125626723|NCT00676208|451915777|FG000|Overall Study|Incomplete data|2|||
125626724|NCT00676208|451915778|FG001|Overall Study|Incomplete data|4|||
125626725|NCT04126031|451915781|FG000|Part A|Withdrawal by Subject|0|||
125626726|NCT04126031|451915782|FG001|Part A|Withdrawal by Subject|0|||
125626727|NCT04126031|451915783|FG002|Part A|Withdrawal by Subject|1|||
125626728|NCT04126031|451915784|FG003|Part A|Withdrawal by Subject|0|||
125626729|NCT04126031|451915785|FG004|Part A|Withdrawal by Subject|0|||
125626730|NCT04126031|451915786|FG005|Part A|Withdrawal by Subject|0|||
125626731|NCT04126031|451915781|FG000|Part A|Other|1|||
125626732|NCT04126031|451915782|FG001|Part A|Other|0|||
125626733|NCT04126031|451915783|FG002|Part A|Other|0|||
125626734|NCT04126031|451915784|FG003|Part A|Other|0|||
125626735|NCT04126031|451915785|FG004|Part A|Other|0|||
125626736|NCT04126031|451915786|FG005|Part A|Other|0|||
125626737|NCT04126031|451915781|FG000|Part B|Adverse Event|0|||
125626738|NCT04126031|451915782|FG001|Part B|Adverse Event|0|||
125626739|NCT04126031|451915783|FG002|Part B|Adverse Event|0|||
125626740|NCT04126031|451915784|FG003|Part B|Adverse Event|0|||
125626741|NCT04126031|451915785|FG004|Part B|Adverse Event|0|||
125626742|NCT04126031|451915786|FG005|Part B|Adverse Event|2|||
125626743|NCT04126031|451915781|FG000|Part B|Pre-existing hypertransaminasemia|0|||
125626744|NCT04126031|451915782|FG001|Part B|Pre-existing hypertransaminasemia|0|||
125626745|NCT04126031|451915783|FG002|Part B|Pre-existing hypertransaminasemia|0|||
125626746|NCT04126031|451915784|FG003|Part B|Pre-existing hypertransaminasemia|0|||
125626747|NCT04126031|451915785|FG004|Part B|Pre-existing hypertransaminasemia|1|||
125626748|NCT04126031|451915786|FG005|Part B|Pre-existing hypertransaminasemia|0|||
125626749|NCT00617656|451915787|FG000|Overall Study|Inclusion error|4|||
125626750|NCT00617656|451915788|FG001|Overall Study|Inclusion error|4|||
125626751|NCT00617656|451915789|FG002|Overall Study|Inclusion error|0|||
125374923|NCT00642460|451002281|FG000|Part III: Open-Label Up to Week 260|Other|0|||
125374924|NCT00642460|451002282|FG001|Part III: Open-Label Up to Week 260|Other|0|||
125626752|NCT00617656|451915790|FG003|Overall Study|Inclusion error|0|||
125626753|NCT00617656|451915787|FG000|Overall Study|Missing data|44|||
125626754|NCT00617656|451915788|FG001|Overall Study|Missing data|30|||
125626755|NCT00617656|451915789|FG002|Overall Study|Missing data|13|||
125626756|NCT00617656|451915790|FG003|Overall Study|Missing data|6|||
125626757|NCT00617656|451915787|FG000|Overall Study|Withdrawal by Subject|0|||
125626758|NCT00617656|451915788|FG001|Overall Study|Withdrawal by Subject|2|||
125626759|NCT00617656|451915789|FG002|Overall Study|Withdrawal by Subject|0|||
125626760|NCT00617656|451915790|FG003|Overall Study|Withdrawal by Subject|0|||
125626761|NCT00131664|451915791|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
125215582|NCT01188668|450417444|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
125374925|NCT00642460|451002283|FG002|Part III: Open-Label Up to Week 260|Other|0|||
125374926|NCT00642460|451002284|FG003|Part III: Open-Label Up to Week 260|Other|0|||
125374927|NCT00642460|451002285|FG004|Part III: Open-Label Up to Week 260|Other|2|||
125626762|NCT00131664|451915792|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
125626763|NCT00131664|451915793|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
125626764|NCT00131664|451915794|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
125626765|NCT00131664|451915795|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
125626766|NCT00131664|451915796|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
125626767|NCT00131664|451915791|FG000|First Period (First 6 Months)|Death|0|||
125626768|NCT00131664|451915792|FG001|First Period (First 6 Months)|Death|1|||
125626769|NCT00131664|451915793|FG002|First Period (First 6 Months)|Death|0|||
125626770|NCT00131664|451915794|FG003|First Period (First 6 Months)|Death|0|||
125626771|NCT00131664|451915795|FG004|First Period (First 6 Months)|Death|0|||
125626772|NCT00131664|451915796|FG005|First Period (First 6 Months)|Death|0|||
125626773|NCT00131664|451915791|FG000|First Period (First 6 Months)|Protocol Violation|2|||
125626774|NCT00131664|451915792|FG001|First Period (First 6 Months)|Protocol Violation|2|||
125626775|NCT00131664|451915793|FG002|First Period (First 6 Months)|Protocol Violation|1|||
125626776|NCT00131664|451915794|FG003|First Period (First 6 Months)|Protocol Violation|0|||
125626777|NCT00131664|451915795|FG004|First Period (First 6 Months)|Protocol Violation|0|||
125626778|NCT00131664|451915796|FG005|First Period (First 6 Months)|Protocol Violation|0|||
125626779|NCT00131664|451915791|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
125626780|NCT00131664|451915792|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
125626781|NCT00131664|451915793|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
125626782|NCT00131664|451915794|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
125626783|NCT00131664|451915795|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
125626784|NCT00131664|451915796|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
125626785|NCT00131664|451915791|FG000|First Period (First 6 Months)|Adverse Event|9|||
125626786|NCT00131664|451915792|FG001|First Period (First 6 Months)|Adverse Event|4|||
125626787|NCT00131664|451915793|FG002|First Period (First 6 Months)|Adverse Event|5|||
125626788|NCT00131664|451915794|FG003|First Period (First 6 Months)|Adverse Event|0|||
125626789|NCT00131664|451915795|FG004|First Period (First 6 Months)|Adverse Event|0|||
125626790|NCT00131664|451915796|FG005|First Period (First 6 Months)|Adverse Event|0|||
125626791|NCT00131664|451915791|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
125626792|NCT00131664|451915792|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
125626793|NCT00131664|451915793|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
125626794|NCT00131664|451915794|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
125626795|NCT00131664|451915795|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
125626796|NCT00131664|451915796|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
125626797|NCT00131664|451915791|FG000|First Period (First 6 Months)|Administrative reasons|2|||
125626798|NCT00131664|451915792|FG001|First Period (First 6 Months)|Administrative reasons|0|||
125433335|NCT03485911|451214457|FG003|Part 1|Perceived lack of efficacy|0|||
125433336|NCT03485911|451214454|FG000|Part 1|Subject withdrew consent|0|||
125433337|NCT03485911|451214455|FG001|Part 1|Subject withdrew consent|1|||
125626799|NCT00131664|451915793|FG002|First Period (First 6 Months)|Administrative reasons|5|||
125626800|NCT00131664|451915794|FG003|First Period (First 6 Months)|Administrative reasons|0|||
125626801|NCT00131664|451915795|FG004|First Period (First 6 Months)|Administrative reasons|0|||
125626802|NCT00131664|451915796|FG005|First Period (First 6 Months)|Administrative reasons|0|||
125626803|NCT00131664|451915791|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
125626804|NCT00131664|451915792|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
125626805|NCT00131664|451915793|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
125626806|NCT00131664|451915794|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
125626807|NCT00131664|451915795|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
125626808|NCT00131664|451915796|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
125626809|NCT00131664|451915791|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
125626810|NCT00131664|451915792|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
125626811|NCT00131664|451915793|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
125626812|NCT00131664|451915794|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
125626813|NCT00131664|451915795|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
125626814|NCT00131664|451915796|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
125626815|NCT00131664|451915791|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
125626816|NCT00131664|451915792|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
125626817|NCT00131664|451915793|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
125626818|NCT00131664|451915794|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
125626819|NCT00131664|451915795|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
125626820|NCT00131664|451915796|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
125626821|NCT00131664|451915791|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
125626822|NCT00131664|451915792|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
125626823|NCT00131664|451915793|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
125626824|NCT00131664|451915794|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
125626825|NCT00131664|451915795|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
125626826|NCT00131664|451915796|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
125626827|NCT00131664|451915791|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
125626828|NCT00131664|451915792|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
125626829|NCT00131664|451915793|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
125626830|NCT00131664|451915794|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
125626831|NCT00131664|451915795|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
125626832|NCT00131664|451915796|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
125626833|NCT00131664|451915791|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
125626834|NCT00131664|451915792|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
125626835|NCT00131664|451915793|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
125626836|NCT00131664|451915794|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
125626837|NCT00131664|451915795|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
125626838|NCT00131664|451915796|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
125626839|NCT01105936|451917411|FG000|Period 1|Adverse Event|0|||
125626840|NCT01105936|451917412|FG001|Period 1|Adverse Event|0|||
125626841|NCT01105936|451917413|FG002|Period 1|Adverse Event|0|||
125626842|NCT01105936|451917414|FG003|Period 1|Adverse Event|1|||
125626843|NCT01105936|451917411|FG000|Period 2|Adverse Event|1|||
125626844|NCT01105936|451917412|FG001|Period 2|Adverse Event|0|||
125626845|NCT01105936|451917413|FG002|Period 2|Adverse Event|0|||
125626846|NCT01105936|451917414|FG003|Period 2|Adverse Event|0|||
125626847|NCT01105936|451917411|FG000|Period 3|Protocol Violation|0|||
125626848|NCT01105936|451917412|FG001|Period 3|Protocol Violation|2|||
125626849|NCT01105936|451917413|FG002|Period 3|Protocol Violation|0|||
125626850|NCT01105936|451917414|FG003|Period 3|Protocol Violation|0|||
125626851|NCT02657434|451917417|FG000|Overall Study|Study Terminated By Sponsor|64|||
125626852|NCT02657434|451917418|FG001|Overall Study|Study Terminated By Sponsor|82|||
125626853|NCT02657434|451917417|FG000|Overall Study|Death|189|||
125626854|NCT02657434|451917418|FG001|Overall Study|Death|190|||
125626855|NCT02657434|451917417|FG000|Overall Study|Lost to Follow-up|2|||
125626856|NCT02657434|451917418|FG001|Overall Study|Lost to Follow-up|2|||
125626857|NCT02657434|451917417|FG000|Overall Study|Randomization by Error|2|||
125626858|NCT02657434|451917418|FG001|Overall Study|Randomization by Error|0|||
125626859|NCT02657434|451917417|FG000|Overall Study|Withdrawal by Subject|28|||
125626860|NCT02657434|451917418|FG001|Overall Study|Withdrawal by Subject|17|||
125626861|NCT02657434|451917417|FG000|Overall Study|Protocol Violation|1|||
125626862|NCT02657434|451917418|FG001|Overall Study|Protocol Violation|0|||
125626863|NCT02657434|451917417|FG000|Overall Study|Physician Decision|0|||
125626864|NCT02657434|451917418|FG001|Overall Study|Physician Decision|1|||
125626865|NCT00608881|451917419|FG000|Overall Study|Death|22|||
125626866|NCT00608881|451917420|FG001|Overall Study|Death|13|||
125626867|NCT00608881|451917419|FG000|Overall Study|Adverse Event|5|||
125626868|NCT00608881|451917420|FG001|Overall Study|Adverse Event|3|||
125626869|NCT00608881|451917419|FG000|Overall Study|Lost to Follow-up|28|||
125626870|NCT00608881|451917420|FG001|Overall Study|Lost to Follow-up|14|||
125626871|NCT00608881|451917419|FG000|Overall Study|Withdrawal by Subject|18|||
125626872|NCT00608881|451917420|FG001|Overall Study|Withdrawal by Subject|29|||
125626873|NCT00608881|451917419|FG000|Overall Study|Physician Decision|5|||
125626874|NCT00608881|451917420|FG001|Overall Study|Physician Decision|5|||
125626875|NCT00608881|451917419|FG000|Overall Study|Institutionalized|1|||
125626876|NCT00608881|451917420|FG001|Overall Study|Institutionalized|2|||
125626877|NCT01998958|451917421|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626878|NCT01998958|451917422|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
125626879|NCT01998958|451917423|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626880|NCT01998958|451917424|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626881|NCT01998958|451917425|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626882|NCT01998958|451917426|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125215583|NCT01188668|450417444|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
125374928|NCT00642460|451002286|FG005|Part III: Open-Label Up to Week 260|Other|2|||
125626883|NCT01998958|451917427|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125374929|NCT00642460|451002281|FG000|Part III: Open-Label Up to Week 260|Death|0|||
125215584|NCT01188668|450417444|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
125626884|NCT01998958|451917428|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626885|NCT01998958|451917429|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626886|NCT01998958|451917430|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626887|NCT01998958|451917431|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626888|NCT01998958|451917432|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125433338|NCT03485911|451214456|FG002|Part 1|Subject withdrew consent|0|||
125433339|NCT03485911|451214457|FG003|Part 1|Subject withdrew consent|1|||
125433340|NCT03485911|451214454|FG000|Part 1|Lab abnormalities/AEs|3|||
125433341|NCT03485911|451214455|FG001|Part 1|Lab abnormalities/AEs|1|||
125433342|NCT03485911|451214456|FG002|Part 1|Lab abnormalities/AEs|1|||
125433343|NCT03485911|451214457|FG003|Part 1|Lab abnormalities/AEs|0|||
125433344|NCT03485911|451214454|FG000|Part 1|Withdrew Consent prior to dosing|0|||
125433345|NCT03485911|451214455|FG001|Part 1|Withdrew Consent prior to dosing|0|||
125433346|NCT03485911|451214456|FG002|Part 1|Withdrew Consent prior to dosing|0|||
125433347|NCT03485911|451214457|FG003|Part 1|Withdrew Consent prior to dosing|1|||
125433348|NCT03485911|451214454|FG000|Part 1|Other NOS|0|||
125626889|NCT01998958|451917433|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626890|NCT01998958|451917434|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125433349|NCT03485911|451214455|FG001|Part 1|Other NOS|0|||
125433350|NCT03485911|451214456|FG002|Part 1|Other NOS|0|||
125433351|NCT03485911|451214457|FG003|Part 1|Other NOS|1|||
125433352|NCT03485911|451214454|FG000|Part 2|Perceived lack of efficacy|5|||
125433353|NCT03485911|451214455|FG001|Part 2|Perceived lack of efficacy|3|||
125626891|NCT01998958|451917435|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626892|NCT01998958|451917436|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626893|NCT01998958|451917437|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626894|NCT01998958|451917438|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626895|NCT01998958|451917439|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626896|NCT01998958|451917440|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626897|NCT01998958|451917441|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626898|NCT01998958|451917442|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626899|NCT01998958|451917443|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125433354|NCT03485911|451214456|FG002|Part 2|Perceived lack of efficacy|0|||
125433355|NCT03485911|451214457|FG003|Part 2|Perceived lack of efficacy|2|||
125433356|NCT03485911|451214454|FG000|Part 2|Subject withdrew consent|1|||
125433357|NCT03485911|451214455|FG001|Part 2|Subject withdrew consent|0|||
125433358|NCT03485911|451214456|FG002|Part 2|Subject withdrew consent|2|||
125433359|NCT03485911|451214457|FG003|Part 2|Subject withdrew consent|1|||
125433360|NCT03485911|451214454|FG000|Part 2|Lab abnormalities/AEs|1|||
125433361|NCT03485911|451214455|FG001|Part 2|Lab abnormalities/AEs|2|||
125433362|NCT03485911|451214456|FG002|Part 2|Lab abnormalities/AEs|0|||
125433363|NCT03485911|451214457|FG003|Part 2|Lab abnormalities/AEs|0|||
125433364|NCT03485911|451214454|FG000|Part 2|Other NOS|0|||
125433365|NCT03485911|451214455|FG001|Part 2|Other NOS|1|||
125433366|NCT03485911|451214456|FG002|Part 2|Other NOS|0|||
125433367|NCT03485911|451214457|FG003|Part 2|Other NOS|0|||
125433368|NCT03485911|451214454|FG000|Part 2|Intercurrent illness/new medical condition|1|||
125433369|NCT03485911|451214455|FG001|Part 2|Intercurrent illness/new medical condition|0|||
125433370|NCT03485911|451214456|FG002|Part 2|Intercurrent illness/new medical condition|0|||
125433371|NCT03485911|451214457|FG003|Part 2|Intercurrent illness/new medical condition|0|||
125626900|NCT01998958|451917444|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626901|NCT01998958|451917445|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626902|NCT01998958|451917446|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626903|NCT01998958|451917447|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626904|NCT01998958|451917448|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626905|NCT01998958|451917449|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626906|NCT01998958|451917450|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626907|NCT01998958|451917451|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626908|NCT01998958|451917452|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
125626909|NCT01998958|451917421|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626910|NCT01998958|451917422|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
125626911|NCT01998958|451917423|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125433372|NCT03485911|451214454|FG000|Part 2|Investigator judgement|1|||
125433373|NCT03485911|451214455|FG001|Part 2|Investigator judgement|0|||
125433374|NCT03485911|451214456|FG002|Part 2|Investigator judgement|0|||
125433375|NCT03485911|451214457|FG003|Part 2|Investigator judgement|0|||
125433376|NCT03485911|451214454|FG000|Part 3|Perceived lack of efficacy|2|||
125433377|NCT03485911|451214455|FG001|Part 3|Perceived lack of efficacy|2|||
125433378|NCT03485911|451214456|FG002|Part 3|Perceived lack of efficacy|2|||
125626912|NCT01998958|451917424|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626913|NCT01998958|451917425|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626914|NCT01998958|451917426|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125433379|NCT03485911|451214457|FG003|Part 3|Perceived lack of efficacy|0|||
125433380|NCT03485911|451214454|FG000|Part 3|Subject withdrew consent|1|||
125433381|NCT03485911|451214455|FG001|Part 3|Subject withdrew consent|4|||
125433382|NCT03485911|451214456|FG002|Part 3|Subject withdrew consent|0|||
125433383|NCT03485911|451214457|FG003|Part 3|Subject withdrew consent|1|||
125433384|NCT03485911|451214454|FG000|Part 3|Lab abnormalities/AEs|1|||
125433385|NCT03485911|451214455|FG001|Part 3|Lab abnormalities/AEs|1|||
125433386|NCT03485911|451214456|FG002|Part 3|Lab abnormalities/AEs|0|||
125433387|NCT03485911|451214457|FG003|Part 3|Lab abnormalities/AEs|2|||
125433388|NCT03485911|451214454|FG000|Part 3|Other NOS|1|||
125626915|NCT01998958|451917427|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626916|NCT01998958|451917428|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626917|NCT01998958|451917429|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626918|NCT01998958|451917430|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626919|NCT01998958|451917431|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626920|NCT01998958|451917432|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626921|NCT01998958|451917433|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626922|NCT01998958|451917434|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626923|NCT01998958|451917435|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626924|NCT01998958|451917436|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626925|NCT01998958|451917437|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626926|NCT01998958|451917438|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626927|NCT01998958|451917439|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626928|NCT01998958|451917440|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626929|NCT01998958|451917441|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626930|NCT01998958|451917442|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626931|NCT01998958|451917443|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626932|NCT01998958|451917444|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626933|NCT01998958|451917445|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626934|NCT01998958|451917446|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626935|NCT01998958|451917447|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626936|NCT01998958|451917448|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626937|NCT01998958|451917449|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626938|NCT01998958|451917450|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626939|NCT01998958|451917451|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626940|NCT01998958|451917452|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
125626941|NCT01998958|451917421|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
125626942|NCT01998958|451917422|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
125626943|NCT01998958|451917423|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
125626944|NCT01998958|451917424|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
125626945|NCT01998958|451917425|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
125626946|NCT01998958|451917426|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
125626947|NCT01998958|451917427|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
125626948|NCT01998958|451917428|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
125626949|NCT01998958|451917429|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
125626950|NCT01998958|451917430|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
125626951|NCT01998958|451917431|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
125626952|NCT01998958|451917432|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
125626953|NCT01998958|451917433|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
125626954|NCT01998958|451917434|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
125626955|NCT01998958|451917435|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
125626956|NCT01998958|451917436|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
125626957|NCT01998958|451917437|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
125626958|NCT01998958|451917438|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
125626959|NCT01998958|451917439|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
125626960|NCT01998958|451917440|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
125626961|NCT01998958|451917441|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
125626962|NCT01998958|451917442|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
125626963|NCT01998958|451917443|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
125626964|NCT01998958|451917444|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
125626965|NCT01998958|451917445|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
125374930|NCT00642460|451002282|FG001|Part III: Open-Label Up to Week 260|Death|0|||
125374931|NCT00642460|451002283|FG002|Part III: Open-Label Up to Week 260|Death|0|||
125374932|NCT00642460|451002284|FG003|Part III: Open-Label Up to Week 260|Death|0|||
125374933|NCT00642460|451002285|FG004|Part III: Open-Label Up to Week 260|Death|0|||
125626966|NCT01998958|451917446|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
125626967|NCT01998958|451917447|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
125626968|NCT01998958|451917448|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
125626969|NCT01998958|451917449|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
125626970|NCT01998958|451917450|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
125626971|NCT01998958|451917451|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
125626972|NCT01998958|451917452|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
125626973|NCT01998958|451917421|FG000|Period 1 (Panel A and B)|Other|1|||
125626974|NCT01998958|451917422|FG001|Period 1 (Panel A and B)|Other|0|||
125626975|NCT01998958|451917423|FG002|Period 1 (Panel A and B)|Other|0|||
125626976|NCT01998958|451917424|FG003|Period 1 (Panel A and B)|Other|0|||
125626977|NCT01998958|451917425|FG004|Period 1 (Panel A and B)|Other|0|||
125626978|NCT01998958|451917426|FG005|Period 1 (Panel A and B)|Other|0|||
125626979|NCT01998958|451917427|FG006|Period 1 (Panel A and B)|Other|0|||
125374934|NCT00642460|451002286|FG005|Part III: Open-Label Up to Week 260|Death|3|||
125626980|NCT01998958|451917428|FG007|Period 1 (Panel A and B)|Other|0|||
125626981|NCT01998958|451917429|FG008|Period 1 (Panel A and B)|Other|0|||
125626982|NCT01998958|451917430|FG009|Period 1 (Panel A and B)|Other|0|||
125626983|NCT01998958|451917431|FG010|Period 1 (Panel A and B)|Other|0|||
125626984|NCT01998958|451917432|FG011|Period 1 (Panel A and B)|Other|0|||
125626985|NCT01998958|451917433|FG012|Period 1 (Panel A and B)|Other|0|||
125626986|NCT01998958|451917434|FG013|Period 1 (Panel A and B)|Other|0|||
125626987|NCT01998958|451917435|FG014|Period 1 (Panel A and B)|Other|0|||
125626988|NCT01998958|451917436|FG015|Period 1 (Panel A and B)|Other|0|||
125626989|NCT01998958|451917437|FG016|Period 1 (Panel A and B)|Other|0|||
125626990|NCT01998958|451917438|FG017|Period 1 (Panel A and B)|Other|0|||
125626991|NCT01998958|451917439|FG018|Period 1 (Panel A and B)|Other|0|||
125626992|NCT01998958|451917440|FG019|Period 1 (Panel A and B)|Other|0|||
125626993|NCT01998958|451917441|FG020|Period 1 (Panel A and B)|Other|0|||
125626994|NCT01998958|451917442|FG021|Period 1 (Panel A and B)|Other|0|||
125626995|NCT01998958|451917443|FG022|Period 1 (Panel A and B)|Other|0|||
125626996|NCT01998958|451917444|FG023|Period 1 (Panel A and B)|Other|0|||
125626997|NCT01998958|451917445|FG024|Period 1 (Panel A and B)|Other|0|||
125626998|NCT01998958|451917446|FG025|Period 1 (Panel A and B)|Other|0|||
125626999|NCT01998958|451917447|FG026|Period 1 (Panel A and B)|Other|0|||
125627000|NCT01998958|451917448|FG027|Period 1 (Panel A and B)|Other|0|||
125627001|NCT01998958|451917449|FG028|Period 1 (Panel A and B)|Other|0|||
125627002|NCT01998958|451917450|FG029|Period 1 (Panel A and B)|Other|0|||
125627003|NCT01998958|451917451|FG030|Period 1 (Panel A and B)|Other|0|||
125627004|NCT01998958|451917452|FG031|Period 1 (Panel A and B)|Other|0|||
125627005|NCT01998958|451917421|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
125627006|NCT01998958|451917422|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
125627007|NCT01998958|451917423|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
125627008|NCT01998958|451917424|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
125627009|NCT01998958|451917425|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
125627010|NCT01998958|451917426|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
125627011|NCT01998958|451917427|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
125627012|NCT01998958|451917428|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
125627013|NCT01998958|451917429|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
125627014|NCT01998958|451917430|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
125627015|NCT01998958|451917431|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
125627016|NCT01998958|451917432|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
125627017|NCT01998958|451917433|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
125627018|NCT01998958|451917434|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
125627019|NCT01998958|451917435|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
125627020|NCT01998958|451917436|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
125627021|NCT01998958|451917437|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
125627022|NCT01998958|451917438|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
125627023|NCT01998958|451917439|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
125627024|NCT01998958|451917440|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
125627025|NCT01998958|451917441|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
125627026|NCT01998958|451917442|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
125627027|NCT01998958|451917443|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
125627028|NCT01998958|451917444|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
125627029|NCT01998958|451917445|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
125627030|NCT01998958|451917446|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
125627031|NCT01998958|451917447|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
125627032|NCT01998958|451917448|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
125627033|NCT01998958|451917449|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
125627034|NCT01998958|451917450|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
125627035|NCT01998958|451917451|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
125627036|NCT01998958|451917452|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
125627037|NCT01998958|451917421|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627038|NCT01998958|451917422|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627039|NCT01998958|451917423|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627040|NCT01998958|451917424|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627041|NCT01998958|451917425|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627042|NCT01998958|451917426|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627043|NCT01998958|451917427|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627044|NCT01998958|451917428|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627045|NCT01998958|451917429|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125215585|NCT00902746|450417445|FG000|Overall Study|Protocol Violation|7|||
125627046|NCT01998958|451917430|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627047|NCT01998958|451917431|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627048|NCT01998958|451917432|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627049|NCT01998958|451917433|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627050|NCT01998958|451917434|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627051|NCT01998958|451917435|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
125627052|NCT01998958|451917436|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627053|NCT01998958|451917437|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627054|NCT01998958|451917438|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627055|NCT01998958|451917439|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
125627056|NCT01998958|451917440|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627057|NCT01998958|451917441|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627058|NCT01998958|451917442|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627059|NCT01998958|451917443|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627060|NCT01998958|451917444|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627061|NCT01998958|451917445|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627062|NCT01998958|451917446|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627063|NCT01998958|451917447|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627064|NCT01998958|451917448|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627065|NCT01998958|451917449|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627066|NCT01998958|451917450|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627067|NCT01998958|451917451|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627068|NCT01998958|451917452|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
125627069|NCT01998958|451917421|FG000|Open Label Phase (Optional)|Adverse Event|0|||
125627070|NCT01998958|451917422|FG001|Open Label Phase (Optional)|Adverse Event|0|||
125627071|NCT01998958|451917423|FG002|Open Label Phase (Optional)|Adverse Event|0|||
125627072|NCT01998958|451917424|FG003|Open Label Phase (Optional)|Adverse Event|0|||
125627073|NCT01998958|451917425|FG004|Open Label Phase (Optional)|Adverse Event|0|||
125627074|NCT01998958|451917426|FG005|Open Label Phase (Optional)|Adverse Event|0|||
125627075|NCT01998958|451917427|FG006|Open Label Phase (Optional)|Adverse Event|0|||
125627076|NCT01998958|451917428|FG007|Open Label Phase (Optional)|Adverse Event|0|||
125627077|NCT01998958|451917429|FG008|Open Label Phase (Optional)|Adverse Event|0|||
125627078|NCT01998958|451917430|FG009|Open Label Phase (Optional)|Adverse Event|0|||
125627079|NCT01998958|451917431|FG010|Open Label Phase (Optional)|Adverse Event|0|||
125627080|NCT01998958|451917432|FG011|Open Label Phase (Optional)|Adverse Event|0|||
125627081|NCT01998958|451917433|FG012|Open Label Phase (Optional)|Adverse Event|0|||
125627082|NCT01998958|451917434|FG013|Open Label Phase (Optional)|Adverse Event|0|||
125627083|NCT01998958|451917435|FG014|Open Label Phase (Optional)|Adverse Event|0|||
125627084|NCT01998958|451917436|FG015|Open Label Phase (Optional)|Adverse Event|0|||
125627085|NCT01998958|451917437|FG016|Open Label Phase (Optional)|Adverse Event|0|||
125627086|NCT01998958|451917438|FG017|Open Label Phase (Optional)|Adverse Event|0|||
125627087|NCT01998958|451917439|FG018|Open Label Phase (Optional)|Adverse Event|0|||
125627088|NCT01998958|451917440|FG019|Open Label Phase (Optional)|Adverse Event|0|||
125627089|NCT01998958|451917441|FG020|Open Label Phase (Optional)|Adverse Event|0|||
125627090|NCT01998958|451917442|FG021|Open Label Phase (Optional)|Adverse Event|0|||
125627091|NCT01998958|451917443|FG022|Open Label Phase (Optional)|Adverse Event|0|||
125627092|NCT01998958|451917444|FG023|Open Label Phase (Optional)|Adverse Event|1|||
125627093|NCT01998958|451917445|FG024|Open Label Phase (Optional)|Adverse Event|0|||
125627094|NCT01998958|451917446|FG025|Open Label Phase (Optional)|Adverse Event|0|||
125627095|NCT01998958|451917447|FG026|Open Label Phase (Optional)|Adverse Event|0|||
125627096|NCT01998958|451917448|FG027|Open Label Phase (Optional)|Adverse Event|0|||
125627097|NCT01998958|451917449|FG028|Open Label Phase (Optional)|Adverse Event|0|||
125627098|NCT01998958|451917450|FG029|Open Label Phase (Optional)|Adverse Event|0|||
125627099|NCT01998958|451917451|FG030|Open Label Phase (Optional)|Adverse Event|0|||
125627100|NCT01998958|451917452|FG031|Open Label Phase (Optional)|Adverse Event|0|||
125627101|NCT01998958|451917421|FG000|Open Label Phase (Optional)|Other|0|||
125627102|NCT01998958|451917422|FG001|Open Label Phase (Optional)|Other|0|||
125627103|NCT01998958|451917423|FG002|Open Label Phase (Optional)|Other|0|||
125627104|NCT01998958|451917424|FG003|Open Label Phase (Optional)|Other|0|||
125627105|NCT01998958|451917425|FG004|Open Label Phase (Optional)|Other|0|||
125627106|NCT01998958|451917426|FG005|Open Label Phase (Optional)|Other|0|||
125627107|NCT01998958|451917427|FG006|Open Label Phase (Optional)|Other|0|||
125627108|NCT01998958|451917428|FG007|Open Label Phase (Optional)|Other|0|||
125627109|NCT01998958|451917429|FG008|Open Label Phase (Optional)|Other|0|||
125627110|NCT01998958|451917430|FG009|Open Label Phase (Optional)|Other|0|||
125627111|NCT01998958|451917431|FG010|Open Label Phase (Optional)|Other|0|||
125627112|NCT01998958|451917432|FG011|Open Label Phase (Optional)|Other|0|||
125627113|NCT01998958|451917433|FG012|Open Label Phase (Optional)|Other|0|||
125627114|NCT01998958|451917434|FG013|Open Label Phase (Optional)|Other|0|||
125627115|NCT01998958|451917435|FG014|Open Label Phase (Optional)|Other|0|||
125627116|NCT01998958|451917436|FG015|Open Label Phase (Optional)|Other|0|||
125374935|NCT00642460|451002281|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
125374936|NCT00642460|451002282|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
125374937|NCT00642460|451002283|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
125374938|NCT00642460|451002284|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
125374939|NCT00642460|451002285|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
125627117|NCT01998958|451917437|FG016|Open Label Phase (Optional)|Other|0|||
125627118|NCT01998958|451917438|FG017|Open Label Phase (Optional)|Other|0|||
125627119|NCT01998958|451917439|FG018|Open Label Phase (Optional)|Other|0|||
125627120|NCT01998958|451917440|FG019|Open Label Phase (Optional)|Other|0|||
125627121|NCT01998958|451917441|FG020|Open Label Phase (Optional)|Other|0|||
125627122|NCT01998958|451917442|FG021|Open Label Phase (Optional)|Other|0|||
125627123|NCT01998958|451917443|FG022|Open Label Phase (Optional)|Other|5|||
125627124|NCT01998958|451917444|FG023|Open Label Phase (Optional)|Other|1|||
125627125|NCT01998958|451917445|FG024|Open Label Phase (Optional)|Other|0|||
125627126|NCT01998958|451917446|FG025|Open Label Phase (Optional)|Other|0|||
125627127|NCT01998958|451917447|FG026|Open Label Phase (Optional)|Other|0|||
125627128|NCT01998958|451917448|FG027|Open Label Phase (Optional)|Other|0|||
125627129|NCT01998958|451917449|FG028|Open Label Phase (Optional)|Other|0|||
125627130|NCT01998958|451917450|FG029|Open Label Phase (Optional)|Other|0|||
125627131|NCT01998958|451917451|FG030|Open Label Phase (Optional)|Other|0|||
125627132|NCT01998958|451917452|FG031|Open Label Phase (Optional)|Other|0|||
125433389|NCT03485911|451214455|FG001|Part 3|Other NOS|1|||
125433390|NCT03485911|451214456|FG002|Part 3|Other NOS|0|||
125433391|NCT03485911|451214457|FG003|Part 3|Other NOS|0|||
125433392|NCT03485911|451214454|FG000|Part 3|Intercurrent illness/new medical condition|0|||
125433393|NCT03485911|451214455|FG001|Part 3|Intercurrent illness/new medical condition|1|||
125433394|NCT03485911|451214456|FG002|Part 3|Intercurrent illness/new medical condition|1|||
125627133|NCT01998958|451917421|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627134|NCT01998958|451917422|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627135|NCT01998958|451917423|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627136|NCT01998958|451917424|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627137|NCT01998958|451917425|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627138|NCT01998958|451917426|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627139|NCT01998958|451917427|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627140|NCT01998958|451917428|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627141|NCT01998958|451917429|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627142|NCT01998958|451917430|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627143|NCT01998958|451917431|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
125433395|NCT03485911|451214457|FG003|Part 3|Intercurrent illness/new medical condition|0|||
125433396|NCT03485911|451214454|FG000|Part 3|Sponsor discontinuation|1|||
125433397|NCT03485911|451214455|FG001|Part 3|Sponsor discontinuation|0|||
125433398|NCT03485911|451214456|FG002|Part 3|Sponsor discontinuation|0|||
125433399|NCT03485911|451214457|FG003|Part 3|Sponsor discontinuation|0|||
125433400|NCT03485911|451214454|FG000|Part 3|Berotralstat provided by alternative means|13|||
125433401|NCT03485911|451214455|FG001|Part 3|Berotralstat provided by alternative means|13|||
125433402|NCT03485911|451214456|FG002|Part 3|Berotralstat provided by alternative means|7|||
125433403|NCT03485911|451214457|FG003|Part 3|Berotralstat provided by alternative means|7|||
125433404|NCT01215357|451214458|FG000|Overall Study|Withdrawal by Subject|3|||
125433405|NCT01215357|451214458|FG000|Overall Study|Protocol Violation|9|||
125433406|NCT00909480|451214462|FG000|Overall Study|Adverse Event|5|||
125433407|NCT00909480|451214463|FG001|Overall Study|Adverse Event|3|||
125433408|NCT00909480|451214462|FG000|Overall Study|Protocol Violation|6|||
125433409|NCT00909480|451214463|FG001|Overall Study|Protocol Violation|8|||
125433410|NCT00909480|451214462|FG000|Overall Study|Withdrawal criteria|9|||
125433411|NCT00909480|451214463|FG001|Overall Study|Withdrawal criteria|11|||
125433412|NCT00909480|451214462|FG000|Overall Study|Unclassified|18|||
125433413|NCT00909480|451214463|FG001|Overall Study|Unclassified|19|||
125433414|NCT03528174|451214464|FG000|Overall Study|Adverse Event|1|||
125433415|NCT03528174|451214464|FG000|Overall Study|sensors dislodged|1|||
125433416|NCT03002038|451214465|FG000|Overall Study|Adverse Event|3|||
125433417|NCT03002038|451214466|FG001|Overall Study|Adverse Event|1|||
125433418|NCT03002038|451214465|FG000|Overall Study|Withdrawal by Subject|8|||
125433419|NCT03002038|451214466|FG001|Overall Study|Withdrawal by Subject|4|||
125433420|NCT03002038|451214465|FG000|Overall Study|Immigration to another region|0|||
125433421|NCT03002038|451214466|FG001|Overall Study|Immigration to another region|2|||
125433422|NCT05266963|451214472|FG000|Drug Period A|Withdrawal by Subject|0|||
125433423|NCT05266963|451214473|FG001|Drug Period A|Withdrawal by Subject|1|||
125433424|NCT02712398|451214474|FG000|Overall Study|Withdrawal by Subject|6|||
125433425|NCT02712398|451214474|FG000|Overall Study|Lost to Follow-up|6|||
125433426|NCT02712398|451214474|FG000|Overall Study|Sponsor Decision|1|||
125433427|NCT02712398|451214474|FG000|Overall Study|Physician Decision|1|||
125433428|NCT02712398|451214474|FG000|Overall Study|Death|2|||
125433429|NCT02712398|451214474|FG000|Overall Study|Re-operation|21|||
125433430|NCT01719237|451214475|FG000|Overall Study|Physician Decision|0|||
125433431|NCT01719237|451214476|FG001|Overall Study|Physician Decision|1|||
125433432|NCT01725386|451214478|FG000|Overall Study|Death|84|||
125433433|NCT01725386|451214479|FG001|Overall Study|Death|40|||
125433434|NCT01725386|451214478|FG000|Overall Study|Lost to Follow-up|81|||
125433435|NCT01725386|451214479|FG001|Overall Study|Lost to Follow-up|6|||
125433436|NCT01725386|451214478|FG000|Overall Study|Withdrawal by Subject|10|||
125433437|NCT01725386|451214479|FG001|Overall Study|Withdrawal by Subject|0|||
125627144|NCT01998958|451917432|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627145|NCT01998958|451917433|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
125433438|NCT03812536|451214484|FG000|Overall Study|Protocol Violation|2|||
125433439|NCT03812536|451214485|FG001|Overall Study|Protocol Violation|0|||
125433440|NCT03812536|451214484|FG000|Overall Study|Withdrawal by Subject|1|||
125433441|NCT03812536|451214485|FG001|Overall Study|Withdrawal by Subject|1|||
125627146|NCT01998958|451917434|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627147|NCT01998958|451917435|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627148|NCT01998958|451917436|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627149|NCT01998958|451917437|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627150|NCT01998958|451917438|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627151|NCT01998958|451917439|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627152|NCT01998958|451917440|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627153|NCT01998958|451917441|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627154|NCT01998958|451917442|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627155|NCT01998958|451917443|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
125627156|NCT01998958|451917444|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627157|NCT01998958|451917445|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627158|NCT01998958|451917446|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627159|NCT01998958|451917447|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627160|NCT01998958|451917448|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627161|NCT01998958|451917449|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627162|NCT01998958|451917450|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627163|NCT01998958|451917451|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627164|NCT01998958|451917452|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
125627165|NCT01998958|451917421|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627166|NCT01998958|451917422|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627167|NCT01998958|451917423|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627168|NCT01998958|451917424|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627169|NCT01998958|451917425|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627170|NCT01998958|451917426|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627171|NCT01998958|451917427|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627172|NCT01998958|451917428|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627173|NCT01998958|451917429|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627174|NCT01998958|451917430|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627175|NCT01998958|451917431|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627176|NCT01998958|451917432|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627177|NCT01998958|451917433|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627178|NCT01998958|451917434|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627179|NCT01998958|451917435|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627180|NCT01998958|451917436|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
125374940|NCT00642460|451002286|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
125374941|NCT00642460|451002281|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
125374942|NCT00642460|451002282|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
125374943|NCT00642460|451002283|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
125374944|NCT00642460|451002284|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
125374945|NCT00642460|451002285|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
125374946|NCT00642460|451002286|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
125374947|NCT00320411|451002287|FG000|Overall Study|No investigational product admin.|4|||
125374948|NCT02557646|451002290|FG000|Overall Study|Adverse Event|40|||
125374949|NCT02557646|451002290|FG000|Overall Study|Death|1|||
125374950|NCT02557646|451002290|FG000|Overall Study|Lack of Efficacy|186|||
125374951|NCT02557646|451002290|FG000|Overall Study|Withdrawal by Subject|18|||
125374952|NCT02557646|451002290|FG000|Overall Study|Lost to Follow-up|17|||
125374953|NCT02557646|451002290|FG000|Overall Study|Other|14|||
125374954|NCT04448171|451002291|FG000|Overall Study|Procedure Cancelled|1|||
125374955|NCT04448171|451002292|FG001|Overall Study|Procedure Cancelled|0|||
125374956|NCT04448171|451002291|FG000|Overall Study|Protocol Violation|1|||
125374957|NCT04448171|451002292|FG001|Overall Study|Protocol Violation|0|||
125374958|NCT04605484|451002295|FG000|Overall Study|Lost to Follow-up|0|||
125374959|NCT04605484|451002296|FG001|Overall Study|Lost to Follow-up|1|||
125374960|NCT04605484|451002297|FG002|Overall Study|Lost to Follow-up|1|||
125374961|NCT04605484|451002295|FG000|Overall Study|Other|0|||
125374962|NCT04605484|451002296|FG001|Overall Study|Other|1|||
125374963|NCT04605484|451002297|FG002|Overall Study|Other|0|||
125374964|NCT00660309|451002298|FG000|Overall Study|Adverse Event|2|||
125374965|NCT00660309|451002299|FG001|Overall Study|Adverse Event|0|||
125374966|NCT00660309|451002298|FG000|Overall Study|Withdrawal by Subject|0|||
125374967|NCT00660309|451002299|FG001|Overall Study|Withdrawal by Subject|3|||
125374968|NCT02573311|451002302|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
125374969|NCT02573311|451002303|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
125374970|NCT02573311|451002302|FG000|Disposition for Part 2|Physician Decision|25|||
125627181|NCT01998958|451917437|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
125374971|NCT02573311|451002303|FG001|Disposition for Part 2|Physician Decision|7|||
125374972|NCT02573311|451002302|FG000|Disposition for Part 2|Adverse Event|36|||
125374973|NCT02573311|451002303|FG001|Disposition for Part 2|Adverse Event|5|||
125374974|NCT02573311|451002302|FG000|Disposition for Part 2|Lost to Follow-up|76|||
125374975|NCT02573311|451002303|FG001|Disposition for Part 2|Lost to Follow-up|7|||
125374976|NCT02573311|451002302|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
125627182|NCT01998958|451917438|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627183|NCT01998958|451917439|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627184|NCT01998958|451917440|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627185|NCT01998958|451917441|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627186|NCT01998958|451917442|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
125627187|NCT01998958|451917443|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
125627188|NCT01998958|451917444|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627189|NCT01998958|451917445|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627190|NCT01998958|451917446|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627191|NCT01998958|451917447|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627192|NCT01998958|451917448|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627193|NCT01998958|451917449|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
125128394|NCT00376623|450096058|FG001|Overall Study|Increase of tumour markers|1|||
125374977|NCT02573311|451002303|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
125374978|NCT02573311|451002302|FG000|Disposition for Part 2|Investigator decision|0|||
125374979|NCT02573311|451002303|FG001|Disposition for Part 2|Investigator decision|1|||
125374980|NCT02573311|451002302|FG000|Disposition for Part 2|Other than specified above|13|||
125374981|NCT02573311|451002303|FG001|Disposition for Part 2|Other than specified above|3|||
125374982|NCT05683249|451002305|FG000|Overall Study|Adverse Event|3|||
125374983|NCT05683249|451002306|FG001|Overall Study|Adverse Event|1|||
125374984|NCT05683249|451002305|FG000|Overall Study|Lack of Efficacy|0|||
125374985|NCT05683249|451002306|FG001|Overall Study|Lack of Efficacy|2|||
125374986|NCT05683249|451002305|FG000|Overall Study|Lost to Follow-up|6|||
125374987|NCT05683249|451002306|FG001|Overall Study|Lost to Follow-up|5|||
125374988|NCT05683249|451002305|FG000|Overall Study|Non-compliance with Study Drug|2|||
125374989|NCT05683249|451002306|FG001|Overall Study|Non-compliance with Study Drug|0|||
125374990|NCT05683249|451002305|FG000|Overall Study|Protocol Violation|6|||
125374991|NCT05683249|451002306|FG001|Overall Study|Protocol Violation|3|||
125374992|NCT05683249|451002305|FG000|Overall Study|Withdrawal by Subject|9|||
125374993|NCT05683249|451002306|FG001|Overall Study|Withdrawal by Subject|8|||
125374994|NCT05683249|451002305|FG000|Overall Study|Other|0|||
125374995|NCT05683249|451002306|FG001|Overall Study|Other|2|||
125374996|NCT01370356|451002307|FG000|Overall Study|Death|1|||
125374997|NCT01370356|451002308|FG001|Overall Study|Death|0|||
125374998|NCT01370356|451002307|FG000|Overall Study|Lack of Efficacy|6|||
125374999|NCT01370356|451002308|FG001|Overall Study|Lack of Efficacy|28|||
125375000|NCT01370356|451002307|FG000|Overall Study|Lost to Follow-up|76|||
125375001|NCT01370356|451002308|FG001|Overall Study|Lost to Follow-up|81|||
125375002|NCT01370356|451002307|FG000|Overall Study|Withdrawal by Subject|54|||
125375003|NCT01370356|451002308|FG001|Overall Study|Withdrawal by Subject|59|||
125375004|NCT01370356|451002307|FG000|Overall Study|Reason not specified|39|||
125375005|NCT01370356|451002308|FG001|Overall Study|Reason not specified|43|||
125375006|NCT01370356|451002307|FG000|Overall Study|Protocol Violation|3|||
125375007|NCT01370356|451002308|FG001|Overall Study|Protocol Violation|3|||
125375008|NCT01370356|451002307|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
125375009|NCT01370356|451002308|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
125375010|NCT01370356|451002307|FG000|Overall Study|AE Not Related to Study Drug|1|||
125375011|NCT01370356|451002308|FG001|Overall Study|AE Not Related to Study Drug|4|||
125375012|NCT00040664|451002309|FG000|Overall Study|Adverse Event|12|||
125375013|NCT00040664|451002310|FG001|Overall Study|Adverse Event|3|||
125375014|NCT00040664|451002311|FG002|Overall Study|Adverse Event|2|||
125375015|NCT00040664|451002312|FG003|Overall Study|Adverse Event|7|||
125375016|NCT00040664|451002309|FG000|Overall Study|Lack of Efficacy|9|||
125375017|NCT00040664|451002310|FG001|Overall Study|Lack of Efficacy|2|||
125375018|NCT00040664|451002311|FG002|Overall Study|Lack of Efficacy|3|||
125375019|NCT00040664|451002312|FG003|Overall Study|Lack of Efficacy|4|||
125375020|NCT00040664|451002309|FG000|Overall Study|Insufficient CD4 response|1|||
125375021|NCT00040664|451002310|FG001|Overall Study|Insufficient CD4 response|0|||
125375022|NCT00040664|451002311|FG002|Overall Study|Insufficient CD4 response|1|||
125375023|NCT00040664|451002312|FG003|Overall Study|Insufficient CD4 response|0|||
125433442|NCT02914314|451214486|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
125375024|NCT00040664|451002309|FG000|Overall Study|Lost to Follow-up|4|||
125375025|NCT00040664|451002310|FG001|Overall Study|Lost to Follow-up|2|||
125375026|NCT00040664|451002311|FG002|Overall Study|Lost to Follow-up|0|||
125375027|NCT00040664|451002312|FG003|Overall Study|Lost to Follow-up|2|||
125375028|NCT00040664|451002309|FG000|Overall Study|Protocol Violation|2|||
125375029|NCT00040664|451002310|FG001|Overall Study|Protocol Violation|1|||
125375030|NCT00040664|451002311|FG002|Overall Study|Protocol Violation|0|||
125375031|NCT00040664|451002312|FG003|Overall Study|Protocol Violation|1|||
125375032|NCT00040664|451002309|FG000|Overall Study|Withdrawal by Subject|7|||
125375033|NCT00040664|451002310|FG001|Overall Study|Withdrawal by Subject|0|||
125375034|NCT00040664|451002311|FG002|Overall Study|Withdrawal by Subject|3|||
125375035|NCT00040664|451002312|FG003|Overall Study|Withdrawal by Subject|4|||
125375036|NCT00040664|451002309|FG000|Overall Study|Pregnancy|3|||
125375037|NCT00040664|451002310|FG001|Overall Study|Pregnancy|0|||
125627194|NCT01998958|451917450|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627195|NCT01998958|451917451|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627196|NCT01998958|451917452|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
125627197|NCT01998958|451917421|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627198|NCT01998958|451917422|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627199|NCT01998958|451917423|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627200|NCT01998958|451917424|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627201|NCT01998958|451917425|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627202|NCT01998958|451917426|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627203|NCT01998958|451917427|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627204|NCT01998958|451917428|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627205|NCT01998958|451917429|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627206|NCT01998958|451917430|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125433443|NCT02914314|451214487|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
125433444|NCT02914314|451214488|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
125433445|NCT02914314|451214489|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
125433446|NCT02914314|451214486|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
125433447|NCT02914314|451214487|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
125433448|NCT02914314|451214488|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
125433449|NCT02914314|451214489|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
125433450|NCT02914314|451214486|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
125433451|NCT02914314|451214487|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
125433452|NCT02914314|451214488|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
125433453|NCT02914314|451214489|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
125433454|NCT02914314|451214486|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
125433455|NCT02914314|451214487|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
125433456|NCT02914314|451214488|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
125433457|NCT02914314|451214489|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
125433458|NCT02914314|451214486|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
125433459|NCT02914314|451214487|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
125433460|NCT02914314|451214488|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
125433461|NCT02914314|451214489|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
125433462|NCT01306201|451214492|FG000|Overall Study|Arrhythmia|4|||
125433463|NCT01306201|451214492|FG000|Overall Study|Files could not be processed|3|||
125433464|NCT01306201|451214492|FG000|Overall Study|Files unreadable|3|||
125433465|NCT04702568|451214493|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
125433466|NCT04702568|451214494|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
125433467|NCT04702568|451214493|FG000|Overall Study|Pregnancy|1|||
125433468|NCT04702568|451214494|FG001|Overall Study|Pregnancy|0|||
125433469|NCT04702568|451214493|FG000|Overall Study|Bone marrow transplant|1|||
125433470|NCT04702568|451214494|FG001|Overall Study|Bone marrow transplant|0|||
125433471|NCT04702568|451214493|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
125433472|NCT04702568|451214494|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
125433473|NCT04702568|451214493|FG000|Overall Study|Withdrawal by Subject|0|||
125433474|NCT04702568|451214494|FG001|Overall Study|Withdrawal by Subject|2|||
125433475|NCT04599101|451214499|FG000|Overall Study|Lost to Follow-up|5|||
125433476|NCT04599101|451214500|FG001|Overall Study|Lost to Follow-up|5|||
125433477|NCT00098254|451214503|FG000|Overall Study|Adverse Event|2|||
125433478|NCT00098254|451214503|FG000|Overall Study|Death|1|||
125433479|NCT04146896|451214504|FG000|Overall Study|Adverse Event|5|||
125433480|NCT04146896|451214505|FG001|Overall Study|Adverse Event|8|||
125433481|NCT04146896|451214504|FG000|Overall Study|Lack of Efficacy|3|||
125433482|NCT04146896|451214505|FG001|Overall Study|Lack of Efficacy|2|||
125433483|NCT04146896|451214504|FG000|Overall Study|Lost to Follow-up|0|||
125433484|NCT04146896|451214505|FG001|Overall Study|Lost to Follow-up|1|||
125433485|NCT04146896|451214504|FG000|Overall Study|Non-compliance|5|||
125433486|NCT04146896|451214505|FG001|Overall Study|Non-compliance|4|||
125433487|NCT04146896|451214504|FG000|Overall Study|Withdrawal by Subject|3|||
125433488|NCT04146896|451214505|FG001|Overall Study|Withdrawal by Subject|5|||
125433489|NCT04146896|451214504|FG000|Overall Study|Randomized in error|1|||
125627207|NCT01998958|451917431|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627208|NCT01998958|451917432|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627209|NCT01998958|451917433|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627210|NCT01998958|451917434|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627211|NCT01998958|451917435|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125433490|NCT04146896|451214505|FG001|Overall Study|Randomized in error|2|||
125433491|NCT02118337|451214506|FG000|Overall Study|Other|1|||
125433492|NCT02118337|451214507|FG001|Overall Study|Other|0|||
125433493|NCT02118337|451214508|FG002|Overall Study|Other|0|||
125433494|NCT02118337|451214509|FG003|Overall Study|Other|0|||
125627212|NCT01998958|451917436|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627213|NCT01998958|451917437|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627214|NCT01998958|451917438|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627215|NCT01998958|451917439|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627216|NCT01998958|451917440|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627217|NCT01998958|451917441|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627218|NCT01998958|451917442|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
125627219|NCT01998958|451917443|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
125627220|NCT01998958|451917444|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
125627221|NCT01998958|451917445|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627222|NCT01998958|451917446|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627223|NCT01998958|451917447|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627224|NCT01998958|451917448|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627225|NCT01998958|451917449|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627226|NCT01998958|451917450|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627227|NCT01998958|451917451|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627228|NCT01998958|451917452|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
125627229|NCT01831804|451917457|FG000|Overall Study|Adverse Event|0|||
125627230|NCT01831804|451917458|FG001|Overall Study|Adverse Event|0|||
125627231|NCT01831804|451917459|FG002|Overall Study|Adverse Event|0|||
125627232|NCT01831804|451917460|FG003|Overall Study|Adverse Event|0|||
125627233|NCT01831804|451917461|FG004|Overall Study|Adverse Event|0|||
125627234|NCT01831804|451917462|FG005|Overall Study|Adverse Event|0|||
125627235|NCT01831804|451917463|FG006|Overall Study|Adverse Event|1|||
125627236|NCT01831804|451917464|FG007|Overall Study|Adverse Event|0|||
125627237|NCT01831804|451917465|FG008|Overall Study|Adverse Event|1|||
125627238|NCT01831804|451917457|FG000|Overall Study|Protocol Violation|0|||
125627239|NCT01831804|451917458|FG001|Overall Study|Protocol Violation|0|||
125627240|NCT01831804|451917459|FG002|Overall Study|Protocol Violation|2|||
125627241|NCT01831804|451917460|FG003|Overall Study|Protocol Violation|0|||
125627242|NCT01831804|451917461|FG004|Overall Study|Protocol Violation|0|||
125627243|NCT01831804|451917462|FG005|Overall Study|Protocol Violation|0|||
125627244|NCT01831804|451917463|FG006|Overall Study|Protocol Violation|0|||
125627245|NCT01831804|451917464|FG007|Overall Study|Protocol Violation|0|||
125627246|NCT01831804|451917465|FG008|Overall Study|Protocol Violation|0|||
125627247|NCT01831804|451917457|FG000|Overall Study|Protocol defined stopping criteria|1|||
125627248|NCT01831804|451917458|FG001|Overall Study|Protocol defined stopping criteria|1|||
125627249|NCT01831804|451917459|FG002|Overall Study|Protocol defined stopping criteria|3|||
125627250|NCT01831804|451917460|FG003|Overall Study|Protocol defined stopping criteria|0|||
125627251|NCT01831804|451917461|FG004|Overall Study|Protocol defined stopping criteria|1|||
125627252|NCT01831804|451917462|FG005|Overall Study|Protocol defined stopping criteria|0|||
125627253|NCT01831804|451917463|FG006|Overall Study|Protocol defined stopping criteria|0|||
125627254|NCT01831804|451917464|FG007|Overall Study|Protocol defined stopping criteria|0|||
125627255|NCT01831804|451917465|FG008|Overall Study|Protocol defined stopping criteria|0|||
125627256|NCT01831804|451917457|FG000|Overall Study|Lost to Follow-up|0|||
125627257|NCT01831804|451917458|FG001|Overall Study|Lost to Follow-up|0|||
125627258|NCT01831804|451917459|FG002|Overall Study|Lost to Follow-up|1|||
125627259|NCT01831804|451917460|FG003|Overall Study|Lost to Follow-up|0|||
125627260|NCT01831804|451917461|FG004|Overall Study|Lost to Follow-up|0|||
125627261|NCT01831804|451917462|FG005|Overall Study|Lost to Follow-up|0|||
125433495|NCT02118337|451214510|FG004|Overall Study|Other|2|||
125433496|NCT02118337|451214511|FG005|Overall Study|Other|3|||
125375038|NCT00040664|451002311|FG002|Overall Study|Pregnancy|0|||
125375039|NCT00040664|451002312|FG003|Overall Study|Pregnancy|3|||
125375040|NCT00040664|451002309|FG000|Overall Study|Medication adherence/compliance problems|8|||
125375041|NCT00040664|451002310|FG001|Overall Study|Medication adherence/compliance problems|2|||
125375042|NCT00040664|451002311|FG002|Overall Study|Medication adherence/compliance problems|1|||
125375043|NCT00040664|451002312|FG003|Overall Study|Medication adherence/compliance problems|5|||
125375044|NCT00040664|451002309|FG000|Overall Study|Poor taste|2|||
125375045|NCT00040664|451002310|FG001|Overall Study|Poor taste|0|||
125375046|NCT00040664|451002311|FG002|Overall Study|Poor taste|2|||
125375047|NCT00040664|451002312|FG003|Overall Study|Poor taste|0|||
125375048|NCT00040664|451002309|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
125375049|NCT00040664|451002310|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
125433497|NCT02118337|451214512|FG006|Overall Study|Other|1|||
125627262|NCT01831804|451917463|FG006|Overall Study|Lost to Follow-up|0|||
125627263|NCT01831804|451917464|FG007|Overall Study|Lost to Follow-up|0|||
125627264|NCT01831804|451917465|FG008|Overall Study|Lost to Follow-up|1|||
125627265|NCT01831804|451917457|FG000|Overall Study|Investigator discretion|0|||
125375050|NCT00040664|451002311|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
125375051|NCT00040664|451002312|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
125375052|NCT00040664|451002309|FG000|Overall Study|Change of formulation|2|||
125375053|NCT00040664|451002310|FG001|Overall Study|Change of formulation|2|||
125433498|NCT02118337|451214513|FG007|Overall Study|Other|28|||
125627266|NCT01831804|451917458|FG001|Overall Study|Investigator discretion|0|||
125627267|NCT01831804|451917459|FG002|Overall Study|Investigator discretion|0|||
125627268|NCT01831804|451917460|FG003|Overall Study|Investigator discretion|0|||
125627269|NCT01831804|451917461|FG004|Overall Study|Investigator discretion|1|||
125627270|NCT01831804|451917462|FG005|Overall Study|Investigator discretion|0|||
125627271|NCT01831804|451917463|FG006|Overall Study|Investigator discretion|0|||
125627272|NCT01831804|451917464|FG007|Overall Study|Investigator discretion|1|||
125627273|NCT01831804|451917465|FG008|Overall Study|Investigator discretion|0|||
125627274|NCT01831804|451917457|FG000|Overall Study|Withdrew Consent|0|||
125627275|NCT01831804|451917458|FG001|Overall Study|Withdrew Consent|1|||
125627276|NCT01831804|451917459|FG002|Overall Study|Withdrew Consent|0|||
125433499|NCT02118337|451214514|FG008|Overall Study|Other|15|||
125433500|NCT02118337|451214506|FG000|Overall Study|Lost to Follow-up|0|||
125433501|NCT02118337|451214507|FG001|Overall Study|Lost to Follow-up|0|||
125433502|NCT02118337|451214508|FG002|Overall Study|Lost to Follow-up|0|||
125433503|NCT02118337|451214509|FG003|Overall Study|Lost to Follow-up|0|||
125433504|NCT02118337|451214510|FG004|Overall Study|Lost to Follow-up|0|||
125433505|NCT02118337|451214511|FG005|Overall Study|Lost to Follow-up|0|||
125433506|NCT02118337|451214512|FG006|Overall Study|Lost to Follow-up|0|||
125433507|NCT02118337|451214513|FG007|Overall Study|Lost to Follow-up|1|||
125433508|NCT02118337|451214514|FG008|Overall Study|Lost to Follow-up|0|||
125433509|NCT02118337|451214506|FG000|Overall Study|Withdrawal by Subject|1|||
125433510|NCT02118337|451214507|FG001|Overall Study|Withdrawal by Subject|3|||
125433511|NCT02118337|451214508|FG002|Overall Study|Withdrawal by Subject|2|||
125433512|NCT02118337|451214509|FG003|Overall Study|Withdrawal by Subject|1|||
125433513|NCT02118337|451214510|FG004|Overall Study|Withdrawal by Subject|2|||
125433514|NCT02118337|451214511|FG005|Overall Study|Withdrawal by Subject|2|||
125433515|NCT02118337|451214512|FG006|Overall Study|Withdrawal by Subject|1|||
125433516|NCT02118337|451214513|FG007|Overall Study|Withdrawal by Subject|4|||
125433517|NCT02118337|451214514|FG008|Overall Study|Withdrawal by Subject|2|||
125433518|NCT02118337|451214506|FG000|Overall Study|Death|2|||
125433519|NCT02118337|451214507|FG001|Overall Study|Death|2|||
125433520|NCT02118337|451214508|FG002|Overall Study|Death|1|||
125433521|NCT02118337|451214509|FG003|Overall Study|Death|2|||
125433522|NCT02118337|451214510|FG004|Overall Study|Death|5|||
125433523|NCT02118337|451214511|FG005|Overall Study|Death|1|||
125433524|NCT02118337|451214512|FG006|Overall Study|Death|2|||
125433525|NCT02118337|451214513|FG007|Overall Study|Death|9|||
125433526|NCT02118337|451214514|FG008|Overall Study|Death|4|||
125433527|NCT01515189|451214516|FG000|Induction|Disease Progression|109|||
125433528|NCT01515189|451214517|FG001|Induction|Disease Progression|155|||
125433529|NCT01515189|451214516|FG000|Induction|Study drug toxicity|86|||
125433530|NCT01515189|451214517|FG001|Induction|Study drug toxicity|36|||
125433531|NCT01515189|451214516|FG000|Induction|Death|24|||
125433532|NCT01515189|451214517|FG001|Induction|Death|17|||
125433533|NCT01515189|451214516|FG000|Induction|Adverse Event|14|||
125433534|NCT01515189|451214517|FG001|Induction|Adverse Event|9|||
125433535|NCT01515189|451214516|FG000|Induction|Withdrawal by Subject|3|||
125433536|NCT01515189|451214517|FG001|Induction|Withdrawal by Subject|9|||
125433537|NCT01515189|451214516|FG000|Induction|No longer meets study criteria|0|||
125433538|NCT01515189|451214517|FG001|Induction|No longer meets study criteria|2|||
125433539|NCT01515189|451214516|FG000|Induction|Lost to Follow-up|1|||
125433540|NCT01515189|451214517|FG001|Induction|Lost to Follow-up|0|||
125433541|NCT01515189|451214516|FG000|Induction|Other|0|||
125433542|NCT01515189|451214517|FG001|Induction|Other|4|||
125433543|NCT01515189|451214516|FG000|First Re-Induction Phase|Disease progression|6|||
125433544|NCT01515189|451214517|FG001|First Re-Induction Phase|Disease progression|14|||
125433545|NCT01515189|451214516|FG000|First Re-Induction Phase|Study drug toxicity|5|||
125433546|NCT01515189|451214517|FG001|First Re-Induction Phase|Study drug toxicity|0|||
125433547|NCT01515189|451214516|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
125433548|NCT01515189|451214517|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
125433549|NCT01515189|451214516|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
125433550|NCT01515189|451214517|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
125433551|NCT01515189|451214516|FG000|First Re-Induction Phase|Other|1|||
125433552|NCT01515189|451214517|FG001|First Re-Induction Phase|Other|0|||
125433553|NCT01395823|451214522|FG000|Overall Study|Death|4|||
125433554|NCT01395823|451214523|FG001|Overall Study|Death|4|||
125433555|NCT01395823|451214522|FG000|Overall Study|Physician Decision|3|||
125433556|NCT01395823|451214523|FG001|Overall Study|Physician Decision|1|||
125433557|NCT01395823|451214522|FG000|Overall Study|Lost to Follow-up|1|||
125433558|NCT01395823|451214523|FG001|Overall Study|Lost to Follow-up|0|||
125433559|NCT01395823|451214522|FG000|Overall Study|Transplant|1|||
125433560|NCT01395823|451214523|FG001|Overall Study|Transplant|0|||
125433561|NCT01395823|451214522|FG000|Overall Study|GI symptoms|1|||
125433562|NCT01395823|451214523|FG001|Overall Study|GI symptoms|0|||
125433563|NCT01395823|451214522|FG000|Overall Study|Withdrawal by Subject|5|||
125433564|NCT01395823|451214523|FG001|Overall Study|Withdrawal by Subject|4|||
125433565|NCT05076149|451214524|FG000|Overall Study|Adverse Event|3|||
125627277|NCT01831804|451917460|FG003|Overall Study|Withdrew Consent|0|||
125627278|NCT01831804|451917461|FG004|Overall Study|Withdrew Consent|0|||
125433566|NCT05076149|451214525|FG001|Overall Study|Adverse Event|9|||
125433567|NCT05076149|451214524|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
125433568|NCT05076149|451214525|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
125433569|NCT05076149|451214524|FG000|Overall Study|Lost to Follow-up|0|||
125433570|NCT05076149|451214525|FG001|Overall Study|Lost to Follow-up|1|||
125433571|NCT05076149|451214524|FG000|Overall Study|Commercial drug is available for participant|0|||
125433572|NCT05076149|451214525|FG001|Overall Study|Commercial drug is available for participant|1|||
125433573|NCT05076149|451214524|FG000|Overall Study|Other non compliance|1|||
125433574|NCT05076149|451214525|FG001|Overall Study|Other non compliance|1|||
125433575|NCT05076149|451214524|FG000|Overall Study|Physician Decision|0|||
125433576|NCT05076149|451214525|FG001|Overall Study|Physician Decision|1|||
125433577|NCT05076149|451214524|FG000|Overall Study|Other|5|||
125433578|NCT05076149|451214525|FG001|Overall Study|Other|4|||
125433579|NCT02087501|451214526|FG000|Overall Study|Death|7|||
125433580|NCT02087501|451214526|FG000|Overall Study|Open repair of aneurysm|1|||
125433581|NCT02087501|451214526|FG000|Overall Study|Lost to Follow-up|2|||
125433582|NCT00094328|451214528|FG000|Overall Study|Lost to Follow-up|1|||
125433583|NCT00117156|451214529|FG000|Overall Study|Adverse Event|9|||
125433584|NCT00117156|451214529|FG000|Overall Study|Physician Decision|1|||
125433585|NCT00117156|451214529|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
125433586|NCT01919970|451214530|FG000|Overall Study|Withdrawal by Subject|3|||
125433587|NCT01919970|451214531|FG001|Overall Study|Withdrawal by Subject|0|||
125433588|NCT04043962|451214532|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
125433589|NCT04043962|451214532|FG000|Post-Treatment|Withdrawal by Subject|5|||
125433590|NCT04043962|451214532|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
125433591|NCT01126060|451214534|FG000|Overall Study|Protocol Violation|0|||
125433592|NCT01126060|451214535|FG001|Overall Study|Protocol Violation|2|||
125433593|NCT04631705|451214538|FG000|Overall Study|Withdrawal by Subject|0|||
125433594|NCT04631705|451214539|FG001|Overall Study|Withdrawal by Subject|0|||
125433595|NCT04631705|451214540|FG002|Overall Study|Withdrawal by Subject|0|||
125433596|NCT04631705|451214541|FG003|Overall Study|Withdrawal by Subject|0|||
125433597|NCT04631705|451214542|FG004|Overall Study|Withdrawal by Subject|0|||
125433598|NCT04631705|451214543|FG005|Overall Study|Withdrawal by Subject|0|||
125433599|NCT04631705|451214544|FG006|Overall Study|Withdrawal by Subject|1|||
125433600|NCT04631705|451214545|FG007|Overall Study|Withdrawal by Subject|0|||
125433601|NCT04631705|451214546|FG008|Overall Study|Withdrawal by Subject|0|||
125433602|NCT02130284|451214547|FG000|Overall Study|Withdrawal by Subject|3|||
125433603|NCT02130284|451214547|FG000|Overall Study|Subject Withdrew Consent|1|||
125433604|NCT02130284|451214547|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
125433605|NCT02130284|451214547|FG000|Overall Study|Subject was screened as backup for study|3|||
125433606|NCT02130284|451214547|FG000|Overall Study|Screen Failure|1|||
125433607|NCT01875185|451214548|FG000|Overall Study|study was terminated|52|||
125433608|NCT01875185|451214549|FG001|Overall Study|study was terminated|48|||
125433609|NCT01521884|451214550|FG000|Overall Study|Non Responders|10|||
125433610|NCT01521884|451214550|FG000|Overall Study|Adverse Event|5|||
125433611|NCT01521884|451214550|FG000|Overall Study|Pregnancy|1|||
125433612|NCT01521884|451214550|FG000|Overall Study|Withdrawal by Subject|1|||
125433613|NCT01521884|451214550|FG000|Overall Study|Physician Decision|2|||
125433614|NCT01521884|451214550|FG000|Overall Study|Protocol Violation|3|||
125433615|NCT01521884|451214550|FG000|Overall Study|Participant non-eligible|1|||
125433616|NCT01521884|451214550|FG000|Overall Study|Lost to Follow-up|4|||
125433617|NCT04838613|451214551|FG000|Overall Study|Withdrawal by Subject|3|||
125433618|NCT04838613|451214552|FG001|Overall Study|Withdrawal by Subject|6|||
125433619|NCT04838613|451214551|FG000|Overall Study|Protocol Deviation|3|||
125433620|NCT04838613|451214552|FG001|Overall Study|Protocol Deviation|2|||
125433621|NCT04838613|451214551|FG000|Overall Study|Technical Problems|0|||
125433622|NCT04838613|451214552|FG001|Overall Study|Technical Problems|5|||
125433623|NCT04838613|451214551|FG000|Overall Study|Physician Decision|2|||
125433624|NCT04838613|451214552|FG001|Overall Study|Physician Decision|0|||
125433625|NCT01686581|451214553|FG000|Overall Study|Side-effects or Health Problems|15|||
125433626|NCT01686581|451214553|FG000|Overall Study|Lack of Efficacy|90|||
125433627|NCT01686581|451214553|FG000|Overall Study|Participant Concerned about Risks|6|||
125433628|NCT01686581|451214553|FG000|Overall Study|Thinks Injections Too Painful|8|||
125433629|NCT01686581|451214553|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
125433630|NCT01686581|451214553|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
125433631|NCT01686581|451214553|FG000|Overall Study|Thinks it is Inconvenient|17|||
125433632|NCT01686581|451214553|FG000|Overall Study|Other Miscellaneous Reasons|36|||
125433633|NCT01686581|451214553|FG000|Overall Study|Reason Missing|1|||
125433634|NCT02217280|451214558|FG000|Overall Study|Withdrawal by Subject|2|||
125433635|NCT02217280|451214558|FG000|Overall Study|Post-consent sceen fail|2|||
125433636|NCT00736489|451214559|FG000|Period 1|Lost to Follow-up|1|||
125433637|NCT00736489|451214560|FG001|Period 1|Lost to Follow-up|0|||
125433638|NCT00736489|451214561|FG002|Period 1|Lost to Follow-up|0|||
125433639|NCT00736489|451214562|FG003|Period 1|Lost to Follow-up|0|||
125128395|NCT00376623|450096059|FG002|Overall Study|Increase of tumour markers|0|||
125433640|NCT00736489|451214563|FG004|Period 1|Lost to Follow-up|0|||
125433641|NCT00736489|451214564|FG005|Period 1|Lost to Follow-up|0|||
125433642|NCT00736489|451214559|FG000|Period 1|Withdrawal by Subject|0|||
125433643|NCT00736489|451214560|FG001|Period 1|Withdrawal by Subject|0|||
125433644|NCT00736489|451214561|FG002|Period 1|Withdrawal by Subject|0|||
125433645|NCT00736489|451214562|FG003|Period 1|Withdrawal by Subject|0|||
125433646|NCT00736489|451214563|FG004|Period 1|Withdrawal by Subject|0|||
125433647|NCT00736489|451214564|FG005|Period 1|Withdrawal by Subject|1|||
125433648|NCT01933880|451214565|FG000|Overall Study|Withdrawal by Subject|5|||
125433649|NCT01933880|451214566|FG001|Overall Study|Withdrawal by Subject|0|||
125433650|NCT01933880|451214565|FG000|Overall Study|Lack of Efficacy|1|||
125433651|NCT01933880|451214566|FG001|Overall Study|Lack of Efficacy|0|||
125433652|NCT01933880|451214565|FG000|Overall Study|Concomitant medication Interference|0|||
125433653|NCT01933880|451214566|FG001|Overall Study|Concomitant medication Interference|1|||
125433654|NCT01933880|451214565|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
125433655|NCT01933880|451214566|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
125433656|NCT01933880|451214565|FG000|Overall Study|Other|4|||
125433657|NCT01933880|451214566|FG001|Overall Study|Other|0|||
125433658|NCT01933880|451214565|FG000|Overall Study|Protocol Violation|1|||
125433659|NCT01933880|451214566|FG001|Overall Study|Protocol Violation|0|||
125433660|NCT02395133|451214567|FG000|Overall Study|Adverse Event|4|||
125433661|NCT02395133|451214568|FG001|Overall Study|Adverse Event|1|||
125433662|NCT02395133|451214569|FG002|Overall Study|Adverse Event|3|||
125433663|NCT02395133|451214570|FG003|Overall Study|Adverse Event|0|||
125433664|NCT02395133|451214567|FG000|Overall Study|Lack of Efficacy|1|||
125433665|NCT02395133|451214568|FG001|Overall Study|Lack of Efficacy|0|||
125433666|NCT02395133|451214569|FG002|Overall Study|Lack of Efficacy|1|||
125433667|NCT02395133|451214570|FG003|Overall Study|Lack of Efficacy|1|||
125433668|NCT02395133|451214567|FG000|Overall Study|Protocol Violation|1|||
125433669|NCT02395133|451214568|FG001|Overall Study|Protocol Violation|1|||
125433670|NCT02395133|451214569|FG002|Overall Study|Protocol Violation|0|||
125433671|NCT02395133|451214570|FG003|Overall Study|Protocol Violation|3|||
125433672|NCT02395133|451214567|FG000|Overall Study|Lost to Follow-up|0|||
125433673|NCT02395133|451214568|FG001|Overall Study|Lost to Follow-up|1|||
125433674|NCT02395133|451214569|FG002|Overall Study|Lost to Follow-up|1|||
125433675|NCT02395133|451214570|FG003|Overall Study|Lost to Follow-up|0|||
125433676|NCT02395133|451214567|FG000|Overall Study|Pregnancy|0|||
125433677|NCT02395133|451214568|FG001|Overall Study|Pregnancy|0|||
125433678|NCT02395133|451214569|FG002|Overall Study|Pregnancy|3|||
125433679|NCT02395133|451214570|FG003|Overall Study|Pregnancy|0|||
125433680|NCT02395133|451214567|FG000|Overall Study|Consent withdrawn with no reason given|1|||
125433681|NCT02395133|451214568|FG001|Overall Study|Consent withdrawn with no reason given|3|||
125433682|NCT02395133|451214569|FG002|Overall Study|Consent withdrawn with no reason given|0|||
125433683|NCT02395133|451214570|FG003|Overall Study|Consent withdrawn with no reason given|2|||
125433684|NCT02395133|451214567|FG000|Overall Study|Consent withdrawn with personal reason|0|||
125433685|NCT02395133|451214568|FG001|Overall Study|Consent withdrawn with personal reason|1|||
125433686|NCT02395133|451214569|FG002|Overall Study|Consent withdrawn with personal reason|0|||
125433687|NCT02395133|451214570|FG003|Overall Study|Consent withdrawn with personal reason|3|||
125433688|NCT02395133|451214567|FG000|Overall Study|Sponsor decision|2|||
125433689|NCT02395133|451214568|FG001|Overall Study|Sponsor decision|0|||
125433690|NCT02395133|451214569|FG002|Overall Study|Sponsor decision|0|||
125433691|NCT02395133|451214570|FG003|Overall Study|Sponsor decision|1|||
125433692|NCT02395133|451214567|FG000|Overall Study|Other than specified above|5|||
125433693|NCT02395133|451214568|FG001|Overall Study|Other than specified above|2|||
125433694|NCT02395133|451214569|FG002|Overall Study|Other than specified above|2|||
125433695|NCT02395133|451214570|FG003|Overall Study|Other than specified above|4|||
125433696|NCT00709059|451214572|FG000|Overall Study|Lost to Follow-up|34|||
125433697|NCT00709059|451214572|FG000|Overall Study|Withdrawal by Subject|19|||
125433698|NCT00709059|451214572|FG000|Overall Study|Physician Decision|7|||
125433699|NCT00709059|451214572|FG000|Overall Study|Disease complication|3|||
125433700|NCT00709059|451214572|FG000|Overall Study|Side effects|20|||
125433701|NCT00709059|451214572|FG000|Overall Study|Serious side effects|11|||
125433702|NCT00976703|451216162|FG000|Overall Study|Physician Decision|1|||
125433703|NCT00976703|451216163|FG001|Overall Study|Physician Decision|1|||
125433704|NCT00976703|451216162|FG000|Overall Study|ineligible for study|2|||
125433705|NCT00976703|451216163|FG001|Overall Study|ineligible for study|2|||
125433706|NCT02202434|451216164|FG000|Overall Study|Death|70|||
125433707|NCT02202434|451216165|FG001|Overall Study|Death|39|||
125433708|NCT02202434|451216166|FG002|Overall Study|Death|13|||
125433709|NCT02202434|451216167|FG003|Overall Study|Death|27|||
125433710|NCT02202434|451216164|FG000|Overall Study|Lost to Follow-up|1|||
125433711|NCT02202434|451216165|FG001|Overall Study|Lost to Follow-up|1|||
125433712|NCT02202434|451216166|FG002|Overall Study|Lost to Follow-up|1|||
125433713|NCT02202434|451216167|FG003|Overall Study|Lost to Follow-up|0|||
125433714|NCT02202434|451216164|FG000|Overall Study|Physician Decision|2|||
125433715|NCT02202434|451216165|FG001|Overall Study|Physician Decision|3|||
125433716|NCT02202434|451216166|FG002|Overall Study|Physician Decision|0|||
125375054|NCT00040664|451002311|FG002|Overall Study|Change of formulation|0|||
125375055|NCT00040664|451002312|FG003|Overall Study|Change of formulation|0|||
125375056|NCT00040664|451002309|FG000|Overall Study|Non-viability of oral suspension|1|||
125375057|NCT00040664|451002310|FG001|Overall Study|Non-viability of oral suspension|0|||
125375058|NCT00040664|451002311|FG002|Overall Study|Non-viability of oral suspension|1|||
125375059|NCT00040664|451002312|FG003|Overall Study|Non-viability of oral suspension|0|||
125375060|NCT02925494|451002313|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
125375061|NCT02925494|451002314|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
125375062|NCT02925494|451002315|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
125375063|NCT02925494|451002316|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
125375064|NCT02925494|451002313|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
125375065|NCT02925494|451002314|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
125375066|NCT02925494|451002315|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
125375067|NCT02925494|451002316|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
125375068|NCT02925494|451002313|FG000|Post-Treatment Follow-Up Period|Other|1|||
125375069|NCT02925494|451002314|FG001|Post-Treatment Follow-Up Period|Other|4|||
125375070|NCT02925494|451002315|FG002|Post-Treatment Follow-Up Period|Other|3|||
125375071|NCT02925494|451002316|FG003|Post-Treatment Follow-Up Period|Other|6|||
125375072|NCT02925494|451002313|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
125375073|NCT02925494|451002314|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
125375074|NCT02925494|451002315|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
125375075|NCT02925494|451002316|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
125375076|NCT02925494|451002313|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
125375077|NCT02925494|451002314|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
125375078|NCT02925494|451002315|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
125375079|NCT02925494|451002316|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
125375080|NCT02925494|451002313|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
125375081|NCT02925494|451002314|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
125375082|NCT02925494|451002315|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
125375083|NCT02925494|451002316|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
125375084|NCT02925494|451002313|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
125375085|NCT02925494|451002314|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
125375086|NCT02925494|451002315|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
125375087|NCT02925494|451002316|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
125375088|NCT06149247|451002321|FG000|Overall Study|Adverse Event|0|||
125375089|NCT06149247|451002322|FG001|Overall Study|Adverse Event|1|||
125375090|NCT05182125|451002323|FG000|Overall Study|Withdrawal by Subject|0|||
125375091|NCT05182125|451002324|FG001|Overall Study|Withdrawal by Subject|0|||
125375092|NCT05182125|451002325|FG002|Overall Study|Withdrawal by Subject|0|||
125375093|NCT05182125|451002326|FG003|Overall Study|Withdrawal by Subject|0|||
125375094|NCT05182125|451002327|FG004|Overall Study|Withdrawal by Subject|2|||
125375095|NCT05182125|451002328|FG005|Overall Study|Withdrawal by Subject|0|||
125375096|NCT05182125|451002323|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
125375097|NCT05182125|451002324|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
125375098|NCT05182125|451002325|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
125375099|NCT05182125|451002326|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
125375100|NCT05182125|451002327|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
125375101|NCT05182125|451002328|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
125375102|NCT05182125|451002323|FG000|Overall Study|Death|0|||
125375103|NCT05182125|451002324|FG001|Overall Study|Death|0|||
125375104|NCT05182125|451002325|FG002|Overall Study|Death|0|||
125375105|NCT05182125|451002326|FG003|Overall Study|Death|0|||
125375106|NCT05182125|451002327|FG004|Overall Study|Death|1|||
125375107|NCT05182125|451002328|FG005|Overall Study|Death|0|||
125375108|NCT05182125|451002323|FG000|Overall Study|Health Contact Follow-up|5|||
125375109|NCT05182125|451002324|FG001|Overall Study|Health Contact Follow-up|5|||
125375110|NCT05182125|451002325|FG002|Overall Study|Health Contact Follow-up|2|||
125375111|NCT05182125|451002326|FG003|Overall Study|Health Contact Follow-up|9|||
125375112|NCT05182125|451002327|FG004|Overall Study|Health Contact Follow-up|7|||
125375113|NCT05182125|451002328|FG005|Overall Study|Health Contact Follow-up|2|||
125375114|NCT01218243|451002329|FG000|Overall Study|Lack of Efficacy|1|||
125375115|NCT01218243|451002330|FG001|Overall Study|Lack of Efficacy|1|||
125375116|NCT01218243|451002329|FG000|Overall Study|Lost to Follow-up|3|||
125375117|NCT01218243|451002330|FG001|Overall Study|Lost to Follow-up|3|||
125375118|NCT01218243|451002329|FG000|Overall Study|Protocol Violation|5|||
125375119|NCT01218243|451002330|FG001|Overall Study|Protocol Violation|10|||
125375120|NCT02615145|451002332|FG000|Overall Study|Did Not Start Treatment|0|||
125375121|NCT02615145|451002333|FG001|Overall Study|Did Not Start Treatment|0|||
125627279|NCT01831804|451917462|FG005|Overall Study|Withdrew Consent|0|||
125627280|NCT01831804|451917463|FG006|Overall Study|Withdrew Consent|0|||
125375122|NCT02615145|451002334|FG002|Overall Study|Did Not Start Treatment|1|||
125375123|NCT02615145|451002335|FG003|Overall Study|Did Not Start Treatment|1|||
125627281|NCT01831804|451917464|FG007|Overall Study|Withdrew Consent|2|||
125433717|NCT02202434|451216167|FG003|Overall Study|Physician Decision|0|||
125433718|NCT02202434|451216164|FG000|Overall Study|Withdrawal by Subject|13|||
125433719|NCT02202434|451216165|FG001|Overall Study|Withdrawal by Subject|14|||
125433720|NCT02202434|451216166|FG002|Overall Study|Withdrawal by Subject|1|||
125433721|NCT02202434|451216167|FG003|Overall Study|Withdrawal by Subject|4|||
125433722|NCT02202434|451216164|FG000|Overall Study|Completed Study|1|||
125433723|NCT02202434|451216165|FG001|Overall Study|Completed Study|0|||
125627282|NCT01831804|451917465|FG008|Overall Study|Withdrew Consent|0|||
125627283|NCT00268463|451917468|FG000|Overall Study|study terminated due to low accrual|10|||
125627284|NCT00268463|451917469|FG001|Overall Study|study terminated due to low accrual|12|||
125627285|NCT02920450|451917470|FG000|Overall Study|Death|1|||
125627286|NCT02920450|451917471|FG001|Overall Study|Death|0|||
125627287|NCT02920450|451917472|FG002|Overall Study|Death|0|||
125627288|NCT02920450|451917473|FG003|Overall Study|Death|0|||
125627289|NCT02920450|451917470|FG000|Overall Study|Withdrawal by Subject|1|||
125627290|NCT02920450|451917471|FG001|Overall Study|Withdrawal by Subject|0|||
125627291|NCT02920450|451917472|FG002|Overall Study|Withdrawal by Subject|0|||
125627292|NCT02920450|451917473|FG003|Overall Study|Withdrawal by Subject|0|||
125627293|NCT00968708|451917476|FG000|Overall Study|Adverse Event|169|||
125627294|NCT00968708|451917477|FG001|Overall Study|Adverse Event|150|||
125433724|NCT02202434|451216166|FG002|Overall Study|Completed Study|0|||
125433725|NCT02202434|451216167|FG003|Overall Study|Completed Study|0|||
125433726|NCT02202434|451216164|FG000|Overall Study|Visit Missed|21|||
125433727|NCT02202434|451216165|FG001|Overall Study|Visit Missed|12|||
125433728|NCT02202434|451216166|FG002|Overall Study|Visit Missed|0|||
125433729|NCT02202434|451216167|FG003|Overall Study|Visit Missed|5|||
125433730|NCT02202434|451216164|FG000|Overall Study|Other|1|||
125433731|NCT02202434|451216165|FG001|Overall Study|Other|0|||
125433732|NCT02202434|451216166|FG002|Overall Study|Other|0|||
125433733|NCT02202434|451216167|FG003|Overall Study|Other|1|||
125433734|NCT03075501|451216168|FG000|Overall Study|Scheduling difficulties|15|||
125433735|NCT03075501|451216169|FG001|Overall Study|Scheduling difficulties|9|||
125433736|NCT01062763|451216173|FG000|Overall Study|Adverse Event|3|||
125433737|NCT01062763|451216174|FG001|Overall Study|Adverse Event|4|||
125433738|NCT02494921|451216175|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
125433739|NCT02494921|451216176|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
125433740|NCT02494921|451216177|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
125433741|NCT02494921|451216178|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
125433742|NCT02494921|451216179|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
125433743|NCT02494921|451216175|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
125433744|NCT02494921|451216176|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
125433745|NCT02494921|451216177|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
125433746|NCT02494921|451216178|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
125433747|NCT02494921|451216179|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
125433748|NCT02494921|451216175|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
125433749|NCT02494921|451216176|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
125433750|NCT02494921|451216177|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
125433751|NCT02494921|451216178|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
125433752|NCT02494921|451216179|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
125433753|NCT02714868|451216182|FG000|Overall Study|Withdrawal by Subject|3|||
125433754|NCT02714868|451216183|FG001|Overall Study|Withdrawal by Subject|0|||
125433755|NCT02714868|451216182|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
125433756|NCT02714868|451216183|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
125433757|NCT02714868|451216182|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
125433758|NCT02714868|451216183|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
125433759|NCT00369681|451216184|FG000|Overall Study|Death|1|||
125433760|NCT02948959|451216189|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
125433761|NCT02948959|451216190|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
125433762|NCT02948959|451216189|FG000|52 Weeks Treatment Period|Adverse Event|2|||
125433763|NCT02948959|451216190|FG001|52 Weeks Treatment Period|Adverse Event|5|||
125433764|NCT02948959|451216189|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
125433765|NCT02948959|451216190|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
125433766|NCT02948959|451216189|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
125433767|NCT02948959|451216190|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
125433768|NCT02948959|451216189|FG000|52 Weeks Treatment Period|Randomized by error|0|||
125433769|NCT02948959|451216190|FG001|52 Weeks Treatment Period|Randomized by error|5|||
125433770|NCT02948959|451216189|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
125433771|NCT02948959|451216190|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
125433772|NCT02948959|451216189|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
125433773|NCT02948959|451216190|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
125433774|NCT02948959|451216189|FG000|52 Weeks Treatment Period|Change of residence location|0|||
125433775|NCT02948959|451216190|FG001|52 Weeks Treatment Period|Change of residence location|1|||
125433776|NCT02948959|451216189|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
125627295|NCT00968708|451917476|FG000|Overall Study|Major Protocol Deviation|0|||
125433777|NCT02948959|451216190|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
125433778|NCT02948959|451216189|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
125433779|NCT02948959|451216190|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
125433780|NCT02948959|451216189|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
125433781|NCT02948959|451216190|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
125433782|NCT02948959|451216189|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
125433783|NCT02948959|451216190|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
125433784|NCT02948959|451216189|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
125433785|NCT02948959|451216190|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
125433786|NCT02948959|451216189|FG000|12 Weeks Follow-up Period|Study site closure|1|||
125433787|NCT02948959|451216190|FG001|12 Weeks Follow-up Period|Study site closure|0|||
125433788|NCT02508532|451216193|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125433789|NCT02508532|451216194|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125433790|NCT02508532|451216195|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125433791|NCT02508532|451216196|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125433792|NCT02508532|451216197|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125433793|NCT02508532|451216198|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125433794|NCT02508532|451216199|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
125433795|NCT02508532|451216200|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125433796|NCT02508532|451216201|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
125433797|NCT02508532|451216193|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
125433798|NCT02508532|451216194|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
125433799|NCT02508532|451216195|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
125433800|NCT02508532|451216196|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
125433801|NCT02508532|451216197|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
125433802|NCT02508532|451216198|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
125433803|NCT02508532|451216199|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
125433804|NCT02508532|451216200|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
125433805|NCT02508532|451216201|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
125433806|NCT02508532|451216193|FG000|Part 2 - Treatment|Disease Progression|0|||
125433807|NCT02508532|451216194|FG001|Part 2 - Treatment|Disease Progression|0|||
125433808|NCT02508532|451216195|FG002|Part 2 - Treatment|Disease Progression|0|||
125433809|NCT02508532|451216196|FG003|Part 2 - Treatment|Disease Progression|0|||
125433810|NCT02508532|451216197|FG004|Part 2 - Treatment|Disease Progression|0|||
125433811|NCT02508532|451216198|FG005|Part 2 - Treatment|Disease Progression|0|||
125433812|NCT02508532|451216199|FG006|Part 2 - Treatment|Disease Progression|0|||
125433813|NCT02508532|451216200|FG007|Part 2 - Treatment|Disease Progression|0|||
125433814|NCT02508532|451216201|FG008|Part 2 - Treatment|Disease Progression|118|||
125433815|NCT02508532|451216193|FG000|Part 2 - Treatment|Adverse Event|0|||
125433816|NCT02508532|451216194|FG001|Part 2 - Treatment|Adverse Event|0|||
125433817|NCT02508532|451216195|FG002|Part 2 - Treatment|Adverse Event|0|||
125433818|NCT02508532|451216196|FG003|Part 2 - Treatment|Adverse Event|0|||
125433819|NCT02508532|451216197|FG004|Part 2 - Treatment|Adverse Event|0|||
125433820|NCT02508532|451216198|FG005|Part 2 - Treatment|Adverse Event|0|||
125433821|NCT02508532|451216199|FG006|Part 2 - Treatment|Adverse Event|0|||
125433822|NCT02508532|451216200|FG007|Part 2 - Treatment|Adverse Event|0|||
125433823|NCT02508532|451216201|FG008|Part 2 - Treatment|Adverse Event|49|||
125433824|NCT02508532|451216193|FG000|Part 2 - Treatment|Physician Decision|0|||
125433825|NCT02508532|451216194|FG001|Part 2 - Treatment|Physician Decision|0|||
125627296|NCT00968708|451917477|FG001|Overall Study|Major Protocol Deviation|1|||
125627297|NCT00968708|451917476|FG000|Overall Study|Lost to Follow-up|19|||
125627298|NCT00968708|451917477|FG001|Overall Study|Lost to Follow-up|11|||
125627299|NCT00968708|451917476|FG000|Overall Study|Voluntary Withdrawal|104|||
125433826|NCT02508532|451216195|FG002|Part 2 - Treatment|Physician Decision|0|||
125433827|NCT02508532|451216196|FG003|Part 2 - Treatment|Physician Decision|0|||
125433828|NCT02508532|451216197|FG004|Part 2 - Treatment|Physician Decision|0|||
125433829|NCT02508532|451216198|FG005|Part 2 - Treatment|Physician Decision|0|||
125433830|NCT02508532|451216199|FG006|Part 2 - Treatment|Physician Decision|0|||
125433831|NCT02508532|451216200|FG007|Part 2 - Treatment|Physician Decision|0|||
125433832|NCT02508532|451216201|FG008|Part 2 - Treatment|Physician Decision|12|||
125433833|NCT02508532|451216193|FG000|Part 2 - Treatment|Administrative|0|||
125433834|NCT02508532|451216194|FG001|Part 2 - Treatment|Administrative|0|||
125433835|NCT02508532|451216195|FG002|Part 2 - Treatment|Administrative|0|||
125433836|NCT02508532|451216196|FG003|Part 2 - Treatment|Administrative|0|||
125433837|NCT02508532|451216197|FG004|Part 2 - Treatment|Administrative|0|||
125433838|NCT02508532|451216198|FG005|Part 2 - Treatment|Administrative|0|||
125433839|NCT02508532|451216199|FG006|Part 2 - Treatment|Administrative|0|||
125433840|NCT02508532|451216200|FG007|Part 2 - Treatment|Administrative|0|||
125433841|NCT02508532|451216201|FG008|Part 2 - Treatment|Administrative|3|||
125627300|NCT00968708|451917477|FG001|Overall Study|Voluntary Withdrawal|101|||
125627301|NCT00968708|451917476|FG000|Overall Study|Investigator Discretion|0|||
125627302|NCT00968708|451917477|FG001|Overall Study|Investigator Discretion|1|||
125627303|NCT00968708|451917476|FG000|Overall Study|Other|26|||
125375124|NCT02615145|451002332|FG000|Overall Study|Failure to Return|20|||
125375125|NCT02615145|451002333|FG001|Overall Study|Failure to Return|10|||
125375126|NCT02615145|451002334|FG002|Overall Study|Failure to Return|7|||
125375127|NCT02615145|451002335|FG003|Overall Study|Failure to Return|0|||
125375128|NCT02615145|451002332|FG000|Overall Study|Death|2|||
125375129|NCT02615145|451002333|FG001|Overall Study|Death|3|||
125375130|NCT02615145|451002334|FG002|Overall Study|Death|0|||
125375131|NCT02615145|451002335|FG003|Overall Study|Death|0|||
125375132|NCT02615145|451002332|FG000|Overall Study|Other, Not Specified|5|||
125375133|NCT02615145|451002333|FG001|Overall Study|Other, Not Specified|2|||
125375134|NCT02615145|451002334|FG002|Overall Study|Other, Not Specified|0|||
125375135|NCT02615145|451002335|FG003|Overall Study|Other, Not Specified|0|||
125375136|NCT03727347|451002336|FG000|Overall Study|Withdrawal by Subject|2|||
125375137|NCT03727347|451002336|FG000|Overall Study|Lost to Follow-up|1|||
125375138|NCT03200860|451002337|FG000|Overall Study|Withdrawal by Subject|1|||
125375139|NCT03200860|451002338|FG001|Overall Study|Withdrawal by Subject|0|||
125375140|NCT01744197|451002340|FG000|Overall Study|Received 1 patch|2|||
125375141|NCT01744197|451002341|FG001|Overall Study|Received 1 patch|1|||
125375142|NCT01744197|451002340|FG000|Overall Study|No patch received|2|||
125375143|NCT01744197|451002341|FG001|Overall Study|No patch received|2|||
125375144|NCT04342897|451002342|FG000|Overall Study|Death|7|||
125375145|NCT04342897|451002343|FG001|Overall Study|Death|4|||
125375146|NCT04342897|451002342|FG000|Overall Study|Lost to Follow-up|6|||
125375147|NCT04342897|451002343|FG001|Overall Study|Lost to Follow-up|6|||
125375148|NCT04342897|451002342|FG000|Overall Study|Withdrawal by Subject|1|||
125375149|NCT04342897|451002343|FG001|Overall Study|Withdrawal by Subject|2|||
125375150|NCT03199274|451002345|FG000|Overall Study|Withdrawal by Subject|4|||
125375151|NCT03199274|451002346|FG001|Overall Study|Withdrawal by Subject|0|||
125375152|NCT03199274|451002345|FG000|Overall Study|Lost to Follow-up|0|||
125375153|NCT03199274|451002346|FG001|Overall Study|Lost to Follow-up|1|||
125375154|NCT03199274|451002345|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
125375155|NCT03199274|451002346|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
125375156|NCT02846779|451002349|FG000|Overall Study|Lost Enrollment|83|||
125375157|NCT02846779|451002350|FG001|Overall Study|Lost Enrollment|82|||
125375158|NCT02846779|451002351|FG002|Overall Study|Lost Enrollment|86|||
125375159|NCT02846779|451002349|FG000|Overall Study|Less than 31 days of follow-up|56|||
125375160|NCT02846779|451002350|FG001|Overall Study|Less than 31 days of follow-up|45|||
125375161|NCT02846779|451002351|FG002|Overall Study|Less than 31 days of follow-up|52|||
125375162|NCT01325584|451002356|FG000|Overall Study|Death|1|||
125375163|NCT00887978|451002357|FG000|Overall Study|Adverse Event|18|||
125375164|NCT00887978|451002358|FG001|Overall Study|Adverse Event|5|||
125375165|NCT00887978|451002357|FG000|Overall Study|Clinical Worsening|4|||
125375166|NCT00887978|451002358|FG001|Overall Study|Clinical Worsening|4|||
125375167|NCT00887978|451002357|FG000|Overall Study|Death|2|||
125375168|NCT00887978|451002358|FG001|Overall Study|Death|3|||
125375169|NCT00887978|451002357|FG000|Overall Study|Withdrawal by Subject|1|||
125375170|NCT00887978|451002358|FG001|Overall Study|Withdrawal by Subject|2|||
125375171|NCT00887978|451002357|FG000|Overall Study|Lost to Follow-up|0|||
125375172|NCT00887978|451002358|FG001|Overall Study|Lost to Follow-up|1|||
125375173|NCT01943292|451003563|FG000|Overall Study|Withdrawal by Subject|1|||
125375174|NCT01943292|451003564|FG001|Overall Study|Withdrawal by Subject|0|||
125375175|NCT01943292|451003565|FG002|Overall Study|Withdrawal by Subject|0|||
125375176|NCT00638378|451003566|FG000|Overall Study|Death|2|||
125375177|NCT00638378|451003566|FG000|Overall Study|Adverse Event|1|||
125375178|NCT00638378|451003566|FG000|Overall Study|Disease progression|15|||
125375179|NCT00638378|451003566|FG000|Overall Study|Physician Decision|4|||
125375180|NCT00759031|451003567|FG000|First Intervention (1 Day)|Physician Decision|1|||
125375181|NCT00759031|451003568|FG001|First Intervention (1 Day)|Physician Decision|0|||
125375182|NCT00759031|451003567|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
125375183|NCT00759031|451003568|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
125375184|NCT00759031|451003567|FG000|First Intervention (1 Day)|Screening failure|1|||
125375185|NCT00759031|451003568|FG001|First Intervention (1 Day)|Screening failure|0|||
125375186|NCT00309387|451003571|FG000|Overall Study|Death|72|||
125375187|NCT00309387|451003572|FG001|Overall Study|Death|73|||
125375188|NCT00309387|451003571|FG000|Overall Study|Lost to Follow-up|70|||
125375189|NCT00309387|451003572|FG001|Overall Study|Lost to Follow-up|86|||
125375190|NCT02483520|451003574|FG000|Overall Study|Lost to Follow-up|3|||
125375191|NCT02483520|451003575|FG001|Overall Study|Lost to Follow-up|4|||
125375192|NCT02483520|451003574|FG000|Overall Study|Withdrawal by Subject|4|||
125375193|NCT02483520|451003575|FG001|Overall Study|Withdrawal by Subject|14|||
125375194|NCT02483520|451003574|FG000|Overall Study|Hospitalized|2|||
125375195|NCT02483520|451003575|FG001|Overall Study|Hospitalized|3|||
125375196|NCT02483520|451003574|FG000|Overall Study|Moved to LTC|2|||
125375197|NCT02483520|451003575|FG001|Overall Study|Moved to LTC|3|||
125375198|NCT04492618|451003577|FG000|Overall Study|Withdrawal by Subject|1|||
125375199|NCT01401283|451003578|FG000|Overall Study|surgery cancelled|5|||
125375200|NCT01401283|451003579|FG001|Overall Study|surgery cancelled|8|||
125433842|NCT02508532|451216193|FG000|Part 2 - Treatment|Sponsor Decision|0|||
125433843|NCT02508532|451216194|FG001|Part 2 - Treatment|Sponsor Decision|0|||
125433844|NCT02508532|451216195|FG002|Part 2 - Treatment|Sponsor Decision|0|||
125433845|NCT02508532|451216196|FG003|Part 2 - Treatment|Sponsor Decision|0|||
125433846|NCT02508532|451216197|FG004|Part 2 - Treatment|Sponsor Decision|0|||
125433847|NCT02508532|451216198|FG005|Part 2 - Treatment|Sponsor Decision|0|||
125433848|NCT02508532|451216199|FG006|Part 2 - Treatment|Sponsor Decision|0|||
125433849|NCT02508532|451216200|FG007|Part 2 - Treatment|Sponsor Decision|0|||
125433850|NCT02508532|451216201|FG008|Part 2 - Treatment|Sponsor Decision|28|||
125433851|NCT02508532|451216193|FG000|Part 2 - Treatment|Death|0|||
125433852|NCT02508532|451216194|FG001|Part 2 - Treatment|Death|0|||
125433853|NCT02508532|451216195|FG002|Part 2 - Treatment|Death|0|||
125433854|NCT02508532|451216196|FG003|Part 2 - Treatment|Death|0|||
125433855|NCT02508532|451216197|FG004|Part 2 - Treatment|Death|0|||
125433856|NCT02508532|451216198|FG005|Part 2 - Treatment|Death|0|||
125433857|NCT02508532|451216199|FG006|Part 2 - Treatment|Death|0|||
125433858|NCT02508532|451216200|FG007|Part 2 - Treatment|Death|0|||
125433859|NCT02508532|451216201|FG008|Part 2 - Treatment|Death|1|||
125433860|NCT02508532|451216193|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
125433861|NCT02508532|451216194|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
125433862|NCT02508532|451216195|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
125433863|NCT02508532|451216196|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
125433864|NCT02508532|451216197|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
125433865|NCT02508532|451216198|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
125433866|NCT02508532|451216199|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
125433867|NCT02508532|451216200|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
125433868|NCT02508532|451216201|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
125433869|NCT02508532|451216193|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
125433870|NCT02508532|451216194|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
125128396|NCT00376623|450096057|FG000|Overall Study|Bone metastasis|1|||
125433871|NCT02508532|451216195|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
125433872|NCT02508532|451216196|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
125433873|NCT02508532|451216197|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
125433874|NCT02508532|451216198|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
125433875|NCT02508532|451216199|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
125128397|NCT00376623|450096058|FG001|Overall Study|Bone metastasis|0|||
125128398|NCT00376623|450096059|FG002|Overall Study|Bone metastasis|0|||
125128399|NCT00286754|450096060|FG000|Overall Study|Adverse Event|2|||
125128400|NCT00286754|450096061|FG001|Overall Study|Adverse Event|2|||
125128401|NCT00286754|450096062|FG002|Overall Study|Adverse Event|3|||
125128402|NCT00286754|450096060|FG000|Overall Study|Withdrawal by Subject|6|||
125128403|NCT00286754|450096061|FG001|Overall Study|Withdrawal by Subject|2|||
125128404|NCT00286754|450096062|FG002|Overall Study|Withdrawal by Subject|0|||
125128405|NCT00286754|450096060|FG000|Overall Study|Lost to Follow-up|12|||
125128406|NCT00286754|450096061|FG001|Overall Study|Lost to Follow-up|14|||
125128407|NCT00286754|450096062|FG002|Overall Study|Lost to Follow-up|6|||
125128408|NCT00286754|450096060|FG000|Overall Study|Moved out of state|0|||
125128409|NCT00286754|450096061|FG001|Overall Study|Moved out of state|0|||
125128410|NCT00286754|450096062|FG002|Overall Study|Moved out of state|1|||
125128411|NCT00910663|450096063|FG000|Period 1|Withdrawal by Subject|0|||
125128412|NCT00910663|450096064|FG001|Period 1|Withdrawal by Subject|1|||
125128413|NCT02865850|450096065|FG000|Overall Study|Death|15|||
125128414|NCT02865850|450096066|FG001|Overall Study|Death|19|||
125128415|NCT02865850|450096065|FG000|Overall Study|Withdrawal by Subject|3|||
125128416|NCT02865850|450096066|FG001|Overall Study|Withdrawal by Subject|2|||
125128417|NCT02865850|450096065|FG000|Overall Study|Lost to Follow-up|3|||
125128418|NCT02865850|450096066|FG001|Overall Study|Lost to Follow-up|2|||
125128419|NCT02726581|450096067|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
125128420|NCT02726581|450096068|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
125128421|NCT02726581|450096069|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
125128422|NCT02726581|450096067|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
125128423|NCT02726581|450096068|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
125128424|NCT02726581|450096069|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
125128425|NCT02726581|450096067|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
125128426|NCT02726581|450096068|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125128427|NCT02726581|450096069|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125128428|NCT02726581|450096067|FG000|Treatment Period|Disease progression|47|||
125128429|NCT02726581|450096068|FG001|Treatment Period|Disease progression|50|||
125128430|NCT02726581|450096069|FG002|Treatment Period|Disease progression|16|||
125128431|NCT02726581|450096067|FG000|Treatment Period|Other reasons|9|||
125433876|NCT02508532|451216200|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
125433877|NCT02508532|451216201|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
125627304|NCT00968708|451917477|FG001|Overall Study|Other|34|||
125128432|NCT02726581|450096068|FG001|Treatment Period|Other reasons|8|||
125433878|NCT02508532|451216193|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
125433879|NCT02508532|451216194|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
125433880|NCT02508532|451216195|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
125433881|NCT02508532|451216196|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
125433882|NCT02508532|451216197|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
125433883|NCT02508532|451216198|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
125433884|NCT02508532|451216199|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
125433885|NCT02508532|451216200|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
125433886|NCT02508532|451216201|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
125433887|NCT02508532|451216193|FG000|Part 1 and Part 2 End of Study|Death|0|||
125433888|NCT02508532|451216194|FG001|Part 1 and Part 2 End of Study|Death|4|||
125433889|NCT02508532|451216195|FG002|Part 1 and Part 2 End of Study|Death|2|||
125433890|NCT02508532|451216196|FG003|Part 1 and Part 2 End of Study|Death|4|||
125433891|NCT02508532|451216197|FG004|Part 1 and Part 2 End of Study|Death|3|||
125433892|NCT02508532|451216198|FG005|Part 1 and Part 2 End of Study|Death|0|||
125433893|NCT02508532|451216199|FG006|Part 1 and Part 2 End of Study|Death|0|||
125433894|NCT02508532|451216200|FG007|Part 1 and Part 2 End of Study|Death|1|||
125433895|NCT02508532|451216201|FG008|Part 1 and Part 2 End of Study|Death|111|||
125433896|NCT02508532|451216193|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
125433897|NCT02508532|451216194|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
125433898|NCT02508532|451216195|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
125433899|NCT02508532|451216196|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
125433900|NCT02508532|451216197|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
125433901|NCT02508532|451216198|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
125433902|NCT02508532|451216199|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
125433903|NCT02508532|451216200|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
125433904|NCT02508532|451216201|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
125433905|NCT02508532|451216193|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125433906|NCT02508532|451216194|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125433907|NCT02508532|451216195|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125433908|NCT02508532|451216196|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125433909|NCT02508532|451216197|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125433910|NCT02508532|451216198|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125433911|NCT02508532|451216199|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125433912|NCT02508532|451216200|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
125433913|NCT02508532|451216201|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
125433914|NCT02508532|451216193|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
125433915|NCT02508532|451216194|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
125433916|NCT02508532|451216195|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
125433917|NCT02508532|451216196|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
125433918|NCT02508532|451216197|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
125433919|NCT02508532|451216198|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
125433920|NCT02508532|451216199|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
125433921|NCT02508532|451216200|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
125433922|NCT02508532|451216201|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
125433923|NCT02508532|451216193|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125433924|NCT02508532|451216194|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125433925|NCT02508532|451216195|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125433926|NCT02508532|451216196|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125433927|NCT02508532|451216197|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125433928|NCT02508532|451216198|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125433929|NCT02508532|451216199|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125433930|NCT02508532|451216200|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
125433931|NCT02508532|451216201|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
125433932|NCT02508532|451216193|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
125433933|NCT02508532|451216194|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
125433934|NCT02508532|451216195|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
125433935|NCT02508532|451216196|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
125433936|NCT02508532|451216197|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
125433937|NCT02508532|451216198|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
125433938|NCT02508532|451216199|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
125433939|NCT02508532|451216200|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
125433940|NCT02508532|451216201|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
125433941|NCT03097861|451216204|FG000|Overall Study|Adverse Event|3|||
125433942|NCT03097861|451216205|FG001|Overall Study|Adverse Event|8|||
125433943|NCT03097861|451216206|FG002|Overall Study|Adverse Event|4|||
125433944|NCT03097861|451216204|FG000|Overall Study|Investigator Decision|0|||
125627305|NCT01732107|451917478|FG000|Overall Study|Adverse Event|2|||
125627306|NCT01732107|451917478|FG000|Overall Study|Disease Progression|8|||
125433945|NCT03097861|451216205|FG001|Overall Study|Investigator Decision|1|||
125433946|NCT03097861|451216206|FG002|Overall Study|Investigator Decision|0|||
125433947|NCT03097861|451216204|FG000|Overall Study|Lost to Follow-up|0|||
125433948|NCT03097861|451216205|FG001|Overall Study|Lost to Follow-up|7|||
125433949|NCT03097861|451216206|FG002|Overall Study|Lost to Follow-up|1|||
125433950|NCT03097861|451216204|FG000|Overall Study|Withdrawal by Subject|1|||
125433951|NCT03097861|451216205|FG001|Overall Study|Withdrawal by Subject|5|||
125433952|NCT03097861|451216206|FG002|Overall Study|Withdrawal by Subject|3|||
125433953|NCT03097861|451216204|FG000|Overall Study|Reason not provided|3|||
125433954|NCT03097861|451216205|FG001|Overall Study|Reason not provided|1|||
125433955|NCT03097861|451216206|FG002|Overall Study|Reason not provided|1|||
125433956|NCT02281760|451216209|FG000|Overall Study|Withdrawal by Subject|1|||
125433957|NCT00154310|451216213|FG000|Overall Study|Adverse Event|19|||
125433958|NCT00154310|451216214|FG001|Overall Study|Adverse Event|9|||
125433959|NCT00154310|451216213|FG000|Overall Study|Lack of Efficacy|5|||
125433960|NCT00154310|451216214|FG001|Overall Study|Lack of Efficacy|4|||
125433961|NCT00154310|451216213|FG000|Overall Study|Protocol Violation|4|||
125433962|NCT00154310|451216214|FG001|Overall Study|Protocol Violation|2|||
125433963|NCT00154310|451216213|FG000|Overall Study|Withdrawal by Subject|9|||
125433964|NCT00154310|451216214|FG001|Overall Study|Withdrawal by Subject|3|||
125433965|NCT00154310|451216213|FG000|Overall Study|Lost to Follow-up|0|||
125433966|NCT00154310|451216214|FG001|Overall Study|Lost to Follow-up|8|||
125433967|NCT00154310|451216213|FG000|Overall Study|Administrative problems|0|||
125433968|NCT00154310|451216214|FG001|Overall Study|Administrative problems|1|||
125433969|NCT00154310|451216213|FG000|Overall Study|Death|0|||
125433970|NCT00154310|451216214|FG001|Overall Study|Death|1|||
125433971|NCT01346514|451216219|FG000|Overall Study|Lost to Follow-up|19|||
125433972|NCT01346514|451216220|FG001|Overall Study|Lost to Follow-up|30|||
125433973|NCT01346514|451216219|FG000|Overall Study|Withdrawal by Subject|7|||
125433974|NCT01346514|451216220|FG001|Overall Study|Withdrawal by Subject|3|||
125433975|NCT01346514|451216219|FG000|Overall Study|Death|3|||
125433976|NCT01346514|451216220|FG001|Overall Study|Death|4|||
125433977|NCT00152009|451216233|FG000|Overall Study|Adverse Event|9|||
125433978|NCT00152009|451216234|FG001|Overall Study|Adverse Event|13|||
125433979|NCT00152009|451216235|FG002|Overall Study|Adverse Event|20|||
125627307|NCT01732107|451917478|FG000|Overall Study|Physician Decision|1|||
125627308|NCT01732107|451917478|FG000|Overall Study|Withdrawal by Subject|2|||
125627309|NCT03407170|451917479|FG000|Overall Study|Adverse Event|1|||
125627310|NCT00615459|451917481|FG000|Period I|Adverse Event|2|||
125627311|NCT00615459|451917482|FG001|Period I|Adverse Event|0|||
125627312|NCT00615459|451917483|FG002|Period I|Adverse Event|1|||
125627313|NCT00615459|451917484|FG003|Period I|Adverse Event|0|||
125627314|NCT00615459|451917481|FG000|Period I|Subject withdrew consent|1|||
125627315|NCT00615459|451917482|FG001|Period I|Subject withdrew consent|0|||
125627316|NCT00615459|451917483|FG002|Period I|Subject withdrew consent|0|||
125627317|NCT00615459|451917484|FG003|Period I|Subject withdrew consent|1|||
125627318|NCT00615459|451917481|FG000|Period I|Abnormal test procedure results|1|||
125627319|NCT00615459|451917482|FG001|Period I|Abnormal test procedure results|1|||
125627320|NCT00615459|451917483|FG002|Period I|Abnormal test procedure results|1|||
125627321|NCT00615459|451917484|FG003|Period I|Abnormal test procedure results|0|||
125627322|NCT00615459|451917481|FG000|Period II|Adverse Event|1|||
125627323|NCT00615459|451917482|FG001|Period II|Adverse Event|0|||
125627324|NCT00615459|451917483|FG002|Period II|Adverse Event|0|||
125627325|NCT00615459|451917484|FG003|Period II|Adverse Event|0|||
125627326|NCT00615459|451917481|FG000|Period II|Lost to Follow-up|0|||
125627327|NCT00615459|451917482|FG001|Period II|Lost to Follow-up|0|||
125627328|NCT00615459|451917483|FG002|Period II|Lost to Follow-up|0|||
125627329|NCT00615459|451917484|FG003|Period II|Lost to Follow-up|1|||
125627330|NCT00615459|451917481|FG000|Period III|Adverse Event|0|||
125627331|NCT00615459|451917482|FG001|Period III|Adverse Event|1|||
125627332|NCT00615459|451917483|FG002|Period III|Adverse Event|0|||
125627333|NCT00615459|451917484|FG003|Period III|Adverse Event|0|||
125433980|NCT00152009|451216236|FG003|Overall Study|Adverse Event|1|||
125433981|NCT00152009|451216233|FG000|Overall Study|Protocol Violation|3|||
125433982|NCT00152009|451216234|FG001|Overall Study|Protocol Violation|0|||
125433983|NCT00152009|451216235|FG002|Overall Study|Protocol Violation|0|||
125433984|NCT00152009|451216236|FG003|Overall Study|Protocol Violation|1|||
125627334|NCT00615459|451917481|FG000|Period III|Administrative problems|0|||
125627335|NCT00615459|451917482|FG001|Period III|Administrative problems|1|||
125627336|NCT00615459|451917483|FG002|Period III|Administrative problems|1|||
125433985|NCT00152009|451216233|FG000|Overall Study|Withdrawal by Subject|2|||
125433986|NCT00152009|451216234|FG001|Overall Study|Withdrawal by Subject|3|||
125433987|NCT00152009|451216235|FG002|Overall Study|Withdrawal by Subject|4|||
125433988|NCT00152009|451216236|FG003|Overall Study|Withdrawal by Subject|9|||
125433989|NCT00152009|451216233|FG000|Overall Study|Lost to Follow-up|2|||
125433990|NCT00152009|451216234|FG001|Overall Study|Lost to Follow-up|4|||
125433991|NCT00152009|451216235|FG002|Overall Study|Lost to Follow-up|3|||
125433992|NCT00152009|451216236|FG003|Overall Study|Lost to Follow-up|3|||
125433993|NCT00152009|451216233|FG000|Overall Study|Lack of Efficacy|8|||
125433994|NCT00152009|451216234|FG001|Overall Study|Lack of Efficacy|6|||
125433995|NCT00152009|451216235|FG002|Overall Study|Lack of Efficacy|7|||
125433996|NCT00152009|451216236|FG003|Overall Study|Lack of Efficacy|15|||
125433997|NCT00152009|451216233|FG000|Overall Study|ECG abnormalities|2|||
125433998|NCT00152009|451216234|FG001|Overall Study|ECG abnormalities|2|||
125433999|NCT00152009|451216235|FG002|Overall Study|ECG abnormalities|2|||
125434000|NCT00152009|451216236|FG003|Overall Study|ECG abnormalities|1|||
125434001|NCT00152009|451216233|FG000|Overall Study|Sponsor's decision|3|||
125434002|NCT00152009|451216234|FG001|Overall Study|Sponsor's decision|3|||
125434003|NCT00152009|451216235|FG002|Overall Study|Sponsor's decision|1|||
125434004|NCT00152009|451216236|FG003|Overall Study|Sponsor's decision|3|||
125434005|NCT00393523|451216237|FG000|Overall Study|Lost to Follow-up|0|||
125434006|NCT00393523|451216238|FG001|Overall Study|Lost to Follow-up|0|||
125434007|NCT00393523|451216239|FG002|Overall Study|Lost to Follow-up|0|||
125434008|NCT00393523|451216240|FG003|Overall Study|Lost to Follow-up|2|||
125434009|NCT00393523|451216241|FG004|Overall Study|Lost to Follow-up|1|||
125434010|NCT00393523|451216237|FG000|Overall Study|Protocol Violation|6|||
125434011|NCT00393523|451216238|FG001|Overall Study|Protocol Violation|2|||
125434012|NCT00393523|451216239|FG002|Overall Study|Protocol Violation|0|||
125434013|NCT00393523|451216240|FG003|Overall Study|Protocol Violation|1|||
125434014|NCT00393523|451216241|FG004|Overall Study|Protocol Violation|0|||
125434015|NCT00393523|451216237|FG000|Overall Study|Withdrawal by Subject|6|||
125434016|NCT00393523|451216238|FG001|Overall Study|Withdrawal by Subject|7|||
125434017|NCT00393523|451216239|FG002|Overall Study|Withdrawal by Subject|2|||
125434018|NCT00393523|451216240|FG003|Overall Study|Withdrawal by Subject|3|||
125434019|NCT00393523|451216241|FG004|Overall Study|Withdrawal by Subject|0|||
125434020|NCT00393523|451216237|FG000|Overall Study|Difficulties in specimen collection|0|||
125434021|NCT00393523|451216238|FG001|Overall Study|Difficulties in specimen collection|0|||
125434022|NCT00393523|451216239|FG002|Overall Study|Difficulties in specimen collection|1|||
125434023|NCT00393523|451216240|FG003|Overall Study|Difficulties in specimen collection|0|||
125434024|NCT00393523|451216241|FG004|Overall Study|Difficulties in specimen collection|0|||
125434025|NCT00393523|451216237|FG000|Overall Study|Vaccine supply issue|0|||
125434026|NCT00393523|451216238|FG001|Overall Study|Vaccine supply issue|0|||
125434027|NCT00393523|451216239|FG002|Overall Study|Vaccine supply issue|1|||
125434028|NCT00393523|451216240|FG003|Overall Study|Vaccine supply issue|0|||
125434029|NCT00393523|451216241|FG004|Overall Study|Vaccine supply issue|0|||
125434030|NCT04772053|451216246|FG000|Overall Study|Physician Decision|2|||
125434031|NCT04772053|451216246|FG000|Overall Study|Withdrawal by Subject|3|||
125434032|NCT04772053|451216246|FG000|Overall Study|Study Terminated by Sponsor|1|||
125434033|NCT03787680|451216250|FG000|Overall Study|Physician Decision|2|||
125434034|NCT03787680|451216251|FG001|Overall Study|Physician Decision|3|||
125434035|NCT03787680|451216250|FG000|Overall Study|Adverse Event|7|||
125434036|NCT03787680|451216251|FG001|Overall Study|Adverse Event|3|||
125434037|NCT03787680|451216250|FG000|Overall Study|Withdrawal by Subject|2|||
125434038|NCT03787680|451216251|FG001|Overall Study|Withdrawal by Subject|1|||
125434039|NCT00594217|451216252|FG000|Overall Study|Withdrawal by Subject|1|||
125434040|NCT00594217|451216253|FG001|Overall Study|Withdrawal by Subject|3|||
125434041|NCT00943306|451216254|FG000|Overall Study|Physician Decision|1|||
125434042|NCT00943306|451216254|FG000|Overall Study|Death|1|||
125434043|NCT00943306|451216254|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
125434044|NCT01036022|451216255|FG000|Overall Study|Adverse Event|1|||
125434045|NCT01036022|451216256|FG001|Overall Study|Adverse Event|3|||
125627337|NCT00615459|451917484|FG003|Period III|Administrative problems|0|||
125627338|NCT00615459|451917481|FG000|Period III|Unsatisfactory therapeutic effect|0|||
125627339|NCT00615459|451917482|FG001|Period III|Unsatisfactory therapeutic effect|1|||
125627340|NCT00615459|451917483|FG002|Period III|Unsatisfactory therapeutic effect|0|||
125627341|NCT00615459|451917484|FG003|Period III|Unsatisfactory therapeutic effect|0|||
125627342|NCT02076334|451917487|FG000|Overall Study|Protocol Violation|1|||
125627343|NCT02076334|451917488|FG001|Overall Study|Protocol Violation|0|||
125627344|NCT02076334|451917489|FG002|Overall Study|Protocol Violation|0|||
125627345|NCT02076334|451917490|FG003|Overall Study|Protocol Violation|0|||
125627346|NCT02076334|451917487|FG000|Overall Study|Lost to Follow-up|0|||
125627347|NCT02076334|451917488|FG001|Overall Study|Lost to Follow-up|1|||
125627348|NCT02076334|451917489|FG002|Overall Study|Lost to Follow-up|1|||
125627349|NCT02076334|451917490|FG003|Overall Study|Lost to Follow-up|0|||
125627350|NCT02076334|451917487|FG000|Overall Study|muscle soreness|0|||
125627351|NCT02076334|451917488|FG001|Overall Study|muscle soreness|0|||
125627352|NCT02076334|451917489|FG002|Overall Study|muscle soreness|0|||
125627353|NCT02076334|451917490|FG003|Overall Study|muscle soreness|1|||
125627354|NCT03238352|451917491|FG000|Overall Study|Lost to Follow-up|0|||
125627355|NCT03238352|451917492|FG001|Overall Study|Lost to Follow-up|2|||
125627356|NCT03238352|451917493|FG002|Overall Study|Lost to Follow-up|1|||
125627357|NCT03238352|451917491|FG000|Overall Study|Withdrawal by Subject|0|||
125627358|NCT03238352|451917492|FG001|Overall Study|Withdrawal by Subject|1|||
125627359|NCT03238352|451917493|FG002|Overall Study|Withdrawal by Subject|0|||
125627360|NCT01296698|451917494|FG000|Overall Study|Adverse Event|1|||
125627361|NCT01296698|451917495|FG001|Overall Study|Adverse Event|0|||
125627362|NCT01296698|451917494|FG000|Overall Study|Death|1|||
125627363|NCT01296698|451917495|FG001|Overall Study|Death|0|||
125627364|NCT01296698|451917494|FG000|Overall Study|Lost to Follow-up|19|||
125627365|NCT01296698|451917495|FG001|Overall Study|Lost to Follow-up|1|||
125627366|NCT01296698|451917494|FG000|Overall Study|Withdrawal by Subject|12|||
125627367|NCT01296698|451917495|FG001|Overall Study|Withdrawal by Subject|0|||
125627368|NCT01296698|451917494|FG000|Overall Study|Difficulty Contacting Subject|2|||
125627369|NCT01296698|451917495|FG001|Overall Study|Difficulty Contacting Subject|0|||
125627370|NCT01296698|451917494|FG000|Overall Study|Study Terminated by Sponsor|209|||
125627371|NCT01296698|451917495|FG001|Overall Study|Study Terminated by Sponsor|12|||
125627372|NCT01975675|451917496|FG000|Overall Study|Death|0|||
125627373|NCT01975675|451917497|FG001|Overall Study|Death|1|||
125627374|NCT01975675|451917498|FG002|Overall Study|Death|0|||
125627375|NCT01975675|451917499|FG003|Overall Study|Death|0|||
125627376|NCT00224003|451917500|FG000|Overall Study|Adverse Event|1|||
125627377|NCT00224003|451917500|FG000|Overall Study|Protocol Violation|2|||
125627378|NCT00224003|451917500|FG000|Overall Study|Withdrawal by Subject|1|||
125627379|NCT00224003|451917500|FG000|Overall Study|unk|3|||
125627380|NCT01202760|451917501|FG000|Overall Study|Entry Criteria Not Met|0|||
125627381|NCT01202760|451917502|FG001|Overall Study|Entry Criteria Not Met|3|||
125627382|NCT01202760|451917503|FG002|Overall Study|Entry Criteria Not Met|1|||
125627383|NCT01202760|451917501|FG000|Overall Study|Adverse Event|11|||
125627384|NCT01202760|451917502|FG001|Overall Study|Adverse Event|9|||
125627385|NCT01202760|451917503|FG002|Overall Study|Adverse Event|10|||
125627386|NCT01202760|451917501|FG000|Overall Study|Death|2|||
125627387|NCT01202760|451917502|FG001|Overall Study|Death|1|||
125627388|NCT01202760|451917503|FG002|Overall Study|Death|0|||
125627389|NCT01202760|451917501|FG000|Overall Study|Lack of Efficacy|6|||
125627390|NCT01202760|451917502|FG001|Overall Study|Lack of Efficacy|8|||
125627391|NCT01202760|451917503|FG002|Overall Study|Lack of Efficacy|7|||
125627392|NCT01202760|451917501|FG000|Overall Study|Lost to Follow-up|0|||
125215586|NCT00902746|450417445|FG000|Overall Study|Withdrawal by Subject|16|||
125434046|NCT01036022|451216257|FG002|Overall Study|Adverse Event|2|||
125434047|NCT01036022|451216258|FG003|Overall Study|Adverse Event|1|||
125434048|NCT01036022|451216259|FG004|Overall Study|Adverse Event|0|||
125434049|NCT01036022|451216260|FG005|Overall Study|Adverse Event|2|||
125434050|NCT01036022|451216255|FG000|Overall Study|Lack of Efficacy|1|||
125434051|NCT01036022|451216256|FG001|Overall Study|Lack of Efficacy|1|||
125434052|NCT01036022|451216257|FG002|Overall Study|Lack of Efficacy|1|||
125434053|NCT01036022|451216258|FG003|Overall Study|Lack of Efficacy|0|||
125434054|NCT01036022|451216259|FG004|Overall Study|Lack of Efficacy|1|||
125434055|NCT01036022|451216260|FG005|Overall Study|Lack of Efficacy|1|||
125434056|NCT01036022|451216255|FG000|Overall Study|Physician Decision|0|||
125434057|NCT01036022|451216256|FG001|Overall Study|Physician Decision|0|||
125434058|NCT01036022|451216257|FG002|Overall Study|Physician Decision|1|||
125434059|NCT01036022|451216258|FG003|Overall Study|Physician Decision|0|||
125434060|NCT01036022|451216259|FG004|Overall Study|Physician Decision|0|||
125434061|NCT01036022|451216260|FG005|Overall Study|Physician Decision|0|||
125434062|NCT01036022|451216255|FG000|Overall Study|Withdrawal by Subject|0|||
125434063|NCT01036022|451216256|FG001|Overall Study|Withdrawal by Subject|0|||
125434064|NCT01036022|451216257|FG002|Overall Study|Withdrawal by Subject|0|||
125434065|NCT01036022|451216258|FG003|Overall Study|Withdrawal by Subject|1|||
125434066|NCT01036022|451216259|FG004|Overall Study|Withdrawal by Subject|2|||
125434067|NCT01036022|451216260|FG005|Overall Study|Withdrawal by Subject|0|||
125434068|NCT00576732|451216261|FG000|DOUBLE BLIND|Adverse Event|0|||
125434069|NCT00576732|451216262|FG001|DOUBLE BLIND|Adverse Event|0|||
125434070|NCT00576732|451216263|FG002|DOUBLE BLIND|Adverse Event|1|||
125434071|NCT00576732|451216264|FG003|DOUBLE BLIND|Adverse Event|0|||
125434072|NCT00576732|451216265|FG004|DOUBLE BLIND|Adverse Event|0|||
125434073|NCT00576732|451216266|FG005|DOUBLE BLIND|Adverse Event|0|||
125434074|NCT00576732|451216261|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
125434075|NCT00576732|451216262|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
125434076|NCT00576732|451216263|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
125434077|NCT00576732|451216264|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
125434078|NCT00576732|451216265|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
125434079|NCT00576732|451216266|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
125434080|NCT00576732|451216261|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
125434081|NCT00576732|451216262|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
125627393|NCT01202760|451917502|FG001|Overall Study|Lost to Follow-up|2|||
125627394|NCT01202760|451917503|FG002|Overall Study|Lost to Follow-up|1|||
125627395|NCT01202760|451917501|FG000|Overall Study|Parent / Caregiver Decision|0|||
125434082|NCT00576732|451216263|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
125434083|NCT00576732|451216264|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
125434084|NCT00576732|451216265|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
125434085|NCT00576732|451216266|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
125434086|NCT00576732|451216261|FG000|DOUBLE BLIND|OTHER|0|||
125434087|NCT00576732|451216262|FG001|DOUBLE BLIND|OTHER|2|||
125627396|NCT01202760|451917502|FG001|Overall Study|Parent / Caregiver Decision|1|||
125627397|NCT01202760|451917503|FG002|Overall Study|Parent / Caregiver Decision|0|||
125627398|NCT01202760|451917501|FG000|Overall Study|Withdrawal by Subject|17|||
125434088|NCT00576732|451216263|FG002|DOUBLE BLIND|OTHER|1|||
125434089|NCT00576732|451216264|FG003|DOUBLE BLIND|OTHER|0|||
125434090|NCT00576732|451216265|FG004|DOUBLE BLIND|OTHER|0|||
125434091|NCT00576732|451216266|FG005|DOUBLE BLIND|OTHER|0|||
125434092|NCT00576732|451216261|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
125627399|NCT01202760|451917502|FG001|Overall Study|Withdrawal by Subject|18|||
125627400|NCT01202760|451917503|FG002|Overall Study|Withdrawal by Subject|14|||
125627401|NCT01202760|451917501|FG000|Overall Study|Physician Decision|0|||
125627402|NCT01202760|451917502|FG001|Overall Study|Physician Decision|1|||
125627403|NCT01202760|451917503|FG002|Overall Study|Physician Decision|0|||
125627404|NCT01202760|451917501|FG000|Overall Study|Protocol Violation|7|||
125627405|NCT01202760|451917502|FG001|Overall Study|Protocol Violation|5|||
125627406|NCT01202760|451917503|FG002|Overall Study|Protocol Violation|2|||
125627407|NCT01202760|451917501|FG000|Overall Study|Sponsor Decision|4|||
125434093|NCT00576732|451216262|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
125434094|NCT00576732|451216263|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
125434095|NCT00576732|451216264|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
125434096|NCT00576732|451216265|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
125434097|NCT00576732|451216266|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
125434098|NCT00576732|451216261|FG000|DOUBLE BLIND|Protocol Violation|1|||
125434099|NCT00576732|451216262|FG001|DOUBLE BLIND|Protocol Violation|0|||
125434100|NCT00576732|451216263|FG002|DOUBLE BLIND|Protocol Violation|0|||
125434101|NCT00576732|451216264|FG003|DOUBLE BLIND|Protocol Violation|0|||
125434102|NCT00576732|451216265|FG004|DOUBLE BLIND|Protocol Violation|0|||
125434103|NCT00576732|451216266|FG005|DOUBLE BLIND|Protocol Violation|0|||
125434104|NCT00576732|451216261|FG000|OPEN LABEL|Adverse Event|0|||
125434105|NCT00576732|451216262|FG001|OPEN LABEL|Adverse Event|0|||
125434106|NCT00576732|451216263|FG002|OPEN LABEL|Adverse Event|0|||
125434107|NCT00576732|451216264|FG003|OPEN LABEL|Adverse Event|4|||
125434108|NCT00576732|451216265|FG004|OPEN LABEL|Adverse Event|0|||
125434109|NCT00576732|451216266|FG005|OPEN LABEL|Adverse Event|1|||
125434110|NCT00576732|451216261|FG000|OPEN LABEL|Lost to Follow-up|0|||
125434111|NCT00576732|451216262|FG001|OPEN LABEL|Lost to Follow-up|0|||
125434112|NCT00576732|451216263|FG002|OPEN LABEL|Lost to Follow-up|0|||
125434113|NCT00576732|451216264|FG003|OPEN LABEL|Lost to Follow-up|2|||
125627408|NCT01202760|451917502|FG001|Overall Study|Sponsor Decision|4|||
125627409|NCT01202760|451917503|FG002|Overall Study|Sponsor Decision|0|||
125627410|NCT00871572|451917504|FG000|Overall Study|Adverse Event|0|||
125434114|NCT00576732|451216265|FG004|OPEN LABEL|Lost to Follow-up|1|||
125434115|NCT00576732|451216266|FG005|OPEN LABEL|Lost to Follow-up|1|||
125434116|NCT00576732|451216261|FG000|OPEN LABEL|Withdrawal by Subject|0|||
125434117|NCT00576732|451216262|FG001|OPEN LABEL|Withdrawal by Subject|0|||
125434118|NCT00576732|451216263|FG002|OPEN LABEL|Withdrawal by Subject|0|||
125434119|NCT00576732|451216264|FG003|OPEN LABEL|Withdrawal by Subject|1|||
125434120|NCT00576732|451216265|FG004|OPEN LABEL|Withdrawal by Subject|0|||
125434121|NCT00576732|451216266|FG005|OPEN LABEL|Withdrawal by Subject|1|||
125434122|NCT00576732|451216261|FG000|OPEN LABEL|OTHER|0|||
125434123|NCT00576732|451216262|FG001|OPEN LABEL|OTHER|0|||
125434124|NCT00576732|451216263|FG002|OPEN LABEL|OTHER|0|||
125434125|NCT00576732|451216264|FG003|OPEN LABEL|OTHER|0|||
125434126|NCT00576732|451216265|FG004|OPEN LABEL|OTHER|0|||
125434127|NCT00576732|451216266|FG005|OPEN LABEL|OTHER|2|||
125434128|NCT00576732|451216261|FG000|OPEN LABEL|Lack of Efficacy|0|||
125434129|NCT00576732|451216262|FG001|OPEN LABEL|Lack of Efficacy|0|||
125434130|NCT00576732|451216263|FG002|OPEN LABEL|Lack of Efficacy|0|||
125434131|NCT00576732|451216264|FG003|OPEN LABEL|Lack of Efficacy|2|||
125434132|NCT00576732|451216265|FG004|OPEN LABEL|Lack of Efficacy|2|||
125434133|NCT00576732|451216266|FG005|OPEN LABEL|Lack of Efficacy|3|||
125434134|NCT00576732|451216261|FG000|OPEN LABEL|Protocol Violation|0|||
125434135|NCT00576732|451216262|FG001|OPEN LABEL|Protocol Violation|0|||
125434136|NCT00576732|451216263|FG002|OPEN LABEL|Protocol Violation|0|||
125434137|NCT00576732|451216264|FG003|OPEN LABEL|Protocol Violation|2|||
125434138|NCT00576732|451216265|FG004|OPEN LABEL|Protocol Violation|1|||
125434139|NCT00576732|451216266|FG005|OPEN LABEL|Protocol Violation|0|||
125434140|NCT02213328|451216269|FG000|Overall Study|Withdrawal by Subject|10|||
125434141|NCT02213328|451216269|FG000|Overall Study|Physician Decision|2|||
125434142|NCT02213328|451216269|FG000|Overall Study|Lost to Follow-up|16|||
125434143|NCT02487095|451216272|FG000|Dose Expansion|Unable to scan/restage participant|0|||
125434144|NCT02487095|451216273|FG001|Dose Expansion|Unable to scan/restage participant|0|||
125434145|NCT02487095|451216274|FG002|Dose Expansion|Unable to scan/restage participant|0|||
125434146|NCT02487095|451216275|FG003|Dose Expansion|Unable to scan/restage participant|0|||
125434147|NCT02487095|451216276|FG004|Dose Expansion|Unable to scan/restage participant|1|||
125434148|NCT01807650|451216277|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
125434149|NCT01807650|451216277|FG000|Overall Study|Adverse Event|5|||
125627411|NCT00871572|451917505|FG001|Overall Study|Adverse Event|2|||
125434150|NCT01807650|451216277|FG000|Overall Study|Other|2|||
125434151|NCT00962247|451216280|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
125434152|NCT00962247|451216280|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
125434153|NCT02234063|451216281|FG000|Overall Study|Lost to Follow-up|235|||
125434154|NCT02234063|451216282|FG001|Overall Study|Lost to Follow-up|42|||
125434155|NCT02234063|451216281|FG000|Overall Study|Withdrawal by Subject|20|||
125434156|NCT02234063|451216282|FG001|Overall Study|Withdrawal by Subject|1|||
125434157|NCT02946918|451216283|FG000|Overall Study|Patient unblinded himself|1|||
125434158|NCT02946918|451216284|FG001|Overall Study|Patient unblinded himself|0|||
125434159|NCT02946918|451216283|FG000|Overall Study|Physician Decision|0|||
125627412|NCT00871572|451917506|FG002|Overall Study|Adverse Event|0|||
125434160|NCT02946918|451216284|FG001|Overall Study|Physician Decision|2|||
125434161|NCT02946918|451216283|FG000|Overall Study|Ran out of study medication|0|||
125434162|NCT02946918|451216284|FG001|Overall Study|Ran out of study medication|1|||
125434163|NCT01125722|451216285|FG000|Overall Study|Withdrawal by Subject|2|||
125434164|NCT01125722|451216286|FG001|Overall Study|Withdrawal by Subject|1|||
125434165|NCT01125722|451216285|FG000|Overall Study|Lost to Follow-up|1|||
125434166|NCT01125722|451216286|FG001|Overall Study|Lost to Follow-up|0|||
125434167|NCT00069784|451216287|FG000|Overall Study|Adverse Event|105|||
125434168|NCT00069784|451216288|FG001|Overall Study|Adverse Event|0|||
125434169|NCT00069784|451216287|FG000|Overall Study|Withdrawal by Subject|1090|||
125434170|NCT00069784|451216288|FG001|Overall Study|Withdrawal by Subject|0|||
125434171|NCT00069784|451216287|FG000|Overall Study|Other|17|||
125434172|NCT00069784|451216288|FG001|Overall Study|Other|0|||
125434173|NCT01786330|451216295|FG000|Overall Study|Withdrawal by Subject|0|||
125434174|NCT01786330|451216296|FG001|Overall Study|Withdrawal by Subject|1|||
125434175|NCT01786330|451216295|FG000|Overall Study|Lost to Follow-up|0|||
125434176|NCT01786330|451216296|FG001|Overall Study|Lost to Follow-up|1|||
125434177|NCT01786330|451216295|FG000|Overall Study|Excluded intraoperatively|0|||
125627413|NCT00871572|451917507|FG003|Overall Study|Adverse Event|3|||
125627414|NCT00871572|451917504|FG000|Overall Study|Investigator Decision|0|||
125627415|NCT00871572|451917505|FG001|Overall Study|Investigator Decision|1|||
125627416|NCT00871572|451917506|FG002|Overall Study|Investigator Decision|0|||
125627417|NCT00871572|451917507|FG003|Overall Study|Investigator Decision|1|||
125627418|NCT00871572|451917504|FG000|Overall Study|Lost to Follow-up|0|||
125627419|NCT00871572|451917505|FG001|Overall Study|Lost to Follow-up|1|||
125627420|NCT00871572|451917506|FG002|Overall Study|Lost to Follow-up|0|||
125627421|NCT00871572|451917507|FG003|Overall Study|Lost to Follow-up|1|||
125627422|NCT00871572|451917504|FG000|Overall Study|Protocol Violation|0|||
125627423|NCT00871572|451917505|FG001|Overall Study|Protocol Violation|0|||
125627424|NCT00871572|451917506|FG002|Overall Study|Protocol Violation|1|||
125627425|NCT00871572|451917507|FG003|Overall Study|Protocol Violation|1|||
125627426|NCT00871572|451917504|FG000|Overall Study|Sponsor Decision|1|||
125627427|NCT00871572|451917505|FG001|Overall Study|Sponsor Decision|0|||
125627428|NCT00871572|451917506|FG002|Overall Study|Sponsor Decision|0|||
125627429|NCT00871572|451917507|FG003|Overall Study|Sponsor Decision|0|||
125627430|NCT00871572|451917504|FG000|Overall Study|Withdrawal by Subject|1|||
125627431|NCT00871572|451917505|FG001|Overall Study|Withdrawal by Subject|2|||
125627432|NCT00871572|451917506|FG002|Overall Study|Withdrawal by Subject|3|||
125627433|NCT00871572|451917507|FG003|Overall Study|Withdrawal by Subject|1|||
125627434|NCT00108953|451917515|FG000|Follow-up|Death|18|||
125627435|NCT00108953|451917516|FG001|Follow-up|Death|26|||
125627436|NCT00108953|451917515|FG000|Follow-up|Lost to Follow-up|1|||
125128433|NCT02726581|450096069|FG002|Treatment Period|Other reasons|2|||
125128434|NCT02726581|450096067|FG000|Treatment Period|Study drug toxicity|6|||
125128435|NCT02726581|450096068|FG001|Treatment Period|Study drug toxicity|3|||
125128436|NCT02726581|450096069|FG002|Treatment Period|Study drug toxicity|2|||
125128437|NCT02726581|450096067|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
125128438|NCT02726581|450096068|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
125128439|NCT02726581|450096069|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
125128440|NCT02726581|450096067|FG000|Treatment Period|Participant withdrew consent|3|||
125128441|NCT02726581|450096068|FG001|Treatment Period|Participant withdrew consent|1|||
125128442|NCT02726581|450096069|FG002|Treatment Period|Participant withdrew consent|1|||
125128443|NCT02726581|450096067|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
125128444|NCT02726581|450096068|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
125128445|NCT02726581|450096069|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
125128446|NCT02726581|450096067|FG000|Treatment Period|Maximum clinical benefit|0|||
125128447|NCT02726581|450096068|FG001|Treatment Period|Maximum clinical benefit|2|||
125128448|NCT02726581|450096069|FG002|Treatment Period|Maximum clinical benefit|0|||
125128449|NCT02726581|450096067|FG000|Treatment Period|Death|1|||
125128450|NCT02726581|450096068|FG001|Treatment Period|Death|0|||
125128451|NCT02726581|450096069|FG002|Treatment Period|Death|0|||
125128452|NCT02726581|450096067|FG000|Treatment Period|Poor/non-compliance|1|||
125128453|NCT02726581|450096068|FG001|Treatment Period|Poor/non-compliance|0|||
125128454|NCT02726581|450096069|FG002|Treatment Period|Poor/non-compliance|0|||
125128455|NCT02726581|450096067|FG000|Treatment Period|Participant no longer meets study criteria|0|||
125128456|NCT02726581|450096068|FG001|Treatment Period|Participant no longer meets study criteria|1|||
125128457|NCT02726581|450096069|FG002|Treatment Period|Participant no longer meets study criteria|0|||
125128458|NCT00552669|450096073|FG000|Overall Study|Death|3|||
125128459|NCT00552669|450096074|FG001|Overall Study|Death|7|||
125128460|NCT01844375|450096075|FG000|Overall Study|Protocol Violation|1|||
125128461|NCT01844375|450096076|FG001|Overall Study|Protocol Violation|1|||
125128462|NCT01772537|450096078|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
125128463|NCT01772537|450096079|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
125128464|NCT01772537|450096080|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
125128465|NCT01263704|450096081|FG000|Overall Study|Progressive disease|18|||
125627437|NCT00108953|451917516|FG001|Follow-up|Lost to Follow-up|1|||
125627438|NCT00108953|451917515|FG000|Follow-up|Study terminated by sponsor|10|||
125627439|NCT00108953|451917516|FG001|Follow-up|Study terminated by sponsor|6|||
125627440|NCT03803202|451917517|FG000|Overall Study|Other|0|||
125627441|NCT03803202|451917518|FG001|Overall Study|Other|1|||
125627442|NCT03803202|451917519|FG002|Overall Study|Other|0|||
125627443|NCT03803202|451917520|FG003|Overall Study|Other|0|||
125627444|NCT03803202|451917521|FG004|Overall Study|Other|0|||
125627445|NCT03803202|451917522|FG005|Overall Study|Other|0|||
125627446|NCT03803202|451917523|FG006|Overall Study|Other|0|||
125627447|NCT03803202|451917524|FG007|Overall Study|Other|0|||
125627448|NCT03803202|451917525|FG008|Overall Study|Other|0|||
125627449|NCT03803202|451917517|FG000|Overall Study|Death|0|||
125627450|NCT03803202|451917518|FG001|Overall Study|Death|0|||
125434178|NCT01786330|451216296|FG001|Overall Study|Excluded intraoperatively|1|||
125434179|NCT01786330|451216295|FG000|Overall Study|Protocol Violation|1|||
125434180|NCT01786330|451216296|FG001|Overall Study|Protocol Violation|0|||
125434181|NCT02969525|451216299|FG000|Double-Blind Period|Adverse Event|0|||
125434182|NCT02969525|451216300|FG001|Double-Blind Period|Adverse Event|0|||
125434183|NCT02969525|451216301|FG002|Double-Blind Period|Adverse Event|1|||
125434184|NCT02969525|451216302|FG003|Double-Blind Period|Adverse Event|1|||
125434185|NCT02969525|451216303|FG004|Double-Blind Period|Adverse Event|0|||
125434186|NCT02969525|451216304|FG005|Double-Blind Period|Adverse Event|0|||
125434187|NCT02969525|451216305|FG006|Double-Blind Period|Adverse Event|0|||
125434188|NCT02969525|451216306|FG007|Double-Blind Period|Adverse Event|0|||
125434189|NCT02969525|451216307|FG008|Double-Blind Period|Adverse Event|0|||
125434190|NCT02969525|451216308|FG009|Double-Blind Period|Adverse Event|0|||
125434191|NCT02969525|451216309|FG010|Double-Blind Period|Adverse Event|0|||
125434192|NCT02969525|451216310|FG011|Double-Blind Period|Adverse Event|0|||
125434193|NCT02969525|451216299|FG000|Double-Blind Period|LOW EGFR|0|||
125434194|NCT02969525|451216300|FG001|Double-Blind Period|LOW EGFR|0|||
125434195|NCT02969525|451216301|FG002|Double-Blind Period|LOW EGFR|0|||
125434196|NCT02969525|451216302|FG003|Double-Blind Period|LOW EGFR|1|||
125434197|NCT02969525|451216303|FG004|Double-Blind Period|LOW EGFR|0|||
125434198|NCT02969525|451216304|FG005|Double-Blind Period|LOW EGFR|0|||
125434199|NCT02969525|451216305|FG006|Double-Blind Period|LOW EGFR|0|||
125434200|NCT02969525|451216306|FG007|Double-Blind Period|LOW EGFR|0|||
125434201|NCT02969525|451216307|FG008|Double-Blind Period|LOW EGFR|0|||
125434202|NCT02969525|451216308|FG009|Double-Blind Period|LOW EGFR|0|||
125434203|NCT02969525|451216309|FG010|Double-Blind Period|LOW EGFR|0|||
125434204|NCT02969525|451216310|FG011|Double-Blind Period|LOW EGFR|0|||
125434205|NCT02969525|451216299|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
125434206|NCT02969525|451216300|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125434207|NCT02969525|451216301|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125434208|NCT02969525|451216302|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
125434209|NCT02969525|451216303|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125434210|NCT02969525|451216304|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125434211|NCT02969525|451216305|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125434212|NCT02969525|451216306|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125627451|NCT03803202|451917519|FG002|Overall Study|Death|0|||
125627452|NCT03803202|451917520|FG003|Overall Study|Death|0|||
125627453|NCT03803202|451917521|FG004|Overall Study|Death|0|||
125627454|NCT03803202|451917522|FG005|Overall Study|Death|1|||
125627455|NCT03803202|451917523|FG006|Overall Study|Death|0|||
125627456|NCT03803202|451917524|FG007|Overall Study|Death|0|||
125627457|NCT03803202|451917525|FG008|Overall Study|Death|0|||
125434213|NCT02969525|451216307|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125627458|NCT03803202|451917517|FG000|Overall Study|Withdrawal by Subject|0|||
125627459|NCT03803202|451917518|FG001|Overall Study|Withdrawal by Subject|0|||
125627460|NCT03803202|451917519|FG002|Overall Study|Withdrawal by Subject|1|||
125627461|NCT03803202|451917520|FG003|Overall Study|Withdrawal by Subject|0|||
125627462|NCT03803202|451917521|FG004|Overall Study|Withdrawal by Subject|0|||
125627463|NCT03803202|451917522|FG005|Overall Study|Withdrawal by Subject|0|||
125627464|NCT03803202|451917523|FG006|Overall Study|Withdrawal by Subject|0|||
125434214|NCT02969525|451216308|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125434215|NCT02969525|451216309|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125434216|NCT02969525|451216310|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
125434217|NCT02969525|451216299|FG000|Dose-Blind Period|Adverse Event|0|||
125434218|NCT02969525|451216300|FG001|Dose-Blind Period|Adverse Event|0|||
125434219|NCT02969525|451216301|FG002|Dose-Blind Period|Adverse Event|0|||
125627465|NCT03803202|451917524|FG007|Overall Study|Withdrawal by Subject|1|||
125627466|NCT03803202|451917525|FG008|Overall Study|Withdrawal by Subject|0|||
125627467|NCT03803202|451917517|FG000|Overall Study|Lost to Follow-up|0|||
125627468|NCT03803202|451917518|FG001|Overall Study|Lost to Follow-up|0|||
125128466|NCT01263704|450096081|FG000|Overall Study|Adverse Event|3|||
125627469|NCT03803202|451917519|FG002|Overall Study|Lost to Follow-up|0|||
125627470|NCT03803202|451917520|FG003|Overall Study|Lost to Follow-up|1|||
125627471|NCT03803202|451917521|FG004|Overall Study|Lost to Follow-up|1|||
125627472|NCT03803202|451917522|FG005|Overall Study|Lost to Follow-up|0|||
125627473|NCT03803202|451917523|FG006|Overall Study|Lost to Follow-up|1|||
125627474|NCT03803202|451917524|FG007|Overall Study|Lost to Follow-up|0|||
125627475|NCT03803202|451917525|FG008|Overall Study|Lost to Follow-up|0|||
125627476|NCT01125293|451917526|FG000|Overall Study|Disease Progression|1|||
125627477|NCT01125293|451917527|FG001|Overall Study|Disease Progression|3|||
125627478|NCT01125293|451917528|FG002|Overall Study|Disease Progression|4|||
125627479|NCT01125293|451917529|FG003|Overall Study|Disease Progression|3|||
125215587|NCT00902746|450417445|FG000|Overall Study|Adverse Event|8|||
125215588|NCT00902746|450417445|FG000|Overall Study|Lost to Follow-up|3|||
125375201|NCT01401283|451003578|FG000|Overall Study|preoperative arrhythmia|5|||
125375202|NCT01401283|451003579|FG001|Overall Study|preoperative arrhythmia|0|||
125375203|NCT01401283|451003578|FG000|Overall Study|no central venous access|0|||
125375204|NCT01401283|451003579|FG001|Overall Study|no central venous access|1|||
125375205|NCT01401283|451003578|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
125375206|NCT01401283|451003579|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
125375207|NCT03489720|451003580|FG000|Overall Study|Withdrawal by Subject|2|||
125375208|NCT03489720|451003581|FG001|Overall Study|Withdrawal by Subject|0|||
125375209|NCT02101060|451003587|FG000|Overall Study|Adverse Event|1|||
125375210|NCT02101060|451003588|FG001|Overall Study|Adverse Event|0|||
125375211|NCT02101060|451003587|FG000|Overall Study|Withdrawal by Subject|1|||
125375212|NCT02101060|451003588|FG001|Overall Study|Withdrawal by Subject|1|||
125375213|NCT02101060|451003587|FG000|Overall Study|Lost to Follow-up|3|||
125375214|NCT02101060|451003588|FG001|Overall Study|Lost to Follow-up|3|||
125375215|NCT03462082|451003590|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
125375216|NCT03462082|451003591|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
125375217|NCT03462082|451003592|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
125375218|NCT03462082|451003593|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
125375219|NCT03462082|451003594|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
125375220|NCT03462082|451003595|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
125375221|NCT03462082|451003596|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
125375222|NCT03462082|451003597|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
125375223|NCT00166114|451003600|FG000|Overall Study|Protocol Violation|2|||
125375224|NCT00166114|451003601|FG001|Overall Study|Protocol Violation|1|||
125375225|NCT00166114|451003600|FG000|Overall Study|Withdrawal by Subject|10|||
125375226|NCT00166114|451003601|FG001|Overall Study|Withdrawal by Subject|4|||
125375227|NCT00166114|451003600|FG000|Overall Study|Adverse Event|2|||
125375228|NCT00166114|451003601|FG001|Overall Study|Adverse Event|1|||
125375229|NCT00545168|451003608|FG000|Overall Study|Lost to Follow-up|5|||
125375230|NCT00545168|451003609|FG001|Overall Study|Lost to Follow-up|5|||
125375231|NCT00545168|451003610|FG002|Overall Study|Lost to Follow-up|5|||
125375232|NCT00545168|451003608|FG000|Overall Study|Withdrawal by Subject|9|||
125375233|NCT00545168|451003609|FG001|Overall Study|Withdrawal by Subject|0|||
125375234|NCT00545168|451003610|FG002|Overall Study|Withdrawal by Subject|13|||
125375235|NCT00545168|451003608|FG000|Overall Study|Protocol Violation|1|||
125375236|NCT00545168|451003609|FG001|Overall Study|Protocol Violation|0|||
125375237|NCT00545168|451003610|FG002|Overall Study|Protocol Violation|1|||
125375238|NCT00545168|451003608|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
125375239|NCT00545168|451003609|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
125375240|NCT00545168|451003610|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
125375241|NCT01987505|451003616|FG000|Overall Study|Other|9|||
125375242|NCT01987505|451003616|FG000|Overall Study|Withdrawal by Subject|2|||
125375243|NCT01987505|451003616|FG000|Overall Study|Other Reason|2|||
125375244|NCT01987505|451003616|FG000|Overall Study|Lost to Follow-up|15|||
125375245|NCT01987505|451003616|FG000|Overall Study|Investigator Decision|2|||
125375246|NCT01987505|451003616|FG000|Overall Study|Death|4|||
125375247|NCT05131646|451003617|FG000|Overall Study|Withdrawal by Subject|1|||
125375248|NCT05131646|451003618|FG001|Overall Study|Withdrawal by Subject|0|||
125375249|NCT05131646|451003619|FG002|Overall Study|Withdrawal by Subject|0|||
125375250|NCT03266107|451003620|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
125375251|NCT03266107|451003620|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
125375252|NCT03266107|451003620|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
125375253|NCT03266107|451003620|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
125375254|NCT03454997|451003621|FG000|Overall Study|Staff Coach - Left Oranization|1|||
125375255|NCT03454997|451003622|FG001|Overall Study|Staff Coach - Left Oranization|1|||
125375256|NCT03454997|451003621|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
125375257|NCT03454997|451003622|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
125375258|NCT03454997|451003621|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
125375259|NCT03454997|451003622|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
125375260|NCT03454997|451003621|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
125375261|NCT03454997|451003622|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
125375262|NCT03454997|451003621|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
125627480|NCT01125293|451917530|FG004|Overall Study|Disease Progression|5|||
125627481|NCT01125293|451917531|FG005|Overall Study|Disease Progression|12|||
125627482|NCT01125293|451917526|FG000|Overall Study|Adverse Event|1|||
125434220|NCT02969525|451216302|FG003|Dose-Blind Period|Adverse Event|0|||
125434221|NCT02969525|451216303|FG004|Dose-Blind Period|Adverse Event|0|||
125434222|NCT02969525|451216304|FG005|Dose-Blind Period|Adverse Event|0|||
125434223|NCT02969525|451216305|FG006|Dose-Blind Period|Adverse Event|0|||
125627483|NCT01125293|451917527|FG001|Overall Study|Adverse Event|0|||
125434224|NCT02969525|451216306|FG007|Dose-Blind Period|Adverse Event|0|||
125434225|NCT02969525|451216307|FG008|Dose-Blind Period|Adverse Event|0|||
125434226|NCT02969525|451216308|FG009|Dose-Blind Period|Adverse Event|1|||
125434227|NCT02969525|451216309|FG010|Dose-Blind Period|Adverse Event|1|||
125434228|NCT02969525|451216310|FG011|Dose-Blind Period|Adverse Event|1|||
125434229|NCT02969525|451216299|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
125627484|NCT01125293|451917528|FG002|Overall Study|Adverse Event|0|||
125627485|NCT01125293|451917529|FG003|Overall Study|Adverse Event|0|||
125627486|NCT01125293|451917530|FG004|Overall Study|Adverse Event|2|||
125627487|NCT01125293|451917531|FG005|Overall Study|Adverse Event|8|||
125627488|NCT01125293|451917526|FG000|Overall Study|Symptomatic Deterioration|1|||
125627489|NCT01125293|451917527|FG001|Overall Study|Symptomatic Deterioration|0|||
125627490|NCT01125293|451917528|FG002|Overall Study|Symptomatic Deterioration|0|||
125627491|NCT01125293|451917529|FG003|Overall Study|Symptomatic Deterioration|0|||
125627492|NCT01125293|451917530|FG004|Overall Study|Symptomatic Deterioration|0|||
125627493|NCT01125293|451917531|FG005|Overall Study|Symptomatic Deterioration|0|||
125627494|NCT01125293|451917526|FG000|Overall Study|Death|0|||
125627495|NCT01125293|451917527|FG001|Overall Study|Death|0|||
125627496|NCT01125293|451917528|FG002|Overall Study|Death|0|||
125627497|NCT01125293|451917529|FG003|Overall Study|Death|0|||
125627498|NCT01125293|451917530|FG004|Overall Study|Death|1|||
125627499|NCT01125293|451917531|FG005|Overall Study|Death|0|||
125627500|NCT01125293|451917526|FG000|Overall Study|Withdrawal by Subject|0|||
125627501|NCT01125293|451917527|FG001|Overall Study|Withdrawal by Subject|0|||
125215589|NCT00902746|450417445|FG000|Overall Study|Physician Decision|2|||
125434230|NCT02969525|451216300|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
125434231|NCT02969525|451216301|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
125434232|NCT02969525|451216302|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
125434233|NCT02969525|451216303|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
125434234|NCT02969525|451216304|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
125434235|NCT02969525|451216305|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
125434236|NCT02969525|451216306|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
125434237|NCT02969525|451216307|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
125434238|NCT02969525|451216308|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
125434239|NCT02969525|451216309|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
125434240|NCT02969525|451216310|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
125434241|NCT02969525|451216299|FG000|Dose-Blind Period|Non-cooperating patient|0|||
125434242|NCT02969525|451216300|FG001|Dose-Blind Period|Non-cooperating patient|0|||
125434243|NCT02969525|451216301|FG002|Dose-Blind Period|Non-cooperating patient|0|||
125434244|NCT02969525|451216302|FG003|Dose-Blind Period|Non-cooperating patient|0|||
125434245|NCT02969525|451216303|FG004|Dose-Blind Period|Non-cooperating patient|0|||
125434246|NCT02969525|451216304|FG005|Dose-Blind Period|Non-cooperating patient|0|||
125434247|NCT02969525|451216305|FG006|Dose-Blind Period|Non-cooperating patient|0|||
125434248|NCT02969525|451216306|FG007|Dose-Blind Period|Non-cooperating patient|0|||
125434249|NCT02969525|451216307|FG008|Dose-Blind Period|Non-cooperating patient|0|||
125434250|NCT02969525|451216308|FG009|Dose-Blind Period|Non-cooperating patient|0|||
125434251|NCT02969525|451216309|FG010|Dose-Blind Period|Non-cooperating patient|0|||
125434252|NCT02969525|451216310|FG011|Dose-Blind Period|Non-cooperating patient|1|||
125434253|NCT02969525|451216299|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125434254|NCT02969525|451216300|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125434255|NCT02969525|451216301|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125434256|NCT02969525|451216302|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125434257|NCT02969525|451216303|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125434258|NCT02969525|451216304|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125434259|NCT02969525|451216305|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125434260|NCT02969525|451216306|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125434261|NCT02969525|451216307|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125434262|NCT02969525|451216308|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125434263|NCT02969525|451216309|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
125434264|NCT02969525|451216310|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
125434265|NCT02172625|451216311|FG000|Overall Study|Adverse Event|0|||
125434266|NCT02172625|451216312|FG001|Overall Study|Adverse Event|1|||
125434267|NCT02172625|451216311|FG000|Overall Study|Pregnancy|0|||
125627502|NCT01125293|451917528|FG002|Overall Study|Withdrawal by Subject|0|||
125627503|NCT01125293|451917529|FG003|Overall Study|Withdrawal by Subject|0|||
125434268|NCT02172625|451216312|FG001|Overall Study|Pregnancy|1|||
125434269|NCT02172625|451216311|FG000|Overall Study|car accident|0|||
125627504|NCT01125293|451917530|FG004|Overall Study|Withdrawal by Subject|2|||
125627505|NCT01125293|451917531|FG005|Overall Study|Withdrawal by Subject|1|||
125627506|NCT01125293|451917526|FG000|Overall Study|Physician Decision|0|||
125627507|NCT01125293|451917527|FG001|Overall Study|Physician Decision|0|||
125434270|NCT02172625|451216312|FG001|Overall Study|car accident|1|||
125434271|NCT00524030|451216313|FG000|Overall Study|Lack of Efficacy|10|||
125434272|NCT00524030|451216314|FG001|Overall Study|Lack of Efficacy|24|||
125434273|NCT00524030|451216313|FG000|Overall Study|Lost to Follow-up|0|||
125434274|NCT00524030|451216314|FG001|Overall Study|Lost to Follow-up|2|||
125434275|NCT00524030|451216313|FG000|Overall Study|Withdrawal by Subject|3|||
125434276|NCT00524030|451216314|FG001|Overall Study|Withdrawal by Subject|8|||
125434277|NCT00524030|451216313|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
125627508|NCT01125293|451917528|FG002|Overall Study|Physician Decision|0|||
125627509|NCT01125293|451917529|FG003|Overall Study|Physician Decision|0|||
125627510|NCT01125293|451917530|FG004|Overall Study|Physician Decision|0|||
125627511|NCT01125293|451917531|FG005|Overall Study|Physician Decision|2|||
125627512|NCT01270958|451917534|FG000|Overall Study|Lost to Follow-up|2|||
125627513|NCT01270958|451917534|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
125627514|NCT00659126|451917541|FG000|Overall Study|Adverse Event|2|||
125627515|NCT00659126|451917542|FG001|Overall Study|Adverse Event|2|||
125627516|NCT00659126|451917541|FG000|Overall Study|Screen failure|1|||
125434278|NCT00524030|451216314|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
125434279|NCT00524030|451216313|FG000|Overall Study|Protocol Violation|0|||
125434280|NCT00524030|451216314|FG001|Overall Study|Protocol Violation|1|||
125434281|NCT00524030|451216313|FG000|Overall Study|Pregnancy|1|||
125434282|NCT00524030|451216314|FG001|Overall Study|Pregnancy|0|||
125434283|NCT00524030|451216313|FG000|Overall Study|Adverse Event|3|||
125434284|NCT00524030|451216314|FG001|Overall Study|Adverse Event|21|||
125434285|NCT00524030|451216313|FG000|Overall Study|Death|0|||
125434286|NCT00524030|451216314|FG001|Overall Study|Death|1|||
125627517|NCT00659126|451917542|FG001|Overall Study|Screen failure|1|||
125627518|NCT00659126|451917541|FG000|Overall Study|Technical problems with MRI|0|||
125627519|NCT00659126|451917542|FG001|Overall Study|Technical problems with MRI|1|||
125627520|NCT02633046|451917546|FG000|Overall Study|Adverse Event|8|||
125627521|NCT02633046|451917546|FG000|Overall Study|Physician Decision|7|||
125627522|NCT02633046|451917546|FG000|Overall Study|Withdrawal by Subject|8|||
125627523|NCT02633046|451917546|FG000|Overall Study|Increased proteinuria|2|||
125627524|NCT02633046|451917546|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
125627525|NCT02633046|451917546|FG000|Overall Study|Mutual decision patient and physician|1|||
125627526|NCT02925312|451917547|FG000|Overall Study|Lost to Follow-up|25|||
125627527|NCT02925312|451917548|FG001|Overall Study|Lost to Follow-up|0|||
125627528|NCT02925312|451917547|FG000|Overall Study|Adverse Event|2|||
125627529|NCT02925312|451917548|FG001|Overall Study|Adverse Event|0|||
125627530|NCT03205982|451917556|FG000|Overall Study|Lost to Follow-up|20|||
125627531|NCT03205982|451917557|FG001|Overall Study|Lost to Follow-up|19|||
125627532|NCT03205982|451917556|FG000|Overall Study|Withdrawal by Subject|4|||
125627533|NCT03205982|451917557|FG001|Overall Study|Withdrawal by Subject|3|||
125627534|NCT03205982|451917556|FG000|Overall Study|Withdrawal by PI|0|||
125627535|NCT03205982|451917557|FG001|Overall Study|Withdrawal by PI|1|||
125627536|NCT00994162|451917558|FG000|Overall Study|Withdrawal by Subject|1|||
125627537|NCT00994162|451917558|FG000|Overall Study|Lost to Follow-up|2|||
125627538|NCT00994162|451917558|FG000|Overall Study|Product Complaint|1|||
125627539|NCT00994162|451917558|FG000|Overall Study|Poor Compliance|5|||
125627540|NCT00994162|451917558|FG000|Overall Study|Lack of Response|3|||
125627541|NCT00994162|451917558|FG000|Overall Study|Discharged from Hospital|4|||
125627542|NCT00994162|451917558|FG000|Overall Study|Death|2|||
125627543|NCT00994162|451917558|FG000|Overall Study|Care Transferred to Another Physician|2|||
125627544|NCT00994162|451917558|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
125627545|NCT00994162|451917558|FG000|Overall Study|Physician Decision|2|||
125434287|NCT01816763|451217529|FG000|Overall Study|The main reason for an incomplete survey|4|||
125434288|NCT01816763|451217530|FG001|Overall Study|The main reason for an incomplete survey|15|||
125434289|NCT01816763|451217531|FG002|Overall Study|The main reason for an incomplete survey|11|||
125434290|NCT00311155|451217534|FG000|Overall Study|Adverse Event|21|||
125434291|NCT00311155|451217534|FG000|Overall Study|Withdrawal by Subject|17|||
125434292|NCT00311155|451217534|FG000|Overall Study|Did not meet entry criteria|55|||
125434293|NCT00429494|451217536|FG000|Overall Study|Withdrawal by Subject|9|||
125434294|NCT00429494|451217536|FG000|Overall Study|Death|6|||
125434295|NCT02392611|451217541|FG000|Overall Study|Adverse Event|0|||
125434296|NCT02392611|451217542|FG001|Overall Study|Adverse Event|0|||
125434297|NCT02392611|451217543|FG002|Overall Study|Adverse Event|0|||
125627546|NCT00994162|451917558|FG000|Overall Study|Surrounding Wound Erythematous|1|||
125627547|NCT00994162|451917558|FG000|Overall Study|Machine Losing Vaccum|1|||
125627548|NCT00994162|451917558|FG000|Overall Study|Patient Lived Too Far Away|1|||
125627549|NCT00994162|451917558|FG000|Overall Study|Above Knee Amputation|1|||
125627550|NCT00994162|451917558|FG000|Overall Study|Reason Not Reported By Site|1|||
125627551|NCT01425749|451917559|FG000|Overall Study|progression of melanoma|0|||
125627552|NCT01425749|451917560|FG001|Overall Study|progression of melanoma|1|||
125434298|NCT02392611|451217544|FG003|Overall Study|Adverse Event|1|||
125434299|NCT02392611|451217545|FG004|Overall Study|Adverse Event|0|||
125434300|NCT02392611|451217546|FG005|Overall Study|Adverse Event|0|||
125627553|NCT01293084|451917561|FG000|Overall Study|Physician Decision|3|||
125434301|NCT02392611|451217547|FG006|Overall Study|Adverse Event|0|||
125434302|NCT02392611|451217548|FG007|Overall Study|Adverse Event|0|||
125627554|NCT01293084|451917561|FG000|Overall Study|Withdrawal by Subject|2|||
125627555|NCT02096042|451917562|FG000|Overall Study|Disease Progression|1|||
125627556|NCT02096042|451917563|FG001|Overall Study|Disease Progression|0|||
125627557|NCT02096042|451917564|FG002|Overall Study|Disease Progression|0|||
125627558|NCT02983799|451917565|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
125627559|NCT02983799|451917566|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
125627560|NCT02983799|451917567|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
125627561|NCT02983799|451917568|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
125627562|NCT02983799|451917569|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
125627563|NCT02983799|451917565|FG000|Overall Study|Death|20|||
125627564|NCT02983799|451917566|FG001|Overall Study|Death|5|||
125627565|NCT02983799|451917567|FG002|Overall Study|Death|23|||
125627566|NCT02983799|451917568|FG003|Overall Study|Death|47|||
125627567|NCT02983799|451917569|FG004|Overall Study|Death|7|||
125627568|NCT02983799|451917565|FG000|Overall Study|Withdrawal by Subject|1|||
125627569|NCT02983799|451917566|FG001|Overall Study|Withdrawal by Subject|0|||
125434303|NCT02392611|451217549|FG008|Overall Study|Adverse Event|0|||
125434304|NCT02392611|451217541|FG000|Overall Study|Progressive disease|0|||
125434305|NCT02392611|451217542|FG001|Overall Study|Progressive disease|0|||
125434306|NCT02392611|451217543|FG002|Overall Study|Progressive disease|0|||
125434307|NCT02392611|451217544|FG003|Overall Study|Progressive disease|2|||
125434308|NCT02392611|451217545|FG004|Overall Study|Progressive disease|1|||
125434309|NCT02392611|451217546|FG005|Overall Study|Progressive disease|0|||
125434310|NCT02392611|451217547|FG006|Overall Study|Progressive disease|0|||
125434311|NCT02392611|451217548|FG007|Overall Study|Progressive disease|0|||
125434312|NCT02392611|451217549|FG008|Overall Study|Progressive disease|0|||
125434313|NCT02392611|451217541|FG000|Overall Study|Death|1|||
125434314|NCT02392611|451217542|FG001|Overall Study|Death|0|||
125434315|NCT02392611|451217543|FG002|Overall Study|Death|0|||
125434316|NCT02392611|451217544|FG003|Overall Study|Death|0|||
125627570|NCT02983799|451917567|FG002|Overall Study|Withdrawal by Subject|3|||
125627571|NCT02983799|451917568|FG003|Overall Study|Withdrawal by Subject|4|||
125627572|NCT02983799|451917569|FG004|Overall Study|Withdrawal by Subject|1|||
125627573|NCT02983799|451917565|FG000|Overall Study|Protocol Violation|0|||
125627574|NCT02983799|451917566|FG001|Overall Study|Protocol Violation|1|||
125627575|NCT02983799|451917567|FG002|Overall Study|Protocol Violation|0|||
125627576|NCT02983799|451917568|FG003|Overall Study|Protocol Violation|0|||
125627577|NCT02983799|451917569|FG004|Overall Study|Protocol Violation|1|||
125627578|NCT02983799|451917565|FG000|Overall Study|Lost to Follow-up|1|||
125627579|NCT02983799|451917566|FG001|Overall Study|Lost to Follow-up|0|||
125627580|NCT02983799|451917567|FG002|Overall Study|Lost to Follow-up|1|||
125627581|NCT02983799|451917568|FG003|Overall Study|Lost to Follow-up|0|||
125627582|NCT02983799|451917569|FG004|Overall Study|Lost to Follow-up|0|||
125627583|NCT01225172|451917576|FG000|Overall Study|Subject decision to stop|1|||
125627584|NCT01225172|451917577|FG001|Overall Study|Subject decision to stop|0|||
125627585|NCT01225172|451917576|FG000|Overall Study|Subject request to discontinue treatment|3|||
125627586|NCT01225172|451917577|FG001|Overall Study|Subject request to discontinue treatment|1|||
125627587|NCT01225172|451917576|FG000|Overall Study|Subject no longer meets study criteria|1|||
125627588|NCT01225172|451917577|FG001|Overall Study|Subject no longer meets study criteria|0|||
125627589|NCT01225172|451917576|FG000|Overall Study|Withdrawal by Subject|1|||
125627590|NCT01225172|451917577|FG001|Overall Study|Withdrawal by Subject|0|||
125627591|NCT00795509|451917579|FG000|Overall Study|Protocol Violation|31|||
125627592|NCT01601470|451917580|FG000|Period 2 - LCZ696|Physician Decision|1|||
125627593|NCT01041404|451917583|FG000|Overall Study|Adverse Event|45|||
125627594|NCT01041404|451917584|FG001|Overall Study|Adverse Event|35|||
125627595|NCT01041404|451917583|FG000|Overall Study|Lack of Efficacy|200|||
125627596|NCT01041404|451917584|FG001|Overall Study|Lack of Efficacy|210|||
125627597|NCT01041404|451917583|FG000|Overall Study|Violation of Selection Criteria|0|||
125627598|NCT01041404|451917584|FG001|Overall Study|Violation of Selection Criteria|1|||
125627599|NCT01041404|451917583|FG000|Overall Study|Protocol Violation|4|||
125627600|NCT01041404|451917584|FG001|Overall Study|Protocol Violation|0|||
125434317|NCT02392611|451217545|FG004|Overall Study|Death|0|||
125434318|NCT02392611|451217546|FG005|Overall Study|Death|1|||
125434319|NCT02392611|451217547|FG006|Overall Study|Death|0|||
125434320|NCT02392611|451217548|FG007|Overall Study|Death|0|||
125434321|NCT02392611|451217549|FG008|Overall Study|Death|0|||
125434322|NCT02392611|451217541|FG000|Overall Study|Withdrawal by Subject|0|||
125434323|NCT02392611|451217542|FG001|Overall Study|Withdrawal by Subject|0|||
125434324|NCT02392611|451217543|FG002|Overall Study|Withdrawal by Subject|0|||
125434325|NCT02392611|451217544|FG003|Overall Study|Withdrawal by Subject|1|||
125434326|NCT02392611|451217545|FG004|Overall Study|Withdrawal by Subject|0|||
125627601|NCT01041404|451917583|FG000|Overall Study|Withdrawal by Subject|29|||
125627602|NCT01041404|451917584|FG001|Overall Study|Withdrawal by Subject|23|||
125434327|NCT02392611|451217546|FG005|Overall Study|Withdrawal by Subject|0|||
125434328|NCT02392611|451217547|FG006|Overall Study|Withdrawal by Subject|0|||
125627603|NCT01041404|451917583|FG000|Overall Study|Failure to Return|1|||
125434329|NCT02392611|451217548|FG007|Overall Study|Withdrawal by Subject|0|||
125434330|NCT02392611|451217549|FG008|Overall Study|Withdrawal by Subject|0|||
125434331|NCT02392611|451217541|FG000|Overall Study|Lost to Follow-up|0|||
125434332|NCT02392611|451217542|FG001|Overall Study|Lost to Follow-up|0|||
125434333|NCT02392611|451217543|FG002|Overall Study|Lost to Follow-up|0|||
125434334|NCT02392611|451217544|FG003|Overall Study|Lost to Follow-up|0|||
125434335|NCT02392611|451217545|FG004|Overall Study|Lost to Follow-up|0|||
125434336|NCT02392611|451217546|FG005|Overall Study|Lost to Follow-up|0|||
125434337|NCT02392611|451217547|FG006|Overall Study|Lost to Follow-up|1|||
125434338|NCT02392611|451217548|FG007|Overall Study|Lost to Follow-up|0|||
125434339|NCT02392611|451217549|FG008|Overall Study|Lost to Follow-up|0|||
125434340|NCT02392611|451217541|FG000|Overall Study|Enrolled, not treated|0|||
125434341|NCT02392611|451217542|FG001|Overall Study|Enrolled, not treated|0|||
125434342|NCT02392611|451217543|FG002|Overall Study|Enrolled, not treated|0|||
125434343|NCT02392611|451217544|FG003|Overall Study|Enrolled, not treated|2|||
125434344|NCT02392611|451217545|FG004|Overall Study|Enrolled, not treated|0|||
125434345|NCT02392611|451217546|FG005|Overall Study|Enrolled, not treated|0|||
125434346|NCT02392611|451217547|FG006|Overall Study|Enrolled, not treated|0|||
125434347|NCT02392611|451217548|FG007|Overall Study|Enrolled, not treated|0|||
125434348|NCT02392611|451217549|FG008|Overall Study|Enrolled, not treated|0|||
125434349|NCT03585296|451217565|FG000|Overall Study|Adverse Event|1|||
125434350|NCT03585296|451217565|FG000|Overall Study|Lost to Follow-up|2|||
125434351|NCT03585296|451217565|FG000|Overall Study|Withdrawal by Subject|2|||
125434352|NCT00462670|451217569|FG000|Overall Study|Adverse Event|3|||
125434353|NCT00462670|451217570|FG001|Overall Study|Adverse Event|5|||
125434354|NCT00462670|451217569|FG000|Overall Study|Lack of Efficacy|1|||
125434355|NCT00462670|451217570|FG001|Overall Study|Lack of Efficacy|0|||
125434356|NCT00462670|451217569|FG000|Overall Study|Protocol Violation|1|||
125434357|NCT00462670|451217570|FG001|Overall Study|Protocol Violation|0|||
125434358|NCT00462670|451217569|FG000|Overall Study|Resolution of signs and symptoms|0|||
125434359|NCT00462670|451217570|FG001|Overall Study|Resolution of signs and symptoms|2|||
125434360|NCT02110732|451217571|FG000|Overall Study|Physician Decision|5|||
125434361|NCT02110732|451217572|FG001|Overall Study|Physician Decision|2|||
125434362|NCT02110732|451217571|FG000|Overall Study|Lost to Follow-up|1|||
125434363|NCT02110732|451217572|FG001|Overall Study|Lost to Follow-up|1|||
125434364|NCT00633932|451217573|FG000|Overall Study|Adverse Event|1|||
125434365|NCT00633932|451217574|FG001|Overall Study|Adverse Event|3|||
125434366|NCT00633932|451217575|FG002|Overall Study|Adverse Event|4|||
125434367|NCT00633932|451217573|FG000|Overall Study|Withdrawal by Subject|3|||
125434368|NCT00633932|451217574|FG001|Overall Study|Withdrawal by Subject|9|||
125434369|NCT00633932|451217575|FG002|Overall Study|Withdrawal by Subject|1|||
125434370|NCT00633932|451217573|FG000|Overall Study|Lost to Follow-up|1|||
125434371|NCT00633932|451217574|FG001|Overall Study|Lost to Follow-up|0|||
125434372|NCT00633932|451217575|FG002|Overall Study|Lost to Follow-up|2|||
125434373|NCT00633932|451217573|FG000|Overall Study|Protocol Violation|5|||
125434374|NCT00633932|451217574|FG001|Overall Study|Protocol Violation|2|||
125434375|NCT00633932|451217575|FG002|Overall Study|Protocol Violation|3|||
125434376|NCT00633932|451217573|FG000|Overall Study|Physician Decision|0|||
125434377|NCT00633932|451217574|FG001|Overall Study|Physician Decision|0|||
125434378|NCT00633932|451217575|FG002|Overall Study|Physician Decision|1|||
125434379|NCT00633932|451217573|FG000|Overall Study|Doctor's judgement|1|||
125434380|NCT00633932|451217574|FG001|Overall Study|Doctor's judgement|0|||
125434381|NCT00633932|451217575|FG002|Overall Study|Doctor's judgement|0|||
125434382|NCT00633932|451217573|FG000|Overall Study|Moved Away|1|||
125434383|NCT00633932|451217574|FG001|Overall Study|Moved Away|0|||
125434384|NCT00633932|451217575|FG002|Overall Study|Moved Away|0|||
125434385|NCT00482274|451217576|FG000|Overall Study|Adverse Event|1|||
125434386|NCT04836858|451217577|FG000|Overall Study|Adverse Event|0|||
125434387|NCT04836858|451217578|FG001|Overall Study|Adverse Event|0|||
125434388|NCT04836858|451217579|FG002|Overall Study|Adverse Event|0|||
125434389|NCT04836858|451217580|FG003|Overall Study|Adverse Event|1|||
125434390|NCT04836858|451217577|FG000|Overall Study|Lost to Follow-up|1|||
125434391|NCT04836858|451217578|FG001|Overall Study|Lost to Follow-up|0|||
125434392|NCT04836858|451217579|FG002|Overall Study|Lost to Follow-up|0|||
125434393|NCT04836858|451217580|FG003|Overall Study|Lost to Follow-up|0|||
125434394|NCT04836858|451217577|FG000|Overall Study|Subject/Guardian decision|3|||
125434395|NCT04836858|451217578|FG001|Overall Study|Subject/Guardian decision|0|||
125434396|NCT04836858|451217579|FG002|Overall Study|Subject/Guardian decision|0|||
125434397|NCT04836858|451217580|FG003|Overall Study|Subject/Guardian decision|1|||
125434398|NCT04836858|451217577|FG000|Overall Study|Randomized but not treated|4|||
125434399|NCT04836858|451217578|FG001|Overall Study|Randomized but not treated|0|||
125434400|NCT04836858|451217579|FG002|Overall Study|Randomized but not treated|0|||
125434401|NCT04836858|451217580|FG003|Overall Study|Randomized but not treated|0|||
125434402|NCT00597714|451217581|FG000|Overall Study|Death|56|||
125434403|NCT00597714|451217582|FG001|Overall Study|Death|46|||
125434404|NCT00597714|451217583|FG002|Overall Study|Death|0|||
125434405|NCT00597714|451217581|FG000|Overall Study|Recipient death|0|||
125434406|NCT00597714|451217582|FG001|Overall Study|Recipient death|0|||
125434407|NCT00597714|451217583|FG002|Overall Study|Recipient death|10|||
125434408|NCT01350141|451217584|FG000|Overall Study|Lost to Follow-up|1|||
125434409|NCT01350141|451217585|FG001|Overall Study|Lost to Follow-up|0|||
125434410|NCT01350141|451217586|FG002|Overall Study|Lost to Follow-up|1|||
125434411|NCT01350141|451217584|FG000|Overall Study|Withdrawal by Subject|1|||
125434412|NCT01350141|451217585|FG001|Overall Study|Withdrawal by Subject|0|||
125434413|NCT01350141|451217586|FG002|Overall Study|Withdrawal by Subject|0|||
125434414|NCT01350141|451217584|FG000|Overall Study|Randomized but not treated|1|||
125627604|NCT01041404|451917584|FG001|Overall Study|Failure to Return|2|||
125627605|NCT01041404|451917583|FG000|Overall Study|Other|11|||
125434415|NCT01350141|451217585|FG001|Overall Study|Randomized but not treated|0|||
125434416|NCT01350141|451217586|FG002|Overall Study|Randomized but not treated|0|||
125434417|NCT00519896|451217587|FG000|Overall Study|Protocol Violation|1|||
125434418|NCT00519896|451217587|FG000|Overall Study|Adverse Event|1|||
125434419|NCT00810082|451217588|FG000|Overall Study|Lost to Follow-up|0|||
125434420|NCT00810082|451217589|FG001|Overall Study|Lost to Follow-up|4|||
125627606|NCT01041404|451917584|FG001|Overall Study|Other|23|||
125627607|NCT01607073|451917585|FG000|Overall Study|Adverse Event|1|||
125627608|NCT03726333|451917586|FG000|Overall Study|Progressive Disease|0|||
125627609|NCT03726333|451917587|FG001|Overall Study|Progressive Disease|0|||
125627610|NCT03726333|451917588|FG002|Overall Study|Progressive Disease|1|||
125627611|NCT03726333|451917589|FG003|Overall Study|Progressive Disease|0|||
125627612|NCT03726333|451917590|FG004|Overall Study|Progressive Disease|0|||
125627613|NCT01946412|451917591|FG000|Overall Study|Adverse Event|1|||
125627614|NCT01946412|451917591|FG000|Overall Study|Non-Compliance|1|||
125627615|NCT01946412|451917591|FG000|Overall Study|Continued with commercial Kalydeco|2|||
125627616|NCT01946412|451917591|FG000|Overall Study|Difficulty in swallowing|1|||
125627617|NCT02088541|451919641|FG000|Overall Study|Adverse Event|3|||
125627618|NCT02088541|451919642|FG001|Overall Study|Adverse Event|0|||
125627619|NCT02088541|451919643|FG002|Overall Study|Adverse Event|3|||
125627620|NCT02088541|451919644|FG003|Overall Study|Adverse Event|3|||
125627621|NCT02088541|451919645|FG004|Overall Study|Adverse Event|0|||
125627622|NCT02088541|451919641|FG000|Overall Study|Death|51|||
125627623|NCT02088541|451919642|FG001|Overall Study|Death|21|||
125627624|NCT02088541|451919643|FG002|Overall Study|Death|85|||
125627625|NCT02088541|451919644|FG003|Overall Study|Death|28|||
125627626|NCT02088541|451919645|FG004|Overall Study|Death|38|||
125627627|NCT02088541|451919641|FG000|Overall Study|Lost to Follow-up|2|||
125627628|NCT02088541|451919642|FG001|Overall Study|Lost to Follow-up|0|||
125627629|NCT02088541|451919643|FG002|Overall Study|Lost to Follow-up|1|||
125627630|NCT02088541|451919644|FG003|Overall Study|Lost to Follow-up|0|||
125627631|NCT02088541|451919645|FG004|Overall Study|Lost to Follow-up|0|||
125627632|NCT02088541|451919641|FG000|Overall Study|Physician Decision|2|||
125627633|NCT02088541|451919642|FG001|Overall Study|Physician Decision|1|||
125627634|NCT02088541|451919643|FG002|Overall Study|Physician Decision|2|||
125627635|NCT02088541|451919644|FG003|Overall Study|Physician Decision|0|||
125627636|NCT02088541|451919645|FG004|Overall Study|Physician Decision|2|||
125627637|NCT02088541|451919641|FG000|Overall Study|Disease progression|7|||
125627638|NCT02088541|451919642|FG001|Overall Study|Disease progression|1|||
125627639|NCT02088541|451919643|FG002|Overall Study|Disease progression|2|||
125627640|NCT02088541|451919644|FG003|Overall Study|Disease progression|3|||
125627641|NCT02088541|451919645|FG004|Overall Study|Disease progression|1|||
125627642|NCT02088541|451919641|FG000|Overall Study|Study terminated by sponsor|1|||
125627643|NCT02088541|451919642|FG001|Overall Study|Study terminated by sponsor|1|||
125627644|NCT02088541|451919643|FG002|Overall Study|Study terminated by sponsor|12|||
125627645|NCT02088541|451919644|FG003|Overall Study|Study terminated by sponsor|2|||
125627646|NCT02088541|451919645|FG004|Overall Study|Study terminated by sponsor|6|||
125627647|NCT02088541|451919641|FG000|Overall Study|Withdrawal by Subject|3|||
125627648|NCT02088541|451919642|FG001|Overall Study|Withdrawal by Subject|2|||
125627649|NCT02088541|451919643|FG002|Overall Study|Withdrawal by Subject|9|||
125627650|NCT02088541|451919644|FG003|Overall Study|Withdrawal by Subject|7|||
125627651|NCT02088541|451919645|FG004|Overall Study|Withdrawal by Subject|10|||
125128467|NCT01263704|450096081|FG000|Overall Study|Death|2|||
125434421|NCT01588990|451217590|FG000|Phase A|Withdrawal by Subject|5|||
125434422|NCT01588990|451217590|FG000|Phase A|Physician Decision|11|||
125434423|NCT01588990|451217590|FG000|Phase A|Other|14|||
125434424|NCT01588990|451217590|FG000|Phase A|Lost to Follow-up|1|||
125434425|NCT01588990|451217590|FG000|Phase A|Death|5|||
125627652|NCT02088541|451919641|FG000|Overall Study|Other|2|||
125627653|NCT02088541|451919642|FG001|Overall Study|Other|1|||
125627654|NCT02088541|451919643|FG002|Overall Study|Other|3|||
125627655|NCT02088541|451919644|FG003|Overall Study|Other|1|||
125627656|NCT02088541|451919645|FG004|Overall Study|Other|1|||
125627657|NCT01625611|451919646|FG000|Overall Study|No adlib drinks Lab 1|3|||
125627658|NCT01625611|451919647|FG001|Overall Study|No adlib drinks Lab 1|0|||
125434426|NCT01588990|451217590|FG000|Phase A|Adverse Event|28|||
125434427|NCT01588990|451217590|FG000|Phase A|Still on therapy at end of study|6|||
125434428|NCT01588990|451217590|FG000|Phase B|Adverse Event|2|||
125627659|NCT01625611|451919646|FG000|Overall Study|Technical issues with PET|1|||
125627660|NCT01625611|451919647|FG001|Overall Study|Technical issues with PET|0|||
125627661|NCT01625611|451919646|FG000|Overall Study|Unable to complete study procedures|1|||
125627662|NCT01625611|451919647|FG001|Overall Study|Unable to complete study procedures|0|||
125434429|NCT01588990|451217590|FG000|Phase B|Still on therapy at end of study|5|||
125434430|NCT01588990|451217590|FG000|Phase B|Withdrawal by Subject|3|||
125627663|NCT01625611|451919646|FG000|Overall Study|Withdrawal by Subject|3|||
125627664|NCT01625611|451919647|FG001|Overall Study|Withdrawal by Subject|0|||
125627665|NCT02431793|451919648|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
125627666|NCT02431793|451919649|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
125627667|NCT02431793|451919650|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
125627668|NCT02431793|451919648|FG000|Overall Study|Withdrawal by Subject|7|||
125627669|NCT02431793|451919649|FG001|Overall Study|Withdrawal by Subject|5|||
125215590|NCT00303472|450417446|FG000|Treatment Period|Adverse Event|0|||
125215591|NCT00303472|450417447|FG001|Treatment Period|Adverse Event|0|||
125375263|NCT03454997|451003622|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
125434431|NCT01588990|451217590|FG000|Phase B|Physician Decision|4|||
125434432|NCT01588990|451217590|FG000|Phase B|Other|2|||
125434433|NCT02367716|451217595|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
125434434|NCT01834222|451217602|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
125434435|NCT04251065|451217603|FG000|Overall Study|Death|2|||
125434436|NCT04251065|451217603|FG000|Overall Study|Lack of Efficacy|3|||
125434437|NCT04251065|451217603|FG000|Overall Study|Death|1|||
125434438|NCT01054573|451217604|FG000|Overall Study|Adverse Event|1|||
125434439|NCT01054573|451217605|FG001|Overall Study|Adverse Event|0|||
125434440|NCT01054573|451217606|FG002|Overall Study|Adverse Event|1|||
125434441|NCT01054573|451217607|FG003|Overall Study|Adverse Event|1|||
125434442|NCT01054573|451217604|FG000|Overall Study|Lost to Follow-up|0|||
125434443|NCT01054573|451217605|FG001|Overall Study|Lost to Follow-up|2|||
125434444|NCT01054573|451217606|FG002|Overall Study|Lost to Follow-up|0|||
125434445|NCT01054573|451217607|FG003|Overall Study|Lost to Follow-up|0|||
125434446|NCT01054573|451217604|FG000|Overall Study|Withdrawal by Subject|0|||
125434447|NCT01054573|451217605|FG001|Overall Study|Withdrawal by Subject|2|||
125434448|NCT01054573|451217606|FG002|Overall Study|Withdrawal by Subject|2|||
125434449|NCT01054573|451217607|FG003|Overall Study|Withdrawal by Subject|1|||
125434450|NCT00979602|451217608|FG000|Overall Study|Serious Adverse Event|5|||
125434451|NCT00979602|451217609|FG001|Overall Study|Serious Adverse Event|3|||
125434452|NCT00979602|451217608|FG000|Overall Study|Protocol Violation|3|||
125375264|NCT03454997|451003621|FG000|Overall Study|Client with SMI - Left organization|0|||
125375265|NCT03454997|451003622|FG001|Overall Study|Client with SMI - Left organization|1|||
125375266|NCT03454997|451003621|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
125375267|NCT03454997|451003622|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
125375268|NCT01191801|451003625|FG000|Overall Study|Death|36|||
125375269|NCT01191801|451003626|FG001|Overall Study|Death|12|||
125375270|NCT01191801|451003625|FG000|Overall Study|Lack of Efficacy|176|||
125375271|NCT01191801|451003626|FG001|Overall Study|Lack of Efficacy|258|||
125375272|NCT01191801|451003625|FG000|Overall Study|Adverse Event|9|||
125375273|NCT01191801|451003626|FG001|Overall Study|Adverse Event|8|||
125375274|NCT01191801|451003625|FG000|Overall Study|Protocol Violation|2|||
125375275|NCT01191801|451003626|FG001|Overall Study|Protocol Violation|4|||
125375276|NCT01191801|451003625|FG000|Overall Study|Physician Decision|47|||
125375277|NCT01191801|451003626|FG001|Overall Study|Physician Decision|24|||
125375278|NCT01191801|451003625|FG000|Overall Study|Withdrawal by Subject|1|||
125375279|NCT01191801|451003626|FG001|Overall Study|Withdrawal by Subject|4|||
125375280|NCT01191801|451003625|FG000|Overall Study|Not Provided|45|||
125375281|NCT01191801|451003626|FG001|Overall Study|Not Provided|27|||
125375282|NCT00299975|451003637|FG000|Overall Study|Adverse Event|1|||
125375283|NCT00299975|451003638|FG001|Overall Study|Adverse Event|0|||
125375284|NCT00299975|451003639|FG002|Overall Study|Adverse Event|2|||
125375285|NCT00299975|451003637|FG000|Overall Study|Pregnancy|0|||
125375286|NCT00299975|451003638|FG001|Overall Study|Pregnancy|0|||
125375287|NCT00299975|451003639|FG002|Overall Study|Pregnancy|1|||
125375288|NCT00299975|451003637|FG000|Overall Study|Lack of Efficacy|1|||
125375289|NCT00299975|451003638|FG001|Overall Study|Lack of Efficacy|0|||
125375290|NCT00299975|451003639|FG002|Overall Study|Lack of Efficacy|1|||
125375291|NCT00299975|451003637|FG000|Overall Study|Lost to Follow-up|1|||
125375292|NCT00299975|451003638|FG001|Overall Study|Lost to Follow-up|0|||
125434453|NCT00979602|451217609|FG001|Overall Study|Protocol Violation|0|||
125375293|NCT00299975|451003639|FG002|Overall Study|Lost to Follow-up|0|||
125375294|NCT00299975|451003637|FG000|Overall Study|Withdrawal by Subject|0|||
125375295|NCT00299975|451003638|FG001|Overall Study|Withdrawal by Subject|1|||
125375296|NCT00299975|451003639|FG002|Overall Study|Withdrawal by Subject|3|||
125375297|NCT00299975|451003637|FG000|Overall Study|Physician Decision|0|||
125434454|NCT00979602|451217608|FG000|Overall Study|Withdrawal by Subject|31|||
125434455|NCT00979602|451217609|FG001|Overall Study|Withdrawal by Subject|25|||
125375298|NCT00299975|451003638|FG001|Overall Study|Physician Decision|0|||
125434456|NCT00979602|451217608|FG000|Overall Study|Lost to Follow-up|100|||
125434457|NCT00979602|451217609|FG001|Overall Study|Lost to Follow-up|96|||
125434458|NCT00979602|451217608|FG000|Overall Study|Migrated/moved from study area|3|||
125434459|NCT00979602|451217609|FG001|Overall Study|Migrated/moved from study area|6|||
125627670|NCT02431793|451919650|FG002|Overall Study|Withdrawal by Subject|5|||
125375299|NCT00299975|451003639|FG002|Overall Study|Physician Decision|1|||
125434460|NCT00979602|451217608|FG000|Overall Study|Others|3|||
125434461|NCT00979602|451217609|FG001|Overall Study|Others|3|||
125434462|NCT04091360|451217610|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125434463|NCT04091360|451217611|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125434464|NCT04091360|451217612|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125434465|NCT04091360|451217613|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125434466|NCT04091360|451217614|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125434467|NCT04091360|451217615|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125434468|NCT04091360|451217616|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125434469|NCT04091360|451217617|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
125434470|NCT04091360|451217618|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
125434471|NCT04091360|451217619|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
125434472|NCT04091360|451217610|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125434473|NCT04091360|451217611|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125434474|NCT04091360|451217612|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125434475|NCT04091360|451217613|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125434476|NCT04091360|451217614|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125434477|NCT04091360|451217615|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125434478|NCT04091360|451217616|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
125434479|NCT04091360|451217617|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
125434480|NCT04091360|451217618|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125434481|NCT04091360|451217619|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
125434482|NCT04091360|451217610|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125434483|NCT04091360|451217611|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125434484|NCT04091360|451217612|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125434485|NCT04091360|451217613|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125434486|NCT04091360|451217614|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125434487|NCT04091360|451217615|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125434488|NCT04091360|451217616|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
125434489|NCT04091360|451217617|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125434490|NCT04091360|451217618|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
125434491|NCT04091360|451217619|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
125434492|NCT00423852|451217620|FG000|Overall Study|Removed pior to the high-dose portion|3|||
125434493|NCT02541383|451217622|FG000|Overall Study|Death|50|||
125434494|NCT02541383|451217623|FG001|Overall Study|Death|37|||
125434495|NCT02541383|451217624|FG002|Overall Study|Death|48|||
125434496|NCT02541383|451217625|FG003|Overall Study|Death|41|||
125434497|NCT02541383|451217626|FG004|Overall Study|Death|21|||
125434498|NCT02541383|451217627|FG005|Overall Study|Death|25|||
125434499|NCT02541383|451217622|FG000|Overall Study|Lost to Follow-up|5|||
125434500|NCT02541383|451217623|FG001|Overall Study|Lost to Follow-up|3|||
125434501|NCT02541383|451217624|FG002|Overall Study|Lost to Follow-up|1|||
125434502|NCT02541383|451217625|FG003|Overall Study|Lost to Follow-up|1|||
125434503|NCT02541383|451217626|FG004|Overall Study|Lost to Follow-up|3|||
125434504|NCT02541383|451217627|FG005|Overall Study|Lost to Follow-up|0|||
125434505|NCT02541383|451217622|FG000|Overall Study|Consent withdrawn|5|||
125434506|NCT02541383|451217623|FG001|Overall Study|Consent withdrawn|6|||
125434507|NCT02541383|451217624|FG002|Overall Study|Consent withdrawn|1|||
125434508|NCT02541383|451217625|FG003|Overall Study|Consent withdrawn|1|||
125434509|NCT02541383|451217626|FG004|Overall Study|Consent withdrawn|0|||
125434510|NCT02541383|451217627|FG005|Overall Study|Consent withdrawn|0|||
125434511|NCT02541383|451217622|FG000|Overall Study|Sponsor's decision|1|||
125434512|NCT02541383|451217623|FG001|Overall Study|Sponsor's decision|1|||
125434513|NCT02541383|451217624|FG002|Overall Study|Sponsor's decision|0|||
125434514|NCT02541383|451217625|FG003|Overall Study|Sponsor's decision|0|||
125434515|NCT02541383|451217626|FG004|Overall Study|Sponsor's decision|0|||
125434516|NCT02541383|451217627|FG005|Overall Study|Sponsor's decision|0|||
125434517|NCT03500640|451217628|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
125434518|NCT03500640|451217629|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
125215592|NCT00303472|450417448|FG002|Treatment Period|Adverse Event|0|||
125215593|NCT00303472|450417449|FG003|Treatment Period|Adverse Event|0|||
125215594|NCT00303472|450417450|FG004|Treatment Period|Adverse Event|1|||
125215595|NCT00303472|450417451|FG005|Treatment Period|Adverse Event|0|||
125215596|NCT00303472|450417452|FG006|Treatment Period|Adverse Event|0|||
125434519|NCT03500640|451217630|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
125434520|NCT03500640|451217628|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
125434521|NCT03500640|451217629|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
125434522|NCT03500640|451217630|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
125434523|NCT03500640|451217628|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
125434524|NCT03500640|451217629|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
125434525|NCT03500640|451217630|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
125434526|NCT03500640|451217628|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
125434527|NCT03500640|451217629|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
125434528|NCT03500640|451217630|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
125434529|NCT03500640|451217628|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
125434530|NCT03500640|451217629|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
125434531|NCT03500640|451217630|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
125434532|NCT03500640|451217628|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
125434533|NCT03500640|451217629|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
125434534|NCT03500640|451217630|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
125434535|NCT03500640|451217628|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
125434536|NCT03500640|451217629|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
125434537|NCT03500640|451217630|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
125434538|NCT03500640|451217628|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
125434539|NCT03500640|451217629|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
125128468|NCT01263704|450096081|FG000|Overall Study|Patient withdrew consent|2|||
125375300|NCT00171730|451003642|FG000|Overall Study|Adverse Event|3|||
125375301|NCT00171730|451003642|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
125375302|NCT00171730|451003642|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
125375303|NCT00171730|451003642|FG000|Overall Study|Withdrawal by Subject|3|||
125375304|NCT05025241|451003643|FG000|Screening|Failed Screening|5|||
125375305|NCT05025241|451003643|FG000|Treatment and Follow Up|Adverse Event|3|||
125375306|NCT01053221|451003644|FG000|Overall Study|The study was closed prematurely|5|||
125375307|NCT01053221|451003645|FG001|Overall Study|The study was closed prematurely|9|||
125375308|NCT02266225|451003646|FG000|Overall Study|Lost to Follow-up|2|||
125375309|NCT02266225|451003646|FG000|Overall Study|Death|1|||
125375310|NCT02266225|451003646|FG000|Overall Study|Withdrawal by Subject|13|||
125375311|NCT05288062|451003651|FG000|Overall Study|Ineligible|0|||
125375312|NCT05288062|451003652|FG001|Overall Study|Ineligible|0|||
125375313|NCT05288062|451003653|FG002|Overall Study|Ineligible|1|||
125375314|NCT05288062|451003654|FG003|Overall Study|Ineligible|0|||
125375315|NCT05288062|451003651|FG000|Overall Study|Withdrawal by Subject|0|||
125375316|NCT05288062|451003652|FG001|Overall Study|Withdrawal by Subject|0|||
125375317|NCT05288062|451003653|FG002|Overall Study|Withdrawal by Subject|1|||
125375318|NCT05288062|451003654|FG003|Overall Study|Withdrawal by Subject|0|||
125375319|NCT01217814|451003655|FG000|Overall Study|Adverse Event|1|||
125375320|NCT01217814|451003656|FG001|Overall Study|Adverse Event|1|||
125375321|NCT01217814|451003657|FG002|Overall Study|Adverse Event|0|||
125375322|NCT01217814|451003655|FG000|Overall Study|Lack of Efficacy|0|||
125375323|NCT01217814|451003656|FG001|Overall Study|Lack of Efficacy|0|||
125375324|NCT01217814|451003657|FG002|Overall Study|Lack of Efficacy|1|||
125375325|NCT03926169|451003660|FG000|Period A|Adverse Event|2|||
125375326|NCT03926169|451003661|FG001|Period A|Adverse Event|2|||
125375327|NCT03926169|451003662|FG002|Period A|Adverse Event|1|||
125375328|NCT03926169|451003660|FG000|Period A|Withdrawal by Subject|2|||
125375329|NCT03926169|451003661|FG001|Period A|Withdrawal by Subject|2|||
125375330|NCT03926169|451003662|FG002|Period A|Withdrawal by Subject|2|||
125375331|NCT03926169|451003660|FG000|Period A|Lost to Follow-up|3|||
125375332|NCT03926169|451003661|FG001|Period A|Lost to Follow-up|1|||
125375333|NCT03926169|451003662|FG002|Period A|Lost to Follow-up|0|||
125375334|NCT03926169|451003660|FG000|Period A|Lack of Efficacy|0|||
125375335|NCT03926169|451003661|FG001|Period A|Lack of Efficacy|2|||
125375336|NCT03926169|451003662|FG002|Period A|Lack of Efficacy|2|||
125375337|NCT03926169|451003660|FG000|Period A|COVID-19 Infection|0|||
125375338|NCT03926169|451003661|FG001|Period A|COVID-19 Infection|1|||
125375339|NCT03926169|451003662|FG002|Period A|COVID-19 Infection|0|||
125375340|NCT03926169|451003660|FG000|Period A|COVID-19 Logistical Restrictions|0|||
125375341|NCT03926169|451003661|FG001|Period A|COVID-19 Logistical Restrictions|2|||
125434540|NCT03500640|451217630|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
125434541|NCT03500640|451217628|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
125434542|NCT03500640|451217629|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
125434543|NCT03500640|451217630|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
125627671|NCT02431793|451919648|FG000|Overall Study|Lost to Follow-up|101|||
125627672|NCT02431793|451919649|FG001|Overall Study|Lost to Follow-up|122|||
125375342|NCT03926169|451003662|FG002|Period A|COVID-19 Logistical Restrictions|1|||
125375343|NCT03926169|451003660|FG000|Period A|Other, Not Specified|1|||
125375344|NCT03926169|451003661|FG001|Period A|Other, Not Specified|0|||
125375345|NCT03926169|451003662|FG002|Period A|Other, Not Specified|0|||
125375346|NCT03926169|451003660|FG000|Period B|Adverse Event|3|||
125375347|NCT03926169|451003661|FG001|Period B|Adverse Event|1|||
125375348|NCT03926169|451003662|FG002|Period B|Adverse Event|1|||
125375349|NCT03926169|451003660|FG000|Period B|Withdrawal by Subject|1|||
125375350|NCT03926169|451003661|FG001|Period B|Withdrawal by Subject|3|||
125375351|NCT03926169|451003662|FG002|Period B|Withdrawal by Subject|0|||
125375352|NCT03926169|451003660|FG000|Period B|Lack of Efficacy|3|||
125375353|NCT03926169|451003661|FG001|Period B|Lack of Efficacy|1|||
125375354|NCT03926169|451003662|FG002|Period B|Lack of Efficacy|1|||
125215597|NCT00303472|450417446|FG000|Treatment Period|Death|0|||
125215598|NCT00303472|450417447|FG001|Treatment Period|Death|0|||
125215599|NCT00303472|450417448|FG002|Treatment Period|Death|0|||
125215600|NCT00303472|450417449|FG003|Treatment Period|Death|1|||
125215601|NCT00303472|450417450|FG004|Treatment Period|Death|0|||
125215602|NCT00303472|450417451|FG005|Treatment Period|Death|0|||
125215603|NCT00303472|450417452|FG006|Treatment Period|Death|1|||
125215604|NCT00303472|450417446|FG000|Treatment Period|Withdrawal by Subject|0|||
125215605|NCT00303472|450417447|FG001|Treatment Period|Withdrawal by Subject|0|||
125215606|NCT00303472|450417448|FG002|Treatment Period|Withdrawal by Subject|0|||
125215607|NCT00303472|450417449|FG003|Treatment Period|Withdrawal by Subject|1|||
125215608|NCT00303472|450417450|FG004|Treatment Period|Withdrawal by Subject|0|||
125215609|NCT00303472|450417451|FG005|Treatment Period|Withdrawal by Subject|1|||
125215610|NCT00303472|450417452|FG006|Treatment Period|Withdrawal by Subject|0|||
125215611|NCT00303472|450417446|FG000|Treatment Period|Other|0|||
125215612|NCT00303472|450417447|FG001|Treatment Period|Other|0|||
125215613|NCT00303472|450417448|FG002|Treatment Period|Other|0|||
125215614|NCT00303472|450417449|FG003|Treatment Period|Other|0|||
125215615|NCT00303472|450417450|FG004|Treatment Period|Other|1|||
125215616|NCT00303472|450417451|FG005|Treatment Period|Other|0|||
125215617|NCT00303472|450417452|FG006|Treatment Period|Other|1|||
125215618|NCT00303472|450417446|FG000|Treatment Period|Disease Progression (to AML)|0|||
125215619|NCT00303472|450417447|FG001|Treatment Period|Disease Progression (to AML)|0|||
125215620|NCT00303472|450417448|FG002|Treatment Period|Disease Progression (to AML)|0|||
125215621|NCT00303472|450417449|FG003|Treatment Period|Disease Progression (to AML)|0|||
125215622|NCT00303472|450417450|FG004|Treatment Period|Disease Progression (to AML)|1|||
125215623|NCT00303472|450417451|FG005|Treatment Period|Disease Progression (to AML)|0|||
125215624|NCT00303472|450417452|FG006|Treatment Period|Disease Progression (to AML)|0|||
125215625|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Adverse Event|1|||
125215626|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Adverse Event|0|||
125215627|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Adverse Event|1|||
125215628|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Adverse Event|0|||
125215629|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Adverse Event|0|||
125215630|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Adverse Event|0|||
125215631|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Adverse Event|0|||
125215632|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Death|2|||
125215633|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Death|0|||
125215634|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Death|1|||
125215635|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Death|0|||
125215636|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Death|0|||
125215637|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Death|0|||
125215638|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Death|0|||
125215639|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
125215640|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
125215641|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
125215642|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
125215643|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
125215644|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
125375355|NCT03926169|451003660|FG000|Period B|Lost to Follow-up|1|||
125375356|NCT03926169|451003661|FG001|Period B|Lost to Follow-up|1|||
125375357|NCT03926169|451003662|FG002|Period B|Lost to Follow-up|4|||
125375358|NCT03926169|451003660|FG000|Period B|Other, Not Specified|62|||
125375359|NCT03926169|451003661|FG001|Period B|Other, Not Specified|57|||
125375360|NCT03926169|451003662|FG002|Period B|Other, Not Specified|65|||
125375361|NCT01950741|451003665|FG000|Overall Study|Lost to Follow-up|1|||
125375362|NCT01950741|451003665|FG000|Overall Study|Death|1|||
125375363|NCT01950741|451003665|FG000|Overall Study|Withdrawal by Subject|1|||
125375364|NCT00844896|451003666|FG000|Overall Study|Lost to Follow-up|12|||
125375365|NCT00844896|451003667|FG001|Overall Study|Lost to Follow-up|16|||
125375366|NCT00844896|451003666|FG000|Overall Study|Parents did not have time to complete|0|||
125375367|NCT00844896|451003667|FG001|Overall Study|Parents did not have time to complete|1|||
125375368|NCT02233647|451003671|FG000|Overall Study|Adverse Event|1|||
125375369|NCT01835587|451003672|FG000|Overall Study|Disease Recurrence or Relapse|0|||
125375370|NCT01835587|451003673|FG001|Overall Study|Disease Recurrence or Relapse|3|||
125375371|NCT01835587|451003674|FG002|Overall Study|Disease Recurrence or Relapse|0|||
125375372|NCT01835587|451003675|FG003|Overall Study|Disease Recurrence or Relapse|3|||
125375373|NCT01835587|451003672|FG000|Overall Study|Withdrawal by Subject|2|||
125375374|NCT01835587|451003673|FG001|Overall Study|Withdrawal by Subject|0|||
125375375|NCT01835587|451003674|FG002|Overall Study|Withdrawal by Subject|0|||
125375376|NCT01835587|451003675|FG003|Overall Study|Withdrawal by Subject|3|||
125375377|NCT01835587|451003672|FG000|Overall Study|Adverse Event|0|||
125375378|NCT01835587|451003673|FG001|Overall Study|Adverse Event|0|||
125375379|NCT01835587|451003674|FG002|Overall Study|Adverse Event|2|||
125375380|NCT01835587|451003675|FG003|Overall Study|Adverse Event|2|||
125375381|NCT01835587|451003672|FG000|Overall Study|Death|0|||
125375382|NCT01835587|451003673|FG001|Overall Study|Death|0|||
125375383|NCT01835587|451003674|FG002|Overall Study|Death|0|||
125627673|NCT02431793|451919650|FG002|Overall Study|Lost to Follow-up|104|||
125627674|NCT03170258|451919654|FG000|Overall Study|Physician Decision|4|||
125627675|NCT03170258|451919655|FG001|Overall Study|Physician Decision|0|||
125627676|NCT03170258|451919654|FG000|Overall Study|Equipment issues|1|||
125627677|NCT03170258|451919655|FG001|Overall Study|Equipment issues|0|||
125627678|NCT03170258|451919654|FG000|Overall Study|Medication|1|||
125627679|NCT03170258|451919655|FG001|Overall Study|Medication|0|||
125627680|NCT03170258|451919654|FG000|Overall Study|Sleep issues|1|||
125627681|NCT03170258|451919655|FG001|Overall Study|Sleep issues|0|||
125627682|NCT01563107|451919656|FG000|Overall Study|Physician Decision|0|||
125627683|NCT01563107|451919657|FG001|Overall Study|Physician Decision|1|||
125627684|NCT01563107|451919658|FG002|Overall Study|Physician Decision|1|||
125627685|NCT01563107|451919659|FG003|Overall Study|Physician Decision|3|||
125627686|NCT01563107|451919656|FG000|Overall Study|Withdrawal by Subject|1|||
125627687|NCT01563107|451919657|FG001|Overall Study|Withdrawal by Subject|2|||
125627688|NCT01563107|451919658|FG002|Overall Study|Withdrawal by Subject|1|||
125627689|NCT01563107|451919659|FG003|Overall Study|Withdrawal by Subject|2|||
125627690|NCT03907969|451919660|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
125627691|NCT03907969|451919661|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
125627692|NCT03907969|451919662|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
125627693|NCT03907969|451919663|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
125627694|NCT03907969|451919664|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
125627695|NCT03907969|451919665|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
125627696|NCT03907969|451919666|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
125627697|NCT03907969|451919667|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
125627698|NCT03907969|451919668|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
125627699|NCT03907969|451919669|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
125627700|NCT03907969|451919670|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
125627701|NCT03907969|451919660|FG000|Monotherapy Part A|Progressive Disease|0|||
125627702|NCT03907969|451919661|FG001|Monotherapy Part A|Progressive Disease|1|||
125627703|NCT03907969|451919662|FG002|Monotherapy Part A|Progressive Disease|0|||
125627704|NCT03907969|451919663|FG003|Monotherapy Part A|Progressive Disease|0|||
125627705|NCT03907969|451919664|FG004|Monotherapy Part A|Progressive Disease|0|||
125627706|NCT03907969|451919665|FG005|Monotherapy Part A|Progressive Disease|1|||
125627707|NCT03907969|451919666|FG006|Monotherapy Part A|Progressive Disease|2|||
125627708|NCT03907969|451919667|FG007|Monotherapy Part A|Progressive Disease|0|||
125627709|NCT03907969|451919668|FG008|Monotherapy Part A|Progressive Disease|0|||
125627710|NCT03907969|451919669|FG009|Monotherapy Part A|Progressive Disease|0|||
125627711|NCT03907969|451919670|FG010|Monotherapy Part A|Progressive Disease|0|||
125627712|NCT03907969|451919660|FG000|Monotherapy Part A|Death|0|||
125627713|NCT03907969|451919661|FG001|Monotherapy Part A|Death|0|||
125627714|NCT03907969|451919662|FG002|Monotherapy Part A|Death|1|||
125627715|NCT03907969|451919663|FG003|Monotherapy Part A|Death|1|||
125627716|NCT03907969|451919664|FG004|Monotherapy Part A|Death|0|||
125627717|NCT03907969|451919665|FG005|Monotherapy Part A|Death|1|||
125627718|NCT03907969|451919666|FG006|Monotherapy Part A|Death|0|||
125627719|NCT03907969|451919667|FG007|Monotherapy Part A|Death|0|||
125627720|NCT03907969|451919668|FG008|Monotherapy Part A|Death|0|||
125627721|NCT03907969|451919669|FG009|Monotherapy Part A|Death|0|||
125627722|NCT03907969|451919670|FG010|Monotherapy Part A|Death|0|||
125627723|NCT03907969|451919660|FG000|Combination Therapy Part A|Adverse Event|0|||
125215645|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
125215646|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Physician Decision|0|||
125215647|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Physician Decision|4|||
125627724|NCT03907969|451919661|FG001|Combination Therapy Part A|Adverse Event|0|||
125627725|NCT03907969|451919662|FG002|Combination Therapy Part A|Adverse Event|0|||
125627726|NCT03907969|451919663|FG003|Combination Therapy Part A|Adverse Event|0|||
125627727|NCT03907969|451919664|FG004|Combination Therapy Part A|Adverse Event|0|||
125627728|NCT03907969|451919665|FG005|Combination Therapy Part A|Adverse Event|0|||
125375384|NCT01835587|451003675|FG003|Overall Study|Death|1|||
125627729|NCT03907969|451919666|FG006|Combination Therapy Part A|Adverse Event|0|||
125627730|NCT03907969|451919667|FG007|Combination Therapy Part A|Adverse Event|0|||
125627731|NCT03907969|451919668|FG008|Combination Therapy Part A|Adverse Event|0|||
125627732|NCT03907969|451919669|FG009|Combination Therapy Part A|Adverse Event|1|||
125627733|NCT03907969|451919670|FG010|Combination Therapy Part A|Adverse Event|1|||
125375385|NCT01835587|451003672|FG000|Overall Study|Miscellaneous|0|||
125375386|NCT01835587|451003673|FG001|Overall Study|Miscellaneous|1|||
125375387|NCT01835587|451003674|FG002|Overall Study|Miscellaneous|0|||
125375388|NCT01835587|451003675|FG003|Overall Study|Miscellaneous|0|||
125375389|NCT02239978|451004869|FG000|Overall Study|Withdrawal by Subject|2|||
125375390|NCT02239978|451004870|FG001|Overall Study|Withdrawal by Subject|0|||
125375391|NCT01852110|451004876|FG000|Overall Study|Adverse Event|12|||
125375392|NCT01852110|451004877|FG001|Overall Study|Adverse Event|5|||
125375393|NCT01852110|451004878|FG002|Overall Study|Adverse Event|0|||
125375394|NCT01852110|451004879|FG003|Overall Study|Adverse Event|0|||
125375395|NCT01852110|451004880|FG004|Overall Study|Adverse Event|0|||
125375396|NCT01852110|451004881|FG005|Overall Study|Adverse Event|0|||
125375397|NCT01852110|451004876|FG000|Overall Study|Lost to Follow-up|1|||
125215648|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Physician Decision|2|||
125215649|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Physician Decision|3|||
125215650|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Physician Decision|2|||
125215651|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Physician Decision|0|||
125215652|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Physician Decision|0|||
125627734|NCT03907969|451919660|FG000|Combination Therapy Part A|Progressive disease|0|||
125627735|NCT03907969|451919661|FG001|Combination Therapy Part A|Progressive disease|0|||
125627736|NCT03907969|451919662|FG002|Combination Therapy Part A|Progressive disease|0|||
125627737|NCT03907969|451919663|FG003|Combination Therapy Part A|Progressive disease|0|||
125627738|NCT03907969|451919664|FG004|Combination Therapy Part A|Progressive disease|0|||
125627739|NCT03907969|451919665|FG005|Combination Therapy Part A|Progressive disease|0|||
125627740|NCT03907969|451919666|FG006|Combination Therapy Part A|Progressive disease|0|||
125627741|NCT03907969|451919667|FG007|Combination Therapy Part A|Progressive disease|1|||
125627742|NCT03907969|451919668|FG008|Combination Therapy Part A|Progressive disease|0|||
125627743|NCT03907969|451919669|FG009|Combination Therapy Part A|Progressive disease|2|||
125627744|NCT03907969|451919670|FG010|Combination Therapy Part A|Progressive disease|3|||
125627745|NCT03907969|451919660|FG000|Combination Therapy Part A|Death|0|||
125627746|NCT03907969|451919661|FG001|Combination Therapy Part A|Death|0|||
125627747|NCT03907969|451919662|FG002|Combination Therapy Part A|Death|0|||
125627748|NCT03907969|451919663|FG003|Combination Therapy Part A|Death|0|||
125215653|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
125215654|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
125215655|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
125215656|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
125215657|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
125215658|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
125215659|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
125215660|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Other|0|||
125215661|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Other|2|||
125215662|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Other|4|||
125215663|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Other|2|||
125215664|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Other|1|||
125215665|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Other|0|||
125215666|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Other|0|||
125215667|NCT00303472|450417446|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
125215668|NCT00303472|450417447|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
125215669|NCT00303472|450417448|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
125215670|NCT00303472|450417449|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
125215671|NCT00303472|450417450|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
125215672|NCT00303472|450417451|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
125215673|NCT00303472|450417452|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
125215674|NCT02081001|450417453|FG000|Overall Study|Adverse Event|0|||
125215675|NCT02081001|450417454|FG001|Overall Study|Adverse Event|0|||
125215676|NCT02081001|450417455|FG002|Overall Study|Adverse Event|0|||
125215677|NCT02081001|450417456|FG003|Overall Study|Adverse Event|0|||
125215678|NCT02081001|450417457|FG004|Overall Study|Adverse Event|1|||
125215679|NCT02081001|450417458|FG005|Overall Study|Adverse Event|0|||
125215680|NCT02081001|450417459|FG006|Overall Study|Adverse Event|0|||
125215681|NCT02081001|450417460|FG007|Overall Study|Adverse Event|0|||
125215682|NCT02081001|450417461|FG008|Overall Study|Adverse Event|0|||
125215683|NCT02081001|450417462|FG009|Overall Study|Adverse Event|0|||
125215684|NCT02081001|450417463|FG010|Overall Study|Adverse Event|0|||
125215685|NCT02081001|450417464|FG011|Overall Study|Adverse Event|0|||
125215686|NCT02347072|450417467|FG000|Overall Study|Adverse Event|2|||
125375398|NCT01852110|451004877|FG001|Overall Study|Lost to Follow-up|3|||
125375399|NCT01852110|451004878|FG002|Overall Study|Lost to Follow-up|0|||
125375400|NCT01852110|451004879|FG003|Overall Study|Lost to Follow-up|0|||
125375401|NCT01852110|451004880|FG004|Overall Study|Lost to Follow-up|0|||
125375402|NCT01852110|451004881|FG005|Overall Study|Lost to Follow-up|0|||
125375403|NCT01852110|451004876|FG000|Overall Study|Non-compliance with Study Drug|2|||
125375404|NCT01852110|451004877|FG001|Overall Study|Non-compliance with Study Drug|1|||
125375405|NCT01852110|451004878|FG002|Overall Study|Non-compliance with Study Drug|0|||
125375406|NCT01852110|451004879|FG003|Overall Study|Non-compliance with Study Drug|0|||
125375407|NCT01852110|451004880|FG004|Overall Study|Non-compliance with Study Drug|0|||
125375408|NCT01852110|451004881|FG005|Overall Study|Non-compliance with Study Drug|0|||
125375409|NCT01852110|451004876|FG000|Overall Study|Physician Decision|1|||
125375410|NCT01852110|451004877|FG001|Overall Study|Physician Decision|0|||
125375411|NCT01852110|451004878|FG002|Overall Study|Physician Decision|0|||
125375412|NCT01852110|451004879|FG003|Overall Study|Physician Decision|0|||
125627749|NCT03907969|451919664|FG004|Combination Therapy Part A|Death|0|||
125627750|NCT03907969|451919665|FG005|Combination Therapy Part A|Death|0|||
125627751|NCT03907969|451919666|FG006|Combination Therapy Part A|Death|0|||
125627752|NCT03907969|451919667|FG007|Combination Therapy Part A|Death|0|||
125627753|NCT03907969|451919668|FG008|Combination Therapy Part A|Death|1|||
125627754|NCT03907969|451919669|FG009|Combination Therapy Part A|Death|0|||
125627755|NCT03907969|451919670|FG010|Combination Therapy Part A|Death|1|||
125627756|NCT03907969|451919660|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
125627757|NCT03907969|451919661|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
125627758|NCT03907969|451919662|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
125627759|NCT03907969|451919663|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
125627760|NCT03907969|451919664|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
125627761|NCT03907969|451919665|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
125627762|NCT03907969|451919666|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
125627763|NCT03907969|451919667|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
125627764|NCT03907969|451919668|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
125627765|NCT03907969|451919669|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
125627766|NCT03907969|451919670|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
125627767|NCT03907969|451919660|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
125627768|NCT03907969|451919661|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
125627769|NCT03907969|451919662|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
125627770|NCT03907969|451919663|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
125627771|NCT03907969|451919664|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
125627772|NCT03907969|451919665|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
125627773|NCT03907969|451919666|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
125627774|NCT03907969|451919667|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
125627775|NCT03907969|451919668|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
125627776|NCT03907969|451919669|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
125627777|NCT03907969|451919670|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
125627778|NCT03907969|451919660|FG000|Combination Therapy Part A|Physician Decision|0|||
125627779|NCT03907969|451919661|FG001|Combination Therapy Part A|Physician Decision|0|||
125627780|NCT03907969|451919662|FG002|Combination Therapy Part A|Physician Decision|0|||
125627781|NCT03907969|451919663|FG003|Combination Therapy Part A|Physician Decision|0|||
125627782|NCT03907969|451919664|FG004|Combination Therapy Part A|Physician Decision|0|||
125627783|NCT03907969|451919665|FG005|Combination Therapy Part A|Physician Decision|0|||
125627784|NCT03907969|451919666|FG006|Combination Therapy Part A|Physician Decision|0|||
125627785|NCT03907969|451919667|FG007|Combination Therapy Part A|Physician Decision|1|||
125627786|NCT03907969|451919668|FG008|Combination Therapy Part A|Physician Decision|0|||
125627787|NCT03907969|451919669|FG009|Combination Therapy Part A|Physician Decision|0|||
125627788|NCT03907969|451919670|FG010|Combination Therapy Part A|Physician Decision|1|||
125627789|NCT00666536|451919671|FG000|Overall Study|Adverse Event|9|||
125627790|NCT00666536|451919672|FG001|Overall Study|Adverse Event|19|||
125627791|NCT00666536|451919671|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125627792|NCT00666536|451919672|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125627793|NCT00666536|451919671|FG000|Overall Study|Protocol deviation(s)|8|||
125627794|NCT00666536|451919672|FG001|Overall Study|Protocol deviation(s)|6|||
125627795|NCT00666536|451919671|FG000|Overall Study|Withdrawal by Subject|10|||
125627796|NCT00666536|451919672|FG001|Overall Study|Withdrawal by Subject|9|||
125627797|NCT00666536|451919671|FG000|Overall Study|Lost to Follow-up|4|||
125627798|NCT00666536|451919672|FG001|Overall Study|Lost to Follow-up|3|||
125627799|NCT00511108|451919676|FG000|Overall Study|Adverse Event|2|||
125627800|NCT00511108|451919677|FG001|Overall Study|Adverse Event|0|||
125627801|NCT00511108|451919678|FG002|Overall Study|Adverse Event|1|||
125627802|NCT00511108|451919679|FG003|Overall Study|Adverse Event|2|||
125627803|NCT00511108|451919676|FG000|Overall Study|Lost to Follow-up|0|||
125627804|NCT00511108|451919677|FG001|Overall Study|Lost to Follow-up|2|||
125627805|NCT00511108|451919678|FG002|Overall Study|Lost to Follow-up|1|||
125627806|NCT00511108|451919679|FG003|Overall Study|Lost to Follow-up|0|||
125627807|NCT00511108|451919676|FG000|Overall Study|Physician Decision|0|||
125627808|NCT00511108|451919677|FG001|Overall Study|Physician Decision|0|||
125627809|NCT00511108|451919678|FG002|Overall Study|Physician Decision|0|||
125627810|NCT00511108|451919679|FG003|Overall Study|Physician Decision|1|||
125627811|NCT00511108|451919676|FG000|Overall Study|Withdrawal by Subject|4|||
125627812|NCT00511108|451919677|FG001|Overall Study|Withdrawal by Subject|0|||
125627813|NCT00511108|451919678|FG002|Overall Study|Withdrawal by Subject|3|||
125627814|NCT00511108|451919679|FG003|Overall Study|Withdrawal by Subject|2|||
125627815|NCT02147691|451919682|FG000|Overall Study|Withdrawal by Subject|2|||
125627816|NCT02147691|451919683|FG001|Overall Study|Withdrawal by Subject|0|||
125627817|NCT02147691|451919682|FG000|Overall Study|Adverse Event|2|||
125627818|NCT02147691|451919683|FG001|Overall Study|Adverse Event|0|||
125627819|NCT02147691|451919682|FG000|Overall Study|Lost to Follow-up|0|||
125627820|NCT02147691|451919683|FG001|Overall Study|Lost to Follow-up|1|||
125627821|NCT02954952|451919684|FG000|Overall Study|Withdrawal by Subject|1|||
125627822|NCT02954952|451919685|FG001|Overall Study|Withdrawal by Subject|0|||
125627823|NCT02954952|451919686|FG002|Overall Study|Withdrawal by Subject|0|||
125627824|NCT02954952|451919684|FG000|Overall Study|No data collected|0|||
125627825|NCT02954952|451919685|FG001|Overall Study|No data collected|1|||
125627826|NCT02954952|451919686|FG002|Overall Study|No data collected|0|||
125627827|NCT01392742|451919689|FG000|Overall Study|Premature study termination|42|||
125627828|NCT01392742|451919689|FG000|Overall Study|Failure to return|35|||
125627829|NCT01392742|451919689|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
125627830|NCT01392742|451919689|FG000|Overall Study|Lost to Follow-up|34|||
125627831|NCT01392742|451919689|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
125627832|NCT01392742|451919689|FG000|Overall Study|ITR and Protocol deviation|1|||
125627833|NCT01392742|451919689|FG000|Overall Study|Adverse event/intercurrent illness|17|||
125627834|NCT01392742|451919689|FG000|Overall Study|Protocol Violation|14|||
125627835|NCT01392742|451919689|FG000|Overall Study|Other|3|||
125627836|NCT01392742|451919689|FG000|Overall Study|Missing information|13|||
125627837|NCT04179032|451919690|FG000|Part B (Up to Week 52)|Adverse Event|1|||
125627838|NCT04179032|451919690|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
125627839|NCT04179032|451919690|FG000|Access Extension Phase|Ongoing|11|||
125627840|NCT03210220|451919691|FG000|Overall Study|Physician Decision|1|||
125627841|NCT03210220|451919692|FG001|Overall Study|Physician Decision|0|||
125627842|NCT02911519|451919693|FG000|Overall Study|Lost to Follow-up|2|||
125627843|NCT02911519|451919694|FG001|Overall Study|Lost to Follow-up|2|||
125627844|NCT02911519|451919693|FG000|Overall Study|Death|0|||
125627845|NCT02911519|451919694|FG001|Overall Study|Death|2|||
125627846|NCT00839436|451919697|FG000|Overall Study|Developed exclusionary condition|1|||
125627847|NCT00839436|451919698|FG001|Overall Study|Developed exclusionary condition|0|||
125627848|NCT00839436|451919699|FG002|Overall Study|Developed exclusionary condition|0|||
125627849|NCT00839436|451919697|FG000|Overall Study|Withdrawal by Subject|0|||
125627850|NCT00839436|451919698|FG001|Overall Study|Withdrawal by Subject|1|||
125627851|NCT00839436|451919699|FG002|Overall Study|Withdrawal by Subject|0|||
125627852|NCT00839436|451919697|FG000|Overall Study|Study drug no longer available|0|||
125627853|NCT00839436|451919698|FG001|Overall Study|Study drug no longer available|0|||
125627854|NCT00839436|451919699|FG002|Overall Study|Study drug no longer available|1|||
125627855|NCT01444898|451919701|FG000|Overall Study|Withdrawal by Subject|1|||
125627856|NCT02580591|451919703|FG000|Overall Study|Adverse Event|0|||
125627857|NCT02580591|451919704|FG001|Overall Study|Adverse Event|1|||
125627858|NCT02580591|451919705|FG002|Overall Study|Adverse Event|2|||
125627859|NCT02580591|451919706|FG003|Overall Study|Adverse Event|5|||
125627860|NCT02580591|451919703|FG000|Overall Study|Protocol Violation|3|||
125627861|NCT02580591|451919704|FG001|Overall Study|Protocol Violation|2|||
125627862|NCT02580591|451919705|FG002|Overall Study|Protocol Violation|1|||
125375413|NCT01852110|451004880|FG004|Overall Study|Physician Decision|0|||
125375414|NCT01852110|451004881|FG005|Overall Study|Physician Decision|0|||
125375415|NCT01852110|451004876|FG000|Overall Study|Protocol Violation|0|||
125375416|NCT01852110|451004877|FG001|Overall Study|Protocol Violation|1|||
125375417|NCT01852110|451004878|FG002|Overall Study|Protocol Violation|0|||
125375418|NCT01852110|451004879|FG003|Overall Study|Protocol Violation|0|||
125375419|NCT01852110|451004880|FG004|Overall Study|Protocol Violation|0|||
125375420|NCT01852110|451004881|FG005|Overall Study|Protocol Violation|0|||
125375421|NCT01852110|451004876|FG000|Overall Study|Study Terminated by Sponsor|30|||
125375422|NCT01852110|451004877|FG001|Overall Study|Study Terminated by Sponsor|32|||
125375423|NCT01852110|451004878|FG002|Overall Study|Study Terminated by Sponsor|0|||
125375424|NCT01852110|451004879|FG003|Overall Study|Study Terminated by Sponsor|0|||
125375425|NCT01852110|451004880|FG004|Overall Study|Study Terminated by Sponsor|0|||
125375426|NCT01852110|451004881|FG005|Overall Study|Study Terminated by Sponsor|0|||
125375427|NCT01852110|451004876|FG000|Overall Study|Withdrawal by Subject|4|||
125375428|NCT01852110|451004877|FG001|Overall Study|Withdrawal by Subject|4|||
125375429|NCT01852110|451004878|FG002|Overall Study|Withdrawal by Subject|0|||
125627863|NCT02580591|451919706|FG003|Overall Study|Protocol Violation|1|||
125627864|NCT02580591|451919703|FG000|Overall Study|Lost to Follow-up|5|||
125627865|NCT02580591|451919704|FG001|Overall Study|Lost to Follow-up|3|||
125627866|NCT02580591|451919705|FG002|Overall Study|Lost to Follow-up|3|||
125627867|NCT02580591|451919706|FG003|Overall Study|Lost to Follow-up|1|||
125627868|NCT02580591|451919703|FG000|Overall Study|Withdrawal by Subject|6|||
125627869|NCT02580591|451919704|FG001|Overall Study|Withdrawal by Subject|1|||
125627870|NCT02580591|451919705|FG002|Overall Study|Withdrawal by Subject|2|||
125627871|NCT02580591|451919706|FG003|Overall Study|Withdrawal by Subject|3|||
125627872|NCT02580591|451919703|FG000|Overall Study|Not treated|1|||
125375430|NCT01852110|451004879|FG003|Overall Study|Withdrawal by Subject|0|||
125375431|NCT01852110|451004880|FG004|Overall Study|Withdrawal by Subject|0|||
125375432|NCT01852110|451004881|FG005|Overall Study|Withdrawal by Subject|0|||
125375433|NCT02430311|451004886|FG000|Part A|Adverse Event|0|||
125627873|NCT02580591|451919704|FG001|Overall Study|Not treated|1|||
125627874|NCT02580591|451919705|FG002|Overall Study|Not treated|0|||
125627875|NCT02580591|451919706|FG003|Overall Study|Not treated|0|||
125627876|NCT02580591|451919703|FG000|Overall Study|Other than specified|3|||
125375434|NCT02430311|451004887|FG001|Part A|Adverse Event|1|||
125627877|NCT02580591|451919704|FG001|Overall Study|Other than specified|2|||
125627878|NCT02580591|451919705|FG002|Overall Study|Other than specified|5|||
125627879|NCT02580591|451919706|FG003|Overall Study|Other than specified|2|||
125627880|NCT00561340|451919710|FG000|Overall Study|refused to drink pediasure|6|||
125627881|NCT00561340|451919711|FG001|Overall Study|refused to drink pediasure|0|||
125627882|NCT00445341|451919712|FG000|Overall Study|refused further treatment|1|||
125627883|NCT00445341|451919712|FG000|Overall Study|taken off treatment too early|1|||
125627884|NCT02443805|451919715|FG000|Overall Study|Adverse Event|100|||
125627885|NCT02443805|451919716|FG001|Overall Study|Adverse Event|18|||
125627886|NCT02443805|451919715|FG000|Overall Study|Withdrawal by Subject|73|||
125627887|NCT02443805|451919716|FG001|Overall Study|Withdrawal by Subject|74|||
125627888|NCT02443805|451919715|FG000|Overall Study|Lost to Follow-up|19|||
125627889|NCT02443805|451919716|FG001|Overall Study|Lost to Follow-up|14|||
125627890|NCT02443805|451919715|FG000|Overall Study|Pregnancy|6|||
125627891|NCT02443805|451919716|FG001|Overall Study|Pregnancy|5|||
125627892|NCT02443805|451919715|FG000|Overall Study|Protocol Violation|2|||
125627893|NCT02443805|451919716|FG001|Overall Study|Protocol Violation|4|||
125627894|NCT02443805|451919715|FG000|Overall Study|Lack of Efficacy|1|||
125627895|NCT02443805|451919716|FG001|Overall Study|Lack of Efficacy|1|||
125627896|NCT02443805|451919715|FG000|Overall Study|Non-compliance with study drug|6|||
125627897|NCT02443805|451919716|FG001|Overall Study|Non-compliance with study drug|4|||
125627898|NCT02443805|451919715|FG000|Overall Study|Withdrawal by parent/guardian|3|||
125627899|NCT02443805|451919716|FG001|Overall Study|Withdrawal by parent/guardian|5|||
125627900|NCT02443805|451919715|FG000|Overall Study|Any other reason not above-mentioned|3|||
125627901|NCT02443805|451919716|FG001|Overall Study|Any other reason not above-mentioned|2|||
125434544|NCT03500640|451217628|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
125434545|NCT03500640|451217629|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
125434546|NCT03500640|451217630|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
125434547|NCT01650519|451217631|FG000|Overall Study|Withdrawal by Subject|1|||
125434548|NCT01650519|451217632|FG001|Overall Study|Withdrawal by Subject|0|||
125434549|NCT05458024|451217635|FG000|Overall Study|Withdrawal by Subject|1|||
125434550|NCT05458024|451217636|FG001|Overall Study|Withdrawal by Subject|1|||
125434551|NCT05229653|451217638|FG000|Overall Study|Lost to Follow-up|1|||
125627902|NCT04362813|451919717|FG000|Overall Study|Death|12|||
125215687|NCT02347072|450417467|FG000|Overall Study|Withdrawal by Subject|6|||
125215688|NCT02347072|450417467|FG000|Overall Study|Physician Decision|1|||
125434552|NCT05229653|451217639|FG001|Overall Study|Lost to Follow-up|0|||
125434553|NCT01845974|451217640|FG000|Overall Study|screen failure|1|||
125434554|NCT01845974|451217641|FG001|Overall Study|screen failure|0|||
125434555|NCT02667886|451217642|FG000|Dose Escalation (Part A)|Adverse Event|1|||
125434556|NCT02667886|451217643|FG001|Dose Escalation (Part A)|Adverse Event|3|||
125434557|NCT02667886|451217644|FG002|Dose Escalation (Part A)|Adverse Event|1|||
125434558|NCT02667886|451217645|FG003|Dose Escalation (Part A)|Adverse Event|0|||
125434559|NCT02667886|451217646|FG004|Dose Escalation (Part A)|Adverse Event|0|||
125434560|NCT02667886|451217642|FG000|Dose Escalation (Part A)|Disease Progression|1|||
125434561|NCT02667886|451217643|FG001|Dose Escalation (Part A)|Disease Progression|4|||
125434562|NCT02667886|451217644|FG002|Dose Escalation (Part A)|Disease Progression|3|||
125434563|NCT02667886|451217645|FG003|Dose Escalation (Part A)|Disease Progression|0|||
125434564|NCT02667886|451217646|FG004|Dose Escalation (Part A)|Disease Progression|0|||
125434565|NCT02667886|451217642|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
125434566|NCT02667886|451217643|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
125434567|NCT02667886|451217644|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
125434568|NCT02667886|451217645|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
125434569|NCT02667886|451217646|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
125434570|NCT02667886|451217642|FG000|Dose Expansion (Part B)|Adverse Event|0|||
125434571|NCT02667886|451217643|FG001|Dose Expansion (Part B)|Adverse Event|0|||
125434572|NCT02667886|451217644|FG002|Dose Expansion (Part B)|Adverse Event|0|||
125434573|NCT02667886|451217645|FG003|Dose Expansion (Part B)|Adverse Event|9|||
125434574|NCT02667886|451217646|FG004|Dose Expansion (Part B)|Adverse Event|0|||
125434575|NCT02667886|451217642|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
125627903|NCT04362813|451919718|FG001|Overall Study|Death|16|||
125627904|NCT04362813|451919717|FG000|Overall Study|Withdrawal by Subject|3|||
125627905|NCT04362813|451919718|FG001|Overall Study|Withdrawal by Subject|1|||
125627906|NCT04362813|451919717|FG000|Overall Study|Protocol Violation|0|||
125627907|NCT04362813|451919718|FG001|Overall Study|Protocol Violation|3|||
125627908|NCT04362813|451919717|FG000|Overall Study|Lost to Follow-up|1|||
125627909|NCT04362813|451919718|FG001|Overall Study|Lost to Follow-up|1|||
125627910|NCT04362813|451919717|FG000|Overall Study|Enrolled but did not receive treatment|2|||
125627911|NCT04362813|451919718|FG001|Overall Study|Enrolled but did not receive treatment|4|||
125627912|NCT00961116|451919719|FG000|Washout Period of 7 Days|Adverse Event|1|||
125627913|NCT00961116|451919720|FG001|Washout Period of 7 Days|Adverse Event|1|||
125627914|NCT00961116|451919719|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
125215689|NCT02347072|450417467|FG000|Overall Study|Lost to Follow-up|2|||
125434576|NCT02667886|451217643|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
125434577|NCT02667886|451217644|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
125434578|NCT02667886|451217645|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
125434579|NCT02667886|451217646|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
125627915|NCT00961116|451919720|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125434580|NCT02667886|451217642|FG000|Dose Expansion (Part B)|Disease Progression|0|||
125434581|NCT02667886|451217643|FG001|Dose Expansion (Part B)|Disease Progression|0|||
125434582|NCT02667886|451217644|FG002|Dose Expansion (Part B)|Disease Progression|0|||
125627916|NCT00961116|451919719|FG000|Washout Period of 7 Days|Protocol Violation|0|||
125627917|NCT00961116|451919720|FG001|Washout Period of 7 Days|Protocol Violation|1|||
125627918|NCT04354155|451919725|FG000|Overall Study|Withdrawal by Subject|1|||
125627919|NCT04354155|451919725|FG000|Overall Study|Did not meet criteria for study intervention|1|||
125627920|NCT02565615|451919726|FG000|Overall Study|Death|0|||
125627921|NCT02565615|451919727|FG001|Overall Study|Death|1|||
125627922|NCT02565615|451919728|FG002|Overall Study|Death|0|||
125627923|NCT02565615|451919729|FG003|Overall Study|Death|0|||
125434583|NCT02667886|451217645|FG003|Dose Expansion (Part B)|Disease Progression|38|||
125434584|NCT02667886|451217646|FG004|Dose Expansion (Part B)|Disease Progression|0|||
125434585|NCT02667886|451217642|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
125434586|NCT02667886|451217643|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
125434587|NCT02667886|451217644|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
125434588|NCT02667886|451217645|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
125627924|NCT02565615|451919730|FG004|Overall Study|Death|4|||
125627925|NCT02565615|451919726|FG000|Overall Study|Not willing to participate in study|2|||
125627926|NCT02565615|451919727|FG001|Overall Study|Not willing to participate in study|21|||
125627927|NCT02565615|451919728|FG002|Overall Study|Not willing to participate in study|0|||
125627928|NCT02565615|451919729|FG003|Overall Study|Not willing to participate in study|1|||
125627929|NCT02565615|451919730|FG004|Overall Study|Not willing to participate in study|169|||
125627930|NCT02565615|451919726|FG000|Overall Study|Lost to Follow-up|0|||
125627931|NCT02565615|451919727|FG001|Overall Study|Lost to Follow-up|4|||
125627932|NCT02565615|451919728|FG002|Overall Study|Lost to Follow-up|0|||
125627933|NCT02565615|451919729|FG003|Overall Study|Lost to Follow-up|1|||
125627934|NCT02565615|451919730|FG004|Overall Study|Lost to Follow-up|765|||
125627935|NCT02565615|451919726|FG000|Overall Study|Not meeting eligibility criteria|0|||
125627936|NCT02565615|451919727|FG001|Overall Study|Not meeting eligibility criteria|7|||
125627937|NCT02565615|451919728|FG002|Overall Study|Not meeting eligibility criteria|0|||
125627938|NCT02565615|451919729|FG003|Overall Study|Not meeting eligibility criteria|0|||
125627939|NCT02565615|451919730|FG004|Overall Study|Not meeting eligibility criteria|25|||
125627940|NCT02565615|451919726|FG000|Overall Study|Reason not defined|0|||
125215690|NCT02347072|450417467|FG000|Overall Study|Protocol Violation|1|||
125215691|NCT02347072|450417467|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
125215692|NCT03124537|450417469|FG000|Overall Study|Lost to Follow-up|3|||
125215693|NCT03124537|450417470|FG001|Overall Study|Lost to Follow-up|5|||
125215694|NCT03124537|450417469|FG000|Overall Study|App Crash, Incomplete Data|7|||
125215695|NCT03124537|450417470|FG001|Overall Study|App Crash, Incomplete Data|8|||
125215696|NCT03681184|450417473|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
125215697|NCT03681184|450417474|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
125215698|NCT00396383|450417477|FG000|Overall Study|Death|2|||
125215699|NCT00396383|450417477|FG000|Overall Study|Lost to Follow-up|1|||
125434589|NCT02667886|451217646|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
125434590|NCT02667886|451217642|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
125434591|NCT02667886|451217643|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
125434592|NCT02667886|451217644|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
125434593|NCT02667886|451217645|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
125434594|NCT02667886|451217646|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
125434595|NCT02667886|451217642|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
125434596|NCT02667886|451217643|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
125434597|NCT02667886|451217644|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
125434598|NCT02667886|451217645|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
125434599|NCT02667886|451217646|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
125434600|NCT03635489|451217647|FG000|Overall Study|Death|19|||
125434601|NCT03635489|451217648|FG001|Overall Study|Death|13|||
125434602|NCT03635489|451217647|FG000|Overall Study|Lost to Follow-up|1|||
125434603|NCT03635489|451217648|FG001|Overall Study|Lost to Follow-up|2|||
125434604|NCT03635489|451217647|FG000|Overall Study|Withdrawal by Subject|1|||
125627941|NCT02565615|451919727|FG001|Overall Study|Reason not defined|2|||
125627942|NCT02565615|451919728|FG002|Overall Study|Reason not defined|0|||
125627943|NCT02565615|451919729|FG003|Overall Study|Reason not defined|1|||
125627944|NCT02565615|451919730|FG004|Overall Study|Reason not defined|62|||
125627945|NCT02565615|451919726|FG000|Overall Study|Adverse Event|1|||
125627946|NCT02565615|451919727|FG001|Overall Study|Adverse Event|1|||
125627947|NCT02565615|451919728|FG002|Overall Study|Adverse Event|0|||
125627948|NCT02565615|451919729|FG003|Overall Study|Adverse Event|0|||
125627949|NCT02565615|451919730|FG004|Overall Study|Adverse Event|9|||
125627950|NCT02565615|451919726|FG000|Overall Study|Untreated|0|||
125627951|NCT02565615|451919727|FG001|Overall Study|Untreated|0|||
125627952|NCT02565615|451919728|FG002|Overall Study|Untreated|0|||
125627953|NCT02565615|451919729|FG003|Overall Study|Untreated|0|||
125434605|NCT03635489|451217648|FG001|Overall Study|Withdrawal by Subject|2|||
125434606|NCT03635489|451217647|FG000|Overall Study|Study Ended by Sponsor|28|||
125434607|NCT03635489|451217648|FG001|Overall Study|Study Ended by Sponsor|34|||
125434608|NCT05096208|451217649|FG000|Overall Study|Lost to Follow-up|3|||
125434609|NCT05096208|451217650|FG001|Overall Study|Lost to Follow-up|5|||
125434610|NCT05096208|451217651|FG002|Overall Study|Lost to Follow-up|5|||
125434611|NCT05096208|451217652|FG003|Overall Study|Lost to Follow-up|2|||
125434612|NCT05096208|451217649|FG000|Overall Study|Withdrawal by Subject|0|||
125434613|NCT05096208|451217650|FG001|Overall Study|Withdrawal by Subject|1|||
125434614|NCT05096208|451217651|FG002|Overall Study|Withdrawal by Subject|2|||
125434615|NCT05096208|451217652|FG003|Overall Study|Withdrawal by Subject|3|||
125434616|NCT05096208|451217649|FG000|Overall Study|No longer met eligibility criteria|1|||
125434617|NCT05096208|451217650|FG001|Overall Study|No longer met eligibility criteria|0|||
125434618|NCT05096208|451217651|FG002|Overall Study|No longer met eligibility criteria|0|||
125434619|NCT05096208|451217652|FG003|Overall Study|No longer met eligibility criteria|0|||
125434620|NCT05096208|451217649|FG000|Overall Study|Other|0|||
125434621|NCT05096208|451217650|FG001|Overall Study|Other|0|||
125434622|NCT05096208|451217651|FG002|Overall Study|Other|1|||
125434623|NCT05096208|451217652|FG003|Overall Study|Other|0|||
125434624|NCT01279343|451217658|FG000|Overall Study|Did not receive treatment|2|||
125434625|NCT01279343|451217659|FG001|Overall Study|Did not receive treatment|6|||
125627954|NCT02565615|451919730|FG004|Overall Study|Untreated|567|||
125627955|NCT00753688|451919733|FG000|Overall Study|Death|102|||
125627956|NCT00753688|451919734|FG001|Overall Study|Death|203|||
125627957|NCT00753688|451919733|FG000|Overall Study|Missing|4|||
125627958|NCT00753688|451919734|FG001|Overall Study|Missing|9|||
125627959|NCT00753688|451919733|FG000|Overall Study|Participant Withdrew Consent|2|||
125434626|NCT05648357|451219317|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
125434627|NCT00255346|451219318|FG000|Overall Study|Adverse Event|1|||
125434628|NCT00255346|451219319|FG001|Overall Study|Adverse Event|0|||
125434629|NCT00255346|451219320|FG002|Overall Study|Adverse Event|0|||
125434630|NCT00255346|451219321|FG003|Overall Study|Adverse Event|0|||
125434631|NCT00255346|451219322|FG004|Overall Study|Adverse Event|0|||
125434632|NCT00409786|451219323|FG000|Overall Study|Withdrawal by Subject|3|||
125434633|NCT01641926|451219329|FG000|Overall Study|Adverse Event|5|||
125434634|NCT01641926|451219330|FG001|Overall Study|Adverse Event|2|||
125434635|NCT01641926|451219331|FG002|Overall Study|Adverse Event|3|||
125434636|NCT01641926|451219332|FG003|Overall Study|Adverse Event|1|||
125434637|NCT01641926|451219329|FG000|Overall Study|Lost to Follow-up|2|||
125434638|NCT01641926|451219330|FG001|Overall Study|Lost to Follow-up|2|||
125434639|NCT01641926|451219331|FG002|Overall Study|Lost to Follow-up|1|||
125434640|NCT01641926|451219332|FG003|Overall Study|Lost to Follow-up|0|||
125434641|NCT01641926|451219329|FG000|Overall Study|Physician Decision|6|||
125434642|NCT01641926|451219330|FG001|Overall Study|Physician Decision|5|||
125434643|NCT01641926|451219331|FG002|Overall Study|Physician Decision|0|||
125434644|NCT01641926|451219332|FG003|Overall Study|Physician Decision|1|||
125434645|NCT01641926|451219329|FG000|Overall Study|Protocol Violation|1|||
125434646|NCT01641926|451219330|FG001|Overall Study|Protocol Violation|0|||
125434647|NCT01641926|451219331|FG002|Overall Study|Protocol Violation|0|||
125434648|NCT01641926|451219332|FG003|Overall Study|Protocol Violation|1|||
125434649|NCT01641926|451219329|FG000|Overall Study|Withdrawal by Subject|13|||
125434650|NCT01641926|451219330|FG001|Overall Study|Withdrawal by Subject|5|||
125434651|NCT01641926|451219331|FG002|Overall Study|Withdrawal by Subject|6|||
125434652|NCT01641926|451219332|FG003|Overall Study|Withdrawal by Subject|1|||
125434653|NCT01641926|451219329|FG000|Overall Study|Not Treated|1|||
125434654|NCT01641926|451219330|FG001|Overall Study|Not Treated|1|||
125434655|NCT01641926|451219331|FG002|Overall Study|Not Treated|1|||
125434656|NCT01641926|451219332|FG003|Overall Study|Not Treated|0|||
125434657|NCT01111838|451219333|FG000|Overall Study|Patient Ineligible|2|||
125434658|NCT01111838|451219333|FG000|Overall Study|Not Treated|3|||
125434659|NCT01111838|451219333|FG000|Overall Study|Clinical deterioration|1|||
125434660|NCT01111838|451219333|FG000|Overall Study|Other Complicating Disease|1|||
125434661|NCT03303469|451219334|FG000|Overall Study|Lost to Follow-up|2|||
125434662|NCT02567825|451219341|FG000|Overall Study|No follow-up post-randomization|5|||
125434663|NCT02567825|451219342|FG001|Overall Study|No follow-up post-randomization|1|||
125434664|NCT02567825|451219341|FG000|Overall Study|Follow-up less than 23 months|16|||
125434665|NCT02567825|451219342|FG001|Overall Study|Follow-up less than 23 months|20|||
125434666|NCT04741802|451219344|FG000|Overall Study|Death|1|||
125627960|NCT00753688|451919734|FG001|Overall Study|Participant Withdrew Consent|2|||
125627961|NCT00753688|451919733|FG000|Overall Study|Ongoing - in Follow-up|15|||
125434667|NCT04741802|451219344|FG000|Overall Study|Lost to Follow-up|11|||
125434668|NCT01785563|451219347|FG000|Overall Study|Physician Decision|10|||
125434669|NCT01785563|451219347|FG000|Overall Study|Withdrawal by Subject|1|||
125434670|NCT01785563|451219347|FG000|Overall Study|Protocol Violation|2|||
125434671|NCT01540565|451219348|FG000|Overall Study|Ineligible|2|||
125434672|NCT04399356|451219349|FG000|Overall Study|Lost to Follow-up|1|||
125434673|NCT04399356|451219350|FG001|Overall Study|Lost to Follow-up|1|||
125434674|NCT04399356|451219349|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
125434675|NCT04399356|451219350|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
125434676|NCT04399356|451219349|FG000|Overall Study|Withdrawal by Subject|1|||
125434677|NCT04399356|451219350|FG001|Overall Study|Withdrawal by Subject|0|||
125434678|NCT03447730|451219351|FG000|Overall Study|Adverse Event|0|||
125434679|NCT03447730|451219352|FG001|Overall Study|Adverse Event|2|||
125434680|NCT03447730|451219353|FG002|Overall Study|Adverse Event|0|||
125434681|NCT00980005|451219358|FG000|Overall Study|Withdrawal by Subject|6|||
125434682|NCT00980005|451219359|FG001|Overall Study|Withdrawal by Subject|17|||
125434683|NCT00980005|451219358|FG000|Overall Study|Lost to Follow-up|37|||
125434684|NCT00980005|451219359|FG001|Overall Study|Lost to Follow-up|43|||
125434685|NCT00980005|451219358|FG000|Overall Study|Other|4|||
125434686|NCT00980005|451219359|FG001|Overall Study|Other|3|||
125434687|NCT00572624|451219360|FG000|Overall Study|Lost to Follow-up|10|||
125434688|NCT00572624|451219361|FG001|Overall Study|Lost to Follow-up|4|||
125434689|NCT00572624|451219360|FG000|Overall Study|Wanted to do a different diet program|1|||
125434690|NCT00572624|451219361|FG001|Overall Study|Wanted to do a different diet program|0|||
125434691|NCT00572624|451219360|FG000|Overall Study|Medication change|1|||
125434692|NCT00572624|451219361|FG001|Overall Study|Medication change|0|||
125434693|NCT00572624|451219360|FG000|Overall Study|Started a new job-- no time for study|1|||
125434694|NCT00572624|451219361|FG001|Overall Study|Started a new job-- no time for study|0|||
125434695|NCT00572624|451219360|FG000|Overall Study|Admitted to being a smoker|1|||
125434696|NCT00572624|451219361|FG001|Overall Study|Admitted to being a smoker|0|||
125434697|NCT00572624|451219360|FG000|Overall Study|Refused to do the stress test|1|||
125434698|NCT00572624|451219361|FG001|Overall Study|Refused to do the stress test|0|||
125434699|NCT00572624|451219360|FG000|Overall Study|Problem with vascular access|1|||
125434700|NCT00572624|451219361|FG001|Overall Study|Problem with vascular access|0|||
125434701|NCT00572624|451219360|FG000|Overall Study|Health issues unrelated to the study|1|||
125434702|NCT00572624|451219361|FG001|Overall Study|Health issues unrelated to the study|0|||
125434703|NCT02307513|451219362|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
125434704|NCT02307513|451219363|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
125434705|NCT02307513|451219362|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
125434706|NCT02307513|451219363|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
125434707|NCT02307513|451219362|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
125434708|NCT02307513|451219363|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
125434709|NCT02307513|451219362|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
125434710|NCT02307513|451219363|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
125434711|NCT02307513|451219362|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
125434712|NCT02307513|451219363|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
125434713|NCT02307513|451219362|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
125434714|NCT02307513|451219363|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
125434715|NCT02307513|451219362|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
125434716|NCT02307513|451219363|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
125434717|NCT02307513|451219362|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
125434718|NCT02307513|451219363|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
125434719|NCT02307513|451219362|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
125434720|NCT02307513|451219363|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
125434721|NCT02307513|451219362|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
125434722|NCT02307513|451219363|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
125627962|NCT00753688|451919734|FG001|Overall Study|Ongoing - in Follow-up|31|||
125627963|NCT00753688|451919733|FG000|Overall Study|Adverse Event|0|||
125627964|NCT00753688|451919734|FG001|Overall Study|Adverse Event|1|||
125627965|NCT02999100|451919737|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
125627966|NCT02999100|451919738|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
125627967|NCT02999100|451919739|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
125627968|NCT02999100|451919740|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
125627969|NCT02999100|451919741|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
125627970|NCT02999100|451919742|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
125627971|NCT02999100|451919737|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
125627972|NCT02999100|451919738|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
125627973|NCT02999100|451919739|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
125434723|NCT02307513|451219362|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
125434724|NCT02307513|451219363|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
125434725|NCT02307513|451219362|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
125434726|NCT02307513|451219363|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
125434727|NCT02307513|451219362|FG000|Long-term Extension|Physician Decision|1|||
125434728|NCT02307513|451219363|FG001|Long-term Extension|Physician Decision|0|||
125434729|NCT00525265|451219365|FG000|Overall Study|Protocol Violation|1|||
125434730|NCT00525265|451219366|FG001|Overall Study|Protocol Violation|0|||
125434731|NCT00744263|451219367|FG000|Overall Study|Death|3006|||
125434732|NCT00744263|451219368|FG001|Overall Study|Death|3005|||
125627974|NCT02999100|451919740|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
125627975|NCT02999100|451919741|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
125627976|NCT02999100|451919742|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
125434733|NCT00744263|451219367|FG000|Overall Study|Lost to Follow-up|2038|||
125434734|NCT00744263|451219368|FG001|Overall Study|Lost to Follow-up|2135|||
125434735|NCT00744263|451219367|FG000|Overall Study|Withdrawal by Subject|166|||
125434736|NCT00744263|451219368|FG001|Overall Study|Withdrawal by Subject|150|||
125434737|NCT00744263|451219367|FG000|Overall Study|Physician Decision|20|||
125434738|NCT00744263|451219368|FG001|Overall Study|Physician Decision|23|||
125434739|NCT00744263|451219367|FG000|Overall Study|Protocol Violation|3|||
125434740|NCT00744263|451219368|FG001|Overall Study|Protocol Violation|5|||
125434741|NCT00744263|451219367|FG000|Overall Study|Adverse Event|1|||
125434742|NCT00744263|451219368|FG001|Overall Study|Adverse Event|0|||
125434743|NCT00744263|451219367|FG000|Overall Study|Other|2|||
125434744|NCT00744263|451219368|FG001|Overall Study|Other|2|||
125434745|NCT03107377|451219369|FG000|Overall Study|Adverse Event|3|||
125434746|NCT03107377|451219370|FG001|Overall Study|Adverse Event|3|||
125434747|NCT03107377|451219369|FG000|Overall Study|Protocol Violation|9|||
125434748|NCT03107377|451219370|FG001|Overall Study|Protocol Violation|12|||
125434749|NCT03107377|451219369|FG000|Overall Study|Physician Decision|3|||
125434750|NCT03107377|451219370|FG001|Overall Study|Physician Decision|6|||
125434751|NCT03107377|451219369|FG000|Overall Study|Pregnancy|7|||
125434752|NCT03107377|451219370|FG001|Overall Study|Pregnancy|7|||
125434753|NCT03107377|451219369|FG000|Overall Study|Withdrawal by Subject|16|||
125215700|NCT04318132|450417480|FG000|Overall Study|Protocol Violation|0|||
125215701|NCT04318132|450417481|FG001|Overall Study|Protocol Violation|0|||
125215702|NCT04318132|450417482|FG002|Overall Study|Protocol Violation|3|||
125215703|NCT04318132|450417483|FG003|Overall Study|Protocol Violation|0|||
125215704|NCT00585325|450417484|FG000|Overall Study|Withdrawal by Subject|1|||
125215705|NCT00585325|450417485|FG001|Overall Study|Withdrawal by Subject|1|||
125375435|NCT02430311|451004886|FG000|Part A|Withdrawal by Subject|1|||
125375436|NCT02430311|451004887|FG001|Part A|Withdrawal by Subject|0|||
125375437|NCT02430311|451004886|FG000|Part B|Meet study-specific withdrawal criteria|6|||
125375438|NCT02430311|451004887|FG001|Part B|Meet study-specific withdrawal criteria|6|||
125375439|NCT02430311|451004886|FG000|Part B|Withdrawal by Subject|2|||
125375440|NCT02430311|451004887|FG001|Part B|Withdrawal by Subject|2|||
125375441|NCT02430311|451004886|FG000|Part B|Adverse Event|1|||
125375442|NCT02430311|451004887|FG001|Part B|Adverse Event|0|||
125375443|NCT02430311|451004886|FG000|Part B|Death|1|||
125375444|NCT02430311|451004887|FG001|Part B|Death|0|||
125375445|NCT04180488|451004888|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
125375446|NCT04180488|451004889|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
125375447|NCT04180488|451004890|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
125375448|NCT04180488|451004891|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
125375449|NCT04180488|451004892|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
125375450|NCT04180488|451004893|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
125375451|NCT04180488|451004888|FG000|Overall Study|Withdrawal by Subject|8|||
125375452|NCT04180488|451004889|FG001|Overall Study|Withdrawal by Subject|4|||
125375453|NCT04180488|451004890|FG002|Overall Study|Withdrawal by Subject|5|||
125375454|NCT04180488|451004891|FG003|Overall Study|Withdrawal by Subject|2|||
125375455|NCT04180488|451004892|FG004|Overall Study|Withdrawal by Subject|8|||
125375456|NCT04180488|451004893|FG005|Overall Study|Withdrawal by Subject|6|||
125375457|NCT04180488|451004888|FG000|Overall Study|Adverse Event|3|||
125375458|NCT04180488|451004889|FG001|Overall Study|Adverse Event|2|||
125375459|NCT04180488|451004890|FG002|Overall Study|Adverse Event|0|||
125375460|NCT04180488|451004891|FG003|Overall Study|Adverse Event|0|||
125375461|NCT04180488|451004892|FG004|Overall Study|Adverse Event|0|||
125375462|NCT04180488|451004893|FG005|Overall Study|Adverse Event|0|||
125375463|NCT04180488|451004888|FG000|Overall Study|Poor compliance to protocol|0|||
125375464|NCT04180488|451004889|FG001|Overall Study|Poor compliance to protocol|0|||
125375465|NCT04180488|451004890|FG002|Overall Study|Poor compliance to protocol|1|||
125375466|NCT04180488|451004891|FG003|Overall Study|Poor compliance to protocol|0|||
125375467|NCT04180488|451004892|FG004|Overall Study|Poor compliance to protocol|0|||
125375468|NCT04180488|451004893|FG005|Overall Study|Poor compliance to protocol|0|||
125375469|NCT00381095|451004901|FG000|Overall Study|Death|3|||
125375470|NCT00381095|451004902|FG001|Overall Study|Death|4|||
125375471|NCT00381095|451004901|FG000|Overall Study|Lack of Efficacy|2|||
125375472|NCT00381095|451004902|FG001|Overall Study|Lack of Efficacy|4|||
125434754|NCT03107377|451219370|FG001|Overall Study|Withdrawal by Subject|22|||
125215706|NCT04424914|450417486|FG000|Overall Study|Other|0|||
125215707|NCT04424914|450417487|FG001|Overall Study|Other|0|||
125215708|NCT04424914|450417488|FG002|Overall Study|Other|28|||
125375473|NCT00381095|451004901|FG000|Overall Study|Other|2|||
125375474|NCT00381095|451004902|FG001|Overall Study|Other|2|||
125434755|NCT03107377|451219369|FG000|Overall Study|Lost to Follow-up|37|||
125375475|NCT00381095|451004901|FG000|Overall Study|Protocol Violation|1|||
125375476|NCT00381095|451004902|FG001|Overall Study|Protocol Violation|1|||
125375477|NCT00381095|451004901|FG000|Overall Study|Withdrawal by Subject|3|||
125375478|NCT00381095|451004902|FG001|Overall Study|Withdrawal by Subject|3|||
125375479|NCT00381095|451004901|FG000|Overall Study|Adverse Event|2|||
125434756|NCT03107377|451219370|FG001|Overall Study|Lost to Follow-up|34|||
125434757|NCT03107377|451219369|FG000|Overall Study|Other reason not specified|16|||
125434758|NCT03107377|451219370|FG001|Overall Study|Other reason not specified|15|||
125434759|NCT00130793|451219373|FG000|Overall Study|Lost to Follow-up|1|||
125627977|NCT02999100|451919737|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
125627978|NCT02999100|451919738|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
125627979|NCT02999100|451919739|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
125627980|NCT02999100|451919740|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
125627981|NCT02999100|451919741|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
125627982|NCT02999100|451919742|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
125627983|NCT00293241|451919747|FG000|Overall Study|Lost to Follow-up|9|||
125627984|NCT00293241|451919748|FG001|Overall Study|Lost to Follow-up|16|||
125627985|NCT00293241|451919747|FG000|Overall Study|Physician Decision|23|||
125627986|NCT00293241|451919748|FG001|Overall Study|Physician Decision|17|||
125627987|NCT00293241|451919747|FG000|Overall Study|Withdrawal by Subject|4|||
125627988|NCT00293241|451919748|FG001|Overall Study|Withdrawal by Subject|8|||
125627989|NCT03595384|451919749|FG000|Overall Study|Other time commitments|8|||
125627990|NCT03595384|451919749|FG000|Overall Study|Changes to session time|7|||
125627991|NCT03595384|451919749|FG000|Overall Study|Relocation out of country|1|||
125627992|NCT02224638|451919750|FG000|Overall Study|Adverse Event|1|||
125627993|NCT02224638|451919751|FG001|Overall Study|Adverse Event|1|||
125627994|NCT01455415|451919763|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
125627995|NCT01455415|451919764|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
125627996|NCT01455415|451919763|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
125627997|NCT01455415|451919764|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
125627998|NCT01455415|451919763|FG000|Period 1|Drug Error not Associated to AE|0|||
125627999|NCT01455415|451919764|FG001|Period 1|Drug Error not Associated to AE|1|||
125628000|NCT01455415|451919763|FG000|Period 1|AE Not Related to Study Drug|2|||
125628001|NCT01455415|451919764|FG001|Period 1|AE Not Related to Study Drug|6|||
125628002|NCT01455415|451919763|FG000|Period 1|Withdrawal by Subject|4|||
125628003|NCT01455415|451919764|FG001|Period 1|Withdrawal by Subject|5|||
125628004|NCT01455415|451919763|FG000|Period 1|Unspecified Reason|1|||
125628005|NCT01455415|451919764|FG001|Period 1|Unspecified Reason|1|||
125628006|NCT01455415|451919763|FG000|Period 1|Protocol Violation|0|||
125628007|NCT01455415|451919764|FG001|Period 1|Protocol Violation|2|||
125628008|NCT01455415|451919763|FG000|Washout|AE Related to Study Drug|2|||
125628009|NCT01455415|451919764|FG001|Washout|AE Related to Study Drug|0|||
125628010|NCT01455415|451919763|FG000|Washout|Lost to Follow-up|1|||
125628011|NCT01455415|451919764|FG001|Washout|Lost to Follow-up|0|||
125628012|NCT01455415|451919763|FG000|Washout|Drug Error not Associated to AE|2|||
125628013|NCT01455415|451919764|FG001|Washout|Drug Error not Associated to AE|1|||
125628014|NCT01455415|451919763|FG000|Washout|AE Not Related to Study Drug|2|||
125628015|NCT01455415|451919764|FG001|Washout|AE Not Related to Study Drug|3|||
125628016|NCT01455415|451919763|FG000|Washout|Unspecified Reason|1|||
125628017|NCT01455415|451919764|FG001|Washout|Unspecified Reason|2|||
125628018|NCT01455415|451919763|FG000|Washout|Protocol Violation|0|||
125628019|NCT01455415|451919764|FG001|Washout|Protocol Violation|1|||
125128469|NCT01263704|450096081|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
125128470|NCT01263704|450096081|FG000|Overall Study|Lost to Follow-up|1|||
125434760|NCT00130793|451219374|FG001|Overall Study|Lost to Follow-up|4|||
125434761|NCT00130793|451219373|FG000|Overall Study|Withdrew consent|2|||
125434762|NCT00130793|451219374|FG001|Overall Study|Withdrew consent|0|||
125434763|NCT00211237|451219375|FG000|Baseline|Withdrew|1|||
125434764|NCT00211237|451219376|FG001|Baseline|Withdrew|3|||
125434765|NCT00211237|451219377|FG002|Baseline|Withdrew|0|||
125434766|NCT00211237|451219375|FG000|Baseline|Refused random assignment|1|||
125434767|NCT00211237|451219376|FG001|Baseline|Refused random assignment|0|||
125434768|NCT00211237|451219377|FG002|Baseline|Refused random assignment|0|||
125434769|NCT00211237|451219375|FG000|1 Month|Death|2|||
125628020|NCT01455415|451919763|FG000|Period 2|AE Related to Study Drug|1|||
125628021|NCT01455415|451919764|FG001|Period 2|AE Related to Study Drug|2|||
125628022|NCT01455415|451919763|FG000|Period 2|Lost to Follow-up|2|||
125628023|NCT01455415|451919764|FG001|Period 2|Lost to Follow-up|1|||
125628024|NCT01455415|451919763|FG000|Period 2|AE Not Related to Study Drug|2|||
125628025|NCT01455415|451919764|FG001|Period 2|AE Not Related to Study Drug|1|||
125628026|NCT01455415|451919763|FG000|Period 2|Lack of Efficacy|2|||
125628027|NCT01455415|451919764|FG001|Period 2|Lack of Efficacy|0|||
125628028|NCT01455415|451919763|FG000|Period 2|Withdrawal by Subject|2|||
125628029|NCT01455415|451919764|FG001|Period 2|Withdrawal by Subject|3|||
125628030|NCT01455415|451919763|FG000|Period 2|Unspecified Reason|2|||
125628031|NCT01455415|451919764|FG001|Period 2|Unspecified Reason|3|||
125628032|NCT01455415|451919763|FG000|Period 2|Protocol Violation|2|||
125628033|NCT01455415|451919764|FG001|Period 2|Protocol Violation|0|||
125628034|NCT01455415|451919763|FG000|Follow-up|AE Related to Study Drug|0|||
125434770|NCT00211237|451219376|FG001|1 Month|Death|1|||
125434771|NCT00211237|451219377|FG002|1 Month|Death|0|||
125434772|NCT00211237|451219375|FG000|1 Month|Lost to Follow-up|0|||
125434773|NCT00211237|451219376|FG001|1 Month|Lost to Follow-up|2|||
125434774|NCT00211237|451219377|FG002|1 Month|Lost to Follow-up|0|||
125628035|NCT01455415|451919764|FG001|Follow-up|AE Related to Study Drug|1|||
125628036|NCT01455415|451919763|FG000|Follow-up|Lack of Efficacy|0|||
125434775|NCT00211237|451219375|FG000|1 Month|Withdrew|0|||
125434776|NCT00211237|451219376|FG001|1 Month|Withdrew|4|||
125434777|NCT00211237|451219377|FG002|1 Month|Withdrew|0|||
125434778|NCT00211237|451219375|FG000|1 Month|Additional surgery needed|1|||
125434779|NCT00211237|451219376|FG001|1 Month|Additional surgery needed|0|||
125434780|NCT00211237|451219377|FG002|1 Month|Additional surgery needed|0|||
125434781|NCT00211237|451219375|FG000|1 Month|Non-medical problem|0|||
125434782|NCT00211237|451219376|FG001|1 Month|Non-medical problem|2|||
125434783|NCT00211237|451219377|FG002|1 Month|Non-medical problem|0|||
125434784|NCT00211237|451219375|FG000|3 Months|Death|7|||
125434785|NCT00211237|451219376|FG001|3 Months|Death|3|||
125434786|NCT00211237|451219377|FG002|3 Months|Death|0|||
125434787|NCT00211237|451219375|FG000|3 Months|Could not comply with protocol|1|||
125434788|NCT00211237|451219376|FG001|3 Months|Could not comply with protocol|0|||
125434789|NCT00211237|451219377|FG002|3 Months|Could not comply with protocol|0|||
125434790|NCT00211237|451219375|FG000|3 Months|Withdrew|0|||
125434791|NCT00211237|451219376|FG001|3 Months|Withdrew|1|||
125434792|NCT00211237|451219377|FG002|3 Months|Withdrew|0|||
125434793|NCT00211237|451219375|FG000|3 Months|Non-medical problem|0|||
125434794|NCT00211237|451219376|FG001|3 Months|Non-medical problem|0|||
125434795|NCT00211237|451219377|FG002|3 Months|Non-medical problem|1|||
125434796|NCT00211237|451219375|FG000|6 Months|Death|6|||
125434797|NCT00211237|451219376|FG001|6 Months|Death|0|||
125434798|NCT00211237|451219377|FG002|6 Months|Death|3|||
125434799|NCT00211237|451219375|FG000|6 Months|Lost to Follow-up|2|||
125434800|NCT00211237|451219376|FG001|6 Months|Lost to Follow-up|0|||
125434801|NCT00211237|451219377|FG002|6 Months|Lost to Follow-up|0|||
125434802|NCT00211237|451219375|FG000|6 Months|Could not comply with protocol|0|||
125434803|NCT00211237|451219376|FG001|6 Months|Could not comply with protocol|2|||
125434804|NCT00211237|451219377|FG002|6 Months|Could not comply with protocol|0|||
125434805|NCT00211237|451219375|FG000|12 Months|Death|8|||
125434806|NCT00211237|451219376|FG001|12 Months|Death|2|||
125434807|NCT00211237|451219377|FG002|12 Months|Death|3|||
125434808|NCT00211237|451219375|FG000|12 Months|Lost to Follow-up|1|||
125434809|NCT00211237|451219376|FG001|12 Months|Lost to Follow-up|0|||
125434810|NCT00211237|451219377|FG002|12 Months|Lost to Follow-up|1|||
125434811|NCT00211237|451219375|FG000|12 Months|Withdrew|0|||
125434812|NCT00211237|451219376|FG001|12 Months|Withdrew|0|||
125434813|NCT00211237|451219377|FG002|12 Months|Withdrew|1|||
125434814|NCT00211237|451219375|FG000|12 Months|unrelated medical problem|0|||
125434815|NCT00211237|451219376|FG001|12 Months|unrelated medical problem|0|||
125434816|NCT00211237|451219377|FG002|12 Months|unrelated medical problem|1|||
125434817|NCT00453102|451219380|FG000|Overall Study|Withdrawal by Subject|2|||
125434818|NCT01013792|451219383|FG000|Overall Study|Study suspended|2|||
125434819|NCT01013792|451219384|FG001|Overall Study|Study suspended|1|||
125434820|NCT01013792|451219383|FG000|Overall Study|Adverse Event|0|||
125434821|NCT01013792|451219384|FG001|Overall Study|Adverse Event|3|||
125434822|NCT01013792|451219383|FG000|Overall Study|Lost to Follow-up|0|||
125434823|NCT01013792|451219384|FG001|Overall Study|Lost to Follow-up|1|||
125434824|NCT02100722|451219388|FG000|Overall Study|Withdrawal pre-procedure|4|||
125434825|NCT02100722|451219389|FG001|Overall Study|Withdrawal pre-procedure|9|||
125434826|NCT02100722|451219388|FG000|Overall Study|Withdrawal post-procedure|0|||
125434827|NCT02100722|451219389|FG001|Overall Study|Withdrawal post-procedure|3|||
125434828|NCT02100722|451219388|FG000|Overall Study|Lost to Follow-up|2|||
125434829|NCT02100722|451219389|FG001|Overall Study|Lost to Follow-up|2|||
125434830|NCT02100722|451219388|FG000|Overall Study|Continuing on study|751|||
125434831|NCT02100722|451219389|FG001|Overall Study|Continuing on study|729|||
125434832|NCT02690077|451219394|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
125434833|NCT02690077|451219395|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
125434834|NCT02690077|451219394|FG000|Overall Study|Withdrawal by Subject|0|||
125434835|NCT02690077|451219395|FG001|Overall Study|Withdrawal by Subject|5|||
125434836|NCT02690077|451219394|FG000|Overall Study|Excluded by IRB|0|||
125434837|NCT02690077|451219395|FG001|Overall Study|Excluded by IRB|2|||
125434838|NCT05672680|451219396|FG000|Overall Study|Patient Did Not Complete the Form|5|||
125434839|NCT05672680|451219397|FG001|Overall Study|Patient Did Not Complete the Form|4|||
125434840|NCT05672680|451219396|FG000|Overall Study|Procedure Aborted|1|||
125434841|NCT05672680|451219397|FG001|Overall Study|Procedure Aborted|0|||
125434842|NCT05408468|451219398|FG000|Overall Study|Lost to Follow-up|3|||
125434843|NCT05408468|451219399|FG001|Overall Study|Lost to Follow-up|1|||
125434844|NCT05408468|451219398|FG000|Overall Study|Physician Decision|1|||
125434845|NCT05408468|451219399|FG001|Overall Study|Physician Decision|0|||
125434846|NCT05408468|451219398|FG000|Overall Study|Overwhelmed by clinical situation|3|||
125434847|NCT05408468|451219399|FG001|Overall Study|Overwhelmed by clinical situation|0|||
125434848|NCT05408468|451219398|FG000|Overall Study|Personal illness precluding participation|1|||
125434849|NCT05408468|451219399|FG001|Overall Study|Personal illness precluding participation|0|||
125434850|NCT05408468|451219398|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
125434851|NCT05408468|451219399|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
125434852|NCT00747123|451219400|FG000|Overall Study|Investigator's request|0|||
125434853|NCT00747123|451219401|FG001|Overall Study|Investigator's request|0|||
125434854|NCT00747123|451219402|FG002|Overall Study|Investigator's request|1|||
125434855|NCT00747123|451219403|FG003|Overall Study|Investigator's request|0|||
125434856|NCT00747123|451219400|FG000|Overall Study|Withdrew consent|0|||
125434857|NCT00747123|451219401|FG001|Overall Study|Withdrew consent|1|||
125434858|NCT00747123|451219402|FG002|Overall Study|Withdrew consent|0|||
125434859|NCT00747123|451219403|FG003|Overall Study|Withdrew consent|0|||
125434860|NCT00747123|451219400|FG000|Overall Study|Adverse Event|0|||
125434861|NCT00747123|451219401|FG001|Overall Study|Adverse Event|1|||
125434862|NCT00747123|451219402|FG002|Overall Study|Adverse Event|0|||
125434863|NCT00747123|451219403|FG003|Overall Study|Adverse Event|1|||
125434864|NCT04186403|451219404|FG000|Overall Study|Adverse Event|1|||
125434865|NCT04186403|451219405|FG001|Overall Study|Adverse Event|8|||
125434866|NCT04186403|451219404|FG000|Overall Study|Lost to Follow-up|7|||
125434867|NCT04186403|451219405|FG001|Overall Study|Lost to Follow-up|3|||
125434868|NCT04186403|451219404|FG000|Overall Study|Physician Decision|1|||
125434869|NCT04186403|451219405|FG001|Overall Study|Physician Decision|0|||
125434870|NCT04186403|451219404|FG000|Overall Study|Withdrawal by Subject|7|||
125434871|NCT04186403|451219405|FG001|Overall Study|Withdrawal by Subject|8|||
125434872|NCT04186403|451219404|FG000|Overall Study|Other: Not Related to Covid-19|3|||
125434873|NCT04186403|451219405|FG001|Overall Study|Other: Not Related to Covid-19|0|||
125434874|NCT00405639|451219417|FG000|Overall Study|Withdrawal by Subject|1|||
125434875|NCT00405639|451219418|FG001|Overall Study|Withdrawal by Subject|0|||
125434876|NCT00405639|451219417|FG000|Overall Study|Adverse Event|1|||
125434877|NCT00405639|451219418|FG001|Overall Study|Adverse Event|0|||
125434878|NCT00405639|451219417|FG000|Overall Study|Seizure prior to receiving BNP|1|||
125434879|NCT00405639|451219418|FG001|Overall Study|Seizure prior to receiving BNP|0|||
125628037|NCT01455415|451919764|FG001|Follow-up|Lack of Efficacy|1|||
125628038|NCT01455415|451919763|FG000|Follow-up|Withdrawal by Subject|2|||
125628039|NCT01455415|451919764|FG001|Follow-up|Withdrawal by Subject|0|||
125628040|NCT01455415|451919763|FG000|Follow-up|Unspecified Reason|1|||
125628041|NCT01455415|451919764|FG001|Follow-up|Unspecified Reason|0|||
125628042|NCT00587301|451919765|FG000|Overall Study|Screen Failure|9|||
125628043|NCT00587301|451919765|FG000|Overall Study|Lost to Follow-up|22|||
125628044|NCT00587301|451919765|FG000|Overall Study|Withdrawal by Subject|7|||
125375480|NCT00381095|451004902|FG001|Overall Study|Adverse Event|7|||
125375481|NCT01104493|451004903|FG000|Overall Study|Lost to Follow-up|0|||
125375482|NCT01104493|451004904|FG001|Overall Study|Lost to Follow-up|2|||
125375483|NCT01342796|451004906|FG000|Overall Study|Withdrawal by Subject|2|||
125375484|NCT01342796|451004907|FG001|Overall Study|Withdrawal by Subject|0|||
125375485|NCT01342796|451004906|FG000|Overall Study|Lost to Follow-up|0|||
125375486|NCT01342796|451004907|FG001|Overall Study|Lost to Follow-up|3|||
125375487|NCT01342796|451004906|FG000|Overall Study|Inappropriate enrollment|1|||
125375488|NCT01342796|451004907|FG001|Overall Study|Inappropriate enrollment|0|||
125375489|NCT01599234|451004908|FG000|Overall Study|Adverse Event|9|||
125375490|NCT01599234|451004909|FG001|Overall Study|Adverse Event|5|||
125375491|NCT01599234|451004908|FG000|Overall Study|Withdrawal by Subject|2|||
125375492|NCT01599234|451004909|FG001|Overall Study|Withdrawal by Subject|1|||
125375493|NCT01599234|451004908|FG000|Overall Study|Lost to Follow-up|1|||
125375494|NCT01599234|451004909|FG001|Overall Study|Lost to Follow-up|2|||
125375495|NCT01599234|451004908|FG000|Overall Study|Lack of Efficacy|2|||
125375496|NCT01599234|451004909|FG001|Overall Study|Lack of Efficacy|4|||
125375497|NCT01599234|451004908|FG000|Overall Study|Unable to operate spray|1|||
125375498|NCT01599234|451004909|FG001|Overall Study|Unable to operate spray|0|||
125375499|NCT01599234|451004908|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
125375500|NCT01599234|451004909|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
125375501|NCT01599234|451004908|FG000|Overall Study|Death|1|||
125375502|NCT01599234|451004909|FG001|Overall Study|Death|0|||
125375503|NCT01599234|451004908|FG000|Overall Study|Patient would not stop driving|1|||
125375504|NCT01599234|451004909|FG001|Overall Study|Patient would not stop driving|0|||
125375505|NCT01599234|451004908|FG000|Overall Study|Contra-indication discovered|0|||
125375506|NCT01599234|451004909|FG001|Overall Study|Contra-indication discovered|1|||
125375507|NCT01599234|451004908|FG000|Overall Study|Pregnancy|0|||
125375508|NCT01599234|451004909|FG001|Overall Study|Pregnancy|1|||
125375509|NCT02433483|451004911|FG000|Overall Study|Unacceptable toxicity|1|||
125375510|NCT02433483|451004911|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
125375511|NCT03342690|451004912|FG000|Overall Study|Missing Information|9|||
125375512|NCT03342690|451004912|FG000|Overall Study|Protocol Violation|16|||
125375513|NCT03585504|451004915|FG000|Overall Study|Lost to Follow-up|26|||
125434880|NCT01483937|451219419|FG000|Overall Study|Withdrawal by Subject|4|||
125434881|NCT01483937|451219420|FG001|Overall Study|Withdrawal by Subject|3|||
125628045|NCT00587301|451919765|FG000|Overall Study|Protocol Violation|7|||
125628046|NCT01496274|451919766|FG000|Overall Study|Protocol Violation|0|||
125128471|NCT01263704|450096081|FG000|Overall Study|Colon metastases|1|||
125434882|NCT00265330|451219421|FG000|Overall Study|Adverse Event|41|||
125434883|NCT00265330|451219421|FG000|Overall Study|Lost to Follow-up|8|||
125434884|NCT00265330|451219421|FG000|Overall Study|Withdrawal by Subject|34|||
125434885|NCT00265330|451219421|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
125434886|NCT00265330|451219421|FG000|Overall Study|Lack of Efficacy|4|||
125434887|NCT00265330|451219421|FG000|Overall Study|Family Scheduling Conflicts|1|||
125434888|NCT00265330|451219421|FG000|Overall Study|Began Taking Formulary Geodon|1|||
125434889|NCT00265330|451219421|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
125434890|NCT00265330|451219421|FG000|Overall Study|Site Closed by Sponsor|1|||
125434891|NCT00265330|451219421|FG000|Overall Study|Principal Investigators Request|1|||
125434892|NCT00265330|451219421|FG000|Overall Study|Withdrew Consent|1|||
125434893|NCT00265330|451219421|FG000|Overall Study|Protocol Violation|1|||
125434894|NCT03108157|451219424|FG000|Overall Study|Protocol Violation|15|||
125434895|NCT03108157|451219425|FG001|Overall Study|Protocol Violation|4|||
125434896|NCT04534114|451219426|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
125434897|NCT04534114|451219427|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
125434898|NCT04534114|451219428|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
125434899|NCT04534114|451219429|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
125434900|NCT04534114|451219426|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
125628047|NCT01496274|451919767|FG001|Overall Study|Protocol Violation|1|||
125375514|NCT03585504|451004916|FG001|Overall Study|Lost to Follow-up|29|||
125434901|NCT04534114|451219427|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
125434902|NCT04534114|451219428|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
125628048|NCT01496274|451919766|FG000|Overall Study|Adverse Event|1|||
125628049|NCT01496274|451919767|FG001|Overall Study|Adverse Event|1|||
125628050|NCT01496274|451919766|FG000|Overall Study|Withdrawal by Subject|2|||
125628051|NCT01496274|451919767|FG001|Overall Study|Withdrawal by Subject|0|||
125628052|NCT01496274|451919766|FG000|Overall Study|Lost to Follow-up|0|||
125628053|NCT01496274|451919767|FG001|Overall Study|Lost to Follow-up|3|||
125628054|NCT02758613|451919769|FG000|Treatment|Physician and Sponsor Decision|1|||
125628055|NCT02758613|451919770|FG001|Treatment|Physician and Sponsor Decision|0|||
125628056|NCT02758613|451919771|FG002|Treatment|Physician and Sponsor Decision|0|||
125375515|NCT01414114|451004917|FG000|Overall Study|Adverse Event|2|||
125375516|NCT01414114|451004917|FG000|Overall Study|Withdrawal by Subject|1|||
125375517|NCT01414114|451004917|FG000|Overall Study|Other|2|||
125375518|NCT00105482|451004918|FG000|Overall Study|Adverse Event|1|||
125375519|NCT00105482|451004919|FG001|Overall Study|Adverse Event|1|||
125375520|NCT00105482|451004918|FG000|Overall Study|Lost to Follow-up|26|||
125375521|NCT00105482|451004919|FG001|Overall Study|Lost to Follow-up|17|||
125375522|NCT00105482|451004918|FG000|Overall Study|Withdrawal by Subject|0|||
125375523|NCT00105482|451004919|FG001|Overall Study|Withdrawal by Subject|1|||
125375524|NCT00105482|451004918|FG000|Overall Study|Lost Interest|29|||
125375525|NCT00105482|451004919|FG001|Overall Study|Lost Interest|32|||
125375526|NCT00105482|451004918|FG000|Overall Study|Scheduling Conflict|2|||
125375527|NCT00105482|451004919|FG001|Overall Study|Scheduling Conflict|3|||
125375528|NCT00105482|451004918|FG000|Overall Study|Withdrawn by PI|1|||
125375529|NCT00105482|451004919|FG001|Overall Study|Withdrawn by PI|1|||
125375530|NCT05620563|451004920|FG000|Overall Study|Adverse Event|3|||
125375531|NCT05620563|451004921|FG001|Overall Study|Adverse Event|1|||
125375532|NCT05620563|451004920|FG000|Overall Study|Lost to Follow-up|0|||
125375533|NCT05620563|451004921|FG001|Overall Study|Lost to Follow-up|2|||
125375534|NCT05620563|451004920|FG000|Overall Study|Protocol Deviation|1|||
125375535|NCT05620563|451004921|FG001|Overall Study|Protocol Deviation|2|||
125375536|NCT05620563|451004920|FG000|Overall Study|Withdrawal by Subject|3|||
125375537|NCT05620563|451004921|FG001|Overall Study|Withdrawal by Subject|3|||
125375538|NCT05620563|451004920|FG000|Overall Study|Physician Decision|0|||
125375539|NCT05620563|451004921|FG001|Overall Study|Physician Decision|1|||
125375540|NCT04626297|451004924|FG000|Overall Study|Adverse Event|5|||
125375541|NCT04626297|451004925|FG001|Overall Study|Adverse Event|3|||
125375542|NCT04626297|451004924|FG000|Overall Study|Lost to Follow-up|7|||
125375543|NCT04626297|451004925|FG001|Overall Study|Lost to Follow-up|3|||
125375544|NCT04626297|451004924|FG000|Overall Study|Protocol Violation|5|||
125375545|NCT04626297|451004925|FG001|Overall Study|Protocol Violation|1|||
125375546|NCT04626297|451004924|FG000|Overall Study|Withdrawal by Subject|20|||
125628057|NCT02758613|451919772|FG003|Treatment|Physician and Sponsor Decision|0|||
125128472|NCT01263704|450096081|FG000|Overall Study|Principal Investigator (PI) decision|1|||
125375547|NCT04626297|451004925|FG001|Overall Study|Withdrawal by Subject|6|||
125375548|NCT04626297|451004924|FG000|Overall Study|Sponsor decision|2|||
125375549|NCT04626297|451004925|FG001|Overall Study|Sponsor decision|1|||
125375550|NCT03167411|451004926|FG000|Overall Study|Adverse Event|0|||
125375551|NCT03167411|451004927|FG001|Overall Study|Adverse Event|1|||
125375552|NCT02651922|451004931|FG000|Overall Study|due to exclusion criteria|2|||
125375553|NCT00729651|451004932|FG000|Overall Study|Withdrawal by Subject|5|||
125375554|NCT00729651|451004933|FG001|Overall Study|Withdrawal by Subject|6|||
125375555|NCT00729651|451004932|FG000|Overall Study|Lost to Follow-up|5|||
125375556|NCT00729651|451004933|FG001|Overall Study|Lost to Follow-up|4|||
125375557|NCT00729651|451004932|FG000|Overall Study|Protocol Violation|0|||
125434903|NCT04534114|451219429|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
125434904|NCT04534114|451219426|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
125434905|NCT04534114|451219427|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
125628058|NCT02758613|451919769|FG000|Treatment|Withdrawal by Subject|1|||
125628059|NCT02758613|451919770|FG001|Treatment|Withdrawal by Subject|0|||
125434906|NCT04534114|451219428|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
125434907|NCT04534114|451219429|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
125434908|NCT04534114|451219426|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
125434909|NCT04534114|451219427|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
125434910|NCT04534114|451219428|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
125434911|NCT04534114|451219429|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
125628060|NCT02758613|451919771|FG002|Treatment|Withdrawal by Subject|1|||
125628061|NCT02758613|451919772|FG003|Treatment|Withdrawal by Subject|0|||
125628062|NCT00351819|451919773|FG000|Overall Study|Lost to Follow-up|4|||
125628063|NCT00351819|451919774|FG001|Overall Study|Lost to Follow-up|4|||
125628064|NCT00351819|451919773|FG000|Overall Study|Withdrawal by Subject|0|||
125628065|NCT00351819|451919774|FG001|Overall Study|Withdrawal by Subject|4|||
125628066|NCT00351819|451919773|FG000|Overall Study|Elevated PSA|1|||
125628067|NCT00351819|451919774|FG001|Overall Study|Elevated PSA|1|||
125628068|NCT00351819|451919773|FG000|Overall Study|Traumatic ankle fracture|1|||
125628069|NCT00351819|451919774|FG001|Overall Study|Traumatic ankle fracture|0|||
125628070|NCT00351819|451919773|FG000|Overall Study|Unprofessional behavior|1|||
125628071|NCT00351819|451919774|FG001|Overall Study|Unprofessional behavior|0|||
125628072|NCT00351819|451919773|FG000|Overall Study|Non-compliance|0|||
125628073|NCT00351819|451919774|FG001|Overall Study|Non-compliance|1|||
125628074|NCT00351819|451919773|FG000|Overall Study|Incarcerated|0|||
125628075|NCT00351819|451919774|FG001|Overall Study|Incarcerated|1|||
125628076|NCT00351819|451919773|FG000|Overall Study|Enrolled in another trial|0|||
125628077|NCT00351819|451919774|FG001|Overall Study|Enrolled in another trial|1|||
125628078|NCT00719537|451919778|FG000|Overall Study|Withdrawal by Subject|1|||
125628079|NCT00719537|451919779|FG001|Overall Study|Withdrawal by Subject|0|||
125628080|NCT00719537|451919778|FG000|Overall Study|Lost to Follow-up|0|||
125628081|NCT00719537|451919779|FG001|Overall Study|Lost to Follow-up|1|||
125628082|NCT01459068|451919780|FG000|Overall Study|Withdrawal by Subject|8|||
125628083|NCT01459068|451919781|FG001|Overall Study|Withdrawal by Subject|18|||
125628084|NCT01459068|451919780|FG000|Overall Study|Lost to Follow-up|31|||
125628085|NCT01459068|451919781|FG001|Overall Study|Lost to Follow-up|15|||
125628086|NCT01459068|451919780|FG000|Overall Study|Death|0|||
125434912|NCT04534114|451219426|FG000|Main Treatment Period|Physician Decision|0|||
125434913|NCT04534114|451219427|FG001|Main Treatment Period|Physician Decision|0|||
125434914|NCT04534114|451219428|FG002|Main Treatment Period|Physician Decision|0|||
125434915|NCT04534114|451219429|FG003|Main Treatment Period|Physician Decision|1|||
125434916|NCT04534114|451219426|FG000|Main Treatment Period|Death|1|||
125434917|NCT04534114|451219427|FG001|Main Treatment Period|Death|0|||
125434918|NCT04534114|451219428|FG002|Main Treatment Period|Death|0|||
125434919|NCT04534114|451219429|FG003|Main Treatment Period|Death|1|||
125434920|NCT04534114|451219426|FG000|Main Treatment Period|Other reason|1|||
125434921|NCT04534114|451219427|FG001|Main Treatment Period|Other reason|1|||
125628087|NCT01459068|451919781|FG001|Overall Study|Death|1|||
125628088|NCT00196196|451919784|FG000|Overall Study|Withdrawal by Subject|2|||
125434922|NCT04534114|451219428|FG002|Main Treatment Period|Other reason|0|||
125434923|NCT04534114|451219429|FG003|Main Treatment Period|Other reason|0|||
125628089|NCT00196196|451919784|FG000|Overall Study|Did not have required condition (hydroce|5|||
125628090|NCT02910219|451919785|FG000|Overall Study|Withdrawal by Subject|1|||
125434924|NCT04534114|451219426|FG000|Main Treatment Period|Participant decision|1|||
125434925|NCT04534114|451219427|FG001|Main Treatment Period|Participant decision|3|||
125434926|NCT04534114|451219428|FG002|Main Treatment Period|Participant decision|3|||
125434927|NCT04534114|451219429|FG003|Main Treatment Period|Participant decision|1|||
125434928|NCT04534114|451219426|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
125434929|NCT04534114|451219427|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
125434930|NCT04534114|451219428|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
125434931|NCT04534114|451219429|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
125434932|NCT04534114|451219426|FG000|Main Treatment Period|Adverse Event|4|||
125434933|NCT04534114|451219427|FG001|Main Treatment Period|Adverse Event|2|||
125434934|NCT04534114|451219428|FG002|Main Treatment Period|Adverse Event|1|||
125434935|NCT04534114|451219429|FG003|Main Treatment Period|Adverse Event|2|||
125434936|NCT04534114|451219426|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
125434937|NCT04534114|451219427|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
125434938|NCT04534114|451219428|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
125434939|NCT04534114|451219429|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
125628091|NCT02910219|451919786|FG001|Overall Study|Withdrawal by Subject|1|||
125628092|NCT00701441|451919787|FG000|Overall Study|failure in cpap compliance|0|||
125628093|NCT00701441|451919788|FG001|Overall Study|failure in cpap compliance|4|||
125628094|NCT01015820|451919789|FG000|Overall Study|Suboptimal measurements|1|||
125628095|NCT01015820|451919790|FG001|Overall Study|Suboptimal measurements|0|||
125628096|NCT01313078|451919796|FG000|Overall Study|Death|1|||
125628097|NCT01313078|451919796|FG000|Overall Study|Discontinued study drug|1|||
125628098|NCT01313078|451919796|FG000|Overall Study|Withdrawal by Subject|1|||
125628099|NCT02679781|451919798|FG000|Overall Study|Lost to Follow-up|1|||
125628100|NCT02679781|451919799|FG001|Overall Study|Lost to Follow-up|2|||
125628101|NCT02679781|451919798|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
125628102|NCT02679781|451919799|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
125628103|NCT04209400|451919800|FG000|Overall Study|Withdrawal by Subject|0|||
125434940|NCT04534114|451219426|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
125434941|NCT04534114|451219427|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
125434942|NCT04534114|451219428|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
125434943|NCT04534114|451219429|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
125434944|NCT04534114|451219426|FG000|Extension Treatment Period|Other reason|0|||
125434945|NCT04534114|451219427|FG001|Extension Treatment Period|Other reason|1|||
125434946|NCT04534114|451219428|FG002|Extension Treatment Period|Other reason|0|||
125434947|NCT04534114|451219429|FG003|Extension Treatment Period|Other reason|0|||
125434948|NCT04534114|451219426|FG000|Extension Treatment Period|Death|0|||
125434949|NCT04534114|451219427|FG001|Extension Treatment Period|Death|0|||
125434950|NCT04534114|451219428|FG002|Extension Treatment Period|Death|1|||
125434951|NCT04534114|451219429|FG003|Extension Treatment Period|Death|2|||
125434952|NCT04534114|451219426|FG000|Extension Treatment Period|Adverse Event|0|||
125628104|NCT04209400|451919801|FG001|Overall Study|Withdrawal by Subject|1|||
125628105|NCT01203787|451919809|FG000|Overall Study|Death|12|||
125434953|NCT04534114|451219427|FG001|Extension Treatment Period|Adverse Event|1|||
125434954|NCT04534114|451219428|FG002|Extension Treatment Period|Adverse Event|0|||
125434955|NCT04534114|451219429|FG003|Extension Treatment Period|Adverse Event|1|||
125434956|NCT04534114|451219426|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
125434957|NCT04534114|451219427|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
125434958|NCT04534114|451219428|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
125434959|NCT04534114|451219429|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
125434960|NCT03287414|451219430|FG000|Treatment Epoch|Adverse Event|0|||
125434961|NCT03287414|451219431|FG001|Treatment Epoch|Adverse Event|1|||
125434962|NCT03287414|451219430|FG000|Treatment Epoch|Study terminated by sponsor|2|||
125434963|NCT03287414|451219431|FG001|Treatment Epoch|Study terminated by sponsor|2|||
125434964|NCT03287414|451219430|FG000|Treatment Epoch|Subject/Guardian decision|4|||
125434965|NCT03287414|451219431|FG001|Treatment Epoch|Subject/Guardian decision|0|||
125434966|NCT03287414|451219430|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
125434967|NCT03287414|451219431|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
125434968|NCT03287414|451219430|FG000|Treatment Epoch|Withdrawal by Subject|1|||
125434969|NCT03287414|451219431|FG001|Treatment Epoch|Withdrawal by Subject|0|||
125434970|NCT03287414|451219430|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
125434971|NCT03287414|451219431|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
125434972|NCT03287414|451219430|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
125434973|NCT03287414|451219431|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
125434974|NCT02759185|451219432|FG000|Stage 1|Adverse Event|0|||
125434975|NCT02759185|451219433|FG001|Stage 1|Adverse Event|1|||
125434976|NCT02759185|451219434|FG002|Stage 1|Adverse Event|3|||
125434977|NCT02759185|451219435|FG003|Stage 1|Adverse Event|0|||
125434978|NCT02759185|451219436|FG004|Stage 1|Adverse Event|0|||
125434979|NCT02759185|451219437|FG005|Stage 1|Adverse Event|0|||
125434980|NCT02759185|451219438|FG006|Stage 1|Adverse Event|0|||
125434981|NCT02759185|451219432|FG000|Stage 1|Withdrawal by Subject|1|||
125434982|NCT02759185|451219433|FG001|Stage 1|Withdrawal by Subject|0|||
125434983|NCT02759185|451219434|FG002|Stage 1|Withdrawal by Subject|0|||
125434984|NCT02759185|451219435|FG003|Stage 1|Withdrawal by Subject|0|||
125434985|NCT02759185|451219436|FG004|Stage 1|Withdrawal by Subject|0|||
125434986|NCT02759185|451219437|FG005|Stage 1|Withdrawal by Subject|0|||
125434987|NCT02759185|451219438|FG006|Stage 1|Withdrawal by Subject|0|||
125434988|NCT02759185|451219432|FG000|Stage 2|Adverse Event|0|||
125434989|NCT02759185|451219433|FG001|Stage 2|Adverse Event|0|||
125434990|NCT02759185|451219434|FG002|Stage 2|Adverse Event|0|||
125434991|NCT02759185|451219435|FG003|Stage 2|Adverse Event|0|||
125434992|NCT02759185|451219436|FG004|Stage 2|Adverse Event|1|||
125434993|NCT02759185|451219437|FG005|Stage 2|Adverse Event|2|||
125434994|NCT02759185|451219438|FG006|Stage 2|Adverse Event|0|||
125434995|NCT02759185|451219432|FG000|Stage 2|Withdrawal by Subject|0|||
125434996|NCT02759185|451219433|FG001|Stage 2|Withdrawal by Subject|0|||
125434997|NCT02759185|451219434|FG002|Stage 2|Withdrawal by Subject|0|||
125628106|NCT01203787|451919810|FG001|Overall Study|Death|10|||
125434998|NCT02759185|451219435|FG003|Stage 2|Withdrawal by Subject|0|||
125434999|NCT02759185|451219436|FG004|Stage 2|Withdrawal by Subject|1|||
125435000|NCT02759185|451219437|FG005|Stage 2|Withdrawal by Subject|1|||
125435001|NCT02759185|451219438|FG006|Stage 2|Withdrawal by Subject|1|||
125435002|NCT02613221|451219441|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
125435003|NCT02613221|451219441|FG000|Overall Study|Adverse Event|2|||
125435004|NCT02613221|451219441|FG000|Overall Study|Voluntary Discontinuation|1|||
125435005|NCT02613221|451219441|FG000|Overall Study|Delayed Treatment|1|||
125435006|NCT02613221|451219441|FG000|Overall Study|Enrolled but Not Treated|1|||
125435007|NCT02668016|451219444|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
125435008|NCT02668016|451219444|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
125435009|NCT02668016|451219444|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
125435010|NCT02668016|451219444|FG000|Month 4|Withdrawal due to severe symptoms|1|||
125435011|NCT02668016|451219444|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
125435012|NCT02668016|451219444|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
125435013|NCT02668016|451219444|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
125435014|NCT02668016|451219444|FG000|Month 6|Withdrawal due to severe symptoms|2|||
125435015|NCT02668016|451219444|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
125435016|NCT02668016|451219444|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
125435017|NCT02668016|451219444|FG000|Month 8|Withdrawal due to severe symptoms|1|||
125435018|NCT02668016|451219444|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
125435019|NCT02668016|451219444|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
125435020|NCT02668016|451219444|FG000|Month 10|Withdrawal due to severe symptoms|1|||
125435021|NCT02668016|451219444|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
125435022|NCT00399763|451219449|FG000|Overall Study|Lost to Follow-up|2|||
125435023|NCT00399763|451219450|FG001|Overall Study|Lost to Follow-up|3|||
125435024|NCT05067933|451219458|FG000|Overall Study|Withdrawal by Subject|2|||
125435025|NCT05067933|451219459|FG001|Overall Study|Withdrawal by Subject|0|||
125435026|NCT05067933|451219460|FG002|Overall Study|Withdrawal by Subject|0|||
125435027|NCT05067933|451219461|FG003|Overall Study|Withdrawal by Subject|0|||
125435028|NCT05067933|451219462|FG004|Overall Study|Withdrawal by Subject|0|||
125435029|NCT05067933|451219463|FG005|Overall Study|Withdrawal by Subject|0|||
125435030|NCT05067933|451219458|FG000|Overall Study|Lost to Follow-up|1|||
125435031|NCT05067933|451219459|FG001|Overall Study|Lost to Follow-up|1|||
125435032|NCT05067933|451219460|FG002|Overall Study|Lost to Follow-up|1|||
125435033|NCT05067933|451219461|FG003|Overall Study|Lost to Follow-up|2|||
125435034|NCT05067933|451219462|FG004|Overall Study|Lost to Follow-up|1|||
125435035|NCT05067933|451219463|FG005|Overall Study|Lost to Follow-up|0|||
125435036|NCT05067933|451219458|FG000|Overall Study|Miscellaneous|1|||
125435037|NCT05067933|451219459|FG001|Overall Study|Miscellaneous|0|||
125435038|NCT05067933|451219460|FG002|Overall Study|Miscellaneous|0|||
125435039|NCT05067933|451219461|FG003|Overall Study|Miscellaneous|0|||
125435040|NCT05067933|451219462|FG004|Overall Study|Miscellaneous|0|||
125435041|NCT05067933|451219463|FG005|Overall Study|Miscellaneous|0|||
125435042|NCT05067933|451219458|FG000|Overall Study|Death|0|||
125435043|NCT05067933|451219459|FG001|Overall Study|Death|0|||
125435044|NCT05067933|451219460|FG002|Overall Study|Death|0|||
125435045|NCT05067933|451219461|FG003|Overall Study|Death|1|||
125435046|NCT05067933|451219462|FG004|Overall Study|Death|0|||
125435047|NCT05067933|451219463|FG005|Overall Study|Death|0|||
125435048|NCT01065350|451219469|FG000|Overall Study|Received incorrect drug allocation|0|||
125435049|NCT01065350|451219470|FG001|Overall Study|Received incorrect drug allocation|1|||
125435050|NCT01657266|451219474|FG000|Overall Study|Lost to Follow-up|2|||
125435051|NCT01657266|451219475|FG001|Overall Study|Lost to Follow-up|2|||
125435052|NCT01657266|451219474|FG000|Overall Study|Adverse Event|2|||
125435053|NCT01657266|451219475|FG001|Overall Study|Adverse Event|3|||
125435054|NCT02944656|451219486|FG000|Overall Study|No longer eligible|3|||
125435055|NCT02944656|451219487|FG001|Overall Study|No longer eligible|0|||
125435056|NCT02944656|451219486|FG000|Overall Study|Lost to Follow-up|7|||
125435057|NCT02944656|451219487|FG001|Overall Study|Lost to Follow-up|10|||
125435058|NCT02243631|451220815|FG000|Overall Study|no synovial fluid on second aspirate|0|||
125435059|NCT02243631|451220816|FG001|Overall Study|no synovial fluid on second aspirate|1|||
125435060|NCT01785628|451220820|FG000|Overall Study|Lost to Follow-up|2|||
125435061|NCT01785628|451220821|FG001|Overall Study|Lost to Follow-up|3|||
125435062|NCT00840996|451220822|FG000|Overall Study|Withdrawal by Subject|1|||
125435063|NCT00840996|451220823|FG001|Overall Study|Withdrawal by Subject|0|||
125435064|NCT00957931|451220825|FG000|Overall Study|Death|4|||
125435065|NCT00857805|451220826|FG000|Overall Study|Withdrawal by Subject|1|||
125435066|NCT00857805|451220827|FG001|Overall Study|Withdrawal by Subject|1|||
125435067|NCT04867785|451220828|FG000|Overall Study|Adverse Event|1|||
125435068|NCT04867785|451220829|FG001|Overall Study|Adverse Event|0|||
125435069|NCT04867785|451220830|FG002|Overall Study|Adverse Event|1|||
125435070|NCT04867785|451220831|FG003|Overall Study|Adverse Event|0|||
125435071|NCT04867785|451220832|FG004|Overall Study|Adverse Event|0|||
125628107|NCT01203787|451919809|FG000|Overall Study|Withdrawal by Subject|6|||
125628108|NCT01203787|451919810|FG001|Overall Study|Withdrawal by Subject|2|||
125435072|NCT04867785|451220833|FG005|Overall Study|Adverse Event|0|||
125435073|NCT04867785|451220834|FG006|Overall Study|Adverse Event|0|||
125435074|NCT04867785|451220835|FG007|Overall Study|Adverse Event|2|||
125435075|NCT04867785|451220828|FG000|Overall Study|Lost to Follow-up|4|||
125435076|NCT04867785|451220829|FG001|Overall Study|Lost to Follow-up|4|||
125435077|NCT04867785|451220830|FG002|Overall Study|Lost to Follow-up|3|||
125628109|NCT01203787|451919809|FG000|Overall Study|Lost to Follow-up|2|||
125435078|NCT04867785|451220831|FG003|Overall Study|Lost to Follow-up|2|||
125435079|NCT04867785|451220832|FG004|Overall Study|Lost to Follow-up|0|||
125435080|NCT04867785|451220833|FG005|Overall Study|Lost to Follow-up|1|||
125435081|NCT04867785|451220834|FG006|Overall Study|Lost to Follow-up|0|||
125435082|NCT04867785|451220835|FG007|Overall Study|Lost to Follow-up|1|||
125435083|NCT04867785|451220828|FG000|Overall Study|Withdrawal by Subject|6|||
125435084|NCT04867785|451220829|FG001|Overall Study|Withdrawal by Subject|2|||
125435085|NCT04867785|451220830|FG002|Overall Study|Withdrawal by Subject|2|||
125435086|NCT04867785|451220831|FG003|Overall Study|Withdrawal by Subject|1|||
125435087|NCT04867785|451220832|FG004|Overall Study|Withdrawal by Subject|2|||
125435088|NCT04867785|451220833|FG005|Overall Study|Withdrawal by Subject|0|||
125435089|NCT04867785|451220834|FG006|Overall Study|Withdrawal by Subject|2|||
125435090|NCT04867785|451220835|FG007|Overall Study|Withdrawal by Subject|5|||
125435091|NCT04867785|451220828|FG000|Overall Study|Physician Decision|0|||
125435092|NCT04867785|451220829|FG001|Overall Study|Physician Decision|0|||
125435093|NCT04867785|451220830|FG002|Overall Study|Physician Decision|0|||
125435094|NCT04867785|451220831|FG003|Overall Study|Physician Decision|0|||
125435095|NCT04867785|451220832|FG004|Overall Study|Physician Decision|0|||
125435096|NCT04867785|451220833|FG005|Overall Study|Physician Decision|0|||
125435097|NCT04867785|451220834|FG006|Overall Study|Physician Decision|0|||
125435098|NCT04867785|451220835|FG007|Overall Study|Physician Decision|1|||
125435099|NCT04867785|451220828|FG000|Overall Study|Inadvertent Enrollment|0|||
125435100|NCT04867785|451220829|FG001|Overall Study|Inadvertent Enrollment|0|||
125435101|NCT04867785|451220830|FG002|Overall Study|Inadvertent Enrollment|0|||
125435102|NCT04867785|451220831|FG003|Overall Study|Inadvertent Enrollment|1|||
125435103|NCT04867785|451220832|FG004|Overall Study|Inadvertent Enrollment|1|||
125435104|NCT04867785|451220833|FG005|Overall Study|Inadvertent Enrollment|0|||
125435105|NCT04867785|451220834|FG006|Overall Study|Inadvertent Enrollment|0|||
125435106|NCT04867785|451220835|FG007|Overall Study|Inadvertent Enrollment|1|||
125628110|NCT01203787|451919810|FG001|Overall Study|Lost to Follow-up|0|||
125628111|NCT01203787|451919809|FG000|Overall Study|Adverse Event|11|||
125628112|NCT01203787|451919810|FG001|Overall Study|Adverse Event|15|||
125628113|NCT03404518|451919811|FG000|Overall Study|Lost to Follow-up|28|||
125128473|NCT03020615|450096082|FG000|Overall Study|Physician Decision|3|||
125435107|NCT04867785|451220828|FG000|Overall Study|Eligibility Criteria Not Met|0|||
125435108|NCT04867785|451220829|FG001|Overall Study|Eligibility Criteria Not Met|0|||
125435109|NCT04867785|451220830|FG002|Overall Study|Eligibility Criteria Not Met|0|||
125435110|NCT04867785|451220831|FG003|Overall Study|Eligibility Criteria Not Met|0|||
125435111|NCT04867785|451220832|FG004|Overall Study|Eligibility Criteria Not Met|0|||
125435112|NCT04867785|451220833|FG005|Overall Study|Eligibility Criteria Not Met|0|||
125435113|NCT04867785|451220834|FG006|Overall Study|Eligibility Criteria Not Met|0|||
125435114|NCT04867785|451220835|FG007|Overall Study|Eligibility Criteria Not Met|1|||
125435115|NCT01289041|451220836|FG000|Overall Study|Adverse Event|24|||
125435116|NCT01289041|451220836|FG000|Overall Study|Physician Decision|1|||
125435117|NCT01289041|451220836|FG000|Overall Study|Progressive Disease|41|||
125435118|NCT01289041|451220836|FG000|Overall Study|Withdrawal by Subject|3|||
125435119|NCT01289041|451220836|FG000|Overall Study|Death|1|||
125435120|NCT03239873|451220843|FG000|Overall Study|Lost to Follow-up|15|||
125435121|NCT03239873|451220844|FG001|Overall Study|Lost to Follow-up|16|||
125435122|NCT03239873|451220843|FG000|Overall Study|Physician Decision|1|||
125435123|NCT03239873|451220844|FG001|Overall Study|Physician Decision|0|||
125435124|NCT03239873|451220843|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
125435125|NCT03239873|451220844|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
125435126|NCT03239873|451220843|FG000|Overall Study|Withdrawal by Subject|2|||
125435127|NCT03239873|451220844|FG001|Overall Study|Withdrawal by Subject|0|||
125435128|NCT03239873|451220843|FG000|Overall Study|Contraindication to study medication|1|||
125435129|NCT03239873|451220844|FG001|Overall Study|Contraindication to study medication|0|||
125435130|NCT03239873|451220843|FG000|Overall Study|Protocol Violation|1|||
125435131|NCT03239873|451220844|FG001|Overall Study|Protocol Violation|0|||
125435132|NCT01250119|451220849|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
125435133|NCT01250119|451220850|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
125435134|NCT01250119|451220849|FG000|Diagnostic Phase|Participants Not Tested|44|||
125435135|NCT01250119|451220850|FG001|Diagnostic Phase|Participants Not Tested|0|||
125435136|NCT01250119|451220849|FG000|Treatment Phase|Progressive Disease|0|||
125435137|NCT01250119|451220850|FG001|Treatment Phase|Progressive Disease|32|||
125435138|NCT01250119|451220849|FG000|Treatment Phase|Death|0|||
125435139|NCT01250119|451220850|FG001|Treatment Phase|Death|2|||
125435140|NCT01250119|451220849|FG000|Treatment Phase|Withdrawal by Subject|0|||
125435141|NCT01250119|451220850|FG001|Treatment Phase|Withdrawal by Subject|1|||
125435142|NCT01250119|451220849|FG000|Treatment Phase|Adverse Event|0|||
125435143|NCT01250119|451220850|FG001|Treatment Phase|Adverse Event|2|||
125435144|NCT01250119|451220849|FG000|Treatment Phase|Unknown reason|0|||
125435145|NCT01250119|451220850|FG001|Treatment Phase|Unknown reason|4|||
125435146|NCT02670538|451220851|FG000|Overall Study|Withdrawal of Consent|8|||
125435147|NCT02670538|451220852|FG001|Overall Study|Withdrawal of Consent|6|||
125628114|NCT03404518|451919812|FG001|Overall Study|Lost to Follow-up|30|||
125628115|NCT03404518|451919811|FG000|Overall Study|Protocol Violation|13|||
125435148|NCT02670538|451220853|FG002|Overall Study|Withdrawal of Consent|5|||
125435149|NCT02670538|451220851|FG000|Overall Study|Lost to Follow-up|8|||
125435150|NCT02670538|451220852|FG001|Overall Study|Lost to Follow-up|12|||
125435151|NCT02670538|451220853|FG002|Overall Study|Lost to Follow-up|7|||
125435152|NCT02670538|451220851|FG000|Overall Study|Adverse Event|5|||
125435153|NCT02670538|451220852|FG001|Overall Study|Adverse Event|5|||
125435154|NCT02670538|451220853|FG002|Overall Study|Adverse Event|11|||
125435155|NCT02670538|451220851|FG000|Overall Study|Lack of Efficacy|7|||
125435156|NCT02670538|451220852|FG001|Overall Study|Lack of Efficacy|1|||
125435157|NCT02670538|451220853|FG002|Overall Study|Lack of Efficacy|2|||
125435158|NCT02670538|451220851|FG000|Overall Study|Protocol Violation|3|||
125435159|NCT02670538|451220852|FG001|Overall Study|Protocol Violation|4|||
125435160|NCT02670538|451220853|FG002|Overall Study|Protocol Violation|1|||
125435161|NCT02670538|451220851|FG000|Overall Study|Noncompliance with Study Drug|1|||
125435162|NCT02670538|451220852|FG001|Overall Study|Noncompliance with Study Drug|3|||
125435163|NCT02670538|451220853|FG002|Overall Study|Noncompliance with Study Drug|2|||
125435164|NCT02670538|451220851|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125435165|NCT02670538|451220852|FG001|Overall Study|Other Miscellaneous Reasons|1|||
125435166|NCT02670538|451220853|FG002|Overall Study|Other Miscellaneous Reasons|2|||
125435167|NCT02887989|451220854|FG000|Overall Study|Withdrawal by Subject|8|||
125435168|NCT02887989|451220855|FG001|Overall Study|Withdrawal by Subject|11|||
125435169|NCT02887989|451220854|FG000|Overall Study|Death|1|||
125435170|NCT02887989|451220855|FG001|Overall Study|Death|0|||
125435171|NCT00674323|451220859|FG000|Overall Study|Adverse Event|0|||
125435172|NCT00674323|451220860|FG001|Overall Study|Adverse Event|1|||
125435173|NCT00674323|451220861|FG002|Overall Study|Adverse Event|0|||
125435174|NCT00674323|451220859|FG000|Overall Study|Protocol Violation|1|||
125435175|NCT00674323|451220860|FG001|Overall Study|Protocol Violation|0|||
125435176|NCT00674323|451220861|FG002|Overall Study|Protocol Violation|0|||
125435177|NCT02045433|451220868|FG000|Overall Study|Withdrawal by Subject|1|||
125435178|NCT01112514|451220869|FG000|Overall Study|Lost to Follow-up|1|||
125435179|NCT02176421|451220870|FG000|Overall Study|Lost to Follow-up|4|||
125435180|NCT02176421|451220870|FG000|Overall Study|Adverse Event|1|||
125435181|NCT02145078|451220873|FG000|Overall Study|Death|1|||
125435182|NCT02145078|451220873|FG000|Overall Study|Reason not given|3|||
125435183|NCT02440594|451220877|FG000|Overall Study|Lost to Follow-up|34|||
125435184|NCT02440594|451220878|FG001|Overall Study|Lost to Follow-up|33|||
125435185|NCT02440594|451220879|FG002|Overall Study|Lost to Follow-up|54|||
125435186|NCT02440594|451220880|FG003|Overall Study|Lost to Follow-up|47|||
125435187|NCT02440594|451220881|FG004|Overall Study|Lost to Follow-up|5|||
125435188|NCT02440594|451220882|FG005|Overall Study|Lost to Follow-up|4|||
125435189|NCT02440594|451220883|FG006|Overall Study|Lost to Follow-up|28|||
125435190|NCT02440594|451220884|FG007|Overall Study|Lost to Follow-up|48|||
125435191|NCT02440594|451220877|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
125435192|NCT02440594|451220878|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
125435193|NCT02440594|451220879|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
125435194|NCT02440594|451220880|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
125435195|NCT02440594|451220881|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
125435196|NCT02440594|451220882|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
125435197|NCT02440594|451220883|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
125435198|NCT02440594|451220884|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
125435199|NCT02440594|451220877|FG000|Overall Study|Withdrawal by Subject|81|||
125435200|NCT02440594|451220878|FG001|Overall Study|Withdrawal by Subject|67|||
125435201|NCT02440594|451220879|FG002|Overall Study|Withdrawal by Subject|59|||
125435202|NCT02440594|451220880|FG003|Overall Study|Withdrawal by Subject|38|||
125435203|NCT02440594|451220881|FG004|Overall Study|Withdrawal by Subject|2|||
125435204|NCT02440594|451220882|FG005|Overall Study|Withdrawal by Subject|2|||
125435205|NCT02440594|451220883|FG006|Overall Study|Withdrawal by Subject|7|||
125435206|NCT02440594|451220884|FG007|Overall Study|Withdrawal by Subject|7|||
125435207|NCT02440594|451220877|FG000|Overall Study|Administratively w/drawn|3|||
125435208|NCT02440594|451220878|FG001|Overall Study|Administratively w/drawn|2|||
125435209|NCT02440594|451220879|FG002|Overall Study|Administratively w/drawn|0|||
125435210|NCT02440594|451220880|FG003|Overall Study|Administratively w/drawn|0|||
125435211|NCT02440594|451220881|FG004|Overall Study|Administratively w/drawn|0|||
125435212|NCT02440594|451220882|FG005|Overall Study|Administratively w/drawn|0|||
125435213|NCT02440594|451220883|FG006|Overall Study|Administratively w/drawn|2|||
125435214|NCT02440594|451220884|FG007|Overall Study|Administratively w/drawn|1|||
125435215|NCT00584805|451220885|FG000|Overall Study|No longer at risk of exposure|39|||
125435216|NCT00584805|451220885|FG000|Overall Study|Relocation|36|||
125435217|NCT00584805|451220885|FG000|Overall Study|Withdrawal by Subject|18|||
125435218|NCT00584805|451220885|FG000|Overall Study|Non-compliance|1|||
125435219|NCT00584805|451220885|FG000|Overall Study|Lost to follow up|3|||
125435220|NCT00584805|451220885|FG000|Overall Study|Screen failures|2|||
125435221|NCT01993823|451220886|FG000|Overall Study|Requested by the patient|6|||
125435222|NCT01993823|451220887|FG001|Overall Study|Requested by the patient|11|||
125435223|NCT01993823|451220886|FG000|Overall Study|Protocol Violation|0|||
125435224|NCT01993823|451220887|FG001|Overall Study|Protocol Violation|1|||
125435225|NCT01993823|451220886|FG000|Overall Study|Lost to Follow-up|1|||
125435226|NCT01993823|451220887|FG001|Overall Study|Lost to Follow-up|4|||
125435227|NCT02341456|451220888|FG000|Overall Study|Disease progression|2|||
125435228|NCT02341456|451220889|FG001|Overall Study|Disease progression|3|||
125435229|NCT02341456|451220890|FG002|Overall Study|Disease progression|1|||
125435230|NCT02341456|451220888|FG000|Overall Study|Death|1|||
125435231|NCT02341456|451220889|FG001|Overall Study|Death|1|||
125435232|NCT02341456|451220890|FG002|Overall Study|Death|1|||
125435233|NCT02341456|451220888|FG000|Overall Study|Withdrawal by Subject|0|||
125435234|NCT02341456|451220889|FG001|Overall Study|Withdrawal by Subject|1|||
125435235|NCT02341456|451220890|FG002|Overall Study|Withdrawal by Subject|1|||
125435236|NCT02341456|451220888|FG000|Overall Study|Moved to local access programme.|0|||
125435237|NCT02341456|451220889|FG001|Overall Study|Moved to local access programme.|1|||
125435238|NCT02341456|451220890|FG002|Overall Study|Moved to local access programme.|1|||
125435239|NCT02341456|451220888|FG000|Overall Study|Physician Decision|1|||
125435240|NCT02341456|451220889|FG001|Overall Study|Physician Decision|0|||
125435241|NCT02341456|451220890|FG002|Overall Study|Physician Decision|0|||
125435242|NCT01077362|451220891|FG000|Overall Study|Lack of Efficacy|13|||
125435243|NCT01077362|451220892|FG001|Overall Study|Lack of Efficacy|8|||
125435244|NCT01077362|451220893|FG002|Overall Study|Lack of Efficacy|10|||
125435245|NCT01077362|451220891|FG000|Overall Study|Lost to Follow-up|1|||
125435246|NCT01077362|451220892|FG001|Overall Study|Lost to Follow-up|0|||
125435247|NCT01077362|451220893|FG002|Overall Study|Lost to Follow-up|3|||
125435248|NCT01077362|451220891|FG000|Overall Study|Adverse Event|12|||
125435249|NCT01077362|451220892|FG001|Overall Study|Adverse Event|7|||
125435250|NCT01077362|451220893|FG002|Overall Study|Adverse Event|4|||
125435251|NCT01077362|451220891|FG000|Overall Study|Withdrawal by Subject|5|||
125435252|NCT01077362|451220892|FG001|Overall Study|Withdrawal by Subject|3|||
125435253|NCT01077362|451220893|FG002|Overall Study|Withdrawal by Subject|5|||
125435254|NCT01077362|451220891|FG000|Overall Study|Other|0|||
125435255|NCT01077362|451220892|FG001|Overall Study|Other|1|||
125435256|NCT01077362|451220893|FG002|Overall Study|Other|2|||
125435257|NCT00301080|451220895|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
125435258|NCT00301080|451220896|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
125435259|NCT00301080|451220897|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
125435260|NCT00301080|451220898|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
125435261|NCT00301080|451220899|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
125435262|NCT03066622|451220901|FG000|Overall Study|Lost to Follow-up|24|||
125435263|NCT03066622|451220902|FG001|Overall Study|Lost to Follow-up|25|||
125435264|NCT03066622|451220901|FG000|Overall Study|Withdrawal by Subject|2|||
125435265|NCT03066622|451220902|FG001|Overall Study|Withdrawal by Subject|1|||
125435266|NCT00641719|451220903|FG000|Overall Study|Lack of Efficacy|1|||
125435267|NCT00641719|451220904|FG001|Overall Study|Lack of Efficacy|2|||
125435268|NCT00641719|451220903|FG000|Overall Study|Adverse Event|24|||
125435269|NCT00641719|451220904|FG001|Overall Study|Adverse Event|29|||
125435270|NCT00641719|451220903|FG000|Overall Study|Withdrawal by Subject|4|||
125435271|NCT00641719|451220904|FG001|Overall Study|Withdrawal by Subject|4|||
125435272|NCT00641719|451220903|FG000|Overall Study|Reason Not Specified|1|||
125435273|NCT00641719|451220904|FG001|Overall Study|Reason Not Specified|2|||
125435274|NCT01872910|451220905|FG000|Overall Study|Lost to Follow-up|2|||
125435275|NCT01872910|451220906|FG001|Overall Study|Lost to Follow-up|0|||
125435276|NCT01872910|451220907|FG002|Overall Study|Lost to Follow-up|2|||
125435277|NCT01872910|451220908|FG003|Overall Study|Lost to Follow-up|0|||
125435278|NCT01872910|451220909|FG004|Overall Study|Lost to Follow-up|0|||
125435279|NCT01872910|451220910|FG005|Overall Study|Lost to Follow-up|0|||
125435280|NCT03101241|451220915|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
125435281|NCT03101241|451220916|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
125435282|NCT03101241|451220915|FG000|Overall Study|Participant withdrew consent|3|||
125435283|NCT03101241|451220916|FG001|Overall Study|Participant withdrew consent|1|||
125435284|NCT03101241|451220915|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
125435285|NCT03101241|451220916|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
125435286|NCT03101241|451220915|FG000|Overall Study|Lost to Follow-up|2|||
125435287|NCT03101241|451220916|FG001|Overall Study|Lost to Follow-up|0|||
125435288|NCT03101241|451220915|FG000|Overall Study|Lack of Efficacy|0|||
125435289|NCT03101241|451220916|FG001|Overall Study|Lack of Efficacy|1|||
125435290|NCT03101241|451220915|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
125435291|NCT03101241|451220916|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
125435292|NCT03469349|451220917|FG000|Overall Study|Withdrawal by Subject|1|||
125435293|NCT03469349|451220918|FG001|Overall Study|Withdrawal by Subject|3|||
125435294|NCT03469349|451220917|FG000|Overall Study|Progressive Disease|0|||
125435295|NCT03469349|451220918|FG001|Overall Study|Progressive Disease|1|||
125435296|NCT03469349|451220917|FG000|Overall Study|Lost to Follow-up|2|||
125435297|NCT03469349|451220918|FG001|Overall Study|Lost to Follow-up|2|||
125435298|NCT03469349|451220917|FG000|Overall Study|Adverse Event|2|||
125435299|NCT03469349|451220918|FG001|Overall Study|Adverse Event|4|||
125435300|NCT01678820|451220920|FG000|Overall Study|Study Terminated by Sponsor|45|||
125435301|NCT01678820|451220921|FG001|Overall Study|Study Terminated by Sponsor|43|||
125435302|NCT01678820|451220922|FG002|Overall Study|Study Terminated by Sponsor|43|||
125435303|NCT01678820|451220920|FG000|Overall Study|Withdrawal by Subject|2|||
125435304|NCT01678820|451220921|FG001|Overall Study|Withdrawal by Subject|5|||
125628116|NCT03404518|451919812|FG001|Overall Study|Protocol Violation|6|||
125628117|NCT01079195|451919813|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
125628118|NCT01079195|451919813|FG000|Overall Study|No Documentation Available|437|||
125628119|NCT01079195|451919813|FG000|Overall Study|Adverse Event|157|||
125628120|NCT01079195|451919813|FG000|Overall Study|Reason Unknown|39|||
125628121|NCT01079195|451919813|FG000|Overall Study|Withdrawal by Subject|18|||
125628122|NCT01079195|451919813|FG000|Overall Study|Financial Reasons|15|||
125628123|NCT01079195|451919813|FG000|Overall Study|Lack of Effectiveness|12|||
125628124|NCT01079195|451919813|FG000|Overall Study|Physician Decision|4|||
125628125|NCT01079195|451919813|FG000|Overall Study|Improved Status of Participant|4|||
125628126|NCT01079195|451919813|FG000|Overall Study|No Follow-up Documentation Available|4|||
125628127|NCT01079195|451919813|FG000|Overall Study|Non-compliance|2|||
125628128|NCT03693404|451919818|FG000|Overall Study|Withdrawal by Subject|1|||
125628129|NCT03693404|451919819|FG001|Overall Study|Withdrawal by Subject|0|||
125628130|NCT03693404|451919818|FG000|Overall Study|Lost to Follow-up|0|||
125628131|NCT03693404|451919819|FG001|Overall Study|Lost to Follow-up|5|||
125628132|NCT03693404|451919818|FG000|Overall Study|Excluded from Analysis|0|||
125628133|NCT03693404|451919819|FG001|Overall Study|Excluded from Analysis|1|||
125628134|NCT02079519|451919820|FG000|Overall Study|Disease Progression|9|||
125628135|NCT02079519|451919820|FG000|Overall Study|Adverse Event|1|||
125628136|NCT01685203|451919825|FG000|Overall Study|Lost to Follow-up|3|||
125628137|NCT01685203|451919826|FG001|Overall Study|Lost to Follow-up|3|||
125628138|NCT01685203|451919827|FG002|Overall Study|Lost to Follow-up|0|||
125628139|NCT01685203|451919828|FG003|Overall Study|Lost to Follow-up|1|||
125628140|NCT01685203|451919829|FG004|Overall Study|Lost to Follow-up|0|||
125628141|NCT01685203|451919830|FG005|Overall Study|Lost to Follow-up|0|||
125628142|NCT01685203|451919831|FG006|Overall Study|Lost to Follow-up|0|||
125128474|NCT03020615|450096083|FG001|Overall Study|Physician Decision|1|||
125375558|NCT00729651|451004933|FG001|Overall Study|Protocol Violation|1|||
125375559|NCT00729651|451004932|FG000|Overall Study|Adverse Event|7|||
125375560|NCT00729651|451004933|FG001|Overall Study|Adverse Event|3|||
125375561|NCT00729651|451004932|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
125375562|NCT00729651|451004933|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
125375563|NCT00729651|451004932|FG000|Overall Study|Subject's private reason|2|||
125375564|NCT00729651|451004933|FG001|Overall Study|Subject's private reason|0|||
125375565|NCT01049308|451004934|FG000|Pill Counts|Withdrawal by Subject|83|||
125375566|NCT02521870|451004945|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125375567|NCT02521870|451004946|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
125375568|NCT02521870|451004947|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125375569|NCT02521870|451004948|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125375570|NCT02521870|451004949|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125375571|NCT02521870|451004950|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125375572|NCT02521870|451004951|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125375573|NCT02521870|451004952|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125375574|NCT02521870|451004953|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125375575|NCT02521870|451004954|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125375576|NCT02521870|451004955|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125435305|NCT01678820|451220922|FG002|Overall Study|Withdrawal by Subject|2|||
125435306|NCT01678820|451220920|FG000|Overall Study|Protocol Specified Criteria|2|||
125435307|NCT01678820|451220921|FG001|Overall Study|Protocol Specified Criteria|3|||
125435308|NCT01678820|451220922|FG002|Overall Study|Protocol Specified Criteria|1|||
125435309|NCT01678820|451220920|FG000|Overall Study|Adverse Event|2|||
125435310|NCT01678820|451220921|FG001|Overall Study|Adverse Event|2|||
125435311|NCT01678820|451220922|FG002|Overall Study|Adverse Event|2|||
125435312|NCT01678820|451220920|FG000|Overall Study|Lost to Follow-up|7|||
125435313|NCT01678820|451220921|FG001|Overall Study|Lost to Follow-up|2|||
125435314|NCT01678820|451220922|FG002|Overall Study|Lost to Follow-up|2|||
125435315|NCT01678820|451220920|FG000|Overall Study|Non-compliance with study drug|0|||
125435316|NCT01678820|451220921|FG001|Overall Study|Non-compliance with study drug|1|||
125628143|NCT01685203|451919825|FG000|Overall Study|Adverse Event|0|||
125628144|NCT01685203|451919826|FG001|Overall Study|Adverse Event|0|||
125628145|NCT01685203|451919827|FG002|Overall Study|Adverse Event|0|||
125628146|NCT01685203|451919828|FG003|Overall Study|Adverse Event|0|||
125628147|NCT01685203|451919829|FG004|Overall Study|Adverse Event|0|||
125628148|NCT01685203|451919830|FG005|Overall Study|Adverse Event|2|||
125628149|NCT01685203|451919831|FG006|Overall Study|Adverse Event|0|||
125628150|NCT01685203|451919825|FG000|Overall Study|Adverse event and withdrew consent|1|||
125628151|NCT01685203|451919826|FG001|Overall Study|Adverse event and withdrew consent|0|||
125628152|NCT01685203|451919827|FG002|Overall Study|Adverse event and withdrew consent|0|||
125628153|NCT01685203|451919828|FG003|Overall Study|Adverse event and withdrew consent|0|||
125628154|NCT01685203|451919829|FG004|Overall Study|Adverse event and withdrew consent|0|||
125628155|NCT01685203|451919830|FG005|Overall Study|Adverse event and withdrew consent|0|||
125628156|NCT01685203|451919831|FG006|Overall Study|Adverse event and withdrew consent|0|||
125628157|NCT01685203|451919825|FG000|Overall Study|Patient's decision|0|||
125628158|NCT01685203|451919826|FG001|Overall Study|Patient's decision|0|||
125628159|NCT01685203|451919827|FG002|Overall Study|Patient's decision|0|||
125628160|NCT01685203|451919828|FG003|Overall Study|Patient's decision|0|||
125628161|NCT01685203|451919829|FG004|Overall Study|Patient's decision|0|||
125628162|NCT01685203|451919830|FG005|Overall Study|Patient's decision|1|||
125435317|NCT01678820|451220922|FG002|Overall Study|Non-compliance with study drug|0|||
125435318|NCT01678820|451220920|FG000|Overall Study|Physician Decision|0|||
125435319|NCT01678820|451220921|FG001|Overall Study|Physician Decision|0|||
125435320|NCT01678820|451220922|FG002|Overall Study|Physician Decision|1|||
125435321|NCT01678820|451220920|FG000|Overall Study|Protocol Violation|4|||
125435322|NCT01678820|451220921|FG001|Overall Study|Protocol Violation|5|||
125435323|NCT01678820|451220922|FG002|Overall Study|Protocol Violation|4|||
125435324|NCT01678820|451220920|FG000|Overall Study|Not treated with double-blind study drug|0|||
125435325|NCT01678820|451220921|FG001|Overall Study|Not treated with double-blind study drug|2|||
125435326|NCT01678820|451220922|FG002|Overall Study|Not treated with double-blind study drug|2|||
125435327|NCT02306265|451220923|FG000|Overall Study|Withdrawal by Subject|1|||
125435328|NCT04488003|451220924|FG000|Assessed for Eligibility|Screen Failure|24|||
125435329|NCT04488003|451220925|FG001|Assessed for Eligibility|Screen Failure|0|||
125435330|NCT04488003|451220926|FG002|Assessed for Eligibility|Screen Failure|0|||
125435331|NCT04488003|451220924|FG000|Assessed for Eligibility|Adverse Event|1|||
125435332|NCT04488003|451220925|FG001|Assessed for Eligibility|Adverse Event|0|||
125435333|NCT04488003|451220926|FG002|Assessed for Eligibility|Adverse Event|0|||
125435334|NCT04488003|451220924|FG000|Assessed for Eligibility|Death|1|||
125435335|NCT04488003|451220925|FG001|Assessed for Eligibility|Death|0|||
125435336|NCT04488003|451220926|FG002|Assessed for Eligibility|Death|0|||
125435337|NCT04488003|451220924|FG000|Assessed for Eligibility|Physician Decision|1|||
125435338|NCT04488003|451220925|FG001|Assessed for Eligibility|Physician Decision|0|||
125435339|NCT04488003|451220926|FG002|Assessed for Eligibility|Physician Decision|0|||
125435340|NCT04488003|451220924|FG000|Allocated to Treatment|Progressive Disease|51|||
125435341|NCT04488003|451220925|FG001|Allocated to Treatment|Progressive Disease|0|||
125435342|NCT04488003|451220926|FG002|Allocated to Treatment|Progressive Disease|0|||
125435343|NCT04488003|451220924|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
125435344|NCT04488003|451220925|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
125435345|NCT04488003|451220926|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
125435346|NCT04488003|451220924|FG000|Allocated to Treatment|Adverse Event|6|||
125435347|NCT04488003|451220925|FG001|Allocated to Treatment|Adverse Event|0|||
125435348|NCT04488003|451220926|FG002|Allocated to Treatment|Adverse Event|0|||
125435349|NCT04488003|451220924|FG000|Allocated to Treatment|Other|5|||
125435350|NCT04488003|451220925|FG001|Allocated to Treatment|Other|0|||
125435351|NCT04488003|451220926|FG002|Allocated to Treatment|Other|0|||
125435352|NCT04488003|451220924|FG000|Allocated to Treatment|Physician Decision|4|||
125435353|NCT04488003|451220925|FG001|Allocated to Treatment|Physician Decision|0|||
125435354|NCT04488003|451220926|FG002|Allocated to Treatment|Physician Decision|0|||
125435355|NCT04488003|451220924|FG000|Allocated to Treatment|Death|4|||
125435356|NCT04488003|451220925|FG001|Allocated to Treatment|Death|0|||
125435357|NCT04488003|451220926|FG002|Allocated to Treatment|Death|0|||
125435358|NCT00692406|451220930|FG000|Overall Study|PI dropped, bad data|57|||
125435359|NCT04145037|451220931|FG000|Overall Study|Study terminated|2|||
125435360|NCT04145037|451220932|FG001|Overall Study|Study terminated|0|||
125435361|NCT04145037|451220931|FG000|Overall Study|Withdrawal by Subject|1|||
125435362|NCT04145037|451220932|FG001|Overall Study|Withdrawal by Subject|0|||
125435363|NCT04145037|451220931|FG000|Overall Study|Lost to Follow-up|1|||
125435364|NCT04145037|451220932|FG001|Overall Study|Lost to Follow-up|0|||
125435365|NCT05952297|451220935|FG000|Overall Study|Withdrawal by Subject|1|||
125435366|NCT05952297|451220936|FG001|Overall Study|Withdrawal by Subject|0|||
125435367|NCT05796518|451220943|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
125435368|NCT05778526|451220948|FG000|Overall Study|Lost to Follow-up|0|||
125435369|NCT05778526|451220949|FG001|Overall Study|Lost to Follow-up|1|||
125435370|NCT05778526|451220950|FG002|Overall Study|Lost to Follow-up|3|||
125435371|NCT05778526|451220948|FG000|Overall Study|Protocol Violation|0|||
125628163|NCT01685203|451919831|FG006|Overall Study|Patient's decision|0|||
125628164|NCT01576406|451919833|FG000|Overall Study|Lost to Follow-up|1|||
125628165|NCT01576406|451919834|FG001|Overall Study|Lost to Follow-up|2|||
125628166|NCT01576406|451919835|FG002|Overall Study|Lost to Follow-up|0|||
125628167|NCT01576406|451919836|FG003|Overall Study|Lost to Follow-up|0|||
125628168|NCT01576406|451919837|FG004|Overall Study|Lost to Follow-up|0|||
125628169|NCT01576406|451919838|FG005|Overall Study|Lost to Follow-up|0|||
125435372|NCT05778526|451220949|FG001|Overall Study|Protocol Violation|0|||
125435373|NCT05778526|451220950|FG002|Overall Study|Protocol Violation|8|||
125435374|NCT02294474|451220953|FG000|Overall Study|Adverse Event|7|||
125435375|NCT02294474|451220954|FG001|Overall Study|Adverse Event|7|||
125435376|NCT02294474|451220953|FG000|Overall Study|Lack of Efficacy|2|||
125435377|NCT02294474|451220954|FG001|Overall Study|Lack of Efficacy|1|||
125435378|NCT02294474|451220953|FG000|Overall Study|Protocol Violation|4|||
125435379|NCT02294474|451220954|FG001|Overall Study|Protocol Violation|2|||
125435380|NCT02294474|451220953|FG000|Overall Study|Other than specified above|12|||
125435381|NCT02294474|451220954|FG001|Overall Study|Other than specified above|12|||
125435382|NCT05200936|451220955|FG000|Overall Study|Withdrawal by Subject|2|||
125435383|NCT05200936|451220956|FG001|Overall Study|Withdrawal by Subject|2|||
125435384|NCT05200936|451220955|FG000|Overall Study|Lost to Follow-up|2|||
125435385|NCT05200936|451220956|FG001|Overall Study|Lost to Follow-up|0|||
125435386|NCT05200936|451220955|FG000|Overall Study|Pregnancy|0|||
125435387|NCT05200936|451220956|FG001|Overall Study|Pregnancy|1|||
125435388|NCT03443713|451220957|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
125435389|NCT03443713|451220958|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
125435390|NCT03443713|451220959|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
125435391|NCT01672853|451220961|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
125435392|NCT01672853|451220962|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
125435393|NCT01672853|451220963|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
125435394|NCT01672853|451220961|FG000|Overall Study|Pregnancy|0|||
125435395|NCT01672853|451220962|FG001|Overall Study|Pregnancy|1|||
125435396|NCT01672853|451220963|FG002|Overall Study|Pregnancy|0|||
125435397|NCT01672853|451220961|FG000|Overall Study|Investigator's Discretion|1|||
125435398|NCT01672853|451220962|FG001|Overall Study|Investigator's Discretion|0|||
125435399|NCT01672853|451220963|FG002|Overall Study|Investigator's Discretion|0|||
125435400|NCT01672853|451220961|FG000|Overall Study|Withdrew Consent|5|||
125435401|NCT01672853|451220962|FG001|Overall Study|Withdrew Consent|5|||
125435402|NCT01672853|451220963|FG002|Overall Study|Withdrew Consent|5|||
125435403|NCT01672853|451220961|FG000|Overall Study|Adverse Event|4|||
125435404|NCT01672853|451220962|FG001|Overall Study|Adverse Event|6|||
125435405|NCT01672853|451220963|FG002|Overall Study|Adverse Event|8|||
125435406|NCT01672853|451220961|FG000|Overall Study|Lost to Follow-up|0|||
125435407|NCT01672853|451220962|FG001|Overall Study|Lost to Follow-up|1|||
125435408|NCT01672853|451220963|FG002|Overall Study|Lost to Follow-up|0|||
125435409|NCT01672853|451220961|FG000|Overall Study|Randomized but Never Treated|0|||
125435410|NCT01672853|451220962|FG001|Overall Study|Randomized but Never Treated|0|||
125435411|NCT01672853|451220963|FG002|Overall Study|Randomized but Never Treated|1|||
125435412|NCT00118898|451220965|FG000|Overall Study|Death|6|||
125435413|NCT00118898|451220966|FG001|Overall Study|Death|11|||
125435414|NCT00118898|451220967|FG002|Overall Study|Death|6|||
125435415|NCT00118898|451220968|FG003|Overall Study|Death|8|||
125628170|NCT01576406|451919833|FG000|Overall Study|Death|3|||
125628171|NCT01576406|451919834|FG001|Overall Study|Death|4|||
125628172|NCT01576406|451919835|FG002|Overall Study|Death|8|||
125628173|NCT01576406|451919836|FG003|Overall Study|Death|5|||
125628174|NCT01576406|451919837|FG004|Overall Study|Death|7|||
125628175|NCT01576406|451919838|FG005|Overall Study|Death|9|||
125628176|NCT01576406|451919833|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
125628177|NCT01576406|451919834|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
125628178|NCT01576406|451919835|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
125628179|NCT01576406|451919836|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
125628180|NCT01576406|451919837|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
125628181|NCT01576406|451919838|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
125628182|NCT01576406|451919833|FG000|Overall Study|Withdrawal the consent|2|||
125628183|NCT01576406|451919834|FG001|Overall Study|Withdrawal the consent|2|||
125628184|NCT01576406|451919835|FG002|Overall Study|Withdrawal the consent|5|||
125628185|NCT01576406|451919836|FG003|Overall Study|Withdrawal the consent|1|||
125628186|NCT01576406|451919837|FG004|Overall Study|Withdrawal the consent|1|||
125628187|NCT01576406|451919838|FG005|Overall Study|Withdrawal the consent|3|||
125628188|NCT01576406|451919833|FG000|Overall Study|Other|0|||
125628189|NCT01576406|451919834|FG001|Overall Study|Other|0|||
125628190|NCT01576406|451919835|FG002|Overall Study|Other|2|||
125215709|NCT04424914|450417486|FG000|Overall Study|Withdrawal by Subject|3|||
125435416|NCT00118898|451220965|FG000|Overall Study|Lost to Follow-up|26|||
125435417|NCT00118898|451220966|FG001|Overall Study|Lost to Follow-up|34|||
125435418|NCT00118898|451220967|FG002|Overall Study|Lost to Follow-up|33|||
125435419|NCT00118898|451220968|FG003|Overall Study|Lost to Follow-up|33|||
125435420|NCT00118898|451220965|FG000|Overall Study|Withdrawal by Subject|10|||
125435421|NCT00118898|451220966|FG001|Overall Study|Withdrawal by Subject|5|||
125435422|NCT00118898|451220967|FG002|Overall Study|Withdrawal by Subject|8|||
125435423|NCT00118898|451220968|FG003|Overall Study|Withdrawal by Subject|8|||
125435424|NCT00118898|451220965|FG000|Overall Study|Site Closure|33|||
125435425|NCT00118898|451220966|FG001|Overall Study|Site Closure|31|||
125628191|NCT01576406|451919836|FG003|Overall Study|Other|2|||
125628192|NCT01576406|451919837|FG004|Overall Study|Other|0|||
125628193|NCT01576406|451919838|FG005|Overall Study|Other|0|||
125628194|NCT01375647|451922173|FG000|Overall Study|Lost to Follow-up|3|||
125628195|NCT01375647|451922174|FG001|Overall Study|Lost to Follow-up|3|||
125628196|NCT01375647|451922175|FG002|Overall Study|Lost to Follow-up|7|||
125628197|NCT01375647|451922176|FG003|Overall Study|Lost to Follow-up|10|||
125628198|NCT01375647|451922173|FG000|Overall Study|Death|1|||
125628199|NCT01375647|451922174|FG001|Overall Study|Death|2|||
125628200|NCT01375647|451922175|FG002|Overall Study|Death|1|||
125628201|NCT01375647|451922176|FG003|Overall Study|Death|0|||
125628202|NCT01375647|451922173|FG000|Overall Study|Withdrawal by Subject|17|||
125628203|NCT01375647|451922174|FG001|Overall Study|Withdrawal by Subject|20|||
125215710|NCT04424914|450417487|FG001|Overall Study|Withdrawal by Subject|0|||
125375577|NCT02521870|451004956|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
125375578|NCT02521870|451004945|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
125375579|NCT02521870|451004946|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
125375580|NCT02521870|451004947|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
125375581|NCT02521870|451004948|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
125375582|NCT02521870|451004949|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
125375583|NCT02521870|451004950|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
125375584|NCT02521870|451004951|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
125375585|NCT02521870|451004952|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
125375586|NCT02521870|451004953|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
125375587|NCT02521870|451004954|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
125375588|NCT02521870|451004955|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
125375589|NCT02521870|451004956|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
125375590|NCT02521870|451004945|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
125375591|NCT02521870|451004946|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
125375592|NCT02521870|451004947|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
125375593|NCT02521870|451004948|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
125375594|NCT02521870|451004949|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
125375595|NCT02521870|451004950|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
125375596|NCT02521870|451004951|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
125375597|NCT02521870|451004952|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
125375598|NCT02521870|451004953|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
125375599|NCT02521870|451004954|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
125375600|NCT02521870|451004955|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
125375601|NCT02521870|451004956|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
125375602|NCT02521870|451004945|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125375603|NCT02521870|451004946|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125375604|NCT02521870|451004947|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125375605|NCT02521870|451004948|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125375606|NCT02521870|451004949|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
125375607|NCT02521870|451004950|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
125375608|NCT02521870|451004951|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
125375609|NCT02521870|451004952|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125375610|NCT02521870|451004953|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
125375611|NCT02521870|451004954|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
125375612|NCT02521870|451004955|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
125375613|NCT02521870|451004956|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
125375614|NCT02521870|451004945|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
125375615|NCT02521870|451004946|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
125375616|NCT02521870|451004947|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
125375617|NCT02521870|451004948|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
125375618|NCT02521870|451004949|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
125375619|NCT02521870|451004950|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
125375620|NCT02521870|451004951|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
125375621|NCT02521870|451004952|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
125375622|NCT02521870|451004953|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
125375623|NCT02521870|451004954|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
125375624|NCT02521870|451004955|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
125375625|NCT02521870|451004956|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
125375626|NCT02521870|451004945|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
125375627|NCT02521870|451004946|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
125375628|NCT02521870|451004947|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
125375629|NCT02521870|451004948|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
125375630|NCT02521870|451004949|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
125375631|NCT02521870|451004950|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
125375632|NCT02521870|451004951|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
125375633|NCT02521870|451004952|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
125375634|NCT02521870|451004953|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
125375635|NCT02521870|451004954|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
125375636|NCT02521870|451004955|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
125375637|NCT02521870|451004956|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
125375638|NCT02521870|451004945|FG000|Phase 2: Dose Expansion|Death|0|||
125375639|NCT02521870|451004946|FG001|Phase 2: Dose Expansion|Death|0|||
125375640|NCT02521870|451004947|FG002|Phase 2: Dose Expansion|Death|0|||
125375641|NCT02521870|451004948|FG003|Phase 2: Dose Expansion|Death|0|||
125375642|NCT02521870|451004949|FG004|Phase 2: Dose Expansion|Death|1|||
125375643|NCT02521870|451004950|FG005|Phase 2: Dose Expansion|Death|1|||
125375644|NCT02521870|451004951|FG006|Phase 2: Dose Expansion|Death|3|||
125628204|NCT01375647|451922175|FG002|Overall Study|Withdrawal by Subject|26|||
125628205|NCT01375647|451922176|FG003|Overall Study|Withdrawal by Subject|14|||
125628206|NCT01375647|451922173|FG000|Overall Study|Physician Decision|1|||
125628207|NCT01375647|451922174|FG001|Overall Study|Physician Decision|0|||
125628208|NCT01375647|451922175|FG002|Overall Study|Physician Decision|0|||
125435426|NCT00118898|451220967|FG002|Overall Study|Site Closure|28|||
125435427|NCT00118898|451220968|FG003|Overall Study|Site Closure|37|||
125435428|NCT00118898|451220965|FG000|Overall Study|Severe debilitation|1|||
125435429|NCT00118898|451220966|FG001|Overall Study|Severe debilitation|4|||
125435430|NCT00118898|451220967|FG002|Overall Study|Severe debilitation|6|||
125435431|NCT00118898|451220968|FG003|Overall Study|Severe debilitation|4|||
125628209|NCT01375647|451922176|FG003|Overall Study|Physician Decision|0|||
125628210|NCT03984812|451922179|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125628211|NCT03984812|451922180|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125628212|NCT03984812|451922181|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
125628213|NCT03984812|451922182|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125628214|NCT03984812|451922183|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125628215|NCT03984812|451922184|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125628216|NCT03984812|451922185|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125628217|NCT03984812|451922186|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125628218|NCT03984812|451922187|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125628219|NCT03984812|451922188|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125628220|NCT03984812|451922189|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
125628221|NCT03424044|451922191|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125628222|NCT03424044|451922192|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125628223|NCT03424044|451922193|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
125628224|NCT03424044|451922194|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125628225|NCT03424044|451922195|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125628226|NCT03424044|451922196|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125628227|NCT03424044|451922197|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125628228|NCT03424044|451922198|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125628229|NCT03424044|451922199|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
125628230|NCT03424044|451922191|FG000|First Intervention (76 Hours)|Adverse Event|0|||
125628231|NCT03424044|451922192|FG001|First Intervention (76 Hours)|Adverse Event|0|||
125628232|NCT03424044|451922193|FG002|First Intervention (76 Hours)|Adverse Event|0|||
125628233|NCT03424044|451922194|FG003|First Intervention (76 Hours)|Adverse Event|0|||
125628234|NCT03424044|451922195|FG004|First Intervention (76 Hours)|Adverse Event|1|||
125628235|NCT03424044|451922196|FG005|First Intervention (76 Hours)|Adverse Event|0|||
125628236|NCT03424044|451922197|FG006|First Intervention (76 Hours)|Adverse Event|0|||
125628237|NCT03424044|451922198|FG007|First Intervention (76 Hours)|Adverse Event|0|||
125628238|NCT03424044|451922199|FG008|First Intervention (76 Hours)|Adverse Event|0|||
125628239|NCT03424044|451922191|FG000|First Intervention (76 Hours)|device issues|0|||
125628240|NCT03424044|451922192|FG001|First Intervention (76 Hours)|device issues|0|||
125435432|NCT00118898|451220965|FG000|Overall Study|Not compliant with requirements|11|||
125435433|NCT00118898|451220966|FG001|Overall Study|Not compliant with requirements|13|||
125435434|NCT00118898|451220967|FG002|Overall Study|Not compliant with requirements|11|||
125435435|NCT00118898|451220968|FG003|Overall Study|Not compliant with requirements|11|||
125435436|NCT00118898|451220965|FG000|Overall Study|Not able to get to clinic|34|||
125435437|NCT00118898|451220966|FG001|Overall Study|Not able to get to clinic|43|||
125435438|NCT00118898|451220967|FG002|Overall Study|Not able to get to clinic|31|||
125435439|NCT00118898|451220968|FG003|Overall Study|Not able to get to clinic|40|||
125435440|NCT05879198|451220971|FG000|Overall Study|Lost to Follow-up|1|||
125435441|NCT01693692|451220972|FG000|Overall Study|Withdrawal by Subject|12|||
125435442|NCT01693692|451220973|FG001|Overall Study|Withdrawal by Subject|10|||
125435443|NCT01693692|451220974|FG002|Overall Study|Withdrawal by Subject|11|||
125435444|NCT01693692|451220972|FG000|Overall Study|Adverse Event|7|||
125435445|NCT01693692|451220973|FG001|Overall Study|Adverse Event|14|||
125435446|NCT01693692|451220974|FG002|Overall Study|Adverse Event|9|||
125435447|NCT01693692|451220972|FG000|Overall Study|Physician Decision|0|||
125435448|NCT01693692|451220973|FG001|Overall Study|Physician Decision|0|||
125435449|NCT01693692|451220974|FG002|Overall Study|Physician Decision|1|||
125435450|NCT01693692|451220972|FG000|Overall Study|Protocol Violation|5|||
125435451|NCT01693692|451220973|FG001|Overall Study|Protocol Violation|4|||
125435452|NCT01693692|451220974|FG002|Overall Study|Protocol Violation|6|||
125628241|NCT03424044|451922193|FG002|First Intervention (76 Hours)|device issues|0|||
125628242|NCT03424044|451922194|FG003|First Intervention (76 Hours)|device issues|0|||
125628243|NCT03424044|451922195|FG004|First Intervention (76 Hours)|device issues|0|||
125628244|NCT03424044|451922196|FG005|First Intervention (76 Hours)|device issues|0|||
125628245|NCT03424044|451922197|FG006|First Intervention (76 Hours)|device issues|1|||
125628246|NCT03424044|451922198|FG007|First Intervention (76 Hours)|device issues|1|||
125435453|NCT01693692|451220972|FG000|Overall Study|Lost to Follow-up|2|||
125435454|NCT01693692|451220973|FG001|Overall Study|Lost to Follow-up|2|||
125435455|NCT01693692|451220974|FG002|Overall Study|Lost to Follow-up|3|||
125435456|NCT01693692|451220972|FG000|Overall Study|Other|4|||
125628247|NCT03424044|451922199|FG008|First Intervention (76 Hours)|device issues|1|||
125628248|NCT03424044|451922191|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
125628249|NCT03424044|451922192|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
125628250|NCT03424044|451922193|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
125628251|NCT03424044|451922194|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
125628252|NCT03424044|451922195|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
125628253|NCT03424044|451922196|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
125375645|NCT02521870|451004952|FG007|Phase 2: Dose Expansion|Death|1|||
125375646|NCT02521870|451004953|FG008|Phase 2: Dose Expansion|Death|1|||
125375647|NCT02521870|451004954|FG009|Phase 2: Dose Expansion|Death|5|||
125375648|NCT02521870|451004955|FG010|Phase 2: Dose Expansion|Death|2|||
125375649|NCT02521870|451004956|FG011|Phase 2: Dose Expansion|Death|2|||
125375650|NCT02521870|451004945|FG000|Phase 2: Dose Expansion|Other|0|||
125375651|NCT02521870|451004946|FG001|Phase 2: Dose Expansion|Other|0|||
125375652|NCT02521870|451004947|FG002|Phase 2: Dose Expansion|Other|0|||
125375653|NCT02521870|451004948|FG003|Phase 2: Dose Expansion|Other|0|||
125375654|NCT02521870|451004949|FG004|Phase 2: Dose Expansion|Other|10|||
125375655|NCT02521870|451004950|FG005|Phase 2: Dose Expansion|Other|3|||
125375656|NCT02521870|451004951|FG006|Phase 2: Dose Expansion|Other|2|||
125375657|NCT02521870|451004952|FG007|Phase 2: Dose Expansion|Other|0|||
125375658|NCT02521870|451004953|FG008|Phase 2: Dose Expansion|Other|10|||
125375659|NCT02521870|451004954|FG009|Phase 2: Dose Expansion|Other|5|||
125375660|NCT02521870|451004955|FG010|Phase 2: Dose Expansion|Other|1|||
125375661|NCT02521870|451004956|FG011|Phase 2: Dose Expansion|Other|7|||
125375662|NCT02521870|451004945|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125375663|NCT02521870|451004946|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125375664|NCT02521870|451004947|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125375665|NCT02521870|451004948|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125375666|NCT02521870|451004949|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
125375667|NCT02521870|451004950|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125375668|NCT02521870|451004951|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125375669|NCT02521870|451004952|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125375670|NCT02521870|451004953|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125375671|NCT02521870|451004954|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125375672|NCT02521870|451004955|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125375673|NCT02521870|451004956|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
125375674|NCT02521870|451004945|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125375675|NCT02521870|451004946|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125375676|NCT02521870|451004947|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125375677|NCT02521870|451004948|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125375678|NCT02521870|451004949|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
125375679|NCT02521870|451004950|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125375680|NCT02521870|451004951|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125375681|NCT02521870|451004952|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125375682|NCT02521870|451004953|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125375683|NCT02521870|451004954|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125375684|NCT02521870|451004955|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125375685|NCT02521870|451004956|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
125375686|NCT00519831|451004957|FG000|Overall Study|Adverse Event|3|||
125375687|NCT02854631|451004958|FG000|Overall Study|Adverse Event|1|||
125375688|NCT02854631|451004959|FG001|Overall Study|Adverse Event|2|||
125375689|NCT02854631|451004958|FG000|Overall Study|Withdrew Consent|3|||
125375690|NCT02854631|451004959|FG001|Overall Study|Withdrew Consent|2|||
125375691|NCT02854631|451004958|FG000|Overall Study|Investigator's Discretion|2|||
125375692|NCT02854631|451004959|FG001|Overall Study|Investigator's Discretion|0|||
125375693|NCT02854631|451004958|FG000|Overall Study|Death|12|||
125375694|NCT02854631|451004959|FG001|Overall Study|Death|8|||
125375695|NCT02854631|451004958|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
125375696|NCT02854631|451004959|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
125375697|NCT02854631|451004958|FG000|Overall Study|Protocol Violation|0|||
125375698|NCT02854631|451004959|FG001|Overall Study|Protocol Violation|1|||
125375699|NCT02854631|451004958|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
125375700|NCT02854631|451004959|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
125375701|NCT02854631|451004958|FG000|Overall Study|Lost to Follow-up|4|||
125375702|NCT02854631|451004959|FG001|Overall Study|Lost to Follow-up|2|||
125375703|NCT02634320|451004965|FG000|Overall Study|Adverse Event|2|||
125375704|NCT02634320|451004965|FG000|Overall Study|Lost to Follow-up|3|||
125215711|NCT04424914|450417488|FG002|Overall Study|Withdrawal by Subject|0|||
125375705|NCT02634320|451004965|FG000|Overall Study|Moved out of area|2|||
125375706|NCT02634320|451004965|FG000|Overall Study|Out of window for study visits|1|||
125375707|NCT02634320|451004965|FG000|Overall Study|Protocol Violation|1|||
125375708|NCT02634320|451004965|FG000|Overall Study|Withdrawal by Subject|5|||
125375709|NCT02634320|451004965|FG000|Overall Study|Lack of Efficacy|2|||
125375710|NCT00357968|451004969|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
125375711|NCT00357968|451004970|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
125435457|NCT01693692|451220973|FG001|Overall Study|Other|4|||
125435458|NCT01693692|451220974|FG002|Overall Study|Other|6|||
125435459|NCT00663117|451221978|FG000|Overall Study|Lack of Efficacy|1|||
125435460|NCT00663117|451221979|FG001|Overall Study|Lack of Efficacy|0|||
125435461|NCT01992549|451221985|FG000|Overall Study|Lost to Follow-up|2|||
125435462|NCT01992549|451221985|FG000|Overall Study|Serious Adverse Event|1|||
125435463|NCT01992549|451221985|FG000|Overall Study|Product Switch to Extend Half Life|1|||
125435464|NCT01590771|451221986|FG000|Overall Study|Other Protocol Specified Criteria|5|||
125435465|NCT01590771|451221987|FG001|Overall Study|Other Protocol Specified Criteria|14|||
125435466|NCT01590771|451221986|FG000|Overall Study|Withdrawal by Subject|8|||
125435467|NCT01590771|451221987|FG001|Overall Study|Withdrawal by Subject|15|||
125435468|NCT01590771|451221986|FG000|Overall Study|Protocol Violation|1|||
125435469|NCT01590771|451221987|FG001|Overall Study|Protocol Violation|2|||
125435470|NCT01590771|451221986|FG000|Overall Study|Lost to Follow-up|1|||
125435471|NCT01590771|451221987|FG001|Overall Study|Lost to Follow-up|1|||
125435472|NCT01590771|451221986|FG000|Overall Study|Lack of Efficacy|1|||
125435473|NCT01590771|451221987|FG001|Overall Study|Lack of Efficacy|0|||
125435474|NCT01590771|451221986|FG000|Overall Study|Adverse Event|3|||
125435475|NCT01590771|451221987|FG001|Overall Study|Adverse Event|7|||
125435476|NCT04022889|451221992|FG000|Stage 1: Period 1|Adverse Event|1|||
125435477|NCT04022889|451221993|FG001|Stage 1: Period 1|Adverse Event|0|||
125435478|NCT04022889|451221994|FG002|Stage 1: Period 1|Adverse Event|0|||
125435479|NCT04022889|451221992|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
125435480|NCT04022889|451221993|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
125435481|NCT04022889|451221994|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
125435482|NCT04022889|451221992|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
125435483|NCT04022889|451221993|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
125435484|NCT04022889|451221994|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
125435485|NCT04022889|451221992|FG000|Stage 2|Screen Failure|0|||
125435486|NCT04022889|451221993|FG001|Stage 2|Screen Failure|0|||
125435487|NCT04022889|451221994|FG002|Stage 2|Screen Failure|3|||
125435488|NCT04022889|451221992|FG000|Stage 2|Ineligible for apheresis donation|0|||
125435489|NCT04022889|451221993|FG001|Stage 2|Ineligible for apheresis donation|0|||
125435490|NCT04022889|451221994|FG002|Stage 2|Ineligible for apheresis donation|2|||
125435491|NCT04022889|451221992|FG000|Stage 2|Adverse Event|0|||
125435492|NCT04022889|451221993|FG001|Stage 2|Adverse Event|0|||
125435493|NCT04022889|451221994|FG002|Stage 2|Adverse Event|2|||
125435494|NCT04022889|451221992|FG000|Stage 2|Protocol Violation|0|||
125435495|NCT04022889|451221993|FG001|Stage 2|Protocol Violation|0|||
125628254|NCT03424044|451922197|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
125628255|NCT03424044|451922198|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
125628256|NCT03424044|451922199|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
125628257|NCT03424044|451922191|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125628258|NCT03424044|451922192|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125628259|NCT03424044|451922193|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125628260|NCT03424044|451922194|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
125628261|NCT03424044|451922195|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125628262|NCT03424044|451922196|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125628263|NCT03424044|451922197|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125628264|NCT03424044|451922198|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125628265|NCT03424044|451922199|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
125628266|NCT02971007|451922200|FG000|Overall Study|Adverse Event|1|||
125628267|NCT02971007|451922201|FG001|Overall Study|Adverse Event|0|||
125628268|NCT02971007|451922202|FG002|Overall Study|Adverse Event|0|||
125628269|NCT02971007|451922200|FG000|Overall Study|Lost to Follow-up|0|||
125628270|NCT02971007|451922201|FG001|Overall Study|Lost to Follow-up|1|||
125628271|NCT02971007|451922202|FG002|Overall Study|Lost to Follow-up|1|||
125628272|NCT02971007|451922200|FG000|Overall Study|Withdrawal by Subject|0|||
125628273|NCT02971007|451922201|FG001|Overall Study|Withdrawal by Subject|1|||
125628274|NCT02971007|451922202|FG002|Overall Study|Withdrawal by Subject|0|||
125628275|NCT02971007|451922200|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
125628276|NCT02971007|451922201|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
125435496|NCT04022889|451221994|FG002|Stage 2|Protocol Violation|1|||
125628277|NCT02971007|451922202|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
125628278|NCT02971007|451922200|FG000|Overall Study|Patient discontinued study drug|0|||
125628279|NCT02971007|451922201|FG001|Overall Study|Patient discontinued study drug|1|||
125628280|NCT02971007|451922202|FG002|Overall Study|Patient discontinued study drug|0|||
125628281|NCT00402285|451922205|FG000|Overall Study|insufficient RNA quality|7|||
125435497|NCT04022889|451221992|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
125435498|NCT04022889|451221993|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
125435499|NCT04022889|451221994|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
125435500|NCT01900054|451221995|FG000|Overall Study|Physician Decision|1|||
125435501|NCT01900054|451221995|FG000|Overall Study|Withdrawal by Subject|1|||
125435502|NCT03285295|451221998|FG000|Alinity s HBsAg|Protocol Violation|11|||
125628282|NCT00402285|451922206|FG001|Overall Study|insufficient RNA quality|6|||
125628283|NCT00402285|451922207|FG002|Overall Study|insufficient RNA quality|2|||
125628284|NCT00784459|451922208|FG000|Overall Study|Adverse Event|0|||
125628285|NCT00784459|451922209|FG001|Overall Study|Adverse Event|2|||
125628286|NCT02009930|451922210|FG000|Overall Study|withdrawn|5|||
125628287|NCT02707601|451922211|FG000|Overall Study|Death|0|||
125628288|NCT02707601|451922212|FG001|Overall Study|Death|1|||
125628289|NCT02707601|451922211|FG000|Overall Study|Lack of Efficacy|0|||
125628290|NCT02707601|451922212|FG001|Overall Study|Lack of Efficacy|1|||
125628291|NCT02707601|451922211|FG000|Overall Study|Investigator's Discretion|1|||
125628292|NCT02707601|451922212|FG001|Overall Study|Investigator's Discretion|0|||
125628293|NCT02707601|451922211|FG000|Overall Study|Withdrew Consent|0|||
125628294|NCT02707601|451922212|FG001|Overall Study|Withdrew Consent|1|||
125628295|NCT02707601|451922211|FG000|Overall Study|Lost to Follow-up|1|||
125628296|NCT02707601|451922212|FG001|Overall Study|Lost to Follow-up|1|||
125628297|NCT02707601|451922211|FG000|Overall Study|Participants Randomized but Not Treated|2|||
125628298|NCT02707601|451922212|FG001|Overall Study|Participants Randomized but Not Treated|0|||
125628299|NCT02959970|451922214|FG000|Overall Study|Adverse Event|1|||
125628300|NCT02959970|451922215|FG001|Overall Study|Adverse Event|0|||
125628301|NCT02959970|451922214|FG000|Overall Study|Withdrawal by Subject|0|||
125435503|NCT03285295|451221999|FG001|Alinity s HBsAg|Protocol Violation|0|||
125628302|NCT02959970|451922215|FG001|Overall Study|Withdrawal by Subject|2|||
125628303|NCT02959970|451922214|FG000|Overall Study|Lost to Follow-up|1|||
125628304|NCT02959970|451922215|FG001|Overall Study|Lost to Follow-up|5|||
125628305|NCT00693420|451922218|FG000|Overall Study|Adverse Event|4|||
125628306|NCT00693420|451922219|FG001|Overall Study|Adverse Event|4|||
125628307|NCT00693420|451922218|FG000|Overall Study|Lost to Follow-up|0|||
125628308|NCT00693420|451922219|FG001|Overall Study|Lost to Follow-up|3|||
125628309|NCT00693420|451922218|FG000|Overall Study|Withdrawal by Subject|1|||
125628310|NCT00693420|451922219|FG001|Overall Study|Withdrawal by Subject|0|||
125628311|NCT00693420|451922218|FG000|Overall Study|Protocol Violation|0|||
125628312|NCT00693420|451922219|FG001|Overall Study|Protocol Violation|2|||
125628313|NCT00693420|451922218|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
125628314|NCT00693420|451922219|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
125628315|NCT00693420|451922218|FG000|Overall Study|Personal Reasons|1|||
125628316|NCT00693420|451922219|FG001|Overall Study|Personal Reasons|4|||
125628317|NCT00063986|451922225|FG000|Overall Study|Withdrawal by Subject|1|||
125628318|NCT00063986|451922225|FG000|Overall Study|Ineligible|1|||
125628319|NCT00063986|451922225|FG000|Overall Study|Intra-operatively ineligible|4|||
125628320|NCT01235338|451922226|FG000|Overall Study|Adverse Event|3|||
125628321|NCT01235338|451922227|FG001|Overall Study|Adverse Event|2|||
125628322|NCT01235338|451922226|FG000|Overall Study|Protocol Violation|1|||
125628323|NCT01235338|451922227|FG001|Overall Study|Protocol Violation|1|||
125628324|NCT01235338|451922226|FG000|Overall Study|Withdrawal by Subject|5|||
125628325|NCT01235338|451922227|FG001|Overall Study|Withdrawal by Subject|0|||
125628326|NCT01235338|451922226|FG000|Overall Study|Exclusion criteria violations|1|||
125628327|NCT01235338|451922227|FG001|Overall Study|Exclusion criteria violations|1|||
125628328|NCT01235338|451922226|FG000|Overall Study|Positive drug screen|0|||
125628329|NCT01235338|451922227|FG001|Overall Study|Positive drug screen|1|||
125628330|NCT01235338|451922226|FG000|Overall Study|Prohibited meds|1|||
125628331|NCT01235338|451922227|FG001|Overall Study|Prohibited meds|0|||
125435504|NCT03285295|451222000|FG002|Alinity s HBsAg|Protocol Violation|0|||
125435505|NCT03285295|451222001|FG003|Alinity s HBsAg|Protocol Violation|0|||
125435506|NCT03285295|451222002|FG004|Alinity s HBsAg|Protocol Violation|0|||
125628332|NCT00509028|451922231|FG000|Overall Study|Adverse Event|2|||
125628333|NCT00509028|451922232|FG001|Overall Study|Adverse Event|0|||
125628334|NCT00509028|451922231|FG000|Overall Study|Withdrawal by Subject|4|||
125628335|NCT00509028|451922232|FG001|Overall Study|Withdrawal by Subject|3|||
125628336|NCT00509028|451922231|FG000|Overall Study|Lost to Follow-up|0|||
125628337|NCT00509028|451922232|FG001|Overall Study|Lost to Follow-up|1|||
125628338|NCT00509028|451922231|FG000|Overall Study|Protocol Violation|4|||
125628339|NCT00509028|451922232|FG001|Overall Study|Protocol Violation|2|||
125628340|NCT00509028|451922231|FG000|Overall Study|Non-compliance|2|||
125628341|NCT00509028|451922232|FG001|Overall Study|Non-compliance|1|||
125628342|NCT00948428|451922233|FG000|Overall Study|Withdrawal by Subject|6|||
125628343|NCT00948428|451922234|FG001|Overall Study|Withdrawal by Subject|12|||
125628344|NCT00948428|451922235|FG002|Overall Study|Withdrawal by Subject|7|||
125628345|NCT00948428|451922233|FG000|Overall Study|Adverse Event|6|||
125628346|NCT00948428|451922234|FG001|Overall Study|Adverse Event|3|||
125628347|NCT00948428|451922235|FG002|Overall Study|Adverse Event|0|||
125628348|NCT00948428|451922233|FG000|Overall Study|Lost to Follow-up|2|||
125628349|NCT00948428|451922234|FG001|Overall Study|Lost to Follow-up|1|||
125628350|NCT00948428|451922235|FG002|Overall Study|Lost to Follow-up|1|||
125628351|NCT00948428|451922233|FG000|Overall Study|Death|2|||
125628352|NCT00948428|451922234|FG001|Overall Study|Death|0|||
125628353|NCT00948428|451922235|FG002|Overall Study|Death|0|||
125435507|NCT03285295|451221998|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
125628354|NCT00948428|451922233|FG000|Overall Study|Intercurrent Illness|1|||
125435508|NCT03285295|451221999|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
125435509|NCT03285295|451222000|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
125435510|NCT03285295|451222001|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
125435511|NCT03285295|451222002|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
125435512|NCT03285295|451221998|FG000|Alinity s HBsAg|No Results Generated|74|||
125435513|NCT03285295|451221999|FG001|Alinity s HBsAg|No Results Generated|6|||
125435514|NCT03285295|451222000|FG002|Alinity s HBsAg|No Results Generated|0|||
125435515|NCT03285295|451222001|FG003|Alinity s HBsAg|No Results Generated|0|||
125435516|NCT03285295|451222002|FG004|Alinity s HBsAg|No Results Generated|0|||
125435517|NCT03285295|451221998|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
125435518|NCT03285295|451221999|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
125435519|NCT03285295|451222000|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
125435520|NCT03285295|451222001|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
125435521|NCT03285295|451222002|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
125435522|NCT03285295|451221998|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
125435523|NCT03285295|451221999|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
125435524|NCT03285295|451222000|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
125435525|NCT03285295|451222001|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
125435526|NCT03285295|451222002|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
125435527|NCT03285295|451221998|FG000|Alinity s HTLV I/II|No Results Generated|70|||
125435528|NCT03285295|451221999|FG001|Alinity s HTLV I/II|No Results Generated|0|||
125435529|NCT03285295|451222000|FG002|Alinity s HTLV I/II|No Results Generated|0|||
125435530|NCT03285295|451222001|FG003|Alinity s HTLV I/II|No Results Generated|0|||
125435531|NCT03285295|451222002|FG004|Alinity s HTLV I/II|No Results Generated|0|||
125435532|NCT03285295|451221998|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
125435533|NCT03285295|451221999|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
125435534|NCT03285295|451222000|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
125435535|NCT03285295|451222001|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
125435536|NCT03285295|451222002|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
125628355|NCT00948428|451922234|FG001|Overall Study|Intercurrent Illness|0|||
125628356|NCT00948428|451922235|FG002|Overall Study|Intercurrent Illness|0|||
125628357|NCT00948428|451922233|FG000|Overall Study|Non-compliance|1|||
125628358|NCT00948428|451922234|FG001|Overall Study|Non-compliance|2|||
125628359|NCT00948428|451922235|FG002|Overall Study|Non-compliance|0|||
125628360|NCT04839393|451922239|FG000|Overall Study|Adverse Event|0|||
125628361|NCT04839393|451922240|FG001|Overall Study|Adverse Event|0|||
125628362|NCT04839393|451922241|FG002|Overall Study|Adverse Event|2|||
125628363|NCT04839393|451922239|FG000|Overall Study|Withdrawal by participant|0|||
125628364|NCT04839393|451922240|FG001|Overall Study|Withdrawal by participant|0|||
125628365|NCT04839393|451922241|FG002|Overall Study|Withdrawal by participant|1|||
125628366|NCT00633893|451922244|FG000|Overall Study|Death|1|||
125628367|NCT00633893|451922245|FG001|Overall Study|Death|3|||
125628368|NCT00633893|451922246|FG002|Overall Study|Death|9|||
125628369|NCT00633893|451922244|FG000|Overall Study|Adverse Event|65|||
125628370|NCT00633893|451922245|FG001|Overall Study|Adverse Event|58|||
125628371|NCT00633893|451922246|FG002|Overall Study|Adverse Event|126|||
125628372|NCT00633893|451922244|FG000|Overall Study|Withdrawal by Subject|7|||
125628373|NCT00633893|451922245|FG001|Overall Study|Withdrawal by Subject|12|||
125628374|NCT00633893|451922246|FG002|Overall Study|Withdrawal by Subject|6|||
125628375|NCT00633893|451922244|FG000|Overall Study|Lost to Follow-up|2|||
125628376|NCT00633893|451922245|FG001|Overall Study|Lost to Follow-up|4|||
125628377|NCT00633893|451922246|FG002|Overall Study|Lost to Follow-up|8|||
125628378|NCT00633893|451922244|FG000|Overall Study|Poor/non-compliance|5|||
125628379|NCT00633893|451922245|FG001|Overall Study|Poor/non-compliance|12|||
125628380|NCT00633893|451922246|FG002|Overall Study|Poor/non-compliance|3|||
125628381|NCT00633893|451922244|FG000|Overall Study|Pregnancy|2|||
125628382|NCT00633893|451922245|FG001|Overall Study|Pregnancy|1|||
125628383|NCT00633893|451922246|FG002|Overall Study|Pregnancy|1|||
125628384|NCT00633893|451922244|FG000|Overall Study|Not meet/no longer meets criteria|4|||
125628385|NCT00633893|451922245|FG001|Overall Study|Not meet/no longer meets criteria|6|||
125628386|NCT00633893|451922246|FG002|Overall Study|Not meet/no longer meets criteria|4|||
125628387|NCT00633893|451922244|FG000|Overall Study|Other|28|||
125628388|NCT00633893|451922245|FG001|Overall Study|Other|33|||
125628389|NCT00633893|451922246|FG002|Overall Study|Other|31|||
125628390|NCT02741310|451922247|FG000|Overall Study|Sponsor Decision|2|||
125628391|NCT02741310|451922248|FG001|Overall Study|Sponsor Decision|2|||
125628392|NCT05091918|451922249|FG000|Overall Study|Adverse Event|1|||
125628393|NCT05091918|451922249|FG000|Overall Study|Withdrawal by Subject|81|||
125628394|NCT00239356|451922250|FG000|Overall Study|Lack of Efficacy|1|||
125215712|NCT04424914|450417486|FG000|Overall Study|Study terminated by sponsor|23|||
125215713|NCT04424914|450417487|FG001|Overall Study|Study terminated by sponsor|7|||
125215714|NCT04424914|450417488|FG002|Overall Study|Study terminated by sponsor|0|||
125435537|NCT03285295|451221998|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
125435538|NCT03285295|451221999|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
125435539|NCT03285295|451222000|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
125628395|NCT00239356|451922251|FG001|Overall Study|Lack of Efficacy|0|||
125628396|NCT00239356|451922250|FG000|Overall Study|Adverse Event|6|||
125628397|NCT00239356|451922251|FG001|Overall Study|Adverse Event|0|||
125628398|NCT00239356|451922250|FG000|Overall Study|Withdrawal by Subject|15|||
125628399|NCT00239356|451922251|FG001|Overall Study|Withdrawal by Subject|6|||
125628400|NCT00239356|451922250|FG000|Overall Study|Lost to Follow-up|3|||
125628401|NCT00239356|451922251|FG001|Overall Study|Lost to Follow-up|0|||
125628402|NCT00239356|451922250|FG000|Overall Study|poor/non-compliance|2|||
125628403|NCT00239356|451922251|FG001|Overall Study|poor/non-compliance|0|||
125628404|NCT00239356|451922250|FG000|Overall Study|Pregnancy|1|||
125628405|NCT00239356|451922251|FG001|Overall Study|Pregnancy|0|||
125628406|NCT00239356|451922250|FG000|Overall Study|Administrative reason|0|||
125628407|NCT00239356|451922251|FG001|Overall Study|Administrative reason|1|||
125628408|NCT00239356|451922250|FG000|Overall Study|Drug available on market|11|||
125628409|NCT00239356|451922251|FG001|Overall Study|Drug available on market|2|||
125628410|NCT02044822|451922252|FG000|Overall Study|Study Terminated by Sponsor|77|||
125628411|NCT02044822|451922252|FG000|Overall Study|Investigator's Discretion|10|||
125628412|NCT02044822|451922252|FG000|Overall Study|Withdrew Consent|3|||
125628413|NCT02044822|451922252|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
125628414|NCT02044822|451922252|FG000|Overall Study|Lost to Follow-up|1|||
125628415|NCT03417505|451922255|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
125628416|NCT03417505|451922256|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
125628417|NCT02432703|451922257|FG000|Overall Study|Adverse Event|1|||
125628418|NCT02432703|451922258|FG001|Overall Study|Adverse Event|4|||
125628419|NCT02432703|451922257|FG000|Overall Study|Lack of Efficacy|1|||
125628420|NCT02432703|451922258|FG001|Overall Study|Lack of Efficacy|0|||
125628421|NCT02432703|451922257|FG000|Overall Study|Lost to Follow-up|5|||
125628422|NCT02432703|451922258|FG001|Overall Study|Lost to Follow-up|3|||
125628423|NCT02432703|451922257|FG000|Overall Study|Withdrawal by Subject|9|||
125628424|NCT02432703|451922258|FG001|Overall Study|Withdrawal by Subject|6|||
125628425|NCT02432703|451922257|FG000|Overall Study|Other|6|||
125628426|NCT02432703|451922258|FG001|Overall Study|Other|5|||
125628427|NCT00653328|451922259|FG000|Overall Study|Withdrawal by Subject|1|||
125628428|NCT00653328|451922259|FG000|Overall Study|Adverse Event|2|||
125628429|NCT00653328|451922259|FG000|Overall Study|Disease progression|10|||
125628430|NCT00653328|451922259|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
125628431|NCT03051217|451922260|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
125628432|NCT03051217|451922261|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125628433|NCT03051217|451922262|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
125628434|NCT03051217|451922263|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125628435|NCT03051217|451922264|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125628436|NCT03051217|451922265|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125628437|NCT03051217|451922266|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125628438|NCT03051217|451922260|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
125628439|NCT03051217|451922261|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
125628440|NCT03051217|451922262|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
125628441|NCT03051217|451922263|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
125628442|NCT03051217|451922264|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
125628443|NCT03051217|451922265|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
125628444|NCT03051217|451922266|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
125628445|NCT03051217|451922260|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
125628446|NCT03051217|451922261|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
125628447|NCT03051217|451922262|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
125628448|NCT03051217|451922263|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125628449|NCT03051217|451922264|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125628450|NCT03051217|451922265|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125628451|NCT03051217|451922266|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125628452|NCT03051217|451922260|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
125628453|NCT03051217|451922261|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
125628454|NCT03051217|451922262|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
125628455|NCT03051217|451922263|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
125628456|NCT03051217|451922264|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
125628457|NCT03051217|451922265|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
125628458|NCT03051217|451922266|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
125628459|NCT03051217|451922260|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
125628460|NCT03051217|451922261|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
125628461|NCT03051217|451922262|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
125628462|NCT03051217|451922263|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
125628463|NCT03051217|451922264|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
125628464|NCT03051217|451922265|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
125628465|NCT03051217|451922266|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
125628466|NCT03051217|451922260|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
125628467|NCT03051217|451922261|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
125628468|NCT03051217|451922262|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
125628469|NCT03051217|451922263|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
125628470|NCT03051217|451922264|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
125628471|NCT03051217|451922265|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
125628472|NCT03051217|451922266|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
125628473|NCT03051217|451922260|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
125628474|NCT03051217|451922261|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
125628475|NCT03051217|451922262|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
125628476|NCT03051217|451922263|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
125628477|NCT03051217|451922264|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
125628478|NCT03051217|451922265|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
125628479|NCT03051217|451922266|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
125628480|NCT03051217|451922260|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
125628481|NCT03051217|451922261|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
125628482|NCT03051217|451922262|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
125628483|NCT03051217|451922263|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
125628484|NCT03051217|451922264|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
125628485|NCT03051217|451922265|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
125628486|NCT03051217|451922266|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
125628487|NCT00109772|451922267|FG000|Double-blind Treatment|Adverse Event|14|||
125628488|NCT00109772|451922268|FG001|Double-blind Treatment|Adverse Event|5|||
125628489|NCT00109772|451922267|FG000|Double-blind Treatment|Lack of Efficacy|1|||
125628490|NCT00109772|451922268|FG001|Double-blind Treatment|Lack of Efficacy|0|||
125628491|NCT00109772|451922267|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
125628492|NCT00109772|451922268|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
125628493|NCT00109772|451922267|FG000|Double-blind Treatment|Lost to Follow-up|2|||
125628494|NCT00109772|451922268|FG001|Double-blind Treatment|Lost to Follow-up|3|||
125628495|NCT00109772|451922267|FG000|Double-blind Treatment|Protocol Violation|0|||
125628496|NCT00109772|451922268|FG001|Double-blind Treatment|Protocol Violation|1|||
125628497|NCT00109772|451922267|FG000|Double-blind Treatment|Other|0|||
125628498|NCT00109772|451922268|FG001|Double-blind Treatment|Other|4|||
125628499|NCT00109772|451922267|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
125628500|NCT00109772|451922268|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
125628501|NCT00109772|451922267|FG000|Open-label Extension|Adverse Event|10|||
125628502|NCT00109772|451922268|FG001|Open-label Extension|Adverse Event|19|||
125628503|NCT00109772|451922267|FG000|Open-label Extension|Lack of Efficacy|19|||
125628504|NCT00109772|451922268|FG001|Open-label Extension|Lack of Efficacy|11|||
125628505|NCT00109772|451922267|FG000|Open-label Extension|Withdrawal by Subject|9|||
125628506|NCT00109772|451922268|FG001|Open-label Extension|Withdrawal by Subject|6|||
125628507|NCT00109772|451922267|FG000|Open-label Extension|Lost to Follow-up|1|||
125628508|NCT00109772|451922268|FG001|Open-label Extension|Lost to Follow-up|0|||
125628509|NCT00109772|451922267|FG000|Open-label Extension|Death|0|||
125628510|NCT00109772|451922268|FG001|Open-label Extension|Death|1|||
125628511|NCT00109772|451922267|FG000|Open-label Extension|Protocol Violation|2|||
125628512|NCT00109772|451922268|FG001|Open-label Extension|Protocol Violation|2|||
125628513|NCT00109772|451922267|FG000|Open-label Extension|Other|4|||
125628514|NCT00109772|451922268|FG001|Open-label Extension|Other|10|||
125628515|NCT01359046|451922271|FG000|Overall Study|Did not receive allocated intervention|6|||
125435540|NCT03285295|451222001|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
125435541|NCT03285295|451222002|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
125435542|NCT03285295|451221998|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
125435543|NCT03285295|451221999|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
125435544|NCT03285295|451222000|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
125435545|NCT03285295|451222001|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
125435546|NCT03285295|451222002|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
125435547|NCT03285295|451221998|FG000|Alinity s Anti-HCV|No Results Generated|71|||
125435548|NCT03285295|451221999|FG001|Alinity s Anti-HCV|No Results Generated|0|||
125435549|NCT03285295|451222000|FG002|Alinity s Anti-HCV|No Results Generated|0|||
125435550|NCT03285295|451222001|FG003|Alinity s Anti-HCV|No Results Generated|0|||
125628516|NCT01359046|451922272|FG001|Overall Study|Did not receive allocated intervention|6|||
125628517|NCT01359046|451922271|FG000|Overall Study|Physician Decision|1|||
125435551|NCT03285295|451222002|FG004|Alinity s Anti-HCV|No Results Generated|0|||
125435552|NCT03285295|451221998|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
125435553|NCT03285295|451221999|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
125628518|NCT01359046|451922272|FG001|Overall Study|Physician Decision|11|||
125628519|NCT04539262|451922273|FG000|Overall Study|Adverse Event|0|||
125628520|NCT04539262|451922274|FG001|Overall Study|Adverse Event|0|||
125628521|NCT04539262|451922275|FG002|Overall Study|Adverse Event|1|||
125628522|NCT04539262|451922276|FG003|Overall Study|Adverse Event|0|||
125435554|NCT03285295|451222000|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
125435555|NCT03285295|451222001|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
125435556|NCT03285295|451222002|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
125435557|NCT03285295|451221998|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
125435558|NCT03285295|451221999|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
125435559|NCT03285295|451222000|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
125435560|NCT03285295|451222001|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
125435561|NCT03285295|451222002|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
125435562|NCT03285295|451221998|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
125435563|NCT03285295|451221999|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
125435564|NCT03285295|451222000|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
125628523|NCT04539262|451922277|FG004|Overall Study|Adverse Event|0|||
125628524|NCT04539262|451922278|FG005|Overall Study|Adverse Event|0|||
125628525|NCT04539262|451922279|FG006|Overall Study|Adverse Event|0|||
125628526|NCT04539262|451922280|FG007|Overall Study|Adverse Event|0|||
125628527|NCT04539262|451922273|FG000|Overall Study|Withdrew Consent|0|||
125628528|NCT04539262|451922274|FG001|Overall Study|Withdrew Consent|0|||
125628529|NCT04539262|451922275|FG002|Overall Study|Withdrew Consent|0|||
125628530|NCT04539262|451922276|FG003|Overall Study|Withdrew Consent|1|||
125628531|NCT04539262|451922277|FG004|Overall Study|Withdrew Consent|0|||
125628532|NCT04539262|451922278|FG005|Overall Study|Withdrew Consent|0|||
125435565|NCT03285295|451222001|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
125435566|NCT03285295|451222002|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
125435567|NCT03285295|451221998|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
125435568|NCT03285295|451221999|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
125435569|NCT03285295|451222000|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
125435570|NCT03285295|451222001|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
125435571|NCT03285295|451222002|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
125435572|NCT03285295|451221998|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
125435573|NCT03285295|451221999|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
125435574|NCT03285295|451222000|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
125435575|NCT03285295|451222001|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
125435576|NCT03285295|451222002|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
125435577|NCT03285295|451221998|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
125435578|NCT03285295|451221999|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
125435579|NCT03285295|451222000|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
125435580|NCT03285295|451222001|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
125435581|NCT03285295|451222002|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
125435582|NCT03285295|451221998|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
125435583|NCT03285295|451221999|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
125435584|NCT03285295|451222000|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
125435585|NCT03285295|451222001|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
125435586|NCT03285295|451222002|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
125435587|NCT03285295|451221998|FG000|Alinity s Anti-HBc|No Results Generated|70|||
125435588|NCT03285295|451221999|FG001|Alinity s Anti-HBc|No Results Generated|0|||
125435589|NCT03285295|451222000|FG002|Alinity s Anti-HBc|No Results Generated|0|||
125435590|NCT03285295|451222001|FG003|Alinity s Anti-HBc|No Results Generated|0|||
125435591|NCT03285295|451222002|FG004|Alinity s Anti-HBc|No Results Generated|0|||
125435592|NCT03285295|451221998|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
125435593|NCT03285295|451221999|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
125435594|NCT03285295|451222000|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
125435595|NCT03285295|451222001|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
125435596|NCT03285295|451222002|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
125435597|NCT03285295|451221998|FG000|Alinity s Chagas|Protocol Violation|76|||
125435598|NCT03285295|451221999|FG001|Alinity s Chagas|Protocol Violation|0|||
125435599|NCT03285295|451222000|FG002|Alinity s Chagas|Protocol Violation|0|||
125435600|NCT03285295|451222001|FG003|Alinity s Chagas|Protocol Violation|0|||
125435601|NCT03285295|451222002|FG004|Alinity s Chagas|Protocol Violation|0|||
125435602|NCT03285295|451221998|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
125435603|NCT03285295|451221999|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
125435604|NCT03285295|451222000|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
125435605|NCT03285295|451222001|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
125435606|NCT03285295|451222002|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
125435607|NCT03285295|451221998|FG000|Alinity s Chagas|No Results Generated|105|||
125435608|NCT03285295|451221999|FG001|Alinity s Chagas|No Results Generated|0|||
125628533|NCT04539262|451922279|FG006|Overall Study|Withdrew Consent|0|||
125628534|NCT04539262|451922280|FG007|Overall Study|Withdrew Consent|0|||
125628535|NCT04539262|451922273|FG000|Overall Study|Randomized, Not treated|0|||
125628536|NCT04539262|451922274|FG001|Overall Study|Randomized, Not treated|1|||
125435609|NCT03285295|451222000|FG002|Alinity s Chagas|No Results Generated|0|||
125435610|NCT03285295|451222001|FG003|Alinity s Chagas|No Results Generated|0|||
125435611|NCT03285295|451222002|FG004|Alinity s Chagas|No Results Generated|0|||
125628537|NCT04539262|451922275|FG002|Overall Study|Randomized, Not treated|0|||
125628538|NCT04539262|451922276|FG003|Overall Study|Randomized, Not treated|0|||
125628539|NCT04539262|451922277|FG004|Overall Study|Randomized, Not treated|0|||
125628540|NCT04539262|451922278|FG005|Overall Study|Randomized, Not treated|0|||
125628541|NCT04539262|451922279|FG006|Overall Study|Randomized, Not treated|1|||
125628542|NCT04539262|451922280|FG007|Overall Study|Randomized, Not treated|0|||
125628543|NCT03725293|451922285|FG000|Overall Study|Physician Decision|9|||
125628544|NCT03725293|451922286|FG001|Overall Study|Physician Decision|6|||
125628545|NCT03725293|451922285|FG000|Overall Study|alternative vascular access needs|1|||
125628546|NCT03725293|451922286|FG001|Overall Study|alternative vascular access needs|2|||
125628547|NCT03725293|451922285|FG000|Overall Study|venous anatomy screen failures|2|||
125628548|NCT03725293|451922286|FG001|Overall Study|venous anatomy screen failures|1|||
125628549|NCT04397796|451922289|FG000|Overall Study|Death|3|||
125628550|NCT04397796|451922290|FG001|Overall Study|Death|1|||
125628551|NCT00802867|451922291|FG000|Overall Study|Lost to Follow-up|6|||
125628552|NCT00802867|451922291|FG000|Overall Study|Protocol Violation|6|||
125628553|NCT00802867|451922291|FG000|Overall Study|Withdrawal by Subject|1|||
125628554|NCT01061567|451922292|FG000|Overall Study|Adverse Event|32|||
125628555|NCT01061567|451922292|FG000|Overall Study|Death|2|||
125628556|NCT01061567|451922292|FG000|Overall Study|Lack of Efficacy|3|||
125435612|NCT03285295|451221998|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
125628557|NCT01061567|451922292|FG000|Overall Study|Lost to Follow-up|24|||
125628558|NCT01061567|451922292|FG000|Overall Study|Protocol Violation|1|||
125628559|NCT01061567|451922292|FG000|Overall Study|Withdrawal by Subject|11|||
125628560|NCT01061567|451922292|FG000|Overall Study|Other reason than stated above|3|||
125628561|NCT01156532|451922299|FG000|Overall Study|Family Reasons|1|||
125628562|NCT01156532|451922299|FG000|Overall Study|Lost to Follow-up|1|||
125435613|NCT03285295|451221999|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
125435614|NCT03285295|451222000|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
125435615|NCT03285295|451222001|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
125628563|NCT01484561|451922300|FG000|Overall Study|Lack of Efficacy|3|||
125628564|NCT01484561|451922301|FG001|Overall Study|Lack of Efficacy|1|||
125628565|NCT01484561|451922300|FG000|Overall Study|Lost to Follow-up|1|||
125628566|NCT01484561|451922301|FG001|Overall Study|Lost to Follow-up|0|||
125628567|NCT01484561|451922300|FG000|Overall Study|Withdrawal by Subject|3|||
125628568|NCT01484561|451922301|FG001|Overall Study|Withdrawal by Subject|0|||
125628569|NCT01484561|451922300|FG000|Overall Study|Other|1|||
125628570|NCT01484561|451922301|FG001|Overall Study|Other|1|||
125628571|NCT01484561|451922300|FG000|Overall Study|Adverse Event|1|||
125628572|NCT01484561|451922301|FG001|Overall Study|Adverse Event|4|||
125628573|NCT03371251|451922302|FG000|Overall Study|Withdrawal by Subject|1|||
125628574|NCT03371251|451922303|FG001|Overall Study|Withdrawal by Subject|0|||
125628575|NCT03371251|451922304|FG002|Overall Study|Withdrawal by Subject|1|||
125628576|NCT03371251|451922305|FG003|Overall Study|Withdrawal by Subject|0|||
125628577|NCT03371251|451922306|FG004|Overall Study|Withdrawal by Subject|2|||
125628578|NCT03371251|451922307|FG005|Overall Study|Withdrawal by Subject|2|||
125628579|NCT03371251|451922302|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
125628580|NCT03371251|451922303|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
125628581|NCT03371251|451922304|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
125628582|NCT03371251|451922305|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
125628583|NCT03371251|451922306|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
125628584|NCT03371251|451922307|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
125628585|NCT03371251|451922302|FG000|Overall Study|Adverse Event|0|||
125628586|NCT03371251|451922303|FG001|Overall Study|Adverse Event|0|||
125628587|NCT03371251|451922304|FG002|Overall Study|Adverse Event|0|||
125628588|NCT03371251|451922305|FG003|Overall Study|Adverse Event|0|||
125628589|NCT03371251|451922306|FG004|Overall Study|Adverse Event|1|||
125628590|NCT03371251|451922307|FG005|Overall Study|Adverse Event|0|||
125435616|NCT03285295|451222002|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
125435617|NCT02746575|451222003|FG000|Overall Study|Surgery cancelled or time chaned|13|||
125435618|NCT02746575|451222003|FG000|Overall Study|Received epidural|10|||
125628591|NCT03371251|451922302|FG000|Overall Study|Decision by Sponsor|0|||
125628592|NCT03371251|451922303|FG001|Overall Study|Decision by Sponsor|0|||
125628593|NCT03371251|451922304|FG002|Overall Study|Decision by Sponsor|0|||
125628594|NCT03371251|451922305|FG003|Overall Study|Decision by Sponsor|0|||
125628595|NCT03371251|451922306|FG004|Overall Study|Decision by Sponsor|2|||
125628596|NCT03371251|451922307|FG005|Overall Study|Decision by Sponsor|0|||
125628597|NCT00291187|451922308|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
125435619|NCT02746575|451222003|FG000|Overall Study|Withdrawal by Subject|3|||
125628598|NCT00291187|451922309|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
125628599|NCT00291187|451922310|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
125628600|NCT00291187|451922311|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
125628601|NCT00114218|451922312|FG000|Overall Study|Wrong Cell Type|2|||
125628602|NCT00114218|451922312|FG000|Overall Study|Wrong Primary|1|||
125628603|NCT00114218|451922312|FG000|Overall Study|Never Treated|1|||
125628604|NCT03168555|451922314|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
125628605|NCT03168555|451922314|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
125628606|NCT03168555|451922314|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
125628607|NCT03168555|451922314|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
125628608|NCT01040845|451922315|FG000|Overall Study|Withdrawal by Subject|1|||
125628609|NCT01040845|451922316|FG001|Overall Study|Withdrawal by Subject|1|||
125628610|NCT01040845|451922315|FG000|Overall Study|Physician Decision|1|||
125628611|NCT01040845|451922316|FG001|Overall Study|Physician Decision|0|||
125628612|NCT02708966|451922320|FG000|Overall Study|Lost to Follow-up|2|||
125628613|NCT02708966|451922321|FG001|Overall Study|Lost to Follow-up|2|||
125628614|NCT02959190|451922325|FG000|Open Label|Adverse Event|5|||
125628615|NCT02959190|451922326|FG001|Open Label|Adverse Event|7|||
125628616|NCT02959190|451922327|FG002|Open Label|Adverse Event|3|||
125628617|NCT02959190|451922328|FG003|Open Label|Adverse Event|4|||
125628618|NCT02959190|451922325|FG000|Open Label|Pregnancy|0|||
125628619|NCT02959190|451922326|FG001|Open Label|Pregnancy|1|||
125628620|NCT02959190|451922327|FG002|Open Label|Pregnancy|0|||
125628621|NCT02959190|451922328|FG003|Open Label|Pregnancy|0|||
125628622|NCT02959190|451922325|FG000|Open Label|Withdrawal by Subject|2|||
125628623|NCT02959190|451922326|FG001|Open Label|Withdrawal by Subject|8|||
125628624|NCT02959190|451922327|FG002|Open Label|Withdrawal by Subject|0|||
125628625|NCT02959190|451922328|FG003|Open Label|Withdrawal by Subject|0|||
125628626|NCT02959190|451922325|FG000|Open Label|Physician Decision|0|||
125628627|NCT02959190|451922326|FG001|Open Label|Physician Decision|0|||
125628628|NCT02959190|451922327|FG002|Open Label|Physician Decision|1|||
125628629|NCT02959190|451922328|FG003|Open Label|Physician Decision|0|||
125628630|NCT02959190|451922325|FG000|Open Label|Protocol Violation|0|||
125628631|NCT02959190|451922326|FG001|Open Label|Protocol Violation|0|||
125628632|NCT02959190|451922327|FG002|Open Label|Protocol Violation|0|||
125628633|NCT02959190|451922328|FG003|Open Label|Protocol Violation|2|||
125628634|NCT02959190|451922325|FG000|Post Treatment Follow Up|Adverse Event|1|||
125628635|NCT02959190|451922326|FG001|Post Treatment Follow Up|Adverse Event|1|||
125628636|NCT02959190|451922327|FG002|Post Treatment Follow Up|Adverse Event|0|||
125628637|NCT02959190|451922328|FG003|Post Treatment Follow Up|Adverse Event|0|||
125628638|NCT02959190|451922325|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
125628639|NCT02959190|451922326|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
125628640|NCT02959190|451922327|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
125628641|NCT02959190|451922328|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
125628642|NCT02023268|451922329|FG000|Overall Study|Lack of Efficacy|0|||
125628643|NCT02023268|451922330|FG001|Overall Study|Lack of Efficacy|1|||
125628644|NCT02023268|451922329|FG000|Overall Study|Adverse Event|0|||
125628645|NCT02023268|451922330|FG001|Overall Study|Adverse Event|2|||
125628646|NCT02023268|451922329|FG000|Overall Study|Withdrawal by Subject|0|||
125628647|NCT02023268|451922330|FG001|Overall Study|Withdrawal by Subject|1|||
125628648|NCT04445688|451922331|FG000|Washout (One Week)|Adverse Event|2|||
125628649|NCT04445688|451922331|FG000|Washout (One Week)|Withdrawal by Subject|1|||
125628650|NCT01142193|451922340|FG000|Overall Study|Adverse Event|12|||
125628651|NCT01142193|451922341|FG001|Overall Study|Adverse Event|4|||
125628652|NCT01142193|451922340|FG000|Overall Study|Lack of Efficacy|2|||
125628653|NCT01142193|451922341|FG001|Overall Study|Lack of Efficacy|1|||
125628654|NCT01142193|451922340|FG000|Overall Study|Physician Decision|1|||
125628655|NCT01142193|451922341|FG001|Overall Study|Physician Decision|1|||
125628656|NCT01142193|451922340|FG000|Overall Study|Withdrawal by Subject|4|||
125628657|NCT01142193|451922341|FG001|Overall Study|Withdrawal by Subject|3|||
125628658|NCT01142193|451922340|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
125628659|NCT01142193|451922341|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
125628660|NCT01142193|451922340|FG000|Overall Study|Other|1|||
125628661|NCT01142193|451922341|FG001|Overall Study|Other|2|||
125628662|NCT00970268|451922342|FG000|Overall Study|Withdrawal by Subject|12|||
125628663|NCT00970268|451922343|FG001|Overall Study|Withdrawal by Subject|19|||
125628664|NCT00970268|451922342|FG000|Overall Study|Adverse Event|15|||
125628665|NCT00970268|451922343|FG001|Overall Study|Adverse Event|12|||
125375712|NCT00357968|451004969|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
125628666|NCT00970268|451922342|FG000|Overall Study|Lack of Efficacy|3|||
125628667|NCT00970268|451922343|FG001|Overall Study|Lack of Efficacy|6|||
125628668|NCT00970268|451922342|FG000|Overall Study|Protocol Violation|4|||
125628669|NCT00970268|451922343|FG001|Overall Study|Protocol Violation|7|||
125628670|NCT00970268|451922342|FG000|Overall Study|Other Reason|3|||
125628671|NCT00970268|451922343|FG001|Overall Study|Other Reason|1|||
125628672|NCT00970268|451922342|FG000|Overall Study|COPD Exacerbation|4|||
125628673|NCT00970268|451922343|FG001|Overall Study|COPD Exacerbation|2|||
125628674|NCT00970268|451922342|FG000|Overall Study|Lost to Follow-up|1|||
125628675|NCT00970268|451922343|FG001|Overall Study|Lost to Follow-up|2|||
125628676|NCT00970268|451922342|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
125628677|NCT00970268|451922343|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
125628678|NCT00383708|451922344|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
125628679|NCT00383708|451922344|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
125628680|NCT00383708|451922344|FG000|Run-in Period|Protocol Violation|4|||
125628681|NCT00383708|451922344|FG000|Run-in Period|Adverse Event|2|||
125628682|NCT00383708|451922344|FG000|Run-in Period|Claustrophobia|1|||
125628683|NCT00383708|451922344|FG000|Co-administration Period|Adverse Event|5|||
125628684|NCT00318370|451922345|FG000|Period 1|Lack of Efficacy|5|||
125628685|NCT00318370|451922346|FG001|Period 1|Lack of Efficacy|0|||
125628686|NCT00318370|451922347|FG002|Period 1|Lack of Efficacy|0|||
125628687|NCT00318370|451922345|FG000|Period 1|Physician Decision|1|||
125628688|NCT00318370|451922346|FG001|Period 1|Physician Decision|0|||
125628689|NCT00318370|451922347|FG002|Period 1|Physician Decision|0|||
125628690|NCT00318370|451922345|FG000|Period 1|Withdrawal by Subject|1|||
125628691|NCT00318370|451922346|FG001|Period 1|Withdrawal by Subject|0|||
125628692|NCT00318370|451922347|FG002|Period 1|Withdrawal by Subject|0|||
125628693|NCT00318370|451922345|FG000|Period 2|Adverse Event|0|||
125628694|NCT00318370|451922346|FG001|Period 2|Adverse Event|3|||
125628695|NCT00318370|451922347|FG002|Period 2|Adverse Event|0|||
125628696|NCT00318370|451922345|FG000|Period 2|Lack of Efficacy|0|||
125628697|NCT00318370|451922346|FG001|Period 2|Lack of Efficacy|5|||
125628698|NCT00318370|451922347|FG002|Period 2|Lack of Efficacy|0|||
125628699|NCT00318370|451922345|FG000|Period 2|Physician Decision|0|||
125628700|NCT00318370|451922346|FG001|Period 2|Physician Decision|1|||
125628701|NCT00318370|451922347|FG002|Period 2|Physician Decision|0|||
125628702|NCT00318370|451922345|FG000|Period 2|Withdrawal by Subject|0|||
125628703|NCT00318370|451922346|FG001|Period 2|Withdrawal by Subject|1|||
125628704|NCT00318370|451922347|FG002|Period 2|Withdrawal by Subject|0|||
125628705|NCT00318370|451922345|FG000|Period 2|Other|0|||
125628706|NCT00318370|451922346|FG001|Period 2|Other|1|||
125628707|NCT00318370|451922347|FG002|Period 2|Other|0|||
125628708|NCT00318370|451922345|FG000|Period 3|Adverse Event|0|||
125628709|NCT00318370|451922346|FG001|Period 3|Adverse Event|0|||
125215715|NCT04424914|450417486|FG000|Overall Study|Lost to Follow-up|0|||
125628710|NCT00318370|451922347|FG002|Period 3|Adverse Event|1|||
125628711|NCT00318370|451922345|FG000|Period 3|Lack of Efficacy|0|||
125628712|NCT00318370|451922346|FG001|Period 3|Lack of Efficacy|0|||
125628713|NCT00318370|451922347|FG002|Period 3|Lack of Efficacy|24|||
125628714|NCT00318370|451922345|FG000|Period 3|Death|0|||
125628715|NCT00318370|451922346|FG001|Period 3|Death|0|||
125215716|NCT04424914|450417487|FG001|Overall Study|Lost to Follow-up|0|||
125628716|NCT00318370|451922347|FG002|Period 3|Death|1|||
125215717|NCT04424914|450417488|FG002|Overall Study|Lost to Follow-up|1|||
125375713|NCT00357968|451004970|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
125375714|NCT04656691|451004973|FG000|Overall Study|Adverse Event|1|||
125375715|NCT00600483|451004974|FG000|Overall Study|Lost to Follow-up|26|||
125375716|NCT00600483|451004975|FG001|Overall Study|Lost to Follow-up|47|||
125375717|NCT00600483|451004974|FG000|Overall Study|Randomized but not treated|10|||
125375718|NCT00600483|451004975|FG001|Overall Study|Randomized but not treated|0|||
125375719|NCT01482884|451004981|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
125375720|NCT01482884|451004982|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
125375721|NCT01482884|451004981|FG000|Overall Study|Protocol Violation|1|||
125375722|NCT01482884|451004982|FG001|Overall Study|Protocol Violation|0|||
125375723|NCT01482884|451004981|FG000|Overall Study|Lost to Follow-up|2|||
125375724|NCT01482884|451004982|FG001|Overall Study|Lost to Follow-up|2|||
125375725|NCT01482884|451004981|FG000|Overall Study|Lack of Efficacy|0|||
125375726|NCT01482884|451004982|FG001|Overall Study|Lack of Efficacy|1|||
125375727|NCT01482884|451004981|FG000|Overall Study|Adverse Event|2|||
125375728|NCT01482884|451004982|FG001|Overall Study|Adverse Event|1|||
125375729|NCT01482884|451004981|FG000|Overall Study|Withdrawal by Subject|8|||
125375730|NCT01482884|451004982|FG001|Overall Study|Withdrawal by Subject|13|||
125375731|NCT04102020|451004983|FG000|Overall Study|Adverse Event|1|||
125375732|NCT04102020|451004984|FG001|Overall Study|Adverse Event|0|||
125375733|NCT04102020|451004985|FG002|Overall Study|Adverse Event|0|||
125375734|NCT04102020|451004986|FG003|Overall Study|Adverse Event|1|||
125375735|NCT04102020|451004987|FG004|Overall Study|Adverse Event|0|||
125375736|NCT04102020|451004983|FG000|Overall Study|Withdrawal by Subject|0|||
125375737|NCT04102020|451004984|FG001|Overall Study|Withdrawal by Subject|1|||
125375738|NCT04102020|451004985|FG002|Overall Study|Withdrawal by Subject|1|||
125375739|NCT04102020|451004986|FG003|Overall Study|Withdrawal by Subject|1|||
125375740|NCT04102020|451004987|FG004|Overall Study|Withdrawal by Subject|1|||
125375741|NCT04102020|451004983|FG000|Overall Study|Death|1|||
125375742|NCT04102020|451004984|FG001|Overall Study|Death|4|||
125375743|NCT04102020|451004985|FG002|Overall Study|Death|1|||
125375744|NCT04102020|451004986|FG003|Overall Study|Death|1|||
125628717|NCT00318370|451922345|FG000|Period 3|Physician Decision|0|||
125628718|NCT00318370|451922346|FG001|Period 3|Physician Decision|0|||
125628719|NCT00318370|451922347|FG002|Period 3|Physician Decision|1|||
125628720|NCT00318370|451922345|FG000|Period 3|Withdrawal by Subject|0|||
125375745|NCT04102020|451004987|FG004|Overall Study|Death|0|||
125375746|NCT04102020|451004983|FG000|Overall Study|Physician Decision|1|||
125375747|NCT04102020|451004984|FG001|Overall Study|Physician Decision|2|||
125628721|NCT00318370|451922346|FG001|Period 3|Withdrawal by Subject|0|||
125628722|NCT00318370|451922347|FG002|Period 3|Withdrawal by Subject|3|||
125628723|NCT00318370|451922345|FG000|Period 3|Other|0|||
125628724|NCT00318370|451922346|FG001|Period 3|Other|0|||
125628725|NCT00318370|451922347|FG002|Period 3|Other|3|||
125628726|NCT01750840|451922348|FG000|Overall Study|Lost to Follow-up|4|||
125628727|NCT00669032|451922351|FG000|Overall Study|Lost to Follow-up|6|||
125628728|NCT00669032|451922352|FG001|Overall Study|Lost to Follow-up|5|||
125628729|NCT00669032|451922351|FG000|Overall Study|Lack of Efficacy|8|||
125628730|NCT00669032|451922352|FG001|Overall Study|Lack of Efficacy|19|||
125628731|NCT00669032|451922351|FG000|Overall Study|Withdrawal by Subject|12|||
125628732|NCT00669032|451922352|FG001|Overall Study|Withdrawal by Subject|13|||
125628733|NCT00669032|451922351|FG000|Overall Study|Adverse Event|12|||
125628734|NCT00669032|451922352|FG001|Overall Study|Adverse Event|16|||
125628735|NCT00669032|451922351|FG000|Overall Study|Physician Decision|1|||
125628736|NCT00669032|451922352|FG001|Overall Study|Physician Decision|1|||
125628737|NCT00669032|451922351|FG000|Overall Study|No fulfilment of the selection criteria|5|||
125628738|NCT00669032|451922352|FG001|Overall Study|No fulfilment of the selection criteria|5|||
125628739|NCT03627494|451922353|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
125628740|NCT03627494|451922354|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
125628741|NCT03627494|451922355|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
125628742|NCT03627494|451922356|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
125628743|NCT03627494|451922357|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
125628744|NCT03627494|451922358|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
125628745|NCT03627494|451922359|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
125628746|NCT03627494|451922360|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
125375748|NCT04102020|451004985|FG002|Overall Study|Physician Decision|2|||
125375749|NCT04102020|451004986|FG003|Overall Study|Physician Decision|0|||
125375750|NCT04102020|451004987|FG004|Overall Study|Physician Decision|1|||
125375751|NCT04102020|451004983|FG000|Overall Study|COVID-19 Infection|1|||
125375752|NCT04102020|451004984|FG001|Overall Study|COVID-19 Infection|0|||
125375753|NCT04102020|451004985|FG002|Overall Study|COVID-19 Infection|0|||
125375754|NCT04102020|451004986|FG003|Overall Study|COVID-19 Infection|0|||
125375755|NCT04102020|451004987|FG004|Overall Study|COVID-19 Infection|0|||
125375756|NCT04102020|451004983|FG000|Overall Study|Not disclosed|5|||
125375757|NCT04102020|451004984|FG001|Overall Study|Not disclosed|3|||
125375758|NCT04102020|451004985|FG002|Overall Study|Not disclosed|8|||
125375759|NCT04102020|451004986|FG003|Overall Study|Not disclosed|0|||
125375760|NCT04102020|451004987|FG004|Overall Study|Not disclosed|1|||
125375761|NCT04102020|451004983|FG000|Overall Study|MIssing|1|||
125375762|NCT04102020|451004984|FG001|Overall Study|MIssing|0|||
125375763|NCT04102020|451004985|FG002|Overall Study|MIssing|1|||
125375764|NCT04102020|451004986|FG003|Overall Study|MIssing|1|||
125375765|NCT04102020|451004987|FG004|Overall Study|MIssing|1|||
125375766|NCT04102020|451004983|FG000|Overall Study|Continuing in ongoing study|13|||
125375767|NCT04102020|451004984|FG001|Overall Study|Continuing in ongoing study|13|||
125375768|NCT04102020|451004985|FG002|Overall Study|Continuing in ongoing study|7|||
125375769|NCT04102020|451004986|FG003|Overall Study|Continuing in ongoing study|26|||
125375770|NCT04102020|451004987|FG004|Overall Study|Continuing in ongoing study|12|||
125375771|NCT05980182|451004999|FG000|Overall Study|Lost to Follow-up|10|||
125375772|NCT04600921|451005000|FG000|Overall Study|Withdrawal by Subject|3|||
125375773|NCT04600921|451005001|FG001|Overall Study|Withdrawal by Subject|5|||
125375774|NCT04600921|451005000|FG000|Overall Study|Death|0|||
125375775|NCT04600921|451005001|FG001|Overall Study|Death|1|||
125375776|NCT00410046|451007596|FG000|Overall Study|Adverse Event|3|||
125375777|NCT00410046|451007596|FG000|Overall Study|Withdrawal by Subject|1|||
125375778|NCT00410046|451007596|FG000|Overall Study|Lost to Follow-up|1|||
125375779|NCT01384760|451007598|FG000|Overall Study|Lost to Follow-up|0|||
125375780|NCT01384760|451007599|FG001|Overall Study|Lost to Follow-up|6|||
125375781|NCT01384760|451007598|FG000|Overall Study|Protocol Violation|16|||
125375782|NCT01384760|451007599|FG001|Overall Study|Protocol Violation|0|||
125375783|NCT00963547|451007600|FG000|Overall Study|Adverse Event|0|||
125375784|NCT00963547|451007601|FG001|Overall Study|Adverse Event|1|||
125375785|NCT00963547|451007602|FG002|Overall Study|Adverse Event|0|||
125375786|NCT00963547|451007603|FG003|Overall Study|Adverse Event|1|||
125375787|NCT00963547|451007604|FG004|Overall Study|Adverse Event|0|||
125375788|NCT00963547|451007605|FG005|Overall Study|Adverse Event|0|||
125375789|NCT00963547|451007606|FG006|Overall Study|Adverse Event|0|||
125375790|NCT00963547|451007600|FG000|Overall Study|Physician Decision|1|||
125375791|NCT00963547|451007601|FG001|Overall Study|Physician Decision|1|||
125375792|NCT00963547|451007602|FG002|Overall Study|Physician Decision|0|||
125375793|NCT00963547|451007603|FG003|Overall Study|Physician Decision|0|||
125375794|NCT00963547|451007604|FG004|Overall Study|Physician Decision|0|||
125375795|NCT00963547|451007605|FG005|Overall Study|Physician Decision|0|||
125375796|NCT00963547|451007606|FG006|Overall Study|Physician Decision|0|||
125375797|NCT00963547|451007600|FG000|Overall Study|Progressive Disease|3|||
125375798|NCT00963547|451007601|FG001|Overall Study|Progressive Disease|8|||
125375799|NCT00963547|451007602|FG002|Overall Study|Progressive Disease|9|||
125375800|NCT00963547|451007603|FG003|Overall Study|Progressive Disease|5|||
125375801|NCT00963547|451007604|FG004|Overall Study|Progressive Disease|0|||
125375802|NCT00963547|451007605|FG005|Overall Study|Progressive Disease|0|||
125375803|NCT00963547|451007606|FG006|Overall Study|Progressive Disease|0|||
125375804|NCT00963547|451007600|FG000|Overall Study|Withdrawal by Subject|0|||
125375805|NCT00963547|451007601|FG001|Overall Study|Withdrawal by Subject|0|||
125628747|NCT03627494|451922361|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
125628748|NCT03627494|451922362|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
125628749|NCT03627494|451922363|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
125628750|NCT03627494|451922364|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
125628751|NCT03627494|451922353|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
125628752|NCT03627494|451922354|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
125628753|NCT03627494|451922355|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
125628754|NCT03627494|451922356|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
125628755|NCT03627494|451922357|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
125628756|NCT03627494|451922358|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
125628757|NCT03627494|451922359|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
125628758|NCT03627494|451922360|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
125628759|NCT03627494|451922361|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
125628760|NCT03627494|451922362|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
125628761|NCT03627494|451922363|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
125628762|NCT03627494|451922364|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
125628763|NCT03627494|451922353|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
125628764|NCT03627494|451922354|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
125628765|NCT03627494|451922355|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
125628766|NCT03627494|451922356|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
125628767|NCT03627494|451922357|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
125628768|NCT03627494|451922358|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
125628769|NCT03627494|451922359|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
125628770|NCT03627494|451922360|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
125628771|NCT03627494|451922361|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
125628772|NCT03627494|451922362|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
125628773|NCT03627494|451922363|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
125435620|NCT02746575|451222003|FG000|Overall Study|Bradycardia/hypotension|9|||
125435621|NCT02746575|451222003|FG000|Overall Study|Study paused|8|||
125435622|NCT02746575|451222003|FG000|Overall Study|put on beta-blocker|3|||
125435623|NCT02746575|451222003|FG000|Overall Study|type of surgery|1|||
125435624|NCT02746575|451222003|FG000|Overall Study|typ of surgery|1|||
125435625|NCT02746575|451222003|FG000|Overall Study|PI unavailable|1|||
125435626|NCT02746575|451222003|FG000|Overall Study|Unknown history of CVA|1|||
125435627|NCT00605319|451222005|FG000|Overall Study|Adverse Event|6|||
125435628|NCT01350505|451222011|FG000|Overall Study|Lost to Follow-up|4|||
125435629|NCT02357810|451222012|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
125628774|NCT03627494|451922364|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
125628775|NCT03906136|451924431|FG000|Overall Study|Adverse Event|1|||
125628776|NCT03906136|451924432|FG001|Overall Study|Adverse Event|0|||
125628777|NCT03906136|451924431|FG000|Overall Study|Lost to Follow-up|7|||
125628778|NCT03906136|451924432|FG001|Overall Study|Lost to Follow-up|4|||
125628779|NCT03906136|451924431|FG000|Overall Study|Physician Decision|1|||
125628780|NCT03906136|451924432|FG001|Overall Study|Physician Decision|0|||
125628781|NCT03906136|451924431|FG000|Overall Study|Withdrawal by Subject|3|||
125628782|NCT03906136|451924432|FG001|Overall Study|Withdrawal by Subject|7|||
125628783|NCT00323310|451924433|FG000|Overall Study|Withdrawal by Subject|1|||
125628784|NCT00323310|451924433|FG000|Overall Study|a parent refused blood draw|1|||
125628785|NCT00323310|451924433|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
125628786|NCT00446641|451924434|FG000|Overall Study|Withdrawal by Subject|8|||
125628787|NCT00446641|451924435|FG001|Overall Study|Withdrawal by Subject|3|||
125628788|NCT00446641|451924434|FG000|Overall Study|poor compliance|8|||
125628789|NCT00446641|451924435|FG001|Overall Study|poor compliance|6|||
125628790|NCT00446641|451924434|FG000|Overall Study|Lost to Follow-up|1|||
125628791|NCT00446641|451924435|FG001|Overall Study|Lost to Follow-up|1|||
125628792|NCT03565991|451924437|FG000|Overall Study|Other|11|||
125628793|NCT03565991|451924438|FG001|Overall Study|Other|0|||
125628794|NCT03565991|451924437|FG000|Overall Study|Global deterioration of health status|14|||
125628795|NCT03565991|451924438|FG001|Overall Study|Global deterioration of health status|4|||
125628796|NCT03565991|451924437|FG000|Overall Study|Withdrawal by Subject|2|||
125628797|NCT03565991|451924438|FG001|Overall Study|Withdrawal by Subject|6|||
125628798|NCT03565991|451924437|FG000|Overall Study|Progressive disease|121|||
125215718|NCT04424914|450417486|FG000|Overall Study|Death|3|||
125435630|NCT02357810|451222012|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
125628799|NCT03565991|451924438|FG001|Overall Study|Progressive disease|29|||
125215719|NCT04424914|450417487|FG001|Overall Study|Death|1|||
125628800|NCT03565991|451924437|FG000|Overall Study|Death|3|||
125628801|NCT03565991|451924438|FG001|Overall Study|Death|0|||
125628802|NCT03565991|451924437|FG000|Overall Study|Adverse Event|7|||
125628803|NCT03565991|451924438|FG001|Overall Study|Adverse Event|2|||
125628804|NCT01826448|451924439|FG000|Overall Study|Adverse Event|1|||
125628805|NCT01826448|451924440|FG001|Overall Study|Adverse Event|3|||
125628806|NCT01826448|451924439|FG000|Overall Study|Disease progression|2|||
125628807|NCT01826448|451924440|FG001|Overall Study|Disease progression|4|||
125628808|NCT01826448|451924439|FG000|Overall Study|Withdrawal by Subject|1|||
125628809|NCT01826448|451924440|FG001|Overall Study|Withdrawal by Subject|0|||
125628810|NCT01826448|451924439|FG000|Overall Study|Physician Decision|0|||
125628811|NCT01826448|451924440|FG001|Overall Study|Physician Decision|1|||
125628812|NCT01826448|451924439|FG000|Overall Study|2 active cancers|0|||
125628813|NCT01826448|451924440|FG001|Overall Study|2 active cancers|1|||
125628814|NCT03250624|451924451|FG000|Overall Study|Lack of Efficacy|1|||
125628815|NCT03250624|451924452|FG001|Overall Study|Lack of Efficacy|4|||
125628816|NCT03250624|451924451|FG000|Overall Study|Adverse Event|0|||
125628817|NCT03250624|451924452|FG001|Overall Study|Adverse Event|1|||
125628818|NCT03250624|451924451|FG000|Overall Study|Other|1|||
125628819|NCT03250624|451924452|FG001|Overall Study|Other|2|||
125628820|NCT01510028|451924471|FG000|Overall Study|Lack of Efficacy|1|||
125628821|NCT01510028|451924472|FG001|Overall Study|Lack of Efficacy|0|||
125628822|NCT01510028|451924473|FG002|Overall Study|Lack of Efficacy|0|||
125628823|NCT01510028|451924474|FG003|Overall Study|Lack of Efficacy|0|||
125628824|NCT03235726|451924475|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125628825|NCT03235726|451924476|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125628826|NCT03235726|451924477|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125628827|NCT03235726|451924478|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125628828|NCT03235726|451924479|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
125628829|NCT03235726|451924480|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125628830|NCT03235726|451924481|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125628831|NCT03235726|451924482|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125628832|NCT03235726|451924483|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125628833|NCT03235726|451924484|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
125628834|NCT03235726|451924475|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125628835|NCT03235726|451924476|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125628836|NCT03235726|451924477|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125628837|NCT03235726|451924478|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125628838|NCT03235726|451924479|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
125628839|NCT03235726|451924480|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125628840|NCT03235726|451924481|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125628841|NCT03235726|451924482|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125628842|NCT03235726|451924483|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125628843|NCT03235726|451924484|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
125628844|NCT00282568|451924496|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
125628845|NCT00282568|451924496|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
125628846|NCT00282568|451924496|FG000|Extended Treatment Period|Adverse Event|17|||
125628847|NCT00282568|451924496|FG000|Extended Treatment Period|Non-compliance|4|||
125628848|NCT00282568|451924496|FG000|Extended Treatment Period|Physician Decision|1|||
125628849|NCT00282568|451924496|FG000|Extended Treatment Period|Lost to Follow-up|2|||
125628850|NCT03006926|451924497|FG000|Overall Study|Adverse Event|0|||
125628851|NCT03006926|451924498|FG001|Overall Study|Adverse Event|27|||
125628852|NCT03006926|451924497|FG000|Overall Study|Withdrawal by Subject|0|||
125628853|NCT03006926|451924498|FG001|Overall Study|Withdrawal by Subject|1|||
125628854|NCT03006926|451924497|FG000|Overall Study|Radiological Disease Progression|0|||
125628855|NCT03006926|451924498|FG001|Overall Study|Radiological Disease Progression|52|||
125628856|NCT03006926|451924497|FG000|Overall Study|Clinical Disease Progression|0|||
125628857|NCT03006926|451924498|FG001|Overall Study|Clinical Disease Progression|10|||
125628858|NCT03006926|451924497|FG000|Overall Study|Other|0|||
125628859|NCT03006926|451924498|FG001|Overall Study|Other|8|||
125628860|NCT03689972|451924499|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
125628861|NCT03689972|451924500|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
125628862|NCT03689972|451924501|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
125628863|NCT03689972|451924502|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
125628864|NCT03689972|451924503|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
125628865|NCT03689972|451924499|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
125628866|NCT03689972|451924500|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
125628867|NCT03689972|451924501|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
125628868|NCT03689972|451924502|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
125628869|NCT03689972|451924503|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
125628870|NCT03689972|451924499|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
125628871|NCT03689972|451924500|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
125628872|NCT03689972|451924501|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
125628873|NCT03689972|451924502|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
125628874|NCT03689972|451924503|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
125628875|NCT03689972|451924499|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
125215720|NCT04424914|450417488|FG002|Overall Study|Death|0|||
125215721|NCT00334295|450417493|FG000|Overall Study|Patients received fewer than 3 injection|5|||
125435631|NCT02357810|451222012|FG000|Reached 12 Weeks Response|Adverse Event|5|||
125435632|NCT02357810|451222012|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
125435633|NCT02357810|451222012|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
125435634|NCT02357810|451222012|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
125435635|NCT02357810|451222012|FG000|Reached 12 Weeks Response|Death|1|||
125628876|NCT03689972|451924500|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
125435636|NCT02357810|451222012|FG000|Reached 12 Weeks Response|Physician Decision|1|||
125435637|NCT02357810|451222012|FG000|Reached 12 Weeks Response|Other|1|||
125435638|NCT02357810|451222012|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
125435639|NCT02357810|451222012|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
125628877|NCT03689972|451924501|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
125628878|NCT03689972|451924502|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
125628879|NCT03689972|451924503|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
125628880|NCT03689972|451924499|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
125628881|NCT03689972|451924500|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
125435640|NCT02357810|451222012|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
125628882|NCT03689972|451924501|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
125628883|NCT03689972|451924502|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
125628884|NCT03689972|451924503|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
125628885|NCT03689972|451924499|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
125628886|NCT03689972|451924500|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
125628887|NCT03689972|451924501|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
125628888|NCT03689972|451924502|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
125628889|NCT03689972|451924503|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
125628890|NCT03689972|451924499|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
125628891|NCT03689972|451924500|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
125628892|NCT03689972|451924501|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
125628893|NCT03689972|451924502|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
125628894|NCT03689972|451924503|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
125628895|NCT03689972|451924499|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
125628896|NCT03689972|451924500|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
125628897|NCT03689972|451924501|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
125628898|NCT03689972|451924502|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
125628899|NCT03689972|451924503|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
125628900|NCT03689972|451924499|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
125628901|NCT03689972|451924500|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
125628902|NCT03689972|451924501|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
125628903|NCT03689972|451924502|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
125628904|NCT03689972|451924503|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
125628905|NCT03689972|451924499|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
125628906|NCT03689972|451924500|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
125628907|NCT03689972|451924501|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
125628908|NCT03689972|451924502|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
125628909|NCT03689972|451924503|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
125628910|NCT03689972|451924499|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
125628911|NCT03689972|451924500|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
125628912|NCT03689972|451924501|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
125628913|NCT03689972|451924502|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
125628914|NCT03689972|451924503|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
125628915|NCT03689972|451924499|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
125628916|NCT03689972|451924500|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
125628917|NCT03689972|451924501|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
125628918|NCT03689972|451924502|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
125628919|NCT03689972|451924503|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
125628920|NCT03689972|451924499|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
125628921|NCT03689972|451924500|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
125628922|NCT03689972|451924501|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
125628923|NCT03689972|451924502|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
125628924|NCT03689972|451924503|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
125628925|NCT03689972|451924499|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
125628926|NCT03689972|451924500|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
125628927|NCT03689972|451924501|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
125628928|NCT03689972|451924502|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
125435641|NCT02357810|451222012|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
125628929|NCT03689972|451924503|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
125628930|NCT03689972|451924499|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
125628931|NCT03689972|451924500|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
125628932|NCT03689972|451924501|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
125628933|NCT03689972|451924502|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
125628934|NCT03689972|451924503|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
125128475|NCT03020615|450096084|FG002|Overall Study|Physician Decision|2|||
125128476|NCT03020615|450096082|FG000|Overall Study|Parent/guardian/patient choice|3|||
125128477|NCT03020615|450096083|FG001|Overall Study|Parent/guardian/patient choice|0|||
125128478|NCT03020615|450096084|FG002|Overall Study|Parent/guardian/patient choice|4|||
125128479|NCT03020615|450096082|FG000|Overall Study|Screen failure|0|||
125128480|NCT03020615|450096083|FG001|Overall Study|Screen failure|0|||
125128481|NCT03020615|450096084|FG002|Overall Study|Screen failure|1|||
125128482|NCT03020615|450096082|FG000|Overall Study|Death|1|||
125128483|NCT03020615|450096083|FG001|Overall Study|Death|0|||
125128484|NCT03020615|450096084|FG002|Overall Study|Death|0|||
125128485|NCT03020615|450096082|FG000|Overall Study|Lost to Follow-up|0|||
125128486|NCT03020615|450096083|FG001|Overall Study|Lost to Follow-up|1|||
125128487|NCT03020615|450096084|FG002|Overall Study|Lost to Follow-up|0|||
125628935|NCT03689972|451924499|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
125628936|NCT03689972|451924500|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
125628937|NCT03689972|451924501|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
125628938|NCT03689972|451924502|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
125628939|NCT03689972|451924503|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
125628940|NCT03689972|451924499|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
125628941|NCT03689972|451924500|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
125628942|NCT03689972|451924501|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
125628943|NCT03689972|451924502|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
125628944|NCT03689972|451924503|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
125628945|NCT03689972|451924499|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
125628946|NCT03689972|451924500|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
125628947|NCT03689972|451924501|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
125628948|NCT03689972|451924502|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
125628949|NCT03689972|451924503|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
125628950|NCT03689972|451924499|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
125628951|NCT03689972|451924500|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
125628952|NCT03689972|451924501|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
125628953|NCT03689972|451924502|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
125628954|NCT03689972|451924503|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
125628955|NCT01838213|451924504|FG000|Overall Study|Ineligible|166|||
125628956|NCT01838213|451924505|FG001|Overall Study|Ineligible|191|||
125628957|NCT02417064|451924510|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
125628958|NCT02417064|451924511|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
125628959|NCT02417064|451924512|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
125628960|NCT02417064|451924510|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
125628961|NCT02417064|451924511|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
125628962|NCT02417064|451924512|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
125628963|NCT02417064|451924510|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
125628964|NCT02417064|451924511|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
125628965|NCT02417064|451924512|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
125628966|NCT02417064|451924510|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
125628967|NCT02417064|451924511|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
125628968|NCT02417064|451924512|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
125628969|NCT02417064|451924510|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
125628970|NCT02417064|451924511|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
125628971|NCT02417064|451924512|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
125628972|NCT02417064|451924510|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
125628973|NCT02417064|451924511|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
125128488|NCT00252720|450096086|FG000|Overall Study|Withdrawal by Subject|95|||
125128489|NCT00252720|450096087|FG001|Overall Study|Withdrawal by Subject|97|||
125628974|NCT02417064|451924512|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
125628975|NCT02417064|451924510|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
125628976|NCT02417064|451924511|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
125128490|NCT00252720|450096086|FG000|Overall Study|Death|7|||
125128491|NCT00252720|450096087|FG001|Overall Study|Death|8|||
125128492|NCT00252720|450096086|FG000|Overall Study|Moving|23|||
125128493|NCT00252720|450096087|FG001|Overall Study|Moving|42|||
125128494|NCT00252720|450096086|FG000|Overall Study|Mainly patients lost to follow-up|7|||
125435642|NCT02357810|451222012|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
125435643|NCT02357810|451222012|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
125435644|NCT00612534|451222016|FG000|Overall Study|Adverse Event|0|||
125435645|NCT00612534|451222017|FG001|Overall Study|Adverse Event|4|||
125435646|NCT00612534|451222018|FG002|Overall Study|Adverse Event|2|||
125435647|NCT00612534|451222019|FG003|Overall Study|Adverse Event|1|||
125435648|NCT00612534|451222016|FG000|Overall Study|Lack of Efficacy|13|||
125435649|NCT00612534|451222017|FG001|Overall Study|Lack of Efficacy|12|||
125435650|NCT00612534|451222018|FG002|Overall Study|Lack of Efficacy|5|||
125435651|NCT00612534|451222019|FG003|Overall Study|Lack of Efficacy|16|||
125435652|NCT00612534|451222016|FG000|Overall Study|Other Reason|0|||
125435653|NCT00612534|451222017|FG001|Overall Study|Other Reason|1|||
125435654|NCT00612534|451222018|FG002|Overall Study|Other Reason|0|||
125435655|NCT00612534|451222019|FG003|Overall Study|Other Reason|0|||
125435656|NCT02223754|451222020|FG000|Period 1|Adverse Event|1|||
125435657|NCT02223754|451222021|FG001|Period 1|Adverse Event|0|||
125435658|NCT02223754|451222020|FG000|Period 1|Lost to Follow-up|0|||
125435659|NCT02223754|451222021|FG001|Period 1|Lost to Follow-up|1|||
125435660|NCT02223754|451222020|FG000|Period 1|Protocol Violation|2|||
125435661|NCT02223754|451222021|FG001|Period 1|Protocol Violation|4|||
125435662|NCT02223754|451222020|FG000|Period 1|Withdrawal by Subject|0|||
125435663|NCT02223754|451222021|FG001|Period 1|Withdrawal by Subject|4|||
125435664|NCT02223754|451222020|FG000|Period 1|Test Article No Longer Available|1|||
125435665|NCT02223754|451222021|FG001|Period 1|Test Article No Longer Available|5|||
125435666|NCT02223754|451222020|FG000|Period 1|Unsatisfactory Visual Response|0|||
125435667|NCT02223754|451222021|FG001|Period 1|Unsatisfactory Visual Response|1|||
125435668|NCT02223754|451222020|FG000|Period 2|Adverse Event|0|||
125435669|NCT02223754|451222021|FG001|Period 2|Adverse Event|1|||
125435670|NCT02223754|451222020|FG000|Period 2|Protocol Violation|1|||
125435671|NCT02223754|451222021|FG001|Period 2|Protocol Violation|0|||
125435672|NCT02223754|451222020|FG000|Period 2|Lens Discomfort|1|||
125435673|NCT02223754|451222021|FG001|Period 2|Lens Discomfort|1|||
125435674|NCT02223754|451222020|FG000|Period 2|Lost to Follow-up|1|||
125435675|NCT02223754|451222021|FG001|Period 2|Lost to Follow-up|0|||
125435676|NCT02223754|451222020|FG000|Period 2|Test Article No Longer Available|0|||
125435677|NCT02223754|451222021|FG001|Period 2|Test Article No Longer Available|1|||
125435678|NCT01008475|451222022|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
125435679|NCT01008475|451222023|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
125435680|NCT01008475|451222024|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
125435681|NCT01008475|451222025|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
125435682|NCT01008475|451222026|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
125435683|NCT01008475|451222027|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
125435684|NCT01008475|451222028|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
125435685|NCT03556358|451222030|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
125435686|NCT03556358|451222031|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
125435687|NCT03556358|451222030|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
125435688|NCT03556358|451222031|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
125435689|NCT03556358|451222030|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
125435690|NCT03556358|451222031|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
125128495|NCT00252720|450096087|FG001|Overall Study|Mainly patients lost to follow-up|18|||
125128496|NCT02514122|450096092|FG000|Overall Study|Withdrawal by Subject|2|||
125128497|NCT02514122|450096093|FG001|Overall Study|Withdrawal by Subject|0|||
125128498|NCT00112463|450096094|FG000|Overall Study|Physician Decision|1|||
125128499|NCT00112463|450096094|FG000|Overall Study|Progression|30|||
125128500|NCT00112463|450096094|FG000|Overall Study|Second Primary|1|||
125128501|NCT00112463|450096094|FG000|Overall Study|Toxicity|3|||
125128502|NCT00112463|450096094|FG000|Overall Study|Withdrawal by Subject|2|||
125128503|NCT00112463|450096094|FG000|Overall Study|Never started treatment|2|||
125128504|NCT01118312|450096101|FG000|Overall Study|Lost to Follow-up|33|||
125128505|NCT01118312|450096102|FG001|Overall Study|Lost to Follow-up|32|||
125128506|NCT01118312|450096101|FG000|Overall Study|Withdrawal by Subject|1|||
125435691|NCT03556358|451222030|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
125435692|NCT03556358|451222031|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
125435693|NCT03556358|451222030|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
125435694|NCT03556358|451222031|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
125128507|NCT01118312|450096102|FG001|Overall Study|Withdrawal by Subject|3|||
125128508|NCT01546545|450096106|FG000|Overall Study|Withdrawal by Subject|1|||
125628977|NCT02417064|451924512|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
125628978|NCT02417064|451924510|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
125628979|NCT02417064|451924511|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
125628980|NCT02417064|451924512|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
125628981|NCT02417064|451924510|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
125628982|NCT02417064|451924511|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
125628983|NCT02417064|451924512|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
125628984|NCT02417064|451924510|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
125628985|NCT02417064|451924511|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
125628986|NCT02417064|451924512|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
125628987|NCT02417064|451924510|FG000|Follow-up Phase (24 Weeks)|Other|2|||
125628988|NCT02417064|451924511|FG001|Follow-up Phase (24 Weeks)|Other|2|||
125628989|NCT02417064|451924512|FG002|Follow-up Phase (24 Weeks)|Other|3|||
125628990|NCT00990249|451924513|FG000|Overall Study|Disease Progression|8|||
125628991|NCT00990249|451924513|FG000|Overall Study|Non-Compliance|1|||
125628992|NCT00990249|451924513|FG000|Overall Study|Death|2|||
125628993|NCT00990249|451924513|FG000|Overall Study|Not treated|2|||
125628994|NCT01548417|451924516|FG000|Overall Study|Withdrawal by Subject|0|||
125628995|NCT01548417|451924517|FG001|Overall Study|Withdrawal by Subject|2|||
125628996|NCT04583969|451924518|FG000|Overall Study|Death|31|||
125628997|NCT04583969|451924519|FG001|Overall Study|Death|38|||
125628998|NCT04583969|451924518|FG000|Overall Study|Lost to Follow-up|16|||
125628999|NCT04583969|451924519|FG001|Overall Study|Lost to Follow-up|13|||
125629000|NCT04583969|451924518|FG000|Overall Study|Protocol Violation|1|||
125629001|NCT04583969|451924519|FG001|Overall Study|Protocol Violation|0|||
125629002|NCT04583969|451924518|FG000|Overall Study|Withdrawal by Subject|3|||
125629003|NCT04583969|451924519|FG001|Overall Study|Withdrawal by Subject|3|||
125629004|NCT04583969|451924518|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
125629005|NCT04583969|451924519|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
125629006|NCT04583969|451924518|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
125629007|NCT04583969|451924519|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
125629008|NCT04583969|451924518|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
125629009|NCT04583969|451924519|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
125629010|NCT04583969|451924518|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
125629011|NCT04583969|451924519|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
125629012|NCT04583969|451924518|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
125629013|NCT04583969|451924519|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
125629014|NCT01057862|451924520|FG000|Overall Study|Withdrawal by Subject|1|||
125629015|NCT01057862|451924521|FG001|Overall Study|Withdrawal by Subject|2|||
125629016|NCT00415584|451924522|FG000|Overall Study|Withdrawal by Subject|1|||
125629017|NCT02640755|451924523|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
125629018|NCT02640755|451924524|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
125629019|NCT02640755|451924523|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
125629020|NCT02640755|451924524|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
125629021|NCT02640755|451924523|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
125629022|NCT02640755|451924524|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
125629023|NCT03434041|451924525|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
125629024|NCT03434041|451924526|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
125629025|NCT03434041|451924525|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
125128509|NCT00735904|450096107|FG000|Overall Study|Adverse Event|3|||
125128510|NCT00735904|450096107|FG000|Overall Study|Death|20|||
125629026|NCT03434041|451924526|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
125629027|NCT03434041|451924525|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
125629028|NCT03434041|451924526|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
125629029|NCT03434041|451924525|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
125629030|NCT03434041|451924526|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
125629031|NCT03434041|451924525|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
125629032|NCT03434041|451924526|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
125629033|NCT03434041|451924525|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
125629034|NCT03434041|451924526|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
125629035|NCT03434041|451924525|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
125629036|NCT03434041|451924526|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
125128511|NCT00735904|450096107|FG000|Overall Study|Protocol Violation|1|||
125629037|NCT03434041|451924525|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
125629038|NCT03434041|451924526|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
125629039|NCT03434041|451924525|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
125629040|NCT03434041|451924526|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
125629041|NCT03434041|451924525|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
125128512|NCT00735904|450096107|FG000|Overall Study|Withdrawal by Subject|1|||
125128513|NCT00735904|450096107|FG000|Overall Study|Study Terminated by Sponsor|5|||
125128514|NCT00735904|450096107|FG000|Overall Study|Other|8|||
125128515|NCT01390844|450096108|FG000|Treatment Phase|Adverse Event|12|||
125128516|NCT01390844|450096109|FG001|Treatment Phase|Adverse Event|2|||
125128517|NCT01390844|450096110|FG002|Treatment Phase|Adverse Event|3|||
125128518|NCT01390844|450096111|FG003|Treatment Phase|Adverse Event|2|||
125128519|NCT01390844|450096108|FG000|Treatment Phase|Treatment Failure|23|||
125128520|NCT01390844|450096109|FG001|Treatment Phase|Treatment Failure|25|||
125128521|NCT01390844|450096110|FG002|Treatment Phase|Treatment Failure|10|||
125128522|NCT01390844|450096111|FG003|Treatment Phase|Treatment Failure|13|||
125128523|NCT01390844|450096108|FG000|Treatment Phase|Non-Medical Reasons|5|||
125128524|NCT01390844|450096109|FG001|Treatment Phase|Non-Medical Reasons|1|||
125128525|NCT01390844|450096110|FG002|Treatment Phase|Non-Medical Reasons|8|||
125128526|NCT01390844|450096111|FG003|Treatment Phase|Non-Medical Reasons|1|||
125128527|NCT01390844|450096108|FG000|Treatment Phase|Non-GCP Compliant|0|||
125128528|NCT01390844|450096109|FG001|Treatment Phase|Non-GCP Compliant|0|||
125128529|NCT01390844|450096110|FG002|Treatment Phase|Non-GCP Compliant|10|||
125128530|NCT01390844|450096111|FG003|Treatment Phase|Non-GCP Compliant|3|||
125128531|NCT01390844|450096108|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
125128532|NCT01390844|450096109|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
125128533|NCT01390844|450096110|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
125128534|NCT01390844|450096111|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
125128535|NCT03204539|450096114|FG000|Overall Study|Loss of funding|0|||
125128536|NCT03204539|450096115|FG001|Overall Study|Loss of funding|1|||
125128537|NCT05093205|450096116|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
125128538|NCT05093205|450096117|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
125128539|NCT05093205|450096118|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
125128540|NCT05093205|450096119|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
125128541|NCT05093205|450096120|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
125128542|NCT05093205|450096121|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
125128543|NCT05093205|450096122|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
125128544|NCT05093205|450096123|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
125128545|NCT05093205|450096124|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
125128546|NCT05093205|450096125|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
125128547|NCT05093205|450096126|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
125128548|NCT05093205|450096127|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
125128549|NCT05093205|450096128|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
125128550|NCT05093205|450096116|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125435695|NCT03556358|451222030|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
125435696|NCT03556358|451222031|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
125629042|NCT03434041|451924526|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
125629043|NCT03434041|451924525|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
125629044|NCT03434041|451924526|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
125629045|NCT04075396|451924527|FG000|Overall Study|Death|11|||
125629046|NCT04075396|451924528|FG001|Overall Study|Death|9|||
125629047|NCT04075396|451924527|FG000|Overall Study|Withdrawal by Subject|1|||
125629048|NCT04075396|451924528|FG001|Overall Study|Withdrawal by Subject|2|||
125629049|NCT04075396|451924527|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
125629050|NCT04075396|451924528|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
125629051|NCT04075396|451924527|FG000|Overall Study|Enrolled but not-treated|0|||
125629052|NCT04075396|451924528|FG001|Overall Study|Enrolled but not-treated|1|||
125629053|NCT03363165|451924529|FG000|3-month Follow-up|Death|0|||
125629054|NCT03363165|451924530|FG001|3-month Follow-up|Death|1|||
125629055|NCT03363165|451924529|FG000|6-month Follow-up|Death|0|||
125629056|NCT03363165|451924530|FG001|6-month Follow-up|Death|1|||
125629057|NCT03363165|451924529|FG000|6-month Follow-up|Withdrawal by Subject|1|||
125629058|NCT03363165|451924530|FG001|6-month Follow-up|Withdrawal by Subject|1|||
125629059|NCT03363165|451924529|FG000|12-month Follow-up|Death|1|||
125128551|NCT05093205|450096117|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128552|NCT05093205|450096118|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
125128553|NCT05093205|450096119|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128554|NCT05093205|450096120|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128555|NCT05093205|450096121|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128556|NCT05093205|450096122|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125215722|NCT03383692|450417498|FG000|Overall Study|Progressive disease as per RECIST|3|||
125215723|NCT03383692|450417499|FG001|Overall Study|Progressive disease as per RECIST|3|||
125629060|NCT03363165|451924530|FG001|12-month Follow-up|Death|1|||
125128557|NCT05093205|450096123|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128558|NCT05093205|450096124|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128559|NCT05093205|450096125|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128560|NCT05093205|450096126|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125629061|NCT03363165|451924529|FG000|12-month Follow-up|Withdrawal by Subject|1|||
125629062|NCT03363165|451924530|FG001|12-month Follow-up|Withdrawal by Subject|1|||
125629063|NCT02255760|451924531|FG000|Overall Study|Lost to Follow-up|0|||
125629064|NCT02255760|451924532|FG001|Overall Study|Lost to Follow-up|1|||
125629065|NCT02255760|451924533|FG002|Overall Study|Lost to Follow-up|0|||
125629066|NCT02255760|451924534|FG003|Overall Study|Lost to Follow-up|0|||
125629067|NCT02255760|451924535|FG004|Overall Study|Lost to Follow-up|0|||
125629068|NCT00618813|451924536|FG000|Overall Study|Lack of Efficacy|1|||
125629069|NCT00618813|451924536|FG000|Overall Study|Physician Decision|2|||
125629070|NCT00618813|451924536|FG000|Overall Study|Withdrawal by Subject|1|||
125629071|NCT00003838|451924537|FG000|Overall Study|Death|0|||
125629072|NCT00003838|451924538|FG001|Overall Study|Death|12|||
125629073|NCT00003838|451924539|FG002|Overall Study|Death|7|||
125629074|NCT00003838|451924537|FG000|Overall Study|Lost to Follow-up|0|||
125629075|NCT00003838|451924538|FG001|Overall Study|Lost to Follow-up|1|||
125629076|NCT00003838|451924539|FG002|Overall Study|Lost to Follow-up|1|||
125629077|NCT00003838|451924537|FG000|Overall Study|Disease Progression|0|||
125629078|NCT00003838|451924538|FG001|Overall Study|Disease Progression|12|||
125629079|NCT00003838|451924539|FG002|Overall Study|Disease Progression|0|||
125629080|NCT01809197|451924540|FG000|Overall Study|Lost to Follow-up|4|||
125629081|NCT01809197|451924541|FG001|Overall Study|Lost to Follow-up|2|||
125629082|NCT01809197|451924540|FG000|Overall Study|Adverse Event|2|||
125629083|NCT01809197|451924541|FG001|Overall Study|Adverse Event|3|||
125629084|NCT01809197|451924540|FG000|Overall Study|Failed slit lamp exam|1|||
125629085|NCT01809197|451924541|FG001|Overall Study|Failed slit lamp exam|0|||
125629086|NCT01809197|451924540|FG000|Overall Study|Non-Compliance|1|||
125629087|NCT01809197|451924541|FG001|Overall Study|Non-Compliance|1|||
125629088|NCT01809197|451924540|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
125629089|NCT01809197|451924541|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
125629090|NCT01809197|451924540|FG000|Overall Study|Withdrawal by Subject|1|||
125629091|NCT01809197|451924541|FG001|Overall Study|Withdrawal by Subject|1|||
125629092|NCT01809197|451924540|FG000|Overall Study|Product not available|0|||
125629093|NCT01809197|451924541|FG001|Overall Study|Product not available|1|||
125629094|NCT04685538|451924548|FG000|Overall Study|Adverse Event|0|||
125629095|NCT04685538|451924549|FG001|Overall Study|Adverse Event|1|||
125629096|NCT04685538|451924548|FG000|Overall Study|Lost to Follow-up|0|||
125629097|NCT04685538|451924549|FG001|Overall Study|Lost to Follow-up|2|||
125629098|NCT04423757|451924563|FG000|Overall Study|Adverse Event|2|||
125629099|NCT04423757|451924564|FG001|Overall Study|Adverse Event|0|||
125629100|NCT04423757|451924563|FG000|Overall Study|Not treated|1|||
125629101|NCT04423757|451924564|FG001|Overall Study|Not treated|1|||
125629102|NCT02709109|451924565|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
125629103|NCT02709109|451924566|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
125629104|NCT02709109|451924567|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
125629105|NCT02709109|451924568|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
125629106|NCT02709109|451924565|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
125629107|NCT02709109|451924566|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
125629108|NCT02709109|451924567|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
125629109|NCT02709109|451924568|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
125629110|NCT02709109|451924565|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
125629111|NCT02709109|451924566|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
125629112|NCT02709109|451924567|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
125629113|NCT02709109|451924568|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
125629114|NCT02709109|451924565|FG000|Washout Period (28 Days)|Other|2|||
125629115|NCT02709109|451924566|FG001|Washout Period (28 Days)|Other|2|||
125629116|NCT02709109|451924567|FG002|Washout Period (28 Days)|Other|3|||
125629117|NCT02709109|451924568|FG003|Washout Period (28 Days)|Other|0|||
125128561|NCT05093205|450096127|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128562|NCT05093205|450096128|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
125128563|NCT05093205|450096116|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
125629118|NCT02709109|451924565|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
125629119|NCT02709109|451924566|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
125629120|NCT02709109|451924567|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
125629121|NCT02709109|451924568|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
125629122|NCT02709109|451924565|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
125629123|NCT02709109|451924566|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
125629124|NCT02709109|451924567|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
125629125|NCT02709109|451924568|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
125629126|NCT02709109|451924565|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
125629127|NCT02709109|451924566|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
125128564|NCT05093205|450096117|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
125629128|NCT02709109|451924567|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
125629129|NCT02709109|451924568|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
125629130|NCT02709109|451924565|FG000|Treatment Period 2 (28 Days)|Other|0|||
125128565|NCT05093205|450096118|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
125128566|NCT05093205|450096119|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
125128567|NCT05093205|450096120|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
125128568|NCT05093205|450096121|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
125128569|NCT05093205|450096122|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
125128570|NCT05093205|450096123|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
125128571|NCT05093205|450096124|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
125128572|NCT05093205|450096125|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
125128573|NCT05093205|450096126|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
125128574|NCT05093205|450096127|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
125128575|NCT05093205|450096128|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
125128576|NCT05093205|450096116|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
125128577|NCT05093205|450096117|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
125128578|NCT05093205|450096118|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
125128579|NCT05093205|450096119|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
125128580|NCT05093205|450096120|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
125128581|NCT05093205|450096121|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
125128582|NCT05093205|450096122|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
125128583|NCT05093205|450096123|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
125128584|NCT05093205|450096124|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
125128585|NCT05093205|450096125|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
125128586|NCT05093205|450096126|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
125128587|NCT05093205|450096127|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
125128588|NCT05093205|450096128|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
125128589|NCT05093205|450096116|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
125128590|NCT05093205|450096117|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
125128591|NCT05093205|450096118|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
125128592|NCT05093205|450096119|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
125128593|NCT05093205|450096120|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
125128594|NCT05093205|450096121|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
125128595|NCT05093205|450096122|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
125128596|NCT05093205|450096123|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
125128597|NCT05093205|450096124|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
125128598|NCT05093205|450096125|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
125375806|NCT00963547|451007602|FG002|Overall Study|Withdrawal by Subject|3|||
125629131|NCT02709109|451924566|FG001|Treatment Period 2 (28 Days)|Other|0|||
125629132|NCT02709109|451924567|FG002|Treatment Period 2 (28 Days)|Other|1|||
125629133|NCT02709109|451924568|FG003|Treatment Period 2 (28 Days)|Other|0|||
125629134|NCT05563714|451924569|FG000|Overall Study|Death|2|||
125629135|NCT05563714|451924570|FG001|Overall Study|Death|2|||
125629136|NCT05563714|451924571|FG002|Overall Study|Death|0|||
125629137|NCT05563714|451924572|FG003|Overall Study|Death|0|||
125629138|NCT05563714|451924569|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
125629139|NCT05563714|451924570|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
125629140|NCT05563714|451924571|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
125629141|NCT05563714|451924572|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
125629142|NCT05563714|451924569|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
125629143|NCT05563714|451924570|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
125629144|NCT05563714|451924571|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
125629145|NCT05563714|451924572|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
125629146|NCT05563714|451924569|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
125629147|NCT05563714|451924570|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
125629148|NCT05563714|451924571|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
125629149|NCT05563714|451924572|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
125629150|NCT05563714|451924569|FG000|Overall Study|Lost to Follow-up|22|||
125629151|NCT05563714|451924570|FG001|Overall Study|Lost to Follow-up|19|||
125629152|NCT05563714|451924571|FG002|Overall Study|Lost to Follow-up|0|||
125629153|NCT05563714|451924572|FG003|Overall Study|Lost to Follow-up|0|||
125128599|NCT05093205|450096126|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
125128600|NCT05093205|450096127|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
125375807|NCT00963547|451007603|FG003|Overall Study|Withdrawal by Subject|0|||
125375808|NCT00963547|451007604|FG004|Overall Study|Withdrawal by Subject|0|||
125629154|NCT01815580|451924573|FG000|Overall Study|Lost to Follow-up|4|||
125629155|NCT01815580|451924574|FG001|Overall Study|Lost to Follow-up|7|||
125629156|NCT01815580|451924573|FG000|Overall Study|Withdrawal by Subject|3|||
125128601|NCT05093205|450096128|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
125128602|NCT05093205|450096116|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
125128603|NCT05093205|450096117|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
125215724|NCT03383692|450417498|FG000|Overall Study|Clinical progression|0|||
125128604|NCT05093205|450096118|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
125128605|NCT05093205|450096119|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
125128606|NCT05093205|450096120|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
125128607|NCT05093205|450096121|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
125128608|NCT05093205|450096122|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
125128609|NCT05093205|450096123|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
125629157|NCT01815580|451924574|FG001|Overall Study|Withdrawal by Subject|4|||
125629158|NCT01815580|451924573|FG000|Overall Study|Excluded from analysis|5|||
125629159|NCT01815580|451924574|FG001|Overall Study|Excluded from analysis|4|||
125629160|NCT02228564|451924575|FG000|Overall Study|Withdrawal by Subject|10|||
125629161|NCT02228564|451924575|FG000|Overall Study|Death|11|||
125629162|NCT02228564|451924575|FG000|Overall Study|Physician Decision|5|||
125629163|NCT02228564|451924575|FG000|Overall Study|Lost to Follow-up|17|||
125629164|NCT02228564|451924575|FG000|Overall Study|Other|6|||
125629165|NCT01998399|451924576|FG000|Overall Study|Lost to Follow-up|1|||
125629166|NCT01998399|451924577|FG001|Overall Study|Lost to Follow-up|3|||
125629167|NCT01998399|451924576|FG000|Overall Study|Death|4|||
125629168|NCT01998399|451924577|FG001|Overall Study|Death|2|||
125629169|NCT01998399|451924576|FG000|Overall Study|Study stopped before dosing completed|3|||
125629170|NCT01998399|451924577|FG001|Overall Study|Study stopped before dosing completed|3|||
125629171|NCT01998399|451924576|FG000|Overall Study|Withdrawal by Subject|0|||
125629172|NCT01998399|451924577|FG001|Overall Study|Withdrawal by Subject|1|||
125629173|NCT04114539|451924581|FG000|Overall Study|Adverse Event|14|||
125629174|NCT04114539|451924581|FG000|Overall Study|Lost to Follow-up|2|||
125629175|NCT04114539|451924581|FG000|Overall Study|Non-compliance with Protocol|2|||
125629176|NCT04114539|451924581|FG000|Overall Study|Non-compliance with Study Drug|1|||
125629177|NCT04114539|451924581|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
125629178|NCT04114539|451924581|FG000|Overall Study|Withdrew consent|10|||
125629179|NCT04114539|451924581|FG000|Overall Study|Others not specified|5|||
125629180|NCT04114539|451924581|FG000|Overall Study|Investigator Decision|2|||
125629181|NCT00617591|451924582|FG000|Overall Study|Withdrew consent during Induction|4|||
125629182|NCT00617591|451924582|FG000|Overall Study|Withdrew consent during Maintenance|6|||
125629183|NCT00376246|451924583|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
125629184|NCT00376246|451924584|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
125629185|NCT00376246|451924583|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
125629186|NCT00376246|451924584|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
125629187|NCT00376246|451924583|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
125629188|NCT00376246|451924584|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125629189|NCT01072448|451924589|FG000|Overall Study|Adverse Event|9|||
125629190|NCT01072448|451924590|FG001|Overall Study|Adverse Event|10|||
125629191|NCT01072448|451924589|FG000|Overall Study|Subject withdrew consent|4|||
125629192|NCT01072448|451924590|FG001|Overall Study|Subject withdrew consent|9|||
125629193|NCT01072448|451924589|FG000|Overall Study|Protocol deviation|3|||
125629194|NCT01072448|451924590|FG001|Overall Study|Protocol deviation|4|||
125629195|NCT01072448|451924589|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125629196|NCT01072448|451924590|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125629197|NCT01072448|451924589|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125629198|NCT01072448|451924590|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125629199|NCT01072448|451924589|FG000|Overall Study|Lost to Follow-up|1|||
125629200|NCT01072448|451924590|FG001|Overall Study|Lost to Follow-up|1|||
125629201|NCT01072448|451924589|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125629202|NCT01072448|451924590|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125629203|NCT01072448|451924589|FG000|Overall Study|Death|0|||
125629204|NCT01072448|451924590|FG001|Overall Study|Death|2|||
125629205|NCT01400139|451924593|FG000|HYD Core Study|Adverse Event|210|||
125629206|NCT01400139|451924593|FG000|HYD Core Study|Lack of Efficacy|59|||
125629207|NCT01400139|451924593|FG000|HYD Core Study|Withdrawal by Subject|114|||
125629208|NCT01400139|451924593|FG000|HYD Core Study|Lost to Follow-up|39|||
125629209|NCT01400139|451924593|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
125629210|NCT01400139|451924593|FG000|HYD Core Study|Administrative|56|||
125629211|NCT01400139|451924593|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
125629212|NCT01400139|451924593|FG000|HYD Extension Period|Adverse Event|8|||
125629213|NCT01400139|451924593|FG000|HYD Extension Period|Withdrawal by Subject|5|||
125629214|NCT01400139|451924593|FG000|HYD Extension Period|Administrative|10|||
125629215|NCT00418717|451924594|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
125629216|NCT00418717|451924594|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
125629217|NCT00249795|451924595|FG000|Overall Study|Not treated|16|||
125629218|NCT00249795|451924596|FG001|Overall Study|Not treated|14|||
125629219|NCT00249795|451924595|FG000|Overall Study|Symptomatic hypotension|127|||
125128610|NCT05093205|450096124|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
125128611|NCT05093205|450096125|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
125128612|NCT05093205|450096126|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
125629220|NCT00249795|451924596|FG001|Overall Study|Symptomatic hypotension|64|||
125629221|NCT00249795|451924595|FG000|Overall Study|Other Serious Adverse Event|84|||
125629222|NCT00249795|451924596|FG001|Overall Study|Other Serious Adverse Event|93|||
125435697|NCT03556358|451222030|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
125435698|NCT03556358|451222031|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
125435699|NCT02917941|451222034|FG000|Treatment Period|Adverse Event|11|||
125435700|NCT02917941|451222034|FG000|Treatment Period|Progressive Disease|11|||
125435701|NCT02917941|451222034|FG000|Treatment Period|Reason not Specified|2|||
125435702|NCT02917941|451222034|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
125128613|NCT05093205|450096127|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
125435703|NCT02917941|451222034|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
125435704|NCT01351025|451222035|FG000|Week 0 - 20|Lost to Follow-up|2|||
125435705|NCT01351025|451222036|FG001|Week 0 - 20|Lost to Follow-up|1|||
125435706|NCT01351025|451222035|FG000|Week 0 - 20|Withdrawal by Subject|1|||
125435707|NCT01351025|451222036|FG001|Week 0 - 20|Withdrawal by Subject|0|||
125435708|NCT01351025|451222035|FG000|Week 24 - 44|Lost to Follow-up|0|||
125435709|NCT01351025|451222036|FG001|Week 24 - 44|Lost to Follow-up|2|||
125435710|NCT01351025|451222035|FG000|Week 24 - 44|Site closed|0|||
125435711|NCT01351025|451222036|FG001|Week 24 - 44|Site closed|1|||
125435712|NCT01351025|451222035|FG000|Week 24 - 44|unable to get to clinic|1|||
125435713|NCT01351025|451222036|FG001|Week 24 - 44|unable to get to clinic|1|||
125435714|NCT00510458|451222053|FG000|Overall Study|5 year not evaluable/missed|21|||
125435715|NCT00510458|451222053|FG000|Overall Study|Death|1|||
125435716|NCT00510458|451222053|FG000|Overall Study|Terminated|14|||
125435717|NCT00510458|451222053|FG000|Overall Study|Lost to Follow-up|6|||
125435718|NCT00510458|451222053|FG000|Overall Study|Withdrawal by Subject|3|||
125435719|NCT00510458|451222053|FG000|Overall Study|Revision|2|||
125435720|NCT01861522|451222054|FG000|Overall Study|Adverse Event|1|||
125435721|NCT01861522|451222055|FG001|Overall Study|Adverse Event|0|||
125435722|NCT01861522|451222054|FG000|Overall Study|Withdrawal by Subject|2|||
125435723|NCT01861522|451222055|FG001|Overall Study|Withdrawal by Subject|0|||
125435724|NCT02716038|451222056|FG000|Overall Study|Not evaluable|1|||
125435725|NCT02716038|451222056|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
125435726|NCT02716038|451222056|FG000|Overall Study|Unresectable|3|||
125435727|NCT03573908|451222057|FG000|Treatment Period|Adverse Event|4|||
125435728|NCT03573908|451222058|FG001|Treatment Period|Adverse Event|9|||
125435729|NCT03573908|451222059|FG002|Treatment Period|Adverse Event|0|||
125435730|NCT03573908|451222060|FG003|Treatment Period|Adverse Event|0|||
125435731|NCT03573908|451222061|FG004|Treatment Period|Adverse Event|0|||
125435732|NCT03573908|451222057|FG000|Treatment Period|Protocol Violation|1|||
125128614|NCT05093205|450096128|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
125128615|NCT05093205|450096116|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
125128616|NCT05093205|450096117|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
125128617|NCT05093205|450096118|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
125128618|NCT05093205|450096119|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
125128619|NCT05093205|450096120|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
125128620|NCT05093205|450096121|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
125128621|NCT05093205|450096122|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
125128622|NCT05093205|450096123|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
125128623|NCT05093205|450096124|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
125128624|NCT05093205|450096125|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
125128625|NCT05093205|450096126|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
125128626|NCT05093205|450096127|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
125128627|NCT05093205|450096128|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
125128628|NCT05093205|450096116|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
125128629|NCT05093205|450096117|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
125128630|NCT05093205|450096118|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
125128631|NCT05093205|450096119|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
125128632|NCT05093205|450096120|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
125128633|NCT05093205|450096121|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
125128634|NCT05093205|450096122|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
125128635|NCT05093205|450096123|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
125128636|NCT05093205|450096124|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
125128637|NCT05093205|450096125|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
125435733|NCT03573908|451222058|FG001|Treatment Period|Protocol Violation|0|||
125435734|NCT03573908|451222059|FG002|Treatment Period|Protocol Violation|0|||
125128638|NCT05093205|450096126|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
125128639|NCT05093205|450096127|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
125128640|NCT05093205|450096128|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
125128641|NCT05093205|450096116|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128642|NCT05093205|450096117|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125435735|NCT03573908|451222060|FG003|Treatment Period|Protocol Violation|0|||
125435736|NCT03573908|451222061|FG004|Treatment Period|Protocol Violation|0|||
125435737|NCT03573908|451222057|FG000|Treatment Period|Withdrawal by Subject|7|||
125435738|NCT03573908|451222058|FG001|Treatment Period|Withdrawal by Subject|5|||
125435739|NCT03573908|451222059|FG002|Treatment Period|Withdrawal by Subject|0|||
125435740|NCT03573908|451222060|FG003|Treatment Period|Withdrawal by Subject|0|||
125435741|NCT03573908|451222061|FG004|Treatment Period|Withdrawal by Subject|0|||
125128643|NCT05093205|450096118|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128644|NCT05093205|450096119|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128645|NCT05093205|450096120|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128646|NCT05093205|450096121|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128647|NCT05093205|450096122|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128648|NCT05093205|450096123|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128649|NCT05093205|450096124|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128650|NCT05093205|450096125|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
125128651|NCT05093205|450096126|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128652|NCT05093205|450096127|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128653|NCT05093205|450096128|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
125128654|NCT05093205|450096116|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
125128655|NCT05093205|450096117|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
125128656|NCT05093205|450096118|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
125128657|NCT05093205|450096119|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
125128658|NCT05093205|450096120|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
125128659|NCT05093205|450096121|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
125128660|NCT05093205|450096122|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
125128661|NCT05093205|450096123|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
125128662|NCT05093205|450096124|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
125128663|NCT05093205|450096125|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
125128664|NCT05093205|450096126|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
125128665|NCT05093205|450096127|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
125128666|NCT05093205|450096128|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
125128667|NCT05093205|450096116|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128668|NCT05093205|450096117|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128669|NCT05093205|450096118|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128670|NCT05093205|450096119|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128671|NCT05093205|450096120|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128672|NCT05093205|450096121|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128673|NCT05093205|450096122|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128674|NCT05093205|450096123|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128675|NCT05093205|450096124|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128676|NCT05093205|450096125|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128677|NCT05093205|450096126|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
125128678|NCT05093205|450096127|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128679|NCT05093205|450096128|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
125128680|NCT05093205|450096116|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128681|NCT05093205|450096117|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128682|NCT05093205|450096118|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128683|NCT05093205|450096119|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128684|NCT05093205|450096120|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128685|NCT05093205|450096121|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128686|NCT05093205|450096122|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128687|NCT05093205|450096123|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128688|NCT05093205|450096124|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128689|NCT05093205|450096125|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128690|NCT05093205|450096126|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128691|NCT05093205|450096127|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
125128692|NCT05093205|450096128|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
125128693|NCT05093205|450096116|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
125128694|NCT05093205|450096117|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
125128695|NCT05093205|450096118|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
125128696|NCT05093205|450096119|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
125128697|NCT05093205|450096120|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
125629223|NCT00249795|451924595|FG000|Overall Study|Qualifying condition not present|26|||
125629224|NCT00249795|451924596|FG001|Overall Study|Qualifying condition not present|29|||
125629225|NCT00249795|451924595|FG000|Overall Study|Withdrawal by Subject|678|||
125629226|NCT00249795|451924596|FG001|Overall Study|Withdrawal by Subject|742|||
125629227|NCT00249795|451924595|FG000|Overall Study|Thromboembolic / outcome event|39|||
125629228|NCT00249795|451924596|FG001|Overall Study|Thromboembolic / outcome event|45|||
125629229|NCT00249795|451924595|FG000|Overall Study|Oral anticoagulant required|2|||
125629230|NCT00249795|451924596|FG001|Overall Study|Oral anticoagulant required|0|||
125629231|NCT00249795|451924595|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
125629232|NCT00249795|451924596|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
125128698|NCT05093205|450096121|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
125629233|NCT00249795|451924595|FG000|Overall Study|Non-compliance|71|||
125128699|NCT05093205|450096122|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
125128700|NCT05093205|450096123|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
125128701|NCT05093205|450096124|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
125128702|NCT05093205|450096125|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
125128703|NCT05093205|450096126|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
125629234|NCT00249795|451924596|FG001|Overall Study|Non-compliance|69|||
125629235|NCT00249795|451924595|FG000|Overall Study|Study drug intolerance|3|||
125629236|NCT00249795|451924596|FG001|Overall Study|Study drug intolerance|3|||
125128704|NCT05093205|450096127|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
125128705|NCT05093205|450096128|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
125128706|NCT05093205|450096116|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128707|NCT05093205|450096117|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128708|NCT05093205|450096118|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128709|NCT05093205|450096119|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128710|NCT05093205|450096120|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128711|NCT05093205|450096121|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128712|NCT05093205|450096122|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128713|NCT05093205|450096123|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128714|NCT05093205|450096124|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128715|NCT05093205|450096125|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128716|NCT05093205|450096126|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128717|NCT05093205|450096127|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
125128718|NCT05093205|450096128|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
125128719|NCT03361228|450096130|FG000|Overall Study|Other|1|||
125128720|NCT03361228|450096131|FG001|Overall Study|Other|1|||
125128721|NCT03361228|450096130|FG000|Overall Study|Death|3|||
125128722|NCT03361228|450096131|FG001|Overall Study|Death|0|||
125128723|NCT03693430|450096139|FG000|Overall Study|Lost to Follow-up|3|||
125128724|NCT03693430|450096140|FG001|Overall Study|Lost to Follow-up|14|||
125128725|NCT03693430|450096139|FG000|Overall Study|Death|1|||
125128726|NCT03693430|450096140|FG001|Overall Study|Death|0|||
125128727|NCT03693430|450096139|FG000|Overall Study|Withdrawal by Subject|0|||
125128728|NCT03693430|450096140|FG001|Overall Study|Withdrawal by Subject|4|||
125128729|NCT04185909|450096141|FG000|Overall Study|Lost to Follow-up|1|||
125128730|NCT01417078|450096142|FG000|Overall Study|Withdrawal by Subject|1|||
125128731|NCT01223365|450096151|FG000|Open-label Titration Period|Enrolled but not treated|1|||
125128732|NCT01223365|450096151|FG000|Open-label Titration Period|Adverse Event|23|||
125128733|NCT01223365|450096151|FG000|Open-label Titration Period|Lack of Efficacy|3|||
125128734|NCT01223365|450096151|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
125128735|NCT01223365|450096151|FG000|Open-label Titration Period|Protocol Violation|1|||
125128736|NCT01223365|450096151|FG000|Open-label Titration Period|Lost to Follow-up|2|||
125128737|NCT01223365|450096151|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
125128738|NCT01223365|450096151|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
125128739|NCT01223365|450096151|FG000|Open-label Titration Period|Starting physical therapy|1|||
125128740|NCT01223365|450096151|FG000|Open-label Treatment Period|Adverse Event|39|||
125128741|NCT01223365|450096151|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
125215725|NCT03383692|450417499|FG001|Overall Study|Clinical progression|1|||
125375809|NCT00963547|451007605|FG005|Overall Study|Withdrawal by Subject|0|||
125375810|NCT00963547|451007606|FG006|Overall Study|Withdrawal by Subject|0|||
125375811|NCT00963547|451007600|FG000|Overall Study|Reason Unknown|0|||
125375812|NCT00963547|451007601|FG001|Overall Study|Reason Unknown|1|||
125375813|NCT00963547|451007602|FG002|Overall Study|Reason Unknown|0|||
125375814|NCT00963547|451007603|FG003|Overall Study|Reason Unknown|0|||
125375815|NCT00963547|451007604|FG004|Overall Study|Reason Unknown|0|||
125375816|NCT00963547|451007605|FG005|Overall Study|Reason Unknown|0|||
125375817|NCT00963547|451007606|FG006|Overall Study|Reason Unknown|0|||
125375818|NCT00482612|451007609|FG000|In-treatment Period|No study medication administered|0|||
125375819|NCT00482612|451007610|FG001|In-treatment Period|No study medication administered|0|||
125375820|NCT00482612|451007611|FG002|In-treatment Period|No study medication administered|1|||
125375821|NCT00482612|451007612|FG003|In-treatment Period|No study medication administered|0|||
125375822|NCT00482612|451007609|FG000|Follow-up Period|Other|4|||
125375823|NCT00482612|451007610|FG001|Follow-up Period|Other|2|||
125375824|NCT00482612|451007611|FG002|Follow-up Period|Other|1|||
125375825|NCT00482612|451007612|FG003|Follow-up Period|Other|2|||
125375826|NCT00482612|451007609|FG000|Follow-up Period|Lack of compliance|0|||
125375827|NCT00482612|451007610|FG001|Follow-up Period|Lack of compliance|0|||
125375828|NCT00482612|451007611|FG002|Follow-up Period|Lack of compliance|1|||
125375829|NCT00482612|451007612|FG003|Follow-up Period|Lack of compliance|0|||
125375830|NCT00482612|451007609|FG000|Follow-up Period|Lost to Follow-up|0|||
125128742|NCT01223365|450096151|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
125128743|NCT01223365|450096151|FG000|Open-label Treatment Period|Protocol Violation|15|||
125128744|NCT01223365|450096151|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
125128745|NCT01223365|450096151|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
125215726|NCT03383692|450417498|FG000|Overall Study|Adverse Event|3|||
125375831|NCT00482612|451007610|FG001|Follow-up Period|Lost to Follow-up|4|||
125375832|NCT00482612|451007611|FG002|Follow-up Period|Lost to Follow-up|2|||
125629237|NCT00249795|451924595|FG000|Overall Study|Other adverse events (non-serious)|188|||
125215727|NCT03383692|450417499|FG001|Overall Study|Adverse Event|0|||
125375833|NCT00482612|451007612|FG003|Follow-up Period|Lost to Follow-up|1|||
125128746|NCT01223365|450096151|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
125128747|NCT01223365|450096151|FG000|Open-label Treatment Period|Moved out of area|2|||
125128748|NCT01223365|450096151|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
125128749|NCT01223365|450096151|FG000|Open-label Treatment Period|"Out of window"|1|||
125128750|NCT01223365|450096151|FG000|Open-label Treatment Period|Starting physical therapy|1|||
125375834|NCT00482612|451007609|FG000|Follow-up Period|Adverse Event|4|||
125375835|NCT00482612|451007610|FG001|Follow-up Period|Adverse Event|7|||
125375836|NCT00482612|451007611|FG002|Follow-up Period|Adverse Event|9|||
125375837|NCT00482612|451007612|FG003|Follow-up Period|Adverse Event|0|||
125375838|NCT00482612|451007609|FG000|Follow-up Period|Lack of Efficacy|2|||
125375839|NCT00482612|451007610|FG001|Follow-up Period|Lack of Efficacy|0|||
125375840|NCT00482612|451007611|FG002|Follow-up Period|Lack of Efficacy|1|||
125375841|NCT00482612|451007612|FG003|Follow-up Period|Lack of Efficacy|0|||
125375842|NCT00482612|451007609|FG000|Follow-up Period|Withdrawal by Subject|3|||
125375843|NCT00482612|451007610|FG001|Follow-up Period|Withdrawal by Subject|5|||
125375844|NCT00482612|451007611|FG002|Follow-up Period|Withdrawal by Subject|7|||
125375845|NCT00482612|451007612|FG003|Follow-up Period|Withdrawal by Subject|2|||
125375846|NCT00482612|451007609|FG000|Follow-up Period|Reasons not related to trial|1|||
125375847|NCT00482612|451007610|FG001|Follow-up Period|Reasons not related to trial|0|||
125375848|NCT00482612|451007611|FG002|Follow-up Period|Reasons not related to trial|1|||
125375849|NCT00482612|451007612|FG003|Follow-up Period|Reasons not related to trial|3|||
125375850|NCT01366521|451007613|FG000|Overall Study|Adverse Event|1|||
125375851|NCT01366521|451007614|FG001|Overall Study|Adverse Event|0|||
125375852|NCT01366521|451007615|FG002|Overall Study|Adverse Event|0|||
125375853|NCT01366521|451007616|FG003|Overall Study|Adverse Event|0|||
125375854|NCT01366521|451007613|FG000|Overall Study|Protocol Violation|0|||
125375855|NCT01366521|451007614|FG001|Overall Study|Protocol Violation|0|||
125375856|NCT01366521|451007615|FG002|Overall Study|Protocol Violation|1|||
125375857|NCT01366521|451007616|FG003|Overall Study|Protocol Violation|0|||
125375858|NCT01366521|451007613|FG000|Overall Study|Physician Decision|0|||
125375859|NCT01366521|451007614|FG001|Overall Study|Physician Decision|0|||
125375860|NCT01366521|451007615|FG002|Overall Study|Physician Decision|1|||
125375861|NCT01366521|451007616|FG003|Overall Study|Physician Decision|0|||
125375862|NCT01366521|451007613|FG000|Overall Study|Withdrawal by Subject|0|||
125375863|NCT01366521|451007614|FG001|Overall Study|Withdrawal by Subject|1|||
125375864|NCT01366521|451007615|FG002|Overall Study|Withdrawal by Subject|0|||
125375865|NCT01366521|451007616|FG003|Overall Study|Withdrawal by Subject|0|||
125375866|NCT00684307|451007617|FG000|Overall Study|Adverse Event|11|||
125375867|NCT00684307|451007618|FG001|Overall Study|Adverse Event|6|||
125375868|NCT00684307|451007619|FG002|Overall Study|Adverse Event|15|||
125375869|NCT00684307|451007620|FG003|Overall Study|Adverse Event|16|||
125375870|NCT00684307|451007621|FG004|Overall Study|Adverse Event|8|||
125375871|NCT00684307|451007617|FG000|Overall Study|Development of increasing Liver Function|0|||
125375872|NCT00684307|451007618|FG001|Overall Study|Development of increasing Liver Function|2|||
125375873|NCT00684307|451007619|FG002|Overall Study|Development of increasing Liver Function|0|||
125435742|NCT03573908|451222057|FG000|Treatment Period|Lost to Follow-up|7|||
125435743|NCT03573908|451222058|FG001|Treatment Period|Lost to Follow-up|6|||
125128751|NCT01223365|450096151|FG000|Open-label Treatment Period|Physician Decision|2|||
125128752|NCT03567174|450096152|FG000|Overall Study|Death|24|||
125375874|NCT00684307|451007620|FG003|Overall Study|Development of increasing Liver Function|1|||
125375875|NCT00684307|451007621|FG004|Overall Study|Development of increasing Liver Function|0|||
125128753|NCT03567174|450096153|FG001|Overall Study|Death|31|||
125375876|NCT00684307|451007617|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
125375877|NCT00684307|451007618|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
125375878|NCT00684307|451007619|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
125435744|NCT03573908|451222059|FG002|Treatment Period|Lost to Follow-up|0|||
125375879|NCT00684307|451007620|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
125375880|NCT00684307|451007621|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
125375881|NCT00684307|451007617|FG000|Overall Study|Incorrect enrolment or randomization|4|||
125375882|NCT00684307|451007618|FG001|Overall Study|Incorrect enrolment or randomization|0|||
125375883|NCT00684307|451007619|FG002|Overall Study|Incorrect enrolment or randomization|0|||
125375884|NCT00684307|451007620|FG003|Overall Study|Incorrect enrolment or randomization|0|||
125375885|NCT00684307|451007621|FG004|Overall Study|Incorrect enrolment or randomization|0|||
125375886|NCT00684307|451007617|FG000|Overall Study|Interupted IP for more than 7 days|0|||
125375887|NCT00684307|451007618|FG001|Overall Study|Interupted IP for more than 7 days|4|||
125375888|NCT00684307|451007619|FG002|Overall Study|Interupted IP for more than 7 days|1|||
125375889|NCT00684307|451007620|FG003|Overall Study|Interupted IP for more than 7 days|3|||
125375890|NCT00684307|451007621|FG004|Overall Study|Interupted IP for more than 7 days|3|||
125375891|NCT00684307|451007617|FG000|Overall Study|Severe non compliance to protocol|1|||
125375892|NCT00684307|451007618|FG001|Overall Study|Severe non compliance to protocol|0|||
125375893|NCT00684307|451007619|FG002|Overall Study|Severe non compliance to protocol|0|||
125375894|NCT00684307|451007620|FG003|Overall Study|Severe non compliance to protocol|1|||
125375895|NCT00684307|451007621|FG004|Overall Study|Severe non compliance to protocol|2|||
125375896|NCT00684307|451007617|FG000|Overall Study|Participant not willing to continue|7|||
125375897|NCT00684307|451007618|FG001|Overall Study|Participant not willing to continue|10|||
125375898|NCT00684307|451007619|FG002|Overall Study|Participant not willing to continue|11|||
125375899|NCT00684307|451007620|FG003|Overall Study|Participant not willing to continue|5|||
125375900|NCT00684307|451007621|FG004|Overall Study|Participant not willing to continue|8|||
125375901|NCT00684307|451007617|FG000|Overall Study|Criteria from the CSR|0|||
125375902|NCT00684307|451007618|FG001|Overall Study|Criteria from the CSR|0|||
125375903|NCT00684307|451007619|FG002|Overall Study|Criteria from the CSR|1|||
125375904|NCT00684307|451007620|FG003|Overall Study|Criteria from the CSR|3|||
125375905|NCT00684307|451007621|FG004|Overall Study|Criteria from the CSR|3|||
125375906|NCT00660023|451007622|FG000|Overall Study|Adverse Event|2|||
125435745|NCT03573908|451222060|FG003|Treatment Period|Lost to Follow-up|0|||
125435746|NCT03573908|451222061|FG004|Treatment Period|Lost to Follow-up|0|||
125435747|NCT03573908|451222057|FG000|Treatment Period|Pregnancy|1|||
125435748|NCT03573908|451222058|FG001|Treatment Period|Pregnancy|0|||
125435749|NCT03573908|451222059|FG002|Treatment Period|Pregnancy|0|||
125435750|NCT03573908|451222060|FG003|Treatment Period|Pregnancy|0|||
125435751|NCT03573908|451222061|FG004|Treatment Period|Pregnancy|0|||
125435752|NCT03573908|451222057|FG000|Treatment Period|Other, Not Specified|4|||
125435753|NCT03573908|451222058|FG001|Treatment Period|Other, Not Specified|6|||
125435754|NCT03573908|451222059|FG002|Treatment Period|Other, Not Specified|0|||
125435755|NCT03573908|451222060|FG003|Treatment Period|Other, Not Specified|0|||
125435756|NCT03573908|451222061|FG004|Treatment Period|Other, Not Specified|0|||
125435757|NCT03573908|451222057|FG000|Randomized Withdrawal Period|Adverse Event|0|||
125435758|NCT03573908|451222058|FG001|Randomized Withdrawal Period|Adverse Event|0|||
125435759|NCT03573908|451222059|FG002|Randomized Withdrawal Period|Adverse Event|3|||
125435760|NCT03573908|451222060|FG003|Randomized Withdrawal Period|Adverse Event|0|||
125435761|NCT03573908|451222061|FG004|Randomized Withdrawal Period|Adverse Event|0|||
125435762|NCT03573908|451222057|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125435763|NCT03573908|451222058|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125435764|NCT03573908|451222059|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125435765|NCT03573908|451222060|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
125435766|NCT03573908|451222061|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
125435767|NCT03573908|451222057|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
125435768|NCT03573908|451222058|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
125435769|NCT03573908|451222059|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
125435770|NCT03573908|451222060|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
125435771|NCT03573908|451222061|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
125435772|NCT03573908|451222057|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
125435773|NCT03573908|451222058|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
125435774|NCT03573908|451222059|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
125435775|NCT03573908|451222060|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
125435776|NCT03573908|451222061|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
125435777|NCT04006925|451222062|FG000|Overall Study|Side effects|2|||
125435778|NCT04006925|451222063|FG001|Overall Study|Side effects|0|||
125435779|NCT02669095|451222068|FG000|Overall Study|Adverse Event|1|||
125435780|NCT02669095|451222069|FG001|Overall Study|Adverse Event|0|||
125435781|NCT02669095|451222068|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
125435782|NCT02669095|451222069|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
125435783|NCT02669095|451222068|FG000|Overall Study|Torn Lens|0|||
125435784|NCT02669095|451222069|FG001|Overall Study|Torn Lens|1|||
125435785|NCT02669095|451222068|FG000|Overall Study|Visit 5 assessments not completed|0|||
125435786|NCT02669095|451222069|FG001|Overall Study|Visit 5 assessments not completed|1|||
125435787|NCT03757234|451222070|FG000|Overall Study|Adverse Event|0|||
125435788|NCT03757234|451222071|FG001|Overall Study|Adverse Event|0|||
125435789|NCT03757234|451222072|FG002|Overall Study|Adverse Event|0|||
125435790|NCT03757234|451222073|FG003|Overall Study|Adverse Event|0|||
125435791|NCT03757234|451222074|FG004|Overall Study|Adverse Event|1|||
125435792|NCT03757234|451222070|FG000|Overall Study|Lost to Follow-up|1|||
125435793|NCT03757234|451222071|FG001|Overall Study|Lost to Follow-up|0|||
125435794|NCT03757234|451222072|FG002|Overall Study|Lost to Follow-up|0|||
125435795|NCT03757234|451222073|FG003|Overall Study|Lost to Follow-up|0|||
125435796|NCT03757234|451222074|FG004|Overall Study|Lost to Follow-up|1|||
125435797|NCT03757234|451222070|FG000|Overall Study|Withdrawal by Subject|1|||
125435798|NCT03757234|451222071|FG001|Overall Study|Withdrawal by Subject|1|||
125435799|NCT03757234|451222072|FG002|Overall Study|Withdrawal by Subject|0|||
125435800|NCT03757234|451222073|FG003|Overall Study|Withdrawal by Subject|1|||
125435801|NCT03757234|451222074|FG004|Overall Study|Withdrawal by Subject|2|||
125435802|NCT03757234|451222070|FG000|Overall Study|Other|1|||
125435803|NCT03757234|451222071|FG001|Overall Study|Other|1|||
125435804|NCT03757234|451222072|FG002|Overall Study|Other|0|||
125435805|NCT03757234|451222073|FG003|Overall Study|Other|0|||
125435806|NCT03757234|451222074|FG004|Overall Study|Other|0|||
125435807|NCT01555164|451222076|FG000|Overall Study|Adverse Event|5|||
125435808|NCT01555164|451222077|FG001|Overall Study|Adverse Event|7|||
125435809|NCT01555164|451222076|FG000|Overall Study|Hyperglycemia|0|||
125435810|NCT01555164|451222077|FG001|Overall Study|Hyperglycemia|1|||
125435811|NCT01555164|451222076|FG000|Overall Study|Investigator's Discretion|2|||
125435812|NCT01555164|451222077|FG001|Overall Study|Investigator's Discretion|2|||
125435813|NCT01555164|451222076|FG000|Overall Study|Lost to Follow-up|4|||
125435814|NCT01555164|451222077|FG001|Overall Study|Lost to Follow-up|3|||
125435815|NCT01555164|451222076|FG000|Overall Study|Protocol Violation|9|||
125435816|NCT01555164|451222077|FG001|Overall Study|Protocol Violation|5|||
125435817|NCT01555164|451222076|FG000|Overall Study|Subject Non-compliance|14|||
125128754|NCT03567174|450096152|FG000|Overall Study|Lost to Follow-up|165|||
125128755|NCT03567174|450096153|FG001|Overall Study|Lost to Follow-up|174|||
125128756|NCT03243630|450096154|FG000|Overall Study|Protocol Violation|1|||
125128757|NCT03243630|450096154|FG000|Overall Study|Physician Decision|1|||
125128758|NCT01387737|450097629|FG000|Overall Study|Adverse Event|20|||
125128759|NCT01387737|450097630|FG001|Overall Study|Adverse Event|30|||
125128760|NCT01387737|450097629|FG000|Overall Study|Lack of Efficacy|1|||
125128761|NCT01387737|450097630|FG001|Overall Study|Lack of Efficacy|0|||
125128762|NCT01387737|450097629|FG000|Overall Study|Physician Decision|3|||
125128763|NCT01387737|450097630|FG001|Overall Study|Physician Decision|10|||
125128764|NCT01387737|450097629|FG000|Overall Study|Withdrawal by Subject|27|||
125435818|NCT01555164|451222077|FG001|Overall Study|Subject Non-compliance|6|||
125435819|NCT01555164|451222076|FG000|Overall Study|Subject Withdrew Consent|6|||
125435820|NCT01555164|451222077|FG001|Overall Study|Subject Withdrew Consent|11|||
125435821|NCT00926003|451222078|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
125435822|NCT00926003|451222079|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
125435823|NCT00926003|451222080|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
125128765|NCT01387737|450097630|FG001|Overall Study|Withdrawal by Subject|31|||
125128766|NCT01387737|450097629|FG000|Overall Study|Clearly not eligible for the study|1|||
125128767|NCT01387737|450097630|FG001|Overall Study|Clearly not eligible for the study|3|||
125128768|NCT02817841|450097632|FG000|Overall Study|Lost to Follow-up|287|||
125435824|NCT00926003|451222078|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
125629238|NCT00249795|451924596|FG001|Overall Study|Other adverse events (non-serious)|159|||
125128769|NCT02817841|450097632|FG000|Overall Study|Withdrawal by Subject|183|||
125128770|NCT02817841|450097632|FG000|Overall Study|Adverse event not related to bleeding|131|||
125128771|NCT02817841|450097632|FG000|Overall Study|Adverse event related to bleeding|51|||
125128772|NCT02817841|450097632|FG000|Overall Study|Pregnancy|32|||
125128773|NCT02817841|450097632|FG000|Overall Study|Pregnancy wish|17|||
125128774|NCT02817841|450097632|FG000|Overall Study|Other reasons|53|||
125128775|NCT02817841|450097632|FG000|Overall Study|Protocol Violation|94|||
125128776|NCT01746017|450097641|FG000|Period 1|Withdrawal by Subject|0|||
125128777|NCT01746017|450097642|FG001|Period 1|Withdrawal by Subject|0|||
125128778|NCT01746017|450097643|FG002|Period 1|Withdrawal by Subject|0|||
125128779|NCT01746017|450097644|FG003|Period 1|Withdrawal by Subject|0|||
125128780|NCT01746017|450097645|FG004|Period 1|Withdrawal by Subject|0|||
125128781|NCT01746017|450097646|FG005|Period 1|Withdrawal by Subject|0|||
125128782|NCT01746017|450097647|FG006|Period 1|Withdrawal by Subject|1|||
125128783|NCT01746017|450097648|FG007|Period 1|Withdrawal by Subject|0|||
125128784|NCT01746017|450097649|FG008|Period 1|Withdrawal by Subject|0|||
125128785|NCT01746017|450097650|FG009|Period 1|Withdrawal by Subject|0|||
125128786|NCT01746017|450097651|FG010|Period 1|Withdrawal by Subject|0|||
125128787|NCT01746017|450097641|FG000|Period 3|Withdrawal by Subject|0|||
125128788|NCT01746017|450097642|FG001|Period 3|Withdrawal by Subject|0|||
125435825|NCT00926003|451222079|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
125629239|NCT00249795|451924595|FG000|Overall Study|Physician withdrew consent|71|||
125629240|NCT00249795|451924596|FG001|Overall Study|Physician withdrew consent|63|||
125629241|NCT00249795|451924595|FG000|Overall Study|Surgery / procedure|4|||
125629242|NCT00249795|451924596|FG001|Overall Study|Surgery / procedure|5|||
125629243|NCT00249795|451924595|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
125629244|NCT00249795|451924596|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
125629245|NCT00249795|451924595|FG000|Overall Study|Lightheadedness / dizziness|15|||
125629246|NCT00249795|451924596|FG001|Overall Study|Lightheadedness / dizziness|11|||
125629247|NCT00249795|451924595|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
125629248|NCT00249795|451924596|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
125629249|NCT00249795|451924595|FG000|Overall Study|Other contraindicated medication|1|||
125629250|NCT00249795|451924596|FG001|Overall Study|Other contraindicated medication|1|||
125629251|NCT00249795|451924595|FG000|Overall Study|Event related to cardiac condition|17|||
125629252|NCT00249795|451924596|FG001|Overall Study|Event related to cardiac condition|16|||
125629253|NCT00249795|451924595|FG000|Overall Study|Patient not wish to continue after May08|4|||
125629254|NCT00249795|451924596|FG001|Overall Study|Patient not wish to continue after May08|6|||
125629255|NCT00249795|451924595|FG000|Overall Study|Site not agree to continue after May08|1|||
125629256|NCT00249795|451924596|FG001|Overall Study|Site not agree to continue after May08|1|||
125629257|NCT00249795|451924595|FG000|Overall Study|Lost to Follow-up|0|||
125629258|NCT00249795|451924596|FG001|Overall Study|Lost to Follow-up|2|||
125629259|NCT00249795|451924595|FG000|Overall Study|Missing|0|||
125629260|NCT00249795|451924596|FG001|Overall Study|Missing|1|||
125128789|NCT01746017|450097643|FG002|Period 3|Withdrawal by Subject|0|||
125128790|NCT01746017|450097644|FG003|Period 3|Withdrawal by Subject|0|||
125128791|NCT01746017|450097645|FG004|Period 3|Withdrawal by Subject|0|||
125128792|NCT01746017|450097646|FG005|Period 3|Withdrawal by Subject|1|||
125128793|NCT01746017|450097647|FG006|Period 3|Withdrawal by Subject|0|||
125128794|NCT01746017|450097648|FG007|Period 3|Withdrawal by Subject|0|||
125128795|NCT01746017|450097649|FG008|Period 3|Withdrawal by Subject|0|||
125128796|NCT01746017|450097650|FG009|Period 3|Withdrawal by Subject|0|||
125128797|NCT01746017|450097651|FG010|Period 3|Withdrawal by Subject|0|||
125215728|NCT00893971|450417500|FG000|Overall Study|Physician Decision|3|||
125128798|NCT00397488|450097652|FG000|Overall Study|Withdrawal by Subject|3|||
125128799|NCT00397488|450097652|FG000|Overall Study|Adverse Event|3|||
125128800|NCT00397488|450097652|FG000|Overall Study|Death|1|||
125128801|NCT01215981|450097655|FG000|Overall Study|Physician Decision|0|||
125128802|NCT01215981|450097656|FG001|Overall Study|Physician Decision|1|||
125128803|NCT01215981|450097655|FG000|Overall Study|Protocol Violation|1|||
125128804|NCT01215981|450097656|FG001|Overall Study|Protocol Violation|0|||
125128805|NCT01215981|450097655|FG000|Overall Study|Withdrawal by Subject|1|||
125128806|NCT01215981|450097656|FG001|Overall Study|Withdrawal by Subject|0|||
125128807|NCT03075761|450097657|FG000|Overall Study|Lost to Follow-up|1|||
125128808|NCT03075761|450097658|FG001|Overall Study|Lost to Follow-up|6|||
125128809|NCT00840632|450097662|FG000|First Intervention|Withdrawal by Subject|0|||
125128810|NCT00840632|450097663|FG001|First Intervention|Withdrawal by Subject|1|||
125128811|NCT00840632|450097662|FG000|Washout|Withdrawal by Subject|1|||
125128812|NCT00840632|450097663|FG001|Washout|Withdrawal by Subject|1|||
125128813|NCT01294787|450097664|FG000|Period 1|Adverse Event|0|||
125128814|NCT01294787|450097665|FG001|Period 1|Adverse Event|0|||
125128815|NCT01294787|450097666|FG002|Period 1|Adverse Event|0|||
125128816|NCT01294787|450097667|FG003|Period 1|Adverse Event|0|||
125375907|NCT00660023|451007622|FG000|Overall Study|Death|8|||
125375908|NCT00660023|451007622|FG000|Overall Study|Blood Transfusion|5|||
125375909|NCT00660023|451007622|FG000|Overall Study|Renal Transplantation|3|||
125375910|NCT00660023|451007622|FG000|Overall Study|Withdrawal by Subject|1|||
125375911|NCT00660023|451007622|FG000|Overall Study|Missed Pregnancy Test|1|||
125375912|NCT00660023|451007622|FG000|Overall Study|Other Screening Failure|9|||
125375913|NCT03506815|451007623|FG000|Overall Study|Adverse Event|8|||
125375914|NCT03506815|451007624|FG001|Overall Study|Adverse Event|0|||
125375915|NCT03506815|451007623|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
125375916|NCT03506815|451007624|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
125375917|NCT03506815|451007623|FG000|Overall Study|Protocol Violation|1|||
125375918|NCT03506815|451007624|FG001|Overall Study|Protocol Violation|0|||
125375919|NCT03506815|451007623|FG000|Overall Study|Elective Surgery|1|||
125629261|NCT02460978|451924598|FG000|Overall Study|Adverse Event|17|||
125629262|NCT02460978|451924599|FG001|Overall Study|Adverse Event|11|||
125629263|NCT02460978|451924600|FG002|Overall Study|Adverse Event|11|||
125629264|NCT02460978|451924598|FG000|Overall Study|Withdrawal by Subject|5|||
125629265|NCT02460978|451924599|FG001|Overall Study|Withdrawal by Subject|5|||
125629266|NCT02460978|451924600|FG002|Overall Study|Withdrawal by Subject|14|||
125629267|NCT02460978|451924598|FG000|Overall Study|Lost to Follow-up|2|||
125629268|NCT02460978|451924599|FG001|Overall Study|Lost to Follow-up|3|||
125629269|NCT02460978|451924600|FG002|Overall Study|Lost to Follow-up|1|||
125629270|NCT02460978|451924598|FG000|Overall Study|Protocol Violation|1|||
125629271|NCT02460978|451924599|FG001|Overall Study|Protocol Violation|1|||
125629272|NCT02460978|451924600|FG002|Overall Study|Protocol Violation|1|||
125629273|NCT02460978|451924598|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
125629274|NCT02460978|451924599|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
125629275|NCT02460978|451924600|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
125629276|NCT02460978|451924598|FG000|Overall Study|Pregnancy|0|||
125629277|NCT02460978|451924599|FG001|Overall Study|Pregnancy|0|||
125629278|NCT02460978|451924600|FG002|Overall Study|Pregnancy|2|||
125629279|NCT03549429|451924603|FG000|Overall Study|Protocol Violation|5|||
125629280|NCT03549429|451924604|FG001|Overall Study|Protocol Violation|3|||
125629281|NCT00588523|451924608|FG000|Overall Study|Not treated|3|||
125629282|NCT03032510|451924609|FG000|Overall Study|Adverse Event|5|||
125629283|NCT03032510|451924610|FG001|Overall Study|Adverse Event|2|||
125629284|NCT03032510|451924609|FG000|Overall Study|Lost to Follow-up|8|||
125629285|NCT03032510|451924610|FG001|Overall Study|Lost to Follow-up|7|||
125128817|NCT01294787|450097668|FG004|Period 1|Adverse Event|1|||
125128818|NCT01294787|450097669|FG005|Period 1|Adverse Event|0|||
125128819|NCT01294787|450097664|FG000|Period 1|Withdrawal by Subject|0|||
125375920|NCT03506815|451007624|FG001|Overall Study|Elective Surgery|0|||
125375921|NCT04160091|451007625|FG000|Overall Study|Terminated by Sponsor|7|||
125375922|NCT04160091|451007626|FG001|Overall Study|Terminated by Sponsor|3|||
125629286|NCT03032510|451924609|FG000|Overall Study|Withdrawal by Subject|8|||
125629287|NCT03032510|451924610|FG001|Overall Study|Withdrawal by Subject|7|||
125629288|NCT03032510|451924609|FG000|Overall Study|Subject noncompliance|4|||
125629289|NCT03032510|451924610|FG001|Overall Study|Subject noncompliance|2|||
125629290|NCT03032510|451924609|FG000|Overall Study|Physician Decision|2|||
125629291|NCT03032510|451924610|FG001|Overall Study|Physician Decision|0|||
125629292|NCT02431702|451926080|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
125629293|NCT02431702|451926081|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
125629294|NCT02431702|451926082|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
125629295|NCT02431702|451926083|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
125629296|NCT02431702|451926084|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
125128820|NCT01294787|450097665|FG001|Period 1|Withdrawal by Subject|0|||
125128821|NCT01294787|450097666|FG002|Period 1|Withdrawal by Subject|0|||
125128822|NCT01294787|450097667|FG003|Period 1|Withdrawal by Subject|1|||
125128823|NCT01294787|450097668|FG004|Period 1|Withdrawal by Subject|1|||
125375923|NCT04160091|451007627|FG002|Overall Study|Terminated by Sponsor|5|||
125375924|NCT04160091|451007628|FG003|Overall Study|Terminated by Sponsor|2|||
125629297|NCT02431702|451926085|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
125629298|NCT02431702|451926086|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
125629299|NCT02431702|451926080|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
125629300|NCT02431702|451926081|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
125629301|NCT02431702|451926082|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
125629302|NCT02431702|451926083|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
125629303|NCT02431702|451926084|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
125629304|NCT02431702|451926085|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
125629305|NCT02431702|451926086|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
125629306|NCT02431702|451926080|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
125629307|NCT02431702|451926081|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
125629308|NCT02431702|451926082|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
125629309|NCT02431702|451926083|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
125629310|NCT02431702|451926084|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
125629311|NCT02431702|451926085|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
125629312|NCT02431702|451926086|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
125629313|NCT02431702|451926080|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
125629314|NCT02431702|451926081|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
125629315|NCT02431702|451926082|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
125629316|NCT02431702|451926083|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
125629317|NCT02431702|451926084|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
125629318|NCT02431702|451926085|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
125629319|NCT02431702|451926086|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
125629320|NCT02431702|451926080|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
125629321|NCT02431702|451926081|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
125629322|NCT02431702|451926082|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
125629323|NCT02431702|451926083|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
125629324|NCT02431702|451926084|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
125629325|NCT02431702|451926085|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
125629326|NCT02431702|451926086|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
125629327|NCT02431702|451926080|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
125629328|NCT02431702|451926081|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
125629329|NCT02431702|451926082|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
125629330|NCT02431702|451926083|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
125629331|NCT02431702|451926084|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
125629332|NCT02431702|451926085|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
125629333|NCT02431702|451926086|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
125629334|NCT02431702|451926080|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
125629335|NCT02431702|451926081|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
125629336|NCT02431702|451926082|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
125629337|NCT02431702|451926083|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
125629338|NCT02431702|451926084|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
125629339|NCT02431702|451926085|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
125629340|NCT02431702|451926086|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
125629341|NCT02431702|451926080|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
125629342|NCT02431702|451926081|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
125629343|NCT02431702|451926082|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
125629344|NCT02431702|451926083|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
125629345|NCT02431702|451926084|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
125629346|NCT02431702|451926085|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
125629347|NCT02431702|451926086|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
125629348|NCT02431702|451926080|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
125629349|NCT02431702|451926081|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
125629350|NCT02431702|451926082|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
125629351|NCT02431702|451926083|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
125629352|NCT02431702|451926084|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
125629353|NCT02431702|451926085|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
125629354|NCT02431702|451926086|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
125629355|NCT02431702|451926080|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
125629356|NCT02431702|451926081|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
125629357|NCT02431702|451926082|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
125128824|NCT01294787|450097669|FG005|Period 1|Withdrawal by Subject|1|||
125375925|NCT04160091|451007625|FG000|Overall Study|Noncompliance|0|||
125128825|NCT01294787|450097664|FG000|Period 1|Administrative problem|0|||
125128826|NCT01294787|450097665|FG001|Period 1|Administrative problem|0|||
125128827|NCT01294787|450097666|FG002|Period 1|Administrative problem|1|||
125128828|NCT01294787|450097667|FG003|Period 1|Administrative problem|0|||
125128829|NCT01294787|450097668|FG004|Period 1|Administrative problem|0|||
125128830|NCT01294787|450097669|FG005|Period 1|Administrative problem|1|||
125128831|NCT01294787|450097664|FG000|Period 2|Adverse Event|0|||
125128832|NCT01294787|450097665|FG001|Period 2|Adverse Event|3|||
125128833|NCT01294787|450097666|FG002|Period 2|Adverse Event|0|||
125128834|NCT01294787|450097667|FG003|Period 2|Adverse Event|1|||
125128835|NCT01294787|450097668|FG004|Period 2|Adverse Event|0|||
125128836|NCT01294787|450097669|FG005|Period 2|Adverse Event|0|||
125128837|NCT01294787|450097664|FG000|Period 2|No longer needs study drug|0|||
125128838|NCT01294787|450097665|FG001|Period 2|No longer needs study drug|0|||
125128839|NCT01294787|450097666|FG002|Period 2|No longer needs study drug|0|||
125128840|NCT01294787|450097667|FG003|Period 2|No longer needs study drug|1|||
125128841|NCT01294787|450097668|FG004|Period 2|No longer needs study drug|0|||
125128842|NCT01294787|450097669|FG005|Period 2|No longer needs study drug|0|||
125128843|NCT01294787|450097664|FG000|Period 3|Adverse Event|0|||
125128844|NCT01294787|450097665|FG001|Period 3|Adverse Event|0|||
125128845|NCT01294787|450097666|FG002|Period 3|Adverse Event|0|||
125128846|NCT01294787|450097667|FG003|Period 3|Adverse Event|0|||
125128847|NCT01294787|450097668|FG004|Period 3|Adverse Event|1|||
125128848|NCT01294787|450097669|FG005|Period 3|Adverse Event|0|||
125128849|NCT01725529|450097670|FG000|Overall Study|Adverse Event|1|||
125128850|NCT01725529|450097671|FG001|Overall Study|Adverse Event|0|||
125128851|NCT01725529|450097672|FG002|Overall Study|Adverse Event|0|||
125375926|NCT04160091|451007626|FG001|Overall Study|Noncompliance|0|||
125375927|NCT04160091|451007627|FG002|Overall Study|Noncompliance|0|||
125629358|NCT02431702|451926083|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
125629359|NCT02431702|451926084|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
125629360|NCT02431702|451926085|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
125629361|NCT02431702|451926086|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
125629362|NCT02431702|451926080|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
125629363|NCT02431702|451926081|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
125629364|NCT02431702|451926082|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
125629365|NCT02431702|451926083|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
125629366|NCT02431702|451926084|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
125629367|NCT02431702|451926085|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
125629368|NCT02431702|451926086|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
125629369|NCT02431702|451926080|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
125629370|NCT02431702|451926081|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
125629371|NCT02431702|451926082|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
125629372|NCT02431702|451926083|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
125629373|NCT02431702|451926084|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
125629374|NCT02431702|451926085|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
125629375|NCT02431702|451926086|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
125629376|NCT02431702|451926080|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
125629377|NCT02431702|451926081|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
125629378|NCT02431702|451926082|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
125629379|NCT02431702|451926083|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
125629380|NCT02431702|451926084|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
125629381|NCT02431702|451926085|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
125629382|NCT02431702|451926086|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
125629383|NCT02431702|451926080|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
125629384|NCT02431702|451926081|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
125629385|NCT02431702|451926082|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
125629386|NCT02431702|451926083|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
125629387|NCT02431702|451926084|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
125629388|NCT02431702|451926085|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
125128852|NCT01725529|450097670|FG000|Overall Study|Lost to Follow-up|2|||
125375928|NCT04160091|451007628|FG003|Overall Study|Noncompliance|1|||
125128853|NCT01725529|450097671|FG001|Overall Study|Lost to Follow-up|1|||
125128854|NCT01725529|450097672|FG002|Overall Study|Lost to Follow-up|1|||
125128855|NCT01725529|450097670|FG000|Overall Study|Protocol Violation|0|||
125128856|NCT01725529|450097671|FG001|Overall Study|Protocol Violation|1|||
125128857|NCT01725529|450097672|FG002|Overall Study|Protocol Violation|1|||
125128858|NCT01725529|450097670|FG000|Overall Study|Withdrawal by Subject|12|||
125128859|NCT01725529|450097671|FG001|Overall Study|Withdrawal by Subject|14|||
125128860|NCT01725529|450097672|FG002|Overall Study|Withdrawal by Subject|8|||
125128861|NCT01948258|450097677|FG000|Overall Study|Pregnancy|41|||
125128862|NCT01948258|450097677|FG000|Overall Study|Did not complete by cut-off date|35|||
125128863|NCT01948258|450097677|FG000|Overall Study|Lost to Follow-up|27|||
125128864|NCT01948258|450097677|FG000|Overall Study|Withdrawal by SPD|8|||
125128865|NCT01948258|450097677|FG000|Overall Study|Withdrawal by Subject|6|||
125128866|NCT01948258|450097677|FG000|Overall Study|Health Care Professional|43|||
125128867|NCT01948258|450097677|FG000|Overall Study|Removed from statistical analysis|2|||
125128868|NCT02262377|450097678|FG000|Overall Study|Lost to Follow-up|5|||
125128869|NCT02262377|450097679|FG001|Overall Study|Lost to Follow-up|6|||
125128870|NCT02262377|450097678|FG000|Overall Study|Found ineligible after enrollment|3|||
125128871|NCT02262377|450097679|FG001|Overall Study|Found ineligible after enrollment|0|||
125128872|NCT02262377|450097678|FG000|Overall Study|Withdrawal by Subject|4|||
125128873|NCT02262377|450097679|FG001|Overall Study|Withdrawal by Subject|0|||
125128874|NCT00723528|450097683|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
125375929|NCT04160091|451007625|FG000|Overall Study|Withdrawal by Subject|0|||
125375930|NCT04160091|451007626|FG001|Overall Study|Withdrawal by Subject|0|||
125629389|NCT02431702|451926086|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
125629390|NCT02431702|451926080|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
125629391|NCT02431702|451926081|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
125629392|NCT02431702|451926082|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
125629393|NCT02431702|451926083|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
125629394|NCT02431702|451926084|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
125629395|NCT02431702|451926085|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
125629396|NCT02431702|451926086|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
125629397|NCT02809118|451926087|FG000|Overall Study|Withdrawal by Subject|0|||
125629398|NCT02809118|451926088|FG001|Overall Study|Withdrawal by Subject|1|||
125629399|NCT02809118|451926089|FG002|Overall Study|Withdrawal by Subject|1|||
125629400|NCT02408484|451926090|FG000|Overall Study|Withdrawal by Subject|3|||
125629401|NCT02408484|451926090|FG000|Overall Study|Not treated during study period|1|||
125629402|NCT03805971|451926092|FG000|Overall Study|Withdrawal by Subject|1|||
125629403|NCT03805971|451926092|FG000|Overall Study|Protocol Violation|2|||
125629404|NCT00517413|451926093|FG000|Overall Study|Adverse Event|7|||
125629405|NCT00517413|451926093|FG000|Overall Study|Death|13|||
125629406|NCT00517413|451926093|FG000|Overall Study|Protocol Violation|15|||
125629407|NCT00517413|451926093|FG000|Overall Study|Withdrawal by Subject|2|||
125629408|NCT00517413|451926093|FG000|Overall Study|Failure to return|1|||
125629409|NCT00517413|451926093|FG000|Overall Study|Other-Reasons|23|||
125629410|NCT01355497|451926094|FG000|Overall Study|Death|19|||
125629411|NCT01355497|451926095|FG001|Overall Study|Death|18|||
125629412|NCT01355497|451926094|FG000|Overall Study|Lost to Follow-up|3|||
125629413|NCT01355497|451926095|FG001|Overall Study|Lost to Follow-up|0|||
125629414|NCT01355497|451926094|FG000|Overall Study|Protocol Violation|0|||
125629415|NCT01355497|451926095|FG001|Overall Study|Protocol Violation|1|||
125629416|NCT01355497|451926094|FG000|Overall Study|other-not provided|9|||
125629417|NCT01355497|451926095|FG001|Overall Study|other-not provided|4|||
125629418|NCT01355497|451926094|FG000|Overall Study|Withdrawal by Subject|12|||
125629419|NCT01355497|451926095|FG001|Overall Study|Withdrawal by Subject|20|||
125629420|NCT01355497|451926094|FG000|Overall Study|noncompliance|1|||
125629421|NCT01355497|451926095|FG001|Overall Study|noncompliance|2|||
125629422|NCT01355497|451926094|FG000|Overall Study|progressive disease|11|||
125629423|NCT01355497|451926095|FG001|Overall Study|progressive disease|8|||
125629424|NCT01355497|451926094|FG000|Overall Study|Adverse Event|11|||
125629425|NCT01355497|451926095|FG001|Overall Study|Adverse Event|10|||
125629426|NCT00441727|451926102|FG000|Overall Study|Protocol Violation|19|||
125629427|NCT00441727|451926103|FG001|Overall Study|Protocol Violation|28|||
125629428|NCT00441727|451926104|FG002|Overall Study|Protocol Violation|32|||
125629429|NCT00441727|451926102|FG000|Overall Study|Adverse Event|26|||
125629430|NCT00441727|451926103|FG001|Overall Study|Adverse Event|33|||
125629431|NCT00441727|451926104|FG002|Overall Study|Adverse Event|28|||
125629432|NCT00441727|451926102|FG000|Overall Study|Lack of Efficacy|7|||
125629433|NCT00441727|451926103|FG001|Overall Study|Lack of Efficacy|8|||
125629434|NCT00441727|451926104|FG002|Overall Study|Lack of Efficacy|48|||
125629435|NCT00441727|451926102|FG000|Overall Study|Withdrawal by Subject|40|||
125629436|NCT00441727|451926103|FG001|Overall Study|Withdrawal by Subject|34|||
125629437|NCT00441727|451926104|FG002|Overall Study|Withdrawal by Subject|47|||
125629438|NCT00441727|451926102|FG000|Overall Study|Lost to Follow-up|5|||
125629439|NCT00441727|451926103|FG001|Overall Study|Lost to Follow-up|6|||
125629440|NCT00441727|451926104|FG002|Overall Study|Lost to Follow-up|5|||
125629441|NCT00441727|451926102|FG000|Overall Study|Safety Reasons|3|||
125629442|NCT00441727|451926103|FG001|Overall Study|Safety Reasons|1|||
125629443|NCT00441727|451926104|FG002|Overall Study|Safety Reasons|3|||
125128875|NCT00723528|450097684|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
125128876|NCT00723528|450097685|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
125629444|NCT00441727|451926102|FG000|Overall Study|Various reason specified|6|||
125629445|NCT00441727|451926103|FG001|Overall Study|Various reason specified|8|||
125629446|NCT00441727|451926104|FG002|Overall Study|Various reason specified|5|||
125629447|NCT01237223|451926111|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
125629448|NCT01237223|451926112|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
125629449|NCT01237223|451926113|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
125629450|NCT01237223|451926114|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
125629451|NCT01237223|451926115|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
125629452|NCT01237223|451926116|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
125629453|NCT01237223|451926111|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
125629454|NCT01237223|451926112|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
125629455|NCT01237223|451926113|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
125629456|NCT01237223|451926114|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
125629457|NCT01237223|451926115|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
125629458|NCT01237223|451926116|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
125629459|NCT01237223|451926111|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
125629460|NCT01237223|451926112|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
125629461|NCT01237223|451926113|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
125629462|NCT01237223|451926114|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
125629463|NCT01237223|451926115|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
125629464|NCT01237223|451926116|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
125629465|NCT01237223|451926111|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
125629466|NCT01237223|451926112|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
125629467|NCT01237223|451926113|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
125629468|NCT01237223|451926114|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
125629469|NCT01237223|451926115|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
125629470|NCT01237223|451926116|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
125629471|NCT01237223|451926111|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
125629472|NCT01237223|451926112|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
125629473|NCT01237223|451926113|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
125629474|NCT01237223|451926114|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
125629475|NCT01237223|451926115|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
125629476|NCT01237223|451926116|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
125629477|NCT01237223|451926111|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
125629478|NCT01237223|451926112|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
125629479|NCT01237223|451926113|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
125629480|NCT01237223|451926114|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
125629481|NCT01237223|451926115|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
125629482|NCT01237223|451926116|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
125629483|NCT01237223|451926111|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
125629484|NCT01237223|451926112|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
125629485|NCT01237223|451926113|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
125629486|NCT01237223|451926114|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
125629487|NCT01237223|451926115|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
125629488|NCT01237223|451926116|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
125629489|NCT01237223|451926111|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
125629490|NCT01237223|451926112|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
125629491|NCT01237223|451926113|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
125629492|NCT01237223|451926114|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
125629493|NCT01237223|451926115|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
125629494|NCT01237223|451926116|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
125629495|NCT01237223|451926111|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
125629496|NCT01237223|451926112|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
125629497|NCT01237223|451926113|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
125629498|NCT01237223|451926114|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
125629499|NCT01237223|451926115|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
125629500|NCT01237223|451926116|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
125629501|NCT01237223|451926111|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
125629502|NCT01237223|451926112|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
125629503|NCT01237223|451926113|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
125629504|NCT01237223|451926114|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
125629505|NCT01237223|451926115|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
125629506|NCT01237223|451926116|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
125629507|NCT00407550|451926123|FG000|Overall Study|Adverse Event|0|||
125629508|NCT00407550|451926124|FG001|Overall Study|Adverse Event|1|||
125629509|NCT00407550|451926123|FG000|Overall Study|Withdrawal by Subject|0|||
125215729|NCT00492232|450417501|FG000|Placebo Run-in|Adverse Event|0|||
125128877|NCT00723528|450097686|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
125128878|NCT00723528|450097687|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
125128879|NCT00723528|450097688|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
125128880|NCT00723528|450097689|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
125128881|NCT00723528|450097683|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
125128882|NCT00723528|450097684|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
125128883|NCT00723528|450097685|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
125128884|NCT00723528|450097686|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
125128885|NCT00723528|450097687|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
125629510|NCT00407550|451926124|FG001|Overall Study|Withdrawal by Subject|2|||
125629511|NCT00407550|451926123|FG000|Overall Study|Death|1|||
125629512|NCT00407550|451926124|FG001|Overall Study|Death|0|||
125629513|NCT00407550|451926123|FG000|Overall Study|Insurance or Other medical condition|2|||
125629514|NCT00407550|451926124|FG001|Overall Study|Insurance or Other medical condition|1|||
125629515|NCT00443846|451926125|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
125629516|NCT00443846|451926126|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
125629517|NCT00443846|451926125|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
125629518|NCT00443846|451926126|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
125629519|NCT00443846|451926125|FG000|Overall Study|Adverse Event|0|||
125629520|NCT00443846|451926126|FG001|Overall Study|Adverse Event|1|||
125629521|NCT00443846|451926125|FG000|Overall Study|Personal reason|8|||
125629522|NCT00443846|451926126|FG001|Overall Study|Personal reason|3|||
125629523|NCT00443846|451926125|FG000|Overall Study|Lost to Follow-up|1|||
125629524|NCT00443846|451926126|FG001|Overall Study|Lost to Follow-up|2|||
125629525|NCT00641706|451926128|FG000|Overall Study|Adverse Event|2|||
125629526|NCT00641706|451926129|FG001|Overall Study|Adverse Event|1|||
125629527|NCT00641706|451926128|FG000|Overall Study|Withdrawal by Subject|6|||
125629528|NCT00641706|451926129|FG001|Overall Study|Withdrawal by Subject|1|||
125629529|NCT00641706|451926128|FG000|Overall Study|Clinical Decline|1|||
125629530|NCT00641706|451926129|FG001|Overall Study|Clinical Decline|0|||
125629531|NCT00641706|451926128|FG000|Overall Study|Lead Investigator Decision|0|||
125629532|NCT00641706|451926129|FG001|Overall Study|Lead Investigator Decision|1|||
125629533|NCT01599806|451926132|FG000|Overall Study|Lost to Follow-up|20|||
125629534|NCT01599806|451926133|FG001|Overall Study|Lost to Follow-up|20|||
125629535|NCT01599806|451926132|FG000|Overall Study|Withdrawal by Subject|12|||
125629536|NCT01599806|451926133|FG001|Overall Study|Withdrawal by Subject|12|||
125629537|NCT01599806|451926132|FG000|Overall Study|Other Eligibility criteria|11|||
125629538|NCT01599806|451926133|FG001|Overall Study|Other Eligibility criteria|9|||
125629539|NCT00391807|451926135|FG000|Overall Study|Did not receive study medication|23|||
125629540|NCT00391807|451926135|FG000|Overall Study|Adverse Event|177|||
125629541|NCT00391807|451926135|FG000|Overall Study|Pregnancy|25|||
125629542|NCT00391807|451926135|FG000|Overall Study|Lost to Follow-up|227|||
125629543|NCT00391807|451926135|FG000|Overall Study|Withdrawal by Subject|147|||
125629544|NCT00391807|451926135|FG000|Overall Study|Protocol Violation|20|||
125629545|NCT00391807|451926135|FG000|Overall Study|Various|96|||
125629546|NCT01266070|451926136|FG000|Overall Study|Adverse Event|3|||
125629547|NCT01266070|451926136|FG000|Overall Study|Protocol Violation|1|||
125629548|NCT01585168|451926137|FG000|Overall Study|Lost to Follow-up|3|||
125629549|NCT01585168|451926138|FG001|Overall Study|Lost to Follow-up|1|||
125629550|NCT01585168|451926139|FG002|Overall Study|Lost to Follow-up|1|||
125629551|NCT01585168|451926140|FG003|Overall Study|Lost to Follow-up|1|||
125629552|NCT01194414|451926141|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
125629553|NCT01194414|451926142|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
125629554|NCT01194414|451926143|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
125629555|NCT01194414|451926144|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
125629556|NCT01194414|451926141|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
125629557|NCT01194414|451926142|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
125629558|NCT01194414|451926143|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
125629559|NCT01194414|451926144|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
125629560|NCT01194414|451926141|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
125128886|NCT00723528|450097688|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
125128887|NCT00723528|450097689|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
125629561|NCT01194414|451926142|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
125629562|NCT01194414|451926143|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
125629563|NCT01194414|451926144|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
125629564|NCT01194414|451926141|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
125629565|NCT01194414|451926142|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
125629566|NCT01194414|451926143|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
125629567|NCT01194414|451926144|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
125629568|NCT01194414|451926141|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
125629569|NCT01194414|451926142|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
125215730|NCT00492232|450417502|FG001|Placebo Run-in|Adverse Event|2|||
125375931|NCT04160091|451007627|FG002|Overall Study|Withdrawal by Subject|0|||
125629570|NCT01194414|451926143|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
125629571|NCT01194414|451926144|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
125629572|NCT01194414|451926141|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
125629573|NCT01194414|451926142|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
125629574|NCT01194414|451926143|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
125629575|NCT01194414|451926144|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
125629576|NCT01194414|451926141|FG000|24 Weeks Double Blind Period|Other|0|||
125629577|NCT01194414|451926142|FG001|24 Weeks Double Blind Period|Other|1|||
125629578|NCT01194414|451926143|FG002|24 Weeks Double Blind Period|Other|0|||
125629579|NCT01194414|451926144|FG003|24 Weeks Double Blind Period|Other|0|||
125629580|NCT01194414|451926141|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
125629581|NCT01194414|451926142|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
125629582|NCT01194414|451926143|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
125629583|NCT01194414|451926144|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
125629584|NCT01194414|451926141|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
125629585|NCT01194414|451926142|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
125629586|NCT01194414|451926143|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
125629587|NCT01194414|451926144|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
125629588|NCT01194414|451926141|FG000|24 Weeks Double Blind Period|Death|0|||
125629589|NCT01194414|451926142|FG001|24 Weeks Double Blind Period|Death|1|||
125629590|NCT01194414|451926143|FG002|24 Weeks Double Blind Period|Death|0|||
125629591|NCT01194414|451926144|FG003|24 Weeks Double Blind Period|Death|0|||
125629592|NCT01194414|451926141|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
125629593|NCT01194414|451926142|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
125629594|NCT01194414|451926143|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
125629595|NCT01194414|451926144|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
125629596|NCT01194414|451926141|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
125629597|NCT01194414|451926142|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
125629598|NCT01194414|451926143|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
125629599|NCT01194414|451926144|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
125629600|NCT01194414|451926141|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
125629601|NCT01194414|451926142|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
125629602|NCT01194414|451926143|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
125629603|NCT01194414|451926144|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
125629604|NCT01194414|451926141|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
125629605|NCT01194414|451926142|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
125629606|NCT01194414|451926143|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
125629607|NCT01194414|451926144|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
125629608|NCT01194414|451926141|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
125629609|NCT01194414|451926142|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
125629610|NCT01194414|451926143|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
125629611|NCT01194414|451926144|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
125629612|NCT01194414|451926141|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
125629613|NCT01194414|451926142|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
125629614|NCT01194414|451926143|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
125629615|NCT01194414|451926144|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
125629616|NCT01194414|451926141|FG000|72 Weeks Open Label Extension|Other|2|||
125375932|NCT04160091|451007628|FG003|Overall Study|Withdrawal by Subject|1|||
125629617|NCT01194414|451926142|FG001|72 Weeks Open Label Extension|Other|1|||
125629618|NCT01194414|451926143|FG002|72 Weeks Open Label Extension|Other|0|||
125629619|NCT01194414|451926144|FG003|72 Weeks Open Label Extension|Other|0|||
125629620|NCT01194414|451926141|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
125629621|NCT01194414|451926142|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
125629622|NCT01194414|451926143|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
125629623|NCT01194414|451926144|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
125629624|NCT01194414|451926141|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
125629625|NCT01194414|451926142|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
125629626|NCT01194414|451926143|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
125629627|NCT01194414|451926144|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
125629628|NCT01194414|451926141|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
125629629|NCT01194414|451926142|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
125629630|NCT01194414|451926143|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
125629631|NCT01194414|451926144|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
125629632|NCT01194414|451926141|FG000|72 Weeks Open Label Extension|Death|1|||
125629633|NCT01194414|451926142|FG001|72 Weeks Open Label Extension|Death|2|||
125629634|NCT01194414|451926143|FG002|72 Weeks Open Label Extension|Death|0|||
125629635|NCT01194414|451926144|FG003|72 Weeks Open Label Extension|Death|2|||
125629636|NCT00770224|451926153|FG000|Step 1: Induction|Adverse Event|3|||
125629637|NCT00770224|451926154|FG001|Step 1: Induction|Adverse Event|0|||
125629638|NCT00770224|451926153|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
125629639|NCT00770224|451926154|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
125629640|NCT00770224|451926153|FG000|Step 1: Induction|Other reason not protocol specified|2|||
125629641|NCT00770224|451926154|FG001|Step 1: Induction|Other reason not protocol specified|0|||
125629642|NCT00770224|451926153|FG000|Step 1: Induction|Ineligible|2|||
125629643|NCT00770224|451926154|FG001|Step 1: Induction|Ineligible|0|||
125629644|NCT00770224|451926153|FG000|Step 1: Induction|No protocol treatment given|1|||
125629645|NCT00770224|451926154|FG001|Step 1: Induction|No protocol treatment given|0|||
125629646|NCT00770224|451926153|FG000|Step 2: Maintenance|Adverse Event|0|||
125629647|NCT00770224|451926154|FG001|Step 2: Maintenance|Adverse Event|10|||
125629648|NCT00770224|451926153|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
125629649|NCT00770224|451926154|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
125629650|NCT00770224|451926153|FG000|Step 2: Maintenance|Progression/relapse|0|||
125629651|NCT00770224|451926154|FG001|Step 2: Maintenance|Progression/relapse|1|||
125629652|NCT00770224|451926153|FG000|Step 2: Maintenance|Death|0|||
125629653|NCT00770224|451926154|FG001|Step 2: Maintenance|Death|2|||
125629654|NCT00770224|451926153|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
125629655|NCT00770224|451926154|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
125629656|NCT00770224|451926153|FG000|Step 2: Maintenance|Ineligible|0|||
125629657|NCT00770224|451926154|FG001|Step 2: Maintenance|Ineligible|2|||
125629658|NCT01505114|451926155|FG000|Overall Study|Withdrawal by Subject|5|||
125629659|NCT01505114|451926156|FG001|Overall Study|Withdrawal by Subject|4|||
125629660|NCT01505114|451926157|FG002|Overall Study|Withdrawal by Subject|4|||
125629661|NCT01505114|451926158|FG003|Overall Study|Withdrawal by Subject|7|||
125629662|NCT01505114|451926155|FG000|Overall Study|Death|1|||
125629663|NCT01505114|451926156|FG001|Overall Study|Death|0|||
125629664|NCT01505114|451926157|FG002|Overall Study|Death|0|||
125629665|NCT01505114|451926158|FG003|Overall Study|Death|1|||
125629666|NCT01505114|451926155|FG000|Overall Study|unable to adhere to visit schedule|3|||
125629667|NCT01505114|451926156|FG001|Overall Study|unable to adhere to visit schedule|2|||
125629668|NCT01505114|451926157|FG002|Overall Study|unable to adhere to visit schedule|3|||
125629669|NCT01505114|451926158|FG003|Overall Study|unable to adhere to visit schedule|3|||
125629670|NCT01505114|451926155|FG000|Overall Study|Lost to Follow-up|11|||
125629671|NCT01505114|451926156|FG001|Overall Study|Lost to Follow-up|5|||
125629672|NCT01505114|451926157|FG002|Overall Study|Lost to Follow-up|8|||
125629673|NCT01505114|451926158|FG003|Overall Study|Lost to Follow-up|7|||
125629674|NCT01505114|451926155|FG000|Overall Study|relocated|4|||
125629675|NCT01505114|451926156|FG001|Overall Study|relocated|2|||
125375933|NCT02899988|451007637|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
125375934|NCT02899988|451007638|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
125375935|NCT02899988|451007639|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125629676|NCT01505114|451926157|FG002|Overall Study|relocated|2|||
125629677|NCT01505114|451926158|FG003|Overall Study|relocated|3|||
125629678|NCT01505114|451926155|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
125629679|NCT01505114|451926156|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
125629680|NCT01505114|451926157|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
125629681|NCT01505114|451926158|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
125629682|NCT01505114|451926155|FG000|Overall Study|staff safety concerns|0|||
125629683|NCT01505114|451926156|FG001|Overall Study|staff safety concerns|0|||
125629684|NCT01505114|451926157|FG002|Overall Study|staff safety concerns|0|||
125629685|NCT01505114|451926158|FG003|Overall Study|staff safety concerns|1|||
125375936|NCT02899988|451007640|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125629686|NCT01505114|451926155|FG000|Overall Study|investigator decision|1|||
125128888|NCT00723528|450097683|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
125128889|NCT00723528|450097684|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
125128890|NCT00723528|450097685|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
125629687|NCT01505114|451926156|FG001|Overall Study|investigator decision|0|||
125629688|NCT01505114|451926157|FG002|Overall Study|investigator decision|1|||
125629689|NCT01505114|451926158|FG003|Overall Study|investigator decision|0|||
125629690|NCT01235507|451926159|FG000|Overall Study|Adverse Event|1|||
125629691|NCT01235507|451926159|FG000|Overall Study|Withdrawal by Subject|1|||
125629692|NCT01587274|451926163|FG000|Overall Study|Lost to Follow-up|4|||
125629693|NCT01587274|451926164|FG001|Overall Study|Lost to Follow-up|5|||
125629694|NCT01587274|451926165|FG002|Overall Study|Lost to Follow-up|3|||
125629695|NCT02475629|451926166|FG000|Overall Study|Adverse Event|1|||
125629696|NCT02475629|451926166|FG000|Overall Study|Death|4|||
125629697|NCT02475629|451926166|FG000|Overall Study|Physician Decision|1|||
125629698|NCT02475629|451926166|FG000|Overall Study|Withdrawal by Subject|1|||
125629699|NCT02475629|451926166|FG000|Overall Study|Lost to Follow-up|1|||
125629700|NCT02475629|451926166|FG000|Overall Study|Subject non-compliance|1|||
125629701|NCT01641081|451926172|FG000|Period 1|Sponsor request (potential unblinding)|0|||
125629702|NCT01641081|451926173|FG001|Period 1|Sponsor request (potential unblinding)|0|||
125629703|NCT01641081|451926174|FG002|Period 1|Sponsor request (potential unblinding)|0|||
125629704|NCT01641081|451926175|FG003|Period 1|Sponsor request (potential unblinding)|0|||
125629705|NCT01641081|451926176|FG004|Period 1|Sponsor request (potential unblinding)|0|||
125629706|NCT01641081|451926177|FG005|Period 1|Sponsor request (potential unblinding)|0|||
125629707|NCT01641081|451926178|FG006|Period 1|Sponsor request (potential unblinding)|1|||
125629708|NCT01641081|451926179|FG007|Period 1|Sponsor request (potential unblinding)|0|||
125629709|NCT01641081|451926180|FG008|Period 1|Sponsor request (potential unblinding)|0|||
125629710|NCT01641081|451926181|FG009|Period 1|Sponsor request (potential unblinding)|0|||
125629711|NCT01641081|451926172|FG000|Period 1|Protocol Violation|0|||
125629712|NCT01641081|451926173|FG001|Period 1|Protocol Violation|0|||
125629713|NCT01641081|451926174|FG002|Period 1|Protocol Violation|0|||
125629714|NCT01641081|451926175|FG003|Period 1|Protocol Violation|0|||
125629715|NCT01641081|451926176|FG004|Period 1|Protocol Violation|1|||
125629716|NCT01641081|451926177|FG005|Period 1|Protocol Violation|0|||
125629717|NCT01641081|451926178|FG006|Period 1|Protocol Violation|0|||
125629718|NCT01641081|451926179|FG007|Period 1|Protocol Violation|1|||
125629719|NCT01641081|451926180|FG008|Period 1|Protocol Violation|0|||
125629720|NCT01641081|451926181|FG009|Period 1|Protocol Violation|0|||
125629721|NCT01641081|451926172|FG000|Period 1|Adverse Event|1|||
125629722|NCT01641081|451926173|FG001|Period 1|Adverse Event|0|||
125629723|NCT01641081|451926174|FG002|Period 1|Adverse Event|0|||
125629724|NCT01641081|451926175|FG003|Period 1|Adverse Event|0|||
125629725|NCT01641081|451926176|FG004|Period 1|Adverse Event|0|||
125629726|NCT01641081|451926177|FG005|Period 1|Adverse Event|0|||
125629727|NCT01641081|451926178|FG006|Period 1|Adverse Event|0|||
125629728|NCT01641081|451926179|FG007|Period 1|Adverse Event|2|||
125629729|NCT01641081|451926180|FG008|Period 1|Adverse Event|0|||
125629730|NCT01641081|451926181|FG009|Period 1|Adverse Event|0|||
125629731|NCT01641081|451926172|FG000|Period 2|Adverse Event|0|||
125629732|NCT01641081|451926173|FG001|Period 2|Adverse Event|0|||
125629733|NCT01641081|451926174|FG002|Period 2|Adverse Event|0|||
125629734|NCT01641081|451926175|FG003|Period 2|Adverse Event|0|||
125629735|NCT01641081|451926176|FG004|Period 2|Adverse Event|0|||
125629736|NCT01641081|451926177|FG005|Period 2|Adverse Event|1|||
125629737|NCT01641081|451926178|FG006|Period 2|Adverse Event|0|||
125629738|NCT01641081|451926179|FG007|Period 2|Adverse Event|0|||
125629739|NCT01641081|451926180|FG008|Period 2|Adverse Event|0|||
125629740|NCT01641081|451926181|FG009|Period 2|Adverse Event|0|||
125629741|NCT01641081|451926172|FG000|Period 2|Withdrawal by Subject|0|||
125629742|NCT01641081|451926173|FG001|Period 2|Withdrawal by Subject|0|||
125629743|NCT01641081|451926174|FG002|Period 2|Withdrawal by Subject|0|||
125629744|NCT01641081|451926175|FG003|Period 2|Withdrawal by Subject|1|||
125629745|NCT01641081|451926176|FG004|Period 2|Withdrawal by Subject|0|||
125629746|NCT01641081|451926177|FG005|Period 2|Withdrawal by Subject|0|||
125629747|NCT01641081|451926178|FG006|Period 2|Withdrawal by Subject|2|||
125629748|NCT01641081|451926179|FG007|Period 2|Withdrawal by Subject|0|||
125629749|NCT01641081|451926180|FG008|Period 2|Withdrawal by Subject|0|||
125629750|NCT01641081|451926181|FG009|Period 2|Withdrawal by Subject|0|||
125629751|NCT01641081|451926172|FG000|Period 2|Protocol Violation|1|||
125629752|NCT01641081|451926173|FG001|Period 2|Protocol Violation|0|||
125629753|NCT01641081|451926174|FG002|Period 2|Protocol Violation|0|||
125629754|NCT01641081|451926175|FG003|Period 2|Protocol Violation|0|||
125629755|NCT01641081|451926176|FG004|Period 2|Protocol Violation|0|||
125629756|NCT01641081|451926177|FG005|Period 2|Protocol Violation|0|||
125629757|NCT01641081|451926178|FG006|Period 2|Protocol Violation|0|||
125629758|NCT01641081|451926179|FG007|Period 2|Protocol Violation|0|||
125215731|NCT00492232|450417501|FG000|Placebo Run-in|Protocol Violation|0|||
125629759|NCT01641081|451926180|FG008|Period 2|Protocol Violation|0|||
125629760|NCT01641081|451926181|FG009|Period 2|Protocol Violation|0|||
125629761|NCT01641081|451926172|FG000|Period 3|Adverse Event|0|||
125629762|NCT01641081|451926173|FG001|Period 3|Adverse Event|0|||
125375937|NCT02899988|451007641|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125629763|NCT01641081|451926174|FG002|Period 3|Adverse Event|1|||
125629764|NCT01641081|451926175|FG003|Period 3|Adverse Event|0|||
125629765|NCT01641081|451926176|FG004|Period 3|Adverse Event|0|||
125629766|NCT01641081|451926177|FG005|Period 3|Adverse Event|0|||
125629767|NCT01641081|451926178|FG006|Period 3|Adverse Event|0|||
125629768|NCT01641081|451926179|FG007|Period 3|Adverse Event|0|||
125629769|NCT01641081|451926180|FG008|Period 3|Adverse Event|0|||
125629770|NCT01641081|451926181|FG009|Period 3|Adverse Event|0|||
125629771|NCT01641081|451926172|FG000|Period 3|Withdrawal by Subject|0|||
125629772|NCT01641081|451926173|FG001|Period 3|Withdrawal by Subject|0|||
125629773|NCT01641081|451926174|FG002|Period 3|Withdrawal by Subject|0|||
125629774|NCT01641081|451926175|FG003|Period 3|Withdrawal by Subject|0|||
125629775|NCT01641081|451926176|FG004|Period 3|Withdrawal by Subject|0|||
125629776|NCT01641081|451926177|FG005|Period 3|Withdrawal by Subject|0|||
125629777|NCT01641081|451926178|FG006|Period 3|Withdrawal by Subject|0|||
125629778|NCT01641081|451926179|FG007|Period 3|Withdrawal by Subject|0|||
125629779|NCT01641081|451926180|FG008|Period 3|Withdrawal by Subject|1|||
125629780|NCT01641081|451926181|FG009|Period 3|Withdrawal by Subject|0|||
125629781|NCT01641081|451926172|FG000|Period 4|Adverse Event|0|||
125629782|NCT01641081|451926173|FG001|Period 4|Adverse Event|1|||
125629783|NCT01641081|451926174|FG002|Period 4|Adverse Event|0|||
125629784|NCT01641081|451926175|FG003|Period 4|Adverse Event|1|||
125629785|NCT01641081|451926176|FG004|Period 4|Adverse Event|0|||
125629786|NCT01641081|451926177|FG005|Period 4|Adverse Event|0|||
125629787|NCT01641081|451926178|FG006|Period 4|Adverse Event|0|||
125629788|NCT01641081|451926179|FG007|Period 4|Adverse Event|0|||
125629789|NCT01641081|451926180|FG008|Period 4|Adverse Event|0|||
125629790|NCT01641081|451926181|FG009|Period 4|Adverse Event|0|||
125629791|NCT01641081|451926172|FG000|Period 5|Adverse Event|0|||
125629792|NCT01641081|451926173|FG001|Period 5|Adverse Event|0|||
125629793|NCT01641081|451926174|FG002|Period 5|Adverse Event|2|||
125629794|NCT01641081|451926175|FG003|Period 5|Adverse Event|0|||
125629795|NCT01641081|451926176|FG004|Period 5|Adverse Event|0|||
125629796|NCT01641081|451926177|FG005|Period 5|Adverse Event|0|||
125629797|NCT01641081|451926178|FG006|Period 5|Adverse Event|0|||
125629798|NCT01641081|451926179|FG007|Period 5|Adverse Event|0|||
125629799|NCT01641081|451926180|FG008|Period 5|Adverse Event|0|||
125629800|NCT01641081|451926181|FG009|Period 5|Adverse Event|0|||
125629801|NCT01749800|451926185|FG000|Overall Study|not meeting inclusion criteria|3|||
125629802|NCT01749800|451926186|FG001|Overall Study|not meeting inclusion criteria|0|||
125629803|NCT01749800|451926187|FG002|Overall Study|not meeting inclusion criteria|0|||
125629804|NCT01749800|451926185|FG000|Overall Study|Withdrawal by Subject|0|||
125629805|NCT01749800|451926186|FG001|Overall Study|Withdrawal by Subject|1|||
125629806|NCT01749800|451926187|FG002|Overall Study|Withdrawal by Subject|0|||
125629807|NCT01000025|451926190|FG000|Overall Study|Adverse Event|43|||
125629808|NCT01000025|451926191|FG001|Overall Study|Adverse Event|2|||
125629809|NCT01000025|451926190|FG000|Overall Study|Withdrawal by Subject|13|||
125629810|NCT01000025|451926191|FG001|Overall Study|Withdrawal by Subject|8|||
125629811|NCT01000025|451926190|FG000|Overall Study|Death|23|||
125629812|NCT01000025|451926191|FG001|Overall Study|Death|13|||
125629813|NCT01000025|451926190|FG000|Overall Study|Lack of Efficacy|363|||
125629814|NCT01000025|451926191|FG001|Overall Study|Lack of Efficacy|208|||
125629815|NCT01000025|451926190|FG000|Overall Study|Intercurrent Illness|26|||
125629816|NCT01000025|451926191|FG001|Overall Study|Intercurrent Illness|7|||
125629817|NCT00422669|451926192|FG000|Overall Study|The study was terminated early.|98|||
125629818|NCT00422669|451926193|FG001|Overall Study|The study was terminated early.|100|||
125629819|NCT00422669|451926194|FG002|Overall Study|The study was terminated early.|7|||
125128891|NCT00723528|450097686|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
125128892|NCT00723528|450097687|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
125128893|NCT00723528|450097688|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
125128894|NCT00723528|450097689|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
125128895|NCT00723528|450097683|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
125128896|NCT00723528|450097684|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
125629820|NCT00996593|451926195|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
125629821|NCT00996593|451926195|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
125629822|NCT00996593|451926195|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
125629823|NCT00996593|451926195|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
125629824|NCT00996593|451926195|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
125629825|NCT00996593|451926195|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
125629826|NCT00996593|451926195|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
125629827|NCT00996593|451926195|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
125629828|NCT00996593|451926195|FG000|Long-Term Follow-Up|Site Closed|1|||
125629829|NCT02738580|451926197|FG000|Overall Study|Adverse Event|1|||
125629830|NCT02738580|451926198|FG001|Overall Study|Adverse Event|0|||
125629831|NCT02738580|451926197|FG000|Overall Study|Lack of Efficacy|3|||
125629832|NCT02738580|451926198|FG001|Overall Study|Lack of Efficacy|2|||
125629833|NCT02738580|451926197|FG000|Overall Study|Withdrawal by Subject|0|||
125128897|NCT00723528|450097685|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
125128898|NCT00723528|450097686|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
125128899|NCT00723528|450097687|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
125629834|NCT02738580|451926198|FG001|Overall Study|Withdrawal by Subject|1|||
125629835|NCT02738580|451926197|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
125629836|NCT02738580|451926198|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
125629837|NCT00741260|451926199|FG000|Overall Study|Disease Progression|3|||
125629838|NCT00741260|451926200|FG001|Overall Study|Disease Progression|5|||
125629839|NCT00741260|451926201|FG002|Overall Study|Disease Progression|3|||
125629840|NCT00741260|451926202|FG003|Overall Study|Disease Progression|3|||
125629841|NCT00741260|451926203|FG004|Overall Study|Disease Progression|5|||
125629842|NCT00741260|451926204|FG005|Overall Study|Disease Progression|37|||
125629843|NCT00741260|451926205|FG006|Overall Study|Disease Progression|4|||
125629844|NCT00741260|451926199|FG000|Overall Study|Death|0|||
125629845|NCT00741260|451926200|FG001|Overall Study|Death|1|||
125629846|NCT00741260|451926201|FG002|Overall Study|Death|0|||
125629847|NCT00741260|451926202|FG003|Overall Study|Death|1|||
125629848|NCT00741260|451926203|FG004|Overall Study|Death|2|||
125629849|NCT00741260|451926204|FG005|Overall Study|Death|2|||
125629850|NCT00741260|451926205|FG006|Overall Study|Death|1|||
125629851|NCT00741260|451926199|FG000|Overall Study|Withdrawal by Subject|0|||
125629852|NCT00741260|451926200|FG001|Overall Study|Withdrawal by Subject|0|||
125629853|NCT00741260|451926201|FG002|Overall Study|Withdrawal by Subject|0|||
125629854|NCT00741260|451926202|FG003|Overall Study|Withdrawal by Subject|0|||
125629855|NCT00741260|451926203|FG004|Overall Study|Withdrawal by Subject|1|||
125629856|NCT00741260|451926204|FG005|Overall Study|Withdrawal by Subject|3|||
125629857|NCT00741260|451926205|FG006|Overall Study|Withdrawal by Subject|1|||
125629858|NCT00741260|451926199|FG000|Overall Study|Physician Decision|1|||
125629859|NCT00741260|451926200|FG001|Overall Study|Physician Decision|1|||
125629860|NCT00741260|451926201|FG002|Overall Study|Physician Decision|0|||
125629861|NCT00741260|451926202|FG003|Overall Study|Physician Decision|0|||
125629862|NCT00741260|451926203|FG004|Overall Study|Physician Decision|0|||
125629863|NCT00741260|451926204|FG005|Overall Study|Physician Decision|0|||
125629864|NCT00741260|451926205|FG006|Overall Study|Physician Decision|0|||
125629865|NCT00741260|451926199|FG000|Overall Study|Other|2|||
125629866|NCT00741260|451926200|FG001|Overall Study|Other|1|||
125629867|NCT00741260|451926201|FG002|Overall Study|Other|1|||
125629868|NCT00741260|451926202|FG003|Overall Study|Other|2|||
125629869|NCT00741260|451926203|FG004|Overall Study|Other|1|||
125629870|NCT00741260|451926204|FG005|Overall Study|Other|3|||
125629871|NCT00741260|451926205|FG006|Overall Study|Other|1|||
125629872|NCT02810951|451926206|FG000|Overall Study|Adverse Event|1|||
125629873|NCT01250756|451926207|FG000|Infant Series|Withdrawal by Subject|4|||
125629874|NCT01250756|451926208|FG001|Infant Series|Withdrawal by Subject|5|||
125629875|NCT01250756|451926207|FG000|Infant Series|Randomized, Not Vaccinated|2|||
125629876|NCT01250756|451926208|FG001|Infant Series|Randomized, Not Vaccinated|2|||
125629877|NCT01250756|451926207|FG000|Infant Series|Other|22|||
125629878|NCT01250756|451926208|FG001|Infant Series|Other|0|||
125629879|NCT01250756|451926207|FG000|After Infant Series|Adverse Event|5|||
125629880|NCT01250756|451926208|FG001|After Infant Series|Adverse Event|2|||
125629881|NCT01250756|451926207|FG000|After Infant Series|Withdrawal by Subject|4|||
125629882|NCT01250756|451926208|FG001|After Infant Series|Withdrawal by Subject|1|||
125629883|NCT01250756|451926207|FG000|After Infant Series|Other|2|||
125629884|NCT01250756|451926208|FG001|After Infant Series|Other|1|||
125629885|NCT01250756|451926207|FG000|Toddler Dose|Adverse Event|0|||
125629886|NCT01250756|451926208|FG001|Toddler Dose|Adverse Event|1|||
125629887|NCT01250756|451926207|FG000|After Toddler Dose|Adverse Event|0|||
125629888|NCT01250756|451926208|FG001|After Toddler Dose|Adverse Event|1|||
125375938|NCT02899988|451007642|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125629889|NCT01928082|451926209|FG000|Overall Study|Study terminated.|1|||
125629890|NCT02142504|451926215|FG000|Overall Study|Protocol Violation|2|||
125629891|NCT02142504|451926216|FG001|Overall Study|Protocol Violation|1|||
125629892|NCT02142504|451926217|FG002|Overall Study|Protocol Violation|2|||
125629893|NCT02142504|451926215|FG000|Overall Study|Adverse Event|2|||
125375939|NCT02899988|451007643|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125629894|NCT02142504|451926216|FG001|Overall Study|Adverse Event|3|||
125629895|NCT02142504|451926217|FG002|Overall Study|Adverse Event|4|||
125629896|NCT02142504|451926215|FG000|Overall Study|Lost to Follow-up|12|||
125629897|NCT02142504|451926216|FG001|Overall Study|Lost to Follow-up|19|||
125629898|NCT02142504|451926217|FG002|Overall Study|Lost to Follow-up|17|||
125629899|NCT02142504|451926215|FG000|Overall Study|Withdrawal by Subject|7|||
125629900|NCT02142504|451926216|FG001|Overall Study|Withdrawal by Subject|9|||
125629901|NCT02142504|451926217|FG002|Overall Study|Withdrawal by Subject|11|||
125629902|NCT02142504|451926215|FG000|Overall Study|Pregnancy|4|||
125629903|NCT02142504|451926216|FG001|Overall Study|Pregnancy|4|||
125629904|NCT02142504|451926217|FG002|Overall Study|Pregnancy|2|||
125629905|NCT02142504|451926215|FG000|Overall Study|Physician Decision|0|||
125629906|NCT02142504|451926216|FG001|Overall Study|Physician Decision|1|||
125629907|NCT02142504|451926217|FG002|Overall Study|Physician Decision|3|||
125629908|NCT02142504|451926215|FG000|Overall Study|Reason Not Specified|4|||
125128900|NCT00723528|450097688|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
125629909|NCT02142504|451926216|FG001|Overall Study|Reason Not Specified|5|||
125629910|NCT02142504|451926217|FG002|Overall Study|Reason Not Specified|4|||
125629911|NCT02120352|451926218|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
125629912|NCT02120352|451926219|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
125629913|NCT02120352|451926220|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
125629914|NCT02120352|451926221|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
125629915|NCT02120352|451926222|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
125629916|NCT02120352|451926223|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
125629917|NCT02120352|451926224|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
125629918|NCT02120352|451926218|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
125629919|NCT02120352|451926219|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
125629920|NCT02120352|451926220|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
125629921|NCT02120352|451926221|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
125629922|NCT02120352|451926222|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
125629923|NCT02120352|451926223|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
125629924|NCT02120352|451926224|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
125629925|NCT02120352|451926218|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
125629926|NCT02120352|451926219|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
125629927|NCT02120352|451926220|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
125629928|NCT02120352|451926221|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
125629929|NCT02120352|451926222|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
125629930|NCT02120352|451926223|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
125629931|NCT02120352|451926224|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
125629932|NCT02120352|451926218|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
125629933|NCT02120352|451926219|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
125629934|NCT02120352|451926220|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
125629935|NCT02120352|451926221|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
125629936|NCT02120352|451926222|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
125629937|NCT02120352|451926223|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
125629938|NCT02120352|451926224|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
125629939|NCT02120352|451926218|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
125629940|NCT02120352|451926219|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
125629941|NCT02120352|451926220|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
125629942|NCT02120352|451926221|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
125629943|NCT02120352|451926222|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
125629944|NCT02120352|451926223|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
125629945|NCT02120352|451926224|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
125629946|NCT02120352|451926218|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
125629947|NCT02120352|451926219|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
125629948|NCT02120352|451926220|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
125629949|NCT02120352|451926221|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
125629950|NCT02120352|451926222|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
125629951|NCT02120352|451926223|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
125629952|NCT02120352|451926224|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
125629953|NCT02120352|451926218|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
125629954|NCT02120352|451926219|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
125629955|NCT02120352|451926220|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
125629956|NCT02120352|451926221|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
125629957|NCT02120352|451926222|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
125629958|NCT02120352|451926223|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
125629959|NCT02120352|451926224|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
125629960|NCT02120352|451926218|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
125629961|NCT02120352|451926219|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
125629962|NCT02120352|451926220|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
125629963|NCT02120352|451926221|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
125629964|NCT02120352|451926222|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
125629965|NCT02120352|451926223|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
125629966|NCT02120352|451926224|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
125629967|NCT02120352|451926218|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
125629968|NCT02120352|451926219|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
125629969|NCT02120352|451926220|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
125629970|NCT02120352|451926221|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
125629971|NCT02120352|451926222|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
125629972|NCT02120352|451926223|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
125629973|NCT02120352|451926224|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
125128901|NCT00723528|450097689|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
125128902|NCT00723528|450097683|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
125128903|NCT00723528|450097684|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
125128904|NCT00723528|450097685|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
125128905|NCT00723528|450097686|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
125128906|NCT00723528|450097687|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
125128907|NCT00723528|450097688|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
125128908|NCT00723528|450097689|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
125128909|NCT00723528|450097683|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
125215732|NCT00492232|450417502|FG001|Placebo Run-in|Protocol Violation|3|||
125629974|NCT02120352|451926218|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
125629975|NCT02120352|451926219|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
125629976|NCT02120352|451926220|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
125629977|NCT02120352|451926221|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
125629978|NCT02120352|451926222|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
125629979|NCT02120352|451926223|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
125629980|NCT02120352|451926224|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
125629981|NCT02120352|451926218|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
125629982|NCT02120352|451926219|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
125629983|NCT02120352|451926220|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
125629984|NCT02120352|451926221|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
125629985|NCT02120352|451926222|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
125629986|NCT02120352|451926223|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
125629987|NCT02120352|451926224|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
125629988|NCT02120352|451926218|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
125629989|NCT02120352|451926219|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
125629990|NCT02120352|451926220|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
125629991|NCT02120352|451926221|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
125629992|NCT02120352|451926222|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
125629993|NCT02120352|451926223|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
125629994|NCT02120352|451926224|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
125629995|NCT02120352|451926218|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
125629996|NCT02120352|451926219|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
125629997|NCT02120352|451926220|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
125629998|NCT02120352|451926221|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
125629999|NCT02120352|451926222|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
125630000|NCT02120352|451926223|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
125630001|NCT02120352|451926224|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
125630002|NCT02120352|451926218|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
125630003|NCT02120352|451926219|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
125630004|NCT02120352|451926220|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
125630005|NCT02120352|451926221|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
125630006|NCT02120352|451926222|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
125630007|NCT02120352|451926223|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
125630008|NCT02120352|451926224|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
125630009|NCT02120352|451926218|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
125630010|NCT02120352|451926219|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
125630011|NCT02120352|451926220|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
125630012|NCT02120352|451926221|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
125630013|NCT02120352|451926222|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
125630014|NCT02120352|451926223|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
125630015|NCT02120352|451926224|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
125630016|NCT02120352|451926218|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
125630017|NCT02120352|451926219|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
125630018|NCT02120352|451926220|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
125630019|NCT02120352|451926221|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
125630020|NCT02120352|451926222|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
125630021|NCT02120352|451926223|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
125128910|NCT00723528|450097684|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
125128911|NCT00723528|450097685|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
125128912|NCT00723528|450097686|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
125215733|NCT00492232|450417501|FG000|Placebo Run-in|Lost to Follow-up|0|||
125375940|NCT02899988|451007644|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125128913|NCT00723528|450097687|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
125128914|NCT00723528|450097688|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
125128915|NCT00723528|450097689|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
125435826|NCT00926003|451222080|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
125435827|NCT01709305|451222085|FG000|Phase 1|Clinical Adverse Event|80|||
125435828|NCT01709305|451222086|FG001|Phase 1|Clinical Adverse Event|0|||
125435829|NCT01709305|451222087|FG002|Phase 1|Clinical Adverse Event|0|||
125435830|NCT01709305|451222088|FG003|Phase 1|Clinical Adverse Event|0|||
125435831|NCT01709305|451222089|FG004|Phase 1|Clinical Adverse Event|0|||
125435832|NCT01709305|451222085|FG000|Phase 1|Death|2|||
125435833|NCT01709305|451222086|FG001|Phase 1|Death|0|||
125435834|NCT01709305|451222087|FG002|Phase 1|Death|0|||
125435835|NCT01709305|451222088|FG003|Phase 1|Death|0|||
125435836|NCT01709305|451222089|FG004|Phase 1|Death|0|||
125435837|NCT01709305|451222085|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
125435838|NCT01709305|451222086|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
125435839|NCT01709305|451222087|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
125435840|NCT01709305|451222088|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
125435841|NCT01709305|451222089|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
125435842|NCT01709305|451222085|FG000|Phase 1|Laboratory Adverse Event|16|||
125435843|NCT01709305|451222086|FG001|Phase 1|Laboratory Adverse Event|0|||
125435844|NCT01709305|451222087|FG002|Phase 1|Laboratory Adverse Event|0|||
125435845|NCT01709305|451222088|FG003|Phase 1|Laboratory Adverse Event|0|||
125435846|NCT01709305|451222089|FG004|Phase 1|Laboratory Adverse Event|0|||
125435847|NCT01709305|451222085|FG000|Phase 1|Lost to Follow-up|147|||
125435848|NCT01709305|451222086|FG001|Phase 1|Lost to Follow-up|0|||
125435849|NCT01709305|451222087|FG002|Phase 1|Lost to Follow-up|0|||
125435850|NCT01709305|451222088|FG003|Phase 1|Lost to Follow-up|0|||
125435851|NCT01709305|451222089|FG004|Phase 1|Lost to Follow-up|0|||
125435852|NCT01709305|451222085|FG000|Phase 1|Travel, moving, etc.|30|||
125435853|NCT01709305|451222086|FG001|Phase 1|Travel, moving, etc.|0|||
125435854|NCT01709305|451222087|FG002|Phase 1|Travel, moving, etc.|0|||
125435855|NCT01709305|451222088|FG003|Phase 1|Travel, moving, etc.|0|||
125435856|NCT01709305|451222089|FG004|Phase 1|Travel, moving, etc.|0|||
125435857|NCT01709305|451222085|FG000|Phase 1|Physician Decision|13|||
125435858|NCT01709305|451222086|FG001|Phase 1|Physician Decision|0|||
125435859|NCT01709305|451222087|FG002|Phase 1|Physician Decision|0|||
125435860|NCT01709305|451222088|FG003|Phase 1|Physician Decision|0|||
125435861|NCT01709305|451222089|FG004|Phase 1|Physician Decision|0|||
125435862|NCT01709305|451222085|FG000|Phase 1|Protocol Violation|118|||
125435863|NCT01709305|451222086|FG001|Phase 1|Protocol Violation|0|||
125435864|NCT01709305|451222087|FG002|Phase 1|Protocol Violation|0|||
125435865|NCT01709305|451222088|FG003|Phase 1|Protocol Violation|0|||
125435866|NCT01709305|451222089|FG004|Phase 1|Protocol Violation|0|||
125435867|NCT01709305|451222085|FG000|Phase 1|Withdrawal by Subject|218|||
125630022|NCT02120352|451926224|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
125630023|NCT02120352|451926218|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
125630024|NCT02120352|451926219|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
125128916|NCT00723528|450097683|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
125128917|NCT00723528|450097684|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
125128918|NCT00723528|450097685|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
125128919|NCT00723528|450097686|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
125128920|NCT00723528|450097687|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
125128921|NCT00723528|450097688|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
125128922|NCT00723528|450097689|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
125128923|NCT00723528|450097683|FG000|Period 2: After Controlled Period|Other|0|||
125128924|NCT00723528|450097684|FG001|Period 2: After Controlled Period|Other|0|||
125128925|NCT00723528|450097685|FG002|Period 2: After Controlled Period|Other|0|||
125630025|NCT02120352|451926220|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
125630026|NCT02120352|451926221|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
125630027|NCT02120352|451926222|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
125630028|NCT02120352|451926223|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
125630029|NCT02120352|451926224|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
125630030|NCT02120352|451926218|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
125630031|NCT02120352|451926219|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
125630032|NCT02120352|451926220|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
125630033|NCT02120352|451926221|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
125630034|NCT02120352|451926222|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
125630035|NCT02120352|451926223|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
125630036|NCT02120352|451926224|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
125630037|NCT02120352|451926218|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
125630038|NCT02120352|451926219|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
125630039|NCT02120352|451926220|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
125630040|NCT02120352|451926221|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
125128926|NCT00723528|450097686|FG003|Period 2: After Controlled Period|Other|0|||
125128927|NCT00723528|450097687|FG004|Period 2: After Controlled Period|Other|1|||
125128928|NCT00723528|450097688|FG005|Period 2: After Controlled Period|Other|4|||
125215734|NCT00492232|450417502|FG001|Placebo Run-in|Lost to Follow-up|3|||
125215735|NCT00492232|450417501|FG000|Placebo Run-in|Withdrawal by Subject|0|||
125215736|NCT00492232|450417502|FG001|Placebo Run-in|Withdrawal by Subject|8|||
125215737|NCT00492232|450417501|FG000|Placebo Run-in|Pregnancy|0|||
125215738|NCT00492232|450417502|FG001|Placebo Run-in|Pregnancy|1|||
125215739|NCT00492232|450417501|FG000|Placebo Run-in|Entrance criteria not met|0|||
125128929|NCT00723528|450097689|FG006|Period 2: After Controlled Period|Other|0|||
125128930|NCT00723528|450097683|FG000|Period 2: After Controlled Period|Adverse Event|0|||
125215740|NCT00492232|450417502|FG001|Placebo Run-in|Entrance criteria not met|45|||
125215741|NCT00492232|450417501|FG000|Placebo Run-in|Other|0|||
125375941|NCT02899988|451007645|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125375942|NCT02899988|451007646|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125375943|NCT02899988|451007647|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125375944|NCT02899988|451007637|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
125375945|NCT02899988|451007638|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
125375946|NCT02899988|451007639|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
125375947|NCT02899988|451007640|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
125375948|NCT02899988|451007641|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
125375949|NCT02899988|451007642|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
125375950|NCT02899988|451007643|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
125375951|NCT02899988|451007644|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
125375952|NCT02899988|451007645|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
125375953|NCT02899988|451007646|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
125375954|NCT02899988|451007647|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
125375955|NCT02899988|451007637|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
125375956|NCT02899988|451007638|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
125375957|NCT02899988|451007639|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
125375958|NCT02899988|451007640|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
125375959|NCT02899988|451007641|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
125375960|NCT02899988|451007642|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
125375961|NCT02899988|451007643|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
125375962|NCT02899988|451007644|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
125375963|NCT02899988|451007645|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
125375964|NCT02899988|451007646|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
125375965|NCT02899988|451007647|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
125375966|NCT02899988|451007637|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
125375967|NCT02899988|451007638|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
125435868|NCT01709305|451222086|FG001|Phase 1|Withdrawal by Subject|0|||
125435869|NCT01709305|451222087|FG002|Phase 1|Withdrawal by Subject|0|||
125435870|NCT01709305|451222088|FG003|Phase 1|Withdrawal by Subject|0|||
125435871|NCT01709305|451222089|FG004|Phase 1|Withdrawal by Subject|0|||
125435872|NCT01709305|451222085|FG000|Phase 2|Clinical Adverse Event|0|||
125435873|NCT01709305|451222086|FG001|Phase 2|Clinical Adverse Event|10|||
125435874|NCT01709305|451222087|FG002|Phase 2|Clinical Adverse Event|10|||
125435875|NCT01709305|451222088|FG003|Phase 2|Clinical Adverse Event|6|||
125435876|NCT01709305|451222089|FG004|Phase 2|Clinical Adverse Event|11|||
125435877|NCT01709305|451222085|FG000|Phase 2|Death|0|||
125435878|NCT01709305|451222086|FG001|Phase 2|Death|0|||
125435879|NCT01709305|451222087|FG002|Phase 2|Death|1|||
125435880|NCT01709305|451222088|FG003|Phase 2|Death|0|||
125435881|NCT01709305|451222089|FG004|Phase 2|Death|0|||
125435882|NCT01709305|451222085|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
125435883|NCT01709305|451222086|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
125435884|NCT01709305|451222087|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
125435885|NCT01709305|451222088|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
125435886|NCT01709305|451222089|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
125435887|NCT01709305|451222085|FG000|Phase 2|Laboratory Adverse Event|0|||
125435888|NCT01709305|451222086|FG001|Phase 2|Laboratory Adverse Event|1|||
125435889|NCT01709305|451222087|FG002|Phase 2|Laboratory Adverse Event|0|||
125435890|NCT01709305|451222088|FG003|Phase 2|Laboratory Adverse Event|1|||
125435891|NCT01709305|451222089|FG004|Phase 2|Laboratory Adverse Event|1|||
125128931|NCT00723528|450097684|FG001|Period 2: After Controlled Period|Adverse Event|0|||
125128932|NCT00723528|450097685|FG002|Period 2: After Controlled Period|Adverse Event|0|||
125435892|NCT01709305|451222085|FG000|Phase 2|Lost to Follow-up|0|||
125435893|NCT01709305|451222086|FG001|Phase 2|Lost to Follow-up|10|||
125435894|NCT01709305|451222087|FG002|Phase 2|Lost to Follow-up|6|||
125435895|NCT01709305|451222088|FG003|Phase 2|Lost to Follow-up|9|||
125128933|NCT00723528|450097686|FG003|Period 2: After Controlled Period|Adverse Event|0|||
125435896|NCT01709305|451222089|FG004|Phase 2|Lost to Follow-up|5|||
125128934|NCT00723528|450097687|FG004|Period 2: After Controlled Period|Adverse Event|1|||
125128935|NCT00723528|450097688|FG005|Period 2: After Controlled Period|Adverse Event|0|||
125215742|NCT00492232|450417502|FG001|Placebo Run-in|Other|6|||
125435897|NCT01709305|451222085|FG000|Phase 2|Travel, moving, etc.|0|||
125435898|NCT01709305|451222086|FG001|Phase 2|Travel, moving, etc.|2|||
125435899|NCT01709305|451222087|FG002|Phase 2|Travel, moving, etc.|3|||
125435900|NCT01709305|451222088|FG003|Phase 2|Travel, moving, etc.|3|||
125435901|NCT01709305|451222089|FG004|Phase 2|Travel, moving, etc.|5|||
125435902|NCT01709305|451222085|FG000|Phase 2|Physician Decision|0|||
125435903|NCT01709305|451222086|FG001|Phase 2|Physician Decision|2|||
125435904|NCT01709305|451222087|FG002|Phase 2|Physician Decision|0|||
125128936|NCT00723528|450097689|FG006|Period 2: After Controlled Period|Adverse Event|1|||
125128937|NCT00723528|450097683|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
125128938|NCT00723528|450097684|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
125128939|NCT00723528|450097685|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
125128940|NCT00723528|450097686|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
125128941|NCT00723528|450097687|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
125128942|NCT00723528|450097688|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
125128943|NCT00723528|450097689|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
125128944|NCT00723528|450097683|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
125128945|NCT00723528|450097684|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
125128946|NCT00723528|450097685|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
125128947|NCT00723528|450097686|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
125128948|NCT00723528|450097687|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
125128949|NCT00723528|450097688|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
125128950|NCT00723528|450097689|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
125128951|NCT01993030|450097690|FG000|Overall Study|Adverse Event|0|||
125128952|NCT01993030|450097691|FG001|Overall Study|Adverse Event|4|||
125128953|NCT03785548|450097692|FG000|Overall Study|age > 80|1|||
125128954|NCT03785548|450097693|FG001|Overall Study|age > 80|0|||
125128955|NCT03785548|450097692|FG000|Overall Study|no Postop queries|1|||
125128956|NCT03785548|450097693|FG001|Overall Study|no Postop queries|0|||
125128957|NCT01710657|450097694|FG000|Overall Study|Lost to Follow-up|2|||
125128958|NCT01710657|450097695|FG001|Overall Study|Lost to Follow-up|0|||
125128959|NCT01710657|450097696|FG002|Overall Study|Lost to Follow-up|1|||
125128960|NCT01710657|450097694|FG000|Overall Study|Protocol Violation|2|||
125128961|NCT01710657|450097695|FG001|Overall Study|Protocol Violation|2|||
125128962|NCT01710657|450097696|FG002|Overall Study|Protocol Violation|0|||
125128963|NCT01710657|450097694|FG000|Overall Study|Adverse Event|14|||
125128964|NCT01710657|450097695|FG001|Overall Study|Adverse Event|8|||
125128965|NCT01710657|450097696|FG002|Overall Study|Adverse Event|28|||
125128966|NCT01710657|450097694|FG000|Overall Study|Withdrawal by Subject|0|||
125128967|NCT01710657|450097695|FG001|Overall Study|Withdrawal by Subject|1|||
125128968|NCT01710657|450097696|FG002|Overall Study|Withdrawal by Subject|2|||
125128969|NCT01710657|450097694|FG000|Overall Study|Lack of Efficacy|0|||
125128970|NCT01710657|450097695|FG001|Overall Study|Lack of Efficacy|1|||
125128971|NCT01710657|450097696|FG002|Overall Study|Lack of Efficacy|1|||
125128972|NCT01591785|450097699|FG000|Overall Study|worsening condition|1|||
125128973|NCT01591785|450097700|FG001|Overall Study|worsening condition|2|||
125128974|NCT01591785|450097699|FG000|Overall Study|Protocol Violation|2|||
125128975|NCT01591785|450097700|FG001|Overall Study|Protocol Violation|0|||
125128976|NCT01591785|450097699|FG000|Overall Study|Lost to Follow-up|1|||
125128977|NCT01591785|450097700|FG001|Overall Study|Lost to Follow-up|0|||
125128978|NCT00358449|450097701|FG000|Overall Study|Adverse Event|1|||
125128979|NCT00358449|450097702|FG001|Overall Study|Adverse Event|0|||
125128980|NCT00358449|450097703|FG002|Overall Study|Adverse Event|1|||
125128981|NCT00358449|450097701|FG000|Overall Study|Lost to Follow-up|1|||
125375968|NCT02899988|451007639|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
125375969|NCT02899988|451007640|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
125375970|NCT02899988|451007641|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
125375971|NCT02899988|451007642|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
125375972|NCT02899988|451007643|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
125630041|NCT02120352|451926222|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
125630042|NCT02120352|451926223|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
125630043|NCT02120352|451926224|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
125630044|NCT02120352|451926218|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
125630045|NCT02120352|451926219|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
125630046|NCT02120352|451926220|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
125630047|NCT02120352|451926221|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
125630048|NCT02120352|451926222|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
125630049|NCT02120352|451926223|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
125630050|NCT02120352|451926224|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
125630051|NCT02120352|451926218|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
125630052|NCT02120352|451926219|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
125630053|NCT02120352|451926220|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
125630054|NCT02120352|451926221|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
125630055|NCT02120352|451926222|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
125630056|NCT02120352|451926223|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
125630057|NCT02120352|451926224|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
125630058|NCT02120352|451926218|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
125435905|NCT01709305|451222088|FG003|Phase 2|Physician Decision|1|||
125630059|NCT02120352|451926219|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
125630060|NCT02120352|451926220|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
125630061|NCT02120352|451926221|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
125630062|NCT02120352|451926222|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
125630063|NCT02120352|451926223|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
125630064|NCT02120352|451926224|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
125630065|NCT01610206|451926227|FG000|Overall Study|Adverse Event|10|||
125630066|NCT01610206|451926228|FG001|Overall Study|Adverse Event|30|||
125630067|NCT00166517|451926230|FG000|Overall Study|Lost to Follow-up|1|||
125630068|NCT00166517|451926231|FG001|Overall Study|Lost to Follow-up|0|||
125630069|NCT00166517|451926230|FG000|Overall Study|Protocol Violation|4|||
125630070|NCT00166517|451926231|FG001|Overall Study|Protocol Violation|1|||
125630071|NCT00166517|451926230|FG000|Overall Study|Withdrawal by Subject|0|||
125630072|NCT00166517|451926231|FG001|Overall Study|Withdrawal by Subject|1|||
125630073|NCT02186561|451926232|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
125630074|NCT02186561|451926232|FG000|Enrollment|Enrollment Cap Reached|5|||
125630075|NCT02186561|451926232|FG000|Enrollment|Insurance Denial|2|||
125630076|NCT02186561|451926232|FG000|Enrollment|Withdrawal by Subject|2|||
125630077|NCT02186561|451926232|FG000|Enrollment|Investigator Withdrew Consent|1|||
125630078|NCT02186561|451926232|FG000|30-Day Post Index Procedure Visit|Death|1|||
125630079|NCT02186561|451926232|FG000|1- Year Post Index Procedure Visit|Death|1|||
125630080|NCT02186561|451926232|FG000|1- Year Post Index Procedure Visit|Missed|1|||
125630081|NCT04285853|451926233|FG000|Overall Study|Withdrawal by Subject|1|||
125630082|NCT04285853|451926234|FG001|Overall Study|Withdrawal by Subject|0|||
125630083|NCT04285853|451926233|FG000|Overall Study|Lost to Follow-up|9|||
125630084|NCT04285853|451926234|FG001|Overall Study|Lost to Follow-up|5|||
125630085|NCT02371980|451928428|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
125630086|NCT02371980|451928429|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
125630087|NCT02371980|451928430|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
125630088|NCT02371980|451928431|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
125630089|NCT02371980|451928432|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
125630090|NCT02371980|451928428|FG000|Open-label Period|Significant Protocol Deviation|19|||
125630091|NCT02371980|451928429|FG001|Open-label Period|Significant Protocol Deviation|0|||
125630092|NCT02371980|451928430|FG002|Open-label Period|Significant Protocol Deviation|0|||
125630093|NCT02371980|451928431|FG003|Open-label Period|Significant Protocol Deviation|0|||
125630094|NCT02371980|451928432|FG004|Open-label Period|Significant Protocol Deviation|0|||
125630095|NCT02371980|451928428|FG000|Open-label Period|Noncompliance with Study Drug|10|||
125630096|NCT02371980|451928429|FG001|Open-label Period|Noncompliance with Study Drug|0|||
125630097|NCT02371980|451928430|FG002|Open-label Period|Noncompliance with Study Drug|0|||
125630098|NCT02371980|451928431|FG003|Open-label Period|Noncompliance with Study Drug|0|||
125630099|NCT02371980|451928432|FG004|Open-label Period|Noncompliance with Study Drug|0|||
125630100|NCT02371980|451928428|FG000|Open-label Period|Lost to Follow-up|55|||
125630101|NCT02371980|451928429|FG001|Open-label Period|Lost to Follow-up|0|||
125630102|NCT02371980|451928430|FG002|Open-label Period|Lost to Follow-up|0|||
125630103|NCT02371980|451928431|FG003|Open-label Period|Lost to Follow-up|0|||
125630104|NCT02371980|451928432|FG004|Open-label Period|Lost to Follow-up|0|||
125630105|NCT02371980|451928428|FG000|Open-label Period|Voluntary Withdrawal|91|||
125630106|NCT02371980|451928429|FG001|Open-label Period|Voluntary Withdrawal|0|||
125630107|NCT02371980|451928430|FG002|Open-label Period|Voluntary Withdrawal|0|||
125630108|NCT02371980|451928431|FG003|Open-label Period|Voluntary Withdrawal|0|||
125630109|NCT02371980|451928432|FG004|Open-label Period|Voluntary Withdrawal|0|||
125630110|NCT02371980|451928428|FG000|Open-label Period|Pregnancy|1|||
125630111|NCT02371980|451928429|FG001|Open-label Period|Pregnancy|0|||
125630112|NCT02371980|451928430|FG002|Open-label Period|Pregnancy|0|||
125630113|NCT02371980|451928431|FG003|Open-label Period|Pregnancy|0|||
125630114|NCT02371980|451928432|FG004|Open-label Period|Pregnancy|0|||
125630115|NCT02371980|451928428|FG000|Open-label Period|Lack of Efficacy|116|||
125630116|NCT02371980|451928429|FG001|Open-label Period|Lack of Efficacy|0|||
125375973|NCT02899988|451007644|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
125630117|NCT02371980|451928430|FG002|Open-label Period|Lack of Efficacy|0|||
125630118|NCT02371980|451928431|FG003|Open-label Period|Lack of Efficacy|0|||
125630119|NCT02371980|451928432|FG004|Open-label Period|Lack of Efficacy|0|||
125630120|NCT02371980|451928428|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
125630121|NCT02371980|451928429|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
125630122|NCT02371980|451928430|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
125630123|NCT02371980|451928431|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
125630124|NCT02371980|451928432|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
125630125|NCT02371980|451928428|FG000|Open-label Period|Reason not Specified|9|||
125630126|NCT02371980|451928429|FG001|Open-label Period|Reason not Specified|0|||
125630127|NCT02371980|451928430|FG002|Open-label Period|Reason not Specified|0|||
125630128|NCT02371980|451928431|FG003|Open-label Period|Reason not Specified|0|||
125630129|NCT02371980|451928432|FG004|Open-label Period|Reason not Specified|0|||
125630130|NCT02371980|451928428|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
125630131|NCT02371980|451928429|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
125630132|NCT02371980|451928430|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
125630133|NCT02371980|451928431|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
125630134|NCT02371980|451928432|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
125630135|NCT02371980|451928428|FG000|Double-blind Period|Significant Protocol Deviation|0|||
125630136|NCT02371980|451928429|FG001|Double-blind Period|Significant Protocol Deviation|2|||
125630137|NCT02371980|451928430|FG002|Double-blind Period|Significant Protocol Deviation|7|||
125630138|NCT02371980|451928431|FG003|Double-blind Period|Significant Protocol Deviation|3|||
125630139|NCT02371980|451928432|FG004|Double-blind Period|Significant Protocol Deviation|3|||
125630140|NCT02371980|451928428|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
125630141|NCT02371980|451928429|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
125630142|NCT02371980|451928430|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
125630143|NCT02371980|451928431|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
125630144|NCT02371980|451928432|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
125630145|NCT02371980|451928428|FG000|Double-blind Period|Lost to Follow-up|0|||
125630146|NCT02371980|451928429|FG001|Double-blind Period|Lost to Follow-up|8|||
125630147|NCT02371980|451928430|FG002|Double-blind Period|Lost to Follow-up|8|||
125630148|NCT02371980|451928431|FG003|Double-blind Period|Lost to Follow-up|6|||
125630149|NCT02371980|451928432|FG004|Double-blind Period|Lost to Follow-up|5|||
125630150|NCT02371980|451928428|FG000|Double-blind Period|Voluntary Withdrawal|0|||
125630151|NCT02371980|451928429|FG001|Double-blind Period|Voluntary Withdrawal|12|||
125630152|NCT02371980|451928430|FG002|Double-blind Period|Voluntary Withdrawal|8|||
125630153|NCT02371980|451928431|FG003|Double-blind Period|Voluntary Withdrawal|9|||
125630154|NCT02371980|451928432|FG004|Double-blind Period|Voluntary Withdrawal|11|||
125630155|NCT02371980|451928428|FG000|Double-blind Period|Relapse|0|||
125630156|NCT02371980|451928429|FG001|Double-blind Period|Relapse|50|||
125630157|NCT02371980|451928430|FG002|Double-blind Period|Relapse|25|||
125630158|NCT02371980|451928431|FG003|Double-blind Period|Relapse|25|||
125630159|NCT02371980|451928432|FG004|Double-blind Period|Relapse|26|||
125630160|NCT02371980|451928428|FG000|Double-blind Period|Reason not Specified|0|||
125630161|NCT02371980|451928429|FG001|Double-blind Period|Reason not Specified|3|||
125630162|NCT02371980|451928430|FG002|Double-blind Period|Reason not Specified|3|||
125630163|NCT02371980|451928431|FG003|Double-blind Period|Reason not Specified|2|||
125630164|NCT02371980|451928432|FG004|Double-blind Period|Reason not Specified|1|||
125630165|NCT02371980|451928428|FG000|Double-blind Period|Missing|0|||
125630166|NCT02371980|451928429|FG001|Double-blind Period|Missing|1|||
125630167|NCT02371980|451928430|FG002|Double-blind Period|Missing|0|||
125630168|NCT02371980|451928431|FG003|Double-blind Period|Missing|0|||
125630169|NCT02371980|451928432|FG004|Double-blind Period|Missing|0|||
125630170|NCT01731990|451928433|FG000|Overall Study|Adverse Event|1|||
125630171|NCT01731990|451928434|FG001|Overall Study|Adverse Event|5|||
125375974|NCT02899988|451007645|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
125375975|NCT02899988|451007646|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
125630172|NCT01731990|451928433|FG000|Overall Study|Withdrawal by Subject|1|||
125630173|NCT01731990|451928434|FG001|Overall Study|Withdrawal by Subject|1|||
125630174|NCT01731990|451928433|FG000|Overall Study|Protocol deviation|1|||
125630175|NCT01731990|451928434|FG001|Overall Study|Protocol deviation|2|||
125375976|NCT02899988|451007647|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
125630176|NCT01731990|451928433|FG000|Overall Study|Death|1|||
125630177|NCT01731990|451928434|FG001|Overall Study|Death|0|||
125630178|NCT01280812|451928435|FG000|Overall Study|Withdrawal by Subject|2|||
125630179|NCT01280812|451928436|FG001|Overall Study|Withdrawal by Subject|1|||
125630180|NCT01280812|451928437|FG002|Overall Study|Withdrawal by Subject|0|||
125630181|NCT01280812|451928435|FG000|Overall Study|Lost to Follow-up|1|||
125630182|NCT01280812|451928436|FG001|Overall Study|Lost to Follow-up|1|||
125630183|NCT01280812|451928437|FG002|Overall Study|Lost to Follow-up|1|||
125630184|NCT04483544|451928438|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
125630185|NCT04483544|451928438|FG000|Post-Treatment|Admitted to hospice|2|||
125630186|NCT04483544|451928438|FG000|Post-Treatment|Study terminated|3|||
125128982|NCT00358449|450097702|FG001|Overall Study|Lost to Follow-up|0|||
125128983|NCT00358449|450097703|FG002|Overall Study|Lost to Follow-up|0|||
125128984|NCT00358449|450097701|FG000|Overall Study|Withdrawal by Subject|2|||
125435906|NCT01709305|451222089|FG004|Phase 2|Physician Decision|2|||
125435907|NCT01709305|451222085|FG000|Phase 2|Protocol Violation|0|||
125435908|NCT01709305|451222086|FG001|Phase 2|Protocol Violation|19|||
125435909|NCT01709305|451222087|FG002|Phase 2|Protocol Violation|19|||
125435910|NCT01709305|451222088|FG003|Phase 2|Protocol Violation|13|||
125128985|NCT00358449|450097702|FG001|Overall Study|Withdrawal by Subject|0|||
125128986|NCT00358449|450097703|FG002|Overall Study|Withdrawal by Subject|0|||
125435911|NCT01709305|451222089|FG004|Phase 2|Protocol Violation|9|||
125435912|NCT01709305|451222085|FG000|Phase 2|Withdrawal by Subject|0|||
125435913|NCT01709305|451222086|FG001|Phase 2|Withdrawal by Subject|8|||
125435914|NCT01709305|451222087|FG002|Phase 2|Withdrawal by Subject|6|||
125435915|NCT01709305|451222088|FG003|Phase 2|Withdrawal by Subject|15|||
125435916|NCT01709305|451222089|FG004|Phase 2|Withdrawal by Subject|12|||
125435917|NCT01396317|451222090|FG000|Overall Study|Adverse Event|1|||
125435918|NCT01396317|451222091|FG001|Overall Study|Adverse Event|0|||
125435919|NCT00171873|451222095|FG000|Overall Study|Withdrawal by Subject|4|||
125435920|NCT00171873|451222096|FG001|Overall Study|Withdrawal by Subject|2|||
125435921|NCT00171873|451222095|FG000|Overall Study|Adverse Event|5|||
125435922|NCT00171873|451222096|FG001|Overall Study|Adverse Event|0|||
125435923|NCT00171873|451222095|FG000|Overall Study|Switched to Octreotide|0|||
125435924|NCT00171873|451222096|FG001|Overall Study|Switched to Octreotide|1|||
125435925|NCT00539279|451222098|FG000|Treatment|Withdrawal by Subject|10|||
125435926|NCT00539279|451222099|FG001|Treatment|Withdrawal by Subject|8|||
125435927|NCT00539279|451222098|FG000|Treatment|Death|1|||
125435928|NCT00539279|451222099|FG001|Treatment|Death|0|||
125435929|NCT00539279|451222098|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
125435930|NCT00539279|451222099|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
125435931|NCT00539279|451222098|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
125435932|NCT00539279|451222099|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
125435933|NCT01338012|451222104|FG000|Overall Study|Death|4|||
125435934|NCT01338012|451222104|FG000|Overall Study|Study terminated|4|||
125435935|NCT02073097|451222105|FG000|Overall Study|Adverse Event|0|||
125435936|NCT02073097|451222106|FG001|Overall Study|Adverse Event|0|||
125435937|NCT02073097|451222107|FG002|Overall Study|Adverse Event|0|||
125435938|NCT02073097|451222108|FG003|Overall Study|Adverse Event|0|||
125435939|NCT02073097|451222109|FG004|Overall Study|Adverse Event|0|||
125435940|NCT02073097|451222110|FG005|Overall Study|Adverse Event|0|||
125435941|NCT02073097|451222111|FG006|Overall Study|Adverse Event|0|||
125435942|NCT02073097|451222112|FG007|Overall Study|Adverse Event|2|||
125435943|NCT02073097|451222105|FG000|Overall Study|Withdrawal by Subject|0|||
125435944|NCT02073097|451222106|FG001|Overall Study|Withdrawal by Subject|0|||
125435945|NCT02073097|451222107|FG002|Overall Study|Withdrawal by Subject|0|||
125435946|NCT02073097|451222108|FG003|Overall Study|Withdrawal by Subject|0|||
125435947|NCT02073097|451222109|FG004|Overall Study|Withdrawal by Subject|0|||
125435948|NCT02073097|451222110|FG005|Overall Study|Withdrawal by Subject|0|||
125630187|NCT01131078|451928441|FG000|Overall Study|Adverse Event|22|||
125630188|NCT01131078|451928442|FG001|Overall Study|Adverse Event|12|||
125630189|NCT01131078|451928443|FG002|Overall Study|Adverse Event|17|||
125630190|NCT01131078|451928441|FG000|Overall Study|Progressive Disease|58|||
125630191|NCT01131078|451928442|FG001|Overall Study|Progressive Disease|77|||
125630192|NCT01131078|451928443|FG002|Overall Study|Progressive Disease|71|||
125630193|NCT01131078|451928441|FG000|Overall Study|Protocol Violation|1|||
125630194|NCT01131078|451928442|FG001|Overall Study|Protocol Violation|0|||
125630195|NCT01131078|451928443|FG002|Overall Study|Protocol Violation|0|||
125630196|NCT01131078|451928441|FG000|Overall Study|Lost to Follow-up|1|||
125630197|NCT01131078|451928442|FG001|Overall Study|Lost to Follow-up|1|||
125630198|NCT01131078|451928443|FG002|Overall Study|Lost to Follow-up|1|||
125630199|NCT01131078|451928441|FG000|Overall Study|Withdrawal by Subject|2|||
125128987|NCT00358449|450097701|FG000|Overall Study|Lack of Efficacy|0|||
125128988|NCT00358449|450097702|FG001|Overall Study|Lack of Efficacy|1|||
125128989|NCT00358449|450097703|FG002|Overall Study|Lack of Efficacy|0|||
125215743|NCT00492232|450417501|FG000|Placebo Run-in|Missing|0|||
125435949|NCT02073097|451222111|FG006|Overall Study|Withdrawal by Subject|0|||
125435950|NCT02073097|451222112|FG007|Overall Study|Withdrawal by Subject|2|||
125435951|NCT02073097|451222105|FG000|Overall Study|Death|0|||
125435952|NCT02073097|451222106|FG001|Overall Study|Death|0|||
125435953|NCT02073097|451222107|FG002|Overall Study|Death|0|||
125435954|NCT02073097|451222108|FG003|Overall Study|Death|0|||
125435955|NCT02073097|451222109|FG004|Overall Study|Death|0|||
125435956|NCT02073097|451222110|FG005|Overall Study|Death|0|||
125435957|NCT02073097|451222111|FG006|Overall Study|Death|0|||
125630200|NCT01131078|451928442|FG001|Overall Study|Withdrawal by Subject|4|||
125630201|NCT01131078|451928443|FG002|Overall Study|Withdrawal by Subject|3|||
125630202|NCT01131078|451928441|FG000|Overall Study|Non-compliance|3|||
125630203|NCT01131078|451928442|FG001|Overall Study|Non-compliance|0|||
125630204|NCT01131078|451928443|FG002|Overall Study|Non-compliance|0|||
125630205|NCT01131078|451928441|FG000|Overall Study|Physician Decision|10|||
125128990|NCT00358449|450097701|FG000|Overall Study|Steriod Inhaler was Increased|0|||
125128991|NCT00358449|450097702|FG001|Overall Study|Steriod Inhaler was Increased|0|||
125128992|NCT00358449|450097703|FG002|Overall Study|Steriod Inhaler was Increased|1|||
125128993|NCT00496964|450097711|FG000|Overall Study|Withdrawal by Subject|0|||
125128994|NCT00496964|450097712|FG001|Overall Study|Withdrawal by Subject|1|||
125630206|NCT01131078|451928442|FG001|Overall Study|Physician Decision|6|||
125630207|NCT01131078|451928443|FG002|Overall Study|Physician Decision|8|||
125630208|NCT01131078|451928441|FG000|Overall Study|Death|4|||
125630209|NCT01131078|451928442|FG001|Overall Study|Death|0|||
125630210|NCT01131078|451928443|FG002|Overall Study|Death|2|||
125128995|NCT00469417|450097713|FG000|Overall Study|Treatment failure all lesions|18|||
125128996|NCT00469417|450097714|FG001|Overall Study|Treatment failure all lesions|11|||
125128997|NCT00469417|450097713|FG000|Overall Study|Consent withdrawn|1|||
125128998|NCT00469417|450097714|FG001|Overall Study|Consent withdrawn|1|||
125128999|NCT00469417|450097713|FG000|Overall Study|Adverse Event|8|||
125129000|NCT00469417|450097714|FG001|Overall Study|Adverse Event|2|||
125375977|NCT02899988|451007637|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125375978|NCT02899988|451007638|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125375979|NCT02899988|451007639|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125375980|NCT02899988|451007640|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125375981|NCT02899988|451007641|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125375982|NCT02899988|451007642|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
125375983|NCT02899988|451007643|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125375984|NCT02899988|451007644|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
125375985|NCT02899988|451007645|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125375986|NCT02899988|451007646|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125375987|NCT02899988|451007647|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
125375988|NCT02899988|451007637|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125375989|NCT02899988|451007638|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125375990|NCT02899988|451007639|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125375991|NCT02899988|451007640|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125375992|NCT02899988|451007641|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
125375993|NCT02899988|451007642|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125375994|NCT02899988|451007643|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
125375995|NCT02899988|451007644|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
125375996|NCT02899988|451007645|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
125375997|NCT02899988|451007646|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
125375998|NCT02899988|451007647|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
125375999|NCT04271605|451007652|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
125376000|NCT02485301|451007653|FG000|Overall Study|Serious Adverse Events|2|||
125376001|NCT02485301|451007654|FG001|Overall Study|Serious Adverse Events|1|||
125376002|NCT02485301|451007653|FG000|Overall Study|Protocol Violation|0|||
125376003|NCT02485301|451007654|FG001|Overall Study|Protocol Violation|1|||
125376004|NCT02485301|451007653|FG000|Overall Study|Withdrawal by Subject|6|||
125376005|NCT02485301|451007654|FG001|Overall Study|Withdrawal by Subject|7|||
125376006|NCT02485301|451007653|FG000|Overall Study|Migrated/moved from study area|10|||
125376007|NCT02485301|451007654|FG001|Overall Study|Migrated/moved from study area|19|||
125376008|NCT02485301|451007653|FG000|Overall Study|Lost to Follow-up|17|||
125376009|NCT02485301|451007654|FG001|Overall Study|Lost to Follow-up|17|||
125376010|NCT02485301|451007653|FG000|Overall Study|Other|3|||
125376011|NCT02485301|451007654|FG001|Overall Study|Other|4|||
125376012|NCT01059825|451007655|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
125376013|NCT01059825|451007656|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
125376014|NCT01059825|451007657|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
125376015|NCT01059825|451007658|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
125376016|NCT01059825|451007659|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
125376017|NCT01059825|451007660|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
125376018|NCT01059825|451007661|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
125376019|NCT01059825|451007655|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
125435958|NCT02073097|451222112|FG007|Overall Study|Death|1|||
125630211|NCT01131078|451928441|FG000|Overall Study|Other|0|||
125630212|NCT01131078|451928442|FG001|Overall Study|Other|1|||
125630213|NCT01131078|451928443|FG002|Overall Study|Other|0|||
125630214|NCT00790218|451928445|FG000|Overall Study|Death|1|||
125129001|NCT00469417|450097713|FG000|Overall Study|Lost to Follow-up|1|||
125129002|NCT00469417|450097714|FG001|Overall Study|Lost to Follow-up|2|||
125129003|NCT00469417|450097713|FG000|Overall Study|Intercurrent disease|0|||
125376020|NCT01059825|451007656|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
125376021|NCT01059825|451007657|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
125630215|NCT00790218|451928446|FG001|Overall Study|Death|0|||
125630216|NCT00790218|451928447|FG002|Overall Study|Death|0|||
125630217|NCT05283499|451928450|FG000|Overall Study|Did not receive intervention|1|||
125630218|NCT05283499|451928451|FG001|Overall Study|Did not receive intervention|2|||
125630219|NCT05516134|451928452|FG000|Overall Study|Lost to Follow-up|1|||
125630220|NCT05516134|451928453|FG001|Overall Study|Lost to Follow-up|0|||
125630221|NCT05516134|451928454|FG002|Overall Study|Lost to Follow-up|0|||
125630222|NCT01094808|451928456|FG000|Overall Study|Withdrawal by Subject|1|||
125630223|NCT01094808|451928457|FG001|Overall Study|Withdrawal by Subject|1|||
125630224|NCT01094808|451928458|FG002|Overall Study|Withdrawal by Subject|0|||
125630225|NCT00369278|451928459|FG000|Overall Study|Adverse Event|14|||
125630226|NCT00369278|451928460|FG001|Overall Study|Adverse Event|11|||
125630227|NCT00369278|451928459|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125630228|NCT00369278|451928460|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
125630229|NCT00369278|451928459|FG000|Overall Study|Protocol Violation|2|||
125630230|NCT00369278|451928460|FG001|Overall Study|Protocol Violation|1|||
125630231|NCT00369278|451928459|FG000|Overall Study|Withdrawal by Subject|2|||
125630232|NCT00369278|451928460|FG001|Overall Study|Withdrawal by Subject|2|||
125630233|NCT00369278|451928459|FG000|Overall Study|Lost to Follow-up|1|||
125630234|NCT00369278|451928460|FG001|Overall Study|Lost to Follow-up|0|||
125630235|NCT00369278|451928459|FG000|Overall Study|Graft loss|1|||
125630236|NCT00369278|451928460|FG001|Overall Study|Graft loss|2|||
125630237|NCT01224106|451928461|FG000|Double-Blind Treatment Phase|Death|3|||
125630238|NCT01224106|451928462|FG001|Double-Blind Treatment Phase|Death|0|||
125630239|NCT01224106|451928463|FG002|Double-Blind Treatment Phase|Death|0|||
125630240|NCT01224106|451928464|FG003|Double-Blind Treatment Phase|Death|0|||
125630241|NCT01224106|451928465|FG004|Double-Blind Treatment Phase|Death|0|||
125630242|NCT01224106|451928461|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
125630243|NCT01224106|451928462|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
125630244|NCT01224106|451928463|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
125630245|NCT01224106|451928464|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
125630246|NCT01224106|451928465|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
125630247|NCT01224106|451928461|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
125630248|NCT01224106|451928462|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
125630249|NCT01224106|451928463|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
125630250|NCT01224106|451928464|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
125630251|NCT01224106|451928465|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
125630252|NCT01224106|451928461|FG000|Double-Blind Treatment Phase|Other|0|||
125630253|NCT01224106|451928462|FG001|Double-Blind Treatment Phase|Other|0|||
125630254|NCT01224106|451928463|FG002|Double-Blind Treatment Phase|Other|1|||
125630255|NCT01224106|451928464|FG003|Double-Blind Treatment Phase|Other|0|||
125630256|NCT01224106|451928465|FG004|Double-Blind Treatment Phase|Other|0|||
125630257|NCT01224106|451928461|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
125630258|NCT01224106|451928462|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
125630259|NCT01224106|451928463|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
125630260|NCT01224106|451928464|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
125630261|NCT01224106|451928465|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
125630262|NCT01224106|451928461|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
125630263|NCT01224106|451928462|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
125630264|NCT01224106|451928463|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
125630265|NCT01224106|451928464|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
125630266|NCT01224106|451928465|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
125630267|NCT01224106|451928461|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
125630268|NCT01224106|451928462|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125630269|NCT01224106|451928463|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
125630270|NCT01224106|451928464|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125630271|NCT01224106|451928465|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125630272|NCT01224106|451928461|FG000|Open-Label Extension (OLE) Phase|Death|0|||
125630273|NCT01224106|451928462|FG001|Open-Label Extension (OLE) Phase|Death|0|||
125630274|NCT01224106|451928463|FG002|Open-Label Extension (OLE) Phase|Death|0|||
125630275|NCT01224106|451928464|FG003|Open-Label Extension (OLE) Phase|Death|1|||
125630276|NCT01224106|451928465|FG004|Open-Label Extension (OLE) Phase|Death|3|||
125630277|NCT01224106|451928461|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
125630278|NCT01224106|451928462|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
125630279|NCT01224106|451928463|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
125630280|NCT01224106|451928464|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
125129004|NCT00469417|450097714|FG001|Overall Study|Intercurrent disease|1|||
125129005|NCT00469417|450097713|FG000|Overall Study|Randomized but not treated|2|||
125129006|NCT00469417|450097714|FG001|Overall Study|Randomized but not treated|0|||
125129007|NCT00909610|450097715|FG000|Period: First Intervention|Adverse Event|0|||
125630281|NCT01224106|451928465|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
125630282|NCT01224106|451928461|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
125630283|NCT01224106|451928462|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
125630284|NCT01224106|451928463|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
125630285|NCT01224106|451928464|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
125630286|NCT01224106|451928465|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
125630287|NCT01224106|451928461|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
125630288|NCT01224106|451928462|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
125630289|NCT01224106|451928463|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
125630290|NCT01224106|451928464|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
125630291|NCT01224106|451928465|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
125630292|NCT01224106|451928461|FG000|Open-Label Extension (OLE) Phase|Other|0|||
125630293|NCT01224106|451928462|FG001|Open-Label Extension (OLE) Phase|Other|0|||
125630294|NCT01224106|451928463|FG002|Open-Label Extension (OLE) Phase|Other|0|||
125630295|NCT01224106|451928464|FG003|Open-Label Extension (OLE) Phase|Other|5|||
125630296|NCT01224106|451928465|FG004|Open-Label Extension (OLE) Phase|Other|3|||
125630297|NCT00446797|451928466|FG000|Overall Study|Lack of Efficacy|0|||
125630298|NCT00446797|451928467|FG001|Overall Study|Lack of Efficacy|2|||
125630299|NCT00446797|451928466|FG000|Overall Study|Lost to Follow-up|5|||
125630300|NCT00446797|451928467|FG001|Overall Study|Lost to Follow-up|3|||
125630301|NCT00446797|451928466|FG000|Overall Study|Withdrawal by Subject|2|||
125630302|NCT00446797|451928467|FG001|Overall Study|Withdrawal by Subject|2|||
125630303|NCT00446797|451928466|FG000|Overall Study|Protocol Violation|1|||
125630304|NCT00446797|451928467|FG001|Overall Study|Protocol Violation|3|||
125630305|NCT00446797|451928466|FG000|Overall Study|subject entered at another site|0|||
125630306|NCT00446797|451928467|FG001|Overall Study|subject entered at another site|1|||
125630307|NCT00446797|451928466|FG000|Overall Study|did not meet entrance criteria|0|||
125630308|NCT00446797|451928467|FG001|Overall Study|did not meet entrance criteria|1|||
125630309|NCT02133001|451928468|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
125630310|NCT02133001|451928469|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
125630311|NCT02133001|451928468|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
125630312|NCT02133001|451928469|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
125630313|NCT02133001|451928468|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
125630314|NCT02133001|451928469|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
125630315|NCT02133001|451928468|FG000|Double Blind (Day 1-25)|Other|2|||
125630316|NCT02133001|451928469|FG001|Double Blind (Day 1-25)|Other|2|||
125630317|NCT02133001|451928468|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
125630318|NCT02133001|451928469|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
125630319|NCT02133001|451928468|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
125630320|NCT02133001|451928469|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
125630321|NCT02133001|451928468|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
125630322|NCT02133001|451928469|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
125630323|NCT02133001|451928468|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
125630324|NCT02133001|451928469|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
125630325|NCT02498392|451928474|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
125630326|NCT02498392|451928475|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
125630327|NCT02498392|451928474|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
125630328|NCT02498392|451928475|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
125630329|NCT02498392|451928474|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
125630330|NCT02498392|451928475|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
125630331|NCT02498392|451928474|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
125630332|NCT02498392|451928475|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
125630333|NCT02498392|451928474|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
125630334|NCT02498392|451928475|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
125630335|NCT02498392|451928474|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
125630336|NCT02498392|451928475|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
125630337|NCT03135262|451928478|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
125630338|NCT03135262|451928479|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
125630339|NCT03135262|451928480|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
125630340|NCT03135262|451928481|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
125630341|NCT03135262|451928482|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
125630342|NCT03135262|451928478|FG000|Overall Study|Progression of disease|0|||
125630343|NCT03135262|451928479|FG001|Overall Study|Progression of disease|0|||
125630344|NCT03135262|451928480|FG002|Overall Study|Progression of disease|0|||
125630345|NCT03135262|451928481|FG003|Overall Study|Progression of disease|1|||
125630346|NCT03135262|451928482|FG004|Overall Study|Progression of disease|0|||
125630347|NCT03135262|451928478|FG000|Overall Study|Death|6|||
125435959|NCT02073097|451222105|FG000|Overall Study|Physician Decision|0|||
125630348|NCT03135262|451928479|FG001|Overall Study|Death|2|||
125630349|NCT03135262|451928480|FG002|Overall Study|Death|2|||
125630350|NCT03135262|451928481|FG003|Overall Study|Death|2|||
125630351|NCT03135262|451928482|FG004|Overall Study|Death|0|||
125630352|NCT03135262|451928478|FG000|Overall Study|Withdrawal by Subject|0|||
125435960|NCT02073097|451222106|FG001|Overall Study|Physician Decision|0|||
125630353|NCT03135262|451928479|FG001|Overall Study|Withdrawal by Subject|0|||
125630354|NCT03135262|451928480|FG002|Overall Study|Withdrawal by Subject|1|||
125129008|NCT00909610|450097716|FG001|Period: First Intervention|Adverse Event|1|||
125129009|NCT00909610|450097715|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
125129010|NCT00909610|450097716|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
125129011|NCT00909610|450097715|FG000|Period: Second Intervention|Adverse Event|1|||
125435961|NCT02073097|451222107|FG002|Overall Study|Physician Decision|0|||
125435962|NCT02073097|451222108|FG003|Overall Study|Physician Decision|0|||
125435963|NCT02073097|451222109|FG004|Overall Study|Physician Decision|0|||
125435964|NCT02073097|451222110|FG005|Overall Study|Physician Decision|0|||
125435965|NCT02073097|451222111|FG006|Overall Study|Physician Decision|0|||
125630355|NCT03135262|451928481|FG003|Overall Study|Withdrawal by Subject|0|||
125630356|NCT03135262|451928482|FG004|Overall Study|Withdrawal by Subject|1|||
125630357|NCT03135262|451928478|FG000|Overall Study|Study terminated by sponsor|2|||
125630358|NCT03135262|451928479|FG001|Overall Study|Study terminated by sponsor|4|||
125630359|NCT03135262|451928480|FG002|Overall Study|Study terminated by sponsor|4|||
125630360|NCT03135262|451928481|FG003|Overall Study|Study terminated by sponsor|3|||
125630361|NCT03135262|451928482|FG004|Overall Study|Study terminated by sponsor|0|||
125630362|NCT01675141|451928483|FG000|Overall Study|Lenalidomide outside NIH|3|||
125630363|NCT01675141|451928483|FG000|Overall Study|Withdrawal by Subject|3|||
125630364|NCT01675141|451928483|FG000|Overall Study|Physician Decision|4|||
125630365|NCT01675141|451928483|FG000|Overall Study|No treatment, per protocol|1|||
125630366|NCT03097133|451928486|FG000|Overall Study|Lost to Follow-up|3|||
125630367|NCT03097133|451928487|FG001|Overall Study|Lost to Follow-up|2|||
125630368|NCT03097133|451928486|FG000|Overall Study|Withdrawal by Subject|2|||
125630369|NCT03097133|451928487|FG001|Overall Study|Withdrawal by Subject|5|||
125630370|NCT03097133|451928486|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
125630371|NCT03097133|451928487|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
125630372|NCT03097133|451928486|FG000|Overall Study|Other|3|||
125630373|NCT03097133|451928487|FG001|Overall Study|Other|2|||
125630374|NCT03097133|451928486|FG000|Overall Study|Adverse Event|1|||
125630375|NCT03097133|451928487|FG001|Overall Study|Adverse Event|0|||
125630376|NCT02873208|451928488|FG000|Overall Study|Withdrawal by Subject|36|||
125630377|NCT02873208|451928488|FG000|Overall Study|Lost to Follow-up|22|||
125630378|NCT02873208|451928488|FG000|Overall Study|Adverse Event|15|||
125630379|NCT02873208|451928488|FG000|Overall Study|Non-compliance with study drug|12|||
125630380|NCT02873208|451928488|FG000|Overall Study|Protocol Violation|8|||
125630381|NCT02873208|451928488|FG000|Overall Study|Pregnancy|2|||
125630382|NCT02873208|451928488|FG000|Overall Study|Incarceration|1|||
125630383|NCT02873208|451928488|FG000|Overall Study|Lack of Efficacy|1|||
125630384|NCT02873208|451928488|FG000|Overall Study|Physician Decision|1|||
125630385|NCT04080752|451928489|FG000|Overall Study|Adverse Event|2|||
125630386|NCT04080752|451928490|FG001|Overall Study|Adverse Event|3|||
125630387|NCT04080752|451928489|FG000|Overall Study|Lack of Efficacy|1|||
125630388|NCT04080752|451928490|FG001|Overall Study|Lack of Efficacy|0|||
125435966|NCT02073097|451222112|FG007|Overall Study|Physician Decision|1|||
125630389|NCT04080752|451928489|FG000|Overall Study|Lost to Follow-up|1|||
125630390|NCT04080752|451928490|FG001|Overall Study|Lost to Follow-up|0|||
125630391|NCT04080752|451928489|FG000|Overall Study|Pregnancy|0|||
125630392|NCT04080752|451928490|FG001|Overall Study|Pregnancy|1|||
125630393|NCT04080752|451928489|FG000|Overall Study|Withdrawal by Subject|7|||
125129012|NCT00909610|450097716|FG001|Period: Second Intervention|Adverse Event|0|||
125129013|NCT05327491|450097721|FG000|Periods 1 & 2|Miscellaneous|0|||
125630394|NCT04080752|451928490|FG001|Overall Study|Withdrawal by Subject|0|||
125630395|NCT04080752|451928489|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125630396|NCT04080752|451928490|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125630397|NCT04080752|451928489|FG000|Overall Study|Other|2|||
125630398|NCT04080752|451928490|FG001|Overall Study|Other|1|||
125630399|NCT01192100|451928491|FG000|Overall Study|Withdrawal by Subject|0|||
125630400|NCT01192100|451928492|FG001|Overall Study|Withdrawal by Subject|0|||
125630401|NCT01192100|451928493|FG002|Overall Study|Withdrawal by Subject|0|||
125630402|NCT01192100|451928494|FG003|Overall Study|Withdrawal by Subject|0|||
125630403|NCT01192100|451928495|FG004|Overall Study|Withdrawal by Subject|1|||
125630404|NCT01192100|451928496|FG005|Overall Study|Withdrawal by Subject|0|||
125630405|NCT01192100|451928491|FG000|Overall Study|Protocol Violation|0|||
125630406|NCT01192100|451928492|FG001|Overall Study|Protocol Violation|0|||
125630407|NCT01192100|451928493|FG002|Overall Study|Protocol Violation|0|||
125630408|NCT01192100|451928494|FG003|Overall Study|Protocol Violation|1|||
125630409|NCT01192100|451928495|FG004|Overall Study|Protocol Violation|0|||
125630410|NCT01192100|451928496|FG005|Overall Study|Protocol Violation|0|||
125630411|NCT04737759|451928497|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
125630412|NCT04737759|451928498|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
125630413|NCT04737759|451928497|FG000|Overall Study|Death|2|||
125630414|NCT04737759|451928498|FG001|Overall Study|Death|0|||
125630415|NCT04737759|451928497|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
125630416|NCT04737759|451928498|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
125630417|NCT04737759|451928497|FG000|Overall Study|Lost to Follow-up|4|||
125630418|NCT04737759|451928498|FG001|Overall Study|Lost to Follow-up|12|||
125630419|NCT02260388|451928499|FG000|Overall Study|Lost to Follow-up|2|||
125630420|NCT02260388|451928500|FG001|Overall Study|Lost to Follow-up|8|||
125630421|NCT02260388|451928501|FG002|Overall Study|Lost to Follow-up|3|||
125630422|NCT02260388|451928502|FG003|Overall Study|Lost to Follow-up|4|||
125630423|NCT02017704|451928506|FG000|Overall Study|Withdrawal by Subject|2|||
125630424|NCT02017704|451928507|FG001|Overall Study|Withdrawal by Subject|0|||
125630425|NCT00918346|451928508|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
125630426|NCT00918346|451928509|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
125630427|NCT01421069|451928510|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
125630428|NCT01421069|451928510|FG000|Parent Study|Failed to return|3|||
125630429|NCT01421069|451928510|FG000|Parent Study|Withdrawal by Subject|1|||
125630430|NCT01421069|451928510|FG000|Parent Study|Lost to Follow-up|2|||
125630431|NCT01421069|451928510|FG000|Parent Study|Lack of Efficacy|1|||
125630432|NCT01421069|451928510|FG000|Overall Period for Extension Study|Other|2|||
125630433|NCT01421069|451928510|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
125630434|NCT01421069|451928510|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
125630435|NCT01421069|451928510|FG000|Overall Period for Extension Study|Pregnancy|1|||
125630436|NCT01421069|451928510|FG000|Overall Period for Extension Study|Adverse Event|1|||
125630437|NCT01421069|451928510|FG000|Overall Period for Extension Study|Protocol Violation|1|||
125630438|NCT01421069|451928510|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
125630439|NCT01421069|451928510|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
125630440|NCT01421069|451928510|FG000|Active Treatment Period|Other|1|||
125630441|NCT01421069|451928510|FG000|Active Treatment Period|No longer willing to participate in study|8|||
125630442|NCT01421069|451928510|FG000|Active Treatment Period|Insufficient clinical response|1|||
125630443|NCT01421069|451928510|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
125129014|NCT05327491|450097722|FG001|Periods 1 & 2|Miscellaneous|1|||
125129015|NCT05327491|450097723|FG002|Periods 1 & 2|Miscellaneous|0|||
125129016|NCT05327491|450097724|FG003|Periods 1 & 2|Miscellaneous|0|||
125129017|NCT05327491|450097721|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
125129018|NCT05327491|450097722|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
125129019|NCT05327491|450097723|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
125129020|NCT05327491|450097724|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
125129021|NCT05038293|450097725|FG000|Overall Study|device was not operating properly for one subject.|1|||
125376022|NCT01059825|451007658|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
125376023|NCT01059825|451007659|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
125376024|NCT01059825|451007660|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
125376025|NCT01059825|451007661|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
125376026|NCT01059825|451007655|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
125376027|NCT01059825|451007656|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
125630444|NCT01421069|451928510|FG000|Active Treatment Period|Pregnancy|1|||
125630445|NCT01421069|451928510|FG000|Active Treatment Period|Adverse Event|1|||
125129022|NCT05038293|450097726|FG001|Overall Study|device was not operating properly for one subject.|0|||
125129023|NCT05038293|450097725|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
125215744|NCT00492232|450417502|FG001|Placebo Run-in|Missing|2|||
125630446|NCT01421069|451928510|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
125129024|NCT05038293|450097726|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
125376028|NCT01059825|451007657|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
125376029|NCT01059825|451007658|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
125376030|NCT01059825|451007659|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
125376031|NCT01059825|451007660|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
125376032|NCT01059825|451007661|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
125376033|NCT01059825|451007655|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
125376034|NCT01059825|451007656|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
125376035|NCT01059825|451007657|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
125376036|NCT01059825|451007658|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
125376037|NCT01059825|451007659|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
125376038|NCT01059825|451007660|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
125376039|NCT01059825|451007661|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
125376040|NCT01059825|451007655|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
125376041|NCT01059825|451007656|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
125376042|NCT01059825|451007657|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
125376043|NCT01059825|451007658|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
125376044|NCT01059825|451007659|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
125376045|NCT01059825|451007660|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
125376046|NCT01059825|451007661|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
125376047|NCT01059825|451007655|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
125376048|NCT01059825|451007656|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
125376049|NCT01059825|451007657|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
125376050|NCT01059825|451007658|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
125376051|NCT01059825|451007659|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
125376052|NCT01059825|451007660|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
125376053|NCT01059825|451007661|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
125376054|NCT01059825|451007655|FG000|Treatment Period|Lost to Follow-up|2|||
125376055|NCT01059825|451007656|FG001|Treatment Period|Lost to Follow-up|1|||
125376056|NCT01059825|451007657|FG002|Treatment Period|Lost to Follow-up|0|||
125376057|NCT01059825|451007658|FG003|Treatment Period|Lost to Follow-up|1|||
125376058|NCT01059825|451007659|FG004|Treatment Period|Lost to Follow-up|2|||
125376059|NCT01059825|451007660|FG005|Treatment Period|Lost to Follow-up|0|||
125376060|NCT01059825|451007661|FG006|Treatment Period|Lost to Follow-up|0|||
125376061|NCT01059825|451007655|FG000|Treatment Period|Withdrawal by Subject|3|||
125376062|NCT01059825|451007656|FG001|Treatment Period|Withdrawal by Subject|0|||
125376063|NCT01059825|451007657|FG002|Treatment Period|Withdrawal by Subject|1|||
125376064|NCT01059825|451007658|FG003|Treatment Period|Withdrawal by Subject|5|||
125376065|NCT01059825|451007659|FG004|Treatment Period|Withdrawal by Subject|4|||
125376066|NCT01059825|451007660|FG005|Treatment Period|Withdrawal by Subject|1|||
125376067|NCT01059825|451007661|FG006|Treatment Period|Withdrawal by Subject|0|||
125376068|NCT01059825|451007655|FG000|Treatment Period|Other reason not specified|1|||
125376069|NCT01059825|451007656|FG001|Treatment Period|Other reason not specified|2|||
125376070|NCT01059825|451007657|FG002|Treatment Period|Other reason not specified|1|||
125376071|NCT01059825|451007658|FG003|Treatment Period|Other reason not specified|2|||
125376072|NCT01059825|451007659|FG004|Treatment Period|Other reason not specified|0|||
125376073|NCT01059825|451007660|FG005|Treatment Period|Other reason not specified|0|||
125376074|NCT01059825|451007661|FG006|Treatment Period|Other reason not specified|0|||
125376075|NCT01059825|451007655|FG000|Treatment Period|Protocol Violation|0|||
125129025|NCT01247701|450097730|FG000|Overall Study|Death|2|||
125129026|NCT01247701|450097730|FG000|Overall Study|Relapsed|8|||
125376076|NCT01059825|451007656|FG001|Treatment Period|Protocol Violation|0|||
125376077|NCT01059825|451007657|FG002|Treatment Period|Protocol Violation|1|||
125376078|NCT01059825|451007658|FG003|Treatment Period|Protocol Violation|1|||
125376079|NCT01059825|451007659|FG004|Treatment Period|Protocol Violation|1|||
125435967|NCT02769065|451224236|FG000|Overall Study|Voluntary Withdrawal|1|||
125435968|NCT02769065|451224237|FG001|Overall Study|Voluntary Withdrawal|0|||
125435969|NCT02769065|451224238|FG002|Overall Study|Voluntary Withdrawal|0|||
125435970|NCT02769065|451224239|FG003|Overall Study|Voluntary Withdrawal|0|||
125435971|NCT02769065|451224240|FG004|Overall Study|Voluntary Withdrawal|0|||
125435972|NCT02769065|451224241|FG005|Overall Study|Voluntary Withdrawal|0|||
125435973|NCT02769065|451224242|FG006|Overall Study|Voluntary Withdrawal|0|||
125435974|NCT02769065|451224243|FG007|Overall Study|Voluntary Withdrawal|0|||
125435975|NCT02769065|451224244|FG008|Overall Study|Voluntary Withdrawal|0|||
125435976|NCT02769065|451224245|FG009|Overall Study|Voluntary Withdrawal|0|||
125435977|NCT02769065|451224246|FG010|Overall Study|Voluntary Withdrawal|0|||
125435978|NCT02769065|451224247|FG011|Overall Study|Voluntary Withdrawal|0|||
125435979|NCT02769065|451224248|FG012|Overall Study|Voluntary Withdrawal|0|||
125435980|NCT02769065|451224249|FG013|Overall Study|Voluntary Withdrawal|0|||
125435981|NCT02769065|451224250|FG014|Overall Study|Voluntary Withdrawal|0|||
125435982|NCT02769065|451224251|FG015|Overall Study|Voluntary Withdrawal|0|||
125435983|NCT02769065|451224252|FG016|Overall Study|Voluntary Withdrawal|0|||
125435984|NCT02769065|451224253|FG017|Overall Study|Voluntary Withdrawal|0|||
125129027|NCT04166630|450097731|FG000|Overall Study|Withdrawal by Subject|0|||
125435985|NCT02769065|451224254|FG018|Overall Study|Voluntary Withdrawal|0|||
125435986|NCT02769065|451224255|FG019|Overall Study|Voluntary Withdrawal|0|||
125435987|NCT02769065|451224256|FG020|Overall Study|Voluntary Withdrawal|0|||
125435988|NCT02769065|451224257|FG021|Overall Study|Voluntary Withdrawal|0|||
125435989|NCT02769065|451224258|FG022|Overall Study|Voluntary Withdrawal|0|||
125435990|NCT02769065|451224259|FG023|Overall Study|Voluntary Withdrawal|0|||
125435991|NCT02769065|451224260|FG024|Overall Study|Voluntary Withdrawal|0|||
125435992|NCT02769065|451224261|FG025|Overall Study|Voluntary Withdrawal|0|||
125435993|NCT02769065|451224262|FG026|Overall Study|Voluntary Withdrawal|0|||
125435994|NCT02769065|451224263|FG027|Overall Study|Voluntary Withdrawal|0|||
125435995|NCT02769065|451224264|FG028|Overall Study|Voluntary Withdrawal|0|||
125435996|NCT02769065|451224265|FG029|Overall Study|Voluntary Withdrawal|0|||
125435997|NCT02769065|451224236|FG000|Overall Study|Reason Not Specified|0|||
125435998|NCT02769065|451224237|FG001|Overall Study|Reason Not Specified|0|||
125435999|NCT02769065|451224238|FG002|Overall Study|Reason Not Specified|0|||
125436000|NCT02769065|451224239|FG003|Overall Study|Reason Not Specified|0|||
125436001|NCT02769065|451224240|FG004|Overall Study|Reason Not Specified|0|||
125436002|NCT02769065|451224241|FG005|Overall Study|Reason Not Specified|0|||
125436003|NCT02769065|451224242|FG006|Overall Study|Reason Not Specified|1|||
125436004|NCT02769065|451224243|FG007|Overall Study|Reason Not Specified|0|||
125436005|NCT02769065|451224244|FG008|Overall Study|Reason Not Specified|0|||
125436006|NCT02769065|451224245|FG009|Overall Study|Reason Not Specified|0|||
125436007|NCT02769065|451224246|FG010|Overall Study|Reason Not Specified|0|||
125436008|NCT02769065|451224247|FG011|Overall Study|Reason Not Specified|0|||
125436009|NCT02769065|451224248|FG012|Overall Study|Reason Not Specified|0|||
125436010|NCT02769065|451224249|FG013|Overall Study|Reason Not Specified|0|||
125436011|NCT02769065|451224250|FG014|Overall Study|Reason Not Specified|0|||
125436012|NCT02769065|451224251|FG015|Overall Study|Reason Not Specified|0|||
125436013|NCT02769065|451224252|FG016|Overall Study|Reason Not Specified|0|||
125436014|NCT02769065|451224253|FG017|Overall Study|Reason Not Specified|0|||
125436015|NCT02769065|451224254|FG018|Overall Study|Reason Not Specified|0|||
125436016|NCT02769065|451224255|FG019|Overall Study|Reason Not Specified|0|||
125436017|NCT02769065|451224256|FG020|Overall Study|Reason Not Specified|0|||
125436018|NCT02769065|451224257|FG021|Overall Study|Reason Not Specified|0|||
125436019|NCT02769065|451224258|FG022|Overall Study|Reason Not Specified|0|||
125436020|NCT02769065|451224259|FG023|Overall Study|Reason Not Specified|0|||
125436021|NCT02769065|451224260|FG024|Overall Study|Reason Not Specified|0|||
125630447|NCT01421069|451928510|FG000|Active Treatment Period|Enrolled in observational period|29|||
125630448|NCT01421069|451928510|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
125630449|NCT01421069|451928510|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
125630450|NCT01421069|451928510|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
125630451|NCT01421069|451928510|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
125630452|NCT01421069|451928510|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
125630453|NCT01421069|451928510|FG000|2b. Retreatment Period|Protocol Violation|1|||
125129028|NCT04166630|450097732|FG001|Overall Study|Withdrawal by Subject|1|||
125129029|NCT00096447|450097733|FG000|Overall Study|Never treated|1|||
125436022|NCT02769065|451224261|FG025|Overall Study|Reason Not Specified|0|||
125436023|NCT02769065|451224262|FG026|Overall Study|Reason Not Specified|0|||
125436024|NCT02769065|451224263|FG027|Overall Study|Reason Not Specified|0|||
125436025|NCT02769065|451224264|FG028|Overall Study|Reason Not Specified|0|||
125436026|NCT02769065|451224265|FG029|Overall Study|Reason Not Specified|0|||
125436027|NCT02769065|451224236|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436028|NCT02769065|451224237|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436029|NCT02769065|451224238|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436030|NCT02769065|451224239|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
125630454|NCT01421069|451928510|FG000|Observational Period|Other|1|||
125630455|NCT01421069|451928510|FG000|Observational Period|No longer willing to participate in study|4|||
125630456|NCT01421069|451928510|FG000|Observational Period|Lost to Follow-up|3|||
125630457|NCT01095666|451928511|FG000|Overall Study|Lack of Efficacy|0|||
125630458|NCT01095666|451928512|FG001|Overall Study|Lack of Efficacy|0|||
125630459|NCT01095666|451928513|FG002|Overall Study|Lack of Efficacy|1|||
125630460|NCT01095666|451928511|FG000|Overall Study|Adverse Event|2|||
125630461|NCT01095666|451928512|FG001|Overall Study|Adverse Event|1|||
125630462|NCT01095666|451928513|FG002|Overall Study|Adverse Event|3|||
125630463|NCT01095666|451928511|FG000|Overall Study|Lost to Follow-up|2|||
125630464|NCT01095666|451928512|FG001|Overall Study|Lost to Follow-up|2|||
125630465|NCT01095666|451928513|FG002|Overall Study|Lost to Follow-up|0|||
125630466|NCT01095666|451928511|FG000|Overall Study|Withdrawal by Subject|6|||
125630467|NCT01095666|451928512|FG001|Overall Study|Withdrawal by Subject|6|||
125630468|NCT01095666|451928513|FG002|Overall Study|Withdrawal by Subject|1|||
125630469|NCT01095666|451928511|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
125630470|NCT01095666|451928512|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
125630471|NCT01095666|451928513|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
125630472|NCT00841672|451928522|FG000|Overall Study|Adverse Event|7|||
125630473|NCT00841672|451928523|FG001|Overall Study|Adverse Event|16|||
125630474|NCT00841672|451928522|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125630475|NCT00841672|451928523|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125630476|NCT00841672|451928522|FG000|Overall Study|Subject withdrew consent|2|||
125630477|NCT00841672|451928523|FG001|Overall Study|Subject withdrew consent|4|||
125630478|NCT00841672|451928522|FG000|Overall Study|Lost to Follow-up|1|||
125630479|NCT00841672|451928523|FG001|Overall Study|Lost to Follow-up|1|||
125630480|NCT00841672|451928522|FG000|Overall Study|Administrative problems|9|||
125630481|NCT00841672|451928523|FG001|Overall Study|Administrative problems|9|||
125630482|NCT00841672|451928522|FG000|Overall Study|Misrandomized|1|||
125630483|NCT00841672|451928523|FG001|Overall Study|Misrandomized|0|||
125630484|NCT00841672|451928522|FG000|Overall Study|Protocol Deviation|0|||
125630485|NCT00841672|451928523|FG001|Overall Study|Protocol Deviation|1|||
125630486|NCT01451398|451928527|FG000|Overall Study|Adverse Event|7|||
125630487|NCT01451398|451928528|FG001|Overall Study|Adverse Event|9|||
125630488|NCT01451398|451928527|FG000|Overall Study|Protocol Violation|1|||
125630489|NCT01451398|451928528|FG001|Overall Study|Protocol Violation|2|||
125630490|NCT01451398|451928527|FG000|Overall Study|Physician Decision|1|||
125630491|NCT01451398|451928528|FG001|Overall Study|Physician Decision|1|||
125630492|NCT01451398|451928527|FG000|Overall Study|Withdrawal by Subject|10|||
125630493|NCT01451398|451928528|FG001|Overall Study|Withdrawal by Subject|14|||
125436031|NCT02769065|451224240|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436032|NCT02769065|451224241|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436033|NCT02769065|451224242|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436034|NCT02769065|451224243|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436035|NCT02769065|451224244|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436036|NCT02769065|451224245|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436037|NCT02769065|451224246|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
125436038|NCT02769065|451224247|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436039|NCT02769065|451224248|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436040|NCT02769065|451224249|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436041|NCT02769065|451224250|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436042|NCT02769065|451224251|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436043|NCT02769065|451224252|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436044|NCT02769065|451224253|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436045|NCT02769065|451224254|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436046|NCT02769065|451224255|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436047|NCT02769065|451224256|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436048|NCT02769065|451224257|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436049|NCT02769065|451224258|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436050|NCT02769065|451224259|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436051|NCT02769065|451224260|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436052|NCT02769065|451224261|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436053|NCT02769065|451224262|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
125630494|NCT01451398|451928527|FG000|Overall Study|Lost to Follow-up|6|||
125630495|NCT01451398|451928528|FG001|Overall Study|Lost to Follow-up|4|||
125630496|NCT01451398|451928527|FG000|Overall Study|Non-compliance with study drug|1|||
125630497|NCT01451398|451928528|FG001|Overall Study|Non-compliance with study drug|3|||
125630498|NCT01451398|451928527|FG000|Overall Study|Non-compliance with protocol|1|||
125630499|NCT01451398|451928528|FG001|Overall Study|Non-compliance with protocol|1|||
125630500|NCT01451398|451928527|FG000|Overall Study|Moved out of country|0|||
125630501|NCT01451398|451928528|FG001|Overall Study|Moved out of country|1|||
125630502|NCT01451398|451928527|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
125215745|NCT00492232|450417501|FG000|Double-Blind Treatment|Adverse Event|1|||
125215746|NCT00492232|450417502|FG001|Double-Blind Treatment|Adverse Event|2|||
125215747|NCT00492232|450417501|FG000|Double-Blind Treatment|Protocol Violation|3|||
125376080|NCT01059825|451007660|FG005|Treatment Period|Protocol Violation|1|||
125376081|NCT01059825|451007661|FG006|Treatment Period|Protocol Violation|0|||
125376082|NCT01059825|451007655|FG000|Treatment Period|Adverse event related to study drug|1|||
125376083|NCT01059825|451007656|FG001|Treatment Period|Adverse event related to study drug|0|||
125376084|NCT01059825|451007657|FG002|Treatment Period|Adverse event related to study drug|1|||
125376085|NCT01059825|451007658|FG003|Treatment Period|Adverse event related to study drug|1|||
125376086|NCT01059825|451007659|FG004|Treatment Period|Adverse event related to study drug|0|||
125376087|NCT01059825|451007660|FG005|Treatment Period|Adverse event related to study drug|0|||
125376088|NCT01059825|451007661|FG006|Treatment Period|Adverse event related to study drug|0|||
125376089|NCT01059825|451007655|FG000|Treatment Period|Insufficient clinical response|3|||
125376090|NCT01059825|451007656|FG001|Treatment Period|Insufficient clinical response|0|||
125376091|NCT01059825|451007657|FG002|Treatment Period|Insufficient clinical response|0|||
125376092|NCT01059825|451007658|FG003|Treatment Period|Insufficient clinical response|0|||
125376093|NCT01059825|451007659|FG004|Treatment Period|Insufficient clinical response|0|||
125376094|NCT01059825|451007660|FG005|Treatment Period|Insufficient clinical response|0|||
125376095|NCT01059825|451007661|FG006|Treatment Period|Insufficient clinical response|0|||
125376096|NCT01059825|451007655|FG000|Treatment Period|Adverse event not related to study drug|0|||
125376097|NCT01059825|451007656|FG001|Treatment Period|Adverse event not related to study drug|1|||
125376098|NCT01059825|451007657|FG002|Treatment Period|Adverse event not related to study drug|2|||
125376099|NCT01059825|451007658|FG003|Treatment Period|Adverse event not related to study drug|1|||
125376100|NCT01059825|451007659|FG004|Treatment Period|Adverse event not related to study drug|1|||
125376101|NCT01059825|451007660|FG005|Treatment Period|Adverse event not related to study drug|1|||
125376102|NCT01059825|451007661|FG006|Treatment Period|Adverse event not related to study drug|0|||
125376103|NCT00549302|451007662|FG000|Double-Blind|Death|2|||
125376104|NCT00549302|451007663|FG001|Double-Blind|Death|9|||
125376105|NCT00549302|451007664|FG002|Double-Blind|Death|0|||
125376106|NCT00549302|451007662|FG000|Double-Blind|Adverse Event|3|||
125376107|NCT00549302|451007663|FG001|Double-Blind|Adverse Event|16|||
125376108|NCT00549302|451007664|FG002|Double-Blind|Adverse Event|0|||
125376109|NCT00549302|451007662|FG000|Double-Blind|Withdrawal by Subject|3|||
125376110|NCT00549302|451007663|FG001|Double-Blind|Withdrawal by Subject|8|||
125376111|NCT00549302|451007664|FG002|Double-Blind|Withdrawal by Subject|0|||
125376112|NCT00549302|451007662|FG000|Double-Blind|Investigator Decision|1|||
125376113|NCT00549302|451007663|FG001|Double-Blind|Investigator Decision|5|||
125376114|NCT00549302|451007664|FG002|Double-Blind|Investigator Decision|0|||
125376115|NCT00549302|451007662|FG000|Double-Blind|Sponsor Decision|0|||
125376116|NCT00549302|451007663|FG001|Double-Blind|Sponsor Decision|1|||
125376117|NCT00549302|451007664|FG002|Double-Blind|Sponsor Decision|0|||
125376118|NCT00549302|451007662|FG000|Double-Blind|Lost to Follow-up|1|||
125376119|NCT00549302|451007663|FG001|Double-Blind|Lost to Follow-up|2|||
125376120|NCT00549302|451007664|FG002|Double-Blind|Lost to Follow-up|0|||
125376121|NCT00549302|451007662|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
125376122|NCT00549302|451007663|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
125376123|NCT00549302|451007664|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
125376124|NCT00549302|451007662|FG000|Double-Blind|New condition or starts new therapy|0|||
125376125|NCT00549302|451007663|FG001|Double-Blind|New condition or starts new therapy|2|||
125376126|NCT00549302|451007664|FG002|Double-Blind|New condition or starts new therapy|0|||
125376127|NCT00549302|451007662|FG000|Open-Label|Adverse Event|0|||
125376128|NCT00549302|451007663|FG001|Open-Label|Adverse Event|0|||
125376129|NCT00549302|451007664|FG002|Open-Label|Adverse Event|11|||
125376130|NCT00549302|451007662|FG000|Open-Label|Death|0|||
125376131|NCT00549302|451007663|FG001|Open-Label|Death|0|||
125376132|NCT00549302|451007664|FG002|Open-Label|Death|40|||
125376133|NCT00549302|451007662|FG000|Open-Label|Investigator Decision|0|||
125376134|NCT00549302|451007663|FG001|Open-Label|Investigator Decision|0|||
125376135|NCT00549302|451007664|FG002|Open-Label|Investigator Decision|5|||
125376136|NCT00549302|451007662|FG000|Open-Label|Lost to Follow-up|0|||
125376137|NCT00549302|451007663|FG001|Open-Label|Lost to Follow-up|0|||
125376138|NCT00549302|451007664|FG002|Open-Label|Lost to Follow-up|2|||
125376139|NCT00549302|451007662|FG000|Open-Label|Other|0|||
125376140|NCT00549302|451007663|FG001|Open-Label|Other|0|||
125376141|NCT00549302|451007664|FG002|Open-Label|Other|3|||
125376142|NCT00549302|451007662|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
125376143|NCT00549302|451007663|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
125376144|NCT00549302|451007664|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
125376145|NCT00549302|451007662|FG000|Open-Label|Withdrawal by Subject|0|||
125376146|NCT00549302|451007663|FG001|Open-Label|Withdrawal by Subject|0|||
125376147|NCT00549302|451007664|FG002|Open-Label|Withdrawal by Subject|6|||
125376148|NCT00411645|451007668|FG000|Overall Study|Consent Withdrawn|13|||
125376149|NCT00411645|451007669|FG001|Overall Study|Consent Withdrawn|22|||
125376150|NCT00411645|451007668|FG000|Overall Study|Death|56|||
125376151|NCT00411645|451007669|FG001|Overall Study|Death|135|||
125376152|NCT00411645|451007668|FG000|Overall Study|Investigator/Sponsor Decision|10|||
125436054|NCT02769065|451224263|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436055|NCT02769065|451224264|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436056|NCT02769065|451224265|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
125436057|NCT02764775|451224268|FG000|Overall Study|Death|1|||
125436058|NCT02764775|451224268|FG000|Overall Study|Lost to Follow-up|2|||
125436059|NCT02764775|451224268|FG000|Overall Study|Withdrawal by Subject|3|||
125436060|NCT00767104|451224271|FG000|Overall Study|Lost to Follow-up|1|||
125436061|NCT00767104|451224272|FG001|Overall Study|Lost to Follow-up|2|||
125436062|NCT01186328|451224280|FG000|Overall Study|Death|1|||
125436063|NCT01186328|451224281|FG001|Overall Study|Death|0|||
125436064|NCT01186328|451224282|FG002|Overall Study|Death|0|||
125436065|NCT03015116|451224285|FG000|Overall Study|Lost to Follow-up|3|||
125436066|NCT03015116|451224286|FG001|Overall Study|Lost to Follow-up|0|||
125436067|NCT03015116|451224287|FG002|Overall Study|Lost to Follow-up|2|||
125436068|NCT03015116|451224285|FG000|Overall Study|Withdrawal by Subject|3|||
125436069|NCT03015116|451224286|FG001|Overall Study|Withdrawal by Subject|1|||
125436070|NCT03015116|451224287|FG002|Overall Study|Withdrawal by Subject|0|||
125436071|NCT03015116|451224285|FG000|Overall Study|Subject has New Medical Status|1|||
125436072|NCT03015116|451224286|FG001|Overall Study|Subject has New Medical Status|0|||
125436073|NCT03015116|451224287|FG002|Overall Study|Subject has New Medical Status|0|||
125436074|NCT03015116|451224285|FG000|Overall Study|Physician Decision|0|||
125436075|NCT03015116|451224286|FG001|Overall Study|Physician Decision|1|||
125436076|NCT03015116|451224287|FG002|Overall Study|Physician Decision|0|||
125436077|NCT02200939|451224292|FG000|Overall Study|Participant withdrew consent|0|||
125436078|NCT02200939|451224293|FG001|Overall Study|Participant withdrew consent|1|||
125436079|NCT02200939|451224292|FG000|Overall Study|Lost to Follow-up|2|||
125436080|NCT02200939|451224293|FG001|Overall Study|Lost to Follow-up|9|||
125436081|NCT02200939|451224292|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
125436082|NCT02200939|451224293|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
125436083|NCT02762981|451224294|FG000|Overall Study|Adverse Event|2|||
125436084|NCT02762981|451224295|FG001|Overall Study|Adverse Event|3|||
125436085|NCT02762981|451224296|FG002|Overall Study|Adverse Event|1|||
125436086|NCT02762981|451224297|FG003|Overall Study|Adverse Event|1|||
125436087|NCT02762981|451224298|FG004|Overall Study|Adverse Event|3|||
125436088|NCT02762981|451224294|FG000|Overall Study|Physician Decision|0|||
125436089|NCT02762981|451224295|FG001|Overall Study|Physician Decision|1|||
125436090|NCT02762981|451224296|FG002|Overall Study|Physician Decision|0|||
125436091|NCT02762981|451224297|FG003|Overall Study|Physician Decision|0|||
125436092|NCT02762981|451224298|FG004|Overall Study|Physician Decision|1|||
125436093|NCT02762981|451224294|FG000|Overall Study|Disease progression|11|||
125436094|NCT02762981|451224295|FG001|Overall Study|Disease progression|23|||
125436095|NCT02762981|451224296|FG002|Overall Study|Disease progression|4|||
125436096|NCT02762981|451224297|FG003|Overall Study|Disease progression|10|||
125436097|NCT02762981|451224298|FG004|Overall Study|Disease progression|1|||
125436098|NCT02762981|451224294|FG000|Overall Study|Enrolled not treated|1|||
125129030|NCT00834743|450097734|FG000|Second Intervention|Withdrawal by Subject|1|||
125129031|NCT00834743|450097735|FG001|Second Intervention|Withdrawal by Subject|0|||
125129032|NCT04088760|450097736|FG000|Overall Study|Physician Decision|1|||
125129033|NCT04091971|450097737|FG000|Overall Study|Withdrawal by Subject|1|||
125129034|NCT04091971|450097737|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
125436099|NCT02762981|451224295|FG001|Overall Study|Enrolled not treated|5|||
125436100|NCT02762981|451224296|FG002|Overall Study|Enrolled not treated|0|||
125436101|NCT02762981|451224297|FG003|Overall Study|Enrolled not treated|2|||
125129035|NCT04091971|450097737|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
125129036|NCT02472366|450097741|FG000|Overall Study|Lost to Follow-up|1|||
125129037|NCT02472366|450097742|FG001|Overall Study|Lost to Follow-up|0|||
125129038|NCT02728102|450097743|FG000|Overall Study|Death|3|||
125129039|NCT02728102|450097744|FG001|Overall Study|Death|0|||
125129040|NCT02728102|450097745|FG002|Overall Study|Death|1|||
125129041|NCT02728102|450097743|FG000|Overall Study|Withdrawal by Subject|0|||
125129042|NCT02728102|450097744|FG001|Overall Study|Withdrawal by Subject|2|||
125129043|NCT02728102|450097745|FG002|Overall Study|Withdrawal by Subject|3|||
125436102|NCT02762981|451224298|FG004|Overall Study|Enrolled not treated|0|||
125129044|NCT02728102|450097743|FG000|Overall Study|Physician Decision|1|||
125129045|NCT02728102|450097744|FG001|Overall Study|Physician Decision|1|||
125436103|NCT02762981|451224294|FG000|Overall Study|Other|2|||
125436104|NCT02762981|451224295|FG001|Overall Study|Other|3|||
125129046|NCT02728102|450097745|FG002|Overall Study|Physician Decision|0|||
125129047|NCT02728102|450097743|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
125129048|NCT02728102|450097744|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
125129049|NCT02728102|450097745|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
125436105|NCT02762981|451224296|FG002|Overall Study|Other|1|||
125436106|NCT02762981|451224297|FG003|Overall Study|Other|0|||
125436107|NCT02762981|451224298|FG004|Overall Study|Other|0|||
125436108|NCT02762981|451224294|FG000|Overall Study|Missing|1|||
125436109|NCT02762981|451224295|FG001|Overall Study|Missing|0|||
125436110|NCT02762981|451224296|FG002|Overall Study|Missing|0|||
125129050|NCT02728102|450097743|FG000|Overall Study|Covid|0|||
125129051|NCT02728102|450097744|FG001|Overall Study|Covid|0|||
125129052|NCT02728102|450097745|FG002|Overall Study|Covid|1|||
125129053|NCT02419937|450097748|FG000|Overall Study|Lost to Follow-up|1|||
125129054|NCT02419937|450097749|FG001|Overall Study|Lost to Follow-up|0|||
125129055|NCT02924883|450097750|FG000|Overall Study|Death|39|||
125129056|NCT02924883|450097751|FG001|Overall Study|Death|20|||
125129057|NCT02924883|450097750|FG000|Overall Study|Lost to Follow-up|1|||
125129058|NCT02924883|450097751|FG001|Overall Study|Lost to Follow-up|0|||
125129059|NCT02924883|450097750|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
125129060|NCT02924883|450097751|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
125129061|NCT02924883|450097750|FG000|Overall Study|Protocol Violation|1|||
125129062|NCT02924883|450097751|FG001|Overall Study|Protocol Violation|0|||
125129063|NCT02924883|450097750|FG000|Overall Study|Withdrawal by Subject|22|||
125129064|NCT02924883|450097751|FG001|Overall Study|Withdrawal by Subject|16|||
125129065|NCT02924883|450097750|FG000|Overall Study|Progressive Disease|1|||
125436111|NCT02762981|451224297|FG003|Overall Study|Missing|0|||
125436112|NCT02762981|451224298|FG004|Overall Study|Missing|0|||
125436113|NCT02762981|451224294|FG000|Overall Study|Withdrawal by Subject|0|||
125436114|NCT02762981|451224295|FG001|Overall Study|Withdrawal by Subject|5|||
125129066|NCT02924883|450097751|FG001|Overall Study|Progressive Disease|0|||
125129067|NCT02924883|450097750|FG000|Overall Study|Study Terminated by Sponsor|69|||
125436115|NCT02762981|451224296|FG002|Overall Study|Withdrawal by Subject|1|||
125436116|NCT02762981|451224297|FG003|Overall Study|Withdrawal by Subject|3|||
125436117|NCT02762981|451224298|FG004|Overall Study|Withdrawal by Subject|0|||
125436118|NCT01382940|451224299|FG000|Overall Study|Adverse Event|19|||
125436119|NCT01382940|451224299|FG000|Overall Study|Lost to Follow-up|4|||
125436120|NCT01382940|451224299|FG000|Overall Study|Physician Decision|7|||
125436121|NCT01382940|451224299|FG000|Overall Study|Withdrawal by Subject|23|||
125436122|NCT01382940|451224299|FG000|Overall Study|Protocol Violation|20|||
125436123|NCT00244374|451224302|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
125436124|NCT00244374|451224303|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
125436125|NCT00244374|451224304|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
125436126|NCT00244374|451224305|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
125436127|NCT00244374|451224306|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
125436128|NCT00244374|451224302|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
125436129|NCT00244374|451224303|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
125436130|NCT00244374|451224304|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
125436131|NCT00244374|451224305|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
125436132|NCT00244374|451224306|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
125436133|NCT00244374|451224302|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
125436134|NCT00244374|451224303|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
125436135|NCT00244374|451224304|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
125436136|NCT00244374|451224305|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
125630503|NCT01451398|451928528|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
125129068|NCT02924883|450097751|FG001|Overall Study|Study Terminated by Sponsor|32|||
125129069|NCT01182415|450097752|FG000|Overall Study|Lost to Follow-up|1|||
125129070|NCT01981720|450097753|FG000|Overall Study|Adverse Event|1|||
125129071|NCT01981720|450097753|FG000|Overall Study|Withdrawal by Subject|3|||
125129072|NCT01981720|450097753|FG000|Overall Study|Pregnancy|1|||
125129073|NCT00004562|450097756|FG000|Overall Study|Lost to Follow-up|102|||
125129074|NCT00004562|450097757|FG001|Overall Study|Lost to Follow-up|91|||
125129075|NCT02770820|450097758|FG000|Overall Study|Death|1|||
125129076|NCT02770820|450097758|FG000|Overall Study|Physician Decision|2|||
125129077|NCT02336165|450097759|FG000|Overall Study|Death|3|||
125129078|NCT02336165|450097760|FG001|Overall Study|Death|0|||
125129079|NCT02336165|450097761|FG002|Overall Study|Death|0|||
125630504|NCT01451398|451928527|FG000|Overall Study|Lack of Efficacy|0|||
125630505|NCT01451398|451928528|FG001|Overall Study|Lack of Efficacy|1|||
125630506|NCT02427100|451928532|FG000|Overall Study|Lost to Follow-up|0|||
125630507|NCT02427100|451928533|FG001|Overall Study|Lost to Follow-up|2|||
125630508|NCT03094611|451928534|FG000|Overall Study|Lack of Efficacy|1|||
125630509|NCT03094611|451928534|FG000|Overall Study|Stem Cell Transplant|1|||
125630510|NCT00842361|451928535|FG000|Overall Study|Protocol Violation|1|||
125630511|NCT00842361|451928536|FG001|Overall Study|Protocol Violation|0|||
125630512|NCT00842361|451928535|FG000|Overall Study|Unclassified|0|||
125630513|NCT00842361|451928536|FG001|Overall Study|Unclassified|2|||
125630514|NCT00924729|451928542|FG000|Overall Study|insufficient volume for analysis|1|||
125630515|NCT00924729|451928543|FG001|Overall Study|insufficient volume for analysis|0|||
125630516|NCT00924729|451928542|FG000|Overall Study|Protocol Violation|1|||
125129080|NCT02336165|450097762|FG003|Overall Study|Death|0|||
125129081|NCT02336165|450097763|FG004|Overall Study|Death|1|||
125129082|NCT02336165|450097759|FG000|Overall Study|Physician Decision|2|||
125129083|NCT02336165|450097760|FG001|Overall Study|Physician Decision|2|||
125436137|NCT00244374|451224306|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
125630517|NCT00924729|451928543|FG001|Overall Study|Protocol Violation|0|||
125436138|NCT00244374|451224302|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
125630518|NCT00981747|451928546|FG000|Losartan|Withdrawal by Subject|1|||
125630519|NCT00981747|451928546|FG000|Losartan|Death|1|||
125630520|NCT00981747|451928546|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
125630521|NCT01814826|451928547|FG000|Overall Study|Other|3|||
125630522|NCT01814826|451928548|FG001|Overall Study|Other|5|||
125630523|NCT01814826|451928549|FG002|Overall Study|Other|0|||
125630524|NCT01814826|451928547|FG000|Overall Study|Death|29|||
125630525|NCT01814826|451928548|FG001|Overall Study|Death|24|||
125630526|NCT01814826|451928549|FG002|Overall Study|Death|3|||
125630527|NCT02917629|451928550|FG000|Overall Study|Withdrawal by Subject|0|||
125630528|NCT02917629|451928551|FG001|Overall Study|Withdrawal by Subject|1|||
125630529|NCT03339401|451928552|FG000|Overall Study|Death|2|||
125630530|NCT03339401|451928553|FG001|Overall Study|Death|1|||
125630531|NCT03339401|451928552|FG000|Overall Study|Withdrawal by Subject|2|||
125630532|NCT03339401|451928553|FG001|Overall Study|Withdrawal by Subject|0|||
125630533|NCT03339401|451928552|FG000|Overall Study|Study terminated|4|||
125630534|NCT03339401|451928553|FG001|Overall Study|Study terminated|3|||
125630535|NCT03339401|451928552|FG000|Overall Study|Investigator Decision|1|||
125630536|NCT03339401|451928553|FG001|Overall Study|Investigator Decision|0|||
125630537|NCT00718523|451928554|FG000|Overall Study|Withdrawal by Subject|5|||
125630538|NCT00718523|451928555|FG001|Overall Study|Withdrawal by Subject|7|||
125630539|NCT00718523|451928554|FG000|Overall Study|Death|13|||
125630540|NCT00718523|451928555|FG001|Overall Study|Death|17|||
125630541|NCT03271307|451928556|FG000|Overall Study|Lost to Follow-up|0|||
125630542|NCT03271307|451928557|FG001|Overall Study|Lost to Follow-up|0|||
125630543|NCT03271307|451928558|FG002|Overall Study|Lost to Follow-up|0|||
125630544|NCT03271307|451928559|FG003|Overall Study|Lost to Follow-up|28|||
125630545|NCT03271307|451928560|FG004|Overall Study|Lost to Follow-up|91|||
125630546|NCT03365947|451928561|FG000|Overall Study|Lost to Follow-up|0|||
125630547|NCT03365947|451928562|FG001|Overall Study|Lost to Follow-up|0|||
125630548|NCT03365947|451928563|FG002|Overall Study|Lost to Follow-up|0|||
125630549|NCT03365947|451928564|FG003|Overall Study|Lost to Follow-up|0|||
125630550|NCT03365947|451928565|FG004|Overall Study|Lost to Follow-up|0|||
125630551|NCT03365947|451928566|FG005|Overall Study|Lost to Follow-up|1|||
125630552|NCT03365947|451928567|FG006|Overall Study|Lost to Follow-up|0|||
125630553|NCT03365947|451928568|FG007|Overall Study|Lost to Follow-up|0|||
125630554|NCT03365947|451928569|FG008|Overall Study|Lost to Follow-up|0|||
125630555|NCT03365947|451928570|FG009|Overall Study|Lost to Follow-up|0|||
125630556|NCT03365947|451928571|FG010|Overall Study|Lost to Follow-up|0|||
125630557|NCT03365947|451928572|FG011|Overall Study|Lost to Follow-up|0|||
125630558|NCT03365947|451928573|FG012|Overall Study|Lost to Follow-up|0|||
125630559|NCT03365947|451928574|FG013|Overall Study|Lost to Follow-up|0|||
125630560|NCT03365947|451928575|FG014|Overall Study|Lost to Follow-up|0|||
125630561|NCT03365947|451928576|FG015|Overall Study|Lost to Follow-up|0|||
125630562|NCT03365947|451928577|FG016|Overall Study|Lost to Follow-up|0|||
125630563|NCT03365947|451928578|FG017|Overall Study|Lost to Follow-up|0|||
125630564|NCT03365947|451928579|FG018|Overall Study|Lost to Follow-up|0|||
125630565|NCT01042938|451928580|FG000|Overall Study|Withdrawal by Subject|1|||
125630566|NCT01042938|451928581|FG001|Overall Study|Withdrawal by Subject|1|||
125630567|NCT01042938|451928580|FG000|Overall Study|Protocol Violation|1|||
125630568|NCT01042938|451928581|FG001|Overall Study|Protocol Violation|1|||
125630569|NCT01042938|451928580|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
125630570|NCT01042938|451928581|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
125630571|NCT03136484|451928582|FG000|Overall Study|Withdrawal by Subject|19|||
125630572|NCT03136484|451928583|FG001|Overall Study|Withdrawal by Subject|14|||
125630573|NCT03136484|451928582|FG000|Overall Study|Lost to Follow-up|7|||
125630574|NCT03136484|451928583|FG001|Overall Study|Lost to Follow-up|8|||
125630575|NCT03136484|451928582|FG000|Overall Study|Death|1|||
125630576|NCT03136484|451928583|FG001|Overall Study|Death|0|||
125630577|NCT03997760|451928588|FG000|Overall Study|Protocol Deviation|0|||
125630578|NCT03997760|451928589|FG001|Overall Study|Protocol Deviation|1|||
125630579|NCT03997760|451928590|FG002|Overall Study|Protocol Deviation|0|||
125630580|NCT03997760|451928591|FG003|Overall Study|Protocol Deviation|0|||
125630581|NCT00856986|451928592|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
125630582|NCT00856986|451928593|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
125630583|NCT00856986|451928594|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
125630584|NCT00856986|451928595|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
125630585|NCT00856986|451928596|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
125630586|NCT00856986|451928592|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
125630587|NCT00856986|451928593|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
125630588|NCT00856986|451928594|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
125630589|NCT00856986|451928595|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
125630590|NCT00856986|451928596|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
125630591|NCT00856986|451928592|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
125630592|NCT00856986|451928593|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
125129084|NCT02336165|450097761|FG002|Overall Study|Physician Decision|1|||
125129085|NCT02336165|450097762|FG003|Overall Study|Physician Decision|1|||
125129086|NCT02336165|450097763|FG004|Overall Study|Physician Decision|0|||
125129087|NCT02336165|450097759|FG000|Overall Study|Withdrawal by Subject|0|||
125129088|NCT02336165|450097760|FG001|Overall Study|Withdrawal by Subject|0|||
125129089|NCT02336165|450097761|FG002|Overall Study|Withdrawal by Subject|1|||
125129090|NCT02336165|450097762|FG003|Overall Study|Withdrawal by Subject|0|||
125129091|NCT02336165|450097763|FG004|Overall Study|Withdrawal by Subject|1|||
125129092|NCT02336165|450097759|FG000|Overall Study|Adverse Event|4|||
125129093|NCT02336165|450097760|FG001|Overall Study|Adverse Event|1|||
125436542|NCT02597933|451224423|FG001|Overall Study|Other than stated above|14|||
125630593|NCT00856986|451928594|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
125630594|NCT00856986|451928595|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
125630595|NCT00856986|451928596|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
125630596|NCT00856986|451928592|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
125630597|NCT00856986|451928593|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
125630598|NCT00856986|451928594|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
125630599|NCT00856986|451928595|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
125630600|NCT00856986|451928596|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
125630601|NCT00856986|451928592|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
125630602|NCT00856986|451928593|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
125630603|NCT00856986|451928594|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
125630604|NCT00856986|451928595|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
125630605|NCT00856986|451928596|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
125630606|NCT00856986|451928592|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
125630607|NCT00856986|451928593|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
125630608|NCT00856986|451928594|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
125630609|NCT00856986|451928595|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
125630610|NCT00856986|451928596|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
125630611|NCT00856986|451928592|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
125630612|NCT00856986|451928593|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
125630613|NCT00856986|451928594|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
125630614|NCT00856986|451928595|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
125630615|NCT00856986|451928596|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
125630616|NCT00856986|451928592|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
125630617|NCT00856986|451928593|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
125630618|NCT00856986|451928594|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
125630619|NCT00856986|451928595|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
125630620|NCT00856986|451928596|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
125630621|NCT00856986|451928592|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
125630622|NCT00856986|451928593|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
125630623|NCT00856986|451928594|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
125630624|NCT00856986|451928595|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
125630625|NCT00856986|451928596|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
125630626|NCT00856986|451928592|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
125630627|NCT00856986|451928593|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
125630628|NCT00856986|451928594|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
125630629|NCT00856986|451928595|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
125630630|NCT00856986|451928596|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
125630631|NCT00856986|451928592|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
125630632|NCT00856986|451928593|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
125630633|NCT00856986|451928594|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
125630634|NCT00856986|451928595|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
125630635|NCT00856986|451928596|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
125630636|NCT00856986|451928592|FG000|Main Period, Weeks 0-26|Unclassified|7|||
125630637|NCT00856986|451928593|FG001|Main Period, Weeks 0-26|Unclassified|6|||
125630638|NCT00856986|451928594|FG002|Main Period, Weeks 0-26|Unclassified|7|||
125630639|NCT00856986|451928595|FG003|Main Period, Weeks 0-26|Unclassified|0|||
125630640|NCT00856986|451928596|FG004|Main Period, Weeks 0-26|Unclassified|0|||
125630641|NCT00856986|451928592|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
125630642|NCT00856986|451928593|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
125630643|NCT00856986|451928594|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
125630644|NCT00856986|451928595|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
125630645|NCT00856986|451928596|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
125630646|NCT00856986|451928592|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
125630647|NCT00856986|451928593|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
125630648|NCT00856986|451928594|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
125630649|NCT00856986|451928595|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
125630650|NCT00856986|451928596|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
125129094|NCT02336165|450097761|FG002|Overall Study|Adverse Event|2|||
125129095|NCT02336165|450097762|FG003|Overall Study|Adverse Event|4|||
125129096|NCT02336165|450097763|FG004|Overall Study|Adverse Event|1|||
125129097|NCT02336165|450097759|FG000|Overall Study|Progressive disease|23|||
125630651|NCT00856986|451928592|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
125630652|NCT00856986|451928593|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
125630653|NCT00856986|451928594|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
125630654|NCT00856986|451928595|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
125630655|NCT00856986|451928596|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
125630656|NCT00856986|451928592|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
125630657|NCT00856986|451928593|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
125630658|NCT00856986|451928594|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
125630659|NCT00856986|451928595|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
125630660|NCT00856986|451928596|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
125630661|NCT00856986|451928592|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
125630662|NCT00856986|451928593|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
125630663|NCT00856986|451928594|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
125630664|NCT00856986|451928595|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
125630665|NCT00856986|451928596|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
125630666|NCT00856986|451928592|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
125630667|NCT00856986|451928593|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
125630668|NCT00856986|451928594|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
125630669|NCT00856986|451928595|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
125630670|NCT00856986|451928596|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
125129098|NCT02336165|450097760|FG001|Overall Study|Progressive disease|22|||
125129099|NCT02336165|450097761|FG002|Overall Study|Progressive disease|27|||
125129100|NCT02336165|450097762|FG003|Overall Study|Progressive disease|24|||
125129101|NCT02336165|450097763|FG004|Overall Study|Progressive disease|19|||
125129102|NCT02336165|450097759|FG000|Overall Study|Non-compliance|1|||
125630671|NCT05041062|451928597|FG000|Overall Study|Adverse Event|2|||
125630672|NCT01915095|451928598|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
125630673|NCT01915095|451928599|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
125630674|NCT01915095|451928600|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
125630675|NCT01915095|451928601|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
125630676|NCT01915095|451928602|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
125129103|NCT02336165|450097760|FG001|Overall Study|Non-compliance|0|||
125630677|NCT04018612|451928603|FG000|Overall Study|Withdrawal by Subject|1|||
125129104|NCT02336165|450097761|FG002|Overall Study|Non-compliance|0|||
125129105|NCT02336165|450097762|FG003|Overall Study|Non-compliance|1|||
125376153|NCT00411645|451007669|FG001|Overall Study|Investigator/Sponsor Decision|7|||
125376154|NCT00411645|451007668|FG000|Overall Study|Lost to Follow-up|2|||
125376155|NCT00411645|451007669|FG001|Overall Study|Lost to Follow-up|0|||
125376156|NCT00779467|451007670|FG000|Overall Study|Lack of Efficacy|11|||
125376157|NCT00779467|451007671|FG001|Overall Study|Lack of Efficacy|2|||
125376158|NCT00779467|451007672|FG002|Overall Study|Lack of Efficacy|6|||
125376159|NCT00779467|451007673|FG003|Overall Study|Lack of Efficacy|11|||
125376160|NCT00779467|451007670|FG000|Overall Study|failed inclusion criteria|3|||
125376161|NCT00779467|451007671|FG001|Overall Study|failed inclusion criteria|3|||
125376162|NCT00779467|451007672|FG002|Overall Study|failed inclusion criteria|1|||
125376163|NCT00779467|451007673|FG003|Overall Study|failed inclusion criteria|2|||
125376164|NCT00779467|451007670|FG000|Overall Study|missing data|1|||
125376165|NCT00779467|451007671|FG001|Overall Study|missing data|0|||
125376166|NCT00779467|451007672|FG002|Overall Study|missing data|1|||
125376167|NCT00779467|451007673|FG003|Overall Study|missing data|4|||
125376168|NCT00779467|451007670|FG000|Overall Study|technical issue|0|||
125376169|NCT00779467|451007671|FG001|Overall Study|technical issue|0|||
125376170|NCT00779467|451007672|FG002|Overall Study|technical issue|2|||
125376171|NCT00779467|451007673|FG003|Overall Study|technical issue|1|||
125376172|NCT00779467|451007670|FG000|Overall Study|unavailable research staff|0|||
125376173|NCT00779467|451007671|FG001|Overall Study|unavailable research staff|0|||
125376174|NCT00779467|451007672|FG002|Overall Study|unavailable research staff|0|||
125376175|NCT00779467|451007673|FG003|Overall Study|unavailable research staff|1|||
125376176|NCT04118166|451007676|FG000|Overall Study|Adverse Event|1|||
125376177|NCT05048784|451007683|FG000|Period 1|Adverse Event|3|||
125376178|NCT05048784|451007684|FG001|Period 1|Adverse Event|1|||
125376179|NCT05048784|451007685|FG002|Period 1|Adverse Event|0|||
125376180|NCT05048784|451007686|FG003|Period 1|Adverse Event|0|||
125376181|NCT05048784|451007683|FG000|Period 2|Lost to Follow-up|0|||
125376182|NCT05048784|451007684|FG001|Period 2|Lost to Follow-up|1|||
125630678|NCT04018612|451928604|FG001|Overall Study|Withdrawal by Subject|0|||
125376183|NCT05048784|451007685|FG002|Period 2|Lost to Follow-up|0|||
125630679|NCT04018612|451928605|FG002|Overall Study|Withdrawal by Subject|1|||
125630680|NCT02671760|451928609|FG000|Overall Study|Lost to Follow-up|0|||
125630681|NCT02671760|451928610|FG001|Overall Study|Lost to Follow-up|1|||
125129106|NCT02336165|450097763|FG004|Overall Study|Non-compliance|0|||
125129107|NCT02336165|450097759|FG000|Overall Study|Other|1|||
125129108|NCT02336165|450097760|FG001|Overall Study|Other|0|||
125129109|NCT02336165|450097761|FG002|Overall Study|Other|0|||
125376184|NCT05048784|451007686|FG003|Period 2|Lost to Follow-up|0|||
125129110|NCT02336165|450097762|FG003|Overall Study|Other|1|||
125129111|NCT02336165|450097763|FG004|Overall Study|Other|0|||
125129112|NCT03195491|450097769|FG000|Overall Study|Study drug toxicity|25|||
125129113|NCT03195491|450097770|FG001|Overall Study|Study drug toxicity|3|||
125129114|NCT03195491|450097769|FG000|Overall Study|Maximum clinical benefit|5|||
125129115|NCT03195491|450097770|FG001|Overall Study|Maximum clinical benefit|0|||
125129116|NCT03195491|450097769|FG000|Overall Study|Lost to Follow-up|1|||
125129117|NCT03195491|450097770|FG001|Overall Study|Lost to Follow-up|0|||
125129118|NCT03195491|450097769|FG000|Overall Study|Death|3|||
125129119|NCT03195491|450097770|FG001|Overall Study|Death|0|||
125129120|NCT03195491|450097769|FG000|Overall Study|Adverse event unrelated to study drug|19|||
125129121|NCT03195491|450097770|FG001|Overall Study|Adverse event unrelated to study drug|2|||
125129122|NCT03195491|450097769|FG000|Overall Study|Disease progression|266|||
125129123|NCT03195491|450097770|FG001|Overall Study|Disease progression|8|||
125129124|NCT03195491|450097769|FG000|Overall Study|Other reasons|10|||
125129125|NCT03195491|450097770|FG001|Overall Study|Other reasons|0|||
125129126|NCT03195491|450097769|FG000|Overall Study|Participant withdrew consent|8|||
125129127|NCT03195491|450097770|FG001|Overall Study|Participant withdrew consent|1|||
125129128|NCT03195491|450097769|FG000|Overall Study|Participant no longer meets study criteria|0|||
125129129|NCT03195491|450097770|FG001|Overall Study|Participant no longer meets study criteria|1|||
125129130|NCT03195491|450097769|FG000|Overall Study|Participant request to discontinue study treatment|10|||
125215748|NCT00492232|450417502|FG001|Double-Blind Treatment|Protocol Violation|7|||
125215749|NCT00492232|450417501|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
125376185|NCT03521934|451007687|FG000|Overall Study|Death|65|||
125630682|NCT02671760|451928611|FG002|Overall Study|Lost to Follow-up|0|||
125630683|NCT02999191|451928612|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
125630684|NCT02999191|451928613|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
125630685|NCT02999191|451928614|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
125630686|NCT01802515|451928621|FG000|Overall Study|Withdrawal by Subject|3|||
125630687|NCT01802515|451928622|FG001|Overall Study|Withdrawal by Subject|0|||
125630688|NCT01802515|451928623|FG002|Overall Study|Withdrawal by Subject|0|||
125630689|NCT03038672|451930275|FG000|Initial Treatment|Unacceptable chemistry|0|||
125630690|NCT03038672|451930276|FG001|Initial Treatment|Unacceptable chemistry|1|||
125630691|NCT03038672|451930275|FG000|Initial Treatment|Progression prior to treatment|1|||
125630692|NCT03038672|451930276|FG001|Initial Treatment|Progression prior to treatment|0|||
125630693|NCT03038672|451930275|FG000|Initial Treatment|No treatment per protocol|1|||
125630694|NCT03038672|451930276|FG001|Initial Treatment|No treatment per protocol|0|||
125630695|NCT00959894|451930281|FG000|Overall Study|Lost to Follow-up|10|||
125630696|NCT00959894|451930281|FG000|Overall Study|Adverse Event|3|||
125630697|NCT00959894|451930281|FG000|Overall Study|Withdrawal by Subject|1|||
125630698|NCT00959894|451930281|FG000|Overall Study|Need for contraindicated medication|1|||
125630699|NCT00959894|451930281|FG000|Overall Study|Subject moved out of town|1|||
125630700|NCT00653068|451930282|FG000|Overall Study|Death|9|||
125630701|NCT00653068|451930282|FG000|Overall Study|Lack of Efficacy|34|||
125630702|NCT00653068|451930282|FG000|Overall Study|Physician Decision|4|||
125630703|NCT00653068|451930282|FG000|Overall Study|Withdrawal by Subject|1|||
125630704|NCT00653068|451930282|FG000|Overall Study|Ineligible|2|||
125630705|NCT01305941|451930283|FG000|Overall Study|Adverse Event|6|||
125630706|NCT01305941|451930283|FG000|Overall Study|Clinical decline|2|||
125630707|NCT01305941|451930283|FG000|Overall Study|Withdrawal by Subject|1|||
125630708|NCT01305941|451930283|FG000|Overall Study|Death|1|||
125630709|NCT02892734|451930284|FG000|Treatment on Study|Progressive Disease|2|||
125630710|NCT02892734|451930284|FG000|Follow up for 2 Years|Death|2|||
125129131|NCT03195491|450097770|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125129132|NCT04239872|450097772|FG000|Overall Study|Lost to Follow-up|0|||
125129133|NCT04239872|450097773|FG001|Overall Study|Lost to Follow-up|1|||
125129134|NCT01185821|450097781|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125129135|NCT01185821|450097782|FG001|Overall Study|Abnormal laboratory value(s)|2|||
125129136|NCT01185821|450097783|FG002|Overall Study|Abnormal laboratory value(s)|1|||
125129137|NCT01185821|450097784|FG003|Overall Study|Abnormal laboratory value(s)|0|||
125129138|NCT01185821|450097785|FG004|Overall Study|Abnormal laboratory value(s)|0|||
125129139|NCT01185821|450097781|FG000|Overall Study|Protocol Violation|0|||
125129140|NCT01185821|450097782|FG001|Overall Study|Protocol Violation|0|||
125630711|NCT02892734|451930284|FG000|Follow up for 2 Years|Study closed early|1|||
125630712|NCT02043509|451930285|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
125630713|NCT02043509|451930286|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
125630714|NCT02043509|451930285|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
125630715|NCT02043509|451930286|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
125630716|NCT02043509|451930285|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
125630717|NCT02043509|451930286|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
125129141|NCT01185821|450097783|FG002|Overall Study|Protocol Violation|0|||
125129142|NCT01185821|450097784|FG003|Overall Study|Protocol Violation|1|||
125129143|NCT01185821|450097785|FG004|Overall Study|Protocol Violation|1|||
125129144|NCT01185821|450097781|FG000|Overall Study|Abnormal test procedure result|0|||
125129145|NCT01185821|450097782|FG001|Overall Study|Abnormal test procedure result|0|||
125376186|NCT03521934|451007688|FG001|Overall Study|Death|73|||
125436139|NCT00244374|451224303|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
125436140|NCT00244374|451224304|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
125436141|NCT00244374|451224305|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
125436142|NCT00244374|451224306|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
125436143|NCT00244374|451224302|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
125436144|NCT00244374|451224303|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
125436145|NCT00244374|451224304|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
125436146|NCT00244374|451224305|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
125436147|NCT00244374|451224306|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
125436148|NCT00244374|451224302|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
125436149|NCT00244374|451224303|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
125436150|NCT00244374|451224304|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
125436151|NCT00244374|451224305|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
125436152|NCT00244374|451224306|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
125436153|NCT00244374|451224302|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
125436154|NCT00244374|451224303|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
125436155|NCT00244374|451224304|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
125436156|NCT00244374|451224305|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
125436157|NCT00244374|451224306|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
125436158|NCT00244374|451224302|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
125436159|NCT00244374|451224303|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
125436160|NCT00244374|451224304|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
125436161|NCT00244374|451224305|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
125436162|NCT00244374|451224306|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
125436163|NCT00244374|451224302|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
125436164|NCT00244374|451224303|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
125436165|NCT00244374|451224304|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
125436166|NCT00244374|451224305|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
125436167|NCT00244374|451224306|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
125436168|NCT00976482|451224307|FG000|Overall Study|Death|208|||
125436169|NCT00976482|451224307|FG000|Overall Study|Withdrawal by Subject|45|||
125436170|NCT00976482|451224307|FG000|Overall Study|Center terminated|1|||
125436171|NCT00976482|451224307|FG000|Overall Study|Protocol Violation|5|||
125436172|NCT00720902|451224310|FG000|Overall Study|Withdrawal by Subject|1|||
125436173|NCT00720902|451224311|FG001|Overall Study|Withdrawal by Subject|0|||
125436174|NCT00720902|451224310|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
125436175|NCT00720902|451224311|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
125436176|NCT01486758|451224312|FG000|Overall Study|Lost to Follow-up|0|||
125436177|NCT01486758|451224313|FG001|Overall Study|Lost to Follow-up|1|||
125436178|NCT02254408|451224321|FG000|Overall Study|Randomized But Not Treated|1|||
125436179|NCT02254408|451224322|FG001|Overall Study|Randomized But Not Treated|3|||
125436180|NCT02254408|451224321|FG000|Overall Study|Adverse Event|1|||
125436181|NCT02254408|451224322|FG001|Overall Study|Adverse Event|0|||
125436182|NCT02254408|451224321|FG000|Overall Study|Death|2|||
125436183|NCT02254408|451224322|FG001|Overall Study|Death|3|||
125436184|NCT02254408|451224321|FG000|Overall Study|Investigator's Discretion|0|||
125436185|NCT02254408|451224322|FG001|Overall Study|Investigator's Discretion|1|||
125436186|NCT02254408|451224321|FG000|Overall Study|Withdrawal by Subject|3|||
125436187|NCT02254408|451224322|FG001|Overall Study|Withdrawal by Subject|3|||
125436188|NCT02254408|451224321|FG000|Overall Study|Lost to Follow-up|1|||
125436189|NCT02254408|451224322|FG001|Overall Study|Lost to Follow-up|0|||
125436190|NCT02914184|451224324|FG000|Overall Study|Lost to Follow-up|7|||
125436191|NCT02914184|451224325|FG001|Overall Study|Lost to Follow-up|10|||
125376187|NCT03521934|451007687|FG000|Overall Study|Withdrawal by Subject|18|||
125376188|NCT03521934|451007688|FG001|Overall Study|Withdrawal by Subject|23|||
125376189|NCT03521934|451007687|FG000|Overall Study|Site Terminated by Sponsor|39|||
125376190|NCT03521934|451007688|FG001|Overall Study|Site Terminated by Sponsor|35|||
125376191|NCT03521934|451007687|FG000|Overall Study|Study Terminated by Sponsor|483|||
125376192|NCT03521934|451007688|FG001|Overall Study|Study Terminated by Sponsor|477|||
125376193|NCT03521934|451007687|FG000|Overall Study|Reason not Specified|3|||
125376194|NCT03521934|451007688|FG001|Overall Study|Reason not Specified|6|||
125376195|NCT03020160|451007691|FG000|Overall Study|Withdrawal by Subject|1|||
125376196|NCT03020160|451007692|FG001|Overall Study|Withdrawal by Subject|0|||
125376197|NCT01513473|451007693|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
125376198|NCT01513473|451007694|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
125129146|NCT01185821|450097783|FG002|Overall Study|Abnormal test procedure result|0|||
125129147|NCT01185821|450097784|FG003|Overall Study|Abnormal test procedure result|0|||
125129148|NCT01185821|450097785|FG004|Overall Study|Abnormal test procedure result|1|||
125129149|NCT01185821|450097781|FG000|Overall Study|Death|0|||
125129150|NCT01185821|450097782|FG001|Overall Study|Death|1|||
125129151|NCT01185821|450097783|FG002|Overall Study|Death|0|||
125129152|NCT01185821|450097784|FG003|Overall Study|Death|0|||
125376199|NCT01513473|451007693|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
125376200|NCT01513473|451007694|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
125376201|NCT01513473|451007693|FG000|Main Trial (26 Weeks)|Unclassified|0|||
125376202|NCT01513473|451007694|FG001|Main Trial (26 Weeks)|Unclassified|2|||
125376203|NCT01513473|451007693|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
125376204|NCT01513473|451007694|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
125376205|NCT01513473|451007693|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
125376206|NCT01513473|451007694|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
125376207|NCT00743340|451007695|FG000|Overall Study|Study medication non-compliance|1|||
125376208|NCT00743340|451007695|FG000|Overall Study|Lost to Follow-up|1|||
125376209|NCT00743340|451007695|FG000|Overall Study|Withdrawal from the Study|5|||
125376210|NCT00743340|451007695|FG000|Overall Study|Protocol Violation|1|||
125376211|NCT00743340|451007695|FG000|Overall Study|Virologic failure|8|||
125376212|NCT00743340|451007695|FG000|Overall Study|Pregnancy|1|||
125376213|NCT00743340|451007695|FG000|Overall Study|Rolled over to other Gilead Study|23|||
125376214|NCT00743340|451007695|FG000|Overall Study|Participant Relocated|1|||
125376215|NCT01425281|451007696|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
125376216|NCT01425281|451007697|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
125376217|NCT01425281|451007696|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
125376218|NCT01425281|451007697|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
125376219|NCT01425281|451007696|FG000|At 180-day Clinical Follow-up|Death|0|||
125376220|NCT01425281|451007697|FG001|At 180-day Clinical Follow-up|Death|1|||
125376221|NCT01425281|451007696|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
125376222|NCT01425281|451007697|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
125376223|NCT01425281|451007696|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
125376224|NCT01425281|451007697|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
125376225|NCT01425281|451007696|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
125376226|NCT01425281|451007697|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
125376227|NCT01425281|451007696|FG000|At 2-year Clinical Follow-up|Death|2|||
125376228|NCT01425281|451007697|FG001|At 2-year Clinical Follow-up|Death|0|||
125376229|NCT01425281|451007696|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
125376230|NCT01425281|451007697|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
125376231|NCT01425281|451007696|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
125376232|NCT01425281|451007697|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
125376233|NCT01425281|451007696|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
125376234|NCT01425281|451007697|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
125376235|NCT01425281|451007696|FG000|At 3-year Clinical Follow-up|Death|2|||
125376236|NCT01425281|451007697|FG001|At 3-year Clinical Follow-up|Death|3|||
125376237|NCT01425281|451007696|FG000|At 4-year Clinical Follow-up|Death|7|||
125376238|NCT01425281|451007697|FG001|At 4-year Clinical Follow-up|Death|3|||
125376239|NCT01425281|451007696|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
125376240|NCT01425281|451007697|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
125376241|NCT01425281|451007696|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
125376242|NCT01425281|451007697|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
125376243|NCT01425281|451007696|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
125376244|NCT01425281|451007697|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
125376245|NCT01425281|451007696|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
125376246|NCT01425281|451007697|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
125376247|NCT01425281|451007696|FG000|At 5-year Clinical Follow-up|Death|2|||
125376248|NCT01425281|451007697|FG001|At 5-year Clinical Follow-up|Death|0|||
125376249|NCT01425281|451007696|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
125376250|NCT01425281|451007697|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
125376251|NCT01425281|451007696|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
125376252|NCT01425281|451007697|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
125376253|NCT01425281|451007696|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
125376254|NCT01425281|451007697|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
125376255|NCT02509156|451007698|FG000|Randomized Phase|Death|1|||
125376256|NCT02509156|451007699|FG001|Randomized Phase|Death|0|||
125376257|NCT02509156|451007698|FG000|Randomized Phase|Withdrawal by Subject|1|||
125376258|NCT02509156|451007699|FG001|Randomized Phase|Withdrawal by Subject|1|||
125376259|NCT01678911|451007710|FG000|Second Intervention|Lost to Follow-up|2|||
125376260|NCT01678911|451007711|FG001|Second Intervention|Lost to Follow-up|0|||
125376261|NCT02706691|451007713|FG000|Overall Study|Adverse Event|1|||
125376262|NCT01402492|451007714|FG000|Overall Study|Withdrawal by Subject|17|||
125129153|NCT01185821|450097785|FG004|Overall Study|Death|0|||
125129154|NCT01185821|450097781|FG000|Overall Study|Condition no longer required study drug|0|||
125129155|NCT01185821|450097782|FG001|Overall Study|Condition no longer required study drug|0|||
125129156|NCT01185821|450097783|FG002|Overall Study|Condition no longer required study drug|0|||
125129157|NCT01185821|450097784|FG003|Overall Study|Condition no longer required study drug|0|||
125129158|NCT01185821|450097785|FG004|Overall Study|Condition no longer required study drug|1|||
125129159|NCT01185821|450097781|FG000|Overall Study|Adverse Event|2|||
125129160|NCT01185821|450097782|FG001|Overall Study|Adverse Event|3|||
125129161|NCT01185821|450097783|FG002|Overall Study|Adverse Event|1|||
125129162|NCT01185821|450097784|FG003|Overall Study|Adverse Event|2|||
125129163|NCT01185821|450097785|FG004|Overall Study|Adverse Event|5|||
125129164|NCT01185821|450097781|FG000|Overall Study|Lack of Efficacy|0|||
125129165|NCT01185821|450097782|FG001|Overall Study|Lack of Efficacy|0|||
125129166|NCT01185821|450097783|FG002|Overall Study|Lack of Efficacy|3|||
125129167|NCT01185821|450097784|FG003|Overall Study|Lack of Efficacy|0|||
125129168|NCT01185821|450097785|FG004|Overall Study|Lack of Efficacy|9|||
125129169|NCT01185821|450097781|FG000|Overall Study|Withdrawal by Subject|3|||
125129170|NCT01185821|450097782|FG001|Overall Study|Withdrawal by Subject|2|||
125129171|NCT01185821|450097783|FG002|Overall Study|Withdrawal by Subject|2|||
125129172|NCT01185821|450097784|FG003|Overall Study|Withdrawal by Subject|1|||
125129173|NCT01185821|450097785|FG004|Overall Study|Withdrawal by Subject|3|||
125129174|NCT01185821|450097781|FG000|Overall Study|Lost to Follow-up|1|||
125129175|NCT01185821|450097782|FG001|Overall Study|Lost to Follow-up|1|||
125129176|NCT01185821|450097783|FG002|Overall Study|Lost to Follow-up|2|||
125630718|NCT02043509|451930285|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
125630719|NCT02043509|451930286|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
125630720|NCT00608244|451930291|FG000|Overall Study|Adverse Event|1|||
125630721|NCT00608244|451930291|FG000|Overall Study|Low trough levels|1|||
125630722|NCT01957215|451930296|FG000|Overall Study|Adverse Event|2|||
125630723|NCT01957215|451930297|FG001|Overall Study|Adverse Event|2|||
125630724|NCT01957215|451930296|FG000|Overall Study|Lost to Follow-up|3|||
125630725|NCT01957215|451930297|FG001|Overall Study|Lost to Follow-up|3|||
125630726|NCT01957215|451930296|FG000|Overall Study|Protocol Violation|1|||
125630727|NCT01957215|451930297|FG001|Overall Study|Protocol Violation|2|||
125630728|NCT01957215|451930296|FG000|Overall Study|Withdrawal by Subject|7|||
125630729|NCT01957215|451930297|FG001|Overall Study|Withdrawal by Subject|5|||
125630730|NCT01685060|451930305|FG000|Overall Study|Rollover patients|16|||
125630731|NCT01685060|451930305|FG000|Overall Study|Adverse Event|12|||
125630732|NCT01685060|451930305|FG000|Overall Study|Progressive disease|69|||
125630733|NCT01685060|451930305|FG000|Overall Study|Physician Decision|14|||
125630734|NCT01685060|451930305|FG000|Overall Study|Subject/guardian decision|20|||
125630735|NCT01685060|451930305|FG000|Overall Study|Lost to Follow-up|1|||
125630736|NCT01685060|451930305|FG000|Overall Study|Death|8|||
125630737|NCT03597503|451930306|FG000|Overall Study|Withdrawal by Subject|0|||
125630738|NCT03597503|451930307|FG001|Overall Study|Withdrawal by Subject|2|||
125630739|NCT03597503|451930306|FG000|Overall Study|Lost to Follow-up|1|||
125630740|NCT03597503|451930307|FG001|Overall Study|Lost to Follow-up|2|||
125630741|NCT03597503|451930306|FG000|Overall Study|Protocol Violation|1|||
125630742|NCT03597503|451930307|FG001|Overall Study|Protocol Violation|0|||
125630743|NCT02944513|451930308|FG000|Overall Study|Withdrawal by Subject|4|||
125630744|NCT02944513|451930309|FG001|Overall Study|Withdrawal by Subject|1|||
125630745|NCT00937326|451930313|FG000|Overall Study|Adverse Event|0|||
125630746|NCT00937326|451930314|FG001|Overall Study|Adverse Event|3|||
125630747|NCT00937326|451930315|FG002|Overall Study|Adverse Event|1|||
125630748|NCT00937326|451930316|FG003|Overall Study|Adverse Event|1|||
125630749|NCT00937326|451930317|FG004|Overall Study|Adverse Event|2|||
125630750|NCT00937326|451930313|FG000|Overall Study|Death|0|||
125630751|NCT00937326|451930314|FG001|Overall Study|Death|0|||
125630752|NCT00937326|451930315|FG002|Overall Study|Death|1|||
125630753|NCT00937326|451930316|FG003|Overall Study|Death|0|||
125129177|NCT01185821|450097784|FG003|Overall Study|Lost to Follow-up|1|||
125129178|NCT01185821|450097785|FG004|Overall Study|Lost to Follow-up|2|||
125215750|NCT00492232|450417502|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
125630754|NCT00937326|451930317|FG004|Overall Study|Death|0|||
125630755|NCT00937326|451930313|FG000|Overall Study|Withdrawal by Subject|3|||
125630756|NCT00937326|451930314|FG001|Overall Study|Withdrawal by Subject|4|||
125630757|NCT00937326|451930315|FG002|Overall Study|Withdrawal by Subject|1|||
125630758|NCT00937326|451930316|FG003|Overall Study|Withdrawal by Subject|4|||
125630759|NCT00937326|451930317|FG004|Overall Study|Withdrawal by Subject|3|||
125630760|NCT00937326|451930313|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
125129179|NCT01185821|450097781|FG000|Overall Study|Administrative problems|0|||
125129180|NCT01185821|450097782|FG001|Overall Study|Administrative problems|0|||
125129181|NCT01185821|450097783|FG002|Overall Study|Administrative problems|1|||
125215751|NCT00492232|450417501|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
125630761|NCT00937326|451930314|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
125630762|NCT00937326|451930315|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
125630763|NCT00937326|451930316|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
125129182|NCT01185821|450097784|FG003|Overall Study|Administrative problems|1|||
125129183|NCT01185821|450097785|FG004|Overall Study|Administrative problems|2|||
125129184|NCT00296647|450097786|FG000|Overall Study|Death|4|||
125129185|NCT00296647|450097787|FG001|Overall Study|Death|1|||
125129186|NCT00296647|450097788|FG002|Overall Study|Death|2|||
125129187|NCT00296647|450097789|FG003|Overall Study|Death|1|||
125129188|NCT00296647|450097790|FG004|Overall Study|Death|1|||
125129189|NCT00296647|450097786|FG000|Overall Study|Withdrawal by Subject|28|||
125129190|NCT00296647|450097787|FG001|Overall Study|Withdrawal by Subject|27|||
125129191|NCT00296647|450097788|FG002|Overall Study|Withdrawal by Subject|32|||
125129192|NCT00296647|450097789|FG003|Overall Study|Withdrawal by Subject|16|||
125129193|NCT00296647|450097790|FG004|Overall Study|Withdrawal by Subject|19|||
125129194|NCT00854100|450097795|FG000|Overall Study|Inability to complete the study visits|0|||
125129195|NCT00854100|450097796|FG001|Overall Study|Inability to complete the study visits|0|||
125129196|NCT00854100|450097797|FG002|Overall Study|Inability to complete the study visits|1|||
125129197|NCT00854100|450097795|FG000|Overall Study|Lost to Follow-up|2|||
125129198|NCT00854100|450097796|FG001|Overall Study|Lost to Follow-up|0|||
125129199|NCT00854100|450097797|FG002|Overall Study|Lost to Follow-up|3|||
125129200|NCT00854100|450097795|FG000|Overall Study|Withdrawal by Subject|3|||
125630764|NCT00937326|451930317|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
125630765|NCT02578992|451930318|FG000|Overall Study|equipment not available or malfunction|3|||
125630766|NCT02578992|451930319|FG001|Overall Study|equipment not available or malfunction|3|||
125630767|NCT00086385|451930322|FG000|Overall Study|Death|2|||
125630768|NCT00086385|451930323|FG001|Overall Study|Death|2|||
125630769|NCT00086385|451930324|FG002|Overall Study|Death|1|||
125630770|NCT00086385|451930325|FG003|Overall Study|Death|1|||
125630771|NCT00880100|451930328|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
125630772|NCT00880100|451930328|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
125630773|NCT00880100|451930328|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
125630774|NCT00405275|451930330|FG000|Overall Study|Death|1|||
125630775|NCT00405275|451930331|FG001|Overall Study|Death|0|||
125630776|NCT00405275|451930330|FG000|Overall Study|Lost to Follow-up|5|||
125630777|NCT00405275|451930331|FG001|Overall Study|Lost to Follow-up|1|||
125630778|NCT00405275|451930330|FG000|Overall Study|Withdrawal by Subject|7|||
125630779|NCT00405275|451930331|FG001|Overall Study|Withdrawal by Subject|9|||
125630780|NCT00405275|451930330|FG000|Overall Study|Unwilling to continue|10|||
125630781|NCT00405275|451930331|FG001|Overall Study|Unwilling to continue|9|||
125630782|NCT00731666|451930332|FG000|Overall Study|Adverse Event|2|||
125630783|NCT00731666|451930332|FG000|Overall Study|Lost to Follow-up|8|||
125630784|NCT00731666|451930332|FG000|Overall Study|Withdrawal by Subject|2|||
125630785|NCT02853123|451930335|FG000|Treatment Period 1|Adverse Event|0|||
125630786|NCT02853123|451930336|FG001|Treatment Period 1|Adverse Event|3|||
125630787|NCT02853123|451930335|FG000|Washout Period|Worsening of COPD|0|||
125630788|NCT02853123|451930336|FG001|Washout Period|Worsening of COPD|3|||
125630789|NCT02853123|451930335|FG000|Washout Period|Adverse Event|1|||
125630790|NCT02853123|451930336|FG001|Washout Period|Adverse Event|0|||
125630791|NCT02471586|451930337|FG000|Overall Study|Lost to Follow-up|3|||
125630792|NCT02471586|451930338|FG001|Overall Study|Lost to Follow-up|8|||
125630793|NCT02471586|451930339|FG002|Overall Study|Lost to Follow-up|4|||
125630794|NCT02471586|451930337|FG000|Overall Study|Death|2|||
125630795|NCT02471586|451930338|FG001|Overall Study|Death|2|||
125630796|NCT02471586|451930339|FG002|Overall Study|Death|0|||
125630797|NCT01495689|451930347|FG000|Overall Study|Death|0|||
125630798|NCT01495689|451930348|FG001|Overall Study|Death|1|||
125630799|NCT01495689|451930347|FG000|Overall Study|Withdrawal by Subject|3|||
125630800|NCT01495689|451930348|FG001|Overall Study|Withdrawal by Subject|0|||
125630801|NCT01495689|451930347|FG000|Overall Study|Lost to Follow-up|7|||
125630802|NCT01495689|451930348|FG001|Overall Study|Lost to Follow-up|6|||
125630803|NCT00254163|451930349|FG000|Overall Study|Adverse Event|29|||
125630804|NCT00254163|451930350|FG001|Overall Study|Adverse Event|26|||
125630805|NCT00254163|451930349|FG000|Overall Study|Patient request/withdrew consent|6|||
125630806|NCT00254163|451930350|FG001|Overall Study|Patient request/withdrew consent|4|||
125630807|NCT00254163|451930349|FG000|Overall Study|Investigator request|1|||
125630808|NCT00254163|451930350|FG001|Overall Study|Investigator request|3|||
125630809|NCT00254163|451930349|FG000|Overall Study|Failed entry|1|||
125630810|NCT00254163|451930350|FG001|Overall Study|Failed entry|3|||
125630811|NCT00254163|451930349|FG000|Overall Study|Progressive disease|0|||
125129201|NCT00854100|450097796|FG001|Overall Study|Withdrawal by Subject|1|||
125129202|NCT00854100|450097797|FG002|Overall Study|Withdrawal by Subject|2|||
125630812|NCT00254163|451930350|FG001|Overall Study|Progressive disease|1|||
125129203|NCT00854100|450097795|FG000|Overall Study|Protocol Violation|2|||
125129204|NCT00854100|450097796|FG001|Overall Study|Protocol Violation|4|||
125630813|NCT00254163|451930349|FG000|Overall Study|Death|0|||
125630814|NCT00254163|451930350|FG001|Overall Study|Death|1|||
125630815|NCT00254163|451930349|FG000|Overall Study|Other|8|||
125630816|NCT00254163|451930350|FG001|Overall Study|Other|8|||
125630817|NCT00606177|451930353|FG000|Overall Study|Adverse Event|9|||
125630818|NCT00606177|451930354|FG001|Overall Study|Adverse Event|5|||
125630819|NCT00606177|451930353|FG000|Overall Study|Lack of Efficacy|3|||
125129205|NCT00854100|450097797|FG002|Overall Study|Protocol Violation|3|||
125129206|NCT00854100|450097795|FG000|Overall Study|Adverse Event|2|||
125129207|NCT00854100|450097796|FG001|Overall Study|Adverse Event|1|||
125129208|NCT00854100|450097797|FG002|Overall Study|Adverse Event|2|||
125376263|NCT01402492|451007715|FG001|Overall Study|Withdrawal by Subject|11|||
125376264|NCT01402492|451007716|FG002|Overall Study|Withdrawal by Subject|11|||
125376265|NCT01402492|451007714|FG000|Overall Study|Adverse Event|2|||
125376266|NCT01402492|451007715|FG001|Overall Study|Adverse Event|3|||
125376267|NCT01402492|451007716|FG002|Overall Study|Adverse Event|4|||
125376268|NCT01402492|451007714|FG000|Overall Study|Physician Decision|0|||
125376269|NCT01402492|451007715|FG001|Overall Study|Physician Decision|3|||
125376270|NCT01402492|451007716|FG002|Overall Study|Physician Decision|0|||
125376271|NCT01402492|451007714|FG000|Overall Study|Incarcerated (N=3)|2|||
125376272|NCT01402492|451007715|FG001|Overall Study|Incarcerated (N=3)|0|||
125376273|NCT01402492|451007716|FG002|Overall Study|Incarcerated (N=3)|1|||
125376274|NCT01980992|451007717|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
125376275|NCT01980992|451007718|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
125376276|NCT01980992|451007717|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
125376277|NCT01980992|451007718|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
125376278|NCT01980992|451007717|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
125376279|NCT01980992|451007718|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
125376280|NCT01980992|451007717|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
125376281|NCT01980992|451007718|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
125376282|NCT01980992|451007717|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
125376283|NCT01980992|451007718|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
125376284|NCT01980992|451007717|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
125376285|NCT01980992|451007718|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
125376286|NCT00211809|451007723|FG000|Overall Study|Lack of Efficacy|1|||
125376287|NCT00211809|451007723|FG000|Overall Study|Lost to Follow-up|2|||
125376288|NCT00211809|451007723|FG000|Overall Study|Pregnancy|1|||
125376289|NCT00211809|451007723|FG000|Overall Study|side effects|2|||
125376290|NCT04294472|451007724|FG000|Overall Study|Adverse Event|0|||
125376291|NCT04294472|451007725|FG001|Overall Study|Adverse Event|1|||
125376292|NCT04294472|451007726|FG002|Overall Study|Adverse Event|1|||
125376293|NCT04294472|451007724|FG000|Overall Study|Randomized but not treated|0|||
125376294|NCT04294472|451007725|FG001|Overall Study|Randomized but not treated|1|||
125376295|NCT04294472|451007726|FG002|Overall Study|Randomized but not treated|1|||
125376296|NCT02603419|451007732|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
125376297|NCT02603419|451007733|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
125376298|NCT02603419|451007734|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
125376299|NCT02603419|451007735|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
125376300|NCT02603419|451007736|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
125376301|NCT02603419|451007737|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
125376302|NCT02603419|451007732|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
125376303|NCT02603419|451007733|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
125376304|NCT02603419|451007734|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
125376305|NCT02603419|451007735|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
125376306|NCT02603419|451007736|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
125376307|NCT02603419|451007737|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
125376308|NCT02603419|451007732|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
125376309|NCT02603419|451007733|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
125376310|NCT02603419|451007734|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
125376311|NCT02603419|451007735|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
125376312|NCT02603419|451007736|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
125376313|NCT02603419|451007737|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
125376314|NCT02603419|451007732|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
125376315|NCT02603419|451007733|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
125376316|NCT02603419|451007734|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
125376317|NCT02603419|451007735|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
125376318|NCT02603419|451007736|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
125376319|NCT02603419|451007737|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
125376320|NCT02603419|451007732|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
125376321|NCT02603419|451007733|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
125376322|NCT02603419|451007734|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
125376323|NCT02603419|451007735|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
125376324|NCT02603419|451007736|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
125376325|NCT02603419|451007737|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
125376326|NCT02603419|451007732|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
125376327|NCT02603419|451007733|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
125436192|NCT02914184|451224326|FG002|Overall Study|Lost to Follow-up|8|||
125436193|NCT02914184|451224327|FG003|Overall Study|Lost to Follow-up|7|||
125436194|NCT02914184|451224324|FG000|Overall Study|Withdrawal by Subject|4|||
125436195|NCT02914184|451224325|FG001|Overall Study|Withdrawal by Subject|2|||
125436196|NCT02914184|451224326|FG002|Overall Study|Withdrawal by Subject|7|||
125436197|NCT02914184|451224327|FG003|Overall Study|Withdrawal by Subject|3|||
125436198|NCT02914184|451224324|FG000|Overall Study|Other|1|||
125436199|NCT02914184|451224325|FG001|Overall Study|Other|0|||
125436200|NCT02914184|451224326|FG002|Overall Study|Other|0|||
125436201|NCT02914184|451224327|FG003|Overall Study|Other|0|||
125436202|NCT02914184|451224324|FG000|Overall Study|Migrated/moved from the study area|2|||
125436203|NCT02914184|451224325|FG001|Overall Study|Migrated/moved from the study area|1|||
125436204|NCT02914184|451224326|FG002|Overall Study|Migrated/moved from the study area|2|||
125436205|NCT02914184|451224327|FG003|Overall Study|Migrated/moved from the study area|1|||
125436206|NCT00798174|451224328|FG000|Overall Study|inability to implant azygos coil|3|||
125436207|NCT00798174|451224329|FG001|Overall Study|inability to implant azygos coil|3|||
125436208|NCT00798174|451224328|FG000|Overall Study|Inability to sedate for DFT testing|1|||
125436209|NCT00798174|451224329|FG001|Overall Study|Inability to sedate for DFT testing|0|||
125436210|NCT01478113|451224330|FG000|Overall Study|Withdrawal by Subject|0|||
125436211|NCT01478113|451224331|FG001|Overall Study|Withdrawal by Subject|1|||
125436212|NCT01478113|451224330|FG000|Overall Study|Physician Decision|1|||
125436213|NCT01478113|451224331|FG001|Overall Study|Physician Decision|0|||
125215752|NCT00492232|450417502|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
125436214|NCT03093428|451224338|FG000|Overall Study|Not eligible for treatment|2|||
125436215|NCT03093428|451224339|FG001|Overall Study|Not eligible for treatment|1|||
125436216|NCT03093428|451224338|FG000|Overall Study|Progression|14|||
125436217|NCT03093428|451224339|FG001|Overall Study|Progression|4|||
125436218|NCT03093428|451224338|FG000|Overall Study|Death|1|||
125436219|NCT03093428|451224339|FG001|Overall Study|Death|0|||
125436220|NCT03093428|451224338|FG000|Overall Study|Adverse Event|1|||
125436221|NCT03093428|451224339|FG001|Overall Study|Adverse Event|0|||
125436222|NCT03093428|451224338|FG000|Overall Study|Withdrawal by Subject|1|||
125436223|NCT03093428|451224339|FG001|Overall Study|Withdrawal by Subject|1|||
125436224|NCT03980184|451224340|FG000|Overall Study|Dropped out before treatment|2|||
125436225|NCT03980184|451224341|FG001|Overall Study|Dropped out before treatment|2|||
125436226|NCT03980184|451224340|FG000|Overall Study|Lost to Follow-up|11|||
125436227|NCT03980184|451224341|FG001|Overall Study|Lost to Follow-up|13|||
125436228|NCT01642602|451224343|FG000|Overall Study|Adverse Event|2|||
125436229|NCT01460160|451224344|FG000|Treatment Phase|Lack of Efficacy|3|||
125436230|NCT01460160|451224344|FG000|Treatment Phase|Study Drug Toxicity|2|||
125436231|NCT01460160|451224344|FG000|Treatment Phase|Adverse Event|8|||
125436232|NCT01460160|451224344|FG000|Treatment Phase|Withdrawal by Subject|4|||
125436233|NCT01460160|451224344|FG000|Treatment Phase|Death|2|||
125436234|NCT01460160|451224344|FG000|Treatment Phase|Other reasons|9|||
125436235|NCT01460160|451224344|FG000|Follow-up Phase|Withdrawal by Subject|4|||
125436236|NCT01460160|451224344|FG000|Follow-up Phase|Death|14|||
125436237|NCT01460160|451224344|FG000|Follow-up Phase|Lost to Follow-up|7|||
125436238|NCT01460160|451224344|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
125436239|NCT01460160|451224344|FG000|Follow-up Phase|Other and not reported reasons|5|||
125436240|NCT00100932|451224345|FG000|Overall Study|Adverse Event|11|||
125436241|NCT00100932|451224346|FG001|Overall Study|Adverse Event|2|||
125436242|NCT00100932|451224345|FG000|Overall Study|Withdrawal by Subject|6|||
125436243|NCT00100932|451224346|FG001|Overall Study|Withdrawal by Subject|0|||
125436244|NCT00100932|451224345|FG000|Overall Study|Progressive Disease|44|||
125436245|NCT00100932|451224346|FG001|Overall Study|Progressive Disease|18|||
125436246|NCT00100932|451224345|FG000|Overall Study|Physician Decision|7|||
125436247|NCT00100932|451224346|FG001|Overall Study|Physician Decision|5|||
125436248|NCT00100932|451224345|FG000|Overall Study|Other|5|||
125215753|NCT00492232|450417501|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
125436249|NCT00100932|451224346|FG001|Overall Study|Other|2|||
125436250|NCT01616771|451224347|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
125436251|NCT00744328|451224348|FG000|Overall Study|Lost to Follow-up|2|||
125436252|NCT00744328|451224349|FG001|Overall Study|Lost to Follow-up|5|||
125630820|NCT00606177|451930354|FG001|Overall Study|Lack of Efficacy|7|||
125630821|NCT00606177|451930353|FG000|Overall Study|Physician Decision|1|||
125630822|NCT00606177|451930354|FG001|Overall Study|Physician Decision|0|||
125630823|NCT00606177|451930353|FG000|Overall Study|Protocol Violation|1|||
125630824|NCT00606177|451930354|FG001|Overall Study|Protocol Violation|4|||
125630825|NCT00606177|451930353|FG000|Overall Study|Withdrawal by Subject|5|||
125630826|NCT00606177|451930354|FG001|Overall Study|Withdrawal by Subject|6|||
125376328|NCT02603419|451007734|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
125376329|NCT02603419|451007735|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
125376330|NCT02603419|451007736|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
125376331|NCT02603419|451007737|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
125376332|NCT02603419|451007732|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
125376333|NCT02603419|451007733|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
125376334|NCT02603419|451007734|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
125376335|NCT02603419|451007735|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
125376336|NCT02603419|451007736|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
125376337|NCT02603419|451007737|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
125376338|NCT02603419|451007732|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
125376339|NCT02603419|451007733|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
125376340|NCT02603419|451007734|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
125376341|NCT02603419|451007735|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
125376342|NCT02603419|451007736|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
125376343|NCT02603419|451007737|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
125376344|NCT02603419|451007732|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
125376345|NCT02603419|451007733|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
125376346|NCT02603419|451007734|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
125376347|NCT02603419|451007735|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
125376348|NCT02603419|451007736|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
125376349|NCT02603419|451007737|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
125376350|NCT02603419|451007732|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
125376351|NCT02603419|451007733|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
125376352|NCT02603419|451007734|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
125376353|NCT02603419|451007735|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
125376354|NCT02603419|451007736|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
125376355|NCT02603419|451007737|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
125376356|NCT02289417|451007739|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
125376357|NCT02289417|451007740|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125376358|NCT02289417|451007741|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
125376359|NCT02289417|451007742|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125376360|NCT02289417|451007743|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125376361|NCT02289417|451007744|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125376362|NCT02289417|451007745|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125376363|NCT02289417|451007746|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125376364|NCT02289417|451007747|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
125376365|NCT02289417|451007739|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
125376366|NCT02289417|451007740|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
125376367|NCT02289417|451007741|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
125376368|NCT02289417|451007742|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
125376369|NCT02289417|451007743|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
125376370|NCT02289417|451007744|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
125376371|NCT02289417|451007745|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
125376372|NCT02289417|451007746|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
125376373|NCT02289417|451007747|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
125376374|NCT02289417|451007739|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125376375|NCT02289417|451007740|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
125376376|NCT02289417|451007741|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125376377|NCT02289417|451007742|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125376378|NCT02289417|451007743|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125376379|NCT02289417|451007744|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125376380|NCT02289417|451007745|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125376381|NCT02289417|451007746|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125376382|NCT02289417|451007747|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
125376383|NCT02289417|451007739|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
125630827|NCT00606177|451930353|FG000|Overall Study|Progression to depressive phase|6|||
125630828|NCT00606177|451930354|FG001|Overall Study|Progression to depressive phase|1|||
125630829|NCT00606177|451930353|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
125630830|NCT00606177|451930354|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
125129209|NCT02883452|450099256|FG000|Overall Study|Withdrawal by Subject|1|||
125129210|NCT02883452|450099257|FG001|Overall Study|Withdrawal by Subject|1|||
125129211|NCT02883452|450099258|FG002|Overall Study|Withdrawal by Subject|3|||
125129212|NCT02883452|450099259|FG003|Overall Study|Withdrawal by Subject|0|||
125129213|NCT02883452|450099260|FG004|Overall Study|Withdrawal by Subject|2|||
125129214|NCT02883452|450099261|FG005|Overall Study|Withdrawal by Subject|5|||
125129215|NCT02883452|450099256|FG000|Overall Study|Disease progression|1|||
125129216|NCT02883452|450099257|FG001|Overall Study|Disease progression|0|||
125129217|NCT02883452|450099258|FG002|Overall Study|Disease progression|0|||
125630831|NCT00606177|451930353|FG000|Overall Study|Change of residence or other commitments|1|||
125630832|NCT00606177|451930354|FG001|Overall Study|Change of residence or other commitments|1|||
125630833|NCT00136357|451930355|FG000|Overall Study|Withdrawal by Subject|3|||
125630834|NCT00136357|451930356|FG001|Overall Study|Withdrawal by Subject|2|||
125630835|NCT00216086|451930361|FG000|Overall Study|Protocol Violation|1|||
125630836|NCT00216086|451930361|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
125630837|NCT00216086|451930361|FG000|Overall Study|Social Reasons|2|||
125630838|NCT01784211|451930365|FG000|Part A (Days 1-15)|Adverse Event|1|||
125630839|NCT01784211|451930366|FG001|Part A (Days 1-15)|Adverse Event|1|||
125630840|NCT01784211|451930367|FG002|Part A (Days 1-15)|Adverse Event|0|||
125630841|NCT01784211|451930368|FG003|Part A (Days 1-15)|Adverse Event|0|||
125630842|NCT01784211|451930369|FG004|Part A (Days 1-15)|Adverse Event|0|||
125630843|NCT01784211|451930370|FG005|Part A (Days 1-15)|Adverse Event|0|||
125630844|NCT01784211|451930365|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
125129218|NCT02883452|450099259|FG003|Overall Study|Disease progression|1|||
125129219|NCT02883452|450099260|FG004|Overall Study|Disease progression|4|||
125129220|NCT02883452|450099261|FG005|Overall Study|Disease progression|5|||
125129221|NCT02883452|450099256|FG000|Overall Study|Adverse Event|2|||
125129222|NCT02883452|450099257|FG001|Overall Study|Adverse Event|1|||
125129223|NCT02883452|450099258|FG002|Overall Study|Adverse Event|1|||
125129224|NCT02883452|450099259|FG003|Overall Study|Adverse Event|1|||
125215754|NCT00492232|450417502|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
125215755|NCT00492232|450417501|FG000|Double-Blind Treatment|Other|6|||
125129225|NCT02883452|450099260|FG004|Overall Study|Adverse Event|1|||
125215756|NCT00492232|450417502|FG001|Double-Blind Treatment|Other|5|||
125215757|NCT00492232|450417501|FG000|Double-Blind Treatment|Randomized not treated|1|||
125630845|NCT01784211|451930366|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
125630846|NCT01784211|451930367|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
125630847|NCT01784211|451930368|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
125630848|NCT01784211|451930369|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
125630849|NCT01784211|451930370|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
125630850|NCT01001572|451930371|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
125630851|NCT01001572|451930372|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
125630852|NCT01001572|451930373|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
125630853|NCT01001572|451930371|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
125630854|NCT01001572|451930372|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
125630855|NCT01001572|451930373|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
125630856|NCT01001572|451930371|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
125630857|NCT01001572|451930372|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
125129226|NCT02883452|450099261|FG005|Overall Study|Adverse Event|3|||
125215758|NCT00492232|450417502|FG001|Double-Blind Treatment|Randomized not treated|0|||
125436253|NCT00744328|451224350|FG002|Overall Study|Lost to Follow-up|3|||
125436254|NCT00744328|451224348|FG000|Overall Study|Withdrawal by Subject|5|||
125436255|NCT00744328|451224349|FG001|Overall Study|Withdrawal by Subject|3|||
125436256|NCT00744328|451224350|FG002|Overall Study|Withdrawal by Subject|4|||
125436257|NCT00744328|451224348|FG000|Overall Study|Found ineligible after randomization|0|||
125436258|NCT00744328|451224349|FG001|Overall Study|Found ineligible after randomization|0|||
125436259|NCT00744328|451224350|FG002|Overall Study|Found ineligible after randomization|1|||
125436260|NCT02387216|451224353|FG000|Overall Study|Progressive disease|2|||
125436261|NCT02387216|451224354|FG001|Overall Study|Progressive disease|0|||
125129227|NCT02883452|450099256|FG000|Overall Study|Physician Decision|0|||
125129228|NCT02883452|450099257|FG001|Overall Study|Physician Decision|0|||
125129229|NCT02883452|450099258|FG002|Overall Study|Physician Decision|0|||
125129230|NCT02883452|450099259|FG003|Overall Study|Physician Decision|0|||
125129231|NCT02883452|450099260|FG004|Overall Study|Physician Decision|4|||
125129232|NCT02883452|450099261|FG005|Overall Study|Physician Decision|1|||
125436262|NCT02387216|451224353|FG000|Overall Study|Withdrawal by Subject|3|||
125436263|NCT02387216|451224354|FG001|Overall Study|Withdrawal by Subject|5|||
125436264|NCT02387216|451224353|FG000|Overall Study|Physician Decision|2|||
125129233|NCT02883452|450099256|FG000|Overall Study|Death|1|||
125129234|NCT02883452|450099257|FG001|Overall Study|Death|0|||
125630858|NCT01001572|451930373|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
125630859|NCT01001572|451930371|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
125129235|NCT02883452|450099258|FG002|Overall Study|Death|1|||
125215759|NCT00492232|450417501|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
125129236|NCT02883452|450099259|FG003|Overall Study|Death|0|||
125436265|NCT02387216|451224354|FG001|Overall Study|Physician Decision|0|||
125215760|NCT00492232|450417502|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
125215761|NCT02453256|450417503|FG000|Double Blind Period|Death|1|||
125215762|NCT02453256|450417504|FG001|Double Blind Period|Death|1|||
125215763|NCT02453256|450417503|FG000|Double Blind Period|Adverse Event|3|||
125215764|NCT02453256|450417504|FG001|Double Blind Period|Adverse Event|2|||
125215765|NCT02453256|450417503|FG000|Double Blind Period|Withdrawal by Subject|9|||
125215766|NCT02453256|450417504|FG001|Double Blind Period|Withdrawal by Subject|5|||
125436266|NCT02387216|451224353|FG000|Overall Study|Sponsor Decision|28|||
125436267|NCT02387216|451224354|FG001|Overall Study|Sponsor Decision|12|||
125436268|NCT02387216|451224353|FG000|Overall Study|Death|60|||
125436269|NCT02387216|451224354|FG001|Overall Study|Death|23|||
125436270|NCT02387216|451224353|FG000|Overall Study|Other|5|||
125436271|NCT02387216|451224354|FG001|Overall Study|Other|4|||
125630860|NCT01001572|451930372|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
125630861|NCT01001572|451930373|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
125630862|NCT01001572|451930371|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
125630863|NCT01001572|451930372|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
125630864|NCT01001572|451930373|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
125630865|NCT01001572|451930371|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
125630866|NCT01001572|451930372|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
125630867|NCT01001572|451930373|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
125630868|NCT01001572|451930371|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
125630869|NCT01001572|451930372|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
125630870|NCT01001572|451930373|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
125630871|NCT01001572|451930371|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
125630872|NCT01001572|451930372|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
125630873|NCT01001572|451930373|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
125630874|NCT01001572|451930371|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
125630875|NCT01001572|451930372|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
125630876|NCT01001572|451930373|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
125630877|NCT01001572|451930371|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
125630878|NCT01001572|451930372|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
125630879|NCT01001572|451930373|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
125630880|NCT01001572|451930371|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
125630881|NCT01001572|451930372|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
125630882|NCT01001572|451930373|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
125630883|NCT01001572|451930371|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
125630884|NCT01001572|451930372|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
125630885|NCT01001572|451930373|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
125630886|NCT01001572|451930371|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
125630887|NCT01001572|451930372|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
125630888|NCT01001572|451930373|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
125630889|NCT01001572|451930371|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125630890|NCT01001572|451930372|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125630891|NCT01001572|451930373|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
125630892|NCT02025530|451930376|FG000|Overall Study|No longer met elligibility criteria|5|||
125630893|NCT02025530|451930377|FG001|Overall Study|No longer met elligibility criteria|1|||
125630894|NCT03551626|451930378|FG000|Overall Study|Adverse Event|88|||
125630895|NCT03551626|451930378|FG000|Overall Study|Disease relapse|18|||
125630896|NCT03551626|451930378|FG000|Overall Study|Withdrawal of informed consent|6|||
125630897|NCT03551626|451930378|FG000|Overall Study|Patient decision|5|||
125630898|NCT03551626|451930378|FG000|Overall Study|Physician Decision|4|||
125630899|NCT03551626|451930378|FG000|Overall Study|Lost to Follow-up|3|||
125630900|NCT03551626|451930378|FG000|Overall Study|Pregnancy|1|||
125630901|NCT03551626|451930378|FG000|Overall Study|Protocol deviation|1|||
125630902|NCT03551626|451930378|FG000|Overall Study|Technical problems|1|||
125630903|NCT04882072|451930382|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
125630904|NCT04882072|451930383|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
125630905|NCT04882072|451930382|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
125630906|NCT04882072|451930383|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
125630907|NCT04882072|451930382|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
125630908|NCT04882072|451930383|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
125630909|NCT02918318|451930384|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
125630910|NCT02918318|451930385|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
125630911|NCT02918318|451930386|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
125630912|NCT02918318|451930387|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
125436272|NCT02387216|451224353|FG000|Overall Study|Lost to Follow-up|0|||
125215767|NCT02453256|450417503|FG000|Double Blind Period|Other|0|||
125436273|NCT02387216|451224354|FG001|Overall Study|Lost to Follow-up|3|||
125436274|NCT04041440|451224355|FG000|Overall Study|Withdrawal by Subject|0|||
125630913|NCT02918318|451930388|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
125630914|NCT02918318|451930384|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
125630915|NCT02918318|451930385|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
125630916|NCT02918318|451930386|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
125630917|NCT02918318|451930387|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
125630918|NCT02918318|451930388|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
125630919|NCT02918318|451930384|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
125630920|NCT02918318|451930385|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
125630921|NCT02918318|451930386|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
125630922|NCT02918318|451930387|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
125630923|NCT02918318|451930388|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
125630924|NCT02918318|451930384|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
125630925|NCT02918318|451930385|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
125129237|NCT02883452|450099260|FG004|Overall Study|Death|0|||
125129238|NCT02883452|450099261|FG005|Overall Study|Death|0|||
125129239|NCT02883452|450099256|FG000|Overall Study|Other|0|||
125129240|NCT02883452|450099257|FG001|Overall Study|Other|0|||
125129241|NCT02883452|450099258|FG002|Overall Study|Other|0|||
125129242|NCT02883452|450099259|FG003|Overall Study|Other|0|||
125129243|NCT02883452|450099260|FG004|Overall Study|Other|0|||
125129244|NCT02883452|450099261|FG005|Overall Study|Other|1|||
125129245|NCT03447262|450099262|FG000|Overall Study|Adverse Event|7|||
125129246|NCT03447262|450099262|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
125129247|NCT03447262|450099262|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
125129248|NCT03447262|450099262|FG000|Overall Study|Death|2|||
125129249|NCT03447262|450099262|FG000|Overall Study|Study Termination by Sponsor|455|||
125630926|NCT02918318|451930386|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
125129250|NCT03447262|450099262|FG000|Overall Study|Other|4|||
125129251|NCT00830206|450099263|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
125129252|NCT00830206|450099264|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
125129253|NCT00328926|450099265|FG000|Overall Study|Pregnancy|2|||
125129254|NCT00328926|450099266|FG001|Overall Study|Pregnancy|1|||
125129255|NCT00328926|450099267|FG002|Overall Study|Pregnancy|0|||
125129256|NCT00328926|450099265|FG000|Overall Study|Lost to Follow-up|0|||
125129257|NCT00328926|450099266|FG001|Overall Study|Lost to Follow-up|1|||
125129258|NCT00328926|450099267|FG002|Overall Study|Lost to Follow-up|0|||
125129259|NCT00328926|450099265|FG000|Overall Study|Death|0|||
125129260|NCT00328926|450099266|FG001|Overall Study|Death|0|||
125129261|NCT00328926|450099267|FG002|Overall Study|Death|1|||
125129262|NCT00328926|450099265|FG000|Overall Study|In vitro fertilization treatment|0|||
125129263|NCT00328926|450099266|FG001|Overall Study|In vitro fertilization treatment|0|||
125129264|NCT00328926|450099267|FG002|Overall Study|In vitro fertilization treatment|1|||
125129265|NCT00328926|450099265|FG000|Overall Study|Lack of ovarian response|0|||
125129266|NCT00328926|450099266|FG001|Overall Study|Lack of ovarian response|1|||
125129267|NCT00328926|450099267|FG002|Overall Study|Lack of ovarian response|0|||
125630927|NCT02918318|451930387|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
125630928|NCT02918318|451930388|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
125630929|NCT02918318|451930384|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
125630930|NCT02918318|451930385|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
125630931|NCT02918318|451930386|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
125129268|NCT04123548|450099268|FG000|Overall Study|Withdrawal by Subject|1|||
125129269|NCT04123548|450099268|FG000|Overall Study|Lost to Follow-up|8|||
125129270|NCT04123548|450099268|FG000|Overall Study|Death|4|||
125129271|NCT04123548|450099268|FG000|Overall Study|Reason Not Specified|1|||
125129272|NCT01171989|450099269|FG000|Overall Study|Lost to Follow-up|0|||
125129273|NCT01171989|450099270|FG001|Overall Study|Lost to Follow-up|0|||
125129274|NCT01171989|450099271|FG002|Overall Study|Lost to Follow-up|1|||
125129275|NCT00418184|450099272|FG000|Double-blind Phase|Withdrawal by Subject|22|||
125129276|NCT00418184|450099273|FG001|Double-blind Phase|Withdrawal by Subject|9|||
125129277|NCT00418184|450099272|FG000|Double-blind Phase|Adverse Event|2|||
125129278|NCT00418184|450099273|FG001|Double-blind Phase|Adverse Event|1|||
125129279|NCT00418184|450099272|FG000|Double-blind Phase|Poor compliance|3|||
125129280|NCT00418184|450099273|FG001|Double-blind Phase|Poor compliance|1|||
125129281|NCT02300103|450099274|FG000|Overall Study|Lack of Efficacy|3|||
125129282|NCT02300103|450099274|FG000|Overall Study|Protocol Violation|1|||
125129283|NCT02300103|450099274|FG000|Overall Study|Withdrew Consent|2|||
125129284|NCT01015625|450099275|FG000|Overall Study|Lost to Follow-up|3|||
125129285|NCT01015625|450099276|FG001|Overall Study|Lost to Follow-up|1|||
125129286|NCT01015625|450099275|FG000|Overall Study|Withdrawal by Subject|2|||
125129287|NCT01015625|450099276|FG001|Overall Study|Withdrawal by Subject|3|||
125129288|NCT01015625|450099275|FG000|Overall Study|Physician Decision|2|||
125129289|NCT01015625|450099276|FG001|Overall Study|Physician Decision|0|||
125129290|NCT01015625|450099275|FG000|Overall Study|Death|30|||
125129291|NCT01015625|450099276|FG001|Overall Study|Death|22|||
125129292|NCT01256684|450099277|FG000|Overall Study|Adverse Event|1|||
125129293|NCT01256684|450099278|FG001|Overall Study|Adverse Event|4|||
125129294|NCT01256684|450099279|FG002|Overall Study|Adverse Event|2|||
125630932|NCT02918318|451930387|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
125630933|NCT02918318|451930388|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
125630934|NCT02918318|451930384|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
125630935|NCT02918318|451930385|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
125630936|NCT02918318|451930386|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
125630937|NCT02918318|451930387|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
125630938|NCT02918318|451930388|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
125630939|NCT02918318|451930384|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
125630940|NCT02918318|451930385|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
125630941|NCT02918318|451930386|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
125630942|NCT02918318|451930387|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
125630943|NCT02918318|451930388|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
125630944|NCT02918318|451930384|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
125630945|NCT02918318|451930385|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
125630946|NCT02918318|451930386|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
125630947|NCT02918318|451930387|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
125630948|NCT02918318|451930388|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
125630949|NCT02918318|451930384|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
125129295|NCT01256684|450099277|FG000|Overall Study|Withdrawal by Subject|4|||
125129296|NCT01256684|450099278|FG001|Overall Study|Withdrawal by Subject|0|||
125129297|NCT01256684|450099279|FG002|Overall Study|Withdrawal by Subject|2|||
125129298|NCT01256684|450099277|FG000|Overall Study|Physician Decision|0|||
125129299|NCT01256684|450099278|FG001|Overall Study|Physician Decision|1|||
125129300|NCT01256684|450099279|FG002|Overall Study|Physician Decision|0|||
125129301|NCT01256684|450099277|FG000|Overall Study|Lack of Efficacy|0|||
125129302|NCT01256684|450099278|FG001|Overall Study|Lack of Efficacy|1|||
125129303|NCT01256684|450099279|FG002|Overall Study|Lack of Efficacy|1|||
125129304|NCT01256684|450099277|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
125129305|NCT01256684|450099278|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
125129306|NCT01256684|450099279|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
125129307|NCT02674477|450099281|FG000|Overall Study|Protocol Violation|8|||
125129308|NCT02674477|450099282|FG001|Overall Study|Protocol Violation|2|||
125129309|NCT02098876|450099286|FG000|Overall Study|Withdrawal by Subject|5|||
125129310|NCT02098876|450099287|FG001|Overall Study|Withdrawal by Subject|5|||
125129311|NCT01061866|450099288|FG000|Overall Study|Adverse Event|2|||
125129312|NCT00772941|450099289|FG000|Overall Study|CRFs not available|195|||
125129313|NCT00772941|450099289|FG000|Overall Study|Study not completed|16|||
125129314|NCT00772941|450099289|FG000|Overall Study|Missed Visits|374|||
125129315|NCT00772941|450099289|FG000|Overall Study|Poor Compliance|7|||
125129316|NCT00772941|450099289|FG000|Overall Study|GPSP Violation|90|||
125630950|NCT02918318|451930385|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
125129317|NCT04786184|450099290|FG000|Overall Study|Adverse Event|4|||
125129318|NCT04786184|450099291|FG001|Overall Study|Adverse Event|0|||
125129319|NCT04786184|450099290|FG000|Overall Study|Withdrawal by Subject|3|||
125129320|NCT04786184|450099291|FG001|Overall Study|Withdrawal by Subject|1|||
125129321|NCT04786184|450099290|FG000|Overall Study|Lost to Follow-up|4|||
125129322|NCT04786184|450099291|FG001|Overall Study|Lost to Follow-up|2|||
125630951|NCT02918318|451930386|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
125630952|NCT02918318|451930387|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
125129323|NCT00834756|450099292|FG000|First Intervention|Adverse Event|1|||
125129324|NCT00834756|450099293|FG001|First Intervention|Adverse Event|0|||
125129325|NCT00834756|450099292|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
125129326|NCT00834756|450099293|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
125129327|NCT01472341|450099294|FG000|Overall Study|Started insulin therapy|55|||
125215768|NCT02453256|450417504|FG001|Double Blind Period|Other|1|||
125630953|NCT02918318|451930388|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
125630954|NCT02918318|451930384|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
125630955|NCT02918318|451930385|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
125630956|NCT02918318|451930386|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
125630957|NCT02918318|451930387|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
125630958|NCT02918318|451930388|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
125630959|NCT02918318|451930384|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
125630960|NCT02918318|451930385|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
125630961|NCT02918318|451930386|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
125630962|NCT02918318|451930387|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
125630963|NCT02918318|451930388|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
125630964|NCT02918318|451930384|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
125630965|NCT02918318|451930385|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
125630966|NCT02918318|451930386|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
125630967|NCT02918318|451930387|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
125630968|NCT02918318|451930388|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
125630969|NCT00045630|451930392|FG000|Overall Study|Adverse Event|1|||
125630970|NCT00045630|451930392|FG000|Overall Study|Refusal unrelated to adverse event|1|||
125630971|NCT00045630|451930392|FG000|Overall Study|Progression/relapse|1|||
125630972|NCT00045630|451930392|FG000|Overall Study|Death|1|||
125630973|NCT00045630|451930392|FG000|Overall Study|Ineligible|2|||
125630974|NCT02023112|451930397|FG000|Overall Study|Withdrawal by Subject|2|||
125630975|NCT02023112|451930398|FG001|Overall Study|Withdrawal by Subject|1|||
125630976|NCT01906476|451930402|FG000|Overall Study|Lost to Follow-up|17|||
125630977|NCT01906476|451930403|FG001|Overall Study|Lost to Follow-up|16|||
125630978|NCT01176240|451930406|FG000|Study 306A|Lack of Efficacy|2|||
125630979|NCT01176240|451930407|FG001|Study 306A|Lack of Efficacy|1|||
125630980|NCT01176240|451930406|FG000|Study 306A|Protocol Violation|0|||
125630981|NCT01176240|451930407|FG001|Study 306A|Protocol Violation|1|||
125630982|NCT01176240|451930406|FG000|Study 306A|Withdrawal by Subject|0|||
125630983|NCT01176240|451930407|FG001|Study 306A|Withdrawal by Subject|1|||
125630984|NCT01176240|451930406|FG000|Study 306A|Stop due to diverse problems|1|||
125630985|NCT01176240|451930407|FG001|Study 306A|Stop due to diverse problems|0|||
125630986|NCT01176240|451930406|FG000|Study 306B|Lack of Efficacy|5|||
125630987|NCT01176240|451930407|FG001|Study 306B|Lack of Efficacy|3|||
125630988|NCT01176240|451930406|FG000|Study 306B|Adverse Event|10|||
125630989|NCT01176240|451930407|FG001|Study 306B|Adverse Event|5|||
125630990|NCT01176240|451930406|FG000|Study 306B|Protocol Violation|2|||
125630991|NCT01176240|451930407|FG001|Study 306B|Protocol Violation|3|||
125630992|NCT01176240|451930406|FG000|Study 306B|Withdrawal by Subject|4|||
125630993|NCT01176240|451930407|FG001|Study 306B|Withdrawal by Subject|1|||
125630994|NCT01176240|451930406|FG000|Study 306B|Physician Decision|2|||
125630995|NCT01176240|451930407|FG001|Study 306B|Physician Decision|1|||
125630996|NCT01176240|451930406|FG000|Study 306B|Supine Hypertension|1|||
125630997|NCT01176240|451930407|FG001|Study 306B|Supine Hypertension|2|||
125630998|NCT01176240|451930406|FG000|Study 306B|Lost to Follow-up|0|||
125436275|NCT04041440|451224356|FG001|Overall Study|Withdrawal by Subject|1|||
125436276|NCT04041440|451224355|FG000|Overall Study|Lost to Follow-up|0|||
125436277|NCT04041440|451224356|FG001|Overall Study|Lost to Follow-up|1|||
125436278|NCT01381874|451224357|FG000|Overall Study|Lost to Follow-up|1|||
125436279|NCT01381874|451224358|FG001|Overall Study|Lost to Follow-up|1|||
125436280|NCT01381874|451224359|FG002|Overall Study|Lost to Follow-up|0|||
125436281|NCT01381874|451224357|FG000|Overall Study|Withdrawal by Subject|9|||
125436282|NCT01381874|451224358|FG001|Overall Study|Withdrawal by Subject|10|||
125436283|NCT01381874|451224359|FG002|Overall Study|Withdrawal by Subject|9|||
125436284|NCT01381874|451224357|FG000|Overall Study|Other|67|||
125436285|NCT01381874|451224358|FG001|Overall Study|Other|52|||
125436286|NCT01381874|451224359|FG002|Overall Study|Other|67|||
125436287|NCT02247804|451224360|FG000|Treatment Period 1|Adverse Event|9|||
125630999|NCT01176240|451930407|FG001|Study 306B|Lost to Follow-up|1|||
125631000|NCT01176240|451930406|FG000|Study 306B|withdrew prior to dosing|2|||
125631001|NCT01176240|451930407|FG001|Study 306B|withdrew prior to dosing|1|||
125631002|NCT01931150|451930408|FG000|Overall Study|Withdrawal by Subject|1|||
125631003|NCT01931150|451930409|FG001|Overall Study|Withdrawal by Subject|2|||
125631004|NCT02896192|451930413|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
125436288|NCT02247804|451224361|FG001|Treatment Period 1|Adverse Event|2|||
125631005|NCT02896192|451930413|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
125631006|NCT02896192|451930413|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
125631007|NCT00479167|451930418|FG000|Overall Study|Withdrawal by Subject|1|||
125436289|NCT02247804|451224362|FG002|Treatment Period 1|Adverse Event|0|||
125631008|NCT01390038|451930421|FG000|Overall Study|Death|1|||
125631009|NCT01390038|451930421|FG000|Overall Study|Lost to Follow-up|1|||
125436290|NCT02247804|451224360|FG000|Treatment Period 1|Lack of Efficacy|0|||
125436291|NCT02247804|451224361|FG001|Treatment Period 1|Lack of Efficacy|0|||
125631010|NCT01390038|451930421|FG000|Overall Study|Withdrawal by Subject|4|||
125631011|NCT01390038|451930421|FG000|Overall Study|Simpliciti System Removal|2|||
125631012|NCT03619837|451930425|FG000|Screening|received organs from HCV-negative donors|47|||
125376384|NCT02289417|451007740|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125376385|NCT02289417|451007741|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125631013|NCT03619837|451930425|FG000|Screening|died on the wait-list|2|||
125631014|NCT03619837|451930425|FG000|Screening|remained on the wait list|40|||
125631015|NCT03619837|451930425|FG000|Screening|didn't meet eligibility criteria|3|||
125631016|NCT03619837|451930425|FG000|Screening|withdrew consent|2|||
125631017|NCT03619837|451930425|FG000|Screening|never listed for HCV-viremic donor|1|||
125631018|NCT03619837|451930425|FG000|Screening|developed exclusion criteria|2|||
125631019|NCT03619837|451930425|FG000|Screening|excluded by the investigator due to non-compliance|1|||
125631020|NCT00807014|451930429|FG000|Overall Study|Participant Considered Disease Cured|13|||
125631021|NCT00807014|451930430|FG001|Overall Study|Participant Considered Disease Cured|2|||
125631022|NCT00807014|451930429|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
125631023|NCT00807014|451930430|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
125631024|NCT00807014|451930429|FG000|Overall Study|Protocol Violation|2|||
125631025|NCT00807014|451930430|FG001|Overall Study|Protocol Violation|8|||
125631026|NCT00807014|451930429|FG000|Overall Study|Adverse Event|0|||
125631027|NCT00807014|451930430|FG001|Overall Study|Adverse Event|2|||
125631028|NCT00807014|451930429|FG000|Overall Study|Lost to Follow-up|9|||
125376386|NCT02289417|451007742|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125376387|NCT02289417|451007743|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125376388|NCT02289417|451007744|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125376389|NCT02289417|451007745|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125376390|NCT02289417|451007746|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125376391|NCT02289417|451007747|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
125376392|NCT02289417|451007739|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
125376393|NCT02289417|451007740|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
125376394|NCT02289417|451007741|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
125376395|NCT02289417|451007742|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
125376396|NCT02289417|451007743|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
125376397|NCT02289417|451007744|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
125376398|NCT02289417|451007745|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
125376399|NCT02289417|451007746|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
125376400|NCT02289417|451007747|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
125376401|NCT02289417|451007739|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125376402|NCT02289417|451007740|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125376403|NCT02289417|451007741|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
125376404|NCT02289417|451007742|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125376405|NCT02289417|451007743|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125376406|NCT02289417|451007744|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125376407|NCT02289417|451007745|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125376408|NCT02289417|451007746|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125376409|NCT02289417|451007747|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
125376410|NCT02289417|451007739|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
125376411|NCT02289417|451007740|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
125376412|NCT02289417|451007741|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
125376413|NCT02289417|451007742|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
125376414|NCT02289417|451007743|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
125376415|NCT02289417|451007744|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
125376416|NCT02289417|451007745|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
125376417|NCT02289417|451007746|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
125376418|NCT02289417|451007747|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
125376419|NCT02289417|451007739|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
125376420|NCT02289417|451007740|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
125376421|NCT02289417|451007741|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
125376422|NCT02289417|451007742|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
125376423|NCT02289417|451007743|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
125631029|NCT00807014|451930430|FG001|Overall Study|Lost to Follow-up|7|||
125631030|NCT00807014|451930429|FG000|Overall Study|Recovery|1|||
125631031|NCT00807014|451930430|FG001|Overall Study|Recovery|0|||
125631032|NCT00807014|451930429|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
125215769|NCT02453256|450417503|FG000|Open Label Period|Adverse Event|1|||
125376424|NCT02289417|451007744|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
125436292|NCT02247804|451224362|FG002|Treatment Period 1|Lack of Efficacy|2|||
125376425|NCT02289417|451007745|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
125376426|NCT02289417|451007746|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
125215770|NCT02453256|450417504|FG001|Open Label Period|Adverse Event|3|||
125129328|NCT01472341|450099294|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
125436293|NCT02247804|451224360|FG000|Treatment Period 1|Lost to Follow-up|1|||
125436294|NCT02247804|451224361|FG001|Treatment Period 1|Lost to Follow-up|0|||
125436295|NCT02247804|451224362|FG002|Treatment Period 1|Lost to Follow-up|2|||
125436296|NCT02247804|451224360|FG000|Treatment Period 1|Personal Reasons|7|||
125436297|NCT02247804|451224361|FG001|Treatment Period 1|Personal Reasons|1|||
125436298|NCT02247804|451224362|FG002|Treatment Period 1|Personal Reasons|2|||
125436299|NCT02247804|451224360|FG000|Treatment Period 1|Protocol Deviation|0|||
125436300|NCT02247804|451224361|FG001|Treatment Period 1|Protocol Deviation|0|||
125436301|NCT02247804|451224362|FG002|Treatment Period 1|Protocol Deviation|1|||
125436302|NCT02247804|451224360|FG000|Treatment Period 1|Randomized but not Treated|5|||
125436303|NCT02247804|451224361|FG001|Treatment Period 1|Randomized but not Treated|1|||
125436304|NCT02247804|451224362|FG002|Treatment Period 1|Randomized but not Treated|1|||
125436305|NCT02247804|451224360|FG000|Treatment Period 2|Adverse Event|6|||
125436306|NCT02247804|451224361|FG001|Treatment Period 2|Adverse Event|3|||
125436307|NCT02247804|451224362|FG002|Treatment Period 2|Adverse Event|3|||
125436308|NCT02247804|451224360|FG000|Treatment Period 2|Lack of Efficacy|0|||
125436309|NCT02247804|451224361|FG001|Treatment Period 2|Lack of Efficacy|0|||
125436310|NCT02247804|451224362|FG002|Treatment Period 2|Lack of Efficacy|1|||
125436311|NCT02247804|451224360|FG000|Treatment Period 2|Lost to Follow-up|0|||
125436312|NCT02247804|451224361|FG001|Treatment Period 2|Lost to Follow-up|1|||
125436313|NCT02247804|451224362|FG002|Treatment Period 2|Lost to Follow-up|1|||
125436314|NCT02247804|451224360|FG000|Treatment Period 2|Personal Reasons|2|||
125436315|NCT02247804|451224361|FG001|Treatment Period 2|Personal Reasons|1|||
125436316|NCT02247804|451224362|FG002|Treatment Period 2|Personal Reasons|1|||
125436317|NCT02247804|451224360|FG000|Treatment Period 2|Reason not Specified|0|||
125436318|NCT02247804|451224361|FG001|Treatment Period 2|Reason not Specified|0|||
125436319|NCT02247804|451224362|FG002|Treatment Period 2|Reason not Specified|2|||
125436320|NCT02247804|451224360|FG000|Treatment Period 3|Adverse Event|4|||
125436321|NCT02247804|451224361|FG001|Treatment Period 3|Adverse Event|3|||
125436322|NCT02247804|451224362|FG002|Treatment Period 3|Adverse Event|3|||
125436323|NCT02247804|451224360|FG000|Treatment Period 3|Lack of Efficacy|0|||
125436324|NCT02247804|451224361|FG001|Treatment Period 3|Lack of Efficacy|1|||
125436325|NCT02247804|451224362|FG002|Treatment Period 3|Lack of Efficacy|0|||
125436326|NCT02247804|451224360|FG000|Treatment Period 3|Lost to Follow-up|1|||
125436327|NCT02247804|451224361|FG001|Treatment Period 3|Lost to Follow-up|2|||
125436328|NCT02247804|451224362|FG002|Treatment Period 3|Lost to Follow-up|2|||
125436329|NCT02247804|451224360|FG000|Treatment Period 3|Personal Reasons|4|||
125436330|NCT02247804|451224361|FG001|Treatment Period 3|Personal Reasons|3|||
125436331|NCT02247804|451224362|FG002|Treatment Period 3|Personal Reasons|2|||
125436332|NCT02247804|451224360|FG000|Treatment Period 3|Reason not Specified|2|||
125436333|NCT02247804|451224361|FG001|Treatment Period 3|Reason not Specified|1|||
125436334|NCT02247804|451224362|FG002|Treatment Period 3|Reason not Specified|3|||
125436335|NCT02917265|451224365|FG000|Overall Study|Physician Decision|1|||
125436336|NCT02917265|451224366|FG001|Overall Study|Physician Decision|0|||
125436337|NCT02917265|451224365|FG000|Overall Study|Withdrawal by Subject|1|||
125436338|NCT02917265|451224366|FG001|Overall Study|Withdrawal by Subject|0|||
125436339|NCT01737996|451224371|FG000|Overall Study|Adverse Event|0|||
125436340|NCT01737996|451224372|FG001|Overall Study|Adverse Event|1|||
125436341|NCT01737996|451224373|FG002|Overall Study|Adverse Event|1|||
125436342|NCT01737996|451224371|FG000|Overall Study|Withdrawal by Subject|0|||
125436343|NCT01737996|451224372|FG001|Overall Study|Withdrawal by Subject|0|||
125436344|NCT01737996|451224373|FG002|Overall Study|Withdrawal by Subject|1|||
125436345|NCT00452413|451224374|FG000|Overall Study|Progressive Disease|4|||
125129329|NCT01472341|450099294|FG000|Overall Study|Withdrawal by Subject|39|||
125436346|NCT00452413|451224375|FG001|Overall Study|Progressive Disease|11|||
125436347|NCT00452413|451224376|FG002|Overall Study|Progressive Disease|30|||
125436348|NCT00452413|451224374|FG000|Overall Study|Withdrawal by Subject|0|||
125436349|NCT00452413|451224375|FG001|Overall Study|Withdrawal by Subject|1|||
125436350|NCT00452413|451224376|FG002|Overall Study|Withdrawal by Subject|4|||
125436351|NCT00452413|451224374|FG000|Overall Study|Adverse Event|0|||
125436352|NCT00452413|451224375|FG001|Overall Study|Adverse Event|0|||
125436353|NCT00452413|451224376|FG002|Overall Study|Adverse Event|5|||
125436354|NCT00452413|451224374|FG000|Overall Study|Physician Decision|0|||
125436355|NCT00452413|451224375|FG001|Overall Study|Physician Decision|0|||
125129330|NCT01472341|450099294|FG000|Overall Study|Lost to Follow-up|52|||
125129331|NCT01472341|450099294|FG000|Overall Study|Laboratory parameters unavailable|25|||
125436356|NCT00452413|451224376|FG002|Overall Study|Physician Decision|4|||
125436357|NCT00452413|451224374|FG000|Overall Study|Death due to study disease|0|||
125436358|NCT00452413|451224375|FG001|Overall Study|Death due to study disease|0|||
125436359|NCT00452413|451224376|FG002|Overall Study|Death due to study disease|2|||
125436360|NCT00452413|451224374|FG000|Overall Study|Death due to adverse event (AE)|0|||
125436361|NCT00452413|451224375|FG001|Overall Study|Death due to adverse event (AE)|0|||
125436362|NCT00452413|451224376|FG002|Overall Study|Death due to adverse event (AE)|1|||
125436363|NCT00452413|451224374|FG000|Overall Study|On treatment|0|||
125436364|NCT00452413|451224375|FG001|Overall Study|On treatment|0|||
125436365|NCT00452413|451224376|FG002|Overall Study|On treatment|3|||
125436366|NCT03119610|451224377|FG000|Overall Study|Adverse Event|1|||
125436367|NCT03119610|451224378|FG001|Overall Study|Adverse Event|0|||
125436368|NCT03119610|451224377|FG000|Overall Study|Lost to Follow-up|0|||
125436369|NCT03119610|451224378|FG001|Overall Study|Lost to Follow-up|1|||
125436370|NCT00114634|451224379|FG000|Overall Study|failure to return forms|3|||
125436371|NCT03283696|451224380|FG000|Overall Study|Physician Decision|5|||
125436372|NCT03283696|451224381|FG001|Overall Study|Physician Decision|6|||
125436373|NCT03283696|451224380|FG000|Overall Study|Withdrawal by Subject|2|||
125436374|NCT03283696|451224381|FG001|Overall Study|Withdrawal by Subject|0|||
125436375|NCT01539863|451224382|FG000|Overall Study|Lost to Follow-up|5|||
125436376|NCT01539863|451224383|FG001|Overall Study|Lost to Follow-up|4|||
125436377|NCT00557622|451224384|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
125436378|NCT00557622|451224385|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
125436379|NCT00557622|451224384|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
125436380|NCT00557622|451224385|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
125436381|NCT00557622|451224384|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
125436382|NCT00557622|451224385|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
125436383|NCT02765490|451224388|FG000|Overall Study|Lost to Follow-up|1|||
125436384|NCT02765490|451224389|FG001|Overall Study|Lost to Follow-up|1|||
125436385|NCT02765490|451224388|FG000|Overall Study|Other|0|||
125436386|NCT02765490|451224389|FG001|Overall Study|Other|1|||
125436387|NCT02765490|451224388|FG000|Overall Study|Death|0|||
125436388|NCT02765490|451224389|FG001|Overall Study|Death|1|||
125436389|NCT01468922|451224390|FG000|Overall Study|Screening failure|0|||
125215771|NCT02453256|450417503|FG000|Open Label Period|Death|0|||
125215772|NCT02453256|450417504|FG001|Open Label Period|Death|1|||
125215773|NCT02453256|450417503|FG000|Open Label Period|Lost to Follow-up|1|||
125215774|NCT02453256|450417504|FG001|Open Label Period|Lost to Follow-up|0|||
125215775|NCT02453256|450417503|FG000|Open Label Period|Other|0|||
125215776|NCT02453256|450417504|FG001|Open Label Period|Other|2|||
125215777|NCT02453256|450417503|FG000|Open Label Period|Withdrawal by Subject|5|||
125215778|NCT02453256|450417504|FG001|Open Label Period|Withdrawal by Subject|1|||
125215779|NCT01216332|450417505|FG000|Overall Study|Withdrawal by Subject|4|||
125215780|NCT01216332|450417506|FG001|Overall Study|Withdrawal by Subject|0|||
125215781|NCT00636636|450417507|FG000|Overall Study|Other reason|4|||
125215782|NCT00636636|450417508|FG001|Overall Study|Other reason|6|||
125215783|NCT00636636|450417507|FG000|Overall Study|Adverse Event|19|||
125215784|NCT00636636|450417508|FG001|Overall Study|Adverse Event|8|||
125215785|NCT00636636|450417507|FG000|Overall Study|Lack of Efficacy|7|||
125215786|NCT00636636|450417508|FG001|Overall Study|Lack of Efficacy|12|||
125215787|NCT00636636|450417507|FG000|Overall Study|Protocol Violation|2|||
125215788|NCT00636636|450417508|FG001|Overall Study|Protocol Violation|2|||
125215789|NCT00636636|450417507|FG000|Overall Study|Lost to Follow-up|0|||
125215790|NCT00636636|450417508|FG001|Overall Study|Lost to Follow-up|1|||
125215791|NCT00636636|450417507|FG000|Overall Study|Death|0|||
125215792|NCT00636636|450417508|FG001|Overall Study|Death|1|||
125215793|NCT00636636|450417507|FG000|Overall Study|Withdrawal by Subject|4|||
125215794|NCT00636636|450417508|FG001|Overall Study|Withdrawal by Subject|9|||
125215795|NCT00524173|450417509|FG000|Overall Study|Lost to Follow-up|0|||
125215796|NCT00524173|450417510|FG001|Overall Study|Lost to Follow-up|1|||
125376427|NCT02289417|451007747|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
125376428|NCT02289417|451007739|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125376429|NCT02289417|451007740|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125376430|NCT02289417|451007741|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125376431|NCT02289417|451007742|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125376432|NCT02289417|451007743|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125376433|NCT02289417|451007744|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125376434|NCT02289417|451007745|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
125376435|NCT02289417|451007746|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125376436|NCT02289417|451007747|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
125376437|NCT02289417|451007739|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125436390|NCT01468922|451224391|FG001|Overall Study|Screening failure|0|||
125436391|NCT01468922|451224392|FG002|Overall Study|Screening failure|0|||
125436392|NCT01468922|451224393|FG003|Overall Study|Screening failure|0|||
125436393|NCT01468922|451224394|FG004|Overall Study|Screening failure|0|||
125436394|NCT01468922|451224395|FG005|Overall Study|Screening failure|0|||
125436395|NCT01468922|451224396|FG006|Overall Study|Screening failure|0|||
125436396|NCT01468922|451224397|FG007|Overall Study|Screening failure|0|||
125215797|NCT00524173|450417509|FG000|Overall Study|Death|1|||
125215798|NCT00524173|450417510|FG001|Overall Study|Death|0|||
125215799|NCT00524173|450417509|FG000|Overall Study|Had not reached endpoint at study close|4|||
125215800|NCT00524173|450417510|FG001|Overall Study|Had not reached endpoint at study close|1|||
125215801|NCT01237327|450417511|FG000|Overall Study|Protocol Violation: Core Study|1|||
125376438|NCT02289417|451007740|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125631033|NCT00807014|451930430|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
125631034|NCT02650895|451930431|FG000|Overall Study|Withdrawal by Subject|0|||
125631035|NCT02650895|451930432|FG001|Overall Study|Withdrawal by Subject|1|||
125631036|NCT02650895|451930433|FG002|Overall Study|Withdrawal by Subject|0|||
125631037|NCT02650895|451930434|FG003|Overall Study|Withdrawal by Subject|0|||
125631038|NCT02650895|451930435|FG004|Overall Study|Withdrawal by Subject|0|||
125631039|NCT02650895|451930436|FG005|Overall Study|Withdrawal by Subject|0|||
125631040|NCT01696396|451932442|FG000|Overall Study|Withdrawal by Subject|19|||
125631041|NCT01696396|451932443|FG001|Overall Study|Withdrawal by Subject|5|||
125631042|NCT01696396|451932444|FG002|Overall Study|Withdrawal by Subject|19|||
125631043|NCT01696396|451932445|FG003|Overall Study|Withdrawal by Subject|11|||
125631044|NCT01696396|451932442|FG000|Overall Study|Decision by Sponsor|3|||
125631045|NCT01696396|451932443|FG001|Overall Study|Decision by Sponsor|1|||
125631046|NCT01696396|451932444|FG002|Overall Study|Decision by Sponsor|2|||
125631047|NCT01696396|451932445|FG003|Overall Study|Decision by Sponsor|2|||
125631048|NCT01696396|451932442|FG000|Overall Study|Lost to Follow-up|9|||
125631049|NCT01696396|451932443|FG001|Overall Study|Lost to Follow-up|1|||
125631050|NCT01696396|451932444|FG002|Overall Study|Lost to Follow-up|4|||
125631051|NCT01696396|451932445|FG003|Overall Study|Lost to Follow-up|1|||
125631052|NCT01696396|451932442|FG000|Overall Study|Death|0|||
125631053|NCT01696396|451932443|FG001|Overall Study|Death|0|||
125631054|NCT01696396|451932444|FG002|Overall Study|Death|1|||
125631055|NCT01696396|451932445|FG003|Overall Study|Death|0|||
125631056|NCT02712008|451932448|FG000|Baseline (Day 1) up to Week 12|Death|3|||
125631057|NCT02712008|451932449|FG001|Baseline (Day 1) up to Week 12|Death|0|||
125376439|NCT02289417|451007741|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125376440|NCT02289417|451007742|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
125376441|NCT02289417|451007743|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125376442|NCT02289417|451007744|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125376443|NCT02289417|451007745|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
125376444|NCT02289417|451007746|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125376445|NCT02289417|451007747|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
125376446|NCT02289417|451007739|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
125376447|NCT02289417|451007740|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
125376448|NCT02289417|451007741|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
125376449|NCT02289417|451007742|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
125376450|NCT02289417|451007743|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
125376451|NCT02289417|451007744|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
125376452|NCT02289417|451007745|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
125376453|NCT02289417|451007746|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
125376454|NCT02289417|451007747|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
125376455|NCT02289417|451007739|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125376456|NCT02289417|451007740|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125376457|NCT02289417|451007741|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125376458|NCT02289417|451007742|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125376459|NCT02289417|451007743|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125376460|NCT02289417|451007744|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125376461|NCT02289417|451007745|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
125376462|NCT02289417|451007746|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
125376463|NCT02289417|451007747|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
125376464|NCT02289417|451007739|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125376465|NCT02289417|451007740|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125376466|NCT02289417|451007741|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125376467|NCT02289417|451007742|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125376468|NCT02289417|451007743|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125376469|NCT02289417|451007744|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125376470|NCT02289417|451007745|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
125376471|NCT02289417|451007746|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
125376472|NCT02289417|451007747|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
125376473|NCT02289417|451007739|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
125376474|NCT02289417|451007740|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
125376475|NCT02289417|451007741|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
125376476|NCT02289417|451007742|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
125376477|NCT02289417|451007743|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
125376478|NCT02289417|451007744|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
125376479|NCT02289417|451007745|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
125631058|NCT02712008|451932450|FG002|Baseline (Day 1) up to Week 12|Death|0|||
125631059|NCT02712008|451932451|FG003|Baseline (Day 1) up to Week 12|Death|0|||
125631060|NCT02712008|451932452|FG004|Baseline (Day 1) up to Week 12|Death|0|||
125631061|NCT02712008|451932453|FG005|Baseline (Day 1) up to Week 12|Death|0|||
125436397|NCT01468922|451224398|FG008|Overall Study|Screening failure|1|||
125436398|NCT01468922|451224390|FG000|Overall Study|Per patient choice|1|||
125436399|NCT01468922|451224391|FG001|Overall Study|Per patient choice|0|||
125631062|NCT02712008|451932454|FG006|Baseline (Day 1) up to Week 12|Death|0|||
125631063|NCT02712008|451932455|FG007|Baseline (Day 1) up to Week 12|Death|0|||
125631064|NCT02712008|451932448|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125631065|NCT02712008|451932449|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
125631066|NCT02712008|451932450|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
125631067|NCT02712008|451932451|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125631068|NCT02712008|451932452|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125631069|NCT02712008|451932453|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125631070|NCT02712008|451932454|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125631071|NCT02712008|451932455|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
125631072|NCT02712008|451932448|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
125631073|NCT02712008|451932449|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125631074|NCT02712008|451932450|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
125631075|NCT02712008|451932451|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125631076|NCT02712008|451932452|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125631077|NCT02712008|451932453|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125631078|NCT02712008|451932454|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125631079|NCT02712008|451932455|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
125631080|NCT02712008|451932448|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125631081|NCT02712008|451932449|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125631082|NCT02712008|451932450|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
125631083|NCT02712008|451932451|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125631084|NCT02712008|451932452|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125631085|NCT02712008|451932453|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125631086|NCT02712008|451932454|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125631087|NCT02712008|451932455|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
125631088|NCT02712008|451932448|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125631089|NCT02712008|451932449|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
125631090|NCT02712008|451932450|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125631091|NCT02712008|451932451|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125631092|NCT02712008|451932452|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125631093|NCT02712008|451932453|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125631094|NCT02712008|451932454|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125631095|NCT02712008|451932455|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
125631096|NCT02712008|451932448|FG000|From Week 12 up to Week 36|Adverse Event|0|||
125631097|NCT02712008|451932449|FG001|From Week 12 up to Week 36|Adverse Event|0|||
125631098|NCT02712008|451932450|FG002|From Week 12 up to Week 36|Adverse Event|0|||
125631099|NCT02712008|451932451|FG003|From Week 12 up to Week 36|Adverse Event|0|||
125631100|NCT02712008|451932452|FG004|From Week 12 up to Week 36|Adverse Event|1|||
125631101|NCT02712008|451932453|FG005|From Week 12 up to Week 36|Adverse Event|0|||
125631102|NCT02712008|451932454|FG006|From Week 12 up to Week 36|Adverse Event|0|||
125631103|NCT02712008|451932455|FG007|From Week 12 up to Week 36|Adverse Event|2|||
125631104|NCT02712008|451932448|FG000|From Week 12 up to Week 36|Death|1|||
125631105|NCT02712008|451932449|FG001|From Week 12 up to Week 36|Death|0|||
125631106|NCT02712008|451932450|FG002|From Week 12 up to Week 36|Death|0|||
125631107|NCT02712008|451932451|FG003|From Week 12 up to Week 36|Death|0|||
125631108|NCT02712008|451932452|FG004|From Week 12 up to Week 36|Death|0|||
125631109|NCT02712008|451932453|FG005|From Week 12 up to Week 36|Death|0|||
125631110|NCT02712008|451932454|FG006|From Week 12 up to Week 36|Death|1|||
125631111|NCT02712008|451932455|FG007|From Week 12 up to Week 36|Death|0|||
125631112|NCT02712008|451932448|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
125631113|NCT02712008|451932449|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
125631114|NCT02712008|451932450|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
125631115|NCT02712008|451932451|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
125436400|NCT01468922|451224392|FG002|Overall Study|Per patient choice|0|||
125436401|NCT01468922|451224393|FG003|Overall Study|Per patient choice|0|||
125436402|NCT01468922|451224394|FG004|Overall Study|Per patient choice|0|||
125436403|NCT01468922|451224395|FG005|Overall Study|Per patient choice|0|||
125436404|NCT01468922|451224396|FG006|Overall Study|Per patient choice|0|||
125436405|NCT01468922|451224397|FG007|Overall Study|Per patient choice|0|||
125631116|NCT02712008|451932452|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
125631117|NCT02712008|451932453|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
125631118|NCT02712008|451932454|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
125631119|NCT02712008|451932455|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
125631120|NCT02712008|451932448|FG000|From Week 12 up to Week 36|Physician Decision|0|||
125436406|NCT01468922|451224398|FG008|Overall Study|Per patient choice|0|||
125436407|NCT01468922|451224390|FG000|Overall Study|Switched to alternative treatment|1|||
125436408|NCT01468922|451224391|FG001|Overall Study|Switched to alternative treatment|0|||
125631121|NCT02712008|451932449|FG001|From Week 12 up to Week 36|Physician Decision|0|||
125631122|NCT02712008|451932450|FG002|From Week 12 up to Week 36|Physician Decision|0|||
125436409|NCT01468922|451224392|FG002|Overall Study|Switched to alternative treatment|0|||
125436410|NCT01468922|451224393|FG003|Overall Study|Switched to alternative treatment|0|||
125436411|NCT01468922|451224394|FG004|Overall Study|Switched to alternative treatment|1|||
125436412|NCT01468922|451224395|FG005|Overall Study|Switched to alternative treatment|0|||
125436413|NCT01468922|451224396|FG006|Overall Study|Switched to alternative treatment|0|||
125436414|NCT01468922|451224397|FG007|Overall Study|Switched to alternative treatment|0|||
125436415|NCT01468922|451224398|FG008|Overall Study|Switched to alternative treatment|0|||
125436416|NCT01468922|451224390|FG000|Overall Study|Enrolled on new protocol|0|||
125436417|NCT01468922|451224391|FG001|Overall Study|Enrolled on new protocol|0|||
125436418|NCT01468922|451224392|FG002|Overall Study|Enrolled on new protocol|0|||
125436419|NCT01468922|451224393|FG003|Overall Study|Enrolled on new protocol|0|||
125436420|NCT01468922|451224394|FG004|Overall Study|Enrolled on new protocol|1|||
125436421|NCT01468922|451224395|FG005|Overall Study|Enrolled on new protocol|0|||
125436422|NCT01468922|451224396|FG006|Overall Study|Enrolled on new protocol|0|||
125436423|NCT01468922|451224397|FG007|Overall Study|Enrolled on new protocol|0|||
125436424|NCT01468922|451224398|FG008|Overall Study|Enrolled on new protocol|0|||
125436425|NCT01468922|451224390|FG000|Overall Study|Adverse Event|0|||
125436426|NCT01468922|451224391|FG001|Overall Study|Adverse Event|0|||
125376480|NCT02289417|451007746|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
125376481|NCT02289417|451007747|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
125376482|NCT04786990|451007748|FG000|Overall Study|Withdrawal by Subject|1|||
125376483|NCT04786990|451007748|FG000|Overall Study|Adverse Event|1|||
125376484|NCT04786990|451007748|FG000|Overall Study|Lost to Follow-up|1|||
125376485|NCT04786990|451007748|FG000|Overall Study|Noncompliance|1|||
125376486|NCT04786990|451007748|FG000|Overall Study|Unable to complete site visits|1|||
125376487|NCT04786990|451007748|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
125376488|NCT01782222|451007751|FG000|Overall Study|Adverse Event|4|||
125376489|NCT01782222|451007752|FG001|Overall Study|Adverse Event|5|||
125376490|NCT01782222|451007753|FG002|Overall Study|Adverse Event|3|||
125376491|NCT01782222|451007751|FG000|Overall Study|Lack of Efficacy|2|||
125376492|NCT01782222|451007752|FG001|Overall Study|Lack of Efficacy|1|||
125376493|NCT01782222|451007753|FG002|Overall Study|Lack of Efficacy|0|||
125376494|NCT01782222|451007751|FG000|Overall Study|Protocol Violation|1|||
125376495|NCT01782222|451007752|FG001|Overall Study|Protocol Violation|0|||
125376496|NCT01782222|451007753|FG002|Overall Study|Protocol Violation|0|||
125376497|NCT01782222|451007751|FG000|Overall Study|Withdrawal by Subject|1|||
125376498|NCT01782222|451007752|FG001|Overall Study|Withdrawal by Subject|4|||
125376499|NCT01782222|451007753|FG002|Overall Study|Withdrawal by Subject|1|||
125376500|NCT01782222|451007751|FG000|Overall Study|Moved to other state|0|||
125376501|NCT01782222|451007752|FG001|Overall Study|Moved to other state|1|||
125376502|NCT01782222|451007753|FG002|Overall Study|Moved to other state|0|||
125376503|NCT01756898|451007757|FG000|Overall Study|Adverse Event|7|||
125376504|NCT01756898|451007758|FG001|Overall Study|Adverse Event|1|||
125376505|NCT01756898|451007759|FG002|Overall Study|Adverse Event|0|||
125376506|NCT01756898|451007760|FG003|Overall Study|Adverse Event|0|||
125376507|NCT01756898|451007757|FG000|Overall Study|Lack of Efficacy|4|||
125376508|NCT01756898|451007758|FG001|Overall Study|Lack of Efficacy|7|||
125376509|NCT01756898|451007759|FG002|Overall Study|Lack of Efficacy|6|||
125376510|NCT01756898|451007760|FG003|Overall Study|Lack of Efficacy|6|||
125376511|NCT01756898|451007757|FG000|Overall Study|Lost to Follow-up|2|||
125376512|NCT01756898|451007758|FG001|Overall Study|Lost to Follow-up|4|||
125376513|NCT01756898|451007759|FG002|Overall Study|Lost to Follow-up|2|||
125376514|NCT01756898|451007760|FG003|Overall Study|Lost to Follow-up|3|||
125376515|NCT01756898|451007757|FG000|Overall Study|Protocol Violation|1|||
125376516|NCT01756898|451007758|FG001|Overall Study|Protocol Violation|2|||
125436427|NCT01468922|451224392|FG002|Overall Study|Adverse Event|0|||
125436428|NCT01468922|451224393|FG003|Overall Study|Adverse Event|0|||
125436429|NCT01468922|451224394|FG004|Overall Study|Adverse Event|0|||
125436430|NCT01468922|451224395|FG005|Overall Study|Adverse Event|0|||
125436431|NCT01468922|451224396|FG006|Overall Study|Adverse Event|0|||
125436432|NCT01468922|451224397|FG007|Overall Study|Adverse Event|1|||
125376517|NCT01756898|451007759|FG002|Overall Study|Protocol Violation|2|||
125376518|NCT01756898|451007760|FG003|Overall Study|Protocol Violation|1|||
125376519|NCT01756898|451007757|FG000|Overall Study|Withdrew Consent|5|||
125376520|NCT01756898|451007758|FG001|Overall Study|Withdrew Consent|3|||
125376521|NCT01756898|451007759|FG002|Overall Study|Withdrew Consent|5|||
125376522|NCT01756898|451007760|FG003|Overall Study|Withdrew Consent|6|||
125376523|NCT01756898|451007757|FG000|Overall Study|Other|0|||
125376524|NCT01756898|451007758|FG001|Overall Study|Other|2|||
125436433|NCT01468922|451224398|FG008|Overall Study|Adverse Event|0|||
125436434|NCT01468922|451224390|FG000|Overall Study|Infection of blood|0|||
125436435|NCT01468922|451224391|FG001|Overall Study|Infection of blood|0|||
125436436|NCT01468922|451224392|FG002|Overall Study|Infection of blood|0|||
125436437|NCT01468922|451224393|FG003|Overall Study|Infection of blood|0|||
125436438|NCT01468922|451224394|FG004|Overall Study|Infection of blood|0|||
125436439|NCT01468922|451224395|FG005|Overall Study|Infection of blood|0|||
125436440|NCT01468922|451224396|FG006|Overall Study|Infection of blood|0|||
125436441|NCT01468922|451224397|FG007|Overall Study|Infection of blood|1|||
125436442|NCT01468922|451224398|FG008|Overall Study|Infection of blood|0|||
125436443|NCT01468922|451224390|FG000|Overall Study|Patient choice - surgery|0|||
125436444|NCT01468922|451224391|FG001|Overall Study|Patient choice - surgery|0|||
125436445|NCT01468922|451224392|FG002|Overall Study|Patient choice - surgery|0|||
125436446|NCT01468922|451224393|FG003|Overall Study|Patient choice - surgery|0|||
125436447|NCT01468922|451224394|FG004|Overall Study|Patient choice - surgery|0|||
125436448|NCT01468922|451224395|FG005|Overall Study|Patient choice - surgery|0|||
125436449|NCT01468922|451224396|FG006|Overall Study|Patient choice - surgery|0|||
125436450|NCT01468922|451224397|FG007|Overall Study|Patient choice - surgery|1|||
125436451|NCT01468922|451224398|FG008|Overall Study|Patient choice - surgery|0|||
125436452|NCT01468922|451224390|FG000|Overall Study|Refused further treatment|0|||
125436453|NCT01468922|451224391|FG001|Overall Study|Refused further treatment|0|||
125436454|NCT01468922|451224392|FG002|Overall Study|Refused further treatment|0|||
125436455|NCT01468922|451224393|FG003|Overall Study|Refused further treatment|0|||
125436456|NCT01468922|451224394|FG004|Overall Study|Refused further treatment|0|||
125436457|NCT01468922|451224395|FG005|Overall Study|Refused further treatment|0|||
125436458|NCT01468922|451224396|FG006|Overall Study|Refused further treatment|0|||
125436459|NCT01468922|451224397|FG007|Overall Study|Refused further treatment|1|||
125436460|NCT01468922|451224398|FG008|Overall Study|Refused further treatment|0|||
125436461|NCT00007475|451224403|FG000|Overall Study|Withdrawal by Subject|1|||
125436462|NCT00007475|451224404|FG001|Overall Study|Withdrawal by Subject|0|||
125436463|NCT00007475|451224405|FG002|Overall Study|Withdrawal by Subject|0|||
125436464|NCT00007475|451224406|FG003|Overall Study|Withdrawal by Subject|0|||
125436465|NCT00007475|451224403|FG000|Overall Study|Adverse Event|3|||
125129332|NCT01472341|450099294|FG000|Overall Study|Death|9|||
125376525|NCT01756898|451007759|FG002|Overall Study|Other|2|||
125376526|NCT01756898|451007760|FG003|Overall Study|Other|0|||
125376527|NCT01500694|451007761|FG000|Overall Study|Adverse Event|4|||
125376528|NCT01500694|451007762|FG001|Overall Study|Adverse Event|3|||
125376529|NCT01500694|451007761|FG000|Overall Study|Protocol Violation|0|||
125376530|NCT01500694|451007762|FG001|Overall Study|Protocol Violation|1|||
125376531|NCT01500694|451007761|FG000|Overall Study|Withdrawal by Subject|23|||
125376532|NCT01500694|451007762|FG001|Overall Study|Withdrawal by Subject|14|||
125376533|NCT01500694|451007761|FG000|Overall Study|Lost to Follow-up|2|||
125376534|NCT01500694|451007762|FG001|Overall Study|Lost to Follow-up|3|||
125376535|NCT01500694|451007761|FG000|Overall Study|Lack of Efficacy|14|||
125376536|NCT01500694|451007762|FG001|Overall Study|Lack of Efficacy|5|||
125376537|NCT01500694|451007761|FG000|Overall Study|Other|9|||
125376538|NCT01500694|451007762|FG001|Overall Study|Other|3|||
125376539|NCT00496054|451007765|FG000|Overall Study|Adverse Event|1|||
125376540|NCT00496054|451007765|FG000|Overall Study|Lost to Follow-up|7|||
125376541|NCT01858389|451007768|FG000|Overall Study|Death|1|||
125376542|NCT01858389|451007769|FG001|Overall Study|Death|3|||
125376543|NCT01858389|451007768|FG000|Overall Study|Study terminated by sponsor|0|||
125376544|NCT01858389|451007769|FG001|Overall Study|Study terminated by sponsor|2|||
125376545|NCT01858389|451007768|FG000|Overall Study|Withdrawal by Subject|0|||
125376546|NCT01858389|451007769|FG001|Overall Study|Withdrawal by Subject|1|||
125376547|NCT01858389|451007768|FG000|Overall Study|Progressive disease|10|||
125376548|NCT01858389|451007769|FG001|Overall Study|Progressive disease|11|||
125376549|NCT01858389|451007768|FG000|Overall Study|Other|2|||
125376550|NCT01858389|451007769|FG001|Overall Study|Other|4|||
125376551|NCT01858389|451007768|FG000|Overall Study|Adverse Event|3|||
125376552|NCT01858389|451007769|FG001|Overall Study|Adverse Event|1|||
125376553|NCT01858389|451007768|FG000|Overall Study|Did not receive treatment|0|||
125436466|NCT00007475|451224404|FG001|Overall Study|Adverse Event|0|||
125436467|NCT00007475|451224405|FG002|Overall Study|Adverse Event|0|||
125436468|NCT00007475|451224406|FG003|Overall Study|Adverse Event|0|||
125436469|NCT01512745|451224408|FG000|Overall Study|Adverse Event|22|||
125436470|NCT01512745|451224409|FG001|Overall Study|Adverse Event|3|||
125436471|NCT01512745|451224408|FG000|Overall Study|Death|9|||
125376554|NCT01858389|451007769|FG001|Overall Study|Did not receive treatment|3|||
125436472|NCT01512745|451224409|FG001|Overall Study|Death|13|||
125376555|NCT03572062|451007770|FG000|Overall Study|Adverse Event|0|||
125376556|NCT03572062|451007771|FG001|Overall Study|Adverse Event|0|||
125376557|NCT03572062|451007772|FG002|Overall Study|Adverse Event|0|||
125376558|NCT03572062|451007773|FG003|Overall Study|Adverse Event|0|||
125376559|NCT03572062|451007774|FG004|Overall Study|Adverse Event|0|||
125376560|NCT03572062|451007775|FG005|Overall Study|Adverse Event|0|||
125376561|NCT03572062|451007776|FG006|Overall Study|Adverse Event|0|||
125376562|NCT03572062|451007777|FG007|Overall Study|Adverse Event|0|||
125376563|NCT03572062|451007778|FG008|Overall Study|Adverse Event|1|||
125436473|NCT01512745|451224408|FG000|Overall Study|Withdrawal by Subject|2|||
125436474|NCT01512745|451224409|FG001|Overall Study|Withdrawal by Subject|2|||
125436475|NCT01512745|451224408|FG000|Overall Study|Lost to Follow-up|4|||
125436476|NCT01512745|451224409|FG001|Overall Study|Lost to Follow-up|0|||
125436477|NCT01512745|451224408|FG000|Overall Study|Lack of Efficacy|2|||
125436478|NCT01512745|451224409|FG001|Overall Study|Lack of Efficacy|2|||
125436479|NCT01512745|451224408|FG000|Overall Study|Protocol Violation|1|||
125436480|NCT01512745|451224409|FG001|Overall Study|Protocol Violation|0|||
125436481|NCT02563522|451224410|FG000|Overall Study|Adverse Event|2|||
125436482|NCT02563522|451224411|FG001|Overall Study|Adverse Event|3|||
125436483|NCT02563522|451224410|FG000|Overall Study|Lost to Follow-up|1|||
125436484|NCT02563522|451224411|FG001|Overall Study|Lost to Follow-up|0|||
125436485|NCT02563522|451224410|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
125436486|NCT02563522|451224411|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
125436487|NCT00675506|451224413|FG000|Overall Study|Lost to Follow-up|1|||
125215802|NCT01237327|450417512|FG001|Overall Study|Protocol Violation: Core Study|0|||
125215803|NCT01237327|450417511|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
125215804|NCT01237327|450417512|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
125215805|NCT01237327|450417511|FG000|Overall Study|Progression of Disease: Core Study|18|||
125215806|NCT01237327|450417512|FG001|Overall Study|Progression of Disease: Core Study|22|||
125215807|NCT01237327|450417511|FG000|Overall Study|Progression of Disease: Extension Study|15|||
125376564|NCT03572062|451007779|FG009|Overall Study|Adverse Event|3|||
125376565|NCT03572062|451007770|FG000|Overall Study|Death|0|||
125376566|NCT03572062|451007771|FG001|Overall Study|Death|0|||
125376567|NCT03572062|451007772|FG002|Overall Study|Death|0|||
125376568|NCT03572062|451007773|FG003|Overall Study|Death|0|||
125376569|NCT03572062|451007774|FG004|Overall Study|Death|0|||
125376570|NCT03572062|451007775|FG005|Overall Study|Death|1|||
125376571|NCT03572062|451007776|FG006|Overall Study|Death|0|||
125376572|NCT03572062|451007777|FG007|Overall Study|Death|0|||
125376573|NCT03572062|451007778|FG008|Overall Study|Death|0|||
125376574|NCT03572062|451007779|FG009|Overall Study|Death|0|||
125376575|NCT03572062|451007770|FG000|Overall Study|Lost to Follow-up|0|||
125376576|NCT03572062|451007771|FG001|Overall Study|Lost to Follow-up|0|||
125376577|NCT03572062|451007772|FG002|Overall Study|Lost to Follow-up|0|||
125376578|NCT03572062|451007773|FG003|Overall Study|Lost to Follow-up|0|||
125376579|NCT03572062|451007774|FG004|Overall Study|Lost to Follow-up|0|||
125376580|NCT03572062|451007775|FG005|Overall Study|Lost to Follow-up|1|||
125376581|NCT03572062|451007776|FG006|Overall Study|Lost to Follow-up|1|||
125376582|NCT03572062|451007777|FG007|Overall Study|Lost to Follow-up|0|||
125376583|NCT03572062|451007778|FG008|Overall Study|Lost to Follow-up|0|||
125376584|NCT03572062|451007779|FG009|Overall Study|Lost to Follow-up|0|||
125376585|NCT03572062|451007770|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125376586|NCT03572062|451007771|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125376587|NCT03572062|451007772|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
125376588|NCT03572062|451007773|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
125376589|NCT03572062|451007774|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
125376590|NCT03572062|451007775|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
125376591|NCT03572062|451007776|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
125376592|NCT03572062|451007777|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
125376593|NCT03572062|451007778|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
125376594|NCT03572062|451007779|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
125376595|NCT03572062|451007770|FG000|Overall Study|Study Terminated By Sponsor|0|||
125376596|NCT03572062|451007771|FG001|Overall Study|Study Terminated By Sponsor|0|||
125376597|NCT03572062|451007772|FG002|Overall Study|Study Terminated By Sponsor|0|||
125376598|NCT03572062|451007773|FG003|Overall Study|Study Terminated By Sponsor|0|||
125376599|NCT03572062|451007774|FG004|Overall Study|Study Terminated By Sponsor|0|||
125376600|NCT03572062|451007775|FG005|Overall Study|Study Terminated By Sponsor|0|||
125376601|NCT03572062|451007776|FG006|Overall Study|Study Terminated By Sponsor|0|||
125376602|NCT03572062|451007777|FG007|Overall Study|Study Terminated By Sponsor|0|||
125376603|NCT03572062|451007778|FG008|Overall Study|Study Terminated By Sponsor|29|||
125376604|NCT03572062|451007779|FG009|Overall Study|Study Terminated By Sponsor|27|||
125376605|NCT03572062|451007770|FG000|Overall Study|Physician Decision|0|||
125376606|NCT03572062|451007771|FG001|Overall Study|Physician Decision|0|||
125376607|NCT03572062|451007772|FG002|Overall Study|Physician Decision|0|||
125376608|NCT03572062|451007773|FG003|Overall Study|Physician Decision|0|||
125376609|NCT03572062|451007774|FG004|Overall Study|Physician Decision|0|||
125215808|NCT01237327|450417512|FG001|Overall Study|Progression of Disease: Extension Study|13|||
125215809|NCT01237327|450417511|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
125215810|NCT01237327|450417512|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
125376610|NCT03572062|451007775|FG005|Overall Study|Physician Decision|0|||
125376611|NCT03572062|451007776|FG006|Overall Study|Physician Decision|0|||
125436488|NCT00675506|451224414|FG001|Overall Study|Lost to Follow-up|5|||
125376612|NCT03572062|451007777|FG007|Overall Study|Physician Decision|0|||
125376613|NCT03572062|451007778|FG008|Overall Study|Physician Decision|1|||
125376614|NCT03572062|451007779|FG009|Overall Study|Physician Decision|0|||
125631123|NCT02712008|451932451|FG003|From Week 12 up to Week 36|Physician Decision|1|||
125631124|NCT02712008|451932452|FG004|From Week 12 up to Week 36|Physician Decision|1|||
125631125|NCT02712008|451932453|FG005|From Week 12 up to Week 36|Physician Decision|0|||
125631126|NCT02712008|451932454|FG006|From Week 12 up to Week 36|Physician Decision|0|||
125631127|NCT02712008|451932455|FG007|From Week 12 up to Week 36|Physician Decision|0|||
125631128|NCT02712008|451932448|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
125631129|NCT02712008|451932449|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
125631130|NCT02712008|451932450|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
125631131|NCT02712008|451932451|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
125631132|NCT02712008|451932452|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
125631133|NCT02712008|451932453|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
125631134|NCT02712008|451932454|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
125631135|NCT02712008|451932455|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
125631136|NCT03950440|451932456|FG000|Overall Study|Death|8|||
125631137|NCT03950440|451932457|FG001|Overall Study|Death|2|||
125631138|NCT03950440|451932458|FG002|Overall Study|Death|1|||
125631139|NCT00088595|451932462|FG000|Overall Study|Adverse Event|11|||
125631140|NCT00088595|451932462|FG000|Overall Study|Withdrawal by Subject|8|||
125631141|NCT00088595|451932462|FG000|Overall Study|Ongoing (After Core)|7|||
125631142|NCT00088595|451932462|FG000|Overall Study|New Cancer Therapy|2|||
125631143|NCT00524043|451932472|FG000|Overall Study|Lack of Efficacy|15|||
125631144|NCT00524043|451932473|FG001|Overall Study|Lack of Efficacy|13|||
125631145|NCT00524043|451932474|FG002|Overall Study|Lack of Efficacy|14|||
125631146|NCT00524043|451932472|FG000|Overall Study|Withdrawal by Subject|5|||
125631147|NCT00524043|451932473|FG001|Overall Study|Withdrawal by Subject|7|||
125631148|NCT00524043|451932474|FG002|Overall Study|Withdrawal by Subject|7|||
125631149|NCT00524043|451932472|FG000|Overall Study|Adverse Event|5|||
125631150|NCT00524043|451932473|FG001|Overall Study|Adverse Event|2|||
125631151|NCT00524043|451932474|FG002|Overall Study|Adverse Event|7|||
125631152|NCT00524043|451932472|FG000|Overall Study|Lost to Follow-up|3|||
125631153|NCT00524043|451932473|FG001|Overall Study|Lost to Follow-up|5|||
125631154|NCT00524043|451932474|FG002|Overall Study|Lost to Follow-up|3|||
125631155|NCT00524043|451932472|FG000|Overall Study|Various (eg, incarceration)|2|||
125631156|NCT00524043|451932473|FG001|Overall Study|Various (eg, incarceration)|1|||
125631157|NCT00524043|451932474|FG002|Overall Study|Various (eg, incarceration)|0|||
125631158|NCT04211961|451932481|FG000|Overall Study|Death|0|||
125631159|NCT04211961|451932482|FG001|Overall Study|Death|1|||
125631160|NCT04211961|451932481|FG000|Overall Study|Lost to Follow-up|0|||
125631161|NCT04211961|451932482|FG001|Overall Study|Lost to Follow-up|1|||
125631162|NCT04211961|451932481|FG000|Overall Study|Withdrawal by Subject|0|||
125631163|NCT04211961|451932482|FG001|Overall Study|Withdrawal by Subject|1|||
125129333|NCT04060147|450099302|FG000|Overall Study|Withdrew consent|1|||
125129334|NCT02057458|450099306|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
125631188|NCT05784129|451932491|FG000|Overall Study|Study terminated by sponsor|2|||
125631189|NCT05784129|451932492|FG001|Overall Study|Study terminated by sponsor|2|||
125631190|NCT01156363|451932493|FG000|Overall Study|Adverse Event|6|||
125631191|NCT01156363|451932493|FG000|Overall Study|Insufficient Therapeutic Response|5|||
125631192|NCT01156363|451932493|FG000|Overall Study|Failure to Return|1|||
125631193|NCT01156363|451932493|FG000|Overall Study|Refused Treatment|4|||
125631194|NCT01156363|451932493|FG000|Overall Study|Other|6|||
125129335|NCT02057458|450099307|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
125631195|NCT02728206|451932495|FG000|Overall Study|Death|1|||
125631196|NCT00429572|451932498|FG000|Overall Study|Disease progression|1|||
125631197|NCT02773368|451932499|FG000|Overall Study|Lost to Follow-up|4|||
125631198|NCT02773368|451932500|FG001|Overall Study|Lost to Follow-up|1|||
125129336|NCT02057458|450099308|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
125129337|NCT02057458|450099306|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
125129338|NCT02057458|450099307|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
125631199|NCT02773368|451932499|FG000|Overall Study|Withdrawal by Subject|5|||
125631200|NCT02773368|451932500|FG001|Overall Study|Withdrawal by Subject|1|||
125631201|NCT02773368|451932499|FG000|Overall Study|Unclassified|1|||
125631202|NCT02773368|451932500|FG001|Overall Study|Unclassified|1|||
125631203|NCT02773368|451932499|FG000|Overall Study|Missing|0|||
125631204|NCT02773368|451932500|FG001|Overall Study|Missing|1|||
125631205|NCT01929018|451932504|FG000|Overall Study|Lost to Follow-up|1|||
125631206|NCT01929018|451932505|FG001|Overall Study|Lost to Follow-up|0|||
125631207|NCT01929018|451932504|FG000|Overall Study|Hospitalization|0|||
125631208|NCT01929018|451932505|FG001|Overall Study|Hospitalization|1|||
125631209|NCT01366534|451932506|FG000|Overall Study|Lost to Follow-up|1|||
125631210|NCT01366534|451932507|FG001|Overall Study|Lost to Follow-up|0|||
125631211|NCT01366534|451932508|FG002|Overall Study|Lost to Follow-up|0|||
125631212|NCT01366534|451932506|FG000|Overall Study|Migrated|1|||
125631213|NCT01366534|451932507|FG001|Overall Study|Migrated|1|||
125631214|NCT01366534|451932508|FG002|Overall Study|Migrated|0|||
125631215|NCT01366534|451932506|FG000|Overall Study|Declined challenged|0|||
125631216|NCT01366534|451932507|FG001|Overall Study|Declined challenged|1|||
125631217|NCT01366534|451932508|FG002|Overall Study|Declined challenged|0|||
125631218|NCT02635867|451932515|FG000|Overall Study|Lost to Follow-up|4|||
125631219|NCT02635867|451932516|FG001|Overall Study|Lost to Follow-up|3|||
125631220|NCT02635867|451932517|FG002|Overall Study|Lost to Follow-up|3|||
125631221|NCT02635867|451932518|FG003|Overall Study|Lost to Follow-up|4|||
125631222|NCT02635867|451932519|FG004|Overall Study|Lost to Follow-up|1|||
125631223|NCT02565576|451932520|FG000|Overall Study|abnormal lab value|2|||
125631224|NCT02565576|451932521|FG001|Overall Study|abnormal lab value|0|||
125631225|NCT02565576|451932520|FG000|Overall Study|subject / guardian decision|1|||
125631226|NCT02565576|451932521|FG001|Overall Study|subject / guardian decision|3|||
125631227|NCT02565576|451932520|FG000|Overall Study|Lost to Follow-up|1|||
125631228|NCT02565576|451932521|FG001|Overall Study|Lost to Follow-up|0|||
125631229|NCT02565576|451932520|FG000|Overall Study|Death|0|||
125631230|NCT02565576|451932521|FG001|Overall Study|Death|2|||
125631231|NCT02565576|451932520|FG000|Overall Study|Adverse Event|1|||
125631232|NCT02565576|451932521|FG001|Overall Study|Adverse Event|0|||
125631233|NCT03377452|451932522|FG000|Overall Study|Refused assessment|0|||
125631234|NCT03377452|451932523|FG001|Overall Study|Refused assessment|2|||
125631235|NCT03377452|451932522|FG000|Overall Study|Lost to Follow-up|5|||
125631236|NCT03377452|451932523|FG001|Overall Study|Lost to Follow-up|4|||
125631237|NCT03345342|451932524|FG000|Open-Label Phase|Adverse Event|30|||
125631238|NCT03345342|451932525|FG001|Open-Label Phase|Adverse Event|0|||
125631239|NCT03345342|451932526|FG002|Open-Label Phase|Adverse Event|0|||
125631240|NCT03345342|451932527|FG003|Open-Label Phase|Adverse Event|0|||
125631241|NCT03345342|451932528|FG004|Open-Label Phase|Adverse Event|0|||
125631242|NCT03345342|451932524|FG000|Open-Label Phase|Death|1|||
125631243|NCT03345342|451932525|FG001|Open-Label Phase|Death|0|||
125631244|NCT03345342|451932526|FG002|Open-Label Phase|Death|0|||
125631245|NCT03345342|451932527|FG003|Open-Label Phase|Death|0|||
125631246|NCT03345342|451932528|FG004|Open-Label Phase|Death|0|||
125631247|NCT03345342|451932524|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
125631248|NCT03345342|451932525|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
125631249|NCT03345342|451932526|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
125631250|NCT03345342|451932527|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
125631251|NCT03345342|451932528|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
125631252|NCT03345342|451932524|FG000|Open-Label Phase|Lack of Efficacy|6|||
125631253|NCT03345342|451932525|FG001|Open-Label Phase|Lack of Efficacy|0|||
125631254|NCT03345342|451932526|FG002|Open-Label Phase|Lack of Efficacy|0|||
125631255|NCT03345342|451932527|FG003|Open-Label Phase|Lack of Efficacy|0|||
125129339|NCT02057458|450099308|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
125631256|NCT03345342|451932528|FG004|Open-Label Phase|Lack of Efficacy|0|||
125631257|NCT03345342|451932524|FG000|Open-Label Phase|Lost to Follow-up|9|||
125631258|NCT03345342|451932525|FG001|Open-Label Phase|Lost to Follow-up|0|||
125631259|NCT03345342|451932526|FG002|Open-Label Phase|Lost to Follow-up|0|||
125631260|NCT03345342|451932527|FG003|Open-Label Phase|Lost to Follow-up|0|||
125631261|NCT03345342|451932528|FG004|Open-Label Phase|Lost to Follow-up|0|||
125631262|NCT03345342|451932524|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
125631263|NCT03345342|451932525|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
125631264|NCT03345342|451932526|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
125631265|NCT03345342|451932527|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
125631266|NCT03345342|451932528|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
125631267|NCT03345342|451932524|FG000|Open-Label Phase|Physician Decision|4|||
125631268|NCT03345342|451932525|FG001|Open-Label Phase|Physician Decision|0|||
125129340|NCT02057458|450099306|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
125631269|NCT03345342|451932526|FG002|Open-Label Phase|Physician Decision|0|||
125631270|NCT03345342|451932527|FG003|Open-Label Phase|Physician Decision|0|||
125631271|NCT03345342|451932528|FG004|Open-Label Phase|Physician Decision|0|||
125631272|NCT03345342|451932524|FG000|Open-Label Phase|Protocol Violation|8|||
125631273|NCT03345342|451932525|FG001|Open-Label Phase|Protocol Violation|0|||
125631274|NCT03345342|451932526|FG002|Open-Label Phase|Protocol Violation|0|||
125631275|NCT03345342|451932527|FG003|Open-Label Phase|Protocol Violation|0|||
125631276|NCT03345342|451932528|FG004|Open-Label Phase|Protocol Violation|0|||
125631277|NCT03345342|451932524|FG000|Open-Label Phase|Withdrawal by Subject|57|||
125631278|NCT03345342|451932525|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125631279|NCT03345342|451932526|FG002|Open-Label Phase|Withdrawal by Subject|0|||
125631280|NCT03345342|451932527|FG003|Open-Label Phase|Withdrawal by Subject|0|||
125631281|NCT03345342|451932528|FG004|Open-Label Phase|Withdrawal by Subject|0|||
125631282|NCT03345342|451932524|FG000|Open-Label Phase|Other|15|||
125631283|NCT03345342|451932525|FG001|Open-Label Phase|Other|0|||
125631284|NCT03345342|451932526|FG002|Open-Label Phase|Other|0|||
125631285|NCT03345342|451932527|FG003|Open-Label Phase|Other|0|||
125631286|NCT03345342|451932528|FG004|Open-Label Phase|Other|0|||
125631287|NCT03345342|451932524|FG000|Double-Blind Phase|Adverse Event|0|||
125631288|NCT03345342|451932525|FG001|Double-Blind Phase|Adverse Event|1|||
125631289|NCT03345342|451932526|FG002|Double-Blind Phase|Adverse Event|6|||
125631290|NCT03345342|451932527|FG003|Double-Blind Phase|Adverse Event|0|||
125631291|NCT03345342|451932528|FG004|Double-Blind Phase|Adverse Event|0|||
125631292|NCT03345342|451932524|FG000|Double-Blind Phase|Death|0|||
125631293|NCT03345342|451932525|FG001|Double-Blind Phase|Death|2|||
125631294|NCT03345342|451932526|FG002|Double-Blind Phase|Death|1|||
125631295|NCT03345342|451932527|FG003|Double-Blind Phase|Death|0|||
125631296|NCT03345342|451932528|FG004|Double-Blind Phase|Death|0|||
125631297|NCT03345342|451932524|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
125631298|NCT03345342|451932525|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
125631299|NCT03345342|451932526|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
125631300|NCT03345342|451932527|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
125631301|NCT03345342|451932528|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
125631302|NCT03345342|451932524|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125631303|NCT03345342|451932525|FG001|Double-Blind Phase|Lost to Follow-up|1|||
125631304|NCT03345342|451932526|FG002|Double-Blind Phase|Lost to Follow-up|7|||
125631305|NCT03345342|451932527|FG003|Double-Blind Phase|Lost to Follow-up|0|||
125631306|NCT03345342|451932528|FG004|Double-Blind Phase|Lost to Follow-up|0|||
125631307|NCT03345342|451932524|FG000|Double-Blind Phase|Physician Decision|0|||
125631308|NCT03345342|451932525|FG001|Double-Blind Phase|Physician Decision|1|||
125631309|NCT03345342|451932526|FG002|Double-Blind Phase|Physician Decision|4|||
125631310|NCT03345342|451932527|FG003|Double-Blind Phase|Physician Decision|0|||
125631311|NCT03345342|451932528|FG004|Double-Blind Phase|Physician Decision|0|||
125631312|NCT03345342|451932524|FG000|Double-Blind Phase|Protocol Violation|0|||
125631313|NCT03345342|451932525|FG001|Double-Blind Phase|Protocol Violation|0|||
125631314|NCT03345342|451932526|FG002|Double-Blind Phase|Protocol Violation|1|||
125631315|NCT03345342|451932527|FG003|Double-Blind Phase|Protocol Violation|0|||
125631316|NCT03345342|451932528|FG004|Double-Blind Phase|Protocol Violation|0|||
125631317|NCT03345342|451932524|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
125631318|NCT03345342|451932525|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
125631319|NCT03345342|451932526|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
125631320|NCT03345342|451932527|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
125631321|NCT03345342|451932528|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
125631322|NCT03345342|451932524|FG000|Double-Blind Phase|Other|0|||
125631323|NCT03345342|451932525|FG001|Double-Blind Phase|Other|1|||
125631324|NCT03345342|451932526|FG002|Double-Blind Phase|Other|3|||
125631325|NCT03345342|451932527|FG003|Double-Blind Phase|Other|0|||
125631326|NCT03345342|451932528|FG004|Double-Blind Phase|Other|0|||
125631327|NCT03345342|451932524|FG000|Follow-Up Phase|Adverse Event|0|||
125631328|NCT03345342|451932525|FG001|Follow-Up Phase|Adverse Event|0|||
125631329|NCT03345342|451932526|FG002|Follow-Up Phase|Adverse Event|0|||
125631330|NCT03345342|451932527|FG003|Follow-Up Phase|Adverse Event|0|||
125631331|NCT03345342|451932528|FG004|Follow-Up Phase|Adverse Event|4|||
125631332|NCT03345342|451932524|FG000|Follow-Up Phase|Lost to Follow-up|0|||
125631333|NCT03345342|451932525|FG001|Follow-Up Phase|Lost to Follow-up|0|||
125631334|NCT03345342|451932526|FG002|Follow-Up Phase|Lost to Follow-up|0|||
125631335|NCT03345342|451932527|FG003|Follow-Up Phase|Lost to Follow-up|0|||
125631336|NCT03345342|451932528|FG004|Follow-Up Phase|Lost to Follow-up|6|||
125631337|NCT03345342|451932524|FG000|Follow-Up Phase|Physician Decision|0|||
125631338|NCT03345342|451932525|FG001|Follow-Up Phase|Physician Decision|0|||
125631339|NCT03345342|451932526|FG002|Follow-Up Phase|Physician Decision|0|||
125631340|NCT03345342|451932527|FG003|Follow-Up Phase|Physician Decision|0|||
125631341|NCT03345342|451932528|FG004|Follow-Up Phase|Physician Decision|5|||
125631342|NCT03345342|451932524|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
125631343|NCT03345342|451932525|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
125631344|NCT03345342|451932526|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
125631345|NCT03345342|451932527|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
125631346|NCT03345342|451932528|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
125631347|NCT03345342|451932524|FG000|Follow-Up Phase|Other|0|||
125631348|NCT03345342|451932525|FG001|Follow-Up Phase|Other|0|||
125631349|NCT03345342|451932526|FG002|Follow-Up Phase|Other|0|||
125215811|NCT01237327|450417511|FG000|Overall Study|Withdrawal by Subject|1|||
125215812|NCT01237327|450417512|FG001|Overall Study|Withdrawal by Subject|3|||
125215813|NCT01237327|450417511|FG000|Overall Study|Lost to Follow-up|3|||
125215814|NCT01237327|450417512|FG001|Overall Study|Lost to Follow-up|0|||
125215815|NCT02483572|450417515|FG000|Overall Study|Withdrawal by Subject|1|||
125215816|NCT02483572|450417516|FG001|Overall Study|Withdrawal by Subject|0|||
125215817|NCT02483572|450417515|FG000|Overall Study|Lost to Follow-up|1|||
125215818|NCT02483572|450417516|FG001|Overall Study|Lost to Follow-up|0|||
125215819|NCT02483572|450417515|FG000|Overall Study|Physician Decision|0|||
125215820|NCT02483572|450417516|FG001|Overall Study|Physician Decision|1|||
125215821|NCT04811664|450417517|FG000|Overall Study|Lost to Follow-up|78|||
125215822|NCT04811664|450417518|FG001|Overall Study|Lost to Follow-up|125|||
125215823|NCT04811664|450417519|FG002|Overall Study|Lost to Follow-up|46|||
125215824|NCT04811664|450417517|FG000|Overall Study|Withdrawal by Subject|39|||
125215825|NCT04811664|450417518|FG001|Overall Study|Withdrawal by Subject|76|||
125215826|NCT04811664|450417519|FG002|Overall Study|Withdrawal by Subject|12|||
125215827|NCT04811664|450417517|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
125215828|NCT04811664|450417518|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
125215829|NCT04811664|450417519|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
125215830|NCT04811664|450417517|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
125215831|NCT04811664|450417518|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
125215832|NCT04811664|450417519|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
125215833|NCT04811664|450417517|FG000|Overall Study|Protocol Violation|0|||
125215834|NCT04811664|450417518|FG001|Overall Study|Protocol Violation|5|||
125215835|NCT04811664|450417519|FG002|Overall Study|Protocol Violation|11|||
125215836|NCT04811664|450417517|FG000|Overall Study|Study Terminated by Sponsor|4|||
125215837|NCT04811664|450417518|FG001|Overall Study|Study Terminated by Sponsor|3|||
125215838|NCT04811664|450417519|FG002|Overall Study|Study Terminated by Sponsor|34|||
125215839|NCT04811664|450417517|FG000|Overall Study|Early Study Closure|3|||
125215840|NCT04811664|450417518|FG001|Overall Study|Early Study Closure|7|||
125215841|NCT04811664|450417519|FG002|Overall Study|Early Study Closure|79|||
125215842|NCT04811664|450417517|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
125215843|NCT04811664|450417518|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
125215844|NCT04811664|450417519|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
125215845|NCT05052697|450417520|FG000|Substudy A|Lost to Follow-up|0|||
125215846|NCT05052697|450417521|FG001|Substudy A|Lost to Follow-up|0|||
125215847|NCT05052697|450417522|FG002|Substudy A|Lost to Follow-up|0|||
125215848|NCT05052697|450417523|FG003|Substudy A|Lost to Follow-up|0|||
125215849|NCT05052697|450417524|FG004|Substudy A|Lost to Follow-up|0|||
125215850|NCT05052697|450417525|FG005|Substudy A|Lost to Follow-up|1|||
125215851|NCT05052697|450417526|FG006|Substudy A|Lost to Follow-up|0|||
125215852|NCT05052697|450417527|FG007|Substudy A|Lost to Follow-up|0|||
125215853|NCT05052697|450417528|FG008|Substudy A|Lost to Follow-up|0|||
125215854|NCT05052697|450417529|FG009|Substudy A|Lost to Follow-up|0|||
125215855|NCT05052697|450417530|FG010|Substudy A|Lost to Follow-up|0|||
125215856|NCT05052697|450417531|FG011|Substudy A|Lost to Follow-up|0|||
125215857|NCT05052697|450417532|FG012|Substudy A|Lost to Follow-up|0|||
125376615|NCT03572062|451007770|FG000|Overall Study|Withdrawal by Subject|0|||
125215858|NCT05052697|450417533|FG013|Substudy A|Lost to Follow-up|0|||
125215859|NCT05052697|450417534|FG014|Substudy A|Lost to Follow-up|0|||
125215860|NCT05052697|450417535|FG015|Substudy A|Lost to Follow-up|2|||
125215861|NCT05052697|450417536|FG016|Substudy A|Lost to Follow-up|0|||
125215862|NCT05052697|450417537|FG017|Substudy A|Lost to Follow-up|0|||
125215863|NCT05052697|450417538|FG018|Substudy A|Lost to Follow-up|0|||
125215864|NCT05052697|450417539|FG019|Substudy A|Lost to Follow-up|0|||
125215865|NCT05052697|450417540|FG020|Substudy A|Lost to Follow-up|0|||
125215866|NCT05052697|450417541|FG021|Substudy A|Lost to Follow-up|0|||
125215867|NCT05052697|450417542|FG022|Substudy A|Lost to Follow-up|0|||
125215868|NCT05052697|450417543|FG023|Substudy A|Lost to Follow-up|0|||
125215869|NCT05052697|450417544|FG024|Substudy A|Lost to Follow-up|0|||
125215870|NCT05052697|450417545|FG025|Substudy A|Lost to Follow-up|0|||
125215871|NCT05052697|450417546|FG026|Substudy A|Lost to Follow-up|0|||
125215872|NCT05052697|450417547|FG027|Substudy A|Lost to Follow-up|0|||
125215873|NCT05052697|450417548|FG028|Substudy A|Lost to Follow-up|0|||
125215874|NCT05052697|450417549|FG029|Substudy A|Lost to Follow-up|0|||
125376616|NCT03572062|451007771|FG001|Overall Study|Withdrawal by Subject|0|||
125376617|NCT03572062|451007772|FG002|Overall Study|Withdrawal by Subject|0|||
125376618|NCT03572062|451007773|FG003|Overall Study|Withdrawal by Subject|0|||
125376619|NCT03572062|451007774|FG004|Overall Study|Withdrawal by Subject|0|||
125376620|NCT03572062|451007775|FG005|Overall Study|Withdrawal by Subject|0|||
125376621|NCT03572062|451007776|FG006|Overall Study|Withdrawal by Subject|0|||
125376622|NCT03572062|451007777|FG007|Overall Study|Withdrawal by Subject|0|||
125376623|NCT03572062|451007778|FG008|Overall Study|Withdrawal by Subject|0|||
125215875|NCT05052697|450417550|FG030|Substudy A|Lost to Follow-up|0|||
125376624|NCT03572062|451007779|FG009|Overall Study|Withdrawal by Subject|1|||
125376625|NCT03572062|451007770|FG000|Overall Study|Randomized But Not Treated|0|||
125215876|NCT05052697|450417551|FG031|Substudy A|Lost to Follow-up|0|||
125215877|NCT05052697|450417552|FG032|Substudy A|Lost to Follow-up|0|||
125215878|NCT05052697|450417553|FG033|Substudy A|Lost to Follow-up|0|||
125215879|NCT05052697|450417520|FG000|Substudy A|No longer met eligibility criteria|0|||
125376626|NCT03572062|451007771|FG001|Overall Study|Randomized But Not Treated|0|||
125215880|NCT05052697|450417521|FG001|Substudy A|No longer met eligibility criteria|0|||
125215881|NCT05052697|450417522|FG002|Substudy A|No longer met eligibility criteria|0|||
125215882|NCT05052697|450417523|FG003|Substudy A|No longer met eligibility criteria|0|||
125215883|NCT05052697|450417524|FG004|Substudy A|No longer met eligibility criteria|0|||
125215884|NCT05052697|450417525|FG005|Substudy A|No longer met eligibility criteria|0|||
125215885|NCT05052697|450417526|FG006|Substudy A|No longer met eligibility criteria|0|||
125215886|NCT05052697|450417527|FG007|Substudy A|No longer met eligibility criteria|0|||
125215887|NCT05052697|450417528|FG008|Substudy A|No longer met eligibility criteria|0|||
125215888|NCT05052697|450417529|FG009|Substudy A|No longer met eligibility criteria|0|||
125215889|NCT05052697|450417530|FG010|Substudy A|No longer met eligibility criteria|0|||
125215890|NCT05052697|450417531|FG011|Substudy A|No longer met eligibility criteria|0|||
125215891|NCT05052697|450417532|FG012|Substudy A|No longer met eligibility criteria|0|||
125215892|NCT05052697|450417533|FG013|Substudy A|No longer met eligibility criteria|1|||
125215893|NCT05052697|450417534|FG014|Substudy A|No longer met eligibility criteria|0|||
125129341|NCT02057458|450099307|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
125129342|NCT02057458|450099308|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
125129343|NCT01534520|450099309|FG000|Overall Study|Adverse Event|0|||
125129344|NCT01534520|450099310|FG001|Overall Study|Adverse Event|1|||
125129345|NCT02979353|450099313|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
125129346|NCT02979353|450099314|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
125129347|NCT02979353|450099313|FG000|Overall Study|Withdrawal by Subject|16|||
125129348|NCT02979353|450099314|FG001|Overall Study|Withdrawal by Subject|12|||
125129349|NCT02979353|450099313|FG000|Overall Study|Death|10|||
125129350|NCT02979353|450099314|FG001|Overall Study|Death|11|||
125129351|NCT02979353|450099313|FG000|Overall Study|Transfer to Hospice Care|19|||
125129352|NCT02979353|450099314|FG001|Overall Study|Transfer to Hospice Care|14|||
125129353|NCT02979353|450099313|FG000|Overall Study|Lost to Follow-up|1|||
125129354|NCT02979353|450099314|FG001|Overall Study|Lost to Follow-up|5|||
125129355|NCT01079988|450099315|FG000|Overall Study|Lost to Follow-up|0|||
125215894|NCT05052697|450417535|FG015|Substudy A|No longer met eligibility criteria|0|||
125215895|NCT05052697|450417536|FG016|Substudy A|No longer met eligibility criteria|0|||
125376627|NCT03572062|451007772|FG002|Overall Study|Randomized But Not Treated|0|||
125376628|NCT03572062|451007773|FG003|Overall Study|Randomized But Not Treated|0|||
125376629|NCT03572062|451007774|FG004|Overall Study|Randomized But Not Treated|1|||
125376630|NCT03572062|451007775|FG005|Overall Study|Randomized But Not Treated|2|||
125376631|NCT03572062|451007776|FG006|Overall Study|Randomized But Not Treated|0|||
125376632|NCT03572062|451007777|FG007|Overall Study|Randomized But Not Treated|1|||
125376633|NCT03572062|451007778|FG008|Overall Study|Randomized But Not Treated|0|||
125376634|NCT03572062|451007779|FG009|Overall Study|Randomized But Not Treated|0|||
125376635|NCT00471328|451007780|FG000|Core Phase|Adverse Event|18|||
125376636|NCT00471328|451007781|FG001|Core Phase|Adverse Event|6|||
125376637|NCT00471328|451007780|FG000|Core Phase|Death|8|||
125376638|NCT00471328|451007781|FG001|Core Phase|Death|4|||
125376639|NCT00471328|451007780|FG000|Core Phase|Withdrawal by Subject|2|||
125376640|NCT00471328|451007781|FG001|Core Phase|Withdrawal by Subject|2|||
125376641|NCT00471328|451007780|FG000|Core Phase|Abnormal laboratory value|1|||
125376642|NCT00471328|451007781|FG001|Core Phase|Abnormal laboratory value|0|||
125376643|NCT00471328|451007780|FG000|Core Phase|Disease Progression|78|||
125376644|NCT00471328|451007781|FG001|Core Phase|Disease Progression|53|||
125376645|NCT00471328|451007780|FG000|Core Phase|Administrative Problem|0|||
125376646|NCT00471328|451007781|FG001|Core Phase|Administrative Problem|1|||
125376647|NCT00471328|451007780|FG000|Core Phase|Protocol Deviation|0|||
125376648|NCT00471328|451007781|FG001|Core Phase|Protocol Deviation|1|||
125376649|NCT00471328|451007780|FG000|Extension Phase|Adverse Event|3|||
125376650|NCT00471328|451007781|FG001|Extension Phase|Adverse Event|12|||
125376651|NCT00471328|451007780|FG000|Extension Phase|Withdrawal by Subject|0|||
125376652|NCT00471328|451007781|FG001|Extension Phase|Withdrawal by Subject|2|||
125376653|NCT00471328|451007780|FG000|Extension Phase|Death|1|||
125376654|NCT00471328|451007781|FG001|Extension Phase|Death|7|||
125376655|NCT00471328|451007780|FG000|Extension Phase|Protocol Deviation|3|||
125376656|NCT00471328|451007781|FG001|Extension Phase|Protocol Deviation|1|||
125376657|NCT00471328|451007780|FG000|Extension Phase|Treatment duration as per protocol|0|||
125376658|NCT00471328|451007781|FG001|Extension Phase|Treatment duration as per protocol|1|||
125376659|NCT00471328|451007780|FG000|Extension Phase|Disease Progression|32|||
125376660|NCT00471328|451007781|FG001|Extension Phase|Disease Progression|44|||
125376661|NCT00471328|451007780|FG000|Extension Phase|New cancer Therapy|1|||
125376662|NCT00471328|451007781|FG001|Extension Phase|New cancer Therapy|0|||
125376663|NCT00471328|451007780|FG000|Extension Phase|Administrative Problem|1|||
125129356|NCT01079988|450099316|FG001|Overall Study|Lost to Follow-up|0|||
125129357|NCT01079988|450099317|FG002|Overall Study|Lost to Follow-up|0|||
125129358|NCT01079988|450099318|FG003|Overall Study|Lost to Follow-up|1|||
125376664|NCT00471328|451007781|FG001|Extension Phase|Administrative Problem|0|||
125129359|NCT01079988|450099319|FG004|Overall Study|Lost to Follow-up|0|||
125129360|NCT01079988|450099315|FG000|Overall Study|Lack of Efficacy|1|||
125129361|NCT01079988|450099316|FG001|Overall Study|Lack of Efficacy|0|||
125129362|NCT01079988|450099317|FG002|Overall Study|Lack of Efficacy|0|||
125129363|NCT01079988|450099318|FG003|Overall Study|Lack of Efficacy|0|||
125129364|NCT01079988|450099319|FG004|Overall Study|Lack of Efficacy|0|||
125129365|NCT01079988|450099315|FG000|Overall Study|Other|0|||
125129366|NCT01079988|450099316|FG001|Overall Study|Other|0|||
125129367|NCT01079988|450099317|FG002|Overall Study|Other|0|||
125129368|NCT01079988|450099318|FG003|Overall Study|Other|2|||
125129369|NCT01079988|450099319|FG004|Overall Study|Other|1|||
125129370|NCT00585689|450099320|FG000|Overall Study|Received different ABI-007 schedule|3|||
125129371|NCT00585689|450099320|FG000|Overall Study|Adverse Event|1|||
125129372|NCT00585689|450099320|FG000|Overall Study|Patient Declined Surgery|1|||
125129373|NCT00585689|450099320|FG000|Overall Study|Patient had unresectable disease|1|||
125129374|NCT00585689|450099320|FG000|Overall Study|Death|1|||
125129375|NCT00550537|450099321|FG000|Overall Study|Death|18|||
125129376|NCT00550537|450099321|FG000|Overall Study|Adverse Event|20|||
125129377|NCT00550537|450099321|FG000|Overall Study|Disease progression before|46|||
125129378|NCT00550537|450099321|FG000|Overall Study|Withdrawal by Subject|7|||
125129379|NCT00550537|450099321|FG000|Overall Study|Change in treatment plan|4|||
125129380|NCT00550537|450099321|FG000|Overall Study|Other complicating ilness|3|||
125129381|NCT00550537|450099321|FG000|Overall Study|Declining performance status|2|||
125129382|NCT00550537|450099321|FG000|Overall Study|Treated closer to home|4|||
125129383|NCT00268905|450099322|FG000|Overall Study|Adverse Event|3|||
125129384|NCT00268905|450099323|FG001|Overall Study|Adverse Event|0|||
125129385|NCT00268905|450099324|FG002|Overall Study|Adverse Event|4|||
125129386|NCT00268905|450099322|FG000|Overall Study|Lost to Follow-up|0|||
125129387|NCT00268905|450099323|FG001|Overall Study|Lost to Follow-up|1|||
125129388|NCT00268905|450099324|FG002|Overall Study|Lost to Follow-up|0|||
125129389|NCT00268905|450099322|FG000|Overall Study|Withdrawal by Subject|0|||
125129390|NCT00268905|450099323|FG001|Overall Study|Withdrawal by Subject|0|||
125129391|NCT00268905|450099324|FG002|Overall Study|Withdrawal by Subject|3|||
125129392|NCT00268905|450099322|FG000|Overall Study|Progressive Disease|28|||
125129393|NCT00268905|450099323|FG001|Overall Study|Progressive Disease|4|||
125129394|NCT00268905|450099324|FG002|Overall Study|Progressive Disease|3|||
125129395|NCT00268905|450099322|FG000|Overall Study|Physician Decision|3|||
125129396|NCT00268905|450099323|FG001|Overall Study|Physician Decision|0|||
125129397|NCT00268905|450099324|FG002|Overall Study|Physician Decision|1|||
125129398|NCT00268905|450099322|FG000|Overall Study|Clinical Progression|9|||
125129399|NCT00268905|450099323|FG001|Overall Study|Clinical Progression|4|||
125129400|NCT00268905|450099324|FG002|Overall Study|Clinical Progression|1|||
125129401|NCT00617305|450099325|FG000|Overall Study|Adverse Event|4|||
125129402|NCT00617305|450099326|FG001|Overall Study|Adverse Event|0|||
125129403|NCT00617305|450099327|FG002|Overall Study|Adverse Event|0|||
125129404|NCT00617305|450099325|FG000|Overall Study|Death|1|||
125129405|NCT00617305|450099326|FG001|Overall Study|Death|0|||
125129406|NCT00617305|450099327|FG002|Overall Study|Death|0|||
125129407|NCT00617305|450099325|FG000|Overall Study|Physician Decision|1|||
125129408|NCT00617305|450099326|FG001|Overall Study|Physician Decision|0|||
125129409|NCT00617305|450099327|FG002|Overall Study|Physician Decision|0|||
125129410|NCT00617305|450099325|FG000|Overall Study|Protocol Violation|1|||
125129411|NCT00617305|450099326|FG001|Overall Study|Protocol Violation|0|||
125129412|NCT00617305|450099327|FG002|Overall Study|Protocol Violation|1|||
125129413|NCT00617305|450099325|FG000|Overall Study|Withdrawal by Subject|1|||
125129414|NCT00617305|450099326|FG001|Overall Study|Withdrawal by Subject|0|||
125129415|NCT00617305|450099327|FG002|Overall Study|Withdrawal by Subject|0|||
125129416|NCT03459807|450099329|FG000|Overall Study|Withdrawal due to transplant|0|||
125129417|NCT03459807|450099330|FG001|Overall Study|Withdrawal due to transplant|1|||
125129418|NCT04510285|450099331|FG000|Overall Study|Death|1|||
125129419|NCT01406795|450099332|FG000|Overall Study|Withdrawal by Subject|1|||
125129420|NCT03897088|450099335|FG000|Overall Study|Withdrawal by Subject|12|||
125129421|NCT03897088|450099336|FG001|Overall Study|Withdrawal by Subject|12|||
125376665|NCT04051008|451007782|FG000|Overall Study|Withdrawal by Subject|2|||
125631350|NCT03345342|451932527|FG003|Follow-Up Phase|Other|3|||
125631351|NCT03345342|451932528|FG004|Follow-Up Phase|Other|1|||
125631352|NCT02782104|451932533|FG000|Overall Study|Other|215|||
125631353|NCT02782104|451932533|FG000|Overall Study|Induction Day 28 Non Responder|9|||
125631354|NCT02782104|451932533|FG000|Overall Study|Non-Compliance with Study Drug|2|||
125631355|NCT02782104|451932533|FG000|Overall Study|Death|8|||
125631356|NCT02782104|451932533|FG000|Overall Study|Pregnancy|6|||
125631357|NCT02782104|451932533|FG000|Overall Study|Withdrawal by Subject|63|||
125631358|NCT02782104|451932533|FG000|Overall Study|Protocol Violation|7|||
125631359|NCT02782104|451932533|FG000|Overall Study|Lack of Efficacy|61|||
125631360|NCT02782104|451932533|FG000|Overall Study|Lost to Follow-up|23|||
125631361|NCT02782104|451932533|FG000|Overall Study|Adverse Event|74|||
125631362|NCT03185819|451932534|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
125631363|NCT03185819|451932535|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
125631364|NCT03185819|451932536|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
125631365|NCT03185819|451932537|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
125631366|NCT03185819|451932534|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
125631367|NCT03185819|451932535|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
125631368|NCT03185819|451932536|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
125631369|NCT03185819|451932537|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
125631370|NCT03185819|451932534|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
125631371|NCT03185819|451932535|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
125631372|NCT03185819|451932536|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
125631373|NCT03185819|451932537|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
125631374|NCT03185819|451932534|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
125631375|NCT03185819|451932535|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
125631376|NCT03185819|451932536|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
125631377|NCT03185819|451932537|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
125631378|NCT03185819|451932534|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
125631379|NCT03185819|451932535|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
125631380|NCT03185819|451932536|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
125631381|NCT03185819|451932537|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
125631382|NCT03185819|451932534|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
125631383|NCT03185819|451932535|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
125631384|NCT03185819|451932536|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
125631385|NCT03185819|451932537|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
125631386|NCT03185819|451932534|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
125631387|NCT03185819|451932535|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
125631388|NCT03185819|451932536|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
125631389|NCT03185819|451932537|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
125631390|NCT03185819|451932534|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
125631391|NCT03185819|451932535|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
125631392|NCT03185819|451932536|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
125631393|NCT03185819|451932537|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
125631394|NCT03185819|451932534|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
125631395|NCT03185819|451932535|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
125631396|NCT03185819|451932536|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
125631397|NCT03185819|451932537|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
125631398|NCT03185819|451932534|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
125631399|NCT03185819|451932535|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
125631400|NCT03185819|451932536|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
125631401|NCT03185819|451932537|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
125631402|NCT03185819|451932534|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
125631403|NCT03185819|451932535|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
125631404|NCT03185819|451932536|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
125631405|NCT03185819|451932537|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
125631406|NCT03185819|451932534|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
125631407|NCT03185819|451932535|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
125376666|NCT04051008|451007783|FG001|Overall Study|Withdrawal by Subject|0|||
125376667|NCT04051008|451007784|FG002|Overall Study|Withdrawal by Subject|1|||
125376668|NCT00458211|451007785|FG000|Overall Study|Lack of Efficacy|12|||
125376669|NCT00458211|451007785|FG000|Overall Study|Withdrawal by Subject|2|||
125376670|NCT00458211|451007785|FG000|Overall Study|Protocol Violation|2|||
125376671|NCT01605877|451007786|FG000|Overall Study|Withdrawal by Subject|1|||
125376672|NCT00687323|451007794|FG000|Overall Study|Death|25|||
125376673|NCT00687323|451007794|FG000|Overall Study|Withdrawal by Subject|1|||
125376674|NCT00687323|451007794|FG000|Overall Study|Excluded from efficacy evaluations|6|||
125376675|NCT00687323|451007794|FG000|Overall Study|Screen failure|148|||
125376676|NCT02132130|451007795|FG000|Overall Study|Lost to Follow-up|0|||
125376677|NCT02132130|451007796|FG001|Overall Study|Lost to Follow-up|2|||
125376678|NCT02132130|451007797|FG002|Overall Study|Lost to Follow-up|0|||
125376679|NCT02132130|451007798|FG003|Overall Study|Lost to Follow-up|0|||
125376680|NCT02132130|451007795|FG000|Overall Study|Withdrawal by Subject|0|||
125376681|NCT02132130|451007796|FG001|Overall Study|Withdrawal by Subject|0|||
125376682|NCT02132130|451007797|FG002|Overall Study|Withdrawal by Subject|0|||
125376683|NCT02132130|451007798|FG003|Overall Study|Withdrawal by Subject|1|||
125376684|NCT03310775|451007805|FG000|Overall Study|Lost to Follow-up|2|||
125376685|NCT03310775|451007806|FG001|Overall Study|Lost to Follow-up|3|||
125376686|NCT03310775|451007805|FG000|Overall Study|aggravation of depression|0|||
125376687|NCT03310775|451007806|FG001|Overall Study|aggravation of depression|1|||
125376688|NCT00838578|451007807|FG000|Overall Study|Protocol Violation|2|||
125376689|NCT04847557|451007808|FG000|Overall Study|Adverse Event|1|||
125376690|NCT04847557|451007809|FG001|Overall Study|Adverse Event|0|||
125376691|NCT04847557|451007808|FG000|Overall Study|Death|19|||
125376692|NCT04847557|451007809|FG001|Overall Study|Death|15|||
125376693|NCT04847557|451007808|FG000|Overall Study|Lost to Follow-up|3|||
125215896|NCT05052697|450417537|FG017|Substudy A|No longer met eligibility criteria|0|||
125631408|NCT03185819|451932536|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
125631409|NCT03185819|451932537|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
125631410|NCT03185819|451932534|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
125631411|NCT03185819|451932535|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
125631412|NCT03185819|451932536|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
125631413|NCT03185819|451932537|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
125631414|NCT02438787|451932538|FG000|Overall Study|Adverse Event|1|||
125631415|NCT02438787|451932539|FG001|Overall Study|Adverse Event|0|||
125631416|NCT02438787|451932540|FG002|Overall Study|Adverse Event|2|||
125631417|NCT02438787|451932538|FG000|Overall Study|Lack of Efficacy|1|||
125631418|NCT02438787|451932539|FG001|Overall Study|Lack of Efficacy|2|||
125631419|NCT02438787|451932540|FG002|Overall Study|Lack of Efficacy|0|||
125631420|NCT02438787|451932538|FG000|Overall Study|Lost to Follow-up|0|||
125631421|NCT02438787|451932539|FG001|Overall Study|Lost to Follow-up|1|||
125631422|NCT02438787|451932540|FG002|Overall Study|Lost to Follow-up|0|||
125631423|NCT02438787|451932538|FG000|Overall Study|Protocol Violation|0|||
125631424|NCT02438787|451932539|FG001|Overall Study|Protocol Violation|0|||
125631425|NCT02438787|451932540|FG002|Overall Study|Protocol Violation|1|||
125631426|NCT02438787|451932538|FG000|Overall Study|Withdrawal by Subject|15|||
125631427|NCT02438787|451932539|FG001|Overall Study|Withdrawal by Subject|7|||
125631428|NCT02438787|451932540|FG002|Overall Study|Withdrawal by Subject|10|||
125631429|NCT02438787|451932538|FG000|Overall Study|Study discontinued by sponsor|64|||
125631430|NCT02438787|451932539|FG001|Overall Study|Study discontinued by sponsor|72|||
125631431|NCT02438787|451932540|FG002|Overall Study|Study discontinued by sponsor|69|||
125631432|NCT02438787|451932538|FG000|Overall Study|Other|0|||
125631433|NCT02438787|451932539|FG001|Overall Study|Other|1|||
125631434|NCT02438787|451932540|FG002|Overall Study|Other|0|||
125631435|NCT02438787|451932538|FG000|Overall Study|Site terminated by sponsor|0|||
125631436|NCT02438787|451932539|FG001|Overall Study|Site terminated by sponsor|0|||
125631437|NCT02438787|451932540|FG002|Overall Study|Site terminated by sponsor|1|||
125631438|NCT03375203|451932541|FG000|Overall Study|Protocol Violation|0|||
125631439|NCT03375203|451932542|FG001|Overall Study|Protocol Violation|0|||
125631440|NCT03375203|451932543|FG002|Overall Study|Protocol Violation|1|||
125631441|NCT03375203|451932544|FG003|Overall Study|Protocol Violation|0|||
125631442|NCT03375203|451932545|FG004|Overall Study|Protocol Violation|0|||
125376694|NCT04847557|451007809|FG001|Overall Study|Lost to Follow-up|6|||
125376695|NCT04847557|451007808|FG000|Overall Study|Physician Decision|1|||
125376696|NCT04847557|451007809|FG001|Overall Study|Physician Decision|0|||
125376697|NCT04847557|451007808|FG000|Overall Study|Protocol Violation|0|||
125376698|NCT04847557|451007809|FG001|Overall Study|Protocol Violation|1|||
125376699|NCT04847557|451007808|FG000|Overall Study|Withdrawal by Subject|8|||
125376700|NCT04847557|451007809|FG001|Overall Study|Withdrawal by Subject|14|||
125376701|NCT00996216|451010142|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
125631443|NCT03375203|451932541|FG000|Overall Study|Adverse Event|2|||
125631444|NCT03375203|451932542|FG001|Overall Study|Adverse Event|3|||
125631445|NCT03375203|451932543|FG002|Overall Study|Adverse Event|0|||
125631446|NCT03375203|451932544|FG003|Overall Study|Adverse Event|2|||
125631447|NCT03375203|451932545|FG004|Overall Study|Adverse Event|2|||
125631448|NCT03375203|451932541|FG000|Overall Study|Withdrawal by Subject|3|||
125215897|NCT05052697|450417538|FG018|Substudy A|No longer met eligibility criteria|0|||
125215898|NCT05052697|450417539|FG019|Substudy A|No longer met eligibility criteria|0|||
125215899|NCT05052697|450417540|FG020|Substudy A|No longer met eligibility criteria|0|||
125215900|NCT05052697|450417541|FG021|Substudy A|No longer met eligibility criteria|0|||
125215901|NCT05052697|450417542|FG022|Substudy A|No longer met eligibility criteria|0|||
125215902|NCT05052697|450417543|FG023|Substudy A|No longer met eligibility criteria|0|||
125215903|NCT05052697|450417544|FG024|Substudy A|No longer met eligibility criteria|0|||
125215904|NCT05052697|450417545|FG025|Substudy A|No longer met eligibility criteria|0|||
125215905|NCT05052697|450417546|FG026|Substudy A|No longer met eligibility criteria|0|||
125215906|NCT05052697|450417547|FG027|Substudy A|No longer met eligibility criteria|0|||
125215907|NCT05052697|450417548|FG028|Substudy A|No longer met eligibility criteria|0|||
125215908|NCT05052697|450417549|FG029|Substudy A|No longer met eligibility criteria|0|||
125215909|NCT05052697|450417550|FG030|Substudy A|No longer met eligibility criteria|0|||
125631449|NCT03375203|451932542|FG001|Overall Study|Withdrawal by Subject|0|||
125631450|NCT03375203|451932543|FG002|Overall Study|Withdrawal by Subject|1|||
125631451|NCT03375203|451932544|FG003|Overall Study|Withdrawal by Subject|0|||
125631452|NCT03375203|451932545|FG004|Overall Study|Withdrawal by Subject|2|||
125631453|NCT03375203|451932541|FG000|Overall Study|Non-compliance with study drug|1|||
125631454|NCT03375203|451932542|FG001|Overall Study|Non-compliance with study drug|0|||
125631455|NCT03375203|451932543|FG002|Overall Study|Non-compliance with study drug|0|||
125631456|NCT03375203|451932544|FG003|Overall Study|Non-compliance with study drug|0|||
125631457|NCT03375203|451932545|FG004|Overall Study|Non-compliance with study drug|0|||
125631458|NCT03375203|451932541|FG000|Overall Study|Randomized, not treated.|0|||
125631459|NCT03375203|451932542|FG001|Overall Study|Randomized, not treated.|1|||
125631460|NCT03375203|451932543|FG002|Overall Study|Randomized, not treated.|0|||
125631461|NCT03375203|451932544|FG003|Overall Study|Randomized, not treated.|0|||
125631462|NCT03375203|451932545|FG004|Overall Study|Randomized, not treated.|0|||
125631463|NCT03321526|451932546|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
125631464|NCT03321526|451932547|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
125631465|NCT03321526|451932546|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
125631466|NCT03321526|451932547|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
125631467|NCT03321526|451932546|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
125631468|NCT03321526|451932547|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
125631469|NCT03321526|451932546|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
125631470|NCT03321526|451932547|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
125631471|NCT03321526|451932546|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
125631472|NCT03321526|451932547|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
125631473|NCT03321526|451932546|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
125631474|NCT03321526|451932547|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
125631475|NCT03321526|451932546|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
125631476|NCT03321526|451932547|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
125631477|NCT03321526|451932546|FG000|Follow-up Phase (2 Weeks)|Other|24|||
125631478|NCT03321526|451932547|FG001|Follow-up Phase (2 Weeks)|Other|24|||
125631479|NCT00732641|451932548|FG000|Overall Study|Relapse or Progressive Disease|65|||
125631480|NCT00732641|451932549|FG001|Overall Study|Relapse or Progressive Disease|101|||
125631481|NCT00732641|451932548|FG000|Overall Study|Serious Adverse Events|12|||
125631482|NCT00732641|451932549|FG001|Overall Study|Serious Adverse Events|3|||
125631483|NCT00732641|451932548|FG000|Overall Study|Physician Decision|6|||
125631484|NCT00732641|451932549|FG001|Overall Study|Physician Decision|0|||
125631485|NCT00732641|451932548|FG000|Overall Study|Withdrawal by Subject|4|||
125631486|NCT00732641|451932549|FG001|Overall Study|Withdrawal by Subject|2|||
125631487|NCT00732641|451932548|FG000|Overall Study|Unable to Complete|1|||
125631488|NCT00732641|451932549|FG001|Overall Study|Unable to Complete|1|||
125631489|NCT00732641|451932548|FG000|Overall Study|Other|18|||
125631490|NCT00732641|451932549|FG001|Overall Study|Other|5|||
125631491|NCT02910089|451932550|FG000|Overall Study|Lost insurance eligibility|22|||
125631492|NCT02910089|451932551|FG001|Overall Study|Lost insurance eligibility|16|||
125631493|NCT03034057|451932556|FG000|Overall Study|Withdrawal by Subject|10|||
125631494|NCT03034057|451932556|FG000|Overall Study|Protocol Violation|1|||
125631495|NCT03034057|451932556|FG000|Overall Study|Not defined|2|||
125631496|NCT03034057|451932556|FG000|Overall Study|Lost to Follow-up|19|||
125215910|NCT05052697|450417551|FG031|Substudy A|No longer met eligibility criteria|0|||
125215911|NCT05052697|450417552|FG032|Substudy A|No longer met eligibility criteria|0|||
125215912|NCT05052697|450417553|FG033|Substudy A|No longer met eligibility criteria|0|||
125631497|NCT03034057|451932556|FG000|Overall Study|Adverse Event|22|||
125631498|NCT03034057|451932556|FG000|Overall Study|Medication error without associated AE|1|||
125631499|NCT00701103|451932560|FG000|Overall Study|Adverse Event|0|||
125631500|NCT00701103|451932561|FG001|Overall Study|Adverse Event|0|||
125631501|NCT00701103|451932562|FG002|Overall Study|Adverse Event|1|||
125631502|NCT00701103|451932563|FG003|Overall Study|Adverse Event|1|||
125215913|NCT05052697|450417520|FG000|Substudy A|Not vaccinated|0|||
125215914|NCT05052697|450417521|FG001|Substudy A|Not vaccinated|0|||
125215915|NCT05052697|450417522|FG002|Substudy A|Not vaccinated|0|||
125631503|NCT00701103|451932564|FG004|Overall Study|Adverse Event|0|||
125631504|NCT00701103|451932565|FG005|Overall Study|Adverse Event|1|||
125631505|NCT00701103|451932566|FG006|Overall Study|Adverse Event|1|||
125631506|NCT00701103|451932567|FG007|Overall Study|Adverse Event|0|||
125631507|NCT00701103|451932568|FG008|Overall Study|Adverse Event|0|||
125631508|NCT00701103|451932569|FG009|Overall Study|Adverse Event|2|||
125631509|NCT00701103|451932570|FG010|Overall Study|Adverse Event|0|||
125631510|NCT00701103|451932560|FG000|Overall Study|Progressive Disease|5|||
125631511|NCT00701103|451932561|FG001|Overall Study|Progressive Disease|2|||
125631512|NCT00701103|451932562|FG002|Overall Study|Progressive Disease|6|||
125631513|NCT00701103|451932563|FG003|Overall Study|Progressive Disease|5|||
125631514|NCT00701103|451932564|FG004|Overall Study|Progressive Disease|6|||
125631515|NCT00701103|451932565|FG005|Overall Study|Progressive Disease|5|||
125631516|NCT00701103|451932566|FG006|Overall Study|Progressive Disease|7|||
125631517|NCT00701103|451932567|FG007|Overall Study|Progressive Disease|7|||
125631518|NCT00701103|451932568|FG008|Overall Study|Progressive Disease|8|||
125631519|NCT00701103|451932569|FG009|Overall Study|Progressive Disease|8|||
125631520|NCT00701103|451932570|FG010|Overall Study|Progressive Disease|11|||
125631521|NCT00701103|451932560|FG000|Overall Study|Withdrawal by Subject|0|||
125631522|NCT00701103|451932561|FG001|Overall Study|Withdrawal by Subject|1|||
125631523|NCT00701103|451932562|FG002|Overall Study|Withdrawal by Subject|1|||
125631524|NCT00701103|451932563|FG003|Overall Study|Withdrawal by Subject|0|||
125631525|NCT00701103|451932564|FG004|Overall Study|Withdrawal by Subject|0|||
125631526|NCT00701103|451932565|FG005|Overall Study|Withdrawal by Subject|0|||
125631527|NCT00701103|451932566|FG006|Overall Study|Withdrawal by Subject|0|||
125631528|NCT00701103|451932567|FG007|Overall Study|Withdrawal by Subject|0|||
125631529|NCT00701103|451932568|FG008|Overall Study|Withdrawal by Subject|0|||
125631530|NCT00701103|451932569|FG009|Overall Study|Withdrawal by Subject|0|||
125631531|NCT00701103|451932570|FG010|Overall Study|Withdrawal by Subject|0|||
125631532|NCT00701103|451932560|FG000|Overall Study|Other|0|||
125631533|NCT00701103|451932561|FG001|Overall Study|Other|0|||
125631534|NCT00701103|451932562|FG002|Overall Study|Other|0|||
125631535|NCT00701103|451932563|FG003|Overall Study|Other|0|||
125631536|NCT00701103|451932564|FG004|Overall Study|Other|0|||
125631537|NCT00701103|451932565|FG005|Overall Study|Other|0|||
125631538|NCT00701103|451932566|FG006|Overall Study|Other|0|||
125631539|NCT00701103|451932567|FG007|Overall Study|Other|0|||
125631540|NCT00701103|451932568|FG008|Overall Study|Other|1|||
125631541|NCT00701103|451932569|FG009|Overall Study|Other|1|||
125631542|NCT00701103|451932570|FG010|Overall Study|Other|0|||
125631543|NCT01929707|451932571|FG000|Intervention Period 1|Lost to Follow-up|0|||
125631544|NCT01929707|451932572|FG001|Intervention Period 1|Lost to Follow-up|0|||
125631545|NCT01929707|451932573|FG002|Intervention Period 1|Lost to Follow-up|0|||
125631546|NCT01929707|451932574|FG003|Intervention Period 1|Lost to Follow-up|1|||
125631547|NCT01929707|451932575|FG004|Intervention Period 1|Lost to Follow-up|0|||
125631548|NCT01929707|451932576|FG005|Intervention Period 1|Lost to Follow-up|0|||
125631549|NCT01929707|451932577|FG006|Intervention Period 1|Lost to Follow-up|0|||
125631550|NCT01929707|451932578|FG007|Intervention Period 1|Lost to Follow-up|0|||
125631551|NCT01929707|451932571|FG000|Intervention Period 1|Withdrawal by Subject|0|||
125631552|NCT01929707|451932572|FG001|Intervention Period 1|Withdrawal by Subject|0|||
125631553|NCT01929707|451932573|FG002|Intervention Period 1|Withdrawal by Subject|0|||
125631554|NCT01929707|451932574|FG003|Intervention Period 1|Withdrawal by Subject|2|||
125631555|NCT01929707|451932575|FG004|Intervention Period 1|Withdrawal by Subject|0|||
125631556|NCT01929707|451932576|FG005|Intervention Period 1|Withdrawal by Subject|0|||
125631557|NCT01929707|451932577|FG006|Intervention Period 1|Withdrawal by Subject|0|||
125631558|NCT01929707|451932578|FG007|Intervention Period 1|Withdrawal by Subject|0|||
125631559|NCT01929707|451932571|FG000|Intervention Period 2|Withdrawal by Subject|0|||
125631560|NCT01929707|451932572|FG001|Intervention Period 2|Withdrawal by Subject|0|||
125631561|NCT01929707|451932573|FG002|Intervention Period 2|Withdrawal by Subject|0|||
125631562|NCT01929707|451932574|FG003|Intervention Period 2|Withdrawal by Subject|0|||
125631563|NCT01929707|451932575|FG004|Intervention Period 2|Withdrawal by Subject|0|||
125631564|NCT01929707|451932576|FG005|Intervention Period 2|Withdrawal by Subject|2|||
125631565|NCT01929707|451932577|FG006|Intervention Period 2|Withdrawal by Subject|0|||
125631566|NCT01929707|451932578|FG007|Intervention Period 2|Withdrawal by Subject|0|||
125631567|NCT00179517|451932579|FG000|Overall Study|Withdrawal by Subject|2|||
125631568|NCT00179517|451932580|FG001|Overall Study|Withdrawal by Subject|1|||
125631569|NCT00437203|451932581|FG000|Overall Study|Death|0|||
125631570|NCT00437203|451932582|FG001|Overall Study|Death|0|||
125631571|NCT00437203|451932583|FG002|Overall Study|Death|1|||
125631572|NCT00437203|451932584|FG003|Overall Study|Death|0|||
125631573|NCT00437203|451932585|FG004|Overall Study|Death|0|||
125631574|NCT00437203|451932586|FG005|Overall Study|Death|0|||
125631575|NCT00437203|451932587|FG006|Overall Study|Death|0|||
125631576|NCT00437203|451932588|FG007|Overall Study|Death|1|||
125215916|NCT05052697|450417523|FG003|Substudy A|Not vaccinated|1|||
125631577|NCT00437203|451932589|FG008|Overall Study|Death|0|||
125631578|NCT00437203|451932590|FG009|Overall Study|Death|1|||
125631579|NCT00437203|451932581|FG000|Overall Study|Adverse Event|1|||
125631580|NCT00437203|451932582|FG001|Overall Study|Adverse Event|1|||
125631581|NCT00437203|451932583|FG002|Overall Study|Adverse Event|0|||
125631582|NCT00437203|451932584|FG003|Overall Study|Adverse Event|0|||
125631583|NCT00437203|451932585|FG004|Overall Study|Adverse Event|0|||
125631584|NCT00437203|451932586|FG005|Overall Study|Adverse Event|0|||
125631585|NCT00437203|451932587|FG006|Overall Study|Adverse Event|0|||
125631586|NCT00437203|451932588|FG007|Overall Study|Adverse Event|1|||
125631587|NCT00437203|451932589|FG008|Overall Study|Adverse Event|0|||
125631588|NCT00437203|451932590|FG009|Overall Study|Adverse Event|1|||
125631589|NCT00437203|451932581|FG000|Overall Study|Study terminated by sponsor|0|||
125631590|NCT00437203|451932582|FG001|Overall Study|Study terminated by sponsor|0|||
125631591|NCT00437203|451932583|FG002|Overall Study|Study terminated by sponsor|0|||
125631592|NCT00437203|451932584|FG003|Overall Study|Study terminated by sponsor|0|||
125631593|NCT00437203|451932585|FG004|Overall Study|Study terminated by sponsor|0|||
125631594|NCT00437203|451932586|FG005|Overall Study|Study terminated by sponsor|0|||
125631595|NCT00437203|451932587|FG006|Overall Study|Study terminated by sponsor|0|||
125631596|NCT00437203|451932588|FG007|Overall Study|Study terminated by sponsor|0|||
125631597|NCT00437203|451932589|FG008|Overall Study|Study terminated by sponsor|1|||
125631598|NCT00437203|451932590|FG009|Overall Study|Study terminated by sponsor|0|||
125631599|NCT00437203|451932581|FG000|Overall Study|Objective progression or relapse|5|||
125631600|NCT00437203|451932582|FG001|Overall Study|Objective progression or relapse|6|||
125631601|NCT00437203|451932583|FG002|Overall Study|Objective progression or relapse|2|||
125631602|NCT00437203|451932584|FG003|Overall Study|Objective progression or relapse|3|||
125631603|NCT00437203|451932585|FG004|Overall Study|Objective progression or relapse|3|||
125631604|NCT00437203|451932586|FG005|Overall Study|Objective progression or relapse|3|||
125631605|NCT00437203|451932587|FG006|Overall Study|Objective progression or relapse|6|||
125631606|NCT00437203|451932588|FG007|Overall Study|Objective progression or relapse|1|||
125631607|NCT00437203|451932589|FG008|Overall Study|Objective progression or relapse|2|||
125631608|NCT00437203|451932590|FG009|Overall Study|Objective progression or relapse|2|||
125631609|NCT00437203|451932581|FG000|Overall Study|Other|0|||
125631610|NCT00437203|451932582|FG001|Overall Study|Other|1|||
125631611|NCT00437203|451932583|FG002|Overall Study|Other|0|||
125631612|NCT00437203|451932584|FG003|Overall Study|Other|0|||
125631613|NCT00437203|451932585|FG004|Overall Study|Other|0|||
125631614|NCT00437203|451932586|FG005|Overall Study|Other|0|||
125631615|NCT00437203|451932587|FG006|Overall Study|Other|1|||
125631616|NCT00437203|451932588|FG007|Overall Study|Other|0|||
125631617|NCT00437203|451932589|FG008|Overall Study|Other|0|||
125631618|NCT00437203|451932590|FG009|Overall Study|Other|0|||
125631619|NCT01449955|451932591|FG000|Overall Study|Withdrawal by Subject|1|||
125631620|NCT01449955|451932592|FG001|Overall Study|Withdrawal by Subject|2|||
125631621|NCT02067533|451932599|FG000|Overall Study|Lost to Follow-up|4|||
125631622|NCT02067533|451932600|FG001|Overall Study|Lost to Follow-up|2|||
125631623|NCT02566109|451932601|FG000|Overall Study|Withdrawal by Subject|1|||
125631624|NCT01993667|451932602|FG000|Overall Study|Insufficient data to analyze|16|||
125631625|NCT01993667|451932603|FG001|Overall Study|Insufficient data to analyze|16|||
125631626|NCT01993667|451932602|FG000|Overall Study|Insufficient altitude reached|3|||
125631627|NCT01993667|451932603|FG001|Overall Study|Insufficient altitude reached|1|||
125631628|NCT01993667|451932602|FG000|Overall Study|Lost to Follow-up|2|||
125631629|NCT01993667|451932603|FG001|Overall Study|Lost to Follow-up|2|||
125631630|NCT01997281|451932608|FG000|Overall Study|Withdrawal by Subject|1|||
125631631|NCT01997281|451932609|FG001|Overall Study|Withdrawal by Subject|0|||
125631632|NCT01570309|451932610|FG000|Overall Study|Withdrawal by Subject|3|||
125631633|NCT01570309|451932611|FG001|Overall Study|Withdrawal by Subject|3|||
125631634|NCT00560794|451932612|FG000|Overall Study|Adverse Event|2|||
125631635|NCT00560794|451932612|FG000|Overall Study|Patient was not Compliant|1|||
125631636|NCT00560794|451932612|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
125631637|NCT00560794|451932612|FG000|Overall Study|Hematological Relapse|1|||
125631638|NCT00560794|451932612|FG000|Overall Study|Received Bone Marrow Transplant|6|||
125631639|NCT04857892|451932613|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
125631640|NCT04857892|451932614|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
125631641|NCT04857892|451932615|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
125631642|NCT04857892|451932616|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
125631643|NCT04857892|451932617|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
125215917|NCT05052697|450417524|FG004|Substudy A|Not vaccinated|0|||
125215918|NCT05052697|450417525|FG005|Substudy A|Not vaccinated|0|||
125215919|NCT05052697|450417526|FG006|Substudy A|Not vaccinated|0|||
125631644|NCT04857892|451932613|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
125215920|NCT05052697|450417527|FG007|Substudy A|Not vaccinated|0|||
125631645|NCT04857892|451932614|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
125631646|NCT04857892|451932615|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
125631647|NCT04857892|451932616|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
125631648|NCT04857892|451932617|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
125215921|NCT05052697|450417528|FG008|Substudy A|Not vaccinated|1|||
125215922|NCT05052697|450417529|FG009|Substudy A|Not vaccinated|0|||
125215923|NCT05052697|450417530|FG010|Substudy A|Not vaccinated|0|||
125215924|NCT05052697|450417531|FG011|Substudy A|Not vaccinated|0|||
125631649|NCT04857892|451932613|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
125631650|NCT04857892|451932614|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
125631651|NCT04857892|451932615|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
125631652|NCT04857892|451932616|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
125631653|NCT04857892|451932617|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
125631654|NCT00368472|451932622|FG000|Overall Study|Adverse Event|22|||
125631655|NCT00368472|451932622|FG000|Overall Study|Medication non-compliance|4|||
125631656|NCT00368472|451932622|FG000|Overall Study|Protocol Violation|2|||
125631657|NCT00368472|451932622|FG000|Overall Study|Request of Investigator or Sponsor|3|||
125631658|NCT00368472|451932622|FG000|Overall Study|Withdrawal by Subject|40|||
125631659|NCT00368472|451932622|FG000|Overall Study|Diary non-compliance|1|||
125631660|NCT00368472|451932622|FG000|Overall Study|Other|32|||
125631661|NCT00368472|451932622|FG000|Overall Study|Missing Final Disposition Date|1|||
125631662|NCT04095793|451932623|FG000|Overall Study|Adverse Event|3|||
125631663|NCT04095793|451932623|FG000|Overall Study|Study Terminated by Sponsor|103|||
125631664|NCT04095793|451932623|FG000|Overall Study|Withdrawal by Subject|4|||
125631665|NCT02384993|451932624|FG000|Overall Study|Adverse Event|0|||
125631666|NCT02384993|451932625|FG001|Overall Study|Adverse Event|1|||
125631667|NCT00981682|451932626|FG000|Overall Study|Adverse Event|48|||
125631668|NCT00981682|451932626|FG000|Overall Study|Withdrawal by Subject|52|||
125631669|NCT00981682|451932626|FG000|Overall Study|Lost to Follow-up|14|||
125631670|NCT00981682|451932626|FG000|Overall Study|Lack of Efficacy|13|||
125631671|NCT00981682|451932626|FG000|Overall Study|Protocol Violation|6|||
125631672|NCT00981682|451932626|FG000|Overall Study|administrative|9|||
125631673|NCT00651313|451932627|FG000|Overall Study|Adverse Event|0|||
125631674|NCT00651313|451932628|FG001|Overall Study|Adverse Event|1|||
125631675|NCT00651313|451932627|FG000|Overall Study|Withdrawal by Subject|3|||
125631676|NCT00651313|451932628|FG001|Overall Study|Withdrawal by Subject|1|||
125631677|NCT00651313|451932627|FG000|Overall Study|Lost to Follow-up|1|||
125631678|NCT00651313|451932628|FG001|Overall Study|Lost to Follow-up|1|||
125631679|NCT00651313|451932627|FG000|Overall Study|Adminstrative Discontinuation|2|||
125631680|NCT00651313|451932628|FG001|Overall Study|Adminstrative Discontinuation|3|||
125631681|NCT01199198|451934707|FG000|Overall Study|Adverse Event|3|||
125631682|NCT01199198|451934708|FG001|Overall Study|Adverse Event|0|||
125631683|NCT01199198|451934707|FG000|Overall Study|Lost to Follow-up|1|||
125631684|NCT01199198|451934708|FG001|Overall Study|Lost to Follow-up|5|||
125631685|NCT01199198|451934707|FG000|Overall Study|Withdrawal by Subject|1|||
125631686|NCT01199198|451934708|FG001|Overall Study|Withdrawal by Subject|2|||
125631687|NCT01199198|451934707|FG000|Overall Study|ICU Transfer|1|||
125631688|NCT01199198|451934708|FG001|Overall Study|ICU Transfer|2|||
125631689|NCT01199198|451934707|FG000|Overall Study|Hospice-care transfer|1|||
125631690|NCT01199198|451934708|FG001|Overall Study|Hospice-care transfer|2|||
125631691|NCT00922974|451934709|FG000|Phase II Component|Protocol Violation|2|||
125631692|NCT00922974|451934710|FG001|Phase II Component|Protocol Violation|0|||
125631693|NCT00922974|451934709|FG000|Phase II Component|Not evaluable for treatment review|5|||
125631694|NCT00922974|451934710|FG001|Phase II Component|Not evaluable for treatment review|0|||
125631695|NCT00922974|451934709|FG000|Phase III Component|Protocol Violation|8|||
125631696|NCT00922974|451934710|FG001|Phase III Component|Protocol Violation|6|||
125631697|NCT00430027|451934711|FG000|Overall Study|Study terminated|8|||
125631698|NCT02443155|451934714|FG000|Overall Study|Adverse Event|3|||
125631699|NCT02443155|451934715|FG001|Overall Study|Adverse Event|4|||
125631700|NCT02443155|451934716|FG002|Overall Study|Adverse Event|1|||
125631701|NCT02443155|451934717|FG003|Overall Study|Adverse Event|2|||
125631702|NCT02443155|451934714|FG000|Overall Study|Unclassified|0|||
125631703|NCT02443155|451934715|FG001|Overall Study|Unclassified|0|||
125376702|NCT00996216|451010142|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
125631704|NCT02443155|451934716|FG002|Overall Study|Unclassified|2|||
125631705|NCT02443155|451934717|FG003|Overall Study|Unclassified|1|||
125631706|NCT02443155|451934714|FG000|Overall Study|Withdrawal by Subject|4|||
125631707|NCT02443155|451934715|FG001|Overall Study|Withdrawal by Subject|7|||
125631708|NCT02443155|451934716|FG002|Overall Study|Withdrawal by Subject|3|||
125631709|NCT02443155|451934717|FG003|Overall Study|Withdrawal by Subject|9|||
125631710|NCT02443155|451934714|FG000|Overall Study|Pregnancy|3|||
125376703|NCT00996216|451010142|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
125376704|NCT00793403|451010145|FG000|Overall Study|Other|73|||
125129422|NCT03897088|450099335|FG000|Overall Study|Lost to Follow-up|7|||
125129423|NCT03897088|450099336|FG001|Overall Study|Lost to Follow-up|15|||
125376705|NCT00842712|451010146|FG000|Safety Run-in Part|Adverse Event|0|||
125376706|NCT00842712|451010147|FG001|Safety Run-in Part|Adverse Event|1|||
125376707|NCT00842712|451010148|FG002|Safety Run-in Part|Adverse Event|0|||
125376708|NCT00842712|451010149|FG003|Safety Run-in Part|Adverse Event|0|||
125376709|NCT00842712|451010150|FG004|Safety Run-in Part|Adverse Event|0|||
125631711|NCT02443155|451934715|FG001|Overall Study|Pregnancy|1|||
125631712|NCT02443155|451934716|FG002|Overall Study|Pregnancy|1|||
125631713|NCT02443155|451934717|FG003|Overall Study|Pregnancy|2|||
125631714|NCT02443155|451934714|FG000|Overall Study|Lost to Follow-up|1|||
125631715|NCT02443155|451934715|FG001|Overall Study|Lost to Follow-up|2|||
125376710|NCT00842712|451010151|FG005|Safety Run-in Part|Adverse Event|0|||
125376711|NCT00842712|451010152|FG006|Safety Run-in Part|Adverse Event|0|||
125376712|NCT00842712|451010146|FG000|Safety Run-in Part|Progressive disease|3|||
125376713|NCT00842712|451010147|FG001|Safety Run-in Part|Progressive disease|1|||
125376714|NCT00842712|451010148|FG002|Safety Run-in Part|Progressive disease|0|||
125376715|NCT00842712|451010149|FG003|Safety Run-in Part|Progressive disease|1|||
125376716|NCT00842712|451010150|FG004|Safety Run-in Part|Progressive disease|0|||
125376717|NCT00842712|451010151|FG005|Safety Run-in Part|Progressive disease|0|||
125631716|NCT02443155|451934716|FG002|Overall Study|Lost to Follow-up|0|||
125631717|NCT02443155|451934717|FG003|Overall Study|Lost to Follow-up|1|||
125631718|NCT02443155|451934714|FG000|Overall Study|Protocol Violation|1|||
125631719|NCT02443155|451934715|FG001|Overall Study|Protocol Violation|0|||
125631720|NCT02443155|451934716|FG002|Overall Study|Protocol Violation|1|||
125631721|NCT02443155|451934717|FG003|Overall Study|Protocol Violation|1|||
125631722|NCT02443155|451934714|FG000|Overall Study|Death|0|||
125631723|NCT02443155|451934715|FG001|Overall Study|Death|0|||
125631724|NCT02443155|451934716|FG002|Overall Study|Death|1|||
125631725|NCT02443155|451934717|FG003|Overall Study|Death|0|||
125631726|NCT02000219|451934718|FG000|14-Week Study Period|Physician Decision|1|||
125129424|NCT03897088|450099335|FG000|Overall Study|Sponsor Decision|1|||
125129425|NCT03897088|450099336|FG001|Overall Study|Sponsor Decision|2|||
125129426|NCT03897088|450099335|FG000|Overall Study|COVID-19|2|||
125129427|NCT03897088|450099336|FG001|Overall Study|COVID-19|0|||
125129428|NCT03897088|450099335|FG000|Overall Study|Other|3|||
125631727|NCT02000219|451934718|FG000|14-Week Study Period|Adverse Event|1|||
125631728|NCT02000219|451934718|FG000|14-Week Study Period|Underwent transplantation|1|||
125631729|NCT02000219|451934718|FG000|Continuation Period|Withdrawal by Subject|1|||
125631730|NCT02000219|451934718|FG000|Continuation Period|Had liver transplant|2|||
125631731|NCT02000219|451934718|FG000|Continuation Period|Non-compliance with study drug|2|||
125631732|NCT00634751|451934719|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
125631733|NCT00634751|451934720|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
125631734|NCT00634751|451934721|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
125631735|NCT00634751|451934722|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
125631736|NCT00634751|451934719|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
125631737|NCT00634751|451934720|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
125631738|NCT00634751|451934721|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
125631739|NCT00634751|451934722|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
125631740|NCT00634751|451934719|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
125631741|NCT00634751|451934720|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
125631742|NCT00634751|451934721|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
125631743|NCT00634751|451934722|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
125631744|NCT00608894|451934723|FG000|Overall Study|Withdrawal by Subject|0|||
125631745|NCT00608894|451934724|FG001|Overall Study|Withdrawal by Subject|2|||
125631746|NCT01376388|451934727|FG000|Overall Study|Adverse Event|13|||
125631747|NCT01376388|451934727|FG000|Overall Study|Lack of Efficacy|2|||
125631748|NCT01376388|451934727|FG000|Overall Study|Withdrawal by Subject|3|||
125631749|NCT01473355|451934729|FG000|Overall Study|Protocol Violation|2|||
125631750|NCT01473355|451934729|FG000|Overall Study|Adverse Event|2|||
125631751|NCT01473355|451934729|FG000|Overall Study|Lost to Follow-up|2|||
125631752|NCT00106249|451934730|FG000|Overall Study|Lost to Follow-up|3|||
125631753|NCT00106249|451934731|FG001|Overall Study|Lost to Follow-up|2|||
125631754|NCT01119963|451934732|FG000|Overall Study|Lost to Follow-up|1|||
125631755|NCT01119963|451934733|FG001|Overall Study|Lost to Follow-up|1|||
125129429|NCT03897088|450099336|FG001|Overall Study|Other|0|||
125129430|NCT03897088|450099335|FG000|Overall Study|Non-compliance with Study Drug|1|||
125129431|NCT03897088|450099336|FG001|Overall Study|Non-compliance with Study Drug|1|||
125376718|NCT00842712|451010152|FG006|Safety Run-in Part|Progressive disease|0|||
125376719|NCT00842712|451010146|FG000|Randomized Part|Randomized but not treated|0|||
125376720|NCT00842712|451010147|FG001|Randomized Part|Randomized but not treated|0|||
125376721|NCT00842712|451010148|FG002|Randomized Part|Randomized but not treated|0|||
125376722|NCT00842712|451010149|FG003|Randomized Part|Randomized but not treated|0|||
125436489|NCT00675506|451224413|FG000|Overall Study|Lost interest|3|||
125129432|NCT03897088|450099335|FG000|Overall Study|Pregnancy|0|||
125129433|NCT03897088|450099336|FG001|Overall Study|Pregnancy|1|||
125129434|NCT00855738|450099337|FG000|Overall Study|Lost to Follow-up|2|||
125129435|NCT00855738|450099337|FG000|Overall Study|Adverse Event|1|||
125129436|NCT00855738|450099337|FG000|Overall Study|Subject Defaulted|1|||
125129437|NCT00855738|450099337|FG000|Overall Study|Death|1|||
125129438|NCT02392000|450099340|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
125129439|NCT02392000|450099340|FG000|Overall Study|Withdrawal by Subject|1|||
125129440|NCT02392000|450099340|FG000|Overall Study|Lost to Follow-up|8|||
125215925|NCT05052697|450417532|FG012|Substudy A|Not vaccinated|0|||
125631756|NCT01843205|451934738|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
125631757|NCT01843205|451934739|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
125129441|NCT04384978|450099341|FG000|Overall Study|Withdrawal by Subject|4|||
125129442|NCT04384978|450099342|FG001|Overall Study|Withdrawal by Subject|0|||
125631758|NCT03938636|451934740|FG000|Overall Study|Protocol Violation|0|||
125631759|NCT03938636|451934741|FG001|Overall Study|Protocol Violation|1|||
125631760|NCT03938636|451934742|FG002|Overall Study|Protocol Violation|1|||
125631761|NCT03938636|451934740|FG000|Overall Study|Subject withdrew due to death in family|0|||
125631762|NCT03938636|451934741|FG001|Overall Study|Subject withdrew due to death in family|1|||
125631763|NCT03938636|451934742|FG002|Overall Study|Subject withdrew due to death in family|0|||
125631764|NCT03938636|451934740|FG000|Overall Study|Missed visit|0|||
125631765|NCT03938636|451934741|FG001|Overall Study|Missed visit|1|||
125631766|NCT03938636|451934742|FG002|Overall Study|Missed visit|0|||
125631767|NCT03938636|451934740|FG000|Overall Study|Adverse Event|0|||
125631768|NCT03938636|451934741|FG001|Overall Study|Adverse Event|0|||
125631769|NCT03938636|451934742|FG002|Overall Study|Adverse Event|1|||
125631770|NCT03938636|451934740|FG000|Overall Study|Lost to Follow-up|0|||
125631771|NCT03938636|451934741|FG001|Overall Study|Lost to Follow-up|0|||
125631772|NCT03938636|451934742|FG002|Overall Study|Lost to Follow-up|1|||
125631773|NCT02603172|451934743|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125631774|NCT02603172|451934744|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125631775|NCT02603172|451934745|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
125631776|NCT02603172|451934746|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125631777|NCT02603172|451934747|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125631778|NCT02603172|451934748|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125631779|NCT02603172|451934749|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125631780|NCT02603172|451934750|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
125631781|NCT00711412|451934751|FG000|Induction Treatment|Death|2|||
125631782|NCT00711412|451934751|FG000|Induction Treatment|Adverse Event|1|||
125631783|NCT00711412|451934751|FG000|Induction Treatment|Other|1|||
125631784|NCT00711412|451934751|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
125631785|NCT00711412|451934751|FG000|Evaluated for Combination Treatment|Death|1|||
125631786|NCT00711412|451934751|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
125631787|NCT00711412|451934751|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
125631788|NCT00711412|451934751|FG000|Combination Treatment|Progressive Disease|1|||
125631789|NCT00711412|451934751|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
125631790|NCT00711412|451934751|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
125631791|NCT00711412|451934751|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
125631792|NCT00711412|451934751|FG000|Evaluation for Response and Surgery|Death|1|||
125631793|NCT00711412|451934751|FG000|Survival Follow up Until Death|Other|12|||
125631794|NCT03285490|451934752|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
125631795|NCT03285490|451934753|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
125631796|NCT03285490|451934752|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
125631797|NCT03285490|451934753|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
125631798|NCT03745989|451934754|FG000|Overall Study|Death|3|||
125631799|NCT03745989|451934755|FG001|Overall Study|Death|7|||
125631800|NCT03745989|451934756|FG002|Overall Study|Death|4|||
125631801|NCT03745989|451934754|FG000|Overall Study|Lost to Follow-up|0|||
125631802|NCT03745989|451934755|FG001|Overall Study|Lost to Follow-up|2|||
125631803|NCT03745989|451934756|FG002|Overall Study|Lost to Follow-up|0|||
125631804|NCT03745989|451934754|FG000|Overall Study|Sponsor Decision|0|||
125631805|NCT03745989|451934755|FG001|Overall Study|Sponsor Decision|2|||
125631806|NCT03745989|451934756|FG002|Overall Study|Sponsor Decision|8|||
125631807|NCT03745989|451934754|FG000|Overall Study|Withdrawal by Subject|0|||
125631808|NCT03745989|451934755|FG001|Overall Study|Withdrawal by Subject|1|||
125631809|NCT03745989|451934756|FG002|Overall Study|Withdrawal by Subject|3|||
125631810|NCT01047436|451934757|FG000|Overall Study|Protocol Violation|1|||
125631811|NCT01047436|451934758|FG001|Overall Study|Protocol Violation|0|||
125631812|NCT00939341|451934759|FG000|Overall Study|Adverse Event|15|||
125631813|NCT00939341|451934759|FG000|Overall Study|Pregnancy|1|||
125631814|NCT00939341|451934759|FG000|Overall Study|Lost to Follow-up|23|||
125631815|NCT00939341|451934759|FG000|Overall Study|Withdrawal by Subject|13|||
125631816|NCT00939341|451934759|FG000|Overall Study|Protocol Violation|6|||
125631817|NCT00939341|451934759|FG000|Overall Study|Incorrect enrolment|8|||
125631818|NCT00424099|451934760|FG000|Overall Study|Adverse Event|0|||
125631819|NCT00424099|451934761|FG001|Overall Study|Adverse Event|1|||
125631820|NCT00424099|451934762|FG002|Overall Study|Adverse Event|1|||
125631821|NCT00424099|451934763|FG003|Overall Study|Adverse Event|0|||
125631822|NCT00424099|451934760|FG000|Overall Study|Death|0|||
125631823|NCT00424099|451934761|FG001|Overall Study|Death|1|||
125631824|NCT00424099|451934762|FG002|Overall Study|Death|0|||
125631825|NCT00424099|451934763|FG003|Overall Study|Death|0|||
125631826|NCT00424099|451934760|FG000|Overall Study|Illness|2|||
125631827|NCT00424099|451934761|FG001|Overall Study|Illness|0|||
125631828|NCT00424099|451934762|FG002|Overall Study|Illness|1|||
125631829|NCT00424099|451934763|FG003|Overall Study|Illness|4|||
125631830|NCT00424099|451934760|FG000|Overall Study|Lost to Follow-up|0|||
125631831|NCT00424099|451934761|FG001|Overall Study|Lost to Follow-up|0|||
125631832|NCT00424099|451934762|FG002|Overall Study|Lost to Follow-up|3|||
125129443|NCT03725605|450099343|FG000|Overall Study|Unsuccessful TIL expansion|2|||
125129444|NCT03555305|450099344|FG000|Period 1|Physician Decision|0|||
125129445|NCT03555305|450099345|FG001|Period 1|Physician Decision|1|||
125129446|NCT03555305|450099344|FG000|Period 1|Adverse Event|0|||
125631833|NCT00424099|451934763|FG003|Overall Study|Lost to Follow-up|0|||
125631834|NCT00424099|451934760|FG000|Overall Study|Hospitalized|1|||
125631835|NCT00424099|451934761|FG001|Overall Study|Hospitalized|2|||
125631836|NCT00424099|451934762|FG002|Overall Study|Hospitalized|1|||
125631837|NCT00424099|451934763|FG003|Overall Study|Hospitalized|3|||
125631838|NCT00424099|451934760|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
125631839|NCT00424099|451934761|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
125631840|NCT00424099|451934762|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
125631841|NCT00424099|451934763|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
125631842|NCT00424099|451934760|FG000|Overall Study|Withdrawal by Subject|1|||
125631843|NCT00424099|451934761|FG001|Overall Study|Withdrawal by Subject|9|||
125631844|NCT00424099|451934762|FG002|Overall Study|Withdrawal by Subject|4|||
125631845|NCT00424099|451934763|FG003|Overall Study|Withdrawal by Subject|6|||
125631846|NCT00424099|451934760|FG000|Overall Study|Physician Decision|0|||
125631847|NCT00424099|451934761|FG001|Overall Study|Physician Decision|0|||
125631848|NCT00424099|451934762|FG002|Overall Study|Physician Decision|1|||
125631849|NCT00424099|451934763|FG003|Overall Study|Physician Decision|0|||
125631850|NCT00424099|451934760|FG000|Overall Study|Missing|0|||
125631851|NCT00424099|451934761|FG001|Overall Study|Missing|0|||
125631852|NCT00424099|451934762|FG002|Overall Study|Missing|1|||
125631853|NCT00424099|451934763|FG003|Overall Study|Missing|0|||
125631854|NCT02280096|451934764|FG000|Overall Study|Pregnancy|1|||
125631855|NCT02280096|451934765|FG001|Overall Study|Pregnancy|0|||
125631856|NCT02280096|451934764|FG000|Overall Study|Functional neurological disorder|1|||
125631857|NCT02280096|451934765|FG001|Overall Study|Functional neurological disorder|0|||
125631858|NCT02280096|451934764|FG000|Overall Study|Lack of attachment|0|||
125631859|NCT02280096|451934765|FG001|Overall Study|Lack of attachment|1|||
125631860|NCT02939976|451934766|FG000|Overall Study|Lost to Follow-up|7|||
125129447|NCT03555305|450099345|FG001|Period 1|Adverse Event|1|||
125129448|NCT03586726|450099353|FG000|Overall Study|Withdrawal by Subject|1|||
125129449|NCT00965185|450099354|FG000|Overall Study|Lost to Follow-up|2|||
125129450|NCT00965185|450099355|FG001|Overall Study|Lost to Follow-up|0|||
125129451|NCT00965185|450099354|FG000|Overall Study|Withdrawal by Subject|0|||
125129452|NCT00965185|450099355|FG001|Overall Study|Withdrawal by Subject|1|||
125129453|NCT02100228|450099358|FG000|Overall Study|Other|19|||
125129454|NCT02100228|450099359|FG001|Overall Study|Other|19|||
125129455|NCT02100228|450099358|FG000|Overall Study|Administrative reason|0|||
125129456|NCT02100228|450099359|FG001|Overall Study|Administrative reason|1|||
125129457|NCT02100228|450099358|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
125129458|NCT02100228|450099359|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
125129459|NCT02100228|450099358|FG000|Overall Study|Non-compliance|0|||
125129460|NCT02100228|450099359|FG001|Overall Study|Non-compliance|3|||
125129461|NCT02100228|450099358|FG000|Overall Study|Lost to Follow-up|0|||
125129462|NCT02100228|450099359|FG001|Overall Study|Lost to Follow-up|1|||
125129463|NCT02100228|450099358|FG000|Overall Study|Withdrawal by Subject|27|||
125129464|NCT02100228|450099359|FG001|Overall Study|Withdrawal by Subject|37|||
125129465|NCT02100228|450099358|FG000|Overall Study|Adverse Event|16|||
125129466|NCT02100228|450099359|FG001|Overall Study|Adverse Event|12|||
125129467|NCT02100228|450099358|FG000|Overall Study|Death|1|||
125129468|NCT02100228|450099359|FG001|Overall Study|Death|1|||
125129469|NCT02216071|450099384|FG000|Overall Study|Withdrawal by Subject|7|||
125129470|NCT02216071|450099385|FG001|Overall Study|Withdrawal by Subject|2|||
125129471|NCT02216071|450099384|FG000|Overall Study|Lost to Follow-up|3|||
125129472|NCT02216071|450099385|FG001|Overall Study|Lost to Follow-up|3|||
125129473|NCT02216071|450099384|FG000|Overall Study|Protocol Violation|3|||
125129474|NCT02216071|450099385|FG001|Overall Study|Protocol Violation|5|||
125129475|NCT02216071|450099384|FG000|Overall Study|Other|2|||
125129476|NCT02216071|450099385|FG001|Overall Study|Other|2|||
125129477|NCT00389064|450099386|FG000|Overall Study|Adverse Event|11|||
125129478|NCT00389064|450099387|FG001|Overall Study|Adverse Event|3|||
125129479|NCT00389064|450099386|FG000|Overall Study|Lack of Efficacy|3|||
125129480|NCT00389064|450099387|FG001|Overall Study|Lack of Efficacy|14|||
125129481|NCT00389064|450099386|FG000|Overall Study|Withdrawal by Subject|17|||
125129482|NCT00389064|450099387|FG001|Overall Study|Withdrawal by Subject|27|||
125129483|NCT00389064|450099386|FG000|Overall Study|Physician Decision|2|||
125129484|NCT00389064|450099387|FG001|Overall Study|Physician Decision|2|||
125129485|NCT00389064|450099386|FG000|Overall Study|Lost to Follow-up|1|||
125129486|NCT00389064|450099387|FG001|Overall Study|Lost to Follow-up|2|||
125129487|NCT00389064|450099386|FG000|Overall Study|Protocol Violation|2|||
125129488|NCT00389064|450099387|FG001|Overall Study|Protocol Violation|0|||
125129489|NCT00389064|450099386|FG000|Overall Study|Multiple Reasons|9|||
125129490|NCT00389064|450099387|FG001|Overall Study|Multiple Reasons|11|||
125129491|NCT03707912|450099396|FG000|Overall Study|Violation of inclusion criteria|1|||
125129492|NCT03707912|450099397|FG001|Overall Study|Violation of inclusion criteria|0|||
125129493|NCT01811953|450100959|FG000|Overall Study|Adverse Event|0|||
125129494|NCT01811953|450100960|FG001|Overall Study|Adverse Event|0|||
125129495|NCT01811953|450100961|FG002|Overall Study|Adverse Event|0|||
125129496|NCT01811953|450100962|FG003|Overall Study|Adverse Event|1|||
125129497|NCT01811953|450100963|FG004|Overall Study|Adverse Event|0|||
125129498|NCT01811953|450100964|FG005|Overall Study|Adverse Event|1|||
125129499|NCT01811953|450100959|FG000|Overall Study|Protocol Violation|0|||
125129500|NCT01811953|450100960|FG001|Overall Study|Protocol Violation|0|||
125129501|NCT01811953|450100961|FG002|Overall Study|Protocol Violation|0|||
125631861|NCT02939976|451934767|FG001|Overall Study|Lost to Follow-up|1|||
125631862|NCT02939976|451934768|FG002|Overall Study|Lost to Follow-up|1|||
125631863|NCT02939976|451934769|FG003|Overall Study|Lost to Follow-up|2|||
125631864|NCT02939976|451934766|FG000|Overall Study|Withdrawal by Subject|4|||
125631865|NCT02939976|451934767|FG001|Overall Study|Withdrawal by Subject|0|||
125631866|NCT02939976|451934768|FG002|Overall Study|Withdrawal by Subject|2|||
125631867|NCT02939976|451934769|FG003|Overall Study|Withdrawal by Subject|4|||
125631868|NCT02939976|451934766|FG000|Overall Study|Due to early study closure|4|||
125631869|NCT02939976|451934767|FG001|Overall Study|Due to early study closure|3|||
125631870|NCT02939976|451934768|FG002|Overall Study|Due to early study closure|2|||
125631871|NCT02939976|451934769|FG003|Overall Study|Due to early study closure|3|||
125631872|NCT01872897|451934770|FG000|Overall Study|Withdrawal by Subject|1|||
125631873|NCT01872897|451934771|FG001|Overall Study|Withdrawal by Subject|0|||
125631874|NCT02418585|451934772|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
125631875|NCT02418585|451934773|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
125631876|NCT02418585|451934772|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
125631877|NCT02418585|451934773|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
125631878|NCT02418585|451934772|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
125631879|NCT02418585|451934773|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
125631880|NCT02418585|451934772|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
125631881|NCT02418585|451934773|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
125631882|NCT02418585|451934772|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
125631883|NCT02418585|451934773|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
125631884|NCT02418585|451934772|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
125631885|NCT02418585|451934773|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
125631886|NCT02418585|451934772|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
125631887|NCT02418585|451934773|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
125631888|NCT02418585|451934772|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
125631889|NCT02418585|451934773|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
125631890|NCT02418585|451934772|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
125631891|NCT02418585|451934773|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
125631892|NCT02418585|451934772|FG000|Follow-up Phase (24 Weeks)|Other|3|||
125631893|NCT02418585|451934773|FG001|Follow-up Phase (24 Weeks)|Other|2|||
125631894|NCT02040857|451934774|FG000|Overall Study|Adverse Event|14|||
125631895|NCT02040857|451934774|FG000|Overall Study|Physician Decision|5|||
125631896|NCT02040857|451934774|FG000|Overall Study|Withdrawal by Subject|31|||
125631897|NCT02040857|451934774|FG000|Overall Study|patient non-compliance|3|||
125631898|NCT02040857|451934774|FG000|Overall Study|Lost to Follow-up|2|||
125631899|NCT02040857|451934774|FG000|Overall Study|recurrence|4|||
125631900|NCT02040857|451934774|FG000|Overall Study|ineligible|1|||
125631901|NCT04159701|451934775|FG000|Period 1: Treatment Period|Pregnancy|1|||
125631902|NCT04159701|451934776|FG001|Period 1: Treatment Period|Pregnancy|0|||
125631903|NCT04159701|451934775|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
125631904|NCT04159701|451934776|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
125631905|NCT04159701|451934775|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
125631906|NCT04159701|451934776|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
125631907|NCT04159701|451934775|FG000|Washout Period|site terminated by sponsor|0|||
125631908|NCT04159701|451934776|FG001|Washout Period|site terminated by sponsor|1|||
125631909|NCT04159701|451934775|FG000|Washout Period|study terminated by sponsor|10|||
125631910|NCT04159701|451934776|FG001|Washout Period|study terminated by sponsor|3|||
125631911|NCT04159701|451934775|FG000|Washout Period|Withdrawal by Subject|1|||
125631912|NCT04159701|451934776|FG001|Washout Period|Withdrawal by Subject|0|||
125631913|NCT04159701|451934775|FG000|Washout Period|Inadvertent Enrollment|1|||
125631914|NCT04159701|451934776|FG001|Washout Period|Inadvertent Enrollment|0|||
125631915|NCT04159701|451934775|FG000|Washout Period|Miscellaneous|1|||
125631916|NCT04159701|451934776|FG001|Washout Period|Miscellaneous|0|||
125631917|NCT04159701|451934775|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
125631918|NCT04159701|451934776|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
125631919|NCT04159701|451934775|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
125631920|NCT04159701|451934776|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
125631921|NCT04159701|451934775|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
125631922|NCT04159701|451934776|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
125129502|NCT01811953|450100962|FG003|Overall Study|Protocol Violation|0|||
125631923|NCT04159701|451934775|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
125129503|NCT01811953|450100963|FG004|Overall Study|Protocol Violation|1|||
125129504|NCT01811953|450100964|FG005|Overall Study|Protocol Violation|0|||
125129505|NCT00371839|450100965|FG000|Overall Study|Death|4|||
125631924|NCT04159701|451934776|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
125129506|NCT00371839|450100966|FG001|Overall Study|Death|0|||
125215926|NCT05052697|450417533|FG013|Substudy A|Not vaccinated|0|||
125215927|NCT05052697|450417534|FG014|Substudy A|Not vaccinated|0|||
125215928|NCT05052697|450417535|FG015|Substudy A|Not vaccinated|0|||
125215929|NCT05052697|450417536|FG016|Substudy A|Not vaccinated|0|||
125215930|NCT05052697|450417537|FG017|Substudy A|Not vaccinated|0|||
125215931|NCT05052697|450417538|FG018|Substudy A|Not vaccinated|0|||
125215932|NCT05052697|450417539|FG019|Substudy A|Not vaccinated|0|||
125215933|NCT05052697|450417540|FG020|Substudy A|Not vaccinated|0|||
125215934|NCT05052697|450417541|FG021|Substudy A|Not vaccinated|0|||
125215935|NCT05052697|450417542|FG022|Substudy A|Not vaccinated|0|||
125215936|NCT05052697|450417543|FG023|Substudy A|Not vaccinated|0|||
125215937|NCT05052697|450417544|FG024|Substudy A|Not vaccinated|0|||
125215938|NCT05052697|450417545|FG025|Substudy A|Not vaccinated|0|||
125215939|NCT05052697|450417546|FG026|Substudy A|Not vaccinated|0|||
125215940|NCT05052697|450417547|FG027|Substudy A|Not vaccinated|0|||
125215941|NCT05052697|450417548|FG028|Substudy A|Not vaccinated|0|||
125215942|NCT05052697|450417549|FG029|Substudy A|Not vaccinated|0|||
125215943|NCT05052697|450417550|FG030|Substudy A|Not vaccinated|0|||
125215944|NCT05052697|450417551|FG031|Substudy A|Not vaccinated|0|||
125215945|NCT05052697|450417552|FG032|Substudy A|Not vaccinated|0|||
125215946|NCT05052697|450417553|FG033|Substudy A|Not vaccinated|0|||
125215947|NCT05052697|450417520|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215948|NCT05052697|450417521|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215949|NCT05052697|450417522|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215950|NCT05052697|450417523|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215951|NCT05052697|450417524|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215952|NCT05052697|450417525|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125129507|NCT00371839|450100967|FG002|Overall Study|Death|0|||
125129508|NCT00371839|450100965|FG000|Overall Study|Withdrawal by Subject|7|||
125129509|NCT00371839|450100966|FG001|Overall Study|Withdrawal by Subject|4|||
125129510|NCT00371839|450100967|FG002|Overall Study|Withdrawal by Subject|0|||
125129511|NCT00371839|450100965|FG000|Overall Study|Lost to Follow-up|6|||
125129512|NCT00371839|450100966|FG001|Overall Study|Lost to Follow-up|3|||
125129513|NCT00371839|450100967|FG002|Overall Study|Lost to Follow-up|2|||
125129514|NCT01049334|450100968|FG000|Overall Study|Withdrawal by Subject|5|||
125129515|NCT01049334|450100969|FG001|Overall Study|Withdrawal by Subject|3|||
125129516|NCT01049334|450100968|FG000|Overall Study|Adverse Event|2|||
125215953|NCT05052697|450417526|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215954|NCT05052697|450417527|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215955|NCT05052697|450417528|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215956|NCT05052697|450417529|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215957|NCT05052697|450417530|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215958|NCT05052697|450417531|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215959|NCT05052697|450417532|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215960|NCT05052697|450417533|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215961|NCT05052697|450417534|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215962|NCT05052697|450417535|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215963|NCT05052697|450417536|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215964|NCT05052697|450417537|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215965|NCT05052697|450417538|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
125215966|NCT05052697|450417539|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
125215967|NCT05052697|450417540|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215968|NCT05052697|450417541|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
125215969|NCT05052697|450417542|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
125215970|NCT05052697|450417543|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125631925|NCT04159701|451934775|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
125631926|NCT04159701|451934776|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
125631927|NCT03605836|451934777|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
125631928|NCT03605836|451934778|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
125129517|NCT01049334|450100969|FG001|Overall Study|Adverse Event|3|||
125215971|NCT05052697|450417544|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215972|NCT05052697|450417545|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215973|NCT05052697|450417546|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215974|NCT05052697|450417547|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215975|NCT05052697|450417548|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125631929|NCT03605836|451934779|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
125215976|NCT05052697|450417549|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125631930|NCT03605836|451934780|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
125631931|NCT03605836|451934777|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
125631932|NCT03605836|451934778|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
125631933|NCT03605836|451934779|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
125436490|NCT00675506|451224414|FG001|Overall Study|Lost interest|5|||
125129518|NCT01049334|450100968|FG000|Overall Study|Physician Decision|2|||
125631934|NCT03605836|451934780|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
125631935|NCT03605836|451934777|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
125631936|NCT03605836|451934778|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
125631937|NCT03605836|451934779|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
125631938|NCT03605836|451934780|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
125631939|NCT03605836|451934777|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
125631940|NCT03605836|451934778|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
125631941|NCT03605836|451934779|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
125631942|NCT03605836|451934780|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
125631943|NCT03605836|451934777|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
125631944|NCT03605836|451934778|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
125631945|NCT03605836|451934779|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
125631946|NCT03605836|451934780|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
125631947|NCT03605836|451934777|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
125631948|NCT03605836|451934778|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
125631949|NCT03605836|451934779|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
125631950|NCT03605836|451934780|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
125631951|NCT03605836|451934777|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
125631952|NCT03605836|451934778|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
125631953|NCT03605836|451934779|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
125631954|NCT03605836|451934780|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
125631955|NCT03605836|451934777|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
125631956|NCT03605836|451934778|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
125631957|NCT03605836|451934779|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
125631958|NCT03605836|451934780|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
125631959|NCT03605836|451934777|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
125631960|NCT03605836|451934778|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
125631961|NCT03605836|451934779|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
125631962|NCT03605836|451934780|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
125631963|NCT03605836|451934777|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
125631964|NCT03605836|451934778|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
125631965|NCT03605836|451934779|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
125631966|NCT03605836|451934780|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
125631967|NCT03605836|451934777|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
125631968|NCT03605836|451934778|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
125631969|NCT03605836|451934779|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
125631970|NCT03605836|451934780|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
125631971|NCT03605836|451934777|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
125631972|NCT03605836|451934778|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
125631973|NCT03605836|451934779|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
125631974|NCT03605836|451934780|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
125631975|NCT03605836|451934777|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
125631976|NCT03605836|451934778|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
125631977|NCT03605836|451934779|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
125631978|NCT03605836|451934780|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
125631979|NCT03605836|451934777|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
125631980|NCT03605836|451934778|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
125631981|NCT03605836|451934779|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
125631982|NCT03605836|451934780|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
125631983|NCT03605836|451934777|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
125631984|NCT03605836|451934778|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
125631985|NCT03605836|451934779|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
125631986|NCT03605836|451934780|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
125631987|NCT03605836|451934777|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
125631988|NCT03605836|451934778|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
125631989|NCT03605836|451934779|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
125631990|NCT03605836|451934780|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
125631991|NCT03605836|451934777|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
125631992|NCT03605836|451934778|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
125631993|NCT03605836|451934779|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
125631994|NCT03605836|451934780|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
125631995|NCT03605836|451934777|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
125129519|NCT01049334|450100969|FG001|Overall Study|Physician Decision|0|||
125129520|NCT01049334|450100968|FG000|Overall Study|Protocol Violation|0|||
125129521|NCT01049334|450100969|FG001|Overall Study|Protocol Violation|1|||
125129522|NCT00396279|450100970|FG000|Overall Study|Ongoing in study|26|||
125129523|NCT00396279|450100970|FG000|Overall Study|Disease progression|2|||
125129524|NCT00396279|450100970|FG000|Overall Study|Withdrawal by Subject|1|||
125129525|NCT00396279|450100970|FG000|Overall Study|Physician Decision|1|||
125129526|NCT00667095|450100978|FG000|Overall Study|Withdrawal by Subject|0|||
125129527|NCT00667095|450100979|FG001|Overall Study|Withdrawal by Subject|1|||
125129528|NCT00905346|450100983|FG000|Period 1|Withdrawal by Subject|1|||
125129529|NCT00905346|450100984|FG001|Period 1|Withdrawal by Subject|0|||
125129530|NCT03351335|450100985|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
125129531|NCT03351335|450100986|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
125129532|NCT03351335|450100987|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
125129533|NCT05612724|450100992|FG000|Overall Study|Lost to Follow-up|4|||
125129534|NCT04000815|450100995|FG000|Overall Study|Lost to Follow-up|9|||
125129535|NCT04000815|450100996|FG001|Overall Study|Lost to Follow-up|2|||
125129536|NCT04000815|450100997|FG002|Overall Study|Lost to Follow-up|3|||
125129537|NCT04000815|450100995|FG000|Overall Study|Withdrawal by Subject|4|||
125376723|NCT00842712|451010150|FG004|Randomized Part|Randomized but not treated|0|||
125631996|NCT03605836|451934778|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
125631997|NCT03605836|451934779|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
125631998|NCT03605836|451934780|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
125631999|NCT03605836|451934777|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
125632000|NCT03605836|451934778|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
125632001|NCT03605836|451934779|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
125632002|NCT03605836|451934780|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
125632003|NCT03605836|451934777|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
125632004|NCT03605836|451934778|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
125632005|NCT03605836|451934779|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
125632006|NCT03605836|451934780|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
125632007|NCT03605836|451934777|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
125632008|NCT03605836|451934778|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
125632009|NCT03605836|451934779|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
125632010|NCT03605836|451934780|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
125632011|NCT03605836|451934777|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
125632012|NCT03605836|451934778|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
125632013|NCT03605836|451934779|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
125632014|NCT03605836|451934780|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
125632015|NCT02057068|451934787|FG000|Overall Study|Withdrawal by Subject|2|||
125632016|NCT02057068|451934788|FG001|Overall Study|Withdrawal by Subject|2|||
125632017|NCT02057068|451934787|FG000|Overall Study|Caregiver (CG) Health|0|||
125632018|NCT02057068|451934788|FG001|Overall Study|Caregiver (CG) Health|2|||
125632019|NCT02057068|451934787|FG000|Overall Study|Carepartner (CP) Health|4|||
125632020|NCT02057068|451934788|FG001|Overall Study|Carepartner (CP) Health|2|||
125632021|NCT02057068|451934787|FG000|Overall Study|Lost to Follow-up|2|||
125632022|NCT02057068|451934788|FG001|Overall Study|Lost to Follow-up|2|||
125632023|NCT01782885|451934789|FG000|Overall Study|Lost to Follow-up|4|||
125632024|NCT01782885|451934790|FG001|Overall Study|Lost to Follow-up|6|||
125632025|NCT03447821|451934791|FG000|Overall Study|Withdrawal by Subject|1|||
125632026|NCT03447821|451934792|FG001|Overall Study|Withdrawal by Subject|1|||
125632027|NCT03447821|451934793|FG002|Overall Study|Withdrawal by Subject|0|||
125632028|NCT03447821|451934791|FG000|Overall Study|Lost to Follow-up|0|||
125632029|NCT03447821|451934792|FG001|Overall Study|Lost to Follow-up|0|||
125632030|NCT03447821|451934793|FG002|Overall Study|Lost to Follow-up|1|||
125632031|NCT00329784|451934796|FG000|Overall Study|Lost to Follow-up|0|||
125632032|NCT00329784|451934797|FG001|Overall Study|Lost to Follow-up|1|||
125632033|NCT00329784|451934798|FG002|Overall Study|Lost to Follow-up|0|||
125632034|NCT00329784|451934799|FG003|Overall Study|Lost to Follow-up|0|||
125632035|NCT00329784|451934796|FG000|Overall Study|Withdrawal by Subject|4|||
125632036|NCT00329784|451934797|FG001|Overall Study|Withdrawal by Subject|2|||
125129538|NCT04000815|450100996|FG001|Overall Study|Withdrawal by Subject|3|||
125129539|NCT04000815|450100997|FG002|Overall Study|Withdrawal by Subject|2|||
125632037|NCT00329784|451934798|FG002|Overall Study|Withdrawal by Subject|0|||
125632038|NCT00329784|451934799|FG003|Overall Study|Withdrawal by Subject|0|||
125632039|NCT00329784|451934796|FG000|Overall Study|Other|1|||
125632040|NCT00329784|451934797|FG001|Overall Study|Other|2|||
125632041|NCT00329784|451934798|FG002|Overall Study|Other|0|||
125632042|NCT00329784|451934799|FG003|Overall Study|Other|0|||
125129540|NCT04000815|450100995|FG000|Overall Study|Right ovarian cyst occured|1|||
125129541|NCT04000815|450100996|FG001|Overall Study|Right ovarian cyst occured|0|||
125129542|NCT04000815|450100997|FG002|Overall Study|Right ovarian cyst occured|0|||
125436543|NCT01617005|451224426|FG000|Overall Study|Pregnancy|1|||
125215977|NCT05052697|450417550|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215978|NCT05052697|450417551|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215979|NCT05052697|450417552|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215980|NCT05052697|450417553|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
125215981|NCT05052697|450417520|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215982|NCT05052697|450417521|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215983|NCT05052697|450417522|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215984|NCT05052697|450417523|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215985|NCT05052697|450417524|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215986|NCT05052697|450417525|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215987|NCT05052697|450417526|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215988|NCT05052697|450417527|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215989|NCT05052697|450417528|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215990|NCT05052697|450417529|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215991|NCT05052697|450417530|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215992|NCT05052697|450417531|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215993|NCT05052697|450417532|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215994|NCT05052697|450417533|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215995|NCT05052697|450417534|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215996|NCT05052697|450417535|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215997|NCT05052697|450417536|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
125215998|NCT05052697|450417537|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
125215999|NCT05052697|450417538|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216000|NCT05052697|450417539|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216001|NCT05052697|450417540|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216002|NCT05052697|450417541|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216003|NCT05052697|450417542|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216004|NCT05052697|450417543|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216005|NCT05052697|450417544|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216006|NCT05052697|450417545|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216007|NCT05052697|450417546|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216008|NCT05052697|450417547|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216009|NCT05052697|450417548|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216010|NCT05052697|450417549|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216011|NCT05052697|450417550|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216012|NCT05052697|450417551|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216013|NCT05052697|450417552|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216014|NCT05052697|450417553|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
125216015|NCT05052697|450417520|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216016|NCT05052697|450417521|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216017|NCT05052697|450417522|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216018|NCT05052697|450417523|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216019|NCT05052697|450417524|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216020|NCT05052697|450417525|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216021|NCT05052697|450417526|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216022|NCT05052697|450417527|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216023|NCT05052697|450417528|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216024|NCT05052697|450417529|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216025|NCT05052697|450417530|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216026|NCT05052697|450417531|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216027|NCT05052697|450417532|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216028|NCT05052697|450417533|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216029|NCT05052697|450417534|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216030|NCT05052697|450417535|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216031|NCT05052697|450417536|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216032|NCT05052697|450417537|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216033|NCT05052697|450417538|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216034|NCT05052697|450417539|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
125129543|NCT04000815|450100995|FG000|Overall Study|Hypertension occured on follow up|0|||
125129544|NCT04000815|450100996|FG001|Overall Study|Hypertension occured on follow up|0|||
125129545|NCT04000815|450100997|FG002|Overall Study|Hypertension occured on follow up|2|||
125129546|NCT00239577|450100998|FG000|Primary Phase|Adverse Event|0|||
125129547|NCT00239577|450100999|FG001|Primary Phase|Adverse Event|0|||
125129548|NCT00239577|450101000|FG002|Primary Phase|Adverse Event|1|||
125129549|NCT00239577|450101001|FG003|Primary Phase|Adverse Event|0|||
125129550|NCT00239577|450100998|FG000|Primary Phase|Other|5|||
125129551|NCT00239577|450100999|FG001|Primary Phase|Other|3|||
125129552|NCT00239577|450101000|FG002|Primary Phase|Other|2|||
125129553|NCT00239577|450101001|FG003|Primary Phase|Other|0|||
125129554|NCT03988803|450101004|FG000|Period 2|Prematurely discontinued from medication|2|||
125129555|NCT03988803|450101004|FG000|Period 2|Adverse Event|1|||
125216035|NCT05052697|450417540|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216036|NCT05052697|450417541|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216037|NCT05052697|450417542|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216038|NCT05052697|450417543|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216039|NCT05052697|450417544|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216040|NCT05052697|450417545|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216041|NCT05052697|450417546|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216042|NCT05052697|450417547|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216043|NCT05052697|450417548|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216044|NCT05052697|450417549|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216045|NCT05052697|450417550|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216046|NCT05052697|450417551|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216047|NCT05052697|450417552|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216048|NCT05052697|450417553|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
125216049|NCT05052697|450417520|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216050|NCT05052697|450417521|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216051|NCT05052697|450417522|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216052|NCT05052697|450417523|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216053|NCT05052697|450417524|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216054|NCT05052697|450417525|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216055|NCT05052697|450417526|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216056|NCT05052697|450417527|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216057|NCT05052697|450417528|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216058|NCT05052697|450417529|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216059|NCT05052697|450417530|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216060|NCT05052697|450417531|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216061|NCT05052697|450417532|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216062|NCT05052697|450417533|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216063|NCT05052697|450417534|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216064|NCT05052697|450417535|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216065|NCT05052697|450417536|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216066|NCT05052697|450417537|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
125216067|NCT05052697|450417538|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125129556|NCT02736721|450101005|FG000|Overall Study|Adverse Event|8|||
125129557|NCT02736721|450101005|FG000|Overall Study|Lost to Follow-up|3|||
125129558|NCT02736721|450101005|FG000|Overall Study|Other|5|||
125129559|NCT03021018|450101008|FG000|Overall Study|Adverse Event|1|||
125129560|NCT03021018|450101009|FG001|Overall Study|Adverse Event|0|||
125129561|NCT03021018|450101010|FG002|Overall Study|Adverse Event|0|||
125129562|NCT03021018|450101008|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
125129563|NCT03021018|450101009|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
125129564|NCT03021018|450101010|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
125129565|NCT02269657|450101021|FG000|Overall Study|Protocol Violation|3|||
125129566|NCT00620074|450101024|FG000|Overall Study|Adverse Event|1|||
125129567|NCT03450057|450101025|FG000|Overall Study|Death|17|||
125129568|NCT03450057|450101025|FG000|Overall Study|ICF withdrawal|4|||
125129569|NCT03450057|450101025|FG000|Overall Study|Lost to Follow-up|2|||
125129570|NCT01838941|450101026|FG000|Overall Study|Adverse Event|1|||
125216068|NCT05052697|450417539|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216069|NCT05052697|450417540|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216070|NCT05052697|450417541|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216071|NCT05052697|450417542|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216072|NCT05052697|450417543|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125129571|NCT01838941|450101026|FG000|Overall Study|Withdrawal by Subject|1|||
125129572|NCT02822235|450101027|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
125129573|NCT02822235|450101028|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
125129574|NCT02822235|450101027|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
125129575|NCT02822235|450101028|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
125216073|NCT05052697|450417544|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216074|NCT05052697|450417545|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
125129576|NCT02822235|450101027|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
125129577|NCT02822235|450101028|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
125216075|NCT05052697|450417546|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216076|NCT05052697|450417547|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
125216077|NCT05052697|450417548|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216078|NCT05052697|450417549|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216079|NCT05052697|450417550|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216080|NCT05052697|450417551|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216081|NCT05052697|450417552|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216082|NCT05052697|450417553|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
125216083|NCT05052697|450417520|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125632043|NCT01098032|451934800|FG000|Overall Study|Withdrawal by Subject|1|||
125632044|NCT01098032|451934801|FG001|Overall Study|Withdrawal by Subject|1|||
125632045|NCT00481988|451934802|FG000|Overall Study|Withdrawal by Subject|1|||
125632046|NCT00481988|451934803|FG001|Overall Study|Withdrawal by Subject|1|||
125632047|NCT00654420|451934804|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
125632048|NCT00654420|451934805|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
125632049|NCT00654420|451934806|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
125632050|NCT00654420|451934807|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
125632051|NCT00654420|451934804|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
125632052|NCT00654420|451934805|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
125632053|NCT00654420|451934806|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
125632054|NCT00654420|451934807|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
125632055|NCT00654420|451934804|FG000|Phase II|Adverse Event|0|||
125632056|NCT00654420|451934805|FG001|Phase II|Adverse Event|0|||
125632057|NCT00654420|451934806|FG002|Phase II|Adverse Event|3|||
125632058|NCT00654420|451934807|FG003|Phase II|Adverse Event|3|||
125632059|NCT00654420|451934804|FG000|Phase II|Lost to Follow-up|0|||
125632060|NCT00654420|451934805|FG001|Phase II|Lost to Follow-up|0|||
125632061|NCT00654420|451934806|FG002|Phase II|Lost to Follow-up|0|||
125632062|NCT00654420|451934807|FG003|Phase II|Lost to Follow-up|1|||
125632063|NCT00654420|451934804|FG000|Phase II|Physician Decision|0|||
125632064|NCT00654420|451934805|FG001|Phase II|Physician Decision|0|||
125632065|NCT00654420|451934806|FG002|Phase II|Physician Decision|0|||
125632066|NCT00654420|451934807|FG003|Phase II|Physician Decision|4|||
125632067|NCT00654420|451934804|FG000|Phase II|Progressive Disease|0|||
125632068|NCT00654420|451934805|FG001|Phase II|Progressive Disease|0|||
125632069|NCT00654420|451934806|FG002|Phase II|Progressive Disease|29|||
125632070|NCT00654420|451934807|FG003|Phase II|Progressive Disease|29|||
125632071|NCT00654420|451934804|FG000|Phase II|Withdrawal by Subject|0|||
125632072|NCT00654420|451934805|FG001|Phase II|Withdrawal by Subject|0|||
125632073|NCT00654420|451934806|FG002|Phase II|Withdrawal by Subject|4|||
125632074|NCT00654420|451934807|FG003|Phase II|Withdrawal by Subject|1|||
125632075|NCT00654420|451934804|FG000|Phase II|Missing Disposition Record|0|||
125632076|NCT00654420|451934805|FG001|Phase II|Missing Disposition Record|0|||
125632077|NCT00654420|451934806|FG002|Phase II|Missing Disposition Record|1|||
125632078|NCT00654420|451934807|FG003|Phase II|Missing Disposition Record|0|||
125632079|NCT00471276|451934810|FG000|Overall Study|Death|2|||
125632080|NCT00471276|451934810|FG000|Overall Study|Adverse Event|16|||
125632081|NCT00471276|451934810|FG000|Overall Study|Protocol Violation|1|||
125632082|NCT00471276|451934810|FG000|Overall Study|Objective progression or relapse|54|||
125632083|NCT00471276|451934810|FG000|Overall Study|Global deterioration of health status|1|||
125632084|NCT00471276|451934810|FG000|Overall Study|Other|3|||
125632085|NCT00471276|451934810|FG000|Overall Study|Refused treatment|6|||
125632086|NCT01594411|451934811|FG000|Overall Study|Lost to Follow-up|2|||
125632087|NCT00910728|451934815|FG000|Overall Study|Lack of Efficacy|2|||
125632088|NCT00910728|451934816|FG001|Overall Study|Lack of Efficacy|3|||
125632089|NCT00910728|451934817|FG002|Overall Study|Lack of Efficacy|1|||
125632090|NCT00910728|451934818|FG003|Overall Study|Lack of Efficacy|2|||
125632091|NCT00910728|451934819|FG004|Overall Study|Lack of Efficacy|1|||
125632092|NCT00910728|451934820|FG005|Overall Study|Lack of Efficacy|0|||
125632093|NCT00910728|451934821|FG006|Overall Study|Lack of Efficacy|2|||
125632094|NCT00910728|451934822|FG007|Overall Study|Lack of Efficacy|2|||
125632095|NCT00910728|451934823|FG008|Overall Study|Lack of Efficacy|2|||
125632096|NCT00910728|451934815|FG000|Overall Study|Withdrawal by Subject|0|||
125632097|NCT00910728|451934816|FG001|Overall Study|Withdrawal by Subject|0|||
125632098|NCT00910728|451934817|FG002|Overall Study|Withdrawal by Subject|0|||
125632099|NCT00910728|451934818|FG003|Overall Study|Withdrawal by Subject|0|||
125632100|NCT00910728|451934819|FG004|Overall Study|Withdrawal by Subject|3|||
125632101|NCT00910728|451934820|FG005|Overall Study|Withdrawal by Subject|1|||
125632102|NCT00910728|451934821|FG006|Overall Study|Withdrawal by Subject|2|||
125632103|NCT00910728|451934822|FG007|Overall Study|Withdrawal by Subject|0|||
125632104|NCT00910728|451934823|FG008|Overall Study|Withdrawal by Subject|0|||
125632105|NCT00910728|451934815|FG000|Overall Study|(not specified)|2|||
125632106|NCT00910728|451934816|FG001|Overall Study|(not specified)|0|||
125632107|NCT00910728|451934817|FG002|Overall Study|(not specified)|1|||
125632108|NCT00910728|451934818|FG003|Overall Study|(not specified)|0|||
125632109|NCT00910728|451934819|FG004|Overall Study|(not specified)|1|||
125632110|NCT00910728|451934820|FG005|Overall Study|(not specified)|0|||
125632111|NCT00910728|451934821|FG006|Overall Study|(not specified)|0|||
125632112|NCT00910728|451934822|FG007|Overall Study|(not specified)|0|||
125632113|NCT00910728|451934823|FG008|Overall Study|(not specified)|0|||
125632114|NCT00910728|451934815|FG000|Overall Study|Adverse Event|2|||
125632115|NCT00910728|451934816|FG001|Overall Study|Adverse Event|0|||
125129578|NCT02822235|450101027|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
125632116|NCT00910728|451934817|FG002|Overall Study|Adverse Event|1|||
125632117|NCT00910728|451934818|FG003|Overall Study|Adverse Event|1|||
125632118|NCT00910728|451934819|FG004|Overall Study|Adverse Event|0|||
125632119|NCT00910728|451934820|FG005|Overall Study|Adverse Event|0|||
125632120|NCT00910728|451934821|FG006|Overall Study|Adverse Event|2|||
125632121|NCT00910728|451934822|FG007|Overall Study|Adverse Event|1|||
125632122|NCT00910728|451934823|FG008|Overall Study|Adverse Event|1|||
125632123|NCT00431496|451934824|FG000|Overall Study|Adverse Event|3|||
125632124|NCT00431496|451934824|FG000|Overall Study|Lost to Follow-up|1|||
125632125|NCT00431496|451934824|FG000|Overall Study|Withdrawal by Subject|2|||
125632126|NCT00431496|451934824|FG000|Overall Study|Protocol-specified criteria|5|||
125632127|NCT00361218|451934825|FG000|Overall Study|Lost to Follow-up|11|||
125632128|NCT00361218|451934825|FG000|Overall Study|Personal Reasons|7|||
125632129|NCT00361218|451934825|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
125632130|NCT00044213|451934828|FG000|Overall Study|Withdrawal by Subject|50|||
125632131|NCT00044213|451934829|FG001|Overall Study|Withdrawal by Subject|65|||
125632132|NCT00044213|451934830|FG002|Overall Study|Withdrawal by Subject|91|||
125632133|NCT00044213|451934831|FG003|Overall Study|Withdrawal by Subject|83|||
125632134|NCT00044213|451934828|FG000|Overall Study|Death|42|||
125632135|NCT00044213|451934829|FG001|Overall Study|Death|42|||
125632136|NCT00044213|451934830|FG002|Overall Study|Death|42|||
125632137|NCT00044213|451934831|FG003|Overall Study|Death|49|||
125632138|NCT00044213|451934828|FG000|Overall Study|Lost to Follow-up|8|||
125632139|NCT00044213|451934829|FG001|Overall Study|Lost to Follow-up|5|||
125632140|NCT00044213|451934830|FG002|Overall Study|Lost to Follow-up|5|||
125632141|NCT00044213|451934831|FG003|Overall Study|Lost to Follow-up|4|||
125632142|NCT01927068|451934833|FG000|Overall Study|Death|37|||
125632143|NCT01927068|451934834|FG001|Overall Study|Death|3|||
125632144|NCT01927068|451934833|FG000|Overall Study|Withdrawal by Subject|50|||
125632145|NCT01927068|451934834|FG001|Overall Study|Withdrawal by Subject|3|||
125632146|NCT01927068|451934833|FG000|Overall Study|Lost to Follow-up|10|||
125632147|NCT01927068|451934834|FG001|Overall Study|Lost to Follow-up|2|||
125632148|NCT01927068|451934833|FG000|Overall Study|Physician Decision|9|||
125632149|NCT01927068|451934834|FG001|Overall Study|Physician Decision|0|||
125632150|NCT01927068|451934833|FG000|Overall Study|Missed last follow-up visit|2|||
125632151|NCT01927068|451934834|FG001|Overall Study|Missed last follow-up visit|0|||
125632152|NCT00880607|451934835|FG000|Overall Study|Physician Decision|2|||
125632153|NCT00880607|451934836|FG001|Overall Study|Physician Decision|2|||
125632154|NCT00880607|451934835|FG000|Overall Study|Protocol Violation|2|||
125632155|NCT00880607|451934836|FG001|Overall Study|Protocol Violation|1|||
125632156|NCT00880607|451934835|FG000|Overall Study|surgery did not extend past L1 level|3|||
125632157|NCT00880607|451934836|FG001|Overall Study|surgery did not extend past L1 level|0|||
125632158|NCT02963766|451934838|FG000|Double-Blind Period|Adverse Event|1|||
125632159|NCT02963766|451934839|FG001|Double-Blind Period|Adverse Event|0|||
125632160|NCT02963766|451934840|FG002|Double-Blind Period|Adverse Event|1|||
125632161|NCT02963766|451934838|FG000|Double-Blind Period|Physician Decision|1|||
125632162|NCT02963766|451934839|FG001|Double-Blind Period|Physician Decision|0|||
125632163|NCT02963766|451934840|FG002|Double-Blind Period|Physician Decision|0|||
125632164|NCT02963766|451934838|FG000|Double-Blind Period|Withdrawal by Subject|1|||
125632165|NCT02963766|451934839|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125632166|NCT02963766|451934840|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125632167|NCT02963766|451934838|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
125632168|NCT02963766|451934839|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
125632169|NCT02963766|451934840|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
125632170|NCT02963766|451934838|FG000|Double-Blind Period|Protocol Violation|1|||
125632171|NCT02963766|451934839|FG001|Double-Blind Period|Protocol Violation|0|||
125632172|NCT02963766|451934840|FG002|Double-Blind Period|Protocol Violation|0|||
125632173|NCT02963766|451934838|FG000|Double-Blind Period|Lost to Follow-up|0|||
125632174|NCT02963766|451934839|FG001|Double-Blind Period|Lost to Follow-up|1|||
125632175|NCT02963766|451934840|FG002|Double-Blind Period|Lost to Follow-up|0|||
125632176|NCT02963766|451934838|FG000|Open Label Extension (OLE)|Physician Decision|1|||
125632177|NCT02963766|451934839|FG001|Open Label Extension (OLE)|Physician Decision|2|||
125632178|NCT02963766|451934840|FG002|Open Label Extension (OLE)|Physician Decision|2|||
125632179|NCT02963766|451934838|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
125632180|NCT02963766|451934839|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
125632181|NCT02963766|451934840|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
125632182|NCT00499460|451934841|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
125632183|NCT00499460|451934842|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
125632184|NCT00499460|451934841|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
125632185|NCT00499460|451934842|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
125632186|NCT00499460|451934841|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
125632187|NCT00499460|451934842|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
125632188|NCT00814307|451934843|FG000|Overall Study|Randomized but not treated|1|||
125632189|NCT00814307|451934844|FG001|Overall Study|Randomized but not treated|0|||
125632190|NCT00814307|451934845|FG002|Overall Study|Randomized but not treated|0|||
125632191|NCT00814307|451934846|FG003|Overall Study|Randomized but not treated|0|||
125216084|NCT05052697|450417521|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216085|NCT05052697|450417522|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216086|NCT05052697|450417523|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216087|NCT05052697|450417524|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216088|NCT05052697|450417525|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216089|NCT05052697|450417526|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216090|NCT05052697|450417527|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216091|NCT05052697|450417528|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216092|NCT05052697|450417529|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216093|NCT05052697|450417530|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216094|NCT05052697|450417531|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216095|NCT05052697|450417532|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216096|NCT05052697|450417533|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125632192|NCT00814307|451934843|FG000|Overall Study|Adverse Event|3|||
125632193|NCT00814307|451934844|FG001|Overall Study|Adverse Event|9|||
125632194|NCT00814307|451934845|FG002|Overall Study|Adverse Event|3|||
125632195|NCT00814307|451934846|FG003|Overall Study|Adverse Event|2|||
125632196|NCT00814307|451934843|FG000|Overall Study|Lack of Efficacy|1|||
125632197|NCT00814307|451934844|FG001|Overall Study|Lack of Efficacy|1|||
125632198|NCT00814307|451934845|FG002|Overall Study|Lack of Efficacy|3|||
125632199|NCT00814307|451934846|FG003|Overall Study|Lack of Efficacy|4|||
125632200|NCT00814307|451934843|FG000|Overall Study|Other|1|||
125632201|NCT00814307|451934844|FG001|Overall Study|Other|2|||
125632202|NCT00814307|451934845|FG002|Overall Study|Other|0|||
125632203|NCT00814307|451934846|FG003|Overall Study|Other|1|||
125632204|NCT00814307|451934843|FG000|Overall Study|Protocol Violation|2|||
125632205|NCT00814307|451934844|FG001|Overall Study|Protocol Violation|8|||
125632206|NCT00814307|451934845|FG002|Overall Study|Protocol Violation|1|||
125632207|NCT00814307|451934846|FG003|Overall Study|Protocol Violation|1|||
125632208|NCT00814307|451934843|FG000|Overall Study|Withdrawal by Subject|4|||
125632209|NCT00814307|451934844|FG001|Overall Study|Withdrawal by Subject|6|||
125632210|NCT00814307|451934845|FG002|Overall Study|Withdrawal by Subject|0|||
125632211|NCT00814307|451934846|FG003|Overall Study|Withdrawal by Subject|2|||
125632212|NCT00814307|451934843|FG000|Overall Study|Death|0|||
125632213|NCT00814307|451934844|FG001|Overall Study|Death|1|||
125632214|NCT00814307|451934845|FG002|Overall Study|Death|0|||
125632215|NCT00814307|451934846|FG003|Overall Study|Death|0|||
125632216|NCT02290340|451934848|FG000|Overall Study|Lost to Follow-up|0|||
125632217|NCT02290340|451934849|FG001|Overall Study|Lost to Follow-up|0|||
125632218|NCT02290340|451934850|FG002|Overall Study|Lost to Follow-up|0|||
125632219|NCT02290340|451934851|FG003|Overall Study|Lost to Follow-up|1|||
125632220|NCT02290340|451934848|FG000|Overall Study|Withdrawal by Subject|1|||
125632221|NCT02290340|451934849|FG001|Overall Study|Withdrawal by Subject|0|||
125632222|NCT02290340|451934850|FG002|Overall Study|Withdrawal by Subject|0|||
125632223|NCT02290340|451934851|FG003|Overall Study|Withdrawal by Subject|0|||
125632224|NCT02290340|451934848|FG000|Overall Study|Other|1|||
125632225|NCT02290340|451934849|FG001|Overall Study|Other|0|||
125632226|NCT02290340|451934850|FG002|Overall Study|Other|0|||
125632227|NCT02290340|451934851|FG003|Overall Study|Other|1|||
125632228|NCT01594749|451937177|FG000|Overall Study|Adverse Event|2|||
125632229|NCT01594749|451937178|FG001|Overall Study|Adverse Event|1|||
125632230|NCT01594749|451937177|FG000|Overall Study|Withdrawal by Subject|2|||
125632231|NCT01594749|451937178|FG001|Overall Study|Withdrawal by Subject|2|||
125632232|NCT01594749|451937177|FG000|Overall Study|Protocol Violation|2|||
125632233|NCT01594749|451937178|FG001|Overall Study|Protocol Violation|0|||
125632234|NCT01594749|451937177|FG000|Overall Study|Physician Decision|1|||
125632235|NCT01594749|451937178|FG001|Overall Study|Physician Decision|1|||
125632236|NCT01594749|451937177|FG000|Overall Study|Non-compliance with Protocol|0|||
125632237|NCT01594749|451937178|FG001|Overall Study|Non-compliance with Protocol|1|||
125632238|NCT01594749|451937177|FG000|Overall Study|Lost to Follow-up|1|||
125632239|NCT01594749|451937178|FG001|Overall Study|Lost to Follow-up|0|||
125216097|NCT05052697|450417534|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216098|NCT05052697|450417535|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216099|NCT05052697|450417536|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125632240|NCT01594749|451937177|FG000|Overall Study|Death|9|||
125632241|NCT01594749|451937178|FG001|Overall Study|Death|3|||
125632242|NCT01594749|451937177|FG000|Overall Study|Not Treated|4|||
125632243|NCT01594749|451937178|FG001|Overall Study|Not Treated|10|||
125632244|NCT01594749|451937177|FG000|Overall Study|Lost Source Documentation|1|||
125632245|NCT01594749|451937178|FG001|Overall Study|Lost Source Documentation|0|||
125632246|NCT02177786|451937179|FG000|Overall Study|Withdrew Consent|2|||
125632247|NCT02177786|451937180|FG001|Overall Study|Withdrew Consent|6|||
125632248|NCT02177786|451937181|FG002|Overall Study|Withdrew Consent|9|||
125632249|NCT02177786|451937182|FG003|Overall Study|Withdrew Consent|5|||
125632250|NCT02177786|451937179|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
125632251|NCT02177786|451937180|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
125632252|NCT02177786|451937181|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
125632253|NCT02177786|451937182|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
125632254|NCT02177786|451937179|FG000|Overall Study|Adverse Event|1|||
125632255|NCT02177786|451937180|FG001|Overall Study|Adverse Event|1|||
125632256|NCT02177786|451937181|FG002|Overall Study|Adverse Event|2|||
125632257|NCT02177786|451937182|FG003|Overall Study|Adverse Event|3|||
125632258|NCT02177786|451937179|FG000|Overall Study|Death|1|||
125632259|NCT02177786|451937180|FG001|Overall Study|Death|1|||
125632260|NCT02177786|451937181|FG002|Overall Study|Death|1|||
125632261|NCT02177786|451937182|FG003|Overall Study|Death|1|||
125632262|NCT02177786|451937179|FG000|Overall Study|Lost to Follow-up|0|||
125632263|NCT02177786|451937180|FG001|Overall Study|Lost to Follow-up|0|||
125632264|NCT02177786|451937181|FG002|Overall Study|Lost to Follow-up|2|||
125632265|NCT02177786|451937182|FG003|Overall Study|Lost to Follow-up|2|||
125632266|NCT02177786|451937179|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125632267|NCT02177786|451937180|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125632268|NCT02177786|451937181|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125632269|NCT02177786|451937182|FG003|Overall Study|Non-Compliance with Study Drug|1|||
125632270|NCT02177786|451937179|FG000|Overall Study|Protocol Violation|0|||
125632271|NCT02177786|451937180|FG001|Overall Study|Protocol Violation|0|||
125632272|NCT02177786|451937181|FG002|Overall Study|Protocol Violation|2|||
125632273|NCT02177786|451937182|FG003|Overall Study|Protocol Violation|0|||
125632274|NCT02177786|451937179|FG000|Overall Study|Progressive Disease|0|||
125632275|NCT02177786|451937180|FG001|Overall Study|Progressive Disease|1|||
125632276|NCT02177786|451937181|FG002|Overall Study|Progressive Disease|0|||
125632277|NCT02177786|451937182|FG003|Overall Study|Progressive Disease|0|||
125632278|NCT02177786|451937179|FG000|Overall Study|Missing study completion status|0|||
125632279|NCT02177786|451937180|FG001|Overall Study|Missing study completion status|1|||
125632280|NCT02177786|451937181|FG002|Overall Study|Missing study completion status|0|||
125632281|NCT02177786|451937182|FG003|Overall Study|Missing study completion status|0|||
125632282|NCT00439309|451937183|FG000|Follow-Up|Death|1|||
125632283|NCT00439309|451937184|FG001|Follow-Up|Death|0|||
125632284|NCT00439309|451937183|FG000|Follow-Up|Lost to Follow-up|2|||
125632285|NCT00439309|451937184|FG001|Follow-Up|Lost to Follow-up|0|||
125632286|NCT00439309|451937183|FG000|Follow-Up|Withdrawal by Subject|0|||
125632287|NCT00439309|451937184|FG001|Follow-Up|Withdrawal by Subject|1|||
125632288|NCT00439309|451937183|FG000|Follow-Up|Late response by subject|0|||
125632289|NCT00439309|451937184|FG001|Follow-Up|Late response by subject|1|||
125632290|NCT01977040|451937185|FG000|Overall Study|Vasa previa not confirmed|2|||
125632291|NCT02204410|451937193|FG000|Overall Study|Lost to Follow-up|5|||
125632292|NCT02204410|451937193|FG000|Overall Study|Physician Decision|2|||
125632293|NCT02204410|451937193|FG000|Overall Study|Protocol Violation|1|||
125632294|NCT02204410|451937193|FG000|Overall Study|Withdrawal by Subject|3|||
125632295|NCT03654560|451937194|FG000|Overall Study|Death|3|||
125632296|NCT03654560|451937195|FG001|Overall Study|Death|1|||
125632297|NCT03654560|451937194|FG000|Overall Study|Lost to Follow-up|1|||
125632298|NCT03654560|451937195|FG001|Overall Study|Lost to Follow-up|0|||
125632299|NCT01100658|451937196|FG000|Overall Study|Withdrawal by Subject|1|||
125632300|NCT00420342|451937200|FG000|Overall Study|Lost to Follow-up|1|||
125632301|NCT00420342|451937201|FG001|Overall Study|Lost to Follow-up|0|||
125632302|NCT00420342|451937202|FG002|Overall Study|Lost to Follow-up|1|||
125632303|NCT00420342|451937200|FG000|Overall Study|Withdrawal by Subject|0|||
125632304|NCT00420342|451937201|FG001|Overall Study|Withdrawal by Subject|2|||
125632305|NCT00420342|451937202|FG002|Overall Study|Withdrawal by Subject|0|||
125632306|NCT01017549|451937203|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
125632307|NCT01017549|451937203|FG000|One-year Follow-up|Lost to Follow-up|2|||
125632308|NCT01017549|451937203|FG000|One-year Follow-up|Withdrawal by Subject|5|||
125632309|NCT01017549|451937203|FG000|5 Year Follow-up|Lost to Follow-up|9|||
125632310|NCT01017549|451937203|FG000|5 Year Follow-up|Mastectomy|3|||
125632311|NCT04072575|451937204|FG000|Overall Study|Physician Decision|1|||
125632312|NCT04072575|451937204|FG000|Overall Study|Adverse Event|7|||
125632313|NCT04072575|451937204|FG000|Overall Study|Withdrawal by Subject|14|||
125632314|NCT04072575|451937204|FG000|Overall Study|Other|2|||
125632315|NCT02473289|451937205|FG000|Overall Study|Adverse Event|2|||
125632316|NCT02473289|451937206|FG001|Overall Study|Adverse Event|3|||
125632317|NCT02473289|451937205|FG000|Overall Study|Lost to Follow-up|1|||
125632318|NCT02473289|451937206|FG001|Overall Study|Lost to Follow-up|1|||
125632319|NCT02473289|451937205|FG000|Overall Study|Protocol Violation|0|||
125632320|NCT02473289|451937206|FG001|Overall Study|Protocol Violation|1|||
125632321|NCT02473289|451937205|FG000|Overall Study|Withdrawal of consent|6|||
125632322|NCT02473289|451937206|FG001|Overall Study|Withdrawal of consent|7|||
125632323|NCT02473289|451937205|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
125632324|NCT02473289|451937206|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
125632325|NCT02473289|451937205|FG000|Overall Study|Other|2|||
125632326|NCT02473289|451937206|FG001|Overall Study|Other|0|||
125632327|NCT02244619|451937207|FG000|Overall Study|Did not receive study intervention|8|||
125632328|NCT02244619|451937208|FG001|Overall Study|Did not receive study intervention|21|||
125632329|NCT01291511|451937210|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
125632330|NCT01291511|451937211|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
125632331|NCT01291511|451937210|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
125632332|NCT01291511|451937211|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
125632333|NCT01291511|451937210|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
125632334|NCT01291511|451937211|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
125632335|NCT01291511|451937210|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
125632336|NCT01291511|451937211|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
125632337|NCT01291511|451937210|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
125632338|NCT01291511|451937211|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
125632339|NCT01291511|451937210|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
125632340|NCT01291511|451937211|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
125129579|NCT02822235|450101028|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
125129580|NCT02822235|450101027|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
125129581|NCT02822235|450101028|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
125129582|NCT02822235|450101027|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
125129583|NCT02822235|450101028|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
125129584|NCT03214952|450101029|FG000|Overall Study|Protocol Deviation|45|||
125129585|NCT03214952|450101029|FG000|Overall Study|Case Report Forms Uncollected|13|||
125129586|NCT02246166|450101032|FG000|Overall Study|Protocol Violation|1|||
125129587|NCT02246166|450101033|FG001|Overall Study|Protocol Violation|0|||
125129588|NCT03769896|450101034|FG000|Open-label Phase|Lack of Efficacy|5|||
125129589|NCT03769896|450101035|FG001|Open-label Phase|Lack of Efficacy|0|||
125129590|NCT03769896|450101034|FG000|Open-label Phase|Adverse Event|3|||
125129591|NCT03769896|450101035|FG001|Open-label Phase|Adverse Event|0|||
125129592|NCT03769896|450101034|FG000|Open-label Phase|Withdrawal by Subject|1|||
125129593|NCT03769896|450101035|FG001|Open-label Phase|Withdrawal by Subject|0|||
125129594|NCT00377260|450101036|FG000|Overall Study|Lost to Follow-up|0|||
125129595|NCT00377260|450101037|FG001|Overall Study|Lost to Follow-up|1|||
125129596|NCT00377260|450101036|FG000|Overall Study|Withdrawal by Subject|2|||
125129597|NCT00377260|450101037|FG001|Overall Study|Withdrawal by Subject|4|||
125129598|NCT00829530|450101038|FG000|First Intervention|Adverse Event|0|||
125129599|NCT00829530|450101039|FG001|First Intervention|Adverse Event|1|||
125129600|NCT00829530|450101038|FG000|First Intervention|Intolerance to Venopuncture|0|||
125129601|NCT00829530|450101039|FG001|First Intervention|Intolerance to Venopuncture|1|||
125129602|NCT00829530|450101038|FG000|Second Intervention|Intolerance to Venopuncture|1|||
125129603|NCT00829530|450101039|FG001|Second Intervention|Intolerance to Venopuncture|0|||
125376724|NCT00842712|451010151|FG005|Randomized Part|Randomized but not treated|1|||
125376725|NCT00842712|451010152|FG006|Randomized Part|Randomized but not treated|4|||
125376726|NCT00842712|451010146|FG000|Randomized Part|Ongoing at cut-off date|0|||
125376727|NCT00842712|451010147|FG001|Randomized Part|Ongoing at cut-off date|0|||
125376728|NCT00842712|451010148|FG002|Randomized Part|Ongoing at cut-off date|0|||
125376729|NCT00842712|451010149|FG003|Randomized Part|Ongoing at cut-off date|0|||
125376730|NCT00842712|451010150|FG004|Randomized Part|Ongoing at cut-off date|0|||
125376731|NCT00842712|451010151|FG005|Randomized Part|Ongoing at cut-off date|0|||
125632341|NCT01291511|451937210|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
125632342|NCT01291511|451937211|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
125632343|NCT01291511|451937210|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
125376732|NCT00842712|451010152|FG006|Randomized Part|Ongoing at cut-off date|2|||
125376733|NCT01549860|451010158|FG000|Overall Study|Withdrawal by Subject|1|||
125376734|NCT01549860|451010159|FG001|Overall Study|Withdrawal by Subject|0|||
125376735|NCT01549860|451010158|FG000|Overall Study|Physician Decision|1|||
125376736|NCT01549860|451010159|FG001|Overall Study|Physician Decision|1|||
125376737|NCT01327885|451010160|FG000|Overall Study|Disease progression-according to RECIST|173|||
125376738|NCT01327885|451010161|FG001|Overall Study|Disease progression-according to RECIST|165|||
125376739|NCT01327885|451010160|FG000|Overall Study|Clinical progression|24|||
125376740|NCT01327885|451010161|FG001|Overall Study|Clinical progression|27|||
125376741|NCT01327885|451010160|FG000|Overall Study|Adverse Event|14|||
125376742|NCT01327885|451010161|FG001|Overall Study|Adverse Event|10|||
125376743|NCT01327885|451010160|FG000|Overall Study|Subject choice|5|||
125632344|NCT01291511|451937211|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
125632345|NCT01291511|451937210|FG000|Cross-Titration and Stabilization Phase|Death|1|||
125632346|NCT01291511|451937211|FG001|Cross-Titration and Stabilization Phase|Death|0|||
125632347|NCT01291511|451937210|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
125632348|NCT01291511|451937211|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
125632349|NCT01291511|451937210|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
125632350|NCT01291511|451937211|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
125632351|NCT01291511|451937210|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
125632352|NCT01291511|451937211|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
125632353|NCT01291511|451937210|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
125632354|NCT01291511|451937211|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
125632355|NCT01291511|451937210|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
125632356|NCT01291511|451937211|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
125632357|NCT01291511|451937210|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
125632358|NCT01291511|451937211|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
125632359|NCT01291511|451937210|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
125632360|NCT01291511|451937211|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
125632361|NCT01291511|451937210|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
125632362|NCT01291511|451937211|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
125632363|NCT01291511|451937210|FG000|Double-blind Relapse Prevention Phase|Death|1|||
125632364|NCT01291511|451937211|FG001|Double-blind Relapse Prevention Phase|Death|0|||
125632365|NCT00047008|451937213|FG000|Overall Study|Withdrawn consent|2|||
125632366|NCT00047008|451937214|FG001|Overall Study|Withdrawn consent|3|||
125632367|NCT00047008|451937213|FG000|Overall Study|Ineligible|9|||
125632368|NCT00047008|451937214|FG001|Overall Study|Ineligible|8|||
125632369|NCT01408732|451937216|FG000|Overall Study|Withdrawal by Subject|2|||
125632370|NCT01408732|451937217|FG001|Overall Study|Withdrawal by Subject|2|||
125632371|NCT00796003|451937219|FG000|Overall Study|Disease Progression|2|||
125632372|NCT00796003|451937220|FG001|Overall Study|Disease Progression|13|||
125632373|NCT00796003|451937219|FG000|Overall Study|Adverse Event|1|||
125632374|NCT00796003|451937220|FG001|Overall Study|Adverse Event|7|||
125632375|NCT00796003|451937219|FG000|Overall Study|Specified organ function not met|0|||
125632376|NCT00796003|451937220|FG001|Overall Study|Specified organ function not met|1|||
125632377|NCT00796003|451937219|FG000|Overall Study|Physician Decision|0|||
125632378|NCT00796003|451937220|FG001|Overall Study|Physician Decision|4|||
125632379|NCT00796003|451937219|FG000|Overall Study|Withdrawal by Subject|0|||
125632380|NCT00796003|451937220|FG001|Overall Study|Withdrawal by Subject|1|||
125632381|NCT00796003|451937219|FG000|Overall Study|Other|0|||
125632382|NCT00796003|451937220|FG001|Overall Study|Other|1|||
125632383|NCT00796003|451937219|FG000|Overall Study|Participants Not treated|0|||
125632384|NCT00796003|451937220|FG001|Overall Study|Participants Not treated|2|||
125632385|NCT05179057|451937221|FG000|Overall Study|Adverse Event|3|||
125632386|NCT05179057|451937222|FG001|Overall Study|Adverse Event|2|||
125632387|NCT05179057|451937221|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
125632388|NCT05179057|451937222|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
125632389|NCT05179057|451937221|FG000|Overall Study|Study terminated|13|||
125632390|NCT05179057|451937222|FG001|Overall Study|Study terminated|7|||
125632391|NCT05179057|451937221|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
125632392|NCT05179057|451937222|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
125632393|NCT05179057|451937221|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
125632394|NCT05179057|451937222|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
125632395|NCT02437162|451937223|FG000|Overall Study|Protocol Violation|0|||
125632396|NCT02437162|451937224|FG001|Overall Study|Protocol Violation|1|||
125216100|NCT05052697|450417537|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216101|NCT05052697|450417538|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216102|NCT05052697|450417539|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125632397|NCT02437162|451937225|FG002|Overall Study|Protocol Violation|0|||
125632398|NCT02437162|451937223|FG000|Overall Study|Randomized but not treated|0|||
125632399|NCT02437162|451937224|FG001|Overall Study|Randomized but not treated|0|||
125632400|NCT02437162|451937225|FG002|Overall Study|Randomized but not treated|1|||
125632401|NCT02437162|451937223|FG000|Overall Study|Study discontinued by Sponsor|93|||
125632402|NCT02437162|451937224|FG001|Overall Study|Study discontinued by Sponsor|98|||
125632403|NCT02437162|451937225|FG002|Overall Study|Study discontinued by Sponsor|97|||
125632404|NCT02437162|451937223|FG000|Overall Study|Withdrawal by Subject|13|||
125632405|NCT02437162|451937224|FG001|Overall Study|Withdrawal by Subject|7|||
125632406|NCT02437162|451937225|FG002|Overall Study|Withdrawal by Subject|9|||
125632407|NCT02437162|451937223|FG000|Overall Study|Adverse Event|0|||
125632408|NCT02437162|451937224|FG001|Overall Study|Adverse Event|1|||
125632409|NCT02437162|451937225|FG002|Overall Study|Adverse Event|0|||
125632410|NCT02437162|451937223|FG000|Overall Study|Lost to Follow-up|1|||
125632411|NCT02437162|451937224|FG001|Overall Study|Lost to Follow-up|0|||
125632412|NCT02437162|451937225|FG002|Overall Study|Lost to Follow-up|1|||
125632413|NCT02437162|451937223|FG000|Overall Study|Death|0|||
125632414|NCT02437162|451937224|FG001|Overall Study|Death|1|||
125632415|NCT02437162|451937225|FG002|Overall Study|Death|0|||
125632416|NCT02437162|451937223|FG000|Overall Study|Other|0|||
125632417|NCT02437162|451937224|FG001|Overall Study|Other|0|||
125632418|NCT02437162|451937225|FG002|Overall Study|Other|1|||
125632419|NCT04338321|451937226|FG000|Overall Study|Adverse Event|4|||
125632420|NCT04338321|451937227|FG001|Overall Study|Adverse Event|10|||
125632421|NCT04338321|451937226|FG000|Overall Study|Death|1|||
125632422|NCT04338321|451937227|FG001|Overall Study|Death|1|||
125129604|NCT04112823|450101042|FG000|Overall Study|Lost to Follow-up|2|||
125129605|NCT04112823|450101043|FG001|Overall Study|Lost to Follow-up|3|||
125129606|NCT00625443|450101044|FG000|Overall Study|Adverse Event|1|||
125129607|NCT00625443|450101045|FG001|Overall Study|Adverse Event|4|||
125129608|NCT00625443|450101046|FG002|Overall Study|Adverse Event|0|||
125129609|NCT00625443|450101044|FG000|Overall Study|Non-compliance with protocol|0|||
125129610|NCT00625443|450101045|FG001|Overall Study|Non-compliance with protocol|1|||
125129611|NCT00625443|450101046|FG002|Overall Study|Non-compliance with protocol|0|||
125129612|NCT00625443|450101044|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
125129613|NCT00625443|450101045|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
125129614|NCT00625443|450101046|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
125129615|NCT00625443|450101044|FG000|Overall Study|Withdrawal by Subject|0|||
125129616|NCT00625443|450101045|FG001|Overall Study|Withdrawal by Subject|1|||
125129617|NCT00625443|450101046|FG002|Overall Study|Withdrawal by Subject|2|||
125129618|NCT00625443|450101044|FG000|Overall Study|Physician Decision|0|||
125129619|NCT00625443|450101045|FG001|Overall Study|Physician Decision|4|||
125129620|NCT00625443|450101046|FG002|Overall Study|Physician Decision|2|||
125129621|NCT00625443|450101044|FG000|Overall Study|Other|0|||
125129622|NCT00625443|450101045|FG001|Overall Study|Other|1|||
125129623|NCT00625443|450101046|FG002|Overall Study|Other|1|||
125129624|NCT02678286|450101051|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
125129625|NCT02678286|450101052|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
125129626|NCT02678286|450101051|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
125129627|NCT02678286|450101052|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
125129628|NCT02678286|450101051|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
125129629|NCT02678286|450101052|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
125129630|NCT02678286|450101051|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
125129631|NCT02678286|450101052|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
125129632|NCT02678286|450101051|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
125129633|NCT02678286|450101052|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
125129634|NCT01422538|450101055|FG000|Overall Study|Lost to Follow-up|0|||
125129635|NCT01422538|450101056|FG001|Overall Study|Lost to Follow-up|1|||
125129636|NCT01422538|450101057|FG002|Overall Study|Lost to Follow-up|1|||
125129637|NCT01422538|450101055|FG000|Overall Study|Missed visit|0|||
125129638|NCT01422538|450101056|FG001|Overall Study|Missed visit|1|||
125129639|NCT01422538|450101057|FG002|Overall Study|Missed visit|1|||
125129640|NCT01270503|450101058|FG000|Overall Study|Lost to Follow-up|1|||
125129641|NCT02481830|450101062|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
125129642|NCT02481830|450101063|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
125129643|NCT02481830|450101062|FG000|Pre-treatment|Withdrawal by Subject|0|||
125129644|NCT02481830|450101063|FG001|Pre-treatment|Withdrawal by Subject|10|||
125129645|NCT02481830|450101062|FG000|Pre-treatment|Disease Progression|1|||
125129646|NCT02481830|450101063|FG001|Pre-treatment|Disease Progression|1|||
125129647|NCT02481830|450101062|FG000|Pre-treatment|Other reasons|0|||
125129648|NCT02481830|450101063|FG001|Pre-treatment|Other reasons|1|||
125129649|NCT02481830|450101062|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
125129650|NCT02481830|450101063|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
125129651|NCT02481830|450101062|FG000|Treatment|Disease Progression|233|||
125129652|NCT02481830|450101063|FG001|Treatment|Disease Progression|171|||
125129653|NCT02481830|450101062|FG000|Treatment|Study drug toxicity|18|||
125129654|NCT02481830|450101063|FG001|Treatment|Study drug toxicity|38|||
125129655|NCT02481830|450101062|FG000|Treatment|Death|1|||
125129656|NCT02481830|450101063|FG001|Treatment|Death|1|||
125129657|NCT02481830|450101062|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
125129658|NCT02481830|450101063|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
125129659|NCT02481830|450101062|FG000|Treatment|Participants request to discontinue Study treatment|6|||
125129660|NCT02481830|450101063|FG001|Treatment|Participants request to discontinue Study treatment|34|||
125129661|NCT02481830|450101062|FG000|Treatment|Withdrawal by Subject|2|||
125129662|NCT02481830|450101063|FG001|Treatment|Withdrawal by Subject|3|||
125129663|NCT02481830|450101062|FG000|Treatment|Lost to Follow-up|1|||
125436491|NCT00675506|451224413|FG000|Overall Study|Elevated fasting glucose|2|||
125632423|NCT04338321|451937226|FG000|Overall Study|Lost to Follow-up|4|||
125632424|NCT04338321|451937227|FG001|Overall Study|Lost to Follow-up|9|||
125632425|NCT04338321|451937226|FG000|Overall Study|Withdrawal by Subject|45|||
125632426|NCT04338321|451937227|FG001|Overall Study|Withdrawal by Subject|69|||
125376744|NCT01327885|451010161|FG001|Overall Study|Subject choice|10|||
125376745|NCT01327885|451010160|FG000|Overall Study|Other|8|||
125376746|NCT01327885|451010161|FG001|Overall Study|Other|6|||
125376747|NCT01327885|451010160|FG000|Overall Study|Withdrawal of consent from study|3|||
125376748|NCT01327885|451010161|FG001|Overall Study|Withdrawal of consent from study|4|||
125376749|NCT01327885|451010160|FG000|Overall Study|Not treated|1|||
125376750|NCT01327885|451010161|FG001|Overall Study|Not treated|1|||
125376751|NCT01327885|451010160|FG000|Overall Study|Administrative decision|0|||
125376752|NCT01327885|451010161|FG001|Overall Study|Administrative decision|1|||
125376753|NCT00085631|451010164|FG000|Overall Study|Missing Data|4|||
125376754|NCT00085631|451010165|FG001|Overall Study|Missing Data|11|||
125376755|NCT00085631|451010166|FG002|Overall Study|Missing Data|7|||
125376756|NCT01349790|451010167|FG000|Overall Study|Investigator Judgement|3|||
125376757|NCT01349790|451010167|FG000|Overall Study|Death|2|||
125376758|NCT01349790|451010167|FG000|Overall Study|Withdrawal by Patient|2|||
125376759|NCT01349790|451010167|FG000|Overall Study|Adverse Event|1|||
125376760|NCT01349790|451010167|FG000|Overall Study|Lost to Follow-up|1|||
125376761|NCT02085785|451010170|FG000|Overall Study|Withdrawal by Subject|2|||
125376762|NCT02085785|451010171|FG001|Overall Study|Withdrawal by Subject|1|||
125376763|NCT02085785|451010170|FG000|Overall Study|Lost to Follow-up|0|||
125376764|NCT02085785|451010171|FG001|Overall Study|Lost to Follow-up|1|||
125376765|NCT02692703|451010172|FG000|Overall Study|Lost to Follow-up|1|||
125376766|NCT02692703|451010172|FG000|Overall Study|Other|1|||
125376767|NCT00885105|451010173|FG000|Overall Study|Withdrawal by Subject|0|||
125376768|NCT00885105|451010174|FG001|Overall Study|Withdrawal by Subject|8|||
125376769|NCT00885105|451010173|FG000|Overall Study|Adverse Event|1|||
125376770|NCT00885105|451010174|FG001|Overall Study|Adverse Event|0|||
125376771|NCT00885105|451010173|FG000|Overall Study|Protocol Violation|0|||
125376772|NCT00885105|451010174|FG001|Overall Study|Protocol Violation|2|||
125376773|NCT03519932|451010175|FG000|First Intervention|Adverse Event|1|||
125376774|NCT03519932|451010176|FG001|First Intervention|Adverse Event|3|||
125376775|NCT00284050|451010177|FG000|Overall Study|Adverse Event|1|||
125376776|NCT00284050|451010178|FG001|Overall Study|Adverse Event|1|||
125376777|NCT00284050|451010179|FG002|Overall Study|Adverse Event|1|||
125376778|NCT00284050|451010177|FG000|Overall Study|Lack of Efficacy|0|||
125376779|NCT00284050|451010178|FG001|Overall Study|Lack of Efficacy|1|||
125376780|NCT00284050|451010179|FG002|Overall Study|Lack of Efficacy|3|||
125376781|NCT00284050|451010177|FG000|Overall Study|Protocol Violation|0|||
125376782|NCT00284050|451010178|FG001|Overall Study|Protocol Violation|1|||
125376783|NCT00284050|451010179|FG002|Overall Study|Protocol Violation|2|||
125376784|NCT00284050|451010177|FG000|Overall Study|Withdrawal by Subject|2|||
125376785|NCT00284050|451010178|FG001|Overall Study|Withdrawal by Subject|2|||
125376786|NCT00284050|451010179|FG002|Overall Study|Withdrawal by Subject|2|||
125376787|NCT00284050|451010177|FG000|Overall Study|Lost to Follow-up|1|||
125376788|NCT00284050|451010178|FG001|Overall Study|Lost to Follow-up|0|||
125376789|NCT00284050|451010179|FG002|Overall Study|Lost to Follow-up|1|||
125376790|NCT00284050|451010177|FG000|Overall Study|Death|1|||
125376791|NCT00284050|451010178|FG001|Overall Study|Death|0|||
125376792|NCT00284050|451010179|FG002|Overall Study|Death|0|||
125376793|NCT02573350|451010182|FG000|Overall Study|Lost to Follow-up|2|||
125376794|NCT02573350|451010183|FG001|Overall Study|Lost to Follow-up|1|||
125376795|NCT02573350|451010182|FG000|Overall Study|Adverse Event|3|||
125376796|NCT02573350|451010183|FG001|Overall Study|Adverse Event|4|||
125376797|NCT02573350|451010182|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
125376798|NCT02573350|451010183|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
125376799|NCT02573350|451010182|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
125376800|NCT02573350|451010183|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
125376801|NCT02573350|451010182|FG000|Overall Study|Subject withdrew consent to participate|6|||
125129664|NCT02481830|450101063|FG001|Treatment|Lost to Follow-up|0|||
125129665|NCT02481830|450101062|FG000|Treatment|Maximum Clinical Benefit|0|||
125129666|NCT02481830|450101063|FG001|Treatment|Maximum Clinical Benefit|5|||
125129667|NCT02481830|450101062|FG000|Treatment|Administrative reason by sponsor|1|||
125129668|NCT02481830|450101063|FG001|Treatment|Administrative reason by sponsor|1|||
125129669|NCT02481830|450101062|FG000|Treatment|Other reasons|6|||
125376802|NCT02573350|451010183|FG001|Overall Study|Subject withdrew consent to participate|1|||
125376803|NCT02573350|451010182|FG000|Overall Study|Protocol Deviation|1|||
125376804|NCT02573350|451010183|FG001|Overall Study|Protocol Deviation|1|||
125376805|NCT02708121|451010186|FG000|Overall Study|Withdrawn by Study Team|1|||
125376806|NCT02708121|451010187|FG001|Overall Study|Withdrawn by Study Team|1|||
125376807|NCT02708121|451010186|FG000|Overall Study|Withdrawal by Subject|0|||
125376808|NCT02708121|451010187|FG001|Overall Study|Withdrawal by Subject|4|||
125376809|NCT01833520|451010190|FG000|Overall Study|Lack of Efficacy|3|||
125376810|NCT01833520|451010191|FG001|Overall Study|Lack of Efficacy|3|||
125376811|NCT01833520|451010192|FG002|Overall Study|Lack of Efficacy|8|||
125376812|NCT01833520|451010193|FG003|Overall Study|Lack of Efficacy|3|||
125376813|NCT02743520|451010194|FG000|Overall Study|Withdrawal by Subject|1|||
125376814|NCT01749514|451010195|FG000|Overall Study|Lost to Follow-up|0|||
125376815|NCT01749514|451010196|FG001|Overall Study|Lost to Follow-up|0|||
125376816|NCT01749514|451010197|FG002|Overall Study|Lost to Follow-up|0|||
125376817|NCT01749514|451010198|FG003|Overall Study|Lost to Follow-up|0|||
125376818|NCT01749514|451010199|FG004|Overall Study|Lost to Follow-up|0|||
125376819|NCT01749514|451010200|FG005|Overall Study|Lost to Follow-up|0|||
125376820|NCT01749514|451010201|FG006|Overall Study|Lost to Follow-up|0|||
125376821|NCT01749514|451010202|FG007|Overall Study|Lost to Follow-up|1|||
125376822|NCT01749514|451010195|FG000|Overall Study|Withdrawal by Subject|0|||
125376823|NCT01749514|451010196|FG001|Overall Study|Withdrawal by Subject|0|||
125376824|NCT01749514|451010197|FG002|Overall Study|Withdrawal by Subject|0|||
125376825|NCT01749514|451010198|FG003|Overall Study|Withdrawal by Subject|0|||
125376826|NCT01749514|451010199|FG004|Overall Study|Withdrawal by Subject|0|||
125376827|NCT01749514|451010200|FG005|Overall Study|Withdrawal by Subject|1|||
125376828|NCT01749514|451010201|FG006|Overall Study|Withdrawal by Subject|0|||
125376829|NCT01749514|451010202|FG007|Overall Study|Withdrawal by Subject|1|||
125376830|NCT01749514|451010195|FG000|Overall Study|Not Reported|0|||
125376831|NCT01749514|451010196|FG001|Overall Study|Not Reported|0|||
125376832|NCT01749514|451010197|FG002|Overall Study|Not Reported|0|||
125376833|NCT01749514|451010198|FG003|Overall Study|Not Reported|0|||
125376834|NCT01749514|451010199|FG004|Overall Study|Not Reported|0|||
125376835|NCT01749514|451010200|FG005|Overall Study|Not Reported|0|||
125376836|NCT01749514|451010201|FG006|Overall Study|Not Reported|0|||
125376837|NCT01749514|451010202|FG007|Overall Study|Not Reported|5|||
125376838|NCT01979016|451010203|FG000|Overall Study|Withdrawal by Subject|2|||
125376839|NCT01979016|451010204|FG001|Overall Study|Withdrawal by Subject|0|||
125376840|NCT01979016|451010203|FG000|Overall Study|Adverse Event|0|||
125376841|NCT01979016|451010204|FG001|Overall Study|Adverse Event|1|||
125376842|NCT04983264|451010206|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
125376843|NCT04983264|451010207|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
125376844|NCT04983264|451010208|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
125376845|NCT04983264|451010206|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
125376846|NCT04983264|451010207|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
125376847|NCT04983264|451010208|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
125376848|NCT00938639|451010209|FG000|Overall Study|Moved away from study area|0|||
125129670|NCT02481830|450101063|FG001|Treatment|Other reasons|1|||
125376849|NCT00938639|451010210|FG001|Overall Study|Moved away from study area|1|||
125376850|NCT00938639|451010209|FG000|Overall Study|Lost to Follow-up|1|||
125436492|NCT00675506|451224414|FG001|Overall Study|Elevated fasting glucose|1|||
125376851|NCT00938639|451010210|FG001|Overall Study|Lost to Follow-up|2|||
125632427|NCT04338321|451937226|FG000|Overall Study|Physician Decision|5|||
125632428|NCT04338321|451937227|FG001|Overall Study|Physician Decision|9|||
125632429|NCT04338321|451937226|FG000|Overall Study|Other|3|||
125632430|NCT04338321|451937227|FG001|Overall Study|Other|10|||
125632431|NCT03107793|451937228|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
125632432|NCT03107793|451937229|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
125632433|NCT03107793|451937230|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
125632434|NCT03107793|451937231|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
125632435|NCT03107793|451937232|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
125632436|NCT03107793|451937228|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
125632437|NCT03107793|451937229|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
125632438|NCT03107793|451937230|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
125632439|NCT03107793|451937231|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
125632440|NCT03107793|451937232|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
125632441|NCT03107793|451937228|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
125632442|NCT03107793|451937229|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
125632443|NCT03107793|451937230|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
125632444|NCT03107793|451937231|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
125632445|NCT03107793|451937232|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
125632446|NCT03107793|451937228|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
125632447|NCT03107793|451937229|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125632448|NCT03107793|451937230|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125632449|NCT03107793|451937231|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125632450|NCT03107793|451937232|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125632451|NCT03107793|451937228|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125632452|NCT03107793|451937229|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
125632453|NCT03107793|451937230|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
125632454|NCT03107793|451937231|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125632455|NCT03107793|451937232|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125632456|NCT03107793|451937228|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
125632457|NCT03107793|451937229|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
125632458|NCT03107793|451937230|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
125632459|NCT03107793|451937231|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
125632460|NCT03107793|451937232|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
125632461|NCT03107793|451937228|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
125632462|NCT03107793|451937229|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
125632463|NCT03107793|451937230|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
125632464|NCT03107793|451937231|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
125632465|NCT03107793|451937232|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
125632466|NCT03107793|451937228|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125632467|NCT03107793|451937229|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
125632468|NCT03107793|451937230|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
125632469|NCT03107793|451937231|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125632470|NCT03107793|451937232|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125632471|NCT03107793|451937228|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
125632472|NCT03107793|451937229|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
125632473|NCT03107793|451937230|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
125632474|NCT03107793|451937231|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
125632475|NCT03107793|451937232|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
125632476|NCT03107793|451937228|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
125632477|NCT03107793|451937229|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
125632478|NCT03107793|451937230|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
125632479|NCT03107793|451937231|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
125632480|NCT03107793|451937232|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
125632481|NCT03107793|451937228|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125632482|NCT03107793|451937229|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
125632483|NCT03107793|451937230|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125632484|NCT03107793|451937231|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125632485|NCT03107793|451937232|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125632486|NCT03107793|451937228|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
125632487|NCT03107793|451937229|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
125632488|NCT03107793|451937230|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
125632489|NCT03107793|451937231|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
125632490|NCT03107793|451937232|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
125632491|NCT03107793|451937228|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
125632492|NCT03107793|451937229|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
125632493|NCT03107793|451937230|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
125632494|NCT03107793|451937231|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
125216103|NCT05052697|450417540|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216104|NCT05052697|450417541|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216105|NCT05052697|450417542|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216106|NCT05052697|450417543|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216107|NCT05052697|450417544|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216108|NCT05052697|450417545|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216109|NCT05052697|450417546|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216110|NCT05052697|450417547|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216111|NCT05052697|450417548|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
125216112|NCT05052697|450417549|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216113|NCT05052697|450417550|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
125216114|NCT05052697|450417551|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
125216115|NCT05052697|450417552|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
125216116|NCT05052697|450417553|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
125216117|NCT05052697|450417520|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216118|NCT05052697|450417521|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216119|NCT05052697|450417522|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216120|NCT05052697|450417523|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216121|NCT05052697|450417524|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216122|NCT05052697|450417525|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216123|NCT05052697|450417526|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216124|NCT05052697|450417527|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216125|NCT05052697|450417528|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216126|NCT05052697|450417529|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216127|NCT05052697|450417530|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125632495|NCT03107793|451937232|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
125632496|NCT03107793|451937228|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
125632497|NCT03107793|451937229|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
125632498|NCT03107793|451937230|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
125632499|NCT03107793|451937231|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
125632500|NCT03107793|451937232|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
125632501|NCT03107793|451937228|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
125632502|NCT03107793|451937229|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
125632503|NCT03107793|451937230|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
125632504|NCT03107793|451937231|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
125632505|NCT03107793|451937232|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
125632506|NCT03107793|451937228|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
125632507|NCT03107793|451937229|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
125632508|NCT03107793|451937230|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
125632509|NCT03107793|451937231|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
125632510|NCT03107793|451937232|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
125632511|NCT03107793|451937228|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
125632512|NCT03107793|451937229|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
125632513|NCT03107793|451937230|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
125632514|NCT03107793|451937231|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
125632515|NCT03107793|451937232|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
125632516|NCT03107793|451937228|FG000|Extension Period (Week 48- Week 104)|Death|0|||
125632517|NCT03107793|451937229|FG001|Extension Period (Week 48- Week 104)|Death|0|||
125632518|NCT03107793|451937230|FG002|Extension Period (Week 48- Week 104)|Death|0|||
125632519|NCT03107793|451937231|FG003|Extension Period (Week 48- Week 104)|Death|0|||
125632520|NCT03107793|451937232|FG004|Extension Period (Week 48- Week 104)|Death|1|||
125632521|NCT03107793|451937228|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
125632522|NCT03107793|451937229|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
125632523|NCT03107793|451937230|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
125632524|NCT03107793|451937231|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
125632525|NCT03107793|451937232|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
125632526|NCT03107793|451937228|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
125632527|NCT03107793|451937229|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
125632528|NCT03107793|451937230|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
125632529|NCT03107793|451937231|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
125632530|NCT03107793|451937232|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
125632531|NCT03107793|451937228|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
125216128|NCT05052697|450417531|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216129|NCT05052697|450417532|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216130|NCT05052697|450417533|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125376852|NCT00938639|451010209|FG000|Overall Study|Family issues|1|||
125129671|NCT04627038|450101064|FG000|Overall Study|Adverse Event|36|||
125129672|NCT04627038|450101065|FG001|Overall Study|Adverse Event|8|||
125129673|NCT04627038|450101064|FG000|Overall Study|Lost to Follow-up|1|||
125129674|NCT04627038|450101065|FG001|Overall Study|Lost to Follow-up|0|||
125129675|NCT04627038|450101064|FG000|Overall Study|Physician Decision|0|||
125129676|NCT04627038|450101065|FG001|Overall Study|Physician Decision|1|||
125129677|NCT04627038|450101064|FG000|Overall Study|Protocol Violation|3|||
125129678|NCT04627038|450101065|FG001|Overall Study|Protocol Violation|1|||
125129679|NCT04627038|450101064|FG000|Overall Study|Withdrawal by Subject|13|||
125129680|NCT04627038|450101065|FG001|Overall Study|Withdrawal by Subject|3|||
125129681|NCT04627038|450101064|FG000|Overall Study|Non-compliance with study drug|0|||
125376853|NCT00938639|451010210|FG001|Overall Study|Family issues|1|||
125632532|NCT03107793|451937229|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
125632533|NCT03107793|451937230|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
125632534|NCT03107793|451937231|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
125632535|NCT03107793|451937232|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
125632536|NCT03107793|451937228|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
125632537|NCT03107793|451937229|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
125632538|NCT03107793|451937230|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
125632539|NCT03107793|451937231|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
125632540|NCT03107793|451937232|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
125632541|NCT03107793|451937228|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
125632542|NCT03107793|451937229|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
125632543|NCT03107793|451937230|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
125632544|NCT03107793|451937231|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
125632545|NCT03107793|451937232|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
125632546|NCT03107793|451937228|FG000|Extension Period (Week 48- Week 104)|Other|0|||
125632547|NCT03107793|451937229|FG001|Extension Period (Week 48- Week 104)|Other|0|||
125632548|NCT03107793|451937230|FG002|Extension Period (Week 48- Week 104)|Other|0|||
125632549|NCT03107793|451937231|FG003|Extension Period (Week 48- Week 104)|Other|1|||
125632550|NCT03107793|451937232|FG004|Extension Period (Week 48- Week 104)|Other|3|||
125632551|NCT03107793|451937228|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
125632552|NCT03107793|451937229|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
125632553|NCT03107793|451937230|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
125632554|NCT03107793|451937231|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
125632555|NCT03107793|451937232|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
125632556|NCT01989572|451937236|FG000|Overall Study|Lack of Efficacy|35|||
125632557|NCT01989572|451937237|FG001|Overall Study|Lack of Efficacy|48|||
125632558|NCT01989572|451937238|FG002|Overall Study|Lack of Efficacy|48|||
125632559|NCT01989572|451937239|FG003|Overall Study|Lack of Efficacy|43|||
125632560|NCT01989572|451937240|FG004|Overall Study|Lack of Efficacy|71|||
125632561|NCT01989572|451937241|FG005|Overall Study|Lack of Efficacy|79|||
125632562|NCT01989572|451937236|FG000|Overall Study|Adverse Event|2|||
125632563|NCT01989572|451937237|FG001|Overall Study|Adverse Event|1|||
125632564|NCT01989572|451937238|FG002|Overall Study|Adverse Event|3|||
125632565|NCT01989572|451937239|FG003|Overall Study|Adverse Event|0|||
125632566|NCT01989572|451937240|FG004|Overall Study|Adverse Event|3|||
125632567|NCT01989572|451937241|FG005|Overall Study|Adverse Event|0|||
125632568|NCT01989572|451937236|FG000|Overall Study|Death|0|||
125632569|NCT01989572|451937237|FG001|Overall Study|Death|0|||
125632570|NCT01989572|451937238|FG002|Overall Study|Death|0|||
125632571|NCT01989572|451937239|FG003|Overall Study|Death|0|||
125632572|NCT01989572|451937240|FG004|Overall Study|Death|1|||
125632573|NCT01989572|451937241|FG005|Overall Study|Death|0|||
125632574|NCT01989572|451937236|FG000|Overall Study|Withdrawal by Subject|4|||
125632575|NCT01989572|451937237|FG001|Overall Study|Withdrawal by Subject|1|||
125632576|NCT01989572|451937238|FG002|Overall Study|Withdrawal by Subject|5|||
125632577|NCT01989572|451937239|FG003|Overall Study|Withdrawal by Subject|1|||
125632578|NCT01989572|451937240|FG004|Overall Study|Withdrawal by Subject|12|||
125632579|NCT01989572|451937241|FG005|Overall Study|Withdrawal by Subject|4|||
125632580|NCT01989572|451937236|FG000|Overall Study|complicating disease|1|||
125632581|NCT01989572|451937237|FG001|Overall Study|complicating disease|1|||
125632582|NCT01989572|451937238|FG002|Overall Study|complicating disease|2|||
125632583|NCT01989572|451937239|FG003|Overall Study|complicating disease|0|||
125129682|NCT04627038|450101065|FG001|Overall Study|Non-compliance with study drug|1|||
125129683|NCT04627038|450101064|FG000|Overall Study|Prohibited Concomitant Medication|1|||
125129684|NCT04627038|450101065|FG001|Overall Study|Prohibited Concomitant Medication|0|||
125129685|NCT03956862|450101070|FG000|Overall Study|Lost to Follow-up|1|||
125632584|NCT01989572|451937240|FG004|Overall Study|complicating disease|1|||
125632585|NCT01989572|451937241|FG005|Overall Study|complicating disease|0|||
125632586|NCT01989572|451937236|FG000|Overall Study|error|2|||
125632587|NCT01989572|451937237|FG001|Overall Study|error|1|||
125632588|NCT01989572|451937238|FG002|Overall Study|error|1|||
125632589|NCT01989572|451937239|FG003|Overall Study|error|1|||
125632590|NCT01989572|451937240|FG004|Overall Study|error|1|||
125632591|NCT01989572|451937241|FG005|Overall Study|error|1|||
125632592|NCT01989572|451937236|FG000|Overall Study|maximum dose reached|0|||
125632593|NCT01989572|451937237|FG001|Overall Study|maximum dose reached|1|||
125632594|NCT01989572|451937238|FG002|Overall Study|maximum dose reached|0|||
125632595|NCT01989572|451937239|FG003|Overall Study|maximum dose reached|0|||
125632596|NCT01989572|451937240|FG004|Overall Study|maximum dose reached|1|||
125632597|NCT01989572|451937241|FG005|Overall Study|maximum dose reached|0|||
125632598|NCT01989572|451937236|FG000|Overall Study|unknown/not specify|3|||
125632599|NCT01989572|451937237|FG001|Overall Study|unknown/not specify|4|||
125632600|NCT01989572|451937238|FG002|Overall Study|unknown/not specify|1|||
125632601|NCT01989572|451937239|FG003|Overall Study|unknown/not specify|3|||
125632602|NCT01989572|451937240|FG004|Overall Study|unknown/not specify|3|||
125632603|NCT01989572|451937241|FG005|Overall Study|unknown/not specify|5|||
125632604|NCT01989572|451937236|FG000|Overall Study|not start protocol therapy|5|||
125632605|NCT01989572|451937237|FG001|Overall Study|not start protocol therapy|1|||
125632606|NCT01989572|451937238|FG002|Overall Study|not start protocol therapy|2|||
125632607|NCT01989572|451937239|FG003|Overall Study|not start protocol therapy|3|||
125632608|NCT01989572|451937240|FG004|Overall Study|not start protocol therapy|4|||
125632609|NCT01989572|451937241|FG005|Overall Study|not start protocol therapy|18|||
125632610|NCT01989572|451937236|FG000|Overall Study|alternative therapy|3|||
125632611|NCT01989572|451937237|FG001|Overall Study|alternative therapy|0|||
125632612|NCT01989572|451937238|FG002|Overall Study|alternative therapy|0|||
125632613|NCT01989572|451937239|FG003|Overall Study|alternative therapy|0|||
125632614|NCT01989572|451937240|FG004|Overall Study|alternative therapy|1|||
125632615|NCT01989572|451937241|FG005|Overall Study|alternative therapy|3|||
125632616|NCT00865046|451937242|FG000|Overall Study|Lost to Follow-up|1|||
125632617|NCT00865046|451937243|FG001|Overall Study|Lost to Follow-up|4|||
125632618|NCT00865046|451937244|FG002|Overall Study|Lost to Follow-up|0|||
125632619|NCT00865046|451937242|FG000|Overall Study|Death|0|||
125632620|NCT00865046|451937243|FG001|Overall Study|Death|1|||
125632621|NCT00865046|451937244|FG002|Overall Study|Death|1|||
125632622|NCT00865046|451937242|FG000|Overall Study|Withdrawal by Subject|5|||
125632623|NCT00865046|451937243|FG001|Overall Study|Withdrawal by Subject|0|||
125632624|NCT00865046|451937244|FG002|Overall Study|Withdrawal by Subject|0|||
125632625|NCT01024920|451937247|FG000|Overall Study|Progressive disease|47|||
125632626|NCT01024920|451937248|FG001|Overall Study|Progressive disease|25|||
125632627|NCT01024920|451937247|FG000|Overall Study|Adverse Event|8|||
125632628|NCT01024920|451937248|FG001|Overall Study|Adverse Event|4|||
125632629|NCT01024920|451937247|FG000|Overall Study|Lost to Follow-up|0|||
125632630|NCT01024920|451937248|FG001|Overall Study|Lost to Follow-up|1|||
125632631|NCT01024920|451937247|FG000|Overall Study|Patient refusal to continue|4|||
125632632|NCT01024920|451937248|FG001|Overall Study|Patient refusal to continue|0|||
125632633|NCT01024920|451937247|FG000|Overall Study|Other than listed|5|||
125632634|NCT01024920|451937248|FG001|Overall Study|Other than listed|1|||
125632635|NCT01024920|451937247|FG000|Overall Study|Not treated|3|||
125632636|NCT01024920|451937248|FG001|Overall Study|Not treated|0|||
125632637|NCT01024920|451937247|FG000|Overall Study|Protocol Violation|0|||
125632638|NCT01024920|451937248|FG001|Overall Study|Protocol Violation|1|||
125632639|NCT02977507|451937249|FG000|Overall Study|Protocol Deviation|1|||
125216131|NCT05052697|450417534|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216132|NCT05052697|450417535|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216133|NCT05052697|450417536|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216134|NCT05052697|450417537|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216135|NCT05052697|450417538|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216136|NCT05052697|450417539|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216137|NCT05052697|450417540|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216138|NCT05052697|450417541|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216139|NCT05052697|450417542|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216140|NCT05052697|450417543|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216141|NCT05052697|450417544|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216142|NCT05052697|450417545|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216143|NCT05052697|450417546|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216144|NCT05052697|450417547|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216145|NCT05052697|450417548|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
125216146|NCT05052697|450417549|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
125216147|NCT05052697|450417550|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
125216148|NCT05052697|450417551|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
125216149|NCT05052697|450417552|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
125216150|NCT05052697|450417553|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
125216151|NCT05052697|450417520|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216152|NCT05052697|450417521|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216153|NCT05052697|450417522|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216154|NCT05052697|450417523|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216155|NCT05052697|450417524|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216156|NCT05052697|450417525|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216157|NCT05052697|450417526|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125632640|NCT02977507|451937250|FG001|Overall Study|Protocol Deviation|0|||
125632641|NCT02977507|451937249|FG000|Overall Study|Lost to Follow-up|1|||
125632642|NCT02977507|451937250|FG001|Overall Study|Lost to Follow-up|0|||
125632643|NCT00633360|451937251|FG000|Overall Study|Lost to Follow-up|1|||
125632644|NCT00633360|451937252|FG001|Overall Study|Lost to Follow-up|1|||
125632645|NCT00633360|451937251|FG000|Overall Study|Adverse Event|3|||
125632646|NCT00633360|451937252|FG001|Overall Study|Adverse Event|1|||
125632647|NCT00633360|451937251|FG000|Overall Study|Protocol Violation|0|||
125632648|NCT00633360|451937252|FG001|Overall Study|Protocol Violation|1|||
125632649|NCT00621244|451937257|FG000|Overall Study|Withdrawal by Subject|7|||
125632650|NCT00621244|451937258|FG001|Overall Study|Withdrawal by Subject|3|||
125632651|NCT00621244|451937259|FG002|Overall Study|Withdrawal by Subject|3|||
125632652|NCT00621244|451937260|FG003|Overall Study|Withdrawal by Subject|3|||
125632653|NCT00621244|451937257|FG000|Overall Study|Disease progression|44|||
125632654|NCT00621244|451937258|FG001|Overall Study|Disease progression|20|||
125632655|NCT00621244|451937259|FG002|Overall Study|Disease progression|20|||
125632656|NCT00621244|451937260|FG003|Overall Study|Disease progression|15|||
125632657|NCT00621244|451937257|FG000|Overall Study|Death|3|||
125632658|NCT00621244|451937258|FG001|Overall Study|Death|3|||
125632659|NCT00621244|451937259|FG002|Overall Study|Death|1|||
125632660|NCT00621244|451937260|FG003|Overall Study|Death|1|||
125632661|NCT00621244|451937257|FG000|Overall Study|Adverse Event|27|||
125632662|NCT00621244|451937258|FG001|Overall Study|Adverse Event|7|||
125632663|NCT00621244|451937259|FG002|Overall Study|Adverse Event|9|||
125632664|NCT00621244|451937260|FG003|Overall Study|Adverse Event|2|||
125632665|NCT00621244|451937257|FG000|Overall Study|Administrative problems|5|||
125632666|NCT00621244|451937258|FG001|Overall Study|Administrative problems|1|||
125632667|NCT00621244|451937259|FG002|Overall Study|Administrative problems|0|||
125632668|NCT00621244|451937260|FG003|Overall Study|Administrative problems|2|||
125632669|NCT04449276|451937266|FG000|Overall Study|Adverse Event|1|||
125632670|NCT04449276|451937267|FG001|Overall Study|Adverse Event|2|||
125632671|NCT04449276|451937268|FG002|Overall Study|Adverse Event|0|||
125632672|NCT04449276|451937269|FG003|Overall Study|Adverse Event|0|||
125632673|NCT04449276|451937270|FG004|Overall Study|Adverse Event|2|||
125632674|NCT04449276|451937271|FG005|Overall Study|Adverse Event|0|||
125632675|NCT04449276|451937272|FG006|Overall Study|Adverse Event|0|||
125632676|NCT04449276|451937273|FG007|Overall Study|Adverse Event|1|||
125632677|NCT04449276|451937266|FG000|Overall Study|Withdrawal by Subject|2|||
125632678|NCT04449276|451937267|FG001|Overall Study|Withdrawal by Subject|0|||
125632679|NCT04449276|451937268|FG002|Overall Study|Withdrawal by Subject|0|||
125632680|NCT04449276|451937269|FG003|Overall Study|Withdrawal by Subject|1|||
125632681|NCT04449276|451937270|FG004|Overall Study|Withdrawal by Subject|0|||
125632682|NCT04449276|451937271|FG005|Overall Study|Withdrawal by Subject|0|||
125632683|NCT04449276|451937272|FG006|Overall Study|Withdrawal by Subject|0|||
125632684|NCT04449276|451937273|FG007|Overall Study|Withdrawal by Subject|0|||
125632685|NCT04449276|451937266|FG000|Overall Study|Other|0|||
125632686|NCT04449276|451937267|FG001|Overall Study|Other|2|||
125632687|NCT04449276|451937268|FG002|Overall Study|Other|3|||
125632688|NCT04449276|451937269|FG003|Overall Study|Other|2|||
125632689|NCT04449276|451937270|FG004|Overall Study|Other|0|||
125632690|NCT04449276|451937271|FG005|Overall Study|Other|0|||
125632691|NCT04449276|451937272|FG006|Overall Study|Other|0|||
125632692|NCT04449276|451937273|FG007|Overall Study|Other|1|||
125632693|NCT01614795|451937274|FG000|Overall Study|Adverse Event|0|||
125632694|NCT01614795|451937275|FG001|Overall Study|Adverse Event|0|||
125632695|NCT01614795|451937276|FG002|Overall Study|Adverse Event|1|||
125632696|NCT01614795|451937277|FG003|Overall Study|Adverse Event|1|||
125632697|NCT01614795|451937274|FG000|Overall Study|Lack of Efficacy|10|||
125632698|NCT01614795|451937275|FG001|Overall Study|Lack of Efficacy|10|||
125632699|NCT01614795|451937276|FG002|Overall Study|Lack of Efficacy|9|||
125632700|NCT01614795|451937277|FG003|Overall Study|Lack of Efficacy|8|||
125632701|NCT01614795|451937274|FG000|Overall Study|Physician Decision|1|||
125632702|NCT01614795|451937275|FG001|Overall Study|Physician Decision|0|||
125632703|NCT01614795|451937276|FG002|Overall Study|Physician Decision|1|||
125632704|NCT01614795|451937277|FG003|Overall Study|Physician Decision|1|||
125632705|NCT01614795|451937274|FG000|Overall Study|Withdrawal by Subject|0|||
125632706|NCT01614795|451937275|FG001|Overall Study|Withdrawal by Subject|1|||
125632707|NCT01614795|451937276|FG002|Overall Study|Withdrawal by Subject|0|||
125632708|NCT01614795|451937277|FG003|Overall Study|Withdrawal by Subject|2|||
125632709|NCT01614795|451937274|FG000|Overall Study|Ineligible|0|||
125632710|NCT01614795|451937275|FG001|Overall Study|Ineligible|1|||
125632711|NCT01614795|451937276|FG002|Overall Study|Ineligible|0|||
125632712|NCT01614795|451937277|FG003|Overall Study|Ineligible|0|||
125632713|NCT00565812|451937278|FG000|Overall Study|Death|2|||
125632714|NCT00565812|451937279|FG001|Overall Study|Death|1|||
125632715|NCT00565812|451937280|FG002|Overall Study|Death|3|||
125632716|NCT00565812|451937278|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
125632717|NCT00565812|451937279|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
125632718|NCT00565812|451937280|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
125376854|NCT00938639|451010209|FG000|Overall Study|Participant noncompliance|1|||
125376855|NCT00938639|451010210|FG001|Overall Study|Participant noncompliance|0|||
125376856|NCT02547649|451010213|FG000|Overall Study|Lost to Follow-up|3|||
125376857|NCT02547649|451010214|FG001|Overall Study|Lost to Follow-up|1|||
125376858|NCT02547649|451010215|FG002|Overall Study|Lost to Follow-up|1|||
125376859|NCT02547649|451010213|FG000|Overall Study|Not vaccinated|0|||
125376860|NCT02547649|451010214|FG001|Overall Study|Not vaccinated|0|||
125376861|NCT02547649|451010215|FG002|Overall Study|Not vaccinated|1|||
125376862|NCT02547649|451010213|FG000|Overall Study|Withdrawal by Subject|0|||
125376863|NCT02547649|451010214|FG001|Overall Study|Withdrawal by Subject|4|||
125376864|NCT02547649|451010215|FG002|Overall Study|Withdrawal by Subject|2|||
125376865|NCT04326231|451010216|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
125376866|NCT02551731|451010218|FG000|Overall Study|Withdrawal by Subject|2|||
125376867|NCT01750242|451010227|FG000|Overall Study|Unreadable Images|3|||
125376868|NCT03765918|451010230|FG000|Overall Study|Death|109|||
125376869|NCT03765918|451010231|FG001|Overall Study|Death|127|||
125376870|NCT03765918|451010230|FG000|Overall Study|Lost to Follow-up|2|||
125376871|NCT03765918|451010231|FG001|Overall Study|Lost to Follow-up|3|||
125376872|NCT03765918|451010230|FG000|Overall Study|Withdrawal by Subject|12|||
125376873|NCT03765918|451010231|FG001|Overall Study|Withdrawal by Subject|16|||
125376874|NCT03765918|451010230|FG000|Overall Study|Participants Ongoing|240|||
125376875|NCT03765918|451010231|FG001|Overall Study|Participants Ongoing|205|||
125376876|NCT04202965|451010232|FG000|Overall Study|Adverse Event|3|||
125376877|NCT04202965|451010232|FG000|Overall Study|Did not meet inclusion criteria|1|||
125376878|NCT00006903|451010233|FG000|Overall Study|Still receiving treatment|0|||
125376879|NCT00006903|451010234|FG001|Overall Study|Still receiving treatment|0|||
125376880|NCT00006903|451010235|FG002|Overall Study|Still receiving treatment|1|||
125376881|NCT00006903|451010233|FG000|Overall Study|Refused further treatment|0|||
125376882|NCT00006903|451010234|FG001|Overall Study|Refused further treatment|2|||
125376883|NCT00006903|451010235|FG002|Overall Study|Refused further treatment|1|||
125376884|NCT00006903|451010233|FG000|Overall Study|Adverse Event|0|||
125376885|NCT00006903|451010234|FG001|Overall Study|Adverse Event|0|||
125376886|NCT00006903|451010235|FG002|Overall Study|Adverse Event|1|||
125376887|NCT00006903|451010233|FG000|Overall Study|Death|0|||
125376888|NCT00006903|451010234|FG001|Overall Study|Death|1|||
125376889|NCT00006903|451010235|FG002|Overall Study|Death|0|||
125376890|NCT00006903|451010233|FG000|Overall Study|Patient never treated|0|||
125376891|NCT00006903|451010234|FG001|Overall Study|Patient never treated|0|||
125376892|NCT00006903|451010235|FG002|Overall Study|Patient never treated|1|||
125376893|NCT00006903|451010233|FG000|Overall Study|Ineligible|10|||
125376894|NCT00006903|451010234|FG001|Overall Study|Ineligible|1|||
125376895|NCT00006903|451010235|FG002|Overall Study|Ineligible|2|||
125376896|NCT01484197|451010236|FG000|Treatment Period 1|Adverse Event|1|||
125376897|NCT01484197|451010237|FG001|Treatment Period 1|Adverse Event|0|||
125376898|NCT01484197|451010238|FG002|Treatment Period 1|Adverse Event|0|||
125376899|NCT01484197|451010239|FG003|Treatment Period 1|Adverse Event|0|||
125376900|NCT01484197|451010236|FG000|Treatment Period 2|Subject withdrew consent|0|||
125376901|NCT01484197|451010237|FG001|Treatment Period 2|Subject withdrew consent|0|||
125376902|NCT01484197|451010238|FG002|Treatment Period 2|Subject withdrew consent|0|||
125376903|NCT01484197|451010239|FG003|Treatment Period 2|Subject withdrew consent|1|||
125376904|NCT01366209|451010244|FG000|Overall Study|Adverse Event|6|||
125376905|NCT01366209|451010245|FG001|Overall Study|Adverse Event|7|||
125376906|NCT01366209|451010244|FG000|Overall Study|Withdrawal by Subject|4|||
125376907|NCT01366209|451010245|FG001|Overall Study|Withdrawal by Subject|4|||
125376908|NCT01366209|451010244|FG000|Overall Study|Death|12|||
125376909|NCT01366209|451010245|FG001|Overall Study|Death|19|||
125376910|NCT01366209|451010244|FG000|Overall Study|Lung transplantation|6|||
125129686|NCT03956862|450101071|FG001|Overall Study|Lost to Follow-up|1|||
125216158|NCT05052697|450417527|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216159|NCT05052697|450417528|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216160|NCT05052697|450417529|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216161|NCT05052697|450417530|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216162|NCT05052697|450417531|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216163|NCT05052697|450417532|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216164|NCT05052697|450417533|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216165|NCT05052697|450417534|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216166|NCT05052697|450417535|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216167|NCT05052697|450417536|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216168|NCT05052697|450417537|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216169|NCT05052697|450417538|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216170|NCT05052697|450417539|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216171|NCT05052697|450417540|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216172|NCT05052697|450417541|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216173|NCT05052697|450417542|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216174|NCT05052697|450417543|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216175|NCT05052697|450417544|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216176|NCT05052697|450417545|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216177|NCT05052697|450417546|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216178|NCT05052697|450417547|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216179|NCT05052697|450417548|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216180|NCT05052697|450417549|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216181|NCT05052697|450417550|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216182|NCT05052697|450417551|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216183|NCT05052697|450417552|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
125216184|NCT05052697|450417553|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
125216185|NCT05052697|450417520|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216186|NCT05052697|450417521|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216187|NCT05052697|450417522|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216188|NCT05052697|450417523|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216189|NCT05052697|450417524|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216190|NCT05052697|450417525|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216191|NCT05052697|450417526|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216192|NCT05052697|450417527|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216193|NCT05052697|450417528|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216194|NCT05052697|450417529|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125129687|NCT03956862|450101070|FG000|Overall Study|Withdrawal by Subject|1|||
125129688|NCT03956862|450101071|FG001|Overall Study|Withdrawal by Subject|1|||
125129689|NCT01363765|450101072|FG000|Overall Study|non-diagnostic|2621|||
125129690|NCT01363765|450101073|FG001|Overall Study|non-diagnostic|1124|||
125129691|NCT01363765|450101072|FG000|Overall Study|duplicate records|736|||
125129692|NCT01363765|450101073|FG001|Overall Study|duplicate records|3177|||
125129693|NCT01363765|450101072|FG000|Overall Study|non-resident|156|||
125129694|NCT01363765|450101073|FG001|Overall Study|non-resident|76|||
125129695|NCT01363765|450101072|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
125376911|NCT01366209|451010245|FG001|Overall Study|Lung transplantation|1|||
125376912|NCT01366209|451010244|FG000|Overall Study|Lost to Follow-up|2|||
125376913|NCT01366209|451010245|FG001|Overall Study|Lost to Follow-up|1|||
125376914|NCT01366209|451010244|FG000|Overall Study|Physician Decision|1|||
125129696|NCT01363765|450101073|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
125376915|NCT01366209|451010245|FG001|Overall Study|Physician Decision|0|||
125376916|NCT01366209|451010244|FG000|Overall Study|Sponsors decision|0|||
125376917|NCT01366209|451010245|FG001|Overall Study|Sponsors decision|1|||
125376918|NCT01366209|451010244|FG000|Overall Study|Withdrew consent|4|||
125376919|NCT01366209|451010245|FG001|Overall Study|Withdrew consent|3|||
125376920|NCT02670837|451010246|FG000|Overall Study|Death|2|||
125376921|NCT02670837|451010247|FG001|Overall Study|Death|0|||
125376922|NCT02670837|451010248|FG002|Overall Study|Death|0|||
125129697|NCT01363765|450101072|FG000|Overall Study|smear during intervention|2170|||
125216195|NCT05052697|450417530|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216196|NCT05052697|450417531|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216197|NCT05052697|450417532|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125129698|NCT01363765|450101073|FG001|Overall Study|smear during intervention|0|||
125129699|NCT02601560|450101076|FG000|Overall Study|Other|0|||
125129700|NCT02601560|450101077|FG001|Overall Study|Other|0|||
125129701|NCT02601560|450101078|FG002|Overall Study|Other|0|||
125129702|NCT02601560|450101079|FG003|Overall Study|Other|0|||
125129703|NCT02601560|450101080|FG004|Overall Study|Other|0|||
125129704|NCT02601560|450101081|FG005|Overall Study|Other|0|||
125216198|NCT05052697|450417533|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125376923|NCT01985867|451010249|FG000|Overall Study|Lost to Follow-up|3|||
125632719|NCT00565812|451937278|FG000|Overall Study|Lost to Follow-up|10|||
125632720|NCT00565812|451937279|FG001|Overall Study|Lost to Follow-up|8|||
125632721|NCT00565812|451937280|FG002|Overall Study|Lost to Follow-up|8|||
125632722|NCT00565812|451937278|FG000|Overall Study|Withdrawal by Subject|58|||
125632723|NCT00565812|451937279|FG001|Overall Study|Withdrawal by Subject|47|||
125632724|NCT00565812|451937280|FG002|Overall Study|Withdrawal by Subject|48|||
125632725|NCT00565812|451937278|FG000|Overall Study|Work Schedule|5|||
125632726|NCT00565812|451937279|FG001|Overall Study|Work Schedule|3|||
125632727|NCT00565812|451937280|FG002|Overall Study|Work Schedule|1|||
125632728|NCT00565812|451937278|FG000|Overall Study|Protocol Violation|2|||
125632729|NCT00565812|451937279|FG001|Overall Study|Protocol Violation|6|||
125632730|NCT00565812|451937280|FG002|Overall Study|Protocol Violation|4|||
125632731|NCT00565812|451937278|FG000|Overall Study|Adverse Event|41|||
125632732|NCT00565812|451937279|FG001|Overall Study|Adverse Event|54|||
125632733|NCT00565812|451937280|FG002|Overall Study|Adverse Event|40|||
125632734|NCT00565812|451937278|FG000|Overall Study|Jury Duty|1|||
125632735|NCT00565812|451937279|FG001|Overall Study|Jury Duty|0|||
125632736|NCT00565812|451937280|FG002|Overall Study|Jury Duty|0|||
125632737|NCT00565812|451937278|FG000|Overall Study|Relocated Out of Area|5|||
125632738|NCT00565812|451937279|FG001|Overall Study|Relocated Out of Area|8|||
125632739|NCT00565812|451937280|FG002|Overall Study|Relocated Out of Area|9|||
125632740|NCT00565812|451937278|FG000|Overall Study|Sponsor Decision|1|||
125632741|NCT00565812|451937279|FG001|Overall Study|Sponsor Decision|5|||
125632742|NCT00565812|451937280|FG002|Overall Study|Sponsor Decision|1|||
125632743|NCT00565812|451937278|FG000|Overall Study|Domestic Reasons|7|||
125632744|NCT00565812|451937279|FG001|Overall Study|Domestic Reasons|1|||
125632745|NCT00565812|451937280|FG002|Overall Study|Domestic Reasons|3|||
125632746|NCT00565812|451937278|FG000|Overall Study|Research Site Closure|6|||
125632747|NCT00565812|451937279|FG001|Overall Study|Research Site Closure|1|||
125632748|NCT00565812|451937280|FG002|Overall Study|Research Site Closure|8|||
125632749|NCT00565812|451937278|FG000|Overall Study|Surgical Intervention|0|||
125632750|NCT00565812|451937279|FG001|Overall Study|Surgical Intervention|1|||
125632751|NCT00565812|451937280|FG002|Overall Study|Surgical Intervention|2|||
125632752|NCT00565812|451937278|FG000|Overall Study|Low Compliance|1|||
125632753|NCT00565812|451937279|FG001|Overall Study|Low Compliance|0|||
125632754|NCT00565812|451937280|FG002|Overall Study|Low Compliance|1|||
125632755|NCT00565812|451937278|FG000|Overall Study|Follow-up Visit Not Completed|2|||
125632756|NCT00565812|451937279|FG001|Overall Study|Follow-up Visit Not Completed|0|||
125632757|NCT00565812|451937280|FG002|Overall Study|Follow-up Visit Not Completed|1|||
125632758|NCT00565812|451937278|FG000|Overall Study|Physician Decision|2|||
125632759|NCT00565812|451937279|FG001|Overall Study|Physician Decision|0|||
125632760|NCT00565812|451937280|FG002|Overall Study|Physician Decision|0|||
125632761|NCT04968353|451937281|FG000|Overall Study|Non-compliance|1|||
125632762|NCT04968353|451937282|FG001|Overall Study|Non-compliance|0|||
125632763|NCT04968353|451937283|FG002|Overall Study|Non-compliance|2|||
125632764|NCT04968353|451937284|FG003|Overall Study|Non-compliance|0|||
125632765|NCT00845845|451937285|FG000|Overall Study|Lost to Follow-up|0|||
125632766|NCT00845845|451937286|FG001|Overall Study|Lost to Follow-up|4|||
125632767|NCT02033850|451937291|FG000|Overall Study|Death|1|||
125632768|NCT02033850|451937292|FG001|Overall Study|Death|0|||
125632769|NCT02033850|451937291|FG000|Overall Study|unrelated medical reason|1|||
125632770|NCT02033850|451937292|FG001|Overall Study|unrelated medical reason|1|||
125632771|NCT02820038|451937293|FG000|Overall Study|Lost to Follow-up|7|||
125632772|NCT02820038|451937294|FG001|Overall Study|Lost to Follow-up|11|||
125632773|NCT02820038|451937295|FG002|Overall Study|Lost to Follow-up|2|||
125632774|NCT02820038|451937296|FG003|Overall Study|Lost to Follow-up|9|||
125632775|NCT02820038|451937293|FG000|Overall Study|Withdrawal by Subject|3|||
125632776|NCT02820038|451937294|FG001|Overall Study|Withdrawal by Subject|14|||
125632777|NCT02820038|451937295|FG002|Overall Study|Withdrawal by Subject|3|||
125632778|NCT02820038|451937296|FG003|Overall Study|Withdrawal by Subject|13|||
125632779|NCT03148795|451937299|FG000|Overall Study|Progressive Disease|1|||
125632780|NCT03209362|451937304|FG000|Overall Study|Adverse Event|0|||
125632781|NCT03209362|451937305|FG001|Overall Study|Adverse Event|1|||
125632782|NCT03209362|451937304|FG000|Overall Study|Lost to Follow-up|0|||
125632783|NCT03209362|451937305|FG001|Overall Study|Lost to Follow-up|1|||
125632784|NCT03209362|451937304|FG000|Overall Study|Withdrawal by Subject|2|||
125632785|NCT03209362|451937305|FG001|Overall Study|Withdrawal by Subject|0|||
125632786|NCT03209362|451937304|FG000|Overall Study|Other|0|||
125632787|NCT03209362|451937305|FG001|Overall Study|Other|1|||
125632788|NCT00251589|451937310|FG000|Overall Study|Adverse Event|5|||
125632789|NCT00251589|451937311|FG001|Overall Study|Adverse Event|1|||
125632790|NCT00251589|451937312|FG002|Overall Study|Adverse Event|2|||
125632791|NCT00251589|451937313|FG003|Overall Study|Adverse Event|1|||
125632792|NCT00251589|451937310|FG000|Overall Study|Withdrawal by Subject|1|||
125632793|NCT00251589|451937311|FG001|Overall Study|Withdrawal by Subject|1|||
125632794|NCT00251589|451937312|FG002|Overall Study|Withdrawal by Subject|0|||
125632795|NCT00251589|451937313|FG003|Overall Study|Withdrawal by Subject|0|||
125632796|NCT00251589|451937310|FG000|Overall Study|Discontinued due to progressive disease|9|||
125632797|NCT00251589|451937311|FG001|Overall Study|Discontinued due to progressive disease|1|||
125632798|NCT00251589|451937312|FG002|Overall Study|Discontinued due to progressive disease|0|||
125632799|NCT00251589|451937313|FG003|Overall Study|Discontinued due to progressive disease|1|||
125632800|NCT02571972|451937316|FG000|Overall Study|Protocol Violation|2|||
125632801|NCT02571972|451937316|FG000|Overall Study|Withdrawal by Subject|2|||
125632802|NCT03039192|451937317|FG000|Overall Study|Lost to Follow-up|4|||
125632803|NCT03039192|451937318|FG001|Overall Study|Lost to Follow-up|4|||
125632804|NCT03039192|451937317|FG000|Overall Study|Adverse event, serious fatal|0|||
125632805|NCT03039192|451937318|FG001|Overall Study|Adverse event, serious fatal|1|||
125632806|NCT03039192|451937317|FG000|Overall Study|Adverse event, non-fatal|0|||
125632807|NCT03039192|451937318|FG001|Overall Study|Adverse event, non-fatal|2|||
125632808|NCT03039192|451937317|FG000|Overall Study|Withdrawal by Subject|6|||
125632809|NCT03039192|451937318|FG001|Overall Study|Withdrawal by Subject|9|||
125632810|NCT03039192|451937317|FG000|Overall Study|Discontinued from treatment phase|19|||
125632811|NCT03039192|451937318|FG001|Overall Study|Discontinued from treatment phase|12|||
125632812|NCT03039192|451937317|FG000|Overall Study|Other|3|||
125632813|NCT03039192|451937318|FG001|Overall Study|Other|2|||
125632814|NCT02493868|451937319|FG000|Induction Phase: DE Participants|Adverse Event|22|||
125632815|NCT02493868|451937320|FG001|Induction Phase: DE Participants|Adverse Event|0|||
125632816|NCT02493868|451937319|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
125632817|NCT02493868|451937320|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
125632818|NCT02493868|451937319|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
125632819|NCT02493868|451937320|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
125632820|NCT02493868|451937319|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
125632821|NCT02493868|451937320|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
125632822|NCT02493868|451937319|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
125632823|NCT02493868|451937320|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
125632824|NCT02493868|451937319|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
125632825|NCT02493868|451937320|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
125632826|NCT02493868|451937319|FG000|Induction Phase: DE Participants|Other|8|||
125632827|NCT02493868|451937320|FG001|Induction Phase: DE Participants|Other|0|||
125632828|NCT02493868|451937319|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
125632829|NCT02493868|451937320|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
125632830|NCT02493868|451937319|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
125632831|NCT02493868|451937320|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
125632832|NCT02493868|451937319|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
125632833|NCT02493868|451937320|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
125632834|NCT02493868|451937319|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
125632835|NCT02493868|451937320|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
125632836|NCT02493868|451937319|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
125632837|NCT02493868|451937320|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
125632838|NCT02493868|451937319|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
125632839|NCT02493868|451937320|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
125632840|NCT02493868|451937319|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
125632841|NCT02493868|451937320|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
125632842|NCT02493868|451937319|FG000|Optimization Phase: DE+TE Participants|Other|10|||
125632843|NCT02493868|451937320|FG001|Optimization Phase: DE+TE Participants|Other|2|||
125632844|NCT02493868|451937319|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
125632845|NCT02493868|451937320|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
125632846|NCT02493868|451937319|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
125632847|NCT02493868|451937320|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
125632848|NCT02493868|451937319|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
125632849|NCT02493868|451937320|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
125632850|NCT02493868|451937319|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
125632851|NCT02493868|451937320|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
125632852|NCT02493868|451937319|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
125632853|NCT02493868|451937320|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
125632854|NCT02493868|451937319|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
125632855|NCT02493868|451937320|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
125632856|NCT02493868|451937319|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
125632857|NCT02493868|451937320|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
125632858|NCT02493868|451937319|FG000|Follow-up Phase|Lost to Follow-up|1|||
125632859|NCT02493868|451937320|FG001|Follow-up Phase|Lost to Follow-up|0|||
125632860|NCT02493868|451937319|FG000|Follow-up Phase|Withdrawal by Subject|3|||
125632861|NCT02493868|451937320|FG001|Follow-up Phase|Withdrawal by Subject|0|||
125632862|NCT02493868|451937319|FG000|Follow-up Phase|Investigator Decision|5|||
125632863|NCT02493868|451937320|FG001|Follow-up Phase|Investigator Decision|1|||
125632864|NCT02493868|451937319|FG000|Follow-up Phase|Other|2|||
125632865|NCT02493868|451937320|FG001|Follow-up Phase|Other|1|||
125632866|NCT02407236|451937321|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
125632867|NCT02407236|451937322|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
125632868|NCT02407236|451937323|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
125632869|NCT02407236|451937324|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
125632870|NCT02407236|451937325|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
125632871|NCT02407236|451937326|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
125632872|NCT02407236|451937327|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
125632873|NCT02407236|451937328|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
125632874|NCT02407236|451937329|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
125632875|NCT02407236|451937330|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
125632876|NCT02407236|451937331|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
125632877|NCT02407236|451937332|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
125632878|NCT02407236|451937333|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
125632879|NCT02407236|451937321|FG000|Induction Study (8 Weeks)|Death|0|||
125632880|NCT02407236|451937322|FG001|Induction Study (8 Weeks)|Death|0|||
125632881|NCT02407236|451937323|FG002|Induction Study (8 Weeks)|Death|1|||
125632882|NCT02407236|451937324|FG003|Induction Study (8 Weeks)|Death|0|||
125632883|NCT02407236|451937325|FG004|Induction Study (8 Weeks)|Death|0|||
125632884|NCT02407236|451937326|FG005|Induction Study (8 Weeks)|Death|0|||
125632885|NCT02407236|451937327|FG006|Induction Study (8 Weeks)|Death|0|||
125632886|NCT02407236|451937328|FG007|Induction Study (8 Weeks)|Death|0|||
125632887|NCT02407236|451937329|FG008|Induction Study (8 Weeks)|Death|0|||
125632888|NCT02407236|451937330|FG009|Induction Study (8 Weeks)|Death|0|||
125632889|NCT02407236|451937331|FG010|Induction Study (8 Weeks)|Death|0|||
125632890|NCT02407236|451937332|FG011|Induction Study (8 Weeks)|Death|0|||
125632891|NCT02407236|451937333|FG012|Induction Study (8 Weeks)|Death|0|||
125632892|NCT02407236|451937321|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
125632893|NCT02407236|451937322|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
125632894|NCT02407236|451937323|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
125632895|NCT02407236|451937324|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125632896|NCT02407236|451937325|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125632897|NCT02407236|451937326|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125632898|NCT02407236|451937327|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125632899|NCT02407236|451937328|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125632900|NCT02407236|451937329|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125632901|NCT02407236|451937330|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125632902|NCT02407236|451937331|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125632903|NCT02407236|451937332|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125632904|NCT02407236|451937333|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
125632905|NCT02407236|451937321|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125632906|NCT02407236|451937322|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125632907|NCT02407236|451937323|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
125632908|NCT02407236|451937324|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125632909|NCT02407236|451937325|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125632910|NCT02407236|451937326|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125632911|NCT02407236|451937327|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125632912|NCT02407236|451937328|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125632913|NCT02407236|451937329|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125632914|NCT02407236|451937330|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125632915|NCT02407236|451937331|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125632916|NCT02407236|451937332|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125632917|NCT02407236|451937333|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
125632918|NCT02407236|451937321|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
125632919|NCT02407236|451937322|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
125632920|NCT02407236|451937323|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
125632921|NCT02407236|451937324|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
125632922|NCT02407236|451937325|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
125632923|NCT02407236|451937326|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
125632924|NCT02407236|451937327|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
125376924|NCT01985867|451010250|FG001|Overall Study|Lost to Follow-up|4|||
125632925|NCT02407236|451937328|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
125632926|NCT02407236|451937329|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
125632927|NCT02407236|451937330|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
125632928|NCT02407236|451937331|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
125632929|NCT02407236|451937332|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
125632930|NCT02407236|451937333|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
125632931|NCT02407236|451937321|FG000|Induction Study (8 Weeks)|Other|2|||
125632932|NCT02407236|451937322|FG001|Induction Study (8 Weeks)|Other|1|||
125632933|NCT02407236|451937323|FG002|Induction Study (8 Weeks)|Other|5|||
125632934|NCT02407236|451937324|FG003|Induction Study (8 Weeks)|Other|0|||
125632935|NCT02407236|451937325|FG004|Induction Study (8 Weeks)|Other|0|||
125632936|NCT02407236|451937326|FG005|Induction Study (8 Weeks)|Other|0|||
125632937|NCT02407236|451937327|FG006|Induction Study (8 Weeks)|Other|0|||
125632938|NCT02407236|451937328|FG007|Induction Study (8 Weeks)|Other|0|||
125632939|NCT02407236|451937329|FG008|Induction Study (8 Weeks)|Other|0|||
125632940|NCT02407236|451937330|FG009|Induction Study (8 Weeks)|Other|0|||
125632941|NCT02407236|451937331|FG010|Induction Study (8 Weeks)|Other|0|||
125632942|NCT02407236|451937332|FG011|Induction Study (8 Weeks)|Other|0|||
125632943|NCT02407236|451937333|FG012|Induction Study (8 Weeks)|Other|0|||
125632944|NCT02407236|451937321|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
125632945|NCT02407236|451937322|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
125632946|NCT02407236|451937323|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
125632947|NCT02407236|451937324|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
125632948|NCT02407236|451937325|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
125632949|NCT02407236|451937326|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
125632950|NCT02407236|451937327|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
125632951|NCT02407236|451937328|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
125632952|NCT02407236|451937329|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
125632953|NCT02407236|451937330|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
125632954|NCT02407236|451937331|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
125632955|NCT02407236|451937332|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
125632956|NCT02407236|451937333|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
125632957|NCT02407236|451937321|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125632958|NCT02407236|451937322|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125632959|NCT02407236|451937323|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125632960|NCT02407236|451937324|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
125632961|NCT02407236|451937325|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
125632962|NCT02407236|451937326|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
125632963|NCT02407236|451937327|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
125632964|NCT02407236|451937328|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
125632965|NCT02407236|451937329|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125632966|NCT02407236|451937330|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125632967|NCT02407236|451937331|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125632968|NCT02407236|451937332|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125632969|NCT02407236|451937333|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
125632970|NCT02407236|451937321|FG000|Maintenance Study (44 Weeks)|Other|0|||
125632971|NCT02407236|451937322|FG001|Maintenance Study (44 Weeks)|Other|0|||
125632972|NCT02407236|451937323|FG002|Maintenance Study (44 Weeks)|Other|0|||
125632973|NCT02407236|451937324|FG003|Maintenance Study (44 Weeks)|Other|5|||
125632974|NCT02407236|451937325|FG004|Maintenance Study (44 Weeks)|Other|7|||
125632975|NCT02407236|451937326|FG005|Maintenance Study (44 Weeks)|Other|8|||
125632976|NCT02407236|451937327|FG006|Maintenance Study (44 Weeks)|Other|4|||
125632977|NCT02407236|451937328|FG007|Maintenance Study (44 Weeks)|Other|6|||
125632978|NCT02407236|451937329|FG008|Maintenance Study (44 Weeks)|Other|0|||
125632979|NCT02407236|451937330|FG009|Maintenance Study (44 Weeks)|Other|0|||
125632980|NCT02407236|451937331|FG010|Maintenance Study (44 Weeks)|Other|0|||
125632981|NCT02407236|451937332|FG011|Maintenance Study (44 Weeks)|Other|0|||
125632982|NCT02407236|451937333|FG012|Maintenance Study (44 Weeks)|Other|0|||
125632983|NCT02407236|451937321|FG000|Maintenance Study (44 Weeks)|Death|0|||
125632984|NCT02407236|451937322|FG001|Maintenance Study (44 Weeks)|Death|0|||
125632985|NCT02407236|451937323|FG002|Maintenance Study (44 Weeks)|Death|0|||
125632986|NCT02407236|451937324|FG003|Maintenance Study (44 Weeks)|Death|0|||
125632987|NCT02407236|451937325|FG004|Maintenance Study (44 Weeks)|Death|0|||
125632988|NCT02407236|451937326|FG005|Maintenance Study (44 Weeks)|Death|0|||
125632989|NCT02407236|451937327|FG006|Maintenance Study (44 Weeks)|Death|0|||
125632990|NCT02407236|451937328|FG007|Maintenance Study (44 Weeks)|Death|1|||
125632991|NCT02407236|451937329|FG008|Maintenance Study (44 Weeks)|Death|0|||
125632992|NCT02407236|451937330|FG009|Maintenance Study (44 Weeks)|Death|0|||
125632993|NCT02407236|451937331|FG010|Maintenance Study (44 Weeks)|Death|0|||
125632994|NCT02407236|451937332|FG011|Maintenance Study (44 Weeks)|Death|0|||
125632995|NCT02407236|451937333|FG012|Maintenance Study (44 Weeks)|Death|0|||
125632996|NCT02407236|451937321|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125632997|NCT02407236|451937322|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125632998|NCT02407236|451937323|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125632999|NCT02407236|451937324|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125633000|NCT02407236|451937325|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125633001|NCT02407236|451937326|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125633002|NCT02407236|451937327|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125633003|NCT02407236|451937328|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
125216199|NCT05052697|450417534|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216200|NCT05052697|450417535|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216201|NCT05052697|450417536|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216202|NCT05052697|450417537|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216203|NCT05052697|450417538|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216204|NCT05052697|450417539|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216205|NCT05052697|450417540|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216206|NCT05052697|450417541|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216207|NCT05052697|450417542|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216208|NCT05052697|450417543|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216209|NCT05052697|450417544|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125376925|NCT01985867|451010249|FG000|Overall Study|Adverse Event|3|||
125376926|NCT01985867|451010250|FG001|Overall Study|Adverse Event|2|||
125376927|NCT01985867|451010249|FG000|Overall Study|Lack of Efficacy|1|||
125633004|NCT02407236|451937329|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
125633005|NCT02407236|451937330|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
125633006|NCT02407236|451937331|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
125633007|NCT02407236|451937332|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
125633008|NCT02407236|451937333|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
125633009|NCT02407236|451937321|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125633010|NCT02407236|451937322|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125633011|NCT02407236|451937323|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125633012|NCT02407236|451937324|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125633013|NCT02407236|451937325|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125633014|NCT02407236|451937326|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125633015|NCT02407236|451937327|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125633016|NCT02407236|451937328|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125633017|NCT02407236|451937329|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125633018|NCT02407236|451937330|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125633019|NCT02407236|451937331|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
125633020|NCT02407236|451937332|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125633021|NCT02407236|451937333|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
125633022|NCT02407236|451937321|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125633023|NCT02407236|451937322|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125633024|NCT02407236|451937323|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125633025|NCT02407236|451937324|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125376928|NCT01985867|451010250|FG001|Overall Study|Lack of Efficacy|0|||
125376929|NCT00553514|451010253|FG000|Overall Study|Protocol deviation|0|||
125376930|NCT00553514|451010254|FG001|Overall Study|Protocol deviation|0|||
125376931|NCT00553514|451010255|FG002|Overall Study|Protocol deviation|0|||
125376932|NCT00553514|451010256|FG003|Overall Study|Protocol deviation|1|||
125376933|NCT00553514|451010257|FG004|Overall Study|Protocol deviation|0|||
125376934|NCT00553514|451010253|FG000|Overall Study|Lack of ovarian response|4|||
125376935|NCT00553514|451010254|FG001|Overall Study|Lack of ovarian response|5|||
125376936|NCT00553514|451010255|FG002|Overall Study|Lack of ovarian response|5|||
125376937|NCT00553514|451010256|FG003|Overall Study|Lack of ovarian response|5|||
125376938|NCT00553514|451010257|FG004|Overall Study|Lack of ovarian response|6|||
125376939|NCT00553514|451010253|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
125376940|NCT00553514|451010254|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
125376941|NCT00553514|451010255|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
125376942|NCT00553514|451010256|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
125376943|NCT00553514|451010257|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
125633026|NCT02407236|451937325|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125633027|NCT02407236|451937326|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125216210|NCT05052697|450417545|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216211|NCT05052697|450417546|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125376944|NCT00553514|451010253|FG000|Overall Study|Risk of multiple pregnancy|0|||
125376945|NCT00553514|451010254|FG001|Overall Study|Risk of multiple pregnancy|2|||
125376946|NCT00553514|451010255|FG002|Overall Study|Risk of multiple pregnancy|0|||
125376947|NCT00553514|451010256|FG003|Overall Study|Risk of multiple pregnancy|1|||
125376948|NCT00553514|451010257|FG004|Overall Study|Risk of multiple pregnancy|0|||
125129705|NCT02601560|450101082|FG006|Overall Study|Other|1|||
125129706|NCT02601560|450101083|FG007|Overall Study|Other|0|||
125129707|NCT03500692|450101084|FG000|Overall Study|Death|163|||
125129708|NCT03500692|450101084|FG000|Overall Study|Lost to Follow-up|75|||
125633028|NCT02407236|451937327|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125633029|NCT02407236|451937328|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
125633030|NCT02407236|451937329|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
125633031|NCT02407236|451937330|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
125633032|NCT02407236|451937331|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
125633033|NCT02407236|451937332|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
125633034|NCT02407236|451937333|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
125633035|NCT02407236|451937321|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
125633036|NCT02407236|451937322|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
125633037|NCT02407236|451937323|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
125633038|NCT02407236|451937324|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
125633039|NCT02407236|451937325|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
125633040|NCT02407236|451937326|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
125633041|NCT02407236|451937327|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
125633042|NCT02407236|451937328|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
125633043|NCT02407236|451937329|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
125633044|NCT02407236|451937330|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
125633045|NCT02407236|451937331|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
125633046|NCT02407236|451937332|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
125633047|NCT02407236|451937333|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
125633048|NCT03074318|451937334|FG000|Overall Study|Adverse Event|0|||
125633049|NCT03074318|451937335|FG001|Overall Study|Adverse Event|1|||
125633050|NCT03074318|451937336|FG002|Overall Study|Adverse Event|1|||
125633051|NCT03074318|451937337|FG003|Overall Study|Adverse Event|1|||
125633052|NCT03074318|451937334|FG000|Overall Study|Death|1|||
125633053|NCT03074318|451937335|FG001|Overall Study|Death|0|||
125633054|NCT03074318|451937336|FG002|Overall Study|Death|0|||
125633055|NCT03074318|451937337|FG003|Overall Study|Death|0|||
125633056|NCT03074318|451937334|FG000|Overall Study|Withdrawal by Subject|1|||
125633057|NCT03074318|451937335|FG001|Overall Study|Withdrawal by Subject|2|||
125633058|NCT03074318|451937336|FG002|Overall Study|Withdrawal by Subject|2|||
125633059|NCT03074318|451937337|FG003|Overall Study|Withdrawal by Subject|4|||
125633060|NCT03074318|451937334|FG000|Overall Study|Trial Closure|2|||
125633061|NCT03074318|451937335|FG001|Overall Study|Trial Closure|2|||
125633062|NCT03074318|451937336|FG002|Overall Study|Trial Closure|3|||
125633063|NCT03074318|451937337|FG003|Overall Study|Trial Closure|11|||
125633064|NCT00643448|451937340|FG000|Overall Study|Lack of Efficacy|2|||
125633065|NCT00643448|451937341|FG001|Overall Study|Lack of Efficacy|0|||
125633066|NCT00643448|451937342|FG002|Overall Study|Lack of Efficacy|4|||
125633067|NCT00643448|451937340|FG000|Overall Study|Adverse Event|2|||
125633068|NCT00643448|451937341|FG001|Overall Study|Adverse Event|2|||
125633069|NCT00643448|451937342|FG002|Overall Study|Adverse Event|2|||
125633070|NCT00643448|451937340|FG000|Overall Study|QTcF>550 ms|0|||
125633071|NCT00643448|451937341|FG001|Overall Study|QTcF>550 ms|3|||
125129709|NCT03500692|450101084|FG000|Overall Study|Termination Reasons|3|||
125129710|NCT01880593|450101085|FG000|Overall Study|Adverse Event|1|||
125129711|NCT01880593|450101086|FG001|Overall Study|Adverse Event|0|||
125129712|NCT01880593|450101085|FG000|Overall Study|Lack of Efficacy|1|||
125129713|NCT01880593|450101086|FG001|Overall Study|Lack of Efficacy|5|||
125633072|NCT00643448|451937342|FG002|Overall Study|QTcF>550 ms|0|||
125633073|NCT02177812|451937344|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
125633074|NCT02177812|451937345|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
125633075|NCT02177812|451937346|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
125633076|NCT02177812|451937347|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
125633077|NCT02177812|451937348|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
125633078|NCT02177812|451937349|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
125633079|NCT02177812|451937350|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
125633080|NCT02177812|451937351|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
125633081|NCT02177812|451937352|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
125633082|NCT02177812|451937344|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125633083|NCT02177812|451937345|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125633084|NCT02177812|451937346|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125633085|NCT02177812|451937347|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125633086|NCT02177812|451937348|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125633087|NCT02177812|451937349|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
125129714|NCT01880593|450101085|FG000|Overall Study|Withdrawal by Subject|6|||
125129715|NCT01880593|450101086|FG001|Overall Study|Withdrawal by Subject|1|||
125129716|NCT02272777|450101087|FG000|Overall Study|Adverse Event|0|||
125633088|NCT02177812|451937350|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
125633089|NCT02177812|451937351|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125633090|NCT02177812|451937352|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
125633091|NCT02177812|451937344|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
125633092|NCT02177812|451937345|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
125633093|NCT02177812|451937346|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
125633094|NCT02177812|451937347|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
125633095|NCT02177812|451937348|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
125633096|NCT02177812|451937349|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
125633097|NCT02177812|451937350|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
125633098|NCT02177812|451937351|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
125633099|NCT02177812|451937352|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
125633100|NCT00089999|451937353|FG000|Overall Study|Adverse Event|4|||
125633101|NCT00089999|451937354|FG001|Overall Study|Adverse Event|7|||
125633102|NCT00089999|451937353|FG000|Overall Study|Withdrawal by Subject|0|||
125633103|NCT00089999|451937354|FG001|Overall Study|Withdrawal by Subject|4|||
125633104|NCT00089999|451937353|FG000|Overall Study|Lost to Follow-up|2|||
125633105|NCT00089999|451937354|FG001|Overall Study|Lost to Follow-up|1|||
125633106|NCT00089999|451937353|FG000|Overall Study|Radiological Progression of Cancer|52|||
125633107|NCT00089999|451937354|FG001|Overall Study|Radiological Progression of Cancer|44|||
125633108|NCT00089999|451937353|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
125633109|NCT00089999|451937354|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
125633110|NCT00089999|451937353|FG000|Overall Study|Death|3|||
125633111|NCT00089999|451937354|FG001|Overall Study|Death|3|||
125633112|NCT00089999|451937353|FG000|Overall Study|Poor General Condition|1|||
125633113|NCT00089999|451937354|FG001|Overall Study|Poor General Condition|0|||
125633114|NCT00089999|451937353|FG000|Overall Study|Clinical Progression|1|||
125633115|NCT00089999|451937354|FG001|Overall Study|Clinical Progression|2|||
125633116|NCT00089999|451937353|FG000|Overall Study|Physician Decision|2|||
125633117|NCT00089999|451937354|FG001|Overall Study|Physician Decision|2|||
125633118|NCT00089999|451937353|FG000|Overall Study|Patient Underwent Surgery|2|||
125633119|NCT00089999|451937354|FG001|Overall Study|Patient Underwent Surgery|0|||
125633120|NCT00089999|451937353|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
125633121|NCT00089999|451937354|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
125633122|NCT01167153|451937355|FG000|Overall Study|Non-effective therapy|1|||
125633123|NCT01167153|451937356|FG001|Overall Study|Non-effective therapy|4|||
125633124|NCT01167153|451937355|FG000|Overall Study|AE including clinical laboratory AE|2|||
125633125|NCT01167153|451937356|FG001|Overall Study|AE including clinical laboratory AE|8|||
125633126|NCT01167153|451937355|FG000|Overall Study|Hypotension|1|||
125633127|NCT01167153|451937356|FG001|Overall Study|Hypotension|0|||
125633128|NCT01167153|451937355|FG000|Overall Study|Lost to Follow-up|7|||
125633129|NCT01167153|451937356|FG001|Overall Study|Lost to Follow-up|9|||
125633130|NCT01167153|451937355|FG000|Overall Study|Non-compliance to concomitant medication|0|||
125633131|NCT01167153|451937356|FG001|Overall Study|Non-compliance to concomitant medication|2|||
125633132|NCT01167153|451937355|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
125633133|NCT01167153|451937356|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
125633134|NCT01167153|451937355|FG000|Overall Study|Withdrawal consent|1|||
125633135|NCT01167153|451937356|FG001|Overall Study|Withdrawal consent|1|||
125633136|NCT01167153|451937355|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
125633137|NCT01167153|451937356|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
125633138|NCT04402385|451938967|FG000|Overall Study|Withdrawal by Subject|4|||
125633139|NCT04402385|451938968|FG001|Overall Study|Withdrawal by Subject|4|||
125633140|NCT04402385|451938967|FG000|Overall Study|Lost to Follow-up|1|||
125633141|NCT04402385|451938968|FG001|Overall Study|Lost to Follow-up|1|||
125633142|NCT04402385|451938967|FG000|Overall Study|Physician Decision|0|||
125633143|NCT04402385|451938968|FG001|Overall Study|Physician Decision|1|||
125633144|NCT01308853|451938974|FG000|Overall Study|Adverse Event|1|||
125633145|NCT01308853|451938974|FG000|Overall Study|Lost to Follow-up|2|||
125633146|NCT01308853|451938974|FG000|Overall Study|Insertion of permanent implants|1|||
125633147|NCT04984876|451938977|FG000|Overall Study|Subject decision|2|||
125633148|NCT04984876|451938978|FG001|Overall Study|Subject decision|10|||
125633149|NCT04984876|451938979|FG002|Overall Study|Subject decision|3|||
125633150|NCT04984876|451938980|FG003|Overall Study|Subject decision|3|||
125633151|NCT04984876|451938981|FG004|Overall Study|Subject decision|3|||
125129717|NCT02272777|450101088|FG001|Overall Study|Adverse Event|1|||
125129718|NCT02272777|450101087|FG000|Overall Study|Withdrawal by Subject|0|||
125633152|NCT04984876|451938982|FG005|Overall Study|Subject decision|0|||
125633153|NCT04984876|451938977|FG000|Overall Study|Guardian decision|0|||
125633154|NCT04984876|451938978|FG001|Overall Study|Guardian decision|1|||
125633155|NCT04984876|451938979|FG002|Overall Study|Guardian decision|0|||
125633156|NCT04984876|451938980|FG003|Overall Study|Guardian decision|2|||
125633157|NCT04984876|451938981|FG004|Overall Study|Guardian decision|0|||
125633158|NCT04984876|451938982|FG005|Overall Study|Guardian decision|1|||
125633159|NCT04984876|451938977|FG000|Overall Study|Lost to Follow-up|0|||
125633160|NCT04984876|451938978|FG001|Overall Study|Lost to Follow-up|0|||
125129719|NCT02272777|450101088|FG001|Overall Study|Withdrawal by Subject|3|||
125633161|NCT04984876|451938979|FG002|Overall Study|Lost to Follow-up|1|||
125633162|NCT04984876|451938980|FG003|Overall Study|Lost to Follow-up|1|||
125633163|NCT04984876|451938981|FG004|Overall Study|Lost to Follow-up|0|||
125633164|NCT04984876|451938982|FG005|Overall Study|Lost to Follow-up|0|||
125633165|NCT04984876|451938977|FG000|Overall Study|Physician Decision|1|||
125633166|NCT04984876|451938978|FG001|Overall Study|Physician Decision|0|||
125633167|NCT04984876|451938979|FG002|Overall Study|Physician Decision|0|||
125633168|NCT04984876|451938980|FG003|Overall Study|Physician Decision|1|||
125633169|NCT04984876|451938981|FG004|Overall Study|Physician Decision|0|||
125633170|NCT04984876|451938982|FG005|Overall Study|Physician Decision|0|||
125633171|NCT04984876|451938977|FG000|Overall Study|Adverse Event|0|||
125633172|NCT04984876|451938978|FG001|Overall Study|Adverse Event|0|||
125633173|NCT04984876|451938979|FG002|Overall Study|Adverse Event|1|||
125633174|NCT04984876|451938980|FG003|Overall Study|Adverse Event|0|||
125633175|NCT04984876|451938981|FG004|Overall Study|Adverse Event|0|||
125633176|NCT04984876|451938982|FG005|Overall Study|Adverse Event|0|||
125633177|NCT00209092|451938985|FG000|Overall Study|Progression of disease|7|||
125633178|NCT00209092|451938986|FG001|Overall Study|Progression of disease|1|||
125633179|NCT00209092|451938985|FG000|Overall Study|Adverse Event|0|||
125633180|NCT00209092|451938986|FG001|Overall Study|Adverse Event|1|||
125633181|NCT00209092|451938985|FG000|Overall Study|Withdrawal by Subject|1|||
125633182|NCT00209092|451938986|FG001|Overall Study|Withdrawal by Subject|0|||
125633183|NCT01462045|451938987|FG000|Overall Study|Family matter|0|||
125633184|NCT01462045|451938988|FG001|Overall Study|Family matter|1|||
125633185|NCT01462045|451938989|FG002|Overall Study|Family matter|0|||
125633186|NCT02828644|451938994|FG000|Overall Study|Lost to Follow-up|23|||
125633187|NCT02828644|451938995|FG001|Overall Study|Lost to Follow-up|22|||
125633188|NCT02436915|451938998|FG000|Overall Study|Withdrawal by Subject|0|||
125633189|NCT02436915|451938999|FG001|Overall Study|Withdrawal by Subject|1|||
125633190|NCT01117181|451939006|FG000|Overall Study|Lost to Follow-up|1|||
125633191|NCT01117181|451939007|FG001|Overall Study|Lost to Follow-up|0|||
125633192|NCT01117181|451939006|FG000|Overall Study|Withdrawal by Subject|0|||
125633193|NCT01117181|451939007|FG001|Overall Study|Withdrawal by Subject|2|||
125633194|NCT02158728|451939008|FG000|Overall Study|no procedure according to CIP done|3|||
125633195|NCT02158728|451939008|FG000|Overall Study|no qualified dataset|24|||
125633196|NCT00863317|451939009|FG000|Overall Study|Lost to Follow-up|8|||
125633197|NCT00863317|451939010|FG001|Overall Study|Lost to Follow-up|9|||
125633198|NCT03878160|451939011|FG000|Overall Study|Lost to Follow-up|1|||
125633199|NCT03878160|451939012|FG001|Overall Study|Lost to Follow-up|1|||
125633200|NCT03878160|451939013|FG002|Overall Study|Lost to Follow-up|1|||
125633201|NCT03878160|451939011|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
125633202|NCT03878160|451939012|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
125633203|NCT03878160|451939013|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
125633204|NCT00809614|451939020|FG000|Overall Study|Lack of Efficacy|2|||
125633205|NCT00809614|451939021|FG001|Overall Study|Lack of Efficacy|3|||
125633206|NCT00809614|451939020|FG000|Overall Study|Withdrawal by Subject|1|||
125633207|NCT00809614|451939021|FG001|Overall Study|Withdrawal by Subject|1|||
125633208|NCT01080625|451939022|FG000|Overall Study|Physician Decision|0|||
125633209|NCT01080625|451939023|FG001|Overall Study|Physician Decision|2|||
125633210|NCT01080625|451939024|FG002|Overall Study|Physician Decision|1|||
125633211|NCT00364832|451939028|FG000|Core Period|Early Withdrawals|2|||
125633212|NCT00364832|451939029|FG001|Core Period|Early Withdrawals|2|||
125633213|NCT00364832|451939030|FG002|Core Period|Early Withdrawals|1|||
125633214|NCT00364832|451939031|FG003|Core Period|Early Withdrawals|1|||
125633215|NCT00364832|451939032|FG004|Core Period|Early Withdrawals|0|||
125633216|NCT00364832|451939033|FG005|Core Period|Early Withdrawals|0|||
125633217|NCT00364832|451939034|FG006|Core Period|Early Withdrawals|4|||
125633218|NCT00364832|451939035|FG007|Core Period|Early Withdrawals|1|||
125633219|NCT00364832|451939036|FG008|Core Period|Early Withdrawals|0|||
125633220|NCT00364832|451939037|FG009|Core Period|Early Withdrawals|0|||
125633221|NCT00364832|451939038|FG010|Core Period|Early Withdrawals|0|||
125633222|NCT00364832|451939039|FG011|Core Period|Early Withdrawals|0|||
125633223|NCT00364832|451939028|FG000|Extension Year 1|Early Withdrawals|0|||
125633224|NCT00364832|451939029|FG001|Extension Year 1|Early Withdrawals|0|||
125633225|NCT00364832|451939030|FG002|Extension Year 1|Early Withdrawals|0|||
125633226|NCT00364832|451939031|FG003|Extension Year 1|Early Withdrawals|0|||
125633227|NCT00364832|451939032|FG004|Extension Year 1|Early Withdrawals|0|||
125129720|NCT02272777|450101087|FG000|Overall Study|Lost to Follow-up|2|||
125129721|NCT02272777|450101088|FG001|Overall Study|Lost to Follow-up|0|||
125129722|NCT02272777|450101087|FG000|Overall Study|Other|2|||
125376949|NCT00553514|451010253|FG000|Overall Study|Other|1|||
125633228|NCT00364832|451939033|FG005|Extension Year 1|Early Withdrawals|0|||
125633229|NCT00364832|451939034|FG006|Extension Year 1|Early Withdrawals|0|||
125633230|NCT00364832|451939035|FG007|Extension Year 1|Early Withdrawals|0|||
125633231|NCT00364832|451939036|FG008|Extension Year 1|Early Withdrawals|0|||
125633232|NCT00364832|451939037|FG009|Extension Year 1|Early Withdrawals|4|||
125633233|NCT00364832|451939038|FG010|Extension Year 1|Early Withdrawals|2|||
125633234|NCT00364832|451939039|FG011|Extension Year 1|Early Withdrawals|10|||
125633235|NCT00364832|451939028|FG000|Extension Year 2|Early Withdrawals|0|||
125633236|NCT00364832|451939029|FG001|Extension Year 2|Early Withdrawals|0|||
125633237|NCT00364832|451939030|FG002|Extension Year 2|Early Withdrawals|0|||
125633238|NCT00364832|451939031|FG003|Extension Year 2|Early Withdrawals|0|||
125633239|NCT00364832|451939032|FG004|Extension Year 2|Early Withdrawals|0|||
125633240|NCT00364832|451939033|FG005|Extension Year 2|Early Withdrawals|0|||
125633241|NCT00364832|451939034|FG006|Extension Year 2|Early Withdrawals|0|||
125633242|NCT00364832|451939035|FG007|Extension Year 2|Early Withdrawals|0|||
125633243|NCT00364832|451939036|FG008|Extension Year 2|Early Withdrawals|0|||
125633244|NCT00364832|451939037|FG009|Extension Year 2|Early Withdrawals|5|||
125633245|NCT00364832|451939038|FG010|Extension Year 2|Early Withdrawals|5|||
125633246|NCT00364832|451939039|FG011|Extension Year 2|Early Withdrawals|3|||
125633247|NCT02658149|451939043|FG000|Overall Study|Physician Decision|1|||
125633248|NCT02658149|451939044|FG001|Overall Study|Physician Decision|0|||
125633249|NCT01804842|451939050|FG000|Overall Study|Adverse Event|1|||
125633250|NCT01804842|451939051|FG001|Overall Study|Adverse Event|1|||
125633251|NCT01804842|451939052|FG002|Overall Study|Adverse Event|0|||
125633252|NCT01804842|451939050|FG000|Overall Study|Lost to Follow-up|1|||
125633253|NCT01804842|451939051|FG001|Overall Study|Lost to Follow-up|0|||
125633254|NCT01804842|451939052|FG002|Overall Study|Lost to Follow-up|0|||
125633255|NCT01804842|451939050|FG000|Overall Study|Non-Compliance|1|||
125633256|NCT01804842|451939051|FG001|Overall Study|Non-Compliance|1|||
125633257|NCT01804842|451939052|FG002|Overall Study|Non-Compliance|0|||
125633258|NCT01804842|451939050|FG000|Overall Study|Personal Reason|0|||
125633259|NCT01804842|451939051|FG001|Overall Study|Personal Reason|0|||
125633260|NCT01804842|451939052|FG002|Overall Study|Personal Reason|1|||
125633261|NCT01440972|451939053|FG000|Overall Study|Withdrawal by Subject|3|||
125633262|NCT01440972|451939054|FG001|Overall Study|Withdrawal by Subject|2|||
125633263|NCT03933215|451939055|FG000|Overall Study|Other|6|||
125633264|NCT03933215|451939055|FG000|Overall Study|Sponsor decision|5|||
125633265|NCT03933215|451939055|FG000|Overall Study|Protocol Violation|5|||
125633266|NCT03933215|451939055|FG000|Overall Study|Withdrawal by Subject|6|||
125633267|NCT03933215|451939055|FG000|Overall Study|Lost to Follow-up|6|||
125633268|NCT03933215|451939055|FG000|Overall Study|Enrolled but not treated|38|||
125633269|NCT04222673|451939056|FG000|Overall Study|Lost to Follow-up|5|||
125633270|NCT04097028|451939057|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
125633271|NCT04097028|451939057|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
125633272|NCT04097028|451939057|FG000|Overall Study|Disease Progression prior to Surgery|2|||
125633273|NCT04097028|451939057|FG000|Overall Study|Adverse Event prior to Surgery|1|||
125633274|NCT00735072|451939061|FG000|Overall Study|interrupted study med during ARV change|1|||
125633275|NCT00735072|451939062|FG001|Overall Study|interrupted study med during ARV change|0|||
125633276|NCT00735072|451939061|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
125633277|NCT00735072|451939062|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
125633278|NCT00911144|451939063|FG000|Overall Study|Withdrawal by Subject|16|||
125633279|NCT00911144|451939064|FG001|Overall Study|Withdrawal by Subject|5|||
125633280|NCT03981744|451939065|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
125633281|NCT03981744|451939066|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
125633282|NCT03981744|451939067|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
125633283|NCT03981744|451939068|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
125633284|NCT03981744|451939065|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
125633285|NCT03981744|451939066|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
125633286|NCT03981744|451939067|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
125633287|NCT03981744|451939068|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
125633288|NCT03981744|451939065|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
125633289|NCT03981744|451939066|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
125633290|NCT03981744|451939067|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
125633291|NCT03981744|451939068|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
125633292|NCT00732238|451939069|FG000|Overall Study|Bacteremia|4|||
125633293|NCT00732238|451939070|FG001|Overall Study|Bacteremia|1|||
125633294|NCT00732238|451939069|FG000|Overall Study|Asymptomatic bacteriuria|1|||
125633295|NCT00732238|451939070|FG001|Overall Study|Asymptomatic bacteriuria|0|||
125633296|NCT00246376|451939073|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
125129723|NCT02272777|450101088|FG001|Overall Study|Other|0|||
125129724|NCT02066922|450101089|FG000|Overall Study|Adverse Event|1|||
125129725|NCT05275205|450101090|FG000|Overall Study|Adverse Event|1|||
125129726|NCT05275205|450101091|FG001|Overall Study|Adverse Event|2|||
125129727|NCT05275205|450101090|FG000|Overall Study|Physician Decision|1|||
125633297|NCT00246376|451939074|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
125633298|NCT00246376|451939075|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
125633299|NCT00246376|451939076|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
125633300|NCT00246376|451939077|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
125633301|NCT00246376|451939073|FG000|Overall Study|Adverse Event|2|||
125633302|NCT00246376|451939074|FG001|Overall Study|Adverse Event|3|||
125633303|NCT00246376|451939075|FG002|Overall Study|Adverse Event|1|||
125633304|NCT00246376|451939076|FG003|Overall Study|Adverse Event|3|||
125633305|NCT00246376|451939077|FG004|Overall Study|Adverse Event|1|||
125633306|NCT00246376|451939073|FG000|Overall Study|Lost to Follow-up|2|||
125633307|NCT00246376|451939074|FG001|Overall Study|Lost to Follow-up|11|||
125633308|NCT00246376|451939075|FG002|Overall Study|Lost to Follow-up|11|||
125633309|NCT00246376|451939076|FG003|Overall Study|Lost to Follow-up|16|||
125633310|NCT00246376|451939077|FG004|Overall Study|Lost to Follow-up|13|||
125633311|NCT00610207|451939081|FG000|Overall Study|Lost to Follow-up|3|||
125633312|NCT02972593|451939082|FG000|Overall Study|Lost to Follow-up|19|||
125633313|NCT02972593|451939083|FG001|Overall Study|Lost to Follow-up|15|||
125633314|NCT02972593|451939082|FG000|Overall Study|Protocol Violation|1|||
125633315|NCT02972593|451939083|FG001|Overall Study|Protocol Violation|0|||
125633316|NCT00693693|451939086|FG000|Overall Study|Lost to Follow-up|1|||
125633317|NCT00693693|451939087|FG001|Overall Study|Lost to Follow-up|1|||
125633318|NCT00693693|451939088|FG002|Overall Study|Lost to Follow-up|2|||
125633319|NCT02465489|451939089|FG000|Overall Study|Adverse Event|5|||
125633320|NCT04599972|451939090|FG000|Overall Study|Withdrawal by Subject|6|||
125633321|NCT04599972|451939091|FG001|Overall Study|Withdrawal by Subject|1|||
125633322|NCT04599972|451939090|FG000|Overall Study|Adverse Event|1|||
125633323|NCT04599972|451939091|FG001|Overall Study|Adverse Event|1|||
125633324|NCT04599972|451939090|FG000|Overall Study|Lost to Follow-up|1|||
125633325|NCT04599972|451939091|FG001|Overall Study|Lost to Follow-up|6|||
125633326|NCT04599972|451939090|FG000|Overall Study|Protocol Violation|1|||
125633327|NCT04599972|451939091|FG001|Overall Study|Protocol Violation|0|||
125633328|NCT04599972|451939090|FG000|Overall Study|Other reason|1|||
125633329|NCT04599972|451939091|FG001|Overall Study|Other reason|0|||
125633330|NCT00638690|451939094|FG000|Overall Study|Death|655|||
125633331|NCT00638690|451939095|FG001|Overall Study|Death|335|||
125633332|NCT00638690|451939094|FG000|Overall Study|Withdrawal by Subject|22|||
125633333|NCT00638690|451939095|FG001|Overall Study|Withdrawal by Subject|5|||
125633334|NCT00638690|451939094|FG000|Overall Study|Lost to Follow-up|4|||
125633335|NCT00638690|451939095|FG001|Overall Study|Lost to Follow-up|2|||
125633336|NCT01347073|451939099|FG000|Overall Study|Adverse Event|1|||
125633337|NCT01347073|451939099|FG000|Overall Study|Liver Transplant|1|||
125633338|NCT00372489|451939106|FG000|Overall Study|Adverse Event|18|||
125633339|NCT00372489|451939106|FG000|Overall Study|Lack of Efficacy|1|||
125633340|NCT00372489|451939106|FG000|Overall Study|Lost to Follow-up|3|||
125633341|NCT00372489|451939106|FG000|Overall Study|Physician Decision|3|||
125633342|NCT00372489|451939106|FG000|Overall Study|Withdrawal by Subject|5|||
125633343|NCT00372489|451939106|FG000|Overall Study|Patient Relocation|2|||
125633344|NCT00372489|451939106|FG000|Overall Study|Renal transplant|6|||
125633345|NCT00372489|451939106|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
125633346|NCT00552344|451939111|FG000|Overall Study|Lack of Efficacy|55|||
125633347|NCT00552344|451939111|FG000|Overall Study|Loss of efficacy|75|||
125633348|NCT00552344|451939111|FG000|Overall Study|Lost to Follow-up|8|||
125633349|NCT00552344|451939111|FG000|Overall Study|Withdrawal by Subject|48|||
125129728|NCT05275205|450101091|FG001|Overall Study|Physician Decision|1|||
125129729|NCT05275205|450101090|FG000|Overall Study|Withdrawal by Subject|2|||
125633350|NCT00552344|451939111|FG000|Overall Study|SAE, non-fatal|6|||
125633351|NCT00552344|451939111|FG000|Overall Study|AE, non-serious non-fatal|38|||
125129730|NCT05275205|450101091|FG001|Overall Study|Withdrawal by Subject|3|||
125376950|NCT00553514|451010254|FG001|Overall Study|Other|1|||
125633352|NCT00552344|451939111|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
125633353|NCT00552344|451939111|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
125633354|NCT00552344|451939111|FG000|Overall Study|Other Reason|22|||
125633355|NCT00023712|451939112|FG000|Overall Study|Not platinum sensitive|1|||
125633356|NCT00023712|451939113|FG001|Overall Study|Not platinum sensitive|0|||
125633357|NCT00023712|451939112|FG000|Overall Study|Never treated|1|||
125633358|NCT00023712|451939113|FG001|Overall Study|Never treated|1|||
125129731|NCT05275205|450101090|FG000|Overall Study|Death|1|||
125129732|NCT05275205|450101091|FG001|Overall Study|Death|0|||
125633359|NCT01448707|451939117|FG000|Overall Study|Adverse Event|3|||
125633360|NCT01448707|451939118|FG001|Overall Study|Adverse Event|1|||
125633361|NCT01448707|451939117|FG000|Overall Study|Lost to Follow-up|2|||
125633362|NCT01448707|451939118|FG001|Overall Study|Lost to Follow-up|6|||
125633363|NCT01448707|451939117|FG000|Overall Study|Withdrawal by Subject|6|||
125633364|NCT01448707|451939118|FG001|Overall Study|Withdrawal by Subject|7|||
125633365|NCT01448707|451939117|FG000|Overall Study|Other|7|||
125376951|NCT00553514|451010255|FG002|Overall Study|Other|0|||
125633366|NCT01448707|451939118|FG001|Overall Study|Other|4|||
125633367|NCT03215667|451939120|FG000|Overall Study|Physician Decision|4|||
125633368|NCT01810380|451939121|FG000|Overall Study|Randomised not treated|2|||
125633369|NCT01810380|451939122|FG001|Overall Study|Randomised not treated|1|||
125633370|NCT01810380|451939123|FG002|Overall Study|Randomised not treated|1|||
125633371|NCT01810380|451939121|FG000|Overall Study|Adverse Event|11|||
125633372|NCT01810380|451939122|FG001|Overall Study|Adverse Event|14|||
125633373|NCT01810380|451939123|FG002|Overall Study|Adverse Event|4|||
125633374|NCT01810380|451939121|FG000|Overall Study|Lack of Efficacy|24|||
125633375|NCT01810380|451939122|FG001|Overall Study|Lack of Efficacy|10|||
125633376|NCT01810380|451939123|FG002|Overall Study|Lack of Efficacy|11|||
125633377|NCT01810380|451939121|FG000|Overall Study|Protocol Violation|1|||
125633378|NCT01810380|451939122|FG001|Overall Study|Protocol Violation|0|||
125633379|NCT01810380|451939123|FG002|Overall Study|Protocol Violation|1|||
125633380|NCT01810380|451939121|FG000|Overall Study|Withdrawal by Subject|6|||
125633381|NCT01810380|451939122|FG001|Overall Study|Withdrawal by Subject|0|||
125633382|NCT01810380|451939123|FG002|Overall Study|Withdrawal by Subject|6|||
125633383|NCT01810380|451939121|FG000|Overall Study|Administrative or other reasons|11|||
125633384|NCT01810380|451939122|FG001|Overall Study|Administrative or other reasons|13|||
125633385|NCT01810380|451939123|FG002|Overall Study|Administrative or other reasons|9|||
125633386|NCT00614991|451939124|FG000|Overall Study|Adverse Event|3|||
125633387|NCT00614991|451939125|FG001|Overall Study|Adverse Event|3|||
125633388|NCT00614991|451939126|FG002|Overall Study|Adverse Event|0|||
125633389|NCT00614991|451939127|FG003|Overall Study|Adverse Event|0|||
125633390|NCT00614991|451939128|FG004|Overall Study|Adverse Event|1|||
125633391|NCT00614991|451939129|FG005|Overall Study|Adverse Event|0|||
125633392|NCT02623699|451939130|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125633393|NCT02623699|451939131|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
125633394|NCT02623699|451939132|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125633395|NCT02623699|451939133|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125633396|NCT02623699|451939134|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125633397|NCT02623699|451939135|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125633398|NCT02623699|451939136|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125633399|NCT02623699|451939137|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125633400|NCT02623699|451939138|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125633401|NCT02623699|451939139|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125633402|NCT02623699|451939140|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125633403|NCT02623699|451939141|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
125633404|NCT02623699|451939130|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125633405|NCT02623699|451939131|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125633406|NCT02623699|451939132|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125633407|NCT02623699|451939133|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125633408|NCT02623699|451939134|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125633409|NCT02623699|451939135|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125633410|NCT02623699|451939136|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
125633411|NCT02623699|451939137|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125633412|NCT02623699|451939138|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125633413|NCT02623699|451939139|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125633414|NCT02623699|451939140|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125633415|NCT02623699|451939141|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
125633416|NCT02623699|451939130|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125633417|NCT02623699|451939131|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125633418|NCT02623699|451939132|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125633419|NCT02623699|451939133|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125633420|NCT02623699|451939134|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125633421|NCT02623699|451939135|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
125633422|NCT02623699|451939136|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125633423|NCT02623699|451939137|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125633424|NCT02623699|451939138|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125633425|NCT02623699|451939139|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125633426|NCT02623699|451939140|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125633427|NCT02623699|451939141|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
125633428|NCT02623699|451939130|FG000|Part B (Up to 289 Days)|Death|0|||
125633429|NCT02623699|451939131|FG001|Part B (Up to 289 Days)|Death|0|||
125376952|NCT00553514|451010256|FG003|Overall Study|Other|0|||
125633430|NCT02623699|451939132|FG002|Part B (Up to 289 Days)|Death|0|||
125633431|NCT02623699|451939133|FG003|Part B (Up to 289 Days)|Death|0|||
125633432|NCT02623699|451939134|FG004|Part B (Up to 289 Days)|Death|0|||
125633433|NCT02623699|451939135|FG005|Part B (Up to 289 Days)|Death|1|||
125633434|NCT02623699|451939136|FG006|Part B (Up to 289 Days)|Death|1|||
125633435|NCT02623699|451939137|FG007|Part B (Up to 289 Days)|Death|0|||
125633436|NCT02623699|451939138|FG008|Part B (Up to 289 Days)|Death|1|||
125633437|NCT02623699|451939139|FG009|Part B (Up to 289 Days)|Death|0|||
125633438|NCT02623699|451939140|FG010|Part B (Up to 289 Days)|Death|0|||
125633439|NCT02623699|451939141|FG011|Part B (Up to 289 Days)|Death|0|||
125633440|NCT02623699|451939130|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
125633441|NCT02623699|451939131|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
125633442|NCT02623699|451939132|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
125633443|NCT02623699|451939133|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
125633444|NCT02623699|451939134|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
125633445|NCT02623699|451939135|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
125633446|NCT02623699|451939136|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
125633447|NCT02623699|451939137|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
125633448|NCT02623699|451939138|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
125633449|NCT02623699|451939139|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
125633450|NCT02623699|451939140|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
125633451|NCT02623699|451939141|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
125633452|NCT02623699|451939130|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125633453|NCT02623699|451939131|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125633454|NCT02623699|451939132|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125633455|NCT02623699|451939133|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125633456|NCT02623699|451939134|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125633457|NCT02623699|451939135|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125633458|NCT02623699|451939136|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125633459|NCT02623699|451939137|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125633460|NCT02623699|451939138|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125633461|NCT02623699|451939139|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
125633462|NCT02623699|451939140|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
125633463|NCT02623699|451939141|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
125633464|NCT02623699|451939130|FG000|Part C (Up to 236 Days)|Death|0|||
125633465|NCT02623699|451939131|FG001|Part C (Up to 236 Days)|Death|0|||
125633466|NCT02623699|451939132|FG002|Part C (Up to 236 Days)|Death|0|||
125633467|NCT02623699|451939133|FG003|Part C (Up to 236 Days)|Death|0|||
125633468|NCT02623699|451939134|FG004|Part C (Up to 236 Days)|Death|0|||
125633469|NCT02623699|451939135|FG005|Part C (Up to 236 Days)|Death|0|||
125633470|NCT02623699|451939136|FG006|Part C (Up to 236 Days)|Death|0|||
125633471|NCT02623699|451939137|FG007|Part C (Up to 236 Days)|Death|0|||
125633472|NCT02623699|451939138|FG008|Part C (Up to 236 Days)|Death|0|||
125633473|NCT02623699|451939139|FG009|Part C (Up to 236 Days)|Death|0|||
125633474|NCT02623699|451939140|FG010|Part C (Up to 236 Days)|Death|0|||
125633475|NCT02623699|451939141|FG011|Part C (Up to 236 Days)|Death|1|||
125633476|NCT02623699|451939130|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
125633477|NCT02623699|451939131|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
125633478|NCT02623699|451939132|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
125633479|NCT02623699|451939133|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
125633480|NCT02623699|451939134|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
125633481|NCT02623699|451939135|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
125633482|NCT02623699|451939136|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
125633483|NCT02623699|451939137|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
125633484|NCT02623699|451939138|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
125633485|NCT02623699|451939139|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
125633486|NCT02623699|451939140|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
125633487|NCT02623699|451939141|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
125633488|NCT03796195|451939144|FG000|Overall Study|Study closed early|1|||
125633489|NCT05166603|451939145|FG000|Overall Study|Withdrawal by Subject|68|||
125633490|NCT05166603|451939146|FG001|Overall Study|Withdrawal by Subject|0|||
125633491|NCT00464620|451940917|FG000|Overall Study|Physician Decision|1|||
125633492|NCT00464620|451940918|FG001|Overall Study|Physician Decision|0|||
125633493|NCT00464620|451940919|FG002|Overall Study|Physician Decision|0|||
125633494|NCT00464620|451940917|FG000|Overall Study|Withdrawal by Subject|1|||
125376953|NCT00553514|451010257|FG004|Overall Study|Other|1|||
125633495|NCT00464620|451940918|FG001|Overall Study|Withdrawal by Subject|0|||
125633496|NCT00464620|451940919|FG002|Overall Study|Withdrawal by Subject|3|||
125633497|NCT00464620|451940917|FG000|Overall Study|Ineligible sarcoma subtype|0|||
125633498|NCT00464620|451940918|FG001|Overall Study|Ineligible sarcoma subtype|2|||
125633499|NCT00464620|451940919|FG002|Overall Study|Ineligible sarcoma subtype|2|||
125633500|NCT00464620|451940917|FG000|Overall Study|Use of prohibited concomitant medication|0|||
125633501|NCT00464620|451940918|FG001|Overall Study|Use of prohibited concomitant medication|0|||
125633502|NCT00464620|451940919|FG002|Overall Study|Use of prohibited concomitant medication|2|||
125633503|NCT01518309|451940920|FG000|Overall Study|Adverse Event|6|||
125129733|NCT05275205|450101090|FG000|Overall Study|Patient unable to attend visits|1|||
125129734|NCT05275205|450101091|FG001|Overall Study|Patient unable to attend visits|0|||
125129735|NCT00440297|450101092|FG000|Overall Study|Adverse Event|8|||
125633504|NCT01518309|451940920|FG000|Overall Study|Death|6|||
125633505|NCT01518309|451940920|FG000|Overall Study|Lack of Efficacy|7|||
125633506|NCT01518309|451940920|FG000|Overall Study|Withdrawal by Subject|6|||
125633507|NCT01518309|451940920|FG000|Overall Study|Physician Decision|3|||
125633508|NCT01518309|451940920|FG000|Overall Study|Sponsor Decision|2|||
125633509|NCT01518309|451940920|FG000|Overall Study|Not in Predefined Categories|9|||
125633510|NCT02579863|451940921|FG000|Overall Study|Final Disposition Unknown|2|||
125633511|NCT02579863|451940922|FG001|Overall Study|Final Disposition Unknown|1|||
125633512|NCT02579863|451940921|FG000|Overall Study|Adverse Event|18|||
125633513|NCT02579863|451940922|FG001|Overall Study|Adverse Event|11|||
125633514|NCT02579863|451940921|FG000|Overall Study|Death|31|||
125633515|NCT02579863|451940922|FG001|Overall Study|Death|29|||
125633516|NCT02579863|451940921|FG000|Overall Study|Lost to Follow-up|2|||
125633517|NCT02579863|451940922|FG001|Overall Study|Lost to Follow-up|1|||
125633518|NCT02579863|451940921|FG000|Overall Study|Physician Decision|1|||
125633519|NCT02579863|451940922|FG001|Overall Study|Physician Decision|2|||
125633520|NCT02579863|451940921|FG000|Overall Study|Screen Failure|0|||
125633521|NCT02579863|451940922|FG001|Overall Study|Screen Failure|2|||
125633522|NCT02579863|451940921|FG000|Overall Study|Study Terminated at Selected Sites|82|||
125633523|NCT02579863|451940922|FG001|Overall Study|Study Terminated at Selected Sites|88|||
125633524|NCT02579863|451940921|FG000|Overall Study|Withdrawal by Subject|20|||
125633525|NCT02579863|451940922|FG001|Overall Study|Withdrawal by Subject|20|||
125633526|NCT00038142|451940930|FG000|Overall Study|Ineligible|1|||
125633527|NCT00038142|451940931|FG001|Overall Study|Ineligible|0|||
125633528|NCT00038142|451940930|FG000|Overall Study|Progressive Disease|11|||
125633529|NCT00038142|451940931|FG001|Overall Study|Progressive Disease|7|||
125633530|NCT00038142|451940930|FG000|Overall Study|Death|1|||
125633531|NCT00038142|451940931|FG001|Overall Study|Death|0|||
125633532|NCT00038142|451940930|FG000|Overall Study|Adverse Event|1|||
125633533|NCT00038142|451940931|FG001|Overall Study|Adverse Event|0|||
125633534|NCT00038142|451940930|FG000|Overall Study|Unknown Reason|8|||
125633535|NCT00038142|451940931|FG001|Overall Study|Unknown Reason|0|||
125633536|NCT00589602|451940932|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
125633537|NCT02352090|451940937|FG000|Overall Study|general malaise|1|||
125633538|NCT02352090|451940938|FG001|Overall Study|general malaise|0|||
125633539|NCT02352090|451940939|FG002|Overall Study|general malaise|0|||
125633540|NCT02352090|451940937|FG000|Overall Study|non-specified mild side-effects|0|||
125633541|NCT02352090|451940938|FG001|Overall Study|non-specified mild side-effects|0|||
125633542|NCT02352090|451940939|FG002|Overall Study|non-specified mild side-effects|2|||
125633543|NCT00068822|451940940|FG000|First Randomized Intervention|Lost to Follow-up|1|||
125633544|NCT00068822|451940941|FG001|First Randomized Intervention|Lost to Follow-up|2|||
125633545|NCT01849562|451940942|FG000|Overall Study|Lost to Follow-up|1|||
125633546|NCT01849562|451940943|FG001|Overall Study|Lost to Follow-up|0|||
125633547|NCT01849562|451940944|FG002|Overall Study|Lost to Follow-up|0|||
125633548|NCT01849562|451940942|FG000|Overall Study|Non-compliance with Study Drug|1|||
125633549|NCT01849562|451940943|FG001|Overall Study|Non-compliance with Study Drug|0|||
125633550|NCT01849562|451940944|FG002|Overall Study|Non-compliance with Study Drug|0|||
125633551|NCT03146403|451940945|FG000|Overall Study|Withdrawal by Subject|0|||
125633552|NCT03146403|451940946|FG001|Overall Study|Withdrawal by Subject|3|||
125633553|NCT03146403|451940945|FG000|Overall Study|Lost to Follow-up|2|||
125633554|NCT03146403|451940946|FG001|Overall Study|Lost to Follow-up|0|||
125633555|NCT02182999|451940950|FG000|Overall Study|Adverse Event|4|||
125633556|NCT02182999|451940951|FG001|Overall Study|Adverse Event|3|||
125633557|NCT02182999|451940950|FG000|Overall Study|Physician Decision|1|||
125633558|NCT02182999|451940951|FG001|Overall Study|Physician Decision|0|||
125633559|NCT02252588|451940952|FG000|Overall Study|Withdrawal by Subject|4|||
125633560|NCT02252588|451940953|FG001|Overall Study|Withdrawal by Subject|0|||
125633561|NCT03039790|451940954|FG000|Overall Study|Lost to Follow-up|2|||
125633562|NCT03039790|451940955|FG001|Overall Study|Lost to Follow-up|0|||
125129736|NCT00440297|450101093|FG001|Overall Study|Adverse Event|5|||
125129737|NCT00440297|450101092|FG000|Overall Study|Lost to Follow-up|1|||
125129738|NCT00440297|450101093|FG001|Overall Study|Lost to Follow-up|0|||
125129739|NCT00440297|450101092|FG000|Overall Study|Physician Decision|1|||
125129740|NCT00440297|450101093|FG001|Overall Study|Physician Decision|0|||
125633563|NCT03039790|451940956|FG002|Overall Study|Lost to Follow-up|1|||
125633564|NCT03039790|451940957|FG003|Overall Study|Lost to Follow-up|1|||
125633565|NCT03039790|451940958|FG004|Overall Study|Lost to Follow-up|0|||
125633566|NCT03039790|451940959|FG005|Overall Study|Lost to Follow-up|1|||
125633567|NCT03039790|451940960|FG006|Overall Study|Lost to Follow-up|1|||
125633568|NCT03039790|451940961|FG007|Overall Study|Lost to Follow-up|1|||
125633569|NCT03039790|451940962|FG008|Overall Study|Lost to Follow-up|0|||
125633570|NCT03039790|451940963|FG009|Overall Study|Lost to Follow-up|1|||
125129741|NCT00440297|450101092|FG000|Overall Study|Protocol Violation|11|||
125129742|NCT00440297|450101093|FG001|Overall Study|Protocol Violation|7|||
125633571|NCT03039790|451940964|FG010|Overall Study|Lost to Follow-up|1|||
125633572|NCT03039790|451940965|FG011|Overall Study|Lost to Follow-up|0|||
125633573|NCT03039790|451940966|FG012|Overall Study|Lost to Follow-up|1|||
125633574|NCT03039790|451940967|FG013|Overall Study|Lost to Follow-up|0|||
125633575|NCT03039790|451940968|FG014|Overall Study|Lost to Follow-up|3|||
125633576|NCT03039790|451940969|FG015|Overall Study|Lost to Follow-up|1|||
125633577|NCT03039790|451940970|FG016|Overall Study|Lost to Follow-up|2|||
125633578|NCT03039790|451940971|FG017|Overall Study|Lost to Follow-up|2|||
125633579|NCT03039790|451940972|FG018|Overall Study|Lost to Follow-up|1|||
125633580|NCT03039790|451940973|FG019|Overall Study|Lost to Follow-up|3|||
125633581|NCT03039790|451940954|FG000|Overall Study|Withdrawal of Consent|1|||
125633582|NCT03039790|451940955|FG001|Overall Study|Withdrawal of Consent|0|||
125633583|NCT03039790|451940956|FG002|Overall Study|Withdrawal of Consent|0|||
125633584|NCT03039790|451940957|FG003|Overall Study|Withdrawal of Consent|1|||
125633585|NCT03039790|451940958|FG004|Overall Study|Withdrawal of Consent|0|||
125633586|NCT03039790|451940959|FG005|Overall Study|Withdrawal of Consent|0|||
125633587|NCT03039790|451940960|FG006|Overall Study|Withdrawal of Consent|0|||
125633588|NCT03039790|451940961|FG007|Overall Study|Withdrawal of Consent|0|||
125633589|NCT03039790|451940962|FG008|Overall Study|Withdrawal of Consent|0|||
125633590|NCT03039790|451940963|FG009|Overall Study|Withdrawal of Consent|1|||
125633591|NCT03039790|451940964|FG010|Overall Study|Withdrawal of Consent|0|||
125633592|NCT03039790|451940965|FG011|Overall Study|Withdrawal of Consent|0|||
125633593|NCT03039790|451940966|FG012|Overall Study|Withdrawal of Consent|2|||
125633594|NCT03039790|451940967|FG013|Overall Study|Withdrawal of Consent|0|||
125633595|NCT03039790|451940968|FG014|Overall Study|Withdrawal of Consent|1|||
125633596|NCT03039790|451940969|FG015|Overall Study|Withdrawal of Consent|5|||
125633597|NCT03039790|451940970|FG016|Overall Study|Withdrawal of Consent|3|||
125633598|NCT03039790|451940971|FG017|Overall Study|Withdrawal of Consent|0|||
125633599|NCT03039790|451940972|FG018|Overall Study|Withdrawal of Consent|2|||
125633600|NCT03039790|451940973|FG019|Overall Study|Withdrawal of Consent|5|||
125633601|NCT03039790|451940954|FG000|Overall Study|Death|0|||
125633602|NCT03039790|451940955|FG001|Overall Study|Death|0|||
125633603|NCT03039790|451940956|FG002|Overall Study|Death|0|||
125633604|NCT03039790|451940957|FG003|Overall Study|Death|0|||
125633605|NCT03039790|451940958|FG004|Overall Study|Death|0|||
125633606|NCT03039790|451940959|FG005|Overall Study|Death|0|||
125633607|NCT03039790|451940960|FG006|Overall Study|Death|0|||
125633608|NCT03039790|451940961|FG007|Overall Study|Death|0|||
125633609|NCT03039790|451940962|FG008|Overall Study|Death|0|||
125633610|NCT03039790|451940963|FG009|Overall Study|Death|0|||
125633611|NCT03039790|451940964|FG010|Overall Study|Death|0|||
125633612|NCT03039790|451940965|FG011|Overall Study|Death|0|||
125633613|NCT03039790|451940966|FG012|Overall Study|Death|0|||
125633614|NCT03039790|451940967|FG013|Overall Study|Death|0|||
125633615|NCT03039790|451940968|FG014|Overall Study|Death|0|||
125633616|NCT03039790|451940969|FG015|Overall Study|Death|1|||
125633617|NCT03039790|451940970|FG016|Overall Study|Death|3|||
125633618|NCT03039790|451940971|FG017|Overall Study|Death|0|||
125633619|NCT03039790|451940972|FG018|Overall Study|Death|2|||
125633620|NCT03039790|451940973|FG019|Overall Study|Death|0|||
125633621|NCT03039790|451940954|FG000|Overall Study|Reason, not Specified|1|||
125633622|NCT03039790|451940955|FG001|Overall Study|Reason, not Specified|0|||
125633623|NCT03039790|451940956|FG002|Overall Study|Reason, not Specified|0|||
125633624|NCT03039790|451940957|FG003|Overall Study|Reason, not Specified|0|||
125633625|NCT03039790|451940958|FG004|Overall Study|Reason, not Specified|0|||
125633626|NCT03039790|451940959|FG005|Overall Study|Reason, not Specified|0|||
125633627|NCT03039790|451940960|FG006|Overall Study|Reason, not Specified|0|||
125633628|NCT03039790|451940961|FG007|Overall Study|Reason, not Specified|0|||
125633629|NCT03039790|451940962|FG008|Overall Study|Reason, not Specified|0|||
125633630|NCT03039790|451940963|FG009|Overall Study|Reason, not Specified|0|||
125633631|NCT03039790|451940964|FG010|Overall Study|Reason, not Specified|0|||
125633632|NCT03039790|451940965|FG011|Overall Study|Reason, not Specified|0|||
125633633|NCT03039790|451940966|FG012|Overall Study|Reason, not Specified|0|||
125633634|NCT03039790|451940967|FG013|Overall Study|Reason, not Specified|0|||
125633635|NCT03039790|451940968|FG014|Overall Study|Reason, not Specified|0|||
125633636|NCT03039790|451940969|FG015|Overall Study|Reason, not Specified|0|||
125633637|NCT03039790|451940970|FG016|Overall Study|Reason, not Specified|2|||
125633638|NCT03039790|451940971|FG017|Overall Study|Reason, not Specified|0|||
125633639|NCT03039790|451940972|FG018|Overall Study|Reason, not Specified|1|||
125633640|NCT03039790|451940973|FG019|Overall Study|Reason, not Specified|0|||
125633641|NCT02266004|451940983|FG000|Overall Study|unrelated adverse event|1|||
125633642|NCT02266004|451940983|FG000|Overall Study|Physician Decision|1|||
125633643|NCT00537771|451940988|FG000|Overall Study|Withdrawal by Subject|6|||
125633644|NCT00537771|451940989|FG001|Overall Study|Withdrawal by Subject|23|||
125633645|NCT00537771|451940988|FG000|Overall Study|Adverse Event|8|||
125633646|NCT00537771|451940989|FG001|Overall Study|Adverse Event|15|||
125633647|NCT00537771|451940988|FG000|Overall Study|Lost to Follow-up|9|||
125633648|NCT00537771|451940989|FG001|Overall Study|Lost to Follow-up|15|||
125633649|NCT00537771|451940988|FG000|Overall Study|Protocol Violation|2|||
125633650|NCT00537771|451940989|FG001|Overall Study|Protocol Violation|6|||
125633651|NCT00537771|451940988|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
125129743|NCT00440297|450101092|FG000|Overall Study|Withdrawal by Subject|1|||
125129744|NCT00440297|450101093|FG001|Overall Study|Withdrawal by Subject|6|||
125129745|NCT00440297|450101092|FG000|Overall Study|Randomized by mistake|1|||
125129746|NCT00440297|450101093|FG001|Overall Study|Randomized by mistake|0|||
125129747|NCT02039908|450101096|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
125129748|NCT02039908|450101097|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
125129749|NCT02039908|450101098|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
125129750|NCT02039908|450101099|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
125129751|NCT02039908|450101096|FG000|Phase 1-Summer|Protocol Violation|6|||
125129752|NCT02039908|450101097|FG001|Phase 1-Summer|Protocol Violation|0|||
125129753|NCT02039908|450101098|FG002|Phase 1-Summer|Protocol Violation|0|||
125129754|NCT02039908|450101099|FG003|Phase 1-Summer|Protocol Violation|0|||
125129755|NCT02039908|450101096|FG000|Phase 2-School Year|Lost to Follow-up|0|||
125129756|NCT02039908|450101097|FG001|Phase 2-School Year|Lost to Follow-up|0|||
125633652|NCT00537771|451940989|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
125633653|NCT02736929|451940993|FG000|Main Study|Lost to Follow-up|7|||
125633654|NCT02736929|451940994|FG001|Main Study|Lost to Follow-up|1|||
125633655|NCT02736929|451940995|FG002|Main Study|Lost to Follow-up|0|||
125633656|NCT02736929|451940993|FG000|Main Study|Withdrawal by Subject|1|||
125633657|NCT02736929|451940994|FG001|Main Study|Withdrawal by Subject|1|||
125633658|NCT02736929|451940995|FG002|Main Study|Withdrawal by Subject|0|||
125633659|NCT02736929|451940993|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
125633660|NCT02736929|451940994|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
125633661|NCT02736929|451940995|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
125633662|NCT01855425|451941004|FG000|Overall Study|Physician Decision|20|||
125129757|NCT02039908|450101098|FG002|Phase 2-School Year|Lost to Follow-up|1|||
125129758|NCT02039908|450101099|FG003|Phase 2-School Year|Lost to Follow-up|3|||
125129759|NCT02039908|450101096|FG000|Phase 2-School Year|Protocol Violation|0|||
125633663|NCT01690988|451941011|FG000|Overall Study|Withdrawal by Subject|2|||
125633664|NCT01690988|451941012|FG001|Overall Study|Withdrawal by Subject|2|||
125129760|NCT02039908|450101097|FG001|Phase 2-School Year|Protocol Violation|0|||
125129761|NCT02039908|450101098|FG002|Phase 2-School Year|Protocol Violation|3|||
125633665|NCT01690988|451941013|FG002|Overall Study|Withdrawal by Subject|3|||
125633666|NCT01690988|451941011|FG000|Overall Study|Physician Decision|0|||
125633667|NCT01690988|451941012|FG001|Overall Study|Physician Decision|0|||
125633668|NCT01690988|451941013|FG002|Overall Study|Physician Decision|1|||
125633669|NCT01690988|451941011|FG000|Overall Study|Operation Cancelled|1|||
125633670|NCT01690988|451941012|FG001|Overall Study|Operation Cancelled|1|||
125633671|NCT01690988|451941013|FG002|Overall Study|Operation Cancelled|0|||
125633672|NCT01690988|451941011|FG000|Overall Study|Determined ineligible|1|||
125633673|NCT01690988|451941012|FG001|Overall Study|Determined ineligible|0|||
125633674|NCT01690988|451941013|FG002|Overall Study|Determined ineligible|0|||
125633675|NCT01690988|451941011|FG000|Overall Study|Death|1|||
125633676|NCT01690988|451941012|FG001|Overall Study|Death|1|||
125633677|NCT01690988|451941013|FG002|Overall Study|Death|1|||
125633678|NCT01690988|451941011|FG000|Overall Study|Sedated|1|||
125633679|NCT01690988|451941012|FG001|Overall Study|Sedated|1|||
125633680|NCT01690988|451941013|FG002|Overall Study|Sedated|2|||
125633681|NCT01634100|451941016|FG000|Overall Study|Withdrawal by Subject|1|||
125633682|NCT01634100|451941017|FG001|Overall Study|Withdrawal by Subject|0|||
125633683|NCT01634100|451941018|FG002|Overall Study|Withdrawal by Subject|1|||
125633684|NCT01634100|451941019|FG003|Overall Study|Withdrawal by Subject|0|||
125633685|NCT01634100|451941020|FG004|Overall Study|Withdrawal by Subject|0|||
125633686|NCT01634100|451941021|FG005|Overall Study|Withdrawal by Subject|0|||
125633687|NCT01662986|451941025|FG000|Overall Study|Adverse Event|5|||
125633688|NCT01662986|451941026|FG001|Overall Study|Adverse Event|4|||
125633689|NCT01662986|451941025|FG000|Overall Study|Protocol Violation|2|||
125633690|NCT01662986|451941026|FG001|Overall Study|Protocol Violation|3|||
125633691|NCT01662986|451941025|FG000|Overall Study|Lost to Follow-up|5|||
125633692|NCT01662986|451941026|FG001|Overall Study|Lost to Follow-up|4|||
125633693|NCT01662986|451941025|FG000|Overall Study|Withdrawal by Subject|2|||
125633694|NCT01662986|451941026|FG001|Overall Study|Withdrawal by Subject|2|||
125633695|NCT01662986|451941025|FG000|Overall Study|Not Treated|1|||
125633696|NCT01662986|451941026|FG001|Overall Study|Not Treated|0|||
125633697|NCT01662986|451941025|FG000|Overall Study|Other than stated above|3|||
125633698|NCT01662986|451941026|FG001|Overall Study|Other than stated above|0|||
125633699|NCT01512693|451941029|FG000|Overall Study|Withdrawal by Subject|0|||
125633700|NCT01512693|451941030|FG001|Overall Study|Withdrawal by Subject|1|||
125633701|NCT01975376|451941031|FG000|Overall Study|Adverse Event|5|||
125633702|NCT01975376|451941032|FG001|Overall Study|Adverse Event|5|||
125633703|NCT01975376|451941031|FG000|Overall Study|Death|65|||
125633704|NCT01975376|451941032|FG001|Overall Study|Death|72|||
125633705|NCT01975376|451941031|FG000|Overall Study|Lost to Follow-up|70|||
125633706|NCT01975376|451941032|FG001|Overall Study|Lost to Follow-up|66|||
125633707|NCT01975376|451941031|FG000|Overall Study|Withdrew consent|68|||
125633708|NCT01975376|451941032|FG001|Overall Study|Withdrew consent|62|||
125633709|NCT01975376|451941031|FG000|Overall Study|Other|2|||
125633710|NCT01975376|451941032|FG001|Overall Study|Other|4|||
125633711|NCT01975376|451941031|FG000|Overall Study|Randomized, Not Treated|16|||
125633712|NCT01975376|451941032|FG001|Overall Study|Randomized, Not Treated|8|||
125633713|NCT04731922|451941033|FG000|Overall Study|Adverse Event|0|||
125633714|NCT04731922|451941034|FG001|Overall Study|Adverse Event|0|||
125633715|NCT04731922|451941035|FG002|Overall Study|Adverse Event|0|||
125633716|NCT04731922|451941036|FG003|Overall Study|Adverse Event|0|||
125633717|NCT04731922|451941037|FG004|Overall Study|Adverse Event|0|||
125633718|NCT04731922|451941038|FG005|Overall Study|Adverse Event|0|||
125633719|NCT04731922|451941039|FG006|Overall Study|Adverse Event|0|||
125633720|NCT04731922|451941040|FG007|Overall Study|Adverse Event|0|||
125633721|NCT04731922|451941041|FG008|Overall Study|Adverse Event|0|||
125633722|NCT04731922|451941042|FG009|Overall Study|Adverse Event|0|||
125633723|NCT04731922|451941043|FG010|Overall Study|Adverse Event|1|||
125633724|NCT04731922|451941044|FG011|Overall Study|Adverse Event|0|||
125633725|NCT04731922|451941045|FG012|Overall Study|Adverse Event|0|||
125633726|NCT04731922|451941046|FG013|Overall Study|Adverse Event|0|||
125633727|NCT04731922|451941047|FG014|Overall Study|Adverse Event|0|||
125633728|NCT04731922|451941048|FG015|Overall Study|Adverse Event|0|||
125633729|NCT04731922|451941049|FG016|Overall Study|Adverse Event|0|||
125633730|NCT04731922|451941033|FG000|Overall Study|Lost to Follow-up|0|||
125633731|NCT04731922|451941034|FG001|Overall Study|Lost to Follow-up|0|||
125633732|NCT04731922|451941035|FG002|Overall Study|Lost to Follow-up|0|||
125633733|NCT04731922|451941036|FG003|Overall Study|Lost to Follow-up|1|||
125633734|NCT04731922|451941037|FG004|Overall Study|Lost to Follow-up|0|||
125633735|NCT04731922|451941038|FG005|Overall Study|Lost to Follow-up|1|||
125633736|NCT04731922|451941039|FG006|Overall Study|Lost to Follow-up|0|||
125633737|NCT04731922|451941040|FG007|Overall Study|Lost to Follow-up|0|||
125129762|NCT02039908|450101099|FG003|Phase 2-School Year|Protocol Violation|0|||
125129763|NCT02039908|450101096|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
125633738|NCT04731922|451941041|FG008|Overall Study|Lost to Follow-up|0|||
125633739|NCT04731922|451941042|FG009|Overall Study|Lost to Follow-up|0|||
125633740|NCT04731922|451941043|FG010|Overall Study|Lost to Follow-up|0|||
125633741|NCT04731922|451941044|FG011|Overall Study|Lost to Follow-up|0|||
125633742|NCT04731922|451941045|FG012|Overall Study|Lost to Follow-up|0|||
125633743|NCT04731922|451941046|FG013|Overall Study|Lost to Follow-up|0|||
125633744|NCT04731922|451941047|FG014|Overall Study|Lost to Follow-up|0|||
125633745|NCT04731922|451941048|FG015|Overall Study|Lost to Follow-up|0|||
125633746|NCT04731922|451941049|FG016|Overall Study|Lost to Follow-up|0|||
125633747|NCT04731922|451941033|FG000|Overall Study|Withdrawal by Subject|1|||
125633748|NCT04731922|451941034|FG001|Overall Study|Withdrawal by Subject|0|||
125633749|NCT04731922|451941035|FG002|Overall Study|Withdrawal by Subject|0|||
125633750|NCT04731922|451941036|FG003|Overall Study|Withdrawal by Subject|0|||
125633751|NCT04731922|451941037|FG004|Overall Study|Withdrawal by Subject|1|||
125633752|NCT04731922|451941038|FG005|Overall Study|Withdrawal by Subject|0|||
125633753|NCT04731922|451941039|FG006|Overall Study|Withdrawal by Subject|1|||
125633754|NCT04731922|451941040|FG007|Overall Study|Withdrawal by Subject|0|||
125633755|NCT04731922|451941041|FG008|Overall Study|Withdrawal by Subject|0|||
125633756|NCT04731922|451941042|FG009|Overall Study|Withdrawal by Subject|0|||
125633757|NCT04731922|451941043|FG010|Overall Study|Withdrawal by Subject|0|||
125633758|NCT04731922|451941044|FG011|Overall Study|Withdrawal by Subject|0|||
125633759|NCT04731922|451941045|FG012|Overall Study|Withdrawal by Subject|0|||
125633760|NCT04731922|451941046|FG013|Overall Study|Withdrawal by Subject|1|||
125633761|NCT04731922|451941047|FG014|Overall Study|Withdrawal by Subject|0|||
125633762|NCT04731922|451941048|FG015|Overall Study|Withdrawal by Subject|0|||
125633763|NCT04731922|451941049|FG016|Overall Study|Withdrawal by Subject|0|||
125633764|NCT04731922|451941033|FG000|Overall Study|Other|0|||
125633765|NCT04731922|451941034|FG001|Overall Study|Other|0|||
125633766|NCT04731922|451941035|FG002|Overall Study|Other|0|||
125633767|NCT04731922|451941036|FG003|Overall Study|Other|0|||
125633768|NCT04731922|451941037|FG004|Overall Study|Other|0|||
125633769|NCT04731922|451941038|FG005|Overall Study|Other|0|||
125633770|NCT04731922|451941039|FG006|Overall Study|Other|1|||
125633771|NCT04731922|451941040|FG007|Overall Study|Other|0|||
125633772|NCT04731922|451941041|FG008|Overall Study|Other|0|||
125633773|NCT04731922|451941042|FG009|Overall Study|Other|0|||
125633774|NCT04731922|451941043|FG010|Overall Study|Other|0|||
125633775|NCT04731922|451941044|FG011|Overall Study|Other|0|||
125633776|NCT04731922|451941045|FG012|Overall Study|Other|0|||
125633777|NCT04731922|451941046|FG013|Overall Study|Other|0|||
125633778|NCT04731922|451941047|FG014|Overall Study|Other|0|||
125633779|NCT04731922|451941048|FG015|Overall Study|Other|0|||
125633780|NCT04731922|451941049|FG016|Overall Study|Other|0|||
125633781|NCT01819194|451941051|FG000|Overall Study|Loss of study articles|2|||
125633782|NCT02343952|451941056|FG000|Study Treatment|Disease Progression|23|||
125633783|NCT02343952|451941056|FG000|Study Treatment|Death|3|||
125633784|NCT02343952|451941056|FG000|Study Treatment|Adverse Event|19|||
125633785|NCT02343952|451941056|FG000|Study Treatment|Withdrawal by Subject|7|||
125633786|NCT02343952|451941056|FG000|Study Treatment|other complicating Diseases|1|||
125633787|NCT02343952|451941056|FG000|Follow up|Withdrawal by Subject|3|||
125633788|NCT02343952|451941056|FG000|Follow up|Death|33|||
125633789|NCT02343952|451941056|FG000|Follow up|Patient does not meet eligibility for study.|1|||
125633790|NCT02343952|451941056|FG000|Follow up|Research department closed by the practice.|5|||
125633791|NCT02343952|451941056|FG000|Follow up|Patient went home to Russia|1|||
125633792|NCT02343952|451941056|FG000|Follow up|Disease Progression|1|||
125633793|NCT02343952|451941056|FG000|Follow up|study terminated|1|||
125633794|NCT00899678|451941060|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
125633795|NCT00899678|451941061|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
125633796|NCT00899678|451941062|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
125633797|NCT00899678|451941060|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
125633798|NCT00899678|451941061|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
125633799|NCT00899678|451941062|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
125633800|NCT00899678|451941060|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
125633801|NCT00899678|451941061|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
125633802|NCT00899678|451941062|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
125633803|NCT00899678|451941060|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
125633804|NCT00899678|451941061|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
125633805|NCT00899678|451941062|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
125633806|NCT00899678|451941060|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
125633807|NCT00899678|451941061|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
125633808|NCT00899678|451941062|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
125633809|NCT00899678|451941060|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
125633810|NCT00899678|451941061|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
125633811|NCT00899678|451941062|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
125633812|NCT00899678|451941060|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
125633813|NCT00899678|451941061|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
125633814|NCT00899678|451941062|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
125633815|NCT00899678|451941060|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
125633816|NCT00899678|451941061|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
125216212|NCT05052697|450417547|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216213|NCT05052697|450417548|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
125376954|NCT01442675|451010260|FG000|Overall Study|Protocol Violation|6|||
125633817|NCT00899678|451941062|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
125216214|NCT05052697|450417549|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
125633818|NCT00899678|451941060|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
125216215|NCT05052697|450417550|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
125216216|NCT05052697|450417551|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216217|NCT05052697|450417552|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216218|NCT05052697|450417553|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
125216219|NCT01289574|450417554|FG000|Overall Study|Lack of Efficacy|4|||
125216220|NCT01289574|450417555|FG001|Overall Study|Lack of Efficacy|0|||
125216221|NCT01289574|450417556|FG002|Overall Study|Lack of Efficacy|1|||
125216222|NCT01289574|450417554|FG000|Overall Study|Lost to Follow-up|2|||
125216223|NCT01289574|450417555|FG001|Overall Study|Lost to Follow-up|0|||
125216224|NCT01289574|450417556|FG002|Overall Study|Lost to Follow-up|1|||
125216225|NCT01289574|450417554|FG000|Overall Study|Withdrawal by Subject|1|||
125216226|NCT01289574|450417555|FG001|Overall Study|Withdrawal by Subject|1|||
125216227|NCT01289574|450417556|FG002|Overall Study|Withdrawal by Subject|1|||
125216228|NCT01289574|450417554|FG000|Overall Study|Adverse Event|0|||
125216229|NCT01289574|450417555|FG001|Overall Study|Adverse Event|1|||
125216230|NCT01289574|450417556|FG002|Overall Study|Adverse Event|0|||
125216231|NCT01289574|450417554|FG000|Overall Study|Subject wanted alternate treatment|0|||
125216232|NCT01289574|450417555|FG001|Overall Study|Subject wanted alternate treatment|1|||
125216233|NCT01289574|450417556|FG002|Overall Study|Subject wanted alternate treatment|0|||
125216234|NCT00262002|450417557|FG000|Overall Study|Adverse Event|2|||
125216235|NCT00262002|450417558|FG001|Overall Study|Adverse Event|1|||
125216236|NCT00262002|450417559|FG002|Overall Study|Adverse Event|0|||
125216237|NCT00262002|450417560|FG003|Overall Study|Adverse Event|0|||
125216238|NCT00262002|450417561|FG004|Overall Study|Adverse Event|0|||
125216239|NCT00262002|450417562|FG005|Overall Study|Adverse Event|1|||
125216240|NCT00262002|450417563|FG006|Overall Study|Adverse Event|0|||
125216241|NCT00262002|450417557|FG000|Overall Study|Withdrawal by Subject|4|||
125216242|NCT00262002|450417558|FG001|Overall Study|Withdrawal by Subject|2|||
125216243|NCT00262002|450417559|FG002|Overall Study|Withdrawal by Subject|0|||
125216244|NCT00262002|450417560|FG003|Overall Study|Withdrawal by Subject|1|||
125216245|NCT00262002|450417561|FG004|Overall Study|Withdrawal by Subject|2|||
125216246|NCT00262002|450417562|FG005|Overall Study|Withdrawal by Subject|2|||
125216247|NCT00262002|450417563|FG006|Overall Study|Withdrawal by Subject|2|||
125216248|NCT00262002|450417557|FG000|Overall Study|Lost to Follow-up|2|||
125216249|NCT00262002|450417558|FG001|Overall Study|Lost to Follow-up|0|||
125216250|NCT00262002|450417559|FG002|Overall Study|Lost to Follow-up|0|||
125216251|NCT00262002|450417560|FG003|Overall Study|Lost to Follow-up|2|||
125216252|NCT00262002|450417561|FG004|Overall Study|Lost to Follow-up|0|||
125216253|NCT00262002|450417562|FG005|Overall Study|Lost to Follow-up|1|||
125216254|NCT00262002|450417563|FG006|Overall Study|Lost to Follow-up|0|||
125216255|NCT00262002|450417557|FG000|Overall Study|Inapropriate enrollment|0|||
125216256|NCT00262002|450417558|FG001|Overall Study|Inapropriate enrollment|1|||
125216257|NCT00262002|450417559|FG002|Overall Study|Inapropriate enrollment|0|||
125216258|NCT00262002|450417560|FG003|Overall Study|Inapropriate enrollment|0|||
125216259|NCT00262002|450417561|FG004|Overall Study|Inapropriate enrollment|0|||
125216260|NCT00262002|450417562|FG005|Overall Study|Inapropriate enrollment|0|||
125216261|NCT00262002|450417563|FG006|Overall Study|Inapropriate enrollment|0|||
125216262|NCT00262002|450417557|FG000|Overall Study|Protocol Violation|3|||
125216263|NCT00262002|450417558|FG001|Overall Study|Protocol Violation|2|||
125216264|NCT00262002|450417559|FG002|Overall Study|Protocol Violation|0|||
125216265|NCT00262002|450417560|FG003|Overall Study|Protocol Violation|2|||
125216266|NCT00262002|450417561|FG004|Overall Study|Protocol Violation|5|||
125376955|NCT01442675|451010260|FG000|Overall Study|Lost to Follow-up|2|||
125216267|NCT00262002|450417562|FG005|Overall Study|Protocol Violation|3|||
125216268|NCT00262002|450417563|FG006|Overall Study|Protocol Violation|2|||
125216269|NCT00262002|450417557|FG000|Overall Study|Unable to classify|0|||
125216270|NCT00262002|450417558|FG001|Overall Study|Unable to classify|0|||
125216271|NCT00262002|450417559|FG002|Overall Study|Unable to classify|0|||
125216272|NCT00262002|450417560|FG003|Overall Study|Unable to classify|0|||
125216273|NCT00262002|450417561|FG004|Overall Study|Unable to classify|0|||
125216274|NCT00262002|450417562|FG005|Overall Study|Unable to classify|0|||
125216275|NCT00262002|450417563|FG006|Overall Study|Unable to classify|2|||
125216276|NCT01790516|450417564|FG000|Overall Study|Physician Decision|1|||
125216277|NCT01790516|450417565|FG001|Overall Study|Physician Decision|0|||
125216278|NCT01554163|450417566|FG000|Overall Study|Adverse Event|3|||
125216279|NCT01554163|450417567|FG001|Overall Study|Adverse Event|0|||
125216280|NCT01554163|450417566|FG000|Overall Study|Lack of Efficacy|1|||
125216281|NCT01554163|450417567|FG001|Overall Study|Lack of Efficacy|0|||
125216282|NCT01554163|450417566|FG000|Overall Study|Lost to Follow-up|1|||
125216283|NCT01554163|450417567|FG001|Overall Study|Lost to Follow-up|0|||
125216284|NCT01554163|450417566|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125216285|NCT01554163|450417567|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125216286|NCT01554163|450417566|FG000|Overall Study|Protocol Violation|0|||
125129764|NCT02039908|450101097|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
125129765|NCT02039908|450101098|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
125129766|NCT02039908|450101099|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
125129767|NCT01802320|450101100|FG000|Overall Study|Death|1|||
125129768|NCT01802320|450101100|FG000|Overall Study|Withdrawal by Subject|1|||
125129769|NCT01066143|450102422|FG000|Overall Study|ineligible for the study|8|||
125129770|NCT05376319|450102423|FG000|Overall Study|Funding termination|2|||
125129771|NCT05376319|450102424|FG001|Overall Study|Funding termination|4|||
125129772|NCT00942968|450102425|FG000|Overall Study|Adverse Event|60|||
125129773|NCT00942968|450102425|FG000|Overall Study|Death|76|||
125129774|NCT00942968|450102425|FG000|Overall Study|Protocol Violation|9|||
125129775|NCT00942968|450102425|FG000|Overall Study|Lost to Follow-up|4|||
125129776|NCT00942968|450102425|FG000|Overall Study|Withdrawal by Subject|44|||
125129777|NCT00942968|450102425|FG000|Overall Study|Sponsor request|5|||
125129778|NCT00942968|450102425|FG000|Overall Study|Physician Decision|11|||
125129779|NCT00942968|450102425|FG000|Overall Study|Progression of disease|12|||
125129780|NCT00942968|450102425|FG000|Overall Study|Inferior vena cava filter placement|4|||
125129781|NCT00942968|450102425|FG000|Overall Study|Pulmonary embolism (PE)|1|||
125129782|NCT00942968|450102425|FG000|Overall Study|Participant required pancreatic biopsy|1|||
125129783|NCT00942968|450102425|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
125129784|NCT01466166|450102428|FG000|Overall Study|Death|1|||
125129785|NCT01466166|450102428|FG000|Overall Study|Lost to Follow-up|7|||
125129786|NCT01466166|450102428|FG000|Overall Study|Infusion Reaction (IR)|27|||
125129787|NCT01466166|450102428|FG000|Overall Study|Adverse Event (Other than IR)|11|||
125129788|NCT01466166|450102428|FG000|Overall Study|Elevated Serum Uric Acid|78|||
125129789|NCT01466166|450102428|FG000|Overall Study|Withdrawal by Subject|13|||
125129790|NCT01466166|450102428|FG000|Overall Study|Sponsor Decision|4|||
125129791|NCT01466166|450102428|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
125129792|NCT01466166|450102428|FG000|Overall Study|Other|20|||
125129793|NCT01340495|450102431|FG000|Overall Study|Withdrawal by Subject|1|||
125129794|NCT00667862|450102434|FG000|Overall Study|Adverse Event|9|||
125129795|NCT00667862|450102434|FG000|Overall Study|Death|1|||
125129796|NCT00667862|450102434|FG000|Overall Study|Disease Progression|22|||
125129797|NCT00667862|450102434|FG000|Overall Study|Withdrawal by Subject|3|||
125129798|NCT02495857|450102436|FG000|Overall Study|Adverse Event|5|||
125129799|NCT02495857|450102437|FG001|Overall Study|Adverse Event|0|||
125129800|NCT02495857|450102438|FG002|Overall Study|Adverse Event|1|||
125129801|NCT02495857|450102436|FG000|Overall Study|Withdrawal by Subject|9|||
125129802|NCT02495857|450102437|FG001|Overall Study|Withdrawal by Subject|6|||
125129803|NCT02495857|450102438|FG002|Overall Study|Withdrawal by Subject|10|||
125129804|NCT02495857|450102436|FG000|Overall Study|Physician Decision|0|||
125129805|NCT02495857|450102437|FG001|Overall Study|Physician Decision|1|||
125129806|NCT02495857|450102438|FG002|Overall Study|Physician Decision|0|||
125129807|NCT02495857|450102436|FG000|Overall Study|Protocol Violation|1|||
125129808|NCT02495857|450102437|FG001|Overall Study|Protocol Violation|1|||
125129809|NCT02495857|450102438|FG002|Overall Study|Protocol Violation|2|||
125129810|NCT02495857|450102436|FG000|Overall Study|Lost to Follow-up|4|||
125129811|NCT02495857|450102437|FG001|Overall Study|Lost to Follow-up|5|||
125129812|NCT02495857|450102438|FG002|Overall Study|Lost to Follow-up|3|||
125129813|NCT02495857|450102436|FG000|Overall Study|Other|3|||
125129814|NCT02495857|450102437|FG001|Overall Study|Other|3|||
125129815|NCT02495857|450102438|FG002|Overall Study|Other|2|||
125129816|NCT01435265|450102440|FG000|Overall Study|Lost to Follow-up|0|||
125129817|NCT01435265|450102441|FG001|Overall Study|Lost to Follow-up|1|||
125129818|NCT04605094|450102442|FG000|Overall Study|Adverse Event|2|||
125129819|NCT04605094|450102443|FG001|Overall Study|Adverse Event|2|||
125216287|NCT01554163|450417567|FG001|Overall Study|Protocol Violation|4|||
125216288|NCT01554163|450417566|FG000|Overall Study|Withdrawal by Subject|1|||
125216289|NCT01554163|450417567|FG001|Overall Study|Withdrawal by Subject|5|||
125216290|NCT01554163|450417566|FG000|Overall Study|Not Treated|1|||
125216291|NCT01554163|450417567|FG001|Overall Study|Not Treated|0|||
125216292|NCT03034135|450417568|FG000|Overall Study|Withdrawal by Subject|2|||
125216293|NCT01972464|450417569|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
125216294|NCT01972464|450417570|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
125216295|NCT01972464|450417569|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
125216296|NCT01972464|450417570|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
125216297|NCT01972464|450417569|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
125216298|NCT01972464|450417570|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
125216299|NCT01972464|450417569|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
125216300|NCT01972464|450417570|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
125216301|NCT02526160|450419426|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
125216302|NCT02526160|450419427|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
125216303|NCT02526160|450419426|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
125216304|NCT02526160|450419427|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
125216305|NCT02526160|450419426|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
125216306|NCT02526160|450419427|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
125216307|NCT02526160|450419426|FG000|Open-Label Treatment Extension Period I|Death|0|||
125216308|NCT02526160|450419427|FG001|Open-Label Treatment Extension Period I|Death|1|||
125216309|NCT02526160|450419426|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
125216310|NCT02526160|450419427|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
125216311|NCT02526160|450419426|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
125216312|NCT02526160|450419427|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
125216313|NCT02526160|450419426|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
125216314|NCT02526160|450419427|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
125216315|NCT02526160|450419426|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
125216316|NCT02526160|450419427|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
125216317|NCT02576977|450419428|FG000|Overall Study|Adverse Event|13|||
125216318|NCT02576977|450419429|FG001|Overall Study|Adverse Event|2|||
125216319|NCT02576977|450419428|FG000|Overall Study|Death|73|||
125216320|NCT02576977|450419429|FG001|Overall Study|Death|60|||
125216321|NCT02576977|450419428|FG000|Overall Study|Screen failure|1|||
125216322|NCT02576977|450419429|FG001|Overall Study|Screen failure|0|||
125216323|NCT02576977|450419428|FG000|Overall Study|Study Terminated at Selected Sites|27|||
125216324|NCT02576977|450419429|FG001|Overall Study|Study Terminated at Selected Sites|50|||
125216325|NCT02576977|450419428|FG000|Overall Study|Withdrawal by Subject|11|||
125216326|NCT02576977|450419429|FG001|Overall Study|Withdrawal by Subject|11|||
125216327|NCT02576977|450419428|FG000|Overall Study|Final Disposition Unknown|0|||
125216328|NCT02576977|450419429|FG001|Overall Study|Final Disposition Unknown|1|||
125216329|NCT02576977|450419428|FG000|Overall Study|Lost to Follow-up|1|||
125216330|NCT02576977|450419429|FG001|Overall Study|Lost to Follow-up|0|||
125216331|NCT02576977|450419428|FG000|Overall Study|Progressive Disease|0|||
125216332|NCT02576977|450419429|FG001|Overall Study|Progressive Disease|1|||
125216333|NCT00314808|450419435|FG000|Overall Study|Disease Progression without AE|4|||
125216334|NCT00314808|450419435|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
125216335|NCT04304508|450419436|FG000|Overall Study|Subject Decision|29|||
125216336|NCT04304508|450419437|FG001|Overall Study|Subject Decision|39|||
125216337|NCT04304508|450419438|FG002|Overall Study|Subject Decision|37|||
125216338|NCT04304508|450419439|FG003|Overall Study|Subject Decision|48|||
125216339|NCT04304508|450419436|FG000|Overall Study|Death|6|||
125216340|NCT04304508|450419437|FG001|Overall Study|Death|1|||
125216341|NCT04304508|450419438|FG002|Overall Study|Death|8|||
125216342|NCT04304508|450419439|FG003|Overall Study|Death|5|||
125216343|NCT04304508|450419436|FG000|Overall Study|Non-compliance With Study Drug|3|||
125216344|NCT04304508|450419437|FG001|Overall Study|Non-compliance With Study Drug|1|||
125216345|NCT04304508|450419438|FG002|Overall Study|Non-compliance With Study Drug|2|||
125216346|NCT04304508|450419439|FG003|Overall Study|Non-compliance With Study Drug|0|||
125216347|NCT04304508|450419436|FG000|Overall Study|Switching To Other Therapy|1|||
125216348|NCT04304508|450419437|FG001|Overall Study|Switching To Other Therapy|1|||
125216349|NCT04304508|450419438|FG002|Overall Study|Switching To Other Therapy|1|||
125633819|NCT00899678|451941061|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
125633820|NCT00899678|451941062|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
125633821|NCT00033371|451941063|FG000|Overall Study|Adverse Event|1|||
125633822|NCT00033371|451941064|FG001|Overall Study|Adverse Event|5|||
125633823|NCT00033371|451941063|FG000|Overall Study|Lost to Follow-up|2|||
125633824|NCT00033371|451941064|FG001|Overall Study|Lost to Follow-up|1|||
125633825|NCT00033371|451941063|FG000|Overall Study|Withdrawal by Subject|3|||
125633826|NCT00033371|451941064|FG001|Overall Study|Withdrawal by Subject|3|||
125633827|NCT00033371|451941063|FG000|Overall Study|Disease Progression|0|||
125633828|NCT00033371|451941064|FG001|Overall Study|Disease Progression|1|||
125633829|NCT02699125|451941065|FG000|Placebo|Lost to Follow-up|2|||
125633830|NCT02699125|451941066|FG001|Placebo|Lost to Follow-up|0|||
125633831|NCT02699125|451941065|FG000|Placebo|Protocol Violation|1|||
125633832|NCT02699125|451941066|FG001|Placebo|Protocol Violation|0|||
125633833|NCT02699125|451941065|FG000|Placebo|Withdrawal by Subject|0|||
125633834|NCT02699125|451941066|FG001|Placebo|Withdrawal by Subject|4|||
125633835|NCT02699125|451941065|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
125633836|NCT02699125|451941066|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
125633837|NCT03799627|451941071|FG000|Overall Study|Adverse Event|1|||
125633838|NCT03799627|451941072|FG001|Overall Study|Adverse Event|2|||
125633839|NCT03799627|451941073|FG002|Overall Study|Adverse Event|0|||
125633840|NCT03799627|451941074|FG003|Overall Study|Adverse Event|0|||
125633841|NCT03799627|451941075|FG004|Overall Study|Adverse Event|2|||
125633842|NCT03799627|451941076|FG005|Overall Study|Adverse Event|5|||
125633843|NCT03799627|451941077|FG006|Overall Study|Adverse Event|0|||
125633844|NCT03799627|451941078|FG007|Overall Study|Adverse Event|2|||
125633845|NCT03799627|451941079|FG008|Overall Study|Adverse Event|0|||
125633846|NCT03799627|451941071|FG000|Overall Study|Physician Decision|2|||
125633847|NCT03799627|451941072|FG001|Overall Study|Physician Decision|2|||
125633848|NCT03799627|451941073|FG002|Overall Study|Physician Decision|0|||
125633849|NCT03799627|451941074|FG003|Overall Study|Physician Decision|0|||
125633850|NCT03799627|451941075|FG004|Overall Study|Physician Decision|2|||
125633851|NCT03799627|451941076|FG005|Overall Study|Physician Decision|2|||
125633852|NCT03799627|451941077|FG006|Overall Study|Physician Decision|0|||
125633853|NCT03799627|451941078|FG007|Overall Study|Physician Decision|0|||
125633854|NCT03799627|451941079|FG008|Overall Study|Physician Decision|0|||
125633855|NCT03799627|451941071|FG000|Overall Study|Withdrawal by Subject|1|||
125633856|NCT03799627|451941072|FG001|Overall Study|Withdrawal by Subject|1|||
125633857|NCT03799627|451941073|FG002|Overall Study|Withdrawal by Subject|0|||
125633858|NCT03799627|451941074|FG003|Overall Study|Withdrawal by Subject|2|||
125633859|NCT03799627|451941075|FG004|Overall Study|Withdrawal by Subject|0|||
125633860|NCT03799627|451941076|FG005|Overall Study|Withdrawal by Subject|3|||
125633861|NCT03799627|451941077|FG006|Overall Study|Withdrawal by Subject|0|||
125633862|NCT03799627|451941078|FG007|Overall Study|Withdrawal by Subject|0|||
125633863|NCT03799627|451941079|FG008|Overall Study|Withdrawal by Subject|0|||
125633864|NCT03799627|451941071|FG000|Overall Study|Lack of Efficacy|0|||
125633865|NCT03799627|451941072|FG001|Overall Study|Lack of Efficacy|0|||
125633866|NCT03799627|451941073|FG002|Overall Study|Lack of Efficacy|0|||
125633867|NCT03799627|451941074|FG003|Overall Study|Lack of Efficacy|1|||
125633868|NCT03799627|451941075|FG004|Overall Study|Lack of Efficacy|0|||
125633869|NCT03799627|451941076|FG005|Overall Study|Lack of Efficacy|0|||
125633870|NCT03799627|451941077|FG006|Overall Study|Lack of Efficacy|0|||
125633871|NCT03799627|451941078|FG007|Overall Study|Lack of Efficacy|0|||
125633872|NCT03799627|451941079|FG008|Overall Study|Lack of Efficacy|0|||
125633873|NCT03799627|451941071|FG000|Overall Study|Lost to Follow-up|0|||
125633874|NCT03799627|451941072|FG001|Overall Study|Lost to Follow-up|0|||
125633875|NCT03799627|451941073|FG002|Overall Study|Lost to Follow-up|0|||
125633876|NCT03799627|451941074|FG003|Overall Study|Lost to Follow-up|0|||
125633877|NCT03799627|451941075|FG004|Overall Study|Lost to Follow-up|0|||
125633878|NCT03799627|451941076|FG005|Overall Study|Lost to Follow-up|0|||
125633879|NCT03799627|451941077|FG006|Overall Study|Lost to Follow-up|1|||
125633880|NCT03799627|451941078|FG007|Overall Study|Lost to Follow-up|0|||
125633881|NCT03799627|451941079|FG008|Overall Study|Lost to Follow-up|1|||
125633882|NCT03799627|451941071|FG000|Overall Study|Death|0|||
125633883|NCT03799627|451941072|FG001|Overall Study|Death|0|||
125633884|NCT03799627|451941073|FG002|Overall Study|Death|0|||
125633885|NCT03799627|451941074|FG003|Overall Study|Death|1|||
125633886|NCT03799627|451941075|FG004|Overall Study|Death|0|||
125633887|NCT03799627|451941076|FG005|Overall Study|Death|0|||
125633888|NCT03799627|451941077|FG006|Overall Study|Death|0|||
125633889|NCT03799627|451941078|FG007|Overall Study|Death|0|||
125633890|NCT03799627|451941079|FG008|Overall Study|Death|0|||
125633891|NCT03799627|451941071|FG000|Overall Study|Study Drug Put on Hold|1|||
125633892|NCT03799627|451941072|FG001|Overall Study|Study Drug Put on Hold|0|||
125633893|NCT03799627|451941073|FG002|Overall Study|Study Drug Put on Hold|0|||
125633894|NCT03799627|451941074|FG003|Overall Study|Study Drug Put on Hold|0|||
125633895|NCT03799627|451941075|FG004|Overall Study|Study Drug Put on Hold|0|||
125633896|NCT03799627|451941076|FG005|Overall Study|Study Drug Put on Hold|0|||
125633897|NCT03799627|451941077|FG006|Overall Study|Study Drug Put on Hold|0|||
125633898|NCT03799627|451941078|FG007|Overall Study|Study Drug Put on Hold|0|||
125633899|NCT03799627|451941079|FG008|Overall Study|Study Drug Put on Hold|0|||
125633900|NCT03799627|451941071|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
125633901|NCT03799627|451941072|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
125633902|NCT03799627|451941073|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
125633903|NCT03799627|451941074|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
125633904|NCT03799627|451941075|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
125633905|NCT03799627|451941076|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
125633906|NCT03799627|451941077|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
125633907|NCT03799627|451941078|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
125633908|NCT03799627|451941079|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
125633909|NCT03799627|451941071|FG000|Overall Study|Kidney Transplantation|1|||
125633910|NCT03799627|451941072|FG001|Overall Study|Kidney Transplantation|0|||
125633911|NCT03799627|451941073|FG002|Overall Study|Kidney Transplantation|0|||
125633912|NCT03799627|451941074|FG003|Overall Study|Kidney Transplantation|1|||
125633913|NCT03799627|451941075|FG004|Overall Study|Kidney Transplantation|1|||
125633914|NCT03799627|451941076|FG005|Overall Study|Kidney Transplantation|0|||
125633915|NCT03799627|451941077|FG006|Overall Study|Kidney Transplantation|0|||
125376956|NCT01442675|451010260|FG000|Overall Study|Withdrawal by Subject|4|||
125376957|NCT01919723|451010261|FG000|Overall Study|Blood Samples Hemolyzed|2|||
125376958|NCT01919723|451010262|FG001|Overall Study|Blood Samples Hemolyzed|2|||
125376959|NCT00752232|451010263|FG000|Overall Study|Protocol Violation|0|||
125633916|NCT03799627|451941078|FG007|Overall Study|Kidney Transplantation|0|||
125633917|NCT03799627|451941079|FG008|Overall Study|Kidney Transplantation|0|||
125633918|NCT03799627|451941071|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
125633919|NCT03799627|451941072|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
125633920|NCT03799627|451941073|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
125633921|NCT03799627|451941074|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
125633922|NCT03799627|451941075|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
125633923|NCT03799627|451941076|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
125633924|NCT03799627|451941077|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
125633925|NCT03799627|451941078|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
125633926|NCT03799627|451941079|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
125633927|NCT03799627|451941071|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125633928|NCT03799627|451941072|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
125633929|NCT03799627|451941073|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125633930|NCT03799627|451941074|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125633931|NCT03799627|451941075|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125633932|NCT03799627|451941076|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125633933|NCT03799627|451941077|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125633934|NCT03799627|451941078|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125633935|NCT03799627|451941079|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
125376960|NCT00752232|451010264|FG001|Overall Study|Protocol Violation|0|||
125376961|NCT00752232|451010265|FG002|Overall Study|Protocol Violation|0|||
125376962|NCT00752232|451010266|FG003|Overall Study|Protocol Violation|0|||
125376963|NCT00752232|451010267|FG004|Overall Study|Protocol Violation|0|||
125376964|NCT00752232|451010268|FG005|Overall Study|Protocol Violation|1|||
125376965|NCT00752232|451010269|FG006|Overall Study|Protocol Violation|0|||
125376966|NCT00752232|451010263|FG000|Overall Study|Caregiver request|2|||
125376967|NCT00752232|451010264|FG001|Overall Study|Caregiver request|0|||
125376968|NCT00752232|451010265|FG002|Overall Study|Caregiver request|0|||
125376969|NCT00752232|451010266|FG003|Overall Study|Caregiver request|0|||
125376970|NCT00752232|451010267|FG004|Overall Study|Caregiver request|1|||
125376971|NCT00752232|451010268|FG005|Overall Study|Caregiver request|0|||
125376972|NCT00752232|451010269|FG006|Overall Study|Caregiver request|0|||
125376973|NCT00752232|451010263|FG000|Overall Study|Investigator request|0|||
125376974|NCT00752232|451010264|FG001|Overall Study|Investigator request|0|||
125376975|NCT00752232|451010265|FG002|Overall Study|Investigator request|0|||
125376976|NCT00752232|451010266|FG003|Overall Study|Investigator request|0|||
125376977|NCT00752232|451010267|FG004|Overall Study|Investigator request|1|||
125376978|NCT00752232|451010268|FG005|Overall Study|Investigator request|0|||
125376979|NCT00752232|451010269|FG006|Overall Study|Investigator request|0|||
125376980|NCT00752232|451010263|FG000|Overall Study|Subject request|0|||
125376981|NCT00752232|451010264|FG001|Overall Study|Subject request|0|||
125376982|NCT00752232|451010265|FG002|Overall Study|Subject request|1|||
125376983|NCT00752232|451010266|FG003|Overall Study|Subject request|0|||
125376984|NCT00752232|451010267|FG004|Overall Study|Subject request|0|||
125376985|NCT00752232|451010268|FG005|Overall Study|Subject request|0|||
125376986|NCT00752232|451010269|FG006|Overall Study|Subject request|0|||
125376987|NCT00752232|451010263|FG000|Overall Study|Group home admission|0|||
125376988|NCT00752232|451010264|FG001|Overall Study|Group home admission|0|||
125376989|NCT00752232|451010265|FG002|Overall Study|Group home admission|0|||
125376990|NCT00752232|451010266|FG003|Overall Study|Group home admission|1|||
125633936|NCT03799627|451941071|FG000|Overall Study|Met Exclusion Criteria|0|||
125633937|NCT03799627|451941072|FG001|Overall Study|Met Exclusion Criteria|0|||
125633938|NCT03799627|451941073|FG002|Overall Study|Met Exclusion Criteria|0|||
125633939|NCT03799627|451941074|FG003|Overall Study|Met Exclusion Criteria|1|||
125633940|NCT03799627|451941075|FG004|Overall Study|Met Exclusion Criteria|0|||
125633941|NCT03799627|451941076|FG005|Overall Study|Met Exclusion Criteria|0|||
125633942|NCT03799627|451941077|FG006|Overall Study|Met Exclusion Criteria|0|||
125633943|NCT03799627|451941078|FG007|Overall Study|Met Exclusion Criteria|0|||
125633944|NCT03799627|451941079|FG008|Overall Study|Met Exclusion Criteria|0|||
125633945|NCT03799627|451941071|FG000|Overall Study|Investigational Product Noncompliance|0|||
125633946|NCT03799627|451941072|FG001|Overall Study|Investigational Product Noncompliance|0|||
125633947|NCT03799627|451941073|FG002|Overall Study|Investigational Product Noncompliance|0|||
125633948|NCT03799627|451941074|FG003|Overall Study|Investigational Product Noncompliance|1|||
125633949|NCT03799627|451941075|FG004|Overall Study|Investigational Product Noncompliance|0|||
125633950|NCT03799627|451941076|FG005|Overall Study|Investigational Product Noncompliance|0|||
125633951|NCT03799627|451941077|FG006|Overall Study|Investigational Product Noncompliance|0|||
125633952|NCT03799627|451941078|FG007|Overall Study|Investigational Product Noncompliance|0|||
125633953|NCT03799627|451941079|FG008|Overall Study|Investigational Product Noncompliance|0|||
125633954|NCT03799627|451941071|FG000|Overall Study|Participant Relocation|0|||
125633955|NCT03799627|451941072|FG001|Overall Study|Participant Relocation|0|||
125633956|NCT03799627|451941073|FG002|Overall Study|Participant Relocation|0|||
125633957|NCT03799627|451941074|FG003|Overall Study|Participant Relocation|1|||
125633958|NCT03799627|451941075|FG004|Overall Study|Participant Relocation|0|||
125633959|NCT03799627|451941076|FG005|Overall Study|Participant Relocation|1|||
125633960|NCT03799627|451941077|FG006|Overall Study|Participant Relocation|0|||
125633961|NCT03799627|451941078|FG007|Overall Study|Participant Relocation|0|||
125633962|NCT03799627|451941079|FG008|Overall Study|Participant Relocation|0|||
125633963|NCT03799627|451941071|FG000|Overall Study|Eurofin Issue|0|||
125633964|NCT03799627|451941072|FG001|Overall Study|Eurofin Issue|0|||
125633965|NCT03799627|451941073|FG002|Overall Study|Eurofin Issue|0|||
125633966|NCT03799627|451941074|FG003|Overall Study|Eurofin Issue|0|||
125633967|NCT03799627|451941075|FG004|Overall Study|Eurofin Issue|1|||
125633968|NCT03799627|451941076|FG005|Overall Study|Eurofin Issue|0|||
125633969|NCT03799627|451941077|FG006|Overall Study|Eurofin Issue|0|||
125633970|NCT03799627|451941078|FG007|Overall Study|Eurofin Issue|0|||
125633971|NCT03799627|451941079|FG008|Overall Study|Eurofin Issue|0|||
125633972|NCT03799627|451941071|FG000|Overall Study|Noncompliance with Site Instructions|0|||
125633973|NCT03799627|451941072|FG001|Overall Study|Noncompliance with Site Instructions|0|||
125633974|NCT03799627|451941073|FG002|Overall Study|Noncompliance with Site Instructions|0|||
125633975|NCT03799627|451941074|FG003|Overall Study|Noncompliance with Site Instructions|0|||
125633976|NCT03799627|451941075|FG004|Overall Study|Noncompliance with Site Instructions|1|||
125633977|NCT03799627|451941076|FG005|Overall Study|Noncompliance with Site Instructions|0|||
125633978|NCT03799627|451941077|FG006|Overall Study|Noncompliance with Site Instructions|0|||
125633979|NCT03799627|451941078|FG007|Overall Study|Noncompliance with Site Instructions|0|||
125633980|NCT03799627|451941079|FG008|Overall Study|Noncompliance with Site Instructions|0|||
125633981|NCT03799627|451941071|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125633982|NCT03799627|451941072|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125633983|NCT03799627|451941073|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125633984|NCT03799627|451941074|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125633985|NCT03799627|451941075|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
125633986|NCT03799627|451941076|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125633987|NCT03799627|451941077|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125633988|NCT03799627|451941078|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125633989|NCT03799627|451941079|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
125633990|NCT03799627|451941071|FG000|Overall Study|Changes In Hemoglobin Values|1|||
125633991|NCT03799627|451941072|FG001|Overall Study|Changes In Hemoglobin Values|2|||
125633992|NCT03799627|451941073|FG002|Overall Study|Changes In Hemoglobin Values|1|||
125633993|NCT03799627|451941074|FG003|Overall Study|Changes In Hemoglobin Values|0|||
125633994|NCT03799627|451941075|FG004|Overall Study|Changes In Hemoglobin Values|0|||
125633995|NCT03799627|451941076|FG005|Overall Study|Changes In Hemoglobin Values|2|||
125633996|NCT03799627|451941077|FG006|Overall Study|Changes In Hemoglobin Values|1|||
125633997|NCT03799627|451941078|FG007|Overall Study|Changes In Hemoglobin Values|0|||
125633998|NCT03799627|451941079|FG008|Overall Study|Changes In Hemoglobin Values|1|||
125633999|NCT02092324|451941082|FG000|Overall Study|Adverse Event|1|||
125634000|NCT02092324|451941082|FG000|Overall Study|Lack of Efficacy|6|||
125634001|NCT02092324|451941082|FG000|Overall Study|Proceed to Transplant|3|||
125634002|NCT02092324|451941082|FG000|Overall Study|Physician Decision|7|||
125634003|NCT02092324|451941082|FG000|Overall Study|Misdiagnosis|2|||
125634004|NCT01922739|451941089|FG000|Titration/Adjustment Period|Adverse Event|3|||
125634005|NCT01922739|451941089|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
125634006|NCT01922739|451941089|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
125216350|NCT04304508|450419439|FG003|Overall Study|Switching To Other Therapy|2|||
125216351|NCT04304508|450419436|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
125216352|NCT04304508|450419437|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
125216353|NCT04304508|450419438|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
125216354|NCT04304508|450419439|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
125216355|NCT04304508|450419436|FG000|Overall Study|Withdrawal by Subject|7|||
125216356|NCT04304508|450419437|FG001|Overall Study|Withdrawal by Subject|5|||
125216357|NCT04304508|450419438|FG002|Overall Study|Withdrawal by Subject|11|||
125216358|NCT04304508|450419439|FG003|Overall Study|Withdrawal by Subject|6|||
125216359|NCT04304508|450419436|FG000|Overall Study|Logistical Difficulties|2|||
125216360|NCT04304508|450419437|FG001|Overall Study|Logistical Difficulties|2|||
125216361|NCT04304508|450419438|FG002|Overall Study|Logistical Difficulties|3|||
125216362|NCT04304508|450419439|FG003|Overall Study|Logistical Difficulties|2|||
125216363|NCT04304508|450419436|FG000|Overall Study|Missing Information|1|||
125216364|NCT04304508|450419437|FG001|Overall Study|Missing Information|2|||
125216365|NCT04304508|450419438|FG002|Overall Study|Missing Information|1|||
125216366|NCT04304508|450419439|FG003|Overall Study|Missing Information|3|||
125216367|NCT04304508|450419436|FG000|Overall Study|Other|7|||
125216368|NCT04304508|450419437|FG001|Overall Study|Other|6|||
125216369|NCT04304508|450419438|FG002|Overall Study|Other|5|||
125216370|NCT04304508|450419439|FG003|Overall Study|Other|4|||
125216371|NCT04304508|450419436|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
125216372|NCT04304508|450419437|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
125216373|NCT04304508|450419438|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
125216374|NCT04304508|450419439|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
125216375|NCT04304508|450419436|FG000|Overall Study|Physician Decision|3|||
125216376|NCT04304508|450419437|FG001|Overall Study|Physician Decision|4|||
125216377|NCT04304508|450419438|FG002|Overall Study|Physician Decision|9|||
125216378|NCT04304508|450419439|FG003|Overall Study|Physician Decision|7|||
125216379|NCT04304508|450419436|FG000|Overall Study|Study drug never administered|10|||
125216380|NCT04304508|450419437|FG001|Overall Study|Study drug never administered|4|||
125216381|NCT04304508|450419438|FG002|Overall Study|Study drug never administered|4|||
125216382|NCT04304508|450419439|FG003|Overall Study|Study drug never administered|4|||
125216383|NCT04304508|450419436|FG000|Overall Study|Adverse Event|49|||
125216384|NCT04304508|450419437|FG001|Overall Study|Adverse Event|50|||
125216385|NCT04304508|450419438|FG002|Overall Study|Adverse Event|51|||
125216386|NCT04304508|450419439|FG003|Overall Study|Adverse Event|56|||
125216387|NCT04304508|450419436|FG000|Overall Study|Lost to Follow-up|1|||
125216388|NCT04304508|450419437|FG001|Overall Study|Lost to Follow-up|5|||
125216389|NCT04304508|450419438|FG002|Overall Study|Lost to Follow-up|2|||
125216390|NCT04304508|450419439|FG003|Overall Study|Lost to Follow-up|3|||
125216391|NCT02688764|450419440|FG000|Overall Study|Adverse Event|3|||
125216392|NCT02688764|450419441|FG001|Overall Study|Adverse Event|3|||
125216393|NCT02688764|450419440|FG000|Overall Study|AE/Kidney transplant|1|||
125216394|NCT02688764|450419441|FG001|Overall Study|AE/Kidney transplant|0|||
125216395|NCT02688764|450419440|FG000|Overall Study|AE/Lack of efficacy|1|||
125216396|NCT02688764|450419441|FG001|Overall Study|AE/Lack of efficacy|0|||
125216397|NCT02688764|450419440|FG000|Overall Study|AE/Non-compl.|1|||
125216398|NCT02688764|450419441|FG001|Overall Study|AE/Non-compl.|0|||
125216399|NCT02688764|450419440|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
125216400|NCT02688764|450419441|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
125216401|NCT02688764|450419440|FG000|Overall Study|AE/Other|0|||
125216402|NCT02688764|450419441|FG001|Overall Study|AE/Other|1|||
125216403|NCT02688764|450419440|FG000|Overall Study|AE/Physician decision|1|||
125216404|NCT02688764|450419441|FG001|Overall Study|AE/Physician decision|0|||
125216405|NCT02688764|450419440|FG000|Overall Study|AE/Withd. parent|3|||
125216406|NCT02688764|450419441|FG001|Overall Study|AE/Withd. parent|0|||
125216407|NCT02688764|450419440|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
125216408|NCT02688764|450419441|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
125216409|NCT02688764|450419440|FG000|Overall Study|AE/Withd. subject|1|||
125216410|NCT02688764|450419441|FG001|Overall Study|AE/Withd. subject|0|||
125216411|NCT02688764|450419440|FG000|Overall Study|Kidney transplant|10|||
125216412|NCT02688764|450419441|FG001|Overall Study|Kidney transplant|4|||
125216413|NCT02688764|450419440|FG000|Overall Study|Lack of Efficacy|3|||
125216414|NCT02688764|450419441|FG001|Overall Study|Lack of Efficacy|2|||
125216415|NCT02688764|450419440|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
125216416|NCT02688764|450419441|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
125216417|NCT02688764|450419440|FG000|Overall Study|Non-compliance with study drug|4|||
125216418|NCT02688764|450419441|FG001|Overall Study|Non-compliance with study drug|0|||
125216419|NCT02688764|450419440|FG000|Overall Study|Non-compl./Physician decision|2|||
125216420|NCT02688764|450419441|FG001|Overall Study|Non-compl./Physician decision|0|||
125216421|NCT02688764|450419440|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
125216422|NCT02688764|450419441|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
125216423|NCT02688764|450419440|FG000|Overall Study|Non-compl./Withd. subject|0|||
125216424|NCT02688764|450419441|FG001|Overall Study|Non-compl./Withd. subject|2|||
125216425|NCT02688764|450419440|FG000|Overall Study|Phosphorus level outside safe range|0|||
125129820|NCT04605094|450102442|FG000|Overall Study|Lost to Follow-up|1|||
125129821|NCT04605094|450102443|FG001|Overall Study|Lost to Follow-up|4|||
125129822|NCT04605094|450102442|FG000|Overall Study|Physician Decision|2|||
125129823|NCT04605094|450102443|FG001|Overall Study|Physician Decision|2|||
125129824|NCT04605094|450102442|FG000|Overall Study|Study terminated by Sponsor|31|||
125634007|NCT01922739|451941089|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
125634008|NCT01922739|451941089|FG000|Open-label Treatment Period|Adverse Event|6|||
125634009|NCT01922739|451941089|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
125634010|NCT01922739|451941089|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
125634011|NCT01922739|451941089|FG000|Open-label Treatment Period|Protocol Violation|5|||
125634012|NCT01922739|451941089|FG000|Open-label Treatment Period|Pregnancy|1|||
125129825|NCT04605094|450102443|FG001|Overall Study|Study terminated by Sponsor|33|||
125129826|NCT04605094|450102442|FG000|Overall Study|Withdrawal by Subject|22|||
125129827|NCT04605094|450102443|FG001|Overall Study|Withdrawal by Subject|19|||
125129828|NCT04605094|450102442|FG000|Overall Study|Other|1|||
125129829|NCT04605094|450102443|FG001|Overall Study|Other|1|||
125129830|NCT02724462|450102444|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
125129831|NCT02724462|450102445|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
125129832|NCT02724462|450102444|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
125129833|NCT02724462|450102445|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
125129834|NCT02724462|450102444|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
125129835|NCT02724462|450102445|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
125129836|NCT02724462|450102444|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
125129837|NCT02724462|450102445|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
125129838|NCT02724462|450102444|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
125129839|NCT02724462|450102445|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
125129840|NCT02724462|450102444|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
125129841|NCT02724462|450102445|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
125129842|NCT01900691|450102446|FG000|Overall Study|Death|7|||
125129843|NCT01900691|450102446|FG000|Overall Study|Lost to Follow-up|4|||
125129844|NCT01900691|450102446|FG000|Overall Study|Study Device Not Placed|3|||
125129845|NCT01900691|450102446|FG000|Overall Study|Non study stent placed|2|||
125129846|NCT01900691|450102446|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
125129847|NCT01900691|450102446|FG000|Overall Study|Complete stent migration through digestive tract|1|||
125129848|NCT02128997|450102454|FG000|Overall Study|Lost to Follow-up|6|||
125129849|NCT02128997|450102455|FG001|Overall Study|Lost to Follow-up|11|||
125129850|NCT02422264|450102464|FG000|Overall Study|Serious Adverse Event|1|||
125129851|NCT02422264|450102465|FG001|Overall Study|Serious Adverse Event|0|||
125129852|NCT02422264|450102464|FG000|Overall Study|Withdrawal by Subject|1|||
125129853|NCT02422264|450102465|FG001|Overall Study|Withdrawal by Subject|2|||
125129854|NCT02422264|450102464|FG000|Overall Study|Migrated/moved from study area|3|||
125216426|NCT02688764|450419441|FG001|Overall Study|Phosphorus level outside safe range|1|||
125216427|NCT02688764|450419440|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
125216428|NCT02688764|450419441|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
125216429|NCT02688764|450419440|FG000|Overall Study|Study drug taste/Withd. parent|1|||
125216430|NCT02688764|450419441|FG001|Overall Study|Study drug taste/Withd. parent|0|||
125216431|NCT02688764|450419440|FG000|Overall Study|Subject moving out|2|||
125216432|NCT02688764|450419441|FG001|Overall Study|Subject moving out|0|||
125216433|NCT02688764|450419440|FG000|Overall Study|Subject taken off dialysis|1|||
125216434|NCT02688764|450419441|FG001|Overall Study|Subject taken off dialysis|0|||
125216435|NCT02688764|450419440|FG000|Overall Study|Withdrawal by parent|3|||
125216436|NCT02688764|450419441|FG001|Overall Study|Withdrawal by parent|0|||
125216437|NCT02113007|450419442|FG000|Overall Study|Progressive disease|2|||
125216438|NCT00885378|450419443|FG000|Overall Study|Lack of Efficacy|2|||
125216439|NCT00885378|450419444|FG001|Overall Study|Lack of Efficacy|2|||
125129855|NCT02422264|450102465|FG001|Overall Study|Migrated/moved from study area|1|||
125129856|NCT02422264|450102464|FG000|Overall Study|Subject vaccinated outside of the study|0|||
125216440|NCT00885378|450419443|FG000|Overall Study|Withdrawal by Subject|1|||
125216441|NCT00885378|450419444|FG001|Overall Study|Withdrawal by Subject|2|||
125216442|NCT00885378|450419443|FG000|Overall Study|Lost to Follow-up|1|||
125216443|NCT00885378|450419444|FG001|Overall Study|Lost to Follow-up|2|||
125216444|NCT00885378|450419443|FG000|Overall Study|Poor/Noncompliance|2|||
125129857|NCT02422264|450102465|FG001|Overall Study|Subject vaccinated outside of the study|1|||
125129858|NCT03874715|450102467|FG000|Overall Study|Adverse Event|2|||
125216445|NCT00885378|450419444|FG001|Overall Study|Poor/Noncompliance|2|||
125216446|NCT00885378|450419443|FG000|Overall Study|Protocol Violation|2|||
125216447|NCT00885378|450419444|FG001|Overall Study|Protocol Violation|0|||
125216448|NCT04750278|450419445|FG000|Overall Study|Death|9|||
125216449|NCT04750278|450419446|FG001|Overall Study|Death|10|||
125216450|NCT04750278|450419447|FG002|Overall Study|Death|10|||
125216451|NCT04750278|450419445|FG000|Overall Study|Withdrawal by Subject|4|||
125216452|NCT04750278|450419446|FG001|Overall Study|Withdrawal by Subject|1|||
125216453|NCT04750278|450419447|FG002|Overall Study|Withdrawal by Subject|2|||
125216454|NCT04750278|450419445|FG000|Overall Study|Lost to Follow-up|1|||
125216455|NCT04750278|450419446|FG001|Overall Study|Lost to Follow-up|1|||
125216456|NCT04750278|450419447|FG002|Overall Study|Lost to Follow-up|1|||
125216457|NCT04750278|450419445|FG000|Overall Study|Pregnancy|1|||
125216458|NCT04750278|450419446|FG001|Overall Study|Pregnancy|0|||
125216459|NCT04750278|450419447|FG002|Overall Study|Pregnancy|0|||
125216460|NCT04750278|450419445|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
125216461|NCT04750278|450419446|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
125216462|NCT04750278|450419447|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
125216463|NCT04750278|450419445|FG000|Overall Study|Non-compliance|0|||
125216464|NCT04750278|450419446|FG001|Overall Study|Non-compliance|0|||
125216465|NCT04750278|450419447|FG002|Overall Study|Non-compliance|1|||
125216466|NCT04750278|450419445|FG000|Overall Study|Transfer to Outside Facility|0|||
125216467|NCT04750278|450419446|FG001|Overall Study|Transfer to Outside Facility|2|||
125216468|NCT04750278|450419447|FG002|Overall Study|Transfer to Outside Facility|1|||
125216469|NCT04750278|450419445|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
125216470|NCT04750278|450419446|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
125129859|NCT03874715|450102468|FG001|Overall Study|Adverse Event|0|||
125129860|NCT03874715|450102467|FG000|Overall Study|Poor compliance to protocol|5|||
125129861|NCT03874715|450102468|FG001|Overall Study|Poor compliance to protocol|1|||
125129862|NCT03874715|450102467|FG000|Overall Study|Withdrawal by Subject|1|||
125129863|NCT03874715|450102468|FG001|Overall Study|Withdrawal by Subject|0|||
125129864|NCT03874715|450102467|FG000|Overall Study|Other-unspecified|1|||
125129865|NCT03874715|450102468|FG001|Overall Study|Other-unspecified|0|||
125129866|NCT00851877|450102471|FG000|Phase I-1|Death|1|||
125129867|NCT00851877|450102472|FG001|Phase I-1|Death|0|||
125129868|NCT00851877|450102473|FG002|Phase I-1|Death|0|||
125129869|NCT00851877|450102471|FG000|Phase II|Withdrawal by Subject|0|||
125129870|NCT00851877|450102472|FG001|Phase II|Withdrawal by Subject|0|||
125129871|NCT00851877|450102473|FG002|Phase II|Withdrawal by Subject|3|||
125216471|NCT04750278|450419447|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
125216472|NCT04750278|450419445|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
125216473|NCT04750278|450419446|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
125129872|NCT00829673|450102474|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125129873|NCT00829673|450102475|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125129874|NCT00573066|450102476|FG000|Overall Study|Exclusion criteria|18|||
125129875|NCT00573066|450102476|FG000|Overall Study|IV malfunction|1|||
125129876|NCT00573066|450102476|FG000|Overall Study|Postoperative bleeding|1|||
125129877|NCT01034358|450102477|FG000|Overall Study|Withdrawal by Subject|1|||
125129878|NCT01034358|450102477|FG000|Overall Study|Protocol Violation|1|||
125129879|NCT00829790|450102480|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
125129880|NCT00829790|450102481|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
125129881|NCT01534663|450102482|FG000|Overall Study|Lost to Follow-up|0|||
125129882|NCT01534663|450102483|FG001|Overall Study|Lost to Follow-up|2|||
125129883|NCT01534663|450102482|FG000|Overall Study|Adverse Event|2|||
125129884|NCT01534663|450102483|FG001|Overall Study|Adverse Event|1|||
125376991|NCT00752232|451010267|FG004|Overall Study|Group home admission|0|||
125376992|NCT00752232|451010268|FG005|Overall Study|Group home admission|0|||
125376993|NCT00752232|451010269|FG006|Overall Study|Group home admission|0|||
125634013|NCT01922739|451941089|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
125634014|NCT01922739|451941089|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
125634015|NCT01922739|451941089|FG000|Open-label Treatment Period|Physician Decision|1|||
125634016|NCT01922739|451941089|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
125634017|NCT02725268|451941092|FG000|Overall Study|Death|58|||
125634018|NCT02725268|451941093|FG001|Overall Study|Death|59|||
125634019|NCT02725268|451941094|FG002|Overall Study|Death|30|||
125634020|NCT02725268|451941095|FG003|Overall Study|Death|16|||
125634021|NCT02725268|451941092|FG000|Overall Study|Lost to Follow-up|4|||
125634022|NCT02725268|451941093|FG001|Overall Study|Lost to Follow-up|3|||
125634023|NCT02725268|451941094|FG002|Overall Study|Lost to Follow-up|0|||
125634024|NCT02725268|451941095|FG003|Overall Study|Lost to Follow-up|1|||
125634025|NCT02725268|451941092|FG000|Overall Study|Site Terminated by Sponsor|0|||
125634026|NCT02725268|451941093|FG001|Overall Study|Site Terminated by Sponsor|1|||
125634027|NCT02725268|451941094|FG002|Overall Study|Site Terminated by Sponsor|0|||
125634028|NCT02725268|451941095|FG003|Overall Study|Site Terminated by Sponsor|0|||
125634029|NCT02725268|451941092|FG000|Overall Study|Withdrawal by Subject|8|||
125634030|NCT02725268|451941093|FG001|Overall Study|Withdrawal by Subject|6|||
125634031|NCT02725268|451941094|FG002|Overall Study|Withdrawal by Subject|8|||
125634032|NCT02725268|451941095|FG003|Overall Study|Withdrawal by Subject|1|||
125634033|NCT02725268|451941092|FG000|Overall Study|Reason not Specified|2|||
125634034|NCT02725268|451941093|FG001|Overall Study|Reason not Specified|1|||
125634035|NCT02725268|451941094|FG002|Overall Study|Reason not Specified|0|||
125634036|NCT02725268|451941095|FG003|Overall Study|Reason not Specified|0|||
125634037|NCT04498468|451941096|FG000|Overall Study|Lost to Follow-up|3|||
125634038|NCT02224274|451941098|FG000|Overall Study|Death|1|||
125634039|NCT02224274|451941099|FG001|Overall Study|Death|0|||
125634040|NCT01976624|451941100|FG000|Overall Study|Participants contraindicated|2|||
125634041|NCT01976624|451941100|FG000|Overall Study|Participants age less than 19 years|12|||
125634042|NCT04350372|451941101|FG000|Overall Study|Death|1|||
125634043|NCT00412113|451941103|FG000|Overall Study|Adverse Event|11|||
125634044|NCT00412113|451941104|FG001|Overall Study|Adverse Event|15|||
125634045|NCT00412113|451941103|FG000|Overall Study|did not receive treatment|1|||
125634046|NCT00412113|451941104|FG001|Overall Study|did not receive treatment|0|||
125634047|NCT01190020|451941107|FG000|Overall Study|Adverse Event|2|||
125634048|NCT01190020|451941108|FG001|Overall Study|Adverse Event|0|||
125634049|NCT01190020|451941107|FG000|Overall Study|Lost to Follow-up|2|||
125634050|NCT01190020|451941108|FG001|Overall Study|Lost to Follow-up|0|||
125129885|NCT00627016|450102484|FG000|Overall Study|Adverse Event|1|||
125129886|NCT00627016|450102485|FG001|Overall Study|Adverse Event|1|||
125129887|NCT00627016|450102484|FG000|Overall Study|Protocol Violation|0|||
125129888|NCT00627016|450102485|FG001|Overall Study|Protocol Violation|2|||
125129889|NCT00627016|450102484|FG000|Overall Study|Lost to Follow-up|0|||
125129890|NCT00627016|450102485|FG001|Overall Study|Lost to Follow-up|1|||
125129891|NCT00627016|450102484|FG000|Overall Study|Withdrawal by Subject|2|||
125129892|NCT00627016|450102485|FG001|Overall Study|Withdrawal by Subject|1|||
125129893|NCT00627016|450102484|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
125129894|NCT00627016|450102485|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
125129895|NCT00627016|450102484|FG000|Overall Study|Lack of Efficacy|1|||
125129896|NCT00627016|450102485|FG001|Overall Study|Lack of Efficacy|0|||
125129897|NCT00627016|450102484|FG000|Overall Study|Placed on Excluded Drugs|1|||
125129898|NCT00627016|450102485|FG001|Overall Study|Placed on Excluded Drugs|0|||
125129899|NCT00627016|450102484|FG000|Overall Study|Pregnancy|1|||
125129900|NCT00627016|450102485|FG001|Overall Study|Pregnancy|0|||
125129901|NCT03107091|450102486|FG000|Overall Study|Physician Decision|1|||
125129902|NCT04567186|450102487|FG000|Period 1|COVID-19 related|1|||
125129903|NCT04567186|450102488|FG001|Period 1|COVID-19 related|0|||
125216474|NCT04750278|450419447|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
125216475|NCT01775787|450419448|FG000|First 7-10 Days|Adverse Event|0|||
125216476|NCT01775787|450419449|FG001|First 7-10 Days|Adverse Event|1|||
125216477|NCT01775787|450419448|FG000|First 7-10 Days|family emergency|0|||
125129904|NCT04567186|450102487|FG000|Period 1|Protocol Violation|0|||
125129905|NCT04567186|450102488|FG001|Period 1|Protocol Violation|1|||
125129906|NCT04567186|450102487|FG000|Period 1|Adverse Event|0|||
125634051|NCT01190020|451941107|FG000|Overall Study|Withdrawal by Subject|3|||
125634052|NCT01190020|451941108|FG001|Overall Study|Withdrawal by Subject|0|||
125634053|NCT01627782|451941111|FG000|Overall Study|Adverse Event|1|||
125634054|NCT01627782|451941112|FG001|Overall Study|Adverse Event|2|||
125634055|NCT01627782|451941113|FG002|Overall Study|Adverse Event|0|||
125634056|NCT01627782|451941114|FG003|Overall Study|Adverse Event|1|||
125634057|NCT01627782|451941111|FG000|Overall Study|Lack of Efficacy|11|||
125634058|NCT01627782|451941112|FG001|Overall Study|Lack of Efficacy|1|||
125634059|NCT01627782|451941113|FG002|Overall Study|Lack of Efficacy|15|||
125634060|NCT01627782|451941114|FG003|Overall Study|Lack of Efficacy|2|||
125634061|NCT01627782|451941111|FG000|Overall Study|Protocol Violation|1|||
125634062|NCT01627782|451941112|FG001|Overall Study|Protocol Violation|0|||
125634063|NCT01627782|451941113|FG002|Overall Study|Protocol Violation|0|||
125634064|NCT01627782|451941114|FG003|Overall Study|Protocol Violation|0|||
125634065|NCT01627782|451941111|FG000|Overall Study|Withdrawal by Subject|2|||
125634066|NCT01627782|451941112|FG001|Overall Study|Withdrawal by Subject|1|||
125634067|NCT01627782|451941113|FG002|Overall Study|Withdrawal by Subject|0|||
125634068|NCT01627782|451941114|FG003|Overall Study|Withdrawal by Subject|0|||
125634069|NCT01627782|451941111|FG000|Overall Study|Other|0|||
125634070|NCT01627782|451941112|FG001|Overall Study|Other|2|||
125634071|NCT01627782|451941113|FG002|Overall Study|Other|0|||
125634072|NCT01627782|451941114|FG003|Overall Study|Other|3|||
125634073|NCT01627782|451941111|FG000|Overall Study|Randomized But Not Treated|1|||
125634074|NCT01627782|451941112|FG001|Overall Study|Randomized But Not Treated|0|||
125634075|NCT01627782|451941113|FG002|Overall Study|Randomized But Not Treated|0|||
125634076|NCT01627782|451941114|FG003|Overall Study|Randomized But Not Treated|0|||
125634077|NCT03573401|451941115|FG000|Overall Study|Withdrawal by Subject|2|||
125634078|NCT03573401|451941116|FG001|Overall Study|Withdrawal by Subject|0|||
125634079|NCT03573401|451941115|FG000|Overall Study|Subject non-compliance with study schedule|1|||
125634080|NCT03573401|451941116|FG001|Overall Study|Subject non-compliance with study schedule|0|||
125634081|NCT03573401|451941115|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
125634082|NCT03573401|451941116|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
125634083|NCT03573401|451941115|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
125129907|NCT04567186|450102488|FG001|Period 1|Adverse Event|2|||
125129908|NCT04567186|450102487|FG000|Period 2|COVID-19 Related|0|||
125129909|NCT04567186|450102488|FG001|Period 2|COVID-19 Related|1|||
125129910|NCT04567186|450102487|FG000|Period 2|Protocol Violation|0|||
125129911|NCT04567186|450102488|FG001|Period 2|Protocol Violation|1|||
125129912|NCT04567186|450102487|FG000|Period 2|Lost to Follow-up|0|||
125129913|NCT04567186|450102488|FG001|Period 2|Lost to Follow-up|1|||
125129914|NCT04567186|450102487|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
125129915|NCT04567186|450102488|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
125129916|NCT01185548|450102491|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
125129917|NCT02331394|450102492|FG000|Overall Study|Disease progression|1|||
125129918|NCT01313273|450102493|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
125129919|NCT01313273|450102494|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
125129920|NCT01313273|450102493|FG000|Overall Study|Withdrawal by Subject|1|||
125129921|NCT01313273|450102494|FG001|Overall Study|Withdrawal by Subject|0|||
125129922|NCT01313273|450102493|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
125129923|NCT01313273|450102494|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
125129924|NCT03687736|450102495|FG000|Overall Study|Lost to Follow-up|7|||
125129925|NCT03687736|450102495|FG000|Overall Study|Withdrawal by Subject|3|||
125129926|NCT02459951|450102496|FG000|Overall Study|Unable to meet holding requirement|1|||
125129927|NCT00102440|450102497|FG000|Overall Study|Lost to Follow-up|25|||
125129928|NCT00102440|450102498|FG001|Overall Study|Lost to Follow-up|18|||
125129929|NCT00102440|450102499|FG002|Overall Study|Lost to Follow-up|21|||
125129930|NCT00102440|450102497|FG000|Overall Study|Adverse Event|16|||
125129931|NCT00102440|450102498|FG001|Overall Study|Adverse Event|23|||
125129932|NCT00102440|450102499|FG002|Overall Study|Adverse Event|8|||
125129933|NCT00102440|450102497|FG000|Overall Study|Gout Flare|10|||
125129934|NCT00102440|450102498|FG001|Overall Study|Gout Flare|28|||
125634084|NCT03573401|451941116|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
125129935|NCT00102440|450102499|FG002|Overall Study|Gout Flare|9|||
125129936|NCT00102440|450102497|FG000|Overall Study|Personal Reason(s)|19|||
125129937|NCT00102440|450102498|FG001|Overall Study|Personal Reason(s)|13|||
125129938|NCT00102440|450102499|FG002|Overall Study|Personal Reason(s)|13|||
125129939|NCT00102440|450102497|FG000|Overall Study|Other|11|||
125129940|NCT00102440|450102498|FG001|Overall Study|Other|14|||
125129941|NCT00102440|450102499|FG002|Overall Study|Other|14|||
125129942|NCT00102440|450102497|FG000|Overall Study|Protocol Violation|7|||
125634085|NCT00777257|451942870|FG000|Overall Study|Adverse Event|3|||
125129943|NCT00102440|450102498|FG001|Overall Study|Protocol Violation|2|||
125129944|NCT00102440|450102499|FG002|Overall Study|Protocol Violation|1|||
125129945|NCT02255097|450102500|FG000|Overall Study|Death|151|||
125129946|NCT02255097|450102500|FG000|Overall Study|Lost to Follow-up|5|||
125129947|NCT02255097|450102500|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
125216478|NCT01775787|450419449|FG001|First 7-10 Days|family emergency|1|||
125129948|NCT02255097|450102500|FG000|Overall Study|Withdrawal by Subject|7|||
125129949|NCT02255097|450102500|FG000|Overall Study|Allocated but not treated|1|||
125634086|NCT00777257|451942871|FG001|Overall Study|Adverse Event|1|||
125634087|NCT00777257|451942872|FG002|Overall Study|Adverse Event|0|||
125634088|NCT00777257|451942870|FG000|Overall Study|Lost to Follow-up|3|||
125376994|NCT00752232|451010263|FG000|Overall Study|Caregiver could not attend the subject|0|||
125376995|NCT00752232|451010264|FG001|Overall Study|Caregiver could not attend the subject|0|||
125376996|NCT00752232|451010265|FG002|Overall Study|Caregiver could not attend the subject|0|||
125376997|NCT00752232|451010266|FG003|Overall Study|Caregiver could not attend the subject|0|||
125376998|NCT00752232|451010267|FG004|Overall Study|Caregiver could not attend the subject|1|||
125376999|NCT00752232|451010268|FG005|Overall Study|Caregiver could not attend the subject|0|||
125377000|NCT00752232|451010269|FG006|Overall Study|Caregiver could not attend the subject|0|||
125377001|NCT04502589|451010270|FG000|Overall Study|Physician Decision|1|||
125377002|NCT04502589|451010271|FG001|Overall Study|Physician Decision|0|||
125377003|NCT00555321|451010272|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
125377004|NCT00555321|451010273|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
125377005|NCT00555321|451010274|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
125377006|NCT00555321|451010275|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
125377007|NCT00555321|451010276|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
125377008|NCT00555321|451010272|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
125377009|NCT00555321|451010273|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
125377010|NCT00555321|451010274|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
125377011|NCT00555321|451010275|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
125377012|NCT00555321|451010276|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
125377013|NCT00555321|451010272|FG000|Treatment Phase up to 12-months|Death|2|||
125377014|NCT00555321|451010273|FG001|Treatment Phase up to 12-months|Death|1|||
125377015|NCT00555321|451010274|FG002|Treatment Phase up to 12-months|Death|4|||
125377016|NCT00555321|451010275|FG003|Treatment Phase up to 12-months|Death|0|||
125377017|NCT00555321|451010276|FG004|Treatment Phase up to 12-months|Death|0|||
125377018|NCT00555321|451010272|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
125377019|NCT00555321|451010273|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
125377020|NCT00555321|451010274|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
125634089|NCT00777257|451942871|FG001|Overall Study|Lost to Follow-up|3|||
125634090|NCT00777257|451942872|FG002|Overall Study|Lost to Follow-up|2|||
125634091|NCT00777257|451942870|FG000|Overall Study|Protocol Violation|2|||
125634092|NCT00777257|451942871|FG001|Overall Study|Protocol Violation|2|||
125634093|NCT00777257|451942872|FG002|Overall Study|Protocol Violation|2|||
125634094|NCT00777257|451942870|FG000|Overall Study|Withdrawal by Subject|3|||
125634095|NCT00777257|451942871|FG001|Overall Study|Withdrawal by Subject|6|||
125634096|NCT00777257|451942872|FG002|Overall Study|Withdrawal by Subject|5|||
125634097|NCT04315298|451942873|FG000|Overall Study|Withdrawal by Subject|0|||
125634098|NCT04315298|451942874|FG001|Overall Study|Withdrawal by Subject|0|||
125634099|NCT04315298|451942875|FG002|Overall Study|Withdrawal by Subject|0|||
125634100|NCT04315298|451942876|FG003|Overall Study|Withdrawal by Subject|2|||
125634101|NCT04315298|451942877|FG004|Overall Study|Withdrawal by Subject|2|||
125634102|NCT04315298|451942878|FG005|Overall Study|Withdrawal by Subject|2|||
125634103|NCT04315298|451942879|FG006|Overall Study|Withdrawal by Subject|0|||
125634104|NCT04315298|451942880|FG007|Overall Study|Withdrawal by Subject|1|||
125634105|NCT04315298|451942881|FG008|Overall Study|Withdrawal by Subject|1|||
125634106|NCT04315298|451942882|FG009|Overall Study|Withdrawal by Subject|1|||
125634107|NCT04315298|451942883|FG010|Overall Study|Withdrawal by Subject|0|||
125634108|NCT04315298|451942884|FG011|Overall Study|Withdrawal by Subject|0|||
125634109|NCT04315298|451942885|FG012|Overall Study|Withdrawal by Subject|0|||
125634110|NCT04315298|451942886|FG013|Overall Study|Withdrawal by Subject|0|||
125634111|NCT04315298|451942887|FG014|Overall Study|Withdrawal by Subject|0|||
125634112|NCT04315298|451942888|FG015|Overall Study|Withdrawal by Subject|0|||
125634113|NCT04315298|451942889|FG016|Overall Study|Withdrawal by Subject|0|||
125634114|NCT04315298|451942890|FG017|Overall Study|Withdrawal by Subject|0|||
125634115|NCT04315298|451942891|FG018|Overall Study|Withdrawal by Subject|0|||
125634116|NCT04315298|451942873|FG000|Overall Study|Physician Decision|0|||
125634117|NCT04315298|451942874|FG001|Overall Study|Physician Decision|0|||
125634118|NCT04315298|451942875|FG002|Overall Study|Physician Decision|0|||
125634119|NCT04315298|451942876|FG003|Overall Study|Physician Decision|0|||
125634120|NCT04315298|451942877|FG004|Overall Study|Physician Decision|1|||
125129950|NCT01010542|450102504|FG000|Overall Study|Adverse Event|0|||
125129951|NCT01010542|450102505|FG001|Overall Study|Adverse Event|1|||
125129952|NCT01010542|450102506|FG002|Overall Study|Adverse Event|0|||
125129953|NCT01010542|450102504|FG000|Overall Study|Lost to Follow-up|0|||
125634121|NCT04315298|451942878|FG005|Overall Study|Physician Decision|0|||
125634122|NCT04315298|451942879|FG006|Overall Study|Physician Decision|0|||
125634123|NCT04315298|451942880|FG007|Overall Study|Physician Decision|0|||
125634124|NCT04315298|451942881|FG008|Overall Study|Physician Decision|0|||
125129954|NCT01010542|450102505|FG001|Overall Study|Lost to Follow-up|1|||
125634125|NCT04315298|451942882|FG009|Overall Study|Physician Decision|0|||
125634126|NCT04315298|451942883|FG010|Overall Study|Physician Decision|0|||
125634127|NCT04315298|451942884|FG011|Overall Study|Physician Decision|0|||
125634128|NCT04315298|451942885|FG012|Overall Study|Physician Decision|0|||
125634129|NCT04315298|451942886|FG013|Overall Study|Physician Decision|0|||
125634130|NCT04315298|451942887|FG014|Overall Study|Physician Decision|0|||
125634131|NCT04315298|451942888|FG015|Overall Study|Physician Decision|0|||
125634132|NCT04315298|451942889|FG016|Overall Study|Physician Decision|0|||
125634133|NCT04315298|451942890|FG017|Overall Study|Physician Decision|0|||
125634134|NCT04315298|451942891|FG018|Overall Study|Physician Decision|0|||
125634135|NCT04315298|451942873|FG000|Overall Study|Lost to Follow-up|5|||
125634136|NCT04315298|451942874|FG001|Overall Study|Lost to Follow-up|10|||
125634137|NCT04315298|451942875|FG002|Overall Study|Lost to Follow-up|6|||
125634138|NCT04315298|451942876|FG003|Overall Study|Lost to Follow-up|8|||
125634139|NCT04315298|451942877|FG004|Overall Study|Lost to Follow-up|12|||
125634140|NCT04315298|451942878|FG005|Overall Study|Lost to Follow-up|13|||
125634141|NCT04315298|451942879|FG006|Overall Study|Lost to Follow-up|9|||
125634142|NCT04315298|451942880|FG007|Overall Study|Lost to Follow-up|16|||
125634143|NCT04315298|451942881|FG008|Overall Study|Lost to Follow-up|14|||
125634144|NCT04315298|451942882|FG009|Overall Study|Lost to Follow-up|0|||
125634145|NCT04315298|451942883|FG010|Overall Study|Lost to Follow-up|2|||
125634146|NCT04315298|451942884|FG011|Overall Study|Lost to Follow-up|1|||
125634147|NCT04315298|451942885|FG012|Overall Study|Lost to Follow-up|0|||
125634148|NCT04315298|451942886|FG013|Overall Study|Lost to Follow-up|0|||
125634149|NCT04315298|451942887|FG014|Overall Study|Lost to Follow-up|0|||
125634150|NCT04315298|451942888|FG015|Overall Study|Lost to Follow-up|2|||
125634151|NCT04315298|451942889|FG016|Overall Study|Lost to Follow-up|0|||
125634152|NCT04315298|451942890|FG017|Overall Study|Lost to Follow-up|0|||
125634153|NCT04315298|451942891|FG018|Overall Study|Lost to Follow-up|0|||
125634154|NCT04315298|451942873|FG000|Overall Study|Death|24|||
125634155|NCT04315298|451942874|FG001|Overall Study|Death|60|||
125634156|NCT04315298|451942875|FG002|Overall Study|Death|49|||
125634157|NCT04315298|451942876|FG003|Overall Study|Death|59|||
125634158|NCT04315298|451942877|FG004|Overall Study|Death|70|||
125634159|NCT04315298|451942878|FG005|Overall Study|Death|114|||
125634160|NCT04315298|451942879|FG006|Overall Study|Death|9|||
125634161|NCT04315298|451942880|FG007|Overall Study|Death|12|||
125634162|NCT04315298|451942881|FG008|Overall Study|Death|21|||
125634163|NCT04315298|451942882|FG009|Overall Study|Death|16|||
125634164|NCT04315298|451942883|FG010|Overall Study|Death|40|||
125634165|NCT04315298|451942884|FG011|Overall Study|Death|40|||
125634166|NCT04315298|451942885|FG012|Overall Study|Death|3|||
125634167|NCT04315298|451942886|FG013|Overall Study|Death|4|||
125634168|NCT04315298|451942887|FG014|Overall Study|Death|6|||
125634169|NCT04315298|451942888|FG015|Overall Study|Death|4|||
125634170|NCT04315298|451942889|FG016|Overall Study|Death|3|||
125634171|NCT04315298|451942890|FG017|Overall Study|Death|1|||
125634172|NCT04315298|451942891|FG018|Overall Study|Death|0|||
125634173|NCT00736385|451942892|FG000|Overall Study|Withdrawal by Subject|2|||
125634174|NCT00736385|451942893|FG001|Overall Study|Withdrawal by Subject|2|||
125634175|NCT00736385|451942892|FG000|Overall Study|Adverse Event|0|||
125634176|NCT00736385|451942893|FG001|Overall Study|Adverse Event|1|||
125634177|NCT00098865|451942894|FG000|Overall Study|Progressive Disease|6|||
125634178|NCT00098865|451942894|FG000|Overall Study|Adverse Event|2|||
125634179|NCT00098865|451942894|FG000|Overall Study|Alternative Therapy|1|||
125634180|NCT01183104|451942895|FG000|Overall Study|Adverse Event|8|||
125634181|NCT01183104|451942896|FG001|Overall Study|Adverse Event|6|||
125634182|NCT01183104|451942895|FG000|Overall Study|Death|0|||
125634183|NCT01183104|451942896|FG001|Overall Study|Death|1|||
125634184|NCT01183104|451942895|FG000|Overall Study|Lost to Follow-up|14|||
125129955|NCT01010542|450102506|FG002|Overall Study|Lost to Follow-up|0|||
125129956|NCT01010542|450102504|FG000|Overall Study|Withdrawal by Subject|0|||
125129957|NCT01010542|450102505|FG001|Overall Study|Withdrawal by Subject|3|||
125129958|NCT01010542|450102506|FG002|Overall Study|Withdrawal by Subject|2|||
125129959|NCT01745120|450102507|FG000|Overall Study|Investigator decision|1|||
125129960|NCT01745120|450102508|FG001|Overall Study|Investigator decision|0|||
125634185|NCT01183104|451942896|FG001|Overall Study|Lost to Follow-up|7|||
125129961|NCT00579670|450102511|FG000|Overall Study|Death|1|||
125129962|NCT00579670|450102512|FG001|Overall Study|Death|0|||
125129963|NCT00579670|450102513|FG002|Overall Study|Death|0|||
125129964|NCT00579670|450102514|FG003|Overall Study|Death|0|||
125129965|NCT00579670|450102515|FG004|Overall Study|Death|0|||
125129966|NCT00579670|450102511|FG000|Overall Study|Adverse Event|1|||
125634186|NCT01183104|451942895|FG000|Overall Study|Physician Decision|5|||
125634187|NCT01183104|451942896|FG001|Overall Study|Physician Decision|8|||
125634188|NCT01183104|451942895|FG000|Overall Study|Withdrawal by Subject|6|||
125634189|NCT01183104|451942896|FG001|Overall Study|Withdrawal by Subject|11|||
125634190|NCT01183104|451942895|FG000|Overall Study|Nonparticipation in Extension Study|39|||
125634191|NCT01183104|451942896|FG001|Overall Study|Nonparticipation in Extension Study|50|||
125634192|NCT01183104|451942895|FG000|Overall Study|Did not receive study drug|5|||
125634193|NCT01183104|451942896|FG001|Overall Study|Did not receive study drug|9|||
125634194|NCT03267511|451942897|FG000|Overall Study|Lost to Follow-up|0|||
125634195|NCT03267511|451942898|FG001|Overall Study|Lost to Follow-up|0|||
125634196|NCT03267511|451942899|FG002|Overall Study|Lost to Follow-up|0|||
125377021|NCT00555321|451010275|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
125377022|NCT00555321|451010276|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
125377023|NCT00555321|451010272|FG000|Treatment Phase up to 12-months|Other Reason|1|||
125634197|NCT03267511|451942900|FG003|Overall Study|Lost to Follow-up|1|||
125634198|NCT00364351|451942901|FG000|Overall Study|Adverse Event|90|||
125634199|NCT00364351|451942902|FG001|Overall Study|Adverse Event|44|||
125634200|NCT00364351|451942901|FG000|Overall Study|Condition under investigation worsened|469|||
125634201|NCT00364351|451942902|FG001|Overall Study|Condition under investigation worsened|497|||
125634202|NCT00364351|451942901|FG000|Overall Study|Prohibited concomitant medication|0|||
125634203|NCT00364351|451942902|FG001|Overall Study|Prohibited concomitant medication|2|||
125634204|NCT00364351|451942901|FG000|Overall Study|Lost to Follow-up|1|||
125634205|NCT00364351|451942902|FG001|Overall Study|Lost to Follow-up|1|||
125634206|NCT00364351|451942901|FG000|Overall Study|Withdrawal by Subject|30|||
125634207|NCT00364351|451942902|FG001|Overall Study|Withdrawal by Subject|29|||
125634208|NCT00364351|451942901|FG000|Overall Study|Incorrect enrollment|1|||
125634209|NCT00364351|451942902|FG001|Overall Study|Incorrect enrollment|1|||
125634210|NCT00364351|451942901|FG000|Overall Study|Sponsor decision|1|||
125634211|NCT00364351|451942902|FG001|Overall Study|Sponsor decision|0|||
125634212|NCT00364351|451942901|FG000|Overall Study|Poor treatment compliance|0|||
125634213|NCT00364351|451942902|FG001|Overall Study|Poor treatment compliance|3|||
125634214|NCT00364351|451942901|FG000|Overall Study|Investigator error|0|||
125634215|NCT00364351|451942902|FG001|Overall Study|Investigator error|2|||
125634216|NCT00364351|451942901|FG000|Overall Study|Patient could not travel to site|0|||
125634217|NCT00364351|451942902|FG001|Overall Study|Patient could not travel to site|1|||
125634218|NCT00364351|451942901|FG000|Overall Study|Randomised treatment not started|0|||
125634219|NCT00364351|451942902|FG001|Overall Study|Randomised treatment not started|3|||
125634220|NCT00688623|451942904|FG000|Overall Study|Adverse Event|22|||
125634221|NCT00688623|451942904|FG000|Overall Study|abnormal lab value|1|||
125634222|NCT00688623|451942904|FG000|Overall Study|Withdrawal by Subject|4|||
125634223|NCT00688623|451942904|FG000|Overall Study|Death|3|||
125634224|NCT00688623|451942904|FG000|Overall Study|disease progression|23|||
125634225|NCT00688623|451942904|FG000|Overall Study|Protocol Violation|2|||
125634226|NCT02667236|451942905|FG000|Overall Study|Adverse Event|1|||
125634227|NCT02667236|451942906|FG001|Overall Study|Adverse Event|1|||
125377024|NCT00555321|451010273|FG001|Treatment Phase up to 12-months|Other Reason|3|||
125377025|NCT00555321|451010274|FG002|Treatment Phase up to 12-months|Other Reason|2|||
125634228|NCT02667236|451942905|FG000|Overall Study|Withdrawal by Subject|2|||
125634229|NCT02667236|451942906|FG001|Overall Study|Withdrawal by Subject|0|||
125634230|NCT03887052|451942912|FG000|Overall Study|Adverse Event|2|||
125634231|NCT03887052|451942912|FG000|Overall Study|Physician Decision|2|||
125634232|NCT03887052|451942912|FG000|Overall Study|Withdrawal by Subject|3|||
125634233|NCT03887052|451942912|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
125634234|NCT03887052|451942912|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
125634235|NCT03687827|451942916|FG000|Treatment Period 1|Death|0|||
125634236|NCT03687827|451942917|FG001|Treatment Period 1|Death|1|||
125634237|NCT03687827|451942916|FG000|Treatment Period 1|Lost to Follow-up|2|||
125634238|NCT03687827|451942917|FG001|Treatment Period 1|Lost to Follow-up|2|||
125634239|NCT03687827|451942916|FG000|Treatment Period 1|Physician Decision|5|||
125634240|NCT03687827|451942917|FG001|Treatment Period 1|Physician Decision|2|||
125634241|NCT03687827|451942916|FG000|Treatment Period 1|Withdrawal by Subject|7|||
125634242|NCT03687827|451942917|FG001|Treatment Period 1|Withdrawal by Subject|3|||
125634243|NCT03687827|451942916|FG000|Treatment Period 2|Physician Decision|4|||
125634244|NCT03687827|451942917|FG001|Treatment Period 2|Physician Decision|1|||
125634245|NCT03687827|451942916|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125634246|NCT03687827|451942917|FG001|Treatment Period 2|Withdrawal by Subject|2|||
125634247|NCT01678313|451942918|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
125634248|NCT01678313|451942919|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
125634249|NCT01678313|451942918|FG000|Completed the 3-month Therapy|Physician Decision|3|||
125634250|NCT01678313|451942919|FG001|Completed the 3-month Therapy|Physician Decision|4|||
125634251|NCT01678313|451942918|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
125634252|NCT01678313|451942919|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
125634253|NCT01678313|451942918|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
125634254|NCT01678313|451942919|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
125634255|NCT00981292|451942922|FG000|Day 1|Protocol Violation|1|||
125634256|NCT00981292|451942923|FG001|Day 1|Protocol Violation|0|||
125634257|NCT00981292|451942924|FG002|Day 1|Protocol Violation|0|||
125634258|NCT00981292|451942925|FG003|Day 1|Protocol Violation|0|||
125634259|NCT00981292|451942926|FG004|Day 1|Protocol Violation|0|||
125634260|NCT00981292|451942927|FG005|Day 1|Protocol Violation|2|||
125634261|NCT00981292|451942922|FG000|Day 2|Protocol Violation|2|||
125634262|NCT00981292|451942923|FG001|Day 2|Protocol Violation|0|||
125634263|NCT00981292|451942924|FG002|Day 2|Protocol Violation|0|||
125634264|NCT00981292|451942925|FG003|Day 2|Protocol Violation|0|||
125634265|NCT00981292|451942926|FG004|Day 2|Protocol Violation|0|||
125634266|NCT00981292|451942927|FG005|Day 2|Protocol Violation|0|||
125634267|NCT00981292|451942922|FG000|Day 3|Protocol Violation|0|||
125634268|NCT00981292|451942923|FG001|Day 3|Protocol Violation|0|||
125634269|NCT00981292|451942924|FG002|Day 3|Protocol Violation|0|||
125634270|NCT00981292|451942925|FG003|Day 3|Protocol Violation|0|||
125634271|NCT00981292|451942926|FG004|Day 3|Protocol Violation|0|||
125634272|NCT00981292|451942927|FG005|Day 3|Protocol Violation|1|||
125634273|NCT01131130|451942928|FG000|Period 1 - Baseline|Pregnancy|1|||
125634274|NCT01131130|451942928|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
125634275|NCT03464136|451942929|FG000|Overall Study|Lost to Follow-up|5|||
125634276|NCT03464136|451942930|FG001|Overall Study|Lost to Follow-up|8|||
125634277|NCT03464136|451942929|FG000|Overall Study|Withdrawal by Subject|16|||
125634278|NCT03464136|451942930|FG001|Overall Study|Withdrawal by Subject|13|||
125634279|NCT03464136|451942929|FG000|Overall Study|Death|1|||
125634280|NCT03464136|451942930|FG001|Overall Study|Death|0|||
125634281|NCT03464136|451942929|FG000|Overall Study|Other|8|||
125634282|NCT03464136|451942930|FG001|Overall Study|Other|4|||
125634283|NCT03412565|451942931|FG000|Overall Study|Lost to Follow-up|0|||
125634284|NCT03412565|451942932|FG001|Overall Study|Lost to Follow-up|0|||
125634285|NCT03412565|451942933|FG002|Overall Study|Lost to Follow-up|1|||
125634286|NCT03412565|451942934|FG003|Overall Study|Lost to Follow-up|0|||
125634287|NCT03412565|451942931|FG000|Overall Study|Physician Decision|0|||
125634288|NCT03412565|451942932|FG001|Overall Study|Physician Decision|0|||
125634289|NCT03412565|451942933|FG002|Overall Study|Physician Decision|0|||
125634290|NCT03412565|451942934|FG003|Overall Study|Physician Decision|1|||
125634291|NCT03412565|451942931|FG000|Overall Study|Withdrawal by Subject|0|||
125634292|NCT03412565|451942932|FG001|Overall Study|Withdrawal by Subject|4|||
125634293|NCT03412565|451942933|FG002|Overall Study|Withdrawal by Subject|5|||
125377026|NCT00555321|451010275|FG003|Treatment Phase up to 12-months|Other Reason|0|||
125634294|NCT03412565|451942934|FG003|Overall Study|Withdrawal by Subject|5|||
125634295|NCT03412565|451942931|FG000|Overall Study|Death|1|||
125634296|NCT03412565|451942932|FG001|Overall Study|Death|3|||
125634297|NCT03412565|451942933|FG002|Overall Study|Death|4|||
125634298|NCT03412565|451942934|FG003|Overall Study|Death|5|||
125634299|NCT03412565|451942931|FG000|Overall Study|Data collection ended|0|||
125634300|NCT03412565|451942932|FG001|Overall Study|Data collection ended|41|||
125634301|NCT03412565|451942933|FG002|Overall Study|Data collection ended|41|||
125634302|NCT03412565|451942934|FG003|Overall Study|Data collection ended|40|||
125634303|NCT03277105|451942935|FG000|Overall Study|Death|129|||
125634304|NCT03277105|451942936|FG001|Overall Study|Death|124|||
125634305|NCT03277105|451942935|FG000|Overall Study|Lost to Follow-up|2|||
125634306|NCT03277105|451942936|FG001|Overall Study|Lost to Follow-up|4|||
125634307|NCT03277105|451942935|FG000|Overall Study|Withdrawal by Subject|10|||
125634308|NCT03277105|451942936|FG001|Overall Study|Withdrawal by Subject|10|||
125634309|NCT03277105|451942935|FG000|Overall Study|Other|118|||
125634310|NCT03277105|451942936|FG001|Overall Study|Other|125|||
125634311|NCT00498368|451942943|FG000|Overall Study|Withdrawal by Subject|3|||
125634312|NCT00498368|451942944|FG001|Overall Study|Withdrawal by Subject|2|||
125634313|NCT00285649|451942947|FG000|Overall Study|Lost to Follow-up|6|||
125634314|NCT00285649|451942948|FG001|Overall Study|Lost to Follow-up|4|||
125634315|NCT00285649|451942949|FG002|Overall Study|Lost to Follow-up|4|||
125634316|NCT00285649|451942947|FG000|Overall Study|Withdrawal by Subject|3|||
125634317|NCT00285649|451942948|FG001|Overall Study|Withdrawal by Subject|2|||
125634318|NCT00285649|451942949|FG002|Overall Study|Withdrawal by Subject|2|||
125634319|NCT03342404|451942950|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
125634320|NCT03342404|451942951|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
125634321|NCT03342404|451942950|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
125634322|NCT03342404|451942951|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
125634323|NCT03342404|451942950|FG000|Blinded Treatment Phase|Adverse Event|5|||
125634324|NCT03342404|451942951|FG001|Blinded Treatment Phase|Adverse Event|4|||
125634325|NCT03342404|451942950|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
125634326|NCT03342404|451942951|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
125634327|NCT03342404|451942950|FG000|Blinded Treatment Phase|Other reasons|1|||
125634328|NCT03342404|451942951|FG001|Blinded Treatment Phase|Other reasons|0|||
125634329|NCT03342404|451942950|FG000|Blinded Treatment Phase|Physician Decision|1|||
125634330|NCT03342404|451942951|FG001|Blinded Treatment Phase|Physician Decision|0|||
125634331|NCT03342404|451942950|FG000|Blinded Treatment Phase|Death|1|||
125634332|NCT03342404|451942951|FG001|Blinded Treatment Phase|Death|0|||
125634333|NCT03342404|451942950|FG000|Open-Label Phase|Lost to Follow-up|0|||
125634334|NCT03342404|451942951|FG001|Open-Label Phase|Lost to Follow-up|1|||
125634335|NCT03342404|451942950|FG000|Open-Label Phase|Other reasons|0|||
125634336|NCT03342404|451942951|FG001|Open-Label Phase|Other reasons|1|||
125634337|NCT03342404|451942950|FG000|Open-Label Phase|Adverse Event|0|||
125634338|NCT03342404|451942951|FG001|Open-Label Phase|Adverse Event|3|||
125634339|NCT03342404|451942950|FG000|Open-Label Phase|Withdrawal by Subject|0|||
125634340|NCT03342404|451942951|FG001|Open-Label Phase|Withdrawal by Subject|6|||
125634341|NCT03748420|451942954|FG000|Overall Study|No 12 month medication adherence data available|0|||
125634342|NCT03748420|451942955|FG001|Overall Study|No 12 month medication adherence data available|1|||
125634343|NCT03748420|451942954|FG000|Overall Study|Death|24|||
125634344|NCT03748420|451942955|FG001|Overall Study|Death|28|||
125634345|NCT03748420|451942954|FG000|Overall Study|Lost to Follow-up|231|||
125634346|NCT03748420|451942955|FG001|Overall Study|Lost to Follow-up|230|||
125634347|NCT00373880|451942956|FG000|Overall Study|Physician Decision|3|||
125634348|NCT00373880|451942956|FG000|Overall Study|Arrested|1|||
125634349|NCT00373880|451942956|FG000|Overall Study|Protocol Violation|14|||
125634350|NCT00312728|451942957|FG000|Overall Study|Progressive disease|53|||
125634351|NCT00312728|451942957|FG000|Overall Study|Adverse Event|32|||
125634352|NCT00312728|451942957|FG000|Overall Study|Withdrawal by Subject|10|||
125634353|NCT00312728|451942957|FG000|Overall Study|Required non-protocol cancer treatment|2|||
125634354|NCT00312728|451942957|FG000|Overall Study|Protocol Violation|2|||
125634355|NCT00312728|451942957|FG000|Overall Study|Other|10|||
125634356|NCT00312728|451942957|FG000|Overall Study|Other|1|||
125634357|NCT00423592|451942968|FG000|Overall Study|Adverse Event (through Week 12)|2|||
125634358|NCT00423592|451942968|FG000|Overall Study|Adverse Event (post Week 12)|5|||
125634359|NCT03446612|451942969|FG000|Overall Study|Protocol defined stopping criteria|0|||
125634360|NCT03446612|451942970|FG001|Overall Study|Protocol defined stopping criteria|1|||
125634361|NCT01437267|451942971|FG000|Overall Study|Withdrawal by Subject|0|||
125634362|NCT01437267|451942972|FG001|Overall Study|Withdrawal by Subject|0|||
125634363|NCT01437267|451942973|FG002|Overall Study|Withdrawal by Subject|0|||
125634364|NCT01437267|451942974|FG003|Overall Study|Withdrawal by Subject|1|||
125634365|NCT01437267|451942975|FG004|Overall Study|Withdrawal by Subject|0|||
125634366|NCT01437267|451942976|FG005|Overall Study|Withdrawal by Subject|0|||
125634367|NCT01437267|451942971|FG000|Overall Study|Protocol Violation|0|||
125634368|NCT01437267|451942972|FG001|Overall Study|Protocol Violation|1|||
125634369|NCT01437267|451942973|FG002|Overall Study|Protocol Violation|0|||
125634370|NCT01437267|451942974|FG003|Overall Study|Protocol Violation|0|||
125634371|NCT01437267|451942975|FG004|Overall Study|Protocol Violation|0|||
125634372|NCT01437267|451942976|FG005|Overall Study|Protocol Violation|0|||
125634373|NCT03934203|451942979|FG000|Overall Study|Adverse Event|0|||
125634374|NCT03934203|451942980|FG001|Overall Study|Adverse Event|0|||
125634375|NCT03934203|451942981|FG002|Overall Study|Adverse Event|1|||
125634376|NCT03934203|451942982|FG003|Overall Study|Adverse Event|0|||
125634377|NCT03934203|451942983|FG004|Overall Study|Adverse Event|1|||
125634378|NCT03934203|451942984|FG005|Overall Study|Adverse Event|0|||
125634379|NCT03934203|451942985|FG006|Overall Study|Adverse Event|2|||
125634380|NCT03934203|451942986|FG007|Overall Study|Adverse Event|0|||
125634381|NCT03934203|451942987|FG008|Overall Study|Adverse Event|0|||
125634382|NCT03934203|451942988|FG009|Overall Study|Adverse Event|0|||
125634383|NCT03934203|451942989|FG010|Overall Study|Adverse Event|0|||
125634384|NCT03934203|451942990|FG011|Overall Study|Adverse Event|0|||
125634385|NCT03934203|451942991|FG012|Overall Study|Adverse Event|0|||
125634386|NCT03934203|451942992|FG013|Overall Study|Adverse Event|1|||
125634387|NCT03934203|451942993|FG014|Overall Study|Adverse Event|0|||
125634388|NCT00608842|451942996|FG000|Overall Study|Participant's Request|0|||
125634389|NCT00608842|451942997|FG001|Overall Study|Participant's Request|1|||
125634390|NCT00608842|451942998|FG002|Overall Study|Participant's Request|2|||
125634391|NCT00608842|451942999|FG003|Overall Study|Participant's Request|1|||
125634392|NCT00608842|451942996|FG000|Overall Study|Lost to Follow-up|1|||
125634393|NCT00608842|451942997|FG001|Overall Study|Lost to Follow-up|0|||
125634394|NCT00608842|451942998|FG002|Overall Study|Lost to Follow-up|0|||
125634395|NCT00608842|451942999|FG003|Overall Study|Lost to Follow-up|0|||
125634396|NCT01039428|451943002|FG000|Overall Study|Protocol Violation|1|||
125634397|NCT01039428|451943003|FG001|Overall Study|Protocol Violation|0|||
125634398|NCT01039428|451943002|FG000|Overall Study|Withdrawal by Subject|1|||
125634399|NCT01039428|451943003|FG001|Overall Study|Withdrawal by Subject|0|||
125634400|NCT04489940|451943006|FG000|Overall Study|Other|2|||
125634401|NCT04489940|451943006|FG000|Overall Study|Withdrawal by Subject|2|||
125634402|NCT04489940|451943006|FG000|Overall Study|Death|5|||
125634403|NCT04489940|451943006|FG000|Overall Study|Lost to Follow-up|1|||
125634404|NCT01624467|451943007|FG000|Overall Study|Withdrawal by Subject|2|||
125634405|NCT01624467|451943007|FG000|Overall Study|Lost to Follow-up|1|||
125634406|NCT01624467|451943007|FG000|Overall Study|Adverse Event|7|||
125634407|NCT01624467|451943007|FG000|Overall Study|Progressive Disease|19|||
125634408|NCT01624467|451943007|FG000|Overall Study|Per Sponsor Requirement|1|||
125634409|NCT01624467|451943007|FG000|Overall Study|Subject Withdrew from Treatment|1|||
125634410|NCT03964493|451943010|FG000|Overall Study|Withdrawal by Subject|4|||
125634411|NCT03964493|451943011|FG001|Overall Study|Withdrawal by Subject|1|||
125634412|NCT03964493|451943010|FG000|Overall Study|Lost to Follow-up|13|||
125634413|NCT03964493|451943011|FG001|Overall Study|Lost to Follow-up|4|||
125634414|NCT02470429|451943012|FG000|Overall Study|Adverse Event|1|||
125634415|NCT02470429|451943013|FG001|Overall Study|Adverse Event|0|||
125634416|NCT02470429|451943012|FG000|Overall Study|Withdrawal by Subject|1|||
125634417|NCT02470429|451943013|FG001|Overall Study|Withdrawal by Subject|0|||
125634418|NCT00398138|451943014|FG000|Overall Study|Adverse Event|2|||
125634419|NCT01188811|451943017|FG000|Overall Study|Withdrawal by Subject|0|||
125634420|NCT01188811|451943018|FG001|Overall Study|Withdrawal by Subject|2|||
125634421|NCT01188811|451943017|FG000|Overall Study|Adverse Event|6|||
125634422|NCT01188811|451943018|FG001|Overall Study|Adverse Event|0|||
125634423|NCT01602744|451943019|FG000|Overall Study|Death|17|||
125634424|NCT01602744|451943020|FG001|Overall Study|Death|15|||
125634425|NCT01602744|451943019|FG000|Overall Study|Lost to Follow-up|13|||
125634426|NCT01602744|451943020|FG001|Overall Study|Lost to Follow-up|8|||
125634427|NCT03418376|451943021|FG000|Overall Study|Musculoskeletal injury|1|||
125634428|NCT03418376|451943022|FG001|Overall Study|Musculoskeletal injury|2|||
125634429|NCT03418376|451943023|FG002|Overall Study|Musculoskeletal injury|1|||
125634430|NCT03418376|451943024|FG003|Overall Study|Musculoskeletal injury|0|||
125634431|NCT03418376|451943021|FG000|Overall Study|Personal reasons|0|||
125634432|NCT03418376|451943022|FG001|Overall Study|Personal reasons|2|||
125634433|NCT03418376|451943023|FG002|Overall Study|Personal reasons|2|||
125634434|NCT03418376|451943024|FG003|Overall Study|Personal reasons|1|||
125634435|NCT03418376|451943021|FG000|Overall Study|Exacerbation|0|||
125634436|NCT03418376|451943022|FG001|Overall Study|Exacerbation|1|||
125634437|NCT03418376|451943023|FG002|Overall Study|Exacerbation|0|||
125634438|NCT03418376|451943024|FG003|Overall Study|Exacerbation|0|||
125634439|NCT01387594|451943029|FG000|Overall Study|Withdrawal by Subject|0|||
125634440|NCT01387594|451943030|FG001|Overall Study|Withdrawal by Subject|2|||
125634441|NCT01387594|451943029|FG000|Overall Study|Lost to Follow-up|0|||
125634442|NCT01387594|451943030|FG001|Overall Study|Lost to Follow-up|1|||
125634443|NCT03573804|451943034|FG000|Overall Study|claustrophobia or MRI table problems|10|||
125634444|NCT03050307|451944822|FG000|Overall Study|Adverse Event|4|||
125634445|NCT03050307|451944823|FG001|Overall Study|Adverse Event|2|||
125634446|NCT03050307|451944822|FG000|Overall Study|Significant Protocol Deviation|0|||
125634447|NCT03050307|451944823|FG001|Overall Study|Significant Protocol Deviation|1|||
125634448|NCT03050307|451944822|FG000|Overall Study|Lost to Follow-up|0|||
125634449|NCT03050307|451944823|FG001|Overall Study|Lost to Follow-up|1|||
125634450|NCT03050307|451944822|FG000|Overall Study|Voluntary Withdrawal|3|||
125634451|NCT03050307|451944823|FG001|Overall Study|Voluntary Withdrawal|4|||
125634452|NCT03050307|451944822|FG000|Overall Study|Reason not Specified|1|||
125634453|NCT03050307|451944823|FG001|Overall Study|Reason not Specified|1|||
125634454|NCT01998906|451944824|FG000|Overall Study|Participants ongoing in follow-up|77|||
125634455|NCT01998906|451944825|FG001|Overall Study|Participants ongoing in follow-up|60|||
125634456|NCT01998906|451944826|FG002|Overall Study|Participants ongoing in follow-up|58|||
125634457|NCT01998906|451944824|FG000|Overall Study|Death|21|||
125634458|NCT01998906|451944825|FG001|Overall Study|Death|30|||
125634459|NCT01998906|451944826|FG002|Overall Study|Death|17|||
125634460|NCT01998906|451944824|FG000|Overall Study|Lack of Efficacy|10|||
125634461|NCT01998906|451944825|FG001|Overall Study|Lack of Efficacy|9|||
125634462|NCT01998906|451944826|FG002|Overall Study|Lack of Efficacy|8|||
125634463|NCT01998906|451944824|FG000|Overall Study|Failure to return|0|||
125634464|NCT01998906|451944825|FG001|Overall Study|Failure to return|2|||
125634465|NCT01998906|451944826|FG002|Overall Study|Failure to return|4|||
125634466|NCT01998906|451944824|FG000|Overall Study|Violation of Selection Criteria|0|||
125634467|NCT01998906|451944825|FG001|Overall Study|Violation of Selection Criteria|0|||
125634468|NCT01998906|451944826|FG002|Overall Study|Violation of Selection Criteria|1|||
125634469|NCT01998906|451944824|FG000|Overall Study|Withdrawal by Subject|1|||
125634470|NCT01998906|451944825|FG001|Overall Study|Withdrawal by Subject|4|||
125634471|NCT01998906|451944826|FG002|Overall Study|Withdrawal by Subject|3|||
125634472|NCT01998906|451944824|FG000|Overall Study|Administrative/Other|2|||
125634473|NCT01998906|451944825|FG001|Overall Study|Administrative/Other|1|||
125634474|NCT01998906|451944826|FG002|Overall Study|Administrative/Other|3|||
125634475|NCT01998906|451944824|FG000|Overall Study|Other|3|||
125634476|NCT01998906|451944825|FG001|Overall Study|Other|8|||
125634477|NCT01998906|451944826|FG002|Overall Study|Other|4|||
125634478|NCT02996110|451944827|FG000|Pre-Treatment|Other Reasons|0|||
125634479|NCT02996110|451944828|FG001|Pre-Treatment|Other Reasons|1|||
125634480|NCT02996110|451944829|FG002|Pre-Treatment|Other Reasons|0|||
125634481|NCT02996110|451944830|FG003|Pre-Treatment|Other Reasons|0|||
125634482|NCT02996110|451944831|FG004|Pre-Treatment|Other Reasons|1|||
125634483|NCT02996110|451944827|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
125634484|NCT02996110|451944828|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
125634485|NCT02996110|451944829|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
125634486|NCT02996110|451944830|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
125634487|NCT02996110|451944831|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
125634488|NCT02996110|451944827|FG000|Track 1|Disease Progression|15|||
125634489|NCT02996110|451944828|FG001|Track 1|Disease Progression|17|||
125634490|NCT02996110|451944829|FG002|Track 1|Disease Progression|0|||
125634491|NCT02996110|451944830|FG003|Track 1|Disease Progression|0|||
125634492|NCT02996110|451944831|FG004|Track 1|Disease Progression|0|||
125634493|NCT02996110|451944827|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
125634494|NCT02996110|451944828|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
125634495|NCT02996110|451944829|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
125634496|NCT02996110|451944830|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
125634497|NCT02996110|451944831|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
125634498|NCT02996110|451944827|FG000|Track 1|Study Drug Toxicity|5|||
125634499|NCT02996110|451944828|FG001|Track 1|Study Drug Toxicity|3|||
125634500|NCT02996110|451944829|FG002|Track 1|Study Drug Toxicity|0|||
125634501|NCT02996110|451944830|FG003|Track 1|Study Drug Toxicity|0|||
125634502|NCT02996110|451944831|FG004|Track 1|Study Drug Toxicity|0|||
125634503|NCT02996110|451944827|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
125634504|NCT02996110|451944828|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
125634505|NCT02996110|451944829|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
125634506|NCT02996110|451944830|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
125634507|NCT02996110|451944831|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
125634508|NCT02996110|451944827|FG000|Track 1|Administrative Reason by Sponsor|0|||
125634509|NCT02996110|451944828|FG001|Track 1|Administrative Reason by Sponsor|1|||
125634510|NCT02996110|451944829|FG002|Track 1|Administrative Reason by Sponsor|0|||
125634511|NCT02996110|451944830|FG003|Track 1|Administrative Reason by Sponsor|0|||
125634512|NCT02996110|451944831|FG004|Track 1|Administrative Reason by Sponsor|0|||
125634513|NCT02996110|451944827|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
125634514|NCT02996110|451944828|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
125634515|NCT02996110|451944829|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
125634516|NCT02996110|451944830|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
125634517|NCT02996110|451944831|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
125634518|NCT02996110|451944827|FG000|Track 2|Disease Progression|33|||
125634519|NCT02996110|451944828|FG001|Track 2|Disease Progression|26|||
125634520|NCT02996110|451944829|FG002|Track 2|Disease Progression|19|||
125634521|NCT02996110|451944830|FG003|Track 2|Disease Progression|16|||
125634522|NCT02996110|451944831|FG004|Track 2|Disease Progression|15|||
125634523|NCT02996110|451944827|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
125634524|NCT02996110|451944828|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
125634525|NCT02996110|451944829|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
125634526|NCT02996110|451944830|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
125634527|NCT02996110|451944831|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
125634528|NCT02996110|451944827|FG000|Track 2|Death|0|||
125634529|NCT02996110|451944828|FG001|Track 2|Death|0|||
125634530|NCT02996110|451944829|FG002|Track 2|Death|1|||
125634531|NCT02996110|451944830|FG003|Track 2|Death|0|||
125634532|NCT02996110|451944831|FG004|Track 2|Death|1|||
125634533|NCT02996110|451944827|FG000|Track 2|Study Drug Toxicity|4|||
125634534|NCT02996110|451944828|FG001|Track 2|Study Drug Toxicity|1|||
125634535|NCT02996110|451944829|FG002|Track 2|Study Drug Toxicity|4|||
125634536|NCT02996110|451944830|FG003|Track 2|Study Drug Toxicity|1|||
125634537|NCT02996110|451944831|FG004|Track 2|Study Drug Toxicity|0|||
125634538|NCT02996110|451944827|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
125634539|NCT02996110|451944828|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
125634540|NCT02996110|451944829|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
125634541|NCT02996110|451944830|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
125634542|NCT02996110|451944831|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
125634543|NCT02996110|451944827|FG000|Track 2|Participant Withdrew Consent|1|||
125634544|NCT02996110|451944828|FG001|Track 2|Participant Withdrew Consent|2|||
125634545|NCT02996110|451944829|FG002|Track 2|Participant Withdrew Consent|3|||
125634546|NCT02996110|451944830|FG003|Track 2|Participant Withdrew Consent|1|||
125634547|NCT02996110|451944831|FG004|Track 2|Participant Withdrew Consent|1|||
125634548|NCT02996110|451944827|FG000|Track 2|Other Reasons|0|||
125634549|NCT02996110|451944828|FG001|Track 2|Other Reasons|0|||
125634550|NCT02996110|451944829|FG002|Track 2|Other Reasons|1|||
125634551|NCT02996110|451944830|FG003|Track 2|Other Reasons|0|||
125634552|NCT02996110|451944831|FG004|Track 2|Other Reasons|1|||
125634553|NCT01077193|451944832|FG000|Overall Study|Lost to Follow-up|1|||
125634554|NCT01077193|451944832|FG000|Overall Study|Withdrawal by Subject|2|||
125634555|NCT01077193|451944832|FG000|Overall Study|Lack of Efficacy|1|||
125634556|NCT01077193|451944832|FG000|Overall Study|Study Terminated by Sponsor|40|||
125634557|NCT06048809|451944837|FG000|Overall Study|Adverse Event|2|||
125634558|NCT06048809|451944838|FG001|Overall Study|Adverse Event|0|||
125634559|NCT06048809|451944837|FG000|Overall Study|Withdrawal by Subject|1|||
125634560|NCT06048809|451944838|FG001|Overall Study|Withdrawal by Subject|1|||
125634561|NCT02148952|451944846|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
125634562|NCT02148952|451944847|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
125634563|NCT02148952|451944846|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
125634564|NCT02148952|451944847|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
125634565|NCT02148952|451944846|FG000|Follow-Up|Lost to Follow-up|219|||
125634566|NCT02148952|451944847|FG001|Follow-Up|Lost to Follow-up|231|||
125634567|NCT02148952|451944846|FG000|Follow-Up|Withdrawal by Subject|46|||
125634568|NCT02148952|451944847|FG001|Follow-Up|Withdrawal by Subject|48|||
125634569|NCT01600105|451944848|FG000|Total Participants|Withdrawal by Subject|1|||
125634570|NCT01600105|451944849|FG001|Total Participants|Withdrawal by Subject|0|||
125634571|NCT01600105|451944848|FG000|Total Participants|No images in PACS|10|||
125634572|NCT01600105|451944849|FG001|Total Participants|No images in PACS|0|||
125634573|NCT01600105|451944848|FG000|Total Participants|Insufficient image quality|30|||
125634574|NCT01600105|451944849|FG001|Total Participants|Insufficient image quality|10|||
125634575|NCT01600105|451944848|FG000|Sub Study I|Insufficient image quality|0|||
125634576|NCT01600105|451944849|FG001|Sub Study I|Insufficient image quality|10|||
125634577|NCT01600105|451944848|FG000|Sub Study II|Withdrawal by Subject|1|||
125634578|NCT01600105|451944849|FG001|Sub Study II|Withdrawal by Subject|0|||
125634579|NCT01600105|451944848|FG000|Sub Study II|No images in PACS|1|||
125634580|NCT01600105|451944849|FG001|Sub Study II|No images in PACS|0|||
125634581|NCT01600105|451944848|FG000|Sub Study II|Insufficient image quality|3|||
125634582|NCT01600105|451944849|FG001|Sub Study II|Insufficient image quality|0|||
125634583|NCT01600105|451944848|FG000|Sub Study III|Insufficient image quality|5|||
125634584|NCT01600105|451944849|FG001|Sub Study III|Insufficient image quality|0|||
125634585|NCT01600105|451944848|FG000|Sub Study V|Poor Image Quality|2|||
125634586|NCT01600105|451944849|FG001|Sub Study V|Poor Image Quality|0|||
125634587|NCT04007367|451944850|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
125634588|NCT04007367|451944851|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
125634589|NCT04007367|451944852|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
125634590|NCT04007367|451944850|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
125634591|NCT04007367|451944851|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
125634592|NCT04007367|451944852|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
125634593|NCT04007367|451944850|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
125634594|NCT04007367|451944851|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
125634595|NCT04007367|451944852|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
125634596|NCT04007367|451944850|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
125634597|NCT04007367|451944851|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
125634598|NCT04007367|451944852|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
125634599|NCT04007367|451944850|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
125634600|NCT04007367|451944851|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
125634601|NCT04007367|451944852|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
125634602|NCT01764022|451944853|FG000|Overall Study|Death|3|||
125634603|NCT01764022|451944854|FG001|Overall Study|Death|5|||
125634604|NCT01764022|451944853|FG000|Overall Study|Withdrawal by Subject|2|||
125634605|NCT01764022|451944854|FG001|Overall Study|Withdrawal by Subject|6|||
125634606|NCT01764022|451944853|FG000|Overall Study|Lack of Efficacy|0|||
125634607|NCT01764022|451944854|FG001|Overall Study|Lack of Efficacy|1|||
125634608|NCT01764022|451944853|FG000|Overall Study|Physician Decision|0|||
125634609|NCT01764022|451944854|FG001|Overall Study|Physician Decision|2|||
125634610|NCT01764022|451944853|FG000|Overall Study|Lost to Follow-up|2|||
125634611|NCT01764022|451944854|FG001|Overall Study|Lost to Follow-up|0|||
125634612|NCT01764022|451944853|FG000|Overall Study|Protocol Violation|1|||
125634613|NCT01764022|451944854|FG001|Overall Study|Protocol Violation|0|||
125634614|NCT01899768|451944855|FG000|Part A|Adverse Event|2|||
125634615|NCT01899768|451944855|FG000|Part A|Withdrawal by Subject|1|||
125634616|NCT01899768|451944855|FG000|Part B|Adverse Event|1|||
125634617|NCT01899768|451944855|FG000|Part B|Withdrawal by Subject|1|||
125634618|NCT04043416|451944858|FG000|Washout|Change in health condition|0|||
125634619|NCT04043416|451944859|FG001|Washout|Change in health condition|1|||
125634620|NCT01925014|451944868|FG000|Overall Study|Inappropriate enrollment|4|||
125634621|NCT01925014|451944869|FG001|Overall Study|Inappropriate enrollment|6|||
125634622|NCT01925014|451944868|FG000|Overall Study|Withdrawal by Subject|5|||
125634623|NCT01925014|451944869|FG001|Overall Study|Withdrawal by Subject|13|||
125634624|NCT00850135|451944873|FG000|Overall Study|Physician Decision|1|||
125634625|NCT00744991|451944874|FG000|Overall Study|Progressive Disease|11|||
125634626|NCT00744991|451944874|FG000|Overall Study|Withdrawal by Subject|8|||
125634627|NCT00744991|451944874|FG000|Overall Study|Physician Decision|3|||
125634628|NCT00744991|451944874|FG000|Overall Study|Adverse Event|2|||
125634629|NCT00744991|451944874|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
125634630|NCT01487863|451944875|FG000|Overall Study|Death|19|||
125634631|NCT01487863|451944876|FG001|Overall Study|Death|19|||
125634632|NCT02139280|451944877|FG000|Overall Study|No longer eligible|2|||
125634633|NCT02139280|451944878|FG001|Overall Study|No longer eligible|0|||
125634634|NCT00422903|451944891|FG000|Overall Study|Disease Progression|3|||
125634635|NCT00422903|451944892|FG001|Overall Study|Disease Progression|1|||
125634636|NCT00422903|451944891|FG000|Overall Study|Adverse Event|0|||
125634637|NCT00422903|451944892|FG001|Overall Study|Adverse Event|2|||
125634638|NCT00422903|451944891|FG000|Overall Study|Informed Consent Withdrawn|1|||
125634639|NCT00422903|451944892|FG001|Overall Study|Informed Consent Withdrawn|2|||
125634640|NCT01302691|451944893|FG000|Overall Study|Adverse Event|2|||
125216479|NCT01775787|450419448|FG000|First 7-10 Days|time commitment|0|||
125216480|NCT01775787|450419449|FG001|First 7-10 Days|time commitment|2|||
125216481|NCT01775787|450419448|FG000|First 7-10 Days|concerns with using IV|1|||
125216482|NCT01775787|450419449|FG001|First 7-10 Days|concerns with using IV|2|||
125216483|NCT01775787|450419448|FG000|Second 7-10 Days|time commitment|0|||
125216484|NCT01775787|450419449|FG001|Second 7-10 Days|time commitment|1|||
125216485|NCT01775787|450419448|FG000|Second 7-10 Days|concerns with using IV|0|||
125634641|NCT01302691|451944894|FG001|Overall Study|Adverse Event|0|||
125634642|NCT01302691|451944893|FG000|Overall Study|Death|0|||
125634643|NCT01302691|451944894|FG001|Overall Study|Death|1|||
125634644|NCT01302691|451944893|FG000|Overall Study|Lost to Follow-up|1|||
125634645|NCT01302691|451944894|FG001|Overall Study|Lost to Follow-up|0|||
125634646|NCT01302691|451944893|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
125634647|NCT01302691|451944894|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
125634648|NCT01302691|451944893|FG000|Overall Study|Physician Decision|0|||
125634649|NCT01302691|451944894|FG001|Overall Study|Physician Decision|1|||
125634650|NCT01302691|451944893|FG000|Overall Study|Protocol Violation|1|||
125216486|NCT01775787|450419449|FG001|Second 7-10 Days|concerns with using IV|1|||
125634651|NCT01302691|451944894|FG001|Overall Study|Protocol Violation|0|||
125634652|NCT00441480|451944895|FG000|Overall Study|Protocol Violation|1|||
125634653|NCT00441480|451944896|FG001|Overall Study|Protocol Violation|1|||
125634654|NCT00441480|451944895|FG000|Overall Study|Withdrawal by Subject|2|||
125634655|NCT00441480|451944896|FG001|Overall Study|Withdrawal by Subject|3|||
125634656|NCT00422240|451944897|FG000|Overall Study|Lack of Efficacy|1|||
125634657|NCT00422240|451944898|FG001|Overall Study|Lack of Efficacy|2|||
125634658|NCT00422240|451944899|FG002|Overall Study|Lack of Efficacy|0|||
125634659|NCT00422240|451944900|FG003|Overall Study|Lack of Efficacy|1|||
125634660|NCT00422240|451944897|FG000|Overall Study|Adverse Event|11|||
125634661|NCT00422240|451944898|FG001|Overall Study|Adverse Event|4|||
125634662|NCT00422240|451944899|FG002|Overall Study|Adverse Event|5|||
125634663|NCT00422240|451944900|FG003|Overall Study|Adverse Event|2|||
125634664|NCT00422240|451944897|FG000|Overall Study|Subject request|21|||
125634665|NCT00422240|451944898|FG001|Overall Study|Subject request|17|||
125634666|NCT00422240|451944899|FG002|Overall Study|Subject request|18|||
125634667|NCT00422240|451944900|FG003|Overall Study|Subject request|30|||
125634668|NCT00422240|451944897|FG000|Overall Study|Protocol Violation|0|||
125634669|NCT00422240|451944898|FG001|Overall Study|Protocol Violation|1|||
125634670|NCT00422240|451944899|FG002|Overall Study|Protocol Violation|0|||
125634671|NCT00422240|451944900|FG003|Overall Study|Protocol Violation|1|||
125634672|NCT00422240|451944897|FG000|Overall Study|Lost to Follow-up|31|||
125634673|NCT00422240|451944898|FG001|Overall Study|Lost to Follow-up|32|||
125634674|NCT00422240|451944899|FG002|Overall Study|Lost to Follow-up|19|||
125634675|NCT00422240|451944900|FG003|Overall Study|Lost to Follow-up|34|||
125634676|NCT00422240|451944897|FG000|Overall Study|Other|1|||
125634677|NCT00422240|451944898|FG001|Overall Study|Other|0|||
125634678|NCT00422240|451944899|FG002|Overall Study|Other|0|||
125634679|NCT00422240|451944900|FG003|Overall Study|Other|1|||
125634680|NCT00422240|451944897|FG000|Overall Study|Pregnancy|3|||
125634681|NCT00422240|451944898|FG001|Overall Study|Pregnancy|1|||
125634682|NCT00422240|451944899|FG002|Overall Study|Pregnancy|1|||
125634683|NCT00422240|451944900|FG003|Overall Study|Pregnancy|2|||
125634684|NCT00441012|451944901|FG000|Overall Study|Adverse Event|0|||
125634685|NCT00441012|451944902|FG001|Overall Study|Adverse Event|1|||
125129967|NCT00579670|450102512|FG001|Overall Study|Adverse Event|0|||
125377027|NCT00555321|451010276|FG004|Treatment Phase up to 12-months|Other Reason|0|||
125377028|NCT00555321|451010272|FG000|Treatment Phase up to 12-months|Never treated|2|||
125377029|NCT00555321|451010273|FG001|Treatment Phase up to 12-months|Never treated|3|||
125377030|NCT00555321|451010274|FG002|Treatment Phase up to 12-months|Never treated|1|||
125377031|NCT00555321|451010275|FG003|Treatment Phase up to 12-months|Never treated|0|||
125377032|NCT00555321|451010276|FG004|Treatment Phase up to 12-months|Never treated|4|||
125377033|NCT00555321|451010272|FG000|Long-term Extension Phase|Adverse Event|2|||
125377034|NCT00555321|451010273|FG001|Long-term Extension Phase|Adverse Event|5|||
125377035|NCT00555321|451010274|FG002|Long-term Extension Phase|Adverse Event|2|||
125377036|NCT00555321|451010275|FG003|Long-term Extension Phase|Adverse Event|1|||
125377037|NCT00555321|451010276|FG004|Long-term Extension Phase|Adverse Event|0|||
125377038|NCT00555321|451010272|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
125377039|NCT00555321|451010273|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
125377040|NCT00555321|451010274|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
125377041|NCT00555321|451010275|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
125377042|NCT00555321|451010276|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
125377043|NCT00555321|451010272|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
125377044|NCT00555321|451010273|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
125377045|NCT00555321|451010274|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
125377046|NCT00555321|451010275|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
125377047|NCT00555321|451010276|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
125377048|NCT00555321|451010272|FG000|Long-term Extension Phase|Death|2|||
125377049|NCT00555321|451010273|FG001|Long-term Extension Phase|Death|0|||
125377050|NCT00555321|451010274|FG002|Long-term Extension Phase|Death|0|||
125377051|NCT00555321|451010275|FG003|Long-term Extension Phase|Death|3|||
125377052|NCT00555321|451010276|FG004|Long-term Extension Phase|Death|0|||
125377053|NCT00555321|451010272|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
125377054|NCT00555321|451010273|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
125377055|NCT00555321|451010274|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
125377056|NCT00555321|451010275|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
125377057|NCT00555321|451010276|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
125129968|NCT00579670|450102513|FG002|Overall Study|Adverse Event|1|||
125377058|NCT00555321|451010272|FG000|Long-term Extension Phase|Other Reason|1|||
125634686|NCT00441012|451944901|FG000|Overall Study|Lost to Follow-up|3|||
125634687|NCT00441012|451944902|FG001|Overall Study|Lost to Follow-up|3|||
125634688|NCT00441012|451944901|FG000|Overall Study|Protocol Violation|10|||
125634689|NCT00441012|451944902|FG001|Overall Study|Protocol Violation|9|||
125634690|NCT00441012|451944901|FG000|Overall Study|Withdrawal by Subject|4|||
125634691|NCT00441012|451944902|FG001|Overall Study|Withdrawal by Subject|0|||
125634692|NCT00441012|451944901|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
125129969|NCT00579670|450102514|FG003|Overall Study|Adverse Event|2|||
125129970|NCT00579670|450102515|FG004|Overall Study|Adverse Event|0|||
125129971|NCT00579670|450102511|FG000|Overall Study|Lack of Efficacy|0|||
125129972|NCT00579670|450102512|FG001|Overall Study|Lack of Efficacy|0|||
125129973|NCT00579670|450102513|FG002|Overall Study|Lack of Efficacy|1|||
125129974|NCT00579670|450102514|FG003|Overall Study|Lack of Efficacy|14|||
125129975|NCT00579670|450102515|FG004|Overall Study|Lack of Efficacy|0|||
125129976|NCT00579670|450102511|FG000|Overall Study|Lost to Follow-up|0|||
125129977|NCT00579670|450102512|FG001|Overall Study|Lost to Follow-up|1|||
125129978|NCT00579670|450102513|FG002|Overall Study|Lost to Follow-up|0|||
125129979|NCT00579670|450102514|FG003|Overall Study|Lost to Follow-up|4|||
125634693|NCT00441012|451944902|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
125634694|NCT02201472|451944903|FG000|Overall Study|Lack of Efficacy|2|||
125634695|NCT00262314|451944906|FG000|Overall Study|Changing physicians|38|||
125634696|NCT00262314|451944906|FG000|Overall Study|Death|12|||
125634697|NCT00262314|451944906|FG000|Overall Study|Patient's decision|92|||
125634698|NCT00262314|451944906|FG000|Overall Study|Other|95|||
125634699|NCT00262314|451944906|FG000|Overall Study|Lost to Follow-up|70|||
125634700|NCT00262314|451944906|FG000|Overall Study|Administrative withdrawal|30|||
125634701|NCT05104749|451944907|FG000|Overall Study|Lost to Follow-up|2|||
125634702|NCT05104749|451944908|FG001|Overall Study|Lost to Follow-up|3|||
125634703|NCT01300767|451944909|FG000|Overall Study|Discomfort|2|||
125634704|NCT01300767|451944909|FG000|Overall Study|Biomicroscopy|1|||
125634705|NCT01300767|451944909|FG000|Overall Study|Unacceptable fit|1|||
125634706|NCT00117572|451944910|FG000|Overall Study|Site withdrew before starting treatment|2|||
125634707|NCT00117572|451944911|FG001|Overall Study|Site withdrew before starting treatment|3|||
125634708|NCT00117572|451944910|FG000|Overall Study|Withdrawal by Subject|3|||
125634709|NCT00117572|451944911|FG001|Overall Study|Withdrawal by Subject|3|||
125634710|NCT00117572|451944910|FG000|Overall Study|Protocol Violation|1|||
125634711|NCT00117572|451944911|FG001|Overall Study|Protocol Violation|0|||
125634712|NCT04973085|451944916|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
125634713|NCT04973085|451944917|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
125634714|NCT00887068|451944918|FG000|Overall Study|Withdrawal by Subject|2|||
125634715|NCT00887068|451944919|FG001|Overall Study|Withdrawal by Subject|0|||
125634716|NCT00887068|451944918|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
125634717|NCT00887068|451944919|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
125634718|NCT00796224|451944937|FG000|Overall Study|Adverse Event|1|||
125634719|NCT00796224|451944938|FG001|Overall Study|Adverse Event|0|||
125634720|NCT00796224|451944937|FG000|Overall Study|Protocol Violation|0|||
125634721|NCT00796224|451944938|FG001|Overall Study|Protocol Violation|1|||
125634722|NCT02569398|451944939|FG000|Overall Study|Adverse Event|0|||
125634723|NCT02569398|451944940|FG001|Overall Study|Adverse Event|1|||
125634724|NCT02569398|451944941|FG002|Overall Study|Adverse Event|6|||
125634725|NCT02569398|451944939|FG000|Overall Study|Withdrawal by Subject|43|||
125634726|NCT02569398|451944940|FG001|Overall Study|Withdrawal by Subject|43|||
125634727|NCT02569398|451944941|FG002|Overall Study|Withdrawal by Subject|30|||
125634728|NCT02569398|451944939|FG000|Overall Study|Study terminated by sponsor|130|||
125634729|NCT02569398|451944940|FG001|Overall Study|Study terminated by sponsor|131|||
125129980|NCT00579670|450102515|FG004|Overall Study|Lost to Follow-up|0|||
125129981|NCT00579670|450102511|FG000|Overall Study|Other|0|||
125129982|NCT00579670|450102512|FG001|Overall Study|Other|0|||
125129983|NCT00579670|450102513|FG002|Overall Study|Other|1|||
125129984|NCT00579670|450102514|FG003|Overall Study|Other|2|||
125129985|NCT00579670|450102515|FG004|Overall Study|Other|0|||
125634730|NCT02569398|451944941|FG002|Overall Study|Study terminated by sponsor|134|||
125634731|NCT02569398|451944939|FG000|Overall Study|Other|12|||
125634732|NCT02569398|451944940|FG001|Overall Study|Other|14|||
125634733|NCT02569398|451944941|FG002|Overall Study|Other|13|||
125634734|NCT02116361|451944942|FG000|Overall Study|Pregnancy|0|||
125634735|NCT02116361|451944943|FG001|Overall Study|Pregnancy|0|||
125634736|NCT02116361|451944944|FG002|Overall Study|Pregnancy|0|||
125129986|NCT00579670|450102511|FG000|Overall Study|Withdrawal by Subject|0|||
125634737|NCT02116361|451944945|FG003|Overall Study|Pregnancy|1|||
125634738|NCT02116361|451944942|FG000|Overall Study|Protocol Violation|1|||
125634739|NCT02116361|451944943|FG001|Overall Study|Protocol Violation|0|||
125634740|NCT02116361|451944944|FG002|Overall Study|Protocol Violation|0|||
125634741|NCT02116361|451944945|FG003|Overall Study|Protocol Violation|2|||
125634742|NCT02116361|451944942|FG000|Overall Study|Physician Decision|2|||
125634743|NCT02116361|451944943|FG001|Overall Study|Physician Decision|3|||
125634744|NCT02116361|451944944|FG002|Overall Study|Physician Decision|0|||
125634745|NCT02116361|451944945|FG003|Overall Study|Physician Decision|0|||
125634746|NCT02116361|451944942|FG000|Overall Study|Adverse Event|1|||
125634747|NCT02116361|451944943|FG001|Overall Study|Adverse Event|0|||
125634748|NCT02116361|451944944|FG002|Overall Study|Adverse Event|0|||
125634749|NCT02116361|451944945|FG003|Overall Study|Adverse Event|3|||
125634750|NCT02116361|451944942|FG000|Overall Study|Other Reasons|3|||
125634751|NCT02116361|451944943|FG001|Overall Study|Other Reasons|3|||
125634752|NCT02116361|451944944|FG002|Overall Study|Other Reasons|3|||
125634753|NCT02116361|451944945|FG003|Overall Study|Other Reasons|3|||
125634754|NCT02116361|451944942|FG000|Overall Study|Lack of Efficacy|5|||
125634755|NCT02116361|451944943|FG001|Overall Study|Lack of Efficacy|7|||
125634756|NCT02116361|451944944|FG002|Overall Study|Lack of Efficacy|4|||
125634757|NCT02116361|451944945|FG003|Overall Study|Lack of Efficacy|3|||
125634758|NCT02116361|451944942|FG000|Overall Study|Lost to Follow-up|4|||
125634759|NCT02116361|451944943|FG001|Overall Study|Lost to Follow-up|5|||
125634760|NCT02116361|451944944|FG002|Overall Study|Lost to Follow-up|7|||
125634761|NCT02116361|451944945|FG003|Overall Study|Lost to Follow-up|5|||
125634762|NCT02116361|451944942|FG000|Overall Study|Personal Reasons|6|||
125634763|NCT02116361|451944943|FG001|Overall Study|Personal Reasons|6|||
125634764|NCT02116361|451944944|FG002|Overall Study|Personal Reasons|4|||
125634765|NCT02116361|451944945|FG003|Overall Study|Personal Reasons|9|||
125634766|NCT02116361|451944942|FG000|Overall Study|Investigator Decision - Relapse|9|||
125634767|NCT02116361|451944943|FG001|Overall Study|Investigator Decision - Relapse|7|||
125634768|NCT02116361|451944944|FG002|Overall Study|Investigator Decision - Relapse|8|||
125634769|NCT02116361|451944945|FG003|Overall Study|Investigator Decision - Relapse|5|||
125634770|NCT03227224|451944946|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
125634771|NCT03227224|451944947|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
125634772|NCT03227224|451944948|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
125634773|NCT03227224|451944949|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
125634774|NCT03227224|451944946|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
125634775|NCT03227224|451944947|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
125634776|NCT03227224|451944948|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
125634777|NCT03227224|451944949|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
125634778|NCT03227224|451944946|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
125634779|NCT03227224|451944947|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
125634780|NCT03227224|451944948|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
125634781|NCT03227224|451944949|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
125634782|NCT03227224|451944946|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
125634783|NCT03227224|451944947|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125634784|NCT03227224|451944948|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125634785|NCT03227224|451944949|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125634786|NCT03227224|451944946|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
125634787|NCT03227224|451944947|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
125634788|NCT03227224|451944948|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
125634789|NCT03227224|451944949|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
125634790|NCT03227224|451944946|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
125634791|NCT03227224|451944947|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
125634792|NCT03227224|451944948|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
125634793|NCT03227224|451944949|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
125634794|NCT03227224|451944946|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
125634795|NCT03227224|451944947|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
125634796|NCT03227224|451944948|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
125634797|NCT03227224|451944949|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
125634798|NCT03227224|451944946|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
125634799|NCT03227224|451944947|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
125634800|NCT03227224|451944948|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
125634801|NCT03227224|451944949|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
125634802|NCT03227224|451944946|FG000|Follow-up Phase (2 Weeks)|Other|4|||
125634803|NCT03227224|451944947|FG001|Follow-up Phase (2 Weeks)|Other|4|||
125634804|NCT03227224|451944948|FG002|Follow-up Phase (2 Weeks)|Other|6|||
125634805|NCT03227224|451944949|FG003|Follow-up Phase (2 Weeks)|Other|3|||
125634806|NCT04195750|451944950|FG000|Overall Study|Death|245|||
125634807|NCT04195750|451944951|FG001|Overall Study|Death|253|||
125634808|NCT04195750|451944952|FG002|Overall Study|Death|5|||
125634809|NCT04195750|451944950|FG000|Overall Study|Physician Decision|0|||
125216487|NCT01616758|450419454|FG000|Overall Study|Adverse Event|1|||
125129987|NCT00579670|450102512|FG001|Overall Study|Withdrawal by Subject|0|||
125129988|NCT00579670|450102513|FG002|Overall Study|Withdrawal by Subject|1|||
125129989|NCT00579670|450102514|FG003|Overall Study|Withdrawal by Subject|0|||
125129990|NCT00579670|450102515|FG004|Overall Study|Withdrawal by Subject|0|||
125634810|NCT04195750|451944951|FG001|Overall Study|Physician Decision|1|||
125634811|NCT04195750|451944952|FG002|Overall Study|Physician Decision|0|||
125634812|NCT04195750|451944950|FG000|Overall Study|Withdrawal by Subject|9|||
125634813|NCT04195750|451944951|FG001|Overall Study|Withdrawal by Subject|8|||
125634814|NCT04195750|451944952|FG002|Overall Study|Withdrawal by Subject|0|||
125634815|NCT04195750|451944950|FG000|Overall Study|Ongoing|120|||
125634816|NCT04195750|451944951|FG001|Overall Study|Ongoing|110|||
125634817|NCT04195750|451944952|FG002|Overall Study|Ongoing|4|||
125634818|NCT02406027|451944953|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
125634819|NCT02406027|451944954|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
125634820|NCT02406027|451944955|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
125634821|NCT02406027|451944956|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
125634822|NCT02406027|451944957|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
125634823|NCT02406027|451944958|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
125634824|NCT02406027|451944959|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
125634825|NCT02406027|451944953|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
125634826|NCT02406027|451944954|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
125634827|NCT02406027|451944955|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
125634828|NCT02406027|451944956|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
125634829|NCT02406027|451944957|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
125634830|NCT02406027|451944958|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
125634831|NCT02406027|451944959|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
125634832|NCT02406027|451944953|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
125634833|NCT02406027|451944954|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
125634834|NCT02406027|451944955|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
125634835|NCT02406027|451944956|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
125634836|NCT02406027|451944957|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
125634837|NCT02406027|451944958|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
125634838|NCT02406027|451944959|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
125634839|NCT02406027|451944953|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
125634840|NCT02406027|451944954|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
125634841|NCT02406027|451944955|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
125634842|NCT02406027|451944956|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
125634843|NCT02406027|451944957|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
125634844|NCT02406027|451944958|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
125634845|NCT02406027|451944959|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
125634846|NCT02406027|451944953|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
125634847|NCT02406027|451944954|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
125634848|NCT02406027|451944955|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
125634849|NCT02406027|451944956|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
125634850|NCT02406027|451944957|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
125634851|NCT02406027|451944958|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
125634852|NCT02406027|451944959|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
125129991|NCT00850174|450102519|FG000|Washout: One Week|Withdrawal by Subject|0|||
125129992|NCT00850174|450102520|FG001|Washout: One Week|Withdrawal by Subject|2|||
125129993|NCT00850174|450102519|FG000|Second Intervention|Withdrawal by Subject|1|||
125129994|NCT00850174|450102520|FG001|Second Intervention|Withdrawal by Subject|0|||
125129995|NCT00635492|450102521|FG000|Overall Study|Death|12|||
125129996|NCT00635492|450102522|FG001|Overall Study|Death|40|||
125129997|NCT00635492|450102521|FG000|Overall Study|Lost to Follow-up|151|||
125129998|NCT00635492|450102522|FG001|Overall Study|Lost to Follow-up|172|||
125129999|NCT00635492|450102521|FG000|Overall Study|Physician Decision|32|||
125130000|NCT00635492|450102522|FG001|Overall Study|Physician Decision|22|||
125130001|NCT00635492|450102521|FG000|Overall Study|Sponsor decision|2|||
125634853|NCT02406027|451944953|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
125634854|NCT02406027|451944954|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
125634855|NCT02406027|451944955|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
125634856|NCT02406027|451944956|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
125634857|NCT02406027|451944957|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
125634858|NCT02406027|451944958|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
125634859|NCT02406027|451944959|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
125634860|NCT02406027|451944953|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
125130002|NCT00635492|450102522|FG001|Overall Study|Sponsor decision|3|||
125130003|NCT00635492|450102521|FG000|Overall Study|Withdrawal by Subject|82|||
125130004|NCT00635492|450102522|FG001|Overall Study|Withdrawal by Subject|45|||
125634861|NCT02406027|451944954|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
125634862|NCT02406027|451944955|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
125634863|NCT02406027|451944956|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
125634864|NCT02406027|451944957|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
125634865|NCT02406027|451944958|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
125634866|NCT02406027|451944959|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
125634867|NCT02406027|451944953|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
125634868|NCT02406027|451944954|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
125634869|NCT02406027|451944955|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
125634870|NCT02406027|451944956|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
125634871|NCT02406027|451944957|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
125634872|NCT02406027|451944958|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
125634873|NCT02406027|451944959|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
125634874|NCT02406027|451944953|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
125634875|NCT02406027|451944954|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
125634876|NCT02406027|451944955|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
125634877|NCT02406027|451944956|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
125634878|NCT02406027|451944957|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
125634879|NCT02406027|451944958|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
125634880|NCT02406027|451944959|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
125634881|NCT02406027|451944953|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
125634882|NCT02406027|451944954|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
125634883|NCT02406027|451944955|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
125634884|NCT02406027|451944956|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
125634885|NCT02406027|451944957|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
125634886|NCT02406027|451944958|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
125634887|NCT02406027|451944959|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
125634888|NCT02497287|451944960|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
125634889|NCT02497287|451944960|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
125634890|NCT02497287|451944960|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
125634891|NCT02497287|451944960|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
125634892|NCT02497287|451944960|FG000|Induction Phase (4 Weeks)|Other|13|||
125130005|NCT01900626|450102523|FG000|Overall Study|study was closed due to low enrollment|1|||
125130006|NCT01900626|450102524|FG001|Overall Study|study was closed due to low enrollment|1|||
125130007|NCT01702987|450102525|FG000|Overall Study|Withdrawal by Subject|1|||
125130008|NCT01702987|450102526|FG001|Overall Study|Withdrawal by Subject|0|||
125130009|NCT02017223|450102527|FG000|Overall Study|Algorithm problems|2|||
125130010|NCT04263649|450102528|FG000|Overall Study|Adverse Event|53|||
125130011|NCT04263649|450102528|FG000|Overall Study|Lost to Follow-up|3|||
125130012|NCT04263649|450102528|FG000|Overall Study|Death|29|||
125130013|NCT04263649|450102528|FG000|Overall Study|Device deficiency|19|||
125130014|NCT04263649|450102528|FG000|Overall Study|other reasons|11|||
125130015|NCT05169710|450102530|FG000|Overall Study|Adverse Event|1|||
125130016|NCT05169710|450102531|FG001|Overall Study|Adverse Event|2|||
125130017|NCT05169710|450102532|FG002|Overall Study|Adverse Event|2|||
125130018|NCT05169710|450102530|FG000|Overall Study|Lost to Follow-up|0|||
125130019|NCT05169710|450102531|FG001|Overall Study|Lost to Follow-up|0|||
125130020|NCT05169710|450102532|FG002|Overall Study|Lost to Follow-up|1|||
125130021|NCT05169710|450102530|FG000|Overall Study|Withdrawal by Subject|2|||
125130022|NCT05169710|450102531|FG001|Overall Study|Withdrawal by Subject|1|||
125130023|NCT05169710|450102532|FG002|Overall Study|Withdrawal by Subject|0|||
125130024|NCT05169710|450102530|FG000|Overall Study|Other Study Discontinuation Reason|0|||
125130025|NCT05169710|450102531|FG001|Overall Study|Other Study Discontinuation Reason|2|||
125130026|NCT05169710|450102532|FG002|Overall Study|Other Study Discontinuation Reason|0|||
125130027|NCT00846495|450102541|FG000|Overall Study|Lost to Follow-up|1|||
125130028|NCT00846495|450102542|FG001|Overall Study|Lost to Follow-up|0|||
125130029|NCT00846495|450102541|FG000|Overall Study|Adverse Event|5|||
125634893|NCT02497287|451944960|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
125634894|NCT02497287|451944960|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
125634895|NCT02497287|451944960|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
125634896|NCT02497287|451944960|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
125634897|NCT02497287|451944960|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
125130030|NCT00846495|450102542|FG001|Overall Study|Adverse Event|1|||
125130031|NCT00846495|450102541|FG000|Overall Study|Lack of Efficacy|1|||
125130032|NCT00846495|450102542|FG001|Overall Study|Lack of Efficacy|2|||
125130033|NCT00846495|450102541|FG000|Overall Study|Physician Decision|1|||
125130034|NCT00846495|450102542|FG001|Overall Study|Physician Decision|0|||
125130035|NCT01686438|450102543|FG000|Overall Study|Lost to Follow-up|8|||
125130036|NCT01686438|450102544|FG001|Overall Study|Lost to Follow-up|9|||
125130037|NCT01686438|450102545|FG002|Overall Study|Lost to Follow-up|10|||
125130038|NCT01686438|450102543|FG000|Overall Study|Adverse Event|0|||
125130039|NCT01686438|450102544|FG001|Overall Study|Adverse Event|0|||
125130040|NCT01686438|450102545|FG002|Overall Study|Adverse Event|1|||
125130041|NCT01686438|450102543|FG000|Overall Study|Protocol Violation|0|||
125130042|NCT01686438|450102544|FG001|Overall Study|Protocol Violation|0|||
125130043|NCT01686438|450102545|FG002|Overall Study|Protocol Violation|1|||
125130044|NCT01686438|450102543|FG000|Overall Study|Withdrawal by Subject|0|||
125130045|NCT01686438|450102544|FG001|Overall Study|Withdrawal by Subject|0|||
125130046|NCT01686438|450102545|FG002|Overall Study|Withdrawal by Subject|1|||
125130047|NCT06358820|450104408|FG000|Overall Study|Adverse Event|11|||
125130048|NCT06358820|450104408|FG000|Overall Study|kidney transplantation|3|||
125130049|NCT06358820|450104408|FG000|Overall Study|patient voluntary withdrawal|6|||
125130050|NCT06358820|450104408|FG000|Overall Study|Physician Decision|1|||
125130051|NCT01124175|450104409|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
125130052|NCT01124175|450104410|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
125130053|NCT00218257|450104416|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
125130054|NCT00218257|450104417|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
125130055|NCT00462345|450104420|FG000|Overall Study|Withdrawal by Subject|2|||
125130056|NCT00462345|450104420|FG000|Overall Study|Did not complete second course|1|||
125130057|NCT00070291|450104423|FG000|Step 1|Withdrawal by Subject|1|||
125130058|NCT00070291|450104423|FG000|Step 1|Adverse Event|1|||
125130059|NCT00070291|450104423|FG000|Step 2|Adverse Event|1|||
125130060|NCT00520130|450104426|FG000|Overall Study|Disease progression on study|4|||
125130061|NCT00520130|450104427|FG001|Overall Study|Disease progression on study|0|||
125130062|NCT00520130|450104426|FG000|Overall Study|Physician Decision|1|||
125130063|NCT00520130|450104427|FG001|Overall Study|Physician Decision|1|||
125130064|NCT02028715|450104428|FG000|Overall Study|Adverse Event|2|||
125130065|NCT02028715|450104429|FG001|Overall Study|Adverse Event|2|||
125130066|NCT02028715|450104428|FG000|Overall Study|Physician Decision|1|||
125130067|NCT02028715|450104429|FG001|Overall Study|Physician Decision|0|||
125130068|NCT02028715|450104428|FG000|Overall Study|Did not complete satisfaction surveys|2|||
125130069|NCT02028715|450104429|FG001|Overall Study|Did not complete satisfaction surveys|2|||
125130070|NCT04915755|450104430|FG000|Overall Study|Physician Decision|3|||
125130071|NCT04915755|450104431|FG001|Overall Study|Physician Decision|2|||
125130072|NCT04915755|450104430|FG000|Overall Study|Withdrawal by Subject|1|||
125130073|NCT04915755|450104431|FG001|Overall Study|Withdrawal by Subject|1|||
125130074|NCT04915755|450104430|FG000|Overall Study|Ongoing for PACT|3|||
125130075|NCT04915755|450104431|FG001|Overall Study|Ongoing for PACT|2|||
125130076|NCT04915755|450104430|FG000|Overall Study|Other|7|||
125130077|NCT04915755|450104431|FG001|Overall Study|Other|11|||
125130078|NCT02533258|450104432|FG000|Overall Study|Adverse Event|1|||
125130079|NCT02533258|450104432|FG000|Overall Study|Death|2|||
125634898|NCT02497287|451944960|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
125634899|NCT02497287|451944960|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
125130080|NCT02533258|450104432|FG000|Overall Study|Other|1|||
125130081|NCT02533258|450104432|FG000|Overall Study|Economic factor|1|||
125130082|NCT02533258|450104432|FG000|Overall Study|Progression of pleural effusion|1|||
125130083|NCT02533258|450104432|FG000|Overall Study|Lack of Efficacy|2|||
125130084|NCT01149473|450104433|FG000|First Intervention|Adverse Event|1|||
125130085|NCT01149473|450104434|FG001|First Intervention|Adverse Event|1|||
125130086|NCT01149473|450104433|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125130087|NCT01149473|450104434|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
125130088|NCT01954394|450104437|FG000|Overall Study|Enrolled but not treated|1|||
125130089|NCT01954394|450104438|FG001|Overall Study|Enrolled but not treated|0|||
125130090|NCT01954394|450104437|FG000|Overall Study|Adverse Event|10|||
125130091|NCT01954394|450104438|FG001|Overall Study|Adverse Event|23|||
125130092|NCT01954394|450104437|FG000|Overall Study|Poor compliance to protocol|7|||
125130093|NCT01954394|450104438|FG001|Overall Study|Poor compliance to protocol|7|||
125130094|NCT01954394|450104437|FG000|Overall Study|Participant Moved|0|||
125130095|NCT01954394|450104438|FG001|Overall Study|Participant Moved|4|||
125130096|NCT01954394|450104437|FG000|Overall Study|Related to Study Drug administration|2|||
125130097|NCT01954394|450104438|FG001|Overall Study|Related to Study Drug administration|2|||
125130098|NCT01954394|450104437|FG000|Overall Study|Other than specified above|10|||
125130099|NCT01954394|450104438|FG001|Overall Study|Other than specified above|21|||
125130100|NCT04089735|450104439|FG000|Overall Study|Adverse Event|1|||
125130101|NCT04089735|450104440|FG001|Overall Study|Adverse Event|0|||
125130102|NCT04089735|450104441|FG002|Overall Study|Adverse Event|1|||
125130103|NCT04089735|450104442|FG003|Overall Study|Adverse Event|1|||
125130104|NCT04089735|450104443|FG004|Overall Study|Adverse Event|0|||
125130105|NCT04089735|450104444|FG005|Overall Study|Adverse Event|0|||
125130106|NCT04089735|450104439|FG000|Overall Study|Physician Decision|0|||
125130107|NCT04089735|450104440|FG001|Overall Study|Physician Decision|3|||
125130108|NCT04089735|450104441|FG002|Overall Study|Physician Decision|0|||
125130109|NCT04089735|450104442|FG003|Overall Study|Physician Decision|0|||
125130110|NCT04089735|450104443|FG004|Overall Study|Physician Decision|0|||
125130111|NCT04089735|450104444|FG005|Overall Study|Physician Decision|0|||
125130112|NCT04089735|450104439|FG000|Overall Study|Withdrawal by Subject|0|||
125130113|NCT04089735|450104440|FG001|Overall Study|Withdrawal by Subject|0|||
125130114|NCT04089735|450104441|FG002|Overall Study|Withdrawal by Subject|1|||
125130115|NCT04089735|450104442|FG003|Overall Study|Withdrawal by Subject|0|||
125130116|NCT04089735|450104443|FG004|Overall Study|Withdrawal by Subject|0|||
125130117|NCT04089735|450104444|FG005|Overall Study|Withdrawal by Subject|0|||
125130118|NCT04089735|450104439|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
125130119|NCT04089735|450104440|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
125130120|NCT04089735|450104441|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
125130121|NCT04089735|450104442|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
125130122|NCT04089735|450104443|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
125130123|NCT04089735|450104444|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
125130124|NCT01439880|450104445|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
125130125|NCT01439880|450104446|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
125130126|NCT01439880|450104445|FG000|SOC-controlled Period (Year 1)|Death|2|||
125130127|NCT01439880|450104446|FG001|SOC-controlled Period (Year 1)|Death|1|||
125130128|NCT01439880|450104445|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
125130129|NCT01439880|450104446|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
125130130|NCT01439880|450104445|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
125130131|NCT01439880|450104446|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
125130132|NCT01439880|450104445|FG000|SOC-controlled Period (Year 1)|Other|8|||
125130133|NCT01439880|450104446|FG001|SOC-controlled Period (Year 1)|Other|13|||
125130134|NCT01439880|450104445|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
125130135|NCT01439880|450104446|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
125130136|NCT01439880|450104445|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
125130137|NCT01439880|450104446|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
125130138|NCT01439880|450104445|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
125130139|NCT01439880|450104446|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
125130140|NCT01439880|450104445|FG000|All-IP Period (Years 2 to 5)|Death|3|||
125130141|NCT01439880|450104446|FG001|All-IP Period (Years 2 to 5)|Death|13|||
125130142|NCT01439880|450104445|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
125130143|NCT01439880|450104446|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
125130144|NCT01439880|450104445|FG000|All-IP Period (Years 2 to 5)|Other|14|||
125130145|NCT01439880|450104446|FG001|All-IP Period (Years 2 to 5)|Other|31|||
125130146|NCT01439880|450104445|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
125130147|NCT01439880|450104446|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
125130148|NCT02956460|450104447|FG000|Lens 1|Lost to Follow-up|1|||
125130149|NCT02956460|450104448|FG001|Lens 1|Lost to Follow-up|0|||
125130150|NCT00834067|450104451|FG000|Washout of 21 Days|Protocol Violation|0|||
125130151|NCT00834067|450104452|FG001|Washout of 21 Days|Protocol Violation|1|||
125130152|NCT04129346|450104453|FG000|Overall Study|Death|1|||
125130153|NCT04129346|450104454|FG001|Overall Study|Death|0|||
125130154|NCT01083693|450104455|FG000|Overall Study|Adverse Event|1|||
125130155|NCT01083693|450104456|FG001|Overall Study|Adverse Event|1|||
125130156|NCT01083693|450104457|FG002|Overall Study|Adverse Event|0|||
125130157|NCT01083693|450104455|FG000|Overall Study|Lost to Follow-up|2|||
125130158|NCT01083693|450104456|FG001|Overall Study|Lost to Follow-up|0|||
125130159|NCT01083693|450104457|FG002|Overall Study|Lost to Follow-up|2|||
125130160|NCT01083693|450104455|FG000|Overall Study|Lack of effectiveness|13|||
125130161|NCT01083693|450104456|FG001|Overall Study|Lack of effectiveness|2|||
125130162|NCT01083693|450104457|FG002|Overall Study|Lack of effectiveness|2|||
125130163|NCT01083693|450104455|FG000|Overall Study|Patient Moved|0|||
125130164|NCT01083693|450104456|FG001|Overall Study|Patient Moved|1|||
125130165|NCT01083693|450104457|FG002|Overall Study|Patient Moved|0|||
125130166|NCT01083693|450104455|FG000|Overall Study|Complete remission|0|||
125130167|NCT01083693|450104456|FG001|Overall Study|Complete remission|1|||
125130168|NCT01083693|450104457|FG002|Overall Study|Complete remission|0|||
125130169|NCT01083693|450104455|FG000|Overall Study|Other medical condition/surgery|1|||
125130170|NCT01083693|450104456|FG001|Overall Study|Other medical condition/surgery|1|||
125130171|NCT01083693|450104457|FG002|Overall Study|Other medical condition/surgery|0|||
125130172|NCT01083693|450104455|FG000|Overall Study|Withdrawal by Subject|3|||
125130173|NCT01083693|450104456|FG001|Overall Study|Withdrawal by Subject|0|||
125130174|NCT01083693|450104457|FG002|Overall Study|Withdrawal by Subject|2|||
125130175|NCT01083693|450104455|FG000|Overall Study|Reason unknown|0|||
125130176|NCT01083693|450104456|FG001|Overall Study|Reason unknown|0|||
125130177|NCT01083693|450104457|FG002|Overall Study|Reason unknown|1|||
125130178|NCT00836056|450104465|FG000|First Intervention|Adverse Event|1|||
125130179|NCT00836056|450104466|FG001|First Intervention|Adverse Event|0|||
125130180|NCT01029340|450104468|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
125130181|NCT01029340|450104469|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
125130182|NCT01029340|450104470|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
125130183|NCT01029340|450104471|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
125130184|NCT01029340|450104472|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
125634900|NCT02497287|451944960|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
125634901|NCT02497287|451944960|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
125634902|NCT02497287|451944960|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
125634903|NCT02497287|451944960|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
125634904|NCT02497287|451944960|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
125130185|NCT01029340|450104473|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
125130186|NCT01029340|450104468|FG000|Part B Treatment Period|Protocol Violation|0|||
125130187|NCT01029340|450104469|FG001|Part B Treatment Period|Protocol Violation|0|||
125130188|NCT01029340|450104470|FG002|Part B Treatment Period|Protocol Violation|1|||
125130189|NCT01029340|450104471|FG003|Part B Treatment Period|Protocol Violation|0|||
125130190|NCT01029340|450104472|FG004|Part B Treatment Period|Protocol Violation|0|||
125130191|NCT01029340|450104473|FG005|Part B Treatment Period|Protocol Violation|0|||
125130192|NCT01029340|450104468|FG000|Extension Period|Adverse Event|0|||
125130193|NCT01029340|450104469|FG001|Extension Period|Adverse Event|0|||
125130194|NCT01029340|450104470|FG002|Extension Period|Adverse Event|0|||
125130195|NCT01029340|450104471|FG003|Extension Period|Adverse Event|0|||
125130196|NCT01029340|450104472|FG004|Extension Period|Adverse Event|0|||
125130197|NCT01029340|450104473|FG005|Extension Period|Adverse Event|1|||
125130198|NCT01029340|450104468|FG000|Extension Period|starting another study|0|||
125130199|NCT01029340|450104469|FG001|Extension Period|starting another study|0|||
125130200|NCT01029340|450104470|FG002|Extension Period|starting another study|0|||
125130201|NCT01029340|450104471|FG003|Extension Period|starting another study|0|||
125130202|NCT01029340|450104472|FG004|Extension Period|starting another study|0|||
125130203|NCT01029340|450104473|FG005|Extension Period|starting another study|8|||
125130204|NCT01029340|450104468|FG000|Extension Period|non-compliance|0|||
125130205|NCT01029340|450104469|FG001|Extension Period|non-compliance|0|||
125130206|NCT01029340|450104470|FG002|Extension Period|non-compliance|0|||
125130207|NCT01029340|450104471|FG003|Extension Period|non-compliance|0|||
125130208|NCT01029340|450104472|FG004|Extension Period|non-compliance|0|||
125130209|NCT01029340|450104473|FG005|Extension Period|non-compliance|1|||
125130210|NCT01029340|450104468|FG000|Extension Period|Withdrawal by Subject|0|||
125130211|NCT01029340|450104469|FG001|Extension Period|Withdrawal by Subject|0|||
125130212|NCT01029340|450104470|FG002|Extension Period|Withdrawal by Subject|0|||
125130213|NCT01029340|450104471|FG003|Extension Period|Withdrawal by Subject|0|||
125130214|NCT01029340|450104472|FG004|Extension Period|Withdrawal by Subject|0|||
125130215|NCT01029340|450104473|FG005|Extension Period|Withdrawal by Subject|1|||
125130216|NCT01029340|450104468|FG000|Extension Period|Physician Decision|0|||
125130217|NCT01029340|450104469|FG001|Extension Period|Physician Decision|0|||
125130218|NCT01029340|450104470|FG002|Extension Period|Physician Decision|0|||
125130219|NCT01029340|450104471|FG003|Extension Period|Physician Decision|0|||
125130220|NCT01029340|450104472|FG004|Extension Period|Physician Decision|0|||
125130221|NCT01029340|450104473|FG005|Extension Period|Physician Decision|1|||
125130222|NCT02648347|450104474|FG000|Overall Study|Death|174|||
125130223|NCT02648347|450104475|FG001|Overall Study|Death|167|||
125130224|NCT02648347|450104474|FG000|Overall Study|Withdrawal by Subject|16|||
125130225|NCT02648347|450104475|FG001|Overall Study|Withdrawal by Subject|9|||
125130226|NCT02648347|450104474|FG000|Overall Study|Lost to Follow-up|18|||
125377059|NCT00555321|451010273|FG001|Long-term Extension Phase|Other Reason|0|||
125377060|NCT00555321|451010274|FG002|Long-term Extension Phase|Other Reason|2|||
125377061|NCT00555321|451010275|FG003|Long-term Extension Phase|Other Reason|0|||
125377062|NCT00555321|451010276|FG004|Long-term Extension Phase|Other Reason|0|||
125377063|NCT00160251|451010277|FG000|Prior to Amendment 2|Adverse Event|2|||
125377064|NCT00160251|451010278|FG001|Prior to Amendment 2|Adverse Event|1|||
125377065|NCT00160251|451010279|FG002|Prior to Amendment 2|Adverse Event|3|||
125377066|NCT00160251|451010280|FG003|Prior to Amendment 2|Adverse Event|1|||
125377067|NCT00160251|451010281|FG004|Prior to Amendment 2|Adverse Event|1|||
125377068|NCT00160251|451010282|FG005|Prior to Amendment 2|Adverse Event|1|||
125377069|NCT00160251|451010283|FG006|Prior to Amendment 2|Adverse Event|1|||
125377070|NCT00160251|451010284|FG007|Prior to Amendment 2|Adverse Event|0|||
125377071|NCT00160251|451010277|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
125377072|NCT00160251|451010278|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
125377073|NCT00160251|451010279|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
125377074|NCT00160251|451010280|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
125377075|NCT00160251|451010281|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
125377076|NCT00160251|451010282|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
125377077|NCT00160251|451010283|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
125377078|NCT00160251|451010284|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
125377079|NCT00160251|451010277|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
125377080|NCT00160251|451010278|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
125377081|NCT00160251|451010279|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
125377082|NCT00160251|451010280|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
125377083|NCT00160251|451010281|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
125377084|NCT00160251|451010282|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
125377085|NCT00160251|451010283|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
125377086|NCT00160251|451010284|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
125130227|NCT02648347|450104475|FG001|Overall Study|Lost to Follow-up|21|||
125130228|NCT02648347|450104474|FG000|Overall Study|Missing|1|||
125130229|NCT02648347|450104475|FG001|Overall Study|Missing|0|||
125130230|NCT03546842|450104477|FG000|Overall Study|Protocol Violation|1|||
125130231|NCT03546842|450104477|FG000|Overall Study|Withdrawal by Subject|2|||
125130232|NCT01265056|450104486|FG000|Initial Study Period|Withdrawal by Subject|1|||
125130233|NCT01265056|450104487|FG001|Initial Study Period|Withdrawal by Subject|1|||
125130234|NCT01265056|450104486|FG000|Initial Study Period|Withdrawal by Subject|1|||
125130235|NCT01265056|450104487|FG001|Initial Study Period|Withdrawal by Subject|1|||
125130236|NCT01265056|450104486|FG000|Follow up|Lost to Follow-up|7|||
125130237|NCT01265056|450104487|FG001|Follow up|Lost to Follow-up|3|||
125130238|NCT00833937|450104496|FG000|Washout|Withdrawal by Subject|1|||
125130239|NCT00833937|450104497|FG001|Washout|Withdrawal by Subject|0|||
125130240|NCT04419311|450104499|FG000|Overall Study|Lost to Follow-up|1|||
125130241|NCT04419311|450104500|FG001|Overall Study|Lost to Follow-up|0|||
125130242|NCT00465270|450104501|FG000|Overall Study|Death|7|||
125130243|NCT00465270|450104502|FG001|Overall Study|Death|11|||
125130244|NCT00465270|450104501|FG000|Overall Study|Withdrawal by Subject|34|||
125130245|NCT00465270|450104502|FG001|Overall Study|Withdrawal by Subject|78|||
125130246|NCT00465270|450104501|FG000|Overall Study|Lost to Follow-up|60|||
125130247|NCT00465270|450104502|FG001|Overall Study|Lost to Follow-up|67|||
125130248|NCT00465270|450104501|FG000|Overall Study|Investigator request|3|||
125130249|NCT00465270|450104502|FG001|Overall Study|Investigator request|4|||
125130250|NCT03233724|450104503|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
125130251|NCT03233724|450104504|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
125130252|NCT03233724|450104505|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
125130253|NCT03233724|450104506|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
125130254|NCT03233724|450104507|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
125130255|NCT03233724|450104503|FG000|Phase I Dose Escalation|Best interest of participant|1|||
125130256|NCT03233724|450104504|FG001|Phase I Dose Escalation|Best interest of participant|1|||
125130257|NCT03233724|450104505|FG002|Phase I Dose Escalation|Best interest of participant|1|||
125130258|NCT03233724|450104506|FG003|Phase I Dose Escalation|Best interest of participant|0|||
125130259|NCT03233724|450104507|FG004|Phase I Dose Escalation|Best interest of participant|0|||
125130260|NCT03233724|450104503|FG000|Phase I Dose Escalation|Physician Decision|0|||
125130261|NCT03233724|450104504|FG001|Phase I Dose Escalation|Physician Decision|0|||
125130262|NCT03233724|450104505|FG002|Phase I Dose Escalation|Physician Decision|1|||
125130263|NCT03233724|450104506|FG003|Phase I Dose Escalation|Physician Decision|0|||
125130264|NCT03233724|450104507|FG004|Phase I Dose Escalation|Physician Decision|0|||
125130265|NCT03233724|450104503|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
125130266|NCT03233724|450104504|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
125130267|NCT03233724|450104505|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
125130268|NCT03233724|450104506|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
125130269|NCT03233724|450104507|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
125130270|NCT03135834|450104508|FG000|Stage 1|Adverse Event|1|||
125130271|NCT03135834|450104509|FG001|Stage 1|Adverse Event|2|||
125130272|NCT03135834|450104510|FG002|Stage 1|Adverse Event|2|||
125130273|NCT03135834|450104511|FG003|Stage 1|Adverse Event|1|||
125130274|NCT03135834|450104508|FG000|Stage 1|Death|1|||
125130275|NCT03135834|450104509|FG001|Stage 1|Death|0|||
125130276|NCT03135834|450104510|FG002|Stage 1|Death|0|||
125130277|NCT03135834|450104511|FG003|Stage 1|Death|0|||
125130278|NCT03135834|450104508|FG000|Stage 1|Lost to Follow-up|17|||
125130279|NCT03135834|450104509|FG001|Stage 1|Lost to Follow-up|24|||
125130280|NCT03135834|450104510|FG002|Stage 1|Lost to Follow-up|21|||
125130281|NCT03135834|450104511|FG003|Stage 1|Lost to Follow-up|38|||
125130282|NCT03135834|450104508|FG000|Stage 1|No longer met eligibility criteria|1|||
125130283|NCT03135834|450104509|FG001|Stage 1|No longer met eligibility criteria|6|||
125130284|NCT03135834|450104510|FG002|Stage 1|No longer met eligibility criteria|2|||
125130285|NCT03135834|450104511|FG003|Stage 1|No longer met eligibility criteria|5|||
125634905|NCT02497287|451944960|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
125634906|NCT02497287|451944960|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
125634907|NCT02497287|451944960|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
125634908|NCT02497287|451944960|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
125130286|NCT03135834|450104508|FG000|Stage 1|Other|0|||
125130287|NCT03135834|450104509|FG001|Stage 1|Other|2|||
125634909|NCT02497287|451944960|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
125130288|NCT03135834|450104510|FG002|Stage 1|Other|1|||
125130289|NCT03135834|450104511|FG003|Stage 1|Other|0|||
125130290|NCT03135834|450104508|FG000|Stage 1|Physician Decision|0|||
125130291|NCT03135834|450104509|FG001|Stage 1|Physician Decision|1|||
125130292|NCT03135834|450104510|FG002|Stage 1|Physician Decision|0|||
125130293|NCT03135834|450104511|FG003|Stage 1|Physician Decision|0|||
125130294|NCT03135834|450104508|FG000|Stage 1|Pregnancy|0|||
125130295|NCT03135834|450104509|FG001|Stage 1|Pregnancy|4|||
125130296|NCT03135834|450104510|FG002|Stage 1|Pregnancy|2|||
125130297|NCT03135834|450104511|FG003|Stage 1|Pregnancy|4|||
125130298|NCT03135834|450104508|FG000|Stage 1|Protocol Violation|1|||
125130299|NCT03135834|450104509|FG001|Stage 1|Protocol Violation|1|||
125130300|NCT03135834|450104510|FG002|Stage 1|Protocol Violation|2|||
125130301|NCT03135834|450104511|FG003|Stage 1|Protocol Violation|1|||
125130302|NCT03135834|450104508|FG000|Stage 1|Withdrawal by parent/guardian|2|||
125130303|NCT03135834|450104509|FG001|Stage 1|Withdrawal by parent/guardian|10|||
125130304|NCT03135834|450104510|FG002|Stage 1|Withdrawal by parent/guardian|2|||
125130305|NCT03135834|450104511|FG003|Stage 1|Withdrawal by parent/guardian|1|||
125130306|NCT03135834|450104508|FG000|Stage 1|Withdrawal by Subject|16|||
125130307|NCT03135834|450104509|FG001|Stage 1|Withdrawal by Subject|22|||
125130308|NCT03135834|450104510|FG002|Stage 1|Withdrawal by Subject|7|||
125130309|NCT03135834|450104511|FG003|Stage 1|Withdrawal by Subject|10|||
125130310|NCT03135834|450104508|FG000|Stage 1|Randomized but not Vaccinated|0|||
125130311|NCT03135834|450104509|FG001|Stage 1|Randomized but not Vaccinated|3|||
125130312|NCT03135834|450104510|FG002|Stage 1|Randomized but not Vaccinated|1|||
125130313|NCT03135834|450104511|FG003|Stage 1|Randomized but not Vaccinated|6|||
125130314|NCT03135834|450104508|FG000|Stage 2|Lost to Follow-up|0|||
125130315|NCT03135834|450104509|FG001|Stage 2|Lost to Follow-up|1|||
125130316|NCT03135834|450104510|FG002|Stage 2|Lost to Follow-up|0|||
125130317|NCT03135834|450104511|FG003|Stage 2|Lost to Follow-up|0|||
125130318|NCT03135834|450104508|FG000|Stage 2|Withdrawal by Subject|0|||
125130319|NCT03135834|450104509|FG001|Stage 2|Withdrawal by Subject|1|||
125130320|NCT03135834|450104510|FG002|Stage 2|Withdrawal by Subject|0|||
125130321|NCT03135834|450104511|FG003|Stage 2|Withdrawal by Subject|0|||
125130322|NCT03135834|450104508|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
125130323|NCT03135834|450104509|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
125130324|NCT03135834|450104510|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
125130325|NCT03135834|450104511|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
125130326|NCT03135834|450104508|FG000|Stage 2|Did not receive Booster Vaccination|1|||
125130327|NCT03135834|450104509|FG001|Stage 2|Did not receive Booster Vaccination|1|||
125130328|NCT03135834|450104510|FG002|Stage 2|Did not receive Booster Vaccination|0|||
125130329|NCT03135834|450104511|FG003|Stage 2|Did not receive Booster Vaccination|0|||
125130330|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
125130331|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
125130332|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
125130333|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
125130334|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
125130335|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
125130336|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
125130337|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
125130338|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
125130339|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
125130340|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
125130341|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
125130342|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
125130343|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
125130344|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
125130345|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
125130346|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
125130347|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
125130348|NCT01045161|450104512|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
125130349|NCT01045161|450104513|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
125130350|NCT01045161|450104514|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
125130351|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
125130352|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
125130353|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
125130354|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
125130355|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
125130356|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
125130357|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
125130358|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
125130359|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
125130360|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
125130361|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
125130362|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
125130363|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
125130364|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
125130365|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
125130366|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
125130367|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
125130368|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
125130369|NCT01045161|450104512|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
125130370|NCT01045161|450104513|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
125130371|NCT01045161|450104514|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
125130372|NCT02605928|450104517|FG000|Overall Study|Model tuning phase|28|||
125130373|NCT02605928|450104517|FG000|Overall Study|Lack of Efficacy|5|||
125130374|NCT02612337|450104520|FG000|Overall Study|Lack of Efficacy|1|||
125130375|NCT02612337|450104521|FG001|Overall Study|Lack of Efficacy|0|||
125130376|NCT02612337|450104520|FG000|Overall Study|Withdrawal by Subject|2|||
125130377|NCT02612337|450104521|FG001|Overall Study|Withdrawal by Subject|2|||
125130378|NCT02612337|450104520|FG000|Overall Study|Did not receive study drug|0|||
125130379|NCT02612337|450104521|FG001|Overall Study|Did not receive study drug|1|||
125130380|NCT02242201|450104524|FG000|Overall Study|preoperative identified neuropathy|2|||
125130381|NCT02242201|450104525|FG001|Overall Study|preoperative identified neuropathy|0|||
125130382|NCT02242201|450104526|FG002|Overall Study|preoperative identified neuropathy|0|||
125130383|NCT02242201|450104524|FG000|Overall Study|planned post-op anticoagulation|1|||
125130384|NCT02242201|450104525|FG001|Overall Study|planned post-op anticoagulation|0|||
125130385|NCT02242201|450104526|FG002|Overall Study|planned post-op anticoagulation|0|||
125130386|NCT02242201|450104524|FG000|Overall Study|changed surgical procedure|1|||
125130387|NCT02242201|450104525|FG001|Overall Study|changed surgical procedure|0|||
125130388|NCT02242201|450104526|FG002|Overall Study|changed surgical procedure|0|||
125130389|NCT02242201|450104524|FG000|Overall Study|postponed surgery|0|||
125130390|NCT02242201|450104525|FG001|Overall Study|postponed surgery|0|||
125130391|NCT02242201|450104526|FG002|Overall Study|postponed surgery|1|||
125130392|NCT02242201|450104524|FG000|Overall Study|preoperative opioid consumption|0|||
125130393|NCT02242201|450104525|FG001|Overall Study|preoperative opioid consumption|1|||
125130394|NCT02242201|450104526|FG002|Overall Study|preoperative opioid consumption|0|||
125130395|NCT02374853|450104529|FG000|Overall Study|Surgery Cancelled|5|||
125130396|NCT02374853|450104530|FG001|Overall Study|Surgery Cancelled|11|||
125130397|NCT02281084|450104533|FG000|Overall Study|Death|21|||
125130398|NCT02281084|450104534|FG001|Overall Study|Death|18|||
125130399|NCT02281084|450104535|FG002|Overall Study|Death|3|||
125130400|NCT02281084|450104536|FG003|Overall Study|Death|5|||
125130401|NCT02281084|450104533|FG000|Overall Study|Adverse Event|1|||
125130402|NCT02281084|450104534|FG001|Overall Study|Adverse Event|0|||
125130403|NCT02281084|450104535|FG002|Overall Study|Adverse Event|0|||
125130404|NCT02281084|450104536|FG003|Overall Study|Adverse Event|0|||
125130405|NCT02281084|450104533|FG000|Overall Study|Withdrawal by Subject|2|||
125130406|NCT02281084|450104534|FG001|Overall Study|Withdrawal by Subject|2|||
125130407|NCT02281084|450104535|FG002|Overall Study|Withdrawal by Subject|0|||
125130408|NCT02281084|450104536|FG003|Overall Study|Withdrawal by Subject|0|||
125130409|NCT02281084|450104533|FG000|Overall Study|Site Closure by Sponsor|5|||
125130410|NCT02281084|450104534|FG001|Overall Study|Site Closure by Sponsor|1|||
125130411|NCT02281084|450104535|FG002|Overall Study|Site Closure by Sponsor|2|||
125130412|NCT02281084|450104536|FG003|Overall Study|Site Closure by Sponsor|0|||
125130413|NCT01697696|450104537|FG000|Overall Study|Study terminated by sponsor|0|||
125130414|NCT01697696|450104538|FG001|Overall Study|Study terminated by sponsor|3|||
125130415|NCT01697696|450104537|FG000|Overall Study|Protocol deviation|1|||
125130416|NCT01697696|450104538|FG001|Overall Study|Protocol deviation|0|||
125130417|NCT01697696|450104537|FG000|Overall Study|Physician Decision|1|||
125130418|NCT01697696|450104538|FG001|Overall Study|Physician Decision|0|||
125130419|NCT01697696|450104537|FG000|Overall Study|Death|4|||
125130420|NCT01697696|450104538|FG001|Overall Study|Death|2|||
125130421|NCT01697696|450104537|FG000|Overall Study|Lost to Follow-up|10|||
125130422|NCT01697696|450104538|FG001|Overall Study|Lost to Follow-up|7|||
125130423|NCT01697696|450104537|FG000|Overall Study|Subject/guardian decision|31|||
125130424|NCT01697696|450104538|FG001|Overall Study|Subject/guardian decision|35|||
125130425|NCT01424644|450104539|FG000|Overall Study|Adverse Event|2|||
125130426|NCT01424644|450104540|FG001|Overall Study|Adverse Event|0|||
125130427|NCT01424644|450104539|FG000|Overall Study|Withdrawal by Subject|9|||
125130428|NCT01424644|450104540|FG001|Overall Study|Withdrawal by Subject|12|||
125130429|NCT01424644|450104539|FG000|Overall Study|Lost to Follow-up|16|||
125130430|NCT01424644|450104540|FG001|Overall Study|Lost to Follow-up|12|||
125130431|NCT01424644|450104539|FG000|Overall Study|Protocol Violation|4|||
125130432|NCT01424644|450104540|FG001|Overall Study|Protocol Violation|3|||
125130433|NCT01424644|450104539|FG000|Overall Study|Administrative Reason|1|||
125216488|NCT01616758|450419454|FG000|Overall Study|Withdrawal by Subject|2|||
125130434|NCT01424644|450104540|FG001|Overall Study|Administrative Reason|0|||
125130435|NCT01424644|450104539|FG000|Overall Study|Unable to Classify|1|||
125130436|NCT01424644|450104540|FG001|Overall Study|Unable to Classify|0|||
125130437|NCT05593965|450104541|FG000|1st Intervention (1 Day)|Technical error|1|||
125130438|NCT05593965|450104542|FG001|1st Intervention (1 Day)|Technical error|0|||
125216489|NCT01616758|450419454|FG000|Overall Study|Disease progression|18|||
125130439|NCT02024932|450104561|FG000|Overall Study|Adverse Event|2|||
125130440|NCT02024932|450104562|FG001|Overall Study|Adverse Event|3|||
125130441|NCT02024932|450104563|FG002|Overall Study|Adverse Event|0|||
125130442|NCT02024932|450104564|FG003|Overall Study|Adverse Event|0|||
125130443|NCT02024932|450104565|FG004|Overall Study|Adverse Event|2|||
125130444|NCT02024932|450104566|FG005|Overall Study|Adverse Event|0|||
125130445|NCT02024932|450104561|FG000|Overall Study|Abnormal laboratory value|0|||
125130446|NCT02024932|450104562|FG001|Overall Study|Abnormal laboratory value|0|||
125130447|NCT02024932|450104563|FG002|Overall Study|Abnormal laboratory value|0|||
125130448|NCT02024932|450104564|FG003|Overall Study|Abnormal laboratory value|2|||
125130449|NCT02024932|450104565|FG004|Overall Study|Abnormal laboratory value|0|||
125130450|NCT02024932|450104566|FG005|Overall Study|Abnormal laboratory value|0|||
125130451|NCT02445339|450104567|FG000|Overall Study|Physician Decision|1|||
125130452|NCT02445339|450104568|FG001|Overall Study|Physician Decision|0|||
125130453|NCT02445339|450104567|FG000|Overall Study|Lost to Follow-up|11|||
125130454|NCT02445339|450104568|FG001|Overall Study|Lost to Follow-up|15|||
125130455|NCT03020641|450104569|FG000|Overall Study|Lost to Follow-up|0|||
125130456|NCT03020641|450104570|FG001|Overall Study|Lost to Follow-up|1|||
125130457|NCT03020641|450104569|FG000|Overall Study|Converted to open surgery|2|||
125130458|NCT03020641|450104570|FG001|Overall Study|Converted to open surgery|1|||
125130459|NCT03020641|450104569|FG000|Overall Study|for surgery not performed|0|||
125130460|NCT03020641|450104570|FG001|Overall Study|for surgery not performed|1|||
125130461|NCT03041025|450104571|FG000|Overall Study|Adverse Event|0|||
125130462|NCT03041025|450104572|FG001|Overall Study|Adverse Event|0|||
125130463|NCT03041025|450104573|FG002|Overall Study|Adverse Event|1|||
125130464|NCT03041025|450104571|FG000|Overall Study|Lost to Follow-up|1|||
125130465|NCT03041025|450104572|FG001|Overall Study|Lost to Follow-up|0|||
125130466|NCT03041025|450104573|FG002|Overall Study|Lost to Follow-up|0|||
125130467|NCT03041025|450104571|FG000|Overall Study|Withdrawal by Subject|0|||
125130468|NCT03041025|450104572|FG001|Overall Study|Withdrawal by Subject|0|||
125130469|NCT03041025|450104573|FG002|Overall Study|Withdrawal by Subject|1|||
125130470|NCT02963259|450104575|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
125130471|NCT02963259|450104575|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
125130472|NCT02963259|450104575|FG000|Overall Study|Death|1|||
125130473|NCT02963259|450104575|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
125130474|NCT00939003|450104576|FG000|Double-blind Treatment Period|Adverse Event|1|||
125130475|NCT00939003|450104577|FG001|Double-blind Treatment Period|Adverse Event|1|||
125130476|NCT00939003|450104576|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
125130477|NCT00939003|450104577|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
125130478|NCT00939003|450104576|FG000|Double-blind Treatment Period|Pregnancy|0|||
125130479|NCT00939003|450104577|FG001|Double-blind Treatment Period|Pregnancy|1|||
125130480|NCT00939003|450104576|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
125130481|NCT00939003|450104577|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
125130482|NCT00939003|450104576|FG000|Open-label Treatment Period|Adverse Event|4|||
125130483|NCT00939003|450104577|FG001|Open-label Treatment Period|Adverse Event|8|||
125130484|NCT00939003|450104576|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
125130485|NCT00939003|450104577|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
125130486|NCT00939003|450104576|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
125377087|NCT00160251|451010277|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
125377088|NCT00160251|451010278|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
125377089|NCT00160251|451010279|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
125377090|NCT00160251|451010280|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
125377091|NCT00160251|451010281|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
125377092|NCT00160251|451010282|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
125634910|NCT02497287|451944960|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
125634911|NCT02497287|451944960|FG000|Follow-up Phase (4 Week)|Other|1|||
125634912|NCT03782376|451944961|FG000|Overall Study|Lost to Follow-up|2|||
125634913|NCT03782376|451944962|FG001|Overall Study|Lost to Follow-up|2|||
125634914|NCT03782376|451944961|FG000|Overall Study|Withdrawal by Subject|7|||
125634915|NCT03782376|451944962|FG001|Overall Study|Withdrawal by Subject|11|||
125634916|NCT03782376|451944961|FG000|Overall Study|Death|1|||
125634917|NCT03782376|451944962|FG001|Overall Study|Death|0|||
125634918|NCT03782376|451944961|FG000|Overall Study|Other|16|||
125634919|NCT03782376|451944962|FG001|Overall Study|Other|17|||
125634920|NCT03559192|451944963|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
125634921|NCT03559192|451944964|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
125634922|NCT03559192|451944965|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
125634923|NCT03559192|451944963|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
125634924|NCT03559192|451944964|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
125634925|NCT03559192|451944965|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
125634926|NCT03559192|451944963|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
125634927|NCT03559192|451944964|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
125634928|NCT03559192|451944965|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
125634929|NCT03559192|451944963|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
125634930|NCT03559192|451944964|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
125634931|NCT03559192|451944965|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
125130487|NCT00939003|450104577|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
125130488|NCT00939003|450104576|FG000|Open-label Treatment Period|Pregnancy|1|||
125130489|NCT00939003|450104577|FG001|Open-label Treatment Period|Pregnancy|1|||
125130490|NCT00939003|450104576|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
125130491|NCT00939003|450104577|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
125130492|NCT00939003|450104576|FG000|Open-label Treatment Period|Site Closure|3|||
125130493|NCT00939003|450104577|FG001|Open-label Treatment Period|Site Closure|4|||
125130494|NCT02131129|450104578|FG000|Overall Study|Withdrawal by Subject|1|||
125130495|NCT02131129|450104579|FG001|Overall Study|Withdrawal by Subject|0|||
125130496|NCT00727961|450104580|FG000|Overall Study|Lost to Follow-up|1|||
125130497|NCT00727961|450104580|FG000|Overall Study|Adverse Event|4|||
125130498|NCT00727961|450104580|FG000|Overall Study|Patient's refusal|2|||
125130499|NCT00727961|450104580|FG000|Overall Study|Progression|30|||
125130500|NCT02865122|450104581|FG000|Overall Study|Adverse Event|1|||
125130501|NCT02865122|450104582|FG001|Overall Study|Adverse Event|0|||
125130502|NCT02865122|450104583|FG002|Overall Study|Adverse Event|0|||
125130503|NCT01421277|450104585|FG000|Overall Study|Lack of qualifying event|0|||
125130504|NCT01421277|450104586|FG001|Overall Study|Lack of qualifying event|61|||
125130505|NCT01421277|450104585|FG000|Overall Study|Incomplete baseline data|0|||
125130506|NCT01421277|450104586|FG001|Overall Study|Incomplete baseline data|31|||
125377093|NCT00160251|451010283|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
125377094|NCT00160251|451010284|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
125377095|NCT00160251|451010277|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
125377096|NCT00160251|451010278|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
125377097|NCT00160251|451010279|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
125377098|NCT00160251|451010280|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
125377099|NCT00160251|451010281|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
125377100|NCT00160251|451010282|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
125377101|NCT00160251|451010283|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
125377102|NCT00160251|451010284|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
125377103|NCT00160251|451010277|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
125377104|NCT00160251|451010278|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
125377105|NCT00160251|451010279|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
125377106|NCT00160251|451010280|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
125377107|NCT00160251|451010281|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
125377108|NCT00160251|451010282|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
125377109|NCT00160251|451010283|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
125377110|NCT00160251|451010284|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
125377111|NCT00160251|451010277|FG000|Post-amendment 2|Adverse Event|0|||
125377112|NCT00160251|451010278|FG001|Post-amendment 2|Adverse Event|0|||
125377113|NCT00160251|451010279|FG002|Post-amendment 2|Adverse Event|0|||
125377114|NCT00160251|451010280|FG003|Post-amendment 2|Adverse Event|0|||
125377115|NCT00160251|451010281|FG004|Post-amendment 2|Adverse Event|0|||
125377116|NCT00160251|451010282|FG005|Post-amendment 2|Adverse Event|0|||
125377117|NCT00160251|451010283|FG006|Post-amendment 2|Adverse Event|0|||
125377118|NCT00160251|451010284|FG007|Post-amendment 2|Adverse Event|20|||
125377119|NCT00160251|451010277|FG000|Post-amendment 2|Lack of Efficacy|0|||
125377120|NCT00160251|451010278|FG001|Post-amendment 2|Lack of Efficacy|0|||
125377121|NCT00160251|451010279|FG002|Post-amendment 2|Lack of Efficacy|0|||
125377122|NCT00160251|451010280|FG003|Post-amendment 2|Lack of Efficacy|0|||
125377123|NCT00160251|451010281|FG004|Post-amendment 2|Lack of Efficacy|0|||
125377124|NCT00160251|451010282|FG005|Post-amendment 2|Lack of Efficacy|0|||
125377125|NCT00160251|451010283|FG006|Post-amendment 2|Lack of Efficacy|0|||
125377126|NCT00160251|451010284|FG007|Post-amendment 2|Lack of Efficacy|24|||
125377127|NCT00160251|451010277|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
125377128|NCT00160251|451010278|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
125377129|NCT00160251|451010279|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
125377130|NCT00160251|451010280|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
125377131|NCT00160251|451010281|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
125377132|NCT00160251|451010282|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
125377133|NCT00160251|451010283|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
125130507|NCT01015703|450106299|FG000|Overall Study|Withdrawal by Subject|0|||
125130508|NCT01015703|450106300|FG001|Overall Study|Withdrawal by Subject|1|||
125130509|NCT01015703|450106301|FG002|Overall Study|Withdrawal by Subject|0|||
125377134|NCT00160251|451010284|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
125377135|NCT00582166|451010287|FG000|Overall Study|Death|1|||
125377136|NCT00582166|451010287|FG000|Overall Study|Ineligible pathology|1|||
125377137|NCT00371137|451010288|FG000|Overall Study|Adverse Event|20|||
125377138|NCT00371137|451010289|FG001|Overall Study|Adverse Event|35|||
125130510|NCT01015703|450106302|FG003|Overall Study|Withdrawal by Subject|0|||
125377139|NCT00371137|451010290|FG002|Overall Study|Adverse Event|42|||
125377140|NCT00371137|451010288|FG000|Overall Study|Withdrawal by Subject|11|||
125377141|NCT00371137|451010289|FG001|Overall Study|Withdrawal by Subject|10|||
125377142|NCT00371137|451010290|FG002|Overall Study|Withdrawal by Subject|15|||
125377143|NCT00371137|451010288|FG000|Overall Study|Lost to Follow-up|6|||
125130511|NCT01015703|450106303|FG004|Overall Study|Withdrawal by Subject|0|||
125130512|NCT01015703|450106299|FG000|Overall Study|Adverse Event|1|||
125130513|NCT01015703|450106300|FG001|Overall Study|Adverse Event|0|||
125130514|NCT01015703|450106301|FG002|Overall Study|Adverse Event|0|||
125130515|NCT01015703|450106302|FG003|Overall Study|Adverse Event|0|||
125130516|NCT01015703|450106303|FG004|Overall Study|Adverse Event|0|||
125634932|NCT03559192|451944963|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
125634933|NCT03559192|451944964|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
125634934|NCT03559192|451944965|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
125634935|NCT03559192|451944963|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
125634936|NCT03559192|451944964|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
125634937|NCT03559192|451944965|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
125634938|NCT03559192|451944963|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
125634939|NCT03559192|451944964|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
125634940|NCT03559192|451944965|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
125634941|NCT03559192|451944963|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
125634942|NCT03559192|451944964|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
125634943|NCT03559192|451944965|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
125634944|NCT03559192|451944963|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
125634945|NCT03559192|451944964|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
125634946|NCT03559192|451944965|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
125634947|NCT03517722|451944966|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
125634948|NCT03517722|451944967|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
125130517|NCT01015703|450106299|FG000|Overall Study|Protocol Violation|1|||
125130518|NCT01015703|450106300|FG001|Overall Study|Protocol Violation|0|||
125130519|NCT01015703|450106301|FG002|Overall Study|Protocol Violation|0|||
125130520|NCT01015703|450106302|FG003|Overall Study|Protocol Violation|0|||
125130521|NCT01015703|450106303|FG004|Overall Study|Protocol Violation|0|||
125130522|NCT00834418|450106304|FG000|Overall Study|Adverse Event|0|||
125130523|NCT00834418|450106305|FG001|Overall Study|Adverse Event|2|||
125130524|NCT01705574|450106306|FG000|Double-Blind Phase|Lost to Follow-up|12|||
125130525|NCT01705574|450106307|FG001|Double-Blind Phase|Lost to Follow-up|16|||
125130526|NCT01705574|450106308|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125130527|NCT01705574|450106309|FG003|Double-Blind Phase|Lost to Follow-up|0|||
125130528|NCT01705574|450106306|FG000|Double-Blind Phase|Adverse Event|3|||
125130529|NCT01705574|450106307|FG001|Double-Blind Phase|Adverse Event|10|||
125130530|NCT01705574|450106308|FG002|Double-Blind Phase|Adverse Event|0|||
125130531|NCT01705574|450106309|FG003|Double-Blind Phase|Adverse Event|0|||
125130532|NCT01705574|450106306|FG000|Double-Blind Phase|Withdrew Consent|8|||
125130533|NCT01705574|450106307|FG001|Double-Blind Phase|Withdrew Consent|5|||
125130534|NCT01705574|450106308|FG002|Double-Blind Phase|Withdrew Consent|0|||
125130535|NCT01705574|450106309|FG003|Double-Blind Phase|Withdrew Consent|0|||
125130536|NCT01705574|450106306|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
125130537|NCT01705574|450106307|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
125130538|NCT01705574|450106308|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
125130539|NCT01705574|450106309|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
125130540|NCT01705574|450106306|FG000|Double-Blind Phase|Pregnancy|1|||
125130541|NCT01705574|450106307|FG001|Double-Blind Phase|Pregnancy|1|||
125130542|NCT01705574|450106308|FG002|Double-Blind Phase|Pregnancy|0|||
125130543|NCT01705574|450106309|FG003|Double-Blind Phase|Pregnancy|0|||
125130544|NCT01705574|450106306|FG000|Double-Blind Phase|Protocol Violation|1|||
125130545|NCT01705574|450106307|FG001|Double-Blind Phase|Protocol Violation|0|||
125130546|NCT01705574|450106308|FG002|Double-Blind Phase|Protocol Violation|0|||
125130547|NCT01705574|450106309|FG003|Double-Blind Phase|Protocol Violation|0|||
125130548|NCT01705574|450106306|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
125130549|NCT01705574|450106307|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
125216490|NCT01616758|450419454|FG000|Overall Study|Study termination by Sponsor|1|||
125216491|NCT03252145|450419455|FG000|Overall Study|Withdrawal by Subject|1|||
125216492|NCT03252145|450419456|FG001|Overall Study|Withdrawal by Subject|0|||
125216493|NCT03252145|450419455|FG000|Overall Study|Complicating Disease|1|||
125216494|NCT03252145|450419456|FG001|Overall Study|Complicating Disease|2|||
125216495|NCT03091738|450419457|FG000|Overall Study|Adverse Event|1|||
125634949|NCT03517722|451944966|FG000|Double Blind Period: Week 0-52|Death|0|||
125130550|NCT01705574|450106308|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
125130551|NCT01705574|450106309|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
125634950|NCT03517722|451944967|FG001|Double Blind Period: Week 0-52|Death|4|||
125634951|NCT03517722|451944966|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
125634952|NCT03517722|451944967|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
125634953|NCT03517722|451944966|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
125130552|NCT01705574|450106306|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
125130553|NCT01705574|450106307|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
125216496|NCT03091738|450419457|FG000|Overall Study|Lost to Follow-up|1|||
125216497|NCT00199849|450419466|FG000|Overall Study|Unrelated illness or complication|0|||
125130554|NCT01705574|450106308|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
125130555|NCT01705574|450106309|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
125634954|NCT03517722|451944967|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
125634955|NCT03517722|451944966|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
125634956|NCT03517722|451944967|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
125634957|NCT03517722|451944966|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
125130556|NCT01705574|450106306|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
125130557|NCT01705574|450106307|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
125130558|NCT01705574|450106308|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
125130559|NCT01705574|450106309|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
125130560|NCT01705574|450106306|FG000|Open-Label Extension Phase|Adverse Event|3|||
125130561|NCT01705574|450106307|FG001|Open-Label Extension Phase|Adverse Event|0|||
125130562|NCT01705574|450106308|FG002|Open-Label Extension Phase|Adverse Event|0|||
125130563|NCT01705574|450106309|FG003|Open-Label Extension Phase|Adverse Event|1|||
125130564|NCT01705574|450106306|FG000|Open-Label Extension Phase|Death|2|||
125130565|NCT01705574|450106307|FG001|Open-Label Extension Phase|Death|0|||
125130566|NCT01705574|450106308|FG002|Open-Label Extension Phase|Death|1|||
125130567|NCT01705574|450106309|FG003|Open-Label Extension Phase|Death|0|||
125130568|NCT01705574|450106306|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
125130569|NCT01705574|450106307|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
125130570|NCT01705574|450106308|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
125130571|NCT01705574|450106309|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
125130572|NCT01705574|450106306|FG000|Open-Label Extension Phase|Physician Decision|0|||
125130573|NCT01705574|450106307|FG001|Open-Label Extension Phase|Physician Decision|0|||
125130574|NCT01705574|450106308|FG002|Open-Label Extension Phase|Physician Decision|2|||
125130575|NCT01705574|450106309|FG003|Open-Label Extension Phase|Physician Decision|0|||
125130576|NCT01705574|450106306|FG000|Open-Label Extension Phase|Pregnancy|0|||
125130577|NCT01705574|450106307|FG001|Open-Label Extension Phase|Pregnancy|0|||
125130578|NCT01705574|450106308|FG002|Open-Label Extension Phase|Pregnancy|1|||
125634958|NCT03517722|451944967|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
125634959|NCT03517722|451944966|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
125634960|NCT03517722|451944967|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
125634961|NCT03517722|451944966|FG000|Double Blind Period: Week 0-52|Other|4|||
125634962|NCT03517722|451944967|FG001|Double Blind Period: Week 0-52|Other|3|||
125634963|NCT03517722|451944966|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
125634964|NCT03517722|451944967|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
125634965|NCT03517722|451944966|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
125634966|NCT03517722|451944967|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
125634967|NCT03517722|451944966|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
125634968|NCT03517722|451944967|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
125634969|NCT03517722|451944966|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
125634970|NCT03517722|451944967|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
125634971|NCT03517722|451944966|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
125634972|NCT03517722|451944967|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
125634973|NCT03277794|451944972|FG000|Overall Study|Lost to Follow-up|2|||
125634974|NCT03277794|451944973|FG001|Overall Study|Lost to Follow-up|4|||
125634975|NCT03277794|451944972|FG000|Overall Study|Withdrew due to high acuity|1|||
125634976|NCT03277794|451944973|FG001|Overall Study|Withdrew due to high acuity|0|||
125634977|NCT01226472|451944977|FG000|Overall Study|Progressive Disease|1|||
125634978|NCT00952419|451944978|FG000|Overall Study|Adverse Event|2|||
125634979|NCT00952419|451944979|FG001|Overall Study|Adverse Event|0|||
125634980|NCT00952419|451944980|FG002|Overall Study|Adverse Event|0|||
125634981|NCT00952419|451944978|FG000|Overall Study|Protocol Violation|3|||
125634982|NCT00952419|451944979|FG001|Overall Study|Protocol Violation|7|||
125634983|NCT00952419|451944980|FG002|Overall Study|Protocol Violation|0|||
125130579|NCT01705574|450106309|FG003|Open-Label Extension Phase|Pregnancy|1|||
125130580|NCT00089661|450106314|FG000|Overall Study|Adverse Event|0|||
125130581|NCT00089661|450106315|FG001|Overall Study|Adverse Event|2|||
125130582|NCT00089661|450106314|FG000|Overall Study|Death|1|||
125130583|NCT00089661|450106315|FG001|Overall Study|Death|0|||
125130584|NCT00089661|450106314|FG000|Overall Study|Lost to Follow-up|0|||
125130585|NCT00089661|450106315|FG001|Overall Study|Lost to Follow-up|3|||
125130586|NCT00089661|450106314|FG000|Overall Study|Withdrawal by Subject|11|||
125130587|NCT00089661|450106315|FG001|Overall Study|Withdrawal by Subject|9|||
125130588|NCT00089661|450106314|FG000|Overall Study|Disease progression|1|||
125130589|NCT00089661|450106315|FG001|Overall Study|Disease progression|3|||
125634984|NCT00952419|451944978|FG000|Overall Study|Withdrawal by Subject|1|||
125634985|NCT00952419|451944979|FG001|Overall Study|Withdrawal by Subject|3|||
125634986|NCT00952419|451944980|FG002|Overall Study|Withdrawal by Subject|0|||
125634987|NCT03399786|451944981|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
125634988|NCT03399786|451944982|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125634989|NCT03399786|451944983|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125634990|NCT03399786|451944984|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125634991|NCT03399786|451944981|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
125634992|NCT03399786|451944982|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
125634993|NCT03399786|451944983|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
125634994|NCT03399786|451944984|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
125634995|NCT03399786|451944981|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
125634996|NCT03399786|451944982|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
125634997|NCT03399786|451944983|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
125634998|NCT03399786|451944984|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
125634999|NCT04507360|451946635|FG000|Week 1|Lost to Follow-up|0|||
125635000|NCT04507360|451946636|FG001|Week 1|Lost to Follow-up|0|||
125635001|NCT04507360|451946637|FG002|Week 1|Lost to Follow-up|0|||
125635002|NCT04507360|451946638|FG003|Week 1|Lost to Follow-up|0|||
125635003|NCT04507360|451946639|FG004|Week 1|Lost to Follow-up|0|||
125635004|NCT04507360|451946640|FG005|Week 1|Lost to Follow-up|0|||
125635005|NCT04507360|451946641|FG006|Week 1|Lost to Follow-up|0|||
125635006|NCT04507360|451946642|FG007|Week 1|Lost to Follow-up|0|||
125635007|NCT04507360|451946643|FG008|Week 1|Lost to Follow-up|72|||
125635008|NCT04507360|451946644|FG009|Week 1|Lost to Follow-up|22|||
125635009|NCT04507360|451946645|FG010|Week 1|Lost to Follow-up|10|||
125635010|NCT04507360|451946635|FG000|Week 2|Lost to Follow-up|0|||
125635011|NCT04507360|451946636|FG001|Week 2|Lost to Follow-up|0|||
125635012|NCT04507360|451946637|FG002|Week 2|Lost to Follow-up|0|||
125635013|NCT04507360|451946638|FG003|Week 2|Lost to Follow-up|0|||
125635014|NCT04507360|451946639|FG004|Week 2|Lost to Follow-up|0|||
125635015|NCT04507360|451946640|FG005|Week 2|Lost to Follow-up|0|||
125635016|NCT04507360|451946641|FG006|Week 2|Lost to Follow-up|0|||
125635017|NCT04507360|451946642|FG007|Week 2|Lost to Follow-up|0|||
125635018|NCT04507360|451946643|FG008|Week 2|Lost to Follow-up|121|||
125635019|NCT04507360|451946644|FG009|Week 2|Lost to Follow-up|85|||
125635020|NCT04507360|451946645|FG010|Week 2|Lost to Follow-up|82|||
125635021|NCT04507360|451946635|FG000|Week 3|Lost to Follow-up|0|||
125635022|NCT04507360|451946636|FG001|Week 3|Lost to Follow-up|0|||
125635023|NCT04507360|451946637|FG002|Week 3|Lost to Follow-up|0|||
125635024|NCT04507360|451946638|FG003|Week 3|Lost to Follow-up|0|||
125635025|NCT04507360|451946639|FG004|Week 3|Lost to Follow-up|0|||
125635026|NCT04507360|451946640|FG005|Week 3|Lost to Follow-up|0|||
125635027|NCT04507360|451946641|FG006|Week 3|Lost to Follow-up|0|||
125635028|NCT04507360|451946642|FG007|Week 3|Lost to Follow-up|0|||
125635029|NCT04507360|451946643|FG008|Week 3|Lost to Follow-up|123|||
125635030|NCT04507360|451946644|FG009|Week 3|Lost to Follow-up|92|||
125635031|NCT04507360|451946645|FG010|Week 3|Lost to Follow-up|84|||
125635032|NCT04507360|451946635|FG000|Week 4|Lost to Follow-up|0|||
125635033|NCT04507360|451946636|FG001|Week 4|Lost to Follow-up|0|||
125635034|NCT04507360|451946637|FG002|Week 4|Lost to Follow-up|0|||
125635035|NCT04507360|451946638|FG003|Week 4|Lost to Follow-up|0|||
125635036|NCT04507360|451946639|FG004|Week 4|Lost to Follow-up|0|||
125635037|NCT04507360|451946640|FG005|Week 4|Lost to Follow-up|0|||
125635038|NCT04507360|451946641|FG006|Week 4|Lost to Follow-up|0|||
125635039|NCT04507360|451946642|FG007|Week 4|Lost to Follow-up|0|||
125635040|NCT04507360|451946643|FG008|Week 4|Lost to Follow-up|131|||
125635041|NCT04507360|451946644|FG009|Week 4|Lost to Follow-up|115|||
125635042|NCT04507360|451946645|FG010|Week 4|Lost to Follow-up|102|||
125635043|NCT04507360|451946635|FG000|Week 5|Lost to Follow-up|0|||
125635044|NCT04507360|451946636|FG001|Week 5|Lost to Follow-up|0|||
125635045|NCT04507360|451946637|FG002|Week 5|Lost to Follow-up|0|||
125635046|NCT04507360|451946638|FG003|Week 5|Lost to Follow-up|0|||
125635047|NCT04507360|451946639|FG004|Week 5|Lost to Follow-up|0|||
125635048|NCT04507360|451946640|FG005|Week 5|Lost to Follow-up|0|||
125635049|NCT04507360|451946641|FG006|Week 5|Lost to Follow-up|0|||
125635050|NCT04507360|451946642|FG007|Week 5|Lost to Follow-up|0|||
125635051|NCT04507360|451946643|FG008|Week 5|Lost to Follow-up|103|||
125635052|NCT04507360|451946644|FG009|Week 5|Lost to Follow-up|135|||
125635053|NCT04507360|451946645|FG010|Week 5|Lost to Follow-up|143|||
125635054|NCT04507360|451946635|FG000|Week 8|Lost to Follow-up|0|||
125635055|NCT04507360|451946636|FG001|Week 8|Lost to Follow-up|0|||
125635056|NCT04507360|451946637|FG002|Week 8|Lost to Follow-up|0|||
125635057|NCT04507360|451946638|FG003|Week 8|Lost to Follow-up|0|||
125635058|NCT04507360|451946639|FG004|Week 8|Lost to Follow-up|0|||
125635059|NCT04507360|451946640|FG005|Week 8|Lost to Follow-up|0|||
125635060|NCT04507360|451946641|FG006|Week 8|Lost to Follow-up|0|||
125635061|NCT04507360|451946642|FG007|Week 8|Lost to Follow-up|0|||
125635062|NCT04507360|451946643|FG008|Week 8|Lost to Follow-up|139|||
125635063|NCT04507360|451946644|FG009|Week 8|Lost to Follow-up|145|||
125635064|NCT04507360|451946645|FG010|Week 8|Lost to Follow-up|152|||
125635065|NCT00636155|451946646|FG000|Overall Study|Adverse Event|8|||
125635066|NCT00636155|451946646|FG000|Overall Study|Lack of Efficacy|1|||
125635067|NCT00636155|451946646|FG000|Overall Study|Withdrawal by Subject|3|||
125635068|NCT00636155|451946646|FG000|Overall Study|Stem cell transplant|1|||
125635069|NCT00636155|451946646|FG000|Overall Study|Physician Decision|5|||
125635070|NCT01432756|451946647|FG000|Overall Study|Lost to Follow-up|1|||
125635071|NCT01432756|451946648|FG001|Overall Study|Lost to Follow-up|0|||
125635072|NCT01432756|451946649|FG002|Overall Study|Lost to Follow-up|2|||
125635073|NCT01432756|451946650|FG003|Overall Study|Lost to Follow-up|1|||
125635074|NCT01004159|451946658|FG000|Overall Study|Adverse Event|2|||
125635075|NCT01004159|451946658|FG000|Overall Study|Disease Progression|18|||
125635076|NCT02973997|451946659|FG000|Overall Study|Withdrawal by Subject|4|||
125635077|NCT02973997|451946660|FG001|Overall Study|Withdrawal by Subject|0|||
125635078|NCT02973997|451946659|FG000|Overall Study|Adverse Event|4|||
125635079|NCT02973997|451946660|FG001|Overall Study|Adverse Event|1|||
125635080|NCT02973997|451946659|FG000|Overall Study|Disease Progression|11|||
125635081|NCT02973997|451946660|FG001|Overall Study|Disease Progression|20|||
125635082|NCT02973997|451946659|FG000|Overall Study|Alternative Therapy|3|||
125635083|NCT02973997|451946660|FG001|Overall Study|Alternative Therapy|0|||
125635084|NCT02973997|451946659|FG000|Overall Study|Other complicating disease|0|||
125635085|NCT02973997|451946660|FG001|Overall Study|Other complicating disease|1|||
125635086|NCT02973997|451946659|FG000|Overall Study|Death|0|||
125635087|NCT02973997|451946660|FG001|Overall Study|Death|1|||
125635088|NCT00444951|451946661|FG000|Overall Study|Lost to Follow-up|1|||
125635089|NCT00444951|451946662|FG001|Overall Study|Lost to Follow-up|1|||
125635090|NCT00444951|451946663|FG002|Overall Study|Lost to Follow-up|0|||
125635091|NCT00444951|451946661|FG000|Overall Study|Withdrawal by Subject|4|||
125635092|NCT00444951|451946662|FG001|Overall Study|Withdrawal by Subject|5|||
125635093|NCT00444951|451946663|FG002|Overall Study|Withdrawal by Subject|3|||
125635094|NCT00366444|451946665|FG000|Overall Study|Withdrawal by Subject|1|||
125635095|NCT00366444|451946666|FG001|Overall Study|Withdrawal by Subject|1|||
125635096|NCT00366444|451946665|FG000|Overall Study|Lack of Efficacy|0|||
125635097|NCT00366444|451946666|FG001|Overall Study|Lack of Efficacy|1|||
125635098|NCT01320033|451946675|FG000|Overall Study|Lack of Efficacy|0|||
125635099|NCT01320033|451946676|FG001|Overall Study|Lack of Efficacy|0|||
125635100|NCT01320033|451946677|FG002|Overall Study|Lack of Efficacy|1|||
125635101|NCT01320033|451946675|FG000|Overall Study|Adverse Event|9|||
125635102|NCT01320033|451946676|FG001|Overall Study|Adverse Event|7|||
125635103|NCT01320033|451946677|FG002|Overall Study|Adverse Event|8|||
125635104|NCT01320033|451946675|FG000|Overall Study|Withdrawal by Subject|22|||
125635105|NCT01320033|451946676|FG001|Overall Study|Withdrawal by Subject|23|||
125635106|NCT01320033|451946677|FG002|Overall Study|Withdrawal by Subject|23|||
125635107|NCT01320033|451946675|FG000|Overall Study|Protocol Violation|3|||
125635108|NCT01320033|451946676|FG001|Overall Study|Protocol Violation|5|||
125635109|NCT01320033|451946677|FG002|Overall Study|Protocol Violation|3|||
125635110|NCT01320033|451946675|FG000|Overall Study|Lost to Follow-up|22|||
125635111|NCT01320033|451946676|FG001|Overall Study|Lost to Follow-up|26|||
125635112|NCT01320033|451946677|FG002|Overall Study|Lost to Follow-up|17|||
125635113|NCT01320033|451946675|FG000|Overall Study|Other|2|||
125130590|NCT00089661|450106314|FG000|Overall Study|Ineligibility determined|4|||
125635114|NCT01320033|451946676|FG001|Overall Study|Other|3|||
125635115|NCT01320033|451946677|FG002|Overall Study|Other|1|||
125635116|NCT00963469|451946678|FG000|Overall Study|Adverse Event|15|||
125635117|NCT00963469|451946679|FG001|Overall Study|Adverse Event|11|||
125635118|NCT00963469|451946680|FG002|Overall Study|Adverse Event|1|||
125635119|NCT00963469|451946678|FG000|Overall Study|Lack of Efficacy|10|||
125635120|NCT00963469|451946679|FG001|Overall Study|Lack of Efficacy|7|||
125635121|NCT00963469|451946680|FG002|Overall Study|Lack of Efficacy|2|||
125635122|NCT00963469|451946678|FG000|Overall Study|Lost to Follow-up|1|||
125635123|NCT00963469|451946679|FG001|Overall Study|Lost to Follow-up|1|||
125635124|NCT00963469|451946680|FG002|Overall Study|Lost to Follow-up|0|||
125635125|NCT00963469|451946678|FG000|Overall Study|Protocol Violation|5|||
125635126|NCT00963469|451946679|FG001|Overall Study|Protocol Violation|5|||
125635127|NCT00963469|451946680|FG002|Overall Study|Protocol Violation|3|||
125635128|NCT00963469|451946678|FG000|Overall Study|Withdrawal by Subject|4|||
125130591|NCT00089661|450106315|FG001|Overall Study|Ineligibility determined|4|||
125130592|NCT00089661|450106314|FG000|Overall Study|Noncompliance|2|||
125130593|NCT00089661|450106315|FG001|Overall Study|Noncompliance|4|||
125130594|NCT00089661|450106314|FG000|Overall Study|Other|2|||
125130595|NCT00089661|450106315|FG001|Overall Study|Other|1|||
125130596|NCT01273805|450106316|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
125130597|NCT01273805|450106317|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
125130598|NCT02647944|450106318|FG000|Overall Study|Withdrawal by Subject|0|||
125130599|NCT02647944|450106319|FG001|Overall Study|Withdrawal by Subject|3|||
125130600|NCT02647944|450106318|FG000|Overall Study|Adverse Event|2|||
125130601|NCT02647944|450106319|FG001|Overall Study|Adverse Event|0|||
125130602|NCT02760368|450106321|FG000|Overall Study|Withdrawal by Subject|8|||
125130603|NCT02760368|450106322|FG001|Overall Study|Withdrawal by Subject|12|||
125130604|NCT02760368|450106323|FG002|Overall Study|Withdrawal by Subject|9|||
125130605|NCT02760368|450106321|FG000|Overall Study|Screen Failure|0|||
125635129|NCT00963469|451946679|FG001|Overall Study|Withdrawal by Subject|1|||
125635130|NCT00963469|451946680|FG002|Overall Study|Withdrawal by Subject|1|||
125635131|NCT00963469|451946678|FG000|Overall Study|Pre-randomization Adverse Event|1|||
125635132|NCT00963469|451946679|FG001|Overall Study|Pre-randomization Adverse Event|2|||
125635133|NCT00963469|451946680|FG002|Overall Study|Pre-randomization Adverse Event|0|||
125635134|NCT00963469|451946678|FG000|Overall Study|Moved|1|||
125635135|NCT00963469|451946679|FG001|Overall Study|Moved|0|||
125635136|NCT00963469|451946680|FG002|Overall Study|Moved|0|||
125635137|NCT00963469|451946678|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
125635138|NCT00963469|451946679|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
125635139|NCT00963469|451946680|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
125635140|NCT01938391|451946688|FG000|6 Month Follow up|Withdrawal by Subject|1|||
125635141|NCT01938391|451946688|FG000|12 Month Follow up|Physician Decision|1|||
125635142|NCT01938391|451946688|FG000|12 Month Follow up|Withdrawal by Subject|1|||
125635143|NCT00673816|451946701|FG000|Overall Study|Adverse Event|1|||
125635144|NCT00673816|451946701|FG000|Overall Study|Withdrawal by Subject|1|||
125635145|NCT01536418|451946703|FG000|Overall Study|Protocol Violation|2|||
125635146|NCT01536418|451946704|FG001|Overall Study|Protocol Violation|3|||
125635147|NCT01536418|451946703|FG000|Overall Study|Physician Decision|1|||
125635148|NCT01536418|451946704|FG001|Overall Study|Physician Decision|3|||
125635149|NCT01536418|451946703|FG000|Overall Study|Study closed/terminated|41|||
125635150|NCT01536418|451946704|FG001|Overall Study|Study closed/terminated|37|||
125635151|NCT01536418|451946703|FG000|Overall Study|Lack of Efficacy|10|||
125635152|NCT01536418|451946704|FG001|Overall Study|Lack of Efficacy|16|||
125635153|NCT01536418|451946703|FG000|Overall Study|Adverse Event|9|||
125216498|NCT00199849|450419467|FG001|Overall Study|Unrelated illness or complication|1|||
125216499|NCT00199849|450419468|FG002|Overall Study|Unrelated illness or complication|0|||
125216500|NCT00199849|450419466|FG000|Overall Study|Progressive disease requiring intervention|0|||
125216501|NCT00199849|450419467|FG001|Overall Study|Progressive disease requiring intervention|0|||
125216502|NCT00199849|450419468|FG002|Overall Study|Progressive disease requiring intervention|1|||
125216503|NCT00199849|450419466|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
125216504|NCT00199849|450419467|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
125216505|NCT00199849|450419468|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
125216506|NCT03746405|450419476|FG000|Overall Study|Withdrawal by Subject|3|||
125216507|NCT03746405|450419477|FG001|Overall Study|Withdrawal by Subject|0|||
125216508|NCT03746405|450419476|FG000|Overall Study|technical difficulties|0|||
125216509|NCT03746405|450419477|FG001|Overall Study|technical difficulties|2|||
125216510|NCT01465230|450419479|FG000|Overall Study|Withdrawal by Subject|2|||
125635154|NCT01536418|451946704|FG001|Overall Study|Adverse Event|4|||
125635155|NCT01536418|451946703|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
125130606|NCT02760368|450106322|FG001|Overall Study|Screen Failure|0|||
125130607|NCT02760368|450106323|FG002|Overall Study|Screen Failure|1|||
125130608|NCT02760368|450106321|FG000|Overall Study|Death|0|||
125130609|NCT02760368|450106322|FG001|Overall Study|Death|1|||
125635156|NCT01536418|451946704|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
125635157|NCT01536418|451946703|FG000|Overall Study|Withdrawal by Subject|5|||
125635158|NCT01536418|451946704|FG001|Overall Study|Withdrawal by Subject|3|||
125635159|NCT02234050|451946705|FG000|Overall Study|Lack of Efficacy|38|||
125635160|NCT02234050|451946706|FG001|Overall Study|Lack of Efficacy|22|||
125635161|NCT02234050|451946705|FG000|Overall Study|Adverse Event|13|||
125635162|NCT02234050|451946706|FG001|Overall Study|Adverse Event|1|||
125635163|NCT02234050|451946705|FG000|Overall Study|Withdrawal by Subject|4|||
125130610|NCT02760368|450106323|FG002|Overall Study|Death|0|||
125635164|NCT02234050|451946706|FG001|Overall Study|Withdrawal by Subject|2|||
125635165|NCT02234050|451946705|FG000|Overall Study|Sponsor's decision|6|||
125635166|NCT02234050|451946706|FG001|Overall Study|Sponsor's decision|0|||
125635167|NCT02365506|451946708|FG000|Overall Study|Investigator's Discretion|0|||
125635168|NCT02365506|451946709|FG001|Overall Study|Investigator's Discretion|0|||
125635169|NCT02365506|451946710|FG002|Overall Study|Investigator's Discretion|1|||
125635170|NCT01680991|451946711|FG000|Overall Study|Adverse Event|1|||
125635171|NCT01680991|451946712|FG001|Overall Study|Adverse Event|0|||
125635172|NCT01680991|451946713|FG002|Overall Study|Adverse Event|0|||
125635173|NCT01680991|451946711|FG000|Overall Study|Death|1|||
125635174|NCT01680991|451946712|FG001|Overall Study|Death|0|||
125635175|NCT01680991|451946713|FG002|Overall Study|Death|1|||
125635176|NCT01680991|451946711|FG000|Overall Study|Protocol Violation|0|||
125216511|NCT02372383|450419484|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
125216512|NCT02372383|450419485|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
125216513|NCT02372383|450419486|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
125216514|NCT01704755|450419490|FG000|Overall Study|Adverse Event|4|||
125216515|NCT01704755|450419491|FG001|Overall Study|Adverse Event|1|||
125216516|NCT01704755|450419490|FG000|Overall Study|Lost to Follow-up|3|||
125216517|NCT01704755|450419491|FG001|Overall Study|Lost to Follow-up|4|||
125216518|NCT01704755|450419490|FG000|Overall Study|Withdrew consent|1|||
125216519|NCT01704755|450419491|FG001|Overall Study|Withdrew consent|1|||
125216520|NCT01704755|450419490|FG000|Overall Study|Other (not specified)|3|||
125635177|NCT01680991|451946712|FG001|Overall Study|Protocol Violation|1|||
125635178|NCT01680991|451946713|FG002|Overall Study|Protocol Violation|0|||
125635179|NCT01680991|451946711|FG000|Overall Study|Withdrawal by Subject|5|||
125635180|NCT01680991|451946712|FG001|Overall Study|Withdrawal by Subject|1|||
125635181|NCT01680991|451946713|FG002|Overall Study|Withdrawal by Subject|0|||
125635182|NCT01680991|451946711|FG000|Overall Study|Progressive disease (PD)|0|||
125635183|NCT01680991|451946712|FG001|Overall Study|Progressive disease (PD)|10|||
125635184|NCT01680991|451946713|FG002|Overall Study|Progressive disease (PD)|0|||
125635185|NCT01680991|451946711|FG000|Overall Study|Physician Decision|0|||
125635186|NCT01680991|451946712|FG001|Overall Study|Physician Decision|7|||
125635187|NCT01680991|451946713|FG002|Overall Study|Physician Decision|2|||
125635188|NCT01680991|451946711|FG000|Overall Study|Bad physical condition|0|||
125635189|NCT01680991|451946712|FG001|Overall Study|Bad physical condition|0|||
125635190|NCT01680991|451946713|FG002|Overall Study|Bad physical condition|1|||
125635191|NCT01680991|451946711|FG000|Overall Study|PD confirmed in other hospital|1|||
125635192|NCT01680991|451946712|FG001|Overall Study|PD confirmed in other hospital|0|||
125635193|NCT01680991|451946713|FG002|Overall Study|PD confirmed in other hospital|0|||
125635194|NCT01852591|451946714|FG000|Overall Study|Withdrawal by Subject|2|||
125635195|NCT01852591|451946714|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
125635196|NCT06073054|451946715|FG000|Overall Study|Withdrawal by Subject|2|||
125635197|NCT05505734|451946720|FG000|Overall Study|Withdrawal by Subject|51|||
125635198|NCT05505734|451946721|FG001|Overall Study|Withdrawal by Subject|64|||
125216521|NCT01704755|450419491|FG001|Overall Study|Other (not specified)|1|||
125216522|NCT01704755|450419490|FG000|Overall Study|Withdrew consent and personal issues|1|||
125216523|NCT01704755|450419491|FG001|Overall Study|Withdrew consent and personal issues|0|||
125216524|NCT04105842|450419492|FG000|Overall Study|Withdrawal by Subject|2|||
125377144|NCT00371137|451010289|FG001|Overall Study|Lost to Follow-up|3|||
125635199|NCT05505734|451946720|FG000|Overall Study|Adverse Event|6|||
125635200|NCT05505734|451946721|FG001|Overall Study|Adverse Event|20|||
125635201|NCT05505734|451946720|FG000|Overall Study|Protocol Violation|8|||
125635202|NCT05505734|451946721|FG001|Overall Study|Protocol Violation|15|||
125216525|NCT02087670|450419493|FG000|Overall Study|Withdrawal by Subject|3|||
125635203|NCT05505734|451946720|FG000|Overall Study|Lack of therapeutic response|0|||
125635204|NCT05505734|451946721|FG001|Overall Study|Lack of therapeutic response|1|||
125635205|NCT05505734|451946720|FG000|Overall Study|Lost to Follow-up|247|||
125635206|NCT05505734|451946721|FG001|Overall Study|Lost to Follow-up|237|||
125635207|NCT05505734|451946720|FG000|Overall Study|Physician Decision|22|||
125635208|NCT05505734|451946721|FG001|Overall Study|Physician Decision|13|||
125635209|NCT05505734|451946720|FG000|Overall Study|Death|2|||
125635210|NCT05505734|451946721|FG001|Overall Study|Death|1|||
125635211|NCT05505734|451946720|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125635212|NCT05505734|451946721|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125635213|NCT05505734|451946720|FG000|Overall Study|Pregnancy|1|||
125635214|NCT05505734|451946721|FG001|Overall Study|Pregnancy|0|||
125635215|NCT05505734|451946720|FG000|Overall Study|Other|17|||
125635216|NCT05505734|451946721|FG001|Overall Study|Other|13|||
125635217|NCT00764322|451946722|FG000|Overall Study|Withdrawal by Subject|11|||
125635218|NCT00764322|451946722|FG000|Overall Study|No CYP2D6 genotyping|9|||
125635219|NCT00976963|451946728|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
125635220|NCT00976963|451946729|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
125635221|NCT00976963|451946728|FG000|Overall Study|administrative error|1|||
125635222|NCT00976963|451946729|FG001|Overall Study|administrative error|0|||
125635223|NCT00976963|451946728|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
125635224|NCT00976963|451946729|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
125635225|NCT02768103|451946734|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
125635226|NCT03369704|451946735|FG000|Treatment Epoch|technical problems|1|||
125635227|NCT03369704|451946736|FG001|Treatment Epoch|technical problems|0|||
125635228|NCT03369704|451946735|FG000|Treatment Epoch|Protocol Violation|1|||
125635229|NCT03369704|451946736|FG001|Treatment Epoch|Protocol Violation|0|||
125635230|NCT03369704|451946735|FG000|Treatment Epoch|Lost to Follow-up|0|||
125635231|NCT03369704|451946736|FG001|Treatment Epoch|Lost to Follow-up|1|||
125635232|NCT03369704|451946735|FG000|Treatment Epoch|Lack of Efficacy|0|||
125635233|NCT03369704|451946736|FG001|Treatment Epoch|Lack of Efficacy|2|||
125635234|NCT03369704|451946735|FG000|Treatment Epoch|Adverse Event|2|||
125635235|NCT03369704|451946736|FG001|Treatment Epoch|Adverse Event|0|||
125635236|NCT03369704|451946735|FG000|Follow-up Epoch|Lost to Follow-up|1|||
125635237|NCT03369704|451946736|FG001|Follow-up Epoch|Lost to Follow-up|0|||
125635238|NCT02348840|451946740|FG000|Overall Study|Withdrawal by Subject|2|||
125635239|NCT02348840|451946741|FG001|Overall Study|Withdrawal by Subject|1|||
125635240|NCT02348840|451946742|FG002|Overall Study|Withdrawal by Subject|0|||
125635241|NCT02348840|451946743|FG003|Overall Study|Withdrawal by Subject|0|||
125635242|NCT01263444|451946744|FG000|Overall Study|Adverse Event|8|||
125635243|NCT01263444|451946744|FG000|Overall Study|Withdrawal by Subject|1|||
125635244|NCT01263444|451946744|FG000|Overall Study|Protocol Violation|1|||
125635245|NCT02203916|451946746|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
125635246|NCT02203916|451946747|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
125635247|NCT02203916|451946748|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
125635248|NCT02203916|451946746|FG000|Overall Study|Major Protocol Deviation|1|||
125635249|NCT02203916|451946747|FG001|Overall Study|Major Protocol Deviation|1|||
125635250|NCT02203916|451946748|FG002|Overall Study|Major Protocol Deviation|0|||
125635251|NCT02203916|451946746|FG000|Overall Study|Lost to Follow-up|0|||
125635252|NCT02203916|451946747|FG001|Overall Study|Lost to Follow-up|1|||
125635253|NCT02203916|451946748|FG002|Overall Study|Lost to Follow-up|0|||
125635254|NCT02203916|451946746|FG000|Overall Study|Voluntary Withdrawal|3|||
125635255|NCT02203916|451946747|FG001|Overall Study|Voluntary Withdrawal|3|||
125635256|NCT02203916|451946748|FG002|Overall Study|Voluntary Withdrawal|8|||
125635257|NCT02203916|451946746|FG000|Overall Study|Lack of Efficacy|3|||
125635258|NCT02203916|451946747|FG001|Overall Study|Lack of Efficacy|0|||
125635259|NCT02203916|451946748|FG002|Overall Study|Lack of Efficacy|0|||
125635260|NCT02203916|451946746|FG000|Overall Study|Reason Not Specified|0|||
125130611|NCT02760368|450106321|FG000|Overall Study|Withdrawal by Sponsor|0|||
125130612|NCT02760368|450106322|FG001|Overall Study|Withdrawal by Sponsor|0|||
125635261|NCT02203916|451946747|FG001|Overall Study|Reason Not Specified|2|||
125635262|NCT02203916|451946748|FG002|Overall Study|Reason Not Specified|1|||
125635263|NCT00414973|451946749|FG000|Overall Study|Withdrawal by Subject|14|||
125635264|NCT00414973|451946750|FG001|Overall Study|Withdrawal by Subject|4|||
125635265|NCT00414973|451946751|FG002|Overall Study|Withdrawal by Subject|1|||
125635266|NCT00414973|451946752|FG003|Overall Study|Withdrawal by Subject|0|||
125635267|NCT00414973|451946749|FG000|Overall Study|Adverse Event|10|||
125635268|NCT00414973|451946750|FG001|Overall Study|Adverse Event|0|||
125635269|NCT00414973|451946751|FG002|Overall Study|Adverse Event|1|||
125635270|NCT00414973|451946752|FG003|Overall Study|Adverse Event|0|||
125635271|NCT00414973|451946749|FG000|Overall Study|Protocol Violation|3|||
125635272|NCT00414973|451946750|FG001|Overall Study|Protocol Violation|4|||
125635273|NCT00414973|451946751|FG002|Overall Study|Protocol Violation|0|||
125635274|NCT00414973|451946752|FG003|Overall Study|Protocol Violation|0|||
125635275|NCT00414973|451946749|FG000|Overall Study|Lost to Follow-up|0|||
125635276|NCT00414973|451946750|FG001|Overall Study|Lost to Follow-up|2|||
125635277|NCT00414973|451946751|FG002|Overall Study|Lost to Follow-up|0|||
125635278|NCT00414973|451946752|FG003|Overall Study|Lost to Follow-up|0|||
125635279|NCT00414973|451946749|FG000|Overall Study|Sponsor Decision|1|||
125635280|NCT00414973|451946750|FG001|Overall Study|Sponsor Decision|0|||
125635281|NCT00414973|451946751|FG002|Overall Study|Sponsor Decision|0|||
125635282|NCT00414973|451946752|FG003|Overall Study|Sponsor Decision|0|||
125635283|NCT00414973|451946749|FG000|Overall Study|Death|0|||
125635284|NCT00414973|451946750|FG001|Overall Study|Death|0|||
125635285|NCT00414973|451946751|FG002|Overall Study|Death|1|||
125635286|NCT00414973|451946752|FG003|Overall Study|Death|0|||
125635287|NCT03236506|451946753|FG000|Overall Study|Death|1|||
125635288|NCT03236506|451946754|FG001|Overall Study|Death|1|||
125635289|NCT03236506|451946755|FG002|Overall Study|Death|1|||
125635290|NCT03236506|451946753|FG000|Overall Study|Withdrawal by Subject|3|||
125635291|NCT03236506|451946754|FG001|Overall Study|Withdrawal by Subject|3|||
125635292|NCT03236506|451946755|FG002|Overall Study|Withdrawal by Subject|4|||
125635293|NCT03236506|451946753|FG000|Overall Study|Did not initiate treatment|2|||
125635294|NCT03236506|451946754|FG001|Overall Study|Did not initiate treatment|1|||
125635295|NCT03236506|451946755|FG002|Overall Study|Did not initiate treatment|2|||
125635296|NCT01466062|451946756|FG000|Overall Study|Adverse Event|1|||
125635297|NCT01466062|451946756|FG000|Overall Study|Withdrawal by Subject|1|||
125635298|NCT02865928|451946757|FG000|Overall Study|Withdrawal by Subject|1|||
125635299|NCT02865928|451946758|FG001|Overall Study|Withdrawal by Subject|0|||
125635300|NCT02865928|451946757|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
125635301|NCT02865928|451946758|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
125635302|NCT02865928|451946757|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
125635303|NCT02865928|451946758|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
125635304|NCT03152110|451946759|FG000|Overall Study|Withdrawal by Subject|3|||
125635305|NCT03696576|451946760|FG000|Overall Study|Soreness of throat after therapy|1|||
125635306|NCT03696576|451946761|FG001|Overall Study|Soreness of throat after therapy|1|||
125635307|NCT03696576|451946760|FG000|Overall Study|Lost to Follow-up|2|||
125635308|NCT03696576|451946761|FG001|Overall Study|Lost to Follow-up|4|||
125635309|NCT00338806|451946765|FG000|Acute Phase|Withdrawal by Subject|0|||
125635310|NCT00338806|451946766|FG001|Acute Phase|Withdrawal by Subject|1|||
125635311|NCT00338806|451946765|FG000|Follow-up|Lost to Follow-up|1|||
125635312|NCT00338806|451946766|FG001|Follow-up|Lost to Follow-up|3|||
125635313|NCT04259346|451946773|FG000|Overall Study|Lost to Follow-up|1|||
125635314|NCT04259346|451946774|FG001|Overall Study|Lost to Follow-up|3|||
125635315|NCT04259346|451946773|FG000|Overall Study|Protocol Violation|1|||
125635316|NCT04259346|451946774|FG001|Overall Study|Protocol Violation|0|||
125635317|NCT04259346|451946773|FG000|Overall Study|Withdrawal by Subject|1|||
125635318|NCT04259346|451946774|FG001|Overall Study|Withdrawal by Subject|0|||
125635319|NCT04259346|451946773|FG000|Overall Study|Adverse Event|1|||
125635320|NCT04259346|451946774|FG001|Overall Study|Adverse Event|1|||
125635321|NCT00085644|451946775|FG000|Double-Blind Period|Adverse Event|5|||
125130613|NCT02760368|450106323|FG002|Overall Study|Withdrawal by Sponsor|1|||
125130614|NCT03375463|450106324|FG000|Period 1|Lost to Follow-up|0|||
125130615|NCT03375463|450106325|FG001|Period 1|Lost to Follow-up|0|||
125130616|NCT03375463|450106326|FG002|Period 1|Lost to Follow-up|1|||
125130617|NCT03375463|450106327|FG003|Period 1|Lost to Follow-up|0|||
125130618|NCT03375463|450106328|FG004|Period 1|Lost to Follow-up|0|||
125130619|NCT03375463|450106329|FG005|Period 1|Lost to Follow-up|0|||
125130620|NCT03375463|450106324|FG000|Period 1|Adverse Event|0|||
125377145|NCT00371137|451010290|FG002|Overall Study|Lost to Follow-up|5|||
125377146|NCT00371137|451010288|FG000|Overall Study|Lack of Efficacy|30|||
125377147|NCT00371137|451010289|FG001|Overall Study|Lack of Efficacy|12|||
125377148|NCT00371137|451010290|FG002|Overall Study|Lack of Efficacy|13|||
125635322|NCT00085644|451946776|FG001|Double-Blind Period|Adverse Event|2|||
125635323|NCT00085644|451946777|FG002|Double-Blind Period|Adverse Event|0|||
125635324|NCT00085644|451946775|FG000|Double-Blind Period|Withdrawal by Subject|3|||
125130621|NCT03375463|450106325|FG001|Period 1|Adverse Event|0|||
125130622|NCT03375463|450106326|FG002|Period 1|Adverse Event|0|||
125635325|NCT00085644|451946776|FG001|Double-Blind Period|Withdrawal by Subject|0|||
125635326|NCT00085644|451946777|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125635327|NCT00085644|451946775|FG000|Double-Blind Period|Lost to Follow-up|2|||
125635328|NCT00085644|451946776|FG001|Double-Blind Period|Lost to Follow-up|1|||
125635329|NCT00085644|451946777|FG002|Double-Blind Period|Lost to Follow-up|0|||
125635330|NCT00085644|451946775|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
125130623|NCT03375463|450106327|FG003|Period 1|Adverse Event|0|||
125635331|NCT00085644|451946776|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
125635332|NCT00085644|451946777|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
125635333|NCT00085644|451946775|FG000|Double-Blind Period|Contemplating pregnancy|1|||
125635334|NCT00085644|451946776|FG001|Double-Blind Period|Contemplating pregnancy|0|||
125635335|NCT00085644|451946777|FG002|Double-Blind Period|Contemplating pregnancy|0|||
125635336|NCT00085644|451946775|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
125635337|NCT00085644|451946776|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
125635338|NCT00085644|451946777|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
125635339|NCT00085644|451946775|FG000|Open-Label Period|Adverse Event|0|||
125635340|NCT00085644|451946776|FG001|Open-Label Period|Adverse Event|0|||
125635341|NCT00085644|451946777|FG002|Open-Label Period|Adverse Event|38|||
125635342|NCT00085644|451946775|FG000|Open-Label Period|Withdrawal by Subject|0|||
125635343|NCT00085644|451946776|FG001|Open-Label Period|Withdrawal by Subject|0|||
125635344|NCT00085644|451946777|FG002|Open-Label Period|Withdrawal by Subject|29|||
125635345|NCT00085644|451946775|FG000|Open-Label Period|Lost to Follow-up|0|||
125635346|NCT00085644|451946776|FG001|Open-Label Period|Lost to Follow-up|0|||
125635347|NCT00085644|451946777|FG002|Open-Label Period|Lost to Follow-up|13|||
125635348|NCT00085644|451946775|FG000|Open-Label Period|Lack of Efficacy|0|||
125635349|NCT00085644|451946776|FG001|Open-Label Period|Lack of Efficacy|0|||
125635350|NCT00085644|451946777|FG002|Open-Label Period|Lack of Efficacy|15|||
125635351|NCT00085644|451946775|FG000|Open-Label Period|Pregnancy|0|||
125635352|NCT00085644|451946776|FG001|Open-Label Period|Pregnancy|0|||
125635353|NCT00085644|451946777|FG002|Open-Label Period|Pregnancy|3|||
125635354|NCT00085644|451946775|FG000|Open-Label Period|Contemplating pregnancy|0|||
125635355|NCT00085644|451946776|FG001|Open-Label Period|Contemplating pregnancy|0|||
125635356|NCT00085644|451946777|FG002|Open-Label Period|Contemplating pregnancy|3|||
125635357|NCT00085644|451946775|FG000|Open-Label Period|Protocol Violation|0|||
125635358|NCT00085644|451946776|FG001|Open-Label Period|Protocol Violation|0|||
125635359|NCT00085644|451946777|FG002|Open-Label Period|Protocol Violation|4|||
125635360|NCT00085644|451946775|FG000|Open-Label Period|Personal reason|0|||
125635361|NCT00085644|451946776|FG001|Open-Label Period|Personal reason|0|||
125635362|NCT00085644|451946777|FG002|Open-Label Period|Personal reason|4|||
125635363|NCT03330106|451946778|FG000|Part A|Withdrawal by Subject|1|||
125635364|NCT03330106|451946779|FG001|Part A|Withdrawal by Subject|1|||
125635365|NCT03330106|451946780|FG002|Part A|Withdrawal by Subject|0|||
125635366|NCT03330106|451946781|FG003|Part A|Withdrawal by Subject|0|||
125635367|NCT03330106|451946778|FG000|Part A|Death|2|||
125635368|NCT03330106|451946779|FG001|Part A|Death|1|||
125635369|NCT03330106|451946780|FG002|Part A|Death|0|||
125635370|NCT03330106|451946781|FG003|Part A|Death|0|||
125635371|NCT03330106|451946778|FG000|Part A|Adverse Event|0|||
125635372|NCT03330106|451946779|FG001|Part A|Adverse Event|1|||
125635373|NCT03330106|451946780|FG002|Part A|Adverse Event|0|||
125635374|NCT03330106|451946781|FG003|Part A|Adverse Event|0|||
125635375|NCT03330106|451946778|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
125635376|NCT03330106|451946779|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
125635377|NCT03330106|451946780|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
125635378|NCT03330106|451946781|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
125635379|NCT03330106|451946778|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
125635380|NCT03330106|451946779|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
125635381|NCT03330106|451946780|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
125635382|NCT03330106|451946781|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
125635383|NCT03330106|451946778|FG000|Part A|Progressive Disease|0|||
125635384|NCT03330106|451946779|FG001|Part A|Progressive Disease|1|||
125635385|NCT03330106|451946780|FG002|Part A|Progressive Disease|0|||
125635386|NCT03330106|451946781|FG003|Part A|Progressive Disease|0|||
125635387|NCT03330106|451946778|FG000|Part B|Lost to Follow-up|0|||
125635388|NCT03330106|451946779|FG001|Part B|Lost to Follow-up|0|||
125635389|NCT03330106|451946780|FG002|Part B|Lost to Follow-up|0|||
125635390|NCT03330106|451946781|FG003|Part B|Lost to Follow-up|1|||
125635391|NCT03330106|451946778|FG000|Part B|Withdrawal by Subject|0|||
125635392|NCT03330106|451946779|FG001|Part B|Withdrawal by Subject|0|||
125635393|NCT03330106|451946780|FG002|Part B|Withdrawal by Subject|4|||
125635394|NCT03330106|451946781|FG003|Part B|Withdrawal by Subject|0|||
125635395|NCT03330106|451946778|FG000|Part B|Death|0|||
125635396|NCT03330106|451946779|FG001|Part B|Death|0|||
125635397|NCT03330106|451946780|FG002|Part B|Death|2|||
125635398|NCT03330106|451946781|FG003|Part B|Death|0|||
125635399|NCT03330106|451946778|FG000|Part B|Clinical Progression|0|||
125635400|NCT03330106|451946779|FG001|Part B|Clinical Progression|0|||
125635401|NCT03330106|451946780|FG002|Part B|Clinical Progression|1|||
125635402|NCT03330106|451946781|FG003|Part B|Clinical Progression|1|||
125635403|NCT03330106|451946778|FG000|Part B|Symptomatic Deterioration|0|||
125635404|NCT03330106|451946779|FG001|Part B|Symptomatic Deterioration|0|||
125635405|NCT03330106|451946780|FG002|Part B|Symptomatic Deterioration|0|||
125635406|NCT03330106|451946781|FG003|Part B|Symptomatic Deterioration|1|||
125635407|NCT03330106|451946778|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
125216526|NCT02087670|450419494|FG001|Overall Study|Withdrawal by Subject|2|||
125216527|NCT01639703|450419495|FG000|Overall Study|Withdrawal by Subject|5|||
125216528|NCT01639703|450419495|FG000|Overall Study|Other reason|7|||
125216529|NCT01042392|450419496|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
125216530|NCT01042392|450419497|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
125216531|NCT01042392|450419498|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
125216532|NCT01042392|450419499|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
125216533|NCT01042392|450419496|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
125216534|NCT01042392|450419497|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
125216535|NCT01042392|450419498|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
125216536|NCT01042392|450419499|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
125216537|NCT01042392|450419496|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
125216538|NCT01042392|450419497|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
125216539|NCT01042392|450419498|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
125216540|NCT01042392|450419499|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
125216541|NCT01042392|450419496|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
125216542|NCT01042392|450419497|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
125216543|NCT01042392|450419498|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
125216544|NCT01042392|450419499|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
125216545|NCT01042392|450419496|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
125216546|NCT01042392|450419497|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
125216547|NCT01042392|450419498|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
125216548|NCT01042392|450419499|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
125216549|NCT01042392|450419496|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
125216550|NCT01042392|450419497|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
125216551|NCT01042392|450419498|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
125216552|NCT01042392|450419499|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
125216553|NCT01042392|450419496|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
125216554|NCT01042392|450419497|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
125216555|NCT01042392|450419498|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
125216556|NCT01042392|450419499|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
125216557|NCT01042392|450419496|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
125216558|NCT01042392|450419497|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
125216559|NCT01042392|450419498|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
125216560|NCT01042392|450419499|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
125216561|NCT01042392|450419496|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
125216562|NCT01042392|450419497|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
125216563|NCT01042392|450419498|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
125216564|NCT01042392|450419499|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
125216565|NCT02869893|450419502|FG000|Overall Study|participant aversion to IV|5|||
125216566|NCT02869893|450419502|FG000|Overall Study|participant fear of MRI scanner|2|||
125216567|NCT02588092|450419515|FG000|Overall Study|Death|4|||
125635408|NCT03330106|451946779|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
125635409|NCT03330106|451946780|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
125635410|NCT03330106|451946781|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
125635411|NCT03330106|451946778|FG000|Part B|Progressive Disease|0|||
125635412|NCT03330106|451946779|FG001|Part B|Progressive Disease|0|||
125635413|NCT03330106|451946780|FG002|Part B|Progressive Disease|11|||
125635414|NCT03330106|451946781|FG003|Part B|Progressive Disease|4|||
125635415|NCT00623766|451946782|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
125635416|NCT00623766|451946783|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
125635417|NCT00623766|451946782|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
125635418|NCT00623766|451946783|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
125635419|NCT00623766|451946782|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
125216568|NCT02588092|450419516|FG001|Overall Study|Death|3|||
125635420|NCT00623766|451946783|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
125216569|NCT02588092|450419517|FG002|Overall Study|Death|3|||
125216570|NCT02588092|450419518|FG003|Overall Study|Death|3|||
125216571|NCT02588092|450419519|FG004|Overall Study|Death|2|||
125216572|NCT02588092|450419520|FG005|Overall Study|Death|2|||
125216573|NCT02588092|450419521|FG006|Overall Study|Death|2|||
125216574|NCT02588092|450419522|FG007|Overall Study|Death|1|||
125216575|NCT02588092|450419523|FG008|Overall Study|Death|5|||
125216576|NCT02588092|450419524|FG009|Overall Study|Death|2|||
125635421|NCT00623766|451946782|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
125635422|NCT00623766|451946783|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
125635423|NCT00623766|451946782|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
125635424|NCT00623766|451946783|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
125635425|NCT00486889|451946788|FG000|Overall Study|Death|3|||
125635426|NCT00486889|451946788|FG000|Overall Study|Non-compliant|2|||
125635427|NCT00486889|451946788|FG000|Overall Study|Withdrawal by Subject|6|||
125635428|NCT00893763|451946789|FG000|Overall Study|extubated|110|||
125635429|NCT00893763|451946790|FG001|Overall Study|extubated|110|||
125635430|NCT02324049|451946791|FG000|Part C|Study terminated|11|||
125635431|NCT03198728|451946792|FG000|Overall Study|Adverse Event|10|||
125635432|NCT03198728|451946793|FG001|Overall Study|Adverse Event|5|||
125635433|NCT03198728|451946792|FG000|Overall Study|Lost to Follow-up|21|||
125635434|NCT03198728|451946793|FG001|Overall Study|Lost to Follow-up|7|||
125635435|NCT03198728|451946792|FG000|Overall Study|Physician Decision|7|||
125635436|NCT03198728|451946793|FG001|Overall Study|Physician Decision|2|||
125635437|NCT03198728|451946792|FG000|Overall Study|Withdrawal by Subject|14|||
125635438|NCT03198728|451946793|FG001|Overall Study|Withdrawal by Subject|10|||
125635439|NCT04157751|451946796|FG000|Overall Study|Withdrawal by Subject|12|||
125635440|NCT04157751|451946797|FG001|Overall Study|Withdrawal by Subject|17|||
125377149|NCT00371137|451010288|FG000|Overall Study|Sponsor Decision|2|||
125377150|NCT00371137|451010289|FG001|Overall Study|Sponsor Decision|1|||
125377151|NCT00371137|451010290|FG002|Overall Study|Sponsor Decision|2|||
125377152|NCT00371137|451010288|FG000|Overall Study|Physician Decision|1|||
125377153|NCT00371137|451010289|FG001|Overall Study|Physician Decision|1|||
125377154|NCT00371137|451010290|FG002|Overall Study|Physician Decision|1|||
125377155|NCT00371137|451010288|FG000|Overall Study|Protocol Violation|2|||
125377156|NCT00371137|451010289|FG001|Overall Study|Protocol Violation|1|||
125377157|NCT00371137|451010290|FG002|Overall Study|Protocol Violation|1|||
125377158|NCT02007109|451010291|FG000|Overall Study|Diary not returned or excluded|102|||
125377159|NCT02007109|451010291|FG000|Overall Study|Excluded - Age<7yo|9|||
125377160|NCT01918085|451010292|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
125377161|NCT01918085|451010293|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
125377162|NCT00646776|451010296|FG000|Overall Study|Adverse Event|1|||
125377163|NCT00646776|451010297|FG001|Overall Study|Adverse Event|9|||
125377164|NCT00646776|451010296|FG000|Overall Study|Investigator discretion|0|||
125377165|NCT00646776|451010297|FG001|Overall Study|Investigator discretion|4|||
125377166|NCT00126568|451010298|FG000|Overall Study|Death|2|||
125377167|NCT00580606|451010302|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
125377168|NCT00580606|451010303|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
125377169|NCT00580606|451010302|FG000|Open Label (OL)|Withdrawal by Subject|4|||
125377170|NCT00580606|451010303|FG001|Open Label (OL)|Withdrawal by Subject|6|||
125377171|NCT00580606|451010302|FG000|Open Label (OL)|Dosing Symptoms|0|||
125635441|NCT04157751|451946796|FG000|Overall Study|Lost to Follow-up|6|||
125635442|NCT04157751|451946797|FG001|Overall Study|Lost to Follow-up|2|||
125635443|NCT04157751|451946796|FG000|Overall Study|Adverse Event|34|||
125635444|NCT04157751|451946797|FG001|Overall Study|Adverse Event|23|||
125635445|NCT04157751|451946796|FG000|Overall Study|Not treated|1|||
125635446|NCT04157751|451946797|FG001|Overall Study|Not treated|5|||
125635447|NCT04157751|451946796|FG000|Overall Study|Other reason not stated above|10|||
125635448|NCT04157751|451946797|FG001|Overall Study|Other reason not stated above|10|||
125130624|NCT03375463|450106328|FG004|Period 1|Adverse Event|1|||
125130625|NCT03375463|450106329|FG005|Period 1|Adverse Event|0|||
125635449|NCT02829775|451946807|FG000|Overall Study|Death|1|||
125635450|NCT02829775|451946807|FG000|Overall Study|Withdrawal by Subject|3|||
125635451|NCT02829775|451946807|FG000|Overall Study|Disease remission|1|||
125635452|NCT01249157|451946808|FG000|Overall Study|Withdrawal by Subject|1|||
125635453|NCT04445051|451946810|FG000|Overall Study|Adverse Event|0|||
125635454|NCT04445051|451946811|FG001|Overall Study|Adverse Event|0|||
125635455|NCT04445051|451946812|FG002|Overall Study|Adverse Event|1|||
125635456|NCT04445051|451946813|FG003|Overall Study|Adverse Event|0|||
125635457|NCT04445051|451946814|FG004|Overall Study|Adverse Event|0|||
125635458|NCT04445051|451946815|FG005|Overall Study|Adverse Event|0|||
125635459|NCT00062647|451946816|FG000|Overall Study|Death|2|||
125635460|NCT00062647|451946817|FG001|Overall Study|Death|2|||
125635461|NCT00062647|451946816|FG000|Overall Study|Adverse Event|1|||
125635462|NCT00062647|451946817|FG001|Overall Study|Adverse Event|1|||
125635463|NCT00062647|451946816|FG000|Overall Study|Withdrawal by Subject|2|||
125635464|NCT00062647|451946817|FG001|Overall Study|Withdrawal by Subject|1|||
125635465|NCT00062647|451946816|FG000|Overall Study|Protocol Violation|1|||
125635466|NCT00062647|451946817|FG001|Overall Study|Protocol Violation|0|||
125635467|NCT00062647|451946816|FG000|Overall Study|Lost to Follow-up|1|||
125635468|NCT00062647|451946817|FG001|Overall Study|Lost to Follow-up|2|||
125130626|NCT03375463|450106324|FG000|Period 2|Lost to Follow-up|1|||
125130627|NCT03375463|450106325|FG001|Period 2|Lost to Follow-up|1|||
125130628|NCT03375463|450106326|FG002|Period 2|Lost to Follow-up|0|||
125130629|NCT03375463|450106327|FG003|Period 2|Lost to Follow-up|0|||
125130630|NCT03375463|450106328|FG004|Period 2|Lost to Follow-up|0|||
125130631|NCT03375463|450106329|FG005|Period 2|Lost to Follow-up|0|||
125130632|NCT01602419|450106330|FG000|Overall Study|Not treated with Wilate|9|||
125377172|NCT00580606|451010303|FG001|Open Label (OL)|Dosing Symptoms|1|||
125377173|NCT00580606|451010302|FG000|Open Label (OL)|Lost to Follow-up|0|||
125377174|NCT00580606|451010303|FG001|Open Label (OL)|Lost to Follow-up|1|||
125635469|NCT00062647|451946816|FG000|Overall Study|Failed continuation criteria|4|||
125635470|NCT00062647|451946817|FG001|Overall Study|Failed continuation criteria|2|||
125635471|NCT00062647|451946816|FG000|Overall Study|Other|4|||
125635472|NCT00062647|451946817|FG001|Overall Study|Other|4|||
125635473|NCT00062647|451946816|FG000|Overall Study|Never received study treatment|1|||
125635474|NCT00062647|451946817|FG001|Overall Study|Never received study treatment|1|||
125635475|NCT02392468|451946825|FG000|Overall Study|Adverse Event|0|||
125635476|NCT02392468|451946826|FG001|Overall Study|Adverse Event|1|||
125635477|NCT02392468|451946827|FG002|Overall Study|Adverse Event|0|||
125130633|NCT01602419|450106330|FG000|Overall Study|Adverse Drug Reaction|4|||
125130634|NCT01602419|450106330|FG000|Overall Study|Insurance issues|3|||
125377175|NCT00580606|451010302|FG000|Open Label (OL)|Pregnancy|0|||
125377176|NCT00580606|451010303|FG001|Open Label (OL)|Pregnancy|1|||
125377177|NCT00580606|451010302|FG000|Open Label (OL)|Non-compliance|2|||
125377178|NCT00580606|451010303|FG001|Open Label (OL)|Non-compliance|0|||
125377179|NCT00580606|451010302|FG000|Open Label (OL)|Physician Decision|1|||
125377180|NCT00580606|451010303|FG001|Open Label (OL)|Physician Decision|1|||
125377181|NCT00580606|451010302|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
125377182|NCT00580606|451010303|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
125377183|NCT00439244|451010306|FG000|Overall Study|Adverse Event|5|||
125377184|NCT00439244|451010307|FG001|Overall Study|Adverse Event|2|||
125377185|NCT00439244|451010308|FG002|Overall Study|Adverse Event|3|||
125377186|NCT00439244|451010306|FG000|Overall Study|Withdrawal by Subject|3|||
125377187|NCT00439244|451010307|FG001|Overall Study|Withdrawal by Subject|1|||
125377188|NCT00439244|451010308|FG002|Overall Study|Withdrawal by Subject|2|||
125377189|NCT00439244|451010306|FG000|Overall Study|Lost to Follow-up|2|||
125377190|NCT00439244|451010307|FG001|Overall Study|Lost to Follow-up|1|||
125377191|NCT00439244|451010308|FG002|Overall Study|Lost to Follow-up|2|||
125377192|NCT00439244|451010306|FG000|Overall Study|Death|0|||
125635478|NCT02392468|451946828|FG003|Overall Study|Adverse Event|0|||
125635479|NCT02392468|451946829|FG004|Overall Study|Adverse Event|0|||
125635480|NCT02392468|451946830|FG005|Overall Study|Adverse Event|1|||
125635481|NCT00901394|451946837|FG000|Overall Study|Physician Decision|1|||
125130635|NCT01602419|450106330|FG000|Overall Study|Changed treatment centre|1|||
125130636|NCT01602419|450106330|FG000|Overall Study|Treatment centre closed|1|||
125130637|NCT01602419|450106330|FG000|Overall Study|Withdrawal by Subject|5|||
125635482|NCT00901394|451946838|FG001|Overall Study|Physician Decision|1|||
125635483|NCT00901394|451946839|FG002|Overall Study|Physician Decision|2|||
125635484|NCT02422186|451946840|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
125130638|NCT01602419|450106330|FG000|Overall Study|Lost to Follow-up|6|||
125130639|NCT01792635|450106331|FG000|Part B|Adverse Event|0|||
125377193|NCT00439244|451010307|FG001|Overall Study|Death|1|||
125377194|NCT00439244|451010308|FG002|Overall Study|Death|0|||
125377195|NCT00439244|451010306|FG000|Overall Study|Protocol Violation|0|||
125130640|NCT01792635|450106332|FG001|Part B|Adverse Event|0|||
125216577|NCT02588092|450419515|FG000|Overall Study|Withdrawal by Subject|0|||
125216578|NCT02588092|450419516|FG001|Overall Study|Withdrawal by Subject|0|||
125216579|NCT02588092|450419517|FG002|Overall Study|Withdrawal by Subject|0|||
125216580|NCT02588092|450419518|FG003|Overall Study|Withdrawal by Subject|0|||
125216581|NCT02588092|450419519|FG004|Overall Study|Withdrawal by Subject|0|||
125635485|NCT02422186|451946841|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
125635486|NCT02422186|451946840|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
125635487|NCT02422186|451946841|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
125635488|NCT02422186|451946840|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
125635489|NCT02422186|451946841|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
125635490|NCT02422186|451946840|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
125635491|NCT02422186|451946841|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
125635492|NCT02422186|451946840|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
125216582|NCT02588092|450419520|FG005|Overall Study|Withdrawal by Subject|1|||
125216583|NCT02588092|450419521|FG006|Overall Study|Withdrawal by Subject|1|||
125216584|NCT02588092|450419522|FG007|Overall Study|Withdrawal by Subject|2|||
125216585|NCT02588092|450419523|FG008|Overall Study|Withdrawal by Subject|0|||
125216586|NCT02588092|450419524|FG009|Overall Study|Withdrawal by Subject|0|||
125216587|NCT02588092|450419515|FG000|Overall Study|Started Another Treatment|0|||
125216588|NCT02588092|450419516|FG001|Overall Study|Started Another Treatment|0|||
125216589|NCT02588092|450419517|FG002|Overall Study|Started Another Treatment|0|||
125216590|NCT02588092|450419518|FG003|Overall Study|Started Another Treatment|0|||
125216591|NCT02588092|450419519|FG004|Overall Study|Started Another Treatment|1|||
125216592|NCT02588092|450419520|FG005|Overall Study|Started Another Treatment|0|||
125216593|NCT02588092|450419521|FG006|Overall Study|Started Another Treatment|0|||
125216594|NCT02588092|450419522|FG007|Overall Study|Started Another Treatment|1|||
125216595|NCT02588092|450419523|FG008|Overall Study|Started Another Treatment|0|||
125216596|NCT02588092|450419524|FG009|Overall Study|Started Another Treatment|0|||
125216597|NCT02588092|450419515|FG000|Overall Study|Sponsor Decision|0|||
125216598|NCT02588092|450419516|FG001|Overall Study|Sponsor Decision|0|||
125216599|NCT02588092|450419517|FG002|Overall Study|Sponsor Decision|0|||
125216600|NCT02588092|450419518|FG003|Overall Study|Sponsor Decision|0|||
125216601|NCT02588092|450419519|FG004|Overall Study|Sponsor Decision|0|||
125635493|NCT02422186|451946841|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
125635494|NCT02422186|451946840|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
125216602|NCT02588092|450419520|FG005|Overall Study|Sponsor Decision|0|||
125216603|NCT02588092|450419521|FG006|Overall Study|Sponsor Decision|0|||
125216604|NCT02588092|450419522|FG007|Overall Study|Sponsor Decision|0|||
125216605|NCT02588092|450419523|FG008|Overall Study|Sponsor Decision|1|||
125216606|NCT02588092|450419524|FG009|Overall Study|Sponsor Decision|1|||
125216607|NCT01030718|450419527|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
125216608|NCT01030718|450419528|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
125216609|NCT01030718|450419529|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
125216610|NCT01030718|450419527|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
125216611|NCT01030718|450419528|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
125216612|NCT01030718|450419529|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
125216613|NCT01030718|450419527|FG000|Studies CA180-031 and -036 Combined|Death|0|||
125216614|NCT01030718|450419528|FG001|Studies CA180-031 and -036 Combined|Death|1|||
125216615|NCT01030718|450419529|FG002|Studies CA180-031 and -036 Combined|Death|0|||
125216616|NCT01030718|450419527|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
125216617|NCT01030718|450419528|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
125216618|NCT01030718|450419529|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
125216619|NCT01030718|450419527|FG000|Study CA180-036 Only|insufficient effect|1|||
125216620|NCT01030718|450419528|FG001|Study CA180-036 Only|insufficient effect|1|||
125216621|NCT01030718|450419529|FG002|Study CA180-036 Only|insufficient effect|5|||
125216622|NCT01030718|450419527|FG000|Study CA180-036 Only|Adverse Event|2|||
125216623|NCT01030718|450419528|FG001|Study CA180-036 Only|Adverse Event|3|||
125216624|NCT01030718|450419529|FG002|Study CA180-036 Only|Adverse Event|0|||
125216625|NCT01030718|450419527|FG000|Study CA180-036 Only|Death|0|||
125635495|NCT02422186|451946841|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
125635496|NCT02422186|451946840|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
125635497|NCT02422186|451946841|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
125216626|NCT01030718|450419528|FG001|Study CA180-036 Only|Death|1|||
125635498|NCT02422186|451946840|FG000|Follow-up Phase (2 Weeks)|Other|3|||
125635499|NCT02422186|451946841|FG001|Follow-up Phase (2 Weeks)|Other|0|||
125635500|NCT03039569|451946842|FG000|Overall Study|Lost to Follow-up|5|||
125635501|NCT03039569|451946843|FG001|Overall Study|Lost to Follow-up|4|||
125635502|NCT02254304|451946844|FG000|Overall Study|Adverse Event|2|||
125635503|NCT02254304|451946845|FG001|Overall Study|Adverse Event|1|||
125635504|NCT02254304|451946844|FG000|Overall Study|Lost to Follow-up|2|||
125216627|NCT01030718|450419529|FG002|Study CA180-036 Only|Death|0|||
125216628|NCT01030718|450419527|FG000|Study CA180-036 Only|Other Reasons|0|||
125216629|NCT01030718|450419528|FG001|Study CA180-036 Only|Other Reasons|2|||
125216630|NCT01030718|450419529|FG002|Study CA180-036 Only|Other Reasons|0|||
125216631|NCT00423813|450419530|FG000|Overall Study|Adverse Event|11|||
125216632|NCT00423813|450419531|FG001|Overall Study|Adverse Event|30|||
125216633|NCT00423813|450419532|FG002|Overall Study|Adverse Event|40|||
125216634|NCT00423813|450419530|FG000|Overall Study|Withdrawal by Subject|6|||
125216635|NCT00423813|450419531|FG001|Overall Study|Withdrawal by Subject|8|||
125216636|NCT00423813|450419532|FG002|Overall Study|Withdrawal by Subject|5|||
125216637|NCT00423813|450419530|FG000|Overall Study|Lost to Follow-up|5|||
125216638|NCT00423813|450419531|FG001|Overall Study|Lost to Follow-up|4|||
125216639|NCT00423813|450419532|FG002|Overall Study|Lost to Follow-up|4|||
125216640|NCT00423813|450419530|FG000|Overall Study|Lack of Efficacy|23|||
125216641|NCT00423813|450419531|FG001|Overall Study|Lack of Efficacy|18|||
125216642|NCT00423813|450419532|FG002|Overall Study|Lack of Efficacy|19|||
125216643|NCT00423813|450419530|FG000|Overall Study|Physician Decision|2|||
125216644|NCT00423813|450419531|FG001|Overall Study|Physician Decision|0|||
125377196|NCT00439244|451010307|FG001|Overall Study|Protocol Violation|1|||
125377197|NCT00439244|451010308|FG002|Overall Study|Protocol Violation|0|||
125377198|NCT00439244|451010306|FG000|Overall Study|Administrative problems|1|||
125377199|NCT00439244|451010307|FG001|Overall Study|Administrative problems|0|||
125377200|NCT00439244|451010308|FG002|Overall Study|Administrative problems|0|||
125377201|NCT03655691|451010309|FG000|Overall Study|Adverse Event|0|||
125377202|NCT03655691|451010310|FG001|Overall Study|Adverse Event|0|||
125377203|NCT03655691|451010311|FG002|Overall Study|Adverse Event|1|||
125377204|NCT03655691|451010309|FG000|Overall Study|Lost to Follow-up|1|||
125377205|NCT03655691|451010310|FG001|Overall Study|Lost to Follow-up|1|||
125377206|NCT03655691|451010311|FG002|Overall Study|Lost to Follow-up|2|||
125377207|NCT03655691|451010309|FG000|Overall Study|Protocol Violation|0|||
125377208|NCT03655691|451010310|FG001|Overall Study|Protocol Violation|1|||
125377209|NCT03655691|451010311|FG002|Overall Study|Protocol Violation|0|||
125377210|NCT03655691|451010309|FG000|Overall Study|Withdrawal by Subject|1|||
125377211|NCT03655691|451010310|FG001|Overall Study|Withdrawal by Subject|1|||
125377212|NCT03655691|451010311|FG002|Overall Study|Withdrawal by Subject|0|||
125377213|NCT03918447|451010312|FG000|Overall Study|Death|1|||
125377214|NCT03918447|451010313|FG001|Overall Study|Death|0|||
125377215|NCT03918447|451010312|FG000|Overall Study|Lost to Follow-up|13|||
125377216|NCT03918447|451010313|FG001|Overall Study|Lost to Follow-up|6|||
125377217|NCT03918447|451010312|FG000|Overall Study|Withdrawal by Subject|19|||
125377218|NCT03918447|451010313|FG001|Overall Study|Withdrawal by Subject|17|||
125377219|NCT03918447|451010312|FG000|Overall Study|Study Terminated by Sponsor|195|||
125377220|NCT03918447|451010313|FG001|Overall Study|Study Terminated by Sponsor|197|||
125377221|NCT03918447|451010312|FG000|Overall Study|Reason not Specified|0|||
125377222|NCT03918447|451010313|FG001|Overall Study|Reason not Specified|1|||
125377223|NCT03278613|451010314|FG000|Overall Study|Lost to Follow-up|3|||
125377224|NCT03278613|451010315|FG001|Overall Study|Lost to Follow-up|1|||
125377225|NCT01405456|451010316|FG000|Overall Study|Lost to Follow-up|2|||
125377226|NCT01405456|451010317|FG001|Overall Study|Lost to Follow-up|1|||
125377227|NCT01405456|451010316|FG000|Overall Study|Physician Decision|1|||
125377228|NCT01405456|451010317|FG001|Overall Study|Physician Decision|0|||
125377229|NCT05353985|451010318|FG000|Overall Study|Adverse Event|5|||
125377230|NCT05353985|451010319|FG001|Overall Study|Adverse Event|7|||
125377231|NCT05353985|451010318|FG000|Overall Study|Lost to Follow-up|1|||
125377232|NCT05353985|451010319|FG001|Overall Study|Lost to Follow-up|1|||
125377233|NCT05353985|451010318|FG000|Overall Study|Protocol Violation|1|||
125377234|NCT05353985|451010319|FG001|Overall Study|Protocol Violation|0|||
125377235|NCT05353985|451010318|FG000|Overall Study|Withdrawal by Subject|13|||
125377236|NCT05353985|451010319|FG001|Overall Study|Withdrawal by Subject|17|||
125377237|NCT05353985|451010318|FG000|Overall Study|Reason Not Specified|1|||
125377238|NCT05353985|451010319|FG001|Overall Study|Reason Not Specified|0|||
125377239|NCT05353985|451010318|FG000|Overall Study|Randomized in Error & Not Treated|0|||
125377240|NCT05353985|451010319|FG001|Overall Study|Randomized in Error & Not Treated|1|||
125377241|NCT02989194|451011942|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
125377242|NCT02989194|451011943|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
125216645|NCT00423813|450419532|FG002|Overall Study|Physician Decision|0|||
125216646|NCT00423813|450419530|FG000|Overall Study|Sponsor Decision|0|||
125216647|NCT00423813|450419531|FG001|Overall Study|Sponsor Decision|1|||
125377243|NCT02989194|451011944|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
125377244|NCT02989194|451011942|FG000|Overall Study|Lost to Follow-up|0|||
125377245|NCT02989194|451011943|FG001|Overall Study|Lost to Follow-up|1|||
125377246|NCT02989194|451011944|FG002|Overall Study|Lost to Follow-up|0|||
125377247|NCT02989194|451011942|FG000|Overall Study|Withdrawal by Subject|0|||
125377248|NCT02989194|451011943|FG001|Overall Study|Withdrawal by Subject|1|||
125377249|NCT02989194|451011944|FG002|Overall Study|Withdrawal by Subject|0|||
125377250|NCT03824912|451011945|FG000|Overall Study|Lost to Follow-up|18|||
125377251|NCT03824912|451011946|FG001|Overall Study|Lost to Follow-up|15|||
125216648|NCT00423813|450419532|FG002|Overall Study|Sponsor Decision|0|||
125216649|NCT00423813|450419530|FG000|Overall Study|Protocol Violation|9|||
125216650|NCT00423813|450419531|FG001|Overall Study|Protocol Violation|4|||
125216651|NCT00423813|450419532|FG002|Overall Study|Protocol Violation|4|||
125377252|NCT03824912|451011947|FG002|Overall Study|Lost to Follow-up|8|||
125635505|NCT02254304|451946845|FG001|Overall Study|Lost to Follow-up|2|||
125635506|NCT02254304|451946844|FG000|Overall Study|Protocol Violation|1|||
125635507|NCT02254304|451946845|FG001|Overall Study|Protocol Violation|0|||
125635508|NCT02254304|451946844|FG000|Overall Study|Withdrawal by Subject|3|||
125635509|NCT02254304|451946845|FG001|Overall Study|Withdrawal by Subject|0|||
125635510|NCT02254304|451946844|FG000|Overall Study|Injection site pain and Injection fear|1|||
125635511|NCT02254304|451946845|FG001|Overall Study|Injection site pain and Injection fear|0|||
125635512|NCT02254304|451946844|FG000|Overall Study|Personal causes|4|||
125377253|NCT03824912|451011945|FG000|Overall Study|Negative Baseline Culture Result|118|||
125377254|NCT03824912|451011946|FG001|Overall Study|Negative Baseline Culture Result|112|||
125377255|NCT03824912|451011947|FG002|Overall Study|Negative Baseline Culture Result|57|||
125377256|NCT03824912|451011945|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125377257|NCT03824912|451011946|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125377258|NCT03824912|451011947|FG002|Overall Study|Non-Compliance with Study Drug|1|||
125377259|NCT03824912|451011945|FG000|Overall Study|Protocol Violation|1|||
125377260|NCT03824912|451011946|FG001|Overall Study|Protocol Violation|4|||
125377261|NCT03824912|451011947|FG002|Overall Study|Protocol Violation|1|||
125377262|NCT03824912|451011945|FG000|Overall Study|Withdrawal by Subject|3|||
125377263|NCT03824912|451011946|FG001|Overall Study|Withdrawal by Subject|2|||
125377264|NCT03824912|451011947|FG002|Overall Study|Withdrawal by Subject|1|||
125377265|NCT03824912|451011945|FG000|Overall Study|Participation in another study|0|||
125377266|NCT03824912|451011946|FG001|Overall Study|Participation in another study|1|||
125377267|NCT03824912|451011947|FG002|Overall Study|Participation in another study|0|||
125377268|NCT02254486|451011954|FG000|Overall Study|Adverse Event|1|||
125377269|NCT02254486|451011955|FG001|Overall Study|Adverse Event|1|||
125377270|NCT02254486|451011954|FG000|Overall Study|Lack of Efficacy|1|||
125377271|NCT02254486|451011955|FG001|Overall Study|Lack of Efficacy|0|||
125377272|NCT02254486|451011954|FG000|Overall Study|Lost to Follow-up|2|||
125377273|NCT02254486|451011955|FG001|Overall Study|Lost to Follow-up|4|||
125377274|NCT02254486|451011954|FG000|Overall Study|Protocol Violation|1|||
125377275|NCT02254486|451011955|FG001|Overall Study|Protocol Violation|2|||
125377276|NCT02254486|451011954|FG000|Overall Study|Withdrawal by Subject|17|||
125377277|NCT02254486|451011955|FG001|Overall Study|Withdrawal by Subject|15|||
125377278|NCT02254486|451011954|FG000|Overall Study|GFR<60mL/min|16|||
125377279|NCT02254486|451011955|FG001|Overall Study|GFR<60mL/min|21|||
125377280|NCT02254486|451011954|FG000|Overall Study|Various|12|||
125377281|NCT02254486|451011955|FG001|Overall Study|Various|12|||
125377282|NCT01350414|451011962|FG000|Overall Study|Lost to Follow-up|13|||
125377283|NCT01350414|451011962|FG000|Overall Study|Withdrawal by Subject|4|||
125377284|NCT01350414|451011962|FG000|Overall Study|Physician Decision|2|||
125377285|NCT04166435|451011963|FG000|Overall Study|2 patients ineligible for response|2|||
125377286|NCT03033394|451011966|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
125377287|NCT03033394|451011966|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
125377288|NCT03033394|451011966|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
125377289|NCT03033394|451011966|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
125377290|NCT03033394|451011966|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
125377291|NCT02036294|451011967|FG000|Overall Study|Death|7|||
125377292|NCT02036294|451011968|FG001|Overall Study|Death|8|||
125377293|NCT02036294|451011967|FG000|Overall Study|Withdrawal by Subject|2|||
125377294|NCT02036294|451011968|FG001|Overall Study|Withdrawal by Subject|3|||
125377295|NCT00356369|451011969|FG000|Active Phase|Withdrawal by Subject|2|||
125377296|NCT00356369|451011970|FG001|Active Phase|Withdrawal by Subject|1|||
125377297|NCT02117648|451011972|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
125377298|NCT02117648|451011972|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
125377299|NCT02117648|451011972|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
125377300|NCT02117648|451011972|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
125377301|NCT02117648|451011972|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
125377302|NCT02117648|451011972|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
125377303|NCT02117648|451011972|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
125377304|NCT02117648|451011972|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
125377305|NCT02117648|451011972|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
125377306|NCT02117648|451011972|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
125377307|NCT02117648|451011972|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
125377308|NCT02532972|451011979|FG000|Overall Study|Withdrawal by Subject|1|||
125377309|NCT01606436|451011980|FG000|Overall Study|Withdrawal by Subject|0|||
125377310|NCT01606436|451011981|FG001|Overall Study|Withdrawal by Subject|0|||
125377311|NCT01606436|451011982|FG002|Overall Study|Withdrawal by Subject|1|||
125377312|NCT01606436|451011983|FG003|Overall Study|Withdrawal by Subject|1|||
125377313|NCT01606436|451011984|FG004|Overall Study|Withdrawal by Subject|1|||
125377314|NCT01606436|451011985|FG005|Overall Study|Withdrawal by Subject|0|||
125377315|NCT01606436|451011980|FG000|Overall Study|Adverse Event|0|||
125377316|NCT01606436|451011981|FG001|Overall Study|Adverse Event|0|||
125635513|NCT02254304|451946845|FG001|Overall Study|Personal causes|1|||
125216652|NCT00423813|450419530|FG000|Overall Study|Pregnancy|0|||
125216653|NCT00423813|450419531|FG001|Overall Study|Pregnancy|0|||
125216654|NCT00423813|450419532|FG002|Overall Study|Pregnancy|1|||
125216655|NCT00423813|450419530|FG000|Overall Study|Subject started night shift work|1|||
125216656|NCT00423813|450419531|FG001|Overall Study|Subject started night shift work|0|||
125216657|NCT00423813|450419532|FG002|Overall Study|Subject started night shift work|0|||
125216658|NCT00423813|450419530|FG000|Overall Study|Will start exclusionary medications|0|||
125216659|NCT00423813|450419531|FG001|Overall Study|Will start exclusionary medications|1|||
125216660|NCT00423813|450419532|FG002|Overall Study|Will start exclusionary medications|0|||
125216661|NCT00423813|450419530|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
125216662|NCT00423813|450419531|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
125216663|NCT00423813|450419532|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
125216664|NCT01386944|450419533|FG000|Overall Study|Adverse Event|26|||
125216665|NCT01386944|450419533|FG000|Overall Study|Lack of Efficacy|14|||
125635514|NCT02254304|451946844|FG000|Overall Study|Personal decision|1|||
125635515|NCT02254304|451946845|FG001|Overall Study|Personal decision|0|||
125635516|NCT04888507|451948829|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
125635517|NCT00400946|451948830|FG000|Overall Study|Ineligible|0|||
125216666|NCT01386944|450419533|FG000|Overall Study|Lost to Follow-up|8|||
125216667|NCT01386944|450419533|FG000|Overall Study|Unspecified reason|8|||
125216668|NCT03883477|450419534|FG000|Overall Study|Death|1|||
125216669|NCT03883477|450419535|FG001|Overall Study|Death|0|||
125216670|NCT03883477|450419534|FG000|Overall Study|Protocol Violation|0|||
125216671|NCT03883477|450419535|FG001|Overall Study|Protocol Violation|1|||
125216672|NCT03853291|450419536|FG000|Overall Study|Lost to Follow-up|1|||
125216673|NCT03853291|450419537|FG001|Overall Study|Lost to Follow-up|2|||
125216674|NCT03853291|450419538|FG002|Overall Study|Lost to Follow-up|0|||
125377317|NCT01606436|451011982|FG002|Overall Study|Adverse Event|1|||
125635518|NCT00400946|451948831|FG001|Overall Study|Ineligible|0|||
125635519|NCT00400946|451948832|FG002|Overall Study|Ineligible|0|||
125635520|NCT00400946|451948833|FG003|Overall Study|Ineligible|5|||
125635521|NCT00400946|451948834|FG004|Overall Study|Ineligible|1|||
125635522|NCT00400946|451948830|FG000|Overall Study|Induction Failure|0|||
125635523|NCT00400946|451948831|FG001|Overall Study|Induction Failure|0|||
125635524|NCT00400946|451948832|FG002|Overall Study|Induction Failure|0|||
125216675|NCT03853291|450419539|FG003|Overall Study|Lost to Follow-up|0|||
125216676|NCT03853291|450419540|FG004|Overall Study|Lost to Follow-up|0|||
125635525|NCT00400946|451948833|FG003|Overall Study|Induction Failure|11|||
125635526|NCT00400946|451948834|FG004|Overall Study|Induction Failure|8|||
125130641|NCT01792635|450106333|FG002|Part B|Adverse Event|1|||
125130642|NCT01792635|450106331|FG000|Part B|Study terminated|0|||
125130643|NCT01792635|450106332|FG001|Part B|Study terminated|4|||
125130644|NCT01792635|450106333|FG002|Part B|Study terminated|3|||
125130645|NCT02902211|450106337|FG000|First Three Months|Withdrawal by Subject|7|||
125130646|NCT02902211|450106338|FG001|First Three Months|Withdrawal by Subject|3|||
125130647|NCT01513174|450106341|FG000|Overall Study|Inclusion Error|1|||
125130648|NCT01513174|450106342|FG001|Overall Study|Inclusion Error|7|||
125130649|NCT01513174|450106341|FG000|Overall Study|Not receive study treatment|3|||
125130650|NCT01513174|450106342|FG001|Overall Study|Not receive study treatment|1|||
125130651|NCT02682784|450106350|FG000|Overall Study|Withdrawal by Subject|0|||
125130652|NCT02682784|450106351|FG001|Overall Study|Withdrawal by Subject|2|||
125130653|NCT02682784|450106352|FG002|Overall Study|Withdrawal by Subject|1|||
125130654|NCT02682784|450106353|FG003|Overall Study|Withdrawal by Subject|2|||
125130655|NCT02682784|450106350|FG000|Overall Study|Physician Decision|1|||
125130656|NCT02682784|450106351|FG001|Overall Study|Physician Decision|0|||
125130657|NCT02682784|450106352|FG002|Overall Study|Physician Decision|1|||
125130658|NCT02682784|450106353|FG003|Overall Study|Physician Decision|1|||
125130659|NCT00467363|450106354|FG000|Overall Study|Lost to Follow-up|80|||
125130660|NCT00467363|450106355|FG001|Overall Study|Lost to Follow-up|70|||
125130661|NCT04533594|450106356|FG000|Overall Study|Death|26|||
125130662|NCT01401647|450106359|FG000|Overall Study|Withdrawal by Subject|1|||
125130663|NCT01401647|450106360|FG001|Overall Study|Withdrawal by Subject|5|||
125130664|NCT01401647|450106361|FG002|Overall Study|Withdrawal by Subject|2|||
125130665|NCT01401647|450106359|FG000|Overall Study|Lost to Follow-up|3|||
125130666|NCT01401647|450106360|FG001|Overall Study|Lost to Follow-up|3|||
125130667|NCT01401647|450106361|FG002|Overall Study|Lost to Follow-up|1|||
125130668|NCT00473330|450106366|FG000|Core Study|Adverse Event|4|||
125130669|NCT00473330|450106367|FG001|Core Study|Adverse Event|4|||
125130670|NCT00473330|450106368|FG002|Core Study|Adverse Event|1|||
125130671|NCT00473330|450106366|FG000|Core Study|Death|6|||
125130672|NCT00473330|450106367|FG001|Core Study|Death|4|||
125130673|NCT00473330|450106368|FG002|Core Study|Death|4|||
125130674|NCT00473330|450106366|FG000|Core Study|Lost to Follow-up|5|||
125130675|NCT00473330|450106367|FG001|Core Study|Lost to Follow-up|5|||
125130676|NCT00473330|450106368|FG002|Core Study|Lost to Follow-up|10|||
125130677|NCT00473330|450106366|FG000|Core Study|Physician Decision|2|||
125130678|NCT00473330|450106367|FG001|Core Study|Physician Decision|1|||
125130679|NCT00473330|450106368|FG002|Core Study|Physician Decision|3|||
125130680|NCT00473330|450106366|FG000|Core Study|Subject Non-compliance|1|||
125130681|NCT00473330|450106367|FG001|Core Study|Subject Non-compliance|2|||
125130682|NCT00473330|450106368|FG002|Core Study|Subject Non-compliance|1|||
125130683|NCT00473330|450106366|FG000|Core Study|Subject Required Other Therapy|0|||
125130684|NCT00473330|450106367|FG001|Core Study|Subject Required Other Therapy|1|||
125130685|NCT00473330|450106368|FG002|Core Study|Subject Required Other Therapy|3|||
125130686|NCT00473330|450106366|FG000|Core Study|Subject's Decision|9|||
125130687|NCT00473330|450106367|FG001|Core Study|Subject's Decision|8|||
125130688|NCT00473330|450106368|FG002|Core Study|Subject's Decision|19|||
125130689|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
125130690|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
125130691|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
125130692|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Death|2|||
125130693|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Death|0|||
125130694|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Death|0|||
125130695|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
125130696|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
125130697|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
125130698|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
125130699|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
125130700|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
125130701|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
125130702|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
125130703|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
125130704|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
125130705|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
125130706|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
125216677|NCT03853291|450419541|FG005|Overall Study|Lost to Follow-up|0|||
125216678|NCT03853291|450419536|FG000|Overall Study|Determined to be ineligible|1|||
125216679|NCT03853291|450419537|FG001|Overall Study|Determined to be ineligible|1|||
125216680|NCT03853291|450419538|FG002|Overall Study|Determined to be ineligible|0|||
125216681|NCT03853291|450419539|FG003|Overall Study|Determined to be ineligible|0|||
125216682|NCT03853291|450419540|FG004|Overall Study|Determined to be ineligible|0|||
125216683|NCT03853291|450419541|FG005|Overall Study|Determined to be ineligible|0|||
125216684|NCT03762681|450419547|FG000|Part 1|Withdrawal by Subject|0|||
125216685|NCT03762681|450419548|FG001|Part 1|Withdrawal by Subject|0|||
125216686|NCT03762681|450419549|FG002|Part 1|Withdrawal by Subject|0|||
125216687|NCT03762681|450419550|FG003|Part 1|Withdrawal by Subject|1|||
125216688|NCT03762681|450419551|FG004|Part 1|Withdrawal by Subject|0|||
125216689|NCT03762681|450419552|FG005|Part 1|Withdrawal by Subject|0|||
125216690|NCT03762681|450419553|FG006|Part 1|Withdrawal by Subject|0|||
125216691|NCT03762681|450419554|FG007|Part 1|Withdrawal by Subject|0|||
125216692|NCT03762681|450419547|FG000|Part 2a|Pandemic Travel Restrictions|0|||
125216693|NCT03762681|450419548|FG001|Part 2a|Pandemic Travel Restrictions|0|||
125216694|NCT03762681|450419549|FG002|Part 2a|Pandemic Travel Restrictions|0|||
125216695|NCT03762681|450419550|FG003|Part 2a|Pandemic Travel Restrictions|0|||
125216696|NCT03762681|450419551|FG004|Part 2a|Pandemic Travel Restrictions|0|||
125216697|NCT03762681|450419552|FG005|Part 2a|Pandemic Travel Restrictions|0|||
125216698|NCT03762681|450419553|FG006|Part 2a|Pandemic Travel Restrictions|0|||
125216699|NCT03762681|450419554|FG007|Part 2a|Pandemic Travel Restrictions|1|||
125635527|NCT00400946|451948830|FG000|Overall Study|Induction Death|0|||
125635528|NCT00400946|451948831|FG001|Overall Study|Induction Death|0|||
125635529|NCT00400946|451948832|FG002|Overall Study|Induction Death|0|||
125216700|NCT02137226|450419555|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
125216701|NCT02137226|450419556|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
125216702|NCT02137226|450419557|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
125635530|NCT00400946|451948833|FG003|Overall Study|Induction Death|13|||
125635531|NCT00400946|451948834|FG004|Overall Study|Induction Death|3|||
125635532|NCT00400946|451948830|FG000|Overall Study|Lost to Follow-up|1|||
125216703|NCT02137226|450419558|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
125216704|NCT02137226|450419559|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
125216705|NCT02137226|450419555|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
125216706|NCT02137226|450419556|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
125216707|NCT02137226|450419557|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
125635533|NCT00400946|451948831|FG001|Overall Study|Lost to Follow-up|1|||
125216708|NCT02137226|450419558|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
125216709|NCT02137226|450419559|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
125377318|NCT01606436|451011983|FG003|Overall Study|Adverse Event|0|||
125635534|NCT00400946|451948832|FG002|Overall Study|Lost to Follow-up|0|||
125635535|NCT00400946|451948833|FG003|Overall Study|Lost to Follow-up|0|||
125635536|NCT00400946|451948834|FG004|Overall Study|Lost to Follow-up|1|||
125635537|NCT00400946|451948830|FG000|Overall Study|Remission Death|1|||
125635538|NCT00400946|451948831|FG001|Overall Study|Remission Death|1|||
125635539|NCT00400946|451948832|FG002|Overall Study|Remission Death|0|||
125635540|NCT00400946|451948833|FG003|Overall Study|Remission Death|0|||
125635541|NCT00400946|451948834|FG004|Overall Study|Remission Death|1|||
125635542|NCT00400946|451948830|FG000|Overall Study|Relapse|9|||
125130707|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
125130708|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
125130709|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
125130710|NCT00473330|450106366|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
125130711|NCT00473330|450106367|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
125130712|NCT00473330|450106368|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
125130713|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
125130714|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
125130715|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
125130716|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Death|2|||
125130717|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Death|2|||
125130718|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Death|1|||
125130719|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
125130720|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
125130721|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
125130722|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
125130723|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
125130724|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
125130725|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
125130726|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
125130727|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
125130728|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
125130729|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
125130730|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
125130731|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
125130732|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
125130733|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
125130734|NCT00473330|450106366|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
125130735|NCT00473330|450106367|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
125130736|NCT00473330|450106368|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
125130737|NCT01975948|450106369|FG000|Overall Study|Withdrawal by Subject|17|||
125130738|NCT01975948|450106370|FG001|Overall Study|Withdrawal by Subject|21|||
125635543|NCT00400946|451948831|FG001|Overall Study|Relapse|2|||
125130739|NCT01975948|450106371|FG002|Overall Study|Withdrawal by Subject|7|||
125130740|NCT01975948|450106372|FG003|Overall Study|Withdrawal by Subject|6|||
125130741|NCT01675765|450106373|FG000|Overall Study|Progressive disease|4|||
125130742|NCT01675765|450106374|FG001|Overall Study|Progressive disease|4|||
125130743|NCT01675765|450106373|FG000|Overall Study|Adverse Event|1|||
125130744|NCT01675765|450106374|FG001|Overall Study|Adverse Event|2|||
125130745|NCT01675765|450106373|FG000|Overall Study|Withdrawal by Subject|2|||
125130746|NCT01675765|450106374|FG001|Overall Study|Withdrawal by Subject|0|||
125130747|NCT01675765|450106373|FG000|Overall Study|Death|1|||
125130748|NCT01675765|450106374|FG001|Overall Study|Death|0|||
125130749|NCT01675765|450106373|FG000|Overall Study|Clinical progression|3|||
125130750|NCT01675765|450106374|FG001|Overall Study|Clinical progression|2|||
125130751|NCT01723397|450106379|FG000|Study Period 1|Protocol Violation|0|||
125130752|NCT01723397|450106380|FG001|Study Period 1|Protocol Violation|1|||
125130753|NCT01723397|450106379|FG000|Study Period 2|Protocol Violation|0|||
125130754|NCT01723397|450106380|FG001|Study Period 2|Protocol Violation|1|||
125130755|NCT02196675|450106381|FG000|Overall Study|Withdrawal by Subject|1|||
125130756|NCT02196675|450106382|FG001|Overall Study|Withdrawal by Subject|0|||
125130757|NCT02196675|450106383|FG002|Overall Study|Withdrawal by Subject|0|||
125130758|NCT02196675|450106381|FG000|Overall Study|Intra-operative surgical exclusion|1|||
125130759|NCT02196675|450106382|FG001|Overall Study|Intra-operative surgical exclusion|1|||
125130760|NCT02196675|450106383|FG002|Overall Study|Intra-operative surgical exclusion|0|||
125377319|NCT01606436|451011984|FG004|Overall Study|Adverse Event|0|||
125377320|NCT01606436|451011985|FG005|Overall Study|Adverse Event|0|||
125635544|NCT00400946|451948832|FG002|Overall Study|Relapse|1|||
125635545|NCT00400946|451948833|FG003|Overall Study|Relapse|1|||
125635546|NCT00400946|451948834|FG004|Overall Study|Relapse|5|||
125635547|NCT00400946|451948830|FG000|Overall Study|Transplant in CR1|0|||
125635548|NCT00400946|451948831|FG001|Overall Study|Transplant in CR1|0|||
125635549|NCT00400946|451948832|FG002|Overall Study|Transplant in CR1|0|||
125635550|NCT00400946|451948833|FG003|Overall Study|Transplant in CR1|10|||
125216710|NCT02137226|450419555|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
125216711|NCT02137226|450419556|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
125216712|NCT02137226|450419557|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
125216713|NCT02137226|450419558|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
125216714|NCT02137226|450419559|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
125216715|NCT02137226|450419555|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
125216716|NCT02137226|450419556|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
125216717|NCT02137226|450419557|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
125216718|NCT02137226|450419558|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
125216719|NCT02137226|450419559|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
125216720|NCT02137226|450419555|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
125216721|NCT02137226|450419556|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
125216722|NCT02137226|450419557|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
125216723|NCT02137226|450419558|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
125216724|NCT02137226|450419559|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
125216725|NCT02137226|450419555|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
125216726|NCT02137226|450419556|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
125216727|NCT02137226|450419557|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
125216728|NCT02137226|450419558|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
125216729|NCT02137226|450419559|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
125216730|NCT02137226|450419555|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
125216731|NCT02137226|450419556|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
125216732|NCT02137226|450419557|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
125216733|NCT02137226|450419558|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
125216734|NCT02137226|450419559|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
125216735|NCT02137226|450419555|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
125216736|NCT02137226|450419556|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
125216737|NCT02137226|450419557|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
125216738|NCT02137226|450419558|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
125216739|NCT02137226|450419559|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
125216740|NCT02137226|450419555|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
125216741|NCT02137226|450419556|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
125216742|NCT02137226|450419557|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
125216743|NCT02137226|450419558|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
125216744|NCT02137226|450419559|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
125216745|NCT02137226|450419555|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
125216746|NCT02137226|450419556|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
125216747|NCT02137226|450419557|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
125216748|NCT02137226|450419558|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
125216749|NCT02137226|450419559|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
125216750|NCT02137226|450419555|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
125216751|NCT02137226|450419556|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
125216752|NCT02137226|450419557|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
125216753|NCT02137226|450419558|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
125635551|NCT00400946|451948834|FG004|Overall Study|Transplant in CR1|1|||
125635552|NCT00400946|451948830|FG000|Overall Study|Withdrawal by Subject|2|||
125635553|NCT00400946|451948831|FG001|Overall Study|Withdrawal by Subject|5|||
125635554|NCT00400946|451948832|FG002|Overall Study|Withdrawal by Subject|1|||
125635555|NCT00400946|451948833|FG003|Overall Study|Withdrawal by Subject|5|||
125130761|NCT02196675|450106381|FG000|Overall Study|Protocol Violation|0|||
125130762|NCT02196675|450106382|FG001|Overall Study|Protocol Violation|1|||
125130763|NCT02196675|450106383|FG002|Overall Study|Protocol Violation|0|||
125130764|NCT02196675|450106381|FG000|Overall Study|Death|0|||
125130765|NCT02196675|450106382|FG001|Overall Study|Death|0|||
125130766|NCT02196675|450106383|FG002|Overall Study|Death|1|||
125130767|NCT02711852|450106384|FG000|Overall Study|Death|5|||
125130768|NCT02711852|450106384|FG000|Overall Study|Lost to Follow-up|1|||
125130769|NCT02711852|450106384|FG000|Overall Study|Completed follow-up|3|||
125130770|NCT02711852|450106384|FG000|Overall Study|Withdrawal by Subject|1|||
125130771|NCT00537979|450106385|FG000|Overall Study|Adverse Event|2|||
125130772|NCT00537979|450106386|FG001|Overall Study|Adverse Event|2|||
125130773|NCT00537979|450106385|FG000|Overall Study|Withdrawal by Subject|1|||
125130774|NCT00537979|450106386|FG001|Overall Study|Withdrawal by Subject|4|||
125130775|NCT00537979|450106385|FG000|Overall Study|Lost to Follow-up|1|||
125130776|NCT00537979|450106386|FG001|Overall Study|Lost to Follow-up|4|||
125130777|NCT00537979|450106385|FG000|Overall Study|Lack of Efficacy|0|||
125130778|NCT00537979|450106386|FG001|Overall Study|Lack of Efficacy|1|||
125130779|NCT00537979|450106385|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
125130780|NCT00537979|450106386|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
125130781|NCT00537979|450106385|FG000|Overall Study|Death|0|||
125216754|NCT02137226|450419559|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
125216755|NCT02137226|450419555|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
125216756|NCT02137226|450419556|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
125216757|NCT02137226|450419557|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
125216758|NCT02137226|450419558|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
125216759|NCT02137226|450419559|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
125216760|NCT00003896|450419564|FG000|Overall Study|Adverse Event|16|||
125216761|NCT00003896|450419564|FG000|Overall Study|Withdrawal by Subject|1|||
125216762|NCT00003896|450419564|FG000|Overall Study|Lack of Efficacy|1|||
125216763|NCT00003896|450419564|FG000|Overall Study|Death|3|||
125216764|NCT00003896|450419564|FG000|Overall Study|not protocol specified|3|||
125216765|NCT00003896|450419564|FG000|Overall Study|ineligible|5|||
125216766|NCT00985686|450419567|FG000|Overall Study|Lost to Follow-up|1|||
125216767|NCT00985686|450419568|FG001|Overall Study|Lost to Follow-up|1|||
125216768|NCT00985686|450419569|FG002|Overall Study|Lost to Follow-up|0|||
125216769|NCT00985686|450419570|FG003|Overall Study|Lost to Follow-up|2|||
125216770|NCT01670045|450419571|FG000|Overall Study|Withdrawal by Subject|3|||
125216771|NCT01670045|450419571|FG000|Overall Study|Adverse Event|1|||
125216772|NCT01670045|450419571|FG000|Overall Study|Death|1|||
125216773|NCT01670045|450419571|FG000|Overall Study|Lost to Follow-up|11|||
125216774|NCT02787083|450419577|FG000|Overall Study|Adverse Event|1|||
125216775|NCT02787083|450419578|FG001|Overall Study|Adverse Event|0|||
125216776|NCT02787083|450419577|FG000|Overall Study|Withdrawal by Subject|2|||
125216777|NCT02787083|450419578|FG001|Overall Study|Withdrawal by Subject|2|||
125216778|NCT02710084|450419579|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
125216779|NCT02710084|450419580|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
125216780|NCT03162328|450419581|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
125216781|NCT03162328|450419582|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
125216782|NCT03162328|450419583|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
125216783|NCT03162328|450419581|FG000|Screening Period|Withdrawal by Subject|1|||
125216784|NCT03162328|450419582|FG001|Screening Period|Withdrawal by Subject|0|||
125216785|NCT03162328|450419583|FG002|Screening Period|Withdrawal by Subject|0|||
125216786|NCT03162328|450419581|FG000|Study Period|Withdrawal by Subject|0|||
125216787|NCT03162328|450419582|FG001|Study Period|Withdrawal by Subject|0|||
125216788|NCT03162328|450419583|FG002|Study Period|Withdrawal by Subject|1|||
125216789|NCT00282152|450419584|FG000|Overall Study|Withdrawal by Subject|1|||
125216790|NCT00282152|450419585|FG001|Overall Study|Withdrawal by Subject|0|||
125216791|NCT03301831|450419586|FG000|Overall Study|Lost to Follow-up|5|||
125216792|NCT03301831|450419587|FG001|Overall Study|Lost to Follow-up|3|||
125216793|NCT03301831|450419586|FG000|Overall Study|Protocol Violation|4|||
125216794|NCT03301831|450419587|FG001|Overall Study|Protocol Violation|0|||
125216795|NCT03301831|450419586|FG000|Overall Study|Withdrawal by Subject|11|||
125216796|NCT03301831|450419587|FG001|Overall Study|Withdrawal by Subject|0|||
125216797|NCT03268005|450419589|FG000|Overall Study|Death|2|||
125216798|NCT03268005|450419590|FG001|Overall Study|Death|1|||
125216799|NCT03268005|450419589|FG000|Overall Study|Lost to Follow-up|2|||
125216800|NCT03268005|450419590|FG001|Overall Study|Lost to Follow-up|2|||
125216801|NCT03268005|450419589|FG000|Overall Study|Withdrawal by Subject|11|||
125216802|NCT03268005|450419590|FG001|Overall Study|Withdrawal by Subject|11|||
125216803|NCT00845676|450419593|FG000|Overall Study|Virologic breakthrough at week 20|1|||
125216804|NCT00845676|450419593|FG000|Overall Study|Adverse Event|1|||
125216805|NCT00481767|450419594|FG000|Overall Study|Withdrawal by Subject|16|||
125216806|NCT00481767|450419595|FG001|Overall Study|Withdrawal by Subject|11|||
125216807|NCT00481767|450419594|FG000|Overall Study|Lost to Follow-up|16|||
125216808|NCT00481767|450419595|FG001|Overall Study|Lost to Follow-up|10|||
125216809|NCT04378569|450421926|FG000|Overall Study|Adverse Event|0|||
125216810|NCT04378569|450421927|FG001|Overall Study|Adverse Event|0|||
125216811|NCT04378569|450421928|FG002|Overall Study|Adverse Event|2|||
125216812|NCT04378569|450421929|FG003|Overall Study|Adverse Event|0|||
125216813|NCT04378569|450421930|FG004|Overall Study|Adverse Event|3|||
125216814|NCT04378569|450421931|FG005|Overall Study|Adverse Event|3|||
125216815|NCT04378569|450421926|FG000|Overall Study|Lost to Follow-up|0|||
125216816|NCT04378569|450421927|FG001|Overall Study|Lost to Follow-up|3|||
125216817|NCT04378569|450421928|FG002|Overall Study|Lost to Follow-up|1|||
125216818|NCT04378569|450421929|FG003|Overall Study|Lost to Follow-up|0|||
125216819|NCT04378569|450421930|FG004|Overall Study|Lost to Follow-up|1|||
125216820|NCT04378569|450421931|FG005|Overall Study|Lost to Follow-up|1|||
125216821|NCT04378569|450421926|FG000|Overall Study|Protocol Violation|0|||
125216822|NCT04378569|450421927|FG001|Overall Study|Protocol Violation|0|||
125216823|NCT04378569|450421928|FG002|Overall Study|Protocol Violation|0|||
125216824|NCT04378569|450421929|FG003|Overall Study|Protocol Violation|0|||
125216825|NCT04378569|450421930|FG004|Overall Study|Protocol Violation|0|||
125216826|NCT04378569|450421931|FG005|Overall Study|Protocol Violation|1|||
125216827|NCT04378569|450421926|FG000|Overall Study|Withdrawal by Subject|0|||
125216828|NCT04378569|450421927|FG001|Overall Study|Withdrawal by Subject|6|||
125216829|NCT04378569|450421928|FG002|Overall Study|Withdrawal by Subject|7|||
125216830|NCT04378569|450421929|FG003|Overall Study|Withdrawal by Subject|4|||
125216831|NCT04378569|450421930|FG004|Overall Study|Withdrawal by Subject|5|||
125216832|NCT04378569|450421931|FG005|Overall Study|Withdrawal by Subject|4|||
125130782|NCT00537979|450106386|FG001|Overall Study|Death|3|||
125130783|NCT00537979|450106385|FG000|Overall Study|Kidney transplant|0|||
125130784|NCT00537979|450106386|FG001|Overall Study|Kidney transplant|3|||
125130785|NCT00537979|450106385|FG000|Overall Study|Heart failure|0|||
125130786|NCT00537979|450106386|FG001|Overall Study|Heart failure|1|||
125130787|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
125130788|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
125130789|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
125130790|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
125130791|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
125130792|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
125130793|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
125130794|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
125130795|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
125130796|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
125130797|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
125130798|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
125130799|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
125130800|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
125130801|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
125130802|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
125130803|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
125130804|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
125130805|NCT02009163|450106387|FG000|Open-label Period (Non-randomized)|Other|13|||
125130806|NCT02009163|450106388|FG001|Open-label Period (Non-randomized)|Other|0|||
125130807|NCT02009163|450106389|FG002|Open-label Period (Non-randomized)|Other|0|||
125130808|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
125130809|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
125130810|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
125130811|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
125130812|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
125130813|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
125130814|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Adverse Event|0|||
125130815|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Adverse Event|0|||
125130816|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Adverse Event|6|||
125130817|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
125130818|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
125130819|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
125130820|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
125130821|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
125130822|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
125130823|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Pregnancy|0|||
125130824|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Pregnancy|0|||
125130825|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Pregnancy|2|||
125130826|NCT02009163|450106387|FG000|Randomized-withdrawal Period|Other|0|||
125130827|NCT02009163|450106388|FG001|Randomized-withdrawal Period|Other|9|||
125130828|NCT02009163|450106389|FG002|Randomized-withdrawal Period|Other|5|||
125130829|NCT02453386|450106390|FG000|Overall Study|Adverse Event|22|||
125130830|NCT02453386|450106391|FG001|Overall Study|Adverse Event|30|||
125130831|NCT02453386|450106392|FG002|Overall Study|Adverse Event|15|||
125130832|NCT02453386|450106390|FG000|Overall Study|Protocol Violation|1|||
125130833|NCT02453386|450106391|FG001|Overall Study|Protocol Violation|0|||
125130834|NCT02453386|450106392|FG002|Overall Study|Protocol Violation|1|||
125130835|NCT02453386|450106390|FG000|Overall Study|Withdrawal by Subject|10|||
125130836|NCT02453386|450106391|FG001|Overall Study|Withdrawal by Subject|9|||
125130837|NCT02453386|450106392|FG002|Overall Study|Withdrawal by Subject|9|||
125130838|NCT02453386|450106390|FG000|Overall Study|Sponsor Terminated Study|14|||
125130839|NCT02453386|450106391|FG001|Overall Study|Sponsor Terminated Study|8|||
125130840|NCT02453386|450106392|FG002|Overall Study|Sponsor Terminated Study|11|||
125130841|NCT02453386|450106390|FG000|Overall Study|Subject Terminated by Sponsor|1|||
125130842|NCT02453386|450106391|FG001|Overall Study|Subject Terminated by Sponsor|1|||
125130843|NCT02453386|450106392|FG002|Overall Study|Subject Terminated by Sponsor|1|||
125130844|NCT02453386|450106390|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
125130845|NCT02453386|450106391|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
125377321|NCT01606436|451011980|FG000|Overall Study|Sponsor Decision|0|||
125130846|NCT02453386|450106392|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
125130847|NCT02453386|450106390|FG000|Overall Study|Lost to Follow-up|0|||
125130848|NCT02453386|450106391|FG001|Overall Study|Lost to Follow-up|0|||
125130849|NCT02453386|450106392|FG002|Overall Study|Lost to Follow-up|1|||
125130850|NCT02453386|450106390|FG000|Overall Study|Other|1|||
125130851|NCT02453386|450106391|FG001|Overall Study|Other|0|||
125130852|NCT02453386|450106392|FG002|Overall Study|Other|1|||
125635556|NCT00400946|451948834|FG004|Overall Study|Withdrawal by Subject|8|||
125635557|NCT00400946|451948830|FG000|Overall Study|Clinical|1|||
125635558|NCT00400946|451948831|FG001|Overall Study|Clinical|2|||
125635559|NCT00400946|451948832|FG002|Overall Study|Clinical|0|||
125635560|NCT00400946|451948833|FG003|Overall Study|Clinical|2|||
125635561|NCT00400946|451948834|FG004|Overall Study|Clinical|9|||
125635562|NCT00400946|451948830|FG000|Overall Study|Other|0|||
125635563|NCT00400946|451948831|FG001|Overall Study|Other|0|||
125635564|NCT00400946|451948832|FG002|Overall Study|Other|0|||
125635565|NCT00400946|451948833|FG003|Overall Study|Other|0|||
125635566|NCT00400946|451948834|FG004|Overall Study|Other|1|||
125635567|NCT05643170|451948835|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
125635568|NCT05643170|451948835|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
125635569|NCT01673373|451948837|FG000|Overall Study|Death|2|||
125635570|NCT05426460|451948838|FG000|Overall Study|Protocol Violation|1|||
125635571|NCT05426460|451948839|FG001|Overall Study|Protocol Violation|1|||
125635572|NCT05426460|451948840|FG002|Overall Study|Protocol Violation|1|||
125635573|NCT05426460|451948841|FG003|Overall Study|Protocol Violation|0|||
125635574|NCT01431521|451948847|FG000|Overall Study|Withdrawal by Subject|0|||
125635575|NCT01431521|451948848|FG001|Overall Study|Withdrawal by Subject|0|||
125635576|NCT01431521|451948849|FG002|Overall Study|Withdrawal by Subject|1|||
125635577|NCT01431521|451948850|FG003|Overall Study|Withdrawal by Subject|0|||
125635578|NCT02531633|451948851|FG000|Part A (52 Weeks)|Sponsor request|24|||
125635579|NCT02531633|451948852|FG001|Part A (52 Weeks)|Sponsor request|24|||
125635580|NCT02531633|451948853|FG002|Part A (52 Weeks)|Sponsor request|18|||
125635581|NCT02531633|451948854|FG003|Part A (52 Weeks)|Sponsor request|18|||
125635582|NCT02531633|451948855|FG004|Part A (52 Weeks)|Sponsor request|19|||
125635583|NCT02531633|451948856|FG005|Part A (52 Weeks)|Sponsor request|0|||
125635584|NCT02531633|451948857|FG006|Part A (52 Weeks)|Sponsor request|0|||
125635585|NCT02531633|451948858|FG007|Part A (52 Weeks)|Sponsor request|0|||
125635586|NCT02531633|451948859|FG008|Part A (52 Weeks)|Sponsor request|0|||
125635587|NCT02531633|451948860|FG009|Part A (52 Weeks)|Sponsor request|0|||
125635588|NCT02531633|451948851|FG000|Part A (52 Weeks)|Protocol Violation|1|||
125635589|NCT02531633|451948852|FG001|Part A (52 Weeks)|Protocol Violation|0|||
125635590|NCT02531633|451948853|FG002|Part A (52 Weeks)|Protocol Violation|0|||
125635591|NCT02531633|451948854|FG003|Part A (52 Weeks)|Protocol Violation|0|||
125635592|NCT02531633|451948855|FG004|Part A (52 Weeks)|Protocol Violation|0|||
125635593|NCT02531633|451948856|FG005|Part A (52 Weeks)|Protocol Violation|0|||
125635594|NCT02531633|451948857|FG006|Part A (52 Weeks)|Protocol Violation|0|||
125635595|NCT02531633|451948858|FG007|Part A (52 Weeks)|Protocol Violation|0|||
125635596|NCT02531633|451948859|FG008|Part A (52 Weeks)|Protocol Violation|0|||
125635597|NCT02531633|451948860|FG009|Part A (52 Weeks)|Protocol Violation|0|||
125635598|NCT02531633|451948851|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
125635599|NCT02531633|451948852|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
125635600|NCT02531633|451948853|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
125635601|NCT02531633|451948854|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
125635602|NCT02531633|451948855|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
125635603|NCT02531633|451948856|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
125635604|NCT02531633|451948857|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
125635605|NCT02531633|451948858|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
125635606|NCT02531633|451948859|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
125635607|NCT02531633|451948860|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
125635608|NCT02531633|451948851|FG000|Part A (52 Weeks)|Physician Decision|1|||
125635609|NCT02531633|451948852|FG001|Part A (52 Weeks)|Physician Decision|4|||
125635610|NCT02531633|451948853|FG002|Part A (52 Weeks)|Physician Decision|3|||
125635611|NCT02531633|451948854|FG003|Part A (52 Weeks)|Physician Decision|1|||
125635612|NCT02531633|451948855|FG004|Part A (52 Weeks)|Physician Decision|0|||
125377322|NCT01606436|451011981|FG001|Overall Study|Sponsor Decision|0|||
125635613|NCT02531633|451948856|FG005|Part A (52 Weeks)|Physician Decision|0|||
125635614|NCT02531633|451948857|FG006|Part A (52 Weeks)|Physician Decision|0|||
125635615|NCT02531633|451948858|FG007|Part A (52 Weeks)|Physician Decision|0|||
125635616|NCT02531633|451948859|FG008|Part A (52 Weeks)|Physician Decision|0|||
125635617|NCT02531633|451948860|FG009|Part A (52 Weeks)|Physician Decision|0|||
125635618|NCT02531633|451948851|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
125635619|NCT02531633|451948852|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
125635620|NCT02531633|451948853|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
125635621|NCT02531633|451948854|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
125635622|NCT02531633|451948855|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
125635623|NCT02531633|451948856|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
125635624|NCT02531633|451948857|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
125635625|NCT02531633|451948858|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
125635626|NCT02531633|451948859|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
125635627|NCT02531633|451948860|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
125635628|NCT02531633|451948851|FG000|Part A (52 Weeks)|Other|2|||
125635629|NCT02531633|451948852|FG001|Part A (52 Weeks)|Other|0|||
125635630|NCT02531633|451948853|FG002|Part A (52 Weeks)|Other|0|||
125635631|NCT02531633|451948854|FG003|Part A (52 Weeks)|Other|0|||
125635632|NCT02531633|451948855|FG004|Part A (52 Weeks)|Other|0|||
125130853|NCT02388191|450106415|FG000|Overall Study|Patient did not receive IUD|1|||
125130854|NCT02388191|450106416|FG001|Overall Study|Patient did not receive IUD|0|||
125130855|NCT03686033|450106417|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
125130856|NCT03686033|450106418|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
125377323|NCT01606436|451011982|FG002|Overall Study|Sponsor Decision|0|||
125377324|NCT01606436|451011983|FG003|Overall Study|Sponsor Decision|1|||
125377325|NCT01606436|451011984|FG004|Overall Study|Sponsor Decision|0|||
125377326|NCT01606436|451011985|FG005|Overall Study|Sponsor Decision|0|||
125377327|NCT02859454|451011986|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
125377328|NCT01025752|451011987|FG000|Overall Study|Lost to Follow-up|7|||
125377329|NCT01025752|451011988|FG001|Overall Study|Lost to Follow-up|10|||
125377330|NCT01025752|451011987|FG000|Overall Study|Physician Decision|1|||
125377331|NCT01025752|451011988|FG001|Overall Study|Physician Decision|3|||
125377332|NCT01417234|451011991|FG000|Overall Study|Subject non-compliant|3|||
125377333|NCT00023764|451011992|FG000|Overall Study|Other|1|||
125377334|NCT00023764|451011992|FG000|Overall Study|Adverse Event|4|||
125377335|NCT00023764|451011992|FG000|Overall Study|Withdrawal by Subject|1|||
125635633|NCT02531633|451948856|FG005|Part A (52 Weeks)|Other|0|||
125635634|NCT02531633|451948857|FG006|Part A (52 Weeks)|Other|0|||
125635635|NCT02531633|451948858|FG007|Part A (52 Weeks)|Other|0|||
125635636|NCT02531633|451948859|FG008|Part A (52 Weeks)|Other|0|||
125377336|NCT00023764|451011992|FG000|Overall Study|Progression of disease|6|||
125377337|NCT00023764|451011992|FG000|Overall Study|patient received other treatment|1|||
125377338|NCT00023764|451011992|FG000|Overall Study|delay in obtaining staging images|1|||
125377339|NCT02407704|451011995|FG000|Overall Study|Lost to Follow-up|0|||
125635637|NCT02531633|451948860|FG009|Part A (52 Weeks)|Other|0|||
125635638|NCT02531633|451948851|FG000|Part B (104 Weeks)|Sponsor request|0|||
125635639|NCT02531633|451948852|FG001|Part B (104 Weeks)|Sponsor request|0|||
125635640|NCT02531633|451948853|FG002|Part B (104 Weeks)|Sponsor request|0|||
125635641|NCT02531633|451948854|FG003|Part B (104 Weeks)|Sponsor request|0|||
125635642|NCT02531633|451948855|FG004|Part B (104 Weeks)|Sponsor request|0|||
125635643|NCT02531633|451948856|FG005|Part B (104 Weeks)|Sponsor request|8|||
125635644|NCT02531633|451948857|FG006|Part B (104 Weeks)|Sponsor request|5|||
125635645|NCT02531633|451948858|FG007|Part B (104 Weeks)|Sponsor request|3|||
125635646|NCT02531633|451948859|FG008|Part B (104 Weeks)|Sponsor request|5|||
125635647|NCT02531633|451948860|FG009|Part B (104 Weeks)|Sponsor request|4|||
125635648|NCT02531633|451948851|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
125635649|NCT02531633|451948852|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
125635650|NCT02531633|451948853|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
125635651|NCT02531633|451948854|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
125130857|NCT03686033|450106419|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
125130858|NCT03686033|450106420|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
125130859|NCT03686033|450106421|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
125130860|NCT03686033|450106422|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
125130861|NCT03197883|450106423|FG000|Overall Study|Adverse Event|1|||
125130862|NCT03197883|450106424|FG001|Overall Study|Adverse Event|1|||
125130863|NCT03197883|450106423|FG000|Overall Study|Lost to Follow-up|1|||
125130864|NCT03197883|450106424|FG001|Overall Study|Lost to Follow-up|0|||
125130865|NCT03197883|450106423|FG000|Overall Study|Protocol Violation|1|||
125130866|NCT03197883|450106424|FG001|Overall Study|Protocol Violation|0|||
125130867|NCT03197883|450106423|FG000|Overall Study|Other (Not Specified)|0|||
125130868|NCT03197883|450106424|FG001|Overall Study|Other (Not Specified)|5|||
125130869|NCT00858845|450106425|FG000|Overall Study|Patient underwent heart transplant.|0|||
125130870|NCT00858845|450106426|FG001|Overall Study|Patient underwent heart transplant.|1|||
125130871|NCT03031847|450106428|FG000|Overall Study|Death|1|||
125130872|NCT03031847|450106429|FG001|Overall Study|Death|1|||
125130873|NCT03031847|450106430|FG002|Overall Study|Death|2|||
125130874|NCT03031847|450106431|FG003|Overall Study|Death|3|||
125130875|NCT03031847|450106428|FG000|Overall Study|Lost to Follow-up|1|||
125130876|NCT03031847|450106429|FG001|Overall Study|Lost to Follow-up|1|||
125130877|NCT03031847|450106430|FG002|Overall Study|Lost to Follow-up|2|||
125130878|NCT03031847|450106431|FG003|Overall Study|Lost to Follow-up|3|||
125130879|NCT01353664|450106433|FG000|Overall Study|Other|3|||
125130880|NCT01353664|450106433|FG000|Overall Study|Disease Progression|16|||
125130881|NCT02089997|450106441|FG000|Overall Study|Case report forms uncollected|99|||
125130882|NCT02089997|450106441|FG000|Overall Study|Protocol Violation|147|||
125130883|NCT02441309|450106442|FG000|Overall Study|Disease progression|2|||
125130884|NCT02441309|450106443|FG001|Overall Study|Disease progression|1|||
125130885|NCT02441309|450106444|FG002|Overall Study|Disease progression|2|||
125130886|NCT02441309|450106442|FG000|Overall Study|Adverse Event|0|||
125130887|NCT02441309|450106443|FG001|Overall Study|Adverse Event|1|||
125130888|NCT02441309|450106444|FG002|Overall Study|Adverse Event|0|||
125130889|NCT02441309|450106442|FG000|Overall Study|Withdrawal by Subject|1|||
125130890|NCT02441309|450106443|FG001|Overall Study|Withdrawal by Subject|0|||
125377340|NCT02407704|451011996|FG001|Overall Study|Lost to Follow-up|0|||
125635652|NCT02531633|451948855|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
125635653|NCT02531633|451948856|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
125377341|NCT02407704|451011997|FG002|Overall Study|Lost to Follow-up|0|||
125377342|NCT02407704|451011998|FG003|Overall Study|Lost to Follow-up|2|||
125635654|NCT02531633|451948857|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
125635655|NCT02531633|451948858|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
125635656|NCT02531633|451948859|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
125635657|NCT02531633|451948860|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
125635658|NCT01572844|451948861|FG000|Overall Study|Physician Decision|1|||
125635659|NCT01572844|451948862|FG001|Overall Study|Physician Decision|1|||
125635660|NCT05171816|451948863|FG000|Overall Study|Death|18|||
125130891|NCT02441309|450106444|FG002|Overall Study|Withdrawal by Subject|1|||
125130892|NCT00415363|450106445|FG000|Overall Study|Withdrawal by Subject|4|||
125377343|NCT02407704|451011995|FG000|Overall Study|Protocol Violation|0|||
125377344|NCT02407704|451011996|FG001|Overall Study|Protocol Violation|0|||
125377345|NCT02407704|451011997|FG002|Overall Study|Protocol Violation|0|||
125377346|NCT02407704|451011998|FG003|Overall Study|Protocol Violation|1|||
125377347|NCT02407704|451011995|FG000|Overall Study|Withdrawal by Subject|0|||
125377348|NCT02407704|451011996|FG001|Overall Study|Withdrawal by Subject|0|||
125377349|NCT02407704|451011997|FG002|Overall Study|Withdrawal by Subject|1|||
125377350|NCT02407704|451011998|FG003|Overall Study|Withdrawal by Subject|0|||
125377351|NCT03944954|451011999|FG000|Overall Study|Withdrawal by Subject|22|||
125377352|NCT03944954|451012000|FG001|Overall Study|Withdrawal by Subject|4|||
125377353|NCT03944954|451011999|FG000|Overall Study|Lost to Follow-up|18|||
125377354|NCT03944954|451012000|FG001|Overall Study|Lost to Follow-up|0|||
125377355|NCT03944954|451011999|FG000|Overall Study|Failed Medical Screening|7|||
125377356|NCT03944954|451012000|FG001|Overall Study|Failed Medical Screening|0|||
125377357|NCT02268084|451012007|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
125377358|NCT02268084|451012008|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
125377359|NCT02268084|451012007|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
125377360|NCT02268084|451012008|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
125377361|NCT05227027|451012009|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
125377362|NCT05227027|451012010|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
125377363|NCT03334448|451012016|FG000|Washout|Personal Reason|0|||
125377364|NCT03334448|451012017|FG001|Washout|Personal Reason|1|||
125377365|NCT03334448|451012018|FG002|Washout|Personal Reason|0|||
125377366|NCT03334448|451012019|FG003|Washout|Personal Reason|0|||
125377367|NCT03334448|451012016|FG000|Washout|Protocol Violation|0|||
125377368|NCT03334448|451012017|FG001|Washout|Protocol Violation|0|||
125377369|NCT03334448|451012018|FG002|Washout|Protocol Violation|0|||
125377370|NCT03334448|451012019|FG003|Washout|Protocol Violation|1|||
125377371|NCT01683383|451012020|FG000|Overall Study|Infant was not transported|1|||
125377372|NCT01683383|451012021|FG001|Overall Study|Infant was not transported|0|||
125377373|NCT00855920|451012022|FG000|Overall Study|Protocol Violation|0|||
125377374|NCT00855920|451012023|FG001|Overall Study|Protocol Violation|0|||
125377375|NCT00855920|451012024|FG002|Overall Study|Protocol Violation|2|||
125377376|NCT00855920|451012022|FG000|Overall Study|Adverse Event|2|||
125377377|NCT00855920|451012023|FG001|Overall Study|Adverse Event|1|||
125377378|NCT00855920|451012024|FG002|Overall Study|Adverse Event|1|||
125377379|NCT00855920|451012022|FG000|Overall Study|Lack of Efficacy|2|||
125377380|NCT00855920|451012023|FG001|Overall Study|Lack of Efficacy|2|||
125377381|NCT00855920|451012024|FG002|Overall Study|Lack of Efficacy|2|||
125377382|NCT00855920|451012022|FG000|Overall Study|Withdrawal by Subject|2|||
125377383|NCT00855920|451012023|FG001|Overall Study|Withdrawal by Subject|3|||
125377384|NCT00855920|451012024|FG002|Overall Study|Withdrawal by Subject|2|||
125377385|NCT00855920|451012022|FG000|Overall Study|Lost to Follow-up|1|||
125377386|NCT00855920|451012023|FG001|Overall Study|Lost to Follow-up|0|||
125377387|NCT00855920|451012024|FG002|Overall Study|Lost to Follow-up|2|||
125377388|NCT00855920|451012022|FG000|Overall Study|Death|0|||
125377389|NCT00855920|451012023|FG001|Overall Study|Death|1|||
125377390|NCT00855920|451012024|FG002|Overall Study|Death|0|||
125377391|NCT00855920|451012022|FG000|Overall Study|Decision by the sponsor|0|||
125377392|NCT00855920|451012023|FG001|Overall Study|Decision by the sponsor|1|||
125377393|NCT00855920|451012024|FG002|Overall Study|Decision by the sponsor|1|||
125635661|NCT05171816|451948864|FG001|Overall Study|Death|16|||
125635662|NCT04667949|451948865|FG000|Overall Study|Adverse Event|0|||
125377394|NCT00855920|451012022|FG000|Overall Study|Other than specified above|1|||
125377395|NCT00855920|451012023|FG001|Overall Study|Other than specified above|1|||
125377396|NCT00855920|451012024|FG002|Overall Study|Other than specified above|1|||
125377397|NCT00996307|451012025|FG000|Overall Study|Adverse Event|0|||
125635663|NCT04667949|451948866|FG001|Overall Study|Adverse Event|2|||
125635664|NCT04667949|451948865|FG000|Overall Study|Lost to Follow-up|0|||
125377398|NCT00996307|451012026|FG001|Overall Study|Adverse Event|1|||
125377399|NCT00996307|451012027|FG002|Overall Study|Adverse Event|0|||
125377400|NCT00996307|451012028|FG003|Overall Study|Adverse Event|0|||
125377401|NCT00996307|451012025|FG000|Overall Study|Withdrawal by Subject|3|||
125377402|NCT00996307|451012026|FG001|Overall Study|Withdrawal by Subject|2|||
125377403|NCT00996307|451012027|FG002|Overall Study|Withdrawal by Subject|5|||
125635665|NCT04667949|451948866|FG001|Overall Study|Lost to Follow-up|1|||
125377404|NCT00996307|451012028|FG003|Overall Study|Withdrawal by Subject|5|||
125377405|NCT00996307|451012025|FG000|Overall Study|Lost to Follow-up|13|||
125377406|NCT00996307|451012026|FG001|Overall Study|Lost to Follow-up|13|||
125377407|NCT00996307|451012027|FG002|Overall Study|Lost to Follow-up|7|||
125377408|NCT00996307|451012028|FG003|Overall Study|Lost to Follow-up|15|||
125377409|NCT00996307|451012025|FG000|Overall Study|Administrative reason|0|||
125377410|NCT00996307|451012026|FG001|Overall Study|Administrative reason|1|||
125377411|NCT00996307|451012027|FG002|Overall Study|Administrative reason|0|||
125377412|NCT00996307|451012028|FG003|Overall Study|Administrative reason|0|||
125377413|NCT00996307|451012025|FG000|Overall Study|Unable to classify|4|||
125377414|NCT00996307|451012026|FG001|Overall Study|Unable to classify|0|||
125377415|NCT00996307|451012027|FG002|Overall Study|Unable to classify|2|||
125377416|NCT00996307|451012028|FG003|Overall Study|Unable to classify|1|||
125377417|NCT02496611|451012031|FG000|Overall Study|Lost to Follow-up|2|||
125377418|NCT02496611|451012032|FG001|Overall Study|Lost to Follow-up|1|||
125377419|NCT02496611|451012031|FG000|Overall Study|Withdrawal by Subject|5|||
125377420|NCT02496611|451012032|FG001|Overall Study|Withdrawal by Subject|2|||
125377421|NCT02850965|451012033|FG000|Overall Study|Other than listed|3|||
125377422|NCT02850965|451012034|FG001|Overall Study|Other than listed|4|||
125377423|NCT02850965|451012033|FG000|Overall Study|Protocol Violation|0|||
125130893|NCT00415363|450106446|FG001|Overall Study|Withdrawal by Subject|4|||
125130894|NCT00415363|450106445|FG000|Overall Study|Adverse Event|4|||
125130895|NCT00415363|450106446|FG001|Overall Study|Adverse Event|4|||
125130896|NCT00415363|450106445|FG000|Overall Study|Lost to Follow-up|2|||
125130897|NCT00415363|450106446|FG001|Overall Study|Lost to Follow-up|1|||
125130898|NCT00415363|450106445|FG000|Overall Study|Physician Decision|3|||
125377424|NCT02850965|451012034|FG001|Overall Study|Protocol Violation|2|||
125377425|NCT02850965|451012033|FG000|Overall Study|Lost to Follow-up|5|||
125377426|NCT02850965|451012034|FG001|Overall Study|Lost to Follow-up|3|||
125377427|NCT02850965|451012033|FG000|Overall Study|Lack of Efficacy|4|||
125130899|NCT00415363|450106446|FG001|Overall Study|Physician Decision|1|||
125130900|NCT00415363|450106445|FG000|Overall Study|Death|16|||
125130901|NCT00415363|450106446|FG001|Overall Study|Death|12|||
125130902|NCT00415363|450106445|FG000|Overall Study|Progressive disease|26|||
125130903|NCT00415363|450106446|FG001|Overall Study|Progressive disease|32|||
125130904|NCT00095212|450106451|FG000|Overall Study|Withdrawal by Subject|1|||
125130905|NCT00095212|450106452|FG001|Overall Study|Withdrawal by Subject|3|||
125130906|NCT02335658|450106453|FG000|Overall Study|Adverse Event|18|||
125130907|NCT02335658|450106454|FG001|Overall Study|Adverse Event|12|||
125130908|NCT02335658|450106453|FG000|Overall Study|Lack of Efficacy|4|||
125377428|NCT02850965|451012034|FG001|Overall Study|Lack of Efficacy|8|||
125377429|NCT02850965|451012033|FG000|Overall Study|Adverse Event|3|||
125130909|NCT02335658|450106454|FG001|Overall Study|Lack of Efficacy|5|||
125216833|NCT04378569|450421926|FG000|Overall Study|Lack of response|0|||
125216834|NCT04378569|450421927|FG001|Overall Study|Lack of response|0|||
125377430|NCT02850965|451012034|FG001|Overall Study|Adverse Event|2|||
125377431|NCT02850965|451012033|FG000|Overall Study|Withdrawal by Subject|3|||
125377432|NCT02850965|451012034|FG001|Overall Study|Withdrawal by Subject|4|||
125377433|NCT02850965|451012033|FG000|Overall Study|Physician Decision|0|||
125377434|NCT02850965|451012034|FG001|Overall Study|Physician Decision|1|||
125377435|NCT02850965|451012033|FG000|Overall Study|Randomized but not treated|0|||
125377436|NCT02850965|451012034|FG001|Overall Study|Randomized but not treated|1|||
125377437|NCT02788357|451012037|FG000|Overall Study|Lost to Follow-up|3|||
125377438|NCT02788357|451012038|FG001|Overall Study|Lost to Follow-up|0|||
125377439|NCT01365910|451012039|FG000|Overall Study|Withdrawal by Subject|7|||
125377440|NCT01365910|451012039|FG000|Overall Study|disease progression|18|||
125377441|NCT01365910|451012039|FG000|Overall Study|Adverse Event|3|||
125377442|NCT01365910|451012039|FG000|Overall Study|other complicating disease|1|||
125377443|NCT01365910|451012039|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
125377444|NCT00536198|451012040|FG000|Overall Study|Lost to Follow-up|15|||
125377445|NCT00536198|451012041|FG001|Overall Study|Lost to Follow-up|14|||
125377446|NCT00536198|451012040|FG000|Overall Study|Withdrawal by Subject|16|||
125377447|NCT00536198|451012041|FG001|Overall Study|Withdrawal by Subject|12|||
125377448|NCT00536198|451012040|FG000|Overall Study|Adverse Event|2|||
125130910|NCT02335658|450106453|FG000|Overall Study|Pregnancy|1|||
125130911|NCT02335658|450106454|FG001|Overall Study|Pregnancy|0|||
125130912|NCT02335658|450106453|FG000|Overall Study|Withdrawal by Subject|13|||
125216835|NCT04378569|450421928|FG002|Overall Study|Lack of response|1|||
125216836|NCT04378569|450421929|FG003|Overall Study|Lack of response|0|||
125377449|NCT00536198|451012041|FG001|Overall Study|Adverse Event|2|||
125377450|NCT00536198|451012040|FG000|Overall Study|Rescue|3|||
125377451|NCT00536198|451012041|FG001|Overall Study|Rescue|9|||
125377452|NCT00536198|451012040|FG000|Overall Study|Pregnancy|1|||
125377453|NCT00536198|451012041|FG001|Overall Study|Pregnancy|1|||
125377454|NCT00536198|451012040|FG000|Overall Study|Protocol Violation|0|||
125377455|NCT00536198|451012041|FG001|Overall Study|Protocol Violation|1|||
125377456|NCT02013791|451012042|FG000|Period 1|Lost to Follow-up|0|||
125377457|NCT02013791|451012043|FG001|Period 1|Lost to Follow-up|0|||
125377458|NCT02013791|451012044|FG002|Period 1|Lost to Follow-up|0|||
125377459|NCT02013791|451012045|FG003|Period 1|Lost to Follow-up|1|||
125377460|NCT02013791|451012046|FG004|Period 1|Lost to Follow-up|0|||
125377461|NCT02013791|451012047|FG005|Period 1|Lost to Follow-up|0|||
125377462|NCT02013791|451012048|FG006|Period 1|Lost to Follow-up|1|||
125377463|NCT02013791|451012049|FG007|Period 1|Lost to Follow-up|1|||
125377464|NCT02013791|451012050|FG008|Period 1|Lost to Follow-up|0|||
125377465|NCT02013791|451012042|FG000|Period 1|Other Miscellaneous Reasons|0|||
125377466|NCT02013791|451012043|FG001|Period 1|Other Miscellaneous Reasons|2|||
125377467|NCT02013791|451012044|FG002|Period 1|Other Miscellaneous Reasons|0|||
125377468|NCT02013791|451012045|FG003|Period 1|Other Miscellaneous Reasons|0|||
125377469|NCT02013791|451012046|FG004|Period 1|Other Miscellaneous Reasons|0|||
125377470|NCT02013791|451012047|FG005|Period 1|Other Miscellaneous Reasons|0|||
125377471|NCT02013791|451012048|FG006|Period 1|Other Miscellaneous Reasons|0|||
125377472|NCT02013791|451012049|FG007|Period 1|Other Miscellaneous Reasons|0|||
125377473|NCT02013791|451012050|FG008|Period 1|Other Miscellaneous Reasons|0|||
125377474|NCT03798483|451012051|FG000|Overall Study|Lost to Follow-up|2|||
125377475|NCT00640601|451012053|FG000|Overall Study|Adverse Event|43|||
125377476|NCT00640601|451012053|FG000|Overall Study|Withdrawal by Subject|20|||
125377477|NCT00640601|451012053|FG000|Overall Study|Protocol Violation|6|||
125377478|NCT00640601|451012053|FG000|Overall Study|Lack of Efficacy|16|||
125377479|NCT00640601|451012053|FG000|Overall Study|Lost to Follow-up|9|||
125377480|NCT00640601|451012053|FG000|Overall Study|Physician Decision|8|||
125377481|NCT00640601|451012053|FG000|Overall Study|treatment naive, combination therapy|10|||
125377482|NCT00833794|451012058|FG000|Open-label Phase|Adverse Event|225|||
125377483|NCT00833794|451012059|FG001|Open-label Phase|Adverse Event|0|||
125377484|NCT00833794|451012058|FG000|Open-label Phase|Lack of Efficacy|28|||
125377485|NCT00833794|451012059|FG001|Open-label Phase|Lack of Efficacy|0|||
125377486|NCT00833794|451012058|FG000|Open-label Phase|Withdrawal by Subject|48|||
125377487|NCT00833794|451012059|FG001|Open-label Phase|Withdrawal by Subject|0|||
125377488|NCT00833794|451012058|FG000|Open-label Phase|Physician Decision|20|||
125377489|NCT00833794|451012059|FG001|Open-label Phase|Physician Decision|0|||
125377490|NCT00833794|451012058|FG000|Open-label Phase|Administrative reason|1|||
125377491|NCT00833794|451012059|FG001|Open-label Phase|Administrative reason|0|||
125635666|NCT04667949|451948865|FG000|Overall Study|Physician Decision|0|||
125635667|NCT04667949|451948866|FG001|Overall Study|Physician Decision|2|||
125635668|NCT04667949|451948865|FG000|Overall Study|Subject decision|1|||
125635669|NCT04667949|451948866|FG001|Overall Study|Subject decision|7|||
125635670|NCT02000622|451948867|FG000|Overall Study|Withdrawal by Subject|5|||
125635671|NCT02000622|451948868|FG001|Overall Study|Withdrawal by Subject|7|||
125635672|NCT02000622|451948867|FG000|Overall Study|Lost to Follow-up|4|||
125130913|NCT02335658|450106454|FG001|Overall Study|Withdrawal by Subject|21|||
125130914|NCT02335658|450106453|FG000|Overall Study|non-compliance|2|||
125130915|NCT02335658|450106454|FG001|Overall Study|non-compliance|3|||
125130916|NCT02335658|450106453|FG000|Overall Study|other reason|2|||
125130917|NCT02335658|450106454|FG001|Overall Study|other reason|3|||
125130918|NCT05341622|450106455|FG000|Overall Study|Death|0|||
125130919|NCT05341622|450106456|FG001|Overall Study|Death|0|||
125130920|NCT05341622|450106457|FG002|Overall Study|Death|0|||
125130921|NCT05341622|450106458|FG003|Overall Study|Death|0|||
125130922|NCT05341622|450106459|FG004|Overall Study|Death|1|||
125130923|NCT05341622|450106460|FG005|Overall Study|Death|0|||
125130924|NCT05341622|450106461|FG006|Overall Study|Death|0|||
125130925|NCT05341622|450106462|FG007|Overall Study|Death|1|||
125130926|NCT05341622|450106455|FG000|Overall Study|Invalid Address|0|||
125130927|NCT05341622|450106456|FG001|Overall Study|Invalid Address|1|||
125130928|NCT05341622|450106457|FG002|Overall Study|Invalid Address|0|||
125130929|NCT05341622|450106458|FG003|Overall Study|Invalid Address|0|||
125130930|NCT05341622|450106459|FG004|Overall Study|Invalid Address|0|||
125130931|NCT05341622|450106460|FG005|Overall Study|Invalid Address|0|||
125130932|NCT05341622|450106461|FG006|Overall Study|Invalid Address|0|||
125130933|NCT05341622|450106462|FG007|Overall Study|Invalid Address|0|||
125130934|NCT05341622|450106455|FG000|Overall Study|Ineligible|26|||
125130935|NCT05341622|450106456|FG001|Overall Study|Ineligible|21|||
125130936|NCT05341622|450106457|FG002|Overall Study|Ineligible|28|||
125130937|NCT05341622|450106458|FG003|Overall Study|Ineligible|24|||
125130938|NCT05341622|450106459|FG004|Overall Study|Ineligible|29|||
125130939|NCT05341622|450106460|FG005|Overall Study|Ineligible|31|||
125130940|NCT05341622|450106461|FG006|Overall Study|Ineligible|28|||
125130941|NCT05341622|450106462|FG007|Overall Study|Ineligible|26|||
125130942|NCT02658084|450106463|FG000|Overall Study|Withdrawal by Subject|1|||
125130943|NCT02658084|450106464|FG001|Overall Study|Withdrawal by Subject|0|||
125130944|NCT02658084|450106463|FG000|Overall Study|Study Termination|1|||
125130945|NCT02658084|450106464|FG001|Overall Study|Study Termination|0|||
125130946|NCT02305758|450106465|FG000|Overall Study|Death|27|||
125130947|NCT02305758|450106466|FG001|Overall Study|Death|27|||
125130948|NCT02305758|450106465|FG000|Overall Study|Withdrew consent|9|||
125377492|NCT00833794|451012058|FG000|Open-label Phase|Protocol Violation|47|||
125377493|NCT00833794|451012059|FG001|Open-label Phase|Protocol Violation|0|||
125377494|NCT00833794|451012058|FG000|Open-label Phase|Did not complete wash-out period|12|||
125377495|NCT00833794|451012059|FG001|Open-label Phase|Did not complete wash-out period|0|||
125377496|NCT00833794|451012058|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
125635673|NCT02000622|451948868|FG001|Overall Study|Lost to Follow-up|0|||
125635674|NCT02000622|451948867|FG000|Overall Study|Death|159|||
125635675|NCT02000622|451948868|FG001|Overall Study|Death|73|||
125377497|NCT00833794|451012059|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
125377498|NCT00833794|451012058|FG000|Double-blind Phase|Adverse Event|44|||
125377499|NCT00833794|451012059|FG001|Double-blind Phase|Adverse Event|11|||
125377500|NCT00833794|451012058|FG000|Double-blind Phase|Lack of Efficacy|34|||
125377501|NCT00833794|451012059|FG001|Double-blind Phase|Lack of Efficacy|22|||
125377502|NCT00833794|451012058|FG000|Double-blind Phase|Withdrawal by Subject|23|||
125377503|NCT00833794|451012059|FG001|Double-blind Phase|Withdrawal by Subject|6|||
125377504|NCT00833794|451012058|FG000|Double-blind Phase|Physician Decision|4|||
125377505|NCT00833794|451012059|FG001|Double-blind Phase|Physician Decision|7|||
125377506|NCT00833794|451012058|FG000|Double-blind Phase|Administrative reason|1|||
125377507|NCT00833794|451012059|FG001|Double-blind Phase|Administrative reason|3|||
125377508|NCT00679302|451012060|FG000|Overall Study|Lost to Follow-up|8|||
125377509|NCT00679302|451012061|FG001|Overall Study|Lost to Follow-up|4|||
125377510|NCT03031678|451012063|FG000|Overall Study|Study closed prior to completion|1|||
125377511|NCT01753856|451012064|FG000|Overall Study|Adverse Event|1|||
125377512|NCT01753856|451012065|FG001|Overall Study|Adverse Event|0|||
125377513|NCT01753856|451012064|FG000|Overall Study|Withdrawal by Subject|0|||
125377514|NCT01753856|451012065|FG001|Overall Study|Withdrawal by Subject|2|||
125377515|NCT01753856|451012064|FG000|Overall Study|Sponsor Decision|2|||
125377516|NCT01753856|451012065|FG001|Overall Study|Sponsor Decision|0|||
125377517|NCT00434330|451012066|FG000|Overall Study|Adverse Event|0|||
125635676|NCT02000622|451948867|FG000|Overall Study|Withdrawn due to site closure|1|||
125635677|NCT02000622|451948868|FG001|Overall Study|Withdrawn due to site closure|0|||
125635678|NCT01405027|451948869|FG000|Overall Study|Withdrawn consent|3|||
125635679|NCT01405027|451948870|FG001|Overall Study|Withdrawn consent|0|||
125635680|NCT01405027|451948869|FG000|Overall Study|Lost to Follow-up|16|||
125635681|NCT01405027|451948870|FG001|Overall Study|Lost to Follow-up|24|||
125635682|NCT01405027|451948869|FG000|Overall Study|Investigator judgement|0|||
125635683|NCT01405027|451948870|FG001|Overall Study|Investigator judgement|2|||
125635684|NCT01405027|451948869|FG000|Overall Study|Death|1|||
125635685|NCT01405027|451948870|FG001|Overall Study|Death|0|||
125635686|NCT01405027|451948869|FG000|Overall Study|Other or Unknown|12|||
125635687|NCT01405027|451948870|FG001|Overall Study|Other or Unknown|25|||
125635688|NCT03728881|451948877|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
125635689|NCT03728881|451948878|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
125635690|NCT03728881|451948877|FG000|Enrolled and Received 1st Vaccination|Death|1|||
125635691|NCT03728881|451948878|FG001|Enrolled and Received 1st Vaccination|Death|1|||
125635692|NCT03728881|451948877|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
125635693|NCT03728881|451948878|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
125635694|NCT03728881|451948877|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
125635695|NCT03728881|451948878|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
125635696|NCT03728881|451948877|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
125635697|NCT03728881|451948878|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
125635698|NCT03728881|451948877|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
125635699|NCT03728881|451948878|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
125635700|NCT03728881|451948877|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
125635701|NCT03728881|451948878|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
125635702|NCT03728881|451948877|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
125635703|NCT03728881|451948878|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
125635704|NCT03728881|451948877|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
125635705|NCT03728881|451948878|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
125635706|NCT03728881|451948877|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
125635707|NCT03728881|451948878|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
125635708|NCT03728881|451948877|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
125635709|NCT03728881|451948878|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
125635710|NCT00413777|451948879|FG000|Fixed-dose Period|Lost to Follow-up|1|||
125635711|NCT00413777|451948880|FG001|Fixed-dose Period|Lost to Follow-up|1|||
125635712|NCT00413777|451948879|FG000|Fixed-dose Period|Adverse Event|2|||
125635713|NCT00413777|451948880|FG001|Fixed-dose Period|Adverse Event|1|||
125635714|NCT00413777|451948879|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
125635715|NCT00413777|451948880|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
125635716|NCT00413777|451948879|FG000|Fixed-dose Period|Withdrew Consent|0|||
125635717|NCT00413777|451948880|FG001|Fixed-dose Period|Withdrew Consent|1|||
125377518|NCT00434330|451012067|FG001|Overall Study|Adverse Event|0|||
125377519|NCT00434330|451012068|FG002|Overall Study|Adverse Event|1|||
125377520|NCT00434330|451012069|FG003|Overall Study|Adverse Event|0|||
125377521|NCT00434330|451012070|FG004|Overall Study|Adverse Event|0|||
125635718|NCT04088331|451948881|FG000|Overall Study|Lost to Follow-up|3|||
125635719|NCT04088331|451948881|FG000|Overall Study|Withdrawal by Subject|7|||
125635720|NCT04088331|451948881|FG000|Overall Study|Adverse Event|4|||
125635721|NCT02155712|451948888|FG000|Overall Study|Death|12|||
125635722|NCT02155712|451948889|FG001|Overall Study|Death|0|||
125635723|NCT02155712|451948888|FG000|Overall Study|Lost to Follow-up|37|||
125635724|NCT02155712|451948889|FG001|Overall Study|Lost to Follow-up|22|||
125635725|NCT02155712|451948888|FG000|Overall Study|Revision of device|4|||
125635726|NCT02155712|451948889|FG001|Overall Study|Revision of device|3|||
125377522|NCT00434330|451012071|FG005|Overall Study|Adverse Event|0|||
125377523|NCT00434330|451012066|FG000|Overall Study|Death|1|||
125377524|NCT00434330|451012067|FG001|Overall Study|Death|0|||
125377525|NCT00434330|451012068|FG002|Overall Study|Death|0|||
125377526|NCT00434330|451012069|FG003|Overall Study|Death|0|||
125377527|NCT00434330|451012070|FG004|Overall Study|Death|1|||
125377528|NCT00434330|451012071|FG005|Overall Study|Death|1|||
125377529|NCT00434330|451012066|FG000|Overall Study|Withdrawal by Subject|0|||
125377530|NCT00434330|451012067|FG001|Overall Study|Withdrawal by Subject|0|||
125377531|NCT00434330|451012068|FG002|Overall Study|Withdrawal by Subject|1|||
125377532|NCT00434330|451012069|FG003|Overall Study|Withdrawal by Subject|1|||
125377533|NCT00434330|451012070|FG004|Overall Study|Withdrawal by Subject|0|||
125377534|NCT00434330|451012071|FG005|Overall Study|Withdrawal by Subject|0|||
125377535|NCT00434330|451012066|FG000|Overall Study|Renal transplant|0|||
125377536|NCT00434330|451012067|FG001|Overall Study|Renal transplant|0|||
125377537|NCT00434330|451012068|FG002|Overall Study|Renal transplant|0|||
125377538|NCT00434330|451012069|FG003|Overall Study|Renal transplant|1|||
125377539|NCT00434330|451012070|FG004|Overall Study|Renal transplant|0|||
125377540|NCT00434330|451012071|FG005|Overall Study|Renal transplant|0|||
125377541|NCT00434330|451012066|FG000|Overall Study|Subject Not Compliant With Study|0|||
125377542|NCT00434330|451012067|FG001|Overall Study|Subject Not Compliant With Study|0|||
125377543|NCT00434330|451012068|FG002|Overall Study|Subject Not Compliant With Study|1|||
125377544|NCT00434330|451012069|FG003|Overall Study|Subject Not Compliant With Study|0|||
125377545|NCT00434330|451012070|FG004|Overall Study|Subject Not Compliant With Study|0|||
125377546|NCT00434330|451012071|FG005|Overall Study|Subject Not Compliant With Study|0|||
125377547|NCT05109442|451012074|FG000|Overall Study|Withdrawal by Subject|0|||
125377548|NCT05109442|451012075|FG001|Overall Study|Withdrawal by Subject|0|||
125377549|NCT05109442|451012076|FG002|Overall Study|Withdrawal by Subject|1|||
125377550|NCT05109442|451012077|FG003|Overall Study|Withdrawal by Subject|0|||
125377551|NCT05109442|451012078|FG004|Overall Study|Withdrawal by Subject|0|||
125377552|NCT05109442|451012079|FG005|Overall Study|Withdrawal by Subject|0|||
125377553|NCT05109442|451012074|FG000|Overall Study|Adverse Event|0|||
125377554|NCT05109442|451012075|FG001|Overall Study|Adverse Event|1|||
125377555|NCT05109442|451012076|FG002|Overall Study|Adverse Event|5|||
125377556|NCT05109442|451012077|FG003|Overall Study|Adverse Event|0|||
125377557|NCT05109442|451012078|FG004|Overall Study|Adverse Event|0|||
125377558|NCT05109442|451012079|FG005|Overall Study|Adverse Event|2|||
125377559|NCT05109442|451012074|FG000|Overall Study|Death|0|||
125377560|NCT05109442|451012075|FG001|Overall Study|Death|0|||
125377561|NCT05109442|451012076|FG002|Overall Study|Death|4|||
125377562|NCT05109442|451012077|FG003|Overall Study|Death|0|||
125377563|NCT05109442|451012078|FG004|Overall Study|Death|0|||
125377564|NCT05109442|451012079|FG005|Overall Study|Death|1|||
125377565|NCT05109442|451012074|FG000|Overall Study|Physician Decision|1|||
125377566|NCT05109442|451012075|FG001|Overall Study|Physician Decision|0|||
125377567|NCT05109442|451012076|FG002|Overall Study|Physician Decision|1|||
125377568|NCT05109442|451012077|FG003|Overall Study|Physician Decision|0|||
125377569|NCT05109442|451012078|FG004|Overall Study|Physician Decision|0|||
125377570|NCT05109442|451012079|FG005|Overall Study|Physician Decision|2|||
125377571|NCT05109442|451012074|FG000|Overall Study|Other than listed|0|||
125377572|NCT05109442|451012075|FG001|Overall Study|Other than listed|0|||
125377573|NCT05109442|451012076|FG002|Overall Study|Other than listed|9|||
125377574|NCT05109442|451012077|FG003|Overall Study|Other than listed|2|||
125377575|NCT05109442|451012078|FG004|Overall Study|Other than listed|0|||
125377576|NCT05109442|451012079|FG005|Overall Study|Other than listed|8|||
125635727|NCT02155712|451948888|FG000|Overall Study|Withdrawal by Subject|39|||
125377577|NCT05109442|451012074|FG000|Overall Study|Lack of Efficacy|3|||
125377578|NCT05109442|451012075|FG001|Overall Study|Lack of Efficacy|5|||
125377579|NCT05109442|451012076|FG002|Overall Study|Lack of Efficacy|29|||
125377580|NCT05109442|451012077|FG003|Overall Study|Lack of Efficacy|10|||
125377581|NCT05109442|451012078|FG004|Overall Study|Lack of Efficacy|11|||
125377582|NCT05109442|451012079|FG005|Overall Study|Lack of Efficacy|17|||
125377583|NCT04853225|451012080|FG000|Overall Study|Withdrawal by Subject|81|||
125377584|NCT04853225|451012081|FG001|Overall Study|Withdrawal by Subject|4|||
125377585|NCT04853225|451012082|FG002|Overall Study|Withdrawal by Subject|1|||
125377586|NCT04853225|451012080|FG000|Overall Study|Physician Decision|12|||
125377587|NCT04853225|451012081|FG001|Overall Study|Physician Decision|4|||
125377588|NCT04853225|451012082|FG002|Overall Study|Physician Decision|1|||
125635728|NCT02155712|451948889|FG001|Overall Study|Withdrawal by Subject|21|||
125635729|NCT02155712|451948888|FG000|Overall Study|Site termination|77|||
125377589|NCT04853225|451012080|FG000|Overall Study|Lost to Follow-up|50|||
125635730|NCT02155712|451948889|FG001|Overall Study|Site termination|19|||
125635731|NCT02155712|451948888|FG000|Overall Study|Sponsor terminated study early|150|||
125635732|NCT02155712|451948889|FG001|Overall Study|Sponsor terminated study early|0|||
125635733|NCT02155712|451948888|FG000|Overall Study|Missed final 5-year protocol visit|0|||
125635734|NCT02155712|451948889|FG001|Overall Study|Missed final 5-year protocol visit|32|||
125635735|NCT02155712|451948888|FG000|Overall Study|Censored because surgery cancelled|6|||
125635736|NCT02155712|451948889|FG001|Overall Study|Censored because surgery cancelled|10|||
125635737|NCT02155712|451948888|FG000|Overall Study|Censored because study device was not implanted|61|||
125635738|NCT02155712|451948889|FG001|Overall Study|Censored because study device was not implanted|66|||
125635739|NCT02155712|451948888|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
125635740|NCT02155712|451948889|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
125635741|NCT02756845|451948893|FG000|Overall Study|Death|12|||
125635742|NCT02756845|451948894|FG001|Overall Study|Death|2|||
125635743|NCT02756845|451948893|FG000|Overall Study|Withdrawal by Subject|1|||
125635744|NCT02756845|451948894|FG001|Overall Study|Withdrawal by Subject|0|||
125635745|NCT01688999|451948895|FG000|Overall Study|Withdrawal by Subject|5|||
125635746|NCT01688999|451948896|FG001|Overall Study|Withdrawal by Subject|1|||
125635747|NCT01688999|451948897|FG002|Overall Study|Withdrawal by Subject|1|||
125635748|NCT01688999|451948895|FG000|Overall Study|Adverse Event|2|||
125635749|NCT01688999|451948896|FG001|Overall Study|Adverse Event|0|||
125635750|NCT01688999|451948897|FG002|Overall Study|Adverse Event|2|||
125635751|NCT01688999|451948895|FG000|Overall Study|Ineligible/Not treated|1|||
125130949|NCT02305758|450106466|FG001|Overall Study|Withdrew consent|2|||
125130950|NCT02305758|450106465|FG000|Overall Study|Lost to Follow-up|6|||
125130951|NCT02305758|450106466|FG001|Overall Study|Lost to Follow-up|1|||
125130952|NCT02305758|450106465|FG000|Overall Study|Study Terminated by Sponsor|21|||
125130953|NCT02305758|450106466|FG001|Overall Study|Study Terminated by Sponsor|34|||
125130954|NCT02305758|450106465|FG000|Overall Study|Other, not specified|2|||
125130955|NCT02305758|450106466|FG001|Overall Study|Other, not specified|1|||
125130956|NCT02032888|450106469|FG000|Treatment Period|Poor compliance/noncompliance|1|||
125377590|NCT04853225|451012081|FG001|Overall Study|Lost to Follow-up|0|||
125377591|NCT04853225|451012082|FG002|Overall Study|Lost to Follow-up|0|||
125377592|NCT04853225|451012080|FG000|Overall Study|Other|102|||
125377593|NCT04853225|451012081|FG001|Overall Study|Other|11|||
125377594|NCT04853225|451012082|FG002|Overall Study|Other|5|||
125377595|NCT04853225|451012080|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
125377596|NCT04853225|451012081|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
125635752|NCT01688999|451948896|FG001|Overall Study|Ineligible/Not treated|0|||
125635753|NCT01688999|451948897|FG002|Overall Study|Ineligible/Not treated|0|||
125635754|NCT01025232|451948914|FG000|Overall Study|Study drug no longer available|3|||
125635755|NCT01025232|451948915|FG001|Overall Study|Study drug no longer available|6|||
125635756|NCT04051944|451948918|FG000|Overall Study|Study ending|1|||
125635757|NCT04051944|451948919|FG001|Overall Study|Study ending|1|||
125635758|NCT04051944|451948918|FG000|Overall Study|Early study termination by participant|1|||
125635759|NCT04051944|451948919|FG001|Overall Study|Early study termination by participant|0|||
125635760|NCT04051944|451948918|FG000|Overall Study|Withdrawal by Subject|2|||
125635761|NCT04051944|451948919|FG001|Overall Study|Withdrawal by Subject|2|||
125635762|NCT04051944|451948918|FG000|Overall Study|Lack of Efficacy|3|||
125635763|NCT04051944|451948919|FG001|Overall Study|Lack of Efficacy|0|||
125635764|NCT04051944|451948918|FG000|Overall Study|Adverse event, non- fatal|1|||
125635765|NCT04051944|451948919|FG001|Overall Study|Adverse event, non- fatal|1|||
125635766|NCT00736450|451948920|FG000|Overall Study|Not ABC gene eligible|19|||
125635767|NCT00736450|451948920|FG000|Overall Study|Withdrawal by Subject|5|||
125635768|NCT00736450|451948920|FG000|Overall Study|Physician Decision|1|||
125635769|NCT01313039|451948921|FG000|Overall Study|Physician Decision|1|||
125635770|NCT01313039|451948921|FG000|Overall Study|Adverse Event|1|||
125635771|NCT04228445|451948928|FG000|Overall Study|Lost to Follow-up|1|||
125635772|NCT04228445|451948929|FG001|Overall Study|Lost to Follow-up|1|||
125635773|NCT04228445|451948928|FG000|Overall Study|Physician Decision|1|||
125635774|NCT04228445|451948929|FG001|Overall Study|Physician Decision|2|||
125130957|NCT02032888|450106470|FG001|Treatment Period|Poor compliance/noncompliance|1|||
125130958|NCT02032888|450106471|FG002|Treatment Period|Poor compliance/noncompliance|0|||
125378963|NCT00799487|451019224|FG002|Dose Adjustment Period|Investigator Discretion|0|||
125635775|NCT04228445|451948928|FG000|Overall Study|Withdrawal by Subject|0|||
125635776|NCT04228445|451948929|FG001|Overall Study|Withdrawal by Subject|1|||
125635777|NCT04228445|451948928|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
125635778|NCT04228445|451948929|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
125635779|NCT01316380|451948935|FG000|Overall Study|Adverse Event|0|||
125635780|NCT01316380|451948936|FG001|Overall Study|Adverse Event|2|||
125635781|NCT01316380|451948937|FG002|Overall Study|Adverse Event|1|||
125130959|NCT02032888|450106469|FG000|Treatment Period|Other|1|||
125635782|NCT01316380|451948935|FG000|Overall Study|Protocol Violation|0|||
125635783|NCT01316380|451948936|FG001|Overall Study|Protocol Violation|0|||
125635784|NCT01316380|451948937|FG002|Overall Study|Protocol Violation|1|||
125377597|NCT04853225|451012082|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
125377598|NCT04853225|451012080|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
125377599|NCT04853225|451012081|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
125377600|NCT04853225|451012082|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
125377601|NCT05355805|451012083|FG000|Overall Study|Lost to Follow-up|6|||
125377602|NCT05355805|451012084|FG001|Overall Study|Lost to Follow-up|11|||
125377603|NCT05355805|451012085|FG002|Overall Study|Lost to Follow-up|10|||
125377604|NCT05355805|451012086|FG003|Overall Study|Lost to Follow-up|6|||
125377605|NCT05355805|451012083|FG000|Overall Study|Decision by Sponsor|0|||
125377606|NCT05355805|451012084|FG001|Overall Study|Decision by Sponsor|0|||
125377607|NCT05355805|451012085|FG002|Overall Study|Decision by Sponsor|1|||
125377608|NCT05355805|451012086|FG003|Overall Study|Decision by Sponsor|0|||
125377609|NCT05355805|451012083|FG000|Overall Study|Withdrawal by Subject|7|||
125377610|NCT05355805|451012084|FG001|Overall Study|Withdrawal by Subject|14|||
125377611|NCT05355805|451012085|FG002|Overall Study|Withdrawal by Subject|15|||
125377612|NCT05355805|451012086|FG003|Overall Study|Withdrawal by Subject|13|||
125377613|NCT02167893|451012087|FG000|Overall Study|Investigator transferred|85|||
125377614|NCT02167893|451012087|FG000|Overall Study|Investigator health reasons|10|||
125377615|NCT02167893|451012087|FG000|Overall Study|Case report forms not collected|68|||
125377616|NCT04818840|451012088|FG000|Overall Study|Lost to Follow-up|0|||
125377617|NCT04818840|451012089|FG001|Overall Study|Lost to Follow-up|5|||
125377618|NCT04818840|451012088|FG000|Overall Study|Physician Decision|1|||
125216837|NCT04378569|450421930|FG004|Overall Study|Lack of response|1|||
125216838|NCT04378569|450421931|FG005|Overall Study|Lack of response|1|||
125635785|NCT01316380|451948935|FG000|Overall Study|Withdrawal by Subject|1|||
125635786|NCT01316380|451948936|FG001|Overall Study|Withdrawal by Subject|2|||
125635787|NCT01316380|451948937|FG002|Overall Study|Withdrawal by Subject|0|||
125635788|NCT01316380|451948935|FG000|Overall Study|Other|0|||
125635789|NCT01316380|451948936|FG001|Overall Study|Other|1|||
125635790|NCT01316380|451948937|FG002|Overall Study|Other|1|||
125216839|NCT01962948|450421932|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
125216840|NCT01962948|450421933|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
125216841|NCT01962948|450421934|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
125216842|NCT01962948|450421935|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
125216843|NCT03630705|450421936|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
125216844|NCT03630705|450421937|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
125216845|NCT03630705|450421938|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
125216846|NCT03630705|450421939|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125635791|NCT01316380|451948935|FG000|Overall Study|Not treated|1|||
125635792|NCT01316380|451948936|FG001|Overall Study|Not treated|0|||
125635793|NCT01316380|451948937|FG002|Overall Study|Not treated|0|||
125635794|NCT01894776|451948938|FG000|Overall Study|Withdrawal by Subject|1|||
125635795|NCT03512275|451948939|FG000|Overall Study|Withdrawal by Subject|1|||
125635796|NCT03512275|451948940|FG001|Overall Study|Withdrawal by Subject|3|||
125635797|NCT03512275|451948939|FG000|Overall Study|Physician Decision|0|||
125635798|NCT03512275|451948940|FG001|Overall Study|Physician Decision|1|||
125635799|NCT03512275|451948939|FG000|Overall Study|Lost to Follow-up|0|||
125635800|NCT03512275|451948940|FG001|Overall Study|Lost to Follow-up|3|||
125635801|NCT03512275|451948939|FG000|Overall Study|Other|1|||
125635802|NCT03512275|451948940|FG001|Overall Study|Other|0|||
125635803|NCT01307046|451948941|FG000|Overall Study|Adverse Event|3|||
125635804|NCT01307046|451948942|FG001|Overall Study|Adverse Event|3|||
125635805|NCT01307046|451948941|FG000|Overall Study|Lack of Efficacy|0|||
125635806|NCT01307046|451948942|FG001|Overall Study|Lack of Efficacy|2|||
125635807|NCT01307046|451948941|FG000|Overall Study|Physician Decision|2|||
125635808|NCT01307046|451948942|FG001|Overall Study|Physician Decision|0|||
125635809|NCT01307046|451948941|FG000|Overall Study|Withdrawal by Subject|1|||
125377619|NCT04818840|451012089|FG001|Overall Study|Physician Decision|0|||
125377620|NCT04818840|451012088|FG000|Overall Study|Site Terminated by Sponsor|0|||
125216847|NCT03630705|450421936|FG000|Overall Study|Lost to Follow-up|1|||
125377621|NCT04818840|451012089|FG001|Overall Study|Site Terminated by Sponsor|3|||
125377622|NCT04818840|451012088|FG000|Overall Study|Study Terminated by Sponsor|43|||
125377623|NCT04818840|451012089|FG001|Overall Study|Study Terminated by Sponsor|7|||
125635810|NCT01307046|451948942|FG001|Overall Study|Withdrawal by Subject|1|||
125635811|NCT01307046|451948941|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
125635812|NCT01307046|451948942|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
125635813|NCT01307046|451948941|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
125635814|NCT01307046|451948942|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
125635815|NCT00609167|451948943|FG000|Overall Study|Withdrawal by Subject|1|||
125635816|NCT00609167|451948944|FG001|Overall Study|Withdrawal by Subject|0|||
125635817|NCT00609167|451948943|FG000|Overall Study|Lack of Efficacy|1|||
125635818|NCT00609167|451948944|FG001|Overall Study|Lack of Efficacy|0|||
125635819|NCT00609167|451948943|FG000|Overall Study|Adverse Event|5|||
125635820|NCT00609167|451948944|FG001|Overall Study|Adverse Event|1|||
125635821|NCT00609167|451948943|FG000|Overall Study|Disease Progression|1|||
125635822|NCT00609167|451948944|FG001|Overall Study|Disease Progression|0|||
125635823|NCT00609167|451948943|FG000|Overall Study|Stem Cell Transplant|0|||
125635824|NCT00609167|451948944|FG001|Overall Study|Stem Cell Transplant|6|||
125635825|NCT02574520|451948945|FG000|Overall Study|Not dosed|2|||
125635826|NCT02574520|451948946|FG001|Overall Study|Not dosed|0|||
125635827|NCT02574520|451948947|FG002|Overall Study|Not dosed|5|||
125635828|NCT02574520|451948948|FG003|Overall Study|Not dosed|4|||
125635829|NCT02574520|451948945|FG000|Overall Study|Adverse Event|0|||
125635830|NCT02574520|451948946|FG001|Overall Study|Adverse Event|0|||
125635831|NCT02574520|451948947|FG002|Overall Study|Adverse Event|0|||
125635832|NCT02574520|451948948|FG003|Overall Study|Adverse Event|1|||
125635833|NCT02574520|451948945|FG000|Overall Study|Withdrawal by Subject|0|||
125635834|NCT02574520|451948946|FG001|Overall Study|Withdrawal by Subject|0|||
125635835|NCT02574520|451948947|FG002|Overall Study|Withdrawal by Subject|0|||
125635836|NCT02574520|451948948|FG003|Overall Study|Withdrawal by Subject|1|||
125635837|NCT02574520|451948945|FG000|Overall Study|Other|0|||
125635838|NCT02574520|451948946|FG001|Overall Study|Other|0|||
125635839|NCT02574520|451948947|FG002|Overall Study|Other|0|||
125635840|NCT02574520|451948948|FG003|Overall Study|Other|2|||
125635841|NCT01365091|451948951|FG000|Period 1|Adverse Event|1|||
125635842|NCT01365091|451948952|FG001|Period 1|Adverse Event|0|||
125635843|NCT01365091|451948953|FG002|Period 1|Adverse Event|2|||
125635844|NCT01365091|451948954|FG003|Period 1|Adverse Event|3|||
125635845|NCT01365091|451948951|FG000|Period 1|Positive test result for drugs of abuse|1|||
125635846|NCT01365091|451948952|FG001|Period 1|Positive test result for drugs of abuse|0|||
125635847|NCT01365091|451948953|FG002|Period 1|Positive test result for drugs of abuse|0|||
125635848|NCT01365091|451948954|FG003|Period 1|Positive test result for drugs of abuse|0|||
125635849|NCT01365091|451948951|FG000|Period 1|No longer met study criteria|0|||
125635850|NCT01365091|451948952|FG001|Period 1|No longer met study criteria|1|||
125635851|NCT01365091|451948953|FG002|Period 1|No longer met study criteria|0|||
125635852|NCT01365091|451948954|FG003|Period 1|No longer met study criteria|0|||
125635853|NCT01365091|451948951|FG000|Period 1|Withdrawal by Subject|0|||
125635854|NCT01365091|451948952|FG001|Period 1|Withdrawal by Subject|1|||
125130960|NCT02032888|450106470|FG001|Treatment Period|Other|1|||
125130961|NCT02032888|450106471|FG002|Treatment Period|Other|0|||
125130962|NCT02032888|450106469|FG000|Follow-up Period|Lost to Follow-up|1|||
125130963|NCT02032888|450106470|FG001|Follow-up Period|Lost to Follow-up|1|||
125130964|NCT02032888|450106471|FG002|Follow-up Period|Lost to Follow-up|0|||
125130965|NCT02032888|450106469|FG000|Follow-up Period|Death|1|||
125130966|NCT02032888|450106470|FG001|Follow-up Period|Death|1|||
125130967|NCT02032888|450106471|FG002|Follow-up Period|Death|0|||
125130968|NCT02032888|450106469|FG000|Follow-up Period|Other|1|||
125130969|NCT02032888|450106470|FG001|Follow-up Period|Other|0|||
125130970|NCT02032888|450106471|FG002|Follow-up Period|Other|0|||
125130971|NCT03616106|450106474|FG000|Overall Study|Removed by PI|6|||
125130972|NCT03616106|450106475|FG001|Overall Study|Removed by PI|0|||
125130973|NCT03616106|450106474|FG000|Overall Study|Withdrawal by Subject|1|||
125130974|NCT03616106|450106475|FG001|Overall Study|Withdrawal by Subject|1|||
125130975|NCT03616106|450106474|FG000|Overall Study|Lost to Follow-up|7|||
125130976|NCT03616106|450106475|FG001|Overall Study|Lost to Follow-up|0|||
125130977|NCT03206177|450106477|FG000|Overall Study|Withdrawal by Subject|1|||
125130978|NCT04611789|450106479|FG000|Overall Study|Lost to Follow-up|1|||
125130979|NCT04611789|450106480|FG001|Overall Study|Lost to Follow-up|0|||
125130980|NCT04611789|450106481|FG002|Overall Study|Lost to Follow-up|0|||
125130981|NCT03880266|450106482|FG000|Overall Study|Withdrawal by Subject|0|||
125130982|NCT03880266|450106483|FG001|Overall Study|Withdrawal by Subject|1|||
125130983|NCT03880266|450106484|FG002|Overall Study|Withdrawal by Subject|1|||
125130984|NCT03880266|450106485|FG003|Overall Study|Withdrawal by Subject|0|||
125130985|NCT03880266|450106486|FG004|Overall Study|Withdrawal by Subject|0|||
125130986|NCT03880266|450106487|FG005|Overall Study|Withdrawal by Subject|0|||
125130987|NCT03880266|450106488|FG006|Overall Study|Withdrawal by Subject|0|||
125130988|NCT03880266|450106489|FG007|Overall Study|Withdrawal by Subject|0|||
125130989|NCT03161405|450106490|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
125130990|NCT00837486|450106491|FG000|Blinded-treatment Phase|Physician Decision|1|||
125130991|NCT00837486|450106492|FG001|Blinded-treatment Phase|Physician Decision|0|||
125130992|NCT00837486|450106491|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
125130993|NCT00837486|450106492|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
125130994|NCT00837486|450106491|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
125130995|NCT00837486|450106492|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
125130996|NCT00837486|450106491|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
125130997|NCT00837486|450106492|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
125130998|NCT02655679|450106493|FG000|Overall Study|Adverse Event|0|||
125130999|NCT02655679|450106494|FG001|Overall Study|Adverse Event|1|||
125635855|NCT01365091|451948953|FG002|Period 1|Withdrawal by Subject|0|||
125635856|NCT01365091|451948954|FG003|Period 1|Withdrawal by Subject|0|||
125377624|NCT04818840|451012088|FG000|Overall Study|Withdrawal by Subject|0|||
125377625|NCT04818840|451012089|FG001|Overall Study|Withdrawal by Subject|1|||
125377626|NCT00793598|451013346|FG000|Overall Study|Patient Request|0|||
125377627|NCT00793598|451013347|FG001|Overall Study|Patient Request|1|||
125377628|NCT00793598|451013348|FG002|Overall Study|Patient Request|0|||
125377629|NCT00793598|451013349|FG003|Overall Study|Patient Request|0|||
125377630|NCT00793598|451013350|FG004|Overall Study|Patient Request|0|||
125377631|NCT00793598|451013351|FG005|Overall Study|Patient Request|0|||
125377632|NCT00793598|451013352|FG006|Overall Study|Patient Request|0|||
125377633|NCT00793598|451013353|FG007|Overall Study|Patient Request|0|||
125377634|NCT00793598|451013346|FG000|Overall Study|Protocol Violation|0|||
125377635|NCT00793598|451013347|FG001|Overall Study|Protocol Violation|0|||
125377636|NCT00793598|451013348|FG002|Overall Study|Protocol Violation|0|||
125377637|NCT00793598|451013349|FG003|Overall Study|Protocol Violation|0|||
125377638|NCT00793598|451013350|FG004|Overall Study|Protocol Violation|0|||
125377639|NCT00793598|451013351|FG005|Overall Study|Protocol Violation|0|||
125377640|NCT00793598|451013352|FG006|Overall Study|Protocol Violation|0|||
125377641|NCT00793598|451013353|FG007|Overall Study|Protocol Violation|1|||
125377642|NCT00793598|451013346|FG000|Overall Study|Subject not dosed|0|||
125377643|NCT00793598|451013347|FG001|Overall Study|Subject not dosed|0|||
125377644|NCT00793598|451013348|FG002|Overall Study|Subject not dosed|0|||
125377645|NCT00793598|451013349|FG003|Overall Study|Subject not dosed|0|||
125377646|NCT00793598|451013350|FG004|Overall Study|Subject not dosed|0|||
125635857|NCT01365091|451948951|FG000|Period 1|Personal reasons|0|||
125635858|NCT01365091|451948952|FG001|Period 1|Personal reasons|0|||
125635859|NCT01365091|451948953|FG002|Period 1|Personal reasons|1|||
125635860|NCT01365091|451948954|FG003|Period 1|Personal reasons|0|||
125635861|NCT01365091|451948951|FG000|Period 2|Withdrawal by Subject|1|||
125635862|NCT01365091|451948952|FG001|Period 2|Withdrawal by Subject|0|||
125635863|NCT01365091|451948953|FG002|Period 2|Withdrawal by Subject|0|||
125635864|NCT01365091|451948954|FG003|Period 2|Withdrawal by Subject|0|||
125635865|NCT01365091|451948951|FG000|Period 2|Adverse Event|0|||
125635866|NCT01365091|451948952|FG001|Period 2|Adverse Event|0|||
125635867|NCT01365091|451948953|FG002|Period 2|Adverse Event|1|||
125635868|NCT01365091|451948954|FG003|Period 2|Adverse Event|0|||
125635869|NCT05116683|451948955|FG000|Overall Study|Physician Decision|4|||
125635870|NCT01474889|451948957|FG000|Overall Study|Physician Decision|1|||
125635871|NCT01474889|451948958|FG001|Overall Study|Physician Decision|0|||
125635872|NCT01474889|451948959|FG002|Overall Study|Physician Decision|0|||
125377647|NCT00793598|451013351|FG005|Overall Study|Subject not dosed|1|||
125377648|NCT00793598|451013352|FG006|Overall Study|Subject not dosed|0|||
125377649|NCT00793598|451013353|FG007|Overall Study|Subject not dosed|0|||
125377650|NCT02154490|451013354|FG000|Overall Study|No tissue submitted|23|||
125635873|NCT01474889|451948957|FG000|Overall Study|Did not meet inclusion|1|||
125635874|NCT01474889|451948958|FG001|Overall Study|Did not meet inclusion|0|||
125635875|NCT01474889|451948959|FG002|Overall Study|Did not meet inclusion|0|||
125635876|NCT01474889|451948957|FG000|Overall Study|Withdrawal by Subject|0|||
125635877|NCT01474889|451948958|FG001|Overall Study|Withdrawal by Subject|1|||
125635878|NCT01474889|451948959|FG002|Overall Study|Withdrawal by Subject|0|||
125635879|NCT03935594|451948963|FG000|Overall Study|Physician Decision|3|||
125377651|NCT02154490|451013354|FG000|Overall Study|No biomarker results|167|||
125377652|NCT02154490|451013354|FG000|Overall Study|Not assigned to a sub-study|270|||
125377653|NCT02154490|451013354|FG000|Overall Study|Did not register to a sub-study|749|||
125377654|NCT02961751|451013355|FG000|Overall Study|Lost to Follow-up|11|||
125377655|NCT02961751|451013355|FG000|Overall Study|Physician Decision|2|||
125377656|NCT02961751|451013355|FG000|Overall Study|Not Eligible at Enrollment|1|||
125377657|NCT02961751|451013355|FG000|Overall Study|Protocol Violation|1|||
125377658|NCT02373202|451013356|FG000|Overall Study|Adverse Event|2|||
125377659|NCT02373202|451013357|FG001|Overall Study|Adverse Event|5|||
125377660|NCT02373202|451013358|FG002|Overall Study|Adverse Event|2|||
125377661|NCT02373202|451013359|FG003|Overall Study|Adverse Event|1|||
125377662|NCT02373202|451013356|FG000|Overall Study|Lack of Efficacy|0|||
125377663|NCT02373202|451013357|FG001|Overall Study|Lack of Efficacy|0|||
125377664|NCT02373202|451013358|FG002|Overall Study|Lack of Efficacy|1|||
125377665|NCT02373202|451013359|FG003|Overall Study|Lack of Efficacy|0|||
125377666|NCT02373202|451013356|FG000|Overall Study|Other|0|||
125377667|NCT02373202|451013357|FG001|Overall Study|Other|1|||
125377668|NCT02373202|451013358|FG002|Overall Study|Other|0|||
125377669|NCT02373202|451013359|FG003|Overall Study|Other|0|||
125377670|NCT02310568|451013366|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
125377671|NCT02310568|451013367|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
125377672|NCT02310568|451013368|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
125377673|NCT02310568|451013369|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
125377674|NCT02310568|451013370|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
125377675|NCT02310568|451013366|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
125377676|NCT02310568|451013367|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
125377677|NCT02310568|451013368|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
125377678|NCT02310568|451013369|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
125377679|NCT02310568|451013370|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
125377680|NCT02310568|451013366|FG000|Stage 1 ( 4 Weeks)|Other|1|||
125377681|NCT02310568|451013367|FG001|Stage 1 ( 4 Weeks)|Other|1|||
125377682|NCT02310568|451013368|FG002|Stage 1 ( 4 Weeks)|Other|0|||
125377683|NCT02310568|451013369|FG003|Stage 1 ( 4 Weeks)|Other|0|||
125377684|NCT02310568|451013370|FG004|Stage 1 ( 4 Weeks)|Other|0|||
125377685|NCT02310568|451013366|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
125377686|NCT02310568|451013367|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
125377687|NCT02310568|451013368|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
125377688|NCT02310568|451013369|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
125377689|NCT02310568|451013370|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
125377690|NCT02310568|451013366|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
125377691|NCT02310568|451013367|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
125377692|NCT02310568|451013368|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
125377693|NCT02310568|451013369|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
125377694|NCT02310568|451013370|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
125377695|NCT02310568|451013366|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
125377696|NCT02310568|451013367|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
125377697|NCT02310568|451013368|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
125377698|NCT02310568|451013369|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
125377699|NCT02310568|451013370|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
125377700|NCT02310568|451013366|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
125377701|NCT02310568|451013367|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
125377702|NCT02310568|451013368|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
125377703|NCT02310568|451013369|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
125377704|NCT02310568|451013370|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
125377705|NCT02310568|451013366|FG000|Stage 2 (4 Weeks)|Other|0|||
125377706|NCT02310568|451013367|FG001|Stage 2 (4 Weeks)|Other|1|||
125377707|NCT02310568|451013368|FG002|Stage 2 (4 Weeks)|Other|1|||
125377708|NCT02310568|451013369|FG003|Stage 2 (4 Weeks)|Other|0|||
125377709|NCT02310568|451013370|FG004|Stage 2 (4 Weeks)|Other|0|||
125635880|NCT01435122|451948964|FG000|Overall Study|Early withdrawal due to toxicity|8|||
125635881|NCT04412668|451948965|FG000|Overall Study|Death - multiple comorbidities|2|||
125635882|NCT04412668|451948966|FG001|Overall Study|Death - multiple comorbidities|0|||
125377710|NCT02310568|451013366|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
125377711|NCT02310568|451013367|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
125377712|NCT02310568|451013368|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
125377713|NCT02310568|451013369|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
125377714|NCT02310568|451013370|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
125377715|NCT02310568|451013366|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
125377716|NCT02310568|451013367|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
125377717|NCT02310568|451013368|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
125377718|NCT02310568|451013369|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
125377719|NCT02310568|451013370|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
125377720|NCT02310568|451013366|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
125635883|NCT04412668|451948967|FG002|Overall Study|Death - multiple comorbidities|0|||
125216848|NCT03630705|450421937|FG001|Overall Study|Lost to Follow-up|2|||
125216849|NCT03630705|450421938|FG002|Overall Study|Lost to Follow-up|0|||
125216850|NCT03630705|450421939|FG003|Overall Study|Lost to Follow-up|0|||
125216851|NCT04727528|450421942|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
125216852|NCT04727528|450421943|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
125216853|NCT04727528|450421942|FG000|Open-label Period|Randomized who did not receive treatment|1|||
125216854|NCT04727528|450421943|FG001|Open-label Period|Randomized who did not receive treatment|0|||
125216855|NCT04727528|450421942|FG000|Double-blind Treatment Phase|Adverse Event|0|||
125216856|NCT04727528|450421943|FG001|Double-blind Treatment Phase|Adverse Event|1|||
125216857|NCT04727528|450421942|FG000|Double-blind Treatment Phase|Death|0|||
125216858|NCT04727528|450421943|FG001|Double-blind Treatment Phase|Death|1|||
125216859|NCT04727528|450421942|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
125216860|NCT04727528|450421943|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
125216861|NCT04727528|450421942|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
125216862|NCT04727528|450421943|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
125216863|NCT04727528|450421942|FG000|Double-blind Treatment Phase|Physician Decision|0|||
125216864|NCT04727528|450421943|FG001|Double-blind Treatment Phase|Physician Decision|1|||
125216865|NCT04727528|450421942|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
125216866|NCT04727528|450421943|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125216867|NCT01763827|450421944|FG000|Overall Study|Withdrawal by Subject|1|||
125216868|NCT01763827|450421945|FG001|Overall Study|Withdrawal by Subject|0|||
125216869|NCT01763827|450421946|FG002|Overall Study|Withdrawal by Subject|0|||
125216870|NCT01763827|450421947|FG003|Overall Study|Withdrawal by Subject|0|||
125216871|NCT01763827|450421948|FG004|Overall Study|Withdrawal by Subject|2|||
125216872|NCT01763827|450421949|FG005|Overall Study|Withdrawal by Subject|0|||
125216873|NCT01763827|450421944|FG000|Overall Study|Decision by sponsor|2|||
125216874|NCT01763827|450421945|FG001|Overall Study|Decision by sponsor|0|||
125216875|NCT01763827|450421946|FG002|Overall Study|Decision by sponsor|3|||
125216876|NCT01763827|450421947|FG003|Overall Study|Decision by sponsor|0|||
125216877|NCT01763827|450421948|FG004|Overall Study|Decision by sponsor|2|||
125635884|NCT04412668|451948965|FG000|Overall Study|Withdrawal by Subject|3|||
125635885|NCT04412668|451948966|FG001|Overall Study|Withdrawal by Subject|0|||
125635886|NCT04412668|451948967|FG002|Overall Study|Withdrawal by Subject|0|||
125377721|NCT02310568|451013367|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
125377722|NCT02310568|451013368|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
125377723|NCT02310568|451013369|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
125377724|NCT02310568|451013370|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
125377725|NCT01224431|451013378|FG000|Overall Study|not randomized|0|||
125377726|NCT01224431|451013379|FG001|Overall Study|not randomized|4|||
125377727|NCT01224431|451013378|FG000|Overall Study|no video record|0|||
125377728|NCT01224431|451013379|FG001|Overall Study|no video record|1|||
125377729|NCT02511184|451013386|FG000|Overall Study|Death|1|||
125377730|NCT02511184|451013387|FG001|Overall Study|Death|0|||
125377731|NCT02511184|451013386|FG000|Overall Study|Lost to Follow-up|0|||
125377732|NCT02511184|451013387|FG001|Overall Study|Lost to Follow-up|1|||
125377733|NCT02511184|451013386|FG000|Overall Study|Study terminated by sponsor|1|||
125377734|NCT02511184|451013387|FG001|Overall Study|Study terminated by sponsor|5|||
125377735|NCT02511184|451013386|FG000|Overall Study|Withdrawal by Subject|0|||
125377736|NCT02511184|451013387|FG001|Overall Study|Withdrawal by Subject|1|||
125377737|NCT02041286|451013388|FG000|Overall Study|Adverse Event|1|||
125377738|NCT01963403|451013399|FG000|Overall Study|Lost to Follow-up|2|||
125377739|NCT01963403|451013400|FG001|Overall Study|Lost to Follow-up|3|||
125377740|NCT01963403|451013399|FG000|Overall Study|Implant removal|0|||
125377741|NCT01963403|451013400|FG001|Overall Study|Implant removal|1|||
125377742|NCT02289690|451013401|FG000|Overall Study|Adverse Event Related to Progression|0|||
125377743|NCT02289690|451013402|FG001|Overall Study|Adverse Event Related to Progression|1|||
125377744|NCT02289690|451013403|FG002|Overall Study|Adverse Event Related to Progression|1|||
125377745|NCT02289690|451013404|FG003|Overall Study|Adverse Event Related to Progression|0|||
125377746|NCT02289690|451013405|FG004|Overall Study|Adverse Event Related to Progression|1|||
125377747|NCT02289690|451013406|FG005|Overall Study|Adverse Event Related to Progression|0|||
125377748|NCT02289690|451013407|FG006|Overall Study|Adverse Event Related to Progression|1|||
125635887|NCT04412668|451948965|FG000|Overall Study|Other than Specified|2|||
125635888|NCT04412668|451948966|FG001|Overall Study|Other than Specified|0|||
125377749|NCT02289690|451013408|FG007|Overall Study|Adverse Event Related to Progression|0|||
125377750|NCT02289690|451013409|FG008|Overall Study|Adverse Event Related to Progression|0|||
125377751|NCT02289690|451013410|FG009|Overall Study|Adverse Event Related to Progression|0|||
125216878|NCT01763827|450421949|FG005|Overall Study|Decision by sponsor|1|||
125216879|NCT01763827|450421944|FG000|Overall Study|Lost to Follow-up|0|||
125216880|NCT01763827|450421945|FG001|Overall Study|Lost to Follow-up|1|||
125216881|NCT01763827|450421946|FG002|Overall Study|Lost to Follow-up|1|||
125377752|NCT02289690|451013401|FG000|Overall Study|Withdrawal by Subject|1|||
125635889|NCT04412668|451948967|FG002|Overall Study|Other than Specified|0|||
125216882|NCT01763827|450421947|FG003|Overall Study|Lost to Follow-up|1|||
125216883|NCT01763827|450421948|FG004|Overall Study|Lost to Follow-up|2|||
125216884|NCT01763827|450421949|FG005|Overall Study|Lost to Follow-up|1|||
125216885|NCT02906579|450421950|FG000|Overall Study|Adverse Event|1|||
125216886|NCT02906579|450421950|FG000|Overall Study|Physician Decision|1|||
125216887|NCT01826981|450421953|FG000|Overall Study|Lack of Efficacy|0|||
125216888|NCT01826981|450421954|FG001|Overall Study|Lack of Efficacy|1|||
125216889|NCT01826981|450421955|FG002|Overall Study|Lack of Efficacy|0|||
125216890|NCT01826981|450421956|FG003|Overall Study|Lack of Efficacy|0|||
125216891|NCT01826981|450421957|FG004|Overall Study|Lack of Efficacy|5|||
125216892|NCT01826981|450421958|FG005|Overall Study|Lack of Efficacy|0|||
125216893|NCT01826981|450421959|FG006|Overall Study|Lack of Efficacy|0|||
125216894|NCT01826981|450421960|FG007|Overall Study|Lack of Efficacy|8|||
125216895|NCT01826981|450421961|FG008|Overall Study|Lack of Efficacy|7|||
125216896|NCT01826981|450421962|FG009|Overall Study|Lack of Efficacy|0|||
125216897|NCT01826981|450421963|FG010|Overall Study|Lack of Efficacy|1|||
125216898|NCT01826981|450421964|FG011|Overall Study|Lack of Efficacy|0|||
125216899|NCT01826981|450421965|FG012|Overall Study|Lack of Efficacy|0|||
125216900|NCT01826981|450421966|FG013|Overall Study|Lack of Efficacy|3|||
125216901|NCT01826981|450421967|FG014|Overall Study|Lack of Efficacy|0|||
125216902|NCT01826981|450421953|FG000|Overall Study|Lost to Follow-up|0|||
125216903|NCT01826981|450421954|FG001|Overall Study|Lost to Follow-up|0|||
125216904|NCT01826981|450421955|FG002|Overall Study|Lost to Follow-up|0|||
125216905|NCT01826981|450421956|FG003|Overall Study|Lost to Follow-up|0|||
125216906|NCT01826981|450421957|FG004|Overall Study|Lost to Follow-up|1|||
125216907|NCT01826981|450421958|FG005|Overall Study|Lost to Follow-up|1|||
125216908|NCT01826981|450421959|FG006|Overall Study|Lost to Follow-up|0|||
125216909|NCT01826981|450421960|FG007|Overall Study|Lost to Follow-up|1|||
125216910|NCT01826981|450421961|FG008|Overall Study|Lost to Follow-up|0|||
125216911|NCT01826981|450421962|FG009|Overall Study|Lost to Follow-up|1|||
125216912|NCT01826981|450421963|FG010|Overall Study|Lost to Follow-up|1|||
125216913|NCT01826981|450421964|FG011|Overall Study|Lost to Follow-up|1|||
125216914|NCT01826981|450421965|FG012|Overall Study|Lost to Follow-up|1|||
125216915|NCT01826981|450421966|FG013|Overall Study|Lost to Follow-up|0|||
125216916|NCT01826981|450421967|FG014|Overall Study|Lost to Follow-up|0|||
125216917|NCT01826981|450421953|FG000|Overall Study|Withdrew Consent|0|||
125216918|NCT01826981|450421954|FG001|Overall Study|Withdrew Consent|0|||
125216919|NCT01826981|450421955|FG002|Overall Study|Withdrew Consent|0|||
125216920|NCT01826981|450421956|FG003|Overall Study|Withdrew Consent|0|||
125216921|NCT01826981|450421957|FG004|Overall Study|Withdrew Consent|0|||
125216922|NCT01826981|450421958|FG005|Overall Study|Withdrew Consent|0|||
125216923|NCT01826981|450421959|FG006|Overall Study|Withdrew Consent|1|||
125216924|NCT01826981|450421960|FG007|Overall Study|Withdrew Consent|1|||
125635890|NCT03864627|451948969|FG000|Overall Study|Adverse Event|0|||
125635891|NCT03864627|451948970|FG001|Overall Study|Adverse Event|1|||
125635892|NCT03864627|451948969|FG000|Overall Study|Lack of Efficacy|0|||
125216925|NCT01826981|450421961|FG008|Overall Study|Withdrew Consent|0|||
125216926|NCT01826981|450421962|FG009|Overall Study|Withdrew Consent|0|||
125216927|NCT01826981|450421963|FG010|Overall Study|Withdrew Consent|0|||
125216928|NCT01826981|450421964|FG011|Overall Study|Withdrew Consent|1|||
125216929|NCT01826981|450421965|FG012|Overall Study|Withdrew Consent|0|||
125377753|NCT02289690|451013402|FG001|Overall Study|Withdrawal by Subject|0|||
125377754|NCT02289690|451013403|FG002|Overall Study|Withdrawal by Subject|0|||
125377755|NCT02289690|451013404|FG003|Overall Study|Withdrawal by Subject|0|||
125377756|NCT02289690|451013405|FG004|Overall Study|Withdrawal by Subject|1|||
125377757|NCT02289690|451013406|FG005|Overall Study|Withdrawal by Subject|1|||
125377758|NCT02289690|451013407|FG006|Overall Study|Withdrawal by Subject|0|||
125377759|NCT02289690|451013408|FG007|Overall Study|Withdrawal by Subject|0|||
125377760|NCT02289690|451013409|FG008|Overall Study|Withdrawal by Subject|4|||
125377761|NCT02289690|451013410|FG009|Overall Study|Withdrawal by Subject|2|||
125377762|NCT02289690|451013401|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
125377763|NCT02289690|451013402|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
125377764|NCT02289690|451013403|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
125377765|NCT02289690|451013404|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
125377766|NCT02289690|451013405|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
125377767|NCT02289690|451013406|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
125377768|NCT02289690|451013407|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
125377769|NCT02289690|451013408|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
125377770|NCT02289690|451013409|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
125635893|NCT03864627|451948970|FG001|Overall Study|Lack of Efficacy|1|||
125216930|NCT01826981|450421966|FG013|Overall Study|Withdrew Consent|1|||
125216931|NCT01826981|450421967|FG014|Overall Study|Withdrew Consent|0|||
125216932|NCT01826981|450421953|FG000|Overall Study|Adverse Event|0|||
125216933|NCT01826981|450421954|FG001|Overall Study|Adverse Event|0|||
125635894|NCT03864627|451948969|FG000|Overall Study|Lost to Follow-up|0|||
125216934|NCT01826981|450421955|FG002|Overall Study|Adverse Event|0|||
125216935|NCT01826981|450421956|FG003|Overall Study|Adverse Event|0|||
125216936|NCT01826981|450421957|FG004|Overall Study|Adverse Event|1|||
125216937|NCT01826981|450421958|FG005|Overall Study|Adverse Event|0|||
125377771|NCT02289690|451013410|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
125377772|NCT02289690|451013401|FG000|Overall Study|Lost to Follow-up|0|||
125377773|NCT02289690|451013402|FG001|Overall Study|Lost to Follow-up|0|||
125377774|NCT02289690|451013403|FG002|Overall Study|Lost to Follow-up|0|||
125377775|NCT02289690|451013404|FG003|Overall Study|Lost to Follow-up|0|||
125377776|NCT02289690|451013405|FG004|Overall Study|Lost to Follow-up|0|||
125377777|NCT02289690|451013406|FG005|Overall Study|Lost to Follow-up|0|||
125377778|NCT02289690|451013407|FG006|Overall Study|Lost to Follow-up|0|||
125377779|NCT02289690|451013408|FG007|Overall Study|Lost to Follow-up|1|||
125377780|NCT02289690|451013409|FG008|Overall Study|Lost to Follow-up|0|||
125377781|NCT02289690|451013410|FG009|Overall Study|Lost to Follow-up|2|||
125377782|NCT02289690|451013401|FG000|Overall Study|Death|0|||
125131000|NCT02655679|450106495|FG002|Overall Study|Adverse Event|0|||
125377783|NCT02289690|451013402|FG001|Overall Study|Death|0|||
125216938|NCT01826981|450421959|FG006|Overall Study|Adverse Event|0|||
125216939|NCT01826981|450421960|FG007|Overall Study|Adverse Event|0|||
125216940|NCT01826981|450421961|FG008|Overall Study|Adverse Event|0|||
125216941|NCT01826981|450421962|FG009|Overall Study|Adverse Event|0|||
125216942|NCT01826981|450421963|FG010|Overall Study|Adverse Event|0|||
125216943|NCT01826981|450421964|FG011|Overall Study|Adverse Event|0|||
125216944|NCT01826981|450421965|FG012|Overall Study|Adverse Event|0|||
125216945|NCT01826981|450421966|FG013|Overall Study|Adverse Event|0|||
125216946|NCT01826981|450421967|FG014|Overall Study|Adverse Event|0|||
125216947|NCT01826981|450421953|FG000|Overall Study|Upper G-I Haemorrhage|0|||
125216948|NCT01826981|450421954|FG001|Overall Study|Upper G-I Haemorrhage|0|||
125216949|NCT01826981|450421955|FG002|Overall Study|Upper G-I Haemorrhage|0|||
125216950|NCT01826981|450421956|FG003|Overall Study|Upper G-I Haemorrhage|0|||
125216951|NCT01826981|450421957|FG004|Overall Study|Upper G-I Haemorrhage|0|||
125216952|NCT01826981|450421958|FG005|Overall Study|Upper G-I Haemorrhage|0|||
125216953|NCT01826981|450421959|FG006|Overall Study|Upper G-I Haemorrhage|0|||
125216954|NCT01826981|450421960|FG007|Overall Study|Upper G-I Haemorrhage|0|||
125216955|NCT01826981|450421961|FG008|Overall Study|Upper G-I Haemorrhage|0|||
125216956|NCT01826981|450421962|FG009|Overall Study|Upper G-I Haemorrhage|0|||
125216957|NCT01826981|450421963|FG010|Overall Study|Upper G-I Haemorrhage|0|||
125216958|NCT01826981|450421964|FG011|Overall Study|Upper G-I Haemorrhage|0|||
125216959|NCT01826981|450421965|FG012|Overall Study|Upper G-I Haemorrhage|0|||
125216960|NCT01826981|450421966|FG013|Overall Study|Upper G-I Haemorrhage|1|||
125216961|NCT01826981|450421967|FG014|Overall Study|Upper G-I Haemorrhage|0|||
125216962|NCT01826981|450421953|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216963|NCT01826981|450421954|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216964|NCT01826981|450421955|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216965|NCT01826981|450421956|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216966|NCT01826981|450421957|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216967|NCT01826981|450421958|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216968|NCT01826981|450421959|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216969|NCT01826981|450421960|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
125216970|NCT01826981|450421961|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216971|NCT01826981|450421962|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216972|NCT01826981|450421963|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216973|NCT01826981|450421964|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216974|NCT01826981|450421965|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216975|NCT01826981|450421966|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216976|NCT01826981|450421967|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
125216977|NCT02030119|450421970|FG000|Overall Study|Withdrawal by Subject|3|||
125216978|NCT02030119|450421971|FG001|Overall Study|Withdrawal by Subject|1|||
125216979|NCT02030119|450421972|FG002|Overall Study|Withdrawal by Subject|5|||
125216980|NCT02030119|450421973|FG003|Overall Study|Withdrawal by Subject|3|||
125216981|NCT02030119|450421970|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
125216982|NCT02030119|450421971|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
125216983|NCT02030119|450421972|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
125216984|NCT02030119|450421973|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
125216985|NCT00759655|450421974|FG000|Overall Study|Termination of the study by sponsor|1|||
125216986|NCT02793947|450421975|FG000|Overall Study|Death|1|||
125216987|NCT02793947|450421976|FG001|Overall Study|Death|0|||
125216988|NCT02793947|450421975|FG000|Overall Study|Physician Decision|1|||
125216989|NCT02793947|450421976|FG001|Overall Study|Physician Decision|5|||
125216990|NCT03479008|450421983|FG000|Overall Study|Withdrawal by Subject|3|||
125216991|NCT01310127|450421984|FG000|Overall Study|Protocol Violation|1|||
125131001|NCT02655679|450106496|FG003|Overall Study|Adverse Event|0|||
125131002|NCT02655679|450106497|FG004|Overall Study|Adverse Event|0|||
125131003|NCT02655679|450106493|FG000|Overall Study|Withdrawal by Subject|1|||
125131004|NCT02655679|450106494|FG001|Overall Study|Withdrawal by Subject|1|||
125131005|NCT02655679|450106495|FG002|Overall Study|Withdrawal by Subject|0|||
125131006|NCT02655679|450106496|FG003|Overall Study|Withdrawal by Subject|3|||
125131007|NCT02655679|450106497|FG004|Overall Study|Withdrawal by Subject|1|||
125377784|NCT02289690|451013403|FG002|Overall Study|Death|0|||
125377785|NCT02289690|451013404|FG003|Overall Study|Death|0|||
125377786|NCT02289690|451013405|FG004|Overall Study|Death|0|||
125377787|NCT02289690|451013406|FG005|Overall Study|Death|0|||
125377788|NCT02289690|451013407|FG006|Overall Study|Death|0|||
125377789|NCT02289690|451013408|FG007|Overall Study|Death|49|||
125377790|NCT02289690|451013409|FG008|Overall Study|Death|45|||
125377791|NCT02289690|451013410|FG009|Overall Study|Death|41|||
125377792|NCT02289690|451013401|FG000|Overall Study|Sponsor Discontinued Study|0|||
125377793|NCT02289690|451013402|FG001|Overall Study|Sponsor Discontinued Study|0|||
125377794|NCT02289690|451013403|FG002|Overall Study|Sponsor Discontinued Study|0|||
125377795|NCT02289690|451013404|FG003|Overall Study|Sponsor Discontinued Study|0|||
125131008|NCT02655679|450106493|FG000|Overall Study|Inability to Comply with the Protocol|1|||
125131009|NCT02655679|450106494|FG001|Overall Study|Inability to Comply with the Protocol|0|||
125377796|NCT02289690|451013405|FG004|Overall Study|Sponsor Discontinued Study|0|||
125377797|NCT02289690|451013406|FG005|Overall Study|Sponsor Discontinued Study|0|||
125377798|NCT02289690|451013407|FG006|Overall Study|Sponsor Discontinued Study|0|||
125377799|NCT02289690|451013408|FG007|Overall Study|Sponsor Discontinued Study|9|||
125377800|NCT02289690|451013409|FG008|Overall Study|Sponsor Discontinued Study|7|||
125377801|NCT02289690|451013410|FG009|Overall Study|Sponsor Discontinued Study|15|||
125377802|NCT02289690|451013401|FG000|Overall Study|Other|0|||
125377803|NCT02289690|451013402|FG001|Overall Study|Other|0|||
125377804|NCT02289690|451013403|FG002|Overall Study|Other|0|||
125377805|NCT02289690|451013404|FG003|Overall Study|Other|1|||
125377806|NCT02289690|451013405|FG004|Overall Study|Other|1|||
125377807|NCT02289690|451013406|FG005|Overall Study|Other|0|||
125377808|NCT02289690|451013407|FG006|Overall Study|Other|1|||
125377809|NCT02289690|451013408|FG007|Overall Study|Other|2|||
125377810|NCT02289690|451013409|FG008|Overall Study|Other|3|||
125377811|NCT02289690|451013410|FG009|Overall Study|Other|1|||
125377812|NCT04016285|451013413|FG000|Overall Study|Did not progress to surgery|2|||
125377813|NCT04016285|451013414|FG001|Overall Study|Did not progress to surgery|5|||
125377814|NCT04016285|451013413|FG000|Overall Study|Failed to collect outcome data|5|||
125377815|NCT04016285|451013414|FG001|Overall Study|Failed to collect outcome data|3|||
125377816|NCT00460408|451013417|FG000|Overall Study|Adverse Event|1|||
125377817|NCT00460408|451013418|FG001|Overall Study|Adverse Event|0|||
125377818|NCT00460408|451013419|FG002|Overall Study|Adverse Event|0|||
125377819|NCT00460408|451013420|FG003|Overall Study|Adverse Event|0|||
125377820|NCT00460408|451013417|FG000|Overall Study|Death|7|||
125377821|NCT00460408|451013418|FG001|Overall Study|Death|0|||
125377822|NCT00460408|451013419|FG002|Overall Study|Death|0|||
125377823|NCT00460408|451013420|FG003|Overall Study|Death|0|||
125377824|NCT00460408|451013417|FG000|Overall Study|Lost to Follow-up|11|||
125377825|NCT00460408|451013418|FG001|Overall Study|Lost to Follow-up|0|||
125377826|NCT00460408|451013419|FG002|Overall Study|Lost to Follow-up|1|||
125377827|NCT00460408|451013420|FG003|Overall Study|Lost to Follow-up|0|||
125377828|NCT00460408|451013417|FG000|Overall Study|Withdrawal by Subject|31|||
125377829|NCT00460408|451013418|FG001|Overall Study|Withdrawal by Subject|0|||
125377830|NCT00460408|451013419|FG002|Overall Study|Withdrawal by Subject|0|||
125377831|NCT00460408|451013420|FG003|Overall Study|Withdrawal by Subject|0|||
125377832|NCT00460408|451013417|FG000|Overall Study|Insufficient clinical response|5|||
125377833|NCT00460408|451013418|FG001|Overall Study|Insufficient clinical response|1|||
125377834|NCT00460408|451013419|FG002|Overall Study|Insufficient clinical response|5|||
125377835|NCT00460408|451013420|FG003|Overall Study|Insufficient clinical response|0|||
125377836|NCT00460408|451013417|FG000|Overall Study|Other|12|||
125377837|NCT00460408|451013418|FG001|Overall Study|Other|2|||
125377838|NCT00460408|451013419|FG002|Overall Study|Other|0|||
125377839|NCT00460408|451013420|FG003|Overall Study|Other|0|||
125377840|NCT01442493|451013421|FG000|Overall Study|withdrawn from study|3|||
125377841|NCT01442493|451013422|FG001|Overall Study|withdrawn from study|2|||
125377842|NCT01111149|451013427|FG000|Overall Study|Protocol Violation|1|||
125377843|NCT01111149|451013428|FG001|Overall Study|Protocol Violation|1|||
125377844|NCT01111149|451013429|FG002|Overall Study|Protocol Violation|2|||
125377845|NCT01111149|451013427|FG000|Overall Study|Withdrawal by Subject|1|||
125377846|NCT01111149|451013428|FG001|Overall Study|Withdrawal by Subject|0|||
125377847|NCT01111149|451013429|FG002|Overall Study|Withdrawal by Subject|2|||
125377848|NCT00759954|451013430|FG000|Overall Study|Personal reason|1|||
125377849|NCT00759954|451013431|FG001|Overall Study|Personal reason|0|||
125377850|NCT00759954|451013430|FG000|Overall Study|Adverse Event|1|||
125377851|NCT00759954|451013431|FG001|Overall Study|Adverse Event|2|||
125377852|NCT02730455|451013444|FG000|Overall Study|Death|5|||
125377853|NCT02730455|451013445|FG001|Overall Study|Death|6|||
125377854|NCT02730455|451013446|FG002|Overall Study|Death|4|||
125377855|NCT02730455|451013444|FG000|Overall Study|Consent withdrawn|2|||
125377856|NCT02730455|451013445|FG001|Overall Study|Consent withdrawn|4|||
125377857|NCT02730455|451013446|FG002|Overall Study|Consent withdrawn|1|||
125377858|NCT02730455|451013444|FG000|Overall Study|Lost to Follow-up|3|||
125377859|NCT02730455|451013445|FG001|Overall Study|Lost to Follow-up|1|||
125377860|NCT02730455|451013446|FG002|Overall Study|Lost to Follow-up|4|||
125377861|NCT02730455|451013444|FG000|Overall Study|Other|1|||
125377862|NCT02730455|451013445|FG001|Overall Study|Other|1|||
125377863|NCT02730455|451013446|FG002|Overall Study|Other|2|||
125377864|NCT02730455|451013444|FG000|Overall Study|Other|2|||
125377865|NCT02730455|451013445|FG001|Overall Study|Other|2|||
125377866|NCT02730455|451013446|FG002|Overall Study|Other|0|||
125377867|NCT02725710|451013450|FG000|Overall Study|Lost to Follow-up|1|||
125377868|NCT02725710|451013451|FG001|Overall Study|Lost to Follow-up|0|||
125377869|NCT01666782|451013454|FG000|Overall Study|Received 2 doses of vaccine|0|||
125377870|NCT01666782|451013455|FG001|Overall Study|Received 2 doses of vaccine|1|||
125377871|NCT01666782|451013454|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
125377872|NCT01666782|451013455|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
125377873|NCT03681405|451013456|FG000|Overall Study|Found to be ineligible after randomized|1|||
125377874|NCT03681405|451013457|FG001|Overall Study|Found to be ineligible after randomized|0|||
125377875|NCT01691781|451013470|FG000|Overall Study|Withdrawal by Subject|4|||
125377876|NCT01691781|451013471|FG001|Overall Study|Withdrawal by Subject|3|||
125216992|NCT01310127|450421985|FG001|Overall Study|Protocol Violation|1|||
125216993|NCT01310127|450421984|FG000|Overall Study|advanced psc cataract outlier|1|||
125216994|NCT01310127|450421985|FG001|Overall Study|advanced psc cataract outlier|0|||
125216995|NCT00412932|450421986|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
125216996|NCT00412932|450421986|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
125216997|NCT00412932|450421986|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
125216998|NCT00412932|450421986|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
125216999|NCT00412932|450421986|FG000|Olmesartan (Olm) 20 mg|Other|1|||
125217000|NCT00412932|450421986|FG000|Olmesartan 40 mg|Adverse Event|4|||
125635895|NCT03864627|451948970|FG001|Overall Study|Lost to Follow-up|1|||
125635896|NCT03864627|451948969|FG000|Overall Study|Withdrawal by Subject|4|||
125635897|NCT03864627|451948970|FG001|Overall Study|Withdrawal by Subject|8|||
125635898|NCT03864627|451948969|FG000|Overall Study|Study terminated by sponsor|0|||
125635899|NCT03864627|451948970|FG001|Overall Study|Study terminated by sponsor|1|||
125635900|NCT01388491|451948971|FG000|Overall Study|Adverse Event|10|||
125131010|NCT02655679|450106495|FG002|Overall Study|Inability to Comply with the Protocol|0|||
125131011|NCT02655679|450106496|FG003|Overall Study|Inability to Comply with the Protocol|0|||
125131012|NCT02655679|450106497|FG004|Overall Study|Inability to Comply with the Protocol|0|||
125131013|NCT02655679|450106493|FG000|Overall Study|Lost to Follow-up|0|||
125131014|NCT02655679|450106494|FG001|Overall Study|Lost to Follow-up|1|||
125131015|NCT02655679|450106495|FG002|Overall Study|Lost to Follow-up|1|||
125131016|NCT02655679|450106496|FG003|Overall Study|Lost to Follow-up|1|||
125131017|NCT02655679|450106497|FG004|Overall Study|Lost to Follow-up|0|||
125131018|NCT02655679|450106493|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125131019|NCT02655679|450106494|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125131020|NCT02655679|450106495|FG002|Overall Study|Other Miscellaneous Reasons|0|||
125635901|NCT01388491|451948972|FG001|Overall Study|Adverse Event|9|||
125131021|NCT02655679|450106496|FG003|Overall Study|Other Miscellaneous Reasons|0|||
125131022|NCT02655679|450106497|FG004|Overall Study|Other Miscellaneous Reasons|0|||
125377877|NCT01691781|451013470|FG000|Overall Study|Physician Decision|1|||
125377878|NCT01691781|451013471|FG001|Overall Study|Physician Decision|1|||
125377879|NCT01691781|451013470|FG000|Overall Study|Protocol Violation|2|||
125377880|NCT01691781|451013471|FG001|Overall Study|Protocol Violation|2|||
125377881|NCT01691781|451013470|FG000|Overall Study|Adverse Event|0|||
125377882|NCT01691781|451013471|FG001|Overall Study|Adverse Event|1|||
125377883|NCT01927367|451013472|FG000|Overall Study|Withdrawal by Subject|7|||
125377884|NCT01927367|451013473|FG001|Overall Study|Withdrawal by Subject|4|||
125377885|NCT01927367|451013472|FG000|Overall Study|No baseline data|0|||
125377886|NCT01927367|451013473|FG001|Overall Study|No baseline data|1|||
125377887|NCT00598832|451013476|FG000|Overall Study|Lack of Efficacy|3|||
125377888|NCT00598832|451013477|FG001|Overall Study|Lack of Efficacy|7|||
125377889|NCT00598832|451013476|FG000|Overall Study|Adverse Event|6|||
125377890|NCT00598832|451013477|FG001|Overall Study|Adverse Event|2|||
125377891|NCT00598832|451013476|FG000|Overall Study|Withdrawal by Subject|25|||
125377892|NCT00598832|451013477|FG001|Overall Study|Withdrawal by Subject|36|||
125377893|NCT00598832|451013476|FG000|Overall Study|Protocol Violation|0|||
125377894|NCT00598832|451013477|FG001|Overall Study|Protocol Violation|2|||
125377895|NCT00598832|451013476|FG000|Overall Study|Lost to Follow-up|24|||
125377896|NCT00598832|451013477|FG001|Overall Study|Lost to Follow-up|29|||
125377897|NCT00598832|451013476|FG000|Overall Study|Pregnancy|2|||
125377898|NCT00598832|451013477|FG001|Overall Study|Pregnancy|2|||
125377899|NCT00598832|451013476|FG000|Overall Study|Physician Decision|1|||
125377900|NCT00598832|451013477|FG001|Overall Study|Physician Decision|4|||
125377901|NCT00598832|451013476|FG000|Overall Study|Non compliance|1|||
125377902|NCT00598832|451013477|FG001|Overall Study|Non compliance|0|||
125377903|NCT02760069|451013478|FG000|Overall Study|Withdrawal by Subject|0|||
125377904|NCT02760069|451013479|FG001|Overall Study|Withdrawal by Subject|1|||
125377905|NCT02760069|451013480|FG002|Overall Study|Withdrawal by Subject|1|||
125377906|NCT01648205|451013490|FG000|Placebo|Pregnancy|1|||
125377907|NCT01648205|451013490|FG000|Placebo|Withdrawal by Subject|1|||
125377908|NCT01648205|451013490|FG000|Placebo|Protocol Violation|2|||
125377909|NCT01648205|451013490|FG000|Ranolazine|Death|1|||
125377910|NCT01648205|451013490|FG000|Ranolazine|Withdrawal by Subject|1|||
125377911|NCT01648205|451013490|FG000|Ranolazine|Protocol Violation|3|||
125377912|NCT02142959|451013494|FG000|Overall Study|Adverse Event|1|||
125131023|NCT01577381|450106498|FG000|Overall Study|Discontinued|2|||
125131024|NCT01577381|450106499|FG001|Overall Study|Discontinued|1|||
125217001|NCT00412932|450421986|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
125377913|NCT02142959|451013495|FG001|Overall Study|Adverse Event|0|||
125377914|NCT02142959|451013496|FG002|Overall Study|Adverse Event|0|||
125377915|NCT02142959|451013494|FG000|Overall Study|Death|0|||
125377916|NCT02142959|451013495|FG001|Overall Study|Death|1|||
125377917|NCT02142959|451013496|FG002|Overall Study|Death|0|||
125217002|NCT00412932|450421986|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
125377918|NCT02142959|451013494|FG000|Overall Study|Withdrawal by Subject|3|||
125635902|NCT01388491|451948971|FG000|Overall Study|Sponsor Request|9|||
125131025|NCT01577381|450106500|FG002|Overall Study|Discontinued|2|||
125377919|NCT02142959|451013495|FG001|Overall Study|Withdrawal by Subject|1|||
125377920|NCT02142959|451013496|FG002|Overall Study|Withdrawal by Subject|3|||
125217003|NCT00412932|450421986|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
125217004|NCT00412932|450421986|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
125217005|NCT00412932|450421986|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
125217006|NCT00412932|450421986|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
125217007|NCT01490840|450421990|FG000|Phase 1|Lost to Follow-up|1|||
125217008|NCT01490840|450421991|FG001|Phase 1|Lost to Follow-up|0|||
125217009|NCT01490840|450421990|FG000|Phase 1|Adverse Event|2|||
125217010|NCT01490840|450421991|FG001|Phase 1|Adverse Event|1|||
125217011|NCT01490840|450421990|FG000|Phase 1|Withdrawal by Subject|6|||
125217012|NCT01490840|450421991|FG001|Phase 1|Withdrawal by Subject|5|||
125217013|NCT01490840|450421990|FG000|Phase 1|Visit 6a omitted|1|||
125217014|NCT01490840|450421991|FG001|Phase 1|Visit 6a omitted|0|||
125217015|NCT01490840|450421990|FG000|Phase 2|Withdrawal by Subject|4|||
125217016|NCT01490840|450421991|FG001|Phase 2|Withdrawal by Subject|3|||
125217017|NCT01490840|450421990|FG000|Phase 2|Permanent interruption of fingolimod|0|||
125217018|NCT01490840|450421991|FG001|Phase 2|Permanent interruption of fingolimod|1|||
125217019|NCT01490840|450421990|FG000|Phase 2|Lost to Follow-up|1|||
125217020|NCT01490840|450421991|FG001|Phase 2|Lost to Follow-up|1|||
125217021|NCT01490840|450421990|FG000|Phase 2|Adverse Event|1|||
125217022|NCT01490840|450421991|FG001|Phase 2|Adverse Event|1|||
125217023|NCT01025284|450421996|FG000|Overall Study|Investigator Decision|0|||
125217024|NCT01025284|450421997|FG001|Overall Study|Investigator Decision|1|||
125217025|NCT01025284|450421998|FG002|Overall Study|Investigator Decision|0|||
125217026|NCT01025284|450421996|FG000|Overall Study|Withdrawal by Subject|0|||
125217027|NCT01025284|450421997|FG001|Overall Study|Withdrawal by Subject|1|||
125217028|NCT01025284|450421998|FG002|Overall Study|Withdrawal by Subject|0|||
125217029|NCT00905567|450421999|FG000|Washout|Withdrawal by Subject|0|||
125217030|NCT00905567|450422000|FG001|Washout|Withdrawal by Subject|1|||
125217031|NCT02753816|450422001|FG000|Overall Study|Protocol Violation|0|||
125377921|NCT02142959|451013494|FG000|Overall Study|Administrative Reasons|1|||
125377922|NCT02142959|451013495|FG001|Overall Study|Administrative Reasons|0|||
125377923|NCT02142959|451013496|FG002|Overall Study|Administrative Reasons|1|||
125377924|NCT02142959|451013494|FG000|Overall Study|Missing|0|||
125377925|NCT02142959|451013495|FG001|Overall Study|Missing|1|||
125377926|NCT02142959|451013496|FG002|Overall Study|Missing|0|||
125377927|NCT02142959|451013494|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
125377928|NCT02142959|451013495|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
125377929|NCT02142959|451013496|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
125377930|NCT02142959|451013494|FG000|Overall Study|Patient didn't complete end of study visit|0|||
125377931|NCT02142959|451013495|FG001|Overall Study|Patient didn't complete end of study visit|0|||
125377932|NCT02142959|451013496|FG002|Overall Study|Patient didn't complete end of study visit|1|||
125377933|NCT03547687|451013497|FG000|Overall Study|Withdrawal by Subject|1|||
125377934|NCT03547687|451013497|FG000|Overall Study|Death|1|||
125377935|NCT04557371|451013498|FG000|Overall Study|Covid-19-related|0|||
125377936|NCT04557371|451013499|FG001|Overall Study|Covid-19-related|1|||
125377937|NCT04557371|451013500|FG002|Overall Study|Covid-19-related|0|||
125377938|NCT04557371|451013498|FG000|Overall Study|Withdrawal by Subject|0|||
125377939|NCT04557371|451013499|FG001|Overall Study|Withdrawal by Subject|1|||
125377940|NCT04557371|451013500|FG002|Overall Study|Withdrawal by Subject|0|||
125377941|NCT04557371|451013498|FG000|Overall Study|Adverse Event|1|||
125377942|NCT04557371|451013499|FG001|Overall Study|Adverse Event|0|||
125377943|NCT04557371|451013500|FG002|Overall Study|Adverse Event|0|||
125377944|NCT03694821|451013501|FG000|Overall Study|Study terminated|4|||
125377945|NCT03694821|451013502|FG001|Overall Study|Study terminated|8|||
125377946|NCT03694821|451013503|FG002|Overall Study|Study terminated|4|||
125377947|NCT03064451|451013504|FG000|Overall Study|Lost to Follow-up|1|||
125377948|NCT03064451|451013504|FG000|Overall Study|Mapping Failure|4|||
125377949|NCT03064451|451013504|FG000|Overall Study|Exited prior to procedure|8|||
125377950|NCT03064451|451013504|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
125377951|NCT00850564|451013511|FG000|Overall Study|Withdrawal by Subject|2|||
125377952|NCT02345850|451015483|FG000|Overall Study|Not transplanted|10|||
125377953|NCT02345850|451015484|FG001|Overall Study|Not transplanted|5|||
125377954|NCT02345850|451015485|FG002|Overall Study|Not transplanted|4|||
125377955|NCT02345850|451015483|FG000|Overall Study|Lost to Follow-up|2|||
125377956|NCT02345850|451015484|FG001|Overall Study|Lost to Follow-up|3|||
125217032|NCT02753816|450422002|FG001|Overall Study|Protocol Violation|1|||
125377957|NCT02345850|451015485|FG002|Overall Study|Lost to Follow-up|2|||
125377958|NCT02345850|451015483|FG000|Overall Study|Withdrawal by Subject|1|||
125377959|NCT02345850|451015484|FG001|Overall Study|Withdrawal by Subject|0|||
125377960|NCT02345850|451015485|FG002|Overall Study|Withdrawal by Subject|0|||
125217033|NCT02753816|450422003|FG002|Overall Study|Protocol Violation|0|||
125217034|NCT02542397|450422004|FG000|Overall Study|Death|2|||
125217035|NCT02542397|450422004|FG000|Overall Study|Physician Decision|6|||
125217036|NCT02542397|450422004|FG000|Overall Study|Withdrawal by Subject|6|||
125217037|NCT02542397|450422004|FG000|Overall Study|Lost to Follow-up|2|||
125217038|NCT01738919|450422010|FG000|Overall Study|Lost to Follow-up|1|||
125217039|NCT01738919|450422011|FG001|Overall Study|Lost to Follow-up|0|||
125217040|NCT01738919|450422010|FG000|Overall Study|Immigrated|0|||
125217041|NCT01738919|450422011|FG001|Overall Study|Immigrated|1|||
125217042|NCT01738919|450422010|FG000|Overall Study|Withdrawal by Subject|0|||
125217043|NCT01738919|450422011|FG001|Overall Study|Withdrawal by Subject|1|||
125217044|NCT01738919|450422010|FG000|Overall Study|Not treated in accordance to guidelines|0|||
125217045|NCT01738919|450422011|FG001|Overall Study|Not treated in accordance to guidelines|1|||
125217046|NCT01473940|450422012|FG000|Induction Therapy|Death|0|||
125217047|NCT01473940|450422013|FG001|Induction Therapy|Death|0|||
125217048|NCT01473940|450422014|FG002|Induction Therapy|Death|1|||
125217049|NCT01473940|450422015|FG003|Induction Therapy|Death|1|||
125217050|NCT01473940|450422012|FG000|Induction Therapy|Progressive Disease|0|||
125217051|NCT01473940|450422013|FG001|Induction Therapy|Progressive Disease|1|||
125217052|NCT01473940|450422014|FG002|Induction Therapy|Progressive Disease|1|||
125217053|NCT01473940|450422015|FG003|Induction Therapy|Progressive Disease|0|||
125217054|NCT01473940|450422012|FG000|Maintenance Therapy|Progressive Disease|1|||
125217055|NCT01473940|450422013|FG001|Maintenance Therapy|Progressive Disease|2|||
125217056|NCT01473940|450422014|FG002|Maintenance Therapy|Progressive Disease|1|||
125217057|NCT01473940|450422015|FG003|Maintenance Therapy|Progressive Disease|4|||
125217058|NCT00547248|450422016|FG000|Overall Study|Protocol Violation|0|||
125217059|NCT00547248|450422017|FG001|Overall Study|Protocol Violation|0|||
125217060|NCT00547248|450422018|FG002|Overall Study|Protocol Violation|1|||
125217061|NCT00547248|450422019|FG003|Overall Study|Protocol Violation|1|||
125217062|NCT00547248|450422016|FG000|Overall Study|Migrated/moved from study area|0|||
125217063|NCT00547248|450422017|FG001|Overall Study|Migrated/moved from study area|0|||
125217064|NCT00547248|450422018|FG002|Overall Study|Migrated/moved from study area|2|||
125217065|NCT00547248|450422019|FG003|Overall Study|Migrated/moved from study area|0|||
125217066|NCT00547248|450422016|FG000|Overall Study|Withdrawal by Subject|0|||
125217067|NCT00547248|450422017|FG001|Overall Study|Withdrawal by Subject|0|||
125217068|NCT00547248|450422018|FG002|Overall Study|Withdrawal by Subject|7|||
125217069|NCT00547248|450422019|FG003|Overall Study|Withdrawal by Subject|1|||
125217070|NCT00534248|450422022|FG000|Overall Study|Adverse Event|19|||
125217071|NCT00534248|450422023|FG001|Overall Study|Adverse Event|29|||
125217072|NCT00534248|450422022|FG000|Overall Study|Lost to Follow-up|353|||
125217073|NCT00534248|450422023|FG001|Overall Study|Lost to Follow-up|375|||
125217074|NCT00534248|450422022|FG000|Overall Study|Other protocol specified criteria|13|||
125217075|NCT00534248|450422023|FG001|Overall Study|Other protocol specified criteria|3|||
125217076|NCT00534248|450422022|FG000|Overall Study|Physician Decision|10|||
125217077|NCT00534248|450422023|FG001|Overall Study|Physician Decision|7|||
125217078|NCT00534248|450422022|FG000|Overall Study|Protocol Violation|3|||
125217079|NCT00534248|450422023|FG001|Overall Study|Protocol Violation|4|||
125217080|NCT00534248|450422022|FG000|Overall Study|Withdrawal by Subject|263|||
125217081|NCT00534248|450422023|FG001|Overall Study|Withdrawal by Subject|255|||
125217082|NCT02532257|450422024|FG000|Overall Study|Adverse Event|2|||
125217083|NCT02532257|450422024|FG000|Overall Study|Physician Decision|4|||
125217084|NCT02532257|450422024|FG000|Overall Study|Withdrawal by Subject|3|||
125217085|NCT02532257|450422024|FG000|Overall Study|Progressive Disease|10|||
125217086|NCT02849171|450422025|FG000|Overall Study|Withdrawal by Subject|1|||
125217087|NCT02849171|450422025|FG000|Overall Study|Not treated|1|||
125217088|NCT02259400|450422028|FG000|Overall Study|Death|0|||
125217089|NCT02259400|450422029|FG001|Overall Study|Death|2|||
125217090|NCT00697593|450422031|FG000|Overall Study|Adverse Event|3|||
125217091|NCT00697593|450422031|FG000|Overall Study|Protocol Violation|1|||
125217092|NCT00697593|450422031|FG000|Overall Study|Lack of Efficacy|3|||
125217093|NCT00697593|450422031|FG000|Overall Study|Suspension of the study by sponsor|12|||
125217094|NCT02964338|450422032|FG000|Overall Study|Sponsor terminated study for futility|12|||
125217095|NCT02964338|450422033|FG001|Overall Study|Sponsor terminated study for futility|15|||
125217096|NCT02964338|450422034|FG002|Overall Study|Sponsor terminated study for futility|14|||
125217097|NCT02964338|450422032|FG000|Overall Study|Lack of Efficacy|0|||
125217098|NCT02964338|450422033|FG001|Overall Study|Lack of Efficacy|3|||
125217099|NCT02964338|450422034|FG002|Overall Study|Lack of Efficacy|0|||
125217100|NCT02964338|450422032|FG000|Overall Study|Lost to Follow-up|1|||
125217101|NCT02964338|450422033|FG001|Overall Study|Lost to Follow-up|0|||
125217102|NCT02964338|450422034|FG002|Overall Study|Lost to Follow-up|3|||
125635903|NCT01388491|451948972|FG001|Overall Study|Sponsor Request|7|||
125635904|NCT01388491|451948971|FG000|Overall Study|Withdrawal by Subject|6|||
125217103|NCT02964338|450422032|FG000|Overall Study|Protocol Violation|0|||
125217104|NCT02964338|450422033|FG001|Overall Study|Protocol Violation|1|||
125217105|NCT02964338|450422034|FG002|Overall Study|Protocol Violation|0|||
125217106|NCT02964338|450422032|FG000|Overall Study|Withdrawal by Subject|1|||
125217107|NCT02964338|450422033|FG001|Overall Study|Withdrawal by Subject|3|||
125217108|NCT02964338|450422034|FG002|Overall Study|Withdrawal by Subject|1|||
125217109|NCT02964338|450422032|FG000|Overall Study|Adverse Event|2|||
125217110|NCT02964338|450422033|FG001|Overall Study|Adverse Event|1|||
125217111|NCT02964338|450422034|FG002|Overall Study|Adverse Event|1|||
125217112|NCT02964338|450422032|FG000|Overall Study|Non-compliant with e-diary|0|||
125217113|NCT02964338|450422033|FG001|Overall Study|Non-compliant with e-diary|1|||
125217114|NCT02964338|450422034|FG002|Overall Study|Non-compliant with e-diary|0|||
125217115|NCT02964338|450422032|FG000|Overall Study|Did not meet criteria|1|||
125377961|NCT01991067|451015487|FG000|Overall Study|Lost to Follow-up|6|||
125377962|NCT01991067|451015488|FG001|Overall Study|Lost to Follow-up|5|||
125377963|NCT03909295|451015490|FG000|Overall Study|Adverse Event|2|||
125377964|NCT03909295|451015490|FG000|Overall Study|Study terminated by sponsor|50|||
125377965|NCT01411228|451015491|FG000|Overall Study|Lost to Follow-up|0|||
125377966|NCT01411228|451015492|FG001|Overall Study|Lost to Follow-up|0|||
125377967|NCT01411228|451015493|FG002|Overall Study|Lost to Follow-up|1|||
125377968|NCT01411228|451015491|FG000|Overall Study|Withdrawal by Subject|1|||
125377969|NCT01411228|451015492|FG001|Overall Study|Withdrawal by Subject|0|||
125377970|NCT01411228|451015493|FG002|Overall Study|Withdrawal by Subject|0|||
125377971|NCT01752907|451015494|FG000|Overall Study|Withdrawal by Subject|4|||
125377972|NCT01752907|451015495|FG001|Overall Study|Withdrawal by Subject|10|||
125377973|NCT01752907|451015494|FG000|Overall Study|Lost to Follow-up|2|||
125377974|NCT01752907|451015495|FG001|Overall Study|Lost to Follow-up|1|||
125377975|NCT01752907|451015494|FG000|Overall Study|Decision by Sponsor|6|||
125377976|NCT01752907|451015495|FG001|Overall Study|Decision by Sponsor|9|||
125377977|NCT02670083|451015502|FG000|Overall Study|Adverse Event|16|||
125377978|NCT02670083|451015503|FG001|Overall Study|Adverse Event|13|||
125377979|NCT02670083|451015502|FG000|Overall Study|Death|4|||
125377980|NCT02670083|451015503|FG001|Overall Study|Death|6|||
125377981|NCT02670083|451015502|FG000|Overall Study|Lost to Follow-up|2|||
125377982|NCT02670083|451015503|FG001|Overall Study|Lost to Follow-up|2|||
125377983|NCT02670083|451015502|FG000|Overall Study|Multiple Reasons|9|||
125377984|NCT02670083|451015503|FG001|Overall Study|Multiple Reasons|9|||
125377985|NCT02670083|451015502|FG000|Overall Study|Physician Decision|0|||
125377986|NCT02670083|451015503|FG001|Overall Study|Physician Decision|2|||
125377987|NCT02670083|451015502|FG000|Overall Study|Study Terminated By Sponsor|257|||
125377988|NCT02670083|451015503|FG001|Overall Study|Study Terminated By Sponsor|254|||
125377989|NCT02670083|451015502|FG000|Overall Study|Symptomatic Deterioration|0|||
125377990|NCT02670083|451015503|FG001|Overall Study|Symptomatic Deterioration|2|||
125377991|NCT02670083|451015502|FG000|Overall Study|Withdrawal by Subject|32|||
125377992|NCT02670083|451015503|FG001|Overall Study|Withdrawal by Subject|31|||
125377993|NCT02670083|451015502|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125377994|NCT02670083|451015503|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125377995|NCT02014597|451015504|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
125377996|NCT02014597|451015505|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
125377997|NCT00464087|451015508|FG000|Overall Study|No PCI per inclusion criteria|0|||
125377998|NCT00464087|451015509|FG001|Overall Study|No PCI per inclusion criteria|0|||
125377999|NCT00464087|451015510|FG002|Overall Study|No PCI per inclusion criteria|29|||
125378000|NCT00609492|451015511|FG000|Overall Study|Withdrawal by Subject|0|||
125378001|NCT00609492|451015512|FG001|Overall Study|Withdrawal by Subject|2|||
125378002|NCT00609492|451015513|FG002|Overall Study|Withdrawal by Subject|3|||
125378003|NCT00609492|451015511|FG000|Overall Study|Lost to Follow-up|1|||
125378004|NCT00609492|451015512|FG001|Overall Study|Lost to Follow-up|1|||
125378005|NCT00609492|451015513|FG002|Overall Study|Lost to Follow-up|4|||
125378006|NCT00720434|451015514|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
125378007|NCT00720434|451015515|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
125378008|NCT00720434|451015516|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
125378009|NCT00720434|451015517|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
125378010|NCT00720434|451015514|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
125378011|NCT00720434|451015515|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
125378012|NCT00720434|451015516|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
125378013|NCT00720434|451015517|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
125378014|NCT00720434|451015514|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
125378015|NCT00720434|451015515|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
125378016|NCT00720434|451015516|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
125378017|NCT00720434|451015517|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
125378018|NCT00720434|451015514|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
125378019|NCT00720434|451015515|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
125378020|NCT00720434|451015516|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
125378021|NCT00720434|451015517|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
125378022|NCT00720434|451015514|FG000|Open-Label Period (Week 5-72)|Other|4|||
125378023|NCT00720434|451015515|FG001|Open-Label Period (Week 5-72)|Other|3|||
125378024|NCT00720434|451015516|FG002|Open-Label Period (Week 5-72)|Other|3|||
125378025|NCT00720434|451015517|FG003|Open-Label Period (Week 5-72)|Other|2|||
125378026|NCT02057406|451015518|FG000|Overall Study|Physician Decision|0|||
125378027|NCT02057406|451015519|FG001|Overall Study|Physician Decision|0|||
125378028|NCT02057406|451015520|FG002|Overall Study|Physician Decision|2|||
125378029|NCT02057406|451015518|FG000|Overall Study|Withdrawal by Subject|0|||
125378030|NCT02057406|451015519|FG001|Overall Study|Withdrawal by Subject|2|||
125378031|NCT02057406|451015520|FG002|Overall Study|Withdrawal by Subject|0|||
125378032|NCT02057406|451015518|FG000|Overall Study|Lost to Follow-up|0|||
125378033|NCT02057406|451015519|FG001|Overall Study|Lost to Follow-up|0|||
125378034|NCT02057406|451015520|FG002|Overall Study|Lost to Follow-up|1|||
125378035|NCT02057406|451015518|FG000|Overall Study|Death|1|||
125378036|NCT02057406|451015519|FG001|Overall Study|Death|0|||
125378037|NCT02057406|451015520|FG002|Overall Study|Death|0|||
125378038|NCT02057406|451015518|FG000|Overall Study|Protocol Violation|0|||
125378039|NCT02057406|451015519|FG001|Overall Study|Protocol Violation|1|||
125378040|NCT02057406|451015520|FG002|Overall Study|Protocol Violation|0|||
125378041|NCT02057406|451015518|FG000|Overall Study|Patient transportation issues|0|||
125378042|NCT02057406|451015519|FG001|Overall Study|Patient transportation issues|0|||
125378043|NCT02057406|451015520|FG002|Overall Study|Patient transportation issues|1|||
125378044|NCT02425046|451015521|FG000|Overall Study|Lost to Follow-up|52|||
125378045|NCT02425046|451015522|FG001|Overall Study|Lost to Follow-up|50|||
125378046|NCT02425046|451015523|FG002|Overall Study|Lost to Follow-up|56|||
125378047|NCT02425046|451015521|FG000|Overall Study|Withdrawal by Subject|16|||
125378048|NCT02425046|451015522|FG001|Overall Study|Withdrawal by Subject|12|||
125378049|NCT02425046|451015523|FG002|Overall Study|Withdrawal by Subject|0|||
125378050|NCT00931762|451015524|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
125378051|NCT00931762|451015524|FG000|Overall Study|Administrative Problems|5|||
125378052|NCT00931762|451015524|FG000|Overall Study|Death|1|||
125378053|NCT00931762|451015524|FG000|Overall Study|Disease Progression|3|||
125378054|NCT00931762|451015524|FG000|Overall Study|Adverse Event (s)|11|||
125378055|NCT00931762|451015524|FG000|Overall Study|Subject withdrew consent|13|||
125378056|NCT02692716|451015527|FG000|Overall Study|Lost to Follow-up|2|||
125378057|NCT02692716|451015528|FG001|Overall Study|Lost to Follow-up|5|||
125378058|NCT02692716|451015527|FG000|Overall Study|Withdrawal by Subject|3|||
125378059|NCT02692716|451015528|FG001|Overall Study|Withdrawal by Subject|1|||
125378060|NCT03562481|451015533|FG000|First Intervention|Lost to Follow-up|1|||
125378061|NCT03562481|451015534|FG001|First Intervention|Lost to Follow-up|0|||
125378062|NCT02782780|451015535|FG000|Overall Study|dropped out after randomization.|7|||
125378063|NCT02782780|451015536|FG001|Overall Study|dropped out after randomization.|5|||
125378064|NCT02782780|451015535|FG000|Overall Study|Protocol Violation|0|||
125378065|NCT02782780|451015536|FG001|Overall Study|Protocol Violation|2|||
125378066|NCT02664441|451015537|FG000|Randomization|Withdrawal by Subject|0|||
125378067|NCT02664441|451015538|FG001|Randomization|Withdrawal by Subject|1|||
125378068|NCT02664441|451015537|FG000|36-week Randomized Trial|Adverse Event|2|||
125378069|NCT02664441|451015538|FG001|36-week Randomized Trial|Adverse Event|0|||
125378070|NCT02664441|451015537|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
125378071|NCT02664441|451015538|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
125378072|NCT02664441|451015537|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
125378073|NCT02664441|451015538|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
125378074|NCT02664441|451015537|FG000|18-week Open Label Extension|Adverse Event|1|||
125378075|NCT02664441|451015538|FG001|18-week Open Label Extension|Adverse Event|0|||
125378076|NCT02664441|451015537|FG000|18-week Open Label Extension|Physician Decision|1|||
125378077|NCT02664441|451015538|FG001|18-week Open Label Extension|Physician Decision|0|||
125378078|NCT02664441|451015537|FG000|18-week Open Label Extension|Death|1|||
125378079|NCT02664441|451015538|FG001|18-week Open Label Extension|Death|0|||
125378080|NCT02664441|451015537|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
125378081|NCT02664441|451015538|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
125378082|NCT01413191|451015539|FG000|Overall Study|Lost to Follow-up|5|||
125378083|NCT01413191|451015539|FG000|Overall Study|Disease Progression|5|||
125378084|NCT01413191|451015539|FG000|Overall Study|Death|1|||
125378085|NCT03654651|451015540|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
125378086|NCT03654651|451015541|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
125378087|NCT01702454|451015544|FG000|Overall Study|Consent withdrawal|0|||
125378088|NCT01702454|451015545|FG001|Overall Study|Consent withdrawal|1|||
125378089|NCT01702454|451015544|FG000|Overall Study|Migrated/moved from study area|0|||
125378090|NCT01702454|451015545|FG001|Overall Study|Migrated/moved from study area|1|||
125378091|NCT01702454|451015544|FG000|Overall Study|Lost to Follow-up|3|||
125378092|NCT01702454|451015545|FG001|Overall Study|Lost to Follow-up|6|||
125378093|NCT03510884|451015546|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
125378094|NCT03510884|451015547|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
125378095|NCT03510884|451015548|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
125378096|NCT03510884|451015549|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
125378097|NCT03510884|451015546|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
125378098|NCT03510884|451015547|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
125378099|NCT03510884|451015548|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
125378100|NCT03510884|451015549|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
125378101|NCT03510884|451015546|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
125378102|NCT03510884|451015547|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
125378103|NCT03510884|451015548|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
125378104|NCT03510884|451015549|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
125378105|NCT03510884|451015546|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
125378106|NCT03510884|451015547|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
125131026|NCT01577381|450106501|FG003|Overall Study|Discontinued|2|||
125378107|NCT03510884|451015548|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
125378108|NCT03510884|451015549|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
125635905|NCT01388491|451948972|FG001|Overall Study|Withdrawal by Subject|10|||
125635906|NCT01388491|451948971|FG000|Overall Study|Lost to Follow-up|4|||
125635907|NCT01388491|451948972|FG001|Overall Study|Lost to Follow-up|3|||
125635908|NCT01388491|451948971|FG000|Overall Study|Protocol Violation|2|||
125635909|NCT01388491|451948972|FG001|Overall Study|Protocol Violation|0|||
125378109|NCT03510884|451015546|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
125378110|NCT03510884|451015547|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
125378111|NCT03510884|451015548|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
125378112|NCT03510884|451015549|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
125378113|NCT03510884|451015546|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
125378114|NCT03510884|451015547|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
125378115|NCT03510884|451015548|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
125378116|NCT03510884|451015549|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
125378117|NCT03510884|451015546|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
125378118|NCT03510884|451015547|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
125378119|NCT03510884|451015548|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
125378120|NCT03510884|451015549|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
125378121|NCT03510884|451015546|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
125378122|NCT03510884|451015547|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
125378123|NCT03510884|451015548|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
125378124|NCT03510884|451015549|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
125378125|NCT03510884|451015546|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
125378126|NCT03510884|451015547|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
125378127|NCT03510884|451015548|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
125378128|NCT03510884|451015549|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
125378129|NCT03510884|451015546|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
125378130|NCT03510884|451015547|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
125378131|NCT03510884|451015548|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
125378132|NCT03510884|451015549|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
125378133|NCT00856284|451015554|FG000|Overall Study|Hyperglycemic rescue|231|||
125378134|NCT00856284|451015555|FG001|Overall Study|Hyperglycemic rescue|201|||
125378135|NCT00856284|451015556|FG002|Overall Study|Hyperglycemic rescue|235|||
125378136|NCT00856284|451015554|FG000|Overall Study|Adverse Event|60|||
125378137|NCT00856284|451015555|FG001|Overall Study|Adverse Event|74|||
125378138|NCT00856284|451015556|FG002|Overall Study|Adverse Event|82|||
125378139|NCT00856284|451015554|FG000|Overall Study|Major protocol deviation|24|||
125378140|NCT00856284|451015555|FG001|Overall Study|Major protocol deviation|16|||
125378141|NCT00856284|451015556|FG002|Overall Study|Major protocol deviation|15|||
125378142|NCT00856284|451015554|FG000|Overall Study|Lost to Follow-up|20|||
125378143|NCT00856284|451015555|FG001|Overall Study|Lost to Follow-up|22|||
125378144|NCT00856284|451015556|FG002|Overall Study|Lost to Follow-up|28|||
125378145|NCT00856284|451015554|FG000|Overall Study|Voluntary withdrawal|48|||
125378146|NCT00856284|451015555|FG001|Overall Study|Voluntary withdrawal|52|||
125378147|NCT00856284|451015556|FG002|Overall Study|Voluntary withdrawal|62|||
125378148|NCT00856284|451015554|FG000|Overall Study|Pregnancy|1|||
125378149|NCT00856284|451015555|FG001|Overall Study|Pregnancy|2|||
125378150|NCT00856284|451015556|FG002|Overall Study|Pregnancy|0|||
125378151|NCT00856284|451015554|FG000|Overall Study|Investigator discretion|9|||
125378152|NCT00856284|451015555|FG001|Overall Study|Investigator discretion|8|||
125378153|NCT00856284|451015556|FG002|Overall Study|Investigator discretion|10|||
125378154|NCT00856284|451015554|FG000|Overall Study|Other|15|||
125378155|NCT00856284|451015555|FG001|Overall Study|Other|17|||
125378156|NCT00856284|451015556|FG002|Overall Study|Other|14|||
125378157|NCT00856284|451015554|FG000|Overall Study|Randomized in error|0|||
125378158|NCT00856284|451015555|FG001|Overall Study|Randomized in error|0|||
125378159|NCT00856284|451015556|FG002|Overall Study|Randomized in error|1|||
125378160|NCT02904512|451015559|FG000|Overall Study|Withdrawal by Subject|1|||
125378161|NCT02904512|451015560|FG001|Overall Study|Withdrawal by Subject|0|||
125378162|NCT02904512|451015559|FG000|Overall Study|Transferred to ICU|1|||
125378163|NCT02904512|451015560|FG001|Overall Study|Transferred to ICU|0|||
125378164|NCT02904512|451015559|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
125378165|NCT02904512|451015560|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
125378166|NCT03138889|451015561|FG000|Overall Study|Withdrawal by Subject|5|||
125378167|NCT03138889|451015562|FG001|Overall Study|Withdrawal by Subject|5|||
125378168|NCT03138889|451015563|FG002|Overall Study|Withdrawal by Subject|0|||
125378169|NCT03138889|451015564|FG003|Overall Study|Withdrawal by Subject|2|||
125635910|NCT01388491|451948971|FG000|Overall Study|Noncompliance|2|||
125635911|NCT01388491|451948972|FG001|Overall Study|Noncompliance|0|||
125635912|NCT01388491|451948971|FG000|Overall Study|Pregnancy|1|||
125635913|NCT01388491|451948972|FG001|Overall Study|Pregnancy|0|||
125635914|NCT00397891|451948973|FG000|Overall Study|Withdrawal by Subject|1|||
125635915|NCT00397891|451948974|FG001|Overall Study|Withdrawal by Subject|0|||
125635916|NCT00397891|451948975|FG002|Overall Study|Withdrawal by Subject|0|||
125635917|NCT00397891|451948976|FG003|Overall Study|Withdrawal by Subject|0|||
125635918|NCT00397891|451948977|FG004|Overall Study|Withdrawal by Subject|1|||
125635919|NCT04964557|451948978|FG000|Overall Study|Withdrawal by Subject|3|||
125635920|NCT04964557|451948979|FG001|Overall Study|Withdrawal by Subject|2|||
125635921|NCT04964557|451948978|FG000|Overall Study|Lost to Follow-up|1|||
125635922|NCT04964557|451948979|FG001|Overall Study|Lost to Follow-up|2|||
125635923|NCT04964557|451948978|FG000|Overall Study|Physician Decision|2|||
125635924|NCT04964557|451948979|FG001|Overall Study|Physician Decision|0|||
125635925|NCT04964557|451948978|FG000|Overall Study|Death|3|||
125635926|NCT04964557|451948979|FG001|Overall Study|Death|0|||
125635927|NCT04964557|451948978|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
125635928|NCT04964557|451948979|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
125635929|NCT04924114|451950782|FG000|Overall Study|Withdrawal by Subject|0|||
125635930|NCT04924114|451950783|FG001|Overall Study|Withdrawal by Subject|2|||
125635931|NCT04924114|451950784|FG002|Overall Study|Withdrawal by Subject|2|||
125635932|NCT04924114|451950785|FG003|Overall Study|Withdrawal by Subject|0|||
125635933|NCT04924114|451950786|FG004|Overall Study|Withdrawal by Subject|2|||
125635934|NCT04960202|451950787|FG000|Overall Study|Other|5|||
125635935|NCT04960202|451950788|FG001|Overall Study|Other|0|||
125635936|NCT04960202|451950787|FG000|Overall Study|Withdrawal by Subject|37|||
125635937|NCT04960202|451950788|FG001|Overall Study|Withdrawal by Subject|43|||
125635938|NCT04960202|451950787|FG000|Overall Study|Lost to Follow-up|20|||
125378170|NCT03138889|451015565|FG004|Overall Study|Withdrawal by Subject|1|||
125378171|NCT03138889|451015566|FG005|Overall Study|Withdrawal by Subject|3|||
125378172|NCT03138889|451015567|FG006|Overall Study|Withdrawal by Subject|0|||
125378173|NCT03138889|451015568|FG007|Overall Study|Withdrawal by Subject|1|||
125378174|NCT00267046|451015577|FG000|Overall Study|Disease progression|4|||
125378175|NCT00267046|451015578|FG001|Overall Study|Disease progression|2|||
125378176|NCT00267046|451015577|FG000|Overall Study|Chemotoxicity|2|||
125378177|NCT00267046|451015578|FG001|Overall Study|Chemotoxicity|0|||
125378178|NCT00267046|451015577|FG000|Overall Study|Open-label palifermin|2|||
125378179|NCT00267046|451015578|FG001|Overall Study|Open-label palifermin|7|||
125378180|NCT00267046|451015577|FG000|Overall Study|Surgery|3|||
125378181|NCT00267046|451015578|FG001|Overall Study|Surgery|1|||
125378182|NCT00267046|451015577|FG000|Overall Study|Withdrawal by Subject|1|||
125378183|NCT00267046|451015578|FG001|Overall Study|Withdrawal by Subject|0|||
125378184|NCT00267046|451015577|FG000|Overall Study|Radiation|0|||
125378185|NCT00267046|451015578|FG001|Overall Study|Radiation|1|||
125378186|NCT00865124|451015579|FG000|Overall Study|Physician Decision|2|||
125378187|NCT00865124|451015580|FG001|Overall Study|Physician Decision|1|||
125378188|NCT00865124|451015581|FG002|Overall Study|Physician Decision|0|||
125378189|NCT00865124|451015579|FG000|Overall Study|Withdrawn consent|2|||
125378190|NCT00865124|451015580|FG001|Overall Study|Withdrawn consent|0|||
125378191|NCT00865124|451015581|FG002|Overall Study|Withdrawn consent|0|||
125378192|NCT03247530|451015585|FG000|Overall Study|Withdrawal by caregiver|19|||
125378193|NCT03247530|451015586|FG001|Overall Study|Withdrawal by caregiver|8|||
125378194|NCT03247530|451015587|FG002|Overall Study|Withdrawal by caregiver|10|||
125378195|NCT03247530|451015585|FG000|Overall Study|Lost to Follow-up|3|||
125378196|NCT03247530|451015586|FG001|Overall Study|Lost to Follow-up|9|||
125378197|NCT03247530|451015587|FG002|Overall Study|Lost to Follow-up|6|||
125378198|NCT03247530|451015585|FG000|Overall Study|Adverse Event|2|||
125378199|NCT03247530|451015586|FG001|Overall Study|Adverse Event|5|||
125378200|NCT03247530|451015587|FG002|Overall Study|Adverse Event|2|||
125635939|NCT04960202|451950788|FG001|Overall Study|Lost to Follow-up|16|||
125635940|NCT04960202|451950787|FG000|Overall Study|Death|0|||
125635941|NCT04960202|451950788|FG001|Overall Study|Death|15|||
125635942|NCT03558828|451950792|FG000|Overall Study|Lost to Follow-up|4|||
125635943|NCT03558828|451950793|FG001|Overall Study|Lost to Follow-up|3|||
125378201|NCT03247530|451015585|FG000|Overall Study|Failure to follow procedure|1|||
125378202|NCT03247530|451015586|FG001|Overall Study|Failure to follow procedure|1|||
125378203|NCT03247530|451015587|FG002|Overall Study|Failure to follow procedure|1|||
125378204|NCT03247530|451015585|FG000|Overall Study|Withdrawal by Subject|1|||
125378205|NCT03247530|451015586|FG001|Overall Study|Withdrawal by Subject|1|||
125378206|NCT03247530|451015587|FG002|Overall Study|Withdrawal by Subject|0|||
125378207|NCT03247530|451015585|FG000|Overall Study|Study medication misuse|0|||
125378208|NCT03247530|451015586|FG001|Overall Study|Study medication misuse|1|||
125378209|NCT03247530|451015587|FG002|Overall Study|Study medication misuse|0|||
125378210|NCT03247530|451015585|FG000|Overall Study|Other, multiple categories|1|||
125378211|NCT03247530|451015586|FG001|Overall Study|Other, multiple categories|3|||
125378212|NCT03247530|451015587|FG002|Overall Study|Other, multiple categories|1|||
125378213|NCT01124422|451015592|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
125378214|NCT01124422|451015593|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
125378215|NCT01124422|451015594|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
125378216|NCT01124422|451015592|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
125378217|NCT01124422|451015593|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
125378218|NCT01124422|451015594|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
125378219|NCT01124422|451015592|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
125378220|NCT01124422|451015593|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
125378221|NCT01124422|451015594|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
125378222|NCT01124422|451015592|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
125378223|NCT01124422|451015593|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
125378224|NCT01124422|451015594|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
125378225|NCT01124422|451015592|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
125378226|NCT01124422|451015593|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
125378227|NCT01124422|451015594|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
125378228|NCT01124422|451015592|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
125378229|NCT01124422|451015593|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
125378230|NCT01124422|451015594|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
125378231|NCT01124422|451015592|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
125378232|NCT01124422|451015593|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
125217116|NCT02964338|450422033|FG001|Overall Study|Did not meet criteria|0|||
125217117|NCT02964338|450422034|FG002|Overall Study|Did not meet criteria|0|||
125217118|NCT00741598|450422038|FG000|Overall Study|Lost to Follow-up|3|||
125217119|NCT00741598|450422039|FG001|Overall Study|Lost to Follow-up|4|||
125217120|NCT00741598|450422038|FG000|Overall Study|Lack of Efficacy|1|||
125217121|NCT00741598|450422039|FG001|Overall Study|Lack of Efficacy|2|||
125217122|NCT00741598|450422038|FG000|Overall Study|Physician Decision|1|||
125217123|NCT00741598|450422039|FG001|Overall Study|Physician Decision|1|||
125378233|NCT01124422|451015594|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
125378234|NCT01124422|451015592|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
125378235|NCT01124422|451015593|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
125378236|NCT01124422|451015594|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
125378237|NCT01124422|451015592|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
125378238|NCT01124422|451015593|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
125378239|NCT01124422|451015594|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
125378240|NCT01124422|451015592|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
125378241|NCT01124422|451015593|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
125378242|NCT01124422|451015594|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
125378243|NCT03454893|451015597|FG000|Overall Study|Study Terminated by the Sponsor|5|||
125378244|NCT03454893|451015597|FG000|Overall Study|Did not pass screening|4|||
125378245|NCT01986985|451015602|FG000|Overall Study|Withdrawal by Subject|4|||
125378246|NCT01986985|451015602|FG000|Overall Study|Scan not completed due to malfunction|3|||
125378247|NCT03042533|451015603|FG000|Overall Study|MD left program|1|||
125378248|NCT03042533|451015604|FG001|Overall Study|MD left program|4|||
125378249|NCT03042533|451015605|FG002|Overall Study|MD left program|1|||
125378250|NCT00137046|451015607|FG000|Overall Study|Death|2|||
125378251|NCT00137046|451015608|FG001|Overall Study|Death|1|||
125378252|NCT00137046|451015607|FG000|Overall Study|Adverse Event|16|||
125378253|NCT00137046|451015608|FG001|Overall Study|Adverse Event|5|||
125378254|NCT00137046|451015607|FG000|Overall Study|Laboratory Abnormality|2|||
125378255|NCT00137046|451015608|FG001|Overall Study|Laboratory Abnormality|0|||
125378256|NCT00137046|451015607|FG000|Overall Study|Lack of Efficacy|13|||
125378257|NCT00137046|451015608|FG001|Overall Study|Lack of Efficacy|1|||
125378258|NCT00137046|451015607|FG000|Overall Study|Lost to Follow-up|8|||
125378259|NCT00137046|451015608|FG001|Overall Study|Lost to Follow-up|24|||
125378260|NCT00137046|451015607|FG000|Overall Study|Other|23|||
125378261|NCT00137046|451015608|FG001|Overall Study|Other|19|||
125378262|NCT00137046|451015607|FG000|Overall Study|Withdrawal by Subject|33|||
125378263|NCT00137046|451015608|FG001|Overall Study|Withdrawal by Subject|42|||
125378264|NCT00137046|451015607|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
125378265|NCT00137046|451015608|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
125378266|NCT00137046|451015607|FG000|Overall Study|Withdrew prior to study treatment|1|||
125378267|NCT00137046|451015608|FG001|Overall Study|Withdrew prior to study treatment|1|||
125378268|NCT03235154|451015610|FG000|Overall Study|Withdrawal by Subject|1|||
125378269|NCT03235154|451015610|FG000|Overall Study|Adverse Event|1|||
125378270|NCT03235154|451015610|FG000|Overall Study|Lost to Follow-up|2|||
125378271|NCT02326025|451015611|FG000|Overall Study|Adverse Event|3|||
125378272|NCT02326025|451015612|FG001|Overall Study|Adverse Event|0|||
125378273|NCT02326025|451015611|FG000|Overall Study|Physician Decision|1|||
125378274|NCT02326025|451015612|FG001|Overall Study|Physician Decision|2|||
125378275|NCT02326025|451015611|FG000|Overall Study|Physician and Participant Decision|1|||
125378276|NCT02326025|451015612|FG001|Overall Study|Physician and Participant Decision|0|||
125378277|NCT02326025|451015611|FG000|Overall Study|Withdrawal by Subject|0|||
125378278|NCT02326025|451015612|FG001|Overall Study|Withdrawal by Subject|2|||
125378279|NCT02326025|451015611|FG000|Overall Study|Protocol Violation|0|||
125378280|NCT02326025|451015612|FG001|Overall Study|Protocol Violation|1|||
125378281|NCT03978520|451015615|FG000|Overall Study|Adverse Event|2|||
125378282|NCT03978520|451015616|FG001|Overall Study|Adverse Event|5|||
125378283|NCT03978520|451015617|FG002|Overall Study|Adverse Event|3|||
125217124|NCT00741598|450422038|FG000|Overall Study|Pregnancy|1|||
125217125|NCT00741598|450422039|FG001|Overall Study|Pregnancy|0|||
125217126|NCT00741598|450422038|FG000|Overall Study|Withdrawal by Subject|3|||
125217127|NCT00741598|450422039|FG001|Overall Study|Withdrawal by Subject|2|||
125217128|NCT00587795|450422040|FG000|Overall Study|Withdrawal by Subject|1|||
125217129|NCT00587795|450422041|FG001|Overall Study|Withdrawal by Subject|0|||
125217130|NCT00435461|450422048|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
125217131|NCT00435461|450422049|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
125217132|NCT00435461|450422050|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
125217133|NCT00435461|450422048|FG000|Overall Study|Protocol Violation|6|||
125217134|NCT00435461|450422049|FG001|Overall Study|Protocol Violation|9|||
125217135|NCT00435461|450422050|FG002|Overall Study|Protocol Violation|10|||
125217136|NCT00435461|450422048|FG000|Overall Study|Participant randomized(inadequate score)|1|||
125217137|NCT00435461|450422049|FG001|Overall Study|Participant randomized(inadequate score)|0|||
125217138|NCT00435461|450422050|FG002|Overall Study|Participant randomized(inadequate score)|0|||
125217139|NCT00435461|450422048|FG000|Overall Study|Compliance less than 80 percent|1|||
125217140|NCT00435461|450422049|FG001|Overall Study|Compliance less than 80 percent|0|||
125217141|NCT00435461|450422050|FG002|Overall Study|Compliance less than 80 percent|0|||
125217142|NCT00435461|450422048|FG000|Overall Study|In error, two study medications switched|1|||
125217143|NCT00435461|450422049|FG001|Overall Study|In error, two study medications switched|0|||
125217144|NCT00435461|450422050|FG002|Overall Study|In error, two study medications switched|0|||
125217145|NCT00435461|450422048|FG000|Overall Study|Lack of Efficacy|2|||
125131027|NCT01577381|450106498|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
125131028|NCT01577381|450106499|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
125131029|NCT01577381|450106500|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
125131030|NCT01577381|450106501|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
125131031|NCT02186821|450106502|FG000|Overall Study|Adverse Event|9|||
125131032|NCT02186821|450106502|FG000|Overall Study|Death|2|||
125131033|NCT02186821|450106502|FG000|Overall Study|Disease progression|32|||
125131034|NCT02186821|450106502|FG000|Overall Study|Protocol Violation|1|||
125131035|NCT02186821|450106502|FG000|Overall Study|Physician Decision|1|||
125131036|NCT02186821|450106502|FG000|Overall Study|Study terminated by sponsor|2|||
125131037|NCT00819741|450106507|FG000|Overall Study|Adverse Event|5|||
125131038|NCT00819741|450106508|FG001|Overall Study|Adverse Event|2|||
125131039|NCT00819741|450106507|FG000|Overall Study|Lack of Efficacy|0|||
125131040|NCT00819741|450106508|FG001|Overall Study|Lack of Efficacy|2|||
125131041|NCT00819741|450106507|FG000|Overall Study|Lost to Follow-up|3|||
125131042|NCT00819741|450106508|FG001|Overall Study|Lost to Follow-up|1|||
125131043|NCT00819741|450106507|FG000|Overall Study|Protocol Violation|3|||
125131044|NCT00819741|450106508|FG001|Overall Study|Protocol Violation|4|||
125131045|NCT00819741|450106507|FG000|Overall Study|Withdrawal by Subject|2|||
125131046|NCT00819741|450106508|FG001|Overall Study|Withdrawal by Subject|2|||
125131047|NCT00819741|450106507|FG000|Overall Study|Unclassified|6|||
125131048|NCT00819741|450106508|FG001|Overall Study|Unclassified|0|||
125131049|NCT00819741|450106507|FG000|Overall Study|Reasons unknown|3|||
125131050|NCT00819741|450106508|FG001|Overall Study|Reasons unknown|3|||
125217146|NCT00435461|450422049|FG001|Overall Study|Lack of Efficacy|1|||
125217147|NCT00435461|450422050|FG002|Overall Study|Lack of Efficacy|0|||
125131051|NCT00119015|450106509|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
125217148|NCT00435461|450422048|FG000|Overall Study|Withdrawal by Subject|1|||
125217149|NCT00435461|450422049|FG001|Overall Study|Withdrawal by Subject|0|||
125217150|NCT00435461|450422050|FG002|Overall Study|Withdrawal by Subject|2|||
125217151|NCT00435461|450422048|FG000|Overall Study|Randomized in error|1|||
125217152|NCT00435461|450422049|FG001|Overall Study|Randomized in error|0|||
125217153|NCT00435461|450422050|FG002|Overall Study|Randomized in error|0|||
125217154|NCT00435461|450422048|FG000|Overall Study|Participant could not tolerate symptoms|0|||
125217155|NCT00435461|450422049|FG001|Overall Study|Participant could not tolerate symptoms|0|||
125217156|NCT00435461|450422050|FG002|Overall Study|Participant could not tolerate symptoms|1|||
125217157|NCT00435461|450422048|FG000|Overall Study|Participant could not swallow capsule|0|||
125217158|NCT00435461|450422049|FG001|Overall Study|Participant could not swallow capsule|0|||
125217159|NCT00435461|450422050|FG002|Overall Study|Participant could not swallow capsule|1|||
125217160|NCT00435461|450422048|FG000|Overall Study|Pregnancy|2|||
125217161|NCT00435461|450422049|FG001|Overall Study|Pregnancy|0|||
125217162|NCT00435461|450422050|FG002|Overall Study|Pregnancy|0|||
125217163|NCT00435461|450422048|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
125217164|NCT00435461|450422049|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
125217165|NCT00435461|450422050|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
125217166|NCT00435461|450422048|FG000|Overall Study|Participant ended study one day early|1|||
125217167|NCT00435461|450422049|FG001|Overall Study|Participant ended study one day early|0|||
125217168|NCT00435461|450422050|FG002|Overall Study|Participant ended study one day early|0|||
125217169|NCT00435461|450422048|FG000|Overall Study|Noncompliance with study requirements|1|||
125217170|NCT00435461|450422049|FG001|Overall Study|Noncompliance with study requirements|1|||
125217171|NCT00435461|450422050|FG002|Overall Study|Noncompliance with study requirements|1|||
125217172|NCT00435461|450422048|FG000|Overall Study|Adverse Event|1|||
125217173|NCT00435461|450422049|FG001|Overall Study|Adverse Event|2|||
125217174|NCT00435461|450422050|FG002|Overall Study|Adverse Event|6|||
125217175|NCT00435461|450422048|FG000|Overall Study|Non-Compliance of diary|2|||
125217176|NCT00435461|450422049|FG001|Overall Study|Non-Compliance of diary|0|||
125217177|NCT00435461|450422050|FG002|Overall Study|Non-Compliance of diary|1|||
125217178|NCT00435461|450422048|FG000|Overall Study|Lost to Follow-up|1|||
125217179|NCT00435461|450422049|FG001|Overall Study|Lost to Follow-up|1|||
125217180|NCT00435461|450422050|FG002|Overall Study|Lost to Follow-up|2|||
125217181|NCT00837967|450422051|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
125217182|NCT00837967|450422052|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
125217183|NCT00551525|450422055|FG000|Overall Study|Protocol Violation|5|||
125217184|NCT04676724|450422056|FG000|Overall Study|Adverse Event|2|||
125217185|NCT04676724|450422057|FG001|Overall Study|Adverse Event|0|||
125217186|NCT04676724|450422056|FG000|Overall Study|Lost to Follow-up|1|||
125217187|NCT04676724|450422057|FG001|Overall Study|Lost to Follow-up|0|||
125217188|NCT04676724|450422056|FG000|Overall Study|Physician Decision|0|||
125217189|NCT04676724|450422057|FG001|Overall Study|Physician Decision|1|||
125217190|NCT04676724|450422056|FG000|Overall Study|Withdrawal by Subject|3|||
125217191|NCT04676724|450422057|FG001|Overall Study|Withdrawal by Subject|2|||
125217192|NCT05446142|450422068|FG000|Period 2|Adverse Event|1|||
125217193|NCT05446142|450422069|FG001|Period 2|Adverse Event|0|||
125217194|NCT05446142|450422070|FG002|Period 2|Adverse Event|0|||
125217195|NCT05446142|450422071|FG003|Period 2|Adverse Event|0|||
125217196|NCT05446142|450422072|FG004|Period 2|Adverse Event|0|||
125217197|NCT05446142|450422073|FG005|Period 2|Adverse Event|0|||
125635944|NCT03558828|451950794|FG002|Overall Study|Lost to Follow-up|3|||
125131052|NCT00119015|450106510|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
125131053|NCT00119015|450106511|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
125131054|NCT01313780|450106512|FG000|Overall Study|Lack of Efficacy|4|||
125131055|NCT01313780|450106513|FG001|Overall Study|Lack of Efficacy|2|||
125131056|NCT01313780|450106512|FG000|Overall Study|Adverse Event|6|||
125131057|NCT01313780|450106513|FG001|Overall Study|Adverse Event|11|||
125131058|NCT01313780|450106512|FG000|Overall Study|Withdrawal by Subject|2|||
125217198|NCT02098395|450422074|FG000|Overall Study|Protocol Violation|2|||
125217199|NCT02098395|450422075|FG001|Overall Study|Protocol Violation|2|||
125217200|NCT02098395|450422076|FG002|Overall Study|Protocol Violation|0|||
125217201|NCT02098395|450422077|FG003|Overall Study|Protocol Violation|7|||
125217202|NCT02098395|450422074|FG000|Overall Study|Withdrawal by Subject|10|||
125217203|NCT02098395|450422075|FG001|Overall Study|Withdrawal by Subject|10|||
125635945|NCT03558828|451950795|FG003|Overall Study|Lost to Follow-up|5|||
125217204|NCT02098395|450422076|FG002|Overall Study|Withdrawal by Subject|5|||
125217205|NCT02098395|450422077|FG003|Overall Study|Withdrawal by Subject|13|||
125217206|NCT02098395|450422074|FG000|Overall Study|Adverse Event|12|||
125635946|NCT03558828|451950796|FG004|Overall Study|Lost to Follow-up|2|||
125217207|NCT02098395|450422075|FG001|Overall Study|Adverse Event|19|||
125217208|NCT02098395|450422076|FG002|Overall Study|Adverse Event|34|||
125217209|NCT02098395|450422077|FG003|Overall Study|Adverse Event|2|||
125217210|NCT02098395|450422074|FG000|Overall Study|Lost to Follow-up|2|||
125217211|NCT02098395|450422075|FG001|Overall Study|Lost to Follow-up|1|||
125217212|NCT02098395|450422076|FG002|Overall Study|Lost to Follow-up|0|||
125217213|NCT02098395|450422077|FG003|Overall Study|Lost to Follow-up|3|||
125217214|NCT02098395|450422074|FG000|Overall Study|Unclassified|0|||
125217215|NCT02098395|450422075|FG001|Overall Study|Unclassified|0|||
125217216|NCT02098395|450422076|FG002|Overall Study|Unclassified|3|||
125217217|NCT02098395|450422077|FG003|Overall Study|Unclassified|2|||
125217218|NCT00547157|450422080|FG000|Overall Study|Other|1|||
125217219|NCT00547157|450422081|FG001|Overall Study|Other|0|||
125217220|NCT00547157|450422080|FG000|Overall Study|Death|38|||
125217221|NCT00547157|450422081|FG001|Overall Study|Death|18|||
125217222|NCT00547157|450422080|FG000|Overall Study|Withdrawal by Subject|3|||
125217223|NCT00547157|450422081|FG001|Overall Study|Withdrawal by Subject|1|||
125217224|NCT00547157|450422080|FG000|Overall Study|Administrative decision|3|||
125217225|NCT00547157|450422081|FG001|Overall Study|Administrative decision|2|||
125217226|NCT00547157|450422080|FG000|Overall Study|Lost to Follow-up|4|||
125217227|NCT00547157|450422081|FG001|Overall Study|Lost to Follow-up|2|||
125217228|NCT00110357|450422082|FG000|Overall Study|Deterioration without progression|2|||
125217229|NCT00110357|450422083|FG001|Overall Study|Deterioration without progression|0|||
125217230|NCT00110357|450422082|FG000|Overall Study|Disease progression/relapse|20|||
125217231|NCT00110357|450422083|FG001|Overall Study|Disease progression/relapse|15|||
125217232|NCT00110357|450422082|FG000|Overall Study|Study Closure|1|||
125131059|NCT01313780|450106513|FG001|Overall Study|Withdrawal by Subject|8|||
125131060|NCT01313780|450106512|FG000|Overall Study|Protocol Violation|10|||
125131061|NCT01313780|450106513|FG001|Overall Study|Protocol Violation|4|||
125131062|NCT01313780|450106512|FG000|Overall Study|missing data|3|||
125131063|NCT01313780|450106513|FG001|Overall Study|missing data|3|||
125131064|NCT03235739|450107973|FG000|Overall Study|Withdrawal by Subject|2|||
125131065|NCT03235739|450107974|FG001|Overall Study|Withdrawal by Subject|2|||
125131066|NCT03235739|450107973|FG000|Overall Study|Physician Decision|0|||
125131067|NCT03235739|450107974|FG001|Overall Study|Physician Decision|1|||
125131068|NCT00834522|450107977|FG000|Washout|Adverse Event|1|||
125131069|NCT00834522|450107978|FG001|Washout|Adverse Event|0|||
125131070|NCT00834522|450107977|FG000|Washout|Withdrawal by Subject|2|||
125131071|NCT00834522|450107978|FG001|Washout|Withdrawal by Subject|1|||
125131072|NCT00834249|450107979|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
125131073|NCT00834249|450107980|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
125131074|NCT00834249|450107979|FG000|Second Intervention|Adverse Event|1|||
125131075|NCT00834249|450107980|FG001|Second Intervention|Adverse Event|0|||
125131076|NCT02146105|450107983|FG000|Overall Study|Adverse Event|1|||
125131077|NCT02146105|450107983|FG000|Overall Study|Withdrawal by Subject|5|||
125131078|NCT05755282|450107984|FG000|Overall Study|Protocol Violation|0|||
125131079|NCT05755282|450107985|FG001|Overall Study|Protocol Violation|1|||
125131080|NCT02476994|450107987|FG000|Overall Study|Based on feedback from FDA|1|||
125131081|NCT02476994|450107988|FG001|Overall Study|Based on feedback from FDA|0|||
125131082|NCT01558635|450107991|FG000|Overall Study|Death|1|||
125131083|NCT01558635|450107991|FG000|Overall Study|Withdrawal by Subject|2|||
125131084|NCT01558635|450107991|FG000|Overall Study|Physician Decision|1|||
125131085|NCT01558635|450107991|FG000|Overall Study|Subject received other treatment|1|||
125131086|NCT01558635|450107991|FG000|Overall Study|Reveal XT was explanted|1|||
125131087|NCT03699020|450107992|FG000|Overall Study|Withdrawal by Subject|3|||
125131088|NCT03699020|450107993|FG001|Overall Study|Withdrawal by Subject|2|||
125131089|NCT02246920|450107994|FG000|Overall Study|Adverse Event|3|||
125131090|NCT02246920|450107995|FG001|Overall Study|Adverse Event|1|||
125131091|NCT02246920|450107996|FG002|Overall Study|Adverse Event|1|||
125131092|NCT02246920|450107994|FG000|Overall Study|Lost to Follow-up|2|||
125131093|NCT02246920|450107995|FG001|Overall Study|Lost to Follow-up|1|||
125131094|NCT02246920|450107996|FG002|Overall Study|Lost to Follow-up|0|||
125217233|NCT00110357|450422083|FG001|Overall Study|Study Closure|0|||
125635947|NCT03558828|451950797|FG005|Overall Study|Lost to Follow-up|3|||
125635948|NCT03558828|451950792|FG000|Overall Study|dropped before the intervention|1|||
125635949|NCT03558828|451950793|FG001|Overall Study|dropped before the intervention|1|||
125131095|NCT02246920|450107994|FG000|Overall Study|Protocol Violation|2|||
125131096|NCT02246920|450107995|FG001|Overall Study|Protocol Violation|5|||
125131097|NCT02246920|450107996|FG002|Overall Study|Protocol Violation|1|||
125131098|NCT02246920|450107994|FG000|Overall Study|Withdrawal by Subject|0|||
125217234|NCT00110357|450422082|FG000|Overall Study|Study Drug Toxicity|1|||
125217235|NCT00110357|450422083|FG001|Overall Study|Study Drug Toxicity|3|||
125131099|NCT02246920|450107995|FG001|Overall Study|Withdrawal by Subject|0|||
125131100|NCT02246920|450107996|FG002|Overall Study|Withdrawal by Subject|1|||
125131101|NCT00448019|450107999|FG000|Overall Study|Withdrawal by Subject|3|||
125131102|NCT00448019|450107999|FG000|Overall Study|Disease progression|1|||
125217236|NCT00110357|450422082|FG000|Overall Study|Withdrawal by Subject|3|||
125378284|NCT03978520|451015618|FG003|Overall Study|Adverse Event|5|||
125378285|NCT03978520|451015619|FG004|Overall Study|Adverse Event|6|||
125131103|NCT00448019|450107999|FG000|Overall Study|Death|2|||
125131104|NCT00448019|450107999|FG000|Overall Study|Insurance Issues|1|||
125131105|NCT02543203|450108000|FG000|Overall Study|Unpalatable Fragrance|2|||
125131106|NCT02543203|450108001|FG001|Overall Study|Unpalatable Fragrance|2|||
125217237|NCT00110357|450422083|FG001|Overall Study|Withdrawal by Subject|1|||
125217238|NCT03382418|450422084|FG000|Overall Study|Withdrawal by Subject|1|||
125635950|NCT03558828|451950794|FG002|Overall Study|dropped before the intervention|0|||
125378286|NCT03978520|451015615|FG000|Overall Study|Withdrawal by Subject|10|||
125378287|NCT03978520|451015616|FG001|Overall Study|Withdrawal by Subject|4|||
125378288|NCT03978520|451015617|FG002|Overall Study|Withdrawal by Subject|5|||
125378289|NCT03978520|451015618|FG003|Overall Study|Withdrawal by Subject|6|||
125378290|NCT03978520|451015619|FG004|Overall Study|Withdrawal by Subject|5|||
125378291|NCT03978520|451015615|FG000|Overall Study|Lost to Follow-up|2|||
125378292|NCT03978520|451015616|FG001|Overall Study|Lost to Follow-up|2|||
125378293|NCT03978520|451015617|FG002|Overall Study|Lost to Follow-up|2|||
125378294|NCT03978520|451015618|FG003|Overall Study|Lost to Follow-up|0|||
125378295|NCT03978520|451015619|FG004|Overall Study|Lost to Follow-up|1|||
125378296|NCT03978520|451015615|FG000|Overall Study|COVID-19 infection|0|||
125378297|NCT03978520|451015616|FG001|Overall Study|COVID-19 infection|1|||
125378298|NCT03978520|451015617|FG002|Overall Study|COVID-19 infection|0|||
125635951|NCT03558828|451950795|FG003|Overall Study|dropped before the intervention|0|||
125635952|NCT03558828|451950796|FG004|Overall Study|dropped before the intervention|0|||
125131107|NCT02543203|450108000|FG000|Overall Study|Lost to Follow-up|1|||
125131108|NCT02543203|450108001|FG001|Overall Study|Lost to Follow-up|0|||
125131109|NCT02543203|450108000|FG000|Overall Study|Increased Irritability|1|||
125378299|NCT03978520|451015618|FG003|Overall Study|COVID-19 infection|0|||
125378300|NCT03978520|451015619|FG004|Overall Study|COVID-19 infection|0|||
125378301|NCT03978520|451015615|FG000|Overall Study|Other, not specified|9|||
125378302|NCT03978520|451015616|FG001|Overall Study|Other, not specified|4|||
125378303|NCT03978520|451015617|FG002|Overall Study|Other, not specified|1|||
125378304|NCT03978520|451015618|FG003|Overall Study|Other, not specified|1|||
125378305|NCT03978520|451015619|FG004|Overall Study|Other, not specified|2|||
125378306|NCT03978520|451015615|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
125378307|NCT03978520|451015616|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
125378308|NCT03978520|451015617|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
125378309|NCT03978520|451015618|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
125378310|NCT03978520|451015619|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
125378311|NCT00230607|451015620|FG000|Overall Study|Other|3|||
125378312|NCT02547454|451015626|FG000|Overall Study|Due to hemodialysis|53|||
125378313|NCT02547454|451015626|FG000|Overall Study|Due to transplantation|1|||
125378314|NCT02547454|451015626|FG000|Overall Study|Due to no further need to treat|4|||
125378315|NCT02547454|451015626|FG000|Overall Study|Death|38|||
125378316|NCT02547454|451015626|FG000|Overall Study|Lost to Follow-up|26|||
125378317|NCT02547454|451015626|FG000|Overall Study|Other|39|||
125378318|NCT02547454|451015626|FG000|Overall Study|No data|11|||
125378319|NCT00203996|451015629|FG000|Overall Study|Lost to Follow-up|0|||
125378320|NCT00203996|451015630|FG001|Overall Study|Lost to Follow-up|0|||
125378321|NCT00203996|451015631|FG002|Overall Study|Lost to Follow-up|0|||
125378322|NCT00203996|451015632|FG003|Overall Study|Lost to Follow-up|1|||
125378323|NCT00203996|451015633|FG004|Overall Study|Lost to Follow-up|0|||
125378324|NCT00203996|451015634|FG005|Overall Study|Lost to Follow-up|0|||
125378325|NCT00203996|451015635|FG006|Overall Study|Lost to Follow-up|0|||
125378326|NCT00203996|451015636|FG007|Overall Study|Lost to Follow-up|0|||
125378327|NCT00203996|451015637|FG008|Overall Study|Lost to Follow-up|0|||
125378328|NCT00203996|451015638|FG009|Overall Study|Lost to Follow-up|0|||
125378329|NCT00203996|451015629|FG000|Overall Study|Protocol Violation|0|||
125378330|NCT00203996|451015630|FG001|Overall Study|Protocol Violation|0|||
125378331|NCT00203996|451015631|FG002|Overall Study|Protocol Violation|0|||
125378332|NCT00203996|451015632|FG003|Overall Study|Protocol Violation|6|||
125378333|NCT00203996|451015633|FG004|Overall Study|Protocol Violation|1|||
125378334|NCT00203996|451015634|FG005|Overall Study|Protocol Violation|0|||
125378335|NCT00203996|451015635|FG006|Overall Study|Protocol Violation|0|||
125378336|NCT00203996|451015636|FG007|Overall Study|Protocol Violation|0|||
125378337|NCT00203996|451015637|FG008|Overall Study|Protocol Violation|0|||
125378338|NCT00203996|451015638|FG009|Overall Study|Protocol Violation|0|||
125378339|NCT00203996|451015629|FG000|Overall Study|Physician Decision|0|||
125378340|NCT00203996|451015630|FG001|Overall Study|Physician Decision|0|||
125378341|NCT00203996|451015631|FG002|Overall Study|Physician Decision|0|||
125378342|NCT00203996|451015632|FG003|Overall Study|Physician Decision|2|||
125378343|NCT00203996|451015633|FG004|Overall Study|Physician Decision|0|||
125378344|NCT00203996|451015634|FG005|Overall Study|Physician Decision|0|||
125378345|NCT00203996|451015635|FG006|Overall Study|Physician Decision|0|||
125378346|NCT00203996|451015636|FG007|Overall Study|Physician Decision|0|||
125378347|NCT00203996|451015637|FG008|Overall Study|Physician Decision|0|||
125378348|NCT00203996|451015638|FG009|Overall Study|Physician Decision|1|||
125378349|NCT00203996|451015629|FG000|Overall Study|CPAP machine malfunction|0|||
125378350|NCT00203996|451015630|FG001|Overall Study|CPAP machine malfunction|0|||
125378351|NCT00203996|451015631|FG002|Overall Study|CPAP machine malfunction|0|||
125378352|NCT00203996|451015632|FG003|Overall Study|CPAP machine malfunction|1|||
125378353|NCT00203996|451015633|FG004|Overall Study|CPAP machine malfunction|0|||
125378354|NCT00203996|451015634|FG005|Overall Study|CPAP machine malfunction|0|||
125378355|NCT00203996|451015635|FG006|Overall Study|CPAP machine malfunction|0|||
125378356|NCT00203996|451015636|FG007|Overall Study|CPAP machine malfunction|0|||
125378357|NCT00203996|451015637|FG008|Overall Study|CPAP machine malfunction|0|||
125378358|NCT00203996|451015638|FG009|Overall Study|CPAP machine malfunction|0|||
125378359|NCT00203996|451015629|FG000|Overall Study|Scheduling issue|0|||
125378360|NCT00203996|451015630|FG001|Overall Study|Scheduling issue|0|||
125378361|NCT00203996|451015631|FG002|Overall Study|Scheduling issue|0|||
125378362|NCT00203996|451015632|FG003|Overall Study|Scheduling issue|0|||
125378363|NCT00203996|451015633|FG004|Overall Study|Scheduling issue|0|||
125378364|NCT00203996|451015634|FG005|Overall Study|Scheduling issue|0|||
125378365|NCT00203996|451015635|FG006|Overall Study|Scheduling issue|0|||
125378366|NCT00203996|451015636|FG007|Overall Study|Scheduling issue|2|||
125378367|NCT00203996|451015637|FG008|Overall Study|Scheduling issue|0|||
125378368|NCT00203996|451015638|FG009|Overall Study|Scheduling issue|0|||
125378369|NCT02700815|451017156|FG000|Overall Study|Adverse Event|0|||
125378370|NCT02700815|451017157|FG001|Overall Study|Adverse Event|6|||
125378371|NCT02700815|451017158|FG002|Overall Study|Adverse Event|2|||
125378372|NCT02700815|451017159|FG003|Overall Study|Adverse Event|3|||
125378373|NCT02700815|451017156|FG000|Overall Study|Lack of Efficacy|0|||
125378374|NCT02700815|451017157|FG001|Overall Study|Lack of Efficacy|0|||
125378375|NCT02700815|451017158|FG002|Overall Study|Lack of Efficacy|1|||
125378376|NCT02700815|451017159|FG003|Overall Study|Lack of Efficacy|2|||
125378377|NCT02700815|451017156|FG000|Overall Study|Lost to Follow-up|1|||
125378378|NCT02700815|451017157|FG001|Overall Study|Lost to Follow-up|0|||
125378379|NCT02700815|451017158|FG002|Overall Study|Lost to Follow-up|0|||
125378380|NCT02700815|451017159|FG003|Overall Study|Lost to Follow-up|1|||
125378381|NCT02700815|451017156|FG000|Overall Study|Refusal to continue medication|0|||
125378382|NCT02700815|451017157|FG001|Overall Study|Refusal to continue medication|1|||
125378383|NCT02700815|451017158|FG002|Overall Study|Refusal to continue medication|0|||
125378384|NCT02700815|451017159|FG003|Overall Study|Refusal to continue medication|1|||
125378385|NCT02700815|451017156|FG000|Overall Study|Withdrawal by Subject|0|||
125378386|NCT02700815|451017157|FG001|Overall Study|Withdrawal by Subject|0|||
125378387|NCT02700815|451017158|FG002|Overall Study|Withdrawal by Subject|1|||
125378388|NCT02700815|451017159|FG003|Overall Study|Withdrawal by Subject|0|||
125378389|NCT00524368|451017160|FG000|Overall Study|Adverse Event|10|||
125378390|NCT00524368|451017161|FG001|Overall Study|Adverse Event|12|||
125378391|NCT00524368|451017160|FG000|Overall Study|Lost to Follow-up|9|||
125378392|NCT00524368|451017161|FG001|Overall Study|Lost to Follow-up|13|||
125378393|NCT00524368|451017160|FG000|Overall Study|Withdrawal by Subject|4|||
125378394|NCT00524368|451017161|FG001|Overall Study|Withdrawal by Subject|5|||
125378395|NCT00524368|451017160|FG000|Overall Study|Non-compliant|8|||
125378396|NCT00524368|451017161|FG001|Overall Study|Non-compliant|9|||
125378397|NCT00524368|451017160|FG000|Overall Study|Reached a Virologic Endpoint|3|||
125378398|NCT00524368|451017161|FG001|Overall Study|Reached a Virologic Endpoint|2|||
125378399|NCT00524368|451017160|FG000|Overall Study|Sponsor's Decision|2|||
125378400|NCT00524368|451017161|FG001|Overall Study|Sponsor's Decision|0|||
125378401|NCT00524368|451017160|FG000|Overall Study|Ineligible to Continue the study|2|||
125378402|NCT00524368|451017161|FG001|Overall Study|Ineligible to Continue the study|5|||
125635953|NCT03558828|451950797|FG005|Overall Study|dropped before the intervention|0|||
125635954|NCT00378534|451950798|FG000|Overall Study|Participants did not receive transplant|3|||
125635955|NCT00378534|451950799|FG001|Overall Study|Participants did not receive transplant|0|||
125378403|NCT00524368|451017160|FG000|Overall Study|Other|3|||
125635956|NCT04969900|451950800|FG000|Overall Study|Physician Decision|1|||
125635957|NCT04969900|451950801|FG001|Overall Study|Physician Decision|1|||
125635958|NCT04969900|451950800|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
125635959|NCT04969900|451950801|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
125635960|NCT03671148|451950807|FG000|Overall Study|Adverse Event|3|||
125635961|NCT03671148|451950808|FG001|Overall Study|Adverse Event|2|||
125635962|NCT03671148|451950807|FG000|Overall Study|Withdrawal by Subject|8|||
125635963|NCT03671148|451950808|FG001|Overall Study|Withdrawal by Subject|2|||
125635964|NCT03671148|451950807|FG000|Overall Study|Lost to Follow-up|1|||
125635965|NCT03671148|451950808|FG001|Overall Study|Lost to Follow-up|2|||
125635966|NCT03671148|451950807|FG000|Overall Study|Lack of Efficacy|7|||
125635967|NCT03671148|451950808|FG001|Overall Study|Lack of Efficacy|2|||
125635968|NCT03671148|451950807|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
125635969|NCT03671148|451950808|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
125635970|NCT03671148|451950807|FG000|Overall Study|Other|1|||
125635971|NCT03671148|451950808|FG001|Overall Study|Other|0|||
125635972|NCT03671148|451950807|FG000|Overall Study|Incomplete Randomization Visit|1|||
125378404|NCT00524368|451017161|FG001|Overall Study|Other|2|||
125378405|NCT00531232|451017162|FG000|Overall Study|Investigator decision|0|||
125378406|NCT00531232|451017163|FG001|Overall Study|Investigator decision|0|||
125378407|NCT00531232|451017164|FG002|Overall Study|Investigator decision|4|||
125378408|NCT00531232|451017162|FG000|Overall Study|Participants refused further treatment|0|||
125378409|NCT00531232|451017163|FG001|Overall Study|Participants refused further treatment|1|||
125635973|NCT03671148|451950808|FG001|Overall Study|Incomplete Randomization Visit|0|||
125635974|NCT04423718|451950809|FG000|Main Study|Adverse Event|9|||
125635975|NCT04423718|451950810|FG001|Main Study|Adverse Event|5|||
125635976|NCT04423718|451950811|FG002|Main Study|Adverse Event|8|||
125131110|NCT02543203|450108001|FG001|Overall Study|Increased Irritability|0|||
125131111|NCT02543203|450108000|FG000|Overall Study|Family|1|||
125378410|NCT00531232|451017164|FG002|Overall Study|Participants refused further treatment|2|||
125378411|NCT00531232|451017162|FG000|Overall Study|Adverse events (AEs)|1|||
125378412|NCT00531232|451017163|FG001|Overall Study|Adverse events (AEs)|2|||
125378413|NCT00531232|451017164|FG002|Overall Study|Adverse events (AEs)|2|||
125378414|NCT00531232|451017162|FG000|Overall Study|Treatment failure|1|||
125378415|NCT00531232|451017163|FG001|Overall Study|Treatment failure|3|||
125378416|NCT00531232|451017164|FG002|Overall Study|Treatment failure|7|||
125378417|NCT00531232|451017162|FG000|Overall Study|Disease recurrence|0|||
125131112|NCT02543203|450108001|FG001|Overall Study|Family|2|||
125378418|NCT00531232|451017163|FG001|Overall Study|Disease recurrence|0|||
125378419|NCT00531232|451017164|FG002|Overall Study|Disease recurrence|1|||
125378420|NCT00531232|451017162|FG000|Overall Study|Deceased|2|||
125217239|NCT03382418|450422085|FG001|Overall Study|Withdrawal by Subject|0|||
125217240|NCT03382418|450422086|FG002|Overall Study|Withdrawal by Subject|0|||
125217241|NCT03382418|450422084|FG000|Overall Study|Lost to Follow-up|2|||
125217242|NCT03382418|450422085|FG001|Overall Study|Lost to Follow-up|3|||
125217243|NCT03382418|450422086|FG002|Overall Study|Lost to Follow-up|0|||
125217244|NCT04633226|450422087|FG000|Overall Study|Withdrawal by parent/guardian|4|||
125217245|NCT04633226|450422087|FG000|Overall Study|Randomized by mistake without study treatment|1|||
125217246|NCT01151345|450422088|FG000|First Intervention Period|Protocol Violation|0|||
125217247|NCT01151345|450422089|FG001|First Intervention Period|Protocol Violation|1|||
125217248|NCT00099632|450422092|FG000|Overall Study|Lost to Follow-up|1|||
125217249|NCT00099632|450422093|FG001|Overall Study|Lost to Follow-up|0|||
125217250|NCT00099632|450422094|FG002|Overall Study|Lost to Follow-up|3|||
125217251|NCT00099632|450422095|FG003|Overall Study|Lost to Follow-up|1|||
125378421|NCT00531232|451017163|FG001|Overall Study|Deceased|2|||
125378422|NCT00531232|451017164|FG002|Overall Study|Deceased|2|||
125378423|NCT00531232|451017162|FG000|Overall Study|Withdrawal by Subject|0|||
125378424|NCT00531232|451017163|FG001|Overall Study|Withdrawal by Subject|1|||
125378425|NCT00531232|451017164|FG002|Overall Study|Withdrawal by Subject|2|||
125217252|NCT00099632|450422096|FG004|Overall Study|Lost to Follow-up|1|||
125217253|NCT00099632|450422097|FG005|Overall Study|Lost to Follow-up|0|||
125217254|NCT00099632|450422092|FG000|Overall Study|Withdrawal by Subject|0|||
125217255|NCT00099632|450422093|FG001|Overall Study|Withdrawal by Subject|1|||
125378426|NCT00531232|451017162|FG000|Overall Study|Other|0|||
125378427|NCT00531232|451017163|FG001|Overall Study|Other|0|||
125378428|NCT00531232|451017164|FG002|Overall Study|Other|5|||
125217256|NCT00099632|450422094|FG002|Overall Study|Withdrawal by Subject|0|||
125378429|NCT01948050|451017168|FG000|Overall Study|Withdrawal by Subject|0|||
125378430|NCT01948050|451017169|FG001|Overall Study|Withdrawal by Subject|1|||
125378431|NCT02288559|451017170|FG000|Overall Study|Adverse Event|1|||
125378432|NCT02288559|451017171|FG001|Overall Study|Adverse Event|1|||
125378433|NCT02288559|451017172|FG002|Overall Study|Adverse Event|5|||
125378434|NCT02288559|451017173|FG003|Overall Study|Adverse Event|0|||
125131113|NCT02543203|450108000|FG000|Overall Study|Negative Behavior|1|||
125131114|NCT02543203|450108001|FG001|Overall Study|Negative Behavior|0|||
125131115|NCT02543203|450108000|FG000|Overall Study|Withdrawal by Subject|0|||
125131116|NCT02543203|450108001|FG001|Overall Study|Withdrawal by Subject|1|||
125131117|NCT02077465|450108002|FG000|Overall Study|Withdrew Consent|0|||
125131118|NCT02077465|450108003|FG001|Overall Study|Withdrew Consent|1|||
125131119|NCT02077465|450108002|FG000|Overall Study|Lost to Follow-up|1|||
125131120|NCT02077465|450108003|FG001|Overall Study|Lost to Follow-up|0|||
125131121|NCT01827163|450108004|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
125131122|NCT01827163|450108004|FG000|Overall Study|Adverse Event|9|||
125131123|NCT03620747|450108006|FG000|Overall Study|Participant decision|7|||
125131124|NCT03620747|450108006|FG000|Overall Study|Adverse Event|6|||
125378435|NCT02288559|451017170|FG000|Overall Study|Death|0|||
125378436|NCT02288559|451017171|FG001|Overall Study|Death|0|||
125378437|NCT02288559|451017172|FG002|Overall Study|Death|1|||
125378438|NCT02288559|451017173|FG003|Overall Study|Death|0|||
125131125|NCT03620747|450108006|FG000|Overall Study|Lack of Efficacy|1|||
125378439|NCT02288559|451017170|FG000|Overall Study|Lost to Follow-up|0|||
125131126|NCT03620747|450108006|FG000|Overall Study|Poor compliance to protocol|2|||
125378440|NCT02288559|451017171|FG001|Overall Study|Lost to Follow-up|0|||
125378441|NCT02288559|451017172|FG002|Overall Study|Lost to Follow-up|0|||
125217257|NCT00099632|450422095|FG003|Overall Study|Withdrawal by Subject|0|||
125217258|NCT00099632|450422096|FG004|Overall Study|Withdrawal by Subject|0|||
125217259|NCT00099632|450422097|FG005|Overall Study|Withdrawal by Subject|1|||
125217260|NCT00099632|450422092|FG000|Overall Study|Protocol Violation|0|||
125217261|NCT00099632|450422093|FG001|Overall Study|Protocol Violation|0|||
125217262|NCT00099632|450422094|FG002|Overall Study|Protocol Violation|0|||
125217263|NCT00099632|450422095|FG003|Overall Study|Protocol Violation|0|||
125217264|NCT00099632|450422096|FG004|Overall Study|Protocol Violation|0|||
125217265|NCT00099632|450422097|FG005|Overall Study|Protocol Violation|1|||
125217266|NCT03134911|450422104|FG000|Overall Study|Screen failure|31|||
125217267|NCT03134911|450422104|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
125217268|NCT01087203|450422105|FG000|Overall Study|Lost to Follow-up|2|||
125217269|NCT01087203|450422106|FG001|Overall Study|Lost to Follow-up|0|||
125217270|NCT01087203|450422105|FG000|Overall Study|Withdrawal by Subject|2|||
125217271|NCT01087203|450422106|FG001|Overall Study|Withdrawal by Subject|6|||
125217272|NCT01087203|450422105|FG000|Overall Study|Lack of Efficacy|1|||
125217273|NCT01087203|450422106|FG001|Overall Study|Lack of Efficacy|2|||
125217274|NCT01087203|450422105|FG000|Overall Study|Study terminated by sponsor|27|||
125217275|NCT01087203|450422106|FG001|Overall Study|Study terminated by sponsor|27|||
125217276|NCT05305989|450422108|FG000|Overall Study|Other|3|||
125217277|NCT05305989|450422109|FG001|Overall Study|Other|2|||
125217278|NCT05305989|450422110|FG002|Overall Study|Other|0|||
125217279|NCT05305989|450422108|FG000|Overall Study|Sponsor decision|2|||
125217280|NCT05305989|450422109|FG001|Overall Study|Sponsor decision|1|||
125217281|NCT05305989|450422110|FG002|Overall Study|Sponsor decision|0|||
125217282|NCT05305989|450422108|FG000|Overall Study|Protocol Violation|0|||
125217283|NCT05305989|450422109|FG001|Overall Study|Protocol Violation|1|||
125217284|NCT05305989|450422110|FG002|Overall Study|Protocol Violation|0|||
125217285|NCT05305989|450422108|FG000|Overall Study|Investigator decision|1|||
125217286|NCT05305989|450422109|FG001|Overall Study|Investigator decision|2|||
125217287|NCT05305989|450422110|FG002|Overall Study|Investigator decision|0|||
125217288|NCT05305989|450422108|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
125217289|NCT05305989|450422109|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
125217290|NCT05305989|450422110|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
125217291|NCT05305989|450422108|FG000|Overall Study|Adverse Event|1|||
125217292|NCT05305989|450422109|FG001|Overall Study|Adverse Event|1|||
125217293|NCT05305989|450422110|FG002|Overall Study|Adverse Event|0|||
125217294|NCT05305989|450422108|FG000|Overall Study|Enrolled but never dosed|3|||
125217295|NCT05305989|450422109|FG001|Overall Study|Enrolled but never dosed|2|||
125217296|NCT05305989|450422110|FG002|Overall Study|Enrolled but never dosed|1|||
125217297|NCT02182830|450422111|FG000|Overall Study|Not Treated|1|||
125217298|NCT02182830|450422112|FG001|Overall Study|Not Treated|1|||
125217299|NCT02182830|450422111|FG000|Overall Study|Trial stopped, reason missing|3|||
125217300|NCT02182830|450422112|FG001|Overall Study|Trial stopped, reason missing|3|||
125217301|NCT02182830|450422111|FG000|Overall Study|Consent withdrawn|8|||
125217302|NCT02182830|450422112|FG001|Overall Study|Consent withdrawn|8|||
125217303|NCT02182830|450422111|FG000|Overall Study|Lost to Follow-up|3|||
125217304|NCT02182830|450422112|FG001|Overall Study|Lost to Follow-up|3|||
125217305|NCT00154375|450422113|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
125217306|NCT00154375|450422114|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
125217307|NCT00154375|450422113|FG000|Overall Study|Adverse Event|18|||
125217308|NCT00154375|450422114|FG001|Overall Study|Adverse Event|20|||
125217309|NCT00154375|450422113|FG000|Overall Study|Withdrawal by Subject|14|||
125217310|NCT00154375|450422114|FG001|Overall Study|Withdrawal by Subject|10|||
125217311|NCT00154375|450422113|FG000|Overall Study|Death|5|||
125217312|NCT00154375|450422114|FG001|Overall Study|Death|13|||
125217313|NCT00154375|450422113|FG000|Overall Study|Study drug no longer required|5|||
125217314|NCT00154375|450422114|FG001|Overall Study|Study drug no longer required|3|||
125217315|NCT00154375|450422113|FG000|Overall Study|Lost to Follow-up|2|||
125217316|NCT00154375|450422114|FG001|Overall Study|Lost to Follow-up|1|||
125217317|NCT00154375|450422113|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125217318|NCT00154375|450422114|FG001|Overall Study|Abnormal laboratory value(s)|2|||
125217319|NCT00154375|450422113|FG000|Overall Study|Protocol Violation|0|||
125217320|NCT00154375|450422114|FG001|Overall Study|Protocol Violation|1|||
125217321|NCT00154375|450422113|FG000|Overall Study|Suspected progression of disease|44|||
125217322|NCT00154375|450422114|FG001|Overall Study|Suspected progression of disease|30|||
125217323|NCT02348008|450422115|FG000|Overall Study|Adverse Event|2|||
125217324|NCT02348008|450422116|FG001|Overall Study|Adverse Event|3|||
125217325|NCT02348008|450422117|FG002|Overall Study|Adverse Event|3|||
125217326|NCT02348008|450422115|FG000|Overall Study|Disease Progression|1|||
125217327|NCT02348008|450422116|FG001|Overall Study|Disease Progression|5|||
125217328|NCT02348008|450422117|FG002|Overall Study|Disease Progression|16|||
125217329|NCT02348008|450422115|FG000|Overall Study|Withdrawal by Subject|0|||
125217330|NCT02348008|450422116|FG001|Overall Study|Withdrawal by Subject|1|||
125217331|NCT02348008|450422117|FG002|Overall Study|Withdrawal by Subject|0|||
125217332|NCT02348008|450422115|FG000|Overall Study|Symptomatic Deterioration|0|||
125131127|NCT03620747|450108006|FG000|Overall Study|Other-unspecified|3|||
125131128|NCT02714062|450108007|FG000|Overall Study|Adverse Event|0|||
125378442|NCT02288559|451017173|FG003|Overall Study|Lost to Follow-up|1|||
125378443|NCT02288559|451017170|FG000|Overall Study|Withdrawal by Subject|0|||
125378444|NCT02288559|451017171|FG001|Overall Study|Withdrawal by Subject|0|||
125378445|NCT02288559|451017172|FG002|Overall Study|Withdrawal by Subject|2|||
125378446|NCT02288559|451017173|FG003|Overall Study|Withdrawal by Subject|1|||
125378447|NCT02288559|451017170|FG000|Overall Study|Reason Not Specified|0|||
125378448|NCT02288559|451017171|FG001|Overall Study|Reason Not Specified|0|||
125378449|NCT02288559|451017172|FG002|Overall Study|Reason Not Specified|3|||
125378450|NCT02288559|451017173|FG003|Overall Study|Reason Not Specified|0|||
125378451|NCT03303079|451017174|FG000|Overall Study|Adverse Event|0|||
125378452|NCT03303079|451017175|FG001|Overall Study|Adverse Event|1|||
125378453|NCT03303079|451017176|FG002|Overall Study|Adverse Event|3|||
125378454|NCT03303079|451017174|FG000|Overall Study|Protocol Violation|5|||
125378455|NCT03303079|451017175|FG001|Overall Study|Protocol Violation|4|||
125378456|NCT03303079|451017176|FG002|Overall Study|Protocol Violation|7|||
125378457|NCT03303079|451017174|FG000|Overall Study|Withdrawal by Subject|2|||
125378458|NCT03303079|451017175|FG001|Overall Study|Withdrawal by Subject|4|||
125378459|NCT03303079|451017176|FG002|Overall Study|Withdrawal by Subject|2|||
125378460|NCT03303079|451017174|FG000|Overall Study|Other than specified|0|||
125378461|NCT03303079|451017175|FG001|Overall Study|Other than specified|2|||
125378462|NCT03303079|451017176|FG002|Overall Study|Other than specified|0|||
125378463|NCT02005445|451017177|FG000|Overall Study|Dual study enrollment|0|||
125378464|NCT02005445|451017178|FG001|Overall Study|Dual study enrollment|1|||
125378465|NCT01314443|451017179|FG000|Overall Study|Withdrawal by Subject|2|||
125378466|NCT01314443|451017180|FG001|Overall Study|Withdrawal by Subject|1|||
125378467|NCT01314443|451017181|FG002|Overall Study|Withdrawal by Subject|1|||
125378468|NCT01314443|451017182|FG003|Overall Study|Withdrawal by Subject|1|||
125378469|NCT01314443|451017179|FG000|Overall Study|Protocol Violation|2|||
125378470|NCT01314443|451017180|FG001|Overall Study|Protocol Violation|2|||
125378471|NCT01314443|451017181|FG002|Overall Study|Protocol Violation|1|||
125378472|NCT01314443|451017182|FG003|Overall Study|Protocol Violation|1|||
125378473|NCT00449540|451017184|FG000|Pretreatment Phase|No migraine experienced|66|||
125378474|NCT00449540|451017185|FG001|Pretreatment Phase|No migraine experienced|0|||
125378475|NCT00449540|451017186|FG002|Pretreatment Phase|No migraine experienced|0|||
125378476|NCT00449540|451017184|FG000|Treatment Phase|did not experience or treat migraine|0|||
125378477|NCT00449540|451017185|FG001|Treatment Phase|did not experience or treat migraine|20|||
125378478|NCT00449540|451017186|FG002|Treatment Phase|did not experience or treat migraine|17|||
125378479|NCT02709785|451017187|FG000|Overall Study|Withdrawal by Subject|1|||
125378480|NCT02709785|451017188|FG001|Overall Study|Withdrawal by Subject|2|||
125378481|NCT02709785|451017189|FG002|Overall Study|Withdrawal by Subject|1|||
125378482|NCT00010374|451017190|FG000|Overall Study|False positive phrenic nerve test|1|||
125378483|NCT01961323|451017191|FG000|Overall Study|Withdrawal by Subject|7|||
125378484|NCT01961323|451017191|FG000|Overall Study|Lost to Follow-up|8|||
125378485|NCT01961323|451017191|FG000|Overall Study|screen failure|34|||
125378486|NCT02746874|451017194|FG000|Overall Study|Withdrawal by Subject|0|||
125378487|NCT02746874|451017195|FG001|Overall Study|Withdrawal by Subject|1|||
125378488|NCT02746874|451017194|FG000|Overall Study|Surgery Date Changed|0|||
125378489|NCT02746874|451017195|FG001|Overall Study|Surgery Date Changed|2|||
125378490|NCT02320149|451017198|FG000|Overall Study|Adverse Event|3|||
125635977|NCT04423718|451950809|FG000|Main Study|Physician Decision|3|||
125635978|NCT04423718|451950810|FG001|Main Study|Physician Decision|3|||
125635979|NCT04423718|451950811|FG002|Main Study|Physician Decision|2|||
125635980|NCT04423718|451950809|FG000|Main Study|Protocol Violation|0|||
125635981|NCT04423718|451950810|FG001|Main Study|Protocol Violation|0|||
125635982|NCT04423718|451950811|FG002|Main Study|Protocol Violation|1|||
125635983|NCT04423718|451950809|FG000|Main Study|Lost to Follow-up|3|||
125635984|NCT04423718|451950810|FG001|Main Study|Lost to Follow-up|3|||
125635985|NCT04423718|451950811|FG002|Main Study|Lost to Follow-up|4|||
125131129|NCT02714062|450108008|FG001|Overall Study|Adverse Event|0|||
125131130|NCT02714062|450108009|FG002|Overall Study|Adverse Event|2|||
125131131|NCT02714062|450108007|FG000|Overall Study|Withdrawal by Subject|1|||
125131132|NCT02714062|450108008|FG001|Overall Study|Withdrawal by Subject|0|||
125131133|NCT02714062|450108009|FG002|Overall Study|Withdrawal by Subject|1|||
125378491|NCT02320149|451017199|FG001|Overall Study|Adverse Event|7|||
125131134|NCT02714062|450108007|FG000|Overall Study|Protocol Violation|0|||
125378492|NCT02320149|451017198|FG000|Overall Study|Withdrawal of Consent|28|||
125378493|NCT02320149|451017199|FG001|Overall Study|Withdrawal of Consent|32|||
125378494|NCT02320149|451017198|FG000|Overall Study|Lost to Follow-up|21|||
125131135|NCT02714062|450108008|FG001|Overall Study|Protocol Violation|1|||
125131136|NCT02714062|450108009|FG002|Overall Study|Protocol Violation|0|||
125378495|NCT02320149|451017199|FG001|Overall Study|Lost to Follow-up|34|||
125378496|NCT02320149|451017198|FG000|Overall Study|Protocol Violation|2|||
125378497|NCT02320149|451017199|FG001|Overall Study|Protocol Violation|1|||
125378498|NCT02320149|451017198|FG000|Overall Study|Noncompliance with Study Treatment|7|||
125378499|NCT02320149|451017199|FG001|Overall Study|Noncompliance with Study Treatment|2|||
125635986|NCT04423718|451950809|FG000|Main Study|Lack of Efficacy|2|||
125635987|NCT04423718|451950810|FG001|Main Study|Lack of Efficacy|1|||
125217333|NCT02348008|450422116|FG001|Overall Study|Symptomatic Deterioration|1|||
125217334|NCT02348008|450422117|FG002|Overall Study|Symptomatic Deterioration|0|||
125378500|NCT02320149|451017198|FG000|Overall Study|Lack of Efficacy|0|||
125378501|NCT02320149|451017199|FG001|Overall Study|Lack of Efficacy|1|||
125635988|NCT04423718|451950811|FG002|Main Study|Lack of Efficacy|0|||
125635989|NCT04423718|451950809|FG000|Main Study|Withdrawal by Subject|14|||
125635990|NCT04423718|451950810|FG001|Main Study|Withdrawal by Subject|20|||
125635991|NCT04423718|451950811|FG002|Main Study|Withdrawal by Subject|20|||
125635992|NCT04423718|451950809|FG000|Main Study|Death|10|||
125635993|NCT04423718|451950810|FG001|Main Study|Death|7|||
125635994|NCT04423718|451950811|FG002|Main Study|Death|7|||
125635995|NCT04423718|451950809|FG000|Main Study|COVID-19 pandemic|2|||
125635996|NCT04423718|451950810|FG001|Main Study|COVID-19 pandemic|2|||
125635997|NCT04423718|451950811|FG002|Main Study|COVID-19 pandemic|2|||
125635998|NCT04423718|451950809|FG000|Main Study|Other|7|||
125635999|NCT04423718|451950810|FG001|Main Study|Other|3|||
125636000|NCT04423718|451950811|FG002|Main Study|Other|2|||
125636001|NCT04423718|451950809|FG000|Extension Phase|Other|1|||
125636002|NCT04423718|451950810|FG001|Extension Phase|Other|0|||
125636003|NCT04423718|451950811|FG002|Extension Phase|Other|0|||
125636004|NCT04423718|451950809|FG000|Extension Phase|Logistical problems|0|||
125636005|NCT04423718|451950810|FG001|Extension Phase|Logistical problems|1|||
125636006|NCT04423718|451950811|FG002|Extension Phase|Logistical problems|1|||
125636007|NCT04423718|451950809|FG000|Extension Phase|Physician Decision|1|||
125636008|NCT04423718|451950810|FG001|Extension Phase|Physician Decision|0|||
125636009|NCT04423718|451950811|FG002|Extension Phase|Physician Decision|1|||
125636010|NCT04423718|451950809|FG000|Extension Phase|Lack of Efficacy|2|||
125636011|NCT04423718|451950810|FG001|Extension Phase|Lack of Efficacy|0|||
125636012|NCT04423718|451950811|FG002|Extension Phase|Lack of Efficacy|1|||
125636013|NCT04423718|451950809|FG000|Extension Phase|Lost to Follow-up|0|||
125636014|NCT04423718|451950810|FG001|Extension Phase|Lost to Follow-up|2|||
125636015|NCT04423718|451950811|FG002|Extension Phase|Lost to Follow-up|3|||
125636016|NCT04423718|451950809|FG000|Extension Phase|Adverse Event|2|||
125636017|NCT04423718|451950810|FG001|Extension Phase|Adverse Event|3|||
125636018|NCT04423718|451950811|FG002|Extension Phase|Adverse Event|1|||
125636019|NCT04423718|451950809|FG000|Extension Phase|Death|4|||
125636020|NCT04423718|451950810|FG001|Extension Phase|Death|7|||
125636021|NCT04423718|451950811|FG002|Extension Phase|Death|2|||
125636022|NCT04423718|451950809|FG000|Extension Phase|Withdrawal by Subject|11|||
125636023|NCT04423718|451950810|FG001|Extension Phase|Withdrawal by Subject|11|||
125636024|NCT04423718|451950811|FG002|Extension Phase|Withdrawal by Subject|7|||
125636025|NCT00425945|451950812|FG000|Overall Study|Concern about Supplement|2|||
125636026|NCT00425945|451950813|FG001|Overall Study|Concern about Supplement|0|||
125636027|NCT00425945|451950812|FG000|Overall Study|Inconvenience|0|||
125636028|NCT00425945|451950813|FG001|Overall Study|Inconvenience|2|||
125636029|NCT00425945|451950812|FG000|Overall Study|Lost to Follow-up|0|||
125636030|NCT00425945|451950813|FG001|Overall Study|Lost to Follow-up|2|||
125636031|NCT00425945|451950812|FG000|Overall Study|Began hypertension medication|1|||
125636032|NCT00425945|451950813|FG001|Overall Study|Began hypertension medication|0|||
125636033|NCT00425945|451950812|FG000|Overall Study|Began cancer treatments|1|||
125131137|NCT02294604|450108010|FG000|Overall Study|Did not provide samples for culture|0|||
125131138|NCT02294604|450108011|FG001|Overall Study|Did not provide samples for culture|1|||
125131139|NCT02294604|450108012|FG002|Overall Study|Did not provide samples for culture|0|||
125131140|NCT02294604|450108010|FG000|Overall Study|Culture contamination|1|||
125131141|NCT02294604|450108011|FG001|Overall Study|Culture contamination|2|||
125131142|NCT02294604|450108012|FG002|Overall Study|Culture contamination|0|||
125131143|NCT01200810|450108017|FG000|Overall Study|Physician Decision|1|||
125131144|NCT01200810|450108018|FG001|Overall Study|Physician Decision|0|||
125131145|NCT01200810|450108017|FG000|Overall Study|Withdrawal by Subject|1|||
125131146|NCT01200810|450108018|FG001|Overall Study|Withdrawal by Subject|2|||
125131147|NCT01200810|450108017|FG000|Overall Study|Sponsor stopped making study drug|3|||
125131148|NCT01200810|450108018|FG001|Overall Study|Sponsor stopped making study drug|3|||
125131149|NCT00365846|450108019|FG000|Overall Study|Lost to Follow-up|1|||
125636034|NCT00425945|451950813|FG001|Overall Study|Began cancer treatments|0|||
125636035|NCT00425945|451950812|FG000|Overall Study|Moved from area|0|||
125636036|NCT00425945|451950813|FG001|Overall Study|Moved from area|1|||
125636037|NCT03657576|451950818|FG000|Overall Study|Death|0|||
125636038|NCT03657576|451950819|FG001|Overall Study|Death|1|||
125636039|NCT03657576|451950820|FG002|Overall Study|Death|1|||
125217335|NCT00792116|450422124|FG000|Overall Study|Lost to Follow-up|0|||
125217336|NCT00792116|450422125|FG001|Overall Study|Lost to Follow-up|1|||
125636040|NCT03657576|451950821|FG003|Overall Study|Death|0|||
125636041|NCT03657576|451950822|FG004|Overall Study|Death|0|||
125636042|NCT03657576|451950823|FG005|Overall Study|Death|0|||
125636043|NCT03657576|451950818|FG000|Overall Study|Withdrawal by Subject|0|||
125636044|NCT03657576|451950819|FG001|Overall Study|Withdrawal by Subject|0|||
125636045|NCT03657576|451950820|FG002|Overall Study|Withdrawal by Subject|0|||
125636046|NCT03657576|451950821|FG003|Overall Study|Withdrawal by Subject|1|||
125636047|NCT03657576|451950822|FG004|Overall Study|Withdrawal by Subject|0|||
125636048|NCT03657576|451950823|FG005|Overall Study|Withdrawal by Subject|0|||
125378502|NCT02320149|451017198|FG000|Overall Study|Other Miscellaneous Reasons|2|||
125378503|NCT02320149|451017199|FG001|Overall Study|Other Miscellaneous Reasons|3|||
125378504|NCT01156311|451017203|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
125378505|NCT01156311|451017204|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
125378506|NCT01156311|451017205|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
125378507|NCT01156311|451017206|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
125378508|NCT01156311|451017203|FG000|2-Month Monotherapy Period|Physician Decision|0|||
125378509|NCT01156311|451017204|FG001|2-Month Monotherapy Period|Physician Decision|1|||
125378510|NCT01156311|451017205|FG002|2-Month Monotherapy Period|Physician Decision|0|||
125378511|NCT01156311|451017206|FG003|2-Month Monotherapy Period|Physician Decision|0|||
125378512|NCT01156311|451017203|FG000|2-Month Monotherapy Period|Other|1|||
125378513|NCT01156311|451017204|FG001|2-Month Monotherapy Period|Other|0|||
125378514|NCT01156311|451017205|FG002|2-Month Monotherapy Period|Other|0|||
125378515|NCT01156311|451017206|FG003|2-Month Monotherapy Period|Other|0|||
125378516|NCT01156311|451017203|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
125378517|NCT01156311|451017204|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
125378518|NCT01156311|451017205|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
125378519|NCT01156311|451017206|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
125378520|NCT01156311|451017203|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
125378521|NCT01156311|451017204|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
125378522|NCT01156311|451017205|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
125378523|NCT01156311|451017206|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
125378524|NCT01156311|451017203|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
125378525|NCT01156311|451017204|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
125217337|NCT00792116|450422124|FG000|Overall Study|Discontnued intervention|1|||
125217338|NCT00792116|450422125|FG001|Overall Study|Discontnued intervention|0|||
125217339|NCT04865419|450423503|FG000|Overall Study|Other|1|||
125217340|NCT04865419|450423504|FG001|Overall Study|Other|2|||
125217341|NCT04865419|450423505|FG002|Overall Study|Other|2|||
125217342|NCT04865419|450423506|FG003|Overall Study|Other|1|||
125217343|NCT04865419|450423507|FG004|Overall Study|Other|3|||
125217344|NCT04865419|450423508|FG005|Overall Study|Other|0|||
125217345|NCT04865419|450423509|FG006|Overall Study|Other|0|||
125217346|NCT04865419|450423510|FG007|Overall Study|Other|1|||
125217347|NCT04865419|450423511|FG008|Overall Study|Other|0|||
125217348|NCT04865419|450423512|FG009|Overall Study|Other|0|||
125217349|NCT04865419|450423513|FG010|Overall Study|Other|0|||
125378526|NCT01156311|451017205|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
125636049|NCT03657576|451950818|FG000|Overall Study|Screen Fail|0|||
125636050|NCT03657576|451950819|FG001|Overall Study|Screen Fail|0|||
125636051|NCT03657576|451950820|FG002|Overall Study|Screen Fail|0|||
125636052|NCT03657576|451950821|FG003|Overall Study|Screen Fail|0|||
125636053|NCT03657576|451950822|FG004|Overall Study|Screen Fail|0|||
125636054|NCT03657576|451950823|FG005|Overall Study|Screen Fail|5|||
125636055|NCT03657576|451950818|FG000|Overall Study|Disease Progression|1|||
125636056|NCT03657576|451950819|FG001|Overall Study|Disease Progression|1|||
125636057|NCT03657576|451950820|FG002|Overall Study|Disease Progression|0|||
125636058|NCT03657576|451950821|FG003|Overall Study|Disease Progression|5|||
125636059|NCT03657576|451950822|FG004|Overall Study|Disease Progression|0|||
125636060|NCT03657576|451950823|FG005|Overall Study|Disease Progression|0|||
125636061|NCT03657576|451950818|FG000|Overall Study|Insurance Coverage|0|||
125636062|NCT03657576|451950819|FG001|Overall Study|Insurance Coverage|0|||
125636063|NCT03657576|451950820|FG002|Overall Study|Insurance Coverage|0|||
125636064|NCT03657576|451950821|FG003|Overall Study|Insurance Coverage|1|||
125636065|NCT03657576|451950822|FG004|Overall Study|Insurance Coverage|0|||
125636066|NCT03657576|451950823|FG005|Overall Study|Insurance Coverage|0|||
125636067|NCT05618808|451950826|FG000|Overall Study|Withdrawal by Subject|3|||
125378527|NCT01156311|451017206|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
125378528|NCT01156311|451017203|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
125378529|NCT01156311|451017204|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
125378530|NCT01156311|451017205|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
125217350|NCT04865419|450423503|FG000|Overall Study|Withdrawal by Subject|0|||
125217351|NCT04865419|450423504|FG001|Overall Study|Withdrawal by Subject|1|||
125378531|NCT01156311|451017206|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
125378532|NCT01156311|451017203|FG000|6-month Add-on Therapy Period|Other|0|||
125636068|NCT05618808|451950827|FG001|Overall Study|Withdrawal by Subject|1|||
125636069|NCT05618808|451950828|FG002|Overall Study|Withdrawal by Subject|3|||
125636070|NCT04284787|451950829|FG000|Overall Study|Disease Progression|9|||
125636071|NCT04284787|451950830|FG001|Overall Study|Disease Progression|12|||
125636072|NCT04284787|451950829|FG000|Overall Study|Physician Decision|12|||
125217352|NCT04865419|450423505|FG002|Overall Study|Withdrawal by Subject|1|||
125217353|NCT04865419|450423506|FG003|Overall Study|Withdrawal by Subject|0|||
125217354|NCT04865419|450423507|FG004|Overall Study|Withdrawal by Subject|0|||
125217355|NCT04865419|450423508|FG005|Overall Study|Withdrawal by Subject|0|||
125217356|NCT04865419|450423509|FG006|Overall Study|Withdrawal by Subject|0|||
125217357|NCT04865419|450423510|FG007|Overall Study|Withdrawal by Subject|1|||
125217358|NCT04865419|450423511|FG008|Overall Study|Withdrawal by Subject|2|||
125217359|NCT04865419|450423512|FG009|Overall Study|Withdrawal by Subject|1|||
125217360|NCT04865419|450423513|FG010|Overall Study|Withdrawal by Subject|0|||
125217361|NCT04865419|450423503|FG000|Overall Study|Study terminated by Sponsor|0|||
125217362|NCT04865419|450423504|FG001|Overall Study|Study terminated by Sponsor|0|||
125217363|NCT04865419|450423505|FG002|Overall Study|Study terminated by Sponsor|0|||
125217364|NCT04865419|450423506|FG003|Overall Study|Study terminated by Sponsor|2|||
125217365|NCT04865419|450423507|FG004|Overall Study|Study terminated by Sponsor|2|||
125217366|NCT04865419|450423508|FG005|Overall Study|Study terminated by Sponsor|0|||
125217367|NCT04865419|450423509|FG006|Overall Study|Study terminated by Sponsor|0|||
125217368|NCT04865419|450423510|FG007|Overall Study|Study terminated by Sponsor|0|||
125217369|NCT04865419|450423511|FG008|Overall Study|Study terminated by Sponsor|0|||
125217370|NCT04865419|450423512|FG009|Overall Study|Study terminated by Sponsor|0|||
125217371|NCT04865419|450423513|FG010|Overall Study|Study terminated by Sponsor|1|||
125217372|NCT04865419|450423503|FG000|Overall Study|Death|3|||
125217373|NCT04865419|450423504|FG001|Overall Study|Death|1|||
125217374|NCT04865419|450423505|FG002|Overall Study|Death|4|||
125378533|NCT01156311|451017204|FG001|6-month Add-on Therapy Period|Other|0|||
125378534|NCT01156311|451017205|FG002|6-month Add-on Therapy Period|Other|1|||
125378535|NCT01156311|451017206|FG003|6-month Add-on Therapy Period|Other|2|||
125378536|NCT01741701|451017207|FG000|Overall Study|Adverse Event|5|||
125378537|NCT01741701|451017208|FG001|Overall Study|Adverse Event|1|||
125378538|NCT01741701|451017207|FG000|Overall Study|Withdrawal by Subject|0|||
125636073|NCT04284787|451950830|FG001|Overall Study|Physician Decision|7|||
125636074|NCT04284787|451950829|FG000|Overall Study|Transplant|5|||
125636075|NCT04284787|451950830|FG001|Overall Study|Transplant|4|||
125636076|NCT04284787|451950829|FG000|Overall Study|Death|1|||
125636077|NCT04284787|451950830|FG001|Overall Study|Death|2|||
125636078|NCT04284787|451950829|FG000|Overall Study|Adverse Event|0|||
125636079|NCT04284787|451950830|FG001|Overall Study|Adverse Event|4|||
125636080|NCT04284787|451950829|FG000|Overall Study|Non-adherence|2|||
125636081|NCT04284787|451950830|FG001|Overall Study|Non-adherence|0|||
125636082|NCT04284787|451950829|FG000|Overall Study|Lack of Efficacy|2|||
125636083|NCT04284787|451950830|FG001|Overall Study|Lack of Efficacy|0|||
125636084|NCT01874353|451950831|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
125636085|NCT01874353|451950832|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
125636086|NCT01874353|451950833|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
125636087|NCT01874353|451950834|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
125636088|NCT01874353|451950831|FG000|Overall Study|Lost to Follow-up|2|||
125636089|NCT01874353|451950832|FG001|Overall Study|Lost to Follow-up|2|||
125636090|NCT01874353|451950833|FG002|Overall Study|Lost to Follow-up|2|||
125636091|NCT01874353|451950834|FG003|Overall Study|Lost to Follow-up|0|||
125636092|NCT01874353|451950831|FG000|Overall Study|Death|110|||
125636093|NCT01874353|451950832|FG001|Overall Study|Death|60|||
125636094|NCT01874353|451950833|FG002|Overall Study|Death|13|||
125636095|NCT01874353|451950834|FG003|Overall Study|Death|7|||
125636096|NCT01874353|451950831|FG000|Overall Study|Withdrawal by Subject|13|||
125636097|NCT01874353|451950832|FG001|Overall Study|Withdrawal by Subject|11|||
125636098|NCT01874353|451950833|FG002|Overall Study|Withdrawal by Subject|0|||
125636099|NCT01874353|451950834|FG003|Overall Study|Withdrawal by Subject|0|||
125636100|NCT04392154|451950835|FG000|Overall Study|Adverse Event|3|||
125636101|NCT04392154|451950836|FG001|Overall Study|Adverse Event|46|||
125636102|NCT04392154|451950835|FG000|Overall Study|Due to epidemic/pandemic|0|||
125636103|NCT04392154|451950836|FG001|Overall Study|Due to epidemic/pandemic|1|||
125636104|NCT04392154|451950835|FG000|Overall Study|Lack of Efficacy|1|||
125636105|NCT04392154|451950836|FG001|Overall Study|Lack of Efficacy|47|||
125636106|NCT04392154|451950835|FG000|Overall Study|Lost to Follow-up|11|||
125636107|NCT04392154|451950836|FG001|Overall Study|Lost to Follow-up|61|||
125636108|NCT04392154|451950835|FG000|Overall Study|Geopolitical conflict|1|||
125636109|NCT04392154|451950836|FG001|Overall Study|Geopolitical conflict|1|||
125636110|NCT04392154|451950835|FG000|Overall Study|Physician Decision|1|||
125636111|NCT04392154|451950836|FG001|Overall Study|Physician Decision|5|||
125217375|NCT04865419|450423506|FG003|Overall Study|Death|2|||
125217376|NCT04865419|450423507|FG004|Overall Study|Death|5|||
125636112|NCT04392154|451950835|FG000|Overall Study|Pregnancy|1|||
125636113|NCT04392154|451950836|FG001|Overall Study|Pregnancy|8|||
125636114|NCT04392154|451950835|FG000|Overall Study|Protocol deviation|1|||
125636115|NCT04392154|451950836|FG001|Overall Study|Protocol deviation|12|||
125636116|NCT04392154|451950835|FG000|Overall Study|Withdrawal by Subject|18|||
125636117|NCT04392154|451950836|FG001|Overall Study|Withdrawal by Subject|138|||
125636118|NCT04392154|451950835|FG000|Overall Study|Sponsor Decision|1|||
125636119|NCT04392154|451950836|FG001|Overall Study|Sponsor Decision|14|||
125636120|NCT04392154|451950835|FG000|Overall Study|Site Closure|0|||
125131150|NCT00904215|450108021|FG000|Overall Study|Adverse Event|25|||
125131151|NCT00904215|450108021|FG000|Overall Study|Protocol Violation|10|||
125131152|NCT00904215|450108021|FG000|Overall Study|Lost to Follow-up|63|||
125131153|NCT00904215|450108021|FG000|Overall Study|Withdrawal by Subject|9|||
125131154|NCT00904215|450108021|FG000|Overall Study|Other|28|||
125131155|NCT00960297|450108022|FG000|Overall Study|Physician Decision|1|||
125131156|NCT00960297|450108022|FG000|Overall Study|Venous port infection|1|||
125131157|NCT00960297|450108022|FG000|Overall Study|Disease progression|1|||
125131158|NCT03965091|450108030|FG000|Overall Study|Adverse Event|0|||
125131159|NCT03965091|450108031|FG001|Overall Study|Adverse Event|2|||
125131160|NCT03965091|450108032|FG002|Overall Study|Adverse Event|3|||
125378539|NCT01741701|451017208|FG001|Overall Study|Withdrawal by Subject|1|||
125378540|NCT00487747|451017209|FG000|Overall Study|Adverse Event|1|||
125378541|NCT00487747|451017209|FG000|Overall Study|Lost to Follow-up|9|||
125378542|NCT00487747|451017209|FG000|Overall Study|Lack of Efficacy|1|||
125636121|NCT04392154|451950836|FG001|Overall Study|Site Closure|4|||
125636122|NCT04992507|451950839|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
125636123|NCT04992507|451950840|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
125636124|NCT04992507|451950839|FG000|Overall Study|Death|0|||
125636125|NCT04992507|451950840|FG001|Overall Study|Death|1|||
125636126|NCT03774875|451950841|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
125636127|NCT03774875|451950842|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
125636128|NCT03774875|451950841|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
125636129|NCT03774875|451950842|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
125636130|NCT03774875|451950841|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
125636131|NCT03774875|451950842|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
125636132|NCT03774875|451950841|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
125636133|NCT03774875|451950842|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
125636134|NCT03774875|451950841|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
125636135|NCT03774875|451950842|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
125636136|NCT03774875|451950841|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
125636137|NCT03774875|451950842|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
125636138|NCT03774875|451950841|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
125636139|NCT03774875|451950842|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
125636140|NCT03774875|451950841|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
125636141|NCT03774875|451950842|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
125636142|NCT03774875|451950841|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
125636143|NCT03774875|451950842|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
125636144|NCT03774875|451950841|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
125636145|NCT03774875|451950842|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
125636146|NCT03774875|451950841|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
125636147|NCT03774875|451950842|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
125636148|NCT03774875|451950841|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
125636149|NCT03774875|451950842|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
125636150|NCT03774875|451950841|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
125636151|NCT03774875|451950842|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
125636152|NCT03149029|451950845|FG000|Overall Study|Adverse Event|2|||
125636153|NCT03149029|451950846|FG001|Overall Study|Adverse Event|0|||
125636154|NCT03233308|451950847|FG000|Overall Study|Adverse Event|1|||
125636155|NCT03233308|451950847|FG000|Overall Study|Protocol Violation|1|||
125131161|NCT03965091|450108030|FG000|Overall Study|Withdrawal by Subject|11|||
125131162|NCT03965091|450108031|FG001|Overall Study|Withdrawal by Subject|3|||
125131163|NCT03965091|450108032|FG002|Overall Study|Withdrawal by Subject|5|||
125131164|NCT03965091|450108030|FG000|Overall Study|Non-compliance with study drug|0|||
125131165|NCT03965091|450108031|FG001|Overall Study|Non-compliance with study drug|0|||
125131166|NCT03965091|450108032|FG002|Overall Study|Non-compliance with study drug|1|||
125131167|NCT03965091|450108030|FG000|Overall Study|Lost to Follow-up|1|||
125131168|NCT03965091|450108031|FG001|Overall Study|Lost to Follow-up|1|||
125131169|NCT03965091|450108032|FG002|Overall Study|Lost to Follow-up|1|||
125131170|NCT03965091|450108030|FG000|Overall Study|Lack of Efficacy|2|||
125131171|NCT03965091|450108031|FG001|Overall Study|Lack of Efficacy|0|||
125131172|NCT03965091|450108032|FG002|Overall Study|Lack of Efficacy|0|||
125217377|NCT04865419|450423508|FG005|Overall Study|Death|2|||
125636156|NCT03287830|451950848|FG000|Overall Study|Withdrawal by Subject|1|||
125636157|NCT03287830|451950849|FG001|Overall Study|Withdrawal by Subject|1|||
125636158|NCT03287830|451950848|FG000|Overall Study|not meeting inclusion criteria|5|||
125636159|NCT03287830|451950849|FG001|Overall Study|not meeting inclusion criteria|12|||
125636160|NCT02974621|451950850|FG000|Overall Study|Didn't receive study treatment|1|||
125636161|NCT02974621|451950851|FG001|Overall Study|Didn't receive study treatment|10|||
125636162|NCT00557323|451950853|FG000|Overall Study|Death|3|||
125636163|NCT00557323|451950853|FG000|Overall Study|Withdrawal by Subject|2|||
125636164|NCT00557323|451950853|FG000|Overall Study|Administrative change|2|||
125636165|NCT01196091|451950858|FG000|Overall Study|Adverse Event|22|||
125636166|NCT01196091|451950859|FG001|Overall Study|Adverse Event|27|||
125636167|NCT01196091|451950860|FG002|Overall Study|Adverse Event|26|||
125636168|NCT01196091|451950858|FG000|Overall Study|Death|3|||
125636169|NCT01196091|451950859|FG001|Overall Study|Death|2|||
125636170|NCT01196091|451950860|FG002|Overall Study|Death|2|||
125636171|NCT01196091|451950858|FG000|Overall Study|Entry Criteria Not Met|11|||
125636172|NCT01196091|451950859|FG001|Overall Study|Entry Criteria Not Met|11|||
125636173|NCT01196091|451950860|FG002|Overall Study|Entry Criteria Not Met|10|||
125636174|NCT01196091|451950858|FG000|Overall Study|Lack of Efficacy|15|||
125636175|NCT01196091|451950859|FG001|Overall Study|Lack of Efficacy|12|||
125636176|NCT01196091|451950860|FG002|Overall Study|Lack of Efficacy|17|||
125636177|NCT01196091|451950858|FG000|Overall Study|Lost to Follow-up|5|||
125636178|NCT01196091|451950859|FG001|Overall Study|Lost to Follow-up|5|||
125636179|NCT01196091|451950860|FG002|Overall Study|Lost to Follow-up|6|||
125636180|NCT01196091|451950858|FG000|Overall Study|Parent/Caregiver Decision|0|||
125636181|NCT01196091|451950859|FG001|Overall Study|Parent/Caregiver Decision|0|||
125636182|NCT01196091|451950860|FG002|Overall Study|Parent/Caregiver Decision|1|||
125636183|NCT01196091|451950858|FG000|Overall Study|Withdrawal by Subject|16|||
125636184|NCT01196091|451950859|FG001|Overall Study|Withdrawal by Subject|19|||
125636185|NCT01196091|451950860|FG002|Overall Study|Withdrawal by Subject|22|||
125636186|NCT01196091|451950858|FG000|Overall Study|Physician Decision|3|||
125636187|NCT01196091|451950859|FG001|Overall Study|Physician Decision|3|||
125636188|NCT01196091|451950860|FG002|Overall Study|Physician Decision|4|||
125636189|NCT01196091|451950858|FG000|Overall Study|Protocol Violation|1|||
125636190|NCT01196091|451950859|FG001|Overall Study|Protocol Violation|3|||
125636191|NCT01196091|451950860|FG002|Overall Study|Protocol Violation|3|||
125217378|NCT04865419|450423509|FG006|Overall Study|Death|1|||
125636192|NCT01196091|451950858|FG000|Overall Study|Sponsor Decision|6|||
125636193|NCT01196091|451950859|FG001|Overall Study|Sponsor Decision|5|||
125636194|NCT01196091|451950860|FG002|Overall Study|Sponsor Decision|4|||
125636195|NCT01196091|451950858|FG000|Overall Study|Excluded Site|5|||
125636196|NCT01196091|451950859|FG001|Overall Study|Excluded Site|11|||
125636197|NCT01196091|451950860|FG002|Overall Study|Excluded Site|8|||
125636198|NCT01196091|451950858|FG000|Overall Study|Randomized, No Study Drug Received|1|||
125217379|NCT04865419|450423510|FG007|Overall Study|Death|1|||
125636199|NCT01196091|451950859|FG001|Overall Study|Randomized, No Study Drug Received|0|||
125636200|NCT01196091|451950860|FG002|Overall Study|Randomized, No Study Drug Received|1|||
125636201|NCT03797144|451950861|FG000|Enrollment|Protocol Violation|4|||
125636202|NCT03797144|451950862|FG001|Enrollment|Protocol Violation|1|||
125636203|NCT03797144|451950861|FG000|Surgery|Protocol Violation|1|||
125636204|NCT03797144|451950862|FG001|Surgery|Protocol Violation|0|||
125636205|NCT03797144|451950861|FG000|3 Month|Early termination cut-off date|2|||
125636206|NCT03797144|451950862|FG001|3 Month|Early termination cut-off date|0|||
125636207|NCT03797144|451950861|FG000|12 Month|Early termination cut-off date|8|||
125636208|NCT03797144|451950862|FG001|12 Month|Early termination cut-off date|9|||
125636209|NCT03797144|451950861|FG000|24 Month|Early termination cut-off date|1|||
125636210|NCT03797144|451950862|FG001|24 Month|Early termination cut-off date|1|||
125636211|NCT03077711|451950863|FG000|Overall Study|Lost to Follow-up|2|||
125636212|NCT03077711|451950864|FG001|Overall Study|Lost to Follow-up|2|||
125636213|NCT03077711|451950863|FG000|Overall Study|noncompliant taking medication|2|||
125636214|NCT03077711|451950864|FG001|Overall Study|noncompliant taking medication|0|||
125636215|NCT00376675|451950865|FG000|Overall Study|Withdrawal by Subject|9|||
125636216|NCT00376675|451950866|FG001|Overall Study|Withdrawal by Subject|2|||
125636217|NCT00376675|451950865|FG000|Overall Study|Adverse Event|10|||
125636218|NCT00376675|451950866|FG001|Overall Study|Adverse Event|5|||
125636219|NCT00376675|451950865|FG000|Overall Study|Other Reason|1|||
125636220|NCT00376675|451950866|FG001|Overall Study|Other Reason|7|||
125636221|NCT02943668|451950868|FG000|Overall Study|Disease Progression|1|||
125636222|NCT02201251|451950869|FG000|Overall Study|Adverse Event|1|||
125636223|NCT02201251|451950870|FG001|Overall Study|Adverse Event|1|||
125636224|NCT02201251|451950869|FG000|Overall Study|Protocol Violation|1|||
125636225|NCT02201251|451950870|FG001|Overall Study|Protocol Violation|0|||
125636226|NCT02201251|451950869|FG000|Overall Study|Noncompliance with Study Drug|0|||
125636227|NCT02201251|451950870|FG001|Overall Study|Noncompliance with Study Drug|1|||
125636228|NCT02201251|451950869|FG000|Overall Study|Withdrawal by Subject|2|||
125636229|NCT02201251|451950870|FG001|Overall Study|Withdrawal by Subject|1|||
125636230|NCT01332851|451950871|FG000|Overall Study|Withdrawal by Subject|4|||
125636231|NCT01332851|451950872|FG001|Overall Study|Withdrawal by Subject|2|||
125636232|NCT01332851|451950871|FG000|Overall Study|Lost to Follow-up|7|||
125636233|NCT01332851|451950872|FG001|Overall Study|Lost to Follow-up|11|||
125636234|NCT01947894|451950874|FG000|Overall Study|Other|3|||
125636235|NCT01947894|451950875|FG001|Overall Study|Other|4|||
125636236|NCT01947894|451950876|FG002|Overall Study|Other|3|||
125636237|NCT01947894|451950874|FG000|Overall Study|Withdrawal by Subject|12|||
125636238|NCT01947894|451950875|FG001|Overall Study|Withdrawal by Subject|4|||
125636239|NCT01947894|451950876|FG002|Overall Study|Withdrawal by Subject|1|||
125636240|NCT01947894|451950874|FG000|Overall Study|Death|12|||
125636241|NCT01947894|451950875|FG001|Overall Study|Death|1|||
125636242|NCT01947894|451950876|FG002|Overall Study|Death|0|||
125636243|NCT01947894|451950874|FG000|Overall Study|Physician Decision|2|||
125636244|NCT01947894|451950875|FG001|Overall Study|Physician Decision|0|||
125636245|NCT01947894|451950876|FG002|Overall Study|Physician Decision|0|||
125636246|NCT01947894|451950874|FG000|Overall Study|Adverse Event|5|||
125636247|NCT01947894|451950875|FG001|Overall Study|Adverse Event|1|||
125636248|NCT01947894|451950876|FG002|Overall Study|Adverse Event|0|||
125636249|NCT01947894|451950874|FG000|Overall Study|Switched to other growth hormone brand|53|||
125636250|NCT01947894|451950875|FG001|Overall Study|Switched to other growth hormone brand|8|||
125636251|NCT01947894|451950876|FG002|Overall Study|Switched to other growth hormone brand|23|||
125636252|NCT00333970|451950877|FG000|Overall Study|Withdrawal by Subject|13|||
125636253|NCT00333970|451950878|FG001|Overall Study|Withdrawal by Subject|7|||
125636254|NCT05083949|451950884|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
125217380|NCT04865419|450423511|FG008|Overall Study|Death|2|||
125636255|NCT05083949|451950885|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
125636256|NCT05083949|451950884|FG000|Period 1|Adverse Event|1|||
125636257|NCT05083949|451950885|FG001|Period 1|Adverse Event|1|||
125636258|NCT05083949|451950884|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
125636259|NCT05083949|451950885|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
125636260|NCT05083949|451950884|FG000|Period 2|Adverse Event|0|||
125636261|NCT05083949|451950885|FG001|Period 2|Adverse Event|2|||
125636262|NCT01678560|451950886|FG000|Overall Study|Physician Decision|4|||
125636263|NCT01678560|451950887|FG001|Overall Study|Physician Decision|4|||
125636264|NCT01678560|451950886|FG000|Overall Study|Death|0|||
125636265|NCT01678560|451950887|FG001|Overall Study|Death|1|||
125636266|NCT01678560|451950886|FG000|Overall Study|Withdrawal by Subject|0|||
125636267|NCT01678560|451950887|FG001|Overall Study|Withdrawal by Subject|1|||
125636268|NCT00322387|451950891|FG000|Treatment Period|Adverse Event|0|||
125636269|NCT00322387|451950892|FG001|Treatment Period|Adverse Event|1|||
125636270|NCT00322387|451950891|FG000|Follow-up Period|Final assessment not done|1|||
125636271|NCT00322387|451950892|FG001|Follow-up Period|Final assessment not done|3|||
125636272|NCT00322387|451950891|FG000|Follow-up Period|Death|1|||
125217381|NCT04865419|450423512|FG009|Overall Study|Death|2|||
125636273|NCT00322387|451950892|FG001|Follow-up Period|Death|0|||
125378543|NCT00372112|451017214|FG000|Overall Study|Adverse Event|0|||
125378544|NCT00372112|451017215|FG001|Overall Study|Adverse Event|1|||
125378545|NCT00372112|451017216|FG002|Overall Study|Adverse Event|1|||
125378546|NCT00372112|451017217|FG003|Overall Study|Adverse Event|1|||
125378547|NCT00372112|451017214|FG000|Overall Study|Withdrawal by Subject|0|||
125378548|NCT00372112|451017215|FG001|Overall Study|Withdrawal by Subject|0|||
125378549|NCT00372112|451017216|FG002|Overall Study|Withdrawal by Subject|2|||
125378550|NCT00372112|451017217|FG003|Overall Study|Withdrawal by Subject|1|||
125636274|NCT01828567|451950895|FG000|Overall Study|Lost to Follow-up|27|||
125636275|NCT01828567|451950896|FG001|Overall Study|Lost to Follow-up|9|||
125636276|NCT01828567|451950895|FG000|Overall Study|Excluded - did not meet criteria|4|||
125636277|NCT01828567|451950896|FG001|Overall Study|Excluded - did not meet criteria|1|||
125636278|NCT00707486|451950899|FG000|Overall Study|Withdrawal by Subject|1|||
125636279|NCT00090766|451950900|FG000|Overall Study|Nephrectomy Planned|0|||
125636280|NCT00090766|451950901|FG001|Overall Study|Nephrectomy Planned|0|||
125636281|NCT00090766|451950902|FG002|Overall Study|Nephrectomy Planned|1|||
125636282|NCT00090766|451950900|FG000|Overall Study|Death|1|||
125636283|NCT00090766|451950901|FG001|Overall Study|Death|0|||
125636284|NCT00090766|451950902|FG002|Overall Study|Death|0|||
125636285|NCT00090766|451950900|FG000|Overall Study|Admin|0|||
125636286|NCT00090766|451950901|FG001|Overall Study|Admin|2|||
125636287|NCT00090766|451950902|FG002|Overall Study|Admin|0|||
125636288|NCT00090766|451950900|FG000|Overall Study|Lost to Follow-up|2|||
125636289|NCT00090766|451950901|FG001|Overall Study|Lost to Follow-up|0|||
125636290|NCT00090766|451950902|FG002|Overall Study|Lost to Follow-up|2|||
125636291|NCT00654368|451950909|FG000|Overall Study|Ineligibility determined|6|||
125636292|NCT00654368|451950910|FG001|Overall Study|Ineligibility determined|0|||
125636293|NCT00654368|451950911|FG002|Overall Study|Ineligibility determined|0|||
125636294|NCT00654368|451950909|FG000|Overall Study|Protocol deviation|3|||
125636295|NCT00654368|451950910|FG001|Overall Study|Protocol deviation|2|||
125636296|NCT00654368|451950911|FG002|Overall Study|Protocol deviation|1|||
125636297|NCT00654368|451950909|FG000|Overall Study|Non-compliance|2|||
125636298|NCT00654368|451950910|FG001|Overall Study|Non-compliance|1|||
125636299|NCT00654368|451950911|FG002|Overall Study|Non-compliance|2|||
125636300|NCT00654368|451950909|FG000|Overall Study|Withdrawal by Subject|5|||
125636301|NCT00654368|451950910|FG001|Overall Study|Withdrawal by Subject|2|||
125636302|NCT00654368|451950911|FG002|Overall Study|Withdrawal by Subject|2|||
125636303|NCT00654368|451950909|FG000|Overall Study|Disease progression|21|||
125636304|NCT00654368|451950910|FG001|Overall Study|Disease progression|31|||
125636305|NCT00654368|451950911|FG002|Overall Study|Disease progression|13|||
125636306|NCT00654368|451950909|FG000|Overall Study|Requirement for alternative therapy|1|||
125636307|NCT00654368|451950910|FG001|Overall Study|Requirement for alternative therapy|1|||
125636308|NCT00654368|451950911|FG002|Overall Study|Requirement for alternative therapy|1|||
125636309|NCT00654368|451950909|FG000|Overall Study|Physician Decision|0|||
125636310|NCT00654368|451950910|FG001|Overall Study|Physician Decision|0|||
125636311|NCT00654368|451950911|FG002|Overall Study|Physician Decision|2|||
125636312|NCT00654368|451950909|FG000|Overall Study|Death|1|||
125636313|NCT00654368|451950910|FG001|Overall Study|Death|0|||
125636314|NCT00654368|451950911|FG002|Overall Study|Death|0|||
125636315|NCT00654368|451950909|FG000|Overall Study|Pregnancy|0|||
125636316|NCT00654368|451950910|FG001|Overall Study|Pregnancy|0|||
125636317|NCT00654368|451950911|FG002|Overall Study|Pregnancy|2|||
125636318|NCT00654368|451950909|FG000|Overall Study|Other|0|||
125636319|NCT00654368|451950910|FG001|Overall Study|Other|2|||
125636320|NCT00654368|451950911|FG002|Overall Study|Other|3|||
125636321|NCT00654368|451950909|FG000|Overall Study|Adverse Event|14|||
125636322|NCT00654368|451950910|FG001|Overall Study|Adverse Event|9|||
125636323|NCT00654368|451950911|FG002|Overall Study|Adverse Event|6|||
125636324|NCT00804986|451950912|FG000|Overall Study|Adverse Event|0|||
125636325|NCT00804986|451950913|FG001|Overall Study|Adverse Event|1|||
125636326|NCT00804986|451950914|FG002|Overall Study|Adverse Event|2|||
125636327|NCT00804986|451950915|FG003|Overall Study|Adverse Event|1|||
125636328|NCT00804986|451950916|FG004|Overall Study|Adverse Event|3|||
125636329|NCT00804986|451950917|FG005|Overall Study|Adverse Event|0|||
125636330|NCT00804986|451950912|FG000|Overall Study|Lack of Efficacy|0|||
125636331|NCT00804986|451950913|FG001|Overall Study|Lack of Efficacy|0|||
125636332|NCT00804986|451950914|FG002|Overall Study|Lack of Efficacy|0|||
125636333|NCT00804986|451950915|FG003|Overall Study|Lack of Efficacy|1|||
125636334|NCT00804986|451950916|FG004|Overall Study|Lack of Efficacy|0|||
125636335|NCT00804986|451950917|FG005|Overall Study|Lack of Efficacy|3|||
125636336|NCT00804986|451950912|FG000|Overall Study|Lost to Follow-up|0|||
125636337|NCT00804986|451950913|FG001|Overall Study|Lost to Follow-up|0|||
125636338|NCT00804986|451950914|FG002|Overall Study|Lost to Follow-up|0|||
125636339|NCT00804986|451950915|FG003|Overall Study|Lost to Follow-up|1|||
125636340|NCT00804986|451950916|FG004|Overall Study|Lost to Follow-up|1|||
125636341|NCT00804986|451950917|FG005|Overall Study|Lost to Follow-up|3|||
125636342|NCT00804986|451950912|FG000|Overall Study|Protocol Violation|0|||
125636343|NCT00804986|451950913|FG001|Overall Study|Protocol Violation|1|||
125636344|NCT00804986|451950914|FG002|Overall Study|Protocol Violation|0|||
125636345|NCT00804986|451950915|FG003|Overall Study|Protocol Violation|1|||
125636346|NCT00804986|451950916|FG004|Overall Study|Protocol Violation|0|||
125636347|NCT00804986|451950917|FG005|Overall Study|Protocol Violation|0|||
125636348|NCT00804986|451950912|FG000|Overall Study|Withdrawal by Subject|0|||
125636349|NCT00804986|451950913|FG001|Overall Study|Withdrawal by Subject|3|||
125636350|NCT00804986|451950914|FG002|Overall Study|Withdrawal by Subject|0|||
125636351|NCT00804986|451950915|FG003|Overall Study|Withdrawal by Subject|3|||
125636352|NCT00804986|451950916|FG004|Overall Study|Withdrawal by Subject|5|||
125636353|NCT00804986|451950917|FG005|Overall Study|Withdrawal by Subject|3|||
125636354|NCT00804986|451950912|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
125636355|NCT00804986|451950913|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
125636356|NCT00804986|451950914|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
125636357|NCT00804986|451950915|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
125636358|NCT00804986|451950916|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
125636359|NCT00804986|451950917|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
125636360|NCT00804986|451950912|FG000|Overall Study|Sponsor Decision|0|||
125636361|NCT00804986|451950913|FG001|Overall Study|Sponsor Decision|1|||
125636362|NCT00804986|451950914|FG002|Overall Study|Sponsor Decision|0|||
125636363|NCT00804986|451950915|FG003|Overall Study|Sponsor Decision|0|||
125636364|NCT00804986|451950916|FG004|Overall Study|Sponsor Decision|0|||
125636365|NCT00804986|451950917|FG005|Overall Study|Sponsor Decision|0|||
125636366|NCT00804986|451950912|FG000|Overall Study|Physician Decision|1|||
125636367|NCT00804986|451950913|FG001|Overall Study|Physician Decision|0|||
125636368|NCT00804986|451950914|FG002|Overall Study|Physician Decision|0|||
125636369|NCT00804986|451950915|FG003|Overall Study|Physician Decision|0|||
125636370|NCT00804986|451950916|FG004|Overall Study|Physician Decision|0|||
125636371|NCT00804986|451950917|FG005|Overall Study|Physician Decision|0|||
125636372|NCT00959699|451950918|FG000|Treatment Period|Adverse Event|3|||
125636373|NCT00959699|451950919|FG001|Treatment Period|Adverse Event|13|||
125636374|NCT00959699|451950918|FG000|Treatment Period|Lack of Efficacy|15|||
125636375|NCT00959699|451950919|FG001|Treatment Period|Lack of Efficacy|6|||
125636376|NCT00959699|451950918|FG000|Treatment Period|Lost to Follow-up|0|||
125636377|NCT00959699|451950919|FG001|Treatment Period|Lost to Follow-up|1|||
125636378|NCT00959699|451950918|FG000|Treatment Period|Withdrawal by Subject|1|||
125636379|NCT00959699|451950919|FG001|Treatment Period|Withdrawal by Subject|3|||
125636380|NCT00959699|451950918|FG000|Treatment Period|Non-Compliance with Protocol|0|||
125636381|NCT00959699|451950919|FG001|Treatment Period|Non-Compliance with Protocol|1|||
125636382|NCT00959699|451950918|FG000|Treatment Period|Did not receive treatment|0|||
125636383|NCT00959699|451950919|FG001|Treatment Period|Did not receive treatment|1|||
125636384|NCT00959699|451950918|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
125636385|NCT00959699|451950919|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
125636386|NCT00959699|451950918|FG000|Follow-up Period|Lost to Follow-up|3|||
125636387|NCT00959699|451950919|FG001|Follow-up Period|Lost to Follow-up|2|||
125636388|NCT00959699|451950918|FG000|Follow-up Period|Withdrawal by Subject|3|||
125636389|NCT00959699|451950919|FG001|Follow-up Period|Withdrawal by Subject|4|||
125636390|NCT00606294|451950920|FG000|Overall Study|Withdrawal by Subject|36|||
125636391|NCT00606294|451950921|FG001|Overall Study|Withdrawal by Subject|0|||
125636392|NCT03924427|451950926|FG000|Overall Study|Adverse Event|4|||
125636393|NCT03924427|451950926|FG000|Overall Study|Lack of Efficacy|1|||
125636394|NCT03924427|451950926|FG000|Overall Study|Withdrawal by Subject|1|||
125636395|NCT02774291|451950930|FG000|Overall Study|Lost to Follow-up|1|||
125636396|NCT00126425|451950931|FG000|Overall Study|Withdrawal by Subject|17|||
125636397|NCT00126425|451950932|FG001|Overall Study|Withdrawal by Subject|1|||
125636398|NCT00126425|451950931|FG000|Overall Study|Lost to Follow-up|8|||
125636399|NCT00126425|451950932|FG001|Overall Study|Lost to Follow-up|4|||
125636400|NCT00126425|451950931|FG000|Overall Study|Protocol Violation|9|||
125636401|NCT00126425|451950932|FG001|Overall Study|Protocol Violation|6|||
125636402|NCT00126425|451950931|FG000|Overall Study|Adverse Event|1|||
125636403|NCT00126425|451950932|FG001|Overall Study|Adverse Event|0|||
125636404|NCT00126425|451950931|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
125636405|NCT00126425|451950932|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
125636406|NCT00126425|451950931|FG000|Overall Study|Other|5|||
125636407|NCT00126425|451950932|FG001|Overall Study|Other|0|||
125636408|NCT00149890|451950933|FG000|Overall Study|Adverse Event|1|||
125636409|NCT00149890|451950934|FG001|Overall Study|Adverse Event|8|||
125636410|NCT00149890|451950933|FG000|Overall Study|Lack of Efficacy|8|||
125636411|NCT00149890|451950934|FG001|Overall Study|Lack of Efficacy|9|||
125636412|NCT00149890|451950933|FG000|Overall Study|Protocol Violation|1|||
125636413|NCT00149890|451950934|FG001|Overall Study|Protocol Violation|0|||
125636414|NCT00149890|451950933|FG000|Overall Study|Lost to Follow-up|1|||
125636415|NCT00149890|451950934|FG001|Overall Study|Lost to Follow-up|0|||
125636416|NCT00149890|451950933|FG000|Overall Study|Graft Loss|2|||
125636417|NCT00149890|451950934|FG001|Overall Study|Graft Loss|1|||
125636418|NCT02332876|451950935|FG000|Overall Study|Lost to Follow-up|1|||
125636419|NCT02332876|451950936|FG001|Overall Study|Lost to Follow-up|1|||
125636420|NCT02415595|451950938|FG000|Overall Study|Administrative reason by sponsor|39|||
125636421|NCT02415595|451950939|FG001|Overall Study|Administrative reason by sponsor|40|||
125636422|NCT02415595|451950940|FG002|Overall Study|Administrative reason by sponsor|41|||
125636423|NCT02415595|451950941|FG003|Overall Study|Administrative reason by sponsor|39|||
125636424|NCT02415595|451950938|FG000|Overall Study|Adverse Event|1|||
125636425|NCT02415595|451950939|FG001|Overall Study|Adverse Event|3|||
125636426|NCT02415595|451950940|FG002|Overall Study|Adverse Event|5|||
125636427|NCT02415595|451950941|FG003|Overall Study|Adverse Event|10|||
125636428|NCT02415595|451950938|FG000|Overall Study|Lack of Efficacy|4|||
125636429|NCT02415595|451950939|FG001|Overall Study|Lack of Efficacy|4|||
125636430|NCT02415595|451950940|FG002|Overall Study|Lack of Efficacy|0|||
125636431|NCT02415595|451950941|FG003|Overall Study|Lack of Efficacy|0|||
125636432|NCT02415595|451950938|FG000|Overall Study|Lost to Follow-up|1|||
125636433|NCT02415595|451950939|FG001|Overall Study|Lost to Follow-up|3|||
125636434|NCT02415595|451950940|FG002|Overall Study|Lost to Follow-up|1|||
125636435|NCT02415595|451950941|FG003|Overall Study|Lost to Follow-up|1|||
125636436|NCT02415595|451950938|FG000|Overall Study|Poor/Non-compliance|1|||
125636437|NCT02415595|451950939|FG001|Overall Study|Poor/Non-compliance|0|||
125636438|NCT02415595|451950940|FG002|Overall Study|Poor/Non-compliance|1|||
125636439|NCT02415595|451950941|FG003|Overall Study|Poor/Non-compliance|0|||
125636440|NCT02415595|451950938|FG000|Overall Study|Reached stopping criteria|0|||
125636441|NCT02415595|451950939|FG001|Overall Study|Reached stopping criteria|1|||
125636442|NCT02415595|451950940|FG002|Overall Study|Reached stopping criteria|1|||
125636443|NCT02415595|451950941|FG003|Overall Study|Reached stopping criteria|0|||
125636444|NCT02415595|451950938|FG000|Overall Study|Withdrawal by Subject|4|||
125636445|NCT02415595|451950939|FG001|Overall Study|Withdrawal by Subject|0|||
125636446|NCT02415595|451950940|FG002|Overall Study|Withdrawal by Subject|1|||
125636447|NCT02415595|451950941|FG003|Overall Study|Withdrawal by Subject|3|||
125131173|NCT03965091|450108030|FG000|Overall Study|Other than specified|9|||
125131174|NCT03965091|450108031|FG001|Overall Study|Other than specified|11|||
125131175|NCT03965091|450108032|FG002|Overall Study|Other than specified|8|||
125131176|NCT02159950|450108042|FG000|Overall Study|Adverse Event|0|||
125131177|NCT02159950|450108043|FG001|Overall Study|Adverse Event|1|||
125131178|NCT02159950|450108042|FG000|Overall Study|Progression|0|||
125131179|NCT02159950|450108043|FG001|Overall Study|Progression|1|||
125636448|NCT02415595|451950938|FG000|Overall Study|Other|0|||
125636449|NCT02415595|451950939|FG001|Overall Study|Other|1|||
125636450|NCT02415595|451950940|FG002|Overall Study|Other|1|||
125636451|NCT02415595|451950941|FG003|Overall Study|Other|0|||
125636452|NCT02614261|451950942|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
125636453|NCT02614261|451950943|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
125636454|NCT02614261|451950944|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
125636455|NCT02614261|451950945|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
125636456|NCT02614261|451950942|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
125636457|NCT02614261|451950943|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125636458|NCT02614261|451950944|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125636459|NCT02614261|451950945|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125636460|NCT02614261|451950942|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
125636461|NCT02614261|451950943|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
125636462|NCT02614261|451950944|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
125636463|NCT02614261|451950945|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125636464|NCT02614261|451950942|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
125636465|NCT02614261|451950943|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
125636466|NCT02614261|451950944|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
125636467|NCT02614261|451950945|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
125636468|NCT02614261|451950942|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
125636469|NCT02614261|451950943|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
125636470|NCT02614261|451950944|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
125636471|NCT02614261|451950945|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
125636472|NCT02614261|451950942|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
125636473|NCT02614261|451950943|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
125636474|NCT02614261|451950944|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
125636475|NCT02614261|451950945|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
125636476|NCT02614261|451950942|FG000|Double-Blind Treatment Phase|Screen failure|0|||
125636477|NCT02614261|451950943|FG001|Double-Blind Treatment Phase|Screen failure|1|||
125636478|NCT02614261|451950944|FG002|Double-Blind Treatment Phase|Screen failure|2|||
125636479|NCT02614261|451950945|FG003|Double-Blind Treatment Phase|Screen failure|0|||
125636480|NCT02614261|451950942|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
125636481|NCT02614261|451950943|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
125636482|NCT02614261|451950944|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
125636483|NCT02614261|451950945|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
125636484|NCT02614261|451950942|FG000|Open-Label Extension Phase|Adverse Event|23|||
125636485|NCT02614261|451950943|FG001|Open-Label Extension Phase|Adverse Event|12|||
125636486|NCT02614261|451950944|FG002|Open-Label Extension Phase|Adverse Event|11|||
125636487|NCT02614261|451950945|FG003|Open-Label Extension Phase|Adverse Event|0|||
125636488|NCT02614261|451950942|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
125636489|NCT02614261|451950943|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
125636490|NCT02614261|451950944|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
125636491|NCT02614261|451950945|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
125636492|NCT02614261|451950942|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
125636493|NCT02614261|451950943|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
125636494|NCT02614261|451950944|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
125636495|NCT02614261|451950945|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
125636496|NCT02614261|451950942|FG000|Open-Label Extension Phase|Physician Decision|2|||
125636497|NCT02614261|451950943|FG001|Open-Label Extension Phase|Physician Decision|0|||
125636498|NCT02614261|451950944|FG002|Open-Label Extension Phase|Physician Decision|0|||
125636499|NCT02614261|451950945|FG003|Open-Label Extension Phase|Physician Decision|0|||
125636500|NCT02614261|451950942|FG000|Open-Label Extension Phase|Pregnancy|1|||
125636501|NCT02614261|451950943|FG001|Open-Label Extension Phase|Pregnancy|2|||
125636502|NCT02614261|451950944|FG002|Open-Label Extension Phase|Pregnancy|1|||
125636503|NCT02614261|451950945|FG003|Open-Label Extension Phase|Pregnancy|0|||
125636504|NCT02614261|451950942|FG000|Open-Label Extension Phase|Protocol Violation|3|||
125636505|NCT02614261|451950943|FG001|Open-Label Extension Phase|Protocol Violation|4|||
125636506|NCT02614261|451950944|FG002|Open-Label Extension Phase|Protocol Violation|1|||
125636507|NCT02614261|451950945|FG003|Open-Label Extension Phase|Protocol Violation|0|||
125636508|NCT02614261|451950942|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
125636509|NCT02614261|451950943|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
125636510|NCT02614261|451950944|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
125131180|NCT00003659|450108044|FG000|Overall Study|Withdrawal by Subject|3|||
125131181|NCT02648438|450108047|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125636511|NCT02614261|451950945|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
125636512|NCT02614261|451950942|FG000|Follow-up Phase|Adverse Event|2|||
125636513|NCT02614261|451950943|FG001|Follow-up Phase|Adverse Event|0|||
125636514|NCT02614261|451950944|FG002|Follow-up Phase|Adverse Event|1|||
125636515|NCT02614261|451950945|FG003|Follow-up Phase|Adverse Event|0|||
125636516|NCT02614261|451950942|FG000|Follow-up Phase|Lost to Follow-up|12|||
125636517|NCT02614261|451950943|FG001|Follow-up Phase|Lost to Follow-up|5|||
125636518|NCT02614261|451950944|FG002|Follow-up Phase|Lost to Follow-up|2|||
125636519|NCT02614261|451950945|FG003|Follow-up Phase|Lost to Follow-up|0|||
125636520|NCT02614261|451950942|FG000|Follow-up Phase|Physician Decision|5|||
125636521|NCT02614261|451950943|FG001|Follow-up Phase|Physician Decision|1|||
125636522|NCT02614261|451950944|FG002|Follow-up Phase|Physician Decision|0|||
125636523|NCT02614261|451950945|FG003|Follow-up Phase|Physician Decision|0|||
125636524|NCT02614261|451950942|FG000|Follow-up Phase|Pregnancy|0|||
125636525|NCT02614261|451950943|FG001|Follow-up Phase|Pregnancy|1|||
125636526|NCT02614261|451950944|FG002|Follow-up Phase|Pregnancy|0|||
125636527|NCT02614261|451950945|FG003|Follow-up Phase|Pregnancy|0|||
125636528|NCT02614261|451950942|FG000|Follow-up Phase|Protocol Violation|1|||
125636529|NCT02614261|451950943|FG001|Follow-up Phase|Protocol Violation|0|||
125636530|NCT02614261|451950944|FG002|Follow-up Phase|Protocol Violation|0|||
125636531|NCT02614261|451950945|FG003|Follow-up Phase|Protocol Violation|0|||
125636532|NCT02614261|451950942|FG000|Follow-up Phase|Withdrawal by Subject|12|||
125636533|NCT02614261|451950943|FG001|Follow-up Phase|Withdrawal by Subject|4|||
125636534|NCT02614261|451950944|FG002|Follow-up Phase|Withdrawal by Subject|11|||
125636535|NCT02614261|451950945|FG003|Follow-up Phase|Withdrawal by Subject|0|||
125636536|NCT02614261|451950942|FG000|Israel Addendum|Withdrawal by Subject|0|||
125636537|NCT02614261|451950943|FG001|Israel Addendum|Withdrawal by Subject|0|||
125636538|NCT02614261|451950944|FG002|Israel Addendum|Withdrawal by Subject|0|||
125636539|NCT02614261|451950945|FG003|Israel Addendum|Withdrawal by Subject|4|||
125636540|NCT00471315|451950946|FG000|Overall Study|Adverse Event|7|||
125636541|NCT00471315|451950946|FG000|Overall Study|Withdrawal by Subject|1|||
125636542|NCT03695471|451952701|FG000|Overall Study|Cancellation|1|||
125636543|NCT02859558|451952702|FG000|Step 1|Not Eligible|0|||
125636544|NCT02859558|451952703|FG001|Step 1|Not Eligible|0|||
125636545|NCT02859558|451952704|FG002|Step 1|Not Eligible|0|||
125636546|NCT02859558|451952705|FG003|Step 1|Not Eligible|0|||
125636547|NCT02859558|451952706|FG004|Step 1|Not Eligible|3|||
125636548|NCT02859558|451952702|FG000|Step 1|Lost to Follow-up|1|||
125636549|NCT02859558|451952703|FG001|Step 1|Lost to Follow-up|3|||
125636550|NCT02859558|451952704|FG002|Step 1|Lost to Follow-up|3|||
125636551|NCT02859558|451952705|FG003|Step 1|Lost to Follow-up|0|||
125636552|NCT02859558|451952706|FG004|Step 1|Lost to Follow-up|0|||
125636553|NCT02859558|451952702|FG000|Step 1|Did Not Return to Clinic|2|||
125636554|NCT02859558|451952703|FG001|Step 1|Did Not Return to Clinic|3|||
125636555|NCT02859558|451952704|FG002|Step 1|Did Not Return to Clinic|4|||
125636556|NCT02859558|451952705|FG003|Step 1|Did Not Return to Clinic|0|||
125636557|NCT02859558|451952706|FG004|Step 1|Did Not Return to Clinic|0|||
125636558|NCT02859558|451952702|FG000|Step 1|Moved|0|||
125636559|NCT02859558|451952703|FG001|Step 1|Moved|1|||
125636560|NCT02859558|451952704|FG002|Step 1|Moved|1|||
125636561|NCT02859558|451952705|FG003|Step 1|Moved|0|||
125636562|NCT02859558|451952706|FG004|Step 1|Moved|0|||
125636563|NCT02859558|451952702|FG000|Step 1|Withdrawal By Participant|1|||
125636564|NCT02859558|451952703|FG001|Step 1|Withdrawal By Participant|2|||
125636565|NCT02859558|451952704|FG002|Step 1|Withdrawal By Participant|1|||
125636566|NCT02859558|451952705|FG003|Step 1|Withdrawal By Participant|0|||
125636567|NCT02859558|451952706|FG004|Step 1|Withdrawal By Participant|0|||
125636568|NCT02859558|451952702|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
125636569|NCT02859558|451952703|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
125636570|NCT02859558|451952704|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
125636571|NCT02859558|451952705|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
125636572|NCT02859558|451952706|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
125636573|NCT02859558|451952702|FG000|Step 1|Incarceration|0|||
125636574|NCT02859558|451952703|FG001|Step 1|Incarceration|1|||
125636575|NCT02859558|451952704|FG002|Step 1|Incarceration|0|||
125636576|NCT02859558|451952705|FG003|Step 1|Incarceration|0|||
125636577|NCT02859558|451952706|FG004|Step 1|Incarceration|0|||
125636578|NCT02859558|451952702|FG000|Step 1|Non-Adherence to Study Drug|2|||
125636579|NCT02859558|451952703|FG001|Step 1|Non-Adherence to Study Drug|0|||
125636580|NCT02859558|451952704|FG002|Step 1|Non-Adherence to Study Drug|1|||
125636581|NCT02859558|451952705|FG003|Step 1|Non-Adherence to Study Drug|0|||
125636582|NCT02859558|451952706|FG004|Step 1|Non-Adherence to Study Drug|0|||
125636583|NCT02859558|451952702|FG000|Step 1|Non-Adherence to Study Requirements|3|||
125636584|NCT02859558|451952703|FG001|Step 1|Non-Adherence to Study Requirements|1|||
125636585|NCT02859558|451952704|FG002|Step 1|Non-Adherence to Study Requirements|0|||
125378551|NCT00372112|451017214|FG000|Overall Study|Exacerbation|0|||
125378552|NCT00372112|451017215|FG001|Overall Study|Exacerbation|0|||
125378553|NCT00372112|451017216|FG002|Overall Study|Exacerbation|0|||
125378554|NCT00372112|451017217|FG003|Overall Study|Exacerbation|1|||
125636586|NCT02859558|451952705|FG003|Step 1|Non-Adherence to Study Requirements|0|||
125636587|NCT02859558|451952706|FG004|Step 1|Non-Adherence to Study Requirements|0|||
125636588|NCT02859558|451952702|FG000|Step 1|Virologic Failure|2|||
125636589|NCT02859558|451952703|FG001|Step 1|Virologic Failure|1|||
125636590|NCT02859558|451952704|FG002|Step 1|Virologic Failure|1|||
125636591|NCT02859558|451952705|FG003|Step 1|Virologic Failure|0|||
125636592|NCT02859558|451952706|FG004|Step 1|Virologic Failure|0|||
125636593|NCT02859558|451952702|FG000|Step 2|Lost to Follow-up|3|||
125636594|NCT02859558|451952703|FG001|Step 2|Lost to Follow-up|3|||
125636595|NCT02859558|451952704|FG002|Step 2|Lost to Follow-up|1|||
125378555|NCT00372112|451017214|FG000|Overall Study|PR >240 at Visit 3|0|||
125378556|NCT00372112|451017215|FG001|Overall Study|PR >240 at Visit 3|0|||
125378557|NCT00372112|451017216|FG002|Overall Study|PR >240 at Visit 3|0|||
125378558|NCT00372112|451017217|FG003|Overall Study|PR >240 at Visit 3|1|||
125378559|NCT00372112|451017214|FG000|Overall Study|Hepatitis B|1|||
125378560|NCT00372112|451017215|FG001|Overall Study|Hepatitis B|0|||
125378561|NCT00372112|451017216|FG002|Overall Study|Hepatitis B|0|||
125378562|NCT00372112|451017217|FG003|Overall Study|Hepatitis B|0|||
125217382|NCT04865419|450423513|FG010|Overall Study|Death|1|||
125217383|NCT04865419|450423503|FG000|Overall Study|Lost to Follow-up|0|||
125636596|NCT02859558|451952705|FG003|Step 2|Lost to Follow-up|0|||
125636597|NCT02859558|451952706|FG004|Step 2|Lost to Follow-up|0|||
125636598|NCT02859558|451952702|FG000|Step 2|Withdrawal by Subject|0|||
125636599|NCT02859558|451952703|FG001|Step 2|Withdrawal by Subject|1|||
125636600|NCT02859558|451952704|FG002|Step 2|Withdrawal by Subject|1|||
125636601|NCT02859558|451952705|FG003|Step 2|Withdrawal by Subject|0|||
125636602|NCT02859558|451952706|FG004|Step 2|Withdrawal by Subject|0|||
125636603|NCT02859558|451952702|FG000|Step 2|Unexpected Closure of Site|0|||
125636604|NCT02859558|451952703|FG001|Step 2|Unexpected Closure of Site|1|||
125636605|NCT02859558|451952704|FG002|Step 2|Unexpected Closure of Site|1|||
125636606|NCT02859558|451952705|FG003|Step 2|Unexpected Closure of Site|0|||
125636607|NCT02859558|451952706|FG004|Step 2|Unexpected Closure of Site|0|||
125636608|NCT02859558|451952702|FG000|Step 2|Death|1|||
125636609|NCT02859558|451952703|FG001|Step 2|Death|0|||
125636610|NCT02859558|451952704|FG002|Step 2|Death|0|||
125636611|NCT02859558|451952705|FG003|Step 2|Death|0|||
125636612|NCT02859558|451952706|FG004|Step 2|Death|0|||
125636613|NCT02859558|451952702|FG000|Step 2|Incarceration|0|||
125636614|NCT02859558|451952703|FG001|Step 2|Incarceration|0|||
125636615|NCT02859558|451952704|FG002|Step 2|Incarceration|1|||
125636616|NCT02859558|451952705|FG003|Step 2|Incarceration|0|||
125636617|NCT02859558|451952706|FG004|Step 2|Incarceration|0|||
125636618|NCT05665595|451952707|FG000|Overall Study|Ongoing|692|||
125636619|NCT05665595|451952708|FG001|Overall Study|Ongoing|698|||
125636620|NCT05665595|451952707|FG000|Overall Study|Withdrawal by Subject|2|||
125636621|NCT05665595|451952708|FG001|Overall Study|Withdrawal by Subject|2|||
125636622|NCT05665595|451952707|FG000|Overall Study|Lost to Follow-up|1|||
125636623|NCT05665595|451952708|FG001|Overall Study|Lost to Follow-up|0|||
125636624|NCT05665595|451952707|FG000|Overall Study|Death|6|||
125636625|NCT05665595|451952708|FG001|Overall Study|Death|1|||
125636626|NCT00766142|451952709|FG000|Overall Study|Protocol Violation|4|||
125636627|NCT02358863|451952714|FG000|Overall Study|Physician Decision|3|||
125636628|NCT03793010|451952721|FG000|Overall Study|Withdrawal by Subject|5|||
125636629|NCT03793010|451952722|FG001|Overall Study|Withdrawal by Subject|7|||
125636630|NCT03793010|451952721|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
125636631|NCT03793010|451952722|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
125378563|NCT00372112|451017214|FG000|Overall Study|Other-protocol violation|0|||
125378564|NCT00372112|451017215|FG001|Overall Study|Other-protocol violation|0|||
125378565|NCT00372112|451017216|FG002|Overall Study|Other-protocol violation|1|||
125378566|NCT00372112|451017217|FG003|Overall Study|Other-protocol violation|0|||
125378567|NCT04649060|451017232|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
125378568|NCT04649060|451017233|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
125378569|NCT04649060|451017232|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
125636632|NCT03793010|451952721|FG000|Overall Study|Lost to Follow-up|1|||
125636633|NCT03793010|451952722|FG001|Overall Study|Lost to Follow-up|2|||
125636634|NCT03793010|451952721|FG000|Overall Study|Patient couldn't sit still for injection|1|||
125636635|NCT03793010|451952722|FG001|Overall Study|Patient couldn't sit still for injection|0|||
125636636|NCT03793010|451952721|FG000|Overall Study|Withdrew to pursue other treatment|1|||
125378570|NCT04649060|451017233|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
125636637|NCT03793010|451952722|FG001|Overall Study|Withdrew to pursue other treatment|0|||
125378571|NCT04649060|451017232|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
125636638|NCT03793010|451952721|FG000|Overall Study|Did not meet eligibility criteria|1|||
125636639|NCT03793010|451952722|FG001|Overall Study|Did not meet eligibility criteria|0|||
125636640|NCT05016037|451952723|FG000|Overall Study|Lost to Follow-up|2|||
125217384|NCT04865419|450423504|FG001|Overall Study|Lost to Follow-up|0|||
125636641|NCT00129376|451952728|FG000|Overall Study|Adverse Event|1|||
125636642|NCT00129376|451952728|FG000|Overall Study|Lack of Efficacy|1|||
125378572|NCT04649060|451017233|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
125378573|NCT04649060|451017232|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
125378574|NCT04649060|451017233|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
125378575|NCT04649060|451017232|FG000|Arm A/Arm B Treatment|Patient Request|1|||
125378576|NCT04649060|451017233|FG001|Arm A/Arm B Treatment|Patient Request|0|||
125378577|NCT04649060|451017232|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
125378578|NCT04649060|451017233|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
125378579|NCT04649060|451017232|FG000|Arm A/Arm B Treatment|Other|1|||
125378580|NCT04649060|451017233|FG001|Arm A/Arm B Treatment|Other|0|||
125378581|NCT04649060|451017232|FG000|Crossover (Arm B)|Adverse Event|0|||
125378582|NCT04649060|451017233|FG001|Crossover (Arm B)|Adverse Event|1|||
125378583|NCT04649060|451017232|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
125378584|NCT04649060|451017233|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
125378585|NCT01830972|451017234|FG000|Part II|Withdrawal by Subject|2|||
125378586|NCT01830972|451017235|FG001|Part II|Withdrawal by Subject|2|||
125378587|NCT01830972|451017234|FG000|Part III|Withdrawal by Subject|1|||
125378588|NCT01830972|451017235|FG001|Part III|Withdrawal by Subject|0|||
125378589|NCT01830972|451017234|FG000|Part III|Noncompliance|1|||
125378590|NCT01830972|451017235|FG001|Part III|Noncompliance|0|||
125378591|NCT01830972|451017234|FG000|Part IV|Withdrawal by Subject|2|||
125378592|NCT01830972|451017235|FG001|Part IV|Withdrawal by Subject|1|||
125378593|NCT01830972|451017234|FG000|Part IV|Non-Compliance|1|||
125378594|NCT01830972|451017235|FG001|Part IV|Non-Compliance|0|||
125378595|NCT01907815|451017238|FG000|Overall Study|Withdrawal by Subject|1|||
125378596|NCT01907815|451017239|FG001|Overall Study|Withdrawal by Subject|0|||
125378597|NCT02205814|451017240|FG000|Overall Study|Lost to Follow-up|0|||
125378598|NCT02205814|451017241|FG001|Overall Study|Lost to Follow-up|0|||
125378599|NCT02205814|451017242|FG002|Overall Study|Lost to Follow-up|0|||
125378600|NCT02205814|451017243|FG003|Overall Study|Lost to Follow-up|1|||
125378601|NCT02205814|451017240|FG000|Overall Study|Lack of Efficacy|1|||
125378602|NCT02205814|451017241|FG001|Overall Study|Lack of Efficacy|0|||
125378603|NCT02205814|451017242|FG002|Overall Study|Lack of Efficacy|1|||
125378604|NCT02205814|451017243|FG003|Overall Study|Lack of Efficacy|1|||
125636643|NCT03218826|451952730|FG000|Overall Study|Non-compliance with protocol|1|||
125636644|NCT03218826|451952731|FG001|Overall Study|Non-compliance with protocol|0|||
125636645|NCT03218826|451952732|FG002|Overall Study|Non-compliance with protocol|2|||
125636646|NCT03218826|451952733|FG003|Overall Study|Non-compliance with protocol|1|||
125636647|NCT03218826|451952734|FG004|Overall Study|Non-compliance with protocol|1|||
125636648|NCT01426009|451952735|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
125636649|NCT01426009|451952735|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
125636650|NCT01426009|451952735|FG000|Washout 1|Withdrawal by Subject|1|||
125636651|NCT01426009|451952735|FG000|Washout 1|Personal Reasons|1|||
125636652|NCT01426009|451952735|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
125636653|NCT01426009|451952735|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
125636654|NCT01426009|451952735|FG000|Washout 2|electrive surgery|1|||
125636655|NCT01426009|451952735|FG000|Washout 3|personal reasons|1|||
125636656|NCT01426009|451952735|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
125636657|NCT01426009|451952735|FG000|Washout 4|Lost to Follow-up|1|||
125636658|NCT00796549|451952745|FG000|Overall Study|Adverse Event|11|||
125636659|NCT00796549|451952745|FG000|Overall Study|not entered|149|||
125636660|NCT00796549|451952745|FG000|Overall Study|Other|2|||
125636661|NCT00796549|451952745|FG000|Overall Study|Progressive disease|56|||
125636662|NCT01878175|451952747|FG000|Overall Study|Developed contraindicated health problem|2|||
125636663|NCT03083470|451952748|FG000|Overall Study|Lost to Follow-up|0|||
125636664|NCT03083470|451952749|FG001|Overall Study|Lost to Follow-up|0|||
125636665|NCT03083470|451952750|FG002|Overall Study|Lost to Follow-up|0|||
125636666|NCT03083470|451952751|FG003|Overall Study|Lost to Follow-up|0|||
125131182|NCT02648438|450108048|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
125217385|NCT04865419|450423505|FG002|Overall Study|Lost to Follow-up|0|||
125378605|NCT02205814|451017240|FG000|Overall Study|Physician Decision|0|||
125378606|NCT02205814|451017241|FG001|Overall Study|Physician Decision|0|||
125636667|NCT03083470|451952752|FG004|Overall Study|Lost to Follow-up|1|||
125636668|NCT03083470|451952748|FG000|Overall Study|Withdrawal by Subject|0|||
125378607|NCT02205814|451017242|FG002|Overall Study|Physician Decision|1|||
125378608|NCT02205814|451017243|FG003|Overall Study|Physician Decision|0|||
125378609|NCT02205814|451017240|FG000|Overall Study|Protocol Violation|1|||
125378610|NCT02205814|451017241|FG001|Overall Study|Protocol Violation|0|||
125378611|NCT02205814|451017242|FG002|Overall Study|Protocol Violation|0|||
125378612|NCT02205814|451017243|FG003|Overall Study|Protocol Violation|1|||
125378613|NCT02205814|451017240|FG000|Overall Study|Withdrawal by Subject|0|||
125636669|NCT03083470|451952749|FG001|Overall Study|Withdrawal by Subject|0|||
125636670|NCT03083470|451952750|FG002|Overall Study|Withdrawal by Subject|0|||
125636671|NCT03083470|451952751|FG003|Overall Study|Withdrawal by Subject|0|||
125636672|NCT03083470|451952752|FG004|Overall Study|Withdrawal by Subject|1|||
125378614|NCT02205814|451017241|FG001|Overall Study|Withdrawal by Subject|1|||
125378615|NCT02205814|451017242|FG002|Overall Study|Withdrawal by Subject|2|||
125378616|NCT02205814|451017243|FG003|Overall Study|Withdrawal by Subject|1|||
125217386|NCT04865419|450423506|FG003|Overall Study|Lost to Follow-up|0|||
125217387|NCT04865419|450423507|FG004|Overall Study|Lost to Follow-up|0|||
125217388|NCT04865419|450423508|FG005|Overall Study|Lost to Follow-up|0|||
125217389|NCT04865419|450423509|FG006|Overall Study|Lost to Follow-up|0|||
125217390|NCT04865419|450423510|FG007|Overall Study|Lost to Follow-up|0|||
125217391|NCT04865419|450423511|FG008|Overall Study|Lost to Follow-up|0|||
125217392|NCT04865419|450423512|FG009|Overall Study|Lost to Follow-up|1|||
125217393|NCT04865419|450423513|FG010|Overall Study|Lost to Follow-up|0|||
125636673|NCT00606229|451952753|FG000|Overall Study|Adverse Event|11|||
125636674|NCT00606229|451952753|FG000|Overall Study|Lack of Efficacy|1|||
125636675|NCT00606229|451952753|FG000|Overall Study|Withdrawal by Subject|4|||
125636676|NCT00606229|451952753|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
125636677|NCT00606229|451952753|FG000|Overall Study|change of residence or other commitments|2|||
125636678|NCT01526928|451952754|FG000|Overall Study|Progressive Disease|35|||
125636679|NCT01526928|451952755|FG001|Overall Study|Progressive Disease|17|||
125636680|NCT01526928|451952756|FG002|Overall Study|Progressive Disease|150|||
125636681|NCT01526928|451952757|FG003|Overall Study|Progressive Disease|182|||
125636682|NCT01526928|451952758|FG004|Overall Study|Progressive Disease|76|||
125636683|NCT01526928|451952759|FG005|Overall Study|Progressive Disease|4|||
125636684|NCT01526928|451952754|FG000|Overall Study|Adverse Event|2|||
125636685|NCT01526928|451952755|FG001|Overall Study|Adverse Event|1|||
125636686|NCT01526928|451952756|FG002|Overall Study|Adverse Event|29|||
125636687|NCT01526928|451952757|FG003|Overall Study|Adverse Event|40|||
125636688|NCT01526928|451952758|FG004|Overall Study|Adverse Event|13|||
125636689|NCT01526928|451952759|FG005|Overall Study|Adverse Event|2|||
125636690|NCT01526928|451952754|FG000|Overall Study|Death|0|||
125636691|NCT01526928|451952755|FG001|Overall Study|Death|0|||
125636692|NCT01526928|451952756|FG002|Overall Study|Death|3|||
125636693|NCT01526928|451952757|FG003|Overall Study|Death|0|||
125636694|NCT01526928|451952758|FG004|Overall Study|Death|0|||
125636695|NCT01526928|451952759|FG005|Overall Study|Death|0|||
125636696|NCT01526928|451952754|FG000|Overall Study|Withdrawal by Subject|1|||
125636697|NCT01526928|451952755|FG001|Overall Study|Withdrawal by Subject|0|||
125636698|NCT01526928|451952756|FG002|Overall Study|Withdrawal by Subject|13|||
125636699|NCT01526928|451952757|FG003|Overall Study|Withdrawal by Subject|11|||
125378617|NCT02205814|451017240|FG000|Overall Study|not compliant with study procedures|0|||
125378618|NCT02205814|451017241|FG001|Overall Study|not compliant with study procedures|0|||
125378619|NCT02205814|451017242|FG002|Overall Study|not compliant with study procedures|1|||
125378620|NCT02205814|451017243|FG003|Overall Study|not compliant with study procedures|0|||
125378621|NCT01426373|451017244|FG000|Overall Study|Adverse Event|6|||
125378622|NCT01426373|451017244|FG000|Overall Study|Lost to Follow-up|14|||
125378623|NCT01426373|451017244|FG000|Overall Study|Participant Convenience|10|||
125378624|NCT01426373|451017244|FG000|Overall Study|Miscellaneous Reasons|4|||
125378625|NCT04952402|451017245|FG000|Overall Study|Lost to Follow-up|1|||
125378626|NCT04952402|451017246|FG001|Overall Study|Lost to Follow-up|3|||
125378627|NCT04952402|451017245|FG000|Overall Study|Lack Of Venous Access|0|||
125378628|NCT04952402|451017246|FG001|Overall Study|Lack Of Venous Access|1|||
125378629|NCT01018186|451017249|FG000|2-week Run-in Period|Protocol Violation|1|||
125378630|NCT01018186|451017250|FG001|2-week Run-in Period|Protocol Violation|0|||
125378631|NCT01018186|451017251|FG002|2-week Run-in Period|Protocol Violation|0|||
125378632|NCT01018186|451017252|FG003|2-week Run-in Period|Protocol Violation|0|||
125378633|NCT01018186|451017249|FG000|2-week Run-in Period|Lost to Follow-up|2|||
125378634|NCT01018186|451017250|FG001|2-week Run-in Period|Lost to Follow-up|0|||
125378635|NCT01018186|451017251|FG002|2-week Run-in Period|Lost to Follow-up|0|||
125378636|NCT01018186|451017252|FG003|2-week Run-in Period|Lost to Follow-up|0|||
125378637|NCT01018186|451017249|FG000|2-week Run-in Period|Physician Decision|3|||
125378638|NCT01018186|451017250|FG001|2-week Run-in Period|Physician Decision|0|||
125378639|NCT01018186|451017251|FG002|2-week Run-in Period|Physician Decision|0|||
125378640|NCT01018186|451017252|FG003|2-week Run-in Period|Physician Decision|0|||
125378641|NCT01018186|451017249|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
125378642|NCT01018186|451017250|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
125378643|NCT01018186|451017251|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
125131183|NCT02648438|450108049|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
125131184|NCT02648438|450108047|FG000|Overall Study|Protocol Violation|2|||
125131185|NCT02648438|450108048|FG001|Overall Study|Protocol Violation|0|||
125131186|NCT02648438|450108049|FG002|Overall Study|Protocol Violation|0|||
125378644|NCT01018186|451017252|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
125636700|NCT01526928|451952758|FG004|Overall Study|Withdrawal by Subject|3|||
125636701|NCT01526928|451952759|FG005|Overall Study|Withdrawal by Subject|0|||
125636702|NCT01526928|451952754|FG000|Overall Study|Physician Decision|0|||
125636703|NCT01526928|451952755|FG001|Overall Study|Physician Decision|0|||
125636704|NCT01526928|451952756|FG002|Overall Study|Physician Decision|2|||
125636705|NCT01526928|451952757|FG003|Overall Study|Physician Decision|5|||
125636706|NCT01526928|451952758|FG004|Overall Study|Physician Decision|0|||
125636707|NCT01526928|451952759|FG005|Overall Study|Physician Decision|0|||
125636708|NCT01526928|451952754|FG000|Overall Study|Other Reason|0|||
125636709|NCT01526928|451952755|FG001|Overall Study|Other Reason|1|||
125636710|NCT01526928|451952756|FG002|Overall Study|Other Reason|11|||
125636711|NCT01526928|451952757|FG003|Overall Study|Other Reason|4|||
125636712|NCT01526928|451952758|FG004|Overall Study|Other Reason|1|||
125636713|NCT01526928|451952759|FG005|Overall Study|Other Reason|0|||
125636714|NCT01526928|451952754|FG000|Overall Study|Lost to Follow-up|0|||
125636715|NCT01526928|451952755|FG001|Overall Study|Lost to Follow-up|0|||
125636716|NCT01526928|451952756|FG002|Overall Study|Lost to Follow-up|0|||
125636717|NCT01526928|451952757|FG003|Overall Study|Lost to Follow-up|1|||
125636718|NCT01526928|451952758|FG004|Overall Study|Lost to Follow-up|0|||
125636719|NCT01526928|451952759|FG005|Overall Study|Lost to Follow-up|0|||
125636720|NCT01526928|451952754|FG000|Overall Study|Protocol Deviation|0|||
125636721|NCT01526928|451952755|FG001|Overall Study|Protocol Deviation|0|||
125636722|NCT01526928|451952756|FG002|Overall Study|Protocol Deviation|0|||
125636723|NCT01526928|451952757|FG003|Overall Study|Protocol Deviation|2|||
125636724|NCT01526928|451952758|FG004|Overall Study|Protocol Deviation|0|||
125636725|NCT01526928|451952759|FG005|Overall Study|Protocol Deviation|0|||
125636726|NCT01526928|451952754|FG000|Overall Study|Missing|0|||
125636727|NCT01526928|451952755|FG001|Overall Study|Missing|0|||
125636728|NCT01526928|451952756|FG002|Overall Study|Missing|1|||
125636729|NCT01526928|451952757|FG003|Overall Study|Missing|0|||
125636730|NCT01526928|451952758|FG004|Overall Study|Missing|2|||
125636731|NCT01526928|451952759|FG005|Overall Study|Missing|0|||
125636732|NCT01108068|451952760|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
125636733|NCT01108068|451952761|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
125636734|NCT00836953|451952762|FG000|Overall Study|Withdrawal by Subject|1|||
125636735|NCT00836953|451952762|FG000|Overall Study|Lost to Follow-up|1|||
125636736|NCT02877134|451952766|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
125636737|NCT02877134|451952767|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
125636738|NCT02877134|451952768|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
125636739|NCT02877134|451952769|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
125636740|NCT02877134|451952770|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
125636741|NCT02877134|451952771|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
125636742|NCT02877134|451952772|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
125636743|NCT02877134|451952773|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
125636744|NCT02877134|451952774|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
125636745|NCT02877134|451952775|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
125636746|NCT02877134|451952776|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
125636747|NCT02877134|451952777|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
125636748|NCT02877134|451952766|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125636749|NCT02877134|451952767|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
125636750|NCT02877134|451952768|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125636751|NCT02877134|451952769|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
125636752|NCT02877134|451952770|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125636753|NCT02877134|451952771|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125636754|NCT02877134|451952772|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
125636755|NCT02877134|451952773|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125636756|NCT02877134|451952774|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125636757|NCT02877134|451952775|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125636758|NCT02877134|451952776|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125636759|NCT02877134|451952777|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
125636760|NCT02877134|451952766|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
125636761|NCT02877134|451952767|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
125636762|NCT02877134|451952768|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
125636763|NCT02877134|451952769|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
125636764|NCT02877134|451952770|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
125636765|NCT02877134|451952771|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
125636766|NCT02877134|451952772|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
125636767|NCT02877134|451952773|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
125636768|NCT02877134|451952774|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
125636769|NCT02877134|451952775|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
125636770|NCT02877134|451952776|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
125636771|NCT02877134|451952777|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
125636772|NCT02877134|451952766|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
125636773|NCT02877134|451952767|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
125636774|NCT02877134|451952768|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
125636775|NCT02877134|451952769|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
125636776|NCT02877134|451952770|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
125636777|NCT02877134|451952771|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
125636778|NCT02877134|451952772|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
125636779|NCT02877134|451952773|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
125636780|NCT02877134|451952774|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
125636781|NCT02877134|451952775|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
125636782|NCT02877134|451952776|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
125636783|NCT02877134|451952777|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
125636784|NCT02877134|451952766|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125636785|NCT02877134|451952767|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125636786|NCT02877134|451952768|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125636787|NCT02877134|451952769|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125636788|NCT02877134|451952770|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125636789|NCT02877134|451952771|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125636790|NCT02877134|451952772|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125636791|NCT02877134|451952773|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125636792|NCT02877134|451952774|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
125636793|NCT02877134|451952775|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125636794|NCT02877134|451952776|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125636795|NCT02877134|451952777|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
125636796|NCT02877134|451952766|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125636797|NCT02877134|451952767|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125636798|NCT02877134|451952768|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125636799|NCT02877134|451952769|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125636800|NCT02877134|451952770|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125636801|NCT02877134|451952771|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125636802|NCT02877134|451952772|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
125636803|NCT02877134|451952773|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
125636804|NCT02877134|451952774|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
125636805|NCT02877134|451952775|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
125636806|NCT02877134|451952776|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
125636807|NCT02877134|451952777|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
125636808|NCT02877134|451952766|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125636809|NCT02877134|451952767|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125636810|NCT02877134|451952768|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125636811|NCT02877134|451952769|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125636812|NCT02877134|451952770|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125636813|NCT02877134|451952771|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125636814|NCT02877134|451952772|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125636815|NCT02877134|451952773|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
125636816|NCT02877134|451952774|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
125636817|NCT02877134|451952775|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
125636818|NCT02877134|451952776|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125636819|NCT02877134|451952777|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
125636820|NCT02877134|451952766|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
125636821|NCT02877134|451952767|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
125636822|NCT02877134|451952768|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
125636823|NCT02877134|451952769|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
125636824|NCT02877134|451952770|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
125636825|NCT02877134|451952771|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
125636826|NCT02877134|451952772|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
125636827|NCT02877134|451952773|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
125636828|NCT02877134|451952774|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
125636829|NCT02877134|451952775|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
125636830|NCT02877134|451952776|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
125636831|NCT02877134|451952777|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
125636832|NCT01197794|451952780|FG000|Overall Study|Adverse Event|3|||
125636833|NCT01197794|451952781|FG001|Overall Study|Adverse Event|2|||
125636834|NCT01197794|451952782|FG002|Overall Study|Adverse Event|4|||
125636835|NCT01197794|451952783|FG003|Overall Study|Adverse Event|4|||
125636836|NCT01197794|451952784|FG004|Overall Study|Adverse Event|4|||
125636837|NCT01197794|451952785|FG005|Overall Study|Adverse Event|2|||
125636838|NCT01197794|451952786|FG006|Overall Study|Adverse Event|3|||
125636839|NCT01197794|451952780|FG000|Overall Study|Protocol Violation|0|||
125636840|NCT01197794|451952781|FG001|Overall Study|Protocol Violation|0|||
125636841|NCT01197794|451952782|FG002|Overall Study|Protocol Violation|0|||
125636842|NCT01197794|451952783|FG003|Overall Study|Protocol Violation|0|||
125636843|NCT01197794|451952784|FG004|Overall Study|Protocol Violation|2|||
125636844|NCT01197794|451952785|FG005|Overall Study|Protocol Violation|0|||
125636845|NCT01197794|451952786|FG006|Overall Study|Protocol Violation|1|||
125636846|NCT01197794|451952780|FG000|Overall Study|Development of study withdrawal criteria|3|||
125636847|NCT01197794|451952781|FG001|Overall Study|Development of study withdrawal criteria|0|||
125636848|NCT01197794|451952782|FG002|Overall Study|Development of study withdrawal criteria|0|||
125636849|NCT01197794|451952783|FG003|Overall Study|Development of study withdrawal criteria|1|||
125636850|NCT01197794|451952784|FG004|Overall Study|Development of study withdrawal criteria|0|||
125636851|NCT01197794|451952785|FG005|Overall Study|Development of study withdrawal criteria|0|||
125636852|NCT01197794|451952786|FG006|Overall Study|Development of study withdrawal criteria|1|||
125636853|NCT01197794|451952780|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
125636854|NCT01197794|451952781|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
125636855|NCT01197794|451952782|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
125636856|NCT01197794|451952783|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
125636857|NCT01197794|451952784|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
125636858|NCT01197794|451952785|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
125636859|NCT01197794|451952786|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
125636860|NCT01197794|451952780|FG000|Overall Study|Withdrawal by Subject|3|||
125636861|NCT01197794|451952781|FG001|Overall Study|Withdrawal by Subject|3|||
125636862|NCT01197794|451952782|FG002|Overall Study|Withdrawal by Subject|4|||
125636863|NCT01197794|451952783|FG003|Overall Study|Withdrawal by Subject|1|||
125636864|NCT01197794|451952784|FG004|Overall Study|Withdrawal by Subject|1|||
125636865|NCT01197794|451952785|FG005|Overall Study|Withdrawal by Subject|5|||
125636866|NCT01197794|451952786|FG006|Overall Study|Withdrawal by Subject|6|||
125636867|NCT01197794|451952780|FG000|Overall Study|Lost to Follow-up|1|||
125636868|NCT01197794|451952781|FG001|Overall Study|Lost to Follow-up|1|||
125636869|NCT01197794|451952782|FG002|Overall Study|Lost to Follow-up|0|||
125636870|NCT01197794|451952783|FG003|Overall Study|Lost to Follow-up|1|||
125636871|NCT01197794|451952784|FG004|Overall Study|Lost to Follow-up|0|||
125636872|NCT01197794|451952785|FG005|Overall Study|Lost to Follow-up|1|||
125636873|NCT01197794|451952786|FG006|Overall Study|Lost to Follow-up|0|||
125636874|NCT01197794|451952780|FG000|Overall Study|Other|1|||
125636875|NCT01197794|451952781|FG001|Overall Study|Other|1|||
125636876|NCT01197794|451952782|FG002|Overall Study|Other|3|||
125636877|NCT01197794|451952783|FG003|Overall Study|Other|0|||
125636878|NCT01197794|451952784|FG004|Overall Study|Other|2|||
125636879|NCT01197794|451952785|FG005|Overall Study|Other|2|||
125636880|NCT01197794|451952786|FG006|Overall Study|Other|4|||
125636881|NCT01055457|451952787|FG000|Overall Study|Lost to Follow-up|0|||
125636882|NCT01055457|451952788|FG001|Overall Study|Lost to Follow-up|1|||
125636883|NCT01055457|451952789|FG002|Overall Study|Lost to Follow-up|0|||
125636884|NCT01055457|451952790|FG003|Overall Study|Lost to Follow-up|0|||
125636885|NCT01055457|451952791|FG004|Overall Study|Lost to Follow-up|0|||
125636886|NCT01055457|451952792|FG005|Overall Study|Lost to Follow-up|1|||
125636887|NCT01055457|451952793|FG006|Overall Study|Lost to Follow-up|0|||
125636888|NCT01055457|451952794|FG007|Overall Study|Lost to Follow-up|0|||
125636889|NCT01055457|451952795|FG008|Overall Study|Lost to Follow-up|0|||
125636890|NCT01055457|451952796|FG009|Overall Study|Lost to Follow-up|0|||
125636891|NCT01055457|451952787|FG000|Overall Study|Protocol Violation|0|||
125636892|NCT01055457|451952788|FG001|Overall Study|Protocol Violation|0|||
125131187|NCT02648438|450108047|FG000|Overall Study|Withdrawal by Subject|1|||
125636893|NCT01055457|451952789|FG002|Overall Study|Protocol Violation|1|||
125636894|NCT01055457|451952790|FG003|Overall Study|Protocol Violation|1|||
125636895|NCT01055457|451952791|FG004|Overall Study|Protocol Violation|1|||
125636896|NCT01055457|451952792|FG005|Overall Study|Protocol Violation|2|||
125636897|NCT01055457|451952793|FG006|Overall Study|Protocol Violation|1|||
125636898|NCT01055457|451952794|FG007|Overall Study|Protocol Violation|0|||
125636899|NCT01055457|451952795|FG008|Overall Study|Protocol Violation|0|||
125636900|NCT01055457|451952796|FG009|Overall Study|Protocol Violation|1|||
125636901|NCT01055457|451952787|FG000|Overall Study|Subject Disinterest|0|||
125636902|NCT01055457|451952788|FG001|Overall Study|Subject Disinterest|0|||
125636903|NCT01055457|451952789|FG002|Overall Study|Subject Disinterest|0|||
125636904|NCT01055457|451952790|FG003|Overall Study|Subject Disinterest|0|||
125636905|NCT01055457|451952791|FG004|Overall Study|Subject Disinterest|0|||
125636906|NCT01055457|451952792|FG005|Overall Study|Subject Disinterest|0|||
125636907|NCT01055457|451952793|FG006|Overall Study|Subject Disinterest|0|||
125636908|NCT01055457|451952794|FG007|Overall Study|Subject Disinterest|1|||
125636909|NCT01055457|451952795|FG008|Overall Study|Subject Disinterest|0|||
125636910|NCT01055457|451952796|FG009|Overall Study|Subject Disinterest|0|||
125636911|NCT01055457|451952787|FG000|Overall Study|Subject Ineligible|1|||
125636912|NCT01055457|451952788|FG001|Overall Study|Subject Ineligible|0|||
125636913|NCT01055457|451952789|FG002|Overall Study|Subject Ineligible|1|||
125636914|NCT01055457|451952790|FG003|Overall Study|Subject Ineligible|0|||
125636915|NCT01055457|451952791|FG004|Overall Study|Subject Ineligible|1|||
125636916|NCT01055457|451952792|FG005|Overall Study|Subject Ineligible|0|||
125636917|NCT01055457|451952793|FG006|Overall Study|Subject Ineligible|0|||
125636918|NCT01055457|451952794|FG007|Overall Study|Subject Ineligible|0|||
125636919|NCT01055457|451952795|FG008|Overall Study|Subject Ineligible|0|||
125636920|NCT01055457|451952796|FG009|Overall Study|Subject Ineligible|0|||
125636921|NCT01055457|451952787|FG000|Overall Study|Discomfort|0|||
125636922|NCT01055457|451952788|FG001|Overall Study|Discomfort|0|||
125636923|NCT01055457|451952789|FG002|Overall Study|Discomfort|0|||
125636924|NCT01055457|451952790|FG003|Overall Study|Discomfort|0|||
125636925|NCT01055457|451952791|FG004|Overall Study|Discomfort|1|||
125636926|NCT01055457|451952792|FG005|Overall Study|Discomfort|0|||
125636927|NCT01055457|451952793|FG006|Overall Study|Discomfort|0|||
125636928|NCT01055457|451952794|FG007|Overall Study|Discomfort|0|||
125636929|NCT01055457|451952795|FG008|Overall Study|Discomfort|0|||
125636930|NCT01055457|451952796|FG009|Overall Study|Discomfort|0|||
125636931|NCT01055457|451952787|FG000|Overall Study|Pregnancy|0|||
125636932|NCT01055457|451952788|FG001|Overall Study|Pregnancy|0|||
125636933|NCT01055457|451952789|FG002|Overall Study|Pregnancy|0|||
125636934|NCT01055457|451952790|FG003|Overall Study|Pregnancy|1|||
125636935|NCT01055457|451952791|FG004|Overall Study|Pregnancy|0|||
125636936|NCT01055457|451952792|FG005|Overall Study|Pregnancy|0|||
125636937|NCT01055457|451952793|FG006|Overall Study|Pregnancy|0|||
125636938|NCT01055457|451952794|FG007|Overall Study|Pregnancy|0|||
125636939|NCT01055457|451952795|FG008|Overall Study|Pregnancy|0|||
125636940|NCT01055457|451952796|FG009|Overall Study|Pregnancy|0|||
125636941|NCT01055457|451952787|FG000|Overall Study|Adverse Event|0|||
125636942|NCT01055457|451952788|FG001|Overall Study|Adverse Event|0|||
125636943|NCT01055457|451952789|FG002|Overall Study|Adverse Event|0|||
125636944|NCT01055457|451952790|FG003|Overall Study|Adverse Event|1|||
125636945|NCT01055457|451952791|FG004|Overall Study|Adverse Event|0|||
125636946|NCT01055457|451952792|FG005|Overall Study|Adverse Event|0|||
125636947|NCT01055457|451952793|FG006|Overall Study|Adverse Event|0|||
125636948|NCT01055457|451952794|FG007|Overall Study|Adverse Event|0|||
125636949|NCT01055457|451952795|FG008|Overall Study|Adverse Event|0|||
125636950|NCT01055457|451952796|FG009|Overall Study|Adverse Event|0|||
125636951|NCT04055844|451952797|FG000|Overall Study|Adverse Event|12|||
125636952|NCT04055844|451952797|FG000|Overall Study|Poor Performance|1|||
125217394|NCT04208412|450423514|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
125636953|NCT04055844|451952797|FG000|Overall Study|Death|1|||
125636954|NCT03630016|451952806|FG000|Overall Study|Poor Sensor Placement|1|||
125636955|NCT00255008|451952807|FG000|Overall Study|Adverse Event|1|||
125636956|NCT00255008|451952808|FG001|Overall Study|Adverse Event|1|||
125636957|NCT00255008|451952809|FG002|Overall Study|Adverse Event|2|||
125636958|NCT00255008|451952810|FG003|Overall Study|Adverse Event|0|||
125636959|NCT00255008|451952807|FG000|Overall Study|Lost to Follow-up|1|||
125636960|NCT00255008|451952808|FG001|Overall Study|Lost to Follow-up|0|||
125636961|NCT00255008|451952809|FG002|Overall Study|Lost to Follow-up|1|||
125636962|NCT00255008|451952810|FG003|Overall Study|Lost to Follow-up|2|||
125636963|NCT00255008|451952807|FG000|Overall Study|Did not meet viral reduction criteria|4|||
125217432|NCT01348100|450423526|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125636964|NCT00255008|451952808|FG001|Overall Study|Did not meet viral reduction criteria|5|||
125636965|NCT00255008|451952809|FG002|Overall Study|Did not meet viral reduction criteria|0|||
125636966|NCT00255008|451952810|FG003|Overall Study|Did not meet viral reduction criteria|1|||
125636967|NCT00255008|451952807|FG000|Overall Study|Withdrew consent|0|||
125636968|NCT00255008|451952808|FG001|Overall Study|Withdrew consent|0|||
125636969|NCT00255008|451952809|FG002|Overall Study|Withdrew consent|2|||
125636970|NCT00255008|451952810|FG003|Overall Study|Withdrew consent|0|||
125636971|NCT00255008|451952807|FG000|Overall Study|Sponsor request|18|||
125636972|NCT00255008|451952808|FG001|Overall Study|Sponsor request|3|||
125636973|NCT00255008|451952809|FG002|Overall Study|Sponsor request|8|||
125636974|NCT00255008|451952810|FG003|Overall Study|Sponsor request|17|||
125636975|NCT00255008|451952807|FG000|Overall Study|Adverse lab experience|1|||
125636976|NCT00255008|451952808|FG001|Overall Study|Adverse lab experience|0|||
125636977|NCT00255008|451952809|FG002|Overall Study|Adverse lab experience|0|||
125636978|NCT00255008|451952810|FG003|Overall Study|Adverse lab experience|0|||
125636979|NCT00255008|451952807|FG000|Overall Study|Other|7|||
125636980|NCT00255008|451952808|FG001|Overall Study|Other|0|||
125636981|NCT00255008|451952809|FG002|Overall Study|Other|3|||
125378645|NCT01018186|451017249|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
125378646|NCT01018186|451017250|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
125378647|NCT01018186|451017251|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
125378648|NCT01018186|451017252|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
125378649|NCT01018186|451017249|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
125378650|NCT01018186|451017250|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
125378651|NCT01018186|451017251|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
125378652|NCT01018186|451017252|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
125378653|NCT01018186|451017249|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
125378654|NCT01018186|451017250|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
125378655|NCT01018186|451017251|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
125378656|NCT01018186|451017252|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
125378657|NCT01018186|451017249|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
125378658|NCT01018186|451017250|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
125378659|NCT01018186|451017251|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
125378660|NCT01018186|451017252|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
125378661|NCT01018186|451017249|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
125378662|NCT01018186|451017250|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
125378663|NCT01018186|451017251|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
125636982|NCT00255008|451952810|FG003|Overall Study|Other|2|||
125636983|NCT01833806|451952811|FG000|Overall Study|Alternative treatment|2|||
125636984|NCT01833806|451952811|FG000|Overall Study|Death|5|||
125636985|NCT01833806|451952811|FG000|Overall Study|Physician Decision|1|||
125636986|NCT01833806|451952811|FG000|Overall Study|Lost to Follow-up|1|||
125636987|NCT02724111|451952812|FG000|Overall Study|Protocol Violation|2|||
125636988|NCT02724111|451952813|FG001|Overall Study|Protocol Violation|5|||
125636989|NCT02996500|451952814|FG000|Overall Study|Adverse Event|1|||
125636990|NCT02996500|451952815|FG001|Overall Study|Adverse Event|1|||
125378664|NCT01018186|451017252|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
125378665|NCT01018186|451017249|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
125378666|NCT01018186|451017250|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
125378667|NCT01018186|451017251|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
125378668|NCT01018186|451017252|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
125378669|NCT01018186|451017249|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
125378670|NCT01018186|451017250|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
125378671|NCT01018186|451017251|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
125378672|NCT01018186|451017252|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
125378673|NCT01018186|451017249|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125378674|NCT01018186|451017250|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
125378675|NCT01018186|451017251|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
125378676|NCT01018186|451017252|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
125378677|NCT03049280|451017253|FG000|Overall Study|Physician Decision|1|||
125378678|NCT03552198|451017254|FG000|Overall Study|Lost to Follow-up|42|||
125378679|NCT03552198|451017255|FG001|Overall Study|Lost to Follow-up|48|||
125378680|NCT03552198|451017256|FG002|Overall Study|Lost to Follow-up|15|||
125378681|NCT03552198|451017257|FG003|Overall Study|Lost to Follow-up|19|||
125378682|NCT03552198|451017254|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
125378683|NCT03552198|451017255|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
125378684|NCT03552198|451017256|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
125378685|NCT03552198|451017257|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
125378686|NCT03552198|451017254|FG000|Overall Study|Did not receive air alerts|1|||
125378687|NCT03552198|451017255|FG001|Overall Study|Did not receive air alerts|0|||
125378688|NCT03552198|451017256|FG002|Overall Study|Did not receive air alerts|0|||
125378689|NCT03552198|451017257|FG003|Overall Study|Did not receive air alerts|1|||
125378690|NCT00001723|451017261|FG000|Overall Study|Lack of Efficacy|6|||
125378691|NCT00001723|451017262|FG001|Overall Study|Lack of Efficacy|7|||
125378692|NCT00001723|451017261|FG000|Overall Study|Lack of family interest|4|||
125636991|NCT02996500|451952816|FG002|Overall Study|Adverse Event|4|||
125636992|NCT02996500|451952817|FG003|Overall Study|Adverse Event|3|||
125636993|NCT02996500|451952818|FG004|Overall Study|Adverse Event|1|||
125378693|NCT00001723|451017262|FG001|Overall Study|Lack of family interest|5|||
125636994|NCT02996500|451952819|FG005|Overall Study|Adverse Event|2|||
125378694|NCT00001723|451017261|FG000|Overall Study|Lost to Follow-up|2|||
125217395|NCT04208412|450423515|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
125217396|NCT04208412|450423514|FG000|Overall Study|Withdrawal by Subject|1|||
125217397|NCT04208412|450423515|FG001|Overall Study|Withdrawal by Subject|0|||
125378695|NCT00001723|451017262|FG001|Overall Study|Lost to Follow-up|2|||
125378696|NCT00001723|451017261|FG000|Overall Study|medication intolerance|1|||
125378697|NCT00001723|451017262|FG001|Overall Study|medication intolerance|2|||
125636995|NCT02996500|451952814|FG000|Overall Study|Lack of Efficacy|0|||
125131188|NCT02648438|450108048|FG001|Overall Study|Withdrawal by Subject|1|||
125131189|NCT02648438|450108049|FG002|Overall Study|Withdrawal by Subject|0|||
125131190|NCT03138967|450108050|FG000|Overall Study|Death|0|||
125131191|NCT03138967|450108051|FG001|Overall Study|Death|1|||
125131192|NCT03138967|450108050|FG000|Overall Study|Physician Decision|1|||
125131193|NCT03138967|450108051|FG001|Overall Study|Physician Decision|3|||
125131194|NCT04400890|450108052|FG000|Overall Study|Withdrawal by Subject|3|||
125131195|NCT04400890|450108053|FG001|Overall Study|Withdrawal by Subject|2|||
125131196|NCT03925532|450108054|FG000|Overall Study|Lost to Follow-up|1|||
125131197|NCT02258074|450108055|FG000|Overall Study|Withdrawal by Subject|1|||
125131198|NCT02258074|450108056|FG001|Overall Study|Withdrawal by Subject|0|||
125131199|NCT02258074|450108057|FG002|Overall Study|Withdrawal by Subject|0|||
125131200|NCT02258074|450108058|FG003|Overall Study|Withdrawal by Subject|0|||
125636996|NCT02996500|451952815|FG001|Overall Study|Lack of Efficacy|0|||
125636997|NCT02996500|451952816|FG002|Overall Study|Lack of Efficacy|0|||
125636998|NCT02996500|451952817|FG003|Overall Study|Lack of Efficacy|0|||
125636999|NCT02996500|451952818|FG004|Overall Study|Lack of Efficacy|2|||
125637000|NCT02996500|451952819|FG005|Overall Study|Lack of Efficacy|0|||
125637001|NCT02996500|451952814|FG000|Overall Study|Lost to Follow-up|1|||
125637002|NCT02996500|451952815|FG001|Overall Study|Lost to Follow-up|0|||
125637003|NCT02996500|451952816|FG002|Overall Study|Lost to Follow-up|0|||
125637004|NCT02996500|451952817|FG003|Overall Study|Lost to Follow-up|0|||
125637005|NCT02996500|451952818|FG004|Overall Study|Lost to Follow-up|0|||
125637006|NCT02996500|451952819|FG005|Overall Study|Lost to Follow-up|1|||
125637007|NCT02996500|451952814|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125637008|NCT02996500|451952815|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125637009|NCT02996500|451952816|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
125637010|NCT02996500|451952817|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
125637011|NCT02996500|451952818|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
125637012|NCT02996500|451952819|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
125637013|NCT02996500|451952814|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125637014|NCT02996500|451952815|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125637015|NCT02996500|451952816|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125637016|NCT02996500|451952817|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125637017|NCT02996500|451952818|FG004|Overall Study|Non-Compliance With Study Drug|0|||
125637018|NCT02996500|451952819|FG005|Overall Study|Non-Compliance With Study Drug|1|||
125637019|NCT02996500|451952814|FG000|Overall Study|Progressive Disease|1|||
125637020|NCT02996500|451952815|FG001|Overall Study|Progressive Disease|0|||
125637021|NCT02996500|451952816|FG002|Overall Study|Progressive Disease|0|||
125637022|NCT02996500|451952817|FG003|Overall Study|Progressive Disease|0|||
125637023|NCT02996500|451952818|FG004|Overall Study|Progressive Disease|0|||
125637024|NCT02996500|451952819|FG005|Overall Study|Progressive Disease|0|||
125637025|NCT02996500|451952814|FG000|Overall Study|Other|2|||
125637026|NCT02996500|451952815|FG001|Overall Study|Other|0|||
125637027|NCT02996500|451952816|FG002|Overall Study|Other|2|||
125637028|NCT02996500|451952817|FG003|Overall Study|Other|0|||
125637029|NCT02996500|451952818|FG004|Overall Study|Other|0|||
125637030|NCT02996500|451952819|FG005|Overall Study|Other|0|||
125637031|NCT02996500|451952814|FG000|Overall Study|Protocol Violation|0|||
125637032|NCT02996500|451952815|FG001|Overall Study|Protocol Violation|0|||
125637033|NCT02996500|451952816|FG002|Overall Study|Protocol Violation|0|||
125637034|NCT02996500|451952817|FG003|Overall Study|Protocol Violation|1|||
125637035|NCT02996500|451952818|FG004|Overall Study|Protocol Violation|0|||
125637036|NCT02996500|451952819|FG005|Overall Study|Protocol Violation|0|||
125637037|NCT02996500|451952814|FG000|Overall Study|Withdrawal by Subject|3|||
125637038|NCT02996500|451952815|FG001|Overall Study|Withdrawal by Subject|0|||
125637039|NCT02996500|451952816|FG002|Overall Study|Withdrawal by Subject|3|||
125637040|NCT02996500|451952817|FG003|Overall Study|Withdrawal by Subject|0|||
125637041|NCT02996500|451952818|FG004|Overall Study|Withdrawal by Subject|2|||
125637042|NCT02996500|451952819|FG005|Overall Study|Withdrawal by Subject|0|||
125637043|NCT02485860|451952820|FG000|Overall Study|Lost to Follow-up|4|||
125637044|NCT02485860|451952821|FG001|Overall Study|Lost to Follow-up|1|||
125637045|NCT02485860|451952820|FG000|Overall Study|Physician Decision|1|||
125637046|NCT02485860|451952821|FG001|Overall Study|Physician Decision|2|||
125637047|NCT02485860|451952820|FG000|Overall Study|Health context (COVID-19)|1|||
125637048|NCT02485860|451952821|FG001|Overall Study|Health context (COVID-19)|0|||
125131201|NCT00723710|450108059|FG000|Overall Study|Disease progression|48|||
125131202|NCT00723710|450108059|FG000|Overall Study|Adverse Event|88|||
125637049|NCT03325010|451952822|FG000|Overall Study|Adverse Event|3|||
125637050|NCT03325010|451952823|FG001|Overall Study|Adverse Event|8|||
125637051|NCT03325010|451952822|FG000|Overall Study|Protocol Violation|1|||
125637052|NCT03325010|451952823|FG001|Overall Study|Protocol Violation|8|||
125217398|NCT04208412|450423514|FG000|Overall Study|Lost to Follow-up|0|||
125637053|NCT03325010|451952822|FG000|Overall Study|Withdrawal by Subject|1|||
125131203|NCT00723710|450108059|FG000|Overall Study|Withdrawal by Subject|36|||
125637054|NCT03325010|451952823|FG001|Overall Study|Withdrawal by Subject|3|||
125131204|NCT00723710|450108059|FG000|Overall Study|Physician Decision|2|||
125217399|NCT04208412|450423515|FG001|Overall Study|Lost to Follow-up|1|||
125131205|NCT04405570|450108060|FG000|Overall Study|Adverse Event|0|||
125131206|NCT04405570|450108061|FG001|Overall Study|Adverse Event|1|||
125131207|NCT04405570|450108062|FG002|Overall Study|Adverse Event|1|||
125131208|NCT04405570|450108063|FG003|Overall Study|Adverse Event|1|||
125131209|NCT04405570|450108060|FG000|Overall Study|Lost to Follow-up|0|||
125131210|NCT04405570|450108061|FG001|Overall Study|Lost to Follow-up|1|||
125131211|NCT04405570|450108062|FG002|Overall Study|Lost to Follow-up|0|||
125131212|NCT04405570|450108063|FG003|Overall Study|Lost to Follow-up|0|||
125131213|NCT04405570|450108060|FG000|Overall Study|Physician Decision|0|||
125131214|NCT04405570|450108061|FG001|Overall Study|Physician Decision|0|||
125637055|NCT03325010|451952822|FG000|Overall Study|Lost to Follow-up|1|||
125637056|NCT03325010|451952823|FG001|Overall Study|Lost to Follow-up|0|||
125637057|NCT03325010|451952822|FG000|Overall Study|Physician Decision|1|||
125637058|NCT03325010|451952823|FG001|Overall Study|Physician Decision|1|||
125637059|NCT03325010|451952822|FG000|Overall Study|Lack of Efficacy|2|||
125637060|NCT03325010|451952823|FG001|Overall Study|Lack of Efficacy|0|||
125637061|NCT03073200|451952832|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125637062|NCT03073200|451952833|FG001|Double Blind Treatment Period|Protocol Violation|0|||
125637063|NCT03073200|451952834|FG002|Double Blind Treatment Period|Protocol Violation|0|||
125637064|NCT03073200|451952835|FG003|Double Blind Treatment Period|Protocol Violation|0|||
125637065|NCT03073200|451952836|FG004|Double Blind Treatment Period|Protocol Violation|0|||
125637066|NCT03073200|451952837|FG005|Double Blind Treatment Period|Protocol Violation|0|||
125637067|NCT03073200|451952838|FG006|Double Blind Treatment Period|Protocol Violation|0|||
125637068|NCT03073200|451952839|FG007|Double Blind Treatment Period|Protocol Violation|0|||
125637069|NCT03073200|451952840|FG008|Double Blind Treatment Period|Protocol Violation|0|||
125637070|NCT03073200|451952841|FG009|Double Blind Treatment Period|Protocol Violation|0|||
125637071|NCT03073200|451952842|FG010|Double Blind Treatment Period|Protocol Violation|0|||
125637072|NCT03073200|451952843|FG011|Double Blind Treatment Period|Protocol Violation|0|||
125637073|NCT03073200|451952844|FG012|Double Blind Treatment Period|Protocol Violation|0|||
125637074|NCT03073200|451952845|FG013|Double Blind Treatment Period|Protocol Violation|0|||
125637075|NCT03073200|451952846|FG014|Double Blind Treatment Period|Protocol Violation|0|||
125637076|NCT03073200|451952832|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637077|NCT03073200|451952833|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
125637078|NCT03073200|451952834|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637079|NCT03073200|451952835|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637080|NCT03073200|451952836|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637081|NCT03073200|451952837|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637082|NCT03073200|451952838|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637083|NCT03073200|451952839|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637084|NCT03073200|451952840|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637085|NCT03073200|451952841|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637086|NCT03073200|451952842|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637087|NCT03073200|451952843|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637088|NCT03073200|451952844|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637089|NCT03073200|451952845|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637090|NCT03073200|451952846|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
125637091|NCT03073200|451952832|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
125637092|NCT03073200|451952833|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637093|NCT03073200|451952834|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637094|NCT03073200|451952835|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637095|NCT03073200|451952836|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637096|NCT03073200|451952837|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637097|NCT03073200|451952838|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637098|NCT03073200|451952839|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637099|NCT03073200|451952840|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637100|NCT03073200|451952841|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637101|NCT03073200|451952842|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637102|NCT03073200|451952843|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637103|NCT03073200|451952844|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637104|NCT03073200|451952845|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637105|NCT03073200|451952846|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
125637106|NCT03073200|451952832|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
125637107|NCT03073200|451952833|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
125637108|NCT03073200|451952834|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
125637109|NCT03073200|451952835|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
125637110|NCT03073200|451952836|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
125637111|NCT03073200|451952837|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
125637112|NCT03073200|451952838|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
125131215|NCT04405570|450108062|FG002|Overall Study|Physician Decision|1|||
125131216|NCT04405570|450108063|FG003|Overall Study|Physician Decision|0|||
125131217|NCT04405570|450108060|FG000|Overall Study|Withdrawal by Subject|0|||
125131218|NCT04405570|450108061|FG001|Overall Study|Withdrawal by Subject|1|||
125131219|NCT04405570|450108062|FG002|Overall Study|Withdrawal by Subject|1|||
125131220|NCT04405570|450108063|FG003|Overall Study|Withdrawal by Subject|0|||
125131221|NCT04405570|450108060|FG000|Overall Study|Randomized not dosed|0|||
125378698|NCT02643082|451017263|FG000|Period 1|Adverse Event|1|||
125378699|NCT02643082|451017264|FG001|Period 1|Adverse Event|0|||
125378700|NCT01324999|451017265|FG000|Overall Study|Adverse Event|3|||
125378701|NCT01324999|451017265|FG000|Overall Study|Withdrawal by Subject|2|||
125378702|NCT00276744|451017266|FG000|PART A|Reason unknown|98|||
125378703|NCT03060629|451017269|FG000|Overall Study|Death|4|||
125637113|NCT03073200|451952839|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
125637114|NCT03073200|451952840|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
125637115|NCT03073200|451952841|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
125637116|NCT03073200|451952842|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
125637117|NCT03073200|451952843|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
125637118|NCT03073200|451952844|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
125637119|NCT03073200|451952845|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
125637120|NCT03073200|451952846|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
125637121|NCT03073200|451952832|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
125637122|NCT03073200|451952833|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
125637123|NCT03073200|451952834|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
125637124|NCT03073200|451952835|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
125637125|NCT03073200|451952836|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
125637126|NCT03073200|451952837|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
125637127|NCT03073200|451952838|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
125637128|NCT03073200|451952839|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
125637129|NCT03073200|451952840|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
125637130|NCT03073200|451952841|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
125637131|NCT03073200|451952842|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
125637132|NCT03073200|451952843|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
125637133|NCT03073200|451952844|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
125637134|NCT03073200|451952845|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
125637135|NCT03073200|451952846|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
125637136|NCT03073200|451952832|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
125637137|NCT03073200|451952833|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
125637138|NCT03073200|451952834|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
125637139|NCT03073200|451952835|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
125637140|NCT03073200|451952836|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
125637141|NCT03073200|451952837|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
125637142|NCT03073200|451952838|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
125637143|NCT03073200|451952839|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
125637144|NCT03073200|451952840|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
125378704|NCT03060629|451017270|FG001|Overall Study|Death|5|||
125378705|NCT03060629|451017269|FG000|Overall Study|Withdrawal by Subject|50|||
125378706|NCT03060629|451017270|FG001|Overall Study|Withdrawal by Subject|35|||
125378707|NCT03060629|451017269|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
125378708|NCT03060629|451017270|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
125378709|NCT03060629|451017269|FG000|Overall Study|Participant Relocate|15|||
125378710|NCT03060629|451017270|FG001|Overall Study|Participant Relocate|15|||
125378711|NCT03060629|451017269|FG000|Overall Study|Unable to Contact Participant|34|||
125378712|NCT03060629|451017270|FG001|Overall Study|Unable to Contact Participant|23|||
125378713|NCT03060629|451017269|FG000|Overall Study|Investigator Decision|7|||
125378714|NCT03060629|451017270|FG001|Overall Study|Investigator Decision|7|||
125378715|NCT03060629|451017269|FG000|Overall Study|Study Terminated by Sponsor|1100|||
125378716|NCT03060629|451017270|FG001|Overall Study|Study Terminated by Sponsor|1123|||
125378717|NCT03060629|451017269|FG000|Overall Study|Other|4|||
125378718|NCT03060629|451017270|FG001|Overall Study|Other|4|||
125378719|NCT02505867|451017271|FG000|Overall Study|Lack of Efficacy|6|||
125378720|NCT02505867|451017272|FG001|Overall Study|Lack of Efficacy|6|||
125217400|NCT05415462|450423518|FG000|Overall Study|Death|18|||
125378721|NCT01862874|451017273|FG000|Overall Study|Randomized not treated|1|||
125378722|NCT01862874|451017274|FG001|Overall Study|Randomized not treated|0|||
125378723|NCT01862874|451017273|FG000|Overall Study|Adverse Event|0|||
125378724|NCT01862874|451017274|FG001|Overall Study|Adverse Event|3|||
125378725|NCT01862874|451017273|FG000|Overall Study|Lost to Follow-up|26|||
125378726|NCT01862874|451017274|FG001|Overall Study|Lost to Follow-up|29|||
125378727|NCT01862874|451017273|FG000|Overall Study|Physician Decision|5|||
125131222|NCT04405570|450108061|FG001|Overall Study|Randomized not dosed|2|||
125131223|NCT04405570|450108062|FG002|Overall Study|Randomized not dosed|0|||
125131224|NCT04405570|450108063|FG003|Overall Study|Randomized not dosed|0|||
125131225|NCT04499963|450108064|FG000|Overall Study|Adverse Event|3|||
125131226|NCT04499963|450108065|FG001|Overall Study|Adverse Event|0|||
125131227|NCT04499963|450108064|FG000|Overall Study|Death|3|||
125131228|NCT04499963|450108065|FG001|Overall Study|Death|0|||
125131229|NCT04499963|450108064|FG000|Overall Study|Lack of Efficacy|7|||
125131230|NCT04499963|450108065|FG001|Overall Study|Lack of Efficacy|0|||
125131231|NCT04499963|450108064|FG000|Overall Study|Lost to Follow-up|2|||
125131232|NCT04499963|450108065|FG001|Overall Study|Lost to Follow-up|0|||
125131233|NCT01208337|450108068|FG000|Overall Study|Death|3|||
125131234|NCT03663179|450108074|FG000|Overall Study|Withdrawal by Subject|2|||
125131235|NCT03663179|450108075|FG001|Overall Study|Withdrawal by Subject|0|||
125131236|NCT03663179|450108074|FG000|Overall Study|Lost to Follow-up|1|||
125131237|NCT03663179|450108075|FG001|Overall Study|Lost to Follow-up|1|||
125131238|NCT03663179|450108074|FG000|Overall Study|Revealed exclusionary condition|1|||
125131239|NCT03663179|450108075|FG001|Overall Study|Revealed exclusionary condition|0|||
125131240|NCT00984126|450108079|FG000|Overall Study|Protocol Violation|0|||
125131241|NCT00984126|450108080|FG001|Overall Study|Protocol Violation|0|||
125131242|NCT00984126|450108081|FG002|Overall Study|Protocol Violation|1|||
125131243|NCT00984126|450108082|FG003|Overall Study|Protocol Violation|2|||
125131244|NCT00984126|450108079|FG000|Overall Study|Adverse Event|0|||
125131245|NCT00984126|450108080|FG001|Overall Study|Adverse Event|0|||
125131246|NCT00984126|450108081|FG002|Overall Study|Adverse Event|0|||
125131247|NCT00984126|450108082|FG003|Overall Study|Adverse Event|2|||
125131248|NCT00984126|450108079|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
125131249|NCT00984126|450108080|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
125131250|NCT00984126|450108081|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
125131251|NCT00984126|450108082|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
125131252|NCT00984126|450108079|FG000|Overall Study|Withdrawal criteria|0|||
125131253|NCT00984126|450108080|FG001|Overall Study|Withdrawal criteria|1|||
125131254|NCT00984126|450108081|FG002|Overall Study|Withdrawal criteria|3|||
125131255|NCT00984126|450108082|FG003|Overall Study|Withdrawal criteria|9|||
125131256|NCT01001208|450108083|FG000|Overall Study|Adverse Event|10|||
125131257|NCT01001208|450108084|FG001|Overall Study|Adverse Event|5|||
125131258|NCT01001208|450108083|FG000|Overall Study|Lost to Follow-up|5|||
125131259|NCT01001208|450108084|FG001|Overall Study|Lost to Follow-up|9|||
125131260|NCT01001208|450108083|FG000|Overall Study|Physician Decision|1|||
125131261|NCT01001208|450108084|FG001|Overall Study|Physician Decision|0|||
125378728|NCT01862874|451017274|FG001|Overall Study|Physician Decision|3|||
125378729|NCT01862874|451017273|FG000|Overall Study|Withdrawn by parent/guardian|1|||
125378730|NCT01862874|451017274|FG001|Overall Study|Withdrawn by parent/guardian|1|||
125378731|NCT01862874|451017273|FG000|Overall Study|Withdrawal by Subject|46|||
125378732|NCT01862874|451017274|FG001|Overall Study|Withdrawal by Subject|40|||
125378733|NCT01862874|451017273|FG000|Overall Study|Death|0|||
125378734|NCT01862874|451017274|FG001|Overall Study|Death|1|||
125378735|NCT01714635|451017277|FG000|Overall Study|Discontinued|1|||
125378736|NCT01714635|451017278|FG001|Overall Study|Discontinued|0|||
125378737|NCT01714635|451017279|FG002|Overall Study|Discontinued|2|||
125637145|NCT03073200|451952841|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
125637146|NCT03073200|451952842|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
125637147|NCT03073200|451952843|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
125637148|NCT03073200|451952844|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
125637149|NCT03073200|451952845|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
125637150|NCT03073200|451952846|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
125637151|NCT03073200|451952832|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125637152|NCT03073200|451952833|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125637153|NCT03073200|451952834|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125637154|NCT03073200|451952835|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
125637155|NCT03073200|451952836|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
125637156|NCT03073200|451952837|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125637157|NCT03073200|451952838|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
125131262|NCT01001208|450108083|FG000|Overall Study|Withdrawal by Subject|4|||
125131263|NCT01001208|450108084|FG001|Overall Study|Withdrawal by Subject|5|||
125131264|NCT01001208|450108083|FG000|Overall Study|Ineligibility Determined|4|||
125131265|NCT01001208|450108084|FG001|Overall Study|Ineligibility Determined|2|||
125131266|NCT01001208|450108083|FG000|Overall Study|Noncompliance|4|||
125131267|NCT01001208|450108084|FG001|Overall Study|Noncompliance|7|||
125131268|NCT01001208|450108083|FG000|Overall Study|Disease Progression|0|||
125131269|NCT01001208|450108084|FG001|Overall Study|Disease Progression|3|||
125378738|NCT01714635|451017277|FG000|Overall Study|Missed 6-month exam|1|||
125131270|NCT01001208|450108083|FG000|Overall Study|Other|0|||
125131271|NCT01001208|450108084|FG001|Overall Study|Other|2|||
125131272|NCT01864174|450108085|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
125217401|NCT05415462|450423519|FG001|Overall Study|Death|10|||
125131273|NCT01864174|450108086|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
125131274|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
125131275|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
125131276|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
125378739|NCT01714635|451017278|FG001|Overall Study|Missed 6-month exam|0|||
125378740|NCT01714635|451017279|FG002|Overall Study|Missed 6-month exam|0|||
125378741|NCT02860169|451017280|FG000|Part A|Withdrawal by Subject|1|||
125378742|NCT02860169|451017280|FG000|Part A|Other (Screening failure)|6|||
125378743|NCT02860169|451017280|FG000|Part A|Other (Survey not completed)|3|||
125378744|NCT02860169|451017280|FG000|Part A|Other (did not completed consent)|1|||
125378745|NCT02860169|451017280|FG000|Part B|Other (Screening failure)|10|||
125378746|NCT02860169|451017280|FG000|Part B|Withdrawal by Subject|1|||
125378747|NCT02860169|451017280|FG000|Part C|Other (Screening failure)|1|||
125378748|NCT03667924|451017281|FG000|Baseline Completed|Lost to Follow-up|0|||
125378749|NCT03667924|451017282|FG001|Baseline Completed|Lost to Follow-up|2|||
125378750|NCT03667924|451017283|FG002|Baseline Completed|Lost to Follow-up|0|||
125378751|NCT03667924|451017281|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
125378752|NCT03667924|451017282|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
125378753|NCT03667924|451017283|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
125378754|NCT03667924|451017281|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
125378755|NCT03667924|451017282|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
125378756|NCT03667924|451017283|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
125378757|NCT03667924|451017281|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
125378758|NCT03667924|451017282|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
125378759|NCT03667924|451017283|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
125378760|NCT03667924|451017281|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
125378761|NCT03667924|451017282|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
125378762|NCT03667924|451017283|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
125378763|NCT03667924|451017281|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
125378764|NCT03667924|451017282|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
125378765|NCT03667924|451017283|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
125378766|NCT03667924|451017281|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
125378767|NCT03667924|451017282|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
125378768|NCT03667924|451017283|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
125378769|NCT03789318|451017287|FG000|Overall Study|Adverse Event|0|||
125378770|NCT03789318|451017288|FG001|Overall Study|Adverse Event|0|||
125378771|NCT03789318|451017289|FG002|Overall Study|Adverse Event|1|||
125378772|NCT03789318|451017290|FG003|Overall Study|Adverse Event|1|||
125378773|NCT03789318|451017291|FG004|Overall Study|Adverse Event|0|||
125378774|NCT03789318|451017287|FG000|Overall Study|Lost to Follow-up|0|||
125378775|NCT03789318|451017288|FG001|Overall Study|Lost to Follow-up|0|||
125378776|NCT03789318|451017289|FG002|Overall Study|Lost to Follow-up|1|||
125378777|NCT03789318|451017290|FG003|Overall Study|Lost to Follow-up|0|||
125378778|NCT03789318|451017291|FG004|Overall Study|Lost to Follow-up|0|||
125378779|NCT03789318|451017287|FG000|Overall Study|Withdrawal by Subject|0|||
125378780|NCT03789318|451017288|FG001|Overall Study|Withdrawal by Subject|0|||
125378781|NCT03789318|451017289|FG002|Overall Study|Withdrawal by Subject|1|||
125378782|NCT03789318|451017290|FG003|Overall Study|Withdrawal by Subject|0|||
125378783|NCT03789318|451017291|FG004|Overall Study|Withdrawal by Subject|0|||
125378784|NCT00477971|451017292|FG000|Overall Study|Disease progression|6|||
125378785|NCT00477971|451017293|FG001|Overall Study|Disease progression|0|||
125378786|NCT00477971|451017292|FG000|Overall Study|Withdrawal by Subject|3|||
125378787|NCT00477971|451017293|FG001|Overall Study|Withdrawal by Subject|1|||
125378788|NCT00477971|451017292|FG000|Overall Study|Adverse Event|3|||
125378789|NCT00477971|451017293|FG001|Overall Study|Adverse Event|0|||
125378790|NCT00477971|451017292|FG000|Overall Study|Death|2|||
125378791|NCT00477971|451017293|FG001|Overall Study|Death|4|||
125378792|NCT00477971|451017292|FG000|Overall Study|Alternative treatment|3|||
125378793|NCT00477971|451017293|FG001|Overall Study|Alternative treatment|1|||
125378794|NCT03700671|451017294|FG000|Overall Study|Lack of Efficacy|1|||
125378795|NCT03700671|451017295|FG001|Overall Study|Lack of Efficacy|2|||
125378796|NCT01317160|451017296|FG000|Overall Study|Incorrect inclusion|1|||
125378797|NCT01317160|451017297|FG001|Overall Study|Incorrect inclusion|1|||
125131277|NCT01864174|450108086|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
125131278|NCT01864174|450108085|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
125378798|NCT01317160|451017296|FG000|Overall Study|Lost to Follow-up|3|||
125378799|NCT01317160|451017297|FG001|Overall Study|Lost to Follow-up|3|||
125378800|NCT01317160|451017296|FG000|Overall Study|Withdrawal by Subject|0|||
125378801|NCT01317160|451017297|FG001|Overall Study|Withdrawal by Subject|2|||
125378802|NCT01774968|451017298|FG000|Overall Study|Adverse Event|4|||
125378803|NCT01774968|451017299|FG001|Overall Study|Adverse Event|4|||
125378804|NCT01774968|451017298|FG000|Overall Study|Death|0|||
125378805|NCT01774968|451017299|FG001|Overall Study|Death|1|||
125378806|NCT01774968|451017298|FG000|Overall Study|Lost to Follow-up|1|||
125378807|NCT01774968|451017299|FG001|Overall Study|Lost to Follow-up|3|||
125378808|NCT01774968|451017298|FG000|Overall Study|Physician Decision|5|||
125217440|NCT01348100|450423520|FG000|Overall Study|Administrative Problems|0|||
125217441|NCT01348100|450423521|FG001|Overall Study|Administrative Problems|0|||
125217442|NCT01348100|450423522|FG002|Overall Study|Administrative Problems|0|||
125217443|NCT01348100|450423523|FG003|Overall Study|Administrative Problems|0|||
125217444|NCT01348100|450423524|FG004|Overall Study|Administrative Problems|0|||
125217445|NCT01348100|450423525|FG005|Overall Study|Administrative Problems|1|||
125217446|NCT01348100|450423526|FG006|Overall Study|Administrative Problems|1|||
125217447|NCT03882957|450423529|FG000|Overall Study|Did not complete all three arms|1|||
125217448|NCT04186221|450423534|FG000|Overall Study|Death|1|||
125217449|NCT01134393|450423535|FG000|Overall Study|Adverse Event|18|||
125217450|NCT01134393|450423535|FG000|Overall Study|Lack of Efficacy|2|||
125217451|NCT01134393|450423535|FG000|Overall Study|Protocol Violation|12|||
125217452|NCT01134393|450423535|FG000|Overall Study|Lost to Follow-up|3|||
125217453|NCT01134393|450423535|FG000|Overall Study|Withdrawal by Subject|11|||
125217454|NCT01134393|450423535|FG000|Overall Study|Other|6|||
125217455|NCT00531947|450423536|FG000|Overall Study|Adverse Event|5|||
125217456|NCT00531947|450423537|FG001|Overall Study|Adverse Event|10|||
125217457|NCT00531947|450423536|FG000|Overall Study|Lost to Follow-up|12|||
125217458|NCT00531947|450423537|FG001|Overall Study|Lost to Follow-up|9|||
125217459|NCT00531947|450423536|FG000|Overall Study|Withdrawal by Subject|14|||
125217460|NCT00531947|450423537|FG001|Overall Study|Withdrawal by Subject|19|||
125217461|NCT00531947|450423536|FG000|Overall Study|Protocol Violation|2|||
125217462|NCT00531947|450423537|FG001|Overall Study|Protocol Violation|1|||
125217463|NCT00531947|450423536|FG000|Overall Study|Non-Compliance|4|||
125217464|NCT00531947|450423537|FG001|Overall Study|Non-Compliance|7|||
125217465|NCT00531947|450423536|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
125217466|NCT00531947|450423537|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
125217467|NCT00420628|450423543|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
125217468|NCT00420628|450423544|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
125637272|NCT03073200|451952833|FG001|Randomized Withdrawal Period|Adverse Event|0|||
125637273|NCT03073200|451952834|FG002|Randomized Withdrawal Period|Adverse Event|0|||
125637274|NCT03073200|451952835|FG003|Randomized Withdrawal Period|Adverse Event|0|||
125637275|NCT03073200|451952836|FG004|Randomized Withdrawal Period|Adverse Event|0|||
125637276|NCT03073200|451952837|FG005|Randomized Withdrawal Period|Adverse Event|0|||
125637277|NCT03073200|451952838|FG006|Randomized Withdrawal Period|Adverse Event|0|||
125637278|NCT03073200|451952839|FG007|Randomized Withdrawal Period|Adverse Event|0|||
125637279|NCT03073200|451952840|FG008|Randomized Withdrawal Period|Adverse Event|0|||
125637280|NCT03073200|451952841|FG009|Randomized Withdrawal Period|Adverse Event|0|||
125637281|NCT03073200|451952842|FG010|Randomized Withdrawal Period|Adverse Event|1|||
125637282|NCT03073200|451952843|FG011|Randomized Withdrawal Period|Adverse Event|0|||
125637283|NCT03073200|451952844|FG012|Randomized Withdrawal Period|Adverse Event|0|||
125637284|NCT03073200|451952845|FG013|Randomized Withdrawal Period|Adverse Event|0|||
125637285|NCT03073200|451952846|FG014|Randomized Withdrawal Period|Adverse Event|0|||
125637286|NCT03073200|451952832|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637287|NCT03073200|451952833|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637288|NCT03073200|451952834|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637289|NCT03073200|451952835|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637290|NCT03073200|451952836|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637291|NCT03073200|451952837|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637292|NCT03073200|451952838|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637293|NCT03073200|451952839|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637294|NCT03073200|451952840|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637295|NCT03073200|451952841|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637296|NCT03073200|451952842|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637297|NCT03073200|451952843|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637298|NCT03073200|451952844|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637299|NCT03073200|451952845|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
125637300|NCT03073200|451952846|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
125637301|NCT03073200|451952832|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125637302|NCT03073200|451952833|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125637303|NCT03073200|451952834|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125637304|NCT03073200|451952835|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125637305|NCT03073200|451952836|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125637306|NCT03073200|451952837|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125637307|NCT03073200|451952838|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125217469|NCT00420628|450423543|FG000|Overall Study|Lost to Follow-up|3|||
125637308|NCT03073200|451952839|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125637309|NCT03073200|451952840|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125637310|NCT03073200|451952841|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125637311|NCT03073200|451952842|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125637312|NCT03073200|451952843|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125217470|NCT00420628|450423544|FG001|Overall Study|Lost to Follow-up|2|||
125217471|NCT00420628|450423543|FG000|Overall Study|Adverse Event|1|||
125378964|NCT00799487|451019222|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
125378965|NCT00799487|451019223|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
125378966|NCT00799487|451019224|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
125378967|NCT00799487|451019222|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
125378968|NCT00799487|451019223|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
125378969|NCT00799487|451019224|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
125378970|NCT00799487|451019222|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
125378971|NCT00799487|451019223|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
125378972|NCT00799487|451019224|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
125378973|NCT00799487|451019222|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
125378974|NCT00799487|451019223|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
125378975|NCT00799487|451019224|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
125378976|NCT00799487|451019222|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
125378977|NCT00799487|451019223|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
125217472|NCT00420628|450423544|FG001|Overall Study|Adverse Event|0|||
125217473|NCT05095311|450423554|FG000|Overall Study|Lost to Follow-up|7|||
125217474|NCT05095311|450423555|FG001|Overall Study|Lost to Follow-up|0|||
125217475|NCT05095311|450423556|FG002|Overall Study|Lost to Follow-up|0|||
125217476|NCT02588664|450423559|FG000|Overall Study|Death|56|||
125217477|NCT02588664|450423560|FG001|Overall Study|Death|55|||
125217478|NCT02588664|450423559|FG000|Overall Study|Lost to Follow-up|1305|||
125217479|NCT02588664|450423560|FG001|Overall Study|Lost to Follow-up|990|||
125217480|NCT01429298|450423561|FG000|Overall Study|Protocol Violation|4|||
125217481|NCT01429298|450423562|FG001|Overall Study|Protocol Violation|6|||
125217482|NCT02903420|450423565|FG000|Overall Study|Death|3|||
125217483|NCT03092791|450423567|FG000|Overall Study|Lost to Follow-up|0|||
125217484|NCT03092791|450423568|FG001|Overall Study|Lost to Follow-up|0|||
125217485|NCT03092791|450423569|FG002|Overall Study|Lost to Follow-up|0|||
125217486|NCT03092791|450423570|FG003|Overall Study|Lost to Follow-up|0|||
125217487|NCT03092791|450423571|FG004|Overall Study|Lost to Follow-up|0|||
125217488|NCT03092791|450423572|FG005|Overall Study|Lost to Follow-up|0|||
125131403|NCT03818581|450109962|FG002|Overall Study|Withdrawal by Subject|0|||
125131404|NCT03818581|450109963|FG003|Overall Study|Withdrawal by Subject|0|||
125131405|NCT03818581|450109964|FG004|Overall Study|Withdrawal by Subject|1|||
125131406|NCT03818581|450109960|FG000|Overall Study|No longer met study criteria|0|||
125131407|NCT03818581|450109961|FG001|Overall Study|No longer met study criteria|0|||
125131408|NCT03818581|450109962|FG002|Overall Study|No longer met study criteria|0|||
125131409|NCT03818581|450109963|FG003|Overall Study|No longer met study criteria|0|||
125131410|NCT03818581|450109964|FG004|Overall Study|No longer met study criteria|1|||
125131411|NCT02096211|450109967|FG000|Overall Study|Death|2|||
125131412|NCT02096211|450109967|FG000|Overall Study|Withdrawal by Subject|8|||
125131413|NCT02096211|450109967|FG000|Overall Study|Revision of implant|7|||
125131414|NCT02096211|450109967|FG000|Overall Study|Lost to Follow-up|43|||
125131415|NCT00519194|450109970|FG000|Overall Study|Withdrawal by Subject|9|||
125217489|NCT03092791|450423573|FG006|Overall Study|Lost to Follow-up|1|||
125217490|NCT03092791|450423574|FG007|Overall Study|Lost to Follow-up|0|||
125217491|NCT03092791|450423567|FG000|Overall Study|Withdrawal of Consent|0|||
125217492|NCT03092791|450423568|FG001|Overall Study|Withdrawal of Consent|0|||
125217493|NCT03092791|450423569|FG002|Overall Study|Withdrawal of Consent|0|||
125217494|NCT03092791|450423570|FG003|Overall Study|Withdrawal of Consent|0|||
125378978|NCT00799487|451019224|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
125131416|NCT00519194|450109970|FG000|Overall Study|Death|9|||
125131417|NCT00519194|450109970|FG000|Overall Study|Lost to Follow-up|3|||
125131418|NCT03165994|450109971|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
125131419|NCT03165994|450109971|FG000|Overall Study|Death|2|||
125131420|NCT03165994|450109971|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
125131421|NCT03165994|450109971|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
125131422|NCT03165994|450109971|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
125131423|NCT03165994|450109971|FG000|Overall Study|Miscellaneous|1|||
125131424|NCT00461786|450109978|FG000|Overall Study|Entry Criteria Not Met|2|||
125131425|NCT00461786|450109978|FG000|Overall Study|Inevaluable (Never Treated)|1|||
125131426|NCT00934050|450109979|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
125131427|NCT00934050|450109980|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
125131428|NCT00934050|450109981|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
125131429|NCT00934050|450109982|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
125131430|NCT00934050|450109983|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
125131431|NCT00934050|450109984|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
125131432|NCT00934050|450109979|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
125131433|NCT00934050|450109980|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
125131434|NCT00934050|450109981|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
125131435|NCT00934050|450109982|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
125131436|NCT00934050|450109983|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
125131437|NCT00934050|450109984|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
125131438|NCT00934050|450109979|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
125131439|NCT00934050|450109980|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
125131440|NCT00934050|450109981|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
125131441|NCT00934050|450109982|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
125131442|NCT00934050|450109983|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
125131443|NCT00934050|450109984|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
125131444|NCT00934050|450109979|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
125131445|NCT00934050|450109980|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
125131446|NCT00934050|450109981|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
125131447|NCT00934050|450109982|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
125131448|NCT00934050|450109983|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
125131449|NCT00934050|450109984|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
125217495|NCT03092791|450423571|FG004|Overall Study|Withdrawal of Consent|4|||
125217496|NCT03092791|450423572|FG005|Overall Study|Withdrawal of Consent|12|||
125131450|NCT00934050|450109979|FG000|Enrolled After 15 Dec 2009|Death|0|||
125217497|NCT03092791|450423573|FG006|Overall Study|Withdrawal of Consent|6|||
125217498|NCT03092791|450423574|FG007|Overall Study|Withdrawal of Consent|4|||
125217499|NCT03092791|450423567|FG000|Overall Study|Study Termination|0|||
125217500|NCT03092791|450423568|FG001|Overall Study|Study Termination|0|||
125131451|NCT00934050|450109980|FG001|Enrolled After 15 Dec 2009|Death|0|||
125131452|NCT00934050|450109981|FG002|Enrolled After 15 Dec 2009|Death|0|||
125131453|NCT00934050|450109982|FG003|Enrolled After 15 Dec 2009|Death|0|||
125131454|NCT00934050|450109983|FG004|Enrolled After 15 Dec 2009|Death|0|||
125131455|NCT00934050|450109984|FG005|Enrolled After 15 Dec 2009|Death|1|||
125131456|NCT00934050|450109979|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
125131457|NCT00934050|450109980|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
125131458|NCT00934050|450109981|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
125131459|NCT00934050|450109982|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
125131460|NCT00934050|450109983|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
125131461|NCT00934050|450109984|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
125131462|NCT00934050|450109979|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
125131463|NCT00934050|450109980|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
125131464|NCT00934050|450109981|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
125131465|NCT00934050|450109982|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
125131466|NCT00934050|450109983|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
125131467|NCT00934050|450109984|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
125131468|NCT00835991|450109985|FG000|First Intervention|Adverse Event|0|||
125131469|NCT00835991|450109986|FG001|First Intervention|Adverse Event|1|||
125131470|NCT00835991|450109985|FG000|Washout|Protocol Violation|0|||
125131471|NCT00835991|450109986|FG001|Washout|Protocol Violation|2|||
125217501|NCT03092791|450423569|FG002|Overall Study|Study Termination|0|||
125217502|NCT03092791|450423570|FG003|Overall Study|Study Termination|0|||
125131472|NCT00835991|450109985|FG000|Washout|Withdrawal by Subject|3|||
125378979|NCT00799487|451019222|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
125378980|NCT00799487|451019223|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
125378981|NCT00799487|451019224|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
125378982|NCT00799487|451019222|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
125378983|NCT00799487|451019223|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
125378984|NCT00799487|451019224|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
125378985|NCT00799487|451019222|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
125378986|NCT00799487|451019223|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
125378987|NCT00799487|451019224|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
125637313|NCT03073200|451952844|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125637314|NCT03073200|451952845|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
125637315|NCT03073200|451952846|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125637316|NCT03073200|451952832|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637317|NCT03073200|451952833|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637318|NCT03073200|451952834|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637319|NCT03073200|451952835|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637320|NCT03073200|451952836|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637321|NCT03073200|451952837|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637322|NCT03073200|451952838|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637323|NCT03073200|451952839|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637324|NCT03073200|451952840|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637325|NCT03073200|451952841|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637326|NCT03073200|451952842|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637327|NCT03073200|451952843|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637328|NCT03073200|451952844|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637329|NCT03073200|451952845|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
125637330|NCT03073200|451952846|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
125637331|NCT03073200|451952832|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637332|NCT03073200|451952833|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637333|NCT03073200|451952834|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637334|NCT03073200|451952835|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637335|NCT03073200|451952836|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637336|NCT03073200|451952837|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637337|NCT03073200|451952838|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637338|NCT03073200|451952839|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637339|NCT03073200|451952840|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637340|NCT03073200|451952841|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637341|NCT03073200|451952842|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637342|NCT03073200|451952843|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637343|NCT03073200|451952844|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637344|NCT03073200|451952845|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
125637345|NCT03073200|451952846|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125637346|NCT03073200|451952832|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637347|NCT03073200|451952833|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637348|NCT03073200|451952834|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637349|NCT03073200|451952835|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637350|NCT03073200|451952836|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637351|NCT03073200|451952837|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637352|NCT03073200|451952838|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637353|NCT03073200|451952839|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637354|NCT03073200|451952840|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637355|NCT03073200|451952841|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637356|NCT03073200|451952842|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637357|NCT03073200|451952843|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637358|NCT03073200|451952844|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637359|NCT03073200|451952845|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
125637360|NCT03073200|451952846|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
125637361|NCT03073200|451952832|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125637362|NCT03073200|451952833|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125637363|NCT03073200|451952834|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125217503|NCT03092791|450423571|FG004|Overall Study|Study Termination|55|||
125217504|NCT03092791|450423572|FG005|Overall Study|Study Termination|46|||
125217505|NCT03092791|450423573|FG006|Overall Study|Study Termination|53|||
125217506|NCT03092791|450423574|FG007|Overall Study|Study Termination|55|||
125217507|NCT03092791|450423567|FG000|Overall Study|Death|0|||
125217508|NCT03092791|450423568|FG001|Overall Study|Death|0|||
125217509|NCT03092791|450423569|FG002|Overall Study|Death|0|||
125217510|NCT03092791|450423570|FG003|Overall Study|Death|0|||
125217511|NCT03092791|450423571|FG004|Overall Study|Death|0|||
125217512|NCT03092791|450423572|FG005|Overall Study|Death|1|||
125217513|NCT03092791|450423573|FG006|Overall Study|Death|0|||
125217514|NCT03092791|450423574|FG007|Overall Study|Death|1|||
125217515|NCT03092791|450423567|FG000|Overall Study|Reason Not Specified|0|||
125217516|NCT03092791|450423568|FG001|Overall Study|Reason Not Specified|0|||
125131473|NCT00835991|450109986|FG001|Washout|Withdrawal by Subject|1|||
125131474|NCT02149420|450109987|FG000|Core Study|Administrative problems|0|||
125131475|NCT02149420|450109988|FG001|Core Study|Administrative problems|1|||
125131476|NCT02149420|450109989|FG002|Core Study|Administrative problems|2|||
125131477|NCT02149420|450109987|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
125131478|NCT02149420|450109988|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
125131479|NCT02149420|450109989|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
125131480|NCT02378935|450109992|FG000|Overall Study|Lack of Efficacy|10|||
125131481|NCT02378935|450109993|FG001|Overall Study|Lack of Efficacy|0|||
125131482|NCT02378935|450109994|FG002|Overall Study|Lack of Efficacy|2|||
125131483|NCT02378935|450109995|FG003|Overall Study|Lack of Efficacy|6|||
125131484|NCT02378935|450109996|FG004|Overall Study|Lack of Efficacy|0|||
125131485|NCT02378935|450109997|FG005|Overall Study|Lack of Efficacy|0|||
125131486|NCT02378935|450109998|FG006|Overall Study|Lack of Efficacy|0|||
125131487|NCT02378935|450109992|FG000|Overall Study|Death|0|||
125131488|NCT02378935|450109993|FG001|Overall Study|Death|0|||
125131489|NCT02378935|450109994|FG002|Overall Study|Death|1|||
125131490|NCT02378935|450109995|FG003|Overall Study|Death|0|||
125131491|NCT02378935|450109996|FG004|Overall Study|Death|0|||
125131492|NCT02378935|450109997|FG005|Overall Study|Death|0|||
125131493|NCT02378935|450109998|FG006|Overall Study|Death|0|||
125131494|NCT00272779|450109999|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
125131495|NCT00272779|450110000|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
125131496|NCT00272779|450109999|FG000|Baseline Through Week 48|Death before Week 48|4|||
125131497|NCT00272779|450110000|FG001|Baseline Through Week 48|Death before Week 48|4|||
125131498|NCT00272779|450109999|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
125131499|NCT00272779|450110000|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
125131500|NCT00272779|450109999|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
125131501|NCT00272779|450110000|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
125131502|NCT00272779|450109999|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
125131503|NCT00272779|450110000|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
125131504|NCT00272779|450109999|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
125131505|NCT00272779|450110000|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
125131506|NCT00272779|450109999|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
125131507|NCT00272779|450110000|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
125131508|NCT00272779|450109999|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
125131509|NCT00272779|450110000|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
125131510|NCT00272779|450109999|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
125131511|NCT00272779|450110000|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
125131512|NCT00272779|450109999|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
125131513|NCT00272779|450110000|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
125131514|NCT00272779|450109999|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
125131515|NCT00272779|450110000|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
125131516|NCT00272779|450109999|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
125131517|NCT00272779|450110000|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
125131518|NCT00272779|450109999|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
125131519|NCT00272779|450110000|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
125131520|NCT00272779|450109999|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
125131521|NCT00272779|450110000|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
125131522|NCT00272779|450109999|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
125131523|NCT00272779|450110000|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
125131524|NCT00272779|450109999|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
125131525|NCT00272779|450110000|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
125131526|NCT00272779|450109999|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
125131527|NCT00272779|450110000|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
125131528|NCT00272779|450109999|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
125217517|NCT03092791|450423569|FG002|Overall Study|Reason Not Specified|0|||
125217518|NCT03092791|450423570|FG003|Overall Study|Reason Not Specified|0|||
125217519|NCT03092791|450423571|FG004|Overall Study|Reason Not Specified|1|||
125637364|NCT03073200|451952835|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125637365|NCT03073200|451952836|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125637366|NCT03073200|451952837|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125637367|NCT03073200|451952838|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125637368|NCT03073200|451952839|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125637369|NCT03073200|451952840|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125637370|NCT03073200|451952841|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125637371|NCT03073200|451952842|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125637372|NCT03073200|451952843|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125637373|NCT03073200|451952844|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125637374|NCT03073200|451952845|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
125637375|NCT03073200|451952846|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
125637376|NCT03073200|451952832|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637377|NCT03073200|451952833|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637378|NCT03073200|451952834|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637379|NCT03073200|451952835|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637380|NCT03073200|451952836|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637381|NCT03073200|451952837|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637382|NCT03073200|451952838|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637383|NCT03073200|451952839|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637384|NCT03073200|451952840|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637385|NCT03073200|451952841|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637386|NCT03073200|451952842|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637387|NCT03073200|451952843|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637388|NCT03073200|451952844|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637389|NCT03073200|451952845|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
125637390|NCT03073200|451952846|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125637391|NCT03073200|451952832|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125637392|NCT03073200|451952833|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125637393|NCT03073200|451952834|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125637394|NCT03073200|451952835|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125637395|NCT03073200|451952836|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125217520|NCT03092791|450423572|FG005|Overall Study|Reason Not Specified|1|||
125217521|NCT03092791|450423573|FG006|Overall Study|Reason Not Specified|0|||
125217522|NCT03092791|450423574|FG007|Overall Study|Reason Not Specified|0|||
125217523|NCT00980655|450423576|FG000|Overall Study|Adverse Event|13|||
125217524|NCT00980655|450423577|FG001|Overall Study|Adverse Event|31|||
125217525|NCT00980655|450423576|FG000|Overall Study|Death|0|||
125217526|NCT00980655|450423577|FG001|Overall Study|Death|7|||
125217527|NCT00980655|450423576|FG000|Overall Study|Protocol Violation|2|||
125217528|NCT00980655|450423577|FG001|Overall Study|Protocol Violation|7|||
125217529|NCT00980655|450423576|FG000|Overall Study|Withdrawal by Subject|0|||
125378988|NCT01402544|451019225|FG000|Overall Study|Withdrawal by Subject|6|||
125217530|NCT00980655|450423577|FG001|Overall Study|Withdrawal by Subject|4|||
125378989|NCT01828281|451019226|FG000|Overall Study|Withdrawal by Subject|1|||
125217531|NCT00980655|450423576|FG000|Overall Study|Lost to Follow-up|0|||
125378990|NCT01828281|451019227|FG001|Overall Study|Withdrawal by Subject|0|||
125378991|NCT04876274|451019230|FG000|Overall Study|Lost to Follow-up|9|||
125378992|NCT04876274|451019231|FG001|Overall Study|Lost to Follow-up|12|||
125378993|NCT02051608|451019232|FG000|Part 1: Double Blind Treatment|Death|3|||
125378994|NCT02051608|451019233|FG001|Part 1: Double Blind Treatment|Death|3|||
125378995|NCT02051608|451019234|FG002|Part 1: Double Blind Treatment|Death|0|||
125378996|NCT02051608|451019235|FG003|Part 1: Double Blind Treatment|Death|0|||
125378997|NCT02051608|451019232|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
125378998|NCT02051608|451019233|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
125378999|NCT02051608|451019234|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
125379000|NCT02051608|451019235|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
125379001|NCT02051608|451019232|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
125379002|NCT02051608|451019233|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
125379003|NCT02051608|451019234|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
125379004|NCT02051608|451019235|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
125379005|NCT02051608|451019232|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
125379006|NCT02051608|451019233|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
125379007|NCT02051608|451019234|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
125379008|NCT02051608|451019235|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
125379009|NCT02051608|451019232|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
125217532|NCT00980655|450423577|FG001|Overall Study|Lost to Follow-up|1|||
125217533|NCT00980655|450423576|FG000|Overall Study|Parent/legal guardian request|1|||
125217534|NCT00980655|450423577|FG001|Overall Study|Parent/legal guardian request|0|||
125379010|NCT02051608|451019233|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
125379011|NCT02051608|451019234|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
125379012|NCT02051608|451019235|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
125379013|NCT02051608|451019232|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
125379014|NCT02051608|451019233|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
125379015|NCT02051608|451019234|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
125131529|NCT00272779|450110000|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
125131530|NCT00272779|450109999|FG000|Baseline Through Week 48|Continuing treatment|385|||
125131531|NCT00272779|450110000|FG001|Baseline Through Week 48|Continuing treatment|368|||
125131532|NCT00272779|450109999|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
125131533|NCT00272779|450110000|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
125131534|NCT00272779|450109999|FG000|Baseline Through Week 48|Never treated|2|||
125131535|NCT00272779|450110000|FG001|Baseline Through Week 48|Never treated|3|||
125217535|NCT00980655|450423576|FG000|Overall Study|Other|0|||
125217536|NCT00980655|450423577|FG001|Overall Study|Other|1|||
125217537|NCT01124292|450423581|FG000|Overall Study|Lost to Follow-up|2|||
125217538|NCT01124292|450423582|FG001|Overall Study|Lost to Follow-up|4|||
125217539|NCT01124292|450423583|FG002|Overall Study|Lost to Follow-up|3|||
125217540|NCT01124292|450423581|FG000|Overall Study|Physician Decision|0|||
125217541|NCT01124292|450423582|FG001|Overall Study|Physician Decision|3|||
125217542|NCT01124292|450423583|FG002|Overall Study|Physician Decision|2|||
125217543|NCT01124292|450423581|FG000|Overall Study|Withdrawal by Subject|0|||
125217544|NCT01124292|450423582|FG001|Overall Study|Withdrawal by Subject|6|||
125217545|NCT01124292|450423583|FG002|Overall Study|Withdrawal by Subject|2|||
125217546|NCT01124292|450423581|FG000|Overall Study|medical issue unrelated to the study|0|||
125217547|NCT01124292|450423582|FG001|Overall Study|medical issue unrelated to the study|0|||
125217548|NCT01124292|450423583|FG002|Overall Study|medical issue unrelated to the study|2|||
125217549|NCT01124292|450423581|FG000|Overall Study|piercing track closed|0|||
125217550|NCT01124292|450423582|FG001|Overall Study|piercing track closed|2|||
125217551|NCT01124292|450423583|FG002|Overall Study|piercing track closed|1|||
125217552|NCT03373461|450423584|FG000|Part 2|Adverse Event|0|||
125217553|NCT03373461|450423585|FG001|Part 2|Adverse Event|1|||
125217554|NCT03373461|450423586|FG002|Part 2|Adverse Event|0|||
125217555|NCT03373461|450423587|FG003|Part 2|Adverse Event|0|||
125217556|NCT03373461|450423588|FG004|Part 2|Adverse Event|1|||
125217557|NCT03300180|450423589|FG000|Baseline|Withdrawal by Subject|4|||
125217558|NCT03300180|450423590|FG001|Baseline|Withdrawal by Subject|6|||
125217559|NCT03300180|450423591|FG002|Baseline|Withdrawal by Subject|4|||
125217560|NCT03300180|450423589|FG000|6 Month Outcome|Withdrawal by Subject|12|||
125217561|NCT03300180|450423590|FG001|6 Month Outcome|Withdrawal by Subject|12|||
125217562|NCT03300180|450423591|FG002|6 Month Outcome|Withdrawal by Subject|19|||
125637396|NCT03073200|451952837|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125637397|NCT03073200|451952838|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125637398|NCT03073200|451952839|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125637399|NCT03073200|451952840|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125637400|NCT03073200|451952841|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125637401|NCT03073200|451952842|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125637402|NCT03073200|451952843|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125637403|NCT03073200|451952844|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125637404|NCT03073200|451952845|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
125637405|NCT03073200|451952846|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
125637406|NCT04474366|451952847|FG000|Overall Study|Lost to Follow-up|2|||
125637407|NCT04474366|451952848|FG001|Overall Study|Lost to Follow-up|5|||
125637408|NCT04757376|451952849|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
125637409|NCT04757376|451952850|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
125637410|NCT04757376|451952851|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
125637411|NCT04757376|451952852|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
125637412|NCT04757376|451952853|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
125637413|NCT04757376|451952849|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
125637414|NCT04757376|451952850|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
125637415|NCT04757376|451952851|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
125637416|NCT04757376|451952852|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
125637417|NCT04757376|451952853|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
125637418|NCT04757376|451952849|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
125637419|NCT04757376|451952850|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
125637420|NCT04757376|451952851|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
125637421|NCT04757376|451952852|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
125637422|NCT04757376|451952853|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
125637423|NCT04757376|451952849|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
125637424|NCT04757376|451952850|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
125637425|NCT04757376|451952851|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
125637426|NCT04757376|451952852|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
125637427|NCT04757376|451952853|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
125637428|NCT04757376|451952849|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
125637429|NCT04757376|451952850|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
125217563|NCT03300180|450423589|FG000|6 Month Outcome|Death|2|||
125217564|NCT03300180|450423590|FG001|6 Month Outcome|Death|4|||
125217565|NCT03300180|450423591|FG002|6 Month Outcome|Death|3|||
125217566|NCT03300180|450423589|FG000|6 Month Outcome|Missed Assessment|43|||
125217567|NCT03300180|450423590|FG001|6 Month Outcome|Missed Assessment|52|||
125217568|NCT03300180|450423591|FG002|6 Month Outcome|Missed Assessment|46|||
125217569|NCT03300180|450423589|FG000|12 Month Outcome|Withdrawal by Subject|3|||
125217570|NCT03300180|450423590|FG001|12 Month Outcome|Withdrawal by Subject|6|||
125217571|NCT03300180|450423591|FG002|12 Month Outcome|Withdrawal by Subject|6|||
125131536|NCT00272779|450109999|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
125131537|NCT00272779|450110000|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
125131538|NCT00272779|450109999|FG000|Baseline Through Week 96|Death before Week 96|6|||
125131539|NCT00272779|450110000|FG001|Baseline Through Week 96|Death before Week 96|5|||
125131540|NCT00272779|450109999|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
125379016|NCT02051608|451019235|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
125379017|NCT02051608|451019232|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
125379018|NCT02051608|451019233|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
125379019|NCT02051608|451019234|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
125131541|NCT00272779|450110000|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
125131542|NCT00272779|450109999|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
125131543|NCT00272779|450110000|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
125379020|NCT02051608|451019235|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
125379021|NCT02051608|451019232|FG000|Part 1: Double Blind Treatment|Other|6|||
125217572|NCT03300180|450423589|FG000|12 Month Outcome|Death|9|||
125217573|NCT03300180|450423590|FG001|12 Month Outcome|Death|6|||
125217574|NCT03300180|450423591|FG002|12 Month Outcome|Death|6|||
125217575|NCT03300180|450423589|FG000|12 Month Outcome|Missed Assessment|62|||
125217576|NCT03300180|450423590|FG001|12 Month Outcome|Missed Assessment|59|||
125217577|NCT03300180|450423591|FG002|12 Month Outcome|Missed Assessment|58|||
125217578|NCT03300180|450423589|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
125217579|NCT03300180|450423590|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
125217580|NCT03300180|450423591|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
125217581|NCT03300180|450423589|FG000|18 Month Outcome Assessment|Death|8|||
125217582|NCT03300180|450423590|FG001|18 Month Outcome Assessment|Death|5|||
125217583|NCT03300180|450423591|FG002|18 Month Outcome Assessment|Death|5|||
125217584|NCT03300180|450423589|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
125217585|NCT03300180|450423590|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
125217586|NCT03300180|450423591|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
125217587|NCT03300180|450423589|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
125217588|NCT03300180|450423590|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
125217589|NCT03300180|450423591|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
125217590|NCT03300180|450423589|FG000|24 Month Outcome Assessment|Death|13|||
125217591|NCT03300180|450423590|FG001|24 Month Outcome Assessment|Death|13|||
125217592|NCT03300180|450423591|FG002|24 Month Outcome Assessment|Death|3|||
125217593|NCT03300180|450423589|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
125217594|NCT03300180|450423590|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
125217595|NCT03300180|450423591|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
125217596|NCT01941537|450423594|FG000|Overall Study|Lack of Efficacy|1|||
125217597|NCT01941537|450423595|FG001|Overall Study|Lack of Efficacy|2|||
125217598|NCT01941537|450423594|FG000|Overall Study|Lost to Follow-up|1|||
125217599|NCT01941537|450423595|FG001|Overall Study|Lost to Follow-up|0|||
125217600|NCT01941537|450423594|FG000|Overall Study|Pregnancy|1|||
125217601|NCT01941537|450423595|FG001|Overall Study|Pregnancy|0|||
125217602|NCT01941537|450423594|FG000|Overall Study|Adverse Event|1|||
125217603|NCT01941537|450423595|FG001|Overall Study|Adverse Event|0|||
125217604|NCT01941537|450423594|FG000|Overall Study|Withdrawal by Subject|0|||
125217605|NCT01941537|450423595|FG001|Overall Study|Withdrawal by Subject|1|||
125217606|NCT02557516|450423597|FG000|Overall Study|Adverse Event|1|||
125217607|NCT02557516|450423598|FG001|Overall Study|Adverse Event|0|||
125217608|NCT02557516|450423599|FG002|Overall Study|Adverse Event|2|||
125379022|NCT02051608|451019233|FG001|Part 1: Double Blind Treatment|Other|3|||
125379023|NCT02051608|451019234|FG002|Part 1: Double Blind Treatment|Other|0|||
125379024|NCT02051608|451019235|FG003|Part 1: Double Blind Treatment|Other|0|||
125379025|NCT02051608|451019232|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
125379026|NCT02051608|451019233|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
125379027|NCT02051608|451019234|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
125379028|NCT02051608|451019235|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
125637430|NCT04757376|451952851|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
125637431|NCT04757376|451952852|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
125637432|NCT04757376|451952853|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
125637433|NCT04757376|451952849|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
125637434|NCT04757376|451952850|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
125637435|NCT04757376|451952851|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
125637436|NCT04757376|451952852|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
125637437|NCT04757376|451952853|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
125637438|NCT04757376|451952849|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
125637439|NCT04757376|451952850|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
125637440|NCT04757376|451952851|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
125637441|NCT04757376|451952852|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
125637442|NCT04757376|451952853|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
125637443|NCT04757376|451952849|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
125637444|NCT04757376|451952850|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
125637445|NCT04757376|451952851|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
125637446|NCT04757376|451952852|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
125379029|NCT02051608|451019232|FG000|Part 2: Open-label Extension|Adverse Event|0|||
125379030|NCT02051608|451019233|FG001|Part 2: Open-label Extension|Adverse Event|0|||
125379031|NCT02051608|451019234|FG002|Part 2: Open-label Extension|Adverse Event|6|||
125637447|NCT04757376|451952853|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
125637448|NCT04063865|451952854|FG000|Overall Study|Physician Decision|1|||
125637449|NCT04063865|451952855|FG001|Overall Study|Physician Decision|3|||
125637450|NCT04063865|451952854|FG000|Overall Study|Study Closed Prior to Completion|4|||
125637451|NCT04063865|451952855|FG001|Overall Study|Study Closed Prior to Completion|4|||
125637452|NCT04063865|451952854|FG000|Overall Study|Withdrawal by Subject|1|||
125637453|NCT04063865|451952855|FG001|Overall Study|Withdrawal by Subject|1|||
125637454|NCT03898323|451952856|FG000|Overall Study|Physician Decision|1|||
125637455|NCT00320190|451952858|FG000|First 12 Months|Completed but did not enter extension|5|||
125637456|NCT00320190|451952859|FG001|First 12 Months|Completed but did not enter extension|3|||
125637457|NCT00320190|451952858|FG000|First 12 Months|Sponsor terminated study|2|||
125637458|NCT00320190|451952859|FG001|First 12 Months|Sponsor terminated study|2|||
125637459|NCT00320190|451952858|FG000|First 12 Months|Lost to Follow-up|0|||
125637460|NCT00320190|451952859|FG001|First 12 Months|Lost to Follow-up|1|||
125637461|NCT00320190|451952858|FG000|First 12 Months|Enrollment failure|0|||
125637462|NCT00320190|451952859|FG001|First 12 Months|Enrollment failure|1|||
125637463|NCT00320190|451952858|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
125637464|NCT00320190|451952859|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
125637465|NCT00320190|451952858|FG000|First 12 Months|Investigator request|0|||
125637466|NCT00320190|451952859|FG001|First 12 Months|Investigator request|1|||
125637467|NCT00320190|451952858|FG000|First 12 Months|Study drug toxicity|0|||
125637468|NCT00320190|451952859|FG001|First 12 Months|Study drug toxicity|1|||
125637469|NCT00320190|451952858|FG000|First 12 Months|Withdrawal by Subject|0|||
125637470|NCT00320190|451952859|FG001|First 12 Months|Withdrawal by Subject|1|||
125637471|NCT00320190|451952858|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
125637472|NCT00320190|451952859|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
125637473|NCT00320190|451952858|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
125637474|NCT00320190|451952859|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
125637475|NCT00320190|451952858|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
125637476|NCT00320190|451952859|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
125637477|NCT00712270|451952860|FG000|Overall Study|Withdrawal by Subject|11|||
125637478|NCT00712270|451952860|FG000|Overall Study|Screen Failure|3|||
125637479|NCT02875366|451952874|FG000|Overall Study|Adverse Event|0|||
125637480|NCT02875366|451952875|FG001|Overall Study|Adverse Event|2|||
125637481|NCT02875366|451952874|FG000|Overall Study|Noncompliance|0|||
125637482|NCT02875366|451952875|FG001|Overall Study|Noncompliance|1|||
125637483|NCT02141854|451952878|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
125637484|NCT02141854|451952879|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125637485|NCT02141854|451952880|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125637486|NCT02141854|451952881|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125637487|NCT02141854|451952882|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125637488|NCT02141854|451952883|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125637489|NCT02141854|451952878|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
125637490|NCT02141854|451952879|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125637491|NCT02141854|451952880|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125637492|NCT02141854|451952881|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125637493|NCT02141854|451952882|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125637494|NCT02141854|451952883|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125637495|NCT02141854|451952878|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
125637496|NCT02141854|451952879|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125637497|NCT02141854|451952880|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125637498|NCT02141854|451952881|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125637499|NCT02141854|451952882|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125637500|NCT02141854|451952883|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125379032|NCT02051608|451019235|FG003|Part 2: Open-label Extension|Adverse Event|8|||
125379033|NCT02051608|451019232|FG000|Part 2: Open-label Extension|Death|0|||
125637501|NCT02141854|451952878|FG000|Run-In Period (Pre-assignment)|Other|14|||
125637502|NCT02141854|451952879|FG001|Run-In Period (Pre-assignment)|Other|0|||
125637503|NCT02141854|451952880|FG002|Run-In Period (Pre-assignment)|Other|0|||
125637504|NCT02141854|451952881|FG003|Run-In Period (Pre-assignment)|Other|0|||
125637505|NCT02141854|451952882|FG004|Run-In Period (Pre-assignment)|Other|0|||
125637506|NCT02141854|451952883|FG005|Run-In Period (Pre-assignment)|Other|0|||
125637507|NCT02141854|451952878|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
125637508|NCT02141854|451952879|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
125637509|NCT02141854|451952880|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
125637510|NCT02141854|451952881|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
125637511|NCT02141854|451952882|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
125637512|NCT02141854|451952883|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
125217609|NCT02557516|450423600|FG003|Overall Study|Adverse Event|1|||
125217610|NCT02557516|450423597|FG000|Overall Study|Disease progression|0|||
125217611|NCT02557516|450423598|FG001|Overall Study|Disease progression|2|||
125217612|NCT02557516|450423599|FG002|Overall Study|Disease progression|0|||
125217613|NCT02557516|450423600|FG003|Overall Study|Disease progression|0|||
125217614|NCT02557516|450423597|FG000|Overall Study|Physician Decision|0|||
125217615|NCT02557516|450423598|FG001|Overall Study|Physician Decision|2|||
125217616|NCT02557516|450423599|FG002|Overall Study|Physician Decision|0|||
125217617|NCT02557516|450423600|FG003|Overall Study|Physician Decision|0|||
125217618|NCT02557516|450423597|FG000|Overall Study|Sponsor decision|0|||
125637513|NCT02141854|451952878|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
125637514|NCT02141854|451952879|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125637515|NCT02141854|451952880|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125637516|NCT02141854|451952881|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125637517|NCT02141854|451952882|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125637518|NCT02141854|451952883|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125217619|NCT02557516|450423598|FG001|Overall Study|Sponsor decision|1|||
125217620|NCT02557516|450423599|FG002|Overall Study|Sponsor decision|2|||
125217621|NCT02557516|450423600|FG003|Overall Study|Sponsor decision|8|||
125217622|NCT00588146|450425216|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
125217623|NCT00588146|450425217|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
125217624|NCT02823470|450425218|FG000|Overall Study|Adverse Event|1|||
125217625|NCT02823470|450425219|FG001|Overall Study|Adverse Event|0|||
125217626|NCT02823470|450425218|FG000|Overall Study|Study terminated by sponsor|8|||
125436544|NCT01617005|451224426|FG000|Overall Study|Lack of motivation for treatment|1|||
125436545|NCT01107743|451224430|FG000|Overall Study|Protocol Violation|46|||
125436546|NCT00308737|451224431|FG000|Overall Study|Adverse Event|104|||
125637519|NCT02141854|451952878|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
125637520|NCT02141854|451952879|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125637521|NCT02141854|451952880|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125637522|NCT02141854|451952881|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125637523|NCT02141854|451952882|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125637524|NCT02141854|451952883|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125637525|NCT02141854|451952878|FG000|Treatment Period|Protocol Violation|0|||
125637526|NCT02141854|451952879|FG001|Treatment Period|Protocol Violation|1|||
125637527|NCT02141854|451952880|FG002|Treatment Period|Protocol Violation|0|||
125637528|NCT02141854|451952881|FG003|Treatment Period|Protocol Violation|2|||
125637529|NCT02141854|451952882|FG004|Treatment Period|Protocol Violation|2|||
125637530|NCT02141854|451952883|FG005|Treatment Period|Protocol Violation|1|||
125637531|NCT02141854|451952878|FG000|Treatment Period|Noncompliance|0|||
125637532|NCT02141854|451952879|FG001|Treatment Period|Noncompliance|0|||
125637533|NCT02141854|451952880|FG002|Treatment Period|Noncompliance|0|||
125637534|NCT02141854|451952881|FG003|Treatment Period|Noncompliance|1|||
125637535|NCT02141854|451952882|FG004|Treatment Period|Noncompliance|0|||
125637536|NCT02141854|451952883|FG005|Treatment Period|Noncompliance|0|||
125637537|NCT02141854|451952878|FG000|Treatment Period|Lack of Efficacy|0|||
125637538|NCT02141854|451952879|FG001|Treatment Period|Lack of Efficacy|0|||
125637539|NCT02141854|451952880|FG002|Treatment Period|Lack of Efficacy|0|||
125637540|NCT02141854|451952881|FG003|Treatment Period|Lack of Efficacy|1|||
125637541|NCT02141854|451952882|FG004|Treatment Period|Lack of Efficacy|1|||
125637542|NCT02141854|451952883|FG005|Treatment Period|Lack of Efficacy|7|||
125217627|NCT02823470|450425219|FG001|Overall Study|Study terminated by sponsor|15|||
125217628|NCT00463801|450425222|FG000|Overall Study|Protocol Violation|1|||
125217629|NCT00463801|450425222|FG000|Overall Study|Lack of Efficacy|2|||
125436547|NCT00308737|451224432|FG001|Overall Study|Adverse Event|9|||
125436548|NCT00308737|451224433|FG002|Overall Study|Adverse Event|0|||
125436549|NCT00308737|451224431|FG000|Overall Study|Death|4|||
125436550|NCT00308737|451224432|FG001|Overall Study|Death|3|||
125436551|NCT00308737|451224433|FG002|Overall Study|Death|0|||
125436552|NCT00308737|451224431|FG000|Overall Study|Lost to Follow-up|56|||
125637543|NCT02141854|451952878|FG000|Treatment Period|Pregnancy|0|||
125637544|NCT02141854|451952879|FG001|Treatment Period|Pregnancy|1|||
125637545|NCT02141854|451952880|FG002|Treatment Period|Pregnancy|0|||
125637546|NCT02141854|451952881|FG003|Treatment Period|Pregnancy|0|||
125637547|NCT02141854|451952882|FG004|Treatment Period|Pregnancy|0|||
125637548|NCT02141854|451952883|FG005|Treatment Period|Pregnancy|0|||
125637549|NCT02141854|451952878|FG000|Treatment Period|Other|0|||
125637550|NCT02141854|451952879|FG001|Treatment Period|Other|1|||
125637551|NCT02141854|451952880|FG002|Treatment Period|Other|2|||
125637552|NCT02141854|451952881|FG003|Treatment Period|Other|0|||
125637553|NCT02141854|451952882|FG004|Treatment Period|Other|1|||
125637554|NCT02141854|451952883|FG005|Treatment Period|Other|2|||
125637555|NCT02141854|451952878|FG000|Treatment Period|Adverse Event|0|||
125637556|NCT02141854|451952879|FG001|Treatment Period|Adverse Event|2|||
125637557|NCT02141854|451952880|FG002|Treatment Period|Adverse Event|2|||
125637558|NCT02141854|451952881|FG003|Treatment Period|Adverse Event|0|||
125637559|NCT02141854|451952882|FG004|Treatment Period|Adverse Event|2|||
125637560|NCT02141854|451952883|FG005|Treatment Period|Adverse Event|2|||
125637561|NCT02141854|451952878|FG000|Treatment Period|Withdrawal by Subject|0|||
125637562|NCT02141854|451952879|FG001|Treatment Period|Withdrawal by Subject|2|||
125637563|NCT02141854|451952880|FG002|Treatment Period|Withdrawal by Subject|3|||
125637564|NCT02141854|451952881|FG003|Treatment Period|Withdrawal by Subject|3|||
125637565|NCT02141854|451952882|FG004|Treatment Period|Withdrawal by Subject|4|||
125637566|NCT02141854|451952883|FG005|Treatment Period|Withdrawal by Subject|7|||
125637567|NCT02141854|451952878|FG000|Treatment Period|Disease progression|0|||
125637568|NCT02141854|451952879|FG001|Treatment Period|Disease progression|2|||
125637569|NCT02141854|451952880|FG002|Treatment Period|Disease progression|1|||
125637570|NCT02141854|451952881|FG003|Treatment Period|Disease progression|3|||
125637571|NCT02141854|451952882|FG004|Treatment Period|Disease progression|0|||
125637572|NCT02141854|451952883|FG005|Treatment Period|Disease progression|18|||
125637573|NCT02141854|451952878|FG000|Treatment Period|Lost to Follow-up|0|||
125637574|NCT02141854|451952879|FG001|Treatment Period|Lost to Follow-up|1|||
125637575|NCT02141854|451952880|FG002|Treatment Period|Lost to Follow-up|1|||
125637576|NCT02141854|451952881|FG003|Treatment Period|Lost to Follow-up|1|||
125637577|NCT02141854|451952882|FG004|Treatment Period|Lost to Follow-up|0|||
125637578|NCT02141854|451952883|FG005|Treatment Period|Lost to Follow-up|1|||
125637579|NCT02659098|451952884|FG000|Overall Study|Withdrawal by Subject|7|||
125637580|NCT04363944|451952885|FG000|Overall Study|Withdrawal by Subject|2|||
125637581|NCT04363944|451952886|FG001|Overall Study|Withdrawal by Subject|0|||
125637582|NCT02903966|451954296|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
125637583|NCT02903966|451954297|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
125637584|NCT02903966|451954296|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
125637585|NCT02903966|451954297|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
125637586|NCT02903966|451954296|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
125637587|NCT02903966|451954297|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
125637588|NCT03381274|451954298|FG000|Overall Study|Death|2|||
125637589|NCT03381274|451954299|FG001|Overall Study|Death|9|||
125637590|NCT03381274|451954300|FG002|Overall Study|Death|3|||
125637591|NCT03381274|451954301|FG003|Overall Study|Death|2|||
125637592|NCT03381274|451954302|FG004|Overall Study|Death|3|||
125637593|NCT03381274|451954298|FG000|Overall Study|Lost to Follow-up|0|||
125637594|NCT03381274|451954299|FG001|Overall Study|Lost to Follow-up|0|||
125637595|NCT03381274|451954300|FG002|Overall Study|Lost to Follow-up|0|||
125637596|NCT03381274|451954301|FG003|Overall Study|Lost to Follow-up|1|||
125637597|NCT03381274|451954302|FG004|Overall Study|Lost to Follow-up|0|||
125637598|NCT03381274|451954298|FG000|Overall Study|Withdrawal by Subject|2|||
125637599|NCT03381274|451954299|FG001|Overall Study|Withdrawal by Subject|1|||
125637600|NCT03381274|451954300|FG002|Overall Study|Withdrawal by Subject|3|||
125637601|NCT03381274|451954301|FG003|Overall Study|Withdrawal by Subject|1|||
125637602|NCT03381274|451954302|FG004|Overall Study|Withdrawal by Subject|0|||
125637603|NCT03381274|451954298|FG000|Overall Study|Other|1|||
125637604|NCT03381274|451954299|FG001|Overall Study|Other|11|||
125637605|NCT03381274|451954300|FG002|Overall Study|Other|0|||
125637606|NCT03381274|451954301|FG003|Overall Study|Other|2|||
125217630|NCT00463801|450425222|FG000|Overall Study|Adverse Event|4|||
125436553|NCT00308737|451224432|FG001|Overall Study|Lost to Follow-up|80|||
125637607|NCT03381274|451954302|FG004|Overall Study|Other|2|||
125637608|NCT05298774|451954303|FG000|Overall Study|Physician Decision|3|||
125637609|NCT05298774|451954303|FG000|Overall Study|Withdrawal by Subject|2|||
125637610|NCT05298774|451954303|FG000|Overall Study|Lost to Follow-up|3|||
125637611|NCT05298774|451954303|FG000|Overall Study|Screen failure|1|||
125637612|NCT06048367|451954306|FG000|Overall Study|Withdrawal by Subject|0|||
125379034|NCT02051608|451019233|FG001|Part 2: Open-label Extension|Death|0|||
125379035|NCT02051608|451019234|FG002|Part 2: Open-label Extension|Death|7|||
125131544|NCT00272779|450109999|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
125131545|NCT00272779|450110000|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
125131546|NCT00272779|450109999|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
125131547|NCT00272779|450110000|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
125131548|NCT00272779|450109999|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
125131549|NCT00272779|450110000|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
125131550|NCT00272779|450109999|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
125131551|NCT00272779|450110000|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
125131552|NCT00272779|450109999|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
125131553|NCT00272779|450110000|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
125131554|NCT00272779|450109999|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
125131555|NCT00272779|450110000|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
125131556|NCT00272779|450109999|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
125131557|NCT00272779|450110000|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
125131558|NCT00272779|450109999|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
125131559|NCT00272779|450110000|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
125131560|NCT00272779|450109999|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
125131561|NCT00272779|450110000|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
125131562|NCT00272779|450109999|FG000|Baseline Through Week 96|Never treated|2|||
125131563|NCT00272779|450110000|FG001|Baseline Through Week 96|Never treated|3|||
125131564|NCT00272779|450109999|FG000|Baseline Through Week 96|Continuing on treatment|61|||
125131565|NCT00272779|450110000|FG001|Baseline Through Week 96|Continuing on treatment|38|||
125131566|NCT00561015|450110001|FG000|Overall Study|Adverse Event|0|||
125131567|NCT00561015|450110002|FG001|Overall Study|Adverse Event|0|||
125131568|NCT00561015|450110003|FG002|Overall Study|Adverse Event|0|||
125131569|NCT00561015|450110004|FG003|Overall Study|Adverse Event|0|||
125131570|NCT00561015|450110005|FG004|Overall Study|Adverse Event|1|||
125131571|NCT00561015|450110006|FG005|Overall Study|Adverse Event|0|||
125131572|NCT00561015|450110001|FG000|Overall Study|Lost to Follow-up|2|||
125131573|NCT00561015|450110002|FG001|Overall Study|Lost to Follow-up|0|||
125131574|NCT00561015|450110003|FG002|Overall Study|Lost to Follow-up|0|||
125131575|NCT00561015|450110004|FG003|Overall Study|Lost to Follow-up|1|||
125131576|NCT00561015|450110005|FG004|Overall Study|Lost to Follow-up|0|||
125131577|NCT00561015|450110006|FG005|Overall Study|Lost to Follow-up|3|||
125379036|NCT02051608|451019235|FG003|Part 2: Open-label Extension|Death|4|||
125379037|NCT02051608|451019232|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
125379038|NCT02051608|451019233|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
125379039|NCT02051608|451019234|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
125379040|NCT02051608|451019235|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
125379041|NCT02051608|451019232|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
125131578|NCT00561015|450110001|FG000|Overall Study|Participant non-compliance|2|||
125131579|NCT00561015|450110002|FG001|Overall Study|Participant non-compliance|0|||
125379042|NCT02051608|451019233|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
125379043|NCT02051608|451019234|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
125379044|NCT02051608|451019235|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
125131580|NCT00561015|450110003|FG002|Overall Study|Participant non-compliance|0|||
125131581|NCT00561015|450110004|FG003|Overall Study|Participant non-compliance|0|||
125131582|NCT00561015|450110005|FG004|Overall Study|Participant non-compliance|0|||
125131583|NCT00561015|450110006|FG005|Overall Study|Participant non-compliance|0|||
125131584|NCT03616535|450110007|FG000|Overall Study|Death|2|||
125131585|NCT03616535|450110008|FG001|Overall Study|Death|0|||
125131586|NCT03616535|450110009|FG002|Overall Study|Death|0|||
125131587|NCT03616535|450110010|FG003|Overall Study|Death|1|||
125131588|NCT03616535|450110007|FG000|Overall Study|Lost to Follow-up|2|||
125131589|NCT03616535|450110008|FG001|Overall Study|Lost to Follow-up|1|||
125131590|NCT03616535|450110009|FG002|Overall Study|Lost to Follow-up|0|||
125131591|NCT03616535|450110010|FG003|Overall Study|Lost to Follow-up|2|||
125131592|NCT03616535|450110007|FG000|Overall Study|Withdrawal by Subject|1|||
125131593|NCT03616535|450110008|FG001|Overall Study|Withdrawal by Subject|2|||
125131594|NCT03616535|450110009|FG002|Overall Study|Withdrawal by Subject|5|||
125131595|NCT03616535|450110010|FG003|Overall Study|Withdrawal by Subject|1|||
125131596|NCT03616535|450110007|FG000|Overall Study|Not specified or change in eligibility|2|||
125131597|NCT03616535|450110008|FG001|Overall Study|Not specified or change in eligibility|3|||
125131598|NCT03616535|450110009|FG002|Overall Study|Not specified or change in eligibility|3|||
125131599|NCT03616535|450110010|FG003|Overall Study|Not specified or change in eligibility|1|||
125131600|NCT02440711|450110011|FG000|Second Intervention|Lost to Follow-up|1|||
125131601|NCT02440711|450110012|FG001|Second Intervention|Lost to Follow-up|0|||
125131602|NCT00163657|450110017|FG000|Overall Study|Death|12|||
125131603|NCT00163657|450110018|FG001|Overall Study|Death|14|||
125131604|NCT00163657|450110019|FG002|Overall Study|Death|19|||
125131605|NCT00163657|450110017|FG000|Overall Study|graft loss|4|||
125131606|NCT00163657|450110018|FG001|Overall Study|graft loss|1|||
125131607|NCT00163657|450110019|FG002|Overall Study|graft loss|2|||
125131608|NCT00163657|450110017|FG000|Overall Study|Withdrawal by Subject|2|||
125131609|NCT00163657|450110018|FG001|Overall Study|Withdrawal by Subject|3|||
125131610|NCT00163657|450110019|FG002|Overall Study|Withdrawal by Subject|2|||
125131611|NCT00163657|450110017|FG000|Overall Study|Physician Decision|0|||
125131612|NCT00163657|450110018|FG001|Overall Study|Physician Decision|1|||
125131613|NCT00163657|450110019|FG002|Overall Study|Physician Decision|1|||
125131614|NCT00163657|450110017|FG000|Overall Study|Non Compliance|1|||
125379045|NCT02051608|451019232|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
125131615|NCT00163657|450110018|FG001|Overall Study|Non Compliance|0|||
125637613|NCT06048367|451954307|FG001|Overall Study|Withdrawal by Subject|1|||
125637614|NCT06048367|451954308|FG002|Overall Study|Withdrawal by Subject|0|||
125637615|NCT06048367|451954309|FG003|Overall Study|Withdrawal by Subject|0|||
125637616|NCT06048367|451954310|FG004|Overall Study|Withdrawal by Subject|0|||
125637617|NCT06048367|451954306|FG000|Overall Study|Withdrawal by Subject|0|||
125637618|NCT06048367|451954307|FG001|Overall Study|Withdrawal by Subject|0|||
125637619|NCT06048367|451954308|FG002|Overall Study|Withdrawal by Subject|1|||
125637620|NCT06048367|451954309|FG003|Overall Study|Withdrawal by Subject|0|||
125637621|NCT06048367|451954310|FG004|Overall Study|Withdrawal by Subject|0|||
125637622|NCT06048367|451954306|FG000|Overall Study|Withdrawal by Subject|0|||
125637623|NCT06048367|451954307|FG001|Overall Study|Withdrawal by Subject|0|||
125637624|NCT06048367|451954308|FG002|Overall Study|Withdrawal by Subject|0|||
125637625|NCT06048367|451954309|FG003|Overall Study|Withdrawal by Subject|1|||
125637626|NCT06048367|451954310|FG004|Overall Study|Withdrawal by Subject|0|||
125637627|NCT06048367|451954306|FG000|Overall Study|Withdrawal by Subject|0|||
125637628|NCT06048367|451954307|FG001|Overall Study|Withdrawal by Subject|0|||
125637629|NCT06048367|451954308|FG002|Overall Study|Withdrawal by Subject|0|||
125637630|NCT06048367|451954309|FG003|Overall Study|Withdrawal by Subject|1|||
125637631|NCT06048367|451954310|FG004|Overall Study|Withdrawal by Subject|0|||
125637632|NCT02136134|451954311|FG000|Overall Study|Death|170|||
125637633|NCT02136134|451954312|FG001|Overall Study|Death|148|||
125637634|NCT02136134|451954311|FG000|Overall Study|Withdrawal by Subject|19|||
125637635|NCT02136134|451954312|FG001|Overall Study|Withdrawal by Subject|10|||
125637636|NCT02136134|451954311|FG000|Overall Study|Lost to Follow-up|3|||
125637637|NCT02136134|451954312|FG001|Overall Study|Lost to Follow-up|3|||
125637638|NCT02136134|451954311|FG000|Overall Study|Uspecified|55|||
125637639|NCT02136134|451954312|FG001|Overall Study|Uspecified|90|||
125637640|NCT03070119|451954313|FG000|Overall Study|Adverse Event|0|||
125637641|NCT03070119|451954314|FG001|Overall Study|Adverse Event|0|||
125637642|NCT03070119|451954315|FG002|Overall Study|Adverse Event|1|||
125637643|NCT03070119|451954313|FG000|Overall Study|Lost to Follow-up|0|||
125637644|NCT03070119|451954314|FG001|Overall Study|Lost to Follow-up|1|||
125637645|NCT03070119|451954315|FG002|Overall Study|Lost to Follow-up|0|||
125637646|NCT03070119|451954313|FG000|Overall Study|Consent Withdrawn|6|||
125637647|NCT03070119|451954314|FG001|Overall Study|Consent Withdrawn|5|||
125637648|NCT03070119|451954315|FG002|Overall Study|Consent Withdrawn|3|||
125637649|NCT03070119|451954313|FG000|Overall Study|Investigator Decision|0|||
125637650|NCT03070119|451954314|FG001|Overall Study|Investigator Decision|0|||
125637651|NCT03070119|451954315|FG002|Overall Study|Investigator Decision|1|||
125637652|NCT03070119|451954313|FG000|Overall Study|Death|7|||
125637653|NCT03070119|451954314|FG001|Overall Study|Death|14|||
125637654|NCT03070119|451954315|FG002|Overall Study|Death|5|||
125637655|NCT03070119|451954313|FG000|Overall Study|Disease Progression|5|||
125637656|NCT03070119|451954314|FG001|Overall Study|Disease Progression|7|||
125637657|NCT03070119|451954315|FG002|Overall Study|Disease Progression|7|||
125637658|NCT03070119|451954313|FG000|Overall Study|Reason not Specified|2|||
125637659|NCT03070119|451954314|FG001|Overall Study|Reason not Specified|2|||
125637660|NCT03070119|451954315|FG002|Overall Study|Reason not Specified|1|||
125637661|NCT00732472|451954316|FG000|Overall Study|Adverse Event|0|||
125637662|NCT00732472|451954317|FG001|Overall Study|Adverse Event|1|||
125637663|NCT00732472|451954318|FG002|Overall Study|Adverse Event|1|||
125637664|NCT00732472|451954319|FG003|Overall Study|Adverse Event|1|||
125637665|NCT00732472|451954316|FG000|Overall Study|Protocol Violation|0|||
125637666|NCT00732472|451954317|FG001|Overall Study|Protocol Violation|0|||
125637667|NCT00732472|451954318|FG002|Overall Study|Protocol Violation|0|||
125637668|NCT00732472|451954319|FG003|Overall Study|Protocol Violation|1|||
125637669|NCT00732472|451954316|FG000|Overall Study|Withdrawal by Subject|0|||
125637670|NCT00732472|451954317|FG001|Overall Study|Withdrawal by Subject|2|||
125637671|NCT00732472|451954318|FG002|Overall Study|Withdrawal by Subject|0|||
125637672|NCT00732472|451954319|FG003|Overall Study|Withdrawal by Subject|1|||
125637673|NCT01266876|451954321|FG000|Overall Study|Adverse Event|0|||
125637674|NCT01266876|451954322|FG001|Overall Study|Adverse Event|0|||
125637675|NCT01266876|451954323|FG002|Overall Study|Adverse Event|0|||
125637676|NCT01266876|451954324|FG003|Overall Study|Adverse Event|1|||
125131616|NCT00163657|450110019|FG002|Overall Study|Non Compliance|0|||
125637677|NCT01266876|451954325|FG004|Overall Study|Adverse Event|0|||
125637678|NCT05180721|451954326|FG000|Overall Study|Lost to Follow-up|4|||
125637679|NCT01996865|451954328|FG000|Induction Period|Protocol Violation|1|||
125637680|NCT01996865|451954329|FG001|Induction Period|Protocol Violation|0|||
125637681|NCT01996865|451954330|FG002|Induction Period|Protocol Violation|0|||
125637682|NCT01996865|451954328|FG000|Induction Period|Progressive Disease|4|||
125637683|NCT01996865|451954329|FG001|Induction Period|Progressive Disease|0|||
125637684|NCT01996865|451954330|FG002|Induction Period|Progressive Disease|0|||
125637685|NCT01996865|451954328|FG000|Induction Period|Lost to Follow-up|10|||
125637686|NCT01996865|451954329|FG001|Induction Period|Lost to Follow-up|0|||
125637687|NCT01996865|451954330|FG002|Induction Period|Lost to Follow-up|0|||
125637688|NCT01996865|451954328|FG000|Induction Period|Other Reasons|13|||
125637689|NCT01996865|451954329|FG001|Induction Period|Other Reasons|0|||
125637690|NCT01996865|451954330|FG002|Induction Period|Other Reasons|0|||
125637691|NCT01996865|451954328|FG000|Induction Period|Adverse Event|20|||
125637692|NCT01996865|451954329|FG001|Induction Period|Adverse Event|0|||
125637693|NCT01996865|451954330|FG002|Induction Period|Adverse Event|0|||
125637694|NCT01996865|451954328|FG000|Induction Period|Withdrawal by Subject|60|||
125637695|NCT01996865|451954329|FG001|Induction Period|Withdrawal by Subject|0|||
125637696|NCT01996865|451954330|FG002|Induction Period|Withdrawal by Subject|0|||
125637697|NCT01996865|451954328|FG000|Induction Period|Death|111|||
125637698|NCT01996865|451954329|FG001|Induction Period|Death|0|||
125637699|NCT01996865|451954330|FG002|Induction Period|Death|0|||
125637700|NCT01996865|451954328|FG000|Maintenance Period|Protocol Violation|0|||
125637701|NCT01996865|451954329|FG001|Maintenance Period|Protocol Violation|1|||
125637702|NCT01996865|451954330|FG002|Maintenance Period|Protocol Violation|1|||
125637703|NCT01996865|451954328|FG000|Maintenance Period|Other reasons|0|||
125637704|NCT01996865|451954329|FG001|Maintenance Period|Other reasons|8|||
125637705|NCT01996865|451954330|FG002|Maintenance Period|Other reasons|5|||
125637706|NCT01996865|451954328|FG000|Maintenance Period|Progressive Disease|0|||
125637707|NCT01996865|451954329|FG001|Maintenance Period|Progressive Disease|6|||
125637708|NCT01996865|451954330|FG002|Maintenance Period|Progressive Disease|23|||
125637709|NCT01996865|451954328|FG000|Maintenance Period|Withdrawal by Subject|0|||
125637710|NCT01996865|451954329|FG001|Maintenance Period|Withdrawal by Subject|18|||
125637711|NCT01996865|451954330|FG002|Maintenance Period|Withdrawal by Subject|4|||
125637712|NCT01996865|451954328|FG000|Maintenance Period|Adverse Event|0|||
125637713|NCT01996865|451954329|FG001|Maintenance Period|Adverse Event|7|||
125637714|NCT01996865|451954330|FG002|Maintenance Period|Adverse Event|7|||
125637715|NCT01996865|451954328|FG000|Maintenance Period|Death|0|||
125637716|NCT01996865|451954329|FG001|Maintenance Period|Death|15|||
125637717|NCT01996865|451954330|FG002|Maintenance Period|Death|3|||
125637718|NCT01996865|451954328|FG000|Maintenance Period|Lost to Follow-up|0|||
125637719|NCT01996865|451954329|FG001|Maintenance Period|Lost to Follow-up|2|||
125637720|NCT01996865|451954330|FG002|Maintenance Period|Lost to Follow-up|0|||
125637721|NCT03575351|451954331|FG000|Overall Study|Adverse Event|1|||
125637722|NCT03575351|451954332|FG001|Overall Study|Adverse Event|0|||
125637723|NCT03575351|451954331|FG000|Overall Study|Death|2|||
125637724|NCT03575351|451954332|FG001|Overall Study|Death|2|||
125637725|NCT03575351|451954331|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
125637726|NCT03575351|451954332|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
125637727|NCT03575351|451954331|FG000|Overall Study|Lack of Efficacy|28|||
125637728|NCT03575351|451954332|FG001|Overall Study|Lack of Efficacy|0|||
125637729|NCT03575351|451954331|FG000|Overall Study|Withdrawal by Subject|1|||
125637730|NCT03575351|451954332|FG001|Overall Study|Withdrawal by Subject|1|||
125637731|NCT03575351|451954331|FG000|Overall Study|Physician Decision|3|||
125637732|NCT03575351|451954332|FG001|Overall Study|Physician Decision|0|||
125637733|NCT03575351|451954331|FG000|Overall Study|Disease relapse|15|||
125637734|NCT03575351|451954332|FG001|Overall Study|Disease relapse|6|||
125637735|NCT03575351|451954331|FG000|Overall Study|Study drug manufacturing failure|0|||
125637736|NCT03575351|451954332|FG001|Overall Study|Study drug manufacturing failure|1|||
125637737|NCT03575351|451954331|FG000|Overall Study|other reasons|5|||
125637738|NCT03575351|451954332|FG001|Overall Study|other reasons|0|||
125637739|NCT04288089|451954333|FG000|Overall Study|Ongoing Treatment|2|||
125637740|NCT04288089|451954334|FG001|Overall Study|Ongoing Treatment|1|||
125637741|NCT04288089|451954335|FG002|Overall Study|Ongoing Treatment|1|||
125637742|NCT04288089|451954336|FG003|Overall Study|Ongoing Treatment|4|||
125637743|NCT03715205|451954337|FG000|Overall Study|Death|13|||
125637744|NCT03715205|451954337|FG000|Overall Study|Lost to Follow-up|2|||
125637745|NCT03715205|451954337|FG000|Overall Study|Physician Decision|93|||
125637746|NCT03715205|451954337|FG000|Overall Study|Withdrawal by Subject|26|||
125637747|NCT02286089|451954340|FG000|Overall Study|Ongoing in Study|1|||
125637748|NCT02286089|451954341|FG001|Overall Study|Ongoing in Study|1|||
125637749|NCT02286089|451954342|FG002|Overall Study|Ongoing in Study|4|||
125637750|NCT02286089|451954343|FG003|Overall Study|Ongoing in Study|10|||
125637751|NCT02286089|451954340|FG000|Overall Study|Withdrawal by Subject|0|||
125637752|NCT02286089|451954341|FG001|Overall Study|Withdrawal by Subject|0|||
125637753|NCT02286089|451954342|FG002|Overall Study|Withdrawal by Subject|2|||
125637754|NCT02286089|451954343|FG003|Overall Study|Withdrawal by Subject|2|||
125637755|NCT03733249|451954344|FG000|Overall Study|Death|7|||
125637756|NCT03733249|451954344|FG000|Overall Study|Disease relapse|16|||
125637757|NCT03733249|451954344|FG000|Overall Study|Lost to Follow-up|4|||
125637758|NCT03733249|451954344|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
125637759|NCT03733249|451954344|FG000|Overall Study|Withdrawal by Subject|1|||
125379046|NCT02051608|451019233|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
125379047|NCT02051608|451019234|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
125379048|NCT02051608|451019235|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
125379049|NCT02051608|451019232|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
125379050|NCT02051608|451019233|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
125379051|NCT02051608|451019234|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
125379052|NCT02051608|451019235|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
125379053|NCT02051608|451019232|FG000|Part 2: Open-label Extension|Physician Decision|0|||
125379054|NCT02051608|451019233|FG001|Part 2: Open-label Extension|Physician Decision|0|||
125379055|NCT02051608|451019234|FG002|Part 2: Open-label Extension|Physician Decision|8|||
125379056|NCT02051608|451019235|FG003|Part 2: Open-label Extension|Physician Decision|5|||
125379057|NCT02051608|451019232|FG000|Part 2: Open-label Extension|Other|0|||
125131617|NCT00163657|450110017|FG000|Overall Study|Lost to Follow-up|1|||
125131618|NCT00163657|450110018|FG001|Overall Study|Lost to Follow-up|3|||
125131619|NCT00163657|450110019|FG002|Overall Study|Lost to Follow-up|10|||
125131620|NCT00163657|450110017|FG000|Overall Study|Other reason|0|||
125131621|NCT00163657|450110018|FG001|Overall Study|Other reason|1|||
125131622|NCT00163657|450110019|FG002|Overall Study|Other reason|3|||
125131623|NCT03935880|450110020|FG000|Overall Study|Lost to Follow-up|0|||
125131624|NCT03935880|450110021|FG001|Overall Study|Lost to Follow-up|1|||
125131625|NCT02563561|450110022|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
125131626|NCT02563561|450110023|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
125131627|NCT02563561|450110024|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
125131628|NCT02563561|450110022|FG000|Overall Study|Withdrew of Consent|1|||
125131629|NCT02563561|450110023|FG001|Overall Study|Withdrew of Consent|1|||
125131630|NCT02563561|450110024|FG002|Overall Study|Withdrew of Consent|2|||
125131631|NCT02563561|450110022|FG000|Overall Study|Lost to Follow-up|1|||
125131632|NCT02563561|450110023|FG001|Overall Study|Lost to Follow-up|1|||
125131633|NCT02563561|450110024|FG002|Overall Study|Lost to Follow-up|0|||
125131634|NCT02563561|450110022|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
125131635|NCT02563561|450110023|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
125131636|NCT02563561|450110024|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
125131637|NCT02563561|450110022|FG000|Overall Study|Investigator Decision|3|||
125131638|NCT02563561|450110023|FG001|Overall Study|Investigator Decision|4|||
125131639|NCT02563561|450110024|FG002|Overall Study|Investigator Decision|2|||
125131640|NCT02563561|450110022|FG000|Overall Study|Sponsor Decision|5|||
125131641|NCT02563561|450110023|FG001|Overall Study|Sponsor Decision|2|||
125131642|NCT02563561|450110024|FG002|Overall Study|Sponsor Decision|4|||
125131643|NCT02563561|450110022|FG000|Overall Study|Other|1|||
125131644|NCT02563561|450110023|FG001|Overall Study|Other|5|||
125131645|NCT02563561|450110024|FG002|Overall Study|Other|2|||
125131646|NCT03122535|450110027|FG000|Overall Study|Lost to Follow-up|68|||
125131647|NCT03122535|450110028|FG001|Overall Study|Lost to Follow-up|68|||
125131648|NCT03122535|450110027|FG000|Overall Study|Physician Decision|3|||
125131649|NCT03122535|450110028|FG001|Overall Study|Physician Decision|3|||
125131650|NCT03122535|450110027|FG000|Overall Study|Withdrawal by Subject|2|||
125131651|NCT03122535|450110028|FG001|Overall Study|Withdrawal by Subject|2|||
125131652|NCT02718326|450110029|FG000|Overall Study|Adverse Event|4|||
125131653|NCT02718326|450110030|FG001|Overall Study|Adverse Event|9|||
125131654|NCT02718326|450110031|FG002|Overall Study|Adverse Event|0|||
125131655|NCT02718326|450110029|FG000|Overall Study|Death|8|||
125131656|NCT02718326|450110030|FG001|Overall Study|Death|1|||
125217631|NCT00463801|450425222|FG000|Overall Study|Lost to Follow-up|5|||
125217632|NCT00463801|450425222|FG000|Overall Study|No longer require therapy|1|||
125217633|NCT02315664|450425223|FG000|Overall Study|Lost to Follow-up|1|||
125217634|NCT02315664|450425224|FG001|Overall Study|Lost to Follow-up|1|||
125217635|NCT02315664|450425223|FG000|Overall Study|Withdrawal by Subject|0|||
125217636|NCT02315664|450425224|FG001|Overall Study|Withdrawal by Subject|3|||
125217637|NCT02501161|450425225|FG000|Overall Study|Adverse Event|2|||
125217638|NCT02501161|450425226|FG001|Overall Study|Adverse Event|6|||
125217639|NCT02501161|450425225|FG000|Overall Study|Lost to Follow-up|7|||
125217640|NCT02501161|450425226|FG001|Overall Study|Lost to Follow-up|4|||
125217641|NCT02501161|450425225|FG000|Overall Study|Withdrawal by Subject|10|||
125217642|NCT02501161|450425226|FG001|Overall Study|Withdrawal by Subject|15|||
125217643|NCT02501161|450425225|FG000|Overall Study|Other|3|||
125217644|NCT02501161|450425226|FG001|Overall Study|Other|0|||
125217645|NCT01990573|450425229|FG000|Overall Study|Physician Decision|0|||
125217646|NCT01990573|450425230|FG001|Overall Study|Physician Decision|0|||
125379058|NCT02051608|451019233|FG001|Part 2: Open-label Extension|Other|0|||
125379059|NCT02051608|451019234|FG002|Part 2: Open-label Extension|Other|9|||
125379060|NCT02051608|451019235|FG003|Part 2: Open-label Extension|Other|9|||
125379061|NCT00142584|451019236|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
125379062|NCT00142584|451019237|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
125379063|NCT00142584|451019236|FG000|Overall Study|Withdrawal by Subject|30|||
125379064|NCT00142584|451019237|FG001|Overall Study|Withdrawal by Subject|16|||
125379065|NCT00142584|451019236|FG000|Overall Study|Lost to Follow-up|22|||
125379066|NCT00142584|451019237|FG001|Overall Study|Lost to Follow-up|12|||
125379067|NCT00142584|451019236|FG000|Overall Study|Adverse Event|14|||
125379068|NCT00142584|451019237|FG001|Overall Study|Adverse Event|5|||
125379069|NCT00142584|451019236|FG000|Overall Study|Protocol Violation|4|||
125131657|NCT02718326|450110031|FG002|Overall Study|Death|2|||
125131658|NCT02718326|450110029|FG000|Overall Study|Withdrawal by Subject|4|||
125131659|NCT02718326|450110030|FG001|Overall Study|Withdrawal by Subject|9|||
125379070|NCT00142584|451019237|FG001|Overall Study|Protocol Violation|7|||
125379071|NCT00142584|451019236|FG000|Overall Study|Treatment Failure|2|||
125379072|NCT00142584|451019237|FG001|Overall Study|Treatment Failure|0|||
125131660|NCT02718326|450110031|FG002|Overall Study|Withdrawal by Subject|6|||
125131661|NCT02718326|450110029|FG000|Overall Study|Lost to Follow-up|18|||
125131662|NCT02718326|450110030|FG001|Overall Study|Lost to Follow-up|5|||
125217647|NCT01990573|450425231|FG002|Overall Study|Physician Decision|1|||
125217648|NCT03335813|450425233|FG000|Overall Study|Withdrawal by Subject|1|||
125379073|NCT03070782|451019239|FG000|Overall Study|Adverse Event|3|||
125379074|NCT03070782|451019240|FG001|Overall Study|Adverse Event|0|||
125379075|NCT03070782|451019241|FG002|Overall Study|Adverse Event|3|||
125379076|NCT03070782|451019242|FG003|Overall Study|Adverse Event|1|||
125379077|NCT03070782|451019243|FG004|Overall Study|Adverse Event|6|||
125637760|NCT04247828|451954345|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
125637761|NCT03299166|451954346|FG000|Overall Study|Adverse Event|9|||
125637762|NCT03299166|451954347|FG001|Overall Study|Adverse Event|4|||
125637763|NCT03299166|451954346|FG000|Overall Study|Withdrawal by Subject|6|||
125637764|NCT03299166|451954347|FG001|Overall Study|Withdrawal by Subject|5|||
125637765|NCT03299166|451954346|FG000|Overall Study|Physician Decision|1|||
125637766|NCT03299166|451954347|FG001|Overall Study|Physician Decision|1|||
125637767|NCT03299166|451954346|FG000|Overall Study|Sponsor Decision|3|||
125637768|NCT03299166|451954347|FG001|Overall Study|Sponsor Decision|0|||
125637769|NCT03299166|451954346|FG000|Overall Study|Lost to Follow-up|2|||
125637770|NCT03299166|451954347|FG001|Overall Study|Lost to Follow-up|4|||
125637771|NCT03299166|451954346|FG000|Overall Study|Randomization Error|0|||
125637772|NCT03299166|451954347|FG001|Overall Study|Randomization Error|1|||
125637773|NCT03299166|451954346|FG000|Overall Study|Subject unable to return due to COVID|1|||
125637774|NCT03299166|451954347|FG001|Overall Study|Subject unable to return due to COVID|0|||
125637775|NCT03299166|451954346|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
125637776|NCT03299166|451954347|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
125637777|NCT00572728|451954348|FG000|Overall Study|Withdrawal by Subject|10|||
125637778|NCT00572728|451954348|FG000|Overall Study|Ineligible|3|||
125637779|NCT00572728|451954348|FG000|Overall Study|Enrolled under Amendment 4|5|||
125637780|NCT00572728|451954348|FG000|Overall Study|Offstudy due to complicating disease|1|||
125637781|NCT00572728|451954348|FG000|Overall Study|FLT1 not completed|4|||
125637782|NCT00572728|451954348|FG000|Overall Study|First Chemotherapy not initiated|2|||
125637783|NCT00572728|451954348|FG000|Overall Study|FLT2 not completed|5|||
125637784|NCT00572728|451954348|FG000|Overall Study|Second chemotherapy not initiated|1|||
125637785|NCT00572728|451954348|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
125637786|NCT00572728|451954348|FG000|Overall Study|Pathology missing|1|||
125637787|NCT00002981|451954349|FG000|Overall Study|Inevaluable|6|||
125637788|NCT03457636|451954352|FG000|Overall Study|Lost to Follow-up|2|||
125637789|NCT00102804|451954353|FG000|Overall Study|Progressive Disease (PD)|307|||
125637790|NCT00102804|451954354|FG001|Overall Study|Progressive Disease (PD)|196|||
125637791|NCT00102804|451954353|FG000|Overall Study|Withdrawal by Subject|46|||
125637792|NCT00102804|451954354|FG001|Overall Study|Withdrawal by Subject|7|||
125637793|NCT00102804|451954353|FG000|Overall Study|Adverse Event|37|||
125637794|NCT00102804|451954354|FG001|Overall Study|Adverse Event|3|||
125637795|NCT00102804|451954353|FG000|Overall Study|Physician Decision|24|||
125637796|NCT00102804|451954354|FG001|Overall Study|Physician Decision|6|||
125637797|NCT00102804|451954353|FG000|Overall Study|Death|5|||
125637798|NCT00102804|451954354|FG001|Overall Study|Death|6|||
125637799|NCT00102804|451954353|FG000|Overall Study|Enrollment Criteria Not Met|6|||
125637800|NCT00102804|451954354|FG001|Overall Study|Enrollment Criteria Not Met|0|||
125637801|NCT00102804|451954353|FG000|Overall Study|Lost to Follow-up|4|||
125637802|NCT00102804|451954354|FG001|Overall Study|Lost to Follow-up|1|||
125637803|NCT00102804|451954353|FG000|Overall Study|Protocol Violation|2|||
125637804|NCT00102804|451954354|FG001|Overall Study|Protocol Violation|1|||
125637805|NCT00102804|451954353|FG000|Overall Study|Satisfactory Response|2|||
125637806|NCT00102804|451954354|FG001|Overall Study|Satisfactory Response|0|||
125637807|NCT00102804|451954353|FG000|Overall Study|Sponsor Decision|1|||
125637808|NCT00102804|451954354|FG001|Overall Study|Sponsor Decision|0|||
125637809|NCT00102804|451954353|FG000|Overall Study|Alive, Receiving Treatment|7|||
125637810|NCT00102804|451954354|FG001|Overall Study|Alive, Receiving Treatment|2|||
125637811|NCT03954704|451954355|FG000|Overall Study|Death|1|||
125637812|NCT03954704|451954356|FG001|Overall Study|Death|1|||
125637813|NCT03954704|451954357|FG002|Overall Study|Death|1|||
125637814|NCT03954704|451954358|FG003|Overall Study|Death|3|||
125637815|NCT03954704|451954359|FG004|Overall Study|Death|2|||
125637816|NCT03954704|451954360|FG005|Overall Study|Death|2|||
125637817|NCT03954704|451954361|FG006|Overall Study|Death|0|||
125637818|NCT03954704|451954355|FG000|Overall Study|Withdrew Consent|0|||
125637819|NCT03954704|451954356|FG001|Overall Study|Withdrew Consent|0|||
125637820|NCT03954704|451954357|FG002|Overall Study|Withdrew Consent|1|||
125637821|NCT03954704|451954358|FG003|Overall Study|Withdrew Consent|0|||
125637822|NCT03954704|451954359|FG004|Overall Study|Withdrew Consent|0|||
125637823|NCT03954704|451954360|FG005|Overall Study|Withdrew Consent|1|||
125637824|NCT03954704|451954361|FG006|Overall Study|Withdrew Consent|0|||
125637825|NCT03954704|451954355|FG000|Overall Study|Lost to Follow-up|0|||
125637826|NCT03954704|451954356|FG001|Overall Study|Lost to Follow-up|0|||
125637827|NCT03954704|451954357|FG002|Overall Study|Lost to Follow-up|0|||
125637828|NCT03954704|451954358|FG003|Overall Study|Lost to Follow-up|0|||
125637829|NCT03954704|451954359|FG004|Overall Study|Lost to Follow-up|0|||
125637830|NCT03954704|451954360|FG005|Overall Study|Lost to Follow-up|0|||
125637831|NCT03954704|451954361|FG006|Overall Study|Lost to Follow-up|1|||
125637832|NCT03954704|451954355|FG000|Overall Study|Study Terminated by Sponsor|0|||
125637833|NCT03954704|451954356|FG001|Overall Study|Study Terminated by Sponsor|0|||
125637834|NCT03954704|451954357|FG002|Overall Study|Study Terminated by Sponsor|1|||
125379078|NCT03070782|451019244|FG005|Overall Study|Adverse Event|2|||
125379079|NCT03070782|451019239|FG000|Overall Study|Withdrawal by Subject|2|||
125379080|NCT03070782|451019240|FG001|Overall Study|Withdrawal by Subject|1|||
125379081|NCT03070782|451019241|FG002|Overall Study|Withdrawal by Subject|1|||
125217649|NCT01957579|450425234|FG000|Overall Study|Withdrawal of concent|0|||
125217650|NCT01957579|450425235|FG001|Overall Study|Withdrawal of concent|1|||
125131663|NCT02718326|450110031|FG002|Overall Study|Lost to Follow-up|14|||
125436554|NCT00308737|451224433|FG002|Overall Study|Lost to Follow-up|5|||
125436555|NCT00308737|451224431|FG000|Overall Study|Physician Decision|15|||
125436556|NCT00308737|451224432|FG001|Overall Study|Physician Decision|2|||
125436557|NCT00308737|451224433|FG002|Overall Study|Physician Decision|1|||
125436558|NCT00308737|451224431|FG000|Overall Study|Protocol Violation|34|||
125436559|NCT00308737|451224432|FG001|Overall Study|Protocol Violation|9|||
125436560|NCT00308737|451224433|FG002|Overall Study|Protocol Violation|5|||
125637835|NCT03954704|451954358|FG003|Overall Study|Study Terminated by Sponsor|0|||
125637836|NCT03954704|451954359|FG004|Overall Study|Study Terminated by Sponsor|1|||
125637837|NCT03954704|451954360|FG005|Overall Study|Study Terminated by Sponsor|4|||
125637838|NCT03954704|451954361|FG006|Overall Study|Study Terminated by Sponsor|2|||
125637839|NCT03954704|451954355|FG000|Overall Study|Enrolled but not Treated|0|||
125637840|NCT03954704|451954356|FG001|Overall Study|Enrolled but not Treated|0|||
125637841|NCT03954704|451954357|FG002|Overall Study|Enrolled but not Treated|0|||
125637842|NCT03954704|451954358|FG003|Overall Study|Enrolled but not Treated|0|||
125637843|NCT03954704|451954359|FG004|Overall Study|Enrolled but not Treated|0|||
125637844|NCT03954704|451954360|FG005|Overall Study|Enrolled but not Treated|1|||
125637845|NCT03954704|451954361|FG006|Overall Study|Enrolled but not Treated|0|||
125637846|NCT00374127|451954364|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
125637847|NCT00374127|451954364|FG000|Overall Study|Blood could not be drawn.|2|||
125637848|NCT00374127|451954364|FG000|Overall Study|Protocol Violation|5|||
125637849|NCT00374127|451954364|FG000|Overall Study|Pregnancy|1|||
125637850|NCT04035473|451954369|FG000|Screening/Baseline|Death|0|||
125637851|NCT04035473|451954370|FG001|Screening/Baseline|Death|1|||
125637852|NCT04035473|451954369|FG000|Screening/Baseline|Adverse Event|0|||
125637853|NCT04035473|451954370|FG001|Screening/Baseline|Adverse Event|1|||
125637854|NCT04035473|451954369|FG000|Follow-up Period|Adverse Event|2|||
125637855|NCT04035473|451954370|FG001|Follow-up Period|Adverse Event|0|||
125637856|NCT00112840|451954371|FG000|Overall Study|Physician Decision|1|||
125637857|NCT00112840|451954372|FG001|Overall Study|Physician Decision|0|||
125637858|NCT00112840|451954373|FG002|Overall Study|Physician Decision|0|||
125637859|NCT00112840|451954371|FG000|Overall Study|Withdrawal by Subject|1|||
125637860|NCT00112840|451954372|FG001|Overall Study|Withdrawal by Subject|0|||
125637861|NCT00112840|451954373|FG002|Overall Study|Withdrawal by Subject|1|||
125637862|NCT00112840|451954371|FG000|Overall Study|Protocol Violation|0|||
125637863|NCT00112840|451954372|FG001|Overall Study|Protocol Violation|0|||
125637864|NCT00112840|451954373|FG002|Overall Study|Protocol Violation|5|||
125637865|NCT02299206|451954374|FG000|Overall Study|Lost to Follow-up|1|||
125637866|NCT02299206|451954374|FG000|Overall Study|Withdrawal by Subject|1|||
125637867|NCT00683774|451954375|FG000|Overall Study|Withdrawal by Subject|0|||
125637868|NCT00683774|451954376|FG001|Overall Study|Withdrawal by Subject|1|||
125637869|NCT00683774|451954375|FG000|Overall Study|Physician Decision|3|||
125637870|NCT00683774|451954376|FG001|Overall Study|Physician Decision|0|||
125637871|NCT00691054|451954377|FG000|Overall Study|Withdrawal by Subject|1|||
125637872|NCT03595176|451954378|FG000|Overall Study|Death|0|||
125637873|NCT03595176|451954379|FG001|Overall Study|Death|2|||
125637874|NCT03595176|451954378|FG000|Overall Study|Lost to Follow-up|0|||
125637875|NCT03595176|451954379|FG001|Overall Study|Lost to Follow-up|1|||
125637876|NCT02735044|451954381|FG000|Overall Study|Adverse Event|3|||
125637877|NCT02735044|451954382|FG001|Overall Study|Adverse Event|3|||
125637878|NCT02735044|451954381|FG000|Overall Study|Lack of Efficacy|1|||
125637879|NCT02735044|451954382|FG001|Overall Study|Lack of Efficacy|0|||
125637880|NCT02735044|451954381|FG000|Overall Study|Poor compliance to protocol|7|||
125637881|NCT02735044|451954382|FG001|Overall Study|Poor compliance to protocol|7|||
125637882|NCT02735044|451954381|FG000|Overall Study|Randomized and not treated|0|||
125637883|NCT02735044|451954382|FG001|Overall Study|Randomized and not treated|2|||
125637884|NCT02735044|451954381|FG000|Overall Study|Other, not specified above|5|||
125637885|NCT02735044|451954382|FG001|Overall Study|Other, not specified above|11|||
125637886|NCT01682759|451954383|FG000|Overall Study|Death|2|||
125637887|NCT01682759|451954384|FG001|Overall Study|Death|1|||
125637888|NCT01682759|451954383|FG000|Overall Study|Lost to Follow-up|10|||
125637889|NCT01682759|451954384|FG001|Overall Study|Lost to Follow-up|13|||
125637890|NCT01682759|451954383|FG000|Overall Study|Physician Decision|1|||
125637891|NCT01682759|451954384|FG001|Overall Study|Physician Decision|1|||
125637892|NCT01682759|451954383|FG000|Overall Study|Withdrawal by Subject|56|||
125637893|NCT01682759|451954384|FG001|Overall Study|Withdrawal by Subject|55|||
125637894|NCT01868594|451954386|FG000|Overall Study|Do not meet inclusion criteria|4|||
125637895|NCT01868594|451954387|FG001|Overall Study|Do not meet inclusion criteria|3|||
125637896|NCT01201967|451954392|FG000|Overall Study|Lost to Follow-up|6|||
125637897|NCT01201967|451954393|FG001|Overall Study|Lost to Follow-up|5|||
125637898|NCT03128307|451954401|FG000|Overall Study|Lost to Follow-up|29|||
125637899|NCT03128307|451954401|FG000|Overall Study|Withdrawal by Subject|5|||
125637900|NCT02632344|451956158|FG000|Overall Study|Adverse Event|3|||
125637901|NCT02632344|451956158|FG000|Overall Study|Lack of Efficacy|3|||
125637902|NCT02632344|451956158|FG000|Overall Study|Withdrawal by Subject|2|||
125637903|NCT04076579|451956160|FG000|Overall Study|Adverse Event|2|||
125637904|NCT04076579|451956161|FG001|Overall Study|Adverse Event|0|||
125637905|NCT04076579|451956160|FG000|Overall Study|discontinued due to toxicity|1|||
125637906|NCT04076579|451956161|FG001|Overall Study|discontinued due to toxicity|0|||
125637907|NCT04076579|451956160|FG000|Overall Study|Physician Decision|1|||
125637908|NCT04076579|451956161|FG001|Overall Study|Physician Decision|0|||
125637909|NCT04076579|451956160|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
125637910|NCT04076579|451956161|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
125637911|NCT04076579|451956160|FG000|Overall Study|Noncompliance|0|||
125637912|NCT04076579|451956161|FG001|Overall Study|Noncompliance|1|||
125637913|NCT04076579|451956160|FG000|Overall Study|Withdrawal by Subject|0|||
125637914|NCT04076579|451956161|FG001|Overall Study|Withdrawal by Subject|2|||
125637915|NCT01693562|451956162|FG000|Escalation Phase|Withdrawal by Subject|0|||
125637916|NCT01693562|451956163|FG001|Escalation Phase|Withdrawal by Subject|1|||
125436561|NCT00308737|451224431|FG000|Overall Study|Withdrawal by Subject|218|||
125436562|NCT00308737|451224432|FG001|Overall Study|Withdrawal by Subject|166|||
125436563|NCT00308737|451224433|FG002|Overall Study|Withdrawal by Subject|18|||
125637917|NCT01693562|451956164|FG002|Escalation Phase|Withdrawal by Subject|0|||
125379082|NCT03070782|451019242|FG003|Overall Study|Withdrawal by Subject|0|||
125379083|NCT03070782|451019243|FG004|Overall Study|Withdrawal by Subject|4|||
125379084|NCT03070782|451019244|FG005|Overall Study|Withdrawal by Subject|3|||
125379085|NCT03070782|451019239|FG000|Overall Study|Reason Not Specified|2|||
125379086|NCT03070782|451019240|FG001|Overall Study|Reason Not Specified|0|||
125379087|NCT03070782|451019241|FG002|Overall Study|Reason Not Specified|0|||
125379088|NCT03070782|451019242|FG003|Overall Study|Reason Not Specified|1|||
125379089|NCT03070782|451019243|FG004|Overall Study|Reason Not Specified|2|||
125379090|NCT03070782|451019244|FG005|Overall Study|Reason Not Specified|1|||
125379091|NCT03070782|451019239|FG000|Overall Study|Ineligibility|0|||
125379092|NCT03070782|451019240|FG001|Overall Study|Ineligibility|0|||
125379093|NCT03070782|451019241|FG002|Overall Study|Ineligibility|0|||
125379094|NCT03070782|451019242|FG003|Overall Study|Ineligibility|1|||
125379095|NCT03070782|451019243|FG004|Overall Study|Ineligibility|0|||
125379096|NCT03070782|451019244|FG005|Overall Study|Ineligibility|1|||
125379097|NCT03070782|451019239|FG000|Overall Study|Pregnancy|0|||
125379098|NCT03070782|451019240|FG001|Overall Study|Pregnancy|0|||
125379099|NCT03070782|451019241|FG002|Overall Study|Pregnancy|0|||
125379100|NCT03070782|451019242|FG003|Overall Study|Pregnancy|1|||
125379101|NCT03070782|451019243|FG004|Overall Study|Pregnancy|0|||
125379102|NCT03070782|451019244|FG005|Overall Study|Pregnancy|0|||
125379103|NCT03070782|451019239|FG000|Overall Study|Investigator Judgement|0|||
125379104|NCT03070782|451019240|FG001|Overall Study|Investigator Judgement|0|||
125379105|NCT03070782|451019241|FG002|Overall Study|Investigator Judgement|0|||
125379106|NCT03070782|451019242|FG003|Overall Study|Investigator Judgement|1|||
125379107|NCT03070782|451019243|FG004|Overall Study|Investigator Judgement|0|||
125436564|NCT00308737|451224431|FG000|Overall Study|Various|32|||
125436565|NCT00308737|451224432|FG001|Overall Study|Various|20|||
125637918|NCT01693562|451956165|FG003|Escalation Phase|Withdrawal by Subject|0|||
125637919|NCT01693562|451956166|FG004|Escalation Phase|Withdrawal by Subject|0|||
125637920|NCT01693562|451956167|FG005|Escalation Phase|Withdrawal by Subject|2|||
125379108|NCT03070782|451019244|FG005|Overall Study|Investigator Judgement|0|||
125379109|NCT01083576|451019245|FG000|Overall Study|Treatment Failure|6|||
125379110|NCT01083576|451019246|FG001|Overall Study|Treatment Failure|1|||
125379111|NCT02875860|451019248|FG000|Overall Study|Withdrawal by Subject|0|||
125379112|NCT02875860|451019249|FG001|Overall Study|Withdrawal by Subject|1|||
125379113|NCT01881776|451019250|FG000|Overall Study|Lost to Follow-up|1|||
125436566|NCT00308737|451224433|FG002|Overall Study|Various|8|||
125637921|NCT01693562|451956168|FG006|Escalation Phase|Withdrawal by Subject|0|||
125637922|NCT01693562|451956169|FG007|Escalation Phase|Withdrawal by Subject|0|||
125637923|NCT01693562|451956170|FG008|Escalation Phase|Withdrawal by Subject|0|||
125637924|NCT01693562|451956171|FG009|Escalation Phase|Withdrawal by Subject|0|||
125637925|NCT01693562|451956172|FG010|Escalation Phase|Withdrawal by Subject|0|||
125637926|NCT01693562|451956173|FG011|Escalation Phase|Withdrawal by Subject|0|||
125637927|NCT01693562|451956174|FG012|Escalation Phase|Withdrawal by Subject|0|||
125637928|NCT01693562|451956175|FG013|Escalation Phase|Withdrawal by Subject|0|||
125637929|NCT01693562|451956176|FG014|Escalation Phase|Withdrawal by Subject|0|||
125131664|NCT02718326|450110029|FG000|Overall Study|Protocol Deviation|1|||
125131665|NCT02718326|450110030|FG001|Overall Study|Protocol Deviation|0|||
125131666|NCT02718326|450110031|FG002|Overall Study|Protocol Deviation|0|||
125131667|NCT02718326|450110029|FG000|Overall Study|Pregnancy|1|||
125131668|NCT02718326|450110030|FG001|Overall Study|Pregnancy|0|||
125131669|NCT02718326|450110031|FG002|Overall Study|Pregnancy|0|||
125131670|NCT02646124|450110032|FG000|Overall Study|Lost to Follow-up|0|||
125131671|NCT02646124|450110033|FG001|Overall Study|Lost to Follow-up|2|||
125131672|NCT03154047|450110035|FG000|Overall Study|Death|1|||
125131673|NCT03154047|450110035|FG000|Overall Study|Study terminated by sponsor|76|||
125131674|NCT03154047|450110035|FG000|Overall Study|Withdrawal by Subject|3|||
125131675|NCT00857454|450110036|FG000|Overall Study|Withdrawal by Subject|2|||
125131676|NCT00857454|450110036|FG000|Overall Study|Lost to Follow-up|1|||
125131677|NCT00857454|450110036|FG000|Overall Study|Adverse Event|2|||
125131678|NCT00857454|450110036|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
125131679|NCT00857454|450110036|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
125131680|NCT00857454|450110036|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
125131681|NCT02436005|450110037|FG000|Second Intervention|Adverse Event|0|||
125131682|NCT02436005|450110038|FG001|Second Intervention|Adverse Event|1|||
125131683|NCT00573443|450110039|FG000|Double-Blind Phase|Lost to Follow-up|1|||
125131684|NCT00573443|450110040|FG001|Double-Blind Phase|Lost to Follow-up|3|||
125131685|NCT00573443|450110041|FG002|Double-Blind Phase|Lost to Follow-up|2|||
125131686|NCT00573443|450110039|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
125131687|NCT00573443|450110040|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
125131688|NCT00573443|450110041|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
125131689|NCT00573443|450110039|FG000|Double-Blind Phase|Adverse Event|1|||
125217651|NCT01957579|450425236|FG002|Overall Study|Withdrawal of concent|0|||
125217652|NCT01957579|450425237|FG003|Overall Study|Withdrawal of concent|0|||
125217653|NCT01957579|450425234|FG000|Overall Study|Death|0|||
125217654|NCT01957579|450425235|FG001|Overall Study|Death|0|||
125217655|NCT01957579|450425236|FG002|Overall Study|Death|2|||
125131690|NCT00573443|450110040|FG001|Double-Blind Phase|Adverse Event|5|||
125131691|NCT00573443|450110041|FG002|Double-Blind Phase|Adverse Event|0|||
125131692|NCT00573443|450110039|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
125131693|NCT00573443|450110040|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
125131694|NCT00573443|450110041|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
125217656|NCT01957579|450425237|FG003|Overall Study|Death|0|||
125217657|NCT01639144|450425240|FG000|Overall Study|Withdrawal by Subject|4|||
125217658|NCT01639144|450425241|FG001|Overall Study|Withdrawal by Subject|2|||
125217659|NCT01639144|450425240|FG000|Overall Study|Physician Decision|2|||
125217660|NCT01639144|450425241|FG001|Overall Study|Physician Decision|0|||
125217661|NCT01639144|450425240|FG000|Overall Study|Met postoperative exclusion criteria|4|||
125217662|NCT01639144|450425241|FG001|Overall Study|Met postoperative exclusion criteria|3|||
125217663|NCT02239640|450425250|FG000|Overall Study|Withdrawal by Subject|3|||
125217664|NCT02239640|450425250|FG000|Overall Study|Lost to Follow-up|72|||
125217665|NCT02239640|450425250|FG000|Overall Study|Death|142|||
125217666|NCT02630563|450425251|FG000|Overall Study|Administrative|1|||
125217667|NCT02485483|450425252|FG000|Overall Study|Depression at baseline|15|||
125217668|NCT02485483|450425253|FG001|Overall Study|Depression at baseline|0|||
125217669|NCT02485483|450425252|FG000|Overall Study|Discontinued after baseline|39|||
125217670|NCT02485483|450425253|FG001|Overall Study|Discontinued after baseline|0|||
125217671|NCT02061813|450425254|FG000|Overall Study|Withdrawal by Subject|1|||
125217672|NCT02061813|450425254|FG000|Overall Study|Protocol Violation|2|||
125217673|NCT01724177|450425258|FG000|Overall Study|Adverse Event|8|||
125217674|NCT01724177|450425258|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
125217675|NCT01724177|450425258|FG000|Overall Study|Nervous participant|1|||
125217676|NCT01724177|450425258|FG000|Overall Study|Serious Adverse Event Related|1|||
125217677|NCT01705080|450425261|FG000|Overall Study|Missed visit|10|||
125217678|NCT01705080|450425262|FG001|Overall Study|Missed visit|4|||
125217679|NCT01705080|450425263|FG002|Overall Study|Missed visit|1|||
125217680|NCT01705080|450425261|FG000|Overall Study|Death|4|||
125217681|NCT01705080|450425262|FG001|Overall Study|Death|4|||
125217682|NCT01705080|450425263|FG002|Overall Study|Death|6|||
125217683|NCT01705080|450425261|FG000|Overall Study|Withdrawal by Subject|61|||
125217684|NCT01705080|450425262|FG001|Overall Study|Withdrawal by Subject|44|||
125217685|NCT01705080|450425263|FG002|Overall Study|Withdrawal by Subject|9|||
125217686|NCT00206427|450425266|FG000|Overall Study|Adverse Event|2|||
125217687|NCT00281697|450425270|FG000|Overall Study|> 60 days since last dose of study drug|4|||
125379114|NCT01881776|451019251|FG001|Overall Study|Lost to Follow-up|2|||
125217688|NCT00281697|450425271|FG001|Overall Study|> 60 days since last dose of study drug|4|||
125217689|NCT00281697|450425270|FG000|Overall Study|Adverse Event|54|||
125217690|NCT00281697|450425271|FG001|Overall Study|Adverse Event|15|||
125217691|NCT00281697|450425270|FG000|Overall Study|Death|8|||
125217692|NCT00281697|450425271|FG001|Overall Study|Death|3|||
125217693|NCT00281697|450425270|FG000|Overall Study|Disease progression|279|||
125217694|NCT00281697|450425271|FG001|Overall Study|Disease progression|149|||
125217695|NCT00281697|450425270|FG000|Overall Study|Other|5|||
125217696|NCT00281697|450425271|FG001|Overall Study|Other|6|||
125217697|NCT00281697|450425270|FG000|Overall Study|Physician's decision to withdraw|15|||
125217698|NCT00281697|450425271|FG001|Overall Study|Physician's decision to withdraw|12|||
125217699|NCT00281697|450425270|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
125217700|NCT00281697|450425271|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
125217701|NCT00281697|450425270|FG000|Overall Study|Did not receive study drug|3|||
125217702|NCT00281697|450425271|FG001|Overall Study|Did not receive study drug|2|||
125217703|NCT03130959|450425284|FG000|Overall Study|Disease progression|19|||
125217704|NCT03130959|450425285|FG001|Overall Study|Disease progression|7|||
125217705|NCT03130959|450425286|FG002|Overall Study|Disease progression|12|||
125217706|NCT03130959|450425287|FG003|Overall Study|Disease progression|7|||
125217707|NCT03130959|450425288|FG004|Overall Study|Disease progression|12|||
125217708|NCT03130959|450425289|FG005|Overall Study|Disease progression|3|||
125217709|NCT03130959|450425290|FG006|Overall Study|Disease progression|6|||
125217710|NCT03130959|450425291|FG007|Overall Study|Disease progression|3|||
125217711|NCT03130959|450425292|FG008|Overall Study|Disease progression|15|||
125217712|NCT03130959|450425293|FG009|Overall Study|Disease progression|8|||
125217713|NCT03130959|450425284|FG000|Overall Study|Study drug toxicity|2|||
125217714|NCT03130959|450425285|FG001|Overall Study|Study drug toxicity|2|||
125217715|NCT03130959|450425286|FG002|Overall Study|Study drug toxicity|1|||
125217716|NCT03130959|450425287|FG003|Overall Study|Study drug toxicity|2|||
125217717|NCT03130959|450425288|FG004|Overall Study|Study drug toxicity|1|||
125217718|NCT03130959|450425289|FG005|Overall Study|Study drug toxicity|1|||
125217719|NCT03130959|450425290|FG006|Overall Study|Study drug toxicity|3|||
125217720|NCT03130959|450425291|FG007|Overall Study|Study drug toxicity|0|||
125217721|NCT03130959|450425292|FG008|Overall Study|Study drug toxicity|3|||
125217722|NCT03130959|450425293|FG009|Overall Study|Study drug toxicity|3|||
125217723|NCT03130959|450425284|FG000|Overall Study|Other reasons|0|||
125217724|NCT03130959|450425285|FG001|Overall Study|Other reasons|0|||
125217725|NCT03130959|450425286|FG002|Overall Study|Other reasons|0|||
125217726|NCT03130959|450425287|FG003|Overall Study|Other reasons|0|||
125217727|NCT03130959|450425288|FG004|Overall Study|Other reasons|0|||
125217728|NCT03130959|450425289|FG005|Overall Study|Other reasons|1|||
125217729|NCT03130959|450425290|FG006|Overall Study|Other reasons|1|||
125217730|NCT03130959|450425291|FG007|Overall Study|Other reasons|0|||
125217731|NCT03130959|450425292|FG008|Overall Study|Other reasons|0|||
125217732|NCT03130959|450425293|FG009|Overall Study|Other reasons|0|||
125217733|NCT03130959|450425284|FG000|Overall Study|Subject request to discontinue therapy|0|||
125217734|NCT03130959|450425285|FG001|Overall Study|Subject request to discontinue therapy|0|||
125217735|NCT03130959|450425286|FG002|Overall Study|Subject request to discontinue therapy|1|||
125217736|NCT03130959|450425287|FG003|Overall Study|Subject request to discontinue therapy|1|||
125217737|NCT03130959|450425288|FG004|Overall Study|Subject request to discontinue therapy|0|||
125217738|NCT03130959|450425289|FG005|Overall Study|Subject request to discontinue therapy|0|||
125217739|NCT03130959|450425290|FG006|Overall Study|Subject request to discontinue therapy|1|||
125217740|NCT03130959|450425291|FG007|Overall Study|Subject request to discontinue therapy|1|||
125217741|NCT03130959|450425292|FG008|Overall Study|Subject request to discontinue therapy|0|||
125217742|NCT03130959|450425293|FG009|Overall Study|Subject request to discontinue therapy|0|||
125217743|NCT03130959|450425284|FG000|Overall Study|Not reported|0|||
125217744|NCT03130959|450425285|FG001|Overall Study|Not reported|0|||
125217745|NCT03130959|450425286|FG002|Overall Study|Not reported|0|||
125217746|NCT03130959|450425287|FG003|Overall Study|Not reported|1|||
125217747|NCT03130959|450425288|FG004|Overall Study|Not reported|0|||
125217748|NCT03130959|450425289|FG005|Overall Study|Not reported|1|||
125217749|NCT03130959|450425290|FG006|Overall Study|Not reported|0|||
125436567|NCT01225822|451224445|FG000|Overall Study|Adverse Event|13|||
125436568|NCT01225822|451224446|FG001|Overall Study|Adverse Event|31|||
125436569|NCT01225822|451224447|FG002|Overall Study|Adverse Event|18|||
125436570|NCT01225822|451224448|FG003|Overall Study|Adverse Event|23|||
125436571|NCT01225822|451224449|FG004|Overall Study|Adverse Event|14|||
125436572|NCT01225822|451224445|FG000|Overall Study|Protocol Violation|6|||
125436573|NCT01225822|451224446|FG001|Overall Study|Protocol Violation|8|||
125436574|NCT01225822|451224447|FG002|Overall Study|Protocol Violation|6|||
125436575|NCT01225822|451224448|FG003|Overall Study|Protocol Violation|7|||
125436576|NCT01225822|451224449|FG004|Overall Study|Protocol Violation|4|||
125436577|NCT01225822|451224445|FG000|Overall Study|Lost to Follow-up|0|||
125131695|NCT00573443|450110039|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
125131696|NCT00573443|450110040|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
125131697|NCT00573443|450110041|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
125131698|NCT00573443|450110039|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
125131699|NCT00573443|450110040|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
125131700|NCT00573443|450110041|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
125131701|NCT00573443|450110039|FG000|Double-Blind Phase|Protocol Violation|0|||
125379115|NCT01881776|451019252|FG002|Overall Study|Lost to Follow-up|1|||
125379116|NCT01881776|451019250|FG000|Overall Study|Protocol Violation|0|||
125379117|NCT01881776|451019251|FG001|Overall Study|Protocol Violation|2|||
125379118|NCT01881776|451019252|FG002|Overall Study|Protocol Violation|1|||
125379119|NCT04997161|451019257|FG000|Overall Study|Study terminated by sponsor|3|||
125379120|NCT00005937|451019260|FG000|Overall Study|Lack of Efficacy|5|||
125379121|NCT01288469|451019261|FG000|Overall Study|Adverse Event|4|||
125379122|NCT01288469|451019262|FG001|Overall Study|Adverse Event|1|||
125379123|NCT01288469|451019263|FG002|Overall Study|Adverse Event|1|||
125379124|NCT01288469|451019261|FG000|Overall Study|Poor compliance to protocol|0|||
125379125|NCT01288469|451019262|FG001|Overall Study|Poor compliance to protocol|1|||
125379126|NCT01288469|451019263|FG002|Overall Study|Poor compliance to protocol|0|||
125379127|NCT01288469|451019261|FG000|Overall Study|Participant Moved|1|||
125379128|NCT01288469|451019262|FG001|Overall Study|Participant Moved|0|||
125379129|NCT01288469|451019263|FG002|Overall Study|Participant Moved|0|||
125379130|NCT01288469|451019261|FG000|Overall Study|Consent withdrawn by subject|1|||
125379131|NCT01288469|451019262|FG001|Overall Study|Consent withdrawn by subject|1|||
125379132|NCT01288469|451019263|FG002|Overall Study|Consent withdrawn by subject|1|||
125379133|NCT01288469|451019261|FG000|Overall Study|Exclusion criteria finally met|1|||
125379134|NCT01288469|451019262|FG001|Overall Study|Exclusion criteria finally met|0|||
125379135|NCT01288469|451019263|FG002|Overall Study|Exclusion criteria finally met|0|||
125379136|NCT00255047|451019264|FG000|Overall Study|Serious Adverse Events|2|||
125379137|NCT00255047|451019265|FG001|Overall Study|Serious Adverse Events|1|||
125379138|NCT00255047|451019266|FG002|Overall Study|Serious Adverse Events|2|||
125379139|NCT00255047|451019267|FG003|Overall Study|Serious Adverse Events|1|||
125379140|NCT00255047|451019264|FG000|Overall Study|Adverse Event|0|||
125379141|NCT00255047|451019265|FG001|Overall Study|Adverse Event|3|||
125379142|NCT00255047|451019266|FG002|Overall Study|Adverse Event|2|||
125379143|NCT00255047|451019267|FG003|Overall Study|Adverse Event|1|||
125379144|NCT00255047|451019264|FG000|Overall Study|Protocol Violation|13|||
125379145|NCT00255047|451019265|FG001|Overall Study|Protocol Violation|13|||
125379146|NCT00255047|451019266|FG002|Overall Study|Protocol Violation|16|||
125379147|NCT00255047|451019267|FG003|Overall Study|Protocol Violation|20|||
125379148|NCT00255047|451019264|FG000|Overall Study|Lost to Follow-up|9|||
125379149|NCT00255047|451019265|FG001|Overall Study|Lost to Follow-up|8|||
125379150|NCT00255047|451019266|FG002|Overall Study|Lost to Follow-up|5|||
125379151|NCT00255047|451019267|FG003|Overall Study|Lost to Follow-up|6|||
125379152|NCT00255047|451019264|FG000|Overall Study|Withdrawal by Subject|24|||
125379153|NCT00255047|451019265|FG001|Overall Study|Withdrawal by Subject|23|||
125436578|NCT01225822|451224446|FG001|Overall Study|Lost to Follow-up|0|||
125436579|NCT01225822|451224447|FG002|Overall Study|Lost to Follow-up|0|||
125379154|NCT00255047|451019266|FG002|Overall Study|Withdrawal by Subject|25|||
125379155|NCT00255047|451019267|FG003|Overall Study|Withdrawal by Subject|18|||
125379156|NCT01574612|451019268|FG000|Overall Study|Adverse Event|3|||
125379157|NCT01574612|451019268|FG000|Overall Study|non compliant with drug|2|||
125379158|NCT01574612|451019268|FG000|Overall Study|Withdrawal by Subject|1|||
125379159|NCT01574612|451019268|FG000|Overall Study|Lost to Follow-up|2|||
125379160|NCT04044716|451019269|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
125436580|NCT01225822|451224448|FG003|Overall Study|Lost to Follow-up|1|||
125131702|NCT00573443|450110040|FG001|Double-Blind Phase|Protocol Violation|2|||
125131703|NCT00573443|450110041|FG002|Double-Blind Phase|Protocol Violation|1|||
125131704|NCT00573443|450110039|FG000|Double-Blind Phase|Other|0|||
125131705|NCT00573443|450110040|FG001|Double-Blind Phase|Other|2|||
125131706|NCT00573443|450110041|FG002|Double-Blind Phase|Other|3|||
125131707|NCT00573443|450110039|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
125131708|NCT00573443|450110040|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
125131709|NCT00573443|450110041|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
125131710|NCT00573443|450110039|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
125131711|NCT00573443|450110040|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
125131712|NCT00573443|450110041|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
125131713|NCT00573443|450110039|FG000|Open-Label Extension Phase|Adverse Event|3|||
125131714|NCT00573443|450110040|FG001|Open-Label Extension Phase|Adverse Event|0|||
125131715|NCT00573443|450110041|FG002|Open-Label Extension Phase|Adverse Event|0|||
125379161|NCT04044716|451019270|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
125379162|NCT04044716|451019271|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
125379163|NCT04044716|451019269|FG000|Overall Study|Lost to Follow-up|2|||
125379164|NCT04044716|451019270|FG001|Overall Study|Lost to Follow-up|3|||
125379165|NCT04044716|451019271|FG002|Overall Study|Lost to Follow-up|0|||
125379166|NCT01782495|451019276|FG000|Overall Study|Adverse Event|0|||
125379167|NCT01782495|451019277|FG001|Overall Study|Adverse Event|0|||
125379168|NCT01782495|451019278|FG002|Overall Study|Adverse Event|0|||
125379169|NCT01782495|451019279|FG003|Overall Study|Adverse Event|0|||
125379170|NCT01782495|451019280|FG004|Overall Study|Adverse Event|0|||
125379171|NCT01782495|451019281|FG005|Overall Study|Adverse Event|0|||
125379172|NCT01782495|451019282|FG006|Overall Study|Adverse Event|0|||
125379173|NCT01782495|451019283|FG007|Overall Study|Adverse Event|2|||
125379174|NCT01782495|451019284|FG008|Overall Study|Adverse Event|0|||
125379175|NCT01782495|451019285|FG009|Overall Study|Adverse Event|0|||
125379176|NCT01782495|451019286|FG010|Overall Study|Adverse Event|0|||
125379177|NCT01782495|451019276|FG000|Overall Study|Withdrew Consent|0|||
125379178|NCT01782495|451019277|FG001|Overall Study|Withdrew Consent|1|||
125379179|NCT01782495|451019278|FG002|Overall Study|Withdrew Consent|0|||
125379180|NCT01782495|451019279|FG003|Overall Study|Withdrew Consent|0|||
125379181|NCT01782495|451019280|FG004|Overall Study|Withdrew Consent|0|||
125379182|NCT01782495|451019281|FG005|Overall Study|Withdrew Consent|0|||
125379183|NCT01782495|451019282|FG006|Overall Study|Withdrew Consent|0|||
125379184|NCT01782495|451019283|FG007|Overall Study|Withdrew Consent|1|||
125379185|NCT01782495|451019284|FG008|Overall Study|Withdrew Consent|0|||
125379186|NCT01782495|451019285|FG009|Overall Study|Withdrew Consent|0|||
125379187|NCT01782495|451019286|FG010|Overall Study|Withdrew Consent|0|||
125379188|NCT00071513|451019287|FG000|Intervention Component|Withdrawal by Subject|2|||
125379189|NCT00071513|451019288|FG001|Intervention Component|Withdrawal by Subject|3|||
125379190|NCT00071513|451019287|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
125379191|NCT00071513|451019288|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
125379192|NCT02260921|451019289|FG000|Overall Study|Adverse Event|1|||
125379193|NCT02260921|451019290|FG001|Overall Study|Adverse Event|0|||
125379194|NCT02260921|451019289|FG000|Overall Study|Lost to Follow-up|4|||
125379195|NCT02260921|451019290|FG001|Overall Study|Lost to Follow-up|3|||
125379196|NCT02260921|451019289|FG000|Overall Study|Withdraw Consent|4|||
125379197|NCT02260921|451019290|FG001|Overall Study|Withdraw Consent|1|||
125379198|NCT02260921|451019289|FG000|Overall Study|Death|1|||
125379199|NCT02260921|451019290|FG001|Overall Study|Death|0|||
125379200|NCT02260921|451019289|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
125379201|NCT02260921|451019290|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
125379202|NCT01244425|451019291|FG000|Overall Study|Withdrawal by Subject|2|||
125379203|NCT01244425|451019292|FG001|Overall Study|Withdrawal by Subject|2|||
125379204|NCT01244425|451019291|FG000|Overall Study|Adverse Event|1|||
125436581|NCT01225822|451224449|FG004|Overall Study|Lost to Follow-up|0|||
125379205|NCT01244425|451019292|FG001|Overall Study|Adverse Event|1|||
125379206|NCT02743871|451019293|FG000|Overall Study|Lost to Follow-up|0|||
125379207|NCT02743871|451019294|FG001|Overall Study|Lost to Follow-up|0|||
125379208|NCT02743871|451019295|FG002|Overall Study|Lost to Follow-up|0|||
125379209|NCT02743871|451019296|FG003|Overall Study|Lost to Follow-up|1|||
125379210|NCT02743871|451019297|FG004|Overall Study|Lost to Follow-up|0|||
125131716|NCT00573443|450110039|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
125131717|NCT00573443|450110040|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
125379211|NCT02743871|451019298|FG005|Overall Study|Lost to Follow-up|0|||
125379212|NCT02743871|451019299|FG006|Overall Study|Lost to Follow-up|1|||
125379213|NCT02743871|451019300|FG007|Overall Study|Lost to Follow-up|0|||
125379214|NCT02743871|451019301|FG008|Overall Study|Lost to Follow-up|0|||
125436582|NCT01225822|451224445|FG000|Overall Study|Withdrawal by Subject|6|||
125436583|NCT01225822|451224446|FG001|Overall Study|Withdrawal by Subject|7|||
125436584|NCT01225822|451224447|FG002|Overall Study|Withdrawal by Subject|7|||
125436585|NCT01225822|451224448|FG003|Overall Study|Withdrawal by Subject|11|||
125436586|NCT01225822|451224449|FG004|Overall Study|Withdrawal by Subject|6|||
125436587|NCT01225822|451224445|FG000|Overall Study|Other|13|||
125436588|NCT01225822|451224446|FG001|Overall Study|Other|10|||
125436589|NCT01225822|451224447|FG002|Overall Study|Other|7|||
125436590|NCT01225822|451224448|FG003|Overall Study|Other|10|||
125436591|NCT01225822|451224449|FG004|Overall Study|Other|7|||
125436592|NCT04078035|451224450|FG000|Session 2|Lost to Follow-up|3|||
125436593|NCT04078035|451224451|FG001|Session 2|Lost to Follow-up|1|||
125436594|NCT04078035|451224450|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
125436595|NCT04078035|451224451|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
125436596|NCT05644353|451224452|FG000|Overall Study|Physician Decision|1|||
125436597|NCT05644353|451224453|FG001|Overall Study|Physician Decision|0|||
125436598|NCT05644353|451224454|FG002|Overall Study|Physician Decision|0|||
125436599|NCT05644353|451224455|FG003|Overall Study|Physician Decision|0|||
125637930|NCT01693562|451956177|FG015|Escalation Phase|Withdrawal by Subject|0|||
125436600|NCT05644353|451224456|FG004|Overall Study|Physician Decision|0|||
125436601|NCT05644353|451224457|FG005|Overall Study|Physician Decision|0|||
125436602|NCT05644353|451224452|FG000|Overall Study|Protocol Violation|1|||
125436603|NCT05644353|451224453|FG001|Overall Study|Protocol Violation|0|||
125436604|NCT05644353|451224454|FG002|Overall Study|Protocol Violation|0|||
125436605|NCT05644353|451224455|FG003|Overall Study|Protocol Violation|0|||
125637931|NCT01693562|451956178|FG016|Escalation Phase|Withdrawal by Subject|0|||
125637932|NCT01693562|451956179|FG017|Escalation Phase|Withdrawal by Subject|0|||
125637933|NCT01693562|451956180|FG018|Escalation Phase|Withdrawal by Subject|0|||
125637934|NCT01693562|451956181|FG019|Escalation Phase|Withdrawal by Subject|0|||
125637935|NCT01693562|451956182|FG020|Escalation Phase|Withdrawal by Subject|0|||
125637936|NCT01693562|451956183|FG021|Escalation Phase|Withdrawal by Subject|0|||
125637937|NCT01693562|451956184|FG022|Escalation Phase|Withdrawal by Subject|0|||
125637938|NCT01693562|451956162|FG000|Escalation Phase|Death|4|||
125637939|NCT01693562|451956163|FG001|Escalation Phase|Death|2|||
125637940|NCT01693562|451956164|FG002|Escalation Phase|Death|0|||
125637941|NCT01693562|451956165|FG003|Escalation Phase|Death|3|||
125637942|NCT01693562|451956166|FG004|Escalation Phase|Death|6|||
125637943|NCT01693562|451956167|FG005|Escalation Phase|Death|4|||
125637944|NCT01693562|451956168|FG006|Escalation Phase|Death|0|||
125637945|NCT01693562|451956169|FG007|Escalation Phase|Death|0|||
125637946|NCT01693562|451956170|FG008|Escalation Phase|Death|0|||
125637947|NCT01693562|451956171|FG009|Escalation Phase|Death|0|||
125637948|NCT01693562|451956172|FG010|Escalation Phase|Death|0|||
125637949|NCT01693562|451956173|FG011|Escalation Phase|Death|0|||
125637950|NCT01693562|451956174|FG012|Escalation Phase|Death|0|||
125637951|NCT01693562|451956175|FG013|Escalation Phase|Death|0|||
125637952|NCT01693562|451956176|FG014|Escalation Phase|Death|0|||
125637953|NCT01693562|451956177|FG015|Escalation Phase|Death|0|||
125637954|NCT01693562|451956178|FG016|Escalation Phase|Death|0|||
125637955|NCT01693562|451956179|FG017|Escalation Phase|Death|0|||
125637956|NCT01693562|451956180|FG018|Escalation Phase|Death|0|||
125637957|NCT01693562|451956181|FG019|Escalation Phase|Death|0|||
125637958|NCT01693562|451956182|FG020|Escalation Phase|Death|0|||
125637959|NCT01693562|451956183|FG021|Escalation Phase|Death|0|||
125637960|NCT01693562|451956184|FG022|Escalation Phase|Death|0|||
125637961|NCT01693562|451956162|FG000|Escalation Phase|Lost to Follow-up|0|||
125637962|NCT01693562|451956163|FG001|Escalation Phase|Lost to Follow-up|1|||
125637963|NCT01693562|451956164|FG002|Escalation Phase|Lost to Follow-up|1|||
125637964|NCT01693562|451956165|FG003|Escalation Phase|Lost to Follow-up|0|||
125637965|NCT01693562|451956166|FG004|Escalation Phase|Lost to Follow-up|0|||
125637966|NCT01693562|451956167|FG005|Escalation Phase|Lost to Follow-up|0|||
125637967|NCT01693562|451956168|FG006|Escalation Phase|Lost to Follow-up|0|||
125637968|NCT01693562|451956169|FG007|Escalation Phase|Lost to Follow-up|0|||
125637969|NCT01693562|451956170|FG008|Escalation Phase|Lost to Follow-up|0|||
125637970|NCT01693562|451956171|FG009|Escalation Phase|Lost to Follow-up|0|||
125637971|NCT01693562|451956172|FG010|Escalation Phase|Lost to Follow-up|0|||
125637972|NCT01693562|451956173|FG011|Escalation Phase|Lost to Follow-up|0|||
125436606|NCT05644353|451224456|FG004|Overall Study|Protocol Violation|0|||
125436607|NCT05644353|451224457|FG005|Overall Study|Protocol Violation|0|||
125436608|NCT05644353|451224452|FG000|Overall Study|Withdrawal by Subject|0|||
125436609|NCT05644353|451224453|FG001|Overall Study|Withdrawal by Subject|2|||
125637973|NCT01693562|451956174|FG012|Escalation Phase|Lost to Follow-up|0|||
125637974|NCT01693562|451956175|FG013|Escalation Phase|Lost to Follow-up|0|||
125637975|NCT01693562|451956176|FG014|Escalation Phase|Lost to Follow-up|0|||
125436610|NCT05644353|451224454|FG002|Overall Study|Withdrawal by Subject|0|||
125436611|NCT05644353|451224455|FG003|Overall Study|Withdrawal by Subject|0|||
125436612|NCT05644353|451224456|FG004|Overall Study|Withdrawal by Subject|1|||
125436613|NCT05644353|451224457|FG005|Overall Study|Withdrawal by Subject|0|||
125637976|NCT01693562|451956177|FG015|Escalation Phase|Lost to Follow-up|0|||
125637977|NCT01693562|451956178|FG016|Escalation Phase|Lost to Follow-up|0|||
125637978|NCT01693562|451956179|FG017|Escalation Phase|Lost to Follow-up|0|||
125436614|NCT05644353|451224452|FG000|Overall Study|Lost to Follow-up|0|||
125436615|NCT05644353|451224453|FG001|Overall Study|Lost to Follow-up|0|||
125637979|NCT01693562|451956180|FG018|Escalation Phase|Lost to Follow-up|0|||
125637980|NCT01693562|451956181|FG019|Escalation Phase|Lost to Follow-up|0|||
125637981|NCT01693562|451956182|FG020|Escalation Phase|Lost to Follow-up|0|||
125637982|NCT01693562|451956183|FG021|Escalation Phase|Lost to Follow-up|0|||
125637983|NCT01693562|451956184|FG022|Escalation Phase|Lost to Follow-up|0|||
125637984|NCT01693562|451956162|FG000|Escalation Phase|Other|0|||
125637985|NCT01693562|451956163|FG001|Escalation Phase|Other|0|||
125637986|NCT01693562|451956164|FG002|Escalation Phase|Other|2|||
125637987|NCT01693562|451956165|FG003|Escalation Phase|Other|0|||
125637988|NCT01693562|451956166|FG004|Escalation Phase|Other|0|||
125637989|NCT01693562|451956167|FG005|Escalation Phase|Other|1|||
125637990|NCT01693562|451956168|FG006|Escalation Phase|Other|0|||
125637991|NCT01693562|451956169|FG007|Escalation Phase|Other|0|||
125637992|NCT01693562|451956170|FG008|Escalation Phase|Other|0|||
125637993|NCT01693562|451956171|FG009|Escalation Phase|Other|0|||
125637994|NCT01693562|451956172|FG010|Escalation Phase|Other|0|||
125637995|NCT01693562|451956173|FG011|Escalation Phase|Other|0|||
125637996|NCT01693562|451956174|FG012|Escalation Phase|Other|0|||
125637997|NCT01693562|451956175|FG013|Escalation Phase|Other|0|||
125637998|NCT01693562|451956176|FG014|Escalation Phase|Other|0|||
125637999|NCT01693562|451956177|FG015|Escalation Phase|Other|0|||
125638000|NCT01693562|451956178|FG016|Escalation Phase|Other|0|||
125638001|NCT01693562|451956179|FG017|Escalation Phase|Other|0|||
125638002|NCT01693562|451956180|FG018|Escalation Phase|Other|0|||
125638003|NCT01693562|451956181|FG019|Escalation Phase|Other|0|||
125638004|NCT01693562|451956182|FG020|Escalation Phase|Other|0|||
125638005|NCT01693562|451956183|FG021|Escalation Phase|Other|0|||
125638006|NCT01693562|451956184|FG022|Escalation Phase|Other|0|||
125638007|NCT01693562|451956162|FG000|Exploration Phase|Withdrawal by Subject|0|||
125638008|NCT01693562|451956163|FG001|Exploration Phase|Withdrawal by Subject|0|||
125638009|NCT01693562|451956164|FG002|Exploration Phase|Withdrawal by Subject|0|||
125638010|NCT01693562|451956165|FG003|Exploration Phase|Withdrawal by Subject|0|||
125638011|NCT01693562|451956166|FG004|Exploration Phase|Withdrawal by Subject|0|||
125638012|NCT01693562|451956167|FG005|Exploration Phase|Withdrawal by Subject|0|||
125638013|NCT01693562|451956168|FG006|Exploration Phase|Withdrawal by Subject|2|||
125638014|NCT01693562|451956169|FG007|Exploration Phase|Withdrawal by Subject|0|||
125638015|NCT01693562|451956170|FG008|Exploration Phase|Withdrawal by Subject|0|||
125638016|NCT01693562|451956171|FG009|Exploration Phase|Withdrawal by Subject|0|||
125638017|NCT01693562|451956172|FG010|Exploration Phase|Withdrawal by Subject|0|||
125638018|NCT01693562|451956173|FG011|Exploration Phase|Withdrawal by Subject|0|||
125638019|NCT01693562|451956174|FG012|Exploration Phase|Withdrawal by Subject|0|||
125638020|NCT01693562|451956175|FG013|Exploration Phase|Withdrawal by Subject|0|||
125638021|NCT01693562|451956176|FG014|Exploration Phase|Withdrawal by Subject|0|||
125638022|NCT01693562|451956177|FG015|Exploration Phase|Withdrawal by Subject|0|||
125638023|NCT01693562|451956178|FG016|Exploration Phase|Withdrawal by Subject|0|||
125638024|NCT01693562|451956179|FG017|Exploration Phase|Withdrawal by Subject|0|||
125638025|NCT01693562|451956180|FG018|Exploration Phase|Withdrawal by Subject|0|||
125638026|NCT01693562|451956181|FG019|Exploration Phase|Withdrawal by Subject|0|||
125638027|NCT01693562|451956182|FG020|Exploration Phase|Withdrawal by Subject|0|||
125638028|NCT01693562|451956183|FG021|Exploration Phase|Withdrawal by Subject|0|||
125638029|NCT01693562|451956184|FG022|Exploration Phase|Withdrawal by Subject|0|||
125638030|NCT01693562|451956162|FG000|Exploration Phase|Death|0|||
125638031|NCT01693562|451956163|FG001|Exploration Phase|Death|0|||
125638032|NCT01693562|451956164|FG002|Exploration Phase|Death|0|||
125638033|NCT01693562|451956165|FG003|Exploration Phase|Death|0|||
125638034|NCT01693562|451956166|FG004|Exploration Phase|Death|0|||
125638035|NCT01693562|451956167|FG005|Exploration Phase|Death|0|||
125638036|NCT01693562|451956168|FG006|Exploration Phase|Death|17|||
125638037|NCT01693562|451956169|FG007|Exploration Phase|Death|0|||
125638038|NCT01693562|451956170|FG008|Exploration Phase|Death|0|||
125638039|NCT01693562|451956171|FG009|Exploration Phase|Death|0|||
125638040|NCT01693562|451956172|FG010|Exploration Phase|Death|0|||
125638041|NCT01693562|451956173|FG011|Exploration Phase|Death|0|||
125638042|NCT01693562|451956174|FG012|Exploration Phase|Death|0|||
125436616|NCT05644353|451224454|FG002|Overall Study|Lost to Follow-up|1|||
125638043|NCT01693562|451956175|FG013|Exploration Phase|Death|0|||
125436617|NCT05644353|451224455|FG003|Overall Study|Lost to Follow-up|0|||
125638044|NCT01693562|451956176|FG014|Exploration Phase|Death|0|||
125638045|NCT01693562|451956177|FG015|Exploration Phase|Death|0|||
125638046|NCT01693562|451956178|FG016|Exploration Phase|Death|0|||
125131718|NCT00573443|450110041|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
125436618|NCT05644353|451224456|FG004|Overall Study|Lost to Follow-up|0|||
125436619|NCT05644353|451224457|FG005|Overall Study|Lost to Follow-up|0|||
125436620|NCT01407354|451224458|FG000|First Intervention|Withdrawal by Subject|0|||
125436621|NCT01407354|451224459|FG001|First Intervention|Withdrawal by Subject|2|||
125436622|NCT01407354|451224458|FG000|First Intervention|Adverse Event|1|||
125436623|NCT01407354|451224459|FG001|First Intervention|Adverse Event|0|||
125436624|NCT01407354|451224458|FG000|First Intervention|Physician Decision|1|||
125436625|NCT01407354|451224459|FG001|First Intervention|Physician Decision|0|||
125436626|NCT02204579|451224460|FG000|Overall Study|Screen failures|2|||
125436627|NCT02778399|451224461|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
125436628|NCT02778399|451224462|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
125436629|NCT02778399|451224463|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
125436630|NCT02778399|451224464|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
125638047|NCT01693562|451956179|FG017|Exploration Phase|Death|0|||
125638048|NCT01693562|451956180|FG018|Exploration Phase|Death|0|||
125638049|NCT01693562|451956181|FG019|Exploration Phase|Death|0|||
125638050|NCT01693562|451956182|FG020|Exploration Phase|Death|0|||
125638051|NCT01693562|451956183|FG021|Exploration Phase|Death|0|||
125638052|NCT01693562|451956184|FG022|Exploration Phase|Death|0|||
125638053|NCT01693562|451956162|FG000|Exploration Phase|Other|0|||
125638054|NCT01693562|451956163|FG001|Exploration Phase|Other|0|||
125638055|NCT01693562|451956164|FG002|Exploration Phase|Other|0|||
125638056|NCT01693562|451956165|FG003|Exploration Phase|Other|0|||
125638057|NCT01693562|451956166|FG004|Exploration Phase|Other|0|||
125638058|NCT01693562|451956167|FG005|Exploration Phase|Other|0|||
125638059|NCT01693562|451956168|FG006|Exploration Phase|Other|2|||
125638060|NCT01693562|451956169|FG007|Exploration Phase|Other|0|||
125638061|NCT01693562|451956170|FG008|Exploration Phase|Other|0|||
125638062|NCT01693562|451956171|FG009|Exploration Phase|Other|0|||
125638063|NCT01693562|451956172|FG010|Exploration Phase|Other|0|||
125638064|NCT01693562|451956173|FG011|Exploration Phase|Other|0|||
125638065|NCT01693562|451956174|FG012|Exploration Phase|Other|0|||
125131719|NCT00573443|450110039|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
125131720|NCT00573443|450110040|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
125131721|NCT00573443|450110041|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
125131722|NCT00573443|450110039|FG000|Open-Label Extension Phase|Protocol Violation|2|||
125131723|NCT00573443|450110040|FG001|Open-Label Extension Phase|Protocol Violation|0|||
125131724|NCT00573443|450110041|FG002|Open-Label Extension Phase|Protocol Violation|0|||
125131725|NCT00573443|450110039|FG000|Open-Label Extension Phase|Other|2|||
125436631|NCT02778399|451224465|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
125131726|NCT00573443|450110040|FG001|Open-Label Extension Phase|Other|0|||
125131727|NCT00573443|450110041|FG002|Open-Label Extension Phase|Other|0|||
125131728|NCT00804856|450110042|FG000|Overall Study|Progressive Disease|3|||
125131729|NCT00804856|450110043|FG001|Overall Study|Progressive Disease|2|||
125131730|NCT00804856|450110044|FG002|Overall Study|Progressive Disease|4|||
125131731|NCT00804856|450110045|FG003|Overall Study|Progressive Disease|6|||
125131732|NCT00804856|450110046|FG004|Overall Study|Progressive Disease|4|||
125131733|NCT00804856|450110047|FG005|Overall Study|Progressive Disease|1|||
125131734|NCT00804856|450110048|FG006|Overall Study|Progressive Disease|8|||
125131735|NCT00804856|450110049|FG007|Overall Study|Progressive Disease|2|||
125131736|NCT00804856|450110050|FG008|Overall Study|Progressive Disease|4|||
125131737|NCT00804856|450110051|FG009|Overall Study|Progressive Disease|5|||
125131738|NCT00804856|450110052|FG010|Overall Study|Progressive Disease|12|||
125131739|NCT00804856|450110053|FG011|Overall Study|Progressive Disease|2|||
125131740|NCT00804856|450110054|FG012|Overall Study|Progressive Disease|2|||
125131741|NCT00804856|450110055|FG013|Overall Study|Progressive Disease|26|||
125436632|NCT02778399|451224466|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
125131742|NCT00804856|450110056|FG014|Overall Study|Progressive Disease|20|||
125217750|NCT03130959|450425291|FG007|Overall Study|Not reported|0|||
125436633|NCT02778399|451224461|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
125638066|NCT01693562|451956175|FG013|Exploration Phase|Other|0|||
125638067|NCT01693562|451956176|FG014|Exploration Phase|Other|0|||
125638068|NCT01693562|451956177|FG015|Exploration Phase|Other|0|||
125638069|NCT01693562|451956178|FG016|Exploration Phase|Other|0|||
125638070|NCT01693562|451956179|FG017|Exploration Phase|Other|0|||
125638071|NCT01693562|451956180|FG018|Exploration Phase|Other|0|||
125638072|NCT01693562|451956181|FG019|Exploration Phase|Other|0|||
125131743|NCT00804856|450110042|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131744|NCT00804856|450110043|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125379215|NCT02743871|451019302|FG009|Overall Study|Lost to Follow-up|0|||
125379216|NCT02743871|451019303|FG010|Overall Study|Lost to Follow-up|0|||
125379217|NCT02743871|451019304|FG011|Overall Study|Lost to Follow-up|2|||
125379218|NCT02743871|451019305|FG012|Overall Study|Lost to Follow-up|0|||
125379219|NCT02743871|451019306|FG013|Overall Study|Lost to Follow-up|0|||
125379220|NCT02743871|451019293|FG000|Overall Study|Withdrawal by Subject|0|||
125379221|NCT02743871|451019294|FG001|Overall Study|Withdrawal by Subject|0|||
125379222|NCT02743871|451019295|FG002|Overall Study|Withdrawal by Subject|0|||
125379223|NCT02743871|451019296|FG003|Overall Study|Withdrawal by Subject|0|||
125379224|NCT02743871|451019297|FG004|Overall Study|Withdrawal by Subject|0|||
125379225|NCT02743871|451019298|FG005|Overall Study|Withdrawal by Subject|0|||
125379226|NCT02743871|451019299|FG006|Overall Study|Withdrawal by Subject|0|||
125379227|NCT02743871|451019300|FG007|Overall Study|Withdrawal by Subject|0|||
125379228|NCT02743871|451019301|FG008|Overall Study|Withdrawal by Subject|0|||
125379229|NCT02743871|451019302|FG009|Overall Study|Withdrawal by Subject|0|||
125379230|NCT02743871|451019303|FG010|Overall Study|Withdrawal by Subject|1|||
125379231|NCT02743871|451019304|FG011|Overall Study|Withdrawal by Subject|0|||
125379232|NCT02743871|451019305|FG012|Overall Study|Withdrawal by Subject|12|||
125379233|NCT02743871|451019306|FG013|Overall Study|Withdrawal by Subject|6|||
125379234|NCT02743871|451019293|FG000|Overall Study|Adverse Event|1|||
125379235|NCT02743871|451019294|FG001|Overall Study|Adverse Event|0|||
125379236|NCT02743871|451019295|FG002|Overall Study|Adverse Event|0|||
125379237|NCT02743871|451019296|FG003|Overall Study|Adverse Event|0|||
125379238|NCT02743871|451019297|FG004|Overall Study|Adverse Event|0|||
125379239|NCT02743871|451019298|FG005|Overall Study|Adverse Event|0|||
125379240|NCT02743871|451019299|FG006|Overall Study|Adverse Event|0|||
125379241|NCT02743871|451019300|FG007|Overall Study|Adverse Event|0|||
125379242|NCT02743871|451019301|FG008|Overall Study|Adverse Event|0|||
125379243|NCT02743871|451019302|FG009|Overall Study|Adverse Event|0|||
125379244|NCT02743871|451019303|FG010|Overall Study|Adverse Event|0|||
125379245|NCT02743871|451019304|FG011|Overall Study|Adverse Event|0|||
125379246|NCT02743871|451019305|FG012|Overall Study|Adverse Event|0|||
125379247|NCT02743871|451019306|FG013|Overall Study|Adverse Event|0|||
125379248|NCT02743871|451019293|FG000|Overall Study|Other|0|||
125379249|NCT02743871|451019294|FG001|Overall Study|Other|0|||
125379250|NCT02743871|451019295|FG002|Overall Study|Other|0|||
125379251|NCT02743871|451019296|FG003|Overall Study|Other|0|||
125379252|NCT02743871|451019297|FG004|Overall Study|Other|0|||
125379253|NCT02743871|451019298|FG005|Overall Study|Other|0|||
125379254|NCT02743871|451019299|FG006|Overall Study|Other|0|||
125379255|NCT02743871|451019300|FG007|Overall Study|Other|0|||
125379256|NCT02743871|451019301|FG008|Overall Study|Other|0|||
125379257|NCT02743871|451019302|FG009|Overall Study|Other|0|||
125379258|NCT02743871|451019303|FG010|Overall Study|Other|0|||
125379259|NCT02743871|451019304|FG011|Overall Study|Other|1|||
125379260|NCT02743871|451019305|FG012|Overall Study|Other|1|||
125379261|NCT02743871|451019306|FG013|Overall Study|Other|1|||
125379262|NCT02743871|451019293|FG000|Overall Study|Protocol Violation|0|||
125379263|NCT02743871|451019294|FG001|Overall Study|Protocol Violation|0|||
125379264|NCT02743871|451019295|FG002|Overall Study|Protocol Violation|0|||
125379265|NCT02743871|451019296|FG003|Overall Study|Protocol Violation|0|||
125379266|NCT02743871|451019297|FG004|Overall Study|Protocol Violation|0|||
125379267|NCT02743871|451019298|FG005|Overall Study|Protocol Violation|0|||
125379268|NCT02743871|451019299|FG006|Overall Study|Protocol Violation|0|||
125379269|NCT02743871|451019300|FG007|Overall Study|Protocol Violation|0|||
125379270|NCT02743871|451019301|FG008|Overall Study|Protocol Violation|0|||
125379271|NCT02743871|451019302|FG009|Overall Study|Protocol Violation|0|||
125379272|NCT02743871|451019303|FG010|Overall Study|Protocol Violation|0|||
125379273|NCT02743871|451019304|FG011|Overall Study|Protocol Violation|0|||
125379274|NCT02743871|451019305|FG012|Overall Study|Protocol Violation|2|||
125638073|NCT01693562|451956182|FG020|Exploration Phase|Other|0|||
125638074|NCT01693562|451956183|FG021|Exploration Phase|Other|0|||
125638075|NCT01693562|451956184|FG022|Exploration Phase|Other|0|||
125638076|NCT01693562|451956162|FG000|Expansion Phase|Withdrawal by Subject|0|||
125638077|NCT01693562|451956163|FG001|Expansion Phase|Withdrawal by Subject|0|||
125379275|NCT02743871|451019306|FG013|Overall Study|Protocol Violation|0|||
125379276|NCT02848651|451019311|FG000|Overall Study|Death|85|||
125379277|NCT02848651|451019311|FG000|Overall Study|Lost to Follow-up|1|||
125379278|NCT02848651|451019311|FG000|Overall Study|Non-Compliance|1|||
125379279|NCT02848651|451019311|FG000|Overall Study|Symptomatic Deterioration|1|||
125379280|NCT02848651|451019311|FG000|Overall Study|Physician Decision|4|||
125379281|NCT02848651|451019311|FG000|Overall Study|Withdrawal by Subject|14|||
125379282|NCT00897104|451019316|FG000|Overall Study|Lost to Follow-up|12|||
125379283|NCT00897104|451019317|FG001|Overall Study|Lost to Follow-up|17|||
125379284|NCT00897104|451019318|FG002|Overall Study|Lost to Follow-up|2|||
125379285|NCT00897104|451019316|FG000|Overall Study|Pregnancy|0|||
125379286|NCT00897104|451019317|FG001|Overall Study|Pregnancy|1|||
125379287|NCT00897104|451019318|FG002|Overall Study|Pregnancy|0|||
125379288|NCT00897104|451019316|FG000|Overall Study|Protocol Violation|0|||
125379289|NCT00897104|451019317|FG001|Overall Study|Protocol Violation|1|||
125379290|NCT00897104|451019318|FG002|Overall Study|Protocol Violation|0|||
125379291|NCT00897104|451019316|FG000|Overall Study|Withdrawal by Subject|23|||
125379292|NCT00897104|451019317|FG001|Overall Study|Withdrawal by Subject|27|||
125379293|NCT00897104|451019318|FG002|Overall Study|Withdrawal by Subject|3|||
125638078|NCT01693562|451956164|FG002|Expansion Phase|Withdrawal by Subject|0|||
125638079|NCT01693562|451956165|FG003|Expansion Phase|Withdrawal by Subject|0|||
125638080|NCT01693562|451956166|FG004|Expansion Phase|Withdrawal by Subject|0|||
125638081|NCT01693562|451956167|FG005|Expansion Phase|Withdrawal by Subject|0|||
125638082|NCT01693562|451956168|FG006|Expansion Phase|Withdrawal by Subject|0|||
125638083|NCT01693562|451956169|FG007|Expansion Phase|Withdrawal by Subject|16|||
125638084|NCT01693562|451956170|FG008|Expansion Phase|Withdrawal by Subject|2|||
125638085|NCT01693562|451956171|FG009|Expansion Phase|Withdrawal by Subject|54|||
125638086|NCT01693562|451956172|FG010|Expansion Phase|Withdrawal by Subject|2|||
125638087|NCT01693562|451956173|FG011|Expansion Phase|Withdrawal by Subject|2|||
125638088|NCT01693562|451956174|FG012|Expansion Phase|Withdrawal by Subject|3|||
125638089|NCT01693562|451956175|FG013|Expansion Phase|Withdrawal by Subject|5|||
125638090|NCT01693562|451956176|FG014|Expansion Phase|Withdrawal by Subject|16|||
125638091|NCT01693562|451956177|FG015|Expansion Phase|Withdrawal by Subject|7|||
125638092|NCT01693562|451956178|FG016|Expansion Phase|Withdrawal by Subject|40|||
125638093|NCT01693562|451956179|FG017|Expansion Phase|Withdrawal by Subject|4|||
125638094|NCT01693562|451956180|FG018|Expansion Phase|Withdrawal by Subject|8|||
125638095|NCT01693562|451956181|FG019|Expansion Phase|Withdrawal by Subject|3|||
125638096|NCT01693562|451956182|FG020|Expansion Phase|Withdrawal by Subject|1|||
125638097|NCT01693562|451956183|FG021|Expansion Phase|Withdrawal by Subject|8|||
125638098|NCT01693562|451956184|FG022|Expansion Phase|Withdrawal by Subject|1|||
125638099|NCT01693562|451956162|FG000|Expansion Phase|Death|0|||
125638100|NCT01693562|451956163|FG001|Expansion Phase|Death|0|||
125638101|NCT01693562|451956164|FG002|Expansion Phase|Death|0|||
125638102|NCT01693562|451956165|FG003|Expansion Phase|Death|0|||
125638103|NCT01693562|451956166|FG004|Expansion Phase|Death|0|||
125638104|NCT01693562|451956167|FG005|Expansion Phase|Death|0|||
125638105|NCT01693562|451956168|FG006|Expansion Phase|Death|0|||
125638106|NCT01693562|451956169|FG007|Expansion Phase|Death|42|||
125638107|NCT01693562|451956170|FG008|Expansion Phase|Death|17|||
125638108|NCT01693562|451956171|FG009|Expansion Phase|Death|208|||
125638109|NCT01693562|451956172|FG010|Expansion Phase|Death|30|||
125638110|NCT01693562|451956173|FG011|Expansion Phase|Death|8|||
125379294|NCT00897104|451019316|FG000|Overall Study|Abnormal Prestudy Labs|2|||
125379295|NCT00897104|451019317|FG001|Overall Study|Abnormal Prestudy Labs|0|||
125379296|NCT00897104|451019318|FG002|Overall Study|Abnormal Prestudy Labs|0|||
125379297|NCT00897104|451019316|FG000|Overall Study|Abnormal Baseline ECG|2|||
125379298|NCT00897104|451019317|FG001|Overall Study|Abnormal Baseline ECG|2|||
125379299|NCT00897104|451019318|FG002|Overall Study|Abnormal Baseline ECG|0|||
125638111|NCT01693562|451956174|FG012|Expansion Phase|Death|19|||
125379300|NCT00897104|451019316|FG000|Overall Study|Need for Concom. Med.|0|||
125379301|NCT00897104|451019317|FG001|Overall Study|Need for Concom. Med.|1|||
125379302|NCT00897104|451019318|FG002|Overall Study|Need for Concom. Med.|1|||
125638112|NCT01693562|451956175|FG013|Expansion Phase|Death|42|||
125638113|NCT01693562|451956176|FG014|Expansion Phase|Death|23|||
125638114|NCT01693562|451956177|FG015|Expansion Phase|Death|23|||
125638115|NCT01693562|451956178|FG016|Expansion Phase|Death|128|||
125638116|NCT01693562|451956179|FG017|Expansion Phase|Death|16|||
125638117|NCT01693562|451956180|FG018|Expansion Phase|Death|36|||
125638118|NCT01693562|451956181|FG019|Expansion Phase|Death|16|||
125638119|NCT01693562|451956182|FG020|Expansion Phase|Death|17|||
125638120|NCT01693562|451956183|FG021|Expansion Phase|Death|35|||
125638121|NCT01693562|451956184|FG022|Expansion Phase|Death|7|||
125638122|NCT01693562|451956162|FG000|Expansion Phase|Lost to Follow-up|0|||
125638123|NCT01693562|451956163|FG001|Expansion Phase|Lost to Follow-up|0|||
125436634|NCT02778399|451224462|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
125436635|NCT02778399|451224463|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
125436636|NCT02778399|451224464|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
125436637|NCT02778399|451224465|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
125436638|NCT02778399|451224466|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
125436639|NCT02778399|451224461|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
125436640|NCT02778399|451224462|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
125131745|NCT00804856|450110044|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125379303|NCT00897104|451019316|FG000|Overall Study|Lack of Migraine Attack|20|||
125379304|NCT00897104|451019317|FG001|Overall Study|Lack of Migraine Attack|22|||
125379305|NCT00897104|451019318|FG002|Overall Study|Lack of Migraine Attack|1|||
125379306|NCT00897104|451019316|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
125379307|NCT00897104|451019317|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
125379308|NCT00897104|451019318|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
125379309|NCT00897104|451019316|FG000|Overall Study|Other|3|||
125379310|NCT00897104|451019317|FG001|Overall Study|Other|0|||
125379311|NCT00897104|451019318|FG002|Overall Study|Other|0|||
125379312|NCT00897104|451019316|FG000|Overall Study|Protocol Violation|1|||
125379313|NCT00897104|451019317|FG001|Overall Study|Protocol Violation|0|||
125379314|NCT00897104|451019318|FG002|Overall Study|Protocol Violation|0|||
125379315|NCT00897104|451019316|FG000|Overall Study|Withdrawal by Subject|0|||
125379316|NCT00897104|451019317|FG001|Overall Study|Withdrawal by Subject|0|||
125379317|NCT00897104|451019318|FG002|Overall Study|Withdrawal by Subject|1|||
125379318|NCT01059799|451019321|FG000|Overall Study|Adverse Event|2|||
125379319|NCT01059799|451019322|FG001|Overall Study|Adverse Event|3|||
125379320|NCT01059799|451019321|FG000|Overall Study|Lack of Efficacy|1|||
125379321|NCT01059799|451019322|FG001|Overall Study|Lack of Efficacy|0|||
125379322|NCT01059799|451019321|FG000|Overall Study|Protocol Violation|3|||
125379323|NCT01059799|451019322|FG001|Overall Study|Protocol Violation|2|||
125379324|NCT01059799|451019321|FG000|Overall Study|Withdrawal criteria|13|||
125379325|NCT01059799|451019322|FG001|Overall Study|Withdrawal criteria|2|||
125379326|NCT01059799|451019321|FG000|Overall Study|Other|12|||
125379327|NCT01059799|451019322|FG001|Overall Study|Other|3|||
125379328|NCT00750204|451019323|FG000|Overall Study|study halted prematurely|1|||
125379329|NCT00750204|451019324|FG001|Overall Study|study halted prematurely|1|||
125379330|NCT00662363|451019325|FG000|Overall Study|Withdrawal by Subject|6|||
125379331|NCT00662363|451019326|FG001|Overall Study|Withdrawal by Subject|5|||
125379332|NCT00662363|451019325|FG000|Overall Study|Adverse Event|0|||
125379333|NCT00662363|451019326|FG001|Overall Study|Adverse Event|3|||
125379334|NCT00662363|451019325|FG000|Overall Study|Discharged early from rehab|4|||
125379335|NCT00662363|451019326|FG001|Overall Study|Discharged early from rehab|1|||
125379336|NCT00662363|451019325|FG000|Overall Study|Protocol Violation|1|||
125379337|NCT00662363|451019326|FG001|Overall Study|Protocol Violation|1|||
125379338|NCT01428453|451019327|FG000|Overall Study|Adverse Event|2|||
125379339|NCT01428453|451019328|FG001|Overall Study|Adverse Event|7|||
125379340|NCT01428453|451019327|FG000|Overall Study|Protocol Violation|1|||
125379341|NCT01428453|451019328|FG001|Overall Study|Protocol Violation|0|||
125379342|NCT01428453|451019327|FG000|Overall Study|Lost to Follow-up|0|||
125379343|NCT01428453|451019328|FG001|Overall Study|Lost to Follow-up|1|||
125379344|NCT01428453|451019327|FG000|Overall Study|Withdrawal by Subject|3|||
125379345|NCT01428453|451019328|FG001|Overall Study|Withdrawal by Subject|1|||
125379346|NCT02480114|451019334|FG000|Overall Study|Not completing surveys|3|||
125379347|NCT02480114|451019335|FG001|Overall Study|Not completing surveys|2|||
125379348|NCT02480114|451019334|FG000|Overall Study|Withdrawal by Subject|2|||
125379349|NCT02480114|451019335|FG001|Overall Study|Withdrawal by Subject|4|||
125379350|NCT02480114|451019334|FG000|Overall Study|Disease progression|3|||
125379351|NCT02480114|451019335|FG001|Overall Study|Disease progression|0|||
125379352|NCT02480114|451019334|FG000|Overall Study|Improper completion of survey|1|||
125379353|NCT02480114|451019335|FG001|Overall Study|Improper completion of survey|1|||
125379354|NCT02480114|451019334|FG000|Overall Study|Not eligible|0|||
125379355|NCT02480114|451019335|FG001|Overall Study|Not eligible|1|||
125379356|NCT01535053|451019336|FG000|Overall Study|Ineligible|1|||
125379357|NCT01535053|451019337|FG001|Overall Study|Ineligible|2|||
125379358|NCT00512707|451019338|FG000|Overall Study|Lost to Follow-up|5|||
125379359|NCT00512707|451019339|FG001|Overall Study|Lost to Follow-up|11|||
125379360|NCT00512707|451019338|FG000|Overall Study|Developed skin irritation|2|||
125379361|NCT00512707|451019339|FG001|Overall Study|Developed skin irritation|1|||
125379362|NCT00512707|451019338|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
125379363|NCT00512707|451019339|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
125131746|NCT00804856|450110045|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125379364|NCT00512707|451019338|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
125379365|NCT00512707|451019339|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
125379366|NCT04405037|451019340|FG000|Overall Study|Withdrawal by Subject|1|||
125379367|NCT04405037|451019341|FG001|Overall Study|Withdrawal by Subject|0|||
125379368|NCT04405037|451019340|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
125379369|NCT04405037|451019341|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
125436641|NCT02778399|451224463|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
125436642|NCT02778399|451224464|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
125436643|NCT02778399|451224465|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
125436644|NCT02778399|451224466|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
125436645|NCT02778399|451224461|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
125436646|NCT02778399|451224462|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
125436647|NCT02778399|451224463|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
125436648|NCT02778399|451224464|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
125436649|NCT02778399|451224465|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
125436650|NCT02778399|451224466|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
125436651|NCT02778399|451224461|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
125436652|NCT02778399|451224462|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
125436653|NCT02778399|451224463|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
125436654|NCT02778399|451224464|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
125436655|NCT02778399|451224465|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
125436656|NCT02778399|451224466|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
125436657|NCT02778399|451224461|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
125436658|NCT02778399|451224462|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
125436659|NCT02778399|451224463|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
125436660|NCT02778399|451224464|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
125436661|NCT02778399|451224465|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
125436662|NCT02778399|451224466|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
125436663|NCT02778399|451224461|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
125436664|NCT02778399|451224462|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
125436665|NCT02778399|451224463|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
125436666|NCT02778399|451224464|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
125436667|NCT02778399|451224465|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
125436668|NCT02778399|451224466|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
125436669|NCT02778399|451224461|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
125436670|NCT02778399|451224462|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
125436671|NCT02778399|451224463|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
125436672|NCT02778399|451224464|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
125436673|NCT02778399|451224465|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
125436674|NCT02778399|451224466|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
125436675|NCT02778399|451224461|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
125436676|NCT02778399|451224462|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
125436677|NCT02778399|451224463|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
125436678|NCT02778399|451224464|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
125436679|NCT02778399|451224465|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
125436680|NCT02778399|451224466|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
125436681|NCT02778399|451224461|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
125436682|NCT02778399|451224462|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
125436683|NCT02778399|451224463|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
125436684|NCT02778399|451224464|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
125436685|NCT02778399|451224465|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
125379370|NCT02759471|451019342|FG000|Overall Study|discomfort|2|||
125379371|NCT02879305|451019343|FG000|Overall Study|Investigator Site Closed|55|||
125379372|NCT02879305|451019344|FG001|Overall Study|Investigator Site Closed|57|||
125379373|NCT02879305|451019343|FG000|Overall Study|Withdrawal by Subject|44|||
125379374|NCT02879305|451019344|FG001|Overall Study|Withdrawal by Subject|42|||
125379375|NCT02879305|451019343|FG000|Overall Study|Lost to Follow-up|17|||
125379376|NCT02879305|451019344|FG001|Overall Study|Lost to Follow-up|12|||
125379377|NCT02879305|451019343|FG000|Overall Study|Other|1|||
125379378|NCT02879305|451019344|FG001|Overall Study|Other|0|||
125379379|NCT02329730|451021246|FG000|Overall Study|Protocol Violation|0|||
125379380|NCT02329730|451021247|FG001|Overall Study|Protocol Violation|0|||
125379381|NCT02329730|451021248|FG002|Overall Study|Protocol Violation|0|||
125379382|NCT02329730|451021249|FG003|Overall Study|Protocol Violation|0|||
125379383|NCT02329730|451021250|FG004|Overall Study|Protocol Violation|2|||
125379384|NCT02329730|451021251|FG005|Overall Study|Protocol Violation|2|||
125379385|NCT02329730|451021252|FG006|Overall Study|Protocol Violation|0|||
125379386|NCT02329730|451021253|FG007|Overall Study|Protocol Violation|0|||
125436686|NCT02778399|451224466|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
125436687|NCT02778399|451224461|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
125436688|NCT02778399|451224462|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
125436689|NCT02778399|451224463|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
125379387|NCT02329730|451021254|FG008|Overall Study|Protocol Violation|0|||
125379388|NCT02329730|451021255|FG009|Overall Study|Protocol Violation|0|||
125485436|NCT02240238|451412514|FG011|Phase 2|Disease progression|1|||
125436690|NCT02778399|451224464|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
125436691|NCT02778399|451224465|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
125436692|NCT02778399|451224466|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
125436693|NCT03916744|451224467|FG000|Overall Study|Withdrawal by Subject|0|||
125436694|NCT03916744|451224468|FG001|Overall Study|Withdrawal by Subject|1|||
125436695|NCT03916744|451224469|FG002|Overall Study|Withdrawal by Subject|2|||
125436696|NCT02936037|451226209|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
125436697|NCT02936037|451226210|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
125436698|NCT02936037|451226209|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
125436699|NCT02936037|451226210|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
125436700|NCT02936037|451226209|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
125436701|NCT02936037|451226210|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
125436702|NCT02936037|451226209|FG000|Double-Blind Treatment Period|Death|0|||
125436703|NCT02936037|451226210|FG001|Double-Blind Treatment Period|Death|1|||
125436704|NCT02936037|451226209|FG000|Double-Blind Treatment Period|Adverse Event|11|||
125436705|NCT02936037|451226210|FG001|Double-Blind Treatment Period|Adverse Event|11|||
125436706|NCT02936037|451226209|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
125436707|NCT02936037|451226210|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
125436708|NCT02936037|451226209|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125436709|NCT02936037|451226210|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
125436710|NCT02936037|451226209|FG000|Open Label Extension|Adverse Event|0|||
125436711|NCT02936037|451226210|FG001|Open Label Extension|Adverse Event|3|||
125436712|NCT02936037|451226209|FG000|Open Label Extension|Other|0|||
125436713|NCT02936037|451226210|FG001|Open Label Extension|Other|3|||
125436714|NCT02936037|451226209|FG000|Open Label Extension|Withdrawal by Subject|0|||
125436715|NCT02936037|451226210|FG001|Open Label Extension|Withdrawal by Subject|4|||
125436716|NCT04567693|451226211|FG000|Overall Study|Death|0|||
125436717|NCT04567693|451226212|FG001|Overall Study|Death|0|||
125436718|NCT04567693|451226213|FG002|Overall Study|Death|2|||
125436719|NCT04567693|451226211|FG000|Overall Study|Lost to Follow-up|1|||
125436720|NCT04567693|451226212|FG001|Overall Study|Lost to Follow-up|0|||
125436721|NCT04567693|451226213|FG002|Overall Study|Lost to Follow-up|2|||
125436722|NCT04567693|451226211|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
125436723|NCT04567693|451226212|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
125436724|NCT04567693|451226213|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
125436725|NCT03462706|451226214|FG000|Overall Study|Polyp was pedunculated|1|||
125436726|NCT03462706|451226215|FG001|Overall Study|Polyp was pedunculated|0|||
125436727|NCT03462706|451226216|FG002|Overall Study|Polyp was pedunculated|1|||
125436728|NCT03462706|451226217|FG003|Overall Study|Polyp was pedunculated|0|||
125436729|NCT03462706|451226214|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
125436730|NCT03462706|451226215|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
125436731|NCT03462706|451226216|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
125436732|NCT03462706|451226217|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
125436733|NCT04105972|451226222|FG000|Overall Study|Adverse Event|2|||
125436734|NCT04105972|451226223|FG001|Overall Study|Adverse Event|1|||
125436735|NCT01161472|451226224|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
125436736|NCT01161472|451226225|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
125436737|NCT01161472|451226226|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
125436738|NCT01161472|451226227|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
125436739|NCT00067990|451226236|FG000|Overall Study|Death|5|||
125436740|NCT00067990|451226237|FG001|Overall Study|Death|7|||
125436741|NCT00067990|451226236|FG000|Overall Study|ESRD, Non IF/TA|1|||
125436742|NCT00067990|451226237|FG001|Overall Study|ESRD, Non IF/TA|3|||
125436743|NCT00067990|451226236|FG000|Overall Study|Withdrawal by Subject|4|||
125436744|NCT00067990|451226237|FG001|Overall Study|Withdrawal by Subject|12|||
125436745|NCT01118455|451226238|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
125436746|NCT01118455|451226239|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
125436747|NCT03327402|451226244|FG000|Overall Study|Withdrawal by Subject|1|||
125436748|NCT03327402|451226244|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
125436749|NCT03810313|451226245|FG000|Overall Study|Study terminated by sponsor|164|||
125436750|NCT03810313|451226246|FG001|Overall Study|Study terminated by sponsor|159|||
125436751|NCT03810313|451226245|FG000|Overall Study|Subject decision|10|||
125436752|NCT03810313|451226246|FG001|Overall Study|Subject decision|11|||
125436753|NCT03810313|451226245|FG000|Overall Study|Lost to Follow-up|3|||
125436754|NCT03810313|451226246|FG001|Overall Study|Lost to Follow-up|3|||
125436755|NCT03810313|451226245|FG000|Overall Study|Adverse Event|2|||
125436756|NCT03810313|451226246|FG001|Overall Study|Adverse Event|1|||
125436757|NCT03810313|451226245|FG000|Overall Study|Death|2|||
125436758|NCT03810313|451226246|FG001|Overall Study|Death|1|||
125436759|NCT03810313|451226245|FG000|Overall Study|Physician Decision|0|||
125131747|NCT00804856|450110046|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125131748|NCT00804856|450110047|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131749|NCT00804856|450110048|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131750|NCT00804856|450110049|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131751|NCT00804856|450110050|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131752|NCT00804856|450110051|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131753|NCT00804856|450110052|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131754|NCT00804856|450110053|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131755|NCT00804856|450110054|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131756|NCT00804856|450110055|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125131757|NCT00804856|450110056|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125131758|NCT00804856|450110042|FG000|Overall Study|Other Adverse Event|1|||
125131759|NCT00804856|450110043|FG001|Overall Study|Other Adverse Event|1|||
125131760|NCT00804856|450110044|FG002|Overall Study|Other Adverse Event|1|||
125131761|NCT00804856|450110045|FG003|Overall Study|Other Adverse Event|2|||
125131762|NCT00804856|450110046|FG004|Overall Study|Other Adverse Event|2|||
125131763|NCT00804856|450110047|FG005|Overall Study|Other Adverse Event|1|||
125131764|NCT00804856|450110048|FG006|Overall Study|Other Adverse Event|3|||
125131765|NCT00804856|450110049|FG007|Overall Study|Other Adverse Event|0|||
125131766|NCT00804856|450110050|FG008|Overall Study|Other Adverse Event|0|||
125131767|NCT00804856|450110051|FG009|Overall Study|Other Adverse Event|1|||
125131768|NCT00804856|450110052|FG010|Overall Study|Other Adverse Event|5|||
125131769|NCT00804856|450110053|FG011|Overall Study|Other Adverse Event|2|||
125131770|NCT00804856|450110054|FG012|Overall Study|Other Adverse Event|0|||
125131771|NCT00804856|450110055|FG013|Overall Study|Other Adverse Event|6|||
125131772|NCT00804856|450110056|FG014|Overall Study|Other Adverse Event|13|||
125131773|NCT00804856|450110042|FG000|Overall Study|Non compliance with protocol|0|||
125131774|NCT00804856|450110043|FG001|Overall Study|Non compliance with protocol|0|||
125131775|NCT00804856|450110044|FG002|Overall Study|Non compliance with protocol|0|||
125131776|NCT00804856|450110045|FG003|Overall Study|Non compliance with protocol|0|||
125131777|NCT00804856|450110046|FG004|Overall Study|Non compliance with protocol|0|||
125131778|NCT00804856|450110047|FG005|Overall Study|Non compliance with protocol|0|||
125131779|NCT00804856|450110048|FG006|Overall Study|Non compliance with protocol|0|||
125131780|NCT00804856|450110049|FG007|Overall Study|Non compliance with protocol|0|||
125131781|NCT00804856|450110050|FG008|Overall Study|Non compliance with protocol|0|||
125131782|NCT00804856|450110051|FG009|Overall Study|Non compliance with protocol|0|||
125131783|NCT00804856|450110052|FG010|Overall Study|Non compliance with protocol|0|||
125131784|NCT00804856|450110053|FG011|Overall Study|Non compliance with protocol|0|||
125131785|NCT00804856|450110054|FG012|Overall Study|Non compliance with protocol|0|||
125131786|NCT00804856|450110055|FG013|Overall Study|Non compliance with protocol|2|||
125131787|NCT00804856|450110056|FG014|Overall Study|Non compliance with protocol|0|||
125131788|NCT00804856|450110042|FG000|Overall Study|Refused to continue medication|0|||
125131789|NCT00804856|450110043|FG001|Overall Study|Refused to continue medication|0|||
125131790|NCT00804856|450110044|FG002|Overall Study|Refused to continue medication|0|||
125131791|NCT00804856|450110045|FG003|Overall Study|Refused to continue medication|1|||
125131792|NCT00804856|450110046|FG004|Overall Study|Refused to continue medication|1|||
125131793|NCT00804856|450110047|FG005|Overall Study|Refused to continue medication|0|||
125131794|NCT00804856|450110048|FG006|Overall Study|Refused to continue medication|0|||
125131795|NCT00804856|450110049|FG007|Overall Study|Refused to continue medication|0|||
125131796|NCT00804856|450110050|FG008|Overall Study|Refused to continue medication|0|||
125131797|NCT00804856|450110051|FG009|Overall Study|Refused to continue medication|0|||
125217751|NCT03130959|450425292|FG008|Overall Study|Not reported|0|||
125217752|NCT03130959|450425293|FG009|Overall Study|Not reported|1|||
125379389|NCT02329730|451021256|FG010|Overall Study|Protocol Violation|0|||
125379390|NCT02329730|451021257|FG011|Overall Study|Protocol Violation|0|||
125379391|NCT02329730|451021246|FG000|Overall Study|Withdrawal by Subject|0|||
125379392|NCT02329730|451021247|FG001|Overall Study|Withdrawal by Subject|0|||
125379393|NCT02329730|451021248|FG002|Overall Study|Withdrawal by Subject|0|||
125379394|NCT02329730|451021249|FG003|Overall Study|Withdrawal by Subject|0|||
125379395|NCT02329730|451021250|FG004|Overall Study|Withdrawal by Subject|1|||
125379396|NCT02329730|451021251|FG005|Overall Study|Withdrawal by Subject|0|||
125131798|NCT00804856|450110052|FG010|Overall Study|Refused to continue medication|3|||
125131799|NCT00804856|450110053|FG011|Overall Study|Refused to continue medication|0|||
125131800|NCT00804856|450110054|FG012|Overall Study|Refused to continue medication|1|||
125131801|NCT00804856|450110055|FG013|Overall Study|Refused to continue medication|1|||
125131802|NCT00804856|450110056|FG014|Overall Study|Refused to continue medication|5|||
125131803|NCT00804856|450110042|FG000|Overall Study|Other reason than listed above|0|||
125131804|NCT00804856|450110043|FG001|Overall Study|Other reason than listed above|0|||
125131805|NCT00804856|450110044|FG002|Overall Study|Other reason than listed above|0|||
125131806|NCT00804856|450110045|FG003|Overall Study|Other reason than listed above|0|||
125131807|NCT00804856|450110046|FG004|Overall Study|Other reason than listed above|0|||
125131808|NCT00804856|450110047|FG005|Overall Study|Other reason than listed above|1|||
125131809|NCT00804856|450110048|FG006|Overall Study|Other reason than listed above|0|||
125131810|NCT00804856|450110049|FG007|Overall Study|Other reason than listed above|0|||
125131811|NCT00804856|450110050|FG008|Overall Study|Other reason than listed above|1|||
125379397|NCT02329730|451021252|FG006|Overall Study|Withdrawal by Subject|1|||
125379398|NCT02329730|451021253|FG007|Overall Study|Withdrawal by Subject|1|||
125379399|NCT02329730|451021254|FG008|Overall Study|Withdrawal by Subject|1|||
125379400|NCT02329730|451021255|FG009|Overall Study|Withdrawal by Subject|1|||
125379401|NCT02329730|451021256|FG010|Overall Study|Withdrawal by Subject|0|||
125379402|NCT02329730|451021257|FG011|Overall Study|Withdrawal by Subject|0|||
125379403|NCT03010254|451021260|FG000|Overall Study|Adverse Event|0|||
125379404|NCT03010254|451021261|FG001|Overall Study|Adverse Event|1|||
125379405|NCT03010254|451021260|FG000|Overall Study|Lost to Follow-up|4|||
125379406|NCT03010254|451021261|FG001|Overall Study|Lost to Follow-up|0|||
125379407|NCT03010254|451021260|FG000|Overall Study|Withdrawal by Subject|1|||
125379408|NCT03010254|451021261|FG001|Overall Study|Withdrawal by Subject|1|||
125379409|NCT03010254|451021260|FG000|Overall Study|Other|2|||
125379410|NCT03010254|451021261|FG001|Overall Study|Other|3|||
125379411|NCT01404325|451021262|FG000|Overall Study|Lost to Follow-up|1|||
125379412|NCT01404325|451021263|FG001|Overall Study|Lost to Follow-up|0|||
125379413|NCT01404325|451021262|FG000|Overall Study|Death|2|||
125379414|NCT01404325|451021263|FG001|Overall Study|Death|0|||
125379415|NCT01404325|451021262|FG000|Overall Study|Graft loss/Retransplantation|1|||
125379416|NCT01404325|451021263|FG001|Overall Study|Graft loss/Retransplantation|0|||
125379417|NCT01404325|451021262|FG000|Overall Study|non-specified reason|0|||
125379418|NCT01404325|451021263|FG001|Overall Study|non-specified reason|2|||
125379419|NCT02141282|451021269|FG000|Overall Study|Adverse event, not related to progression|8|||
125379420|NCT02141282|451021270|FG001|Overall Study|Adverse event, not related to progression|1|||
125379421|NCT02141282|451021271|FG002|Overall Study|Adverse event, not related to progression|3|||
125379422|NCT02141282|451021272|FG003|Overall Study|Adverse event, not related to progression|1|||
125379423|NCT02141282|451021269|FG000|Overall Study|Adverse event, related to progression|1|||
125379424|NCT02141282|451021270|FG001|Overall Study|Adverse event, related to progression|0|||
125379425|NCT02141282|451021271|FG002|Overall Study|Adverse event, related to progression|2|||
125379426|NCT02141282|451021272|FG003|Overall Study|Adverse event, related to progression|0|||
125379427|NCT02141282|451021269|FG000|Overall Study|COVID-19 infection|1|||
125379428|NCT02141282|451021270|FG001|Overall Study|COVID-19 infection|0|||
125379429|NCT02141282|451021271|FG002|Overall Study|COVID-19 infection|0|||
125379430|NCT02141282|451021272|FG003|Overall Study|COVID-19 infection|0|||
125379431|NCT02141282|451021269|FG000|Overall Study|Lost to Follow-up|0|||
125379432|NCT02141282|451021270|FG001|Overall Study|Lost to Follow-up|0|||
125379433|NCT02141282|451021271|FG002|Overall Study|Lost to Follow-up|4|||
125379434|NCT02141282|451021272|FG003|Overall Study|Lost to Follow-up|2|||
125379435|NCT02141282|451021269|FG000|Overall Study|Other, not specified|14|||
125379436|NCT02141282|451021270|FG001|Overall Study|Other, not specified|11|||
125379437|NCT02141282|451021271|FG002|Overall Study|Other, not specified|23|||
125379438|NCT02141282|451021272|FG003|Overall Study|Other, not specified|9|||
125379439|NCT02141282|451021269|FG000|Overall Study|Progressive disease, Richter's|4|||
125379440|NCT02141282|451021270|FG001|Overall Study|Progressive disease, Richter's|1|||
125379441|NCT02141282|451021271|FG002|Overall Study|Progressive disease, Richter's|1|||
125379442|NCT02141282|451021272|FG003|Overall Study|Progressive disease, Richter's|1|||
125379443|NCT02141282|451021269|FG000|Overall Study|Progressive disease per protocol|12|||
125379444|NCT02141282|451021270|FG001|Overall Study|Progressive disease per protocol|7|||
125379445|NCT02141282|451021271|FG002|Overall Study|Progressive disease per protocol|9|||
125379446|NCT02141282|451021272|FG003|Overall Study|Progressive disease per protocol|2|||
125379447|NCT02141282|451021269|FG000|Overall Study|Stem cell transplant|1|||
125379448|NCT02141282|451021270|FG001|Overall Study|Stem cell transplant|0|||
125379449|NCT02141282|451021271|FG002|Overall Study|Stem cell transplant|1|||
125379450|NCT02141282|451021272|FG003|Overall Study|Stem cell transplant|0|||
125379451|NCT02141282|451021269|FG000|Overall Study|Study terminated by Sponsor|0|||
125379452|NCT02141282|451021270|FG001|Overall Study|Study terminated by Sponsor|1|||
125379453|NCT02141282|451021271|FG002|Overall Study|Study terminated by Sponsor|0|||
125379454|NCT02141282|451021272|FG003|Overall Study|Study terminated by Sponsor|0|||
125379455|NCT02141282|451021269|FG000|Overall Study|Subject non-compliance|0|||
125379456|NCT02141282|451021270|FG001|Overall Study|Subject non-compliance|0|||
125379457|NCT02141282|451021271|FG002|Overall Study|Subject non-compliance|1|||
125379458|NCT02141282|451021272|FG003|Overall Study|Subject non-compliance|0|||
125436760|NCT03810313|451226246|FG001|Overall Study|Physician Decision|1|||
125217753|NCT03130959|450425284|FG000|Overall Study|Adverse Event unrelated to drug|0|||
125379459|NCT02141282|451021269|FG000|Overall Study|Withdrew consent|2|||
125436761|NCT00422799|451226249|FG000|Overall Study|Withdrawal by Subject|6|||
125436762|NCT00422799|451226249|FG000|Overall Study|Adverse Event|7|||
125379460|NCT02141282|451021270|FG001|Overall Study|Withdrew consent|0|||
125379461|NCT02141282|451021271|FG002|Overall Study|Withdrew consent|4|||
125379462|NCT02141282|451021272|FG003|Overall Study|Withdrew consent|0|||
125379463|NCT03312933|451021273|FG000|Overall Study|Protocol Violation|15|||
125379464|NCT03312933|451021273|FG000|Overall Study|Lost to Follow-up|36|||
125436763|NCT03029780|451226251|FG000|Overall Study|Disease Progression|20|||
125379465|NCT03312933|451021273|FG000|Overall Study|Withdrawal by Subject|3|||
125379466|NCT00224055|451021279|FG000|Overall Study|Adverse Event|9|||
125379467|NCT00224055|451021280|FG001|Overall Study|Adverse Event|3|||
125638124|NCT01693562|451956164|FG002|Expansion Phase|Lost to Follow-up|0|||
125638125|NCT01693562|451956165|FG003|Expansion Phase|Lost to Follow-up|0|||
125638126|NCT01693562|451956166|FG004|Expansion Phase|Lost to Follow-up|0|||
125638127|NCT01693562|451956167|FG005|Expansion Phase|Lost to Follow-up|0|||
125638128|NCT01693562|451956168|FG006|Expansion Phase|Lost to Follow-up|0|||
125638129|NCT01693562|451956169|FG007|Expansion Phase|Lost to Follow-up|1|||
125638130|NCT01693562|451956170|FG008|Expansion Phase|Lost to Follow-up|2|||
125638131|NCT01693562|451956171|FG009|Expansion Phase|Lost to Follow-up|10|||
125638132|NCT01693562|451956172|FG010|Expansion Phase|Lost to Follow-up|4|||
125638133|NCT01693562|451956173|FG011|Expansion Phase|Lost to Follow-up|4|||
125638134|NCT01693562|451956174|FG012|Expansion Phase|Lost to Follow-up|1|||
125638135|NCT01693562|451956175|FG013|Expansion Phase|Lost to Follow-up|3|||
125638136|NCT01693562|451956176|FG014|Expansion Phase|Lost to Follow-up|0|||
125638137|NCT01693562|451956177|FG015|Expansion Phase|Lost to Follow-up|1|||
125638138|NCT01693562|451956178|FG016|Expansion Phase|Lost to Follow-up|1|||
125638139|NCT01693562|451956179|FG017|Expansion Phase|Lost to Follow-up|0|||
125638140|NCT01693562|451956180|FG018|Expansion Phase|Lost to Follow-up|2|||
125638141|NCT01693562|451956181|FG019|Expansion Phase|Lost to Follow-up|1|||
125638142|NCT01693562|451956182|FG020|Expansion Phase|Lost to Follow-up|2|||
125638143|NCT01693562|451956183|FG021|Expansion Phase|Lost to Follow-up|2|||
125638144|NCT01693562|451956184|FG022|Expansion Phase|Lost to Follow-up|1|||
125638145|NCT01693562|451956162|FG000|Expansion Phase|Other|0|||
125638146|NCT01693562|451956163|FG001|Expansion Phase|Other|0|||
125638147|NCT01693562|451956164|FG002|Expansion Phase|Other|0|||
125638148|NCT01693562|451956165|FG003|Expansion Phase|Other|0|||
125638149|NCT01693562|451956166|FG004|Expansion Phase|Other|0|||
125638150|NCT01693562|451956167|FG005|Expansion Phase|Other|0|||
125638151|NCT01693562|451956168|FG006|Expansion Phase|Other|0|||
125638152|NCT01693562|451956169|FG007|Expansion Phase|Other|3|||
125638153|NCT01693562|451956170|FG008|Expansion Phase|Other|1|||
125638154|NCT01693562|451956171|FG009|Expansion Phase|Other|28|||
125638155|NCT01693562|451956172|FG010|Expansion Phase|Other|4|||
125638156|NCT01693562|451956173|FG011|Expansion Phase|Other|7|||
125131812|NCT00804856|450110051|FG009|Overall Study|Other reason than listed above|0|||
125131813|NCT00804856|450110052|FG010|Overall Study|Other reason than listed above|3|||
125131814|NCT00804856|450110053|FG011|Overall Study|Other reason than listed above|1|||
125131815|NCT00804856|450110054|FG012|Overall Study|Other reason than listed above|1|||
125131816|NCT00804856|450110055|FG013|Overall Study|Other reason than listed above|10|||
125131817|NCT00804856|450110056|FG014|Overall Study|Other reason than listed above|3|||
125131818|NCT00418561|450110057|FG000|Overall Study|Participant's (guardian's) decision|0|||
125131819|NCT00418561|450110058|FG001|Overall Study|Participant's (guardian's) decision|1|||
125131820|NCT00418561|450110059|FG002|Overall Study|Participant's (guardian's) decision|0|||
125131821|NCT01796171|450110060|FG000|Enrolled|Death|0|||
125131822|NCT01796171|450110061|FG001|Enrolled|Death|0|||
125131823|NCT01796171|450110062|FG002|Enrolled|Death|0|||
125131824|NCT01796171|450110063|FG003|Enrolled|Death|0|||
125131825|NCT01796171|450110064|FG004|Enrolled|Death|0|||
125131826|NCT01796171|450110065|FG005|Enrolled|Death|0|||
125638157|NCT01693562|451956174|FG012|Expansion Phase|Other|0|||
125131827|NCT01796171|450110066|FG006|Enrolled|Death|0|||
125638158|NCT01693562|451956175|FG013|Expansion Phase|Other|1|||
125638159|NCT01693562|451956176|FG014|Expansion Phase|Other|1|||
125638160|NCT01693562|451956177|FG015|Expansion Phase|Other|0|||
125638161|NCT01693562|451956178|FG016|Expansion Phase|Other|28|||
125638162|NCT01693562|451956179|FG017|Expansion Phase|Other|0|||
125638163|NCT01693562|451956180|FG018|Expansion Phase|Other|1|||
125638164|NCT01693562|451956181|FG019|Expansion Phase|Other|0|||
125131828|NCT01796171|450110067|FG007|Enrolled|Death|0|||
125131829|NCT01796171|450110068|FG008|Enrolled|Death|0|||
125131830|NCT01796171|450110069|FG009|Enrolled|Death|0|||
125131831|NCT01796171|450110070|FG010|Enrolled|Death|0|||
125131832|NCT01796171|450110071|FG011|Enrolled|Death|0|||
125131833|NCT01796171|450110072|FG012|Enrolled|Death|0|||
125131834|NCT01796171|450110073|FG013|Enrolled|Death|0|||
125131835|NCT01796171|450110074|FG014|Enrolled|Death|1|||
125131836|NCT01796171|450110060|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
125131837|NCT01796171|450110061|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
125131838|NCT01796171|450110062|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
125131839|NCT01796171|450110063|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
125131840|NCT01796171|450110064|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
125131841|NCT01796171|450110065|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
125131842|NCT01796171|450110066|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
125131843|NCT01796171|450110067|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
125131844|NCT01796171|450110068|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
125638165|NCT01693562|451956182|FG020|Expansion Phase|Other|1|||
125638166|NCT01693562|451956183|FG021|Expansion Phase|Other|17|||
125638167|NCT01693562|451956184|FG022|Expansion Phase|Other|1|||
125638168|NCT05815758|451956189|FG000|Overall Study|Adverse Event|6|||
125638169|NCT05815758|451956190|FG001|Overall Study|Adverse Event|2|||
125638170|NCT05815758|451956189|FG000|Overall Study|Lost to Follow-up|14|||
125638171|NCT05815758|451956190|FG001|Overall Study|Lost to Follow-up|1|||
125638172|NCT05815758|451956189|FG000|Overall Study|Withdrawal by Subject|6|||
125638173|NCT05815758|451956190|FG001|Overall Study|Withdrawal by Subject|6|||
125131845|NCT01796171|450110069|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
125131846|NCT01796171|450110070|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
125131847|NCT01796171|450110071|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
125131848|NCT01796171|450110072|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
125131849|NCT01796171|450110073|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
125131850|NCT01796171|450110074|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
125379468|NCT00224055|451021279|FG000|Overall Study|Lost to Follow-up|1|||
125379469|NCT00224055|451021280|FG001|Overall Study|Lost to Follow-up|2|||
125379470|NCT00224055|451021279|FG000|Overall Study|Protocol Violation|1|||
125379471|NCT00224055|451021280|FG001|Overall Study|Protocol Violation|1|||
125379472|NCT00224055|451021279|FG000|Overall Study|Inclusion Violation|3|||
125379473|NCT00224055|451021280|FG001|Overall Study|Inclusion Violation|6|||
125379474|NCT00224055|451021279|FG000|Overall Study|Withdrawal by Subject|0|||
125379475|NCT00224055|451021280|FG001|Overall Study|Withdrawal by Subject|2|||
125379476|NCT00224055|451021279|FG000|Overall Study|Other|1|||
125379477|NCT00224055|451021280|FG001|Overall Study|Other|0|||
125379478|NCT02068443|451021281|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125379479|NCT02068443|451021282|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
125379480|NCT02068443|451021283|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
125379481|NCT02068443|451021281|FG000|Overall Study|Voluntary Withdrawal|4|||
125379482|NCT02068443|451021282|FG001|Overall Study|Voluntary Withdrawal|0|||
125379483|NCT02068443|451021283|FG002|Overall Study|Voluntary Withdrawal|1|||
125379484|NCT02068443|451021281|FG000|Overall Study|Lack of Efficacy|2|||
125379485|NCT02068443|451021282|FG001|Overall Study|Lack of Efficacy|1|||
125379486|NCT02068443|451021283|FG002|Overall Study|Lack of Efficacy|0|||
125379487|NCT02068443|451021281|FG000|Overall Study|Other Reason Not Specified|1|||
125379488|NCT02068443|451021282|FG001|Overall Study|Other Reason Not Specified|0|||
125379489|NCT02068443|451021283|FG002|Overall Study|Other Reason Not Specified|0|||
125638174|NCT05815758|451956189|FG000|Overall Study|Protocol Violation|1|||
125638175|NCT05815758|451956190|FG001|Overall Study|Protocol Violation|1|||
125638176|NCT05815758|451956189|FG000|Overall Study|Discontinued|4|||
125638177|NCT05815758|451956190|FG001|Overall Study|Discontinued|4|||
125379490|NCT00664742|451021284|FG000|Overall Study|Withdrawn due to adverse events|3|||
125638178|NCT02987205|451956191|FG000|Overall Study|Adverse Event|1|||
125638179|NCT02987205|451956191|FG000|Overall Study|Withdrawal by Subject|3|||
125131851|NCT01796171|450110060|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131852|NCT01796171|450110061|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125379491|NCT00664742|451021284|FG000|Overall Study|Withdrawal by Subject|31|||
125379492|NCT00664742|451021284|FG000|Overall Study|Lost to Follow-up|92|||
125379493|NCT01986855|451021285|FG000|Overall Study|Adverse Event|1|||
125379494|NCT01986855|451021286|FG001|Overall Study|Adverse Event|0|||
125379495|NCT01986855|451021287|FG002|Overall Study|Adverse Event|0|||
125379496|NCT01986855|451021285|FG000|Overall Study|Death|3|||
125379497|NCT01986855|451021286|FG001|Overall Study|Death|4|||
125379498|NCT01986855|451021287|FG002|Overall Study|Death|4|||
125379499|NCT01986855|451021285|FG000|Overall Study|Lost to Follow-up|2|||
125379500|NCT01986855|451021286|FG001|Overall Study|Lost to Follow-up|1|||
125379501|NCT01986855|451021287|FG002|Overall Study|Lost to Follow-up|0|||
125379502|NCT01986855|451021285|FG000|Overall Study|Screen Failure|0|||
125379503|NCT01986855|451021286|FG001|Overall Study|Screen Failure|1|||
125379504|NCT01986855|451021287|FG002|Overall Study|Screen Failure|0|||
125379505|NCT01986855|451021285|FG000|Overall Study|Participant Moved|0|||
125379506|NCT01986855|451021286|FG001|Overall Study|Participant Moved|0|||
125379507|NCT01986855|451021287|FG002|Overall Study|Participant Moved|2|||
125379508|NCT01986855|451021285|FG000|Overall Study|Withdrawal by Subject|7|||
125379509|NCT01986855|451021286|FG001|Overall Study|Withdrawal by Subject|8|||
125379510|NCT01986855|451021287|FG002|Overall Study|Withdrawal by Subject|5|||
125379511|NCT04317066|451021288|FG000|Overall Study|Sponsor decision|5|||
125379512|NCT04317066|451021288|FG000|Overall Study|Death|2|||
125379513|NCT00710710|451021289|FG000|Overall Study|Consent withdrawn|2|||
125379514|NCT00710710|451021290|FG001|Overall Study|Consent withdrawn|2|||
125379515|NCT00710710|451021289|FG000|Overall Study|Protocol Violation|0|||
125379516|NCT00710710|451021290|FG001|Overall Study|Protocol Violation|1|||
125379517|NCT00710710|451021289|FG000|Overall Study|Adverse Event|3|||
125379518|NCT00710710|451021290|FG001|Overall Study|Adverse Event|3|||
125379519|NCT00710710|451021289|FG000|Overall Study|Progressive disease|40|||
125379520|NCT00710710|451021290|FG001|Overall Study|Progressive disease|38|||
125379521|NCT00715078|451021291|FG000|Overall Study|Death|29|||
125379522|NCT00715078|451021292|FG001|Overall Study|Death|36|||
125379523|NCT00715078|451021293|FG002|Overall Study|Death|36|||
125379524|NCT00715078|451021291|FG000|Overall Study|Withdrawal by Subject|1|||
125379525|NCT00715078|451021292|FG001|Overall Study|Withdrawal by Subject|0|||
125379526|NCT00715078|451021293|FG002|Overall Study|Withdrawal by Subject|1|||
125379527|NCT00715078|451021291|FG000|Overall Study|Unable to start due to disease prog.|0|||
125379528|NCT00715078|451021292|FG001|Overall Study|Unable to start due to disease prog.|0|||
125379529|NCT00715078|451021293|FG002|Overall Study|Unable to start due to disease prog.|1|||
125379530|NCT03263442|451021299|FG000|Inpatient Phase|Death|1|||
125379531|NCT03263442|451021300|FG001|Inpatient Phase|Death|0|||
125638180|NCT04167514|451956196|FG000|Overall Study|Adverse event, not serious|0|||
125436764|NCT03029780|451226252|FG001|Overall Study|Disease Progression|22|||
125436765|NCT03029780|451226251|FG000|Overall Study|Study Drug Toxicity|15|||
125436766|NCT03029780|451226252|FG001|Overall Study|Study Drug Toxicity|11|||
125436767|NCT03029780|451226251|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
125436768|NCT03029780|451226252|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
125436769|NCT03029780|451226251|FG000|Overall Study|Participant request to discontinue study treatment|4|||
125436770|NCT03029780|451226252|FG001|Overall Study|Participant request to discontinue study treatment|1|||
125436771|NCT03029780|451226251|FG000|Overall Study|Maximum clinical benefit|1|||
125436772|NCT03029780|451226252|FG001|Overall Study|Maximum clinical benefit|0|||
125436773|NCT03029780|451226251|FG000|Overall Study|Participant no longer meets study criteria|0|||
125436774|NCT03029780|451226252|FG001|Overall Study|Participant no longer meets study criteria|1|||
125436775|NCT03029780|451226251|FG000|Overall Study|Other reasons|6|||
125436776|NCT03029780|451226252|FG001|Overall Study|Other reasons|6|||
125436777|NCT03029780|451226251|FG000|Overall Study|Not reported|1|||
125436778|NCT03029780|451226252|FG001|Overall Study|Not reported|1|||
125436779|NCT03029780|451226251|FG000|Overall Study|Death|2|||
125436780|NCT03029780|451226252|FG001|Overall Study|Death|6|||
125436781|NCT03560258|451226253|FG000|Overall Study|Lost to Follow-up|3|||
125436782|NCT03560258|451226254|FG001|Overall Study|Lost to Follow-up|0|||
125436783|NCT03560258|451226255|FG002|Overall Study|Lost to Follow-up|0|||
125436784|NCT03560258|451226253|FG000|Overall Study|Protocol Violation|0|||
125436785|NCT03560258|451226254|FG001|Overall Study|Protocol Violation|1|||
125436786|NCT03560258|451226255|FG002|Overall Study|Protocol Violation|0|||
125436787|NCT03560258|451226253|FG000|Overall Study|Withdrawal by Subject|0|||
125436788|NCT03560258|451226254|FG001|Overall Study|Withdrawal by Subject|0|||
125436789|NCT03560258|451226255|FG002|Overall Study|Withdrawal by Subject|1|||
125436790|NCT04498247|451226258|FG000|Overall Study|Lost to Follow-up|0|||
125436791|NCT04498247|451226259|FG001|Overall Study|Lost to Follow-up|0|||
125436792|NCT04498247|451226260|FG002|Overall Study|Lost to Follow-up|0|||
125436793|NCT04498247|451226261|FG003|Overall Study|Lost to Follow-up|1|||
125436794|NCT04498247|451226262|FG004|Overall Study|Lost to Follow-up|0|||
125436795|NCT04498247|451226263|FG005|Overall Study|Lost to Follow-up|0|||
125436796|NCT04498247|451226264|FG006|Overall Study|Lost to Follow-up|0|||
125638181|NCT04167514|451956197|FG001|Overall Study|Adverse event, not serious|1|||
125638182|NCT04167514|451956196|FG000|Overall Study|Lost to Follow-up|1|||
125638183|NCT04167514|451956197|FG001|Overall Study|Lost to Follow-up|0|||
125638184|NCT04167514|451956196|FG000|Overall Study|Participant Decision|2|||
125638185|NCT04167514|451956197|FG001|Overall Study|Participant Decision|4|||
125638186|NCT04167514|451956196|FG000|Overall Study|Physician Decision|3|||
125638187|NCT04167514|451956197|FG001|Overall Study|Physician Decision|2|||
125131853|NCT01796171|450110062|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131854|NCT01796171|450110063|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131855|NCT01796171|450110064|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131856|NCT01796171|450110065|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131857|NCT01796171|450110066|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131858|NCT01796171|450110067|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131859|NCT01796171|450110068|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131860|NCT01796171|450110069|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131861|NCT01796171|450110070|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131862|NCT01796171|450110071|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131863|NCT01796171|450110072|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131864|NCT01796171|450110073|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
125131865|NCT01796171|450110074|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
125131866|NCT01796171|450110060|FG000|Treatment Period With Betalutin|Progressive disease|0|||
125436797|NCT04498247|451226265|FG007|Overall Study|Lost to Follow-up|0|||
125436798|NCT04498247|451226258|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
125436799|NCT04498247|451226259|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
125638188|NCT04167514|451956196|FG000|Overall Study|Death|14|||
125638189|NCT04167514|451956197|FG001|Overall Study|Death|18|||
125379532|NCT03263442|451021299|FG000|Inpatient Phase|Withdrawal by Subject|1|||
125379533|NCT03263442|451021300|FG001|Inpatient Phase|Withdrawal by Subject|0|||
125379534|NCT03263442|451021299|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
125379535|NCT03263442|451021300|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
125379536|NCT03263442|451021299|FG000|1-month Follow-Up|Lost to Follow-up|1|||
125379537|NCT03263442|451021300|FG001|1-month Follow-Up|Lost to Follow-up|0|||
125379538|NCT03263442|451021299|FG000|3-month Follow-Up|Lost to Follow-up|1|||
125379539|NCT03263442|451021300|FG001|3-month Follow-Up|Lost to Follow-up|3|||
125379540|NCT03263442|451021299|FG000|6-month Follow-Up|Lost to Follow-up|2|||
125379541|NCT03263442|451021300|FG001|6-month Follow-Up|Lost to Follow-up|2|||
125379542|NCT01463878|451021301|FG000|Overall Study|no longer met criteria for tube feed|2|||
125379543|NCT01463878|451021302|FG001|Overall Study|no longer met criteria for tube feed|2|||
125379544|NCT03804879|451021303|FG000|Overall Study|Adverse Event|3|||
125379545|NCT03804879|451021304|FG001|Overall Study|Adverse Event|0|||
125379546|NCT03804879|451021303|FG000|Overall Study|Study Terminated By Sponsor|10|||
125379547|NCT03804879|451021304|FG001|Overall Study|Study Terminated By Sponsor|12|||
125379548|NCT03804879|451021303|FG000|Overall Study|Withdrawal by Subject|3|||
125379549|NCT03804879|451021304|FG001|Overall Study|Withdrawal by Subject|1|||
125379550|NCT01585428|451021305|FG000|Overall Study|Death during treatment|1|||
125379551|NCT01585428|451021306|FG001|Overall Study|Death during treatment|0|||
125379552|NCT01084174|451021307|FG000|Overall Study|gastrointestinal symptoms|1|||
125379553|NCT01084174|451021308|FG001|Overall Study|gastrointestinal symptoms|1|||
125379554|NCT01084174|451021307|FG000|Overall Study|Eosinophilic esophagitis|0|||
125379555|NCT01084174|451021308|FG001|Overall Study|Eosinophilic esophagitis|1|||
125379556|NCT01084174|451021307|FG000|Overall Study|Anaphylaxis|0|||
125379557|NCT01084174|451021308|FG001|Overall Study|Anaphylaxis|1|||
125379558|NCT01084174|451021307|FG000|Overall Study|Participant noncompliance|0|||
125379559|NCT01084174|451021308|FG001|Overall Study|Participant noncompliance|1|||
125379560|NCT00333866|451021311|FG000|Overall Study|Adverse Event|23|||
125379561|NCT00333866|451021312|FG001|Overall Study|Adverse Event|37|||
125379562|NCT00333866|451021313|FG002|Overall Study|Adverse Event|38|||
125379563|NCT00333866|451021314|FG003|Overall Study|Adverse Event|47|||
125379564|NCT00333866|451021311|FG000|Overall Study|Other|3|||
125379565|NCT00333866|451021312|FG001|Overall Study|Other|2|||
125379566|NCT00333866|451021313|FG002|Overall Study|Other|2|||
125379567|NCT00333866|451021314|FG003|Overall Study|Other|2|||
125379568|NCT00333866|451021311|FG000|Overall Study|Lack of Efficacy|8|||
125379569|NCT00333866|451021312|FG001|Overall Study|Lack of Efficacy|6|||
125379570|NCT00333866|451021313|FG002|Overall Study|Lack of Efficacy|3|||
125379571|NCT00333866|451021314|FG003|Overall Study|Lack of Efficacy|5|||
125379572|NCT00333866|451021311|FG000|Overall Study|Lost to Follow-up|1|||
125379573|NCT00333866|451021312|FG001|Overall Study|Lost to Follow-up|2|||
125379574|NCT00333866|451021313|FG002|Overall Study|Lost to Follow-up|2|||
125379575|NCT00333866|451021314|FG003|Overall Study|Lost to Follow-up|2|||
125379576|NCT00333866|451021311|FG000|Overall Study|Withdrawal by Subject|8|||
125379577|NCT00333866|451021312|FG001|Overall Study|Withdrawal by Subject|14|||
125379578|NCT00333866|451021313|FG002|Overall Study|Withdrawal by Subject|4|||
125379579|NCT00333866|451021314|FG003|Overall Study|Withdrawal by Subject|9|||
125379580|NCT00333866|451021311|FG000|Overall Study|Randomized but not Treated|5|||
125379581|NCT00333866|451021312|FG001|Overall Study|Randomized but not Treated|3|||
125379582|NCT00333866|451021313|FG002|Overall Study|Randomized but not Treated|2|||
125379583|NCT00333866|451021314|FG003|Overall Study|Randomized but not Treated|1|||
125379584|NCT01359449|451021317|FG000|Overall Study|Lost to Follow-up|1|||
125379585|NCT01359449|451021318|FG001|Overall Study|Lost to Follow-up|0|||
125379586|NCT01359449|451021317|FG000|Overall Study|Protocol Violation|0|||
125379587|NCT01359449|451021318|FG001|Overall Study|Protocol Violation|2|||
125379588|NCT01359449|451021317|FG000|Overall Study|Withdrawal by Subject|3|||
125379589|NCT01359449|451021318|FG001|Overall Study|Withdrawal by Subject|2|||
125379590|NCT02393547|451021322|FG000|Overall Study|Adverse Event|2|||
125379591|NCT02393547|451021322|FG000|Overall Study|Withdrawal by Subject|3|||
125379592|NCT02393547|451021322|FG000|Overall Study|Lost to Follow-up|1|||
125379593|NCT00673465|451021323|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
125379594|NCT00673465|451021324|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
125379595|NCT00673465|451021325|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
125379596|NCT00673465|451021326|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
125379597|NCT00673465|451021327|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
125379598|NCT00673465|451021328|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
125379599|NCT00673465|451021329|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
125379600|NCT00673465|451021330|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
125379601|NCT00673465|451021331|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
125379602|NCT00673465|451021332|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
125379603|NCT00673465|451021333|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
125379604|NCT00673465|451021334|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
125379605|NCT00673465|451021323|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
125379606|NCT00673465|451021324|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
125379607|NCT00673465|451021325|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
125379608|NCT00673465|451021326|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
125379609|NCT00673465|451021327|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
125638190|NCT04167514|451956196|FG000|Overall Study|Enrolled but treatment not administered|2|||
125638191|NCT04167514|451956197|FG001|Overall Study|Enrolled but treatment not administered|0|||
125638192|NCT04167514|451956196|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
125638193|NCT04167514|451956197|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
125638194|NCT04167514|451956196|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
125638195|NCT04167514|451956197|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
125638196|NCT03991936|451956198|FG000|Overall Study|Lost to Follow-up|1|||
125638197|NCT03991936|451956199|FG001|Overall Study|Lost to Follow-up|1|||
125638198|NCT03991936|451956200|FG002|Overall Study|Lost to Follow-up|1|||
125638199|NCT03991936|451956201|FG003|Overall Study|Lost to Follow-up|1|||
125638200|NCT03991936|451956202|FG004|Overall Study|Lost to Follow-up|1|||
125638201|NCT00939055|451956203|FG000|Overall Study|Discontinuation prior to procedure|4|||
125638202|NCT00939055|451956204|FG001|Overall Study|Discontinuation prior to procedure|0|||
125638203|NCT00584987|451956207|FG000|Overall Study|Protocol Violation|1|||
125638204|NCT00584987|451956208|FG001|Overall Study|Protocol Violation|1|||
125638205|NCT00584987|451956209|FG002|Overall Study|Protocol Violation|1|||
125638206|NCT00584987|451956210|FG003|Overall Study|Protocol Violation|0|||
125638207|NCT00584987|451956207|FG000|Overall Study|Adverse Event|0|||
125638208|NCT00584987|451956208|FG001|Overall Study|Adverse Event|0|||
125638209|NCT00584987|451956209|FG002|Overall Study|Adverse Event|0|||
125638210|NCT00584987|451956210|FG003|Overall Study|Adverse Event|1|||
125638211|NCT02881151|451956211|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
125638212|NCT03225833|451956212|FG000|Overall Study|Adverse Event|0|||
125638213|NCT03225833|451956213|FG001|Overall Study|Adverse Event|1|||
125217754|NCT03130959|450425285|FG001|Overall Study|Adverse Event unrelated to drug|0|||
125379610|NCT00673465|451021328|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
125379611|NCT00673465|451021329|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
125638214|NCT03225833|451956214|FG002|Overall Study|Adverse Event|2|||
125379612|NCT00673465|451021330|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
125379613|NCT00673465|451021331|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
125379614|NCT00673465|451021332|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
125379615|NCT00673465|451021333|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
125379616|NCT00673465|451021334|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
125379617|NCT01829191|451021335|FG000|Overall Study|Relocation|0|||
125379618|NCT01829191|451021336|FG001|Overall Study|Relocation|1|||
125379619|NCT01829191|451021335|FG000|Overall Study|Lens discomfort|0|||
125379620|NCT01829191|451021336|FG001|Overall Study|Lens discomfort|3|||
125379621|NCT01829191|451021335|FG000|Overall Study|Lens handling difficulty|1|||
125379622|NCT01829191|451021336|FG001|Overall Study|Lens handling difficulty|4|||
125379623|NCT01829191|451021335|FG000|Overall Study|Protocol Violation|4|||
125379624|NCT01829191|451021336|FG001|Overall Study|Protocol Violation|1|||
125379625|NCT01829191|451021335|FG000|Overall Study|Withdrawal by Subject|2|||
125379626|NCT01829191|451021336|FG001|Overall Study|Withdrawal by Subject|3|||
125379627|NCT01829191|451021335|FG000|Overall Study|Lost to Follow-up|0|||
125379628|NCT01829191|451021336|FG001|Overall Study|Lost to Follow-up|1|||
125379629|NCT01829191|451021335|FG000|Overall Study|Subject was fit for ortho - k|0|||
125379630|NCT01829191|451021336|FG001|Overall Study|Subject was fit for ortho - k|1|||
125379631|NCT00429104|451021337|FG000|Overall Study|Protocol Violation|1|||
125379632|NCT00726661|451021338|FG000|Overall Study|Lost to Follow-up|36|||
125379633|NCT00726661|451021339|FG001|Overall Study|Lost to Follow-up|11|||
125379634|NCT00726661|451021338|FG000|Overall Study|Withdrawal by Subject|17|||
125379635|NCT00726661|451021339|FG001|Overall Study|Withdrawal by Subject|13|||
125379636|NCT00726661|451021338|FG000|Overall Study|Trial terminated by sponsor|214|||
125379637|NCT00726661|451021339|FG001|Overall Study|Trial terminated by sponsor|187|||
125379638|NCT00726661|451021338|FG000|Overall Study|Death|475|||
125379639|NCT00726661|451021339|FG001|Overall Study|Death|159|||
125379640|NCT00726661|451021338|FG000|Overall Study|Physician Decision|25|||
125379641|NCT00726661|451021339|FG001|Overall Study|Physician Decision|13|||
125379642|NCT00726661|451021338|FG000|Overall Study|Other|47|||
125379643|NCT00726661|451021339|FG001|Overall Study|Other|35|||
125379644|NCT01285310|451021340|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
125379645|NCT01285310|451021341|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
125379646|NCT01285310|451021342|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
125379647|NCT01285310|451021343|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
125379648|NCT01285310|451021344|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
125379649|NCT01285310|451021340|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
125379650|NCT01285310|451021341|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
125379651|NCT01285310|451021342|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
125379652|NCT01285310|451021343|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
125379653|NCT01285310|451021344|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
125379654|NCT01285310|451021340|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
125379655|NCT01285310|451021341|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
125379656|NCT01285310|451021342|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
125379657|NCT01285310|451021343|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
125379658|NCT01285310|451021344|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
125379659|NCT01285310|451021340|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
125379660|NCT01285310|451021341|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
125379661|NCT01285310|451021342|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
125485437|NCT02240238|451412503|FG000|Phase 2|Withdrawal by Subject|0|||
125638215|NCT03225833|451956215|FG003|Overall Study|Adverse Event|0|||
125638216|NCT03225833|451956216|FG004|Overall Study|Adverse Event|0|||
125638217|NCT03225833|451956217|FG005|Overall Study|Adverse Event|2|||
125638218|NCT03225833|451956212|FG000|Overall Study|Withdrawal by Subject|1|||
125638219|NCT03225833|451956213|FG001|Overall Study|Withdrawal by Subject|0|||
125638220|NCT03225833|451956214|FG002|Overall Study|Withdrawal by Subject|0|||
125638221|NCT03225833|451956215|FG003|Overall Study|Withdrawal by Subject|0|||
125638222|NCT03225833|451956216|FG004|Overall Study|Withdrawal by Subject|1|||
125638223|NCT03225833|451956217|FG005|Overall Study|Withdrawal by Subject|0|||
125638224|NCT03225833|451956212|FG000|Overall Study|Termination of Study by Sponsor|4|||
125638225|NCT03225833|451956213|FG001|Overall Study|Termination of Study by Sponsor|0|||
125638226|NCT03225833|451956214|FG002|Overall Study|Termination of Study by Sponsor|0|||
125638227|NCT03225833|451956215|FG003|Overall Study|Termination of Study by Sponsor|0|||
125638228|NCT03225833|451956216|FG004|Overall Study|Termination of Study by Sponsor|0|||
125638229|NCT03225833|451956217|FG005|Overall Study|Termination of Study by Sponsor|7|||
125638230|NCT03225833|451956212|FG000|Overall Study|Sponsor Decision|0|||
125638231|NCT03225833|451956213|FG001|Overall Study|Sponsor Decision|0|||
125638232|NCT03225833|451956214|FG002|Overall Study|Sponsor Decision|0|||
125638233|NCT03225833|451956215|FG003|Overall Study|Sponsor Decision|0|||
125638234|NCT03225833|451956216|FG004|Overall Study|Sponsor Decision|0|||
125379662|NCT01285310|451021343|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
125379663|NCT01285310|451021344|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
125638235|NCT03225833|451956217|FG005|Overall Study|Sponsor Decision|1|||
125379664|NCT01285310|451021340|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
125379665|NCT01285310|451021341|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
125379666|NCT01285310|451021342|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
125379667|NCT01285310|451021343|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
125379668|NCT01285310|451021344|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
125379669|NCT01285310|451021340|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
125379670|NCT01285310|451021341|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
125379671|NCT01285310|451021342|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
125379672|NCT01285310|451021343|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
125379673|NCT01285310|451021344|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
125379674|NCT01285310|451021340|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
125379675|NCT01285310|451021341|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
125379676|NCT01285310|451021342|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
125379677|NCT01285310|451021343|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
125379678|NCT01285310|451021344|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
125379679|NCT01285310|451021340|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
125379680|NCT01285310|451021341|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
125379681|NCT01285310|451021342|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
125379682|NCT01285310|451021343|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
125379683|NCT01285310|451021344|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
125379684|NCT01285310|451021340|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
125379685|NCT01285310|451021341|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
125379686|NCT01285310|451021342|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
125379687|NCT01285310|451021343|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
125379688|NCT01285310|451021344|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
125379689|NCT01285310|451021340|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
125379690|NCT01285310|451021341|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
125379691|NCT01285310|451021342|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
125379692|NCT01285310|451021343|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
125379693|NCT01285310|451021344|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
125379694|NCT01285310|451021340|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
125379695|NCT01285310|451021341|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
125379696|NCT01285310|451021342|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
125379697|NCT01285310|451021343|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
125379698|NCT01285310|451021344|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
125379699|NCT01285310|451021340|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
125379700|NCT01285310|451021341|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
125379701|NCT01285310|451021342|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
125379702|NCT01285310|451021343|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
125379703|NCT01285310|451021344|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
125379704|NCT00143403|451021345|FG000|Overall Study|Adverse Event|3|||
125379705|NCT00143403|451021346|FG001|Overall Study|Adverse Event|8|||
125379706|NCT00143403|451021345|FG000|Overall Study|Death|1|||
125379707|NCT00143403|451021346|FG001|Overall Study|Death|0|||
125379708|NCT00143403|451021345|FG000|Overall Study|Withdrawal by Subject|3|||
125379709|NCT00143403|451021346|FG001|Overall Study|Withdrawal by Subject|12|||
125379710|NCT00143403|451021345|FG000|Overall Study|Relapse|15|||
125379711|NCT00143403|451021346|FG001|Overall Study|Relapse|7|||
125379712|NCT00143403|451021345|FG000|Overall Study|Protocol Violation|2|||
125379713|NCT00143403|451021346|FG001|Overall Study|Protocol Violation|2|||
125379714|NCT00143403|451021345|FG000|Overall Study|specified by site|4|||
125379715|NCT00143403|451021346|FG001|Overall Study|specified by site|9|||
125379716|NCT00143403|451021345|FG000|Overall Study|Randomized Not Treated|7|||
125379717|NCT00143403|451021346|FG001|Overall Study|Randomized Not Treated|8|||
125379718|NCT00514540|451021347|FG000|First-Line Chemo|Withdrawal by Subject|1|||
125436800|NCT04498247|451226260|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
125436801|NCT04498247|451226261|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
125638236|NCT03258593|451956218|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
125638237|NCT03258593|451956219|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
125638238|NCT03258593|451956220|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
125638239|NCT03258593|451956221|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
125638240|NCT03258593|451956218|FG000|Run-In Maintenance Phase|Disease progression|3|||
125638241|NCT03258593|451956219|FG001|Run-In Maintenance Phase|Disease progression|0|||
125638242|NCT03258593|451956220|FG002|Run-In Maintenance Phase|Disease progression|0|||
125638243|NCT03258593|451956221|FG003|Run-In Maintenance Phase|Disease progression|0|||
125638244|NCT03258593|451956218|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
125638245|NCT03258593|451956219|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
125638246|NCT03258593|451956220|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
125638247|NCT03258593|451956221|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
125436802|NCT04498247|451226262|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
125436803|NCT04498247|451226263|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
125436804|NCT04498247|451226264|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
125436805|NCT04498247|451226265|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
125436806|NCT04498247|451226258|FG000|Overall Study|Withdrawal by Subject|0|||
125436807|NCT04498247|451226259|FG001|Overall Study|Withdrawal by Subject|8|||
125436808|NCT04498247|451226260|FG002|Overall Study|Withdrawal by Subject|0|||
125436809|NCT04498247|451226261|FG003|Overall Study|Withdrawal by Subject|7|||
125436810|NCT04498247|451226262|FG004|Overall Study|Withdrawal by Subject|0|||
125436811|NCT04498247|451226263|FG005|Overall Study|Withdrawal by Subject|0|||
125436812|NCT04498247|451226264|FG006|Overall Study|Withdrawal by Subject|1|||
125436813|NCT04498247|451226265|FG007|Overall Study|Withdrawal by Subject|0|||
125436814|NCT04498247|451226258|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
125436815|NCT04498247|451226259|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
125436816|NCT04498247|451226260|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
125436817|NCT04498247|451226261|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
125436818|NCT04498247|451226262|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
125436819|NCT04498247|451226263|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
125436820|NCT04498247|451226264|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
125436821|NCT04498247|451226265|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
125436822|NCT02086162|451226266|FG000|Overall Study|Withdrawal by Subject|4|||
125379719|NCT00514540|451021347|FG000|First-Line Chemo|Protocol Violation|7|||
125379720|NCT00514540|451021347|FG000|Second-Line|Physician/Patient Decision|31|||
125379721|NCT03402386|451021348|FG000|Overall Study|Adverse Event|3|||
125379722|NCT03402386|451021348|FG000|Overall Study|Physician Decision|1|||
125379723|NCT03402386|451021348|FG000|Overall Study|Difficult to control Hb|2|||
125379724|NCT00587639|451021349|FG000|Overall Study|Withdrawal by Subject|1|||
125379725|NCT01996982|451021352|FG000|Overall Study|PI/team left institution|7|||
125436823|NCT02086162|451226267|FG001|Overall Study|Withdrawal by Subject|4|||
125436824|NCT02086162|451226266|FG000|Overall Study|moved|1|||
125436825|NCT02086162|451226267|FG001|Overall Study|moved|1|||
125436826|NCT02086162|451226266|FG000|Overall Study|Lost to Follow-up|4|||
125436827|NCT02086162|451226267|FG001|Overall Study|Lost to Follow-up|2|||
125436828|NCT02086162|451226266|FG000|Overall Study|Death|1|||
125436829|NCT02086162|451226267|FG001|Overall Study|Death|0|||
125638248|NCT03258593|451956218|FG000|Expansion Maintenance Phase|Physician Decision|0|||
125638249|NCT03258593|451956219|FG001|Expansion Maintenance Phase|Physician Decision|1|||
125379726|NCT01574326|451021353|FG000|Overall Study|Randomized but not treated|0|||
125379727|NCT01574326|451021354|FG001|Overall Study|Randomized but not treated|1|||
125379728|NCT01574326|451021353|FG000|Overall Study|Withdrawal by Participant|2|||
125379729|NCT01574326|451021354|FG001|Overall Study|Withdrawal by Participant|4|||
125436830|NCT01248962|451226268|FG000|Overall Study|Withdrawal by Subject|1|||
125436831|NCT01248962|451226269|FG001|Overall Study|Withdrawal by Subject|1|||
125436832|NCT01248962|451226268|FG000|Overall Study|Adverse Event|2|||
125436833|NCT01248962|451226269|FG001|Overall Study|Adverse Event|1|||
125436834|NCT01248962|451226268|FG000|Overall Study|Complete Response after 4 Cycles|1|||
125436835|NCT01248962|451226269|FG001|Overall Study|Complete Response after 4 Cycles|0|||
125638250|NCT03258593|451956220|FG002|Expansion Maintenance Phase|Physician Decision|0|||
125638251|NCT03258593|451956221|FG003|Expansion Maintenance Phase|Physician Decision|0|||
125638252|NCT05318183|451956222|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
125638253|NCT05318183|451956223|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
125638254|NCT05318183|451956222|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
125638255|NCT05318183|451956223|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
125638256|NCT01263470|451956238|FG000|Overall Study|Adverse Event|2|||
125638257|NCT01263470|451956239|FG001|Overall Study|Adverse Event|2|||
125638258|NCT01263470|451956240|FG002|Overall Study|Adverse Event|1|||
125217755|NCT03130959|450425286|FG002|Overall Study|Adverse Event unrelated to drug|1|||
125217756|NCT03130959|450425287|FG003|Overall Study|Adverse Event unrelated to drug|1|||
125217757|NCT03130959|450425288|FG004|Overall Study|Adverse Event unrelated to drug|1|||
125217758|NCT03130959|450425289|FG005|Overall Study|Adverse Event unrelated to drug|0|||
125217759|NCT03130959|450425290|FG006|Overall Study|Adverse Event unrelated to drug|1|||
125217760|NCT03130959|450425291|FG007|Overall Study|Adverse Event unrelated to drug|0|||
125217761|NCT03130959|450425292|FG008|Overall Study|Adverse Event unrelated to drug|1|||
125217762|NCT03130959|450425293|FG009|Overall Study|Adverse Event unrelated to drug|1|||
125217763|NCT03130959|450425284|FG000|Overall Study|Participant withdrew consent|0|||
125217764|NCT03130959|450425285|FG001|Overall Study|Participant withdrew consent|1|||
125217765|NCT03130959|450425286|FG002|Overall Study|Participant withdrew consent|0|||
125217766|NCT03130959|450425287|FG003|Overall Study|Participant withdrew consent|2|||
125217767|NCT03130959|450425288|FG004|Overall Study|Participant withdrew consent|1|||
125217768|NCT03130959|450425289|FG005|Overall Study|Participant withdrew consent|0|||
125379730|NCT01574326|451021353|FG000|Overall Study|Physician Decision|5|||
125379731|NCT01574326|451021354|FG001|Overall Study|Physician Decision|3|||
125379732|NCT01574326|451021353|FG000|Overall Study|Adverse Event|1|||
125638259|NCT01263470|451956241|FG003|Overall Study|Adverse Event|1|||
125638260|NCT01263470|451956242|FG004|Overall Study|Adverse Event|2|||
125638261|NCT01263470|451956243|FG005|Overall Study|Adverse Event|2|||
125638262|NCT01263470|451956238|FG000|Overall Study|Protocol Violation|0|||
125638263|NCT01263470|451956239|FG001|Overall Study|Protocol Violation|1|||
125638264|NCT01263470|451956240|FG002|Overall Study|Protocol Violation|0|||
125638265|NCT01263470|451956241|FG003|Overall Study|Protocol Violation|0|||
125638266|NCT01263470|451956242|FG004|Overall Study|Protocol Violation|0|||
125638267|NCT01263470|451956243|FG005|Overall Study|Protocol Violation|1|||
125638268|NCT01263470|451956238|FG000|Overall Study|Withdrawal by Subject|0|||
125638269|NCT01263470|451956239|FG001|Overall Study|Withdrawal by Subject|1|||
125638270|NCT01263470|451956240|FG002|Overall Study|Withdrawal by Subject|1|||
125638271|NCT01263470|451956241|FG003|Overall Study|Withdrawal by Subject|2|||
125638272|NCT01263470|451956242|FG004|Overall Study|Withdrawal by Subject|0|||
125638273|NCT01263470|451956243|FG005|Overall Study|Withdrawal by Subject|2|||
125638274|NCT01263470|451956238|FG000|Overall Study|Lack of Efficacy|0|||
125638275|NCT01263470|451956239|FG001|Overall Study|Lack of Efficacy|0|||
125638276|NCT01263470|451956240|FG002|Overall Study|Lack of Efficacy|2|||
125638277|NCT01263470|451956241|FG003|Overall Study|Lack of Efficacy|0|||
125638278|NCT01263470|451956242|FG004|Overall Study|Lack of Efficacy|0|||
125638279|NCT01263470|451956243|FG005|Overall Study|Lack of Efficacy|0|||
125638280|NCT01263470|451956238|FG000|Overall Study|Participant Unavailability|0|||
125638281|NCT01263470|451956239|FG001|Overall Study|Participant Unavailability|1|||
125638282|NCT01263470|451956240|FG002|Overall Study|Participant Unavailability|0|||
125638283|NCT01263470|451956241|FG003|Overall Study|Participant Unavailability|0|||
125638284|NCT01263470|451956242|FG004|Overall Study|Participant Unavailability|0|||
125638285|NCT01263470|451956243|FG005|Overall Study|Participant Unavailability|0|||
125638286|NCT01263470|451956238|FG000|Overall Study|Study Drug Non-compliance|0|||
125638287|NCT01263470|451956239|FG001|Overall Study|Study Drug Non-compliance|0|||
125638288|NCT01263470|451956240|FG002|Overall Study|Study Drug Non-compliance|0|||
125379733|NCT01574326|451021354|FG001|Overall Study|Adverse Event|3|||
125379734|NCT01574326|451021353|FG000|Overall Study|Other: Mainly kidney transplant|8|||
125638289|NCT01263470|451956241|FG003|Overall Study|Study Drug Non-compliance|0|||
125638290|NCT01263470|451956242|FG004|Overall Study|Study Drug Non-compliance|1|||
125379735|NCT01574326|451021354|FG001|Overall Study|Other: Mainly kidney transplant|8|||
125379736|NCT01195415|451021373|FG000|Overall Study|No repeat biopsy due to progression|2|||
125379737|NCT00533845|451021374|FG000|Overall Study|Physician Decision|1|||
125379738|NCT00533845|451021375|FG001|Overall Study|Physician Decision|0|||
125379739|NCT02452398|451021376|FG000|Overall Study|Adverse Event|1|||
125379740|NCT02452398|451021376|FG000|Overall Study|Lost to Follow-up|28|||
125379741|NCT02452398|451021376|FG000|Overall Study|Physician Decision|2|||
125379742|NCT02452398|451021376|FG000|Overall Study|Withdrawal by Subject|6|||
125379743|NCT02452398|451021376|FG000|Overall Study|Moved away|4|||
125379744|NCT01957644|451021379|FG000|Overall Study|Adverse Event|4|||
125379745|NCT01957644|451021380|FG001|Overall Study|Adverse Event|2|||
125379746|NCT01957644|451021381|FG002|Overall Study|Adverse Event|0|||
125379747|NCT01957644|451021382|FG003|Overall Study|Adverse Event|0|||
125379748|NCT01957644|451021383|FG004|Overall Study|Adverse Event|1|||
125379749|NCT01957644|451021379|FG000|Overall Study|Progressive disease / relapse|0|||
125379750|NCT01957644|451021380|FG001|Overall Study|Progressive disease / relapse|1|||
125379751|NCT01957644|451021381|FG002|Overall Study|Progressive disease / relapse|0|||
125379752|NCT01957644|451021382|FG003|Overall Study|Progressive disease / relapse|1|||
125379753|NCT01957644|451021383|FG004|Overall Study|Progressive disease / relapse|0|||
125379754|NCT01957644|451021379|FG000|Overall Study|Other reason|1|||
125379755|NCT01957644|451021380|FG001|Overall Study|Other reason|2|||
125379756|NCT01957644|451021381|FG002|Overall Study|Other reason|1|||
125379757|NCT01957644|451021382|FG003|Overall Study|Other reason|1|||
125379758|NCT01957644|451021383|FG004|Overall Study|Other reason|0|||
125379759|NCT01957644|451021379|FG000|Overall Study|Withdrawal by Subject|1|||
125379760|NCT01957644|451021380|FG001|Overall Study|Withdrawal by Subject|0|||
125379761|NCT01957644|451021381|FG002|Overall Study|Withdrawal by Subject|0|||
125379762|NCT01957644|451021382|FG003|Overall Study|Withdrawal by Subject|0|||
125379763|NCT01957644|451021383|FG004|Overall Study|Withdrawal by Subject|0|||
125638291|NCT01263470|451956243|FG005|Overall Study|Study Drug Non-compliance|0|||
125638292|NCT00610714|451956244|FG000|Overall Study|Adverse Event|3|||
125379764|NCT01957644|451021379|FG000|Overall Study|Protocol Violation|0|||
125379765|NCT01957644|451021380|FG001|Overall Study|Protocol Violation|1|||
125638293|NCT00610714|451956245|FG001|Overall Study|Adverse Event|1|||
125638294|NCT00610714|451956244|FG000|Overall Study|Death|12|||
125638295|NCT00610714|451956245|FG001|Overall Study|Death|18|||
125638296|NCT00610714|451956244|FG000|Overall Study|Withdrawal by Subject|9|||
125638297|NCT00610714|451956245|FG001|Overall Study|Withdrawal by Subject|3|||
125638298|NCT00610714|451956244|FG000|Overall Study|Study completion at 120 PFS events|2|||
125638299|NCT00610714|451956245|FG001|Overall Study|Study completion at 120 PFS events|2|||
125638300|NCT01327573|451956246|FG000|Overall Study|Physician Decision|3|||
125638301|NCT01327573|451956247|FG001|Overall Study|Physician Decision|1|||
125638302|NCT00712712|451956248|FG000|Overall Study|Protocol Violation|11|||
125638303|NCT00712712|451956248|FG000|Overall Study|Radiofrequency not done|3|||
125638304|NCT00712712|451956248|FG000|Overall Study|Death|8|||
125638305|NCT00712712|451956248|FG000|Overall Study|Withdrawal by Subject|1|||
125638306|NCT01058395|451956252|FG000|Overall Study|Death|2|||
125638307|NCT01058395|451956253|FG001|Overall Study|Death|1|||
125638308|NCT01058395|451956252|FG000|Overall Study|Lost to Follow-up|1|||
125638309|NCT01058395|451956253|FG001|Overall Study|Lost to Follow-up|0|||
125638310|NCT04083781|451956254|FG000|Main Part|Physician Decision|0|||
125638311|NCT04083781|451956255|FG001|Main Part|Physician Decision|1|||
125638312|NCT04083781|451956256|FG002|Main Part|Physician Decision|2|||
125638313|NCT04083781|451956257|FG003|Main Part|Physician Decision|0|||
125638314|NCT04083781|451956254|FG000|Main Part|Death|1|||
125638315|NCT04083781|451956255|FG001|Main Part|Death|3|||
125638316|NCT04083781|451956256|FG002|Main Part|Death|1|||
125638317|NCT04083781|451956257|FG003|Main Part|Death|0|||
125638318|NCT04083781|451956254|FG000|Main Part|Withdrawal by Subject|5|||
125638319|NCT04083781|451956255|FG001|Main Part|Withdrawal by Subject|2|||
125638320|NCT04083781|451956256|FG002|Main Part|Withdrawal by Subject|3|||
125638321|NCT04083781|451956257|FG003|Main Part|Withdrawal by Subject|7|||
125638322|NCT04083781|451956254|FG000|Extension Part|Physician Decision|0|||
125638323|NCT04083781|451956255|FG001|Extension Part|Physician Decision|0|||
125638324|NCT04083781|451956256|FG002|Extension Part|Physician Decision|0|||
125638325|NCT04083781|451956257|FG003|Extension Part|Physician Decision|1|||
125638326|NCT04083781|451956254|FG000|Extension Part|Death|0|||
125638327|NCT04083781|451956255|FG001|Extension Part|Death|1|||
125638328|NCT04083781|451956256|FG002|Extension Part|Death|0|||
125638329|NCT04083781|451956257|FG003|Extension Part|Death|1|||
125638330|NCT04083781|451956254|FG000|Extension Part|Withdrawal by Subject|0|||
125638331|NCT04083781|451956255|FG001|Extension Part|Withdrawal by Subject|1|||
125638332|NCT04083781|451956256|FG002|Extension Part|Withdrawal by Subject|0|||
125217769|NCT03130959|450425290|FG006|Overall Study|Participant withdrew consent|0|||
125638333|NCT04083781|451956257|FG003|Extension Part|Withdrawal by Subject|0|||
125638334|NCT04083781|451956254|FG000|Extension Part|Ongoing|13|||
125638335|NCT04083781|451956255|FG001|Extension Part|Ongoing|25|||
125638336|NCT04083781|451956256|FG002|Extension Part|Ongoing|15|||
125638337|NCT04083781|451956257|FG003|Extension Part|Ongoing|51|||
125638338|NCT01602822|451956266|FG000|Overall Study|Adverse Event|11|||
125638339|NCT05492877|451956267|FG000|Overall Study|Adverse Event|11|||
125379766|NCT01957644|451021381|FG002|Overall Study|Protocol Violation|0|||
125638340|NCT05492877|451956268|FG001|Overall Study|Adverse Event|7|||
125638341|NCT05492877|451956267|FG000|Overall Study|Death|1|||
125638342|NCT05492877|451956268|FG001|Overall Study|Death|0|||
125217770|NCT03130959|450425291|FG007|Overall Study|Participant withdrew consent|0|||
125217771|NCT03130959|450425292|FG008|Overall Study|Participant withdrew consent|0|||
125131867|NCT01796171|450110061|FG001|Treatment Period With Betalutin|Progressive disease|1|||
125131868|NCT01796171|450110062|FG002|Treatment Period With Betalutin|Progressive disease|0|||
125131869|NCT01796171|450110063|FG003|Treatment Period With Betalutin|Progressive disease|0|||
125131870|NCT01796171|450110064|FG004|Treatment Period With Betalutin|Progressive disease|0|||
125131871|NCT01796171|450110065|FG005|Treatment Period With Betalutin|Progressive disease|0|||
125131872|NCT01796171|450110066|FG006|Treatment Period With Betalutin|Progressive disease|0|||
125131873|NCT01796171|450110067|FG007|Treatment Period With Betalutin|Progressive disease|0|||
125131874|NCT01796171|450110068|FG008|Treatment Period With Betalutin|Progressive disease|0|||
125131875|NCT01796171|450110069|FG009|Treatment Period With Betalutin|Progressive disease|0|||
125131876|NCT01796171|450110070|FG010|Treatment Period With Betalutin|Progressive disease|0|||
125131877|NCT01796171|450110071|FG011|Treatment Period With Betalutin|Progressive disease|0|||
125131878|NCT01796171|450110072|FG012|Treatment Period With Betalutin|Progressive disease|0|||
125131879|NCT01796171|450110073|FG013|Treatment Period With Betalutin|Progressive disease|0|||
125131880|NCT01796171|450110074|FG014|Treatment Period With Betalutin|Progressive disease|0|||
125131881|NCT01796171|450110060|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131882|NCT01796171|450110061|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131883|NCT01796171|450110062|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131884|NCT01796171|450110063|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131885|NCT01796171|450110064|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131886|NCT01796171|450110065|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131887|NCT01796171|450110066|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125217772|NCT03130959|450425293|FG009|Overall Study|Participant withdrew consent|2|||
125217773|NCT03130959|450425284|FG000|Overall Study|Administrative reason by sponsor|1|||
125379767|NCT01957644|451021382|FG003|Overall Study|Protocol Violation|0|||
125379768|NCT01957644|451021383|FG004|Overall Study|Protocol Violation|0|||
125379769|NCT00927784|451021384|FG000|Overall Study|Death|1|||
125379770|NCT00927784|451021385|FG001|Overall Study|Death|0|||
125379771|NCT00927784|451021384|FG000|Overall Study|Withdrawal by Subject|1|||
125379772|NCT00927784|451021385|FG001|Overall Study|Withdrawal by Subject|0|||
125379773|NCT02170051|451021386|FG000|Overall Study|Withdrawal by Subject|10|||
125638343|NCT05492877|451956267|FG000|Overall Study|Lost to Follow-up|1|||
125638344|NCT05492877|451956268|FG001|Overall Study|Lost to Follow-up|1|||
125638345|NCT05492877|451956267|FG000|Overall Study|Physician Decision|1|||
125638346|NCT05492877|451956268|FG001|Overall Study|Physician Decision|2|||
125638347|NCT05492877|451956267|FG000|Overall Study|Protocol Violation|1|||
125638348|NCT05492877|451956268|FG001|Overall Study|Protocol Violation|1|||
125638349|NCT05492877|451956267|FG000|Overall Study|Withdrawal by Subject|3|||
125638350|NCT05492877|451956268|FG001|Overall Study|Withdrawal by Subject|7|||
125638351|NCT05492877|451956267|FG000|Overall Study|Reason not specified|6|||
125638352|NCT05492877|451956268|FG001|Overall Study|Reason not specified|4|||
125638353|NCT05333289|451956277|FG000|Overall Study|Other|1|||
125638354|NCT05333289|451956278|FG001|Overall Study|Other|0|||
125638355|NCT05333289|451956279|FG002|Overall Study|Other|0|||
125638356|NCT05333289|451956280|FG003|Overall Study|Other|1|||
125638357|NCT05333289|451956281|FG004|Overall Study|Other|1|||
125638358|NCT05333289|451956282|FG005|Overall Study|Other|2|||
125638359|NCT05333289|451956283|FG006|Overall Study|Other|2|||
125638360|NCT05333289|451956284|FG007|Overall Study|Other|0|||
125638361|NCT05333289|451956277|FG000|Overall Study|Withdrawal by Subject|1|||
125638362|NCT05333289|451956278|FG001|Overall Study|Withdrawal by Subject|2|||
125638363|NCT05333289|451956279|FG002|Overall Study|Withdrawal by Subject|2|||
125638364|NCT05333289|451956280|FG003|Overall Study|Withdrawal by Subject|1|||
125638365|NCT05333289|451956281|FG004|Overall Study|Withdrawal by Subject|1|||
125638366|NCT05333289|451956282|FG005|Overall Study|Withdrawal by Subject|2|||
125638367|NCT05333289|451956283|FG006|Overall Study|Withdrawal by Subject|1|||
125638368|NCT05333289|451956284|FG007|Overall Study|Withdrawal by Subject|3|||
125638369|NCT05333289|451956277|FG000|Overall Study|Protocol Violation|1|||
125638370|NCT05333289|451956278|FG001|Overall Study|Protocol Violation|0|||
125638371|NCT05333289|451956279|FG002|Overall Study|Protocol Violation|0|||
125638372|NCT05333289|451956280|FG003|Overall Study|Protocol Violation|0|||
125638373|NCT05333289|451956281|FG004|Overall Study|Protocol Violation|0|||
125638374|NCT05333289|451956282|FG005|Overall Study|Protocol Violation|0|||
125638375|NCT05333289|451956283|FG006|Overall Study|Protocol Violation|0|||
125638376|NCT05333289|451956284|FG007|Overall Study|Protocol Violation|0|||
125638377|NCT05333289|451956277|FG000|Overall Study|Physician Decision|0|||
125638378|NCT05333289|451956278|FG001|Overall Study|Physician Decision|0|||
125638379|NCT05333289|451956279|FG002|Overall Study|Physician Decision|1|||
125638380|NCT05333289|451956280|FG003|Overall Study|Physician Decision|0|||
125638381|NCT05333289|451956281|FG004|Overall Study|Physician Decision|0|||
125638382|NCT05333289|451956282|FG005|Overall Study|Physician Decision|2|||
125638383|NCT05333289|451956283|FG006|Overall Study|Physician Decision|0|||
125638384|NCT05333289|451956284|FG007|Overall Study|Physician Decision|0|||
125638385|NCT05333289|451956277|FG000|Overall Study|Lost to Follow-up|6|||
125638386|NCT05333289|451956278|FG001|Overall Study|Lost to Follow-up|0|||
125638387|NCT05333289|451956279|FG002|Overall Study|Lost to Follow-up|1|||
125638388|NCT05333289|451956280|FG003|Overall Study|Lost to Follow-up|6|||
125638389|NCT05333289|451956281|FG004|Overall Study|Lost to Follow-up|3|||
125638390|NCT05333289|451956282|FG005|Overall Study|Lost to Follow-up|3|||
125638391|NCT05333289|451956283|FG006|Overall Study|Lost to Follow-up|2|||
125638392|NCT05333289|451956284|FG007|Overall Study|Lost to Follow-up|1|||
125638393|NCT05333289|451956277|FG000|Overall Study|Death|1|||
125638394|NCT05333289|451956278|FG001|Overall Study|Death|0|||
125638395|NCT05333289|451956279|FG002|Overall Study|Death|0|||
125638396|NCT05333289|451956280|FG003|Overall Study|Death|0|||
125638397|NCT05333289|451956281|FG004|Overall Study|Death|0|||
125379774|NCT02170051|451021387|FG001|Overall Study|Withdrawal by Subject|10|||
125379775|NCT02170051|451021386|FG000|Overall Study|Lost to Follow-up|1|||
125638398|NCT05333289|451956282|FG005|Overall Study|Death|0|||
125638399|NCT05333289|451956283|FG006|Overall Study|Death|0|||
125638400|NCT05333289|451956284|FG007|Overall Study|Death|0|||
125638401|NCT04476108|451956285|FG000|Overall Study|Adverse Event|4|||
125638402|NCT04476108|451956286|FG001|Overall Study|Adverse Event|1|||
125638403|NCT04476108|451956285|FG000|Overall Study|Lost to Follow-up|1|||
125638404|NCT04476108|451956286|FG001|Overall Study|Lost to Follow-up|0|||
125638405|NCT04476108|451956285|FG000|Overall Study|Inadvertent Enrollment|1|||
125638406|NCT04476108|451956286|FG001|Overall Study|Inadvertent Enrollment|0|||
125379776|NCT02170051|451021387|FG001|Overall Study|Lost to Follow-up|3|||
125379777|NCT01867021|451021388|FG000|Overall Study|Adverse Event|0|||
125638407|NCT04476108|451956285|FG000|Overall Study|Protocol Violation|1|||
125638408|NCT04476108|451956286|FG001|Overall Study|Protocol Violation|1|||
125638409|NCT04476108|451956285|FG000|Overall Study|Withdrawal by Subject|1|||
125379778|NCT01867021|451021389|FG001|Overall Study|Adverse Event|1|||
125379779|NCT01867021|451021388|FG000|Overall Study|Not Eligible|0|||
125379780|NCT01867021|451021389|FG001|Overall Study|Not Eligible|1|||
125379781|NCT01867021|451021388|FG000|Overall Study|Death|1|||
125379782|NCT01867021|451021389|FG001|Overall Study|Death|0|||
125379783|NCT01867021|451021388|FG000|Overall Study|Lost to Follow-up|0|||
125379784|NCT01867021|451021389|FG001|Overall Study|Lost to Follow-up|2|||
125379785|NCT01867021|451021388|FG000|Overall Study|Withdrawal by Subject|1|||
125379786|NCT01867021|451021389|FG001|Overall Study|Withdrawal by Subject|6|||
125436836|NCT01248962|451226268|FG000|Overall Study|Complete Response after 3 Cycles|0|||
125436837|NCT01248962|451226269|FG001|Overall Study|Complete Response after 3 Cycles|1|||
125436838|NCT01248962|451226268|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
125436839|NCT01248962|451226269|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
125436840|NCT01027364|451226270|FG000|Overall Study|Adverse Event|1|||
125436841|NCT01027364|451226271|FG001|Overall Study|Adverse Event|0|||
125436842|NCT01027364|451226272|FG002|Overall Study|Adverse Event|1|||
125436843|NCT01027364|451226273|FG003|Overall Study|Adverse Event|0|||
125436844|NCT01027364|451226270|FG000|Overall Study|Lost to Follow-up|1|||
125436845|NCT01027364|451226271|FG001|Overall Study|Lost to Follow-up|0|||
125436846|NCT01027364|451226272|FG002|Overall Study|Lost to Follow-up|0|||
125436847|NCT01027364|451226273|FG003|Overall Study|Lost to Follow-up|0|||
125436848|NCT01027364|451226270|FG000|Overall Study|Protocol Violation|1|||
125436849|NCT01027364|451226271|FG001|Overall Study|Protocol Violation|0|||
125436850|NCT01027364|451226272|FG002|Overall Study|Protocol Violation|0|||
125436851|NCT01027364|451226273|FG003|Overall Study|Protocol Violation|1|||
125436852|NCT01027364|451226270|FG000|Overall Study|Withdrawal by Subject|1|||
125436853|NCT01027364|451226271|FG001|Overall Study|Withdrawal by Subject|2|||
125436854|NCT01027364|451226272|FG002|Overall Study|Withdrawal by Subject|0|||
125436855|NCT01027364|451226273|FG003|Overall Study|Withdrawal by Subject|0|||
125436856|NCT03662997|451226279|FG000|Overall Study|Adverse Event|0|||
125436857|NCT03662997|451226280|FG001|Overall Study|Adverse Event|2|||
125436858|NCT03662997|451226281|FG002|Overall Study|Adverse Event|0|||
125436859|NCT03662997|451226282|FG003|Overall Study|Adverse Event|0|||
125436860|NCT02954458|451226286|FG000|Overall Study|Adverse Event|0|||
125436861|NCT02954458|451226287|FG001|Overall Study|Adverse Event|0|||
125436862|NCT02954458|451226288|FG002|Overall Study|Adverse Event|0|||
125436863|NCT02954458|451226289|FG003|Overall Study|Adverse Event|1|||
125436864|NCT02954458|451226286|FG000|Overall Study|Withdrawal by Subject|0|||
125436865|NCT02954458|451226287|FG001|Overall Study|Withdrawal by Subject|0|||
125436866|NCT02954458|451226288|FG002|Overall Study|Withdrawal by Subject|0|||
125436867|NCT02954458|451226289|FG003|Overall Study|Withdrawal by Subject|1|||
125436868|NCT02954458|451226286|FG000|Overall Study|Physician Decision|0|||
125436869|NCT02954458|451226287|FG001|Overall Study|Physician Decision|0|||
125638410|NCT04476108|451956286|FG001|Overall Study|Withdrawal by Subject|1|||
125638411|NCT02253992|451956287|FG000|Overall Study|Study drug toxicity|1|||
125638412|NCT02253992|451956288|FG001|Overall Study|Study drug toxicity|0|||
125638413|NCT02253992|451956289|FG002|Overall Study|Study drug toxicity|10|||
125638414|NCT02253992|451956287|FG000|Overall Study|Disease progression|4|||
125638415|NCT02253992|451956288|FG001|Overall Study|Disease progression|3|||
125638416|NCT02253992|451956289|FG002|Overall Study|Disease progression|98|||
125638417|NCT02253992|451956287|FG000|Overall Study|Withdrawal by Subject|0|||
125638418|NCT02253992|451956288|FG001|Overall Study|Withdrawal by Subject|0|||
125638419|NCT02253992|451956289|FG002|Overall Study|Withdrawal by Subject|3|||
125379787|NCT00881712|451021390|FG000|Overall Study|Death|1|||
125379788|NCT00881712|451021391|FG001|Overall Study|Death|0|||
125379789|NCT00881712|451021392|FG002|Overall Study|Death|0|||
125379790|NCT00881712|451021390|FG000|Overall Study|Withdrawal by Subject|1|||
125379791|NCT00881712|451021391|FG001|Overall Study|Withdrawal by Subject|0|||
125379792|NCT00881712|451021392|FG002|Overall Study|Withdrawal by Subject|0|||
125379793|NCT01405742|451021400|FG000|Overall Study|Lost to Follow-up|1|||
125379794|NCT01405742|451021401|FG001|Overall Study|Lost to Follow-up|0|||
125379795|NCT03672747|451021403|FG000|Overall Study|Lost to Follow-up|1|||
125436870|NCT02954458|451226288|FG002|Overall Study|Physician Decision|1|||
125436871|NCT02954458|451226289|FG003|Overall Study|Physician Decision|1|||
125436872|NCT02954458|451226286|FG000|Overall Study|Lost to Follow-up|1|||
125436873|NCT02954458|451226287|FG001|Overall Study|Lost to Follow-up|0|||
125436874|NCT02954458|451226288|FG002|Overall Study|Lost to Follow-up|0|||
125436875|NCT02954458|451226289|FG003|Overall Study|Lost to Follow-up|1|||
125436876|NCT02954458|451226286|FG000|Overall Study|Death|0|||
125436877|NCT02954458|451226287|FG001|Overall Study|Death|0|||
125436878|NCT02954458|451226288|FG002|Overall Study|Death|0|||
125436879|NCT02954458|451226289|FG003|Overall Study|Death|1|||
125436880|NCT02954458|451226286|FG000|Overall Study|Other|0|||
125436881|NCT02954458|451226287|FG001|Overall Study|Other|0|||
125638420|NCT02253992|451956287|FG000|Overall Study|Adverse Event|0|||
125638421|NCT02253992|451956288|FG001|Overall Study|Adverse Event|0|||
125217774|NCT03130959|450425285|FG001|Overall Study|Administrative reason by sponsor|0|||
125379796|NCT03672747|451021404|FG001|Overall Study|Lost to Follow-up|1|||
125379797|NCT03672747|451021405|FG002|Overall Study|Lost to Follow-up|2|||
125379798|NCT03672747|451021406|FG003|Overall Study|Lost to Follow-up|2|||
125217775|NCT03130959|450425286|FG002|Overall Study|Administrative reason by sponsor|1|||
125379799|NCT03672747|451021407|FG004|Overall Study|Lost to Follow-up|2|||
125379800|NCT03672747|451021408|FG005|Overall Study|Lost to Follow-up|1|||
125379801|NCT03428360|451021409|FG000|Overall Study|Informed consent withdrawn|5|||
125379802|NCT03428360|451021409|FG000|Overall Study|Withdrawal by Subject|4|||
125379803|NCT03428360|451021409|FG000|Overall Study|Lost to Follow-up|5|||
125379804|NCT03428360|451021409|FG000|Overall Study|Physician Decision|2|||
125379805|NCT03428360|451021409|FG000|Overall Study|Informed consent withdrawn|5|||
125379806|NCT03428360|451021409|FG000|Overall Study|Study terminated by sponsor|10|||
125379807|NCT03428360|451021409|FG000|Overall Study|Non-compliant with study|1|||
125379808|NCT03428360|451021409|FG000|Overall Study|Non-compliant with study drug|3|||
125379809|NCT03428360|451021409|FG000|Overall Study|Death|3|||
125379810|NCT03428360|451021409|FG000|Overall Study|Adverse Event|1|||
125379811|NCT03428360|451021409|FG000|Overall Study|Not on antiepileptic drug|1|||
125379812|NCT04772755|451021415|FG000|Overall Study|Withdrawal by Subject|1|||
125379813|NCT04772755|451021416|FG001|Overall Study|Withdrawal by Subject|0|||
125379814|NCT04772755|451021415|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
125379815|NCT04772755|451021416|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
125379816|NCT01905657|451021417|FG000|Overall Study|Adverse Event|23|||
125379817|NCT01905657|451021418|FG001|Overall Study|Adverse Event|17|||
125379818|NCT01905657|451021419|FG002|Overall Study|Adverse Event|18|||
125379819|NCT01905657|451021417|FG000|Overall Study|Clinical Progression|103|||
125379820|NCT01905657|451021418|FG001|Overall Study|Clinical Progression|78|||
125379821|NCT01905657|451021419|FG002|Overall Study|Clinical Progression|59|||
125379822|NCT01905657|451021417|FG000|Overall Study|Death|40|||
125379823|NCT01905657|451021418|FG001|Overall Study|Death|43|||
125379824|NCT01905657|451021419|FG002|Overall Study|Death|47|||
125379825|NCT01905657|451021417|FG000|Overall Study|Excluded Medication|13|||
125379826|NCT01905657|451021418|FG001|Overall Study|Excluded Medication|16|||
125379827|NCT01905657|451021419|FG002|Overall Study|Excluded Medication|9|||
125379828|NCT01905657|451021417|FG000|Overall Study|Lost to Follow-up|1|||
125379829|NCT01905657|451021418|FG001|Overall Study|Lost to Follow-up|2|||
125379830|NCT01905657|451021419|FG002|Overall Study|Lost to Follow-up|1|||
125379831|NCT01905657|451021417|FG000|Overall Study|Physician Decision|5|||
125379832|NCT01905657|451021418|FG001|Overall Study|Physician Decision|8|||
125379833|NCT01905657|451021419|FG002|Overall Study|Physician Decision|12|||
125379834|NCT01905657|451021417|FG000|Overall Study|Protocol Violation|2|||
125379835|NCT01905657|451021418|FG001|Overall Study|Protocol Violation|1|||
125436882|NCT02954458|451226288|FG002|Overall Study|Other|0|||
125436883|NCT02954458|451226289|FG003|Overall Study|Other|7|||
125217776|NCT03130959|450425287|FG003|Overall Study|Administrative reason by sponsor|0|||
125379836|NCT01905657|451021419|FG002|Overall Study|Protocol Violation|1|||
125379837|NCT01905657|451021417|FG000|Overall Study|Screen Failure|0|||
125379838|NCT01905657|451021418|FG001|Overall Study|Screen Failure|1|||
125379839|NCT01905657|451021419|FG002|Overall Study|Screen Failure|0|||
125379840|NCT01905657|451021417|FG000|Overall Study|Withdrawal by Subject|15|||
125379841|NCT01905657|451021418|FG001|Overall Study|Withdrawal by Subject|21|||
125379842|NCT01905657|451021419|FG002|Overall Study|Withdrawal by Subject|53|||
125379843|NCT01905657|451021417|FG000|Overall Study|Sponsor Decision|1|||
125436884|NCT01396395|451226295|FG000|Overall Study|Withdrawal by Subject|10|||
125436885|NCT01396395|451226296|FG001|Overall Study|Withdrawal by Subject|12|||
125436886|NCT01396395|451226295|FG000|Overall Study|Protocol Violation|3|||
125436887|NCT01396395|451226296|FG001|Overall Study|Protocol Violation|1|||
125436888|NCT01396395|451226295|FG000|Overall Study|Adverse Event|10|||
125436889|NCT01396395|451226296|FG001|Overall Study|Adverse Event|2|||
125436890|NCT01396395|451226295|FG000|Overall Study|Lost to Follow-up|17|||
125436891|NCT01396395|451226296|FG001|Overall Study|Lost to Follow-up|11|||
125436892|NCT01396395|451226295|FG000|Overall Study|Other|0|||
125436893|NCT01396395|451226296|FG001|Overall Study|Other|1|||
125436894|NCT00882921|451226297|FG000|Overall Study|Death|2|||
125436895|NCT00882921|451226297|FG000|Overall Study|Other|3|||
125436896|NCT00882921|451226297|FG000|Overall Study|Lost to Follow-up|2|||
125436897|NCT00882921|451226297|FG000|Overall Study|Termination By Investigator|3|||
125436898|NCT00882921|451226297|FG000|Overall Study|Withdrawal Of Consent|1|||
125436899|NCT02460263|451226299|FG000|Transition Period|Withdrawal by Subject|1|||
125436900|NCT02460263|451226299|FG000|Transition Period|Death|1|||
125436901|NCT03176238|451226302|FG000|Overall Study|Unacceptable AEs|15|||
125436902|NCT03176238|451226303|FG001|Overall Study|Unacceptable AEs|8|||
125436903|NCT03176238|451226302|FG000|Overall Study|Abnormal lab value(s)|2|||
125436904|NCT03176238|451226303|FG001|Overall Study|Abnormal lab value(s)|0|||
125436905|NCT03176238|451226302|FG000|Overall Study|Inter-current illness|0|||
125436906|NCT03176238|451226303|FG001|Overall Study|Inter-current illness|1|||
125436907|NCT03176238|451226302|FG000|Overall Study|Consent withdrawal|14|||
125436908|NCT03176238|451226303|FG001|Overall Study|Consent withdrawal|2|||
125436909|NCT03176238|451226302|FG000|Overall Study|Lost to Follow-up|3|||
125436910|NCT03176238|451226303|FG001|Overall Study|Lost to Follow-up|0|||
125436911|NCT03176238|451226302|FG000|Overall Study|Administrative problems|1|||
125436912|NCT03176238|451226303|FG001|Overall Study|Administrative problems|0|||
125436913|NCT03176238|451226302|FG000|Overall Study|Death|3|||
125436914|NCT03176238|451226303|FG001|Overall Study|Death|0|||
125436915|NCT03176238|451226302|FG000|Overall Study|Disease Progression|133|||
125436916|NCT03176238|451226303|FG001|Overall Study|Disease Progression|22|||
125436917|NCT03176238|451226302|FG000|Overall Study|Tx duration completed per EAP|0|||
125436918|NCT03176238|451226303|FG001|Overall Study|Tx duration completed per EAP|1|||
125436919|NCT03176238|451226302|FG000|Overall Study|Patient is switched to commercial drug|16|||
125436920|NCT03176238|451226303|FG001|Overall Study|Patient is switched to commercial drug|1|||
125436921|NCT03176238|451226302|FG000|Overall Study|Protocol Violation|1|||
125436922|NCT03176238|451226303|FG001|Overall Study|Protocol Violation|0|||
125436923|NCT03176238|451226302|FG000|Overall Study|Changes in the patient's condition|2|||
125436924|NCT03176238|451226303|FG001|Overall Study|Changes in the patient's condition|1|||
125436925|NCT03176238|451226302|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
125436926|NCT03176238|451226303|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
125436927|NCT04524598|451226304|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
125436928|NCT04524598|451226305|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
125436929|NCT04524598|451226306|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
125436930|NCT04524598|451226307|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
125436931|NCT04524598|451226308|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
125436932|NCT04524598|451226304|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
125436933|NCT04524598|451226305|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
125436934|NCT04524598|451226306|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
125436935|NCT04524598|451226307|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
125436936|NCT04524598|451226308|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
125436937|NCT04524598|451226304|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
125436938|NCT04524598|451226305|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
125436939|NCT04524598|451226306|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
125436940|NCT04524598|451226307|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
125436941|NCT04524598|451226308|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
125436942|NCT04524598|451226304|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
125436943|NCT04524598|451226305|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
125638422|NCT02253992|451956289|FG002|Overall Study|Adverse Event|8|||
125638423|NCT02253992|451956287|FG000|Overall Study|Death|0|||
125436944|NCT04524598|451226306|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
125436945|NCT04524598|451226307|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
125436946|NCT04524598|451226308|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
125436947|NCT04524598|451226304|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
125436948|NCT04524598|451226305|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
125436949|NCT04524598|451226306|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
125436950|NCT04524598|451226307|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
125436951|NCT04524598|451226308|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
125436952|NCT04524598|451226304|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
125436953|NCT04524598|451226305|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
125638424|NCT02253992|451956288|FG001|Overall Study|Death|0|||
125379844|NCT01905657|451021418|FG001|Overall Study|Sponsor Decision|0|||
125379845|NCT01905657|451021419|FG002|Overall Study|Sponsor Decision|0|||
125379846|NCT02744391|451021421|FG000|Overall Study|Lost to Follow-up|9|||
125379847|NCT02744391|451021421|FG000|Overall Study|Physician Decision|2|||
125638425|NCT02253992|451956289|FG002|Overall Study|Death|1|||
125638426|NCT02253992|451956287|FG000|Overall Study|Subject discontinued study drug|1|||
125638427|NCT02253992|451956288|FG001|Overall Study|Subject discontinued study drug|0|||
125638428|NCT02253992|451956289|FG002|Overall Study|Subject discontinued study drug|1|||
125638429|NCT02253992|451956287|FG000|Overall Study|Completed treatment as per protocol|0|||
125638430|NCT02253992|451956288|FG001|Overall Study|Completed treatment as per protocol|1|||
125638431|NCT02253992|451956289|FG002|Overall Study|Completed treatment as per protocol|22|||
125638432|NCT02253992|451956287|FG000|Overall Study|Other|0|||
125638433|NCT02253992|451956288|FG001|Overall Study|Other|0|||
125638434|NCT02253992|451956289|FG002|Overall Study|Other|1|||
125638435|NCT00772889|451956290|FG000|Overall Study|Adverse Event|7|||
125638436|NCT00772889|451956291|FG001|Overall Study|Adverse Event|4|||
125638437|NCT00772889|451956292|FG002|Overall Study|Adverse Event|0|||
125638438|NCT00772889|451956290|FG000|Overall Study|Withdrawal by Subject|9|||
125638439|NCT00772889|451956291|FG001|Overall Study|Withdrawal by Subject|8|||
125638440|NCT00772889|451956292|FG002|Overall Study|Withdrawal by Subject|9|||
125638441|NCT00772889|451956290|FG000|Overall Study|Lost to Follow-up|6|||
125638442|NCT00772889|451956291|FG001|Overall Study|Lost to Follow-up|6|||
125638443|NCT00772889|451956292|FG002|Overall Study|Lost to Follow-up|7|||
125638444|NCT03323086|451956293|FG000|Overall Study|Lost to Follow-up|3|||
125638445|NCT03323086|451956294|FG001|Overall Study|Lost to Follow-up|2|||
125638446|NCT00355615|451956295|FG000|Randomized Double Blind Period|Adverse Event|1|||
125638447|NCT00355615|451956296|FG001|Randomized Double Blind Period|Adverse Event|0|||
125638448|NCT00355615|451956297|FG002|Randomized Double Blind Period|Adverse Event|0|||
125638449|NCT00355615|451956298|FG003|Randomized Double Blind Period|Adverse Event|0|||
125638450|NCT00355615|451956299|FG004|Randomized Double Blind Period|Adverse Event|0|||
125638451|NCT00355615|451956295|FG000|Randomized Double Blind Period|Protocol Violation|0|||
125638452|NCT00355615|451956296|FG001|Randomized Double Blind Period|Protocol Violation|0|||
125638453|NCT00355615|451956297|FG002|Randomized Double Blind Period|Protocol Violation|1|||
125638454|NCT00355615|451956298|FG003|Randomized Double Blind Period|Protocol Violation|1|||
125638455|NCT00355615|451956299|FG004|Randomized Double Blind Period|Protocol Violation|0|||
125638456|NCT00355615|451956295|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
125638457|NCT00355615|451956296|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
125638458|NCT00355615|451956297|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
125638459|NCT00355615|451956298|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
125638460|NCT00355615|451956299|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
125638461|NCT00355615|451956295|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
125638462|NCT00355615|451956296|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
125638463|NCT00355615|451956297|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
125638464|NCT00355615|451956298|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
125638465|NCT00355615|451956299|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
125638466|NCT00355615|451956295|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
125638467|NCT00355615|451956296|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
125638468|NCT00355615|451956297|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
125638469|NCT00355615|451956298|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
125638470|NCT00355615|451956299|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
125638471|NCT00355615|451956295|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
125638472|NCT00355615|451956296|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
125638473|NCT00355615|451956297|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
125638474|NCT00355615|451956298|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
125638475|NCT00355615|451956299|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
125638476|NCT03685643|451956303|FG000|Overall Study|Lost to Follow-up|14|||
125638477|NCT03685643|451956304|FG001|Overall Study|Lost to Follow-up|22|||
125638478|NCT02159365|451956305|FG000|Overall Study|Disease Progression|23|||
125638479|NCT02159365|451956305|FG000|Overall Study|Other reasons|11|||
125379848|NCT02744391|451021421|FG000|Overall Study|Withdrawal by Subject|3|||
125379849|NCT01996709|451021422|FG000|Overall Study|Withdrawal by Subject|1|||
125379850|NCT01996709|451021423|FG001|Overall Study|Withdrawal by Subject|0|||
125379851|NCT01996709|451021422|FG000|Overall Study|Lost to Follow-up|3|||
125638480|NCT02159365|451956305|FG000|Overall Study|Administrative reason by Sponsor|9|||
125638481|NCT02159365|451956305|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
125638482|NCT02159365|451956305|FG000|Overall Study|Study drug toxicity|7|||
125638483|NCT02159365|451956305|FG000|Overall Study|Maximum clinical benefit|3|||
125638484|NCT02159365|451956305|FG000|Overall Study|Subject request to discontinue treatment|3|||
125638485|NCT02159365|451956305|FG000|Overall Study|Subject withdrew consent|3|||
125379852|NCT01996709|451021423|FG001|Overall Study|Lost to Follow-up|0|||
125379853|NCT01996709|451021422|FG000|Overall Study|Subject Non-Compliant|1|||
125379854|NCT01996709|451021423|FG001|Overall Study|Subject Non-Compliant|0|||
125638486|NCT02159365|451956305|FG000|Overall Study|Death|1|||
125638487|NCT02159365|451956305|FG000|Overall Study|Lost to Follow-up|1|||
125638488|NCT03523715|451956306|FG000|Overall Study|Lost to Follow-up|11|||
125638489|NCT03523715|451956307|FG001|Overall Study|Lost to Follow-up|14|||
125638490|NCT03523715|451956306|FG000|Overall Study|Did not meet inclusion criteria|1|||
125638491|NCT03523715|451956307|FG001|Overall Study|Did not meet inclusion criteria|0|||
125638492|NCT03523715|451956306|FG000|Overall Study|Internally inconsistent reporting|0|||
125638493|NCT03523715|451956307|FG001|Overall Study|Internally inconsistent reporting|2|||
125638494|NCT04430036|451956308|FG000|Safety Run in Phase|Progression of disease|2|||
125638495|NCT01842334|451956309|FG000|Overall Study|Withdrawal by Subject|3|||
125638496|NCT01842334|451956310|FG001|Overall Study|Withdrawal by Subject|3|||
125638497|NCT01842334|451956309|FG000|Overall Study|Moved away mid-study|0|||
125638498|NCT01842334|451956310|FG001|Overall Study|Moved away mid-study|1|||
125638499|NCT01885104|451956314|FG000|Overall Study|Withdrawal of Consent|1|||
125638500|NCT01885104|451956315|FG001|Overall Study|Withdrawal of Consent|0|||
125638501|NCT01885104|451956314|FG000|Overall Study|Lost to Follow-up|0|||
125638502|NCT01885104|451956315|FG001|Overall Study|Lost to Follow-up|1|||
125638503|NCT01885104|451956314|FG000|Overall Study|Physician Decision|1|||
125638504|NCT01885104|451956315|FG001|Overall Study|Physician Decision|0|||
125638505|NCT00113555|451956317|FG000|Overall Study|Baseline Failure|59|||
125638506|NCT00113555|451956317|FG000|Overall Study|Permanently Explanted|7|||
125638507|NCT00113555|451956317|FG000|Overall Study|Death|1|||
125638508|NCT00113555|451956317|FG000|Overall Study|Missed Followup|4|||
125638509|NCT00113555|451956317|FG000|Overall Study|Lost to Follow-up|8|||
125638510|NCT01060124|451956318|FG000|Overall Study|Other|16|||
125638511|NCT01060124|451956318|FG000|Overall Study|Adverse Event|14|||
125638512|NCT01060124|451956318|FG000|Overall Study|Withdrawal by Subject|7|||
125638513|NCT03858686|451956326|FG000|Period 1|Adverse Event|1|||
125638514|NCT03858686|451956327|FG001|Period 1|Adverse Event|1|||
125638515|NCT03858686|451956326|FG000|Period 1|Lack of compliance|0|||
125638516|NCT03858686|451956327|FG001|Period 1|Lack of compliance|1|||
125638517|NCT03858686|451956326|FG000|Period 1|Adverse Event|0|||
125638518|NCT03858686|451956327|FG001|Period 1|Adverse Event|1|||
125638519|NCT03858686|451956326|FG000|Period 2|Adverse Event|0|||
125638520|NCT03858686|451956327|FG001|Period 2|Adverse Event|1|||
125638521|NCT01432938|451956328|FG000|First Intervention|Protocol Violation|1|||
125638522|NCT01432938|451956329|FG001|First Intervention|Protocol Violation|0|||
125638523|NCT01432938|451956328|FG000|First Intervention|Physician Decision|1|||
125638524|NCT01432938|451956329|FG001|First Intervention|Physician Decision|0|||
125638525|NCT01432938|451956328|FG000|Second Intervention|Adverse Event|1|||
125638526|NCT01432938|451956329|FG001|Second Intervention|Adverse Event|0|||
125638527|NCT04191096|451956331|FG000|Overall Study|Death|102|||
125638528|NCT04191096|451956332|FG001|Overall Study|Death|89|||
125638529|NCT04191096|451956331|FG000|Overall Study|Lost to Follow-up|1|||
125638530|NCT04191096|451956332|FG001|Overall Study|Lost to Follow-up|1|||
125638531|NCT04191096|451956331|FG000|Overall Study|Withdrawal by Subject|5|||
125638532|NCT04191096|451956332|FG001|Overall Study|Withdrawal by Subject|5|||
125638533|NCT04191096|451956331|FG000|Overall Study|Participants Ongoing|518|||
125638534|NCT04191096|451956332|FG001|Overall Study|Participants Ongoing|530|||
125638535|NCT02683668|451956334|FG000|Period 2|Withdrawal by Subject|0|||
125638536|NCT02683668|451956335|FG001|Period 2|Withdrawal by Subject|1|||
125638537|NCT02683668|451956336|FG002|Period 2|Withdrawal by Subject|0|||
125638538|NCT04418427|451958036|FG000|Overall Study|Death|0|||
125638539|NCT04418427|451958037|FG001|Overall Study|Death|1|||
125638540|NCT04418427|451958038|FG002|Overall Study|Death|0|||
125638541|NCT04418427|451958036|FG000|Overall Study|Lost to Follow-up|0|||
125638542|NCT04418427|451958037|FG001|Overall Study|Lost to Follow-up|2|||
125638543|NCT04418427|451958038|FG002|Overall Study|Lost to Follow-up|2|||
125638544|NCT04418427|451958036|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
125638545|NCT04418427|451958037|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
125638546|NCT04418427|451958038|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
125638547|NCT04418427|451958036|FG000|Overall Study|Pre-existing medical condition|0|||
125638548|NCT04418427|451958037|FG001|Overall Study|Pre-existing medical condition|1|||
125638549|NCT04418427|451958038|FG002|Overall Study|Pre-existing medical condition|0|||
125638550|NCT01888965|451958041|FG000|Overall Study|Adverse Event|5|||
125638551|NCT01888965|451958041|FG000|Overall Study|Lack of Efficacy|4|||
125638552|NCT04124952|451958043|FG000|Overall Study|Lost to Follow-up|1|||
125638553|NCT01654224|451958044|FG000|Overall Study|Lost to Follow-up|2|||
125638554|NCT01654224|451958045|FG001|Overall Study|Lost to Follow-up|2|||
125638555|NCT01654224|451958044|FG000|Overall Study|Did not receive allocation|1|||
125420811|NCT01260350|451166150|FG006|Overall Study|Lack of Efficacy|0|||
125638556|NCT01654224|451958045|FG001|Overall Study|Did not receive allocation|8|||
125638557|NCT01654224|451958044|FG000|Overall Study|Insufficient blood sample|3|||
125638558|NCT01654224|451958045|FG001|Overall Study|Insufficient blood sample|2|||
125638559|NCT03345849|451958046|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
125638560|NCT03345849|451958047|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
125379855|NCT01996709|451021422|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
125379856|NCT01996709|451021423|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
125379857|NCT02825992|451023365|FG000|Overall Study|Withdrawal by Subject|4|||
125379858|NCT02825992|451023365|FG000|Overall Study|Lost to Follow-up|2|||
125379859|NCT02825992|451023365|FG000|Overall Study|Procedure terminated|2|||
125638561|NCT03345849|451958048|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
125638562|NCT03345849|451958049|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
125638563|NCT03345849|451958046|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
125638564|NCT03345849|451958047|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
125638565|NCT03345849|451958048|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
125638566|NCT03345849|451958049|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
125638567|NCT03345849|451958046|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
125638568|NCT03345849|451958047|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
125638569|NCT03345849|451958048|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
125638570|NCT03345849|451958049|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
125638571|NCT03345849|451958046|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
125638572|NCT03345849|451958047|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
125638573|NCT03345849|451958048|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
125638574|NCT03345849|451958049|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
125638575|NCT03345849|451958046|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
125638576|NCT03345849|451958047|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
125638577|NCT03345849|451958048|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
125638578|NCT03345849|451958049|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
125638579|NCT03345849|451958046|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
125638580|NCT03345849|451958047|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
125638581|NCT03345849|451958048|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
125638582|NCT03345849|451958049|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
125638583|NCT03345849|451958046|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
125638584|NCT03345849|451958047|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
125638585|NCT03345849|451958048|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
125638586|NCT03345849|451958049|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
125638587|NCT03345849|451958046|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
125638588|NCT03345849|451958047|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
125638589|NCT03345849|451958048|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
125638590|NCT03345849|451958049|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
125638591|NCT03345849|451958046|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
125638592|NCT03345849|451958047|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
125638593|NCT03345849|451958048|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
125638594|NCT03345849|451958049|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
125638595|NCT03345849|451958046|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
125638596|NCT03345849|451958047|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
125638597|NCT03345849|451958048|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
125638598|NCT03345849|451958049|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
125638599|NCT03345849|451958046|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
125638600|NCT03345849|451958047|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
125379860|NCT02279173|451023366|FG000|Overall Study|Protocol-specified Criteria|67|||
125379861|NCT02279173|451023366|FG000|Overall Study|Withdrawal by Subject|20|||
125379862|NCT02279173|451023366|FG000|Overall Study|Decision by Sponsor|4|||
125379863|NCT02279173|451023366|FG000|Overall Study|Lost to Follow-up|3|||
125379864|NCT00157950|451023367|FG000|Overall Study|Death|1|||
125379865|NCT00157950|451023368|FG001|Overall Study|Death|0|||
125379866|NCT01529346|451023369|FG000|Overall Study|Lost to Follow-up|2|||
125638601|NCT03345849|451958048|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
125131888|NCT01796171|450110067|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125379867|NCT01529346|451023370|FG001|Overall Study|Lost to Follow-up|0|||
125379868|NCT01529346|451023371|FG002|Overall Study|Lost to Follow-up|1|||
125379869|NCT01529346|451023372|FG003|Overall Study|Lost to Follow-up|0|||
125379870|NCT01529346|451023373|FG004|Overall Study|Lost to Follow-up|0|||
125436954|NCT04524598|451226306|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
125436955|NCT04524598|451226307|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
125436956|NCT04524598|451226308|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
125436957|NCT04524598|451226304|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
125436958|NCT04524598|451226305|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
125436959|NCT04524598|451226306|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
125436960|NCT04524598|451226307|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
125436961|NCT04524598|451226308|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
125436962|NCT04395183|451226309|FG000|Overall Study|Withdrawal by Subject|1|||
125436963|NCT04395183|451226310|FG001|Overall Study|Withdrawal by Subject|0|||
125436964|NCT04395183|451226311|FG002|Overall Study|Withdrawal by Subject|2|||
125436965|NCT04395183|451226312|FG003|Overall Study|Withdrawal by Subject|2|||
125436966|NCT02569710|451226314|FG000|Overall Study|Adverse Event|1|||
125436967|NCT02569710|451226315|FG001|Overall Study|Adverse Event|0|||
125436968|NCT02569710|451226316|FG002|Overall Study|Adverse Event|0|||
125436969|NCT02569710|451226317|FG003|Overall Study|Adverse Event|0|||
125436970|NCT02569710|451226318|FG004|Overall Study|Adverse Event|0|||
125436971|NCT02569710|451226319|FG005|Overall Study|Adverse Event|0|||
125217777|NCT03130959|450425288|FG004|Overall Study|Administrative reason by sponsor|0|||
125436972|NCT02569710|451226320|FG006|Overall Study|Adverse Event|0|||
125436973|NCT02569710|451226321|FG007|Overall Study|Adverse Event|0|||
125436974|NCT02569710|451226322|FG008|Overall Study|Adverse Event|0|||
125436975|NCT02569710|451226323|FG009|Overall Study|Adverse Event|0|||
125131889|NCT01796171|450110068|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
125131890|NCT01796171|450110069|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131891|NCT01796171|450110070|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
125131892|NCT01796171|450110071|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
125131893|NCT01796171|450110072|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131894|NCT01796171|450110073|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131895|NCT01796171|450110074|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
125131896|NCT01796171|450110060|FG000|Treatment Period With Betalutin|Physician Decision|0|||
125131897|NCT01796171|450110061|FG001|Treatment Period With Betalutin|Physician Decision|0|||
125131898|NCT01796171|450110062|FG002|Treatment Period With Betalutin|Physician Decision|0|||
125131899|NCT01796171|450110063|FG003|Treatment Period With Betalutin|Physician Decision|0|||
125131900|NCT01796171|450110064|FG004|Treatment Period With Betalutin|Physician Decision|0|||
125131901|NCT01796171|450110065|FG005|Treatment Period With Betalutin|Physician Decision|0|||
125131902|NCT01796171|450110066|FG006|Treatment Period With Betalutin|Physician Decision|0|||
125131903|NCT01796171|450110067|FG007|Treatment Period With Betalutin|Physician Decision|0|||
125131904|NCT01796171|450110068|FG008|Treatment Period With Betalutin|Physician Decision|0|||
125131905|NCT01796171|450110069|FG009|Treatment Period With Betalutin|Physician Decision|0|||
125131906|NCT01796171|450110070|FG010|Treatment Period With Betalutin|Physician Decision|5|||
125131907|NCT01796171|450110071|FG011|Treatment Period With Betalutin|Physician Decision|1|||
125131908|NCT01796171|450110072|FG012|Treatment Period With Betalutin|Physician Decision|1|||
125131909|NCT01796171|450110073|FG013|Treatment Period With Betalutin|Physician Decision|0|||
125131910|NCT01796171|450110074|FG014|Treatment Period With Betalutin|Physician Decision|0|||
125131911|NCT01796171|450110060|FG000|Treatment Period With Betalutin|Death|0|||
125379871|NCT01529346|451023369|FG000|Overall Study|Other|0|||
125379872|NCT01529346|451023370|FG001|Overall Study|Other|1|||
125379873|NCT01529346|451023371|FG002|Overall Study|Other|1|||
125379874|NCT01529346|451023372|FG003|Overall Study|Other|0|||
125379875|NCT01529346|451023373|FG004|Overall Study|Other|0|||
125379876|NCT02892760|451023374|FG000|Overall Study|Withdrawal by Subject|3|||
125379877|NCT00386776|451023375|FG000|Overall Study|Withdrawal by Subject|8|||
125379878|NCT01499667|451023379|FG000|Overall Study|administrative problems|4|||
125379879|NCT01499667|451023380|FG001|Overall Study|administrative problems|5|||
125379880|NCT01499667|451023381|FG002|Overall Study|administrative problems|5|||
125379881|NCT01499667|451023379|FG000|Overall Study|Protocol Violation|1|||
125379882|NCT01499667|451023380|FG001|Overall Study|Protocol Violation|3|||
125638602|NCT03345849|451958049|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
125638603|NCT03261037|451958050|FG000|Overall Study|Withdrawal by Subject|2|||
125638604|NCT03261037|451958051|FG001|Overall Study|Withdrawal by Subject|13|||
125638605|NCT03261037|451958052|FG002|Overall Study|Withdrawal by Subject|0|||
125638606|NCT03261037|451958053|FG003|Overall Study|Withdrawal by Subject|18|||
125638607|NCT03261037|451958050|FG000|Overall Study|Non-compliance with study procedures|0|||
125638608|NCT03261037|451958051|FG001|Overall Study|Non-compliance with study procedures|2|||
125638609|NCT03261037|451958052|FG002|Overall Study|Non-compliance with study procedures|0|||
125638610|NCT03261037|451958053|FG003|Overall Study|Non-compliance with study procedures|6|||
125638611|NCT03261037|451958050|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
125638612|NCT03261037|451958051|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
125638613|NCT03261037|451958052|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
125638614|NCT03261037|451958053|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
125638615|NCT03261037|451958050|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
125638616|NCT03261037|451958051|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
125638617|NCT03261037|451958052|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
125638618|NCT03261037|451958053|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
125638619|NCT03261037|451958050|FG000|Overall Study|Diagnosed but protocol deviation|1|||
125638620|NCT03261037|451958051|FG001|Overall Study|Diagnosed but protocol deviation|0|||
125638621|NCT03261037|451958052|FG002|Overall Study|Diagnosed but protocol deviation|0|||
125638622|NCT03261037|451958053|FG003|Overall Study|Diagnosed but protocol deviation|0|||
125638623|NCT03261037|451958050|FG000|Overall Study|Participant did not want to continue the study|0|||
125638624|NCT03261037|451958051|FG001|Overall Study|Participant did not want to continue the study|1|||
125638625|NCT03261037|451958052|FG002|Overall Study|Participant did not want to continue the study|0|||
125638626|NCT03261037|451958053|FG003|Overall Study|Participant did not want to continue the study|0|||
125638627|NCT03261037|451958050|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
125638628|NCT03261037|451958051|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
125131912|NCT01796171|450110061|FG001|Treatment Period With Betalutin|Death|0|||
125131913|NCT01796171|450110062|FG002|Treatment Period With Betalutin|Death|0|||
125379883|NCT01499667|451023381|FG002|Overall Study|Protocol Violation|2|||
125379884|NCT01499667|451023379|FG000|Overall Study|Adverse Event|0|||
125379885|NCT01499667|451023380|FG001|Overall Study|Adverse Event|2|||
125379886|NCT01499667|451023381|FG002|Overall Study|Adverse Event|2|||
125638629|NCT03261037|451958052|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
125638630|NCT03261037|451958053|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
125638631|NCT03261037|451958050|FG000|Overall Study|Participant presented clinical improvement|0|||
125638632|NCT03261037|451958051|FG001|Overall Study|Participant presented clinical improvement|2|||
125638633|NCT03261037|451958052|FG002|Overall Study|Participant presented clinical improvement|0|||
125638634|NCT03261037|451958053|FG003|Overall Study|Participant presented clinical improvement|0|||
125638635|NCT03261037|451958050|FG000|Overall Study|Technical difficulties|0|||
125638636|NCT03261037|451958051|FG001|Overall Study|Technical difficulties|0|||
125638637|NCT03261037|451958052|FG002|Overall Study|Technical difficulties|0|||
125638638|NCT03261037|451958053|FG003|Overall Study|Technical difficulties|1|||
125638639|NCT03261037|451958050|FG000|Overall Study|Equipment failed to work|0|||
125638640|NCT03261037|451958051|FG001|Overall Study|Equipment failed to work|0|||
125638641|NCT03261037|451958052|FG002|Overall Study|Equipment failed to work|0|||
125638642|NCT03261037|451958053|FG003|Overall Study|Equipment failed to work|1|||
125638643|NCT03261037|451958050|FG000|Overall Study|End of study for participant and no follow up|0|||
125638644|NCT03261037|451958051|FG001|Overall Study|End of study for participant and no follow up|0|||
125638645|NCT03261037|451958052|FG002|Overall Study|End of study for participant and no follow up|0|||
125638646|NCT03261037|451958053|FG003|Overall Study|End of study for participant and no follow up|1|||
125638647|NCT03261037|451958050|FG000|Overall Study|Participant was too weak to continue in study|1|||
125638648|NCT03261037|451958051|FG001|Overall Study|Participant was too weak to continue in study|0|||
125638649|NCT03261037|451958052|FG002|Overall Study|Participant was too weak to continue in study|0|||
125638650|NCT03261037|451958053|FG003|Overall Study|Participant was too weak to continue in study|0|||
125638651|NCT02943577|451958054|FG000|Overall Study|Protocol Violation|0|||
125638652|NCT02943577|451958055|FG001|Overall Study|Protocol Violation|1|||
125638653|NCT02943577|451958054|FG000|Overall Study|Adverse Event|3|||
125638654|NCT02943577|451958055|FG001|Overall Study|Adverse Event|2|||
125638655|NCT02943577|451958054|FG000|Overall Study|Lost to Follow-up|0|||
125638656|NCT02943577|451958055|FG001|Overall Study|Lost to Follow-up|1|||
125638657|NCT02943577|451958054|FG000|Overall Study|Withdrawal by Subject|1|||
125638658|NCT02943577|451958055|FG001|Overall Study|Withdrawal by Subject|1|||
125638659|NCT02943577|451958054|FG000|Overall Study|Pregnancy|1|||
125638660|NCT02943577|451958055|FG001|Overall Study|Pregnancy|0|||
125638661|NCT04437511|451958062|FG000|Overall Study|Adverse Event|50|||
125217778|NCT03130959|450425289|FG005|Overall Study|Administrative reason by sponsor|0|||
125217779|NCT03130959|450425290|FG006|Overall Study|Administrative reason by sponsor|0|||
125217780|NCT03130959|450425291|FG007|Overall Study|Administrative reason by sponsor|0|||
125217781|NCT03130959|450425292|FG008|Overall Study|Administrative reason by sponsor|0|||
125217782|NCT03130959|450425293|FG009|Overall Study|Administrative reason by sponsor|0|||
125217783|NCT03130959|450425284|FG000|Overall Study|Lost to Follow-up|1|||
125217784|NCT03130959|450425285|FG001|Overall Study|Lost to Follow-up|0|||
125217785|NCT03130959|450425286|FG002|Overall Study|Lost to Follow-up|0|||
125217786|NCT03130959|450425287|FG003|Overall Study|Lost to Follow-up|0|||
125217787|NCT03130959|450425288|FG004|Overall Study|Lost to Follow-up|0|||
125217788|NCT03130959|450425289|FG005|Overall Study|Lost to Follow-up|0|||
125217789|NCT03130959|450425290|FG006|Overall Study|Lost to Follow-up|0|||
125217790|NCT03130959|450425291|FG007|Overall Study|Lost to Follow-up|0|||
125217791|NCT03130959|450425292|FG008|Overall Study|Lost to Follow-up|0|||
125217792|NCT03130959|450425293|FG009|Overall Study|Lost to Follow-up|0|||
125217793|NCT02384538|450425294|FG000|Overall Study|Adverse Event|1|||
125217794|NCT02384538|450425295|FG001|Overall Study|Adverse Event|4|||
125217795|NCT02384538|450425294|FG000|Overall Study|Lack of Efficacy|4|||
125638662|NCT04437511|451958063|FG001|Overall Study|Adverse Event|21|||
125217796|NCT02384538|450425295|FG001|Overall Study|Lack of Efficacy|4|||
125217797|NCT02384538|450425294|FG000|Overall Study|Withdrew Consent|0|||
125638663|NCT04437511|451958062|FG000|Overall Study|Death|15|||
125638664|NCT04437511|451958063|FG001|Overall Study|Death|10|||
125638665|NCT04437511|451958062|FG000|Overall Study|Lost to Follow-up|11|||
125638666|NCT04437511|451958063|FG001|Overall Study|Lost to Follow-up|11|||
125638667|NCT04437511|451958062|FG000|Overall Study|Physician Decision|19|||
125638668|NCT04437511|451958063|FG001|Overall Study|Physician Decision|10|||
125638669|NCT04437511|451958062|FG000|Overall Study|Progressive Disease|4|||
125638670|NCT04437511|451958063|FG001|Overall Study|Progressive Disease|7|||
125638671|NCT04437511|451958062|FG000|Overall Study|Withdrawal by Subject|111|||
125638672|NCT04437511|451958063|FG001|Overall Study|Withdrawal by Subject|94|||
125638673|NCT04437511|451958062|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
125638674|NCT04437511|451958063|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
125638675|NCT04437511|451958062|FG000|Overall Study|Continuing Study|7|||
125638676|NCT04437511|451958063|FG001|Overall Study|Continuing Study|5|||
125638677|NCT04654468|451958066|FG000|Overall Study|Death|1|||
125638678|NCT04654468|451958066|FG000|Overall Study|Ongoing in the Study|50|||
125217798|NCT02384538|450425295|FG001|Overall Study|Withdrew Consent|4|||
125217799|NCT02384538|450425294|FG000|Overall Study|Other|1|||
125217800|NCT02384538|450425295|FG001|Overall Study|Other|3|||
125217801|NCT04446429|450425296|FG000|Overall Study|Lost to Follow-up|6|||
125217802|NCT04446429|450425297|FG001|Overall Study|Lost to Follow-up|0|||
125638679|NCT03093350|451958071|FG000|Overall Study|Death|1|||
125436976|NCT02569710|451226314|FG000|Overall Study|Lost to Follow-up|0|||
125436977|NCT02569710|451226315|FG001|Overall Study|Lost to Follow-up|0|||
125436978|NCT02569710|451226316|FG002|Overall Study|Lost to Follow-up|0|||
125436979|NCT02569710|451226317|FG003|Overall Study|Lost to Follow-up|0|||
125436980|NCT02569710|451226318|FG004|Overall Study|Lost to Follow-up|0|||
125436981|NCT02569710|451226319|FG005|Overall Study|Lost to Follow-up|0|||
125436982|NCT02569710|451226320|FG006|Overall Study|Lost to Follow-up|1|||
125436983|NCT02569710|451226321|FG007|Overall Study|Lost to Follow-up|0|||
125436984|NCT02569710|451226322|FG008|Overall Study|Lost to Follow-up|1|||
125436985|NCT02569710|451226323|FG009|Overall Study|Lost to Follow-up|0|||
125436986|NCT02569710|451226314|FG000|Overall Study|Virologic failure|0|||
125436987|NCT02569710|451226315|FG001|Overall Study|Virologic failure|0|||
125436988|NCT02569710|451226316|FG002|Overall Study|Virologic failure|0|||
125436989|NCT02569710|451226317|FG003|Overall Study|Virologic failure|0|||
125436990|NCT02569710|451226318|FG004|Overall Study|Virologic failure|1|||
125436991|NCT02569710|451226319|FG005|Overall Study|Virologic failure|0|||
125436992|NCT02569710|451226320|FG006|Overall Study|Virologic failure|1|||
125436993|NCT02569710|451226321|FG007|Overall Study|Virologic failure|0|||
125436994|NCT02569710|451226322|FG008|Overall Study|Virologic failure|0|||
125436995|NCT02569710|451226323|FG009|Overall Study|Virologic failure|0|||
125436996|NCT02569710|451226314|FG000|Overall Study|Withdrawal by Subject|0|||
125436997|NCT02569710|451226315|FG001|Overall Study|Withdrawal by Subject|0|||
125436998|NCT02569710|451226316|FG002|Overall Study|Withdrawal by Subject|0|||
125436999|NCT02569710|451226317|FG003|Overall Study|Withdrawal by Subject|0|||
125437000|NCT02569710|451226318|FG004|Overall Study|Withdrawal by Subject|0|||
125437001|NCT02569710|451226319|FG005|Overall Study|Withdrawal by Subject|1|||
125437002|NCT02569710|451226320|FG006|Overall Study|Withdrawal by Subject|0|||
125437003|NCT02569710|451226321|FG007|Overall Study|Withdrawal by Subject|0|||
125437004|NCT02569710|451226322|FG008|Overall Study|Withdrawal by Subject|0|||
125437005|NCT02569710|451226323|FG009|Overall Study|Withdrawal by Subject|0|||
125437006|NCT04152343|451226324|FG000|Overall Study|Transplanted|5|||
125437007|NCT04152343|451226324|FG000|Overall Study|Death|20|||
125437008|NCT04152343|451226324|FG000|Overall Study|Lost to Follow-up|3|||
125437009|NCT00550550|451226325|FG000|Overall Study|Adverse Event|13|||
125437010|NCT00550550|451226326|FG001|Overall Study|Adverse Event|5|||
125437011|NCT00550550|451226325|FG000|Overall Study|Treatment Failure|0|||
125437012|NCT00550550|451226326|FG001|Overall Study|Treatment Failure|1|||
125437013|NCT00550550|451226325|FG000|Overall Study|Lost to Follow-up|4|||
125437014|NCT00550550|451226326|FG001|Overall Study|Lost to Follow-up|0|||
125437015|NCT00550550|451226325|FG000|Overall Study|Withdrawal by Subject|10|||
125437016|NCT00550550|451226326|FG001|Overall Study|Withdrawal by Subject|8|||
125437017|NCT00550550|451226325|FG000|Overall Study|Protocol Violation|5|||
125437018|NCT00550550|451226326|FG001|Overall Study|Protocol Violation|14|||
125437019|NCT00550550|451226325|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
125437020|NCT00550550|451226326|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
125437021|NCT00550550|451226325|FG000|Overall Study|Randomized But Not Treated|1|||
125437022|NCT00550550|451226326|FG001|Overall Study|Randomized But Not Treated|0|||
125437023|NCT01164228|451226331|FG000|Overall Study|Progression|24|||
125217803|NCT02256917|450425298|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
125217804|NCT02256917|450425298|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
125217805|NCT02256917|450425298|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
125217806|NCT02256917|450425298|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
125217807|NCT02256917|450425298|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
125217808|NCT00313586|450425299|FG000|Overall Study|Disease progression|14|||
125217809|NCT00313586|450425300|FG001|Overall Study|Disease progression|19|||
125217810|NCT00313586|450425301|FG002|Overall Study|Disease progression|10|||
125217811|NCT00313586|450425302|FG003|Overall Study|Disease progression|3|||
125217812|NCT00313586|450425299|FG000|Overall Study|Adverse Event|12|||
125217813|NCT00313586|450425300|FG001|Overall Study|Adverse Event|18|||
125217814|NCT00313586|450425301|FG002|Overall Study|Adverse Event|3|||
125217815|NCT00313586|450425302|FG003|Overall Study|Adverse Event|10|||
125217816|NCT00313586|450425299|FG000|Overall Study|Death|11|||
125217817|NCT00313586|450425300|FG001|Overall Study|Death|8|||
125217818|NCT00313586|450425301|FG002|Overall Study|Death|1|||
125217819|NCT00313586|450425302|FG003|Overall Study|Death|7|||
125217820|NCT00313586|450425299|FG000|Overall Study|Withdrawal by Subject|13|||
125217821|NCT00313586|450425300|FG001|Overall Study|Withdrawal by Subject|6|||
125437024|NCT01164228|451226332|FG001|Overall Study|Progression|25|||
125437025|NCT01164228|451226331|FG000|Overall Study|Adverse Event|13|||
125437026|NCT01164228|451226332|FG001|Overall Study|Adverse Event|7|||
125437027|NCT01164228|451226331|FG000|Overall Study|Death|1|||
125437028|NCT01164228|451226332|FG001|Overall Study|Death|1|||
125437029|NCT01164228|451226331|FG000|Overall Study|Withdrawal by Subject|2|||
125217822|NCT00313586|450425301|FG002|Overall Study|Withdrawal by Subject|6|||
125437030|NCT01164228|451226332|FG001|Overall Study|Withdrawal by Subject|0|||
125437031|NCT01164228|451226331|FG000|Overall Study|Physician Decision|1|||
125437032|NCT01164228|451226332|FG001|Overall Study|Physician Decision|2|||
125437033|NCT01164228|451226331|FG000|Overall Study|Symptomatic deterioration|1|||
125437034|NCT01164228|451226332|FG001|Overall Study|Symptomatic deterioration|0|||
125638680|NCT03093350|451958071|FG000|Overall Study|Signed consent, never began treartment|1|||
125638681|NCT04564027|451958087|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
125638682|NCT04564027|451958088|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
125638683|NCT04564027|451958089|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
125638684|NCT04564027|451958090|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
125638685|NCT00777036|451958091|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
125638686|NCT00777036|451958092|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
125638687|NCT00777036|451958093|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
125638688|NCT00777036|451958094|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
125638689|NCT00777036|451958091|FG000|On Treatment|Administrative Reason By Sponsor|1|||
125638690|NCT00777036|451958092|FG001|On Treatment|Administrative Reason By Sponsor|0|||
125638691|NCT00777036|451958093|FG002|On Treatment|Administrative Reason By Sponsor|9|||
125638692|NCT00777036|451958094|FG003|On Treatment|Administrative Reason By Sponsor|0|||
125638693|NCT00777036|451958091|FG000|On Treatment|Failure to Meet Study Criteria|0|||
125638694|NCT00777036|451958092|FG001|On Treatment|Failure to Meet Study Criteria|1|||
125638695|NCT00777036|451958093|FG002|On Treatment|Failure to Meet Study Criteria|4|||
125638696|NCT00777036|451958094|FG003|On Treatment|Failure to Meet Study Criteria|0|||
125638697|NCT00777036|451958091|FG000|On Treatment|Pregnancy|1|||
125638698|NCT00777036|451958092|FG001|On Treatment|Pregnancy|0|||
125638699|NCT00777036|451958093|FG002|On Treatment|Pregnancy|1|||
125638700|NCT00777036|451958094|FG003|On Treatment|Pregnancy|0|||
125638701|NCT00777036|451958091|FG000|On Treatment|Non-compliance with Study Drug|1|||
125638702|NCT00777036|451958092|FG001|On Treatment|Non-compliance with Study Drug|0|||
125638703|NCT00777036|451958093|FG002|On Treatment|Non-compliance with Study Drug|1|||
125638704|NCT00777036|451958094|FG003|On Treatment|Non-compliance with Study Drug|0|||
125638705|NCT00777036|451958091|FG000|On Treatment|Maximum Clinical Benefit|2|||
125638706|NCT00777036|451958092|FG001|On Treatment|Maximum Clinical Benefit|0|||
125638707|NCT00777036|451958093|FG002|On Treatment|Maximum Clinical Benefit|5|||
125638708|NCT00777036|451958094|FG003|On Treatment|Maximum Clinical Benefit|0|||
125638709|NCT00777036|451958091|FG000|On Treatment|Withdrawal by Subject|0|||
125638710|NCT00777036|451958092|FG001|On Treatment|Withdrawal by Subject|2|||
125638711|NCT00777036|451958093|FG002|On Treatment|Withdrawal by Subject|2|||
125638712|NCT00777036|451958094|FG003|On Treatment|Withdrawal by Subject|0|||
125638713|NCT00777036|451958091|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
125638714|NCT00777036|451958092|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
125638715|NCT00777036|451958093|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
125638716|NCT00777036|451958094|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
125217823|NCT00313586|450425302|FG003|Overall Study|Withdrawal by Subject|2|||
125217824|NCT00313586|450425299|FG000|Overall Study|Alternative therapy|3|||
125217825|NCT00313586|450425300|FG001|Overall Study|Alternative therapy|6|||
125217826|NCT00313586|450425301|FG002|Overall Study|Alternative therapy|2|||
125217827|NCT00313586|450425302|FG003|Overall Study|Alternative therapy|0|||
125217828|NCT00313586|450425299|FG000|Overall Study|Other complicating disease|2|||
125217829|NCT00313586|450425300|FG001|Overall Study|Other complicating disease|2|||
125217830|NCT00313586|450425301|FG002|Overall Study|Other complicating disease|0|||
125217831|NCT00313586|450425302|FG003|Overall Study|Other complicating disease|0|||
125217832|NCT00313586|450425299|FG000|Overall Study|Did not achieve HI-major/better response|10|||
125217833|NCT00313586|450425300|FG001|Overall Study|Did not achieve HI-major/better response|7|||
125217834|NCT00313586|450425301|FG002|Overall Study|Did not achieve HI-major/better response|2|||
125217835|NCT00313586|450425302|FG003|Overall Study|Did not achieve HI-major/better response|1|||
125217836|NCT00313586|450425299|FG000|Overall Study|Physician Decision|2|||
125379887|NCT01499667|451023379|FG000|Overall Study|Withdrawal by Subject|2|||
125379888|NCT01499667|451023380|FG001|Overall Study|Withdrawal by Subject|1|||
125379889|NCT01499667|451023381|FG002|Overall Study|Withdrawal by Subject|1|||
125379890|NCT01499667|451023379|FG000|Overall Study|Lack of Efficacy|2|||
125379891|NCT01499667|451023380|FG001|Overall Study|Lack of Efficacy|0|||
125379892|NCT01499667|451023381|FG002|Overall Study|Lack of Efficacy|0|||
125379893|NCT02902965|451023382|FG000|Overall Study|Withdrawal by Subject|10|||
125379894|NCT02673489|451023383|FG000|Treatment Period|Lost to Follow-up|3|||
125379895|NCT02673489|451023384|FG001|Treatment Period|Lost to Follow-up|0|||
125379896|NCT02673489|451023383|FG000|Treatment Period|Participant request to discontinue|1|||
125379897|NCT02673489|451023384|FG001|Treatment Period|Participant request to discontinue|1|||
125379898|NCT02673489|451023383|FG000|Treatment Period|Participant moved to another province|1|||
125379899|NCT02673489|451023384|FG001|Treatment Period|Participant moved to another province|0|||
125379900|NCT02673489|451023383|FG000|Treatment Period|Participant was incarcerated|0|||
125379901|NCT02673489|451023384|FG001|Treatment Period|Participant was incarcerated|1|||
125379902|NCT02673489|451023383|FG000|Treatment Period|Adverse Event|0|||
125638717|NCT00777036|451958091|FG000|On Treatment|Death|0|||
125638718|NCT00777036|451958092|FG001|On Treatment|Death|2|||
125638719|NCT00777036|451958093|FG002|On Treatment|Death|0|||
125638720|NCT00777036|451958094|FG003|On Treatment|Death|0|||
125638721|NCT00777036|451958091|FG000|On Treatment|Study Drug Toxicity|1|||
125131914|NCT01796171|450110063|FG003|Treatment Period With Betalutin|Death|0|||
125131915|NCT01796171|450110064|FG004|Treatment Period With Betalutin|Death|0|||
125131916|NCT01796171|450110065|FG005|Treatment Period With Betalutin|Death|0|||
125131917|NCT01796171|450110066|FG006|Treatment Period With Betalutin|Death|0|||
125131918|NCT01796171|450110067|FG007|Treatment Period With Betalutin|Death|0|||
125131919|NCT01796171|450110068|FG008|Treatment Period With Betalutin|Death|0|||
125379903|NCT02673489|451023384|FG001|Treatment Period|Adverse Event|1|||
125379904|NCT02673489|451023383|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
125379905|NCT02673489|451023384|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
125379906|NCT02673489|451023383|FG000|Follow Up Period|Unable to return for follow-up|0|||
125379907|NCT02673489|451023384|FG001|Follow Up Period|Unable to return for follow-up|1|||
125379908|NCT02259582|451023385|FG000|Overall Study|Physician Decision|0|||
125379909|NCT02259582|451023386|FG001|Overall Study|Physician Decision|1|||
125379910|NCT02259582|451023387|FG002|Overall Study|Physician Decision|0|||
125379911|NCT02259582|451023385|FG000|Overall Study|Death|0|||
125379912|NCT02259582|451023386|FG001|Overall Study|Death|0|||
125379913|NCT02259582|451023387|FG002|Overall Study|Death|1|||
125379914|NCT02259582|451023385|FG000|Overall Study|Adverse Event|1|||
125379915|NCT02259582|451023386|FG001|Overall Study|Adverse Event|0|||
125379916|NCT02259582|451023387|FG002|Overall Study|Adverse Event|1|||
125379917|NCT02259582|451023385|FG000|Overall Study|Withdrawal by Subject|0|||
125379918|NCT02259582|451023386|FG001|Overall Study|Withdrawal by Subject|0|||
125379919|NCT02259582|451023387|FG002|Overall Study|Withdrawal by Subject|1|||
125379920|NCT02259582|451023385|FG000|Overall Study|Disease progression|14|||
125379921|NCT02259582|451023386|FG001|Overall Study|Disease progression|15|||
125379922|NCT02259582|451023387|FG002|Overall Study|Disease progression|17|||
125379923|NCT02259582|451023385|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
125379924|NCT02259582|451023386|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
125379925|NCT02259582|451023387|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
125379926|NCT00232817|451023388|FG000|Overall Study|Protocol Violation|2|||
125379927|NCT00232817|451023389|FG001|Overall Study|Protocol Violation|1|||
125379928|NCT04481750|451023390|FG000|Period 1 (Fasted)|Adverse Event|0|||
125379929|NCT04481750|451023391|FG001|Period 1 (Fasted)|Adverse Event|0|||
125379930|NCT04481750|451023392|FG002|Period 1 (Fasted)|Adverse Event|1|||
125379931|NCT04481750|451023393|FG003|Period 1 (Fasted)|Adverse Event|0|||
125379932|NCT04481750|451023394|FG004|Period 1 (Fasted)|Adverse Event|0|||
125379933|NCT04481750|451023395|FG005|Period 1 (Fasted)|Adverse Event|0|||
125379934|NCT04481750|451023396|FG006|Period 1 (Fasted)|Adverse Event|0|||
125379935|NCT04481750|451023397|FG007|Period 1 (Fasted)|Adverse Event|0|||
125379936|NCT04481750|451023398|FG008|Period 1 (Fasted)|Adverse Event|0|||
125379937|NCT04481750|451023399|FG009|Period 1 (Fasted)|Adverse Event|0|||
125379938|NCT04481750|451023400|FG010|Period 1 (Fasted)|Adverse Event|0|||
125379939|NCT00475176|451023401|FG000|Overall Study|Adverse Event|2|||
125379940|NCT00475176|451023401|FG000|Overall Study|Withdrawal by Subject|1|||
125379941|NCT00475176|451023401|FG000|Overall Study|Protocol Violation|1|||
125379942|NCT02436889|451023402|FG000|Overall Study|No improvement in symptoms|1|||
125379943|NCT02436889|451023403|FG001|Overall Study|No improvement in symptoms|0|||
125379944|NCT02436889|451023402|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
125379945|NCT02436889|451023403|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
125379946|NCT01034462|451023404|FG000|Overall Study|Adverse Event|7|||
125379947|NCT01034462|451023405|FG001|Overall Study|Adverse Event|17|||
125379948|NCT01034462|451023404|FG000|Overall Study|Lack of Efficacy|4|||
125379949|NCT01034462|451023405|FG001|Overall Study|Lack of Efficacy|4|||
125379950|NCT01034462|451023404|FG000|Overall Study|Protocol Violation|10|||
125379951|NCT01034462|451023405|FG001|Overall Study|Protocol Violation|7|||
125379952|NCT01034462|451023404|FG000|Overall Study|Withdrawal by Subject|9|||
125379953|NCT01034462|451023405|FG001|Overall Study|Withdrawal by Subject|8|||
125379954|NCT01034462|451023404|FG000|Overall Study|Lost to Follow-up|14|||
125379955|NCT01034462|451023405|FG001|Overall Study|Lost to Follow-up|16|||
125379956|NCT01034462|451023404|FG000|Overall Study|Other reasons|1|||
125379957|NCT01034462|451023405|FG001|Overall Study|Other reasons|2|||
125379958|NCT01594125|451023406|FG000|Overall Study|Withdrawal by Subject|1|||
125437035|NCT01164228|451226331|FG000|Overall Study|Never started treatment|1|||
125437036|NCT01164228|451226332|FG001|Overall Study|Never started treatment|3|||
125131920|NCT01796171|450110069|FG009|Treatment Period With Betalutin|Death|0|||
125379959|NCT01594125|451023407|FG001|Overall Study|Withdrawal by Subject|0|||
125379960|NCT01594125|451023408|FG002|Overall Study|Withdrawal by Subject|0|||
125379961|NCT01594125|451023409|FG003|Overall Study|Withdrawal by Subject|1|||
125131921|NCT01796171|450110070|FG010|Treatment Period With Betalutin|Death|2|||
125379962|NCT01594125|451023410|FG004|Overall Study|Withdrawal by Subject|0|||
125379963|NCT01594125|451023406|FG000|Overall Study|Progressive Disease|3|||
125437037|NCT01164228|451226331|FG000|Overall Study|Ineligible|1|||
125379964|NCT01594125|451023407|FG001|Overall Study|Progressive Disease|12|||
125379965|NCT01594125|451023408|FG002|Overall Study|Progressive Disease|3|||
125379966|NCT01594125|451023409|FG003|Overall Study|Progressive Disease|3|||
125379967|NCT01594125|451023410|FG004|Overall Study|Progressive Disease|7|||
125379968|NCT01484873|451023411|FG000|Overall Study|Withdrawal by Subject|2|||
125379969|NCT02564042|451023412|FG000|Overall Study|Adverse Event|4|||
125638722|NCT00777036|451958092|FG001|On Treatment|Study Drug Toxicity|0|||
125131922|NCT01796171|450110071|FG011|Treatment Period With Betalutin|Death|0|||
125379970|NCT02564042|451023413|FG001|Overall Study|Adverse Event|4|||
125379971|NCT02564042|451023414|FG002|Overall Study|Adverse Event|3|||
125379972|NCT02564042|451023415|FG003|Overall Study|Adverse Event|0|||
125379973|NCT02564042|451023416|FG004|Overall Study|Adverse Event|0|||
125379974|NCT02564042|451023417|FG005|Overall Study|Adverse Event|1|||
125379975|NCT02564042|451023412|FG000|Overall Study|Lost to Follow-up|1|||
125379976|NCT02564042|451023413|FG001|Overall Study|Lost to Follow-up|1|||
125379977|NCT02564042|451023414|FG002|Overall Study|Lost to Follow-up|1|||
125379978|NCT02564042|451023415|FG003|Overall Study|Lost to Follow-up|0|||
125379979|NCT02564042|451023416|FG004|Overall Study|Lost to Follow-up|1|||
125379980|NCT02564042|451023417|FG005|Overall Study|Lost to Follow-up|1|||
125379981|NCT02564042|451023412|FG000|Overall Study|Physician Decision|1|||
125379982|NCT02564042|451023413|FG001|Overall Study|Physician Decision|0|||
125379983|NCT02564042|451023414|FG002|Overall Study|Physician Decision|0|||
125379984|NCT02564042|451023415|FG003|Overall Study|Physician Decision|1|||
125379985|NCT02564042|451023416|FG004|Overall Study|Physician Decision|0|||
125379986|NCT02564042|451023417|FG005|Overall Study|Physician Decision|0|||
125379987|NCT02564042|451023412|FG000|Overall Study|Withdrawal by Subject|5|||
125379988|NCT02564042|451023413|FG001|Overall Study|Withdrawal by Subject|3|||
125638723|NCT00777036|451958093|FG002|On Treatment|Study Drug Toxicity|4|||
125638724|NCT00777036|451958094|FG003|On Treatment|Study Drug Toxicity|0|||
125638725|NCT00777036|451958091|FG000|On Treatment|Progressive Disease|6|||
125638726|NCT00777036|451958092|FG001|On Treatment|Progressive Disease|4|||
125131923|NCT01796171|450110072|FG012|Treatment Period With Betalutin|Death|0|||
125131924|NCT01796171|450110073|FG013|Treatment Period With Betalutin|Death|0|||
125131925|NCT01796171|450110074|FG014|Treatment Period With Betalutin|Death|0|||
125379989|NCT02564042|451023414|FG002|Overall Study|Withdrawal by Subject|2|||
125638727|NCT00777036|451958093|FG002|On Treatment|Progressive Disease|7|||
125638728|NCT00777036|451958094|FG003|On Treatment|Progressive Disease|0|||
125638729|NCT00777036|451958091|FG000|On Treatment|Not Reported|0|||
125638730|NCT00777036|451958092|FG001|On Treatment|Not Reported|0|||
125638731|NCT00777036|451958093|FG002|On Treatment|Not Reported|2|||
125638732|NCT00777036|451958094|FG003|On Treatment|Not Reported|0|||
125638733|NCT00777036|451958091|FG000|On Treatment|Site Closed|0|||
125638734|NCT00777036|451958092|FG001|On Treatment|Site Closed|1|||
125638735|NCT00777036|451958093|FG002|On Treatment|Site Closed|1|||
125638736|NCT00777036|451958094|FG003|On Treatment|Site Closed|0|||
125638737|NCT00777036|451958091|FG000|Follow-Up|Withdrawal by Subject|0|||
125638738|NCT00777036|451958092|FG001|Follow-Up|Withdrawal by Subject|0|||
125638739|NCT00777036|451958093|FG002|Follow-Up|Withdrawal by Subject|5|||
125638740|NCT00777036|451958094|FG003|Follow-Up|Withdrawal by Subject|0|||
125638741|NCT00777036|451958091|FG000|Follow-Up|Death|1|||
125638742|NCT00777036|451958092|FG001|Follow-Up|Death|9|||
125638743|NCT00777036|451958093|FG002|Follow-Up|Death|0|||
125638744|NCT00777036|451958094|FG003|Follow-Up|Death|0|||
125638745|NCT00777036|451958091|FG000|Follow-Up|Lost to Follow-up|3|||
125638746|NCT00777036|451958092|FG001|Follow-Up|Lost to Follow-up|0|||
125638747|NCT00777036|451958093|FG002|Follow-Up|Lost to Follow-up|0|||
125638748|NCT00777036|451958094|FG003|Follow-Up|Lost to Follow-up|0|||
125638749|NCT00777036|451958091|FG000|Follow-Up|Reason Not Specified|4|||
125638750|NCT00777036|451958092|FG001|Follow-Up|Reason Not Specified|0|||
125638751|NCT00777036|451958093|FG002|Follow-Up|Reason Not Specified|13|||
125638752|NCT00777036|451958094|FG003|Follow-Up|Reason Not Specified|0|||
125638753|NCT00777036|451958091|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
125638754|NCT00777036|451958092|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
125638755|NCT00777036|451958093|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
125638756|NCT00777036|451958094|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
125638757|NCT01267955|451958097|FG000|Stage 1 (6 Months)|Death|3|||
125638758|NCT01267955|451958097|FG000|Stage 2 (6 Months)|Death|5|||
125638759|NCT01267955|451958097|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
125379990|NCT02564042|451023415|FG003|Overall Study|Withdrawal by Subject|2|||
125379991|NCT02564042|451023416|FG004|Overall Study|Withdrawal by Subject|10|||
125638760|NCT05564039|451958102|FG000|Overall Study|Adverse Event|1|||
125638761|NCT05564039|451958103|FG001|Overall Study|Adverse Event|0|||
125638762|NCT05564039|451958102|FG000|Overall Study|Death|1|||
125638763|NCT05564039|451958103|FG001|Overall Study|Death|1|||
125638764|NCT05564039|451958102|FG000|Overall Study|Lost to Follow-up|3|||
125638765|NCT05564039|451958103|FG001|Overall Study|Lost to Follow-up|2|||
125638766|NCT05564039|451958102|FG000|Overall Study|Withdrawal by Subject|2|||
125131926|NCT01796171|450110060|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
125379992|NCT02564042|451023417|FG005|Overall Study|Withdrawal by Subject|12|||
125379993|NCT01356966|451023418|FG000|Overall Study|Withdrawal by Subject|1|||
125379994|NCT01356966|451023419|FG001|Overall Study|Withdrawal by Subject|2|||
125379995|NCT01356966|451023418|FG000|Overall Study|Physician Decision|1|||
125638767|NCT05564039|451958103|FG001|Overall Study|Withdrawal by Subject|0|||
125638768|NCT05564039|451958102|FG000|Overall Study|Inadvertent enrollment|3|||
125638769|NCT05564039|451958103|FG001|Overall Study|Inadvertent enrollment|6|||
125638770|NCT04651777|451958104|FG000|Overall Study|Adverse Event|1|||
125131927|NCT01796171|450110061|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
125131928|NCT01796171|450110062|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
125131929|NCT01796171|450110063|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
125131930|NCT01796171|450110064|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
125131931|NCT01796171|450110065|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
125131932|NCT01796171|450110066|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
125131933|NCT01796171|450110067|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
125131934|NCT01796171|450110068|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
125131935|NCT01796171|450110069|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
125131936|NCT01796171|450110070|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
125131937|NCT01796171|450110071|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
125131938|NCT01796171|450110072|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
125131939|NCT01796171|450110073|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
125131940|NCT01796171|450110074|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
125131941|NCT01796171|450110060|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131942|NCT01796171|450110061|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131943|NCT01796171|450110062|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131944|NCT01796171|450110063|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131945|NCT01796171|450110064|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131946|NCT01796171|450110065|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131947|NCT01796171|450110066|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131948|NCT01796171|450110067|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131949|NCT01796171|450110068|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131950|NCT01796171|450110069|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131951|NCT01796171|450110070|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
125131952|NCT01796171|450110071|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
125131953|NCT01796171|450110072|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131954|NCT01796171|450110073|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131955|NCT01796171|450110074|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
125131956|NCT01796171|450110060|FG000|Follow-up Period|Start of further anticancer therapy|4|||
125131957|NCT01796171|450110061|FG001|Follow-up Period|Start of further anticancer therapy|25|||
125131958|NCT01796171|450110062|FG002|Follow-up Period|Start of further anticancer therapy|2|||
125131959|NCT01796171|450110063|FG003|Follow-up Period|Start of further anticancer therapy|1|||
125131960|NCT01796171|450110064|FG004|Follow-up Period|Start of further anticancer therapy|2|||
125131961|NCT01796171|450110065|FG005|Follow-up Period|Start of further anticancer therapy|2|||
125131962|NCT01796171|450110066|FG006|Follow-up Period|Start of further anticancer therapy|1|||
125131963|NCT01796171|450110067|FG007|Follow-up Period|Start of further anticancer therapy|15|||
125131964|NCT01796171|450110068|FG008|Follow-up Period|Start of further anticancer therapy|2|||
125131965|NCT01796171|450110069|FG009|Follow-up Period|Start of further anticancer therapy|0|||
125131966|NCT01796171|450110070|FG010|Follow-up Period|Start of further anticancer therapy|0|||
125131967|NCT01796171|450110071|FG011|Follow-up Period|Start of further anticancer therapy|0|||
125131968|NCT01796171|450110072|FG012|Follow-up Period|Start of further anticancer therapy|0|||
125131969|NCT01796171|450110073|FG013|Follow-up Period|Start of further anticancer therapy|0|||
125131970|NCT01796171|450110074|FG014|Follow-up Period|Start of further anticancer therapy|0|||
125131971|NCT01796171|450110060|FG000|Follow-up Period|Progressive disease|0|||
125131972|NCT01796171|450110061|FG001|Follow-up Period|Progressive disease|1|||
125131973|NCT01796171|450110062|FG002|Follow-up Period|Progressive disease|0|||
125131974|NCT01796171|450110063|FG003|Follow-up Period|Progressive disease|0|||
125131975|NCT01796171|450110064|FG004|Follow-up Period|Progressive disease|0|||
125131976|NCT01796171|450110065|FG005|Follow-up Period|Progressive disease|0|||
125131977|NCT01796171|450110066|FG006|Follow-up Period|Progressive disease|0|||
125131978|NCT01796171|450110067|FG007|Follow-up Period|Progressive disease|3|||
125131979|NCT01796171|450110068|FG008|Follow-up Period|Progressive disease|0|||
125131980|NCT01796171|450110069|FG009|Follow-up Period|Progressive disease|0|||
125131981|NCT01796171|450110070|FG010|Follow-up Period|Progressive disease|0|||
125131982|NCT01796171|450110071|FG011|Follow-up Period|Progressive disease|0|||
125131983|NCT01796171|450110072|FG012|Follow-up Period|Progressive disease|0|||
125131984|NCT01796171|450110073|FG013|Follow-up Period|Progressive disease|0|||
125131985|NCT01796171|450110074|FG014|Follow-up Period|Progressive disease|0|||
125379996|NCT01356966|451023419|FG001|Overall Study|Physician Decision|0|||
125379997|NCT01549392|451023420|FG000|Overall Study|Withdrawal by Subject|1|||
125131986|NCT01796171|450110060|FG000|Follow-up Period|Physician Decision|0|||
125379998|NCT01549392|451023421|FG001|Overall Study|Withdrawal by Subject|0|||
125379999|NCT02743806|451023422|FG000|Overall Study|Adverse Event|9|||
125638771|NCT04651777|451958104|FG000|Overall Study|Withdrawal by Subject|2|||
125638772|NCT04566445|451958105|FG000|Overall Study|Death|4|||
125638773|NCT04566445|451958106|FG001|Overall Study|Death|1|||
125638774|NCT04566445|451958107|FG002|Overall Study|Death|1|||
125638775|NCT04566445|451958105|FG000|Overall Study|Lost to Follow-up|3|||
125638776|NCT04566445|451958106|FG001|Overall Study|Lost to Follow-up|1|||
125638777|NCT04566445|451958107|FG002|Overall Study|Lost to Follow-up|1|||
125638778|NCT04566445|451958105|FG000|Overall Study|Study terminated by sponsor|11|||
125638779|NCT04566445|451958106|FG001|Overall Study|Study terminated by sponsor|17|||
125638780|NCT04566445|451958107|FG002|Overall Study|Study terminated by sponsor|32|||
125638781|NCT04566445|451958105|FG000|Overall Study|Withdrawal by Subject|12|||
125638782|NCT04566445|451958106|FG001|Overall Study|Withdrawal by Subject|14|||
125638783|NCT04566445|451958107|FG002|Overall Study|Withdrawal by Subject|13|||
125638784|NCT04566445|451958105|FG000|Overall Study|Randomized but not treated due to AE|2|||
125638785|NCT04566445|451958106|FG001|Overall Study|Randomized but not treated due to AE|1|||
125638786|NCT04566445|451958107|FG002|Overall Study|Randomized but not treated due to AE|0|||
125638787|NCT04566445|451958105|FG000|Overall Study|Adverse Event|1|||
125638788|NCT04566445|451958106|FG001|Overall Study|Adverse Event|1|||
125638789|NCT04566445|451958107|FG002|Overall Study|Adverse Event|0|||
125638790|NCT02421939|451958108|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
125638791|NCT02421939|451958109|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
125638792|NCT02421939|451958108|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
125638793|NCT02421939|451958109|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
125638794|NCT02421939|451958108|FG000|Randomization Period: Up to 3 Years|Death|38|||
125638795|NCT02421939|451958109|FG001|Randomization Period: Up to 3 Years|Death|10|||
125638796|NCT02421939|451958108|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
125638797|NCT02421939|451958109|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
125638798|NCT02421939|451958108|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
125638799|NCT02421939|451958109|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
125638800|NCT02421939|451958108|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
125638801|NCT02421939|451958109|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
125638802|NCT02421939|451958108|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
125638803|NCT02421939|451958109|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
125638804|NCT02421939|451958108|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
125638805|NCT02421939|451958109|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
125638806|NCT02421939|451958108|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
125638807|NCT02421939|451958109|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
125638808|NCT02421939|451958108|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
125638809|NCT02421939|451958109|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
125638810|NCT02421939|451958108|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
125638811|NCT02421939|451958109|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
125638812|NCT02421939|451958108|FG000|Long Term Follow up: up to 3 Years|Death|118|||
125638813|NCT02421939|451958109|FG001|Long Term Follow up: up to 3 Years|Death|65|||
125638814|NCT02421939|451958108|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
125638815|NCT02421939|451958109|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
125638816|NCT04785144|451958110|FG000|Overall Study|Withdrawal by Subject|4|||
125638817|NCT04785144|451958111|FG001|Overall Study|Withdrawal by Subject|1|||
125638818|NCT04785144|451958112|FG002|Overall Study|Withdrawal by Subject|0|||
125638819|NCT04785144|451958113|FG003|Overall Study|Withdrawal by Subject|0|||
125638820|NCT04785144|451958114|FG004|Overall Study|Withdrawal by Subject|0|||
125638821|NCT04785144|451958115|FG005|Overall Study|Withdrawal by Subject|2|||
125638822|NCT04785144|451958116|FG006|Overall Study|Withdrawal by Subject|2|||
125638823|NCT04785144|451958117|FG007|Overall Study|Withdrawal by Subject|0|||
125638824|NCT04785144|451958118|FG008|Overall Study|Withdrawal by Subject|1|||
125638825|NCT04785144|451958119|FG009|Overall Study|Withdrawal by Subject|0|||
125638826|NCT04785144|451958110|FG000|Overall Study|Lost to Follow-up|1|||
125638827|NCT04785144|451958111|FG001|Overall Study|Lost to Follow-up|0|||
125638828|NCT04785144|451958112|FG002|Overall Study|Lost to Follow-up|0|||
125638829|NCT04785144|451958113|FG003|Overall Study|Lost to Follow-up|0|||
125638830|NCT04785144|451958114|FG004|Overall Study|Lost to Follow-up|1|||
125638831|NCT04785144|451958115|FG005|Overall Study|Lost to Follow-up|2|||
125638832|NCT04785144|451958116|FG006|Overall Study|Lost to Follow-up|1|||
125638833|NCT04785144|451958117|FG007|Overall Study|Lost to Follow-up|2|||
125217837|NCT00313586|450425300|FG001|Overall Study|Physician Decision|1|||
125217838|NCT00313586|450425301|FG002|Overall Study|Physician Decision|0|||
125638834|NCT04785144|451958118|FG008|Overall Study|Lost to Follow-up|4|||
125638835|NCT04785144|451958119|FG009|Overall Study|Lost to Follow-up|1|||
125638836|NCT04785144|451958110|FG000|Overall Study|Protocol Violation|0|||
125638837|NCT04785144|451958111|FG001|Overall Study|Protocol Violation|0|||
125638838|NCT04785144|451958112|FG002|Overall Study|Protocol Violation|0|||
125638839|NCT04785144|451958113|FG003|Overall Study|Protocol Violation|0|||
125638840|NCT04785144|451958114|FG004|Overall Study|Protocol Violation|0|||
125638841|NCT04785144|451958115|FG005|Overall Study|Protocol Violation|0|||
125638842|NCT04785144|451958116|FG006|Overall Study|Protocol Violation|1|||
125131987|NCT01796171|450110061|FG001|Follow-up Period|Physician Decision|2|||
125131988|NCT01796171|450110062|FG002|Follow-up Period|Physician Decision|0|||
125131989|NCT01796171|450110063|FG003|Follow-up Period|Physician Decision|0|||
125131990|NCT01796171|450110064|FG004|Follow-up Period|Physician Decision|0|||
125131991|NCT01796171|450110065|FG005|Follow-up Period|Physician Decision|0|||
125131992|NCT01796171|450110066|FG006|Follow-up Period|Physician Decision|0|||
125131993|NCT01796171|450110067|FG007|Follow-up Period|Physician Decision|0|||
125131994|NCT01796171|450110068|FG008|Follow-up Period|Physician Decision|0|||
125131995|NCT01796171|450110069|FG009|Follow-up Period|Physician Decision|0|||
125131996|NCT01796171|450110070|FG010|Follow-up Period|Physician Decision|5|||
125131997|NCT01796171|450110071|FG011|Follow-up Period|Physician Decision|0|||
125131998|NCT01796171|450110072|FG012|Follow-up Period|Physician Decision|0|||
125131999|NCT01796171|450110073|FG013|Follow-up Period|Physician Decision|0|||
125132000|NCT01796171|450110074|FG014|Follow-up Period|Physician Decision|0|||
125132001|NCT01796171|450110060|FG000|Follow-up Period|Withdrawal by Subject|0|||
125132002|NCT01796171|450110061|FG001|Follow-up Period|Withdrawal by Subject|1|||
125132003|NCT01796171|450110062|FG002|Follow-up Period|Withdrawal by Subject|0|||
125132004|NCT01796171|450110063|FG003|Follow-up Period|Withdrawal by Subject|0|||
125132005|NCT01796171|450110064|FG004|Follow-up Period|Withdrawal by Subject|0|||
125132006|NCT01796171|450110065|FG005|Follow-up Period|Withdrawal by Subject|1|||
125132007|NCT01796171|450110066|FG006|Follow-up Period|Withdrawal by Subject|0|||
125132008|NCT01796171|450110067|FG007|Follow-up Period|Withdrawal by Subject|0|||
125132009|NCT01796171|450110068|FG008|Follow-up Period|Withdrawal by Subject|0|||
125132010|NCT01796171|450110069|FG009|Follow-up Period|Withdrawal by Subject|0|||
125132011|NCT01796171|450110070|FG010|Follow-up Period|Withdrawal by Subject|3|||
125132012|NCT01796171|450110071|FG011|Follow-up Period|Withdrawal by Subject|1|||
125132013|NCT01796171|450110072|FG012|Follow-up Period|Withdrawal by Subject|0|||
125132014|NCT01796171|450110073|FG013|Follow-up Period|Withdrawal by Subject|0|||
125132015|NCT01796171|450110074|FG014|Follow-up Period|Withdrawal by Subject|0|||
125132016|NCT01796171|450110060|FG000|Follow-up Period|Death|0|||
125132017|NCT01796171|450110061|FG001|Follow-up Period|Death|0|||
125132018|NCT01796171|450110062|FG002|Follow-up Period|Death|0|||
125217839|NCT00313586|450425302|FG003|Overall Study|Physician Decision|0|||
125217840|NCT00313586|450425299|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
125217841|NCT00313586|450425300|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
125217842|NCT00313586|450425301|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
125638843|NCT04785144|451958117|FG007|Overall Study|Protocol Violation|0|||
125638844|NCT04785144|451958118|FG008|Overall Study|Protocol Violation|0|||
125638845|NCT04785144|451958119|FG009|Overall Study|Protocol Violation|0|||
125380000|NCT02743806|451023422|FG000|Overall Study|Lost to Follow-up|8|||
125380001|NCT02743806|451023422|FG000|Overall Study|Voluntary Withdrawal|54|||
125380002|NCT02743806|451023422|FG000|Overall Study|Study Termination|65|||
125638846|NCT04785144|451958110|FG000|Overall Study|Physician Decision|0|||
125638847|NCT04785144|451958111|FG001|Overall Study|Physician Decision|0|||
125638848|NCT04785144|451958112|FG002|Overall Study|Physician Decision|0|||
125638849|NCT04785144|451958113|FG003|Overall Study|Physician Decision|0|||
125638850|NCT04785144|451958114|FG004|Overall Study|Physician Decision|0|||
125638851|NCT04785144|451958115|FG005|Overall Study|Physician Decision|0|||
125638852|NCT04785144|451958116|FG006|Overall Study|Physician Decision|0|||
125638853|NCT04785144|451958117|FG007|Overall Study|Physician Decision|0|||
125638854|NCT04785144|451958118|FG008|Overall Study|Physician Decision|0|||
125638855|NCT04785144|451958119|FG009|Overall Study|Physician Decision|1|||
125638856|NCT04785144|451958110|FG000|Overall Study|Unable to continue due to work schedule|0|||
125132019|NCT01796171|450110063|FG003|Follow-up Period|Death|0|||
125380003|NCT02743806|451023422|FG000|Overall Study|Pregnancy|6|||
125638857|NCT04785144|451958111|FG001|Overall Study|Unable to continue due to work schedule|0|||
125132020|NCT01796171|450110064|FG004|Follow-up Period|Death|0|||
125217843|NCT00313586|450425302|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
125217844|NCT00313586|450425299|FG000|Overall Study|Lost insurance|0|||
125380004|NCT02743806|451023422|FG000|Overall Study|No Longer Clinically Benefiting|27|||
125380005|NCT02743806|451023422|FG000|Overall Study|Reason Not Specified|12|||
125638858|NCT04785144|451958112|FG002|Overall Study|Unable to continue due to work schedule|0|||
125638859|NCT04785144|451958113|FG003|Overall Study|Unable to continue due to work schedule|0|||
125638860|NCT04785144|451958114|FG004|Overall Study|Unable to continue due to work schedule|0|||
125638861|NCT04785144|451958115|FG005|Overall Study|Unable to continue due to work schedule|0|||
125638862|NCT04785144|451958116|FG006|Overall Study|Unable to continue due to work schedule|0|||
125638863|NCT04785144|451958117|FG007|Overall Study|Unable to continue due to work schedule|0|||
125217845|NCT00313586|450425300|FG001|Overall Study|Lost insurance|1|||
125380006|NCT04273217|451023424|FG000|Overall Study|Lost to Follow-up|0|||
125132021|NCT01796171|450110065|FG005|Follow-up Period|Death|0|||
125132022|NCT01796171|450110066|FG006|Follow-up Period|Death|1|||
125132023|NCT01796171|450110067|FG007|Follow-up Period|Death|0|||
125132024|NCT01796171|450110068|FG008|Follow-up Period|Death|0|||
125132025|NCT01796171|450110069|FG009|Follow-up Period|Death|0|||
125132026|NCT01796171|450110070|FG010|Follow-up Period|Death|17|||
125132027|NCT01796171|450110071|FG011|Follow-up Period|Death|9|||
125638864|NCT04785144|451958118|FG008|Overall Study|Unable to continue due to work schedule|0|||
125638865|NCT04785144|451958119|FG009|Overall Study|Unable to continue due to work schedule|1|||
125638866|NCT03598140|451958120|FG000|Overall Study|enrolled but didn't start|1|||
125638867|NCT03598140|451958121|FG001|Overall Study|enrolled but didn't start|0|||
125638868|NCT05245071|451958122|FG000|Overall Study|Progressive disease|18|||
125638869|NCT05245071|451958122|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
125638870|NCT05245071|451958122|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
125638871|NCT05304611|451958123|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
125638872|NCT05304611|451958124|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
125638873|NCT05304611|451958125|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
125638874|NCT05304611|451958126|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
125638875|NCT05304611|451958127|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
125638876|NCT05304611|451958128|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
125638877|NCT05304611|451958129|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
125638878|NCT05304611|451958130|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
125638879|NCT05304611|451958131|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
125638880|NCT05304611|451958132|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
125638881|NCT05304611|451958133|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
125638882|NCT05304611|451958134|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
125638883|NCT05304611|451958123|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
125638884|NCT05304611|451958124|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
125638885|NCT05304611|451958125|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
125638886|NCT05304611|451958126|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
125638887|NCT05304611|451958127|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
125638888|NCT05304611|451958128|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
125638889|NCT05304611|451958129|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
125638890|NCT05304611|451958130|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
125638891|NCT05304611|451958131|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
125638892|NCT05304611|451958132|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
125638893|NCT05304611|451958133|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
125638894|NCT05304611|451958134|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
125638895|NCT05304611|451958123|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
125638896|NCT05304611|451958124|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
125638897|NCT05304611|451958125|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
125638898|NCT05304611|451958126|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
125638899|NCT05304611|451958127|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
125638900|NCT05304611|451958128|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
125638901|NCT05304611|451958129|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
125638902|NCT05304611|451958130|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
125638903|NCT05304611|451958131|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
125638904|NCT05304611|451958132|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
125638905|NCT05304611|451958133|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
125638906|NCT05304611|451958134|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
125638907|NCT02354690|451958135|FG000|Overall Study|Physician Decision|1|||
125638908|NCT00963820|451958136|FG000|Dose Escalation Phase|Progressive Disease|3|||
125638909|NCT00963820|451958137|FG001|Dose Escalation Phase|Progressive Disease|3|||
125638910|NCT00963820|451958138|FG002|Dose Escalation Phase|Progressive Disease|3|||
125638911|NCT00963820|451958139|FG003|Dose Escalation Phase|Progressive Disease|3|||
125638912|NCT00963820|451958140|FG004|Dose Escalation Phase|Progressive Disease|4|||
125638913|NCT00963820|451958141|FG005|Dose Escalation Phase|Progressive Disease|3|||
125638914|NCT00963820|451958142|FG006|Dose Escalation Phase|Progressive Disease|3|||
125638915|NCT00963820|451958143|FG007|Dose Escalation Phase|Progressive Disease|2|||
125638916|NCT00963820|451958144|FG008|Dose Escalation Phase|Progressive Disease|0|||
125638917|NCT00963820|451958145|FG009|Dose Escalation Phase|Progressive Disease|0|||
125638918|NCT00963820|451958146|FG010|Dose Escalation Phase|Progressive Disease|0|||
125638919|NCT00963820|451958147|FG011|Dose Escalation Phase|Progressive Disease|0|||
125638920|NCT00963820|451958136|FG000|Dose Escalation Phase|Adverse Event|0|||
125638921|NCT00963820|451958137|FG001|Dose Escalation Phase|Adverse Event|0|||
125638922|NCT00963820|451958138|FG002|Dose Escalation Phase|Adverse Event|0|||
125638923|NCT00963820|451958139|FG003|Dose Escalation Phase|Adverse Event|0|||
125638924|NCT00963820|451958140|FG004|Dose Escalation Phase|Adverse Event|0|||
125638925|NCT00963820|451958141|FG005|Dose Escalation Phase|Adverse Event|0|||
125638926|NCT00963820|451958142|FG006|Dose Escalation Phase|Adverse Event|3|||
125638927|NCT00963820|451958143|FG007|Dose Escalation Phase|Adverse Event|1|||
125638928|NCT00963820|451958144|FG008|Dose Escalation Phase|Adverse Event|0|||
125638929|NCT00963820|451958145|FG009|Dose Escalation Phase|Adverse Event|0|||
125638930|NCT00963820|451958146|FG010|Dose Escalation Phase|Adverse Event|0|||
125638931|NCT00963820|451958147|FG011|Dose Escalation Phase|Adverse Event|0|||
125638932|NCT00963820|451958136|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
125638933|NCT00963820|451958137|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
125638934|NCT00963820|451958138|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
125132028|NCT01796171|450110072|FG012|Follow-up Period|Death|1|||
125132029|NCT01796171|450110073|FG013|Follow-up Period|Death|0|||
125132030|NCT01796171|450110074|FG014|Follow-up Period|Death|0|||
125132031|NCT01796171|450110060|FG000|Follow-up Period|Patient transferred to other hospital|0|||
125132032|NCT01796171|450110061|FG001|Follow-up Period|Patient transferred to other hospital|1|||
125132033|NCT01796171|450110062|FG002|Follow-up Period|Patient transferred to other hospital|0|||
125132034|NCT01796171|450110063|FG003|Follow-up Period|Patient transferred to other hospital|0|||
125132035|NCT01796171|450110064|FG004|Follow-up Period|Patient transferred to other hospital|0|||
125132036|NCT01796171|450110065|FG005|Follow-up Period|Patient transferred to other hospital|0|||
125132037|NCT01796171|450110066|FG006|Follow-up Period|Patient transferred to other hospital|0|||
125132038|NCT01796171|450110067|FG007|Follow-up Period|Patient transferred to other hospital|0|||
125132039|NCT01796171|450110068|FG008|Follow-up Period|Patient transferred to other hospital|0|||
125132040|NCT01796171|450110069|FG009|Follow-up Period|Patient transferred to other hospital|0|||
125132041|NCT01796171|450110070|FG010|Follow-up Period|Patient transferred to other hospital|0|||
125132042|NCT01796171|450110071|FG011|Follow-up Period|Patient transferred to other hospital|0|||
125132043|NCT01796171|450110072|FG012|Follow-up Period|Patient transferred to other hospital|0|||
125132044|NCT01796171|450110073|FG013|Follow-up Period|Patient transferred to other hospital|0|||
125132045|NCT01796171|450110074|FG014|Follow-up Period|Patient transferred to other hospital|0|||
125132046|NCT01796171|450110060|FG000|Follow-up Period|Sponsor Decision|0|||
125132047|NCT01796171|450110061|FG001|Follow-up Period|Sponsor Decision|0|||
125132048|NCT01796171|450110062|FG002|Follow-up Period|Sponsor Decision|0|||
125638935|NCT00963820|451958139|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
125638936|NCT00963820|451958140|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
125638937|NCT00963820|451958141|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
125638938|NCT00963820|451958142|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
125638939|NCT00963820|451958143|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
125638940|NCT00963820|451958144|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
125638941|NCT00963820|451958145|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
125638942|NCT00963820|451958146|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
125638943|NCT00963820|451958147|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
125638944|NCT00963820|451958136|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125638945|NCT00963820|451958137|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125638946|NCT00963820|451958138|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125638947|NCT00963820|451958139|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125638948|NCT00963820|451958140|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125638949|NCT00963820|451958141|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125638950|NCT00963820|451958142|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
125638951|NCT00963820|451958143|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125638952|NCT00963820|451958144|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125638953|NCT00963820|451958145|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125638954|NCT00963820|451958146|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125638955|NCT00963820|451958147|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
125638956|NCT00963820|451958136|FG000|Expansion Phase|Progressive Disease|0|||
125638957|NCT00963820|451958137|FG001|Expansion Phase|Progressive Disease|0|||
125638958|NCT00963820|451958138|FG002|Expansion Phase|Progressive Disease|0|||
125638959|NCT00963820|451958139|FG003|Expansion Phase|Progressive Disease|0|||
125638960|NCT00963820|451958140|FG004|Expansion Phase|Progressive Disease|0|||
125638961|NCT00963820|451958141|FG005|Expansion Phase|Progressive Disease|0|||
125638962|NCT00963820|451958142|FG006|Expansion Phase|Progressive Disease|0|||
125638963|NCT00963820|451958143|FG007|Expansion Phase|Progressive Disease|0|||
125638964|NCT00963820|451958144|FG008|Expansion Phase|Progressive Disease|8|||
125638965|NCT00963820|451958145|FG009|Expansion Phase|Progressive Disease|6|||
125638966|NCT00963820|451958146|FG010|Expansion Phase|Progressive Disease|4|||
125638967|NCT00963820|451958147|FG011|Expansion Phase|Progressive Disease|2|||
125638968|NCT00963820|451958136|FG000|Expansion Phase|Adverse Event|0|||
125638969|NCT00963820|451958137|FG001|Expansion Phase|Adverse Event|0|||
125638970|NCT00963820|451958138|FG002|Expansion Phase|Adverse Event|0|||
125638971|NCT00963820|451958139|FG003|Expansion Phase|Adverse Event|0|||
125638972|NCT00963820|451958140|FG004|Expansion Phase|Adverse Event|0|||
125132049|NCT01796171|450110063|FG003|Follow-up Period|Sponsor Decision|0|||
125132050|NCT01796171|450110064|FG004|Follow-up Period|Sponsor Decision|0|||
125132051|NCT01796171|450110065|FG005|Follow-up Period|Sponsor Decision|0|||
125132052|NCT01796171|450110066|FG006|Follow-up Period|Sponsor Decision|0|||
125437038|NCT01164228|451226332|FG001|Overall Study|Ineligible|0|||
125638973|NCT00963820|451958141|FG005|Expansion Phase|Adverse Event|0|||
125638974|NCT00963820|451958142|FG006|Expansion Phase|Adverse Event|0|||
125132053|NCT01796171|450110067|FG007|Follow-up Period|Sponsor Decision|0|||
125132054|NCT01796171|450110068|FG008|Follow-up Period|Sponsor Decision|0|||
125132055|NCT01796171|450110069|FG009|Follow-up Period|Sponsor Decision|0|||
125217846|NCT00313586|450425301|FG002|Overall Study|Lost insurance|0|||
125437039|NCT02090634|451226333|FG000|Overall Study|Lost to Follow-up|0|||
125638975|NCT00963820|451958143|FG007|Expansion Phase|Adverse Event|0|||
125638976|NCT00963820|451958144|FG008|Expansion Phase|Adverse Event|1|||
125132056|NCT01796171|450110070|FG010|Follow-up Period|Sponsor Decision|40|||
125132057|NCT01796171|450110071|FG011|Follow-up Period|Sponsor Decision|15|||
125132058|NCT01796171|450110072|FG012|Follow-up Period|Sponsor Decision|7|||
125132059|NCT01796171|450110073|FG013|Follow-up Period|Sponsor Decision|0|||
125380007|NCT04273217|451023425|FG001|Overall Study|Lost to Follow-up|0|||
125380008|NCT04273217|451023426|FG002|Overall Study|Lost to Follow-up|0|||
125380009|NCT04273217|451023427|FG003|Overall Study|Lost to Follow-up|0|||
125132060|NCT01796171|450110074|FG014|Follow-up Period|Sponsor Decision|0|||
125132061|NCT00829309|450110077|FG000|Washout: 7 Days|Protocol Violation|1|||
125132062|NCT00829309|450110078|FG001|Washout: 7 Days|Protocol Violation|0|||
125132063|NCT00455312|450110081|FG000|Overall Study|Death|0|||
125132064|NCT00455312|450110082|FG001|Overall Study|Death|1|||
125132065|NCT01693523|450110083|FG000|Overall Study|Adverse Event|2|||
125132066|NCT01693523|450110084|FG001|Overall Study|Adverse Event|1|||
125132067|NCT01693523|450110085|FG002|Overall Study|Adverse Event|0|||
125132068|NCT01693523|450110083|FG000|Overall Study|Death|0|||
125132069|NCT01693523|450110084|FG001|Overall Study|Death|1|||
125132070|NCT01693523|450110085|FG002|Overall Study|Death|1|||
125132071|NCT01693523|450110083|FG000|Overall Study|Lost to Follow-up|0|||
125132072|NCT01693523|450110084|FG001|Overall Study|Lost to Follow-up|0|||
125132073|NCT01693523|450110085|FG002|Overall Study|Lost to Follow-up|4|||
125132074|NCT01693523|450110083|FG000|Overall Study|Physician Decision|0|||
125132075|NCT01693523|450110084|FG001|Overall Study|Physician Decision|0|||
125132076|NCT01693523|450110085|FG002|Overall Study|Physician Decision|1|||
125132077|NCT01693523|450110083|FG000|Overall Study|Withdrawal by Subject|1|||
125132078|NCT01693523|450110084|FG001|Overall Study|Withdrawal by Subject|2|||
125132079|NCT01693523|450110085|FG002|Overall Study|Withdrawal by Subject|2|||
125132080|NCT01693523|450110083|FG000|Overall Study|Lack of compliance study medication|1|||
125132081|NCT01693523|450110084|FG001|Overall Study|Lack of compliance study medication|2|||
125132082|NCT01693523|450110085|FG002|Overall Study|Lack of compliance study medication|0|||
125132083|NCT01693523|450110083|FG000|Overall Study|Chemotherapy was held|1|||
125132084|NCT01693523|450110084|FG001|Overall Study|Chemotherapy was held|2|||
125132085|NCT01693523|450110085|FG002|Overall Study|Chemotherapy was held|0|||
125132086|NCT03343535|450110086|FG000|Overall Study|Lost to Follow-up|1|||
125132087|NCT03343535|450110086|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
125132088|NCT03343535|450110086|FG000|Overall Study|Death|12|||
125132089|NCT02659150|450110088|FG000|Subject Enrollment|Physician Decision|3|||
125132090|NCT02659150|450110088|FG000|Subject Enrollment|Withdrawal by Subject|2|||
125132091|NCT02659150|450110088|FG000|Baseline Imaging|Withdrawal by Subject|1|||
125132092|NCT02659150|450110088|FG000|Baseline Imaging|Physician Decision|1|||
125132093|NCT02659150|450110088|FG000|Study Drug Dosing|Adverse Event|1|||
125132094|NCT02576938|450110099|FG000|Overall Study|Adverse Event|5|||
125132095|NCT02576938|450110100|FG001|Overall Study|Adverse Event|3|||
125132096|NCT02576938|450110101|FG002|Overall Study|Adverse Event|6|||
125132097|NCT02576938|450110099|FG000|Overall Study|Protocol Violation|1|||
125132098|NCT02576938|450110100|FG001|Overall Study|Protocol Violation|1|||
125132099|NCT02576938|450110101|FG002|Overall Study|Protocol Violation|1|||
125132100|NCT02576938|450110099|FG000|Overall Study|Withdrawal by Subject|3|||
125132101|NCT02576938|450110100|FG001|Overall Study|Withdrawal by Subject|2|||
125132102|NCT02576938|450110101|FG002|Overall Study|Withdrawal by Subject|4|||
125380010|NCT04273217|451023428|FG004|Overall Study|Lost to Follow-up|0|||
125132103|NCT02576938|450110099|FG000|Overall Study|Lack of Efficacy|9|||
125132104|NCT02576938|450110100|FG001|Overall Study|Lack of Efficacy|4|||
125132105|NCT02576938|450110101|FG002|Overall Study|Lack of Efficacy|0|||
125132106|NCT02576938|450110099|FG000|Overall Study|Lost to Follow-up|2|||
125132107|NCT02576938|450110100|FG001|Overall Study|Lost to Follow-up|0|||
125132108|NCT02576938|450110101|FG002|Overall Study|Lost to Follow-up|1|||
125132109|NCT02576938|450110099|FG000|Overall Study|Physician Decision|0|||
125132110|NCT02576938|450110100|FG001|Overall Study|Physician Decision|1|||
125132111|NCT02576938|450110101|FG002|Overall Study|Physician Decision|0|||
125132112|NCT02576938|450110099|FG000|Overall Study|Met Exclusion Criteria|0|||
125132113|NCT02576938|450110100|FG001|Overall Study|Met Exclusion Criteria|1|||
125217847|NCT00313586|450425302|FG003|Overall Study|Lost insurance|0|||
125217848|NCT00313586|450425299|FG000|Overall Study|Moved|0|||
125217849|NCT00313586|450425300|FG001|Overall Study|Moved|1|||
125380011|NCT04273217|451023429|FG005|Overall Study|Lost to Follow-up|1|||
125380012|NCT04273217|451023424|FG000|Overall Study|Participant non-compliance|0|||
125380013|NCT04273217|451023425|FG001|Overall Study|Participant non-compliance|0|||
125380014|NCT04273217|451023426|FG002|Overall Study|Participant non-compliance|0|||
125380015|NCT04273217|451023427|FG003|Overall Study|Participant non-compliance|0|||
125380016|NCT04273217|451023428|FG004|Overall Study|Participant non-compliance|1|||
125380017|NCT04273217|451023429|FG005|Overall Study|Participant non-compliance|0|||
125217850|NCT00313586|450425301|FG002|Overall Study|Moved|0|||
125217851|NCT00313586|450425302|FG003|Overall Study|Moved|0|||
125380018|NCT04273217|451023424|FG000|Overall Study|Positive urine drug screen|1|||
125380019|NCT04273217|451023425|FG001|Overall Study|Positive urine drug screen|0|||
125380020|NCT04273217|451023426|FG002|Overall Study|Positive urine drug screen|1|||
125217852|NCT00313586|450425299|FG000|Overall Study|Death before starting treatment|1|||
125380021|NCT04273217|451023427|FG003|Overall Study|Positive urine drug screen|0|||
125380022|NCT04273217|451023428|FG004|Overall Study|Positive urine drug screen|0|||
125420812|NCT01260350|451166151|FG007|Overall Study|Lack of Efficacy|0|||
125132114|NCT02576938|450110101|FG002|Overall Study|Met Exclusion Criteria|0|||
125380023|NCT04273217|451023429|FG005|Overall Study|Positive urine drug screen|1|||
125638977|NCT00963820|451958145|FG009|Expansion Phase|Adverse Event|3|||
125638978|NCT00963820|451958146|FG010|Expansion Phase|Adverse Event|0|||
125638979|NCT00963820|451958147|FG011|Expansion Phase|Adverse Event|0|||
125638980|NCT00963820|451958136|FG000|Expansion Phase|Withdrawal by Subject|0|||
125638981|NCT00963820|451958137|FG001|Expansion Phase|Withdrawal by Subject|0|||
125638982|NCT00963820|451958138|FG002|Expansion Phase|Withdrawal by Subject|0|||
125638983|NCT00963820|451958139|FG003|Expansion Phase|Withdrawal by Subject|0|||
125638984|NCT00963820|451958140|FG004|Expansion Phase|Withdrawal by Subject|0|||
125638985|NCT00963820|451958141|FG005|Expansion Phase|Withdrawal by Subject|0|||
125638986|NCT00963820|451958142|FG006|Expansion Phase|Withdrawal by Subject|0|||
125638987|NCT00963820|451958143|FG007|Expansion Phase|Withdrawal by Subject|0|||
125638988|NCT00963820|451958144|FG008|Expansion Phase|Withdrawal by Subject|1|||
125638989|NCT00963820|451958145|FG009|Expansion Phase|Withdrawal by Subject|0|||
125638990|NCT00963820|451958146|FG010|Expansion Phase|Withdrawal by Subject|1|||
125638991|NCT00963820|451958147|FG011|Expansion Phase|Withdrawal by Subject|1|||
125638992|NCT00963820|451958136|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125638993|NCT00963820|451958137|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125638994|NCT00963820|451958138|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125638995|NCT00963820|451958139|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125638996|NCT00963820|451958140|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125638997|NCT00963820|451958141|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125638998|NCT00963820|451958142|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125638999|NCT00963820|451958143|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125639000|NCT00963820|451958144|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125639001|NCT00963820|451958145|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125639002|NCT00963820|451958146|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
125639003|NCT00963820|451958147|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
125639004|NCT04556175|451958155|FG000|Overall Study|Study terminated due to COVID-19|8|||
125639005|NCT04556175|451958156|FG001|Overall Study|Study terminated due to COVID-19|8|||
125639006|NCT05549505|451958158|FG000|Overall Study|Lost to Follow-up|2|||
125639007|NCT05549505|451958159|FG001|Overall Study|Lost to Follow-up|0|||
125639008|NCT05549505|451958158|FG000|Overall Study|Withdrawal by Subject|3|||
125639009|NCT05549505|451958159|FG001|Overall Study|Withdrawal by Subject|3|||
125639010|NCT05549505|451958158|FG000|Overall Study|Other: Miscellaneous|3|||
125639011|NCT05549505|451958159|FG001|Overall Study|Other: Miscellaneous|6|||
125639012|NCT02871791|451958163|FG000|Phase 1b|Death|0|||
125639013|NCT02871791|451958164|FG001|Phase 1b|Death|1|||
125639014|NCT02871791|451958163|FG000|Phase 1b|progressive disease|6|||
125639015|NCT02871791|451958164|FG001|Phase 1b|progressive disease|2|||
125639016|NCT02871791|451958163|FG000|Phase 2|Death|1|||
125639017|NCT02871791|451958164|FG001|Phase 2|Death|0|||
125639018|NCT02871791|451958163|FG000|Phase 2|Lost to Follow-up|2|||
125639019|NCT02871791|451958164|FG001|Phase 2|Lost to Follow-up|0|||
125639020|NCT04005755|451958165|FG000|Overall Study|Adverse Event|6|||
125639021|NCT04005755|451958165|FG000|Overall Study|Physician Decision|3|||
125639022|NCT04005755|451958165|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
125639023|NCT04005755|451958165|FG000|Overall Study|Withdrawal by Subject|3|||
125639024|NCT04005755|451958165|FG000|Overall Study|Lost to Follow-up|1|||
125639025|NCT02723019|451958166|FG000|Overall Study|Death|17|||
125639026|NCT02723019|451958167|FG001|Overall Study|Death|13|||
125639027|NCT02723019|451958166|FG000|Overall Study|Withdrawal by Subject|11|||
125639028|NCT02723019|451958167|FG001|Overall Study|Withdrawal by Subject|7|||
125639029|NCT02723019|451958166|FG000|Overall Study|Lost to Follow-up|57|||
125639030|NCT02723019|451958167|FG001|Overall Study|Lost to Follow-up|70|||
125639031|NCT00515099|451958169|FG000|Overall Study|Lost to Follow-up|0|||
125639032|NCT00515099|451958170|FG001|Overall Study|Lost to Follow-up|4|||
125639033|NCT00515099|451958169|FG000|Overall Study|Withdrawal by Subject|2|||
125639034|NCT00515099|451958170|FG001|Overall Study|Withdrawal by Subject|0|||
125639035|NCT00515099|451958169|FG000|Overall Study|IRB Recommendation|1|||
125639036|NCT00515099|451958170|FG001|Overall Study|IRB Recommendation|0|||
125639037|NCT00592072|451958171|FG000|Wash Out Period|Lost to Follow-up|1|||
125639038|NCT00592072|451958172|FG001|Wash Out Period|Lost to Follow-up|1|||
125639039|NCT02750501|451958178|FG000|Overall Study|Adverse Event|4|||
125639040|NCT02750501|451958178|FG000|Overall Study|Physician Decision|1|||
125639041|NCT02750501|451958178|FG000|Overall Study|Protocol Violation|1|||
125639042|NCT02750501|451958178|FG000|Overall Study|G-tube came out|1|||
125639043|NCT02750501|451958178|FG000|Overall Study|Non-compliant use of PERT|1|||
125380024|NCT00849381|451023430|FG000|Overall Study|Adverse Event|1|||
125639044|NCT01738594|451958179|FG000|Registration and Treatment Start|Adverse Event|0|||
125639045|NCT01738594|451958180|FG001|Registration and Treatment Start|Adverse Event|1|||
125639046|NCT01738594|451958181|FG002|Registration and Treatment Start|Adverse Event|0|||
125639047|NCT01738594|451958182|FG003|Registration and Treatment Start|Adverse Event|0|||
125639048|NCT01738594|451958183|FG004|Registration and Treatment Start|Adverse Event|0|||
125639049|NCT01738594|451958184|FG005|Registration and Treatment Start|Adverse Event|0|||
125132115|NCT03500341|450110102|FG000|Overall Study|Withdrawn prior to Completion|2|||
125132116|NCT00838630|450110104|FG000|First Intervention|Adverse Event|1|||
125132117|NCT00838630|450110105|FG001|First Intervention|Adverse Event|0|||
125437040|NCT02090634|451226334|FG001|Overall Study|Lost to Follow-up|1|||
125132118|NCT00838630|450110104|FG000|Washout: 7 Days|Protocol Violation|1|||
125132119|NCT00838630|450110105|FG001|Washout: 7 Days|Protocol Violation|0|||
125132120|NCT00448591|450110106|FG000|Overall Study|Withdrawal by Subject|178|||
125437041|NCT02090634|451226333|FG000|Overall Study|Death|0|||
125217853|NCT00313586|450425300|FG001|Overall Study|Death before starting treatment|0|||
125217854|NCT00313586|450425301|FG002|Overall Study|Death before starting treatment|0|||
125217855|NCT00313586|450425302|FG003|Overall Study|Death before starting treatment|0|||
125217856|NCT03076996|450425303|FG000|Overall Study|Withdrawal by Subject|2|||
125217857|NCT03076996|450425303|FG000|Overall Study|Lost to Follow-up|3|||
125217858|NCT03076996|450425303|FG000|Overall Study|Literacy precluded participation|1|||
125217859|NCT03117361|450425305|FG000|Overall Study|Progressive disease|5|||
125217860|NCT03117361|450425305|FG000|Overall Study|Death|1|||
125217861|NCT03117361|450425305|FG000|Overall Study|Physician Decision|2|||
125217862|NCT03117361|450425305|FG000|Overall Study|On study treatment at the end of study|1|||
125217863|NCT03117361|450425305|FG000|Overall Study|Treatment-related adverse event|1|||
125217864|NCT03280056|450425309|FG000|Overall Study|Withdrawal by Subject|12|||
125217865|NCT03280056|450425310|FG001|Overall Study|Withdrawal by Subject|14|||
125217866|NCT03280056|450425309|FG000|Overall Study|Death|9|||
125217867|NCT03280056|450425310|FG001|Overall Study|Death|2|||
125217868|NCT03280056|450425309|FG000|Overall Study|Adverse Event|1|||
125217869|NCT03280056|450425310|FG001|Overall Study|Adverse Event|3|||
125217870|NCT03280056|450425309|FG000|Overall Study|Lost to Follow-up|1|||
125217871|NCT03280056|450425310|FG001|Overall Study|Lost to Follow-up|1|||
125217872|NCT03280056|450425309|FG000|Overall Study|Physician Decision|0|||
125217873|NCT03280056|450425310|FG001|Overall Study|Physician Decision|1|||
125217874|NCT03280056|450425309|FG000|Overall Study|Early Discontinuation|1|||
125217875|NCT03280056|450425310|FG001|Overall Study|Early Discontinuation|0|||
125217876|NCT02144077|450425311|FG000|Overall Study|Withdrawal by Subject|3|||
125217877|NCT02144077|450425312|FG001|Overall Study|Withdrawal by Subject|3|||
125217878|NCT02144077|450425311|FG000|Overall Study|Adverse Event|2|||
125217879|NCT02144077|450425312|FG001|Overall Study|Adverse Event|3|||
125217880|NCT02144077|450425311|FG000|Overall Study|Lost to Follow-up|2|||
125217881|NCT02144077|450425312|FG001|Overall Study|Lost to Follow-up|2|||
125217882|NCT02144077|450425311|FG000|Overall Study|Protocol Violation|1|||
125217883|NCT02144077|450425312|FG001|Overall Study|Protocol Violation|2|||
125217884|NCT02144077|450425311|FG000|Overall Study|Death|0|||
125217885|NCT02144077|450425312|FG001|Overall Study|Death|1|||
125217886|NCT02144077|450425311|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
125217887|NCT02144077|450425312|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
125217888|NCT00610168|450425313|FG000|Overall Study|Withdrawal by Subject|2|||
125217889|NCT00610168|450425314|FG001|Overall Study|Withdrawal by Subject|0|||
125217890|NCT00943592|450425315|FG000|Overall Study|Death|3|||
125217891|NCT01247350|450425316|FG000|Overall Study|Adverse Event|0|||
125217892|NCT01247350|450425317|FG001|Overall Study|Adverse Event|0|||
125217893|NCT01247350|450425318|FG002|Overall Study|Adverse Event|1|||
125217894|NCT01247350|450425319|FG003|Overall Study|Adverse Event|0|||
125217895|NCT01247350|450425320|FG004|Overall Study|Adverse Event|0|||
125217896|NCT01247350|450425316|FG000|Overall Study|Withdrawal by Subject|0|||
125217897|NCT01247350|450425317|FG001|Overall Study|Withdrawal by Subject|0|||
125217898|NCT01247350|450425318|FG002|Overall Study|Withdrawal by Subject|0|||
125217899|NCT01247350|450425319|FG003|Overall Study|Withdrawal by Subject|1|||
125217900|NCT01247350|450425320|FG004|Overall Study|Withdrawal by Subject|0|||
125217901|NCT01247350|450425316|FG000|Overall Study|Entry criteria not met|0|||
125217902|NCT01247350|450425317|FG001|Overall Study|Entry criteria not met|0|||
125380025|NCT00849381|451023430|FG000|Overall Study|Lost to Follow-up|129|||
125217903|NCT01247350|450425318|FG002|Overall Study|Entry criteria not met|0|||
125217904|NCT01247350|450425319|FG003|Overall Study|Entry criteria not met|0|||
125380026|NCT00849381|451023430|FG000|Overall Study|Protocol Violation|5|||
125380027|NCT00849381|451023430|FG000|Overall Study|Withdrawal by Subject|6|||
125639050|NCT01738594|451958185|FG006|Registration and Treatment Start|Adverse Event|0|||
125639051|NCT01738594|451958186|FG007|Registration and Treatment Start|Adverse Event|0|||
125639052|NCT01738594|451958179|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125639053|NCT01738594|451958180|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125639054|NCT01738594|451958181|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125639055|NCT01738594|451958182|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125639056|NCT01738594|451958183|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125639057|NCT01738594|451958184|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
125639058|NCT01738594|451958185|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125639059|NCT01738594|451958186|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
125639060|NCT01738594|451958179|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
125639061|NCT01738594|451958180|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
125639062|NCT01738594|451958181|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
125639063|NCT01738594|451958182|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
125639064|NCT01738594|451958183|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
125639065|NCT01738594|451958184|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
125639066|NCT01738594|451958185|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
125639067|NCT01738594|451958186|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
125639068|NCT01738594|451958179|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125380028|NCT00849381|451023430|FG000|Overall Study|Other|4|||
125380029|NCT00303498|451023431|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
125380030|NCT00303498|451023432|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
125380031|NCT00303498|451023431|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
125380032|NCT00303498|451023432|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
125380033|NCT00303498|451023431|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
125380034|NCT00303498|451023432|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
125380035|NCT00303498|451023431|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
125380036|NCT00303498|451023432|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
125380037|NCT00303498|451023431|FG000|Run-In-Phase (10 Weeks)|Other|4|||
125380038|NCT00303498|451023432|FG001|Run-In-Phase (10 Weeks)|Other|1|||
125380039|NCT00303498|451023431|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
125380040|NCT00303498|451023432|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
125380041|NCT00303498|451023431|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
125380042|NCT00303498|451023432|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
125132121|NCT00448591|450110106|FG000|Overall Study|Progressive Disease|1382|||
125380043|NCT00303498|451023431|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
125380044|NCT00303498|451023432|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
125380045|NCT00303498|451023431|FG000|Maintenance Phase (24 Weeks)|Death|1|||
125380046|NCT00303498|451023432|FG001|Maintenance Phase (24 Weeks)|Death|0|||
125380047|NCT00303498|451023431|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
125380048|NCT00303498|451023432|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
125380049|NCT00303498|451023431|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
125380050|NCT00303498|451023432|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
125380051|NCT00303498|451023431|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
125380052|NCT00303498|451023432|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
125132122|NCT00448591|450110106|FG000|Overall Study|Adverse Event|382|||
125132123|NCT00448591|450110106|FG000|Overall Study|Protocol Violation|41|||
125132124|NCT00448591|450110106|FG000|Overall Study|Lost to Follow-up|19|||
125132125|NCT00448591|450110106|FG000|Overall Study|Treatment Regimen Completed|70|||
125132126|NCT00448591|450110106|FG000|Overall Study|Other|154|||
125132127|NCT00448591|450110106|FG000|Overall Study|Termination of Study|70|||
125132128|NCT03017885|450110107|FG000|Overall Study|Adverse Event|2|||
125132129|NCT03017885|450110108|FG001|Overall Study|Adverse Event|0|||
125132130|NCT03017885|450110109|FG002|Overall Study|Adverse Event|0|||
125132131|NCT03017885|450110110|FG003|Overall Study|Adverse Event|0|||
125132132|NCT03017885|450110111|FG004|Overall Study|Adverse Event|0|||
125132133|NCT03017885|450110112|FG005|Overall Study|Adverse Event|0|||
125132134|NCT03017885|450110107|FG000|Overall Study|Progression of disease|4|||
125132135|NCT03017885|450110108|FG001|Overall Study|Progression of disease|3|||
125132136|NCT03017885|450110109|FG002|Overall Study|Progression of disease|4|||
125132137|NCT03017885|450110110|FG003|Overall Study|Progression of disease|0|||
125132138|NCT03017885|450110111|FG004|Overall Study|Progression of disease|0|||
125132139|NCT03017885|450110112|FG005|Overall Study|Progression of disease|0|||
125132140|NCT03017885|450110107|FG000|Overall Study|Other than listed|1|||
125132141|NCT03017885|450110108|FG001|Overall Study|Other than listed|2|||
125132142|NCT03017885|450110109|FG002|Overall Study|Other than listed|1|||
125132143|NCT03017885|450110110|FG003|Overall Study|Other than listed|0|||
125132144|NCT03017885|450110111|FG004|Overall Study|Other than listed|0|||
125132145|NCT03017885|450110112|FG005|Overall Study|Other than listed|0|||
125380053|NCT00303498|451023431|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
125639069|NCT01738594|451958180|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125639070|NCT01738594|451958181|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125639071|NCT01738594|451958182|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125639072|NCT01738594|451958183|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125639073|NCT01738594|451958184|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
125639074|NCT01738594|451958185|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125639075|NCT01738594|451958186|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
125639076|NCT01738594|451958179|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125639077|NCT01738594|451958180|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125639078|NCT01738594|451958181|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125639079|NCT01738594|451958182|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125639080|NCT01738594|451958183|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125639081|NCT01738594|451958184|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
125639082|NCT01738594|451958185|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125639083|NCT01738594|451958186|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
125639084|NCT01738594|451958179|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125639085|NCT01738594|451958180|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125639086|NCT01738594|451958181|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125639087|NCT01738594|451958182|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125639088|NCT01738594|451958183|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
125639089|NCT01738594|451958184|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125639090|NCT01738594|451958185|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125639091|NCT01738594|451958186|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
125639092|NCT01738594|451958179|FG000|Follow up for 1 Year|Death|0|||
125639093|NCT01738594|451958180|FG001|Follow up for 1 Year|Death|0|||
125639094|NCT01738594|451958181|FG002|Follow up for 1 Year|Death|0|||
125639095|NCT01738594|451958182|FG003|Follow up for 1 Year|Death|0|||
125639096|NCT01738594|451958183|FG004|Follow up for 1 Year|Death|0|||
125639097|NCT01738594|451958184|FG005|Follow up for 1 Year|Death|1|||
125639098|NCT01738594|451958185|FG006|Follow up for 1 Year|Death|0|||
125639099|NCT01738594|451958186|FG007|Follow up for 1 Year|Death|0|||
125639100|NCT01738594|451958179|FG000|Follow up for 1 Year|Other|0|||
125639101|NCT01738594|451958180|FG001|Follow up for 1 Year|Other|0|||
125639102|NCT01738594|451958181|FG002|Follow up for 1 Year|Other|0|||
125639103|NCT01738594|451958182|FG003|Follow up for 1 Year|Other|0|||
125639104|NCT01738594|451958183|FG004|Follow up for 1 Year|Other|0|||
125639105|NCT01738594|451958184|FG005|Follow up for 1 Year|Other|2|||
125639106|NCT01738594|451958185|FG006|Follow up for 1 Year|Other|0|||
125639107|NCT01738594|451958186|FG007|Follow up for 1 Year|Other|0|||
125639108|NCT00403390|451958187|FG000|Overall Study|Withdrawal by Subject|1|||
125639109|NCT00403390|451958188|FG001|Overall Study|Withdrawal by Subject|0|||
125639110|NCT00403390|451958187|FG000|Overall Study|samples lost|1|||
125639111|NCT00403390|451958188|FG001|Overall Study|samples lost|0|||
125639112|NCT00403390|451958187|FG000|Overall Study|non-compliant|1|||
125639113|NCT00403390|451958188|FG001|Overall Study|non-compliant|0|||
125639114|NCT01708915|451958198|FG000|Overall Study|Adverse Event|1|||
125639115|NCT01708915|451958199|FG001|Overall Study|Adverse Event|0|||
125639116|NCT01708915|451958200|FG002|Overall Study|Adverse Event|9|||
125639117|NCT01708915|451958201|FG003|Overall Study|Adverse Event|13|||
125639118|NCT01708915|451958198|FG000|Overall Study|Lack of Efficacy|84|||
125639119|NCT01708915|451958199|FG001|Overall Study|Lack of Efficacy|60|||
125639120|NCT01708915|451958200|FG002|Overall Study|Lack of Efficacy|35|||
125639121|NCT01708915|451958201|FG003|Overall Study|Lack of Efficacy|15|||
125639122|NCT01708915|451958198|FG000|Overall Study|Protocol Violation|0|||
125639123|NCT01708915|451958199|FG001|Overall Study|Protocol Violation|0|||
125639124|NCT01708915|451958200|FG002|Overall Study|Protocol Violation|0|||
125639125|NCT01708915|451958201|FG003|Overall Study|Protocol Violation|1|||
125639126|NCT01708915|451958198|FG000|Overall Study|Withdrawal by Subject|0|||
125639127|NCT01708915|451958199|FG001|Overall Study|Withdrawal by Subject|1|||
125639128|NCT01708915|451958200|FG002|Overall Study|Withdrawal by Subject|2|||
125639129|NCT01708915|451958201|FG003|Overall Study|Withdrawal by Subject|2|||
125639130|NCT01708915|451958198|FG000|Overall Study|Other reasons than stated above|1|||
125639131|NCT01708915|451958199|FG001|Overall Study|Other reasons than stated above|1|||
125639132|NCT01708915|451958200|FG002|Overall Study|Other reasons than stated above|0|||
125132146|NCT03017885|450110107|FG000|Overall Study|Lost to Follow-up|2|||
125132147|NCT03017885|450110108|FG001|Overall Study|Lost to Follow-up|0|||
125132148|NCT03017885|450110109|FG002|Overall Study|Lost to Follow-up|3|||
125132149|NCT03017885|450110110|FG003|Overall Study|Lost to Follow-up|0|||
125132150|NCT03017885|450110111|FG004|Overall Study|Lost to Follow-up|0|||
125132151|NCT03017885|450110112|FG005|Overall Study|Lost to Follow-up|0|||
125132152|NCT03017885|450110107|FG000|Overall Study|Change to other anti-cancer therapy|0|||
125132153|NCT03017885|450110108|FG001|Overall Study|Change to other anti-cancer therapy|0|||
125132154|NCT03017885|450110109|FG002|Overall Study|Change to other anti-cancer therapy|1|||
125132155|NCT03017885|450110110|FG003|Overall Study|Change to other anti-cancer therapy|0|||
125132156|NCT03017885|450110111|FG004|Overall Study|Change to other anti-cancer therapy|0|||
125132157|NCT03017885|450110112|FG005|Overall Study|Change to other anti-cancer therapy|0|||
125132158|NCT01289262|450110113|FG000|Overall Study|Lost to Follow-up|29|||
125639133|NCT01708915|451958201|FG003|Overall Study|Other reasons than stated above|2|||
125639134|NCT03231228|451958202|FG000|Overall Study|Lost to Follow-up|2|||
125639135|NCT03231228|451958203|FG001|Overall Study|Lost to Follow-up|0|||
125639136|NCT03231228|451958202|FG000|Overall Study|Physician Decision|1|||
125639137|NCT03231228|451958203|FG001|Overall Study|Physician Decision|0|||
125639138|NCT02554721|451959894|FG000|Overall Study|Adverse Event|1|||
125639139|NCT02554721|451959895|FG001|Overall Study|Adverse Event|0|||
125639140|NCT02554721|451959896|FG002|Overall Study|Adverse Event|0|||
125639141|NCT02554721|451959897|FG003|Overall Study|Adverse Event|0|||
125639142|NCT02554721|451959898|FG004|Overall Study|Adverse Event|1|||
125639143|NCT02554721|451959894|FG000|Overall Study|Noncompliance|0|||
125639144|NCT02554721|451959895|FG001|Overall Study|Noncompliance|0|||
125639145|NCT02554721|451959896|FG002|Overall Study|Noncompliance|0|||
125639146|NCT02554721|451959897|FG003|Overall Study|Noncompliance|0|||
125639147|NCT02554721|451959898|FG004|Overall Study|Noncompliance|1|||
125639148|NCT00908895|451959900|FG000|Overall Study|Lost to Follow-up|1|||
125639149|NCT00908895|451959901|FG001|Overall Study|Lost to Follow-up|3|||
125639150|NCT00908895|451959900|FG000|Overall Study|algodystrophy|2|||
125639151|NCT00908895|451959901|FG001|Overall Study|algodystrophy|2|||
125639152|NCT00908895|451959900|FG000|Overall Study|Adverse Event|1|||
125639153|NCT00908895|451959901|FG001|Overall Study|Adverse Event|1|||
125639154|NCT03661983|451959902|FG000|Open Label Stabilization Phase|Adverse Event|5|||
125639155|NCT03661983|451959903|FG001|Open Label Stabilization Phase|Adverse Event|0|||
125639156|NCT03661983|451959904|FG002|Open Label Stabilization Phase|Adverse Event|0|||
125639157|NCT03661983|451959905|FG003|Open Label Stabilization Phase|Adverse Event|0|||
125639158|NCT03661983|451959902|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
125639159|NCT03661983|451959903|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
125639160|NCT03661983|451959904|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
125639161|NCT03661983|451959905|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
125639162|NCT03661983|451959902|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
125639163|NCT03661983|451959903|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
125639164|NCT03661983|451959904|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
125639165|NCT03661983|451959905|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
125639166|NCT03661983|451959902|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
125639167|NCT03661983|451959903|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
125639168|NCT03661983|451959904|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
125639169|NCT03661983|451959905|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
125639170|NCT03661983|451959902|FG000|Double-blind Randomized Phase|Adverse Event|0|||
125639171|NCT03661983|451959903|FG001|Double-blind Randomized Phase|Adverse Event|1|||
125639172|NCT03661983|451959904|FG002|Double-blind Randomized Phase|Adverse Event|0|||
125639173|NCT03661983|451959905|FG003|Double-blind Randomized Phase|Adverse Event|0|||
125639174|NCT03661983|451959902|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
125639175|NCT03661983|451959903|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
125639176|NCT03661983|451959904|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
125639177|NCT03661983|451959905|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
125639178|NCT03661983|451959902|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
125639179|NCT03661983|451959903|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
125639180|NCT03661983|451959904|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
125639181|NCT03661983|451959905|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
125639182|NCT03661983|451959902|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
125639183|NCT03661983|451959903|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
125639184|NCT03661983|451959904|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
125639185|NCT03661983|451959905|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
125132159|NCT01289262|450110114|FG001|Overall Study|Lost to Follow-up|16|||
125639186|NCT00166504|451959909|FG000|Overall Study|Adverse Event|3|||
125639187|NCT00166504|451959910|FG001|Overall Study|Adverse Event|3|||
125639188|NCT00166504|451959909|FG000|Overall Study|Lost to Follow-up|1|||
125639189|NCT00166504|451959910|FG001|Overall Study|Lost to Follow-up|1|||
125639190|NCT00166504|451959909|FG000|Overall Study|Withdrawal by Subject|1|||
125639191|NCT00166504|451959910|FG001|Overall Study|Withdrawal by Subject|0|||
125639192|NCT02094612|451959911|FG000|Overall Study|Lost to Follow-up|47|||
125639193|NCT02094612|451959912|FG001|Overall Study|Lost to Follow-up|47|||
125639194|NCT02094612|451959911|FG000|Overall Study|Never started ADHD medication|32|||
125132160|NCT01289262|450110113|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
125639195|NCT02094612|451959912|FG001|Overall Study|Never started ADHD medication|23|||
125639196|NCT01222767|451959913|FG000|Overall Study|Progressive disease|13|||
125132161|NCT01289262|450110114|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
125639197|NCT01222767|451959913|FG000|Overall Study|Adverse Event|2|||
125639198|NCT01222767|451959913|FG000|Overall Study|Surgical resection|1|||
125639199|NCT01222767|451959913|FG000|Overall Study|Never treated|1|||
125639200|NCT00723489|451959914|FG000|Overall Study|Physician Decision|0|||
125639201|NCT00723489|451959915|FG001|Overall Study|Physician Decision|1|||
125639202|NCT00723489|451959916|FG002|Overall Study|Physician Decision|0|||
125639203|NCT00723489|451959917|FG003|Overall Study|Physician Decision|0|||
125639204|NCT00723489|451959914|FG000|Overall Study|Pregnancy|0|||
125639205|NCT00723489|451959915|FG001|Overall Study|Pregnancy|0|||
125639206|NCT00723489|451959916|FG002|Overall Study|Pregnancy|0|||
125639207|NCT00723489|451959917|FG003|Overall Study|Pregnancy|1|||
125639208|NCT00723489|451959914|FG000|Overall Study|Withdrawal by Subject|0|||
125639209|NCT00723489|451959915|FG001|Overall Study|Withdrawal by Subject|0|||
125639210|NCT00723489|451959916|FG002|Overall Study|Withdrawal by Subject|0|||
125639211|NCT00723489|451959917|FG003|Overall Study|Withdrawal by Subject|1|||
125639212|NCT00723489|451959914|FG000|Overall Study|Seropositive at baseline|1|||
125639213|NCT00723489|451959915|FG001|Overall Study|Seropositive at baseline|0|||
125639214|NCT00723489|451959916|FG002|Overall Study|Seropositive at baseline|0|||
125639215|NCT00723489|451959917|FG003|Overall Study|Seropositive at baseline|0|||
125639216|NCT00723489|451959914|FG000|Overall Study|Prohibited Medication|0|||
125639217|NCT00723489|451959915|FG001|Overall Study|Prohibited Medication|0|||
125639218|NCT00723489|451959916|FG002|Overall Study|Prohibited Medication|0|||
125639219|NCT00723489|451959917|FG003|Overall Study|Prohibited Medication|1|||
125639220|NCT00723489|451959914|FG000|Overall Study|Samples Collected Out of Window|0|||
125639221|NCT00723489|451959915|FG001|Overall Study|Samples Collected Out of Window|3|||
125639222|NCT00723489|451959916|FG002|Overall Study|Samples Collected Out of Window|0|||
125639223|NCT00723489|451959917|FG003|Overall Study|Samples Collected Out of Window|0|||
125639224|NCT00081263|451959918|FG000|Overall Study|clerical error|1|||
125639225|NCT00081263|451959919|FG001|Overall Study|clerical error|0|||
125639226|NCT00081263|451959918|FG000|Overall Study|wrong cell type|7|||
125639227|NCT00081263|451959919|FG001|Overall Study|wrong cell type|5|||
125639228|NCT00081263|451959918|FG000|Overall Study|improper pre-protocol therapy|0|||
125639229|NCT00081263|451959919|FG001|Overall Study|improper pre-protocol therapy|1|||
125639230|NCT00081263|451959918|FG000|Overall Study|Inadequate pathology|0|||
125639231|NCT00081263|451959919|FG001|Overall Study|Inadequate pathology|1|||
125639232|NCT00081263|451959918|FG000|Overall Study|Never treated|4|||
125639233|NCT00081263|451959919|FG001|Overall Study|Never treated|5|||
125639234|NCT00081263|451959918|FG000|Overall Study|Inadequate data|5|||
125639235|NCT00081263|451959919|FG001|Overall Study|Inadequate data|10|||
125639236|NCT04517253|451959920|FG000|Primary Treatment Period|Adverse Event|1|||
125639237|NCT04517253|451959921|FG001|Primary Treatment Period|Adverse Event|0|||
125639238|NCT04517253|451959922|FG002|Primary Treatment Period|Adverse Event|0|||
125639239|NCT04517253|451959920|FG000|Primary Treatment Period|Death|0|||
125639240|NCT04517253|451959921|FG001|Primary Treatment Period|Death|1|||
125639241|NCT04517253|451959922|FG002|Primary Treatment Period|Death|0|||
125639242|NCT04517253|451959920|FG000|Maintenance Period|Withdrawal by Subject|1|||
125639243|NCT04517253|451959921|FG001|Maintenance Period|Withdrawal by Subject|0|||
125639244|NCT04517253|451959922|FG002|Maintenance Period|Withdrawal by Subject|0|||
125639245|NCT04517253|451959920|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
125639246|NCT04517253|451959921|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
125639247|NCT04517253|451959922|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
125639248|NCT02559115|451959923|FG000|Overall Study|Withdrawal by Subject|3|||
125639249|NCT02060903|451959926|FG000|Overall Study|Lost to Follow-up|4|||
125639250|NCT02060903|451959927|FG001|Overall Study|Lost to Follow-up|0|||
125639251|NCT02060903|451959926|FG000|Overall Study|Withdrawal by Subject|0|||
125639252|NCT02060903|451959927|FG001|Overall Study|Withdrawal by Subject|7|||
125639253|NCT00958191|451959936|FG000|Overall Study|Death|4|||
125639254|NCT00958191|451959936|FG000|Overall Study|Lost to Follow-up|5|||
125639255|NCT00958191|451959936|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
125639256|NCT00958191|451959936|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
125639257|NCT00958191|451959936|FG000|Overall Study|Revision of study device|4|||
125132162|NCT00838279|450110115|FG000|Washout|Protocol Violation|1|||
125132163|NCT00838279|450110116|FG001|Washout|Protocol Violation|0|||
125132164|NCT00838279|450110115|FG000|Washout|Withdrawal by Subject|0|||
125132165|NCT00838279|450110116|FG001|Washout|Withdrawal by Subject|1|||
125132166|NCT01250912|450110120|FG000|Overall Study|Lost to Follow-up|1|||
125380054|NCT00303498|451023432|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
125380055|NCT00303498|451023431|FG000|Maintenance Phase (24 Weeks)|Other|1|||
125639258|NCT00958191|451959936|FG000|Overall Study|Site termination|11|||
125380056|NCT00303498|451023432|FG001|Maintenance Phase (24 Weeks)|Other|0|||
125639259|NCT00958191|451959936|FG000|Overall Study|No 5 yr x-rays|56|||
125639260|NCT00611767|451959937|FG000|Overall Study|Withdrawal by Subject|4|||
125639261|NCT00611767|451959938|FG001|Overall Study|Withdrawal by Subject|1|||
125639262|NCT00611767|451959937|FG000|Overall Study|Thiopental not available|3|||
125639263|NCT00611767|451959938|FG001|Overall Study|Thiopental not available|0|||
125639264|NCT00611767|451959937|FG000|Overall Study|didn't like the medication|1|||
125639265|NCT00611767|451959938|FG001|Overall Study|didn't like the medication|1|||
125217905|NCT01247350|450425320|FG004|Overall Study|Entry criteria not met|1|||
125217906|NCT00169104|450425321|FG000|Overall Study|Withdrawal by Subject|2|||
125217907|NCT00169104|450425322|FG001|Overall Study|Withdrawal by Subject|0|||
125217908|NCT00169104|450425321|FG000|Overall Study|Protocol Violation|0|||
125217909|NCT00169104|450425322|FG001|Overall Study|Protocol Violation|1|||
125217910|NCT00169104|450425321|FG000|Overall Study|Physician Decision|0|||
125217911|NCT00169104|450425322|FG001|Overall Study|Physician Decision|1|||
125217912|NCT01540981|450425328|FG000|Overall Study|Withdrawal by Subject|1|||
125217913|NCT01540981|450425329|FG001|Overall Study|Withdrawal by Subject|0|||
125217914|NCT00141518|450425332|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
125217915|NCT00141518|450425333|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
125217916|NCT00141518|450425334|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
125217917|NCT00141518|450425332|FG000|Overall Study|Adverse Event|7|||
125217918|NCT00141518|450425333|FG001|Overall Study|Adverse Event|5|||
125217919|NCT00141518|450425334|FG002|Overall Study|Adverse Event|2|||
125217920|NCT00141518|450425332|FG000|Overall Study|Withdrawal by Subject|2|||
125217921|NCT00141518|450425333|FG001|Overall Study|Withdrawal by Subject|0|||
125217922|NCT00141518|450425334|FG002|Overall Study|Withdrawal by Subject|2|||
125217923|NCT00141518|450425332|FG000|Overall Study|Protocol Violation|1|||
125217924|NCT00141518|450425333|FG001|Overall Study|Protocol Violation|1|||
125217925|NCT00141518|450425334|FG002|Overall Study|Protocol Violation|2|||
125217926|NCT00141518|450425332|FG000|Overall Study|Lack of Efficacy|5|||
125217927|NCT00141518|450425333|FG001|Overall Study|Lack of Efficacy|0|||
125217928|NCT00141518|450425334|FG002|Overall Study|Lack of Efficacy|0|||
125217929|NCT01806168|450425336|FG000|Overall Study|Adverse Event|1|||
125217930|NCT01806168|450425337|FG001|Overall Study|Adverse Event|0|||
125217931|NCT01806168|450425338|FG002|Overall Study|Adverse Event|0|||
125217932|NCT01806168|450425336|FG000|Overall Study|Withdrawal by Subject|0|||
125217933|NCT01806168|450425337|FG001|Overall Study|Withdrawal by Subject|1|||
125217934|NCT01806168|450425338|FG002|Overall Study|Withdrawal by Subject|2|||
125217935|NCT01806168|450425336|FG000|Overall Study|Protocol Violation|0|||
125217936|NCT01806168|450425337|FG001|Overall Study|Protocol Violation|0|||
125217937|NCT01806168|450425338|FG002|Overall Study|Protocol Violation|1|||
125217938|NCT02438280|450425343|FG000|Overall Study|Physician Decision|1|||
125217939|NCT02438280|450425344|FG001|Overall Study|Physician Decision|0|||
125217940|NCT03066778|450425347|FG000|Overall Study|Death|195|||
125217941|NCT03066778|450425348|FG001|Overall Study|Death|205|||
125217942|NCT03066778|450425347|FG000|Overall Study|Withdrawal by Subject|5|||
125217943|NCT03066778|450425348|FG001|Overall Study|Withdrawal by Subject|7|||
125217944|NCT02328937|450425349|FG000|Period 1|Lost to Follow-up|0|||
125217945|NCT02328937|450425350|FG001|Period 1|Lost to Follow-up|0|||
125217946|NCT02328937|450425351|FG002|Period 1|Lost to Follow-up|0|||
125217947|NCT02328937|450425352|FG003|Period 1|Lost to Follow-up|1|||
125217948|NCT02328937|450425353|FG004|Period 1|Lost to Follow-up|0|||
125217949|NCT02328937|450425354|FG005|Period 1|Lost to Follow-up|0|||
125217950|NCT02328937|450425349|FG000|Period 2|Adverse Event|0|||
125217951|NCT02328937|450425350|FG001|Period 2|Adverse Event|0|||
125217952|NCT02328937|450425351|FG002|Period 2|Adverse Event|1|||
125217953|NCT02328937|450425352|FG003|Period 2|Adverse Event|0|||
125217954|NCT02328937|450425353|FG004|Period 2|Adverse Event|0|||
125217955|NCT02328937|450425354|FG005|Period 2|Adverse Event|0|||
125217956|NCT02091414|450425355|FG000|Overall Study|Withdrawal by Subject|2|||
125217957|NCT02091414|450425355|FG000|Overall Study|Death|2|||
125217958|NCT03665077|450425358|FG000|Overall Study|Lost to Follow-up|2|||
125217959|NCT03665077|450425358|FG000|Overall Study|Physician Decision|2|||
125217960|NCT02959918|450425359|FG000|Overall Study|Adverse Event|1|||
125217961|NCT02959918|450425360|FG001|Overall Study|Adverse Event|1|||
125217962|NCT02959918|450425361|FG002|Overall Study|Adverse Event|2|||
125217963|NCT02959918|450425362|FG003|Overall Study|Adverse Event|0|||
125217964|NCT02959918|450425363|FG004|Overall Study|Adverse Event|0|||
125380057|NCT00303498|451023431|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
125380058|NCT00303498|451023432|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
125420813|NCT01260350|451166152|FG008|Overall Study|Lack of Efficacy|0|||
125639266|NCT00611767|451959937|FG000|Overall Study|Physician Decision|1|||
125639267|NCT00611767|451959938|FG001|Overall Study|Physician Decision|0|||
125217965|NCT02959918|450425364|FG005|Overall Study|Adverse Event|2|||
125217966|NCT02959918|450425365|FG006|Overall Study|Adverse Event|2|||
125217967|NCT02959918|450425366|FG007|Overall Study|Adverse Event|1|||
125217968|NCT02959918|450425367|FG008|Overall Study|Adverse Event|2|||
125217969|NCT02959918|450425368|FG009|Overall Study|Adverse Event|1|||
125217970|NCT02959918|450425369|FG010|Overall Study|Adverse Event|1|||
125217971|NCT02959918|450425370|FG011|Overall Study|Adverse Event|3|||
125217972|NCT02959918|450425371|FG012|Overall Study|Adverse Event|2|||
125217973|NCT02959918|450425372|FG013|Overall Study|Adverse Event|4|||
125217974|NCT02959918|450425359|FG000|Overall Study|Lost to Follow-up|0|||
125217975|NCT02959918|450425360|FG001|Overall Study|Lost to Follow-up|0|||
125217976|NCT02959918|450425361|FG002|Overall Study|Lost to Follow-up|0|||
125217977|NCT02959918|450425362|FG003|Overall Study|Lost to Follow-up|0|||
125217978|NCT02959918|450425363|FG004|Overall Study|Lost to Follow-up|0|||
125639268|NCT02010567|451959939|FG000|Overall Study|Adverse Event|0|||
125639269|NCT02010567|451959940|FG001|Overall Study|Adverse Event|0|||
125639270|NCT02010567|451959941|FG002|Overall Study|Adverse Event|1|||
125639271|NCT02010567|451959942|FG003|Overall Study|Adverse Event|0|||
125639272|NCT02010567|451959943|FG004|Overall Study|Adverse Event|1|||
125639273|NCT00118040|451959944|FG000|Overall Study|Adverse Event|0|||
125639274|NCT00118040|451959945|FG001|Overall Study|Adverse Event|1|||
125639275|NCT00118040|451959946|FG002|Overall Study|Adverse Event|0|||
125639276|NCT00118040|451959944|FG000|Overall Study|Withdrawal by Subject|0|||
125639277|NCT00118040|451959945|FG001|Overall Study|Withdrawal by Subject|0|||
125639278|NCT00118040|451959946|FG002|Overall Study|Withdrawal by Subject|2|||
125639279|NCT00118040|451959944|FG000|Overall Study|Medical Contraindication|0|||
125639280|NCT00118040|451959945|FG001|Overall Study|Medical Contraindication|0|||
125639281|NCT00118040|451959946|FG002|Overall Study|Medical Contraindication|1|||
125639282|NCT00118040|451959944|FG000|Overall Study|Non-Compliant Participant|1|||
125132167|NCT01218867|450110123|FG000|Overall Study|Death during treatment|0|||
125132168|NCT01218867|450110124|FG001|Overall Study|Death during treatment|0|||
125132169|NCT01218867|450110125|FG002|Overall Study|Death during treatment|0|||
125132170|NCT01218867|450110126|FG003|Overall Study|Death during treatment|0|||
125132171|NCT01218867|450110127|FG004|Overall Study|Death during treatment|0|||
125132172|NCT01218867|450110128|FG005|Overall Study|Death during treatment|0|||
125132173|NCT01218867|450110129|FG006|Overall Study|Death during treatment|1|||
125132174|NCT01218867|450110130|FG007|Overall Study|Death during treatment|0|||
125132175|NCT01218867|450110131|FG008|Overall Study|Death during treatment|0|||
125132176|NCT01218867|450110132|FG009|Overall Study|Death during treatment|0|||
125132177|NCT01218867|450110133|FG010|Overall Study|Death during treatment|0|||
125132178|NCT01474551|450110134|FG000|Overall Study|Death|1|||
125639283|NCT00118040|451959945|FG001|Overall Study|Non-Compliant Participant|1|||
125639284|NCT00118040|451959946|FG002|Overall Study|Non-Compliant Participant|2|||
125639285|NCT00118040|451959944|FG000|Overall Study|Other|0|||
125639286|NCT00118040|451959945|FG001|Overall Study|Other|0|||
125437042|NCT02090634|451226334|FG001|Overall Study|Death|1|||
125437043|NCT02090634|451226333|FG000|Overall Study|Protocol Violation|3|||
125437044|NCT02090634|451226334|FG001|Overall Study|Protocol Violation|1|||
125437045|NCT02090634|451226333|FG000|Overall Study|Adverse Event|2|||
125639287|NCT00118040|451959946|FG002|Overall Study|Other|1|||
125639288|NCT00942422|451959947|FG000|Overall Study|Withdrawal by Subject|1|||
125639289|NCT00942422|451959947|FG000|Overall Study|Death|1|||
125639290|NCT00942422|451959947|FG000|Overall Study|Progressive diease|1|||
125639291|NCT03117309|451959950|FG000|Overall Study|Not meeting inclusion criteria|0|||
125639292|NCT03117309|451959951|FG001|Overall Study|Not meeting inclusion criteria|1|||
125639293|NCT04048876|451959952|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
125639294|NCT04048876|451959953|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
125639295|NCT04048876|451959954|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
125639296|NCT04048876|451959955|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
125639297|NCT04048876|451959952|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
125639298|NCT04048876|451959953|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
125639299|NCT04048876|451959954|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
125639300|NCT04048876|451959955|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
125639301|NCT04048876|451959952|FG000|Placebo Controlled Phase|Adverse Event|0|||
125639302|NCT04048876|451959953|FG001|Placebo Controlled Phase|Adverse Event|1|||
125639303|NCT04048876|451959954|FG002|Placebo Controlled Phase|Adverse Event|0|||
125639304|NCT04048876|451959955|FG003|Placebo Controlled Phase|Adverse Event|0|||
125639305|NCT04048876|451959952|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
125639306|NCT04048876|451959953|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
125639307|NCT04048876|451959954|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
125639308|NCT04048876|451959955|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
125639309|NCT01347840|451959964|FG000|Overall Study|Withdrawal by Subject|1|||
125639310|NCT01010776|451959967|FG000|Main Phase|Withdrawal by Subject|14|||
125639311|NCT01010776|451959967|FG000|Main Phase|Lack of Efficacy|8|||
125639312|NCT01010776|451959967|FG000|Main Phase|Adverse Event|7|||
125639313|NCT01010776|451959967|FG000|Main Phase|Lost to Follow-up|6|||
125639314|NCT01010776|451959967|FG000|Main Phase|Non-compliance to study medication|5|||
125639315|NCT01010776|451959967|FG000|Main Phase|Selection failure|2|||
125639316|NCT01010776|451959967|FG000|Main Phase|Inform consent withdrawal|1|||
125639317|NCT01010776|451959967|FG000|Main Phase|Other|1|||
125639318|NCT01010776|451959967|FG000|Main Phase|Did not received study medication|5|||
125639319|NCT01010776|451959967|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
125639320|NCT01010776|451959967|FG000|Extension Phase|Other|3|||
125639321|NCT01012037|451959969|FG000|Overall Study|Adverse Event|0|||
125639322|NCT01012037|451959970|FG001|Overall Study|Adverse Event|8|||
125639323|NCT01012037|451959971|FG002|Overall Study|Adverse Event|3|||
125639324|NCT01012037|451959969|FG000|Overall Study|Protocol Violation|0|||
125639325|NCT01012037|451959970|FG001|Overall Study|Protocol Violation|3|||
125639326|NCT01012037|451959971|FG002|Overall Study|Protocol Violation|5|||
125639327|NCT01012037|451959969|FG000|Overall Study|Withdrawal by Subject|0|||
125639328|NCT01012037|451959970|FG001|Overall Study|Withdrawal by Subject|4|||
125639329|NCT01012037|451959971|FG002|Overall Study|Withdrawal by Subject|1|||
125639330|NCT01012037|451959969|FG000|Overall Study|Other reason (not specified)|1|||
125639331|NCT01012037|451959970|FG001|Overall Study|Other reason (not specified)|1|||
125639332|NCT01012037|451959971|FG002|Overall Study|Other reason (not specified)|1|||
125639333|NCT02583711|451959972|FG000|Overall Study|Withdrawal by Subject|0|||
125639334|NCT02583711|451959973|FG001|Overall Study|Withdrawal by Subject|10|||
125639335|NCT02583711|451959974|FG002|Overall Study|Withdrawal by Subject|0|||
125639336|NCT00415623|451959976|FG000|Overall Study|Adverse Event|3|||
125639337|NCT00415623|451959977|FG001|Overall Study|Adverse Event|4|||
125639338|NCT00415623|451959976|FG000|Overall Study|Death|1|||
125639339|NCT00415623|451959977|FG001|Overall Study|Death|0|||
125639340|NCT00415623|451959976|FG000|Overall Study|Withdrawal by Subject|1|||
125639341|NCT00415623|451959977|FG001|Overall Study|Withdrawal by Subject|1|||
125639342|NCT05307523|451959978|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
125639343|NCT05307523|451959979|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
125380059|NCT00303498|451023431|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
125380060|NCT00303498|451023432|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
125380061|NCT02618434|451023434|FG000|Overall Study|Withdrawal by Subject|0|||
125380062|NCT02618434|451023435|FG001|Overall Study|Withdrawal by Subject|2|||
125380063|NCT02618434|451023436|FG002|Overall Study|Withdrawal by Subject|3|||
125380064|NCT02618434|451023434|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
125639344|NCT05307523|451959978|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
125639345|NCT05307523|451959979|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
125639346|NCT00542425|451959985|FG000|Initial 24 Weeks|Administrative reasons|0|||
125639347|NCT00542425|451959986|FG001|Initial 24 Weeks|Administrative reasons|0|||
125639348|NCT00542425|451959987|FG002|Initial 24 Weeks|Administrative reasons|1|||
125639349|NCT00542425|451959988|FG003|Initial 24 Weeks|Administrative reasons|1|||
125639350|NCT00542425|451959989|FG004|Initial 24 Weeks|Administrative reasons|0|||
125639351|NCT00542425|451959985|FG000|Initial 24 Weeks|Adverse Event|0|||
125639352|NCT00542425|451959986|FG001|Initial 24 Weeks|Adverse Event|1|||
125639353|NCT00542425|451959987|FG002|Initial 24 Weeks|Adverse Event|1|||
125639354|NCT00542425|451959988|FG003|Initial 24 Weeks|Adverse Event|3|||
125639355|NCT00542425|451959989|FG004|Initial 24 Weeks|Adverse Event|2|||
125639356|NCT00542425|451959985|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
125639357|NCT00542425|451959986|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
125639358|NCT00542425|451959987|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
125639359|NCT00542425|451959988|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
125639360|NCT00542425|451959989|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
125639361|NCT00542425|451959985|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
125639362|NCT00542425|451959986|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
125639363|NCT00542425|451959987|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
125639364|NCT00542425|451959988|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
125639365|NCT00542425|451959989|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
125639366|NCT00542425|451959985|FG000|Initial 24 Weeks|Non-compliance|0|||
125639367|NCT00542425|451959986|FG001|Initial 24 Weeks|Non-compliance|0|||
125639368|NCT00542425|451959987|FG002|Initial 24 Weeks|Non-compliance|0|||
125639369|NCT00542425|451959988|FG003|Initial 24 Weeks|Non-compliance|1|||
125639370|NCT00542425|451959989|FG004|Initial 24 Weeks|Non-compliance|1|||
125639371|NCT00542425|451959985|FG000|Initial 24 Weeks|Protocol Violation|0|||
125639372|NCT00542425|451959986|FG001|Initial 24 Weeks|Protocol Violation|0|||
125639373|NCT00542425|451959987|FG002|Initial 24 Weeks|Protocol Violation|0|||
125639374|NCT00542425|451959988|FG003|Initial 24 Weeks|Protocol Violation|1|||
125639375|NCT00542425|451959989|FG004|Initial 24 Weeks|Protocol Violation|0|||
125639376|NCT00542425|451959985|FG000|Initial 24 Weeks|Refusal of treatment|2|||
125639377|NCT00542425|451959986|FG001|Initial 24 Weeks|Refusal of treatment|2|||
125639378|NCT00542425|451959987|FG002|Initial 24 Weeks|Refusal of treatment|1|||
125639379|NCT00542425|451959988|FG003|Initial 24 Weeks|Refusal of treatment|4|||
125639380|NCT00542425|451959989|FG004|Initial 24 Weeks|Refusal of treatment|1|||
125639381|NCT00542425|451959985|FG000|Initial 24 Weeks|Other|0|||
125132179|NCT01921062|450110135|FG000|Overall Study|Withdrawal by Subject|0|||
125132180|NCT01921062|450110136|FG001|Overall Study|Withdrawal by Subject|7|||
125132181|NCT01921062|450110135|FG000|Overall Study|Adverse Event|5|||
125132182|NCT01921062|450110136|FG001|Overall Study|Adverse Event|6|||
125132183|NCT01921062|450110135|FG000|Overall Study|Protocol Violation|0|||
125217979|NCT02959918|450425364|FG005|Overall Study|Lost to Follow-up|0|||
125217980|NCT02959918|450425365|FG006|Overall Study|Lost to Follow-up|0|||
125217981|NCT02959918|450425366|FG007|Overall Study|Lost to Follow-up|0|||
125217982|NCT02959918|450425367|FG008|Overall Study|Lost to Follow-up|0|||
125132184|NCT01921062|450110136|FG001|Overall Study|Protocol Violation|1|||
125132185|NCT01921062|450110135|FG000|Overall Study|VMIQ score > 72|4|||
125132186|NCT01921062|450110136|FG001|Overall Study|VMIQ score > 72|1|||
125132187|NCT01921062|450110135|FG000|Overall Study|Logistic error|0|||
125132188|NCT01921062|450110136|FG001|Overall Study|Logistic error|1|||
125217983|NCT02959918|450425368|FG009|Overall Study|Lost to Follow-up|1|||
125217984|NCT02959918|450425369|FG010|Overall Study|Lost to Follow-up|0|||
125217985|NCT02959918|450425370|FG011|Overall Study|Lost to Follow-up|0|||
125217986|NCT02959918|450425371|FG012|Overall Study|Lost to Follow-up|1|||
125217987|NCT02959918|450425372|FG013|Overall Study|Lost to Follow-up|0|||
125217988|NCT02959918|450425359|FG000|Overall Study|Withdrawal by Subject|0|||
125217989|NCT02959918|450425360|FG001|Overall Study|Withdrawal by Subject|0|||
125217990|NCT02959918|450425361|FG002|Overall Study|Withdrawal by Subject|1|||
125217991|NCT02959918|450425362|FG003|Overall Study|Withdrawal by Subject|2|||
125639382|NCT00542425|451959986|FG001|Initial 24 Weeks|Other|2|||
125639383|NCT00542425|451959987|FG002|Initial 24 Weeks|Other|1|||
125639384|NCT00542425|451959988|FG003|Initial 24 Weeks|Other|0|||
125639385|NCT00542425|451959989|FG004|Initial 24 Weeks|Other|0|||
125639386|NCT00542425|451959985|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
125217992|NCT02959918|450425363|FG004|Overall Study|Withdrawal by Subject|0|||
125639387|NCT00542425|451959986|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
125639388|NCT00542425|451959987|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
125132189|NCT05323396|450110137|FG000|Overall Study|Lost to Follow-up|1|||
125132190|NCT05323396|450110138|FG001|Overall Study|Lost to Follow-up|35|||
125217993|NCT02959918|450425364|FG005|Overall Study|Withdrawal by Subject|0|||
125639389|NCT00542425|451959988|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
125639390|NCT00542425|451959989|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
125132191|NCT05323396|450110137|FG000|Overall Study|Pregnancy|1|||
125217994|NCT02959918|450425365|FG006|Overall Study|Withdrawal by Subject|1|||
125217995|NCT02959918|450425366|FG007|Overall Study|Withdrawal by Subject|0|||
125639391|NCT00542425|451959985|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
125639392|NCT00542425|451959986|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
125639393|NCT00542425|451959987|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
125639394|NCT00542425|451959988|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
125639395|NCT00542425|451959989|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
125639396|NCT00542425|451959985|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
125639397|NCT00542425|451959986|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
125639398|NCT00542425|451959987|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
125639399|NCT00542425|451959988|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
125639400|NCT00542425|451959989|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
125639401|NCT00542425|451959985|FG000|Extended 24 Weeks of Treatment|Other|1|||
125639402|NCT00542425|451959986|FG001|Extended 24 Weeks of Treatment|Other|1|||
125639403|NCT00542425|451959987|FG002|Extended 24 Weeks of Treatment|Other|0|||
125639404|NCT00542425|451959988|FG003|Extended 24 Weeks of Treatment|Other|0|||
125639405|NCT00542425|451959989|FG004|Extended 24 Weeks of Treatment|Other|1|||
125639406|NCT02096471|451959990|FG000|Overall Study|Adverse Event|1|||
125639407|NCT02096471|451959990|FG000|Overall Study|Lack of Efficacy|7|||
125639408|NCT02096471|451959990|FG000|Overall Study|Withdrawal by Subject|3|||
125639409|NCT02096471|451959990|FG000|Overall Study|Non-Compliant|2|||
125639410|NCT01610414|451959991|FG000|Study Start - Month 13|Serious Adverse Event|65|||
125639411|NCT01610414|451959992|FG001|Study Start - Month 13|Serious Adverse Event|67|||
125639412|NCT01610414|451959991|FG000|Study Start - Month 13|Adverse Event|14|||
125639413|NCT01610414|451959992|FG001|Study Start - Month 13|Adverse Event|14|||
125639414|NCT01610414|451959991|FG000|Study Start - Month 13|Protocol Violation|3|||
125639415|NCT01610414|451959992|FG001|Study Start - Month 13|Protocol Violation|1|||
125639416|NCT01610414|451959991|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
125639417|NCT01610414|451959992|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
125639418|NCT01610414|451959991|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
125639419|NCT01610414|451959992|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
125639420|NCT01610414|451959991|FG000|Study Start - Month 13|Lost to Follow-up|4|||
125639421|NCT01610414|451959992|FG001|Study Start - Month 13|Lost to Follow-up|6|||
125639422|NCT01610414|451959991|FG000|Study Start - Month 13|Suspected HZ episode|1|||
125639423|NCT01610414|451959992|FG001|Study Start - Month 13|Suspected HZ episode|3|||
125639424|NCT01610414|451959991|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
125639425|NCT01610414|451959992|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
125639426|NCT01610414|451959991|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
125639427|NCT01610414|451959992|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
125639428|NCT01610414|451959991|FG000|Month 13 - Month 25|Adverse Event|8|||
125639429|NCT01610414|451959992|FG001|Month 13 - Month 25|Adverse Event|4|||
125639430|NCT01610414|451959991|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
125639431|NCT01610414|451959992|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
125639432|NCT01610414|451959991|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
125639433|NCT01610414|451959992|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
125639434|NCT01610414|451959991|FG000|Month 13 - Month 25|Protocol Violation|0|||
125639435|NCT01610414|451959992|FG001|Month 13 - Month 25|Protocol Violation|2|||
125639436|NCT01610414|451959991|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
125639437|NCT01610414|451959992|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
125639438|NCT01610414|451959991|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
125639439|NCT01610414|451959992|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
125639440|NCT01610414|451959991|FG000|After Month 25|Study end not reached|48|||
125639441|NCT01610414|451959992|FG001|After Month 25|Study end not reached|53|||
125639442|NCT02736474|451959993|FG000|Overall Study|Lost to Follow-up|0|||
125639443|NCT02736474|451959994|FG001|Overall Study|Lost to Follow-up|1|||
125639444|NCT02483611|451959995|FG000|Overall Study|Protocol Violation|0|||
125639445|NCT02483611|451959996|FG001|Overall Study|Protocol Violation|0|||
125380065|NCT02618434|451023435|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
125380066|NCT02618434|451023436|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
125380067|NCT02618434|451023434|FG000|Overall Study|Lost to Follow-up|3|||
125380068|NCT02618434|451023435|FG001|Overall Study|Lost to Follow-up|1|||
125639446|NCT02483611|451959997|FG002|Overall Study|Protocol Violation|1|||
125639447|NCT02382276|451959998|FG000|Overall Study|Withdrawal by Subject|4|||
125639448|NCT02382276|451959999|FG001|Overall Study|Withdrawal by Subject|8|||
125639449|NCT02382276|451960000|FG002|Overall Study|Withdrawal by Subject|5|||
125639450|NCT02382276|451959998|FG000|Overall Study|Adverse Event|7|||
125639451|NCT02382276|451959999|FG001|Overall Study|Adverse Event|2|||
125639452|NCT02382276|451960000|FG002|Overall Study|Adverse Event|32|||
125639453|NCT02382276|451959998|FG000|Overall Study|Physician Decision|0|||
125639454|NCT02382276|451959999|FG001|Overall Study|Physician Decision|0|||
125639455|NCT02382276|451960000|FG002|Overall Study|Physician Decision|2|||
125639456|NCT04223778|451960003|FG000|Overall Study|Death|1|||
125639457|NCT04223778|451960004|FG001|Overall Study|Death|1|||
125639458|NCT04223778|451960003|FG000|Overall Study|Lost to Follow-up|4|||
125639459|NCT04223778|451960004|FG001|Overall Study|Lost to Follow-up|5|||
125380069|NCT02618434|451023436|FG002|Overall Study|Lost to Follow-up|3|||
125380070|NCT02618434|451023434|FG000|Overall Study|Adverse Event|1|||
125380071|NCT02618434|451023435|FG001|Overall Study|Adverse Event|0|||
125380072|NCT02618434|451023436|FG002|Overall Study|Adverse Event|12|||
125380073|NCT02618434|451023434|FG000|Overall Study|Physician Decision|0|||
125380074|NCT02618434|451023435|FG001|Overall Study|Physician Decision|1|||
125380075|NCT02618434|451023436|FG002|Overall Study|Physician Decision|0|||
125380076|NCT02618434|451023434|FG000|Overall Study|Protocol Violation|0|||
125380077|NCT02618434|451023435|FG001|Overall Study|Protocol Violation|0|||
125639460|NCT04223778|451960003|FG000|Overall Study|Physician Decision|10|||
125217996|NCT02959918|450425367|FG008|Overall Study|Withdrawal by Subject|1|||
125217997|NCT02959918|450425368|FG009|Overall Study|Withdrawal by Subject|1|||
125217998|NCT02959918|450425369|FG010|Overall Study|Withdrawal by Subject|2|||
125217999|NCT02959918|450425370|FG011|Overall Study|Withdrawal by Subject|3|||
125218000|NCT02959918|450425371|FG012|Overall Study|Withdrawal by Subject|1|||
125218001|NCT02959918|450425372|FG013|Overall Study|Withdrawal by Subject|1|||
125218002|NCT02959918|450425359|FG000|Overall Study|Protocol Violation|0|||
125218003|NCT02959918|450425360|FG001|Overall Study|Protocol Violation|0|||
125218004|NCT02959918|450425361|FG002|Overall Study|Protocol Violation|1|||
125218005|NCT02959918|450425362|FG003|Overall Study|Protocol Violation|0|||
125218006|NCT02959918|450425363|FG004|Overall Study|Protocol Violation|0|||
125218007|NCT02959918|450425364|FG005|Overall Study|Protocol Violation|1|||
125218008|NCT02959918|450425365|FG006|Overall Study|Protocol Violation|0|||
125218009|NCT02959918|450425366|FG007|Overall Study|Protocol Violation|0|||
125218010|NCT02959918|450425367|FG008|Overall Study|Protocol Violation|2|||
125218011|NCT02959918|450425368|FG009|Overall Study|Protocol Violation|1|||
125218012|NCT02959918|450425369|FG010|Overall Study|Protocol Violation|0|||
125218013|NCT02959918|450425370|FG011|Overall Study|Protocol Violation|1|||
125218014|NCT02959918|450425371|FG012|Overall Study|Protocol Violation|1|||
125218015|NCT02959918|450425372|FG013|Overall Study|Protocol Violation|0|||
125218016|NCT02959918|450425359|FG000|Overall Study|Stopping Rule Met|1|||
125218017|NCT02959918|450425360|FG001|Overall Study|Stopping Rule Met|0|||
125218018|NCT02959918|450425361|FG002|Overall Study|Stopping Rule Met|3|||
125218019|NCT02959918|450425362|FG003|Overall Study|Stopping Rule Met|4|||
125218020|NCT02959918|450425363|FG004|Overall Study|Stopping Rule Met|5|||
125218021|NCT02959918|450425364|FG005|Overall Study|Stopping Rule Met|3|||
125218022|NCT02959918|450425365|FG006|Overall Study|Stopping Rule Met|2|||
125218023|NCT02959918|450425366|FG007|Overall Study|Stopping Rule Met|4|||
125218024|NCT02959918|450425367|FG008|Overall Study|Stopping Rule Met|1|||
125218025|NCT02959918|450425368|FG009|Overall Study|Stopping Rule Met|1|||
125218026|NCT02959918|450425369|FG010|Overall Study|Stopping Rule Met|3|||
125218027|NCT02959918|450425370|FG011|Overall Study|Stopping Rule Met|5|||
125218028|NCT02959918|450425371|FG012|Overall Study|Stopping Rule Met|2|||
125218029|NCT02959918|450425372|FG013|Overall Study|Stopping Rule Met|1|||
125218030|NCT02959918|450425359|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
125218031|NCT02959918|450425360|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
125218032|NCT02959918|450425361|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
125218033|NCT02959918|450425362|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
125218034|NCT02959918|450425363|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218035|NCT02959918|450425364|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218036|NCT02959918|450425365|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218037|NCT02959918|450425366|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218038|NCT02959918|450425367|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218039|NCT02959918|450425368|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218040|NCT02959918|450425369|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218041|NCT02959918|450425370|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218042|NCT02959918|450425371|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125218043|NCT02959918|450425372|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
125380078|NCT02618434|451023436|FG002|Overall Study|Protocol Violation|1|||
125639461|NCT04223778|451960004|FG001|Overall Study|Physician Decision|6|||
125639462|NCT04223778|451960003|FG000|Overall Study|Withdrawal by Subject|35|||
125639463|NCT04223778|451960004|FG001|Overall Study|Withdrawal by Subject|17|||
125639464|NCT04223778|451960003|FG000|Overall Study|Not Reported|7|||
125639465|NCT04223778|451960004|FG001|Overall Study|Not Reported|8|||
125218044|NCT02959918|450425359|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218045|NCT02959918|450425360|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125639466|NCT03893630|451960005|FG000|Overall Study|Lost to Follow-up|5|||
125218046|NCT02959918|450425361|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218047|NCT02959918|450425362|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218048|NCT02959918|450425363|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218049|NCT02959918|450425364|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218050|NCT02959918|450425365|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218051|NCT02959918|450425366|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
125639467|NCT03893630|451960006|FG001|Overall Study|Lost to Follow-up|4|||
125218052|NCT02959918|450425367|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125639468|NCT03893630|451960007|FG002|Overall Study|Lost to Follow-up|2|||
125639469|NCT03893630|451960005|FG000|Overall Study|Withdrawal by Subject|3|||
125639470|NCT03893630|451960006|FG001|Overall Study|Withdrawal by Subject|6|||
125639471|NCT03893630|451960007|FG002|Overall Study|Withdrawal by Subject|3|||
125639472|NCT03893630|451960005|FG000|Overall Study|Discontinued Intervention|0|||
125639473|NCT03893630|451960006|FG001|Overall Study|Discontinued Intervention|4|||
125639474|NCT03893630|451960007|FG002|Overall Study|Discontinued Intervention|2|||
125639475|NCT01569568|451961525|FG000|Overall Study|Physician Decision|0|||
125639476|NCT01569568|451961526|FG001|Overall Study|Physician Decision|2|||
125639477|NCT01370499|451961527|FG000|Overall Study|Adverse Event|38|||
125639478|NCT01370499|451961528|FG001|Overall Study|Adverse Event|12|||
125639479|NCT01370499|451961527|FG000|Overall Study|Lack of Efficacy|4|||
125639480|NCT01370499|451961528|FG001|Overall Study|Lack of Efficacy|2|||
125639481|NCT01370499|451961527|FG000|Overall Study|Lost to Follow-up|2|||
125639482|NCT01370499|451961528|FG001|Overall Study|Lost to Follow-up|1|||
125639483|NCT01370499|451961527|FG000|Overall Study|Physician Decision|3|||
125639484|NCT01370499|451961528|FG001|Overall Study|Physician Decision|3|||
125639485|NCT01370499|451961527|FG000|Overall Study|Protocol Violation|5|||
125639486|NCT01370499|451961528|FG001|Overall Study|Protocol Violation|4|||
125639487|NCT01370499|451961527|FG000|Overall Study|Withdrawal by Subject|18|||
125639488|NCT01370499|451961528|FG001|Overall Study|Withdrawal by Subject|7|||
125639489|NCT01370499|451961527|FG000|Overall Study|Sponsor Decision|41|||
125639490|NCT01370499|451961528|FG001|Overall Study|Sponsor Decision|15|||
125639491|NCT00887822|451961529|FG000|Overall Study|Insufficient therapeutic response|53|||
125639492|NCT00887822|451961530|FG001|Overall Study|Insufficient therapeutic response|55|||
125639493|NCT00887822|451961529|FG000|Overall Study|Adverse Event|14|||
125639494|NCT00887822|451961530|FG001|Overall Study|Adverse Event|17|||
125639495|NCT00887822|451961529|FG000|Overall Study|Failure to return|11|||
125639496|NCT00887822|451961530|FG001|Overall Study|Failure to return|11|||
125639497|NCT00887822|451961529|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
125639498|NCT00887822|451961530|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
125639499|NCT00887822|451961529|FG000|Overall Study|Administrative/Other than specified|5|||
125639500|NCT00887822|451961530|FG001|Overall Study|Administrative/Other than specified|4|||
125639501|NCT00887822|451961529|FG000|Overall Study|Death|2|||
125639502|NCT00887822|451961530|FG001|Overall Study|Death|3|||
125639503|NCT00887822|451961529|FG000|Overall Study|Protocol Violation|0|||
125639504|NCT00887822|451961530|FG001|Overall Study|Protocol Violation|1|||
125639505|NCT00887822|451961529|FG000|Overall Study|Randomized but not treated|0|||
125639506|NCT00887822|451961530|FG001|Overall Study|Randomized but not treated|1|||
125639507|NCT02045979|451961531|FG000|Overall Study|Informed Consent Withdrawn|2|||
125639508|NCT02045979|451961532|FG001|Overall Study|Informed Consent Withdrawn|0|||
125639509|NCT02045979|451961533|FG002|Overall Study|Informed Consent Withdrawn|1|||
125639510|NCT02045979|451961531|FG000|Overall Study|not specified above|0|||
125639511|NCT02045979|451961532|FG001|Overall Study|not specified above|1|||
125639512|NCT02045979|451961533|FG002|Overall Study|not specified above|0|||
125639513|NCT02425891|451961534|FG000|Overall Study|Death|333|||
125639514|NCT02425891|451961535|FG001|Overall Study|Death|314|||
125639515|NCT02425891|451961534|FG000|Overall Study|Lost to Follow-up|4|||
125639516|NCT02425891|451961535|FG001|Overall Study|Lost to Follow-up|6|||
125639517|NCT02425891|451961534|FG000|Overall Study|Non-Compliance|1|||
125639518|NCT02425891|451961535|FG001|Overall Study|Non-Compliance|1|||
125639519|NCT02425891|451961534|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
125639520|NCT02425891|451961535|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
125639521|NCT02425891|451961534|FG000|Overall Study|Physician Decision|0|||
125639522|NCT02425891|451961535|FG001|Overall Study|Physician Decision|1|||
125639523|NCT02425891|451961534|FG000|Overall Study|Protocol Violation|1|||
125639524|NCT02425891|451961535|FG001|Overall Study|Protocol Violation|1|||
125639525|NCT02425891|451961534|FG000|Overall Study|Study Terminated By Sponsor|85|||
125639526|NCT02425891|451961535|FG001|Overall Study|Study Terminated By Sponsor|95|||
125639527|NCT02425891|451961534|FG000|Overall Study|Withdrawal by Subject|27|||
125639528|NCT02425891|451961535|FG001|Overall Study|Withdrawal by Subject|32|||
125639529|NCT02145429|451961537|FG000|Overall Study|Death|4|||
125639530|NCT02145429|451961538|FG001|Overall Study|Death|5|||
125639531|NCT02145429|451961537|FG000|Overall Study|Lost to Follow-up|4|||
125639532|NCT02145429|451961538|FG001|Overall Study|Lost to Follow-up|3|||
125639533|NCT02145429|451961537|FG000|Overall Study|Withdrawal by Subject|8|||
125639534|NCT02145429|451961538|FG001|Overall Study|Withdrawal by Subject|3|||
125639535|NCT01944462|451961539|FG000|PPPP Educational Program|Lost to Follow-up|60|||
125639536|NCT01599585|451961540|FG000|Overall Study|Withdrawal by Subject|16|||
125639537|NCT01599585|451961541|FG001|Overall Study|Withdrawal by Subject|9|||
125639538|NCT01599585|451961540|FG000|Overall Study|Lost to Follow-up|3|||
125639539|NCT01599585|451961541|FG001|Overall Study|Lost to Follow-up|5|||
125639540|NCT01599585|451961540|FG000|Overall Study|randomized did not start treatment|3|||
125639541|NCT01599585|451961541|FG001|Overall Study|randomized did not start treatment|3|||
125639542|NCT05827978|451961542|FG000|Overall Study|Adverse Event|1|||
125639543|NCT05827978|451961543|FG001|Overall Study|Adverse Event|0|||
125639544|NCT05827978|451961544|FG002|Overall Study|Adverse Event|0|||
125639545|NCT05827978|451961545|FG003|Overall Study|Adverse Event|1|||
125132192|NCT05323396|450110138|FG001|Overall Study|Pregnancy|0|||
125132193|NCT01110005|450110139|FG000|Overall Study|ineligible|1|||
125132194|NCT01110005|450110140|FG001|Overall Study|ineligible|2|||
125132195|NCT01110005|450110139|FG000|Overall Study|missing consent|3|||
125132196|NCT01110005|450110140|FG001|Overall Study|missing consent|2|||
125132197|NCT01110005|450110139|FG000|Overall Study|Withdrawal by Subject|0|||
125132198|NCT01110005|450110140|FG001|Overall Study|Withdrawal by Subject|1|||
125132199|NCT04646213|450110141|FG000|Overall Study|Physician Decision|3|||
125132200|NCT04646213|450110141|FG000|Overall Study|Withdrawal by Subject|2|||
125132201|NCT00731783|450110148|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
125132202|NCT00731783|450110149|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
125132203|NCT00731783|450110148|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
125132204|NCT00731783|450110149|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
125132205|NCT00731783|450110148|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
125132206|NCT00731783|450110149|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
125132207|NCT00731783|450110148|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
125132208|NCT00731783|450110149|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
125132209|NCT00467896|450111704|FG000|Overall Study|Consent Withdrawal|18|||
125132210|NCT00467896|450111704|FG000|Overall Study|Adverse Event|7|||
125132211|NCT00467896|450111704|FG000|Overall Study|Serious Adverse Event|13|||
125132212|NCT00467896|450111704|FG000|Overall Study|Non-compliance|3|||
125132213|NCT00467896|450111704|FG000|Overall Study|Changed therapy|2|||
125132214|NCT00467896|450111704|FG000|Overall Study|Patient received transplant|2|||
125132215|NCT00467896|450111704|FG000|Overall Study|Patient had atrial septostomy|1|||
125132216|NCT00467896|450111704|FG000|Overall Study|Patient weaned off iloprost|1|||
125132217|NCT00467896|450111704|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
125132218|NCT00467896|450111704|FG000|Overall Study|Started intravenous prostacyclin|1|||
125132219|NCT00467896|450111704|FG000|Overall Study|Started inhaled Remodulin|1|||
125132220|NCT00467896|450111704|FG000|Overall Study|Patient had no improvement|1|||
125132221|NCT03772522|450111705|FG000|Pre-intervention|Withdrawal by Subject|3|||
125132222|NCT03772522|450111706|FG001|Pre-intervention|Withdrawal by Subject|4|||
125132223|NCT03772522|450111705|FG000|Intervention|Withdrawal by Subject|1|||
125132224|NCT03772522|450111706|FG001|Intervention|Withdrawal by Subject|0|||
125132225|NCT03772522|450111705|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
125132226|NCT03772522|450111706|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
125132227|NCT00834795|450111707|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
125132228|NCT00834795|450111708|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
125132229|NCT00834795|450111707|FG000|Second Intervention|Adverse Event|1|||
125132230|NCT00834795|450111708|FG001|Second Intervention|Adverse Event|0|||
125132231|NCT00579345|450111709|FG000|Overall Study|Withdrawal by Subject|2|||
125132232|NCT00579345|450111710|FG001|Overall Study|Withdrawal by Subject|0|||
125132233|NCT00579345|450111711|FG002|Overall Study|Withdrawal by Subject|0|||
125132234|NCT00579345|450111712|FG003|Overall Study|Withdrawal by Subject|0|||
125132235|NCT00579345|450111713|FG004|Overall Study|Withdrawal by Subject|0|||
125132236|NCT00579345|450111714|FG005|Overall Study|Withdrawal by Subject|0|||
125132237|NCT00579345|450111715|FG006|Overall Study|Withdrawal by Subject|0|||
125132238|NCT00579345|450111716|FG007|Overall Study|Withdrawal by Subject|1|||
125132239|NCT00579345|450111709|FG000|Overall Study|Lost to Follow-up|1|||
125132240|NCT00579345|450111710|FG001|Overall Study|Lost to Follow-up|0|||
125132241|NCT00579345|450111711|FG002|Overall Study|Lost to Follow-up|0|||
125132242|NCT00579345|450111712|FG003|Overall Study|Lost to Follow-up|0|||
125132243|NCT00579345|450111713|FG004|Overall Study|Lost to Follow-up|0|||
125132244|NCT00579345|450111714|FG005|Overall Study|Lost to Follow-up|0|||
125132245|NCT00579345|450111715|FG006|Overall Study|Lost to Follow-up|0|||
125132246|NCT00579345|450111716|FG007|Overall Study|Lost to Follow-up|0|||
125132247|NCT00579345|450111709|FG000|Overall Study|Adverse Event|0|||
125132248|NCT00579345|450111710|FG001|Overall Study|Adverse Event|0|||
125132249|NCT00579345|450111711|FG002|Overall Study|Adverse Event|1|||
125132250|NCT00579345|450111712|FG003|Overall Study|Adverse Event|0|||
125132251|NCT00579345|450111713|FG004|Overall Study|Adverse Event|0|||
125132252|NCT00579345|450111714|FG005|Overall Study|Adverse Event|0|||
125132253|NCT00579345|450111715|FG006|Overall Study|Adverse Event|0|||
125132254|NCT00579345|450111716|FG007|Overall Study|Adverse Event|0|||
125132255|NCT00579345|450111709|FG000|Overall Study|Protocol Violation|1|||
125132256|NCT00579345|450111710|FG001|Overall Study|Protocol Violation|0|||
125132257|NCT00579345|450111711|FG002|Overall Study|Protocol Violation|0|||
125132258|NCT00579345|450111712|FG003|Overall Study|Protocol Violation|0|||
125218053|NCT02959918|450425368|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218054|NCT02959918|450425369|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125639546|NCT05827978|451961546|FG004|Overall Study|Adverse Event|0|||
125639547|NCT05827978|451961547|FG005|Overall Study|Adverse Event|0|||
125639548|NCT05827978|451961542|FG000|Overall Study|Death|1|||
125639549|NCT05827978|451961543|FG001|Overall Study|Death|5|||
125639550|NCT05827978|451961544|FG002|Overall Study|Death|2|||
125639551|NCT05827978|451961545|FG003|Overall Study|Death|3|||
125639552|NCT05827978|451961546|FG004|Overall Study|Death|1|||
125639553|NCT05827978|451961547|FG005|Overall Study|Death|3|||
125639554|NCT05827978|451961542|FG000|Overall Study|Lost to Follow-up|57|||
125639555|NCT05827978|451961543|FG001|Overall Study|Lost to Follow-up|88|||
125639556|NCT05827978|451961544|FG002|Overall Study|Lost to Follow-up|54|||
125639557|NCT05827978|451961545|FG003|Overall Study|Lost to Follow-up|47|||
125639558|NCT05827978|451961546|FG004|Overall Study|Lost to Follow-up|25|||
125639559|NCT05827978|451961547|FG005|Overall Study|Lost to Follow-up|10|||
125639560|NCT05827978|451961542|FG000|Overall Study|Noncompliance with Study Procedures|0|||
125639561|NCT05827978|451961543|FG001|Overall Study|Noncompliance with Study Procedures|1|||
125639562|NCT05827978|451961544|FG002|Overall Study|Noncompliance with Study Procedures|1|||
125639563|NCT05827978|451961545|FG003|Overall Study|Noncompliance with Study Procedures|1|||
125639564|NCT05827978|451961546|FG004|Overall Study|Noncompliance with Study Procedures|1|||
125639565|NCT05827978|451961547|FG005|Overall Study|Noncompliance with Study Procedures|0|||
125639566|NCT05827978|451961542|FG000|Overall Study|Physician Decision|2|||
125639567|NCT05827978|451961543|FG001|Overall Study|Physician Decision|0|||
125639568|NCT05827978|451961544|FG002|Overall Study|Physician Decision|1|||
125639569|NCT05827978|451961545|FG003|Overall Study|Physician Decision|2|||
125639570|NCT05827978|451961546|FG004|Overall Study|Physician Decision|1|||
125639571|NCT05827978|451961547|FG005|Overall Study|Physician Decision|1|||
125639572|NCT05827978|451961542|FG000|Overall Study|Protocol Violation|5|||
125639573|NCT05827978|451961543|FG001|Overall Study|Protocol Violation|2|||
125639574|NCT05827978|451961544|FG002|Overall Study|Protocol Violation|0|||
125639575|NCT05827978|451961545|FG003|Overall Study|Protocol Violation|0|||
125639576|NCT05827978|451961546|FG004|Overall Study|Protocol Violation|0|||
125639577|NCT05827978|451961547|FG005|Overall Study|Protocol Violation|0|||
125639578|NCT05827978|451961542|FG000|Overall Study|Withdrawal by Subject|17|||
125639579|NCT05827978|451961543|FG001|Overall Study|Withdrawal by Subject|16|||
125639580|NCT05827978|451961544|FG002|Overall Study|Withdrawal by Subject|10|||
125639581|NCT05827978|451961545|FG003|Overall Study|Withdrawal by Subject|12|||
125639582|NCT05827978|451961546|FG004|Overall Study|Withdrawal by Subject|10|||
125639583|NCT05827978|451961547|FG005|Overall Study|Withdrawal by Subject|9|||
125639584|NCT05827978|451961542|FG000|Overall Study|Other Than Specified|0|||
125639585|NCT05827978|451961543|FG001|Overall Study|Other Than Specified|0|||
125639586|NCT05827978|451961544|FG002|Overall Study|Other Than Specified|1|||
125639587|NCT05827978|451961545|FG003|Overall Study|Other Than Specified|0|||
125639588|NCT05827978|451961546|FG004|Overall Study|Other Than Specified|2|||
125639589|NCT05827978|451961547|FG005|Overall Study|Other Than Specified|0|||
125639590|NCT00729560|451961548|FG000|Overall Study|Withdrawal by Subject|3|||
125639591|NCT00103207|451961549|FG000|Overall Study|Adverse Event|3|||
125639592|NCT00103207|451961549|FG000|Overall Study|Death|1|||
125639593|NCT00103207|451961549|FG000|Overall Study|Withdrawal by Subject|2|||
125639594|NCT00103207|451961549|FG000|Overall Study|Other complicating disease|1|||
125639595|NCT00103207|451961549|FG000|Overall Study|Ineligible|4|||
125639596|NCT00103207|451961549|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
125639597|NCT03662789|451961550|FG000|Overall Study|Lost to Follow-up|1|||
125639598|NCT03662789|451961551|FG001|Overall Study|Lost to Follow-up|2|||
125639599|NCT03662789|451961550|FG000|Overall Study|Could not perform treadmill test|4|||
125639600|NCT03662789|451961551|FG001|Overall Study|Could not perform treadmill test|4|||
125639601|NCT03662789|451961550|FG000|Overall Study|Death|0|||
125639602|NCT03662789|451961551|FG001|Overall Study|Death|1|||
125639603|NCT01029691|451961552|FG000|Continued APAP to Delivery|Death|0|||
125639604|NCT01029691|451961553|FG001|Continued APAP to Delivery|Death|0|||
125639605|NCT01029691|451961554|FG002|Continued APAP to Delivery|Death|1|||
125639606|NCT01023516|451961555|FG000|Overall Study|Voluntary discontinuation|7|||
125639607|NCT01023516|451961556|FG001|Overall Study|Voluntary discontinuation|5|||
125639608|NCT01023516|451961555|FG000|Overall Study|Adverse Event|9|||
125639609|NCT01023516|451961556|FG001|Overall Study|Adverse Event|6|||
125639610|NCT01023516|451961555|FG000|Overall Study|Safety reason|0|||
125639611|NCT01023516|451961556|FG001|Overall Study|Safety reason|3|||
125639612|NCT01023516|451961555|FG000|Overall Study|Study-specific criteria|4|||
125639613|NCT01023516|451961556|FG001|Overall Study|Study-specific criteria|2|||
125639614|NCT01023516|451961555|FG000|Overall Study|Incorrect enrolment|4|||
125639615|NCT01023516|451961556|FG001|Overall Study|Incorrect enrolment|2|||
125218055|NCT02959918|450425370|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125639616|NCT00137267|451961559|FG000|Overall Study|Lost to Follow-up|15|||
125639617|NCT00137267|451961560|FG001|Overall Study|Lost to Follow-up|21|||
125639618|NCT00638989|451961561|FG000|Overall Study|Lost to Follow-up|0|||
125639619|NCT00638989|451961562|FG001|Overall Study|Lost to Follow-up|0|||
125639620|NCT00638989|451961563|FG002|Overall Study|Lost to Follow-up|1|||
125218056|NCT02959918|450425371|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218057|NCT02959918|450425372|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
125218058|NCT02959918|450425359|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218059|NCT02959918|450425360|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218060|NCT02959918|450425361|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125380079|NCT02618434|451023434|FG000|Overall Study|Other, Multiple categories|1|||
125380080|NCT02618434|451023435|FG001|Overall Study|Other, Multiple categories|1|||
125380081|NCT02618434|451023436|FG002|Overall Study|Other, Multiple categories|1|||
125380082|NCT01988103|451023441|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
125380083|NCT01988103|451023442|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
125380084|NCT01988103|451023443|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
125132259|NCT00579345|450111713|FG004|Overall Study|Protocol Violation|0|||
125132260|NCT00579345|450111714|FG005|Overall Study|Protocol Violation|0|||
125132261|NCT00579345|450111715|FG006|Overall Study|Protocol Violation|0|||
125132262|NCT00579345|450111716|FG007|Overall Study|Protocol Violation|1|||
125132263|NCT00579345|450111709|FG000|Overall Study|Death|1|||
125132264|NCT00579345|450111710|FG001|Overall Study|Death|1|||
125132265|NCT00579345|450111711|FG002|Overall Study|Death|1|||
125132266|NCT00579345|450111712|FG003|Overall Study|Death|1|||
125132267|NCT00579345|450111713|FG004|Overall Study|Death|0|||
125132268|NCT00579345|450111714|FG005|Overall Study|Death|0|||
125132269|NCT00579345|450111715|FG006|Overall Study|Death|0|||
125132270|NCT00579345|450111716|FG007|Overall Study|Death|0|||
125132271|NCT02175095|450111717|FG000|Overall Study|Withdrawal by Subject|3|||
125132272|NCT03697109|450111718|FG000|Open-label (OL) Phase|Adverse Event|24|||
125132273|NCT03697109|450111719|FG001|Open-label (OL) Phase|Adverse Event|0|||
125132274|NCT03697109|450111720|FG002|Open-label (OL) Phase|Adverse Event|0|||
125132275|NCT03697109|450111718|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
125132276|NCT03697109|450111719|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
125132277|NCT03697109|450111720|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
125132278|NCT03697109|450111718|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
125132279|NCT03697109|450111719|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
125132280|NCT03697109|450111720|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
125132281|NCT03697109|450111718|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
125437046|NCT02090634|451226334|FG001|Overall Study|Adverse Event|0|||
125437047|NCT01965938|451226335|FG000|Overall Study|Withdrawal by Subject|1|||
125132282|NCT03697109|450111719|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
125132283|NCT03697109|450111720|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
125132284|NCT03697109|450111718|FG000|Open-label (OL) Phase|Physician Decision|2|||
125132285|NCT03697109|450111719|FG001|Open-label (OL) Phase|Physician Decision|0|||
125132286|NCT03697109|450111720|FG002|Open-label (OL) Phase|Physician Decision|0|||
125132287|NCT03697109|450111718|FG000|Open-label (OL) Phase|Death|2|||
125132288|NCT03697109|450111719|FG001|Open-label (OL) Phase|Death|0|||
125132289|NCT03697109|450111720|FG002|Open-label (OL) Phase|Death|0|||
125132290|NCT03697109|450111718|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
125218061|NCT02959918|450425362|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218062|NCT02959918|450425363|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125437048|NCT01965938|451226336|FG001|Overall Study|Withdrawal by Subject|0|||
125639621|NCT00853112|451961564|FG000|Overall Study|Randomized but not treated|0|||
125639622|NCT00853112|451961565|FG001|Overall Study|Randomized but not treated|1|||
125639623|NCT00853112|451961566|FG002|Overall Study|Randomized but not treated|0|||
125639624|NCT00853112|451961567|FG003|Overall Study|Randomized but not treated|2|||
125639625|NCT00853112|451961568|FG004|Overall Study|Randomized but not treated|0|||
125639626|NCT00853112|451961569|FG005|Overall Study|Randomized but not treated|0|||
125639627|NCT00853112|451961570|FG006|Overall Study|Randomized but not treated|1|||
125639628|NCT01553591|451961571|FG000|Overall Study|Voluntarily withdrew|94|||
125639629|NCT01553591|451961572|FG001|Overall Study|Voluntarily withdrew|79|||
125639630|NCT01553591|451961573|FG002|Overall Study|Voluntarily withdrew|96|||
125639631|NCT01553591|451961571|FG000|Overall Study|Adverse Event|36|||
125639632|NCT01553591|451961572|FG001|Overall Study|Adverse Event|45|||
125639633|NCT01553591|451961573|FG002|Overall Study|Adverse Event|16|||
125639634|NCT01553591|451961571|FG000|Overall Study|Lost to Follow-up|25|||
125639635|NCT01553591|451961572|FG001|Overall Study|Lost to Follow-up|23|||
125639636|NCT01553591|451961573|FG002|Overall Study|Lost to Follow-up|16|||
125639637|NCT01553591|451961571|FG000|Overall Study|Physician decision: other|11|||
125639638|NCT01553591|451961572|FG001|Overall Study|Physician decision: other|14|||
125639639|NCT01553591|451961573|FG002|Overall Study|Physician decision: other|16|||
125639640|NCT01553591|451961571|FG000|Overall Study|Physician decision: lack of efficacy|2|||
125639641|NCT01553591|451961572|FG001|Overall Study|Physician decision: lack of efficacy|3|||
125639642|NCT01553591|451961573|FG002|Overall Study|Physician decision: lack of efficacy|7|||
125639643|NCT01553591|451961571|FG000|Overall Study|Protocol Violation|3|||
125639644|NCT01553591|451961572|FG001|Overall Study|Protocol Violation|4|||
125639645|NCT01553591|451961573|FG002|Overall Study|Protocol Violation|4|||
125639646|NCT01553591|451961571|FG000|Overall Study|Sponsor decision|1|||
125639647|NCT01553591|451961572|FG001|Overall Study|Sponsor decision|0|||
125639648|NCT01553591|451961573|FG002|Overall Study|Sponsor decision|3|||
125639649|NCT01553591|451961571|FG000|Overall Study|Randomized and never dispensed drug|0|||
125639650|NCT01553591|451961572|FG001|Overall Study|Randomized and never dispensed drug|1|||
125639651|NCT01553591|451961573|FG002|Overall Study|Randomized and never dispensed drug|0|||
125639652|NCT01818765|451961574|FG000|Overall Study|Death|2|||
125639653|NCT02005211|451961575|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
125639654|NCT02005211|451961576|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
125639655|NCT02005211|451961577|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
125639656|NCT02005211|451961578|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
125639657|NCT02005211|451961579|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
125639658|NCT02005211|451961580|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
125639659|NCT02005211|451961581|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
125639660|NCT00397631|451961583|FG000|Overall Study|Adverse Event|5|||
125639661|NCT00397631|451961584|FG001|Overall Study|Adverse Event|6|||
125639662|NCT00397631|451961583|FG000|Overall Study|Lack of Efficacy|7|||
125639663|NCT00397631|451961584|FG001|Overall Study|Lack of Efficacy|10|||
125639664|NCT00397631|451961583|FG000|Overall Study|Lost to Follow-up|8|||
125639665|NCT00397631|451961584|FG001|Overall Study|Lost to Follow-up|9|||
125639666|NCT00397631|451961583|FG000|Overall Study|Physician Decision|2|||
125639667|NCT00397631|451961584|FG001|Overall Study|Physician Decision|0|||
125639668|NCT00397631|451961583|FG000|Overall Study|Protocol Violation|0|||
125639669|NCT00397631|451961584|FG001|Overall Study|Protocol Violation|1|||
125639670|NCT00397631|451961583|FG000|Overall Study|Withdrawal by Subject|7|||
125639671|NCT00397631|451961584|FG001|Overall Study|Withdrawal by Subject|14|||
125639672|NCT00397631|451961583|FG000|Overall Study|protocol discontinuation criteria|1|||
125639673|NCT00397631|451961584|FG001|Overall Study|protocol discontinuation criteria|4|||
125639674|NCT02202161|451961585|FG000|Overall Study|Adverse Event|1|||
125639675|NCT02202161|451961586|FG001|Overall Study|Adverse Event|1|||
125639676|NCT02202161|451961587|FG002|Overall Study|Adverse Event|0|||
125639677|NCT02202161|451961588|FG003|Overall Study|Adverse Event|0|||
125639678|NCT02202161|451961589|FG004|Overall Study|Adverse Event|0|||
125639679|NCT02202161|451961590|FG005|Overall Study|Adverse Event|1|||
125639680|NCT02202161|451961591|FG006|Overall Study|Adverse Event|0|||
125639681|NCT02202161|451961592|FG007|Overall Study|Adverse Event|0|||
125639682|NCT02202161|451961585|FG000|Overall Study|Did not meet continuation criteria|0|||
125218063|NCT02959918|450425364|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125639683|NCT02202161|451961586|FG001|Overall Study|Did not meet continuation criteria|0|||
125639684|NCT02202161|451961587|FG002|Overall Study|Did not meet continuation criteria|0|||
125639685|NCT02202161|451961588|FG003|Overall Study|Did not meet continuation criteria|0|||
125639686|NCT02202161|451961589|FG004|Overall Study|Did not meet continuation criteria|0|||
125639687|NCT02202161|451961590|FG005|Overall Study|Did not meet continuation criteria|0|||
125639688|NCT02202161|451961591|FG006|Overall Study|Did not meet continuation criteria|0|||
125639689|NCT02202161|451961592|FG007|Overall Study|Did not meet continuation criteria|3|||
125639690|NCT02202161|451961585|FG000|Overall Study|Physician Decision|0|||
125132291|NCT03697109|450111719|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
125132292|NCT03697109|450111720|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
125132293|NCT03697109|450111718|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
125132294|NCT03697109|450111719|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
125132295|NCT03697109|450111720|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
125132296|NCT03697109|450111718|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
125132297|NCT03697109|450111719|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
125132298|NCT03697109|450111720|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
125132299|NCT01111461|450111721|FG000|Overall Study|Adverse Event|32|||
125132300|NCT01111461|450111721|FG000|Overall Study|Participant choice|11|||
125132301|NCT01111461|450111721|FG000|Overall Study|Lost to Follow-up|1|||
125132302|NCT01111461|450111721|FG000|Overall Study|Withdrawal by Subject|1|||
125437049|NCT02714205|451226346|FG000|Overall Study|Cannot tolerate medication|1|||
125437050|NCT02714205|451226347|FG001|Overall Study|Cannot tolerate medication|0|||
125437051|NCT02714205|451226346|FG000|Overall Study|Adverse Event|2|||
125437052|NCT02714205|451226347|FG001|Overall Study|Adverse Event|0|||
125380085|NCT01988103|451023444|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
125380086|NCT01988103|451023445|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
125380087|NCT01988103|451023441|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
125380088|NCT01988103|451023442|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
125420814|NCT01260350|451166153|FG009|Overall Study|Lack of Efficacy|0|||
125639691|NCT02202161|451961586|FG001|Overall Study|Physician Decision|0|||
125639692|NCT02202161|451961587|FG002|Overall Study|Physician Decision|0|||
125639693|NCT02202161|451961588|FG003|Overall Study|Physician Decision|0|||
125639694|NCT02202161|451961589|FG004|Overall Study|Physician Decision|0|||
125639695|NCT02202161|451961590|FG005|Overall Study|Physician Decision|0|||
125639696|NCT02202161|451961591|FG006|Overall Study|Physician Decision|0|||
125639697|NCT02202161|451961592|FG007|Overall Study|Physician Decision|3|||
125639698|NCT02202161|451961585|FG000|Overall Study|Withdrawal by Subject|0|||
125639699|NCT02202161|451961586|FG001|Overall Study|Withdrawal by Subject|0|||
125639700|NCT02202161|451961587|FG002|Overall Study|Withdrawal by Subject|0|||
125639701|NCT02202161|451961588|FG003|Overall Study|Withdrawal by Subject|0|||
125639702|NCT02202161|451961589|FG004|Overall Study|Withdrawal by Subject|1|||
125639703|NCT02202161|451961590|FG005|Overall Study|Withdrawal by Subject|0|||
125639704|NCT02202161|451961591|FG006|Overall Study|Withdrawal by Subject|0|||
125639705|NCT02202161|451961592|FG007|Overall Study|Withdrawal by Subject|0|||
125639706|NCT00832091|451961593|FG000|Overall Study|Adverse Event|1|||
125639707|NCT00832091|451961594|FG001|Overall Study|Adverse Event|1|||
125639708|NCT00832091|451961593|FG000|Overall Study|Protocol Violation|1|||
125639709|NCT00832091|451961594|FG001|Overall Study|Protocol Violation|0|||
125639710|NCT00832091|451961593|FG000|Overall Study|Withdrawal by Subject|2|||
125639711|NCT00832091|451961594|FG001|Overall Study|Withdrawal by Subject|1|||
125639712|NCT00832091|451961593|FG000|Overall Study|Prohibited Medication|1|||
125639713|NCT00832091|451961594|FG001|Overall Study|Prohibited Medication|0|||
125639714|NCT02711553|451961600|FG000|Overall Study|Withdrawal by Subject|2|||
125639715|NCT02711553|451961601|FG001|Overall Study|Withdrawal by Subject|1|||
125639716|NCT02711553|451961602|FG002|Overall Study|Withdrawal by Subject|1|||
125639717|NCT02711553|451961603|FG003|Overall Study|Withdrawal by Subject|0|||
125639718|NCT02711553|451961600|FG000|Overall Study|Lost to Follow-up|3|||
125639719|NCT02711553|451961601|FG001|Overall Study|Lost to Follow-up|3|||
125639720|NCT02711553|451961602|FG002|Overall Study|Lost to Follow-up|6|||
125639721|NCT02711553|451961603|FG003|Overall Study|Lost to Follow-up|3|||
125639722|NCT02711553|451961600|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
125639723|NCT02711553|451961601|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
125639724|NCT02711553|451961602|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
125639725|NCT02711553|451961603|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
125639726|NCT05559203|451961604|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
125639727|NCT02187224|451961605|FG000|Overall Study|Did not show up for test day|1|||
125639728|NCT02187224|451961606|FG001|Overall Study|Did not show up for test day|0|||
125639729|NCT01700140|451961611|FG000|Overall Study|Use of rescue drugs|3|||
125639730|NCT01700140|451961612|FG001|Overall Study|Use of rescue drugs|3|||
125639731|NCT01700140|451961613|FG002|Overall Study|Use of rescue drugs|1|||
125639732|NCT01700140|451961611|FG000|Overall Study|Discontinuation of radiotherapy|1|||
125639733|NCT01700140|451961612|FG001|Overall Study|Discontinuation of radiotherapy|0|||
125639734|NCT01700140|451961613|FG002|Overall Study|Discontinuation of radiotherapy|0|||
125639735|NCT01700140|451961611|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
125639736|NCT01700140|451961612|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
125639737|NCT01700140|451961613|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
125639738|NCT01700140|451961611|FG000|Overall Study|Aggravation of symptoms|1|||
125639739|NCT01700140|451961612|FG001|Overall Study|Aggravation of symptoms|0|||
125639740|NCT01700140|451961613|FG002|Overall Study|Aggravation of symptoms|0|||
125639741|NCT01700140|451961611|FG000|Overall Study|Adverse Event|0|||
125639742|NCT01700140|451961612|FG001|Overall Study|Adverse Event|1|||
125639743|NCT01700140|451961613|FG002|Overall Study|Adverse Event|0|||
125639744|NCT01700140|451961611|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
125639745|NCT01700140|451961612|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
125639746|NCT01700140|451961613|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
125639747|NCT02573012|451961614|FG000|Overall Study|Adverse Event|5|||
125639748|NCT02573012|451961615|FG001|Overall Study|Adverse Event|5|||
125132303|NCT01111461|450111721|FG000|Overall Study|Other|6|||
125639749|NCT02573012|451961614|FG000|Overall Study|Lack of Efficacy|5|||
125639750|NCT02573012|451961615|FG001|Overall Study|Lack of Efficacy|4|||
125639751|NCT02573012|451961614|FG000|Overall Study|Non-compliance|1|||
125639752|NCT02573012|451961615|FG001|Overall Study|Non-compliance|2|||
125639753|NCT02573012|451961614|FG000|Overall Study|Withdrawal by Subject|2|||
125218064|NCT02959918|450425365|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125380089|NCT01988103|451023443|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
125380090|NCT01988103|451023444|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
125420815|NCT01260350|451166154|FG010|Overall Study|Lack of Efficacy|0|||
125639754|NCT02573012|451961615|FG001|Overall Study|Withdrawal by Subject|2|||
125639755|NCT02573012|451961614|FG000|Overall Study|Study Ended per Protocol|1|||
125639756|NCT02573012|451961615|FG001|Overall Study|Study Ended per Protocol|0|||
125639757|NCT02573012|451961614|FG000|Overall Study|Physician Decision|1|||
125639758|NCT02573012|451961615|FG001|Overall Study|Physician Decision|2|||
125639759|NCT01601873|451961616|FG000|Overall Study|Lost to Follow-up|2|||
125639760|NCT01601873|451961617|FG001|Overall Study|Lost to Follow-up|3|||
125639761|NCT01222416|451961618|FG000|Overall Study|ineligible;metastasis|3|||
125639762|NCT01222416|451961619|FG001|Overall Study|ineligible;metastasis|0|||
125639763|NCT01222416|451961618|FG000|Overall Study|Adverse Event|4|||
125639764|NCT01222416|451961619|FG001|Overall Study|Adverse Event|0|||
125639765|NCT01222416|451961618|FG000|Overall Study|Withdrawal by Subject|5|||
125639766|NCT01222416|451961619|FG001|Overall Study|Withdrawal by Subject|0|||
125639767|NCT01222416|451961618|FG000|Overall Study|scheduling|6|||
125639768|NCT01222416|451961619|FG001|Overall Study|scheduling|0|||
125639769|NCT01222416|451961618|FG000|Overall Study|missed view/scan|1|||
125639770|NCT01222416|451961619|FG001|Overall Study|missed view/scan|0|||
125639771|NCT01222416|451961618|FG000|Overall Study|Death|1|||
125639772|NCT01222416|451961619|FG001|Overall Study|Death|0|||
125639773|NCT00518336|451961620|FG000|Year 7|Lost to Follow-up|2|||
125639774|NCT00518336|451961621|FG001|Year 7|Lost to Follow-up|0|||
125639775|NCT00518336|451961620|FG000|Year 7|Could not attend in time|0|||
125639776|NCT00518336|451961621|FG001|Year 7|Could not attend in time|3|||
125639777|NCT00518336|451961620|FG000|Year 8|Lost to Follow-up|1|||
125639778|NCT00518336|451961621|FG001|Year 8|Lost to Follow-up|1|||
125639779|NCT00518336|451961620|FG000|Year 8|Could not attend in time|0|||
125639780|NCT00518336|451961621|FG001|Year 8|Could not attend in time|1|||
125639781|NCT00518336|451961620|FG000|Year 9|Migrated/moved from study area|1|||
125639782|NCT00518336|451961621|FG001|Year 9|Migrated/moved from study area|1|||
125639783|NCT00518336|451961620|FG000|Year 9|Lost to Follow-up|3|||
125639784|NCT00518336|451961621|FG001|Year 9|Lost to Follow-up|0|||
125639785|NCT00518336|451961620|FG000|Year 9|Personal reasons|1|||
125639786|NCT00518336|451961621|FG001|Year 9|Personal reasons|0|||
125639787|NCT00125268|451961622|FG000|Overall Study|Withdrawal by Subject|1|||
125639788|NCT00125268|451961623|FG001|Overall Study|Withdrawal by Subject|1|||
125639789|NCT00286156|451961624|FG000|Overall Study|Missed 12 month visit|0|||
125639790|NCT00286156|451961625|FG001|Overall Study|Missed 12 month visit|0|||
125639791|NCT00286156|451961626|FG002|Overall Study|Missed 12 month visit|1|||
125639792|NCT00286156|451961624|FG000|Overall Study|AE: pulmonary embolus|0|||
125639793|NCT00286156|451961625|FG001|Overall Study|AE: pulmonary embolus|1|||
125639794|NCT00286156|451961626|FG002|Overall Study|AE: pulmonary embolus|0|||
125639795|NCT00286156|451961624|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
125639796|NCT00286156|451961625|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
125639797|NCT00286156|451961626|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
125639798|NCT00286156|451961624|FG000|Overall Study|AE: pneumonia|1|||
125639799|NCT00286156|451961625|FG001|Overall Study|AE: pneumonia|0|||
125639800|NCT00286156|451961626|FG002|Overall Study|AE: pneumonia|0|||
125639801|NCT02449915|451961628|FG000|Overall Study|Exclusion criteria - drug use|1|||
125639802|NCT02449915|451961629|FG001|Overall Study|Exclusion criteria - drug use|0|||
125639803|NCT02449915|451961628|FG000|Overall Study|Withdrawal by Subject|0|||
125639804|NCT02449915|451961629|FG001|Overall Study|Withdrawal by Subject|2|||
125639805|NCT02449915|451961628|FG000|Overall Study|Intraoperative surgical findings|1|||
125639806|NCT02449915|451961629|FG001|Overall Study|Intraoperative surgical findings|1|||
125639807|NCT02449915|451961628|FG000|Overall Study|Abnormal preop lab|0|||
125639808|NCT02449915|451961629|FG001|Overall Study|Abnormal preop lab|1|||
125639809|NCT04610827|451962674|FG000|Overall Study|Withdrawal by Subject|1|||
125639810|NCT04610827|451962675|FG001|Overall Study|Withdrawal by Subject|1|||
125639811|NCT04610827|451962676|FG002|Overall Study|Withdrawal by Subject|0|||
125639812|NCT02059174|451962699|FG000|Period 1|Withdrawal by Subject|0|||
125639813|NCT02059174|451962700|FG001|Period 1|Withdrawal by Subject|2|||
125639814|NCT02059174|451962699|FG000|Period 2|Withdrawal by Subject|0|||
125639815|NCT02059174|451962700|FG001|Period 2|Withdrawal by Subject|2|||
125639816|NCT02059174|451962699|FG000|Period 2|Protocol Violation|1|||
125639817|NCT02059174|451962700|FG001|Period 2|Protocol Violation|0|||
125639818|NCT02059174|451962699|FG000|Period 3|Physician Decision|1|||
125639819|NCT02059174|451962700|FG001|Period 3|Physician Decision|0|||
125639820|NCT02306148|451962701|FG000|Overall Study|Adverse Event|12|||
125639821|NCT02306148|451962702|FG001|Overall Study|Adverse Event|6|||
125639822|NCT02306148|451962701|FG000|Overall Study|Lost to Follow-up|1|||
125639823|NCT02306148|451962702|FG001|Overall Study|Lost to Follow-up|4|||
125639824|NCT00087594|451962707|FG000|Overall Study|Adverse Event|2|||
125639825|NCT00087594|451962708|FG001|Overall Study|Adverse Event|3|||
125639826|NCT00087594|451962707|FG000|Overall Study|Lost to Follow-up|0|||
125639827|NCT00087594|451962708|FG001|Overall Study|Lost to Follow-up|2|||
125639828|NCT00087594|451962707|FG000|Overall Study|Withdrawal by Subject|4|||
125639829|NCT00087594|451962708|FG001|Overall Study|Withdrawal by Subject|2|||
125639830|NCT00087594|451962707|FG000|Overall Study|Lack of Efficacy|2|||
125380091|NCT01988103|451023445|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
125380092|NCT01988103|451023441|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
125380093|NCT01988103|451023442|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
125380094|NCT01988103|451023443|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
125380095|NCT01988103|451023444|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
125639831|NCT00087594|451962708|FG001|Overall Study|Lack of Efficacy|5|||
125639832|NCT01952041|451962711|FG000|Overall Study|Lost to Follow-up|9|||
125639833|NCT01952041|451962712|FG001|Overall Study|Lost to Follow-up|16|||
125639834|NCT01952041|451962711|FG000|Overall Study|Withdrawal by Subject|7|||
125639835|NCT01952041|451962712|FG001|Overall Study|Withdrawal by Subject|5|||
125639836|NCT01952041|451962711|FG000|Overall Study|Death|1|||
125639837|NCT01952041|451962712|FG001|Overall Study|Death|0|||
125639838|NCT01736176|451962713|FG000|Overall Study|Adverse Event|3|||
125639839|NCT01736176|451962713|FG000|Overall Study|Withdrawal by Subject|4|||
125639840|NCT01736176|451962713|FG000|Overall Study|Lack of Efficacy|3|||
125639841|NCT01736176|451962713|FG000|Overall Study|Unable to Complete PEG Placement|1|||
125639842|NCT00186121|451962714|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
125639843|NCT00186121|451962714|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
125639844|NCT00186121|451962714|FG000|Overall Study|Not eligible (no treatment)|1|||
125639845|NCT03650387|451962715|FG000|Overall Study|Withdrawal by Subject|13|||
125639846|NCT03650387|451962715|FG000|Overall Study|Lost to Follow-up|12|||
125639847|NCT03650387|451962715|FG000|Overall Study|Adverse Event (Not related)|1|||
125639848|NCT03650387|451962715|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
125639849|NCT00934791|451962716|FG000|Overall Study|Withdrawal by Subject|1|||
125639850|NCT00934791|451962717|FG001|Overall Study|Withdrawal by Subject|0|||
125639851|NCT03763942|451962719|FG000|Overall Study|Lost to Follow-up|114|||
125639852|NCT03763942|451962720|FG001|Overall Study|Lost to Follow-up|54|||
125639853|NCT03763942|451962719|FG000|Overall Study|Protocol Violation|1|||
125639854|NCT03763942|451962720|FG001|Overall Study|Protocol Violation|0|||
125639855|NCT03763942|451962719|FG000|Overall Study|Withdrawal by Subject|2|||
125639856|NCT03763942|451962720|FG001|Overall Study|Withdrawal by Subject|0|||
125639857|NCT03763942|451962719|FG000|Overall Study|Other|2|||
125639858|NCT03763942|451962720|FG001|Overall Study|Other|3|||
125639859|NCT03558503|451962721|FG000|Overall Study|Adverse Event|1|||
125639860|NCT03558503|451962721|FG000|Overall Study|Death|1|||
125639861|NCT03558503|451962721|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
125639862|NCT02646891|451962722|FG000|Overall Study|Adverse Event|0|||
125639863|NCT02646891|451962723|FG001|Overall Study|Adverse Event|1|||
125639864|NCT02646891|451962724|FG002|Overall Study|Adverse Event|0|||
125639865|NCT02646891|451962725|FG003|Overall Study|Adverse Event|0|||
125639866|NCT02646891|451962726|FG004|Overall Study|Adverse Event|0|||
125639867|NCT02646891|451962727|FG005|Overall Study|Adverse Event|0|||
125639868|NCT02646891|451962728|FG006|Overall Study|Adverse Event|0|||
125639869|NCT02646891|451962729|FG007|Overall Study|Adverse Event|0|||
125132304|NCT00440518|450111723|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
125132305|NCT00440518|450111724|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
125132306|NCT00440518|450111725|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
125132307|NCT00440518|450111723|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
125132308|NCT00440518|450111724|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
125132309|NCT00440518|450111725|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
125132310|NCT00440518|450111723|FG000|Randomized /Titration Period|Protocol Deviation|1|||
125132311|NCT00440518|450111724|FG001|Randomized /Titration Period|Protocol Deviation|0|||
125132312|NCT00440518|450111725|FG002|Randomized /Titration Period|Protocol Deviation|0|||
125132313|NCT00440518|450111723|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
125132314|NCT00440518|450111724|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
125132315|NCT00440518|450111725|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
125132316|NCT00440518|450111723|FG000|Randomized /Titration Period|Other|1|||
125132317|NCT00440518|450111724|FG001|Randomized /Titration Period|Other|0|||
125132318|NCT00440518|450111725|FG002|Randomized /Titration Period|Other|0|||
125132319|NCT00440518|450111723|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
125132320|NCT00440518|450111724|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
125132321|NCT00440518|450111725|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
125132322|NCT00440518|450111723|FG000|Randomized /Titration Period|Adverse Event|2|||
125132323|NCT00440518|450111724|FG001|Randomized /Titration Period|Adverse Event|3|||
125639870|NCT02646891|451962730|FG008|Overall Study|Adverse Event|0|||
125639871|NCT02646891|451962731|FG009|Overall Study|Adverse Event|0|||
125639872|NCT02646891|451962722|FG000|Overall Study|Lost to Follow-up|0|||
125639873|NCT02646891|451962723|FG001|Overall Study|Lost to Follow-up|0|||
125639874|NCT02646891|451962724|FG002|Overall Study|Lost to Follow-up|0|||
125639875|NCT02646891|451962725|FG003|Overall Study|Lost to Follow-up|0|||
125639876|NCT02646891|451962726|FG004|Overall Study|Lost to Follow-up|0|||
125639877|NCT02646891|451962727|FG005|Overall Study|Lost to Follow-up|0|||
125639878|NCT02646891|451962728|FG006|Overall Study|Lost to Follow-up|2|||
125639879|NCT02646891|451962729|FG007|Overall Study|Lost to Follow-up|2|||
125639880|NCT02646891|451962730|FG008|Overall Study|Lost to Follow-up|2|||
125132324|NCT00440518|450111725|FG002|Randomized /Titration Period|Adverse Event|0|||
125132325|NCT00440518|450111723|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
125132326|NCT00440518|450111724|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
125132327|NCT00440518|450111725|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
125132328|NCT00440518|450111723|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
125132329|NCT00440518|450111724|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
125132330|NCT00440518|450111725|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
125132331|NCT00440518|450111723|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
125132332|NCT00440518|450111724|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
125132333|NCT00440518|450111725|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
125132334|NCT00440518|450111723|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
125132335|NCT00440518|450111724|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
125132336|NCT00440518|450111725|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
125132337|NCT00440518|450111723|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
125132338|NCT00440518|450111724|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
125132339|NCT00440518|450111725|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
125132340|NCT00440518|450111723|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
125132341|NCT00440518|450111724|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
125132342|NCT00440518|450111725|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
125132343|NCT00365365|450111726|FG000|Overall Study|Randomized but not treated|0|||
125132344|NCT00365365|450111727|FG001|Overall Study|Randomized but not treated|2|||
125132345|NCT00365365|450111728|FG002|Overall Study|Randomized but not treated|0|||
125132346|NCT00365365|450111726|FG000|Overall Study|Poor compliance to protocol|0|||
125132347|NCT00365365|450111727|FG001|Overall Study|Poor compliance to protocol|1|||
125132348|NCT00365365|450111728|FG002|Overall Study|Poor compliance to protocol|0|||
125132349|NCT00365365|450111726|FG000|Overall Study|Lost to Follow-up|3|||
125132350|NCT00365365|450111727|FG001|Overall Study|Lost to Follow-up|3|||
125132351|NCT00365365|450111728|FG002|Overall Study|Lost to Follow-up|3|||
125132352|NCT00365365|450111726|FG000|Overall Study|Death|1|||
125132353|NCT00365365|450111727|FG001|Overall Study|Death|3|||
125132354|NCT00365365|450111728|FG002|Overall Study|Death|0|||
125132355|NCT00365365|450111726|FG000|Overall Study|Subject's request|11|||
125132356|NCT00365365|450111727|FG001|Overall Study|Subject's request|13|||
125132357|NCT00365365|450111728|FG002|Overall Study|Subject's request|1|||
125132358|NCT00365365|450111726|FG000|Overall Study|Disease progression/relapse|9|||
125132359|NCT00365365|450111727|FG001|Overall Study|Disease progression/relapse|6|||
125132360|NCT00365365|450111728|FG002|Overall Study|Disease progression/relapse|7|||
125132361|NCT00365365|450111726|FG000|Overall Study|Adverse Event|6|||
125132362|NCT00365365|450111727|FG001|Overall Study|Adverse Event|6|||
125132363|NCT00365365|450111728|FG002|Overall Study|Adverse Event|3|||
125132364|NCT00365365|450111726|FG000|Overall Study|Moved|2|||
125132365|NCT00365365|450111727|FG001|Overall Study|Moved|0|||
125132366|NCT00365365|450111728|FG002|Overall Study|Moved|0|||
125132367|NCT00365365|450111726|FG000|Overall Study|New cancer|1|||
125132368|NCT00365365|450111727|FG001|Overall Study|New cancer|0|||
125132369|NCT00365365|450111728|FG002|Overall Study|New cancer|0|||
125132370|NCT00365365|450111726|FG000|Overall Study|Withdrew consent|1|||
125132371|NCT00365365|450111727|FG001|Overall Study|Withdrew consent|1|||
125132372|NCT00365365|450111728|FG002|Overall Study|Withdrew consent|0|||
125132373|NCT00365365|450111726|FG000|Overall Study|Second malignancy|0|||
125132374|NCT00365365|450111727|FG001|Overall Study|Second malignancy|1|||
125132375|NCT00365365|450111728|FG002|Overall Study|Second malignancy|0|||
125132376|NCT00365365|450111726|FG000|Overall Study|Patient/physician decision|0|||
125132377|NCT00365365|450111727|FG001|Overall Study|Patient/physician decision|0|||
125132378|NCT00365365|450111728|FG002|Overall Study|Patient/physician decision|1|||
125132379|NCT00984022|450111729|FG000|Overall Study|Lost to Follow-up|10|||
125132380|NCT00984022|450111730|FG001|Overall Study|Lost to Follow-up|14|||
125132381|NCT00905606|450111734|FG000|Period 1|Adverse Event|0|||
125132382|NCT00905606|450111735|FG001|Period 1|Adverse Event|1|||
125437053|NCT02714205|451226346|FG000|Overall Study|Too busy|1|||
125437054|NCT02714205|451226347|FG001|Overall Study|Too busy|0|||
125437055|NCT02714205|451226346|FG000|Overall Study|Incomplete outcome data|0|||
125437056|NCT02714205|451226347|FG001|Overall Study|Incomplete outcome data|1|||
125437057|NCT00381641|451226348|FG000|Overall Study|Withdrawal by Subject|0|||
125437058|NCT00381641|451226349|FG001|Overall Study|Withdrawal by Subject|2|||
125132383|NCT00905606|450111734|FG000|Washout|Withdrawal by Subject|1|||
125132384|NCT00905606|450111735|FG001|Washout|Withdrawal by Subject|0|||
125132385|NCT03868891|450111742|FG000|Overall Study|Adverse Event|1|||
125132386|NCT03868891|450111743|FG001|Overall Study|Adverse Event|0|||
125132387|NCT03868891|450111742|FG000|Overall Study|Lost to Follow-up|2|||
125132388|NCT03868891|450111743|FG001|Overall Study|Lost to Follow-up|1|||
125132389|NCT03868891|450111742|FG000|Overall Study|COVID-19 Restrictions|1|||
125132390|NCT03868891|450111743|FG001|Overall Study|COVID-19 Restrictions|2|||
125132391|NCT00777023|450111744|FG000|Overall Study|Adverse Event|15|||
125132392|NCT00777023|450111745|FG001|Overall Study|Adverse Event|21|||
125132393|NCT00777023|450111746|FG002|Overall Study|Adverse Event|8|||
125218065|NCT02959918|450425366|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125437059|NCT01598298|451226350|FG000|Overall Study|Not eligible|5|||
125218066|NCT02959918|450425367|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
125218067|NCT02959918|450425368|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218068|NCT02959918|450425369|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218069|NCT02959918|450425370|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218070|NCT02959918|450425371|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218071|NCT02959918|450425372|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
125218072|NCT02959918|450425359|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218073|NCT02959918|450425360|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218074|NCT02959918|450425361|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218075|NCT02959918|450425362|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218076|NCT02959918|450425363|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218077|NCT02959918|450425364|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125639881|NCT02646891|451962731|FG009|Overall Study|Lost to Follow-up|2|||
125639882|NCT02646891|451962722|FG000|Overall Study|Protocol Violation|0|||
125639883|NCT02646891|451962723|FG001|Overall Study|Protocol Violation|0|||
125639884|NCT02646891|451962724|FG002|Overall Study|Protocol Violation|0|||
125639885|NCT02646891|451962725|FG003|Overall Study|Protocol Violation|0|||
125639886|NCT02646891|451962726|FG004|Overall Study|Protocol Violation|0|||
125639887|NCT02646891|451962727|FG005|Overall Study|Protocol Violation|0|||
125639888|NCT02646891|451962728|FG006|Overall Study|Protocol Violation|1|||
125639889|NCT02646891|451962729|FG007|Overall Study|Protocol Violation|1|||
125639890|NCT02646891|451962730|FG008|Overall Study|Protocol Violation|0|||
125639891|NCT02646891|451962731|FG009|Overall Study|Protocol Violation|0|||
125639892|NCT02646891|451962722|FG000|Overall Study|Withdrawal by Subject|2|||
125639893|NCT02646891|451962723|FG001|Overall Study|Withdrawal by Subject|0|||
125639894|NCT02646891|451962724|FG002|Overall Study|Withdrawal by Subject|1|||
125639895|NCT02646891|451962725|FG003|Overall Study|Withdrawal by Subject|0|||
125639896|NCT02646891|451962726|FG004|Overall Study|Withdrawal by Subject|0|||
125639897|NCT02646891|451962727|FG005|Overall Study|Withdrawal by Subject|0|||
125639898|NCT02646891|451962728|FG006|Overall Study|Withdrawal by Subject|5|||
125639899|NCT02646891|451962729|FG007|Overall Study|Withdrawal by Subject|9|||
125639900|NCT02646891|451962730|FG008|Overall Study|Withdrawal by Subject|7|||
125639901|NCT02646891|451962731|FG009|Overall Study|Withdrawal by Subject|3|||
125639902|NCT02646891|451962722|FG000|Overall Study|Death|0|||
125639903|NCT02646891|451962723|FG001|Overall Study|Death|0|||
125639904|NCT02646891|451962724|FG002|Overall Study|Death|0|||
125639905|NCT02646891|451962725|FG003|Overall Study|Death|0|||
125639906|NCT02646891|451962726|FG004|Overall Study|Death|0|||
125639907|NCT02646891|451962727|FG005|Overall Study|Death|0|||
125218078|NCT02959918|450425365|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125420816|NCT01260350|451166155|FG011|Overall Study|Lack of Efficacy|0|||
125420817|NCT01260350|451166156|FG012|Overall Study|Lack of Efficacy|0|||
125639908|NCT02646891|451962728|FG006|Overall Study|Death|1|||
125639909|NCT02646891|451962729|FG007|Overall Study|Death|1|||
125639910|NCT02646891|451962730|FG008|Overall Study|Death|1|||
125639911|NCT02646891|451962731|FG009|Overall Study|Death|0|||
125639912|NCT02274311|451962732|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
125132394|NCT00777023|450111744|FG000|Overall Study|Lack of Efficacy|1|||
125132395|NCT00777023|450111745|FG001|Overall Study|Lack of Efficacy|0|||
125132396|NCT00777023|450111746|FG002|Overall Study|Lack of Efficacy|14|||
125132397|NCT00777023|450111744|FG000|Overall Study|Protocol Violation|2|||
125132398|NCT00777023|450111745|FG001|Overall Study|Protocol Violation|1|||
125132399|NCT00777023|450111746|FG002|Overall Study|Protocol Violation|1|||
125132400|NCT00777023|450111744|FG000|Overall Study|Lost to Follow-up|2|||
125132401|NCT00777023|450111745|FG001|Overall Study|Lost to Follow-up|3|||
125132402|NCT00777023|450111746|FG002|Overall Study|Lost to Follow-up|3|||
125132403|NCT00777023|450111744|FG000|Overall Study|Death|0|||
125132404|NCT00777023|450111745|FG001|Overall Study|Death|1|||
125132405|NCT00777023|450111746|FG002|Overall Study|Death|0|||
125132406|NCT00777023|450111744|FG000|Overall Study|Withdrawal by Subject|7|||
125132407|NCT00777023|450111745|FG001|Overall Study|Withdrawal by Subject|7|||
125639913|NCT02477800|451962734|FG000|Placebo-Controlled Period|Adverse Event|16|||
125639914|NCT02477800|451962735|FG001|Placebo-Controlled Period|Adverse Event|25|||
125639915|NCT02477800|451962736|FG002|Placebo-Controlled Period|Adverse Event|28|||
125639916|NCT02477800|451962737|FG003|Placebo-Controlled Period|Adverse Event|0|||
125639917|NCT02477800|451962738|FG004|Placebo-Controlled Period|Adverse Event|0|||
125639918|NCT02477800|451962739|FG005|Placebo-Controlled Period|Adverse Event|0|||
125132408|NCT00777023|450111746|FG002|Overall Study|Withdrawal by Subject|8|||
125132409|NCT00777023|450111744|FG000|Overall Study|Missing data|1|||
125132410|NCT00777023|450111745|FG001|Overall Study|Missing data|1|||
125132411|NCT00777023|450111746|FG002|Overall Study|Missing data|0|||
125132412|NCT00777023|450111744|FG000|Overall Study|Reasons not specified|4|||
125132413|NCT00777023|450111745|FG001|Overall Study|Reasons not specified|4|||
125132414|NCT00777023|450111746|FG002|Overall Study|Reasons not specified|2|||
125132415|NCT00777023|450111744|FG000|Overall Study|Last dose date unknown|3|||
125132416|NCT00777023|450111745|FG001|Overall Study|Last dose date unknown|3|||
125132417|NCT00777023|450111746|FG002|Overall Study|Last dose date unknown|1|||
125132418|NCT03123094|450111747|FG000|Overall Study|Withdrawal by Subject|0|||
125218079|NCT02959918|450425366|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125380096|NCT01988103|451023445|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
125420818|NCT01260350|451166157|FG013|Overall Study|Lack of Efficacy|0|||
125639919|NCT02477800|451962740|FG006|Placebo-Controlled Period|Adverse Event|0|||
125639920|NCT02477800|451962734|FG000|Placebo-Controlled Period|Change of Treatment|1|||
125639921|NCT02477800|451962735|FG001|Placebo-Controlled Period|Change of Treatment|2|||
125639922|NCT02477800|451962736|FG002|Placebo-Controlled Period|Change of Treatment|1|||
125639923|NCT02477800|451962737|FG003|Placebo-Controlled Period|Change of Treatment|0|||
125639924|NCT02477800|451962738|FG004|Placebo-Controlled Period|Change of Treatment|0|||
125639925|NCT02477800|451962739|FG005|Placebo-Controlled Period|Change of Treatment|0|||
125639926|NCT02477800|451962740|FG006|Placebo-Controlled Period|Change of Treatment|0|||
125639927|NCT02477800|451962734|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
125639928|NCT02477800|451962735|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
125639929|NCT02477800|451962736|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
125639930|NCT02477800|451962737|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
125639931|NCT02477800|451962738|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
125639932|NCT02477800|451962739|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
125639933|NCT02477800|451962740|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
125639934|NCT02477800|451962734|FG000|Placebo-Controlled Period|Death|0|||
125639935|NCT02477800|451962735|FG001|Placebo-Controlled Period|Death|3|||
125639936|NCT02477800|451962736|FG002|Placebo-Controlled Period|Death|2|||
125639937|NCT02477800|451962737|FG003|Placebo-Controlled Period|Death|0|||
125639938|NCT02477800|451962738|FG004|Placebo-Controlled Period|Death|0|||
125639939|NCT02477800|451962739|FG005|Placebo-Controlled Period|Death|0|||
125639940|NCT02477800|451962740|FG006|Placebo-Controlled Period|Death|0|||
125639941|NCT02477800|451962734|FG000|Placebo-Controlled Period|Disease Progression|1|||
125639942|NCT02477800|451962735|FG001|Placebo-Controlled Period|Disease Progression|0|||
125639943|NCT02477800|451962736|FG002|Placebo-Controlled Period|Disease Progression|1|||
125639944|NCT02477800|451962737|FG003|Placebo-Controlled Period|Disease Progression|0|||
125639945|NCT02477800|451962738|FG004|Placebo-Controlled Period|Disease Progression|0|||
125639946|NCT02477800|451962739|FG005|Placebo-Controlled Period|Disease Progression|0|||
125639947|NCT02477800|451962740|FG006|Placebo-Controlled Period|Disease Progression|0|||
125639948|NCT02477800|451962734|FG000|Placebo-Controlled Period|Investigator Decision|3|||
125639949|NCT02477800|451962735|FG001|Placebo-Controlled Period|Investigator Decision|2|||
125132419|NCT03123094|450111748|FG001|Overall Study|Withdrawal by Subject|2|||
125132420|NCT03123094|450111749|FG002|Overall Study|Withdrawal by Subject|1|||
125132421|NCT03123094|450111750|FG003|Overall Study|Withdrawal by Subject|0|||
125132422|NCT03123094|450111751|FG004|Overall Study|Withdrawal by Subject|1|||
125132423|NCT04247282|450111752|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
125639950|NCT02477800|451962736|FG002|Placebo-Controlled Period|Investigator Decision|1|||
125639951|NCT02477800|451962737|FG003|Placebo-Controlled Period|Investigator Decision|0|||
125639952|NCT02477800|451962738|FG004|Placebo-Controlled Period|Investigator Decision|0|||
125132424|NCT04247282|450111753|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
125132425|NCT04247282|450111754|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
125132426|NCT04247282|450111755|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
125132427|NCT04247282|450111752|FG000|Overall Study|Refused further treatment|0|||
125132428|NCT04247282|450111753|FG001|Overall Study|Refused further treatment|1|||
125132429|NCT04247282|450111754|FG002|Overall Study|Refused further treatment|0|||
125132430|NCT04247282|450111755|FG003|Overall Study|Refused further treatment|0|||
125132431|NCT03496623|450111760|FG000|Run-In Period (2 Weeks)|Death|1|||
125132432|NCT03496623|450111761|FG001|Run-In Period (2 Weeks)|Death|0|||
125132433|NCT03496623|450111762|FG002|Run-In Period (2 Weeks)|Death|0|||
125132434|NCT03496623|450111763|FG003|Run-In Period (2 Weeks)|Death|0|||
125132435|NCT03496623|450111764|FG004|Run-In Period (2 Weeks)|Death|0|||
125132436|NCT03496623|450111760|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
125132437|NCT03496623|450111761|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
125132438|NCT03496623|450111762|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
125132439|NCT03496623|450111763|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
125132440|NCT03496623|450111764|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
125132441|NCT03496623|450111760|FG000|Period 1 (12 Weeks)|Death|0|||
125132442|NCT03496623|450111761|FG001|Period 1 (12 Weeks)|Death|3|||
125132443|NCT03496623|450111762|FG002|Period 1 (12 Weeks)|Death|0|||
125132444|NCT03496623|450111763|FG003|Period 1 (12 Weeks)|Death|0|||
125132445|NCT03496623|450111764|FG004|Period 1 (12 Weeks)|Death|0|||
125132446|NCT03496623|450111760|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
125132447|NCT03496623|450111761|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
125132448|NCT03496623|450111762|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
125132449|NCT03496623|450111763|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
125132450|NCT03496623|450111764|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
125132451|NCT03496623|450111760|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125132452|NCT03496623|450111761|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
125132453|NCT03496623|450111762|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
125132454|NCT03496623|450111763|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125132455|NCT03496623|450111764|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125132456|NCT03496623|450111760|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
125218080|NCT02959918|450425367|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218081|NCT02959918|450425368|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
125437060|NCT01598298|451226351|FG001|Overall Study|Not eligible|5|||
125437061|NCT01598298|451226350|FG000|Overall Study|Adverse Event|21|||
125437062|NCT01598298|451226351|FG001|Overall Study|Adverse Event|19|||
125132457|NCT03496623|450111761|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
125132458|NCT03496623|450111762|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
125132459|NCT03496623|450111763|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
125132460|NCT03496623|450111764|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
125437063|NCT01598298|451226350|FG000|Overall Study|Progression/relapse|0|||
125132461|NCT03496623|450111760|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
125132462|NCT03496623|450111761|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
125132463|NCT03496623|450111762|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
125132464|NCT03496623|450111763|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
125132465|NCT03496623|450111764|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
125132466|NCT03496623|450111760|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
125132467|NCT03496623|450111761|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
125132468|NCT03496623|450111762|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
125132469|NCT03496623|450111763|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
125132470|NCT03496623|450111764|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
125132471|NCT03496623|450111760|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125132472|NCT03496623|450111761|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
125132473|NCT03496623|450111762|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
125132474|NCT03496623|450111763|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125132475|NCT03496623|450111764|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125132476|NCT01037114|450111765|FG000|Year 20|Others|1|||
125132477|NCT03181594|450111773|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
125420819|NCT01260350|451166158|FG014|Overall Study|Lack of Efficacy|0|||
125380097|NCT01988103|451023441|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
125380098|NCT01988103|451023442|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
125380099|NCT01988103|451023443|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
125437064|NCT01598298|451226351|FG001|Overall Study|Progression/relapse|2|||
125639953|NCT02477800|451962739|FG005|Placebo-Controlled Period|Investigator Decision|0|||
125639954|NCT02477800|451962740|FG006|Placebo-Controlled Period|Investigator Decision|0|||
125639955|NCT02477800|451962734|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
125639956|NCT02477800|451962735|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
125639957|NCT02477800|451962736|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
125639958|NCT02477800|451962737|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
125639959|NCT02477800|451962738|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
125639960|NCT02477800|451962739|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
125639961|NCT02477800|451962740|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
125639962|NCT02477800|451962734|FG000|Placebo-Controlled Period|Relocation|2|||
125639963|NCT02477800|451962735|FG001|Placebo-Controlled Period|Relocation|0|||
125639964|NCT02477800|451962736|FG002|Placebo-Controlled Period|Relocation|0|||
125639965|NCT02477800|451962737|FG003|Placebo-Controlled Period|Relocation|0|||
125639966|NCT02477800|451962738|FG004|Placebo-Controlled Period|Relocation|0|||
125639967|NCT02477800|451962739|FG005|Placebo-Controlled Period|Relocation|0|||
125639968|NCT02477800|451962740|FG006|Placebo-Controlled Period|Relocation|0|||
125639969|NCT02477800|451962734|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
125639970|NCT02477800|451962735|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
125639971|NCT02477800|451962736|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
125132478|NCT03181594|450111773|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
125132479|NCT03181594|450111773|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
125132480|NCT03181594|450111773|FG000|Initial Study Protocol (12-month FU)|Death|1|||
125132481|NCT03181594|450111773|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
125132482|NCT03181594|450111773|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
125132483|NCT03247972|450111775|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
125132484|NCT03247972|450111775|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
125132485|NCT00968812|450111776|FG000|Overall Study|Adverse Event|30|||
125132486|NCT00968812|450111777|FG001|Overall Study|Adverse Event|46|||
125132487|NCT00968812|450111778|FG002|Overall Study|Adverse Event|33|||
125639972|NCT02477800|451962737|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
125639973|NCT02477800|451962738|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
125639974|NCT02477800|451962739|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
125639975|NCT02477800|451962740|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
125639976|NCT02477800|451962734|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
125639977|NCT02477800|451962735|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
125639978|NCT02477800|451962736|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
125639979|NCT02477800|451962737|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
125639980|NCT02477800|451962738|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
125639981|NCT02477800|451962739|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
125639982|NCT02477800|451962740|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
125639983|NCT02477800|451962734|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
125639984|NCT02477800|451962735|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
125639985|NCT02477800|451962736|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
125639986|NCT02477800|451962737|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
125639987|NCT02477800|451962738|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
125639988|NCT02477800|451962739|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
125639989|NCT02477800|451962740|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
125132488|NCT00968812|450111776|FG000|Overall Study|Death|2|||
125132489|NCT00968812|450111777|FG001|Overall Study|Death|2|||
125132490|NCT00968812|450111778|FG002|Overall Study|Death|1|||
125132491|NCT00968812|450111776|FG000|Overall Study|Lack of Efficacy|9|||
125132492|NCT00968812|450111777|FG001|Overall Study|Lack of Efficacy|7|||
125132493|NCT00968812|450111778|FG002|Overall Study|Lack of Efficacy|16|||
125132494|NCT00968812|450111776|FG000|Overall Study|Lost to Follow-up|17|||
125132495|NCT00968812|450111777|FG001|Overall Study|Lost to Follow-up|12|||
125132496|NCT00968812|450111778|FG002|Overall Study|Lost to Follow-up|11|||
125132497|NCT00968812|450111776|FG000|Overall Study|Physician Decision|8|||
125132498|NCT00968812|450111777|FG001|Overall Study|Physician Decision|5|||
125132499|NCT00968812|450111778|FG002|Overall Study|Physician Decision|9|||
125132500|NCT00968812|450111776|FG000|Overall Study|Protocol Violation|7|||
125132501|NCT00968812|450111777|FG001|Overall Study|Protocol Violation|4|||
125132502|NCT00968812|450111778|FG002|Overall Study|Protocol Violation|3|||
125132503|NCT00968812|450111776|FG000|Overall Study|Withdrawal by Subject|17|||
125132504|NCT00968812|450111777|FG001|Overall Study|Withdrawal by Subject|23|||
125132505|NCT00968812|450111778|FG002|Overall Study|Withdrawal by Subject|25|||
125132506|NCT00968812|450111776|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
125132507|NCT00968812|450111777|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
125132508|NCT00968812|450111778|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
125132509|NCT00968812|450111776|FG000|Overall Study|Noncompliance with study drug|4|||
125132510|NCT00968812|450111777|FG001|Overall Study|Noncompliance with study drug|1|||
125132511|NCT00968812|450111778|FG002|Overall Study|Noncompliance with study drug|6|||
125437065|NCT01598298|451226350|FG000|Overall Study|Withdrawal by Subject|10|||
125132512|NCT00968812|450111776|FG000|Overall Study|Unable to take rescue therapy|12|||
125132513|NCT00968812|450111777|FG001|Overall Study|Unable to take rescue therapy|12|||
125132514|NCT00968812|450111778|FG002|Overall Study|Unable to take rescue therapy|17|||
125132515|NCT00968812|450111776|FG000|Overall Study|Other|25|||
125132516|NCT00968812|450111777|FG001|Overall Study|Other|37|||
125132517|NCT00968812|450111778|FG002|Overall Study|Other|40|||
125132518|NCT00123734|450111783|FG000|Overall Study|Death|3|||
125132519|NCT00123734|450111783|FG000|Overall Study|Lost to Follow-up|3|||
125132520|NCT00123734|450111783|FG000|Overall Study|Dropout|1|||
125132521|NCT00123734|450111783|FG000|Overall Study|Withdrawal by Subject|1|||
125132522|NCT00113386|450111784|FG000|Overall Study|Withdrawal by Subject|1|||
125132523|NCT00113386|450111785|FG001|Overall Study|Withdrawal by Subject|0|||
125132524|NCT00113386|450111784|FG000|Overall Study|Physician Decision|0|||
125132525|NCT00113386|450111785|FG001|Overall Study|Physician Decision|1|||
125132526|NCT00113386|450111784|FG000|Overall Study|Toxicity|3|||
125132527|NCT00113386|450111785|FG001|Overall Study|Toxicity|0|||
125132528|NCT00113386|450111784|FG000|Overall Study|Ineligible|1|||
125132529|NCT00113386|450111785|FG001|Overall Study|Ineligible|2|||
125132530|NCT00113386|450111784|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
125132531|NCT00113386|450111785|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
125132532|NCT00640562|450111786|FG000|Overall Study|Adverse Event|8|||
125132533|NCT00640562|450111787|FG001|Overall Study|Adverse Event|5|||
125132534|NCT00640562|450111786|FG000|Overall Study|Lack of Efficacy|1|||
125132535|NCT00640562|450111787|FG001|Overall Study|Lack of Efficacy|4|||
125132536|NCT00640562|450111786|FG000|Overall Study|Protocol Violation|2|||
125132537|NCT00640562|450111787|FG001|Overall Study|Protocol Violation|4|||
125132538|NCT00640562|450111786|FG000|Overall Study|Withdrawal by Subject|6|||
125132539|NCT00640562|450111787|FG001|Overall Study|Withdrawal by Subject|10|||
125132540|NCT00640562|450111786|FG000|Overall Study|Known risperidone intolerance|0|||
125132541|NCT00640562|450111787|FG001|Overall Study|Known risperidone intolerance|1|||
125132542|NCT00640562|450111786|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
125132543|NCT00640562|450111787|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
125132544|NCT00640562|450111786|FG000|Overall Study|Low study drug dose|0|||
125437066|NCT01598298|451226351|FG001|Overall Study|Withdrawal by Subject|15|||
125437067|NCT01598298|451226350|FG000|Overall Study|Other reason (not protocol specified)|4|||
125437068|NCT01598298|451226351|FG001|Overall Study|Other reason (not protocol specified)|0|||
125437069|NCT04287868|451226352|FG000|Overall Study|Screening fail|1|||
125132545|NCT00640562|450111787|FG001|Overall Study|Low study drug dose|1|||
125132546|NCT00640562|450111786|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
125132547|NCT00640562|450111787|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
125132548|NCT02937870|450111788|FG000|Overall Study|Adverse Event|1|||
125132549|NCT02937870|450111788|FG000|Overall Study|Protocol Deviation|2|||
125132550|NCT00609674|450111792|FG000|Overall Study|Adverse Event|1|||
125132551|NCT00609674|450111793|FG001|Overall Study|Adverse Event|1|||
125132552|NCT00609674|450111792|FG000|Overall Study|Protocol Violation|3|||
125132553|NCT00609674|450111793|FG001|Overall Study|Protocol Violation|5|||
125639990|NCT02477800|451962734|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
125639991|NCT02477800|451962735|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
125639992|NCT02477800|451962736|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
125639993|NCT02477800|451962737|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125639994|NCT02477800|451962738|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125639995|NCT02477800|451962739|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125639996|NCT02477800|451962740|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125639997|NCT02477800|451962734|FG000|Placebo-Controlled Period|Reason not Specified|161|||
125639998|NCT02477800|451962735|FG001|Placebo-Controlled Period|Reason not Specified|161|||
125639999|NCT02477800|451962736|FG002|Placebo-Controlled Period|Reason not Specified|189|||
125640000|NCT02477800|451962737|FG003|Placebo-Controlled Period|Reason not Specified|0|||
125640001|NCT02477800|451962738|FG004|Placebo-Controlled Period|Reason not Specified|0|||
125640002|NCT02477800|451962739|FG005|Placebo-Controlled Period|Reason not Specified|0|||
125640003|NCT02477800|451962740|FG006|Placebo-Controlled Period|Reason not Specified|0|||
125640004|NCT02477800|451962734|FG000|Long Term Extension Period|Adverse Event|0|||
125640005|NCT02477800|451962735|FG001|Long Term Extension Period|Adverse Event|0|||
125640006|NCT02477800|451962736|FG002|Long Term Extension Period|Adverse Event|0|||
125640007|NCT02477800|451962737|FG003|Long Term Extension Period|Adverse Event|6|||
125640008|NCT02477800|451962738|FG004|Long Term Extension Period|Adverse Event|2|||
125218082|NCT02959918|450425369|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218083|NCT02959918|450425370|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218084|NCT02959918|450425371|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218085|NCT02959918|450425372|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
125218086|NCT03231306|450425373|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
125218087|NCT03231306|450425373|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
125218088|NCT03231306|450425373|FG000|Overall Study|Treatment delay > 21 days|2|||
125218089|NCT03231306|450425373|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
125218090|NCT03231306|450425373|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
125218091|NCT03231306|450425373|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
125640009|NCT02477800|451962739|FG005|Long Term Extension Period|Adverse Event|4|||
125640010|NCT02477800|451962740|FG006|Long Term Extension Period|Adverse Event|3|||
125640011|NCT02477800|451962734|FG000|Long Term Extension Period|Death|0|||
125640012|NCT02477800|451962735|FG001|Long Term Extension Period|Death|0|||
125640013|NCT02477800|451962736|FG002|Long Term Extension Period|Death|0|||
125640014|NCT02477800|451962737|FG003|Long Term Extension Period|Death|1|||
125640015|NCT02477800|451962738|FG004|Long Term Extension Period|Death|1|||
125640016|NCT02477800|451962739|FG005|Long Term Extension Period|Death|1|||
125640017|NCT02477800|451962740|FG006|Long Term Extension Period|Death|2|||
125640018|NCT02477800|451962734|FG000|Long Term Extension Period|Consent Withdrawn|0|||
125640019|NCT02477800|451962735|FG001|Long Term Extension Period|Consent Withdrawn|0|||
125640020|NCT02477800|451962736|FG002|Long Term Extension Period|Consent Withdrawn|0|||
125640021|NCT02477800|451962737|FG003|Long Term Extension Period|Consent Withdrawn|10|||
125640022|NCT02477800|451962738|FG004|Long Term Extension Period|Consent Withdrawn|4|||
125640023|NCT02477800|451962739|FG005|Long Term Extension Period|Consent Withdrawn|13|||
125132554|NCT00609674|450111792|FG000|Overall Study|Lost to Follow-up|1|||
125132555|NCT00609674|450111793|FG001|Overall Study|Lost to Follow-up|0|||
125132556|NCT00609674|450111792|FG000|Overall Study|Withdrew consent|2|||
125132557|NCT00609674|450111793|FG001|Overall Study|Withdrew consent|1|||
125132558|NCT03098394|450111794|FG000|Overall Study|Pregnancy|0|||
125132559|NCT03098394|450111795|FG001|Overall Study|Pregnancy|1|||
125132560|NCT00571064|450111797|FG000|Overall Study|Adverse Event|13|||
125132561|NCT00571064|450111797|FG000|Overall Study|Protocol Violation|4|||
125132562|NCT00571064|450111797|FG000|Overall Study|Withdrawal by Subject|2|||
125437070|NCT04287868|451226353|FG001|Overall Study|Screening fail|0|||
125437071|NCT03813147|451226354|FG000|Overall Study|Lack of Efficacy|4|||
125437072|NCT03813147|451226355|FG001|Overall Study|Lack of Efficacy|4|||
125437073|NCT03813147|451226354|FG000|Overall Study|Physician Decision|2|||
125437074|NCT03813147|451226355|FG001|Overall Study|Physician Decision|1|||
125437075|NCT02291432|451227975|FG000|Overall Study|Withdrawal by Subject|2|||
125437076|NCT03377790|451227976|FG000|Overall Study|Withdrawal by Subject|1|||
125437077|NCT03377790|451227977|FG001|Overall Study|Withdrawal by Subject|0|||
125437078|NCT03377790|451227976|FG000|Overall Study|Adverse Event|1|||
125437079|NCT03377790|451227977|FG001|Overall Study|Adverse Event|0|||
125132563|NCT00571064|450111797|FG000|Overall Study|Other|2|||
125132564|NCT00244764|450111798|FG000|Overall Study|Adverse Event|37|||
125132565|NCT00244764|450111798|FG000|Overall Study|Lost to Follow-up|23|||
125132566|NCT00244764|450111798|FG000|Overall Study|Withdrawal by Subject|12|||
125132567|NCT00244764|450111798|FG000|Overall Study|Disease Progression|13|||
125437080|NCT03377790|451227976|FG000|Overall Study|Lost to Follow-up|0|||
125437081|NCT03377790|451227977|FG001|Overall Study|Lost to Follow-up|2|||
125640024|NCT02477800|451962740|FG006|Long Term Extension Period|Consent Withdrawn|16|||
125640025|NCT02477800|451962734|FG000|Long Term Extension Period|Disease Progression|0|||
125640026|NCT02477800|451962735|FG001|Long Term Extension Period|Disease Progression|0|||
125640027|NCT02477800|451962736|FG002|Long Term Extension Period|Disease Progression|0|||
125640028|NCT02477800|451962737|FG003|Long Term Extension Period|Disease Progression|3|||
125640029|NCT02477800|451962738|FG004|Long Term Extension Period|Disease Progression|1|||
125640030|NCT02477800|451962739|FG005|Long Term Extension Period|Disease Progression|1|||
125640031|NCT02477800|451962740|FG006|Long Term Extension Period|Disease Progression|0|||
125640032|NCT02477800|451962734|FG000|Long Term Extension Period|Investigator Decision|0|||
125640033|NCT02477800|451962735|FG001|Long Term Extension Period|Investigator Decision|0|||
125640034|NCT02477800|451962736|FG002|Long Term Extension Period|Investigator Decision|0|||
125640035|NCT02477800|451962737|FG003|Long Term Extension Period|Investigator Decision|0|||
125640036|NCT02477800|451962738|FG004|Long Term Extension Period|Investigator Decision|0|||
125640037|NCT02477800|451962739|FG005|Long Term Extension Period|Investigator Decision|0|||
125640038|NCT02477800|451962740|FG006|Long Term Extension Period|Investigator Decision|2|||
125640039|NCT02477800|451962734|FG000|Long Term Extension Period|Lost to Follow-up|0|||
125640040|NCT02477800|451962735|FG001|Long Term Extension Period|Lost to Follow-up|0|||
125640041|NCT02477800|451962736|FG002|Long Term Extension Period|Lost to Follow-up|0|||
125640042|NCT02477800|451962737|FG003|Long Term Extension Period|Lost to Follow-up|0|||
125640043|NCT02477800|451962738|FG004|Long Term Extension Period|Lost to Follow-up|1|||
125640044|NCT02477800|451962739|FG005|Long Term Extension Period|Lost to Follow-up|3|||
125640045|NCT02477800|451962740|FG006|Long Term Extension Period|Lost to Follow-up|0|||
125640046|NCT02477800|451962734|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
125640047|NCT02477800|451962735|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
125640048|NCT02477800|451962736|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
125640049|NCT02477800|451962737|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
125640050|NCT02477800|451962738|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
125640051|NCT02477800|451962739|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
125640052|NCT02477800|451962740|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
125640053|NCT02477800|451962734|FG000|Long Term Extension Period|Study Visit Burden|0|||
125640054|NCT02477800|451962735|FG001|Long Term Extension Period|Study Visit Burden|0|||
125640055|NCT02477800|451962736|FG002|Long Term Extension Period|Study Visit Burden|0|||
125640056|NCT02477800|451962737|FG003|Long Term Extension Period|Study Visit Burden|3|||
125640057|NCT02477800|451962738|FG004|Long Term Extension Period|Study Visit Burden|0|||
125640058|NCT02477800|451962739|FG005|Long Term Extension Period|Study Visit Burden|2|||
125640059|NCT02477800|451962740|FG006|Long Term Extension Period|Study Visit Burden|2|||
125640060|NCT02477800|451962734|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
125640061|NCT02477800|451962735|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
125640062|NCT02477800|451962736|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
125640063|NCT02477800|451962737|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
125640064|NCT02477800|451962738|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
125640065|NCT02477800|451962739|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
125640066|NCT02477800|451962740|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
125640067|NCT02477800|451962734|FG000|Long Term Extension Period|Reason not Specified|0|||
125640068|NCT02477800|451962735|FG001|Long Term Extension Period|Reason not Specified|0|||
125640069|NCT02477800|451962736|FG002|Long Term Extension Period|Reason not Specified|0|||
125640070|NCT02477800|451962737|FG003|Long Term Extension Period|Reason not Specified|126|||
125640071|NCT02477800|451962738|FG004|Long Term Extension Period|Reason not Specified|140|||
125640072|NCT02477800|451962739|FG005|Long Term Extension Period|Reason not Specified|270|||
125640073|NCT02477800|451962740|FG006|Long Term Extension Period|Reason not Specified|224|||
125640074|NCT00170846|451962745|FG000|Overall Study|Subject withdrew Informed Consent|5|||
125640075|NCT00170846|451962746|FG001|Overall Study|Subject withdrew Informed Consent|12|||
125640076|NCT00170846|451962747|FG002|Overall Study|Subject withdrew Informed Consent|8|||
125640077|NCT00170846|451962745|FG000|Overall Study|Lost to Follow-up|6|||
125640078|NCT00170846|451962746|FG001|Overall Study|Lost to Follow-up|3|||
125640079|NCT00170846|451962747|FG002|Overall Study|Lost to Follow-up|2|||
125640080|NCT00170846|451962745|FG000|Overall Study|Death|0|||
125640081|NCT00170846|451962746|FG001|Overall Study|Death|3|||
125640082|NCT00170846|451962747|FG002|Overall Study|Death|3|||
125132568|NCT00244764|450111798|FG000|Overall Study|Protocol Violation|2|||
125132569|NCT00244764|450111798|FG000|Overall Study|Death|1|||
125132570|NCT00244764|450111798|FG000|Overall Study|Off Study Medication for >21 Days|1|||
125132571|NCT00244764|450111798|FG000|Overall Study|Declining Performance Status|1|||
125132572|NCT00244764|450111798|FG000|Overall Study|Participant was Hospitalized until Death|1|||
125132573|NCT00244764|450111798|FG000|Overall Study|Primary Investigator Discretion|2|||
125132574|NCT00244764|450111798|FG000|Overall Study|Sponsor Terminated Study|2|||
125132575|NCT00244764|450111798|FG000|Overall Study|Developed Secondary Malignancy|1|||
125132576|NCT00840073|450111811|FG000|Second Intervention|Missed 72 hour blood draw|1|||
125132577|NCT00840073|450111812|FG001|Second Intervention|Missed 72 hour blood draw|1|||
125132578|NCT03285594|450111813|FG000|Overall Study|At the Participant's Own Request|10|||
125132579|NCT03285594|450111814|FG001|Overall Study|At the Participant's Own Request|5|||
125132580|NCT03285594|450111815|FG002|Overall Study|At the Participant's Own Request|21|||
125132581|NCT03285594|450111813|FG000|Overall Study|Adverse Event|2|||
125132582|NCT03285594|450111814|FG001|Overall Study|Adverse Event|2|||
125132583|NCT03285594|450111815|FG002|Overall Study|Adverse Event|6|||
125132584|NCT03285594|450111813|FG000|Overall Study|Poor Compliance to Protocol|0|||
125132585|NCT03285594|450111814|FG001|Overall Study|Poor Compliance to Protocol|0|||
125132586|NCT03285594|450111815|FG002|Overall Study|Poor Compliance to Protocol|1|||
125132587|NCT03285594|450111813|FG000|Overall Study|Lost to Follow-up|0|||
125132588|NCT03285594|450111814|FG001|Overall Study|Lost to Follow-up|0|||
125132589|NCT03285594|450111815|FG002|Overall Study|Lost to Follow-up|1|||
125132590|NCT03285594|450111813|FG000|Overall Study|Reason Not Specified|3|||
125132591|NCT03285594|450111814|FG001|Overall Study|Reason Not Specified|4|||
125132592|NCT03285594|450111815|FG002|Overall Study|Reason Not Specified|8|||
125132593|NCT01615198|450111821|FG000|Overall Study|Withdrawal by Subject|5|||
125132594|NCT01615198|450111822|FG001|Overall Study|Withdrawal by Subject|5|||
125132595|NCT01615198|450111821|FG000|Overall Study|Protocol deviation|1|||
125132596|NCT01615198|450111822|FG001|Overall Study|Protocol deviation|1|||
125132597|NCT01615198|450111821|FG000|Overall Study|Physician Decision|5|||
125132598|NCT01615198|450111822|FG001|Overall Study|Physician Decision|1|||
125132599|NCT01615198|450111821|FG000|Overall Study|Lost to Follow-up|1|||
125132600|NCT01615198|450111822|FG001|Overall Study|Lost to Follow-up|1|||
125132601|NCT01615198|450111821|FG000|Overall Study|Lack of Efficacy|1|||
125132602|NCT01615198|450111822|FG001|Overall Study|Lack of Efficacy|6|||
125132603|NCT01615198|450111821|FG000|Overall Study|Adverse Event|11|||
125132604|NCT01615198|450111822|FG001|Overall Study|Adverse Event|5|||
125132605|NCT04608188|450111824|FG000|Overall Study|Withdrawal by Subject|4|||
125132606|NCT04608188|450111825|FG001|Overall Study|Withdrawal by Subject|8|||
125132607|NCT03122457|450111826|FG000|Overall Study|Withdrawal by Subject|6|||
125132608|NCT03273153|450111830|FG000|Overall Study|Adverse Event|1|||
125132609|NCT03273153|450111831|FG001|Overall Study|Adverse Event|2|||
125132610|NCT03273153|450111830|FG000|Overall Study|Missing|0|||
125132611|NCT03273153|450111831|FG001|Overall Study|Missing|2|||
125132612|NCT03273153|450111830|FG000|Overall Study|Other|3|||
125132613|NCT03273153|450111831|FG001|Overall Study|Other|2|||
125132614|NCT03273153|450111830|FG000|Overall Study|Symptomatic Deterioration|0|||
125132615|NCT03273153|450111831|FG001|Overall Study|Symptomatic Deterioration|1|||
125218092|NCT03231306|450425373|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
125218093|NCT03231306|450425373|FG000|Overall Study|More than 1 Reason|2|||
125218094|NCT02306850|450425374|FG000|Overall Study|Lack of Efficacy|2|||
125132616|NCT03273153|450111830|FG000|Overall Study|Progressive Disease|6|||
125132617|NCT03273153|450111831|FG001|Overall Study|Progressive Disease|5|||
125218095|NCT00237692|450425375|FG000|Overall Study|Lost to Follow-up|9|||
125132618|NCT03273153|450111830|FG000|Overall Study|Physician Decision|1|||
125132619|NCT03273153|450111831|FG001|Overall Study|Physician Decision|3|||
125132620|NCT03273153|450111830|FG000|Overall Study|Study Terminated by Sponsor|112|||
125132621|NCT03273153|450111831|FG001|Overall Study|Study Terminated by Sponsor|102|||
125132622|NCT03273153|450111830|FG000|Overall Study|Withdrawal by Subject|26|||
125132623|NCT03273153|450111831|FG001|Overall Study|Withdrawal by Subject|25|||
125132624|NCT03273153|450111830|FG000|Overall Study|Protocol Deviation|3|||
125218096|NCT00237692|450425376|FG001|Overall Study|Lost to Follow-up|3|||
125132625|NCT03273153|450111831|FG001|Overall Study|Protocol Deviation|0|||
125132626|NCT03273153|450111830|FG000|Overall Study|Lost to Follow-up|6|||
125132627|NCT03273153|450111831|FG001|Overall Study|Lost to Follow-up|11|||
125132628|NCT03273153|450111830|FG000|Overall Study|Death|66|||
125132629|NCT03273153|450111831|FG001|Overall Study|Death|69|||
125132630|NCT01908205|450111832|FG000|Overall Study|Lost to Follow-up|2|||
125132631|NCT01908205|450111833|FG001|Overall Study|Lost to Follow-up|0|||
125132632|NCT01908205|450111832|FG000|Overall Study|Withdrawal by Subject|3|||
125132633|NCT01908205|450111833|FG001|Overall Study|Withdrawal by Subject|1|||
125132634|NCT03134222|450111838|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
125132635|NCT03134222|450111839|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
125132636|NCT03134222|450111840|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
125132637|NCT03134222|450111841|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
125132638|NCT03134222|450111842|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
125132639|NCT03134222|450111838|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
125132640|NCT03134222|450111839|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
125132641|NCT03134222|450111840|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
125132642|NCT03134222|450111841|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
125132643|NCT03134222|450111842|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
125132644|NCT03134222|450111838|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
125132645|NCT03134222|450111839|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
125218097|NCT00237692|450425377|FG002|Overall Study|Lost to Follow-up|5|||
125218098|NCT00237692|450425378|FG003|Overall Study|Lost to Follow-up|3|||
125218099|NCT00237692|450425375|FG000|Overall Study|Death|1|||
125218100|NCT00237692|450425376|FG001|Overall Study|Death|2|||
125218101|NCT00237692|450425377|FG002|Overall Study|Death|2|||
125132646|NCT03134222|450111840|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
125132647|NCT03134222|450111841|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
125218102|NCT00237692|450425378|FG003|Overall Study|Death|3|||
125132648|NCT03134222|450111842|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
125132649|NCT03134222|450111838|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
125132650|NCT03134222|450111839|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
125132651|NCT03134222|450111840|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
125132652|NCT03134222|450111841|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
125132653|NCT03134222|450111842|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
125132654|NCT03134222|450111838|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
125132655|NCT03134222|450111839|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
125132656|NCT03134222|450111840|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
125132657|NCT03134222|450111841|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
125132658|NCT03134222|450111842|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
125132659|NCT03134222|450111838|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
125132660|NCT03134222|450111839|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
125132661|NCT03134222|450111840|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
125132662|NCT03134222|450111841|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
125132663|NCT03134222|450111842|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
125132664|NCT03134222|450111838|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
125132665|NCT03134222|450111839|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
125132666|NCT03134222|450111840|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
125132667|NCT03134222|450111841|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
125132668|NCT03134222|450111842|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
125132669|NCT03134222|450111838|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
125132670|NCT03134222|450111839|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
125132671|NCT03134222|450111840|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
125132672|NCT03134222|450111841|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
125132673|NCT03134222|450111842|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
125132674|NCT03681470|450111845|FG000|Overall Study|Lack of Efficacy|3|||
125132675|NCT03681470|450111845|FG000|Overall Study|Lost to Follow-up|1|||
125132676|NCT03681470|450111845|FG000|Overall Study|Protocol Violation|3|||
125132677|NCT03681470|450111845|FG000|Overall Study|Withdrawal by Subject|1|||
125132678|NCT01686477|450111846|FG000|Feeding Intervention|Death|1|||
125132679|NCT01686477|450111847|FG001|Feeding Intervention|Death|0|||
125132680|NCT01686477|450111848|FG002|Feeding Intervention|Death|1|||
125132681|NCT01686477|450111846|FG000|Feeding Intervention|Withdrawal by Subject|0|||
125132682|NCT01686477|450111847|FG001|Feeding Intervention|Withdrawal by Subject|6|||
125218103|NCT00237692|450425375|FG000|Overall Study|Excluded - did not meet criteria|4|||
125132683|NCT01686477|450111848|FG002|Feeding Intervention|Withdrawal by Subject|0|||
125132684|NCT01686477|450111846|FG000|Feeding Intervention|Physician Decision|1|||
125132685|NCT01686477|450111847|FG001|Feeding Intervention|Physician Decision|2|||
125132686|NCT01686477|450111848|FG002|Feeding Intervention|Physician Decision|0|||
125132687|NCT01686477|450111846|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
125132688|NCT01686477|450111847|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
125132689|NCT01686477|450111848|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
125218104|NCT00237692|450425376|FG001|Overall Study|Excluded - did not meet criteria|3|||
125132690|NCT01686477|450111846|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
125218105|NCT00237692|450425377|FG002|Overall Study|Excluded - did not meet criteria|5|||
125132691|NCT01686477|450111847|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
125132692|NCT01686477|450111848|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
125132693|NCT01686477|450111846|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
125132694|NCT01686477|450111847|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
125132695|NCT01686477|450111848|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
125132696|NCT01686477|450111846|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
125132697|NCT01686477|450111847|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
125132698|NCT01686477|450111848|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
125132699|NCT01686477|450111846|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
125132700|NCT01686477|450111847|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
125132701|NCT01686477|450111848|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
125132702|NCT01686477|450111846|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
125132703|NCT01686477|450111847|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
125132704|NCT01686477|450111848|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
125132705|NCT01686477|450111846|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
125132706|NCT01686477|450111847|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
125132707|NCT01686477|450111848|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
125132708|NCT03290781|450111850|FG000|Overall Study|Adverse Event|5|||
125132709|NCT03290781|450111851|FG001|Overall Study|Adverse Event|7|||
125132710|NCT03290781|450111852|FG002|Overall Study|Adverse Event|4|||
125132711|NCT03290781|450111853|FG003|Overall Study|Adverse Event|1|||
125132712|NCT03290781|450111854|FG004|Overall Study|Adverse Event|0|||
125132713|NCT03290781|450111855|FG005|Overall Study|Adverse Event|0|||
125132714|NCT03290781|450111856|FG006|Overall Study|Adverse Event|0|||
125132715|NCT03290781|450111850|FG000|Overall Study|Death|0|||
125218106|NCT00237692|450425378|FG003|Overall Study|Excluded - did not meet criteria|9|||
125218107|NCT00237692|450425375|FG000|Overall Study|Withdrawal by Subject|4|||
125218108|NCT00237692|450425376|FG001|Overall Study|Withdrawal by Subject|6|||
125380100|NCT01988103|451023444|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
125640083|NCT00170846|451962745|FG000|Overall Study|Reason Missing|0|||
125640084|NCT00170846|451962746|FG001|Overall Study|Reason Missing|1|||
125640085|NCT00170846|451962747|FG002|Overall Study|Reason Missing|0|||
125640086|NCT01756833|451962749|FG000|Overall Study|Withdrawal by Subject|4|||
125640087|NCT01756833|451962750|FG001|Overall Study|Withdrawal by Subject|3|||
125640088|NCT00998985|451962754|FG000|Overall Study|Withdrawal by Subject|0|||
125640089|NCT00998985|451962755|FG001|Overall Study|Withdrawal by Subject|0|||
125640090|NCT00998985|451962756|FG002|Overall Study|Withdrawal by Subject|0|||
125640091|NCT00998985|451962757|FG003|Overall Study|Withdrawal by Subject|0|||
125640092|NCT00998985|451962758|FG004|Overall Study|Withdrawal by Subject|0|||
125640093|NCT00998985|451962759|FG005|Overall Study|Withdrawal by Subject|0|||
125640094|NCT00998985|451962760|FG006|Overall Study|Withdrawal by Subject|0|||
125640095|NCT00998985|451962761|FG007|Overall Study|Withdrawal by Subject|0|||
125640096|NCT00998985|451962762|FG008|Overall Study|Withdrawal by Subject|1|||
125640097|NCT00998985|451962763|FG009|Overall Study|Withdrawal by Subject|0|||
125640098|NCT00998985|451962764|FG010|Overall Study|Withdrawal by Subject|0|||
125640099|NCT00998985|451962765|FG011|Overall Study|Withdrawal by Subject|0|||
125640100|NCT00998985|451962766|FG012|Overall Study|Withdrawal by Subject|0|||
125640101|NCT00998985|451962767|FG013|Overall Study|Withdrawal by Subject|0|||
125640102|NCT00998985|451962754|FG000|Overall Study|Protocol Violation|0|||
125640103|NCT00998985|451962755|FG001|Overall Study|Protocol Violation|0|||
125640104|NCT00998985|451962756|FG002|Overall Study|Protocol Violation|0|||
125640105|NCT00998985|451962757|FG003|Overall Study|Protocol Violation|0|||
125640106|NCT00998985|451962758|FG004|Overall Study|Protocol Violation|0|||
125640107|NCT00998985|451962759|FG005|Overall Study|Protocol Violation|1|||
125640108|NCT00998985|451962760|FG006|Overall Study|Protocol Violation|0|||
125640109|NCT00998985|451962761|FG007|Overall Study|Protocol Violation|0|||
125640110|NCT00998985|451962762|FG008|Overall Study|Protocol Violation|0|||
125640111|NCT00998985|451962763|FG009|Overall Study|Protocol Violation|0|||
125640112|NCT00998985|451962764|FG010|Overall Study|Protocol Violation|0|||
125640113|NCT00998985|451962765|FG011|Overall Study|Protocol Violation|0|||
125640114|NCT00998985|451962766|FG012|Overall Study|Protocol Violation|0|||
125640115|NCT00998985|451962767|FG013|Overall Study|Protocol Violation|0|||
125640116|NCT01040728|451962768|FG000|Overall Study|Adverse Event|4|||
125640117|NCT01040728|451962769|FG001|Overall Study|Adverse Event|8|||
125640118|NCT01040728|451962770|FG002|Overall Study|Adverse Event|0|||
125640119|NCT01040728|451962771|FG003|Overall Study|Adverse Event|4|||
125640120|NCT01040728|451962768|FG000|Overall Study|Withdrawal by Subject|0|||
125640121|NCT01040728|451962769|FG001|Overall Study|Withdrawal by Subject|1|||
125640122|NCT01040728|451962770|FG002|Overall Study|Withdrawal by Subject|1|||
125640123|NCT01040728|451962771|FG003|Overall Study|Withdrawal by Subject|0|||
125640124|NCT01040728|451962768|FG000|Overall Study|Protocol Violation|0|||
125640125|NCT01040728|451962769|FG001|Overall Study|Protocol Violation|0|||
125132716|NCT03290781|450111851|FG001|Overall Study|Death|0|||
125132717|NCT03290781|450111852|FG002|Overall Study|Death|1|||
125640126|NCT01040728|451962770|FG002|Overall Study|Protocol Violation|0|||
125132718|NCT03290781|450111853|FG003|Overall Study|Death|0|||
125132719|NCT03290781|450111854|FG004|Overall Study|Death|1|||
125132720|NCT03290781|450111855|FG005|Overall Study|Death|0|||
125132721|NCT03290781|450111856|FG006|Overall Study|Death|0|||
125132722|NCT03290781|450111850|FG000|Overall Study|Withdrawal by Subject|6|||
125132723|NCT03290781|450111851|FG001|Overall Study|Withdrawal by Subject|5|||
125132724|NCT03290781|450111852|FG002|Overall Study|Withdrawal by Subject|9|||
125132725|NCT03290781|450111853|FG003|Overall Study|Withdrawal by Subject|10|||
125132726|NCT03290781|450111854|FG004|Overall Study|Withdrawal by Subject|1|||
125132727|NCT03290781|450111855|FG005|Overall Study|Withdrawal by Subject|2|||
125132728|NCT03290781|450111856|FG006|Overall Study|Withdrawal by Subject|0|||
125132729|NCT03290781|450111850|FG000|Overall Study|Physician Decision|0|||
125132730|NCT03290781|450111851|FG001|Overall Study|Physician Decision|1|||
125132731|NCT03290781|450111852|FG002|Overall Study|Physician Decision|0|||
125132732|NCT03290781|450111853|FG003|Overall Study|Physician Decision|0|||
125380101|NCT01988103|451023445|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
125132733|NCT03290781|450111854|FG004|Overall Study|Physician Decision|0|||
125132734|NCT03290781|450111855|FG005|Overall Study|Physician Decision|0|||
125132735|NCT03290781|450111856|FG006|Overall Study|Physician Decision|0|||
125132736|NCT03290781|450111850|FG000|Overall Study|Site Terminated by Sponsor|1|||
125132737|NCT03290781|450111851|FG001|Overall Study|Site Terminated by Sponsor|0|||
125132738|NCT03290781|450111852|FG002|Overall Study|Site Terminated by Sponsor|2|||
125132739|NCT03290781|450111853|FG003|Overall Study|Site Terminated by Sponsor|1|||
125132740|NCT03290781|450111854|FG004|Overall Study|Site Terminated by Sponsor|0|||
125132741|NCT03290781|450111855|FG005|Overall Study|Site Terminated by Sponsor|0|||
125132742|NCT03290781|450111856|FG006|Overall Study|Site Terminated by Sponsor|0|||
125132743|NCT03290781|450111850|FG000|Overall Study|Lost to Follow-up|0|||
125132744|NCT03290781|450111851|FG001|Overall Study|Lost to Follow-up|0|||
125132745|NCT03290781|450111852|FG002|Overall Study|Lost to Follow-up|0|||
125132746|NCT03290781|450111853|FG003|Overall Study|Lost to Follow-up|1|||
125132747|NCT03290781|450111854|FG004|Overall Study|Lost to Follow-up|0|||
125132748|NCT03290781|450111855|FG005|Overall Study|Lost to Follow-up|0|||
125132749|NCT03290781|450111856|FG006|Overall Study|Lost to Follow-up|0|||
125132750|NCT03290781|450111850|FG000|Overall Study|Protocol Deviation|2|||
125132751|NCT03290781|450111851|FG001|Overall Study|Protocol Deviation|0|||
125132752|NCT03290781|450111852|FG002|Overall Study|Protocol Deviation|0|||
125132753|NCT03290781|450111853|FG003|Overall Study|Protocol Deviation|1|||
125132754|NCT03290781|450111854|FG004|Overall Study|Protocol Deviation|0|||
125132755|NCT03290781|450111855|FG005|Overall Study|Protocol Deviation|0|||
125132756|NCT03290781|450111856|FG006|Overall Study|Protocol Deviation|0|||
125132757|NCT03290781|450111850|FG000|Overall Study|Disease Relapse|32|||
125132758|NCT03290781|450111851|FG001|Overall Study|Disease Relapse|5|||
125132759|NCT03290781|450111852|FG002|Overall Study|Disease Relapse|38|||
125132760|NCT03290781|450111853|FG003|Overall Study|Disease Relapse|7|||
125132761|NCT03290781|450111854|FG004|Overall Study|Disease Relapse|3|||
125132762|NCT03290781|450111855|FG005|Overall Study|Disease Relapse|1|||
125132763|NCT03290781|450111856|FG006|Overall Study|Disease Relapse|4|||
125132764|NCT03290781|450111850|FG000|Overall Study|Other|3|||
125132765|NCT03290781|450111851|FG001|Overall Study|Other|0|||
125132766|NCT03290781|450111852|FG002|Overall Study|Other|2|||
125132767|NCT03290781|450111853|FG003|Overall Study|Other|2|||
125132768|NCT03290781|450111854|FG004|Overall Study|Other|0|||
125132769|NCT03290781|450111855|FG005|Overall Study|Other|0|||
125132770|NCT03290781|450111856|FG006|Overall Study|Other|0|||
125132771|NCT01136174|450111857|FG000|Overall Study|Adverse Event|0|||
125132772|NCT01136174|450111858|FG001|Overall Study|Adverse Event|0|||
125132773|NCT01136174|450111859|FG002|Overall Study|Adverse Event|0|||
125132774|NCT01136174|450111860|FG003|Overall Study|Adverse Event|4|||
125132775|NCT02820350|450111870|FG000|Overall Study|Withdrawal by Subject|3|||
125380102|NCT01988103|451023441|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
125380103|NCT01988103|451023442|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
125380104|NCT01988103|451023443|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
125420820|NCT01260350|451166159|FG015|Overall Study|Lack of Efficacy|0|||
125132776|NCT02820350|450111870|FG000|Overall Study|Death|4|||
125132777|NCT01597245|450111871|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
125132778|NCT01597245|450111872|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
125132779|NCT01597245|450111873|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
125132780|NCT01597245|450111874|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
125132781|NCT01597245|450111875|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132782|NCT01597245|450111876|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132783|NCT01597245|450111877|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132784|NCT01597245|450111878|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132785|NCT01597245|450111879|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132786|NCT01597245|450111880|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132787|NCT01597245|450111881|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132788|NCT01597245|450111882|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132789|NCT01597245|450111883|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132790|NCT01597245|450111884|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132791|NCT01597245|450111885|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132792|NCT01597245|450111886|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132793|NCT01597245|450111887|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132794|NCT01597245|450111888|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132795|NCT01597245|450111889|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132796|NCT01597245|450111890|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132797|NCT01597245|450111891|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
125132798|NCT01597245|450111871|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
125132799|NCT01597245|450111872|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
125132800|NCT01597245|450111873|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
125132801|NCT01597245|450111874|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
125132802|NCT01597245|450111875|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132803|NCT01597245|450111876|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132804|NCT01597245|450111877|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132805|NCT01597245|450111878|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132806|NCT01597245|450111879|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132807|NCT01597245|450111880|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132808|NCT01597245|450111881|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132809|NCT01597245|450111882|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132810|NCT01597245|450111883|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132811|NCT01597245|450111884|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132812|NCT01597245|450111885|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132813|NCT01597245|450111886|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132814|NCT01597245|450111887|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132815|NCT01597245|450111888|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132816|NCT01597245|450111889|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132817|NCT01597245|450111890|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132818|NCT01597245|450111891|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
125132819|NCT01597245|450111871|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
125132820|NCT01597245|450111872|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
125132821|NCT01597245|450111873|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
125132822|NCT01597245|450111874|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
125132823|NCT01597245|450111875|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132824|NCT01597245|450111876|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132825|NCT01597245|450111877|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132826|NCT01597245|450111878|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132827|NCT01597245|450111879|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132828|NCT01597245|450111880|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132829|NCT01597245|450111881|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132830|NCT01597245|450111882|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132831|NCT01597245|450111883|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125218109|NCT00237692|450425377|FG002|Overall Study|Withdrawal by Subject|10|||
125132832|NCT01597245|450111884|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125420821|NCT01260350|451166160|FG016|Overall Study|Lack of Efficacy|0|||
125420822|NCT01260350|451166161|FG017|Overall Study|Lack of Efficacy|1|||
125132833|NCT01597245|450111885|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132834|NCT01597245|450111886|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132835|NCT01597245|450111887|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132836|NCT01597245|450111888|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132837|NCT01597245|450111889|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132838|NCT01597245|450111890|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132839|NCT01597245|450111891|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
125132840|NCT01597245|450111871|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
125132841|NCT01597245|450111872|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
125132842|NCT01597245|450111873|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
125132843|NCT01597245|450111874|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132844|NCT01597245|450111875|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132845|NCT01597245|450111876|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132846|NCT01597245|450111877|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132847|NCT01597245|450111878|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132848|NCT01597245|450111879|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132849|NCT01597245|450111880|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132850|NCT01597245|450111881|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132851|NCT01597245|450111882|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132852|NCT01597245|450111883|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132853|NCT01597245|450111884|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132854|NCT01597245|450111885|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132855|NCT01597245|450111886|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125218110|NCT00237692|450425378|FG003|Overall Study|Withdrawal by Subject|4|||
125132856|NCT01597245|450111887|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132857|NCT01597245|450111888|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132858|NCT01597245|450111889|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132859|NCT01597245|450111890|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132860|NCT01597245|450111891|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
125132861|NCT01597245|450111871|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
125132862|NCT01597245|450111872|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132863|NCT01597245|450111873|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132864|NCT01597245|450111874|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
125132865|NCT01597245|450111875|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132866|NCT01597245|450111876|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132867|NCT01597245|450111877|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132868|NCT01597245|450111878|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132869|NCT01597245|450111879|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132870|NCT01597245|450111880|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125218111|NCT00685360|450425381|FG000|Overall Study|Lost to Follow-up|0|||
125218112|NCT00685360|450425382|FG001|Overall Study|Lost to Follow-up|1|||
125218113|NCT00685360|450425383|FG002|Overall Study|Lost to Follow-up|2|||
125218114|NCT00685360|450425381|FG000|Overall Study|Adverse Event|4|||
125218115|NCT00685360|450425382|FG001|Overall Study|Adverse Event|6|||
125218116|NCT00685360|450425383|FG002|Overall Study|Adverse Event|4|||
125218117|NCT00685360|450425381|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
125218118|NCT00685360|450425382|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
125218119|NCT00685360|450425383|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
125218120|NCT00685360|450425381|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
125218121|NCT00685360|450425382|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
125218122|NCT00685360|450425383|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
125218123|NCT00685360|450425381|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
125218124|NCT00685360|450425382|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
125218125|NCT00685360|450425383|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
125218126|NCT00685360|450425381|FG000|Overall Study|Protocol Deviation|0|||
125218127|NCT00685360|450425382|FG001|Overall Study|Protocol Deviation|1|||
125218128|NCT00685360|450425383|FG002|Overall Study|Protocol Deviation|1|||
125218129|NCT03654729|450427276|FG000|Overall Study|Death|9|||
125218130|NCT03654729|450427277|FG001|Overall Study|Death|9|||
125218131|NCT03654729|450427278|FG002|Overall Study|Death|16|||
125132871|NCT01597245|450111881|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132872|NCT01597245|450111882|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132873|NCT01597245|450111883|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132874|NCT01597245|450111884|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125218132|NCT03654729|450427276|FG000|Overall Study|Withdrawal by Subject|8|||
125218133|NCT03654729|450427277|FG001|Overall Study|Withdrawal by Subject|6|||
125218134|NCT03654729|450427278|FG002|Overall Study|Withdrawal by Subject|4|||
125218135|NCT03654729|450427276|FG000|Overall Study|Study terminated by Sponsor|3|||
125132875|NCT01597245|450111885|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132876|NCT01597245|450111886|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132877|NCT01597245|450111887|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132878|NCT01597245|450111888|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132879|NCT01597245|450111889|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132880|NCT01597245|450111890|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132881|NCT01597245|450111891|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
125132882|NCT01597245|450111871|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
125132883|NCT01597245|450111872|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
125132884|NCT01597245|450111873|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
125132885|NCT01597245|450111874|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132886|NCT01597245|450111875|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132887|NCT01597245|450111876|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132888|NCT01597245|450111877|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132889|NCT01597245|450111878|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132890|NCT01597245|450111879|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132891|NCT01597245|450111880|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132892|NCT01597245|450111881|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132893|NCT01597245|450111882|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132894|NCT01597245|450111883|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132895|NCT01597245|450111884|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132896|NCT01597245|450111885|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132897|NCT01597245|450111886|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132898|NCT01597245|450111887|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132899|NCT01597245|450111888|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132900|NCT01597245|450111889|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132901|NCT01597245|450111890|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132902|NCT01597245|450111891|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
125132903|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132904|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132905|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132906|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132907|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132908|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
125132909|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
125132910|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132911|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132912|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132913|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132914|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132915|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132916|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132917|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132918|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132919|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132920|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132921|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132922|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132923|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
125132924|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132925|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132926|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132927|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132928|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
125132929|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
125640127|NCT01040728|451962771|FG003|Overall Study|Protocol Violation|1|||
125640128|NCT01040728|451962768|FG000|Overall Study|Lack of Efficacy|0|||
125640129|NCT01040728|451962769|FG001|Overall Study|Lack of Efficacy|1|||
125640130|NCT01040728|451962770|FG002|Overall Study|Lack of Efficacy|0|||
125640131|NCT01040728|451962771|FG003|Overall Study|Lack of Efficacy|1|||
125640132|NCT01040728|451962768|FG000|Overall Study|Other reasons not listed above|0|||
125640133|NCT01040728|451962769|FG001|Overall Study|Other reasons not listed above|1|||
125132930|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
125132931|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
125132932|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132933|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
125132934|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132935|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132936|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132937|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132938|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132939|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132940|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132941|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132942|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132943|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132944|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
125132945|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132946|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132947|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132948|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132949|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132950|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
125132951|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132952|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132953|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
125132954|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132955|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
125132956|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
125132957|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
125132958|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132959|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132960|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132961|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132962|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132963|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132964|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132965|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
125132966|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132967|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132968|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132969|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132970|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
125132971|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
125132972|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
125132973|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
125132974|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
125132975|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
125132976|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
125132977|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
125132978|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
125132979|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132980|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132981|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132982|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132983|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132984|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132985|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132986|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
125132987|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125132988|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125420823|NCT01260350|451166162|FG018|Overall Study|Lack of Efficacy|0|||
125640134|NCT01040728|451962770|FG002|Overall Study|Other reasons not listed above|0|||
125132989|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125132990|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125132991|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
125132992|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
125132993|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
125132994|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125132995|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
125132996|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
125380105|NCT01988103|451023444|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
125380106|NCT01988103|451023445|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
125380107|NCT01988103|451023441|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
125380108|NCT01988103|451023442|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
125380109|NCT01988103|451023443|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
125380110|NCT01988103|451023444|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
125640135|NCT01040728|451962771|FG003|Overall Study|Other reasons not listed above|0|||
125640136|NCT01875874|451962773|FG000|Overall Study|Death|3|||
125640137|NCT00590031|451962774|FG000|Overall Study|Adverse Event|3|||
125640138|NCT00590031|451962774|FG000|Overall Study|Withdrawal by Subject|1|||
125640139|NCT00590031|451962774|FG000|Overall Study|Metastatic Disease|1|||
125640140|NCT00590031|451962774|FG000|Overall Study|Admin Hold|1|||
125640141|NCT00826540|451962788|FG000|Overall Study|ineligible|3|||
125640142|NCT00826540|451962788|FG000|Overall Study|Withdrawal by Subject|1|||
125640143|NCT02178592|451962791|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
125640144|NCT02178592|451962792|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
125640145|NCT02178592|451962791|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
125640146|NCT02178592|451962792|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
125640147|NCT02178592|451962791|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
125640148|NCT02178592|451962792|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
125640149|NCT02178592|451962791|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
125640150|NCT02178592|451962792|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
125640151|NCT02178592|451962791|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
125640152|NCT02178592|451962792|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
125640153|NCT02178592|451962791|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
125640154|NCT02178592|451962792|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
125640155|NCT02178592|451962791|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
125640156|NCT02178592|451962792|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
125640157|NCT02178592|451962791|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
125640158|NCT02178592|451962792|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
125640159|NCT02178592|451962791|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
125640160|NCT02178592|451962792|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
125640161|NCT02178592|451962791|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
125640162|NCT02178592|451962792|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
125640163|NCT02178592|451962791|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
125640164|NCT02178592|451962792|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
125640165|NCT02178592|451962791|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
125640166|NCT02178592|451962792|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
125640167|NCT02520141|451962795|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
125640168|NCT00703781|451962796|FG000|Overall Study|Withdrawal by Subject|1|||
125640169|NCT00703781|451962797|FG001|Overall Study|Withdrawal by Subject|2|||
125640170|NCT00703781|451962796|FG000|Overall Study|Cancelled surgery|1|||
125640171|NCT00703781|451962797|FG001|Overall Study|Cancelled surgery|0|||
125640172|NCT03452397|451962798|FG000|Overall Study|Adverse Event|1|||
125640173|NCT03452397|451962799|FG001|Overall Study|Adverse Event|0|||
125640174|NCT03452397|451962800|FG002|Overall Study|Adverse Event|0|||
125640175|NCT03452397|451962801|FG003|Overall Study|Adverse Event|0|||
125640176|NCT03452397|451962798|FG000|Overall Study|Administrative reason|0|||
125640177|NCT03452397|451962799|FG001|Overall Study|Administrative reason|0|||
125640178|NCT03452397|451962800|FG002|Overall Study|Administrative reason|1|||
125640179|NCT03452397|451962801|FG003|Overall Study|Administrative reason|1|||
125132997|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
125132998|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
125218136|NCT03654729|450427277|FG001|Overall Study|Study terminated by Sponsor|5|||
125218137|NCT03654729|450427278|FG002|Overall Study|Study terminated by Sponsor|4|||
125218138|NCT03654729|450427276|FG000|Overall Study|Not reported|2|||
125218139|NCT03654729|450427277|FG001|Overall Study|Not reported|4|||
125218140|NCT03654729|450427278|FG002|Overall Study|Not reported|5|||
125218141|NCT03654729|450427276|FG000|Overall Study|Progressive disease|3|||
125218142|NCT03654729|450427277|FG001|Overall Study|Progressive disease|0|||
125218143|NCT03654729|450427278|FG002|Overall Study|Progressive disease|0|||
125218144|NCT03654729|450427276|FG000|Overall Study|Lost to Follow-up|2|||
125218145|NCT03654729|450427277|FG001|Overall Study|Lost to Follow-up|0|||
125218146|NCT03654729|450427278|FG002|Overall Study|Lost to Follow-up|0|||
125218147|NCT03654729|450427276|FG000|Overall Study|Physician Decision|2|||
125218148|NCT03654729|450427277|FG001|Overall Study|Physician Decision|0|||
125218149|NCT03654729|450427278|FG002|Overall Study|Physician Decision|0|||
125218150|NCT03654729|450427276|FG000|Overall Study|Protocol Violation|1|||
125218151|NCT03654729|450427277|FG001|Overall Study|Protocol Violation|1|||
125218152|NCT03654729|450427278|FG002|Overall Study|Protocol Violation|0|||
125218153|NCT03654729|450427276|FG000|Overall Study|Non-compliance with study drug|0|||
125380111|NCT01988103|451023445|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
125380112|NCT01988103|451023441|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
125380113|NCT01988103|451023442|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
125218154|NCT03654729|450427277|FG001|Overall Study|Non-compliance with study drug|1|||
125218155|NCT03654729|450427278|FG002|Overall Study|Non-compliance with study drug|0|||
125218156|NCT03654729|450427276|FG000|Overall Study|Site terminated by Sponsor|1|||
125218157|NCT03654729|450427277|FG001|Overall Study|Site terminated by Sponsor|0|||
125218158|NCT03654729|450427278|FG002|Overall Study|Site terminated by Sponsor|0|||
125218159|NCT01000974|450427282|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
125218160|NCT01000974|450427283|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
125218161|NCT01000974|450427284|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
125218162|NCT01000974|450427282|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
125218163|NCT01000974|450427283|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
125420824|NCT01260350|451166163|FG019|Overall Study|Lack of Efficacy|0|||
125218164|NCT01000974|450427284|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
125218165|NCT01000974|450427282|FG000|Primary Vaccination Phase|Protocol Violation|40|||
125218166|NCT01000974|450427283|FG001|Primary Vaccination Phase|Protocol Violation|3|||
125218167|NCT01000974|450427284|FG002|Primary Vaccination Phase|Protocol Violation|2|||
125218168|NCT01000974|450427282|FG000|Primary Vaccination Phase|Adverse Event|14|||
125218169|NCT01000974|450427283|FG001|Primary Vaccination Phase|Adverse Event|2|||
125218170|NCT01000974|450427284|FG002|Primary Vaccination Phase|Adverse Event|2|||
125218171|NCT01000974|450427282|FG000|Primary Vaccination Phase|Other|4|||
125218172|NCT01000974|450427283|FG001|Primary Vaccination Phase|Other|9|||
125218173|NCT01000974|450427284|FG002|Primary Vaccination Phase|Other|12|||
125218174|NCT01000974|450427282|FG000|Booster Vaccination Phase|Protocol Violation|0|||
125218175|NCT01000974|450427283|FG001|Booster Vaccination Phase|Protocol Violation|0|||
125218176|NCT01000974|450427284|FG002|Booster Vaccination Phase|Protocol Violation|2|||
125218177|NCT01000974|450427282|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
125218178|NCT01000974|450427283|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
125218179|NCT01000974|450427284|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
125218180|NCT01000974|450427282|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
125218181|NCT01000974|450427283|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
125218182|NCT01000974|450427284|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
125218183|NCT01000974|450427282|FG000|Booster Vaccination Phase|Other|24|||
125218184|NCT01000974|450427283|FG001|Booster Vaccination Phase|Other|6|||
125218185|NCT01000974|450427284|FG002|Booster Vaccination Phase|Other|4|||
125218186|NCT02750332|450427285|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125218187|NCT02750332|450427286|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125218188|NCT00621257|450427287|FG000|Overall Study|Lost to Follow-up|4|||
125218189|NCT00621257|450427288|FG001|Overall Study|Lost to Follow-up|0|||
125218190|NCT00621257|450427289|FG002|Overall Study|Lost to Follow-up|2|||
125218191|NCT00621257|450427290|FG003|Overall Study|Lost to Follow-up|4|||
125218192|NCT00621257|450427291|FG004|Overall Study|Lost to Follow-up|7|||
125218193|NCT00621257|450427287|FG000|Overall Study|Adverse Event|0|||
125218194|NCT00621257|450427288|FG001|Overall Study|Adverse Event|1|||
125218195|NCT00621257|450427289|FG002|Overall Study|Adverse Event|1|||
125380114|NCT01988103|451023443|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
125380115|NCT01988103|451023444|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
125380116|NCT01988103|451023445|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
125132999|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
125133000|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133001|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133002|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133003|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133004|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133005|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133006|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133007|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
125133008|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133009|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133010|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133011|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133012|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
125133013|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133014|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133015|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133016|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
125133017|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
125133018|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
125133019|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133020|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
125133021|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133022|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125218196|NCT00621257|450427290|FG003|Overall Study|Adverse Event|0|||
125218197|NCT00621257|450427291|FG004|Overall Study|Adverse Event|0|||
125218198|NCT00621257|450427287|FG000|Overall Study|Physician Decision|0|||
125218199|NCT00621257|450427288|FG001|Overall Study|Physician Decision|2|||
125218200|NCT00621257|450427289|FG002|Overall Study|Physician Decision|0|||
125218201|NCT00621257|450427290|FG003|Overall Study|Physician Decision|1|||
125218202|NCT00621257|450427291|FG004|Overall Study|Physician Decision|1|||
125218203|NCT00621257|450427287|FG000|Overall Study|Withdrawal by Subject|0|||
125218204|NCT00621257|450427288|FG001|Overall Study|Withdrawal by Subject|0|||
125380117|NCT03590041|451023446|FG000|Overall Study|Protocol Violation|4|||
125380118|NCT03590041|451023447|FG001|Overall Study|Protocol Violation|3|||
125380119|NCT03590041|451023446|FG000|Overall Study|No session data recorded|14|||
125380120|NCT03590041|451023447|FG001|Overall Study|No session data recorded|2|||
125380121|NCT02289898|451023451|FG000|Overall Study|Death|5|||
125380122|NCT02289898|451023452|FG001|Overall Study|Death|4|||
125380123|NCT02289898|451023453|FG002|Overall Study|Death|3|||
125380124|NCT02289898|451023451|FG000|Overall Study|Physician Decision|2|||
125380125|NCT02289898|451023452|FG001|Overall Study|Physician Decision|5|||
125380126|NCT02289898|451023453|FG002|Overall Study|Physician Decision|2|||
125380127|NCT02289898|451023451|FG000|Overall Study|Withdrawal by Subject|0|||
125380128|NCT02289898|451023452|FG001|Overall Study|Withdrawal by Subject|4|||
125380129|NCT02289898|451023453|FG002|Overall Study|Withdrawal by Subject|1|||
125133023|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133024|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133025|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133026|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133027|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133028|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
125133029|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133030|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133031|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133032|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133033|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
125133034|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
125133035|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
125133036|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133037|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
125133038|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
125133039|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
125133040|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
125133041|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
125380130|NCT02289898|451023451|FG000|Overall Study|Adverse Event|3|||
125380131|NCT02289898|451023452|FG001|Overall Study|Adverse Event|5|||
125380132|NCT02289898|451023453|FG002|Overall Study|Adverse Event|5|||
125380133|NCT02289898|451023451|FG000|Overall Study|Disease progression|34|||
125133042|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125380134|NCT02289898|451023452|FG001|Overall Study|Disease progression|28|||
125380135|NCT02289898|451023453|FG002|Overall Study|Disease progression|34|||
125380136|NCT02289898|451023451|FG000|Overall Study|Use of another anticancer therapy|0|||
125380137|NCT02289898|451023452|FG001|Overall Study|Use of another anticancer therapy|0|||
125218205|NCT00621257|450427289|FG002|Overall Study|Withdrawal by Subject|0|||
125218206|NCT00621257|450427290|FG003|Overall Study|Withdrawal by Subject|1|||
125218207|NCT00621257|450427291|FG004|Overall Study|Withdrawal by Subject|1|||
125218208|NCT01255904|450427292|FG000|Overall Study|Physician Decision|1|||
125640180|NCT03452397|451962798|FG000|Overall Study|Withdrawal by Subject|0|||
125640181|NCT03452397|451962799|FG001|Overall Study|Withdrawal by Subject|0|||
125640182|NCT03452397|451962800|FG002|Overall Study|Withdrawal by Subject|1|||
125640183|NCT03452397|451962801|FG003|Overall Study|Withdrawal by Subject|0|||
125640184|NCT06334055|451962803|FG000|Overall Study|Adverse Event|4|||
125640185|NCT06334055|451962803|FG000|Overall Study|Disqualified|72|||
125640186|NCT02545049|451962804|FG000|Overall Study|Withdrawal by Subject|1|||
125640187|NCT02545049|451962805|FG001|Overall Study|Withdrawal by Subject|7|||
125640188|NCT02545049|451962804|FG000|Overall Study|Lost to Follow-up|4|||
125640189|NCT02545049|451962805|FG001|Overall Study|Lost to Follow-up|6|||
125640190|NCT02545049|451962804|FG000|Overall Study|GCP violations|37|||
125640191|NCT02545049|451962805|FG001|Overall Study|GCP violations|48|||
125640192|NCT01855919|451964994|FG000|Overall Study|Adverse Event|16|||
125640193|NCT01855919|451964995|FG001|Overall Study|Adverse Event|8|||
125640194|NCT01855919|451964994|FG000|Overall Study|Lack of Efficacy|1|||
125640195|NCT01855919|451964995|FG001|Overall Study|Lack of Efficacy|3|||
125640196|NCT01855919|451964994|FG000|Overall Study|Withdrawal by Subject|4|||
125640197|NCT01855919|451964995|FG001|Overall Study|Withdrawal by Subject|10|||
125640198|NCT01855919|451964994|FG000|Overall Study|Entry Criteria Not Met|1|||
125640199|NCT01855919|451964995|FG001|Overall Study|Entry Criteria Not Met|1|||
125640200|NCT01855919|451964994|FG000|Overall Study|Protocol Violation|1|||
125640201|NCT01855919|451964995|FG001|Overall Study|Protocol Violation|4|||
125640202|NCT04459416|451964996|FG000|Overall Study|Lost to Follow-up|2|||
125640203|NCT04459416|451964997|FG001|Overall Study|Lost to Follow-up|0|||
125640204|NCT04459416|451964996|FG000|Overall Study|Withdrawal by Subject|8|||
125640205|NCT04459416|451964997|FG001|Overall Study|Withdrawal by Subject|10|||
125640206|NCT04459416|451964996|FG000|Overall Study|Disease progression|0|||
125380138|NCT02289898|451023453|FG002|Overall Study|Use of another anticancer therapy|1|||
125380139|NCT02289898|451023451|FG000|Overall Study|Other|8|||
125380140|NCT02289898|451023452|FG001|Overall Study|Other|7|||
125380141|NCT02289898|451023453|FG002|Overall Study|Other|10|||
125380142|NCT00103142|451023459|FG000|Overall Study|Adverse Event|1|||
125640207|NCT04459416|451964997|FG001|Overall Study|Disease progression|3|||
125640208|NCT03455530|451964998|FG000|Overall Study|Withdrawal by Subject|9|||
125640209|NCT03455530|451964999|FG001|Overall Study|Withdrawal by Subject|1|||
125640210|NCT03455530|451965000|FG002|Overall Study|Withdrawal by Subject|3|||
125640211|NCT03455530|451965001|FG003|Overall Study|Withdrawal by Subject|3|||
125640212|NCT01592773|451965002|FG000|Overall Study|Study Terminated by Sponsor|582|||
125640213|NCT01592773|451965002|FG000|Overall Study|Withdrawal by Subject|35|||
125640214|NCT01592773|451965002|FG000|Overall Study|Lost to Follow-up|19|||
125133043|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133044|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133045|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133046|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133047|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133048|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133049|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
125133050|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133051|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133052|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133053|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133054|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133055|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
125133056|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133057|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133058|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
125380143|NCT00103142|451023460|FG001|Overall Study|Adverse Event|0|||
125640215|NCT01592773|451965002|FG000|Overall Study|Adverse Event|17|||
125133059|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
125218209|NCT01255904|450427293|FG001|Overall Study|Physician Decision|4|||
125640216|NCT01592773|451965002|FG000|Overall Study|Lack of Efficacy|9|||
125640217|NCT01592773|451965002|FG000|Overall Study|Protocol Violation|2|||
125218210|NCT00632125|450427295|FG000|Overall Study|Death|82|||
125218211|NCT00632125|450427295|FG000|Overall Study|Withdrawal by Subject|44|||
125380144|NCT00103142|451023459|FG000|Overall Study|Progression of disease|2|||
125380145|NCT00103142|451023460|FG001|Overall Study|Progression of disease|1|||
125640218|NCT01592773|451965002|FG000|Overall Study|Inclusion/exclusion not meet|1|||
125640219|NCT01592773|451965002|FG000|Overall Study|Other Reason|1|||
125640220|NCT00740116|451965006|FG000|Overall Study|Withdrawal by Subject|1|||
125640221|NCT00740116|451965007|FG001|Overall Study|Withdrawal by Subject|1|||
125133060|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
125133061|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
125133062|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133063|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133064|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133065|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133066|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133067|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133068|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133069|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133070|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
125133071|NCT01597245|450111871|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133072|NCT01597245|450111872|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133073|NCT01597245|450111873|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133074|NCT01597245|450111874|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133075|NCT01597245|450111875|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125380146|NCT02598076|451023462|FG000|Overall Study|Lost to Follow-up|2|||
125380147|NCT02598076|451023463|FG001|Overall Study|Lost to Follow-up|3|||
125380148|NCT01946425|451023464|FG000|Overall Study|Protocol Violation|1|||
125133076|NCT01597245|450111876|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133077|NCT01597245|450111877|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133078|NCT01597245|450111878|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133079|NCT01597245|450111879|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133080|NCT01597245|450111880|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133081|NCT01597245|450111881|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
125133082|NCT01597245|450111882|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133083|NCT01597245|450111883|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133084|NCT01597245|450111884|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125640222|NCT00740116|451965006|FG000|Overall Study|Protocol Violation|1|||
125640223|NCT00740116|451965007|FG001|Overall Study|Protocol Violation|4|||
125133085|NCT01597245|450111885|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133086|NCT01597245|450111886|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133087|NCT01597245|450111887|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133088|NCT01597245|450111888|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133089|NCT01597245|450111889|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133090|NCT01597245|450111890|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133091|NCT01597245|450111891|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
125133092|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133093|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125640224|NCT03037489|451965008|FG000|Overall Study|Adverse Event|4|||
125640225|NCT03037489|451965009|FG001|Overall Study|Adverse Event|0|||
125640226|NCT03037489|451965008|FG000|Overall Study|Withdrawal by Subject|3|||
125640227|NCT03037489|451965009|FG001|Overall Study|Withdrawal by Subject|0|||
125640228|NCT00621764|451965010|FG000|Overall Study|Protocol Violation|0|||
125640229|NCT00621764|451965011|FG001|Overall Study|Protocol Violation|0|||
125640230|NCT00621764|451965012|FG002|Overall Study|Protocol Violation|0|||
125640231|NCT00621764|451965013|FG003|Overall Study|Protocol Violation|1|||
125640232|NCT00121485|451965014|FG000|Overall Study|Not implanted|1|||
125640233|NCT00121485|451965015|FG001|Overall Study|Not implanted|5|||
125640234|NCT00121485|451965014|FG000|Overall Study|Crossover|0|||
125640235|NCT00121485|451965015|FG001|Overall Study|Crossover|2|||
125640236|NCT00724243|451965018|FG000|Overall Study|Lack of Efficacy|10|||
125640237|NCT00724243|451965018|FG000|Overall Study|Adverse Event|5|||
125640238|NCT03031327|451965021|FG000|Overall Study|Withdrawal by Subject|0|||
125640239|NCT03031327|451965022|FG001|Overall Study|Withdrawal by Subject|1|||
125640240|NCT03031327|451965023|FG002|Overall Study|Withdrawal by Subject|1|||
125640241|NCT00211536|451965024|FG000|Overall Study|Withdrawal by Subject|2|||
125640242|NCT00211536|451965025|FG001|Overall Study|Withdrawal by Subject|2|||
125640243|NCT00211536|451965024|FG000|Overall Study|Physician Decision|0|||
125640244|NCT00211536|451965025|FG001|Overall Study|Physician Decision|5|||
125640245|NCT00211536|451965024|FG000|Overall Study|Adverse Event|2|||
125640246|NCT00211536|451965025|FG001|Overall Study|Adverse Event|0|||
125133094|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133095|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133096|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125640247|NCT01004861|451965026|FG000|Overall Study|Disease progression|3|||
125380149|NCT01946425|451023465|FG001|Overall Study|Protocol Violation|0|||
125640248|NCT01004861|451965027|FG001|Overall Study|Disease progression|4|||
125640249|NCT01004861|451965028|FG002|Overall Study|Disease progression|5|||
125640250|NCT01004861|451965029|FG003|Overall Study|Disease progression|4|||
125640251|NCT01004861|451965030|FG004|Overall Study|Disease progression|4|||
125380150|NCT01946425|451023464|FG000|Overall Study|Withdrawal by Subject|1|||
125380151|NCT01946425|451023465|FG001|Overall Study|Withdrawal by Subject|0|||
125380152|NCT03527966|451023466|FG000|Overall Study|Lost to Follow-up|3|||
125380153|NCT03527966|451023467|FG001|Overall Study|Lost to Follow-up|0|||
125380154|NCT00558025|451023468|FG000|Overall Study|Adverse Event|1|||
125380155|NCT00558025|451023469|FG001|Overall Study|Adverse Event|1|||
125380156|NCT00558025|451023468|FG000|Overall Study|Withdrawal by Subject|2|||
125380157|NCT00558025|451023469|FG001|Overall Study|Withdrawal by Subject|2|||
125380158|NCT00558025|451023468|FG000|Overall Study|Protocol Violation|1|||
125380159|NCT00558025|451023469|FG001|Overall Study|Protocol Violation|0|||
125380160|NCT03315208|451023472|FG000|Overall Study|Lost to Follow-up|11|||
125380161|NCT03315208|451023473|FG001|Overall Study|Lost to Follow-up|6|||
125640252|NCT01004861|451965031|FG005|Overall Study|Disease progression|4|||
125640253|NCT01004861|451965032|FG006|Overall Study|Disease progression|5|||
125640254|NCT01004861|451965033|FG007|Overall Study|Disease progression|1|||
125640255|NCT01004861|451965034|FG008|Overall Study|Disease progression|4|||
125640256|NCT01004861|451965035|FG009|Overall Study|Disease progression|7|||
125640257|NCT01004861|451965036|FG010|Overall Study|Disease progression|6|||
125640258|NCT01004861|451965037|FG011|Overall Study|Disease progression|3|||
125640259|NCT01004861|451965038|FG012|Overall Study|Disease progression|8|||
125640260|NCT01004861|451965026|FG000|Overall Study|Physician Decision|0|||
125640261|NCT01004861|451965027|FG001|Overall Study|Physician Decision|2|||
125640262|NCT01004861|451965028|FG002|Overall Study|Physician Decision|1|||
125640263|NCT01004861|451965029|FG003|Overall Study|Physician Decision|1|||
125640264|NCT01004861|451965030|FG004|Overall Study|Physician Decision|1|||
125640265|NCT01004861|451965031|FG005|Overall Study|Physician Decision|0|||
125640266|NCT01004861|451965032|FG006|Overall Study|Physician Decision|0|||
125640267|NCT01004861|451965033|FG007|Overall Study|Physician Decision|1|||
125640268|NCT01004861|451965034|FG008|Overall Study|Physician Decision|0|||
125640269|NCT01004861|451965035|FG009|Overall Study|Physician Decision|0|||
125640270|NCT01004861|451965036|FG010|Overall Study|Physician Decision|0|||
125640271|NCT01004861|451965037|FG011|Overall Study|Physician Decision|0|||
125640272|NCT01004861|451965038|FG012|Overall Study|Physician Decision|3|||
125640273|NCT01004861|451965026|FG000|Overall Study|Adverse Event|0|||
125640274|NCT01004861|451965027|FG001|Overall Study|Adverse Event|0|||
125640275|NCT01004861|451965028|FG002|Overall Study|Adverse Event|0|||
125640276|NCT01004861|451965029|FG003|Overall Study|Adverse Event|1|||
125640277|NCT01004861|451965030|FG004|Overall Study|Adverse Event|0|||
125640278|NCT01004861|451965031|FG005|Overall Study|Adverse Event|2|||
125640279|NCT01004861|451965032|FG006|Overall Study|Adverse Event|1|||
125640280|NCT01004861|451965033|FG007|Overall Study|Adverse Event|1|||
125640281|NCT01004861|451965034|FG008|Overall Study|Adverse Event|13|||
125640282|NCT01004861|451965035|FG009|Overall Study|Adverse Event|1|||
125640283|NCT01004861|451965036|FG010|Overall Study|Adverse Event|1|||
125640284|NCT01004861|451965037|FG011|Overall Study|Adverse Event|0|||
125640285|NCT01004861|451965038|FG012|Overall Study|Adverse Event|2|||
125640286|NCT01004861|451965026|FG000|Overall Study|Protocol Violation|0|||
125640287|NCT01004861|451965027|FG001|Overall Study|Protocol Violation|0|||
125640288|NCT01004861|451965028|FG002|Overall Study|Protocol Violation|0|||
125133097|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133098|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133099|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133100|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125380162|NCT03315208|451023472|FG000|Overall Study|Withdrawal by Subject|2|||
125640289|NCT01004861|451965029|FG003|Overall Study|Protocol Violation|0|||
125640290|NCT01004861|451965030|FG004|Overall Study|Protocol Violation|1|||
125640291|NCT01004861|451965031|FG005|Overall Study|Protocol Violation|0|||
125640292|NCT01004861|451965032|FG006|Overall Study|Protocol Violation|0|||
125640293|NCT01004861|451965033|FG007|Overall Study|Protocol Violation|0|||
125640294|NCT01004861|451965034|FG008|Overall Study|Protocol Violation|0|||
125640295|NCT01004861|451965035|FG009|Overall Study|Protocol Violation|0|||
125640296|NCT01004861|451965036|FG010|Overall Study|Protocol Violation|0|||
125437082|NCT03377790|451227976|FG000|Overall Study|Randomized but not treated|1|||
125437083|NCT03377790|451227977|FG001|Overall Study|Randomized but not treated|0|||
125437084|NCT03377790|451227976|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
125437085|NCT03377790|451227977|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
125640297|NCT01004861|451965037|FG011|Overall Study|Protocol Violation|0|||
125640298|NCT01004861|451965038|FG012|Overall Study|Protocol Violation|0|||
125640299|NCT01004861|451965026|FG000|Overall Study|Lost to Follow-up|0|||
125640300|NCT01004861|451965027|FG001|Overall Study|Lost to Follow-up|0|||
125640301|NCT01004861|451965028|FG002|Overall Study|Lost to Follow-up|0|||
125640302|NCT01004861|451965029|FG003|Overall Study|Lost to Follow-up|0|||
125640303|NCT01004861|451965030|FG004|Overall Study|Lost to Follow-up|0|||
125640304|NCT01004861|451965031|FG005|Overall Study|Lost to Follow-up|0|||
125640305|NCT01004861|451965032|FG006|Overall Study|Lost to Follow-up|0|||
125640306|NCT01004861|451965033|FG007|Overall Study|Lost to Follow-up|1|||
125640307|NCT01004861|451965034|FG008|Overall Study|Lost to Follow-up|3|||
125640308|NCT01004861|451965035|FG009|Overall Study|Lost to Follow-up|0|||
125640309|NCT01004861|451965036|FG010|Overall Study|Lost to Follow-up|0|||
125640310|NCT01004861|451965037|FG011|Overall Study|Lost to Follow-up|1|||
125640311|NCT01004861|451965038|FG012|Overall Study|Lost to Follow-up|0|||
125640312|NCT01004861|451965026|FG000|Overall Study|Non-compliance|0|||
125640313|NCT01004861|451965027|FG001|Overall Study|Non-compliance|0|||
125640314|NCT01004861|451965028|FG002|Overall Study|Non-compliance|0|||
125640315|NCT01004861|451965029|FG003|Overall Study|Non-compliance|0|||
125640316|NCT01004861|451965030|FG004|Overall Study|Non-compliance|0|||
125640317|NCT01004861|451965031|FG005|Overall Study|Non-compliance|0|||
125640318|NCT01004861|451965032|FG006|Overall Study|Non-compliance|0|||
125640319|NCT01004861|451965033|FG007|Overall Study|Non-compliance|0|||
125640320|NCT01004861|451965034|FG008|Overall Study|Non-compliance|5|||
125640321|NCT01004861|451965035|FG009|Overall Study|Non-compliance|0|||
125640322|NCT01004861|451965036|FG010|Overall Study|Non-compliance|0|||
125640323|NCT01004861|451965037|FG011|Overall Study|Non-compliance|0|||
125640324|NCT01004861|451965038|FG012|Overall Study|Non-compliance|1|||
125640325|NCT01004861|451965026|FG000|Overall Study|Other|0|||
125640326|NCT01004861|451965027|FG001|Overall Study|Other|0|||
125640327|NCT01004861|451965028|FG002|Overall Study|Other|0|||
125640328|NCT01004861|451965029|FG003|Overall Study|Other|0|||
125640329|NCT01004861|451965030|FG004|Overall Study|Other|0|||
125640330|NCT01004861|451965031|FG005|Overall Study|Other|0|||
125640331|NCT01004861|451965032|FG006|Overall Study|Other|0|||
125640332|NCT01004861|451965033|FG007|Overall Study|Other|0|||
125640333|NCT01004861|451965034|FG008|Overall Study|Other|0|||
125437086|NCT02632786|451227981|FG000|Overall Study|Adverse Event|2|||
125640334|NCT01004861|451965035|FG009|Overall Study|Other|2|||
125640335|NCT01004861|451965036|FG010|Overall Study|Other|1|||
125640336|NCT01004861|451965037|FG011|Overall Study|Other|2|||
125640337|NCT01004861|451965038|FG012|Overall Study|Other|3|||
125640338|NCT01004861|451965026|FG000|Overall Study|Patient decision|0|||
125640339|NCT01004861|451965027|FG001|Overall Study|Patient decision|0|||
125640340|NCT01004861|451965028|FG002|Overall Study|Patient decision|0|||
125640341|NCT01004861|451965029|FG003|Overall Study|Patient decision|0|||
125640342|NCT01004861|451965030|FG004|Overall Study|Patient decision|1|||
125640343|NCT01004861|451965031|FG005|Overall Study|Patient decision|0|||
125640344|NCT01004861|451965032|FG006|Overall Study|Patient decision|1|||
125640345|NCT01004861|451965033|FG007|Overall Study|Patient decision|0|||
125218212|NCT00632125|450427295|FG000|Overall Study|Adverse Event|36|||
125218213|NCT00632125|450427295|FG000|Overall Study|Renal transplantation|17|||
125218214|NCT00632125|450427295|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
125218215|NCT00632125|450427295|FG000|Overall Study|Non-compliance|8|||
125218216|NCT00632125|450427295|FG000|Overall Study|Development of uncontrolled hypertension|5|||
125218217|NCT00632125|450427295|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
125218218|NCT00540644|450427298|FG000|Overall Study|Adverse Event|3|||
125218219|NCT00540644|450427299|FG001|Overall Study|Adverse Event|1|||
125218220|NCT00540644|450427298|FG000|Overall Study|Disease Progression|3|||
125218221|NCT00540644|450427299|FG001|Overall Study|Disease Progression|1|||
125218222|NCT00540644|450427298|FG000|Overall Study|Physician Decision|0|||
125218223|NCT00540644|450427299|FG001|Overall Study|Physician Decision|5|||
125218224|NCT00540644|450427298|FG000|Overall Study|Withdrawal by Subject|2|||
125218225|NCT00540644|450427299|FG001|Overall Study|Withdrawal by Subject|2|||
125218226|NCT00540644|450427298|FG000|Overall Study|Noncomplilance|1|||
125218227|NCT00540644|450427299|FG001|Overall Study|Noncomplilance|0|||
125218228|NCT00809094|450427300|FG000|Overall Study|Lost to Follow-up|0|||
125218229|NCT00809094|450427301|FG001|Overall Study|Lost to Follow-up|1|||
125218230|NCT00397189|450427303|FG000|3 Weeks Period|Lost to Follow-up|5|||
125218231|NCT00397189|450427304|FG001|3 Weeks Period|Lost to Follow-up|4|||
125218232|NCT00397189|450427303|FG000|3 Weeks Period|Adverse Event|3|||
125218233|NCT00397189|450427304|FG001|3 Weeks Period|Adverse Event|2|||
125218234|NCT00397189|450427303|FG000|3 Weeks Period|Withdrawal by Subject|13|||
125218235|NCT00397189|450427304|FG001|3 Weeks Period|Withdrawal by Subject|9|||
125218236|NCT00397189|450427303|FG000|3 Weeks Period|Physician Decision|0|||
125218237|NCT00397189|450427304|FG001|3 Weeks Period|Physician Decision|2|||
125218238|NCT00397189|450427303|FG000|3 Weeks Period|Protocol Violation|0|||
125218239|NCT00397189|450427304|FG001|3 Weeks Period|Protocol Violation|3|||
125218240|NCT00397189|450427303|FG000|3 Weeks Period|Other|0|||
125218241|NCT00397189|450427304|FG001|3 Weeks Period|Other|2|||
125218242|NCT01535443|450427307|FG000|Overall Study|Physician Decision|3|||
125133101|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133102|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133103|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133104|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133105|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
125133106|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
125133107|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
125133108|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133109|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133110|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133111|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133112|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
125133113|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133114|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125218243|NCT00232557|450427308|FG000|Overall Study|Lost to Follow-up|3|||
125218244|NCT00232557|450427309|FG001|Overall Study|Lost to Follow-up|5|||
125218245|NCT01059773|450427310|FG000|Overall Study|Adverse Event|2|||
125218246|NCT01059773|450427311|FG001|Overall Study|Adverse Event|2|||
125218247|NCT01059773|450427310|FG000|Overall Study|Withdrawal by Subject|1|||
125218248|NCT01059773|450427311|FG001|Overall Study|Withdrawal by Subject|5|||
125218249|NCT01059773|450427310|FG000|Overall Study|Lost to Follow-up|1|||
125218250|NCT01059773|450427311|FG001|Overall Study|Lost to Follow-up|1|||
125218251|NCT01059773|450427310|FG000|Overall Study|Pregnancy|1|||
125218252|NCT01059773|450427311|FG001|Overall Study|Pregnancy|1|||
125380163|NCT03315208|451023473|FG001|Overall Study|Withdrawal by Subject|0|||
125380164|NCT00276159|451023477|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
125380165|NCT02927431|451023491|FG000|Overall Study|Withdrawal by Subject|0|||
125380166|NCT02927431|451023492|FG001|Overall Study|Withdrawal by Subject|0|||
125133115|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133116|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125380167|NCT02927431|451023493|FG002|Overall Study|Withdrawal by Subject|1|||
125380168|NCT01276353|451023494|FG000|Double-blind|Adverse Event|2|||
125133117|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133118|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133119|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133120|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133121|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133122|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125380169|NCT01276353|451023495|FG001|Double-blind|Adverse Event|0|||
125380170|NCT01276353|451023494|FG000|Double-blind|Withdrawal by Subject|1|||
125380171|NCT01276353|451023495|FG001|Double-blind|Withdrawal by Subject|0|||
125380172|NCT01276353|451023494|FG000|Extension|Adverse Event|2|||
125640346|NCT01004861|451965034|FG008|Overall Study|Patient decision|7|||
125640347|NCT01004861|451965035|FG009|Overall Study|Patient decision|1|||
125640348|NCT01004861|451965036|FG010|Overall Study|Patient decision|1|||
125640349|NCT01004861|451965037|FG011|Overall Study|Patient decision|2|||
125640350|NCT01004861|451965038|FG012|Overall Study|Patient decision|3|||
125640351|NCT01004861|451965026|FG000|Overall Study|Transitioned to Phase 4 study|0|||
125640352|NCT01004861|451965027|FG001|Overall Study|Transitioned to Phase 4 study|0|||
125640353|NCT01004861|451965028|FG002|Overall Study|Transitioned to Phase 4 study|0|||
125640354|NCT01004861|451965029|FG003|Overall Study|Transitioned to Phase 4 study|0|||
125640355|NCT01004861|451965030|FG004|Overall Study|Transitioned to Phase 4 study|0|||
125640356|NCT01004861|451965031|FG005|Overall Study|Transitioned to Phase 4 study|0|||
125640357|NCT01004861|451965032|FG006|Overall Study|Transitioned to Phase 4 study|0|||
125640358|NCT01004861|451965033|FG007|Overall Study|Transitioned to Phase 4 study|0|||
125640359|NCT01004861|451965034|FG008|Overall Study|Transitioned to Phase 4 study|2|||
125640360|NCT01004861|451965035|FG009|Overall Study|Transitioned to Phase 4 study|0|||
125640361|NCT01004861|451965036|FG010|Overall Study|Transitioned to Phase 4 study|0|||
125640362|NCT01004861|451965037|FG011|Overall Study|Transitioned to Phase 4 study|0|||
125640363|NCT01004861|451965038|FG012|Overall Study|Transitioned to Phase 4 study|0|||
125640364|NCT01004861|451965026|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125640365|NCT01004861|451965027|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125640366|NCT01004861|451965028|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125640367|NCT01004861|451965029|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125640368|NCT01004861|451965030|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125640369|NCT01004861|451965031|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125640370|NCT01004861|451965032|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125640371|NCT01004861|451965033|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125640372|NCT01004861|451965034|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
125640373|NCT01004861|451965035|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125640374|NCT01004861|451965036|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125640375|NCT01004861|451965037|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125640376|NCT01004861|451965038|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
125640377|NCT01004861|451965026|FG000|Overall Study|Patient withdrew|0|||
125640378|NCT01004861|451965027|FG001|Overall Study|Patient withdrew|0|||
125640379|NCT01004861|451965028|FG002|Overall Study|Patient withdrew|0|||
125640380|NCT01004861|451965029|FG003|Overall Study|Patient withdrew|0|||
125640381|NCT01004861|451965030|FG004|Overall Study|Patient withdrew|0|||
125640382|NCT01004861|451965031|FG005|Overall Study|Patient withdrew|0|||
125640383|NCT01004861|451965032|FG006|Overall Study|Patient withdrew|0|||
125640384|NCT01004861|451965033|FG007|Overall Study|Patient withdrew|0|||
125640385|NCT01004861|451965034|FG008|Overall Study|Patient withdrew|1|||
125640386|NCT01004861|451965035|FG009|Overall Study|Patient withdrew|0|||
125640387|NCT01004861|451965036|FG010|Overall Study|Patient withdrew|0|||
125640388|NCT01004861|451965037|FG011|Overall Study|Patient withdrew|0|||
125640389|NCT01004861|451965038|FG012|Overall Study|Patient withdrew|0|||
125640390|NCT01004861|451965026|FG000|Overall Study|Surgical resection|0|||
125640391|NCT01004861|451965027|FG001|Overall Study|Surgical resection|0|||
125640392|NCT01004861|451965028|FG002|Overall Study|Surgical resection|0|||
125640393|NCT01004861|451965029|FG003|Overall Study|Surgical resection|0|||
125640394|NCT01004861|451965030|FG004|Overall Study|Surgical resection|0|||
125640395|NCT01004861|451965031|FG005|Overall Study|Surgical resection|0|||
125640396|NCT01004861|451965032|FG006|Overall Study|Surgical resection|0|||
125380173|NCT01276353|451023495|FG001|Extension|Adverse Event|5|||
125380174|NCT01276353|451023494|FG000|Extension|Withdrawal by Subject|1|||
125380175|NCT01276353|451023495|FG001|Extension|Withdrawal by Subject|2|||
125133123|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133124|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133125|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133126|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
125133127|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
125133128|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
125133129|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133130|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133131|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133132|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133133|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
125133134|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133135|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133136|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133137|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133138|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133139|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133140|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133141|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133142|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133143|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133144|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133145|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133146|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133147|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133148|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
125133149|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
125133150|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133151|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133152|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133153|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133154|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
125133155|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133156|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133157|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133158|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133159|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133160|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133161|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133162|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133163|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133164|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133165|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133166|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133167|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133168|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125218253|NCT01059773|450427310|FG000|Overall Study|Protocol Violation|6|||
125133169|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
125133170|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
125133171|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133172|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133173|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133174|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133175|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
125133176|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133177|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133178|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133179|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133180|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133181|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133182|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133183|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133184|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125218254|NCT01059773|450427311|FG001|Overall Study|Protocol Violation|2|||
125380176|NCT01276353|451023494|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
125380177|NCT01276353|451023495|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
125380178|NCT01276353|451023494|FG000|Extension|Physician Decision|1|||
125218255|NCT01059773|450427310|FG000|Overall Study|Physician Decision|5|||
125380179|NCT01276353|451023495|FG001|Extension|Physician Decision|0|||
125133185|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133186|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133187|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133188|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133189|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
125133190|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
125133191|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
125437087|NCT02632786|451227982|FG001|Overall Study|Adverse Event|1|||
125133192|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133193|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133194|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125218256|NCT01059773|450427311|FG001|Overall Study|Physician Decision|4|||
125380180|NCT01276353|451023494|FG000|Extension|Prohibited concomitant medications|0|||
125380181|NCT01276353|451023495|FG001|Extension|Prohibited concomitant medications|1|||
125380182|NCT01896531|451023497|FG000|Overall Study|Death|57|||
125380183|NCT01896531|451023498|FG001|Overall Study|Death|59|||
125380184|NCT01896531|451023497|FG000|Overall Study|Lost to Follow-up|3|||
125380185|NCT01896531|451023498|FG001|Overall Study|Lost to Follow-up|0|||
125380186|NCT01896531|451023497|FG000|Overall Study|Non-compliance|0|||
125437088|NCT02632786|451227981|FG000|Overall Study|Death|3|||
125437089|NCT02632786|451227982|FG001|Overall Study|Death|2|||
125437090|NCT02632786|451227981|FG000|Overall Study|Physician Decision|5|||
125437091|NCT02632786|451227982|FG001|Overall Study|Physician Decision|4|||
125437092|NCT02632786|451227981|FG000|Overall Study|Withdrawal by Subject|1|||
125437093|NCT02632786|451227982|FG001|Overall Study|Withdrawal by Subject|0|||
125437094|NCT01454830|451227986|FG000|Overall Study|Withdrawal by Subject|4|||
125437095|NCT01454830|451227987|FG001|Overall Study|Withdrawal by Subject|4|||
125437096|NCT01454830|451227986|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
125437097|NCT01454830|451227987|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
125437098|NCT01454830|451227986|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
125380187|NCT01896531|451023498|FG001|Overall Study|Non-compliance|1|||
125380188|NCT01896531|451023497|FG000|Overall Study|Study Ended by Sponsor|7|||
125380189|NCT01896531|451023498|FG001|Overall Study|Study Ended by Sponsor|20|||
125380190|NCT01896531|451023497|FG000|Overall Study|Withdrawal by Subject|3|||
125380191|NCT01896531|451023498|FG001|Overall Study|Withdrawal by Subject|2|||
125380192|NCT01896531|451023497|FG000|Overall Study|Death Prior to Treatment|1|||
125380193|NCT01896531|451023498|FG001|Overall Study|Death Prior to Treatment|0|||
125380194|NCT02956486|451023501|FG000|Core Phase|Adverse Event|51|||
125380195|NCT02956486|451023502|FG001|Core Phase|Adverse Event|88|||
125380196|NCT02956486|451023503|FG002|Core Phase|Adverse Event|0|||
125380197|NCT02956486|451023501|FG000|Core Phase|Lost to Follow-up|8|||
125380198|NCT02956486|451023502|FG001|Core Phase|Lost to Follow-up|6|||
125380199|NCT02956486|451023503|FG002|Core Phase|Lost to Follow-up|0|||
125380200|NCT02956486|451023501|FG000|Core Phase|Inadequate therapeutic effect|4|||
125437099|NCT01454830|451227987|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
125380201|NCT02956486|451023502|FG001|Core Phase|Inadequate therapeutic effect|5|||
125380202|NCT02956486|451023503|FG002|Core Phase|Inadequate therapeutic effect|0|||
125380203|NCT02956486|451023501|FG000|Core Phase|Withdrawal by Subject|101|||
125380204|NCT02956486|451023502|FG001|Core Phase|Withdrawal by Subject|104|||
125380205|NCT02956486|451023503|FG002|Core Phase|Withdrawal by Subject|0|||
125380206|NCT02956486|451023501|FG000|Core Phase|Study terminated by sponsor|888|||
125133195|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133196|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
125133197|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133198|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133199|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133200|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133201|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133202|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133203|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133204|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133205|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133206|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133207|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
125437100|NCT01454830|451227986|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
125437101|NCT01454830|451227987|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
125437102|NCT01454830|451227986|FG000|Overall Study|Withdrawal - no polysomnography|3|||
125437103|NCT01454830|451227987|FG001|Overall Study|Withdrawal - no polysomnography|2|||
125133208|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133209|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133210|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
125218257|NCT01059773|450427310|FG000|Overall Study|Lack of Efficacy|3|||
125218258|NCT01059773|450427311|FG001|Overall Study|Lack of Efficacy|3|||
125218259|NCT01059773|450427310|FG000|Overall Study|Death|0|||
125133211|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
125133212|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
125218260|NCT01059773|450427311|FG001|Overall Study|Death|1|||
125218261|NCT01059773|450427310|FG000|Overall Study|Malignancy including squamous cell skin|0|||
125218262|NCT01059773|450427311|FG001|Overall Study|Malignancy including squamous cell skin|1|||
125218263|NCT01059773|450427310|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
125218264|NCT01059773|450427311|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
125218265|NCT01059773|450427310|FG000|Overall Study|Other|1|||
125218266|NCT01059773|450427311|FG001|Overall Study|Other|3|||
125218267|NCT01029262|450427313|FG000|Overall Study|Adverse Event|9|||
125218268|NCT01029262|450427314|FG001|Overall Study|Adverse Event|52|||
125218269|NCT01029262|450427313|FG000|Overall Study|Lack of therapeutic effect|57|||
125218270|NCT01029262|450427314|FG001|Overall Study|Lack of therapeutic effect|76|||
125218271|NCT01029262|450427313|FG000|Overall Study|Withdrawal by Subject|10|||
125218272|NCT01029262|450427314|FG001|Overall Study|Withdrawal by Subject|17|||
125218273|NCT01029262|450427313|FG000|Overall Study|Protocol Violation|2|||
125218274|NCT01029262|450427314|FG001|Overall Study|Protocol Violation|3|||
125218275|NCT01029262|450427313|FG000|Overall Study|Miscellaneous|1|||
125218276|NCT01029262|450427314|FG001|Overall Study|Miscellaneous|9|||
125218277|NCT01029262|450427313|FG000|Overall Study|Death|0|||
125218278|NCT01029262|450427314|FG001|Overall Study|Death|3|||
125218279|NCT03410992|450427315|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218280|NCT03410992|450427316|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
125218281|NCT03410992|450427317|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218282|NCT03410992|450427318|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218283|NCT03410992|450427319|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218284|NCT03410992|450427320|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218285|NCT03410992|450427321|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218286|NCT03410992|450427322|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218287|NCT03410992|450427323|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218288|NCT03410992|450427324|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125218289|NCT03410992|450427325|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
125380207|NCT02956486|451023502|FG001|Core Phase|Study terminated by sponsor|848|||
125380208|NCT02956486|451023503|FG002|Core Phase|Study terminated by sponsor|0|||
125380209|NCT02956486|451023501|FG000|Core Phase|Other|27|||
125133213|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133214|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133215|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133216|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133217|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
125133218|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133219|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133220|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133221|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133222|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133223|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133224|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133225|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133226|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125218290|NCT03410992|450427315|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
125218291|NCT03410992|450427316|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
125218292|NCT03410992|450427317|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125218293|NCT03410992|450427318|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125218294|NCT03410992|450427319|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125133227|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133228|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133229|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133230|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133231|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133232|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
125218295|NCT03410992|450427320|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125218296|NCT03410992|450427321|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125380210|NCT02956486|451023502|FG001|Core Phase|Other|18|||
125380211|NCT02956486|451023503|FG002|Core Phase|Other|0|||
125380212|NCT02956486|451023501|FG000|Core Phase|Not treated|0|||
125380213|NCT02956486|451023502|FG001|Core Phase|Not treated|3|||
125380214|NCT02956486|451023503|FG002|Core Phase|Not treated|0|||
125380215|NCT02956486|451023501|FG000|Extension Phase|Adverse Event|0|||
125380216|NCT02956486|451023502|FG001|Extension Phase|Adverse Event|0|||
125380217|NCT02956486|451023503|FG002|Extension Phase|Adverse Event|2|||
125380218|NCT02956486|451023501|FG000|Extension Phase|Study terminated by sponsor|0|||
125380219|NCT02956486|451023502|FG001|Extension Phase|Study terminated by sponsor|0|||
125380220|NCT02956486|451023503|FG002|Extension Phase|Study terminated by sponsor|16|||
125380221|NCT02956486|451023501|FG000|Extension Phase|Not Treated|0|||
125380222|NCT02956486|451023502|FG001|Extension Phase|Not Treated|0|||
125380223|NCT02956486|451023503|FG002|Extension Phase|Not Treated|1|||
125380224|NCT00422591|451023504|FG000|Overall Study|Physician Decision|4|||
125380225|NCT00422591|451023504|FG000|Overall Study|Withdrawal by Subject|2|||
125380226|NCT03241342|451023505|FG000|Overall Study|Adverse Event|5|||
125380227|NCT03241342|451023506|FG001|Overall Study|Adverse Event|8|||
125380228|NCT03241342|451023507|FG002|Overall Study|Adverse Event|4|||
125380229|NCT03241342|451023505|FG000|Overall Study|Lack of Efficacy|0|||
125380230|NCT03241342|451023506|FG001|Overall Study|Lack of Efficacy|0|||
125380231|NCT03241342|451023507|FG002|Overall Study|Lack of Efficacy|1|||
125380232|NCT03241342|451023505|FG000|Overall Study|noncompliance with study drug|2|||
125380233|NCT03241342|451023506|FG001|Overall Study|noncompliance with study drug|1|||
125380234|NCT03241342|451023507|FG002|Overall Study|noncompliance with study drug|1|||
125380235|NCT03241342|451023505|FG000|Overall Study|sponsor decision|0|||
125380236|NCT03241342|451023506|FG001|Overall Study|sponsor decision|1|||
125380237|NCT03241342|451023507|FG002|Overall Study|sponsor decision|2|||
125380238|NCT03241342|451023505|FG000|Overall Study|not reported|15|||
125380239|NCT03241342|451023506|FG001|Overall Study|not reported|21|||
125380240|NCT03241342|451023507|FG002|Overall Study|not reported|19|||
125380241|NCT01846611|451023509|FG000|Overall Study|Lost to Follow-up|4|||
125380242|NCT01846611|451023510|FG001|Overall Study|Lost to Follow-up|6|||
125380243|NCT01846611|451023509|FG000|Overall Study|Withdrawal by Subject|15|||
125380244|NCT01846611|451023510|FG001|Overall Study|Withdrawal by Subject|19|||
125380245|NCT01846611|451023509|FG000|Overall Study|Other|19|||
125380246|NCT01846611|451023510|FG001|Overall Study|Other|18|||
125380247|NCT02671422|451023514|FG000|Overall Study|Lost to Follow-up|1|||
125380248|NCT02671422|451023514|FG000|Overall Study|Adverse Event|68|||
125380249|NCT02671422|451023514|FG000|Overall Study|Lack of Efficacy|1|||
125133233|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
125133234|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133235|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133236|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133237|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133238|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
125133239|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133240|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133241|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133242|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133243|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133244|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133245|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133246|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133247|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125380250|NCT02671422|451023514|FG000|Overall Study|Lost to Follow-up|4|||
125380251|NCT02671422|451023514|FG000|Overall Study|Withdrawal by Subject|7|||
125380252|NCT02671422|451023514|FG000|Overall Study|Progressive Disease|156|||
125380253|NCT02671422|451023514|FG000|Overall Study|Worsening of Disease|4|||
125380254|NCT02671422|451023514|FG000|Overall Study|Sponsor decision|5|||
125380255|NCT02671422|451023514|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
125380256|NCT02671422|451023514|FG000|Overall Study|Not treated with Vargatef®|3|||
125380257|NCT02671422|451023514|FG000|Overall Study|Other not defined above|3|||
125380258|NCT04702997|451023515|FG000|Overall Study|Withdrawal by Subject|1|||
125380259|NCT04702997|451023516|FG001|Overall Study|Withdrawal by Subject|1|||
125380260|NCT03915496|451023517|FG000|Overall Study|Adverse Event|2|||
125380261|NCT03915496|451023518|FG001|Overall Study|Adverse Event|1|||
125380262|NCT03915496|451023519|FG002|Overall Study|Adverse Event|2|||
125380263|NCT03032705|451023528|FG000|Overall Study|Lost to Follow-up|16|||
125380264|NCT03032705|451023529|FG001|Overall Study|Lost to Follow-up|17|||
125380265|NCT03032705|451023528|FG000|Overall Study|did not quality|6|||
125133248|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133249|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125380266|NCT03032705|451023529|FG001|Overall Study|did not quality|6|||
125380267|NCT00293254|451025132|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
125380268|NCT00293254|451025133|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
125133250|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133251|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133252|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133253|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
125133254|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
125133255|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133256|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133257|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133258|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133259|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
125133260|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133261|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133262|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133263|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133264|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133265|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133266|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133267|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133268|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133269|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133270|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133271|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133272|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133273|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133274|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
125133275|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
125133276|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133277|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133278|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133279|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133280|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
125133281|NCT01597245|450111871|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133282|NCT01597245|450111872|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133283|NCT01597245|450111873|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125218297|NCT03410992|450427322|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125218298|NCT03410992|450427323|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125218299|NCT03410992|450427324|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125437104|NCT00152763|451227988|FG000|Overall Study|Death|4|||
125640397|NCT01004861|451965033|FG007|Overall Study|Surgical resection|0|||
125640398|NCT01004861|451965034|FG008|Overall Study|Surgical resection|1|||
125640399|NCT01004861|451965035|FG009|Overall Study|Surgical resection|0|||
125640400|NCT01004861|451965036|FG010|Overall Study|Surgical resection|0|||
125640401|NCT01004861|451965037|FG011|Overall Study|Surgical resection|0|||
125640402|NCT01004861|451965038|FG012|Overall Study|Surgical resection|0|||
125640403|NCT01004861|451965026|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125640404|NCT01004861|451965027|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125640405|NCT01004861|451965028|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125640406|NCT01004861|451965029|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125640407|NCT01004861|451965030|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125640408|NCT01004861|451965031|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125640409|NCT01004861|451965032|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125640410|NCT01004861|451965033|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125640411|NCT01004861|451965034|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
125640412|NCT01004861|451965035|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125640413|NCT01004861|451965036|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125640414|NCT01004861|451965037|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125640415|NCT01004861|451965038|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
125640416|NCT01004861|451965026|FG000|Overall Study|Study termination by Sponsor|0|||
125640417|NCT01004861|451965027|FG001|Overall Study|Study termination by Sponsor|0|||
125640418|NCT01004861|451965028|FG002|Overall Study|Study termination by Sponsor|0|||
125640419|NCT01004861|451965029|FG003|Overall Study|Study termination by Sponsor|0|||
125640420|NCT01004861|451965030|FG004|Overall Study|Study termination by Sponsor|0|||
125640421|NCT01004861|451965031|FG005|Overall Study|Study termination by Sponsor|0|||
125640422|NCT01004861|451965032|FG006|Overall Study|Study termination by Sponsor|0|||
125218300|NCT03410992|450427325|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
125133284|NCT01597245|450111874|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133285|NCT01597245|450111875|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133286|NCT01597245|450111876|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133287|NCT01597245|450111877|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133288|NCT01597245|450111878|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133289|NCT01597245|450111879|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133290|NCT01597245|450111880|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133291|NCT01597245|450111881|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133292|NCT01597245|450111882|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133293|NCT01597245|450111883|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133294|NCT01597245|450111884|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
125133295|NCT01597245|450111885|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133296|NCT01597245|450111886|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133297|NCT01597245|450111887|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133298|NCT01597245|450111888|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133299|NCT01597245|450111889|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133300|NCT01597245|450111890|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133301|NCT01597245|450111891|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
125133302|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133303|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133304|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133305|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133306|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133307|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133308|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133309|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133310|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133311|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133312|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133313|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133314|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133315|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133316|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133317|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
125133318|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
125133319|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
125133320|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
125133321|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
125133322|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
125133323|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133324|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133325|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133326|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133327|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133328|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133329|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133330|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133331|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133332|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133333|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133334|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133335|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133336|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133337|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133338|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133339|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
125133340|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
125133341|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
125133342|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
125133343|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
125133344|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133345|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133346|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125218301|NCT03410992|450427315|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
125218302|NCT03410992|450427316|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
125218303|NCT03410992|450427317|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218304|NCT03410992|450427318|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218305|NCT03410992|450427319|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218306|NCT03410992|450427320|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218307|NCT03410992|450427321|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218308|NCT03410992|450427322|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218309|NCT03410992|450427323|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218310|NCT03410992|450427324|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218311|NCT03410992|450427325|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
125218312|NCT03410992|450427315|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
125218313|NCT03410992|450427316|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218314|NCT03410992|450427317|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218315|NCT03410992|450427318|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218316|NCT03410992|450427319|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218317|NCT03410992|450427320|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218318|NCT03410992|450427321|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218319|NCT03410992|450427322|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218320|NCT03410992|450427323|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218321|NCT03410992|450427324|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218322|NCT03410992|450427325|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
125218323|NCT03410992|450427315|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
125218324|NCT03410992|450427316|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
125218325|NCT03410992|450427317|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218326|NCT03410992|450427318|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218327|NCT03410992|450427319|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218328|NCT03410992|450427320|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218329|NCT03410992|450427321|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218330|NCT03410992|450427322|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218331|NCT03410992|450427323|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125380269|NCT00293254|451025132|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
125380270|NCT00293254|451025133|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
125380271|NCT00293254|451025132|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
125640423|NCT01004861|451965033|FG007|Overall Study|Study termination by Sponsor|0|||
125640424|NCT01004861|451965034|FG008|Overall Study|Study termination by Sponsor|1|||
125640425|NCT01004861|451965035|FG009|Overall Study|Study termination by Sponsor|0|||
125133347|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133348|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133349|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133350|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133351|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133352|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133353|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133354|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133355|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133356|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133357|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133358|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133359|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133360|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
125133361|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133362|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
125133363|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
125133364|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
125133365|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133366|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133367|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133368|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133369|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133370|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133371|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125218332|NCT03410992|450427324|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125218333|NCT03410992|450427325|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
125380272|NCT00293254|451025133|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
125133372|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133373|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133374|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133375|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133376|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133377|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133378|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133379|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133380|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133381|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133382|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
125133383|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
125133384|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
125133385|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
125133386|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133387|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133388|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133389|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133390|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133391|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133392|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133393|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133394|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133395|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133396|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133397|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133398|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133399|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133400|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133401|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133402|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
125133403|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133404|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
125133405|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
125133406|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
125133407|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133408|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133409|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133410|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133411|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133412|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133413|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133414|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133415|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133416|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133417|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125420825|NCT01260350|451166164|FG020|Overall Study|Lack of Efficacy|3|||
125640426|NCT01004861|451965036|FG010|Overall Study|Study termination by Sponsor|0|||
125640427|NCT01004861|451965037|FG011|Overall Study|Study termination by Sponsor|0|||
125640428|NCT01004861|451965038|FG012|Overall Study|Study termination by Sponsor|0|||
125640429|NCT00003389|451965039|FG000|Overall Study|Disease progression|6|||
125640430|NCT00003389|451965040|FG001|Overall Study|Disease progression|1|||
125640431|NCT00003389|451965039|FG000|Overall Study|Adverse Event|13|||
125640432|NCT00003389|451965040|FG001|Overall Study|Adverse Event|2|||
125640433|NCT00003389|451965039|FG000|Overall Study|Death|0|||
125640434|NCT00003389|451965040|FG001|Overall Study|Death|3|||
125640435|NCT00003389|451965039|FG000|Overall Study|Withdrawal by Subject|12|||
125640436|NCT00003389|451965040|FG001|Overall Study|Withdrawal by Subject|5|||
125640437|NCT00003389|451965039|FG000|Overall Study|Alternative therapy|2|||
125640438|NCT00003389|451965040|FG001|Overall Study|Alternative therapy|1|||
125640439|NCT00003389|451965039|FG000|Overall Study|Complicating disease|1|||
125640440|NCT00003389|451965040|FG001|Overall Study|Complicating disease|0|||
125640441|NCT00003389|451965039|FG000|Overall Study|Off-treatment reason missing|31|||
125640442|NCT00003389|451965040|FG001|Overall Study|Off-treatment reason missing|21|||
125640443|NCT00003389|451965039|FG000|Overall Study|Ineligible|33|||
125640444|NCT00003389|451965040|FG001|Overall Study|Ineligible|27|||
125218334|NCT03410992|450427315|FG000|Week 16 Assessment|Incorrect escapers|0|||
125218335|NCT03410992|450427316|FG001|Week 16 Assessment|Incorrect escapers|6|||
125218336|NCT03410992|450427317|FG002|Week 16 Assessment|Incorrect escapers|0|||
125218337|NCT03410992|450427318|FG003|Week 16 Assessment|Incorrect escapers|0|||
125218338|NCT03410992|450427319|FG004|Week 16 Assessment|Incorrect escapers|0|||
125218339|NCT03410992|450427320|FG005|Week 16 Assessment|Incorrect escapers|0|||
125218340|NCT03410992|450427321|FG006|Week 16 Assessment|Incorrect escapers|0|||
125218341|NCT03410992|450427322|FG007|Week 16 Assessment|Incorrect escapers|0|||
125218342|NCT03410992|450427323|FG008|Week 16 Assessment|Incorrect escapers|0|||
125218343|NCT03410992|450427324|FG009|Week 16 Assessment|Incorrect escapers|0|||
125218344|NCT03410992|450427325|FG010|Week 16 Assessment|Incorrect escapers|0|||
125218345|NCT03410992|450427315|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218346|NCT03410992|450427316|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218347|NCT03410992|450427317|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218348|NCT03410992|450427318|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
125218349|NCT03410992|450427319|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
125640445|NCT00686699|451965041|FG000|Treatment Period 1|Adverse Event|0|||
125640446|NCT00686699|451965042|FG001|Treatment Period 1|Adverse Event|2|||
125640447|NCT01997892|451965043|FG000|Overall Study|Physician Decision|2|||
125640448|NCT01997892|451965043|FG000|Overall Study|Lost to Follow-up|6|||
125640449|NCT01997892|451965043|FG000|Overall Study|Death|14|||
125640450|NCT01997892|451965043|FG000|Overall Study|Renal transplant|8|||
125640451|NCT01997892|451965043|FG000|Overall Study|Other|3|||
125640452|NCT01997892|451965043|FG000|Overall Study|Study completion data not recorded|35|||
125640453|NCT02608099|451965047|FG000|Overall Study|Ablation procedure not initiated|3|||
125640454|NCT02608099|451965048|FG001|Overall Study|Ablation procedure not initiated|2|||
125640455|NCT04657003|451965052|FG000|Overall Study|Adverse Event|5|||
125640456|NCT04657003|451965053|FG001|Overall Study|Adverse Event|1|||
125640457|NCT04657003|451965054|FG002|Overall Study|Adverse Event|5|||
125640458|NCT04657003|451965052|FG000|Overall Study|Death|0|||
125640459|NCT04657003|451965053|FG001|Overall Study|Death|2|||
125640460|NCT04657003|451965054|FG002|Overall Study|Death|0|||
125640461|NCT04657003|451965052|FG000|Overall Study|Lost to Follow-up|8|||
125640462|NCT04657003|451965053|FG001|Overall Study|Lost to Follow-up|4|||
125640463|NCT04657003|451965054|FG002|Overall Study|Lost to Follow-up|10|||
125640464|NCT04657003|451965052|FG000|Overall Study|Other - As Reported by Investigator|3|||
125640465|NCT04657003|451965053|FG001|Overall Study|Other - As Reported by Investigator|2|||
125640466|NCT04657003|451965054|FG002|Overall Study|Other - As Reported by Investigator|2|||
125640467|NCT04657003|451965052|FG000|Overall Study|Pregnancy|2|||
125640468|NCT04657003|451965053|FG001|Overall Study|Pregnancy|0|||
125640469|NCT04657003|451965054|FG002|Overall Study|Pregnancy|2|||
125640470|NCT04657003|451965052|FG000|Overall Study|Withdrawal by Subject|16|||
125640471|NCT04657003|451965053|FG001|Overall Study|Withdrawal by Subject|7|||
125640472|NCT04657003|451965054|FG002|Overall Study|Withdrawal by Subject|10|||
125640473|NCT00768040|451965057|FG000|Overall Study|Adverse Event|3|||
125640474|NCT00768040|451965058|FG001|Overall Study|Adverse Event|2|||
125640475|NCT00768040|451965057|FG000|Overall Study|Abnormal laboratory value|1|||
125640476|NCT00768040|451965058|FG001|Overall Study|Abnormal laboratory value|1|||
125640477|NCT00417248|451965060|FG000|Overall Study|Study Terminated|6|||
125640478|NCT00417248|451965060|FG000|Overall Study|Death|1|||
125640479|NCT00417248|451965060|FG000|Overall Study|Lack of Efficacy|1|||
125640480|NCT02185040|451965061|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
125640481|NCT02185040|451965062|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
125640482|NCT02185040|451965063|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
125640483|NCT02185040|451965064|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
125640484|NCT02185040|451965065|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
125640485|NCT02185040|451965066|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
125640486|NCT02185040|451965067|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
125640487|NCT02185040|451965061|FG000|Part 1 Treatment Phase|Adverse Event|1|||
125640488|NCT02185040|451965062|FG001|Part 1 Treatment Phase|Adverse Event|0|||
125640489|NCT02185040|451965063|FG002|Part 1 Treatment Phase|Adverse Event|0|||
125218350|NCT03410992|450427320|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218351|NCT03410992|450427321|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218352|NCT03410992|450427322|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125640490|NCT02185040|451965064|FG003|Part 1 Treatment Phase|Adverse Event|2|||
125218353|NCT03410992|450427323|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125437105|NCT00152763|451227989|FG001|Overall Study|Death|1|||
125640491|NCT02185040|451965065|FG004|Part 1 Treatment Phase|Adverse Event|3|||
125640492|NCT02185040|451965066|FG005|Part 1 Treatment Phase|Adverse Event|0|||
125640493|NCT02185040|451965067|FG006|Part 1 Treatment Phase|Adverse Event|0|||
125640494|NCT02185040|451965061|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
125640495|NCT02185040|451965062|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
125640496|NCT02185040|451965063|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
125640497|NCT02185040|451965064|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
125640498|NCT02185040|451965065|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
125640499|NCT02185040|451965066|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
125218354|NCT03410992|450427324|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218355|NCT03410992|450427325|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
125218356|NCT03410992|450427315|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218357|NCT03410992|450427316|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218358|NCT03410992|450427317|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218359|NCT03410992|450427318|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
125218360|NCT03410992|450427319|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
125218361|NCT03410992|450427320|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
125218362|NCT03410992|450427321|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218363|NCT03410992|450427322|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218364|NCT03410992|450427323|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218365|NCT03410992|450427324|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218366|NCT03410992|450427325|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
125218367|NCT03410992|450427315|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218368|NCT03410992|450427316|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218369|NCT03410992|450427317|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218370|NCT03410992|450427318|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218371|NCT03410992|450427319|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218372|NCT03410992|450427320|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
125218373|NCT03410992|450427321|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218374|NCT03410992|450427322|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218375|NCT03410992|450427323|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218376|NCT03410992|450427324|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218377|NCT03410992|450427325|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
125218378|NCT03410992|450427315|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218379|NCT03410992|450427316|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218380|NCT03410992|450427317|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218381|NCT03410992|450427318|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
125218382|NCT03410992|450427319|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
125218383|NCT03410992|450427320|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
125218384|NCT03410992|450427321|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218385|NCT03410992|450427322|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218386|NCT03410992|450427323|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218387|NCT03410992|450427324|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218388|NCT03410992|450427325|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
125218389|NCT03410992|450427315|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218390|NCT03410992|450427316|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218391|NCT03410992|450427317|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218392|NCT03410992|450427318|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218393|NCT03410992|450427319|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218394|NCT03410992|450427320|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218395|NCT03410992|450427321|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218396|NCT03410992|450427322|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
125218397|NCT03410992|450427323|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218398|NCT03410992|450427324|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218399|NCT03410992|450427325|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
125218400|NCT03410992|450427315|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218401|NCT03410992|450427316|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218402|NCT03410992|450427317|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218403|NCT03410992|450427318|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218404|NCT03410992|450427319|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218405|NCT03410992|450427320|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218406|NCT03410992|450427321|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218407|NCT03410992|450427322|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218408|NCT03410992|450427323|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
125437106|NCT00152763|451227990|FG002|Overall Study|Death|2|||
125640500|NCT02185040|451965067|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
125640501|NCT02185040|451965061|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
125640502|NCT02185040|451965062|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
125640503|NCT02185040|451965063|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
125640504|NCT02185040|451965064|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
125640505|NCT02185040|451965065|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
125640506|NCT02185040|451965066|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
125640507|NCT02185040|451965067|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
125640508|NCT02185040|451965061|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
125640509|NCT02185040|451965062|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
125133418|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133419|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133420|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133421|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133422|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133423|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
125133424|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133425|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
125133426|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
125133427|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
125133428|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133429|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133430|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133431|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133432|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133433|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133434|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133435|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133436|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133437|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133438|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133439|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133440|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133441|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133442|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133443|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133444|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
125133445|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133446|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133447|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
125133448|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
125133449|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133450|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133451|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133452|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133453|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133454|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133455|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133456|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133457|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133458|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133459|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133460|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133461|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133462|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133463|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133464|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133465|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
125133466|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133467|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133468|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
125380273|NCT00293254|451025132|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
125380274|NCT00293254|451025133|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
125380275|NCT00293254|451025132|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
125380276|NCT00293254|451025133|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
125640510|NCT02185040|451965063|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
125640511|NCT02185040|451965064|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
125640512|NCT02185040|451965065|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
125640513|NCT02185040|451965066|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
125640514|NCT02185040|451965067|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
125640515|NCT02185040|451965061|FG000|Active Treatment Extension Phase|Adverse Event|0|||
125640516|NCT02185040|451965062|FG001|Active Treatment Extension Phase|Adverse Event|0|||
125640517|NCT02185040|451965063|FG002|Active Treatment Extension Phase|Adverse Event|0|||
125640518|NCT02185040|451965064|FG003|Active Treatment Extension Phase|Adverse Event|0|||
125218409|NCT03410992|450427324|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218410|NCT03410992|450427325|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
125218411|NCT02260817|450427326|FG000|Overall Study|Lost to Follow-up|0|||
125380277|NCT00293254|451025132|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
125380278|NCT00293254|451025133|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
125380279|NCT00293254|451025132|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
125420826|NCT01260350|451166165|FG021|Overall Study|Lack of Efficacy|0|||
125640519|NCT02185040|451965065|FG004|Active Treatment Extension Phase|Adverse Event|0|||
125640520|NCT02185040|451965066|FG005|Active Treatment Extension Phase|Adverse Event|1|||
125640521|NCT02185040|451965067|FG006|Active Treatment Extension Phase|Adverse Event|4|||
125640522|NCT02185040|451965061|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
125640523|NCT02185040|451965062|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
125640524|NCT02185040|451965063|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
125640525|NCT02185040|451965064|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
125640526|NCT02185040|451965065|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
125640527|NCT02185040|451965066|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
125640528|NCT02185040|451965067|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
125640529|NCT02185040|451965061|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
125640530|NCT02185040|451965062|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
125640531|NCT02185040|451965063|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
125640532|NCT02185040|451965064|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
125640533|NCT02185040|451965065|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
125640534|NCT02185040|451965066|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
125640535|NCT02185040|451965067|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
125640536|NCT03347279|451965068|FG000|Overall Study|Withdrawal by Subject|8|||
125640537|NCT03347279|451965069|FG001|Overall Study|Withdrawal by Subject|15|||
125640538|NCT03347279|451965068|FG000|Overall Study|Death|0|||
125640539|NCT03347279|451965069|FG001|Overall Study|Death|2|||
125640540|NCT03347279|451965068|FG000|Overall Study|Lost to Follow-up|5|||
125640541|NCT03347279|451965069|FG001|Overall Study|Lost to Follow-up|2|||
125640542|NCT03347279|451965068|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
125640543|NCT03347279|451965069|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
125640544|NCT03818399|451965074|FG000|Overall Study|Lost to Follow-up|11|||
125640545|NCT03818399|451965074|FG000|Overall Study|Withdrawal by Subject|1|||
125640546|NCT03818399|451965074|FG000|Overall Study|Protocol Violation|2|||
125640547|NCT03557801|451965077|FG000|Overall Study|Protocol Violation|1|||
125640548|NCT03557801|451965078|FG001|Overall Study|Protocol Violation|0|||
125640549|NCT03557801|451965079|FG002|Overall Study|Protocol Violation|0|||
125640550|NCT03557801|451965077|FG000|Overall Study|Withdrawal by Subject|1|||
125640551|NCT03557801|451965078|FG001|Overall Study|Withdrawal by Subject|0|||
125640552|NCT03557801|451965079|FG002|Overall Study|Withdrawal by Subject|3|||
125640553|NCT03557801|451965077|FG000|Overall Study|Lost to Follow-up|0|||
125640554|NCT03557801|451965078|FG001|Overall Study|Lost to Follow-up|1|||
125640555|NCT03557801|451965079|FG002|Overall Study|Lost to Follow-up|0|||
125640556|NCT00535236|451965080|FG000|Overall Study|Adverse Event|1|||
125640557|NCT00535236|451965081|FG001|Overall Study|Adverse Event|0|||
125640558|NCT00535236|451965082|FG002|Overall Study|Adverse Event|9|||
125640559|NCT00535236|451965083|FG003|Overall Study|Adverse Event|3|||
125640560|NCT00535236|451965084|FG004|Overall Study|Adverse Event|3|||
125640561|NCT00535236|451965085|FG005|Overall Study|Adverse Event|0|||
125218412|NCT02260817|450427327|FG001|Overall Study|Lost to Follow-up|14|||
125218413|NCT02260817|450427326|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
125218414|NCT02260817|450427327|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
125218415|NCT02260817|450427326|FG000|Overall Study|Observation, no biopsy|0|||
125218416|NCT02260817|450427327|FG001|Overall Study|Observation, no biopsy|1|||
125218417|NCT02260817|450427326|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
125218418|NCT02260817|450427327|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
125218419|NCT02260817|450427326|FG000|Overall Study|Protocol Violation|0|||
125218420|NCT02260817|450427327|FG001|Overall Study|Protocol Violation|14|||
125218421|NCT04435808|450427328|FG000|Overall Study|Study stopped by DSMB|0|||
125218422|NCT04435808|450427329|FG001|Overall Study|Study stopped by DSMB|1|||
125218423|NCT03299101|450427330|FG000|Overall Study|Lost to Follow-up|1|||
125640562|NCT00535236|451965086|FG006|Overall Study|Adverse Event|5|||
125640563|NCT00535236|451965087|FG007|Overall Study|Adverse Event|1|||
125640564|NCT00535236|451965088|FG008|Overall Study|Adverse Event|2|||
125640565|NCT00535236|451965089|FG009|Overall Study|Adverse Event|1|||
125640566|NCT00535236|451965080|FG000|Overall Study|Lost to Follow-up|1|||
125640567|NCT00535236|451965081|FG001|Overall Study|Lost to Follow-up|2|||
125640568|NCT00535236|451965082|FG002|Overall Study|Lost to Follow-up|0|||
125640569|NCT00535236|451965083|FG003|Overall Study|Lost to Follow-up|0|||
125640570|NCT00535236|451965084|FG004|Overall Study|Lost to Follow-up|2|||
125640571|NCT00535236|451965085|FG005|Overall Study|Lost to Follow-up|0|||
125640572|NCT00535236|451965086|FG006|Overall Study|Lost to Follow-up|0|||
125640573|NCT00535236|451965087|FG007|Overall Study|Lost to Follow-up|0|||
125640574|NCT00535236|451965088|FG008|Overall Study|Lost to Follow-up|6|||
125640575|NCT00535236|451965089|FG009|Overall Study|Lost to Follow-up|1|||
125640576|NCT00535236|451965080|FG000|Overall Study|Physician Decision|0|||
125640577|NCT00535236|451965081|FG001|Overall Study|Physician Decision|0|||
125640578|NCT00535236|451965082|FG002|Overall Study|Physician Decision|0|||
125640579|NCT00535236|451965083|FG003|Overall Study|Physician Decision|0|||
125640580|NCT00535236|451965084|FG004|Overall Study|Physician Decision|1|||
125640581|NCT00535236|451965085|FG005|Overall Study|Physician Decision|0|||
125640582|NCT00535236|451965086|FG006|Overall Study|Physician Decision|1|||
125218424|NCT03299101|450427330|FG000|Overall Study|Withdrawal by Subject|5|||
125218425|NCT03299101|450427330|FG000|Overall Study|Surgery was changed|3|||
125640583|NCT00535236|451965087|FG007|Overall Study|Physician Decision|0|||
125640584|NCT00535236|451965088|FG008|Overall Study|Physician Decision|0|||
125640585|NCT00535236|451965089|FG009|Overall Study|Physician Decision|0|||
125640586|NCT00535236|451965080|FG000|Overall Study|Protocol Violation|2|||
125640587|NCT00535236|451965081|FG001|Overall Study|Protocol Violation|0|||
125133469|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
125133470|NCT01597245|450111871|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133471|NCT01597245|450111872|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133472|NCT01597245|450111873|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133473|NCT01597245|450111874|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133474|NCT01597245|450111875|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133475|NCT01597245|450111876|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133476|NCT01597245|450111877|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133477|NCT01597245|450111878|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133478|NCT01597245|450111879|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133479|NCT01597245|450111880|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133480|NCT01597245|450111881|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133481|NCT01597245|450111882|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133482|NCT01597245|450111883|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133483|NCT01597245|450111884|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133484|NCT01597245|450111885|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133485|NCT01597245|450111886|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133486|NCT01597245|450111887|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125437107|NCT00152763|451227991|FG003|Overall Study|Death|1|||
125640588|NCT00535236|451965082|FG002|Overall Study|Protocol Violation|1|||
125640589|NCT00535236|451965083|FG003|Overall Study|Protocol Violation|0|||
125640590|NCT00535236|451965084|FG004|Overall Study|Protocol Violation|0|||
125640591|NCT00535236|451965085|FG005|Overall Study|Protocol Violation|0|||
125640592|NCT00535236|451965086|FG006|Overall Study|Protocol Violation|0|||
125640593|NCT00535236|451965087|FG007|Overall Study|Protocol Violation|0|||
125640594|NCT00535236|451965088|FG008|Overall Study|Protocol Violation|1|||
125640595|NCT00535236|451965089|FG009|Overall Study|Protocol Violation|0|||
125640596|NCT00535236|451965080|FG000|Overall Study|Withdrawal by Subject|3|||
125640597|NCT00535236|451965081|FG001|Overall Study|Withdrawal by Subject|0|||
125640598|NCT00535236|451965082|FG002|Overall Study|Withdrawal by Subject|2|||
125640599|NCT00535236|451965083|FG003|Overall Study|Withdrawal by Subject|1|||
125640600|NCT00535236|451965084|FG004|Overall Study|Withdrawal by Subject|6|||
125640601|NCT00535236|451965085|FG005|Overall Study|Withdrawal by Subject|1|||
125640602|NCT00535236|451965086|FG006|Overall Study|Withdrawal by Subject|5|||
125640603|NCT00535236|451965087|FG007|Overall Study|Withdrawal by Subject|0|||
125640604|NCT00535236|451965088|FG008|Overall Study|Withdrawal by Subject|4|||
125640605|NCT00535236|451965089|FG009|Overall Study|Withdrawal by Subject|2|||
125640606|NCT00141297|451965091|FG000|Overall Study|Adverse Event|0|||
125640607|NCT00141297|451965092|FG001|Overall Study|Adverse Event|0|||
125640608|NCT00141297|451965093|FG002|Overall Study|Adverse Event|1|||
125640609|NCT00141297|451965094|FG003|Overall Study|Adverse Event|0|||
125640610|NCT00141297|451965095|FG004|Overall Study|Adverse Event|1|||
125640611|NCT00141297|451965096|FG005|Overall Study|Adverse Event|1|||
125133487|NCT01597245|450111888|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133488|NCT01597245|450111889|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133489|NCT01597245|450111890|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
125133490|NCT01597245|450111891|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
125133491|NCT00583453|450113761|FG000|Overall Study|discontinued intervention|0|||
125133492|NCT00583453|450113762|FG001|Overall Study|discontinued intervention|2|||
125133493|NCT00794963|450113763|FG000|Overall Study|Withdrawal by Subject|1|||
125133494|NCT00794963|450113764|FG001|Overall Study|Withdrawal by Subject|4|||
125133495|NCT01527006|450113770|FG000|Core Study|Adverse Event|0|||
125133496|NCT01527006|450113771|FG001|Core Study|Adverse Event|2|||
125133497|NCT01527006|450113770|FG000|Core Study|Lost to Follow-up|0|||
125133498|NCT01527006|450113771|FG001|Core Study|Lost to Follow-up|1|||
125133499|NCT01527006|450113770|FG000|Core Study|Subject Choice|1|||
125133500|NCT01527006|450113771|FG001|Core Study|Subject Choice|0|||
125133501|NCT01527006|450113770|FG000|Core Study|Inadequate Therapeutic Effect|1|||
125133502|NCT01527006|450113771|FG001|Core Study|Inadequate Therapeutic Effect|0|||
125133503|NCT01527006|450113770|FG000|Core Study|Withdrawal by Subject|0|||
125133504|NCT01527006|450113771|FG001|Core Study|Withdrawal by Subject|1|||
125133505|NCT01527006|450113770|FG000|Core Study|Other|0|||
125133506|NCT01527006|450113771|FG001|Core Study|Other|2|||
125133507|NCT01527006|450113770|FG000|Extension Phase|Adverse Event|4|||
125133508|NCT01527006|450113771|FG001|Extension Phase|Adverse Event|2|||
125133509|NCT01527006|450113770|FG000|Extension Phase|Lost to Follow-up|0|||
125133510|NCT01527006|450113771|FG001|Extension Phase|Lost to Follow-up|1|||
125133511|NCT01527006|450113770|FG000|Extension Phase|Subject Choice|1|||
125133512|NCT01527006|450113771|FG001|Extension Phase|Subject Choice|1|||
125133513|NCT01527006|450113770|FG000|Extension Phase|Inadequate therapeutic effect|1|||
125133514|NCT01527006|450113771|FG001|Extension Phase|Inadequate therapeutic effect|1|||
125133515|NCT01527006|450113770|FG000|Extension Phase|Other|0|||
125133516|NCT01527006|450113771|FG001|Extension Phase|Other|3|||
125133517|NCT00834340|450113776|FG000|Washout|Adverse Event|1|||
125133518|NCT00834340|450113777|FG001|Washout|Adverse Event|0|||
125133519|NCT00834340|450113776|FG000|Washout|Withdrawal by Subject|1|||
125133520|NCT00834340|450113777|FG001|Washout|Withdrawal by Subject|0|||
125133521|NCT02849457|450113780|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
125133522|NCT02849457|450113781|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
125133523|NCT02849457|450113782|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
125133524|NCT02849457|450113783|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
125133525|NCT03673670|450113787|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
125133526|NCT03673670|450113788|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
125133527|NCT03673670|450113789|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
125133528|NCT03673670|450113790|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
125133529|NCT03673670|450113791|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
125133530|NCT03673670|450113792|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
125133531|NCT03673670|450113787|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
125133532|NCT03673670|450113788|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
125133533|NCT03673670|450113789|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
125133534|NCT03673670|450113790|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
125133535|NCT03673670|450113791|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
125133536|NCT03673670|450113792|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
125133537|NCT03673670|450113787|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
125133538|NCT03673670|450113788|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
125133539|NCT03673670|450113789|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
125133540|NCT03673670|450113790|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
125133541|NCT03673670|450113791|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
125133542|NCT03673670|450113792|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
125133543|NCT03673670|450113787|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
125133544|NCT03673670|450113788|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
125133545|NCT03673670|450113789|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
125133546|NCT03673670|450113790|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
125133547|NCT03673670|450113791|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
125133548|NCT03673670|450113792|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
125133549|NCT03673670|450113787|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
125133550|NCT03673670|450113788|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
125133551|NCT03673670|450113789|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
125133552|NCT03673670|450113790|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
125133553|NCT03673670|450113791|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
125133554|NCT03673670|450113792|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
125133555|NCT03673670|450113787|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
125133556|NCT03673670|450113788|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
125437108|NCT00152763|451227988|FG000|Overall Study|Lost to Follow-up|6|||
125218426|NCT03299101|450427330|FG000|Overall Study|Not enough time to complete prehab|1|||
125218427|NCT02457195|450427331|FG000|Overall Study|Adverse Event|3|||
125380280|NCT00293254|451025133|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
125380281|NCT00293254|451025132|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
125380282|NCT00293254|451025133|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
125380283|NCT00293254|451025132|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
125380284|NCT00293254|451025133|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
125380285|NCT00293254|451025132|FG000|Extension - Double-Blind Week 49-156|Death|4|||
125380286|NCT00293254|451025133|FG001|Extension - Double-Blind Week 49-156|Death|1|||
125640612|NCT00141297|451965097|FG006|Overall Study|Adverse Event|0|||
125640613|NCT00141297|451965098|FG007|Overall Study|Adverse Event|1|||
125640614|NCT00141297|451965099|FG008|Overall Study|Adverse Event|1|||
125640615|NCT00141297|451965100|FG009|Overall Study|Adverse Event|0|||
125640616|NCT00141297|451965091|FG000|Overall Study|Death|1|||
125640617|NCT00141297|451965092|FG001|Overall Study|Death|0|||
125640618|NCT00141297|451965093|FG002|Overall Study|Death|0|||
125640619|NCT00141297|451965094|FG003|Overall Study|Death|0|||
125640620|NCT00141297|451965095|FG004|Overall Study|Death|0|||
125640621|NCT00141297|451965096|FG005|Overall Study|Death|0|||
125640622|NCT00141297|451965097|FG006|Overall Study|Death|0|||
125640623|NCT00141297|451965098|FG007|Overall Study|Death|0|||
125640624|NCT00141297|451965099|FG008|Overall Study|Death|1|||
125640625|NCT00141297|451965100|FG009|Overall Study|Death|0|||
125640626|NCT00141297|451965091|FG000|Overall Study|Withdrawal by Subject|0|||
125640627|NCT00141297|451965092|FG001|Overall Study|Withdrawal by Subject|0|||
125640628|NCT00141297|451965093|FG002|Overall Study|Withdrawal by Subject|0|||
125640629|NCT00141297|451965094|FG003|Overall Study|Withdrawal by Subject|0|||
125640630|NCT00141297|451965095|FG004|Overall Study|Withdrawal by Subject|0|||
125640631|NCT00141297|451965096|FG005|Overall Study|Withdrawal by Subject|0|||
125640632|NCT00141297|451965097|FG006|Overall Study|Withdrawal by Subject|0|||
125640633|NCT00141297|451965098|FG007|Overall Study|Withdrawal by Subject|0|||
125640634|NCT00141297|451965099|FG008|Overall Study|Withdrawal by Subject|1|||
125640635|NCT00141297|451965100|FG009|Overall Study|Withdrawal by Subject|0|||
125640636|NCT00141297|451965091|FG000|Overall Study|Other|0|||
125640637|NCT00141297|451965092|FG001|Overall Study|Other|0|||
125640638|NCT00141297|451965093|FG002|Overall Study|Other|0|||
125640639|NCT00141297|451965094|FG003|Overall Study|Other|1|||
125640640|NCT00141297|451965095|FG004|Overall Study|Other|5|||
125640641|NCT00141297|451965096|FG005|Overall Study|Other|0|||
125640642|NCT00141297|451965097|FG006|Overall Study|Other|0|||
125640643|NCT00141297|451965098|FG007|Overall Study|Other|0|||
125640644|NCT00141297|451965099|FG008|Overall Study|Other|2|||
125640645|NCT00141297|451965100|FG009|Overall Study|Other|0|||
125640646|NCT00141297|451965091|FG000|Overall Study|Progressive Disease|2|||
125640647|NCT00141297|451965092|FG001|Overall Study|Progressive Disease|3|||
125640648|NCT00141297|451965093|FG002|Overall Study|Progressive Disease|6|||
125640649|NCT00141297|451965094|FG003|Overall Study|Progressive Disease|2|||
125640650|NCT00141297|451965095|FG004|Overall Study|Progressive Disease|15|||
125640651|NCT00141297|451965096|FG005|Overall Study|Progressive Disease|2|||
125640652|NCT00141297|451965097|FG006|Overall Study|Progressive Disease|3|||
125640653|NCT00141297|451965098|FG007|Overall Study|Progressive Disease|3|||
125640654|NCT00141297|451965099|FG008|Overall Study|Progressive Disease|15|||
125640655|NCT00141297|451965100|FG009|Overall Study|Progressive Disease|6|||
125218428|NCT02457195|450427331|FG000|Overall Study|Protocol Violation|2|||
125640656|NCT00141297|451965091|FG000|Overall Study|Transitioned|0|||
125640657|NCT00141297|451965092|FG001|Overall Study|Transitioned|0|||
125640658|NCT00141297|451965093|FG002|Overall Study|Transitioned|0|||
125640659|NCT00141297|451965094|FG003|Overall Study|Transitioned|0|||
125640660|NCT00141297|451965095|FG004|Overall Study|Transitioned|1|||
125640661|NCT00141297|451965096|FG005|Overall Study|Transitioned|0|||
125640662|NCT00141297|451965097|FG006|Overall Study|Transitioned|0|||
125640663|NCT00141297|451965098|FG007|Overall Study|Transitioned|0|||
125640664|NCT00141297|451965099|FG008|Overall Study|Transitioned|0|||
125640665|NCT00141297|451965100|FG009|Overall Study|Transitioned|0|||
125640666|NCT02200510|451965101|FG000|Overall Study|Death|1|||
125640667|NCT02200510|451965102|FG001|Overall Study|Death|1|||
125640668|NCT02200510|451965101|FG000|Overall Study|Protocol Violation|0|||
125640669|NCT02200510|451965102|FG001|Overall Study|Protocol Violation|1|||
125640670|NCT02200510|451965101|FG000|Overall Study|Lost to Follow-up|7|||
125133557|NCT03673670|450113789|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
125133558|NCT03673670|450113790|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
125133559|NCT03673670|450113791|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
125133560|NCT03673670|450113792|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
125133561|NCT03673670|450113787|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
125133562|NCT03673670|450113788|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
125133563|NCT03673670|450113789|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
125133564|NCT03673670|450113790|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
125133565|NCT03673670|450113791|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
125133566|NCT03673670|450113792|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
125133567|NCT04408794|450113793|FG000|Overall Study|Adverse Event|43|||
125133568|NCT04408794|450113793|FG000|Overall Study|Infrequent study drug usage|43|||
125133569|NCT04408794|450113793|FG000|Overall Study|Lack of Efficacy|61|||
125133570|NCT04408794|450113793|FG000|Overall Study|Lost to Follow-up|33|||
125133571|NCT04408794|450113793|FG000|Overall Study|Non-compliance|6|||
125133572|NCT04408794|450113793|FG000|Overall Study|Physician Decision|1|||
125133573|NCT04408794|450113793|FG000|Overall Study|Pregnancy|6|||
125133574|NCT04408794|450113793|FG000|Overall Study|Protocol Deviation|9|||
125133575|NCT04408794|450113793|FG000|Overall Study|Sheehan-STS Result|1|||
125133576|NCT04408794|450113793|FG000|Overall Study|Withdrawal by Subject|57|||
125133577|NCT04408794|450113793|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
125133578|NCT04408794|450113793|FG000|Overall Study|Never Treated Migraine|5|||
125133579|NCT04238754|450113796|FG000|Washout - 1 Week|Lost to Follow-up|1|||
125133580|NCT04238754|450113797|FG001|Washout - 1 Week|Lost to Follow-up|0|||
125133581|NCT01518972|450113801|FG000|Overall Study|Lost to Follow-up|2|||
125133582|NCT01518972|450113802|FG001|Overall Study|Lost to Follow-up|1|||
125133583|NCT01518972|450113801|FG000|Overall Study|Withdrawal by Subject|1|||
125133584|NCT01518972|450113802|FG001|Overall Study|Withdrawal by Subject|0|||
125133585|NCT01518972|450113801|FG000|Overall Study|Moved from area|1|||
125133586|NCT01518972|450113802|FG001|Overall Study|Moved from area|0|||
125133587|NCT01518972|450113801|FG000|Overall Study|Transportation problems|1|||
125133588|NCT01518972|450113802|FG001|Overall Study|Transportation problems|0|||
125133589|NCT01518972|450113801|FG000|Overall Study|Exclusionary medical condition|1|||
125133590|NCT01518972|450113802|FG001|Overall Study|Exclusionary medical condition|0|||
125133591|NCT01518972|450113801|FG000|Overall Study|Missed safety visits|0|||
125133592|NCT01518972|450113802|FG001|Overall Study|Missed safety visits|1|||
125133593|NCT01518972|450113801|FG000|Overall Study|Exclusionary medication|0|||
125133594|NCT01518972|450113802|FG001|Overall Study|Exclusionary medication|1|||
125133595|NCT01518972|450113801|FG000|Overall Study|Declined medication starting on day 12|0|||
125133596|NCT01518972|450113802|FG001|Overall Study|Declined medication starting on day 12|1|||
125133597|NCT01175018|450113803|FG000|Overall Study|Adverse Event|3|||
125133598|NCT01175018|450113804|FG001|Overall Study|Adverse Event|1|||
125133599|NCT04022954|450113806|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
125133600|NCT04022954|450113806|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
125133601|NCT04022954|450113806|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
125133602|NCT03872128|450113809|FG000|Overall Study|Dropped out before treatment|1|||
125133603|NCT03872128|450113810|FG001|Overall Study|Dropped out before treatment|0|||
125133604|NCT03872128|450113811|FG002|Overall Study|Dropped out before treatment|4|||
125133605|NCT03872128|450113809|FG000|Overall Study|Lost to Follow-up|2|||
125133606|NCT03872128|450113810|FG001|Overall Study|Lost to Follow-up|5|||
125133607|NCT03872128|450113811|FG002|Overall Study|Lost to Follow-up|8|||
125133608|NCT00556322|450113812|FG000|Overall Study|Insufficient therapeutic response|158|||
125133609|NCT00556322|450113813|FG001|Overall Study|Insufficient therapeutic response|168|||
125133610|NCT00556322|450113812|FG000|Overall Study|Adverse Event|7|||
125133611|NCT00556322|450113813|FG001|Overall Study|Adverse Event|4|||
125133612|NCT00556322|450113812|FG000|Overall Study|Other|4|||
125133613|NCT00556322|450113813|FG001|Overall Study|Other|1|||
125133614|NCT00556322|450113812|FG000|Overall Study|Lost to Follow-up|5|||
125133615|NCT00556322|450113813|FG001|Overall Study|Lost to Follow-up|3|||
125133616|NCT00556322|450113812|FG000|Overall Study|Withdrawal by Subject|19|||
125133617|NCT00556322|450113813|FG001|Overall Study|Withdrawal by Subject|7|||
125133618|NCT00556322|450113812|FG000|Overall Study|Protocol Violation|5|||
125133619|NCT00556322|450113813|FG001|Overall Study|Protocol Violation|1|||
125133620|NCT00556322|450113812|FG000|Overall Study|Ongoing at data cutoff|3|||
125133621|NCT00556322|450113813|FG001|Overall Study|Ongoing at data cutoff|5|||
125133622|NCT00556322|450113812|FG000|Overall Study|Death|20|||
125133623|NCT00556322|450113813|FG001|Overall Study|Death|14|||
125133624|NCT03733444|450113814|FG000|Overall Study|Adverse Event|8|||
125133625|NCT03733444|450113815|FG001|Overall Study|Adverse Event|10|||
125133626|NCT03733444|450113816|FG002|Overall Study|Adverse Event|5|||
125133627|NCT03733444|450113814|FG000|Overall Study|Death|20|||
125133628|NCT03733444|450113815|FG001|Overall Study|Death|19|||
125133629|NCT03733444|450113816|FG002|Overall Study|Death|11|||
125133630|NCT03733444|450113814|FG000|Overall Study|Lost to Follow-up|3|||
125133631|NCT03733444|450113815|FG001|Overall Study|Lost to Follow-up|0|||
125133632|NCT03733444|450113816|FG002|Overall Study|Lost to Follow-up|1|||
125133633|NCT03733444|450113814|FG000|Overall Study|Lack of Efficacy|0|||
125133634|NCT03733444|450113815|FG001|Overall Study|Lack of Efficacy|1|||
125133635|NCT03733444|450113816|FG002|Overall Study|Lack of Efficacy|1|||
125133636|NCT03733444|450113814|FG000|Overall Study|Physician Decision|2|||
125133637|NCT03733444|450113815|FG001|Overall Study|Physician Decision|1|||
125133638|NCT03733444|450113816|FG002|Overall Study|Physician Decision|0|||
125133639|NCT03733444|450113814|FG000|Overall Study|Protocol Violation|2|||
125133640|NCT03733444|450113815|FG001|Overall Study|Protocol Violation|1|||
125133641|NCT03733444|450113816|FG002|Overall Study|Protocol Violation|0|||
125133642|NCT03733444|450113814|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
125133643|NCT03733444|450113815|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
125640671|NCT02200510|451965102|FG001|Overall Study|Lost to Follow-up|1|||
125640672|NCT02200510|451965101|FG000|Overall Study|potential COI - joined study team|1|||
125640673|NCT02200510|451965102|FG001|Overall Study|potential COI - joined study team|0|||
125640674|NCT00290355|451965103|FG000|Overall Study|Serious adverse event|7|||
125640675|NCT00290355|451965104|FG001|Overall Study|Serious adverse event|4|||
125640676|NCT00290355|451965103|FG000|Overall Study|Study product reactogenicity|1|||
125640677|NCT00290355|451965104|FG001|Overall Study|Study product reactogenicity|0|||
125133644|NCT03733444|450113816|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
125133645|NCT03733444|450113814|FG000|Overall Study|Study Terminated by Sponsor|203|||
125133646|NCT03733444|450113815|FG001|Overall Study|Study Terminated by Sponsor|209|||
125133647|NCT03733444|450113816|FG002|Overall Study|Study Terminated by Sponsor|221|||
125133648|NCT03733444|450113814|FG000|Overall Study|Withdrawal by Subject|19|||
125640678|NCT00290355|451965103|FG000|Overall Study|Protocol Violation|1|||
125640679|NCT00290355|451965104|FG001|Overall Study|Protocol Violation|0|||
125640680|NCT00290355|451965103|FG000|Overall Study|Withdrawal by Subject|2|||
125640681|NCT00290355|451965104|FG001|Overall Study|Withdrawal by Subject|0|||
125640682|NCT00290355|451965103|FG000|Overall Study|Migrated / moved from the study area|1|||
125640683|NCT00290355|451965104|FG001|Overall Study|Migrated / moved from the study area|0|||
125640684|NCT00290355|451965103|FG000|Overall Study|Lost to Follow-up|3|||
125640685|NCT00290355|451965104|FG001|Overall Study|Lost to Follow-up|1|||
125640686|NCT00290355|451965103|FG000|Overall Study|Other|2|||
125640687|NCT00290355|451965104|FG001|Overall Study|Other|0|||
125640688|NCT01542632|451965105|FG000|Overall Study|Withdrawal of Consent|0|||
125640689|NCT01542632|451965106|FG001|Overall Study|Withdrawal of Consent|0|||
125640690|NCT01542632|451965107|FG002|Overall Study|Withdrawal of Consent|0|||
125640691|NCT01542632|451965108|FG003|Overall Study|Withdrawal of Consent|2|||
125640692|NCT01542632|451965109|FG004|Overall Study|Withdrawal of Consent|3|||
125640693|NCT01542632|451965110|FG005|Overall Study|Withdrawal of Consent|0|||
125640694|NCT01542632|451965105|FG000|Overall Study|Adverse Event|0|||
125640695|NCT01542632|451965106|FG001|Overall Study|Adverse Event|0|||
125640696|NCT01542632|451965107|FG002|Overall Study|Adverse Event|1|||
125640697|NCT01542632|451965108|FG003|Overall Study|Adverse Event|0|||
125640698|NCT01542632|451965109|FG004|Overall Study|Adverse Event|0|||
125640699|NCT01542632|451965110|FG005|Overall Study|Adverse Event|0|||
125640700|NCT01542632|451965105|FG000|Overall Study|Lost to Follow-up|0|||
125640701|NCT01542632|451965106|FG001|Overall Study|Lost to Follow-up|1|||
125640702|NCT01542632|451965107|FG002|Overall Study|Lost to Follow-up|0|||
125640703|NCT01542632|451965108|FG003|Overall Study|Lost to Follow-up|0|||
125640704|NCT01542632|451965109|FG004|Overall Study|Lost to Follow-up|0|||
125640705|NCT01542632|451965110|FG005|Overall Study|Lost to Follow-up|0|||
125133649|NCT03733444|450113815|FG001|Overall Study|Withdrawal by Subject|18|||
125133650|NCT03733444|450113816|FG002|Overall Study|Withdrawal by Subject|16|||
125133651|NCT03733444|450113814|FG000|Overall Study|Miscellaneous|1|||
125133652|NCT03733444|450113815|FG001|Overall Study|Miscellaneous|0|||
125133653|NCT03733444|450113816|FG002|Overall Study|Miscellaneous|1|||
125640706|NCT01542632|451965105|FG000|Overall Study|Sponsor/Investigator Decision|0|||
125640707|NCT01542632|451965106|FG001|Overall Study|Sponsor/Investigator Decision|0|||
125640708|NCT01542632|451965107|FG002|Overall Study|Sponsor/Investigator Decision|0|||
125380287|NCT00293254|451025132|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
125380288|NCT00293254|451025133|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
125380289|NCT00293254|451025132|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
125380290|NCT00293254|451025133|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
125380291|NCT00293254|451025132|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
125380292|NCT00293254|451025133|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
125380293|NCT00293254|451025132|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
125380294|NCT00293254|451025133|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
125380295|NCT00293254|451025132|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
125380296|NCT00293254|451025133|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
125380297|NCT00293254|451025132|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
125380298|NCT00293254|451025133|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
125380299|NCT00293254|451025132|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
125380300|NCT00293254|451025133|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
125380301|NCT00293254|451025132|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
125380302|NCT00293254|451025133|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
125380303|NCT00293254|451025132|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
125380304|NCT00293254|451025133|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
125380305|NCT00293254|451025132|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
125380306|NCT00293254|451025133|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
125380307|NCT00293254|451025132|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
125380308|NCT00293254|451025133|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
125380309|NCT00293254|451025132|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
125380310|NCT00293254|451025133|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
125380311|NCT00293254|451025132|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
125380312|NCT00293254|451025133|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
125640709|NCT01542632|451965108|FG003|Overall Study|Sponsor/Investigator Decision|0|||
125640710|NCT01542632|451965109|FG004|Overall Study|Sponsor/Investigator Decision|1|||
125640711|NCT01542632|451965110|FG005|Overall Study|Sponsor/Investigator Decision|0|||
125640712|NCT00033514|451965111|FG000|Overall Study|Lost to Follow-up|1|||
125640713|NCT00033514|451965112|FG001|Overall Study|Lost to Follow-up|1|||
125640714|NCT00033514|451965111|FG000|Overall Study|Withdrawal by Subject|0|||
125640715|NCT00033514|451965112|FG001|Overall Study|Withdrawal by Subject|3|||
125640716|NCT01108263|451965118|FG000|Overall Study|Adverse Event|0|||
125640717|NCT01108263|451965119|FG001|Overall Study|Adverse Event|1|||
125640718|NCT01685372|451965120|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
125640719|NCT01685372|451965121|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
125640720|NCT01072500|451965122|FG000|Overall Study|Death|2|||
125640721|NCT01072500|451965123|FG001|Overall Study|Death|2|||
125640722|NCT01072500|451965122|FG000|Overall Study|Lost to Follow-up|5|||
125640723|NCT01072500|451965123|FG001|Overall Study|Lost to Follow-up|2|||
125640724|NCT01072500|451965122|FG000|Overall Study|Withdrawal by Subject|17|||
125640725|NCT01072500|451965123|FG001|Overall Study|Withdrawal by Subject|10|||
125640726|NCT00829010|451965124|FG000|Overall Study|Adverse Event|1|||
125640727|NCT00829010|451965125|FG001|Overall Study|Adverse Event|0|||
125640728|NCT00829010|451965126|FG002|Overall Study|Adverse Event|0|||
125640729|NCT00829010|451965127|FG003|Overall Study|Adverse Event|0|||
125640730|NCT00829010|451965128|FG004|Overall Study|Adverse Event|0|||
125640731|NCT00829010|451965124|FG000|Overall Study|Withdrawal by Subject|0|||
125640732|NCT00829010|451965125|FG001|Overall Study|Withdrawal by Subject|1|||
125640733|NCT00829010|451965126|FG002|Overall Study|Withdrawal by Subject|1|||
125640734|NCT00829010|451965127|FG003|Overall Study|Withdrawal by Subject|0|||
125640735|NCT00829010|451965128|FG004|Overall Study|Withdrawal by Subject|2|||
125640736|NCT00829010|451965124|FG000|Overall Study|Lost to Follow-up|1|||
125640737|NCT00829010|451965125|FG001|Overall Study|Lost to Follow-up|0|||
125640738|NCT00829010|451965126|FG002|Overall Study|Lost to Follow-up|2|||
125640739|NCT00829010|451965127|FG003|Overall Study|Lost to Follow-up|0|||
125640740|NCT00829010|451965128|FG004|Overall Study|Lost to Follow-up|0|||
125640741|NCT00829010|451965124|FG000|Overall Study|Fatality|5|||
125640742|NCT00829010|451965125|FG001|Overall Study|Fatality|4|||
125640743|NCT00829010|451965126|FG002|Overall Study|Fatality|0|||
125640744|NCT00829010|451965127|FG003|Overall Study|Fatality|3|||
125640745|NCT00829010|451965128|FG004|Overall Study|Fatality|0|||
125640746|NCT00829010|451965124|FG000|Overall Study|Migrated/Moved from study area|3|||
125640747|NCT00829010|451965125|FG001|Overall Study|Migrated/Moved from study area|4|||
125437109|NCT00152763|451227989|FG001|Overall Study|Lost to Follow-up|4|||
125640748|NCT00829010|451965126|FG002|Overall Study|Migrated/Moved from study area|0|||
125640749|NCT00829010|451965127|FG003|Overall Study|Migrated/Moved from study area|5|||
125640750|NCT00829010|451965128|FG004|Overall Study|Migrated/Moved from study area|0|||
125640751|NCT02061540|451965129|FG000|Overall Study|Adverse Event|2|||
125640752|NCT02061540|451965129|FG000|Overall Study|Withdrawal by Subject|2|||
125640753|NCT02289833|451965130|FG000|Overall Study|Study discontinuation|0|||
125380313|NCT00293254|451025132|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
125380314|NCT00293254|451025133|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
125380315|NCT00293254|451025132|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
125380316|NCT00293254|451025133|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
125380317|NCT00293254|451025132|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
125380318|NCT00293254|451025133|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
125380319|NCT00293254|451025132|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
125380320|NCT00293254|451025133|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
125380321|NCT02335489|451025134|FG000|Overall Study|Sponsor terminated study|4|||
125640754|NCT02289833|451965131|FG001|Overall Study|Study discontinuation|1|||
125640755|NCT02289833|451965130|FG000|Overall Study|Lost to Follow-up|4|||
125640756|NCT02289833|451965131|FG001|Overall Study|Lost to Follow-up|0|||
125640757|NCT02289833|451965130|FG000|Overall Study|Death|23|||
125640758|NCT02289833|451965131|FG001|Overall Study|Death|16|||
125640759|NCT01642004|451965132|FG000|Randomization|Adverse Event unrelated to study drug|1|||
125640760|NCT01642004|451965133|FG001|Randomization|Adverse Event unrelated to study drug|0|||
125640761|NCT01642004|451965132|FG000|Randomization|Participant withdrew consent|1|||
125640762|NCT01642004|451965133|FG001|Randomization|Participant withdrew consent|6|||
125640763|NCT01642004|451965132|FG000|Randomization|No longer meets study criteria|2|||
125640764|NCT01642004|451965133|FG001|Randomization|No longer meets study criteria|2|||
125640765|NCT01642004|451965132|FG000|Treatment|Disease progression|95|||
125640766|NCT01642004|451965133|FG001|Treatment|Disease progression|79|||
125640767|NCT01642004|451965132|FG000|Treatment|Study drug toxicity|10|||
125640768|NCT01642004|451965133|FG001|Treatment|Study drug toxicity|13|||
125640769|NCT01642004|451965132|FG000|Treatment|Death|1|||
125640770|NCT01642004|451965133|FG001|Treatment|Death|1|||
125640771|NCT01642004|451965132|FG000|Treatment|Adverse event unrelated to study drug|9|||
125640772|NCT01642004|451965133|FG001|Treatment|Adverse event unrelated to study drug|13|||
125640773|NCT01642004|451965132|FG000|Treatment|Maximum clinical benefit|1|||
125640774|NCT01642004|451965133|FG001|Treatment|Maximum clinical benefit|9|||
125640775|NCT01642004|451965132|FG000|Treatment|Poor/non-compliance|1|||
125640776|NCT01642004|451965133|FG001|Treatment|Poor/non-compliance|0|||
125640777|NCT01642004|451965132|FG000|Treatment|No longer meets study criteria|1|||
125640778|NCT01642004|451965133|FG001|Treatment|No longer meets study criteria|2|||
125640779|NCT01642004|451965132|FG000|Treatment|Other reasons|2|||
125640780|NCT01642004|451965133|FG001|Treatment|Other reasons|0|||
125640781|NCT01642004|451965132|FG000|Treatment|Not reported|0|||
125640782|NCT01642004|451965133|FG001|Treatment|Not reported|3|||
125640783|NCT01642004|451965132|FG000|Treatment|Participant request to discontinue study treatment|6|||
125640784|NCT01642004|451965133|FG001|Treatment|Participant request to discontinue study treatment|4|||
125640785|NCT01642004|451965132|FG000|Treatment|Participant withdrew consent|5|||
125640786|NCT01642004|451965133|FG001|Treatment|Participant withdrew consent|5|||
125640787|NCT00811395|451965136|FG000|Extension Treatment|Adverse Event|1|||
125640788|NCT00811395|451965137|FG001|Extension Treatment|Adverse Event|2|||
125640789|NCT00811395|451965138|FG002|Extension Treatment|Adverse Event|2|||
125640790|NCT00811395|451965139|FG003|Extension Treatment|Adverse Event|2|||
125640791|NCT00811395|451965140|FG004|Extension Treatment|Adverse Event|0|||
125640792|NCT00811395|451965141|FG005|Extension Treatment|Adverse Event|1|||
125640793|NCT00811395|451965136|FG000|Extension Treatment|Progressive disease|1|||
125640794|NCT00811395|451965137|FG001|Extension Treatment|Progressive disease|1|||
125640795|NCT00811395|451965138|FG002|Extension Treatment|Progressive disease|0|||
125640796|NCT00811395|451965139|FG003|Extension Treatment|Progressive disease|0|||
125640797|NCT00811395|451965140|FG004|Extension Treatment|Progressive disease|0|||
125640798|NCT00811395|451965141|FG005|Extension Treatment|Progressive disease|0|||
125640799|NCT00811395|451965136|FG000|Extension Treatment|Participant did not wish to continue|0|||
125640800|NCT00811395|451965137|FG001|Extension Treatment|Participant did not wish to continue|3|||
125640801|NCT00811395|451965138|FG002|Extension Treatment|Participant did not wish to continue|0|||
125640802|NCT00811395|451965139|FG003|Extension Treatment|Participant did not wish to continue|1|||
125640803|NCT00811395|451965140|FG004|Extension Treatment|Participant did not wish to continue|0|||
125640804|NCT00811395|451965141|FG005|Extension Treatment|Participant did not wish to continue|1|||
125640805|NCT00811395|451965136|FG000|Extension Treatment|Other than above|0|||
125640806|NCT00811395|451965137|FG001|Extension Treatment|Other than above|0|||
125640807|NCT00811395|451965138|FG002|Extension Treatment|Other than above|1|||
125640808|NCT00811395|451965139|FG003|Extension Treatment|Other than above|0|||
125380322|NCT02335489|451025134|FG000|Overall Study|Lost to Follow-up|1|||
125640809|NCT00811395|451965140|FG004|Extension Treatment|Other than above|0|||
125640810|NCT00811395|451965141|FG005|Extension Treatment|Other than above|0|||
125640811|NCT02607865|451965144|FG000|Overall Study|Lost to Follow-up|9|||
125640812|NCT02607865|451965145|FG001|Overall Study|Lost to Follow-up|7|||
125640813|NCT02607865|451965146|FG002|Overall Study|Lost to Follow-up|7|||
125640814|NCT02607865|451965147|FG003|Overall Study|Lost to Follow-up|5|||
125640815|NCT02607865|451965144|FG000|Overall Study|Withdrawal by Subject|18|||
125640816|NCT02607865|451965145|FG001|Overall Study|Withdrawal by Subject|18|||
125640817|NCT02607865|451965146|FG002|Overall Study|Withdrawal by Subject|17|||
125640818|NCT02607865|451965147|FG003|Overall Study|Withdrawal by Subject|8|||
125640819|NCT02607865|451965144|FG000|Overall Study|Death|5|||
125640820|NCT02607865|451965145|FG001|Overall Study|Death|4|||
125640821|NCT02607865|451965146|FG002|Overall Study|Death|1|||
125133654|NCT03733444|450113814|FG000|Overall Study|Not Treated|1|||
125133655|NCT03733444|450113815|FG001|Overall Study|Not Treated|2|||
125133656|NCT03733444|450113816|FG002|Overall Study|Not Treated|1|||
125133657|NCT01788423|450113817|FG000|Overall Study|See Comments in Completed (above)|0|||
125133658|NCT01788423|450113818|FG001|Overall Study|See Comments in Completed (above)|4|||
125133659|NCT01788423|450113819|FG002|Overall Study|See Comments in Completed (above)|5|||
125133660|NCT03637764|450113820|FG000|Overall Study|Adverse Event|2|||
125133661|NCT03637764|450113821|FG001|Overall Study|Adverse Event|0|||
125133662|NCT03637764|450113822|FG002|Overall Study|Adverse Event|0|||
125133663|NCT03637764|450113823|FG003|Overall Study|Adverse Event|1|||
125133664|NCT03637764|450113820|FG000|Overall Study|Progressive Disease|23|||
125133665|NCT03637764|450113821|FG001|Overall Study|Progressive Disease|23|||
125133666|NCT03637764|450113822|FG002|Overall Study|Progressive Disease|18|||
125133667|NCT03637764|450113823|FG003|Overall Study|Progressive Disease|31|||
125133668|NCT03637764|450113820|FG000|Overall Study|Withdrawal by Subject|1|||
125133669|NCT03637764|450113821|FG001|Overall Study|Withdrawal by Subject|3|||
125133670|NCT03637764|450113822|FG002|Overall Study|Withdrawal by Subject|0|||
125133671|NCT03637764|450113823|FG003|Overall Study|Withdrawal by Subject|1|||
125133672|NCT02760927|450113824|FG000|Overall Study|Tube Slippage from Device|1|||
125133673|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
125380323|NCT02335489|451025134|FG000|Overall Study|Withdrawal by Subject|2|||
125380324|NCT02335489|451025134|FG000|Overall Study|Physician Decision|2|||
125380325|NCT02335489|451025134|FG000|Overall Study|Lack of Efficacy|1|||
125380326|NCT00759863|451025135|FG000|Overall Study|Death, moved, or lost contact|20|||
125133674|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
125133675|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
125133676|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
125218429|NCT02457195|450427331|FG000|Overall Study|Withdrawal by Subject|4|||
125380327|NCT00759863|451025136|FG001|Overall Study|Death, moved, or lost contact|18|||
125133677|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
125133678|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
125133679|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
125133680|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
125133681|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
125133682|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
125133683|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
125133684|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
125133685|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
125640822|NCT02607865|451965147|FG003|Overall Study|Death|3|||
125640823|NCT02607865|451965144|FG000|Overall Study|Unclassified|1|||
125640824|NCT02607865|451965145|FG001|Overall Study|Unclassified|1|||
125640825|NCT02607865|451965146|FG002|Overall Study|Unclassified|2|||
125640826|NCT02607865|451965147|FG003|Overall Study|Unclassified|0|||
125640827|NCT00528840|451965148|FG000|Overall Study|Lost to Follow-up|10|||
125640828|NCT00528840|451965148|FG000|Overall Study|Adverse Event|1|||
125640829|NCT00528840|451965148|FG000|Overall Study|Withdrawal by Subject|17|||
125640830|NCT00528840|451965148|FG000|Overall Study|Death|2|||
125640831|NCT00528840|451965148|FG000|Overall Study|Administrative Reasons|1|||
125640832|NCT00528840|451965148|FG000|Overall Study|Other|2|||
125640833|NCT02447952|451965149|FG000|Overall Study|Adverse Event|2|||
125640834|NCT02447952|451965149|FG000|Overall Study|Physician Decision|1|||
125640835|NCT02447952|451965149|FG000|Overall Study|Withdrawal by Subject|4|||
125640836|NCT01766401|451965154|FG000|Overall Study|Adverse Event|7|||
125640837|NCT01766401|451965155|FG001|Overall Study|Adverse Event|22|||
125640838|NCT01766401|451965154|FG000|Overall Study|Lack of Efficacy|1|||
125640839|NCT01766401|451965155|FG001|Overall Study|Lack of Efficacy|2|||
125640840|NCT01766401|451965154|FG000|Overall Study|Protocol Violation|3|||
125640841|NCT01766401|451965155|FG001|Overall Study|Protocol Violation|8|||
125640842|NCT01766401|451965154|FG000|Overall Study|Withdrawal by Subject|15|||
125640843|NCT01766401|451965155|FG001|Overall Study|Withdrawal by Subject|12|||
125133686|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
125133687|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
125133688|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
125133689|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
125133690|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
125133691|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
125133692|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
125133693|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Death|0|||
125133694|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Death|1|||
125133695|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Death|0|||
125133696|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Death|0|||
125133697|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
125133698|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
125133699|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
125133700|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
125133701|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
125133702|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
125133703|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
125133704|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
125133705|NCT01940341|450113828|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
125133706|NCT01940341|450113829|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
125133707|NCT01940341|450113830|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
125133708|NCT01940341|450113831|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
125133709|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
125133710|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
125133711|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
125133712|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
125133713|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
125133714|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
125133715|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
125133716|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
125133717|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
125133718|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
125218430|NCT01896193|450427333|FG000|Overall Study|Lack of Efficacy|20|||
125640844|NCT01766401|451965154|FG000|Overall Study|Lost to Follow-up|10|||
125640845|NCT01766401|451965155|FG001|Overall Study|Lost to Follow-up|11|||
125640846|NCT01766401|451965154|FG000|Overall Study|Pregnancy|1|||
125640847|NCT01766401|451965155|FG001|Overall Study|Pregnancy|1|||
125640848|NCT00398086|451965159|FG000|Overall Study|Unacceptable Toxicity|2|||
125640849|NCT00398086|451965160|FG001|Overall Study|Unacceptable Toxicity|8|||
125380328|NCT00503308|451025140|FG000|Overall Study|Protocol Violation|2|||
125380329|NCT00503308|451025141|FG001|Overall Study|Protocol Violation|1|||
125380330|NCT00311623|451025146|FG000|Overall Study|Physician Decision|0|||
125437110|NCT00152763|451227990|FG002|Overall Study|Lost to Follow-up|2|||
125437111|NCT00152763|451227991|FG003|Overall Study|Lost to Follow-up|13|||
125437112|NCT00569803|451227992|FG000|Overall Study|Lost to Follow-up|1|||
125437113|NCT00569803|451227993|FG001|Overall Study|Lost to Follow-up|0|||
125640850|NCT00398086|451965161|FG002|Overall Study|Unacceptable Toxicity|2|||
125640851|NCT00398086|451965159|FG000|Overall Study|Adverse Event|1|||
125640852|NCT00398086|451965160|FG001|Overall Study|Adverse Event|4|||
125640853|NCT00398086|451965161|FG002|Overall Study|Adverse Event|0|||
125640854|NCT00398086|451965159|FG000|Overall Study|Physician Decision|1|||
125640855|NCT00398086|451965160|FG001|Overall Study|Physician Decision|4|||
125640856|NCT00398086|451965161|FG002|Overall Study|Physician Decision|0|||
125640857|NCT00398086|451965159|FG000|Overall Study|Withdrawal by Subject|5|||
125640858|NCT00398086|451965160|FG001|Overall Study|Withdrawal by Subject|7|||
125640859|NCT00398086|451965161|FG002|Overall Study|Withdrawal by Subject|0|||
125640860|NCT01950364|451965162|FG000|Overall Study|Adverse Event|3|||
125640861|NCT01950364|451965163|FG001|Overall Study|Adverse Event|0|||
125640862|NCT01950364|451965162|FG000|Overall Study|Stem Cell Transplant|2|||
125640863|NCT01950364|451965163|FG001|Overall Study|Stem Cell Transplant|6|||
125640864|NCT01950364|451965162|FG000|Overall Study|Disease Progression|5|||
125640865|NCT01950364|451965163|FG001|Overall Study|Disease Progression|2|||
125640866|NCT01950364|451965162|FG000|Overall Study|Withdrawal by Subject|0|||
125640867|NCT01950364|451965163|FG001|Overall Study|Withdrawal by Subject|1|||
125640868|NCT01950364|451965162|FG000|Overall Study|Protocol Violation|0|||
125640869|NCT01950364|451965163|FG001|Overall Study|Protocol Violation|1|||
125640870|NCT02463331|451965166|FG000|Overall Study|Adverse Event|4|||
125640871|NCT02463331|451965167|FG001|Overall Study|Adverse Event|2|||
125640872|NCT02463331|451965166|FG000|Overall Study|Lost to Follow-up|1|||
125640873|NCT02463331|451965167|FG001|Overall Study|Lost to Follow-up|1|||
125640874|NCT02463331|451965166|FG000|Overall Study|Pregnancy|2|||
125640875|NCT02463331|451965167|FG001|Overall Study|Pregnancy|3|||
125640876|NCT02463331|451965166|FG000|Overall Study|Lack of Efficacy|6|||
125640877|NCT02463331|451965167|FG001|Overall Study|Lack of Efficacy|0|||
125640878|NCT02463331|451965166|FG000|Overall Study|Physician Decision|3|||
125640879|NCT02463331|451965167|FG001|Overall Study|Physician Decision|0|||
125640880|NCT01166386|451965168|FG000|Overall Study|Withdrawal by Subject|3|||
125640881|NCT01166386|451965169|FG001|Overall Study|Withdrawal by Subject|5|||
125640882|NCT02274766|451965170|FG000|Overall Study|Withdrawal by Subject|3|||
125640883|NCT02274766|451965171|FG001|Overall Study|Withdrawal by Subject|6|||
125640884|NCT02274766|451965170|FG000|Overall Study|Did Not Receive Study Drug|1|||
125640885|NCT02274766|451965171|FG001|Overall Study|Did Not Receive Study Drug|1|||
125640886|NCT02274766|451965170|FG000|Overall Study|Subject Unwilling to Proceed|0|||
125640887|NCT02274766|451965171|FG001|Overall Study|Subject Unwilling to Proceed|1|||
125640888|NCT02274766|451965170|FG000|Overall Study|Adverse Event|0|||
125640889|NCT02274766|451965171|FG001|Overall Study|Adverse Event|1|||
125640890|NCT02691468|451965174|FG000|Overall Study|Bronchial blocker use|2|||
125640891|NCT02691468|451965175|FG001|Overall Study|Bronchial blocker use|1|||
125640892|NCT02691468|451965174|FG000|Overall Study|Lost to Follow-up|2|||
125640893|NCT02691468|451965175|FG001|Overall Study|Lost to Follow-up|1|||
125640894|NCT02691468|451965174|FG000|Overall Study|Failure to advance FOB|2|||
125640895|NCT02691468|451965175|FG001|Overall Study|Failure to advance FOB|0|||
125640896|NCT02972658|451966628|FG000|Overall Study|Adverse Event|0|||
125640897|NCT02972658|451966629|FG001|Overall Study|Adverse Event|3|||
125640898|NCT02972658|451966630|FG002|Overall Study|Adverse Event|0|||
125640899|NCT02972658|451966631|FG003|Overall Study|Adverse Event|2|||
125640900|NCT02972658|451966628|FG000|Overall Study|Other-determined by Investigator|1|||
125640901|NCT02972658|451966629|FG001|Overall Study|Other-determined by Investigator|1|||
125640902|NCT02972658|451966630|FG002|Overall Study|Other-determined by Investigator|0|||
125640903|NCT02972658|451966631|FG003|Overall Study|Other-determined by Investigator|0|||
125640904|NCT02972658|451966628|FG000|Overall Study|Death|0|||
125640905|NCT02972658|451966629|FG001|Overall Study|Death|0|||
125640906|NCT02972658|451966630|FG002|Overall Study|Death|0|||
125640907|NCT02972658|451966631|FG003|Overall Study|Death|1|||
125437114|NCT00569803|451227994|FG002|Overall Study|Lost to Follow-up|0|||
125437115|NCT00569803|451227995|FG003|Overall Study|Lost to Follow-up|0|||
125640908|NCT02972658|451966628|FG000|Overall Study|Lost to Follow-up|0|||
125640909|NCT02972658|451966629|FG001|Overall Study|Lost to Follow-up|1|||
125640910|NCT02972658|451966630|FG002|Overall Study|Lost to Follow-up|1|||
125640911|NCT02972658|451966631|FG003|Overall Study|Lost to Follow-up|2|||
125640912|NCT02972658|451966628|FG000|Overall Study|Progressive Disease|0|||
125640913|NCT02972658|451966629|FG001|Overall Study|Progressive Disease|1|||
125640914|NCT02972658|451966630|FG002|Overall Study|Progressive Disease|0|||
125640915|NCT02972658|451966631|FG003|Overall Study|Progressive Disease|1|||
125640916|NCT02972658|451966628|FG000|Overall Study|Withdrawal by Subject|4|||
125437116|NCT00569803|451227996|FG004|Overall Study|Lost to Follow-up|0|||
125640917|NCT02972658|451966629|FG001|Overall Study|Withdrawal by Subject|4|||
125640918|NCT02972658|451966630|FG002|Overall Study|Withdrawal by Subject|1|||
125640919|NCT02972658|451966631|FG003|Overall Study|Withdrawal by Subject|6|||
125640920|NCT02972658|451966628|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
125218431|NCT01896193|450427334|FG001|Overall Study|Lack of Efficacy|11|||
125218432|NCT01896193|450427333|FG000|Overall Study|Protocol Violation|0|||
125218433|NCT01896193|450427334|FG001|Overall Study|Protocol Violation|1|||
125218434|NCT01896193|450427333|FG000|Overall Study|Withdrew Consent|1|||
125218435|NCT01896193|450427334|FG001|Overall Study|Withdrew Consent|0|||
125218436|NCT02028507|450427335|FG000|Overall Study|Progressive Disease|122|||
125218437|NCT02028507|450427336|FG001|Overall Study|Progressive Disease|90|||
125218438|NCT02028507|450427337|FG002|Overall Study|Progressive Disease|102|||
125218439|NCT02028507|450427338|FG003|Overall Study|Progressive Disease|89|||
125218440|NCT02028507|450427335|FG000|Overall Study|Adverse Event|8|||
125218441|NCT02028507|450427336|FG001|Overall Study|Adverse Event|25|||
125218442|NCT02028507|450427337|FG002|Overall Study|Adverse Event|3|||
125218443|NCT02028507|450427338|FG003|Overall Study|Adverse Event|16|||
125380331|NCT00311623|451025147|FG001|Overall Study|Physician Decision|0|||
125640921|NCT02972658|451966629|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
125640922|NCT02972658|451966630|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
125640923|NCT02972658|451966631|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
125640924|NCT02972658|451966628|FG000|Overall Study|Sponsor Decision|70|||
125640925|NCT02972658|451966629|FG001|Overall Study|Sponsor Decision|127|||
125640926|NCT02972658|451966630|FG002|Overall Study|Sponsor Decision|72|||
125640927|NCT02972658|451966631|FG003|Overall Study|Sponsor Decision|119|||
125640928|NCT03958149|451966632|FG000|Overall Study|Withdrawal by Subject|0|||
125640929|NCT03958149|451966633|FG001|Overall Study|Withdrawal by Subject|1|||
125640930|NCT02785588|451966634|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
125640931|NCT02785588|451966634|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
125640932|NCT02499172|451966636|FG000|Overall Study|Financial reason|0|||
125640933|NCT02499172|451966637|FG001|Overall Study|Financial reason|0|||
125640934|NCT02499172|451966638|FG002|Overall Study|Financial reason|523|||
125640935|NCT02499172|451966639|FG003|Overall Study|Financial reason|436|||
125640936|NCT02499172|451966636|FG000|Overall Study|Lost to Follow-up|65|||
125640937|NCT02499172|451966637|FG001|Overall Study|Lost to Follow-up|64|||
125640938|NCT02499172|451966638|FG002|Overall Study|Lost to Follow-up|0|||
125640939|NCT02499172|451966639|FG003|Overall Study|Lost to Follow-up|0|||
125640940|NCT01293123|451966640|FG000|Overall Study|Lost to Follow-up|0|||
125640941|NCT01293123|451966641|FG001|Overall Study|Lost to Follow-up|1|||
125640942|NCT02710422|451966644|FG000|Overall Study|Termination of study|9|||
125640943|NCT02710422|451966645|FG001|Overall Study|Termination of study|9|||
125640944|NCT01488994|451966652|FG000|Overall Study|Withdrawal by Subject|0|||
125640945|NCT01488994|451966653|FG001|Overall Study|Withdrawal by Subject|1|||
125640946|NCT03798366|451966656|FG000|Overall Study|Lost to Follow-up|0|||
125640947|NCT03798366|451966657|FG001|Overall Study|Lost to Follow-up|1|||
125640948|NCT00474539|451966660|FG000|Infant Series|Withdrawal by Subject|3|||
125640949|NCT00474539|451966661|FG001|Infant Series|Withdrawal by Subject|4|||
125640950|NCT00474539|451966660|FG000|Infant Series|Randomization error|5|||
125640951|NCT00474539|451966661|FG001|Infant Series|Randomization error|0|||
125640952|NCT00474539|451966660|FG000|Infant Series|Lost to Follow-up|2|||
125640953|NCT00474539|451966661|FG001|Infant Series|Lost to Follow-up|1|||
125640954|NCT00474539|451966660|FG000|Infant Series|Protocol Violation|0|||
125640955|NCT00474539|451966661|FG001|Infant Series|Protocol Violation|1|||
125640956|NCT00474539|451966660|FG000|After Infant Series|Lost to Follow-up|3|||
125640957|NCT00474539|451966661|FG001|After Infant Series|Lost to Follow-up|0|||
125640958|NCT00474539|451966660|FG000|After Infant Series|Withdrawal by Subject|1|||
125640959|NCT00474539|451966661|FG001|After Infant Series|Withdrawal by Subject|0|||
125640960|NCT00474539|451966660|FG000|Toddler Dose|Protocol Violation|1|||
125640961|NCT00474539|451966661|FG001|Toddler Dose|Protocol Violation|0|||
125640962|NCT01227252|451966663|FG000|Overall Study|Sponsor Decision|0|||
125640963|NCT01227252|451966664|FG001|Overall Study|Sponsor Decision|1|||
125640964|NCT01227252|451966665|FG002|Overall Study|Sponsor Decision|0|||
125640965|NCT01227252|451966666|FG003|Overall Study|Sponsor Decision|0|||
125640966|NCT01227252|451966663|FG000|Overall Study|Lost to Follow-up|0|||
125640967|NCT01227252|451966664|FG001|Overall Study|Lost to Follow-up|1|||
125380332|NCT00311623|451025148|FG002|Overall Study|Physician Decision|2|||
125640968|NCT01227252|451966665|FG002|Overall Study|Lost to Follow-up|0|||
125218444|NCT02028507|450427335|FG000|Overall Study|Withdrawal by Subject|6|||
125640969|NCT01227252|451966666|FG003|Overall Study|Lost to Follow-up|0|||
125640970|NCT01227252|451966663|FG000|Overall Study|Withdrawal by Subject|0|||
125640971|NCT01227252|451966664|FG001|Overall Study|Withdrawal by Subject|1|||
125640972|NCT01227252|451966665|FG002|Overall Study|Withdrawal by Subject|0|||
125640973|NCT01227252|451966666|FG003|Overall Study|Withdrawal by Subject|0|||
125218445|NCT02028507|450427336|FG001|Overall Study|Withdrawal by Subject|8|||
125218446|NCT02028507|450427337|FG002|Overall Study|Withdrawal by Subject|5|||
125218447|NCT02028507|450427338|FG003|Overall Study|Withdrawal by Subject|9|||
125640974|NCT02561273|451966673|FG000|Overall Study|Protocol Violation|1|||
125640975|NCT02561273|451966674|FG001|Overall Study|Protocol Violation|0|||
125640976|NCT03442595|451966675|FG000|Overall Study|Lost to Follow-up|94|||
125640977|NCT03442595|451966676|FG001|Overall Study|Lost to Follow-up|0|||
125640978|NCT02192190|451966685|FG000|Overall Study|Adverse Event|1|||
125640979|NCT02192190|451966686|FG001|Overall Study|Adverse Event|1|||
125218448|NCT02028507|450427335|FG000|Overall Study|Protocol Violation|2|||
125218449|NCT02028507|450427336|FG001|Overall Study|Protocol Violation|4|||
125218450|NCT02028507|450427337|FG002|Overall Study|Protocol Violation|1|||
125218451|NCT02028507|450427338|FG003|Overall Study|Protocol Violation|3|||
125218452|NCT02028507|450427335|FG000|Overall Study|Physician Decision|0|||
125218453|NCT02028507|450427336|FG001|Overall Study|Physician Decision|4|||
125218454|NCT02028507|450427337|FG002|Overall Study|Physician Decision|0|||
125218455|NCT02028507|450427338|FG003|Overall Study|Physician Decision|0|||
125218456|NCT02028507|450427335|FG000|Overall Study|Death|1|||
125218457|NCT02028507|450427336|FG001|Overall Study|Death|0|||
125218458|NCT02028507|450427337|FG002|Overall Study|Death|1|||
125218459|NCT02028507|450427338|FG003|Overall Study|Death|3|||
125218460|NCT02028507|450427335|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
125218461|NCT02028507|450427336|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
125380333|NCT03998189|451025149|FG000|Overall Study|Lack of Efficacy|0|||
125380334|NCT03998189|451025150|FG001|Overall Study|Lack of Efficacy|1|||
125380335|NCT03227029|451025151|FG000|Overall Study|Child Wheezed (no treatment)|0|||
125640980|NCT02192190|451966687|FG002|Overall Study|Adverse Event|0|||
125640981|NCT02192190|451966688|FG003|Overall Study|Adverse Event|0|||
125640982|NCT02192190|451966689|FG004|Overall Study|Adverse Event|0|||
125640983|NCT02192190|451966690|FG005|Overall Study|Adverse Event|0|||
125640984|NCT02192190|451966685|FG000|Overall Study|Lost to Follow-up|3|||
125640985|NCT02192190|451966686|FG001|Overall Study|Lost to Follow-up|3|||
125640986|NCT02192190|451966687|FG002|Overall Study|Lost to Follow-up|2|||
125640987|NCT02192190|451966688|FG003|Overall Study|Lost to Follow-up|1|||
125640988|NCT02192190|451966689|FG004|Overall Study|Lost to Follow-up|4|||
125640989|NCT02192190|451966690|FG005|Overall Study|Lost to Follow-up|3|||
125640990|NCT02192190|451966685|FG000|Overall Study|Physician Decision|2|||
125640991|NCT02192190|451966686|FG001|Overall Study|Physician Decision|0|||
125640992|NCT02192190|451966687|FG002|Overall Study|Physician Decision|0|||
125640993|NCT02192190|451966688|FG003|Overall Study|Physician Decision|0|||
125640994|NCT02192190|451966689|FG004|Overall Study|Physician Decision|0|||
125640995|NCT02192190|451966690|FG005|Overall Study|Physician Decision|0|||
125640996|NCT02192190|451966685|FG000|Overall Study|Terminated by Sponsor|43|||
125640997|NCT02192190|451966686|FG001|Overall Study|Terminated by Sponsor|23|||
125640998|NCT02192190|451966687|FG002|Overall Study|Terminated by Sponsor|20|||
125640999|NCT02192190|451966688|FG003|Overall Study|Terminated by Sponsor|23|||
125641000|NCT02192190|451966689|FG004|Overall Study|Terminated by Sponsor|21|||
125641001|NCT02192190|451966690|FG005|Overall Study|Terminated by Sponsor|23|||
125641002|NCT02192190|451966685|FG000|Overall Study|Withdrawal by Subject|4|||
125641003|NCT02192190|451966686|FG001|Overall Study|Withdrawal by Subject|1|||
125641004|NCT02192190|451966687|FG002|Overall Study|Withdrawal by Subject|2|||
125641005|NCT02192190|451966688|FG003|Overall Study|Withdrawal by Subject|1|||
125641006|NCT02192190|451966689|FG004|Overall Study|Withdrawal by Subject|5|||
125641007|NCT02192190|451966690|FG005|Overall Study|Withdrawal by Subject|3|||
125641008|NCT02192190|451966685|FG000|Overall Study|Could not Keep Visit Schedule|1|||
125641009|NCT02192190|451966686|FG001|Overall Study|Could not Keep Visit Schedule|0|||
125641010|NCT02192190|451966687|FG002|Overall Study|Could not Keep Visit Schedule|0|||
125641011|NCT02192190|451966688|FG003|Overall Study|Could not Keep Visit Schedule|0|||
125641012|NCT02192190|451966689|FG004|Overall Study|Could not Keep Visit Schedule|0|||
125641013|NCT02192190|451966690|FG005|Overall Study|Could not Keep Visit Schedule|0|||
125641014|NCT02192190|451966685|FG000|Overall Study|Positive Drug Screen|0|||
125641015|NCT02192190|451966686|FG001|Overall Study|Positive Drug Screen|0|||
125641016|NCT02192190|451966687|FG002|Overall Study|Positive Drug Screen|0|||
125641017|NCT02192190|451966688|FG003|Overall Study|Positive Drug Screen|1|||
125641018|NCT02192190|451966689|FG004|Overall Study|Positive Drug Screen|0|||
125641019|NCT02192190|451966690|FG005|Overall Study|Positive Drug Screen|0|||
125641020|NCT02192190|451966685|FG000|Overall Study|Inadequate Pain Relief|0|||
125641021|NCT02192190|451966686|FG001|Overall Study|Inadequate Pain Relief|1|||
125641022|NCT02192190|451966687|FG002|Overall Study|Inadequate Pain Relief|1|||
125641023|NCT02192190|451966688|FG003|Overall Study|Inadequate Pain Relief|0|||
125641024|NCT02192190|451966689|FG004|Overall Study|Inadequate Pain Relief|0|||
125641025|NCT02192190|451966690|FG005|Overall Study|Inadequate Pain Relief|0|||
125641026|NCT03227692|451966691|FG000|Overall Study|Protocol Violation|1|||
125218462|NCT02028507|450427337|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
125380336|NCT03227029|451025152|FG001|Overall Study|Child Wheezed (no treatment)|1|||
125641027|NCT03227692|451966692|FG001|Overall Study|Protocol Violation|1|||
125641028|NCT03227692|451966691|FG000|Overall Study|Lost to Follow-up|4|||
125641029|NCT03227692|451966692|FG001|Overall Study|Lost to Follow-up|2|||
125641030|NCT03227692|451966691|FG000|Overall Study|Adverse Event|0|||
125641031|NCT03227692|451966692|FG001|Overall Study|Adverse Event|2|||
125641032|NCT01657253|451966693|FG000|Overall Study|Lost to Follow-up|6|||
125218463|NCT02028507|450427338|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
125641033|NCT01657253|451966694|FG001|Overall Study|Lost to Follow-up|5|||
125641034|NCT01657253|451966693|FG000|Overall Study|Withdrawal by Subject|11|||
125641035|NCT01657253|451966694|FG001|Overall Study|Withdrawal by Subject|12|||
125641036|NCT01657253|451966693|FG000|Overall Study|Adverse Event|0|||
125133719|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
125133720|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
125133721|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
125133722|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
125133723|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
125133724|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
125133725|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
125133726|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
125133727|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
125133728|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
125133729|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
125133730|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
125133731|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
125133732|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
125133733|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
125133734|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
125133735|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
125133736|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
125133737|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
125133738|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
125133739|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
125133740|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
125133741|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
125133742|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
125133743|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
125133744|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
125133745|NCT01940341|450113828|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
125133746|NCT01940341|450113829|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
125133747|NCT01940341|450113830|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
125133748|NCT01940341|450113831|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
125133749|NCT00841698|450113836|FG000|First Intervention|Withdrawal by Subject|1|||
125133750|NCT00841698|450113837|FG001|First Intervention|Withdrawal by Subject|0|||
125133751|NCT00185458|450113838|FG000|Contraception Phase|Adverse Event|37|||
125133752|NCT00185458|450113838|FG000|Contraception Phase|Lost to Follow-up|10|||
125133753|NCT00185458|450113838|FG000|Contraception Phase|Protocol Violation|2|||
125133754|NCT00185458|450113838|FG000|Contraception Phase|Physician Decision|2|||
125133755|NCT00185458|450113838|FG000|Contraception Phase|Withdrawal by Subject|7|||
125133756|NCT00185458|450113838|FG000|HRT Phase|Adverse Event|18|||
125133757|NCT00185458|450113838|FG000|HRT Phase|Lost to Follow-up|4|||
125133758|NCT00185458|450113838|FG000|HRT Phase|Protocol Violation|2|||
125133759|NCT00185458|450113838|FG000|HRT Phase|Withdrawal by Subject|3|||
125133760|NCT00251979|450113839|FG000|Overall Study|Protocol Violation|3|||
125133761|NCT00251979|450113840|FG001|Overall Study|Protocol Violation|5|||
125133762|NCT00251979|450113839|FG000|Overall Study|Adverse Event|11|||
125133763|NCT00251979|450113840|FG001|Overall Study|Adverse Event|17|||
125133764|NCT00251979|450113839|FG000|Overall Study|Withdrawal by Subject|13|||
125133765|NCT00251979|450113840|FG001|Overall Study|Withdrawal by Subject|7|||
125133766|NCT00251979|450113839|FG000|Overall Study|Lost to Follow-up|8|||
125133767|NCT00251979|450113840|FG001|Overall Study|Lost to Follow-up|6|||
125133768|NCT00251979|450113839|FG000|Overall Study|Death|3|||
125133769|NCT00251979|450113840|FG001|Overall Study|Death|5|||
125133770|NCT01576042|450113841|FG000|Overall Study|Physician Decision|2|||
125133771|NCT01576042|450113842|FG001|Overall Study|Physician Decision|0|||
125133772|NCT00835536|450113849|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
125437117|NCT00569803|451227997|FG005|Overall Study|Lost to Follow-up|0|||
125437118|NCT00569803|451227998|FG006|Overall Study|Lost to Follow-up|0|||
125133773|NCT00835536|450113850|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
125437119|NCT00569803|451227999|FG007|Overall Study|Lost to Follow-up|0|||
125641037|NCT01657253|451966694|FG001|Overall Study|Adverse Event|1|||
125641038|NCT01970540|451966697|FG000|Overall Study|Non-treatment-related AE|0|||
125641039|NCT01970540|451966698|FG001|Overall Study|Non-treatment-related AE|0|||
125641040|NCT01970540|451966699|FG002|Overall Study|Non-treatment-related AE|1|||
125641041|NCT01970540|451966697|FG000|Overall Study|Progressive disease|55|||
125641042|NCT01970540|451966698|FG001|Overall Study|Progressive disease|23|||
125641043|NCT01970540|451966699|FG002|Overall Study|Progressive disease|10|||
125641044|NCT01970540|451966697|FG000|Overall Study|Treatment delay over protocol|0|||
125641045|NCT01970540|451966698|FG001|Overall Study|Treatment delay over protocol|0|||
125641046|NCT01970540|451966699|FG002|Overall Study|Treatment delay over protocol|1|||
125641047|NCT01970540|451966697|FG000|Overall Study|Physician Decision|7|||
125641048|NCT01970540|451966698|FG001|Overall Study|Physician Decision|2|||
125641049|NCT01970540|451966699|FG002|Overall Study|Physician Decision|0|||
125641050|NCT01970540|451966697|FG000|Overall Study|Clinical progression|0|||
125641051|NCT01970540|451966698|FG001|Overall Study|Clinical progression|1|||
125641052|NCT01970540|451966699|FG002|Overall Study|Clinical progression|1|||
125641053|NCT01970540|451966697|FG000|Overall Study|End of study|2|||
125641054|NCT01970540|451966698|FG001|Overall Study|End of study|0|||
125641055|NCT01970540|451966699|FG002|Overall Study|End of study|2|||
125641056|NCT01970540|451966697|FG000|Overall Study|Adverse Event|0|||
125641057|NCT01970540|451966698|FG001|Overall Study|Adverse Event|2|||
125641058|NCT01970540|451966699|FG002|Overall Study|Adverse Event|1|||
125641059|NCT01970540|451966697|FG000|Overall Study|Treatment-related AE|4|||
125641060|NCT01970540|451966698|FG001|Overall Study|Treatment-related AE|0|||
125641061|NCT01970540|451966699|FG002|Overall Study|Treatment-related AE|2|||
125641062|NCT01970540|451966697|FG000|Overall Study|Withdrawal by Subject|4|||
125641063|NCT01970540|451966698|FG001|Overall Study|Withdrawal by Subject|0|||
125641064|NCT01970540|451966699|FG002|Overall Study|Withdrawal by Subject|1|||
125641065|NCT01970540|451966697|FG000|Overall Study|Clinical deterioration|1|||
125641066|NCT01970540|451966698|FG001|Overall Study|Clinical deterioration|0|||
125380337|NCT03227029|451025153|FG002|Overall Study|Child Wheezed (no treatment)|0|||
125380338|NCT03227029|451025151|FG000|Overall Study|No post RSV season visit due to COVID|3|||
125380339|NCT03227029|451025152|FG001|Overall Study|No post RSV season visit due to COVID|3|||
125380340|NCT03227029|451025153|FG002|Overall Study|No post RSV season visit due to COVID|2|||
125641067|NCT01970540|451966699|FG002|Overall Study|Clinical deterioration|0|||
125641068|NCT01603628|451966700|FG000|Overall Study|Personal Reasons|1|||
125641069|NCT01603628|451966701|FG001|Overall Study|Personal Reasons|1|||
125641070|NCT01603628|451966702|FG002|Overall Study|Personal Reasons|2|||
125641071|NCT01603628|451966700|FG000|Overall Study|Protocol Violation|1|||
125641072|NCT01603628|451966701|FG001|Overall Study|Protocol Violation|1|||
125641073|NCT01603628|451966702|FG002|Overall Study|Protocol Violation|0|||
125133774|NCT03173547|450113851|FG000|Overall Study|Adverse Event|2|||
125133775|NCT03173547|450113852|FG001|Overall Study|Adverse Event|0|||
125133776|NCT03173547|450113851|FG000|Overall Study|Withdrawal by Subject|2|||
125133777|NCT03173547|450113852|FG001|Overall Study|Withdrawal by Subject|2|||
125133778|NCT00657553|450113853|FG000|Overall Study|low accrual, no analysis run|5|||
125133779|NCT00657553|450113854|FG001|Overall Study|low accrual, no analysis run|5|||
125133780|NCT00446563|450113855|FG000|Overall Study|Adverse Event|4|||
125133781|NCT00446563|450113856|FG001|Overall Study|Adverse Event|3|||
125133782|NCT00446563|450113855|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125133783|NCT00446563|450113856|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125133784|NCT00446563|450113855|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125133785|NCT00446563|450113856|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125133786|NCT00446563|450113855|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125133787|NCT00446563|450113856|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125133788|NCT00446563|450113855|FG000|Overall Study|Withdrawal by Subject|2|||
125133789|NCT00446563|450113856|FG001|Overall Study|Withdrawal by Subject|1|||
125133790|NCT00446563|450113855|FG000|Overall Study|Administrative problems|0|||
125133791|NCT00446563|450113856|FG001|Overall Study|Administrative problems|1|||
125133792|NCT03769025|450113857|FG000|Overall Study|Withdrawal by Subject|1|||
125133793|NCT03769025|450113858|FG001|Overall Study|Withdrawal by Subject|1|||
125133794|NCT03769025|450113857|FG000|Overall Study|Lost to Follow-up|4|||
125133795|NCT03769025|450113858|FG001|Overall Study|Lost to Follow-up|3|||
125133796|NCT01169558|450113859|FG000|Overall Study|Disease progression|98|||
125133797|NCT01169558|450113859|FG000|Overall Study|Adverse Event|25|||
125133798|NCT01169558|450113859|FG000|Overall Study|Withdrawal of Consent|8|||
125133799|NCT01169558|450113859|FG000|Overall Study|Medical Decision|7|||
125133800|NCT01169558|450113859|FG000|Overall Study|Stable Disease|4|||
125133801|NCT01169558|450113859|FG000|Overall Study|Lost to Follow-up|4|||
125641074|NCT01603628|451966700|FG000|Overall Study|Lost to Follow-up|0|||
125641075|NCT01603628|451966701|FG001|Overall Study|Lost to Follow-up|1|||
125641076|NCT01603628|451966702|FG002|Overall Study|Lost to Follow-up|0|||
125641077|NCT01603628|451966700|FG000|Overall Study|Other Miscellaneous Reason|1|||
125641078|NCT01603628|451966701|FG001|Overall Study|Other Miscellaneous Reason|0|||
125641079|NCT01603628|451966702|FG002|Overall Study|Other Miscellaneous Reason|0|||
125641080|NCT00952588|451966704|FG000|Overall Study|Death|28|||
125641081|NCT00952588|451966705|FG001|Overall Study|Death|13|||
125641082|NCT00952588|451966704|FG000|Overall Study|Withdrawal by Subject|2|||
125641083|NCT00952588|451966705|FG001|Overall Study|Withdrawal by Subject|5|||
125641084|NCT00952588|451966704|FG000|Overall Study|Adverse Event|2|||
125641085|NCT00952588|451966705|FG001|Overall Study|Adverse Event|3|||
125641086|NCT00952588|451966704|FG000|Overall Study|Lost to Follow-up|2|||
125641087|NCT00952588|451966705|FG001|Overall Study|Lost to Follow-up|0|||
125641088|NCT00952588|451966704|FG000|Overall Study|Physician Decision|0|||
125641089|NCT00952588|451966705|FG001|Overall Study|Physician Decision|1|||
125641090|NCT00952588|451966704|FG000|Overall Study|Lack of Efficacy|2|||
125641091|NCT00952588|451966705|FG001|Overall Study|Lack of Efficacy|2|||
125641092|NCT01796106|451966706|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
125641093|NCT01796106|451966707|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
125641094|NCT02795182|451966708|FG000|Overall Study|Death|5|||
125641095|NCT02795182|451966709|FG001|Overall Study|Death|4|||
125641096|NCT02795182|451966710|FG002|Overall Study|Death|4|||
125641097|NCT02795182|451966711|FG003|Overall Study|Death|18|||
125641098|NCT02795182|451966708|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
125641099|NCT02795182|451966709|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
125641100|NCT02795182|451966710|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
125641101|NCT02795182|451966711|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
125641102|NCT02795182|451966708|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
125641103|NCT02795182|451966709|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
125133802|NCT01169558|450113859|FG000|Overall Study|Need for Surgery|4|||
125133803|NCT01169558|450113859|FG000|Overall Study|Non-compliance|2|||
125133804|NCT01169558|450113859|FG000|Overall Study|Protocol Violation|2|||
125133805|NCT01169558|450113859|FG000|Overall Study|Partial response|2|||
125133806|NCT02409355|450113865|FG000|Overall Study|Withdrawal by Subject|1|||
125133807|NCT02409355|450113866|FG001|Overall Study|Withdrawal by Subject|0|||
125133808|NCT02409355|450113865|FG000|Overall Study|Death|1|||
125133809|NCT02409355|450113866|FG001|Overall Study|Death|1|||
125133810|NCT02409355|450113865|FG000|Overall Study|Study terminated by Sponsor|2|||
125133811|NCT02409355|450113866|FG001|Overall Study|Study terminated by Sponsor|3|||
125133812|NCT00838539|450113867|FG000|Overall Study|Disease Progression|2|||
125133813|NCT00838539|450113868|FG001|Overall Study|Disease Progression|4|||
125380341|NCT03227029|451025151|FG000|Overall Study|Not able to get to clinic|0|||
125380342|NCT03227029|451025152|FG001|Overall Study|Not able to get to clinic|0|||
125380343|NCT03227029|451025153|FG002|Overall Study|Not able to get to clinic|1|||
125641104|NCT02795182|451966710|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
125133814|NCT00838539|450113869|FG002|Overall Study|Disease Progression|3|||
125133815|NCT00838539|450113870|FG003|Overall Study|Disease Progression|2|||
125133816|NCT00838539|450113871|FG004|Overall Study|Disease Progression|4|||
125133817|NCT00838539|450113872|FG005|Overall Study|Disease Progression|2|||
125133818|NCT00838539|450113873|FG006|Overall Study|Disease Progression|3|||
125380344|NCT03227029|451025151|FG000|Overall Study|Withdrawal by Subject|1|||
125641105|NCT02795182|451966711|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
125641106|NCT02795182|451966708|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
125133819|NCT00838539|450113874|FG007|Overall Study|Disease Progression|4|||
125133820|NCT00838539|450113875|FG008|Overall Study|Disease Progression|4|||
125380345|NCT03227029|451025152|FG001|Overall Study|Withdrawal by Subject|0|||
125218464|NCT02028507|450427335|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
125218465|NCT02028507|450427336|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
125218466|NCT02028507|450427337|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
125218467|NCT02028507|450427338|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
125218468|NCT02028507|450427335|FG000|Overall Study|Randomized But Not Treated|3|||
125218469|NCT02028507|450427336|FG001|Overall Study|Randomized But Not Treated|6|||
125218470|NCT02028507|450427337|FG002|Overall Study|Randomized But Not Treated|0|||
125218471|NCT02028507|450427338|FG003|Overall Study|Randomized But Not Treated|4|||
125218472|NCT02028507|450427335|FG000|Overall Study|Enzyme defect|0|||
125218473|NCT02028507|450427336|FG001|Overall Study|Enzyme defect|0|||
125218474|NCT02028507|450427337|FG002|Overall Study|Enzyme defect|0|||
125218475|NCT02028507|450427338|FG003|Overall Study|Enzyme defect|1|||
125218476|NCT02028507|450427335|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
125218477|NCT02028507|450427336|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
125218478|NCT02028507|450427337|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
125218479|NCT02028507|450427338|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
125218480|NCT02028507|450427335|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
125218481|NCT02028507|450427336|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
125218482|NCT02028507|450427337|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
125218483|NCT02028507|450427338|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
125218484|NCT02420262|450427341|FG000|Overall Study|Adverse Event|1|||
125641107|NCT02795182|451966709|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
125641108|NCT02795182|451966710|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
125641109|NCT02795182|451966711|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
125641110|NCT02795182|451966708|FG000|Overall Study|Withdrawal by Subject|4|||
125641111|NCT02795182|451966709|FG001|Overall Study|Withdrawal by Subject|0|||
125641112|NCT02795182|451966710|FG002|Overall Study|Withdrawal by Subject|0|||
125641113|NCT02795182|451966711|FG003|Overall Study|Withdrawal by Subject|3|||
125641114|NCT02795182|451966708|FG000|Overall Study|Lost to Follow-up|0|||
125641115|NCT02795182|451966709|FG001|Overall Study|Lost to Follow-up|0|||
125641116|NCT02795182|451966710|FG002|Overall Study|Lost to Follow-up|1|||
125641117|NCT02795182|451966711|FG003|Overall Study|Lost to Follow-up|1|||
125641118|NCT02795182|451966708|FG000|Overall Study|Roll Over to Long Term Extension|3|||
125218485|NCT02420262|450427342|FG001|Overall Study|Adverse Event|0|||
125218486|NCT02420262|450427341|FG000|Overall Study|Withdrawal by Subject|1|||
125218487|NCT02420262|450427342|FG001|Overall Study|Withdrawal by Subject|4|||
125218488|NCT02420262|450427341|FG000|Overall Study|Unclassified|0|||
125641119|NCT02795182|451966709|FG001|Overall Study|Roll Over to Long Term Extension|3|||
125641120|NCT02795182|451966710|FG002|Overall Study|Roll Over to Long Term Extension|2|||
125641121|NCT02795182|451966711|FG003|Overall Study|Roll Over to Long Term Extension|5|||
125641122|NCT02795182|451966708|FG000|Overall Study|Progressive Disease|0|||
125641123|NCT02795182|451966709|FG001|Overall Study|Progressive Disease|1|||
125641124|NCT02795182|451966710|FG002|Overall Study|Progressive Disease|0|||
125641125|NCT02795182|451966711|FG003|Overall Study|Progressive Disease|4|||
125641126|NCT02795182|451966708|FG000|Overall Study|Physician Decision|0|||
125641127|NCT02795182|451966709|FG001|Overall Study|Physician Decision|0|||
125641128|NCT02795182|451966710|FG002|Overall Study|Physician Decision|0|||
125641129|NCT02795182|451966711|FG003|Overall Study|Physician Decision|1|||
125641130|NCT04107935|451966712|FG000|Overall Study|Death|1|||
125641131|NCT04107935|451966713|FG001|Overall Study|Death|0|||
125641132|NCT01021553|451966714|FG000|Overall Study|Adverse Event|1|||
125641133|NCT01021553|451966715|FG001|Overall Study|Adverse Event|0|||
125641134|NCT01021553|451966716|FG002|Overall Study|Adverse Event|0|||
125641135|NCT01021553|451966714|FG000|Overall Study|Lack of Efficacy|2|||
125641136|NCT01021553|451966715|FG001|Overall Study|Lack of Efficacy|2|||
125641137|NCT01021553|451966716|FG002|Overall Study|Lack of Efficacy|0|||
125641138|NCT01021553|451966714|FG000|Overall Study|Protocol Violation|0|||
125641139|NCT01021553|451966715|FG001|Overall Study|Protocol Violation|2|||
125641140|NCT01021553|451966716|FG002|Overall Study|Protocol Violation|2|||
125641141|NCT01021553|451966714|FG000|Overall Study|Lost to Follow-up|0|||
125641142|NCT01021553|451966715|FG001|Overall Study|Lost to Follow-up|0|||
125641143|NCT01021553|451966716|FG002|Overall Study|Lost to Follow-up|1|||
125641144|NCT01021553|451966714|FG000|Overall Study|Withdrawal by Subject|1|||
125641145|NCT01021553|451966715|FG001|Overall Study|Withdrawal by Subject|1|||
125641146|NCT01021553|451966716|FG002|Overall Study|Withdrawal by Subject|0|||
125641147|NCT00890201|451966717|FG000|Overall Study|Protocol Violation|5|||
125641148|NCT00890201|451966718|FG001|Overall Study|Protocol Violation|56|||
125641149|NCT00033293|451966719|FG000|Overall Study|Death|0|||
125641150|NCT00033293|451966720|FG001|Overall Study|Death|1|||
125641151|NCT00033293|451966719|FG000|Overall Study|Lack of Efficacy|5|||
125641152|NCT00033293|451966720|FG001|Overall Study|Lack of Efficacy|8|||
125641153|NCT00033293|451966719|FG000|Overall Study|Lost to Follow-up|0|||
125641154|NCT00033293|451966720|FG001|Overall Study|Lost to Follow-up|1|||
125641155|NCT00033293|451966719|FG000|Overall Study|Physician Decision|3|||
125641156|NCT00033293|451966720|FG001|Overall Study|Physician Decision|1|||
125641157|NCT00033293|451966719|FG000|Overall Study|Withdrawal by Subject|1|||
125641158|NCT00033293|451966720|FG001|Overall Study|Withdrawal by Subject|0|||
125641159|NCT00033293|451966719|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
125641160|NCT00033293|451966720|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
125641161|NCT00033293|451966719|FG000|Overall Study|Treatment refused|0|||
125641162|NCT00033293|451966720|FG001|Overall Study|Treatment refused|6|||
125641163|NCT00935701|451966721|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
125641164|NCT02087241|451966722|FG000|Overall Study|Death|2|||
125133821|NCT00838539|450113876|FG009|Overall Study|Disease Progression|5|||
125133822|NCT00838539|450113877|FG010|Overall Study|Disease Progression|1|||
125641165|NCT02087241|451966723|FG001|Overall Study|Death|1|||
125641166|NCT02087241|451966724|FG002|Overall Study|Death|1|||
125641167|NCT02087241|451966725|FG003|Overall Study|Death|1|||
125641168|NCT02087241|451966722|FG000|Overall Study|Withdrawal by Subject|1|||
125641169|NCT02087241|451966723|FG001|Overall Study|Withdrawal by Subject|0|||
125641170|NCT02087241|451966724|FG002|Overall Study|Withdrawal by Subject|0|||
125641171|NCT02087241|451966725|FG003|Overall Study|Withdrawal by Subject|1|||
125641172|NCT02087241|451966722|FG000|Overall Study|Progressive Disease|0|||
125641173|NCT02087241|451966723|FG001|Overall Study|Progressive Disease|0|||
125641174|NCT02087241|451966724|FG002|Overall Study|Progressive Disease|0|||
125641175|NCT02087241|451966725|FG003|Overall Study|Progressive Disease|1|||
125641176|NCT02087241|451966722|FG000|Overall Study|Study Terminated by Sponsor|0|||
125641177|NCT02087241|451966723|FG001|Overall Study|Study Terminated by Sponsor|2|||
125641178|NCT02087241|451966724|FG002|Overall Study|Study Terminated by Sponsor|0|||
125641179|NCT02087241|451966725|FG003|Overall Study|Study Terminated by Sponsor|4|||
125641180|NCT02181504|451966726|FG000|Overall Study|Adverse Event|1|||
125641181|NCT02181504|451966727|FG001|Overall Study|Adverse Event|1|||
125641182|NCT02181504|451966728|FG002|Overall Study|Adverse Event|1|||
125641183|NCT00545584|451966729|FG000|Overall Study|Only one reason for discontinuation|62|||
125641184|NCT00545584|451966730|FG001|Overall Study|Only one reason for discontinuation|61|||
125641185|NCT00545584|451966731|FG002|Overall Study|Only one reason for discontinuation|48|||
125641186|NCT00545584|451966729|FG000|Overall Study|Two or more reasons for discontinuation|17|||
125641187|NCT00545584|451966730|FG001|Overall Study|Two or more reasons for discontinuation|19|||
125641188|NCT00545584|451966731|FG002|Overall Study|Two or more reasons for discontinuation|8|||
125641189|NCT03525613|451966732|FG000|Overall Study|Adverse Event|11|||
125641190|NCT03525613|451966733|FG001|Overall Study|Adverse Event|8|||
125641191|NCT03525613|451966734|FG002|Overall Study|Adverse Event|3|||
125641192|NCT03525613|451966735|FG003|Overall Study|Adverse Event|3|||
125641193|NCT03525613|451966732|FG000|Overall Study|Lost to Follow-up|4|||
125641194|NCT03525613|451966733|FG001|Overall Study|Lost to Follow-up|5|||
125641195|NCT03525613|451966734|FG002|Overall Study|Lost to Follow-up|3|||
125641196|NCT03525613|451966735|FG003|Overall Study|Lost to Follow-up|2|||
125380346|NCT03227029|451025153|FG002|Overall Study|Withdrawal by Subject|0|||
125380347|NCT03227029|451025151|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
125380348|NCT03227029|451025152|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
125380349|NCT03227029|451025153|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
125380350|NCT03414424|451025154|FG000|Overall Study|Screened out after consent|0|||
125380351|NCT03414424|451025155|FG001|Overall Study|Screened out after consent|2|||
125380352|NCT03414424|451025154|FG000|Overall Study|Lost to Follow-up|0|||
125380353|NCT03414424|451025155|FG001|Overall Study|Lost to Follow-up|1|||
125380354|NCT00022633|451025158|FG000|Overall Study|Adverse Event|11|||
125380355|NCT00022633|451025159|FG001|Overall Study|Adverse Event|1|||
125380356|NCT00022633|451025158|FG000|Overall Study|Refusal unrelated to adverse event|1|||
125380357|NCT00022633|451025159|FG001|Overall Study|Refusal unrelated to adverse event|0|||
125380358|NCT00022633|451025158|FG000|Overall Study|Progression/relapse|9|||
125437120|NCT00569803|451227992|FG000|Overall Study|injection syringe leaked during dosing|0|||
125437121|NCT00569803|451227993|FG001|Overall Study|injection syringe leaked during dosing|0|||
125641197|NCT03525613|451966732|FG000|Overall Study|Physician Decision|0|||
125641198|NCT03525613|451966733|FG001|Overall Study|Physician Decision|1|||
125641199|NCT03525613|451966734|FG002|Overall Study|Physician Decision|0|||
125641200|NCT03525613|451966735|FG003|Overall Study|Physician Decision|1|||
125641201|NCT03525613|451966732|FG000|Overall Study|Consent Withdrawal|25|||
125641202|NCT03525613|451966733|FG001|Overall Study|Consent Withdrawal|16|||
125641203|NCT03525613|451966734|FG002|Overall Study|Consent Withdrawal|12|||
125641204|NCT03525613|451966735|FG003|Overall Study|Consent Withdrawal|9|||
125641205|NCT03525613|451966732|FG000|Overall Study|Death|20|||
125641206|NCT03525613|451966733|FG001|Overall Study|Death|9|||
125641207|NCT03525613|451966734|FG002|Overall Study|Death|7|||
125641208|NCT03525613|451966735|FG003|Overall Study|Death|1|||
125641209|NCT03525613|451966732|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
125641210|NCT03525613|451966733|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
125641211|NCT03525613|451966734|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
125641212|NCT03525613|451966735|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
125641213|NCT02584660|451966736|FG000|Overall Study|Adverse Event|4|||
125641214|NCT02584660|451966737|FG001|Overall Study|Adverse Event|0|||
125641215|NCT02584660|451966736|FG000|Overall Study|Lost to Follow-up|3|||
125641216|NCT02584660|451966737|FG001|Overall Study|Lost to Follow-up|4|||
125641217|NCT02584660|451966736|FG000|Overall Study|Protocol Violation|0|||
125641218|NCT02584660|451966737|FG001|Overall Study|Protocol Violation|1|||
125641219|NCT02584660|451966736|FG000|Overall Study|Withdrawal by Subject|0|||
125641220|NCT02584660|451966737|FG001|Overall Study|Withdrawal by Subject|2|||
125641221|NCT02584660|451966736|FG000|Overall Study|Other|0|||
125641222|NCT02584660|451966737|FG001|Overall Study|Other|1|||
125641223|NCT00461552|451966740|FG000|Overall Study|Drug Dispensing error|0|||
125641224|NCT00461552|451966741|FG001|Overall Study|Drug Dispensing error|2|||
125641225|NCT01289028|451966744|FG000|Overall Study|Progressive Disease|49|||
125641226|NCT01289028|451966744|FG000|Overall Study|Adverse Event|14|||
125641227|NCT01289028|451966744|FG000|Overall Study|Withdrawal by Subject|6|||
125641228|NCT01289028|451966744|FG000|Overall Study|Death|4|||
125641229|NCT01289028|451966744|FG000|Overall Study|Lack of Efficacy|2|||
125641230|NCT01289028|451966744|FG000|Overall Study|No longer required|2|||
125641231|NCT01289028|451966744|FG000|Overall Study|Lost to Follow-up|2|||
125641232|NCT01289028|451966744|FG000|Overall Study|New Cancer Therapy|2|||
125641233|NCT01289028|451966744|FG000|Overall Study|Abnormal Lab Value|1|||
125641234|NCT01289028|451966744|FG000|Overall Study|Missing reason for discon|1|||
125641235|NCT02120469|451966745|FG000|Overall Study|HER-2/neu-amplified|1|||
125641236|NCT02120469|451966746|FG001|Overall Study|HER-2/neu-amplified|0|||
125641237|NCT02120469|451966747|FG002|Overall Study|HER-2/neu-amplified|1|||
125641238|NCT01846208|451966749|FG000|Overall Study|Withdrew prior to treatment|1|||
125641239|NCT01846208|451966750|FG001|Overall Study|Withdrew prior to treatment|1|||
125641240|NCT01846208|451966751|FG002|Overall Study|Withdrew prior to treatment|1|||
125641241|NCT01846208|451966749|FG000|Overall Study|Dosing Symptoms|1|||
125641242|NCT01846208|451966750|FG001|Overall Study|Dosing Symptoms|2|||
125641243|NCT01846208|451966751|FG002|Overall Study|Dosing Symptoms|6|||
125641244|NCT01846208|451966749|FG000|Overall Study|Withdrawal by Subject|5|||
125641245|NCT01846208|451966750|FG001|Overall Study|Withdrawal by Subject|0|||
125641246|NCT01846208|451966751|FG002|Overall Study|Withdrawal by Subject|0|||
125641247|NCT01846208|451966749|FG000|Overall Study|Non-compliance|1|||
125641248|NCT01846208|451966750|FG001|Overall Study|Non-compliance|1|||
125641249|NCT01846208|451966751|FG002|Overall Study|Non-compliance|0|||
125641250|NCT01846208|451966749|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
125641251|NCT01846208|451966750|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
125641252|NCT01846208|451966751|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
125641253|NCT01846208|451966749|FG000|Overall Study|Refused SU OFC|0|||
125641254|NCT01846208|451966750|FG001|Overall Study|Refused SU OFC|0|||
125641255|NCT01846208|451966751|FG002|Overall Study|Refused SU OFC|1|||
125641256|NCT01424306|451966752|FG000|Overall Study|Protocol Violation|0|||
125641257|NCT01424306|451966753|FG001|Overall Study|Protocol Violation|0|||
125641258|NCT01424306|451966754|FG002|Overall Study|Protocol Violation|0|||
125641259|NCT01424306|451966755|FG003|Overall Study|Protocol Violation|0|||
125641260|NCT01424306|451966756|FG004|Overall Study|Protocol Violation|1|||
125641261|NCT01424306|451966757|FG005|Overall Study|Protocol Violation|0|||
125641262|NCT03344562|451966763|FG000|Overall Study|Withdrawal by Subject|2|||
125641263|NCT03344562|451966764|FG001|Overall Study|Withdrawal by Subject|0|||
125641264|NCT02608892|451966775|FG000|Overall Study|Lost to Follow-up|1|||
125641265|NCT02608892|451966776|FG001|Overall Study|Lost to Follow-up|0|||
125133823|NCT00838539|450113878|FG011|Overall Study|Disease Progression|4|||
125133824|NCT00838539|450113867|FG000|Overall Study|Adverse Event|1|||
125133825|NCT00838539|450113868|FG001|Overall Study|Adverse Event|1|||
125133826|NCT00838539|450113869|FG002|Overall Study|Adverse Event|1|||
125133827|NCT00838539|450113870|FG003|Overall Study|Adverse Event|1|||
125133828|NCT00838539|450113871|FG004|Overall Study|Adverse Event|2|||
125133829|NCT00838539|450113872|FG005|Overall Study|Adverse Event|1|||
125133830|NCT00838539|450113873|FG006|Overall Study|Adverse Event|0|||
125133831|NCT00838539|450113874|FG007|Overall Study|Adverse Event|2|||
125133832|NCT00838539|450113875|FG008|Overall Study|Adverse Event|0|||
125133833|NCT00838539|450113876|FG009|Overall Study|Adverse Event|1|||
125133834|NCT00838539|450113877|FG010|Overall Study|Adverse Event|2|||
125133835|NCT00838539|450113878|FG011|Overall Study|Adverse Event|0|||
125133836|NCT00838539|450113867|FG000|Overall Study|Withdrawal by Subject|0|||
125133837|NCT00838539|450113868|FG001|Overall Study|Withdrawal by Subject|1|||
125133838|NCT00838539|450113869|FG002|Overall Study|Withdrawal by Subject|0|||
125133839|NCT00838539|450113870|FG003|Overall Study|Withdrawal by Subject|0|||
125133840|NCT00838539|450113871|FG004|Overall Study|Withdrawal by Subject|0|||
125133841|NCT00838539|450113872|FG005|Overall Study|Withdrawal by Subject|0|||
125133842|NCT00838539|450113873|FG006|Overall Study|Withdrawal by Subject|0|||
125133843|NCT00838539|450113874|FG007|Overall Study|Withdrawal by Subject|0|||
125133844|NCT00838539|450113875|FG008|Overall Study|Withdrawal by Subject|0|||
125133845|NCT00838539|450113876|FG009|Overall Study|Withdrawal by Subject|1|||
125133846|NCT00838539|450113877|FG010|Overall Study|Withdrawal by Subject|2|||
125133847|NCT00838539|450113878|FG011|Overall Study|Withdrawal by Subject|0|||
125133848|NCT00838539|450113867|FG000|Overall Study|Death|0|||
125133849|NCT00838539|450113868|FG001|Overall Study|Death|0|||
125641266|NCT02590406|451966777|FG000|Overall Study|Adverse Event|1|||
125641267|NCT02590406|451966778|FG001|Overall Study|Adverse Event|0|||
125641268|NCT02590406|451966777|FG000|Overall Study|Saturometer malfunction|0|||
125641269|NCT02590406|451966778|FG001|Overall Study|Saturometer malfunction|1|||
125641270|NCT00984009|451966779|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
125641271|NCT02036476|451966782|FG000|Overall Study|Withdrawal by Subject|2|||
125641272|NCT02036476|451966782|FG000|Overall Study|Progressive Disease|4|||
125641273|NCT02036476|451966782|FG000|Overall Study|Unacceptable Toxicity|2|||
125641274|NCT02168816|451966783|FG000|Overall Study|Lost to Follow-up|2|||
125641275|NCT02168816|451966784|FG001|Overall Study|Lost to Follow-up|2|||
125641276|NCT02985684|451966785|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
125641277|NCT02985684|451966785|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
125641278|NCT02985684|451966785|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
125641279|NCT00424463|451966786|FG000|Overall Study|Adverse Event|2|||
125641280|NCT00424463|451966787|FG001|Overall Study|Adverse Event|3|||
125641281|NCT00424463|451966788|FG002|Overall Study|Adverse Event|2|||
125641282|NCT00424463|451966786|FG000|Overall Study|Physician Decision|0|||
125641283|NCT00424463|451966787|FG001|Overall Study|Physician Decision|2|||
125641284|NCT00424463|451966788|FG002|Overall Study|Physician Decision|2|||
125641285|NCT00424463|451966786|FG000|Overall Study|Withdrawal by Subject|4|||
125641286|NCT00424463|451966787|FG001|Overall Study|Withdrawal by Subject|2|||
125641287|NCT00424463|451966788|FG002|Overall Study|Withdrawal by Subject|5|||
125641288|NCT00424463|451966786|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
125641289|NCT00424463|451966787|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
125641290|NCT00424463|451966788|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
125641291|NCT00424463|451966786|FG000|Overall Study|Patient's convenience|0|||
125641292|NCT00424463|451966787|FG001|Overall Study|Patient's convenience|0|||
125641293|NCT00424463|451966788|FG002|Overall Study|Patient's convenience|1|||
125641294|NCT01436357|451966789|FG000|Overall Study|Death|5|||
125641295|NCT01436357|451966790|FG001|Overall Study|Death|1|||
125641296|NCT01436357|451966789|FG000|Overall Study|Enrolled but not vaccinated|1|||
125641297|NCT01436357|451966790|FG001|Overall Study|Enrolled but not vaccinated|1|||
125641298|NCT01436357|451966789|FG000|Overall Study|Incarceration|18|||
125641299|NCT01436357|451966790|FG001|Overall Study|Incarceration|20|||
125641300|NCT01436357|451966789|FG000|Overall Study|Lost to Follow-up|67|||
125641301|NCT01436357|451966790|FG001|Overall Study|Lost to Follow-up|61|||
125641302|NCT01436357|451966789|FG000|Overall Study|Protocol Violation|1|||
125641303|NCT01436357|451966790|FG001|Overall Study|Protocol Violation|0|||
125641304|NCT01436357|451966789|FG000|Overall Study|Withdrawal by Subject|26|||
125641305|NCT01436357|451966790|FG001|Overall Study|Withdrawal by Subject|38|||
125641306|NCT01436357|451966789|FG000|Overall Study|Physician Decision|3|||
125641307|NCT01436357|451966790|FG001|Overall Study|Physician Decision|4|||
125641308|NCT01436357|451966789|FG000|Overall Study|Moved out of area|1|||
125641309|NCT01436357|451966790|FG001|Overall Study|Moved out of area|2|||
125641310|NCT01436357|451966789|FG000|Overall Study|Subject in rehab|0|||
125641311|NCT01436357|451966790|FG001|Overall Study|Subject in rehab|1|||
125641312|NCT05281094|451966791|FG000|Overall Study|Adverse Event|1|||
125641313|NCT05281094|451966792|FG001|Overall Study|Adverse Event|0|||
125133850|NCT00838539|450113869|FG002|Overall Study|Death|0|||
125133851|NCT00838539|450113870|FG003|Overall Study|Death|0|||
125641314|NCT05281094|451966791|FG000|Overall Study|Lost to Follow-up|29|||
125641315|NCT05281094|451966792|FG001|Overall Study|Lost to Follow-up|22|||
125641316|NCT05281094|451966791|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
125641317|NCT05281094|451966792|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
125641318|NCT05281094|451966791|FG000|Overall Study|Death|1|||
125641319|NCT05281094|451966792|FG001|Overall Study|Death|2|||
125641320|NCT05281094|451966791|FG000|Overall Study|Not pre-specified reason|8|||
125641321|NCT05281094|451966792|FG001|Overall Study|Not pre-specified reason|5|||
125133852|NCT00838539|450113871|FG004|Overall Study|Death|0|||
125133853|NCT00838539|450113872|FG005|Overall Study|Death|0|||
125133854|NCT00838539|450113873|FG006|Overall Study|Death|1|||
125133855|NCT00838539|450113874|FG007|Overall Study|Death|0|||
125133856|NCT00838539|450113875|FG008|Overall Study|Death|0|||
125133857|NCT00838539|450113876|FG009|Overall Study|Death|0|||
125133858|NCT00838539|450113877|FG010|Overall Study|Death|0|||
125641322|NCT05315297|451966793|FG000|Overall Study|Lost to Follow-up|6|||
125641323|NCT05315297|451966794|FG001|Overall Study|Lost to Follow-up|4|||
125641324|NCT05315297|451966793|FG000|Overall Study|Withdrawal by Subject|0|||
125641325|NCT05315297|451966794|FG001|Overall Study|Withdrawal by Subject|1|||
125641326|NCT02583399|451968649|FG000|Overall Study|Able to be discharged|3|||
125641327|NCT02583399|451968649|FG000|Overall Study|Wanted to use a restricted medication|3|||
125641328|NCT02759939|451968657|FG000|Overall Study|Missing data on first outcome assessed|11|||
125641329|NCT02759939|451968658|FG001|Overall Study|Missing data on first outcome assessed|2|||
125641330|NCT02759939|451968659|FG002|Overall Study|Missing data on first outcome assessed|5|||
125641331|NCT02759939|451968660|FG003|Overall Study|Missing data on first outcome assessed|2|||
125133859|NCT00838539|450113878|FG011|Overall Study|Death|0|||
125133860|NCT00838539|450113867|FG000|Overall Study|Physician Decision|0|||
125133861|NCT00838539|450113868|FG001|Overall Study|Physician Decision|0|||
125133862|NCT00838539|450113869|FG002|Overall Study|Physician Decision|0|||
125133863|NCT00838539|450113870|FG003|Overall Study|Physician Decision|0|||
125133864|NCT00838539|450113871|FG004|Overall Study|Physician Decision|0|||
125133865|NCT00838539|450113872|FG005|Overall Study|Physician Decision|0|||
125133866|NCT00838539|450113873|FG006|Overall Study|Physician Decision|0|||
125133867|NCT00838539|450113874|FG007|Overall Study|Physician Decision|0|||
125133868|NCT00838539|450113875|FG008|Overall Study|Physician Decision|1|||
125133869|NCT00838539|450113876|FG009|Overall Study|Physician Decision|0|||
125133870|NCT00838539|450113877|FG010|Overall Study|Physician Decision|0|||
125133871|NCT00838539|450113878|FG011|Overall Study|Physician Decision|0|||
125133872|NCT00838539|450113867|FG000|Overall Study|Clinical Progression|0|||
125133873|NCT00838539|450113868|FG001|Overall Study|Clinical Progression|0|||
125133874|NCT00838539|450113869|FG002|Overall Study|Clinical Progression|0|||
125133875|NCT00838539|450113870|FG003|Overall Study|Clinical Progression|0|||
125133876|NCT00838539|450113871|FG004|Overall Study|Clinical Progression|0|||
125133877|NCT00838539|450113872|FG005|Overall Study|Clinical Progression|0|||
125133878|NCT00838539|450113873|FG006|Overall Study|Clinical Progression|1|||
125133879|NCT00838539|450113874|FG007|Overall Study|Clinical Progression|0|||
125133880|NCT00838539|450113875|FG008|Overall Study|Clinical Progression|0|||
125133881|NCT00838539|450113876|FG009|Overall Study|Clinical Progression|0|||
125133882|NCT00838539|450113877|FG010|Overall Study|Clinical Progression|0|||
125133883|NCT00838539|450113878|FG011|Overall Study|Clinical Progression|0|||
125133884|NCT00838539|450113867|FG000|Overall Study|Symptomatic Deterioration|0|||
125133885|NCT00838539|450113868|FG001|Overall Study|Symptomatic Deterioration|0|||
125133886|NCT00838539|450113869|FG002|Overall Study|Symptomatic Deterioration|1|||
125133887|NCT00838539|450113870|FG003|Overall Study|Symptomatic Deterioration|1|||
125133888|NCT00838539|450113871|FG004|Overall Study|Symptomatic Deterioration|0|||
125133889|NCT00838539|450113872|FG005|Overall Study|Symptomatic Deterioration|1|||
125133890|NCT00838539|450113873|FG006|Overall Study|Symptomatic Deterioration|0|||
125133891|NCT00838539|450113874|FG007|Overall Study|Symptomatic Deterioration|0|||
125133892|NCT00838539|450113875|FG008|Overall Study|Symptomatic Deterioration|0|||
125133893|NCT00838539|450113876|FG009|Overall Study|Symptomatic Deterioration|1|||
125133894|NCT00838539|450113877|FG010|Overall Study|Symptomatic Deterioration|0|||
125133895|NCT00838539|450113878|FG011|Overall Study|Symptomatic Deterioration|0|||
125133896|NCT03482882|450113879|FG000|Overall Study|Adverse Event|3|||
125133897|NCT03482882|450113879|FG000|Overall Study|Lost to Follow-up|1|||
125133898|NCT03482882|450113879|FG000|Overall Study|Protocol Violation|2|||
125133899|NCT03482882|450113879|FG000|Overall Study|Not further specified|1|||
125133900|NCT03123471|450113884|FG000|Placebo-controlled Phase|Adverse Event|3|||
125133901|NCT03123471|450113885|FG001|Placebo-controlled Phase|Adverse Event|8|||
125133902|NCT03123471|450113884|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
125133903|NCT03123471|450113885|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
125133904|NCT03123471|450113884|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
125133905|NCT03123471|450113885|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
125133906|NCT03123471|450113884|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
125133907|NCT03123471|450113885|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
125133908|NCT03123471|450113884|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
125133909|NCT03123471|450113885|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
125133910|NCT03123471|450113884|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
125133911|NCT03123471|450113885|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
125133912|NCT03123471|450113884|FG000|Placebo-controlled Phase|Miscellaneous|0|||
125133913|NCT03123471|450113885|FG001|Placebo-controlled Phase|Miscellaneous|1|||
125133914|NCT03123471|450113884|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
125133915|NCT03123471|450113885|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
125133916|NCT03123471|450113884|FG000|Apremilast Extension Phase|Adverse Event|1|||
125133917|NCT03123471|450113885|FG001|Apremilast Extension Phase|Adverse Event|5|||
125133918|NCT03123471|450113884|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
125133919|NCT03123471|450113885|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
125133920|NCT03123471|450113884|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
125133921|NCT03123471|450113885|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
125133922|NCT02957942|450113888|FG000|Overall Study|Withdrawal by Subject|0|||
125133923|NCT02957942|450113889|FG001|Overall Study|Withdrawal by Subject|1|||
125133924|NCT02957942|450113888|FG000|Overall Study|Practicing experiment protocol|0|||
125133925|NCT02957942|450113889|FG001|Overall Study|Practicing experiment protocol|6|||
125133926|NCT03238781|450113890|FG000|Overall Study|Adverse Event|1|||
125133927|NCT03238781|450113891|FG001|Overall Study|Adverse Event|1|||
125133928|NCT03238781|450113892|FG002|Overall Study|Adverse Event|2|||
125133929|NCT03238781|450113890|FG000|Overall Study|Lost to Follow-up|2|||
125133930|NCT03238781|450113891|FG001|Overall Study|Lost to Follow-up|1|||
125133931|NCT03238781|450113892|FG002|Overall Study|Lost to Follow-up|2|||
125133932|NCT03238781|450113890|FG000|Overall Study|Withdrawal by Subject|23|||
125437122|NCT00569803|451227994|FG002|Overall Study|injection syringe leaked during dosing|0|||
125437123|NCT00569803|451227995|FG003|Overall Study|injection syringe leaked during dosing|1|||
125437124|NCT00569803|451227996|FG004|Overall Study|injection syringe leaked during dosing|0|||
125641332|NCT02759939|451968657|FG000|Overall Study|Ineligible for T2 and T3|310|||
125641333|NCT02759939|451968658|FG001|Overall Study|Ineligible for T2 and T3|179|||
125641334|NCT02759939|451968659|FG002|Overall Study|Ineligible for T2 and T3|366|||
125641335|NCT02759939|451968660|FG003|Overall Study|Ineligible for T2 and T3|391|||
125641336|NCT02759939|451968657|FG000|Overall Study|Lost to Follow-up|735|||
125641337|NCT02759939|451968658|FG001|Overall Study|Lost to Follow-up|791|||
125641338|NCT02759939|451968659|FG002|Overall Study|Lost to Follow-up|783|||
125641339|NCT02759939|451968660|FG003|Overall Study|Lost to Follow-up|650|||
125641340|NCT03288987|451968661|FG000|Overall Study|Protocol Violation|10|||
125641341|NCT03288987|451968662|FG001|Overall Study|Protocol Violation|4|||
125641342|NCT04905563|451968665|FG000|Overall Study|Withdrawal by Subject|1|||
125641343|NCT04905563|451968666|FG001|Overall Study|Withdrawal by Subject|0|||
125641344|NCT04905563|451968665|FG000|Overall Study|Standard of care orders entered by resident|1|||
125641345|NCT04905563|451968666|FG001|Overall Study|Standard of care orders entered by resident|0|||
125641346|NCT04905563|451968665|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
125641347|NCT04905563|451968666|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
125641348|NCT04905563|451968665|FG000|Overall Study|Withdrawal by Subject|0|||
125641349|NCT04905563|451968666|FG001|Overall Study|Withdrawal by Subject|1|||
125641350|NCT04652102|451968678|FG000|Overall Study|Adverse Event|14|||
125641351|NCT04652102|451968679|FG001|Overall Study|Adverse Event|13|||
125641352|NCT04652102|451968678|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
125133933|NCT03238781|450113891|FG001|Overall Study|Withdrawal by Subject|14|||
125133934|NCT03238781|450113892|FG002|Overall Study|Withdrawal by Subject|16|||
125133935|NCT03238781|450113890|FG000|Overall Study|Decision by sponsor|0|||
125133936|NCT03238781|450113891|FG001|Overall Study|Decision by sponsor|1|||
125133937|NCT03238781|450113892|FG002|Overall Study|Decision by sponsor|0|||
125641353|NCT04652102|451968679|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
125641354|NCT04652102|451968678|FG000|Overall Study|Physician Decision|78|||
125641355|NCT04652102|451968679|FG001|Overall Study|Physician Decision|40|||
125641356|NCT04652102|451968678|FG000|Overall Study|Study Ended by Sponsor|64|||
125641357|NCT04652102|451968679|FG001|Overall Study|Study Ended by Sponsor|17|||
125641358|NCT04652102|451968678|FG000|Overall Study|Withdrawal by Subject|4625|||
125641359|NCT04652102|451968679|FG001|Overall Study|Withdrawal by Subject|5594|||
125641360|NCT04652102|451968678|FG000|Overall Study|Lost to Follow-up|2019|||
125641361|NCT04652102|451968679|FG001|Overall Study|Lost to Follow-up|1082|||
125641362|NCT04652102|451968678|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
125641363|NCT04652102|451968679|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
125437125|NCT00569803|451227997|FG005|Overall Study|injection syringe leaked during dosing|0|||
125437126|NCT00569803|451227998|FG006|Overall Study|injection syringe leaked during dosing|0|||
125437127|NCT00569803|451227999|FG007|Overall Study|injection syringe leaked during dosing|0|||
125437128|NCT00569803|451227992|FG000|Overall Study|Withdrawal by Subject|0|||
125437129|NCT00569803|451227993|FG001|Overall Study|Withdrawal by Subject|0|||
125641364|NCT04652102|451968678|FG000|Overall Study|Miscellaneous|80|||
125641365|NCT04652102|451968679|FG001|Overall Study|Miscellaneous|64|||
125641366|NCT00696774|451968685|FG000|Period II|Adverse Event|0|||
125641367|NCT00696774|451968686|FG001|Period II|Adverse Event|0|||
125641368|NCT00696774|451968687|FG002|Period II|Adverse Event|15|||
125641369|NCT00696774|451968685|FG000|Period II|Lost to Follow-up|0|||
125641370|NCT00696774|451968686|FG001|Period II|Lost to Follow-up|0|||
125641371|NCT00696774|451968687|FG002|Period II|Lost to Follow-up|4|||
125641372|NCT00696774|451968685|FG000|Period II|Protocol Violation|0|||
125641373|NCT00696774|451968686|FG001|Period II|Protocol Violation|0|||
125641374|NCT00696774|451968687|FG002|Period II|Protocol Violation|11|||
125641375|NCT00696774|451968685|FG000|Period II|Withdrawal by Subject|0|||
125641376|NCT00696774|451968686|FG001|Period II|Withdrawal by Subject|0|||
125641377|NCT00696774|451968687|FG002|Period II|Withdrawal by Subject|4|||
125641378|NCT00696774|451968685|FG000|Period II|Sponsor Decision|0|||
125641379|NCT00696774|451968686|FG001|Period II|Sponsor Decision|0|||
125641380|NCT00696774|451968687|FG002|Period II|Sponsor Decision|0|||
125641381|NCT00696774|451968685|FG000|Period II|Lack of Efficacy|0|||
125641382|NCT00696774|451968686|FG001|Period II|Lack of Efficacy|0|||
125641383|NCT00696774|451968687|FG002|Period II|Lack of Efficacy|2|||
125641384|NCT00696774|451968685|FG000|Period III|Adverse Event|1|||
125641385|NCT00696774|451968686|FG001|Period III|Adverse Event|1|||
125641386|NCT00696774|451968687|FG002|Period III|Adverse Event|0|||
125641387|NCT00696774|451968685|FG000|Period III|Lost to Follow-up|2|||
125641388|NCT00696774|451968686|FG001|Period III|Lost to Follow-up|1|||
125641389|NCT00696774|451968687|FG002|Period III|Lost to Follow-up|0|||
125437130|NCT00569803|451227994|FG002|Overall Study|Withdrawal by Subject|0|||
125437131|NCT00569803|451227995|FG003|Overall Study|Withdrawal by Subject|0|||
125437132|NCT00569803|451227996|FG004|Overall Study|Withdrawal by Subject|0|||
125437133|NCT00569803|451227997|FG005|Overall Study|Withdrawal by Subject|0|||
125437134|NCT00569803|451227998|FG006|Overall Study|Withdrawal by Subject|0|||
125437135|NCT00569803|451227999|FG007|Overall Study|Withdrawal by Subject|1|||
125437136|NCT01235975|451228000|FG000|Overall Study|Serious Adverse Event|0|||
125437137|NCT01235975|451228001|FG001|Overall Study|Serious Adverse Event|1|||
125437138|NCT01235975|451228000|FG000|Overall Study|Withdrawal by Subject|8|||
125437139|NCT01235975|451228001|FG001|Overall Study|Withdrawal by Subject|2|||
125437140|NCT01235975|451228000|FG000|Overall Study|Migrated/moved from study area|2|||
125437141|NCT01235975|451228001|FG001|Overall Study|Migrated/moved from study area|1|||
125437142|NCT01235975|451228000|FG000|Overall Study|Lost to Follow-up|7|||
125437143|NCT01235975|451228001|FG001|Overall Study|Lost to Follow-up|3|||
125641390|NCT00696774|451968685|FG000|Period III|Protocol Violation|1|||
125641391|NCT00696774|451968686|FG001|Period III|Protocol Violation|1|||
125641392|NCT00696774|451968687|FG002|Period III|Protocol Violation|0|||
125641393|NCT00696774|451968685|FG000|Period III|Withdrawal by Subject|1|||
125641394|NCT00696774|451968686|FG001|Period III|Withdrawal by Subject|2|||
125641395|NCT00696774|451968687|FG002|Period III|Withdrawal by Subject|0|||
125641396|NCT00696774|451968685|FG000|Period III|Sponsor Decision|2|||
125641397|NCT00696774|451968686|FG001|Period III|Sponsor Decision|0|||
125641398|NCT00696774|451968687|FG002|Period III|Sponsor Decision|0|||
125641399|NCT00696774|451968685|FG000|Period III|Lack of Efficacy|0|||
125641400|NCT00696774|451968686|FG001|Period III|Lack of Efficacy|2|||
125641401|NCT00696774|451968687|FG002|Period III|Lack of Efficacy|0|||
125641402|NCT00887913|451968695|FG000|Overall Study|Withdrawal by Subject|6|||
125641403|NCT02442765|451968698|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
125641404|NCT02442765|451968699|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
125641405|NCT02442765|451968700|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
125641406|NCT02442765|451968701|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
125133938|NCT01249651|450113894|FG000|Overall Study|Withdrawal by Subject|4|||
125133939|NCT01249651|450113894|FG000|Overall Study|Adverse Event|1|||
125133940|NCT01249651|450113894|FG000|Overall Study|Protocol Violation|1|||
125133941|NCT01249651|450113894|FG000|Overall Study|Sponsor Decision|1|||
125133942|NCT00813592|450113900|FG000|Overall Study|Disease assessment was not completed per|2|||
125133943|NCT00811655|450113901|FG000|Overall Study|Physician Decision|1|||
125133944|NCT03801707|450113906|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
125641407|NCT02442765|451968702|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
125641408|NCT02442765|451968703|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
125641409|NCT02442765|451968704|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
125641410|NCT02442765|451968705|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
125133945|NCT03873272|450113907|FG000|Overall Study|Withdrawal by Subject|2|||
125133946|NCT03873272|450113908|FG001|Overall Study|Withdrawal by Subject|0|||
125133947|NCT03873272|450113909|FG002|Overall Study|Withdrawal by Subject|1|||
125380359|NCT00022633|451025159|FG001|Overall Study|Progression/relapse|2|||
125380360|NCT00022633|451025158|FG000|Overall Study|Death|4|||
125133948|NCT03873272|450113907|FG000|Overall Study|Death|0|||
125133949|NCT03873272|450113908|FG001|Overall Study|Death|2|||
125133950|NCT03873272|450113909|FG002|Overall Study|Death|1|||
125133951|NCT00787254|450113912|FG000|Overall Study|Adverse Event|24|||
125133952|NCT00787254|450113913|FG001|Overall Study|Adverse Event|23|||
125133953|NCT00787254|450113912|FG000|Overall Study|Protocol Violation|26|||
125133954|NCT00787254|450113913|FG001|Overall Study|Protocol Violation|23|||
125133955|NCT00787254|450113912|FG000|Overall Study|Withdrawal by Subject|16|||
125133956|NCT00787254|450113913|FG001|Overall Study|Withdrawal by Subject|11|||
125133957|NCT00787254|450113912|FG000|Overall Study|Lack of Efficacy|4|||
125133958|NCT00787254|450113913|FG001|Overall Study|Lack of Efficacy|15|||
125133959|NCT00787254|450113912|FG000|Overall Study|NSAIDs discontinuation|1|||
125380361|NCT00022633|451025159|FG001|Overall Study|Death|0|||
125380362|NCT00022633|451025158|FG000|Overall Study|Other - not protocol specified|3|||
125380363|NCT00022633|451025159|FG001|Overall Study|Other - not protocol specified|2|||
125380364|NCT00022633|451025158|FG000|Overall Study|Ineligible|4|||
125380365|NCT00022633|451025159|FG001|Overall Study|Ineligible|0|||
125641411|NCT02442765|451968698|FG000|Stage 2- (Days 43 to 85)|Death|0|||
125641412|NCT02442765|451968699|FG001|Stage 2- (Days 43 to 85)|Death|0|||
125641413|NCT02442765|451968700|FG002|Stage 2- (Days 43 to 85)|Death|0|||
125641414|NCT02442765|451968701|FG003|Stage 2- (Days 43 to 85)|Death|1|||
125641415|NCT02442765|451968702|FG004|Stage 2- (Days 43 to 85)|Death|1|||
125641416|NCT02442765|451968703|FG005|Stage 2- (Days 43 to 85)|Death|0|||
125641417|NCT02442765|451968704|FG006|Stage 2- (Days 43 to 85)|Death|2|||
125641418|NCT02442765|451968705|FG007|Stage 2- (Days 43 to 85)|Death|0|||
125641419|NCT02442765|451968698|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125641420|NCT02442765|451968699|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125641421|NCT02442765|451968700|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125641422|NCT02442765|451968701|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
125641423|NCT02442765|451968702|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125641424|NCT02442765|451968703|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125641425|NCT02442765|451968704|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125641426|NCT02442765|451968705|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
125641427|NCT02442765|451968698|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125641428|NCT02442765|451968699|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125641429|NCT02442765|451968700|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125641430|NCT02442765|451968701|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
125641431|NCT02442765|451968702|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125641432|NCT02442765|451968703|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125133960|NCT00787254|450113913|FG001|Overall Study|NSAIDs discontinuation|2|||
125133961|NCT00787254|450113912|FG000|Overall Study|Institution closed|1|||
125133962|NCT00787254|450113913|FG001|Overall Study|Institution closed|0|||
125133963|NCT00787254|450113912|FG000|Overall Study|Physician Decision|4|||
125133964|NCT00787254|450113913|FG001|Overall Study|Physician Decision|8|||
125133965|NCT00316186|450113914|FG000|Overall Study|Adverse Event|6|||
125133966|NCT00316186|450113914|FG000|Overall Study|Disease Progression|4|||
125133967|NCT00316186|450113914|FG000|Overall Study|Lost to Follow-up|1|||
125133968|NCT00316186|450113914|FG000|Overall Study|Other|1|||
125133969|NCT03071575|450115499|FG000|Overall Study|Death|0|||
125133970|NCT03071575|450115500|FG001|Overall Study|Death|1|||
125437144|NCT00791921|451228004|FG000|Overall Study|Protocol planed|24|||
125641433|NCT02442765|451968704|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125641434|NCT02442765|451968705|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
125641435|NCT02442765|451968698|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
125380366|NCT03325075|451025166|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
125380367|NCT03325075|451025167|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
125380368|NCT03325075|451025168|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
125641436|NCT02442765|451968699|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
125641437|NCT02442765|451968700|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
125641438|NCT02442765|451968701|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
125641439|NCT02442765|451968702|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
125641440|NCT02442765|451968703|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
125641441|NCT02442765|451968704|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
125641442|NCT02442765|451968705|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
125641443|NCT02442765|451968698|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
125133971|NCT03071575|450115499|FG000|Overall Study|Lost to Follow-up|5|||
125133972|NCT03071575|450115500|FG001|Overall Study|Lost to Follow-up|11|||
125133973|NCT03071575|450115499|FG000|Overall Study|Withdrawal by Subject|4|||
125133974|NCT03071575|450115500|FG001|Overall Study|Withdrawal by Subject|2|||
125133975|NCT03255733|450115504|FG000|Overall Study|Lost to Follow-up|4|||
125133976|NCT04299087|450115505|FG000|Overall Study|Lost to Follow-up|2|||
125133977|NCT04299087|450115506|FG001|Overall Study|Lost to Follow-up|1|||
125133978|NCT00594035|450115507|FG000|Overall Study|Lost to Follow-up|1|||
125133979|NCT00594035|450115508|FG001|Overall Study|Lost to Follow-up|1|||
125133980|NCT00594035|450115507|FG000|Overall Study|Withdrawal by Subject|1|||
125133981|NCT00594035|450115508|FG001|Overall Study|Withdrawal by Subject|0|||
125133982|NCT00594035|450115507|FG000|Overall Study|Subject transferred to nursing home|0|||
125133983|NCT00594035|450115508|FG001|Overall Study|Subject transferred to nursing home|1|||
125218489|NCT02420262|450427342|FG001|Overall Study|Unclassified|1|||
125133984|NCT00594035|450115507|FG000|Overall Study|Subject couldn't return due to job|0|||
125133985|NCT00594035|450115508|FG001|Overall Study|Subject couldn't return due to job|1|||
125133986|NCT00795821|450115509|FG000|Acute Treatment Phase|Adverse Event|23|||
125133987|NCT00795821|450115510|FG001|Acute Treatment Phase|Adverse Event|4|||
125133988|NCT00795821|450115509|FG000|Acute Treatment Phase|Death|1|||
125133989|NCT00795821|450115510|FG001|Acute Treatment Phase|Death|0|||
125437145|NCT00791921|451228005|FG001|Overall Study|Protocol planed|88|||
125641444|NCT02442765|451968699|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
125641445|NCT02442765|451968700|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
125641446|NCT02442765|451968701|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
125641447|NCT02442765|451968702|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
125641448|NCT02442765|451968703|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
125641449|NCT02442765|451968704|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
125641450|NCT02442765|451968705|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
125641451|NCT02442765|451968698|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
125641452|NCT02442765|451968699|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
125641453|NCT02442765|451968700|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
125641454|NCT02442765|451968701|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
125641455|NCT02442765|451968702|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
125641456|NCT02442765|451968703|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
125641457|NCT02442765|451968704|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
125641458|NCT02442765|451968705|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
125641459|NCT02442765|451968698|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
125641460|NCT02442765|451968699|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
125641461|NCT02442765|451968700|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
125641462|NCT02442765|451968701|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
125641463|NCT02442765|451968702|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
125641464|NCT02442765|451968703|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
125641465|NCT02442765|451968704|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
125641466|NCT02442765|451968705|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
125641467|NCT01200758|451968706|FG000|Stage I|Death|0|||
125641468|NCT01200758|451968707|FG001|Stage I|Death|1|||
125641469|NCT01200758|451968708|FG002|Stage I|Death|0|||
125641470|NCT01200758|451968709|FG003|Stage I|Death|0|||
125641471|NCT01200758|451968706|FG000|Stage I|Physician Decision|1|||
125641472|NCT01200758|451968707|FG001|Stage I|Physician Decision|1|||
125641473|NCT01200758|451968708|FG002|Stage I|Physician Decision|0|||
125641474|NCT01200758|451968709|FG003|Stage I|Physician Decision|0|||
125641475|NCT01200758|451968706|FG000|Stage I|Lack of Efficacy|2|||
125641476|NCT01200758|451968707|FG001|Stage I|Lack of Efficacy|1|||
125641477|NCT01200758|451968708|FG002|Stage I|Lack of Efficacy|0|||
125641478|NCT01200758|451968709|FG003|Stage I|Lack of Efficacy|0|||
125641479|NCT01200758|451968706|FG000|Stage I|Adverse Event|5|||
125641480|NCT01200758|451968707|FG001|Stage I|Adverse Event|5|||
125641481|NCT01200758|451968708|FG002|Stage I|Adverse Event|0|||
125641482|NCT01200758|451968709|FG003|Stage I|Adverse Event|0|||
125641483|NCT01200758|451968706|FG000|Stage I|Withdrawal by Subject|1|||
125641484|NCT01200758|451968707|FG001|Stage I|Withdrawal by Subject|2|||
125641485|NCT01200758|451968708|FG002|Stage I|Withdrawal by Subject|0|||
125641486|NCT01200758|451968709|FG003|Stage I|Withdrawal by Subject|0|||
125641487|NCT01200758|451968706|FG000|Stage I|Disease Progression|9|||
125641488|NCT01200758|451968707|FG001|Stage I|Disease Progression|7|||
125641489|NCT01200758|451968708|FG002|Stage I|Disease Progression|0|||
125641490|NCT01200758|451968709|FG003|Stage I|Disease Progression|0|||
125641491|NCT01200758|451968706|FG000|Stage 2|Disease Progression|0|||
125641492|NCT01200758|451968707|FG001|Stage 2|Disease Progression|0|||
125641493|NCT01200758|451968708|FG002|Stage 2|Disease Progression|16|||
125641494|NCT01200758|451968709|FG003|Stage 2|Disease Progression|21|||
125641495|NCT01200758|451968706|FG000|Stage 2|Lack of Efficacy|0|||
125641496|NCT01200758|451968707|FG001|Stage 2|Lack of Efficacy|0|||
125641497|NCT01200758|451968708|FG002|Stage 2|Lack of Efficacy|4|||
125641498|NCT01200758|451968709|FG003|Stage 2|Lack of Efficacy|2|||
125641499|NCT01200758|451968706|FG000|Stage 2|Physician Decision|0|||
125641500|NCT01200758|451968707|FG001|Stage 2|Physician Decision|0|||
125641501|NCT01200758|451968708|FG002|Stage 2|Physician Decision|5|||
125641502|NCT01200758|451968709|FG003|Stage 2|Physician Decision|7|||
125641503|NCT01200758|451968706|FG000|Stage 2|Adverse Event|0|||
125641504|NCT01200758|451968707|FG001|Stage 2|Adverse Event|0|||
125641505|NCT01200758|451968708|FG002|Stage 2|Adverse Event|5|||
125641506|NCT01200758|451968709|FG003|Stage 2|Adverse Event|9|||
125641507|NCT01200758|451968706|FG000|Stage 2|Withdrawal by Subject|0|||
125641508|NCT01200758|451968707|FG001|Stage 2|Withdrawal by Subject|0|||
125437146|NCT00791921|451228004|FG000|Overall Study|Withdrawal by Subject|1|||
125437147|NCT00791921|451228005|FG001|Overall Study|Withdrawal by Subject|2|||
125641509|NCT01200758|451968708|FG002|Stage 2|Withdrawal by Subject|4|||
125641510|NCT01200758|451968709|FG003|Stage 2|Withdrawal by Subject|1|||
125641511|NCT01200758|451968706|FG000|Stage 2|Lost to Follow-up|0|||
125641512|NCT01200758|451968707|FG001|Stage 2|Lost to Follow-up|0|||
125641513|NCT01200758|451968708|FG002|Stage 2|Lost to Follow-up|3|||
125641514|NCT01200758|451968709|FG003|Stage 2|Lost to Follow-up|1|||
125641515|NCT01200758|451968706|FG000|Stage 2|Protocol Violation|0|||
125641516|NCT01200758|451968707|FG001|Stage 2|Protocol Violation|0|||
125641517|NCT01200758|451968708|FG002|Stage 2|Protocol Violation|1|||
125641518|NCT01200758|451968709|FG003|Stage 2|Protocol Violation|4|||
125641519|NCT01200758|451968706|FG000|Stage 2|Death|0|||
125641520|NCT01200758|451968707|FG001|Stage 2|Death|0|||
125641521|NCT01200758|451968708|FG002|Stage 2|Death|3|||
125641522|NCT01200758|451968709|FG003|Stage 2|Death|5|||
125641523|NCT01371721|451968710|FG000|Overall Study|Adverse Event|5|||
125641524|NCT01371721|451968711|FG001|Overall Study|Adverse Event|4|||
125641525|NCT01371721|451968712|FG002|Overall Study|Adverse Event|5|||
125641526|NCT01371721|451968710|FG000|Overall Study|Protocol Violation|6|||
125641527|NCT01371721|451968711|FG001|Overall Study|Protocol Violation|4|||
125641528|NCT01371721|451968712|FG002|Overall Study|Protocol Violation|5|||
125641529|NCT01371721|451968710|FG000|Overall Study|Lost to Follow-up|8|||
125641530|NCT01371721|451968711|FG001|Overall Study|Lost to Follow-up|2|||
125641531|NCT01371721|451968712|FG002|Overall Study|Lost to Follow-up|6|||
125641532|NCT01371721|451968710|FG000|Overall Study|Withdrawal by Subject|5|||
125641533|NCT01371721|451968711|FG001|Overall Study|Withdrawal by Subject|7|||
125641534|NCT01371721|451968712|FG002|Overall Study|Withdrawal by Subject|11|||
125641535|NCT01371721|451968710|FG000|Overall Study|Other|2|||
125641536|NCT01371721|451968711|FG001|Overall Study|Other|3|||
125641537|NCT01371721|451968712|FG002|Overall Study|Other|0|||
125641538|NCT01371721|451968710|FG000|Overall Study|Lack of Efficacy|2|||
125641539|NCT01371721|451968711|FG001|Overall Study|Lack of Efficacy|4|||
125641540|NCT01371721|451968712|FG002|Overall Study|Lack of Efficacy|3|||
125641541|NCT01371721|451968710|FG000|Overall Study|Randomized but not treated|1|||
125641542|NCT01371721|451968711|FG001|Overall Study|Randomized but not treated|0|||
125641543|NCT01371721|451968712|FG002|Overall Study|Randomized but not treated|0|||
125641544|NCT03267576|451968719|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
125641545|NCT03267576|451968720|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
125641546|NCT03267576|451968719|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
125641547|NCT03267576|451968720|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
125641548|NCT01369069|451968721|FG000|Overall Study|Lost to Follow-up|8|||
125641549|NCT01369069|451968722|FG001|Overall Study|Lost to Follow-up|9|||
125641550|NCT01369069|451968721|FG000|Overall Study|Withdrawal by Subject|9|||
125641551|NCT01369069|451968722|FG001|Overall Study|Withdrawal by Subject|7|||
125641552|NCT00882362|451968723|FG000|Overall Study|Adverse Event|13|||
125641553|NCT00882362|451968724|FG001|Overall Study|Adverse Event|10|||
125641554|NCT00882362|451968723|FG000|Overall Study|Withdrawal by Subject|13|||
125641555|NCT00882362|451968724|FG001|Overall Study|Withdrawal by Subject|10|||
125641556|NCT00882362|451968723|FG000|Overall Study|Lack of Efficacy|3|||
125641557|NCT00882362|451968724|FG001|Overall Study|Lack of Efficacy|0|||
125641558|NCT00882362|451968723|FG000|Overall Study|Protocol Violation|7|||
125641559|NCT00882362|451968724|FG001|Overall Study|Protocol Violation|2|||
125641560|NCT00882362|451968723|FG000|Overall Study|Pregnancy|1|||
125641561|NCT00882362|451968724|FG001|Overall Study|Pregnancy|0|||
125641562|NCT00882362|451968723|FG000|Overall Study|Physician Decision|5|||
125641563|NCT00882362|451968724|FG001|Overall Study|Physician Decision|1|||
125641564|NCT00882362|451968723|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
125133990|NCT00795821|450115509|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
125133991|NCT00795821|450115510|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
125133992|NCT00795821|450115509|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
125133993|NCT00795821|450115510|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
125133994|NCT00795821|450115509|FG000|Acute Treatment Phase|Physician Decision|1|||
125133995|NCT00795821|450115510|FG001|Acute Treatment Phase|Physician Decision|1|||
125133996|NCT00795821|450115509|FG000|Acute Treatment Phase|Protocol Violation|1|||
125133997|NCT00795821|450115510|FG001|Acute Treatment Phase|Protocol Violation|2|||
125133998|NCT00795821|450115509|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
125133999|NCT00795821|450115510|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
125134000|NCT00795821|450115509|FG000|Long-term Extension Phase|Adverse Event|25|||
125134001|NCT00795821|450115510|FG001|Long-term Extension Phase|Adverse Event|32|||
125380369|NCT03325075|451025169|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
125641565|NCT00882362|451968724|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
125641566|NCT00882362|451968723|FG000|Overall Study|change of residence or other commitments|5|||
125641567|NCT00882362|451968724|FG001|Overall Study|change of residence or other commitments|0|||
125641568|NCT01268514|451968725|FG000|Overall Study|Adverse Event|20|||
125641569|NCT01268514|451968725|FG000|Overall Study|Death|8|||
125641570|NCT01268514|451968725|FG000|Overall Study|Lost to Follow-up|5|||
125641571|NCT01268514|451968725|FG000|Overall Study|Withdrawal by Subject|3|||
125641572|NCT01268514|451968725|FG000|Overall Study|Withdrawal by Surgeon|5|||
125641573|NCT01809327|451968728|FG000|Overall Study|Lost to Follow-up|5|||
125641574|NCT01809327|451968729|FG001|Overall Study|Lost to Follow-up|2|||
125641575|NCT01809327|451968730|FG002|Overall Study|Lost to Follow-up|4|||
125641576|NCT01809327|451968731|FG003|Overall Study|Lost to Follow-up|2|||
125641577|NCT01809327|451968732|FG004|Overall Study|Lost to Follow-up|3|||
125641578|NCT01809327|451968728|FG000|Overall Study|Withdrawal by Subject|6|||
125641579|NCT01809327|451968729|FG001|Overall Study|Withdrawal by Subject|4|||
125641580|NCT01809327|451968730|FG002|Overall Study|Withdrawal by Subject|4|||
125641581|NCT01809327|451968731|FG003|Overall Study|Withdrawal by Subject|2|||
125641582|NCT01809327|451968732|FG004|Overall Study|Withdrawal by Subject|5|||
125641583|NCT01809327|451968728|FG000|Overall Study|Adverse Event|4|||
125641584|NCT01809327|451968729|FG001|Overall Study|Adverse Event|3|||
125641585|NCT01809327|451968730|FG002|Overall Study|Adverse Event|7|||
125641586|NCT01809327|451968731|FG003|Overall Study|Adverse Event|4|||
125641587|NCT01809327|451968732|FG004|Overall Study|Adverse Event|8|||
125641588|NCT01809327|451968728|FG000|Overall Study|Death|1|||
125641589|NCT01809327|451968729|FG001|Overall Study|Death|0|||
125641590|NCT01809327|451968730|FG002|Overall Study|Death|0|||
125641591|NCT01809327|451968731|FG003|Overall Study|Death|0|||
125641592|NCT01809327|451968732|FG004|Overall Study|Death|0|||
125641593|NCT01809327|451968728|FG000|Overall Study|Protocol Violation|0|||
125641594|NCT01809327|451968729|FG001|Overall Study|Protocol Violation|1|||
125641595|NCT01809327|451968730|FG002|Overall Study|Protocol Violation|0|||
125641596|NCT01809327|451968731|FG003|Overall Study|Protocol Violation|0|||
125641597|NCT01809327|451968732|FG004|Overall Study|Protocol Violation|0|||
125641598|NCT01809327|451968728|FG000|Overall Study|Physician Decision|1|||
125641599|NCT01809327|451968729|FG001|Overall Study|Physician Decision|1|||
125641600|NCT01809327|451968730|FG002|Overall Study|Physician Decision|0|||
125641601|NCT01809327|451968731|FG003|Overall Study|Physician Decision|0|||
125641602|NCT01809327|451968732|FG004|Overall Study|Physician Decision|0|||
125641603|NCT01809327|451968728|FG000|Overall Study|Pregnancy|1|||
125641604|NCT01809327|451968729|FG001|Overall Study|Pregnancy|0|||
125641605|NCT01809327|451968730|FG002|Overall Study|Pregnancy|0|||
125641606|NCT01809327|451968731|FG003|Overall Study|Pregnancy|0|||
125641607|NCT01809327|451968732|FG004|Overall Study|Pregnancy|0|||
125641608|NCT01809327|451968728|FG000|Overall Study|Other|14|||
125641609|NCT01809327|451968729|FG001|Overall Study|Other|15|||
125641610|NCT01809327|451968730|FG002|Overall Study|Other|7|||
125641611|NCT01809327|451968731|FG003|Overall Study|Other|4|||
125641612|NCT01809327|451968732|FG004|Overall Study|Other|9|||
125641613|NCT03196973|451968733|FG000|Overall Study|Adverse Event|1|||
125641614|NCT03196973|451968734|FG001|Overall Study|Adverse Event|1|||
125641615|NCT03196973|451968735|FG002|Overall Study|Adverse Event|2|||
125641616|NCT03196973|451968733|FG000|Overall Study|Lack of Efficacy|2|||
125641617|NCT03196973|451968734|FG001|Overall Study|Lack of Efficacy|6|||
125641618|NCT03196973|451968735|FG002|Overall Study|Lack of Efficacy|1|||
125641619|NCT03196973|451968733|FG000|Overall Study|Lost to Follow-up|4|||
125641620|NCT03196973|451968734|FG001|Overall Study|Lost to Follow-up|3|||
125641621|NCT03196973|451968735|FG002|Overall Study|Lost to Follow-up|2|||
125641622|NCT03196973|451968733|FG000|Overall Study|Consent withdrawn|2|||
125641623|NCT03196973|451968734|FG001|Overall Study|Consent withdrawn|1|||
125641624|NCT03196973|451968735|FG002|Overall Study|Consent withdrawn|0|||
125641625|NCT03196973|451968733|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
125641626|NCT03196973|451968734|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
125641627|NCT03196973|451968735|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
125641628|NCT02390362|451968741|FG000|Overall Study|Withdrawal by Subject|0|||
125641629|NCT02390362|451968742|FG001|Overall Study|Withdrawal by Subject|1|||
125134002|NCT00795821|450115509|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
125134003|NCT00795821|450115510|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
125134004|NCT00795821|450115509|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
125134005|NCT00795821|450115510|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
125134006|NCT00795821|450115509|FG000|Long-term Extension Phase|Physician Decision|1|||
125134007|NCT00795821|450115510|FG001|Long-term Extension Phase|Physician Decision|2|||
125134008|NCT00795821|450115509|FG000|Long-term Extension Phase|Protocol Violation|3|||
125134009|NCT00795821|450115510|FG001|Long-term Extension Phase|Protocol Violation|5|||
125134010|NCT00795821|450115509|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
125134011|NCT00795821|450115510|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
125134012|NCT00795821|450115509|FG000|Taper Phase|Adverse Event|2|||
125134013|NCT00795821|450115510|FG001|Taper Phase|Adverse Event|0|||
125134014|NCT00795821|450115509|FG000|Taper Phase|Lost to Follow-up|1|||
125134015|NCT00795821|450115510|FG001|Taper Phase|Lost to Follow-up|0|||
125134016|NCT00795821|450115509|FG000|Taper Phase|Physician Decision|2|||
125134017|NCT00795821|450115510|FG001|Taper Phase|Physician Decision|0|||
125134018|NCT00795821|450115509|FG000|Taper Phase|Withdrawal by Subject|4|||
125134019|NCT00795821|450115510|FG001|Taper Phase|Withdrawal by Subject|0|||
125134020|NCT02301975|450115519|FG000|Overall Study|Adverse Event|8|||
125134021|NCT02301975|450115520|FG001|Overall Study|Adverse Event|3|||
125641630|NCT04009824|451968743|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
125641631|NCT04009824|451968744|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
125641632|NCT04009824|451968745|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
125641633|NCT04009824|451968746|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
125641634|NCT04009824|451968747|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
125641635|NCT01142791|451968750|FG000|Overall Study|Alternative Treatment|1|||
125641636|NCT01142791|451968751|FG001|Overall Study|Alternative Treatment|0|||
125641637|NCT01142791|451968750|FG000|Overall Study|Lost to Follow-up|1|||
125641638|NCT01142791|451968751|FG001|Overall Study|Lost to Follow-up|0|||
125641639|NCT01142791|451968750|FG000|Overall Study|Withdrawal by Subject|5|||
125641640|NCT01142791|451968751|FG001|Overall Study|Withdrawal by Subject|0|||
125641641|NCT01142791|451968750|FG000|Overall Study|Received only 1 sonication|0|||
125641642|NCT01142791|451968751|FG001|Overall Study|Received only 1 sonication|6|||
125641643|NCT03032523|451968752|FG000|Overall Study|Withdrawal by Subject|2|||
125641644|NCT03032523|451968753|FG001|Overall Study|Withdrawal by Subject|2|||
125641645|NCT03032523|451968752|FG000|Overall Study|Physician Decision|1|||
125641646|NCT03032523|451968753|FG001|Overall Study|Physician Decision|0|||
125641647|NCT00957723|451968756|FG000|Overall Study|Death|3|||
125641648|NCT00957723|451968756|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
125641649|NCT00957723|451968756|FG000|Overall Study|Lost to Follow-up|8|||
125641650|NCT00957723|451968756|FG000|Overall Study|Withdrawal by Subject|24|||
125641651|NCT00957723|451968756|FG000|Overall Study|Investigative Site Terminated|61|||
125641652|NCT00957723|451968756|FG000|Overall Study|Intercurrent Illness|2|||
125641653|NCT00957723|451968756|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
125641654|NCT00281528|451968757|FG000|Overall Study|Progressive Disease|28|||
125641655|NCT00281528|451968758|FG001|Overall Study|Progressive Disease|18|||
125641656|NCT00281528|451968759|FG002|Overall Study|Progressive Disease|27|||
125641657|NCT00281528|451968757|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
125641658|NCT00281528|451968758|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
125641659|NCT00281528|451968759|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
125641660|NCT00281528|451968757|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
125641661|NCT00281528|451968758|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
125641662|NCT00281528|451968759|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
125641663|NCT00281528|451968757|FG000|Overall Study|Physician Decision|11|||
125641664|NCT00281528|451968758|FG001|Overall Study|Physician Decision|4|||
125641665|NCT00281528|451968759|FG002|Overall Study|Physician Decision|5|||
125641666|NCT00281528|451968757|FG000|Overall Study|Protocol Violation|1|||
125641667|NCT00281528|451968758|FG001|Overall Study|Protocol Violation|0|||
125641668|NCT00281528|451968759|FG002|Overall Study|Protocol Violation|1|||
125641669|NCT00281528|451968757|FG000|Overall Study|Withdrawal by Subject|5|||
125641670|NCT00281528|451968758|FG001|Overall Study|Withdrawal by Subject|5|||
125641671|NCT00281528|451968759|FG002|Overall Study|Withdrawal by Subject|7|||
125641672|NCT00281528|451968757|FG000|Overall Study|Other|6|||
125641673|NCT00281528|451968758|FG001|Overall Study|Other|3|||
125641674|NCT00281528|451968759|FG002|Overall Study|Other|5|||
125641675|NCT01984294|451968767|FG000|Overall Study|Randomized but Never Treated|0|||
125641676|NCT01984294|451968768|FG001|Overall Study|Randomized but Never Treated|0|||
125641677|NCT01984294|451968769|FG002|Overall Study|Randomized but Never Treated|1|||
125641678|NCT01984294|451968767|FG000|Overall Study|Lack of Efficacy|4|||
125134022|NCT02301975|450115521|FG002|Overall Study|Adverse Event|2|||
125134023|NCT02301975|450115519|FG000|Overall Study|Lack of Efficacy|1|||
125134024|NCT02301975|450115520|FG001|Overall Study|Lack of Efficacy|1|||
125134025|NCT02301975|450115521|FG002|Overall Study|Lack of Efficacy|1|||
125134026|NCT02301975|450115519|FG000|Overall Study|Protocol Violation|3|||
125134027|NCT02301975|450115520|FG001|Overall Study|Protocol Violation|5|||
125641679|NCT01984294|451968768|FG001|Overall Study|Lack of Efficacy|2|||
125134028|NCT02301975|450115521|FG002|Overall Study|Protocol Violation|3|||
125134029|NCT02301975|450115519|FG000|Overall Study|Lost to Follow-up|0|||
125134030|NCT02301975|450115520|FG001|Overall Study|Lost to Follow-up|2|||
125134031|NCT02301975|450115521|FG002|Overall Study|Lost to Follow-up|2|||
125134032|NCT02301975|450115519|FG000|Overall Study|Physician Decision|4|||
125134033|NCT02301975|450115520|FG001|Overall Study|Physician Decision|2|||
125134034|NCT02301975|450115521|FG002|Overall Study|Physician Decision|3|||
125134035|NCT02301975|450115519|FG000|Overall Study|Withdrawal by Subject|15|||
125134036|NCT02301975|450115520|FG001|Overall Study|Withdrawal by Subject|12|||
125134037|NCT02301975|450115521|FG002|Overall Study|Withdrawal by Subject|11|||
125134038|NCT01440803|450115522|FG000|Overall Study|Met study stopping rule|2|||
125134039|NCT01440803|450115523|FG001|Overall Study|Met study stopping rule|1|||
125134040|NCT01440803|450115522|FG000|Overall Study|Lost to Follow-up|0|||
125134041|NCT01440803|450115523|FG001|Overall Study|Lost to Follow-up|2|||
125134042|NCT01440803|450115522|FG000|Overall Study|Withdrawal by Subject|0|||
125134043|NCT01440803|450115523|FG001|Overall Study|Withdrawal by Subject|1|||
125134044|NCT01609257|450115526|FG000|Overall Study|Lost to Follow-up|2|||
125134045|NCT01609257|450115527|FG001|Overall Study|Lost to Follow-up|1|||
125134046|NCT01609257|450115526|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
125134047|NCT01609257|450115527|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
125134048|NCT01609257|450115526|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
125134049|NCT01609257|450115527|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
125134050|NCT02125461|450115528|FG000|Overall Study|Withdrawal by Subject|30|||
125134051|NCT02125461|450115529|FG001|Overall Study|Withdrawal by Subject|16|||
125134052|NCT02125461|450115528|FG000|Overall Study|Lost to Follow-up|8|||
125134053|NCT02125461|450115529|FG001|Overall Study|Lost to Follow-up|3|||
125134054|NCT02125461|450115528|FG000|Overall Study|Death|260|||
125134055|NCT02125461|450115529|FG001|Overall Study|Death|149|||
125218490|NCT00436826|450427346|FG000|Double Blind Period (DBP)|Adverse Event|2|||
125218491|NCT00436826|450427347|FG001|Double Blind Period (DBP)|Adverse Event|0|||
125641680|NCT01984294|451968769|FG002|Overall Study|Lack of Efficacy|6|||
125641681|NCT01984294|451968767|FG000|Overall Study|Adverse Event|0|||
125641682|NCT01984294|451968768|FG001|Overall Study|Adverse Event|1|||
125641683|NCT01984294|451968769|FG002|Overall Study|Adverse Event|0|||
125641684|NCT01987609|451968772|FG000|Overall Study|Adverse Event|1|||
125641685|NCT02610231|451968773|FG000|Overall Study|Withdrawal by Subject|27|||
125641686|NCT02610231|451968773|FG000|Overall Study|Adverse Event|20|||
125641687|NCT02610231|451968773|FG000|Overall Study|Death|5|||
125641688|NCT02610231|451968773|FG000|Overall Study|Surgery|2|||
125641689|NCT02610231|451968773|FG000|Overall Study|Physician Decision|1|||
125641690|NCT02610231|451968773|FG000|Overall Study|Non Compliance|2|||
125641691|NCT02610231|451968773|FG000|Overall Study|Other|3|||
125641692|NCT00806494|451968774|FG000|Overall Study|Adverse Event|29|||
125641693|NCT00806494|451968774|FG000|Overall Study|Lack of Efficacy|6|||
125641694|NCT00806494|451968774|FG000|Overall Study|Lost to Follow-up|10|||
125641695|NCT00806494|451968774|FG000|Overall Study|Other|30|||
125641696|NCT00806494|451968774|FG000|Overall Study|Withdrawal by Subject|5|||
125641697|NCT01279954|451968775|FG000|Overall Study|Lack of Efficacy|3|||
125641698|NCT01279954|451968776|FG001|Overall Study|Lack of Efficacy|4|||
125641699|NCT02709889|451968777|FG000|Overall Study|Withdrawal by Subject|11|||
125641700|NCT02709889|451968778|FG001|Overall Study|Withdrawal by Subject|10|||
125641701|NCT02709889|451968779|FG002|Overall Study|Withdrawal by Subject|2|||
125134056|NCT02125461|450115528|FG000|Overall Study|Missing Termination Reason|0|||
125134057|NCT02125461|450115529|FG001|Overall Study|Missing Termination Reason|1|||
125134058|NCT03049748|450115530|FG000|Overall Study|Lost to Follow-up|1|||
125134059|NCT03049748|450115531|FG001|Overall Study|Lost to Follow-up|0|||
125218492|NCT00436826|450427348|FG002|Double Blind Period (DBP)|Adverse Event|0|||
125218493|NCT00436826|450427349|FG003|Double Blind Period (DBP)|Adverse Event|0|||
125641702|NCT02709889|451968780|FG003|Overall Study|Withdrawal by Subject|12|||
125641703|NCT02709889|451968777|FG000|Overall Study|Death|25|||
125641704|NCT02709889|451968778|FG001|Overall Study|Death|38|||
125641705|NCT02709889|451968779|FG002|Overall Study|Death|4|||
125641706|NCT02709889|451968780|FG003|Overall Study|Death|44|||
125641707|NCT02709889|451968777|FG000|Overall Study|Physician Decision|1|||
125134060|NCT03049748|450115530|FG000|Overall Study|Death|3|||
125134061|NCT03049748|450115531|FG001|Overall Study|Death|0|||
125134062|NCT03049748|450115530|FG000|Overall Study|Withdrawal by Subject|0|||
125134063|NCT03049748|450115531|FG001|Overall Study|Withdrawal by Subject|3|||
125134064|NCT03049748|450115530|FG000|Overall Study|Protocol Violation|0|||
125134065|NCT03049748|450115531|FG001|Overall Study|Protocol Violation|2|||
125134066|NCT03049748|450115530|FG000|Overall Study|Moved out of state (relocation)|0|||
125134067|NCT03049748|450115531|FG001|Overall Study|Moved out of state (relocation)|1|||
125134068|NCT04994535|450115535|FG000|Overall Study|Lost to Follow-up|7|||
125134069|NCT04994535|450115536|FG001|Overall Study|Lost to Follow-up|7|||
125134070|NCT04994535|450115535|FG000|Overall Study|Withdrawal by Subject|10|||
125380370|NCT03325075|451025166|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
125380371|NCT03325075|451025167|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
125380372|NCT03325075|451025168|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
125641708|NCT02709889|451968778|FG001|Overall Study|Physician Decision|2|||
125641709|NCT02709889|451968779|FG002|Overall Study|Physician Decision|3|||
125641710|NCT02709889|451968780|FG003|Overall Study|Physician Decision|5|||
125641711|NCT02709889|451968777|FG000|Overall Study|Lost to Follow-up|2|||
125641712|NCT02709889|451968778|FG001|Overall Study|Lost to Follow-up|0|||
125641713|NCT02709889|451968779|FG002|Overall Study|Lost to Follow-up|0|||
125641714|NCT02709889|451968780|FG003|Overall Study|Lost to Follow-up|4|||
125641715|NCT02709889|451968777|FG000|Overall Study|Study Terminated by Sponsor|4|||
125641716|NCT02709889|451968778|FG001|Overall Study|Study Terminated by Sponsor|6|||
125641717|NCT02709889|451968779|FG002|Overall Study|Study Terminated by Sponsor|2|||
125641718|NCT02709889|451968780|FG003|Overall Study|Study Terminated by Sponsor|17|||
125641719|NCT02709889|451968777|FG000|Overall Study|Other, Not Specified|0|||
125641720|NCT02709889|451968778|FG001|Overall Study|Other, Not Specified|1|||
125641721|NCT02709889|451968779|FG002|Overall Study|Other, Not Specified|1|||
125641722|NCT02709889|451968780|FG003|Overall Study|Other, Not Specified|6|||
125641723|NCT00537810|451968781|FG000|Overall Study|Withdrawal by Subject|4|||
125641724|NCT00537810|451968782|FG001|Overall Study|Withdrawal by Subject|11|||
125641725|NCT00537810|451968783|FG002|Overall Study|Withdrawal by Subject|4|||
125641726|NCT00537810|451968784|FG003|Overall Study|Withdrawal by Subject|3|||
125641727|NCT00537810|451968781|FG000|Overall Study|Medically withdrawn|2|||
125641728|NCT00537810|451968782|FG001|Overall Study|Medically withdrawn|2|||
125641729|NCT00537810|451968783|FG002|Overall Study|Medically withdrawn|0|||
125641730|NCT00537810|451968784|FG003|Overall Study|Medically withdrawn|1|||
125641731|NCT01066546|451968785|FG000|Overall Study|Study terminated by sponsor|5|||
125641732|NCT03258762|451968786|FG000|Overall Study|Lost to Follow-up|0|||
125641733|NCT03258762|451968787|FG001|Overall Study|Lost to Follow-up|1|||
125641734|NCT01711359|451968788|FG000|Treatment Period|Withdrawal by Subject|18|||
125641735|NCT01711359|451968789|FG001|Treatment Period|Withdrawal by Subject|7|||
125641736|NCT01711359|451968790|FG002|Treatment Period|Withdrawal by Subject|13|||
125641737|NCT01711359|451968788|FG000|Treatment Period|Lack of Efficacy|13|||
125641738|NCT01711359|451968789|FG001|Treatment Period|Lack of Efficacy|2|||
125641739|NCT01711359|451968790|FG002|Treatment Period|Lack of Efficacy|2|||
125641740|NCT01711359|451968788|FG000|Treatment Period|Adverse Event|8|||
125641741|NCT01711359|451968789|FG001|Treatment Period|Adverse Event|10|||
125641742|NCT01711359|451968790|FG002|Treatment Period|Adverse Event|24|||
125641743|NCT01711359|451968788|FG000|Treatment Period|Physician Decision|4|||
125641744|NCT01711359|451968789|FG001|Treatment Period|Physician Decision|3|||
125641745|NCT01711359|451968790|FG002|Treatment Period|Physician Decision|2|||
125641746|NCT01711359|451968788|FG000|Treatment Period|Death|3|||
125641747|NCT01711359|451968789|FG001|Treatment Period|Death|0|||
125641748|NCT01711359|451968790|FG002|Treatment Period|Death|0|||
125641749|NCT01711359|451968788|FG000|Treatment Period|Entry Criteria Not Met|1|||
125641750|NCT01711359|451968789|FG001|Treatment Period|Entry Criteria Not Met|0|||
125641751|NCT01711359|451968790|FG002|Treatment Period|Entry Criteria Not Met|0|||
125380373|NCT03325075|451025169|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
125380374|NCT03325075|451025166|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
125380375|NCT03325075|451025167|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
125380376|NCT03325075|451025168|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
125641752|NCT01711359|451968788|FG000|Treatment Period|Sponsor Decision|1|||
125641753|NCT01711359|451968789|FG001|Treatment Period|Sponsor Decision|0|||
125641754|NCT01711359|451968790|FG002|Treatment Period|Sponsor Decision|0|||
125641755|NCT01711359|451968788|FG000|Treatment Period|Lost to Follow-up|1|||
125641756|NCT01711359|451968789|FG001|Treatment Period|Lost to Follow-up|1|||
125641757|NCT01711359|451968790|FG002|Treatment Period|Lost to Follow-up|1|||
125134071|NCT04994535|450115536|FG001|Overall Study|Withdrawal by Subject|7|||
125134072|NCT04994535|450115535|FG000|Overall Study|Other|1|||
125134073|NCT04994535|450115536|FG001|Overall Study|Other|1|||
125641758|NCT01711359|451968788|FG000|Treatment Period|Randomized, Not Treated|3|||
125134074|NCT01158118|450115537|FG000|Overall Study|Screen failure|1|||
125134075|NCT01158118|450115538|FG001|Overall Study|Screen failure|0|||
125641759|NCT01711359|451968789|FG001|Treatment Period|Randomized, Not Treated|1|||
125641760|NCT01711359|451968790|FG002|Treatment Period|Randomized, Not Treated|0|||
125641761|NCT02698176|451968791|FG000|Overall Study|Progressive disease|4|||
125134076|NCT01158118|450115537|FG000|Overall Study|Donor match was a screen failure|0|||
125641762|NCT02698176|451968792|FG001|Overall Study|Progressive disease|3|||
125641763|NCT02698176|451968793|FG002|Overall Study|Progressive disease|1|||
125641764|NCT02698176|451968794|FG003|Overall Study|Progressive disease|0|||
125641765|NCT02698176|451968791|FG000|Overall Study|Adverse Event|2|||
125134077|NCT01158118|450115538|FG001|Overall Study|Donor match was a screen failure|1|||
125134078|NCT01158118|450115537|FG000|Overall Study|Suffered stroke prior to transplant|0|||
125134079|NCT01158118|450115538|FG001|Overall Study|Suffered stroke prior to transplant|1|||
125134080|NCT01158118|450115537|FG000|Overall Study|Death|0|||
125134081|NCT01158118|450115538|FG001|Overall Study|Death|1|||
125134082|NCT00604162|450115539|FG000|Overall Study|Physician Decision|3|||
125134083|NCT00604162|450115539|FG000|Overall Study|Withdrawal by Subject|1|||
125134084|NCT01015287|450115542|FG000|Overall Study|Death|21|||
125134085|NCT01015287|450115543|FG001|Overall Study|Death|16|||
125134086|NCT01015287|450115542|FG000|Overall Study|Adverse Event|1|||
125134087|NCT01015287|450115543|FG001|Overall Study|Adverse Event|0|||
125134088|NCT01015287|450115542|FG000|Overall Study|Sponsor Decision|3|||
125134089|NCT01015287|450115543|FG001|Overall Study|Sponsor Decision|7|||
125134090|NCT01015287|450115542|FG000|Overall Study|Physician Decision|19|||
125134091|NCT01015287|450115543|FG001|Overall Study|Physician Decision|21|||
125134092|NCT01015287|450115542|FG000|Overall Study|Withdrawal by Subject|14|||
125134093|NCT01015287|450115543|FG001|Overall Study|Withdrawal by Subject|19|||
125134094|NCT01015287|450115542|FG000|Overall Study|Entry Criteria not Met|11|||
125134095|NCT01015287|450115543|FG001|Overall Study|Entry Criteria not Met|14|||
125134096|NCT01015287|450115542|FG000|Overall Study|Lost to Follow-up|2|||
125134097|NCT01015287|450115543|FG001|Overall Study|Lost to Follow-up|1|||
125134098|NCT01015287|450115542|FG000|Overall Study|Protocol Violation|1|||
125134099|NCT01015287|450115543|FG001|Overall Study|Protocol Violation|1|||
125134100|NCT00905840|450115544|FG000|Overall Study|Lost to Follow-up|11|||
125134101|NCT00905840|450115544|FG000|Overall Study|Death|3|||
125134102|NCT00905840|450115544|FG000|Overall Study|Withdrawal by Subject|1|||
125134103|NCT00905840|450115544|FG000|Overall Study|Adverse Event|1|||
125134104|NCT01370317|450115545|FG000|Overall Study|Participant withdrew consent|1|||
125134105|NCT01370317|450115546|FG001|Overall Study|Participant withdrew consent|0|||
125134106|NCT01370317|450115545|FG000|Overall Study|Protocol deviation|0|||
125134107|NCT01370317|450115546|FG001|Overall Study|Protocol deviation|1|||
125134108|NCT02105272|450115554|FG000|Overall Study|Adverse Event|1|||
125134109|NCT02105272|450115555|FG001|Overall Study|Adverse Event|2|||
125134110|NCT02105272|450115554|FG000|Overall Study|Physician Decision|0|||
125218494|NCT00436826|450427350|FG004|Double Blind Period (DBP)|Adverse Event|0|||
125218495|NCT00436826|450427351|FG005|Double Blind Period (DBP)|Adverse Event|0|||
125218496|NCT00436826|450427346|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
125218497|NCT00436826|450427347|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
125641766|NCT02698176|451968792|FG001|Overall Study|Adverse Event|0|||
125641767|NCT02698176|451968793|FG002|Overall Study|Adverse Event|0|||
125641768|NCT02698176|451968794|FG003|Overall Study|Adverse Event|0|||
125641769|NCT02698176|451968791|FG000|Overall Study|Clinical progression|3|||
125641770|NCT02698176|451968792|FG001|Overall Study|Clinical progression|0|||
125641771|NCT02698176|451968793|FG002|Overall Study|Clinical progression|0|||
125641772|NCT02698176|451968794|FG003|Overall Study|Clinical progression|0|||
125641773|NCT02561572|451968801|FG000|Overall Study|Inadequate time before surgery|2|||
125641774|NCT02561572|451968802|FG001|Overall Study|Inadequate time before surgery|1|||
125641775|NCT02561572|451968801|FG000|Overall Study|Protocol Violation|0|||
125641776|NCT02561572|451968802|FG001|Overall Study|Protocol Violation|1|||
125641777|NCT00795717|451968803|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
125641778|NCT00795717|451968804|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
125641779|NCT00795717|451968803|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
125641780|NCT00795717|451968804|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
125641781|NCT00795717|451968803|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
125134111|NCT02105272|450115555|FG001|Overall Study|Physician Decision|1|||
125134112|NCT02105272|450115554|FG000|Overall Study|Protocol Violation|2|||
125134113|NCT02105272|450115555|FG001|Overall Study|Protocol Violation|0|||
125134114|NCT02105272|450115554|FG000|Overall Study|Withdrawal by Subject|2|||
125218498|NCT00436826|450427348|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
125641782|NCT00795717|451968804|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
125134115|NCT02105272|450115555|FG001|Overall Study|Withdrawal by Subject|0|||
125134116|NCT03190915|450115557|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
125134117|NCT03190915|450115557|FG000|Overall Study|Progressive Disease|3|||
125134118|NCT02964039|450115558|FG000|Overall Study|Medical reason unrelated to study participation|1|||
125134119|NCT02964039|450115559|FG001|Overall Study|Medical reason unrelated to study participation|0|||
125134120|NCT02964039|450115560|FG002|Overall Study|Medical reason unrelated to study participation|3|||
125134121|NCT02964039|450115558|FG000|Overall Study|Research shutdown due to pandemic|2|||
125218499|NCT00436826|450427349|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
125641783|NCT00795717|451968803|FG000|Phase II|too busy|0|||
125641784|NCT00795717|451968804|FG001|Phase II|too busy|1|||
125134122|NCT02964039|450115559|FG001|Overall Study|Research shutdown due to pandemic|0|||
125437148|NCT00791921|451228004|FG000|Overall Study|Adverse Event|8|||
125641785|NCT04728815|451968818|FG000|Overall Study|Lost to Follow-up|3|||
125641786|NCT04728815|451968819|FG001|Overall Study|Lost to Follow-up|0|||
125641787|NCT04728815|451968820|FG002|Overall Study|Lost to Follow-up|0|||
125641788|NCT04728815|451968821|FG003|Overall Study|Lost to Follow-up|1|||
125641789|NCT04728815|451968822|FG004|Overall Study|Lost to Follow-up|1|||
125641790|NCT04728815|451968823|FG005|Overall Study|Lost to Follow-up|0|||
125641791|NCT04728815|451968824|FG006|Overall Study|Lost to Follow-up|2|||
125641792|NCT04728815|451968825|FG007|Overall Study|Lost to Follow-up|0|||
125641793|NCT04728815|451968818|FG000|Overall Study|Physician Decision|0|||
125641794|NCT04728815|451968819|FG001|Overall Study|Physician Decision|0|||
125437149|NCT00791921|451228005|FG001|Overall Study|Adverse Event|2|||
125641795|NCT04728815|451968820|FG002|Overall Study|Physician Decision|1|||
125641796|NCT04728815|451968821|FG003|Overall Study|Physician Decision|0|||
125641797|NCT04728815|451968822|FG004|Overall Study|Physician Decision|0|||
125134123|NCT02964039|450115560|FG002|Overall Study|Research shutdown due to pandemic|1|||
125134124|NCT02964039|450115558|FG000|Overall Study|Withdrawal by Subject|0|||
125134125|NCT02964039|450115559|FG001|Overall Study|Withdrawal by Subject|1|||
125134126|NCT02964039|450115560|FG002|Overall Study|Withdrawal by Subject|0|||
125134127|NCT02964039|450115558|FG000|Overall Study|Lost to Follow-up|1|||
125134128|NCT02964039|450115559|FG001|Overall Study|Lost to Follow-up|0|||
125134129|NCT02964039|450115560|FG002|Overall Study|Lost to Follow-up|1|||
125134130|NCT01103713|450115561|FG000|Overall Study|Lost to Follow-up|2|||
125134131|NCT01103713|450115561|FG000|Overall Study|Withdrawal by Subject|8|||
125134132|NCT01103713|450115561|FG000|Overall Study|Study terminated by sponsor|2|||
125134133|NCT01103713|450115561|FG000|Overall Study|Other|1|||
125134134|NCT03084471|450115564|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
125134135|NCT03084471|450115564|FG000|Overall Study|Condition under investigation worsened|84|||
125134136|NCT03084471|450115564|FG000|Overall Study|Lack of therapeutic response|2|||
125134137|NCT03084471|450115564|FG000|Overall Study|Protocol Violation|1|||
125134138|NCT03084471|450115564|FG000|Overall Study|Adverse Event|73|||
125134139|NCT03084471|450115564|FG000|Overall Study|Withdrawal by Subject|12|||
125134140|NCT03084471|450115564|FG000|Overall Study|Disease relapse|181|||
125134141|NCT03084471|450115564|FG000|Overall Study|Subjective disease progression|359|||
125134142|NCT03084471|450115564|FG000|Overall Study|Other (as recorded)|33|||
125134143|NCT03084471|450115564|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
125134144|NCT00505622|450115567|FG000|Overall Study|Adverse Event|5|||
125134145|NCT00505622|450115568|FG001|Overall Study|Adverse Event|6|||
125134146|NCT00505622|450115569|FG002|Overall Study|Adverse Event|4|||
125134147|NCT00505622|450115567|FG000|Overall Study|Protocol Violation|1|||
125134148|NCT00505622|450115568|FG001|Overall Study|Protocol Violation|1|||
125134149|NCT00505622|450115569|FG002|Overall Study|Protocol Violation|0|||
125134150|NCT00505622|450115567|FG000|Overall Study|Withdrawal by Subject|0|||
125134151|NCT00505622|450115568|FG001|Overall Study|Withdrawal by Subject|3|||
125134152|NCT00505622|450115569|FG002|Overall Study|Withdrawal by Subject|2|||
125134153|NCT00505622|450115567|FG000|Overall Study|Study termination by sponsor|115|||
125134154|NCT00505622|450115568|FG001|Overall Study|Study termination by sponsor|98|||
125641798|NCT04728815|451968823|FG005|Overall Study|Physician Decision|0|||
125641799|NCT04728815|451968824|FG006|Overall Study|Physician Decision|0|||
125641800|NCT04728815|451968825|FG007|Overall Study|Physician Decision|0|||
125641801|NCT04728815|451968818|FG000|Overall Study|Treatment drop|0|||
125641802|NCT04728815|451968819|FG001|Overall Study|Treatment drop|2|||
125641803|NCT04728815|451968820|FG002|Overall Study|Treatment drop|1|||
125641804|NCT04728815|451968821|FG003|Overall Study|Treatment drop|0|||
125641805|NCT04728815|451968822|FG004|Overall Study|Treatment drop|3|||
125641806|NCT04728815|451968823|FG005|Overall Study|Treatment drop|1|||
125641807|NCT04728815|451968824|FG006|Overall Study|Treatment drop|3|||
125641808|NCT04728815|451968825|FG007|Overall Study|Treatment drop|0|||
125641809|NCT04728815|451968818|FG000|Overall Study|Study drop|0|||
125641810|NCT04728815|451968819|FG001|Overall Study|Study drop|3|||
125641811|NCT04728815|451968820|FG002|Overall Study|Study drop|3|||
125641812|NCT04728815|451968821|FG003|Overall Study|Study drop|0|||
125641813|NCT04728815|451968822|FG004|Overall Study|Study drop|0|||
125641814|NCT04728815|451968823|FG005|Overall Study|Study drop|0|||
125641815|NCT04728815|451968824|FG006|Overall Study|Study drop|7|||
125134155|NCT00505622|450115569|FG002|Overall Study|Study termination by sponsor|90|||
125134156|NCT01848938|450115576|FG000|Overall Study|Lost to Follow-up|1|||
125134157|NCT01848938|450115577|FG001|Overall Study|Lost to Follow-up|1|||
125134158|NCT01757392|450115578|FG000|Overall Study|Withdrawal by Subject|1|||
125134159|NCT01757392|450115578|FG000|Overall Study|Screen Fail|3|||
125134160|NCT00651820|450115587|FG000|Overall Study|Lost to Follow-up|2|||
125134161|NCT01878292|450115588|FG000|Randomized|Protocol Violation|1|||
125134162|NCT01878292|450115589|FG001|Randomized|Protocol Violation|0|||
125134163|NCT01878292|450115590|FG002|Randomized|Protocol Violation|0|||
125134164|NCT01878292|450115588|FG000|Randomized|Lost to Follow-up|1|||
125134165|NCT01878292|450115589|FG001|Randomized|Lost to Follow-up|0|||
125134166|NCT01878292|450115590|FG002|Randomized|Lost to Follow-up|0|||
125134167|NCT01878292|450115588|FG000|Randomized|Adverse Event|1|||
125134168|NCT01878292|450115589|FG001|Randomized|Adverse Event|0|||
125641816|NCT04728815|451968825|FG007|Overall Study|Study drop|0|||
125641817|NCT00631969|451968826|FG000|Overall Study|Adverse Event|3|||
125641818|NCT00631969|451968827|FG001|Overall Study|Adverse Event|1|||
125641819|NCT00631969|451968826|FG000|Overall Study|Lack of Efficacy|2|||
125134169|NCT01878292|450115590|FG002|Randomized|Adverse Event|0|||
125134170|NCT01878292|450115588|FG000|Double-blind Treatment Period|Other Reasons|2|||
125134171|NCT01878292|450115589|FG001|Double-blind Treatment Period|Other Reasons|0|||
125134172|NCT01878292|450115590|FG002|Double-blind Treatment Period|Other Reasons|0|||
125134173|NCT01878292|450115588|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
125134174|NCT01878292|450115589|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
125134175|NCT01878292|450115590|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
125437150|NCT00791921|451228004|FG000|Overall Study|Lack of Efficacy|0|||
125641820|NCT00631969|451968827|FG001|Overall Study|Lack of Efficacy|8|||
125641821|NCT00631969|451968826|FG000|Overall Study|Lost to Follow-up|2|||
125218500|NCT00436826|450427350|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
125218501|NCT00436826|450427351|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
125218502|NCT00436826|450427346|FG000|Double Blind Period (DBP)|Other|10|||
125218503|NCT00436826|450427347|FG001|Double Blind Period (DBP)|Other|11|||
125218504|NCT00436826|450427348|FG002|Double Blind Period (DBP)|Other|0|||
125218505|NCT00436826|450427349|FG003|Double Blind Period (DBP)|Other|0|||
125218506|NCT00436826|450427350|FG004|Double Blind Period (DBP)|Other|0|||
125380377|NCT03325075|451025169|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
125641822|NCT00631969|451968827|FG001|Overall Study|Lost to Follow-up|1|||
125641823|NCT00631969|451968826|FG000|Overall Study|Protocol Violation|1|||
125641824|NCT00631969|451968827|FG001|Overall Study|Protocol Violation|1|||
125641825|NCT00631969|451968826|FG000|Overall Study|Consent Withdrawn|5|||
125641826|NCT00631969|451968827|FG001|Overall Study|Consent Withdrawn|7|||
125641827|NCT00631969|451968826|FG000|Overall Study|Noncompliant With Study Medication|0|||
125641828|NCT00631969|451968827|FG001|Overall Study|Noncompliant With Study Medication|1|||
125641829|NCT00631969|451968826|FG000|Overall Study|No Drug Exposure|2|||
125641830|NCT00631969|451968827|FG001|Overall Study|No Drug Exposure|2|||
125641831|NCT00957034|451968828|FG000|Overall Study|Adverse Event|0|||
125218507|NCT00436826|450427351|FG005|Double Blind Period (DBP)|Other|0|||
125380378|NCT02659631|451025172|FG000|Overall Study|Lost to Follow-up|0|||
125380379|NCT02659631|451025173|FG001|Overall Study|Lost to Follow-up|0|||
125380380|NCT02659631|451025174|FG002|Overall Study|Lost to Follow-up|2|||
125134176|NCT01878292|450115588|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
125134177|NCT01878292|450115589|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
125134178|NCT01878292|450115590|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
125134179|NCT01878292|450115588|FG000|Double-blind Treatment Period|Protocol Violation|3|||
125380381|NCT02659631|451025175|FG003|Overall Study|Lost to Follow-up|0|||
125380382|NCT02659631|451025176|FG004|Overall Study|Lost to Follow-up|0|||
125380383|NCT02659631|451025177|FG005|Overall Study|Lost to Follow-up|1|||
125380384|NCT02659631|451025178|FG006|Overall Study|Lost to Follow-up|0|||
125380385|NCT02659631|451025179|FG007|Overall Study|Lost to Follow-up|0|||
125134180|NCT01878292|450115589|FG001|Double-blind Treatment Period|Protocol Violation|4|||
125134181|NCT01878292|450115590|FG002|Double-blind Treatment Period|Protocol Violation|2|||
125134182|NCT01878292|450115588|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
125134183|NCT01878292|450115589|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
125134184|NCT01878292|450115590|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
125134185|NCT01878292|450115588|FG000|Double-blind Treatment Period|Adverse Event|4|||
125134186|NCT01878292|450115589|FG001|Double-blind Treatment Period|Adverse Event|9|||
125134187|NCT01878292|450115590|FG002|Double-blind Treatment Period|Adverse Event|8|||
125134188|NCT01878292|450115588|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
125134189|NCT01878292|450115589|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
125134190|NCT01878292|450115590|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
125134191|NCT01302548|450115591|FG000|Overall Study|Lost to Follow-up|2|||
125134192|NCT01302548|450115592|FG001|Overall Study|Lost to Follow-up|1|||
125134193|NCT00950989|450115593|FG000|Overall Study|Death|0|||
125134194|NCT00950989|450115594|FG001|Overall Study|Death|0|||
125134195|NCT00950989|450115595|FG002|Overall Study|Death|1|||
125134196|NCT00950989|450115596|FG003|Overall Study|Death|0|||
125134197|NCT00950989|450115593|FG000|Overall Study|Administrative Decision|0|||
125134198|NCT00950989|450115594|FG001|Overall Study|Administrative Decision|1|||
125134199|NCT00950989|450115595|FG002|Overall Study|Administrative Decision|0|||
125134200|NCT00950989|450115596|FG003|Overall Study|Administrative Decision|0|||
125134201|NCT00950989|450115593|FG000|Overall Study|Disease Progression|0|||
125134202|NCT00950989|450115594|FG001|Overall Study|Disease Progression|0|||
125134203|NCT00950989|450115595|FG002|Overall Study|Disease Progression|1|||
125134204|NCT00950989|450115596|FG003|Overall Study|Disease Progression|0|||
125134205|NCT00950989|450115593|FG000|Overall Study|Withdrawal by Subject|2|||
125134206|NCT00950989|450115594|FG001|Overall Study|Withdrawal by Subject|1|||
125134207|NCT00950989|450115595|FG002|Overall Study|Withdrawal by Subject|0|||
125641832|NCT00957034|451968829|FG001|Overall Study|Adverse Event|1|||
125641833|NCT00957034|451968830|FG002|Overall Study|Adverse Event|1|||
125380386|NCT02659631|451025180|FG008|Overall Study|Lost to Follow-up|0|||
125380387|NCT02659631|451025181|FG009|Overall Study|Lost to Follow-up|0|||
125437151|NCT00791921|451228005|FG001|Overall Study|Lack of Efficacy|2|||
125437152|NCT00791921|451228004|FG000|Overall Study|Lack of study drug administration|1|||
125641834|NCT00957034|451968828|FG000|Overall Study|Sponsor Terminated Study|6|||
125641835|NCT00957034|451968829|FG001|Overall Study|Sponsor Terminated Study|1|||
125641836|NCT00957034|451968830|FG002|Overall Study|Sponsor Terminated Study|5|||
125641837|NCT00957034|451968828|FG000|Overall Study|Withdrawal by Subject|0|||
125641838|NCT00957034|451968829|FG001|Overall Study|Withdrawal by Subject|2|||
125641839|NCT00957034|451968830|FG002|Overall Study|Withdrawal by Subject|0|||
125641840|NCT03053180|451970482|FG000|Overall Study|Failure to Return|1|||
125641841|NCT01465958|451970485|FG000|Run-in Phase|Protocol Violation|1|||
125641842|NCT01465958|451970486|FG001|Run-in Phase|Protocol Violation|0|||
125641843|NCT01465958|451970485|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
125641844|NCT01465958|451970486|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
125641845|NCT00669240|451970491|FG000|Overall Study|Lack of Efficacy|33|||
125641846|NCT00669240|451970491|FG000|Overall Study|Withdrawal by Subject|42|||
125641847|NCT00669240|451970491|FG000|Overall Study|Lost to Follow-up|34|||
125641848|NCT00669240|451970491|FG000|Overall Study|Adverse Event|21|||
125641849|NCT00669240|451970491|FG000|Overall Study|Other|19|||
125641850|NCT00669240|451970491|FG000|Overall Study|Enrolled but not treated|15|||
125641851|NCT00669240|451970491|FG000|Overall Study|Enrolled but no dosing record|1|||
125641852|NCT00532441|451970494|FG000|Overall Study|Death|1|||
125641853|NCT00532441|451970495|FG001|Overall Study|Death|0|||
125641854|NCT00626327|451970501|FG000|Overall Study|Withdrawal by Subject|21|||
125641855|NCT00626327|451970502|FG001|Overall Study|Withdrawal by Subject|29|||
125641856|NCT00626327|451970503|FG002|Overall Study|Withdrawal by Subject|30|||
125641857|NCT00626327|451970501|FG000|Overall Study|Adverse Event|1|||
125641858|NCT00626327|451970502|FG001|Overall Study|Adverse Event|0|||
125380388|NCT02659631|451025172|FG000|Overall Study|Withdrawal prior to treatment|0|||
125641859|NCT00626327|451970503|FG002|Overall Study|Adverse Event|0|||
125641860|NCT00626327|451970501|FG000|Overall Study|Lost to Follow-up|24|||
125641861|NCT00626327|451970502|FG001|Overall Study|Lost to Follow-up|21|||
125641862|NCT00626327|451970503|FG002|Overall Study|Lost to Follow-up|23|||
125641863|NCT00626327|451970501|FG000|Overall Study|Inappropriate enrollment|4|||
125218508|NCT00436826|450427346|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
125380389|NCT02659631|451025173|FG001|Overall Study|Withdrawal prior to treatment|0|||
125641864|NCT00626327|451970502|FG001|Overall Study|Inappropriate enrollment|5|||
125134208|NCT00950989|450115596|FG003|Overall Study|Withdrawal by Subject|0|||
125134209|NCT00950989|450115593|FG000|Overall Study|Adverse Event|2|||
125134210|NCT00950989|450115594|FG001|Overall Study|Adverse Event|1|||
125641865|NCT00626327|451970503|FG002|Overall Study|Inappropriate enrollment|3|||
125641866|NCT00626327|451970501|FG000|Overall Study|Administrative Reason|2|||
125641867|NCT00626327|451970502|FG001|Overall Study|Administrative Reason|0|||
125641868|NCT00626327|451970503|FG002|Overall Study|Administrative Reason|6|||
125641869|NCT00626327|451970501|FG000|Overall Study|Protocol Violation|26|||
125641870|NCT00626327|451970502|FG001|Overall Study|Protocol Violation|4|||
125641871|NCT00626327|451970503|FG002|Overall Study|Protocol Violation|26|||
125134211|NCT00950989|450115595|FG002|Overall Study|Adverse Event|1|||
125134212|NCT00950989|450115596|FG003|Overall Study|Adverse Event|0|||
125134213|NCT00730691|450115599|FG000|Overall Study|Adverse Event|4|||
125134214|NCT00730691|450115600|FG001|Overall Study|Adverse Event|8|||
125134215|NCT00730691|450115601|FG002|Overall Study|Adverse Event|11|||
125134216|NCT00730691|450115602|FG003|Overall Study|Adverse Event|11|||
125134217|NCT00730691|450115603|FG004|Overall Study|Adverse Event|23|||
125134218|NCT00730691|450115599|FG000|Overall Study|Lack of Efficacy|4|||
125134219|NCT00730691|450115600|FG001|Overall Study|Lack of Efficacy|4|||
125134220|NCT00730691|450115601|FG002|Overall Study|Lack of Efficacy|2|||
125134221|NCT00730691|450115602|FG003|Overall Study|Lack of Efficacy|1|||
125134222|NCT00730691|450115603|FG004|Overall Study|Lack of Efficacy|1|||
125134223|NCT00730691|450115599|FG000|Overall Study|Non-compliance with Study Drug|6|||
125134224|NCT00730691|450115600|FG001|Overall Study|Non-compliance with Study Drug|1|||
125134225|NCT00730691|450115601|FG002|Overall Study|Non-compliance with Study Drug|6|||
125134226|NCT00730691|450115602|FG003|Overall Study|Non-compliance with Study Drug|3|||
125134227|NCT00730691|450115603|FG004|Overall Study|Non-compliance with Study Drug|3|||
125134228|NCT00730691|450115599|FG000|Overall Study|Protocol Deviations|3|||
125134229|NCT00730691|450115600|FG001|Overall Study|Protocol Deviations|5|||
125134230|NCT00730691|450115601|FG002|Overall Study|Protocol Deviations|3|||
125134231|NCT00730691|450115602|FG003|Overall Study|Protocol Deviations|7|||
125134232|NCT00730691|450115603|FG004|Overall Study|Protocol Deviations|5|||
125134233|NCT00730691|450115599|FG000|Overall Study|Withdrawal of Consent|7|||
125134234|NCT00730691|450115600|FG001|Overall Study|Withdrawal of Consent|9|||
125134235|NCT00730691|450115601|FG002|Overall Study|Withdrawal of Consent|3|||
125134236|NCT00730691|450115602|FG003|Overall Study|Withdrawal of Consent|6|||
125134237|NCT00730691|450115603|FG004|Overall Study|Withdrawal of Consent|3|||
125134238|NCT00730691|450115599|FG000|Overall Study|Lost to Follow-up|11|||
125134239|NCT00730691|450115600|FG001|Overall Study|Lost to Follow-up|8|||
125380390|NCT02659631|451025174|FG002|Overall Study|Withdrawal prior to treatment|0|||
125380391|NCT02659631|451025175|FG003|Overall Study|Withdrawal prior to treatment|0|||
125380392|NCT02659631|451025176|FG004|Overall Study|Withdrawal prior to treatment|1|||
125485438|NCT02240238|451412504|FG001|Phase 2|Withdrawal by Subject|0|||
125641872|NCT02807376|451970507|FG000|Overall Study|Intra-operative exclusion criteria|3|||
125641873|NCT02807376|451970508|FG001|Overall Study|Intra-operative exclusion criteria|0|||
125641874|NCT02807376|451970507|FG000|Overall Study|Lost to Follow-up|0|||
125641875|NCT02807376|451970508|FG001|Overall Study|Lost to Follow-up|1|||
125641876|NCT00846027|451970509|FG000|Overall Study|Death|3|||
125641877|NCT00846027|451970509|FG000|Overall Study|Disease Progression|30|||
125641878|NCT00846027|451970509|FG000|Overall Study|Toxicity|12|||
125641879|NCT00846027|451970509|FG000|Overall Study|Patient Decision|7|||
125641880|NCT00846027|451970509|FG000|Overall Study|Investigator Discretion|29|||
125641881|NCT00846027|451970509|FG000|Overall Study|Protocol Violation|2|||
125641882|NCT00846027|451970509|FG000|Overall Study|Subject Not Treated|7|||
125641883|NCT01797302|451970510|FG000|Overall Study|Lost to Follow-up|16|||
125641884|NCT01797302|451970511|FG001|Overall Study|Lost to Follow-up|23|||
125641885|NCT01797302|451970512|FG002|Overall Study|Lost to Follow-up|22|||
125641886|NCT01797302|451970510|FG000|Overall Study|Withdrawal by Subject|1|||
125641887|NCT01797302|451970511|FG001|Overall Study|Withdrawal by Subject|3|||
125641888|NCT01797302|451970512|FG002|Overall Study|Withdrawal by Subject|4|||
125641889|NCT03228836|451970513|FG000|Overall Study|Adverse Event|3|||
125641890|NCT03228836|451970513|FG000|Overall Study|Withdrawal by Subject|1|||
125641891|NCT03228836|451970513|FG000|Overall Study|Death|1|||
125641892|NCT03228836|451970513|FG000|Overall Study|Physician Decision|1|||
125134240|NCT00730691|450115601|FG002|Overall Study|Lost to Follow-up|13|||
125134241|NCT00730691|450115602|FG003|Overall Study|Lost to Follow-up|15|||
125134242|NCT00730691|450115603|FG004|Overall Study|Lost to Follow-up|13|||
125134243|NCT00730691|450115599|FG000|Overall Study|Other|1|||
125134244|NCT00730691|450115600|FG001|Overall Study|Other|1|||
125134245|NCT00730691|450115601|FG002|Overall Study|Other|1|||
125134246|NCT00730691|450115602|FG003|Overall Study|Other|2|||
125134247|NCT00730691|450115603|FG004|Overall Study|Other|2|||
125134248|NCT02178787|450115604|FG000|Overall Study|Lost to Follow-up|1|||
125134249|NCT02178787|450115605|FG001|Overall Study|Lost to Follow-up|0|||
125134250|NCT02178787|450115604|FG000|Overall Study|Withdrawal by Subject|0|||
125641893|NCT03228836|451970513|FG000|Overall Study|Disease Progression|7|||
125134251|NCT02178787|450115605|FG001|Overall Study|Withdrawal by Subject|2|||
125134252|NCT02178787|450115604|FG000|Overall Study|No TCD window|3|||
125134253|NCT02178787|450115605|FG001|Overall Study|No TCD window|7|||
125134254|NCT02178787|450115604|FG000|Overall Study|Physician Decision|1|||
125134255|NCT02178787|450115605|FG001|Overall Study|Physician Decision|0|||
125134256|NCT02554890|450115606|FG000|Double-blind|Adverse Event|45|||
125641894|NCT03228836|451970513|FG000|Overall Study|Other|4|||
125134257|NCT02554890|450115607|FG001|Double-blind|Adverse Event|51|||
125134258|NCT02554890|450115606|FG000|Double-blind|Death|6|||
125134259|NCT02554890|450115607|FG001|Double-blind|Death|4|||
125134260|NCT02554890|450115606|FG000|Double-blind|Protocol Violation|1|||
125134261|NCT02554890|450115607|FG001|Double-blind|Protocol Violation|1|||
125134262|NCT02554890|450115606|FG000|Double-blind|Physician Decision|4|||
125134263|NCT02554890|450115607|FG001|Double-blind|Physician Decision|3|||
125134264|NCT02554890|450115606|FG000|Double-blind|Subject/Guardian decision|21|||
125134265|NCT02554890|450115607|FG001|Double-blind|Subject/Guardian decision|16|||
125134266|NCT02554890|450115606|FG000|Double-blind|Lost to Follow-up|7|||
125134267|NCT02554890|450115607|FG001|Double-blind|Lost to Follow-up|5|||
125134268|NCT02554890|450115606|FG000|Double-blind|Technical problems|1|||
125134269|NCT02554890|450115607|FG001|Double-blind|Technical problems|0|||
125134270|NCT02554890|450115606|FG000|Double-blind|Withdrawal by Subject|5|||
125134271|NCT02554890|450115607|FG001|Double-blind|Withdrawal by Subject|6|||
125134272|NCT02554890|450115606|FG000|Double-blind|Noncompliance with study treatment|6|||
125134273|NCT02554890|450115607|FG001|Double-blind|Noncompliance with study treatment|5|||
125134274|NCT02554890|450115606|FG000|Open-label|Adverse Event|0|||
125134275|NCT02554890|450115607|FG001|Open-label|Adverse Event|30|||
125134276|NCT02554890|450115606|FG000|Open-label|Death|0|||
125380393|NCT02659631|451025177|FG005|Overall Study|Withdrawal prior to treatment|0|||
125380394|NCT02659631|451025178|FG006|Overall Study|Withdrawal prior to treatment|0|||
125134277|NCT02554890|450115607|FG001|Open-label|Death|1|||
125134278|NCT02554890|450115606|FG000|Open-label|Physician Decision|0|||
125134279|NCT02554890|450115607|FG001|Open-label|Physician Decision|1|||
125134280|NCT02554890|450115606|FG000|Open-label|Subject/Guardian decision|0|||
125380395|NCT02659631|451025179|FG007|Overall Study|Withdrawal prior to treatment|0|||
125134281|NCT02554890|450115607|FG001|Open-label|Subject/Guardian decision|11|||
125134282|NCT02554890|450115606|FG000|Open-label|Lost to Follow-up|0|||
125134283|NCT02554890|450115607|FG001|Open-label|Lost to Follow-up|7|||
125134284|NCT02554890|450115606|FG000|Open-label|Technical problems|0|||
125134285|NCT02554890|450115607|FG001|Open-label|Technical problems|1|||
125380396|NCT02659631|451025180|FG008|Overall Study|Withdrawal prior to treatment|0|||
125380397|NCT02659631|451025181|FG009|Overall Study|Withdrawal prior to treatment|0|||
125380398|NCT02659631|451025172|FG000|Overall Study|Participant refused further follow-up|0|||
125380399|NCT02659631|451025173|FG001|Overall Study|Participant refused further follow-up|0|||
125641895|NCT02418000|451970515|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
125641896|NCT02418000|451970516|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
125641897|NCT02418000|451970517|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
125641898|NCT02418000|451970518|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
125641899|NCT02418000|451970519|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
125641900|NCT02418000|451970515|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
125641901|NCT02418000|451970516|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
125641902|NCT02418000|451970517|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
125641903|NCT02418000|451970518|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
125641904|NCT02418000|451970519|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
125641905|NCT02418000|451970515|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
125641906|NCT02418000|451970516|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
125641907|NCT02418000|451970517|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
125641908|NCT02418000|451970518|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
125641909|NCT02418000|451970519|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
125641910|NCT02418000|451970515|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
125641911|NCT02418000|451970516|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
125641912|NCT02418000|451970517|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
125641913|NCT02418000|451970518|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
125641914|NCT02418000|451970519|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
125641915|NCT02418000|451970515|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
125641916|NCT02418000|451970516|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
125641917|NCT02418000|451970517|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
125641918|NCT02418000|451970518|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
125641919|NCT02418000|451970519|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
125641920|NCT02418000|451970515|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125641921|NCT02418000|451970516|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125641922|NCT02418000|451970517|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
125641923|NCT02418000|451970518|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125641924|NCT02418000|451970519|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125641925|NCT02418000|451970515|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125641926|NCT02418000|451970516|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125641927|NCT02418000|451970517|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125641928|NCT02418000|451970518|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
125641929|NCT02418000|451970519|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125641930|NCT02418000|451970515|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
125641931|NCT02418000|451970516|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
125641932|NCT02418000|451970517|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
125641933|NCT02418000|451970518|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
125641934|NCT02418000|451970519|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
125641935|NCT02418000|451970515|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125641936|NCT02418000|451970516|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125641937|NCT02418000|451970517|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125641938|NCT02418000|451970518|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
125641939|NCT02418000|451970519|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
125641940|NCT02176226|451970522|FG000|Overall Study|Lost to Follow-up|3|||
125641941|NCT02176226|451970522|FG000|Overall Study|Withdrew prior to treatment|6|||
125641942|NCT02908841|451970527|FG000|Overall Study|Physician Decision|4|||
125641943|NCT02908841|451970528|FG001|Overall Study|Physician Decision|0|||
125641944|NCT01611558|451970529|FG000|Induction Phase|Study drug toxicity|15|||
125641945|NCT01611558|451970529|FG000|Induction Phase|Disease progression|18|||
125641946|NCT01611558|451970529|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
125641947|NCT01611558|451970529|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
125641948|NCT01611558|451970529|FG000|Induction Phase|Death|1|||
125641949|NCT01611558|451970529|FG000|Maintenance Phase|Withdrawal by Subject|1|||
125641950|NCT01611558|451970529|FG000|Maintenance Phase|Elevated Uric acid|1|||
125641951|NCT04005885|451970530|FG000|First Intervention|Withdrawal by Subject|1|||
125218509|NCT00436826|450427347|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
125641952|NCT04005885|451970531|FG001|First Intervention|Withdrawal by Subject|1|||
125641953|NCT04005885|451970530|FG000|Second Intervention|Withdrawal by Subject|0|||
125641954|NCT04005885|451970531|FG001|Second Intervention|Withdrawal by Subject|2|||
125641955|NCT02718625|451970533|FG000|Overall Study|Adverse Event|0|||
125641956|NCT02718625|451970534|FG001|Overall Study|Adverse Event|1|||
125641957|NCT02718625|451970533|FG000|Overall Study|Termination of Study by Sponsor|0|||
125485439|NCT02240238|451412505|FG002|Phase 2|Withdrawal by Subject|0|||
125641958|NCT02718625|451970534|FG001|Overall Study|Termination of Study by Sponsor|1|||
125641959|NCT01947127|451970539|FG000|Overall Study|Protocol Violation|18|||
125641960|NCT01947127|451970540|FG001|Overall Study|Protocol Violation|38|||
125641961|NCT01947127|451970539|FG000|Overall Study|Withdrawal by Subject|1|||
125641962|NCT01947127|451970540|FG001|Overall Study|Withdrawal by Subject|1|||
125641963|NCT01947127|451970539|FG000|Overall Study|Data loss|4|||
125641964|NCT01947127|451970540|FG001|Overall Study|Data loss|4|||
125641965|NCT01836549|451970541|FG000|Overall Study|Did not receive study drug|0|||
125641966|NCT01836549|451970542|FG001|Overall Study|Did not receive study drug|0|||
125641967|NCT01836549|451970543|FG002|Overall Study|Did not receive study drug|1|||
125641968|NCT01836549|451970544|FG003|Overall Study|Did not receive study drug|0|||
125641969|NCT01836549|451970545|FG004|Overall Study|Did not receive study drug|0|||
125641970|NCT01836549|451970546|FG005|Overall Study|Did not receive study drug|0|||
125641971|NCT01836549|451970547|FG006|Overall Study|Did not receive study drug|0|||
125641972|NCT01836549|451970541|FG000|Overall Study|Patient declared ineligible|0|||
125641973|NCT01836549|451970542|FG001|Overall Study|Patient declared ineligible|0|||
125641974|NCT01836549|451970543|FG002|Overall Study|Patient declared ineligible|0|||
125641975|NCT01836549|451970544|FG003|Overall Study|Patient declared ineligible|1|||
125641976|NCT01836549|451970545|FG004|Overall Study|Patient declared ineligible|0|||
125641977|NCT01836549|451970546|FG005|Overall Study|Patient declared ineligible|0|||
125641978|NCT01836549|451970547|FG006|Overall Study|Patient declared ineligible|0|||
125641979|NCT01836549|451970541|FG000|Overall Study|Patient inevaluable to start therapy|0|||
125641980|NCT01836549|451970542|FG001|Overall Study|Patient inevaluable to start therapy|0|||
125641981|NCT01836549|451970543|FG002|Overall Study|Patient inevaluable to start therapy|0|||
125641982|NCT01836549|451970544|FG003|Overall Study|Patient inevaluable to start therapy|0|||
125641983|NCT01836549|451970545|FG004|Overall Study|Patient inevaluable to start therapy|0|||
125641984|NCT01836549|451970546|FG005|Overall Study|Patient inevaluable to start therapy|0|||
125641985|NCT01836549|451970547|FG006|Overall Study|Patient inevaluable to start therapy|1|||
125641986|NCT02516306|451970548|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
125641987|NCT02516306|451970549|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
125641988|NCT00242710|451970553|FG000|Core Study (up to Year 1)|Adverse Event|30|||
125641989|NCT00242710|451970554|FG001|Core Study (up to Year 1)|Adverse Event|25|||
125641990|NCT00242710|451970555|FG002|Core Study (up to Year 1)|Adverse Event|23|||
125641991|NCT00242710|451970556|FG003|Core Study (up to Year 1)|Adverse Event|14|||
125641992|NCT00242710|451970553|FG000|Core Study (up to Year 1)|Death|0|||
125641993|NCT00242710|451970554|FG001|Core Study (up to Year 1)|Death|0|||
125641994|NCT00242710|451970555|FG002|Core Study (up to Year 1)|Death|1|||
125641995|NCT00242710|451970556|FG003|Core Study (up to Year 1)|Death|0|||
125641996|NCT00242710|451970553|FG000|Core Study (up to Year 1)|Physician Decision|0|||
125641997|NCT00242710|451970554|FG001|Core Study (up to Year 1)|Physician Decision|1|||
125641998|NCT00242710|451970555|FG002|Core Study (up to Year 1)|Physician Decision|0|||
125641999|NCT00242710|451970556|FG003|Core Study (up to Year 1)|Physician Decision|1|||
125642000|NCT00242710|451970553|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
125642001|NCT00242710|451970554|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
125642002|NCT00242710|451970555|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
125642003|NCT00242710|451970556|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
125642004|NCT00242710|451970553|FG000|Core Study (up to Year 1)|Other|6|||
125642005|NCT00242710|451970554|FG001|Core Study (up to Year 1)|Other|1|||
125642006|NCT00242710|451970555|FG002|Core Study (up to Year 1)|Other|0|||
125642007|NCT00242710|451970556|FG003|Core Study (up to Year 1)|Other|2|||
125642008|NCT00242710|451970553|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
125642009|NCT00242710|451970554|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
125642010|NCT00242710|451970555|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
125642011|NCT00242710|451970556|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
125642012|NCT00242710|451970553|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
125642013|NCT00242710|451970554|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
125642014|NCT00242710|451970555|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
125642015|NCT00242710|451970556|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
125642016|NCT00242710|451970553|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
125642017|NCT00242710|451970554|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
125642018|NCT00242710|451970555|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
125642019|NCT00242710|451970556|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
125642020|NCT00242710|451970553|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
125642021|NCT00242710|451970554|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
125642022|NCT00242710|451970555|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
125642023|NCT00242710|451970556|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
125642024|NCT00242710|451970553|FG000|Period Between Core Study and Extension|Adverse Event|2|||
125642025|NCT00242710|451970554|FG001|Period Between Core Study and Extension|Adverse Event|3|||
125642026|NCT00242710|451970555|FG002|Period Between Core Study and Extension|Adverse Event|5|||
125642027|NCT00242710|451970556|FG003|Period Between Core Study and Extension|Adverse Event|2|||
125642028|NCT00242710|451970553|FG000|Period Between Core Study and Extension|Physician Decision|1|||
125134286|NCT02554890|450115606|FG000|Open-label|Withdrawal by Subject|0|||
125134287|NCT02554890|450115607|FG001|Open-label|Withdrawal by Subject|1|||
125134288|NCT03043872|450115611|FG000|Overall Study|Withdrawal by Subject|6|||
125134289|NCT03043872|450115612|FG001|Overall Study|Withdrawal by Subject|6|||
125134290|NCT03043872|450115613|FG002|Overall Study|Withdrawal by Subject|15|||
125134291|NCT03043872|450115611|FG000|Overall Study|Lost to Follow-up|2|||
125134292|NCT03043872|450115612|FG001|Overall Study|Lost to Follow-up|1|||
125134293|NCT03043872|450115613|FG002|Overall Study|Lost to Follow-up|1|||
125134294|NCT03043872|450115611|FG000|Overall Study|Death|270|||
125134295|NCT03043872|450115612|FG001|Overall Study|Death|269|||
125134296|NCT03043872|450115613|FG002|Overall Study|Death|296|||
125134297|NCT03649477|450115614|FG000|Overall Study|Adverse Event|2|||
125134298|NCT03649477|450115615|FG001|Overall Study|Adverse Event|0|||
125134299|NCT03649477|450115616|FG002|Overall Study|Adverse Event|0|||
125134300|NCT02430480|450115617|FG000|Overall Study|Death|1|||
125134301|NCT02430480|450115617|FG000|Overall Study|Anesthesia concerns|1|||
125134302|NCT02430480|450115617|FG000|Overall Study|Progressed on treatment|1|||
125134303|NCT01154231|450115618|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
125134304|NCT01154231|450115618|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
125134305|NCT04852978|450115624|FG000|Overall Study|Physician Decision|0|||
125134306|NCT04852978|450115625|FG001|Overall Study|Physician Decision|1|||
125134307|NCT04852978|450115626|FG002|Overall Study|Physician Decision|0|||
125134308|NCT04852978|450115627|FG003|Overall Study|Physician Decision|0|||
125134309|NCT04852978|450115628|FG004|Overall Study|Physician Decision|0|||
125134310|NCT04852978|450115629|FG005|Overall Study|Physician Decision|0|||
125134311|NCT04852978|450115630|FG006|Overall Study|Physician Decision|0|||
125134312|NCT04852978|450115631|FG007|Overall Study|Physician Decision|2|||
125134313|NCT04852978|450115632|FG008|Overall Study|Physician Decision|0|||
125134314|NCT04852978|450115624|FG000|Overall Study|Sponsor request|0|||
125134315|NCT04852978|450115625|FG001|Overall Study|Sponsor request|0|||
125134316|NCT04852978|450115626|FG002|Overall Study|Sponsor request|1|||
125134317|NCT04852978|450115627|FG003|Overall Study|Sponsor request|0|||
125134318|NCT04852978|450115628|FG004|Overall Study|Sponsor request|0|||
125134319|NCT04852978|450115629|FG005|Overall Study|Sponsor request|0|||
125134320|NCT04852978|450115630|FG006|Overall Study|Sponsor request|0|||
125642029|NCT00242710|451970554|FG001|Period Between Core Study and Extension|Physician Decision|1|||
125642030|NCT00242710|451970555|FG002|Period Between Core Study and Extension|Physician Decision|0|||
125642031|NCT00242710|451970556|FG003|Period Between Core Study and Extension|Physician Decision|0|||
125642032|NCT00242710|451970553|FG000|Period Between Core Study and Extension|Other|24|||
125642033|NCT00242710|451970554|FG001|Period Between Core Study and Extension|Other|24|||
125642034|NCT00242710|451970555|FG002|Period Between Core Study and Extension|Other|9|||
125642035|NCT00242710|451970556|FG003|Period Between Core Study and Extension|Other|11|||
125642036|NCT00242710|451970553|FG000|Period Between Core Study and Extension|Extension not Available|17|||
125642037|NCT00242710|451970554|FG001|Period Between Core Study and Extension|Extension not Available|21|||
125642038|NCT00242710|451970555|FG002|Period Between Core Study and Extension|Extension not Available|8|||
125642039|NCT00242710|451970556|FG003|Period Between Core Study and Extension|Extension not Available|7|||
125642040|NCT00242710|451970553|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
125642041|NCT00242710|451970554|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
125642042|NCT00242710|451970555|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
125642043|NCT00242710|451970556|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
125134321|NCT04852978|450115631|FG007|Overall Study|Sponsor request|0|||
125134322|NCT04852978|450115632|FG008|Overall Study|Sponsor request|0|||
125134323|NCT04852978|450115624|FG000|Overall Study|Death|0|||
125134324|NCT04852978|450115625|FG001|Overall Study|Death|0|||
125134325|NCT04852978|450115626|FG002|Overall Study|Death|0|||
125134326|NCT04852978|450115627|FG003|Overall Study|Death|0|||
125134327|NCT04852978|450115628|FG004|Overall Study|Death|0|||
125134328|NCT04852978|450115629|FG005|Overall Study|Death|0|||
125134329|NCT04852978|450115630|FG006|Overall Study|Death|1|||
125134330|NCT04852978|450115631|FG007|Overall Study|Death|0|||
125134331|NCT04852978|450115632|FG008|Overall Study|Death|0|||
125134332|NCT04852978|450115624|FG000|Overall Study|Lost to Follow-up|3|||
125134333|NCT04852978|450115625|FG001|Overall Study|Lost to Follow-up|2|||
125134334|NCT04852978|450115626|FG002|Overall Study|Lost to Follow-up|2|||
125134335|NCT04852978|450115627|FG003|Overall Study|Lost to Follow-up|0|||
125134336|NCT04852978|450115628|FG004|Overall Study|Lost to Follow-up|2|||
125134337|NCT04852978|450115629|FG005|Overall Study|Lost to Follow-up|4|||
125134338|NCT04852978|450115630|FG006|Overall Study|Lost to Follow-up|1|||
125134339|NCT04852978|450115631|FG007|Overall Study|Lost to Follow-up|2|||
125134340|NCT04852978|450115632|FG008|Overall Study|Lost to Follow-up|2|||
125642044|NCT00242710|451970553|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
125642045|NCT00242710|451970554|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
125642046|NCT00242710|451970555|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
125642047|NCT00242710|451970556|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
125642048|NCT00242710|451970553|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
125642049|NCT00242710|451970554|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
125642050|NCT00242710|451970555|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
125642051|NCT00242710|451970556|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
125642052|NCT00242710|451970553|FG000|Study Extension (up to Year 2)|Death|0|||
125642053|NCT00242710|451970554|FG001|Study Extension (up to Year 2)|Death|0|||
125642054|NCT00242710|451970555|FG002|Study Extension (up to Year 2)|Death|0|||
125642055|NCT00242710|451970556|FG003|Study Extension (up to Year 2)|Death|1|||
125642056|NCT00242710|451970553|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
125642057|NCT00242710|451970554|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
125642058|NCT00242710|451970555|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
125642059|NCT00242710|451970556|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
125642060|NCT00242710|451970553|FG000|Study Extension (up to Year 2)|Other|3|||
125642061|NCT00242710|451970554|FG001|Study Extension (up to Year 2)|Other|5|||
125642062|NCT00242710|451970555|FG002|Study Extension (up to Year 2)|Other|4|||
125642063|NCT00242710|451970556|FG003|Study Extension (up to Year 2)|Other|3|||
125642064|NCT00242710|451970553|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
125642065|NCT00242710|451970554|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
125642066|NCT00242710|451970555|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
125642067|NCT00242710|451970556|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
125642068|NCT00242710|451970553|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
125642069|NCT00242710|451970554|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
125642070|NCT00242710|451970555|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
125642071|NCT00242710|451970556|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
125642072|NCT00579527|451970557|FG000|Overall Study|Death|4|||
125642073|NCT03961529|451970558|FG000|Overall Study|Adverse Event|13|||
125642074|NCT03961529|451970559|FG001|Overall Study|Adverse Event|5|||
125642075|NCT03961529|451970560|FG002|Overall Study|Adverse Event|2|||
125642076|NCT03961529|451970558|FG000|Overall Study|Withdrawal by Subject|17|||
125642077|NCT03961529|451970559|FG001|Overall Study|Withdrawal by Subject|2|||
125642078|NCT03961529|451970560|FG002|Overall Study|Withdrawal by Subject|1|||
125642079|NCT03961529|451970558|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125642080|NCT03961529|451970559|FG001|Overall Study|Withdrawal by parent/guardian|7|||
125642081|NCT03961529|451970560|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125642082|NCT03961529|451970558|FG000|Overall Study|Physician Decision|2|||
125642083|NCT03961529|451970559|FG001|Overall Study|Physician Decision|1|||
125642084|NCT03961529|451970560|FG002|Overall Study|Physician Decision|1|||
125642085|NCT03961529|451970558|FG000|Overall Study|Lost to Follow-up|2|||
125642086|NCT03961529|451970559|FG001|Overall Study|Lost to Follow-up|1|||
125642087|NCT03961529|451970560|FG002|Overall Study|Lost to Follow-up|0|||
125642088|NCT03961529|451970558|FG000|Overall Study|Lack of Efficacy|2|||
125642089|NCT03961529|451970559|FG001|Overall Study|Lack of Efficacy|0|||
125642090|NCT03961529|451970560|FG002|Overall Study|Lack of Efficacy|1|||
125642091|NCT03961529|451970558|FG000|Overall Study|Other|6|||
125642092|NCT03961529|451970559|FG001|Overall Study|Other|1|||
125642093|NCT03961529|451970560|FG002|Overall Study|Other|0|||
125642094|NCT03644173|451970561|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
125642095|NCT03644173|451970561|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
125642096|NCT03644173|451970561|FG000|Participants at the 1-month Follow up|Death|2|||
125642097|NCT03644173|451970561|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
125134341|NCT04852978|450115624|FG000|Overall Study|Withdrawal by Subject|4|||
125218510|NCT00436826|450427348|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
125134342|NCT04852978|450115625|FG001|Overall Study|Withdrawal by Subject|2|||
125134343|NCT04852978|450115626|FG002|Overall Study|Withdrawal by Subject|2|||
125134344|NCT04852978|450115627|FG003|Overall Study|Withdrawal by Subject|1|||
125642098|NCT00381706|451970564|FG000|Overall Study|Never treated|7|||
125642099|NCT00381706|451970565|FG001|Overall Study|Never treated|2|||
125642100|NCT00381706|451970566|FG002|Overall Study|Never treated|1|||
125642101|NCT04554394|451970567|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
125642102|NCT04554394|451970568|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
125134345|NCT04852978|450115628|FG004|Overall Study|Withdrawal by Subject|5|||
125134346|NCT04852978|450115629|FG005|Overall Study|Withdrawal by Subject|3|||
125134347|NCT04852978|450115630|FG006|Overall Study|Withdrawal by Subject|2|||
125134348|NCT04852978|450115631|FG007|Overall Study|Withdrawal by Subject|2|||
125380400|NCT02659631|451025174|FG002|Overall Study|Participant refused further follow-up|0|||
125380401|NCT02659631|451025175|FG003|Overall Study|Participant refused further follow-up|1|||
125380402|NCT02659631|451025176|FG004|Overall Study|Participant refused further follow-up|0|||
125380403|NCT02659631|451025177|FG005|Overall Study|Participant refused further follow-up|0|||
125380404|NCT02659631|451025178|FG006|Overall Study|Participant refused further follow-up|0|||
125380405|NCT02659631|451025179|FG007|Overall Study|Participant refused further follow-up|0|||
125642103|NCT04554394|451970567|FG000|Overall Study|Withdrawal by Subject|2|||
125642104|NCT04554394|451970568|FG001|Overall Study|Withdrawal by Subject|2|||
125642105|NCT04554394|451970567|FG000|Overall Study|Lost to Follow-up|2|||
125642106|NCT04554394|451970568|FG001|Overall Study|Lost to Follow-up|2|||
125642107|NCT04554394|451970567|FG000|Overall Study|Physician Decision|1|||
125642108|NCT04554394|451970568|FG001|Overall Study|Physician Decision|1|||
125642109|NCT00886587|451970572|FG000|Overall Study|Adverse Event|2|||
125642110|NCT00886587|451970573|FG001|Overall Study|Adverse Event|1|||
125642111|NCT00886587|451970572|FG000|Overall Study|Protocol Violation|2|||
125642112|NCT00886587|451970573|FG001|Overall Study|Protocol Violation|0|||
125642113|NCT00886587|451970572|FG000|Overall Study|Withdrawal by Subject|0|||
125642114|NCT00886587|451970573|FG001|Overall Study|Withdrawal by Subject|1|||
125642115|NCT03490734|451970574|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
125642116|NCT03490734|451970575|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
125642117|NCT03490734|451970576|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
125642118|NCT03490734|451970577|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
125642119|NCT03490734|451970574|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
125642120|NCT03490734|451970575|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
125642121|NCT03490734|451970576|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
125642122|NCT03490734|451970577|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
125642123|NCT03490734|451970574|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
125642124|NCT03490734|451970575|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
125642125|NCT03490734|451970576|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
125642126|NCT03490734|451970577|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
125642127|NCT03490734|451970574|FG000|Post-intervention Scan Visit|Adverse Event|2|||
125642128|NCT03490734|451970575|FG001|Post-intervention Scan Visit|Adverse Event|0|||
125642129|NCT03490734|451970576|FG002|Post-intervention Scan Visit|Adverse Event|0|||
125642130|NCT03490734|451970577|FG003|Post-intervention Scan Visit|Adverse Event|0|||
125642131|NCT03490734|451970574|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
125642132|NCT03490734|451970575|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
125642133|NCT03490734|451970576|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
125642134|NCT03490734|451970577|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
125642135|NCT03490734|451970574|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
125642136|NCT03490734|451970575|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
125642137|NCT03490734|451970576|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
125642138|NCT03490734|451970577|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
125642139|NCT00374452|451970581|FG000|Overall Study|Left clinic before intervention started|4|||
125642140|NCT00374452|451970582|FG001|Overall Study|Left clinic before intervention started|1|||
125642141|NCT00374452|451970581|FG000|Overall Study|Change in job role before intervention|0|||
125642142|NCT00374452|451970582|FG001|Overall Study|Change in job role before intervention|1|||
125642143|NCT00374452|451970581|FG000|Overall Study|Left clinic after intervention started|1|||
125642144|NCT00374452|451970582|FG001|Overall Study|Left clinic after intervention started|1|||
125642145|NCT00374452|451970581|FG000|Overall Study|Withdrawal by Subject|0|||
125642146|NCT00374452|451970582|FG001|Overall Study|Withdrawal by Subject|2|||
125642147|NCT00523744|451970583|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
125642148|NCT00523744|451970583|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
125642149|NCT00523744|451970583|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
125642150|NCT00523744|451970583|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
125642151|NCT00523744|451970583|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
125642152|NCT00523744|451970583|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
125642153|NCT03099304|451970586|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
125642154|NCT03099304|451970587|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
125642155|NCT03099304|451970588|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
125642156|NCT03099304|451970589|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
125642157|NCT03099304|451970590|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
125642158|NCT03099304|451970591|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
125642159|NCT03099304|451970586|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
125642160|NCT03099304|451970587|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
125642161|NCT03099304|451970588|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
125380406|NCT02659631|451025180|FG008|Overall Study|Participant refused further follow-up|1|||
125437153|NCT00791921|451228005|FG001|Overall Study|Lack of study drug administration|1|||
125642162|NCT03099304|451970589|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
125642163|NCT03099304|451970590|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
125642164|NCT03099304|451970591|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
125642165|NCT03099304|451970586|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
125642166|NCT03099304|451970587|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
125642167|NCT03099304|451970588|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
125642168|NCT03099304|451970589|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
125642169|NCT03099304|451970590|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
125642170|NCT03099304|451970591|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
125642171|NCT03099304|451970586|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
125642172|NCT03099304|451970587|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
125642173|NCT03099304|451970588|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
125642174|NCT03099304|451970589|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
125642175|NCT03099304|451970590|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
125642176|NCT03099304|451970591|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
125642177|NCT03099304|451970586|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
125642178|NCT03099304|451970587|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
125642179|NCT03099304|451970588|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
125642180|NCT03099304|451970589|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
125642181|NCT03099304|451970590|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
125642182|NCT03099304|451970591|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
125642183|NCT03099304|451970586|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
125642184|NCT03099304|451970587|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
125642185|NCT03099304|451970588|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
125642186|NCT03099304|451970589|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
125642187|NCT03099304|451970590|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
125642188|NCT03099304|451970591|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
125642189|NCT03099304|451970586|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
125642190|NCT03099304|451970587|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
125642191|NCT03099304|451970588|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
125642192|NCT03099304|451970589|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
125642193|NCT03099304|451970590|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
125642194|NCT03099304|451970591|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
125642195|NCT03099304|451970586|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
125642196|NCT03099304|451970587|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
125642197|NCT03099304|451970588|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
125642198|NCT03099304|451970589|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
125642199|NCT03099304|451970590|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
125642200|NCT03099304|451970591|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
125642201|NCT03099304|451970586|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
125642202|NCT03099304|451970587|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
125642203|NCT03099304|451970588|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
125642204|NCT03099304|451970589|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
125642205|NCT03099304|451970590|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
125642206|NCT03099304|451970591|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
125642207|NCT03099304|451970586|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
125642208|NCT03099304|451970587|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
125642209|NCT03099304|451970588|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
125642210|NCT03099304|451970589|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
125642211|NCT03099304|451970590|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
125642212|NCT03099304|451970591|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
125642213|NCT03099304|451970586|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
125642214|NCT03099304|451970587|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
125642215|NCT03099304|451970588|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
125642216|NCT03099304|451970589|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
125642217|NCT03099304|451970590|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
125642218|NCT03099304|451970591|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
125642219|NCT03099304|451970586|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
125642220|NCT03099304|451970587|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
125642221|NCT03099304|451970588|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
125642222|NCT03099304|451970589|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
125642223|NCT03099304|451970590|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
125642224|NCT03099304|451970591|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
125642225|NCT03099304|451970586|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
125642226|NCT03099304|451970587|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
125642227|NCT03099304|451970588|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
125642228|NCT03099304|451970589|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
125485440|NCT02240238|451412506|FG003|Phase 2|Withdrawal by Subject|0|||
125134349|NCT04852978|450115632|FG008|Overall Study|Withdrawal by Subject|1|||
125134350|NCT00859430|450115633|FG000|First Intervention|Withdrawal by Subject|0|||
125134351|NCT00859430|450115634|FG001|First Intervention|Withdrawal by Subject|1|||
125134352|NCT00001703|450118134|FG000|Overall Study|progressed disease|2|||
125134353|NCT00001703|450118134|FG000|Overall Study|No evidence of disease|1|||
125134354|NCT00001703|450118134|FG000|Overall Study|recurrent disease|2|||
125134355|NCT03733730|450118137|FG000|Overall Study|Lost to Follow-up|1|||
125134356|NCT03733730|450118138|FG001|Overall Study|Lost to Follow-up|32|||
125134357|NCT03733730|450118137|FG000|Overall Study|Other|1|||
125134358|NCT03733730|450118138|FG001|Overall Study|Other|0|||
125134359|NCT03733730|450118137|FG000|Overall Study|Adverse Event|0|||
125642229|NCT03099304|451970590|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
125642230|NCT03099304|451970591|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
125642231|NCT03099304|451970586|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
125642232|NCT03099304|451970587|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
125642233|NCT03099304|451970588|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
125642234|NCT03099304|451970589|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
125642235|NCT03099304|451970590|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
125642236|NCT03099304|451970591|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
125642237|NCT03099304|451970586|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
125642238|NCT03099304|451970587|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
125642239|NCT03099304|451970588|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
125642240|NCT03099304|451970589|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
125642241|NCT03099304|451970590|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
125380407|NCT02659631|451025181|FG009|Overall Study|Participant refused further follow-up|0|||
125642242|NCT03099304|451970591|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
125134360|NCT03733730|450118138|FG001|Overall Study|Adverse Event|4|||
125134361|NCT03733730|450118137|FG000|Overall Study|Death|0|||
125134362|NCT03733730|450118138|FG001|Overall Study|Death|5|||
125642243|NCT03099304|451970586|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
125642244|NCT03099304|451970587|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
125642245|NCT03099304|451970588|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
125134363|NCT03733730|450118137|FG000|Overall Study|Withdrawal by Subject|0|||
125642246|NCT03099304|451970589|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
125642247|NCT03099304|451970590|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
125642248|NCT03099304|451970591|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
125642249|NCT03099304|451970586|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
125642250|NCT03099304|451970587|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
125642251|NCT03099304|451970588|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
125642252|NCT03099304|451970589|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
125642253|NCT03099304|451970590|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
125642254|NCT03099304|451970591|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
125642255|NCT00715949|451970594|FG000|Overall Study|could not finish first test|4|||
125642256|NCT01024946|451970595|FG000|Overall Study|Screen Failure|3|||
125642257|NCT01024946|451970595|FG000|Overall Study|Withdrawal by Subject|1|||
125642258|NCT01024946|451970595|FG000|Overall Study|Adverse Event|1|||
125642259|NCT05375838|451970596|FG000|Overall Study|Other|0|||
125642260|NCT05375838|451970597|FG001|Overall Study|Other|0|||
125642261|NCT05375838|451970598|FG002|Overall Study|Other|0|||
125642262|NCT05375838|451970599|FG003|Overall Study|Other|1|||
125642263|NCT05375838|451970600|FG004|Overall Study|Other|1|||
125642264|NCT05375838|451970601|FG005|Overall Study|Other|0|||
125642265|NCT05375838|451970596|FG000|Overall Study|Withdrawal by Subject|2|||
125134364|NCT03733730|450118138|FG001|Overall Study|Withdrawal by Subject|8|||
125134365|NCT01531894|450118139|FG000|Overall Study|Physician Decision|8|||
125134366|NCT01531894|450118139|FG000|Overall Study|Death|1|||
125218511|NCT00436826|450427349|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
125218512|NCT00436826|450427350|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
125218513|NCT00436826|450427351|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
125218514|NCT00436826|450427346|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
125218515|NCT00436826|450427347|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
125642266|NCT05375838|451970597|FG001|Overall Study|Withdrawal by Subject|1|||
125642267|NCT05375838|451970598|FG002|Overall Study|Withdrawal by Subject|3|||
125642268|NCT05375838|451970599|FG003|Overall Study|Withdrawal by Subject|2|||
125642269|NCT05375838|451970600|FG004|Overall Study|Withdrawal by Subject|2|||
125642270|NCT05375838|451970601|FG005|Overall Study|Withdrawal by Subject|0|||
125642271|NCT05375838|451970596|FG000|Overall Study|Protocol Violation|0|||
125642272|NCT05375838|451970597|FG001|Overall Study|Protocol Violation|0|||
125642273|NCT05375838|451970598|FG002|Overall Study|Protocol Violation|0|||
125642274|NCT05375838|451970599|FG003|Overall Study|Protocol Violation|0|||
125134367|NCT06195579|450118140|FG000|Overall Study|Withdrawal by Subject|1|||
125134368|NCT02545283|450118141|FG000|Overall Study|Lost to Follow-up|2|||
125134369|NCT02545283|450118142|FG001|Overall Study|Lost to Follow-up|4|||
125134370|NCT02545283|450118141|FG000|Overall Study|Withdrawal by Subject|5|||
125134371|NCT02545283|450118142|FG001|Overall Study|Withdrawal by Subject|9|||
125218516|NCT00436826|450427348|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
125218517|NCT00436826|450427349|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
125218518|NCT00436826|450427350|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
125218519|NCT00436826|450427351|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
125218520|NCT00436826|450427346|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
125218521|NCT00436826|450427347|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
125218522|NCT00436826|450427348|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
125218523|NCT00436826|450427349|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
125437154|NCT00791921|451228004|FG000|Overall Study|Reason other than those above|0|||
125437155|NCT00791921|451228005|FG001|Overall Study|Reason other than those above|1|||
125437156|NCT01965158|451228007|FG000|Overall Study|Adverse Event|14|||
125437157|NCT01965158|451228008|FG001|Overall Study|Adverse Event|5|||
125437158|NCT01965158|451228007|FG000|Overall Study|Withdrawal by Subject|16|||
125437159|NCT01965158|451228008|FG001|Overall Study|Withdrawal by Subject|24|||
125437160|NCT01965158|451228007|FG000|Overall Study|Lost to Follow-up|7|||
125437161|NCT01965158|451228008|FG001|Overall Study|Lost to Follow-up|5|||
125437162|NCT01965158|451228007|FG000|Overall Study|Protocol Violation|1|||
125437163|NCT01965158|451228008|FG001|Overall Study|Protocol Violation|1|||
125437164|NCT01965158|451228007|FG000|Overall Study|Other - Miscellaneous|3|||
125437165|NCT01965158|451228008|FG001|Overall Study|Other - Miscellaneous|0|||
125437166|NCT00474175|451228009|FG000|Overall Study|Lack of Efficacy|0|||
125437167|NCT00474175|451228010|FG001|Overall Study|Lack of Efficacy|0|||
125437168|NCT00474175|451228011|FG002|Overall Study|Lack of Efficacy|1|||
125437169|NCT00474175|451228009|FG000|Overall Study|Withdrawal by Subject|0|||
125437170|NCT00474175|451228010|FG001|Overall Study|Withdrawal by Subject|1|||
125437171|NCT00474175|451228011|FG002|Overall Study|Withdrawal by Subject|1|||
125437172|NCT00474175|451228009|FG000|Overall Study|Ineligible|1|||
125437173|NCT00474175|451228010|FG001|Overall Study|Ineligible|3|||
125437174|NCT00474175|451228011|FG002|Overall Study|Ineligible|1|||
125437175|NCT00474175|451228009|FG000|Overall Study|Protocol Violation|0|||
125134372|NCT02545283|450118141|FG000|Overall Study|Death|109|||
125218524|NCT00436826|450427350|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
125218525|NCT00436826|450427351|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
125218526|NCT00784719|450427352|FG000|Overall Study|Adverse Event|0|||
125218527|NCT00784719|450427353|FG001|Overall Study|Adverse Event|2|||
125218528|NCT00784719|450427354|FG002|Overall Study|Adverse Event|0|||
125218529|NCT00784719|450427355|FG003|Overall Study|Adverse Event|0|||
125642275|NCT05375838|451970600|FG004|Overall Study|Protocol Violation|1|||
125642276|NCT05375838|451970601|FG005|Overall Study|Protocol Violation|0|||
125642277|NCT05375838|451970596|FG000|Overall Study|Physician Decision|0|||
125642278|NCT05375838|451970597|FG001|Overall Study|Physician Decision|1|||
125642279|NCT05375838|451970598|FG002|Overall Study|Physician Decision|0|||
125642280|NCT05375838|451970599|FG003|Overall Study|Physician Decision|0|||
125642281|NCT05375838|451970600|FG004|Overall Study|Physician Decision|0|||
125642282|NCT05375838|451970601|FG005|Overall Study|Physician Decision|1|||
125642283|NCT05375838|451970596|FG000|Overall Study|Lost to Follow-up|2|||
125642284|NCT05375838|451970597|FG001|Overall Study|Lost to Follow-up|7|||
125642285|NCT05375838|451970598|FG002|Overall Study|Lost to Follow-up|0|||
125642286|NCT05375838|451970599|FG003|Overall Study|Lost to Follow-up|4|||
125642287|NCT05375838|451970600|FG004|Overall Study|Lost to Follow-up|2|||
125642288|NCT05375838|451970601|FG005|Overall Study|Lost to Follow-up|3|||
125642289|NCT02993783|451970610|FG000|Overall Study|Reason not Specified|6|||
125642290|NCT02993783|451970611|FG001|Overall Study|Reason not Specified|9|||
125642291|NCT03049852|451970615|FG000|Overall Study|Lost to Follow-up|0|||
125642292|NCT03049852|451970616|FG001|Overall Study|Lost to Follow-up|1|||
125642293|NCT03049852|451970617|FG002|Overall Study|Lost to Follow-up|0|||
125642294|NCT02067104|451970618|FG000|Overall Study|Study termination due to low accrual|4|||
125642295|NCT02067104|451970619|FG001|Overall Study|Study termination due to low accrual|5|||
125642296|NCT01385098|451970633|FG000|Overall Study|Adverse Event|10|||
125218530|NCT00784719|450427356|FG004|Overall Study|Adverse Event|1|||
125642297|NCT01385098|451970633|FG000|Overall Study|Lost to Follow-up|4|||
125642298|NCT00554840|451970634|FG000|Overall Study|Physician Decision|0|||
125134373|NCT02545283|450118142|FG001|Overall Study|Death|211|||
125642299|NCT00554840|451970635|FG001|Overall Study|Physician Decision|1|||
125642300|NCT00925522|451970636|FG000|Overall Study|study closed -- business decision|20|||
125642301|NCT00410514|451970637|FG000|Overall Study|Adverse Event|2|||
125642302|NCT00410514|451970638|FG001|Overall Study|Adverse Event|2|||
125642303|NCT00410514|451970639|FG002|Overall Study|Adverse Event|2|||
125642304|NCT00410514|451970637|FG000|Overall Study|Protocol Violation|0|||
125642305|NCT00410514|451970638|FG001|Overall Study|Protocol Violation|1|||
125642306|NCT00410514|451970639|FG002|Overall Study|Protocol Violation|1|||
125642307|NCT00410514|451970637|FG000|Overall Study|Lost to Follow-up|0|||
125642308|NCT00410514|451970638|FG001|Overall Study|Lost to Follow-up|0|||
125642309|NCT00410514|451970639|FG002|Overall Study|Lost to Follow-up|2|||
125642310|NCT00410514|451970637|FG000|Overall Study|Non-compliant with study procedures|0|||
125642311|NCT00410514|451970638|FG001|Overall Study|Non-compliant with study procedures|0|||
125642312|NCT00410514|451970639|FG002|Overall Study|Non-compliant with study procedures|2|||
125642313|NCT00656799|451970641|FG000|Overall Study|Death|2|||
125642314|NCT04144140|451972625|FG000|Overall Study|Other|0|||
125642315|NCT04144140|451972626|FG001|Overall Study|Other|0|||
125642316|NCT04144140|451972627|FG002|Overall Study|Other|0|||
125642317|NCT04144140|451972628|FG003|Overall Study|Other|0|||
125642318|NCT04144140|451972629|FG004|Overall Study|Other|0|||
125642319|NCT04144140|451972630|FG005|Overall Study|Other|1|||
125642320|NCT04144140|451972631|FG006|Overall Study|Other|0|||
125642321|NCT00959192|451972636|FG000|Overall Study|Adverse Event|1|||
125642322|NCT00959192|451972637|FG001|Overall Study|Adverse Event|1|||
125642323|NCT00959192|451972638|FG002|Overall Study|Adverse Event|1|||
125642324|NCT00959192|451972639|FG003|Overall Study|Adverse Event|0|||
125642325|NCT00959192|451972636|FG000|Overall Study|Investigator Request|1|||
125642326|NCT00959192|451972637|FG001|Overall Study|Investigator Request|0|||
125642327|NCT00959192|451972638|FG002|Overall Study|Investigator Request|0|||
125642328|NCT00959192|451972639|FG003|Overall Study|Investigator Request|0|||
125642329|NCT00959192|451972636|FG000|Overall Study|Caregiver Request|0|||
125642330|NCT00959192|451972637|FG001|Overall Study|Caregiver Request|0|||
125642331|NCT00959192|451972638|FG002|Overall Study|Caregiver Request|2|||
125642332|NCT00959192|451972639|FG003|Overall Study|Caregiver Request|1|||
125642333|NCT01967134|451972640|FG000|Overall Study|Lost to Follow-up|0|||
125642334|NCT01967134|451972641|FG001|Overall Study|Lost to Follow-up|1|||
125642335|NCT01967134|451972642|FG002|Overall Study|Lost to Follow-up|0|||
125642336|NCT00443534|451972643|FG000|Overall Study|Lack of Efficacy|67|||
125642337|NCT00443534|451972643|FG000|Overall Study|Adverse Event|16|||
125642338|NCT00443534|451972643|FG000|Overall Study|Death|9|||
125642339|NCT00443534|451972643|FG000|Overall Study|Withdrawal by Subject|8|||
125642340|NCT00443534|451972643|FG000|Overall Study|Study Terminated by Sponsor|12|||
125642341|NCT00443534|451972643|FG000|Overall Study|Other|10|||
125642342|NCT00443534|451972643|FG000|Overall Study|Enrolled, Not Treated|1|||
125642343|NCT00364611|451972644|FG000|Overall Study|Did not receive study medication|0|||
125642344|NCT00364611|451972645|FG001|Overall Study|Did not receive study medication|1|||
125642345|NCT00364611|451972644|FG000|Overall Study|Adverse Event|7|||
125642346|NCT00364611|451972645|FG001|Overall Study|Adverse Event|4|||
125642347|NCT00364611|451972644|FG000|Overall Study|Participant's Request|3|||
125642348|NCT00364611|451972645|FG001|Overall Study|Participant's Request|4|||
125642349|NCT00364611|451972644|FG000|Overall Study|Disease Progression|38|||
125642350|NCT00364611|451972645|FG001|Overall Study|Disease Progression|8|||
125642351|NCT00364611|451972644|FG000|Overall Study|Investigator decision|2|||
125642352|NCT00364611|451972645|FG001|Overall Study|Investigator decision|2|||
125642353|NCT00364611|451972644|FG000|Overall Study|Found Ineligible|1|||
125642354|NCT00364611|451972645|FG001|Overall Study|Found Ineligible|0|||
125642355|NCT00364611|451972644|FG000|Overall Study|Presumed CR on Study|0|||
125642356|NCT00364611|451972645|FG001|Overall Study|Presumed CR on Study|1|||
125642357|NCT00364611|451972644|FG000|Overall Study|Receiving Liver Ablation|0|||
125642358|NCT00364611|451972645|FG001|Overall Study|Receiving Liver Ablation|1|||
125642359|NCT05466240|451972646|FG000|Overall Study|Adverse Event|1|||
125642360|NCT05466240|451972647|FG001|Overall Study|Adverse Event|0|||
125642361|NCT05466240|451972646|FG000|Overall Study|Withdrawal by Subject|1|||
125642362|NCT05466240|451972647|FG001|Overall Study|Withdrawal by Subject|0|||
125642363|NCT00305773|451972648|FG000|Overall Study|Death|3|||
125642364|NCT00305773|451972649|FG001|Overall Study|Death|2|||
125642365|NCT00305773|451972648|FG000|Overall Study|Adverse Event|1|||
125642366|NCT00305773|451972649|FG001|Overall Study|Adverse Event|2|||
125642367|NCT00305773|451972648|FG000|Overall Study|Alternative Treatment|4|||
125642368|NCT00305773|451972649|FG001|Overall Study|Alternative Treatment|4|||
125642369|NCT00305773|451972648|FG000|Overall Study|Physician Decision|1|||
125642370|NCT00305773|451972649|FG001|Overall Study|Physician Decision|1|||
125642371|NCT00305773|451972648|FG000|Overall Study|Withdrawal by Subject|1|||
125642372|NCT00305773|451972649|FG001|Overall Study|Withdrawal by Subject|4|||
125134374|NCT02545283|450118141|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
125134375|NCT02545283|450118142|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
125134376|NCT02545283|450118141|FG000|Overall Study|Study Terminated By Sponsor|33|||
125134377|NCT02545283|450118142|FG001|Overall Study|Study Terminated By Sponsor|71|||
125134378|NCT03635320|450118143|FG000|Overall Study|not implanted the device|1|||
125134379|NCT03635320|450118144|FG001|Overall Study|not implanted the device|2|||
125134380|NCT03635320|450118143|FG000|Overall Study|Withdrawal by Subject|11|||
125134381|NCT03635320|450118144|FG001|Overall Study|Withdrawal by Subject|6|||
125134382|NCT00835575|450118148|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
125134383|NCT00835575|450118149|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
125134384|NCT00443651|450118150|FG000|Overall Study|Death|1|||
125134385|NCT00443651|450118151|FG001|Overall Study|Death|5|||
125134386|NCT00443651|450118150|FG000|Overall Study|Adverse Event|5|||
125380408|NCT02659631|451025172|FG000|Overall Study|Death (follow-up phase)|1|||
125134387|NCT00443651|450118151|FG001|Overall Study|Adverse Event|6|||
125134388|NCT00443651|450118150|FG000|Overall Study|Lost to Follow-up|18|||
125134389|NCT00443651|450118151|FG001|Overall Study|Lost to Follow-up|12|||
125134390|NCT00443651|450118150|FG000|Overall Study|Patient's/Guardian's Decision|58|||
125134391|NCT00443651|450118151|FG001|Overall Study|Patient's/Guardian's Decision|30|||
125134392|NCT00443651|450118150|FG000|Overall Study|Physician Decision|13|||
125134393|NCT00443651|450118151|FG001|Overall Study|Physician Decision|4|||
125134394|NCT00443651|450118150|FG000|Overall Study|Pregnancy|0|||
125134395|NCT00443651|450118151|FG001|Overall Study|Pregnancy|1|||
125134396|NCT03606174|450118152|FG000|Overall Study|Death|37|||
125134397|NCT03606174|450118153|FG001|Overall Study|Death|15|||
125134398|NCT03606174|450118154|FG002|Overall Study|Death|15|||
125134399|NCT03606174|450118155|FG003|Overall Study|Death|7|||
125134400|NCT03606174|450118156|FG004|Overall Study|Death|35|||
125134401|NCT03606174|450118157|FG005|Overall Study|Death|12|||
125134402|NCT03606174|450118158|FG006|Overall Study|Death|35|||
125134403|NCT03606174|450118159|FG007|Overall Study|Death|8|||
125134404|NCT03606174|450118160|FG008|Overall Study|Death|5|||
125134405|NCT03606174|450118161|FG009|Overall Study|Death|3|||
125134406|NCT03606174|450118162|FG010|Overall Study|Death|0|||
125134407|NCT03606174|450118152|FG000|Overall Study|Lost to Follow-up|0|||
125218531|NCT00784719|450427357|FG005|Overall Study|Adverse Event|1|||
125218532|NCT00784719|450427358|FG006|Overall Study|Adverse Event|1|||
125218533|NCT00784719|450427352|FG000|Overall Study|Lost to Follow-up|0|||
125218534|NCT00784719|450427353|FG001|Overall Study|Lost to Follow-up|0|||
125218535|NCT00784719|450427354|FG002|Overall Study|Lost to Follow-up|0|||
125218536|NCT00784719|450427355|FG003|Overall Study|Lost to Follow-up|0|||
125218537|NCT00784719|450427356|FG004|Overall Study|Lost to Follow-up|1|||
125218538|NCT00784719|450427357|FG005|Overall Study|Lost to Follow-up|1|||
125218539|NCT00784719|450427358|FG006|Overall Study|Lost to Follow-up|0|||
125218540|NCT00784719|450427352|FG000|Overall Study|Other|2|||
125380409|NCT02659631|451025173|FG001|Overall Study|Death (follow-up phase)|2|||
125380410|NCT02659631|451025174|FG002|Overall Study|Death (follow-up phase)|1|||
125380411|NCT02659631|451025175|FG003|Overall Study|Death (follow-up phase)|1|||
125380412|NCT02659631|451025176|FG004|Overall Study|Death (follow-up phase)|3|||
125642373|NCT00305773|451972648|FG000|Overall Study|Disease Progression|1|||
125642374|NCT00305773|451972649|FG001|Overall Study|Disease Progression|3|||
125642375|NCT00305773|451972648|FG000|Overall Study|All other reasons|3|||
125642376|NCT00305773|451972649|FG001|Overall Study|All other reasons|2|||
125642377|NCT04097925|451972650|FG000|Overall Study|Withdrawal by Subject|1|||
125642378|NCT02679222|451972651|FG000|Overall Study|No time for project|1|||
125642379|NCT04735432|451972655|FG000|Overall Study|Other - due to personal reason|1|||
125642380|NCT04735432|451972656|FG001|Overall Study|Other - due to personal reason|0|||
125642381|NCT04735432|451972655|FG000|Overall Study|Adverse Event|2|||
125642382|NCT04735432|451972656|FG001|Overall Study|Adverse Event|0|||
125642383|NCT04397757|451972657|FG000|Overall Study|Death|3|||
125642384|NCT04397757|451972658|FG001|Overall Study|Death|11|||
125642385|NCT04397757|451972657|FG000|Overall Study|Withdrawal by Subject|2|||
125642386|NCT04397757|451972658|FG001|Overall Study|Withdrawal by Subject|0|||
125642387|NCT04397757|451972657|FG000|Overall Study|Lost to Follow-up|4|||
125642388|NCT04397757|451972658|FG001|Overall Study|Lost to Follow-up|3|||
125642389|NCT00413231|451972659|FG000|0 to 30-day Post Treatment|Death|5|||
125642390|NCT00413231|451972659|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
125134408|NCT03606174|450118153|FG001|Overall Study|Lost to Follow-up|0|||
125134409|NCT03606174|450118154|FG002|Overall Study|Lost to Follow-up|0|||
125134410|NCT03606174|450118155|FG003|Overall Study|Lost to Follow-up|0|||
125134411|NCT03606174|450118156|FG004|Overall Study|Lost to Follow-up|1|||
125218541|NCT00784719|450427353|FG001|Overall Study|Other|1|||
125642391|NCT00413231|451972659|FG000|30-day to 365-day Post Treatment|Death|13|||
125134412|NCT03606174|450118157|FG005|Overall Study|Lost to Follow-up|1|||
125134413|NCT03606174|450118158|FG006|Overall Study|Lost to Follow-up|0|||
125134414|NCT03606174|450118159|FG007|Overall Study|Lost to Follow-up|0|||
125218542|NCT00784719|450427354|FG002|Overall Study|Other|1|||
125218543|NCT00784719|450427355|FG003|Overall Study|Other|0|||
125380413|NCT02659631|451025177|FG005|Overall Study|Death (follow-up phase)|2|||
125380414|NCT02659631|451025178|FG006|Overall Study|Death (follow-up phase)|0|||
125380415|NCT02659631|451025179|FG007|Overall Study|Death (follow-up phase)|3|||
125380416|NCT02659631|451025180|FG008|Overall Study|Death (follow-up phase)|1|||
125380417|NCT02659631|451025181|FG009|Overall Study|Death (follow-up phase)|0|||
125642392|NCT00413231|451972659|FG000|365-day to 60-month Post Treatment|Death|36|||
125642393|NCT00413231|451972659|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
125642394|NCT00413231|451972659|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
125642395|NCT00413231|451972659|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
125642396|NCT00945945|451972660|FG000|Overall Study|Adverse Event|15|||
125642397|NCT00945945|451972661|FG001|Overall Study|Adverse Event|35|||
125642398|NCT00945945|451972660|FG000|Overall Study|Withdrawal by Subject|7|||
125642399|NCT00945945|451972661|FG001|Overall Study|Withdrawal by Subject|10|||
125642400|NCT00945945|451972660|FG000|Overall Study|Lost to Follow-up|4|||
125642401|NCT00945945|451972661|FG001|Overall Study|Lost to Follow-up|5|||
125642402|NCT00945945|451972660|FG000|Overall Study|Lack of Efficacy|6|||
125642403|NCT00945945|451972661|FG001|Overall Study|Lack of Efficacy|2|||
125642404|NCT00945945|451972660|FG000|Overall Study|Protocol Violation|4|||
125642405|NCT00945945|451972661|FG001|Overall Study|Protocol Violation|2|||
125642406|NCT00945945|451972660|FG000|Overall Study|Entry Criteria Not Met|0|||
125642407|NCT00945945|451972661|FG001|Overall Study|Entry Criteria Not Met|1|||
125642408|NCT01823991|451972662|FG000|Overall Study|Withdrawal by Subject|8|||
125642409|NCT01823991|451972663|FG001|Overall Study|Withdrawal by Subject|5|||
125642410|NCT05158244|451972664|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
125642411|NCT05158244|451972665|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
125642412|NCT05158244|451972666|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
125642413|NCT05158244|451972667|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
125642414|NCT05158244|451972668|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
125642415|NCT05158244|451972664|FG000|Overall Study|Withdrawal by Subject|0|||
125642416|NCT05158244|451972665|FG001|Overall Study|Withdrawal by Subject|0|||
125642417|NCT05158244|451972666|FG002|Overall Study|Withdrawal by Subject|1|||
125642418|NCT05158244|451972667|FG003|Overall Study|Withdrawal by Subject|0|||
125642419|NCT05158244|451972668|FG004|Overall Study|Withdrawal by Subject|0|||
125642420|NCT01066819|451972669|FG000|Overall Study|Adverse Event|18|||
125642421|NCT01066819|451972670|FG001|Overall Study|Adverse Event|1|||
125642422|NCT01066819|451972671|FG002|Overall Study|Adverse Event|6|||
125642423|NCT01066819|451972672|FG003|Overall Study|Adverse Event|0|||
125642424|NCT01066819|451972673|FG004|Overall Study|Adverse Event|0|||
125642425|NCT01066819|451972674|FG005|Overall Study|Adverse Event|0|||
125642426|NCT01066819|451972669|FG000|Overall Study|Death|5|||
125642427|NCT01066819|451972670|FG001|Overall Study|Death|0|||
125642428|NCT01066819|451972671|FG002|Overall Study|Death|1|||
125642429|NCT01066819|451972672|FG003|Overall Study|Death|0|||
125134415|NCT03606174|450118160|FG008|Overall Study|Lost to Follow-up|0|||
125642430|NCT01066819|451972673|FG004|Overall Study|Death|0|||
125380418|NCT02659631|451025172|FG000|Overall Study|Death (treatment phase)|0|||
125380419|NCT02659631|451025173|FG001|Overall Study|Death (treatment phase)|0|||
125134416|NCT03606174|450118161|FG009|Overall Study|Lost to Follow-up|0|||
125134417|NCT03606174|450118162|FG010|Overall Study|Lost to Follow-up|0|||
125134418|NCT03606174|450118152|FG000|Overall Study|Withdrawal by Subject|6|||
125134419|NCT03606174|450118153|FG001|Overall Study|Withdrawal by Subject|0|||
125134420|NCT03606174|450118154|FG002|Overall Study|Withdrawal by Subject|0|||
125134421|NCT03606174|450118155|FG003|Overall Study|Withdrawal by Subject|1|||
125134422|NCT03606174|450118156|FG004|Overall Study|Withdrawal by Subject|2|||
125134423|NCT03606174|450118157|FG005|Overall Study|Withdrawal by Subject|1|||
125134424|NCT03606174|450118158|FG006|Overall Study|Withdrawal by Subject|4|||
125134425|NCT03606174|450118159|FG007|Overall Study|Withdrawal by Subject|0|||
125134426|NCT03606174|450118160|FG008|Overall Study|Withdrawal by Subject|0|||
125134427|NCT03606174|450118161|FG009|Overall Study|Withdrawal by Subject|0|||
125134428|NCT03606174|450118162|FG010|Overall Study|Withdrawal by Subject|1|||
125134429|NCT03606174|450118152|FG000|Overall Study|Study Terminated by Sponsor|5|||
125134430|NCT03606174|450118153|FG001|Overall Study|Study Terminated by Sponsor|7|||
125134431|NCT03606174|450118154|FG002|Overall Study|Study Terminated by Sponsor|3|||
125134432|NCT03606174|450118155|FG003|Overall Study|Study Terminated by Sponsor|0|||
125134433|NCT03606174|450118156|FG004|Overall Study|Study Terminated by Sponsor|11|||
125134434|NCT03606174|450118157|FG005|Overall Study|Study Terminated by Sponsor|6|||
125134435|NCT03606174|450118158|FG006|Overall Study|Study Terminated by Sponsor|12|||
125134436|NCT03606174|450118159|FG007|Overall Study|Study Terminated by Sponsor|1|||
125134437|NCT03606174|450118160|FG008|Overall Study|Study Terminated by Sponsor|3|||
125134438|NCT03606174|450118161|FG009|Overall Study|Study Terminated by Sponsor|1|||
125134439|NCT03606174|450118162|FG010|Overall Study|Study Terminated by Sponsor|2|||
125134440|NCT03606174|450118152|FG000|Overall Study|Miscellaneous|1|||
125134441|NCT03606174|450118153|FG001|Overall Study|Miscellaneous|1|||
125134442|NCT03606174|450118154|FG002|Overall Study|Miscellaneous|0|||
125134443|NCT03606174|450118155|FG003|Overall Study|Miscellaneous|1|||
125134444|NCT03606174|450118156|FG004|Overall Study|Miscellaneous|4|||
125134445|NCT03606174|450118157|FG005|Overall Study|Miscellaneous|7|||
125134446|NCT03606174|450118158|FG006|Overall Study|Miscellaneous|5|||
125134447|NCT03606174|450118159|FG007|Overall Study|Miscellaneous|0|||
125134448|NCT03606174|450118160|FG008|Overall Study|Miscellaneous|0|||
125134449|NCT03606174|450118161|FG009|Overall Study|Miscellaneous|0|||
125134450|NCT03606174|450118162|FG010|Overall Study|Miscellaneous|1|||
125218544|NCT00784719|450427356|FG004|Overall Study|Other|2|||
125134451|NCT02241551|450118165|FG000|Overall Study|Adverse Event|1|||
125218545|NCT00784719|450427357|FG005|Overall Study|Other|1|||
125218546|NCT00784719|450427358|FG006|Overall Study|Other|3|||
125218547|NCT00784719|450427352|FG000|Overall Study|Withdrawal by Subject|1|||
125218548|NCT00784719|450427353|FG001|Overall Study|Withdrawal by Subject|0|||
125218549|NCT00784719|450427354|FG002|Overall Study|Withdrawal by Subject|0|||
125134452|NCT02241551|450118166|FG001|Overall Study|Adverse Event|0|||
125134453|NCT00469898|450118167|FG000|Overall Study|Adverse Event|7|||
125134454|NCT00469898|450118167|FG000|Overall Study|Withdrawal by Subject|4|||
125134455|NCT00469898|450118167|FG000|Overall Study|Death|4|||
125218550|NCT00784719|450427355|FG003|Overall Study|Withdrawal by Subject|0|||
125134456|NCT00469898|450118167|FG000|Overall Study|Disease progression|9|||
125134457|NCT00469898|450118167|FG000|Overall Study|Decreased performance status|1|||
125134458|NCT01205035|450118168|FG000|Overall Study|Withdrawal by Subject|1|||
125134459|NCT01205035|450118169|FG001|Overall Study|Withdrawal by Subject|0|||
125134460|NCT01205035|450118168|FG000|Overall Study|Physician Decision|1|||
125134461|NCT01205035|450118169|FG001|Overall Study|Physician Decision|0|||
125134462|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
125134463|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
125134464|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
125134465|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
125134466|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
125134467|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
125134468|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
125134469|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
125134470|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
125134471|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
125134472|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
125134473|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
125134474|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
125380420|NCT02659631|451025174|FG002|Overall Study|Death (treatment phase)|0|||
125380421|NCT02659631|451025175|FG003|Overall Study|Death (treatment phase)|0|||
125380422|NCT02659631|451025176|FG004|Overall Study|Death (treatment phase)|1|||
125380423|NCT02659631|451025177|FG005|Overall Study|Death (treatment phase)|0|||
125380424|NCT02659631|451025178|FG006|Overall Study|Death (treatment phase)|1|||
125380425|NCT02659631|451025179|FG007|Overall Study|Death (treatment phase)|0|||
125380426|NCT02659631|451025180|FG008|Overall Study|Death (treatment phase)|0|||
125380427|NCT02659631|451025181|FG009|Overall Study|Death (treatment phase)|0|||
125134475|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
125134476|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
125134477|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
125134478|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
125134479|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
125134480|NCT01667679|450118171|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
125134481|NCT01667679|450118172|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
125134482|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
125134483|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
125134484|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
125134485|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
125134486|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
125218551|NCT00784719|450427356|FG004|Overall Study|Withdrawal by Subject|2|||
125218552|NCT00784719|450427357|FG005|Overall Study|Withdrawal by Subject|0|||
125642431|NCT01066819|451972674|FG005|Overall Study|Death|0|||
125642432|NCT01066819|451972669|FG000|Overall Study|Lack of Efficacy|22|||
125642433|NCT01066819|451972670|FG001|Overall Study|Lack of Efficacy|1|||
125642434|NCT01066819|451972671|FG002|Overall Study|Lack of Efficacy|2|||
125642435|NCT01066819|451972672|FG003|Overall Study|Lack of Efficacy|1|||
125642436|NCT01066819|451972673|FG004|Overall Study|Lack of Efficacy|0|||
125642437|NCT01066819|451972674|FG005|Overall Study|Lack of Efficacy|0|||
125642438|NCT01066819|451972669|FG000|Overall Study|Physician Decision|6|||
125642439|NCT01066819|451972670|FG001|Overall Study|Physician Decision|2|||
125642440|NCT01066819|451972671|FG002|Overall Study|Physician Decision|3|||
125642441|NCT01066819|451972672|FG003|Overall Study|Physician Decision|0|||
125642442|NCT01066819|451972673|FG004|Overall Study|Physician Decision|0|||
125642443|NCT01066819|451972674|FG005|Overall Study|Physician Decision|0|||
125642444|NCT01066819|451972669|FG000|Overall Study|Protocol Violation|12|||
125642445|NCT01066819|451972670|FG001|Overall Study|Protocol Violation|6|||
125642446|NCT01066819|451972671|FG002|Overall Study|Protocol Violation|0|||
125642447|NCT01066819|451972672|FG003|Overall Study|Protocol Violation|0|||
125642448|NCT01066819|451972673|FG004|Overall Study|Protocol Violation|0|||
125642449|NCT01066819|451972674|FG005|Overall Study|Protocol Violation|0|||
125642450|NCT01066819|451972669|FG000|Overall Study|Withdrawal by Subject|29|||
125642451|NCT01066819|451972670|FG001|Overall Study|Withdrawal by Subject|11|||
125642452|NCT01066819|451972671|FG002|Overall Study|Withdrawal by Subject|6|||
125642453|NCT01066819|451972672|FG003|Overall Study|Withdrawal by Subject|0|||
125642454|NCT01066819|451972673|FG004|Overall Study|Withdrawal by Subject|0|||
125642455|NCT01066819|451972674|FG005|Overall Study|Withdrawal by Subject|0|||
125642456|NCT01066819|451972669|FG000|Overall Study|Administrative|6|||
125642457|NCT01066819|451972670|FG001|Overall Study|Administrative|4|||
125642458|NCT01066819|451972671|FG002|Overall Study|Administrative|2|||
125642459|NCT01066819|451972672|FG003|Overall Study|Administrative|0|||
125642460|NCT01066819|451972673|FG004|Overall Study|Administrative|0|||
125642461|NCT01066819|451972674|FG005|Overall Study|Administrative|0|||
125642462|NCT01066819|451972669|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
125642463|NCT01066819|451972670|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
125642464|NCT01066819|451972671|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
125642465|NCT01066819|451972672|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
125642466|NCT01066819|451972673|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
125642467|NCT01066819|451972674|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
125642468|NCT01066819|451972669|FG000|Overall Study|Early termination|2|||
125642469|NCT01066819|451972670|FG001|Overall Study|Early termination|0|||
125642470|NCT01066819|451972671|FG002|Overall Study|Early termination|0|||
125642471|NCT01066819|451972672|FG003|Overall Study|Early termination|0|||
125642472|NCT01066819|451972673|FG004|Overall Study|Early termination|0|||
125642473|NCT01066819|451972674|FG005|Overall Study|Early termination|0|||
125642474|NCT01066819|451972669|FG000|Overall Study|Failed to return|298|||
125642475|NCT01066819|451972670|FG001|Overall Study|Failed to return|107|||
125642476|NCT01066819|451972671|FG002|Overall Study|Failed to return|68|||
125642477|NCT01066819|451972672|FG003|Overall Study|Failed to return|7|||
125642478|NCT01066819|451972673|FG004|Overall Study|Failed to return|2|||
125642479|NCT01066819|451972674|FG005|Overall Study|Failed to return|3|||
125134487|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
125134488|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
125218553|NCT00784719|450427358|FG006|Overall Study|Withdrawal by Subject|1|||
125218554|NCT03131687|450427362|FG000|Overall Study|Adverse Event|0|||
125642480|NCT01066819|451972669|FG000|Overall Study|Lab test not done|9|||
125642481|NCT01066819|451972670|FG001|Overall Study|Lab test not done|0|||
125642482|NCT01066819|451972671|FG002|Overall Study|Lab test not done|2|||
125642483|NCT01066819|451972672|FG003|Overall Study|Lab test not done|1|||
125218555|NCT03131687|450427363|FG001|Overall Study|Adverse Event|1|||
125218556|NCT03131687|450427364|FG002|Overall Study|Adverse Event|0|||
125642484|NCT01066819|451972673|FG004|Overall Study|Lab test not done|0|||
125642485|NCT01066819|451972674|FG005|Overall Study|Lab test not done|0|||
125642486|NCT01066819|451972669|FG000|Overall Study|Miscellaneous|28|||
125380428|NCT02377466|451025182|FG000|Overall Study|Other: Randomized and not treated|0|||
125380429|NCT02377466|451025183|FG001|Overall Study|Other: Randomized and not treated|2|||
125380430|NCT02485574|451025192|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
125380431|NCT00563381|451025200|FG000|Overall Study|Adverse Event|264|||
125380432|NCT00563381|451025201|FG001|Overall Study|Adverse Event|292|||
125380433|NCT00563381|451025200|FG000|Overall Study|Protocol Violation|66|||
125380434|NCT00563381|451025201|FG001|Overall Study|Protocol Violation|74|||
125380435|NCT00563381|451025200|FG000|Overall Study|Lost to Follow-up|7|||
125380436|NCT00563381|451025201|FG001|Overall Study|Lost to Follow-up|15|||
125380437|NCT00563381|451025200|FG000|Overall Study|Withdrawal by Subject|192|||
125380438|NCT00563381|451025201|FG001|Overall Study|Withdrawal by Subject|209|||
125380439|NCT00563381|451025200|FG000|Overall Study|Lack of Efficacy|32|||
125642487|NCT01066819|451972670|FG001|Overall Study|Miscellaneous|10|||
125642488|NCT01066819|451972671|FG002|Overall Study|Miscellaneous|18|||
125642489|NCT01066819|451972672|FG003|Overall Study|Miscellaneous|1|||
125642490|NCT01066819|451972673|FG004|Overall Study|Miscellaneous|0|||
125642491|NCT01066819|451972674|FG005|Overall Study|Miscellaneous|0|||
125642492|NCT01066819|451972669|FG000|Overall Study|Non responders|123|||
125642493|NCT01066819|451972670|FG001|Overall Study|Non responders|2|||
125642494|NCT01066819|451972671|FG002|Overall Study|Non responders|7|||
125642495|NCT01066819|451972672|FG003|Overall Study|Non responders|2|||
125642496|NCT01066819|451972673|FG004|Overall Study|Non responders|0|||
125642497|NCT01066819|451972674|FG005|Overall Study|Non responders|1|||
125642498|NCT01066819|451972669|FG000|Overall Study|Not categorised|9|||
125642499|NCT01066819|451972670|FG001|Overall Study|Not categorised|2|||
125642500|NCT01066819|451972671|FG002|Overall Study|Not categorised|6|||
125642501|NCT01066819|451972672|FG003|Overall Study|Not categorised|1|||
125642502|NCT01066819|451972673|FG004|Overall Study|Not categorised|0|||
125642503|NCT01066819|451972674|FG005|Overall Study|Not categorised|0|||
125642504|NCT01066819|451972669|FG000|Overall Study|Relapse|16|||
125642505|NCT01066819|451972670|FG001|Overall Study|Relapse|4|||
125642506|NCT01066819|451972671|FG002|Overall Study|Relapse|3|||
125642507|NCT01066819|451972672|FG003|Overall Study|Relapse|0|||
125642508|NCT01066819|451972673|FG004|Overall Study|Relapse|0|||
125642509|NCT01066819|451972674|FG005|Overall Study|Relapse|0|||
125642510|NCT01066819|451972669|FG000|Overall Study|Results not available|1|||
125642511|NCT01066819|451972670|FG001|Overall Study|Results not available|0|||
125642512|NCT01066819|451972671|FG002|Overall Study|Results not available|0|||
125642513|NCT01066819|451972672|FG003|Overall Study|Results not available|0|||
125642514|NCT01066819|451972673|FG004|Overall Study|Results not available|0|||
125642515|NCT01066819|451972674|FG005|Overall Study|Results not available|0|||
125642516|NCT01066819|451972669|FG000|Overall Study|Screen failure|1|||
125642517|NCT01066819|451972670|FG001|Overall Study|Screen failure|0|||
125642518|NCT01066819|451972671|FG002|Overall Study|Screen failure|0|||
125642519|NCT01066819|451972672|FG003|Overall Study|Screen failure|0|||
125642520|NCT01066819|451972673|FG004|Overall Study|Screen failure|0|||
125642521|NCT01066819|451972674|FG005|Overall Study|Screen failure|0|||
125642522|NCT01066819|451972669|FG000|Overall Study|Spontaneous cure|1|||
125642523|NCT01066819|451972670|FG001|Overall Study|Spontaneous cure|0|||
125642524|NCT01066819|451972671|FG002|Overall Study|Spontaneous cure|0|||
125642525|NCT01066819|451972672|FG003|Overall Study|Spontaneous cure|0|||
125642526|NCT01066819|451972673|FG004|Overall Study|Spontaneous cure|0|||
125642527|NCT01066819|451972674|FG005|Overall Study|Spontaneous cure|0|||
125642528|NCT01066819|451972669|FG000|Overall Study|Treatment never started|85|||
125642529|NCT01066819|451972670|FG001|Overall Study|Treatment never started|19|||
125642530|NCT01066819|451972671|FG002|Overall Study|Treatment never started|19|||
125642531|NCT01066819|451972672|FG003|Overall Study|Treatment never started|3|||
125642532|NCT01066819|451972673|FG004|Overall Study|Treatment never started|2|||
125642533|NCT01066819|451972674|FG005|Overall Study|Treatment never started|2|||
125642534|NCT01066819|451972669|FG000|Overall Study|Treatment stopped|12|||
125642535|NCT01066819|451972670|FG001|Overall Study|Treatment stopped|1|||
125642536|NCT01066819|451972671|FG002|Overall Study|Treatment stopped|2|||
125642537|NCT01066819|451972672|FG003|Overall Study|Treatment stopped|1|||
125642538|NCT01066819|451972673|FG004|Overall Study|Treatment stopped|0|||
125437176|NCT00474175|451228010|FG001|Overall Study|Protocol Violation|2|||
125642539|NCT01066819|451972674|FG005|Overall Study|Treatment stopped|0|||
125642540|NCT01066819|451972669|FG000|Overall Study|Other|5|||
125642541|NCT01066819|451972670|FG001|Overall Study|Other|1|||
125642542|NCT01066819|451972671|FG002|Overall Study|Other|1|||
125642543|NCT01066819|451972672|FG003|Overall Study|Other|0|||
125380440|NCT00563381|451025201|FG001|Overall Study|Lack of Efficacy|24|||
125437177|NCT00474175|451228011|FG002|Overall Study|Protocol Violation|1|||
125642544|NCT01066819|451972673|FG004|Overall Study|Other|0|||
125380441|NCT00563381|451025200|FG000|Overall Study|Individual different reasons|24|||
125437178|NCT00474175|451228009|FG000|Overall Study|Administrative|0|||
125642545|NCT01066819|451972674|FG005|Overall Study|Other|0|||
125642546|NCT00805194|451972676|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
125642547|NCT00805194|451972677|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
125642548|NCT00805194|451972676|FG000|Overall Study|Worsening or AE of underlying disease|64|||
125642549|NCT00805194|451972677|FG001|Overall Study|Worsening or AE of underlying disease|70|||
125642550|NCT00805194|451972676|FG000|Overall Study|Other AE|84|||
125642551|NCT00805194|451972677|FG001|Overall Study|Other AE|73|||
125642552|NCT00805194|451972676|FG000|Overall Study|Protocol Violation|9|||
125642553|NCT00805194|451972677|FG001|Overall Study|Protocol Violation|9|||
125642554|NCT00805194|451972676|FG000|Overall Study|Lost to Follow-up|5|||
125642555|NCT00805194|451972677|FG001|Overall Study|Lost to Follow-up|5|||
125642556|NCT00805194|451972676|FG000|Overall Study|Withdrawal by Subject|60|||
125642557|NCT00805194|451972677|FG001|Overall Study|Withdrawal by Subject|42|||
125642558|NCT00805194|451972676|FG000|Overall Study|Not treated|3|||
125642559|NCT00805194|451972677|FG001|Overall Study|Not treated|4|||
125642560|NCT00805194|451972676|FG000|Overall Study|Reasons other than stated above|20|||
125642561|NCT00805194|451972677|FG001|Overall Study|Reasons other than stated above|16|||
125642562|NCT02275052|451972683|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125642563|NCT02275052|451972684|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
125642564|NCT02275052|451972685|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125642565|NCT02275052|451972686|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125642566|NCT02275052|451972683|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
125642567|NCT02275052|451972684|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
125642568|NCT02275052|451972685|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
125642569|NCT02275052|451972686|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
125642570|NCT02275052|451972683|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
125642571|NCT02275052|451972684|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
125642572|NCT02275052|451972685|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125642573|NCT02275052|451972686|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125642574|NCT02275052|451972683|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
125642575|NCT02275052|451972684|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
125642576|NCT02275052|451972685|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
125642577|NCT02275052|451972686|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
125642578|NCT02275052|451972683|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
125642579|NCT02275052|451972684|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
125642580|NCT02275052|451972685|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
125642581|NCT02275052|451972686|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
125642582|NCT02275052|451972683|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
125642583|NCT02275052|451972684|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
125642584|NCT02275052|451972685|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
125642585|NCT02275052|451972686|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
125642586|NCT02275052|451972683|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
125642587|NCT02275052|451972684|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
125642588|NCT02275052|451972685|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
125642589|NCT02275052|451972686|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
125642590|NCT02275052|451972683|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
125642591|NCT02275052|451972684|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
125642592|NCT02275052|451972685|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
125642593|NCT02275052|451972686|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
125642594|NCT02275052|451972683|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125642595|NCT02275052|451972684|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125642596|NCT02275052|451972685|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
125642597|NCT02275052|451972686|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
125642598|NCT02275052|451972683|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
125642599|NCT02275052|451972684|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
125642600|NCT02275052|451972685|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
125642601|NCT02275052|451972686|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
125642602|NCT02275052|451972683|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
125642603|NCT02275052|451972684|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
125642604|NCT02275052|451972685|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
125642605|NCT02275052|451972686|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
125642606|NCT00808028|451972689|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
125437179|NCT00474175|451228010|FG001|Overall Study|Administrative|1|||
125642607|NCT00808028|451972690|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
125134489|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
125134490|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
125134491|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
125134492|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
125134493|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
125134494|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
125134495|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
125134496|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
125134497|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
125134498|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
125134499|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
125134500|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
125437180|NCT00474175|451228011|FG002|Overall Study|Administrative|0|||
125437181|NCT01619787|451228014|FG000|Overall Study|Lost to Follow-up|5|||
125218557|NCT03131687|450427365|FG003|Overall Study|Adverse Event|1|||
125642608|NCT00808028|451972691|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
125642609|NCT00808028|451972692|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
125642610|NCT00808028|451972689|FG000|Stage 1 (6 Months)|Other|1|||
125642611|NCT00808028|451972690|FG001|Stage 1 (6 Months)|Other|0|||
125642612|NCT00808028|451972691|FG002|Stage 1 (6 Months)|Other|2|||
125642613|NCT00808028|451972692|FG003|Stage 1 (6 Months)|Other|4|||
125642614|NCT00808028|451972689|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
125642615|NCT00808028|451972690|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
125642616|NCT00808028|451972691|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
125642617|NCT00808028|451972692|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
125642618|NCT00808028|451972689|FG000|Stage 1 (6 Months)|Adverse Event|0|||
125642619|NCT00808028|451972690|FG001|Stage 1 (6 Months)|Adverse Event|0|||
125642620|NCT00808028|451972691|FG002|Stage 1 (6 Months)|Adverse Event|1|||
125642621|NCT00808028|451972692|FG003|Stage 1 (6 Months)|Adverse Event|2|||
125642622|NCT00808028|451972689|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
125642623|NCT00808028|451972690|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
125642624|NCT00808028|451972691|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
125642625|NCT00808028|451972692|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
125642626|NCT00808028|451972689|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
125642627|NCT00808028|451972690|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
125642628|NCT00808028|451972691|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
125642629|NCT00808028|451972692|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
125642630|NCT00808028|451972689|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
125642631|NCT00808028|451972690|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
125642632|NCT00808028|451972691|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
125642633|NCT00808028|451972692|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
125642634|NCT00808028|451972689|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
125642635|NCT00808028|451972690|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
125642636|NCT00808028|451972691|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
125642637|NCT00808028|451972692|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
125642638|NCT00808028|451972689|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
125642639|NCT00808028|451972690|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
125642640|NCT00808028|451972691|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
125642641|NCT00808028|451972692|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
125642642|NCT00808028|451972689|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
125642643|NCT00808028|451972690|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
125642644|NCT00808028|451972691|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
125642645|NCT00808028|451972692|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
125642646|NCT00808028|451972689|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
125642647|NCT00808028|451972690|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
125642648|NCT00808028|451972691|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
125642649|NCT00808028|451972692|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
125642650|NCT00808028|451972689|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
125642651|NCT00808028|451972690|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
125642652|NCT00808028|451972691|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
125642653|NCT00808028|451972692|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
125642654|NCT00808028|451972689|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
125642655|NCT00808028|451972690|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
125642656|NCT00808028|451972691|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
125134501|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
125134502|NCT01667679|450118171|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
125134503|NCT01667679|450118172|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
125134504|NCT02159183|450118173|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
125134505|NCT02159183|450118174|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
125134506|NCT02159183|450118173|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
125134507|NCT02159183|450118174|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
125134508|NCT02159183|450118173|FG000|Analysis After the 36 Months Follow-up|Death|0|||
125134509|NCT02159183|450118174|FG001|Analysis After the 36 Months Follow-up|Death|1|||
125134510|NCT02159183|450118173|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
125134511|NCT02159183|450118174|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
125642657|NCT00808028|451972692|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
125642658|NCT00808028|451972689|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
125642659|NCT00808028|451972690|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
125642660|NCT00808028|451972691|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
125642661|NCT00808028|451972692|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
125642662|NCT00808028|451972689|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
125642663|NCT00808028|451972690|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
125642664|NCT00808028|451972691|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
125642665|NCT00808028|451972692|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
125642666|NCT02773849|451972693|FG000|Overall Study|Lost to Follow-up|11|||
125437182|NCT01130883|451228015|FG000|Overall Study|Patient Noncompliance|6|||
125642667|NCT02773849|451972693|FG000|Overall Study|Death|26|||
125642668|NCT02773849|451972693|FG000|Overall Study|Withdrawal by Subject|5|||
125642669|NCT02773849|451972693|FG000|Overall Study|Withdrawal of Consent|9|||
125642670|NCT02773849|451972693|FG000|Overall Study|Other: not due to lack of tolerability|11|||
125642671|NCT00948389|451972694|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
125642672|NCT00948389|451972695|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
125642673|NCT00948389|451972696|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
125642674|NCT00948389|451972697|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
125642675|NCT00948389|451972698|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
125642676|NCT00948389|451972694|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
125642677|NCT00948389|451972695|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
125642678|NCT00948389|451972696|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
125642679|NCT00948389|451972697|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
125642680|NCT00948389|451972698|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
125642681|NCT00948389|451972694|FG000|Overall Study|Both Progression and Toxicity|1|||
125642682|NCT00948389|451972695|FG001|Overall Study|Both Progression and Toxicity|0|||
125642683|NCT00948389|451972696|FG002|Overall Study|Both Progression and Toxicity|0|||
125642684|NCT00948389|451972697|FG003|Overall Study|Both Progression and Toxicity|0|||
125642685|NCT00948389|451972698|FG004|Overall Study|Both Progression and Toxicity|0|||
125642686|NCT00508001|451972703|FG000|Overall Study|Adverse Event|2|||
125642687|NCT00508001|451972704|FG001|Overall Study|Adverse Event|0|||
125642688|NCT00508001|451972705|FG002|Overall Study|Adverse Event|4|||
125642689|NCT00508001|451972703|FG000|Overall Study|condition under investigation worsened|13|||
125642690|NCT00508001|451972704|FG001|Overall Study|condition under investigation worsened|7|||
125642691|NCT00508001|451972705|FG002|Overall Study|condition under investigation worsened|1|||
125642692|NCT00508001|451972703|FG000|Overall Study|Death|0|||
125642693|NCT00508001|451972704|FG001|Overall Study|Death|1|||
125642694|NCT00508001|451972705|FG002|Overall Study|Death|1|||
125642695|NCT00508001|451972703|FG000|Overall Study|Withdrawal by Subject|4|||
125642696|NCT00508001|451972704|FG001|Overall Study|Withdrawal by Subject|4|||
125642697|NCT00508001|451972705|FG002|Overall Study|Withdrawal by Subject|1|||
125642698|NCT00732199|451972711|FG000|Overall Study|Withdrawal by Subject|25|||
125642699|NCT00732199|451972712|FG001|Overall Study|Withdrawal by Subject|18|||
125642700|NCT00732199|451972711|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
125642701|NCT00732199|451972712|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
125642702|NCT02870348|451972727|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
125642703|NCT01051856|451972728|FG000|Overall Study|Withdrawal by Subject|1|||
125642704|NCT01051856|451972729|FG001|Overall Study|Withdrawal by Subject|0|||
125642705|NCT00672139|451972730|FG000|Overall Study|Death|14|||
125642706|NCT00672139|451972731|FG001|Overall Study|Death|23|||
125642707|NCT00672139|451972730|FG000|Overall Study|Withdrawal by Subject|2|||
125642708|NCT00672139|451972731|FG001|Overall Study|Withdrawal by Subject|11|||
125642709|NCT00672139|451972730|FG000|Overall Study|Adverse Event|4|||
125642710|NCT00672139|451972731|FG001|Overall Study|Adverse Event|7|||
125642711|NCT00672139|451972730|FG000|Overall Study|Physician Decision|2|||
125642712|NCT00672139|451972731|FG001|Overall Study|Physician Decision|0|||
125642713|NCT00672139|451972730|FG000|Overall Study|Lack of Efficacy|4|||
125642714|NCT00672139|451972731|FG001|Overall Study|Lack of Efficacy|1|||
125642715|NCT00672139|451972730|FG000|Overall Study|Protocol Violation|1|||
125642716|NCT00672139|451972731|FG001|Overall Study|Protocol Violation|1|||
125642717|NCT00672139|451972730|FG000|Overall Study|hospice discharge, caregiver requests|3|||
125642718|NCT00672139|451972731|FG001|Overall Study|hospice discharge, caregiver requests|2|||
125642719|NCT02381795|451972735|FG000|Overall Study|Withdrawal by Subject|1|||
125642720|NCT02381795|451972735|FG000|Overall Study|Study Terminated|2|||
125642721|NCT01412333|451972743|FG000|Overall Study|Adverse Event|40|||
125642722|NCT01412333|451972744|FG001|Overall Study|Adverse Event|42|||
125642723|NCT01412333|451972743|FG000|Overall Study|Death|5|||
125642724|NCT01412333|451972744|FG001|Overall Study|Death|6|||
125642725|NCT01412333|451972743|FG000|Overall Study|Lack of Efficacy|22|||
125642726|NCT01412333|451972744|FG001|Overall Study|Lack of Efficacy|10|||
125642727|NCT01412333|451972743|FG000|Overall Study|Lost to Follow-up|15|||
125642728|NCT01412333|451972744|FG001|Overall Study|Lost to Follow-up|12|||
125642729|NCT01412333|451972743|FG000|Overall Study|Non-Compliance|3|||
125642730|NCT01412333|451972744|FG001|Overall Study|Non-Compliance|7|||
125642731|NCT01412333|451972743|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125642732|NCT01412333|451972744|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125642733|NCT01412333|451972743|FG000|Overall Study|Other|30|||
125642734|NCT01412333|451972744|FG001|Overall Study|Other|33|||
125642735|NCT01412333|451972743|FG000|Overall Study|Physician Decision|11|||
125642736|NCT01412333|451972744|FG001|Overall Study|Physician Decision|16|||
125437183|NCT01130883|451228015|FG000|Overall Study|Reason Unknown|1|||
125642737|NCT01412333|451972743|FG000|Overall Study|Pregnancy|6|||
125642738|NCT01412333|451972744|FG001|Overall Study|Pregnancy|4|||
125642739|NCT01412333|451972743|FG000|Overall Study|Protocol Violation|1|||
125134512|NCT02159183|450118173|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
125134513|NCT02159183|450118174|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
125134514|NCT01294917|450118178|FG000|Overall Study|Relocation|5|||
125134515|NCT01294917|450118178|FG000|Overall Study|Inconvenience|1|||
125134516|NCT02519348|450118179|FG000|Overall Study|Death|31|||
125134517|NCT02519348|450118180|FG001|Overall Study|Death|74|||
125134518|NCT02519348|450118181|FG002|Overall Study|Death|47|||
125134519|NCT02519348|450118182|FG003|Overall Study|Death|54|||
125134520|NCT02519348|450118183|FG004|Overall Study|Death|63|||
125134521|NCT02519348|450118184|FG005|Overall Study|Death|18|||
125134522|NCT02519348|450118185|FG006|Overall Study|Death|2|||
125134523|NCT02519348|450118186|FG007|Overall Study|Death|5|||
125134524|NCT02519348|450118187|FG008|Overall Study|Death|5|||
125134525|NCT02519348|450118179|FG000|Overall Study|Withdrawal by Subject|4|||
125134526|NCT02519348|450118180|FG001|Overall Study|Withdrawal by Subject|7|||
125134527|NCT02519348|450118181|FG002|Overall Study|Withdrawal by Subject|4|||
125218558|NCT03131687|450427366|FG004|Overall Study|Adverse Event|2|||
125218559|NCT03131687|450427367|FG005|Overall Study|Adverse Event|2|||
125218560|NCT03131687|450427362|FG000|Overall Study|Death|1|||
125218561|NCT03131687|450427363|FG001|Overall Study|Death|0|||
125642740|NCT01412333|451972744|FG001|Overall Study|Protocol Violation|2|||
125642741|NCT01412333|451972743|FG000|Overall Study|Study Terminated By Sponsor|3|||
125642742|NCT01412333|451972744|FG001|Overall Study|Study Terminated By Sponsor|2|||
125642743|NCT01412333|451972743|FG000|Overall Study|Withdrawal by Subject|51|||
125642744|NCT01412333|451972744|FG001|Overall Study|Withdrawal by Subject|54|||
125642745|NCT01412333|451972743|FG000|Overall Study|Missing|1|||
125642746|NCT01412333|451972744|FG001|Overall Study|Missing|3|||
125642747|NCT00750867|451972745|FG000|Overall Study|Adverse Event|2|||
125642748|NCT01060150|451972746|FG000|Overall Study|Adverse Event|6|||
125642749|NCT01060150|451972746|FG000|Overall Study|Lost to Follow-up|1|||
125642750|NCT01060150|451972746|FG000|Overall Study|Protocol Violation|6|||
125642751|NCT01060150|451972746|FG000|Overall Study|Withdrawal by Subject|8|||
125642752|NCT01060150|451972746|FG000|Overall Study|Enrolled, but not treated|2|||
125642753|NCT01969565|451972747|FG000|Overall Study|Withdrawal by Subject|1|||
125642754|NCT01683058|451972748|FG000|Overall Study|Lost to Follow-up|9|||
125642755|NCT01683058|451972748|FG000|Overall Study|Adverse Event|6|||
125642756|NCT01683058|451972748|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
125642757|NCT01683058|451972748|FG000|Overall Study|Withdrawal by Subject|7|||
125642758|NCT01683058|451972748|FG000|Overall Study|Lack of Efficacy|2|||
125642759|NCT04062240|451972749|FG000|Overall Study|equipment malfunction|1|||
125642760|NCT01957111|451972750|FG000|Overall Study|Withdrawal by Subject|1|||
125642761|NCT01957111|451972751|FG001|Overall Study|Withdrawal by Subject|1|||
125642762|NCT01057394|451972752|FG000|Overall Study|Not eligible|0|||
125642763|NCT01057394|451972753|FG001|Overall Study|Not eligible|2|||
125642764|NCT03500419|451972754|FG000|Overall Study|Withdrawal by Subject|2|||
125642765|NCT03500419|451972755|FG001|Overall Study|Withdrawal by Subject|25|||
125642766|NCT01948791|451972760|FG000|Overall Study|Adverse Event|12|||
125642767|NCT01948791|451972760|FG000|Overall Study|Lack of Efficacy|3|||
125642768|NCT01948791|451972760|FG000|Overall Study|Protocol Violation|2|||
125642769|NCT01948791|451972760|FG000|Overall Study|Withdrawal by Subject|5|||
125642770|NCT01948791|451972760|FG000|Overall Study|Lost to Follow-up|6|||
125642771|NCT01948791|451972760|FG000|Overall Study|Management issues|1|||
125642772|NCT01948791|451972760|FG000|Overall Study|Others|7|||
125642773|NCT01948791|451972760|FG000|Overall Study|Screening failure|35|||
125642774|NCT03481634|451972761|FG000|Overall Study|Withdrawal by Subject|16|||
125642775|NCT03481634|451972762|FG001|Overall Study|Withdrawal by Subject|19|||
125642776|NCT03481634|451972763|FG002|Overall Study|Withdrawal by Subject|14|||
125642777|NCT03481634|451972761|FG000|Overall Study|Protocol Violation|1|||
125642778|NCT03481634|451972762|FG001|Overall Study|Protocol Violation|0|||
125642779|NCT03481634|451972763|FG002|Overall Study|Protocol Violation|1|||
125642780|NCT03481634|451972761|FG000|Overall Study|Progressive disease|0|||
125642781|NCT03481634|451972762|FG001|Overall Study|Progressive disease|1|||
125642782|NCT03481634|451972763|FG002|Overall Study|Progressive disease|0|||
125642783|NCT03481634|451972761|FG000|Overall Study|Physician Decision|3|||
125642784|NCT03481634|451972762|FG001|Overall Study|Physician Decision|0|||
125642785|NCT03481634|451972763|FG002|Overall Study|Physician Decision|1|||
125642786|NCT03481634|451972761|FG000|Overall Study|Lost to Follow-up|3|||
125642787|NCT03481634|451972762|FG001|Overall Study|Lost to Follow-up|4|||
125642788|NCT03481634|451972763|FG002|Overall Study|Lost to Follow-up|4|||
125642789|NCT03481634|451972761|FG000|Overall Study|Death|4|||
125642790|NCT03481634|451972762|FG001|Overall Study|Death|8|||
125134528|NCT02519348|450118182|FG003|Overall Study|Withdrawal by Subject|3|||
125134529|NCT02519348|450118183|FG004|Overall Study|Withdrawal by Subject|3|||
125642791|NCT03481634|451972763|FG002|Overall Study|Death|7|||
125218562|NCT03131687|450427364|FG002|Overall Study|Death|0|||
125134530|NCT02519348|450118184|FG005|Overall Study|Withdrawal by Subject|2|||
125642792|NCT03481634|451972761|FG000|Overall Study|Adverse Event|6|||
125642793|NCT03481634|451972762|FG001|Overall Study|Adverse Event|3|||
125642794|NCT03481634|451972763|FG002|Overall Study|Adverse Event|7|||
125642795|NCT00994890|451972764|FG000|Overall Study|Adverse Event|13|||
125134531|NCT02519348|450118185|FG006|Overall Study|Withdrawal by Subject|0|||
125134532|NCT02519348|450118186|FG007|Overall Study|Withdrawal by Subject|0|||
125134533|NCT02519348|450118187|FG008|Overall Study|Withdrawal by Subject|1|||
125134534|NCT02519348|450118179|FG000|Overall Study|Lost to Follow-up|0|||
125134535|NCT02519348|450118180|FG001|Overall Study|Lost to Follow-up|0|||
125134536|NCT02519348|450118181|FG002|Overall Study|Lost to Follow-up|1|||
125134537|NCT02519348|450118182|FG003|Overall Study|Lost to Follow-up|0|||
125134538|NCT02519348|450118183|FG004|Overall Study|Lost to Follow-up|2|||
125134539|NCT02519348|450118184|FG005|Overall Study|Lost to Follow-up|1|||
125134540|NCT02519348|450118185|FG006|Overall Study|Lost to Follow-up|1|||
125134541|NCT02519348|450118186|FG007|Overall Study|Lost to Follow-up|0|||
125134542|NCT02519348|450118187|FG008|Overall Study|Lost to Follow-up|0|||
125437184|NCT01130883|451228015|FG000|Overall Study|Adverse Event|3|||
125437185|NCT02091739|451228023|FG000|MP: 16 Weeks|Adverse Event|1|||
125134543|NCT02519348|450118179|FG000|Overall Study|Other|0|||
125134544|NCT02519348|450118180|FG001|Overall Study|Other|3|||
125134545|NCT02519348|450118181|FG002|Overall Study|Other|0|||
125134546|NCT02519348|450118182|FG003|Overall Study|Other|0|||
125134547|NCT02519348|450118183|FG004|Overall Study|Other|1|||
125134548|NCT02519348|450118184|FG005|Overall Study|Other|0|||
125134549|NCT02519348|450118185|FG006|Overall Study|Other|0|||
125134550|NCT02519348|450118186|FG007|Overall Study|Other|0|||
125134551|NCT02519348|450118187|FG008|Overall Study|Other|0|||
125134552|NCT02519348|450118179|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
125134553|NCT02519348|450118180|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
125134554|NCT02519348|450118181|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
125134555|NCT02519348|450118182|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
125134556|NCT02519348|450118183|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
125134557|NCT02519348|450118184|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
125134558|NCT02519348|450118185|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
125134559|NCT02519348|450118186|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
125134560|NCT02519348|450118187|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
125134561|NCT01444378|450118188|FG000|Overall Study|Lost to Follow-up|1|||
125134562|NCT01444378|450118188|FG000|Overall Study|Withdrawal by Subject|1|||
125134563|NCT01444378|450118188|FG000|Overall Study|Death|3|||
125134564|NCT01444378|450118188|FG000|Overall Study|Administrative Closure Of The Study|2|||
125134565|NCT01444378|450118188|FG000|Overall Study|Missed Visits|10|||
125134566|NCT02911792|450118189|FG000|Overall Study|Lost to Follow-up|3|||
125134567|NCT02911792|450118190|FG001|Overall Study|Lost to Follow-up|3|||
125134568|NCT02911792|450118191|FG002|Overall Study|Lost to Follow-up|3|||
125134569|NCT02911792|450118192|FG003|Overall Study|Lost to Follow-up|3|||
125134570|NCT01244620|450118195|FG000|Overall Study|Study terminated|4|||
125134571|NCT01244620|450118196|FG001|Overall Study|Study terminated|4|||
125134572|NCT01244620|450118197|FG002|Overall Study|Study terminated|4|||
125134573|NCT01244620|450118198|FG003|Overall Study|Study terminated|4|||
125134574|NCT02321098|450118200|FG000|12 Weeks Treament|Lost to Follow-up|1|||
125134575|NCT02321098|450118201|FG001|12 Weeks Treament|Lost to Follow-up|1|||
125134576|NCT02321098|450118202|FG002|12 Weeks Treament|Lost to Follow-up|0|||
125134577|NCT02321098|450118200|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
125134578|NCT02321098|450118201|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
125134579|NCT02321098|450118202|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
125134580|NCT02321098|450118200|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
125134581|NCT02321098|450118201|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
125134582|NCT02321098|450118202|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
125134583|NCT02321098|450118200|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
125134584|NCT02321098|450118201|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
125134585|NCT02321098|450118202|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
125134586|NCT01663233|450118203|FG000|Overall Study|Withdrawal by Subject|3|||
125134587|NCT01663233|450118204|FG001|Overall Study|Withdrawal by Subject|2|||
125437186|NCT02091739|451228024|FG001|MP: 16 Weeks|Adverse Event|1|||
125437187|NCT02091739|451228025|FG002|MP: 16 Weeks|Adverse Event|1|||
125437188|NCT02091739|451228026|FG003|MP: 16 Weeks|Adverse Event|0|||
125642796|NCT00994890|451972765|FG001|Overall Study|Adverse Event|9|||
125642797|NCT00994890|451972766|FG002|Overall Study|Adverse Event|11|||
125642798|NCT00994890|451972764|FG000|Overall Study|Lack of Efficacy|0|||
125642799|NCT00994890|451972765|FG001|Overall Study|Lack of Efficacy|0|||
125642800|NCT00994890|451972766|FG002|Overall Study|Lack of Efficacy|1|||
125642801|NCT00994890|451972764|FG000|Overall Study|Lost to Follow-up|6|||
125642802|NCT00994890|451972765|FG001|Overall Study|Lost to Follow-up|1|||
125642803|NCT00994890|451972766|FG002|Overall Study|Lost to Follow-up|3|||
125642804|NCT00994890|451972764|FG000|Overall Study|No longer willing to participate|8|||
125642805|NCT00994890|451972765|FG001|Overall Study|No longer willing to participate|5|||
125642806|NCT00994890|451972766|FG002|Overall Study|No longer willing to participate|13|||
125642807|NCT00994890|451972764|FG000|Overall Study|Protocol Violation|2|||
125642808|NCT00994890|451972765|FG001|Overall Study|Protocol Violation|4|||
125642809|NCT00994890|451972766|FG002|Overall Study|Protocol Violation|0|||
125642810|NCT00994890|451972764|FG000|Overall Study|Study terminated by sponsor|199|||
125642811|NCT00994890|451972765|FG001|Overall Study|Study terminated by sponsor|201|||
125642812|NCT00994890|451972766|FG002|Overall Study|Study terminated by sponsor|197|||
125642813|NCT00994890|451972764|FG000|Overall Study|Randomized, but not treated|1|||
125642814|NCT00994890|451972765|FG001|Overall Study|Randomized, but not treated|0|||
125642815|NCT00994890|451972766|FG002|Overall Study|Randomized, but not treated|0|||
125134588|NCT01663233|450118203|FG000|Overall Study|Protocol Deviation|1|||
125134589|NCT01663233|450118204|FG001|Overall Study|Protocol Deviation|4|||
125134590|NCT01663233|450118203|FG000|Overall Study|Lost to Follow-up|0|||
125134591|NCT01663233|450118204|FG001|Overall Study|Lost to Follow-up|1|||
125134592|NCT05630885|450118207|FG000|Study Completion|Took prohibited medications|2|||
125134593|NCT05630885|450118208|FG001|Study Completion|Took prohibited medications|0|||
125218563|NCT03131687|450427365|FG003|Overall Study|Death|0|||
125642816|NCT00994890|451972764|FG000|Overall Study|Other|2|||
125642817|NCT00994890|451972765|FG001|Overall Study|Other|2|||
125642818|NCT00994890|451972766|FG002|Overall Study|Other|1|||
125642819|NCT01469637|451972767|FG000|First Intervention|Unacceptable behavior|0|||
125642820|NCT01469637|451972768|FG001|First Intervention|Unacceptable behavior|1|||
125642821|NCT01469637|451972767|FG000|Second Intervention|Incarcerated|1|||
125642822|NCT01469637|451972768|FG001|Second Intervention|Incarcerated|0|||
125642823|NCT04491591|451972769|FG000|Overall Study|Accidently randomized|3|||
125642824|NCT04491591|451972770|FG001|Overall Study|Accidently randomized|1|||
125642825|NCT04491591|451972771|FG002|Overall Study|Accidently randomized|0|||
125642826|NCT04491591|451972769|FG000|Overall Study|Did not complete survey|28|||
125642827|NCT04491591|451972770|FG001|Overall Study|Did not complete survey|20|||
125642828|NCT04491591|451972771|FG002|Overall Study|Did not complete survey|3|||
125642829|NCT00472043|451972772|FG000|Overall Study|Withdrawal by Subject|1|||
125642830|NCT00472043|451972773|FG001|Overall Study|Withdrawal by Subject|0|||
125642831|NCT00472043|451972772|FG000|Overall Study|Death|1|||
125642832|NCT00472043|451972773|FG001|Overall Study|Death|0|||
125642833|NCT02802735|451972774|FG000|Overall Study|Withdrawal by Subject|0|||
125642834|NCT02802735|451972775|FG001|Overall Study|Withdrawal by Subject|1|||
125642835|NCT02802735|451972776|FG002|Overall Study|Withdrawal by Subject|0|||
125642836|NCT02802735|451972777|FG003|Overall Study|Withdrawal by Subject|0|||
125642837|NCT02802735|451972778|FG004|Overall Study|Withdrawal by Subject|0|||
125642838|NCT02975206|451972779|FG000|Overall Study|Withdrawal by Subject|14|||
125642839|NCT02975206|451972780|FG001|Overall Study|Withdrawal by Subject|11|||
125642840|NCT02975206|451972781|FG002|Overall Study|Withdrawal by Subject|11|||
125642841|NCT02975206|451972779|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
125642842|NCT02975206|451972780|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
125134594|NCT05630885|450118207|FG000|Study Completion|Non-compliance with study drug|1|||
125134595|NCT05630885|450118208|FG001|Study Completion|Non-compliance with study drug|0|||
125134596|NCT05630885|450118207|FG000|Study Completion|Adverse Event|1|||
125134597|NCT05630885|450118208|FG001|Study Completion|Adverse Event|0|||
125134598|NCT05630885|450118207|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
125134599|NCT05630885|450118208|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
125134600|NCT05630885|450118207|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
125134601|NCT05630885|450118208|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
125134602|NCT01370733|450118209|FG000|Overall Study|Withdrawal by Subject|8|||
125134603|NCT01370733|450118210|FG001|Overall Study|Withdrawal by Subject|8|||
125134604|NCT01370733|450118209|FG000|Overall Study|Lost to Follow-up|3|||
125134605|NCT01370733|450118210|FG001|Overall Study|Lost to Follow-up|0|||
125134606|NCT01370733|450118209|FG000|Overall Study|Adverse Event|2|||
125134607|NCT01370733|450118210|FG001|Overall Study|Adverse Event|4|||
125134608|NCT01370733|450118209|FG000|Overall Study|Lack of Efficacy|3|||
125134609|NCT01370733|450118210|FG001|Overall Study|Lack of Efficacy|5|||
125218564|NCT03131687|450427366|FG004|Overall Study|Death|0|||
125642843|NCT02975206|451972781|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
125642844|NCT00866606|451972783|FG000|Overall Study|Lost to Follow-up|3|||
125642845|NCT00866606|451972783|FG000|Overall Study|Adverse Event|1|||
125642846|NCT01058356|451972787|FG000|Overall Study|Adverse Event|5|||
125642847|NCT01058356|451972787|FG000|Overall Study|Administration of contraindicated drugs|12|||
125642848|NCT01058356|451972787|FG000|Overall Study|Withdrawal by Subject|21|||
125642849|NCT01058356|451972787|FG000|Overall Study|Lost to Follow-up|4|||
125642850|NCT00606021|451972790|FG000|Induction Phase|Death|73|||
125642851|NCT00606021|451972791|FG001|Induction Phase|Death|0|||
125642852|NCT00606021|451972792|FG002|Induction Phase|Death|0|||
125642853|NCT00606021|451972790|FG000|Induction Phase|Physician Decision|2|||
125642854|NCT00606021|451972791|FG001|Induction Phase|Physician Decision|0|||
125642855|NCT00606021|451972792|FG002|Induction Phase|Physician Decision|0|||
125642856|NCT00606021|451972790|FG000|Induction Phase|Withdrawal by Subject|2|||
125642857|NCT00606021|451972791|FG001|Induction Phase|Withdrawal by Subject|0|||
125642858|NCT00606021|451972792|FG002|Induction Phase|Withdrawal by Subject|0|||
125642859|NCT00606021|451972790|FG000|Induction Phase|Lost to Follow-up|10|||
125642860|NCT00606021|451972791|FG001|Induction Phase|Lost to Follow-up|0|||
125642861|NCT00606021|451972792|FG002|Induction Phase|Lost to Follow-up|0|||
125642862|NCT00606021|451972790|FG000|Maintenance Phase|Death|0|||
125642863|NCT00606021|451972791|FG001|Maintenance Phase|Death|17|||
125642864|NCT00606021|451972792|FG002|Maintenance Phase|Death|15|||
125642865|NCT00606021|451972790|FG000|Maintenance Phase|Physician Decision|0|||
125134610|NCT01370733|450118209|FG000|Overall Study|Physician Decision|0|||
125134611|NCT01370733|450118210|FG001|Overall Study|Physician Decision|2|||
125134612|NCT01370733|450118209|FG000|Overall Study|Protocol Violation|1|||
125134613|NCT01370733|450118210|FG001|Overall Study|Protocol Violation|3|||
125134614|NCT06539676|450118211|FG000|Overall Study|Early study termination|1|||
125218565|NCT03131687|450427367|FG005|Overall Study|Death|0|||
125134615|NCT06539676|450118212|FG001|Overall Study|Early study termination|0|||
125218566|NCT03131687|450427362|FG000|Overall Study|Withdrawal by Subject|3|||
125642866|NCT00606021|451972791|FG001|Maintenance Phase|Physician Decision|1|||
125642867|NCT00606021|451972792|FG002|Maintenance Phase|Physician Decision|0|||
125380442|NCT00563381|451025201|FG001|Overall Study|Individual different reasons|34|||
125380443|NCT00110149|451025202|FG000|Overall Study|Physician Decision|3|||
125380444|NCT00667368|451025207|FG000|Overall Study|Lost to Follow-up|176|||
125380445|NCT00667368|451025208|FG001|Overall Study|Lost to Follow-up|155|||
125642868|NCT00606021|451972790|FG000|Maintenance Phase|Lost to Follow-up|0|||
125642869|NCT00606021|451972791|FG001|Maintenance Phase|Lost to Follow-up|5|||
125642870|NCT00606021|451972792|FG002|Maintenance Phase|Lost to Follow-up|2|||
125642871|NCT02390167|451974737|FG000|Overall Study|Lost to Follow-up|1|||
125642872|NCT02033369|451974738|FG000|Overall Study|Physician Decision|1|||
125642873|NCT02033369|451974739|FG001|Overall Study|Physician Decision|2|||
125642874|NCT02033369|451974738|FG000|Overall Study|Not a good demographic match|0|||
125642875|NCT02033369|451974739|FG001|Overall Study|Not a good demographic match|2|||
125642876|NCT02033369|451974738|FG000|Overall Study|Withdrawal by Subject|1|||
125642877|NCT02033369|451974739|FG001|Overall Study|Withdrawal by Subject|1|||
125642878|NCT02033369|451974738|FG000|Overall Study|Lost to Follow-up|1|||
125642879|NCT02033369|451974739|FG001|Overall Study|Lost to Follow-up|0|||
125642880|NCT02033369|451974738|FG000|Overall Study|Protocol Violation|2|||
125642881|NCT02033369|451974739|FG001|Overall Study|Protocol Violation|0|||
125642882|NCT01265719|451974745|FG000|Overall Study|Does not meet entrance criteria|0|||
125642883|NCT01265719|451974746|FG001|Overall Study|Does not meet entrance criteria|3|||
125642884|NCT01265719|451974745|FG000|Overall Study|Other reasons|2|||
125642885|NCT01265719|451974746|FG001|Overall Study|Other reasons|0|||
125642886|NCT01265719|451974745|FG000|Overall Study|Withdrawal by Subject|8|||
125642887|NCT01265719|451974746|FG001|Overall Study|Withdrawal by Subject|3|||
125642888|NCT01265719|451974745|FG000|Overall Study|Lost to Follow-up|2|||
125642889|NCT01265719|451974746|FG001|Overall Study|Lost to Follow-up|7|||
125642890|NCT01265719|451974745|FG000|Overall Study|Adverse Event|2|||
125642891|NCT01265719|451974746|FG001|Overall Study|Adverse Event|0|||
125642892|NCT04335929|451974747|FG000|Overall Study|Lost to Follow-up|10|||
125642893|NCT05604781|451974752|FG000|Overall Study|Lost to Follow-up|3|||
125642894|NCT05604781|451974752|FG000|Overall Study|Adverse Event|1|||
125642895|NCT02408016|451974753|FG000|Overall Study|Death|6|||
125642896|NCT02408016|451974754|FG001|Overall Study|Death|1|||
125642897|NCT02408016|451974755|FG002|Overall Study|Death|0|||
125642898|NCT02408016|451974753|FG000|Overall Study|Physician Decision|0|||
125642899|NCT02408016|451974754|FG001|Overall Study|Physician Decision|2|||
125642900|NCT02408016|451974755|FG002|Overall Study|Physician Decision|0|||
125642901|NCT02967562|451974757|FG000|Overall Study|Consent not obtained|1|||
125642902|NCT02967562|451974758|FG001|Overall Study|Consent not obtained|0|||
125642903|NCT02967562|451974757|FG000|Overall Study|High leak precluding analysis|1|||
125642904|NCT02967562|451974758|FG001|Overall Study|High leak precluding analysis|1|||
125642905|NCT00106626|451974759|FG000|Overall Study|Adverse Event|5|||
125642906|NCT00106626|451974760|FG001|Overall Study|Adverse Event|4|||
125642907|NCT00106626|451974761|FG002|Overall Study|Adverse Event|3|||
125642908|NCT00106626|451974762|FG003|Overall Study|Adverse Event|3|||
125642909|NCT00106626|451974759|FG000|Overall Study|Progressive Disease|4|||
125642910|NCT00106626|451974760|FG001|Overall Study|Progressive Disease|1|||
125642911|NCT00106626|451974761|FG002|Overall Study|Progressive Disease|9|||
125642912|NCT00106626|451974762|FG003|Overall Study|Progressive Disease|10|||
125642913|NCT00106626|451974759|FG000|Overall Study|Received radiation on new therapy|1|||
125642914|NCT00106626|451974760|FG001|Overall Study|Received radiation on new therapy|0|||
125642915|NCT00106626|451974761|FG002|Overall Study|Received radiation on new therapy|0|||
125642916|NCT00106626|451974762|FG003|Overall Study|Received radiation on new therapy|0|||
125642917|NCT00106626|451974759|FG000|Overall Study|> 14 day delay in therapy start|0|||
125380446|NCT00667368|451025207|FG000|Overall Study|Discontinued early|24|||
125642918|NCT00106626|451974760|FG001|Overall Study|> 14 day delay in therapy start|1|||
125642919|NCT00106626|451974761|FG002|Overall Study|> 14 day delay in therapy start|0|||
125642920|NCT00106626|451974762|FG003|Overall Study|> 14 day delay in therapy start|0|||
125380447|NCT00667368|451025208|FG001|Overall Study|Discontinued early|17|||
125380448|NCT01957553|451025209|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
125380449|NCT01957553|451025210|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
125380450|NCT01957553|451025209|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
125380451|NCT01957553|451025210|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
125642921|NCT01038635|451974770|FG000|Overall Study|Disease Progression|2|||
125642922|NCT01038635|451974771|FG001|Overall Study|Disease Progression|0|||
125642923|NCT01038635|451974772|FG002|Overall Study|Disease Progression|0|||
125642924|NCT01038635|451974773|FG003|Overall Study|Disease Progression|0|||
125642925|NCT01038635|451974774|FG004|Overall Study|Disease Progression|0|||
125642926|NCT01038635|451974775|FG005|Overall Study|Disease Progression|0|||
125642927|NCT01038635|451974776|FG006|Overall Study|Disease Progression|1|||
125642928|NCT01038635|451974777|FG007|Overall Study|Disease Progression|4|||
125642929|NCT01038635|451974778|FG008|Overall Study|Disease Progression|0|||
125642930|NCT01038635|451974770|FG000|Overall Study|Death|0|||
125642931|NCT01038635|451974771|FG001|Overall Study|Death|0|||
125642932|NCT01038635|451974772|FG002|Overall Study|Death|0|||
125642933|NCT01038635|451974773|FG003|Overall Study|Death|0|||
125380452|NCT01957553|451025209|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
125642934|NCT01038635|451974774|FG004|Overall Study|Death|1|||
125642935|NCT01038635|451974775|FG005|Overall Study|Death|0|||
125642936|NCT01038635|451974776|FG006|Overall Study|Death|1|||
125642937|NCT01038635|451974777|FG007|Overall Study|Death|1|||
125642938|NCT01038635|451974778|FG008|Overall Study|Death|2|||
125642939|NCT01034709|451974779|FG000|Overall Study|Protocol Violation|9|||
125642940|NCT01034709|451974780|FG001|Overall Study|Protocol Violation|16|||
125642941|NCT01562327|451974783|FG000|Overall Study|Adverse Event|2|||
125642942|NCT01562327|451974783|FG000|Overall Study|Lack of Efficacy|1|||
125642943|NCT01562327|451974783|FG000|Overall Study|Participant drop-out|1|||
125642944|NCT01562327|451974783|FG000|Overall Study|Infusion not received at 6 month window|4|||
125642945|NCT03018340|451974784|FG000|Overall Study|Adverse Event|1|||
125642946|NCT03018340|451974785|FG001|Overall Study|Adverse Event|2|||
125642947|NCT03018340|451974784|FG000|Overall Study|Withdrawal by Subject|0|||
125642948|NCT03018340|451974785|FG001|Overall Study|Withdrawal by Subject|8|||
125642949|NCT03018340|451974784|FG000|Overall Study|Lack of Efficacy|0|||
125642950|NCT03018340|451974785|FG001|Overall Study|Lack of Efficacy|1|||
125642951|NCT03018340|451974784|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
125642952|NCT03018340|451974785|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
125642953|NCT03018340|451974784|FG000|Overall Study|Lost to Follow-up|1|||
125642954|NCT03018340|451974785|FG001|Overall Study|Lost to Follow-up|7|||
125642955|NCT03018340|451974784|FG000|Overall Study|Protocol Violation|3|||
125642956|NCT03018340|451974785|FG001|Overall Study|Protocol Violation|7|||
125642957|NCT03018340|451974784|FG000|Overall Study|Not further specified|0|||
125642958|NCT03018340|451974785|FG001|Overall Study|Not further specified|1|||
125642959|NCT01195636|451974790|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
125642960|NCT01195636|451974791|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
125642961|NCT01195636|451974790|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
125642962|NCT01195636|451974791|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
125642963|NCT01195636|451974790|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125642964|NCT01195636|451974791|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
125642965|NCT01195636|451974790|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
125642966|NCT01195636|451974791|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
125642967|NCT01195636|451974790|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
125642968|NCT01195636|451974791|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
125642969|NCT01195636|451974790|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
125642970|NCT01195636|451974791|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
125642971|NCT01195636|451974790|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
125642972|NCT01195636|451974791|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
125642973|NCT01195636|451974790|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
125642974|NCT01195636|451974791|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
125642975|NCT00203294|451974792|FG000|Overall Study|Withdrawal by Subject|8|||
125642976|NCT00203294|451974793|FG001|Overall Study|Withdrawal by Subject|13|||
125642977|NCT00256204|451974794|FG000|Overall Study|Adverse Event|10|||
125642978|NCT00256204|451974795|FG001|Overall Study|Adverse Event|14|||
125642979|NCT00256204|451974796|FG002|Overall Study|Adverse Event|16|||
125642980|NCT00256204|451974797|FG003|Overall Study|Adverse Event|14|||
125642981|NCT00256204|451974794|FG000|Overall Study|Death|0|||
125642982|NCT00256204|451974795|FG001|Overall Study|Death|1|||
125642983|NCT00256204|451974796|FG002|Overall Study|Death|0|||
125642984|NCT00256204|451974797|FG003|Overall Study|Death|0|||
125642985|NCT00256204|451974794|FG000|Overall Study|Lost to Follow-up|1|||
125642986|NCT00256204|451974795|FG001|Overall Study|Lost to Follow-up|1|||
125642987|NCT00256204|451974796|FG002|Overall Study|Lost to Follow-up|1|||
125642988|NCT00256204|451974797|FG003|Overall Study|Lost to Follow-up|2|||
125642989|NCT00256204|451974794|FG000|Overall Study|Protocol Violation|1|||
125642990|NCT00256204|451974795|FG001|Overall Study|Protocol Violation|0|||
125642991|NCT00256204|451974796|FG002|Overall Study|Protocol Violation|2|||
125642992|NCT00256204|451974797|FG003|Overall Study|Protocol Violation|1|||
125642993|NCT00256204|451974794|FG000|Overall Study|Physician Decision|0|||
125642994|NCT00256204|451974795|FG001|Overall Study|Physician Decision|0|||
125642995|NCT00256204|451974796|FG002|Overall Study|Physician Decision|1|||
125642996|NCT00256204|451974797|FG003|Overall Study|Physician Decision|2|||
125642997|NCT00256204|451974794|FG000|Overall Study|Withdrawal by Subject|17|||
125642998|NCT00256204|451974795|FG001|Overall Study|Withdrawal by Subject|6|||
125642999|NCT00256204|451974796|FG002|Overall Study|Withdrawal by Subject|7|||
125643000|NCT00256204|451974797|FG003|Overall Study|Withdrawal by Subject|5|||
125643001|NCT00256204|451974794|FG000|Overall Study|Need for additional prohibited treatment|38|||
125643002|NCT00256204|451974795|FG001|Overall Study|Need for additional prohibited treatment|28|||
125643003|NCT00256204|451974796|FG002|Overall Study|Need for additional prohibited treatment|27|||
125134616|NCT06539676|450118213|FG002|Overall Study|Early study termination|6|||
125134617|NCT02645409|450118214|FG000|Overall Study|Withdrawal by Subject|3|||
125134618|NCT02645409|450118215|FG001|Overall Study|Withdrawal by Subject|0|||
125134619|NCT02645409|450118214|FG000|Overall Study|Physician Decision|1|||
125134620|NCT02645409|450118215|FG001|Overall Study|Physician Decision|0|||
125134621|NCT03419403|450118216|FG000|Overall Study|Withdrawal by Subject|5|||
125134622|NCT03419403|450118217|FG001|Overall Study|Withdrawal by Subject|2|||
125134623|NCT03419403|450118218|FG002|Overall Study|Withdrawal by Subject|5|||
125134624|NCT03419403|450118219|FG003|Overall Study|Withdrawal by Subject|1|||
125134625|NCT03419403|450118216|FG000|Overall Study|Progressive disease (per protocol)|0|||
125134626|NCT03419403|450118217|FG001|Overall Study|Progressive disease (per protocol)|2|||
125134627|NCT03419403|450118218|FG002|Overall Study|Progressive disease (per protocol)|2|||
125134628|NCT03419403|450118219|FG003|Overall Study|Progressive disease (per protocol)|0|||
125134629|NCT03419403|450118216|FG000|Overall Study|Other, not specified|6|||
125134630|NCT03419403|450118217|FG001|Overall Study|Other, not specified|4|||
125134631|NCT03419403|450118218|FG002|Overall Study|Other, not specified|5|||
125134632|NCT03419403|450118219|FG003|Overall Study|Other, not specified|1|||
125134633|NCT03419403|450118216|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
125218567|NCT03131687|450427363|FG001|Overall Study|Withdrawal by Subject|3|||
125218568|NCT03131687|450427364|FG002|Overall Study|Withdrawal by Subject|3|||
125643004|NCT00256204|451974797|FG003|Overall Study|Need for additional prohibited treatment|25|||
125643005|NCT00808132|451974800|FG000|Overall Study|Adverse Event|34|||
125643006|NCT00808132|451974801|FG001|Overall Study|Adverse Event|33|||
125643007|NCT00808132|451974802|FG002|Overall Study|Adverse Event|16|||
125643008|NCT00808132|451974803|FG003|Overall Study|Adverse Event|31|||
125643009|NCT00808132|451974804|FG004|Overall Study|Adverse Event|33|||
125643010|NCT00808132|451974800|FG000|Overall Study|Death|0|||
125643011|NCT00808132|451974801|FG001|Overall Study|Death|0|||
125643012|NCT00808132|451974802|FG002|Overall Study|Death|0|||
125134634|NCT03419403|450118217|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
125134635|NCT03419403|450118218|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
125218569|NCT03131687|450427365|FG003|Overall Study|Withdrawal by Subject|1|||
125218570|NCT03131687|450427366|FG004|Overall Study|Withdrawal by Subject|2|||
125218571|NCT03131687|450427367|FG005|Overall Study|Withdrawal by Subject|1|||
125643013|NCT00808132|451974803|FG003|Overall Study|Death|0|||
125643014|NCT00808132|451974804|FG004|Overall Study|Death|1|||
125134636|NCT03419403|450118219|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
125218572|NCT03131687|450427362|FG000|Overall Study|Lost to Follow-up|1|||
125134637|NCT02089685|450118222|FG000|Overall Study|Adverse Event|1|||
125643015|NCT00808132|451974800|FG000|Overall Study|Physician Decision|0|||
125643016|NCT00808132|451974801|FG001|Overall Study|Physician Decision|1|||
125643017|NCT00808132|451974802|FG002|Overall Study|Physician Decision|0|||
125134638|NCT02089685|450118223|FG001|Overall Study|Adverse Event|0|||
125134639|NCT02089685|450118224|FG002|Overall Study|Adverse Event|0|||
125134640|NCT02089685|450118225|FG003|Overall Study|Adverse Event|0|||
125134641|NCT02089685|450118226|FG004|Overall Study|Adverse Event|1|||
125134642|NCT02089685|450118227|FG005|Overall Study|Adverse Event|0|||
125134643|NCT02089685|450118222|FG000|Overall Study|Clinical Progression|4|||
125134644|NCT02089685|450118223|FG001|Overall Study|Clinical Progression|0|||
125134645|NCT02089685|450118224|FG002|Overall Study|Clinical Progression|0|||
125134646|NCT02089685|450118225|FG003|Overall Study|Clinical Progression|5|||
125134647|NCT02089685|450118226|FG004|Overall Study|Clinical Progression|1|||
125134648|NCT02089685|450118227|FG005|Overall Study|Clinical Progression|2|||
125134649|NCT02089685|450118222|FG000|Overall Study|Excluded Medication|1|||
125134650|NCT02089685|450118223|FG001|Overall Study|Excluded Medication|0|||
125134651|NCT02089685|450118224|FG002|Overall Study|Excluded Medication|0|||
125134652|NCT02089685|450118225|FG003|Overall Study|Excluded Medication|11|||
125134653|NCT02089685|450118226|FG004|Overall Study|Excluded Medication|2|||
125134654|NCT02089685|450118227|FG005|Overall Study|Excluded Medication|1|||
125134655|NCT02089685|450118222|FG000|Overall Study|Progressive disease|13|||
125134656|NCT02089685|450118223|FG001|Overall Study|Progressive disease|10|||
125134657|NCT02089685|450118224|FG002|Overall Study|Progressive disease|3|||
125134658|NCT02089685|450118225|FG003|Overall Study|Progressive disease|51|||
125134659|NCT02089685|450118226|FG004|Overall Study|Progressive disease|17|||
125134660|NCT02089685|450118227|FG005|Overall Study|Progressive disease|12|||
125134661|NCT02089685|450118222|FG000|Overall Study|Follow up ended by sponsor|2|||
125134662|NCT02089685|450118223|FG001|Overall Study|Follow up ended by sponsor|2|||
125134663|NCT02089685|450118224|FG002|Overall Study|Follow up ended by sponsor|0|||
125134664|NCT02089685|450118225|FG003|Overall Study|Follow up ended by sponsor|70|||
125134665|NCT02089685|450118226|FG004|Overall Study|Follow up ended by sponsor|26|||
125134666|NCT02089685|450118227|FG005|Overall Study|Follow up ended by sponsor|26|||
125134667|NCT02089685|450118222|FG000|Overall Study|Withdrawal by Subject|0|||
125134668|NCT02089685|450118223|FG001|Overall Study|Withdrawal by Subject|2|||
125134669|NCT02089685|450118224|FG002|Overall Study|Withdrawal by Subject|0|||
125134670|NCT02089685|450118225|FG003|Overall Study|Withdrawal by Subject|8|||
125134671|NCT02089685|450118226|FG004|Overall Study|Withdrawal by Subject|1|||
125643018|NCT00808132|451974803|FG003|Overall Study|Physician Decision|0|||
125643019|NCT00808132|451974804|FG004|Overall Study|Physician Decision|0|||
125643020|NCT00808132|451974800|FG000|Overall Study|Lost to Follow-up|8|||
125643021|NCT00808132|451974801|FG001|Overall Study|Lost to Follow-up|10|||
125643022|NCT00808132|451974802|FG002|Overall Study|Lost to Follow-up|11|||
125643023|NCT00808132|451974803|FG003|Overall Study|Lost to Follow-up|8|||
125643024|NCT00808132|451974804|FG004|Overall Study|Lost to Follow-up|9|||
125643025|NCT00808132|451974800|FG000|Overall Study|Protocol Violation|8|||
125643026|NCT00808132|451974801|FG001|Overall Study|Protocol Violation|9|||
125643027|NCT00808132|451974802|FG002|Overall Study|Protocol Violation|4|||
125643028|NCT00808132|451974803|FG003|Overall Study|Protocol Violation|9|||
125643029|NCT00808132|451974804|FG004|Overall Study|Protocol Violation|5|||
125643030|NCT00808132|451974800|FG000|Overall Study|Withdrawal by Subject|27|||
125643031|NCT00808132|451974801|FG001|Overall Study|Withdrawal by Subject|18|||
125643032|NCT00808132|451974802|FG002|Overall Study|Withdrawal by Subject|2|||
125643033|NCT00808132|451974803|FG003|Overall Study|Withdrawal by Subject|7|||
125643034|NCT00808132|451974804|FG004|Overall Study|Withdrawal by Subject|16|||
125643035|NCT00808132|451974800|FG000|Overall Study|Other|6|||
125643036|NCT00808132|451974801|FG001|Overall Study|Other|4|||
125643037|NCT00808132|451974802|FG002|Overall Study|Other|6|||
125643038|NCT00808132|451974803|FG003|Overall Study|Other|2|||
125643039|NCT00808132|451974804|FG004|Overall Study|Other|15|||
125643040|NCT00808132|451974800|FG000|Overall Study|Randomized, but not treated|10|||
125643041|NCT00808132|451974801|FG001|Overall Study|Randomized, but not treated|7|||
125643042|NCT00808132|451974802|FG002|Overall Study|Randomized, but not treated|9|||
125643043|NCT00808132|451974803|FG003|Overall Study|Randomized, but not treated|8|||
125643044|NCT00808132|451974804|FG004|Overall Study|Randomized, but not treated|9|||
125643045|NCT00808132|451974800|FG000|Overall Study|Unsatisfactory response|5|||
125134672|NCT02089685|450118227|FG005|Overall Study|Withdrawal by Subject|1|||
125134673|NCT02089685|450118222|FG000|Overall Study|Status not recorded|1|||
125134674|NCT02089685|450118223|FG001|Overall Study|Status not recorded|0|||
125134675|NCT02089685|450118224|FG002|Overall Study|Status not recorded|0|||
125134676|NCT02089685|450118225|FG003|Overall Study|Status not recorded|0|||
125134677|NCT02089685|450118226|FG004|Overall Study|Status not recorded|1|||
125134678|NCT02089685|450118227|FG005|Overall Study|Status not recorded|0|||
125134679|NCT02089685|450118222|FG000|Overall Study|Death|0|||
125134680|NCT02089685|450118223|FG001|Overall Study|Death|0|||
125134681|NCT02089685|450118224|FG002|Overall Study|Death|0|||
125134682|NCT02089685|450118225|FG003|Overall Study|Death|7|||
125643046|NCT00808132|451974801|FG001|Overall Study|Unsatisfactory response|6|||
125643047|NCT00808132|451974802|FG002|Overall Study|Unsatisfactory response|6|||
125643048|NCT00808132|451974803|FG003|Overall Study|Unsatisfactory response|4|||
125643049|NCT00808132|451974804|FG004|Overall Study|Unsatisfactory response|12|||
125643050|NCT00550615|451974805|FG000|Overall Study|Withdrawal by Subject|0|||
125643051|NCT00550615|451974806|FG001|Overall Study|Withdrawal by Subject|0|||
125437189|NCT02091739|451228027|FG004|MP: 16 Weeks|Adverse Event|0|||
125437190|NCT02091739|451228023|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
125643052|NCT00550615|451974807|FG002|Overall Study|Withdrawal by Subject|2|||
125643053|NCT00550615|451974808|FG003|Overall Study|Withdrawal by Subject|3|||
125643054|NCT00550615|451974805|FG000|Overall Study|Not evaluable|0|||
125643055|NCT00550615|451974806|FG001|Overall Study|Not evaluable|0|||
125643056|NCT00550615|451974807|FG002|Overall Study|Not evaluable|2|||
125643057|NCT00550615|451974808|FG003|Overall Study|Not evaluable|7|||
125643058|NCT02405091|451974809|FG000|Overall Study|Adverse Event|16|||
125643059|NCT02405091|451974810|FG001|Overall Study|Adverse Event|10|||
125643060|NCT02405091|451974811|FG002|Overall Study|Adverse Event|0|||
125643061|NCT02405091|451974809|FG000|Overall Study|Protocol Violation|1|||
125643062|NCT02405091|451974810|FG001|Overall Study|Protocol Violation|0|||
125643063|NCT02405091|451974811|FG002|Overall Study|Protocol Violation|0|||
125643064|NCT02405091|451974809|FG000|Overall Study|Noncompliance|1|||
125643065|NCT02405091|451974810|FG001|Overall Study|Noncompliance|6|||
125643066|NCT02405091|451974811|FG002|Overall Study|Noncompliance|2|||
125643067|NCT02405091|451974809|FG000|Overall Study|Withdrawal by Subject|4|||
125643068|NCT02405091|451974810|FG001|Overall Study|Withdrawal by Subject|8|||
125643069|NCT02405091|451974811|FG002|Overall Study|Withdrawal by Subject|0|||
125643070|NCT02405091|451974809|FG000|Overall Study|Death|0|||
125643071|NCT02405091|451974810|FG001|Overall Study|Death|1|||
125643072|NCT02405091|451974811|FG002|Overall Study|Death|0|||
125643073|NCT02405091|451974809|FG000|Overall Study|Lost to Follow-up|5|||
125643074|NCT02405091|451974810|FG001|Overall Study|Lost to Follow-up|6|||
125643075|NCT02405091|451974811|FG002|Overall Study|Lost to Follow-up|0|||
125643076|NCT02405091|451974809|FG000|Overall Study|Physician Decision|2|||
125643077|NCT02405091|451974810|FG001|Overall Study|Physician Decision|2|||
125643078|NCT02405091|451974811|FG002|Overall Study|Physician Decision|0|||
125643079|NCT00247962|451974829|FG000|Overall Study|Adverse Event|15|||
125643080|NCT00247962|451974830|FG001|Overall Study|Adverse Event|12|||
125643081|NCT00247962|451974829|FG000|Overall Study|Lost to Follow-up|3|||
125643082|NCT00247962|451974830|FG001|Overall Study|Lost to Follow-up|1|||
125643083|NCT00247962|451974829|FG000|Overall Study|Physician Decision|0|||
125643084|NCT00247962|451974830|FG001|Overall Study|Physician Decision|1|||
125643085|NCT00247962|451974829|FG000|Overall Study|Protocol Violation|1|||
125643086|NCT00247962|451974830|FG001|Overall Study|Protocol Violation|1|||
125643087|NCT00247962|451974829|FG000|Overall Study|Withdrawal by Subject|3|||
125643088|NCT00247962|451974830|FG001|Overall Study|Withdrawal by Subject|2|||
125643089|NCT00247962|451974829|FG000|Overall Study|Lack of Efficacy|4|||
125643090|NCT00247962|451974830|FG001|Overall Study|Lack of Efficacy|2|||
125643091|NCT01955005|451974831|FG000|Overall Study|Withdrawal by Subject|3|||
125643092|NCT01955005|451974832|FG001|Overall Study|Withdrawal by Subject|5|||
125643093|NCT02555722|451974833|FG000|Week 2|Adverse Event|0|||
125643094|NCT02555722|451974834|FG001|Week 2|Adverse Event|1|||
125643095|NCT02555722|451974833|FG000|Week 2|Withdrawal by Subject|1|||
125643096|NCT02555722|451974834|FG001|Week 2|Withdrawal by Subject|0|||
125643097|NCT02555722|451974833|FG000|Month 1|Lens Discomfort|1|||
125643098|NCT02555722|451974834|FG001|Month 1|Lens Discomfort|0|||
125643099|NCT02555722|451974833|FG000|Month 2|Withdrawal by Subject|3|||
125643100|NCT02555722|451974834|FG001|Month 2|Withdrawal by Subject|0|||
125643101|NCT02555722|451974833|FG000|Month 2|Lost to Follow-up|1|||
125643102|NCT02555722|451974834|FG001|Month 2|Lost to Follow-up|0|||
125643103|NCT00352027|451974839|FG000|Overall Study|Progressive disease|3|||
125643104|NCT00702949|451974840|FG000|Overall Study|Refusal|3|||
125643105|NCT00702949|451974841|FG001|Overall Study|Refusal|2|||
125643106|NCT00702949|451974842|FG002|Overall Study|Refusal|2|||
125643107|NCT00702949|451974840|FG000|Overall Study|Adverse Event|1|||
125643108|NCT00702949|451974841|FG001|Overall Study|Adverse Event|6|||
125643109|NCT00702949|451974842|FG002|Overall Study|Adverse Event|3|||
125643110|NCT00702949|451974840|FG000|Overall Study|Other Medical Reason/unknown|1|||
125643111|NCT00702949|451974841|FG001|Overall Study|Other Medical Reason/unknown|1|||
125437191|NCT02091739|451228024|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
125643112|NCT00702949|451974842|FG002|Overall Study|Other Medical Reason/unknown|3|||
125643113|NCT00598585|451974843|FG000|Overall Study|Lost to Follow-up|1|||
125643114|NCT00598585|451974844|FG001|Overall Study|Lost to Follow-up|0|||
125643115|NCT00135694|451974846|FG000|Overall Study|Adverse Event|17|||
125643116|NCT00135694|451974847|FG001|Overall Study|Adverse Event|4|||
125643117|NCT00135694|451974848|FG002|Overall Study|Adverse Event|0|||
125643118|NCT00135694|451974846|FG000|Overall Study|Death|14|||
125643119|NCT00135694|451974847|FG001|Overall Study|Death|1|||
125643120|NCT00135694|451974848|FG002|Overall Study|Death|2|||
125643121|NCT00135694|451974846|FG000|Overall Study|Lost to Follow-up|8|||
125643122|NCT00135694|451974847|FG001|Overall Study|Lost to Follow-up|7|||
125643123|NCT00135694|451974848|FG002|Overall Study|Lost to Follow-up|1|||
125643124|NCT00135694|451974846|FG000|Overall Study|Withdrawal by Subject|41|||
125643125|NCT00135694|451974847|FG001|Overall Study|Withdrawal by Subject|7|||
125643126|NCT00135694|451974848|FG002|Overall Study|Withdrawal by Subject|4|||
125643127|NCT00135694|451974846|FG000|Overall Study|Protocol Violation|19|||
125643128|NCT00135694|451974847|FG001|Overall Study|Protocol Violation|1|||
125643129|NCT00135694|451974848|FG002|Overall Study|Protocol Violation|0|||
125643130|NCT00135694|451974846|FG000|Overall Study|Hepatitis C related reasons|39|||
125643131|NCT00135694|451974847|FG001|Overall Study|Hepatitis C related reasons|1|||
125643132|NCT00135694|451974848|FG002|Overall Study|Hepatitis C related reasons|0|||
125643133|NCT00135694|451974846|FG000|Overall Study|Ineligible for Random assignment|42|||
125643134|NCT00135694|451974847|FG001|Overall Study|Ineligible for Random assignment|0|||
125643135|NCT00135694|451974848|FG002|Overall Study|Ineligible for Random assignment|0|||
125643136|NCT03922711|451974850|FG000|Overall Study|Adverse Event|3|||
125643137|NCT03922711|451974851|FG001|Overall Study|Adverse Event|2|||
125643138|NCT03922711|451974852|FG002|Overall Study|Adverse Event|2|||
125643139|NCT03922711|451974850|FG000|Overall Study|Protocol Violation|1|||
125643140|NCT03922711|451974851|FG001|Overall Study|Protocol Violation|0|||
125643141|NCT03922711|451974852|FG002|Overall Study|Protocol Violation|0|||
125643142|NCT03922711|451974850|FG000|Overall Study|Withdrawal by Subject|0|||
125643143|NCT03922711|451974851|FG001|Overall Study|Withdrawal by Subject|3|||
125643144|NCT03922711|451974852|FG002|Overall Study|Withdrawal by Subject|1|||
125643145|NCT03922711|451974850|FG000|Overall Study|Not further specified|0|||
125643146|NCT03922711|451974851|FG001|Overall Study|Not further specified|0|||
125643147|NCT03922711|451974852|FG002|Overall Study|Not further specified|1|||
125643148|NCT03147495|451974855|FG000|Overall Study|Physician Decision|0|||
125643149|NCT03147495|451974856|FG001|Overall Study|Physician Decision|6|||
125643150|NCT02607735|451974857|FG000|Primary Study|Randomized but Never Treated|1|||
125643151|NCT02607735|451974858|FG001|Primary Study|Randomized but Never Treated|0|||
125643152|NCT02607735|451974859|FG002|Primary Study|Randomized but Never Treated|0|||
125643153|NCT02607735|451974857|FG000|Primary Study|Lost to Follow-up|4|||
125643154|NCT02607735|451974858|FG001|Primary Study|Lost to Follow-up|0|||
125643155|NCT02607735|451974859|FG002|Primary Study|Lost to Follow-up|0|||
125643156|NCT02607735|451974857|FG000|Primary Study|Withdrew Consent|2|||
125643157|NCT02607735|451974858|FG001|Primary Study|Withdrew Consent|0|||
125643158|NCT02607735|451974859|FG002|Primary Study|Withdrew Consent|0|||
125643159|NCT02607735|451974857|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
125643160|NCT02607735|451974858|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
125643161|NCT02607735|451974859|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
125643162|NCT02607735|451974857|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
125643163|NCT02607735|451974858|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
125643164|NCT02607735|451974859|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
125643165|NCT00877890|451974864|FG000|Overall Study|Adverse Event|6|||
125643166|NCT00877890|451974865|FG001|Overall Study|Adverse Event|6|||
125643167|NCT00877890|451974864|FG000|Overall Study|Lost to Follow-up|5|||
125643168|NCT00877890|451974865|FG001|Overall Study|Lost to Follow-up|5|||
125643169|NCT00877890|451974864|FG000|Overall Study|Protocol Violation|0|||
125643170|NCT00877890|451974865|FG001|Overall Study|Protocol Violation|1|||
125643171|NCT00877890|451974864|FG000|Overall Study|Withdrawal of Consent|6|||
125134683|NCT02089685|450118226|FG004|Overall Study|Death|2|||
125134684|NCT02089685|450118227|FG005|Overall Study|Death|5|||
125134685|NCT02089685|450118222|FG000|Overall Study|Lost to Follow-up|0|||
125134686|NCT02089685|450118223|FG001|Overall Study|Lost to Follow-up|0|||
125134687|NCT02089685|450118224|FG002|Overall Study|Lost to Follow-up|0|||
125134688|NCT02089685|450118225|FG003|Overall Study|Lost to Follow-up|1|||
125134689|NCT02089685|450118226|FG004|Overall Study|Lost to Follow-up|0|||
125134690|NCT02089685|450118227|FG005|Overall Study|Lost to Follow-up|0|||
125134691|NCT02089685|450118222|FG000|Overall Study|Physician Decision|0|||
125134692|NCT02089685|450118223|FG001|Overall Study|Physician Decision|0|||
125134693|NCT02089685|450118224|FG002|Overall Study|Physician Decision|0|||
125134694|NCT02089685|450118225|FG003|Overall Study|Physician Decision|0|||
125134695|NCT02089685|450118226|FG004|Overall Study|Physician Decision|0|||
125134696|NCT02089685|450118227|FG005|Overall Study|Physician Decision|4|||
125134697|NCT02089685|450118222|FG000|Overall Study|Screen failure|1|||
125134698|NCT02089685|450118223|FG001|Overall Study|Screen failure|0|||
125134699|NCT02089685|450118224|FG002|Overall Study|Screen failure|0|||
125134700|NCT02089685|450118225|FG003|Overall Study|Screen failure|0|||
125134701|NCT02089685|450118226|FG004|Overall Study|Screen failure|0|||
125134702|NCT02089685|450118227|FG005|Overall Study|Screen failure|0|||
125134703|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Adverse Event|11|||
125134704|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Adverse Event|23|||
125134705|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Adverse Event|29|||
125134706|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Adverse Event|2|||
125134707|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Adverse Event|8|||
125134708|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
125134709|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
125134710|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
125643172|NCT00877890|451974865|FG001|Overall Study|Withdrawal of Consent|12|||
125643173|NCT00877890|451974864|FG000|Overall Study|Investigator Decision|0|||
125643174|NCT00877890|451974865|FG001|Overall Study|Investigator Decision|2|||
125643175|NCT00877890|451974864|FG000|Overall Study|Loss of Glucose Control|3|||
125643176|NCT00877890|451974865|FG001|Overall Study|Loss of Glucose Control|4|||
125643177|NCT00742391|451974866|FG000|Overall Study|Adverse Event|2|||
125643178|NCT00742391|451974867|FG001|Overall Study|Adverse Event|1|||
125643179|NCT00742391|451974866|FG000|Overall Study|Lost to Follow-up|1|||
125643180|NCT00742391|451974867|FG001|Overall Study|Lost to Follow-up|0|||
125643181|NCT00742391|451974866|FG000|Overall Study|Protocol Violation|1|||
125643182|NCT00742391|451974867|FG001|Overall Study|Protocol Violation|0|||
125643183|NCT02363322|451974884|FG000|Overall Study|Lost to Follow-up|1|||
125643184|NCT02363322|451974885|FG001|Overall Study|Lost to Follow-up|0|||
125643185|NCT01230827|451974886|FG000|Overall Study|Lost to Follow-up|0|||
125643186|NCT01230827|451974887|FG001|Overall Study|Lost to Follow-up|0|||
125643187|NCT01230827|451974888|FG002|Overall Study|Lost to Follow-up|1|||
125643188|NCT01230827|451974889|FG003|Overall Study|Lost to Follow-up|3|||
125643189|NCT01230827|451974886|FG000|Overall Study|Withdrawal by Subject|1|||
125643190|NCT01230827|451974887|FG001|Overall Study|Withdrawal by Subject|0|||
125643191|NCT01230827|451974888|FG002|Overall Study|Withdrawal by Subject|3|||
125643192|NCT01230827|451974889|FG003|Overall Study|Withdrawal by Subject|2|||
125643193|NCT01230827|451974886|FG000|Overall Study|Lack of Efficacy|14|||
125643194|NCT01230827|451974887|FG001|Overall Study|Lack of Efficacy|1|||
125643195|NCT01230827|451974888|FG002|Overall Study|Lack of Efficacy|2|||
125643196|NCT01230827|451974889|FG003|Overall Study|Lack of Efficacy|3|||
125643197|NCT01230827|451974886|FG000|Overall Study|Adverse Event|4|||
125643198|NCT01230827|451974887|FG001|Overall Study|Adverse Event|2|||
125643199|NCT01230827|451974888|FG002|Overall Study|Adverse Event|3|||
125643200|NCT01230827|451974889|FG003|Overall Study|Adverse Event|7|||
125643201|NCT01230827|451974886|FG000|Overall Study|Recovery|0|||
125643202|NCT01230827|451974887|FG001|Overall Study|Recovery|6|||
125643203|NCT01230827|451974888|FG002|Overall Study|Recovery|0|||
125643204|NCT01230827|451974889|FG003|Overall Study|Recovery|0|||
125643205|NCT01230827|451974886|FG000|Overall Study|Study terminated by Sponsor|0|||
125643206|NCT01230827|451974887|FG001|Overall Study|Study terminated by Sponsor|2|||
125643207|NCT01230827|451974888|FG002|Overall Study|Study terminated by Sponsor|56|||
125643208|NCT01230827|451974889|FG003|Overall Study|Study terminated by Sponsor|63|||
125643209|NCT00805142|451974890|FG000|Titration Period|Adverse Event|3|||
125643210|NCT00805142|451974891|FG001|Titration Period|Adverse Event|3|||
125643211|NCT00805142|451974890|FG000|Titration Period|Lack of Efficacy|1|||
125643212|NCT00805142|451974891|FG001|Titration Period|Lack of Efficacy|1|||
125643213|NCT00805142|451974890|FG000|Titration Period|Lost to Follow-up|0|||
125643214|NCT00805142|451974891|FG001|Titration Period|Lost to Follow-up|1|||
125643215|NCT00805142|451974890|FG000|Titration Period|Disease Progression|2|||
125643216|NCT00805142|451974891|FG001|Titration Period|Disease Progression|1|||
125643217|NCT00805142|451974890|FG000|Titration Period|Withdrawal of consent|0|||
125643218|NCT00805142|451974891|FG001|Titration Period|Withdrawal of consent|1|||
125643219|NCT00805142|451974890|FG000|Titration Period|Other|0|||
125643220|NCT00805142|451974891|FG001|Titration Period|Other|3|||
125643221|NCT00805142|451974890|FG000|Maintenance Period|Adverse Event|0|||
125643222|NCT00805142|451974891|FG001|Maintenance Period|Adverse Event|1|||
125643223|NCT00805142|451974890|FG000|Maintenance Period|Other|0|||
125643224|NCT00805142|451974891|FG001|Maintenance Period|Other|1|||
125643225|NCT01021423|451974893|FG000|Overall Study|Study terminated|4|||
125643226|NCT01021423|451974894|FG001|Overall Study|Study terminated|5|||
125643227|NCT00394654|451974895|FG000|Overall Study|Lost to Follow-up|1|||
125643228|NCT00394654|451974896|FG001|Overall Study|Lost to Follow-up|0|||
125643229|NCT00394654|451974895|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
125380453|NCT01957553|451025210|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
125380454|NCT01957553|451025209|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
125218573|NCT03131687|450427363|FG001|Overall Study|Lost to Follow-up|4|||
125380455|NCT01957553|451025210|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
125485441|NCT02240238|451412507|FG004|Phase 2|Withdrawal by Subject|0|||
125218574|NCT03131687|450427364|FG002|Overall Study|Lost to Follow-up|0|||
125134711|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
125134712|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
125134713|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
125380456|NCT01957553|451025209|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
125380457|NCT01957553|451025210|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
125643230|NCT00394654|451974896|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
125643231|NCT00122317|451974897|FG000|Overall Study|Death|3|||
125643232|NCT00122317|451974897|FG000|Overall Study|Adverse Event|4|||
125643233|NCT00122317|451974897|FG000|Overall Study|Physician Decision|2|||
125643234|NCT00122317|451974897|FG000|Overall Study|patient non-compliance|1|||
125643235|NCT00122317|451974897|FG000|Overall Study|Withdrawal by Subject|1|||
125643236|NCT02886338|451974898|FG000|Overall Study|Withdrawal by Subject|1|||
125643237|NCT03756285|451974899|FG000|Overall Study|Lost to Follow-up|0|||
125643238|NCT03756285|451974900|FG001|Overall Study|Lost to Follow-up|1|||
125643239|NCT03756285|451974899|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
125643240|NCT03756285|451974900|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
125643241|NCT03756285|451974899|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
125643242|NCT03756285|451974900|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
125134714|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
125134715|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
125485442|NCT02240238|451412508|FG005|Phase 2|Withdrawal by Subject|0|||
125643243|NCT02705755|451974902|FG000|Part A (6 Days)|Adverse Event|1|||
125134716|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
125134717|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
125134718|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
125134719|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
125134720|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
125134721|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
125134722|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
125134723|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
125134724|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
125134725|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
125134726|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
125134727|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
125134728|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
125134729|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
125134730|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
125134731|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
125134732|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
125134733|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
125134734|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
125134735|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
125134736|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
125134737|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
125134738|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Move|0|||
125134739|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Move|1|||
125134740|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Move|0|||
125134741|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Move|0|||
125134742|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Move|0|||
125134743|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
125134744|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
125134745|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
125134746|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
125134747|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
125134748|NCT00318461|450118230|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
125134749|NCT00318461|450118231|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
125134750|NCT00318461|450118232|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
125134751|NCT00318461|450118233|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
125134752|NCT00318461|450118234|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
125134753|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Work commitment|0|||
125134754|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Work commitment|0|||
125134755|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Work commitment|0|||
125134756|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Work commitment|0|||
125134757|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Work commitment|1|||
125218575|NCT03131687|450427365|FG003|Overall Study|Lost to Follow-up|1|||
125218576|NCT03131687|450427366|FG004|Overall Study|Lost to Follow-up|4|||
125134758|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Investigator decision|0|||
125134759|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Investigator decision|0|||
125134760|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Investigator decision|0|||
125380458|NCT01957553|451025209|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
125380459|NCT01957553|451025210|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
125380460|NCT01957553|451025209|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
125134761|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Investigator decision|0|||
125134762|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Investigator decision|1|||
125134763|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Lack of time|1|||
125134764|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Lack of time|0|||
125134765|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Lack of time|0|||
125134766|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Lack of time|0|||
125134767|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Lack of time|0|||
125134768|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
125134769|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
125134770|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
125134771|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
125134772|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
125134773|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
125134774|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
125134775|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
125134776|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
125134777|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
125134778|NCT00318461|450118230|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
125134779|NCT00318461|450118231|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
125134780|NCT00318461|450118232|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
125134781|NCT00318461|450118233|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
125134782|NCT00318461|450118234|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
125134783|NCT00318461|450118230|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
125134784|NCT00318461|450118231|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
125134785|NCT00318461|450118232|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
125134786|NCT00318461|450118233|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
125485443|NCT02240238|451412509|FG006|Phase 2|Withdrawal by Subject|0|||
125134787|NCT00318461|450118234|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
125134788|NCT00318461|450118230|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
125134789|NCT00318461|450118231|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
125218577|NCT03131687|450427367|FG005|Overall Study|Lost to Follow-up|2|||
125380461|NCT01957553|451025210|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
125380462|NCT01957553|451025209|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
125380463|NCT01957553|451025210|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
125380464|NCT01957553|451025209|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
125380465|NCT01957553|451025210|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
125134790|NCT00318461|450118232|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
125134791|NCT00318461|450118233|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
125380466|NCT00732615|451025211|FG000|Overall Study|Withdrawal by Subject|3|||
125134792|NCT00318461|450118234|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
125380467|NCT00732615|451025212|FG001|Overall Study|Withdrawal by Subject|1|||
125380468|NCT00732615|451025211|FG000|Overall Study|Lost to Follow-up|0|||
125380469|NCT00732615|451025212|FG001|Overall Study|Lost to Follow-up|1|||
125134793|NCT00318461|450118230|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
125134794|NCT00318461|450118231|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
125134795|NCT00318461|450118232|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
125134796|NCT00318461|450118233|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
125134797|NCT00318461|450118234|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
125134798|NCT00318461|450118230|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
125134799|NCT00318461|450118231|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
125134800|NCT00318461|450118232|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
125134801|NCT00318461|450118233|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
125134802|NCT00318461|450118234|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
125134803|NCT00318461|450118230|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
125134804|NCT00318461|450118231|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
125134805|NCT00318461|450118232|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
125134806|NCT00318461|450118233|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
125134807|NCT00318461|450118234|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
125134808|NCT00796653|450118238|FG000|Overall Study|Adverse Event|19|||
125134809|NCT00796653|450118239|FG001|Overall Study|Adverse Event|16|||
125134810|NCT00796653|450118240|FG002|Overall Study|Adverse Event|16|||
125134811|NCT00796653|450118241|FG003|Overall Study|Adverse Event|16|||
125134812|NCT00796653|450118238|FG000|Overall Study|Lost to Follow-up|2|||
125134813|NCT00796653|450118239|FG001|Overall Study|Lost to Follow-up|1|||
125134814|NCT00796653|450118240|FG002|Overall Study|Lost to Follow-up|2|||
125134815|NCT00796653|450118241|FG003|Overall Study|Lost to Follow-up|3|||
125134816|NCT00796653|450118238|FG000|Overall Study|Withdrawal by Subject|16|||
125134817|NCT00796653|450118239|FG001|Overall Study|Withdrawal by Subject|8|||
125134818|NCT00796653|450118240|FG002|Overall Study|Withdrawal by Subject|8|||
125134819|NCT00796653|450118241|FG003|Overall Study|Withdrawal by Subject|13|||
125134820|NCT00796653|450118238|FG000|Overall Study|Lack of Efficacy|8|||
125134821|NCT00796653|450118239|FG001|Overall Study|Lack of Efficacy|1|||
125134822|NCT00796653|450118240|FG002|Overall Study|Lack of Efficacy|3|||
125380470|NCT00732615|451025211|FG000|Overall Study|Adverse Event|0|||
125380471|NCT00732615|451025212|FG001|Overall Study|Adverse Event|2|||
125380472|NCT00732615|451025211|FG000|Overall Study|Physician Decision|3|||
125380473|NCT00732615|451025212|FG001|Overall Study|Physician Decision|0|||
125134823|NCT00796653|450118241|FG003|Overall Study|Lack of Efficacy|2|||
125380474|NCT00732615|451025211|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
125380475|NCT00732615|451025212|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
125134824|NCT00796653|450118238|FG000|Overall Study|Non compliance with protocol|2|||
125380476|NCT01333059|451025215|FG000|Overall Study|Physician Decision|3|||
125134825|NCT00796653|450118239|FG001|Overall Study|Non compliance with protocol|2|||
125134826|NCT00796653|450118240|FG002|Overall Study|Non compliance with protocol|0|||
125134827|NCT00796653|450118241|FG003|Overall Study|Non compliance with protocol|2|||
125134828|NCT00796653|450118238|FG000|Overall Study|Other reason not described above|4|||
125134829|NCT00796653|450118239|FG001|Overall Study|Other reason not described above|9|||
125134830|NCT00796653|450118240|FG002|Overall Study|Other reason not described above|7|||
125134831|NCT00796653|450118241|FG003|Overall Study|Other reason not described above|4|||
125134832|NCT00207090|450118248|FG000|Overall Study|Study drug toxicity|3|||
125134833|NCT00207090|450118248|FG000|Overall Study|Chest wall mass larger|1|||
125134834|NCT00207090|450118248|FG000|Overall Study|Disease progression/relapse|2|||
125134835|NCT00207090|450118248|FG000|Overall Study|Physician Decision|1|||
125134836|NCT01911676|450118251|FG000|Period 1 of Study|Withdrawal by Subject|4|||
125134837|NCT01911676|450118252|FG001|Period 1 of Study|Withdrawal by Subject|2|||
125380477|NCT01333059|451025216|FG001|Overall Study|Physician Decision|3|||
125134838|NCT01911676|450118253|FG002|Period 1 of Study|Withdrawal by Subject|1|||
125643244|NCT02705755|451974903|FG001|Part A (6 Days)|Adverse Event|0|||
125643245|NCT02705755|451974904|FG002|Part A (6 Days)|Adverse Event|0|||
125643246|NCT02705755|451974905|FG003|Part A (6 Days)|Adverse Event|0|||
125643247|NCT02705755|451974902|FG000|Part A (6 Days)|Physician Decision|3|||
125643248|NCT02705755|451974903|FG001|Part A (6 Days)|Physician Decision|0|||
125643249|NCT02705755|451974904|FG002|Part A (6 Days)|Physician Decision|0|||
125643250|NCT02705755|451974905|FG003|Part A (6 Days)|Physician Decision|0|||
125643251|NCT02705755|451974902|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
125643252|NCT02705755|451974903|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
125643253|NCT02705755|451974904|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
125643254|NCT02705755|451974905|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
125643255|NCT02705755|451974902|FG000|Part C (20 Weeks)|Physician Decision|0|||
125643256|NCT02705755|451974903|FG001|Part C (20 Weeks)|Physician Decision|0|||
125643257|NCT02705755|451974904|FG002|Part C (20 Weeks)|Physician Decision|0|||
125643258|NCT02705755|451974905|FG003|Part C (20 Weeks)|Physician Decision|2|||
125643259|NCT02705755|451974902|FG000|Part C (20 Weeks)|Adverse Event|0|||
125643260|NCT02705755|451974903|FG001|Part C (20 Weeks)|Adverse Event|0|||
125643261|NCT02705755|451974904|FG002|Part C (20 Weeks)|Adverse Event|0|||
125643262|NCT02705755|451974905|FG003|Part C (20 Weeks)|Adverse Event|6|||
125643263|NCT02705755|451974902|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
125643264|NCT02705755|451974903|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
125643265|NCT02705755|451974904|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
125643266|NCT02705755|451974905|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
125643267|NCT01021293|451974908|FG000|Overall Study|Serious Adverse Event|2|||
125643268|NCT01021293|451974909|FG001|Overall Study|Serious Adverse Event|1|||
125134839|NCT01911676|450118254|FG003|Period 1 of Study|Withdrawal by Subject|2|||
125134840|NCT01911676|450118251|FG000|Period 1 of Study|Physician Decision|2|||
125134841|NCT01911676|450118252|FG001|Period 1 of Study|Physician Decision|0|||
125134842|NCT01911676|450118253|FG002|Period 1 of Study|Physician Decision|0|||
125134843|NCT01911676|450118254|FG003|Period 1 of Study|Physician Decision|1|||
125134844|NCT01911676|450118251|FG000|Period 2 of Study|Physician Decision|2|||
125134845|NCT01911676|450118252|FG001|Period 2 of Study|Physician Decision|0|||
125134846|NCT01911676|450118253|FG002|Period 2 of Study|Physician Decision|0|||
125134847|NCT01911676|450118254|FG003|Period 2 of Study|Physician Decision|1|||
125134848|NCT01911676|450118251|FG000|Period 2 of Study|Lost to Follow-up|0|||
125134849|NCT01911676|450118252|FG001|Period 2 of Study|Lost to Follow-up|0|||
125380478|NCT01333059|451025215|FG000|Overall Study|Protocol Violation|3|||
125380479|NCT01333059|451025216|FG001|Overall Study|Protocol Violation|0|||
125218578|NCT03131687|450427362|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
125218579|NCT03131687|450427363|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
125218580|NCT03131687|450427364|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
125218581|NCT03131687|450427365|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
125218582|NCT03131687|450427366|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
125218583|NCT03131687|450427367|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
125218584|NCT03131687|450427362|FG000|Overall Study|Principle Investigator Decision|0|||
125218585|NCT03131687|450427363|FG001|Overall Study|Principle Investigator Decision|1|||
125218586|NCT03131687|450427364|FG002|Overall Study|Principle Investigator Decision|0|||
125218587|NCT03131687|450427365|FG003|Overall Study|Principle Investigator Decision|0|||
125218588|NCT03131687|450427366|FG004|Overall Study|Principle Investigator Decision|0|||
125218589|NCT03131687|450427367|FG005|Overall Study|Principle Investigator Decision|0|||
125218590|NCT03131687|450427362|FG000|Overall Study|Inadvertent Enrollment|0|||
125218591|NCT03131687|450427363|FG001|Overall Study|Inadvertent Enrollment|0|||
125218592|NCT03131687|450427364|FG002|Overall Study|Inadvertent Enrollment|0|||
125218593|NCT03131687|450427365|FG003|Overall Study|Inadvertent Enrollment|1|||
125218594|NCT03131687|450427366|FG004|Overall Study|Inadvertent Enrollment|0|||
125218595|NCT03131687|450427367|FG005|Overall Study|Inadvertent Enrollment|0|||
125218596|NCT01904032|450427377|FG000|Overall Study|Adverse Event|3|||
125218597|NCT01904032|450427378|FG001|Overall Study|Adverse Event|1|||
125218598|NCT01904032|450427377|FG000|Overall Study|Lost to Follow-up|4|||
125218599|NCT01904032|450427378|FG001|Overall Study|Lost to Follow-up|2|||
125218600|NCT04074330|450427386|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
125218601|NCT04074330|450427387|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
125218602|NCT04074330|450427388|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
125218603|NCT04074330|450427389|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
125218604|NCT04074330|450427390|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
125218605|NCT04074330|450427391|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
125218606|NCT04074330|450427392|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
125218607|NCT04074330|450427393|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
125437192|NCT02091739|451228025|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
125437193|NCT02091739|451228026|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
125380480|NCT03566823|451025217|FG000|Overall Study|Lack of Efficacy|0|||
125380481|NCT03566823|451025218|FG001|Overall Study|Lack of Efficacy|1|||
125134850|NCT01911676|450118253|FG002|Period 2 of Study|Lost to Follow-up|0|||
125134851|NCT01911676|450118254|FG003|Period 2 of Study|Lost to Follow-up|1|||
125134852|NCT00773253|450118255|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
125134853|NCT00773253|450118256|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
125134854|NCT01566721|450118257|FG000|Treatment Period|Withdrawal by Subject|35|||
125380482|NCT03566823|451025219|FG002|Overall Study|Lack of Efficacy|0|||
125134855|NCT01566721|450118258|FG001|Treatment Period|Withdrawal by Subject|9|||
125380483|NCT03566823|451025217|FG000|Overall Study|Withdrawal by Subject|1|||
125380484|NCT03566823|451025218|FG001|Overall Study|Withdrawal by Subject|2|||
125218608|NCT04074330|450427394|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
125218609|NCT04074330|450427395|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
125380485|NCT03566823|451025219|FG002|Overall Study|Withdrawal by Subject|0|||
125380486|NCT03566823|451025217|FG000|Overall Study|Adverse Event|1|||
125134856|NCT01566721|450118257|FG000|Treatment Period|Disease Progression/Recurrence|37|||
125218610|NCT04074330|450427386|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
125134857|NCT01566721|450118258|FG001|Treatment Period|Disease Progression/Recurrence|13|||
125134858|NCT01566721|450118257|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
125134859|NCT01566721|450118258|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
125134860|NCT01566721|450118257|FG000|Treatment Period|Other|13|||
125437194|NCT02091739|451228027|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
125380487|NCT03566823|451025218|FG001|Overall Study|Adverse Event|0|||
125380488|NCT03566823|451025219|FG002|Overall Study|Adverse Event|2|||
125380489|NCT02733367|451025220|FG000|Overall Study|Withdrawal by Subject|6|||
125380490|NCT01348347|451025221|FG000|Overall Study|Withdrawal by Subject|1|||
125380491|NCT01348347|451025222|FG001|Overall Study|Withdrawal by Subject|1|||
125380492|NCT01348347|451025223|FG002|Overall Study|Withdrawal by Subject|1|||
125380493|NCT01348347|451025221|FG000|Overall Study|Progressive disease|2|||
125380494|NCT01348347|451025222|FG001|Overall Study|Progressive disease|5|||
125380495|NCT01348347|451025223|FG002|Overall Study|Progressive disease|5|||
125134861|NCT01566721|450118258|FG001|Treatment Period|Other|2|||
125134862|NCT01566721|450118257|FG000|Treatment Period|Lack of Compliance|5|||
125134863|NCT01566721|450118258|FG001|Treatment Period|Lack of Compliance|1|||
125134864|NCT01566721|450118257|FG000|Treatment Period|Adverse Event|100|||
125134865|NCT01566721|450118258|FG001|Treatment Period|Adverse Event|30|||
125134866|NCT01566721|450118257|FG000|Treatment Period|Pregnancy|1|||
125134867|NCT01566721|450118258|FG001|Treatment Period|Pregnancy|0|||
125134868|NCT01566721|450118257|FG000|Safety Follow-up|Physician Decision|6|||
125134869|NCT01566721|450118258|FG001|Safety Follow-up|Physician Decision|4|||
125134870|NCT01566721|450118257|FG000|Safety Follow-up|Lost to Follow-up|101|||
125134871|NCT01566721|450118258|FG001|Safety Follow-up|Lost to Follow-up|48|||
125134872|NCT01566721|450118257|FG000|Safety Follow-up|Withdrawal by Subject|155|||
125134873|NCT01566721|450118258|FG001|Safety Follow-up|Withdrawal by Subject|49|||
125134874|NCT01566721|450118257|FG000|Safety Follow-up|Death|28|||
125134875|NCT01566721|450118258|FG001|Safety Follow-up|Death|4|||
125134876|NCT01566721|450118257|FG000|Safety Follow-up|Non-compliance|7|||
125134877|NCT01566721|450118258|FG001|Safety Follow-up|Non-compliance|3|||
125134878|NCT01566721|450118257|FG000|Safety Follow-up|Protocol Violation|7|||
125218611|NCT04074330|450427387|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
125134879|NCT01566721|450118258|FG001|Safety Follow-up|Protocol Violation|0|||
125134880|NCT01566721|450118257|FG000|Safety Follow-up|Site closure|2|||
125134881|NCT01566721|450118258|FG001|Safety Follow-up|Site closure|3|||
125134882|NCT01566721|450118257|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
125380496|NCT00748033|451025227|FG000|Overall Study|Adverse Event|0|||
125380497|NCT00748033|451025228|FG001|Overall Study|Adverse Event|1|||
125380498|NCT00191789|451025229|FG000|Overall Study|Adverse Event|5|||
125380499|NCT00191789|451025229|FG000|Overall Study|Patient: Satisfactory Response|5|||
125380500|NCT00191789|451025229|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
125380501|NCT00191789|451025229|FG000|Overall Study|Withdrawal by Subject|4|||
125380502|NCT00191789|451025229|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
125380503|NCT00191789|451025229|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
125380504|NCT00191789|451025229|FG000|Overall Study|Death - Not Study-Drug Related|1|||
125380505|NCT01922089|451025234|FG000|Overall Study|Adverse Event|18|||
125380506|NCT01922089|451025235|FG001|Overall Study|Adverse Event|13|||
125380507|NCT01922089|451025234|FG000|Overall Study|Protocol Deviation|10|||
125380508|NCT01922089|451025235|FG001|Overall Study|Protocol Deviation|7|||
125380509|NCT01922089|451025234|FG000|Overall Study|Withdrawal by Subject|3|||
125380510|NCT01922089|451025235|FG001|Overall Study|Withdrawal by Subject|4|||
125380511|NCT01922089|451025234|FG000|Overall Study|administrative problems|4|||
125380512|NCT01922089|451025235|FG001|Overall Study|administrative problems|1|||
125380513|NCT01922089|451025234|FG000|Overall Study|Physician Decision|2|||
125380514|NCT01922089|451025235|FG001|Overall Study|Physician Decision|3|||
125380515|NCT01922089|451025234|FG000|Overall Study|Death|2|||
125380516|NCT01922089|451025235|FG001|Overall Study|Death|1|||
125380517|NCT01922089|451025234|FG000|Overall Study|Lost to Follow-up|0|||
125380518|NCT01922089|451025235|FG001|Overall Study|Lost to Follow-up|1|||
125380519|NCT01129960|451025245|FG000|Overall Study|Withdrawal by Subject|3|||
125380520|NCT01129960|451025246|FG001|Overall Study|Withdrawal by Subject|0|||
125380521|NCT01129960|451025247|FG002|Overall Study|Withdrawal by Subject|3|||
125437195|NCT02091739|451228023|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
125380522|NCT01129960|451025248|FG003|Overall Study|Withdrawal by Subject|2|||
125380523|NCT01129960|451025245|FG000|Overall Study|Lack of Efficacy|1|||
125380524|NCT01129960|451025246|FG001|Overall Study|Lack of Efficacy|1|||
125134883|NCT01566721|450118258|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
125437196|NCT02091739|451228024|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
125134884|NCT01566721|450118257|FG000|Safety Follow-up|Missing|7|||
125134885|NCT01566721|450118258|FG001|Safety Follow-up|Missing|2|||
125437197|NCT02091739|451228025|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
125437198|NCT02091739|451228026|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
125437199|NCT02091739|451228027|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
125437200|NCT02091739|451228023|FG000|EP: 48 Weeks|Other|0|||
125437201|NCT02091739|451228024|FG001|EP: 48 Weeks|Other|0|||
125437202|NCT02091739|451228025|FG002|EP: 48 Weeks|Other|0|||
125437203|NCT02091739|451228026|FG003|EP: 48 Weeks|Other|1|||
125437204|NCT02091739|451228027|FG004|EP: 48 Weeks|Other|0|||
125437205|NCT02091739|451228023|FG000|EP: 48 Weeks|Death|0|||
125437206|NCT02091739|451228024|FG001|EP: 48 Weeks|Death|0|||
125437207|NCT02091739|451228025|FG002|EP: 48 Weeks|Death|0|||
125437208|NCT02091739|451228026|FG003|EP: 48 Weeks|Death|3|||
125437209|NCT02091739|451228027|FG004|EP: 48 Weeks|Death|2|||
125437210|NCT02091739|451228023|FG000|EP: 48 Weeks|Adverse Event|0|||
125437211|NCT02091739|451228024|FG001|EP: 48 Weeks|Adverse Event|0|||
125437212|NCT02091739|451228025|FG002|EP: 48 Weeks|Adverse Event|0|||
125437213|NCT02091739|451228026|FG003|EP: 48 Weeks|Adverse Event|2|||
125437214|NCT02091739|451228027|FG004|EP: 48 Weeks|Adverse Event|6|||
125437215|NCT02091739|451228023|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
125437216|NCT02091739|451228024|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
125134886|NCT01566721|450118257|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
125134887|NCT01566721|450118258|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
125134888|NCT01566721|450118257|FG000|Safety Follow-up|Sponsor decision|1|||
125134889|NCT01566721|450118258|FG001|Safety Follow-up|Sponsor decision|0|||
125134890|NCT01566721|450118257|FG000|Safety Follow-up|Adverse Event|8|||
125134891|NCT01566721|450118258|FG001|Safety Follow-up|Adverse Event|4|||
125134892|NCT02911701|450118263|FG000|Overall Study|Withdrawal by Subject|2|||
125134893|NCT02911701|450118264|FG001|Overall Study|Withdrawal by Subject|4|||
125134894|NCT02911701|450118263|FG000|Overall Study|Adverse Event|1|||
125134895|NCT02911701|450118264|FG001|Overall Study|Adverse Event|0|||
125437217|NCT02091739|451228025|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
125437218|NCT02091739|451228026|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
125437219|NCT02091739|451228027|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
125437220|NCT00192023|451228028|FG000|Period III - Double-Blind|Adverse Event|3|||
125437221|NCT00192023|451228029|FG001|Period III - Double-Blind|Adverse Event|0|||
125380525|NCT01129960|451025247|FG002|Overall Study|Lack of Efficacy|1|||
125380526|NCT01129960|451025248|FG003|Overall Study|Lack of Efficacy|1|||
125380527|NCT01129960|451025245|FG000|Overall Study|Adverse Event|23|||
125380528|NCT01129960|451025246|FG001|Overall Study|Adverse Event|16|||
125380529|NCT01129960|451025247|FG002|Overall Study|Adverse Event|16|||
125380530|NCT01129960|451025248|FG003|Overall Study|Adverse Event|7|||
125380531|NCT01129960|451025245|FG000|Overall Study|Protocol Violation|1|||
125380532|NCT01129960|451025246|FG001|Overall Study|Protocol Violation|2|||
125380533|NCT01129960|451025247|FG002|Overall Study|Protocol Violation|3|||
125380534|NCT01129960|451025248|FG003|Overall Study|Protocol Violation|0|||
125380535|NCT01129960|451025245|FG000|Overall Study|Lost to Follow-up|0|||
125380536|NCT01129960|451025246|FG001|Overall Study|Lost to Follow-up|2|||
125380537|NCT01129960|451025247|FG002|Overall Study|Lost to Follow-up|3|||
125380538|NCT01129960|451025248|FG003|Overall Study|Lost to Follow-up|3|||
125380539|NCT01129960|451025245|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
125380540|NCT01129960|451025246|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
125134896|NCT01237054|450118265|FG000|Overall Study|imaging 10C0096|1|||
125134897|NCT01983969|450118266|FG000|Overall Study|Disease Progression|0|||
125134898|NCT01983969|450118267|FG001|Overall Study|Disease Progression|1|||
125134899|NCT01983969|450118268|FG002|Overall Study|Disease Progression|0|||
125134900|NCT02619682|450118269|FG000|Overall Study|Withdrawal by Subject|3|||
125134901|NCT02619682|450118269|FG000|Overall Study|Lack of Efficacy|8|||
125134902|NCT02619682|450118269|FG000|Overall Study|new secondary cancer|1|||
125134903|NCT02619682|450118269|FG000|Overall Study|post surgery complications|2|||
125134904|NCT00268203|450118272|FG000|Overall Study|Lost to Follow-up|92|||
125134905|NCT00268203|450118272|FG000|Overall Study|Withdrawal by Subject|9|||
125134906|NCT00268203|450118272|FG000|Overall Study|Received Other NHL Therapy|7|||
125437222|NCT00192023|451228028|FG000|Period III - Double-Blind|Physician Decision|2|||
125134907|NCT00268203|450118272|FG000|Overall Study|Progressive Disease|359|||
125134908|NCT00268203|450118272|FG000|Overall Study|Death|84|||
125134909|NCT00268203|450118272|FG000|Overall Study|Reason Not Specified|34|||
125134910|NCT00268203|450118272|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
125134911|NCT01841554|450118274|FG000|Overall Study|Death|7|||
125134912|NCT01841554|450118274|FG000|Overall Study|No Implantation|1|||
125134913|NCT01841554|450118274|FG000|Overall Study|Discontinued Follow Up|5|||
125134914|NCT01841554|450118274|FG000|Overall Study|Study exit due to secondary intervention|6|||
125134915|NCT03600376|450118278|FG000|Overall Study|Adverse Event|1|||
125134916|NCT03600376|450118279|FG001|Overall Study|Adverse Event|1|||
125437223|NCT00192023|451228029|FG001|Period III - Double-Blind|Physician Decision|0|||
125437224|NCT00192023|451228028|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
125437225|NCT00192023|451228029|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
125437226|NCT00192023|451228028|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
125437227|NCT00192023|451228029|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
125437228|NCT00192023|451228028|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
125437229|NCT00192023|451228029|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
125437230|NCT00192023|451228028|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
125437231|NCT00192023|451228029|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
125437232|NCT00192023|451228028|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
125437233|NCT00192023|451228029|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
125380541|NCT01129960|451025247|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
125380542|NCT01129960|451025248|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
125380543|NCT01129960|451025245|FG000|Overall Study|Physician Decision|1|||
125380544|NCT01129960|451025246|FG001|Overall Study|Physician Decision|0|||
125380545|NCT01129960|451025247|FG002|Overall Study|Physician Decision|0|||
125380546|NCT01129960|451025248|FG003|Overall Study|Physician Decision|0|||
125380547|NCT01129960|451025245|FG000|Overall Study|Pregnancy|1|||
125380548|NCT01129960|451025246|FG001|Overall Study|Pregnancy|0|||
125380549|NCT01129960|451025247|FG002|Overall Study|Pregnancy|0|||
125380550|NCT01129960|451025248|FG003|Overall Study|Pregnancy|0|||
125134917|NCT03600376|450118278|FG000|Overall Study|Transferred to other facility|1|||
125134918|NCT03600376|450118279|FG001|Overall Study|Transferred to other facility|0|||
125134919|NCT03600376|450118278|FG000|Overall Study|Investigator Decision|0|||
125134920|NCT03600376|450118279|FG001|Overall Study|Investigator Decision|4|||
125134921|NCT03600376|450118278|FG000|Overall Study|Determined to be ineligible for study|0|||
125134922|NCT03600376|450118279|FG001|Overall Study|Determined to be ineligible for study|1|||
125134923|NCT03804983|450118280|FG000|Overall Study|Adverse Event|0|||
125380551|NCT00165776|451025249|FG000|Overall Study|Lack of Efficacy|0|||
125380552|NCT00165776|451025250|FG001|Overall Study|Lack of Efficacy|0|||
125437234|NCT00192023|451228028|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
125380553|NCT00165776|451025251|FG002|Overall Study|Lack of Efficacy|0|||
125380554|NCT00165776|451025252|FG003|Overall Study|Lack of Efficacy|1|||
125380555|NCT00165776|451025249|FG000|Overall Study|Withdrawal by Subject|4|||
125134924|NCT03804983|450118281|FG001|Overall Study|Adverse Event|1|||
125134925|NCT03804983|450118280|FG000|Overall Study|Family Obligation|1|||
125134926|NCT03804983|450118281|FG001|Overall Study|Family Obligation|0|||
125380556|NCT00165776|451025250|FG001|Overall Study|Withdrawal by Subject|1|||
125380557|NCT00165776|451025251|FG002|Overall Study|Withdrawal by Subject|2|||
125380558|NCT00165776|451025252|FG003|Overall Study|Withdrawal by Subject|0|||
125380559|NCT00165776|451025249|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
125380560|NCT00165776|451025250|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
125134927|NCT02152163|450118282|FG000|Overall Study|Physician Decision|12|||
125134928|NCT02152163|450118283|FG001|Overall Study|Physician Decision|13|||
125134929|NCT00796562|450118287|FG000|Overall Study|Death|49|||
125134930|NCT00424047|450118288|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
125134931|NCT00424047|450118289|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
125134932|NCT00424047|450118288|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
125134933|NCT00424047|450118289|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
125380561|NCT00165776|451025251|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
125134934|NCT00424047|450118288|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
125218612|NCT04074330|450427388|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
125218613|NCT04074330|450427389|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
125218614|NCT04074330|450427390|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
125218615|NCT04074330|450427391|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
125380562|NCT00165776|451025252|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
125380563|NCT02622321|451025255|FG000|Overall Study|Withdrawal by Subject|2|||
125380564|NCT02622321|451025256|FG001|Overall Study|Withdrawal by Subject|0|||
125380565|NCT02622321|451025257|FG002|Overall Study|Withdrawal by Subject|0|||
125380566|NCT02622321|451025258|FG003|Overall Study|Withdrawal by Subject|0|||
125134935|NCT00424047|450118289|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
125134936|NCT00424047|450118288|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
125134937|NCT00424047|450118289|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
125134938|NCT00424047|450118288|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
125134939|NCT00424047|450118289|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
125134940|NCT00424047|450118288|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
125134941|NCT00424047|450118289|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
125134942|NCT00424047|450118288|FG000|On Study at Time of Unblinding|Adverse Event|22|||
125134943|NCT00424047|450118289|FG001|On Study at Time of Unblinding|Adverse Event|12|||
125134944|NCT00424047|450118288|FG000|On Study at Time of Unblinding|Progression of disease|92|||
125134945|NCT00424047|450118289|FG001|On Study at Time of Unblinding|Progression of disease|128|||
125134946|NCT00424047|450118288|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
125134947|NCT00424047|450118289|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
125134948|NCT00424047|450118288|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
125134949|NCT00424047|450118289|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
125134950|NCT00424047|450118288|FG000|On Study at Time of Unblinding|Death|11|||
125134951|NCT00424047|450118289|FG001|On Study at Time of Unblinding|Death|11|||
125134952|NCT00424047|450118288|FG000|On Study at Time of Unblinding|Other|5|||
125134953|NCT00424047|450118289|FG001|On Study at Time of Unblinding|Other|4|||
125134954|NCT00424047|450118288|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
125134955|NCT00424047|450118289|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
125134956|NCT00424047|450118288|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
125134957|NCT00424047|450118289|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
125134958|NCT00424047|450118288|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
125134959|NCT00424047|450118289|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
125134960|NCT00424047|450118288|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
125134961|NCT00424047|450118289|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
125134962|NCT00424047|450118288|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
125134963|NCT00424047|450118289|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
125134964|NCT00312897|450118291|FG000|Overall Study|Adverse Event|1|||
125134965|NCT00312897|450118292|FG001|Overall Study|Adverse Event|0|||
125134966|NCT00312897|450118291|FG000|Overall Study|Lost to Follow-up|2|||
125134967|NCT00312897|450118292|FG001|Overall Study|Lost to Follow-up|0|||
125134968|NCT00312897|450118291|FG000|Overall Study|Physician Decision|1|||
125134969|NCT00312897|450118292|FG001|Overall Study|Physician Decision|0|||
125134970|NCT00312897|450118291|FG000|Overall Study|Withdrawal by Subject|1|||
125134971|NCT00312897|450118292|FG001|Overall Study|Withdrawal by Subject|3|||
125134972|NCT00312897|450118291|FG000|Overall Study|Pregnancy|1|||
125134973|NCT00312897|450118292|FG001|Overall Study|Pregnancy|0|||
125134974|NCT00312897|450118291|FG000|Overall Study|discontinued prior to getting treatment|0|||
125218616|NCT04074330|450427392|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
125380567|NCT02622321|451025255|FG000|Overall Study|Death|0|||
125380568|NCT02622321|451025256|FG001|Overall Study|Death|0|||
125380569|NCT02622321|451025257|FG002|Overall Study|Death|1|||
125218617|NCT04074330|450427393|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
125218618|NCT04074330|450427394|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
125134975|NCT00312897|450118292|FG001|Overall Study|discontinued prior to getting treatment|3|||
125134976|NCT04633564|450118293|FG000|Period 1|Adverse Event|28|||
125134977|NCT04633564|450118294|FG001|Period 1|Adverse Event|19|||
125134978|NCT04633564|450118293|FG000|Period 1|Death|8|||
125134979|NCT04633564|450118294|FG001|Period 1|Death|7|||
125134980|NCT04633564|450118293|FG000|Period 1|Lost to Follow-up|3|||
125134981|NCT04633564|450118294|FG001|Period 1|Lost to Follow-up|5|||
125134982|NCT04633564|450118293|FG000|Period 1|Physician Decision|4|||
125134983|NCT04633564|450118294|FG001|Period 1|Physician Decision|12|||
125134984|NCT04633564|450118293|FG000|Period 1|Protocol Violation|0|||
125134985|NCT04633564|450118294|FG001|Period 1|Protocol Violation|1|||
125134986|NCT04633564|450118293|FG000|Period 1|Withdrawal by Subject|10|||
125134987|NCT04633564|450118294|FG001|Period 1|Withdrawal by Subject|8|||
125134988|NCT04633564|450118293|FG000|Period 1|Progressive disease|47|||
125134989|NCT04633564|450118294|FG001|Period 1|Progressive disease|51|||
125134990|NCT04633564|450118293|FG000|Period 1|Terminated by Sponsor|8|||
125134991|NCT04633564|450118294|FG001|Period 1|Terminated by Sponsor|6|||
125134992|NCT04633564|450118293|FG000|Period 2|Adverse Event|3|||
125134993|NCT04633564|450118294|FG001|Period 2|Adverse Event|4|||
125134994|NCT04633564|450118293|FG000|Period 2|Death|0|||
125134995|NCT04633564|450118294|FG001|Period 2|Death|2|||
125134996|NCT04633564|450118293|FG000|Period 2|Lost to Follow-up|0|||
125134997|NCT04633564|450118294|FG001|Period 2|Lost to Follow-up|1|||
125134998|NCT04633564|450118293|FG000|Period 2|Physician Decision|2|||
125134999|NCT04633564|450118294|FG001|Period 2|Physician Decision|4|||
125135000|NCT04633564|450118293|FG000|Period 2|Withdrawal by Subject|5|||
125135001|NCT04633564|450118294|FG001|Period 2|Withdrawal by Subject|1|||
125135002|NCT04633564|450118293|FG000|Period 2|Progressive Disease|74|||
125135003|NCT04633564|450118294|FG001|Period 2|Progressive Disease|82|||
125135004|NCT04633564|450118293|FG000|Period 2|Terminated by Sponsor|9|||
125135005|NCT04633564|450118294|FG001|Period 2|Terminated by Sponsor|3|||
125135006|NCT01010503|450118295|FG000|Overall Study|Adverse Event|1|||
125135007|NCT01010503|450118295|FG000|Overall Study|Death|1|||
125135008|NCT01097577|450118296|FG000|Overall Study|Adverse Event|0|||
125135009|NCT01097577|450118297|FG001|Overall Study|Adverse Event|1|||
125135010|NCT04493684|450118300|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
125218619|NCT04074330|450427395|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
125135011|NCT04493684|450118301|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135012|NCT04493684|450118302|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
125135013|NCT04493684|450118303|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135014|NCT04493684|450118304|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135015|NCT04493684|450118305|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
125135016|NCT04493684|450118306|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135017|NCT04493684|450118307|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135018|NCT04493684|450118308|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135019|NCT04493684|450118309|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135020|NCT04493684|450118310|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135021|NCT04493684|450118311|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135022|NCT04493684|450118312|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135023|NCT04493684|450118313|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135024|NCT04493684|450118314|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135025|NCT04493684|450118315|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135026|NCT04493684|450118316|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
125135027|NCT04493684|450118300|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
125135028|NCT04493684|450118301|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135029|NCT04493684|450118302|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135030|NCT04493684|450118303|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135031|NCT04493684|450118304|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135032|NCT04493684|450118305|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135033|NCT04493684|450118306|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135034|NCT04493684|450118307|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135035|NCT04493684|450118308|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135036|NCT04493684|450118309|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135037|NCT04493684|450118310|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135038|NCT04493684|450118311|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135039|NCT04493684|450118312|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135040|NCT04493684|450118313|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135041|NCT04493684|450118314|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135042|NCT04493684|450118315|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135043|NCT04493684|450118316|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
125135044|NCT04493684|450118300|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135045|NCT04493684|450118301|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135046|NCT04493684|450118302|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135047|NCT04493684|450118303|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135048|NCT04493684|450118304|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135049|NCT04493684|450118305|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135050|NCT04493684|450118306|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
125135051|NCT04493684|450118307|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135052|NCT04493684|450118308|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125437235|NCT00192023|451228029|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
125135053|NCT04493684|450118309|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135054|NCT04493684|450118310|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135055|NCT04493684|450118311|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135056|NCT04493684|450118312|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125218620|NCT04074330|450427386|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218621|NCT04074330|450427387|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218622|NCT04074330|450427388|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
125218623|NCT04074330|450427389|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218624|NCT04074330|450427390|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218625|NCT04074330|450427391|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218626|NCT04074330|450427392|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218627|NCT04074330|450427393|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218628|NCT04074330|450427394|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218629|NCT04074330|450427395|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
125218630|NCT04074330|450427386|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218631|NCT04074330|450427387|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218632|NCT04074330|450427388|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218633|NCT04074330|450427389|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218634|NCT04074330|450427390|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218635|NCT04074330|450427391|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
125218636|NCT04074330|450427392|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218637|NCT04074330|450427393|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
125218638|NCT04074330|450427394|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218639|NCT04074330|450427395|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
125218640|NCT04074330|450427386|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
125218641|NCT04074330|450427387|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
125218642|NCT04074330|450427388|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
125218643|NCT04074330|450427389|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
125218644|NCT04074330|450427390|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
125218645|NCT04074330|450427391|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
125218646|NCT04074330|450427392|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
125218647|NCT04074330|450427393|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
125218648|NCT04074330|450427394|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
125218649|NCT04074330|450427395|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
125218650|NCT04074330|450427386|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
125218651|NCT04074330|450427387|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
125218652|NCT04074330|450427388|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
125218653|NCT04074330|450427389|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
125218654|NCT04074330|450427390|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
125218655|NCT04074330|450427391|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
125218656|NCT04074330|450427392|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
125218657|NCT04074330|450427393|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
125218658|NCT04074330|450427394|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
125218659|NCT04074330|450427395|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
125218660|NCT04074330|450427386|FG000|Dose Expansion (up to 42 Months)|Death|0|||
125218661|NCT04074330|450427387|FG001|Dose Expansion (up to 42 Months)|Death|0|||
125218662|NCT04074330|450427388|FG002|Dose Expansion (up to 42 Months)|Death|0|||
125218663|NCT04074330|450427389|FG003|Dose Expansion (up to 42 Months)|Death|0|||
125218664|NCT04074330|450427390|FG004|Dose Expansion (up to 42 Months)|Death|0|||
125218665|NCT04074330|450427391|FG005|Dose Expansion (up to 42 Months)|Death|0|||
125218666|NCT04074330|450427392|FG006|Dose Expansion (up to 42 Months)|Death|0|||
125218667|NCT04074330|450427393|FG007|Dose Expansion (up to 42 Months)|Death|0|||
125218668|NCT04074330|450427394|FG008|Dose Expansion (up to 42 Months)|Death|1|||
125218669|NCT04074330|450427395|FG009|Dose Expansion (up to 42 Months)|Death|0|||
125218670|NCT04074330|450427386|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218671|NCT04074330|450427387|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218672|NCT04074330|450427388|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218673|NCT04074330|450427389|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218674|NCT04074330|450427390|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218675|NCT04074330|450427391|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218676|NCT04074330|450427392|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218677|NCT04074330|450427393|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
125218678|NCT04074330|450427394|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
125218679|NCT04074330|450427395|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
125218680|NCT01903993|450427396|FG000|Overall Study|Death|118|||
125218681|NCT01903993|450427397|FG001|Overall Study|Death|121|||
125218682|NCT01903993|450427396|FG000|Overall Study|Withdrawal by Subject|15|||
125218683|NCT01903993|450427397|FG001|Overall Study|Withdrawal by Subject|4|||
125380570|NCT02622321|451025258|FG003|Overall Study|Death|0|||
125380571|NCT02622321|451025255|FG000|Overall Study|Physician Decision|1|||
125380572|NCT02622321|451025256|FG001|Overall Study|Physician Decision|0|||
125380573|NCT02622321|451025257|FG002|Overall Study|Physician Decision|0|||
125380574|NCT02622321|451025258|FG003|Overall Study|Physician Decision|0|||
125380575|NCT00965718|451025260|FG000|Overall Study|Withdrawal by Subject|4|||
125380576|NCT00241280|451025262|FG000|Overall Study|Adverse Event|2|||
125643269|NCT01021293|451974908|FG000|Overall Study|Adverse Event|2|||
125643270|NCT01021293|451974909|FG001|Overall Study|Adverse Event|1|||
125643271|NCT01021293|451974908|FG000|Overall Study|Withdrawal by Subject|1|||
125643272|NCT01021293|451974909|FG001|Overall Study|Withdrawal by Subject|3|||
125643273|NCT01021293|451974908|FG000|Overall Study|Migrated/moved from study area|6|||
125643274|NCT01021293|451974909|FG001|Overall Study|Migrated/moved from study area|18|||
125643275|NCT01021293|451974908|FG000|Overall Study|Lost to Follow-up|1|||
125643276|NCT01021293|451974909|FG001|Overall Study|Lost to Follow-up|1|||
125643277|NCT01084096|451977856|FG000|Overall Study|Lost to Follow-up|1501|||
125643278|NCT01084096|451977857|FG001|Overall Study|Lost to Follow-up|1833|||
125643279|NCT01084096|451977856|FG000|Overall Study|Withdrawal by Subject|3|||
125643280|NCT01084096|451977857|FG001|Overall Study|Withdrawal by Subject|0|||
125643281|NCT01084096|451977856|FG000|Overall Study|Woman had a miscarriage|21|||
125643282|NCT01084096|451977857|FG001|Overall Study|Woman had a miscarriage|17|||
125643283|NCT00027846|451977858|FG000|Overall Study|Lost to Follow-up|0|||
125643284|NCT00027846|451977859|FG001|Overall Study|Lost to Follow-up|41|||
125643285|NCT00027846|451977860|FG002|Overall Study|Lost to Follow-up|9|||
125643286|NCT00027846|451977858|FG000|Overall Study|Withdrawal by Subject|0|||
125643287|NCT00027846|451977859|FG001|Overall Study|Withdrawal by Subject|14|||
125643288|NCT00027846|451977860|FG002|Overall Study|Withdrawal by Subject|7|||
125643289|NCT00027846|451977858|FG000|Overall Study|Ineligible for study|2|||
125643290|NCT00027846|451977859|FG001|Overall Study|Ineligible for study|6|||
125380577|NCT00241280|451025263|FG001|Overall Study|Adverse Event|6|||
125380578|NCT00241280|451025262|FG000|Overall Study|Discomfort|11|||
125643291|NCT00027846|451977860|FG002|Overall Study|Ineligible for study|14|||
125643292|NCT00027846|451977858|FG000|Overall Study|Entry into another COG therapeutic study|0|||
125643293|NCT00027846|451977859|FG001|Overall Study|Entry into another COG therapeutic study|5|||
125135057|NCT04493684|450118313|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135058|NCT04493684|450118314|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135059|NCT04493684|450118315|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135060|NCT04493684|450118316|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
125135061|NCT04493684|450118300|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
125135062|NCT04493684|450118301|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135063|NCT04493684|450118302|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135064|NCT04493684|450118303|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135065|NCT04493684|450118304|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135066|NCT04493684|450118305|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135067|NCT04493684|450118306|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135068|NCT04493684|450118307|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135069|NCT04493684|450118308|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135070|NCT04493684|450118309|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135071|NCT04493684|450118310|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135072|NCT04493684|450118311|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135073|NCT04493684|450118312|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135074|NCT04493684|450118313|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135075|NCT04493684|450118314|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135076|NCT04493684|450118315|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135077|NCT04493684|450118316|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
125135078|NCT04493684|450118300|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125380579|NCT00241280|451025263|FG001|Overall Study|Discomfort|16|||
125380580|NCT00241280|451025262|FG000|Overall Study|Pregnancy|1|||
125380581|NCT00241280|451025263|FG001|Overall Study|Pregnancy|5|||
125380582|NCT00241280|451025262|FG000|Overall Study|Lost to Follow-up|5|||
125380583|NCT00241280|451025263|FG001|Overall Study|Lost to Follow-up|8|||
125380584|NCT00241280|451025262|FG000|Overall Study|Withdrawal by Subject|7|||
125135079|NCT04493684|450118301|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135080|NCT04493684|450118302|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135081|NCT04493684|450118303|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135082|NCT04493684|450118304|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125218684|NCT01903993|450427396|FG000|Overall Study|Lost to Follow-up|2|||
125218685|NCT01903993|450427397|FG001|Overall Study|Lost to Follow-up|3|||
125380585|NCT00241280|451025263|FG001|Overall Study|Withdrawal by Subject|4|||
125380586|NCT00241280|451025262|FG000|Overall Study|Protocol Violation|4|||
125380587|NCT00241280|451025263|FG001|Overall Study|Protocol Violation|10|||
125380588|NCT00241280|451025262|FG000|Overall Study|Relocation|4|||
125380589|NCT00241280|451025263|FG001|Overall Study|Relocation|4|||
125135083|NCT04493684|450118305|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
125135084|NCT04493684|450118306|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135085|NCT04493684|450118307|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135086|NCT04493684|450118308|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135087|NCT04493684|450118309|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135088|NCT04493684|450118310|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135089|NCT04493684|450118311|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135090|NCT04493684|450118312|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135091|NCT04493684|450118313|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135092|NCT04493684|450118314|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135093|NCT04493684|450118315|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135094|NCT04493684|450118316|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
125135095|NCT04493684|450118300|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135096|NCT04493684|450118301|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135097|NCT04493684|450118302|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135098|NCT04493684|450118303|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135099|NCT04493684|450118304|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135100|NCT04493684|450118305|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135101|NCT04493684|450118306|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135102|NCT04493684|450118307|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135103|NCT04493684|450118308|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135104|NCT04493684|450118309|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135105|NCT04493684|450118310|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135106|NCT04493684|450118311|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
125135107|NCT04493684|450118312|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135108|NCT04493684|450118313|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135109|NCT04493684|450118314|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125485444|NCT02240238|451412510|FG007|Phase 2|Withdrawal by Subject|0|||
125135110|NCT04493684|450118315|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135111|NCT04493684|450118316|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
125135112|NCT04493684|450118300|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135113|NCT04493684|450118301|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135114|NCT04493684|450118302|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135115|NCT04493684|450118303|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135116|NCT04493684|450118304|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135117|NCT04493684|450118305|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135118|NCT04493684|450118306|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135119|NCT04493684|450118307|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135120|NCT04493684|450118308|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125218686|NCT01903993|450427396|FG000|Overall Study|Study Terminated by Sponsor|8|||
125218687|NCT01903993|450427397|FG001|Overall Study|Study Terminated by Sponsor|14|||
125218688|NCT01903993|450427396|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
125218689|NCT01903993|450427397|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
125218690|NCT00184093|450427398|FG000|Overall Study|Adverse Event|3|||
125218691|NCT00184093|450427398|FG000|Overall Study|Lost to Follow-up|3|||
125218692|NCT00184093|450427398|FG000|Overall Study|Physician Decision|1|||
125218693|NCT00184093|450427398|FG000|Overall Study|Withdrawal by Subject|2|||
125218694|NCT00972283|450427402|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
125218695|NCT00972283|450427403|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
125218696|NCT00972283|450427402|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
125218697|NCT00972283|450427403|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
125218698|NCT00972283|450427402|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
125218699|NCT00972283|450427403|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
125218700|NCT00972283|450427402|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
125218701|NCT00972283|450427403|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
125218702|NCT00972283|450427402|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
125218703|NCT00972283|450427403|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
125218704|NCT00972283|450427402|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
125218705|NCT00972283|450427403|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
125218706|NCT00972283|450427402|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
125218707|NCT00972283|450427403|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
125135121|NCT04493684|450118309|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135122|NCT04493684|450118310|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135123|NCT04493684|450118311|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125218708|NCT00972283|450427402|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
125218709|NCT00972283|450427403|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
125218710|NCT00972283|450427402|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
125135124|NCT04493684|450118312|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135125|NCT04493684|450118313|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135126|NCT04493684|450118314|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135127|NCT04493684|450118315|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
125135128|NCT04493684|450118316|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
125135129|NCT04493684|450118300|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135130|NCT04493684|450118301|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135131|NCT04493684|450118302|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135132|NCT04493684|450118303|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135133|NCT04493684|450118304|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135134|NCT04493684|450118305|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135135|NCT04493684|450118306|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135136|NCT04493684|450118307|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135137|NCT04493684|450118308|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135138|NCT04493684|450118309|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135139|NCT04493684|450118310|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125380590|NCT00241280|451025262|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
125380591|NCT00241280|451025263|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
125380592|NCT00241280|451025262|FG000|Overall Study|Unsatisfactory Visual Response|1|||
125380593|NCT00241280|451025263|FG001|Overall Study|Unsatisfactory Visual Response|1|||
125380594|NCT00241280|451025262|FG000|Overall Study|Diabetic|1|||
125380595|NCT00241280|451025263|FG001|Overall Study|Diabetic|0|||
125380596|NCT00241280|451025262|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
125380597|NCT00241280|451025263|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
125380598|NCT00241280|451025262|FG000|Overall Study|Dispensed incorrect test article|1|||
125135140|NCT04493684|450118311|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125380599|NCT00241280|451025263|FG001|Overall Study|Dispensed incorrect test article|2|||
125380600|NCT00241280|451025262|FG000|Overall Study|Unacceptable Fit|0|||
125380601|NCT00241280|451025263|FG001|Overall Study|Unacceptable Fit|1|||
125380602|NCT00241280|451025262|FG000|Overall Study|Scheduling Conflict|0|||
125380603|NCT00241280|451025263|FG001|Overall Study|Scheduling Conflict|2|||
125380604|NCT00241280|451025262|FG000|Overall Study|History of Ocular Surgery|0|||
125380605|NCT00241280|451025263|FG001|Overall Study|History of Ocular Surgery|1|||
125380606|NCT00241280|451025262|FG000|Overall Study|Coating on Lens|1|||
125380607|NCT00241280|451025263|FG001|Overall Study|Coating on Lens|0|||
125380608|NCT00241280|451025262|FG000|Overall Study|Excessive Dryness|0|||
125380609|NCT00241280|451025263|FG001|Overall Study|Excessive Dryness|1|||
125380610|NCT01414855|451025266|FG000|Overall Study|Death|17|||
125380611|NCT01414855|451025266|FG000|Overall Study|Lost to Follow-up|5|||
125380612|NCT01414855|451025266|FG000|Overall Study|Withdrawal by Subject|7|||
125380613|NCT01850524|451025267|FG000|Overall Study|Lost to Follow-up|5|||
125380614|NCT01850524|451025268|FG001|Overall Study|Lost to Follow-up|10|||
125380615|NCT01850524|451025267|FG000|Overall Study|Withdrawal by Subject|24|||
125380616|NCT01850524|451025268|FG001|Overall Study|Withdrawal by Subject|22|||
125380617|NCT01850524|451025267|FG000|Overall Study|Reason not Specified|142|||
125380618|NCT01850524|451025268|FG001|Overall Study|Reason not Specified|141|||
125380619|NCT00368355|451025269|FG000|Overall Study|Adverse Event|1|||
125643294|NCT00027846|451977860|FG002|Overall Study|Entry into another COG therapeutic study|2|||
125643295|NCT00027846|451977858|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
125643296|NCT00027846|451977859|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
125643297|NCT00027846|451977860|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
125643298|NCT01354964|451977861|FG000|Overall Study|Lost to Follow-up|2|||
125643299|NCT01354964|451977862|FG001|Overall Study|Lost to Follow-up|0|||
125643300|NCT01354964|451977861|FG000|Overall Study|IV access issues|1|||
125643301|NCT01354964|451977862|FG001|Overall Study|IV access issues|1|||
125643302|NCT01354964|451977861|FG000|Overall Study|Physician Decision|1|||
125643303|NCT01354964|451977862|FG001|Overall Study|Physician Decision|0|||
125643304|NCT02889861|451977873|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
125643305|NCT01864746|451977874|FG000|Overall Study|Disease recurrence|25|||
125643306|NCT01864746|451977875|FG001|Overall Study|Disease recurrence|40|||
125643307|NCT01864746|451977874|FG000|Overall Study|Second primary invasive nonbreast|2|||
125643308|NCT01864746|451977875|FG001|Overall Study|Second primary invasive nonbreast|3|||
125643309|NCT01864746|451977874|FG000|Overall Study|Death|2|||
125643310|NCT01864746|451977875|FG001|Overall Study|Death|1|||
125643311|NCT01864746|451977874|FG000|Overall Study|Adverse Event|33|||
125643312|NCT01864746|451977875|FG001|Overall Study|Adverse Event|5|||
125643313|NCT01864746|451977874|FG000|Overall Study|Withdrawal by Subject|56|||
125643314|NCT01864746|451977875|FG001|Overall Study|Withdrawal by Subject|41|||
125643315|NCT01864746|451977874|FG000|Overall Study|Physician Decision|5|||
125643316|NCT01864746|451977875|FG001|Overall Study|Physician Decision|6|||
125643317|NCT01005966|451977876|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
125643318|NCT01005966|451977877|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
125643319|NCT01005966|451977878|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
125643320|NCT01005966|451977879|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
125643321|NCT01005966|451977880|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
125643322|NCT01005966|451977876|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
125643323|NCT01005966|451977877|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
125643324|NCT01005966|451977878|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
125643325|NCT01005966|451977879|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
125643326|NCT01005966|451977880|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
125643327|NCT01005966|451977876|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
125643328|NCT01005966|451977877|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
125643329|NCT01005966|451977878|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
125643330|NCT01005966|451977879|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
125643331|NCT01005966|451977880|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
125643332|NCT01005966|451977876|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
125643333|NCT01005966|451977877|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
125643334|NCT01005966|451977878|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
125643335|NCT01005966|451977879|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
125643336|NCT01005966|451977880|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
125643337|NCT01005966|451977876|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125643338|NCT01005966|451977877|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125643339|NCT01005966|451977878|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125643340|NCT01005966|451977879|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
125380620|NCT00368355|451025270|FG001|Overall Study|Adverse Event|0|||
125380621|NCT00368355|451025269|FG000|Overall Study|Death|2|||
125643341|NCT01005966|451977880|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125643342|NCT01005966|451977876|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125643343|NCT01005966|451977877|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125135141|NCT04493684|450118312|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135142|NCT04493684|450118313|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135143|NCT04493684|450118314|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135144|NCT04493684|450118315|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
125135145|NCT04493684|450118316|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
125135146|NCT01963728|450118317|FG000|Overall Study|Study terminated early|0|||
125135147|NCT01963728|450118318|FG001|Overall Study|Study terminated early|1|||
125135148|NCT05152576|450118319|FG000|Overall Study|Lost to Follow-up|3|||
125135149|NCT05152576|450118320|FG001|Overall Study|Lost to Follow-up|0|||
125135150|NCT05152576|450118321|FG002|Overall Study|Lost to Follow-up|0|||
125380622|NCT00368355|451025270|FG001|Overall Study|Death|4|||
125380623|NCT00368355|451025269|FG000|Overall Study|Relapse|6|||
125380624|NCT00368355|451025270|FG001|Overall Study|Relapse|10|||
125380625|NCT00368355|451025269|FG000|Overall Study|Subsequent transplant|0|||
125380626|NCT00368355|451025270|FG001|Overall Study|Subsequent transplant|3|||
125380627|NCT00368355|451025269|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
125380628|NCT00368355|451025270|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
125380629|NCT03358290|451025272|FG000|Overall Study|Study discontinued by Sponsor|0|||
125380630|NCT03358290|451025273|FG001|Overall Study|Study discontinued by Sponsor|1|||
125380631|NCT03358290|451025274|FG002|Overall Study|Study discontinued by Sponsor|1|||
125380632|NCT03358290|451025275|FG003|Overall Study|Study discontinued by Sponsor|0|||
125380633|NCT03358290|451025276|FG004|Overall Study|Study discontinued by Sponsor|0|||
125135151|NCT05152576|450118322|FG003|Overall Study|Lost to Follow-up|1|||
125135152|NCT05152576|450118319|FG000|Overall Study|Withdrawal by Subject|0|||
125380634|NCT03358290|451025272|FG000|Overall Study|Adverse Event|0|||
125380635|NCT03358290|451025273|FG001|Overall Study|Adverse Event|0|||
125380636|NCT03358290|451025274|FG002|Overall Study|Adverse Event|1|||
125380637|NCT03358290|451025275|FG003|Overall Study|Adverse Event|2|||
125380638|NCT03358290|451025276|FG004|Overall Study|Adverse Event|0|||
125380639|NCT03358290|451025272|FG000|Overall Study|Withdrawal by Subject|0|||
125380640|NCT03358290|451025273|FG001|Overall Study|Withdrawal by Subject|0|||
125380641|NCT03358290|451025274|FG002|Overall Study|Withdrawal by Subject|0|||
125380642|NCT03358290|451025275|FG003|Overall Study|Withdrawal by Subject|0|||
125380643|NCT03358290|451025276|FG004|Overall Study|Withdrawal by Subject|1|||
125380644|NCT02999854|451025283|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
125380645|NCT02999854|451025284|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
125380646|NCT02999854|451025283|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
125380647|NCT02999854|451025284|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
125380648|NCT02999854|451025283|FG000|Active Study Phase (up to 18 Months)|Death|7|||
125380649|NCT02999854|451025284|FG001|Active Study Phase (up to 18 Months)|Death|5|||
125380650|NCT02999854|451025283|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
125380651|NCT02999854|451025284|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
125380652|NCT02999854|451025283|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
125380653|NCT02999854|451025284|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
125380654|NCT02999854|451025283|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
125380655|NCT02999854|451025284|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
125380656|NCT02999854|451025283|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
125380657|NCT02999854|451025284|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
125380658|NCT02999854|451025283|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
125380659|NCT02999854|451025284|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
125380660|NCT04140292|451025285|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
125380661|NCT04140292|451025286|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
125380662|NCT00459667|451025287|FG000|Overall Study|Adverse Event|9|||
125380663|NCT00459667|451025288|FG001|Overall Study|Adverse Event|12|||
125380664|NCT00459667|451025289|FG002|Overall Study|Adverse Event|8|||
125380665|NCT00459667|451025287|FG000|Overall Study|Lost to Follow-up|5|||
125380666|NCT00459667|451025288|FG001|Overall Study|Lost to Follow-up|9|||
125380667|NCT00459667|451025289|FG002|Overall Study|Lost to Follow-up|3|||
125380668|NCT00459667|451025287|FG000|Overall Study|Pregnancy|1|||
125380669|NCT00459667|451025288|FG001|Overall Study|Pregnancy|1|||
125643344|NCT01005966|451977878|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
125643345|NCT01005966|451977879|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125643346|NCT01005966|451977880|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125643347|NCT01005966|451977876|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
125643348|NCT01005966|451977877|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
125643349|NCT01005966|451977878|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
125643350|NCT01005966|451977879|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
125643351|NCT01005966|451977880|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
125643352|NCT01005966|451977876|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
125643353|NCT01005966|451977877|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
125643354|NCT01005966|451977878|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
125643355|NCT01005966|451977879|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
125643356|NCT01005966|451977880|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
125643357|NCT01005966|451977876|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
125643358|NCT01005966|451977877|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
125643359|NCT01005966|451977878|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
125643360|NCT01005966|451977879|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
125643361|NCT01005966|451977880|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
125643362|NCT01451203|451977881|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
125643363|NCT01451203|451977882|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
125643364|NCT01451203|451977881|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
125643365|NCT01451203|451977882|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
125643366|NCT01451203|451977881|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
125643367|NCT01451203|451977882|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
125643368|NCT01451203|451977881|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
125643369|NCT01451203|451977882|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
125643370|NCT01451203|451977881|FG000|Double-blind Treatment Period|Adverse Event|6|||
125643371|NCT01451203|451977882|FG001|Double-blind Treatment Period|Adverse Event|9|||
125643372|NCT01451203|451977881|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
125643373|NCT01451203|451977882|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
125643374|NCT01451203|451977881|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
125643375|NCT01451203|451977882|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
125643376|NCT01451203|451977881|FG000|Double-blind Treatment Period|Investigator decision|2|||
125643377|NCT01451203|451977882|FG001|Double-blind Treatment Period|Investigator decision|0|||
125643378|NCT01451203|451977881|FG000|Post-treatment Period|Consent withdrawn|2|||
125643379|NCT01451203|451977882|FG001|Post-treatment Period|Consent withdrawn|4|||
125643380|NCT01451203|451977881|FG000|Post-treatment Period|Lack of Efficacy|12|||
125643381|NCT01451203|451977882|FG001|Post-treatment Period|Lack of Efficacy|28|||
125643382|NCT01451203|451977881|FG000|Post-treatment Period|Adverse Event|0|||
125135153|NCT05152576|450118320|FG001|Overall Study|Withdrawal by Subject|1|||
125135154|NCT05152576|450118321|FG002|Overall Study|Withdrawal by Subject|0|||
125135155|NCT05152576|450118322|FG003|Overall Study|Withdrawal by Subject|1|||
125380670|NCT00459667|451025289|FG002|Overall Study|Pregnancy|1|||
125380671|NCT00459667|451025287|FG000|Overall Study|Protocol Violation|1|||
125380672|NCT00459667|451025288|FG001|Overall Study|Protocol Violation|0|||
125380673|NCT00459667|451025289|FG002|Overall Study|Protocol Violation|0|||
125380674|NCT00459667|451025287|FG000|Overall Study|Withdrawal by Subject|3|||
125380675|NCT00459667|451025288|FG001|Overall Study|Withdrawal by Subject|5|||
125380676|NCT00459667|451025289|FG002|Overall Study|Withdrawal by Subject|5|||
125380677|NCT00459667|451025287|FG000|Overall Study|Other disease modifying treatment|1|||
125380678|NCT00459667|451025288|FG001|Overall Study|Other disease modifying treatment|2|||
125380679|NCT00459667|451025289|FG002|Overall Study|Other disease modifying treatment|1|||
125380680|NCT00459667|451025287|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
125380681|NCT00459667|451025288|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
125380682|NCT00459667|451025289|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
125380683|NCT00459667|451025287|FG000|Overall Study|No treatment administered|6|||
125380684|NCT00459667|451025288|FG001|Overall Study|No treatment administered|3|||
125380685|NCT00459667|451025289|FG002|Overall Study|No treatment administered|1|||
125380686|NCT01013701|451025290|FG000|Overall Study|study prematurely terminated|7|||
125380687|NCT01386554|451025291|FG000|Overall Study|Lost to Follow-up|0|||
125380688|NCT01386554|451025292|FG001|Overall Study|Lost to Follow-up|0|||
125380689|NCT01386554|451025293|FG002|Overall Study|Lost to Follow-up|1|||
125380690|NCT01386554|451025291|FG000|Overall Study|Adverse Event|2|||
125380691|NCT01386554|451025292|FG001|Overall Study|Adverse Event|5|||
125380692|NCT01386554|451025293|FG002|Overall Study|Adverse Event|2|||
125380693|NCT01386554|451025291|FG000|Overall Study|Progressive disease|1|||
125380694|NCT01386554|451025292|FG001|Overall Study|Progressive disease|2|||
125380695|NCT01386554|451025293|FG002|Overall Study|Progressive disease|2|||
125135156|NCT05152576|450118319|FG000|Overall Study|Other|2|||
125135157|NCT05152576|450118320|FG001|Overall Study|Other|0|||
125380696|NCT01386554|451025291|FG000|Overall Study|Administration of live vaccines|0|||
125380697|NCT01386554|451025292|FG001|Overall Study|Administration of live vaccines|1|||
125380698|NCT01386554|451025293|FG002|Overall Study|Administration of live vaccines|0|||
125485445|NCT02240238|451412511|FG008|Phase 2|Withdrawal by Subject|0|||
125135158|NCT05152576|450118321|FG002|Overall Study|Other|0|||
125135159|NCT05152576|450118322|FG003|Overall Study|Other|0|||
125135160|NCT04115293|450120062|FG000|Overall Study|Adverse Event|0|||
125135161|NCT04115293|450120063|FG001|Overall Study|Adverse Event|2|||
125135162|NCT04115293|450120062|FG000|Overall Study|Withdrawal by Subject|2|||
125218711|NCT00972283|450427403|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
125218712|NCT00972283|450427402|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
125218713|NCT00972283|450427403|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
125218714|NCT01868165|450427408|FG000|Overall Study|Withdrawal by Subject|36|||
125218715|NCT01868165|450427408|FG000|Overall Study|Physician Decision|2|||
125218716|NCT01868165|450427408|FG000|Overall Study|Lost to Follow-up|3|||
125218717|NCT01868165|450427408|FG000|Overall Study|Death|4|||
125218718|NCT02282163|450427411|FG000|Overall Study|Protocol Violation|1|||
125218719|NCT01603407|450427412|FG000|Overall Study|Adverse Event|1|||
125218720|NCT01603407|450427413|FG001|Overall Study|Adverse Event|1|||
125218721|NCT01603407|450427414|FG002|Overall Study|Adverse Event|1|||
125218722|NCT01603407|450427412|FG000|Overall Study|Protocol Violation|2|||
125218723|NCT01603407|450427413|FG001|Overall Study|Protocol Violation|2|||
125218724|NCT01603407|450427414|FG002|Overall Study|Protocol Violation|0|||
125218725|NCT01603407|450427412|FG000|Overall Study|Withdrawal by Subject|8|||
125218726|NCT01603407|450427413|FG001|Overall Study|Withdrawal by Subject|5|||
125218727|NCT01603407|450427414|FG002|Overall Study|Withdrawal by Subject|7|||
125218728|NCT01603407|450427412|FG000|Overall Study|Lost to Follow-up|0|||
125218729|NCT01603407|450427413|FG001|Overall Study|Lost to Follow-up|3|||
125218730|NCT01603407|450427414|FG002|Overall Study|Lost to Follow-up|2|||
125218731|NCT02500719|450427415|FG000|Overall Study|Lost to Follow-up|2|||
125218732|NCT02500719|450427416|FG001|Overall Study|Lost to Follow-up|3|||
125218733|NCT02500719|450427415|FG000|Overall Study|Trauma history|1|||
125218734|NCT02500719|450427416|FG001|Overall Study|Trauma history|0|||
125218735|NCT02500719|450427415|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
125218736|NCT02500719|450427416|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
125218737|NCT02500719|450427415|FG000|Overall Study|Did not meet criteria for PTSD|0|||
125218738|NCT02500719|450427416|FG001|Overall Study|Did not meet criteria for PTSD|1|||
125218739|NCT02500719|450427415|FG000|Overall Study|Claustrophobia|0|||
125218740|NCT02500719|450427416|FG001|Overall Study|Claustrophobia|1|||
125218741|NCT02500719|450427415|FG000|Overall Study|History of head trauma|0|||
125218742|NCT02500719|450427416|FG001|Overall Study|History of head trauma|1|||
125218743|NCT01990768|450427417|FG000|Intervention Started|Found to be ineligible|14|||
125218744|NCT01990768|450427418|FG001|Intervention Started|Found to be ineligible|13|||
125218745|NCT01990768|450427419|FG002|Intervention Started|Found to be ineligible|11|||
125218746|NCT01990768|450427417|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
125218747|NCT01990768|450427418|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
125218748|NCT01990768|450427419|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
125135163|NCT04115293|450120063|FG001|Overall Study|Withdrawal by Subject|1|||
125135164|NCT04115293|450120062|FG000|Overall Study|Physician Decision|1|||
125135165|NCT04115293|450120063|FG001|Overall Study|Physician Decision|0|||
125135166|NCT04115293|450120062|FG000|Overall Study|Death|1|||
125135167|NCT04115293|450120063|FG001|Overall Study|Death|1|||
125135168|NCT02057835|450120068|FG000|Overall Study|Withdrawal by Subject|0|||
125135169|NCT02057835|450120069|FG001|Overall Study|Withdrawal by Subject|2|||
125135170|NCT02057835|450120070|FG002|Overall Study|Withdrawal by Subject|0|||
125218749|NCT01990768|450427417|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
125218750|NCT01990768|450427418|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
125218751|NCT01990768|450427419|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
125218752|NCT01990768|450427417|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
125218753|NCT01990768|450427418|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
125218754|NCT01990768|450427419|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
125218755|NCT01990768|450427417|FG000|Intervention Started|Patient care priority|1|||
125218756|NCT01990768|450427418|FG001|Intervention Started|Patient care priority|2|||
125218757|NCT01990768|450427419|FG002|Intervention Started|Patient care priority|3|||
125218758|NCT01990768|450427417|FG000|Intervention Started|IV lost|2|||
125218759|NCT01990768|450427418|FG001|Intervention Started|IV lost|2|||
125218760|NCT01990768|450427419|FG002|Intervention Started|IV lost|2|||
125218761|NCT01990768|450427417|FG000|Intervention Started|Required CPR|1|||
125218762|NCT01990768|450427418|FG001|Intervention Started|Required CPR|1|||
125218763|NCT01990768|450427419|FG002|Intervention Started|Required CPR|0|||
125380699|NCT01386554|451025291|FG000|Overall Study|Investigator discretion|0|||
125380700|NCT01386554|451025292|FG001|Overall Study|Investigator discretion|0|||
125380701|NCT01386554|451025293|FG002|Overall Study|Investigator discretion|1|||
125380702|NCT01386554|451025291|FG000|Overall Study|Reason not collected|0|||
125380703|NCT01386554|451025292|FG001|Overall Study|Reason not collected|1|||
125380704|NCT01386554|451025293|FG002|Overall Study|Reason not collected|0|||
125380705|NCT00001596|451026947|FG000|Overall Study|Death|1|||
125380706|NCT00001596|451026948|FG001|Overall Study|Death|0|||
125380707|NCT00001596|451026947|FG000|Overall Study|Withdrawal by Subject|3|||
125380708|NCT00001596|451026948|FG001|Overall Study|Withdrawal by Subject|1|||
125380709|NCT00001596|451026947|FG000|Overall Study|Study Termination|12|||
125380710|NCT00001596|451026948|FG001|Overall Study|Study Termination|9|||
125380711|NCT00001596|451026947|FG000|Overall Study|Adverse Event|1|||
125380712|NCT00001596|451026948|FG001|Overall Study|Adverse Event|0|||
125380713|NCT00180414|451026954|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
125380714|NCT00180414|451026955|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
125380715|NCT02927080|451026956|FG000|Overall Study|Withdrawal by Subject|0|||
125380716|NCT02927080|451026957|FG001|Overall Study|Withdrawal by Subject|0|||
125380717|NCT02927080|451026958|FG002|Overall Study|Withdrawal by Subject|0|||
125380718|NCT02927080|451026959|FG003|Overall Study|Withdrawal by Subject|0|||
125218764|NCT01990768|450427417|FG000|Intervention Started|Seizure or hx of seizure|0|||
125218765|NCT01990768|450427418|FG001|Intervention Started|Seizure or hx of seizure|0|||
125380719|NCT02927080|451026960|FG004|Overall Study|Withdrawal by Subject|1|||
125380720|NCT02927080|451026961|FG005|Overall Study|Withdrawal by Subject|0|||
125643383|NCT01451203|451977882|FG001|Post-treatment Period|Adverse Event|1|||
125643384|NCT01451203|451977881|FG000|Post-treatment Period|Investigator decision|0|||
125643385|NCT01451203|451977882|FG001|Post-treatment Period|Investigator decision|1|||
125643386|NCT03890731|451977883|FG000|Overall Study|Progressive disease|1|||
125643387|NCT03890731|451977883|FG000|Overall Study|Patient's decision|1|||
125643388|NCT03890731|451977883|FG000|Overall Study|Adverse Event|4|||
125643389|NCT00027027|451977887|FG000|Overall Study|Adverse Event|0|||
125643390|NCT00027027|451977888|FG001|Overall Study|Adverse Event|0|||
125643391|NCT00027027|451977889|FG002|Overall Study|Adverse Event|1|||
125643392|NCT00027027|451977890|FG003|Overall Study|Adverse Event|0|||
125643393|NCT00027027|451977891|FG004|Overall Study|Adverse Event|1|||
125643394|NCT00027027|451977887|FG000|Overall Study|Admitted for Signs of PD|0|||
125643395|NCT00027027|451977888|FG001|Overall Study|Admitted for Signs of PD|0|||
125643396|NCT00027027|451977889|FG002|Overall Study|Admitted for Signs of PD|0|||
125643397|NCT00027027|451977890|FG003|Overall Study|Admitted for Signs of PD|0|||
125643398|NCT00027027|451977891|FG004|Overall Study|Admitted for Signs of PD|1|||
125643399|NCT00027027|451977887|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
125643400|NCT00027027|451977888|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
125643401|NCT00027027|451977889|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
125643402|NCT00027027|451977890|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
125643403|NCT00027027|451977891|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
125643404|NCT00027027|451977887|FG000|Overall Study|PD Requiring Surgery|0|||
125643405|NCT00027027|451977888|FG001|Overall Study|PD Requiring Surgery|0|||
125643406|NCT00027027|451977889|FG002|Overall Study|PD Requiring Surgery|1|||
125643407|NCT00027027|451977890|FG003|Overall Study|PD Requiring Surgery|0|||
125643408|NCT00027027|451977891|FG004|Overall Study|PD Requiring Surgery|0|||
125135171|NCT02057835|450120071|FG003|Overall Study|Withdrawal by Subject|0|||
125135172|NCT02057835|450120072|FG004|Overall Study|Withdrawal by Subject|0|||
125135173|NCT02057835|450120073|FG005|Overall Study|Withdrawal by Subject|0|||
125135174|NCT02057835|450120074|FG006|Overall Study|Withdrawal by Subject|0|||
125135175|NCT02057835|450120075|FG007|Overall Study|Withdrawal by Subject|0|||
125135176|NCT02057835|450120076|FG008|Overall Study|Withdrawal by Subject|0|||
125135177|NCT02057835|450120077|FG009|Overall Study|Withdrawal by Subject|0|||
125135178|NCT00712959|450120081|FG000|Overall Study|Protocol Violation|3|||
125135179|NCT00712959|450120082|FG001|Overall Study|Protocol Violation|1|||
125135180|NCT00712959|450120081|FG000|Overall Study|Lost to Follow-up|13|||
125135181|NCT00712959|450120082|FG001|Overall Study|Lost to Follow-up|2|||
125135182|NCT00712959|450120081|FG000|Overall Study|Withdrawal by Subject|3|||
125135183|NCT00712959|450120082|FG001|Overall Study|Withdrawal by Subject|0|||
125135184|NCT01376037|450120092|FG000|Overall Study|Lost to Follow-up|0|||
125135185|NCT01376037|450120093|FG001|Overall Study|Lost to Follow-up|2|||
125135186|NCT02328040|450120094|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
125135187|NCT02328040|450120095|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
125135188|NCT04278560|450120100|FG000|Overall Study|Adverse Event|1|||
125135189|NCT04278560|450120101|FG001|Overall Study|Adverse Event|2|||
125135190|NCT04278560|450120100|FG000|Overall Study|Withdrawal by Subject|0|||
125135191|NCT04278560|450120101|FG001|Overall Study|Withdrawal by Subject|1|||
125135192|NCT02832063|450120102|FG000|Overall Study|Adverse Event|2|||
125135193|NCT02832063|450120103|FG001|Overall Study|Adverse Event|1|||
125135194|NCT02832063|450120102|FG000|Overall Study|Physician Decision|5|||
125135195|NCT02832063|450120103|FG001|Overall Study|Physician Decision|7|||
125135196|NCT02832063|450120102|FG000|Overall Study|Lost to Follow-up|15|||
125135197|NCT02832063|450120103|FG001|Overall Study|Lost to Follow-up|8|||
125135198|NCT02832063|450120102|FG000|Overall Study|Withdrawal by Subject|10|||
125135199|NCT02832063|450120103|FG001|Overall Study|Withdrawal by Subject|21|||
125135200|NCT02832063|450120102|FG000|Overall Study|Other|2|||
125135201|NCT02832063|450120103|FG001|Overall Study|Other|1|||
125135202|NCT03086460|450120108|FG000|Study Participants|Lost to Follow-up|2|||
125135203|NCT03086460|450120108|FG000|Study Participants|Protocol Violation|1|||
125135204|NCT03086460|450120108|FG000|Study Participants|Withdrawal by Subject|6|||
125135205|NCT03086460|450120108|FG000|Treatment A|Lost to Follow-up|1|||
125135206|NCT03086460|450120108|FG000|Treatment A|Protocol Violation|1|||
125135207|NCT03086460|450120108|FG000|Treatment A|Withdrawal by Subject|2|||
125135208|NCT03086460|450120108|FG000|Treatment C|Withdrawal by Subject|2|||
125135209|NCT03086460|450120108|FG000|Treatment E|Lost to Follow-up|1|||
125135210|NCT03086460|450120108|FG000|Treatment E|Withdrawal by Subject|3|||
125135211|NCT03600805|450120109|FG000|Overall Study|Adverse Event|2|||
125135212|NCT03600805|450120110|FG001|Overall Study|Adverse Event|1|||
125135213|NCT03600805|450120111|FG002|Overall Study|Adverse Event|1|||
125135214|NCT03600805|450120112|FG003|Overall Study|Adverse Event|7|||
125135215|NCT03600805|450120109|FG000|Overall Study|Lack of Efficacy|2|||
125135216|NCT03600805|450120110|FG001|Overall Study|Lack of Efficacy|1|||
125135217|NCT03600805|450120111|FG002|Overall Study|Lack of Efficacy|0|||
125135218|NCT03600805|450120112|FG003|Overall Study|Lack of Efficacy|0|||
125135219|NCT03600805|450120109|FG000|Overall Study|Withdrawal by Subject|1|||
125135220|NCT03600805|450120110|FG001|Overall Study|Withdrawal by Subject|0|||
125135221|NCT03600805|450120111|FG002|Overall Study|Withdrawal by Subject|0|||
125135222|NCT03600805|450120112|FG003|Overall Study|Withdrawal by Subject|1|||
125135223|NCT03600805|450120109|FG000|Overall Study|Other unspecified|14|||
125135224|NCT03600805|450120110|FG001|Overall Study|Other unspecified|6|||
125135225|NCT03600805|450120111|FG002|Overall Study|Other unspecified|7|||
125135226|NCT03600805|450120112|FG003|Overall Study|Other unspecified|11|||
125218766|NCT01990768|450427419|FG002|Intervention Started|Seizure or hx of seizure|2|||
125218767|NCT01990768|450427417|FG000|Intervention Started|Discovered to be pregnant|0|||
125380721|NCT02927080|451026962|FG006|Overall Study|Withdrawal by Subject|1|||
125380722|NCT02927080|451026963|FG007|Overall Study|Withdrawal by Subject|1|||
125380723|NCT02927080|451026964|FG008|Overall Study|Withdrawal by Subject|0|||
125380724|NCT02927080|451026965|FG009|Overall Study|Withdrawal by Subject|2|||
125380725|NCT02927080|451026956|FG000|Overall Study|Willingness to comply with protocol|0|||
125135227|NCT03415308|450120115|FG000|Overall Study|Lost to Follow-up|0|||
125135228|NCT03415308|450120116|FG001|Overall Study|Lost to Follow-up|0|||
125135229|NCT03415308|450120117|FG002|Overall Study|Lost to Follow-up|1|||
125135230|NCT03415308|450120115|FG000|Overall Study|Scheduling Conflicts|0|||
125135231|NCT03415308|450120116|FG001|Overall Study|Scheduling Conflicts|0|||
125135232|NCT03415308|450120117|FG002|Overall Study|Scheduling Conflicts|7|||
125135233|NCT01471353|450120119|FG000|Overall Study|remain on study|3|||
125135234|NCT00836472|450120120|FG000|Washout|Adverse Event|1|||
125135235|NCT00836472|450120121|FG001|Washout|Adverse Event|2|||
125135236|NCT00836472|450120120|FG000|Washout|Withdrawal by Subject|1|||
125218768|NCT01990768|450427418|FG001|Intervention Started|Discovered to be pregnant|1|||
125135237|NCT00836472|450120121|FG001|Washout|Withdrawal by Subject|1|||
125135238|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
125135239|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
125135240|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
125135241|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
125485446|NCT02240238|451412512|FG009|Phase 2|Withdrawal by Subject|1|||
125135242|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135243|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135244|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135245|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135246|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135247|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135248|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135249|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135250|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135251|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
125135252|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
125135253|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
125135254|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
125135255|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
125135256|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135257|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135258|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135259|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135260|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135261|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135262|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135263|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135264|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135265|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
125135266|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
125135267|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135268|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
125135269|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135270|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135271|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135272|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135273|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135274|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135275|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135276|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135277|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135278|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135279|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
125135280|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
125135281|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
125135282|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
125135283|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135284|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135285|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135286|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135287|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135288|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135289|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135290|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135291|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135292|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135293|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
125135294|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
125135295|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135296|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
125135297|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135298|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135299|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135300|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135301|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135302|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135303|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125485447|NCT02240238|451412513|FG010|Phase 2|Withdrawal by Subject|1|||
125135304|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135305|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135306|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135307|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
125135308|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
125135309|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135310|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
125135311|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135312|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135313|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135314|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135315|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135316|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135317|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135318|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135319|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135320|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135321|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
125135322|NCT01695239|450120122|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
125135323|NCT01695239|450120123|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135324|NCT01695239|450120124|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135325|NCT01695239|450120125|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135326|NCT01695239|450120126|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135327|NCT01695239|450120127|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135328|NCT01695239|450120128|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135329|NCT01695239|450120129|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135330|NCT01695239|450120130|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135331|NCT01695239|450120131|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135332|NCT01695239|450120132|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135333|NCT01695239|450120133|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135334|NCT01695239|450120134|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135335|NCT01695239|450120135|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
125135336|NCT01695239|450120122|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125218769|NCT01990768|450427419|FG002|Intervention Started|Discovered to be pregnant|0|||
125218770|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
125218771|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
125218772|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
125485448|NCT02240238|451412514|FG011|Phase 2|Withdrawal by Subject|0|||
125135337|NCT01695239|450120123|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135338|NCT01695239|450120124|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135339|NCT01695239|450120125|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125485449|NCT02240238|451412503|FG000|Phase 2|Physician Decision|0|||
125135340|NCT01695239|450120126|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135341|NCT01695239|450120127|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135342|NCT01695239|450120128|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135343|NCT01695239|450120129|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
125135344|NCT01695239|450120130|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135345|NCT01695239|450120131|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135346|NCT01695239|450120132|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135347|NCT01695239|450120133|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135348|NCT01695239|450120134|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135349|NCT01695239|450120135|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
125135350|NCT01695239|450120122|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135351|NCT01695239|450120123|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135352|NCT01695239|450120124|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135353|NCT01695239|450120125|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135354|NCT01695239|450120126|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135355|NCT01695239|450120127|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135356|NCT01695239|450120128|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135357|NCT01695239|450120129|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
125135358|NCT01695239|450120130|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135359|NCT01695239|450120131|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135360|NCT01695239|450120132|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135361|NCT01695239|450120133|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135362|NCT01695239|450120134|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135363|NCT01695239|450120135|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
125135364|NCT01695239|450120122|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135365|NCT01695239|450120123|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135366|NCT01695239|450120124|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135367|NCT01695239|450120125|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135368|NCT01695239|450120126|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135369|NCT01695239|450120127|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135370|NCT01695239|450120128|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135371|NCT01695239|450120129|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
125135372|NCT01695239|450120130|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135373|NCT01695239|450120131|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135374|NCT01695239|450120132|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135375|NCT01695239|450120133|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135376|NCT01695239|450120134|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125218773|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
125218774|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
125218775|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
125218776|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
125218777|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
125218778|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
125218779|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
125218780|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
125218781|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
125380726|NCT02927080|451026957|FG001|Overall Study|Willingness to comply with protocol|0|||
125380727|NCT02927080|451026958|FG002|Overall Study|Willingness to comply with protocol|0|||
125380728|NCT02927080|451026959|FG003|Overall Study|Willingness to comply with protocol|0|||
125218782|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Death|3|||
125218783|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Death|1|||
125218784|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Death|1|||
125218785|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Discharged|2|||
125218786|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Discharged|1|||
125218787|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Discharged|0|||
125218788|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
125218789|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
125218790|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
125218791|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
125218792|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
125218793|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
125218794|NCT01990768|450427417|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
125218795|NCT01990768|450427418|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
125218796|NCT01990768|450427419|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
125218797|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
125218798|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
125218799|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
125218800|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
125218801|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
125218802|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
125218803|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
125218804|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
125218805|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
125218806|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
125218807|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
125218808|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
125218809|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
125218810|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
125218811|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
125218812|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
125218813|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
125218814|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
125218815|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
125218816|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
125218817|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
125218818|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
125218819|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
125218820|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
125380729|NCT02927080|451026960|FG004|Overall Study|Willingness to comply with protocol|0|||
125643409|NCT00027027|451977887|FG000|Overall Study|Physician Decision Due To PD|2|||
125643410|NCT00027027|451977888|FG001|Overall Study|Physician Decision Due To PD|3|||
125643411|NCT00027027|451977889|FG002|Overall Study|Physician Decision Due To PD|2|||
125643412|NCT00027027|451977890|FG003|Overall Study|Physician Decision Due To PD|3|||
125643413|NCT00027027|451977891|FG004|Overall Study|Physician Decision Due To PD|5|||
125643414|NCT00027027|451977887|FG000|Overall Study|Withdrawal by Subject|0|||
125643415|NCT00027027|451977888|FG001|Overall Study|Withdrawal by Subject|0|||
125643416|NCT00027027|451977889|FG002|Overall Study|Withdrawal by Subject|0|||
125643417|NCT00027027|451977890|FG003|Overall Study|Withdrawal by Subject|0|||
125643418|NCT00027027|451977891|FG004|Overall Study|Withdrawal by Subject|1|||
125643419|NCT02039687|451977897|FG000|Overall Study|Adverse Event|0|||
125643420|NCT02039687|451977898|FG001|Overall Study|Adverse Event|0|||
125643421|NCT02039687|451977899|FG002|Overall Study|Adverse Event|1|||
125643422|NCT02039687|451977900|FG003|Overall Study|Adverse Event|0|||
125643423|NCT02039687|451977897|FG000|Overall Study|Withdrawal by Subject|0|||
125643424|NCT02039687|451977898|FG001|Overall Study|Withdrawal by Subject|1|||
125643425|NCT02039687|451977899|FG002|Overall Study|Withdrawal by Subject|0|||
125643426|NCT02039687|451977900|FG003|Overall Study|Withdrawal by Subject|0|||
125135377|NCT01695239|450120135|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
125135378|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135379|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135380|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135381|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135382|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125643427|NCT02039687|451977897|FG000|Overall Study|treatment assignment could not be confir|0|||
125643428|NCT02039687|451977898|FG001|Overall Study|treatment assignment could not be confir|0|||
125643429|NCT02039687|451977899|FG002|Overall Study|treatment assignment could not be confir|2|||
125643430|NCT02039687|451977900|FG003|Overall Study|treatment assignment could not be confir|0|||
125643431|NCT00303329|451977912|FG000|Overall Study|Adverse Event|7|||
125643432|NCT00303329|451977913|FG001|Overall Study|Adverse Event|14|||
125643433|NCT00303329|451977912|FG000|Overall Study|Abnormal Laboratory Values|0|||
125643434|NCT00303329|451977913|FG001|Overall Study|Abnormal Laboratory Values|1|||
125643435|NCT00303329|451977912|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
125643436|NCT00303329|451977913|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125643437|NCT00303329|451977912|FG000|Overall Study|Condition no longer requires study drug|0|||
125643438|NCT00303329|451977913|FG001|Overall Study|Condition no longer requires study drug|8|||
125643439|NCT00303329|451977912|FG000|Overall Study|Protocol Violation|3|||
125643440|NCT00303329|451977913|FG001|Overall Study|Protocol Violation|0|||
125643441|NCT00303329|451977912|FG000|Overall Study|Withdrawal by Subject|9|||
125643442|NCT00303329|451977913|FG001|Overall Study|Withdrawal by Subject|15|||
125643443|NCT00303329|451977912|FG000|Overall Study|Lost to Follow-up|0|||
125643444|NCT00303329|451977913|FG001|Overall Study|Lost to Follow-up|1|||
125643445|NCT00303329|451977912|FG000|Overall Study|Administrative problems|1|||
125643446|NCT00303329|451977913|FG001|Overall Study|Administrative problems|0|||
125643447|NCT00303329|451977912|FG000|Overall Study|Death|2|||
125643448|NCT00303329|451977913|FG001|Overall Study|Death|12|||
125643449|NCT00303329|451977912|FG000|Overall Study|Stopped at end of core|3|||
125643450|NCT00303329|451977913|FG001|Overall Study|Stopped at end of core|9|||
125643451|NCT00303329|451977912|FG000|Overall Study|Stopped at end of extension 1|1|||
125643452|NCT00303329|451977913|FG001|Overall Study|Stopped at end of extension 1|0|||
125643453|NCT03812224|451977914|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
125643454|NCT03812224|451977915|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
125643455|NCT03812224|451977914|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
125643456|NCT03812224|451977915|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
125643457|NCT03812224|451977914|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
125643458|NCT03812224|451977915|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
125643459|NCT03812224|451977914|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
125643460|NCT03812224|451977915|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
125643461|NCT01641952|451977916|FG000|Overall Study|Lost to Follow-up|28|||
125643462|NCT01641952|451977916|FG000|Overall Study|Adverse Event|6|||
125643463|NCT02500901|451977917|FG000|Overall Study|Disease ProgressionDD|2|||
125643464|NCT00561912|451977918|FG000|Overall Study|ineligible|1|||
125643465|NCT01398176|451977919|FG000|Overall Study|Lost to Follow-up|1|||
125643466|NCT01398176|451977920|FG001|Overall Study|Lost to Follow-up|3|||
125643467|NCT01398176|451977919|FG000|Overall Study|Physician Decision|2|||
125643468|NCT01398176|451977920|FG001|Overall Study|Physician Decision|3|||
125643469|NCT01258738|451977921|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
125643470|NCT01258738|451977922|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
125643471|NCT01258738|451977921|FG000|Double-blind Period|Withdrawal by Subject|2|||
125643472|NCT01258738|451977922|FG001|Double-blind Period|Withdrawal by Subject|2|||
125643473|NCT01258738|451977921|FG000|Double-blind Period|Protocol Violation|1|||
125643474|NCT01258738|451977922|FG001|Double-blind Period|Protocol Violation|1|||
125643475|NCT01258738|451977921|FG000|Double-blind Period|Adverse Event|3|||
125643476|NCT01258738|451977922|FG001|Double-blind Period|Adverse Event|1|||
125643477|NCT01258738|451977921|FG000|Open-label Period|Did not meet inclusion criteria|0|||
125643478|NCT01258738|451977922|FG001|Open-label Period|Did not meet inclusion criteria|1|||
125643479|NCT01258738|451977921|FG000|Open-label Period|Insufficient clinical response|5|||
125135383|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135384|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135385|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135386|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
125135387|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
125135388|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135389|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135390|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135391|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
125135392|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
125135393|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
125135394|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
125135395|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
125135396|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
125135397|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
125380730|NCT02927080|451026961|FG005|Overall Study|Willingness to comply with protocol|0|||
125380731|NCT02927080|451026962|FG006|Overall Study|Willingness to comply with protocol|0|||
125135398|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
125135399|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
125485450|NCT02240238|451412504|FG001|Phase 2|Physician Decision|0|||
125380732|NCT02927080|451026963|FG007|Overall Study|Willingness to comply with protocol|0|||
125135400|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
125135401|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
125135402|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
125135403|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
125135404|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
125135405|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
125135406|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125380733|NCT02927080|451026964|FG008|Overall Study|Willingness to comply with protocol|0|||
125135407|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135408|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135409|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135410|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135411|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135412|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135413|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135414|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
125135415|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
125135416|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135417|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135418|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135419|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
125135420|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
125135421|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
125135422|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
125135423|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
125135424|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
125135425|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
125135426|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
125135427|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
125135428|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
125135429|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
125135430|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
125135431|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
125437236|NCT00192023|451228028|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
125437237|NCT00192023|451228029|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
125437238|NCT00192023|451228028|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
125135432|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
125485451|NCT02240238|451412505|FG002|Phase 2|Physician Decision|0|||
125218821|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
125218822|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
125218823|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
125218824|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
125218825|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
125218826|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
125218827|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
125218828|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
125218829|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
125218830|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
125218831|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
125218832|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
125218833|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
125218834|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
125218835|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
125218836|NCT01990768|450427417|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
125218837|NCT01990768|450427418|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
125218838|NCT01990768|450427419|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
125218839|NCT01990768|450427417|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
125218840|NCT01990768|450427418|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
125218841|NCT01990768|450427419|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
125218842|NCT01990768|450427417|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
125218843|NCT01990768|450427418|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
125218844|NCT01990768|450427419|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
125218845|NCT01990768|450427417|FG000|6-Month Follow-up|No contact information|5|||
125218846|NCT01990768|450427418|FG001|6-Month Follow-up|No contact information|6|||
125218847|NCT01990768|450427419|FG002|6-Month Follow-up|No contact information|5|||
125218848|NCT01990768|450427417|FG000|6-Month Follow-up|Homeless|4|||
125218849|NCT01990768|450427418|FG001|6-Month Follow-up|Homeless|3|||
125218850|NCT01990768|450427419|FG002|6-Month Follow-up|Homeless|6|||
125218851|NCT01990768|450427417|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
125218852|NCT01990768|450427418|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
125218853|NCT01990768|450427419|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
125218854|NCT01990768|450427417|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
125218855|NCT01990768|450427418|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
125218856|NCT01990768|450427419|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
125218857|NCT01990768|450427417|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
125218858|NCT01990768|450427418|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
125218859|NCT01990768|450427419|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
125218860|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
125218861|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
125218862|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
125135433|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
125135434|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135435|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135436|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135437|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135438|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135439|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135440|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135441|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135442|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
125135443|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
125135444|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135445|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135446|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135447|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
125135448|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135449|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135450|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135451|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135452|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125380734|NCT02927080|451026965|FG009|Overall Study|Willingness to comply with protocol|1|||
125380735|NCT02927080|451026956|FG000|Overall Study|Study terminated by Sponsor|0|||
125380736|NCT02927080|451026957|FG001|Overall Study|Study terminated by Sponsor|0|||
125380737|NCT02927080|451026958|FG002|Overall Study|Study terminated by Sponsor|0|||
125380738|NCT02927080|451026959|FG003|Overall Study|Study terminated by Sponsor|0|||
125380739|NCT02927080|451026960|FG004|Overall Study|Study terminated by Sponsor|0|||
125380740|NCT02927080|451026961|FG005|Overall Study|Study terminated by Sponsor|0|||
125380741|NCT02927080|451026962|FG006|Overall Study|Study terminated by Sponsor|6|||
125380742|NCT02927080|451026963|FG007|Overall Study|Study terminated by Sponsor|7|||
125380743|NCT02927080|451026964|FG008|Overall Study|Study terminated by Sponsor|2|||
125380744|NCT02927080|451026965|FG009|Overall Study|Study terminated by Sponsor|3|||
125380745|NCT02927080|451026956|FG000|Overall Study|Adverse Event|0|||
125437239|NCT00192023|451228029|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
125437240|NCT00245856|451228033|FG000|Period Two|Withdrawal by Subject|0|||
125437241|NCT00245856|451228034|FG001|Period Two|Withdrawal by Subject|1|||
125437242|NCT01003184|451228035|FG000|Overall Study|Adverse Event|12|||
125380746|NCT02927080|451026957|FG001|Overall Study|Adverse Event|1|||
125437243|NCT01003184|451228036|FG001|Overall Study|Adverse Event|5|||
125135453|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135454|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135455|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135456|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
125135457|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
125135458|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135459|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135460|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135461|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
125135462|NCT01695239|450120122|FG000|Extension Long-Term Extension Periods|Death|0|||
125135463|NCT01695239|450120123|FG001|Extension Long-Term Extension Periods|Death|0|||
125135464|NCT01695239|450120124|FG002|Extension Long-Term Extension Periods|Death|0|||
125135465|NCT01695239|450120125|FG003|Extension Long-Term Extension Periods|Death|0|||
125135466|NCT01695239|450120126|FG004|Extension Long-Term Extension Periods|Death|0|||
125135467|NCT01695239|450120127|FG005|Extension Long-Term Extension Periods|Death|0|||
125380747|NCT02927080|451026958|FG002|Overall Study|Adverse Event|0|||
125380748|NCT02927080|451026959|FG003|Overall Study|Adverse Event|0|||
125380749|NCT02927080|451026960|FG004|Overall Study|Adverse Event|0|||
125135468|NCT01695239|450120128|FG006|Extension Long-Term Extension Periods|Death|0|||
125135469|NCT01695239|450120129|FG007|Extension Long-Term Extension Periods|Death|0|||
125135470|NCT01695239|450120130|FG008|Extension Long-Term Extension Periods|Death|1|||
125380750|NCT02927080|451026961|FG005|Overall Study|Adverse Event|0|||
125380751|NCT02927080|451026962|FG006|Overall Study|Adverse Event|0|||
125135471|NCT01695239|450120131|FG009|Extension Long-Term Extension Periods|Death|0|||
125380752|NCT02927080|451026963|FG007|Overall Study|Adverse Event|1|||
125380753|NCT02927080|451026964|FG008|Overall Study|Adverse Event|0|||
125218863|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
125218864|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
125218865|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
125218866|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
125380754|NCT02927080|451026965|FG009|Overall Study|Adverse Event|1|||
125380755|NCT02927080|451026956|FG000|Overall Study|Other|0|||
125135472|NCT01695239|450120132|FG010|Extension Long-Term Extension Periods|Death|0|||
125135473|NCT01695239|450120133|FG011|Extension Long-Term Extension Periods|Death|0|||
125135474|NCT01695239|450120134|FG012|Extension Long-Term Extension Periods|Death|0|||
125135475|NCT01695239|450120135|FG013|Extension Long-Term Extension Periods|Death|0|||
125135476|NCT01695239|450120122|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135477|NCT01695239|450120123|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135478|NCT01695239|450120124|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135479|NCT01695239|450120125|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135480|NCT01695239|450120126|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135481|NCT01695239|450120127|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135482|NCT01695239|450120128|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135483|NCT01695239|450120129|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135484|NCT01695239|450120130|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135485|NCT01695239|450120131|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135486|NCT01695239|450120132|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125135487|NCT01695239|450120133|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
125135488|NCT01695239|450120134|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
125135489|NCT01695239|450120135|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
125135490|NCT01695239|450120122|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135491|NCT01695239|450120123|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135492|NCT01695239|450120124|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135493|NCT01695239|450120125|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135494|NCT01695239|450120126|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135495|NCT01695239|450120127|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135496|NCT01695239|450120128|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135497|NCT01695239|450120129|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135498|NCT01695239|450120130|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135499|NCT01695239|450120131|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135500|NCT01695239|450120132|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135501|NCT01695239|450120133|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125135502|NCT01695239|450120134|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
125135503|NCT01695239|450120135|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
125135504|NCT01695239|450120122|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135505|NCT01695239|450120123|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135506|NCT01695239|450120124|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135507|NCT01695239|450120125|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135508|NCT01695239|450120126|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135509|NCT01695239|450120127|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135510|NCT01695239|450120128|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135511|NCT01695239|450120129|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
125380756|NCT02927080|451026957|FG001|Overall Study|Other|0|||
125380757|NCT02927080|451026958|FG002|Overall Study|Other|0|||
125135512|NCT01695239|450120130|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135513|NCT01695239|450120131|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135514|NCT01695239|450120132|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135515|NCT01695239|450120133|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135516|NCT01695239|450120134|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
125135517|NCT01695239|450120135|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
125135518|NCT01695239|450120122|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135519|NCT01695239|450120123|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135520|NCT01695239|450120124|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135521|NCT01695239|450120125|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135522|NCT01695239|450120126|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135523|NCT01695239|450120127|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135524|NCT01695239|450120128|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135525|NCT01695239|450120129|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135526|NCT01695239|450120130|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135527|NCT01695239|450120131|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135528|NCT01695239|450120132|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135529|NCT01695239|450120133|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135530|NCT01695239|450120134|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
125135531|NCT01695239|450120135|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
125135532|NCT03502811|450120137|FG000|Overall Study|Death|157|||
125135533|NCT03502811|450120137|FG000|Overall Study|Withdrawal by Subject|105|||
125135534|NCT03502811|450120137|FG000|Overall Study|Lost to Follow-up|26|||
125135535|NCT03502811|450120137|FG000|Overall Study|No Visits (Missed)|31|||
125135536|NCT01735994|450120138|FG000|Overall Study|Withdrawal by Subject|6|||
125135537|NCT01735994|450120139|FG001|Overall Study|Withdrawal by Subject|4|||
125135538|NCT01735994|450120138|FG000|Overall Study|Injury|2|||
125135539|NCT01735994|450120139|FG001|Overall Study|Injury|0|||
125135540|NCT01735994|450120138|FG000|Overall Study|Kicked off team|5|||
125135541|NCT01735994|450120139|FG001|Overall Study|Kicked off team|0|||
125135542|NCT01735994|450120138|FG000|Overall Study|Lost to Follow-up|50|||
125135543|NCT01735994|450120139|FG001|Overall Study|Lost to Follow-up|62|||
125135544|NCT05239195|450120140|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
125135545|NCT05239195|450120141|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
125135546|NCT03552484|450120144|FG000|Overall Study|Death|6|||
125218867|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
125218868|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
125380758|NCT02927080|451026959|FG003|Overall Study|Other|0|||
125380759|NCT02927080|451026960|FG004|Overall Study|Other|0|||
125380760|NCT02927080|451026961|FG005|Overall Study|Other|0|||
125380761|NCT02927080|451026962|FG006|Overall Study|Other|1|||
125380762|NCT02927080|451026963|FG007|Overall Study|Other|0|||
125380763|NCT02927080|451026964|FG008|Overall Study|Other|1|||
125380764|NCT02927080|451026965|FG009|Overall Study|Other|0|||
125135547|NCT03552484|450120145|FG001|Overall Study|Death|4|||
125135548|NCT03552484|450120144|FG000|Overall Study|Lost to Follow-up|0|||
125135549|NCT03552484|450120145|FG001|Overall Study|Lost to Follow-up|16|||
125135550|NCT02663349|450120154|FG000|Overall Study|Withdrawal by Subject|6|||
125135551|NCT01204294|450120155|FG000|Overall Study|Adverse Event|2|||
125135552|NCT01204294|450120156|FG001|Overall Study|Adverse Event|6|||
125135553|NCT01204294|450120157|FG002|Overall Study|Adverse Event|0|||
125135554|NCT01204294|450120158|FG003|Overall Study|Adverse Event|7|||
125135555|NCT01204294|450120159|FG004|Overall Study|Adverse Event|1|||
125135556|NCT01204294|450120160|FG005|Overall Study|Adverse Event|4|||
125135557|NCT01204294|450120161|FG006|Overall Study|Adverse Event|0|||
125135558|NCT01204294|450120155|FG000|Overall Study|Protocol Violation|1|||
125135559|NCT01204294|450120156|FG001|Overall Study|Protocol Violation|0|||
125135560|NCT01204294|450120157|FG002|Overall Study|Protocol Violation|2|||
125135561|NCT01204294|450120158|FG003|Overall Study|Protocol Violation|1|||
125135562|NCT01204294|450120159|FG004|Overall Study|Protocol Violation|0|||
125135563|NCT01204294|450120160|FG005|Overall Study|Protocol Violation|0|||
125135564|NCT01204294|450120161|FG006|Overall Study|Protocol Violation|0|||
125135565|NCT01204294|450120155|FG000|Overall Study|Withdrawal by Subject|0|||
125135566|NCT01204294|450120156|FG001|Overall Study|Withdrawal by Subject|2|||
125135567|NCT01204294|450120157|FG002|Overall Study|Withdrawal by Subject|2|||
125135568|NCT01204294|450120158|FG003|Overall Study|Withdrawal by Subject|1|||
125135569|NCT01204294|450120159|FG004|Overall Study|Withdrawal by Subject|1|||
125135570|NCT01204294|450120160|FG005|Overall Study|Withdrawal by Subject|1|||
125135571|NCT01204294|450120161|FG006|Overall Study|Withdrawal by Subject|2|||
125135572|NCT01204294|450120155|FG000|Overall Study|Lack of Efficacy|0|||
125135573|NCT01204294|450120156|FG001|Overall Study|Lack of Efficacy|0|||
125135574|NCT01204294|450120157|FG002|Overall Study|Lack of Efficacy|0|||
125135575|NCT01204294|450120158|FG003|Overall Study|Lack of Efficacy|2|||
125135576|NCT01204294|450120159|FG004|Overall Study|Lack of Efficacy|0|||
125135577|NCT01204294|450120160|FG005|Overall Study|Lack of Efficacy|0|||
125135578|NCT01204294|450120161|FG006|Overall Study|Lack of Efficacy|0|||
125135579|NCT01204294|450120155|FG000|Overall Study|Other (house moving)|0|||
125135580|NCT01204294|450120156|FG001|Overall Study|Other (house moving)|0|||
125135581|NCT01204294|450120157|FG002|Overall Study|Other (house moving)|1|||
125135582|NCT01204294|450120158|FG003|Overall Study|Other (house moving)|0|||
125135583|NCT01204294|450120159|FG004|Overall Study|Other (house moving)|0|||
125135584|NCT01204294|450120160|FG005|Overall Study|Other (house moving)|0|||
125135585|NCT01204294|450120161|FG006|Overall Study|Other (house moving)|0|||
125135586|NCT03128723|450120164|FG000|Overall Study|Withdrawal by Subject|2|||
125135587|NCT00673660|450120165|FG000|Overall Study|Lost to Follow-up|107|||
125135588|NCT01383486|450120166|FG000|Overall Study|Lost to Follow-up|10|||
125135589|NCT01383486|450120166|FG000|Overall Study|Incomplete information for analysis|2|||
125135590|NCT01383486|450120166|FG000|Overall Study|Did not take any product|6|||
125135591|NCT01929863|450120176|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
125135592|NCT01929863|450120177|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
125135593|NCT01929863|450120176|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
125135594|NCT01929863|450120177|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
125135595|NCT01929863|450120176|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
125135596|NCT01929863|450120177|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
125135597|NCT00323882|450120178|FG000|Overall Study|Adverse Event|2|||
125135598|NCT00323882|450120179|FG001|Overall Study|Adverse Event|1|||
125135599|NCT00323882|450120180|FG002|Overall Study|Adverse Event|1|||
125135600|NCT00323882|450120181|FG003|Overall Study|Adverse Event|1|||
125135601|NCT00323882|450120182|FG004|Overall Study|Adverse Event|3|||
125135602|NCT00323882|450120178|FG000|Overall Study|Disease Progression|6|||
125135603|NCT00323882|450120179|FG001|Overall Study|Disease Progression|4|||
125135604|NCT00323882|450120180|FG002|Overall Study|Disease Progression|10|||
125135605|NCT00323882|450120181|FG003|Overall Study|Disease Progression|5|||
125135606|NCT00323882|450120182|FG004|Overall Study|Disease Progression|22|||
125135607|NCT00323882|450120178|FG000|Overall Study|Death|0|||
125135608|NCT00323882|450120179|FG001|Overall Study|Death|1|||
125135609|NCT00323882|450120180|FG002|Overall Study|Death|1|||
125135610|NCT00323882|450120181|FG003|Overall Study|Death|0|||
125135611|NCT00323882|450120182|FG004|Overall Study|Death|5|||
125135612|NCT00323882|450120178|FG000|Overall Study|Lost to Follow-up|0|||
125135613|NCT00323882|450120179|FG001|Overall Study|Lost to Follow-up|0|||
125135614|NCT00323882|450120180|FG002|Overall Study|Lost to Follow-up|1|||
125135615|NCT00323882|450120181|FG003|Overall Study|Lost to Follow-up|0|||
125135616|NCT00323882|450120182|FG004|Overall Study|Lost to Follow-up|1|||
125135617|NCT00323882|450120178|FG000|Overall Study|Other|0|||
125135618|NCT00323882|450120179|FG001|Overall Study|Other|0|||
125135619|NCT00323882|450120180|FG002|Overall Study|Other|0|||
125135620|NCT00323882|450120181|FG003|Overall Study|Other|1|||
125135621|NCT00323882|450120182|FG004|Overall Study|Other|1|||
125135622|NCT00830024|450120184|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
125135623|NCT00830024|450120185|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
125135624|NCT01456221|450120186|FG000|Overall Study|Withdrawal by Subject|56|||
125135625|NCT01456221|450120187|FG001|Overall Study|Withdrawal by Subject|49|||
125135626|NCT01456221|450120186|FG000|Overall Study|Lost to Follow-up|1|||
125135627|NCT01456221|450120187|FG001|Overall Study|Lost to Follow-up|4|||
125135628|NCT01456221|450120186|FG000|Overall Study|Received medication|3|||
125135629|NCT01456221|450120187|FG001|Overall Study|Received medication|2|||
125135630|NCT01456221|450120186|FG000|Overall Study|Incomplete data|4|||
125135631|NCT01456221|450120187|FG001|Overall Study|Incomplete data|2|||
125135632|NCT00436163|450120188|FG000|Overall Study|Lost to Follow-up|2|||
125380765|NCT01199289|451026966|FG000|Overall Study|Ineligibility determined|2|||
125380766|NCT01199289|451026967|FG001|Overall Study|Ineligibility determined|1|||
125135633|NCT00436163|450120188|FG000|Overall Study|Adverse Event|1|||
125135634|NCT06647173|450120191|FG000|Overall Study|Lost to Follow-up|24|||
125380767|NCT01199289|451026968|FG002|Overall Study|Ineligibility determined|0|||
125380768|NCT01199289|451026969|FG003|Overall Study|Ineligibility determined|0|||
125380769|NCT01199289|451026966|FG000|Overall Study|Protocol Violation|1|||
125380770|NCT01199289|451026967|FG001|Overall Study|Protocol Violation|0|||
125380771|NCT01199289|451026968|FG002|Overall Study|Protocol Violation|0|||
125380772|NCT01199289|451026969|FG003|Overall Study|Protocol Violation|1|||
125380773|NCT01199289|451026966|FG000|Overall Study|Noncompliance|1|||
125380774|NCT01199289|451026967|FG001|Overall Study|Noncompliance|0|||
125380775|NCT01199289|451026968|FG002|Overall Study|Noncompliance|2|||
125380776|NCT01199289|451026969|FG003|Overall Study|Noncompliance|0|||
125380777|NCT01199289|451026966|FG000|Overall Study|Adverse Event|0|||
125380778|NCT01199289|451026967|FG001|Overall Study|Adverse Event|3|||
125380779|NCT01199289|451026968|FG002|Overall Study|Adverse Event|1|||
125380780|NCT01199289|451026969|FG003|Overall Study|Adverse Event|4|||
125380781|NCT01199289|451026966|FG000|Overall Study|Full consent withdrawn|2|||
125380782|NCT01199289|451026967|FG001|Overall Study|Full consent withdrawn|2|||
125380783|NCT01199289|451026968|FG002|Overall Study|Full consent withdrawn|2|||
125380784|NCT01199289|451026969|FG003|Overall Study|Full consent withdrawn|3|||
125380785|NCT01199289|451026966|FG000|Overall Study|Administrative decision|0|||
125380786|NCT01199289|451026967|FG001|Overall Study|Administrative decision|0|||
125380787|NCT01199289|451026968|FG002|Overall Study|Administrative decision|0|||
125380788|NCT01199289|451026969|FG003|Overall Study|Administrative decision|1|||
125380789|NCT01199289|451026966|FG000|Overall Study|Lost to Follow-up|0|||
125380790|NCT01199289|451026967|FG001|Overall Study|Lost to Follow-up|0|||
125380791|NCT01199289|451026968|FG002|Overall Study|Lost to Follow-up|0|||
125380792|NCT01199289|451026969|FG003|Overall Study|Lost to Follow-up|1|||
125380793|NCT01199289|451026966|FG000|Overall Study|Protocol-specified criteria|3|||
125380794|NCT01199289|451026967|FG001|Overall Study|Protocol-specified criteria|0|||
125380795|NCT01199289|451026968|FG002|Overall Study|Protocol-specified criteria|0|||
125380796|NCT01199289|451026969|FG003|Overall Study|Protocol-specified criteria|1|||
125380797|NCT01199289|451026966|FG000|Overall Study|Pregnancy|0|||
125380798|NCT01199289|451026967|FG001|Overall Study|Pregnancy|1|||
125380799|NCT01199289|451026968|FG002|Overall Study|Pregnancy|0|||
125380800|NCT01199289|451026969|FG003|Overall Study|Pregnancy|1|||
125380801|NCT00127712|451026973|FG000|Overall Study|Adverse Event|3|||
125380802|NCT00127712|451026974|FG001|Overall Study|Adverse Event|0|||
125380803|NCT00127712|451026973|FG000|Overall Study|Lack of GI access to continue|2|||
125380804|NCT00127712|451026974|FG001|Overall Study|Lack of GI access to continue|0|||
125380805|NCT02642614|451026975|FG000|Overall Study|Adverse Event|1|||
125380806|NCT02642614|451026976|FG001|Overall Study|Adverse Event|1|||
125380807|NCT02642614|451026977|FG002|Overall Study|Adverse Event|2|||
125380808|NCT02642614|451026978|FG003|Overall Study|Adverse Event|2|||
125380809|NCT02642614|451026975|FG000|Overall Study|Lost to Follow-up|1|||
125380810|NCT02642614|451026976|FG001|Overall Study|Lost to Follow-up|0|||
125380811|NCT02642614|451026977|FG002|Overall Study|Lost to Follow-up|0|||
125380812|NCT02642614|451026978|FG003|Overall Study|Lost to Follow-up|0|||
125380813|NCT02642614|451026975|FG000|Overall Study|Withdrawal by Subject|1|||
125380814|NCT02642614|451026976|FG001|Overall Study|Withdrawal by Subject|1|||
125380815|NCT02642614|451026977|FG002|Overall Study|Withdrawal by Subject|0|||
125380816|NCT02642614|451026978|FG003|Overall Study|Withdrawal by Subject|0|||
125380817|NCT04067544|451026979|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
125380818|NCT01320085|451026980|FG000|Overall Study|Disease Progression|26|||
125380819|NCT01320085|451026981|FG001|Overall Study|Disease Progression|93|||
125380820|NCT01320085|451026982|FG002|Overall Study|Disease Progression|17|||
125380821|NCT01320085|451026980|FG000|Overall Study|Adverse Event|12|||
125380822|NCT01320085|451026981|FG001|Overall Study|Adverse Event|20|||
125380823|NCT01320085|451026982|FG002|Overall Study|Adverse Event|5|||
125380824|NCT01320085|451026980|FG000|Overall Study|Withdrawal by Subject|2|||
125380825|NCT01320085|451026981|FG001|Overall Study|Withdrawal by Subject|4|||
125380826|NCT01320085|451026982|FG002|Overall Study|Withdrawal by Subject|1|||
125380827|NCT01320085|451026980|FG000|Overall Study|Protocol Deviation|1|||
125380828|NCT01320085|451026981|FG001|Overall Study|Protocol Deviation|0|||
125380829|NCT01320085|451026982|FG002|Overall Study|Protocol Deviation|1|||
125380830|NCT01320085|451026980|FG000|Overall Study|Administrative problems|0|||
125380831|NCT01320085|451026981|FG001|Overall Study|Administrative problems|0|||
125380832|NCT01320085|451026982|FG002|Overall Study|Administrative problems|1|||
125380833|NCT03316131|451026983|FG000|Treatment Period 2|Protocol deviation|1|||
125380834|NCT03316131|451026984|FG001|Treatment Period 2|Protocol deviation|0|||
125380835|NCT02282020|451026990|FG000|Overall Study|Objective Disease Progression|128|||
125380836|NCT02282020|451026991|FG001|Overall Study|Objective Disease Progression|30|||
125380837|NCT02282020|451026990|FG000|Overall Study|Adverse Event|18|||
125380838|NCT02282020|451026991|FG001|Overall Study|Adverse Event|15|||
125380839|NCT02282020|451026990|FG000|Overall Study|Withdrawal by Subject|7|||
125380840|NCT02282020|451026991|FG001|Overall Study|Withdrawal by Subject|10|||
125380841|NCT02282020|451026990|FG000|Overall Study|Miscellaneous|5|||
125380842|NCT02282020|451026991|FG001|Overall Study|Miscellaneous|19|||
125380843|NCT02282020|451026990|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
125380844|NCT02282020|451026991|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
125380845|NCT02282020|451026990|FG000|Overall Study|Developed Discontinuation Criteria|0|||
125380846|NCT02282020|451026991|FG001|Overall Study|Developed Discontinuation Criteria|2|||
125380847|NCT02282020|451026990|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
125380848|NCT02282020|451026991|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
125380849|NCT00100815|451026992|FG000|Overall Study|Progression|24|||
125380850|NCT00100815|451026992|FG000|Overall Study|Adverse Event|18|||
125380851|NCT00100815|451026992|FG000|Overall Study|Death|4|||
125218869|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
125380852|NCT00100815|451026992|FG000|Overall Study|Other|3|||
125380853|NCT01647282|451026993|FG000|Overall Study|Physician Decision|7|||
125380854|NCT01647282|451026994|FG001|Overall Study|Physician Decision|5|||
125380855|NCT00460031|451026995|FG000|Overall Study|Adverse Event|5|||
125380856|NCT00460031|451026995|FG000|Overall Study|Withdrawal by Subject|5|||
125380857|NCT00460031|451026995|FG000|Overall Study|Death|1|||
125380858|NCT02772081|451026996|FG000|Overall Study|Physician Decision|1|||
125380859|NCT02772081|451026997|FG001|Overall Study|Physician Decision|1|||
125380860|NCT02772081|451026996|FG000|Overall Study|Death|1|||
125380861|NCT02772081|451026997|FG001|Overall Study|Death|1|||
125380862|NCT01291173|451027003|FG000|Overall Study|Adverse Event|0|||
125380863|NCT01291173|451027004|FG001|Overall Study|Adverse Event|3|||
125380864|NCT01291173|451027005|FG002|Overall Study|Adverse Event|1|||
125380865|NCT01291173|451027006|FG003|Overall Study|Adverse Event|3|||
125380866|NCT01291173|451027003|FG000|Overall Study|Protocol Violation|7|||
125380867|NCT01291173|451027004|FG001|Overall Study|Protocol Violation|2|||
125380868|NCT01291173|451027005|FG002|Overall Study|Protocol Violation|2|||
125380869|NCT01291173|451027006|FG003|Overall Study|Protocol Violation|5|||
125380870|NCT01291173|451027003|FG000|Overall Study|Withdrawal by Subject|6|||
125380871|NCT01291173|451027004|FG001|Overall Study|Withdrawal by Subject|4|||
125380872|NCT01291173|451027005|FG002|Overall Study|Withdrawal by Subject|4|||
125380873|NCT01291173|451027006|FG003|Overall Study|Withdrawal by Subject|2|||
125380874|NCT01291173|451027003|FG000|Overall Study|Lost to Follow-up|4|||
125380875|NCT01291173|451027004|FG001|Overall Study|Lost to Follow-up|6|||
125380876|NCT01291173|451027005|FG002|Overall Study|Lost to Follow-up|3|||
125380877|NCT01291173|451027006|FG003|Overall Study|Lost to Follow-up|2|||
125380878|NCT01291173|451027003|FG000|Overall Study|Unable to meet visit schedule|0|||
125380879|NCT01291173|451027004|FG001|Overall Study|Unable to meet visit schedule|0|||
125380880|NCT01291173|451027005|FG002|Overall Study|Unable to meet visit schedule|1|||
125380881|NCT01291173|451027006|FG003|Overall Study|Unable to meet visit schedule|0|||
125380882|NCT01291173|451027003|FG000|Overall Study|Lack of compliance|0|||
125380883|NCT01291173|451027004|FG001|Overall Study|Lack of compliance|0|||
125380884|NCT01291173|451027005|FG002|Overall Study|Lack of compliance|0|||
125380885|NCT01291173|451027006|FG003|Overall Study|Lack of compliance|1|||
125380886|NCT01291173|451027003|FG000|Overall Study|Subject was unblinded|0|||
125380887|NCT01291173|451027004|FG001|Overall Study|Subject was unblinded|0|||
125380888|NCT01291173|451027005|FG002|Overall Study|Subject was unblinded|1|||
125380889|NCT01291173|451027006|FG003|Overall Study|Subject was unblinded|0|||
125380890|NCT01291173|451027003|FG000|Overall Study|Excluded therapy|0|||
125380891|NCT01291173|451027004|FG001|Overall Study|Excluded therapy|0|||
125380892|NCT01291173|451027005|FG002|Overall Study|Excluded therapy|1|||
125380893|NCT01291173|451027006|FG003|Overall Study|Excluded therapy|0|||
125380894|NCT00390858|451027007|FG000|Overall Study|Adverse Event|6|||
125380895|NCT00390858|451027008|FG001|Overall Study|Adverse Event|2|||
125380896|NCT00390858|451027007|FG000|Overall Study|Lack of Efficacy|0|||
125218870|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
125218871|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
125218872|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
125218873|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
125218874|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
125218875|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
125218876|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
125218877|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
125218878|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
125218879|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
125218880|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
125218881|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
125218882|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
125218883|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
125218884|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
125218885|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
125218886|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
125218887|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
125218888|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
125380897|NCT00390858|451027008|FG001|Overall Study|Lack of Efficacy|1|||
125380898|NCT00390858|451027007|FG000|Overall Study|Withdrawal by Subject|3|||
125380899|NCT00390858|451027008|FG001|Overall Study|Withdrawal by Subject|4|||
125380900|NCT01113801|451027009|FG000|Overall Study|Adverse Event|4|||
125380901|NCT01113801|451027010|FG001|Overall Study|Adverse Event|0|||
125380902|NCT01113801|451027011|FG002|Overall Study|Adverse Event|2|||
125380903|NCT01113801|451027012|FG003|Overall Study|Adverse Event|6|||
125380904|NCT01113801|451027009|FG000|Overall Study|Death|4|||
125380905|NCT01113801|451027010|FG001|Overall Study|Death|5|||
125380906|NCT01113801|451027011|FG002|Overall Study|Death|3|||
125437244|NCT01003184|451228035|FG000|Overall Study|Lost to Follow-up|1|||
125380907|NCT01113801|451027012|FG003|Overall Study|Death|4|||
125380908|NCT01113801|451027009|FG000|Overall Study|Protocol Violation|0|||
125380909|NCT01113801|451027010|FG001|Overall Study|Protocol Violation|1|||
125380910|NCT01113801|451027011|FG002|Overall Study|Protocol Violation|0|||
125380911|NCT01113801|451027012|FG003|Overall Study|Protocol Violation|0|||
125380912|NCT01113801|451027009|FG000|Overall Study|Withdrawal by Subject|9|||
125380913|NCT01113801|451027010|FG001|Overall Study|Withdrawal by Subject|7|||
125380914|NCT01113801|451027011|FG002|Overall Study|Withdrawal by Subject|7|||
125380915|NCT01113801|451027012|FG003|Overall Study|Withdrawal by Subject|8|||
125380916|NCT01113801|451027009|FG000|Overall Study|Physician Decision|2|||
125380917|NCT01113801|451027010|FG001|Overall Study|Physician Decision|2|||
125380918|NCT01113801|451027011|FG002|Overall Study|Physician Decision|3|||
125380919|NCT01113801|451027012|FG003|Overall Study|Physician Decision|3|||
125380920|NCT01113801|451027009|FG000|Overall Study|Sponsor Decision|15|||
125380921|NCT01113801|451027010|FG001|Overall Study|Sponsor Decision|21|||
125380922|NCT01113801|451027011|FG002|Overall Study|Sponsor Decision|20|||
125135635|NCT02530905|450120192|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
125135636|NCT02530905|450120193|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
125135637|NCT02530905|450120194|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
125135638|NCT01473953|450120197|FG000|Overall Study|Other|1|||
125135639|NCT01473953|450120198|FG001|Overall Study|Other|0|||
125135640|NCT01473953|450120199|FG002|Overall Study|Other|0|||
125135641|NCT01473953|450120200|FG003|Overall Study|Other|0|||
125135642|NCT01473953|450120201|FG004|Overall Study|Other|0|||
125135643|NCT03100344|450120202|FG000|Overall Study|Adverse Event|0|||
125135644|NCT03100344|450120203|FG001|Overall Study|Adverse Event|3|||
125135645|NCT03100344|450120204|FG002|Overall Study|Adverse Event|2|||
125135646|NCT03100344|450120205|FG003|Overall Study|Adverse Event|3|||
125135647|NCT03100344|450120202|FG000|Overall Study|Lack of Efficacy|2|||
125135648|NCT03100344|450120203|FG001|Overall Study|Lack of Efficacy|0|||
125135649|NCT03100344|450120204|FG002|Overall Study|Lack of Efficacy|0|||
125135650|NCT03100344|450120205|FG003|Overall Study|Lack of Efficacy|0|||
125135651|NCT03100344|450120202|FG000|Overall Study|Protocol Violation|1|||
125135652|NCT03100344|450120203|FG001|Overall Study|Protocol Violation|0|||
125135653|NCT03100344|450120204|FG002|Overall Study|Protocol Violation|0|||
125135654|NCT03100344|450120205|FG003|Overall Study|Protocol Violation|0|||
125135655|NCT03100344|450120202|FG000|Overall Study|Withdrawal by Subject|10|||
125135656|NCT03100344|450120203|FG001|Overall Study|Withdrawal by Subject|7|||
125135657|NCT03100344|450120204|FG002|Overall Study|Withdrawal by Subject|4|||
125135658|NCT03100344|450120205|FG003|Overall Study|Withdrawal by Subject|8|||
125135659|NCT03100344|450120202|FG000|Overall Study|Lost to Follow-up|1|||
125135660|NCT03100344|450120203|FG001|Overall Study|Lost to Follow-up|1|||
125135661|NCT03100344|450120204|FG002|Overall Study|Lost to Follow-up|1|||
125135662|NCT03100344|450120205|FG003|Overall Study|Lost to Follow-up|1|||
125135663|NCT02358538|450120206|FG000|Through Week 26|Adverse Event|0|||
125135664|NCT02358538|450120207|FG001|Through Week 26|Adverse Event|1|||
125135665|NCT02358538|450120208|FG002|Through Week 26|Adverse Event|1|||
125135666|NCT02358538|450120209|FG003|Through Week 26|Adverse Event|2|||
125135667|NCT02358538|450120206|FG000|Through Week 26|Lack of Efficacy|1|||
125135668|NCT02358538|450120207|FG001|Through Week 26|Lack of Efficacy|1|||
125135669|NCT02358538|450120208|FG002|Through Week 26|Lack of Efficacy|3|||
125135670|NCT02358538|450120209|FG003|Through Week 26|Lack of Efficacy|3|||
125135671|NCT02358538|450120206|FG000|Through Week 26|Withdrawal by Subject|1|||
125135672|NCT02358538|450120207|FG001|Through Week 26|Withdrawal by Subject|0|||
125135673|NCT02358538|450120208|FG002|Through Week 26|Withdrawal by Subject|0|||
125135674|NCT02358538|450120209|FG003|Through Week 26|Withdrawal by Subject|0|||
125135675|NCT02358538|450120206|FG000|Through Week 26|Non-Compliance|0|||
125135676|NCT02358538|450120207|FG001|Through Week 26|Non-Compliance|0|||
125135677|NCT02358538|450120208|FG002|Through Week 26|Non-Compliance|1|||
125135678|NCT02358538|450120209|FG003|Through Week 26|Non-Compliance|0|||
125135679|NCT02358538|450120206|FG000|Through Week 26|Family did not see benefit from IP|1|||
125135680|NCT02358538|450120207|FG001|Through Week 26|Family did not see benefit from IP|0|||
125135681|NCT02358538|450120208|FG002|Through Week 26|Family did not see benefit from IP|0|||
125135682|NCT02358538|450120209|FG003|Through Week 26|Family did not see benefit from IP|0|||
125135683|NCT02358538|450120206|FG000|52 Week Extension Period|Lack of Efficacy|0|||
125135684|NCT02358538|450120207|FG001|52 Week Extension Period|Lack of Efficacy|0|||
125135685|NCT02358538|450120208|FG002|52 Week Extension Period|Lack of Efficacy|2|||
125135686|NCT02358538|450120209|FG003|52 Week Extension Period|Lack of Efficacy|4|||
125135687|NCT01494532|450120212|FG000|Overall Study|Adverse Event|4|||
125135688|NCT01494532|450120213|FG001|Overall Study|Adverse Event|1|||
125135689|NCT01494532|450120214|FG002|Overall Study|Adverse Event|8|||
125135690|NCT01494532|450120215|FG003|Overall Study|Adverse Event|6|||
125135691|NCT01494532|450120216|FG004|Overall Study|Adverse Event|5|||
125218889|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
125380923|NCT01113801|451027012|FG003|Overall Study|Sponsor Decision|15|||
125380924|NCT01113801|451027009|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
125380925|NCT01113801|451027010|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
125380926|NCT01113801|451027011|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
125380927|NCT01113801|451027012|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
125380928|NCT02728895|451027013|FG000|Overall Study|Other|1|||
125380929|NCT02728895|451027014|FG001|Overall Study|Other|2|||
125380930|NCT02728895|451027013|FG000|Overall Study|Withdrawal by Subject|0|||
125380931|NCT02728895|451027014|FG001|Overall Study|Withdrawal by Subject|3|||
125380932|NCT01949051|451027019|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
125380933|NCT01949051|451027020|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
125380934|NCT01949051|451027021|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
125380935|NCT01949051|451027022|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
125380936|NCT01949051|451027023|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
125380937|NCT01949051|451027024|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
125380938|NCT01949051|451027019|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
125380939|NCT01949051|451027020|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125380940|NCT01949051|451027021|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125380941|NCT01949051|451027022|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125380942|NCT01949051|451027023|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125380943|NCT01949051|451027024|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
125380944|NCT01949051|451027019|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
125380945|NCT01949051|451027020|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
125380946|NCT01949051|451027021|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
125380947|NCT01949051|451027022|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
125380948|NCT01949051|451027023|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
125380949|NCT01949051|451027024|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
125380950|NCT01949051|451027019|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
125380951|NCT01949051|451027020|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
125380952|NCT01949051|451027021|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
125380953|NCT01949051|451027022|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
125380954|NCT01949051|451027023|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
125380955|NCT01949051|451027024|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
125380956|NCT01949051|451027019|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
125380957|NCT01949051|451027020|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
125380958|NCT01949051|451027021|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
125437245|NCT01003184|451228036|FG001|Overall Study|Lost to Follow-up|0|||
125380959|NCT01949051|451027022|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
125380960|NCT01949051|451027023|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
125380961|NCT01949051|451027024|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
125380962|NCT01782859|451027025|FG000|Overall Study|Protocol Violation|6|||
125380963|NCT01782859|451027026|FG001|Overall Study|Protocol Violation|6|||
125380964|NCT01782859|451027025|FG000|Overall Study|Withdrawal by Subject|0|||
125380965|NCT01782859|451027026|FG001|Overall Study|Withdrawal by Subject|1|||
125380966|NCT02611778|451027029|FG000|Overall Study|Withdrawal by Subject|2|||
125380967|NCT02611778|451027030|FG001|Overall Study|Withdrawal by Subject|8|||
125380968|NCT02611778|451027029|FG000|Overall Study|Adverse Event|1|||
125380969|NCT02611778|451027030|FG001|Overall Study|Adverse Event|2|||
125380970|NCT02611778|451027029|FG000|Overall Study|Death|2|||
125380971|NCT02611778|451027030|FG001|Overall Study|Death|1|||
125380972|NCT02611778|451027029|FG000|Overall Study|Protocol Violation|1|||
125380973|NCT02611778|451027030|FG001|Overall Study|Protocol Violation|0|||
125380974|NCT02611778|451027029|FG000|Overall Study|Lost to Follow-up|3|||
125380975|NCT02611778|451027030|FG001|Overall Study|Lost to Follow-up|1|||
125380976|NCT02611778|451027029|FG000|Overall Study|Need for alternative treatment|1|||
125380977|NCT02611778|451027030|FG001|Overall Study|Need for alternative treatment|0|||
125380978|NCT02611778|451027029|FG000|Overall Study|Other Reason|2|||
125380979|NCT02611778|451027030|FG001|Overall Study|Other Reason|1|||
125380980|NCT00770289|451027033|FG000|Overall Study|Other|6|||
125380981|NCT00495170|451027034|FG000|Overall Study|Lost to Follow-up|9|||
125380982|NCT00495170|451027034|FG000|Overall Study|Withdrawal by Subject|3|||
125380983|NCT00495170|451027034|FG000|Overall Study|Inappropriate staging|8|||
125380984|NCT01408914|451027035|FG000|Overall Study|Could not complete tx in protocol period|5|||
125380985|NCT01408914|451027036|FG001|Overall Study|Could not complete tx in protocol period|5|||
125218890|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
125218891|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
125380986|NCT01408914|451027037|FG002|Overall Study|Could not complete tx in protocol period|6|||
125380987|NCT01408914|451027035|FG000|Overall Study|Lost to Follow-up|4|||
125218892|NCT03538691|450427420|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
125380988|NCT01408914|451027036|FG001|Overall Study|Lost to Follow-up|1|||
125380989|NCT01408914|451027037|FG002|Overall Study|Lost to Follow-up|2|||
125218893|NCT03538691|450427421|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
125218894|NCT03538691|450427422|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
125218895|NCT03538691|450427423|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
125218896|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
125218897|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
125218898|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
125380990|NCT01408914|451027035|FG000|Overall Study|Physician Decision|1|||
125380991|NCT01408914|451027036|FG001|Overall Study|Physician Decision|1|||
125380992|NCT01408914|451027037|FG002|Overall Study|Physician Decision|0|||
125380993|NCT01408914|451027035|FG000|Overall Study|Withdrawal by Subject|1|||
125380994|NCT01408914|451027036|FG001|Overall Study|Withdrawal by Subject|0|||
125380995|NCT01408914|451027037|FG002|Overall Study|Withdrawal by Subject|1|||
125380996|NCT01408914|451027035|FG000|Overall Study|Moved out of study jurisdiction|1|||
125380997|NCT01408914|451027036|FG001|Overall Study|Moved out of study jurisdiction|1|||
125380998|NCT01408914|451027037|FG002|Overall Study|Moved out of study jurisdiction|0|||
125380999|NCT01408914|451027035|FG000|Overall Study|Late exclusion|0|||
125381000|NCT01408914|451027036|FG001|Overall Study|Late exclusion|3|||
125381001|NCT01408914|451027037|FG002|Overall Study|Late exclusion|3|||
125381002|NCT01408914|451027035|FG000|Overall Study|Change in local TB/HIV norms|0|||
125135692|NCT01494532|450120217|FG005|Overall Study|Adverse Event|0|||
125135693|NCT01494532|450120212|FG000|Overall Study|Lack of Efficacy|0|||
125135694|NCT01494532|450120213|FG001|Overall Study|Lack of Efficacy|0|||
125381003|NCT01408914|451027036|FG001|Overall Study|Change in local TB/HIV norms|1|||
125135695|NCT01494532|450120214|FG002|Overall Study|Lack of Efficacy|0|||
125135696|NCT01494532|450120215|FG003|Overall Study|Lack of Efficacy|0|||
125135697|NCT01494532|450120216|FG004|Overall Study|Lack of Efficacy|2|||
125135698|NCT01494532|450120217|FG005|Overall Study|Lack of Efficacy|0|||
125135699|NCT01494532|450120212|FG000|Overall Study|Protocol deviation|2|||
125135700|NCT01494532|450120213|FG001|Overall Study|Protocol deviation|1|||
125135701|NCT01494532|450120214|FG002|Overall Study|Protocol deviation|3|||
125135702|NCT01494532|450120215|FG003|Overall Study|Protocol deviation|2|||
125135703|NCT01494532|450120216|FG004|Overall Study|Protocol deviation|3|||
125135704|NCT01494532|450120217|FG005|Overall Study|Protocol deviation|0|||
125135705|NCT01494532|450120212|FG000|Overall Study|Protocol-defined stopping criteria|0|||
125135706|NCT01494532|450120213|FG001|Overall Study|Protocol-defined stopping criteria|0|||
125135707|NCT01494532|450120214|FG002|Overall Study|Protocol-defined stopping criteria|1|||
125135708|NCT01494532|450120215|FG003|Overall Study|Protocol-defined stopping criteria|0|||
125135709|NCT01494532|450120216|FG004|Overall Study|Protocol-defined stopping criteria|0|||
125135710|NCT01494532|450120217|FG005|Overall Study|Protocol-defined stopping criteria|0|||
125135711|NCT01494532|450120212|FG000|Overall Study|Lost to Follow-up|1|||
125135712|NCT01494532|450120213|FG001|Overall Study|Lost to Follow-up|0|||
125135713|NCT01494532|450120214|FG002|Overall Study|Lost to Follow-up|0|||
125135714|NCT01494532|450120215|FG003|Overall Study|Lost to Follow-up|2|||
125135715|NCT01494532|450120216|FG004|Overall Study|Lost to Follow-up|0|||
125135716|NCT01494532|450120217|FG005|Overall Study|Lost to Follow-up|0|||
125135717|NCT01494532|450120212|FG000|Overall Study|Physician Decision|0|||
125135718|NCT01494532|450120213|FG001|Overall Study|Physician Decision|1|||
125135719|NCT01494532|450120214|FG002|Overall Study|Physician Decision|1|||
125135720|NCT01494532|450120215|FG003|Overall Study|Physician Decision|2|||
125135721|NCT01494532|450120216|FG004|Overall Study|Physician Decision|0|||
125135722|NCT01494532|450120217|FG005|Overall Study|Physician Decision|0|||
125135723|NCT01494532|450120212|FG000|Overall Study|Withdrawal by Subject|3|||
125135724|NCT01494532|450120213|FG001|Overall Study|Withdrawal by Subject|1|||
125437246|NCT01003184|451228035|FG000|Overall Study|Loss of glucose control|1|||
125437247|NCT01003184|451228036|FG001|Overall Study|Loss of glucose control|1|||
125437248|NCT01003184|451228035|FG000|Overall Study|Protocol Violation|3|||
125437249|NCT01003184|451228036|FG001|Overall Study|Protocol Violation|0|||
125135725|NCT01494532|450120214|FG002|Overall Study|Withdrawal by Subject|4|||
125135726|NCT01494532|450120215|FG003|Overall Study|Withdrawal by Subject|3|||
125135727|NCT01494532|450120216|FG004|Overall Study|Withdrawal by Subject|2|||
125135728|NCT01494532|450120217|FG005|Overall Study|Withdrawal by Subject|0|||
125135729|NCT00834717|450121669|FG000|First Intervention|Adverse Event|1|||
125135730|NCT00834717|450121670|FG001|First Intervention|Adverse Event|0|||
125135731|NCT00834717|450121669|FG000|First Intervention|Withdrawal by Subject|0|||
125135732|NCT00834717|450121670|FG001|First Intervention|Withdrawal by Subject|1|||
125135733|NCT02222818|450121671|FG000|Period 1|Eligibility criteria not met|0|||
125135734|NCT02222818|450121672|FG001|Period 1|Eligibility criteria not met|3|||
125135735|NCT01660243|450121673|FG000|Overall Study|Adverse Event|1|||
125135736|NCT01660243|450121674|FG001|Overall Study|Adverse Event|0|||
125135737|NCT01660243|450121675|FG002|Overall Study|Adverse Event|1|||
125135738|NCT01660243|450121676|FG003|Overall Study|Adverse Event|0|||
125135739|NCT01660243|450121673|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
125135740|NCT01660243|450121674|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
125135741|NCT01660243|450121675|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
125135742|NCT01660243|450121676|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
125135743|NCT01660243|450121673|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
125135744|NCT01660243|450121674|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
125135745|NCT01660243|450121675|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
125135746|NCT01660243|450121676|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
125135747|NCT01660243|450121673|FG000|Overall Study|Randomization error|0|||
125135748|NCT01660243|450121674|FG001|Overall Study|Randomization error|0|||
125135749|NCT01660243|450121675|FG002|Overall Study|Randomization error|0|||
125135750|NCT01660243|450121676|FG003|Overall Study|Randomization error|1|||
125135751|NCT03025087|450121677|FG000|Overall Study|Physician Decision|3|||
125135752|NCT03025087|450121678|FG001|Overall Study|Physician Decision|3|||
125135753|NCT03025087|450121679|FG002|Overall Study|Physician Decision|0|||
125135754|NCT03025087|450121680|FG003|Overall Study|Physician Decision|0|||
125135755|NCT03025087|450121681|FG004|Overall Study|Physician Decision|0|||
125135756|NCT03025087|450121677|FG000|Overall Study|Withdrawal by Subject|1|||
125135757|NCT03025087|450121678|FG001|Overall Study|Withdrawal by Subject|1|||
125135758|NCT03025087|450121679|FG002|Overall Study|Withdrawal by Subject|0|||
125135759|NCT03025087|450121680|FG003|Overall Study|Withdrawal by Subject|0|||
125218899|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
125218900|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
125218901|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
125218902|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
125218903|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
125218904|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
125218905|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
125135760|NCT03025087|450121681|FG004|Overall Study|Withdrawal by Subject|0|||
125135761|NCT03025087|450121677|FG000|Overall Study|Unable to complete MRI|2|||
125135762|NCT03025087|450121678|FG001|Overall Study|Unable to complete MRI|2|||
125135763|NCT03025087|450121679|FG002|Overall Study|Unable to complete MRI|0|||
125135764|NCT03025087|450121680|FG003|Overall Study|Unable to complete MRI|0|||
125135765|NCT03025087|450121681|FG004|Overall Study|Unable to complete MRI|0|||
125135766|NCT00508651|450121684|FG000|Overall Study|Lost to Follow-up|3|||
125135767|NCT00508651|450121685|FG001|Overall Study|Lost to Follow-up|1|||
125135768|NCT00508651|450121684|FG000|Overall Study|Withdrawal by Subject|1|||
125135769|NCT00508651|450121685|FG001|Overall Study|Withdrawal by Subject|1|||
125135770|NCT05710718|450121692|FG000|Overall Study|Withdrawal by Subject|5|||
125135771|NCT05710718|450121693|FG001|Overall Study|Withdrawal by Subject|1|||
125135772|NCT05710718|450121692|FG000|Overall Study|Lost to Follow-up|0|||
125135773|NCT05710718|450121693|FG001|Overall Study|Lost to Follow-up|1|||
125381004|NCT01408914|451027037|FG002|Overall Study|Change in local TB/HIV norms|1|||
125381005|NCT00330616|451027038|FG000|Overall Study|Adverse Event|13|||
125381006|NCT00330616|451027038|FG000|Overall Study|Lack of Efficacy|1|||
125135774|NCT05710718|450121692|FG000|Overall Study|Death|0|||
125135775|NCT05710718|450121693|FG001|Overall Study|Death|1|||
125135776|NCT06381102|450121694|FG000|Washout 5 Days|Withdrawal by Subject|0|||
125135777|NCT06381102|450121695|FG001|Washout 5 Days|Withdrawal by Subject|2|||
125437250|NCT01003184|451228035|FG000|Overall Study|Withdrawal by Subject|1|||
125437251|NCT01003184|451228036|FG001|Overall Study|Withdrawal by Subject|6|||
125437252|NCT01003184|451228035|FG000|Overall Study|Physician Decision|1|||
125437253|NCT01003184|451228036|FG001|Overall Study|Physician Decision|0|||
125437254|NCT01719224|451228037|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
125135778|NCT01319383|450121696|FG000|Overall Study|No ex vivo or in vivo response|4|||
125135779|NCT01319383|450121697|FG001|Overall Study|No ex vivo or in vivo response|0|||
125135780|NCT01319383|450121696|FG000|Overall Study|Physician Decision|3|||
125135781|NCT01319383|450121697|FG001|Overall Study|Physician Decision|0|||
125135782|NCT01319383|450121696|FG000|Overall Study|Lack of Efficacy|5|||
125135783|NCT01319383|450121697|FG001|Overall Study|Lack of Efficacy|9|||
125135784|NCT01319383|450121696|FG000|Overall Study|No in vivo response to interval doses|0|||
125135785|NCT01319383|450121697|FG001|Overall Study|No in vivo response to interval doses|1|||
125135786|NCT01987765|450121698|FG000|Overall Study|Protocol Violation|65|||
125135787|NCT01987765|450121698|FG000|Overall Study|Lost to Follow-up|37|||
125135788|NCT00772603|450121699|FG000|Overall Study|Withdrawal by Subject|11|||
125135789|NCT00772603|450121700|FG001|Overall Study|Withdrawal by Subject|10|||
125135790|NCT00772603|450121701|FG002|Overall Study|Withdrawal by Subject|6|||
125135791|NCT00772603|450121699|FG000|Overall Study|Adverse Event|37|||
125135792|NCT00772603|450121700|FG001|Overall Study|Adverse Event|18|||
125135793|NCT00772603|450121701|FG002|Overall Study|Adverse Event|10|||
125135794|NCT00772603|450121699|FG000|Overall Study|Subject Non-compliance|1|||
125135795|NCT00772603|450121700|FG001|Overall Study|Subject Non-compliance|6|||
125135796|NCT00772603|450121701|FG002|Overall Study|Subject Non-compliance|4|||
125135797|NCT00772603|450121699|FG000|Overall Study|Protocol Violation|0|||
125135798|NCT00772603|450121700|FG001|Overall Study|Protocol Violation|1|||
125135799|NCT00772603|450121701|FG002|Overall Study|Protocol Violation|1|||
125135800|NCT00772603|450121699|FG000|Overall Study|Lost to Follow-up|1|||
125135801|NCT00772603|450121700|FG001|Overall Study|Lost to Follow-up|5|||
125135802|NCT00772603|450121701|FG002|Overall Study|Lost to Follow-up|2|||
125135803|NCT00772603|450121699|FG000|Overall Study|Physician Decision|0|||
125135804|NCT00772603|450121700|FG001|Overall Study|Physician Decision|0|||
125135805|NCT00772603|450121701|FG002|Overall Study|Physician Decision|1|||
125135806|NCT00772603|450121699|FG000|Overall Study|Other|2|||
125135807|NCT00772603|450121700|FG001|Overall Study|Other|0|||
125135808|NCT00772603|450121701|FG002|Overall Study|Other|2|||
125135809|NCT01528696|450121712|FG000|Overall Study|See detailed description|18|||
125135810|NCT01528696|450121713|FG001|Overall Study|See detailed description|19|||
125135811|NCT01056484|450121714|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
125135812|NCT01056484|450121715|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
125135813|NCT01056484|450121714|FG000|Randomized Controlled Trial|Physician Decision|1|||
125135814|NCT01056484|450121715|FG001|Randomized Controlled Trial|Physician Decision|0|||
125135815|NCT01056484|450121714|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
125135816|NCT01056484|450121715|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
125135817|NCT00446966|450121718|FG000|Overall Study|Lost to Follow-up|10|||
125135818|NCT00446966|450121719|FG001|Overall Study|Lost to Follow-up|7|||
125135819|NCT01564394|450121722|FG000|Overall Study|Withdrawal by Subject|6|||
125135820|NCT01564394|450121723|FG001|Overall Study|Withdrawal by Subject|10|||
125135821|NCT00859521|450121724|FG000|Washout|Withdrawal by Subject|0|||
125135822|NCT00859521|450121725|FG001|Washout|Withdrawal by Subject|1|||
125135823|NCT02888756|450121726|FG000|Analytical Treatment Interruption|Physician Decision|10|||
125135824|NCT02888756|450121727|FG001|Analytical Treatment Interruption|Physician Decision|6|||
125135825|NCT02888756|450121728|FG002|Analytical Treatment Interruption|Physician Decision|5|||
125135826|NCT01547286|450121736|FG000|Overall Study|Did not meet all eligibility criteria|1|||
125135827|NCT01547286|450121736|FG000|Overall Study|Physician Decision|1|||
125135828|NCT00488774|450121739|FG000|Overall Study|Withdrawal of consent|2|||
125135829|NCT00488774|450121740|FG001|Overall Study|Withdrawal of consent|2|||
125135830|NCT00488774|450121741|FG002|Overall Study|Withdrawal of consent|2|||
125135831|NCT00488774|450121742|FG003|Overall Study|Withdrawal of consent|0|||
125135832|NCT00488774|450121739|FG000|Overall Study|Other|6|||
125135833|NCT00488774|450121740|FG001|Overall Study|Other|3|||
125135834|NCT00488774|450121741|FG002|Overall Study|Other|2|||
125135835|NCT00488774|450121742|FG003|Overall Study|Other|2|||
125135836|NCT00488774|450121739|FG000|Overall Study|Lost to Follow-up|0|||
125135837|NCT00488774|450121740|FG001|Overall Study|Lost to Follow-up|0|||
125135838|NCT00488774|450121741|FG002|Overall Study|Lost to Follow-up|1|||
125135839|NCT00488774|450121742|FG003|Overall Study|Lost to Follow-up|1|||
125135840|NCT02682238|450121743|FG000|Overall Study|Lost to Follow-up|0|||
125135841|NCT02682238|450121744|FG001|Overall Study|Lost to Follow-up|2|||
125135842|NCT02682238|450121743|FG000|Overall Study|Withdrawal by Subject|1|||
125135843|NCT02682238|450121744|FG001|Overall Study|Withdrawal by Subject|0|||
125135844|NCT02682238|450121743|FG000|Overall Study|Adverse Event|1|||
125135845|NCT02682238|450121744|FG001|Overall Study|Adverse Event|0|||
125135846|NCT02682238|450121743|FG000|Overall Study|Non-compliance with Study Drug|1|||
125135847|NCT02682238|450121744|FG001|Overall Study|Non-compliance with Study Drug|0|||
125135848|NCT02682238|450121743|FG000|Overall Study|Non-compliance with Protocol|0|||
125135849|NCT02682238|450121744|FG001|Overall Study|Non-compliance with Protocol|2|||
125135850|NCT00075478|450121745|FG000|Overall Study|not eligible|1|||
125135851|NCT00075478|450121746|FG001|Overall Study|not eligible|0|||
125135852|NCT00075478|450121745|FG000|Overall Study|Physician Decision|0|||
125381007|NCT00330616|451027038|FG000|Overall Study|Lost to Follow-up|2|||
125381008|NCT00330616|451027038|FG000|Overall Study|Withdrawal by Subject|4|||
125381009|NCT00330616|451027038|FG000|Overall Study|Other|1|||
125381010|NCT00811473|451027043|FG000|Overall Study|Adverse Event|3|||
125218906|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
125218907|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
125218908|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
125218909|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
125218910|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
125218911|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
125218912|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
125218913|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
125218914|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
125218915|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
125218916|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
125218917|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
125218918|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
125218919|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
125218920|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
125218921|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
125218922|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
125218923|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
125218924|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
125218925|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
125381011|NCT00811473|451027044|FG001|Overall Study|Adverse Event|12|||
125381012|NCT00811473|451027043|FG000|Overall Study|Lost to Follow-up|5|||
125381013|NCT00811473|451027044|FG001|Overall Study|Lost to Follow-up|1|||
125218926|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
125218927|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
125218928|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
125218929|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
125218930|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
125218931|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
125218932|NCT03538691|450427420|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
125218933|NCT03538691|450427421|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
125381014|NCT00811473|451027043|FG000|Overall Study|Withdrawal by Subject|2|||
125381015|NCT00811473|451027044|FG001|Overall Study|Withdrawal by Subject|4|||
125218934|NCT03538691|450427422|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
125381016|NCT00811473|451027043|FG000|Overall Study|Severe non-compliance to protocol|2|||
125381017|NCT00811473|451027044|FG001|Overall Study|Severe non-compliance to protocol|4|||
125218935|NCT03538691|450427423|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
125381018|NCT00811473|451027043|FG000|Overall Study|Lack of therapeutic response|4|||
125381019|NCT00811473|451027044|FG001|Overall Study|Lack of therapeutic response|1|||
125381020|NCT00811473|451027043|FG000|Overall Study|Condition under investigation worsened|1|||
125381021|NCT00811473|451027044|FG001|Overall Study|Condition under investigation worsened|3|||
125135853|NCT00075478|450121746|FG001|Overall Study|Physician Decision|1|||
125381022|NCT00811473|451027043|FG000|Overall Study|Other 2|4|||
125381023|NCT00811473|451027044|FG001|Overall Study|Other 2|1|||
125135854|NCT02075463|450121748|FG000|Overall Study|Adverse Event|3|||
125381024|NCT00811473|451027043|FG000|Overall Study|Incorrect Enrollment|1|||
125135855|NCT02075463|450121748|FG000|Overall Study|Par. reached stopping criteria|4|||
125135856|NCT02075463|450121748|FG000|Overall Study|Withdrawal by Subject|1|||
125135857|NCT00245063|450121750|FG000|Overall Study|Adverse Event|6|||
125135858|NCT00245063|450121751|FG001|Overall Study|Adverse Event|5|||
125135859|NCT00245063|450121750|FG000|Overall Study|Death|1|||
125381025|NCT00811473|451027044|FG001|Overall Study|Incorrect Enrollment|0|||
125381026|NCT00811473|451027043|FG000|Overall Study|Safety Reasons|1|||
125135860|NCT00245063|450121751|FG001|Overall Study|Death|0|||
125135861|NCT05099380|450121753|FG000|Overall Study|Subject enrolled in error|1|||
125135862|NCT05099380|450121754|FG001|Overall Study|Subject enrolled in error|0|||
125381027|NCT00811473|451027044|FG001|Overall Study|Safety Reasons|0|||
125381028|NCT01585194|451027048|FG000|Overall Study|Withdrawal by Subject|1|||
125381029|NCT01585194|451027048|FG000|Overall Study|Physician Decision|2|||
125381030|NCT01585194|451027048|FG000|Overall Study|Lack of insurance|1|||
125381031|NCT00993291|451027049|FG000|Overall Study|Withdrawal by Subject|1|||
125135863|NCT05099380|450121753|FG000|Overall Study|Study Procedure|1|||
125135864|NCT05099380|450121754|FG001|Overall Study|Study Procedure|0|||
125135865|NCT05099380|450121753|FG000|Overall Study|Protocol Violation|1|||
125135866|NCT05099380|450121754|FG001|Overall Study|Protocol Violation|0|||
125135867|NCT05099380|450121753|FG000|Overall Study|Adverse Event|1|||
125135868|NCT05099380|450121754|FG001|Overall Study|Adverse Event|1|||
125135869|NCT05099380|450121753|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
125135870|NCT05099380|450121754|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
125135871|NCT00392665|450121755|FG000|Overall Study|Death|16|||
125135872|NCT00392665|450121756|FG001|Overall Study|Death|14|||
125135873|NCT00392665|450121755|FG000|Overall Study|Lost to Follow-up|1|||
125135874|NCT00392665|450121756|FG001|Overall Study|Lost to Follow-up|1|||
125135875|NCT03276754|450121757|FG000|Overall Study|Withdrawal of informed consent|4|||
125135876|NCT03276754|450121757|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
125135877|NCT03276754|450121757|FG000|Overall Study|Lost to Follow-up|27|||
125135878|NCT03276754|450121757|FG000|Overall Study|No data reported at Month 24|31|||
125135879|NCT03276754|450121757|FG000|Overall Study|Death|39|||
125135880|NCT02294786|450121760|FG000|Overall Study|Withdrawal by Subject|0|||
125135881|NCT02294786|450121761|FG001|Overall Study|Withdrawal by Subject|1|||
125135882|NCT02294786|450121760|FG000|Overall Study|Physician Decision|6|||
125135883|NCT02294786|450121761|FG001|Overall Study|Physician Decision|7|||
125135884|NCT02294786|450121760|FG000|Overall Study|Lost to Follow-up|1|||
125135885|NCT02294786|450121761|FG001|Overall Study|Lost to Follow-up|2|||
125135886|NCT02294786|450121760|FG000|Overall Study|Protocol Violation|1|||
125135887|NCT02294786|450121761|FG001|Overall Study|Protocol Violation|0|||
125135888|NCT02294786|450121760|FG000|Overall Study|Adverse Event|1|||
125135889|NCT02294786|450121761|FG001|Overall Study|Adverse Event|1|||
125135890|NCT02294786|450121760|FG000|Overall Study|Death|2|||
125135891|NCT02294786|450121761|FG001|Overall Study|Death|3|||
125437255|NCT01719224|451228038|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
125437256|NCT02912468|451228043|FG000|Overall Study|Adverse Event|3|||
125437257|NCT02912468|451228044|FG001|Overall Study|Adverse Event|2|||
125437258|NCT02912468|451228043|FG000|Overall Study|Withdrawal by Subject|6|||
125135892|NCT01778010|450121762|FG000|Overall Study|Withdrawal by Subject|2|||
125135893|NCT01778010|450121762|FG000|Overall Study|abnormal ECG before meds|1|||
125135894|NCT01778010|450121762|FG000|Overall Study|Arrested|1|||
125135895|NCT01778010|450121762|FG000|Overall Study|rash while on placebo|1|||
125381032|NCT02049957|451027052|FG000|Overall Study|Progressive Disease|5|||
125135896|NCT00927069|450121764|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
125135897|NCT00927069|450121765|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
125135898|NCT00927069|450121766|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
125135899|NCT00927069|450121767|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
125135900|NCT00927069|450121764|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
125135901|NCT00927069|450121765|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
125135902|NCT00927069|450121766|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
125218936|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
125381033|NCT02049957|451027053|FG001|Overall Study|Progressive Disease|4|||
125381034|NCT02049957|451027054|FG002|Overall Study|Progressive Disease|2|||
125381035|NCT02049957|451027055|FG003|Overall Study|Progressive Disease|2|||
125381036|NCT02049957|451027056|FG004|Overall Study|Progressive Disease|6|||
125381037|NCT02049957|451027057|FG005|Overall Study|Progressive Disease|35|||
125381038|NCT02049957|451027058|FG006|Overall Study|Progressive Disease|7|||
125381039|NCT02049957|451027059|FG007|Overall Study|Progressive Disease|26|||
125135903|NCT00927069|450121767|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
125135904|NCT00927069|450121764|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
125135905|NCT00927069|450121765|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
125135906|NCT00927069|450121766|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
125135907|NCT00927069|450121767|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
125135908|NCT00927069|450121764|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
125135909|NCT00927069|450121765|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
125135910|NCT00927069|450121766|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
125218937|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
125381040|NCT02049957|451027060|FG008|Overall Study|Progressive Disease|6|||
125218938|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
125381041|NCT02049957|451027052|FG000|Overall Study|Adverse Event|1|||
125135911|NCT00927069|450121767|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
125135912|NCT00927069|450121764|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
125135913|NCT00927069|450121765|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
125135914|NCT00927069|450121766|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
125135915|NCT00927069|450121767|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
125135916|NCT02558491|450121768|FG000|First Invention|Withdrawal by Subject|3|||
125135917|NCT02558491|450121769|FG001|First Invention|Withdrawal by Subject|1|||
125381042|NCT02049957|451027053|FG001|Overall Study|Adverse Event|1|||
125381043|NCT02049957|451027054|FG002|Overall Study|Adverse Event|1|||
125381044|NCT02049957|451027055|FG003|Overall Study|Adverse Event|0|||
125381045|NCT02049957|451027056|FG004|Overall Study|Adverse Event|0|||
125381046|NCT02049957|451027057|FG005|Overall Study|Adverse Event|5|||
125381047|NCT02049957|451027058|FG006|Overall Study|Adverse Event|0|||
125381048|NCT02049957|451027059|FG007|Overall Study|Adverse Event|6|||
125381049|NCT02049957|451027060|FG008|Overall Study|Adverse Event|1|||
125381050|NCT02049957|451027052|FG000|Overall Study|Study Terminated by Sponsor|0|||
125381051|NCT02049957|451027053|FG001|Overall Study|Study Terminated by Sponsor|1|||
125381052|NCT02049957|451027054|FG002|Overall Study|Study Terminated by Sponsor|0|||
125437259|NCT02912468|451228044|FG001|Overall Study|Withdrawal by Subject|2|||
125218939|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
125381053|NCT02049957|451027055|FG003|Overall Study|Study Terminated by Sponsor|0|||
125437260|NCT02912468|451228043|FG000|Overall Study|Randomized and not treated|0|||
125437261|NCT02912468|451228044|FG001|Overall Study|Randomized and not treated|1|||
125135918|NCT02558491|450121768|FG000|First Invention|Data collection issues|1|||
125135919|NCT02558491|450121769|FG001|First Invention|Data collection issues|0|||
125135920|NCT02558491|450121768|FG000|First Invention|Stopping criteria|0|||
125135921|NCT02558491|450121769|FG001|First Invention|Stopping criteria|1|||
125135922|NCT02558491|450121768|FG000|First Invention|Changed parameters during trial|1|||
125135923|NCT02558491|450121769|FG001|First Invention|Changed parameters during trial|0|||
125135924|NCT02558491|450121768|FG000|Second Intervention|Withdrawal by Subject|1|||
125135925|NCT02558491|450121769|FG001|Second Intervention|Withdrawal by Subject|0|||
125381054|NCT02049957|451027056|FG004|Overall Study|Study Terminated by Sponsor|0|||
125381055|NCT02049957|451027057|FG005|Overall Study|Study Terminated by Sponsor|0|||
125381056|NCT02049957|451027058|FG006|Overall Study|Study Terminated by Sponsor|1|||
125437262|NCT03853317|451228045|FG000|Overall Study|Progressive Disease|5|||
125437263|NCT03853317|451228045|FG000|Overall Study|Adverse Event|1|||
125437264|NCT03853317|451228045|FG000|Overall Study|Death|1|||
125135926|NCT02558491|450121768|FG000|Second Intervention|Stopping Criteria|1|||
125135927|NCT02558491|450121769|FG001|Second Intervention|Stopping Criteria|0|||
125135928|NCT00834431|450121770|FG000|First Intervention|Adverse Event|0|||
125437265|NCT03853317|451228045|FG000|Overall Study|other event|2|||
125437266|NCT01320735|451228046|FG000|Overall Study|Adverse Event|3|||
125437267|NCT01320735|451228046|FG000|Overall Study|Withdrawal by Subject|3|||
125437268|NCT01320735|451228046|FG000|Overall Study|Lost to Follow-up|13|||
125437269|NCT01320735|451228046|FG000|Overall Study|Administrative Reason|6|||
125437270|NCT01320735|451228046|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
125135929|NCT00834431|450121771|FG001|First Intervention|Adverse Event|1|||
125135930|NCT00834431|450121770|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
125135931|NCT00834431|450121771|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
125135932|NCT00835263|450121774|FG000|Second Intervention|Adverse Event|1|||
125135933|NCT00835263|450121775|FG001|Second Intervention|Adverse Event|0|||
125135934|NCT03249454|450121776|FG000|Overall Study|Withdrawal by Subject|0|||
125135935|NCT03249454|450121777|FG001|Overall Study|Withdrawal by Subject|0|||
125135936|NCT03249454|450121778|FG002|Overall Study|Withdrawal by Subject|0|||
125135937|NCT03249454|450121779|FG003|Overall Study|Withdrawal by Subject|0|||
125135938|NCT03249454|450121780|FG004|Overall Study|Withdrawal by Subject|0|||
125135939|NCT03249454|450121781|FG005|Overall Study|Withdrawal by Subject|0|||
125135940|NCT03249454|450121782|FG006|Overall Study|Withdrawal by Subject|0|||
125135941|NCT03249454|450121783|FG007|Overall Study|Withdrawal by Subject|0|||
125135942|NCT03249454|450121784|FG008|Overall Study|Withdrawal by Subject|0|||
125135943|NCT03249454|450121785|FG009|Overall Study|Withdrawal by Subject|1|||
125135944|NCT03249454|450121786|FG010|Overall Study|Withdrawal by Subject|1|||
125135945|NCT01913405|450121787|FG000|Overall Study|Withdrawal by Subject|1|||
125135946|NCT01913405|450121787|FG000|Overall Study|Adverse Event|1|||
125135947|NCT01020474|450121790|FG000|Overall Study|Adverse Event|4|||
125135948|NCT01020474|450121791|FG001|Overall Study|Adverse Event|4|||
125135949|NCT01020474|450121790|FG000|Overall Study|Protocol Violation|0|||
125135950|NCT01020474|450121791|FG001|Overall Study|Protocol Violation|2|||
125135951|NCT01020474|450121790|FG000|Overall Study|Withdrawal by Subject|5|||
125135952|NCT01020474|450121791|FG001|Overall Study|Withdrawal by Subject|7|||
125135953|NCT01020474|450121790|FG000|Overall Study|Other Reasons|1|||
125135954|NCT01020474|450121791|FG001|Overall Study|Other Reasons|1|||
125135955|NCT01020474|450121790|FG000|Overall Study|Insufficient Clinical Response|0|||
125135956|NCT01020474|450121791|FG001|Overall Study|Insufficient Clinical Response|3|||
125135957|NCT03987191|450121792|FG000|Overall Study|COVID-19 related research disruption|0|||
125135958|NCT03987191|450121793|FG001|Overall Study|COVID-19 related research disruption|2|||
125135959|NCT03261167|450121794|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
125135960|NCT03261167|450121795|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
125643480|NCT01258738|451977922|FG001|Open-label Period|Insufficient clinical response|3|||
125643481|NCT01258738|451977921|FG000|Open-label Period|Lost to Follow-up|0|||
125643482|NCT01258738|451977922|FG001|Open-label Period|Lost to Follow-up|2|||
125643483|NCT01258738|451977921|FG000|Open-label Period|Withdrawal by Subject|5|||
125643484|NCT01258738|451977922|FG001|Open-label Period|Withdrawal by Subject|6|||
125643485|NCT01258738|451977921|FG000|Open-label Period|Protocol Violation|2|||
125643486|NCT01258738|451977922|FG001|Open-label Period|Protocol Violation|2|||
125643487|NCT01258738|451977921|FG000|Open-label Period|Adverse Event|4|||
125643488|NCT01258738|451977922|FG001|Open-label Period|Adverse Event|5|||
125643489|NCT01258738|451977921|FG000|Open-label Period|Other Reasons|0|||
125643490|NCT01258738|451977922|FG001|Open-label Period|Other Reasons|1|||
125643491|NCT01258738|451977921|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
125643492|NCT01258738|451977922|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
125643493|NCT00689611|451977923|FG000|Overall Study|Death|6|||
125643494|NCT00689611|451977924|FG001|Overall Study|Death|9|||
125643495|NCT00689611|451977923|FG000|Overall Study|Withdrawal by Subject|8|||
125643496|NCT00689611|451977924|FG001|Overall Study|Withdrawal by Subject|9|||
125643497|NCT00689611|451977923|FG000|Overall Study|Lost to Follow-up|27|||
125643498|NCT00689611|451977924|FG001|Overall Study|Lost to Follow-up|28|||
125643499|NCT00568399|451977925|FG000|Overall Study|Death|2|||
125643500|NCT00568399|451977925|FG000|Overall Study|Adverse Event|5|||
125643501|NCT00568399|451977925|FG000|Overall Study|Withdrawal by Subject|8|||
125643502|NCT00783263|451977926|FG000|Overall Study|Adverse Event|3|||
125643503|NCT00783263|451977927|FG001|Overall Study|Adverse Event|0|||
125643504|NCT00783263|451977928|FG002|Overall Study|Adverse Event|2|||
125643505|NCT00783263|451977929|FG003|Overall Study|Adverse Event|1|||
125643506|NCT00783263|451977926|FG000|Overall Study|Lost to Follow-up|1|||
125643507|NCT00783263|451977927|FG001|Overall Study|Lost to Follow-up|1|||
125643508|NCT00783263|451977928|FG002|Overall Study|Lost to Follow-up|0|||
125643509|NCT00783263|451977929|FG003|Overall Study|Lost to Follow-up|0|||
125381057|NCT02049957|451027059|FG007|Overall Study|Study Terminated by Sponsor|0|||
125643510|NCT00783263|451977926|FG000|Overall Study|Withdrawal by Subject|0|||
125643511|NCT00783263|451977927|FG001|Overall Study|Withdrawal by Subject|1|||
125218940|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
125218941|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
125218942|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
125218943|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
125218944|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
125381058|NCT02049957|451027060|FG008|Overall Study|Study Terminated by Sponsor|0|||
125381059|NCT02049957|451027052|FG000|Overall Study|Withdrawal by Subject|0|||
125381060|NCT02049957|451027053|FG001|Overall Study|Withdrawal by Subject|0|||
125381061|NCT02049957|451027054|FG002|Overall Study|Withdrawal by Subject|0|||
125381062|NCT02049957|451027055|FG003|Overall Study|Withdrawal by Subject|1|||
125381063|NCT02049957|451027056|FG004|Overall Study|Withdrawal by Subject|0|||
125381064|NCT02049957|451027057|FG005|Overall Study|Withdrawal by Subject|2|||
125381065|NCT02049957|451027058|FG006|Overall Study|Withdrawal by Subject|0|||
125381066|NCT02049957|451027059|FG007|Overall Study|Withdrawal by Subject|3|||
125381067|NCT02049957|451027060|FG008|Overall Study|Withdrawal by Subject|1|||
125381068|NCT02049957|451027052|FG000|Overall Study|Physician Decision|0|||
125381069|NCT02049957|451027053|FG001|Overall Study|Physician Decision|0|||
125381070|NCT02049957|451027054|FG002|Overall Study|Physician Decision|0|||
125381071|NCT02049957|451027055|FG003|Overall Study|Physician Decision|0|||
125381072|NCT02049957|451027056|FG004|Overall Study|Physician Decision|0|||
125381073|NCT02049957|451027057|FG005|Overall Study|Physician Decision|1|||
125381074|NCT02049957|451027058|FG006|Overall Study|Physician Decision|0|||
125381075|NCT02049957|451027059|FG007|Overall Study|Physician Decision|0|||
125381076|NCT02049957|451027060|FG008|Overall Study|Physician Decision|0|||
125381077|NCT03557151|451027061|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
125381078|NCT03557151|451027062|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
125381079|NCT03557151|451027061|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
125381080|NCT03557151|451027062|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
125381081|NCT03557151|451027061|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
125381082|NCT03557151|451027062|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
125381083|NCT01414075|451027063|FG000|Overall Study|Adverse Event|1|||
125381084|NCT01414075|451027064|FG001|Overall Study|Adverse Event|0|||
125381085|NCT01414075|451027065|FG002|Overall Study|Adverse Event|1|||
125381086|NCT01414075|451027066|FG003|Overall Study|Adverse Event|0|||
125381087|NCT01414075|451027063|FG000|Overall Study|Death|1|||
125381088|NCT01414075|451027064|FG001|Overall Study|Death|0|||
125381089|NCT01414075|451027065|FG002|Overall Study|Death|0|||
125381090|NCT01414075|451027066|FG003|Overall Study|Death|1|||
125437271|NCT01320735|451228046|FG000|Overall Study|Protocol Violation|1|||
125218945|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
125381091|NCT01414075|451027063|FG000|Overall Study|Withdrawal by Subject|0|||
125381092|NCT01414075|451027064|FG001|Overall Study|Withdrawal by Subject|0|||
125381093|NCT01414075|451027065|FG002|Overall Study|Withdrawal by Subject|0|||
125381094|NCT01414075|451027066|FG003|Overall Study|Withdrawal by Subject|1|||
125381095|NCT01414075|451027063|FG000|Overall Study|Other than specified|1|||
125381096|NCT01414075|451027064|FG001|Overall Study|Other than specified|0|||
125381097|NCT01414075|451027065|FG002|Overall Study|Other than specified|1|||
125218946|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
125381098|NCT01414075|451027066|FG003|Overall Study|Other than specified|0|||
125381099|NCT04903626|451027071|FG000|Overall Study|Lost to Follow-up|6|||
125437272|NCT01320735|451228046|FG000|Overall Study|Other|1|||
125643512|NCT00783263|451977928|FG002|Overall Study|Withdrawal by Subject|1|||
125643513|NCT00783263|451977929|FG003|Overall Study|Withdrawal by Subject|2|||
125643514|NCT03018028|451977930|FG000|Overall Study|Withdrawal by Subject|3|||
125643515|NCT03018028|451977931|FG001|Overall Study|Withdrawal by Subject|0|||
125643516|NCT03018028|451977932|FG002|Overall Study|Withdrawal by Subject|1|||
125643517|NCT03018028|451977933|FG003|Overall Study|Withdrawal by Subject|2|||
125643518|NCT03018028|451977934|FG004|Overall Study|Withdrawal by Subject|0|||
125643519|NCT02543801|451977935|FG000|Overall Study|Protocol Violation|1|||
125643520|NCT02543801|451977936|FG001|Overall Study|Protocol Violation|2|||
125643521|NCT02543801|451977937|FG002|Overall Study|Protocol Violation|0|||
125643522|NCT02543801|451977938|FG003|Overall Study|Protocol Violation|0|||
125643523|NCT02364999|451977948|FG000|Overall Study|Death|136|||
125643524|NCT02364999|451977949|FG001|Overall Study|Death|138|||
125643525|NCT02364999|451977948|FG000|Overall Study|Lost to Follow-up|10|||
125643526|NCT02364999|451977949|FG001|Overall Study|Lost to Follow-up|15|||
125643527|NCT02364999|451977948|FG000|Overall Study|Protocol Violation|3|||
125643528|NCT02364999|451977949|FG001|Overall Study|Protocol Violation|2|||
125643529|NCT02364999|451977948|FG000|Overall Study|Withdrawal by Subject|14|||
125643530|NCT02364999|451977949|FG001|Overall Study|Withdrawal by Subject|14|||
125381100|NCT04903626|451027071|FG000|Overall Study|Withdrawal by Subject|1|||
125381101|NCT04903626|451027071|FG000|Overall Study|Other, Not Specified|1|||
125381102|NCT00573534|451027072|FG000|Overall Study|oppositional behavior|3|||
125643531|NCT02364999|451977948|FG000|Overall Study|Other|0|||
125643532|NCT02364999|451977949|FG001|Overall Study|Other|1|||
125643533|NCT02364999|451977948|FG000|Overall Study|Randomized but did not receive treatment|2|||
125643534|NCT02364999|451977949|FG001|Overall Study|Randomized but did not receive treatment|3|||
125643535|NCT01566981|451977950|FG000|Overall Study|Lost to Follow-up|5|||
125643536|NCT01566981|451977951|FG001|Overall Study|Lost to Follow-up|8|||
125643537|NCT03323385|451977958|FG000|Overall Study|Withdrawal by Subject|1|||
125643538|NCT03323385|451977959|FG001|Overall Study|Withdrawal by Subject|2|||
125643539|NCT03323385|451977958|FG000|Overall Study|Noncompliance|0|||
125643540|NCT03323385|451977959|FG001|Overall Study|Noncompliance|1|||
125643541|NCT01849289|451977960|FG000|Overall Study|Adverse Event|3|||
125643542|NCT01849289|451977961|FG001|Overall Study|Adverse Event|3|||
125643543|NCT01849289|451977960|FG000|Overall Study|Protocol Violation|3|||
125643544|NCT01849289|451977961|FG001|Overall Study|Protocol Violation|3|||
125643545|NCT01849289|451977960|FG000|Overall Study|Withdrawal criteria|1|||
125643546|NCT01849289|451977961|FG001|Overall Study|Withdrawal criteria|0|||
125643547|NCT01849289|451977960|FG000|Overall Study|Unclassified|25|||
125643548|NCT01849289|451977961|FG001|Overall Study|Unclassified|18|||
125643549|NCT00660816|451977965|FG000|Overall Study|Adverse Event|1|||
125643550|NCT00660816|451977966|FG001|Overall Study|Adverse Event|2|||
125643551|NCT00660816|451977965|FG000|Overall Study|Withdrawal by Subject|1|||
125381103|NCT00467259|451027078|FG000|Overall Study|Adverse Event|24|||
125381104|NCT00467259|451027079|FG001|Overall Study|Adverse Event|90|||
125381105|NCT00467259|451027078|FG000|Overall Study|Protocol Violation|1|||
125381106|NCT00467259|451027079|FG001|Overall Study|Protocol Violation|7|||
125381107|NCT00467259|451027078|FG000|Overall Study|Withdrawal by Subject|34|||
125381108|NCT00467259|451027079|FG001|Overall Study|Withdrawal by Subject|108|||
125381109|NCT00467259|451027078|FG000|Overall Study|Physician Decision|0|||
125643552|NCT00660816|451977966|FG001|Overall Study|Withdrawal by Subject|0|||
125643553|NCT00660816|451977965|FG000|Overall Study|Death|0|||
125643554|NCT00660816|451977966|FG001|Overall Study|Death|2|||
125643555|NCT00660816|451977965|FG000|Overall Study|Lack of Efficacy|1|||
125643556|NCT00660816|451977966|FG001|Overall Study|Lack of Efficacy|0|||
125643557|NCT00660816|451977965|FG000|Overall Study|Physician Decision|0|||
125643558|NCT00660816|451977966|FG001|Overall Study|Physician Decision|2|||
125643559|NCT00660816|451977965|FG000|Overall Study|Protocol Violation|1|||
125643560|NCT00660816|451977966|FG001|Overall Study|Protocol Violation|0|||
125643561|NCT00660816|451977965|FG000|Overall Study|Disease Progression|16|||
125643562|NCT00660816|451977966|FG001|Overall Study|Disease Progression|12|||
125643563|NCT00660816|451977965|FG000|Overall Study|Complicating Disease|0|||
125643564|NCT00660816|451977966|FG001|Overall Study|Complicating Disease|1|||
125643565|NCT02692560|451977967|FG000|Overall Study|Withdrawal by Subject|0|||
125643566|NCT02692560|451977968|FG001|Overall Study|Withdrawal by Subject|6|||
125643567|NCT00420212|451977971|FG000|Overall Study|Adverse Event|22|||
125643568|NCT00420212|451977972|FG001|Overall Study|Adverse Event|40|||
125643569|NCT00420212|451977973|FG002|Overall Study|Adverse Event|36|||
125643570|NCT00420212|451977971|FG000|Overall Study|Lost to Follow-up|9|||
125643571|NCT00420212|451977972|FG001|Overall Study|Lost to Follow-up|11|||
125643572|NCT00420212|451977973|FG002|Overall Study|Lost to Follow-up|11|||
125643573|NCT00420212|451977971|FG000|Overall Study|Withdrawal by Subject|31|||
125643574|NCT00420212|451977972|FG001|Overall Study|Withdrawal by Subject|22|||
125643575|NCT00420212|451977973|FG002|Overall Study|Withdrawal by Subject|19|||
125643576|NCT00420212|451977971|FG000|Overall Study|Physician Decision|4|||
125643577|NCT00420212|451977972|FG001|Overall Study|Physician Decision|4|||
125643578|NCT00420212|451977973|FG002|Overall Study|Physician Decision|3|||
125643579|NCT00420212|451977971|FG000|Overall Study|Protocol Violation|4|||
125643580|NCT00420212|451977972|FG001|Overall Study|Protocol Violation|4|||
125643581|NCT00420212|451977973|FG002|Overall Study|Protocol Violation|8|||
125643582|NCT00420212|451977971|FG000|Overall Study|Death|0|||
125643583|NCT00420212|451977972|FG001|Overall Study|Death|0|||
125643584|NCT00420212|451977973|FG002|Overall Study|Death|1|||
125643585|NCT00420212|451977971|FG000|Overall Study|Other-Unspecified|21|||
125643586|NCT00420212|451977972|FG001|Overall Study|Other-Unspecified|14|||
125643587|NCT00420212|451977973|FG002|Overall Study|Other-Unspecified|18|||
125643588|NCT01326910|451977974|FG000|Overall Study|Withdrawal by Subject|3|||
125643589|NCT01326910|451977975|FG001|Overall Study|Withdrawal by Subject|2|||
125643590|NCT01326910|451977974|FG000|Overall Study|Protocol Violation|1|||
125643591|NCT01326910|451977975|FG001|Overall Study|Protocol Violation|1|||
125643592|NCT01681836|451977976|FG000|Second Intervention|Withdrawal by Subject|0|||
125643593|NCT01681836|451977977|FG001|Second Intervention|Withdrawal by Subject|1|||
125643594|NCT02394028|451977978|FG000|Induction Phase|Adverse Event|2|||
125643595|NCT02394028|451977979|FG001|Induction Phase|Adverse Event|4|||
125643596|NCT02394028|451977980|FG002|Induction Phase|Adverse Event|1|||
125643597|NCT02394028|451977981|FG003|Induction Phase|Adverse Event|2|||
125643598|NCT02394028|451977982|FG004|Induction Phase|Adverse Event|5|||
125643599|NCT02394028|451977983|FG005|Induction Phase|Adverse Event|2|||
125643600|NCT02394028|451977984|FG006|Induction Phase|Adverse Event|0|||
125643601|NCT02394028|451977985|FG007|Induction Phase|Adverse Event|0|||
125643602|NCT02394028|451977986|FG008|Induction Phase|Adverse Event|0|||
125643603|NCT02394028|451977987|FG009|Induction Phase|Adverse Event|0|||
125643604|NCT02394028|451977988|FG010|Induction Phase|Adverse Event|0|||
125643605|NCT02394028|451977978|FG000|Induction Phase|Lack of Efficacy|3|||
125643606|NCT02394028|451977979|FG001|Induction Phase|Lack of Efficacy|6|||
125643607|NCT02394028|451977980|FG002|Induction Phase|Lack of Efficacy|2|||
125643608|NCT02394028|451977981|FG003|Induction Phase|Lack of Efficacy|17|||
125643609|NCT02394028|451977982|FG004|Induction Phase|Lack of Efficacy|14|||
125643610|NCT02394028|451977983|FG005|Induction Phase|Lack of Efficacy|8|||
125643611|NCT02394028|451977984|FG006|Induction Phase|Lack of Efficacy|17|||
125643612|NCT02394028|451977985|FG007|Induction Phase|Lack of Efficacy|23|||
125643613|NCT02394028|451977986|FG008|Induction Phase|Lack of Efficacy|0|||
125381110|NCT00467259|451027079|FG001|Overall Study|Physician Decision|2|||
125381111|NCT00467259|451027078|FG000|Overall Study|Lost to Follow-up|14|||
125643614|NCT02394028|451977987|FG009|Induction Phase|Lack of Efficacy|0|||
125643615|NCT02394028|451977988|FG010|Induction Phase|Lack of Efficacy|0|||
125643616|NCT02394028|451977978|FG000|Induction Phase|Lost to Follow-up|1|||
125643617|NCT02394028|451977979|FG001|Induction Phase|Lost to Follow-up|0|||
125643618|NCT02394028|451977980|FG002|Induction Phase|Lost to Follow-up|0|||
125643619|NCT02394028|451977981|FG003|Induction Phase|Lost to Follow-up|1|||
125643620|NCT02394028|451977982|FG004|Induction Phase|Lost to Follow-up|0|||
125643621|NCT02394028|451977983|FG005|Induction Phase|Lost to Follow-up|0|||
125643622|NCT02394028|451977984|FG006|Induction Phase|Lost to Follow-up|1|||
125643623|NCT02394028|451977985|FG007|Induction Phase|Lost to Follow-up|0|||
125643624|NCT02394028|451977986|FG008|Induction Phase|Lost to Follow-up|0|||
125643625|NCT02394028|451977987|FG009|Induction Phase|Lost to Follow-up|0|||
125643626|NCT02394028|451977988|FG010|Induction Phase|Lost to Follow-up|0|||
125643627|NCT02394028|451977978|FG000|Induction Phase|Non-compliance|0|||
125643628|NCT02394028|451977979|FG001|Induction Phase|Non-compliance|1|||
125643629|NCT02394028|451977980|FG002|Induction Phase|Non-compliance|3|||
125643630|NCT02394028|451977981|FG003|Induction Phase|Non-compliance|1|||
125643631|NCT02394028|451977982|FG004|Induction Phase|Non-compliance|3|||
125643632|NCT02394028|451977983|FG005|Induction Phase|Non-compliance|0|||
125643633|NCT02394028|451977984|FG006|Induction Phase|Non-compliance|1|||
125643634|NCT02394028|451977985|FG007|Induction Phase|Non-compliance|1|||
125643635|NCT02394028|451977986|FG008|Induction Phase|Non-compliance|0|||
125643636|NCT02394028|451977987|FG009|Induction Phase|Non-compliance|0|||
125643637|NCT02394028|451977988|FG010|Induction Phase|Non-compliance|0|||
125643638|NCT02394028|451977978|FG000|Induction Phase|Physician Decision|0|||
125643639|NCT02394028|451977979|FG001|Induction Phase|Physician Decision|0|||
125643640|NCT02394028|451977980|FG002|Induction Phase|Physician Decision|1|||
125643641|NCT02394028|451977981|FG003|Induction Phase|Physician Decision|4|||
125643642|NCT02394028|451977982|FG004|Induction Phase|Physician Decision|0|||
125643643|NCT02394028|451977983|FG005|Induction Phase|Physician Decision|2|||
125643644|NCT02394028|451977984|FG006|Induction Phase|Physician Decision|1|||
125643645|NCT02394028|451977985|FG007|Induction Phase|Physician Decision|0|||
125643646|NCT02394028|451977986|FG008|Induction Phase|Physician Decision|0|||
125643647|NCT02394028|451977987|FG009|Induction Phase|Physician Decision|0|||
125643648|NCT02394028|451977988|FG010|Induction Phase|Physician Decision|0|||
125643649|NCT02394028|451977978|FG000|Induction Phase|Protocol Violation|0|||
125643650|NCT02394028|451977979|FG001|Induction Phase|Protocol Violation|2|||
125643651|NCT02394028|451977980|FG002|Induction Phase|Protocol Violation|0|||
125643652|NCT02394028|451977981|FG003|Induction Phase|Protocol Violation|3|||
125643653|NCT02394028|451977982|FG004|Induction Phase|Protocol Violation|0|||
125643654|NCT02394028|451977983|FG005|Induction Phase|Protocol Violation|1|||
125643655|NCT02394028|451977984|FG006|Induction Phase|Protocol Violation|1|||
125643656|NCT02394028|451977985|FG007|Induction Phase|Protocol Violation|0|||
125643657|NCT02394028|451977986|FG008|Induction Phase|Protocol Violation|0|||
125643658|NCT02394028|451977987|FG009|Induction Phase|Protocol Violation|0|||
125643659|NCT02394028|451977988|FG010|Induction Phase|Protocol Violation|0|||
125643660|NCT02394028|451977978|FG000|Induction Phase|Withdrawal by Subject|1|||
125643661|NCT02394028|451977979|FG001|Induction Phase|Withdrawal by Subject|2|||
125643662|NCT02394028|451977980|FG002|Induction Phase|Withdrawal by Subject|4|||
125643663|NCT02394028|451977981|FG003|Induction Phase|Withdrawal by Subject|6|||
125643664|NCT02394028|451977982|FG004|Induction Phase|Withdrawal by Subject|7|||
125643665|NCT02394028|451977983|FG005|Induction Phase|Withdrawal by Subject|4|||
125643666|NCT02394028|451977984|FG006|Induction Phase|Withdrawal by Subject|3|||
125643667|NCT02394028|451977985|FG007|Induction Phase|Withdrawal by Subject|6|||
125643668|NCT02394028|451977986|FG008|Induction Phase|Withdrawal by Subject|0|||
125643669|NCT02394028|451977987|FG009|Induction Phase|Withdrawal by Subject|0|||
125643670|NCT02394028|451977988|FG010|Induction Phase|Withdrawal by Subject|0|||
125643671|NCT02394028|451977978|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
125643672|NCT02394028|451977979|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
125643673|NCT02394028|451977980|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
125643674|NCT02394028|451977981|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
125643675|NCT02394028|451977982|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
125643676|NCT02394028|451977983|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
125643677|NCT02394028|451977984|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
125643678|NCT02394028|451977985|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
125643679|NCT02394028|451977986|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
125643680|NCT02394028|451977987|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
125643681|NCT02394028|451977988|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
125643682|NCT02394028|451977978|FG000|Induction Phase|Sponsor decision|0|||
125643683|NCT02394028|451977979|FG001|Induction Phase|Sponsor decision|1|||
125643684|NCT02394028|451977980|FG002|Induction Phase|Sponsor decision|2|||
125643685|NCT02394028|451977981|FG003|Induction Phase|Sponsor decision|0|||
125643686|NCT02394028|451977982|FG004|Induction Phase|Sponsor decision|0|||
125643687|NCT02394028|451977983|FG005|Induction Phase|Sponsor decision|0|||
125643688|NCT02394028|451977984|FG006|Induction Phase|Sponsor decision|0|||
125643689|NCT02394028|451977985|FG007|Induction Phase|Sponsor decision|0|||
125643690|NCT02394028|451977986|FG008|Induction Phase|Sponsor decision|0|||
125643691|NCT02394028|451977987|FG009|Induction Phase|Sponsor decision|0|||
125643692|NCT02394028|451977988|FG010|Induction Phase|Sponsor decision|0|||
125643693|NCT02394028|451977978|FG000|Induction Phase|Technical reason|0|||
125643694|NCT02394028|451977979|FG001|Induction Phase|Technical reason|0|||
125643695|NCT02394028|451977980|FG002|Induction Phase|Technical reason|0|||
125643696|NCT02394028|451977981|FG003|Induction Phase|Technical reason|1|||
125643697|NCT02394028|451977982|FG004|Induction Phase|Technical reason|0|||
125643698|NCT02394028|451977983|FG005|Induction Phase|Technical reason|0|||
125643699|NCT02394028|451977984|FG006|Induction Phase|Technical reason|0|||
125643700|NCT02394028|451977985|FG007|Induction Phase|Technical reason|0|||
125643701|NCT02394028|451977986|FG008|Induction Phase|Technical reason|0|||
125643702|NCT02394028|451977987|FG009|Induction Phase|Technical reason|0|||
125643703|NCT02394028|451977988|FG010|Induction Phase|Technical reason|0|||
125643704|NCT02394028|451977978|FG000|Induction Phase|:ack of calculation|0|||
125643705|NCT02394028|451977979|FG001|Induction Phase|:ack of calculation|0|||
125643706|NCT02394028|451977980|FG002|Induction Phase|:ack of calculation|0|||
125643707|NCT02394028|451977981|FG003|Induction Phase|:ack of calculation|0|||
125643708|NCT02394028|451977982|FG004|Induction Phase|:ack of calculation|0|||
125643709|NCT02394028|451977983|FG005|Induction Phase|:ack of calculation|0|||
125643710|NCT02394028|451977984|FG006|Induction Phase|:ack of calculation|0|||
125643711|NCT02394028|451977985|FG007|Induction Phase|:ack of calculation|1|||
125643712|NCT02394028|451977986|FG008|Induction Phase|:ack of calculation|0|||
125643713|NCT02394028|451977987|FG009|Induction Phase|:ack of calculation|0|||
125643714|NCT02394028|451977988|FG010|Induction Phase|:ack of calculation|0|||
125643715|NCT02394028|451977978|FG000|Maintenance Phase|Protocol Violation|0|||
125643716|NCT02394028|451977979|FG001|Maintenance Phase|Protocol Violation|0|||
125643717|NCT02394028|451977980|FG002|Maintenance Phase|Protocol Violation|0|||
125643718|NCT02394028|451977981|FG003|Maintenance Phase|Protocol Violation|0|||
125643719|NCT02394028|451977982|FG004|Maintenance Phase|Protocol Violation|0|||
125643720|NCT02394028|451977983|FG005|Maintenance Phase|Protocol Violation|0|||
125643721|NCT02394028|451977984|FG006|Maintenance Phase|Protocol Violation|0|||
125643722|NCT02394028|451977985|FG007|Maintenance Phase|Protocol Violation|0|||
125643723|NCT02394028|451977986|FG008|Maintenance Phase|Protocol Violation|0|||
125643724|NCT02394028|451977987|FG009|Maintenance Phase|Protocol Violation|0|||
125643725|NCT02394028|451977988|FG010|Maintenance Phase|Protocol Violation|1|||
125643726|NCT02394028|451977978|FG000|Maintenance Phase|Physician Decision|0|||
125643727|NCT02394028|451977979|FG001|Maintenance Phase|Physician Decision|0|||
125643728|NCT02394028|451977980|FG002|Maintenance Phase|Physician Decision|0|||
125643729|NCT02394028|451977981|FG003|Maintenance Phase|Physician Decision|0|||
125643730|NCT02394028|451977982|FG004|Maintenance Phase|Physician Decision|0|||
125643731|NCT02394028|451977983|FG005|Maintenance Phase|Physician Decision|0|||
125643732|NCT02394028|451977984|FG006|Maintenance Phase|Physician Decision|0|||
125643733|NCT02394028|451977985|FG007|Maintenance Phase|Physician Decision|0|||
125643734|NCT02394028|451977986|FG008|Maintenance Phase|Physician Decision|1|||
125643735|NCT02394028|451977987|FG009|Maintenance Phase|Physician Decision|3|||
125643736|NCT02394028|451977988|FG010|Maintenance Phase|Physician Decision|2|||
125643737|NCT02394028|451977978|FG000|Maintenance Phase|Lack of Efficacy|0|||
125643738|NCT02394028|451977979|FG001|Maintenance Phase|Lack of Efficacy|0|||
125643739|NCT02394028|451977980|FG002|Maintenance Phase|Lack of Efficacy|0|||
125643740|NCT02394028|451977981|FG003|Maintenance Phase|Lack of Efficacy|0|||
125643741|NCT02394028|451977982|FG004|Maintenance Phase|Lack of Efficacy|0|||
125643742|NCT02394028|451977983|FG005|Maintenance Phase|Lack of Efficacy|0|||
125643743|NCT02394028|451977984|FG006|Maintenance Phase|Lack of Efficacy|0|||
125643744|NCT02394028|451977985|FG007|Maintenance Phase|Lack of Efficacy|0|||
125643745|NCT02394028|451977986|FG008|Maintenance Phase|Lack of Efficacy|7|||
125643746|NCT02394028|451977987|FG009|Maintenance Phase|Lack of Efficacy|25|||
125643747|NCT02394028|451977988|FG010|Maintenance Phase|Lack of Efficacy|33|||
125643748|NCT02394028|451977978|FG000|Maintenance Phase|Death|0|||
125643749|NCT02394028|451977979|FG001|Maintenance Phase|Death|0|||
125643750|NCT02394028|451977980|FG002|Maintenance Phase|Death|0|||
125643751|NCT02394028|451977981|FG003|Maintenance Phase|Death|0|||
125643752|NCT02394028|451977982|FG004|Maintenance Phase|Death|0|||
125643753|NCT02394028|451977983|FG005|Maintenance Phase|Death|0|||
125643754|NCT02394028|451977984|FG006|Maintenance Phase|Death|0|||
125643755|NCT02394028|451977985|FG007|Maintenance Phase|Death|0|||
125643756|NCT02394028|451977986|FG008|Maintenance Phase|Death|0|||
125643757|NCT02394028|451977987|FG009|Maintenance Phase|Death|0|||
125643758|NCT02394028|451977988|FG010|Maintenance Phase|Death|1|||
125643759|NCT02394028|451977978|FG000|Maintenance Phase|Adverse Event|0|||
125643760|NCT02394028|451977979|FG001|Maintenance Phase|Adverse Event|0|||
125643761|NCT02394028|451977980|FG002|Maintenance Phase|Adverse Event|0|||
125643762|NCT02394028|451977981|FG003|Maintenance Phase|Adverse Event|0|||
125643763|NCT02394028|451977982|FG004|Maintenance Phase|Adverse Event|0|||
125643764|NCT02394028|451977983|FG005|Maintenance Phase|Adverse Event|0|||
125643765|NCT02394028|451977984|FG006|Maintenance Phase|Adverse Event|0|||
125643766|NCT02394028|451977985|FG007|Maintenance Phase|Adverse Event|0|||
125643767|NCT02394028|451977986|FG008|Maintenance Phase|Adverse Event|1|||
125485452|NCT02240238|451412506|FG003|Phase 2|Physician Decision|0|||
125381112|NCT00467259|451027079|FG001|Overall Study|Lost to Follow-up|34|||
125381113|NCT00467259|451027078|FG000|Overall Study|Site Closed|2|||
125381114|NCT00467259|451027079|FG001|Overall Study|Site Closed|1|||
125381115|NCT04285879|451027082|FG000|Overall Study|Lost to Follow-up|1|||
125381116|NCT04285879|451027083|FG001|Overall Study|Lost to Follow-up|8|||
125381117|NCT04285879|451027082|FG000|Overall Study|medical/surgical exclusion|16|||
125381118|NCT04285879|451027083|FG001|Overall Study|medical/surgical exclusion|0|||
125381119|NCT01958008|451027085|FG000|Overall Study|Worsening of disease under study|0|||
125381120|NCT01958008|451027086|FG001|Overall Study|Worsening of disease under study|0|||
125381121|NCT01958008|451027087|FG002|Overall Study|Worsening of disease under study|1|||
125381122|NCT01958008|451027088|FG003|Overall Study|Worsening of disease under study|0|||
125381123|NCT01958008|451027085|FG000|Overall Study|Other adverse event|1|||
125381124|NCT01958008|451027086|FG001|Overall Study|Other adverse event|0|||
125381125|NCT01958008|451027087|FG002|Overall Study|Other adverse event|0|||
125381126|NCT01958008|451027088|FG003|Overall Study|Other adverse event|0|||
125381127|NCT01634360|451027089|FG000|Overall Study|Adverse Event|10|||
125381128|NCT01634360|451027090|FG001|Overall Study|Adverse Event|34|||
125381129|NCT01634360|451027089|FG000|Overall Study|subject withdrew consent|13|||
125381130|NCT01634360|451027090|FG001|Overall Study|subject withdrew consent|23|||
125643768|NCT02394028|451977987|FG009|Maintenance Phase|Adverse Event|1|||
125643769|NCT02394028|451977988|FG010|Maintenance Phase|Adverse Event|3|||
125643770|NCT02394028|451977978|FG000|Maintenance Phase|Site closure|0|||
125643771|NCT02394028|451977979|FG001|Maintenance Phase|Site closure|0|||
125643772|NCT02394028|451977980|FG002|Maintenance Phase|Site closure|0|||
125643773|NCT02394028|451977981|FG003|Maintenance Phase|Site closure|0|||
125643774|NCT02394028|451977982|FG004|Maintenance Phase|Site closure|0|||
125643775|NCT02394028|451977983|FG005|Maintenance Phase|Site closure|0|||
125643776|NCT02394028|451977984|FG006|Maintenance Phase|Site closure|0|||
125643777|NCT02394028|451977985|FG007|Maintenance Phase|Site closure|0|||
125643778|NCT02394028|451977986|FG008|Maintenance Phase|Site closure|0|||
125643779|NCT02394028|451977987|FG009|Maintenance Phase|Site closure|1|||
125381131|NCT01634360|451027089|FG000|Overall Study|Protocol Violation|1|||
125381132|NCT01634360|451027090|FG001|Overall Study|Protocol Violation|1|||
125381133|NCT01634360|451027089|FG000|Overall Study|Lack of Efficacy|4|||
125381134|NCT01634360|451027090|FG001|Overall Study|Lack of Efficacy|14|||
125381135|NCT01634360|451027089|FG000|Overall Study|Other|3|||
125381136|NCT01634360|451027090|FG001|Overall Study|Other|20|||
125381137|NCT01634360|451027089|FG000|Overall Study|Study termination by sponsor|18|||
125381138|NCT01634360|451027090|FG001|Overall Study|Study termination by sponsor|44|||
125381139|NCT02028065|451027091|FG000|Randomization Through Start Treatment|Not treated|1|||
125381140|NCT02028065|451027092|FG001|Randomization Through Start Treatment|Not treated|3|||
125381141|NCT02028065|451027093|FG002|Randomization Through Start Treatment|Not treated|3|||
125381142|NCT02028065|451027091|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
125381143|NCT02028065|451027092|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
125381144|NCT02028065|451027093|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
125381145|NCT02028065|451027091|FG000|Treatment Through Study Completion|Physician Decision|1|||
125381146|NCT02028065|451027092|FG001|Treatment Through Study Completion|Physician Decision|0|||
125381147|NCT02028065|451027093|FG002|Treatment Through Study Completion|Physician Decision|0|||
125381148|NCT02028065|451027091|FG000|Treatment Through Study Completion|Protocol Violation|1|||
125381149|NCT02028065|451027092|FG001|Treatment Through Study Completion|Protocol Violation|4|||
125381150|NCT02028065|451027093|FG002|Treatment Through Study Completion|Protocol Violation|0|||
125381151|NCT02028065|451027091|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
125381152|NCT02028065|451027092|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
125381153|NCT02028065|451027093|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
125381154|NCT02028065|451027091|FG000|Treatment Through Study Completion|Adverse Event|3|||
125381155|NCT02028065|451027092|FG001|Treatment Through Study Completion|Adverse Event|3|||
125381156|NCT02028065|451027093|FG002|Treatment Through Study Completion|Adverse Event|5|||
125381157|NCT00877383|451027094|FG000|Overall Study|Adverse Event|13|||
125381158|NCT00877383|451027095|FG001|Overall Study|Adverse Event|14|||
125437273|NCT01320735|451228046|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
125437274|NCT01320735|451228046|FG000|Overall Study|Investigator Unable to be Contacted|17|||
125643780|NCT02394028|451977988|FG010|Maintenance Phase|Site closure|0|||
125643781|NCT02394028|451977978|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125643782|NCT02394028|451977979|FG001|Maintenance Phase|Withdrawal by Subject|0|||
125381159|NCT00877383|451027094|FG000|Overall Study|Lost to Follow-up|5|||
125381160|NCT00877383|451027095|FG001|Overall Study|Lost to Follow-up|3|||
125381161|NCT00877383|451027094|FG000|Overall Study|Subject withdrew consent|3|||
125381162|NCT00877383|451027095|FG001|Overall Study|Subject withdrew consent|12|||
125643783|NCT02394028|451977980|FG002|Maintenance Phase|Withdrawal by Subject|0|||
125643784|NCT02394028|451977981|FG003|Maintenance Phase|Withdrawal by Subject|0|||
125643785|NCT02394028|451977982|FG004|Maintenance Phase|Withdrawal by Subject|0|||
125643786|NCT02394028|451977983|FG005|Maintenance Phase|Withdrawal by Subject|0|||
125643787|NCT02394028|451977984|FG006|Maintenance Phase|Withdrawal by Subject|0|||
125643788|NCT02394028|451977985|FG007|Maintenance Phase|Withdrawal by Subject|0|||
125643789|NCT02394028|451977986|FG008|Maintenance Phase|Withdrawal by Subject|3|||
125643790|NCT02394028|451977987|FG009|Maintenance Phase|Withdrawal by Subject|12|||
125643791|NCT02394028|451977988|FG010|Maintenance Phase|Withdrawal by Subject|12|||
125643792|NCT02142712|451977991|FG000|Overall Study|Lost to Follow-up|1|||
125643793|NCT02142712|451977992|FG001|Overall Study|Lost to Follow-up|1|||
125643794|NCT02142712|451977993|FG002|Overall Study|Lost to Follow-up|1|||
125643795|NCT02142712|451977994|FG003|Overall Study|Lost to Follow-up|0|||
125643796|NCT01981096|451978001|FG000|Overall Study|Parent illness|1|||
125643797|NCT01981096|451978002|FG001|Overall Study|Parent illness|0|||
125643798|NCT01981096|451978001|FG000|Overall Study|Withdrawal by Subject|0|||
125643799|NCT01981096|451978002|FG001|Overall Study|Withdrawal by Subject|1|||
125643800|NCT01981096|451978001|FG000|Overall Study|Lost to Follow-up|2|||
125643801|NCT01981096|451978002|FG001|Overall Study|Lost to Follow-up|0|||
125643802|NCT01225211|451978003|FG000|Overall Study|Adverse Event|0|||
125643803|NCT01225211|451978004|FG001|Overall Study|Adverse Event|0|||
125643804|NCT01225211|451978005|FG002|Overall Study|Adverse Event|1|||
125643805|NCT01225211|451978006|FG003|Overall Study|Adverse Event|0|||
125643806|NCT01225211|451978007|FG004|Overall Study|Adverse Event|0|||
125643807|NCT01225211|451978008|FG005|Overall Study|Adverse Event|0|||
125643808|NCT01225211|451978009|FG006|Overall Study|Adverse Event|0|||
125643809|NCT01225211|451978010|FG007|Overall Study|Adverse Event|0|||
125643810|NCT01225211|451978011|FG008|Overall Study|Adverse Event|0|||
125643811|NCT01225211|451978012|FG009|Overall Study|Adverse Event|1|||
125218947|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
125218948|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
125218949|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
125218950|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
125218951|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
125218952|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
125218953|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
125218954|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
125643812|NCT01225211|451978003|FG000|Overall Study|Withdrawal by Subject|0|||
125643813|NCT01225211|451978004|FG001|Overall Study|Withdrawal by Subject|0|||
125643814|NCT01225211|451978005|FG002|Overall Study|Withdrawal by Subject|0|||
125643815|NCT01225211|451978006|FG003|Overall Study|Withdrawal by Subject|0|||
125643816|NCT01225211|451978007|FG004|Overall Study|Withdrawal by Subject|0|||
125643817|NCT01225211|451978008|FG005|Overall Study|Withdrawal by Subject|0|||
125643818|NCT01225211|451978009|FG006|Overall Study|Withdrawal by Subject|1|||
125437275|NCT00406419|451228049|FG000|Overall Study|Death|3|||
125643819|NCT01225211|451978010|FG007|Overall Study|Withdrawal by Subject|0|||
125643820|NCT01225211|451978011|FG008|Overall Study|Withdrawal by Subject|1|||
125643821|NCT01225211|451978012|FG009|Overall Study|Withdrawal by Subject|3|||
125643822|NCT01225211|451978003|FG000|Overall Study|Other|0|||
125643823|NCT01225211|451978004|FG001|Overall Study|Other|0|||
125643824|NCT01225211|451978005|FG002|Overall Study|Other|0|||
125643825|NCT01225211|451978006|FG003|Overall Study|Other|0|||
125643826|NCT01225211|451978007|FG004|Overall Study|Other|0|||
125643827|NCT01225211|451978008|FG005|Overall Study|Other|0|||
125643828|NCT01225211|451978009|FG006|Overall Study|Other|0|||
125643829|NCT01225211|451978010|FG007|Overall Study|Other|0|||
125643830|NCT01225211|451978011|FG008|Overall Study|Other|0|||
125437276|NCT00406419|451228050|FG001|Overall Study|Death|1|||
125437277|NCT00406419|451228051|FG002|Overall Study|Death|4|||
125437278|NCT00406419|451228049|FG000|Overall Study|Protocol Violation|6|||
125437279|NCT00406419|451228050|FG001|Overall Study|Protocol Violation|2|||
125437280|NCT00406419|451228051|FG002|Overall Study|Protocol Violation|5|||
125643831|NCT01225211|451978012|FG009|Overall Study|Other|1|||
125643832|NCT01241318|451978017|FG000|Overall Study|Woman: false pregnancies|27|||
125643833|NCT01241318|451978018|FG001|Overall Study|Woman: false pregnancies|15|||
125643834|NCT01241318|451978017|FG000|Overall Study|Woman: miscarriage/abortion|46|||
125643835|NCT01241318|451978018|FG001|Overall Study|Woman: miscarriage/abortion|38|||
125643836|NCT01241318|451978017|FG000|Overall Study|Withdrawal by Subject|175|||
125643837|NCT01241318|451978018|FG001|Overall Study|Withdrawal by Subject|46|||
125643838|NCT01241318|451978017|FG000|Overall Study|Lost to Follow-up|740|||
125643839|NCT01241318|451978018|FG001|Overall Study|Lost to Follow-up|455|||
125643840|NCT01241318|451978017|FG000|Overall Study|Death|2|||
125643841|NCT01241318|451978018|FG001|Overall Study|Death|4|||
125643842|NCT01241318|451978017|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
125643843|NCT01241318|451978018|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
125643844|NCT01241318|451978017|FG000|Overall Study|Woman: Stillborn infant|129|||
125643845|NCT01241318|451978018|FG001|Overall Study|Woman: Stillborn infant|146|||
125643846|NCT02355665|451978024|FG000|Overall Study|Adverse Event|16|||
125643847|NCT02355665|451978025|FG001|Overall Study|Adverse Event|24|||
125643848|NCT02355665|451978024|FG000|Overall Study|Protocol Violation|2|||
125643849|NCT02355665|451978025|FG001|Overall Study|Protocol Violation|0|||
125643850|NCT02355665|451978024|FG000|Overall Study|Withdrawal by Subject|90|||
125643851|NCT02355665|451978025|FG001|Overall Study|Withdrawal by Subject|100|||
125643852|NCT02355665|451978024|FG000|Overall Study|Lost to Follow-up|131|||
125643853|NCT02355665|451978025|FG001|Overall Study|Lost to Follow-up|103|||
125643854|NCT02355665|451978024|FG000|Overall Study|Death|4|||
125643855|NCT02355665|451978025|FG001|Overall Study|Death|2|||
125643856|NCT02355665|451978024|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
125643857|NCT02355665|451978025|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
125643858|NCT04129242|451978026|FG000|Overall Study|Physician Decision|1|||
125643859|NCT04129242|451978027|FG001|Overall Study|Physician Decision|1|||
125643860|NCT04129242|451978026|FG000|Overall Study|Protocol Violation|0|||
125643861|NCT04129242|451978027|FG001|Overall Study|Protocol Violation|1|||
125643862|NCT00392210|451978031|FG000|First Voiding Trial|Physician Decision|2|||
125643863|NCT00392210|451978032|FG001|First Voiding Trial|Physician Decision|2|||
125643864|NCT02140762|451978033|FG000|Overall Study|Adverse Event|1|||
125643865|NCT02140762|451978034|FG001|Overall Study|Adverse Event|1|||
125643866|NCT02140762|451978033|FG000|Overall Study|Lost to Follow-up|9|||
125643867|NCT02140762|451978034|FG001|Overall Study|Lost to Follow-up|5|||
125643868|NCT02140762|451978033|FG000|Overall Study|Protocol Violation|1|||
125643869|NCT02140762|451978034|FG001|Overall Study|Protocol Violation|1|||
125643870|NCT02140762|451978033|FG000|Overall Study|Withdrawal by Subject|6|||
125643871|NCT02140762|451978034|FG001|Overall Study|Withdrawal by Subject|4|||
125643872|NCT02140762|451978033|FG000|Overall Study|Other|0|||
125643873|NCT02140762|451978034|FG001|Overall Study|Other|1|||
125643874|NCT04815291|451978035|FG000|Overall Study|Lost to Follow-up|1|||
125643875|NCT04815291|451978035|FG000|Overall Study|Physician Decision|4|||
125643876|NCT04815291|451978035|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
125643877|NCT00095836|451978036|FG000|Overall Study|Lost to Follow-up|1|||
125643878|NCT00095836|451978036|FG000|Overall Study|Adverse Event|1|||
125643879|NCT00095836|451978036|FG000|Overall Study|Death|2|||
125643880|NCT00989664|451978039|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
125643881|NCT00989664|451978039|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
125643882|NCT00989664|451978039|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
125643883|NCT00989664|451978039|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
125643884|NCT00989664|451978039|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
125643885|NCT00989664|451978039|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
125643886|NCT00989664|451978039|FG000|Long-Term Follow-Up|Death|3|||
125643887|NCT00962780|451978041|FG000|Overall Study|Death|0|||
125643888|NCT00962780|451978042|FG001|Overall Study|Death|1|||
125643889|NCT00962780|451978041|FG000|Overall Study|Protocol Violation|9|||
125643890|NCT00962780|451978042|FG001|Overall Study|Protocol Violation|4|||
125135961|NCT03261167|450121794|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
125135962|NCT03261167|450121795|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
125135963|NCT03261167|450121794|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
125135964|NCT03261167|450121795|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
125135965|NCT03261167|450121794|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
125437281|NCT00406419|451228049|FG000|Overall Study|Study Terminated by Sponsor|260|||
125643891|NCT00962780|451978041|FG000|Overall Study|Withdrawal by Subject|1|||
125643892|NCT00962780|451978042|FG001|Overall Study|Withdrawal by Subject|8|||
125643893|NCT00962780|451978041|FG000|Overall Study|Other|0|||
125643894|NCT00962780|451978042|FG001|Overall Study|Other|1|||
125643895|NCT01775995|451978043|FG000|Overall Study|Lost to Follow-up|1|||
125643896|NCT01775995|451978044|FG001|Overall Study|Lost to Follow-up|1|||
125643897|NCT02055976|451978045|FG000|Overall Study|Other|0|||
125643898|NCT02055976|451978046|FG001|Overall Study|Other|0|||
125643899|NCT02055976|451978047|FG002|Overall Study|Other|1|||
125643900|NCT02055976|451978048|FG003|Overall Study|Other|0|||
125643901|NCT02055976|451978049|FG004|Overall Study|Other|0|||
125643902|NCT02055976|451978050|FG005|Overall Study|Other|0|||
125643903|NCT02055976|451978051|FG006|Overall Study|Other|0|||
125643904|NCT02055976|451978052|FG007|Overall Study|Other|0|||
125643905|NCT02055976|451978053|FG008|Overall Study|Other|0|||
125643906|NCT02055976|451978045|FG000|Overall Study|Adverse Event|0|||
125643907|NCT02055976|451978046|FG001|Overall Study|Adverse Event|0|||
125643908|NCT02055976|451978047|FG002|Overall Study|Adverse Event|0|||
125643909|NCT02055976|451978048|FG003|Overall Study|Adverse Event|0|||
125643910|NCT02055976|451978049|FG004|Overall Study|Adverse Event|0|||
125643911|NCT02055976|451978050|FG005|Overall Study|Adverse Event|1|||
125643912|NCT02055976|451978051|FG006|Overall Study|Adverse Event|1|||
125643913|NCT02055976|451978052|FG007|Overall Study|Adverse Event|0|||
125643914|NCT02055976|451978053|FG008|Overall Study|Adverse Event|0|||
125643915|NCT02055976|451978045|FG000|Overall Study|Does not meet entrance criteria|0|||
125643916|NCT02055976|451978046|FG001|Overall Study|Does not meet entrance criteria|0|||
125643917|NCT02055976|451978047|FG002|Overall Study|Does not meet entrance criteria|0|||
125643918|NCT02055976|451978048|FG003|Overall Study|Does not meet entrance criteria|0|||
125643919|NCT02055976|451978049|FG004|Overall Study|Does not meet entrance criteria|0|||
125643920|NCT02055976|451978050|FG005|Overall Study|Does not meet entrance criteria|0|||
125643921|NCT02055976|451978051|FG006|Overall Study|Does not meet entrance criteria|1|||
125643922|NCT02055976|451978052|FG007|Overall Study|Does not meet entrance criteria|0|||
125643923|NCT02055976|451978053|FG008|Overall Study|Does not meet entrance criteria|0|||
125643924|NCT02055976|451978045|FG000|Overall Study|Lost to Follow-up|0|||
125643925|NCT02055976|451978046|FG001|Overall Study|Lost to Follow-up|0|||
125643926|NCT02055976|451978047|FG002|Overall Study|Lost to Follow-up|0|||
125643927|NCT02055976|451978048|FG003|Overall Study|Lost to Follow-up|1|||
125643928|NCT02055976|451978049|FG004|Overall Study|Lost to Follow-up|0|||
125643929|NCT02055976|451978050|FG005|Overall Study|Lost to Follow-up|0|||
125643930|NCT02055976|451978051|FG006|Overall Study|Lost to Follow-up|0|||
125643931|NCT02055976|451978052|FG007|Overall Study|Lost to Follow-up|0|||
125643932|NCT02055976|451978053|FG008|Overall Study|Lost to Follow-up|0|||
125643933|NCT03458234|451978061|FG000|Overall Study|Withdrawal by Subject|1|||
125381163|NCT00877383|451027094|FG000|Overall Study|Subject no longer requires study drug|2|||
125381164|NCT00877383|451027095|FG001|Overall Study|Subject no longer requires study drug|0|||
125381165|NCT00877383|451027094|FG000|Overall Study|Administrative problems|2|||
125135966|NCT03261167|450121795|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
125135967|NCT03261167|450121794|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
125381166|NCT00877383|451027095|FG001|Overall Study|Administrative problems|0|||
125218955|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
125218956|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
125381167|NCT00877383|451027094|FG000|Overall Study|Protocol deviation|2|||
125218957|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
125218958|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
125218959|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
125218960|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
125218961|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
125218962|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
125218963|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
125218964|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
125218965|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
125218966|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
125218967|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
125218968|NCT03538691|450427420|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
125218969|NCT03538691|450427421|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
125218970|NCT03538691|450427422|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
125218971|NCT03538691|450427423|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
125218972|NCT06597084|450427424|FG000|Overall Study|Withdrawal by Subject|4|||
125218973|NCT06597084|450427425|FG001|Overall Study|Withdrawal by Subject|9|||
125218974|NCT06597084|450427424|FG000|Overall Study|Consent was not given by the patient until V2|0|||
125218975|NCT06597084|450427425|FG001|Overall Study|Consent was not given by the patient until V2|3|||
125218976|NCT06597084|450427424|FG000|Overall Study|Physician Decision|1|||
125218977|NCT06597084|450427425|FG001|Overall Study|Physician Decision|0|||
125218978|NCT06597084|450427424|FG000|Overall Study|Adverse Event|3|||
125218979|NCT06597084|450427425|FG001|Overall Study|Adverse Event|2|||
125218980|NCT06597084|450427424|FG000|Overall Study|Death|4|||
125218981|NCT06597084|450427425|FG001|Overall Study|Death|0|||
125218982|NCT06597084|450427424|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
125218983|NCT06597084|450427425|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
125218984|NCT06597084|450427424|FG000|Overall Study|Lost to Follow-up|4|||
125218985|NCT06597084|450427425|FG001|Overall Study|Lost to Follow-up|2|||
125218986|NCT06597084|450427424|FG000|Overall Study|Other. Not specified|1|||
125218987|NCT06597084|450427425|FG001|Overall Study|Other. Not specified|0|||
125218988|NCT01588405|450427426|FG000|Overall Study|Adverse Event|1|||
125218989|NCT01588405|450427426|FG000|Overall Study|Clinical Worsening|1|||
125218990|NCT02029274|450427432|FG000|Overall Study|Adverse Event|1|||
125218991|NCT02029274|450427433|FG001|Overall Study|Adverse Event|0|||
125218992|NCT02029274|450427434|FG002|Overall Study|Adverse Event|2|||
125218993|NCT02029274|450427435|FG003|Overall Study|Adverse Event|2|||
125218994|NCT01243177|450427438|FG000|Overall Study|Lack of Efficacy|47|||
125218995|NCT01243177|450427439|FG001|Overall Study|Lack of Efficacy|31|||
125218996|NCT01243177|450427438|FG000|Overall Study|Protocol Violation|11|||
125218997|NCT01243177|450427439|FG001|Overall Study|Protocol Violation|10|||
125218998|NCT01243177|450427438|FG000|Overall Study|Lost to Follow-up|15|||
125218999|NCT01243177|450427439|FG001|Overall Study|Lost to Follow-up|18|||
125219000|NCT01243177|450427438|FG000|Overall Study|Withdrawal by Subject|46|||
125219001|NCT01243177|450427439|FG001|Overall Study|Withdrawal by Subject|38|||
125219002|NCT01243177|450427438|FG000|Overall Study|AE, serious fatal|0|||
125219003|NCT01243177|450427439|FG001|Overall Study|AE, serious fatal|1|||
125219004|NCT01243177|450427438|FG000|Overall Study|SAE, non-fatal|7|||
125219005|NCT01243177|450427439|FG001|Overall Study|SAE, non-fatal|9|||
125219006|NCT01243177|450427438|FG000|Overall Study|AE, non-serious non-fatal|40|||
125219007|NCT01243177|450427439|FG001|Overall Study|AE, non-serious non-fatal|58|||
125219008|NCT01243177|450427438|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
125219009|NCT01243177|450427439|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
125219010|NCT01243177|450427438|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
125219011|NCT01243177|450427439|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
125219012|NCT01243177|450427438|FG000|Overall Study|Other Reason|11|||
125381168|NCT00877383|451027095|FG001|Overall Study|Protocol deviation|6|||
125381169|NCT00877383|451027094|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125381170|NCT00877383|451027095|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125381171|NCT00877383|451027094|FG000|Overall Study|Death|1|||
125219013|NCT01243177|450427439|FG001|Overall Study|Other Reason|12|||
125219014|NCT05251233|450429253|FG000|Overall Study|Disease progression - did not start treatment|0|||
125219015|NCT05251233|450429254|FG001|Overall Study|Disease progression - did not start treatment|0|||
125219016|NCT05251233|450429255|FG002|Overall Study|Disease progression - did not start treatment|5|||
125381172|NCT00877383|451027095|FG001|Overall Study|Death|2|||
125219017|NCT05251233|450429253|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
125219018|NCT05251233|450429254|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
125219019|NCT05251233|450429255|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
125219020|NCT05251233|450429253|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
125219021|NCT05251233|450429254|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
125219022|NCT05251233|450429255|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
125219023|NCT05251233|450429253|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
125219024|NCT05251233|450429254|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
125219025|NCT05251233|450429255|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
125219026|NCT05251233|450429253|FG000|Overall Study|Death - did not start treatment|3|||
125219027|NCT05251233|450429254|FG001|Overall Study|Death - did not start treatment|0|||
125219028|NCT05251233|450429255|FG002|Overall Study|Death - did not start treatment|0|||
125219029|NCT05251233|450429253|FG000|Overall Study|Withdrawal by Subject|2|||
125219030|NCT05251233|450429254|FG001|Overall Study|Withdrawal by Subject|2|||
125219031|NCT05251233|450429255|FG002|Overall Study|Withdrawal by Subject|0|||
125219032|NCT05251233|450429253|FG000|Overall Study|Other complicating disease|2|||
125219033|NCT05251233|450429254|FG001|Overall Study|Other complicating disease|1|||
125219034|NCT05251233|450429255|FG002|Overall Study|Other complicating disease|0|||
125219035|NCT05251233|450429253|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
125219036|NCT05251233|450429254|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
125219037|NCT05251233|450429255|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
125219038|NCT05251233|450429253|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
125219039|NCT05251233|450429254|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
125219040|NCT05251233|450429255|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
125219041|NCT01919164|450429266|FG000|Overall Study|Adverse Event|6|||
125219042|NCT01919164|450429267|FG001|Overall Study|Adverse Event|4|||
125219043|NCT01919164|450429268|FG002|Overall Study|Adverse Event|9|||
125219044|NCT01919164|450429269|FG003|Overall Study|Adverse Event|3|||
125219045|NCT01919164|450429270|FG004|Overall Study|Adverse Event|2|||
125219046|NCT01919164|450429266|FG000|Overall Study|Lost to Follow-up|2|||
125219047|NCT01919164|450429267|FG001|Overall Study|Lost to Follow-up|2|||
125219048|NCT01919164|450429268|FG002|Overall Study|Lost to Follow-up|2|||
125219049|NCT01919164|450429269|FG003|Overall Study|Lost to Follow-up|0|||
125381173|NCT04851314|451027096|FG000|Overall Study|Unable to complete research set-up procedures|0|||
125219050|NCT01919164|450429270|FG004|Overall Study|Lost to Follow-up|4|||
125219051|NCT01919164|450429266|FG000|Overall Study|Death|1|||
125219052|NCT01919164|450429267|FG001|Overall Study|Death|0|||
125219053|NCT01919164|450429268|FG002|Overall Study|Death|0|||
125219054|NCT01919164|450429269|FG003|Overall Study|Death|0|||
125219055|NCT01919164|450429270|FG004|Overall Study|Death|0|||
125219056|NCT01919164|450429266|FG000|Overall Study|Protocol Violation|6|||
125219057|NCT01919164|450429267|FG001|Overall Study|Protocol Violation|0|||
125219058|NCT01919164|450429268|FG002|Overall Study|Protocol Violation|3|||
125219059|NCT01919164|450429269|FG003|Overall Study|Protocol Violation|2|||
125219060|NCT01919164|450429270|FG004|Overall Study|Protocol Violation|2|||
125219061|NCT01919164|450429266|FG000|Overall Study|Disease progression|2|||
125219062|NCT01919164|450429267|FG001|Overall Study|Disease progression|2|||
125219063|NCT01919164|450429268|FG002|Overall Study|Disease progression|1|||
125219064|NCT01919164|450429269|FG003|Overall Study|Disease progression|2|||
125219065|NCT01919164|450429270|FG004|Overall Study|Disease progression|1|||
125219066|NCT01919164|450429266|FG000|Overall Study|Withdrew consent|13|||
125219067|NCT01919164|450429267|FG001|Overall Study|Withdrew consent|13|||
125219068|NCT01919164|450429268|FG002|Overall Study|Withdrew consent|14|||
125219069|NCT01919164|450429269|FG003|Overall Study|Withdrew consent|14|||
125219070|NCT01919164|450429270|FG004|Overall Study|Withdrew consent|9|||
125219071|NCT01919164|450429266|FG000|Overall Study|Other Un-specified|13|||
125219072|NCT01919164|450429267|FG001|Overall Study|Other Un-specified|9|||
125219073|NCT01919164|450429268|FG002|Overall Study|Other Un-specified|8|||
125219074|NCT01919164|450429269|FG003|Overall Study|Other Un-specified|7|||
125219075|NCT01919164|450429270|FG004|Overall Study|Other Un-specified|15|||
125219076|NCT00667992|450429273|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
125219077|NCT00667992|450429274|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
125381174|NCT04851314|451027097|FG001|Overall Study|Unable to complete research set-up procedures|2|||
125381175|NCT04851314|451027096|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
125381176|NCT04851314|451027097|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
125219078|NCT00667992|450429273|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
125381177|NCT02107482|451027098|FG000|Overall Study|inconveinence|2|||
125219079|NCT00667992|450429274|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
125219080|NCT00667992|450429273|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
125219081|NCT00667992|450429274|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
125219082|NCT00667992|450429273|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
125219083|NCT00667992|450429274|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
125219084|NCT00667992|450429273|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
125219085|NCT00667992|450429274|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
125219086|NCT00667992|450429273|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
125219087|NCT00667992|450429274|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
125219088|NCT00667992|450429273|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
125219089|NCT00667992|450429274|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
125219090|NCT00667992|450429273|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
125219091|NCT00667992|450429274|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
125219092|NCT00667992|450429273|FG000|Wash-out|Not within one doubling dilution|4|||
125219093|NCT00667992|450429274|FG001|Wash-out|Not within one doubling dilution|3|||
125219094|NCT00667992|450429273|FG000|Wash-out|Failure to wash-out|2|||
125219095|NCT00667992|450429274|FG001|Wash-out|Failure to wash-out|2|||
125219096|NCT00667992|450429273|FG000|Wash-out|Withdrawal by Subject|1|||
125219097|NCT00667992|450429274|FG001|Wash-out|Withdrawal by Subject|0|||
125219098|NCT00667992|450429273|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
125219099|NCT00667992|450429274|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
125219100|NCT00667992|450429273|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
125219101|NCT00667992|450429274|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
125219102|NCT02748057|450429278|FG000|Overall Study|Adverse Event|1|||
125219103|NCT02748057|450429279|FG001|Overall Study|Adverse Event|0|||
125219104|NCT02748057|450429278|FG000|Overall Study|Physician Decision|0|||
125219105|NCT02748057|450429279|FG001|Overall Study|Physician Decision|1|||
125219106|NCT02748057|450429278|FG000|Overall Study|Protocol Violation|2|||
125219107|NCT02748057|450429279|FG001|Overall Study|Protocol Violation|1|||
125219108|NCT02748057|450429278|FG000|Overall Study|Participant Moved|1|||
125219109|NCT02748057|450429279|FG001|Overall Study|Participant Moved|0|||
125219110|NCT02748057|450429278|FG000|Overall Study|Withdrawal by Subject|1|||
125219111|NCT02748057|450429279|FG001|Overall Study|Withdrawal by Subject|0|||
125219112|NCT00524771|450429290|FG000|Overall Study|Protocol Violation|220|||
125219113|NCT00524771|450429291|FG001|Overall Study|Protocol Violation|585|||
125219114|NCT01266824|450429294|FG000|Overall Study|Study terminated prior to completion|2|||
125219115|NCT01266824|450429295|FG001|Overall Study|Study terminated prior to completion|3|||
125219116|NCT02982863|450429296|FG000|Overall Study|Not eligible patients|809|||
125219117|NCT02982863|450429297|FG001|Overall Study|Not eligible patients|4261|||
125219118|NCT02982863|450429298|FG002|Overall Study|Not eligible patients|1852|||
125219119|NCT02982863|450429299|FG003|Overall Study|Not eligible patients|1400|||
125219120|NCT02982863|450429300|FG004|Overall Study|Not eligible patients|492|||
125219121|NCT00807612|450429302|FG000|Overall Study|Death|8|||
125219122|NCT00807612|450429302|FG000|Overall Study|Study early termination|5|||
125219123|NCT00807612|450429302|FG000|Overall Study|Withdrawal by Subject|1|||
125219124|NCT01300247|450429303|FG000|Overall Study|Death|1|||
125219125|NCT01300247|450429304|FG001|Overall Study|Death|1|||
125219126|NCT01300247|450429303|FG000|Overall Study|Lost to Follow-up|2|||
125219127|NCT01300247|450429304|FG001|Overall Study|Lost to Follow-up|0|||
125381178|NCT02107482|451027098|FG000|Overall Study|Lost to Follow-up|1|||
125381179|NCT02107482|451027098|FG000|Overall Study|Lack of Efficacy|1|||
125381180|NCT04868890|451027105|FG000|Overall Study|Death|2|||
125219128|NCT01300247|450429303|FG000|Overall Study|Withdrawal by Subject|1|||
125381181|NCT04868890|451027106|FG001|Overall Study|Death|1|||
125437282|NCT00406419|451228050|FG001|Overall Study|Study Terminated by Sponsor|288|||
125135968|NCT03261167|450121795|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
125437283|NCT00406419|451228051|FG002|Overall Study|Study Terminated by Sponsor|282|||
125219129|NCT01300247|450429304|FG001|Overall Study|Withdrawal by Subject|0|||
125219130|NCT01300247|450429303|FG000|Overall Study|Non-Compliance|0|||
125219131|NCT01300247|450429304|FG001|Overall Study|Non-Compliance|1|||
125219132|NCT04819438|450429305|FG000|Overall Study|Withdrawal by Subject|1|||
125219133|NCT04819438|450429306|FG001|Overall Study|Withdrawal by Subject|0|||
125219134|NCT04819438|450429305|FG000|Overall Study|Adverse Event|0|||
125219135|NCT04819438|450429306|FG001|Overall Study|Adverse Event|1|||
125219136|NCT04819438|450429305|FG000|Overall Study|Protocol Violation|0|||
125381182|NCT04868890|451027105|FG000|Overall Study|Withdrawal by Subject|1|||
125381183|NCT04868890|451027106|FG001|Overall Study|Withdrawal by Subject|5|||
125219137|NCT04819438|450429306|FG001|Overall Study|Protocol Violation|1|||
125219138|NCT03465709|450429308|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
125219139|NCT03465709|450429308|FG000|Overall Study|Withdrawal by Subject|3|||
125219140|NCT05359952|450429309|FG000|Overall Study|Lost to Follow-up|1|||
125219141|NCT05359952|450429310|FG001|Overall Study|Lost to Follow-up|0|||
125219142|NCT02258659|450429311|FG000|Overall Study|Withdrawal by Subject|1|||
125219143|NCT04892446|450429312|FG000|Overall Study|Death|4|||
125219144|NCT04892446|450429313|FG001|Overall Study|Death|4|||
125219145|NCT04892446|450429314|FG002|Overall Study|Death|0|||
125219146|NCT04892446|450429312|FG000|Overall Study|Withdrew consent|3|||
125219147|NCT04892446|450429313|FG001|Overall Study|Withdrew consent|0|||
125219148|NCT04892446|450429314|FG002|Overall Study|Withdrew consent|1|||
125219149|NCT04892446|450429312|FG000|Overall Study|Investigator's discretion|1|||
125219150|NCT04892446|450429313|FG001|Overall Study|Investigator's discretion|1|||
125219151|NCT04892446|450429314|FG002|Overall Study|Investigator's discretion|0|||
125219152|NCT04892446|450429312|FG000|Overall Study|Study terminated by sponsor|0|||
125219153|NCT04892446|450429313|FG001|Overall Study|Study terminated by sponsor|0|||
125219154|NCT04892446|450429314|FG002|Overall Study|Study terminated by sponsor|2|||
125219155|NCT00272844|450429315|FG000|Overall Study|Withdrawal by Subject|5|||
125219156|NCT03060291|450429316|FG000|3-month Follow-up|Declined to respond|8|||
125219157|NCT03060291|450429317|FG001|3-month Follow-up|Declined to respond|10|||
125219158|NCT03060291|450429318|FG002|3-month Follow-up|Declined to respond|2|||
125219159|NCT03060291|450429316|FG000|6-month Follow-up|Declined to respond|7|||
125219160|NCT03060291|450429317|FG001|6-month Follow-up|Declined to respond|13|||
125219161|NCT03060291|450429318|FG002|6-month Follow-up|Declined to respond|4|||
125219162|NCT03060291|450429316|FG000|12-month Follow-up|Declined to respond|7|||
125219163|NCT03060291|450429317|FG001|12-month Follow-up|Declined to respond|16|||
125219164|NCT03060291|450429318|FG002|12-month Follow-up|Declined to respond|6|||
125219165|NCT01556932|450429322|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
125219166|NCT01556932|450429323|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
125219167|NCT01882803|450429324|FG000|Overall Study|Disease Progression|1|||
125219168|NCT01882803|450429324|FG000|Overall Study|Withdrawal by Subject|9|||
125219169|NCT01882803|450429324|FG000|Overall Study|Death|68|||
125219170|NCT01882803|450429324|FG000|Overall Study|Physician Decision|3|||
125219171|NCT01882803|450429324|FG000|Overall Study|Lost to Follow-up|3|||
125219172|NCT01882803|450429324|FG000|Overall Study|Follow-up Completed|39|||
125219173|NCT01882803|450429324|FG000|Overall Study|Study Terminated by the Sponsor|6|||
125219174|NCT01563913|450429325|FG000|Overall Study|Physician Decision|1|||
125219175|NCT01563913|450429326|FG001|Overall Study|Physician Decision|0|||
125381184|NCT00867009|451027107|FG000|Induction Period|Nonserious Adverse Event|5|||
125381185|NCT00867009|451027107|FG000|Induction Period|Serious Adverse Event|10|||
125381186|NCT00867009|451027107|FG000|Induction Period|Death due to serious adverse event|6|||
125381187|NCT00867009|451027107|FG000|Induction Period|Death due to Study Disease|4|||
125381188|NCT00867009|451027107|FG000|Induction Period|Protocol Violation|1|||
125381189|NCT00867009|451027107|FG000|Induction Period|Withdrawal by Subject|8|||
125381190|NCT00867009|451027107|FG000|Induction Period|Physician Decision|3|||
125219176|NCT01563913|450429325|FG000|Overall Study|Spouse Passed Away|1|||
125219177|NCT01563913|450429326|FG001|Overall Study|Spouse Passed Away|0|||
125219178|NCT00705341|450429327|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
125219179|NCT00705341|450429328|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
125219180|NCT00705341|450429329|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
125219181|NCT00705341|450429330|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
125381191|NCT00867009|451027107|FG000|Induction Period|Progressive Disease (PD)|25|||
125219182|NCT00705341|450429327|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
125219183|NCT00705341|450429328|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
125219184|NCT00705341|450429329|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
125219185|NCT00705341|450429330|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
125219186|NCT00791700|450429331|FG000|Overall Study|Insufficient clinical response|1|||
125219187|NCT00791700|450429332|FG001|Overall Study|Insufficient clinical response|4|||
125219188|NCT00791700|450429333|FG002|Overall Study|Insufficient clinical response|1|||
125381192|NCT00867009|451027107|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
125381193|NCT00556712|451027115|FG000|Overall Study|Adverse Event|7|||
125381194|NCT00556712|451027116|FG001|Overall Study|Adverse Event|19|||
125381195|NCT00556712|451027115|FG000|Overall Study|Death|5|||
125381196|NCT00556712|451027116|FG001|Overall Study|Death|10|||
125381197|NCT00556712|451027115|FG000|Overall Study|Progressive Disease|383|||
125381198|NCT00556712|451027116|FG001|Overall Study|Progressive Disease|320|||
125219189|NCT00791700|450429334|FG003|Overall Study|Insufficient clinical response|8|||
125219190|NCT00791700|450429331|FG000|Overall Study|No longer willing to participate|1|||
125219191|NCT00791700|450429332|FG001|Overall Study|No longer willing to participate|1|||
125219192|NCT00791700|450429333|FG002|Overall Study|No longer willing to participate|0|||
125219193|NCT00791700|450429334|FG003|Overall Study|No longer willing to participate|8|||
125219194|NCT00791700|450429331|FG000|Overall Study|Non-compliance with study treatment|0|||
125219195|NCT00791700|450429332|FG001|Overall Study|Non-compliance with study treatment|2|||
125219196|NCT00791700|450429333|FG002|Overall Study|Non-compliance with study treatment|0|||
125219197|NCT00791700|450429334|FG003|Overall Study|Non-compliance with study treatment|4|||
125219198|NCT00791700|450429331|FG000|Overall Study|Withdrawn due to pregnancy|0|||
125219199|NCT00791700|450429332|FG001|Overall Study|Withdrawn due to pregnancy|0|||
125219200|NCT00791700|450429333|FG002|Overall Study|Withdrawn due to pregnancy|0|||
125219201|NCT00791700|450429334|FG003|Overall Study|Withdrawn due to pregnancy|1|||
125219202|NCT00791700|450429331|FG000|Overall Study|Other|0|||
125219203|NCT00791700|450429332|FG001|Overall Study|Other|1|||
125381199|NCT00556712|451027115|FG000|Overall Study|Protocol Violation|3|||
125219204|NCT00791700|450429333|FG002|Overall Study|Other|0|||
125381200|NCT00556712|451027116|FG001|Overall Study|Protocol Violation|2|||
125381201|NCT00556712|451027115|FG000|Overall Study|Refused Treatment|17|||
125219205|NCT00791700|450429334|FG003|Overall Study|Other|1|||
125219206|NCT00791700|450429331|FG000|Overall Study|Death|0|||
125381202|NCT00556712|451027116|FG001|Overall Study|Refused Treatment|16|||
125381203|NCT00556712|451027115|FG000|Overall Study|Failure to Return|2|||
125381204|NCT00556712|451027116|FG001|Overall Study|Failure to Return|3|||
125381205|NCT00556712|451027115|FG000|Overall Study|Other|2|||
125381206|NCT00556712|451027116|FG001|Overall Study|Other|2|||
125381207|NCT00556712|451027115|FG000|Overall Study|Ongoing at Data Cutoff|32|||
125381208|NCT00556712|451027116|FG001|Overall Study|Ongoing at Data Cutoff|66|||
125381209|NCT04080297|451027117|FG000|Overall Study|Adverse Event|1|||
125381210|NCT04080297|451027118|FG001|Overall Study|Adverse Event|3|||
125381211|NCT04080297|451027117|FG000|Overall Study|concurrent illness|1|||
125381212|NCT04080297|451027118|FG001|Overall Study|concurrent illness|0|||
125219207|NCT00791700|450429332|FG001|Overall Study|Death|0|||
125381213|NCT02626520|451027119|FG000|Overall Study|Physician Decision|1|||
125219208|NCT00791700|450429333|FG002|Overall Study|Death|0|||
125381214|NCT02626520|451027120|FG001|Overall Study|Physician Decision|1|||
125381215|NCT02626520|451027119|FG000|Overall Study|Adverse Event|0|||
125219209|NCT00791700|450429334|FG003|Overall Study|Death|1|||
125219210|NCT00791700|450429331|FG000|Overall Study|Lost to Follow-up|4|||
125381216|NCT02626520|451027120|FG001|Overall Study|Adverse Event|4|||
125381217|NCT02626520|451027119|FG000|Overall Study|Lack of Efficacy|0|||
125381218|NCT02626520|451027120|FG001|Overall Study|Lack of Efficacy|2|||
125381219|NCT02626520|451027119|FG000|Overall Study|Did not start protocol therapy|0|||
125381220|NCT02626520|451027120|FG001|Overall Study|Did not start protocol therapy|2|||
125381221|NCT02626520|451027119|FG000|Overall Study|Study terminated|0|||
125381222|NCT02626520|451027120|FG001|Overall Study|Study terminated|1|||
125135969|NCT03199963|450121798|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
125135970|NCT03199963|450121799|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
125135971|NCT03199963|450121798|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
125135972|NCT03199963|450121799|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
125135973|NCT03199963|450121798|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
125135974|NCT03199963|450121799|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
125135975|NCT03199963|450121798|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
125381223|NCT02200445|451027121|FG000|Overall Study|Lack of Efficacy|1|||
125381224|NCT02200445|451027122|FG001|Overall Study|Lack of Efficacy|2|||
125381225|NCT02200445|451027123|FG002|Overall Study|Lack of Efficacy|2|||
125381226|NCT02200445|451027121|FG000|Overall Study|Adverse Event|0|||
125381227|NCT02200445|451027122|FG001|Overall Study|Adverse Event|2|||
125381228|NCT02200445|451027123|FG002|Overall Study|Adverse Event|0|||
125381229|NCT03334903|451027124|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
125219211|NCT00791700|450429332|FG001|Overall Study|Lost to Follow-up|3|||
125219212|NCT00791700|450429333|FG002|Overall Study|Lost to Follow-up|4|||
125219213|NCT00791700|450429334|FG003|Overall Study|Lost to Follow-up|6|||
125219214|NCT00791700|450429331|FG000|Overall Study|Adverse Event|0|||
125219215|NCT00791700|450429332|FG001|Overall Study|Adverse Event|0|||
125381230|NCT03334903|451027125|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
125219216|NCT00791700|450429333|FG002|Overall Study|Adverse Event|1|||
125219217|NCT00791700|450429334|FG003|Overall Study|Adverse Event|1|||
125219218|NCT01720524|450429341|FG000|Part A|Insufficient Clinical Response|2|||
125219219|NCT01720524|450429342|FG001|Part A|Insufficient Clinical Response|4|||
125219220|NCT01720524|450429341|FG000|Part A|Adverse Event|2|||
125219221|NCT01720524|450429342|FG001|Part A|Adverse Event|2|||
125219222|NCT01720524|450429341|FG000|Part A|Death|2|||
125219223|NCT01720524|450429342|FG001|Part A|Death|1|||
125219224|NCT01720524|450429341|FG000|Part A|Lost to Follow-up|0|||
125219225|NCT01720524|450429342|FG001|Part A|Lost to Follow-up|1|||
125219226|NCT01720524|450429341|FG000|Part A|Missed 28 day follow-up visit|1|||
125219227|NCT01720524|450429342|FG001|Part A|Missed 28 day follow-up visit|1|||
125219228|NCT01720524|450429341|FG000|Part A|Withdrawal by Subject|0|||
125219229|NCT01720524|450429342|FG001|Part A|Withdrawal by Subject|1|||
125219230|NCT01720524|450429341|FG000|Part A|Other|0|||
125219231|NCT01720524|450429342|FG001|Part A|Other|1|||
125219232|NCT01720524|450429341|FG000|Part A|Lost to Follow-up|0|||
125219233|NCT01720524|450429342|FG001|Part A|Lost to Follow-up|1|||
125219234|NCT01720524|450429341|FG000|Part B|No longer willing to participate in study|1|||
125219235|NCT01720524|450429342|FG001|Part B|No longer willing to participate in study|4|||
125219236|NCT01720524|450429341|FG000|Part B|Other|2|||
125219237|NCT01720524|450429342|FG001|Part B|Other|0|||
125219238|NCT01720524|450429341|FG000|Part B|Lost to Follow-up|2|||
125219239|NCT01720524|450429342|FG001|Part B|Lost to Follow-up|3|||
125219240|NCT01720524|450429341|FG000|Part B|Death|0|||
125219241|NCT01720524|450429342|FG001|Part B|Death|2|||
125219242|NCT00996034|450429343|FG000|Overall Study|Lost to Follow-up|2|||
125219243|NCT00996034|450429343|FG000|Overall Study|withdrawn by PI|1|||
125219244|NCT00158262|450429347|FG000|Overall Study|Lost to Follow-up|1|||
125219245|NCT00158262|450429348|FG001|Overall Study|Lost to Follow-up|1|||
125219246|NCT00527826|450429349|FG000|Overall Study|Adverse Event|10|||
125219247|NCT00527826|450429350|FG001|Overall Study|Adverse Event|10|||
125219248|NCT00527826|450429349|FG000|Overall Study|Lost to Follow-up|3|||
125219249|NCT00527826|450429350|FG001|Overall Study|Lost to Follow-up|2|||
125219250|NCT00527826|450429349|FG000|Overall Study|Withdrawal by Subject|5|||
125219251|NCT00527826|450429350|FG001|Overall Study|Withdrawal by Subject|8|||
125219252|NCT00527826|450429349|FG000|Overall Study|Inclusion Criteria Not Met|3|||
125219253|NCT00527826|450429350|FG001|Overall Study|Inclusion Criteria Not Met|3|||
125219254|NCT00527826|450429349|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
125219255|NCT00527826|450429350|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
125219256|NCT00527826|450429349|FG000|Overall Study|Additional Intake of Viani forte|0|||
125219257|NCT00527826|450429350|FG001|Overall Study|Additional Intake of Viani forte|1|||
125219258|NCT00527826|450429349|FG000|Overall Study|Participant moved away|0|||
125219259|NCT00527826|450429350|FG001|Overall Study|Participant moved away|1|||
125219260|NCT02105285|450429353|FG000|Overall Study|Adverse Event|1|||
125219261|NCT02105285|450429354|FG001|Overall Study|Adverse Event|1|||
125219262|NCT02105285|450429355|FG002|Overall Study|Adverse Event|0|||
125219263|NCT02105285|450429353|FG000|Overall Study|Protocol Violation|0|||
125219264|NCT02105285|450429354|FG001|Overall Study|Protocol Violation|1|||
125219265|NCT02105285|450429355|FG002|Overall Study|Protocol Violation|0|||
125219266|NCT02105285|450429353|FG000|Overall Study|Withdrawal by Subject|1|||
125219267|NCT02105285|450429354|FG001|Overall Study|Withdrawal by Subject|0|||
125219268|NCT02105285|450429355|FG002|Overall Study|Withdrawal by Subject|0|||
125219269|NCT01421641|450429356|FG000|Overall Study|Protocol Violation|2|||
125219270|NCT01421641|450429357|FG001|Overall Study|Protocol Violation|2|||
125219271|NCT02585713|450429362|FG000|Overall Study|Withdrew prior to treatment|2|||
125219272|NCT02585713|450429363|FG001|Overall Study|Withdrew prior to treatment|7|||
125219273|NCT02585713|450429362|FG000|Overall Study|Other|3|||
125219274|NCT02585713|450429363|FG001|Overall Study|Other|1|||
125219275|NCT03173456|450429366|FG000|Baseline|Medication dispensing system malfunction'|0|||
125219276|NCT03173456|450429367|FG001|Baseline|Medication dispensing system malfunction'|1|||
125219277|NCT03173456|450429368|FG002|Baseline|Medication dispensing system malfunction'|0|||
125219278|NCT03173456|450429369|FG003|Baseline|Medication dispensing system malfunction'|0|||
125219279|NCT03173456|450429370|FG004|Baseline|Medication dispensing system malfunction'|2|||
125219280|NCT03173456|450429366|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
125219281|NCT03173456|450429367|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
125219282|NCT03173456|450429368|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
125219283|NCT03173456|450429369|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
125219284|NCT03173456|450429370|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
125219285|NCT01733121|450429371|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
125219286|NCT01733121|450429372|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
125219287|NCT01733121|450429371|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
125219288|NCT01733121|450429372|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
125219289|NCT01733121|450429371|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
125219290|NCT01733121|450429372|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
125219291|NCT01733121|450429371|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
125219292|NCT01733121|450429372|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
125219293|NCT03061188|450429381|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
125219294|NCT03061188|450429382|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
125219295|NCT03061188|450429383|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
125219296|NCT03061188|450429384|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
125219297|NCT03061188|450429381|FG000|On Follow-up for 3 Years|Death|0|||
125219298|NCT03061188|450429382|FG001|On Follow-up for 3 Years|Death|3|||
125219299|NCT03061188|450429383|FG002|On Follow-up for 3 Years|Death|5|||
125219300|NCT03061188|450429384|FG003|On Follow-up for 3 Years|Death|4|||
125381231|NCT03334903|451027124|FG000|Overall Study|Protocol Violation|1|||
125219301|NCT03061188|450429381|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
125381232|NCT03334903|451027125|FG001|Overall Study|Protocol Violation|3|||
125219302|NCT03061188|450429382|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
125381233|NCT03334903|451027124|FG000|Overall Study|Surgery postponed|1|||
125219303|NCT03061188|450429383|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
125219304|NCT03061188|450429384|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
125219305|NCT04501952|450429385|FG000|Overall Study|Adverse Event|0|||
125381234|NCT03334903|451027125|FG001|Overall Study|Surgery postponed|0|||
125219306|NCT04501952|450429386|FG001|Overall Study|Adverse Event|3|||
125381235|NCT03334903|451027124|FG000|Overall Study|Adverse Event|1|||
125381236|NCT03334903|451027125|FG001|Overall Study|Adverse Event|1|||
125381237|NCT03334903|451027124|FG000|Overall Study|Withdrawal by Subject|0|||
125219307|NCT04501952|450429385|FG000|Overall Study|Investigator's Discretion|0|||
125219308|NCT04501952|450429386|FG001|Overall Study|Investigator's Discretion|1|||
125219309|NCT04501952|450429385|FG000|Overall Study|Protocol Violation|1|||
125437284|NCT00406419|451228049|FG000|Overall Study|Withdrawal by Subject|17|||
125437285|NCT00406419|451228050|FG001|Overall Study|Withdrawal by Subject|24|||
125437286|NCT00406419|451228051|FG002|Overall Study|Withdrawal by Subject|26|||
125437287|NCT00406419|451228049|FG000|Overall Study|Lack of Efficacy|12|||
125381238|NCT03334903|451027125|FG001|Overall Study|Withdrawal by Subject|1|||
125381239|NCT00353262|451027126|FG000|Overall Study|Adverse Event|8|||
125381240|NCT00353262|451027126|FG000|Overall Study|Withdrawal by Subject|2|||
125381241|NCT00353262|451027126|FG000|Overall Study|Insufficient Therapeutic Response|13|||
125381242|NCT00353262|451027126|FG000|Overall Study|Progression|1|||
125381243|NCT00353262|451027126|FG000|Overall Study|Surgery|4|||
125381244|NCT00353262|451027126|FG000|Overall Study|Break from Chemotherapy|1|||
125381245|NCT00463346|451029028|FG000|Overall Study|Withdrawal by Subject|3|||
125381246|NCT00463346|451029029|FG001|Overall Study|Withdrawal by Subject|3|||
125381247|NCT01572909|451029031|FG000|Overall Study|Adverse Event|7|||
125381248|NCT01572909|451029032|FG001|Overall Study|Adverse Event|2|||
125381249|NCT01572909|451029031|FG000|Overall Study|Death|3|||
125381250|NCT01572909|451029032|FG001|Overall Study|Death|1|||
125381251|NCT01572909|451029031|FG000|Overall Study|Lost to Follow-up|8|||
125381252|NCT01572909|451029032|FG001|Overall Study|Lost to Follow-up|7|||
125381253|NCT01572909|451029031|FG000|Overall Study|Physician Decision|1|||
125381254|NCT01572909|451029032|FG001|Overall Study|Physician Decision|1|||
125381255|NCT01572909|451029031|FG000|Overall Study|Technical Issues|1|||
125381256|NCT01572909|451029032|FG001|Overall Study|Technical Issues|0|||
125381257|NCT01572909|451029031|FG000|Overall Study|Withdrawal by Subject|12|||
125381258|NCT01572909|451029032|FG001|Overall Study|Withdrawal by Subject|11|||
125437288|NCT00406419|451228050|FG001|Overall Study|Lack of Efficacy|1|||
125437289|NCT00406419|451228051|FG002|Overall Study|Lack of Efficacy|6|||
125437290|NCT00406419|451228049|FG000|Overall Study|Non-Compliance with Study Drug|5|||
125437291|NCT00406419|451228050|FG001|Overall Study|Non-Compliance with Study Drug|6|||
125381259|NCT01572909|451029031|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
125381260|NCT01572909|451029032|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
125381261|NCT03641651|451029033|FG000|Overall Study|organizational issues at one study site|1|||
125381262|NCT04779489|451029034|FG000|Overall Study|Physician Decision|1|||
125381263|NCT00951665|451029035|FG000|Phase 1b|Adverse Event|2|||
125381264|NCT00951665|451029036|FG001|Phase 1b|Adverse Event|1|||
125381265|NCT00951665|451029037|FG002|Phase 1b|Adverse Event|0|||
125381266|NCT00951665|451029038|FG003|Phase 1b|Adverse Event|1|||
125381267|NCT00951665|451029039|FG004|Phase 1b|Adverse Event|0|||
125381268|NCT00951665|451029040|FG005|Phase 1b|Adverse Event|0|||
125381269|NCT00951665|451029035|FG000|Phase 1b|Death|1|||
125381270|NCT00951665|451029036|FG001|Phase 1b|Death|0|||
125381271|NCT00951665|451029037|FG002|Phase 1b|Death|2|||
125219310|NCT04501952|450429386|FG001|Overall Study|Protocol Violation|1|||
125219311|NCT04501952|450429385|FG000|Overall Study|Withdrew Consent|5|||
125219312|NCT04501952|450429386|FG001|Overall Study|Withdrew Consent|4|||
125219313|NCT04501952|450429385|FG000|Overall Study|Lost to Follow-up|7|||
125219314|NCT04501952|450429386|FG001|Overall Study|Lost to Follow-up|2|||
125219315|NCT04501952|450429385|FG000|Overall Study|Randomized and Never Treated|13|||
125219316|NCT04501952|450429386|FG001|Overall Study|Randomized and Never Treated|9|||
125219317|NCT02080364|450429388|FG000|Baseline Period|Protocol Violation|2|||
125219318|NCT02080364|450429389|FG001|Baseline Period|Protocol Violation|1|||
125381272|NCT00951665|451029038|FG003|Phase 1b|Death|0|||
125381273|NCT00951665|451029039|FG004|Phase 1b|Death|0|||
125381274|NCT00951665|451029040|FG005|Phase 1b|Death|0|||
125381275|NCT00951665|451029035|FG000|Phase 1b|Physician Decision|4|||
125381276|NCT00951665|451029036|FG001|Phase 1b|Physician Decision|0|||
125381277|NCT00951665|451029037|FG002|Phase 1b|Physician Decision|1|||
125381278|NCT00951665|451029038|FG003|Phase 1b|Physician Decision|0|||
125381279|NCT00951665|451029039|FG004|Phase 1b|Physician Decision|0|||
125381280|NCT00951665|451029040|FG005|Phase 1b|Physician Decision|0|||
125219319|NCT02080364|450429390|FG002|Baseline Period|Protocol Violation|0|||
125381281|NCT00951665|451029035|FG000|Phase 1b|Withdrawal by Subject|0|||
125381282|NCT00951665|451029036|FG001|Phase 1b|Withdrawal by Subject|1|||
125381283|NCT00951665|451029037|FG002|Phase 1b|Withdrawal by Subject|0|||
125381284|NCT00951665|451029038|FG003|Phase 1b|Withdrawal by Subject|0|||
125219320|NCT02080364|450429391|FG003|Baseline Period|Protocol Violation|0|||
125219321|NCT02080364|450429388|FG000|Baseline Period|Other|0|||
125219322|NCT02080364|450429389|FG001|Baseline Period|Other|1|||
125219323|NCT02080364|450429390|FG002|Baseline Period|Other|1|||
125219324|NCT02080364|450429391|FG003|Baseline Period|Other|0|||
125219325|NCT02080364|450429388|FG000|Treatment Period|Adverse Event|10|||
125219326|NCT02080364|450429389|FG001|Treatment Period|Adverse Event|15|||
125219327|NCT02080364|450429390|FG002|Treatment Period|Adverse Event|11|||
125381285|NCT00951665|451029039|FG004|Phase 1b|Withdrawal by Subject|0|||
125381286|NCT00951665|451029040|FG005|Phase 1b|Withdrawal by Subject|0|||
125381287|NCT00951665|451029035|FG000|Phase 1b|Disease Progression|13|||
125381288|NCT00951665|451029036|FG001|Phase 1b|Disease Progression|2|||
125381289|NCT00951665|451029037|FG002|Phase 1b|Disease Progression|14|||
125381290|NCT00951665|451029038|FG003|Phase 1b|Disease Progression|0|||
125381291|NCT00951665|451029039|FG004|Phase 1b|Disease Progression|0|||
125381292|NCT00951665|451029040|FG005|Phase 1b|Disease Progression|0|||
125381293|NCT00951665|451029035|FG000|Phase 1b|Protocol Violation|2|||
125381294|NCT00951665|451029036|FG001|Phase 1b|Protocol Violation|0|||
125381295|NCT00951665|451029037|FG002|Phase 1b|Protocol Violation|0|||
125381296|NCT00951665|451029038|FG003|Phase 1b|Protocol Violation|0|||
125381297|NCT00951665|451029039|FG004|Phase 1b|Protocol Violation|0|||
125219328|NCT02080364|450429391|FG003|Treatment Period|Adverse Event|14|||
125381298|NCT00951665|451029040|FG005|Phase 1b|Protocol Violation|0|||
125381299|NCT00951665|451029035|FG000|Phase 2a|Adverse Event|0|||
125219329|NCT02080364|450429388|FG000|Treatment Period|Lost to Follow-up|2|||
125219330|NCT02080364|450429389|FG001|Treatment Period|Lost to Follow-up|3|||
125381300|NCT00951665|451029036|FG001|Phase 2a|Adverse Event|0|||
125381301|NCT00951665|451029037|FG002|Phase 2a|Adverse Event|0|||
125381302|NCT00951665|451029038|FG003|Phase 2a|Adverse Event|0|||
125381303|NCT00951665|451029039|FG004|Phase 2a|Adverse Event|2|||
125381304|NCT00951665|451029040|FG005|Phase 2a|Adverse Event|0|||
125381305|NCT00951665|451029035|FG000|Phase 2a|Death|0|||
125381306|NCT00951665|451029036|FG001|Phase 2a|Death|0|||
125381307|NCT00951665|451029037|FG002|Phase 2a|Death|0|||
125381308|NCT00951665|451029038|FG003|Phase 2a|Death|0|||
125381309|NCT00951665|451029039|FG004|Phase 2a|Death|1|||
125381310|NCT00951665|451029040|FG005|Phase 2a|Death|1|||
125381311|NCT00951665|451029035|FG000|Phase 2a|Lost to Follow-up|0|||
125381312|NCT00951665|451029036|FG001|Phase 2a|Lost to Follow-up|0|||
125381313|NCT00951665|451029037|FG002|Phase 2a|Lost to Follow-up|0|||
125381314|NCT00951665|451029038|FG003|Phase 2a|Lost to Follow-up|0|||
125381315|NCT00951665|451029039|FG004|Phase 2a|Lost to Follow-up|1|||
125381316|NCT00951665|451029040|FG005|Phase 2a|Lost to Follow-up|0|||
125381317|NCT00951665|451029035|FG000|Phase 2a|Physician Decision|0|||
125219331|NCT02080364|450429390|FG002|Treatment Period|Lost to Follow-up|5|||
125219332|NCT02080364|450429391|FG003|Treatment Period|Lost to Follow-up|0|||
125381318|NCT00951665|451029036|FG001|Phase 2a|Physician Decision|0|||
125219333|NCT02080364|450429388|FG000|Treatment Period|Protocol Violation|5|||
125219334|NCT02080364|450429389|FG001|Treatment Period|Protocol Violation|3|||
125219335|NCT02080364|450429390|FG002|Treatment Period|Protocol Violation|5|||
125219336|NCT02080364|450429391|FG003|Treatment Period|Protocol Violation|1|||
125219337|NCT02080364|450429388|FG000|Treatment Period|Withdrawal by Subject|16|||
125219338|NCT02080364|450429389|FG001|Treatment Period|Withdrawal by Subject|16|||
125219339|NCT02080364|450429390|FG002|Treatment Period|Withdrawal by Subject|15|||
125219340|NCT02080364|450429391|FG003|Treatment Period|Withdrawal by Subject|10|||
125219341|NCT02080364|450429388|FG000|Treatment Period|Study Terminated by Sponsor|0|||
125219342|NCT02080364|450429389|FG001|Treatment Period|Study Terminated by Sponsor|0|||
125219343|NCT02080364|450429390|FG002|Treatment Period|Study Terminated by Sponsor|180|||
125219344|NCT02080364|450429391|FG003|Treatment Period|Study Terminated by Sponsor|183|||
125219345|NCT02080364|450429388|FG000|Treatment Period|Other|14|||
125219346|NCT02080364|450429389|FG001|Treatment Period|Other|12|||
125219347|NCT02080364|450429390|FG002|Treatment Period|Other|21|||
125219348|NCT02080364|450429391|FG003|Treatment Period|Other|16|||
125219349|NCT02609984|450429395|FG000|Overall Study|Death|29|||
125219350|NCT02609984|450429396|FG001|Overall Study|Death|26|||
125219351|NCT02609984|450429395|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
125219352|NCT02609984|450429396|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
125219353|NCT02609984|450429395|FG000|Overall Study|Lost to Follow-up|1|||
125219354|NCT02609984|450429396|FG001|Overall Study|Lost to Follow-up|2|||
125219355|NCT02609984|450429395|FG000|Overall Study|Withdrawal by Subject|0|||
125219356|NCT02609984|450429396|FG001|Overall Study|Withdrawal by Subject|1|||
125219357|NCT02609984|450429395|FG000|Overall Study|Disease Progression|2|||
125219358|NCT02609984|450429396|FG001|Overall Study|Disease Progression|0|||
125381319|NCT00951665|451029037|FG002|Phase 2a|Physician Decision|0|||
125219359|NCT02504320|450429397|FG000|Treatment Period 1|Positive Drug Screen|0|||
125219360|NCT02504320|450429398|FG001|Treatment Period 1|Positive Drug Screen|0|||
125219361|NCT02504320|450429399|FG002|Treatment Period 1|Positive Drug Screen|1|||
125381320|NCT00951665|451029038|FG003|Phase 2a|Physician Decision|0|||
125219362|NCT02504320|450429400|FG003|Treatment Period 1|Positive Drug Screen|0|||
125219363|NCT02504320|450429397|FG000|Treatment Period 2|Positive Drug Screen|0|||
125219364|NCT02504320|450429398|FG001|Treatment Period 2|Positive Drug Screen|1|||
125219365|NCT02504320|450429399|FG002|Treatment Period 2|Positive Drug Screen|0|||
125219366|NCT02504320|450429400|FG003|Treatment Period 2|Positive Drug Screen|0|||
125219367|NCT02504320|450429397|FG000|Treatment Period 3|Positive Drug Screen|0|||
125219368|NCT02504320|450429398|FG001|Treatment Period 3|Positive Drug Screen|0|||
125219369|NCT02504320|450429399|FG002|Treatment Period 3|Positive Drug Screen|0|||
125219370|NCT02504320|450429400|FG003|Treatment Period 3|Positive Drug Screen|1|||
125219371|NCT02504320|450429397|FG000|Treatment Period 3|Adverse Event|0|||
125219372|NCT02504320|450429398|FG001|Treatment Period 3|Adverse Event|0|||
125219373|NCT02504320|450429399|FG002|Treatment Period 3|Adverse Event|1|||
125219374|NCT02504320|450429400|FG003|Treatment Period 3|Adverse Event|0|||
125219375|NCT01210222|450429401|FG000|Overall Study|Ineligible|2|||
125219376|NCT01210222|450429401|FG000|Overall Study|Never treated|1|||
125219377|NCT04978337|450429404|FG000|Overall Study|Withdrawal by Subject|0|||
125219378|NCT04978337|450429405|FG001|Overall Study|Withdrawal by Subject|1|||
125219379|NCT02497404|450429406|FG000|Overall Study|Adverse Event|1|||
125219380|NCT01408901|450429409|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
125219381|NCT01408901|450429410|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
125219382|NCT01408901|450429411|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
125219383|NCT01408901|450429412|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
125219384|NCT01408901|450429409|FG000|6-Week Follow-Up|Death|1|||
125219385|NCT01408901|450429410|FG001|6-Week Follow-Up|Death|0|||
125219386|NCT01408901|450429411|FG002|6-Week Follow-Up|Death|0|||
125219387|NCT01408901|450429412|FG003|6-Week Follow-Up|Death|0|||
125219388|NCT01408901|450429409|FG000|6-Week Follow-Up|Cancelled visit|0|||
125219389|NCT01408901|450429410|FG001|6-Week Follow-Up|Cancelled visit|1|||
125219390|NCT01408901|450429411|FG002|6-Week Follow-Up|Cancelled visit|0|||
125219391|NCT01408901|450429412|FG003|6-Week Follow-Up|Cancelled visit|2|||
125219392|NCT01408901|450429409|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
125219393|NCT01408901|450429410|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
125219394|NCT01408901|450429411|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
125219395|NCT01408901|450429412|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
125219396|NCT01408901|450429409|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
125219397|NCT01408901|450429410|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
125219398|NCT01408901|450429411|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
125219399|NCT01408901|450429412|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
125219400|NCT01408901|450429409|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
125219401|NCT01408901|450429410|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
125219402|NCT01408901|450429411|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
125219403|NCT01408901|450429412|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
125219404|NCT01408901|450429409|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
125219405|NCT01408901|450429410|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
125219406|NCT01408901|450429411|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
125219407|NCT01408901|450429412|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
125219408|NCT01408901|450429409|FG000|26-Week Follow-Up|Death|0|||
125219409|NCT01408901|450429410|FG001|26-Week Follow-Up|Death|1|||
125219410|NCT01408901|450429411|FG002|26-Week Follow-Up|Death|0|||
125219411|NCT01408901|450429412|FG003|26-Week Follow-Up|Death|0|||
125219412|NCT01436227|450429416|FG000|Overall Study|Adverse Event|7|||
125219413|NCT01436227|450429416|FG000|Overall Study|Death|1|||
125219414|NCT01436227|450429416|FG000|Overall Study|Lack of Efficacy|1|||
125219415|NCT01436227|450429416|FG000|Overall Study|Lost to Follow-up|3|||
125219416|NCT01436227|450429416|FG000|Overall Study|Physician Decision|1|||
125219417|NCT01436227|450429416|FG000|Overall Study|Withdrawal by Subject|7|||
125219418|NCT01436227|450429416|FG000|Overall Study|Disease progression, relapse|6|||
125219419|NCT05464420|450429421|FG000|Overall Study|Death|0|||
125219420|NCT05464420|450429422|FG001|Overall Study|Death|0|||
125219421|NCT05464420|450429423|FG002|Overall Study|Death|0|||
125219422|NCT05464420|450429424|FG003|Overall Study|Death|1|||
125219423|NCT05464420|450429421|FG000|Overall Study|Lost to Follow-up|16|||
125219424|NCT05464420|450429422|FG001|Overall Study|Lost to Follow-up|11|||
125219425|NCT05464420|450429423|FG002|Overall Study|Lost to Follow-up|11|||
125219426|NCT05464420|450429424|FG003|Overall Study|Lost to Follow-up|11|||
125219427|NCT05464420|450429421|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
125219428|NCT05464420|450429422|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
125219429|NCT05464420|450429423|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
125219430|NCT05464420|450429424|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
125219431|NCT05464420|450429421|FG000|Overall Study|Withdrawal by Subject|4|||
125219432|NCT05464420|450429422|FG001|Overall Study|Withdrawal by Subject|8|||
125219433|NCT05464420|450429423|FG002|Overall Study|Withdrawal by Subject|3|||
125219434|NCT05464420|450429424|FG003|Overall Study|Withdrawal by Subject|1|||
125219435|NCT05464420|450429421|FG000|Overall Study|Protocol Violation|0|||
125219436|NCT05464420|450429422|FG001|Overall Study|Protocol Violation|0|||
125381321|NCT00951665|451029039|FG004|Phase 2a|Physician Decision|0|||
125219437|NCT05464420|450429423|FG002|Overall Study|Protocol Violation|1|||
125219438|NCT05464420|450429424|FG003|Overall Study|Protocol Violation|1|||
125381322|NCT00951665|451029040|FG005|Phase 2a|Physician Decision|1|||
125381323|NCT00951665|451029035|FG000|Phase 2a|Withdrawal by Subject|0|||
125381324|NCT00951665|451029036|FG001|Phase 2a|Withdrawal by Subject|0|||
125381325|NCT00951665|451029037|FG002|Phase 2a|Withdrawal by Subject|0|||
125381326|NCT00951665|451029038|FG003|Phase 2a|Withdrawal by Subject|0|||
125381327|NCT00951665|451029039|FG004|Phase 2a|Withdrawal by Subject|2|||
125381328|NCT00951665|451029040|FG005|Phase 2a|Withdrawal by Subject|0|||
125381329|NCT00951665|451029035|FG000|Phase 2a|Disease Progression|0|||
125381330|NCT00951665|451029036|FG001|Phase 2a|Disease Progression|0|||
125381331|NCT00951665|451029037|FG002|Phase 2a|Disease Progression|0|||
125219439|NCT05464420|450429421|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
125219440|NCT05464420|450429422|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
125219441|NCT05464420|450429423|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
125219442|NCT05464420|450429424|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
125219443|NCT01383018|450429425|FG000|Overall Study|Adverse Event|14|||
125219444|NCT01383018|450429425|FG000|Overall Study|Death|10|||
125219445|NCT01383018|450429425|FG000|Overall Study|Lost to Follow-up|5|||
125219446|NCT01383018|450429425|FG000|Overall Study|Physician Decision|5|||
125219447|NCT01383018|450429425|FG000|Overall Study|Withdrawal by Subject|9|||
125219448|NCT01383018|450429425|FG000|Overall Study|Subject not implanted|76|||
125219449|NCT01383018|450429425|FG000|Overall Study|Missed Visit|247|||
125219450|NCT01383018|450429425|FG000|Overall Study|Site closed early-not compliance related|7|||
125219451|NCT01383018|450429425|FG000|Overall Study|Patient moved away from site|1|||
125219452|NCT01383018|450429425|FG000|Overall Study|Subject Incarcerated|1|||
125219453|NCT03414229|450429428|FG000|Overall Study|Adverse Event|1|||
125219454|NCT03414229|450429429|FG001|Overall Study|Adverse Event|0|||
125219455|NCT03414229|450429430|FG002|Overall Study|Adverse Event|2|||
125219456|NCT03414229|450429431|FG003|Overall Study|Adverse Event|1|||
125219457|NCT03414229|450429428|FG000|Overall Study|Lack of Efficacy|7|||
125219458|NCT03414229|450429429|FG001|Overall Study|Lack of Efficacy|4|||
125381332|NCT00951665|451029038|FG003|Phase 2a|Disease Progression|0|||
125219459|NCT03414229|450429430|FG002|Overall Study|Lack of Efficacy|1|||
125219460|NCT03414229|450429431|FG003|Overall Study|Lack of Efficacy|9|||
125219461|NCT03414229|450429428|FG000|Overall Study|Change in therapy|1|||
125219462|NCT03414229|450429429|FG001|Overall Study|Change in therapy|0|||
125219463|NCT03414229|450429430|FG002|Overall Study|Change in therapy|0|||
125381333|NCT00951665|451029039|FG004|Phase 2a|Disease Progression|6|||
125381334|NCT00951665|451029040|FG005|Phase 2a|Disease Progression|5|||
125381335|NCT02723084|451029041|FG000|Overall Study|Withdrawal by Subject|1|||
125381336|NCT02723084|451029042|FG001|Overall Study|Withdrawal by Subject|1|||
125381337|NCT02723084|451029041|FG000|Overall Study|Lost to Follow-up|3|||
125381338|NCT02723084|451029042|FG001|Overall Study|Lost to Follow-up|0|||
125381339|NCT02450903|451029045|FG000|Overall Study|Adverse Event|3|||
125381340|NCT02450903|451029045|FG000|Overall Study|Progressive disease|15|||
125381341|NCT02450903|451029045|FG000|Overall Study|Switched to commercial drug|1|||
125381342|NCT02450903|451029045|FG000|Overall Study|Subject/guardian decision|1|||
125381343|NCT01164956|451029046|FG000|Overall Study|Side Effects|1|||
125381344|NCT01164956|451029047|FG001|Overall Study|Side Effects|0|||
125437292|NCT00406419|451228051|FG002|Overall Study|Non-Compliance with Study Drug|3|||
125219464|NCT03414229|450429431|FG003|Overall Study|Change in therapy|0|||
125219465|NCT03414229|450429428|FG000|Overall Study|Pregnancy|0|||
125381345|NCT01164956|451029048|FG002|Overall Study|Side Effects|1|||
125381346|NCT00967798|451029049|FG000|Overall Study|Withdrawal by Subject|5|||
125381347|NCT00967798|451029050|FG001|Overall Study|Withdrawal by Subject|2|||
125437293|NCT00406419|451228049|FG000|Overall Study|Adverse Event|10|||
125219466|NCT03414229|450429429|FG001|Overall Study|Pregnancy|0|||
125381348|NCT00967798|451029049|FG000|Overall Study|Lost to Follow-up|4|||
125381349|NCT00967798|451029050|FG001|Overall Study|Lost to Follow-up|1|||
125219467|NCT03414229|450429430|FG002|Overall Study|Pregnancy|1|||
125219468|NCT03414229|450429431|FG003|Overall Study|Pregnancy|0|||
125219469|NCT03414229|450429428|FG000|Overall Study|Withdrawal by Subject|0|||
125219470|NCT03414229|450429429|FG001|Overall Study|Withdrawal by Subject|1|||
125219471|NCT03414229|450429430|FG002|Overall Study|Withdrawal by Subject|1|||
125219472|NCT03414229|450429431|FG003|Overall Study|Withdrawal by Subject|0|||
125219473|NCT04533438|450429435|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
125219474|NCT04533438|450429436|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
125219475|NCT05279131|450429437|FG000|Overall Study|Lost to Follow-up|1|||
125219476|NCT05279131|450429437|FG000|Overall Study|Death|1|||
125219477|NCT05279131|450429437|FG000|Overall Study|Physician Decision|1|||
125219478|NCT01066871|450429450|FG000|Overall Study|Lost to Follow-up|0|||
125219479|NCT01066871|450429451|FG001|Overall Study|Lost to Follow-up|2|||
125219480|NCT01066871|450429452|FG002|Overall Study|Lost to Follow-up|2|||
125219481|NCT01066871|450429453|FG003|Overall Study|Lost to Follow-up|0|||
125219482|NCT01066871|450429450|FG000|Overall Study|Protocol Violation|1|||
125219483|NCT01066871|450429451|FG001|Overall Study|Protocol Violation|0|||
125219484|NCT01066871|450429452|FG002|Overall Study|Protocol Violation|3|||
125219485|NCT01066871|450429453|FG003|Overall Study|Protocol Violation|2|||
125219486|NCT01066871|450429450|FG000|Overall Study|Lack of Efficacy|0|||
125219487|NCT01066871|450429451|FG001|Overall Study|Lack of Efficacy|0|||
125219488|NCT01066871|450429452|FG002|Overall Study|Lack of Efficacy|0|||
125219489|NCT01066871|450429453|FG003|Overall Study|Lack of Efficacy|1|||
125219490|NCT01066871|450429450|FG000|Overall Study|Withdrawal by Subject|3|||
125219491|NCT01066871|450429451|FG001|Overall Study|Withdrawal by Subject|1|||
125219492|NCT01066871|450429452|FG002|Overall Study|Withdrawal by Subject|0|||
125219493|NCT01066871|450429453|FG003|Overall Study|Withdrawal by Subject|0|||
125219494|NCT01066871|450429450|FG000|Overall Study|Other|0|||
125219495|NCT01066871|450429451|FG001|Overall Study|Other|2|||
125219496|NCT01066871|450429452|FG002|Overall Study|Other|1|||
125219497|NCT01066871|450429453|FG003|Overall Study|Other|2|||
125219498|NCT04162795|450429454|FG000|Overall Study|Other|16|||
125219499|NCT04162795|450429454|FG000|Overall Study|Screen failures|10|||
125219500|NCT04530838|450431124|FG000|Overall Study|Other|2|||
125219501|NCT04530838|450431125|FG001|Overall Study|Other|1|||
125219502|NCT04530838|450431126|FG002|Overall Study|Other|0|||
125219503|NCT04530838|450431124|FG000|Overall Study|Physician Decision|0|||
125381350|NCT01409564|451029051|FG000|Overall Study|low medication compliance|4|||
125381351|NCT01409564|451029052|FG001|Overall Study|low medication compliance|3|||
125381352|NCT01409564|451029051|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
125381353|NCT01409564|451029052|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
125381354|NCT00082355|451029055|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
125381355|NCT00082355|451029055|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
125219504|NCT04530838|450431125|FG001|Overall Study|Physician Decision|0|||
125381356|NCT00082355|451029055|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
125437294|NCT00406419|451228050|FG001|Overall Study|Adverse Event|12|||
125219505|NCT04530838|450431126|FG002|Overall Study|Physician Decision|1|||
125219506|NCT04530838|450431124|FG000|Overall Study|Death|0|||
125219507|NCT04530838|450431125|FG001|Overall Study|Death|0|||
125219508|NCT04530838|450431126|FG002|Overall Study|Death|1|||
125219509|NCT04530838|450431124|FG000|Overall Study|Adverse Event|0|||
125219510|NCT04530838|450431125|FG001|Overall Study|Adverse Event|1|||
125219511|NCT04530838|450431126|FG002|Overall Study|Adverse Event|0|||
125219512|NCT04530838|450431124|FG000|Overall Study|No longer meets eligibility criteria|1|||
125219513|NCT04530838|450431125|FG001|Overall Study|No longer meets eligibility criteria|0|||
125219514|NCT04530838|450431126|FG002|Overall Study|No longer meets eligibility criteria|2|||
125219515|NCT04530838|450431124|FG000|Overall Study|Withdrawal by parent/guardian|5|||
125219516|NCT04530838|450431125|FG001|Overall Study|Withdrawal by parent/guardian|2|||
125219517|NCT04530838|450431126|FG002|Overall Study|Withdrawal by parent/guardian|2|||
125219518|NCT00803712|450431127|FG000|Overall Study|Noncompliance|3|||
125219519|NCT00803712|450431128|FG001|Overall Study|Noncompliance|0|||
125219520|NCT00803712|450431127|FG000|Overall Study|Adverse Event|5|||
125219521|NCT00803712|450431128|FG001|Overall Study|Adverse Event|0|||
125219522|NCT00803712|450431127|FG000|Overall Study|Death|8|||
125219523|NCT00803712|450431128|FG001|Overall Study|Death|7|||
125219524|NCT00803712|450431127|FG000|Overall Study|Lost to Follow-up|3|||
125219525|NCT00803712|450431128|FG001|Overall Study|Lost to Follow-up|1|||
125219526|NCT00803712|450431127|FG000|Overall Study|Withdrawal by Subject|2|||
125219527|NCT00803712|450431128|FG001|Overall Study|Withdrawal by Subject|4|||
125219528|NCT00803712|450431127|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
125219529|NCT00803712|450431128|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
125219530|NCT00803712|450431127|FG000|Overall Study|Protocol criteria (other)|0|||
125219531|NCT00803712|450431128|FG001|Overall Study|Protocol criteria (other)|2|||
125219532|NCT00803712|450431127|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
125219533|NCT00803712|450431128|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
125219534|NCT00803712|450431127|FG000|Overall Study|Administrative decision|2|||
125219535|NCT00803712|450431128|FG001|Overall Study|Administrative decision|3|||
125219536|NCT00803712|450431127|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
125219537|NCT00803712|450431128|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
125219538|NCT00669318|450431140|FG000|Overall Study|Withdrawal by Subject|2|||
125219539|NCT01073163|450431141|FG000|Overall Study|Adverse Event|1|||
125219540|NCT01073163|450431141|FG000|Overall Study|Disease Progression|1|||
125219541|NCT01073163|450431141|FG000|Overall Study|Early termination|1|||
125219542|NCT03272347|450431142|FG000|Overall Study|Death|0|||
125219543|NCT03272347|450431143|FG001|Overall Study|Death|0|||
125219544|NCT03272347|450431144|FG002|Overall Study|Death|0|||
125219545|NCT03272347|450431145|FG003|Overall Study|Death|1|||
125219546|NCT03272347|450431142|FG000|Overall Study|Lost to Follow-up|1|||
125219547|NCT03272347|450431143|FG001|Overall Study|Lost to Follow-up|3|||
125219548|NCT03272347|450431144|FG002|Overall Study|Lost to Follow-up|5|||
125219549|NCT03272347|450431145|FG003|Overall Study|Lost to Follow-up|1|||
125219550|NCT03272347|450431142|FG000|Overall Study|Physician Decision|4|||
125219551|NCT03272347|450431143|FG001|Overall Study|Physician Decision|2|||
125219552|NCT03272347|450431144|FG002|Overall Study|Physician Decision|5|||
125219553|NCT03272347|450431145|FG003|Overall Study|Physician Decision|4|||
125219554|NCT03272347|450431142|FG000|Overall Study|Screen Failure|1|||
125219555|NCT03272347|450431143|FG001|Overall Study|Screen Failure|0|||
125219556|NCT03272347|450431144|FG002|Overall Study|Screen Failure|0|||
125219557|NCT03272347|450431145|FG003|Overall Study|Screen Failure|0|||
125219558|NCT03272347|450431142|FG000|Overall Study|Withdrawal by Subject|5|||
125219559|NCT03272347|450431143|FG001|Overall Study|Withdrawal by Subject|1|||
125219560|NCT03272347|450431144|FG002|Overall Study|Withdrawal by Subject|2|||
125219561|NCT03272347|450431145|FG003|Overall Study|Withdrawal by Subject|1|||
125219562|NCT01677182|450431150|FG000|Overall Study|Adverse Event|2|||
125219563|NCT01677182|450431151|FG001|Overall Study|Adverse Event|1|||
125219564|NCT01677182|450431152|FG002|Overall Study|Adverse Event|8|||
125219565|NCT01677182|450431150|FG000|Overall Study|Protocol Violation|5|||
125219566|NCT01677182|450431151|FG001|Overall Study|Protocol Violation|1|||
125219567|NCT01677182|450431152|FG002|Overall Study|Protocol Violation|4|||
125219568|NCT01677182|450431150|FG000|Overall Study|Lost to Follow-up|4|||
125219569|NCT01677182|450431151|FG001|Overall Study|Lost to Follow-up|0|||
125219570|NCT01677182|450431152|FG002|Overall Study|Lost to Follow-up|3|||
125219571|NCT01677182|450431150|FG000|Overall Study|Withdrawal by Subject|7|||
125219572|NCT01677182|450431151|FG001|Overall Study|Withdrawal by Subject|12|||
125219573|NCT01677182|450431152|FG002|Overall Study|Withdrawal by Subject|10|||
125219574|NCT01677182|450431150|FG000|Overall Study|Study termination|12|||
125219575|NCT01677182|450431151|FG001|Overall Study|Study termination|9|||
125219576|NCT01677182|450431152|FG002|Overall Study|Study termination|11|||
125219577|NCT01677182|450431150|FG000|Overall Study|Lack of Efficacy|3|||
125219578|NCT01677182|450431151|FG001|Overall Study|Lack of Efficacy|0|||
125219579|NCT01677182|450431152|FG002|Overall Study|Lack of Efficacy|1|||
125219580|NCT01677182|450431150|FG000|Overall Study|Other reasons|1|||
125219581|NCT01677182|450431151|FG001|Overall Study|Other reasons|5|||
125219582|NCT01677182|450431152|FG002|Overall Study|Other reasons|2|||
125219583|NCT00762762|450431155|FG000|Overall Study|Did not return for appointments|6|||
125219584|NCT00762762|450431156|FG001|Overall Study|Did not return for appointments|8|||
125219585|NCT02489448|450431157|FG000|Overall Study|Death|3|||
125219586|NCT02489448|450431157|FG000|Overall Study|Withdrawal by Subject|2|||
125219587|NCT00391872|450431158|FG000|Overall Study|Protocol Violation|7|||
125219588|NCT00391872|450431159|FG001|Overall Study|Protocol Violation|2|||
125219589|NCT00391872|450431158|FG000|Overall Study|Withdrawal by Subject|296|||
125219590|NCT00391872|450431159|FG001|Overall Study|Withdrawal by Subject|249|||
125381357|NCT03020407|451029063|FG000|Overall Study|Withdrawal by Subject|2|||
125381358|NCT03020407|451029064|FG001|Overall Study|Withdrawal by Subject|1|||
125381359|NCT03020407|451029063|FG000|Overall Study|Lost to Follow-up|2|||
125381360|NCT03020407|451029064|FG001|Overall Study|Lost to Follow-up|3|||
125219591|NCT00391872|450431158|FG000|Overall Study|Reason unknown|2|||
125219592|NCT00391872|450431159|FG001|Overall Study|Reason unknown|4|||
125219593|NCT00391872|450431158|FG000|Overall Study|Lost to Follow-up|2|||
125219594|NCT00391872|450431159|FG001|Overall Study|Lost to Follow-up|0|||
125219595|NCT00215644|450431163|FG000|Overall Study|Disease Progression|28|||
125219596|NCT00215644|450431164|FG001|Overall Study|Disease Progression|10|||
125219597|NCT00215644|450431163|FG000|Overall Study|Adverse Event|2|||
125219598|NCT00215644|450431164|FG001|Overall Study|Adverse Event|9|||
125219599|NCT00215644|450431163|FG000|Overall Study|Death|1|||
125219600|NCT00215644|450431164|FG001|Overall Study|Death|2|||
125219601|NCT00215644|450431163|FG000|Overall Study|Withdrawal by Subject|1|||
125219602|NCT00215644|450431164|FG001|Overall Study|Withdrawal by Subject|0|||
125219603|NCT00215644|450431163|FG000|Overall Study|Other|3|||
125381361|NCT03020407|451029063|FG000|Overall Study|Protocol Violation|0|||
125219604|NCT00215644|450431164|FG001|Overall Study|Other|15|||
125219605|NCT00215644|450431163|FG000|Overall Study|Randomized but Not Treated|1|||
125381362|NCT03020407|451029064|FG001|Overall Study|Protocol Violation|1|||
125381363|NCT00708162|451029065|FG000|Randomized Phase|Randomized but Not Treated|7|||
125381364|NCT00708162|451029066|FG001|Randomized Phase|Randomized but Not Treated|5|||
125381365|NCT00708162|451029065|FG000|Randomized Phase|Participant Noncompliance|40|||
125381366|NCT00708162|451029066|FG001|Randomized Phase|Participant Noncompliance|32|||
125381367|NCT00708162|451029065|FG000|Randomized Phase|Lost to Follow-up|34|||
125381368|NCT00708162|451029066|FG001|Randomized Phase|Lost to Follow-up|34|||
125381369|NCT00708162|451029065|FG000|Randomized Phase|Withdrew Consent|31|||
125219606|NCT00215644|450431164|FG001|Overall Study|Randomized but Not Treated|0|||
125437295|NCT00406419|451228051|FG002|Overall Study|Adverse Event|16|||
125381370|NCT00708162|451029066|FG001|Randomized Phase|Withdrew Consent|22|||
125381371|NCT00708162|451029065|FG000|Randomized Phase|Lack of Efficacy|14|||
125381372|NCT00708162|451029066|FG001|Randomized Phase|Lack of Efficacy|19|||
125381373|NCT00708162|451029065|FG000|Randomized Phase|Protocol Violation|10|||
125381374|NCT00708162|451029066|FG001|Randomized Phase|Protocol Violation|11|||
125381375|NCT00708162|451029065|FG000|Randomized Phase|Adverse Event|8|||
125381376|NCT00708162|451029066|FG001|Randomized Phase|Adverse Event|12|||
125381377|NCT00708162|451029065|FG000|Randomized Phase|Investigator's Discretion|7|||
125381378|NCT00708162|451029066|FG001|Randomized Phase|Investigator's Discretion|10|||
125381379|NCT00708162|451029065|FG000|Randomized Phase|Death|2|||
125381380|NCT00708162|451029066|FG001|Randomized Phase|Death|9|||
125381381|NCT00708162|451029065|FG000|Randomized Phase|Pregnancy|3|||
125381382|NCT00708162|451029066|FG001|Randomized Phase|Pregnancy|0|||
125381383|NCT00708162|451029065|FG000|Open-Label Phase|Lost to Follow-up|10|||
125381384|NCT00708162|451029066|FG001|Open-Label Phase|Lost to Follow-up|8|||
125381385|NCT00708162|451029065|FG000|Open-Label Phase|Withdrew Consent|12|||
125381386|NCT00708162|451029066|FG001|Open-Label Phase|Withdrew Consent|6|||
125381387|NCT00708162|451029065|FG000|Open-Label Phase|Participant Noncompliance|7|||
125381388|NCT00708162|451029066|FG001|Open-Label Phase|Participant Noncompliance|7|||
125219607|NCT02861664|450431165|FG000|Overall Study|Withdrawal of Consent|0|||
125219608|NCT02861664|450431166|FG001|Overall Study|Withdrawal of Consent|1|||
125381389|NCT00708162|451029065|FG000|Open-Label Phase|Lack of Efficacy|7|||
125219609|NCT01239394|450431167|FG000|Overall Study|Adverse Event|1|||
125219610|NCT00905632|450431169|FG000|Overall Study|Adverse Event|0|||
125381390|NCT00708162|451029066|FG001|Open-Label Phase|Lack of Efficacy|4|||
125381391|NCT00708162|451029065|FG000|Open-Label Phase|Investigator's Discretion|3|||
125381392|NCT00708162|451029066|FG001|Open-Label Phase|Investigator's Discretion|2|||
125381393|NCT00708162|451029065|FG000|Open-Label Phase|Death|3|||
125381394|NCT00708162|451029066|FG001|Open-Label Phase|Death|1|||
125381395|NCT00708162|451029065|FG000|Open-Label Phase|Adverse Event|1|||
125381396|NCT00708162|451029066|FG001|Open-Label Phase|Adverse Event|2|||
125381397|NCT00708162|451029065|FG000|Open-Label Phase|Other|1|||
125381398|NCT00708162|451029066|FG001|Open-Label Phase|Other|0|||
125381399|NCT00708643|451029067|FG000|Overall Study|Adverse Event|0|||
125381400|NCT00708643|451029068|FG001|Overall Study|Adverse Event|1|||
125381401|NCT02699554|451029069|FG000|Overall Study|Lost to Follow-up|9|||
125381402|NCT00788151|451029070|FG000|Overall Study|Other adverse event|0|||
125381403|NCT00788151|451029071|FG001|Overall Study|Other adverse event|2|||
125381404|NCT00788151|451029070|FG000|Overall Study|Protocol Violation|0|||
125381405|NCT00788151|451029071|FG001|Overall Study|Protocol Violation|1|||
125381406|NCT00788151|451029070|FG000|Overall Study|Withdrawal by Subject|13|||
125381407|NCT00788151|451029071|FG001|Overall Study|Withdrawal by Subject|6|||
125381408|NCT00788151|451029070|FG000|Overall Study|Enrolled but not treated|1|||
125381409|NCT00788151|451029071|FG001|Overall Study|Enrolled but not treated|1|||
125381410|NCT00503009|451029072|FG000|Overall Study|Protocol Violation|1|||
125381411|NCT00503009|451029073|FG001|Overall Study|Protocol Violation|0|||
125381412|NCT00503009|451029074|FG002|Overall Study|Protocol Violation|1|||
125381413|NCT00503009|451029072|FG000|Overall Study|Withdrawal by Subject|0|||
125381414|NCT00503009|451029073|FG001|Overall Study|Withdrawal by Subject|1|||
125381415|NCT00503009|451029074|FG002|Overall Study|Withdrawal by Subject|1|||
125381416|NCT00503009|451029072|FG000|Overall Study|Physician Decision|0|||
125381417|NCT00503009|451029073|FG001|Overall Study|Physician Decision|1|||
125381418|NCT00503009|451029074|FG002|Overall Study|Physician Decision|1|||
125381419|NCT01349803|451029075|FG000|Overall Study|Adverse Event|0|||
125381420|NCT01349803|451029076|FG001|Overall Study|Adverse Event|0|||
125381421|NCT01349803|451029077|FG002|Overall Study|Adverse Event|0|||
125381422|NCT01349803|451029078|FG003|Overall Study|Adverse Event|2|||
125381423|NCT01349803|451029075|FG000|Overall Study|Withdrawal by Subject|1|||
125381424|NCT01349803|451029076|FG001|Overall Study|Withdrawal by Subject|0|||
125381425|NCT01349803|451029077|FG002|Overall Study|Withdrawal by Subject|0|||
125219611|NCT00905632|450431170|FG001|Overall Study|Adverse Event|0|||
125219612|NCT00905632|450431171|FG002|Overall Study|Adverse Event|0|||
125219613|NCT00905632|450431172|FG003|Overall Study|Adverse Event|0|||
125219614|NCT00905632|450431173|FG004|Overall Study|Adverse Event|0|||
125381426|NCT01349803|451029078|FG003|Overall Study|Withdrawal by Subject|0|||
125381427|NCT01349803|451029075|FG000|Overall Study|Protocol-specified criteria|0|||
125219615|NCT00905632|450431174|FG005|Overall Study|Adverse Event|1|||
125437296|NCT00406419|451228049|FG000|Overall Study|Lost to Follow-up|11|||
125219616|NCT00905632|450431175|FG006|Overall Study|Adverse Event|4|||
125437297|NCT00406419|451228050|FG001|Overall Study|Lost to Follow-up|10|||
125219617|NCT02781818|450431179|FG000|Overall Study|Lost to Follow-up|4|||
125219618|NCT02781818|450431180|FG001|Overall Study|Lost to Follow-up|2|||
125219619|NCT02781818|450431181|FG002|Overall Study|Lost to Follow-up|1|||
125219620|NCT01223404|450431182|FG000|First Intervention (1 Day)|Adverse Event|0|||
125219621|NCT01223404|450431183|FG001|First Intervention (1 Day)|Adverse Event|0|||
125219622|NCT01223404|450431184|FG002|First Intervention (1 Day)|Adverse Event|0|||
125219623|NCT01223404|450431185|FG003|First Intervention (1 Day)|Adverse Event|1|||
125219624|NCT01223404|450431186|FG004|First Intervention (1 Day)|Adverse Event|0|||
125219625|NCT01223404|450431187|FG005|First Intervention (1 Day)|Adverse Event|0|||
125219626|NCT01223404|450431182|FG000|Second Intervention (1 Day)|Adverse Event|1|||
125219627|NCT01223404|450431183|FG001|Second Intervention (1 Day)|Adverse Event|0|||
125219628|NCT01223404|450431184|FG002|Second Intervention (1 Day)|Adverse Event|0|||
125219629|NCT01223404|450431185|FG003|Second Intervention (1 Day)|Adverse Event|0|||
125219630|NCT01223404|450431186|FG004|Second Intervention (1 Day)|Adverse Event|0|||
125219631|NCT01223404|450431187|FG005|Second Intervention (1 Day)|Adverse Event|0|||
125219632|NCT01223404|450431182|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
125219633|NCT01223404|450431183|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
125219634|NCT01223404|450431184|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
125219635|NCT01223404|450431185|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
125219636|NCT01223404|450431186|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
125219637|NCT01223404|450431187|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
125219638|NCT02492165|450431188|FG000|Overall Study|Withdrawal by Subject|0|||
125219639|NCT02492165|450431189|FG001|Overall Study|Withdrawal by Subject|1|||
125219640|NCT02492165|450431190|FG002|Overall Study|Withdrawal by Subject|0|||
125219641|NCT02492165|450431191|FG003|Overall Study|Withdrawal by Subject|0|||
125219642|NCT00707057|450431192|FG000|Overall Study|Withdrawal by Subject|8|||
125219643|NCT00707057|450431193|FG001|Overall Study|Withdrawal by Subject|3|||
125219644|NCT00707057|450431192|FG000|Overall Study|Dosed incorrectly|0|||
125219645|NCT00707057|450431193|FG001|Overall Study|Dosed incorrectly|1|||
125219646|NCT02915159|450431199|FG000|Overall Study|Participant no longer meets criteria|2|||
125219647|NCT02915159|450431200|FG001|Overall Study|Participant no longer meets criteria|0|||
125219648|NCT02915159|450431199|FG000|Overall Study|poor/non-compliance|1|||
125381428|NCT01349803|451029076|FG001|Overall Study|Protocol-specified criteria|1|||
125381429|NCT01349803|451029077|FG002|Overall Study|Protocol-specified criteria|3|||
125381430|NCT01349803|451029078|FG003|Overall Study|Protocol-specified criteria|0|||
125381431|NCT02169739|451029079|FG000|Overall Study|Lost to Follow-up|0|||
125381432|NCT02169739|451029080|FG001|Overall Study|Lost to Follow-up|4|||
125381433|NCT01710033|451029081|FG000|Stage 2|Adverse Event|0|||
125381434|NCT01710033|451029082|FG001|Stage 2|Adverse Event|0|||
125381435|NCT01710033|451029083|FG002|Stage 2|Adverse Event|0|||
125381436|NCT01710033|451029084|FG003|Stage 2|Adverse Event|0|||
125381437|NCT01710033|451029085|FG004|Stage 2|Adverse Event|1|||
125381438|NCT01244906|451029090|FG000|Overall Study|Death|2|||
125381439|NCT01244906|451029090|FG000|Overall Study|Progression of disease post treatment|6|||
125381440|NCT03720470|451029097|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
125381441|NCT03720470|451029098|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
125381442|NCT03720470|451029099|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
125381443|NCT03720470|451029100|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
125381444|NCT03720470|451029101|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
125381445|NCT03720470|451029102|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
125381446|NCT03720470|451029097|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
125381447|NCT03720470|451029098|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
125381448|NCT03720470|451029099|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
125381449|NCT03720470|451029100|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
125381450|NCT03720470|451029101|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
125381451|NCT03720470|451029102|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
125381452|NCT03720470|451029097|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
125381453|NCT03720470|451029098|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
125381454|NCT03720470|451029099|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
125381455|NCT03720470|451029100|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
125381456|NCT03720470|451029101|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
125381457|NCT03720470|451029102|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
125381458|NCT03720470|451029097|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
125381459|NCT03720470|451029098|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
125381460|NCT03720470|451029099|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
125381461|NCT03720470|451029100|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
125381462|NCT03720470|451029101|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
125381463|NCT03720470|451029102|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
125381464|NCT03720470|451029097|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
125381465|NCT03720470|451029098|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
125381466|NCT03720470|451029099|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
125381467|NCT03720470|451029100|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
125381468|NCT03720470|451029101|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
125381469|NCT03720470|451029102|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
125381470|NCT03720470|451029097|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
125381471|NCT03720470|451029098|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
125381472|NCT03720470|451029099|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
125381473|NCT03720470|451029100|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
125381474|NCT03720470|451029101|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
125381475|NCT03720470|451029102|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
125381476|NCT03720470|451029097|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
125381477|NCT03720470|451029098|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
125381478|NCT03720470|451029099|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
125381479|NCT03720470|451029100|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
125381480|NCT03720470|451029101|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
125420827|NCT01260350|451166144|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125219649|NCT02915159|450431200|FG001|Overall Study|poor/non-compliance|0|||
125381481|NCT03720470|451029102|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
125381482|NCT03720470|451029097|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
125381483|NCT03720470|451029098|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
125381484|NCT03720470|451029099|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
125381485|NCT03720470|451029100|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
125219650|NCT02915159|450431199|FG000|Overall Study|Participant withdrew consent|5|||
125219651|NCT02915159|450431200|FG001|Overall Study|Participant withdrew consent|1|||
125219652|NCT02915159|450431199|FG000|Overall Study|Request to discontinue treatment|1|||
125219653|NCT02915159|450431200|FG001|Overall Study|Request to discontinue treatment|2|||
125219654|NCT02915159|450431199|FG000|Overall Study|Adverse Event|2|||
125219655|NCT02915159|450431200|FG001|Overall Study|Adverse Event|2|||
125219656|NCT02915159|450431199|FG000|Overall Study|Lack of Efficacy|0|||
125219657|NCT02915159|450431200|FG001|Overall Study|Lack of Efficacy|3|||
125219658|NCT02821416|450431203|FG000|Overall Study|Adverse Event|0|||
125219659|NCT02821416|450431204|FG001|Overall Study|Adverse Event|1|||
125219660|NCT02821416|450431203|FG000|Overall Study|Withdrawal by Subject|2|||
125219661|NCT02821416|450431204|FG001|Overall Study|Withdrawal by Subject|0|||
125219662|NCT02821416|450431203|FG000|Overall Study|Lost to Follow-up|1|||
125219663|NCT02821416|450431204|FG001|Overall Study|Lost to Follow-up|0|||
125219664|NCT01001520|450431211|FG000|Medication Period 1|Withdrawal by Subject|2|||
125219665|NCT01001520|450431212|FG001|Medication Period 1|Withdrawal by Subject|2|||
125219666|NCT01001520|450431211|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
125219667|NCT01001520|450431212|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
125219668|NCT01001520|450431211|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
125219669|NCT01001520|450431212|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
125219670|NCT01001520|450431211|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
125219671|NCT01001520|450431212|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
125219672|NCT01001520|450431211|FG000|Washout Period|Withdrawal by Subject|2|||
125219673|NCT01001520|450431212|FG001|Washout Period|Withdrawal by Subject|1|||
125219674|NCT01001520|450431211|FG000|Medication Period 2|Withdrawal by Subject|0|||
125219675|NCT01001520|450431212|FG001|Medication Period 2|Withdrawal by Subject|3|||
125219676|NCT00878800|450431223|FG000|Overall Study|Adverse Event|0|||
125219677|NCT00878800|450431224|FG001|Overall Study|Adverse Event|0|||
125219678|NCT00878800|450431225|FG002|Overall Study|Adverse Event|2|||
125219679|NCT00878800|450431226|FG003|Overall Study|Adverse Event|0|||
125219680|NCT00878800|450431227|FG004|Overall Study|Adverse Event|1|||
125219681|NCT00878800|450431223|FG000|Overall Study|Progressive disease|1|||
125219682|NCT00878800|450431224|FG001|Overall Study|Progressive disease|5|||
125219683|NCT00878800|450431225|FG002|Overall Study|Progressive disease|6|||
125219684|NCT00878800|450431226|FG003|Overall Study|Progressive disease|5|||
125219685|NCT00878800|450431227|FG004|Overall Study|Progressive disease|13|||
125219686|NCT00878800|450431223|FG000|Overall Study|Withdrew consent|1|||
125219687|NCT00878800|450431224|FG001|Overall Study|Withdrew consent|1|||
125219688|NCT00878800|450431225|FG002|Overall Study|Withdrew consent|0|||
125219689|NCT00878800|450431226|FG003|Overall Study|Withdrew consent|1|||
125219690|NCT00878800|450431227|FG004|Overall Study|Withdrew consent|1|||
125219691|NCT00878800|450431223|FG000|Overall Study|Death|0|||
125219692|NCT00878800|450431224|FG001|Overall Study|Death|0|||
125219693|NCT00878800|450431225|FG002|Overall Study|Death|1|||
125219694|NCT00878800|450431226|FG003|Overall Study|Death|0|||
125219695|NCT00878800|450431227|FG004|Overall Study|Death|0|||
125381486|NCT03720470|451029101|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
125381487|NCT03720470|451029102|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
125381488|NCT03720470|451029097|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
125381489|NCT03720470|451029098|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
125381490|NCT03720470|451029099|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
125381491|NCT03720470|451029100|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
125219696|NCT00878800|450431223|FG000|Overall Study|Other|1|||
125219697|NCT00878800|450431224|FG001|Overall Study|Other|1|||
125219698|NCT00878800|450431225|FG002|Overall Study|Other|0|||
125219699|NCT00878800|450431226|FG003|Overall Study|Other|0|||
125219700|NCT00878800|450431227|FG004|Overall Study|Other|1|||
125219701|NCT00613821|450431228|FG000|Overall Study|Withdrawal by Subject|1|||
125219702|NCT00613821|450431229|FG001|Overall Study|Withdrawal by Subject|0|||
125219703|NCT00613821|450431228|FG000|Overall Study|Physician Decision|1|||
125219704|NCT00613821|450431229|FG001|Overall Study|Physician Decision|1|||
125219705|NCT02302846|450431231|FG000|Overall Study|Withdrawal by Subject|1|||
125219706|NCT00715299|450431232|FG000|Overall Study|Withdrawal by Subject|1|||
125219707|NCT00715299|450431232|FG000|Overall Study|Adverse Event|3|||
125381492|NCT03720470|451029101|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
125381493|NCT03720470|451029102|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
125437298|NCT00406419|451228051|FG002|Overall Study|Lost to Follow-up|5|||
125219708|NCT00715299|450431232|FG000|Overall Study|failed the pre-screen exercise test|2|||
125219709|NCT00411450|450431233|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
125219710|NCT00872521|450431234|FG000|Completed PAD Induction|Patient choice|0|||
125219711|NCT00872521|450431235|FG001|Completed PAD Induction|Patient choice|1|||
125219712|NCT00872521|450431236|FG002|Completed PAD Induction|Patient choice|0|||
125219713|NCT00872521|450431234|FG000|Completed PAD Induction|Disease progression|0|||
125219714|NCT00872521|450431235|FG001|Completed PAD Induction|Disease progression|2|||
125219715|NCT00872521|450431236|FG002|Completed PAD Induction|Disease progression|0|||
125219716|NCT00872521|450431234|FG000|Completed PAD Induction|Adverse Event|4|||
125219717|NCT00872521|450431235|FG001|Completed PAD Induction|Adverse Event|0|||
125219718|NCT00872521|450431236|FG002|Completed PAD Induction|Adverse Event|0|||
125219719|NCT00872521|450431234|FG000|Completed PAD Induction|Death|1|||
125219720|NCT00872521|450431235|FG001|Completed PAD Induction|Death|1|||
125219721|NCT00872521|450431236|FG002|Completed PAD Induction|Death|0|||
125219722|NCT00872521|450431234|FG000|Primary Endpoint Analysis|Other|1|||
125219723|NCT00872521|450431235|FG001|Primary Endpoint Analysis|Other|2|||
125219724|NCT00872521|450431236|FG002|Primary Endpoint Analysis|Other|0|||
125219725|NCT00872521|450431234|FG000|Primary Endpoint Analysis|Patient choice|0|||
125219726|NCT00872521|450431235|FG001|Primary Endpoint Analysis|Patient choice|1|||
125219727|NCT00872521|450431236|FG002|Primary Endpoint Analysis|Patient choice|0|||
125219728|NCT00872521|450431234|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
125219729|NCT00872521|450431235|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
125219730|NCT00872521|450431236|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
125219731|NCT00872521|450431234|FG000|Primary Endpoint Analysis|Patient response missing|0|||
125219732|NCT00872521|450431235|FG001|Primary Endpoint Analysis|Patient response missing|0|||
125219733|NCT00872521|450431236|FG002|Primary Endpoint Analysis|Patient response missing|1|||
125219734|NCT00872521|450431234|FG000|Completed 3-month Follow up|Other|0|||
125219735|NCT00872521|450431235|FG001|Completed 3-month Follow up|Other|2|||
125219736|NCT00872521|450431236|FG002|Completed 3-month Follow up|Other|0|||
125219737|NCT00872521|450431234|FG000|Completed 3-month Follow up|Physician Decision|0|||
125219738|NCT00872521|450431235|FG001|Completed 3-month Follow up|Physician Decision|1|||
125219739|NCT00872521|450431236|FG002|Completed 3-month Follow up|Physician Decision|0|||
125219740|NCT00872521|450431234|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
125219741|NCT00872521|450431235|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
125219742|NCT00872521|450431236|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
125219743|NCT00614874|450431237|FG000|Overall Study|Protocol Violation|1|||
125219744|NCT00614874|450431237|FG000|Overall Study|Withdrawal by Subject|1|||
125381494|NCT03720470|451029097|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
125219745|NCT01468454|450431238|FG000|Overall Study|Did not have surgery after PET|9|||
125219746|NCT02620787|450431239|FG000|Overall Study|Adverse Event|1|||
125219747|NCT02620787|450431240|FG001|Overall Study|Adverse Event|0|||
125219748|NCT02620787|450431239|FG000|Overall Study|Eligibility Criteria Not Met|1|||
125485453|NCT02240238|451412507|FG004|Phase 2|Physician Decision|0|||
125219749|NCT02620787|450431240|FG001|Overall Study|Eligibility Criteria Not Met|0|||
125219750|NCT01502033|450431242|FG000|Overall Study|1 participant had scalp discomfort|1|||
125219751|NCT01502033|450431242|FG000|Overall Study|1 participant had worsening depression|1|||
125219752|NCT01502033|450431242|FG000|Overall Study|1 participant went back to school|1|||
125219753|NCT01808261|450431243|FG000|Overall Study|Physician Decision|0|||
125219754|NCT01808261|450431244|FG001|Overall Study|Physician Decision|2|||
125219755|NCT01808261|450431243|FG000|Overall Study|Study Closed/Terminated|25|||
125219756|NCT01808261|450431244|FG001|Overall Study|Study Closed/Terminated|23|||
125219757|NCT01808261|450431243|FG000|Overall Study|Adverse event, non-fatal|2|||
125219758|NCT01808261|450431244|FG001|Overall Study|Adverse event, non-fatal|0|||
125219759|NCT01808261|450431243|FG000|Overall Study|Consent withdrawn by subject|6|||
125219760|NCT01808261|450431244|FG001|Overall Study|Consent withdrawn by subject|7|||
125219761|NCT01808261|450431243|FG000|Overall Study|Lost to Follow-up|3|||
125219762|NCT01808261|450431244|FG001|Overall Study|Lost to Follow-up|1|||
125219763|NCT00941304|450431245|FG000|Overall Study|Lost to Follow-up|1|||
125219764|NCT00941304|450431246|FG001|Overall Study|Lost to Follow-up|0|||
125219765|NCT00941304|450431247|FG002|Overall Study|Lost to Follow-up|0|||
125219766|NCT00941304|450431248|FG003|Overall Study|Lost to Follow-up|0|||
125219767|NCT00941304|450431249|FG004|Overall Study|Lost to Follow-up|0|||
125219768|NCT03293394|450431250|FG000|Follow-up (6 Months)|Adverse Event|4|||
125219769|NCT03293394|450431251|FG001|Follow-up (6 Months)|Adverse Event|2|||
125219770|NCT04004260|450431253|FG000|Overall Study|Withdrawal by Subject|7|||
125219771|NCT04004260|450431254|FG001|Overall Study|Withdrawal by Subject|3|||
125219772|NCT04004260|450431253|FG000|Overall Study|Lost to Follow-up|22|||
125219773|NCT04004260|450431254|FG001|Overall Study|Lost to Follow-up|12|||
125219774|NCT04004260|450431253|FG000|Overall Study|Did not engage in intervention|13|||
125219775|NCT04004260|450431254|FG001|Overall Study|Did not engage in intervention|17|||
125219776|NCT01765569|450431255|FG000|Period B|Withdrawal by Subject|1|||
125219777|NCT01765569|450431255|FG000|Period C|Death|1|||
125219778|NCT05568797|450431259|FG000|Overall Study|Adverse Event|0|||
125219779|NCT05568797|450431260|FG001|Overall Study|Adverse Event|8|||
125219780|NCT05568797|450431259|FG000|Overall Study|Lost to Follow-up|2|||
125219781|NCT05568797|450431260|FG001|Overall Study|Lost to Follow-up|3|||
125219782|NCT05568797|450431259|FG000|Overall Study|Withdrawal by Subject|1|||
125219783|NCT05568797|450431260|FG001|Overall Study|Withdrawal by Subject|10|||
125381495|NCT03720470|451029098|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
125381496|NCT03720470|451029099|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
125381497|NCT03720470|451029100|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
125381498|NCT03720470|451029101|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
125381499|NCT03720470|451029102|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
125381500|NCT03720470|451029097|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
125381501|NCT03720470|451029098|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
125381502|NCT03720470|451029099|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
125381503|NCT03720470|451029100|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
125381504|NCT03720470|451029101|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
125381505|NCT03720470|451029102|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
125485454|NCT02240238|451412508|FG005|Phase 2|Physician Decision|0|||
125219784|NCT05568797|450431259|FG000|Overall Study|Other|2|||
125219785|NCT05568797|450431260|FG001|Overall Study|Other|2|||
125219786|NCT02401035|450431262|FG000|Overall Study|Withdrawal by Subject|1|||
125219787|NCT02401035|450431263|FG001|Overall Study|Withdrawal by Subject|0|||
125219788|NCT00869128|450431264|FG000|Overall Study|lack of Compliance|6|||
125219789|NCT00869128|450431265|FG001|Overall Study|lack of Compliance|6|||
125219790|NCT02998996|450431271|FG000|Overall Study|Lost to Follow-up|0|||
125219791|NCT02998996|450431272|FG001|Overall Study|Lost to Follow-up|0|||
125219792|NCT02998996|450431273|FG002|Overall Study|Lost to Follow-up|1|||
125437299|NCT01290822|451228052|FG000|Overall Study|Withdrawal by Subject|1|||
125219793|NCT02998996|450431274|FG003|Overall Study|Lost to Follow-up|0|||
125219794|NCT02998996|450431275|FG004|Overall Study|Lost to Follow-up|0|||
125219795|NCT02998996|450431276|FG005|Overall Study|Lost to Follow-up|0|||
125219796|NCT02998996|450431271|FG000|Overall Study|Pregnancy|0|||
125219797|NCT02998996|450431272|FG001|Overall Study|Pregnancy|1|||
125219798|NCT02998996|450431273|FG002|Overall Study|Pregnancy|0|||
125219799|NCT02998996|450431274|FG003|Overall Study|Pregnancy|0|||
125219800|NCT02998996|450431275|FG004|Overall Study|Pregnancy|0|||
125219801|NCT02998996|450431276|FG005|Overall Study|Pregnancy|0|||
125219802|NCT02998996|450431271|FG000|Overall Study|Family reasons|0|||
125219803|NCT02998996|450431272|FG001|Overall Study|Family reasons|0|||
125219804|NCT02998996|450431273|FG002|Overall Study|Family reasons|0|||
125219805|NCT02998996|450431274|FG003|Overall Study|Family reasons|0|||
125219806|NCT02998996|450431275|FG004|Overall Study|Family reasons|1|||
125219807|NCT02998996|450431276|FG005|Overall Study|Family reasons|0|||
125219808|NCT01118663|450431278|FG000|Overall Study|Adverse Event|2|||
125381506|NCT03720470|451029097|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
125381507|NCT03720470|451029098|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
125381508|NCT03720470|451029099|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
125381509|NCT03720470|451029100|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
125219809|NCT01118663|450431279|FG001|Overall Study|Adverse Event|1|||
125219810|NCT01118663|450431278|FG000|Overall Study|Withdrawal by Subject|0|||
125219811|NCT01118663|450431279|FG001|Overall Study|Withdrawal by Subject|1|||
125219812|NCT03046953|450431280|FG000|Overall Study|Relapse/progressive disease|21|||
125219813|NCT03046953|450431280|FG000|Overall Study|Death|2|||
125219814|NCT03046953|450431280|FG000|Overall Study|Withdrawal by Subject|3|||
125219815|NCT04039204|450431281|FG000|Overall Study|Withdrawal by Subject|0|||
125219816|NCT04039204|450431282|FG001|Overall Study|Withdrawal by Subject|2|||
125219817|NCT01189461|450431283|FG000|Overall Study|Lack of Efficacy|13|||
125381510|NCT03720470|451029101|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
125381511|NCT03720470|451029102|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
125381512|NCT03720470|451029097|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
125381513|NCT03720470|451029098|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
125381514|NCT03720470|451029099|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
125437300|NCT01290822|451228052|FG000|Overall Study|Physician Decision|10|||
125437301|NCT00089895|451228055|FG000|Overall Study|Consent Withdrawn|11|||
125437302|NCT00089895|451228056|FG001|Overall Study|Consent Withdrawn|14|||
125437303|NCT00089895|451228055|FG000|Overall Study|Technical reason|7|||
125437304|NCT00089895|451228056|FG001|Overall Study|Technical reason|2|||
125437305|NCT00089895|451228055|FG000|Overall Study|Surgery|0|||
125437306|NCT00089895|451228056|FG001|Overall Study|Surgery|1|||
125437307|NCT00089895|451228055|FG000|Overall Study|Bleeding|0|||
125437308|NCT00089895|451228056|FG001|Overall Study|Bleeding|2|||
125437309|NCT00089895|451228055|FG000|Overall Study|Physician Decision|3|||
125437310|NCT00089895|451228056|FG001|Overall Study|Physician Decision|7|||
125437311|NCT00089895|451228055|FG000|Overall Study|Exclusion criteria met|6|||
125437312|NCT00089895|451228056|FG001|Overall Study|Exclusion criteria met|6|||
125437313|NCT00089895|451228055|FG000|Overall Study|Not otherwise specified|4|||
125437314|NCT00089895|451228056|FG001|Overall Study|Not otherwise specified|8|||
125437315|NCT00089895|451228055|FG000|Overall Study|Missing|4|||
125437316|NCT00089895|451228056|FG001|Overall Study|Missing|2|||
125381515|NCT03720470|451029100|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
125381516|NCT03720470|451029101|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
125219818|NCT01189461|450431283|FG000|Overall Study|Lost to Follow-up|1|||
125219819|NCT01189461|450431283|FG000|Overall Study|Withdrawal by Subject|6|||
125219820|NCT01189461|450431283|FG000|Overall Study|Protocol Violation|1|||
125219821|NCT01189461|450431283|FG000|Overall Study|Adverse Event|2|||
125219822|NCT01189461|450431283|FG000|Overall Study|Did not meet entrance criteria|3|||
125219823|NCT01189461|450431283|FG000|Overall Study|Other|8|||
125219824|NCT02716584|450431284|FG000|Overall Study|Lost to Follow-up|8|||
125219825|NCT02716584|450431285|FG001|Overall Study|Lost to Follow-up|5|||
125219826|NCT05259163|450432637|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
125219827|NCT05259163|450432638|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
125219828|NCT01381926|450432640|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
125219829|NCT01381926|450432641|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
125219830|NCT01381926|450432640|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
125219831|NCT01381926|450432641|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
125219832|NCT02100839|450432645|FG000|Multiple Ascending Dose|Adverse Event|2|||
125381517|NCT03720470|451029102|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
125381518|NCT03720470|451029097|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
125381519|NCT03720470|451029098|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
125381520|NCT03720470|451029099|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
125381521|NCT03720470|451029100|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
125381522|NCT03720470|451029101|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
125381523|NCT03720470|451029102|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
125381524|NCT03720470|451029097|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
125381525|NCT03720470|451029098|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
125381526|NCT03720470|451029099|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
125381527|NCT03720470|451029100|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
125381528|NCT03720470|451029101|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
125381529|NCT03720470|451029102|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
125381530|NCT03720470|451029097|FG000|Treatment Period: Final 4 Weeks|Other|0|||
125381531|NCT03720470|451029098|FG001|Treatment Period: Final 4 Weeks|Other|1|||
125381532|NCT03720470|451029099|FG002|Treatment Period: Final 4 Weeks|Other|0|||
125381533|NCT03720470|451029100|FG003|Treatment Period: Final 4 Weeks|Other|2|||
125381534|NCT03720470|451029101|FG004|Treatment Period: Final 4 Weeks|Other|1|||
125381535|NCT03720470|451029102|FG005|Treatment Period: Final 4 Weeks|Other|0|||
125381536|NCT00453921|451029103|FG000|Overall Study|Withdrawal by Subject|1|||
125381537|NCT00453921|451029104|FG001|Overall Study|Withdrawal by Subject|1|||
125381538|NCT00453921|451029105|FG002|Overall Study|Withdrawal by Subject|1|||
125381539|NCT00453921|451029106|FG003|Overall Study|Withdrawal by Subject|1|||
125381540|NCT00453921|451029103|FG000|Overall Study|Lost to Follow-up|0|||
125381541|NCT00453921|451029104|FG001|Overall Study|Lost to Follow-up|0|||
125381542|NCT00453921|451029105|FG002|Overall Study|Lost to Follow-up|1|||
125381543|NCT00453921|451029106|FG003|Overall Study|Lost to Follow-up|0|||
125381544|NCT04532099|451029107|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
125381545|NCT04532099|451029108|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
125219833|NCT02100839|450432646|FG001|Multiple Ascending Dose|Adverse Event|0|||
125219834|NCT02100839|450432645|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
125381546|NCT04532099|451029109|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
125381547|NCT00644995|451029114|FG000|Overall Study|Lost to Follow-up|1|||
125381548|NCT00644995|451029115|FG001|Overall Study|Lost to Follow-up|4|||
125381549|NCT00644995|451029114|FG000|Overall Study|Refused|1|||
125381550|NCT00644995|451029115|FG001|Overall Study|Refused|0|||
125381551|NCT02066233|451029116|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
125381552|NCT02066233|451029117|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
125381553|NCT03103919|451029119|FG000|Overall Study|Adverse Event|2|||
125381554|NCT03103919|451029120|FG001|Overall Study|Adverse Event|2|||
125381555|NCT01506479|451029121|FG000|Overall Study|Lost to Follow-up|1|||
125219835|NCT02100839|450432646|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
125219836|NCT00703677|450432648|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
125219837|NCT00940888|450432649|FG000|Overall Study|Unsuccessful Implant|4|||
125219838|NCT00940888|450432649|FG000|Overall Study|Death|461|||
125219839|NCT00940888|450432649|FG000|Overall Study|Withdrawn - Non-Death|364|||
125219840|NCT00940888|450432649|FG000|Overall Study|Lost to Follow-up|6|||
125219841|NCT04441788|450432650|FG000|Overall Study|Voluntary Withdrawl|0|||
125219842|NCT04441788|450432651|FG001|Overall Study|Voluntary Withdrawl|1|||
125219843|NCT04441788|450432652|FG002|Overall Study|Voluntary Withdrawl|0|||
125219844|NCT04441788|450432650|FG000|Overall Study|Ineligibility|1|||
125219845|NCT04441788|450432651|FG001|Overall Study|Ineligibility|0|||
125219846|NCT04441788|450432652|FG002|Overall Study|Ineligibility|0|||
125219847|NCT04441788|450432650|FG000|Overall Study|Adverse Event|0|||
125219848|NCT04441788|450432651|FG001|Overall Study|Adverse Event|0|||
125219849|NCT04441788|450432652|FG002|Overall Study|Adverse Event|4|||
125219850|NCT04441788|450432650|FG000|Overall Study|Study Terminated by Sponsor|16|||
125219851|NCT04441788|450432651|FG001|Overall Study|Study Terminated by Sponsor|16|||
125219852|NCT04441788|450432652|FG002|Overall Study|Study Terminated by Sponsor|12|||
125219853|NCT03859648|450432657|FG000|Overall Study|Lost to Follow-up|1|||
125219854|NCT03859648|450432657|FG000|Overall Study|Adverse Event|1|||
125219855|NCT01971567|450432661|FG000|Overall Study|Withdrawal by Subject|3|||
125219856|NCT01971567|450432662|FG001|Overall Study|Withdrawal by Subject|2|||
125219857|NCT01971567|450432661|FG000|Overall Study|Lost to Follow-up|1|||
125219858|NCT01971567|450432662|FG001|Overall Study|Lost to Follow-up|0|||
125219859|NCT01409915|450432663|FG000|Overall Study|Adverse Event|0|||
125219860|NCT01409915|450432664|FG001|Overall Study|Adverse Event|2|||
125219861|NCT01409915|450432663|FG000|Overall Study|Withdrawal by Subject|0|||
125219862|NCT01409915|450432664|FG001|Overall Study|Withdrawal by Subject|1|||
125219863|NCT01409915|450432663|FG000|Overall Study|Protocol Violation|1|||
125219864|NCT01409915|450432664|FG001|Overall Study|Protocol Violation|0|||
125219865|NCT04826484|450432665|FG000|Overall Study|Lost to Follow-up|2|||
125219866|NCT04826484|450432666|FG001|Overall Study|Lost to Follow-up|0|||
125219867|NCT02250300|450432668|FG000|Expansion Phase|Death|6|||
125219868|NCT02250300|450432669|FG001|Expansion Phase|Death|7|||
125219869|NCT02250300|450432670|FG002|Expansion Phase|Death|0|||
125219870|NCT02250300|450432671|FG003|Expansion Phase|Death|0|||
125219871|NCT00758498|450432675|FG000|Overall Study|Adverse Event|2|||
125381556|NCT01506479|451029122|FG001|Overall Study|Lost to Follow-up|2|||
125381557|NCT01506479|451029123|FG002|Overall Study|Lost to Follow-up|2|||
125381558|NCT01506479|451029121|FG000|Overall Study|Withdrawal by Subject|1|||
125381559|NCT01506479|451029122|FG001|Overall Study|Withdrawal by Subject|2|||
125381560|NCT01506479|451029123|FG002|Overall Study|Withdrawal by Subject|1|||
125381561|NCT01506479|451029121|FG000|Overall Study|Missing assessment|1|||
125381562|NCT01506479|451029122|FG001|Overall Study|Missing assessment|0|||
125381563|NCT01506479|451029123|FG002|Overall Study|Missing assessment|0|||
125381564|NCT01506479|451029121|FG000|Overall Study|Adverse Event|0|||
125381565|NCT01506479|451029122|FG001|Overall Study|Adverse Event|1|||
125381566|NCT01506479|451029123|FG002|Overall Study|Adverse Event|0|||
125381567|NCT02426892|451029124|FG000|Overall Study|Adverse Event|2|||
125381568|NCT02426892|451029124|FG000|Overall Study|Lack of Efficacy|17|||
125381569|NCT02426892|451029124|FG000|Overall Study|Withdrawal by Subject|1|||
125381570|NCT02763189|451029127|FG000|Overall Study|Device failure|0|||
125381571|NCT02763189|451029128|FG001|Overall Study|Device failure|2|||
125381572|NCT03198234|451029134|FG000|Overall Study|Relapse of primary disease|0|||
125381573|NCT03198234|451029135|FG001|Overall Study|Relapse of primary disease|1|||
125219872|NCT00758498|450432676|FG001|Overall Study|Adverse Event|2|||
125219873|NCT00758498|450432677|FG002|Overall Study|Adverse Event|3|||
125219874|NCT00758498|450432675|FG000|Overall Study|Subject legally detained out of state|1|||
125219875|NCT00758498|450432676|FG001|Overall Study|Subject legally detained out of state|0|||
125219876|NCT00758498|450432677|FG002|Overall Study|Subject legally detained out of state|0|||
125381574|NCT03198234|451029136|FG002|Overall Study|Relapse of primary disease|0|||
125381575|NCT01340898|451029137|FG000|Primary Phase|Serious Adverse Events|0|||
125219877|NCT00758498|450432675|FG000|Overall Study|Withdrawal by Subject|0|||
125219878|NCT00758498|450432676|FG001|Overall Study|Withdrawal by Subject|0|||
125219879|NCT00758498|450432677|FG002|Overall Study|Withdrawal by Subject|1|||
125219880|NCT00758498|450432675|FG000|Overall Study|Noncompliance to study procedures|0|||
125219881|NCT00758498|450432676|FG001|Overall Study|Noncompliance to study procedures|0|||
125485455|NCT02240238|451412509|FG006|Phase 2|Physician Decision|0|||
125437317|NCT01535274|451228057|FG000|Overall Study|Determined to be ineligible|0|||
125437318|NCT01535274|451228058|FG001|Overall Study|Determined to be ineligible|1|||
125437319|NCT01535274|451228057|FG000|Overall Study|Misallocated to propofol intervention|0|||
125437320|NCT01535274|451228058|FG001|Overall Study|Misallocated to propofol intervention|1|||
125437321|NCT03679767|451228059|FG000|Overall Study|Death|16|||
125437322|NCT03679767|451228060|FG001|Overall Study|Death|11|||
125219882|NCT00758498|450432677|FG002|Overall Study|Noncompliance to study procedures|1|||
125219883|NCT01516736|450432678|FG000|Overall Study|Withdrawal by Subject|10|||
125219884|NCT01516736|450432679|FG001|Overall Study|Withdrawal by Subject|4|||
125219885|NCT01516736|450432678|FG000|Overall Study|Adverse Event|4|||
125219886|NCT01516736|450432679|FG001|Overall Study|Adverse Event|5|||
125219887|NCT01516736|450432678|FG000|Overall Study|Death|3|||
125219888|NCT01516736|450432679|FG001|Overall Study|Death|1|||
125219889|NCT01516736|450432678|FG000|Overall Study|Physician Decision|2|||
125219890|NCT01516736|450432679|FG001|Overall Study|Physician Decision|1|||
125219891|NCT01516736|450432678|FG000|Overall Study|Lack of Efficacy|1|||
125219892|NCT01516736|450432679|FG001|Overall Study|Lack of Efficacy|0|||
125219893|NCT01516736|450432678|FG000|Overall Study|Protocol Violation|0|||
125219894|NCT01516736|450432679|FG001|Overall Study|Protocol Violation|1|||
125219895|NCT01516736|450432678|FG000|Overall Study|Other (not specified)|0|||
125219896|NCT01516736|450432679|FG001|Overall Study|Other (not specified)|1|||
125381576|NCT01340898|451029138|FG001|Primary Phase|Serious Adverse Events|0|||
125381577|NCT01340898|451029139|FG002|Primary Phase|Serious Adverse Events|1|||
125381578|NCT01340898|451029137|FG000|Primary Phase|Withdrawal by Subject|8|||
125381579|NCT01340898|451029138|FG001|Primary Phase|Withdrawal by Subject|7|||
125381580|NCT01340898|451029139|FG002|Primary Phase|Withdrawal by Subject|5|||
125437323|NCT03679767|451228061|FG002|Overall Study|Death|17|||
125381581|NCT01340898|451029137|FG000|Primary Phase|Migrated/moved from study area|4|||
125381582|NCT01340898|451029138|FG001|Primary Phase|Migrated/moved from study area|1|||
125381583|NCT01340898|451029139|FG002|Primary Phase|Migrated/moved from study area|0|||
125381584|NCT01340898|451029137|FG000|Primary Phase|Lost to Follow-up|4|||
125381585|NCT01340898|451029138|FG001|Primary Phase|Lost to Follow-up|1|||
125381586|NCT01340898|451029139|FG002|Primary Phase|Lost to Follow-up|0|||
125381587|NCT01340898|451029137|FG000|Booster Phase|Withdrawal by Subject|3|||
125381588|NCT01340898|451029138|FG001|Booster Phase|Withdrawal by Subject|0|||
125381589|NCT01340898|451029139|FG002|Booster Phase|Withdrawal by Subject|4|||
125381590|NCT01340898|451029137|FG000|Booster Phase|Migrated/moved from study area|3|||
125381591|NCT01340898|451029138|FG001|Booster Phase|Migrated/moved from study area|0|||
125381592|NCT01340898|451029139|FG002|Booster Phase|Migrated/moved from study area|0|||
125381593|NCT01340898|451029137|FG000|Booster Phase|Lost to Follow-up|4|||
125381594|NCT01340898|451029138|FG001|Booster Phase|Lost to Follow-up|2|||
125381595|NCT01340898|451029139|FG002|Booster Phase|Lost to Follow-up|3|||
125381596|NCT02056340|451029140|FG000|Overall Study|Lost to Follow-up|5|||
125381597|NCT02056340|451029141|FG001|Overall Study|Lost to Follow-up|5|||
125381598|NCT02056340|451029140|FG000|Overall Study|Withdrawal by Subject|2|||
125381599|NCT02056340|451029141|FG001|Overall Study|Withdrawal by Subject|6|||
125381600|NCT04900220|451029142|FG000|Overall Study|Lost to Follow-up|1|||
125381601|NCT04900220|451029143|FG001|Overall Study|Lost to Follow-up|1|||
125381602|NCT01214629|451029145|FG000|Overall Study|Progressive Disease|1|||
125381603|NCT01214629|451029146|FG001|Overall Study|Progressive Disease|1|||
125381604|NCT01214629|451029147|FG002|Overall Study|Progressive Disease|0|||
125381605|NCT01214629|451029148|FG003|Overall Study|Progressive Disease|1|||
125381606|NCT01214629|451029149|FG004|Overall Study|Progressive Disease|2|||
125381607|NCT01214629|451029150|FG005|Overall Study|Progressive Disease|3|||
125381608|NCT01214629|451029151|FG006|Overall Study|Progressive Disease|1|||
125381609|NCT01214629|451029152|FG007|Overall Study|Progressive Disease|1|||
125381610|NCT01214629|451029153|FG008|Overall Study|Progressive Disease|1|||
125381611|NCT01214629|451029154|FG009|Overall Study|Progressive Disease|5|||
125381612|NCT01214629|451029155|FG010|Overall Study|Progressive Disease|1|||
125381613|NCT01214629|451029145|FG000|Overall Study|Adverse Event|0|||
125381614|NCT01214629|451029146|FG001|Overall Study|Adverse Event|0|||
125437324|NCT03679767|451228062|FG003|Overall Study|Death|10|||
125381615|NCT01214629|451029147|FG002|Overall Study|Adverse Event|0|||
125381616|NCT01214629|451029148|FG003|Overall Study|Adverse Event|1|||
125381617|NCT01214629|451029149|FG004|Overall Study|Adverse Event|0|||
125381618|NCT01214629|451029150|FG005|Overall Study|Adverse Event|1|||
125381619|NCT01214629|451029151|FG006|Overall Study|Adverse Event|0|||
125381620|NCT01214629|451029152|FG007|Overall Study|Adverse Event|0|||
125381621|NCT01214629|451029153|FG008|Overall Study|Adverse Event|0|||
125381622|NCT01214629|451029154|FG009|Overall Study|Adverse Event|1|||
125437325|NCT03679767|451228059|FG000|Overall Study|Lost to Follow-up|1|||
125381623|NCT01214629|451029155|FG010|Overall Study|Adverse Event|0|||
125219897|NCT03365934|450432685|FG000|Overall Study|Adverse Event|1|||
125381624|NCT01214629|451029145|FG000|Overall Study|Physician Decision|0|||
125381625|NCT01214629|451029146|FG001|Overall Study|Physician Decision|0|||
125219898|NCT03365934|450432685|FG000|Overall Study|Withdrawal by Subject|1|||
125219899|NCT01307891|450432687|FG000|Overall Study|Progressive Disease|3|||
125219900|NCT01307891|450432688|FG001|Overall Study|Progressive Disease|1|||
125219901|NCT02937740|450432689|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
125219902|NCT02937740|450432690|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
125219903|NCT02937740|450432689|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
125219904|NCT02937740|450432690|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
125219905|NCT02937740|450432689|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
125219906|NCT02937740|450432690|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
125219907|NCT02937740|450432689|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
125219908|NCT02937740|450432690|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
125219909|NCT02937740|450432689|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
125219910|NCT02937740|450432690|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
125219911|NCT02937740|450432689|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
125219912|NCT02937740|450432690|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
125219913|NCT04194489|450432691|FG000|Overall Study|Withdrawal by Subject|5|||
125219914|NCT04194489|450432691|FG000|Overall Study|Lost to Follow-up|48|||
125219915|NCT00305227|450432699|FG000|Overall Study|Lost to Follow-up|7|||
125219916|NCT00305227|450432700|FG001|Overall Study|Lost to Follow-up|6|||
125219917|NCT04085601|450432701|FG000|Overall Study|Lost to Follow-up|1|||
125219918|NCT04085601|450432702|FG001|Overall Study|Lost to Follow-up|0|||
125219919|NCT04085601|450432701|FG000|Overall Study|Death|1|||
125219920|NCT04085601|450432702|FG001|Overall Study|Death|1|||
125219921|NCT03492437|450432703|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125219922|NCT03492437|450432704|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125219923|NCT04534517|450432706|FG000|Overall Study|Adverse Event|1|||
125381626|NCT01214629|451029147|FG002|Overall Study|Physician Decision|0|||
125381627|NCT01214629|451029148|FG003|Overall Study|Physician Decision|0|||
125219924|NCT04534517|450432706|FG000|Overall Study|Withdrawal by Subject|1|||
125219925|NCT04534517|450432706|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
125219926|NCT04534517|450432706|FG000|Overall Study|COVID-19 Related|1|||
125219927|NCT03872843|450432707|FG000|Overall Study|Lost to Follow-up|5|||
125219928|NCT03872843|450432708|FG001|Overall Study|Lost to Follow-up|7|||
125219929|NCT00823264|450432709|FG000|Overall Study|Protocol Violation|2|||
125381628|NCT01214629|451029149|FG004|Overall Study|Physician Decision|0|||
125381629|NCT01214629|451029150|FG005|Overall Study|Physician Decision|0|||
125381630|NCT01214629|451029151|FG006|Overall Study|Physician Decision|0|||
125381631|NCT01214629|451029152|FG007|Overall Study|Physician Decision|0|||
125381632|NCT01214629|451029153|FG008|Overall Study|Physician Decision|0|||
125381633|NCT01214629|451029154|FG009|Overall Study|Physician Decision|0|||
125381634|NCT01214629|451029155|FG010|Overall Study|Physician Decision|1|||
125381635|NCT01214629|451029145|FG000|Overall Study|Withdrawal by Subject|0|||
125381636|NCT01214629|451029146|FG001|Overall Study|Withdrawal by Subject|0|||
125381637|NCT01214629|451029147|FG002|Overall Study|Withdrawal by Subject|0|||
125381638|NCT01214629|451029148|FG003|Overall Study|Withdrawal by Subject|0|||
125381639|NCT01214629|451029149|FG004|Overall Study|Withdrawal by Subject|0|||
125381640|NCT01214629|451029150|FG005|Overall Study|Withdrawal by Subject|0|||
125381641|NCT01214629|451029151|FG006|Overall Study|Withdrawal by Subject|0|||
125381642|NCT01214629|451029152|FG007|Overall Study|Withdrawal by Subject|0|||
125381643|NCT01214629|451029153|FG008|Overall Study|Withdrawal by Subject|0|||
125381644|NCT01214629|451029154|FG009|Overall Study|Withdrawal by Subject|1|||
125381645|NCT01214629|451029155|FG010|Overall Study|Withdrawal by Subject|0|||
125381646|NCT02669433|451029162|FG000|Overall Study|Protocol Violation|0|||
125381647|NCT02669433|451029163|FG001|Overall Study|Protocol Violation|4|||
125381648|NCT02669433|451029164|FG002|Overall Study|Protocol Violation|1|||
125381649|NCT02669433|451029162|FG000|Overall Study|Disease Progression|1|||
125381650|NCT02669433|451029163|FG001|Overall Study|Disease Progression|0|||
125219930|NCT00823264|450432710|FG001|Overall Study|Protocol Violation|0|||
125219931|NCT05133323|450432711|FG000|Overall Study|Lack of Efficacy|0|||
125219932|NCT05133323|450432712|FG001|Overall Study|Lack of Efficacy|0|||
125437326|NCT03679767|451228060|FG001|Overall Study|Lost to Follow-up|1|||
125219933|NCT05133323|450432713|FG002|Overall Study|Lack of Efficacy|1|||
125219934|NCT05133323|450432711|FG000|Overall Study|Withdrawal by Subject|2|||
125437327|NCT03679767|451228061|FG002|Overall Study|Lost to Follow-up|1|||
125437328|NCT03679767|451228062|FG003|Overall Study|Lost to Follow-up|1|||
125437329|NCT03679767|451228059|FG000|Overall Study|Withdrawal by Subject|0|||
125437330|NCT03679767|451228060|FG001|Overall Study|Withdrawal by Subject|0|||
125437331|NCT03679767|451228061|FG002|Overall Study|Withdrawal by Subject|0|||
125437332|NCT03679767|451228062|FG003|Overall Study|Withdrawal by Subject|1|||
125437333|NCT03679767|451228059|FG000|Overall Study|Follow-up Completed|18|||
125437334|NCT03679767|451228060|FG001|Overall Study|Follow-up Completed|11|||
125437335|NCT03679767|451228061|FG002|Overall Study|Follow-up Completed|11|||
125437336|NCT03679767|451228062|FG003|Overall Study|Follow-up Completed|20|||
125437337|NCT03679767|451228059|FG000|Overall Study|Entered Hospice Care|0|||
125437338|NCT03679767|451228060|FG001|Overall Study|Entered Hospice Care|0|||
125437339|NCT03679767|451228061|FG002|Overall Study|Entered Hospice Care|0|||
125437340|NCT03679767|451228062|FG003|Overall Study|Entered Hospice Care|1|||
125219935|NCT05133323|450432712|FG001|Overall Study|Withdrawal by Subject|1|||
125219936|NCT05133323|450432713|FG002|Overall Study|Withdrawal by Subject|0|||
125219937|NCT00113295|450432714|FG000|Overall Study|Adverse Event|4|||
125219938|NCT00113295|450432715|FG001|Overall Study|Adverse Event|1|||
125219939|NCT00113295|450432714|FG000|Overall Study|Unrelated Medical Illness|1|||
125219940|NCT00113295|450432715|FG001|Overall Study|Unrelated Medical Illness|0|||
125219941|NCT01714544|450432716|FG000|Overall Study|Lost to Follow-up|1|||
125219942|NCT01714544|450432716|FG000|Overall Study|Physician Decision|1|||
125219943|NCT01714544|450432716|FG000|Overall Study|Withdrawal by Subject|1|||
125219944|NCT00577772|450432725|FG000|Overall Study|Lost to Follow-up|0|||
125219945|NCT00577772|450432726|FG001|Overall Study|Lost to Follow-up|1|||
125219946|NCT00572455|450432727|FG000|Stage I (14 Days)|Adverse Event|0|||
125219947|NCT00572455|450432728|FG001|Stage I (14 Days)|Adverse Event|0|||
125219948|NCT00572455|450432729|FG002|Stage I (14 Days)|Adverse Event|0|||
125219949|NCT00572455|450432730|FG003|Stage I (14 Days)|Adverse Event|0|||
125219950|NCT00572455|450432731|FG004|Stage I (14 Days)|Adverse Event|0|||
125219951|NCT00572455|450432732|FG005|Stage I (14 Days)|Adverse Event|3|||
125219952|NCT00572455|450432733|FG006|Stage I (14 Days)|Adverse Event|0|||
125219953|NCT00572455|450432734|FG007|Stage I (14 Days)|Adverse Event|0|||
125219954|NCT00572455|450432735|FG008|Stage I (14 Days)|Adverse Event|0|||
125219955|NCT00572455|450432736|FG009|Stage I (14 Days)|Adverse Event|0|||
125219956|NCT00572455|450432737|FG010|Stage I (14 Days)|Adverse Event|0|||
125219957|NCT00572455|450432738|FG011|Stage I (14 Days)|Adverse Event|0|||
125219958|NCT00572455|450432739|FG012|Stage I (14 Days)|Adverse Event|0|||
125219959|NCT00572455|450432740|FG013|Stage I (14 Days)|Adverse Event|0|||
125219960|NCT00572455|450432727|FG000|Stage I (14 Days)|Other|0|||
125219961|NCT00572455|450432728|FG001|Stage I (14 Days)|Other|0|||
125219962|NCT00572455|450432729|FG002|Stage I (14 Days)|Other|0|||
125219963|NCT00572455|450432730|FG003|Stage I (14 Days)|Other|0|||
125219964|NCT00572455|450432731|FG004|Stage I (14 Days)|Other|1|||
125219965|NCT00572455|450432732|FG005|Stage I (14 Days)|Other|0|||
125219966|NCT00572455|450432733|FG006|Stage I (14 Days)|Other|0|||
125219967|NCT00572455|450432734|FG007|Stage I (14 Days)|Other|0|||
125219968|NCT00572455|450432735|FG008|Stage I (14 Days)|Other|0|||
125219969|NCT00572455|450432736|FG009|Stage I (14 Days)|Other|0|||
125219970|NCT00572455|450432737|FG010|Stage I (14 Days)|Other|0|||
125219971|NCT00572455|450432738|FG011|Stage I (14 Days)|Other|0|||
125219972|NCT00572455|450432739|FG012|Stage I (14 Days)|Other|0|||
125219973|NCT00572455|450432740|FG013|Stage I (14 Days)|Other|0|||
125219974|NCT00572455|450432727|FG000|Stage II (28 Days)|Adverse Event|0|||
125219975|NCT00572455|450432728|FG001|Stage II (28 Days)|Adverse Event|0|||
125219976|NCT00572455|450432729|FG002|Stage II (28 Days)|Adverse Event|0|||
125219977|NCT00572455|450432730|FG003|Stage II (28 Days)|Adverse Event|0|||
125219978|NCT00572455|450432731|FG004|Stage II (28 Days)|Adverse Event|0|||
125219979|NCT00572455|450432732|FG005|Stage II (28 Days)|Adverse Event|0|||
125219980|NCT00572455|450432733|FG006|Stage II (28 Days)|Adverse Event|0|||
125219981|NCT00572455|450432734|FG007|Stage II (28 Days)|Adverse Event|0|||
125381651|NCT02669433|451029164|FG002|Overall Study|Disease Progression|0|||
125381652|NCT02669433|451029162|FG000|Overall Study|Physician Decision|1|||
125381653|NCT02669433|451029163|FG001|Overall Study|Physician Decision|1|||
125381654|NCT02669433|451029164|FG002|Overall Study|Physician Decision|0|||
125381655|NCT02669433|451029162|FG000|Overall Study|Adverse Event|6|||
125381656|NCT02669433|451029163|FG001|Overall Study|Adverse Event|7|||
125381657|NCT02669433|451029164|FG002|Overall Study|Adverse Event|10|||
125381658|NCT02669433|451029162|FG000|Overall Study|Sponsor Termination|1|||
125381659|NCT02669433|451029163|FG001|Overall Study|Sponsor Termination|0|||
125381660|NCT02669433|451029164|FG002|Overall Study|Sponsor Termination|1|||
125381661|NCT02669433|451029162|FG000|Overall Study|Withdrawal by Subject|5|||
125381662|NCT02669433|451029163|FG001|Overall Study|Withdrawal by Subject|1|||
125381663|NCT02669433|451029164|FG002|Overall Study|Withdrawal by Subject|0|||
125381664|NCT02669433|451029162|FG000|Overall Study|Withdrawal by Caregiver|1|||
125381665|NCT02669433|451029163|FG001|Overall Study|Withdrawal by Caregiver|0|||
125381666|NCT02669433|451029164|FG002|Overall Study|Withdrawal by Caregiver|2|||
125381667|NCT02669433|451029162|FG000|Overall Study|Death|0|||
125381668|NCT02669433|451029163|FG001|Overall Study|Death|1|||
125381669|NCT02669433|451029164|FG002|Overall Study|Death|1|||
125381670|NCT03128892|451029165|FG000|Overall Study|Withdrawal by Subject|2|||
125381671|NCT03128892|451029165|FG000|Overall Study|Physician Decision|1|||
125381672|NCT00459108|451029166|FG000|Overall Study|Withdrawal by Subject|5|||
125381673|NCT00459108|451029166|FG000|Overall Study|Adverse Event|3|||
125381674|NCT00459108|451029166|FG000|Overall Study|Death|2|||
125381675|NCT00459108|451029166|FG000|Overall Study|Progression|1|||
125381676|NCT03473808|451029169|FG000|Overall Study|Withdrawal by Subject|1|||
125381677|NCT02157298|451029170|FG000|Overall Study|Adverse Event|1|||
125381678|NCT02157298|451029171|FG001|Overall Study|Adverse Event|0|||
125381679|NCT02157298|451029170|FG000|Overall Study|Subject no longer meets study criteria|1|||
125381680|NCT02157298|451029171|FG001|Overall Study|Subject no longer meets study criteria|2|||
125381681|NCT02157298|451029170|FG000|Overall Study|Poor/Non-compliance|1|||
125381682|NCT02157298|451029171|FG001|Overall Study|Poor/Non-compliance|0|||
125381683|NCT02157298|451029170|FG000|Overall Study|Withdrawal by Subject|1|||
125381684|NCT02157298|451029171|FG001|Overall Study|Withdrawal by Subject|0|||
125381685|NCT01339429|451029172|FG000|Overall Study|Withdrawal by Subject|1|||
125381686|NCT01339429|451029172|FG000|Overall Study|Physician Decision|3|||
125381687|NCT01085591|451029173|FG000|Overall Study|Adverse Event|0|||
125381688|NCT01085591|451029174|FG001|Overall Study|Adverse Event|1|||
125381689|NCT01085591|451029175|FG002|Overall Study|Adverse Event|3|||
125381690|NCT01085591|451029173|FG000|Overall Study|Physician Decision|1|||
125381691|NCT01085591|451029174|FG001|Overall Study|Physician Decision|0|||
125381692|NCT01085591|451029175|FG002|Overall Study|Physician Decision|1|||
125381693|NCT01085591|451029173|FG000|Overall Study|Withdrawal by Subject|0|||
125381694|NCT01085591|451029174|FG001|Overall Study|Withdrawal by Subject|2|||
125381695|NCT01085591|451029175|FG002|Overall Study|Withdrawal by Subject|1|||
125381696|NCT01085591|451029173|FG000|Overall Study|Lost to Follow-up|0|||
125381697|NCT01085591|451029174|FG001|Overall Study|Lost to Follow-up|1|||
125381698|NCT01085591|451029175|FG002|Overall Study|Lost to Follow-up|1|||
125381699|NCT01085591|451029173|FG000|Overall Study|Protocol Violation|1|||
125381700|NCT01085591|451029174|FG001|Overall Study|Protocol Violation|1|||
125381701|NCT01085591|451029175|FG002|Overall Study|Protocol Violation|1|||
125381702|NCT01085591|451029173|FG000|Overall Study|Other|0|||
125381703|NCT01085591|451029174|FG001|Overall Study|Other|1|||
125381704|NCT01085591|451029175|FG002|Overall Study|Other|0|||
125437341|NCT03679767|451228059|FG000|Overall Study|Progressive Disease|0|||
125437342|NCT03679767|451228060|FG001|Overall Study|Progressive Disease|0|||
125437343|NCT03679767|451228061|FG002|Overall Study|Progressive Disease|0|||
125437344|NCT03679767|451228062|FG003|Overall Study|Progressive Disease|1|||
125381705|NCT01085591|451029173|FG000|Overall Study|Not Properly Consented|1|||
125381706|NCT01085591|451029174|FG001|Overall Study|Not Properly Consented|0|||
125381707|NCT01085591|451029175|FG002|Overall Study|Not Properly Consented|0|||
125381708|NCT00396591|451029176|FG000|Overall Study|Disease Progression|13|||
125381709|NCT00396591|451029176|FG000|Overall Study|Adverse Event|2|||
125381710|NCT00396591|451029176|FG000|Overall Study|Participant request|1|||
125381711|NCT00818662|451029180|FG000|Overall Study|Adverse Event|5|||
125381712|NCT00818662|451029181|FG001|Overall Study|Adverse Event|14|||
125437345|NCT02009696|451228067|FG000|Overall Study|Withdrawal by Subject|2|||
125219982|NCT00572455|450432735|FG008|Stage II (28 Days)|Adverse Event|1|||
125219983|NCT00572455|450432736|FG009|Stage II (28 Days)|Adverse Event|3|||
125219984|NCT00572455|450432737|FG010|Stage II (28 Days)|Adverse Event|3|||
125219985|NCT00572455|450432738|FG011|Stage II (28 Days)|Adverse Event|4|||
125219986|NCT00572455|450432739|FG012|Stage II (28 Days)|Adverse Event|5|||
125219987|NCT00572455|450432740|FG013|Stage II (28 Days)|Adverse Event|1|||
125219988|NCT00572455|450432727|FG000|Stage II (28 Days)|Death|0|||
125219989|NCT00572455|450432728|FG001|Stage II (28 Days)|Death|0|||
125219990|NCT00572455|450432729|FG002|Stage II (28 Days)|Death|0|||
125219991|NCT00572455|450432730|FG003|Stage II (28 Days)|Death|0|||
125219992|NCT00572455|450432731|FG004|Stage II (28 Days)|Death|0|||
125219993|NCT00572455|450432732|FG005|Stage II (28 Days)|Death|0|||
125219994|NCT00572455|450432733|FG006|Stage II (28 Days)|Death|0|||
125219995|NCT00572455|450432734|FG007|Stage II (28 Days)|Death|0|||
125219996|NCT00572455|450432735|FG008|Stage II (28 Days)|Death|1|||
125219997|NCT00572455|450432736|FG009|Stage II (28 Days)|Death|0|||
125219998|NCT00572455|450432737|FG010|Stage II (28 Days)|Death|0|||
125219999|NCT00572455|450432738|FG011|Stage II (28 Days)|Death|0|||
125220000|NCT00572455|450432739|FG012|Stage II (28 Days)|Death|0|||
125220001|NCT00572455|450432740|FG013|Stage II (28 Days)|Death|0|||
125220002|NCT00572455|450432727|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
125220003|NCT00572455|450432728|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
125220004|NCT00572455|450432729|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
125220005|NCT00572455|450432730|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
125381713|NCT00818662|451029182|FG002|Overall Study|Adverse Event|4|||
125381714|NCT00818662|451029183|FG003|Overall Study|Adverse Event|3|||
125381715|NCT00818662|451029180|FG000|Overall Study|Withdrawal by Subject|5|||
125381716|NCT00818662|451029181|FG001|Overall Study|Withdrawal by Subject|4|||
125220006|NCT00572455|450432731|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
125220007|NCT00572455|450432732|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
125220008|NCT00572455|450432733|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
125220009|NCT00572455|450432734|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
125220010|NCT00572455|450432735|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
125220011|NCT00572455|450432736|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
125220012|NCT00572455|450432737|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
125220013|NCT00572455|450432738|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
125220014|NCT00572455|450432739|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
125220015|NCT00572455|450432740|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
125220016|NCT00572455|450432727|FG000|Stage II (28 Days)|Other|0|||
125220017|NCT00572455|450432728|FG001|Stage II (28 Days)|Other|0|||
125220018|NCT00572455|450432729|FG002|Stage II (28 Days)|Other|0|||
125220019|NCT00572455|450432730|FG003|Stage II (28 Days)|Other|0|||
125220020|NCT00572455|450432731|FG004|Stage II (28 Days)|Other|0|||
125220021|NCT00572455|450432732|FG005|Stage II (28 Days)|Other|0|||
125220022|NCT00572455|450432733|FG006|Stage II (28 Days)|Other|0|||
125220023|NCT00572455|450432734|FG007|Stage II (28 Days)|Other|0|||
125220024|NCT00572455|450432735|FG008|Stage II (28 Days)|Other|1|||
125220025|NCT00572455|450432736|FG009|Stage II (28 Days)|Other|0|||
125220026|NCT00572455|450432737|FG010|Stage II (28 Days)|Other|0|||
125220027|NCT00572455|450432738|FG011|Stage II (28 Days)|Other|0|||
125220028|NCT00572455|450432739|FG012|Stage II (28 Days)|Other|0|||
125220029|NCT00572455|450432740|FG013|Stage II (28 Days)|Other|0|||
125220030|NCT00572455|450432727|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
125220031|NCT00572455|450432728|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
125220032|NCT00572455|450432729|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
125220033|NCT00572455|450432730|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
125220034|NCT00572455|450432731|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
125220035|NCT00572455|450432732|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
125220036|NCT00572455|450432733|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
125220037|NCT00572455|450432734|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
125220038|NCT00572455|450432735|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
125220039|NCT00572455|450432736|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
125220040|NCT00572455|450432737|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
125220041|NCT00572455|450432738|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
125220042|NCT00572455|450432739|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
125220043|NCT00572455|450432740|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
125220044|NCT02824224|450432741|FG000|Overall Study|Discontinued, IUS expulsion|0|||
125220045|NCT02824224|450432742|FG001|Overall Study|Discontinued, IUS expulsion|1|||
125220046|NCT02824224|450432741|FG000|Overall Study|Did not show up for allocation visit|2|||
125220047|NCT02824224|450432742|FG001|Overall Study|Did not show up for allocation visit|0|||
125220048|NCT04152083|450432747|FG000|Overall Study|Lost to Follow-up|2|||
125220049|NCT04152083|450432748|FG001|Overall Study|Lost to Follow-up|1|||
125220050|NCT04152083|450432747|FG000|Overall Study|Adverse Event|1|||
125220051|NCT04152083|450432748|FG001|Overall Study|Adverse Event|0|||
125220052|NCT04152083|450432747|FG000|Overall Study|Randomized but not treated|3|||
125220053|NCT04152083|450432748|FG001|Overall Study|Randomized but not treated|2|||
125220054|NCT00856999|450432749|FG000|Overall Study|Withdrawal by Subject|5|||
125220055|NCT02465437|450432754|FG000|Overall Study|Physician Decision|0|||
125220056|NCT02465437|450432755|FG001|Overall Study|Physician Decision|0|||
125220057|NCT02465437|450432756|FG002|Overall Study|Physician Decision|1|||
125220058|NCT02465437|450432757|FG003|Overall Study|Physician Decision|0|||
125381717|NCT00818662|451029182|FG002|Overall Study|Withdrawal by Subject|2|||
125220059|NCT02465437|450432754|FG000|Overall Study|Withdrawal by Subject|1|||
125220060|NCT02465437|450432755|FG001|Overall Study|Withdrawal by Subject|0|||
125220061|NCT02465437|450432756|FG002|Overall Study|Withdrawal by Subject|0|||
125220062|NCT02465437|450432757|FG003|Overall Study|Withdrawal by Subject|1|||
125381718|NCT00818662|451029183|FG003|Overall Study|Withdrawal by Subject|2|||
125220063|NCT02465437|450432754|FG000|Overall Study|Adverse Event|0|||
125220064|NCT02465437|450432755|FG001|Overall Study|Adverse Event|1|||
125220065|NCT02465437|450432756|FG002|Overall Study|Adverse Event|0|||
125220066|NCT02465437|450432757|FG003|Overall Study|Adverse Event|0|||
125220067|NCT00003483|450432758|FG000|Overall Study|Not evaluable|1|||
125220068|NCT00656175|450432759|FG000|Overall Study|Adverse Event|1|||
125220069|NCT00656175|450432760|FG001|Overall Study|Adverse Event|0|||
125220070|NCT00656175|450432759|FG000|Overall Study|Transportation issues|0|||
125220071|NCT00656175|450432760|FG001|Overall Study|Transportation issues|1|||
125220072|NCT02149264|450432763|FG000|Overall Study|Withdrawal by Subject|9|||
125220073|NCT02149264|450432763|FG000|Overall Study|Adverse Event|7|||
125220074|NCT02149264|450432763|FG000|Overall Study|Physician Decision|3|||
125220075|NCT02149264|450432763|FG000|Overall Study|Protocol Violation|1|||
125220076|NCT03472521|450432764|FG000|Overall Study|Lost to Follow-up|3|||
125220077|NCT03472521|450432765|FG001|Overall Study|Lost to Follow-up|2|||
125220078|NCT03472521|450432764|FG000|Overall Study|Discontinued intervention|3|||
125220079|NCT03472521|450432765|FG001|Overall Study|Discontinued intervention|1|||
125220080|NCT02308228|450432773|FG000|Overall Study|Adverse Event|3|||
125220081|NCT02308228|450432774|FG001|Overall Study|Adverse Event|4|||
125220082|NCT02308228|450432773|FG000|Overall Study|Withdrawal by Subject|5|||
125220083|NCT02308228|450432774|FG001|Overall Study|Withdrawal by Subject|3|||
125220084|NCT03999749|450432775|FG000|Overall Study|Toxicity|16|||
125220085|NCT03999749|450432775|FG000|Overall Study|Withdrawal by Subject|3|||
125220086|NCT03999749|450432775|FG000|Overall Study|Disease progression|26|||
125220087|NCT03999749|450432775|FG000|Overall Study|Physician Decision|4|||
125220088|NCT03999749|450432775|FG000|Overall Study|Death|5|||
125220089|NCT03999749|450432775|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
125220090|NCT00103285|450434391|FG000|Induction|Adverse Event|14|||
125220091|NCT00103285|450434392|FG001|Induction|Adverse Event|0|||
125220092|NCT00103285|450434393|FG002|Induction|Adverse Event|0|||
125220093|NCT00103285|450434394|FG003|Induction|Adverse Event|0|||
125220094|NCT00103285|450434395|FG004|Induction|Adverse Event|0|||
125220095|NCT00103285|450434396|FG005|Induction|Adverse Event|0|||
125220096|NCT00103285|450434397|FG006|Induction|Adverse Event|0|||
125220097|NCT00103285|450434398|FG007|Induction|Adverse Event|0|||
125220098|NCT00103285|450434391|FG000|Induction|Death|24|||
125220099|NCT00103285|450434392|FG001|Induction|Death|0|||
125220100|NCT00103285|450434393|FG002|Induction|Death|0|||
125220101|NCT00103285|450434394|FG003|Induction|Death|0|||
125220102|NCT00103285|450434395|FG004|Induction|Death|0|||
125220103|NCT00103285|450434396|FG005|Induction|Death|0|||
125135976|NCT03199963|450121799|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
125135977|NCT03199963|450121798|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
125135978|NCT03199963|450121799|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
125135979|NCT03199963|450121798|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
125135980|NCT03199963|450121799|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
125135981|NCT00466167|450121800|FG000|Overall Study|Adverse Event|8|||
125135982|NCT00466167|450121801|FG001|Overall Study|Adverse Event|8|||
125135983|NCT00466167|450121802|FG002|Overall Study|Adverse Event|7|||
125135984|NCT00466167|450121800|FG000|Overall Study|Lack of Efficacy|2|||
125135985|NCT00466167|450121801|FG001|Overall Study|Lack of Efficacy|0|||
125135986|NCT00466167|450121802|FG002|Overall Study|Lack of Efficacy|3|||
125135987|NCT00466167|450121800|FG000|Overall Study|Protocol Violation|1|||
125135988|NCT00466167|450121801|FG001|Overall Study|Protocol Violation|1|||
125135989|NCT00466167|450121802|FG002|Overall Study|Protocol Violation|2|||
125135990|NCT00466167|450121800|FG000|Overall Study|Lost to Follow-up|3|||
125135991|NCT00466167|450121801|FG001|Overall Study|Lost to Follow-up|2|||
125135992|NCT00466167|450121802|FG002|Overall Study|Lost to Follow-up|2|||
125135993|NCT00466167|450121800|FG000|Overall Study|Withdrawal by Subject|4|||
125135994|NCT00466167|450121801|FG001|Overall Study|Withdrawal by Subject|1|||
125135995|NCT00466167|450121802|FG002|Overall Study|Withdrawal by Subject|6|||
125135996|NCT00466167|450121800|FG000|Overall Study|patient did not meet inclusion criteria|1|||
125220104|NCT00103285|450434397|FG006|Induction|Death|0|||
125220105|NCT00103285|450434398|FG007|Induction|Death|0|||
125220106|NCT00103285|450434391|FG000|Induction|Physician Decision|103|||
125220107|NCT00103285|450434392|FG001|Induction|Physician Decision|0|||
125135997|NCT00466167|450121801|FG001|Overall Study|patient did not meet inclusion criteria|0|||
125135998|NCT00466167|450121802|FG002|Overall Study|patient did not meet inclusion criteria|1|||
125220108|NCT00103285|450434393|FG002|Induction|Physician Decision|0|||
125220109|NCT00103285|450434394|FG003|Induction|Physician Decision|0|||
125220110|NCT00103285|450434395|FG004|Induction|Physician Decision|0|||
125220111|NCT00103285|450434396|FG005|Induction|Physician Decision|0|||
125135999|NCT00466167|450121800|FG000|Overall Study|Not treated|1|||
125136000|NCT00466167|450121801|FG001|Overall Study|Not treated|0|||
125220112|NCT00103285|450434397|FG006|Induction|Physician Decision|0|||
125220113|NCT00103285|450434398|FG007|Induction|Physician Decision|0|||
125220114|NCT00103285|450434391|FG000|Induction|Withdrawal by Subject|1|||
125220115|NCT00103285|450434392|FG001|Induction|Withdrawal by Subject|0|||
125220116|NCT00103285|450434393|FG002|Induction|Withdrawal by Subject|0|||
125220117|NCT00103285|450434394|FG003|Induction|Withdrawal by Subject|0|||
125220118|NCT00103285|450434395|FG004|Induction|Withdrawal by Subject|0|||
125136001|NCT00466167|450121802|FG002|Overall Study|Not treated|0|||
125136002|NCT03366792|450121809|FG000|Overall Study|Withdrawal by Subject|7|||
125136003|NCT03366792|450121809|FG000|Overall Study|Lost to Follow-up|2|||
125136004|NCT03366792|450121809|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
125136005|NCT03366792|450121809|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
125136006|NCT02450539|450121810|FG000|Overall Study|Withdrawal by Subject|12|||
125136007|NCT02450539|450121811|FG001|Overall Study|Withdrawal by Subject|6|||
125437346|NCT05490329|451228068|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
125437347|NCT05490329|451228069|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
125437348|NCT05490329|451228068|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
125437349|NCT05490329|451228069|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
125437350|NCT05490329|451228068|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
125437351|NCT05490329|451228069|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
125437352|NCT00447954|451228070|FG000|Overall Study|Adverse Event|0|||
125437353|NCT00447954|451228071|FG001|Overall Study|Adverse Event|2|||
125437354|NCT00447954|451228072|FG002|Overall Study|Adverse Event|0|||
125437355|NCT00447954|451228070|FG000|Overall Study|Withdrawal by Subject|0|||
125437356|NCT00447954|451228071|FG001|Overall Study|Withdrawal by Subject|1|||
125437357|NCT00447954|451228072|FG002|Overall Study|Withdrawal by Subject|1|||
125437358|NCT00447954|451228070|FG000|Overall Study|Lost to Follow-up|0|||
125437359|NCT00447954|451228071|FG001|Overall Study|Lost to Follow-up|1|||
125437360|NCT00447954|451228072|FG002|Overall Study|Lost to Follow-up|0|||
125437361|NCT00447954|451228070|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
125136008|NCT02450539|450121810|FG000|Overall Study|Lost to Follow-up|4|||
125136009|NCT02450539|450121811|FG001|Overall Study|Lost to Follow-up|1|||
125136010|NCT00402103|450121814|FG000|Overall Study|Adverse Event|60|||
125136011|NCT00402103|450121815|FG001|Overall Study|Adverse Event|7|||
125136012|NCT00402103|450121814|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125136013|NCT00402103|450121815|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125136014|NCT00402103|450121814|FG000|Overall Study|Condition no longer requires study drug|2|||
125136015|NCT00402103|450121815|FG001|Overall Study|Condition no longer requires study drug|0|||
125136016|NCT00402103|450121814|FG000|Overall Study|Protocol Deviation|8|||
125136017|NCT00402103|450121815|FG001|Overall Study|Protocol Deviation|0|||
125136018|NCT00402103|450121814|FG000|Overall Study|Patient withdrew consent|12|||
125136019|NCT00402103|450121815|FG001|Overall Study|Patient withdrew consent|1|||
125136020|NCT00402103|450121814|FG000|Overall Study|Lost to Follow-up|6|||
125136021|NCT00402103|450121815|FG001|Overall Study|Lost to Follow-up|3|||
125136022|NCT00402103|450121814|FG000|Overall Study|Administrative problems|2|||
125136023|NCT00402103|450121815|FG001|Overall Study|Administrative problems|0|||
125136024|NCT04078022|450121816|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
125220119|NCT00103285|450434396|FG005|Induction|Withdrawal by Subject|0|||
125220120|NCT00103285|450434397|FG006|Induction|Withdrawal by Subject|0|||
125220121|NCT00103285|450434398|FG007|Induction|Withdrawal by Subject|0|||
125381719|NCT00818662|451029180|FG000|Overall Study|Death|1|||
125381720|NCT00818662|451029181|FG001|Overall Study|Death|3|||
125381721|NCT00818662|451029182|FG002|Overall Study|Death|0|||
125381722|NCT00818662|451029183|FG003|Overall Study|Death|0|||
125381723|NCT00818662|451029180|FG000|Overall Study|Physician Decision|1|||
125381724|NCT00818662|451029181|FG001|Overall Study|Physician Decision|0|||
125381725|NCT00818662|451029182|FG002|Overall Study|Physician Decision|0|||
125381726|NCT00818662|451029183|FG003|Overall Study|Physician Decision|0|||
125381727|NCT00818662|451029180|FG000|Overall Study|Lost to Follow-up|0|||
125381728|NCT00818662|451029181|FG001|Overall Study|Lost to Follow-up|0|||
125381729|NCT00818662|451029182|FG002|Overall Study|Lost to Follow-up|0|||
125381730|NCT00818662|451029183|FG003|Overall Study|Lost to Follow-up|1|||
125437362|NCT00447954|451228071|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
125381731|NCT00818662|451029180|FG000|Overall Study|Unwilling or Unable to Participate|4|||
125220122|NCT00103285|450434391|FG000|Induction|Ineligible|43|||
125381732|NCT00818662|451029181|FG001|Overall Study|Unwilling or Unable to Participate|6|||
125381733|NCT00818662|451029182|FG002|Overall Study|Unwilling or Unable to Participate|2|||
125381734|NCT00818662|451029183|FG003|Overall Study|Unwilling or Unable to Participate|4|||
125381735|NCT00818662|451029180|FG000|Overall Study|Protocol Violation|1|||
125381736|NCT00818662|451029181|FG001|Overall Study|Protocol Violation|1|||
125381737|NCT00818662|451029182|FG002|Overall Study|Protocol Violation|0|||
125381738|NCT00818662|451029183|FG003|Overall Study|Protocol Violation|0|||
125381739|NCT00818662|451029180|FG000|Overall Study|Requires a Prohibited Medication|1|||
125381740|NCT00818662|451029181|FG001|Overall Study|Requires a Prohibited Medication|0|||
125381741|NCT00818662|451029182|FG002|Overall Study|Requires a Prohibited Medication|0|||
125381742|NCT00818662|451029183|FG003|Overall Study|Requires a Prohibited Medication|0|||
125381743|NCT00818662|451029180|FG000|Overall Study|Safety Risk|1|||
125381744|NCT00818662|451029181|FG001|Overall Study|Safety Risk|1|||
125381745|NCT00818662|451029182|FG002|Overall Study|Safety Risk|0|||
125381746|NCT00818662|451029183|FG003|Overall Study|Safety Risk|1|||
125381747|NCT00818662|451029180|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
125381748|NCT00818662|451029181|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
125381749|NCT00818662|451029182|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
125381750|NCT00818662|451029183|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
125381751|NCT00818662|451029180|FG000|Overall Study|Participant's health declined|0|||
125381752|NCT00818662|451029181|FG001|Overall Study|Participant's health declined|0|||
125381753|NCT00818662|451029182|FG002|Overall Study|Participant's health declined|0|||
125381754|NCT00818662|451029183|FG003|Overall Study|Participant's health declined|1|||
125381755|NCT00818662|451029180|FG000|Overall Study|Caregiver to pursue other treatment|0|||
125381756|NCT00818662|451029181|FG001|Overall Study|Caregiver to pursue other treatment|1|||
125381757|NCT00818662|451029182|FG002|Overall Study|Caregiver to pursue other treatment|0|||
125381758|NCT00818662|451029183|FG003|Overall Study|Caregiver to pursue other treatment|0|||
125381759|NCT00818662|451029180|FG000|Overall Study|Moving out of state|0|||
125381760|NCT00818662|451029181|FG001|Overall Study|Moving out of state|0|||
125381761|NCT00818662|451029182|FG002|Overall Study|Moving out of state|0|||
125381762|NCT00818662|451029183|FG003|Overall Study|Moving out of state|1|||
125381763|NCT00818662|451029180|FG000|Overall Study|Declined move to another study site|1|||
125381764|NCT00818662|451029181|FG001|Overall Study|Declined move to another study site|0|||
125381765|NCT00818662|451029182|FG002|Overall Study|Declined move to another study site|0|||
125381766|NCT00818662|451029183|FG003|Overall Study|Declined move to another study site|0|||
125381767|NCT00818662|451029180|FG000|Overall Study|Change in living situation|0|||
125381768|NCT00818662|451029181|FG001|Overall Study|Change in living situation|0|||
125381769|NCT00818662|451029182|FG002|Overall Study|Change in living situation|0|||
125381770|NCT00818662|451029183|FG003|Overall Study|Change in living situation|1|||
125381771|NCT00818662|451029180|FG000|Overall Study|Study partner decision|0|||
125381772|NCT00818662|451029181|FG001|Overall Study|Study partner decision|0|||
125381773|NCT00818662|451029182|FG002|Overall Study|Study partner decision|0|||
125136025|NCT04078022|450121817|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
125136026|NCT01895335|450121822|FG000|Overall Study|Adverse Event|106|||
125136027|NCT01895335|450121822|FG000|Overall Study|Lack of Efficacy|53|||
125136028|NCT01895335|450121822|FG000|Overall Study|Poor Compliance to Protocol|11|||
125136029|NCT01895335|450121822|FG000|Overall Study|Included But Not treated|1|||
125136030|NCT01895335|450121822|FG000|Overall Study|Other than Specified Above|44|||
125136031|NCT00418938|450121823|FG000|Overall Study|Reimbursement|1|||
125136032|NCT00418938|450121824|FG001|Overall Study|Reimbursement|0|||
125136033|NCT00418938|450121823|FG000|Overall Study|Administrative decision|3|||
125136034|NCT00418938|450121824|FG001|Overall Study|Administrative decision|3|||
125136035|NCT00418938|450121823|FG000|Overall Study|Withdrawal by Subject|16|||
125136036|NCT00418938|450121824|FG001|Overall Study|Withdrawal by Subject|15|||
125136037|NCT00418938|450121823|FG000|Overall Study|Lost to Follow-up|1|||
125136038|NCT00418938|450121824|FG001|Overall Study|Lost to Follow-up|3|||
125136039|NCT00418938|450121823|FG000|Overall Study|Adverse Event|1|||
125136040|NCT00418938|450121824|FG001|Overall Study|Adverse Event|1|||
125136041|NCT00418938|450121823|FG000|Overall Study|On-going|1|||
125136042|NCT00418938|450121824|FG001|Overall Study|On-going|1|||
125136043|NCT00418938|450121823|FG000|Overall Study|Ineligibility Determined|1|||
125381774|NCT00818662|451029183|FG003|Overall Study|Study partner decision|1|||
125136044|NCT00418938|450121824|FG001|Overall Study|Ineligibility Determined|0|||
125136045|NCT00463684|450121825|FG000|Overall Study|Withdrawal by Subject|1|||
125136046|NCT00463684|450121825|FG000|Overall Study|Lost to Follow-up|3|||
125381775|NCT00818662|451029180|FG000|Overall Study|Admitted to long term nursing care|0|||
125381776|NCT00818662|451029181|FG001|Overall Study|Admitted to long term nursing care|1|||
125381777|NCT00818662|451029182|FG002|Overall Study|Admitted to long term nursing care|0|||
125381778|NCT00818662|451029183|FG003|Overall Study|Admitted to long term nursing care|0|||
125381779|NCT01472081|451029184|FG000|Overall Study|Continuing treatment at time of analysis|1|||
125381780|NCT01472081|451029185|FG001|Overall Study|Continuing treatment at time of analysis|4|||
125381781|NCT01472081|451029186|FG002|Overall Study|Continuing treatment at time of analysis|1|||
125381782|NCT01472081|451029187|FG003|Overall Study|Continuing treatment at time of analysis|8|||
125381783|NCT01472081|451029188|FG004|Overall Study|Continuing treatment at time of analysis|9|||
125381784|NCT01472081|451029189|FG005|Overall Study|Continuing treatment at time of analysis|0|||
125381785|NCT01472081|451029184|FG000|Overall Study|Disease Progression|4|||
125381786|NCT01472081|451029185|FG001|Overall Study|Disease Progression|10|||
125381787|NCT01472081|451029186|FG002|Overall Study|Disease Progression|12|||
125381788|NCT01472081|451029187|FG003|Overall Study|Disease Progression|31|||
125381789|NCT01472081|451029188|FG004|Overall Study|Disease Progression|22|||
125381790|NCT01472081|451029189|FG005|Overall Study|Disease Progression|3|||
125381791|NCT01472081|451029184|FG000|Overall Study|Study drug toxicity|2|||
125381792|NCT01472081|451029185|FG001|Overall Study|Study drug toxicity|9|||
125381793|NCT01472081|451029186|FG002|Overall Study|Study drug toxicity|4|||
125381794|NCT01472081|451029187|FG003|Overall Study|Study drug toxicity|6|||
125381795|NCT01472081|451029188|FG004|Overall Study|Study drug toxicity|13|||
125381796|NCT01472081|451029189|FG005|Overall Study|Study drug toxicity|2|||
125381797|NCT01472081|451029184|FG000|Overall Study|Death|0|||
125381798|NCT01472081|451029185|FG001|Overall Study|Death|0|||
125381799|NCT01472081|451029186|FG002|Overall Study|Death|0|||
125381800|NCT01472081|451029187|FG003|Overall Study|Death|0|||
125381801|NCT01472081|451029188|FG004|Overall Study|Death|1|||
125381802|NCT01472081|451029189|FG005|Overall Study|Death|0|||
125381803|NCT01472081|451029184|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
125381804|NCT01472081|451029185|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
125381805|NCT01472081|451029186|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
125381806|NCT01472081|451029187|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
125381807|NCT01472081|451029188|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
125381808|NCT01472081|451029189|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
125381809|NCT01472081|451029184|FG000|Overall Study|Withdrawal by Subject|0|||
125381810|NCT01472081|451029185|FG001|Overall Study|Withdrawal by Subject|0|||
125381811|NCT01472081|451029186|FG002|Overall Study|Withdrawal by Subject|0|||
125381812|NCT01472081|451029187|FG003|Overall Study|Withdrawal by Subject|0|||
125381813|NCT01472081|451029188|FG004|Overall Study|Withdrawal by Subject|0|||
125381814|NCT01472081|451029189|FG005|Overall Study|Withdrawal by Subject|1|||
125381815|NCT01472081|451029184|FG000|Overall Study|Poor/non-compliance|0|||
125381816|NCT01472081|451029185|FG001|Overall Study|Poor/non-compliance|0|||
125381817|NCT01472081|451029186|FG002|Overall Study|Poor/non-compliance|1|||
125381818|NCT01472081|451029187|FG003|Overall Study|Poor/non-compliance|0|||
125381819|NCT01472081|451029188|FG004|Overall Study|Poor/non-compliance|1|||
125381820|NCT01472081|451029189|FG005|Overall Study|Poor/non-compliance|0|||
125381821|NCT01472081|451029184|FG000|Overall Study|No longer meets study criteria|0|||
125381822|NCT01472081|451029185|FG001|Overall Study|No longer meets study criteria|0|||
125381823|NCT01472081|451029186|FG002|Overall Study|No longer meets study criteria|1|||
125381824|NCT01472081|451029187|FG003|Overall Study|No longer meets study criteria|0|||
125381825|NCT01472081|451029188|FG004|Overall Study|No longer meets study criteria|0|||
125381826|NCT01472081|451029189|FG005|Overall Study|No longer meets study criteria|0|||
125381827|NCT01472081|451029184|FG000|Overall Study|Subject request to discontinue treatment|0|||
125381828|NCT01472081|451029185|FG001|Overall Study|Subject request to discontinue treatment|3|||
125381829|NCT01472081|451029186|FG002|Overall Study|Subject request to discontinue treatment|1|||
125381830|NCT01472081|451029187|FG003|Overall Study|Subject request to discontinue treatment|1|||
125381831|NCT01472081|451029188|FG004|Overall Study|Subject request to discontinue treatment|0|||
125381832|NCT01472081|451029189|FG005|Overall Study|Subject request to discontinue treatment|0|||
125381833|NCT03605303|451029190|FG000|Period 1|Study Terminated|2|||
125381834|NCT03605303|451029191|FG001|Period 1|Study Terminated|1|||
125381835|NCT00623727|451031368|FG000|Double Blind (DB)|Adverse Event|1|||
125381836|NCT00623727|451031369|FG001|Double Blind (DB)|Adverse Event|3|||
125381837|NCT00623727|451031368|FG000|Double Blind (DB)|Physician Decision|0|||
125381838|NCT00623727|451031369|FG001|Double Blind (DB)|Physician Decision|1|||
125381839|NCT00623727|451031368|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
125381840|NCT00623727|451031369|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
125381841|NCT00623727|451031368|FG000|Double Blind (DB)|Lack of Efficacy|2|||
125381842|NCT00623727|451031369|FG001|Double Blind (DB)|Lack of Efficacy|2|||
125381843|NCT00623727|451031368|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
125381844|NCT00623727|451031369|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
125381845|NCT00623727|451031368|FG000|Double Blind (DB)|Lost to Follow-up|1|||
125381846|NCT00623727|451031369|FG001|Double Blind (DB)|Lost to Follow-up|1|||
125381847|NCT00623727|451031368|FG000|Double Blind (DB)|Protocol Violation|2|||
125381848|NCT00623727|451031369|FG001|Double Blind (DB)|Protocol Violation|2|||
125381849|NCT00623727|451031368|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
125381850|NCT00623727|451031369|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
125381851|NCT00623727|451031368|FG000|Open Label Follow-up|Study termination|0|||
125381852|NCT00623727|451031369|FG001|Open Label Follow-up|Study termination|6|||
125381853|NCT00623727|451031368|FG000|Open Label Follow-up|Participant convenience|0|||
125381854|NCT00623727|451031369|FG001|Open Label Follow-up|Participant convenience|1|||
125381855|NCT00501293|451031370|FG000|Optimization Period|Enrolled in error|1|||
125381856|NCT00501293|451031371|FG001|Optimization Period|Enrolled in error|0|||
125381857|NCT00501293|451031370|FG000|Maintenance Period|Withdrawal by Subject|14|||
125381858|NCT00501293|451031371|FG001|Maintenance Period|Withdrawal by Subject|13|||
125381859|NCT00501293|451031370|FG000|Maintenance Period|Lost to Follow-up|12|||
125381860|NCT00501293|451031371|FG001|Maintenance Period|Lost to Follow-up|7|||
125381861|NCT00501293|451031370|FG000|Maintenance Period|Adverse Event|6|||
125381862|NCT00501293|451031371|FG001|Maintenance Period|Adverse Event|6|||
125381863|NCT00501293|451031370|FG000|Maintenance Period|Protocol Violation|2|||
125381864|NCT00501293|451031371|FG001|Maintenance Period|Protocol Violation|1|||
125381865|NCT00501293|451031370|FG000|Maintenance Period|Lack of Efficacy|4|||
125381866|NCT00501293|451031371|FG001|Maintenance Period|Lack of Efficacy|1|||
125381867|NCT00501293|451031370|FG000|Maintenance Period|Noncompliant with study medication|5|||
125381868|NCT00501293|451031371|FG001|Maintenance Period|Noncompliant with study medication|0|||
125381869|NCT00501293|451031370|FG000|Maintenance Period|Went into rehabilitation|1|||
125381870|NCT00501293|451031371|FG001|Maintenance Period|Went into rehabilitation|0|||
125381871|NCT00501293|451031370|FG000|Maintenance Period|Would not wear patch|1|||
125381872|NCT00501293|451031371|FG001|Maintenance Period|Would not wear patch|0|||
125381873|NCT00501293|451031370|FG000|Maintenance Period|Application site reaction|1|||
125381874|NCT00501293|451031371|FG001|Maintenance Period|Application site reaction|0|||
125381875|NCT01104636|451031375|FG000|Overall Study|Lack of Efficacy|43|||
125381876|NCT01104636|451031375|FG000|Overall Study|Lost to Follow-up|24|||
125381877|NCT01104636|451031375|FG000|Overall Study|Withdrawal by Subject|4|||
125381878|NCT01104636|451031375|FG000|Overall Study|Other|43|||
125381879|NCT01104636|451031375|FG000|Overall Study|Study terminated by sponsor|1|||
125381880|NCT01104636|451031375|FG000|Overall Study|Pregnancy|2|||
125381881|NCT01104636|451031375|FG000|Overall Study|Adverse Event|40|||
125381882|NCT01104636|451031375|FG000|Overall Study|Ongoing|21|||
125381883|NCT01706003|451031376|FG000|Overall Study|Withdrawal by Subject|2|||
125381884|NCT01706003|451031377|FG001|Overall Study|Withdrawal by Subject|0|||
125381885|NCT01706003|451031376|FG000|Overall Study|Not scheduled|3|||
125381886|NCT01706003|451031377|FG001|Overall Study|Not scheduled|0|||
125381887|NCT01706003|451031376|FG000|Overall Study|Lost to Follow-up|6|||
125381888|NCT01706003|451031377|FG001|Overall Study|Lost to Follow-up|4|||
125381889|NCT00696696|451031380|FG000|Overall Study|Adverse Event|5|||
125381890|NCT00696696|451031380|FG000|Overall Study|Withdrawal by Subject|8|||
125381891|NCT00696696|451031380|FG000|Overall Study|Physician Decision|2|||
125381892|NCT00696696|451031380|FG000|Overall Study|Death|3|||
125381893|NCT01313767|451031386|FG000|Overall Study|Adverse Event|1|||
125381894|NCT01313767|451031387|FG001|Overall Study|Adverse Event|0|||
125381895|NCT01313767|451031386|FG000|Overall Study|Lost to Follow-up|1|||
125381896|NCT01313767|451031387|FG001|Overall Study|Lost to Follow-up|0|||
125381897|NCT01313767|451031386|FG000|Overall Study|Withdrawal by Subject|2|||
125381898|NCT01313767|451031387|FG001|Overall Study|Withdrawal by Subject|1|||
125381899|NCT01313767|451031386|FG000|Overall Study|Protocol Violation|3|||
125381900|NCT01313767|451031387|FG001|Overall Study|Protocol Violation|1|||
125381901|NCT01287897|451031393|FG000|Overall Study|Adverse Event|5|||
125381902|NCT01287897|451031394|FG001|Overall Study|Adverse Event|3|||
125381903|NCT01287897|451031395|FG002|Overall Study|Adverse Event|6|||
125381904|NCT01287897|451031396|FG003|Overall Study|Adverse Event|4|||
125381905|NCT01287897|451031393|FG000|Overall Study|Lack of Efficacy|2|||
125381906|NCT01287897|451031394|FG001|Overall Study|Lack of Efficacy|0|||
125381907|NCT01287897|451031395|FG002|Overall Study|Lack of Efficacy|0|||
125381908|NCT01287897|451031396|FG003|Overall Study|Lack of Efficacy|0|||
125381909|NCT01287897|451031393|FG000|Overall Study|Protocol Violation|1|||
125381910|NCT01287897|451031394|FG001|Overall Study|Protocol Violation|1|||
125381911|NCT01287897|451031395|FG002|Overall Study|Protocol Violation|0|||
125381912|NCT01287897|451031396|FG003|Overall Study|Protocol Violation|1|||
125381913|NCT01287897|451031393|FG000|Overall Study|Lost to Follow-up|0|||
125381914|NCT01287897|451031394|FG001|Overall Study|Lost to Follow-up|0|||
125381915|NCT01287897|451031395|FG002|Overall Study|Lost to Follow-up|2|||
125381916|NCT01287897|451031396|FG003|Overall Study|Lost to Follow-up|0|||
125381917|NCT01287897|451031393|FG000|Overall Study|Withdrawal by Subject|1|||
125381918|NCT01287897|451031394|FG001|Overall Study|Withdrawal by Subject|5|||
125381919|NCT01287897|451031395|FG002|Overall Study|Withdrawal by Subject|3|||
125381920|NCT01287897|451031396|FG003|Overall Study|Withdrawal by Subject|2|||
125381921|NCT01287897|451031393|FG000|Overall Study|Not consented properly|0|||
125381922|NCT01287897|451031394|FG001|Overall Study|Not consented properly|1|||
125381923|NCT01287897|451031395|FG002|Overall Study|Not consented properly|0|||
125381924|NCT01287897|451031396|FG003|Overall Study|Not consented properly|0|||
125381925|NCT01287897|451031393|FG000|Overall Study|Not meeting entrance criteria|1|||
125381926|NCT01287897|451031394|FG001|Overall Study|Not meeting entrance criteria|1|||
125381927|NCT01287897|451031395|FG002|Overall Study|Not meeting entrance criteria|0|||
125381928|NCT01287897|451031396|FG003|Overall Study|Not meeting entrance criteria|0|||
125381929|NCT01287897|451031393|FG000|Overall Study|Other|1|||
125381930|NCT01287897|451031394|FG001|Overall Study|Other|0|||
125381931|NCT01287897|451031395|FG002|Overall Study|Other|1|||
125381932|NCT01287897|451031396|FG003|Overall Study|Other|0|||
125381933|NCT00249444|451031397|FG000|Overall Study|Lost to Follow-up|2|||
125381934|NCT00249444|451031398|FG001|Overall Study|Lost to Follow-up|2|||
125381935|NCT00249444|451031397|FG000|Overall Study|non-compliant|9|||
125381936|NCT00249444|451031398|FG001|Overall Study|non-compliant|11|||
125381937|NCT00249444|451031397|FG000|Overall Study|Adverse Event|1|||
125381938|NCT00249444|451031398|FG001|Overall Study|Adverse Event|1|||
125381939|NCT00249444|451031397|FG000|Overall Study|life event|0|||
125381940|NCT00249444|451031398|FG001|Overall Study|life event|1|||
125381941|NCT00936910|451031401|FG000|Overall Study|Lack of Efficacy|3|||
125381942|NCT00412854|451031402|FG000|Overall Study|Withdrawn due to adverse events|1|||
125381943|NCT00412854|451031403|FG001|Overall Study|Withdrawn due to adverse events|5|||
125381944|NCT00412854|451031402|FG000|Overall Study|Withdrawn for other reasons|13|||
125381945|NCT00412854|451031403|FG001|Overall Study|Withdrawn for other reasons|11|||
125381946|NCT04483011|451031407|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
125381947|NCT04483011|451031408|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
125381948|NCT03518073|451031409|FG000|Overall Study|Adverse Event|2|||
125381949|NCT03518073|451031410|FG001|Overall Study|Adverse Event|4|||
125381950|NCT03518073|451031411|FG002|Overall Study|Adverse Event|2|||
125381951|NCT03518073|451031409|FG000|Overall Study|Death|2|||
125381952|NCT03518073|451031410|FG001|Overall Study|Death|1|||
125381953|NCT03518073|451031411|FG002|Overall Study|Death|3|||
125381954|NCT03518073|451031409|FG000|Overall Study|Lost to Follow-up|1|||
125381955|NCT03518073|451031410|FG001|Overall Study|Lost to Follow-up|0|||
125381956|NCT03518073|451031411|FG002|Overall Study|Lost to Follow-up|1|||
125381957|NCT03518073|451031409|FG000|Overall Study|Physician Decision|5|||
125381958|NCT03518073|451031410|FG001|Overall Study|Physician Decision|0|||
125381959|NCT03518073|451031411|FG002|Overall Study|Physician Decision|2|||
125381960|NCT03518073|451031409|FG000|Overall Study|Progressive disease|1|||
125381961|NCT03518073|451031410|FG001|Overall Study|Progressive disease|1|||
125381962|NCT03518073|451031411|FG002|Overall Study|Progressive disease|1|||
125381963|NCT03518073|451031409|FG000|Overall Study|Protocol Violation|1|||
125381964|NCT03518073|451031410|FG001|Overall Study|Protocol Violation|0|||
125381965|NCT03518073|451031411|FG002|Overall Study|Protocol Violation|0|||
125381966|NCT03518073|451031409|FG000|Overall Study|Withdrawal by Subject|30|||
125381967|NCT03518073|451031410|FG001|Overall Study|Withdrawal by Subject|34|||
125220123|NCT00103285|450434392|FG001|Induction|Ineligible|0|||
125220124|NCT00103285|450434393|FG002|Induction|Ineligible|0|||
125220125|NCT00103285|450434394|FG003|Induction|Ineligible|0|||
125220126|NCT00103285|450434395|FG004|Induction|Ineligible|0|||
125220127|NCT00103285|450434396|FG005|Induction|Ineligible|0|||
125220128|NCT00103285|450434397|FG006|Induction|Ineligible|0|||
125220129|NCT00103285|450434398|FG007|Induction|Ineligible|0|||
125220130|NCT00103285|450434391|FG000|Induction|Refusal|906|||
125220131|NCT00103285|450434392|FG001|Induction|Refusal|0|||
125220132|NCT00103285|450434393|FG002|Induction|Refusal|0|||
125220133|NCT00103285|450434394|FG003|Induction|Refusal|0|||
125220134|NCT00103285|450434395|FG004|Induction|Refusal|0|||
125220135|NCT00103285|450434396|FG005|Induction|Refusal|0|||
125220136|NCT00103285|450434397|FG006|Induction|Refusal|0|||
125220137|NCT00103285|450434398|FG007|Induction|Refusal|0|||
125220138|NCT00103285|450434391|FG000|Induction|Other|258|||
125220139|NCT00103285|450434392|FG001|Induction|Other|0|||
125220140|NCT00103285|450434393|FG002|Induction|Other|0|||
125220141|NCT00103285|450434394|FG003|Induction|Other|0|||
125220142|NCT00103285|450434395|FG004|Induction|Other|0|||
125220143|NCT00103285|450434396|FG005|Induction|Other|0|||
125220144|NCT00103285|450434397|FG006|Induction|Other|0|||
125381968|NCT03518073|451031411|FG002|Overall Study|Withdrawal by Subject|29|||
125381969|NCT03518073|451031409|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
125381970|NCT03518073|451031410|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
125381971|NCT03518073|451031411|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
125381972|NCT03518073|451031409|FG000|Overall Study|Covid-19|1|||
125381973|NCT03518073|451031410|FG001|Overall Study|Covid-19|2|||
125381974|NCT03518073|451031411|FG002|Overall Study|Covid-19|1|||
125381975|NCT03045081|451031412|FG000|Overall Study|Withdrawal by Subject|6|||
125381976|NCT03045081|451031413|FG001|Overall Study|Withdrawal by Subject|11|||
125381977|NCT01853046|451031414|FG000|Overall Study|Withdrawal by Subject|1|||
125381978|NCT01853046|451031415|FG001|Overall Study|Withdrawal by Subject|1|||
125381979|NCT01853046|451031414|FG000|Overall Study|Adverse Event|4|||
125381980|NCT01853046|451031415|FG001|Overall Study|Adverse Event|2|||
125381981|NCT01853046|451031414|FG000|Overall Study|Disease progression|13|||
125381982|NCT01853046|451031415|FG001|Overall Study|Disease progression|3|||
125381983|NCT01485640|451031416|FG000|Overall Study|Adverse Event|10|||
125381984|NCT01485640|451031416|FG000|Overall Study|Lack of Efficacy|2|||
125381985|NCT01485640|451031416|FG000|Overall Study|Protocol Violation|1|||
125381986|NCT01485640|451031416|FG000|Overall Study|Withdrawal by Subject|14|||
125381987|NCT01485640|451031416|FG000|Overall Study|Terminated by Sponsor|95|||
125381988|NCT00065507|451031420|FG000|Overall Study|Death|16|||
125381989|NCT00065507|451031421|FG001|Overall Study|Death|17|||
125381990|NCT00065507|451031420|FG000|Overall Study|Adverse Event|4|||
125381991|NCT00065507|451031421|FG001|Overall Study|Adverse Event|3|||
125381992|NCT00065507|451031420|FG000|Overall Study|Lack of Efficacy|0|||
125381993|NCT00065507|451031421|FG001|Overall Study|Lack of Efficacy|6|||
125381994|NCT00065507|451031420|FG000|Overall Study|Poor/Non-compliance|3|||
125381995|NCT00065507|451031421|FG001|Overall Study|Poor/Non-compliance|2|||
125381996|NCT00065507|451031420|FG000|Overall Study|Lost to Follow-up|3|||
125381997|NCT00065507|451031421|FG001|Overall Study|Lost to Follow-up|0|||
125381998|NCT00065507|451031420|FG000|Overall Study|Subject Withdrew Consent|2|||
125381999|NCT00065507|451031421|FG001|Overall Study|Subject Withdrew Consent|1|||
125382000|NCT00065507|451031420|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
125220145|NCT00103285|450434398|FG007|Induction|Other|0|||
125382001|NCT00065507|451031421|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
125382002|NCT03635957|451031422|FG000|Run-In Period|Lost to Follow-up|1|||
125382003|NCT03635957|451031422|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
125220146|NCT00103285|450434391|FG000|Response Assignment|Adverse Event|0|||
125220147|NCT00103285|450434392|FG001|Response Assignment|Adverse Event|8|||
125220148|NCT00103285|450434393|FG002|Response Assignment|Adverse Event|3|||
125220149|NCT00103285|450434394|FG003|Response Assignment|Adverse Event|2|||
125382004|NCT00350636|451031423|FG000|Overall Study|Adverse Event|19|||
125220150|NCT00103285|450434395|FG004|Response Assignment|Adverse Event|3|||
125220151|NCT00103285|450434396|FG005|Response Assignment|Adverse Event|1|||
125220152|NCT00103285|450434397|FG006|Response Assignment|Adverse Event|1|||
125382005|NCT00350636|451031424|FG001|Overall Study|Adverse Event|13|||
125220153|NCT00103285|450434398|FG007|Response Assignment|Adverse Event|2|||
125220154|NCT00103285|450434391|FG000|Response Assignment|Death|0|||
125220155|NCT00103285|450434392|FG001|Response Assignment|Death|5|||
125220156|NCT00103285|450434393|FG002|Response Assignment|Death|2|||
125220157|NCT00103285|450434394|FG003|Response Assignment|Death|2|||
125382006|NCT00350636|451031423|FG000|Overall Study|Protocol Violation|1|||
125382007|NCT00350636|451031424|FG001|Overall Study|Protocol Violation|3|||
125437363|NCT00447954|451228072|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
125437364|NCT00856661|451228073|FG000|Overall Study|Death|15|||
125437365|NCT00856661|451228074|FG001|Overall Study|Death|18|||
125437366|NCT00856661|451228073|FG000|Overall Study|Protocol Violation|2|||
125437367|NCT00856661|451228074|FG001|Overall Study|Protocol Violation|1|||
125437368|NCT00856661|451228073|FG000|Overall Study|Withdrawal by Subject|1|||
125437369|NCT00856661|451228074|FG001|Overall Study|Withdrawal by Subject|2|||
125437370|NCT00856661|451228073|FG000|Overall Study|Lost to Follow-up|1|||
125437371|NCT00856661|451228074|FG001|Overall Study|Lost to Follow-up|3|||
125437372|NCT00856661|451228073|FG000|Overall Study|Physician Judgement|8|||
125437373|NCT00856661|451228074|FG001|Overall Study|Physician Judgement|5|||
125437374|NCT02120664|451228075|FG000|Overall Study|Withdrawal by Subject|0|||
125437375|NCT02120664|451228076|FG001|Overall Study|Withdrawal by Subject|0|||
125437376|NCT02120664|451228077|FG002|Overall Study|Withdrawal by Subject|0|||
125437377|NCT02120664|451228078|FG003|Overall Study|Withdrawal by Subject|1|||
125437378|NCT02120664|451228079|FG004|Overall Study|Withdrawal by Subject|0|||
125437379|NCT00105586|451228080|FG000|Overall Study|Adverse Event|4|||
125437380|NCT00105586|451228081|FG001|Overall Study|Adverse Event|3|||
125437381|NCT00105586|451228080|FG000|Overall Study|Physician Decision|13|||
125437382|NCT00105586|451228081|FG001|Overall Study|Physician Decision|13|||
125437383|NCT02306122|451228082|FG000|Initial Physician Randomization|Physician Decision|0|||
125437384|NCT02306122|451228083|FG001|Initial Physician Randomization|Physician Decision|0|||
125437385|NCT02306122|451228084|FG002|Initial Physician Randomization|Physician Decision|0|||
125136047|NCT00115063|450121826|FG000|Overall Study|Lost to Follow-up|98|||
125136048|NCT00115063|450121827|FG001|Overall Study|Lost to Follow-up|104|||
125136049|NCT00115063|450121826|FG000|Overall Study|Death|1|||
125136050|NCT00115063|450121827|FG001|Overall Study|Death|0|||
125136051|NCT00191815|450121828|FG000|Overall Study|Adverse Event|2|||
125136052|NCT00191815|450121828|FG000|Overall Study|Disease progression or relapse|24|||
125136053|NCT00191815|450121828|FG000|Overall Study|Death|2|||
125136054|NCT00191815|450121828|FG000|Overall Study|Protocol Violation|3|||
125136055|NCT00191815|450121828|FG000|Overall Study|Physician Decision|2|||
125136056|NCT00191815|450121828|FG000|Overall Study|Withdrawal by Subject|7|||
125437386|NCT02306122|451228085|FG003|Initial Physician Randomization|Physician Decision|0|||
125136057|NCT01075282|450121829|FG000|Overall Study|Withdrawal by Subject|11|||
125136058|NCT01075282|450121830|FG001|Overall Study|Withdrawal by Subject|7|||
125136059|NCT01075282|450121831|FG002|Overall Study|Withdrawal by Subject|11|||
125136060|NCT01075282|450121829|FG000|Overall Study|Adverse Event|9|||
125136061|NCT01075282|450121830|FG001|Overall Study|Adverse Event|8|||
125136062|NCT01075282|450121831|FG002|Overall Study|Adverse Event|5|||
125136063|NCT01075282|450121829|FG000|Overall Study|Entry Criteria Not Met|3|||
125136064|NCT01075282|450121830|FG001|Overall Study|Entry Criteria Not Met|2|||
125136065|NCT01075282|450121831|FG002|Overall Study|Entry Criteria Not Met|0|||
125136066|NCT01075282|450121829|FG000|Overall Study|Lost to Follow-up|3|||
125136067|NCT01075282|450121830|FG001|Overall Study|Lost to Follow-up|3|||
125136068|NCT01075282|450121831|FG002|Overall Study|Lost to Follow-up|3|||
125136069|NCT01075282|450121829|FG000|Overall Study|Physician Decision|3|||
125136070|NCT01075282|450121830|FG001|Overall Study|Physician Decision|3|||
125136071|NCT01075282|450121831|FG002|Overall Study|Physician Decision|3|||
125136072|NCT01075282|450121829|FG000|Overall Study|Lack of Efficacy|1|||
125136073|NCT01075282|450121830|FG001|Overall Study|Lack of Efficacy|1|||
125136074|NCT01075282|450121831|FG002|Overall Study|Lack of Efficacy|0|||
125220158|NCT00103285|450434395|FG004|Response Assignment|Death|3|||
125437387|NCT02306122|451228086|FG004|Initial Physician Randomization|Physician Decision|0|||
125437388|NCT02306122|451228087|FG005|Initial Physician Randomization|Physician Decision|0|||
125437389|NCT02306122|451228088|FG006|Initial Physician Randomization|Physician Decision|0|||
125437390|NCT02306122|451228089|FG007|Initial Physician Randomization|Physician Decision|0|||
125136075|NCT01075282|450121829|FG000|Overall Study|Treatment Non-compliance|1|||
125136076|NCT01075282|450121830|FG001|Overall Study|Treatment Non-compliance|2|||
125136077|NCT01075282|450121831|FG002|Overall Study|Treatment Non-compliance|2|||
125136078|NCT01075282|450121829|FG000|Overall Study|Protocol Violation|0|||
125136079|NCT01075282|450121830|FG001|Overall Study|Protocol Violation|2|||
125136080|NCT01075282|450121831|FG002|Overall Study|Protocol Violation|1|||
125136081|NCT01075282|450121829|FG000|Overall Study|Death|0|||
125136082|NCT01075282|450121830|FG001|Overall Study|Death|1|||
125437391|NCT02306122|451228090|FG008|Initial Physician Randomization|Physician Decision|1|||
125485456|NCT02240238|451412510|FG007|Phase 2|Physician Decision|0|||
125136083|NCT01075282|450121831|FG002|Overall Study|Death|2|||
125220159|NCT00103285|450434396|FG005|Response Assignment|Death|1|||
125437392|NCT02306122|451228091|FG009|Initial Physician Randomization|Physician Decision|0|||
125437393|NCT02306122|451228092|FG010|Initial Physician Randomization|Physician Decision|0|||
125437394|NCT03734991|451228095|FG000|Overall Study|Adverse Event|4|||
125437395|NCT03734991|451228096|FG001|Overall Study|Adverse Event|0|||
125136084|NCT01794845|450121832|FG000|Overall Study|Withdrawal by Subject|1|||
125136085|NCT02139826|450121833|FG000|Overall Study|Adverse Event|1|||
125136086|NCT00429416|450121834|FG000|Overall Study|Death|1|||
125136087|NCT06999265|450121835|FG000|Overall Study|Lost to Follow-up|1|||
125136088|NCT06999265|450121836|FG001|Overall Study|Lost to Follow-up|1|||
125136089|NCT02316548|450122827|FG000|Overall Study|Protocol Violation|0|||
125136090|NCT02316548|450122828|FG001|Overall Study|Protocol Violation|1|||
125136091|NCT02571907|450122829|FG000|Overall Study|Death|4|||
125136092|NCT02571907|450122829|FG000|Overall Study|Lost to Follow-up|3|||
125382008|NCT00350636|451031423|FG000|Overall Study|Withdrawal by Subject|13|||
125382009|NCT00350636|451031424|FG001|Overall Study|Withdrawal by Subject|17|||
125382010|NCT00350636|451031423|FG000|Overall Study|Lost to Follow-up|9|||
125382011|NCT00350636|451031424|FG001|Overall Study|Lost to Follow-up|8|||
125382012|NCT00350636|451031423|FG000|Overall Study|Physician Decision|0|||
125382013|NCT00350636|451031424|FG001|Overall Study|Physician Decision|2|||
125382014|NCT00350636|451031423|FG000|Overall Study|Other|1|||
125382015|NCT00350636|451031424|FG001|Overall Study|Other|2|||
125382016|NCT01042236|451031427|FG000|Treatment Period 1|Adverse Event|0|||
125382017|NCT01042236|451031428|FG001|Treatment Period 1|Adverse Event|1|||
125382018|NCT01042236|451031429|FG002|Treatment Period 1|Adverse Event|0|||
125382019|NCT01042236|451031430|FG003|Treatment Period 1|Adverse Event|0|||
125382020|NCT01042236|451031431|FG004|Treatment Period 1|Adverse Event|1|||
125382021|NCT01042236|451031432|FG005|Treatment Period 1|Adverse Event|0|||
125382022|NCT01042236|451031427|FG000|Treatment Period 3|Adverse Event|0|||
125382023|NCT01042236|451031428|FG001|Treatment Period 3|Adverse Event|0|||
125382024|NCT01042236|451031429|FG002|Treatment Period 3|Adverse Event|0|||
125382025|NCT01042236|451031430|FG003|Treatment Period 3|Adverse Event|1|||
125382026|NCT01042236|451031431|FG004|Treatment Period 3|Adverse Event|0|||
125382027|NCT01042236|451031432|FG005|Treatment Period 3|Adverse Event|0|||
125382028|NCT01042236|451031427|FG000|Treatment Period 3|Protocol Violation|0|||
125382029|NCT01042236|451031428|FG001|Treatment Period 3|Protocol Violation|0|||
125382030|NCT01042236|451031429|FG002|Treatment Period 3|Protocol Violation|0|||
125382031|NCT01042236|451031430|FG003|Treatment Period 3|Protocol Violation|1|||
125382032|NCT01042236|451031431|FG004|Treatment Period 3|Protocol Violation|0|||
125382033|NCT01042236|451031432|FG005|Treatment Period 3|Protocol Violation|0|||
125382034|NCT00227903|451031433|FG000|Overall Study|Withdrawal by Subject|2|||
125382035|NCT00227903|451031434|FG001|Overall Study|Withdrawal by Subject|5|||
125382036|NCT00227903|451031433|FG000|Overall Study|Subject moved out of area|1|||
125382037|NCT00227903|451031434|FG001|Overall Study|Subject moved out of area|2|||
125382038|NCT00227903|451031433|FG000|Overall Study|Lost to Follow-up|1|||
125382039|NCT00227903|451031434|FG001|Overall Study|Lost to Follow-up|3|||
125382040|NCT00227903|451031433|FG000|Overall Study|Miscarriage|1|||
125382041|NCT00227903|451031434|FG001|Overall Study|Miscarriage|0|||
125382042|NCT01475331|451031435|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
125136093|NCT02571907|450122829|FG000|Overall Study|Withdrawal by Subject|3|||
125136094|NCT02286739|450122835|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
125382043|NCT01475331|451031436|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
125382044|NCT01475331|451031435|FG000|Overall Study|excessive main duct communication|1|||
125437396|NCT03734991|451228095|FG000|Overall Study|Lost to Follow-up|4|||
125220160|NCT00103285|450434397|FG006|Response Assignment|Death|0|||
125220161|NCT00103285|450434398|FG007|Response Assignment|Death|8|||
125220162|NCT00103285|450434391|FG000|Response Assignment|Lost to Follow-up|0|||
125220163|NCT00103285|450434392|FG001|Response Assignment|Lost to Follow-up|9|||
125220164|NCT00103285|450434393|FG002|Response Assignment|Lost to Follow-up|5|||
125220165|NCT00103285|450434394|FG003|Response Assignment|Lost to Follow-up|5|||
125220166|NCT00103285|450434395|FG004|Response Assignment|Lost to Follow-up|1|||
125220167|NCT00103285|450434396|FG005|Response Assignment|Lost to Follow-up|2|||
125220168|NCT00103285|450434397|FG006|Response Assignment|Lost to Follow-up|2|||
125220169|NCT00103285|450434398|FG007|Response Assignment|Lost to Follow-up|5|||
125220170|NCT00103285|450434391|FG000|Response Assignment|Physician Decision|0|||
125220171|NCT00103285|450434392|FG001|Response Assignment|Physician Decision|13|||
125220172|NCT00103285|450434393|FG002|Response Assignment|Physician Decision|14|||
125220173|NCT00103285|450434394|FG003|Response Assignment|Physician Decision|9|||
125220174|NCT00103285|450434395|FG004|Response Assignment|Physician Decision|13|||
125220175|NCT00103285|450434396|FG005|Response Assignment|Physician Decision|7|||
125220176|NCT00103285|450434397|FG006|Response Assignment|Physician Decision|4|||
125220177|NCT00103285|450434398|FG007|Response Assignment|Physician Decision|35|||
125220178|NCT00103285|450434391|FG000|Response Assignment|Protocol Violation|0|||
125220179|NCT00103285|450434392|FG001|Response Assignment|Protocol Violation|2|||
125220180|NCT00103285|450434393|FG002|Response Assignment|Protocol Violation|0|||
125220181|NCT00103285|450434394|FG003|Response Assignment|Protocol Violation|0|||
125220182|NCT00103285|450434395|FG004|Response Assignment|Protocol Violation|0|||
125220183|NCT00103285|450434396|FG005|Response Assignment|Protocol Violation|0|||
125220184|NCT00103285|450434397|FG006|Response Assignment|Protocol Violation|0|||
125220185|NCT00103285|450434398|FG007|Response Assignment|Protocol Violation|0|||
125220186|NCT00103285|450434391|FG000|Response Assignment|Withdrawal by Subject|0|||
125136095|NCT02286739|450122836|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
125136096|NCT02286739|450122835|FG000|Overall Study|No Verasense type documented|0|||
125136097|NCT02286739|450122836|FG001|Overall Study|No Verasense type documented|23|||
125136098|NCT02286739|450122835|FG000|Overall Study|Adverse Event|1|||
125136099|NCT02286739|450122836|FG001|Overall Study|Adverse Event|2|||
125136100|NCT02286739|450122835|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
125136101|NCT02286739|450122836|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
125136102|NCT02566850|450122837|FG000|Overall Study|Protocol Violation|1|||
125136103|NCT03447353|450122841|FG000|Overall Study|Failure at Screening Visit|2|||
125136104|NCT03447353|450122841|FG000|Overall Study|Lost to Follow-up|4|||
125136105|NCT03447353|450122841|FG000|Overall Study|Scheduling Conflicts|3|||
125136106|NCT03447353|450122841|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
125220187|NCT00103285|450434392|FG001|Response Assignment|Withdrawal by Subject|4|||
125220188|NCT00103285|450434393|FG002|Response Assignment|Withdrawal by Subject|1|||
125220189|NCT00103285|450434394|FG003|Response Assignment|Withdrawal by Subject|1|||
125382045|NCT01475331|451031436|FG001|Overall Study|excessive main duct communication|1|||
125382046|NCT01475331|451031435|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
125382047|NCT01475331|451031436|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
125382048|NCT01475331|451031435|FG000|Overall Study|Sign of malignancy during the procedure|2|||
125382049|NCT01475331|451031436|FG001|Overall Study|Sign of malignancy during the procedure|0|||
125382050|NCT01475331|451031435|FG000|Overall Study|cyst found to be prohibitively small|0|||
125382051|NCT01475331|451031436|FG001|Overall Study|cyst found to be prohibitively small|1|||
125382052|NCT01525550|451031437|FG000|Overall Study|Lost to Follow-up|8|||
125382053|NCT01525550|451031438|FG001|Overall Study|Lost to Follow-up|2|||
125382054|NCT01525550|451031437|FG000|Overall Study|Death|19|||
125382055|NCT01525550|451031438|FG001|Overall Study|Death|28|||
125382056|NCT01525550|451031437|FG000|Overall Study|Other|0|||
125382057|NCT01525550|451031438|FG001|Overall Study|Other|4|||
125382058|NCT01525550|451031437|FG000|Overall Study|Sponsor's Decision|30|||
125382059|NCT01525550|451031438|FG001|Overall Study|Sponsor's Decision|11|||
125382060|NCT01525550|451031437|FG000|Overall Study|Withdrawal by Subject|4|||
125382061|NCT01525550|451031438|FG001|Overall Study|Withdrawal by Subject|0|||
125382062|NCT03318315|451031443|FG000|Overall Study|Lost to Follow-up|3|||
125382063|NCT03318315|451031444|FG001|Overall Study|Lost to Follow-up|2|||
125382064|NCT03318315|451031445|FG002|Overall Study|Lost to Follow-up|1|||
125382065|NCT03318315|451031443|FG000|Overall Study|Protocol Violation|1|||
125382066|NCT03318315|451031444|FG001|Overall Study|Protocol Violation|1|||
125382067|NCT03318315|451031445|FG002|Overall Study|Protocol Violation|1|||
125382068|NCT03318315|451031443|FG000|Overall Study|Withdrawal by Subject|0|||
125382069|NCT03318315|451031444|FG001|Overall Study|Withdrawal by Subject|0|||
125382070|NCT03318315|451031445|FG002|Overall Study|Withdrawal by Subject|2|||
125382071|NCT02436356|451031446|FG000|Overall Study|Excluded by MRI Screening|0|||
125382072|NCT02436356|451031447|FG001|Overall Study|Excluded by MRI Screening|0|||
125382073|NCT02436356|451031448|FG002|Overall Study|Excluded by MRI Screening|2|||
125382074|NCT02436356|451031446|FG000|Overall Study|Lost to Follow-up|0|||
125382075|NCT02436356|451031447|FG001|Overall Study|Lost to Follow-up|1|||
125382076|NCT02436356|451031448|FG002|Overall Study|Lost to Follow-up|0|||
125382077|NCT02436356|451031446|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
125382078|NCT02436356|451031447|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
125382079|NCT02436356|451031448|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
125382080|NCT02436356|451031446|FG000|Overall Study|Excluded due to other medical conditions|3|||
125382081|NCT02436356|451031447|FG001|Overall Study|Excluded due to other medical conditions|0|||
125382082|NCT02436356|451031448|FG002|Overall Study|Excluded due to other medical conditions|0|||
125382083|NCT02436356|451031446|FG000|Overall Study|Withdrawal by Subject|1|||
125382084|NCT02436356|451031447|FG001|Overall Study|Withdrawal by Subject|0|||
125382085|NCT02436356|451031448|FG002|Overall Study|Withdrawal by Subject|0|||
125382086|NCT04577118|451031449|FG000|Overall Study|Withdrawal by Subject|4|||
125382087|NCT00810407|451031450|FG000|Overall Study|Protocol Violation|3|||
125382088|NCT00810407|451031450|FG000|Overall Study|No Visit After First Day of Treatment|3|||
125382089|NCT00674661|451031453|FG000|Overall Study|Other|5|||
125382090|NCT00674661|451031454|FG001|Overall Study|Other|7|||
125382091|NCT00674661|451031453|FG000|Overall Study|Lost to Follow-up|6|||
125382092|NCT00674661|451031454|FG001|Overall Study|Lost to Follow-up|3|||
125382093|NCT00674661|451031453|FG000|Overall Study|Withdrawal by Subject|0|||
125382094|NCT00674661|451031454|FG001|Overall Study|Withdrawal by Subject|5|||
125382095|NCT03108027|451031456|FG000|Period 1|Subject/Guardian Decision|0|||
125382096|NCT03108027|451031457|FG001|Period 1|Subject/Guardian Decision|0|||
125382097|NCT03108027|451031458|FG002|Period 1|Subject/Guardian Decision|0|||
125382098|NCT03108027|451031459|FG003|Period 1|Subject/Guardian Decision|2|||
125382099|NCT03108027|451031460|FG004|Period 1|Subject/Guardian Decision|0|||
125382100|NCT03108027|451031461|FG005|Period 1|Subject/Guardian Decision|0|||
125136107|NCT02642653|450122846|FG000|Overall Study|Adverse Event|2|||
125136108|NCT02642653|450122847|FG001|Overall Study|Adverse Event|0|||
125382101|NCT03108027|451031456|FG000|Period 3|Adverse Event|0|||
125382102|NCT03108027|451031457|FG001|Period 3|Adverse Event|1|||
125382103|NCT03108027|451031458|FG002|Period 3|Adverse Event|0|||
125382104|NCT03108027|451031459|FG003|Period 3|Adverse Event|0|||
125382105|NCT03108027|451031460|FG004|Period 3|Adverse Event|0|||
125382106|NCT03108027|451031461|FG005|Period 3|Adverse Event|0|||
125382107|NCT02574247|451031462|FG000|Overall Study|Withdrawal by Subject|1|||
125382108|NCT02574247|451031463|FG001|Overall Study|Withdrawal by Subject|0|||
125382109|NCT02574247|451031464|FG002|Overall Study|Withdrawal by Subject|0|||
125382110|NCT02574247|451031462|FG000|Overall Study|Did not meet inclusion criteria|4|||
125382111|NCT02574247|451031463|FG001|Overall Study|Did not meet inclusion criteria|3|||
125382112|NCT02574247|451031464|FG002|Overall Study|Did not meet inclusion criteria|5|||
125382113|NCT00268996|451031465|FG000|Overall Study|Adverse Event|11|||
125382114|NCT00268996|451031466|FG001|Overall Study|Adverse Event|7|||
125382115|NCT00268996|451031465|FG000|Overall Study|Lost to Follow-up|3|||
125382116|NCT00268996|451031466|FG001|Overall Study|Lost to Follow-up|1|||
125382117|NCT00268996|451031465|FG000|Overall Study|Withdrawal by Subject|5|||
125382118|NCT00268996|451031466|FG001|Overall Study|Withdrawal by Subject|11|||
125382119|NCT00268996|451031465|FG000|Overall Study|Non-compliance|1|||
125382120|NCT00268996|451031466|FG001|Overall Study|Non-compliance|0|||
125382121|NCT00268996|451031465|FG000|Overall Study|Other|1|||
125382122|NCT00268996|451031466|FG001|Overall Study|Other|1|||
125382123|NCT04210310|451031467|FG000|Overall Study|Lost to Follow-up|32|||
125382124|NCT04210310|451031468|FG001|Overall Study|Lost to Follow-up|1|||
125382125|NCT00576927|451031469|FG000|Clinical Assessment|Lack of Efficacy|24|||
125382126|NCT00576927|451031469|FG000|Clinical Assessment|Death|1|||
125382127|NCT00576927|451031469|FG000|Clinical Assessment|Withdrawal by Subject|10|||
125382128|NCT00576927|451031469|FG000|Clinical Assessment|Physician Decision|1|||
125382129|NCT00576927|451031469|FG000|Baseline|Physician Decision|9|||
125382130|NCT00576927|451031469|FG000|Baseline|Medication Change by PCP of subject|1|||
125382131|NCT00576927|451031469|FG000|Baseline|Withdrawal by Subject|3|||
125382132|NCT00576927|451031469|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
125382133|NCT00576927|451031469|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
125382134|NCT00576927|451031469|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
125382135|NCT00576927|451031469|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
125382136|NCT00576927|451031469|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
125382137|NCT03266094|451031470|FG000|Overall Study|Lost to Follow-up|1|||
125382138|NCT03266094|451031470|FG000|Overall Study|Withdrawal by Subject|1|||
125382139|NCT03171415|451031474|FG000|Overall Study|Lost to Follow-up|0|||
125382140|NCT03171415|451031475|FG001|Overall Study|Lost to Follow-up|0|||
125382141|NCT03171415|451031476|FG002|Overall Study|Lost to Follow-up|0|||
125382142|NCT03171415|451031477|FG003|Overall Study|Lost to Follow-up|0|||
125382143|NCT03171415|451031478|FG004|Overall Study|Lost to Follow-up|2|||
125382144|NCT04059094|451031479|FG000|Overall Study|Adverse Event|0|||
125382145|NCT04059094|451031480|FG001|Overall Study|Adverse Event|0|||
125382146|NCT04059094|451031481|FG002|Overall Study|Adverse Event|0|||
125382147|NCT04059094|451031482|FG003|Overall Study|Adverse Event|0|||
125382148|NCT04059094|451031483|FG004|Overall Study|Adverse Event|1|||
125382149|NCT04059094|451031479|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
125382150|NCT04059094|451031480|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
125382151|NCT04059094|451031481|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
125382152|NCT04059094|451031482|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
125382153|NCT04059094|451031483|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
125220190|NCT00103285|450434395|FG004|Response Assignment|Withdrawal by Subject|2|||
125382154|NCT03715764|451031486|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
125382155|NCT03715764|451031487|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
125382156|NCT03715764|451031486|FG000|3 Month Follow-up|Lost to Follow-up|2|||
125382157|NCT03715764|451031487|FG001|3 Month Follow-up|Lost to Follow-up|2|||
125382158|NCT03715764|451031486|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
125437397|NCT03734991|451228096|FG001|Overall Study|Lost to Follow-up|0|||
125382159|NCT03715764|451031487|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
125382160|NCT03715764|451031486|FG000|6 Month Follow-up|Lost to Follow-up|3|||
125437398|NCT03734991|451228095|FG000|Overall Study|Physician Decision|0|||
125437399|NCT03734991|451228096|FG001|Overall Study|Physician Decision|1|||
125437400|NCT03734991|451228095|FG000|Overall Study|Pregnancy|1|||
125437401|NCT03734991|451228096|FG001|Overall Study|Pregnancy|0|||
125437402|NCT03734991|451228095|FG000|Overall Study|Withdrawal by Subject|6|||
125437403|NCT03734991|451228096|FG001|Overall Study|Withdrawal by Subject|3|||
125437404|NCT03734991|451228095|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
125437405|NCT03734991|451228096|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
125437406|NCT03734991|451228095|FG000|Overall Study|Other|2|||
125437407|NCT03734991|451228096|FG001|Overall Study|Other|2|||
125437408|NCT02638623|451228097|FG000|Overall Study|Surgery timing|5|||
125437409|NCT02638623|451228098|FG001|Overall Study|Surgery timing|6|||
125437410|NCT02638623|451228097|FG000|Overall Study|Not given intervention|2|||
125437411|NCT02638623|451228098|FG001|Overall Study|Not given intervention|0|||
125437412|NCT00886639|451228099|FG000|Overall Study|acute exacerbation|14|||
125437413|NCT00886639|451228099|FG000|Overall Study|non-compliance|2|||
125437414|NCT03203694|451228100|FG000|Overall Study|Withdrawal by Subject|2|||
125437415|NCT03203694|451228101|FG001|Overall Study|Withdrawal by Subject|0|||
125437416|NCT03203694|451228102|FG002|Overall Study|Withdrawal by Subject|0|||
125437417|NCT03203694|451228103|FG003|Overall Study|Withdrawal by Subject|0|||
125437418|NCT03203694|451228104|FG004|Overall Study|Withdrawal by Subject|0|||
125437419|NCT03203694|451228105|FG005|Overall Study|Withdrawal by Subject|0|||
125437420|NCT01103960|451228108|FG000|Overall Study|Adverse Event|2|||
125437421|NCT01103960|451228109|FG001|Overall Study|Adverse Event|1|||
125437422|NCT01103960|451228108|FG000|Overall Study|Withdrawal by Subject|2|||
125437423|NCT01103960|451228109|FG001|Overall Study|Withdrawal by Subject|1|||
125437424|NCT01103960|451228108|FG000|Overall Study|Other|1|||
125437425|NCT01103960|451228109|FG001|Overall Study|Other|0|||
125437426|NCT02875834|451228110|FG000|Open-label Phase|Withdrawal by Subject|3|||
125437427|NCT02875834|451228111|FG001|Open-label Phase|Withdrawal by Subject|0|||
125437428|NCT02875834|451228112|FG002|Open-label Phase|Withdrawal by Subject|0|||
125437429|NCT02875834|451228113|FG003|Open-label Phase|Withdrawal by Subject|0|||
125437430|NCT02875834|451228110|FG000|Open-label Phase|(Not collected)|4|||
125437431|NCT02875834|451228111|FG001|Open-label Phase|(Not collected)|0|||
125437432|NCT02875834|451228112|FG002|Open-label Phase|(Not collected)|0|||
125437433|NCT02875834|451228113|FG003|Open-label Phase|(Not collected)|0|||
125437434|NCT02875834|451228110|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
125437435|NCT02875834|451228111|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
125437436|NCT02875834|451228112|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
125437437|NCT02875834|451228113|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
125437438|NCT02875834|451228110|FG000|Randomized Treatment Phase|Protocol Violation|0|||
125437439|NCT02875834|451228111|FG001|Randomized Treatment Phase|Protocol Violation|2|||
125437440|NCT02875834|451228112|FG002|Randomized Treatment Phase|Protocol Violation|0|||
125437441|NCT02875834|451228113|FG003|Randomized Treatment Phase|Protocol Violation|0|||
125437442|NCT02875834|451228110|FG000|Randomized Treatment Phase|(Not collected)|0|||
125437443|NCT02875834|451228111|FG001|Randomized Treatment Phase|(Not collected)|9|||
125437444|NCT02875834|451228112|FG002|Randomized Treatment Phase|(Not collected)|10|||
125437445|NCT02875834|451228113|FG003|Randomized Treatment Phase|(Not collected)|9|||
125437446|NCT01032044|451228114|FG000|Overall Study|Protocol Violation|14|||
125437447|NCT01032044|451228115|FG001|Overall Study|Protocol Violation|8|||
125437448|NCT01032044|451228114|FG000|Overall Study|Adverse Event|0|||
125136109|NCT00830258|450122848|FG000|First Intervention|Adverse Event|1|||
125136110|NCT00830258|450122849|FG001|First Intervention|Adverse Event|0|||
125136111|NCT00830258|450122848|FG000|Washout: 7 Days|Protocol Violation|1|||
125437449|NCT01032044|451228115|FG001|Overall Study|Adverse Event|1|||
125437450|NCT01032044|451228114|FG000|Overall Study|Lost to Follow-up|11|||
125437451|NCT01032044|451228115|FG001|Overall Study|Lost to Follow-up|11|||
125437452|NCT03311230|451228118|FG000|Overall Study|Withdrawal by Subject|1|||
125437453|NCT03311230|451228119|FG001|Overall Study|Withdrawal by Subject|4|||
125437454|NCT03311230|451228120|FG002|Overall Study|Withdrawal by Subject|2|||
125437455|NCT03311230|451228121|FG003|Overall Study|Withdrawal by Subject|7|||
125437456|NCT03311230|451228118|FG000|Overall Study|Unrelated injury|0|||
125437457|NCT03311230|451228119|FG001|Overall Study|Unrelated injury|1|||
125437458|NCT03311230|451228120|FG002|Overall Study|Unrelated injury|0|||
125437459|NCT03311230|451228121|FG003|Overall Study|Unrelated injury|0|||
125437460|NCT03342053|451228122|FG000|Overall Study|Adverse Event|2|||
125437461|NCT03342053|451228123|FG001|Overall Study|Adverse Event|0|||
125437462|NCT03342053|451228122|FG000|Overall Study|Withdrawal by Subject|0|||
125437463|NCT03342053|451228123|FG001|Overall Study|Withdrawal by Subject|1|||
125136112|NCT00830258|450122849|FG001|Washout: 7 Days|Protocol Violation|0|||
125382161|NCT03715764|451031487|FG001|6 Month Follow-up|Lost to Follow-up|0|||
125382162|NCT03715764|451031486|FG000|12 Month Follow-up|Lost to Follow-up|2|||
125382163|NCT03715764|451031487|FG001|12 Month Follow-up|Lost to Follow-up|3|||
125382164|NCT03715764|451031486|FG000|12 Month Follow-up|Pregnancy|0|||
125382165|NCT03715764|451031487|FG001|12 Month Follow-up|Pregnancy|1|||
125382166|NCT03715764|451031486|FG000|12 Month Follow-up|Surgery|2|||
125382167|NCT03715764|451031487|FG001|12 Month Follow-up|Surgery|0|||
125382168|NCT03715764|451031486|FG000|12 Month Follow-up|Wrong address|1|||
125382169|NCT03715764|451031487|FG001|12 Month Follow-up|Wrong address|0|||
125382170|NCT03715764|451031486|FG000|12 Month Follow-up|No symptoms|1|||
125382171|NCT03715764|451031487|FG001|12 Month Follow-up|No symptoms|0|||
125382172|NCT03715764|451031486|FG000|12 Month Follow-up|Changed primary care centre|0|||
125382173|NCT03715764|451031487|FG001|12 Month Follow-up|Changed primary care centre|1|||
125382174|NCT01338493|451031494|FG000|Enrolled|Withdrawal by Subject|1|||
125382175|NCT01338493|451031494|FG000|Enrolled|Patient not implanted|4|||
125382176|NCT01338493|451031494|FG000|Discharge|Death|1|||
125382177|NCT01338493|451031494|FG000|Discharge|Missed visit|1|||
125382178|NCT01338493|451031494|FG000|6 Months Follow up|Lost to Follow-up|11|||
125382179|NCT01338493|451031494|FG000|6 Months Follow up|Missed visit|8|||
125382180|NCT01338493|451031494|FG000|12 Months Follow up|Lost to Follow-up|9|||
125382181|NCT01705652|451031495|FG000|Overall Study|Adverse Event|1|||
125382182|NCT01705652|451031496|FG001|Overall Study|Adverse Event|0|||
125382183|NCT01705652|451031495|FG000|Overall Study|Withdrawal by Subject|1|||
125382184|NCT01705652|451031496|FG001|Overall Study|Withdrawal by Subject|2|||
125382185|NCT01705652|451031495|FG000|Overall Study|non-compliance|1|||
125382186|NCT01705652|451031496|FG001|Overall Study|non-compliance|1|||
125382187|NCT00541034|451031497|FG000|Overall Study|Non-Compliance|3|||
125382188|NCT00656474|451031498|FG000|Overall Study|Other Reason|1|||
125382189|NCT01962207|451031499|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
125382190|NCT01962207|451031500|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
125382191|NCT01962207|451031501|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
125382192|NCT01962207|451031502|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
125382193|NCT01962207|451031499|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
125382194|NCT01962207|451031500|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
125382195|NCT01962207|451031501|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
125382196|NCT01962207|451031502|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
125382197|NCT01962207|451031499|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
125382198|NCT01962207|451031500|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
125382199|NCT01962207|451031501|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
125382200|NCT01962207|451031502|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
125382201|NCT01962207|451031499|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
125382202|NCT01962207|451031500|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
125382203|NCT01962207|451031501|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
125136113|NCT02267187|450122853|FG000|Overall Study|Physician Decision|2|||
125136114|NCT02267187|450122853|FG000|Overall Study|Screen fail|3|||
125136115|NCT00682461|450122854|FG000|Overall Study|Adverse Event|5|||
125136116|NCT00682461|450122855|FG001|Overall Study|Adverse Event|7|||
125136117|NCT00682461|450122854|FG000|Overall Study|Lost to Follow-up|8|||
125136118|NCT00682461|450122855|FG001|Overall Study|Lost to Follow-up|5|||
125136119|NCT00682461|450122854|FG000|Overall Study|Withdrawal by Subject|12|||
125136120|NCT00682461|450122855|FG001|Overall Study|Withdrawal by Subject|19|||
125382204|NCT01962207|451031502|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
125382205|NCT01962207|451031499|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
125382206|NCT01962207|451031500|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
125382207|NCT01962207|451031501|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
125136121|NCT04035187|450122858|FG000|Overall Study|Withdrawal by Subject|2|||
125382208|NCT01962207|451031502|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
125382209|NCT01962207|451031499|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
125136122|NCT04035187|450122859|FG001|Overall Study|Withdrawal by Subject|1|||
125136123|NCT04035187|450122860|FG002|Overall Study|Withdrawal by Subject|0|||
125437464|NCT01302938|451228124|FG000|Overall Study|Withdrawal by Subject|1|||
125437465|NCT01302938|451228125|FG001|Overall Study|Withdrawal by Subject|0|||
125136124|NCT04035187|450122861|FG003|Overall Study|Withdrawal by Subject|0|||
125437466|NCT01302938|451228124|FG000|Overall Study|Adverse Event|1|||
125220191|NCT00103285|450434396|FG005|Response Assignment|Withdrawal by Subject|2|||
125382210|NCT01962207|451031500|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
125136125|NCT04035187|450122858|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
125136126|NCT04035187|450122859|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
125136127|NCT04035187|450122860|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
125136128|NCT04035187|450122861|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
125136129|NCT01116739|450122868|FG000|Overall Study|Child had 2 years of HS|110|||
125136130|NCT01116739|450122869|FG001|Overall Study|Child had 2 years of HS|128|||
125136131|NCT01116739|450122868|FG000|Overall Study|Withdrawal by Subject|6|||
125136132|NCT01116739|450122869|FG001|Overall Study|Withdrawal by Subject|0|||
125382211|NCT01962207|451031501|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
125382212|NCT01962207|451031502|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
125382213|NCT02484729|451031503|FG000|Overall Study|Failure of IntelliCap Error|0|||
125382214|NCT02484729|451031504|FG001|Overall Study|Failure of IntelliCap Error|0|||
125382215|NCT02484729|451031505|FG002|Overall Study|Failure of IntelliCap Error|0|||
125382216|NCT02484729|451031506|FG003|Overall Study|Failure of IntelliCap Error|0|||
125382217|NCT02484729|451031507|FG004|Overall Study|Failure of IntelliCap Error|0|||
125136133|NCT01116739|450122868|FG000|Overall Study|child too young|2|||
125136134|NCT01116739|450122869|FG001|Overall Study|child too young|6|||
125136135|NCT01116739|450122868|FG000|Overall Study|child not enrolled in head start|10|||
125136136|NCT01116739|450122869|FG001|Overall Study|child not enrolled in head start|2|||
125382218|NCT02484729|451031508|FG005|Overall Study|Failure of IntelliCap Error|0|||
125382219|NCT02484729|451031509|FG006|Overall Study|Failure of IntelliCap Error|0|||
125382220|NCT02484729|451031510|FG007|Overall Study|Failure of IntelliCap Error|0|||
125382221|NCT02484729|451031511|FG008|Overall Study|Failure of IntelliCap Error|0|||
125382222|NCT02484729|451031512|FG009|Overall Study|Failure of IntelliCap Error|1|||
125382223|NCT02625259|451031515|FG000|First Intervention (Day 1)|Other|0|||
125382224|NCT02625259|451031516|FG001|First Intervention (Day 1)|Other|0|||
125382225|NCT02625259|451031517|FG002|First Intervention (Day 1)|Other|1|||
125382226|NCT02625259|451031518|FG003|First Intervention (Day 1)|Other|0|||
125382227|NCT02625259|451031519|FG004|First Intervention (Day 1)|Other|0|||
125382228|NCT02625259|451031515|FG000|First Intervention (Day 1)|Adverse Event|2|||
125382229|NCT02625259|451031516|FG001|First Intervention (Day 1)|Adverse Event|1|||
125382230|NCT02625259|451031517|FG002|First Intervention (Day 1)|Adverse Event|0|||
125382231|NCT02625259|451031518|FG003|First Intervention (Day 1)|Adverse Event|0|||
125382232|NCT02625259|451031519|FG004|First Intervention (Day 1)|Adverse Event|0|||
125382233|NCT02625259|451031515|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
125382234|NCT02625259|451031516|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
125382235|NCT02625259|451031517|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
125382236|NCT02625259|451031518|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
125382237|NCT02625259|451031519|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
125382238|NCT01980875|451031520|FG000|Overall Study|Withdrew Consent|1|||
125382239|NCT01980875|451031521|FG001|Overall Study|Withdrew Consent|1|||
125382240|NCT01980875|451031522|FG002|Overall Study|Withdrew Consent|1|||
125382241|NCT01980875|451031520|FG000|Overall Study|Study Terminated by Sponsor|7|||
125382242|NCT01980875|451031521|FG001|Overall Study|Study Terminated by Sponsor|24|||
125382243|NCT01980875|451031522|FG002|Overall Study|Study Terminated by Sponsor|22|||
125382244|NCT01980875|451031520|FG000|Overall Study|Lost to Follow-up|0|||
125382245|NCT01980875|451031521|FG001|Overall Study|Lost to Follow-up|0|||
125382246|NCT01980875|451031522|FG002|Overall Study|Lost to Follow-up|1|||
125382247|NCT00665847|451031523|FG000|Overall Study|Adverse Event|8|||
125382248|NCT00665847|451031523|FG000|Overall Study|Withdrawal by Subject|2|||
125382249|NCT00665847|451031523|FG000|Overall Study|Subject non-compliant|8|||
125136137|NCT01116739|450122868|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
125136138|NCT01116739|450122869|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
125136139|NCT02255149|450122870|FG000|Overall Study|Lost to Follow-up|2|||
125136140|NCT02255149|450122870|FG000|Overall Study|Withdrawal by Subject|1|||
125136141|NCT02255149|450122870|FG000|Overall Study|Withdrawal by PI|1|||
125136142|NCT02255149|450122870|FG000|Overall Study|Implant Failure|1|||
125382250|NCT00665847|451031523|FG000|Overall Study|Subject reached a virologic endpoint|4|||
125382251|NCT00665847|451031523|FG000|Overall Study|Resistance to TMC125|1|||
125136143|NCT03121586|450122873|FG000|Overall Study|Study terminated by sponsor|0|||
125136144|NCT03121586|450122874|FG001|Overall Study|Study terminated by sponsor|0|||
125136145|NCT03121586|450122875|FG002|Overall Study|Study terminated by sponsor|99|||
125136146|NCT03121586|450122873|FG000|Overall Study|Withdrawal by Subject|37|||
125437467|NCT01302938|451228125|FG001|Overall Study|Adverse Event|0|||
125437468|NCT01233609|451228126|FG000|Overall Study|Death|1|||
125437469|NCT01233609|451228127|FG001|Overall Study|Death|0|||
125437470|NCT01233609|451228126|FG000|Overall Study|Lost to Follow-up|3|||
125437471|NCT01233609|451228127|FG001|Overall Study|Lost to Follow-up|1|||
125437472|NCT01233609|451228126|FG000|Overall Study|Adverse Event|2|||
125437473|NCT01233609|451228127|FG001|Overall Study|Adverse Event|1|||
125437474|NCT01233609|451228126|FG000|Overall Study|Withdrawal by Subject|3|||
125437475|NCT01233609|451228127|FG001|Overall Study|Withdrawal by Subject|0|||
125437476|NCT00735644|451228128|FG000|Overall Study|Did not receive study vaccine|0|||
125437477|NCT00735644|451228129|FG001|Overall Study|Did not receive study vaccine|1|||
125437478|NCT00735644|451228130|FG002|Overall Study|Did not receive study vaccine|0|||
125437479|NCT00735644|451228131|FG003|Overall Study|Did not receive study vaccine|0|||
125437480|NCT00735644|451228132|FG004|Overall Study|Did not receive study vaccine|0|||
125437481|NCT00735644|451228128|FG000|Overall Study|Withdrawal by Subject|0|||
125437482|NCT00735644|451228129|FG001|Overall Study|Withdrawal by Subject|1|||
125437483|NCT00735644|451228130|FG002|Overall Study|Withdrawal by Subject|1|||
125437484|NCT00735644|451228131|FG003|Overall Study|Withdrawal by Subject|1|||
125437485|NCT00735644|451228132|FG004|Overall Study|Withdrawal by Subject|0|||
125437486|NCT02961374|451228133|FG000|Overall Study|Adverse Event|4|||
125437487|NCT01518946|451228140|FG000|Open-label Phase|Other|4|||
125437488|NCT01518946|451228141|FG001|Open-label Phase|Other|0|||
125437489|NCT01518946|451228142|FG002|Open-label Phase|Other|0|||
125437490|NCT01518946|451228140|FG000|Randomized Phase (First Intervention)|Other|0|||
125437491|NCT01518946|451228141|FG001|Randomized Phase (First Intervention)|Other|1|||
125437492|NCT01518946|451228142|FG002|Randomized Phase (First Intervention)|Other|0|||
125437493|NCT00384059|451228143|FG000|Infant Series|Not consented|2|||
125437494|NCT00384059|451228144|FG001|Infant Series|Not consented|6|||
125437495|NCT00384059|451228143|FG000|Infant Series|Withdrawal by Subject|2|||
125437496|NCT00384059|451228144|FG001|Infant Series|Withdrawal by Subject|2|||
125437497|NCT00384059|451228143|FG000|Infant Series|Adverse Event|1|||
125437498|NCT00384059|451228144|FG001|Infant Series|Adverse Event|2|||
125437499|NCT00384059|451228143|FG000|Infant Series|Protocol Violation|1|||
125437500|NCT00384059|451228144|FG001|Infant Series|Protocol Violation|2|||
125437501|NCT00384059|451228143|FG000|Infant Series|Lost to Follow-up|0|||
125437502|NCT00384059|451228144|FG001|Infant Series|Lost to Follow-up|1|||
125437503|NCT00384059|451228143|FG000|After Infant Series|Protocol Violation|2|||
125437504|NCT00384059|451228144|FG001|After Infant Series|Protocol Violation|3|||
125437505|NCT00384059|451228143|FG000|After Infant Series|Withdrawal by Subject|2|||
125437506|NCT00384059|451228144|FG001|After Infant Series|Withdrawal by Subject|2|||
125437507|NCT00384059|451228143|FG000|After Infant Series|Failed to Return|0|||
125437508|NCT00384059|451228144|FG001|After Infant Series|Failed to Return|2|||
125437509|NCT00384059|451228143|FG000|After Infant Series|Adverse Event|0|||
125437510|NCT00384059|451228144|FG001|After Infant Series|Adverse Event|1|||
125437511|NCT00384059|451228143|FG000|After Infant Series|Physician Decision|0|||
125437512|NCT00384059|451228144|FG001|After Infant Series|Physician Decision|1|||
125437513|NCT00384059|451228143|FG000|After Infant Series|Lost to Follow-up|0|||
125437514|NCT00384059|451228144|FG001|After Infant Series|Lost to Follow-up|1|||
125437515|NCT00384059|451228143|FG000|Toddler Dose|Lost to Follow-up|1|||
125437516|NCT00384059|451228144|FG001|Toddler Dose|Lost to Follow-up|1|||
125437517|NCT00384059|451228143|FG000|Toddler Dose|Failed to return|0|||
125437518|NCT00384059|451228144|FG001|Toddler Dose|Failed to return|1|||
125437519|NCT00553202|451229889|FG000|Overall Study|Death|16|||
125437520|NCT00553202|451229889|FG000|Overall Study|Lost to Follow-up|1|||
125437521|NCT00553202|451229889|FG000|Overall Study|Physician Decision|28|||
125437522|NCT00553202|451229889|FG000|Overall Study|Withdrawal by Subject|1|||
125437523|NCT00553202|451229889|FG000|Overall Study|No donor identified|16|||
125437524|NCT00553202|451229889|FG000|Overall Study|Fails to meet organ function|6|||
125437525|NCT04651114|451229890|FG000|Overall Study|Withdrawal by Subject|8|||
125437526|NCT01923896|451229895|FG000|Overall Study|Adverse Event|1|||
125437527|NCT01923896|451229896|FG001|Overall Study|Adverse Event|0|||
125437528|NCT00592319|451229899|FG000|Overall Study|Lost to Follow-up|0|||
125437529|NCT00592319|451229900|FG001|Overall Study|Lost to Follow-up|3|||
125437530|NCT00235443|451229903|FG000|Overall Study|Adverse Event|4|||
125437531|NCT00235443|451229904|FG001|Overall Study|Adverse Event|12|||
125437532|NCT00235443|451229905|FG002|Overall Study|Adverse Event|17|||
125382252|NCT00665847|451031523|FG000|Overall Study|Subject ineligible to continue the trial|1|||
125382253|NCT00665847|451031523|FG000|Overall Study|Switch to Commercial Medication|1|||
125382254|NCT00492115|451031530|FG000|Overall Study|Withdrawal by Subject|3|||
125382255|NCT00492115|451031531|FG001|Overall Study|Withdrawal by Subject|4|||
125382256|NCT03564145|451031534|FG000|Overall Study|Adverse Event|4|||
125382257|NCT03564145|451031534|FG000|Overall Study|Lost to Follow-up|21|||
125382258|NCT03564145|451031534|FG000|Overall Study|Protocol Violation|2|||
125382259|NCT03564145|451031534|FG000|Overall Study|Withdrawal by Subject|48|||
125382260|NCT03564145|451031534|FG000|Overall Study|Study Terminated by Sponsor|146|||
125382261|NCT03564145|451031534|FG000|Overall Study|Physician Decision|1|||
125382262|NCT03564145|451031534|FG000|Overall Study|Other Than Specified|1|||
125382263|NCT03564145|451031534|FG000|Overall Study|Pregnancy|1|||
125382264|NCT02663674|451031535|FG000|Overall Study|Lost to Follow-up|5|||
125382265|NCT02663674|451031536|FG001|Overall Study|Lost to Follow-up|4|||
125382266|NCT02663674|451031535|FG000|Overall Study|Withdrawal by Subject|1|||
125382267|NCT02663674|451031536|FG001|Overall Study|Withdrawal by Subject|4|||
125382268|NCT02663674|451031535|FG000|Overall Study|Physician Decision|1|||
125382269|NCT02663674|451031536|FG001|Overall Study|Physician Decision|1|||
125382270|NCT02663674|451031535|FG000|Overall Study|Other Event (Health Related)|0|||
125382271|NCT02663674|451031536|FG001|Overall Study|Other Event (Health Related)|1|||
125382272|NCT01031069|451031537|FG000|Overall Study|Serious Adverse Event|0|||
125382273|NCT01031069|451031538|FG001|Overall Study|Serious Adverse Event|1|||
125382274|NCT01031069|451031539|FG002|Overall Study|Serious Adverse Event|0|||
125382275|NCT01031069|451031540|FG003|Overall Study|Serious Adverse Event|0|||
125382276|NCT01031069|451031537|FG000|Overall Study|Withdrawal by Subject|2|||
125382277|NCT01031069|451031538|FG001|Overall Study|Withdrawal by Subject|3|||
125382278|NCT01031069|451031539|FG002|Overall Study|Withdrawal by Subject|18|||
125382279|NCT01031069|451031540|FG003|Overall Study|Withdrawal by Subject|18|||
125382280|NCT01031069|451031537|FG000|Overall Study|Migrated/moved from study area|1|||
125382281|NCT01031069|451031538|FG001|Overall Study|Migrated/moved from study area|2|||
125382282|NCT01031069|451031539|FG002|Overall Study|Migrated/moved from study area|1|||
125382283|NCT01031069|451031540|FG003|Overall Study|Migrated/moved from study area|1|||
125382284|NCT01031069|451031537|FG000|Overall Study|Lost to Follow-up|9|||
125382285|NCT01031069|451031538|FG001|Overall Study|Lost to Follow-up|5|||
125382286|NCT01031069|451031539|FG002|Overall Study|Lost to Follow-up|21|||
125382287|NCT01031069|451031540|FG003|Overall Study|Lost to Follow-up|15|||
125382288|NCT01031069|451031537|FG000|Overall Study|Other|0|||
125382289|NCT01031069|451031538|FG001|Overall Study|Other|0|||
125382290|NCT01031069|451031539|FG002|Overall Study|Other|1|||
125382291|NCT01031069|451031540|FG003|Overall Study|Other|0|||
125382292|NCT05286307|451031541|FG000|Overall Study|Incomplete outcome assessments|2|||
125382293|NCT05286307|451031542|FG001|Overall Study|Incomplete outcome assessments|1|||
125382294|NCT05286307|451031541|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
125382295|NCT05286307|451031542|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
125382296|NCT05286307|451031541|FG000|Overall Study|Lost to follow up at 6 months|25|||
125382297|NCT05286307|451031542|FG001|Overall Study|Lost to follow up at 6 months|35|||
125382298|NCT05286307|451031541|FG000|Overall Study|Study medication not available|1|||
125136147|NCT03121586|450122874|FG001|Overall Study|Withdrawal by Subject|14|||
125136148|NCT03121586|450122875|FG002|Overall Study|Withdrawal by Subject|9|||
125136149|NCT03121586|450122873|FG000|Overall Study|Not further specified|6|||
125136150|NCT03121586|450122874|FG001|Overall Study|Not further specified|11|||
125136151|NCT03121586|450122875|FG002|Overall Study|Not further specified|10|||
125136152|NCT03121586|450122873|FG000|Overall Study|Adverse Event|16|||
125136153|NCT03121586|450122874|FG001|Overall Study|Adverse Event|5|||
125136154|NCT03121586|450122875|FG002|Overall Study|Adverse Event|6|||
125136155|NCT03121586|450122873|FG000|Overall Study|Protocol Violation|0|||
125136156|NCT03121586|450122874|FG001|Overall Study|Protocol Violation|5|||
125136157|NCT03121586|450122875|FG002|Overall Study|Protocol Violation|0|||
125220192|NCT00103285|450434397|FG006|Response Assignment|Withdrawal by Subject|0|||
125220193|NCT00103285|450434398|FG007|Response Assignment|Withdrawal by Subject|2|||
125382299|NCT05286307|451031542|FG001|Overall Study|Study medication not available|1|||
125382300|NCT01103284|451031543|FG000|Overall Study|Death|2|||
125382301|NCT01103284|451031544|FG001|Overall Study|Death|0|||
125382302|NCT01103284|451031543|FG000|Overall Study|Lost to Follow-up|9|||
125382303|NCT01103284|451031544|FG001|Overall Study|Lost to Follow-up|10|||
125382304|NCT01103284|451031543|FG000|Overall Study|Pregnancy|3|||
125382305|NCT01103284|451031544|FG001|Overall Study|Pregnancy|1|||
125136158|NCT03121586|450122873|FG000|Overall Study|Lack of Efficacy|3|||
125136159|NCT03121586|450122874|FG001|Overall Study|Lack of Efficacy|3|||
125220194|NCT00103285|450434391|FG000|Response Assignment|Ineligible|0|||
125382306|NCT01103284|451031543|FG000|Overall Study|Protocol Violation|12|||
125382307|NCT01103284|451031544|FG001|Overall Study|Protocol Violation|5|||
125382308|NCT01103284|451031543|FG000|Overall Study|Adverse Event|0|||
125136160|NCT03121586|450122875|FG002|Overall Study|Lack of Efficacy|1|||
125136161|NCT03121586|450122873|FG000|Overall Study|Physician Decision|2|||
125136162|NCT03121586|450122874|FG001|Overall Study|Physician Decision|2|||
125136163|NCT03121586|450122875|FG002|Overall Study|Physician Decision|0|||
125220195|NCT00103285|450434392|FG001|Response Assignment|Ineligible|8|||
125220196|NCT00103285|450434393|FG002|Response Assignment|Ineligible|6|||
125220197|NCT00103285|450434394|FG003|Response Assignment|Ineligible|2|||
125220198|NCT00103285|450434395|FG004|Response Assignment|Ineligible|0|||
125382309|NCT01103284|451031544|FG001|Overall Study|Adverse Event|5|||
125382310|NCT01103284|451031543|FG000|Overall Study|Withdrawal by Subject|14|||
125382311|NCT01103284|451031544|FG001|Overall Study|Withdrawal by Subject|18|||
125382312|NCT01103284|451031543|FG000|Overall Study|Dermal Hypersensitivity|0|||
125382313|NCT01103284|451031544|FG001|Overall Study|Dermal Hypersensitivity|1|||
125382314|NCT01103284|451031543|FG000|Overall Study|Termination by the Sponsor|0|||
125382315|NCT01103284|451031544|FG001|Overall Study|Termination by the Sponsor|1|||
125382316|NCT01103284|451031543|FG000|Overall Study|Not described|2|||
125437533|NCT00235443|451229906|FG003|Overall Study|Adverse Event|44|||
125437534|NCT00235443|451229907|FG004|Overall Study|Adverse Event|10|||
125437535|NCT00235443|451229908|FG005|Overall Study|Adverse Event|15|||
125437536|NCT00235443|451229903|FG000|Overall Study|Lack of Efficacy|0|||
125437537|NCT00235443|451229904|FG001|Overall Study|Lack of Efficacy|1|||
125437538|NCT00235443|451229905|FG002|Overall Study|Lack of Efficacy|5|||
125437539|NCT00235443|451229906|FG003|Overall Study|Lack of Efficacy|12|||
125437540|NCT00235443|451229907|FG004|Overall Study|Lack of Efficacy|2|||
125437541|NCT00235443|451229908|FG005|Overall Study|Lack of Efficacy|9|||
125437542|NCT00235443|451229903|FG000|Overall Study|Withdrawal by Subject|3|||
125437543|NCT00235443|451229904|FG001|Overall Study|Withdrawal by Subject|9|||
125437544|NCT00235443|451229905|FG002|Overall Study|Withdrawal by Subject|25|||
125437545|NCT00235443|451229906|FG003|Overall Study|Withdrawal by Subject|24|||
125437546|NCT00235443|451229907|FG004|Overall Study|Withdrawal by Subject|10|||
125437547|NCT00235443|451229908|FG005|Overall Study|Withdrawal by Subject|12|||
125437548|NCT00235443|451229903|FG000|Overall Study|Lost to Follow-up|0|||
125437549|NCT00235443|451229904|FG001|Overall Study|Lost to Follow-up|8|||
125437550|NCT00235443|451229905|FG002|Overall Study|Lost to Follow-up|6|||
125437551|NCT00235443|451229906|FG003|Overall Study|Lost to Follow-up|6|||
125437552|NCT00235443|451229907|FG004|Overall Study|Lost to Follow-up|4|||
125437553|NCT00235443|451229908|FG005|Overall Study|Lost to Follow-up|3|||
125437554|NCT00235443|451229903|FG000|Overall Study|Unsatisfactory compliance|0|||
125437555|NCT00235443|451229904|FG001|Overall Study|Unsatisfactory compliance|2|||
125437556|NCT00235443|451229905|FG002|Overall Study|Unsatisfactory compliance|3|||
125437557|NCT00235443|451229906|FG003|Overall Study|Unsatisfactory compliance|4|||
125437558|NCT00235443|451229907|FG004|Overall Study|Unsatisfactory compliance|1|||
125437559|NCT00235443|451229908|FG005|Overall Study|Unsatisfactory compliance|0|||
125437560|NCT00235443|451229903|FG000|Overall Study|Other reasons for premature termination|1|||
125437561|NCT00235443|451229904|FG001|Overall Study|Other reasons for premature termination|6|||
125437562|NCT00235443|451229905|FG002|Overall Study|Other reasons for premature termination|6|||
125437563|NCT00235443|451229906|FG003|Overall Study|Other reasons for premature termination|7|||
125437564|NCT00235443|451229907|FG004|Overall Study|Other reasons for premature termination|3|||
125437565|NCT00235443|451229908|FG005|Overall Study|Other reasons for premature termination|6|||
125437566|NCT00474929|451229912|FG000|Overall Study|Withdrawal by Subject|0|||
125437567|NCT00474929|451229913|FG001|Overall Study|Withdrawal by Subject|1|||
125437568|NCT00474929|451229914|FG002|Overall Study|Withdrawal by Subject|0|||
125437569|NCT00474929|451229915|FG003|Overall Study|Withdrawal by Subject|0|||
125437570|NCT00474929|451229916|FG004|Overall Study|Withdrawal by Subject|0|||
125437571|NCT00474929|451229912|FG000|Overall Study|Unrelated medical condition|0|||
125437572|NCT00474929|451229913|FG001|Overall Study|Unrelated medical condition|0|||
125437573|NCT00474929|451229914|FG002|Overall Study|Unrelated medical condition|1|||
125437574|NCT00474929|451229915|FG003|Overall Study|Unrelated medical condition|0|||
125437575|NCT00474929|451229916|FG004|Overall Study|Unrelated medical condition|0|||
125437576|NCT00474929|451229912|FG000|Overall Study|Physician Decision|0|||
125437577|NCT00474929|451229913|FG001|Overall Study|Physician Decision|0|||
125437578|NCT00474929|451229914|FG002|Overall Study|Physician Decision|1|||
125437579|NCT00474929|451229915|FG003|Overall Study|Physician Decision|2|||
125437580|NCT00474929|451229916|FG004|Overall Study|Physician Decision|0|||
125437581|NCT03029247|451229919|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
125437582|NCT03029247|451229920|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
125437583|NCT03029247|451229919|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
125437584|NCT03029247|451229920|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
125437585|NCT03029247|451229919|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
125437586|NCT03029247|451229920|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
125437587|NCT03029247|451229919|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
125437588|NCT03029247|451229920|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
125437589|NCT02593305|451229923|FG000|Post 1|Comparison only group. No intervention.|0|||
125437590|NCT02593305|451229924|FG001|Post 1|Comparison only group. No intervention.|0|||
125136164|NCT03121586|450122873|FG000|Overall Study|Noncompliance with study drug|5|||
125437591|NCT02593305|451229925|FG002|Post 1|Comparison only group. No intervention.|10|||
125136165|NCT03121586|450122874|FG001|Overall Study|Noncompliance with study drug|3|||
125382317|NCT01103284|451031544|FG001|Overall Study|Not described|1|||
125382318|NCT01103284|451031543|FG000|Overall Study|Missing CRF entries for study completion|0|||
125382319|NCT01103284|451031544|FG001|Overall Study|Missing CRF entries for study completion|2|||
125382320|NCT05024058|451032987|FG000|Treatment|Study terminated by sponsor|5|||
125382321|NCT05024058|451032988|FG001|Treatment|Study terminated by sponsor|6|||
125382322|NCT05024058|451032989|FG002|Treatment|Study terminated by sponsor|4|||
125382323|NCT05024058|451032990|FG003|Treatment|Study terminated by sponsor|2|||
125382324|NCT05024058|451032991|FG004|Treatment|Study terminated by sponsor|3|||
125382325|NCT05024058|451032992|FG005|Treatment|Study terminated by sponsor|3|||
125382326|NCT05024058|451032993|FG006|Treatment|Study terminated by sponsor|1|||
125382327|NCT05024058|451032994|FG007|Treatment|Study terminated by sponsor|3|||
125382328|NCT05024058|451032995|FG008|Treatment|Study terminated by sponsor|6|||
125382329|NCT05024058|451032996|FG009|Treatment|Study terminated by sponsor|6|||
125382330|NCT05024058|451032987|FG000|Follow-up|Withdrawal by Subject|1|||
125382331|NCT05024058|451032988|FG001|Follow-up|Withdrawal by Subject|0|||
125382332|NCT05024058|451032989|FG002|Follow-up|Withdrawal by Subject|1|||
125382333|NCT05024058|451032990|FG003|Follow-up|Withdrawal by Subject|0|||
125382334|NCT05024058|451032991|FG004|Follow-up|Withdrawal by Subject|0|||
125382335|NCT05024058|451032992|FG005|Follow-up|Withdrawal by Subject|0|||
125382336|NCT05024058|451032993|FG006|Follow-up|Withdrawal by Subject|0|||
125382337|NCT05024058|451032994|FG007|Follow-up|Withdrawal by Subject|1|||
125382338|NCT05024058|451032995|FG008|Follow-up|Withdrawal by Subject|0|||
125382339|NCT05024058|451032996|FG009|Follow-up|Withdrawal by Subject|1|||
125382340|NCT02734810|451033000|FG000|Overall Study|Adverse Event|1|||
125382341|NCT02734810|451033001|FG001|Overall Study|Adverse Event|0|||
125382342|NCT02734810|451033000|FG000|Overall Study|Lack of Efficacy|1|||
125382343|NCT02734810|451033001|FG001|Overall Study|Lack of Efficacy|0|||
125382344|NCT00407563|451033004|FG000|Overall Study|Patient continues on treatment|1|||
125382345|NCT03055260|451033005|FG000|Overall Study|Withdrawal by Subject|1|||
125382346|NCT03055260|451033006|FG001|Overall Study|Withdrawal by Subject|0|||
125382347|NCT02507505|451033007|FG000|Overall Study|Withdrawal by Subject|13|||
125382348|NCT02507505|451033008|FG001|Overall Study|Withdrawal by Subject|11|||
125382349|NCT02507505|451033007|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
125382350|NCT02507505|451033008|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
125382351|NCT02507505|451033007|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
125382352|NCT02507505|451033008|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
125382353|NCT02507505|451033007|FG000|Overall Study|Death before receipt of anesthesia|0|||
125382354|NCT02507505|451033008|FG001|Overall Study|Death before receipt of anesthesia|1|||
125382355|NCT03182829|451033009|FG000|Overall Study|Protocol Violation|12|||
125382356|NCT03182829|451033010|FG001|Overall Study|Protocol Violation|12|||
125382357|NCT03182829|451033009|FG000|Overall Study|Other|4|||
125382358|NCT03182829|451033010|FG001|Overall Study|Other|3|||
125382359|NCT00254540|451033011|FG000|Overall Study|Adverse Event|6|||
125382360|NCT00254540|451033012|FG001|Overall Study|Adverse Event|7|||
125382361|NCT00254540|451033011|FG000|Overall Study|Lack of Efficacy|13|||
125382362|NCT00254540|451033012|FG001|Overall Study|Lack of Efficacy|13|||
125382363|NCT00254540|451033011|FG000|Overall Study|Death|0|||
125382364|NCT00254540|451033012|FG001|Overall Study|Death|1|||
125382365|NCT00254540|451033011|FG000|Overall Study|Laboratory Test Abnormality|0|||
125382366|NCT00254540|451033012|FG001|Overall Study|Laboratory Test Abnormality|1|||
125382367|NCT00225251|451033013|FG000|Overall Study|Withdrawal by Subject|1|||
125382368|NCT00225251|451033014|FG001|Overall Study|Withdrawal by Subject|1|||
125382369|NCT03045328|451033015|FG000|Overall Study|Withdrawal by Subject|2|||
125382370|NCT00592839|451033016|FG000|Overall Study|Withdrawal by Subject|1|||
125382371|NCT00592839|451033017|FG001|Overall Study|Withdrawal by Subject|1|||
125382372|NCT00592839|451033018|FG002|Overall Study|Withdrawal by Subject|3|||
125382373|NCT00592839|451033016|FG000|Overall Study|Protocol Violation|1|||
125382374|NCT00592839|451033017|FG001|Overall Study|Protocol Violation|1|||
125382375|NCT00592839|451033018|FG002|Overall Study|Protocol Violation|2|||
125382376|NCT00592839|451033016|FG000|Overall Study|Adverse Event|0|||
125382377|NCT00592839|451033017|FG001|Overall Study|Adverse Event|1|||
125382378|NCT00592839|451033018|FG002|Overall Study|Adverse Event|0|||
125382379|NCT00592839|451033016|FG000|Overall Study|Lost to Follow-up|0|||
125382380|NCT00592839|451033017|FG001|Overall Study|Lost to Follow-up|1|||
125382381|NCT00592839|451033018|FG002|Overall Study|Lost to Follow-up|1|||
125382382|NCT02057198|451033026|FG000|Overall Study|Death|0|||
125382383|NCT02057198|451033027|FG001|Overall Study|Death|0|||
125382384|NCT02057198|451033028|FG002|Overall Study|Death|1|||
125382385|NCT02057198|451033026|FG000|Overall Study|Discharged early; lost to followup|0|||
125382386|NCT02057198|451033027|FG001|Overall Study|Discharged early; lost to followup|1|||
125382387|NCT02057198|451033028|FG002|Overall Study|Discharged early; lost to followup|0|||
125382388|NCT02345811|451033034|FG000|First Intervention|Withdrawal by Subject|1|||
125382389|NCT02345811|451033035|FG001|First Intervention|Withdrawal by Subject|1|||
125382390|NCT02877082|451033036|FG000|Overall Study|Trial was closed early|5|||
125382391|NCT03480750|451033037|FG000|Overall Study|Withdrawal by Subject|0|||
125136166|NCT03121586|450122875|FG002|Overall Study|Noncompliance with study drug|5|||
125136167|NCT03121586|450122873|FG000|Overall Study|Lost to Follow-up|4|||
125136168|NCT03121586|450122874|FG001|Overall Study|Lost to Follow-up|2|||
125136169|NCT03121586|450122875|FG002|Overall Study|Lost to Follow-up|0|||
125136170|NCT03121586|450122873|FG000|Overall Study|Death|2|||
125136171|NCT03121586|450122874|FG001|Overall Study|Death|0|||
125136172|NCT03121586|450122875|FG002|Overall Study|Death|0|||
125136173|NCT04590027|450122876|FG000|Overall Study|Lost to Follow-up|17|||
125136174|NCT04590027|450122877|FG001|Overall Study|Lost to Follow-up|14|||
125136175|NCT04590027|450122876|FG000|Overall Study|Protocol Violation|0|||
125136176|NCT04590027|450122877|FG001|Overall Study|Protocol Violation|3|||
125382392|NCT03480750|451033038|FG001|Overall Study|Withdrawal by Subject|1|||
125382393|NCT03480750|451033039|FG002|Overall Study|Withdrawal by Subject|0|||
125382394|NCT03480750|451033040|FG003|Overall Study|Withdrawal by Subject|0|||
125382395|NCT03480750|451033041|FG004|Overall Study|Withdrawal by Subject|0|||
125382396|NCT03480750|451033042|FG005|Overall Study|Withdrawal by Subject|0|||
125382397|NCT03480750|451033037|FG000|Overall Study|The interruption in Trientine shippment|0|||
125382398|NCT03480750|451033038|FG001|Overall Study|The interruption in Trientine shippment|0|||
125382399|NCT03480750|451033039|FG002|Overall Study|The interruption in Trientine shippment|0|||
125382400|NCT03480750|451033040|FG003|Overall Study|The interruption in Trientine shippment|0|||
125382401|NCT03480750|451033041|FG004|Overall Study|The interruption in Trientine shippment|0|||
125382402|NCT03480750|451033042|FG005|Overall Study|The interruption in Trientine shippment|1|||
125382403|NCT02489344|451033043|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
125382404|NCT02489344|451033043|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
125382405|NCT02489344|451033043|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
125382406|NCT02489344|451033043|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
125382407|NCT01132482|451033044|FG000|Overall Study|Adverse Event|1|||
125382408|NCT01132482|451033045|FG001|Overall Study|Adverse Event|0|||
125382409|NCT03683758|451033048|FG000|Overall Study|Non-study commitment conflict|1|||
125382410|NCT03683758|451033049|FG001|Overall Study|Non-study commitment conflict|3|||
125382411|NCT03683758|451033048|FG000|Overall Study|Illness preventing participation|1|||
125382412|NCT03683758|451033049|FG001|Overall Study|Illness preventing participation|0|||
125382413|NCT03683758|451033048|FG000|Overall Study|Adverse Event|1|||
125382414|NCT03683758|451033049|FG001|Overall Study|Adverse Event|0|||
125382415|NCT00723892|451033050|FG000|Overall Study|Participant not tracked|33|||
125382416|NCT00723892|451033051|FG001|Overall Study|Participant not tracked|35|||
125382417|NCT00723892|451033050|FG000|Overall Study|Virological criterion|24|||
125382418|NCT00723892|451033051|FG001|Overall Study|Virological criterion|9|||
125382419|NCT00723892|451033050|FG000|Overall Study|Withdrawal by Subject|6|||
125382420|NCT00723892|451033051|FG001|Overall Study|Withdrawal by Subject|9|||
125382421|NCT00723892|451033050|FG000|Overall Study|End planned|11|||
125382422|NCT00723892|451033051|FG001|Overall Study|End planned|7|||
125382423|NCT00723892|451033050|FG000|Overall Study|Bad tolerance|5|||
125382424|NCT00723892|451033051|FG001|Overall Study|Bad tolerance|5|||
125382425|NCT00723892|451033050|FG000|Overall Study|Multiple reasons|17|||
125382426|NCT00723892|451033051|FG001|Overall Study|Multiple reasons|12|||
125382427|NCT00723892|451033050|FG000|Overall Study|Other|6|||
125382428|NCT00723892|451033051|FG001|Overall Study|Other|3|||
125382429|NCT00723892|451033050|FG000|Overall Study|Study end|1|||
125136177|NCT02909907|450122878|FG000|Overall Study|Withdrawal by Subject|0|||
125136178|NCT02909907|450122879|FG001|Overall Study|Withdrawal by Subject|1|||
125136179|NCT01839279|450122881|FG000|Overall Study|Adverse Event|4|||
125136180|NCT01839279|450122882|FG001|Overall Study|Adverse Event|1|||
125136181|NCT01839279|450122883|FG002|Overall Study|Adverse Event|1|||
125136182|NCT01839279|450122881|FG000|Overall Study|Withdrawal by Subject|4|||
125136183|NCT01839279|450122882|FG001|Overall Study|Withdrawal by Subject|1|||
125136184|NCT01839279|450122883|FG002|Overall Study|Withdrawal by Subject|1|||
125136185|NCT01839279|450122881|FG000|Overall Study|Classified as 'Other'|5|||
125382430|NCT00723892|451033051|FG001|Overall Study|Study end|3|||
125382431|NCT00723892|451033050|FG000|Overall Study|Weight loss|1|||
125382432|NCT00723892|451033051|FG001|Overall Study|Weight loss|3|||
125382433|NCT00723892|451033050|FG000|Overall Study|Alcohol abuse|0|||
125382434|NCT00723892|451033051|FG001|Overall Study|Alcohol abuse|1|||
125382435|NCT00723892|451033050|FG000|Overall Study|Intercurrent infection|2|||
125382436|NCT00723892|451033051|FG001|Overall Study|Intercurrent infection|0|||
125382437|NCT00723892|451033050|FG000|Overall Study|Drug addiction|1|||
125382438|NCT00723892|451033051|FG001|Overall Study|Drug addiction|0|||
125382439|NCT01172847|451033052|FG000|Overall Study|Withdrawal by Subject|3|||
125382440|NCT01163279|451033055|FG000|Overall Study|Withdrawal by Subject|2|||
125382441|NCT01163279|451033056|FG001|Overall Study|Withdrawal by Subject|0|||
125382442|NCT02411292|451033058|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
125382443|NCT02411292|451033058|FG000|Overall Study|Death|2|||
125382444|NCT02411292|451033058|FG000|Overall Study|Lost to Follow-up|3|||
125382445|NCT02232425|451033061|FG000|Overall Study|Lost to Follow-up|6|||
125382446|NCT02232425|451033062|FG001|Overall Study|Lost to Follow-up|2|||
125382447|NCT02232425|451033061|FG000|Overall Study|Adverse Event|2|||
125382448|NCT02232425|451033062|FG001|Overall Study|Adverse Event|0|||
125382449|NCT02232425|451033061|FG000|Overall Study|Withdrawal by Subject|5|||
125382450|NCT02232425|451033062|FG001|Overall Study|Withdrawal by Subject|6|||
125136186|NCT01839279|450122882|FG001|Overall Study|Classified as 'Other'|0|||
125437592|NCT02757521|451229926|FG000|Overall Study|Adverse Event|1|||
125437593|NCT02757521|451229927|FG001|Overall Study|Adverse Event|0|||
125437594|NCT01190215|451229928|FG000|Up to Month 6|Lost to Follow-up|2|||
125437595|NCT01190215|451229929|FG001|Up to Month 6|Lost to Follow-up|0|||
125437596|NCT00003511|451229931|FG000|Overall Study|Not evaluable|4|||
125437597|NCT00768430|451229950|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
125437598|NCT00768430|451229951|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
125437599|NCT00041756|451229952|FG000|Overall Study|Adverse Event|4|||
125437600|NCT00041756|451229953|FG001|Overall Study|Adverse Event|10|||
125437601|NCT00041756|451229954|FG002|Overall Study|Adverse Event|6|||
125437602|NCT00041756|451229955|FG003|Overall Study|Adverse Event|11|||
125437603|NCT00041756|451229956|FG004|Overall Study|Adverse Event|34|||
125437604|NCT00041756|451229952|FG000|Overall Study|Protocol Violation|1|||
125437605|NCT00041756|451229953|FG001|Overall Study|Protocol Violation|1|||
125437606|NCT00041756|451229954|FG002|Overall Study|Protocol Violation|2|||
125437607|NCT00041756|451229955|FG003|Overall Study|Protocol Violation|2|||
125437608|NCT00041756|451229956|FG004|Overall Study|Protocol Violation|1|||
125437609|NCT00041756|451229952|FG000|Overall Study|Withdrawal by Subject|3|||
125437610|NCT00041756|451229953|FG001|Overall Study|Withdrawal by Subject|3|||
125437611|NCT00041756|451229954|FG002|Overall Study|Withdrawal by Subject|4|||
125437612|NCT00041756|451229955|FG003|Overall Study|Withdrawal by Subject|2|||
125437613|NCT00041756|451229956|FG004|Overall Study|Withdrawal by Subject|3|||
125437614|NCT00041756|451229952|FG000|Overall Study|Lost to Follow-up|0|||
125437615|NCT00041756|451229953|FG001|Overall Study|Lost to Follow-up|1|||
125437616|NCT00041756|451229954|FG002|Overall Study|Lost to Follow-up|0|||
125437617|NCT00041756|451229955|FG003|Overall Study|Lost to Follow-up|1|||
125136187|NCT01839279|450122883|FG002|Overall Study|Classified as 'Other'|0|||
125136188|NCT03437265|450122884|FG000|Overall Study|Protocol Violation|6|||
125136189|NCT00316277|450122885|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
125136190|NCT00316277|450122886|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
125136191|NCT00316277|450122885|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
125136192|NCT00316277|450122886|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
125136193|NCT00316277|450122885|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
125136194|NCT00316277|450122886|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
125136195|NCT00316277|450122885|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
125136196|NCT00316277|450122886|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
125136197|NCT00316277|450122885|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
125220199|NCT00103285|450434396|FG005|Response Assignment|Ineligible|3|||
125437618|NCT00041756|451229956|FG004|Overall Study|Lost to Follow-up|0|||
125437619|NCT00041756|451229952|FG000|Overall Study|Unable to meet protocol criteria|0|||
125437620|NCT00041756|451229953|FG001|Overall Study|Unable to meet protocol criteria|0|||
125437621|NCT00041756|451229954|FG002|Overall Study|Unable to meet protocol criteria|1|||
125437622|NCT00041756|451229955|FG003|Overall Study|Unable to meet protocol criteria|0|||
125220200|NCT00103285|450434397|FG006|Response Assignment|Ineligible|1|||
125220201|NCT00103285|450434398|FG007|Response Assignment|Ineligible|5|||
125220202|NCT00103285|450434391|FG000|Response Assignment|Refusal|0|||
125220203|NCT00103285|450434392|FG001|Response Assignment|Refusal|53|||
125485457|NCT02240238|451412511|FG008|Phase 2|Physician Decision|0|||
125220204|NCT00103285|450434393|FG002|Response Assignment|Refusal|5|||
125220205|NCT00103285|450434394|FG003|Response Assignment|Refusal|3|||
125220206|NCT00103285|450434395|FG004|Response Assignment|Refusal|25|||
125382451|NCT02232425|451033061|FG000|Overall Study|Lack of Efficacy|1|||
125382452|NCT02232425|451033062|FG001|Overall Study|Lack of Efficacy|0|||
125382453|NCT00665353|451033063|FG000|Study Step 1|Adverse Event|1|||
125382454|NCT00665353|451033063|FG000|Study Step 1|Withdrawal by Subject|2|||
125382455|NCT00665353|451033063|FG000|Study Step 2|Lost to Follow-up|2|||
125382456|NCT00665353|451033063|FG000|Study Step 2|Lack of Efficacy|12|||
125382457|NCT01601626|451033064|FG000|Overall Study|Death|1|||
125382458|NCT01601626|451033065|FG001|Overall Study|Death|1|||
125382459|NCT01601626|451033066|FG002|Overall Study|Death|1|||
125382460|NCT01601626|451033064|FG000|Overall Study|Lost to Follow-up|1|||
125382461|NCT01601626|451033065|FG001|Overall Study|Lost to Follow-up|2|||
125382462|NCT01601626|451033066|FG002|Overall Study|Lost to Follow-up|0|||
125382463|NCT01601626|451033064|FG000|Overall Study|Unable to Get to Clinic|0|||
125382464|NCT01601626|451033065|FG001|Overall Study|Unable to Get to Clinic|1|||
125382465|NCT01601626|451033066|FG002|Overall Study|Unable to Get to Clinic|0|||
125382466|NCT01601626|451033064|FG000|Overall Study|Withdrawal by Subject|0|||
125382467|NCT01601626|451033065|FG001|Overall Study|Withdrawal by Subject|1|||
125382468|NCT01601626|451033066|FG002|Overall Study|Withdrawal by Subject|1|||
125382469|NCT01601626|451033064|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
125382470|NCT01601626|451033065|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
125382471|NCT01601626|451033066|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
125382472|NCT00498602|451033067|FG000|Overall Study|Death|0|||
125382473|NCT00498602|451033068|FG001|Overall Study|Death|0|||
125382474|NCT00498602|451033069|FG002|Overall Study|Death|0|||
125382475|NCT00498602|451033070|FG003|Overall Study|Death|0|||
125382476|NCT00498602|451033071|FG004|Overall Study|Death|0|||
125382477|NCT00498602|451033072|FG005|Overall Study|Death|1|||
125382478|NCT00498602|451033073|FG006|Overall Study|Death|0|||
125382479|NCT00498602|451033067|FG000|Overall Study|Lack of Efficacy|1|||
125382480|NCT00498602|451033068|FG001|Overall Study|Lack of Efficacy|0|||
125382481|NCT00498602|451033069|FG002|Overall Study|Lack of Efficacy|0|||
125382482|NCT00498602|451033070|FG003|Overall Study|Lack of Efficacy|0|||
125220207|NCT00103285|450434396|FG005|Response Assignment|Refusal|15|||
125382483|NCT00498602|451033071|FG004|Overall Study|Lack of Efficacy|0|||
125382484|NCT00498602|451033072|FG005|Overall Study|Lack of Efficacy|0|||
125220208|NCT00103285|450434397|FG006|Response Assignment|Refusal|30|||
125220209|NCT00103285|450434398|FG007|Response Assignment|Refusal|10|||
125220210|NCT00103285|450434391|FG000|Response Assignment|Other|0|||
125220211|NCT00103285|450434392|FG001|Response Assignment|Other|30|||
125220212|NCT00103285|450434393|FG002|Response Assignment|Other|48|||
125220213|NCT00103285|450434394|FG003|Response Assignment|Other|38|||
125220214|NCT00103285|450434395|FG004|Response Assignment|Other|37|||
125220215|NCT00103285|450434396|FG005|Response Assignment|Other|17|||
125220216|NCT00103285|450434397|FG006|Response Assignment|Other|11|||
125220217|NCT00103285|450434398|FG007|Response Assignment|Other|53|||
125220218|NCT02624947|450434401|FG000|Maternal Participants|Adverse Event|5|||
125220219|NCT02624947|450434402|FG001|Maternal Participants|Adverse Event|0|||
125220220|NCT02624947|450434401|FG000|Maternal Participants|Investigator Decision|5|||
125220221|NCT02624947|450434402|FG001|Maternal Participants|Investigator Decision|3|||
125220222|NCT02624947|450434401|FG000|Maternal Participants|Lost to Follow-up|54|||
125220223|NCT02624947|450434402|FG001|Maternal Participants|Lost to Follow-up|24|||
125220224|NCT02624947|450434401|FG000|Maternal Participants|Non Compliance|8|||
125220225|NCT02624947|450434402|FG001|Maternal Participants|Non Compliance|5|||
125220226|NCT02624947|450434401|FG000|Maternal Participants|Sponsor Request|1|||
125220227|NCT02624947|450434402|FG001|Maternal Participants|Sponsor Request|1|||
125220228|NCT02624947|450434401|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
125220229|NCT02624947|450434402|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
125220230|NCT02624947|450434401|FG000|Maternal Participants|Miscellaneous|23|||
125220231|NCT02624947|450434402|FG001|Maternal Participants|Miscellaneous|15|||
125220232|NCT02624947|450434401|FG000|Infant Participants|Adverse Event|18|||
125220233|NCT02624947|450434402|FG001|Infant Participants|Adverse Event|11|||
125220234|NCT02624947|450434401|FG000|Infant Participants|Investigator Decision|5|||
125220235|NCT02624947|450434402|FG001|Infant Participants|Investigator Decision|4|||
125220236|NCT02624947|450434401|FG000|Infant Participants|Lost to Follow-up|93|||
125220237|NCT02624947|450434402|FG001|Infant Participants|Lost to Follow-up|58|||
125220238|NCT02624947|450434401|FG000|Infant Participants|Non Compliance|17|||
125220239|NCT02624947|450434402|FG001|Infant Participants|Non Compliance|7|||
125220240|NCT02624947|450434401|FG000|Infant Participants|Sponsor Request|0|||
125220241|NCT02624947|450434402|FG001|Infant Participants|Sponsor Request|1|||
125220242|NCT02624947|450434401|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
125220243|NCT02624947|450434402|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
125220244|NCT02624947|450434401|FG000|Infant Participants|Miscellaneous|50|||
125220245|NCT02624947|450434402|FG001|Infant Participants|Miscellaneous|26|||
125220246|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
125220247|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
125220248|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
125220249|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
125220250|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
125220251|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
125220252|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
125220253|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
125220254|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
125220255|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
125220256|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
125220257|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
125220258|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
125220259|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
125220260|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
125220261|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
125220262|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
125220263|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
125220264|NCT03569098|450434408|FG000|Double-Blind Treatment Cycle 1|Other|1|||
125220265|NCT03569098|450434409|FG001|Double-Blind Treatment Cycle 1|Other|0|||
125220266|NCT03569098|450434410|FG002|Double-Blind Treatment Cycle 1|Other|1|||
125220267|NCT03569098|450434408|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
125220268|NCT03569098|450434409|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
125220269|NCT03569098|450434410|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
125220270|NCT03569098|450434408|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
125220271|NCT03569098|450434409|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
125220272|NCT03569098|450434410|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
125382485|NCT00498602|451033073|FG006|Overall Study|Lack of Efficacy|0|||
125382486|NCT00498602|451033067|FG000|Overall Study|Lost to Follow-up|0|||
125220273|NCT03569098|450434408|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
125220274|NCT03569098|450434409|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
125382487|NCT00498602|451033068|FG001|Overall Study|Lost to Follow-up|2|||
125382488|NCT00498602|451033069|FG002|Overall Study|Lost to Follow-up|0|||
125382489|NCT00498602|451033070|FG003|Overall Study|Lost to Follow-up|2|||
125382490|NCT00498602|451033071|FG004|Overall Study|Lost to Follow-up|0|||
125382491|NCT00498602|451033072|FG005|Overall Study|Lost to Follow-up|0|||
125382492|NCT00498602|451033073|FG006|Overall Study|Lost to Follow-up|0|||
125136198|NCT00316277|450122886|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
125136199|NCT01572662|450122897|FG000|Overall Study|Withdrawal by Subject|1|||
125136200|NCT01572662|450122898|FG001|Overall Study|Withdrawal by Subject|0|||
125136201|NCT01572662|450122897|FG000|Overall Study|Physician Decision|0|||
125136202|NCT01572662|450122898|FG001|Overall Study|Physician Decision|1|||
125136203|NCT03364192|450122899|FG000|Overall Study|Ineligible|10|||
125136204|NCT03364192|450122899|FG000|Overall Study|Withdrawal by Subject|5|||
125136205|NCT03364192|450122899|FG000|Overall Study|Lost to Follow-up|1|||
125136206|NCT00918645|450122900|FG000|Overall Study|Withdrawal by Subject|1|||
125136207|NCT03446768|450122901|FG000|Overall Study|Withdrawal by Subject|0|||
125136208|NCT03446768|450122902|FG001|Overall Study|Withdrawal by Subject|1|||
125136209|NCT05133180|450122903|FG000|Overall Study|Withdrawal of consent|1|||
125136210|NCT05133180|450122904|FG001|Overall Study|Withdrawal of consent|1|||
125136211|NCT05133180|450122903|FG000|Overall Study|Lost to Follow-up|1|||
125136212|NCT05133180|450122904|FG001|Overall Study|Lost to Follow-up|1|||
125136213|NCT05133180|450122903|FG000|Overall Study|Documented disease progression|0|||
125136214|NCT05133180|450122904|FG001|Overall Study|Documented disease progression|1|||
125136215|NCT00107991|450122905|FG000|Eligibility Assessment|Disease not severe enough|7|||
125136216|NCT00107991|450122905|FG000|Eligibility Assessment|Unwilling to participate|7|||
125136217|NCT00107991|450122905|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
125136218|NCT00107991|450122905|FG000|Eligibility Assessment|Abnormal labs|2|||
125136219|NCT00107991|450122905|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
125136220|NCT00107991|450122905|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
125136221|NCT00107991|450122905|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
125136222|NCT00107991|450122905|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
125136223|NCT00107991|450122905|FG000|12 Week Treatment Period|Adverse Event|1|||
125136224|NCT00107991|450122905|FG000|12 Week Treatment Period|Protocol Violation|1|||
125136225|NCT00107991|450122905|FG000|12 Week Treatment Period|Incarcerated|1|||
125382493|NCT00498602|451033067|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
125136226|NCT00107991|450122905|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
125382494|NCT00498602|451033068|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
125382495|NCT00498602|451033069|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
125485458|NCT02240238|451412512|FG009|Phase 2|Physician Decision|1|||
125136227|NCT01535222|450122906|FG000|Overall Study|Inclusion/exclusion|0|||
125136228|NCT01535222|450122907|FG001|Overall Study|Inclusion/exclusion|0|||
125136229|NCT01535222|450122908|FG002|Overall Study|Inclusion/exclusion|1|||
125136230|NCT01535222|450122909|FG003|Overall Study|Inclusion/exclusion|0|||
125136231|NCT01535222|450122910|FG004|Overall Study|Inclusion/exclusion|0|||
125136232|NCT01535222|450122911|FG005|Overall Study|Inclusion/exclusion|0|||
125136233|NCT00935012|450122912|FG000|Overall Study|Death|19|||
125136234|NCT00935012|450122912|FG000|Overall Study|Withdrawal by Subject|3|||
125136235|NCT00935012|450122912|FG000|Overall Study|Other|5|||
125136236|NCT00935012|450122912|FG000|Overall Study|Adverse Event|2|||
125136237|NCT01442155|450122913|FG000|Overall Study|Complete remission|35|||
125136238|NCT01442155|450122913|FG000|Overall Study|Recurrence|26|||
125136239|NCT01442155|450122913|FG000|Overall Study|Adverse Event|2|||
125136240|NCT01442155|450122913|FG000|Overall Study|Lost to Follow-up|2|||
125136241|NCT03669861|450122914|FG000|Overall Study|Disease Flare|5|||
125136242|NCT03669861|450122914|FG000|Overall Study|Lack of Efficacy|2|||
125136243|NCT00705666|450122916|FG000|Overall Study|No post-treatment questionnaire|279|||
125136244|NCT00705666|450122916|FG000|Overall Study|Withdrawal by Subject|21|||
125136245|NCT00705666|450122916|FG000|Overall Study|Physician Decision|7|||
125136246|NCT00705666|450122916|FG000|Overall Study|Lost to Follow-up|5|||
125136247|NCT00705666|450122916|FG000|Overall Study|Death|1|||
125382496|NCT00498602|451033070|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
125136248|NCT00705666|450122916|FG000|Overall Study|Adverse Event|4|||
125136249|NCT00705666|450122916|FG000|Overall Study|Other|12|||
125136250|NCT00705666|450122916|FG000|Overall Study|Other|2|||
125382497|NCT00498602|451033071|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
125382498|NCT00498602|451033072|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
125382499|NCT00498602|451033073|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
125136251|NCT00705666|450122916|FG000|Overall Study|Lack of data|3|||
125136252|NCT00705666|450122916|FG000|Overall Study|Untreated|5|||
125136253|NCT01590563|450122926|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
125136254|NCT03256695|450122927|FG000|Overall Study|Adverse Event|8|||
125136255|NCT03256695|450122927|FG000|Overall Study|Death|2|||
125136256|NCT03256695|450122927|FG000|Overall Study|Withdrawal by Subject|14|||
125136257|NCT03256695|450122927|FG000|Overall Study|Non-compliance with study drug|1|||
125136258|NCT03256695|450122927|FG000|Overall Study|Lost to Follow-up|3|||
125136259|NCT03256695|450122927|FG000|Overall Study|Lack of Efficacy|3|||
125136260|NCT03256695|450122927|FG000|Overall Study|Protocol Violation|5|||
125136261|NCT03256695|450122927|FG000|Overall Study|Other than specified|3|||
125136262|NCT01604941|450122928|FG000|Overall Study|Adverse Event|1|||
125136263|NCT01604941|450122929|FG001|Overall Study|Adverse Event|2|||
125136264|NCT01604941|450122930|FG002|Overall Study|Adverse Event|0|||
125136265|NCT01604941|450122931|FG003|Overall Study|Adverse Event|0|||
125136266|NCT01604941|450122932|FG004|Overall Study|Adverse Event|1|||
125136267|NCT01604941|450122933|FG005|Overall Study|Adverse Event|5|||
125136268|NCT01604941|450122928|FG000|Overall Study|Non-compliance|1|||
125136269|NCT01604941|450122929|FG001|Overall Study|Non-compliance|0|||
125136270|NCT01604941|450122930|FG002|Overall Study|Non-compliance|0|||
125136271|NCT01604941|450122931|FG003|Overall Study|Non-compliance|0|||
125136272|NCT01604941|450122932|FG004|Overall Study|Non-compliance|0|||
125220275|NCT03569098|450434410|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
125220276|NCT03569098|450434408|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
125220277|NCT03569098|450434409|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
125382500|NCT00498602|451033067|FG000|Overall Study|AE not related to Study Drug|1|||
125136273|NCT01604941|450122933|FG005|Overall Study|Non-compliance|0|||
125136274|NCT01604941|450122928|FG000|Overall Study|Participant Decision|0|||
125136275|NCT01604941|450122929|FG001|Overall Study|Participant Decision|0|||
125136276|NCT01604941|450122930|FG002|Overall Study|Participant Decision|0|||
125136277|NCT01604941|450122931|FG003|Overall Study|Participant Decision|0|||
125136278|NCT01604941|450122932|FG004|Overall Study|Participant Decision|0|||
125136279|NCT01604941|450122933|FG005|Overall Study|Participant Decision|2|||
125136280|NCT01604941|450122928|FG000|Overall Study|Early Study Termination|9|||
125136281|NCT01604941|450122929|FG001|Overall Study|Early Study Termination|2|||
125136282|NCT01604941|450122930|FG002|Overall Study|Early Study Termination|3|||
125136283|NCT01604941|450122931|FG003|Overall Study|Early Study Termination|3|||
125136284|NCT01604941|450122932|FG004|Overall Study|Early Study Termination|0|||
125136285|NCT01604941|450122933|FG005|Overall Study|Early Study Termination|0|||
125136286|NCT03930732|450122934|FG000|Overall Study|Adverse Event|9|||
125136287|NCT03930732|450122935|FG001|Overall Study|Adverse Event|7|||
125136288|NCT03930732|450122934|FG000|Overall Study|Poor compliance to protocol|0|||
125136289|NCT03930732|450122935|FG001|Overall Study|Poor compliance to protocol|1|||
125136290|NCT03930732|450122934|FG000|Overall Study|Withdrawal by Subject|23|||
125136291|NCT03930732|450122935|FG001|Overall Study|Withdrawal by Subject|11|||
125136292|NCT03930732|450122934|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
125136293|NCT03930732|450122935|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
125136294|NCT03930732|450122934|FG000|Overall Study|Other reason not related to COVID-19|5|||
125136295|NCT03930732|450122935|FG001|Overall Study|Other reason not related to COVID-19|8|||
125136296|NCT03406156|450122936|FG000|Overall Study|Death|9|||
125136297|NCT03406156|450122937|FG001|Overall Study|Death|3|||
125136298|NCT03406156|450122936|FG000|Overall Study|Withdrawal by Subject|1|||
125136299|NCT03406156|450122937|FG001|Overall Study|Withdrawal by Subject|2|||
125220278|NCT03569098|450434410|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
125220279|NCT03569098|450434408|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
125220280|NCT03569098|450434409|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
125136300|NCT03406156|450122936|FG000|Overall Study|COVID-19 infection|1|||
125136301|NCT03406156|450122937|FG001|Overall Study|COVID-19 infection|0|||
125136302|NCT03406156|450122936|FG000|Overall Study|Non-compliance with study procedures|1|||
125136303|NCT03406156|450122937|FG001|Overall Study|Non-compliance with study procedures|1|||
125136304|NCT03406156|450122936|FG000|Overall Study|Lost to Follow-up|0|||
125136305|NCT03406156|450122937|FG001|Overall Study|Lost to Follow-up|2|||
125136306|NCT03406156|450122936|FG000|Overall Study|Other, not specified|72|||
125136307|NCT03406156|450122937|FG001|Overall Study|Other, not specified|28|||
125136308|NCT02699463|450122940|FG000|Overall Study|Lost to Follow-up|11|||
125136309|NCT02699463|450122941|FG001|Overall Study|Lost to Follow-up|8|||
125136310|NCT02699463|450122940|FG000|Overall Study|Withdrawal by Subject|4|||
125136311|NCT02699463|450122941|FG001|Overall Study|Withdrawal by Subject|1|||
125136312|NCT00585286|450122944|FG000|Overall Study|Lost to Follow-up|1|||
125136313|NCT01316055|450122951|FG000|Overall Study|Lost to Follow-up|1|||
125136314|NCT01316055|450122952|FG001|Overall Study|Lost to Follow-up|0|||
125136315|NCT01316055|450122953|FG002|Overall Study|Lost to Follow-up|0|||
125136316|NCT00003470|450122954|FG000|Overall Study|Not evaluable|6|||
125136317|NCT01825798|450122955|FG000|Overall Study|Adverse Event|1|||
125136318|NCT01825798|450122956|FG001|Overall Study|Adverse Event|5|||
125136319|NCT01825798|450122955|FG000|Overall Study|Lost to Follow-up|1|||
125382501|NCT00498602|451033068|FG001|Overall Study|AE not related to Study Drug|3|||
125382502|NCT00498602|451033069|FG002|Overall Study|AE not related to Study Drug|0|||
125382503|NCT00498602|451033070|FG003|Overall Study|AE not related to Study Drug|0|||
125382504|NCT00498602|451033071|FG004|Overall Study|AE not related to Study Drug|2|||
125382505|NCT00498602|451033072|FG005|Overall Study|AE not related to Study Drug|2|||
125382506|NCT00498602|451033073|FG006|Overall Study|AE not related to Study Drug|1|||
125382507|NCT00498602|451033067|FG000|Overall Study|Caregiver Request|2|||
125382508|NCT00498602|451033068|FG001|Overall Study|Caregiver Request|2|||
125382509|NCT00498602|451033069|FG002|Overall Study|Caregiver Request|2|||
125382510|NCT00498602|451033070|FG003|Overall Study|Caregiver Request|0|||
125437623|NCT00041756|451229956|FG004|Overall Study|Unable to meet protocol criteria|1|||
125437624|NCT00041756|451229952|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
125136320|NCT01825798|450122956|FG001|Overall Study|Lost to Follow-up|0|||
125136321|NCT03500094|450122961|FG000|Overall Study|Withdrawal by Subject|1|||
125136322|NCT03500094|450122961|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
125136323|NCT03500094|450122961|FG000|Overall Study|Lost to Follow-up|1|||
125136324|NCT01030133|450122962|FG000|Overall Study|failed to experience pain at level 7/10|2|||
125136325|NCT01030133|450122963|FG001|Overall Study|failed to experience pain at level 7/10|2|||
125136326|NCT04025229|450124332|FG000|Overall Study|Adverse Event|1|||
125136327|NCT04025229|450124333|FG001|Overall Study|Adverse Event|0|||
125136328|NCT04025229|450124332|FG000|Overall Study|Withdrawal by Subject|0|||
125136329|NCT04025229|450124333|FG001|Overall Study|Withdrawal by Subject|2|||
125136330|NCT04025229|450124332|FG000|Overall Study|Death|0|||
125136331|NCT04025229|450124333|FG001|Overall Study|Death|1|||
125136332|NCT04025229|450124332|FG000|Overall Study|Physician Decision|0|||
125437625|NCT00041756|451229953|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
125437626|NCT00041756|451229954|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
125437627|NCT00041756|451229955|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
125437628|NCT00041756|451229956|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
125437629|NCT00603265|451229957|FG000|Overall Study|Adverse Event|2|||
125437630|NCT00603265|451229958|FG001|Overall Study|Adverse Event|11|||
125437631|NCT00603265|451229959|FG002|Overall Study|Adverse Event|1|||
125437632|NCT00603265|451229957|FG000|Overall Study|Withdrawal by Subject|1|||
125437633|NCT00603265|451229958|FG001|Overall Study|Withdrawal by Subject|2|||
125437634|NCT00603265|451229959|FG002|Overall Study|Withdrawal by Subject|1|||
125437635|NCT00603265|451229957|FG000|Overall Study|Lack of Efficacy|3|||
125437636|NCT00603265|451229958|FG001|Overall Study|Lack of Efficacy|0|||
125437637|NCT00603265|451229959|FG002|Overall Study|Lack of Efficacy|3|||
125437638|NCT00603265|451229957|FG000|Overall Study|Lost to Follow-up|0|||
125437639|NCT00603265|451229958|FG001|Overall Study|Lost to Follow-up|1|||
125437640|NCT00603265|451229959|FG002|Overall Study|Lost to Follow-up|0|||
125437641|NCT00603265|451229957|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
125437642|NCT00603265|451229958|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
125437643|NCT00603265|451229959|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
125437644|NCT00603265|451229957|FG000|Overall Study|Participant Left Country, No Responses|0|||
125437645|NCT00603265|451229958|FG001|Overall Study|Participant Left Country, No Responses|1|||
125136333|NCT04025229|450124333|FG001|Overall Study|Physician Decision|1|||
125136334|NCT01958294|450124336|FG000|Overall Study|Clinical Circumstances|2|||
125136335|NCT05511935|450124337|FG000|Overall Study|Lost to Follow-up|9|||
125136336|NCT05511935|450124338|FG001|Overall Study|Lost to Follow-up|27|||
125382511|NCT00498602|451033071|FG004|Overall Study|Caregiver Request|1|||
125382512|NCT00498602|451033072|FG005|Overall Study|Caregiver Request|2|||
125382513|NCT00498602|451033073|FG006|Overall Study|Caregiver Request|0|||
125437646|NCT00603265|451229959|FG002|Overall Study|Participant Left Country, No Responses|0|||
125437647|NCT00603265|451229957|FG000|Overall Study|Protocol Violation|1|||
125136337|NCT05090839|450124339|FG000|Overall Study|Lost to Follow-up|2|||
125136338|NCT05090839|450124340|FG001|Overall Study|Lost to Follow-up|3|||
125136339|NCT05090839|450124341|FG002|Overall Study|Lost to Follow-up|1|||
125136340|NCT05090839|450124342|FG003|Overall Study|Lost to Follow-up|1|||
125136341|NCT03913377|450124343|FG000|Period 1|Test Article no longer available|0|||
125136342|NCT03913377|450124344|FG001|Period 1|Test Article no longer available|1|||
125136343|NCT03913377|450124345|FG002|Period 1|Test Article no longer available|0|||
125136344|NCT03913377|450124343|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
125136345|NCT03913377|450124344|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
125136346|NCT03913377|450124345|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
125136347|NCT03499353|450124346|FG000|Treatment|Adverse Event|3|||
125136348|NCT03499353|450124346|FG000|Treatment|Progressive Disease|10|||
125136349|NCT03499353|450124346|FG000|Treatment|Other|1|||
125136350|NCT03499353|450124346|FG000|Treatment|Withdrawal by Subject|2|||
125136351|NCT03499353|450124346|FG000|Long-Term Follow-up|Death|2|||
125136352|NCT03499353|450124346|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
125136353|NCT03499353|450124346|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
125136354|NCT01117623|450124347|FG000|Overall Study|Adverse Event|0|||
125136355|NCT01117623|450124348|FG001|Overall Study|Adverse Event|2|||
125136356|NCT01117623|450124349|FG002|Overall Study|Adverse Event|4|||
125136357|NCT01117623|450124350|FG003|Overall Study|Adverse Event|0|||
125136358|NCT01117623|450124351|FG004|Overall Study|Adverse Event|2|||
125136359|NCT01117623|450124352|FG005|Overall Study|Adverse Event|0|||
125136360|NCT01117623|450124353|FG006|Overall Study|Adverse Event|0|||
125136361|NCT01117623|450124354|FG007|Overall Study|Adverse Event|2|||
125136362|NCT01117623|450124347|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
125382514|NCT00498602|451033067|FG000|Overall Study|Investigator Request|0|||
125136363|NCT01117623|450124348|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
125136364|NCT01117623|450124349|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
125437648|NCT00603265|451229958|FG001|Overall Study|Protocol Violation|0|||
125437649|NCT00603265|451229959|FG002|Overall Study|Protocol Violation|0|||
125136365|NCT01117623|450124350|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
125136366|NCT01117623|450124351|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
125136367|NCT01117623|450124352|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
125382515|NCT00498602|451033068|FG001|Overall Study|Investigator Request|0|||
125382516|NCT00498602|451033069|FG002|Overall Study|Investigator Request|1|||
125382517|NCT00498602|451033070|FG003|Overall Study|Investigator Request|0|||
125382518|NCT00498602|451033071|FG004|Overall Study|Investigator Request|0|||
125382519|NCT00498602|451033072|FG005|Overall Study|Investigator Request|0|||
125382520|NCT00498602|451033073|FG006|Overall Study|Investigator Request|0|||
125382521|NCT00498602|451033067|FG000|Overall Study|Subject Request|3|||
125382522|NCT00498602|451033068|FG001|Overall Study|Subject Request|0|||
125382523|NCT00498602|451033069|FG002|Overall Study|Subject Request|1|||
125136368|NCT01117623|450124353|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
125136369|NCT01117623|450124354|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
125136370|NCT01117623|450124347|FG000|Overall Study|Withdrawal by Subject|0|||
125136371|NCT01117623|450124348|FG001|Overall Study|Withdrawal by Subject|0|||
125136372|NCT01117623|450124349|FG002|Overall Study|Withdrawal by Subject|2|||
125136373|NCT01117623|450124350|FG003|Overall Study|Withdrawal by Subject|0|||
125136374|NCT01117623|450124351|FG004|Overall Study|Withdrawal by Subject|0|||
125136375|NCT01117623|450124352|FG005|Overall Study|Withdrawal by Subject|1|||
125136376|NCT01117623|450124353|FG006|Overall Study|Withdrawal by Subject|1|||
125136377|NCT01117623|450124354|FG007|Overall Study|Withdrawal by Subject|1|||
125136378|NCT01117623|450124347|FG000|Overall Study|Non-compliance with study medication|0|||
125136379|NCT01117623|450124348|FG001|Overall Study|Non-compliance with study medication|0|||
125136380|NCT01117623|450124349|FG002|Overall Study|Non-compliance with study medication|0|||
125136381|NCT01117623|450124350|FG003|Overall Study|Non-compliance with study medication|0|||
125382524|NCT00498602|451033070|FG003|Overall Study|Subject Request|1|||
125382525|NCT00498602|451033071|FG004|Overall Study|Subject Request|1|||
125382526|NCT00498602|451033072|FG005|Overall Study|Subject Request|4|||
125382527|NCT00498602|451033073|FG006|Overall Study|Subject Request|1|||
125382528|NCT00498602|451033067|FG000|Overall Study|Other|2|||
125382529|NCT00498602|451033068|FG001|Overall Study|Other|3|||
125382530|NCT00498602|451033069|FG002|Overall Study|Other|1|||
125382531|NCT00498602|451033070|FG003|Overall Study|Other|0|||
125382532|NCT00498602|451033071|FG004|Overall Study|Other|0|||
125382533|NCT00498602|451033072|FG005|Overall Study|Other|3|||
125136382|NCT01117623|450124351|FG004|Overall Study|Non-compliance with study medication|0|||
125136383|NCT01117623|450124352|FG005|Overall Study|Non-compliance with study medication|0|||
125136384|NCT01117623|450124353|FG006|Overall Study|Non-compliance with study medication|0|||
125136385|NCT01117623|450124354|FG007|Overall Study|Non-compliance with study medication|1|||
125136386|NCT01117623|450124347|FG000|Overall Study|Invest. text: completed all planned txs|0|||
125136387|NCT01117623|450124348|FG001|Overall Study|Invest. text: completed all planned txs|0|||
125136388|NCT01117623|450124349|FG002|Overall Study|Invest. text: completed all planned txs|0|||
125136389|NCT01117623|450124350|FG003|Overall Study|Invest. text: completed all planned txs|0|||
125136390|NCT01117623|450124351|FG004|Overall Study|Invest. text: completed all planned txs|0|||
125136391|NCT01117623|450124352|FG005|Overall Study|Invest. text: completed all planned txs|1|||
125382534|NCT00498602|451033073|FG006|Overall Study|Other|0|||
125136392|NCT01117623|450124353|FG006|Overall Study|Invest. text: completed all planned txs|0|||
125136393|NCT01117623|450124354|FG007|Overall Study|Invest. text: completed all planned txs|0|||
125136394|NCT00736190|450124359|FG000|Overall Study|Pregnancy|1|||
125382535|NCT02632552|451033076|FG000|Overall Study|Lost to Follow-up|14|||
125382536|NCT02632552|451033077|FG001|Overall Study|Lost to Follow-up|8|||
125382537|NCT02632552|451033076|FG000|Overall Study|Withdrawal by Subject|2|||
125382538|NCT02632552|451033077|FG001|Overall Study|Withdrawal by Subject|0|||
125437650|NCT02002884|451229960|FG000|Main Period (MP)|Other|0|||
125136395|NCT00736190|450124359|FG000|Overall Study|Withdrawal by Subject|1|||
125136396|NCT00736190|450124359|FG000|Overall Study|Adverse Event|1|||
125136397|NCT01896934|450124361|FG000|Overall Study|Adverse Event|1|||
125136398|NCT01896934|450124361|FG000|Overall Study|Withdrawal by Subject|1|||
125136399|NCT00933686|450124362|FG000|Overall Study|Protocol Violation|0|||
125382539|NCT02632552|451033076|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
125382540|NCT02632552|451033077|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
125382541|NCT00546637|451033078|FG000|Overall Study|Adverse Event|46|||
125382542|NCT00546637|451033079|FG001|Overall Study|Adverse Event|20|||
125382543|NCT00546637|451033078|FG000|Overall Study|Lack of Efficacy|5|||
125382544|NCT00546637|451033079|FG001|Overall Study|Lack of Efficacy|5|||
125382545|NCT00546637|451033078|FG000|Overall Study|Lost to Follow-up|2|||
125382546|NCT00546637|451033079|FG001|Overall Study|Lost to Follow-up|2|||
125382547|NCT00546637|451033078|FG000|Overall Study|Other|10|||
125437651|NCT02002884|451229961|FG001|Main Period (MP)|Other|3|||
125136400|NCT00933686|450124363|FG001|Overall Study|Protocol Violation|1|||
125136401|NCT00933686|450124362|FG000|Overall Study|Lost to Follow-up|2|||
125136402|NCT00933686|450124363|FG001|Overall Study|Lost to Follow-up|2|||
125136403|NCT00933686|450124362|FG000|Overall Study|Withdrawal by Subject|6|||
125136404|NCT00933686|450124363|FG001|Overall Study|Withdrawal by Subject|5|||
125136405|NCT00933686|450124362|FG000|Overall Study|Adverse Event|1|||
125136406|NCT00933686|450124363|FG001|Overall Study|Adverse Event|1|||
125136407|NCT00933686|450124362|FG000|Overall Study|Physician Decision|1|||
125136408|NCT00933686|450124363|FG001|Overall Study|Physician Decision|0|||
125136409|NCT00933686|450124362|FG000|Overall Study|Failure to show up at endpoint visits|0|||
125136410|NCT00933686|450124363|FG001|Overall Study|Failure to show up at endpoint visits|2|||
125437652|NCT02002884|451229962|FG002|Main Period (MP)|Other|3|||
125437653|NCT02002884|451229963|FG003|Main Period (MP)|Other|0|||
125136411|NCT00840216|450124367|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
125220281|NCT03569098|450434410|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
125136412|NCT00840216|450124368|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
125220282|NCT03569098|450434408|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
125382548|NCT00546637|451033079|FG001|Overall Study|Other|12|||
125382549|NCT00546637|451033078|FG000|Overall Study|Withdrawal by Subject|7|||
125382550|NCT00546637|451033079|FG001|Overall Study|Withdrawal by Subject|9|||
125382551|NCT00546637|451033078|FG000|Overall Study|Randomized, but not treated|3|||
125382552|NCT00546637|451033079|FG001|Overall Study|Randomized, but not treated|1|||
125382553|NCT01074450|451033080|FG000|First Intervention|Emesis in Dosing Interval|0|||
125437654|NCT02002884|451229960|FG000|Main Period (MP)|Adverse Event|0|||
125136413|NCT05041361|450124369|FG000|Overall Study|Lost to Follow-up|1|||
125136414|NCT05041361|450124370|FG001|Overall Study|Lost to Follow-up|3|||
125136415|NCT01642277|450124371|FG000|Overall Study|Adverse Event|10|||
125136416|NCT01642277|450124372|FG001|Overall Study|Adverse Event|0|||
125136417|NCT01642277|450124371|FG000|Overall Study|Physician Decision|2|||
125136418|NCT01642277|450124372|FG001|Overall Study|Physician Decision|0|||
125136419|NCT01642277|450124371|FG000|Overall Study|Protocol Violation|1|||
125136420|NCT01642277|450124372|FG001|Overall Study|Protocol Violation|0|||
125136421|NCT01642277|450124371|FG000|Overall Study|Withdrawal by Subject|11|||
125136422|NCT01642277|450124372|FG001|Overall Study|Withdrawal by Subject|0|||
125136423|NCT03605342|450124375|FG000|Overall Study|Withdrawal by Subject|9|||
125136424|NCT03605342|450124376|FG001|Overall Study|Withdrawal by Subject|7|||
125136425|NCT03605342|450124375|FG000|Overall Study|Lost to Follow-up|1|||
125136426|NCT03605342|450124376|FG001|Overall Study|Lost to Follow-up|1|||
125136427|NCT00848536|450124377|FG000|Overall Study|Adverse Event|2|||
125136428|NCT00848536|450124378|FG001|Overall Study|Adverse Event|2|||
125136429|NCT00848536|450124377|FG000|Overall Study|Withdrawal by Subject|0|||
125136430|NCT00848536|450124378|FG001|Overall Study|Withdrawal by Subject|1|||
125136431|NCT00848536|450124377|FG000|Overall Study|Protocol Violation|0|||
125136432|NCT00848536|450124378|FG001|Overall Study|Protocol Violation|1|||
125136433|NCT00848536|450124377|FG000|Overall Study|Noncompliance|1|||
125136434|NCT00848536|450124378|FG001|Overall Study|Noncompliance|0|||
125136435|NCT00848536|450124377|FG000|Overall Study|Inadequate Control of IOP|1|||
125136436|NCT00848536|450124378|FG001|Overall Study|Inadequate Control of IOP|1|||
125136437|NCT00848536|450124377|FG000|Overall Study|Patient Moved|0|||
125136438|NCT00848536|450124378|FG001|Overall Study|Patient Moved|2|||
125136439|NCT00796328|450124379|FG000|Overall Study|experienced hypotension requiring tx|6|||
125136440|NCT00506831|450124387|FG000|Overall Study|Death|1|||
125437655|NCT02002884|451229961|FG001|Main Period (MP)|Adverse Event|1|||
125136441|NCT00506831|450124387|FG000|Overall Study|Withdrawal by Subject|1|||
125136442|NCT02488239|450124388|FG000|Overall Study|Death|3|||
125136443|NCT02488239|450124388|FG000|Overall Study|Withdrawal by Subject|3|||
125136444|NCT02488239|450124388|FG000|Overall Study|Physician Decision|2|||
125136445|NCT02488239|450124388|FG000|Overall Study|Consent ineligible|1|||
125136446|NCT02488239|450124388|FG000|Overall Study|Did not undergo implant procedure|1|||
125136447|NCT05479058|450124391|FG000|Overall Study|Withdrawal by Subject|1|||
125136448|NCT05479058|450124392|FG001|Overall Study|Withdrawal by Subject|1|||
125136449|NCT05479058|450124391|FG000|Overall Study|Study terminated by sponsor|10|||
125437656|NCT02002884|451229962|FG002|Main Period (MP)|Adverse Event|1|||
125136450|NCT05479058|450124392|FG001|Overall Study|Study terminated by sponsor|10|||
125136451|NCT00263588|450124397|FG000|Overall Study|Death|54|||
125136452|NCT00263588|450124398|FG001|Overall Study|Death|90|||
125382554|NCT01074450|451033081|FG001|First Intervention|Emesis in Dosing Interval|2|||
125382555|NCT01074450|451033080|FG000|Second Intervention|Protocol Violation|1|||
125382556|NCT01074450|451033081|FG001|Second Intervention|Protocol Violation|0|||
125382557|NCT01074450|451033080|FG000|Second Intervention|Physician Decision|0|||
125382558|NCT01074450|451033081|FG001|Second Intervention|Physician Decision|1|||
125382559|NCT01846507|451033082|FG000|Overall Study|Lost to Follow-up|4|||
125136453|NCT00263588|450124397|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
125136454|NCT00263588|450124398|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
125136455|NCT00263588|450124397|FG000|Overall Study|Lost to Follow-up|7|||
125382560|NCT01846507|451033082|FG000|Overall Study|Protocol Violation|1|||
125136456|NCT00263588|450124398|FG001|Overall Study|Lost to Follow-up|10|||
125136457|NCT00263588|450124397|FG000|Overall Study|Withdrawal by Subject|3|||
125136458|NCT00263588|450124398|FG001|Overall Study|Withdrawal by Subject|4|||
125382561|NCT01846507|451033082|FG000|Overall Study|Missing data|2|||
125382562|NCT00450450|451033083|FG000|Overall Study|Death|1|||
125382563|NCT00450450|451033084|FG001|Overall Study|Death|3|||
125382564|NCT00450450|451033083|FG000|Overall Study|Relapse|2|||
125220283|NCT03569098|450434409|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
125220284|NCT03569098|450434410|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
125220285|NCT01697800|450434411|FG000|Overall Study|Death|0|||
125220286|NCT01697800|450434412|FG001|Overall Study|Death|1|||
125220287|NCT00954122|450434413|FG000|Overall Study|Withdrawal by Subject|5|||
125220288|NCT00954122|450434413|FG000|Overall Study|Adverse Event|1|||
125220289|NCT00954122|450434413|FG000|Overall Study|Safety Reason|1|||
125220290|NCT00522548|450434417|FG000|Overall Study|Adverse Event|2|||
125220291|NCT00522548|450434418|FG001|Overall Study|Adverse Event|2|||
125220292|NCT00522548|450434417|FG000|Overall Study|Withdrawal by Subject|0|||
125220293|NCT00522548|450434418|FG001|Overall Study|Withdrawal by Subject|2|||
125220294|NCT02121795|450434419|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
125220295|NCT02121795|450434420|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
125220296|NCT02121795|450434419|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
125220297|NCT02121795|450434420|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
125220298|NCT02121795|450434419|FG000|Double-Blind Phase|Lost to Follow-up|7|||
125220299|NCT02121795|450434420|FG001|Double-Blind Phase|Lost to Follow-up|4|||
125220300|NCT02121795|450434419|FG000|Double-Blind Phase|Physician Decision|2|||
125220301|NCT02121795|450434420|FG001|Double-Blind Phase|Physician Decision|5|||
125220302|NCT02121795|450434419|FG000|Double-Blind Phase|Adverse Event|5|||
125220303|NCT02121795|450434420|FG001|Double-Blind Phase|Adverse Event|0|||
125220304|NCT02121795|450434419|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
125220305|NCT02121795|450434420|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
125220306|NCT02121795|450434419|FG000|Double-Blind Phase|Protocol Violation|0|||
125220307|NCT02121795|450434420|FG001|Double-Blind Phase|Protocol Violation|3|||
125220308|NCT02121795|450434419|FG000|Double-Blind Phase|Death|1|||
125220309|NCT02121795|450434420|FG001|Double-Blind Phase|Death|1|||
125220310|NCT02121795|450434419|FG000|Open-Label Phase|Physician Decision|8|||
125220311|NCT02121795|450434420|FG001|Open-Label Phase|Physician Decision|8|||
125220312|NCT02121795|450434419|FG000|Open-Label Phase|Withdrawal by Subject|3|||
125382565|NCT00450450|451033084|FG001|Overall Study|Relapse|0|||
125382566|NCT00450450|451033083|FG000|Overall Study|Missing Data|2|||
125220313|NCT02121795|450434420|FG001|Open-Label Phase|Withdrawal by Subject|2|||
125220314|NCT02121795|450434419|FG000|Open-Label Phase|Lost to Follow-up|1|||
125220315|NCT02121795|450434420|FG001|Open-Label Phase|Lost to Follow-up|0|||
125382567|NCT00450450|451033084|FG001|Overall Study|Missing Data|0|||
125382568|NCT04984993|451033085|FG000|Overall Study|Withdrawal by Subject|8|||
125382569|NCT04984993|451033086|FG001|Overall Study|Withdrawal by Subject|2|||
125136459|NCT00263588|450124397|FG000|Overall Study|Protocol Violation|0|||
125136460|NCT00263588|450124398|FG001|Overall Study|Protocol Violation|1|||
125136461|NCT00263588|450124397|FG000|Overall Study|Investigator decision|7|||
125136462|NCT00263588|450124398|FG001|Overall Study|Investigator decision|15|||
125136463|NCT00263588|450124397|FG000|Overall Study|Sponsor terminated study|0|||
125136464|NCT00263588|450124398|FG001|Overall Study|Sponsor terminated study|1|||
125136465|NCT00918684|450124399|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
125136466|NCT00918684|450124399|FG000|Treatment Phase|Lack of Efficacy|6|||
125136467|NCT00918684|450124399|FG000|Treatment Phase|Lost to Follow-up|2|||
125136468|NCT00918684|450124399|FG000|Treatment Phase|Physician Decision|8|||
125136469|NCT00918684|450124399|FG000|Treatment Phase|Protocol Violation|1|||
125136470|NCT00918684|450124399|FG000|Treatment Phase|Withdrawal by Subject|8|||
125136471|NCT00909038|450124400|FG000|Overall Study|Protocol Violation|187|||
125136472|NCT00909038|450124400|FG000|Overall Study|Non-evaluable Subjects|230|||
125136473|NCT00484679|450124401|FG000|Overall Study|Withdrawal by Subject|3|||
125136474|NCT00835692|450124402|FG000|First Intervention|Withdrawal by Subject|1|||
125136475|NCT00835692|450124403|FG001|First Intervention|Withdrawal by Subject|0|||
125136476|NCT04345653|450124406|FG000|Overall Study|Withdrawal by Subject|2|||
125136477|NCT03808376|450124407|FG000|Overall Study|Withdrawal by Subject|10|||
125136478|NCT03644550|450124408|FG000|Overall Study|Withdrawal by Subject|3|||
125136479|NCT03644550|450124408|FG000|Overall Study|Progressive disease|15|||
125136480|NCT00700739|450124409|FG000|Overall Study|Lost to Follow-up|4|||
125136481|NCT00700739|450124410|FG001|Overall Study|Lost to Follow-up|4|||
125136482|NCT03488108|450124419|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
125382570|NCT04984993|451033085|FG000|Overall Study|Lost to Follow-up|2|||
125382571|NCT04984993|451033086|FG001|Overall Study|Lost to Follow-up|2|||
125382572|NCT04984993|451033085|FG000|Overall Study|Both patients moved to another country|4|||
125136483|NCT03488108|450124420|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
125136484|NCT03488108|450124419|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
125136485|NCT03488108|450124420|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
125136486|NCT01297504|450124424|FG000|Overall Study|Invalid Consent|1|||
125136487|NCT01297504|450124424|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
125136488|NCT01297504|450124424|FG000|Overall Study|No Study Visits|4|||
125136489|NCT01297504|450124424|FG000|Overall Study|Death|3|||
125136490|NCT01297504|450124424|FG000|Overall Study|Lost to Follow-up|43|||
125136491|NCT01297504|450124424|FG000|Overall Study|Withdrawal by Subject|9|||
125136492|NCT01297504|450124424|FG000|Overall Study|Site Closure|3|||
125136493|NCT01297504|450124424|FG000|Overall Study|Protocol Violation|3|||
125136494|NCT03602339|450124425|FG000|Overall Study|Withdrawal by Subject|9|||
125136495|NCT03602339|450124425|FG000|Overall Study|Physician Decision|2|||
125136496|NCT03602339|450124425|FG000|Overall Study|Other reason|4|||
125136497|NCT01348789|450124426|FG000|Overall Study|Protocol Violation|2|||
125136498|NCT01348789|450124426|FG000|Overall Study|Withdrawal by Subject|2|||
125136499|NCT03503318|450124429|FG000|Overall Study|Death|1|||
125136500|NCT03503318|450124430|FG001|Overall Study|Death|0|||
125136501|NCT03503318|450124431|FG002|Overall Study|Death|4|||
125136502|NCT03503318|450124429|FG000|Overall Study|Adverse Event|3|||
125136503|NCT03503318|450124430|FG001|Overall Study|Adverse Event|4|||
125136504|NCT03503318|450124431|FG002|Overall Study|Adverse Event|2|||
125136505|NCT03503318|450124429|FG000|Overall Study|Withdrawal by Subject|12|||
125136506|NCT03503318|450124430|FG001|Overall Study|Withdrawal by Subject|17|||
125136507|NCT03503318|450124431|FG002|Overall Study|Withdrawal by Subject|16|||
125136508|NCT03503318|450124429|FG000|Overall Study|Protocol Violation|5|||
125136509|NCT03503318|450124430|FG001|Overall Study|Protocol Violation|0|||
125136510|NCT03503318|450124431|FG002|Overall Study|Protocol Violation|3|||
125136511|NCT03503318|450124429|FG000|Overall Study|Lost to Follow-up|17|||
125136512|NCT03503318|450124430|FG001|Overall Study|Lost to Follow-up|15|||
125136513|NCT03503318|450124431|FG002|Overall Study|Lost to Follow-up|12|||
125136514|NCT03503318|450124429|FG000|Overall Study|Other than specified|1|||
125136515|NCT03503318|450124430|FG001|Overall Study|Other than specified|3|||
125136516|NCT03503318|450124431|FG002|Overall Study|Other than specified|3|||
125136517|NCT00834873|450124438|FG000|First Intervention|Adverse Event|0|||
125382573|NCT04984993|451033086|FG001|Overall Study|Both patients moved to another country|0|||
125136518|NCT00834873|450124439|FG001|First Intervention|Adverse Event|1|||
125136519|NCT04827394|450124441|FG000|Overall Study|Physician Decision|0|||
125136520|NCT04827394|450124442|FG001|Overall Study|Physician Decision|2|||
125136521|NCT04594252|450124443|FG000|Overall Study|Adverse Event|0|||
125136522|NCT04594252|450124444|FG001|Overall Study|Adverse Event|2|||
125136523|NCT00477594|450124449|FG000|Year 1 and Year 2|Adverse Event|4|||
125136524|NCT00477594|450124450|FG001|Year 1 and Year 2|Adverse Event|2|||
125136525|NCT00477594|450124449|FG000|Year 1 and Year 2|Physician Decision|2|||
125136526|NCT00477594|450124450|FG001|Year 1 and Year 2|Physician Decision|1|||
125136527|NCT00477594|450124449|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
125136528|NCT00477594|450124450|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
125136529|NCT00477594|450124449|FG000|Year 1 and Year 2|Other|1|||
125136530|NCT00477594|450124450|FG001|Year 1 and Year 2|Other|0|||
125136531|NCT00477594|450124449|FG000|Year 3|Adverse Event|1|||
125136532|NCT00477594|450124450|FG001|Year 3|Adverse Event|0|||
125136533|NCT00477594|450124449|FG000|Year 3|Withdrawal by Subject|1|||
125136534|NCT00477594|450124450|FG001|Year 3|Withdrawal by Subject|0|||
125136535|NCT00477594|450124449|FG000|Follow-up Period|Withdrawal by Subject|2|||
125136536|NCT00477594|450124450|FG001|Follow-up Period|Withdrawal by Subject|1|||
125136537|NCT00477594|450124449|FG000|Follow-up Period|Other|1|||
125136538|NCT00477594|450124450|FG001|Follow-up Period|Other|0|||
125136539|NCT03114891|450124451|FG000|First Treatment Round|Lost to Follow-up|0|||
125136540|NCT03114891|450124452|FG001|First Treatment Round|Lost to Follow-up|1|||
125136541|NCT03114891|450124453|FG002|First Treatment Round|Lost to Follow-up|1|||
125136542|NCT03114891|450124454|FG003|First Treatment Round|Lost to Follow-up|0|||
125136543|NCT03114891|450124451|FG000|First Treatment Round|Withdrawal by Subject|0|||
125136544|NCT03114891|450124452|FG001|First Treatment Round|Withdrawal by Subject|2|||
125136545|NCT03114891|450124453|FG002|First Treatment Round|Withdrawal by Subject|0|||
125136546|NCT03114891|450124454|FG003|First Treatment Round|Withdrawal by Subject|1|||
125136547|NCT03114891|450124451|FG000|3 Week Break|Lost to Follow-up|1|||
125136548|NCT03114891|450124452|FG001|3 Week Break|Lost to Follow-up|0|||
125136549|NCT03114891|450124453|FG002|3 Week Break|Lost to Follow-up|0|||
125136550|NCT03114891|450124454|FG003|3 Week Break|Lost to Follow-up|1|||
125136551|NCT03114891|450124451|FG000|3 Week Break|Withdrawal by Subject|0|||
125136552|NCT03114891|450124452|FG001|3 Week Break|Withdrawal by Subject|1|||
125136553|NCT03114891|450124453|FG002|3 Week Break|Withdrawal by Subject|0|||
125136554|NCT03114891|450124454|FG003|3 Week Break|Withdrawal by Subject|0|||
125136555|NCT03114891|450124451|FG000|Second Treatment Round|Lost to Follow-up|1|||
125136556|NCT03114891|450124452|FG001|Second Treatment Round|Lost to Follow-up|0|||
125382574|NCT02865187|451033089|FG000|Overall Study|Lost to Follow-up|12|||
125382575|NCT02865187|451033090|FG001|Overall Study|Lost to Follow-up|7|||
125136557|NCT03114891|450124453|FG002|Second Treatment Round|Lost to Follow-up|0|||
125136558|NCT03114891|450124454|FG003|Second Treatment Round|Lost to Follow-up|0|||
125136559|NCT03114891|450124451|FG000|Second Treatment Round|Physician Decision|1|||
125136560|NCT03114891|450124452|FG001|Second Treatment Round|Physician Decision|0|||
125136561|NCT03114891|450124453|FG002|Second Treatment Round|Physician Decision|0|||
125136562|NCT03114891|450124454|FG003|Second Treatment Round|Physician Decision|0|||
125136563|NCT02068794|450126297|FG000|Overall Study|Withdrawal by Subject|0|||
125136564|NCT02068794|450126298|FG001|Overall Study|Withdrawal by Subject|1|||
125136565|NCT02068794|450126299|FG002|Overall Study|Withdrawal by Subject|2|||
125136566|NCT02068794|450126297|FG000|Overall Study|Early Progression|1|||
125136567|NCT02068794|450126298|FG001|Overall Study|Early Progression|0|||
125136568|NCT02068794|450126299|FG002|Overall Study|Early Progression|1|||
125136569|NCT02068794|450126297|FG000|Overall Study|Ineligible|0|||
125136570|NCT02068794|450126298|FG001|Overall Study|Ineligible|0|||
125136571|NCT02068794|450126299|FG002|Overall Study|Ineligible|1|||
125136572|NCT02635750|450126300|FG000|Part 1, Period 2|Adverse Event|1|||
125136573|NCT02635750|450126301|FG001|Part 1, Period 2|Adverse Event|0|||
125136574|NCT02635750|450126302|FG002|Part 1, Period 2|Adverse Event|0|||
125136575|NCT02875392|450126304|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
125136576|NCT02875392|450126305|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
125136577|NCT03599193|450126306|FG000|Overall Study|Adverse Event|0|||
125136578|NCT03599193|450126307|FG001|Overall Study|Adverse Event|2|||
125136579|NCT03599193|450126306|FG000|Overall Study|Withdrawal by Subject|1|||
125136580|NCT03599193|450126307|FG001|Overall Study|Withdrawal by Subject|0|||
125136581|NCT03599193|450126306|FG000|Overall Study|Protocol Violation|1|||
125382576|NCT02865187|451033089|FG000|Overall Study|Adverse Event|1|||
125382577|NCT02865187|451033090|FG001|Overall Study|Adverse Event|0|||
125136582|NCT03599193|450126307|FG001|Overall Study|Protocol Violation|0|||
125382578|NCT01382446|451033091|FG000|Overall Study|Withdrawal by Subject|0|||
125382579|NCT01382446|451033092|FG001|Overall Study|Withdrawal by Subject|1|||
125382580|NCT01382446|451033091|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
125136583|NCT03599193|450126306|FG000|Overall Study|Lost to Follow-up|0|||
125136584|NCT03599193|450126307|FG001|Overall Study|Lost to Follow-up|1|||
125136585|NCT00835705|450126308|FG000|First Intervention|Difficulty with vein|1|||
125136586|NCT00835705|450126309|FG001|First Intervention|Difficulty with vein|0|||
125136587|NCT00835705|450126308|FG000|Second Intervention|Difficulty with vein|1|||
125136588|NCT00835705|450126309|FG001|Second Intervention|Difficulty with vein|0|||
125136589|NCT01592240|450126310|FG000|Overall Study|Adverse Event|1|||
125136590|NCT01592240|450126311|FG001|Overall Study|Adverse Event|0|||
125136591|NCT01592240|450126312|FG002|Overall Study|Adverse Event|0|||
125136592|NCT01592240|450126313|FG003|Overall Study|Adverse Event|1|||
125136593|NCT01592240|450126314|FG004|Overall Study|Adverse Event|1|||
125136594|NCT01592240|450126315|FG005|Overall Study|Adverse Event|0|||
125136595|NCT01592240|450126316|FG006|Overall Study|Adverse Event|0|||
125136596|NCT01592240|450126310|FG000|Overall Study|Death|0|||
125136597|NCT01592240|450126311|FG001|Overall Study|Death|1|||
125136598|NCT01592240|450126312|FG002|Overall Study|Death|0|||
125136599|NCT01592240|450126313|FG003|Overall Study|Death|0|||
125136600|NCT01592240|450126314|FG004|Overall Study|Death|0|||
125136601|NCT01592240|450126315|FG005|Overall Study|Death|0|||
125136602|NCT01592240|450126316|FG006|Overall Study|Death|0|||
125136603|NCT01592240|450126310|FG000|Overall Study|Lost to Follow-up|1|||
125136604|NCT01592240|450126311|FG001|Overall Study|Lost to Follow-up|3|||
125220316|NCT00994110|450434421|FG000|Overall Study|Withdrawal by Subject|9|||
125220317|NCT00994110|450434422|FG001|Overall Study|Withdrawal by Subject|9|||
125220318|NCT00994110|450434421|FG000|Overall Study|Not Treated|4|||
125220319|NCT00994110|450434422|FG001|Overall Study|Not Treated|8|||
125220320|NCT00994110|450434421|FG000|Overall Study|Adverse Event|1|||
125220321|NCT00994110|450434422|FG001|Overall Study|Adverse Event|0|||
125220322|NCT00994110|450434421|FG000|Overall Study|Patient not resected|41|||
125220323|NCT00994110|450434422|FG001|Overall Study|Patient not resected|52|||
125220324|NCT00994110|450434421|FG000|Overall Study|Pt not eligible|10|||
125136605|NCT01592240|450126312|FG002|Overall Study|Lost to Follow-up|1|||
125136606|NCT01592240|450126313|FG003|Overall Study|Lost to Follow-up|0|||
125136607|NCT01592240|450126314|FG004|Overall Study|Lost to Follow-up|3|||
125136608|NCT01592240|450126315|FG005|Overall Study|Lost to Follow-up|2|||
125220325|NCT00994110|450434422|FG001|Overall Study|Pt not eligible|5|||
125136609|NCT01592240|450126316|FG006|Overall Study|Lost to Follow-up|0|||
125136610|NCT01592240|450126310|FG000|Overall Study|Protocol Violation|0|||
125136611|NCT01592240|450126311|FG001|Overall Study|Protocol Violation|0|||
125136612|NCT01592240|450126312|FG002|Overall Study|Protocol Violation|0|||
125136613|NCT01592240|450126313|FG003|Overall Study|Protocol Violation|0|||
125136614|NCT01592240|450126314|FG004|Overall Study|Protocol Violation|0|||
125136615|NCT01592240|450126315|FG005|Overall Study|Protocol Violation|1|||
125136616|NCT01592240|450126316|FG006|Overall Study|Protocol Violation|0|||
125136617|NCT01592240|450126310|FG000|Overall Study|Withdrawal by Subject|0|||
125136618|NCT01592240|450126311|FG001|Overall Study|Withdrawal by Subject|4|||
125136619|NCT01592240|450126312|FG002|Overall Study|Withdrawal by Subject|4|||
125136620|NCT01592240|450126313|FG003|Overall Study|Withdrawal by Subject|1|||
125136621|NCT01592240|450126314|FG004|Overall Study|Withdrawal by Subject|3|||
125136622|NCT01592240|450126315|FG005|Overall Study|Withdrawal by Subject|0|||
125136623|NCT01592240|450126316|FG006|Overall Study|Withdrawal by Subject|2|||
125136624|NCT01592240|450126310|FG000|Overall Study|Other|0|||
125136625|NCT01592240|450126311|FG001|Overall Study|Other|3|||
125136626|NCT01592240|450126312|FG002|Overall Study|Other|1|||
125136627|NCT01592240|450126313|FG003|Overall Study|Other|1|||
125136628|NCT01592240|450126314|FG004|Overall Study|Other|0|||
125136629|NCT01592240|450126315|FG005|Overall Study|Other|0|||
125136630|NCT01592240|450126316|FG006|Overall Study|Other|1|||
125136631|NCT01592240|450126310|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
125136632|NCT01592240|450126311|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
125136633|NCT01592240|450126312|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
125136634|NCT01592240|450126313|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
125136635|NCT01592240|450126314|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
125136636|NCT01592240|450126315|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
125136637|NCT01592240|450126316|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
125136638|NCT03246503|450126320|FG000|Overall Study|Lost to Follow-up|23|||
125136639|NCT03246503|450126320|FG000|Overall Study|Withdrawal by Subject|20|||
125382581|NCT01382446|451033092|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
125136640|NCT03246503|450126320|FG000|Overall Study|Physician Decision|5|||
125136641|NCT03246503|450126320|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
125136642|NCT02751424|450126321|FG000|Part 2|Adverse Event|0|||
125136643|NCT02751424|450126322|FG001|Part 2|Adverse Event|0|||
125136644|NCT02751424|450126323|FG002|Part 2|Adverse Event|0|||
125136645|NCT02751424|450126324|FG003|Part 2|Adverse Event|0|||
125382582|NCT02707991|451033093|FG000|Overall Study|Protocol Violation|1|||
125136646|NCT02751424|450126325|FG004|Part 2|Adverse Event|0|||
125136647|NCT02751424|450126326|FG005|Part 2|Adverse Event|0|||
125136648|NCT02751424|450126327|FG006|Part 2|Adverse Event|0|||
125136649|NCT02751424|450126328|FG007|Part 2|Adverse Event|5|||
125136650|NCT02751424|450126329|FG008|Part 2|Adverse Event|0|||
125136651|NCT03206749|450126330|FG000|Overall Study|Withdrawal of consent|5|||
125136652|NCT03206749|450126331|FG001|Overall Study|Withdrawal of consent|3|||
125136653|NCT03206749|450126332|FG002|Overall Study|Withdrawal of consent|6|||
125136654|NCT03206749|450126330|FG000|Overall Study|Lost to Follow-up|0|||
125136655|NCT03206749|450126331|FG001|Overall Study|Lost to Follow-up|0|||
125136656|NCT03206749|450126332|FG002|Overall Study|Lost to Follow-up|1|||
125136657|NCT00716625|450126333|FG000|Overall Study|Safety was not Assessable|1|||
125136658|NCT01492439|450126334|FG000|Overall Study|Withdrew from RTE|4|||
125136659|NCT01492439|450126335|FG001|Overall Study|Withdrew from RTE|9|||
125136660|NCT05523895|450126336|FG000|Overall Study|Adverse Event|2|||
125136661|NCT05523895|450126337|FG001|Overall Study|Adverse Event|1|||
125136662|NCT05523895|450126338|FG002|Overall Study|Adverse Event|1|||
125136663|NCT05523895|450126336|FG000|Overall Study|Lost to Follow-up|0|||
125136664|NCT05523895|450126337|FG001|Overall Study|Lost to Follow-up|1|||
125136665|NCT05523895|450126338|FG002|Overall Study|Lost to Follow-up|2|||
125136666|NCT05523895|450126336|FG000|Overall Study|Noncompliance with study drug|1|||
125136667|NCT05523895|450126337|FG001|Overall Study|Noncompliance with study drug|1|||
125136668|NCT05523895|450126338|FG002|Overall Study|Noncompliance with study drug|1|||
125136669|NCT05523895|450126336|FG000|Overall Study|Protocol Violation|0|||
125136670|NCT05523895|450126337|FG001|Overall Study|Protocol Violation|2|||
125136671|NCT05523895|450126338|FG002|Overall Study|Protocol Violation|0|||
125136672|NCT05523895|450126336|FG000|Overall Study|Withdrawal by Subject|1|||
125382583|NCT02707991|451033094|FG001|Overall Study|Protocol Violation|0|||
125136673|NCT05523895|450126337|FG001|Overall Study|Withdrawal by Subject|3|||
125136674|NCT05523895|450126338|FG002|Overall Study|Withdrawal by Subject|1|||
125136675|NCT05523895|450126336|FG000|Overall Study|Not further specified|0|||
125382584|NCT02707991|451033093|FG000|Overall Study|Became ineligible|0|||
125382585|NCT02707991|451033094|FG001|Overall Study|Became ineligible|1|||
125382586|NCT01166763|451033098|FG000|Overall Study|Withdrawal by Subject|3|||
125382587|NCT01528254|451033099|FG000|Overall Study|Administrative problems|96|||
125382588|NCT01528254|451033100|FG001|Overall Study|Administrative problems|94|||
125382589|NCT01528254|451033099|FG000|Overall Study|Adverse Event|28|||
125382590|NCT01528254|451033100|FG001|Overall Study|Adverse Event|44|||
125382591|NCT01528254|451033099|FG000|Overall Study|Lost to Follow-up|17|||
125382592|NCT01528254|451033100|FG001|Overall Study|Lost to Follow-up|24|||
125382593|NCT01528254|451033099|FG000|Overall Study|Death|13|||
125382594|NCT01528254|451033100|FG001|Overall Study|Death|9|||
125382595|NCT01528254|451033099|FG000|Overall Study|Protocol deviation|9|||
125382596|NCT01528254|451033100|FG001|Overall Study|Protocol deviation|19|||
125382597|NCT01528254|451033099|FG000|Overall Study|New therapy for study indication|8|||
125382598|NCT01528254|451033100|FG001|Overall Study|New therapy for study indication|6|||
125382599|NCT01528254|451033099|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
125382600|NCT01528254|451033100|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
125382601|NCT01528254|451033099|FG000|Overall Study|Withdrawal by Subject|5|||
125382602|NCT01528254|451033100|FG001|Overall Study|Withdrawal by Subject|4|||
125382603|NCT01528254|451033099|FG000|Overall Study|Abnormal laboratory value(s)|3|||
125437657|NCT02002884|451229963|FG003|Main Period (MP)|Adverse Event|0|||
125382604|NCT01528254|451033100|FG001|Overall Study|Abnormal laboratory value(s)|7|||
125382605|NCT01528254|451033099|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125382606|NCT01528254|451033100|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125382607|NCT01528254|451033099|FG000|Overall Study|No longer requires study drug|1|||
125382608|NCT01528254|451033100|FG001|Overall Study|No longer requires study drug|1|||
125382609|NCT04339296|451033101|FG000|Overall Study|Refuse to participate after allocation|1|||
125382610|NCT04339296|451033102|FG001|Overall Study|Refuse to participate after allocation|1|||
125382611|NCT04339296|451033101|FG000|Overall Study|Withdrew after completion of baseline|2|||
125382612|NCT04339296|451033102|FG001|Overall Study|Withdrew after completion of baseline|1|||
125382613|NCT04339296|451033101|FG000|Overall Study|Lost to Follow-up|0|||
125382614|NCT04339296|451033102|FG001|Overall Study|Lost to Follow-up|4|||
125382615|NCT04339296|451033101|FG000|Overall Study|Discontinued intervention|5|||
125382616|NCT04339296|451033102|FG001|Overall Study|Discontinued intervention|3|||
125382617|NCT01909479|451033103|FG000|From Baseline to Week 26|Adverse Event|3|||
125382618|NCT01909479|451033104|FG001|From Baseline to Week 26|Adverse Event|2|||
125382619|NCT01909479|451033103|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
125382620|NCT01909479|451033104|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
125382621|NCT01909479|451033103|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
125382622|NCT01909479|451033104|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
125382623|NCT01909479|451033103|FG000|26 - 52 Weeks|Adverse Event|0|||
125382624|NCT01909479|451033104|FG001|26 - 52 Weeks|Adverse Event|1|||
125382625|NCT01909479|451033103|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
125382626|NCT01909479|451033104|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
125382627|NCT01909479|451033103|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
125382628|NCT01909479|451033104|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
125382629|NCT01909479|451033103|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
125382630|NCT01909479|451033104|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
125382631|NCT01909479|451033103|FG000|52 Weeks to End of Study|Adverse Event|2|||
125382632|NCT01909479|451033104|FG001|52 Weeks to End of Study|Adverse Event|1|||
125382633|NCT01909479|451033103|FG000|52 Weeks to End of Study|Death|0|||
125382634|NCT01909479|451033104|FG001|52 Weeks to End of Study|Death|1|||
125382635|NCT01909479|451033103|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
125382636|NCT01909479|451033104|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
125382637|NCT01909479|451033103|FG000|52 Weeks to End of Study|Protocol Violation|1|||
125382638|NCT01909479|451033104|FG001|52 Weeks to End of Study|Protocol Violation|0|||
125382639|NCT01909479|451033103|FG000|52 Weeks to End of Study|Progressive disease|1|||
125382640|NCT01909479|451033104|FG001|52 Weeks to End of Study|Progressive disease|1|||
125382641|NCT01909479|451033103|FG000|52 Weeks to End of Study|Personal reasons|2|||
125382642|NCT01909479|451033104|FG001|52 Weeks to End of Study|Personal reasons|1|||
125382643|NCT01909479|451033103|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
125382644|NCT01909479|451033104|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
125382645|NCT01909479|451033103|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
125382646|NCT01909479|451033104|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
125382647|NCT01909479|451033103|FG000|52 Weeks to End of Study|Lack of contact|1|||
125382648|NCT01909479|451033104|FG001|52 Weeks to End of Study|Lack of contact|0|||
125382649|NCT01909479|451033103|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
125382650|NCT01909479|451033104|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
125382651|NCT01909479|451033103|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
125382652|NCT01909479|451033104|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
125382653|NCT04446377|451033105|FG000|Overall Study|Withdrawal by Subject|6|||
125382654|NCT04446377|451033106|FG001|Overall Study|Withdrawal by Subject|1|||
125437658|NCT02002884|451229960|FG000|Main Period (MP)|Withdrawal by Subject|6|||
125437659|NCT02002884|451229961|FG001|Main Period (MP)|Withdrawal by Subject|2|||
125382655|NCT04446377|451033105|FG000|Overall Study|Physician Decision|1|||
125382656|NCT04446377|451033106|FG001|Overall Study|Physician Decision|1|||
125382657|NCT04446377|451033105|FG000|Overall Study|Lost to Follow-up|0|||
125382658|NCT04446377|451033106|FG001|Overall Study|Lost to Follow-up|2|||
125382659|NCT04446377|451033105|FG000|Overall Study|Not eligible|0|||
125382660|NCT04446377|451033106|FG001|Overall Study|Not eligible|1|||
125382661|NCT00737282|451033109|FG000|Overall Study|Study prematurely terminated|175|||
125382662|NCT02810392|451033111|FG000|Overall Study|Subject too ill to continue|1|||
125382663|NCT02810392|451033112|FG001|Overall Study|Subject too ill to continue|0|||
125382664|NCT02810392|451033111|FG000|Overall Study|COVID 19 research restrictions|0|||
125382665|NCT02810392|451033112|FG001|Overall Study|COVID 19 research restrictions|1|||
125382666|NCT00840294|451033113|FG000|Overall Study|Withdrawal by Subject|2|||
125382667|NCT00840294|451033114|FG001|Overall Study|Withdrawal by Subject|1|||
125382668|NCT00840294|451033113|FG000|Overall Study|Protocol Violation|1|||
125382669|NCT00840294|451033114|FG001|Overall Study|Protocol Violation|3|||
125382670|NCT00840294|451033113|FG000|Overall Study|Illness|0|||
125382671|NCT00840294|451033114|FG001|Overall Study|Illness|1|||
125382672|NCT01187043|451033115|FG000|Overall Study|Adverse Event|0|||
125382673|NCT01187043|451033116|FG001|Overall Study|Adverse Event|0|||
125382674|NCT01187043|451033117|FG002|Overall Study|Adverse Event|0|||
125382675|NCT01187043|451033118|FG003|Overall Study|Adverse Event|0|||
125382676|NCT01187043|451033119|FG004|Overall Study|Adverse Event|1|||
125382677|NCT01187043|451033115|FG000|Overall Study|Unable to make scheduled visits|1|||
125382678|NCT01187043|451033116|FG001|Overall Study|Unable to make scheduled visits|0|||
125382679|NCT01187043|451033117|FG002|Overall Study|Unable to make scheduled visits|4|||
125382680|NCT01187043|451033118|FG003|Overall Study|Unable to make scheduled visits|0|||
125136676|NCT05523895|450126337|FG001|Overall Study|Not further specified|3|||
125136677|NCT05523895|450126338|FG002|Overall Study|Not further specified|1|||
125136678|NCT03674892|450126339|FG000|Overall Study|Lack of Efficacy|5|||
125382681|NCT01187043|451033119|FG004|Overall Study|Unable to make scheduled visits|1|||
125382682|NCT02196558|451033120|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
125136679|NCT03674892|450126339|FG000|Overall Study|Lost to Follow-up|3|||
125136680|NCT03674892|450126339|FG000|Overall Study|Migraine|2|||
125136681|NCT03674892|450126339|FG000|Overall Study|Excessive Tearing|1|||
125136682|NCT03674892|450126339|FG000|Overall Study|Increased Eye Pain|1|||
125136683|NCT03674892|450126339|FG000|Overall Study|Increased Facial Pain|1|||
125136684|NCT03674892|450126339|FG000|Overall Study|Sinus Irritation|1|||
125136685|NCT03674892|450126339|FG000|Overall Study|Sinus Infection|1|||
125136686|NCT00824291|450126340|FG000|Overall Study|Adverse Event|15|||
125136687|NCT00824291|450126341|FG001|Overall Study|Adverse Event|6|||
125136688|NCT00824291|450126340|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
125136689|NCT00824291|450126341|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
125382683|NCT02196558|451033121|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
125382684|NCT02196558|451033122|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
125136690|NCT00824291|450126340|FG000|Overall Study|Lost to Follow-up|11|||
125136691|NCT00824291|450126341|FG001|Overall Study|Lost to Follow-up|9|||
125136692|NCT00824291|450126340|FG000|Overall Study|Non-compliance|1|||
125136693|NCT00824291|450126341|FG001|Overall Study|Non-compliance|1|||
125382685|NCT02196558|451033120|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
125382686|NCT02196558|451033121|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
125136694|NCT00824291|450126340|FG000|Overall Study|Protocol Violation|4|||
125382687|NCT02196558|451033122|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
125136695|NCT00824291|450126341|FG001|Overall Study|Protocol Violation|1|||
125382688|NCT02196558|451033120|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
125382689|NCT02196558|451033121|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
125136696|NCT00824291|450126340|FG000|Overall Study|Withdrawal by Subject|14|||
125382690|NCT02196558|451033122|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
125382691|NCT02196558|451033120|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
125136697|NCT00824291|450126341|FG001|Overall Study|Withdrawal by Subject|8|||
125136698|NCT00824291|450126340|FG000|Overall Study|Lack of Efficacy|7|||
125136699|NCT00824291|450126341|FG001|Overall Study|Lack of Efficacy|8|||
125382692|NCT02196558|451033121|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
125382693|NCT02196558|451033122|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
125382694|NCT02196558|451033120|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
125382695|NCT02196558|451033121|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
125382696|NCT02196558|451033122|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
125136700|NCT00824291|450126340|FG000|Overall Study|Participant on prohibited medication|1|||
125136701|NCT00824291|450126341|FG001|Overall Study|Participant on prohibited medication|0|||
125136702|NCT00395694|450126345|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
125136703|NCT00395694|450126346|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
125136704|NCT00395694|450126345|FG000|Continuation Phase|Adverse Event|1|||
125136705|NCT00395694|450126346|FG001|Continuation Phase|Adverse Event|0|||
125136706|NCT00395694|450126345|FG000|Continuation Phase|Lack of Efficacy|12|||
125136707|NCT00395694|450126346|FG001|Continuation Phase|Lack of Efficacy|11|||
125136708|NCT00395694|450126345|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
125136709|NCT00395694|450126346|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
125136710|NCT00395694|450126345|FG000|Continuation Phase|Poor Compliance|1|||
125136711|NCT00395694|450126346|FG001|Continuation Phase|Poor Compliance|0|||
125136712|NCT00395694|450126345|FG000|Continuation Phase|Withdrawal by Subject|0|||
125382697|NCT00847704|451033124|FG000|Overall Study|Withdrawal by Subject|1|||
125136713|NCT00395694|450126346|FG001|Continuation Phase|Withdrawal by Subject|2|||
125382698|NCT03036072|451033127|FG000|Overall Study|Death|0|||
125382699|NCT03036072|451033128|FG001|Overall Study|Death|1|||
125136714|NCT01648582|450126347|FG000|Overall Study|Adverse Event|6|||
125382700|NCT03036072|451033127|FG000|Overall Study|Withdrawal by Subject|0|||
125382701|NCT03036072|451033128|FG001|Overall Study|Withdrawal by Subject|1|||
125382702|NCT03036072|451033127|FG000|Overall Study|Physician Decision|0|||
125382703|NCT03036072|451033128|FG001|Overall Study|Physician Decision|1|||
125382704|NCT02111850|451033129|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125382705|NCT02111850|451033130|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125382706|NCT02111850|451033131|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125382707|NCT02111850|451033132|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125382708|NCT02111850|451033133|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
125437660|NCT02002884|451229962|FG002|Main Period (MP)|Withdrawal by Subject|2|||
125136715|NCT01648582|450126348|FG001|Overall Study|Adverse Event|11|||
125136716|NCT01648582|450126349|FG002|Overall Study|Adverse Event|2|||
125437661|NCT02002884|451229963|FG003|Main Period (MP)|Withdrawal by Subject|0|||
125437662|NCT02002884|451229960|FG000|Main Period (MP)|Lost to Follow-up|0|||
125437663|NCT02002884|451229961|FG001|Main Period (MP)|Lost to Follow-up|0|||
125136717|NCT01648582|450126347|FG000|Overall Study|Lost to Follow-up|9|||
125382709|NCT02111850|451033134|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125382710|NCT02111850|451033135|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125382711|NCT02111850|451033136|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125382712|NCT02111850|451033137|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125382713|NCT02111850|451033138|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125382714|NCT02111850|451033139|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
125382715|NCT00513474|451033140|FG000|Overall Study|Death|6|||
125382716|NCT00513474|451033141|FG001|Overall Study|Death|9|||
125382717|NCT00513474|451033140|FG000|Overall Study|Participant Withdrew Consent|1|||
125382718|NCT00513474|451033141|FG001|Overall Study|Participant Withdrew Consent|0|||
125382719|NCT01853826|451035343|FG000|Overall Study|Patients who switched to commercial drug|11|||
125382720|NCT01853826|451035343|FG000|Overall Study|Patient refused to continue medication|21|||
125382721|NCT01853826|451035343|FG000|Overall Study|Lost to Follow-up|2|||
125382722|NCT01853826|451035343|FG000|Overall Study|Non-compliant with protocol|4|||
125382723|NCT01853826|451035343|FG000|Overall Study|Other adverse events (AE)|62|||
125382724|NCT01853826|451035343|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
125382725|NCT01853826|451035343|FG000|Overall Study|Progressive disease|342|||
125382726|NCT01853826|451035343|FG000|Overall Study|Other than listed|13|||
125382727|NCT01853826|451035343|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
125382728|NCT02081690|451035345|FG000|Overall Study|Death|3|||
125382729|NCT02081690|451035345|FG000|Overall Study|Physician Decision|3|||
125382730|NCT02081690|451035345|FG000|Overall Study|Withdrawal by Subject|1|||
125382731|NCT03204981|451035347|FG000|Overall Study|Physician Decision|2|||
125382732|NCT03204981|451035347|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
125382733|NCT00982488|451035348|FG000|Overall Study|Administrative reason by sponsor|81|||
125382734|NCT00982488|451035349|FG001|Overall Study|Administrative reason by sponsor|3|||
125382735|NCT00982488|451035350|FG002|Overall Study|Administrative reason by sponsor|11|||
125382736|NCT00982488|451035351|FG003|Overall Study|Administrative reason by sponsor|0|||
125382737|NCT00982488|451035352|FG004|Overall Study|Administrative reason by sponsor|0|||
125382738|NCT00982488|451035348|FG000|Overall Study|Adverse event unrelated to study drug|5|||
125382739|NCT00982488|451035349|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125382740|NCT00982488|451035350|FG002|Overall Study|Adverse event unrelated to study drug|0|||
125382741|NCT00982488|451035351|FG003|Overall Study|Adverse event unrelated to study drug|0|||
125382742|NCT00982488|451035352|FG004|Overall Study|Adverse event unrelated to study drug|0|||
125382743|NCT00982488|451035348|FG000|Overall Study|Death|11|||
125382744|NCT00982488|451035349|FG001|Overall Study|Death|0|||
125382745|NCT00982488|451035350|FG002|Overall Study|Death|2|||
125382746|NCT00982488|451035351|FG003|Overall Study|Death|0|||
125382747|NCT00982488|451035352|FG004|Overall Study|Death|0|||
125382748|NCT00982488|451035348|FG000|Overall Study|Disease progression|30|||
125382749|NCT00982488|451035349|FG001|Overall Study|Disease progression|5|||
125382750|NCT00982488|451035350|FG002|Overall Study|Disease progression|10|||
125382751|NCT00982488|451035351|FG003|Overall Study|Disease progression|1|||
125382752|NCT00982488|451035352|FG004|Overall Study|Disease progression|1|||
125382753|NCT00982488|451035348|FG000|Overall Study|Lost to Follow-up|1|||
125382754|NCT00982488|451035349|FG001|Overall Study|Lost to Follow-up|0|||
125382755|NCT00982488|451035350|FG002|Overall Study|Lost to Follow-up|0|||
125382756|NCT00982488|451035351|FG003|Overall Study|Lost to Follow-up|0|||
125382757|NCT00982488|451035352|FG004|Overall Study|Lost to Follow-up|0|||
125382758|NCT00982488|451035348|FG000|Overall Study|Maximum clinical benefit|1|||
125382759|NCT00982488|451035349|FG001|Overall Study|Maximum clinical benefit|1|||
125382760|NCT00982488|451035350|FG002|Overall Study|Maximum clinical benefit|1|||
125382761|NCT00982488|451035351|FG003|Overall Study|Maximum clinical benefit|0|||
125382762|NCT00982488|451035352|FG004|Overall Study|Maximum clinical benefit|0|||
125382763|NCT00982488|451035348|FG000|Overall Study|Other|15|||
125382764|NCT00982488|451035349|FG001|Overall Study|Other|1|||
125382765|NCT00982488|451035350|FG002|Overall Study|Other|3|||
125382766|NCT00982488|451035351|FG003|Overall Study|Other|1|||
125382767|NCT00982488|451035352|FG004|Overall Study|Other|0|||
125382768|NCT00982488|451035348|FG000|Overall Study|Poor compliance/noncompliance|0|||
125382769|NCT00982488|451035349|FG001|Overall Study|Poor compliance/noncompliance|1|||
125382770|NCT00982488|451035350|FG002|Overall Study|Poor compliance/noncompliance|0|||
125136718|NCT01648582|450126348|FG001|Overall Study|Lost to Follow-up|6|||
125382771|NCT00982488|451035351|FG003|Overall Study|Poor compliance/noncompliance|0|||
125382772|NCT00982488|451035352|FG004|Overall Study|Poor compliance/noncompliance|0|||
125382773|NCT00982488|451035348|FG000|Overall Study|Stem cell transplant|2|||
125382774|NCT00982488|451035349|FG001|Overall Study|Stem cell transplant|0|||
125382775|NCT00982488|451035350|FG002|Overall Study|Stem cell transplant|0|||
125382776|NCT00982488|451035351|FG003|Overall Study|Stem cell transplant|1|||
125382777|NCT00982488|451035352|FG004|Overall Study|Stem cell transplant|0|||
125382778|NCT00982488|451035348|FG000|Overall Study|Study drug toxicity|34|||
125382779|NCT00982488|451035349|FG001|Overall Study|Study drug toxicity|1|||
125382780|NCT00982488|451035350|FG002|Overall Study|Study drug toxicity|6|||
125382781|NCT00982488|451035351|FG003|Overall Study|Study drug toxicity|0|||
125220326|NCT00666211|450434423|FG000|Overall Study|Withdrawal by Subject|10|||
125220327|NCT00666211|450434424|FG001|Overall Study|Withdrawal by Subject|13|||
125220328|NCT00666211|450434423|FG000|Overall Study|went off medication, no more pain|1|||
125220329|NCT00666211|450434424|FG001|Overall Study|went off medication, no more pain|0|||
125220330|NCT00666211|450434423|FG000|Overall Study|patient non-compliant|6|||
125220331|NCT00666211|450434424|FG001|Overall Study|patient non-compliant|6|||
125220332|NCT00666211|450434423|FG000|Overall Study|disease progression|1|||
125220333|NCT00666211|450434424|FG001|Overall Study|disease progression|8|||
125220334|NCT00666211|450434423|FG000|Overall Study|Lost to Follow-up|2|||
125220335|NCT00666211|450434424|FG001|Overall Study|Lost to Follow-up|0|||
125220336|NCT00666211|450434423|FG000|Overall Study|toxicity|0|||
125220337|NCT00666211|450434424|FG001|Overall Study|toxicity|2|||
125220338|NCT00666211|450434423|FG000|Overall Study|hospital admission|0|||
125220339|NCT00666211|450434424|FG001|Overall Study|hospital admission|5|||
125220340|NCT00666211|450434423|FG000|Overall Study|Death|0|||
125220341|NCT00666211|450434424|FG001|Overall Study|Death|2|||
125220342|NCT00666211|450434423|FG000|Overall Study|off tx for other complicating disease|0|||
125220343|NCT00666211|450434424|FG001|Overall Study|off tx for other complicating disease|1|||
125220344|NCT00666211|450434423|FG000|Overall Study|Physician Decision|0|||
125220345|NCT00666211|450434424|FG001|Overall Study|Physician Decision|1|||
125220346|NCT02683239|450434425|FG000|Overall Study|Protocol Violation|35|||
125220347|NCT02683239|450434426|FG001|Overall Study|Protocol Violation|23|||
125220348|NCT02683239|450434427|FG002|Overall Study|Protocol Violation|26|||
125220349|NCT02683239|450434428|FG003|Overall Study|Protocol Violation|4|||
125220350|NCT02683239|450434429|FG004|Overall Study|Protocol Violation|35|||
125220351|NCT02683239|450434430|FG005|Overall Study|Protocol Violation|4|||
125220352|NCT02683239|450434431|FG006|Overall Study|Protocol Violation|5|||
125220353|NCT02683239|450434425|FG000|Overall Study|Adverse Event|64|||
125220354|NCT02683239|450434426|FG001|Overall Study|Adverse Event|39|||
125220355|NCT02683239|450434427|FG002|Overall Study|Adverse Event|42|||
125220356|NCT02683239|450434428|FG003|Overall Study|Adverse Event|16|||
125220357|NCT02683239|450434429|FG004|Overall Study|Adverse Event|189|||
125220358|NCT02683239|450434430|FG005|Overall Study|Adverse Event|9|||
125220359|NCT02683239|450434431|FG006|Overall Study|Adverse Event|9|||
125220360|NCT02683239|450434425|FG000|Overall Study|Physician Decision|38|||
125220361|NCT02683239|450434426|FG001|Overall Study|Physician Decision|19|||
125220362|NCT02683239|450434427|FG002|Overall Study|Physician Decision|14|||
125220363|NCT02683239|450434428|FG003|Overall Study|Physician Decision|73|||
125220364|NCT02683239|450434429|FG004|Overall Study|Physician Decision|143|||
125136719|NCT01648582|450126349|FG002|Overall Study|Lost to Follow-up|8|||
125136720|NCT01648582|450126347|FG000|Overall Study|Protocol Violation|1|||
125136721|NCT01648582|450126348|FG001|Overall Study|Protocol Violation|2|||
125136722|NCT01648582|450126349|FG002|Overall Study|Protocol Violation|1|||
125136723|NCT01648582|450126347|FG000|Overall Study|Withdrawal by Subject|15|||
125136724|NCT01648582|450126348|FG001|Overall Study|Withdrawal by Subject|17|||
125136725|NCT01648582|450126349|FG002|Overall Study|Withdrawal by Subject|17|||
125136726|NCT01648582|450126347|FG000|Overall Study|Physician Decision|0|||
125136727|NCT01648582|450126348|FG001|Overall Study|Physician Decision|1|||
125136728|NCT01648582|450126349|FG002|Overall Study|Physician Decision|3|||
125136729|NCT01648582|450126347|FG000|Overall Study|Death|1|||
125136730|NCT01648582|450126348|FG001|Overall Study|Death|0|||
125136731|NCT01648582|450126349|FG002|Overall Study|Death|0|||
125136732|NCT01648582|450126347|FG000|Overall Study|Sponsor Decision|0|||
125136733|NCT01648582|450126348|FG001|Overall Study|Sponsor Decision|1|||
125136734|NCT01648582|450126349|FG002|Overall Study|Sponsor Decision|1|||
125136735|NCT02699866|450126350|FG000|Overall Study|Withdrawal by Subject|3|||
125136736|NCT02699866|450126350|FG000|Overall Study|Physician Decision|2|||
125136737|NCT02699866|450126350|FG000|Overall Study|Adverse Event|3|||
125136738|NCT01959672|450126351|FG000|Overall Study|Death|1|||
125136739|NCT01058668|450126352|FG000|Double-blind Treatment Phase|Adverse Event|8|||
125136740|NCT01058668|450126353|FG001|Double-blind Treatment Phase|Adverse Event|15|||
125136741|NCT01058668|450126354|FG002|Double-blind Treatment Phase|Adverse Event|25|||
125136742|NCT01058668|450126352|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
125136743|NCT01058668|450126353|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
125136744|NCT01058668|450126354|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
125136745|NCT01058668|450126352|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
125136746|NCT01058668|450126353|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
125136747|NCT01058668|450126354|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
125220365|NCT02683239|450434430|FG005|Overall Study|Physician Decision|14|||
125220366|NCT02683239|450434431|FG006|Overall Study|Physician Decision|15|||
125220367|NCT02683239|450434425|FG000|Overall Study|Withdrawal by Subject|187|||
125220368|NCT02683239|450434426|FG001|Overall Study|Withdrawal by Subject|99|||
125136748|NCT01058668|450126352|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
125136749|NCT01058668|450126353|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
125136750|NCT01058668|450126354|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
125136751|NCT01058668|450126352|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
125220369|NCT02683239|450434427|FG002|Overall Study|Withdrawal by Subject|91|||
125220370|NCT02683239|450434428|FG003|Overall Study|Withdrawal by Subject|18|||
125220371|NCT02683239|450434429|FG004|Overall Study|Withdrawal by Subject|248|||
125220372|NCT02683239|450434430|FG005|Overall Study|Withdrawal by Subject|22|||
125220373|NCT02683239|450434431|FG006|Overall Study|Withdrawal by Subject|28|||
125220374|NCT02683239|450434425|FG000|Overall Study|Lost to Follow-up|77|||
125220375|NCT02683239|450434426|FG001|Overall Study|Lost to Follow-up|24|||
125220376|NCT02683239|450434427|FG002|Overall Study|Lost to Follow-up|25|||
125220377|NCT02683239|450434428|FG003|Overall Study|Lost to Follow-up|7|||
125220378|NCT02683239|450434429|FG004|Overall Study|Lost to Follow-up|88|||
125220379|NCT02683239|450434430|FG005|Overall Study|Lost to Follow-up|8|||
125220380|NCT02683239|450434431|FG006|Overall Study|Lost to Follow-up|11|||
125220381|NCT02683239|450434425|FG000|Overall Study|Death|9|||
125220382|NCT02683239|450434426|FG001|Overall Study|Death|5|||
125136752|NCT01058668|450126353|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
125136753|NCT01058668|450126354|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
125136754|NCT01058668|450126352|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
125136755|NCT01058668|450126353|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
125136756|NCT01058668|450126354|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
125220383|NCT02683239|450434427|FG002|Overall Study|Death|8|||
125220384|NCT02683239|450434428|FG003|Overall Study|Death|0|||
125220385|NCT02683239|450434429|FG004|Overall Study|Death|12|||
125220386|NCT02683239|450434430|FG005|Overall Study|Death|1|||
125220387|NCT02683239|450434431|FG006|Overall Study|Death|0|||
125382782|NCT00982488|451035352|FG004|Overall Study|Study drug toxicity|0|||
125382783|NCT00982488|451035348|FG000|Overall Study|Withdrawal by Subject|5|||
125382784|NCT00982488|451035349|FG001|Overall Study|Withdrawal by Subject|1|||
125382785|NCT00982488|451035350|FG002|Overall Study|Withdrawal by Subject|1|||
125382786|NCT00982488|451035351|FG003|Overall Study|Withdrawal by Subject|0|||
125382787|NCT00982488|451035352|FG004|Overall Study|Withdrawal by Subject|0|||
125382788|NCT00397982|451035356|FG000|Overall Study|Withdrawal by Subject|1|||
125382789|NCT00397982|451035356|FG000|Overall Study|Adverse Event|1|||
125382790|NCT00397982|451035356|FG000|Overall Study|noncompliance|1|||
125382791|NCT00397982|451035356|FG000|Overall Study|Unrelated health issues|1|||
125382792|NCT04244786|451035357|FG000|Overall Study|Adverse Event|0|||
125382793|NCT04244786|451035358|FG001|Overall Study|Adverse Event|0|||
125382794|NCT04244786|451035359|FG002|Overall Study|Adverse Event|2|||
125382795|NCT04244786|451035357|FG000|Overall Study|Withdrawal by Subject|0|||
125382796|NCT04244786|451035358|FG001|Overall Study|Withdrawal by Subject|0|||
125382797|NCT04244786|451035359|FG002|Overall Study|Withdrawal by Subject|5|||
125382798|NCT00613938|451035366|FG000|Overall Study|Withdrawal by Subject|2|||
125382799|NCT00613938|451035367|FG001|Overall Study|Withdrawal by Subject|4|||
125382800|NCT00613938|451035368|FG002|Overall Study|Withdrawal by Subject|9|||
125382801|NCT00613938|451035369|FG003|Overall Study|Withdrawal by Subject|9|||
125382802|NCT00613938|451035366|FG000|Overall Study|Adverse Event|1|||
125382803|NCT00613938|451035367|FG001|Overall Study|Adverse Event|4|||
125382804|NCT00613938|451035368|FG002|Overall Study|Adverse Event|8|||
125382805|NCT00613938|451035369|FG003|Overall Study|Adverse Event|5|||
125382806|NCT00613938|451035366|FG000|Overall Study|Lack of Efficacy|16|||
125382807|NCT00613938|451035367|FG001|Overall Study|Lack of Efficacy|18|||
125382808|NCT00613938|451035368|FG002|Overall Study|Lack of Efficacy|5|||
125382809|NCT00613938|451035369|FG003|Overall Study|Lack of Efficacy|9|||
125382810|NCT00613938|451035366|FG000|Overall Study|Other|1|||
125382811|NCT00613938|451035367|FG001|Overall Study|Other|2|||
125382812|NCT00613938|451035368|FG002|Overall Study|Other|1|||
125382813|NCT00613938|451035369|FG003|Overall Study|Other|3|||
125382814|NCT02636868|451035370|FG000|Overall Study|Death|0|||
125382815|NCT02636868|451035371|FG001|Overall Study|Death|1|||
125382816|NCT02636868|451035372|FG002|Overall Study|Death|2|||
125382817|NCT03220217|451035373|FG000|Overall Study|Withdrawal by Subject|0|||
125382818|NCT03220217|451035374|FG001|Overall Study|Withdrawal by Subject|1|||
125382819|NCT03220217|451035375|FG002|Overall Study|Withdrawal by Subject|0|||
125382820|NCT03220217|451035373|FG000|Overall Study|Subject Missed Procedure|0|||
125382821|NCT03220217|451035374|FG001|Overall Study|Subject Missed Procedure|0|||
125382822|NCT03220217|451035375|FG002|Overall Study|Subject Missed Procedure|1|||
125382823|NCT03025542|451035376|FG000|Overall Study|Adverse Event|0|||
125136757|NCT02842853|450126363|FG000|Overall Study|Non-compliance with the protocol|3|||
125136758|NCT02842853|450126364|FG001|Overall Study|Non-compliance with the protocol|7|||
125136759|NCT02842853|450126365|FG002|Overall Study|Non-compliance with the protocol|2|||
125136760|NCT02842853|450126366|FG003|Overall Study|Non-compliance with the protocol|5|||
125136761|NCT02842853|450126363|FG000|Overall Study|Subject met exclusion criteria|0|||
125136762|NCT02842853|450126364|FG001|Overall Study|Subject met exclusion criteria|1|||
125136763|NCT02842853|450126365|FG002|Overall Study|Subject met exclusion criteria|0|||
125136764|NCT02842853|450126366|FG003|Overall Study|Subject met exclusion criteria|0|||
125220388|NCT02683239|450434425|FG000|Overall Study|Lack of Efficacy|50|||
125220389|NCT02683239|450434426|FG001|Overall Study|Lack of Efficacy|23|||
125220390|NCT02683239|450434427|FG002|Overall Study|Lack of Efficacy|12|||
125220391|NCT02683239|450434428|FG003|Overall Study|Lack of Efficacy|2|||
125220392|NCT02683239|450434429|FG004|Overall Study|Lack of Efficacy|29|||
125220393|NCT02683239|450434430|FG005|Overall Study|Lack of Efficacy|2|||
125220394|NCT02683239|450434431|FG006|Overall Study|Lack of Efficacy|3|||
125220395|NCT02683239|450434425|FG000|Overall Study|Missing data|0|||
125220396|NCT02683239|450434426|FG001|Overall Study|Missing data|1|||
125220397|NCT02683239|450434427|FG002|Overall Study|Missing data|1|||
125220398|NCT02683239|450434428|FG003|Overall Study|Missing data|0|||
125220399|NCT02683239|450434429|FG004|Overall Study|Missing data|1|||
125220400|NCT02683239|450434430|FG005|Overall Study|Missing data|0|||
125220401|NCT02683239|450434431|FG006|Overall Study|Missing data|0|||
125220402|NCT02609386|450434434|FG000|Overall Study|Withdrawal by Subject|6|||
125220403|NCT02609386|450434435|FG001|Overall Study|Withdrawal by Subject|1|||
125220404|NCT02609386|450434434|FG000|Overall Study|Lost to Follow-up|3|||
125220405|NCT02609386|450434435|FG001|Overall Study|Lost to Follow-up|5|||
125220406|NCT02609386|450434434|FG000|Overall Study|Death|19|||
125220407|NCT02609386|450434435|FG001|Overall Study|Death|9|||
125220408|NCT02609386|450434434|FG000|Overall Study|Physician Decision|0|||
125220409|NCT02609386|450434435|FG001|Overall Study|Physician Decision|2|||
125220410|NCT04131712|450434436|FG000|Overall Study|COVID related|0|||
125220411|NCT04131712|450434437|FG001|Overall Study|COVID related|0|||
125220412|NCT04131712|450434438|FG002|Overall Study|COVID related|2|||
125220413|NCT04131712|450434439|FG003|Overall Study|COVID related|0|||
125220414|NCT04131712|450434436|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
125220415|NCT04131712|450434437|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
125220416|NCT04131712|450434438|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
125220417|NCT04131712|450434439|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
125220418|NCT00873730|450434440|FG000|Overall Study|Protocol Deviation|5|||
125220419|NCT00873730|450434441|FG001|Overall Study|Protocol Deviation|2|||
125220420|NCT00873730|450434440|FG000|Overall Study|Adverse Event|0|||
125220421|NCT00873730|450434441|FG001|Overall Study|Adverse Event|2|||
125220422|NCT00873730|450434440|FG000|Overall Study|Withdrawal by Subject|0|||
125220423|NCT00873730|450434441|FG001|Overall Study|Withdrawal by Subject|1|||
125382824|NCT03025542|451035377|FG001|Overall Study|Adverse Event|2|||
125382825|NCT03025542|451035376|FG000|Overall Study|Lost to Follow-up|1|||
125382826|NCT03025542|451035377|FG001|Overall Study|Lost to Follow-up|0|||
125220424|NCT00873730|450434440|FG000|Overall Study|Sponsor decision|1|||
125220425|NCT00873730|450434441|FG001|Overall Study|Sponsor decision|0|||
125136765|NCT02842853|450126363|FG000|Overall Study|Withdrawal by Subject|11|||
125136766|NCT02842853|450126364|FG001|Overall Study|Withdrawal by Subject|13|||
125136767|NCT02842853|450126365|FG002|Overall Study|Withdrawal by Subject|9|||
125136768|NCT02842853|450126366|FG003|Overall Study|Withdrawal by Subject|8|||
125136769|NCT02842853|450126363|FG000|Overall Study|Lost to Follow-up|9|||
125136770|NCT02842853|450126364|FG001|Overall Study|Lost to Follow-up|13|||
125136771|NCT02842853|450126365|FG002|Overall Study|Lost to Follow-up|10|||
125136772|NCT02842853|450126366|FG003|Overall Study|Lost to Follow-up|11|||
125136773|NCT04089553|450126367|FG000|Overall Study|Death|1|||
125136774|NCT04089553|450126368|FG001|Overall Study|Death|1|||
125136775|NCT04089553|450126367|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
125136776|NCT04089553|450126368|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
125136777|NCT04089553|450126367|FG000|Overall Study|Withdrawal by Subject|3|||
125136778|NCT04089553|450126368|FG001|Overall Study|Withdrawal by Subject|3|||
125136779|NCT04089553|450126367|FG000|Overall Study|Physician Decision|1|||
125136780|NCT04089553|450126368|FG001|Overall Study|Physician Decision|0|||
125136781|NCT04089553|450126367|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
125136782|NCT04089553|450126368|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
125136783|NCT04089553|450126367|FG000|Overall Study|Other|1|||
125136784|NCT04089553|450126368|FG001|Overall Study|Other|0|||
125136785|NCT04089553|450126367|FG000|Overall Study|Adverse Event|1|||
125136786|NCT04089553|450126368|FG001|Overall Study|Adverse Event|1|||
125136787|NCT01403194|450126369|FG000|Overall Study|Screen Failure|2|||
125136788|NCT01403194|450126369|FG000|Overall Study|Lost to Follow-up|8|||
125136789|NCT01808651|450126379|FG000|Study Period 1|Lost to Follow-up|1|||
125136790|NCT01808651|450126380|FG001|Study Period 1|Lost to Follow-up|3|||
125136791|NCT01808651|450126381|FG002|Study Period 1|Lost to Follow-up|0|||
125136792|NCT01808651|450126379|FG000|Study Period 1|Protocol Violation|1|||
125136793|NCT01808651|450126380|FG001|Study Period 1|Protocol Violation|0|||
125136794|NCT01808651|450126381|FG002|Study Period 1|Protocol Violation|1|||
125136795|NCT01808651|450126379|FG000|Study Period 1|Physician Decision|3|||
125136796|NCT01808651|450126380|FG001|Study Period 1|Physician Decision|2|||
125136797|NCT01808651|450126381|FG002|Study Period 1|Physician Decision|0|||
125136798|NCT01808651|450126379|FG000|Study Period 1|Lack of Efficacy|2|||
125136799|NCT01808651|450126380|FG001|Study Period 1|Lack of Efficacy|1|||
125136800|NCT01808651|450126381|FG002|Study Period 1|Lack of Efficacy|0|||
125136801|NCT01808651|450126379|FG000|Study Period 1|Adverse Event|10|||
125136802|NCT01808651|450126380|FG001|Study Period 1|Adverse Event|4|||
125136803|NCT01808651|450126381|FG002|Study Period 1|Adverse Event|1|||
125136804|NCT01808651|450126379|FG000|Study Period 1|Participant Decision|9|||
125136805|NCT01808651|450126380|FG001|Study Period 1|Participant Decision|7|||
125136806|NCT01808651|450126381|FG002|Study Period 1|Participant Decision|3|||
125136807|NCT00608322|450126384|FG000|Overall Study|Death|2|||
125136808|NCT00608322|450126385|FG001|Overall Study|Death|1|||
125136809|NCT00834444|450126386|FG000|First Intervention|Adverse Event|1|||
125136810|NCT00834444|450126387|FG001|First Intervention|Adverse Event|0|||
125136811|NCT00834444|450126386|FG000|First Intervention|Intolerance to Venopuncture|0|||
125136812|NCT00834444|450126387|FG001|First Intervention|Intolerance to Venopuncture|1|||
125136813|NCT00834444|450126386|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
125136814|NCT00834444|450126387|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
125136815|NCT00834444|450126386|FG000|Second Intervention|Adverse Event|1|||
125136816|NCT00834444|450126387|FG001|Second Intervention|Adverse Event|0|||
125136817|NCT03325881|450126390|FG000|Overall Study|Protocol Violation|0|||
125136818|NCT03325881|450126391|FG001|Overall Study|Protocol Violation|1|||
125136819|NCT03325881|450126390|FG000|Overall Study|Withdrawal by Subject|0|||
125136820|NCT03325881|450126391|FG001|Overall Study|Withdrawal by Subject|2|||
125136821|NCT03325881|450126390|FG000|Overall Study|Lack of Efficacy|2|||
125136822|NCT03325881|450126391|FG001|Overall Study|Lack of Efficacy|0|||
125136823|NCT03325881|450126390|FG000|Overall Study|Not treated|1|||
125136824|NCT03325881|450126391|FG001|Overall Study|Not treated|0|||
125136825|NCT00829712|450126396|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
125136826|NCT00829712|450126397|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
125136827|NCT00606281|450126398|FG000|Overall Study|Adverse Event|11|||
125136828|NCT00606281|450126399|FG001|Overall Study|Adverse Event|12|||
125136829|NCT00606281|450126398|FG000|Overall Study|Death|1|||
125136830|NCT00606281|450126399|FG001|Overall Study|Death|0|||
125136831|NCT00606281|450126398|FG000|Overall Study|Lack of Efficacy|28|||
125136832|NCT00606281|450126399|FG001|Overall Study|Lack of Efficacy|35|||
125136833|NCT00606281|450126398|FG000|Overall Study|Physician Decision|0|||
125136834|NCT00606281|450126399|FG001|Overall Study|Physician Decision|1|||
125136835|NCT00606281|450126398|FG000|Overall Study|Protocol Violation|3|||
125220426|NCT02299388|450434444|FG000|Overall Study|Withdrawal by Subject|0|||
125220427|NCT02299388|450434445|FG001|Overall Study|Withdrawal by Subject|1|||
125220428|NCT00103662|450434446|FG000|Overall Study|Entered Rescue Procedure|0|||
125136836|NCT00606281|450126399|FG001|Overall Study|Protocol Violation|3|||
125136837|NCT00606281|450126398|FG000|Overall Study|Withdrawal by Subject|11|||
125136838|NCT00606281|450126399|FG001|Overall Study|Withdrawal by Subject|13|||
125136839|NCT00606281|450126398|FG000|Overall Study|Progression to depressive phase|1|||
125136840|NCT00606281|450126399|FG001|Overall Study|Progression to depressive phase|1|||
125136841|NCT00606281|450126398|FG000|Overall Study|Change of residence or other commitments|1|||
125136842|NCT00606281|450126399|FG001|Overall Study|Change of residence or other commitments|1|||
125136843|NCT02294981|450126400|FG000|Overall Study|Lost to Follow-up|1|||
125220429|NCT00103662|450434447|FG001|Overall Study|Entered Rescue Procedure|7|||
125220430|NCT00103662|450434446|FG000|Overall Study|Death|7|||
125136844|NCT02213263|450126404|FG000|Overall Study|Insufficient clinical response|4|||
125136845|NCT02213263|450126405|FG001|Overall Study|Insufficient clinical response|3|||
125136846|NCT02213263|450126404|FG000|Overall Study|Lost to Follow-up|0|||
125382827|NCT03025542|451035376|FG000|Overall Study|Withdrawal by Subject|1|||
125382828|NCT03025542|451035377|FG001|Overall Study|Withdrawal by Subject|0|||
125136847|NCT02213263|450126405|FG001|Overall Study|Lost to Follow-up|1|||
125136848|NCT02213263|450126404|FG000|Overall Study|No longer willing to participate|3|||
125136849|NCT02213263|450126405|FG001|Overall Study|No longer willing to participate|4|||
125136850|NCT02213263|450126404|FG000|Overall Study|Progressive disease|20|||
125136851|NCT02213263|450126405|FG001|Overall Study|Progressive disease|14|||
125136852|NCT02213263|450126404|FG000|Overall Study|Protocol Violation|0|||
125136853|NCT02213263|450126405|FG001|Overall Study|Protocol Violation|1|||
125136854|NCT02213263|450126404|FG000|Overall Study|Adverse Event|1|||
125136855|NCT02213263|450126405|FG001|Overall Study|Adverse Event|3|||
125136856|NCT05752721|450126406|FG000|Overall Study|Lost to Follow-up|22|||
125136857|NCT05752721|450126407|FG001|Overall Study|Lost to Follow-up|20|||
125136858|NCT05752721|450126406|FG000|Overall Study|Withdrawal by Subject|15|||
125136859|NCT05752721|450126407|FG001|Overall Study|Withdrawal by Subject|12|||
125136860|NCT01188681|450126408|FG000|Overall Study|bladder cancer|0|||
125136861|NCT01188681|450126409|FG001|Overall Study|bladder cancer|0|||
125136862|NCT01188681|450126410|FG002|Overall Study|bladder cancer|1|||
125136863|NCT01188681|450126411|FG003|Overall Study|bladder cancer|0|||
125136864|NCT01188681|450126408|FG000|Overall Study|Withdrawal by Subject|0|||
125136865|NCT01188681|450126409|FG001|Overall Study|Withdrawal by Subject|0|||
125136866|NCT01188681|450126410|FG002|Overall Study|Withdrawal by Subject|0|||
125136867|NCT01188681|450126411|FG003|Overall Study|Withdrawal by Subject|1|||
125136868|NCT02280863|450126412|FG000|Integrated Platform|Met stopping criteria|0|||
125136869|NCT02280863|450126413|FG001|Integrated Platform|Met stopping criteria|1|||
125136870|NCT03236311|450126414|FG000|Overall Study|Study terminated by sponsor|0|||
125136871|NCT03236311|450126415|FG001|Overall Study|Study terminated by sponsor|2|||
125136872|NCT03236311|450126414|FG000|Overall Study|Adverse Event|0|||
125136873|NCT03236311|450126415|FG001|Overall Study|Adverse Event|1|||
125136874|NCT00909753|450126416|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
125136875|NCT00909753|450126417|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
125136876|NCT00909753|450126416|FG000|Period: Second Intervention|Protocol Violation|1|||
125136877|NCT00909753|450126417|FG001|Period: Second Intervention|Protocol Violation|0|||
125136878|NCT02336074|450126420|FG000|Overall Study|Adverse Event|0|||
125136879|NCT02336074|450126421|FG001|Overall Study|Adverse Event|2|||
125136880|NCT02679729|450126422|FG000|Overall Study|Lost to Follow-up|0|||
125136881|NCT02679729|450126423|FG001|Overall Study|Lost to Follow-up|1|||
125136882|NCT02679729|450126424|FG002|Overall Study|Lost to Follow-up|0|||
125136883|NCT02679729|450126425|FG003|Overall Study|Lost to Follow-up|0|||
125136884|NCT02679729|450126426|FG004|Overall Study|Lost to Follow-up|1|||
125136885|NCT02679729|450126427|FG005|Overall Study|Lost to Follow-up|0|||
125136886|NCT02679729|450126428|FG006|Overall Study|Lost to Follow-up|0|||
125136887|NCT02679729|450126429|FG007|Overall Study|Lost to Follow-up|0|||
125136888|NCT02679729|450126430|FG008|Overall Study|Lost to Follow-up|0|||
125136889|NCT02679729|450126422|FG000|Overall Study|Participant decision|0|||
125136890|NCT02679729|450126423|FG001|Overall Study|Participant decision|1|||
125136891|NCT02679729|450126424|FG002|Overall Study|Participant decision|0|||
125136892|NCT02679729|450126425|FG003|Overall Study|Participant decision|0|||
125136893|NCT02679729|450126426|FG004|Overall Study|Participant decision|0|||
125136894|NCT02679729|450126427|FG005|Overall Study|Participant decision|0|||
125136895|NCT02679729|450126428|FG006|Overall Study|Participant decision|1|||
125136896|NCT02679729|450126429|FG007|Overall Study|Participant decision|0|||
125136897|NCT02679729|450126430|FG008|Overall Study|Participant decision|0|||
125136898|NCT00906399|450126432|FG000|Year 1|Randomized But Not Treated|0|||
125136899|NCT00906399|450126433|FG001|Year 1|Randomized But Not Treated|1|||
125136900|NCT00906399|450126434|FG002|Year 1|Randomized But Not Treated|3|||
125136901|NCT00906399|450126435|FG003|Year 1|Randomized But Not Treated|0|||
125136902|NCT00906399|450126436|FG004|Year 1|Randomized But Not Treated|0|||
125136903|NCT00906399|450126437|FG005|Year 1|Randomized But Not Treated|0|||
125136904|NCT00906399|450126438|FG006|Year 1|Randomized But Not Treated|0|||
125136905|NCT00906399|450126432|FG000|Year 1|Adverse Event|4|||
125136906|NCT00906399|450126433|FG001|Year 1|Adverse Event|22|||
125136907|NCT00906399|450126434|FG002|Year 1|Adverse Event|24|||
125136908|NCT00906399|450126435|FG003|Year 1|Adverse Event|0|||
125136909|NCT00906399|450126436|FG004|Year 1|Adverse Event|0|||
125136910|NCT00906399|450126437|FG005|Year 1|Adverse Event|0|||
125136911|NCT00906399|450126438|FG006|Year 1|Adverse Event|0|||
125136912|NCT00906399|450126432|FG000|Year 1|Lost to Follow-up|4|||
125136913|NCT00906399|450126433|FG001|Year 1|Lost to Follow-up|4|||
125136914|NCT00906399|450126434|FG002|Year 1|Lost to Follow-up|2|||
125136915|NCT00906399|450126435|FG003|Year 1|Lost to Follow-up|0|||
125136916|NCT00906399|450126436|FG004|Year 1|Lost to Follow-up|0|||
125136917|NCT00906399|450126437|FG005|Year 1|Lost to Follow-up|0|||
125136918|NCT00906399|450126438|FG006|Year 1|Lost to Follow-up|0|||
125136919|NCT00906399|450126432|FG000|Year 1|Withdrawal by Subject|30|||
125136920|NCT00906399|450126433|FG001|Year 1|Withdrawal by Subject|32|||
125136921|NCT00906399|450126434|FG002|Year 1|Withdrawal by Subject|36|||
125136922|NCT00906399|450126435|FG003|Year 1|Withdrawal by Subject|0|||
125136923|NCT00906399|450126436|FG004|Year 1|Withdrawal by Subject|0|||
125136924|NCT00906399|450126437|FG005|Year 1|Withdrawal by Subject|0|||
125136925|NCT00906399|450126438|FG006|Year 1|Withdrawal by Subject|0|||
125136926|NCT00906399|450126432|FG000|Year 1|Physician Decision|0|||
125136927|NCT00906399|450126433|FG001|Year 1|Physician Decision|1|||
125136928|NCT00906399|450126434|FG002|Year 1|Physician Decision|3|||
125136929|NCT00906399|450126435|FG003|Year 1|Physician Decision|0|||
125136930|NCT00906399|450126436|FG004|Year 1|Physician Decision|0|||
125136931|NCT00906399|450126437|FG005|Year 1|Physician Decision|0|||
125136932|NCT00906399|450126438|FG006|Year 1|Physician Decision|0|||
125136933|NCT00906399|450126432|FG000|Year 1|Death|2|||
125136934|NCT00906399|450126433|FG001|Year 1|Death|1|||
125136935|NCT00906399|450126434|FG002|Year 1|Death|1|||
125136936|NCT00906399|450126435|FG003|Year 1|Death|0|||
125136937|NCT00906399|450126436|FG004|Year 1|Death|0|||
125136938|NCT00906399|450126437|FG005|Year 1|Death|0|||
125136939|NCT00906399|450126438|FG006|Year 1|Death|0|||
125136940|NCT00906399|450126432|FG000|Year 1|Other|4|||
125136941|NCT00906399|450126433|FG001|Year 1|Other|2|||
125136942|NCT00906399|450126434|FG002|Year 1|Other|7|||
125136943|NCT00906399|450126435|FG003|Year 1|Other|0|||
125136944|NCT00906399|450126436|FG004|Year 1|Other|0|||
125136945|NCT00906399|450126437|FG005|Year 1|Other|0|||
125136946|NCT00906399|450126438|FG006|Year 1|Other|0|||
125485459|NCT02240238|451412513|FG010|Phase 2|Physician Decision|3|||
125136947|NCT00906399|450126432|FG000|Year 2|Adverse Event|0|||
125136948|NCT00906399|450126433|FG001|Year 2|Adverse Event|0|||
125136949|NCT00906399|450126434|FG002|Year 2|Adverse Event|0|||
125382829|NCT03745937|451035378|FG000|Overall Study|Withdrawal by Subject|0|||
125382830|NCT03745937|451035379|FG001|Overall Study|Withdrawal by Subject|0|||
125136950|NCT00906399|450126435|FG003|Year 2|Adverse Event|9|||
125136951|NCT00906399|450126436|FG004|Year 2|Adverse Event|8|||
125136952|NCT00906399|450126437|FG005|Year 2|Adverse Event|11|||
125136953|NCT00906399|450126438|FG006|Year 2|Adverse Event|6|||
125136954|NCT00906399|450126432|FG000|Year 2|Lost to Follow-up|0|||
125136955|NCT00906399|450126433|FG001|Year 2|Lost to Follow-up|0|||
125136956|NCT00906399|450126434|FG002|Year 2|Lost to Follow-up|0|||
125136957|NCT00906399|450126435|FG003|Year 2|Lost to Follow-up|1|||
125136958|NCT00906399|450126436|FG004|Year 2|Lost to Follow-up|4|||
125136959|NCT00906399|450126437|FG005|Year 2|Lost to Follow-up|2|||
125136960|NCT00906399|450126438|FG006|Year 2|Lost to Follow-up|4|||
125136961|NCT00906399|450126432|FG000|Year 2|Withdrawal by Subject|0|||
125136962|NCT00906399|450126433|FG001|Year 2|Withdrawal by Subject|0|||
125220431|NCT00103662|450434447|FG001|Overall Study|Death|7|||
125220432|NCT00103662|450434446|FG000|Overall Study|Elective Withdrawal|5|||
125220433|NCT00103662|450434447|FG001|Overall Study|Elective Withdrawal|5|||
125220434|NCT00103662|450434446|FG000|Overall Study|Lost to Follow-up|0|||
125220435|NCT00103662|450434447|FG001|Overall Study|Lost to Follow-up|1|||
125220436|NCT00103662|450434446|FG000|Overall Study|Other|6|||
125220437|NCT00103662|450434447|FG001|Overall Study|Other|9|||
125220438|NCT00103662|450434446|FG000|Overall Study|Failed mobilization|0|||
125220439|NCT00103662|450434447|FG001|Overall Study|Failed mobilization|4|||
125220440|NCT00103662|450434446|FG000|Overall Study|Intercurrent illness|1|||
125220441|NCT00103662|450434447|FG001|Overall Study|Intercurrent illness|0|||
125220442|NCT03334188|450434451|FG000|Overall Study|Withdrawal by Subject|0|||
125220443|NCT03334188|450434452|FG001|Overall Study|Withdrawal by Subject|1|||
125220444|NCT03334188|450434451|FG000|Overall Study|Death|1|||
125220445|NCT03334188|450434452|FG001|Overall Study|Death|0|||
125220446|NCT03334188|450434451|FG000|Overall Study|Never had qualifying clinic visit|7|||
125220447|NCT03334188|450434452|FG001|Overall Study|Never had qualifying clinic visit|7|||
125220448|NCT03373760|450434453|FG000|Overall Study|Adverse Event|8|||
125220449|NCT03373760|450434453|FG000|Overall Study|Disease Progression|46|||
125220450|NCT03373760|450434453|FG000|Overall Study|Death|4|||
125220451|NCT01093586|450434456|FG000|Overall Study|Failed to engraft|3|||
125220452|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
125220453|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
125220454|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
125220455|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
125220456|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
125220457|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
125382831|NCT03745937|451035380|FG002|Overall Study|Withdrawal by Subject|0|||
125382832|NCT03745937|451035381|FG003|Overall Study|Withdrawal by Subject|1|||
125382833|NCT03745937|451035378|FG000|Overall Study|Not-specifed|0|||
125382834|NCT03745937|451035379|FG001|Overall Study|Not-specifed|1|||
125382835|NCT03745937|451035380|FG002|Overall Study|Not-specifed|0|||
125382836|NCT03745937|451035381|FG003|Overall Study|Not-specifed|1|||
125136963|NCT00906399|450126434|FG002|Year 2|Withdrawal by Subject|0|||
125136964|NCT00906399|450126435|FG003|Year 2|Withdrawal by Subject|17|||
125136965|NCT00906399|450126436|FG004|Year 2|Withdrawal by Subject|18|||
125220458|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
125220459|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
125382837|NCT00488345|451035384|FG000|Overall Study|Adverse Event|0|||
125382838|NCT00488345|451035385|FG001|Overall Study|Adverse Event|1|||
125382839|NCT00488345|451035386|FG002|Overall Study|Adverse Event|1|||
125136966|NCT00906399|450126437|FG005|Year 2|Withdrawal by Subject|27|||
125220460|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
125220461|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
125136967|NCT00906399|450126438|FG006|Year 2|Withdrawal by Subject|13|||
125136968|NCT00906399|450126432|FG000|Year 2|Physician Decision|0|||
125136969|NCT00906399|450126433|FG001|Year 2|Physician Decision|0|||
125136970|NCT00906399|450126434|FG002|Year 2|Physician Decision|0|||
125136971|NCT00906399|450126435|FG003|Year 2|Physician Decision|0|||
125136972|NCT00906399|450126436|FG004|Year 2|Physician Decision|2|||
125220462|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
125382840|NCT00488345|451035384|FG000|Overall Study|Unable to administer antibiotics at home|0|||
125382841|NCT00488345|451035385|FG001|Overall Study|Unable to administer antibiotics at home|1|||
125382842|NCT00488345|451035386|FG002|Overall Study|Unable to administer antibiotics at home|0|||
125220463|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
125220464|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
125382843|NCT00488345|451035384|FG000|Overall Study|Institutional Review Board review|0|||
125136973|NCT00906399|450126437|FG005|Year 2|Physician Decision|6|||
125136974|NCT00906399|450126438|FG006|Year 2|Physician Decision|3|||
125136975|NCT00906399|450126432|FG000|Year 2|Death|0|||
125136976|NCT00906399|450126433|FG001|Year 2|Death|0|||
125136977|NCT00906399|450126434|FG002|Year 2|Death|0|||
125136978|NCT00906399|450126435|FG003|Year 2|Death|1|||
125136979|NCT00906399|450126436|FG004|Year 2|Death|0|||
125136980|NCT00906399|450126437|FG005|Year 2|Death|0|||
125136981|NCT00906399|450126438|FG006|Year 2|Death|3|||
125136982|NCT00906399|450126432|FG000|Year 2|Other|0|||
125136983|NCT00906399|450126433|FG001|Year 2|Other|0|||
125136984|NCT00906399|450126434|FG002|Year 2|Other|0|||
125136985|NCT00906399|450126435|FG003|Year 2|Other|2|||
125136986|NCT00906399|450126436|FG004|Year 2|Other|3|||
125136987|NCT00906399|450126437|FG005|Year 2|Other|1|||
125136988|NCT00906399|450126438|FG006|Year 2|Other|0|||
125220465|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
125136989|NCT00574847|450126444|FG000|Overall Study|Adverse Event|2|||
125220466|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Death|1|||
125220467|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Death|0|||
125220468|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
125220469|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
125220470|NCT00105989|450434457|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
125220471|NCT00105989|450434458|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
125220472|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
125220473|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
125220474|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
125220475|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
125136990|NCT00574847|450126445|FG001|Overall Study|Adverse Event|0|||
125136991|NCT00574847|450126444|FG000|Overall Study|Death|1|||
125136992|NCT00574847|450126445|FG001|Overall Study|Death|0|||
125136993|NCT00574847|450126444|FG000|Overall Study|Withdrawal by Subject|2|||
125136994|NCT00574847|450126445|FG001|Overall Study|Withdrawal by Subject|2|||
125136995|NCT00574847|450126444|FG000|Overall Study|Physician Decision|1|||
125136996|NCT00574847|450126445|FG001|Overall Study|Physician Decision|0|||
125136997|NCT00574847|450126444|FG000|Overall Study|Did not receive medication (declined)|2|||
125220476|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
125220477|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
125220478|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
125220479|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
125220480|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
125220481|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
125220482|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
125220483|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
125220484|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
125220485|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
125220486|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Death|0|||
125220487|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Death|0|||
125220488|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
125220489|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
125220490|NCT00105989|450434457|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
125220491|NCT00105989|450434458|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
125220492|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
125220493|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
125220494|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
125220495|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
125220496|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
125220497|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
125220498|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
125220499|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
125220500|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
125220501|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
125220502|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
125220503|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
125220504|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
125220505|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
125220506|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
125220507|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
125220508|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
125220509|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
125220510|NCT00105989|450434457|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
125220511|NCT00105989|450434458|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
125220512|NCT03442088|450434459|FG000|Overall Study|Adverse Event|1|||
125220513|NCT03442088|450434459|FG000|Overall Study|Lack of Efficacy|2|||
125220514|NCT03442088|450434459|FG000|Overall Study|Lost to Follow-up|2|||
125220515|NCT00357877|450434460|FG000|Overall Study|Death|2|||
125220516|NCT00357877|450434461|FG001|Overall Study|Death|1|||
125220517|NCT00357877|450434460|FG000|Overall Study|Lost to Follow-up|20|||
125220518|NCT00357877|450434461|FG001|Overall Study|Lost to Follow-up|23|||
125220519|NCT00357877|450434460|FG000|Overall Study|Withdrawal by Subject|3|||
125220520|NCT00357877|450434461|FG001|Overall Study|Withdrawal by Subject|3|||
125220521|NCT00357877|450434460|FG000|Overall Study|Administrative withdrawal|1|||
125220522|NCT00357877|450434461|FG001|Overall Study|Administrative withdrawal|1|||
125220523|NCT00357877|450434460|FG000|Overall Study|Other|0|||
125220524|NCT00357877|450434461|FG001|Overall Study|Other|2|||
125220525|NCT04668209|450434462|FG000|Overall Study|Withdrawal by Subject|2|||
125220526|NCT04668209|450434463|FG001|Overall Study|Withdrawal by Subject|2|||
125220527|NCT04668209|450434462|FG000|Overall Study|Lost to Follow-up|3|||
125220528|NCT04668209|450434463|FG001|Overall Study|Lost to Follow-up|4|||
125220529|NCT04668209|450434462|FG000|Overall Study|Subject Expired|2|||
125220530|NCT04668209|450434463|FG001|Overall Study|Subject Expired|0|||
125220531|NCT04668209|450434462|FG000|Overall Study|Withdrawn from study|0|||
125220532|NCT04668209|450434463|FG001|Overall Study|Withdrawn from study|1|||
125220533|NCT04668209|450434462|FG000|Overall Study|Adverse Event|0|||
125220534|NCT04668209|450434463|FG001|Overall Study|Adverse Event|1|||
125220535|NCT01869777|450434470|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
125220536|NCT00613366|450434473|FG000|Overall Study|Withdrawal by Subject|3|||
125220537|NCT00613366|450434474|FG001|Overall Study|Withdrawal by Subject|2|||
125220538|NCT00766597|450434475|FG000|Overall Study|Unexpected closure of study|4|||
125220539|NCT00766597|450434475|FG000|Overall Study|Without CCR5-tropic virus|5|||
125437664|NCT02002884|451229962|FG002|Main Period (MP)|Lost to Follow-up|2|||
125437665|NCT02002884|451229963|FG003|Main Period (MP)|Lost to Follow-up|0|||
125220540|NCT01135524|450434479|FG000|Overall Study|Withdrawal by Subject|14|||
125437666|NCT02002884|451229960|FG000|Open-Label Extension Period (OLEX)|Other|0|||
125437667|NCT02002884|451229961|FG001|Open-Label Extension Period (OLEX)|Other|0|||
125437668|NCT02002884|451229962|FG002|Open-Label Extension Period (OLEX)|Other|0|||
125136998|NCT00574847|450126445|FG001|Overall Study|Did not receive medication (declined)|5|||
125136999|NCT02055547|450126447|FG000|Overall Study|Protocol Violation|0|||
125137000|NCT02055547|450126448|FG001|Overall Study|Protocol Violation|0|||
125137001|NCT02055547|450126449|FG002|Overall Study|Protocol Violation|1|||
125137002|NCT02055547|450126450|FG003|Overall Study|Protocol Violation|0|||
125137003|NCT02055547|450126451|FG004|Overall Study|Protocol Violation|0|||
125137004|NCT02055547|450126452|FG005|Overall Study|Protocol Violation|0|||
125137005|NCT02055547|450126453|FG006|Overall Study|Protocol Violation|1|||
125382844|NCT00488345|451035385|FG001|Overall Study|Institutional Review Board review|0|||
125382845|NCT00488345|451035386|FG002|Overall Study|Institutional Review Board review|1|||
125382846|NCT00488345|451035384|FG000|Overall Study|Surgical team recommendation|0|||
125382847|NCT00488345|451035385|FG001|Overall Study|Surgical team recommendation|1|||
125137006|NCT02055547|450126454|FG007|Overall Study|Protocol Violation|0|||
125137007|NCT02055547|450126455|FG008|Overall Study|Protocol Violation|0|||
125382848|NCT00488345|451035386|FG002|Overall Study|Surgical team recommendation|0|||
125382849|NCT00488345|451035384|FG000|Overall Study|Parent/legal guardian request|0|||
125382850|NCT00488345|451035385|FG001|Overall Study|Parent/legal guardian request|1|||
125137008|NCT02055547|450126456|FG009|Overall Study|Protocol Violation|0|||
125137009|NCT02055547|450126457|FG010|Overall Study|Protocol Violation|0|||
125137010|NCT02055547|450126458|FG011|Overall Study|Protocol Violation|0|||
125137011|NCT02055547|450126459|FG012|Overall Study|Protocol Violation|0|||
125220541|NCT01135524|450434479|FG000|Overall Study|Adverse Event|20|||
125220542|NCT01135524|450434479|FG000|Overall Study|Lost to Follow-up|3|||
125220543|NCT01135524|450434479|FG000|Overall Study|Administrative|151|||
125220544|NCT01135524|450434479|FG000|Overall Study|Lack of Efficacy|8|||
125220545|NCT03318003|450434480|FG000|Overall Study|Withdrawal by Subject|1|||
125220546|NCT03318003|450434481|FG001|Overall Study|Withdrawal by Subject|1|||
125220547|NCT03318003|450434480|FG000|Overall Study|fetal loss|0|||
125220548|NCT03318003|450434481|FG001|Overall Study|fetal loss|1|||
125220549|NCT02907463|450434483|FG000|Overall Study|Lost to Follow-up|17|||
125382851|NCT00488345|451035386|FG002|Overall Study|Parent/legal guardian request|1|||
125382852|NCT00903617|451035389|FG000|Overall Study|Adverse Event|0|||
125382853|NCT00903617|451035390|FG001|Overall Study|Adverse Event|1|||
125382854|NCT00903617|451035391|FG002|Overall Study|Adverse Event|1|||
125382855|NCT00903617|451035392|FG003|Overall Study|Adverse Event|0|||
125382856|NCT00903617|451035389|FG000|Overall Study|Protocol-defined stopping criteria|0|||
125382857|NCT00903617|451035390|FG001|Overall Study|Protocol-defined stopping criteria|2|||
125382858|NCT00903617|451035391|FG002|Overall Study|Protocol-defined stopping criteria|0|||
125382859|NCT00903617|451035392|FG003|Overall Study|Protocol-defined stopping criteria|0|||
125382860|NCT00903617|451035389|FG000|Overall Study|Lost to Follow-up|2|||
125382861|NCT00903617|451035390|FG001|Overall Study|Lost to Follow-up|0|||
125220550|NCT02907463|450434483|FG000|Overall Study|Death|10|||
125382862|NCT00903617|451035391|FG002|Overall Study|Lost to Follow-up|1|||
125220551|NCT02907463|450434483|FG000|Overall Study|Withdrawal by Subject|4|||
125220552|NCT02907463|450434483|FG000|Overall Study|MIS Approach was not used|2|||
125220553|NCT02907463|450434483|FG000|Overall Study|Not Implanted with Study Device|2|||
125220554|NCT02907463|450434483|FG000|Overall Study|Device Explanted|1|||
125220555|NCT02907463|450434483|FG000|Overall Study|Missing Exit Form|1|||
125220556|NCT01716663|450434484|FG000|Overall Study|Withdrawn prior to procedure|4|||
125220557|NCT01716663|450434484|FG000|Overall Study|Treated with non-study catheter|2|||
125220558|NCT00511810|450434491|FG000|Overall Study|Lost to Follow-up|1|||
125220559|NCT00511810|450434492|FG001|Overall Study|Lost to Follow-up|2|||
125220560|NCT00511810|450434491|FG000|Overall Study|Lack of Efficacy|0|||
125220561|NCT00511810|450434492|FG001|Overall Study|Lack of Efficacy|2|||
125220562|NCT00511810|450434491|FG000|Overall Study|Refused second scn|0|||
125220563|NCT00511810|450434492|FG001|Overall Study|Refused second scn|1|||
125382863|NCT00903617|451035392|FG003|Overall Study|Lost to Follow-up|1|||
125382864|NCT00903617|451035389|FG000|Overall Study|Withdrawal by Subject|1|||
125382865|NCT00903617|451035390|FG001|Overall Study|Withdrawal by Subject|2|||
125382866|NCT00903617|451035391|FG002|Overall Study|Withdrawal by Subject|3|||
125382867|NCT00903617|451035392|FG003|Overall Study|Withdrawal by Subject|0|||
125382868|NCT02355691|451035393|FG000|Overall Study|Loss of Research Personnel|7|||
125382869|NCT02355691|451035394|FG001|Overall Study|Loss of Research Personnel|9|||
125382870|NCT00462761|451035395|FG000|Overall Study|Adverse Event|6|||
125382871|NCT00462761|451035395|FG000|Overall Study|Withdrawal by Subject|9|||
125382872|NCT00462761|451035395|FG000|Overall Study|Physician Decision|5|||
125382873|NCT00462761|451035395|FG000|Overall Study|Disease progression|43|||
125382874|NCT00462761|451035395|FG000|Overall Study|Death|12|||
125382875|NCT00462761|451035395|FG000|Overall Study|Other|1|||
125382876|NCT03060447|451035396|FG000|Overall Study|Withdrawal by Subject|2|||
125382877|NCT03060447|451035397|FG001|Overall Study|Withdrawal by Subject|0|||
125382878|NCT03274440|451035401|FG000|Overall Study|Time commitment too great|1|||
125382879|NCT03274440|451035402|FG001|Overall Study|Time commitment too great|0|||
125382880|NCT03274440|451035403|FG002|Overall Study|Time commitment too great|0|||
125382881|NCT03274440|451035404|FG003|Overall Study|Time commitment too great|1|||
125382882|NCT03274440|451035405|FG004|Overall Study|Time commitment too great|0|||
125382883|NCT03274440|451035406|FG005|Overall Study|Time commitment too great|0|||
125382884|NCT01110707|451035407|FG000|Overall Study|Protocol Violation|0|||
125382885|NCT01110707|451035408|FG001|Overall Study|Protocol Violation|3|||
125382886|NCT02369341|451035409|FG000|Overall Study|Migrated/moved from study area|1|||
125382887|NCT02369341|451035410|FG001|Overall Study|Migrated/moved from study area|0|||
125382888|NCT02710045|451035413|FG000|Overall Study|Death|1|||
125382889|NCT02710045|451035414|FG001|Overall Study|Death|2|||
125382890|NCT02710045|451035415|FG002|Overall Study|Death|0|||
125382891|NCT02710045|451035413|FG000|Overall Study|Withdrawal by Subject|6|||
125382892|NCT02710045|451035414|FG001|Overall Study|Withdrawal by Subject|6|||
125382893|NCT02710045|451035415|FG002|Overall Study|Withdrawal by Subject|2|||
125382894|NCT02710045|451035413|FG000|Overall Study|Protocol Violation|1|||
125382895|NCT02710045|451035414|FG001|Overall Study|Protocol Violation|2|||
125382896|NCT02710045|451035415|FG002|Overall Study|Protocol Violation|3|||
125382897|NCT02710045|451035413|FG000|Overall Study|Lost to Follow-up|3|||
125382898|NCT02710045|451035414|FG001|Overall Study|Lost to Follow-up|6|||
125382899|NCT02710045|451035415|FG002|Overall Study|Lost to Follow-up|7|||
125382900|NCT02710045|451035413|FG000|Overall Study|Physician Decision|0|||
125382901|NCT02710045|451035414|FG001|Overall Study|Physician Decision|0|||
125382902|NCT02710045|451035415|FG002|Overall Study|Physician Decision|1|||
125382903|NCT02710045|451035413|FG000|Overall Study|Poor Attendance|0|||
125382904|NCT02710045|451035414|FG001|Overall Study|Poor Attendance|1|||
125382905|NCT02710045|451035415|FG002|Overall Study|Poor Attendance|0|||
125382906|NCT03178773|451035416|FG000|Overall Study|Death|0|||
125382907|NCT03178773|451035417|FG001|Overall Study|Death|1|||
125382908|NCT03178773|451035416|FG000|Overall Study|Lost to Follow-up|29|||
125382909|NCT03178773|451035417|FG001|Overall Study|Lost to Follow-up|25|||
125382910|NCT03178773|451035416|FG000|Overall Study|Withdrawal by Subject|10|||
125382911|NCT03178773|451035417|FG001|Overall Study|Withdrawal by Subject|14|||
125382912|NCT01928329|451035422|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
125382913|NCT01928329|451035423|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
125382914|NCT01928329|451035422|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
125382915|NCT01928329|451035423|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
125382916|NCT01928329|451035422|FG000|Overall Study|Adverse Event|5|||
125382917|NCT01928329|451035423|FG001|Overall Study|Adverse Event|3|||
125382918|NCT01928329|451035422|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
125382919|NCT01928329|451035423|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
125382920|NCT01928329|451035422|FG000|Overall Study|Withdrawal by Subject|1|||
125382921|NCT01928329|451035423|FG001|Overall Study|Withdrawal by Subject|5|||
125382922|NCT01928329|451035422|FG000|Overall Study|Physician Decision|1|||
125382923|NCT01928329|451035423|FG001|Overall Study|Physician Decision|1|||
125382924|NCT03187262|451035424|FG000|Induction|Lack of Efficacy|2|||
125382925|NCT03187262|451035424|FG000|Induction|Progressive Disease|4|||
125382926|NCT03187262|451035424|FG000|Consolidation|Progressive Disease|5|||
125382927|NCT02604212|451035427|FG000|Overall Study|Study Terminated by Sponsor|2|||
125382928|NCT02604212|451035428|FG001|Overall Study|Study Terminated by Sponsor|1|||
125382929|NCT02604212|451035429|FG002|Overall Study|Study Terminated by Sponsor|3|||
125382930|NCT02604212|451035430|FG003|Overall Study|Study Terminated by Sponsor|3|||
125382931|NCT02604212|451035427|FG000|Overall Study|Withdrawal by Subject|0|||
125382932|NCT02604212|451035428|FG001|Overall Study|Withdrawal by Subject|0|||
125382933|NCT02604212|451035429|FG002|Overall Study|Withdrawal by Subject|1|||
125382934|NCT02604212|451035430|FG003|Overall Study|Withdrawal by Subject|0|||
125382935|NCT00451321|451035431|FG000|Overall Study|Lost to Follow-up|3|||
125382936|NCT00451321|451035432|FG001|Overall Study|Lost to Follow-up|3|||
125382937|NCT00451321|451035433|FG002|Overall Study|Lost to Follow-up|1|||
125382938|NCT00451321|451035434|FG003|Overall Study|Lost to Follow-up|3|||
125382939|NCT00451321|451035435|FG004|Overall Study|Lost to Follow-up|0|||
125382940|NCT00451321|451035436|FG005|Overall Study|Lost to Follow-up|1|||
125437669|NCT02002884|451229963|FG003|Open-Label Extension Period (OLEX)|Other|24|||
125437670|NCT02002884|451229960|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
125437671|NCT02002884|451229961|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
125437672|NCT02002884|451229962|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
125437673|NCT02002884|451229963|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
125437674|NCT02002884|451229960|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
125437675|NCT02002884|451229961|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
125437676|NCT02002884|451229962|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
125437677|NCT02002884|451229963|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
125437678|NCT02002884|451229960|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
125437679|NCT02002884|451229961|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
125437680|NCT02002884|451229962|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
125437681|NCT02002884|451229963|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
125437682|NCT02002884|451229960|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
125437683|NCT02002884|451229961|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
125437684|NCT02002884|451229962|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
125437685|NCT02002884|451229963|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
125437686|NCT02966002|451229964|FG000|Overall Study|Withdrawal by Subject|2|||
125137012|NCT02055547|450126460|FG013|Overall Study|Protocol Violation|0|||
125137013|NCT02055547|450126461|FG014|Overall Study|Protocol Violation|0|||
125137014|NCT02055547|450126462|FG015|Overall Study|Protocol Violation|0|||
125137015|NCT02055547|450126463|FG016|Overall Study|Protocol Violation|0|||
125137016|NCT02055547|450126464|FG017|Overall Study|Protocol Violation|0|||
125137017|NCT02055547|450126465|FG018|Overall Study|Protocol Violation|0|||
125137018|NCT02055547|450126447|FG000|Overall Study|Physician Decision|0|||
125137019|NCT02055547|450126448|FG001|Overall Study|Physician Decision|1|||
125137020|NCT02055547|450126449|FG002|Overall Study|Physician Decision|1|||
125137021|NCT02055547|450126450|FG003|Overall Study|Physician Decision|0|||
125137022|NCT02055547|450126451|FG004|Overall Study|Physician Decision|1|||
125137023|NCT02055547|450126452|FG005|Overall Study|Physician Decision|0|||
125137024|NCT02055547|450126453|FG006|Overall Study|Physician Decision|0|||
125137025|NCT02055547|450126454|FG007|Overall Study|Physician Decision|0|||
125137026|NCT02055547|450126455|FG008|Overall Study|Physician Decision|0|||
125137027|NCT02055547|450126456|FG009|Overall Study|Physician Decision|1|||
125137028|NCT02055547|450126457|FG010|Overall Study|Physician Decision|1|||
125137029|NCT02055547|450126458|FG011|Overall Study|Physician Decision|0|||
125137030|NCT02055547|450126459|FG012|Overall Study|Physician Decision|0|||
125137031|NCT02055547|450126460|FG013|Overall Study|Physician Decision|0|||
125137032|NCT02055547|450126461|FG014|Overall Study|Physician Decision|0|||
125137033|NCT02055547|450126462|FG015|Overall Study|Physician Decision|0|||
125137034|NCT02055547|450126463|FG016|Overall Study|Physician Decision|0|||
125137035|NCT02055547|450126464|FG017|Overall Study|Physician Decision|0|||
125137036|NCT02055547|450126465|FG018|Overall Study|Physician Decision|0|||
125137037|NCT02055547|450126447|FG000|Overall Study|Adverse Event|0|||
125137038|NCT02055547|450126448|FG001|Overall Study|Adverse Event|0|||
125137039|NCT02055547|450126449|FG002|Overall Study|Adverse Event|0|||
125137040|NCT02055547|450126450|FG003|Overall Study|Adverse Event|0|||
125137041|NCT02055547|450126451|FG004|Overall Study|Adverse Event|0|||
125137042|NCT02055547|450126452|FG005|Overall Study|Adverse Event|0|||
125137043|NCT02055547|450126453|FG006|Overall Study|Adverse Event|1|||
125137044|NCT02055547|450126454|FG007|Overall Study|Adverse Event|0|||
125137045|NCT02055547|450126455|FG008|Overall Study|Adverse Event|1|||
125137046|NCT02055547|450126456|FG009|Overall Study|Adverse Event|0|||
125137047|NCT02055547|450126457|FG010|Overall Study|Adverse Event|0|||
125137048|NCT02055547|450126458|FG011|Overall Study|Adverse Event|0|||
125137049|NCT02055547|450126459|FG012|Overall Study|Adverse Event|0|||
125137050|NCT02055547|450126460|FG013|Overall Study|Adverse Event|0|||
125137051|NCT02055547|450126461|FG014|Overall Study|Adverse Event|0|||
125137052|NCT02055547|450126462|FG015|Overall Study|Adverse Event|0|||
125137053|NCT02055547|450126463|FG016|Overall Study|Adverse Event|0|||
125137054|NCT02055547|450126464|FG017|Overall Study|Adverse Event|0|||
125137055|NCT02055547|450126465|FG018|Overall Study|Adverse Event|0|||
125137056|NCT02055547|450126447|FG000|Overall Study|Withdrawal by Subject|0|||
125137057|NCT02055547|450126448|FG001|Overall Study|Withdrawal by Subject|0|||
125137058|NCT02055547|450126449|FG002|Overall Study|Withdrawal by Subject|0|||
125137059|NCT02055547|450126450|FG003|Overall Study|Withdrawal by Subject|0|||
125137060|NCT02055547|450126451|FG004|Overall Study|Withdrawal by Subject|0|||
125137061|NCT02055547|450126452|FG005|Overall Study|Withdrawal by Subject|1|||
125137062|NCT02055547|450126453|FG006|Overall Study|Withdrawal by Subject|0|||
125137063|NCT02055547|450126454|FG007|Overall Study|Withdrawal by Subject|0|||
125137064|NCT02055547|450126455|FG008|Overall Study|Withdrawal by Subject|1|||
125137065|NCT02055547|450126456|FG009|Overall Study|Withdrawal by Subject|0|||
125137066|NCT02055547|450126457|FG010|Overall Study|Withdrawal by Subject|0|||
125137067|NCT02055547|450126458|FG011|Overall Study|Withdrawal by Subject|0|||
125137068|NCT02055547|450126459|FG012|Overall Study|Withdrawal by Subject|0|||
125382941|NCT00451321|451035437|FG006|Overall Study|Lost to Follow-up|0|||
125382942|NCT00451321|451035438|FG007|Overall Study|Lost to Follow-up|0|||
125382943|NCT00451321|451035431|FG000|Overall Study|Withdrawal by Subject|3|||
125382944|NCT00451321|451035432|FG001|Overall Study|Withdrawal by Subject|1|||
125137069|NCT02055547|450126460|FG013|Overall Study|Withdrawal by Subject|1|||
125137070|NCT02055547|450126461|FG014|Overall Study|Withdrawal by Subject|0|||
125137071|NCT02055547|450126462|FG015|Overall Study|Withdrawal by Subject|1|||
125137072|NCT02055547|450126463|FG016|Overall Study|Withdrawal by Subject|0|||
125382945|NCT00451321|451035433|FG002|Overall Study|Withdrawal by Subject|0|||
125137073|NCT02055547|450126464|FG017|Overall Study|Withdrawal by Subject|0|||
125137074|NCT02055547|450126465|FG018|Overall Study|Withdrawal by Subject|0|||
125382946|NCT00451321|451035434|FG003|Overall Study|Withdrawal by Subject|4|||
125137075|NCT02055547|450126447|FG000|Overall Study|Lost to Follow-up|0|||
125137076|NCT02055547|450126448|FG001|Overall Study|Lost to Follow-up|0|||
125137077|NCT02055547|450126449|FG002|Overall Study|Lost to Follow-up|1|||
125137078|NCT02055547|450126450|FG003|Overall Study|Lost to Follow-up|0|||
125137079|NCT02055547|450126451|FG004|Overall Study|Lost to Follow-up|0|||
125137080|NCT02055547|450126452|FG005|Overall Study|Lost to Follow-up|0|||
125137081|NCT02055547|450126453|FG006|Overall Study|Lost to Follow-up|0|||
125137082|NCT02055547|450126454|FG007|Overall Study|Lost to Follow-up|0|||
125137083|NCT02055547|450126455|FG008|Overall Study|Lost to Follow-up|0|||
125137084|NCT02055547|450126456|FG009|Overall Study|Lost to Follow-up|0|||
125137085|NCT02055547|450126457|FG010|Overall Study|Lost to Follow-up|0|||
125137086|NCT02055547|450126458|FG011|Overall Study|Lost to Follow-up|0|||
125137087|NCT02055547|450126459|FG012|Overall Study|Lost to Follow-up|0|||
125220564|NCT02427841|450434493|FG000|Overall Study|Lack of Efficacy|5|||
125220565|NCT02427841|450434493|FG000|Overall Study|Physician Decision|2|||
125220566|NCT02427841|450434493|FG000|Overall Study|Withdrawal by Subject|1|||
125220567|NCT02896569|450434494|FG000|Overall Study|Lost to Follow-up|2|||
125220568|NCT02896569|450434495|FG001|Overall Study|Lost to Follow-up|1|||
125220569|NCT02896569|450434494|FG000|Overall Study|Physician Decision|1|||
125220570|NCT02896569|450434495|FG001|Overall Study|Physician Decision|3|||
125220571|NCT02896569|450434494|FG000|Overall Study|Adverse Event|0|||
125220572|NCT02896569|450434495|FG001|Overall Study|Adverse Event|1|||
125220573|NCT02896569|450434494|FG000|Overall Study|Withdrawal by Subject|1|||
125220574|NCT02896569|450434495|FG001|Overall Study|Withdrawal by Subject|0|||
125220575|NCT03478371|450434496|FG000|Overall Study|non-compliance|1|||
125382947|NCT00451321|451035435|FG004|Overall Study|Withdrawal by Subject|0|||
125382948|NCT00451321|451035436|FG005|Overall Study|Withdrawal by Subject|0|||
125382949|NCT00451321|451035437|FG006|Overall Study|Withdrawal by Subject|0|||
125382950|NCT00451321|451035438|FG007|Overall Study|Withdrawal by Subject|0|||
125382951|NCT00451321|451035431|FG000|Overall Study|Study closed/terminated|1|||
125382952|NCT00451321|451035432|FG001|Overall Study|Study closed/terminated|1|||
125382953|NCT00451321|451035433|FG002|Overall Study|Study closed/terminated|17|||
125382954|NCT00451321|451035434|FG003|Overall Study|Study closed/terminated|5|||
125382955|NCT00451321|451035435|FG004|Overall Study|Study closed/terminated|7|||
125382956|NCT00451321|451035436|FG005|Overall Study|Study closed/terminated|7|||
125382957|NCT00451321|451035437|FG006|Overall Study|Study closed/terminated|5|||
125382958|NCT00451321|451035438|FG007|Overall Study|Study closed/terminated|3|||
125382959|NCT00451321|451035431|FG000|Overall Study|Sponsor decision to amend protocol|0|||
125382960|NCT00451321|451035432|FG001|Overall Study|Sponsor decision to amend protocol|0|||
125382961|NCT00451321|451035433|FG002|Overall Study|Sponsor decision to amend protocol|0|||
125382962|NCT00451321|451035434|FG003|Overall Study|Sponsor decision to amend protocol|0|||
125382963|NCT00451321|451035435|FG004|Overall Study|Sponsor decision to amend protocol|0|||
125382964|NCT00451321|451035436|FG005|Overall Study|Sponsor decision to amend protocol|1|||
125382965|NCT00451321|451035437|FG006|Overall Study|Sponsor decision to amend protocol|1|||
125382966|NCT00451321|451035438|FG007|Overall Study|Sponsor decision to amend protocol|3|||
125382967|NCT01119131|451035441|FG000|Overall Study|Adverse Event|1|||
125382968|NCT01119131|451035442|FG001|Overall Study|Adverse Event|1|||
125382969|NCT01119131|451035443|FG002|Overall Study|Adverse Event|1|||
125382970|NCT01119131|451035441|FG000|Overall Study|Non-Compliance|1|||
125382971|NCT01119131|451035442|FG001|Overall Study|Non-Compliance|0|||
125382972|NCT01119131|451035443|FG002|Overall Study|Non-Compliance|4|||
125382973|NCT01119131|451035441|FG000|Overall Study|Physician Decision|0|||
125382974|NCT01119131|451035442|FG001|Overall Study|Physician Decision|0|||
125382975|NCT01119131|451035443|FG002|Overall Study|Physician Decision|1|||
125382976|NCT00909389|451035446|FG000|Overall Study|Adverse Event|6|||
125382977|NCT00909389|451035446|FG000|Overall Study|Death|4|||
125382978|NCT00909389|451035446|FG000|Overall Study|Poor Compliance|16|||
125382979|NCT00909389|451035446|FG000|Overall Study|Lost to Follow-up|4|||
125382980|NCT00909389|451035446|FG000|Overall Study|No Information|103|||
125382981|NCT00003492|451035447|FG000|Overall Study|Not evaluable|6|||
125382982|NCT00597766|451035450|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
125382983|NCT00597766|451035451|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
125382984|NCT00597766|451035452|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
125382985|NCT00597766|451035450|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
125382986|NCT00597766|451035451|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
125382987|NCT00597766|451035452|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
125382988|NCT01829230|451035460|FG000|Overall Study|Protocol Violation|0|||
125382989|NCT01829230|451035461|FG001|Overall Study|Protocol Violation|2|||
125382990|NCT01829230|451035460|FG000|Overall Study|Withdrawal by Subject|0|||
125382991|NCT01829230|451035461|FG001|Overall Study|Withdrawal by Subject|1|||
125382992|NCT01829230|451035460|FG000|Overall Study|Lost to Follow-up|1|||
125382993|NCT01829230|451035461|FG001|Overall Study|Lost to Follow-up|1|||
125382994|NCT04387435|451035462|FG000|Overall Study|Physician Decision|1|||
125382995|NCT03855280|451035463|FG000|Treatment Phase|Adverse Event|1|||
125382996|NCT03855280|451035463|FG000|Treatment Phase|Withdrawal by Subject|1|||
125382997|NCT03855280|451035463|FG000|Continuation Phase|Protocol Violation|1|||
125382998|NCT03855280|451035463|FG000|Continuation Phase|Adverse Event|1|||
125382999|NCT03855280|451035463|FG000|Continuation Phase|Sponsor Concluded Study|1|||
125383000|NCT00969150|451035468|FG000|Overall Study|Adverse Event|4|||
125220576|NCT03478371|450434496|FG000|Overall Study|Lost to Follow-up|4|||
125220577|NCT00618826|450434501|FG000|Overall Study|Adverse Event|1|||
125383001|NCT00969150|451035469|FG001|Overall Study|Adverse Event|14|||
125383002|NCT00969150|451035468|FG000|Overall Study|Lack of Efficacy|1|||
125383003|NCT00969150|451035469|FG001|Overall Study|Lack of Efficacy|1|||
125383004|NCT00969150|451035468|FG000|Overall Study|Protocol Violation|9|||
125383005|NCT00969150|451035469|FG001|Overall Study|Protocol Violation|12|||
125383006|NCT00969150|451035468|FG000|Overall Study|Withdrawal by Subject|13|||
125383007|NCT00969150|451035469|FG001|Overall Study|Withdrawal by Subject|9|||
125220578|NCT01509664|450434502|FG000|Overall Study|Lost to Follow-up|15|||
125220579|NCT01509664|450434503|FG001|Overall Study|Lost to Follow-up|21|||
125220580|NCT00905424|450434508|FG000|Overall Study|Lost to Follow-up|3|||
125220581|NCT00905424|450434509|FG001|Overall Study|Lost to Follow-up|3|||
125220582|NCT00905424|450434508|FG000|Overall Study|Withdrawal by Subject|1|||
125220583|NCT00905424|450434509|FG001|Overall Study|Withdrawal by Subject|2|||
125220584|NCT00905424|450434508|FG000|Overall Study|Adverse Event|4|||
125220585|NCT00905424|450434509|FG001|Overall Study|Adverse Event|2|||
125220586|NCT00905424|450434508|FG000|Overall Study|Non-compliance with study medication|2|||
125220587|NCT00905424|450434509|FG001|Overall Study|Non-compliance with study medication|0|||
125220588|NCT00905424|450434508|FG000|Overall Study|Sponsor decision|1|||
125220589|NCT00905424|450434509|FG001|Overall Study|Sponsor decision|0|||
125220590|NCT00905424|450434508|FG000|Overall Study|Positive urine drug screen|0|||
125220591|NCT00905424|450434509|FG001|Overall Study|Positive urine drug screen|1|||
125220592|NCT00905424|450434508|FG000|Overall Study|Non-adherence to visit schedule|0|||
125220593|NCT00905424|450434509|FG001|Overall Study|Non-adherence to visit schedule|1|||
125220594|NCT00426764|450434510|FG000|Overall Study|Protocol Violation|1|||
125220595|NCT00426764|450434510|FG000|Overall Study|Withdrawal by Subject|4|||
125220596|NCT00426764|450434510|FG000|Overall Study|Physician Decision|6|||
125220597|NCT00426764|450434510|FG000|Overall Study|Compassionate Use|1|||
125220598|NCT00426764|450434510|FG000|Overall Study|Progressive Disease|83|||
125220599|NCT00426764|450434510|FG000|Overall Study|Adverse Event|24|||
125220600|NCT00426764|450434510|FG000|Overall Study|Other|1|||
125220601|NCT00426764|450434510|FG000|Overall Study|Death|1|||
125220602|NCT00426764|450434510|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
125220603|NCT05225389|450434511|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
125220604|NCT03804268|450434512|FG000|Overall Study|Adverse Event|2|||
125220605|NCT03804268|450434513|FG001|Overall Study|Adverse Event|2|||
125220606|NCT03804268|450434512|FG000|Overall Study|Withdrawal by Subject|2|||
125220607|NCT03804268|450434513|FG001|Overall Study|Withdrawal by Subject|0|||
125220608|NCT03804268|450434512|FG000|Overall Study|Lost to Follow-up|1|||
125220609|NCT03804268|450434513|FG001|Overall Study|Lost to Follow-up|0|||
125220610|NCT03804268|450434512|FG000|Overall Study|Physician Decision|2|||
125220611|NCT03804268|450434513|FG001|Overall Study|Physician Decision|0|||
125220612|NCT01737879|450434514|FG000|Overall Study|Death|1|||
125220613|NCT01737879|450434514|FG000|Overall Study|Sponsor decision|40|||
125220614|NCT01843803|450434517|FG000|Overall Study|not a Veteran, did not see provider|1|||
125220615|NCT01843803|450434518|FG001|Overall Study|not a Veteran, did not see provider|3|||
125220616|NCT03311841|450434519|FG000|14-day Wash-out|Adverse Event|0|||
125220617|NCT03311841|450434520|FG001|14-day Wash-out|Adverse Event|1|||
125220618|NCT03311841|450434521|FG002|14-day Wash-out|Adverse Event|0|||
125220619|NCT03311841|450434522|FG003|14-day Wash-out|Adverse Event|0|||
125220620|NCT03311841|450434523|FG004|14-day Wash-out|Adverse Event|0|||
125220621|NCT03311841|450434519|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
125220622|NCT03311841|450434520|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
125220623|NCT03311841|450434521|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
125220624|NCT03311841|450434522|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
125220625|NCT03311841|450434523|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
125220626|NCT03360019|450434524|FG000|Overall Study|Withdrawal by Subject|2|||
125220627|NCT03360019|450434525|FG001|Overall Study|Withdrawal by Subject|0|||
125220628|NCT03360019|450434526|FG002|Overall Study|Withdrawal by Subject|0|||
125220629|NCT03360019|450434524|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
125220630|NCT03360019|450434525|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
125220631|NCT03360019|450434526|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
125220632|NCT01462110|450434527|FG000|Overall Study|Adverse Event|1|||
125220633|NCT01462110|450434528|FG001|Overall Study|Adverse Event|0|||
125220634|NCT00964028|450434529|FG000|Overall Study|Withdrawal by Subject|0|||
125220635|NCT00964028|450434530|FG001|Overall Study|Withdrawal by Subject|1|||
125383008|NCT00969150|451035468|FG000|Overall Study|Lost to Follow-up|5|||
125383009|NCT00969150|451035469|FG001|Overall Study|Lost to Follow-up|4|||
125383010|NCT00969150|451035468|FG000|Overall Study|Other reasons|1|||
125383011|NCT00969150|451035469|FG001|Overall Study|Other reasons|0|||
125383012|NCT00461682|451035473|FG000|Overall Study|Protocol Violation|1|||
125383013|NCT00883116|451035476|FG000|Overall Study|Adverse event unrelated to study drug|5|||
125383014|NCT00883116|451035477|FG001|Overall Study|Adverse event unrelated to study drug|10|||
125383015|NCT00883116|451035476|FG000|Overall Study|Death|6|||
125383016|NCT00883116|451035477|FG001|Overall Study|Death|2|||
125383017|NCT00883116|451035476|FG000|Overall Study|Disease progression|130|||
125383018|NCT00883116|451035477|FG001|Overall Study|Disease progression|128|||
125383019|NCT00883116|451035476|FG000|Overall Study|Lost to Follow-up|0|||
125383020|NCT00883116|451035477|FG001|Overall Study|Lost to Follow-up|1|||
125383021|NCT00883116|451035476|FG000|Overall Study|Maximum clinical benefit|13|||
125383022|NCT00883116|451035477|FG001|Overall Study|Maximum clinical benefit|46|||
125383023|NCT00883116|451035476|FG000|Overall Study|Not identified|3|||
125383024|NCT00883116|451035477|FG001|Overall Study|Not identified|6|||
125383025|NCT00883116|451035476|FG000|Overall Study|Study drug toxicity|36|||
125383026|NCT00883116|451035477|FG001|Overall Study|Study drug toxicity|16|||
125383027|NCT00883116|451035476|FG000|Overall Study|Withdrawal by Subject|14|||
125383028|NCT00883116|451035477|FG001|Overall Study|Withdrawal by Subject|8|||
125383029|NCT00883116|451035476|FG000|Overall Study|No longer meets study criteria|2|||
125383030|NCT00883116|451035477|FG001|Overall Study|No longer meets study criteria|2|||
125383031|NCT01361464|451035478|FG000|Overall Study|Death|1|||
125383032|NCT01361464|451035478|FG000|Overall Study|Withdrawal by Subject|2|||
125383033|NCT04501666|451035482|FG000|Overall Study|Physician Decision|0|||
125383034|NCT04501666|451035483|FG001|Overall Study|Physician Decision|1|||
125383035|NCT04501666|451035482|FG000|Overall Study|Adverse Event|12|||
125383036|NCT04501666|451035483|FG001|Overall Study|Adverse Event|4|||
125383037|NCT04501666|451035482|FG000|Overall Study|Subject's request|10|||
125383038|NCT04501666|451035483|FG001|Overall Study|Subject's request|6|||
125383039|NCT04501666|451035482|FG000|Overall Study|Protocol Deviation|2|||
125383040|NCT04501666|451035483|FG001|Overall Study|Protocol Deviation|1|||
125383041|NCT04501666|451035482|FG000|Overall Study|Other-- site permanently closing|0|||
125383042|NCT04501666|451035483|FG001|Overall Study|Other-- site permanently closing|1|||
125383043|NCT04128267|451035484|FG000|Overall Study|Withdrawal by Subject|6|||
125383044|NCT04128267|451035484|FG000|Overall Study|Death|2|||
125383045|NCT04128267|451035484|FG000|Overall Study|Disease progression|1|||
125383046|NCT04128267|451035484|FG000|Overall Study|Participant had other medical issues|4|||
125383047|NCT04128267|451035484|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
125383048|NCT01722071|451035490|FG000|Overall Study|Protocol Violation|1|||
125383049|NCT01722071|451035491|FG001|Overall Study|Protocol Violation|0|||
125383050|NCT03021265|451035492|FG000|Overall Study|Adverse Event|29|||
125383051|NCT03021265|451035492|FG000|Overall Study|Lack of Efficacy|3|||
125383052|NCT03021265|451035492|FG000|Overall Study|Improved|17|||
125383053|NCT03021265|451035492|FG000|Overall Study|Lost to Follow-up|67|||
125383054|NCT03021265|451035492|FG000|Overall Study|No reason given|2|||
125383055|NCT03021265|451035492|FG000|Overall Study|No visit since the first visit|4|||
125383056|NCT00642941|451035493|FG000|Overall Study|Physician Decision|3|||
125383057|NCT00642941|451035494|FG001|Overall Study|Physician Decision|1|||
125220636|NCT02385110|450434531|FG000|Overall Study|Early Death|1|||
125220637|NCT02385110|450434532|FG001|Overall Study|Early Death|0|||
125383058|NCT00642941|451035495|FG002|Overall Study|Physician Decision|0|||
125383059|NCT00642941|451035496|FG003|Overall Study|Physician Decision|0|||
125383060|NCT00642941|451035497|FG004|Overall Study|Physician Decision|0|||
125383061|NCT00642941|451035498|FG005|Overall Study|Physician Decision|0|||
125383062|NCT00642941|451035499|FG006|Overall Study|Physician Decision|1|||
125137088|NCT02055547|450126460|FG013|Overall Study|Lost to Follow-up|0|||
125137089|NCT02055547|450126461|FG014|Overall Study|Lost to Follow-up|0|||
125137090|NCT02055547|450126462|FG015|Overall Study|Lost to Follow-up|0|||
125137091|NCT02055547|450126463|FG016|Overall Study|Lost to Follow-up|0|||
125137092|NCT02055547|450126464|FG017|Overall Study|Lost to Follow-up|0|||
125137093|NCT02055547|450126465|FG018|Overall Study|Lost to Follow-up|0|||
125137094|NCT01279486|450126466|FG000|Overall Study|Lost to Follow-up|1|||
125137095|NCT03067987|450126467|FG000|Overall Study|Lost to Follow-up|7|||
125137096|NCT03067987|450126468|FG001|Overall Study|Lost to Follow-up|10|||
125137097|NCT03067987|450126467|FG000|Overall Study|Protocol Violation|1|||
125137098|NCT03067987|450126468|FG001|Overall Study|Protocol Violation|2|||
125137099|NCT03067987|450126467|FG000|Overall Study|Withdrawal by Subject|2|||
125137100|NCT03067987|450126468|FG001|Overall Study|Withdrawal by Subject|1|||
125137101|NCT00829764|450126471|FG000|First Intervention|Adverse Event|1|||
125137102|NCT00829764|450126472|FG001|First Intervention|Adverse Event|0|||
125137103|NCT00829764|450126471|FG000|First Intervention|Withdrawal by Subject|1|||
125137104|NCT00829764|450126472|FG001|First Intervention|Withdrawal by Subject|1|||
125137105|NCT01750294|450128840|FG000|Overall Study|Withdrawal by Subject|1|||
125137106|NCT01750294|450128840|FG000|Overall Study|Safety Endpoint|1|||
125137107|NCT00665925|450128841|FG000|Overall Study|Lack of Efficacy|10|||
125137108|NCT00665925|450128842|FG001|Overall Study|Lack of Efficacy|8|||
125137109|NCT00665925|450128843|FG002|Overall Study|Lack of Efficacy|9|||
125137110|NCT00665925|450128844|FG003|Overall Study|Lack of Efficacy|8|||
125137111|NCT00665925|450128841|FG000|Overall Study|Lost to Follow-up|1|||
125137112|NCT00665925|450128842|FG001|Overall Study|Lost to Follow-up|2|||
125137113|NCT00665925|450128843|FG002|Overall Study|Lost to Follow-up|2|||
125383063|NCT00642941|451035500|FG007|Overall Study|Physician Decision|0|||
125383064|NCT00642941|451035501|FG008|Overall Study|Physician Decision|0|||
125137114|NCT00665925|450128844|FG003|Overall Study|Lost to Follow-up|2|||
125137115|NCT00665925|450128841|FG000|Overall Study|Withdrawal by Subject|2|||
125137116|NCT00665925|450128842|FG001|Overall Study|Withdrawal by Subject|2|||
125137117|NCT00665925|450128843|FG002|Overall Study|Withdrawal by Subject|3|||
125137118|NCT00665925|450128844|FG003|Overall Study|Withdrawal by Subject|2|||
125383065|NCT00642941|451035502|FG009|Overall Study|Physician Decision|1|||
125383066|NCT00642941|451035503|FG010|Overall Study|Physician Decision|0|||
125383067|NCT00642941|451035504|FG011|Overall Study|Physician Decision|1|||
125383068|NCT00642941|451035493|FG000|Overall Study|Death|4|||
125383069|NCT00642941|451035494|FG001|Overall Study|Death|0|||
125383070|NCT00642941|451035495|FG002|Overall Study|Death|1|||
125137119|NCT00665925|450128841|FG000|Overall Study|Physician Decision|0|||
125137120|NCT00665925|450128842|FG001|Overall Study|Physician Decision|0|||
125137121|NCT00665925|450128843|FG002|Overall Study|Physician Decision|1|||
125137122|NCT00665925|450128844|FG003|Overall Study|Physician Decision|2|||
125137123|NCT00665925|450128841|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
125137124|NCT00665925|450128842|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
125137125|NCT00665925|450128843|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
125137126|NCT00665925|450128844|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
125137127|NCT00665925|450128841|FG000|Overall Study|Adverse Event|1|||
125137128|NCT00665925|450128842|FG001|Overall Study|Adverse Event|5|||
125137129|NCT00665925|450128843|FG002|Overall Study|Adverse Event|10|||
125137130|NCT00665925|450128844|FG003|Overall Study|Adverse Event|5|||
125137131|NCT00665925|450128841|FG000|Overall Study|Enrolled by mistake|0|||
125383071|NCT00642941|451035496|FG003|Overall Study|Death|1|||
125383072|NCT00642941|451035497|FG004|Overall Study|Death|2|||
125137132|NCT00665925|450128842|FG001|Overall Study|Enrolled by mistake|0|||
125220638|NCT00534638|450434534|FG000|Overall Study|Withdrawal by Subject|3|||
125137133|NCT00665925|450128843|FG002|Overall Study|Enrolled by mistake|0|||
125383073|NCT00642941|451035498|FG005|Overall Study|Death|1|||
125220639|NCT00534638|450434535|FG001|Overall Study|Withdrawal by Subject|4|||
125220640|NCT00534638|450434534|FG000|Overall Study|Migrated/moved from study area|13|||
125220641|NCT00534638|450434535|FG001|Overall Study|Migrated/moved from study area|11|||
125220642|NCT00534638|450434534|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
125220643|NCT00534638|450434535|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
125220644|NCT00534638|450434534|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
125220645|NCT00534638|450434535|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
125220646|NCT00534638|450434534|FG000|Overall Study|Other|1685|||
125383074|NCT00642941|451035499|FG006|Overall Study|Death|0|||
125383075|NCT00642941|451035500|FG007|Overall Study|Death|0|||
125383076|NCT00642941|451035501|FG008|Overall Study|Death|0|||
125383077|NCT00642941|451035502|FG009|Overall Study|Death|0|||
125383078|NCT00642941|451035503|FG010|Overall Study|Death|0|||
125383079|NCT00642941|451035504|FG011|Overall Study|Death|1|||
125383080|NCT00642941|451035493|FG000|Overall Study|Study closed by Sponsor|0|||
125383081|NCT00642941|451035494|FG001|Overall Study|Study closed by Sponsor|1|||
125383082|NCT00642941|451035495|FG002|Overall Study|Study closed by Sponsor|0|||
125383083|NCT00642941|451035496|FG003|Overall Study|Study closed by Sponsor|0|||
125383084|NCT00642941|451035497|FG004|Overall Study|Study closed by Sponsor|0|||
125383085|NCT00642941|451035498|FG005|Overall Study|Study closed by Sponsor|0|||
125383086|NCT00642941|451035499|FG006|Overall Study|Study closed by Sponsor|0|||
125383087|NCT00642941|451035500|FG007|Overall Study|Study closed by Sponsor|0|||
125383088|NCT00642941|451035501|FG008|Overall Study|Study closed by Sponsor|0|||
125383089|NCT00642941|451035502|FG009|Overall Study|Study closed by Sponsor|0|||
125383090|NCT00642941|451035503|FG010|Overall Study|Study closed by Sponsor|0|||
125383091|NCT00642941|451035504|FG011|Overall Study|Study closed by Sponsor|0|||
125383092|NCT00642941|451035493|FG000|Overall Study|Withdrawal by Subject|1|||
125383093|NCT00642941|451035494|FG001|Overall Study|Withdrawal by Subject|0|||
125383094|NCT00642941|451035495|FG002|Overall Study|Withdrawal by Subject|0|||
125383095|NCT00642941|451035496|FG003|Overall Study|Withdrawal by Subject|2|||
125383096|NCT00642941|451035497|FG004|Overall Study|Withdrawal by Subject|0|||
125383097|NCT00642941|451035498|FG005|Overall Study|Withdrawal by Subject|0|||
125383098|NCT00642941|451035499|FG006|Overall Study|Withdrawal by Subject|2|||
125383099|NCT00642941|451035500|FG007|Overall Study|Withdrawal by Subject|0|||
125383100|NCT00642941|451035501|FG008|Overall Study|Withdrawal by Subject|1|||
125383101|NCT00642941|451035502|FG009|Overall Study|Withdrawal by Subject|0|||
125383102|NCT00642941|451035503|FG010|Overall Study|Withdrawal by Subject|0|||
125383103|NCT00642941|451035504|FG011|Overall Study|Withdrawal by Subject|1|||
125383104|NCT00642941|451035493|FG000|Overall Study|Protocol Violation|0|||
125383105|NCT00642941|451035494|FG001|Overall Study|Protocol Violation|0|||
125383106|NCT00642941|451035495|FG002|Overall Study|Protocol Violation|0|||
125383107|NCT00642941|451035496|FG003|Overall Study|Protocol Violation|0|||
125383108|NCT00642941|451035497|FG004|Overall Study|Protocol Violation|0|||
125383109|NCT00642941|451035498|FG005|Overall Study|Protocol Violation|0|||
125383110|NCT00642941|451035499|FG006|Overall Study|Protocol Violation|1|||
125383111|NCT00642941|451035500|FG007|Overall Study|Protocol Violation|0|||
125383112|NCT00642941|451035501|FG008|Overall Study|Protocol Violation|0|||
125383113|NCT00642941|451035502|FG009|Overall Study|Protocol Violation|0|||
125383114|NCT00642941|451035503|FG010|Overall Study|Protocol Violation|0|||
125383115|NCT00642941|451035504|FG011|Overall Study|Protocol Violation|0|||
125383116|NCT00642941|451035493|FG000|Overall Study|Adverse Event|1|||
125383117|NCT00642941|451035494|FG001|Overall Study|Adverse Event|1|||
125383118|NCT00642941|451035495|FG002|Overall Study|Adverse Event|0|||
125383119|NCT00642941|451035496|FG003|Overall Study|Adverse Event|0|||
125383120|NCT00642941|451035497|FG004|Overall Study|Adverse Event|0|||
125383121|NCT00642941|451035498|FG005|Overall Study|Adverse Event|0|||
125383122|NCT00642941|451035499|FG006|Overall Study|Adverse Event|1|||
125383123|NCT00642941|451035500|FG007|Overall Study|Adverse Event|1|||
125383124|NCT00642941|451035501|FG008|Overall Study|Adverse Event|0|||
125383125|NCT00642941|451035502|FG009|Overall Study|Adverse Event|1|||
125383126|NCT00642941|451035503|FG010|Overall Study|Adverse Event|0|||
125383127|NCT00642941|451035504|FG011|Overall Study|Adverse Event|0|||
125383128|NCT00642941|451035493|FG000|Overall Study|Other|1|||
125137134|NCT00665925|450128844|FG003|Overall Study|Enrolled by mistake|1|||
125383129|NCT00642941|451035494|FG001|Overall Study|Other|1|||
125383130|NCT00642941|451035495|FG002|Overall Study|Other|1|||
125383131|NCT00642941|451035496|FG003|Overall Study|Other|1|||
125383132|NCT00642941|451035497|FG004|Overall Study|Other|0|||
125383133|NCT00642941|451035498|FG005|Overall Study|Other|1|||
125383134|NCT00642941|451035499|FG006|Overall Study|Other|0|||
125383135|NCT00642941|451035500|FG007|Overall Study|Other|1|||
125383136|NCT00642941|451035501|FG008|Overall Study|Other|0|||
125383137|NCT00642941|451035502|FG009|Overall Study|Other|0|||
125383138|NCT00642941|451035503|FG010|Overall Study|Other|0|||
125383139|NCT00642941|451035504|FG011|Overall Study|Other|1|||
125137135|NCT00665925|450128841|FG000|Overall Study|Due to exclusion criteria|1|||
125137136|NCT00665925|450128842|FG001|Overall Study|Due to exclusion criteria|0|||
125137137|NCT00665925|450128843|FG002|Overall Study|Due to exclusion criteria|0|||
125137138|NCT00665925|450128844|FG003|Overall Study|Due to exclusion criteria|0|||
125137139|NCT00334815|450128845|FG000|Overall Study|Adverse Event|3|||
125137140|NCT00334815|450128846|FG001|Overall Study|Adverse Event|2|||
125137141|NCT00334815|450128845|FG000|Overall Study|Death|0|||
125137142|NCT00334815|450128846|FG001|Overall Study|Death|2|||
125137143|NCT00334815|450128845|FG000|Overall Study|Progression|1|||
125137144|NCT00334815|450128846|FG001|Overall Study|Progression|0|||
125137145|NCT00334815|450128845|FG000|Overall Study|ineligible|1|||
125220647|NCT00534638|450434535|FG001|Overall Study|Other|902|||
125220648|NCT00452439|450436156|FG000|Overall Study|Lost to Follow-up|1|||
125383140|NCT00642941|451035493|FG000|Overall Study|Disease progression|60|||
125383141|NCT00642941|451035494|FG001|Overall Study|Disease progression|50|||
125383142|NCT00642941|451035495|FG002|Overall Study|Disease progression|5|||
125383143|NCT00642941|451035496|FG003|Overall Study|Disease progression|36|||
125383144|NCT00642941|451035497|FG004|Overall Study|Disease progression|23|||
125383145|NCT00642941|451035498|FG005|Overall Study|Disease progression|39|||
125383146|NCT00642941|451035499|FG006|Overall Study|Disease progression|18|||
125383147|NCT00642941|451035500|FG007|Overall Study|Disease progression|12|||
125383148|NCT00642941|451035501|FG008|Overall Study|Disease progression|10|||
125383149|NCT00642941|451035502|FG009|Overall Study|Disease progression|7|||
125383150|NCT00642941|451035503|FG010|Overall Study|Disease progression|12|||
125383151|NCT00642941|451035504|FG011|Overall Study|Disease progression|7|||
125383152|NCT02554812|451035505|FG000|Overall Study|Adverse Event|2|||
125383153|NCT02554812|451035506|FG001|Overall Study|Adverse Event|5|||
125383154|NCT02554812|451035507|FG002|Overall Study|Adverse Event|3|||
125383155|NCT02554812|451035508|FG003|Overall Study|Adverse Event|0|||
125383156|NCT02554812|451035509|FG004|Overall Study|Adverse Event|5|||
125383157|NCT02554812|451035510|FG005|Overall Study|Adverse Event|0|||
125383158|NCT02554812|451035511|FG006|Overall Study|Adverse Event|1|||
125383159|NCT02554812|451035512|FG007|Overall Study|Adverse Event|6|||
125383160|NCT02554812|451035513|FG008|Overall Study|Adverse Event|2|||
125383161|NCT02554812|451035514|FG009|Overall Study|Adverse Event|2|||
125383162|NCT02554812|451035515|FG010|Overall Study|Adverse Event|1|||
125383163|NCT02554812|451035516|FG011|Overall Study|Adverse Event|2|||
125383164|NCT02554812|451035517|FG012|Overall Study|Adverse Event|0|||
125383165|NCT02554812|451035518|FG013|Overall Study|Adverse Event|3|||
125383166|NCT02554812|451035519|FG014|Overall Study|Adverse Event|2|||
125383167|NCT02554812|451035520|FG015|Overall Study|Adverse Event|1|||
125383168|NCT02554812|451035521|FG016|Overall Study|Adverse Event|0|||
125383169|NCT02554812|451035522|FG017|Overall Study|Adverse Event|1|||
125383170|NCT02554812|451035523|FG018|Overall Study|Adverse Event|0|||
125383171|NCT02554812|451035524|FG019|Overall Study|Adverse Event|0|||
125383172|NCT02554812|451035525|FG020|Overall Study|Adverse Event|0|||
125383173|NCT02554812|451035526|FG021|Overall Study|Adverse Event|2|||
125383174|NCT02554812|451035527|FG022|Overall Study|Adverse Event|1|||
125383175|NCT02554812|451035528|FG023|Overall Study|Adverse Event|1|||
125383176|NCT02554812|451035529|FG024|Overall Study|Adverse Event|1|||
125137146|NCT00334815|450128846|FG001|Overall Study|ineligible|1|||
125137147|NCT00334815|450128845|FG000|Overall Study|patient refused treatment|0|||
125383177|NCT02554812|451035530|FG025|Overall Study|Adverse Event|2|||
125383178|NCT02554812|451035531|FG026|Overall Study|Adverse Event|1|||
125383179|NCT02554812|451035505|FG000|Overall Study|Death|1|||
125383180|NCT02554812|451035506|FG001|Overall Study|Death|2|||
125383181|NCT02554812|451035507|FG002|Overall Study|Death|2|||
125383182|NCT02554812|451035508|FG003|Overall Study|Death|2|||
125383183|NCT02554812|451035509|FG004|Overall Study|Death|0|||
125383184|NCT02554812|451035510|FG005|Overall Study|Death|1|||
125220649|NCT00452439|450436157|FG001|Overall Study|Lost to Follow-up|1|||
125220650|NCT00452439|450436156|FG000|Overall Study|Refused Treatment|4|||
125220651|NCT00452439|450436157|FG001|Overall Study|Refused Treatment|3|||
125220652|NCT00452439|450436156|FG000|Overall Study|Death|3|||
125220653|NCT00452439|450436157|FG001|Overall Study|Death|1|||
125220654|NCT00452439|450436156|FG000|Overall Study|Bone Marrow Transplant|0|||
125220655|NCT00452439|450436157|FG001|Overall Study|Bone Marrow Transplant|1|||
125220656|NCT00452439|450436156|FG000|Overall Study|Too Ill to Continue|0|||
125220657|NCT00452439|450436157|FG001|Overall Study|Too Ill to Continue|1|||
125220658|NCT00452439|450436156|FG000|Overall Study|Failed to achieve complete response|2|||
125220659|NCT00452439|450436157|FG001|Overall Study|Failed to achieve complete response|0|||
125220660|NCT00452439|450436156|FG000|Overall Study|Relapse|3|||
125220661|NCT00452439|450436157|FG001|Overall Study|Relapse|0|||
125220662|NCT00452439|450436156|FG000|Overall Study|Fracture|1|||
125220663|NCT00452439|450436157|FG001|Overall Study|Fracture|0|||
125220664|NCT04147247|450436164|FG000|Overall Study|Progressive disease|3|||
125220665|NCT04147247|450436165|FG001|Overall Study|Progressive disease|3|||
125220666|NCT04147247|450436166|FG002|Overall Study|Progressive disease|4|||
125383185|NCT02554812|451035511|FG006|Overall Study|Death|1|||
125383186|NCT02554812|451035512|FG007|Overall Study|Death|1|||
125383187|NCT02554812|451035513|FG008|Overall Study|Death|0|||
125383188|NCT02554812|451035514|FG009|Overall Study|Death|0|||
125383189|NCT02554812|451035515|FG010|Overall Study|Death|0|||
125383190|NCT02554812|451035516|FG011|Overall Study|Death|0|||
125383191|NCT02554812|451035517|FG012|Overall Study|Death|0|||
125383192|NCT02554812|451035518|FG013|Overall Study|Death|0|||
125383193|NCT02554812|451035519|FG014|Overall Study|Death|1|||
125383194|NCT02554812|451035520|FG015|Overall Study|Death|1|||
125383195|NCT02554812|451035521|FG016|Overall Study|Death|1|||
125383196|NCT02554812|451035522|FG017|Overall Study|Death|0|||
125220667|NCT04147247|450436167|FG003|Overall Study|Progressive disease|4|||
125220668|NCT04147247|450436168|FG004|Overall Study|Progressive disease|3|||
125383197|NCT02554812|451035523|FG018|Overall Study|Death|1|||
125383198|NCT02554812|451035524|FG019|Overall Study|Death|2|||
125383199|NCT02554812|451035525|FG020|Overall Study|Death|0|||
125383200|NCT02554812|451035526|FG021|Overall Study|Death|1|||
125383201|NCT02554812|451035527|FG022|Overall Study|Death|1|||
125383202|NCT02554812|451035528|FG023|Overall Study|Death|0|||
125383203|NCT02554812|451035529|FG024|Overall Study|Death|0|||
125383204|NCT02554812|451035530|FG025|Overall Study|Death|0|||
125383205|NCT02554812|451035531|FG026|Overall Study|Death|0|||
125383206|NCT02554812|451035505|FG000|Overall Study|Lost to Follow-up|0|||
125383207|NCT02554812|451035506|FG001|Overall Study|Lost to Follow-up|1|||
125220669|NCT04147247|450436164|FG000|Overall Study|Physician Decision|0|||
125220670|NCT04147247|450436165|FG001|Overall Study|Physician Decision|1|||
125220671|NCT04147247|450436166|FG002|Overall Study|Physician Decision|0|||
125220672|NCT04147247|450436167|FG003|Overall Study|Physician Decision|0|||
125220673|NCT04147247|450436168|FG004|Overall Study|Physician Decision|0|||
125220674|NCT04147247|450436164|FG000|Overall Study|Clinical Disease Progression|0|||
125383208|NCT02554812|451035507|FG002|Overall Study|Lost to Follow-up|0|||
125383209|NCT02554812|451035508|FG003|Overall Study|Lost to Follow-up|0|||
125383210|NCT02554812|451035509|FG004|Overall Study|Lost to Follow-up|0|||
125383211|NCT02554812|451035510|FG005|Overall Study|Lost to Follow-up|0|||
125383212|NCT02554812|451035511|FG006|Overall Study|Lost to Follow-up|0|||
125383213|NCT02554812|451035512|FG007|Overall Study|Lost to Follow-up|0|||
125137148|NCT00334815|450128846|FG001|Overall Study|patient refused treatment|1|||
125137149|NCT00334815|450128845|FG000|Overall Study|Physician Decision|2|||
125137150|NCT00334815|450128846|FG001|Overall Study|Physician Decision|4|||
125137151|NCT02197416|450128847|FG000|Overall Study|Other reasons|0|||
125137152|NCT02197416|450128848|FG001|Overall Study|Other reasons|2|||
125137153|NCT02197416|450128849|FG002|Overall Study|Other reasons|5|||
125137154|NCT02197416|450128847|FG000|Overall Study|Withdrawal by Subject|0|||
125137155|NCT02197416|450128848|FG001|Overall Study|Withdrawal by Subject|2|||
125137156|NCT02197416|450128849|FG002|Overall Study|Withdrawal by Subject|1|||
125137157|NCT02197416|450128847|FG000|Overall Study|Protocol Violation|1|||
125137158|NCT02197416|450128848|FG001|Overall Study|Protocol Violation|0|||
125137159|NCT02197416|450128849|FG002|Overall Study|Protocol Violation|1|||
125137160|NCT02197416|450128847|FG000|Overall Study|Adverse Event|0|||
125137161|NCT02197416|450128848|FG001|Overall Study|Adverse Event|0|||
125137162|NCT02197416|450128849|FG002|Overall Study|Adverse Event|1|||
125137163|NCT02451696|450128850|FG000|Overall Study|Surgery postponed|1|||
125137164|NCT02451696|450128851|FG001|Overall Study|Surgery postponed|0|||
125137165|NCT05014828|450128853|FG000|Overall Study|Study Completed by Sponsor|16|||
125137166|NCT05014828|450128854|FG001|Overall Study|Study Completed by Sponsor|16|||
125137167|NCT05014828|450128855|FG002|Overall Study|Study Completed by Sponsor|3|||
125137168|NCT05014828|450128856|FG003|Overall Study|Study Completed by Sponsor|3|||
125137169|NCT05014828|450128853|FG000|Overall Study|Death|11|||
125137170|NCT05014828|450128854|FG001|Overall Study|Death|6|||
125137171|NCT05014828|450128855|FG002|Overall Study|Death|0|||
125137172|NCT05014828|450128856|FG003|Overall Study|Death|0|||
125137173|NCT05014828|450128853|FG000|Overall Study|Lost to Follow-up|0|||
125137174|NCT05014828|450128854|FG001|Overall Study|Lost to Follow-up|0|||
125137175|NCT05014828|450128855|FG002|Overall Study|Lost to Follow-up|2|||
125137176|NCT05014828|450128856|FG003|Overall Study|Lost to Follow-up|0|||
125137177|NCT05014828|450128853|FG000|Overall Study|Miscellaneous.|0|||
125137178|NCT05014828|450128854|FG001|Overall Study|Miscellaneous.|1|||
125137179|NCT05014828|450128855|FG002|Overall Study|Miscellaneous.|0|||
125137180|NCT05014828|450128856|FG003|Overall Study|Miscellaneous.|0|||
125137181|NCT02392195|450128859|FG000|Overall Study|Lost to Follow-up|4|||
125137182|NCT02392195|450128859|FG000|Overall Study|Withdrawal by Subject|4|||
125137183|NCT00545792|450128862|FG000|Overall Study|Withdrawal by Subject|1|||
125137184|NCT03679598|450128864|FG000|Overall Study|Adverse Event|2|||
125137185|NCT03679598|450128865|FG001|Overall Study|Adverse Event|0|||
125137186|NCT03779334|450128868|FG000|Overall Study|Withdrawal by Subject|3|||
125383214|NCT02554812|451035513|FG008|Overall Study|Lost to Follow-up|0|||
125383215|NCT02554812|451035514|FG009|Overall Study|Lost to Follow-up|0|||
125383216|NCT02554812|451035515|FG010|Overall Study|Lost to Follow-up|0|||
125383217|NCT02554812|451035516|FG011|Overall Study|Lost to Follow-up|0|||
125383218|NCT02554812|451035517|FG012|Overall Study|Lost to Follow-up|0|||
125383219|NCT02554812|451035518|FG013|Overall Study|Lost to Follow-up|0|||
125383220|NCT02554812|451035519|FG014|Overall Study|Lost to Follow-up|0|||
125383221|NCT02554812|451035520|FG015|Overall Study|Lost to Follow-up|0|||
125437687|NCT02966002|451229964|FG000|Overall Study|Adverse Event|1|||
125437688|NCT02966002|451229964|FG000|Overall Study|Lost to Follow-up|1|||
125137187|NCT03779334|450128869|FG001|Overall Study|Withdrawal by Subject|0|||
125137188|NCT03779334|450128870|FG002|Overall Study|Withdrawal by Subject|0|||
125137189|NCT03779334|450128868|FG000|Overall Study|Ongoing in Study|5|||
125137190|NCT03779334|450128869|FG001|Overall Study|Ongoing in Study|13|||
125383222|NCT02554812|451035521|FG016|Overall Study|Lost to Follow-up|0|||
125383223|NCT02554812|451035522|FG017|Overall Study|Lost to Follow-up|0|||
125383224|NCT02554812|451035523|FG018|Overall Study|Lost to Follow-up|0|||
125383225|NCT02554812|451035524|FG019|Overall Study|Lost to Follow-up|0|||
125383226|NCT02554812|451035525|FG020|Overall Study|Lost to Follow-up|0|||
125383227|NCT02554812|451035526|FG021|Overall Study|Lost to Follow-up|0|||
125383228|NCT02554812|451035527|FG022|Overall Study|Lost to Follow-up|0|||
125383229|NCT02554812|451035528|FG023|Overall Study|Lost to Follow-up|0|||
125383230|NCT02554812|451035529|FG024|Overall Study|Lost to Follow-up|0|||
125383231|NCT02554812|451035530|FG025|Overall Study|Lost to Follow-up|0|||
125383232|NCT02554812|451035531|FG026|Overall Study|Lost to Follow-up|0|||
125383233|NCT02554812|451035505|FG000|Overall Study|Global deterioration of health status|4|||
125383234|NCT02554812|451035506|FG001|Overall Study|Global deterioration of health status|3|||
125383235|NCT02554812|451035507|FG002|Overall Study|Global deterioration of health status|3|||
125383236|NCT02554812|451035508|FG003|Overall Study|Global deterioration of health status|2|||
125383237|NCT02554812|451035509|FG004|Overall Study|Global deterioration of health status|5|||
125383238|NCT02554812|451035510|FG005|Overall Study|Global deterioration of health status|0|||
125383239|NCT02554812|451035511|FG006|Overall Study|Global deterioration of health status|2|||
125383240|NCT02554812|451035512|FG007|Overall Study|Global deterioration of health status|1|||
125383241|NCT02554812|451035513|FG008|Overall Study|Global deterioration of health status|1|||
125383242|NCT02554812|451035514|FG009|Overall Study|Global deterioration of health status|1|||
125383243|NCT02554812|451035515|FG010|Overall Study|Global deterioration of health status|2|||
125383244|NCT02554812|451035516|FG011|Overall Study|Global deterioration of health status|1|||
125383245|NCT02554812|451035517|FG012|Overall Study|Global deterioration of health status|0|||
125383246|NCT02554812|451035518|FG013|Overall Study|Global deterioration of health status|0|||
125383247|NCT02554812|451035519|FG014|Overall Study|Global deterioration of health status|0|||
125383248|NCT02554812|451035520|FG015|Overall Study|Global deterioration of health status|1|||
125383249|NCT02554812|451035521|FG016|Overall Study|Global deterioration of health status|0|||
125383250|NCT02554812|451035522|FG017|Overall Study|Global deterioration of health status|0|||
125383251|NCT02554812|451035523|FG018|Overall Study|Global deterioration of health status|0|||
125383252|NCT02554812|451035524|FG019|Overall Study|Global deterioration of health status|0|||
125383253|NCT02554812|451035525|FG020|Overall Study|Global deterioration of health status|0|||
125383254|NCT02554812|451035526|FG021|Overall Study|Global deterioration of health status|0|||
125383255|NCT02554812|451035527|FG022|Overall Study|Global deterioration of health status|0|||
125383256|NCT02554812|451035528|FG023|Overall Study|Global deterioration of health status|0|||
125383257|NCT02554812|451035529|FG024|Overall Study|Global deterioration of health status|0|||
125383258|NCT02554812|451035530|FG025|Overall Study|Global deterioration of health status|0|||
125383259|NCT02554812|451035531|FG026|Overall Study|Global deterioration of health status|0|||
125383260|NCT02554812|451035505|FG000|Overall Study|Progressive disease|20|||
125383261|NCT02554812|451035506|FG001|Overall Study|Progressive disease|16|||
125383262|NCT02554812|451035507|FG002|Overall Study|Progressive disease|19|||
125383263|NCT02554812|451035508|FG003|Overall Study|Progressive disease|18|||
125383264|NCT02554812|451035509|FG004|Overall Study|Progressive disease|21|||
125383265|NCT02554812|451035510|FG005|Overall Study|Progressive disease|15|||
125383266|NCT02554812|451035511|FG006|Overall Study|Progressive disease|6|||
125383267|NCT02554812|451035512|FG007|Overall Study|Progressive disease|13|||
125383268|NCT02554812|451035513|FG008|Overall Study|Progressive disease|6|||
125383269|NCT02554812|451035514|FG009|Overall Study|Progressive disease|6|||
125383270|NCT02554812|451035515|FG010|Overall Study|Progressive disease|8|||
125383271|NCT02554812|451035516|FG011|Overall Study|Progressive disease|8|||
125383272|NCT02554812|451035517|FG012|Overall Study|Progressive disease|6|||
125383273|NCT02554812|451035518|FG013|Overall Study|Progressive disease|10|||
125383274|NCT02554812|451035519|FG014|Overall Study|Progressive disease|20|||
125383275|NCT02554812|451035520|FG015|Overall Study|Progressive disease|6|||
125383276|NCT02554812|451035521|FG016|Overall Study|Progressive disease|3|||
125383277|NCT02554812|451035522|FG017|Overall Study|Progressive disease|3|||
125383278|NCT02554812|451035523|FG018|Overall Study|Progressive disease|11|||
125383279|NCT02554812|451035524|FG019|Overall Study|Progressive disease|7|||
125437689|NCT01928225|451229965|FG000|Overall Study|Pregnancy|1|||
125383280|NCT02554812|451035525|FG020|Overall Study|Progressive disease|11|||
125383281|NCT02554812|451035526|FG021|Overall Study|Progressive disease|6|||
125383282|NCT02554812|451035527|FG022|Overall Study|Progressive disease|9|||
125383283|NCT02554812|451035528|FG023|Overall Study|Progressive disease|9|||
125383284|NCT02554812|451035529|FG024|Overall Study|Progressive disease|4|||
125383285|NCT02554812|451035530|FG025|Overall Study|Progressive disease|5|||
125383286|NCT02554812|451035531|FG026|Overall Study|Progressive disease|5|||
125383287|NCT02554812|451035505|FG000|Overall Study|Other|0|||
125383288|NCT02554812|451035506|FG001|Overall Study|Other|0|||
125383289|NCT02554812|451035507|FG002|Overall Study|Other|2|||
125383290|NCT02554812|451035508|FG003|Overall Study|Other|3|||
125383291|NCT02554812|451035509|FG004|Overall Study|Other|2|||
125383292|NCT02554812|451035510|FG005|Overall Study|Other|1|||
125383293|NCT02554812|451035511|FG006|Overall Study|Other|0|||
125137191|NCT03779334|450128870|FG002|Overall Study|Ongoing in Study|5|||
125137192|NCT01175135|450128871|FG000|Overall Study|Adverse Event|2|||
125137193|NCT01175135|450128872|FG001|Overall Study|Adverse Event|5|||
125137194|NCT01175135|450128873|FG002|Overall Study|Adverse Event|3|||
125137195|NCT01175135|450128874|FG003|Overall Study|Adverse Event|4|||
125137196|NCT01175135|450128871|FG000|Overall Study|Death|1|||
125137197|NCT01175135|450128872|FG001|Overall Study|Death|0|||
125137198|NCT01175135|450128873|FG002|Overall Study|Death|0|||
125137199|NCT01175135|450128874|FG003|Overall Study|Death|0|||
125137200|NCT01175135|450128871|FG000|Overall Study|Lack of Efficacy|4|||
125137201|NCT01175135|450128872|FG001|Overall Study|Lack of Efficacy|5|||
125137202|NCT01175135|450128873|FG002|Overall Study|Lack of Efficacy|0|||
125137203|NCT01175135|450128874|FG003|Overall Study|Lack of Efficacy|5|||
125137204|NCT01175135|450128871|FG000|Overall Study|Lost to Follow-up|1|||
125137205|NCT01175135|450128872|FG001|Overall Study|Lost to Follow-up|2|||
125137206|NCT01175135|450128873|FG002|Overall Study|Lost to Follow-up|0|||
125137207|NCT01175135|450128874|FG003|Overall Study|Lost to Follow-up|0|||
125137208|NCT01175135|450128871|FG000|Overall Study|Protocol Violation|1|||
125137209|NCT01175135|450128872|FG001|Overall Study|Protocol Violation|1|||
125137210|NCT01175135|450128873|FG002|Overall Study|Protocol Violation|0|||
125137211|NCT01175135|450128874|FG003|Overall Study|Protocol Violation|0|||
125137212|NCT01175135|450128871|FG000|Overall Study|Withdrawal by Subject|4|||
125137213|NCT01175135|450128872|FG001|Overall Study|Withdrawal by Subject|8|||
125137214|NCT01175135|450128873|FG002|Overall Study|Withdrawal by Subject|5|||
125137215|NCT01175135|450128874|FG003|Overall Study|Withdrawal by Subject|5|||
125137216|NCT01175135|450128871|FG000|Overall Study|Other|3|||
125137217|NCT01175135|450128872|FG001|Overall Study|Other|1|||
125137218|NCT01175135|450128873|FG002|Overall Study|Other|3|||
125137219|NCT01175135|450128874|FG003|Overall Study|Other|0|||
125137220|NCT01175135|450128871|FG000|Overall Study|Randomized But Not Treated|0|||
125137221|NCT01175135|450128872|FG001|Overall Study|Randomized But Not Treated|0|||
125137222|NCT01175135|450128873|FG002|Overall Study|Randomized But Not Treated|1|||
125137223|NCT01175135|450128874|FG003|Overall Study|Randomized But Not Treated|0|||
125383294|NCT02554812|451035512|FG007|Overall Study|Other|0|||
125137224|NCT04692155|450128878|FG000|Overall Study|Death|1|||
125137225|NCT03957551|450128879|FG000|Overall Study|Adverse Event|2|||
125137226|NCT03957551|450128880|FG001|Overall Study|Adverse Event|2|||
125137227|NCT03957551|450128881|FG002|Overall Study|Adverse Event|6|||
125137228|NCT03957551|450128879|FG000|Overall Study|Physician Decision|1|||
125383295|NCT02554812|451035513|FG008|Overall Study|Other|1|||
125383296|NCT02554812|451035514|FG009|Overall Study|Other|1|||
125383297|NCT02554812|451035515|FG010|Overall Study|Other|0|||
125383298|NCT02554812|451035516|FG011|Overall Study|Other|0|||
125383299|NCT02554812|451035517|FG012|Overall Study|Other|1|||
125383300|NCT02554812|451035518|FG013|Overall Study|Other|0|||
125383301|NCT02554812|451035519|FG014|Overall Study|Other|1|||
125383302|NCT02554812|451035520|FG015|Overall Study|Other|0|||
125383303|NCT02554812|451035521|FG016|Overall Study|Other|0|||
125137229|NCT03957551|450128880|FG001|Overall Study|Physician Decision|0|||
125137230|NCT03957551|450128881|FG002|Overall Study|Physician Decision|2|||
125137231|NCT03957551|450128879|FG000|Overall Study|Withdrawal by Subject|1|||
125137232|NCT03957551|450128880|FG001|Overall Study|Withdrawal by Subject|0|||
125137233|NCT03957551|450128881|FG002|Overall Study|Withdrawal by Subject|2|||
125220675|NCT04147247|450436165|FG001|Overall Study|Clinical Disease Progression|0|||
125137234|NCT03957551|450128879|FG000|Overall Study|Disease progression|1|||
125220676|NCT04147247|450436166|FG002|Overall Study|Clinical Disease Progression|0|||
125137235|NCT03957551|450128880|FG001|Overall Study|Disease progression|0|||
125137236|NCT03957551|450128881|FG002|Overall Study|Disease progression|8|||
125137237|NCT03676634|450128884|FG000|Overall Study|Red blood cell loss|1|||
125220677|NCT04147247|450436167|FG003|Overall Study|Clinical Disease Progression|0|||
125137238|NCT03676634|450128884|FG000|Overall Study|Out-of-limit pulse|2|||
125383304|NCT02554812|451035522|FG017|Overall Study|Other|0|||
125383305|NCT02554812|451035523|FG018|Overall Study|Other|0|||
125383306|NCT02554812|451035524|FG019|Overall Study|Other|0|||
125383307|NCT02554812|451035525|FG020|Overall Study|Other|0|||
125383308|NCT02554812|451035526|FG021|Overall Study|Other|2|||
125383309|NCT02554812|451035527|FG022|Overall Study|Other|0|||
125383310|NCT02554812|451035528|FG023|Overall Study|Other|0|||
125383311|NCT02554812|451035529|FG024|Overall Study|Other|0|||
125383312|NCT02554812|451035530|FG025|Overall Study|Other|0|||
125383313|NCT02554812|451035531|FG026|Overall Study|Other|0|||
125383314|NCT02554812|451035505|FG000|Overall Study|Withdrawal by Subject|1|||
125383315|NCT02554812|451035506|FG001|Overall Study|Withdrawal by Subject|0|||
125383316|NCT02554812|451035507|FG002|Overall Study|Withdrawal by Subject|0|||
125383317|NCT02554812|451035508|FG003|Overall Study|Withdrawal by Subject|2|||
125383318|NCT02554812|451035509|FG004|Overall Study|Withdrawal by Subject|2|||
125383319|NCT02554812|451035510|FG005|Overall Study|Withdrawal by Subject|3|||
125383320|NCT02554812|451035511|FG006|Overall Study|Withdrawal by Subject|0|||
125383321|NCT02554812|451035512|FG007|Overall Study|Withdrawal by Subject|0|||
125383322|NCT02554812|451035513|FG008|Overall Study|Withdrawal by Subject|1|||
125383323|NCT02554812|451035514|FG009|Overall Study|Withdrawal by Subject|1|||
125383324|NCT02554812|451035515|FG010|Overall Study|Withdrawal by Subject|0|||
125383325|NCT02554812|451035516|FG011|Overall Study|Withdrawal by Subject|1|||
125383326|NCT02554812|451035517|FG012|Overall Study|Withdrawal by Subject|1|||
125383327|NCT02554812|451035518|FG013|Overall Study|Withdrawal by Subject|1|||
125383328|NCT02554812|451035519|FG014|Overall Study|Withdrawal by Subject|1|||
125383329|NCT02554812|451035520|FG015|Overall Study|Withdrawal by Subject|1|||
125383330|NCT02554812|451035521|FG016|Overall Study|Withdrawal by Subject|3|||
125383331|NCT02554812|451035522|FG017|Overall Study|Withdrawal by Subject|1|||
125383332|NCT02554812|451035523|FG018|Overall Study|Withdrawal by Subject|0|||
125383333|NCT02554812|451035524|FG019|Overall Study|Withdrawal by Subject|2|||
125383334|NCT02554812|451035525|FG020|Overall Study|Withdrawal by Subject|0|||
125383335|NCT02554812|451035526|FG021|Overall Study|Withdrawal by Subject|1|||
125383336|NCT02554812|451035527|FG022|Overall Study|Withdrawal by Subject|0|||
125383337|NCT02554812|451035528|FG023|Overall Study|Withdrawal by Subject|1|||
125383338|NCT02554812|451035529|FG024|Overall Study|Withdrawal by Subject|0|||
125383339|NCT02554812|451035530|FG025|Overall Study|Withdrawal by Subject|0|||
125383340|NCT02554812|451035531|FG026|Overall Study|Withdrawal by Subject|1|||
125383341|NCT02554812|451035505|FG000|Overall Study|Physician Decision|1|||
125383342|NCT02554812|451035506|FG001|Overall Study|Physician Decision|0|||
125383343|NCT02554812|451035507|FG002|Overall Study|Physician Decision|0|||
125383344|NCT02554812|451035508|FG003|Overall Study|Physician Decision|1|||
125383345|NCT02554812|451035509|FG004|Overall Study|Physician Decision|0|||
125383346|NCT02554812|451035510|FG005|Overall Study|Physician Decision|1|||
125437690|NCT01928225|451229966|FG001|Overall Study|Pregnancy|0|||
125437691|NCT01928225|451229965|FG000|Overall Study|basaloid cervical cancer|1|||
125437692|NCT01928225|451229966|FG001|Overall Study|basaloid cervical cancer|0|||
125437693|NCT01928225|451229965|FG000|Overall Study|Lost to Follow-up|1|||
125137239|NCT00540423|450128890|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125137240|NCT00540423|450128891|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125137241|NCT00540423|450128892|FG002|Double-Blind Treatment Period|Adverse Event|0|||
125383347|NCT02554812|451035511|FG006|Overall Study|Physician Decision|0|||
125383348|NCT02554812|451035512|FG007|Overall Study|Physician Decision|0|||
125383349|NCT02554812|451035513|FG008|Overall Study|Physician Decision|0|||
125383350|NCT02554812|451035514|FG009|Overall Study|Physician Decision|0|||
125383351|NCT02554812|451035515|FG010|Overall Study|Physician Decision|1|||
125383352|NCT02554812|451035516|FG011|Overall Study|Physician Decision|0|||
125383353|NCT02554812|451035517|FG012|Overall Study|Physician Decision|0|||
125383354|NCT02554812|451035518|FG013|Overall Study|Physician Decision|0|||
125383355|NCT02554812|451035519|FG014|Overall Study|Physician Decision|0|||
125383356|NCT02554812|451035520|FG015|Overall Study|Physician Decision|0|||
125383357|NCT02554812|451035521|FG016|Overall Study|Physician Decision|1|||
125383358|NCT02554812|451035522|FG017|Overall Study|Physician Decision|1|||
125383359|NCT02554812|451035523|FG018|Overall Study|Physician Decision|0|||
125383360|NCT02554812|451035524|FG019|Overall Study|Physician Decision|1|||
125383361|NCT02554812|451035525|FG020|Overall Study|Physician Decision|1|||
125383362|NCT02554812|451035526|FG021|Overall Study|Physician Decision|0|||
125383363|NCT02554812|451035527|FG022|Overall Study|Physician Decision|1|||
125383364|NCT02554812|451035528|FG023|Overall Study|Physician Decision|0|||
125383365|NCT02554812|451035529|FG024|Overall Study|Physician Decision|0|||
125383366|NCT02554812|451035530|FG025|Overall Study|Physician Decision|0|||
125383367|NCT02554812|451035531|FG026|Overall Study|Physician Decision|0|||
125383368|NCT02554812|451035505|FG000|Overall Study|Study terminated by sponsor|0|||
125383369|NCT02554812|451035506|FG001|Overall Study|Study terminated by sponsor|0|||
125383370|NCT02554812|451035507|FG002|Overall Study|Study terminated by sponsor|0|||
125383371|NCT02554812|451035508|FG003|Overall Study|Study terminated by sponsor|0|||
125383372|NCT02554812|451035509|FG004|Overall Study|Study terminated by sponsor|0|||
125383373|NCT02554812|451035510|FG005|Overall Study|Study terminated by sponsor|0|||
125437694|NCT01928225|451229966|FG001|Overall Study|Lost to Follow-up|3|||
125437695|NCT03321006|451229969|FG000|Overall Study|Death|1|||
125137242|NCT00540423|450128890|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
125137243|NCT00540423|450128891|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
125137244|NCT00540423|450128892|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
125137245|NCT03131895|450128893|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
125137246|NCT03131895|450128894|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
125383374|NCT02554812|451035511|FG006|Overall Study|Study terminated by sponsor|0|||
125437696|NCT03321006|451229970|FG001|Overall Study|Death|0|||
125383375|NCT02554812|451035512|FG007|Overall Study|Study terminated by sponsor|0|||
125383376|NCT02554812|451035513|FG008|Overall Study|Study terminated by sponsor|0|||
125137247|NCT03131895|450128895|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
125137248|NCT03131895|450128896|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
125137249|NCT03131895|450128893|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
125137250|NCT03131895|450128894|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
125137251|NCT03131895|450128895|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
125137252|NCT03131895|450128896|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
125137253|NCT03131895|450128893|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125137254|NCT03131895|450128894|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
125137255|NCT03131895|450128895|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125137256|NCT03131895|450128896|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
125137257|NCT03131895|450128893|FG000|Washout Period (at Least 5 Days)|Other|0|||
125137258|NCT03131895|450128894|FG001|Washout Period (at Least 5 Days)|Other|0|||
125137259|NCT03131895|450128895|FG002|Washout Period (at Least 5 Days)|Other|2|||
125137260|NCT03131895|450128896|FG003|Washout Period (at Least 5 Days)|Other|0|||
125137261|NCT03131895|450128893|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
125137262|NCT03131895|450128894|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
125137263|NCT03131895|450128895|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
125137264|NCT03131895|450128896|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
125137265|NCT03131895|450128893|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
125137266|NCT03131895|450128894|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
125137267|NCT03131895|450128895|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
125137268|NCT03131895|450128896|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
125137269|NCT00216736|450128905|FG000|Overall Study|Lost to Follow-up|1|||
125137270|NCT00216736|450128906|FG001|Overall Study|Lost to Follow-up|1|||
125137271|NCT00418145|450128907|FG000|Overall Study|study terminated|6|||
125137272|NCT03214588|450128908|FG000|Overall Study|Adverse Event|1|||
125137273|NCT03214588|450128909|FG001|Overall Study|Adverse Event|0|||
125437697|NCT03321006|451229969|FG000|Overall Study|Lack of Efficacy|1|||
125437698|NCT03321006|451229970|FG001|Overall Study|Lack of Efficacy|0|||
125437699|NCT00365378|451229971|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
125437700|NCT00365378|451229972|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
125437701|NCT00365378|451229973|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
125437702|NCT00365378|451229971|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
125437703|NCT00365378|451229972|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
125437704|NCT00365378|451229973|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
125437705|NCT00365378|451229971|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
125437706|NCT00365378|451229972|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
125437707|NCT00365378|451229973|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
125437708|NCT00365378|451229971|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
125437709|NCT00365378|451229972|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
125437710|NCT00365378|451229973|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
125437711|NCT00365378|451229971|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
125437712|NCT00365378|451229972|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
125437713|NCT00365378|451229973|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
125437714|NCT00365378|451229971|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
125437715|NCT00365378|451229972|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
125137274|NCT03214588|450128910|FG002|Overall Study|Adverse Event|2|||
125137275|NCT03214588|450128908|FG000|Overall Study|Reason Not Specified|0|||
125137276|NCT03214588|450128909|FG001|Overall Study|Reason Not Specified|1|||
125137277|NCT03214588|450128910|FG002|Overall Study|Reason Not Specified|0|||
125137278|NCT03480763|450128915|FG000|Overall Study|Withdrawal by Subject|18|||
125137279|NCT03480763|450128916|FG001|Overall Study|Withdrawal by Subject|10|||
125137280|NCT03480763|450128915|FG000|Overall Study|Lost to Follow-up|4|||
125137281|NCT03480763|450128916|FG001|Overall Study|Lost to Follow-up|7|||
125137282|NCT03480763|450128915|FG000|Overall Study|non-study pneumococcal vaccine|1|||
125137283|NCT03480763|450128916|FG001|Overall Study|non-study pneumococcal vaccine|0|||
125137284|NCT03480763|450128915|FG000|Overall Study|oncological treatment|0|||
125437716|NCT00365378|451229973|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
125437717|NCT00365378|451229971|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
125137285|NCT03480763|450128916|FG001|Overall Study|oncological treatment|2|||
125137286|NCT03480763|450128915|FG000|Overall Study|pain with vaccination|1|||
125137287|NCT03480763|450128916|FG001|Overall Study|pain with vaccination|0|||
125137288|NCT03629054|450128920|FG000|Period 2 (4 Days)|Not treated|0|||
125137289|NCT03629054|450128921|FG001|Period 2 (4 Days)|Not treated|1|||
125137290|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
125137291|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
125137292|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
125137293|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
125137294|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
125137295|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
125137296|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Death|9|||
125220678|NCT04147247|450436168|FG004|Overall Study|Clinical Disease Progression|1|||
125137297|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Death|7|||
125137298|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Death|14|||
125137299|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Death|7|||
125137300|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Death|0|||
125137301|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Death|0|||
125137302|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
125137303|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
125137304|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
125137305|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
125137306|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
125137307|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
125137308|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Other Event|49|||
125137309|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Other Event|52|||
125137310|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Other Event|41|||
125137311|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Other Event|58|||
125137312|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Other Event|0|||
125137313|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Other Event|0|||
125137314|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
125137315|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
125137316|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
125137317|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
125137318|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
125137319|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
125137320|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
125137321|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
125137322|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
125137323|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
125137324|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
125137325|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
125137326|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
125137327|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
125137328|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
125137329|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
125137330|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
125137331|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
125137332|NCT00205777|450128922|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
125137333|NCT00205777|450128923|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
125137334|NCT00205777|450128924|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
125137335|NCT00205777|450128925|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
125137336|NCT00205777|450128926|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
125137337|NCT00205777|450128927|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
125137338|NCT00205777|450128922|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
125137339|NCT00205777|450128923|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
125137340|NCT00205777|450128924|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
125137341|NCT00205777|450128925|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
125137342|NCT00205777|450128926|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
125137343|NCT00205777|450128927|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
125137344|NCT00205777|450128922|FG000|Completed Core Study, Entered SE I|Other Event|52|||
125137345|NCT00205777|450128923|FG001|Completed Core Study, Entered SE I|Other Event|46|||
125137346|NCT00205777|450128924|FG002|Completed Core Study, Entered SE I|Other Event|47|||
125137347|NCT00205777|450128925|FG003|Completed Core Study, Entered SE I|Other Event|50|||
125137348|NCT00205777|450128926|FG004|Completed Core Study, Entered SE I|Other Event|0|||
125137349|NCT00205777|450128927|FG005|Completed Core Study, Entered SE I|Other Event|0|||
125220679|NCT04147247|450436164|FG000|Overall Study|Adverse Event|0|||
125137350|NCT00205777|450128922|FG000|Study Extension I|Adverse Event|57|||
125137351|NCT00205777|450128923|FG001|Study Extension I|Adverse Event|0|||
125137352|NCT00205777|450128924|FG002|Study Extension I|Adverse Event|0|||
125137353|NCT00205777|450128925|FG003|Study Extension I|Adverse Event|61|||
125137354|NCT00205777|450128926|FG004|Study Extension I|Adverse Event|58|||
125220680|NCT04147247|450436165|FG001|Overall Study|Adverse Event|0|||
125220681|NCT04147247|450436166|FG002|Overall Study|Adverse Event|1|||
125220682|NCT04147247|450436167|FG003|Overall Study|Adverse Event|0|||
125220683|NCT04147247|450436168|FG004|Overall Study|Adverse Event|1|||
125220684|NCT00130689|450436169|FG000|Overall Study|Progressive Disease|29|||
125220685|NCT00130689|450436169|FG000|Overall Study|Death|1|||
125220686|NCT00130689|450436169|FG000|Overall Study|Clinical Deterioration|4|||
125220687|NCT00130689|450436169|FG000|Overall Study|Withdrawal by Subject|3|||
125220688|NCT00130689|450436169|FG000|Overall Study|Ineligible|6|||
125220689|NCT00943397|450436170|FG000|Overall Study|Adverse Event|0|||
125220690|NCT00943397|450436171|FG001|Overall Study|Adverse Event|6|||
125137355|NCT00205777|450128927|FG005|Study Extension I|Adverse Event|0|||
125137356|NCT00205777|450128922|FG000|Study Extension I|Death|5|||
125137357|NCT00205777|450128923|FG001|Study Extension I|Death|0|||
125137358|NCT00205777|450128924|FG002|Study Extension I|Death|0|||
125137359|NCT00205777|450128925|FG003|Study Extension I|Death|1|||
125137360|NCT00205777|450128926|FG004|Study Extension I|Death|2|||
125137361|NCT00205777|450128927|FG005|Study Extension I|Death|0|||
125137362|NCT00205777|450128922|FG000|Study Extension I|Withdrawal by Subject|99|||
125137363|NCT00205777|450128923|FG001|Study Extension I|Withdrawal by Subject|0|||
125137364|NCT00205777|450128924|FG002|Study Extension I|Withdrawal by Subject|0|||
125137365|NCT00205777|450128925|FG003|Study Extension I|Withdrawal by Subject|106|||
125137366|NCT00205777|450128926|FG004|Study Extension I|Withdrawal by Subject|89|||
125137367|NCT00205777|450128927|FG005|Study Extension I|Withdrawal by Subject|0|||
125137368|NCT00205777|450128922|FG000|Study Extension I|Protocol Violation|4|||
125137369|NCT00205777|450128923|FG001|Study Extension I|Protocol Violation|0|||
125137370|NCT00205777|450128924|FG002|Study Extension I|Protocol Violation|0|||
125137371|NCT00205777|450128925|FG003|Study Extension I|Protocol Violation|8|||
125137372|NCT00205777|450128926|FG004|Study Extension I|Protocol Violation|8|||
125137373|NCT00205777|450128927|FG005|Study Extension I|Protocol Violation|0|||
125137374|NCT00205777|450128922|FG000|Study Extension I|Lack of Efficacy|0|||
125137375|NCT00205777|450128923|FG001|Study Extension I|Lack of Efficacy|0|||
125137376|NCT00205777|450128924|FG002|Study Extension I|Lack of Efficacy|0|||
125137377|NCT00205777|450128925|FG003|Study Extension I|Lack of Efficacy|1|||
125137378|NCT00205777|450128926|FG004|Study Extension I|Lack of Efficacy|2|||
125137379|NCT00205777|450128927|FG005|Study Extension I|Lack of Efficacy|0|||
125137380|NCT00205777|450128922|FG000|Study Extension I|Failed to return|15|||
125137381|NCT00205777|450128923|FG001|Study Extension I|Failed to return|0|||
125137382|NCT00205777|450128924|FG002|Study Extension I|Failed to return|0|||
125220691|NCT00943397|450436170|FG000|Overall Study|Lost to Follow-up|0|||
125220692|NCT00943397|450436171|FG001|Overall Study|Lost to Follow-up|4|||
125383377|NCT02554812|451035514|FG009|Overall Study|Study terminated by sponsor|0|||
125137383|NCT00205777|450128925|FG003|Study Extension I|Failed to return|17|||
125137384|NCT00205777|450128926|FG004|Study Extension I|Failed to return|13|||
125220693|NCT00943397|450436170|FG000|Overall Study|Protocol Violation|2|||
125137385|NCT00205777|450128927|FG005|Study Extension I|Failed to return|0|||
125137386|NCT00205777|450128922|FG000|Study Extension I|Other Event|34|||
125137387|NCT00205777|450128923|FG001|Study Extension I|Other Event|0|||
125137388|NCT00205777|450128924|FG002|Study Extension I|Other Event|0|||
125137389|NCT00205777|450128925|FG003|Study Extension I|Other Event|34|||
125137390|NCT00205777|450128926|FG004|Study Extension I|Other Event|29|||
125137391|NCT00205777|450128927|FG005|Study Extension I|Other Event|0|||
125137392|NCT00205777|450128922|FG000|Study Extension I|Withdrawn as per protocol|0|||
125137393|NCT00205777|450128923|FG001|Study Extension I|Withdrawn as per protocol|0|||
125137394|NCT00205777|450128924|FG002|Study Extension I|Withdrawn as per protocol|1070|||
125137395|NCT00205777|450128925|FG003|Study Extension I|Withdrawn as per protocol|0|||
125137396|NCT00205777|450128926|FG004|Study Extension I|Withdrawn as per protocol|0|||
125137397|NCT00205777|450128927|FG005|Study Extension I|Withdrawn as per protocol|0|||
125137398|NCT00205777|450128922|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
125137399|NCT00205777|450128923|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
125137400|NCT00205777|450128924|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
125137401|NCT00205777|450128925|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
125137402|NCT00205777|450128926|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
125220694|NCT00943397|450436171|FG001|Overall Study|Protocol Violation|5|||
125437718|NCT00365378|451229972|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
125437719|NCT00365378|451229973|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
125437720|NCT00365378|451229971|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
125437721|NCT00365378|451229972|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
125437722|NCT00365378|451229973|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
125437723|NCT00365378|451229971|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
125437724|NCT00365378|451229972|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
125437725|NCT00365378|451229973|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
125437726|NCT00365378|451229971|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
125437727|NCT00365378|451229972|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
125437728|NCT00365378|451229973|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
125437729|NCT00365378|451229971|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
125437730|NCT00365378|451229972|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
125437731|NCT00365378|451229973|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
125437732|NCT00365378|451229971|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
125437733|NCT00365378|451229972|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
125437734|NCT00365378|451229973|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
125437735|NCT00365378|451229971|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
125437736|NCT00365378|451229972|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
125437737|NCT00365378|451229973|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
125437738|NCT00365378|451229971|FG000|Extension|Adverse Event|0|||
125437739|NCT00365378|451229972|FG001|Extension|Adverse Event|0|||
125437740|NCT00365378|451229973|FG002|Extension|Adverse Event|1|||
125437741|NCT00365378|451229971|FG000|Extension|Moved|0|||
125437742|NCT00365378|451229972|FG001|Extension|Moved|0|||
125437743|NCT00365378|451229973|FG002|Extension|Moved|8|||
125437744|NCT00365378|451229971|FG000|Extension|Lost to Follow-up|0|||
125437745|NCT00365378|451229972|FG001|Extension|Lost to Follow-up|0|||
125437746|NCT00365378|451229973|FG002|Extension|Lost to Follow-up|57|||
125437747|NCT00365378|451229971|FG000|Extension|Protocol Violation|0|||
125437748|NCT00365378|451229972|FG001|Extension|Protocol Violation|0|||
125437749|NCT00365378|451229973|FG002|Extension|Protocol Violation|2|||
125437750|NCT00365378|451229971|FG000|Extension|Withdrawal by Subject|0|||
125437751|NCT00365378|451229972|FG001|Extension|Withdrawal by Subject|0|||
125437752|NCT00365378|451229973|FG002|Extension|Withdrawal by Subject|98|||
125437753|NCT00365378|451229971|FG000|Extension|Other|0|||
125437754|NCT00365378|451229972|FG001|Extension|Other|0|||
125437755|NCT00365378|451229973|FG002|Extension|Other|31|||
125437756|NCT04161807|451229979|FG000|Overall Study|Withdrawal by Subject|2|||
125437757|NCT04161807|451229979|FG000|Overall Study|Performed only 1 treatment|2|||
125437758|NCT02006121|451229980|FG000|Double Blind Phase|Adverse Event|6|||
125437759|NCT02006121|451229981|FG001|Double Blind Phase|Adverse Event|0|||
125437760|NCT02006121|451229980|FG000|Double Blind Phase|Lack of Efficacy|1|||
125437761|NCT02006121|451229981|FG001|Double Blind Phase|Lack of Efficacy|16|||
125437762|NCT02006121|451229980|FG000|Double Blind Phase|Withdrawal by Subject|3|||
125437763|NCT02006121|451229981|FG001|Double Blind Phase|Withdrawal by Subject|4|||
125437764|NCT02006121|451229980|FG000|Double Blind Phase|Non-compliance with study drug|1|||
125437765|NCT02006121|451229981|FG001|Double Blind Phase|Non-compliance with study drug|3|||
125437766|NCT02006121|451229980|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
125437767|NCT02006121|451229981|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
125437768|NCT02006121|451229980|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
125437769|NCT02006121|451229981|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
125437770|NCT02006121|451229980|FG000|Open Label Phase|Adverse Event|15|||
125437771|NCT02006121|451229981|FG001|Open Label Phase|Adverse Event|0|||
125437772|NCT02006121|451229980|FG000|Open Label Phase|Lack of Efficacy|2|||
125437773|NCT02006121|451229981|FG001|Open Label Phase|Lack of Efficacy|0|||
125437774|NCT02006121|451229980|FG000|Open Label Phase|Protocol Violation|2|||
125437775|NCT02006121|451229981|FG001|Open Label Phase|Protocol Violation|0|||
125383378|NCT02554812|451035515|FG010|Overall Study|Study terminated by sponsor|0|||
125383379|NCT02554812|451035516|FG011|Overall Study|Study terminated by sponsor|0|||
125383380|NCT02554812|451035517|FG012|Overall Study|Study terminated by sponsor|0|||
125383381|NCT02554812|451035518|FG013|Overall Study|Study terminated by sponsor|0|||
125383382|NCT02554812|451035519|FG014|Overall Study|Study terminated by sponsor|0|||
125383383|NCT02554812|451035520|FG015|Overall Study|Study terminated by sponsor|0|||
125383384|NCT02554812|451035521|FG016|Overall Study|Study terminated by sponsor|0|||
125383385|NCT02554812|451035522|FG017|Overall Study|Study terminated by sponsor|0|||
125383386|NCT02554812|451035523|FG018|Overall Study|Study terminated by sponsor|0|||
125383387|NCT02554812|451035524|FG019|Overall Study|Study terminated by sponsor|0|||
125383388|NCT02554812|451035525|FG020|Overall Study|Study terminated by sponsor|0|||
125383389|NCT02554812|451035526|FG021|Overall Study|Study terminated by sponsor|0|||
125383390|NCT02554812|451035527|FG022|Overall Study|Study terminated by sponsor|0|||
125383391|NCT02554812|451035528|FG023|Overall Study|Study terminated by sponsor|0|||
125383392|NCT02554812|451035529|FG024|Overall Study|Study terminated by sponsor|1|||
125383393|NCT02554812|451035530|FG025|Overall Study|Study terminated by sponsor|0|||
125383394|NCT02554812|451035531|FG026|Overall Study|Study terminated by sponsor|0|||
125383395|NCT02554812|451035505|FG000|Overall Study|No longer meets eligibility criteria|0|||
125383396|NCT02554812|451035506|FG001|Overall Study|No longer meets eligibility criteria|1|||
125383397|NCT02554812|451035507|FG002|Overall Study|No longer meets eligibility criteria|0|||
125383398|NCT02554812|451035508|FG003|Overall Study|No longer meets eligibility criteria|0|||
125383399|NCT02554812|451035509|FG004|Overall Study|No longer meets eligibility criteria|0|||
125383400|NCT02554812|451035510|FG005|Overall Study|No longer meets eligibility criteria|0|||
125383401|NCT02554812|451035511|FG006|Overall Study|No longer meets eligibility criteria|0|||
125383402|NCT02554812|451035512|FG007|Overall Study|No longer meets eligibility criteria|0|||
125383403|NCT02554812|451035513|FG008|Overall Study|No longer meets eligibility criteria|0|||
125383404|NCT02554812|451035514|FG009|Overall Study|No longer meets eligibility criteria|0|||
125383405|NCT02554812|451035515|FG010|Overall Study|No longer meets eligibility criteria|0|||
125383406|NCT02554812|451035516|FG011|Overall Study|No longer meets eligibility criteria|0|||
125383407|NCT02554812|451035517|FG012|Overall Study|No longer meets eligibility criteria|0|||
125383408|NCT02554812|451035518|FG013|Overall Study|No longer meets eligibility criteria|0|||
125383409|NCT02554812|451035519|FG014|Overall Study|No longer meets eligibility criteria|0|||
125383410|NCT02554812|451035520|FG015|Overall Study|No longer meets eligibility criteria|0|||
125383411|NCT02554812|451035521|FG016|Overall Study|No longer meets eligibility criteria|0|||
125383412|NCT02554812|451035522|FG017|Overall Study|No longer meets eligibility criteria|0|||
125383413|NCT02554812|451035523|FG018|Overall Study|No longer meets eligibility criteria|0|||
125383414|NCT02554812|451035524|FG019|Overall Study|No longer meets eligibility criteria|0|||
125383415|NCT02554812|451035525|FG020|Overall Study|No longer meets eligibility criteria|0|||
125383416|NCT02554812|451035526|FG021|Overall Study|No longer meets eligibility criteria|0|||
125383417|NCT02554812|451035527|FG022|Overall Study|No longer meets eligibility criteria|0|||
125383418|NCT02554812|451035528|FG023|Overall Study|No longer meets eligibility criteria|0|||
125383419|NCT02554812|451035529|FG024|Overall Study|No longer meets eligibility criteria|0|||
125137403|NCT00205777|450128927|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
125137404|NCT00205777|450128922|FG000|Study Extension II|Adverse Event|0|||
125137405|NCT00205777|450128923|FG001|Study Extension II|Adverse Event|0|||
125137406|NCT00205777|450128924|FG002|Study Extension II|Adverse Event|0|||
125137407|NCT00205777|450128925|FG003|Study Extension II|Adverse Event|14|||
125137408|NCT00205777|450128926|FG004|Study Extension II|Adverse Event|0|||
125137409|NCT00205777|450128927|FG005|Study Extension II|Adverse Event|30|||
125137410|NCT00205777|450128922|FG000|Study Extension II|Death|0|||
125137411|NCT00205777|450128923|FG001|Study Extension II|Death|0|||
125383420|NCT02554812|451035530|FG025|Overall Study|No longer meets eligibility criteria|0|||
125383421|NCT02554812|451035531|FG026|Overall Study|No longer meets eligibility criteria|0|||
125383422|NCT00605813|451036952|FG000|Overall Study|Protocol Violation|25|||
125383423|NCT00573755|451036953|FG000|Overall Study|Still receiving treatment|1|||
125383424|NCT00573755|451036954|FG001|Overall Study|Still receiving treatment|0|||
125383425|NCT02132767|451036957|FG000|Overall Study|Death|3|||
125383426|NCT02132767|451036958|FG001|Overall Study|Death|2|||
125383427|NCT02132767|451036957|FG000|Overall Study|Withdrawal by Subject|10|||
125383428|NCT02132767|451036958|FG001|Overall Study|Withdrawal by Subject|9|||
125383429|NCT02132767|451036957|FG000|Overall Study|Lost to Follow-up|4|||
125383430|NCT02132767|451036958|FG001|Overall Study|Lost to Follow-up|4|||
125383431|NCT00778700|451036961|FG000|Overall Study|Adverse Event|6|||
125383432|NCT00778700|451036962|FG001|Overall Study|Adverse Event|1|||
125383433|NCT00778700|451036963|FG002|Overall Study|Adverse Event|3|||
125383434|NCT00778700|451036964|FG003|Overall Study|Adverse Event|5|||
125383435|NCT00778700|451036961|FG000|Overall Study|Protocol Violation|1|||
125383436|NCT00778700|451036962|FG001|Overall Study|Protocol Violation|1|||
125383437|NCT00778700|451036963|FG002|Overall Study|Protocol Violation|0|||
125383438|NCT00778700|451036964|FG003|Overall Study|Protocol Violation|0|||
125383439|NCT00778700|451036961|FG000|Overall Study|Subject Withdrew Consent|6|||
125383440|NCT00778700|451036962|FG001|Overall Study|Subject Withdrew Consent|4|||
125137412|NCT00205777|450128924|FG002|Study Extension II|Death|0|||
125137413|NCT00205777|450128925|FG003|Study Extension II|Death|2|||
125137414|NCT00205777|450128926|FG004|Study Extension II|Death|0|||
125137415|NCT00205777|450128927|FG005|Study Extension II|Death|5|||
125137416|NCT00205777|450128922|FG000|Study Extension II|Withdrawal by Subject|0|||
125137417|NCT00205777|450128923|FG001|Study Extension II|Withdrawal by Subject|0|||
125137418|NCT00205777|450128924|FG002|Study Extension II|Withdrawal by Subject|0|||
125137419|NCT00205777|450128925|FG003|Study Extension II|Withdrawal by Subject|35|||
125137420|NCT00205777|450128926|FG004|Study Extension II|Withdrawal by Subject|0|||
125137421|NCT00205777|450128927|FG005|Study Extension II|Withdrawal by Subject|59|||
125137422|NCT00205777|450128922|FG000|Study Extension II|Protocol Violation|0|||
125137423|NCT00205777|450128923|FG001|Study Extension II|Protocol Violation|0|||
125137424|NCT00205777|450128924|FG002|Study Extension II|Protocol Violation|0|||
125137425|NCT00205777|450128925|FG003|Study Extension II|Protocol Violation|1|||
125137426|NCT00205777|450128926|FG004|Study Extension II|Protocol Violation|0|||
125137427|NCT00205777|450128927|FG005|Study Extension II|Protocol Violation|10|||
125137428|NCT00205777|450128922|FG000|Study Extension II|Lack of Efficacy|0|||
125137429|NCT00205777|450128923|FG001|Study Extension II|Lack of Efficacy|0|||
125137430|NCT00205777|450128924|FG002|Study Extension II|Lack of Efficacy|0|||
125137431|NCT00205777|450128925|FG003|Study Extension II|Lack of Efficacy|0|||
125137432|NCT00205777|450128926|FG004|Study Extension II|Lack of Efficacy|0|||
125137433|NCT00205777|450128927|FG005|Study Extension II|Lack of Efficacy|1|||
125137434|NCT00205777|450128922|FG000|Study Extension II|Failed to return|0|||
125137435|NCT00205777|450128923|FG001|Study Extension II|Failed to return|0|||
125137436|NCT00205777|450128924|FG002|Study Extension II|Failed to return|0|||
125137437|NCT00205777|450128925|FG003|Study Extension II|Failed to return|14|||
125137438|NCT00205777|450128926|FG004|Study Extension II|Failed to return|0|||
125137439|NCT00205777|450128927|FG005|Study Extension II|Failed to return|26|||
125137440|NCT00205777|450128922|FG000|Study Extension II|Other Event|0|||
125137441|NCT00205777|450128923|FG001|Study Extension II|Other Event|0|||
125137442|NCT00205777|450128924|FG002|Study Extension II|Other Event|0|||
125137443|NCT00205777|450128925|FG003|Study Extension II|Other Event|12|||
125137444|NCT00205777|450128926|FG004|Study Extension II|Other Event|0|||
125137445|NCT00205777|450128927|FG005|Study Extension II|Other Event|20|||
125137446|NCT00205777|450128922|FG000|Study Extension II|Enrolled but not treated|0|||
125137447|NCT00205777|450128923|FG001|Study Extension II|Enrolled but not treated|0|||
125137448|NCT00205777|450128924|FG002|Study Extension II|Enrolled but not treated|0|||
125137449|NCT00205777|450128925|FG003|Study Extension II|Enrolled but not treated|71|||
125137450|NCT00205777|450128926|FG004|Study Extension II|Enrolled but not treated|0|||
125137451|NCT00205777|450128927|FG005|Study Extension II|Enrolled but not treated|131|||
125137452|NCT00367133|450128930|FG000|2 Years|Death|20|||
125137453|NCT00367133|450128931|FG001|2 Years|Death|12|||
125137454|NCT00367133|450128932|FG002|2 Years|Death|12|||
125137455|NCT00367133|450128930|FG000|2 Years|Dropped|34|||
125220695|NCT00943397|450436170|FG000|Overall Study|Withdrawal by Subject|1|||
125383441|NCT00778700|451036963|FG002|Overall Study|Subject Withdrew Consent|1|||
125383442|NCT00778700|451036964|FG003|Overall Study|Subject Withdrew Consent|4|||
125383443|NCT00778700|451036961|FG000|Overall Study|Lost to Follow-up|3|||
125383444|NCT00778700|451036962|FG001|Overall Study|Lost to Follow-up|1|||
125137456|NCT00367133|450128931|FG001|2 Years|Dropped|19|||
125137457|NCT00367133|450128932|FG002|2 Years|Dropped|33|||
125137458|NCT00367133|450128930|FG000|2 Years|Missed visit|4|||
125137459|NCT00367133|450128931|FG001|2 Years|Missed visit|5|||
125137460|NCT00367133|450128932|FG002|2 Years|Missed visit|4|||
125137461|NCT01252953|450128934|FG000|Overall Study|Withdrawal by Subject|16|||
125137462|NCT01252953|450128935|FG001|Overall Study|Withdrawal by Subject|17|||
125137463|NCT01252953|450128934|FG000|Overall Study|Lost to Follow-up|22|||
125137464|NCT01252953|450128935|FG001|Overall Study|Lost to Follow-up|21|||
125137465|NCT00858780|450128945|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
125383445|NCT00778700|451036963|FG002|Overall Study|Lost to Follow-up|0|||
125383446|NCT00778700|451036964|FG003|Overall Study|Lost to Follow-up|1|||
125383447|NCT00778700|451036961|FG000|Overall Study|Reason not Specified|2|||
125383448|NCT00778700|451036962|FG001|Overall Study|Reason not Specified|0|||
125383449|NCT00778700|451036963|FG002|Overall Study|Reason not Specified|1|||
125383450|NCT00778700|451036964|FG003|Overall Study|Reason not Specified|3|||
125383451|NCT00778700|451036961|FG000|Overall Study|Other|0|||
125383452|NCT00778700|451036962|FG001|Overall Study|Other|0|||
125383453|NCT00778700|451036963|FG002|Overall Study|Other|1|||
125383454|NCT00778700|451036964|FG003|Overall Study|Other|0|||
125383455|NCT04267133|451036968|FG000|Overall Study|Withdrawal by Subject|1|||
125383456|NCT04267133|451036968|FG000|Overall Study|Adverse Event|4|||
125383457|NCT02968563|451036974|FG000|Overall Study|Adverse Event|0|||
125383458|NCT02968563|451036975|FG001|Overall Study|Adverse Event|6|||
125383459|NCT02968563|451036974|FG000|Overall Study|Death|1|||
125383460|NCT02968563|451036975|FG001|Overall Study|Death|1|||
125383461|NCT02968563|451036974|FG000|Overall Study|Lost to Follow-up|0|||
125383462|NCT02968563|451036975|FG001|Overall Study|Lost to Follow-up|1|||
125383463|NCT03287804|451036976|FG000|Overall Study|Death|1|||
125383464|NCT03287804|451036976|FG000|Overall Study|Physician Decision|2|||
125383465|NCT03287804|451036976|FG000|Overall Study|Progressive disease|8|||
125383466|NCT02733991|451036978|FG000|Overall Study|Adverse Event|1|||
125383467|NCT02733991|451036979|FG001|Overall Study|Adverse Event|0|||
125383468|NCT02733991|451036978|FG000|Overall Study|Withdrawal by Subject|0|||
125383469|NCT02733991|451036979|FG001|Overall Study|Withdrawal by Subject|5|||
125383470|NCT00383149|451036990|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
125383471|NCT00383149|451036990|FG000|Overall Study|Death|2|||
125383472|NCT00383149|451036990|FG000|Overall Study|Disease Progression|38|||
125220696|NCT00943397|450436171|FG001|Overall Study|Withdrawal by Subject|1|||
125220697|NCT00943397|450436170|FG000|Overall Study|Site terminated and other|12|||
125220698|NCT00943397|450436171|FG001|Overall Study|Site terminated and other|56|||
125220699|NCT04878055|450436172|FG000|Overall Study|Patient transferred in another department|0|||
125220700|NCT04878055|450436173|FG001|Overall Study|Patient transferred in another department|2|||
125220701|NCT04878055|450436172|FG000|Overall Study|Physician Decision|1|||
125220702|NCT04878055|450436173|FG001|Overall Study|Physician Decision|1|||
125220703|NCT04878055|450436172|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
125220704|NCT04878055|450436173|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
125220705|NCT04878055|450436172|FG000|Overall Study|Adverse Event|12|||
125220706|NCT04878055|450436173|FG001|Overall Study|Adverse Event|7|||
125383473|NCT00383149|451036990|FG000|Overall Study|Lost to Follow-up|1|||
125383474|NCT00383149|451036990|FG000|Overall Study|Other|1|||
125383475|NCT00383149|451036990|FG000|Overall Study|Study Drug Toxicity|4|||
125383476|NCT00383149|451036990|FG000|Overall Study|Request to Discontinue Treatment|4|||
125383477|NCT00383149|451036990|FG000|Overall Study|Participant Withdrew Consent|1|||
125383478|NCT00453544|451036993|FG000|Overall Study|Withdrawal by Subject|1|||
125383479|NCT00453544|451036994|FG001|Overall Study|Withdrawal by Subject|0|||
125383480|NCT00453544|451036995|FG002|Overall Study|Withdrawal by Subject|0|||
125383481|NCT00453544|451036996|FG003|Overall Study|Withdrawal by Subject|0|||
125383482|NCT00453544|451036993|FG000|Overall Study|Primary outcome measure not completed|1|||
125383483|NCT00453544|451036994|FG001|Overall Study|Primary outcome measure not completed|1|||
125383484|NCT00453544|451036995|FG002|Overall Study|Primary outcome measure not completed|0|||
125137466|NCT00858780|450128946|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
125137467|NCT00858780|450128947|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
125137468|NCT00858780|450128948|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
125137469|NCT00858780|450128949|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
125137470|NCT00858780|450128945|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
125137471|NCT00858780|450128946|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
125137472|NCT00858780|450128947|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
125137473|NCT00858780|450128948|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
125137474|NCT00858780|450128949|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
125137475|NCT00858780|450128945|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
125137476|NCT00858780|450128946|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
125137477|NCT00858780|450128947|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
125383485|NCT00453544|451036996|FG003|Overall Study|Primary outcome measure not completed|1|||
125383486|NCT02457910|451036997|FG000|Overall Study|Withdrawal by Subject|0|||
125383487|NCT02457910|451036998|FG001|Overall Study|Withdrawal by Subject|0|||
125485460|NCT02240238|451412514|FG011|Phase 2|Physician Decision|0|||
125383488|NCT02457910|451036999|FG002|Overall Study|Withdrawal by Subject|0|||
125383489|NCT02457910|451037000|FG003|Overall Study|Withdrawal by Subject|0|||
125383490|NCT02457910|451037001|FG004|Overall Study|Withdrawal by Subject|0|||
125137478|NCT00858780|450128948|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
125137479|NCT00858780|450128949|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
125137480|NCT00858780|450128945|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
125137481|NCT00858780|450128946|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
125137482|NCT00858780|450128947|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
125137483|NCT00858780|450128948|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
125137484|NCT00858780|450128949|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
125137485|NCT00858780|450128945|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
125137486|NCT00858780|450128946|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
125137487|NCT00858780|450128947|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
125137488|NCT00858780|450128948|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
125137489|NCT00858780|450128949|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
125383491|NCT02457910|451037002|FG005|Overall Study|Withdrawal by Subject|1|||
125383492|NCT02457910|451036997|FG000|Overall Study|Adverse Event|0|||
125383493|NCT02457910|451036998|FG001|Overall Study|Adverse Event|2|||
125383494|NCT02457910|451036999|FG002|Overall Study|Adverse Event|1|||
125383495|NCT02457910|451037000|FG003|Overall Study|Adverse Event|1|||
125383496|NCT02457910|451037001|FG004|Overall Study|Adverse Event|1|||
125383497|NCT02457910|451037002|FG005|Overall Study|Adverse Event|3|||
125383498|NCT02457910|451036997|FG000|Overall Study|Disease progression|3|||
125383499|NCT02457910|451036998|FG001|Overall Study|Disease progression|3|||
125383500|NCT02457910|451036999|FG002|Overall Study|Disease progression|1|||
125383501|NCT02457910|451037000|FG003|Overall Study|Disease progression|1|||
125383502|NCT02457910|451037001|FG004|Overall Study|Disease progression|4|||
125383503|NCT02457910|451037002|FG005|Overall Study|Disease progression|6|||
125383504|NCT02457910|451036997|FG000|Overall Study|Other complicating illness|0|||
125383505|NCT02457910|451036998|FG001|Overall Study|Other complicating illness|0|||
125383506|NCT02457910|451036999|FG002|Overall Study|Other complicating illness|0|||
125383507|NCT02457910|451037000|FG003|Overall Study|Other complicating illness|0|||
125383508|NCT02457910|451037001|FG004|Overall Study|Other complicating illness|0|||
125220707|NCT04878055|450436172|FG000|Overall Study|Other|5|||
125220708|NCT04878055|450436173|FG001|Overall Study|Other|0|||
125220709|NCT04878055|450436172|FG000|Overall Study|Withdrawal by Subject|7|||
125220710|NCT04878055|450436173|FG001|Overall Study|Withdrawal by Subject|3|||
125220711|NCT04878055|450436172|FG000|Overall Study|Lost to Follow-up|10|||
125220712|NCT04878055|450436173|FG001|Overall Study|Lost to Follow-up|1|||
125220713|NCT01968811|450436174|FG000|Overall Study|Protocol Violation|4|||
125220714|NCT01968811|450436174|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
125220715|NCT01254656|450436175|FG000|Overall Study|Discontinued due to termination of study|40|||
125220716|NCT01254656|450436176|FG001|Overall Study|Discontinued due to termination of study|39|||
125220717|NCT01254656|450436177|FG002|Overall Study|Discontinued due to termination of study|13|||
125220718|NCT01254656|450436175|FG000|Overall Study|Lack of Efficacy|3|||
125220719|NCT01254656|450436176|FG001|Overall Study|Lack of Efficacy|0|||
125220720|NCT01254656|450436177|FG002|Overall Study|Lack of Efficacy|0|||
125220721|NCT01254656|450436175|FG000|Overall Study|Lost to Follow-up|1|||
125220722|NCT01254656|450436176|FG001|Overall Study|Lost to Follow-up|0|||
125220723|NCT01254656|450436177|FG002|Overall Study|Lost to Follow-up|2|||
125220724|NCT01254656|450436175|FG000|Overall Study|Withdrawal by Subject|2|||
125220725|NCT01254656|450436176|FG001|Overall Study|Withdrawal by Subject|2|||
125220726|NCT01254656|450436177|FG002|Overall Study|Withdrawal by Subject|1|||
125220727|NCT01254656|450436175|FG000|Overall Study|Pregnancy|0|||
125220728|NCT01254656|450436176|FG001|Overall Study|Pregnancy|0|||
125220729|NCT01254656|450436177|FG002|Overall Study|Pregnancy|2|||
125220730|NCT01254656|450436175|FG000|Overall Study|Adverse Event|1|||
125220731|NCT01254656|450436176|FG001|Overall Study|Adverse Event|1|||
125220732|NCT01254656|450436177|FG002|Overall Study|Adverse Event|0|||
125220733|NCT01254656|450436175|FG000|Overall Study|Death|0|||
125220734|NCT01254656|450436176|FG001|Overall Study|Death|1|||
125220735|NCT01254656|450436177|FG002|Overall Study|Death|0|||
125220736|NCT02532374|450436185|FG000|Overall Study|Withdrawal by Subject|1|||
125220737|NCT02532374|450436185|FG000|Overall Study|Physician Decision|1|||
125220738|NCT02254772|450436186|FG000|Overall Study|Ineligible|1|||
125220739|NCT02254772|450436186|FG000|Overall Study|Withdrawal by Subject|1|||
125220740|NCT05225558|450436187|FG000|Overall Study|Withdrawal by Subject|4|||
125220741|NCT05225558|450436188|FG001|Overall Study|Withdrawal by Subject|3|||
125220742|NCT05225558|450436187|FG000|Overall Study|Adverse Event|1|||
125220743|NCT05225558|450436188|FG001|Overall Study|Adverse Event|0|||
125220744|NCT05225558|450436187|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
125220745|NCT05225558|450436188|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
125220746|NCT05225558|450436187|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
125220747|NCT05225558|450436188|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
125220748|NCT03904420|450436189|FG000|Overall Study|Study terminated|2|||
125383509|NCT02457910|451037002|FG005|Overall Study|Other complicating illness|1|||
125383510|NCT02457910|451036997|FG000|Overall Study|Death|0|||
125383511|NCT02457910|451036998|FG001|Overall Study|Death|0|||
125383512|NCT02457910|451036999|FG002|Overall Study|Death|1|||
125383513|NCT02457910|451037000|FG003|Overall Study|Death|0|||
125383514|NCT02457910|451037001|FG004|Overall Study|Death|0|||
125383515|NCT02457910|451037002|FG005|Overall Study|Death|0|||
125383516|NCT00619801|451037003|FG000|Overall Study|Lack of Efficacy|0|||
125383517|NCT00619801|451037004|FG001|Overall Study|Lack of Efficacy|1|||
125383518|NCT00619801|451037003|FG000|Overall Study|Withdrawal by Subject|1|||
125383519|NCT00619801|451037004|FG001|Overall Study|Withdrawal by Subject|1|||
125383520|NCT00619801|451037003|FG000|Overall Study|Loss of efficacy|0|||
125383521|NCT00619801|451037004|FG001|Overall Study|Loss of efficacy|1|||
125383522|NCT03721276|451037007|FG000|Overall Study|Lost to Follow-up|5|||
125383523|NCT03721276|451037008|FG001|Overall Study|Lost to Follow-up|3|||
125383524|NCT03721276|451037007|FG000|Overall Study|Adverse Event|0|||
125383525|NCT03721276|451037008|FG001|Overall Study|Adverse Event|1|||
125383526|NCT00450333|451037009|FG000|Overall Study|Study terminated|47|||
125383527|NCT00450333|451037010|FG001|Overall Study|Study terminated|54|||
125383528|NCT00450333|451037011|FG002|Overall Study|Study terminated|16|||
125220749|NCT03904420|450436190|FG001|Overall Study|Study terminated|2|||
125220750|NCT03006562|450436191|FG000|Overall Study|Lost to Follow-up|0|||
125220751|NCT03006562|450436192|FG001|Overall Study|Lost to Follow-up|1|||
125383529|NCT00450333|451037012|FG003|Overall Study|Study terminated|21|||
125383530|NCT00450333|451037009|FG000|Overall Study|Adverse Event|1|||
125383531|NCT00450333|451037010|FG001|Overall Study|Adverse Event|7|||
125437776|NCT02006121|451229980|FG000|Open Label Phase|Withdrawal by Subject|3|||
125383532|NCT00450333|451037011|FG002|Overall Study|Adverse Event|2|||
125383533|NCT00450333|451037012|FG003|Overall Study|Adverse Event|2|||
125437777|NCT02006121|451229981|FG001|Open Label Phase|Withdrawal by Subject|0|||
125437778|NCT02006121|451229980|FG000|Open Label Phase|Non-compliance with study drug|3|||
125437779|NCT02006121|451229981|FG001|Open Label Phase|Non-compliance with study drug|0|||
125437780|NCT04789577|451229984|FG000|Overall Study|Withdrawal by Subject|1|||
125437781|NCT04789577|451229985|FG001|Overall Study|Withdrawal by Subject|1|||
125437782|NCT04789577|451229986|FG002|Overall Study|Withdrawal by Subject|1|||
125437783|NCT04789577|451229987|FG003|Overall Study|Withdrawal by Subject|3|||
125437784|NCT04789577|451229988|FG004|Overall Study|Withdrawal by Subject|1|||
125437785|NCT04789577|451229989|FG005|Overall Study|Withdrawal by Subject|7|||
125437786|NCT04789577|451229990|FG006|Overall Study|Withdrawal by Subject|1|||
125437787|NCT04789577|451229984|FG000|Overall Study|Lost to Follow-up|7|||
125437788|NCT04789577|451229985|FG001|Overall Study|Lost to Follow-up|12|||
125437789|NCT04789577|451229986|FG002|Overall Study|Lost to Follow-up|7|||
125437790|NCT04789577|451229987|FG003|Overall Study|Lost to Follow-up|10|||
125437791|NCT04789577|451229988|FG004|Overall Study|Lost to Follow-up|8|||
125437792|NCT04789577|451229989|FG005|Overall Study|Lost to Follow-up|6|||
125437793|NCT04789577|451229990|FG006|Overall Study|Lost to Follow-up|10|||
125437794|NCT04789577|451229984|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
125437795|NCT04789577|451229985|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
125437796|NCT04789577|451229986|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
125437797|NCT04789577|451229987|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
125437798|NCT04789577|451229988|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
125437799|NCT04789577|451229989|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
125437800|NCT04789577|451229990|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
125437801|NCT04789577|451229984|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
125437802|NCT04789577|451229985|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
125437803|NCT04789577|451229986|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
125437804|NCT04789577|451229987|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
125437805|NCT04789577|451229988|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
125437806|NCT04789577|451229989|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
125437807|NCT04789577|451229990|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
125437808|NCT02693834|451229999|FG000|Baseline Measurement|Withdrawal by Subject|1|||
125437809|NCT02693834|451230000|FG001|Baseline Measurement|Withdrawal by Subject|0|||
125437810|NCT02693834|451229999|FG000|Baseline Measurement|Adverse Event|1|||
125437811|NCT02693834|451230000|FG001|Baseline Measurement|Adverse Event|0|||
125437812|NCT02693834|451229999|FG000|Week 2 Practice|Adverse Event|0|||
125437813|NCT02693834|451230000|FG001|Week 2 Practice|Adverse Event|1|||
125220752|NCT00447772|450436193|FG000|Overall Study|Lack of Efficacy|3|||
125220753|NCT00447772|450436193|FG000|Overall Study|Insufficient compliance|6|||
125220754|NCT00447772|450436193|FG000|Overall Study|Discontinuation of drug therapy|1|||
125220755|NCT00447772|450436193|FG000|Overall Study|Lost to Follow-up|9|||
125220756|NCT00447772|450436193|FG000|Overall Study|Withdrawal by Subject|1|||
125220757|NCT00447772|450436193|FG000|Overall Study|Unable to attend all study visits|2|||
125220758|NCT00447772|450436193|FG000|Overall Study|Adverse Event|1|||
125220759|NCT00447772|450436193|FG000|Overall Study|Patient relocated|1|||
125220760|NCT00447772|450436193|FG000|Overall Study|Incomplete documentation at visit 1|1|||
125220761|NCT00447772|450436193|FG000|Overall Study|Chemotherapy for lung cancer|1|||
125220762|NCT00447772|450436193|FG000|Overall Study|Premature re-injection required|1|||
125220763|NCT00716456|450436194|FG000|Overall Study|Adverse Event|0|||
125220764|NCT00716456|450436195|FG001|Overall Study|Adverse Event|2|||
125220765|NCT00716456|450436196|FG002|Overall Study|Adverse Event|0|||
125220766|NCT00875563|450436198|FG000|Overall Study|Death|4|||
125220767|NCT00875563|450436198|FG000|Overall Study|Withdrawal by Subject|7|||
125220768|NCT00875563|450436198|FG000|Overall Study|No long-term (3-5 year) consent|6|||
125220769|NCT00875563|450436198|FG000|Overall Study|Still be eligible for follow-up|7|||
125220770|NCT05417412|450436199|FG000|Overall Study|Lost to Follow-up|2|||
125220771|NCT01841970|450436202|FG000|Overall Study|Withdrawal by Subject|1|||
125220772|NCT01841970|450436202|FG000|Overall Study|Physician Decision|2|||
125220773|NCT01841970|450436202|FG000|Overall Study|Lost to Follow-up|8|||
125220774|NCT02592447|450436203|FG000|Overall Study|Lost to Follow-up|1|||
125437814|NCT04848662|451230003|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
125437815|NCT04848662|451230004|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
125220775|NCT02592447|450436204|FG001|Overall Study|Lost to Follow-up|0|||
125220776|NCT02592447|450436203|FG000|Overall Study|Ineligible after randomization|1|||
125220777|NCT02592447|450436204|FG001|Overall Study|Ineligible after randomization|0|||
125437816|NCT03000673|451230005|FG000|Overall Study|Withdrawal by Subject|1|||
125437817|NCT03000673|451230006|FG001|Overall Study|Withdrawal by Subject|0|||
125437818|NCT03000673|451230007|FG002|Overall Study|Withdrawal by Subject|0|||
125437819|NCT03000673|451230008|FG003|Overall Study|Withdrawal by Subject|0|||
125437820|NCT01121484|451230009|FG000|Overall Study|Adverse Event|12|||
125437821|NCT01121484|451230010|FG001|Overall Study|Adverse Event|5|||
125437822|NCT01121484|451230009|FG000|Overall Study|Lack of Efficacy|3|||
125220778|NCT02592447|450436203|FG000|Overall Study|Withdrawal by Subject|0|||
125220779|NCT02592447|450436204|FG001|Overall Study|Withdrawal by Subject|1|||
125137490|NCT00858780|450128945|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
125137491|NCT00858780|450128946|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
125137492|NCT00858780|450128947|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
125137493|NCT00858780|450128948|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
125137494|NCT00858780|450128949|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
125137495|NCT00863330|450128950|FG000|Overall Study|study terminated early due to administra|6|||
125137496|NCT02615249|450128951|FG000|Overall Study|Withdrawal by Subject|1|||
125137497|NCT05098743|450128952|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
125137498|NCT05098743|450128953|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
125137499|NCT05098743|450128952|FG000|Overall Study|Lost to Follow-up|1|||
125137500|NCT05098743|450128953|FG001|Overall Study|Lost to Follow-up|2|||
125137501|NCT00842309|450128963|FG000|Overall Study|Withdrawal by Subject|3|||
125137502|NCT00842309|450128964|FG001|Overall Study|Withdrawal by Subject|1|||
125137503|NCT02911025|450128965|FG000|Overall Study|Lost to Follow-up|3|||
125137504|NCT03218787|450128966|FG000|Overall Study|Lost to Follow-up|12|||
125137505|NCT03218787|450128966|FG000|Overall Study|Withdrawal by Subject|72|||
125137506|NCT03218787|450128966|FG000|Overall Study|Physician Decision|11|||
125137507|NCT03218787|450128966|FG000|Overall Study|Death|111|||
125137508|NCT03719040|450128967|FG000|Overall Study|Withdrawal by Subject|177|||
125137509|NCT03719040|450128967|FG000|Overall Study|Lost to Follow-up|26|||
125137510|NCT02264977|450128968|FG000|Overall Study|Death|3|||
125137511|NCT02264977|450128968|FG000|Overall Study|Physician Decision|1|||
125137512|NCT02264977|450128968|FG000|Overall Study|Refuse to return|1|||
125137513|NCT00227370|450128970|FG000|Overall Study|Withdrawal by Subject|1|||
125137514|NCT00227370|450128971|FG001|Overall Study|Withdrawal by Subject|2|||
125137515|NCT00227370|450128970|FG000|Overall Study|Death|3|||
125137516|NCT00227370|450128971|FG001|Overall Study|Death|4|||
125137517|NCT00227370|450128970|FG000|Overall Study|Adverse Event|6|||
125137518|NCT00227370|450128971|FG001|Overall Study|Adverse Event|11|||
125137519|NCT00227370|450128970|FG000|Overall Study|Physician Decision|9|||
125137520|NCT00227370|450128971|FG001|Overall Study|Physician Decision|6|||
125137521|NCT00227370|450128970|FG000|Overall Study|Other reasons|2|||
125137522|NCT00227370|450128971|FG001|Overall Study|Other reasons|1|||
125137523|NCT02923349|450128972|FG000|Overall Study|Other|1|||
125137524|NCT02923349|450128973|FG001|Overall Study|Other|2|||
125137525|NCT02923349|450128974|FG002|Overall Study|Other|4|||
125137526|NCT02923349|450128975|FG003|Overall Study|Other|1|||
125137527|NCT02923349|450128976|FG004|Overall Study|Other|3|||
125137528|NCT02923349|450128977|FG005|Overall Study|Other|0|||
125137529|NCT02923349|450128978|FG006|Overall Study|Other|1|||
125137530|NCT02923349|450128972|FG000|Overall Study|Withdrawal by Subject|2|||
125137531|NCT02923349|450128973|FG001|Overall Study|Withdrawal by Subject|2|||
125137532|NCT02923349|450128974|FG002|Overall Study|Withdrawal by Subject|8|||
125137533|NCT02923349|450128975|FG003|Overall Study|Withdrawal by Subject|10|||
125383534|NCT00450333|451037009|FG000|Overall Study|Protocol Violation|1|||
125383535|NCT00450333|451037010|FG001|Overall Study|Protocol Violation|0|||
125383536|NCT00450333|451037011|FG002|Overall Study|Protocol Violation|1|||
125383537|NCT00450333|451037012|FG003|Overall Study|Protocol Violation|0|||
125383538|NCT00450333|451037009|FG000|Overall Study|Withdrawal by Subject|1|||
125383539|NCT00450333|451037010|FG001|Overall Study|Withdrawal by Subject|0|||
125383540|NCT00450333|451037011|FG002|Overall Study|Withdrawal by Subject|3|||
125383541|NCT00450333|451037012|FG003|Overall Study|Withdrawal by Subject|0|||
125383542|NCT00450333|451037009|FG000|Overall Study|Kidney transplant|1|||
125383543|NCT00450333|451037010|FG001|Overall Study|Kidney transplant|0|||
125383544|NCT00450333|451037011|FG002|Overall Study|Kidney transplant|1|||
125383545|NCT00450333|451037012|FG003|Overall Study|Kidney transplant|3|||
125383546|NCT00450333|451037009|FG000|Overall Study|Death|3|||
125383547|NCT00450333|451037010|FG001|Overall Study|Death|2|||
125383548|NCT00450333|451037011|FG002|Overall Study|Death|2|||
125383549|NCT00450333|451037012|FG003|Overall Study|Death|2|||
125383550|NCT02375113|451037015|FG000|Overall Study|Undisclosed Reason(s).|1|||
125383551|NCT02375113|451037016|FG001|Overall Study|Undisclosed Reason(s).|1|||
125383552|NCT02375113|451037015|FG000|Overall Study|Poor adherence (<70%).|1|||
125383553|NCT02375113|451037016|FG001|Overall Study|Poor adherence (<70%).|0|||
125137534|NCT02923349|450128976|FG004|Overall Study|Withdrawal by Subject|12|||
125137535|NCT02923349|450128977|FG005|Overall Study|Withdrawal by Subject|3|||
125137536|NCT02923349|450128978|FG006|Overall Study|Withdrawal by Subject|0|||
125137537|NCT02923349|450128972|FG000|Overall Study|Physician Decision|0|||
125137538|NCT02923349|450128973|FG001|Overall Study|Physician Decision|0|||
125137539|NCT02923349|450128974|FG002|Overall Study|Physician Decision|0|||
125383554|NCT02375113|451037015|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
125383555|NCT02375113|451037016|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
125383556|NCT00416078|451037029|FG000|Overall Study|Death|3|||
125383557|NCT00416078|451037030|FG001|Overall Study|Death|4|||
125383558|NCT00416078|451037029|FG000|Overall Study|Withdrawal by Subject|3|||
125383559|NCT00416078|451037030|FG001|Overall Study|Withdrawal by Subject|2|||
125383560|NCT00416078|451037029|FG000|Overall Study|Physician Decision|1|||
125383561|NCT00416078|451037030|FG001|Overall Study|Physician Decision|0|||
125437823|NCT01121484|451230010|FG001|Overall Study|Lack of Efficacy|11|||
125437824|NCT01121484|451230009|FG000|Overall Study|Lost to Follow-up|5|||
125437825|NCT01121484|451230010|FG001|Overall Study|Lost to Follow-up|9|||
125437826|NCT01121484|451230009|FG000|Overall Study|Physician Decision|0|||
125437827|NCT01121484|451230010|FG001|Overall Study|Physician Decision|3|||
125437828|NCT01121484|451230009|FG000|Overall Study|Protocol Violation|1|||
125437829|NCT01121484|451230010|FG001|Overall Study|Protocol Violation|0|||
125437830|NCT01121484|451230009|FG000|Overall Study|Withdrawal by Subject|8|||
125437831|NCT01121484|451230010|FG001|Overall Study|Withdrawal by Subject|7|||
125437832|NCT01121484|451230009|FG000|Overall Study|Discontinuation of study by sponsor|0|||
125437833|NCT01121484|451230010|FG001|Overall Study|Discontinuation of study by sponsor|1|||
125437834|NCT01121484|451230009|FG000|Overall Study|Other|3|||
125437835|NCT01121484|451230010|FG001|Overall Study|Other|3|||
125437836|NCT01121484|451230009|FG000|Overall Study|Randomized, not treated|1|||
125437837|NCT01121484|451230010|FG001|Overall Study|Randomized, not treated|4|||
125437838|NCT00562978|451230011|FG000|Overall Study|Patient had imaging dose only|1|||
125437839|NCT00562978|451230012|FG001|Overall Study|Patient had imaging dose only|11|||
125437840|NCT01463293|451230016|FG000|Overall Study|Lost to Follow-up|1|||
125437841|NCT01463293|451230017|FG001|Overall Study|Lost to Follow-up|4|||
125437842|NCT01463293|451230018|FG002|Overall Study|Lost to Follow-up|5|||
125437843|NCT01463293|451230016|FG000|Overall Study|Adverse Event|1|||
125437844|NCT01463293|451230017|FG001|Overall Study|Adverse Event|2|||
125437845|NCT01463293|451230018|FG002|Overall Study|Adverse Event|0|||
125437846|NCT01463293|451230016|FG000|Overall Study|Withdrawal by Subject|4|||
125137540|NCT02923349|450128975|FG003|Overall Study|Physician Decision|1|||
125137541|NCT02923349|450128976|FG004|Overall Study|Physician Decision|1|||
125137542|NCT02923349|450128977|FG005|Overall Study|Physician Decision|0|||
125137543|NCT02923349|450128978|FG006|Overall Study|Physician Decision|2|||
125137544|NCT02923349|450128972|FG000|Overall Study|Lost to Follow-up|0|||
125437847|NCT01463293|451230017|FG001|Overall Study|Withdrawal by Subject|10|||
125437848|NCT01463293|451230018|FG002|Overall Study|Withdrawal by Subject|5|||
125437849|NCT01463293|451230016|FG000|Overall Study|Other|0|||
125437850|NCT01463293|451230017|FG001|Overall Study|Other|0|||
125437851|NCT01463293|451230018|FG002|Overall Study|Other|2|||
125437852|NCT00779584|451230024|FG000|Overall Study|Protocol Violation|0|||
125437853|NCT00779584|451230025|FG001|Overall Study|Protocol Violation|0|||
125437854|NCT00779584|451230026|FG002|Overall Study|Protocol Violation|0|||
125437855|NCT00779584|451230027|FG003|Overall Study|Protocol Violation|0|||
125437856|NCT00779584|451230028|FG004|Overall Study|Protocol Violation|0|||
125437857|NCT00779584|451230029|FG005|Overall Study|Protocol Violation|1|||
125437858|NCT00779584|451230030|FG006|Overall Study|Protocol Violation|0|||
125437859|NCT00779584|451230031|FG007|Overall Study|Protocol Violation|0|||
125437860|NCT00779584|451230032|FG008|Overall Study|Protocol Violation|0|||
125437861|NCT00779584|451230024|FG000|Overall Study|Withdrawal by Subject|1|||
125437862|NCT00779584|451230025|FG001|Overall Study|Withdrawal by Subject|1|||
125437863|NCT00779584|451230026|FG002|Overall Study|Withdrawal by Subject|2|||
125437864|NCT00779584|451230027|FG003|Overall Study|Withdrawal by Subject|0|||
125437865|NCT00779584|451230028|FG004|Overall Study|Withdrawal by Subject|0|||
125437866|NCT00779584|451230029|FG005|Overall Study|Withdrawal by Subject|2|||
125437867|NCT00779584|451230030|FG006|Overall Study|Withdrawal by Subject|1|||
125437868|NCT00779584|451230031|FG007|Overall Study|Withdrawal by Subject|0|||
125437869|NCT00779584|451230032|FG008|Overall Study|Withdrawal by Subject|0|||
125437870|NCT00779584|451230024|FG000|Overall Study|Lost to Follow-up|0|||
125437871|NCT00779584|451230025|FG001|Overall Study|Lost to Follow-up|0|||
125437872|NCT00779584|451230026|FG002|Overall Study|Lost to Follow-up|0|||
125437873|NCT00779584|451230027|FG003|Overall Study|Lost to Follow-up|0|||
125437874|NCT00779584|451230028|FG004|Overall Study|Lost to Follow-up|1|||
125137545|NCT02923349|450128973|FG001|Overall Study|Lost to Follow-up|0|||
125137546|NCT02923349|450128974|FG002|Overall Study|Lost to Follow-up|3|||
125137547|NCT02923349|450128975|FG003|Overall Study|Lost to Follow-up|0|||
125437875|NCT00779584|451230029|FG005|Overall Study|Lost to Follow-up|0|||
125437876|NCT00779584|451230030|FG006|Overall Study|Lost to Follow-up|0|||
125437877|NCT00779584|451230031|FG007|Overall Study|Lost to Follow-up|0|||
125437878|NCT00779584|451230032|FG008|Overall Study|Lost to Follow-up|0|||
125437879|NCT00779584|451230024|FG000|Overall Study|Progression of Disease|0|||
125437880|NCT00779584|451230025|FG001|Overall Study|Progression of Disease|1|||
125437881|NCT00779584|451230026|FG002|Overall Study|Progression of Disease|2|||
125137548|NCT02923349|450128976|FG004|Overall Study|Lost to Follow-up|1|||
125137549|NCT02923349|450128977|FG005|Overall Study|Lost to Follow-up|1|||
125220780|NCT02849743|450436206|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
125220781|NCT02849743|450436207|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
125220782|NCT02849743|450436206|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
125220783|NCT02849743|450436207|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
125220784|NCT01048541|450436210|FG000|Overall Study|Withdrawal by Subject|1|||
125220785|NCT01048541|450436211|FG001|Overall Study|Withdrawal by Subject|0|||
125220786|NCT00627497|450436212|FG000|Overall Study|Lost to Follow-up|1|||
125220787|NCT00627497|450436213|FG001|Overall Study|Lost to Follow-up|1|||
125220788|NCT00627497|450436214|FG002|Overall Study|Lost to Follow-up|0|||
125437882|NCT00779584|451230027|FG003|Overall Study|Progression of Disease|6|||
125437883|NCT00779584|451230028|FG004|Overall Study|Progression of Disease|5|||
125437884|NCT00779584|451230029|FG005|Overall Study|Progression of Disease|1|||
125437885|NCT00779584|451230030|FG006|Overall Study|Progression of Disease|4|||
125437886|NCT00779584|451230031|FG007|Overall Study|Progression of Disease|2|||
125437887|NCT00779584|451230032|FG008|Overall Study|Progression of Disease|1|||
125437888|NCT00779584|451230024|FG000|Overall Study|Adverse Event|1|||
125437889|NCT00779584|451230025|FG001|Overall Study|Adverse Event|0|||
125437890|NCT00779584|451230026|FG002|Overall Study|Adverse Event|2|||
125437891|NCT00779584|451230027|FG003|Overall Study|Adverse Event|0|||
125437892|NCT00779584|451230028|FG004|Overall Study|Adverse Event|0|||
125437893|NCT00779584|451230029|FG005|Overall Study|Adverse Event|0|||
125437894|NCT00779584|451230030|FG006|Overall Study|Adverse Event|2|||
125437895|NCT00779584|451230031|FG007|Overall Study|Adverse Event|1|||
125437896|NCT00779584|451230032|FG008|Overall Study|Adverse Event|1|||
125437897|NCT00779584|451230024|FG000|Overall Study|Symptomatic Deterioration|1|||
125437898|NCT00779584|451230025|FG001|Overall Study|Symptomatic Deterioration|1|||
125437899|NCT00779584|451230026|FG002|Overall Study|Symptomatic Deterioration|1|||
125437900|NCT00779584|451230027|FG003|Overall Study|Symptomatic Deterioration|0|||
125437901|NCT00779584|451230028|FG004|Overall Study|Symptomatic Deterioration|0|||
125437902|NCT00779584|451230029|FG005|Overall Study|Symptomatic Deterioration|1|||
125437903|NCT00779584|451230030|FG006|Overall Study|Symptomatic Deterioration|1|||
125437904|NCT00779584|451230031|FG007|Overall Study|Symptomatic Deterioration|0|||
125437905|NCT00779584|451230032|FG008|Overall Study|Symptomatic Deterioration|0|||
125437906|NCT00779584|451230024|FG000|Overall Study|Ongoing in Study|0|||
125437907|NCT00779584|451230025|FG001|Overall Study|Ongoing in Study|0|||
125437908|NCT00779584|451230026|FG002|Overall Study|Ongoing in Study|0|||
125437909|NCT00779584|451230027|FG003|Overall Study|Ongoing in Study|0|||
125437910|NCT00779584|451230028|FG004|Overall Study|Ongoing in Study|1|||
125437911|NCT00779584|451230029|FG005|Overall Study|Ongoing in Study|1|||
125437912|NCT00779584|451230030|FG006|Overall Study|Ongoing in Study|0|||
125437913|NCT00779584|451230031|FG007|Overall Study|Ongoing in Study|0|||
125437914|NCT00779584|451230032|FG008|Overall Study|Ongoing in Study|0|||
125437915|NCT02878213|451230037|FG000|Overall Study|Withdrawal by Subject|2|||
125437916|NCT02878213|451230037|FG000|Overall Study|Adverse Event|1|||
125437917|NCT01913639|451230038|FG000|Overall Study|Not Eligible|3|||
125437918|NCT02302066|451230039|FG000|Overall Study|Adverse Event|1|||
125437919|NCT02302066|451230040|FG001|Overall Study|Adverse Event|1|||
125137550|NCT02923349|450128978|FG006|Overall Study|Lost to Follow-up|0|||
125137551|NCT02923349|450128972|FG000|Overall Study|Death|1|||
125137552|NCT02923349|450128973|FG001|Overall Study|Death|0|||
125137553|NCT02923349|450128974|FG002|Overall Study|Death|2|||
125137554|NCT02923349|450128975|FG003|Overall Study|Death|4|||
125137555|NCT02923349|450128976|FG004|Overall Study|Death|2|||
125137556|NCT02923349|450128977|FG005|Overall Study|Death|3|||
125137557|NCT02923349|450128978|FG006|Overall Study|Death|0|||
125437920|NCT02302066|451230041|FG002|Overall Study|Adverse Event|3|||
125437921|NCT02302066|451230042|FG003|Overall Study|Adverse Event|0|||
125437922|NCT02302066|451230039|FG000|Overall Study|Lost to Follow-up|4|||
125437923|NCT02302066|451230040|FG001|Overall Study|Lost to Follow-up|5|||
125437924|NCT02302066|451230041|FG002|Overall Study|Lost to Follow-up|24|||
125437925|NCT02302066|451230042|FG003|Overall Study|Lost to Follow-up|7|||
125437926|NCT02302066|451230039|FG000|Overall Study|Withdrawal by Subject|25|||
125437927|NCT02302066|451230040|FG001|Overall Study|Withdrawal by Subject|58|||
125437928|NCT02302066|451230041|FG002|Overall Study|Withdrawal by Subject|124|||
125437929|NCT02302066|451230042|FG003|Overall Study|Withdrawal by Subject|33|||
125437930|NCT02302066|451230039|FG000|Overall Study|Pregnancy|2|||
125437931|NCT02302066|451230040|FG001|Overall Study|Pregnancy|10|||
125437932|NCT02302066|451230041|FG002|Overall Study|Pregnancy|12|||
125437933|NCT02302066|451230042|FG003|Overall Study|Pregnancy|0|||
125437934|NCT02302066|451230039|FG000|Overall Study|Reason Not Specified|1|||
125437935|NCT02302066|451230040|FG001|Overall Study|Reason Not Specified|1|||
125437936|NCT02302066|451230041|FG002|Overall Study|Reason Not Specified|9|||
125437937|NCT02302066|451230042|FG003|Overall Study|Reason Not Specified|1|||
125437938|NCT02301156|451230043|FG000|Overall Study|Adverse Event|13|||
125437939|NCT02301156|451230044|FG001|Overall Study|Adverse Event|14|||
125137558|NCT04063878|450128981|FG000|Overall Study|Withdrawal by Subject|2|||
125137559|NCT04063878|450128981|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
125137560|NCT02751827|450128982|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
125137561|NCT02751827|450128983|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
125437940|NCT02301156|451230043|FG000|Overall Study|Death|1|||
125437941|NCT02301156|451230044|FG001|Overall Study|Death|5|||
125437942|NCT02301156|451230043|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
125437943|NCT02301156|451230044|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
125437944|NCT02301156|451230043|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
125437945|NCT02301156|451230044|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
125437946|NCT02301156|451230043|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
125437947|NCT02301156|451230044|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
125437948|NCT02301156|451230043|FG000|Overall Study|Reason not Specified|6|||
125383562|NCT00416078|451037029|FG000|Overall Study|Lost to Follow-up|4|||
125383563|NCT00416078|451037030|FG001|Overall Study|Lost to Follow-up|2|||
125383564|NCT01614067|451037033|FG000|Overall Study|Pregnancy|1|||
125383565|NCT01614067|451037034|FG001|Overall Study|Pregnancy|0|||
125383566|NCT01614067|451037033|FG000|Overall Study|Physician Decision|6|||
125383567|NCT01614067|451037034|FG001|Overall Study|Physician Decision|5|||
125383568|NCT01614067|451037033|FG000|Overall Study|Withdrawal by Subject|0|||
125383569|NCT01614067|451037034|FG001|Overall Study|Withdrawal by Subject|1|||
125383570|NCT01614067|451037033|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
125383571|NCT01614067|451037034|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
125383572|NCT01505868|451037035|FG000|Overall Study|Withdrawal by Subject|1|||
125383573|NCT01505868|451037036|FG001|Overall Study|Withdrawal by Subject|0|||
125383574|NCT01505868|451037037|FG002|Overall Study|Withdrawal by Subject|0|||
125383575|NCT01505868|451037038|FG003|Overall Study|Withdrawal by Subject|0|||
125383576|NCT01505868|451037039|FG004|Overall Study|Withdrawal by Subject|0|||
125383577|NCT02289079|451037040|FG000|Overall Study|Physician Decision|2|||
125383578|NCT02289079|451037041|FG001|Overall Study|Physician Decision|0|||
125383579|NCT02289079|451037040|FG000|Overall Study|Lost to Follow-up|0|||
125383580|NCT02289079|451037041|FG001|Overall Study|Lost to Follow-up|1|||
125383581|NCT00680043|451037042|FG000|Overall Study|Withdrawal by Subject|1|||
125383582|NCT00680043|451037043|FG001|Overall Study|Withdrawal by Subject|0|||
125383583|NCT00680043|451037044|FG002|Overall Study|Withdrawal by Subject|0|||
125383584|NCT00680043|451037042|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
125383585|NCT00680043|451037043|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
125383586|NCT00680043|451037044|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
125383587|NCT00680043|451037042|FG000|Overall Study|Renal Transplant|1|||
125383588|NCT00680043|451037043|FG001|Overall Study|Renal Transplant|0|||
125383589|NCT00680043|451037044|FG002|Overall Study|Renal Transplant|4|||
125383590|NCT00553150|451037045|FG000|Overall Study|Withdrawal by Subject|0|||
125383591|NCT00553150|451037046|FG001|Overall Study|Withdrawal by Subject|0|||
125137562|NCT02751827|450128984|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
125137563|NCT01248728|450128985|FG000|Overall Study|Adverse Event|1|||
125137564|NCT01248728|450128986|FG001|Overall Study|Adverse Event|1|||
125137565|NCT01248728|450128985|FG000|Overall Study|Withdrawal by Subject|2|||
125137566|NCT01248728|450128986|FG001|Overall Study|Withdrawal by Subject|1|||
125137567|NCT01248728|450128985|FG000|Overall Study|Lack of Efficacy|1|||
125383592|NCT00553150|451037047|FG002|Overall Study|Withdrawal by Subject|0|||
125383593|NCT00553150|451037048|FG003|Overall Study|Withdrawal by Subject|2|||
125383594|NCT00553150|451037045|FG000|Overall Study|Protocol Violation|0|||
125383595|NCT00553150|451037046|FG001|Overall Study|Protocol Violation|0|||
125383596|NCT00553150|451037047|FG002|Overall Study|Protocol Violation|0|||
125383597|NCT00553150|451037048|FG003|Overall Study|Protocol Violation|1|||
125383598|NCT00553150|451037045|FG000|Overall Study|Ineligible|0|||
125383599|NCT00553150|451037046|FG001|Overall Study|Ineligible|0|||
125383600|NCT00553150|451037047|FG002|Overall Study|Ineligible|0|||
125383601|NCT00553150|451037048|FG003|Overall Study|Ineligible|1|||
125383602|NCT03061331|451037049|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
125383603|NCT03061331|451037050|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
125383604|NCT02998840|451037051|FG000|Overall Study|Lost to Follow-up|1|||
125383605|NCT02998840|451037052|FG001|Overall Study|Lost to Follow-up|1|||
125383606|NCT02998840|451037053|FG002|Overall Study|Lost to Follow-up|2|||
125383607|NCT02998840|451037054|FG003|Overall Study|Lost to Follow-up|3|||
125383608|NCT02998840|451037051|FG000|Overall Study|Withdrawal by Subject|1|||
125383609|NCT02998840|451037052|FG001|Overall Study|Withdrawal by Subject|1|||
125383610|NCT02998840|451037053|FG002|Overall Study|Withdrawal by Subject|0|||
125383611|NCT02998840|451037054|FG003|Overall Study|Withdrawal by Subject|1|||
125383612|NCT02998840|451037051|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
125383613|NCT02998840|451037052|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
125383614|NCT02998840|451037053|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
125383615|NCT02998840|451037054|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
125383616|NCT01686633|451037058|FG000|Overall Study|Lack of Efficacy|33|||
125383617|NCT01686633|451037059|FG001|Overall Study|Lack of Efficacy|13|||
125383618|NCT01686633|451037060|FG002|Overall Study|Lack of Efficacy|11|||
125383619|NCT01686633|451037058|FG000|Overall Study|Withdrawal by Subject|8|||
125383620|NCT01686633|451037059|FG001|Overall Study|Withdrawal by Subject|8|||
125383621|NCT01686633|451037060|FG002|Overall Study|Withdrawal by Subject|5|||
125383622|NCT01686633|451037058|FG000|Overall Study|Physician Decision|3|||
125383623|NCT01686633|451037059|FG001|Overall Study|Physician Decision|4|||
125383624|NCT01686633|451037060|FG002|Overall Study|Physician Decision|4|||
125383625|NCT01686633|451037058|FG000|Overall Study|Adverse Event|4|||
125383626|NCT01686633|451037059|FG001|Overall Study|Adverse Event|3|||
125383627|NCT01686633|451037060|FG002|Overall Study|Adverse Event|3|||
125383628|NCT01686633|451037058|FG000|Overall Study|Protocol Violation|2|||
125383629|NCT01686633|451037059|FG001|Overall Study|Protocol Violation|3|||
125383630|NCT01686633|451037060|FG002|Overall Study|Protocol Violation|0|||
125383631|NCT01686633|451037058|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
125383632|NCT01686633|451037059|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
125383633|NCT01686633|451037060|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
125383634|NCT01686633|451037058|FG000|Overall Study|Lost to Follow-up|0|||
125383635|NCT01686633|451037059|FG001|Overall Study|Lost to Follow-up|1|||
125383636|NCT01686633|451037060|FG002|Overall Study|Lost to Follow-up|1|||
125383637|NCT00195676|451037062|FG000|Period O - Open-label Treatment|Adverse Event|82|||
125383638|NCT00195676|451037062|FG000|Period O - Open-label Treatment|Death|6|||
125383639|NCT00195676|451037062|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
125383640|NCT00195676|451037062|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
125383641|NCT00195676|451037062|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
125383642|NCT00195676|451037062|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
125383643|NCT00195676|451037062|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
125383644|NCT00195676|451037062|FG000|Period O - Open-label Treatment|Other reasons|68|||
125383645|NCT00195676|451037062|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
125383646|NCT00195676|451037062|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
125383647|NCT00195676|451037062|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
125383648|NCT00195676|451037062|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
125383649|NCT00195676|451037062|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
125383650|NCT00195676|451037062|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
125383651|NCT00195676|451037062|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
125383652|NCT00195676|451037062|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
125383653|NCT00195676|451037062|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
125383654|NCT00195676|451037062|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
125383655|NCT00195676|451037062|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
125383656|NCT00195676|451037062|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
125383657|NCT00195676|451037062|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
125383658|NCT01189812|451037063|FG000|Overall Study|Withdrawal by Subject|2|||
125383659|NCT01189812|451037064|FG001|Overall Study|Withdrawal by Subject|3|||
125383660|NCT01189812|451037063|FG000|Overall Study|Adverse Event|1|||
125383661|NCT01189812|451037064|FG001|Overall Study|Adverse Event|0|||
125383662|NCT01189812|451037063|FG000|Overall Study|Out of Window|4|||
125383663|NCT01189812|451037064|FG001|Overall Study|Out of Window|3|||
125383664|NCT01189812|451037063|FG000|Overall Study|Moved out of State|1|||
125383665|NCT01189812|451037064|FG001|Overall Study|Moved out of State|2|||
125383666|NCT00616655|451037065|FG000|Overall Study|Adverse Event|10|||
125383667|NCT00616655|451037066|FG001|Overall Study|Adverse Event|7|||
125383668|NCT00616655|451037067|FG002|Overall Study|Adverse Event|12|||
125383669|NCT00616655|451037065|FG000|Overall Study|Lack of Efficacy|5|||
125383670|NCT00616655|451037066|FG001|Overall Study|Lack of Efficacy|5|||
125383671|NCT00616655|451037067|FG002|Overall Study|Lack of Efficacy|5|||
125383672|NCT00616655|451037065|FG000|Overall Study|Lost to Follow-up|3|||
125383673|NCT00616655|451037066|FG001|Overall Study|Lost to Follow-up|12|||
125383674|NCT00616655|451037067|FG002|Overall Study|Lost to Follow-up|10|||
125383675|NCT00616655|451037065|FG000|Overall Study|Protocol Violation|2|||
125383676|NCT00616655|451037066|FG001|Overall Study|Protocol Violation|4|||
125383677|NCT00616655|451037067|FG002|Overall Study|Protocol Violation|3|||
125383678|NCT00616655|451037065|FG000|Overall Study|Withdrawal by Subject|9|||
125383679|NCT00616655|451037066|FG001|Overall Study|Withdrawal by Subject|7|||
125383680|NCT00616655|451037067|FG002|Overall Study|Withdrawal by Subject|11|||
125383681|NCT00616655|451037065|FG000|Overall Study|Does not meet in/ex criteria|0|||
125383682|NCT00616655|451037066|FG001|Overall Study|Does not meet in/ex criteria|0|||
125383683|NCT00616655|451037067|FG002|Overall Study|Does not meet in/ex criteria|2|||
125383684|NCT00616655|451037065|FG000|Overall Study|Other|6|||
125383685|NCT00616655|451037066|FG001|Overall Study|Other|6|||
125383686|NCT00616655|451037067|FG002|Overall Study|Other|5|||
125383687|NCT03761147|451037068|FG000|Overall Study|Withdrawal by Subject|6|||
125383688|NCT03761147|451037069|FG001|Overall Study|Withdrawal by Subject|1|||
125383689|NCT03761147|451037068|FG000|Overall Study|Adverse Event|1|||
125383690|NCT03761147|451037069|FG001|Overall Study|Adverse Event|3|||
125383691|NCT01026792|451037071|FG000|Overall Study|Protocol Violation|1|||
125383692|NCT00309842|451037072|FG000|Overall Study|Lost to Follow-up|1|||
125383693|NCT00423150|451037073|FG000|Overall Study|Adverse Event|11|||
125383694|NCT00423150|451037073|FG000|Overall Study|Progression of disease being studied|69|||
125383695|NCT00423150|451037073|FG000|Overall Study|Withdrawal by Subject|1|||
125383696|NCT00423150|451037073|FG000|Overall Study|Non-compliance with protocol|1|||
125383697|NCT00423150|451037073|FG000|Overall Study|Administrative|4|||
125383698|NCT03204305|451037074|FG000|Overall Study|Lost to Follow-up|6|||
125383699|NCT03204305|451037075|FG001|Overall Study|Lost to Follow-up|4|||
125383700|NCT03204305|451037076|FG002|Overall Study|Lost to Follow-up|0|||
125383701|NCT03204305|451037077|FG003|Overall Study|Lost to Follow-up|0|||
125383702|NCT03204305|451037074|FG000|Overall Study|Physician Decision|1|||
125383703|NCT03204305|451037075|FG001|Overall Study|Physician Decision|0|||
125137568|NCT01248728|450128986|FG001|Overall Study|Lack of Efficacy|0|||
125137569|NCT00147498|450128987|FG000|Overall Study|Adverse Event|1|||
125137570|NCT00147498|450128988|FG001|Overall Study|Adverse Event|6|||
125137571|NCT00147498|450128989|FG002|Overall Study|Adverse Event|7|||
125137572|NCT00147498|450128990|FG003|Overall Study|Adverse Event|3|||
125137573|NCT00147498|450128987|FG000|Overall Study|Lack of Efficacy|1|||
125137574|NCT00147498|450128988|FG001|Overall Study|Lack of Efficacy|1|||
125137575|NCT00147498|450128989|FG002|Overall Study|Lack of Efficacy|1|||
125137576|NCT00147498|450128990|FG003|Overall Study|Lack of Efficacy|8|||
125137577|NCT00147498|450128987|FG000|Overall Study|Laboratory abnormality|0|||
125137578|NCT00147498|450128988|FG001|Overall Study|Laboratory abnormality|0|||
125137579|NCT00147498|450128989|FG002|Overall Study|Laboratory abnormality|2|||
125137580|NCT00147498|450128990|FG003|Overall Study|Laboratory abnormality|0|||
125137581|NCT00147498|450128987|FG000|Overall Study|Participant defaulted|0|||
125137582|NCT00147498|450128988|FG001|Overall Study|Participant defaulted|1|||
125137583|NCT00147498|450128989|FG002|Overall Study|Participant defaulted|4|||
125137584|NCT00147498|450128990|FG003|Overall Study|Participant defaulted|3|||
125137585|NCT00147498|450128987|FG000|Overall Study|Other|1|||
125137586|NCT00147498|450128988|FG001|Overall Study|Other|1|||
125137587|NCT00147498|450128989|FG002|Overall Study|Other|3|||
125137588|NCT00147498|450128990|FG003|Overall Study|Other|3|||
125137589|NCT01838681|450128991|FG000|Period A|Adverse Event|39|||
125137590|NCT01838681|450128992|FG001|Period A|Adverse Event|0|||
125137591|NCT01838681|450128993|FG002|Period A|Adverse Event|0|||
125137592|NCT01838681|450128994|FG003|Period A|Adverse Event|0|||
125137593|NCT01838681|450128991|FG000|Period A|Lack of Efficacy|21|||
125137594|NCT01838681|450128992|FG001|Period A|Lack of Efficacy|0|||
125137595|NCT01838681|450128993|FG002|Period A|Lack of Efficacy|0|||
125137596|NCT01838681|450128994|FG003|Period A|Lack of Efficacy|0|||
125137597|NCT01838681|450128991|FG000|Period A|Early response|148|||
125137598|NCT01838681|450128992|FG001|Period A|Early response|0|||
125137599|NCT01838681|450128993|FG002|Period A|Early response|0|||
125137600|NCT01838681|450128994|FG003|Period A|Early response|0|||
125137601|NCT01838681|450128991|FG000|Period A|Withdrawal by Subject|70|||
125137602|NCT01838681|450128992|FG001|Period A|Withdrawal by Subject|0|||
125137603|NCT01838681|450128993|FG002|Period A|Withdrawal by Subject|0|||
125137604|NCT01838681|450128994|FG003|Period A|Withdrawal by Subject|0|||
125137605|NCT01838681|450128991|FG000|Period A|Protocol Violation|16|||
125137606|NCT01838681|450128992|FG001|Period A|Protocol Violation|0|||
125137607|NCT01838681|450128993|FG002|Period A|Protocol Violation|0|||
125137608|NCT01838681|450128994|FG003|Period A|Protocol Violation|0|||
125137609|NCT01838681|450128991|FG000|Period A|Non-compliance with IMP|6|||
125137610|NCT01838681|450128992|FG001|Period A|Non-compliance with IMP|0|||
125137611|NCT01838681|450128993|FG002|Period A|Non-compliance with IMP|0|||
125137612|NCT01838681|450128994|FG003|Period A|Non-compliance with IMP|0|||
125137613|NCT01838681|450128991|FG000|Period A|Lost to Follow-up|4|||
125137614|NCT01838681|450128992|FG001|Period A|Lost to Follow-up|0|||
125137615|NCT01838681|450128993|FG002|Period A|Lost to Follow-up|0|||
125137616|NCT01838681|450128994|FG003|Period A|Lost to Follow-up|0|||
125137617|NCT01838681|450128991|FG000|Period A|Withdrawal before treatment|4|||
125137618|NCT01838681|450128992|FG001|Period A|Withdrawal before treatment|0|||
125137619|NCT01838681|450128993|FG002|Period A|Withdrawal before treatment|0|||
125137620|NCT01838681|450128994|FG003|Period A|Withdrawal before treatment|0|||
125137621|NCT01838681|450128991|FG000|Period A|Administrative or other reasons|17|||
125137622|NCT01838681|450128992|FG001|Period A|Administrative or other reasons|0|||
125137623|NCT01838681|450128993|FG002|Period A|Administrative or other reasons|0|||
125137624|NCT01838681|450128994|FG003|Period A|Administrative or other reasons|0|||
125137625|NCT01838681|450128991|FG000|Period B/A+|Adverse Event|0|||
125137626|NCT01838681|450128992|FG001|Period B/A+|Adverse Event|13|||
125137627|NCT01838681|450128993|FG002|Period B/A+|Adverse Event|27|||
125137628|NCT01838681|450128994|FG003|Period B/A+|Adverse Event|16|||
125137629|NCT01838681|450128991|FG000|Period B/A+|Lack of Efficacy|0|||
125137630|NCT01838681|450128992|FG001|Period B/A+|Lack of Efficacy|9|||
125137631|NCT01838681|450128993|FG002|Period B/A+|Lack of Efficacy|11|||
125137632|NCT01838681|450128994|FG003|Period B/A+|Lack of Efficacy|6|||
125137633|NCT01838681|450128991|FG000|Period B/A+|Withdrawal by Subject|0|||
125137634|NCT01838681|450128992|FG001|Period B/A+|Withdrawal by Subject|28|||
125137635|NCT01838681|450128993|FG002|Period B/A+|Withdrawal by Subject|35|||
125137636|NCT01838681|450128994|FG003|Period B/A+|Withdrawal by Subject|47|||
125137637|NCT01838681|450128991|FG000|Period B/A+|Protocol Violation|0|||
125137638|NCT01838681|450128992|FG001|Period B/A+|Protocol Violation|1|||
125137639|NCT01838681|450128993|FG002|Period B/A+|Protocol Violation|4|||
125137640|NCT01838681|450128994|FG003|Period B/A+|Protocol Violation|6|||
125137641|NCT01838681|450128991|FG000|Period B/A+|Non-compliance with IMP|0|||
125137642|NCT01838681|450128992|FG001|Period B/A+|Non-compliance with IMP|2|||
125137643|NCT01838681|450128993|FG002|Period B/A+|Non-compliance with IMP|3|||
125137644|NCT01838681|450128994|FG003|Period B/A+|Non-compliance with IMP|3|||
125137645|NCT01838681|450128991|FG000|Period B/A+|Lost to Follow-up|0|||
125137646|NCT01838681|450128992|FG001|Period B/A+|Lost to Follow-up|2|||
125137647|NCT01838681|450128993|FG002|Period B/A+|Lost to Follow-up|5|||
125137648|NCT01838681|450128994|FG003|Period B/A+|Lost to Follow-up|11|||
125437949|NCT02301156|451230044|FG001|Overall Study|Reason not Specified|3|||
125437950|NCT00147225|451230054|FG000|Overall Study|Withdrawal by Subject|1|||
125437951|NCT00147225|451230055|FG001|Overall Study|Withdrawal by Subject|0|||
125437952|NCT00147225|451230056|FG002|Overall Study|Withdrawal by Subject|1|||
125437953|NCT00147225|451230057|FG003|Overall Study|Withdrawal by Subject|0|||
125437954|NCT00147225|451230058|FG004|Overall Study|Withdrawal by Subject|0|||
125437955|NCT00147225|451230059|FG005|Overall Study|Withdrawal by Subject|1|||
125437956|NCT00147225|451230054|FG000|Overall Study|Adverse Event|0|||
125437957|NCT00147225|451230055|FG001|Overall Study|Adverse Event|0|||
125437958|NCT00147225|451230056|FG002|Overall Study|Adverse Event|1|||
125437959|NCT00147225|451230057|FG003|Overall Study|Adverse Event|1|||
125437960|NCT00147225|451230058|FG004|Overall Study|Adverse Event|0|||
125437961|NCT00147225|451230059|FG005|Overall Study|Adverse Event|0|||
125437962|NCT00147225|451230054|FG000|Overall Study|Screen Failure|0|||
125437963|NCT00147225|451230055|FG001|Overall Study|Screen Failure|0|||
125437964|NCT00147225|451230056|FG002|Overall Study|Screen Failure|0|||
125437965|NCT00147225|451230057|FG003|Overall Study|Screen Failure|0|||
125437966|NCT00147225|451230058|FG004|Overall Study|Screen Failure|1|||
125437967|NCT00147225|451230059|FG005|Overall Study|Screen Failure|0|||
125437968|NCT00147225|451230054|FG000|Overall Study|Chemotherapy Changed|0|||
125437969|NCT00147225|451230055|FG001|Overall Study|Chemotherapy Changed|0|||
125437970|NCT00147225|451230056|FG002|Overall Study|Chemotherapy Changed|0|||
125437971|NCT00147225|451230057|FG003|Overall Study|Chemotherapy Changed|0|||
125437972|NCT00147225|451230058|FG004|Overall Study|Chemotherapy Changed|0|||
125437973|NCT00147225|451230059|FG005|Overall Study|Chemotherapy Changed|1|||
125437974|NCT02998021|451230060|FG000|Overall Study|Withdrawal by Subject|3|||
125437975|NCT02998021|451230061|FG001|Overall Study|Withdrawal by Subject|1|||
125437976|NCT02998021|451230060|FG000|Overall Study|unsafe home|0|||
125437977|NCT02998021|451230061|FG001|Overall Study|unsafe home|1|||
125437978|NCT02049710|451230062|FG000|Overall Study|Lost to Follow-up|319|||
125437979|NCT02049710|451230063|FG001|Overall Study|Lost to Follow-up|324|||
125437980|NCT03713021|451230067|FG000|Overall Study|Did not have CT sim scan available|6|||
125437981|NCT03713021|451230067|FG000|Overall Study|Not eligible|4|||
125437982|NCT03713021|451230067|FG000|Overall Study|Issues with TraceIT markers|5|||
125437983|NCT00874432|451230068|FG000|Overall Study|Withdrawal by Subject|1|||
125437984|NCT00874432|451230069|FG001|Overall Study|Withdrawal by Subject|0|||
125437985|NCT00874432|451230070|FG002|Overall Study|Withdrawal by Subject|0|||
125437986|NCT00874432|451230071|FG003|Overall Study|Withdrawal by Subject|0|||
125437987|NCT00874432|451230068|FG000|Overall Study|Physician Decision|1|||
125437988|NCT00874432|451230069|FG001|Overall Study|Physician Decision|0|||
125437989|NCT00874432|451230070|FG002|Overall Study|Physician Decision|0|||
125437990|NCT00874432|451230071|FG003|Overall Study|Physician Decision|0|||
125437991|NCT00874432|451230068|FG000|Overall Study|Other|1|||
125437992|NCT00874432|451230069|FG001|Overall Study|Other|2|||
125437993|NCT00874432|451230070|FG002|Overall Study|Other|8|||
125437994|NCT00874432|451230071|FG003|Overall Study|Other|3|||
125220789|NCT00627497|450436215|FG003|Overall Study|Lost to Follow-up|0|||
125437995|NCT01167179|451232080|FG000|Overall Study|disease recurrence|4|||
125437996|NCT01167179|451232081|FG001|Overall Study|disease recurrence|4|||
125437997|NCT01167179|451232080|FG000|Overall Study|Death|4|||
125437998|NCT01167179|451232081|FG001|Overall Study|Death|10|||
125437999|NCT01167179|451232080|FG000|Overall Study|Withdrawal by Subject|1|||
125438000|NCT01167179|451232081|FG001|Overall Study|Withdrawal by Subject|2|||
125438001|NCT01167179|451232080|FG000|Overall Study|diverse|6|||
125438002|NCT01167179|451232081|FG001|Overall Study|diverse|5|||
125438003|NCT01158378|451232082|FG000|Overall Study|Death|4|||
125438004|NCT01158378|451232083|FG001|Overall Study|Death|5|||
125438005|NCT01158378|451232082|FG000|Overall Study|Lost to Follow-up|2|||
125438006|NCT01158378|451232083|FG001|Overall Study|Lost to Follow-up|4|||
125438007|NCT01158378|451232082|FG000|Overall Study|Withdrawal by Subject|4|||
125137649|NCT01838681|450128991|FG000|Period B/A+|Withdrawal before treatment|0|||
125137650|NCT01838681|450128992|FG001|Period B/A+|Withdrawal before treatment|1|||
125137651|NCT01838681|450128993|FG002|Period B/A+|Withdrawal before treatment|0|||
125137652|NCT01838681|450128994|FG003|Period B/A+|Withdrawal before treatment|0|||
125137653|NCT01838681|450128991|FG000|Period B/A+|Administrative or other reasons|0|||
125137654|NCT01838681|450128992|FG001|Period B/A+|Administrative or other reasons|6|||
125137655|NCT01838681|450128993|FG002|Period B/A+|Administrative or other reasons|10|||
125137656|NCT01838681|450128994|FG003|Period B/A+|Administrative or other reasons|28|||
125137657|NCT01229150|450128997|FG000|Overall Study|Toxicity|2|||
125137658|NCT01229150|450128998|FG001|Overall Study|Toxicity|2|||
125137659|NCT01229150|450128999|FG002|Overall Study|Toxicity|0|||
125137660|NCT01229150|450129000|FG003|Overall Study|Toxicity|0|||
125137661|NCT02011945|450129001|FG000|Overall Study|Participant requested to Discontinue|0|||
125137662|NCT02011945|450129002|FG001|Overall Study|Participant requested to Discontinue|1|||
125137663|NCT02011945|450129003|FG002|Overall Study|Participant requested to Discontinue|1|||
125137664|NCT02011945|450129001|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
125383704|NCT03204305|451037076|FG002|Overall Study|Physician Decision|0|||
125383705|NCT03204305|451037077|FG003|Overall Study|Physician Decision|0|||
125383706|NCT03204305|451037074|FG000|Overall Study|failure to place arterial line|2|||
125383707|NCT03204305|451037075|FG001|Overall Study|failure to place arterial line|1|||
125383708|NCT03204305|451037076|FG002|Overall Study|failure to place arterial line|0|||
125383709|NCT03204305|451037077|FG003|Overall Study|failure to place arterial line|0|||
125383710|NCT03204305|451037074|FG000|Overall Study|Withdrawal by Subject|2|||
125383711|NCT03204305|451037075|FG001|Overall Study|Withdrawal by Subject|0|||
125383712|NCT03204305|451037076|FG002|Overall Study|Withdrawal by Subject|0|||
125383713|NCT03204305|451037077|FG003|Overall Study|Withdrawal by Subject|0|||
125383714|NCT00535223|451037078|FG000|Overall Study|Withdrawal by Subject|4|||
125383715|NCT00535223|451037079|FG001|Overall Study|Withdrawal by Subject|1|||
125383716|NCT02953314|451037080|FG000|Overall Study|Adverse Event|0|||
125383717|NCT02953314|451037081|FG001|Overall Study|Adverse Event|1|||
125383718|NCT02953314|451037080|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
125383719|NCT02953314|451037081|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
125383720|NCT02335099|451037082|FG000|Treatment|Withdrawal by Subject|1|||
125383721|NCT02335099|451037083|FG001|Treatment|Withdrawal by Subject|3|||
125383722|NCT02335099|451037082|FG000|Treatment|Lost to Follow-up|2|||
125383723|NCT02335099|451037083|FG001|Treatment|Lost to Follow-up|0|||
125383724|NCT02335099|451037082|FG000|Treatment|Death|1|||
125383725|NCT02335099|451037083|FG001|Treatment|Death|0|||
125383726|NCT02335099|451037082|FG000|Treatment|Adverse Event|1|||
125383727|NCT02335099|451037083|FG001|Treatment|Adverse Event|2|||
125383728|NCT02335099|451037082|FG000|Follow-up|Death|0|||
125383729|NCT02335099|451037083|FG001|Follow-up|Death|1|||
125383730|NCT02045797|451037084|FG000|Overall Study|Adverse Event|3|||
125383731|NCT02045797|451037085|FG001|Overall Study|Adverse Event|1|||
125383732|NCT02045797|451037086|FG002|Overall Study|Adverse Event|0|||
125383733|NCT02045797|451037084|FG000|Overall Study|Lack of Efficacy|1|||
125383734|NCT02045797|451037085|FG001|Overall Study|Lack of Efficacy|0|||
125383735|NCT02045797|451037086|FG002|Overall Study|Lack of Efficacy|0|||
125383736|NCT02045797|451037084|FG000|Overall Study|Lost to Follow-up|2|||
125383737|NCT02045797|451037085|FG001|Overall Study|Lost to Follow-up|3|||
125383738|NCT02045797|451037086|FG002|Overall Study|Lost to Follow-up|1|||
125383739|NCT02045797|451037084|FG000|Overall Study|Physician Decision|0|||
125383740|NCT02045797|451037085|FG001|Overall Study|Physician Decision|1|||
125383741|NCT02045797|451037086|FG002|Overall Study|Physician Decision|0|||
125383742|NCT02045797|451037084|FG000|Overall Study|Withdrawal by Subject|1|||
125383743|NCT02045797|451037085|FG001|Overall Study|Withdrawal by Subject|2|||
125383744|NCT02045797|451037086|FG002|Overall Study|Withdrawal by Subject|0|||
125383745|NCT01765153|451037087|FG000|Training Phase 1|Format of intervention differed|1|||
125383746|NCT01765153|451037088|FG001|Training Phase 1|Format of intervention differed|0|||
125383747|NCT01765153|451037087|FG000|Training Phase 1|Poor participation in intervention|0|||
125383748|NCT01765153|451037088|FG001|Training Phase 1|Poor participation in intervention|1|||
125383749|NCT01765153|451037087|FG000|Rest Phase 1|Withdrawal by Subject|0|||
125137665|NCT02011945|450129002|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
125137666|NCT02011945|450129003|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
125137667|NCT02011945|450129001|FG000|Overall Study|Study Drug Toxicity|0|||
125137668|NCT02011945|450129002|FG001|Overall Study|Study Drug Toxicity|0|||
125137669|NCT02011945|450129003|FG002|Overall Study|Study Drug Toxicity|1|||
125383750|NCT01765153|451037088|FG001|Rest Phase 1|Withdrawal by Subject|1|||
125383751|NCT01765153|451037087|FG000|Training Phase 2|Withdrawal by Subject|0|||
125383752|NCT01765153|451037088|FG001|Training Phase 2|Withdrawal by Subject|1|||
125383753|NCT01765153|451037087|FG000|Rest Phase 2|Lost to Follow-up|2|||
125383754|NCT01765153|451037088|FG001|Rest Phase 2|Lost to Follow-up|1|||
125383755|NCT00415909|451038127|FG000|Overall Study|Withdrawal by Subject|2|||
125383756|NCT00415909|451038127|FG000|Overall Study|Death|1|||
125383757|NCT00312494|451038128|FG000|Overall Study|Randomized; not treated with study drug|9|||
125383758|NCT00312494|451038129|FG001|Overall Study|Randomized; not treated with study drug|10|||
125137670|NCT02011945|450129001|FG000|Overall Study|Treatment Failure|0|||
125137671|NCT02011945|450129002|FG001|Overall Study|Treatment Failure|7|||
125137672|NCT02011945|450129003|FG002|Overall Study|Treatment Failure|6|||
125137673|NCT02011945|450129001|FG000|Overall Study|No Longer Meets Study Criteria|1|||
125438008|NCT01158378|451232083|FG001|Overall Study|Withdrawal by Subject|0|||
125438009|NCT03017235|451232084|FG000|Overall Study|Withdrawal by Subject|4|||
125438010|NCT03017235|451232085|FG001|Overall Study|Withdrawal by Subject|3|||
125438011|NCT03017235|451232084|FG000|Overall Study|Lost to Follow-up|2|||
125438012|NCT03017235|451232085|FG001|Overall Study|Lost to Follow-up|7|||
125438013|NCT03017235|451232084|FG000|Overall Study|Adverse Event|0|||
125438014|NCT03017235|451232085|FG001|Overall Study|Adverse Event|1|||
125438015|NCT03017235|451232084|FG000|Overall Study|Protocol Violation|2|||
125438016|NCT03017235|451232085|FG001|Overall Study|Protocol Violation|1|||
125438017|NCT03017235|451232084|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
125137674|NCT02011945|450129002|FG001|Overall Study|No Longer Meets Study Criteria|0|||
125137675|NCT02011945|450129003|FG002|Overall Study|No Longer Meets Study Criteria|0|||
125137676|NCT02011945|450129001|FG000|Overall Study|Proceeded to stem cell transplant|0|||
125137677|NCT02011945|450129002|FG001|Overall Study|Proceeded to stem cell transplant|0|||
125137678|NCT02011945|450129003|FG002|Overall Study|Proceeded to stem cell transplant|1|||
125137679|NCT02011945|450129001|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
125137680|NCT02011945|450129002|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
125137681|NCT02011945|450129003|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
125137682|NCT03531827|450129004|FG000|Overall Study|Adverse Event|2|||
125137683|NCT03531827|450129005|FG001|Overall Study|Adverse Event|0|||
125137684|NCT03531827|450129004|FG000|Overall Study|Progressive disease|1|||
125137685|NCT03531827|450129005|FG001|Overall Study|Progressive disease|0|||
125137686|NCT00849797|450129006|FG000|First Intervention|bad veins|1|||
125137687|NCT00849797|450129007|FG001|First Intervention|bad veins|0|||
125137688|NCT00849797|450129006|FG000|First Intervention|Adverse Event|0|||
125137689|NCT00849797|450129007|FG001|First Intervention|Adverse Event|1|||
125137690|NCT00849797|450129006|FG000|Washout: One Week|Withdrawal by Subject|0|||
125137691|NCT00849797|450129007|FG001|Washout: One Week|Withdrawal by Subject|2|||
125137692|NCT00679081|450129008|FG000|Overall Study|Lost to Follow-up|1|||
125137693|NCT04198363|450129010|FG000|Overall Study|Adverse Event|1|||
125137694|NCT04198363|450129011|FG001|Overall Study|Adverse Event|1|||
125137695|NCT04198363|450129010|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
125137696|NCT04198363|450129011|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
125137697|NCT04198363|450129010|FG000|Overall Study|Reason not Specified|1|||
125137698|NCT04198363|450129011|FG001|Overall Study|Reason not Specified|0|||
125137699|NCT01404988|450129015|FG000|Overall Study|Death|2|||
125137700|NCT01404988|450129016|FG001|Overall Study|Death|0|||
125137701|NCT01404988|450129017|FG002|Overall Study|Death|2|||
125137702|NCT01404988|450129015|FG000|Overall Study|Adverse Event|1|||
125137703|NCT01404988|450129016|FG001|Overall Study|Adverse Event|0|||
125137704|NCT01404988|450129017|FG002|Overall Study|Adverse Event|0|||
125137705|NCT01404988|450129015|FG000|Overall Study|Withdrawal by Subject|2|||
125137706|NCT01404988|450129016|FG001|Overall Study|Withdrawal by Subject|2|||
125137707|NCT01404988|450129017|FG002|Overall Study|Withdrawal by Subject|0|||
125137708|NCT01404988|450129015|FG000|Overall Study|Lost to Follow-up|1|||
125137709|NCT01404988|450129016|FG001|Overall Study|Lost to Follow-up|2|||
125137710|NCT01404988|450129017|FG002|Overall Study|Lost to Follow-up|1|||
125137711|NCT02588339|450129018|FG000|Overall Study|Withdrawal by Subject|1|||
125137712|NCT02588339|450129018|FG000|Overall Study|GVHD Progression prior to treatment|2|||
125137713|NCT03578809|450131053|FG000|Overall Study|Death|0|||
125137714|NCT03578809|450131054|FG001|Overall Study|Death|2|||
125137715|NCT03578809|450131055|FG002|Overall Study|Death|0|||
125137716|NCT03578809|450131056|FG003|Overall Study|Death|1|||
125137717|NCT03578809|450131053|FG000|Overall Study|Lost to Follow-up|0|||
125137718|NCT03578809|450131054|FG001|Overall Study|Lost to Follow-up|1|||
125137719|NCT03578809|450131055|FG002|Overall Study|Lost to Follow-up|0|||
125137720|NCT03578809|450131056|FG003|Overall Study|Lost to Follow-up|0|||
125137721|NCT03578809|450131053|FG000|Overall Study|Withdrawal by Subject|3|||
125137722|NCT03578809|450131054|FG001|Overall Study|Withdrawal by Subject|5|||
125438018|NCT03017235|451232085|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
125438019|NCT02593539|451232089|FG000|Overall Study|Adverse Event|1|||
125137723|NCT03578809|450131055|FG002|Overall Study|Withdrawal by Subject|2|||
125137724|NCT03578809|450131056|FG003|Overall Study|Withdrawal by Subject|0|||
125137725|NCT03578809|450131053|FG000|Overall Study|Other|3|||
125137726|NCT03578809|450131054|FG001|Overall Study|Other|6|||
125137727|NCT03578809|450131055|FG002|Overall Study|Other|2|||
125137728|NCT03578809|450131056|FG003|Overall Study|Other|8|||
125137729|NCT02997176|450131059|FG000|Overall Study|Adverse Event|0|||
125137730|NCT02997176|450131060|FG001|Overall Study|Adverse Event|0|||
125137731|NCT02997176|450131061|FG002|Overall Study|Adverse Event|0|||
125137732|NCT02997176|450131062|FG003|Overall Study|Adverse Event|8|||
125137733|NCT02997176|450131059|FG000|Overall Study|Progressive Disease|1|||
125137734|NCT02997176|450131060|FG001|Overall Study|Progressive Disease|0|||
125137735|NCT02997176|450131061|FG002|Overall Study|Progressive Disease|1|||
125438020|NCT01282476|451232090|FG000|Overall Study|Death|11|||
125383759|NCT00312494|451038130|FG002|Overall Study|Randomized; not treated with study drug|5|||
125383760|NCT00312494|451038128|FG000|Overall Study|Adverse Event|33|||
125383761|NCT00312494|451038129|FG001|Overall Study|Adverse Event|15|||
125383762|NCT00312494|451038130|FG002|Overall Study|Adverse Event|11|||
125383763|NCT00312494|451038128|FG000|Overall Study|Lack of Efficacy|4|||
125383764|NCT00312494|451038129|FG001|Overall Study|Lack of Efficacy|6|||
125383765|NCT00312494|451038130|FG002|Overall Study|Lack of Efficacy|8|||
125383766|NCT00312494|451038128|FG000|Overall Study|Laboratory abnormality|1|||
125383767|NCT00312494|451038129|FG001|Overall Study|Laboratory abnormality|0|||
125383768|NCT00312494|451038130|FG002|Overall Study|Laboratory abnormality|0|||
125383769|NCT00312494|451038128|FG000|Overall Study|Lost to Follow-up|8|||
125383770|NCT00312494|451038129|FG001|Overall Study|Lost to Follow-up|8|||
125383771|NCT00312494|451038130|FG002|Overall Study|Lost to Follow-up|8|||
125383772|NCT00312494|451038128|FG000|Overall Study|Withdrawal by Subject|6|||
125383773|NCT00312494|451038129|FG001|Overall Study|Withdrawal by Subject|9|||
125383774|NCT00312494|451038130|FG002|Overall Study|Withdrawal by Subject|10|||
125383775|NCT00312494|451038128|FG000|Overall Study|Other|10|||
125383776|NCT00312494|451038129|FG001|Overall Study|Other|10|||
125383777|NCT00312494|451038130|FG002|Overall Study|Other|1|||
125383778|NCT03232281|451038131|FG000|Overall Study|Adverse Event|1|||
125383779|NCT03232281|451038132|FG001|Overall Study|Adverse Event|1|||
125383780|NCT03232281|451038131|FG000|Overall Study|Withdrawal by Subject|5|||
125383781|NCT03232281|451038132|FG001|Overall Study|Withdrawal by Subject|4|||
125383782|NCT03232281|451038131|FG000|Overall Study|Protocol Deviation|1|||
125383783|NCT03232281|451038132|FG001|Overall Study|Protocol Deviation|1|||
125383784|NCT02522286|451038134|FG000|Overall Study|Withdrawal by Subject|3|||
125383785|NCT02522286|451038135|FG001|Overall Study|Withdrawal by Subject|0|||
125383786|NCT02522286|451038136|FG002|Overall Study|Withdrawal by Subject|0|||
125383787|NCT02522286|451038137|FG003|Overall Study|Withdrawal by Subject|3|||
125383788|NCT00174915|451038138|FG000|Overall Study|Lost to Follow-up|19|||
125383789|NCT00174915|451038139|FG001|Overall Study|Lost to Follow-up|17|||
125383790|NCT00174915|451038140|FG002|Overall Study|Lost to Follow-up|9|||
125383791|NCT00174915|451038141|FG003|Overall Study|Lost to Follow-up|17|||
125383792|NCT00174915|451038142|FG004|Overall Study|Lost to Follow-up|10|||
125383793|NCT00174915|451038138|FG000|Overall Study|Adverse Event|18|||
125383794|NCT00174915|451038139|FG001|Overall Study|Adverse Event|16|||
125383795|NCT00174915|451038140|FG002|Overall Study|Adverse Event|11|||
125383796|NCT00174915|451038141|FG003|Overall Study|Adverse Event|18|||
125383797|NCT00174915|451038142|FG004|Overall Study|Adverse Event|5|||
125383798|NCT00174915|451038138|FG000|Overall Study|Personal Reason(s)|16|||
125383799|NCT00174915|451038139|FG001|Overall Study|Personal Reason(s)|16|||
125383800|NCT00174915|451038140|FG002|Overall Study|Personal Reason(s)|9|||
125383801|NCT00174915|451038141|FG003|Overall Study|Personal Reason(s)|9|||
125383802|NCT00174915|451038142|FG004|Overall Study|Personal Reason(s)|9|||
125383803|NCT00174915|451038138|FG000|Overall Study|Other|15|||
125383804|NCT00174915|451038139|FG001|Overall Study|Other|8|||
125383805|NCT00174915|451038140|FG002|Overall Study|Other|6|||
125383806|NCT00174915|451038141|FG003|Overall Study|Other|5|||
125383807|NCT00174915|451038142|FG004|Overall Study|Other|3|||
125383808|NCT00174915|451038138|FG000|Overall Study|Gout Flare|13|||
125383809|NCT00174915|451038139|FG001|Overall Study|Gout Flare|6|||
125383810|NCT00174915|451038140|FG002|Overall Study|Gout Flare|8|||
125383811|NCT00174915|451038141|FG003|Overall Study|Gout Flare|1|||
125383812|NCT00174915|451038142|FG004|Overall Study|Gout Flare|0|||
125383813|NCT00174915|451038138|FG000|Overall Study|Protocol Violation|6|||
125383814|NCT00174915|451038139|FG001|Overall Study|Protocol Violation|3|||
125383815|NCT00174915|451038140|FG002|Overall Study|Protocol Violation|3|||
125383816|NCT00174915|451038141|FG003|Overall Study|Protocol Violation|6|||
125383817|NCT00174915|451038142|FG004|Overall Study|Protocol Violation|3|||
125383818|NCT00174915|451038138|FG000|Overall Study|Therapeutic Failure|6|||
125383819|NCT00174915|451038139|FG001|Overall Study|Therapeutic Failure|3|||
125383820|NCT00174915|451038140|FG002|Overall Study|Therapeutic Failure|2|||
125383821|NCT00174915|451038141|FG003|Overall Study|Therapeutic Failure|1|||
125383822|NCT00174915|451038142|FG004|Overall Study|Therapeutic Failure|3|||
125137736|NCT02997176|450131062|FG003|Overall Study|Progressive Disease|1|||
125383823|NCT01870583|451038149|FG000|Overall Study|Protocol Violation|0|||
125383824|NCT01870583|451038150|FG001|Overall Study|Protocol Violation|5|||
125383825|NCT01870583|451038151|FG002|Overall Study|Protocol Violation|3|||
125383826|NCT01870583|451038149|FG000|Overall Study|Lost to Follow-up|11|||
125383827|NCT01870583|451038150|FG001|Overall Study|Lost to Follow-up|13|||
125383828|NCT01870583|451038151|FG002|Overall Study|Lost to Follow-up|5|||
125383829|NCT00937157|451038152|FG000|Overall Study|Pregnancy|1|||
125383830|NCT00937157|451038152|FG000|Overall Study|Lost to Follow-up|3|||
125383831|NCT00469092|451038153|FG000|Overall Study|Adverse Event|5|||
125383832|NCT00469092|451038154|FG001|Overall Study|Adverse Event|4|||
125383833|NCT00469092|451038153|FG000|Overall Study|Lack of Efficacy|1|||
125383834|NCT00469092|451038154|FG001|Overall Study|Lack of Efficacy|0|||
125383835|NCT00469092|451038153|FG000|Overall Study|Lost to Follow-up|1|||
125383836|NCT00469092|451038154|FG001|Overall Study|Lost to Follow-up|2|||
125137737|NCT02997176|450131059|FG000|Overall Study|Death|0|||
125383837|NCT00469092|451038153|FG000|Overall Study|Protocol Violation|3|||
125137738|NCT02997176|450131060|FG001|Overall Study|Death|0|||
125137739|NCT02997176|450131061|FG002|Overall Study|Death|1|||
125137740|NCT02997176|450131062|FG003|Overall Study|Death|1|||
125137741|NCT02997176|450131059|FG000|Overall Study|Withdrawal by Subject|0|||
125137742|NCT02997176|450131060|FG001|Overall Study|Withdrawal by Subject|2|||
125137743|NCT02997176|450131061|FG002|Overall Study|Withdrawal by Subject|0|||
125137744|NCT02997176|450131062|FG003|Overall Study|Withdrawal by Subject|1|||
125137745|NCT01624233|450131065|FG000|Period 2 - Induction|Adverse Event|1|||
125137746|NCT01624233|450131065|FG000|Period 3 - Maintenance|Adverse Event|2|||
125137747|NCT01624233|450131065|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
125137748|NCT01624233|450131065|FG000|Period 3 - Maintenance|Physician Decision|2|||
125383838|NCT00469092|451038154|FG001|Overall Study|Protocol Violation|3|||
125383839|NCT00469092|451038153|FG000|Overall Study|Withdrawal by Subject|4|||
125383840|NCT00469092|451038154|FG001|Overall Study|Withdrawal by Subject|4|||
125383841|NCT00469092|451038153|FG000|Overall Study|Withdrawal Criteria|3|||
125383842|NCT00469092|451038154|FG001|Overall Study|Withdrawal Criteria|4|||
125383843|NCT00469092|451038153|FG000|Overall Study|Incorrectly Randomised|4|||
125383844|NCT00469092|451038154|FG001|Overall Study|Incorrectly Randomised|3|||
125383845|NCT00469092|451038153|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
125383846|NCT00469092|451038154|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
125383847|NCT00469092|451038153|FG000|Overall Study|Use of lipid lowering drug|1|||
125383848|NCT00469092|451038154|FG001|Overall Study|Use of lipid lowering drug|0|||
125383849|NCT00469092|451038153|FG000|Overall Study|Hypoglycaemic Episodes|1|||
125383850|NCT00469092|451038154|FG001|Overall Study|Hypoglycaemic Episodes|1|||
125383851|NCT00469092|451038153|FG000|Overall Study|Abnormal lab value|1|||
125383852|NCT00469092|451038154|FG001|Overall Study|Abnormal lab value|0|||
125383853|NCT00469092|451038153|FG000|Overall Study|Use of Corticosteroid|1|||
125383854|NCT00469092|451038154|FG001|Overall Study|Use of Corticosteroid|0|||
125383855|NCT02024867|451038155|FG000|Overall Study|Protocol Violation|3|||
125383856|NCT02024867|451038156|FG001|Overall Study|Protocol Violation|3|||
125383857|NCT02024867|451038155|FG000|Overall Study|Lost to Follow-up|6|||
125383858|NCT02024867|451038156|FG001|Overall Study|Lost to Follow-up|4|||
125383859|NCT01998633|451038157|FG000|Overall Study|Death|1|||
125383860|NCT00413192|451038158|FG000|Overall Study|Disease progression|26|||
125383861|NCT00413192|451038159|FG001|Overall Study|Disease progression|31|||
125383862|NCT00413192|451038160|FG002|Overall Study|Disease progression|16|||
125383863|NCT00413192|451038161|FG003|Overall Study|Disease progression|25|||
125383864|NCT00413192|451038158|FG000|Overall Study|Toxicity|3|||
125383865|NCT00413192|451038159|FG001|Overall Study|Toxicity|2|||
125383866|NCT00413192|451038160|FG002|Overall Study|Toxicity|2|||
125383867|NCT00413192|451038161|FG003|Overall Study|Toxicity|2|||
125383868|NCT00413192|451038158|FG000|Overall Study|Withdrawal by Subject|3|||
125383869|NCT00413192|451038159|FG001|Overall Study|Withdrawal by Subject|5|||
125383870|NCT00413192|451038160|FG002|Overall Study|Withdrawal by Subject|0|||
125383871|NCT00413192|451038161|FG003|Overall Study|Withdrawal by Subject|1|||
125383872|NCT00413192|451038158|FG000|Overall Study|Intercurrent illness|0|||
125383873|NCT00413192|451038159|FG001|Overall Study|Intercurrent illness|0|||
125383874|NCT00413192|451038160|FG002|Overall Study|Intercurrent illness|0|||
125383875|NCT00413192|451038161|FG003|Overall Study|Intercurrent illness|1|||
125383876|NCT00413192|451038158|FG000|Overall Study|Intercurrent death|0|||
125383877|NCT00413192|451038159|FG001|Overall Study|Intercurrent death|1|||
125383878|NCT00413192|451038160|FG002|Overall Study|Intercurrent death|0|||
125383879|NCT00413192|451038161|FG003|Overall Study|Intercurrent death|0|||
125383880|NCT00413192|451038158|FG000|Overall Study|Other|5|||
125383881|NCT00413192|451038159|FG001|Overall Study|Other|1|||
125383882|NCT00413192|451038160|FG002|Overall Study|Other|1|||
125383883|NCT00413192|451038161|FG003|Overall Study|Other|2|||
125383884|NCT00413192|451038158|FG000|Overall Study|Not treated|0|||
125383885|NCT00413192|451038159|FG001|Overall Study|Not treated|0|||
125383886|NCT00413192|451038160|FG002|Overall Study|Not treated|0|||
125383887|NCT00413192|451038161|FG003|Overall Study|Not treated|1|||
125383888|NCT03992781|451038168|FG000|Overall Study|Lost to Follow-up|5|||
125383889|NCT03992781|451038168|FG000|Overall Study|Adverse Event|1|||
125383890|NCT03992781|451038168|FG000|Overall Study|Lack of Efficacy|5|||
125383891|NCT01275833|451038171|FG000|Overall Study|Study terminated|1|||
125383892|NCT01275833|451038172|FG001|Overall Study|Study terminated|1|||
125137749|NCT01624233|450131065|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
125137750|NCT01624233|450131065|FG000|Period 4 - Drug Free Period|Relapsed|61|||
125383893|NCT00003901|451038175|FG000|Overall Study|Adverse Event|1|||
125383894|NCT00003901|451038175|FG000|Overall Study|Withdrawal by Subject|1|||
125383895|NCT00003901|451038175|FG000|Overall Study|Ineligible|6|||
125383896|NCT00003901|451038175|FG000|Overall Study|CT Scan not within protocol requirement|2|||
125383897|NCT00003901|451038175|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
125383898|NCT00003901|451038175|FG000|Overall Study|Medical problems|6|||
125383899|NCT02268864|451038177|FG000|Overall Study|Withdrawal by Subject|2|||
125383900|NCT02268864|451038178|FG001|Overall Study|Withdrawal by Subject|0|||
125383901|NCT02268864|451038179|FG002|Overall Study|Withdrawal by Subject|0|||
125383902|NCT02268864|451038177|FG000|Overall Study|Death|0|||
125383903|NCT02268864|451038178|FG001|Overall Study|Death|1|||
125438021|NCT00437125|451232091|FG000|Overall Study|Adverse Event|12|||
125438022|NCT00437125|451232091|FG000|Overall Study|Death|1|||
125438023|NCT00437125|451232091|FG000|Overall Study|Clinical Relapse|1|||
125438024|NCT00437125|451232091|FG000|Overall Study|Lack of Efficacy|1|||
125220790|NCT00922116|450436216|FG000|Overall Study|Adverse Event|4|||
125220791|NCT00922116|450436216|FG000|Overall Study|Death|1|||
125220792|NCT00922116|450436216|FG000|Overall Study|Lost to Follow-up|1|||
125220793|NCT00922116|450436216|FG000|Overall Study|Withdrawal by Subject|4|||
125438025|NCT00437125|451232091|FG000|Overall Study|Lost to Follow-up|1|||
125438026|NCT00437125|451232091|FG000|Overall Study|Withdrawal by Subject|13|||
125438027|NCT00437125|451232091|FG000|Overall Study|Withdrawal by Caregiver|2|||
125438028|NCT00437125|451232091|FG000|Overall Study|Physician Decision|1|||
125438029|NCT02248961|451232094|FG000|Overall Study|Adverse Event|1|||
125438030|NCT02248961|451232095|FG001|Overall Study|Adverse Event|0|||
125438031|NCT02248961|451232094|FG000|Overall Study|Withdrawal by Subject|1|||
125438032|NCT02248961|451232095|FG001|Overall Study|Withdrawal by Subject|2|||
125438033|NCT02248961|451232094|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
125438034|NCT02248961|451232095|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
125438035|NCT00649389|451232098|FG000|Overall Study|Adverse Event|22|||
125438036|NCT00649389|451232099|FG001|Overall Study|Adverse Event|46|||
125438037|NCT00649389|451232100|FG002|Overall Study|Adverse Event|38|||
125438038|NCT00649389|451232101|FG003|Overall Study|Adverse Event|48|||
125220794|NCT00922116|450436216|FG000|Overall Study|Other|5|||
125438039|NCT00649389|451232098|FG000|Overall Study|Lost to Follow-up|15|||
125220795|NCT04607135|450436217|FG000|Overall Study|Physician Decision|1|||
125220796|NCT04607135|450436217|FG000|Overall Study|Withdrawal by Subject|1|||
125220797|NCT04607135|450436217|FG000|Overall Study|Equipment not working|3|||
125220798|NCT00807885|450436218|FG000|Overall Study|Lost to Follow-up|0|||
125220799|NCT00807885|450436219|FG001|Overall Study|Lost to Follow-up|0|||
125220800|NCT00807885|450436220|FG002|Overall Study|Lost to Follow-up|0|||
125220801|NCT00807885|450436221|FG003|Overall Study|Lost to Follow-up|0|||
125220802|NCT00807885|450436222|FG004|Overall Study|Lost to Follow-up|0|||
125220803|NCT00807885|450436223|FG005|Overall Study|Lost to Follow-up|1|||
125137751|NCT01624233|450131065|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
125137752|NCT01624233|450131065|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
125220804|NCT00807885|450436224|FG006|Overall Study|Lost to Follow-up|0|||
125220805|NCT00807885|450436225|FG007|Overall Study|Lost to Follow-up|0|||
125220806|NCT00807885|450436226|FG008|Overall Study|Lost to Follow-up|0|||
125220807|NCT02364388|450436227|FG000|Overall Study|Protocol Violation|1|||
125220808|NCT02364388|450436227|FG000|Overall Study|Technical Failure|3|||
125220809|NCT02364388|450436227|FG000|Overall Study|No OA/US data|2|||
125220810|NCT02364388|450436227|FG000|Overall Study|No Biopsy|2|||
125220811|NCT00327717|450436228|FG000|Overall Study|Adverse Event|6|||
125220812|NCT00327717|450436229|FG001|Overall Study|Adverse Event|6|||
125220813|NCT00327717|450436228|FG000|Overall Study|Lack of Efficacy|0|||
125220814|NCT00327717|450436229|FG001|Overall Study|Lack of Efficacy|1|||
125220815|NCT00327717|450436228|FG000|Overall Study|Withdrawal by Subject|3|||
125137753|NCT01624233|450131065|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
125137754|NCT01624233|450131065|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
125137755|NCT01624233|450131065|FG000|Period 6: Follow-up|Adverse Event|3|||
125137756|NCT01624233|450131065|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
125137757|NCT01624233|450131065|FG000|Period 6: Follow-up|Physician Decision|1|||
125137758|NCT01624233|450131065|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
125137759|NCT00373256|450131066|FG000|Overall Study|Adverse Event (AE)|1|||
125137760|NCT00373256|450131067|FG001|Overall Study|Adverse Event (AE)|5|||
125137761|NCT00373256|450131066|FG000|Overall Study|Lost to Follow-up|2|||
125137762|NCT00373256|450131067|FG001|Overall Study|Lost to Follow-up|1|||
125137763|NCT00373256|450131066|FG000|Overall Study|Death|9|||
125137764|NCT00373256|450131067|FG001|Overall Study|Death|8|||
125137765|NCT00373256|450131066|FG000|Overall Study|Objective Progression or Relapse|111|||
125137766|NCT00373256|450131067|FG001|Overall Study|Objective Progression or Relapse|104|||
125137767|NCT00373256|450131066|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
125137768|NCT00373256|450131067|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
125137769|NCT00373256|450131066|FG000|Overall Study|Other|73|||
125137770|NCT00373256|450131067|FG001|Overall Study|Other|107|||
125137771|NCT00373256|450131066|FG000|Overall Study|Protocol Violation|0|||
125137772|NCT00373256|450131067|FG001|Overall Study|Protocol Violation|2|||
125137773|NCT00373256|450131066|FG000|Overall Study|Study Terminated by Sponsor|41|||
125137774|NCT00373256|450131067|FG001|Overall Study|Study Terminated by Sponsor|13|||
125137775|NCT04372238|450131068|FG000|Overall Study|Duplicate|3|||
125137776|NCT04372238|450131069|FG001|Overall Study|Duplicate|3|||
125137777|NCT04372238|450131068|FG000|Overall Study|Did not consent for data linkage|6|||
125137778|NCT04372238|450131069|FG001|Overall Study|Did not consent for data linkage|10|||
125220816|NCT00327717|450436229|FG001|Overall Study|Withdrawal by Subject|7|||
125220817|NCT05285787|450436230|FG000|Overall Study|Withdrawal by Subject|1|||
125137779|NCT04241458|450131070|FG000|Overall Study|Withdrawal by Subject|0|||
125137780|NCT04241458|450131071|FG001|Overall Study|Withdrawal by Subject|0|||
125137781|NCT04241458|450131072|FG002|Overall Study|Withdrawal by Subject|0|||
125137782|NCT04241458|450131073|FG003|Overall Study|Withdrawal by Subject|0|||
125137783|NCT04241458|450131074|FG004|Overall Study|Withdrawal by Subject|1|||
125137784|NCT06144424|450131075|FG000|Overall Study|Withdrawal by Subject|2|||
125220818|NCT02360280|450436234|FG000|Overall Study|Withdrawal by Subject|2|||
125220819|NCT02360280|450436235|FG001|Overall Study|Withdrawal by Subject|0|||
125220820|NCT02360280|450436234|FG000|Overall Study|Adverse Event|0|||
125220821|NCT02360280|450436235|FG001|Overall Study|Adverse Event|1|||
125220822|NCT02360280|450436234|FG000|Overall Study|Lost to Follow-up|1|||
125220823|NCT02360280|450436235|FG001|Overall Study|Lost to Follow-up|0|||
125383904|NCT02268864|451038179|FG002|Overall Study|Death|0|||
125383905|NCT00857220|451038182|FG000|Overall Study|Adverse Event|35|||
125383906|NCT00857220|451038182|FG000|Overall Study|Death|1|||
125383907|NCT00857220|451038182|FG000|Overall Study|Lack of Efficacy|11|||
125383908|NCT00857220|451038182|FG000|Overall Study|Lost to Follow-up|30|||
125383909|NCT00857220|451038182|FG000|Overall Study|Physician Decision|4|||
125383910|NCT00857220|451038182|FG000|Overall Study|Protocol Violation|16|||
125383911|NCT00857220|451038182|FG000|Overall Study|Withdrawal by Subject|67|||
125383912|NCT00857220|451038182|FG000|Overall Study|Clinical Hold|6|||
125383913|NCT00857220|451038182|FG000|Overall Study|Site Closed|5|||
125383914|NCT00857220|451038182|FG000|Overall Study|Miscellaneous|8|||
125383915|NCT00680745|451038183|FG000|Overall Study|Withdrawal by Subject|8|||
125383916|NCT00680745|451038184|FG001|Overall Study|Withdrawal by Subject|3|||
125383917|NCT00680745|451038185|FG002|Overall Study|Withdrawal by Subject|2|||
125383918|NCT00680745|451038186|FG003|Overall Study|Withdrawal by Subject|8|||
125383919|NCT00680745|451038183|FG000|Overall Study|Lost to Follow-up|0|||
125383920|NCT00680745|451038184|FG001|Overall Study|Lost to Follow-up|1|||
125383921|NCT00680745|451038185|FG002|Overall Study|Lost to Follow-up|1|||
125383922|NCT00680745|451038186|FG003|Overall Study|Lost to Follow-up|0|||
125383923|NCT00680745|451038183|FG000|Overall Study|Death|1|||
125383924|NCT00680745|451038184|FG001|Overall Study|Death|0|||
125383925|NCT00680745|451038185|FG002|Overall Study|Death|1|||
125383926|NCT00680745|451038186|FG003|Overall Study|Death|0|||
125383927|NCT00680745|451038183|FG000|Overall Study|Adverse Event|5|||
125383928|NCT00680745|451038184|FG001|Overall Study|Adverse Event|3|||
125383929|NCT00680745|451038185|FG002|Overall Study|Adverse Event|3|||
125383930|NCT00680745|451038186|FG003|Overall Study|Adverse Event|3|||
125383931|NCT00680745|451038183|FG000|Overall Study|Poor/Non-compliance|0|||
125383932|NCT00680745|451038184|FG001|Overall Study|Poor/Non-compliance|3|||
125383933|NCT00680745|451038185|FG002|Overall Study|Poor/Non-compliance|0|||
125383934|NCT00680745|451038186|FG003|Overall Study|Poor/Non-compliance|0|||
125220824|NCT02472886|450436236|FG000|Overall Study|Lack of Efficacy|0|||
125220825|NCT02472886|450436237|FG001|Overall Study|Lack of Efficacy|2|||
125383935|NCT00680745|451038183|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
125383936|NCT00680745|451038184|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
125383937|NCT00680745|451038185|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
125383938|NCT00680745|451038186|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
125383939|NCT00680745|451038183|FG000|Overall Study|False Treatment|0|||
125383940|NCT00680745|451038184|FG001|Overall Study|False Treatment|1|||
125137785|NCT06144424|450131076|FG001|Overall Study|Withdrawal by Subject|0|||
125137786|NCT06144424|450131075|FG000|Overall Study|Incarceration|1|||
125137787|NCT06144424|450131076|FG001|Overall Study|Incarceration|0|||
125137788|NCT02752074|450131088|FG000|Overall Study|Lost to Follow-up|1|||
125137789|NCT02752074|450131089|FG001|Overall Study|Lost to Follow-up|4|||
125137790|NCT02752074|450131088|FG000|Overall Study|Death|146|||
125137791|NCT02752074|450131089|FG001|Overall Study|Death|129|||
125137792|NCT02752074|450131088|FG000|Overall Study|Withdrawal by Subject|9|||
125137793|NCT02752074|450131089|FG001|Overall Study|Withdrawal by Subject|10|||
125137794|NCT01701063|450131092|FG000|Overall Study|Lost to Follow-up|0|||
125137795|NCT01701063|450131093|FG001|Overall Study|Lost to Follow-up|1|||
125137796|NCT01701063|450131094|FG002|Overall Study|Lost to Follow-up|0|||
125137797|NCT01701063|450131092|FG000|Overall Study|Withdrawal by Subject|0|||
125137798|NCT01701063|450131093|FG001|Overall Study|Withdrawal by Subject|0|||
125137799|NCT01701063|450131094|FG002|Overall Study|Withdrawal by Subject|1|||
125137800|NCT01701063|450131092|FG000|Overall Study|Other|0|||
125137801|NCT01701063|450131093|FG001|Overall Study|Other|0|||
125137802|NCT01701063|450131094|FG002|Overall Study|Other|1|||
125137803|NCT02554877|450131095|FG000|Overall Study|Adverse Event|2|||
125137804|NCT02554877|450131096|FG001|Overall Study|Adverse Event|0|||
125137805|NCT02554877|450131097|FG002|Overall Study|Adverse Event|0|||
125137806|NCT02554877|450131098|FG003|Overall Study|Adverse Event|1|||
125137807|NCT02554877|450131095|FG000|Overall Study|Lost to Follow-up|1|||
125137808|NCT02554877|450131096|FG001|Overall Study|Lost to Follow-up|1|||
125137809|NCT02554877|450131097|FG002|Overall Study|Lost to Follow-up|1|||
125137810|NCT02554877|450131098|FG003|Overall Study|Lost to Follow-up|2|||
125137811|NCT02554877|450131095|FG000|Overall Study|Did not meet entrance criteria|0|||
125137812|NCT02554877|450131096|FG001|Overall Study|Did not meet entrance criteria|0|||
125137813|NCT02554877|450131097|FG002|Overall Study|Did not meet entrance criteria|1|||
125137814|NCT02554877|450131098|FG003|Overall Study|Did not meet entrance criteria|0|||
125137815|NCT02554877|450131095|FG000|Overall Study|No longer met eligibility criteria|1|||
125137816|NCT02554877|450131096|FG001|Overall Study|No longer met eligibility criteria|0|||
125137817|NCT02554877|450131097|FG002|Overall Study|No longer met eligibility criteria|1|||
125137818|NCT02554877|450131098|FG003|Overall Study|No longer met eligibility criteria|1|||
125137819|NCT02554877|450131095|FG000|Overall Study|Protocol Violation|3|||
125137820|NCT02554877|450131096|FG001|Overall Study|Protocol Violation|1|||
125137821|NCT02554877|450131097|FG002|Overall Study|Protocol Violation|1|||
125137822|NCT02554877|450131098|FG003|Overall Study|Protocol Violation|0|||
125137823|NCT02554877|450131095|FG000|Overall Study|Other|1|||
125137824|NCT02554877|450131096|FG001|Overall Study|Other|3|||
125137825|NCT02554877|450131097|FG002|Overall Study|Other|0|||
125137826|NCT02554877|450131098|FG003|Overall Study|Other|3|||
125137827|NCT02554877|450131095|FG000|Overall Study|Insufficient clinical response|4|||
125137828|NCT02554877|450131096|FG001|Overall Study|Insufficient clinical response|0|||
125137829|NCT02554877|450131097|FG002|Overall Study|Insufficient clinical response|0|||
125137830|NCT02554877|450131098|FG003|Overall Study|Insufficient clinical response|0|||
125137831|NCT02554877|450131095|FG000|Overall Study|No longer willing to participate|0|||
125137832|NCT02554877|450131096|FG001|Overall Study|No longer willing to participate|2|||
125137833|NCT02554877|450131097|FG002|Overall Study|No longer willing to participate|2|||
125137834|NCT02554877|450131098|FG003|Overall Study|No longer willing to participate|0|||
125137835|NCT04474405|450131099|FG000|Overall Study|Withdrawal by Subject|0|||
125137836|NCT04474405|450131100|FG001|Overall Study|Withdrawal by Subject|0|||
125137837|NCT04474405|450131101|FG002|Overall Study|Withdrawal by Subject|1|||
125137838|NCT04474405|450131102|FG003|Overall Study|Withdrawal by Subject|0|||
125137839|NCT04474405|450131103|FG004|Overall Study|Withdrawal by Subject|1|||
125137840|NCT04474405|450131104|FG005|Overall Study|Withdrawal by Subject|0|||
125137841|NCT04474405|450131099|FG000|Overall Study|Other|0|||
125137842|NCT04474405|450131100|FG001|Overall Study|Other|0|||
125137843|NCT04474405|450131101|FG002|Overall Study|Other|0|||
125137844|NCT04474405|450131102|FG003|Overall Study|Other|0|||
125137845|NCT04474405|450131103|FG004|Overall Study|Other|3|||
125137846|NCT04474405|450131104|FG005|Overall Study|Other|0|||
125137847|NCT00274651|450131105|FG000|Overall Study|Adverse Event|6|||
125137848|NCT00274651|450131106|FG001|Overall Study|Adverse Event|3|||
125137849|NCT00274651|450131105|FG000|Overall Study|Lack of Efficacy|13|||
125137850|NCT00274651|450131106|FG001|Overall Study|Lack of Efficacy|6|||
125137851|NCT00274651|450131105|FG000|Overall Study|Death|1|||
125137852|NCT00274651|450131106|FG001|Overall Study|Death|3|||
125137853|NCT00274651|450131105|FG000|Overall Study|Withdrawal by Subject|0|||
125137854|NCT00274651|450131106|FG001|Overall Study|Withdrawal by Subject|1|||
125137855|NCT00274651|450131105|FG000|Overall Study|Physician Decision|8|||
125137856|NCT00274651|450131106|FG001|Overall Study|Physician Decision|7|||
125137857|NCT04547192|450131107|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
125137858|NCT04547192|450131108|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
125137859|NCT04547192|450131109|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
125137860|NCT04547192|450131110|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
125137861|NCT04547192|450131107|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
125137862|NCT04547192|450131108|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
125137863|NCT04547192|450131109|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
125383941|NCT00680745|451038185|FG002|Overall Study|False Treatment|3|||
125383942|NCT00680745|451038186|FG003|Overall Study|False Treatment|0|||
125383943|NCT02612428|451038187|FG000|VTL-308|Death|14|||
125383944|NCT02612428|451038188|FG001|VTL-308|Death|16|||
125383945|NCT02612428|451038187|FG000|VTL-308|Withdrawal by Subject|0|||
125383946|NCT02612428|451038188|FG001|VTL-308|Withdrawal by Subject|1|||
125383947|NCT02612428|451038187|FG000|VTL-308E|Death|9|||
125383948|NCT02612428|451038188|FG001|VTL-308E|Death|7|||
125383949|NCT02612428|451038187|FG000|VTL-308E|Lost to Follow-up|2|||
125383950|NCT02612428|451038188|FG001|VTL-308E|Lost to Follow-up|0|||
125383951|NCT00742001|451038189|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
125383952|NCT00742001|451038190|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
125383953|NCT00742001|451038191|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
125383954|NCT00137423|451038192|FG000|Overall Study|Adverse Event|7|||
125383955|NCT00137423|451038193|FG001|Overall Study|Adverse Event|9|||
125383956|NCT00137423|451038192|FG000|Overall Study|consent withdrawn|1|||
125383957|NCT00137423|451038193|FG001|Overall Study|consent withdrawn|1|||
125383958|NCT00137423|451038192|FG000|Overall Study|Lack of Efficacy|31|||
125383959|NCT00137423|451038193|FG001|Overall Study|Lack of Efficacy|33|||
125383960|NCT00137423|451038192|FG000|Overall Study|Death|0|||
125383961|NCT00137423|451038193|FG001|Overall Study|Death|1|||
125383962|NCT02617511|451038195|FG000|Overall Study|Withdrawal by Subject|1|||
125383963|NCT02617511|451038196|FG001|Overall Study|Withdrawal by Subject|0|||
125383964|NCT02141997|451038197|FG000|Overall Study|Adverse Event|0|||
125383965|NCT02141997|451038198|FG001|Overall Study|Adverse Event|2|||
125383966|NCT02141997|451038199|FG002|Overall Study|Adverse Event|0|||
125383967|NCT02141997|451038200|FG003|Overall Study|Adverse Event|1|||
125383968|NCT02141997|451038197|FG000|Overall Study|Participant noncompliance|1|||
125383969|NCT02141997|451038198|FG001|Overall Study|Participant noncompliance|0|||
125383970|NCT02141997|451038199|FG002|Overall Study|Participant noncompliance|0|||
125383971|NCT02141997|451038200|FG003|Overall Study|Participant noncompliance|0|||
125383972|NCT02141997|451038197|FG000|Overall Study|Withdrew consent|1|||
125383973|NCT02141997|451038198|FG001|Overall Study|Withdrew consent|0|||
125383974|NCT02141997|451038199|FG002|Overall Study|Withdrew consent|3|||
125383975|NCT02141997|451038200|FG003|Overall Study|Withdrew consent|0|||
125383976|NCT02141997|451038197|FG000|Overall Study|Other|1|||
125383977|NCT02141997|451038198|FG001|Overall Study|Other|4|||
125383978|NCT02141997|451038199|FG002|Overall Study|Other|0|||
125383979|NCT02141997|451038200|FG003|Overall Study|Other|0|||
125383980|NCT04105998|451038203|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
125383981|NCT04105998|451038204|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
125383982|NCT01050257|451038207|FG000|Overall Study|Adverse Event|4|||
125383983|NCT01050257|451038208|FG001|Overall Study|Adverse Event|4|||
125383984|NCT01050257|451038209|FG002|Overall Study|Adverse Event|2|||
125383985|NCT01050257|451038207|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
125383986|NCT01050257|451038208|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
125383987|NCT01050257|451038209|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
125383988|NCT01050257|451038207|FG000|Overall Study|Withdrawal by Subject|0|||
125383989|NCT01050257|451038208|FG001|Overall Study|Withdrawal by Subject|3|||
125383990|NCT01050257|451038209|FG002|Overall Study|Withdrawal by Subject|0|||
125383991|NCT01050257|451038207|FG000|Overall Study|No reason specified|0|||
125383992|NCT01050257|451038208|FG001|Overall Study|No reason specified|0|||
125383993|NCT01050257|451038209|FG002|Overall Study|No reason specified|2|||
125383994|NCT01050257|451038207|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
125383995|NCT01050257|451038208|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
125383996|NCT01050257|451038209|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
125383997|NCT01050257|451038207|FG000|Overall Study|Violation criteria|0|||
125383998|NCT01050257|451038208|FG001|Overall Study|Violation criteria|1|||
125137864|NCT04547192|450131110|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
125137865|NCT04547192|450131107|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
125137866|NCT04547192|450131108|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
125137867|NCT04547192|450131109|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
125137868|NCT04547192|450131110|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
125137869|NCT04547192|450131107|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
125137870|NCT04547192|450131108|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
125137871|NCT04547192|450131109|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
125137872|NCT04547192|450131110|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
125137873|NCT04547192|450131107|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
125137874|NCT04547192|450131108|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
125137875|NCT04547192|450131109|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
125137876|NCT04547192|450131110|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
125137877|NCT04723693|450131111|FG000|Overall Study|Withdrawal by Subject|2|||
125137878|NCT01410227|450131114|FG000|Overall Study|Adverse Event|1|||
125137879|NCT01410227|450131115|FG001|Overall Study|Adverse Event|0|||
125137880|NCT01410227|450131116|FG002|Overall Study|Adverse Event|0|||
125137881|NCT01410227|450131117|FG003|Overall Study|Adverse Event|0|||
125137882|NCT01410227|450131114|FG000|Overall Study|Withdrawal by Subject|3|||
125137883|NCT01410227|450131115|FG001|Overall Study|Withdrawal by Subject|0|||
125137884|NCT01410227|450131116|FG002|Overall Study|Withdrawal by Subject|1|||
125137885|NCT01410227|450131117|FG003|Overall Study|Withdrawal by Subject|0|||
125137886|NCT01410227|450131114|FG000|Overall Study|Pregnancy|0|||
125137887|NCT01410227|450131115|FG001|Overall Study|Pregnancy|0|||
125137888|NCT01410227|450131116|FG002|Overall Study|Pregnancy|0|||
125137889|NCT01410227|450131117|FG003|Overall Study|Pregnancy|1|||
125137890|NCT01410227|450131114|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
125137891|NCT01410227|450131115|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
125137892|NCT01410227|450131116|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
125137893|NCT01410227|450131117|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
125137894|NCT03497130|450131118|FG000|Overall Study|Lost to Follow-up|1|||
125137895|NCT03497130|450131119|FG001|Overall Study|Lost to Follow-up|1|||
125137896|NCT04002648|450131120|FG000|Overall Study|Lost to Follow-up|2|||
125137897|NCT04002648|450131121|FG001|Overall Study|Lost to Follow-up|0|||
125137898|NCT01484912|450131122|FG000|Overall Study|Withdrawal by Subject|1|||
125137899|NCT01484912|450131123|FG001|Overall Study|Withdrawal by Subject|0|||
125137900|NCT01484912|450131122|FG000|Overall Study|Physician Decision|0|||
125137901|NCT01484912|450131123|FG001|Overall Study|Physician Decision|1|||
125137902|NCT02622386|450131124|FG000|First Assignment|Withdrawal by Subject|3|||
125137903|NCT02622386|450131125|FG001|First Assignment|Withdrawal by Subject|2|||
125137904|NCT02622386|450131124|FG000|Washout|Withdrawal by Subject|4|||
125137905|NCT02622386|450131125|FG001|Washout|Withdrawal by Subject|4|||
125137906|NCT02622386|450131124|FG000|Second Assignment|Withdrawal by Subject|0|||
125137907|NCT02622386|450131125|FG001|Second Assignment|Withdrawal by Subject|2|||
125383999|NCT01050257|451038209|FG002|Overall Study|Violation criteria|0|||
125384000|NCT01050257|451038207|FG000|Overall Study|Failure to return|0|||
125384001|NCT01050257|451038208|FG001|Overall Study|Failure to return|2|||
125137908|NCT02890992|450131126|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125137909|NCT02890992|450131127|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
125137910|NCT02890992|450131128|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125137911|NCT02890992|450131129|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125137912|NCT02890992|450131130|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125137913|NCT02890992|450131131|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125384002|NCT01050257|451038209|FG002|Overall Study|Failure to return|0|||
125137914|NCT02890992|450131132|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125137915|NCT02890992|450131133|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
125137916|NCT02890992|450131126|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
125384003|NCT01050257|451038207|FG000|Overall Study|Death|0|||
125220826|NCT02472886|450436238|FG002|Overall Study|Lack of Efficacy|1|||
125220827|NCT00320788|450436239|FG000|Overall Study|Adverse Event|0|||
125220828|NCT00320788|450436240|FG001|Overall Study|Adverse Event|0|||
125220829|NCT00320788|450436241|FG002|Overall Study|Adverse Event|0|||
125220830|NCT00320788|450436242|FG003|Overall Study|Adverse Event|1|||
125220831|NCT00320788|450436243|FG004|Overall Study|Adverse Event|0|||
125220832|NCT00320788|450436239|FG000|Overall Study|Death|0|||
125220833|NCT00320788|450436240|FG001|Overall Study|Death|0|||
125220834|NCT00320788|450436241|FG002|Overall Study|Death|1|||
125220835|NCT00320788|450436242|FG003|Overall Study|Death|0|||
125220836|NCT00320788|450436243|FG004|Overall Study|Death|1|||
125220837|NCT00320788|450436239|FG000|Overall Study|Lost to Follow-up|0|||
125220838|NCT00320788|450436240|FG001|Overall Study|Lost to Follow-up|2|||
125220839|NCT00320788|450436241|FG002|Overall Study|Lost to Follow-up|1|||
125220840|NCT00320788|450436242|FG003|Overall Study|Lost to Follow-up|0|||
125220841|NCT00320788|450436243|FG004|Overall Study|Lost to Follow-up|0|||
125438040|NCT00649389|451232099|FG001|Overall Study|Lost to Follow-up|17|||
125438041|NCT00649389|451232100|FG002|Overall Study|Lost to Follow-up|21|||
125438042|NCT00649389|451232101|FG003|Overall Study|Lost to Follow-up|26|||
125438043|NCT00649389|451232098|FG000|Overall Study|Protocol Violation|11|||
125438044|NCT00649389|451232099|FG001|Overall Study|Protocol Violation|13|||
125438045|NCT00649389|451232100|FG002|Overall Study|Protocol Violation|9|||
125438046|NCT00649389|451232101|FG003|Overall Study|Protocol Violation|8|||
125438047|NCT00649389|451232098|FG000|Overall Study|Withdrawal by Subject|20|||
125438048|NCT00649389|451232099|FG001|Overall Study|Withdrawal by Subject|21|||
125438049|NCT00649389|451232100|FG002|Overall Study|Withdrawal by Subject|19|||
125438050|NCT00649389|451232101|FG003|Overall Study|Withdrawal by Subject|23|||
125438051|NCT00649389|451232098|FG000|Overall Study|Other|3|||
125438052|NCT00649389|451232099|FG001|Overall Study|Other|9|||
125438053|NCT00649389|451232100|FG002|Overall Study|Other|1|||
125438054|NCT00649389|451232101|FG003|Overall Study|Other|6|||
125220842|NCT00320788|450436239|FG000|Overall Study|Decision by the Sponsor|1|||
125220843|NCT00320788|450436240|FG001|Overall Study|Decision by the Sponsor|1|||
125438055|NCT00453310|451232104|FG000|Overall Study|Progression of Disease|10|||
125220844|NCT00320788|450436241|FG002|Overall Study|Decision by the Sponsor|0|||
125438056|NCT01267825|451232105|FG000|Overall Study|study terminated. no data collected.|1|||
125384004|NCT01050257|451038208|FG001|Overall Study|Death|0|||
125384005|NCT01050257|451038209|FG002|Overall Study|Death|1|||
125384006|NCT00171223|451038210|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
125384007|NCT00171223|451038211|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
125384008|NCT00171223|451038212|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
125384009|NCT00171223|451038210|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
125384010|NCT00171223|451038211|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
125384011|NCT00171223|451038212|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
125384012|NCT00171223|451038210|FG000|Overall Study|Abnormal Procedure|1|||
125384013|NCT00171223|451038211|FG001|Overall Study|Abnormal Procedure|0|||
125384014|NCT00171223|451038212|FG002|Overall Study|Abnormal Procedure|0|||
125384015|NCT00171223|451038210|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
125384016|NCT00171223|451038211|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
125384017|NCT00171223|451038212|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
125384018|NCT00171223|451038210|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
125384019|NCT00171223|451038211|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
125384020|NCT00171223|451038212|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
125384021|NCT00171223|451038210|FG000|Overall Study|Protocol Violation|2|||
125384022|NCT00171223|451038211|FG001|Overall Study|Protocol Violation|2|||
125384023|NCT00171223|451038212|FG002|Overall Study|Protocol Violation|3|||
125384024|NCT00171223|451038210|FG000|Overall Study|Participant Withdrew Consent|12|||
125384025|NCT00171223|451038211|FG001|Overall Study|Participant Withdrew Consent|21|||
125384026|NCT00171223|451038212|FG002|Overall Study|Participant Withdrew Consent|15|||
125384027|NCT00171223|451038210|FG000|Overall Study|Lost to Follow-up|5|||
125384028|NCT00171223|451038211|FG001|Overall Study|Lost to Follow-up|2|||
125384029|NCT00171223|451038212|FG002|Overall Study|Lost to Follow-up|3|||
125384030|NCT00171223|451038210|FG000|Overall Study|Administrative Problems|4|||
125384031|NCT00171223|451038211|FG001|Overall Study|Administrative Problems|7|||
125384032|NCT00171223|451038212|FG002|Overall Study|Administrative Problems|6|||
125384033|NCT00171223|451038210|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
125384034|NCT00171223|451038211|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
125220845|NCT00320788|450436242|FG003|Overall Study|Decision by the Sponsor|0|||
125220846|NCT00320788|450436243|FG004|Overall Study|Decision by the Sponsor|1|||
125220847|NCT00320788|450436239|FG000|Overall Study|Other|1|||
125220848|NCT00320788|450436240|FG001|Overall Study|Other|2|||
125220849|NCT00320788|450436241|FG002|Overall Study|Other|1|||
125220850|NCT00320788|450436242|FG003|Overall Study|Other|1|||
125220851|NCT00320788|450436243|FG004|Overall Study|Other|1|||
125220852|NCT00320788|450436239|FG000|Overall Study|Physician Decision|1|||
125220853|NCT00320788|450436240|FG001|Overall Study|Physician Decision|1|||
125220854|NCT00320788|450436241|FG002|Overall Study|Physician Decision|0|||
125220855|NCT00320788|450436242|FG003|Overall Study|Physician Decision|0|||
125220856|NCT00320788|450436243|FG004|Overall Study|Physician Decision|0|||
125384035|NCT00171223|451038212|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
125384036|NCT00171223|451038210|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
125384037|NCT00171223|451038211|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
125384038|NCT00171223|451038212|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
125384039|NCT00278109|451038214|FG000|Overall Study|Adverse Event|3|||
125384040|NCT00278109|451038214|FG000|Overall Study|social circumstances|1|||
125384041|NCT02580357|451038215|FG000|Overall Study|Lost to Follow-up|2|||
125384042|NCT02580357|451038216|FG001|Overall Study|Lost to Follow-up|0|||
125384043|NCT02580357|451038217|FG002|Overall Study|Lost to Follow-up|0|||
125384044|NCT02580357|451038215|FG000|Overall Study|Protocol Violation|1|||
125384045|NCT02580357|451038216|FG001|Overall Study|Protocol Violation|0|||
125384046|NCT02580357|451038217|FG002|Overall Study|Protocol Violation|0|||
125384047|NCT02064166|451038218|FG000|Overall Study|Adverse Event|1|||
125384048|NCT02064166|451038219|FG001|Overall Study|Adverse Event|0|||
125384049|NCT01106898|451038222|FG000|Overall Study|Adverse Event|6|||
125384050|NCT01698801|451038223|FG000|Treatment Phase|Adverse Event|4|||
125384051|NCT01698801|451038223|FG000|Treatment Phase|Protocol Violation|1|||
125384052|NCT01698801|451038223|FG000|Treatment Phase|Other|4|||
125384053|NCT01698801|451038223|FG000|Treatment Phase|Withdrawal by Subject|1|||
125384054|NCT01698801|451038223|FG000|Treatment Phase|Disease progression|1|||
125384055|NCT01698801|451038223|FG000|Follow Up Phase|Withdrawal by Subject|1|||
125384056|NCT01698801|451038223|FG000|Follow Up Phase|Death|4|||
125384057|NCT02062879|451038226|FG000|Overall Study|Withdrawal by Subject|4|||
125384058|NCT02062879|451038227|FG001|Overall Study|Withdrawal by Subject|1|||
125384059|NCT03251079|451038230|FG000|Overall Study|Withdrawal by Subject|1|||
125384060|NCT04219891|451038231|FG000|Overall Study|Lost to Follow-up|3|||
125220857|NCT00320788|450436239|FG000|Overall Study|Protocol Violation|0|||
125220858|NCT00320788|450436240|FG001|Overall Study|Protocol Violation|0|||
125220859|NCT00320788|450436241|FG002|Overall Study|Protocol Violation|0|||
125220860|NCT00320788|450436242|FG003|Overall Study|Protocol Violation|0|||
125220861|NCT00320788|450436243|FG004|Overall Study|Protocol Violation|1|||
125384061|NCT04219891|451038231|FG000|Overall Study|Withdrawal by Subject|2|||
125384062|NCT03226392|451040310|FG000|Overall Study|Protocol Deviation|1|||
125384063|NCT03226392|451040311|FG001|Overall Study|Protocol Deviation|0|||
125384064|NCT03226392|451040310|FG000|Overall Study|Physician Decision|1|||
125384065|NCT03226392|451040311|FG001|Overall Study|Physician Decision|0|||
125384066|NCT03226392|451040310|FG000|Overall Study|Lost to Follow-up|1|||
125384067|NCT03226392|451040311|FG001|Overall Study|Lost to Follow-up|0|||
125384068|NCT03226392|451040310|FG000|Overall Study|Adverse Event|1|||
125384069|NCT03226392|451040311|FG001|Overall Study|Adverse Event|0|||
125384070|NCT03226392|451040310|FG000|Overall Study|Technical Problems|0|||
125384071|NCT03226392|451040311|FG001|Overall Study|Technical Problems|2|||
125384072|NCT03226392|451040310|FG000|Overall Study|Subject/Guardian Decision|7|||
125384073|NCT03226392|451040311|FG001|Overall Study|Subject/Guardian Decision|6|||
125384074|NCT02631850|451040313|FG000|Treatment Period|Lost to Follow-up|0|||
125384075|NCT02631850|451040314|FG001|Treatment Period|Lost to Follow-up|1|||
125384076|NCT02631850|451040315|FG002|Treatment Period|Lost to Follow-up|0|||
125137917|NCT02890992|450131127|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
125137918|NCT02890992|450131128|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
125137919|NCT02890992|450131129|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
125137920|NCT02890992|450131130|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
125137921|NCT02890992|450131131|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
125137922|NCT02890992|450131132|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
125137923|NCT02890992|450131133|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
125137924|NCT02890992|450131126|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137925|NCT02890992|450131127|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
125137926|NCT02890992|450131128|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137927|NCT02890992|450131129|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137928|NCT02890992|450131130|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137929|NCT02890992|450131131|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137930|NCT02890992|450131132|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137931|NCT02890992|450131133|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
125137932|NCT03158727|450131134|FG000|Overall Study|Withdrawal by Subject|2|||
125137933|NCT03158727|450131135|FG001|Overall Study|Withdrawal by Subject|6|||
125137934|NCT03158727|450131134|FG000|Overall Study|Death|11|||
125137935|NCT03158727|450131135|FG001|Overall Study|Death|12|||
125137936|NCT03158727|450131134|FG000|Overall Study|Lost to Follow-up|1|||
125137937|NCT03158727|450131135|FG001|Overall Study|Lost to Follow-up|0|||
125137938|NCT03158727|450131134|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
125137939|NCT03158727|450131135|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
125137940|NCT03158727|450131134|FG000|Overall Study|Visit 11 not done by mistake|0|||
125137941|NCT03158727|450131135|FG001|Overall Study|Visit 11 not done by mistake|1|||
125384077|NCT02631850|451040316|FG003|Treatment Period|Lost to Follow-up|0|||
125384078|NCT02631850|451040313|FG000|Treatment Period|Protocol Violation|1|||
125384079|NCT02631850|451040314|FG001|Treatment Period|Protocol Violation|0|||
125384080|NCT02631850|451040315|FG002|Treatment Period|Protocol Violation|0|||
125384081|NCT02631850|451040316|FG003|Treatment Period|Protocol Violation|0|||
125384082|NCT02631850|451040313|FG000|Treatment Period|Withdrawal by Subject|0|||
125384083|NCT02631850|451040314|FG001|Treatment Period|Withdrawal by Subject|5|||
125384084|NCT02631850|451040315|FG002|Treatment Period|Withdrawal by Subject|2|||
125384085|NCT02631850|451040316|FG003|Treatment Period|Withdrawal by Subject|2|||
125384086|NCT02631850|451040313|FG000|Treatment Period|Adverse Event|1|||
125384087|NCT02631850|451040314|FG001|Treatment Period|Adverse Event|0|||
125384088|NCT02631850|451040315|FG002|Treatment Period|Adverse Event|2|||
125384089|NCT02631850|451040316|FG003|Treatment Period|Adverse Event|3|||
125384090|NCT02631850|451040313|FG000|Treatment Period|Family medical issue|1|||
125384091|NCT02631850|451040314|FG001|Treatment Period|Family medical issue|0|||
125384092|NCT02631850|451040315|FG002|Treatment Period|Family medical issue|0|||
125384093|NCT02631850|451040316|FG003|Treatment Period|Family medical issue|0|||
125384094|NCT02631850|451040313|FG000|6 Month Follow up|Lost to Follow-up|5|||
125384095|NCT02631850|451040314|FG001|6 Month Follow up|Lost to Follow-up|8|||
125384096|NCT02631850|451040315|FG002|6 Month Follow up|Lost to Follow-up|3|||
125384097|NCT02631850|451040316|FG003|6 Month Follow up|Lost to Follow-up|5|||
125384098|NCT02631850|451040313|FG000|6 Month Follow up|Withdrawal by Subject|1|||
125384099|NCT02631850|451040314|FG001|6 Month Follow up|Withdrawal by Subject|0|||
125137942|NCT03158727|450131134|FG000|Overall Study|Enrolled, not treated|1|||
125220862|NCT00320788|450436239|FG000|Overall Study|Withdrawal by Subject|3|||
125384100|NCT02631850|451040315|FG002|6 Month Follow up|Withdrawal by Subject|0|||
125384101|NCT02631850|451040316|FG003|6 Month Follow up|Withdrawal by Subject|2|||
125384102|NCT02631850|451040313|FG000|6 Month Follow up|Adverse Event|1|||
125384103|NCT02631850|451040314|FG001|6 Month Follow up|Adverse Event|4|||
125384104|NCT02631850|451040315|FG002|6 Month Follow up|Adverse Event|1|||
125384105|NCT02631850|451040316|FG003|6 Month Follow up|Adverse Event|3|||
125137943|NCT03158727|450131135|FG001|Overall Study|Enrolled, not treated|0|||
125137944|NCT00669162|450131136|FG000|Overall Study|Withdrawal by Subject|1|||
125137945|NCT00807495|450131139|FG000|Overall Study|Adverse Event|6|||
125137946|NCT00807495|450131140|FG001|Overall Study|Adverse Event|3|||
125137947|NCT00807495|450131141|FG002|Overall Study|Adverse Event|1|||
125137948|NCT00807495|450131142|FG003|Overall Study|Adverse Event|1|||
125137949|NCT00807495|450131143|FG004|Overall Study|Adverse Event|2|||
125137950|NCT00807495|450131139|FG000|Overall Study|Withdrawal by Patient|2|||
125137951|NCT00807495|450131140|FG001|Overall Study|Withdrawal by Patient|0|||
125137952|NCT00807495|450131141|FG002|Overall Study|Withdrawal by Patient|1|||
125137953|NCT00807495|450131142|FG003|Overall Study|Withdrawal by Patient|0|||
125137954|NCT00807495|450131143|FG004|Overall Study|Withdrawal by Patient|0|||
125137955|NCT00807495|450131139|FG000|Overall Study|Reason Not Specified|0|||
125137956|NCT00807495|450131140|FG001|Overall Study|Reason Not Specified|3|||
125137957|NCT00807495|450131141|FG002|Overall Study|Reason Not Specified|2|||
125137958|NCT00807495|450131142|FG003|Overall Study|Reason Not Specified|0|||
125137959|NCT00807495|450131143|FG004|Overall Study|Reason Not Specified|3|||
125137960|NCT02412852|450131145|FG000|Overall Study|Withdrawal by Subject|0|||
125137961|NCT02412852|450131146|FG001|Overall Study|Withdrawal by Subject|1|||
125137962|NCT02412852|450131147|FG002|Overall Study|Withdrawal by Subject|0|||
125137963|NCT02412852|450131148|FG003|Overall Study|Withdrawal by Subject|0|||
125137964|NCT02412852|450131145|FG000|Overall Study|Physician Decision|0|||
125137965|NCT02412852|450131146|FG001|Overall Study|Physician Decision|0|||
125137966|NCT02412852|450131147|FG002|Overall Study|Physician Decision|0|||
125137967|NCT02412852|450131148|FG003|Overall Study|Physician Decision|1|||
125137968|NCT00841542|450131149|FG000|Period 1|Adverse Event|1|||
125137969|NCT00841542|450131150|FG001|Period 1|Adverse Event|0|||
125137970|NCT00924638|450131156|FG000|Overall Study|Death|3|||
125137971|NCT00924638|450131157|FG001|Overall Study|Death|2|||
125137972|NCT00924638|450131156|FG000|Overall Study|Lost to Follow-up|1|||
125137973|NCT00924638|450131157|FG001|Overall Study|Lost to Follow-up|1|||
125137974|NCT00924638|450131156|FG000|Overall Study|Withdrawal by Subject|5|||
125137975|NCT00924638|450131157|FG001|Overall Study|Withdrawal by Subject|7|||
125137976|NCT00924638|450131156|FG000|Overall Study|Physician Decision|3|||
125137977|NCT00924638|450131157|FG001|Overall Study|Physician Decision|3|||
125137978|NCT04411680|450131161|FG000|Treatment Period|Adverse Event|3|||
125137979|NCT04411680|450131162|FG001|Treatment Period|Adverse Event|0|||
125137980|NCT04411680|450131161|FG000|Treatment Period|Discharged from hospital|18|||
125137981|NCT04411680|450131162|FG001|Treatment Period|Discharged from hospital|7|||
125137982|NCT04411680|450131161|FG000|Treatment Period|Missed 1 or more doses|8|||
125137983|NCT04411680|450131162|FG001|Treatment Period|Missed 1 or more doses|0|||
125137984|NCT04411680|450131161|FG000|Treatment Period|Transferred to another hospital|0|||
125137985|NCT04411680|450131162|FG001|Treatment Period|Transferred to another hospital|1|||
125384106|NCT02631850|451040313|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
125384107|NCT02631850|451040314|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
125384108|NCT02631850|451040315|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
125384109|NCT02631850|451040316|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
125384110|NCT01086540|451040318|FG000|Overall Study|Death|3|||
125384111|NCT01086540|451040319|FG001|Overall Study|Death|1|||
125384112|NCT01086540|451040318|FG000|Overall Study|Physician Decision|2|||
125384113|NCT01086540|451040319|FG001|Overall Study|Physician Decision|1|||
125384114|NCT01086540|451040318|FG000|Overall Study|Addition of new therapy for PAH|1|||
125384115|NCT01086540|451040319|FG001|Overall Study|Addition of new therapy for PAH|0|||
125384116|NCT03164928|451040320|FG000|Overall Study|Lost to Follow-up|1|||
125384117|NCT03164928|451040321|FG001|Overall Study|Lost to Follow-up|0|||
125384118|NCT01998737|451040322|FG000|Overall Study|Corrupted database|23|||
125384119|NCT01998737|451040323|FG001|Overall Study|Corrupted database|0|||
125384120|NCT00730912|451040332|FG000|Overall Study|Discontinued|0|||
125384121|NCT00730912|451040333|FG001|Overall Study|Discontinued|0|||
125384122|NCT00730912|451040334|FG002|Overall Study|Discontinued|1|||
125384123|NCT03311659|451040339|FG000|Overall Study|Protocol Violation|1|||
125384124|NCT04053023|451040340|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
125384125|NCT04053023|451040341|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
125384126|NCT00071760|451040342|FG000|Overall Study|Adverse Event|2|||
125384127|NCT00071760|451040343|FG001|Overall Study|Adverse Event|1|||
125384128|NCT00071760|451040342|FG000|Overall Study|Lost to Follow-up|0|||
125384129|NCT00071760|451040343|FG001|Overall Study|Lost to Follow-up|3|||
125384130|NCT00071760|451040342|FG000|Overall Study|Protocol Violation|1|||
125384131|NCT00071760|451040343|FG001|Overall Study|Protocol Violation|0|||
125384132|NCT00071760|451040342|FG000|Overall Study|Withdrawal by Subject|0|||
125384133|NCT00071760|451040343|FG001|Overall Study|Withdrawal by Subject|1|||
125137986|NCT04411680|450131161|FG000|Follow up Period|Withdrawal by Subject|2|||
125137987|NCT04411680|450131162|FG001|Follow up Period|Withdrawal by Subject|0|||
125137988|NCT04411680|450131161|FG000|Follow up Period|Lost to Follow-up|5|||
125137989|NCT04411680|450131162|FG001|Follow up Period|Lost to Follow-up|6|||
125137990|NCT04411680|450131161|FG000|Follow up Period|Death|11|||
125384134|NCT00071760|451040342|FG000|Overall Study|Insufficient Viral Load Response|1|||
125384135|NCT00071760|451040343|FG001|Overall Study|Insufficient Viral Load Response|1|||
125384136|NCT00071760|451040342|FG000|Overall Study|Lack of availability of RTV|1|||
125438057|NCT01267825|451232106|FG001|Overall Study|study terminated. no data collected.|0|||
125438058|NCT01806740|451232107|FG000|Overall Study|Withdrawal by Subject|4|||
125438059|NCT01806740|451232107|FG000|Overall Study|Physician Decision|1|||
125438060|NCT01806740|451232107|FG000|Overall Study|Patient's refusal of treatment|1|||
125438061|NCT04666922|451232108|FG000|Overall Study|Withdrawal by Subject|1|||
125438062|NCT04666922|451232109|FG001|Overall Study|Withdrawal by Subject|0|||
125438063|NCT04666922|451232110|FG002|Overall Study|Withdrawal by Subject|0|||
125438064|NCT04666922|451232111|FG003|Overall Study|Withdrawal by Subject|0|||
125438065|NCT04666922|451232112|FG004|Overall Study|Withdrawal by Subject|0|||
125438066|NCT04666922|451232113|FG005|Overall Study|Withdrawal by Subject|0|||
125438067|NCT04666922|451232114|FG006|Overall Study|Withdrawal by Subject|0|||
125438068|NCT03722264|451232122|FG000|Overall Study|Physician Decision|3|||
125438069|NCT00871351|451232123|FG000|Overall Study|Withdrawal by Subject|1|||
125438070|NCT00871351|451232124|FG001|Overall Study|Withdrawal by Subject|0|||
125438071|NCT00871351|451232125|FG002|Overall Study|Withdrawal by Subject|0|||
125438072|NCT00871351|451232123|FG000|Overall Study|Adverse Event|3|||
125438073|NCT00871351|451232124|FG001|Overall Study|Adverse Event|1|||
125438074|NCT00871351|451232125|FG002|Overall Study|Adverse Event|0|||
125438075|NCT02959671|451232127|FG000|Overall Study|Adverse Event|2|||
125438076|NCT02959671|451232127|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
125438077|NCT02791490|451232128|FG000|Overall Study|Lost to Follow-up|1|||
125220863|NCT00320788|450436240|FG001|Overall Study|Withdrawal by Subject|0|||
125220864|NCT00320788|450436241|FG002|Overall Study|Withdrawal by Subject|0|||
125384137|NCT00071760|451040343|FG001|Overall Study|Lack of availability of RTV|0|||
125384138|NCT00071760|451040342|FG000|Overall Study|Physician Decision|2|||
125384139|NCT00071760|451040343|FG001|Overall Study|Physician Decision|1|||
125384140|NCT00071760|451040342|FG000|Overall Study|Relocation|0|||
125384141|NCT00071760|451040343|FG001|Overall Study|Relocation|1|||
125384142|NCT01994629|451040344|FG000|Overall Study|Withdrawal by Subject|1|||
125384143|NCT01994629|451040345|FG001|Overall Study|Withdrawal by Subject|0|||
125384144|NCT01994629|451040344|FG000|Overall Study|Lost to Follow-up|0|||
125384145|NCT01994629|451040345|FG001|Overall Study|Lost to Follow-up|3|||
125384146|NCT03424265|451040346|FG000|Overall Study|screening failure|1|||
125384147|NCT03424265|451040347|FG001|Overall Study|screening failure|0|||
125384148|NCT03424265|451040346|FG000|Overall Study|Withdrawal by Subject|0|||
125384149|NCT03424265|451040347|FG001|Overall Study|Withdrawal by Subject|2|||
125384150|NCT01558752|451040348|FG000|Overall Study|Physician Decision|2|||
125384151|NCT01558752|451040349|FG001|Overall Study|Physician Decision|0|||
125384152|NCT00894322|451040357|FG000|Overall Study|Withdrawal by Subject|1|||
125384153|NCT00894322|451040358|FG001|Overall Study|Withdrawal by Subject|0|||
125384154|NCT00894322|451040359|FG002|Overall Study|Withdrawal by Subject|0|||
125384155|NCT03338855|451040360|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
125384156|NCT03338855|451040361|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
125384157|NCT00511667|451040362|FG000|Overall Study|Adverse Event|1|||
125384158|NCT00511667|451040363|FG001|Overall Study|Adverse Event|0|||
125384159|NCT00511667|451040362|FG000|Overall Study|Protocol Violation|1|||
125384160|NCT00511667|451040363|FG001|Overall Study|Protocol Violation|1|||
125384161|NCT00511667|451040362|FG000|Overall Study|Withdrawal by Subject|2|||
125384162|NCT00511667|451040363|FG001|Overall Study|Withdrawal by Subject|0|||
125384163|NCT00511667|451040362|FG000|Overall Study|Site terminated|6|||
125384164|NCT00511667|451040363|FG001|Overall Study|Site terminated|1|||
125384165|NCT00511667|451040362|FG000|Overall Study|Other|2|||
125384166|NCT00511667|451040363|FG001|Overall Study|Other|1|||
125384167|NCT00056407|451040364|FG000|Overall Study|Adverse Event|282|||
125384168|NCT00056407|451040365|FG001|Overall Study|Adverse Event|364|||
125384169|NCT00056407|451040364|FG000|Overall Study|Withdrawal by Subject|377|||
125384170|NCT00056407|451040365|FG001|Overall Study|Withdrawal by Subject|361|||
125384171|NCT00056407|451040364|FG000|Overall Study|Lost to Follow-up|123|||
125384172|NCT00056407|451040365|FG001|Overall Study|Lost to Follow-up|113|||
125384173|NCT00056407|451040364|FG000|Overall Study|Protocol Violation|104|||
125384174|NCT00056407|451040365|FG001|Overall Study|Protocol Violation|95|||
125384175|NCT00056407|451040364|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
125384176|NCT00056407|451040365|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
125438078|NCT02791490|451232129|FG001|Overall Study|Lost to Follow-up|2|||
125438079|NCT02791490|451232128|FG000|Overall Study|Withdrawal by Subject|2|||
125438080|NCT02791490|451232129|FG001|Overall Study|Withdrawal by Subject|6|||
125438081|NCT01984424|451232130|FG000|Overall Study|Withdrawal by Subject|3|||
125384177|NCT00056407|451040364|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
125384178|NCT00056407|451040365|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
125384179|NCT00056407|451040364|FG000|Overall Study|Missing|25|||
125384180|NCT00056407|451040365|FG001|Overall Study|Missing|34|||
125384181|NCT02738450|451040366|FG000|Overall Study|Withdrawal by Subject|0|||
125384182|NCT02738450|451040367|FG001|Overall Study|Withdrawal by Subject|2|||
125384183|NCT02738450|451040368|FG002|Overall Study|Withdrawal by Subject|0|||
125384184|NCT00455429|451040375|FG000|Overall Study|Study Terminated by Sponsor|0|||
125384185|NCT00455429|451040376|FG001|Overall Study|Study Terminated by Sponsor|0|||
125384186|NCT00455429|451040377|FG002|Overall Study|Study Terminated by Sponsor|0|||
125384187|NCT00455429|451040378|FG003|Overall Study|Study Terminated by Sponsor|3|||
125384188|NCT00455429|451040375|FG000|Overall Study|Lost to Follow-up|1|||
125384189|NCT00455429|451040376|FG001|Overall Study|Lost to Follow-up|0|||
125384190|NCT00455429|451040377|FG002|Overall Study|Lost to Follow-up|0|||
125384191|NCT00455429|451040378|FG003|Overall Study|Lost to Follow-up|3|||
125438082|NCT01984424|451232131|FG001|Overall Study|Withdrawal by Subject|5|||
125438083|NCT01984424|451232130|FG000|Overall Study|Sponsor Decision|0|||
125438084|NCT01984424|451232131|FG001|Overall Study|Sponsor Decision|1|||
125438085|NCT01984424|451232130|FG000|Overall Study|Lost to Follow-up|0|||
125438086|NCT01984424|451232131|FG001|Overall Study|Lost to Follow-up|1|||
125438087|NCT00077636|451232132|FG000|Overall Study|Refused Treatment|9|||
125438088|NCT00077636|451232133|FG001|Overall Study|Refused Treatment|31|||
125438089|NCT00077636|451232132|FG000|Overall Study|Admin|3|||
125438090|NCT00077636|451232133|FG001|Overall Study|Admin|3|||
125438091|NCT00077636|451232132|FG000|Overall Study|Withdrawal by Subject|2|||
125438092|NCT00077636|451232133|FG001|Overall Study|Withdrawal by Subject|2|||
125438093|NCT00077636|451232132|FG000|Overall Study|Adverse Event|17|||
125438094|NCT00077636|451232133|FG001|Overall Study|Adverse Event|34|||
125438095|NCT00077636|451232132|FG000|Overall Study|Protocol Violation|0|||
125438096|NCT00077636|451232133|FG001|Overall Study|Protocol Violation|2|||
125438097|NCT00077636|451232132|FG000|Overall Study|Lost to Follow-up|10|||
125438098|NCT00077636|451232133|FG001|Overall Study|Lost to Follow-up|18|||
125438099|NCT00077636|451232132|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
125438100|NCT00077636|451232133|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
125438101|NCT02032173|451232134|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
125438102|NCT03661996|451232137|FG000|Overall Study|Adverse Event|0|||
125438103|NCT03661996|451232138|FG001|Overall Study|Adverse Event|0|||
125438104|NCT03661996|451232139|FG002|Overall Study|Adverse Event|1|||
125438105|NCT03661996|451232140|FG003|Overall Study|Adverse Event|1|||
125438106|NCT03661996|451232141|FG004|Overall Study|Adverse Event|0|||
125438107|NCT03661996|451232137|FG000|Overall Study|Lost to Follow-up|5|||
125438108|NCT03661996|451232138|FG001|Overall Study|Lost to Follow-up|1|||
125438109|NCT03661996|451232139|FG002|Overall Study|Lost to Follow-up|2|||
125438110|NCT03661996|451232140|FG003|Overall Study|Lost to Follow-up|2|||
125438111|NCT03661996|451232141|FG004|Overall Study|Lost to Follow-up|6|||
125438112|NCT03661996|451232137|FG000|Overall Study|Physician Decision|1|||
125438113|NCT03661996|451232138|FG001|Overall Study|Physician Decision|1|||
125438114|NCT03661996|451232139|FG002|Overall Study|Physician Decision|1|||
125438115|NCT03661996|451232140|FG003|Overall Study|Physician Decision|2|||
125438116|NCT03661996|451232141|FG004|Overall Study|Physician Decision|0|||
125438117|NCT03661996|451232137|FG000|Overall Study|Protocol Violation|0|||
125438118|NCT03661996|451232138|FG001|Overall Study|Protocol Violation|0|||
125438119|NCT03661996|451232139|FG002|Overall Study|Protocol Violation|0|||
125438120|NCT03661996|451232140|FG003|Overall Study|Protocol Violation|0|||
125438121|NCT03661996|451232141|FG004|Overall Study|Protocol Violation|1|||
125438122|NCT03661996|451232137|FG000|Overall Study|Withdrawal by Subject|3|||
125438123|NCT03661996|451232138|FG001|Overall Study|Withdrawal by Subject|5|||
125438124|NCT03661996|451232139|FG002|Overall Study|Withdrawal by Subject|1|||
125438125|NCT03661996|451232140|FG003|Overall Study|Withdrawal by Subject|7|||
125438126|NCT03661996|451232141|FG004|Overall Study|Withdrawal by Subject|7|||
125438127|NCT03661996|451232137|FG000|Overall Study|Sponsors Decision|2|||
125438128|NCT03661996|451232138|FG001|Overall Study|Sponsors Decision|0|||
125438129|NCT03661996|451232139|FG002|Overall Study|Sponsors Decision|0|||
125438130|NCT03661996|451232140|FG003|Overall Study|Sponsors Decision|0|||
125438131|NCT03661996|451232141|FG004|Overall Study|Sponsors Decision|0|||
125438132|NCT03661996|451232137|FG000|Overall Study|Other|1|||
125438133|NCT03661996|451232138|FG001|Overall Study|Other|1|||
125438134|NCT03661996|451232139|FG002|Overall Study|Other|1|||
125438135|NCT03661996|451232140|FG003|Overall Study|Other|1|||
125438136|NCT03661996|451232141|FG004|Overall Study|Other|0|||
125438137|NCT03321513|451232142|FG000|Overall Study|Death|11|||
125438138|NCT03321513|451232143|FG001|Overall Study|Death|5|||
125438139|NCT03321513|451232142|FG000|Overall Study|Withdrawal by Subject|5|||
125438140|NCT03321513|451232143|FG001|Overall Study|Withdrawal by Subject|10|||
125438141|NCT03321513|451232142|FG000|Overall Study|Lost to Follow-up|10|||
125438142|NCT03321513|451232143|FG001|Overall Study|Lost to Follow-up|11|||
125438143|NCT01993017|451232144|FG000|Overall Study|Death|23|||
125438144|NCT01993017|451232145|FG001|Overall Study|Death|26|||
125438145|NCT01993017|451232146|FG002|Overall Study|Death|18|||
125384192|NCT00455429|451040375|FG000|Overall Study|Withdrawal by Subject|0|||
125384193|NCT00455429|451040376|FG001|Overall Study|Withdrawal by Subject|1|||
125384194|NCT00455429|451040377|FG002|Overall Study|Withdrawal by Subject|1|||
125384195|NCT00455429|451040378|FG003|Overall Study|Withdrawal by Subject|0|||
125384196|NCT00455429|451040375|FG000|Overall Study|Lack of Efficacy|0|||
125384197|NCT00455429|451040376|FG001|Overall Study|Lack of Efficacy|1|||
125384198|NCT00455429|451040377|FG002|Overall Study|Lack of Efficacy|0|||
125384199|NCT00455429|451040378|FG003|Overall Study|Lack of Efficacy|1|||
125384200|NCT00455429|451040375|FG000|Overall Study|Adverse Event|0|||
125384201|NCT00455429|451040376|FG001|Overall Study|Adverse Event|1|||
125384202|NCT00455429|451040377|FG002|Overall Study|Adverse Event|0|||
125384203|NCT00455429|451040378|FG003|Overall Study|Adverse Event|3|||
125384204|NCT00455429|451040375|FG000|Overall Study|Randomly assigned but not treated|0|||
125384205|NCT00455429|451040376|FG001|Overall Study|Randomly assigned but not treated|0|||
125384206|NCT00455429|451040377|FG002|Overall Study|Randomly assigned but not treated|0|||
125384207|NCT00455429|451040378|FG003|Overall Study|Randomly assigned but not treated|2|||
125384208|NCT00455429|451040375|FG000|Overall Study|Personal Reason|1|||
125384209|NCT00455429|451040376|FG001|Overall Study|Personal Reason|0|||
125384210|NCT00455429|451040377|FG002|Overall Study|Personal Reason|0|||
125384211|NCT00455429|451040378|FG003|Overall Study|Personal Reason|0|||
125384212|NCT00455429|451040375|FG000|Overall Study|Non-compliance|0|||
125384213|NCT00455429|451040376|FG001|Overall Study|Non-compliance|0|||
125384214|NCT00455429|451040377|FG002|Overall Study|Non-compliance|0|||
125384215|NCT00455429|451040378|FG003|Overall Study|Non-compliance|1|||
125384216|NCT00455429|451040375|FG000|Overall Study|Other|0|||
125384217|NCT00455429|451040376|FG001|Overall Study|Other|2|||
125384218|NCT00455429|451040377|FG002|Overall Study|Other|0|||
125384219|NCT00455429|451040378|FG003|Overall Study|Other|1|||
125384220|NCT01165554|451040379|FG000|Overall Study|Withdrawal by Subject|23|||
125384221|NCT02951156|451040386|FG000|Overall Study|Death|3|||
125384222|NCT02951156|451040387|FG001|Overall Study|Death|8|||
125384223|NCT02951156|451040388|FG002|Overall Study|Death|5|||
125384224|NCT02951156|451040386|FG000|Overall Study|Progressive disease|1|||
125384225|NCT02951156|451040387|FG001|Overall Study|Progressive disease|0|||
125384226|NCT02951156|451040388|FG002|Overall Study|Progressive disease|1|||
125384227|NCT02951156|451040386|FG000|Overall Study|Withdrawal by Subject|0|||
125384228|NCT02951156|451040387|FG001|Overall Study|Withdrawal by Subject|0|||
125384229|NCT02951156|451040388|FG002|Overall Study|Withdrawal by Subject|1|||
125384230|NCT02951156|451040386|FG000|Overall Study|Study terminated by sponsor|0|||
125384231|NCT02951156|451040387|FG001|Overall Study|Study terminated by sponsor|0|||
125384232|NCT02951156|451040388|FG002|Overall Study|Study terminated by sponsor|1|||
125384233|NCT02951156|451040386|FG000|Overall Study|Other|5|||
125384234|NCT02951156|451040387|FG001|Overall Study|Other|1|||
125384235|NCT02951156|451040388|FG002|Overall Study|Other|2|||
125384236|NCT04351087|451040389|FG000|Overall Study|Lost to Follow-up|7|||
125384237|NCT04351087|451040390|FG001|Overall Study|Lost to Follow-up|3|||
125384238|NCT04351087|451040389|FG000|Overall Study|Withdrawal by Subject|3|||
125384239|NCT04351087|451040390|FG001|Overall Study|Withdrawal by Subject|4|||
125384240|NCT04351087|451040389|FG000|Overall Study|Lack of Efficacy|3|||
125384241|NCT04351087|451040390|FG001|Overall Study|Lack of Efficacy|2|||
125384242|NCT03519347|451040393|FG000|Interventional Crossover Period 1|Death|0|||
125384243|NCT03519347|451040394|FG001|Interventional Crossover Period 1|Death|0|||
125384244|NCT03519347|451040395|FG002|Interventional Crossover Period 1|Death|0|||
125438146|NCT01993017|451232144|FG000|Overall Study|Could not be contacted|43|||
125384245|NCT03519347|451040396|FG003|Interventional Crossover Period 1|Death|1|||
125384246|NCT05517382|451040397|FG000|Overall Study|Lost to Follow-up|0|||
125384247|NCT05517382|451040398|FG001|Overall Study|Lost to Follow-up|1|||
125384248|NCT01641692|451040399|FG000|Treatment Period 1|Adverse Event|1|||
125384249|NCT01641692|451040400|FG001|Treatment Period 1|Adverse Event|0|||
125384250|NCT01641692|451040401|FG002|Treatment Period 1|Adverse Event|0|||
125384251|NCT01641692|451040402|FG003|Treatment Period 1|Adverse Event|0|||
125384252|NCT01641692|451040403|FG004|Treatment Period 1|Adverse Event|0|||
125384253|NCT01641692|451040404|FG005|Treatment Period 1|Adverse Event|0|||
125384254|NCT01641692|451040405|FG006|Treatment Period 1|Adverse Event|0|||
125384255|NCT01641692|451040406|FG007|Treatment Period 1|Adverse Event|0|||
125220865|NCT00320788|450436242|FG003|Overall Study|Withdrawal by Subject|3|||
125220866|NCT00320788|450436243|FG004|Overall Study|Withdrawal by Subject|1|||
125438147|NCT01993017|451232145|FG001|Overall Study|Could not be contacted|42|||
125438148|NCT01993017|451232146|FG002|Overall Study|Could not be contacted|38|||
125438149|NCT01993017|451232144|FG000|Overall Study|Dropped out|19|||
125438150|NCT01993017|451232145|FG001|Overall Study|Dropped out|6|||
125438151|NCT01993017|451232146|FG002|Overall Study|Dropped out|11|||
125438152|NCT01993017|451232144|FG000|Overall Study|Other reasons|17|||
125438153|NCT01993017|451232145|FG001|Overall Study|Other reasons|11|||
125438154|NCT01993017|451232146|FG002|Overall Study|Other reasons|7|||
125438155|NCT01993017|451232144|FG000|Overall Study|Ineligible after randomization|4|||
125438156|NCT01993017|451232145|FG001|Overall Study|Ineligible after randomization|5|||
125438157|NCT01993017|451232146|FG002|Overall Study|Ineligible after randomization|5|||
125438158|NCT00068380|451232147|FG000|Overall Study|Withdrawal by Subject|3|||
125438159|NCT00068380|451232147|FG000|Overall Study|Adverse Event|2|||
125438160|NCT01976364|451232148|FG000|Main Study (36 Months)|Adverse Event|63|||
125438161|NCT01976364|451232149|FG001|Main Study (36 Months)|Adverse Event|0|||
125438162|NCT01976364|451232150|FG002|Main Study (36 Months)|Adverse Event|0|||
125438163|NCT01976364|451232148|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
125438164|NCT01976364|451232149|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
125438165|NCT01976364|451232150|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
125438166|NCT01976364|451232148|FG000|Main Study (36 Months)|Other|13|||
125438167|NCT01976364|451232149|FG001|Main Study (36 Months)|Other|0|||
125438168|NCT01976364|451232150|FG002|Main Study (36 Months)|Other|0|||
125438169|NCT01976364|451232148|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
125438170|NCT01976364|451232149|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
125438171|NCT01976364|451232150|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
125438172|NCT01976364|451232148|FG000|Main Study (36 Months)|Medication error|1|||
125438173|NCT01976364|451232149|FG001|Main Study (36 Months)|Medication error|0|||
125438174|NCT01976364|451232150|FG002|Main Study (36 Months)|Medication error|0|||
125438175|NCT01976364|451232148|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
125438176|NCT01976364|451232149|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
125438177|NCT01976364|451232150|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
125438178|NCT01976364|451232148|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
125438179|NCT01976364|451232149|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
125438180|NCT01976364|451232150|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
125438181|NCT01976364|451232148|FG000|Main Study (36 Months)|Protocol Violation|13|||
125438182|NCT01976364|451232149|FG001|Main Study (36 Months)|Protocol Violation|0|||
125438183|NCT01976364|451232150|FG002|Main Study (36 Months)|Protocol Violation|0|||
125438184|NCT01976364|451232148|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
125438185|NCT01976364|451232149|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
125438186|NCT01976364|451232150|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
125438187|NCT01976364|451232148|FG000|Main Study (36 Months)|Death|5|||
125438188|NCT01976364|451232149|FG001|Main Study (36 Months)|Death|0|||
125438189|NCT01976364|451232150|FG002|Main Study (36 Months)|Death|0|||
125137991|NCT04411680|450131162|FG001|Follow up Period|Death|8|||
125137992|NCT00748566|450131163|FG000|Overall Study|Adverse Event|49|||
125137993|NCT00748566|450131163|FG000|Overall Study|Death|1|||
125137994|NCT00748566|450131163|FG000|Overall Study|Lack of Efficacy|12|||
125137995|NCT00748566|450131163|FG000|Overall Study|Lost to Follow-up|1|||
125137996|NCT00748566|450131163|FG000|Overall Study|Protocol Violation|13|||
125137997|NCT00748566|450131163|FG000|Overall Study|Withdrawal by Subject|22|||
125137998|NCT00748566|450131163|FG000|Overall Study|Study terminated by sponsor|5|||
125137999|NCT00748566|450131163|FG000|Overall Study|Other|9|||
125138000|NCT00624286|450131164|FG000|Overall Study|Protocol Deviation|7|||
125138001|NCT00624286|450131165|FG001|Overall Study|Protocol Deviation|9|||
125138002|NCT00624286|450131164|FG000|Overall Study|Adverse Event|6|||
125138003|NCT00624286|450131165|FG001|Overall Study|Adverse Event|3|||
125138004|NCT00624286|450131164|FG000|Overall Study|Withdrawal by Subject|5|||
125220867|NCT00627926|450436244|FG000|Overall Study|Adverse Event|26|||
125438190|NCT01976364|451232148|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
125438191|NCT01976364|451232149|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
125438192|NCT01976364|451232150|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
125438193|NCT01976364|451232148|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
125438194|NCT01976364|451232149|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
125438195|NCT01976364|451232150|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
125438196|NCT01976364|451232148|FG000|Sub-study (12 Months)|Protocol Violation|0|||
125138005|NCT00624286|450131165|FG001|Overall Study|Withdrawal by Subject|4|||
125138006|NCT00624286|450131164|FG000|Overall Study|Lost to Follow-up|3|||
125138007|NCT00624286|450131165|FG001|Overall Study|Lost to Follow-up|2|||
125138008|NCT00624286|450131164|FG000|Overall Study|Administrative problems|3|||
125138009|NCT00624286|450131165|FG001|Overall Study|Administrative problems|0|||
125138010|NCT00624286|450131164|FG000|Overall Study|Lack of Efficacy|1|||
125384256|NCT01641692|451040399|FG000|Treatment Period 1|Lack of Efficacy|0|||
125384257|NCT01641692|451040400|FG001|Treatment Period 1|Lack of Efficacy|0|||
125384258|NCT01641692|451040401|FG002|Treatment Period 1|Lack of Efficacy|0|||
125384259|NCT01641692|451040402|FG003|Treatment Period 1|Lack of Efficacy|0|||
125384260|NCT01641692|451040403|FG004|Treatment Period 1|Lack of Efficacy|0|||
125384261|NCT01641692|451040404|FG005|Treatment Period 1|Lack of Efficacy|0|||
125384262|NCT01641692|451040405|FG006|Treatment Period 1|Lack of Efficacy|0|||
125384263|NCT01641692|451040406|FG007|Treatment Period 1|Lack of Efficacy|1|||
125384264|NCT01641692|451040399|FG000|Treatment Period 1|Protocol Violation|1|||
125384265|NCT01641692|451040400|FG001|Treatment Period 1|Protocol Violation|0|||
125384266|NCT01641692|451040401|FG002|Treatment Period 1|Protocol Violation|0|||
125384267|NCT01641692|451040402|FG003|Treatment Period 1|Protocol Violation|0|||
125384268|NCT01641692|451040403|FG004|Treatment Period 1|Protocol Violation|2|||
125384269|NCT01641692|451040404|FG005|Treatment Period 1|Protocol Violation|0|||
125384270|NCT01641692|451040405|FG006|Treatment Period 1|Protocol Violation|0|||
125384271|NCT01641692|451040406|FG007|Treatment Period 1|Protocol Violation|0|||
125384272|NCT01641692|451040399|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
125384273|NCT01641692|451040400|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
125384274|NCT01641692|451040401|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
125384275|NCT01641692|451040402|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
125384276|NCT01641692|451040403|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
125384277|NCT01641692|451040404|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
125384278|NCT01641692|451040405|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
125384279|NCT01641692|451040406|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
125384280|NCT01641692|451040399|FG000|Treatment Period 1|Lost to Follow-up|0|||
125384281|NCT01641692|451040400|FG001|Treatment Period 1|Lost to Follow-up|0|||
125384282|NCT01641692|451040401|FG002|Treatment Period 1|Lost to Follow-up|1|||
125384283|NCT01641692|451040402|FG003|Treatment Period 1|Lost to Follow-up|0|||
125384284|NCT01641692|451040403|FG004|Treatment Period 1|Lost to Follow-up|0|||
125384285|NCT01641692|451040404|FG005|Treatment Period 1|Lost to Follow-up|0|||
125384286|NCT01641692|451040405|FG006|Treatment Period 1|Lost to Follow-up|0|||
125384287|NCT01641692|451040406|FG007|Treatment Period 1|Lost to Follow-up|0|||
125384288|NCT01641692|451040399|FG000|Treatment Period 1|Physician Decision|0|||
125384289|NCT01641692|451040400|FG001|Treatment Period 1|Physician Decision|0|||
125384290|NCT01641692|451040401|FG002|Treatment Period 1|Physician Decision|0|||
125384291|NCT01641692|451040402|FG003|Treatment Period 1|Physician Decision|0|||
125384292|NCT01641692|451040403|FG004|Treatment Period 1|Physician Decision|1|||
125384293|NCT01641692|451040404|FG005|Treatment Period 1|Physician Decision|0|||
125384294|NCT01641692|451040405|FG006|Treatment Period 1|Physician Decision|0|||
125384295|NCT01641692|451040406|FG007|Treatment Period 1|Physician Decision|0|||
125384296|NCT01641692|451040399|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125384297|NCT01641692|451040400|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125384298|NCT01641692|451040401|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125384299|NCT01641692|451040402|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125384300|NCT01641692|451040403|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125384301|NCT01641692|451040404|FG005|Treatment Period 1|Withdrawal by Subject|2|||
125384302|NCT01641692|451040405|FG006|Treatment Period 1|Withdrawal by Subject|0|||
125384303|NCT01641692|451040406|FG007|Treatment Period 1|Withdrawal by Subject|1|||
125384304|NCT01641692|451040399|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
125384305|NCT01641692|451040400|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125384306|NCT01641692|451040401|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125384307|NCT01641692|451040402|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125384308|NCT01641692|451040403|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125384309|NCT01641692|451040404|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125384310|NCT01641692|451040405|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125384311|NCT01641692|451040406|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
125438197|NCT01976364|451232149|FG001|Sub-study (12 Months)|Protocol Violation|1|||
125438198|NCT01976364|451232150|FG002|Sub-study (12 Months)|Protocol Violation|1|||
125438199|NCT01976364|451232148|FG000|Sub-study (12 Months)|Adverse Event|0|||
125438200|NCT01976364|451232149|FG001|Sub-study (12 Months)|Adverse Event|4|||
125438201|NCT01976364|451232150|FG002|Sub-study (12 Months)|Adverse Event|3|||
125438202|NCT00917267|451232158|FG000|Overall Study|Adverse Event|15|||
125438203|NCT00917267|451232159|FG001|Overall Study|Adverse Event|36|||
125438204|NCT00917267|451232158|FG000|Overall Study|Physician Decision|2|||
125438205|NCT00917267|451232159|FG001|Overall Study|Physician Decision|4|||
125438206|NCT00917267|451232158|FG000|Overall Study|Protocol Violation|9|||
125438207|NCT00917267|451232159|FG001|Overall Study|Protocol Violation|18|||
125438208|NCT00917267|451232158|FG000|Overall Study|Withdrawal by Subject|5|||
125438209|NCT00917267|451232159|FG001|Overall Study|Withdrawal by Subject|12|||
125438210|NCT00917267|451232158|FG000|Overall Study|Lost to follow up|0|||
125438211|NCT00917267|451232159|FG001|Overall Study|Lost to follow up|2|||
125438212|NCT00917267|451232158|FG000|Overall Study|Entry Criteria Not Met|1|||
125438213|NCT00917267|451232159|FG001|Overall Study|Entry Criteria Not Met|0|||
125438214|NCT00917267|451232158|FG000|Overall Study|Sponsor Decision|5|||
125438215|NCT00917267|451232159|FG001|Overall Study|Sponsor Decision|5|||
125438216|NCT00917267|451232158|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
125438217|NCT00917267|451232159|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
125438218|NCT02960763|451232160|FG000|Step 1|Withdrawal by Subject|10|||
125438219|NCT02960763|451232161|FG001|Step 1|Withdrawal by Subject|8|||
125438220|NCT02960763|451232162|FG002|Step 1|Withdrawal by Subject|13|||
125438221|NCT02960763|451232163|FG003|Step 1|Withdrawal by Subject|0|||
125438222|NCT02960763|451232164|FG004|Step 1|Withdrawal by Subject|0|||
125438223|NCT02960763|451232160|FG000|Step 1|Lost to Follow-up|7|||
125220868|NCT00627926|450436245|FG001|Overall Study|Adverse Event|37|||
125220869|NCT00627926|450436246|FG002|Overall Study|Adverse Event|36|||
125220870|NCT00627926|450436244|FG000|Overall Study|Death|1|||
125220871|NCT00627926|450436245|FG001|Overall Study|Death|0|||
125220872|NCT00627926|450436246|FG002|Overall Study|Death|0|||
125220873|NCT00627926|450436244|FG000|Overall Study|Lost to Follow-up|4|||
125220874|NCT00627926|450436245|FG001|Overall Study|Lost to Follow-up|3|||
125220875|NCT00627926|450436246|FG002|Overall Study|Lost to Follow-up|4|||
125220876|NCT00627926|450436244|FG000|Overall Study|Withdrawal by Subject|2|||
125220877|NCT00627926|450436245|FG001|Overall Study|Withdrawal by Subject|1|||
125220878|NCT00627926|450436246|FG002|Overall Study|Withdrawal by Subject|0|||
125220879|NCT00627926|450436244|FG000|Overall Study|Lack of Efficacy|118|||
125220880|NCT00627926|450436245|FG001|Overall Study|Lack of Efficacy|40|||
125220881|NCT00627926|450436246|FG002|Overall Study|Lack of Efficacy|38|||
125220882|NCT00627926|450436244|FG000|Overall Study|Noncompliance/unspecified|8|||
125220883|NCT00627926|450436245|FG001|Overall Study|Noncompliance/unspecified|23|||
125220884|NCT00627926|450436246|FG002|Overall Study|Noncompliance/unspecified|17|||
125384312|NCT01641692|451040399|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125384313|NCT01641692|451040400|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125384314|NCT01641692|451040401|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125384315|NCT01641692|451040402|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125384316|NCT01641692|451040403|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125384317|NCT01641692|451040404|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125384318|NCT01641692|451040405|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
125384319|NCT01641692|451040406|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125384320|NCT01641692|451040399|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
125384321|NCT01641692|451040400|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125384322|NCT01641692|451040401|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
125384323|NCT01641692|451040402|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
125384324|NCT01641692|451040403|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
125384325|NCT01641692|451040404|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125384326|NCT01641692|451040405|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125384327|NCT01641692|451040406|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
125384328|NCT01641692|451040399|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
125384329|NCT01641692|451040400|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
125438224|NCT02960763|451232161|FG001|Step 1|Lost to Follow-up|9|||
125438225|NCT02960763|451232162|FG002|Step 1|Lost to Follow-up|12|||
125384330|NCT01641692|451040401|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125384331|NCT01641692|451040402|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
125384332|NCT01641692|451040403|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
125384333|NCT01641692|451040404|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125384334|NCT01641692|451040405|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
125384335|NCT01641692|451040406|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125384336|NCT01641692|451040399|FG000|Treatment Period 2|Lack of Efficacy|1|||
125384337|NCT01641692|451040400|FG001|Treatment Period 2|Lack of Efficacy|0|||
125384338|NCT01641692|451040401|FG002|Treatment Period 2|Lack of Efficacy|0|||
125384339|NCT01641692|451040402|FG003|Treatment Period 2|Lack of Efficacy|0|||
125384340|NCT01641692|451040403|FG004|Treatment Period 2|Lack of Efficacy|0|||
125384341|NCT01641692|451040404|FG005|Treatment Period 2|Lack of Efficacy|0|||
125384342|NCT01641692|451040405|FG006|Treatment Period 2|Lack of Efficacy|0|||
125384343|NCT01641692|451040406|FG007|Treatment Period 2|Lack of Efficacy|0|||
125384344|NCT01641692|451040399|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
125438226|NCT02960763|451232163|FG003|Step 1|Lost to Follow-up|0|||
125438227|NCT02960763|451232164|FG004|Step 1|Lost to Follow-up|0|||
125384345|NCT01641692|451040400|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125384346|NCT01641692|451040401|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125384347|NCT01641692|451040402|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125384348|NCT01641692|451040403|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125384349|NCT01641692|451040404|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125384350|NCT01641692|451040405|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125384351|NCT01641692|451040406|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
125384352|NCT01641692|451040399|FG000|Treatment Period 2|Lost to Follow-up|0|||
125384353|NCT01641692|451040400|FG001|Treatment Period 2|Lost to Follow-up|0|||
125384354|NCT01641692|451040401|FG002|Treatment Period 2|Lost to Follow-up|0|||
125384355|NCT01641692|451040402|FG003|Treatment Period 2|Lost to Follow-up|0|||
125384356|NCT01641692|451040403|FG004|Treatment Period 2|Lost to Follow-up|0|||
125384357|NCT01641692|451040404|FG005|Treatment Period 2|Lost to Follow-up|1|||
125384358|NCT01641692|451040405|FG006|Treatment Period 2|Lost to Follow-up|0|||
125384359|NCT01641692|451040406|FG007|Treatment Period 2|Lost to Follow-up|0|||
125384360|NCT01641692|451040399|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125384361|NCT01641692|451040400|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125384362|NCT01641692|451040401|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125384363|NCT01641692|451040402|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125384364|NCT01641692|451040403|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125384365|NCT01641692|451040404|FG005|Treatment Period 2|Withdrawal by Subject|1|||
125384366|NCT01641692|451040405|FG006|Treatment Period 2|Withdrawal by Subject|0|||
125384367|NCT01641692|451040406|FG007|Treatment Period 2|Withdrawal by Subject|1|||
125384368|NCT01641692|451040399|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125384369|NCT01641692|451040400|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125384370|NCT01641692|451040401|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125384371|NCT01641692|451040402|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125384372|NCT01641692|451040403|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
125384373|NCT01641692|451040404|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125384374|NCT01641692|451040405|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
125384375|NCT01641692|451040406|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
125384376|NCT01641692|451040399|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125138011|NCT00624286|450131165|FG001|Overall Study|Lack of Efficacy|6|||
125138012|NCT00624286|450131164|FG000|Overall Study|Not stated|0|||
125138013|NCT00624286|450131165|FG001|Overall Study|Not stated|1|||
125138014|NCT00624286|450131164|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125138015|NCT00624286|450131165|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125138016|NCT00624286|450131164|FG000|Overall Study|Death|0|||
125384377|NCT01641692|451040400|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125384378|NCT01641692|451040401|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
125384379|NCT01641692|451040402|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125384380|NCT01641692|451040403|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125384381|NCT01641692|451040404|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
125384382|NCT01641692|451040405|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125384383|NCT01641692|451040406|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
125384384|NCT01641692|451040399|FG000|Treatment Period 3|Adverse Event|0|||
125384385|NCT01641692|451040400|FG001|Treatment Period 3|Adverse Event|0|||
125384386|NCT01641692|451040401|FG002|Treatment Period 3|Adverse Event|0|||
125384387|NCT01641692|451040402|FG003|Treatment Period 3|Adverse Event|0|||
125384388|NCT01641692|451040403|FG004|Treatment Period 3|Adverse Event|0|||
125384389|NCT01641692|451040404|FG005|Treatment Period 3|Adverse Event|0|||
125384390|NCT01641692|451040405|FG006|Treatment Period 3|Adverse Event|1|||
125384391|NCT01641692|451040406|FG007|Treatment Period 3|Adverse Event|0|||
125384392|NCT01641692|451040399|FG000|Treatment Period 3|Protocol Violation|0|||
125384393|NCT01641692|451040400|FG001|Treatment Period 3|Protocol Violation|0|||
125384394|NCT01641692|451040401|FG002|Treatment Period 3|Protocol Violation|1|||
125384395|NCT01641692|451040402|FG003|Treatment Period 3|Protocol Violation|0|||
125384396|NCT01641692|451040403|FG004|Treatment Period 3|Protocol Violation|0|||
125384397|NCT01641692|451040404|FG005|Treatment Period 3|Protocol Violation|0|||
125384398|NCT01641692|451040405|FG006|Treatment Period 3|Protocol Violation|0|||
125384399|NCT01641692|451040406|FG007|Treatment Period 3|Protocol Violation|0|||
125384400|NCT01641692|451040399|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125384401|NCT01641692|451040400|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125384402|NCT01641692|451040401|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125384403|NCT01641692|451040402|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125384404|NCT01641692|451040403|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125384405|NCT01641692|451040404|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125384406|NCT01641692|451040405|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
125384407|NCT01641692|451040406|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
125384408|NCT01641692|451040399|FG000|Treatment Period 3|Lost to Follow-up|0|||
125384409|NCT01641692|451040400|FG001|Treatment Period 3|Lost to Follow-up|1|||
125384410|NCT01641692|451040401|FG002|Treatment Period 3|Lost to Follow-up|0|||
125384411|NCT01641692|451040402|FG003|Treatment Period 3|Lost to Follow-up|0|||
125384412|NCT01641692|451040403|FG004|Treatment Period 3|Lost to Follow-up|0|||
125384413|NCT01641692|451040404|FG005|Treatment Period 3|Lost to Follow-up|0|||
125384414|NCT01641692|451040405|FG006|Treatment Period 3|Lost to Follow-up|0|||
125384415|NCT01641692|451040406|FG007|Treatment Period 3|Lost to Follow-up|0|||
125384416|NCT01641692|451040399|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
125384417|NCT01641692|451040400|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
125384418|NCT01641692|451040401|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
125384419|NCT01641692|451040402|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
125384420|NCT01641692|451040403|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
125384421|NCT01641692|451040404|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
125384422|NCT01641692|451040405|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
125384423|NCT01641692|451040406|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
125384424|NCT01641692|451040399|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
125384425|NCT01641692|451040400|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
125384426|NCT01641692|451040401|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
125384427|NCT01641692|451040402|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
125384428|NCT01641692|451040403|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
125384429|NCT01641692|451040404|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
125384430|NCT01641692|451040405|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
125384431|NCT01641692|451040406|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
125384432|NCT00484939|451040413|FG000|Overall Study|Death|9|||
125384433|NCT00484939|451040414|FG001|Overall Study|Death|13|||
125384434|NCT00484939|451040413|FG000|Overall Study|Adverse Event|22|||
125384435|NCT00484939|451040414|FG001|Overall Study|Adverse Event|12|||
125384436|NCT00484939|451040413|FG000|Overall Study|Patient Withdrew Consent|19|||
125384437|NCT00484939|451040414|FG001|Overall Study|Patient Withdrew Consent|10|||
125384438|NCT00484939|451040413|FG000|Overall Study|Protocol Violation|3|||
125438228|NCT02960763|451232160|FG000|Step 1|Death|1|||
125384439|NCT00484939|451040414|FG001|Overall Study|Protocol Violation|3|||
125384440|NCT00484939|451040413|FG000|Overall Study|Lost to Follow-up|0|||
125438229|NCT02960763|451232161|FG001|Step 1|Death|1|||
125384441|NCT00484939|451040414|FG001|Overall Study|Lost to Follow-up|3|||
125384442|NCT00484939|451040413|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
125384443|NCT00484939|451040414|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
125384444|NCT00484939|451040413|FG000|Overall Study|Disease progression|67|||
125438230|NCT02960763|451232162|FG002|Step 1|Death|1|||
125438231|NCT02960763|451232163|FG003|Step 1|Death|0|||
125438232|NCT02960763|451232164|FG004|Step 1|Death|0|||
125438233|NCT02960763|451232160|FG000|Step 1|Investigator discretion|1|||
125438234|NCT02960763|451232161|FG001|Step 1|Investigator discretion|0|||
125438235|NCT02960763|451232162|FG002|Step 1|Investigator discretion|1|||
125438236|NCT02960763|451232163|FG003|Step 1|Investigator discretion|0|||
125438237|NCT02960763|451232164|FG004|Step 1|Investigator discretion|0|||
125438238|NCT02960763|451232160|FG000|Step 1|Other|0|||
125438239|NCT02960763|451232161|FG001|Step 1|Other|0|||
125438240|NCT02960763|451232162|FG002|Step 1|Other|1|||
125438241|NCT02960763|451232163|FG003|Step 1|Other|0|||
125438242|NCT02960763|451232164|FG004|Step 1|Other|0|||
125438243|NCT02960763|451232160|FG000|Step 2|Withdrawal by Subject|0|||
125438244|NCT02960763|451232161|FG001|Step 2|Withdrawal by Subject|0|||
125438245|NCT02960763|451232162|FG002|Step 2|Withdrawal by Subject|0|||
125438246|NCT02960763|451232163|FG003|Step 2|Withdrawal by Subject|7|||
125438247|NCT02960763|451232164|FG004|Step 2|Withdrawal by Subject|3|||
125438248|NCT02960763|451232160|FG000|Step 2|Lost to Follow-up|0|||
125438249|NCT02960763|451232161|FG001|Step 2|Lost to Follow-up|0|||
125438250|NCT02960763|451232162|FG002|Step 2|Lost to Follow-up|0|||
125438251|NCT02960763|451232163|FG003|Step 2|Lost to Follow-up|4|||
125438252|NCT02960763|451232164|FG004|Step 2|Lost to Follow-up|1|||
125438253|NCT02960763|451232160|FG000|Step 2|Investigator discretion|0|||
125138017|NCT00624286|450131165|FG001|Overall Study|Death|1|||
125138018|NCT00841659|450131166|FG000|Washout: 2 Weeks|Protocol Violation|1|||
125138019|NCT00841659|450131167|FG001|Washout: 2 Weeks|Protocol Violation|0|||
125138020|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
125138021|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
125138022|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
125138023|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
125138024|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
125138025|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
125138026|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
125138027|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
125384445|NCT00484939|451040414|FG001|Overall Study|Disease progression|88|||
125384446|NCT00484939|451040413|FG000|Overall Study|Screen Failure|2|||
125384447|NCT00484939|451040414|FG001|Overall Study|Screen Failure|2|||
125384448|NCT00484939|451040413|FG000|Overall Study|Reason Not Specified|11|||
125384449|NCT00484939|451040414|FG001|Overall Study|Reason Not Specified|6|||
125384450|NCT04948450|451040415|FG000|Overall Study|Return home|1|||
125384451|NCT04948450|451040416|FG001|Overall Study|Return home|3|||
125384452|NCT00101907|451040420|FG000|Overall Study|Adverse Event|1|||
125384453|NCT00101907|451040421|FG001|Overall Study|Adverse Event|0|||
125384454|NCT00101907|451040422|FG002|Overall Study|Adverse Event|0|||
125384455|NCT00101907|451040423|FG003|Overall Study|Adverse Event|0|||
125384456|NCT00101907|451040424|FG004|Overall Study|Adverse Event|0|||
125384457|NCT00101907|451040425|FG005|Overall Study|Adverse Event|0|||
125384458|NCT00101907|451040420|FG000|Overall Study|Death|0|||
125384459|NCT00101907|451040421|FG001|Overall Study|Death|1|||
125384460|NCT00101907|451040422|FG002|Overall Study|Death|0|||
125384461|NCT00101907|451040423|FG003|Overall Study|Death|0|||
125384462|NCT00101907|451040424|FG004|Overall Study|Death|3|||
125384463|NCT00101907|451040425|FG005|Overall Study|Death|0|||
125384464|NCT00101907|451040420|FG000|Overall Study|Physician Decision|0|||
125384465|NCT00101907|451040421|FG001|Overall Study|Physician Decision|0|||
125384466|NCT00101907|451040422|FG002|Overall Study|Physician Decision|0|||
125384467|NCT00101907|451040423|FG003|Overall Study|Physician Decision|1|||
125384468|NCT00101907|451040424|FG004|Overall Study|Physician Decision|1|||
125384469|NCT00101907|451040425|FG005|Overall Study|Physician Decision|0|||
125384470|NCT00101907|451040420|FG000|Overall Study|Withdrawal by Subject|1|||
125384471|NCT00101907|451040421|FG001|Overall Study|Withdrawal by Subject|0|||
125384472|NCT00101907|451040422|FG002|Overall Study|Withdrawal by Subject|1|||
125384473|NCT00101907|451040423|FG003|Overall Study|Withdrawal by Subject|0|||
125384474|NCT00101907|451040424|FG004|Overall Study|Withdrawal by Subject|1|||
125384475|NCT00101907|451040425|FG005|Overall Study|Withdrawal by Subject|0|||
125384476|NCT01474876|451040430|FG000|Overall Study|Adverse Event|11|||
125384477|NCT01474876|451040431|FG001|Overall Study|Adverse Event|5|||
125384478|NCT01474876|451040432|FG002|Overall Study|Adverse Event|0|||
125384479|NCT01474876|451040430|FG000|Overall Study|Serious Adverse Event|2|||
125384480|NCT01474876|451040431|FG001|Overall Study|Serious Adverse Event|3|||
125384481|NCT01474876|451040432|FG002|Overall Study|Serious Adverse Event|0|||
125384482|NCT01474876|451040430|FG000|Overall Study|Lost to Follow-up|5|||
125384483|NCT01474876|451040431|FG001|Overall Study|Lost to Follow-up|4|||
125138028|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
125384484|NCT01474876|451040432|FG002|Overall Study|Lost to Follow-up|0|||
125384485|NCT01474876|451040430|FG000|Overall Study|Investigator's decision|28|||
125138029|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
125138030|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
125138031|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
125138032|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
125138033|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
125138034|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
125138035|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
125138036|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
125438254|NCT02960763|451232161|FG001|Step 2|Investigator discretion|0|||
125138037|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
125138038|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
125138039|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
125138040|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
125138041|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
125138042|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
125138043|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
125138044|NCT00073307|450131169|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
125138045|NCT00073307|450131170|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
125138046|NCT00073307|450131171|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
125138047|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
125138048|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
125138049|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
125138050|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
125138051|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
125138052|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
125138053|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
125138054|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
125138055|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
125138056|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
125138057|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
125138058|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
125138059|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
125138060|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
125138061|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
125138062|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
125138063|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
125138064|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
125138065|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
125138066|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
125138067|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
125138068|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
125138069|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
125138070|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
125138071|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
125138072|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
125138073|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
125138074|NCT00073307|450131169|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
125138075|NCT00073307|450131170|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
125138076|NCT00073307|450131171|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
125138077|NCT01438060|450131172|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
125138078|NCT01438060|450131173|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
125138079|NCT01438060|450131172|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
125138080|NCT01438060|450131173|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
125138081|NCT01438060|450131172|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
125138082|NCT01438060|450131173|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
125138083|NCT01438060|450131172|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
125138084|NCT01438060|450131173|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
125138085|NCT01438060|450131172|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
125138086|NCT01438060|450131173|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
125138087|NCT01438060|450131172|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
125138088|NCT01438060|450131173|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
125138089|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
125438255|NCT02960763|451232162|FG002|Step 2|Investigator discretion|0|||
125138090|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
125138091|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
125138092|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
125138093|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
125138094|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
125138095|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
125138096|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
125138097|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
125138098|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
125138099|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
125138100|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
125138101|NCT01438060|450131172|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
125138102|NCT01438060|450131173|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
125138103|NCT01438060|450131172|FG000|On Study Beyond Week 140|Adverse Event|0|||
125138104|NCT01438060|450131173|FG001|On Study Beyond Week 140|Adverse Event|2|||
125220933|NCT02797678|450436278|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
125384486|NCT01474876|451040431|FG001|Overall Study|Investigator's decision|6|||
125384487|NCT01474876|451040432|FG002|Overall Study|Investigator's decision|0|||
125384488|NCT01474876|451040430|FG000|Overall Study|Patient's request|19|||
125384489|NCT01474876|451040431|FG001|Overall Study|Patient's request|5|||
125384490|NCT01474876|451040432|FG002|Overall Study|Patient's request|0|||
125384491|NCT01474876|451040430|FG000|Overall Study|Investigator's decision and pt request|1|||
125384492|NCT01474876|451040431|FG001|Overall Study|Investigator's decision and pt request|0|||
125384493|NCT01474876|451040432|FG002|Overall Study|Investigator's decision and pt request|0|||
125384494|NCT01523886|451040433|FG000|Overall Study|surgery cancelled|0|||
125384495|NCT01523886|451040434|FG001|Overall Study|surgery cancelled|1|||
125384496|NCT01173718|451040449|FG000|Overall Study|Death|17|||
125384497|NCT01173718|451040449|FG000|Overall Study|Abandonment of study graft|27|||
125384498|NCT01367158|451040450|FG000|Overall Study|Withdrew consent|0|||
125384499|NCT01367158|451040451|FG001|Overall Study|Withdrew consent|2|||
125384500|NCT01367158|451040452|FG002|Overall Study|Withdrew consent|1|||
125384501|NCT01367158|451040453|FG003|Overall Study|Withdrew consent|0|||
125384502|NCT01367158|451040454|FG004|Overall Study|Withdrew consent|2|||
125384503|NCT01367158|451040455|FG005|Overall Study|Withdrew consent|0|||
125384504|NCT01367158|451040456|FG006|Overall Study|Withdrew consent|0|||
125384505|NCT01367158|451040457|FG007|Overall Study|Withdrew consent|1|||
125384506|NCT01367158|451040458|FG008|Overall Study|Withdrew consent|0|||
125384507|NCT01367158|451040459|FG009|Overall Study|Withdrew consent|0|||
125384508|NCT01367158|451040460|FG010|Overall Study|Withdrew consent|0|||
125384509|NCT01367158|451040450|FG000|Overall Study|Lost to Follow-up|0|||
125384510|NCT01367158|451040451|FG001|Overall Study|Lost to Follow-up|0|||
125384511|NCT01367158|451040452|FG002|Overall Study|Lost to Follow-up|0|||
125384512|NCT01367158|451040453|FG003|Overall Study|Lost to Follow-up|1|||
125384513|NCT01367158|451040454|FG004|Overall Study|Lost to Follow-up|0|||
125384514|NCT01367158|451040455|FG005|Overall Study|Lost to Follow-up|2|||
125384515|NCT01367158|451040456|FG006|Overall Study|Lost to Follow-up|0|||
125384516|NCT01367158|451040457|FG007|Overall Study|Lost to Follow-up|1|||
125384517|NCT01367158|451040458|FG008|Overall Study|Lost to Follow-up|0|||
125384518|NCT01367158|451040459|FG009|Overall Study|Lost to Follow-up|0|||
125384519|NCT01367158|451040460|FG010|Overall Study|Lost to Follow-up|1|||
125384520|NCT01367158|451040450|FG000|Overall Study|Protocol Violation|0|||
125384521|NCT01367158|451040451|FG001|Overall Study|Protocol Violation|1|||
125384522|NCT01367158|451040452|FG002|Overall Study|Protocol Violation|0|||
125384523|NCT01367158|451040453|FG003|Overall Study|Protocol Violation|0|||
125384524|NCT01367158|451040454|FG004|Overall Study|Protocol Violation|0|||
125384525|NCT01367158|451040455|FG005|Overall Study|Protocol Violation|0|||
125384526|NCT01367158|451040456|FG006|Overall Study|Protocol Violation|0|||
125384527|NCT01367158|451040457|FG007|Overall Study|Protocol Violation|0|||
125384528|NCT01367158|451040458|FG008|Overall Study|Protocol Violation|0|||
125384529|NCT01367158|451040459|FG009|Overall Study|Protocol Violation|0|||
125384530|NCT01367158|451040460|FG010|Overall Study|Protocol Violation|0|||
125384531|NCT02226003|451040462|FG000|Overall Study|Lost to Follow-up|2|||
125384532|NCT02226003|451040463|FG001|Overall Study|Lost to Follow-up|1|||
125384533|NCT02226003|451040464|FG002|Overall Study|Lost to Follow-up|3|||
125384534|NCT02226003|451040462|FG000|Overall Study|Withdrawal by Subject|0|||
125384535|NCT02226003|451040463|FG001|Overall Study|Withdrawal by Subject|0|||
125384536|NCT02226003|451040464|FG002|Overall Study|Withdrawal by Subject|3|||
125384537|NCT00296374|451040474|FG000|Overall Study|Adverse Event|14|||
125384538|NCT00296374|451040475|FG001|Overall Study|Adverse Event|10|||
125384539|NCT00296374|451040476|FG002|Overall Study|Adverse Event|7|||
125384540|NCT00296374|451040474|FG000|Overall Study|Withdrawal by Subject|3|||
125384541|NCT00296374|451040475|FG001|Overall Study|Withdrawal by Subject|5|||
125384542|NCT00296374|451040476|FG002|Overall Study|Withdrawal by Subject|11|||
125384543|NCT00296374|451040474|FG000|Overall Study|Incorrect enrollment|3|||
125384544|NCT00296374|451040475|FG001|Overall Study|Incorrect enrollment|3|||
125384545|NCT00296374|451040476|FG002|Overall Study|Incorrect enrollment|4|||
125384546|NCT00296374|451040474|FG000|Overall Study|Protocol Violation|1|||
125384547|NCT00296374|451040475|FG001|Overall Study|Protocol Violation|2|||
125384548|NCT00296374|451040476|FG002|Overall Study|Protocol Violation|3|||
125384549|NCT00296374|451040474|FG000|Overall Study|Lost to Follow-up|3|||
125384550|NCT00296374|451040475|FG001|Overall Study|Lost to Follow-up|1|||
125384551|NCT00296374|451040476|FG002|Overall Study|Lost to Follow-up|1|||
125384552|NCT00296374|451040474|FG000|Overall Study|Relocated to another state|1|||
125384553|NCT00296374|451040475|FG001|Overall Study|Relocated to another state|0|||
125384554|NCT00296374|451040476|FG002|Overall Study|Relocated to another state|0|||
125384555|NCT00296374|451040474|FG000|Overall Study|Stopped drug before end of study visit|0|||
125384556|NCT00296374|451040475|FG001|Overall Study|Stopped drug before end of study visit|1|||
125138105|NCT01438060|450131172|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
125384557|NCT00296374|451040476|FG002|Overall Study|Stopped drug before end of study visit|0|||
125138106|NCT01438060|450131173|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
125138107|NCT01438060|450131172|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
125384558|NCT00296374|451040474|FG000|Overall Study|Nephrologist introduced ACE|0|||
125384559|NCT00296374|451040475|FG001|Overall Study|Nephrologist introduced ACE|1|||
125384560|NCT00296374|451040476|FG002|Overall Study|Nephrologist introduced ACE|0|||
125384561|NCT00296374|451040474|FG000|Overall Study|Pregnancy|0|||
125384562|NCT00296374|451040475|FG001|Overall Study|Pregnancy|0|||
125384563|NCT00296374|451040476|FG002|Overall Study|Pregnancy|2|||
125384564|NCT00296374|451040474|FG000|Overall Study|Other|0|||
125384565|NCT00296374|451040475|FG001|Overall Study|Other|0|||
125384566|NCT00296374|451040476|FG002|Overall Study|Other|1|||
125384567|NCT00670800|451042299|FG000|Overall Study|2 controls were insulin resistant|0|||
125384568|NCT00670800|451042300|FG001|Overall Study|2 controls were insulin resistant|2|||
125384569|NCT01786629|451042301|FG000|Overall Study|Lack of Efficacy|0|||
125384570|NCT01786629|451042302|FG001|Overall Study|Lack of Efficacy|4|||
125384571|NCT01786629|451042301|FG000|Overall Study|Adverse Event|0|||
125384572|NCT01786629|451042302|FG001|Overall Study|Adverse Event|1|||
125384573|NCT04736199|451042303|FG000|Overall Study|Adverse Event|28|||
125384574|NCT04736199|451042304|FG001|Overall Study|Adverse Event|22|||
125384575|NCT04736199|451042303|FG000|Overall Study|Death|9|||
125384576|NCT04736199|451042304|FG001|Overall Study|Death|3|||
125384577|NCT04736199|451042303|FG000|Overall Study|Lost to Follow-up|4|||
125384578|NCT04736199|451042304|FG001|Overall Study|Lost to Follow-up|1|||
125384579|NCT04736199|451042303|FG000|Overall Study|Physician Decision|5|||
125384580|NCT04736199|451042304|FG001|Overall Study|Physician Decision|9|||
125384581|NCT04736199|451042303|FG000|Overall Study|Withdrawal by Subject|21|||
125384582|NCT04736199|451042304|FG001|Overall Study|Withdrawal by Subject|9|||
125384583|NCT04736199|451042303|FG000|Overall Study|Progressive disease|120|||
125384584|NCT04736199|451042304|FG001|Overall Study|Progressive disease|101|||
125384585|NCT04736199|451042303|FG000|Overall Study|Subject decision|13|||
125384586|NCT04736199|451042304|FG001|Overall Study|Subject decision|13|||
125384587|NCT04736199|451042303|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
125384588|NCT04736199|451042304|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
125138108|NCT01438060|450131173|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
125384589|NCT04736199|451042303|FG000|Overall Study|Additional primary malignancy|1|||
125384590|NCT04736199|451042304|FG001|Overall Study|Additional primary malignancy|0|||
125384591|NCT04736199|451042303|FG000|Overall Study|Non-compliance with study drug|0|||
125384592|NCT04736199|451042304|FG001|Overall Study|Non-compliance with study drug|1|||
125384593|NCT04736199|451042303|FG000|Overall Study|Other reason|0|||
125384594|NCT04736199|451042304|FG001|Overall Study|Other reason|1|||
125384595|NCT04736199|451042303|FG000|Overall Study|Ongoing with study drug|240|||
125384596|NCT04736199|451042304|FG001|Overall Study|Ongoing with study drug|63|||
125384597|NCT04736199|451042303|FG000|Overall Study|Study drug never administered|3|||
125384598|NCT04736199|451042304|FG001|Overall Study|Study drug never administered|0|||
125384599|NCT04318080|451042305|FG000|Overall Study|Study closed by sponsor|10|||
125438256|NCT02960763|451232163|FG003|Step 2|Investigator discretion|0|||
125138109|NCT01438060|450131172|FG000|On Study Beyond Week 140|Death|0|||
125138110|NCT01438060|450131173|FG001|On Study Beyond Week 140|Death|1|||
125384600|NCT04318080|451042306|FG001|Overall Study|Study closed by sponsor|22|||
125384601|NCT04318080|451042305|FG000|Overall Study|Death|3|||
125384602|NCT04318080|451042306|FG001|Overall Study|Death|9|||
125384603|NCT04318080|451042305|FG000|Overall Study|Withdrawal by Subject|1|||
125384604|NCT04318080|451042306|FG001|Overall Study|Withdrawal by Subject|0|||
125384605|NCT04318080|451042305|FG000|Overall Study|Protocol Deviation|1|||
125384606|NCT04318080|451042306|FG001|Overall Study|Protocol Deviation|0|||
125384607|NCT00410761|451042307|FG000|Randomized Treatment Period|Adverse Event|34|||
125384608|NCT00410761|451042308|FG001|Randomized Treatment Period|Adverse Event|3|||
125384609|NCT00410761|451042307|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
125138111|NCT01438060|450131172|FG000|On Study Beyond Week 140|Other Reason|0|||
125138112|NCT01438060|450131173|FG001|On Study Beyond Week 140|Other Reason|3|||
125138113|NCT04404725|450131174|FG000|First Intervention|Withdrawal by Subject|0|||
125438257|NCT02960763|451232164|FG004|Step 2|Investigator discretion|1|||
125220934|NCT02797678|450436279|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
125220935|NCT02797678|450436280|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
125384610|NCT00410761|451042308|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
125384611|NCT00410761|451042307|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
125384612|NCT00410761|451042308|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
125384613|NCT00410761|451042307|FG000|Randomized Treatment Period|Other|69|||
125384614|NCT00410761|451042308|FG001|Randomized Treatment Period|Other|21|||
125384615|NCT00410761|451042307|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
125384616|NCT00410761|451042308|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
125438258|NCT00312858|451232168|FG000|Overall Study|Adverse Event|0|||
125138114|NCT04404725|450131175|FG001|First Intervention|Withdrawal by Subject|2|||
125138115|NCT04404725|450131174|FG000|Second Intervention|Adverse Event|1|||
125138116|NCT04404725|450131175|FG001|Second Intervention|Adverse Event|1|||
125138117|NCT04404725|450131174|FG000|Second Intervention|Withdrawal by Subject|0|||
125384617|NCT00410761|451042307|FG000|Open-Label Treatment Period|Adverse Event|13|||
125384618|NCT00410761|451042308|FG001|Open-Label Treatment Period|Adverse Event|15|||
125138118|NCT04404725|450131175|FG001|Second Intervention|Withdrawal by Subject|1|||
125138119|NCT01190865|450131191|FG000|Overall Study|Withdrawal by Subject|1|||
125138120|NCT01190865|450131191|FG000|Overall Study|Non-compliance|2|||
125138121|NCT02436200|450131193|FG000|Overall Study|Significant outlier|1|||
125138122|NCT00957021|450131194|FG000|Overall Study|Death|5|||
125138123|NCT00957021|450131194|FG000|Overall Study|Lost to Follow-up|8|||
125138124|NCT00957021|450131194|FG000|Overall Study|Withdrawal by Subject|34|||
125138125|NCT00957021|450131194|FG000|Overall Study|No 2 yr ROM data|35|||
125138126|NCT00957021|450131194|FG000|Overall Study|Revised study component by 2 yr visit|8|||
125138127|NCT00957021|450131194|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
125138128|NCT00957021|450131194|FG000|Overall Study|Surgery Cancelled|9|||
125138129|NCT00957021|450131194|FG000|Overall Study|Termination due to language issue|2|||
125138130|NCT01483820|450131198|FG000|Overall Study|Lack of Efficacy|6|||
125138131|NCT01483820|450131198|FG000|Overall Study|Adverse Event|1|||
125138132|NCT01483820|450131198|FG000|Overall Study|Death|1|||
125220936|NCT02797678|450436281|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
125220937|NCT02797678|450436278|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
125220938|NCT02797678|450436279|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
125138133|NCT00867360|450131199|FG000|Overall Study|Withdrawal by Subject|1|||
125138134|NCT00867360|450131200|FG001|Overall Study|Withdrawal by Subject|0|||
125138135|NCT00867360|450131199|FG000|Overall Study|Physician Decision|0|||
125138136|NCT00867360|450131200|FG001|Overall Study|Physician Decision|1|||
125138137|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
125138138|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
125138139|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
125138140|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
125138141|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
125138142|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
125384619|NCT00410761|451042307|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
125384620|NCT00410761|451042308|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
125138143|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138144|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138145|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138146|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138147|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138148|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138149|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138150|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138151|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138152|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138153|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138154|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138155|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138156|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138157|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138158|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138159|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138160|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138161|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138162|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
125138163|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138164|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
125138165|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138166|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138167|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138168|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125384621|NCT00410761|451042307|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
125384622|NCT00410761|451042308|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
125384623|NCT00410761|451042307|FG000|Open-Label Treatment Period|Other|18|||
125138169|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138170|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138171|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138172|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138173|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138174|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138175|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138176|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138177|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138178|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138179|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138180|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138181|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138182|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138183|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138184|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138185|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138186|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138187|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138188|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
125138189|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138190|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
125138191|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138192|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138193|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138194|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138195|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138196|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138197|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138198|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138199|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138200|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138201|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138202|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138203|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138204|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138205|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138206|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138207|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138208|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138209|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138210|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138211|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138212|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138213|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138214|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
125138215|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
125138216|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138217|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
125138218|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
125138219|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
125138220|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138221|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138222|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138223|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138224|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138225|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138226|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138227|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138228|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138229|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138230|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138231|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138232|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138233|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138234|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138235|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138236|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138237|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138238|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125384624|NCT00410761|451042308|FG001|Open-Label Treatment Period|Other|9|||
125220939|NCT02797678|450436280|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
125220940|NCT02797678|450436281|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
125220941|NCT02797678|450436278|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
125220942|NCT02797678|450436279|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
125220943|NCT02797678|450436280|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
125220944|NCT02797678|450436281|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
125220945|NCT00753675|450436285|FG000|Overall Study|other reason|11|||
125220946|NCT00753675|450436286|FG001|Overall Study|other reason|12|||
125220947|NCT00753675|450436287|FG002|Overall Study|other reason|13|||
125220948|NCT00753675|450436285|FG000|Overall Study|Death|1|||
125220949|NCT00753675|450436286|FG001|Overall Study|Death|2|||
125220950|NCT00753675|450436287|FG002|Overall Study|Death|4|||
125220951|NCT00753675|450436285|FG000|Overall Study|Adverse Event|11|||
125220952|NCT00753675|450436286|FG001|Overall Study|Adverse Event|9|||
125220953|NCT00753675|450436287|FG002|Overall Study|Adverse Event|4|||
125220954|NCT00753675|450436285|FG000|Overall Study|Objective progression of disease|35|||
125220955|NCT00753675|450436286|FG001|Overall Study|Objective progression of disease|35|||
125384625|NCT02926924|451042309|FG000|Overall Study|withdrawal - reason unknown|0|||
125384626|NCT02926924|451042310|FG001|Overall Study|withdrawal - reason unknown|1|||
125384627|NCT03712904|451042312|FG000|Overall Study|Death|0|||
125384628|NCT03712904|451042313|FG001|Overall Study|Death|1|||
125384629|NCT03712904|451042312|FG000|Overall Study|Withdrawal by Subject|0|||
125384630|NCT03712904|451042313|FG001|Overall Study|Withdrawal by Subject|1|||
125384631|NCT03712904|451042312|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
125384632|NCT03712904|451042313|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
125384633|NCT01852942|451042315|FG000|Overall Study|Physician Decision|1|||
125384634|NCT01852942|451042316|FG001|Overall Study|Physician Decision|0|||
125384635|NCT01852942|451042315|FG000|Overall Study|Death|1|||
125384636|NCT01852942|451042316|FG001|Overall Study|Death|1|||
125220956|NCT00753675|450436287|FG002|Overall Study|Objective progression of disease|35|||
125220957|NCT00753675|450436285|FG000|Overall Study|Withdrawal by Subject|0|||
125220958|NCT00753675|450436286|FG001|Overall Study|Withdrawal by Subject|1|||
125384637|NCT01852942|451042315|FG000|Overall Study|Withdrawal by Subject|2|||
125384638|NCT01852942|451042316|FG001|Overall Study|Withdrawal by Subject|3|||
125220959|NCT00753675|450436287|FG002|Overall Study|Withdrawal by Subject|0|||
125220960|NCT00753675|450436285|FG000|Overall Study|Lost to Follow-up|1|||
125220961|NCT00753675|450436286|FG001|Overall Study|Lost to Follow-up|0|||
125220962|NCT00753675|450436287|FG002|Overall Study|Lost to Follow-up|0|||
125220963|NCT02686164|450436291|FG000|Overall Study|Adverse Event|1|||
125220964|NCT02686164|450436291|FG000|Overall Study|Withdrawal of consent|1|||
125220965|NCT02686164|450436291|FG000|Overall Study|Clinical progression|1|||
125220966|NCT03283930|450436292|FG000|Overall Study|Scheduling conflict|8|||
125220967|NCT03283930|450436293|FG001|Overall Study|Scheduling conflict|10|||
125220968|NCT03283930|450436292|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
125220969|NCT03283930|450436293|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
125220970|NCT03283930|450436292|FG000|Overall Study|Technical software issue|2|||
125220971|NCT03283930|450436293|FG001|Overall Study|Technical software issue|2|||
125220972|NCT00805129|450436296|FG000|Overall Study|Not treated|1|||
125220973|NCT02499120|450436299|FG000|Overall Study|Death|52|||
125220974|NCT02499120|450436300|FG001|Overall Study|Death|43|||
125220975|NCT02499120|450436299|FG000|Overall Study|Lost to Follow-up|1|||
125220976|NCT02499120|450436300|FG001|Overall Study|Lost to Follow-up|2|||
125220977|NCT02499120|450436299|FG000|Overall Study|Participant refused further follow-up|1|||
125220978|NCT02499120|450436300|FG001|Overall Study|Participant refused further follow-up|0|||
125220979|NCT02499120|450436299|FG000|Overall Study|Withdrawal by Subject|2|||
125220980|NCT02499120|450436300|FG001|Overall Study|Withdrawal by Subject|5|||
125220981|NCT02499120|450436299|FG000|Overall Study|Other|9|||
125220982|NCT02499120|450436300|FG001|Overall Study|Other|10|||
125220983|NCT02106351|450436314|FG000|Treatment Cycle 1|Adverse Event|2|||
125220984|NCT02106351|450436315|FG001|Treatment Cycle 1|Adverse Event|0|||
125220985|NCT02106351|450436316|FG002|Treatment Cycle 1|Adverse Event|0|||
125138239|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138240|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
125138241|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
125138242|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
125138243|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
125138244|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
125138245|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
125138246|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138247|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138248|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138249|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138250|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138251|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138252|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138253|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138254|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138255|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138256|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138257|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138258|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125220986|NCT02106351|450436314|FG000|Treatment Cycle 1|Consent withdrawn|1|||
125220987|NCT02106351|450436315|FG001|Treatment Cycle 1|Consent withdrawn|0|||
125220988|NCT02106351|450436316|FG002|Treatment Cycle 1|Consent withdrawn|2|||
125220989|NCT02106351|450436314|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
125220990|NCT02106351|450436315|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
125220991|NCT02106351|450436316|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
125220992|NCT02106351|450436314|FG000|Treatment Cycle 1|Other|0|||
125220993|NCT02106351|450436315|FG001|Treatment Cycle 1|Other|3|||
125220994|NCT02106351|450436316|FG002|Treatment Cycle 1|Other|1|||
125220995|NCT02106351|450436314|FG000|Treatment Cycle 1|Randomised but not treated|1|||
125220996|NCT02106351|450436315|FG001|Treatment Cycle 1|Randomised but not treated|0|||
125220997|NCT02106351|450436316|FG002|Treatment Cycle 1|Randomised but not treated|1|||
125220998|NCT02106351|450436314|FG000|Treatment Cycle 2|Adverse Event|0|||
125220999|NCT02106351|450436315|FG001|Treatment Cycle 2|Adverse Event|2|||
125221000|NCT02106351|450436316|FG002|Treatment Cycle 2|Adverse Event|0|||
125221001|NCT02106351|450436314|FG000|Treatment Cycle 2|Consent withdrawn|0|||
125221002|NCT02106351|450436315|FG001|Treatment Cycle 2|Consent withdrawn|1|||
125221003|NCT02106351|450436316|FG002|Treatment Cycle 2|Consent withdrawn|1|||
125221004|NCT02106351|450436314|FG000|Treatment Cycle 2|Other|0|||
125221005|NCT02106351|450436315|FG001|Treatment Cycle 2|Other|2|||
125221006|NCT02106351|450436316|FG002|Treatment Cycle 2|Other|2|||
125221007|NCT02106351|450436314|FG000|Treatment Cycle 3|Adverse Event|0|||
125221008|NCT02106351|450436315|FG001|Treatment Cycle 3|Adverse Event|1|||
125221009|NCT02106351|450436316|FG002|Treatment Cycle 3|Adverse Event|0|||
125221010|NCT02106351|450436314|FG000|Treatment Cycle 3|Consent withdrawn|0|||
125221011|NCT02106351|450436315|FG001|Treatment Cycle 3|Consent withdrawn|0|||
125221012|NCT02106351|450436316|FG002|Treatment Cycle 3|Consent withdrawn|2|||
125384639|NCT01852942|451042315|FG000|Overall Study|Lost to Follow-up|1|||
125384640|NCT01852942|451042316|FG001|Overall Study|Lost to Follow-up|2|||
125384641|NCT01921179|451042317|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
125384642|NCT01921179|451042318|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
125384643|NCT01921179|451042317|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
125384644|NCT01921179|451042318|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
125384645|NCT04568590|451042319|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
125384646|NCT00858442|451042324|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
125384647|NCT00858442|451042325|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
125384648|NCT00202644|451042330|FG000|Overall Study|Adverse Event|12|||
125384649|NCT00202644|451042331|FG001|Overall Study|Adverse Event|13|||
125384650|NCT00202644|451042330|FG000|Overall Study|Withdrawal by Subject|8|||
125384651|NCT00202644|451042331|FG001|Overall Study|Withdrawal by Subject|6|||
125384652|NCT00202644|451042330|FG000|Overall Study|Lack of Efficacy|6|||
125384653|NCT00202644|451042331|FG001|Overall Study|Lack of Efficacy|6|||
125384654|NCT00202644|451042330|FG000|Overall Study|Lost to Follow-up|0|||
125384655|NCT00202644|451042331|FG001|Overall Study|Lost to Follow-up|1|||
125384656|NCT00202644|451042330|FG000|Overall Study|Other|9|||
125384657|NCT00202644|451042331|FG001|Overall Study|Other|1|||
125384658|NCT02750592|451042337|FG000|Overall Study|Adverse Event|3|||
125384659|NCT02750592|451042337|FG000|Overall Study|Lack of Efficacy|2|||
125384660|NCT02981342|451042340|FG000|Overall Study|Adverse Event|0|||
125384661|NCT02981342|451042341|FG001|Overall Study|Adverse Event|0|||
125384662|NCT02981342|451042342|FG002|Overall Study|Adverse Event|0|||
125384663|NCT02981342|451042343|FG003|Overall Study|Adverse Event|1|||
125384664|NCT02981342|451042340|FG000|Overall Study|Death|0|||
125384665|NCT02981342|451042341|FG001|Overall Study|Death|9|||
125384666|NCT02981342|451042342|FG002|Overall Study|Death|9|||
125384667|NCT02981342|451042343|FG003|Overall Study|Death|4|||
125384668|NCT02981342|451042340|FG000|Overall Study|Withdrawal by Subject|0|||
125384669|NCT02981342|451042341|FG001|Overall Study|Withdrawal by Subject|0|||
125384670|NCT02981342|451042342|FG002|Overall Study|Withdrawal by Subject|3|||
125384671|NCT02981342|451042343|FG003|Overall Study|Withdrawal by Subject|1|||
125384672|NCT02981342|451042340|FG000|Overall Study|Study closed by sponsor|0|||
125384673|NCT02981342|451042341|FG001|Overall Study|Study closed by sponsor|0|||
125384674|NCT02981342|451042342|FG002|Overall Study|Study closed by sponsor|1|||
125384675|NCT02981342|451042343|FG003|Overall Study|Study closed by sponsor|1|||
125384676|NCT02981342|451042340|FG000|Overall Study|Randomized, Never Treated|0|||
125384677|NCT02981342|451042341|FG001|Overall Study|Randomized, Never Treated|1|||
125384678|NCT02981342|451042342|FG002|Overall Study|Randomized, Never Treated|0|||
125384679|NCT02981342|451042343|FG003|Overall Study|Randomized, Never Treated|7|||
125384680|NCT02981342|451042340|FG000|Overall Study|Lost to Follow-up|0|||
125384681|NCT02981342|451042341|FG001|Overall Study|Lost to Follow-up|1|||
125384682|NCT02981342|451042342|FG002|Overall Study|Lost to Follow-up|0|||
125384683|NCT02981342|451042343|FG003|Overall Study|Lost to Follow-up|0|||
125384684|NCT01372501|451042344|FG000|Overall Study|Adverse Event|4|||
125384685|NCT01372501|451042344|FG000|Overall Study|Device migration|1|||
125384686|NCT01466348|451042345|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
125384687|NCT01466348|451042346|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
125384688|NCT03989440|451042347|FG000|Overall Study|COVID-19 travel restrictions|0|||
125384689|NCT03989440|451042348|FG001|Overall Study|COVID-19 travel restrictions|0|||
125384690|NCT03989440|451042349|FG002|Overall Study|COVID-19 travel restrictions|1|||
125384691|NCT03989440|451042350|FG003|Overall Study|COVID-19 travel restrictions|0|||
125384692|NCT03989440|451042351|FG004|Overall Study|COVID-19 travel restrictions|0|||
125384693|NCT03989440|451042352|FG005|Overall Study|COVID-19 travel restrictions|0|||
125384694|NCT03989440|451042347|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
125384695|NCT03989440|451042348|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
125384696|NCT03989440|451042349|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
125384697|NCT03989440|451042350|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
125384698|NCT03989440|451042351|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
125384699|NCT03989440|451042352|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
125384700|NCT03970733|451042355|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
125384701|NCT03970733|451042356|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
125384702|NCT03970733|451042357|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
125384703|NCT03970733|451042358|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
125384704|NCT03970733|451042359|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
125384705|NCT03970733|451042355|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
125384706|NCT03970733|451042356|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
125384707|NCT03970733|451042357|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
125384708|NCT03970733|451042358|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
125384709|NCT03970733|451042359|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
125384710|NCT03970733|451042355|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
125384711|NCT03970733|451042356|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
125384712|NCT03970733|451042357|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
125384713|NCT03970733|451042358|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
125384714|NCT03970733|451042359|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
125384715|NCT03970733|451042355|FG000|Main Study Phase (18 Months)|Other|1|||
125384716|NCT03970733|451042356|FG001|Main Study Phase (18 Months)|Other|1|||
125384717|NCT03970733|451042357|FG002|Main Study Phase (18 Months)|Other|0|||
125384718|NCT03970733|451042358|FG003|Main Study Phase (18 Months)|Other|0|||
125384719|NCT03970733|451042359|FG004|Main Study Phase (18 Months)|Other|0|||
125384720|NCT03970733|451042355|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
125384721|NCT03970733|451042356|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
125384722|NCT03970733|451042357|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
125384723|NCT03970733|451042358|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
125384724|NCT03970733|451042359|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
125384725|NCT02189473|451042363|FG000|Overall Study|Death|22|||
125384726|NCT02189473|451042364|FG001|Overall Study|Death|23|||
125384727|NCT02189473|451042363|FG000|Overall Study|Lost to Follow-up|1|||
125384728|NCT02189473|451042364|FG001|Overall Study|Lost to Follow-up|2|||
125384729|NCT01955161|451042365|FG000|Overall Study|Withdrawal before treatment|2|||
125384730|NCT01955161|451042366|FG001|Overall Study|Withdrawal before treatment|0|||
125384731|NCT01955161|451042367|FG002|Overall Study|Withdrawal before treatment|1|||
125384732|NCT01955161|451042365|FG000|Overall Study|Adverse Event|10|||
125384733|NCT01955161|451042366|FG001|Overall Study|Adverse Event|14|||
125384734|NCT01955161|451042367|FG002|Overall Study|Adverse Event|15|||
125384735|NCT01955161|451042365|FG000|Overall Study|Death|1|||
125384736|NCT01955161|451042366|FG001|Overall Study|Death|1|||
125384737|NCT01955161|451042367|FG002|Overall Study|Death|3|||
125384738|NCT01955161|451042365|FG000|Overall Study|Withdrawal by Subject|9|||
125384739|NCT01955161|451042366|FG001|Overall Study|Withdrawal by Subject|8|||
125384740|NCT01955161|451042367|FG002|Overall Study|Withdrawal by Subject|12|||
125384741|NCT01955161|451042365|FG000|Overall Study|Protocol Violation|2|||
125384742|NCT01955161|451042366|FG001|Overall Study|Protocol Violation|0|||
125384743|NCT01955161|451042367|FG002|Overall Study|Protocol Violation|0|||
125384744|NCT01955161|451042365|FG000|Overall Study|Other reason: physician decision|0|||
125384745|NCT01955161|451042366|FG001|Overall Study|Other reason: physician decision|1|||
125384746|NCT01955161|451042367|FG002|Overall Study|Other reason: physician decision|1|||
125384747|NCT01955161|451042365|FG000|Overall Study|Other reason: disallowed medication|1|||
125384748|NCT01955161|451042366|FG001|Overall Study|Other reason: disallowed medication|0|||
125384749|NCT01955161|451042367|FG002|Overall Study|Other reason: disallowed medication|1|||
125384750|NCT01955161|451042365|FG000|Overall Study|Other reason: caregiver unavailable|1|||
125384751|NCT01955161|451042366|FG001|Overall Study|Other reason: caregiver unavailable|0|||
125384752|NCT01955161|451042367|FG002|Overall Study|Other reason: caregiver unavailable|0|||
125384753|NCT01955161|451042365|FG000|Overall Study|Other reason: moved to nursing home|0|||
125384754|NCT01955161|451042366|FG001|Overall Study|Other reason: moved to nursing home|1|||
125384755|NCT01955161|451042367|FG002|Overall Study|Other reason: moved to nursing home|0|||
125384756|NCT01955161|451042365|FG000|Overall Study|Other reason: insufficient compliance|0|||
125384757|NCT01955161|451042366|FG001|Overall Study|Other reason: insufficient compliance|0|||
125438259|NCT00312858|451232169|FG001|Overall Study|Adverse Event|1|||
125438260|NCT00312858|451232168|FG000|Overall Study|Lost to Follow-up|25|||
125438261|NCT00312858|451232169|FG001|Overall Study|Lost to Follow-up|42|||
125438262|NCT00312858|451232168|FG000|Overall Study|Protocol Violation|3|||
125438263|NCT00312858|451232169|FG001|Overall Study|Protocol Violation|8|||
125438264|NCT00312858|451232168|FG000|Overall Study|Withdraw by Participant|20|||
125438265|NCT00312858|451232169|FG001|Overall Study|Withdraw by Participant|20|||
125438266|NCT00312858|451232168|FG000|Overall Study|Participant Moved|11|||
125438267|NCT00312858|451232169|FG001|Overall Study|Participant Moved|10|||
125438268|NCT00312858|451232168|FG000|Overall Study|Other|9|||
125438269|NCT00312858|451232169|FG001|Overall Study|Other|12|||
125438270|NCT02318719|451232170|FG000|Double-blind Phase|Adverse Event|7|||
125438271|NCT02318719|451232171|FG001|Double-blind Phase|Adverse Event|6|||
125438272|NCT02318719|451232172|FG002|Double-blind Phase|Adverse Event|12|||
125138259|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138260|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138261|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138262|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138263|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138264|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138265|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138266|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
125138267|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|moved|0|||
125138268|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|moved|1|||
125138269|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|moved|1|||
125138270|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|moved|0|||
125138271|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|moved|0|||
125138272|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|moved|0|||
125138273|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|moved|0|||
125138274|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|moved|0|||
125138275|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|moved|0|||
125138276|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|moved|0|||
125138277|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|moved|0|||
125138278|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|moved|0|||
125138279|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|moved|0|||
125138280|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|moved|0|||
125138281|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|moved|0|||
125138282|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|moved|0|||
125138283|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|moved|0|||
125138284|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|moved|0|||
125138285|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|moved|0|||
125138286|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|moved|0|||
125438273|NCT02318719|451232173|FG003|Double-blind Phase|Adverse Event|4|||
125438274|NCT02318719|451232174|FG004|Double-blind Phase|Adverse Event|0|||
125438275|NCT02318719|451232170|FG000|Double-blind Phase|Lack of Efficacy|5|||
125438276|NCT02318719|451232171|FG001|Double-blind Phase|Lack of Efficacy|0|||
125438277|NCT02318719|451232172|FG002|Double-blind Phase|Lack of Efficacy|1|||
125438278|NCT02318719|451232173|FG003|Double-blind Phase|Lack of Efficacy|1|||
125438279|NCT02318719|451232174|FG004|Double-blind Phase|Lack of Efficacy|0|||
125438280|NCT02318719|451232170|FG000|Double-blind Phase|Protocol Violation|0|||
125438281|NCT02318719|451232171|FG001|Double-blind Phase|Protocol Violation|1|||
125438282|NCT02318719|451232172|FG002|Double-blind Phase|Protocol Violation|3|||
125438283|NCT02318719|451232173|FG003|Double-blind Phase|Protocol Violation|0|||
125438284|NCT02318719|451232174|FG004|Double-blind Phase|Protocol Violation|0|||
125438285|NCT02318719|451232170|FG000|Double-blind Phase|Withdrawal by Subject|25|||
125138287|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|moved|0|||
125438286|NCT02318719|451232171|FG001|Double-blind Phase|Withdrawal by Subject|7|||
125438287|NCT02318719|451232172|FG002|Double-blind Phase|Withdrawal by Subject|9|||
125438288|NCT02318719|451232173|FG003|Double-blind Phase|Withdrawal by Subject|10|||
125438289|NCT02318719|451232174|FG004|Double-blind Phase|Withdrawal by Subject|0|||
125438290|NCT02318719|451232170|FG000|Double-blind Phase|Other|1|||
125138288|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|moved|0|||
125138289|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|moved|0|||
125438291|NCT02318719|451232171|FG001|Double-blind Phase|Other|2|||
125438292|NCT02318719|451232172|FG002|Double-blind Phase|Other|0|||
125438293|NCT02318719|451232173|FG003|Double-blind Phase|Other|0|||
125438294|NCT02318719|451232174|FG004|Double-blind Phase|Other|0|||
125438295|NCT02318719|451232170|FG000|Open-label Extension Phase|Adverse Event|0|||
125438296|NCT02318719|451232171|FG001|Open-label Extension Phase|Adverse Event|0|||
125438297|NCT02318719|451232172|FG002|Open-label Extension Phase|Adverse Event|0|||
125438298|NCT02318719|451232173|FG003|Open-label Extension Phase|Adverse Event|0|||
125438299|NCT02318719|451232174|FG004|Open-label Extension Phase|Adverse Event|15|||
125438300|NCT02318719|451232170|FG000|Open-label Extension Phase|Death|0|||
125138290|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|moved|0|||
125138291|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|moved|0|||
125138292|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|moved|0|||
125138293|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138294|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138295|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138296|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
125138297|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125221013|NCT02106351|450436314|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
125221014|NCT02106351|450436315|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
125438301|NCT02318719|451232171|FG001|Open-label Extension Phase|Death|0|||
125438302|NCT02318719|451232172|FG002|Open-label Extension Phase|Death|0|||
125438303|NCT02318719|451232173|FG003|Open-label Extension Phase|Death|0|||
125438304|NCT02318719|451232174|FG004|Open-label Extension Phase|Death|1|||
125438305|NCT02318719|451232170|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
125438306|NCT02318719|451232171|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
125438307|NCT02318719|451232172|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
125438308|NCT02318719|451232173|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
125438309|NCT02318719|451232174|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
125438310|NCT02318719|451232170|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
125438311|NCT02318719|451232171|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
125438312|NCT02318719|451232172|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
125438313|NCT02318719|451232173|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
125438314|NCT02318719|451232174|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
125438315|NCT02318719|451232170|FG000|Open-label Extension Phase|Other|0|||
125438316|NCT02318719|451232171|FG001|Open-label Extension Phase|Other|0|||
125438317|NCT02318719|451232172|FG002|Open-label Extension Phase|Other|0|||
125438318|NCT02318719|451232173|FG003|Open-label Extension Phase|Other|0|||
125438319|NCT02318719|451232174|FG004|Open-label Extension Phase|Other|7|||
125438320|NCT01868035|451232175|FG000|Overall Study|Lost to Follow-up|3|||
125438321|NCT01868035|451232175|FG000|Overall Study|Withdrawal by Subject|1|||
125438322|NCT01868035|451232175|FG000|Overall Study|Progressive Disease|2|||
125438323|NCT01868035|451232175|FG000|Overall Study|Non-compliance|1|||
125438324|NCT00432835|451232176|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
125438325|NCT00432835|451232177|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
125438326|NCT05340751|451232180|FG000|Overall Study|Physician Decision|3|||
125438327|NCT04399551|451232181|FG000|Overall Study|Adverse Event|15|||
125438328|NCT04399551|451232181|FG000|Overall Study|Withdrawal by Subject|6|||
125438329|NCT04399551|451232181|FG000|Overall Study|Physician Decision|3|||
125438330|NCT04399551|451232181|FG000|Overall Study|Lost to Follow-up|2|||
125438331|NCT04399551|451232181|FG000|Overall Study|Protocol Deviation|2|||
125438332|NCT02961881|451232194|FG000|Overall Study|Adverse Event|1|||
125438333|NCT02961881|451232195|FG001|Overall Study|Adverse Event|2|||
125438334|NCT02961881|451232196|FG002|Overall Study|Adverse Event|2|||
125438335|NCT02961881|451232197|FG003|Overall Study|Adverse Event|0|||
125438336|NCT02961881|451232198|FG004|Overall Study|Adverse Event|1|||
125438337|NCT02961881|451232194|FG000|Overall Study|Participant request|0|||
125438338|NCT02961881|451232195|FG001|Overall Study|Participant request|2|||
125438339|NCT02961881|451232196|FG002|Overall Study|Participant request|0|||
125438340|NCT02961881|451232197|FG003|Overall Study|Participant request|0|||
125438341|NCT02961881|451232198|FG004|Overall Study|Participant request|0|||
125438342|NCT02961881|451232194|FG000|Overall Study|Disease progression|1|||
125438343|NCT02961881|451232195|FG001|Overall Study|Disease progression|0|||
125438344|NCT02961881|451232196|FG002|Overall Study|Disease progression|1|||
125438345|NCT02961881|451232197|FG003|Overall Study|Disease progression|0|||
125438346|NCT02961881|451232198|FG004|Overall Study|Disease progression|0|||
125438347|NCT01973491|451232199|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
125438348|NCT01973491|451232199|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
125438349|NCT01973491|451232199|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
125438350|NCT03154359|451232202|FG000|Overall Study|Adverse Event|1|||
125438351|NCT03154359|451232202|FG000|Overall Study|Lack of Efficacy|2|||
125438352|NCT03154359|451232202|FG000|Overall Study|Lost to Follow-up|3|||
125438353|NCT03154359|451232202|FG000|Overall Study|Physician Decision|3|||
125438354|NCT03154359|451232202|FG000|Overall Study|Protocol Violation|4|||
125438355|NCT03154359|451232202|FG000|Overall Study|Withdrawal by Subject|5|||
125438356|NCT03154359|451232202|FG000|Overall Study|Disruption of study due to COVID-19|4|||
125438357|NCT04250337|451232203|FG000|Overall Study|Adverse Event|0|||
125438358|NCT04250337|451232204|FG001|Overall Study|Adverse Event|3|||
125438359|NCT04250337|451232203|FG000|Overall Study|Lack of Efficacy|1|||
125438360|NCT04250337|451232204|FG001|Overall Study|Lack of Efficacy|3|||
125438361|NCT04250337|451232203|FG000|Overall Study|Physician Decision|1|||
125438362|NCT04250337|451232204|FG001|Overall Study|Physician Decision|0|||
125438363|NCT04250337|451232203|FG000|Overall Study|Protocol Deviation|2|||
125438364|NCT04250337|451232204|FG001|Overall Study|Protocol Deviation|2|||
125438365|NCT04250337|451232203|FG000|Overall Study|Withdrawal by Subject|4|||
125438366|NCT04250337|451232204|FG001|Overall Study|Withdrawal by Subject|3|||
125438367|NCT00152971|451232213|FG000|Overall Study|Adverse Event|12|||
125438368|NCT00152971|451232214|FG001|Overall Study|Adverse Event|10|||
125438369|NCT00152971|451232215|FG002|Overall Study|Adverse Event|9|||
125438370|NCT00152971|451232213|FG000|Overall Study|Protocol Violation|10|||
125438371|NCT00152971|451232214|FG001|Overall Study|Protocol Violation|11|||
125438372|NCT00152971|451232215|FG002|Overall Study|Protocol Violation|8|||
125438373|NCT00152971|451232213|FG000|Overall Study|Lost to Follow-up|17|||
125438374|NCT00152971|451232214|FG001|Overall Study|Lost to Follow-up|14|||
125438375|NCT00152971|451232215|FG002|Overall Study|Lost to Follow-up|13|||
125438376|NCT00152971|451232213|FG000|Overall Study|Withdrawal by Subject|9|||
125438377|NCT00152971|451232214|FG001|Overall Study|Withdrawal by Subject|8|||
125438378|NCT00152971|451232215|FG002|Overall Study|Withdrawal by Subject|14|||
125438379|NCT00152971|451232213|FG000|Overall Study|Other|3|||
125438380|NCT00152971|451232214|FG001|Overall Study|Other|5|||
125438381|NCT00152971|451232215|FG002|Overall Study|Other|5|||
125438382|NCT00152971|451232213|FG000|Treatment|Adverse Event|49|||
125438383|NCT00152971|451232214|FG001|Treatment|Adverse Event|40|||
125138298|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138299|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138300|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138301|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138302|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138303|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138304|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138305|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138306|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138307|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138308|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138309|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138310|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138311|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138312|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138313|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138314|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138315|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138316|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138317|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138318|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
125138319|NCT00112437|450131204|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138320|NCT00112437|450131205|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138321|NCT00112437|450131206|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138322|NCT00112437|450131207|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138323|NCT00112437|450131208|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
125138324|NCT00112437|450131209|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138325|NCT00112437|450131210|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138326|NCT00112437|450131211|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138327|NCT00112437|450131212|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138328|NCT00112437|450131213|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138329|NCT00112437|450131214|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138330|NCT00112437|450131215|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138331|NCT00112437|450131216|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138332|NCT00112437|450131217|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138333|NCT00112437|450131218|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138334|NCT00112437|450131219|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138335|NCT00112437|450131220|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138336|NCT00112437|450131221|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138337|NCT00112437|450131222|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138338|NCT00112437|450131223|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138339|NCT00112437|450131224|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125438384|NCT00152971|451232215|FG002|Treatment|Adverse Event|54|||
125438385|NCT00152971|451232213|FG000|Treatment|Protocol Violation|8|||
125438386|NCT00152971|451232214|FG001|Treatment|Protocol Violation|6|||
125438387|NCT00152971|451232215|FG002|Treatment|Protocol Violation|10|||
125438388|NCT00152971|451232213|FG000|Treatment|Lost to Follow-up|1|||
125438389|NCT00152971|451232214|FG001|Treatment|Lost to Follow-up|2|||
125438390|NCT00152971|451232215|FG002|Treatment|Lost to Follow-up|1|||
125438391|NCT00152971|451232213|FG000|Treatment|Withdrawal by Subject|4|||
125438392|NCT00152971|451232214|FG001|Treatment|Withdrawal by Subject|4|||
125438393|NCT00152971|451232215|FG002|Treatment|Withdrawal by Subject|5|||
125438394|NCT00152971|451232213|FG000|Treatment|Other|9|||
125138340|NCT00112437|450131225|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138341|NCT00112437|450131226|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138342|NCT00112437|450131227|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138343|NCT00112437|450131228|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138344|NCT00112437|450131229|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
125138345|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
125138346|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
125138347|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
125138348|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
125138349|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
125138350|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
125138351|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
125138352|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
125138353|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
125138354|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
125138355|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
125138356|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
125138357|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
125138358|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
125138359|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
125138360|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
125138361|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
125138362|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
125138363|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
125138364|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
125138365|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
125138366|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
125138367|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
125138368|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
125138369|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
125138370|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
125138371|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138372|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138373|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138374|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138375|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138376|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
125138377|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
125138378|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138379|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138380|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
125138381|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138382|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138383|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138384|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138385|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138386|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138387|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138388|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138389|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138390|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138391|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138392|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138393|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138394|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125438395|NCT00152971|451232214|FG001|Treatment|Other|11|||
125438396|NCT00152971|451232215|FG002|Treatment|Other|10|||
125138395|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125438397|NCT00366301|451232216|FG000|Overall Study|Lost to Follow-up|4|||
125438398|NCT00366301|451232217|FG001|Overall Study|Lost to Follow-up|4|||
125438399|NCT00366301|451232218|FG002|Overall Study|Lost to Follow-up|3|||
125438400|NCT00366301|451232219|FG003|Overall Study|Lost to Follow-up|7|||
125438401|NCT00366301|451232216|FG000|Overall Study|Withdrawal by Subject|4|||
125221015|NCT02106351|450436316|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
125221016|NCT02106351|450436314|FG000|Treatment Cycle 3|Other|0|||
125221017|NCT02106351|450436315|FG001|Treatment Cycle 3|Other|2|||
125221018|NCT02106351|450436316|FG002|Treatment Cycle 3|Other|3|||
125221019|NCT02106351|450436314|FG000|Treatment Cycle 4|Consent withdrawn|0|||
125221020|NCT02106351|450436315|FG001|Treatment Cycle 4|Consent withdrawn|0|||
125221021|NCT02106351|450436316|FG002|Treatment Cycle 4|Consent withdrawn|2|||
125221022|NCT02106351|450436314|FG000|Treatment Cycle 4|Other|0|||
125221023|NCT02106351|450436315|FG001|Treatment Cycle 4|Other|1|||
125221024|NCT02106351|450436316|FG002|Treatment Cycle 4|Other|0|||
125221025|NCT01931397|450436317|FG000|Overall Study|Physician Decision|2|||
125221026|NCT01931397|450436317|FG000|Overall Study|Withdrawal by Subject|8|||
125221027|NCT01931397|450436317|FG000|Overall Study|moved out of state|1|||
125221028|NCT00520039|450436318|FG000|Overall Study|Exclusion criteria met at first visit|7|||
125221029|NCT00520039|450436319|FG001|Overall Study|Exclusion criteria met at first visit|5|||
125221030|NCT05176717|450436321|FG000|Overall Study|Sponsor Decision|1|||
125221031|NCT05176717|450436322|FG001|Overall Study|Sponsor Decision|2|||
125221032|NCT05176717|450436323|FG002|Overall Study|Sponsor Decision|2|||
125221033|NCT03284853|450436324|FG000|Overall Study|Adverse Event|40|||
125221034|NCT03284853|450436325|FG001|Overall Study|Adverse Event|4|||
125221035|NCT03284853|450436324|FG000|Overall Study|Withdrawal by Subject|5|||
125221036|NCT03284853|450436325|FG001|Overall Study|Withdrawal by Subject|1|||
125221037|NCT03284853|450436324|FG000|Overall Study|Lost to Follow-up|1|||
125221038|NCT03284853|450436325|FG001|Overall Study|Lost to Follow-up|0|||
125221039|NCT03284853|450436324|FG000|Overall Study|Lack of Efficacy|1|||
125221040|NCT03284853|450436325|FG001|Overall Study|Lack of Efficacy|0|||
125221041|NCT03284853|450436324|FG000|Overall Study|Disallowed Concurrent Medication|1|||
125221042|NCT03284853|450436325|FG001|Overall Study|Disallowed Concurrent Medication|1|||
125221043|NCT03284853|450436324|FG000|Overall Study|Protocol Violation|3|||
125221044|NCT03284853|450436325|FG001|Overall Study|Protocol Violation|3|||
125221045|NCT03284853|450436324|FG000|Overall Study|Death|0|||
125221046|NCT03284853|450436325|FG001|Overall Study|Death|1|||
125221047|NCT03284853|450436324|FG000|Overall Study|Other - Reason not reported in CSR|4|||
125221048|NCT03284853|450436325|FG001|Overall Study|Other - Reason not reported in CSR|3|||
125221049|NCT00765817|450436327|FG000|Overall Study|Adverse Event|13|||
125221050|NCT00765817|450436328|FG001|Overall Study|Adverse Event|1|||
125221051|NCT00765817|450436327|FG000|Overall Study|Death|0|||
125221052|NCT00765817|450436328|FG001|Overall Study|Death|1|||
125221053|NCT00765817|450436327|FG000|Overall Study|Entry criteria not met|2|||
125221054|NCT00765817|450436328|FG001|Overall Study|Entry criteria not met|2|||
125221055|NCT00765817|450436327|FG000|Overall Study|Loss of glucose control|0|||
125221056|NCT00765817|450436328|FG001|Overall Study|Loss of glucose control|2|||
125221057|NCT00765817|450436327|FG000|Overall Study|Lost to Follow-up|1|||
125221058|NCT00765817|450436328|FG001|Overall Study|Lost to Follow-up|3|||
125221059|NCT00765817|450436327|FG000|Overall Study|Physician Decision|2|||
125221060|NCT00765817|450436328|FG001|Overall Study|Physician Decision|1|||
125221061|NCT00765817|450436327|FG000|Overall Study|Protocol Violation|1|||
125221062|NCT00765817|450436328|FG001|Overall Study|Protocol Violation|1|||
125221063|NCT00765817|450436327|FG000|Overall Study|Subject decision|7|||
125221064|NCT00765817|450436328|FG001|Overall Study|Subject decision|11|||
125221065|NCT00255164|450436331|FG000|Overall Study|Adverse Event|10|||
125221066|NCT00255164|450436332|FG001|Overall Study|Adverse Event|6|||
125221067|NCT00255164|450436333|FG002|Overall Study|Adverse Event|9|||
125221068|NCT00255164|450436331|FG000|Overall Study|Lost to Follow-up|4|||
125221069|NCT00255164|450436332|FG001|Overall Study|Lost to Follow-up|3|||
125221070|NCT00255164|450436333|FG002|Overall Study|Lost to Follow-up|4|||
125221071|NCT00255164|450436331|FG000|Overall Study|Withdrawal by Subject|18|||
125221072|NCT00255164|450436332|FG001|Overall Study|Withdrawal by Subject|17|||
125221073|NCT00255164|450436333|FG002|Overall Study|Withdrawal by Subject|8|||
125221074|NCT00255164|450436331|FG000|Overall Study|Noncompliance|0|||
125221075|NCT00255164|450436332|FG001|Overall Study|Noncompliance|1|||
125221076|NCT00255164|450436333|FG002|Overall Study|Noncompliance|2|||
125221077|NCT00255164|450436331|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
125221078|NCT00255164|450436332|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
125221079|NCT00255164|450436333|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
125221080|NCT00255164|450436331|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
125221081|NCT00255164|450436332|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
125221082|NCT00255164|450436333|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
125221083|NCT00255164|450436331|FG000|Overall Study|Possible Barrett's Esophagus|1|||
125221084|NCT00255164|450436332|FG001|Overall Study|Possible Barrett's Esophagus|3|||
125221085|NCT00255164|450436333|FG002|Overall Study|Possible Barrett's Esophagus|8|||
125221086|NCT00255164|450436331|FG000|Overall Study|Esophageal Stricture|0|||
125221087|NCT00255164|450436332|FG001|Overall Study|Esophageal Stricture|0|||
125221088|NCT00255164|450436333|FG002|Overall Study|Esophageal Stricture|1|||
125221089|NCT00255164|450436331|FG000|Overall Study|Therapeutic Failure|11|||
125221090|NCT00255164|450436332|FG001|Overall Study|Therapeutic Failure|2|||
125384758|NCT01955161|451042367|FG002|Overall Study|Other reason: insufficient compliance|1|||
125384759|NCT01955161|451042365|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
125221091|NCT00255164|450436333|FG002|Overall Study|Therapeutic Failure|3|||
125221092|NCT05219968|450436334|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
125221093|NCT05219968|450436335|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
125221094|NCT05219968|450436336|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
125221095|NCT05219968|450436337|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
125221096|NCT05219968|450436338|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
125221097|NCT05219968|450436334|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
125221098|NCT05219968|450436335|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
125221099|NCT05219968|450436336|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
125221100|NCT05219968|450436337|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
125221101|NCT05219968|450436338|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
125221102|NCT05219968|450436334|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
125221103|NCT05219968|450436335|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
125221104|NCT05219968|450436336|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
125221105|NCT05219968|450436337|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
125221106|NCT05219968|450436338|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
125221107|NCT05219968|450436334|FG000|Week 24 Treatment Period|Adverse Event|3|||
125221108|NCT05219968|450436335|FG001|Week 24 Treatment Period|Adverse Event|0|||
125221109|NCT05219968|450436336|FG002|Week 24 Treatment Period|Adverse Event|0|||
125221110|NCT05219968|450436337|FG003|Week 24 Treatment Period|Adverse Event|0|||
125221111|NCT05219968|450436338|FG004|Week 24 Treatment Period|Adverse Event|0|||
125221112|NCT05219968|450436334|FG000|Week 24 Treatment Period|Physician Decision|0|||
125221113|NCT05219968|450436335|FG001|Week 24 Treatment Period|Physician Decision|1|||
125221114|NCT05219968|450436336|FG002|Week 24 Treatment Period|Physician Decision|0|||
125221115|NCT05219968|450436337|FG003|Week 24 Treatment Period|Physician Decision|0|||
125221116|NCT05219968|450436338|FG004|Week 24 Treatment Period|Physician Decision|0|||
125221117|NCT05219968|450436334|FG000|Week 24 Treatment Period|Other, not specified|3|||
125221118|NCT05219968|450436335|FG001|Week 24 Treatment Period|Other, not specified|0|||
125221119|NCT05219968|450436336|FG002|Week 24 Treatment Period|Other, not specified|0|||
125221120|NCT05219968|450436337|FG003|Week 24 Treatment Period|Other, not specified|0|||
125221121|NCT05219968|450436338|FG004|Week 24 Treatment Period|Other, not specified|0|||
125221122|NCT05219968|450436334|FG000|Safety Extension Period|Treatment administration failure|0|||
125221123|NCT05219968|450436335|FG001|Safety Extension Period|Treatment administration failure|0|||
125221124|NCT05219968|450436336|FG002|Safety Extension Period|Treatment administration failure|0|||
125221125|NCT05219968|450436337|FG003|Safety Extension Period|Treatment administration failure|1|||
125221126|NCT05219968|450436338|FG004|Safety Extension Period|Treatment administration failure|4|||
125221127|NCT05219968|450436334|FG000|Safety Extension Period|Bilateral dislodgement|0|||
125221128|NCT05219968|450436335|FG001|Safety Extension Period|Bilateral dislodgement|0|||
125221129|NCT05219968|450436336|FG002|Safety Extension Period|Bilateral dislodgement|4|||
125221130|NCT05219968|450436337|FG003|Safety Extension Period|Bilateral dislodgement|0|||
125221131|NCT05219968|450436338|FG004|Safety Extension Period|Bilateral dislodgement|1|||
125221132|NCT05219968|450436334|FG000|Safety Extension Period|Withdrawal by Subject|0|||
125221133|NCT05219968|450436335|FG001|Safety Extension Period|Withdrawal by Subject|0|||
125221134|NCT05219968|450436336|FG002|Safety Extension Period|Withdrawal by Subject|2|||
125221135|NCT05219968|450436337|FG003|Safety Extension Period|Withdrawal by Subject|0|||
125221136|NCT05219968|450436338|FG004|Safety Extension Period|Withdrawal by Subject|4|||
125221137|NCT05219968|450436334|FG000|Safety Extension Period|Adverse Event|0|||
125221138|NCT05219968|450436335|FG001|Safety Extension Period|Adverse Event|0|||
125221139|NCT05219968|450436336|FG002|Safety Extension Period|Adverse Event|2|||
125221140|NCT05219968|450436337|FG003|Safety Extension Period|Adverse Event|1|||
125221141|NCT05219968|450436338|FG004|Safety Extension Period|Adverse Event|1|||
125221142|NCT05219968|450436334|FG000|Safety Extension Period|Lost to Follow-up|0|||
125221143|NCT05219968|450436335|FG001|Safety Extension Period|Lost to Follow-up|0|||
125221144|NCT05219968|450436336|FG002|Safety Extension Period|Lost to Follow-up|0|||
125221145|NCT05219968|450436337|FG003|Safety Extension Period|Lost to Follow-up|1|||
125221146|NCT05219968|450436338|FG004|Safety Extension Period|Lost to Follow-up|0|||
125221147|NCT04587336|450436339|FG000|Overall Study|Lost to Follow-up|1|||
125221148|NCT04587336|450436340|FG001|Overall Study|Lost to Follow-up|0|||
125221149|NCT03512353|450438264|FG000|Overall Study|Sponsor Decision|3|||
125221150|NCT03512353|450438264|FG000|Overall Study|Death|1|||
125221151|NCT01845597|450438265|FG000|Overall Study|Death|8|||
125221152|NCT01845597|450438265|FG000|Overall Study|Lost to Follow-up|22|||
125221153|NCT02581488|450438268|FG000|Overall Study|Adverse Event|6|||
125221154|NCT02581488|450438269|FG001|Overall Study|Adverse Event|7|||
125221155|NCT02581488|450438268|FG000|Overall Study|Lost to Follow-up|1|||
125221156|NCT02581488|450438269|FG001|Overall Study|Lost to Follow-up|0|||
125221157|NCT02581488|450438268|FG000|Overall Study|Withdrawal by Subject|1|||
125221158|NCT02581488|450438269|FG001|Overall Study|Withdrawal by Subject|0|||
125221159|NCT02581488|450438268|FG000|Overall Study|Non-Compliance|1|||
125221160|NCT02581488|450438269|FG001|Overall Study|Non-Compliance|0|||
125221161|NCT02581488|450438268|FG000|Overall Study|Protocol Violation|0|||
125221162|NCT02581488|450438269|FG001|Overall Study|Protocol Violation|4|||
125138396|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
125138397|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138398|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138399|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138400|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138401|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138402|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138403|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138404|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138405|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
125138406|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138407|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138408|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138409|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138410|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138411|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138412|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138413|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138414|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138415|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138416|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138417|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138418|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138419|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138420|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138421|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138422|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
125138423|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138424|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138425|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138426|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138427|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138428|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138429|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138430|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138431|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
125138432|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138433|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138434|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138435|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138436|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138437|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138438|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138439|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138440|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138441|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138442|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138443|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138444|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138445|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138446|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138447|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
125138448|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
125384760|NCT01955161|451042366|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
125138449|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138450|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138451|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138452|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138453|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125221163|NCT01877668|450438270|FG000|Overall Study|Death|0|||
125221164|NCT01877668|450438271|FG001|Overall Study|Death|0|||
125384761|NCT01955161|451042367|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
125384762|NCT01955161|451042365|FG000|Overall Study|Other reason: patient's will|0|||
125384763|NCT01955161|451042366|FG001|Overall Study|Other reason: patient's will|0|||
125384764|NCT01955161|451042367|FG002|Overall Study|Other reason: patient's will|1|||
125384765|NCT02784821|451042370|FG000|Overall Study|Death|0|||
125138454|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
125138455|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
125138456|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
125221165|NCT01877668|450438272|FG002|Overall Study|Death|0|||
125221166|NCT01877668|450438273|FG003|Overall Study|Death|1|||
125221167|NCT01877668|450438274|FG004|Overall Study|Death|0|||
125221168|NCT01877668|450438270|FG000|Overall Study|No longer met study criteria|1|||
125221169|NCT01877668|450438271|FG001|Overall Study|No longer met study criteria|0|||
125221170|NCT01877668|450438272|FG002|Overall Study|No longer met study criteria|1|||
125221171|NCT01877668|450438273|FG003|Overall Study|No longer met study criteria|0|||
125221172|NCT01877668|450438274|FG004|Overall Study|No longer met study criteria|0|||
125221173|NCT01877668|450438270|FG000|Overall Study|Insufficient clinical response|0|||
125221174|NCT01877668|450438271|FG001|Overall Study|Insufficient clinical response|1|||
125221175|NCT01877668|450438272|FG002|Overall Study|Insufficient clinical response|2|||
125221176|NCT01877668|450438273|FG003|Overall Study|Insufficient clinical response|2|||
125221177|NCT01877668|450438274|FG004|Overall Study|Insufficient clinical response|0|||
125221178|NCT01877668|450438270|FG000|Overall Study|Lost to Follow-up|0|||
125221179|NCT01877668|450438271|FG001|Overall Study|Lost to Follow-up|2|||
125221180|NCT01877668|450438272|FG002|Overall Study|Lost to Follow-up|1|||
125221181|NCT01877668|450438273|FG003|Overall Study|Lost to Follow-up|0|||
125221182|NCT01877668|450438274|FG004|Overall Study|Lost to Follow-up|0|||
125221183|NCT01877668|450438270|FG000|Overall Study|Withdrawal by Subject|2|||
125221184|NCT01877668|450438271|FG001|Overall Study|Withdrawal by Subject|0|||
125221185|NCT01877668|450438272|FG002|Overall Study|Withdrawal by Subject|3|||
125221186|NCT01877668|450438273|FG003|Overall Study|Withdrawal by Subject|2|||
125221187|NCT01877668|450438274|FG004|Overall Study|Withdrawal by Subject|2|||
125221188|NCT01877668|450438270|FG000|Overall Study|Other|1|||
125221189|NCT01877668|450438271|FG001|Overall Study|Other|1|||
125221190|NCT01877668|450438272|FG002|Overall Study|Other|1|||
125221191|NCT01877668|450438273|FG003|Overall Study|Other|1|||
125221192|NCT01877668|450438274|FG004|Overall Study|Other|3|||
125221193|NCT01877668|450438270|FG000|Overall Study|Protocol Violation|1|||
125221194|NCT01877668|450438271|FG001|Overall Study|Protocol Violation|1|||
125221195|NCT01877668|450438272|FG002|Overall Study|Protocol Violation|0|||
125221196|NCT01877668|450438273|FG003|Overall Study|Protocol Violation|0|||
125221197|NCT01877668|450438274|FG004|Overall Study|Protocol Violation|3|||
125221198|NCT01877668|450438270|FG000|Overall Study|Adverse event related to study drug|2|||
125221199|NCT01877668|450438271|FG001|Overall Study|Adverse event related to study drug|2|||
125221200|NCT01877668|450438272|FG002|Overall Study|Adverse event related to study drug|2|||
125221201|NCT01877668|450438273|FG003|Overall Study|Adverse event related to study drug|2|||
125221202|NCT01877668|450438274|FG004|Overall Study|Adverse event related to study drug|1|||
125221203|NCT01877668|450438270|FG000|Overall Study|Adverse event unrelated to study drug|4|||
125221204|NCT01877668|450438271|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125221205|NCT01877668|450438272|FG002|Overall Study|Adverse event unrelated to study drug|2|||
125221206|NCT01877668|450438273|FG003|Overall Study|Adverse event unrelated to study drug|0|||
125221207|NCT01877668|450438274|FG004|Overall Study|Adverse event unrelated to study drug|1|||
125221208|NCT01302418|450438275|FG000|Overall Study|Protocol Violation|9|||
125221209|NCT01302418|450438275|FG000|Overall Study|Non-evaluable|9|||
125221210|NCT00377637|450438277|FG000|Induction Phase|Adverse Event|12|||
125221211|NCT00377637|450438278|FG001|Induction Phase|Adverse Event|21|||
125221212|NCT00377637|450438279|FG002|Induction Phase|Adverse Event|0|||
125221213|NCT00377637|450438280|FG003|Induction Phase|Adverse Event|0|||
125221214|NCT00377637|450438277|FG000|Induction Phase|Deterioration/serum creatinine|2|||
125221215|NCT00377637|450438278|FG001|Induction Phase|Deterioration/serum creatinine|0|||
125221216|NCT00377637|450438279|FG002|Induction Phase|Deterioration/serum creatinine|0|||
125221217|NCT00377637|450438280|FG003|Induction Phase|Deterioration/serum creatinine|0|||
125221218|NCT00377637|450438277|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
125221219|NCT00377637|450438278|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
125221220|NCT00377637|450438279|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
125221221|NCT00377637|450438280|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
125221222|NCT00377637|450438277|FG000|Induction Phase|Lost to Follow-up|2|||
125221223|NCT00377637|450438278|FG001|Induction Phase|Lost to Follow-up|1|||
125221224|NCT00377637|450438279|FG002|Induction Phase|Lost to Follow-up|0|||
125221225|NCT00377637|450438280|FG003|Induction Phase|Lost to Follow-up|0|||
125221226|NCT00377637|450438277|FG000|Induction Phase|Death|1|||
125221227|NCT00377637|450438278|FG001|Induction Phase|Death|3|||
125221228|NCT00377637|450438279|FG002|Induction Phase|Death|0|||
125221229|NCT00377637|450438280|FG003|Induction Phase|Death|0|||
125221230|NCT00377637|450438277|FG000|Induction Phase|Withdrawal by Subject|5|||
125221231|NCT00377637|450438278|FG001|Induction Phase|Withdrawal by Subject|6|||
125221232|NCT00377637|450438279|FG002|Induction Phase|Withdrawal by Subject|0|||
125221233|NCT00377637|450438280|FG003|Induction Phase|Withdrawal by Subject|0|||
125221234|NCT00377637|450438277|FG000|Induction Phase|Physician Decision|3|||
125221235|NCT00377637|450438278|FG001|Induction Phase|Physician Decision|1|||
125221236|NCT00377637|450438279|FG002|Induction Phase|Physician Decision|0|||
125384766|NCT02784821|451042371|FG001|Overall Study|Death|5|||
125384767|NCT02784821|451042372|FG002|Overall Study|Death|4|||
125384768|NCT02784821|451042373|FG003|Overall Study|Death|5|||
125384769|NCT05333900|451042374|FG000|Overall Study|Protocol Violation|0|||
125384770|NCT05333900|451042375|FG001|Overall Study|Protocol Violation|1|||
125384771|NCT05333900|451042374|FG000|Overall Study|Withdrawal by Subject|0|||
125384772|NCT05333900|451042375|FG001|Overall Study|Withdrawal by Subject|1|||
125384773|NCT05333900|451042374|FG000|Overall Study|COVID-19 Pandemic|1|||
125384774|NCT05333900|451042375|FG001|Overall Study|COVID-19 Pandemic|1|||
125384775|NCT03724812|451042378|FG000|Overall Study|Missed Visit|1|||
125384776|NCT03724812|451042378|FG000|Overall Study|Death|2|||
125384777|NCT03724812|451042378|FG000|Overall Study|Withdrawal by Subject|1|||
125384778|NCT01851720|451042379|FG000|Overall Study|Lost to Follow-up|0|||
125384779|NCT01851720|451042380|FG001|Overall Study|Lost to Follow-up|1|||
125384780|NCT01394523|451042381|FG000|Overall Study|Unable to place block|1|||
125384781|NCT01394523|451042382|FG001|Overall Study|Unable to place block|0|||
125384782|NCT01394523|451042383|FG002|Overall Study|Unable to place block|0|||
125384783|NCT03525574|451042384|FG000|Overall Study|Adverse Event|15|||
125384784|NCT03525574|451042385|FG001|Overall Study|Adverse Event|0|||
125384785|NCT03525574|451042384|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
125384786|NCT03525574|451042385|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
125384787|NCT03525574|451042384|FG000|Overall Study|Lost to Follow-up|4|||
125384788|NCT03525574|451042385|FG001|Overall Study|Lost to Follow-up|0|||
125384789|NCT03525574|451042384|FG000|Overall Study|Commercial drug is Available for participant|48|||
125384790|NCT03525574|451042385|FG001|Overall Study|Commercial drug is Available for participant|0|||
125384791|NCT03525574|451042384|FG000|Overall Study|Death|1|||
125384792|NCT03525574|451042385|FG001|Overall Study|Death|0|||
125384793|NCT03525574|451042384|FG000|Overall Study|Other non-compliance|2|||
125384794|NCT03525574|451042385|FG001|Overall Study|Other non-compliance|0|||
125384795|NCT03525574|451042384|FG000|Overall Study|Physician Decision|6|||
125384796|NCT03525574|451042385|FG001|Overall Study|Physician Decision|0|||
125384797|NCT03525574|451042384|FG000|Overall Study|Other|58|||
125384798|NCT03525574|451042385|FG001|Overall Study|Other|0|||
125384799|NCT03525574|451042384|FG000|Overall Study|Enrolled but never dosed|1|||
125384800|NCT03525574|451042385|FG001|Overall Study|Enrolled but never dosed|0|||
125384801|NCT03525574|451042384|FG000|Overall Study|Not enrolled in 105 study|0|||
125384802|NCT03525574|451042385|FG001|Overall Study|Not enrolled in 105 study|3|||
125384803|NCT04741074|451042388|FG000|Overall Study|Withdrawal by Subject|1|||
125384804|NCT04741074|451042389|FG001|Overall Study|Withdrawal by Subject|1|||
125384805|NCT04741074|451042388|FG000|Overall Study|Study terminated prematurely|1|||
125384806|NCT04741074|451042389|FG001|Overall Study|Study terminated prematurely|0|||
125384807|NCT02432846|451042390|FG000|Overall Study (4 Arms/Strata)|Death|3|||
125384808|NCT02432846|451042391|FG001|Overall Study (4 Arms/Strata)|Death|2|||
125384809|NCT02432846|451042392|FG002|Overall Study (4 Arms/Strata)|Death|4|||
125384810|NCT02432846|451042393|FG003|Overall Study (4 Arms/Strata)|Death|3|||
125384811|NCT02432846|451042394|FG004|Overall Study (4 Arms/Strata)|Death|0|||
125384812|NCT02432846|451042395|FG005|Overall Study (4 Arms/Strata)|Death|0|||
125384813|NCT02432846|451042390|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
125384814|NCT02432846|451042391|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
125384815|NCT02432846|451042392|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
125384816|NCT02432846|451042393|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
125384817|NCT02432846|451042394|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
125384818|NCT02432846|451042395|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
125384819|NCT02432846|451042390|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
125384820|NCT02432846|451042391|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
125384821|NCT02432846|451042392|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
125384822|NCT02432846|451042393|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
125384823|NCT02432846|451042394|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
125384824|NCT02432846|451042395|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
125384825|NCT02432846|451042390|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
125384826|NCT02432846|451042391|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
125384827|NCT02432846|451042392|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
125384828|NCT02432846|451042393|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
125384829|NCT02432846|451042394|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
125384830|NCT02432846|451042395|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
125384831|NCT02432846|451042390|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
125138457|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
125138458|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
125138459|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138460|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138461|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138462|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138463|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138464|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138465|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138466|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138467|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138468|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138469|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138470|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138471|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138472|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138473|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138474|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
125138475|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138476|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138477|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138478|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138479|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138480|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138481|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138482|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138483|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138484|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
125138485|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138486|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138487|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138488|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138489|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138490|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138491|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138492|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138493|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138494|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138495|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138496|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138497|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138498|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138499|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138500|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
125138501|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138502|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138503|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138504|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138505|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138506|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138507|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138508|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138509|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138510|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
125138511|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138512|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138513|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138514|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138515|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138516|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138517|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138518|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138519|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138520|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138521|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138522|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138523|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138524|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138525|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138526|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
125138527|NCT00112437|450131204|FG000|Year 2 (12-Month Extension)|Moved|0|||
125138528|NCT00112437|450131205|FG001|Year 2 (12-Month Extension)|Moved|0|||
125138529|NCT00112437|450131206|FG002|Year 2 (12-Month Extension)|Moved|0|||
125138530|NCT00112437|450131207|FG003|Year 2 (12-Month Extension)|Moved|0|||
125138531|NCT00112437|450131208|FG004|Year 2 (12-Month Extension)|Moved|0|||
125138532|NCT00112437|450131209|FG005|Year 2 (12-Month Extension)|Moved|0|||
125138533|NCT00112437|450131210|FG006|Year 2 (12-Month Extension)|Moved|0|||
125138534|NCT00112437|450131211|FG007|Year 2 (12-Month Extension)|Moved|0|||
125138535|NCT00112437|450131212|FG008|Year 2 (12-Month Extension)|Moved|0|||
125138536|NCT00112437|450131213|FG009|Year 2 (12-Month Extension)|Moved|1|||
125138537|NCT00112437|450131214|FG010|Year 2 (12-Month Extension)|Moved|0|||
125138538|NCT00112437|450131215|FG011|Year 2 (12-Month Extension)|Moved|0|||
125138539|NCT00112437|450131216|FG012|Year 2 (12-Month Extension)|Moved|0|||
125138540|NCT00112437|450131217|FG013|Year 2 (12-Month Extension)|Moved|0|||
125138541|NCT00112437|450131218|FG014|Year 2 (12-Month Extension)|Moved|0|||
125138542|NCT00112437|450131219|FG015|Year 2 (12-Month Extension)|Moved|0|||
125138543|NCT00112437|450131220|FG016|Year 2 (12-Month Extension)|Moved|0|||
125138544|NCT00112437|450131221|FG017|Year 2 (12-Month Extension)|Moved|0|||
125138545|NCT00112437|450131222|FG018|Year 2 (12-Month Extension)|Moved|0|||
125138546|NCT00112437|450131223|FG019|Year 2 (12-Month Extension)|Moved|0|||
125138547|NCT00112437|450131224|FG020|Year 2 (12-Month Extension)|Moved|0|||
125138548|NCT00112437|450131225|FG021|Year 2 (12-Month Extension)|Moved|0|||
125138549|NCT00112437|450131226|FG022|Year 2 (12-Month Extension)|Moved|0|||
125138550|NCT00112437|450131227|FG023|Year 2 (12-Month Extension)|Moved|0|||
125138551|NCT00112437|450131228|FG024|Year 2 (12-Month Extension)|Moved|0|||
125138552|NCT00112437|450131229|FG025|Year 2 (12-Month Extension)|Moved|0|||
125138553|NCT00112437|450131204|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
125138554|NCT00112437|450131205|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
125138555|NCT00112437|450131206|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
125138556|NCT00112437|450131207|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
125138557|NCT00112437|450131208|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
125138558|NCT00112437|450131209|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
125138559|NCT00112437|450131210|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
125138560|NCT00112437|450131211|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
125138561|NCT00112437|450131212|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
125138562|NCT00112437|450131213|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
125138563|NCT00112437|450131214|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
125138564|NCT00112437|450131215|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
125138565|NCT00112437|450131216|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
125138566|NCT00112437|450131217|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
125138567|NCT00112437|450131218|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
125138568|NCT00112437|450131219|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
125138569|NCT00112437|450131220|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
125138570|NCT00112437|450131221|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
125138571|NCT00112437|450131222|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
125138572|NCT00112437|450131223|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
125138573|NCT00112437|450131224|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
125138574|NCT00112437|450131225|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
125138575|NCT00112437|450131226|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
125138576|NCT00112437|450131227|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
125138577|NCT00112437|450131228|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
125138578|NCT00112437|450131229|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
125138579|NCT00112437|450131204|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138580|NCT00112437|450131205|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138581|NCT00112437|450131206|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138582|NCT00112437|450131207|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138583|NCT00112437|450131208|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138584|NCT00112437|450131209|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138585|NCT00112437|450131210|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138586|NCT00112437|450131211|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138587|NCT00112437|450131212|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125384832|NCT02432846|451042391|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
125138588|NCT00112437|450131213|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138589|NCT00112437|450131214|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138590|NCT00112437|450131215|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
125138591|NCT00112437|450131216|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138592|NCT00112437|450131217|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
125138593|NCT00112437|450131218|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138594|NCT00112437|450131219|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
125138595|NCT00112437|450131220|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125221237|NCT00377637|450438280|FG003|Induction Phase|Physician Decision|0|||
125221238|NCT00377637|450438277|FG000|Induction Phase|Sponsor decision|1|||
125221239|NCT00377637|450438278|FG001|Induction Phase|Sponsor decision|2|||
125221240|NCT00377637|450438279|FG002|Induction Phase|Sponsor decision|0|||
125221241|NCT00377637|450438280|FG003|Induction Phase|Sponsor decision|0|||
125221242|NCT00377637|450438277|FG000|Induction Phase|Non-Compliance|1|||
125221243|NCT00377637|450438278|FG001|Induction Phase|Non-Compliance|0|||
125221244|NCT00377637|450438279|FG002|Induction Phase|Non-Compliance|0|||
125221245|NCT00377637|450438280|FG003|Induction Phase|Non-Compliance|0|||
125221246|NCT00377637|450438277|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
125221247|NCT00377637|450438278|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
125221248|NCT00377637|450438279|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
125221249|NCT00377637|450438280|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
125221250|NCT00377637|450438277|FG000|Maintenance Phase|Adverse Event|0|||
125221251|NCT00377637|450438278|FG001|Maintenance Phase|Adverse Event|0|||
125221252|NCT00377637|450438279|FG002|Maintenance Phase|Adverse Event|29|||
125221253|NCT00377637|450438280|FG003|Maintenance Phase|Adverse Event|43|||
125221254|NCT00377637|450438277|FG000|Maintenance Phase|Physician Decision|0|||
125221255|NCT00377637|450438278|FG001|Maintenance Phase|Physician Decision|0|||
125221256|NCT00377637|450438279|FG002|Maintenance Phase|Physician Decision|5|||
125221257|NCT00377637|450438280|FG003|Maintenance Phase|Physician Decision|4|||
125221258|NCT00377637|450438277|FG000|Maintenance Phase|Lost to Follow-up|0|||
125221259|NCT00377637|450438278|FG001|Maintenance Phase|Lost to Follow-up|0|||
125221260|NCT00377637|450438279|FG002|Maintenance Phase|Lost to Follow-up|3|||
125221261|NCT00377637|450438280|FG003|Maintenance Phase|Lost to Follow-up|1|||
125221262|NCT00377637|450438277|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125221263|NCT00377637|450438278|FG001|Maintenance Phase|Withdrawal by Subject|0|||
125221264|NCT00377637|450438279|FG002|Maintenance Phase|Withdrawal by Subject|3|||
125221265|NCT00377637|450438280|FG003|Maintenance Phase|Withdrawal by Subject|3|||
125221266|NCT00377637|450438277|FG000|Maintenance Phase|Sponsor decision|0|||
125221267|NCT00377637|450438278|FG001|Maintenance Phase|Sponsor decision|0|||
125221268|NCT00377637|450438279|FG002|Maintenance Phase|Sponsor decision|2|||
125221269|NCT00377637|450438280|FG003|Maintenance Phase|Sponsor decision|3|||
125221270|NCT00377637|450438277|FG000|Maintenance Phase|Non-compliance|0|||
125221271|NCT00377637|450438278|FG001|Maintenance Phase|Non-compliance|0|||
125221272|NCT00377637|450438279|FG002|Maintenance Phase|Non-compliance|1|||
125221273|NCT00377637|450438280|FG003|Maintenance Phase|Non-compliance|1|||
125221274|NCT00377637|450438277|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
125221275|NCT00377637|450438278|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
125221276|NCT00377637|450438279|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
125221277|NCT00377637|450438280|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
125221278|NCT00377637|450438277|FG000|Maintenance Phase|Death|0|||
125221279|NCT00377637|450438278|FG001|Maintenance Phase|Death|0|||
125221280|NCT00377637|450438279|FG002|Maintenance Phase|Death|0|||
125221281|NCT00377637|450438280|FG003|Maintenance Phase|Death|1|||
125221282|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
125221283|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
125221284|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
125221285|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
125221286|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
125221287|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
125221288|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
125221289|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
125221290|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
125221291|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
125221292|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
125221293|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
125221294|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
125221295|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
125221296|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
125221297|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
125221298|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
125221299|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
125221300|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
125221301|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
125221302|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
125221303|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
125221304|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
125221305|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
125221306|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
125221307|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
125221308|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
125221309|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
125221310|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
125221311|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
125221312|NCT01111565|450438282|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
125221313|NCT01111565|450438283|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
125221314|NCT01111565|450438284|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
125221315|NCT01111565|450438285|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
125221316|NCT01111565|450438286|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
125221317|NCT01111565|450438282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125221318|NCT01111565|450438283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125221319|NCT01111565|450438284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125221320|NCT01111565|450438285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
125221321|NCT01111565|450438286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
125221322|NCT01111565|450438282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125221323|NCT01111565|450438283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125221324|NCT01111565|450438284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
125221325|NCT01111565|450438285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125221326|NCT01111565|450438286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125221327|NCT01111565|450438282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
125221328|NCT01111565|450438283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
125221329|NCT01111565|450438284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
125221330|NCT01111565|450438285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
125221331|NCT01111565|450438286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
125221332|NCT01111565|450438282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
125221333|NCT01111565|450438283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
125221334|NCT01111565|450438284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
125221335|NCT01111565|450438285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
125221336|NCT01111565|450438286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
125221337|NCT01111565|450438282|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
125221338|NCT01111565|450438283|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
125221339|NCT01111565|450438284|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
125221340|NCT01111565|450438285|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
125221341|NCT01111565|450438286|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
125221342|NCT00368108|450438287|FG000|Overall Study|Adverse Event|38|||
125221343|NCT00368108|450438288|FG001|Overall Study|Adverse Event|26|||
125221344|NCT00368108|450438289|FG002|Overall Study|Adverse Event|44|||
125221345|NCT00368108|450438287|FG000|Overall Study|Abnormal Laboratory Value|0|||
125221346|NCT00368108|450438288|FG001|Overall Study|Abnormal Laboratory Value|0|||
125221347|NCT00368108|450438289|FG002|Overall Study|Abnormal Laboratory Value|3|||
125221348|NCT00368108|450438287|FG000|Overall Study|Protocol Violation|5|||
125221349|NCT00368108|450438288|FG001|Overall Study|Protocol Violation|9|||
125221350|NCT00368108|450438289|FG002|Overall Study|Protocol Violation|9|||
125221351|NCT00368108|450438287|FG000|Overall Study|Withdrawal by Subject|9|||
125221352|NCT00368108|450438288|FG001|Overall Study|Withdrawal by Subject|3|||
125221353|NCT00368108|450438289|FG002|Overall Study|Withdrawal by Subject|5|||
125221354|NCT00368108|450438287|FG000|Overall Study|Lack of Efficacy|7|||
125221355|NCT00368108|450438288|FG001|Overall Study|Lack of Efficacy|8|||
125221356|NCT00368108|450438289|FG002|Overall Study|Lack of Efficacy|5|||
125221357|NCT00368108|450438287|FG000|Overall Study|Physician Decision|2|||
125221358|NCT00368108|450438288|FG001|Overall Study|Physician Decision|0|||
125221359|NCT00368108|450438289|FG002|Overall Study|Physician Decision|1|||
125221360|NCT00368108|450438287|FG000|Overall Study|Other|3|||
125438402|NCT00366301|451232217|FG001|Overall Study|Withdrawal by Subject|2|||
125138596|NCT00112437|450131221|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125221361|NCT00368108|450438288|FG001|Overall Study|Other|7|||
125138597|NCT00112437|450131222|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
125138598|NCT00112437|450131223|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138599|NCT00112437|450131224|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125221362|NCT00368108|450438289|FG002|Overall Study|Other|1|||
125221363|NCT01089127|450438312|FG000|Overall Study|Adverse Event|5|||
125221364|NCT01089127|450438313|FG001|Overall Study|Adverse Event|1|||
125221365|NCT01089127|450438314|FG002|Overall Study|Adverse Event|1|||
125221366|NCT01089127|450438315|FG003|Overall Study|Adverse Event|0|||
125221367|NCT01089127|450438316|FG004|Overall Study|Adverse Event|0|||
125221368|NCT01089127|450438317|FG005|Overall Study|Adverse Event|1|||
125221369|NCT01089127|450438312|FG000|Overall Study|Subject withdrew consent|0|||
125221370|NCT01089127|450438313|FG001|Overall Study|Subject withdrew consent|1|||
125221371|NCT01089127|450438314|FG002|Overall Study|Subject withdrew consent|1|||
125221372|NCT01089127|450438315|FG003|Overall Study|Subject withdrew consent|1|||
125221373|NCT01089127|450438316|FG004|Overall Study|Subject withdrew consent|0|||
125221374|NCT01089127|450438317|FG005|Overall Study|Subject withdrew consent|2|||
125221375|NCT01089127|450438312|FG000|Overall Study|Abnormal test procedure result(s)|2|||
125221376|NCT01089127|450438313|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125221377|NCT01089127|450438314|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125221378|NCT01089127|450438315|FG003|Overall Study|Abnormal test procedure result(s)|0|||
125221379|NCT01089127|450438316|FG004|Overall Study|Abnormal test procedure result(s)|0|||
125221380|NCT01089127|450438317|FG005|Overall Study|Abnormal test procedure result(s)|0|||
125221381|NCT01089127|450438312|FG000|Overall Study|Lost to Follow-up|1|||
125221382|NCT01089127|450438313|FG001|Overall Study|Lost to Follow-up|1|||
125221383|NCT01089127|450438314|FG002|Overall Study|Lost to Follow-up|0|||
125221384|NCT01089127|450438315|FG003|Overall Study|Lost to Follow-up|0|||
125221385|NCT01089127|450438316|FG004|Overall Study|Lost to Follow-up|1|||
125221386|NCT01089127|450438317|FG005|Overall Study|Lost to Follow-up|0|||
125138600|NCT00112437|450131225|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138601|NCT00112437|450131226|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138602|NCT00112437|450131227|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138603|NCT00112437|450131228|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138604|NCT00112437|450131229|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
125138605|NCT00112437|450131204|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138606|NCT00112437|450131205|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138607|NCT00112437|450131206|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138608|NCT00112437|450131207|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138609|NCT00112437|450131208|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138610|NCT00112437|450131209|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125221387|NCT01089127|450438312|FG000|Overall Study|Protocol deviation|0|||
125221388|NCT01089127|450438313|FG001|Overall Study|Protocol deviation|1|||
125221389|NCT01089127|450438314|FG002|Overall Study|Protocol deviation|0|||
125221390|NCT01089127|450438315|FG003|Overall Study|Protocol deviation|0|||
125221391|NCT01089127|450438316|FG004|Overall Study|Protocol deviation|1|||
125221392|NCT01089127|450438317|FG005|Overall Study|Protocol deviation|0|||
125221393|NCT03200548|450438318|FG000|Overall Study|Withdrawal by Subject|5|||
125221394|NCT03200548|450438319|FG001|Overall Study|Withdrawal by Subject|11|||
125221395|NCT03200548|450438320|FG002|Overall Study|Withdrawal by Subject|7|||
125221396|NCT03200548|450438321|FG003|Overall Study|Withdrawal by Subject|6|||
125221397|NCT03257436|450438324|FG000|Overall Study|Withdrawal by Subject|76|||
125221398|NCT03257436|450438324|FG000|Overall Study|Death|19|||
125221399|NCT03874013|450438333|FG000|Overall Study|Adverse Event|0|||
125221400|NCT03874013|450438334|FG001|Overall Study|Adverse Event|1|||
125221401|NCT06060496|450438337|FG000|Overall Study|Withdrawal by Subject|2|||
125221402|NCT06060496|450438337|FG000|Overall Study|Lost to Follow-up|2|||
125221403|NCT03990051|450438338|FG000|Masked Period|Lost to Follow-up|1|||
125221404|NCT03990051|450438339|FG001|Masked Period|Lost to Follow-up|0|||
125221405|NCT03990051|450438338|FG000|Long Term Period|Death|1|||
125221406|NCT03990051|450438339|FG001|Long Term Period|Death|1|||
125221407|NCT03990051|450438338|FG000|Long Term Period|Lost to Follow-up|7|||
125221408|NCT03990051|450438339|FG001|Long Term Period|Lost to Follow-up|2|||
125221409|NCT01411852|450438340|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
125221410|NCT01411852|450438341|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
125221411|NCT01411852|450438340|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
125221412|NCT01411852|450438341|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
125221413|NCT01411852|450438340|FG000|Prehospital Intervention Phase|Found to be under age|0|||
125221414|NCT01411852|450438341|FG001|Prehospital Intervention Phase|Found to be under age|1|||
125221415|NCT01411852|450438340|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
125221416|NCT01411852|450438341|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
125221417|NCT01411852|450438340|FG000|Hospital Intervention Phase|Severe head injury|5|||
125221418|NCT01411852|450438341|FG001|Hospital Intervention Phase|Severe head injury|4|||
125221419|NCT01411852|450438340|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
125221420|NCT01411852|450438341|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
125221421|NCT01411852|450438340|FG000|Hospital Intervention Phase|Miscommunication error|1|||
125221422|NCT01411852|450438341|FG001|Hospital Intervention Phase|Miscommunication error|2|||
125221423|NCT01411852|450438340|FG000|Hospital Intervention Phase|CPR administered|3|||
125221424|NCT01411852|450438341|FG001|Hospital Intervention Phase|CPR administered|1|||
125221425|NCT01411852|450438340|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
125221426|NCT01411852|450438341|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
125221427|NCT01411852|450438340|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
125221428|NCT01411852|450438341|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
125221429|NCT01411852|450438340|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
125221430|NCT01411852|450438341|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
125221431|NCT01411852|450438340|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
125221432|NCT01411852|450438341|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
125221433|NCT01411852|450438340|FG000|Hospital Intervention Phase|Other ineligible|2|||
125221434|NCT01411852|450438341|FG001|Hospital Intervention Phase|Other ineligible|2|||
125221435|NCT01411852|450438340|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
125221436|NCT01411852|450438341|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
125221437|NCT01411852|450438340|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
125221438|NCT01411852|450438341|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
125221439|NCT01411852|450438340|FG000|Hospital Intervention Phase|Vascular access failed|1|||
125221440|NCT01411852|450438341|FG001|Hospital Intervention Phase|Vascular access failed|0|||
125221441|NCT03126786|450438346|FG000|Overall Study|Adverse Event|3|||
125221442|NCT03126786|450438347|FG001|Overall Study|Adverse Event|0|||
125221443|NCT03126786|450438346|FG000|Overall Study|Lost to Follow-up|0|||
125221444|NCT03126786|450438347|FG001|Overall Study|Lost to Follow-up|1|||
125221445|NCT03126786|450438346|FG000|Overall Study|Withdrawal by Subject|3|||
125221446|NCT03126786|450438347|FG001|Overall Study|Withdrawal by Subject|1|||
125221447|NCT00991289|450438348|FG000|Overall Study|Adverse Event|1|||
125221448|NCT00991289|450438348|FG000|Overall Study|Physician Decision|2|||
125221449|NCT00991289|450438348|FG000|Overall Study|Withdrawal by Subject|3|||
125221450|NCT00991289|450438348|FG000|Overall Study|Lost to Follow-up|4|||
125221451|NCT00991289|450438348|FG000|Overall Study|Protocol Violation|2|||
125221452|NCT00379899|450438349|FG000|Overall Study|Adverse Event|7|||
125221453|NCT00379899|450438350|FG001|Overall Study|Adverse Event|3|||
125221454|NCT00379899|450438349|FG000|Overall Study|Death|10|||
125221455|NCT00379899|450438350|FG001|Overall Study|Death|10|||
125221456|NCT00379899|450438349|FG000|Overall Study|Lost to Follow-up|2|||
125221457|NCT00379899|450438350|FG001|Overall Study|Lost to Follow-up|4|||
125221458|NCT00379899|450438349|FG000|Overall Study|Physician Decision|3|||
125221459|NCT00379899|450438350|FG001|Overall Study|Physician Decision|4|||
125221460|NCT00379899|450438349|FG000|Overall Study|Withdrawal by Subject|5|||
125221461|NCT00379899|450438350|FG001|Overall Study|Withdrawal by Subject|5|||
125384833|NCT02432846|451042392|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
125384834|NCT02432846|451042393|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
125384835|NCT02432846|451042394|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
125384836|NCT02432846|451042395|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
125384837|NCT02432846|451042390|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
125384838|NCT02432846|451042391|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
125384839|NCT02432846|451042392|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
125384840|NCT02432846|451042393|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
125384841|NCT02432846|451042394|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
125384842|NCT02432846|451042395|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
125384843|NCT02432846|451042390|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
125384844|NCT02432846|451042391|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
125384845|NCT02432846|451042392|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
125384846|NCT02432846|451042393|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
125384847|NCT02432846|451042394|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
125384848|NCT02432846|451042395|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
125384849|NCT02432846|451042390|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
125384850|NCT02432846|451042391|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
125384851|NCT02432846|451042392|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
125384852|NCT02432846|451042393|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
125384853|NCT02432846|451042394|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
125384854|NCT02432846|451042395|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
125384855|NCT02432846|451042390|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
125384856|NCT02432846|451042391|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
125384857|NCT02432846|451042392|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
125384858|NCT02432846|451042393|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
125384859|NCT02432846|451042394|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
125384860|NCT02432846|451042395|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
125384861|NCT02432846|451042390|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
125384862|NCT02432846|451042391|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
125384863|NCT02432846|451042392|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
125384864|NCT02432846|451042393|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
125384865|NCT02432846|451042394|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
125384866|NCT02432846|451042395|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
125384867|NCT02432846|451042390|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
125384868|NCT02432846|451042391|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
125384869|NCT02432846|451042392|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
125384870|NCT02432846|451042393|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
125384871|NCT02432846|451042394|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
125221462|NCT00379899|450438349|FG000|Overall Study|Ineligibility determined|0|||
125221463|NCT00379899|450438350|FG001|Overall Study|Ineligibility determined|1|||
125384872|NCT02432846|451042395|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
125384873|NCT02432846|451042390|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
125384874|NCT02432846|451042391|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
125384875|NCT02432846|451042392|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
125221464|NCT00379899|450438349|FG000|Overall Study|Noncompliance|1|||
125221465|NCT00379899|450438350|FG001|Overall Study|Noncompliance|1|||
125221466|NCT00379899|450438349|FG000|Overall Study|Parathyroidectomy|0|||
125384876|NCT02432846|451042393|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
125384877|NCT02432846|451042394|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
125384878|NCT02432846|451042395|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
125384879|NCT02432846|451042390|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
125384880|NCT02432846|451042391|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
125384881|NCT02432846|451042392|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
125384882|NCT02432846|451042393|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
125384883|NCT02432846|451042394|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
125384884|NCT02432846|451042395|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
125384885|NCT02432846|451042390|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
125384886|NCT02432846|451042391|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
125384887|NCT02432846|451042392|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
125384888|NCT02432846|451042393|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
125384889|NCT02432846|451042394|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
125384890|NCT02432846|451042395|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
125384891|NCT01770379|451042396|FG000|Overall Study|Technical issues|1|||
125384892|NCT01770379|451042397|FG001|Overall Study|Technical issues|0|||
125384893|NCT01770379|451042398|FG002|Overall Study|Technical issues|0|||
125384894|NCT01770379|451042396|FG000|Overall Study|Withdrawal by Subject|7|||
125384895|NCT01770379|451042397|FG001|Overall Study|Withdrawal by Subject|10|||
125384896|NCT01770379|451042398|FG002|Overall Study|Withdrawal by Subject|7|||
125384897|NCT01770379|451042396|FG000|Overall Study|study terminated by sponsor|22|||
125384898|NCT01770379|451042397|FG001|Overall Study|study terminated by sponsor|23|||
125384899|NCT01770379|451042398|FG002|Overall Study|study terminated by sponsor|22|||
125384900|NCT01770379|451042396|FG000|Overall Study|Protocol Violation|0|||
125384901|NCT01770379|451042397|FG001|Overall Study|Protocol Violation|1|||
125384902|NCT01770379|451042398|FG002|Overall Study|Protocol Violation|1|||
125384903|NCT01770379|451042396|FG000|Overall Study|Physician Decision|0|||
125384904|NCT01770379|451042397|FG001|Overall Study|Physician Decision|1|||
125384905|NCT01770379|451042398|FG002|Overall Study|Physician Decision|2|||
125384906|NCT01770379|451042396|FG000|Overall Study|Lost to Follow-up|0|||
125384907|NCT01770379|451042397|FG001|Overall Study|Lost to Follow-up|0|||
125384908|NCT01770379|451042398|FG002|Overall Study|Lost to Follow-up|2|||
125384909|NCT01770379|451042396|FG000|Overall Study|Lack of Efficacy|8|||
125384910|NCT01770379|451042397|FG001|Overall Study|Lack of Efficacy|6|||
125384911|NCT01770379|451042398|FG002|Overall Study|Lack of Efficacy|6|||
125384912|NCT01770379|451042396|FG000|Overall Study|Adverse Event|1|||
125384913|NCT01770379|451042397|FG001|Overall Study|Adverse Event|3|||
125384914|NCT01770379|451042398|FG002|Overall Study|Adverse Event|2|||
125384915|NCT03045887|451042399|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
125384916|NCT03045887|451042400|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125384917|NCT03045887|451042401|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125384918|NCT03045887|451042402|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125384919|NCT03045887|451042403|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125384920|NCT03045887|451042404|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125384921|NCT03045887|451042405|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125384922|NCT03045887|451042406|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125384923|NCT03045887|451042407|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125384924|NCT03045887|451042408|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
125384925|NCT03045887|451042399|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125384926|NCT03045887|451042400|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125384927|NCT03045887|451042401|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125384928|NCT03045887|451042402|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
125384929|NCT03045887|451042403|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125384930|NCT03045887|451042404|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125384931|NCT03045887|451042405|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125384932|NCT03045887|451042406|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125384933|NCT03045887|451042407|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125384934|NCT03045887|451042408|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
125384935|NCT03045887|451042399|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
125384936|NCT03045887|451042400|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
125384937|NCT03045887|451042401|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
125384938|NCT03045887|451042402|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
125384939|NCT03045887|451042403|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
125384940|NCT03045887|451042404|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
125384941|NCT03045887|451042405|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
125384942|NCT03045887|451042406|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
125384943|NCT03045887|451042407|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
125384944|NCT03045887|451042408|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
125384945|NCT03045887|451042399|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125138611|NCT00112437|450131210|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138612|NCT00112437|450131211|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138613|NCT00112437|450131212|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138614|NCT00112437|450131213|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138615|NCT00112437|450131214|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138616|NCT00112437|450131215|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138617|NCT00112437|450131216|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138618|NCT00112437|450131217|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138619|NCT00112437|450131218|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138620|NCT00112437|450131219|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
125138621|NCT00112437|450131220|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138622|NCT00112437|450131221|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138623|NCT00112437|450131222|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138624|NCT00112437|450131223|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138625|NCT00112437|450131224|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138626|NCT00112437|450131225|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138627|NCT00112437|450131226|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138628|NCT00112437|450131227|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138629|NCT00112437|450131228|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125384946|NCT03045887|451042400|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125384947|NCT03045887|451042401|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
125384948|NCT03045887|451042402|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
125384949|NCT03045887|451042403|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125384950|NCT03045887|451042404|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125384951|NCT03045887|451042405|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125384952|NCT03045887|451042406|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125384953|NCT03045887|451042407|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125384954|NCT03045887|451042408|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
125384955|NCT03045887|451042399|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125384956|NCT03045887|451042400|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125384957|NCT03045887|451042401|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125384958|NCT03045887|451042402|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
125384959|NCT03045887|451042403|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125384960|NCT03045887|451042404|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125384961|NCT03045887|451042405|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125384962|NCT03045887|451042406|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125384963|NCT03045887|451042407|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125384964|NCT03045887|451042408|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
125384965|NCT01912287|451042410|FG000|Overall Study|Ineligible|1|||
125384966|NCT01912287|451042411|FG001|Overall Study|Ineligible|0|||
125384967|NCT01912287|451042412|FG002|Overall Study|Ineligible|1|||
125384968|NCT01912287|451042410|FG000|Overall Study|No-show|0|||
125384969|NCT01912287|451042411|FG001|Overall Study|No-show|0|||
125384970|NCT01912287|451042412|FG002|Overall Study|No-show|1|||
125384971|NCT01912287|451042410|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
125384972|NCT01912287|451042411|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
125384973|NCT01912287|451042412|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
125384974|NCT01912287|451042410|FG000|Overall Study|Felt treatment no longer needed|0|||
125384975|NCT01912287|451042411|FG001|Overall Study|Felt treatment no longer needed|1|||
125384976|NCT01912287|451042412|FG002|Overall Study|Felt treatment no longer needed|0|||
125384977|NCT01912287|451042410|FG000|Overall Study|Life circumstances|4|||
125138630|NCT00112437|450131229|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
125138631|NCT00112437|450131204|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138632|NCT00112437|450131205|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138633|NCT00112437|450131206|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
125384978|NCT01912287|451042411|FG001|Overall Study|Life circumstances|2|||
125384979|NCT01912287|451042412|FG002|Overall Study|Life circumstances|0|||
125384980|NCT01912287|451042410|FG000|Overall Study|Lost Interest|1|||
125221467|NCT00379899|450438350|FG001|Overall Study|Parathyroidectomy|2|||
125221468|NCT00379899|450438349|FG000|Overall Study|Renal transplantation|5|||
125221469|NCT00379899|450438350|FG001|Overall Study|Renal transplantation|4|||
125221470|NCT00379899|450438349|FG000|Overall Study|Coronary artery bypass graft|1|||
125221471|NCT00379899|450438350|FG001|Overall Study|Coronary artery bypass graft|1|||
125221472|NCT00379899|450438349|FG000|Overall Study|Other protocol-specified criteria|3|||
125221473|NCT00379899|450438350|FG001|Overall Study|Other protocol-specified criteria|4|||
125221474|NCT00379899|450438349|FG000|Overall Study|Other|3|||
125221475|NCT00379899|450438350|FG001|Overall Study|Other|1|||
125221476|NCT02716779|450438353|FG000|Monotherapy|Adverse Event|0|||
125221477|NCT02716779|450438354|FG001|Monotherapy|Adverse Event|1|||
125221478|NCT02716779|450438355|FG002|Monotherapy|Adverse Event|1|||
125221479|NCT02716779|450438353|FG000|Combination Therapy|Adverse Event|0|||
125221480|NCT02716779|450438354|FG001|Combination Therapy|Adverse Event|2|||
125221481|NCT02716779|450438355|FG002|Combination Therapy|Adverse Event|1|||
125221482|NCT01051817|450438363|FG000|Overall Study|Adverse Event|0|||
125221483|NCT01051817|450438364|FG001|Overall Study|Adverse Event|2|||
125221484|NCT01051817|450438363|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
125221485|NCT01051817|450438364|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
125221486|NCT01051817|450438363|FG000|Overall Study|Withdrawal by Subject|3|||
125221487|NCT01051817|450438364|FG001|Overall Study|Withdrawal by Subject|5|||
125221488|NCT01051817|450438363|FG000|Overall Study|Protocol Violation|0|||
125221489|NCT01051817|450438364|FG001|Overall Study|Protocol Violation|1|||
125221490|NCT01026948|450438365|FG000|Overall Study|Physician Decision|8|||
125221491|NCT00672633|450438367|FG000|Overall Study|Withdrawal by Subject|0|||
125221492|NCT00672633|450438368|FG001|Overall Study|Withdrawal by Subject|1|||
125221493|NCT02824627|450438369|FG000|Overall Study|Adverse Event|1|||
125221494|NCT02824627|450438370|FG001|Overall Study|Adverse Event|2|||
125221495|NCT02824627|450438369|FG000|Overall Study|Lost to Follow-up|2|||
125221496|NCT02824627|450438370|FG001|Overall Study|Lost to Follow-up|1|||
125221497|NCT00571662|450438380|FG000|Overall Study|Withdrawal by Subject|2|||
125221498|NCT00571662|450438380|FG000|Overall Study|psychiatric instability|1|||
125221499|NCT00571662|450438380|FG000|Overall Study|Adverse Event|5|||
125221500|NCT01839916|450438381|FG000|Overall Study|Death|9|||
125221501|NCT01839916|450438381|FG000|Overall Study|Physician Decision|17|||
125221502|NCT01839916|450438381|FG000|Overall Study|Relapse|12|||
125221503|NCT01839916|450438381|FG000|Overall Study|GVHD|2|||
125221504|NCT01839916|450438381|FG000|Overall Study|Graft Failure|1|||
125221505|NCT04235504|450438384|FG000|Study Phase|Withdrawal by Subject|5|||
125221506|NCT04235504|450438385|FG001|Study Phase|Withdrawal by Subject|2|||
125221507|NCT04235504|450438386|FG002|Study Phase|Withdrawal by Subject|0|||
125221508|NCT04235504|450438387|FG003|Study Phase|Withdrawal by Subject|0|||
125221509|NCT04235504|450438384|FG000|Continuation Phase|Withdrawal by Subject|0|||
125221510|NCT04235504|450438385|FG001|Continuation Phase|Withdrawal by Subject|4|||
125221511|NCT04235504|450438386|FG002|Continuation Phase|Withdrawal by Subject|0|||
125221512|NCT04235504|450438387|FG003|Continuation Phase|Withdrawal by Subject|0|||
125221513|NCT04235504|450438384|FG000|Continuation Phase|Adverse Event|0|||
125221514|NCT04235504|450438385|FG001|Continuation Phase|Adverse Event|1|||
125221515|NCT04235504|450438386|FG002|Continuation Phase|Adverse Event|0|||
125221516|NCT04235504|450438387|FG003|Continuation Phase|Adverse Event|0|||
125221517|NCT04235504|450438384|FG000|Continuation Phase|Physician Decision|1|||
125221518|NCT04235504|450438385|FG001|Continuation Phase|Physician Decision|2|||
125221519|NCT04235504|450438386|FG002|Continuation Phase|Physician Decision|1|||
125221520|NCT04235504|450438387|FG003|Continuation Phase|Physician Decision|0|||
125221521|NCT00181883|450438388|FG000|Overall Study|Lack of Efficacy|2|||
125221522|NCT00181883|450438388|FG000|Overall Study|Treatment Limiting AEs|3|||
125221523|NCT00181883|450438388|FG000|Overall Study|Withdrawal by Subject|4|||
125221524|NCT00181883|450438388|FG000|Overall Study|Lost to Follow-up|1|||
125221525|NCT00101868|450438389|FG000|Overall Study|Death|10|||
125221526|NCT00101868|450438390|FG001|Overall Study|Death|10|||
125221527|NCT00101868|450438389|FG000|Overall Study|Withdrawal by Subject|8|||
125221528|NCT00101868|450438390|FG001|Overall Study|Withdrawal by Subject|9|||
125221529|NCT00101868|450438389|FG000|Overall Study|Protocol Violation|3|||
125221530|NCT00101868|450438390|FG001|Overall Study|Protocol Violation|0|||
125221531|NCT00101868|450438389|FG000|Overall Study|Lost to Follow-up|8|||
125221532|NCT00101868|450438390|FG001|Overall Study|Lost to Follow-up|13|||
125221533|NCT00069823|450438391|FG000|Overall Study|Did not have follow-up diary cards|6|||
125221534|NCT00069823|450438392|FG001|Overall Study|Did not have follow-up diary cards|3|||
125221535|NCT02329327|450438395|FG000|Overall Study|Death|78|||
125221536|NCT02329327|450438396|FG001|Overall Study|Death|0|||
125221537|NCT02329327|450438395|FG000|Overall Study|Withdrawal by Subject|3|||
125221538|NCT02329327|450438396|FG001|Overall Study|Withdrawal by Subject|0|||
125384981|NCT01912287|451042411|FG001|Overall Study|Lost Interest|0|||
125384982|NCT01912287|451042412|FG002|Overall Study|Lost Interest|0|||
125221539|NCT02329327|450438395|FG000|Overall Study|Lost to Follow-up|4|||
125221540|NCT02329327|450438396|FG001|Overall Study|Lost to Follow-up|0|||
125221541|NCT03560869|450438397|FG000|Overall Study|Withdrawal by Subject|3|||
125221542|NCT03560869|450438398|FG001|Overall Study|Withdrawal by Subject|4|||
125221543|NCT03560869|450438397|FG000|Overall Study|Screening failure|4|||
125384983|NCT01912287|451042410|FG000|Overall Study|Uknown reason - subject drop out|5|||
125384984|NCT01912287|451042411|FG001|Overall Study|Uknown reason - subject drop out|7|||
125384985|NCT01912287|451042412|FG002|Overall Study|Uknown reason - subject drop out|3|||
125384986|NCT01912287|451042410|FG000|Overall Study|Missed Assesment|1|||
125384987|NCT01912287|451042411|FG001|Overall Study|Missed Assesment|1|||
125384988|NCT01912287|451042412|FG002|Overall Study|Missed Assesment|1|||
125384989|NCT01912287|451042410|FG000|Overall Study|Scheduling/change in availability|17|||
125384990|NCT01912287|451042411|FG001|Overall Study|Scheduling/change in availability|10|||
125384991|NCT01912287|451042412|FG002|Overall Study|Scheduling/change in availability|8|||
125384992|NCT02357901|451042418|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
125384993|NCT02357901|451042419|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
125384994|NCT02357901|451042420|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
125384995|NCT02357901|451042421|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
125384996|NCT02357901|451042418|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
125384997|NCT02357901|451042419|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
125384998|NCT02357901|451042420|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
125384999|NCT02357901|451042421|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
125385000|NCT02357901|451042418|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
125385001|NCT02357901|451042419|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
125385002|NCT02357901|451042420|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
125385003|NCT02357901|451042421|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
125385004|NCT02357901|451042418|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
125385005|NCT02357901|451042419|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
125385006|NCT02357901|451042420|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
125385007|NCT02357901|451042421|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
125385008|NCT02357901|451042418|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
125385009|NCT02357901|451042419|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
125385010|NCT02357901|451042420|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
125385011|NCT02357901|451042421|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
125385012|NCT02357901|451042418|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
125385013|NCT02357901|451042419|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
125385014|NCT02357901|451042420|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
125385015|NCT02357901|451042421|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
125385016|NCT02357901|451042418|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
125385017|NCT02357901|451042419|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
125385018|NCT02357901|451042420|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
125385019|NCT02357901|451042421|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
125385020|NCT02357901|451042418|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
125385021|NCT02357901|451042419|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
125385022|NCT02357901|451042420|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
125385023|NCT02357901|451042421|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
125385024|NCT02357901|451042418|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
125385025|NCT02357901|451042419|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
125385026|NCT02357901|451042420|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
125385027|NCT02357901|451042421|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
125385028|NCT02357901|451042418|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
125385029|NCT02357901|451042419|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
125385030|NCT02357901|451042420|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
125385031|NCT02357901|451042421|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
125385032|NCT02357901|451042418|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
125385033|NCT02357901|451042419|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
125385034|NCT02357901|451042420|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
125385035|NCT02357901|451042421|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
125385036|NCT00491387|451042422|FG000|Overall Study|study terminated|20|||
125385037|NCT02278263|451042423|FG000|Overall Study|Protocol Violation|7|||
125385038|NCT02278263|451042424|FG001|Overall Study|Protocol Violation|0|||
125385039|NCT02278263|451042425|FG002|Overall Study|Protocol Violation|9|||
125385040|NCT05811234|451042431|FG000|Overall Study|Loss of Effectiveness|2|||
125385041|NCT05811234|451042431|FG000|Overall Study|Adverse Event|4|||
125385042|NCT05811234|451042431|FG000|Overall Study|Pregnancy|1|||
125385043|NCT05811234|451042431|FG000|Overall Study|Disease progression|1|||
125385044|NCT05811234|451042431|FG000|Overall Study|Withdrawal by Subject|4|||
125385045|NCT05811234|451042431|FG000|Overall Study|Lost to Follow-up|13|||
125385046|NCT05811234|451042431|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
125385047|NCT04499781|451042432|FG000|Overall Study|Lost to Follow-up|2|||
125385048|NCT04499781|451042433|FG001|Overall Study|Lost to Follow-up|3|||
125385049|NCT04499781|451042432|FG000|Overall Study|Withdrawal by Subject|2|||
125221544|NCT03560869|450438398|FG001|Overall Study|Screening failure|4|||
125221545|NCT03560869|450438397|FG000|Overall Study|Withdrawal by PI|0|||
125221546|NCT03560869|450438398|FG001|Overall Study|Withdrawal by PI|1|||
125221547|NCT01801111|450438399|FG000|Overall Study|Adverse Event|12|||
125221548|NCT01801111|450438399|FG000|Overall Study|Death|8|||
125221549|NCT01801111|450438399|FG000|Overall Study|Physician Decision|5|||
125221550|NCT01801111|450438399|FG000|Overall Study|Other|1|||
125221551|NCT01801111|450438399|FG000|Overall Study|Withdrawal by Subject|4|||
125221552|NCT01801111|450438399|FG000|Overall Study|Study Terminated by Sponsor|27|||
125221553|NCT01801111|450438399|FG000|Overall Study|Progressive Disease|81|||
125221554|NCT01210482|450438400|FG000|Overall Study|Protocol Violation|1|||
125221555|NCT01210482|450438400|FG000|Overall Study|Case Report Forms were not collected|18|||
125221556|NCT01210482|450438400|FG000|Overall Study|Duplicated|2|||
125221557|NCT01210482|450438400|FG000|Overall Study|No Drug Administration|28|||
125221558|NCT01223937|450438401|FG000|Overall Study|Withdrawal by Subject|3|||
125221559|NCT01223937|450438402|FG001|Overall Study|Withdrawal by Subject|2|||
125221560|NCT01223937|450438401|FG000|Overall Study|Lost to Follow-up|1|||
125221561|NCT01223937|450438402|FG001|Overall Study|Lost to Follow-up|4|||
125221562|NCT01223937|450438401|FG000|Overall Study|Adverse Event|1|||
125221563|NCT01223937|450438402|FG001|Overall Study|Adverse Event|4|||
125221564|NCT01223937|450438401|FG000|Overall Study|Protocol Violation|8|||
125221565|NCT01223937|450438402|FG001|Overall Study|Protocol Violation|7|||
125221566|NCT01223937|450438401|FG000|Overall Study|Other|4|||
125221567|NCT01223937|450438402|FG001|Overall Study|Other|1|||
125221568|NCT02058589|450438403|FG000|Overall Study|Serious Adverse Event|1|||
125221569|NCT02058589|450438404|FG001|Overall Study|Serious Adverse Event|1|||
125221570|NCT02058589|450438403|FG000|Overall Study|Non-Serious Adverse Event|1|||
125221571|NCT02058589|450438404|FG001|Overall Study|Non-Serious Adverse Event|0|||
125221572|NCT02058589|450438403|FG000|Overall Study|Withdrawal by Subject|0|||
125385050|NCT04499781|451042433|FG001|Overall Study|Withdrawal by Subject|0|||
125385051|NCT02118012|451042436|FG000|Overall Study|Adverse Event|0|||
125385052|NCT02118012|451042437|FG001|Overall Study|Adverse Event|1|||
125385053|NCT02118012|451042436|FG000|Overall Study|Physician Decision|0|||
125385054|NCT02118012|451042437|FG001|Overall Study|Physician Decision|1|||
125385055|NCT03698994|451042438|FG000|Overall Study|Adverse Event|2|||
125385056|NCT03698994|451042438|FG000|Overall Study|Death|1|||
125385057|NCT03698994|451042438|FG000|Overall Study|Physician Decision|1|||
125385058|NCT03698994|451042438|FG000|Overall Study|Withdrawal by Subject|3|||
125385059|NCT03698994|451042438|FG000|Overall Study|Progressive Disease|12|||
125385060|NCT01603459|451042450|FG000|Overall Study|Adverse Event|5|||
125385061|NCT01603459|451042450|FG000|Overall Study|Withdrawal by Subject|5|||
125385062|NCT01603459|451042450|FG000|Overall Study|Lost to Follow-up|3|||
125385063|NCT01603459|451042450|FG000|Overall Study|Predefined discontinuation criteria|3|||
125385064|NCT01603459|451042450|FG000|Overall Study|Non-compliance|1|||
125385065|NCT01603459|451042450|FG000|Overall Study|Administrative reason|1|||
125385066|NCT01412021|451042451|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
125385067|NCT01412021|451042451|FG000|Overall Study|Treatment Prior to Approval|3|||
125385068|NCT01412021|451042451|FG000|Overall Study|Transferred to Other Hospital|9|||
125385069|NCT01721330|451042454|FG000|Overall Study|Withdrawal by Subject|0|||
125385070|NCT01721330|451042455|FG001|Overall Study|Withdrawal by Subject|1|||
125385071|NCT06308822|451043634|FG000|Overall Study|Mutation Status Not Confirmed|17|||
125385072|NCT06308822|451043634|FG000|Overall Study|Adverse Event|1|||
125385073|NCT06308822|451043634|FG000|Overall Study|Death|5|||
125385074|NCT06308822|451043634|FG000|Overall Study|Disease progression|8|||
125385075|NCT06308822|451043634|FG000|Overall Study|Withdrawal by Subject|1|||
125385076|NCT06308822|451043634|FG000|Overall Study|Physician Decision|3|||
125385077|NCT05608005|451043635|FG000|Overall Study|Adverse Event|2|||
125385078|NCT05608005|451043636|FG001|Overall Study|Adverse Event|1|||
125385079|NCT05608005|451043637|FG002|Overall Study|Adverse Event|3|||
125221573|NCT02058589|450438404|FG001|Overall Study|Withdrawal by Subject|1|||
125221574|NCT02532283|450438406|FG000|Overall Study|Adverse Event|0|||
125221575|NCT02532283|450438407|FG001|Overall Study|Adverse Event|1|||
125221576|NCT02532283|450438406|FG000|Overall Study|Death|1|||
125221577|NCT02532283|450438407|FG001|Overall Study|Death|0|||
125221578|NCT02532283|450438406|FG000|Overall Study|Lost to Follow-up|0|||
125221579|NCT02532283|450438407|FG001|Overall Study|Lost to Follow-up|1|||
125221580|NCT02532283|450438406|FG000|Overall Study|Withdrawal by Subject|8|||
125221581|NCT02532283|450438407|FG001|Overall Study|Withdrawal by Subject|3|||
125221582|NCT02143024|450438408|FG000|Overall Study|Lost to Follow-up|1|||
125221583|NCT02143024|450438409|FG001|Overall Study|Lost to Follow-up|1|||
125385080|NCT05608005|451043635|FG000|Overall Study|Protocol Violation|2|||
125385081|NCT05608005|451043636|FG001|Overall Study|Protocol Violation|3|||
125385082|NCT05608005|451043637|FG002|Overall Study|Protocol Violation|0|||
125385083|NCT05608005|451043635|FG000|Overall Study|Withdrawal by Subject|10|||
125385084|NCT05608005|451043636|FG001|Overall Study|Withdrawal by Subject|12|||
125385085|NCT05608005|451043637|FG002|Overall Study|Withdrawal by Subject|4|||
125385086|NCT05608005|451043635|FG000|Overall Study|Lost to Follow-up|25|||
125385087|NCT05608005|451043636|FG001|Overall Study|Lost to Follow-up|27|||
125385088|NCT05608005|451043637|FG002|Overall Study|Lost to Follow-up|15|||
125385089|NCT05608005|451043635|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
125385090|NCT05608005|451043636|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
125385091|NCT05608005|451043637|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
125385092|NCT04708886|451043638|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
125385093|NCT04708886|451043638|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
125385094|NCT03914326|451043641|FG000|Overall Study|Withdrawal by Subject|27|||
125385095|NCT03914326|451043642|FG001|Overall Study|Withdrawal by Subject|34|||
125385096|NCT03914326|451043641|FG000|Overall Study|Lost to Follow-up|43|||
125385097|NCT03914326|451043642|FG001|Overall Study|Lost to Follow-up|51|||
125385098|NCT03914326|451043641|FG000|Overall Study|Randomised more than once|0|||
125385099|NCT03914326|451043642|FG001|Overall Study|Randomised more than once|1|||
125385100|NCT02769247|451043649|FG000|Overall Study|Withdrawal by Subject|1|||
125385101|NCT02769247|451043650|FG001|Overall Study|Withdrawal by Subject|0|||
125385102|NCT02769247|451043651|FG002|Overall Study|Withdrawal by Subject|0|||
125385103|NCT02769247|451043652|FG003|Overall Study|Withdrawal by Subject|1|||
125385104|NCT02769247|451043649|FG000|Overall Study|Protocol Violation|0|||
125385105|NCT02769247|451043650|FG001|Overall Study|Protocol Violation|0|||
125385106|NCT02769247|451043651|FG002|Overall Study|Protocol Violation|1|||
125385107|NCT02769247|451043652|FG003|Overall Study|Protocol Violation|0|||
125385108|NCT02769247|451043649|FG000|Overall Study|Physician Decision|1|||
125385109|NCT02769247|451043650|FG001|Overall Study|Physician Decision|0|||
125385110|NCT02769247|451043651|FG002|Overall Study|Physician Decision|0|||
125385111|NCT02769247|451043652|FG003|Overall Study|Physician Decision|0|||
125385112|NCT04788953|451043653|FG000|Overall Study|Adverse Event|1|||
125385113|NCT04788953|451043654|FG001|Overall Study|Adverse Event|1|||
125385114|NCT04788953|451043653|FG000|Overall Study|Withdrawal by Subject|1|||
125385115|NCT04788953|451043654|FG001|Overall Study|Withdrawal by Subject|0|||
125385116|NCT04788953|451043653|FG000|Overall Study|Protocol Violation|0|||
125385117|NCT04788953|451043654|FG001|Overall Study|Protocol Violation|1|||
125385118|NCT02150954|451043657|FG000|Overall Study|Protocol Violation|1|||
125385119|NCT02150954|451043658|FG001|Overall Study|Protocol Violation|0|||
125385120|NCT03814746|451043662|FG000|Overall Study|Participant decision|9|||
125385121|NCT03814746|451043663|FG001|Overall Study|Participant decision|6|||
125385122|NCT03814746|451043664|FG002|Overall Study|Participant decision|15|||
125385123|NCT03814746|451043662|FG000|Overall Study|Physician Decision|2|||
125385124|NCT03814746|451043663|FG001|Overall Study|Physician Decision|2|||
125385125|NCT03814746|451043664|FG002|Overall Study|Physician Decision|4|||
125385126|NCT03814746|451043662|FG000|Overall Study|Death|2|||
125385127|NCT03814746|451043663|FG001|Overall Study|Death|2|||
125385128|NCT03814746|451043664|FG002|Overall Study|Death|2|||
125385129|NCT03814746|451043662|FG000|Overall Study|Adverse Event|2|||
125385130|NCT03814746|451043663|FG001|Overall Study|Adverse Event|2|||
125385131|NCT03814746|451043664|FG002|Overall Study|Adverse Event|1|||
125385132|NCT03814746|451043662|FG000|Overall Study|Lost to Follow-up|2|||
125221584|NCT02143024|450438408|FG000|Overall Study|Withdrawal by Subject|1|||
125438403|NCT00366301|451232218|FG002|Overall Study|Withdrawal by Subject|1|||
125221585|NCT02143024|450438409|FG001|Overall Study|Withdrawal by Subject|0|||
125438404|NCT00366301|451232219|FG003|Overall Study|Withdrawal by Subject|1|||
125221586|NCT01945944|450438410|FG000|Overall Study|Adverse Event|0|||
125385133|NCT03814746|451043663|FG001|Overall Study|Lost to Follow-up|1|||
125385134|NCT03814746|451043664|FG002|Overall Study|Lost to Follow-up|2|||
125385135|NCT03814746|451043662|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125385136|NCT03814746|451043663|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125385137|NCT03814746|451043664|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
125385138|NCT03814746|451043662|FG000|Overall Study|Pregnancy|0|||
125385139|NCT03814746|451043663|FG001|Overall Study|Pregnancy|1|||
125385140|NCT03814746|451043664|FG002|Overall Study|Pregnancy|1|||
125385141|NCT03814746|451043662|FG000|Overall Study|Protocol Violation|1|||
125385142|NCT03814746|451043663|FG001|Overall Study|Protocol Violation|0|||
125221587|NCT01945944|450438411|FG001|Overall Study|Adverse Event|2|||
125221588|NCT01945944|450438410|FG000|Overall Study|Physician Decision|1|||
125221589|NCT01945944|450438411|FG001|Overall Study|Physician Decision|0|||
125221590|NCT01945944|450438410|FG000|Overall Study|Withdrawal by Subject|0|||
125221591|NCT01945944|450438411|FG001|Overall Study|Withdrawal by Subject|1|||
125221592|NCT00490971|450438416|FG000|Acute/Continuation|Adverse Event|62|||
125221593|NCT00490971|450438417|FG001|Acute/Continuation|Adverse Event|13|||
125221594|NCT00490971|450438418|FG002|Acute/Continuation|Adverse Event|0|||
125221595|NCT00490971|450438419|FG003|Acute/Continuation|Adverse Event|0|||
125221596|NCT00490971|450438420|FG004|Acute/Continuation|Adverse Event|0|||
125221597|NCT00490971|450438416|FG000|Acute/Continuation|Death|2|||
125221598|NCT00490971|450438417|FG001|Acute/Continuation|Death|0|||
125221599|NCT00490971|450438418|FG002|Acute/Continuation|Death|0|||
125221600|NCT00490971|450438419|FG003|Acute/Continuation|Death|0|||
125221601|NCT00490971|450438420|FG004|Acute/Continuation|Death|0|||
125221602|NCT00490971|450438416|FG000|Acute/Continuation|Lack of Efficacy|106|||
125221603|NCT00490971|450438417|FG001|Acute/Continuation|Lack of Efficacy|12|||
125221604|NCT00490971|450438418|FG002|Acute/Continuation|Lack of Efficacy|0|||
125221605|NCT00490971|450438419|FG003|Acute/Continuation|Lack of Efficacy|0|||
125221606|NCT00490971|450438420|FG004|Acute/Continuation|Lack of Efficacy|0|||
125221607|NCT00490971|450438416|FG000|Acute/Continuation|Lost to Follow-up|23|||
125221608|NCT00490971|450438417|FG001|Acute/Continuation|Lost to Follow-up|7|||
125221609|NCT00490971|450438418|FG002|Acute/Continuation|Lost to Follow-up|0|||
125221610|NCT00490971|450438419|FG003|Acute/Continuation|Lost to Follow-up|0|||
125221611|NCT00490971|450438420|FG004|Acute/Continuation|Lost to Follow-up|0|||
125221612|NCT00490971|450438416|FG000|Acute/Continuation|Protocol Violation|10|||
125221613|NCT00490971|450438417|FG001|Acute/Continuation|Protocol Violation|2|||
125221614|NCT00490971|450438418|FG002|Acute/Continuation|Protocol Violation|0|||
125385143|NCT03814746|451043664|FG002|Overall Study|Protocol Violation|0|||
125221615|NCT00490971|450438419|FG003|Acute/Continuation|Protocol Violation|0|||
125221616|NCT00490971|450438420|FG004|Acute/Continuation|Protocol Violation|0|||
125221617|NCT00490971|450438416|FG000|Acute/Continuation|Withdrawal by Subject|92|||
125221618|NCT00490971|450438417|FG001|Acute/Continuation|Withdrawal by Subject|24|||
125221619|NCT00490971|450438418|FG002|Acute/Continuation|Withdrawal by Subject|0|||
125221620|NCT00490971|450438419|FG003|Acute/Continuation|Withdrawal by Subject|0|||
125221621|NCT00490971|450438420|FG004|Acute/Continuation|Withdrawal by Subject|0|||
125385144|NCT03997383|451043669|FG000|Double-blind Treatment Period|Adverse Event|4|||
125385145|NCT03997383|451043670|FG001|Double-blind Treatment Period|Adverse Event|3|||
125221622|NCT00490971|450438416|FG000|Acute/Continuation|Other|11|||
125221623|NCT00490971|450438417|FG001|Acute/Continuation|Other|4|||
125385146|NCT03997383|451043669|FG000|Double-blind Treatment Period|Death|4|||
125385147|NCT03997383|451043670|FG001|Double-blind Treatment Period|Death|4|||
125385148|NCT03997383|451043669|FG000|Double-blind Treatment Period|Physician Decision|2|||
125385149|NCT03997383|451043670|FG001|Double-blind Treatment Period|Physician Decision|0|||
125385150|NCT03997383|451043669|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
125385151|NCT03997383|451043670|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
125385152|NCT03997383|451043669|FG000|Open-label Extension Period|Ongoing|148|||
125385153|NCT03997383|451043670|FG001|Open-label Extension Period|Ongoing|151|||
125438405|NCT01348776|451232222|FG000|Overall Study|Lost to Follow-up|3|||
125221624|NCT00490971|450438418|FG002|Acute/Continuation|Other|0|||
125221625|NCT00490971|450438419|FG003|Acute/Continuation|Other|0|||
125221626|NCT00490971|450438420|FG004|Acute/Continuation|Other|0|||
125221627|NCT00490971|450438416|FG000|Maintenance|Adverse Event|0|||
125221628|NCT00490971|450438417|FG001|Maintenance|Adverse Event|0|||
125221629|NCT00490971|450438418|FG002|Maintenance|Adverse Event|4|||
125221630|NCT00490971|450438419|FG003|Maintenance|Adverse Event|5|||
125438406|NCT02494206|451232245|FG000|Overall Study|Adverse Event|1|||
125385154|NCT03997383|451043669|FG000|Open-label Extension Period|Adverse Event|4|||
125385155|NCT03997383|451043670|FG001|Open-label Extension Period|Adverse Event|1|||
125221631|NCT00490971|450438420|FG004|Maintenance|Adverse Event|7|||
125221632|NCT00490971|450438416|FG000|Maintenance|Death|0|||
125221633|NCT00490971|450438417|FG001|Maintenance|Death|0|||
125221634|NCT00490971|450438418|FG002|Maintenance|Death|0|||
125221635|NCT00490971|450438419|FG003|Maintenance|Death|2|||
125221636|NCT00490971|450438420|FG004|Maintenance|Death|0|||
125385156|NCT03997383|451043669|FG000|Open-label Extension Period|Death|8|||
125385157|NCT03997383|451043670|FG001|Open-label Extension Period|Death|9|||
125385158|NCT03997383|451043669|FG000|Open-label Extension Period|Physician Decision|1|||
125385159|NCT03997383|451043670|FG001|Open-label Extension Period|Physician Decision|1|||
125385160|NCT03997383|451043669|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
125385161|NCT03997383|451043670|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
125385162|NCT03997383|451043669|FG000|Open-label Extension Period|Reason Not Specified|2|||
125385163|NCT03997383|451043670|FG001|Open-label Extension Period|Reason Not Specified|0|||
125385164|NCT03880019|451043671|FG000|Overall Study|Competing disease|1|||
125385165|NCT00326950|451043672|FG000|Overall Study|Progressive Disease|1|||
125385166|NCT01266460|451043676|FG000|Overall Study|Adverse Event|3|||
125385167|NCT01266460|451043676|FG000|Overall Study|Withdrawal by Subject|5|||
125385168|NCT01266460|451043676|FG000|Overall Study|Disease Progression|18|||
125385169|NCT01266460|451043676|FG000|Overall Study|Not otherwise specified|8|||
125385170|NCT01132547|451043677|FG000|Overall Study|Withdrawal by Subject|3|||
125385171|NCT01132547|451043678|FG001|Overall Study|Withdrawal by Subject|1|||
125385172|NCT01132547|451043677|FG000|Overall Study|Death|1|||
125385173|NCT01132547|451043678|FG001|Overall Study|Death|0|||
125385174|NCT00227305|451043681|FG000|Overall Study|Adverse Event|40|||
125385175|NCT00227305|451043681|FG000|Overall Study|Withdrawal by Subject|42|||
125385176|NCT00227305|451043681|FG000|Overall Study|Lost to Follow-up|33|||
125385177|NCT00227305|451043681|FG000|Overall Study|Study specific discontinuation|13|||
125385178|NCT00227305|451043681|FG000|Overall Study|MOVED OUT OF AREA|3|||
125385179|NCT00227305|451043681|FG000|Overall Study|Lack of Efficacy|7|||
125385180|NCT00227305|451043681|FG000|Overall Study|Physician Decision|3|||
125385181|NCT00227305|451043681|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
125385182|NCT00227305|451043681|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
125385183|NCT00227305|451043681|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
125385184|NCT00483379|451043682|FG000|Treatment Period|Adverse Event|1|||
125385185|NCT00483379|451043683|FG001|Treatment Period|Adverse Event|0|||
125138634|NCT00112437|450131207|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
125385186|NCT00483379|451043682|FG000|Treatment Period|Withdrawal by Subject|1|||
125385187|NCT00483379|451043683|FG001|Treatment Period|Withdrawal by Subject|0|||
125385188|NCT02809677|451043686|FG000|Overall Study|Withdrawal by Subject|8|||
125385189|NCT04969224|451043687|FG000|Overall Study|Adverse Event|1|||
125385190|NCT04969224|451043687|FG000|Overall Study|Enrolled but never dosed|1|||
125385191|NCT03165110|451043688|FG000|Overall Study|Anroid phone software incompatibility|1|||
125385192|NCT05533632|451043689|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
125221637|NCT00490971|450438416|FG000|Maintenance|Lost to Follow-up|0|||
125221638|NCT00490971|450438417|FG001|Maintenance|Lost to Follow-up|0|||
125221639|NCT00490971|450438418|FG002|Maintenance|Lost to Follow-up|5|||
125221640|NCT00490971|450438419|FG003|Maintenance|Lost to Follow-up|8|||
125221641|NCT00490971|450438420|FG004|Maintenance|Lost to Follow-up|10|||
125221642|NCT00490971|450438416|FG000|Maintenance|Pregnancy|0|||
125221643|NCT00490971|450438417|FG001|Maintenance|Pregnancy|0|||
125221644|NCT00490971|450438418|FG002|Maintenance|Pregnancy|1|||
125221645|NCT00490971|450438419|FG003|Maintenance|Pregnancy|0|||
125221646|NCT00490971|450438420|FG004|Maintenance|Pregnancy|0|||
125221647|NCT00490971|450438416|FG000|Maintenance|Protocol Violation|0|||
125221648|NCT00490971|450438417|FG001|Maintenance|Protocol Violation|0|||
125221649|NCT00490971|450438418|FG002|Maintenance|Protocol Violation|4|||
125221650|NCT00490971|450438419|FG003|Maintenance|Protocol Violation|1|||
125385193|NCT05533632|451043689|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
125221651|NCT00490971|450438420|FG004|Maintenance|Protocol Violation|1|||
125385194|NCT05533632|451043689|FG000|Overall Study|Lost to Follow-up|1|||
125221652|NCT00490971|450438416|FG000|Maintenance|Withdrawal by Subject|0|||
125221653|NCT00490971|450438417|FG001|Maintenance|Withdrawal by Subject|0|||
125221654|NCT00490971|450438418|FG002|Maintenance|Withdrawal by Subject|26|||
125138635|NCT00112437|450131208|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138636|NCT00112437|450131209|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138637|NCT00112437|450131210|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138638|NCT00112437|450131211|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138639|NCT00112437|450131212|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138640|NCT00112437|450131213|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138641|NCT00112437|450131214|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138642|NCT00112437|450131215|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138643|NCT00112437|450131216|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138644|NCT00112437|450131217|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138645|NCT00112437|450131218|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138646|NCT00112437|450131219|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
125138647|NCT00112437|450131220|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138648|NCT00112437|450131221|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138649|NCT00112437|450131222|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138650|NCT00112437|450131223|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138651|NCT00112437|450131224|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138652|NCT00112437|450131225|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138653|NCT00112437|450131226|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138654|NCT00112437|450131227|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138655|NCT00112437|450131228|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138656|NCT00112437|450131229|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
125138657|NCT00112437|450131204|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138658|NCT00112437|450131205|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138659|NCT00112437|450131206|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138660|NCT00112437|450131207|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138661|NCT00112437|450131208|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138662|NCT00112437|450131209|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138663|NCT00112437|450131210|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138664|NCT00112437|450131211|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138665|NCT00112437|450131212|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138666|NCT00112437|450131213|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138667|NCT00112437|450131214|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138668|NCT00112437|450131215|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
125138669|NCT00112437|450131216|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138670|NCT00112437|450131217|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138671|NCT00112437|450131218|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
125138672|NCT00112437|450131219|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138673|NCT00112437|450131220|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138674|NCT00112437|450131221|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138675|NCT00112437|450131222|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138676|NCT00112437|450131223|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138677|NCT00112437|450131224|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138678|NCT00112437|450131225|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138679|NCT00112437|450131226|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138680|NCT00112437|450131227|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138681|NCT00112437|450131228|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138682|NCT00112437|450131229|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
125138683|NCT00112437|450131204|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138684|NCT00112437|450131205|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138685|NCT00112437|450131206|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138686|NCT00112437|450131207|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138687|NCT00112437|450131208|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138688|NCT00112437|450131209|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138689|NCT00112437|450131210|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138690|NCT00112437|450131211|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138691|NCT00112437|450131212|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138692|NCT00112437|450131213|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138693|NCT00112437|450131214|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
125221655|NCT00490971|450438419|FG003|Maintenance|Withdrawal by Subject|28|||
125221656|NCT00490971|450438420|FG004|Maintenance|Withdrawal by Subject|18|||
125138694|NCT00112437|450131215|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
125138695|NCT00112437|450131216|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138696|NCT00112437|450131217|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138697|NCT00112437|450131218|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138698|NCT00112437|450131219|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138699|NCT00112437|450131220|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125221657|NCT00490971|450438416|FG000|Maintenance|Other|0|||
125138700|NCT00112437|450131221|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138701|NCT00112437|450131222|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138702|NCT00112437|450131223|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138703|NCT00112437|450131224|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138704|NCT00112437|450131225|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138705|NCT00112437|450131226|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138706|NCT00112437|450131227|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138707|NCT00112437|450131228|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138708|NCT00112437|450131229|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
125138709|NCT00112437|450131204|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138710|NCT00112437|450131205|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138711|NCT00112437|450131206|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138712|NCT00112437|450131207|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138713|NCT00112437|450131208|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138714|NCT00112437|450131209|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138715|NCT00112437|450131210|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138716|NCT00112437|450131211|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138717|NCT00112437|450131212|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138718|NCT00112437|450131213|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138719|NCT00112437|450131214|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138720|NCT00112437|450131215|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138721|NCT00112437|450131216|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138722|NCT00112437|450131217|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138723|NCT00112437|450131218|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138724|NCT00112437|450131219|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138725|NCT00112437|450131220|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138726|NCT00112437|450131221|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138727|NCT00112437|450131222|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138728|NCT00112437|450131223|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138729|NCT00112437|450131224|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
125138730|NCT00112437|450131225|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
125138731|NCT00112437|450131226|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138732|NCT00112437|450131227|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138733|NCT00112437|450131228|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138734|NCT00112437|450131229|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
125138735|NCT00112437|450131204|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138736|NCT00112437|450131205|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138737|NCT00112437|450131206|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138738|NCT00112437|450131207|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138739|NCT00112437|450131208|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138740|NCT00112437|450131209|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138741|NCT00112437|450131210|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138742|NCT00112437|450131211|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138743|NCT00112437|450131212|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138744|NCT00112437|450131213|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138745|NCT00112437|450131214|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138746|NCT00112437|450131215|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138747|NCT00112437|450131216|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138748|NCT00112437|450131217|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138749|NCT00112437|450131218|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138750|NCT00112437|450131219|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138751|NCT00112437|450131220|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138752|NCT00112437|450131221|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138753|NCT00112437|450131222|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138754|NCT00112437|450131223|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138755|NCT00112437|450131224|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
125385195|NCT05533632|451043689|FG000|Overall Study|Withdrawal by Subject|4|||
125385196|NCT05533632|451043689|FG000|Overall Study|Adverse Event|4|||
125385197|NCT04327388|451043699|FG000|Overall Study|Adverse Event|17|||
125138756|NCT00112437|450131225|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138757|NCT00112437|450131226|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138758|NCT00112437|450131227|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138759|NCT00112437|450131228|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138760|NCT00112437|450131229|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
125138761|NCT00112437|450131204|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125385198|NCT04327388|451043700|FG001|Overall Study|Adverse Event|18|||
125221658|NCT00490971|450438417|FG001|Maintenance|Other|0|||
125221659|NCT00490971|450438418|FG002|Maintenance|Other|11|||
125221660|NCT00490971|450438419|FG003|Maintenance|Other|9|||
125221661|NCT00490971|450438420|FG004|Maintenance|Other|3|||
125221662|NCT04376515|450438423|FG000|Overall Study|Found to have been vaccinated before study start|6|||
125221663|NCT04376515|450438424|FG001|Overall Study|Found to have been vaccinated before study start|6|||
125221664|NCT01683604|450438425|FG000|Overall Study|Adverse Event|2|||
125221665|NCT01683604|450438425|FG000|Overall Study|Lack of Efficacy|1|||
125221666|NCT01683604|450438425|FG000|Overall Study|Other|2|||
125221667|NCT03430856|450438429|FG000|Overall Study|Adverse Event|0|||
125221668|NCT03430856|450438430|FG001|Overall Study|Adverse Event|1|||
125221669|NCT03430856|450438431|FG002|Overall Study|Adverse Event|0|||
125221670|NCT03430856|450438429|FG000|Overall Study|Rescue criteria|1|||
125221671|NCT03430856|450438430|FG001|Overall Study|Rescue criteria|1|||
125221672|NCT03430856|450438431|FG002|Overall Study|Rescue criteria|0|||
125221673|NCT03430856|450438429|FG000|Overall Study|Voluntary withdrawal of consent|1|||
125221674|NCT03430856|450438430|FG001|Overall Study|Voluntary withdrawal of consent|1|||
125221675|NCT03430856|450438431|FG002|Overall Study|Voluntary withdrawal of consent|1|||
125221676|NCT01949142|450438432|FG000|Overall Study|Withdrawal of consent|1|||
125221677|NCT01949142|450438433|FG001|Overall Study|Withdrawal of consent|0|||
125221678|NCT01949142|450438432|FG000|Overall Study|Lost to Follow-up|1|||
125221679|NCT01949142|450438433|FG001|Overall Study|Lost to Follow-up|1|||
125221680|NCT01949142|450438432|FG000|Overall Study|Parent changed their mind|1|||
125221681|NCT01949142|450438433|FG001|Overall Study|Parent changed their mind|0|||
125221682|NCT00565604|450438439|FG000|Overall Study|Failure to treat|2|||
125221683|NCT00565604|450438439|FG000|Overall Study|Lost to Follow-up|2|||
125385199|NCT04327388|451043701|FG002|Overall Study|Adverse Event|9|||
125385200|NCT04327388|451043699|FG000|Overall Study|Other|1|||
125385201|NCT04327388|451043700|FG001|Overall Study|Other|2|||
125385202|NCT04327388|451043701|FG002|Overall Study|Other|0|||
125385203|NCT04327388|451043699|FG000|Overall Study|Randomized and not treated|2|||
125385204|NCT04327388|451043700|FG001|Overall Study|Randomized and not treated|0|||
125385205|NCT04327388|451043701|FG002|Overall Study|Randomized and not treated|2|||
125385206|NCT04103892|451043704|FG000|Overall Study|Adverse Event|0|||
125385207|NCT04103892|451043705|FG001|Overall Study|Adverse Event|0|||
125385208|NCT04103892|451043706|FG002|Overall Study|Adverse Event|0|||
125385209|NCT04103892|451043707|FG003|Overall Study|Adverse Event|3|||
125385210|NCT04103892|451043704|FG000|Overall Study|Lost to Follow-up|0|||
125385211|NCT04103892|451043705|FG001|Overall Study|Lost to Follow-up|0|||
125385212|NCT04103892|451043706|FG002|Overall Study|Lost to Follow-up|2|||
125385213|NCT04103892|451043707|FG003|Overall Study|Lost to Follow-up|0|||
125138762|NCT00112437|450131205|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138763|NCT00112437|450131206|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138764|NCT00112437|450131207|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138765|NCT00112437|450131208|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138766|NCT00112437|450131209|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138767|NCT00112437|450131210|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138768|NCT00112437|450131211|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138769|NCT00112437|450131212|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138770|NCT00112437|450131213|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138771|NCT00112437|450131214|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138772|NCT00112437|450131215|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138773|NCT00112437|450131216|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138774|NCT00112437|450131217|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138775|NCT00112437|450131218|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138776|NCT00112437|450131219|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138777|NCT00112437|450131220|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138778|NCT00112437|450131221|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138779|NCT00112437|450131222|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138780|NCT00112437|450131223|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138781|NCT00112437|450131224|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138782|NCT00112437|450131225|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
125138783|NCT00112437|450131226|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138784|NCT00112437|450131227|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138785|NCT00112437|450131228|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138786|NCT00112437|450131229|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
125138787|NCT00112437|450131204|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138788|NCT00112437|450131205|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138789|NCT00112437|450131206|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138790|NCT00112437|450131207|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138791|NCT00112437|450131208|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
125221684|NCT01395810|450438440|FG000|Overall Study|Adverse Event|0|||
125221685|NCT01395810|450438441|FG001|Overall Study|Adverse Event|1|||
125385214|NCT04103892|451043704|FG000|Overall Study|Protocol Violation|0|||
125385215|NCT04103892|451043705|FG001|Overall Study|Protocol Violation|0|||
125138792|NCT00112437|450131209|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138793|NCT00112437|450131210|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138794|NCT00112437|450131211|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138795|NCT00112437|450131212|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138796|NCT00112437|450131213|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138797|NCT00112437|450131214|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
125385216|NCT04103892|451043706|FG002|Overall Study|Protocol Violation|1|||
125385217|NCT04103892|451043707|FG003|Overall Study|Protocol Violation|1|||
125385218|NCT04103892|451043704|FG000|Overall Study|Withdrawal by Subject|1|||
125385219|NCT04103892|451043705|FG001|Overall Study|Withdrawal by Subject|0|||
125385220|NCT04103892|451043706|FG002|Overall Study|Withdrawal by Subject|2|||
125221686|NCT01395810|450438442|FG002|Overall Study|Adverse Event|0|||
125221687|NCT01395810|450438443|FG003|Overall Study|Adverse Event|0|||
125221688|NCT01395810|450438440|FG000|Overall Study|Lack of Efficacy|0|||
125221689|NCT01395810|450438441|FG001|Overall Study|Lack of Efficacy|1|||
125221690|NCT01395810|450438442|FG002|Overall Study|Lack of Efficacy|0|||
125221691|NCT01395810|450438443|FG003|Overall Study|Lack of Efficacy|0|||
125221692|NCT01395810|450438440|FG000|Overall Study|Withdrawal criteria|0|||
125221693|NCT01395810|450438441|FG001|Overall Study|Withdrawal criteria|2|||
125221694|NCT01395810|450438442|FG002|Overall Study|Withdrawal criteria|0|||
125221695|NCT01395810|450438443|FG003|Overall Study|Withdrawal criteria|0|||
125221696|NCT01395810|450438440|FG000|Overall Study|Unclassified|2|||
125221697|NCT01395810|450438441|FG001|Overall Study|Unclassified|0|||
125221698|NCT01395810|450438442|FG002|Overall Study|Unclassified|0|||
125221699|NCT01395810|450438443|FG003|Overall Study|Unclassified|0|||
125221700|NCT04265261|450438448|FG000|Overall Study|Adverse Event|2|||
125221701|NCT04265261|450438449|FG001|Overall Study|Adverse Event|0|||
125221702|NCT04265261|450438450|FG002|Overall Study|Adverse Event|0|||
125221703|NCT04265261|450438448|FG000|Overall Study|Death|1|||
125221704|NCT04265261|450438449|FG001|Overall Study|Death|0|||
125221705|NCT04265261|450438450|FG002|Overall Study|Death|0|||
125221706|NCT04265261|450438448|FG000|Overall Study|Lost to Follow-up|4|||
125221707|NCT04265261|450438449|FG001|Overall Study|Lost to Follow-up|1|||
125221708|NCT04265261|450438450|FG002|Overall Study|Lost to Follow-up|3|||
125221709|NCT04265261|450438448|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125221710|NCT04265261|450438449|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125221711|NCT04265261|450438450|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125221712|NCT04265261|450438448|FG000|Overall Study|Physician Decision|0|||
125221713|NCT04265261|450438449|FG001|Overall Study|Physician Decision|0|||
125385221|NCT04103892|451043707|FG003|Overall Study|Withdrawal by Subject|5|||
125385222|NCT04103892|451043704|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
125385223|NCT04103892|451043705|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
125385224|NCT04103892|451043706|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
125385225|NCT04103892|451043707|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
125385226|NCT04340362|451043708|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
125385227|NCT03051607|451043709|FG000|Overall Study|Adverse Event|66|||
125385228|NCT00399360|451043711|FG000|Overall Study|Lost to Follow-up|2|||
125385229|NCT00399360|451043712|FG001|Overall Study|Lost to Follow-up|1|||
125385230|NCT00399360|451043713|FG002|Overall Study|Lost to Follow-up|2|||
125385231|NCT00399360|451043714|FG003|Overall Study|Lost to Follow-up|4|||
125385232|NCT00399360|451043711|FG000|Overall Study|Adverse Event|0|||
125385233|NCT00399360|451043712|FG001|Overall Study|Adverse Event|0|||
125385234|NCT00399360|451043713|FG002|Overall Study|Adverse Event|1|||
125385235|NCT00399360|451043714|FG003|Overall Study|Adverse Event|0|||
125385236|NCT00399360|451043711|FG000|Overall Study|Withdrawal by Subject|0|||
125385237|NCT00399360|451043712|FG001|Overall Study|Withdrawal by Subject|2|||
125221714|NCT04265261|450438450|FG002|Overall Study|Physician Decision|1|||
125221715|NCT04265261|450438448|FG000|Overall Study|Protocol Deviation|0|||
125221716|NCT04265261|450438449|FG001|Overall Study|Protocol Deviation|2|||
125221717|NCT04265261|450438450|FG002|Overall Study|Protocol Deviation|0|||
125385238|NCT00399360|451043713|FG002|Overall Study|Withdrawal by Subject|0|||
125385239|NCT00399360|451043714|FG003|Overall Study|Withdrawal by Subject|2|||
125221718|NCT04265261|450438448|FG000|Overall Study|Withdrawal by Subject|2|||
125221719|NCT04265261|450438449|FG001|Overall Study|Withdrawal by Subject|1|||
125385240|NCT01166178|451043715|FG000|Overall Study|Withdrawal by Subject|1|||
125385241|NCT01166178|451043716|FG001|Overall Study|Withdrawal by Subject|0|||
125138798|NCT00112437|450131215|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138799|NCT00112437|450131216|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138800|NCT00112437|450131217|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138801|NCT00112437|450131218|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138802|NCT00112437|450131219|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138803|NCT00112437|450131220|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138804|NCT00112437|450131221|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138805|NCT00112437|450131222|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138806|NCT00112437|450131223|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138807|NCT00112437|450131224|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138808|NCT00112437|450131225|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
125138809|NCT00112437|450131226|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138810|NCT00112437|450131227|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138811|NCT00112437|450131228|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138812|NCT00112437|450131229|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
125138813|NCT00112437|450131204|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138814|NCT00112437|450131205|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138815|NCT00112437|450131206|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138816|NCT00112437|450131207|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138817|NCT00112437|450131208|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138818|NCT00112437|450131209|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138819|NCT00112437|450131210|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138820|NCT00112437|450131211|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138821|NCT00112437|450131212|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138822|NCT00112437|450131213|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138823|NCT00112437|450131214|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138824|NCT00112437|450131215|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138825|NCT00112437|450131216|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138826|NCT00112437|450131217|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138827|NCT00112437|450131218|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138828|NCT00112437|450131219|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138829|NCT00112437|450131220|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138830|NCT00112437|450131221|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138831|NCT00112437|450131222|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138832|NCT00112437|450131223|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138833|NCT00112437|450131224|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
125138834|NCT00112437|450131225|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
125138835|NCT00112437|450131226|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138836|NCT00112437|450131227|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138837|NCT00112437|450131228|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138838|NCT00112437|450131229|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
125138839|NCT00112437|450131204|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138840|NCT00112437|450131205|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138841|NCT00112437|450131206|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138842|NCT00112437|450131207|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138843|NCT00112437|450131208|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138844|NCT00112437|450131209|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138845|NCT00112437|450131210|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138846|NCT00112437|450131211|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138847|NCT00112437|450131212|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138848|NCT00112437|450131213|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138849|NCT00112437|450131214|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138850|NCT00112437|450131215|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138851|NCT00112437|450131216|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138852|NCT00112437|450131217|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138853|NCT00112437|450131218|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138854|NCT00112437|450131219|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138855|NCT00112437|450131220|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138856|NCT00112437|450131221|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138857|NCT00112437|450131222|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138858|NCT00112437|450131223|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138859|NCT00112437|450131224|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138860|NCT00112437|450131225|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138861|NCT00112437|450131226|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
125138862|NCT00112437|450131227|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
125138863|NCT00112437|450131228|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
125138864|NCT00112437|450131229|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
125138865|NCT00112437|450131204|FG000|Years 6-10 (60-Month Extension)|Death|0|||
125221720|NCT04265261|450438450|FG002|Overall Study|Withdrawal by Subject|4|||
125221721|NCT00493012|450440332|FG000|Overall Study|Lost to Follow-up|18|||
125138866|NCT00112437|450131205|FG001|Years 6-10 (60-Month Extension)|Death|0|||
125138867|NCT00112437|450131206|FG002|Years 6-10 (60-Month Extension)|Death|0|||
125221722|NCT00493012|450440333|FG001|Overall Study|Lost to Follow-up|17|||
125138868|NCT00112437|450131207|FG003|Years 6-10 (60-Month Extension)|Death|0|||
125138869|NCT00112437|450131208|FG004|Years 6-10 (60-Month Extension)|Death|0|||
125221723|NCT03234036|450440337|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
125438407|NCT02494206|451232245|FG000|Overall Study|Disease Progression|1|||
125385242|NCT01166178|451043715|FG000|Overall Study|Study was terminated|20|||
125385243|NCT01166178|451043716|FG001|Overall Study|Study was terminated|8|||
125385244|NCT00529542|451043720|FG000|Overall Study|Withdrawal by Subject|1|||
125385245|NCT00529542|451043721|FG001|Overall Study|Withdrawal by Subject|0|||
125385246|NCT00529542|451043720|FG000|Overall Study|Lost to Follow-up|0|||
125385247|NCT00529542|451043721|FG001|Overall Study|Lost to Follow-up|1|||
125385248|NCT05778786|451043722|FG000|Period 1|COVID-19 Related|3|||
125385249|NCT05778786|451043723|FG001|Period 1|COVID-19 Related|3|||
125385250|NCT05778786|451043722|FG000|Period 1|Withdrew Consent during Study|1|||
125385251|NCT05778786|451043723|FG001|Period 1|Withdrew Consent during Study|0|||
125385252|NCT05778786|451043722|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
125385253|NCT05778786|451043723|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
125221724|NCT03234036|450440338|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
125221725|NCT03234036|450440339|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
125221726|NCT03234036|450440340|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
125221727|NCT04547140|450440343|FG000|Overall Study|Adverse Event|0|||
125221728|NCT04547140|450440344|FG001|Overall Study|Adverse Event|1|||
125221729|NCT04547140|450440343|FG000|Overall Study|Withdrawal by Subject|0|||
125221730|NCT04547140|450440344|FG001|Overall Study|Withdrawal by Subject|1|||
125221731|NCT04547140|450440343|FG000|Overall Study|Lost to Follow-up|3|||
125221732|NCT04547140|450440344|FG001|Overall Study|Lost to Follow-up|1|||
125221733|NCT04547140|450440343|FG000|Overall Study|Death|2|||
125221734|NCT04547140|450440344|FG001|Overall Study|Death|1|||
125221735|NCT04547140|450440343|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
125221736|NCT04547140|450440344|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
125221737|NCT04547140|450440343|FG000|Overall Study|Pregnancy|1|||
125221738|NCT04547140|450440344|FG001|Overall Study|Pregnancy|0|||
125221739|NCT04547140|450440343|FG000|Overall Study|Reason Not Specified|4|||
125221740|NCT04547140|450440344|FG001|Overall Study|Reason Not Specified|1|||
125221741|NCT04613739|450440345|FG000|Overall Study|Lost to Follow-up|6|||
125221742|NCT04613739|450440346|FG001|Overall Study|Lost to Follow-up|9|||
125221743|NCT04613739|450440345|FG000|Overall Study|potentially duplicative/fraudulent|1|||
125221744|NCT04613739|450440346|FG001|Overall Study|potentially duplicative/fraudulent|3|||
125221745|NCT00003537|450440347|FG000|Overall Study|Not evalauable|1|||
125221746|NCT00735943|450440354|FG000|Overall Study|Lost to Follow-up|1|||
125221747|NCT00735943|450440354|FG000|Overall Study|Adverse Event|1|||
125438408|NCT01799720|451232246|FG000|Overall Study|Withdrawal by Subject|3|||
125221748|NCT01719380|450440359|FG000|Overall Study|Adverse Event|0|||
125221749|NCT01719380|450440360|FG001|Overall Study|Adverse Event|0|||
125221750|NCT01719380|450440361|FG002|Overall Study|Adverse Event|1|||
125221751|NCT01719380|450440362|FG003|Overall Study|Adverse Event|2|||
125221752|NCT01719380|450440363|FG004|Overall Study|Adverse Event|0|||
125221753|NCT01719380|450440364|FG005|Overall Study|Adverse Event|1|||
125221754|NCT01719380|450440365|FG006|Overall Study|Adverse Event|0|||
125221755|NCT01719380|450440366|FG007|Overall Study|Adverse Event|1|||
125221756|NCT01719380|450440367|FG008|Overall Study|Adverse Event|4|||
125221757|NCT01719380|450440368|FG009|Overall Study|Adverse Event|3|||
125221758|NCT01719380|450440359|FG000|Overall Study|Death|0|||
125221759|NCT01719380|450440360|FG001|Overall Study|Death|1|||
125221760|NCT01719380|450440361|FG002|Overall Study|Death|0|||
125221761|NCT01719380|450440362|FG003|Overall Study|Death|0|||
125221762|NCT01719380|450440363|FG004|Overall Study|Death|0|||
125221763|NCT01719380|450440364|FG005|Overall Study|Death|0|||
125221764|NCT01719380|450440365|FG006|Overall Study|Death|0|||
125221765|NCT01719380|450440366|FG007|Overall Study|Death|0|||
125221766|NCT01719380|450440367|FG008|Overall Study|Death|3|||
125221767|NCT01719380|450440368|FG009|Overall Study|Death|3|||
125221768|NCT01719380|450440359|FG000|Overall Study|Participant/Guardian Decision|0|||
125221769|NCT01719380|450440360|FG001|Overall Study|Participant/Guardian Decision|0|||
125221770|NCT01719380|450440361|FG002|Overall Study|Participant/Guardian Decision|1|||
125221771|NCT01719380|450440362|FG003|Overall Study|Participant/Guardian Decision|0|||
125221772|NCT01719380|450440363|FG004|Overall Study|Participant/Guardian Decision|0|||
125221773|NCT01719380|450440364|FG005|Overall Study|Participant/Guardian Decision|0|||
125221774|NCT01719380|450440365|FG006|Overall Study|Participant/Guardian Decision|0|||
125221775|NCT01719380|450440366|FG007|Overall Study|Participant/Guardian Decision|0|||
125221776|NCT01719380|450440367|FG008|Overall Study|Participant/Guardian Decision|2|||
125221777|NCT01719380|450440368|FG009|Overall Study|Participant/Guardian Decision|2|||
125221778|NCT01719380|450440359|FG000|Overall Study|Physician Decision|0|||
125221779|NCT01719380|450440360|FG001|Overall Study|Physician Decision|0|||
125221780|NCT01719380|450440361|FG002|Overall Study|Physician Decision|2|||
125221781|NCT01719380|450440362|FG003|Overall Study|Physician Decision|0|||
125221782|NCT01719380|450440363|FG004|Overall Study|Physician Decision|0|||
125221783|NCT01719380|450440364|FG005|Overall Study|Physician Decision|0|||
125221784|NCT01719380|450440365|FG006|Overall Study|Physician Decision|0|||
125221785|NCT01719380|450440366|FG007|Overall Study|Physician Decision|0|||
125221786|NCT01719380|450440367|FG008|Overall Study|Physician Decision|1|||
125221787|NCT01719380|450440368|FG009|Overall Study|Physician Decision|1|||
125221788|NCT01719380|450440359|FG000|Overall Study|Lack of Efficacy|2|||
125221789|NCT01719380|450440360|FG001|Overall Study|Lack of Efficacy|6|||
125221790|NCT01719380|450440361|FG002|Overall Study|Lack of Efficacy|5|||
125221791|NCT01719380|450440362|FG003|Overall Study|Lack of Efficacy|6|||
125221792|NCT01719380|450440363|FG004|Overall Study|Lack of Efficacy|3|||
125221793|NCT01719380|450440364|FG005|Overall Study|Lack of Efficacy|7|||
125221794|NCT01719380|450440365|FG006|Overall Study|Lack of Efficacy|10|||
125221795|NCT01719380|450440366|FG007|Overall Study|Lack of Efficacy|6|||
125221796|NCT01719380|450440367|FG008|Overall Study|Lack of Efficacy|39|||
125221797|NCT01719380|450440368|FG009|Overall Study|Lack of Efficacy|42|||
125221798|NCT01719380|450440359|FG000|Overall Study|Progressive Disease|0|||
125221799|NCT01719380|450440360|FG001|Overall Study|Progressive Disease|0|||
125221800|NCT01719380|450440361|FG002|Overall Study|Progressive Disease|0|||
125221801|NCT01719380|450440362|FG003|Overall Study|Progressive Disease|0|||
125221802|NCT01719380|450440363|FG004|Overall Study|Progressive Disease|0|||
125221803|NCT01719380|450440364|FG005|Overall Study|Progressive Disease|0|||
125221804|NCT01719380|450440365|FG006|Overall Study|Progressive Disease|0|||
125221805|NCT01719380|450440366|FG007|Overall Study|Progressive Disease|0|||
125221806|NCT01719380|450440367|FG008|Overall Study|Progressive Disease|1|||
125221807|NCT01719380|450440368|FG009|Overall Study|Progressive Disease|0|||
125221808|NCT01064414|450440369|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
125221809|NCT01064414|450440370|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
125221810|NCT01064414|450440371|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
125221811|NCT01064414|450440369|FG000|Core Period: Baseline to Week 26|Death|0|||
125221812|NCT01064414|450440370|FG001|Core Period: Baseline to Week 26|Death|1|||
125221813|NCT01064414|450440371|FG002|Core Period: Baseline to Week 26|Death|0|||
125221814|NCT01064414|450440369|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
125221815|NCT01064414|450440370|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
125221816|NCT01064414|450440371|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
125221817|NCT01064414|450440369|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
125221818|NCT01064414|450440370|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
125221819|NCT01064414|450440371|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
125221820|NCT01064414|450440369|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125221821|NCT01064414|450440370|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
125221822|NCT01064414|450440371|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125221823|NCT01064414|450440369|FG000|Core Period: Baseline to Week 26|Other|4|||
125221824|NCT01064414|450440370|FG001|Core Period: Baseline to Week 26|Other|7|||
125221825|NCT01064414|450440371|FG002|Core Period: Baseline to Week 26|Other|2|||
125221826|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
125221827|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
125221828|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
125221829|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Death|0|||
125221830|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Death|1|||
125221831|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Death|0|||
125221832|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
125221833|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125221834|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125221835|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
125221836|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125221837|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125221838|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125221839|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125221840|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125221841|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
125221842|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
125221843|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
125221844|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
125221845|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
125221846|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
125221847|NCT01064414|450440369|FG000|Extension Period: Week 26 to Week 52|Other|5|||
125221848|NCT01064414|450440370|FG001|Extension Period: Week 26 to Week 52|Other|2|||
125221849|NCT01064414|450440371|FG002|Extension Period: Week 26 to Week 52|Other|1|||
125221850|NCT00249873|450440372|FG000|Overall Study|Not treated|7|||
125221851|NCT00249873|450440373|FG001|Overall Study|Not treated|8|||
125221852|NCT00249873|450440372|FG000|Overall Study|Significant thrombocytopenia|9|||
125221853|NCT00249873|450440373|FG001|Overall Study|Significant thrombocytopenia|8|||
125221854|NCT00249873|450440372|FG000|Overall Study|Severe allergic reaction|8|||
125221855|NCT00249873|450440373|FG001|Overall Study|Severe allergic reaction|1|||
125221856|NCT00249873|450440372|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
125221857|NCT00249873|450440373|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
125221858|NCT00249873|450440372|FG000|Overall Study|Other Serious Adverse Event|86|||
125221859|NCT00249873|450440373|FG001|Overall Study|Other Serious Adverse Event|97|||
125221860|NCT00249873|450440372|FG000|Overall Study|Qualifying condition not present|20|||
125221861|NCT00249873|450440373|FG001|Overall Study|Qualifying condition not present|23|||
125221862|NCT00249873|450440372|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
125221863|NCT00249873|450440373|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
125221864|NCT00249873|450440372|FG000|Overall Study|Withdrawal by Subject|504|||
125221865|NCT00249873|450440373|FG001|Overall Study|Withdrawal by Subject|466|||
125221866|NCT00249873|450440372|FG000|Overall Study|Lost to Follow-up|4|||
125221867|NCT00249873|450440373|FG001|Overall Study|Lost to Follow-up|7|||
125221868|NCT00249873|450440372|FG000|Overall Study|Minor bleeding|99|||
125221869|NCT00249873|450440373|FG001|Overall Study|Minor bleeding|37|||
125221870|NCT00249873|450440372|FG000|Overall Study|Non-compliance|41|||
125221871|NCT00249873|450440373|FG001|Overall Study|Non-compliance|46|||
125221872|NCT00249873|450440372|FG000|Overall Study|Other non serious Adverse Event|112|||
125221873|NCT00249873|450440373|FG001|Overall Study|Other non serious Adverse Event|108|||
125221874|NCT00249873|450440372|FG000|Overall Study|Other contraindicated medication|1|||
125221875|NCT00249873|450440373|FG001|Overall Study|Other contraindicated medication|0|||
125221876|NCT00249873|450440372|FG000|Overall Study|Patient not wish to continue after May08|3|||
125221877|NCT00249873|450440373|FG001|Overall Study|Patient not wish to continue after May08|4|||
125221878|NCT00249873|450440372|FG000|Overall Study|Physician withdrew consent|59|||
125221879|NCT00249873|450440373|FG001|Overall Study|Physician withdrew consent|60|||
125221880|NCT00249873|450440372|FG000|Overall Study|Open label clopidogrel required|31|||
125221881|NCT00249873|450440373|FG001|Overall Study|Open label clopidogrel required|42|||
125221882|NCT00249873|450440372|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
125221883|NCT00249873|450440373|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
125221884|NCT00249873|450440372|FG000|Overall Study|Oral anticoagulant required|159|||
125221885|NCT00249873|450440373|FG001|Overall Study|Oral anticoagulant required|157|||
125221886|NCT00249873|450440372|FG000|Overall Study|Study drug intolerance|5|||
125221887|NCT00249873|450440373|FG001|Overall Study|Study drug intolerance|0|||
125221888|NCT00249873|450440372|FG000|Overall Study|Surgery/ procedure|9|||
125221889|NCT00249873|450440373|FG001|Overall Study|Surgery/ procedure|9|||
125385254|NCT05778786|451043722|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
125385255|NCT05778786|451043723|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
125385256|NCT03658538|451043724|FG000|Overall Study|Death|2|||
125385257|NCT03658538|451043725|FG001|Overall Study|Death|1|||
125385258|NCT03658538|451043724|FG000|Overall Study|Cancer diagnosis|1|||
125385259|NCT03658538|451043725|FG001|Overall Study|Cancer diagnosis|0|||
125385260|NCT03658538|451043724|FG000|Overall Study|Change residence|1|||
125385261|NCT03658538|451043725|FG001|Overall Study|Change residence|2|||
125385262|NCT03658538|451043724|FG000|Overall Study|Lost to Follow-up|3|||
125385263|NCT03658538|451043725|FG001|Overall Study|Lost to Follow-up|3|||
125385264|NCT03658538|451043724|FG000|Overall Study|Unblinded|2|||
125385265|NCT03658538|451043725|FG001|Overall Study|Unblinded|3|||
125385266|NCT03658538|451043724|FG000|Overall Study|Physician Decision|0|||
125385267|NCT03658538|451043725|FG001|Overall Study|Physician Decision|1|||
125385268|NCT03658538|451043724|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
125385269|NCT03658538|451043725|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
125385270|NCT03658538|451043724|FG000|Overall Study|Evicted from home|1|||
125385271|NCT03658538|451043725|FG001|Overall Study|Evicted from home|0|||
125385272|NCT02070744|451043726|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
125385273|NCT02070744|451043727|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
125385274|NCT02070744|451043728|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
125385275|NCT02070744|451043729|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
125385276|NCT02070744|451043730|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
125385277|NCT02070744|451043726|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
125138870|NCT00112437|450131209|FG005|Years 6-10 (60-Month Extension)|Death|0|||
125138871|NCT00112437|450131210|FG006|Years 6-10 (60-Month Extension)|Death|0|||
125138872|NCT00112437|450131211|FG007|Years 6-10 (60-Month Extension)|Death|0|||
125138873|NCT00112437|450131212|FG008|Years 6-10 (60-Month Extension)|Death|0|||
125138874|NCT00112437|450131213|FG009|Years 6-10 (60-Month Extension)|Death|0|||
125138875|NCT00112437|450131214|FG010|Years 6-10 (60-Month Extension)|Death|0|||
125138876|NCT00112437|450131215|FG011|Years 6-10 (60-Month Extension)|Death|0|||
125385278|NCT02070744|451043727|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
125385279|NCT02070744|451043728|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
125138877|NCT00112437|450131216|FG012|Years 6-10 (60-Month Extension)|Death|0|||
125138878|NCT00112437|450131217|FG013|Years 6-10 (60-Month Extension)|Death|0|||
125138879|NCT00112437|450131218|FG014|Years 6-10 (60-Month Extension)|Death|0|||
125385280|NCT02070744|451043729|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
125385281|NCT02070744|451043730|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
125385282|NCT02070744|451043726|FG000|OLE Phase (48 Weeks)|Other|0|||
125385283|NCT02070744|451043727|FG001|OLE Phase (48 Weeks)|Other|0|||
125385284|NCT02070744|451043728|FG002|OLE Phase (48 Weeks)|Other|0|||
125385285|NCT02070744|451043729|FG003|OLE Phase (48 Weeks)|Other|0|||
125385286|NCT02070744|451043730|FG004|OLE Phase (48 Weeks)|Other|1|||
125221890|NCT00249873|450440372|FG000|Overall Study|Event related to cardiac condition|12|||
125221891|NCT00249873|450440373|FG001|Overall Study|Event related to cardiac condition|21|||
125221892|NCT00249873|450440372|FG000|Overall Study|Thromboembolic/outcome event|82|||
125221893|NCT00249873|450440373|FG001|Overall Study|Thromboembolic/outcome event|122|||
125221894|NCT03286218|450440374|FG000|Qualification Phase Period 1|Adverse Event|1|||
125221895|NCT03286218|450440375|FG001|Qualification Phase Period 1|Adverse Event|0|||
125221896|NCT03286218|450440376|FG002|Qualification Phase Period 1|Adverse Event|0|||
125221897|NCT03286218|450440377|FG003|Qualification Phase Period 1|Adverse Event|0|||
125221898|NCT03286218|450440378|FG004|Qualification Phase Period 1|Adverse Event|0|||
125221899|NCT03286218|450440379|FG005|Qualification Phase Period 1|Adverse Event|0|||
125221900|NCT03286218|450440380|FG006|Qualification Phase Period 1|Adverse Event|0|||
125221901|NCT03286218|450440381|FG007|Qualification Phase Period 1|Adverse Event|0|||
125221902|NCT03286218|450440382|FG008|Qualification Phase Period 1|Adverse Event|0|||
125221903|NCT03286218|450440383|FG009|Qualification Phase Period 1|Adverse Event|0|||
125221904|NCT03286218|450440384|FG010|Qualification Phase Period 1|Adverse Event|0|||
125221905|NCT03286218|450440385|FG011|Qualification Phase Period 1|Adverse Event|0|||
125221906|NCT03286218|450440374|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221907|NCT03286218|450440375|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
125221908|NCT03286218|450440376|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221909|NCT03286218|450440377|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221910|NCT03286218|450440378|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221911|NCT03286218|450440379|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221912|NCT03286218|450440380|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221913|NCT03286218|450440381|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221914|NCT03286218|450440382|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221915|NCT03286218|450440383|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221916|NCT03286218|450440384|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221917|NCT03286218|450440385|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
125221918|NCT03286218|450440374|FG000|Qualification Phase Period 2|Adverse Event|0|||
125221919|NCT03286218|450440375|FG001|Qualification Phase Period 2|Adverse Event|1|||
125221920|NCT03286218|450440376|FG002|Qualification Phase Period 2|Adverse Event|0|||
125221921|NCT03286218|450440377|FG003|Qualification Phase Period 2|Adverse Event|0|||
125221922|NCT03286218|450440378|FG004|Qualification Phase Period 2|Adverse Event|0|||
125221923|NCT03286218|450440379|FG005|Qualification Phase Period 2|Adverse Event|0|||
125221924|NCT03286218|450440380|FG006|Qualification Phase Period 2|Adverse Event|0|||
125221925|NCT03286218|450440381|FG007|Qualification Phase Period 2|Adverse Event|0|||
125221926|NCT03286218|450440382|FG008|Qualification Phase Period 2|Adverse Event|0|||
125221927|NCT03286218|450440383|FG009|Qualification Phase Period 2|Adverse Event|0|||
125221928|NCT03286218|450440384|FG010|Qualification Phase Period 2|Adverse Event|0|||
125221929|NCT03286218|450440385|FG011|Qualification Phase Period 2|Adverse Event|0|||
125221930|NCT03286218|450440374|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
125221931|NCT03286218|450440375|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
125221932|NCT03286218|450440376|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221933|NCT03286218|450440377|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221934|NCT03286218|450440378|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221935|NCT03286218|450440379|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221936|NCT03286218|450440380|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221937|NCT03286218|450440381|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221938|NCT03286218|450440382|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221939|NCT03286218|450440383|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221940|NCT03286218|450440384|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221941|NCT03286218|450440385|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
125221942|NCT03286218|450440374|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
125221943|NCT03286218|450440375|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
125221944|NCT03286218|450440376|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
125221945|NCT03286218|450440377|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
125221946|NCT03286218|450440378|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
125221947|NCT03286218|450440379|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
125221948|NCT03286218|450440380|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
125221949|NCT03286218|450440381|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
125221950|NCT03286218|450440382|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
125221951|NCT03286218|450440383|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
125221952|NCT03286218|450440384|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
125221953|NCT03286218|450440385|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
125221954|NCT03286218|450440374|FG000|Qualification Phase Period 2|Protocol Violation|2|||
125221955|NCT03286218|450440375|FG001|Qualification Phase Period 2|Protocol Violation|0|||
125221956|NCT03286218|450440376|FG002|Qualification Phase Period 2|Protocol Violation|0|||
125221957|NCT03286218|450440377|FG003|Qualification Phase Period 2|Protocol Violation|0|||
125221958|NCT03286218|450440378|FG004|Qualification Phase Period 2|Protocol Violation|0|||
125221959|NCT03286218|450440379|FG005|Qualification Phase Period 2|Protocol Violation|0|||
125221960|NCT03286218|450440380|FG006|Qualification Phase Period 2|Protocol Violation|0|||
125221961|NCT03286218|450440381|FG007|Qualification Phase Period 2|Protocol Violation|0|||
125221962|NCT03286218|450440382|FG008|Qualification Phase Period 2|Protocol Violation|0|||
125221963|NCT03286218|450440383|FG009|Qualification Phase Period 2|Protocol Violation|0|||
125221964|NCT03286218|450440384|FG010|Qualification Phase Period 2|Protocol Violation|0|||
125221965|NCT03286218|450440385|FG011|Qualification Phase Period 2|Protocol Violation|0|||
125221966|NCT03286218|450440374|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
125221967|NCT03286218|450440375|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
125221968|NCT03286218|450440376|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221969|NCT03286218|450440377|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221970|NCT03286218|450440378|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221971|NCT03286218|450440379|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221972|NCT03286218|450440380|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221973|NCT03286218|450440381|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221974|NCT03286218|450440382|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221975|NCT03286218|450440383|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221976|NCT03286218|450440384|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221977|NCT03286218|450440385|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
125221978|NCT03286218|450440374|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221979|NCT03286218|450440375|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221980|NCT03286218|450440376|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
125221981|NCT03286218|450440377|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
125221982|NCT03286218|450440378|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221983|NCT03286218|450440379|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
125221984|NCT03286218|450440380|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221985|NCT03286218|450440381|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221986|NCT03286218|450440382|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221987|NCT03286218|450440383|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221988|NCT03286218|450440384|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
125221989|NCT03286218|450440385|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
125221990|NCT03286218|450440374|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221991|NCT03286218|450440375|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221992|NCT03286218|450440376|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221993|NCT03286218|450440377|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221994|NCT03286218|450440378|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221995|NCT03286218|450440379|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221996|NCT03286218|450440380|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221997|NCT03286218|450440381|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221998|NCT03286218|450440382|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
125221999|NCT03286218|450440383|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
125222000|NCT03286218|450440384|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
125222001|NCT03286218|450440385|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
125222002|NCT01348139|450440386|FG000|Period 1|Adverse Event|1|||
125222003|NCT01348139|450440387|FG001|Period 1|Adverse Event|0|||
125222004|NCT01348139|450440388|FG002|Period 1|Adverse Event|0|||
125222005|NCT01348139|450440389|FG003|Period 1|Adverse Event|0|||
125222006|NCT01348139|450440390|FG004|Period 1|Adverse Event|0|||
125222007|NCT01348139|450440391|FG005|Period 1|Adverse Event|0|||
125222008|NCT02762084|450440394|FG000|Overall Study|Withdrawal by Subject|1|||
125222009|NCT02762084|450440395|FG001|Overall Study|Withdrawal by Subject|0|||
125222010|NCT02762084|450440396|FG002|Overall Study|Withdrawal by Subject|0|||
125222011|NCT02762084|450440394|FG000|Overall Study|Adverse Event|0|||
125222012|NCT02762084|450440395|FG001|Overall Study|Adverse Event|0|||
125222013|NCT02762084|450440396|FG002|Overall Study|Adverse Event|1|||
125222014|NCT01001910|450440399|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
125222015|NCT01619852|450440404|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
125222016|NCT01619852|450440405|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
125222017|NCT01619852|450440404|FG000|3 Month Follow up|Lost to Follow-up|31|||
125222018|NCT01619852|450440405|FG001|3 Month Follow up|Lost to Follow-up|34|||
125222019|NCT00970489|450440408|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
125222020|NCT00970489|450440409|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
125222021|NCT02168491|450440410|FG000|Overall Study|Withdrawal by Subject|1|||
125222022|NCT01096160|450440411|FG000|Overall Study|Adverse Event|0|||
125222023|NCT01096160|450440412|FG001|Overall Study|Adverse Event|0|||
125222024|NCT01096160|450440413|FG002|Overall Study|Adverse Event|1|||
125222025|NCT01096160|450440414|FG003|Overall Study|Adverse Event|0|||
125222026|NCT01096160|450440415|FG004|Overall Study|Adverse Event|0|||
125222027|NCT01096160|450440416|FG005|Overall Study|Adverse Event|0|||
125222028|NCT01096160|450440417|FG006|Overall Study|Adverse Event|0|||
125385287|NCT01277523|451044796|FG000|Overall Study|Adverse Event|1|||
125385288|NCT01277523|451044797|FG001|Overall Study|Adverse Event|0|||
125385289|NCT01277523|451044798|FG002|Overall Study|Adverse Event|0|||
125385290|NCT01277523|451044796|FG000|Overall Study|Protocol Violation|2|||
125385291|NCT01277523|451044797|FG001|Overall Study|Protocol Violation|0|||
125385292|NCT01277523|451044798|FG002|Overall Study|Protocol Violation|0|||
125385293|NCT01277523|451044796|FG000|Overall Study|Other Reason not Defined|0|||
125385294|NCT01277523|451044797|FG001|Overall Study|Other Reason not Defined|1|||
125385295|NCT01277523|451044798|FG002|Overall Study|Other Reason not Defined|0|||
125385296|NCT01030523|451044799|FG000|Initial Study (5 Years)|Death|1|||
125385297|NCT01030523|451044800|FG001|Initial Study (5 Years)|Death|0|||
125385298|NCT01030523|451044799|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
125385299|NCT01030523|451044800|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
125385300|NCT01030523|451044799|FG000|Initial Study (5 Years)|Implant failure|1|||
125385301|NCT01030523|451044800|FG001|Initial Study (5 Years)|Implant failure|0|||
125385302|NCT01030523|451044799|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
125385303|NCT01030523|451044800|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
125385304|NCT01030523|451044799|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
125385305|NCT01030523|451044800|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
125385306|NCT01030523|451044799|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
125385307|NCT01030523|451044800|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
125385308|NCT02389998|451044805|FG000|Overall Study|car accident|1|||
125385309|NCT02389998|451044806|FG001|Overall Study|car accident|0|||
125385310|NCT05089682|451044807|FG000|Overall Study|Withdrawal by Subject|2|||
125385311|NCT01996826|451044810|FG000|Overall Study|Lost to Follow-up|6|||
125385312|NCT01996826|451044811|FG001|Overall Study|Lost to Follow-up|2|||
125385313|NCT01996826|451044810|FG000|Overall Study|Physician Decision|1|||
125385314|NCT01996826|451044811|FG001|Overall Study|Physician Decision|1|||
125385315|NCT01514760|451044812|FG000|Overall Study|Lost to Follow-up|2|||
125385316|NCT02092662|451044813|FG000|Overall Study|Lost to Follow-up|13|||
125385317|NCT02092662|451044814|FG001|Overall Study|Lost to Follow-up|0|||
125385318|NCT03329690|451044817|FG000|Overall Study|Progressive disease per RECIST|85|||
125385319|NCT03329690|451044818|FG001|Overall Study|Progressive disease per RECIST|44|||
125385320|NCT03329690|451044819|FG002|Overall Study|Progressive disease per RECIST|6|||
125385321|NCT03329690|451044820|FG003|Overall Study|Progressive disease per RECIST|16|||
125385322|NCT03329690|451044821|FG004|Overall Study|Progressive disease per RECIST|20|||
125385323|NCT03329690|451044817|FG000|Overall Study|Clinical progression|7|||
125385324|NCT03329690|451044818|FG001|Overall Study|Clinical progression|4|||
125385325|NCT03329690|451044819|FG002|Overall Study|Clinical progression|1|||
125385326|NCT03329690|451044820|FG003|Overall Study|Clinical progression|1|||
125385327|NCT03329690|451044821|FG004|Overall Study|Clinical progression|1|||
125385328|NCT03329690|451044817|FG000|Overall Study|Adverse Event|22|||
125385329|NCT03329690|451044818|FG001|Overall Study|Adverse Event|4|||
125385330|NCT03329690|451044819|FG002|Overall Study|Adverse Event|0|||
125385331|NCT03329690|451044820|FG003|Overall Study|Adverse Event|1|||
125385332|NCT03329690|451044821|FG004|Overall Study|Adverse Event|2|||
125385333|NCT03329690|451044817|FG000|Overall Study|Death|2|||
125385334|NCT03329690|451044818|FG001|Overall Study|Death|0|||
125385335|NCT03329690|451044819|FG002|Overall Study|Death|0|||
125385336|NCT03329690|451044820|FG003|Overall Study|Death|1|||
125385337|NCT03329690|451044821|FG004|Overall Study|Death|0|||
125385338|NCT03329690|451044817|FG000|Overall Study|Withdrawal by Subject|2|||
125385339|NCT03329690|451044818|FG001|Overall Study|Withdrawal by Subject|3|||
125385340|NCT03329690|451044819|FG002|Overall Study|Withdrawal by Subject|0|||
125385341|NCT03329690|451044820|FG003|Overall Study|Withdrawal by Subject|1|||
125385342|NCT03329690|451044821|FG004|Overall Study|Withdrawal by Subject|0|||
125385343|NCT03329690|451044817|FG000|Overall Study|Physician Decision|1|||
125385344|NCT03329690|451044818|FG001|Overall Study|Physician Decision|0|||
125385345|NCT03329690|451044819|FG002|Overall Study|Physician Decision|0|||
125385346|NCT03329690|451044820|FG003|Overall Study|Physician Decision|0|||
125385347|NCT03329690|451044821|FG004|Overall Study|Physician Decision|1|||
125385348|NCT03329690|451044817|FG000|Overall Study|Miscellaneous|6|||
125385349|NCT03329690|451044818|FG001|Overall Study|Miscellaneous|0|||
125385350|NCT03329690|451044819|FG002|Overall Study|Miscellaneous|0|||
125385351|NCT03329690|451044820|FG003|Overall Study|Miscellaneous|0|||
125385352|NCT03329690|451044821|FG004|Overall Study|Miscellaneous|0|||
125385353|NCT03329690|451044817|FG000|Overall Study|Did not receive treatment|1|||
125385354|NCT03329690|451044818|FG001|Overall Study|Did not receive treatment|0|||
125385355|NCT03329690|451044819|FG002|Overall Study|Did not receive treatment|0|||
125385356|NCT03329690|451044820|FG003|Overall Study|Did not receive treatment|1|||
125385357|NCT03329690|451044821|FG004|Overall Study|Did not receive treatment|0|||
125385358|NCT00099437|451044823|FG000|Overall Study|Lost to Follow-up|30|||
125385359|NCT00099437|451044824|FG001|Overall Study|Lost to Follow-up|33|||
125385360|NCT00099437|451044823|FG000|Overall Study|Death|293|||
125385361|NCT00099437|451044824|FG001|Overall Study|Death|261|||
125385362|NCT00099437|451044823|FG000|Overall Study|Withdrawal by Subject|6|||
125222029|NCT01096160|450440418|FG007|Overall Study|Adverse Event|0|||
125222030|NCT01096160|450440419|FG008|Overall Study|Adverse Event|0|||
125222031|NCT01096160|450440420|FG009|Overall Study|Adverse Event|1|||
125222032|NCT01096160|450440411|FG000|Overall Study|Met stopping criteria per protocol|0|||
125222033|NCT01096160|450440412|FG001|Overall Study|Met stopping criteria per protocol|0|||
125222034|NCT01096160|450440413|FG002|Overall Study|Met stopping criteria per protocol|0|||
125222035|NCT01096160|450440414|FG003|Overall Study|Met stopping criteria per protocol|0|||
125222036|NCT01096160|450440415|FG004|Overall Study|Met stopping criteria per protocol|1|||
125222037|NCT01096160|450440416|FG005|Overall Study|Met stopping criteria per protocol|0|||
125222038|NCT01096160|450440417|FG006|Overall Study|Met stopping criteria per protocol|2|||
125222039|NCT01096160|450440418|FG007|Overall Study|Met stopping criteria per protocol|0|||
125222040|NCT01096160|450440419|FG008|Overall Study|Met stopping criteria per protocol|2|||
125222041|NCT01096160|450440420|FG009|Overall Study|Met stopping criteria per protocol|0|||
125222042|NCT01610037|450440421|FG000|All Patients|Adverse Event|27|||
125222043|NCT01610037|450440422|FG001|All Patients|Adverse Event|22|||
125222044|NCT01610037|450440423|FG002|All Patients|Adverse Event|26|||
125222045|NCT01610037|450440421|FG000|All Patients|Withdrawal by Subject|12|||
125222046|NCT01610037|450440422|FG001|All Patients|Withdrawal by Subject|10|||
125222047|NCT01610037|450440423|FG002|All Patients|Withdrawal by Subject|20|||
125222048|NCT01610037|450440421|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
125222049|NCT01610037|450440422|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
125222050|NCT01610037|450440423|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
125222051|NCT01610037|450440421|FG000|All Patients|Death|4|||
125222052|NCT01610037|450440422|FG001|All Patients|Death|2|||
125385363|NCT00099437|451044824|FG001|Overall Study|Withdrawal by Subject|10|||
125385364|NCT00099437|451044823|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
125385365|NCT00099437|451044824|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
125385366|NCT02488681|451044827|FG000|Overall Study|Implant unsuccessful|7|||
125385367|NCT05413369|451044828|FG000|Overall Study|Adverse Event|1|||
125385368|NCT05413369|451044829|FG001|Overall Study|Adverse Event|1|||
125385369|NCT05413369|451044828|FG000|Overall Study|Withdrawal by Subject|13|||
125385370|NCT05413369|451044829|FG001|Overall Study|Withdrawal by Subject|4|||
125385371|NCT05413369|451044828|FG000|Overall Study|Non-compliance with study schedule|2|||
125385372|NCT05413369|451044829|FG001|Overall Study|Non-compliance with study schedule|1|||
125385373|NCT05413369|451044828|FG000|Overall Study|Other|1|||
125385374|NCT05413369|451044829|FG001|Overall Study|Other|1|||
125385375|NCT00720057|451044830|FG000|Overall Study|Lost to Follow-up|0|||
125385376|NCT00720057|451044831|FG001|Overall Study|Lost to Follow-up|2|||
125385377|NCT00720057|451044830|FG000|Overall Study|Protocol Violation|1|||
125385378|NCT00720057|451044831|FG001|Overall Study|Protocol Violation|0|||
125385379|NCT00720057|451044830|FG000|Overall Study|Withdrawal by Subject|0|||
125385380|NCT00720057|451044831|FG001|Overall Study|Withdrawal by Subject|1|||
125385381|NCT03341533|451044839|FG000|Overall Study|Withdrawal by Subject|1|||
125385382|NCT03341533|451044840|FG001|Overall Study|Withdrawal by Subject|1|||
125385383|NCT03341533|451044839|FG000|Overall Study|Not eligible after randomization|2|||
125385384|NCT03341533|451044840|FG001|Overall Study|Not eligible after randomization|1|||
125385385|NCT03447990|451044842|FG000|Overall Study|Withdrawal by Subject|0|||
125385386|NCT03447990|451044843|FG001|Overall Study|Withdrawal by Subject|0|||
125385387|NCT03447990|451044844|FG002|Overall Study|Withdrawal by Subject|0|||
125385388|NCT03447990|451044845|FG003|Overall Study|Withdrawal by Subject|0|||
125385389|NCT03447990|451044846|FG004|Overall Study|Withdrawal by Subject|0|||
125385390|NCT03447990|451044847|FG005|Overall Study|Withdrawal by Subject|0|||
125385391|NCT03447990|451044848|FG006|Overall Study|Withdrawal by Subject|1|||
125385392|NCT04170348|451044849|FG000|Overall Study|Lost to Follow-up|2|||
125385393|NCT04170348|451044850|FG001|Overall Study|Lost to Follow-up|2|||
125385394|NCT04170348|451044849|FG000|Overall Study|Withdrawal by Subject|1|||
125385395|NCT04170348|451044850|FG001|Overall Study|Withdrawal by Subject|5|||
125385396|NCT04170348|451044849|FG000|Overall Study|Non-adherence|1|||
125385397|NCT04170348|451044850|FG001|Overall Study|Non-adherence|1|||
125385398|NCT04170348|451044849|FG000|Overall Study|Adverse Event|1|||
125385399|NCT04170348|451044850|FG001|Overall Study|Adverse Event|0|||
125385400|NCT05104567|451044851|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
125385401|NCT05104567|451044852|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
125385402|NCT05104567|451044853|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
125385403|NCT05104567|451044854|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
125385404|NCT05104567|451044855|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
125385405|NCT05104567|451044856|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
125385406|NCT05104567|451044857|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
125222053|NCT01610037|450440423|FG002|All Patients|Death|1|||
125222054|NCT01610037|450440421|FG000|All Patients|Protocol deviation|4|||
125385407|NCT05104567|451044851|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
125385408|NCT05104567|451044852|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
125385409|NCT05104567|451044853|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
125222055|NCT01610037|450440422|FG001|All Patients|Protocol deviation|3|||
125222056|NCT01610037|450440423|FG002|All Patients|Protocol deviation|3|||
125222057|NCT01610037|450440421|FG000|All Patients|Abnormal laboratory value|1|||
125222058|NCT01610037|450440422|FG001|All Patients|Abnormal laboratory value|1|||
125222059|NCT01610037|450440423|FG002|All Patients|Abnormal laboratory value|0|||
125222060|NCT01610037|450440421|FG000|All Patients|Administrative problems|1|||
125222061|NCT01610037|450440422|FG001|All Patients|Administrative problems|4|||
125222062|NCT01610037|450440423|FG002|All Patients|Administrative problems|4|||
125222063|NCT01610037|450440421|FG000|All Patients|Lost to Follow-up|1|||
125222064|NCT01610037|450440422|FG001|All Patients|Lost to Follow-up|0|||
125222065|NCT01610037|450440423|FG002|All Patients|Lost to Follow-up|0|||
125222066|NCT01610037|450440421|FG000|All Patients|Abnormal test procedure result(s)|0|||
125222067|NCT01610037|450440422|FG001|All Patients|Abnormal test procedure result(s)|1|||
125222068|NCT01610037|450440423|FG002|All Patients|Abnormal test procedure result(s)|3|||
125222069|NCT01610037|450440421|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
125222070|NCT01610037|450440422|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
125222071|NCT01610037|450440423|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
125222072|NCT01610037|450440421|FG000|Treatment and Follow up Period|Death|10|||
125222073|NCT01610037|450440422|FG001|Treatment and Follow up Period|Death|5|||
125222074|NCT01610037|450440423|FG002|Treatment and Follow up Period|Death|4|||
125222075|NCT01610037|450440421|FG000|Treatment and Follow up Period|Administrative problems|1|||
125222076|NCT01610037|450440422|FG001|Treatment and Follow up Period|Administrative problems|3|||
125222077|NCT01610037|450440423|FG002|Treatment and Follow up Period|Administrative problems|2|||
125222078|NCT01610037|450440421|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
125222079|NCT01610037|450440422|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
125222080|NCT01610037|450440423|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
125222081|NCT00705757|450440424|FG000|Overall Study|Lack of Efficacy|5|||
125222082|NCT00705757|450440425|FG001|Overall Study|Lack of Efficacy|1|||
125222083|NCT00705757|450440426|FG002|Overall Study|Lack of Efficacy|3|||
125222084|NCT00705757|450440424|FG000|Overall Study|Lost to Follow-up|7|||
125222085|NCT00705757|450440425|FG001|Overall Study|Lost to Follow-up|6|||
125222086|NCT00705757|450440426|FG002|Overall Study|Lost to Follow-up|6|||
125222087|NCT00705757|450440424|FG000|Overall Study|Withdrawal by Subject|1|||
125222088|NCT00705757|450440425|FG001|Overall Study|Withdrawal by Subject|1|||
125222089|NCT00705757|450440426|FG002|Overall Study|Withdrawal by Subject|2|||
125222090|NCT03193047|450440427|FG000|Overall Study|Physician Decision|1|||
125222091|NCT03193047|450440428|FG001|Overall Study|Physician Decision|0|||
125222092|NCT03193047|450440427|FG000|Overall Study|Participant Left State|1|||
125222093|NCT03193047|450440428|FG001|Overall Study|Participant Left State|0|||
125385410|NCT05104567|451044854|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
125385411|NCT05104567|451044855|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
125385412|NCT05104567|451044856|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
125385413|NCT05104567|451044857|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
125385414|NCT05104567|451044851|FG000|Overall Study|Progressive disease|3|||
125385415|NCT05104567|451044852|FG001|Overall Study|Progressive disease|13|||
125385416|NCT05104567|451044853|FG002|Overall Study|Progressive disease|13|||
125385417|NCT05104567|451044854|FG003|Overall Study|Progressive disease|17|||
125385418|NCT05104567|451044855|FG004|Overall Study|Progressive disease|17|||
125385419|NCT05104567|451044856|FG005|Overall Study|Progressive disease|28|||
125385420|NCT05104567|451044857|FG006|Overall Study|Progressive disease|24|||
125385421|NCT05104567|451044851|FG000|Overall Study|Withdrawal by Subject|1|||
125385422|NCT05104567|451044852|FG001|Overall Study|Withdrawal by Subject|1|||
125385423|NCT05104567|451044853|FG002|Overall Study|Withdrawal by Subject|2|||
125385424|NCT05104567|451044854|FG003|Overall Study|Withdrawal by Subject|0|||
125385425|NCT05104567|451044855|FG004|Overall Study|Withdrawal by Subject|0|||
125385426|NCT05104567|451044856|FG005|Overall Study|Withdrawal by Subject|0|||
125385427|NCT05104567|451044857|FG006|Overall Study|Withdrawal by Subject|0|||
125385428|NCT05104567|451044851|FG000|Overall Study|Other|1|||
125385429|NCT05104567|451044852|FG001|Overall Study|Other|1|||
125385430|NCT05104567|451044853|FG002|Overall Study|Other|1|||
125222094|NCT03743025|450440429|FG000|Overall Study|Surgery was cancelled|2|||
125385431|NCT05104567|451044854|FG003|Overall Study|Other|0|||
125385432|NCT05104567|451044855|FG004|Overall Study|Other|0|||
125385433|NCT05104567|451044856|FG005|Overall Study|Other|0|||
125222095|NCT03743025|450440430|FG001|Overall Study|Surgery was cancelled|1|||
125222096|NCT02420119|450440431|FG000|Overall Study|insufficient laboratory data|5|||
125222097|NCT00149396|450440432|FG000|Overall Study|Death|15|||
125222098|NCT00149396|450440432|FG000|Overall Study|Withdrawal by Subject|1|||
125385434|NCT05104567|451044857|FG006|Overall Study|Other|0|||
125385435|NCT01602380|451044861|FG000|Overall Study|Death|147|||
125385436|NCT01602380|451044862|FG001|Overall Study|Death|145|||
125385437|NCT01602380|451044861|FG000|Overall Study|Withdrawal by Subject|39|||
125385438|NCT01602380|451044862|FG001|Overall Study|Withdrawal by Subject|41|||
125222099|NCT00149396|450440432|FG000|Overall Study|Subject noncompliance|2|||
125222100|NCT00149396|450440432|FG000|Overall Study|other treatment|5|||
125222101|NCT00186485|450440435|FG000|Overall Study|Lost to Follow-up|3|||
125222102|NCT00227539|450440438|FG000|Overall Study|Protocol Violation|1|||
125222103|NCT01922258|450440439|FG000|Overall Study|Lost to Follow-up|1|||
125222104|NCT01922258|450440440|FG001|Overall Study|Lost to Follow-up|1|||
125222105|NCT01922258|450440439|FG000|Overall Study|Adverse Event|9|||
125222106|NCT01922258|450440440|FG001|Overall Study|Adverse Event|2|||
125222107|NCT01922258|450440439|FG000|Overall Study|Met Withdrawal Criteria|0|||
125222108|NCT01922258|450440440|FG001|Overall Study|Met Withdrawal Criteria|4|||
125222109|NCT01922258|450440439|FG000|Overall Study|Withdrawn by the Investigator|1|||
125222110|NCT01922258|450440440|FG001|Overall Study|Withdrawn by the Investigator|4|||
125222111|NCT01922258|450440439|FG000|Overall Study|Withdrawal by participant|5|||
125222112|NCT01922258|450440440|FG001|Overall Study|Withdrawal by participant|5|||
125222113|NCT00673257|450440441|FG000|Overall Study|Withdrawal by Subject|4|||
125222114|NCT00673257|450440441|FG000|Overall Study|Unable to obtain specimen|1|||
125222115|NCT04552132|450440442|FG000|Overall Study|Lost to Follow-up|4|||
125222116|NCT04552132|450440443|FG001|Overall Study|Lost to Follow-up|3|||
125222117|NCT04552132|450440442|FG000|Overall Study|Protocol Violation|1|||
125222118|NCT04552132|450440443|FG001|Overall Study|Protocol Violation|0|||
125222119|NCT02256839|450440444|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
125222120|NCT02256839|450440445|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
125222121|NCT01951417|450440460|FG000|Overall Study|Withdrawal by Subject|1|||
125222122|NCT01951417|450440460|FG000|Overall Study|Protocol Violation|2|||
125222123|NCT01951417|450440460|FG000|Overall Study|Lost to Follow-up|6|||
125222124|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
125222125|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
125222126|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Adverse Event|57|||
125222127|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Adverse Event|49|||
125222128|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
125222129|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
125222130|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Site closure|3|||
125222131|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Site closure|2|||
125222132|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
125138880|NCT00112437|450131219|FG015|Years 6-10 (60-Month Extension)|Death|0|||
125138881|NCT00112437|450131220|FG016|Years 6-10 (60-Month Extension)|Death|0|||
125138882|NCT00112437|450131221|FG017|Years 6-10 (60-Month Extension)|Death|0|||
125138883|NCT00112437|450131222|FG018|Years 6-10 (60-Month Extension)|Death|0|||
125138884|NCT00112437|450131223|FG019|Years 6-10 (60-Month Extension)|Death|0|||
125138885|NCT00112437|450131224|FG020|Years 6-10 (60-Month Extension)|Death|0|||
125138886|NCT00112437|450131225|FG021|Years 6-10 (60-Month Extension)|Death|0|||
125138887|NCT00112437|450131226|FG022|Years 6-10 (60-Month Extension)|Death|0|||
125138888|NCT00112437|450131227|FG023|Years 6-10 (60-Month Extension)|Death|2|||
125138889|NCT00112437|450131228|FG024|Years 6-10 (60-Month Extension)|Death|0|||
125138890|NCT00112437|450131229|FG025|Years 6-10 (60-Month Extension)|Death|0|||
125138891|NCT00112437|450131204|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138892|NCT00112437|450131205|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138893|NCT00112437|450131206|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138894|NCT00112437|450131207|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138895|NCT00112437|450131208|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138896|NCT00112437|450131209|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138897|NCT00112437|450131210|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138898|NCT00112437|450131211|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138899|NCT00112437|450131212|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138900|NCT00112437|450131213|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138901|NCT00112437|450131214|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138902|NCT00112437|450131215|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138903|NCT00112437|450131216|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138904|NCT00112437|450131217|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138905|NCT00112437|450131218|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138906|NCT00112437|450131219|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138907|NCT00112437|450131220|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138908|NCT00112437|450131221|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138909|NCT00112437|450131222|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138910|NCT00112437|450131223|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138911|NCT00112437|450131224|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138912|NCT00112437|450131225|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138913|NCT00112437|450131226|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138914|NCT00112437|450131227|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138915|NCT00112437|450131228|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
125138916|NCT00112437|450131229|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
125138917|NCT00112437|450131204|FG000|Years 6-10 (60-Month Extension)|Other|0|||
125138918|NCT00112437|450131205|FG001|Years 6-10 (60-Month Extension)|Other|0|||
125138919|NCT00112437|450131206|FG002|Years 6-10 (60-Month Extension)|Other|0|||
125138920|NCT00112437|450131207|FG003|Years 6-10 (60-Month Extension)|Other|0|||
125138921|NCT00112437|450131208|FG004|Years 6-10 (60-Month Extension)|Other|0|||
125138922|NCT00112437|450131209|FG005|Years 6-10 (60-Month Extension)|Other|0|||
125138923|NCT00112437|450131210|FG006|Years 6-10 (60-Month Extension)|Other|0|||
125138924|NCT00112437|450131211|FG007|Years 6-10 (60-Month Extension)|Other|0|||
125138925|NCT00112437|450131212|FG008|Years 6-10 (60-Month Extension)|Other|0|||
125138926|NCT00112437|450131213|FG009|Years 6-10 (60-Month Extension)|Other|0|||
125138927|NCT00112437|450131214|FG010|Years 6-10 (60-Month Extension)|Other|0|||
125138928|NCT00112437|450131215|FG011|Years 6-10 (60-Month Extension)|Other|0|||
125138929|NCT00112437|450131216|FG012|Years 6-10 (60-Month Extension)|Other|0|||
125138930|NCT00112437|450131217|FG013|Years 6-10 (60-Month Extension)|Other|0|||
125138931|NCT00112437|450131218|FG014|Years 6-10 (60-Month Extension)|Other|0|||
125138932|NCT00112437|450131219|FG015|Years 6-10 (60-Month Extension)|Other|0|||
125138933|NCT00112437|450131220|FG016|Years 6-10 (60-Month Extension)|Other|0|||
125138934|NCT00112437|450131221|FG017|Years 6-10 (60-Month Extension)|Other|0|||
125138935|NCT00112437|450131222|FG018|Years 6-10 (60-Month Extension)|Other|0|||
125138936|NCT00112437|450131223|FG019|Years 6-10 (60-Month Extension)|Other|0|||
125138937|NCT00112437|450131224|FG020|Years 6-10 (60-Month Extension)|Other|0|||
125222133|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
125222134|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Physician Decision|48|||
125222135|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Physician Decision|38|||
125222136|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
125222137|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
125222138|NCT01705977|450440467|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
125222139|NCT01705977|450440468|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
125222140|NCT01705977|450440467|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
125222141|NCT01705977|450440468|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
125222142|NCT01705977|450440467|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
125222143|NCT01705977|450440468|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
125222144|NCT01705977|450440467|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
125222145|NCT01705977|450440468|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
125222146|NCT01705977|450440467|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
125222147|NCT01705977|450440468|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
125222148|NCT00096538|450440470|FG000|Overall Study|Withdrawal by Subject|1|||
125222149|NCT01938846|450440471|FG000|Overall Study|Progressive disease|26|||
125222150|NCT01938846|450440472|FG001|Overall Study|Progressive disease|18|||
125222151|NCT01938846|450440473|FG002|Overall Study|Progressive disease|16|||
125222152|NCT01938846|450440471|FG000|Overall Study|Adverse Event|8|||
125222153|NCT01938846|450440472|FG001|Overall Study|Adverse Event|4|||
125222154|NCT01938846|450440473|FG002|Overall Study|Adverse Event|3|||
125222155|NCT01938846|450440471|FG000|Overall Study|Withdrawal by Subject|2|||
125222156|NCT01938846|450440472|FG001|Overall Study|Withdrawal by Subject|2|||
125222157|NCT01938846|450440473|FG002|Overall Study|Withdrawal by Subject|1|||
125222158|NCT01938846|450440471|FG000|Overall Study|Other than listed|5|||
125222159|NCT01938846|450440472|FG001|Overall Study|Other than listed|1|||
125222160|NCT01938846|450440473|FG002|Overall Study|Other than listed|4|||
125222161|NCT02324361|450440474|FG000|Overall Study|Lost to Follow-up|5|||
125222162|NCT02324361|450440475|FG001|Overall Study|Lost to Follow-up|2|||
125222163|NCT00808067|450440478|FG000|Overall Study|Major/minor bleed|30|||
125222164|NCT00808067|450440479|FG001|Overall Study|Major/minor bleed|44|||
125222165|NCT00808067|450440478|FG000|Overall Study|Outcome event - other|33|||
125222166|NCT00808067|450440479|FG001|Overall Study|Outcome event - other|25|||
125222167|NCT00808067|450440478|FG000|Overall Study|Adverse Event|111|||
125222168|NCT00808067|450440479|FG001|Overall Study|Adverse Event|121|||
125222169|NCT00808067|450440478|FG000|Overall Study|Hospitalization (not including surgery)|18|||
125222170|NCT00808067|450440479|FG001|Overall Study|Hospitalization (not including surgery)|17|||
125222171|NCT00808067|450440478|FG000|Overall Study|Hospitalization due to surgery|37|||
125222172|NCT00808067|450440479|FG001|Overall Study|Hospitalization due to surgery|40|||
125222173|NCT00808067|450440478|FG000|Overall Study|Reduced creatinine clearance|53|||
125222174|NCT00808067|450440479|FG001|Overall Study|Reduced creatinine clearance|55|||
125222175|NCT00808067|450440478|FG000|Overall Study|Elevated LFT results|7|||
125222176|NCT00808067|450440479|FG001|Overall Study|Elevated LFT results|3|||
125222177|NCT00808067|450440478|FG000|Overall Study|Patient refused to take study medication|65|||
125222178|NCT00808067|450440479|FG001|Overall Study|Patient refused to take study medication|76|||
125222179|NCT00808067|450440478|FG000|Overall Study|Missing|1|||
125222180|NCT00808067|450440479|FG001|Overall Study|Missing|0|||
125222181|NCT00808067|450440478|FG000|Overall Study|Death|1|||
125222182|NCT00808067|450440479|FG001|Overall Study|Death|1|||
125222183|NCT00808067|450440478|FG000|Overall Study|Procedure|6|||
125222184|NCT00808067|450440479|FG001|Overall Study|Procedure|7|||
125222185|NCT00808067|450440478|FG000|Overall Study|Withdrawal by Subject|21|||
125222186|NCT00808067|450440479|FG001|Overall Study|Withdrawal by Subject|25|||
125222187|NCT00808067|450440478|FG000|Overall Study|Site closed|4|||
125138938|NCT00112437|450131225|FG021|Years 6-10 (60-Month Extension)|Other|0|||
125138939|NCT00112437|450131226|FG022|Years 6-10 (60-Month Extension)|Other|0|||
125222188|NCT00808067|450440479|FG001|Overall Study|Site closed|3|||
125222189|NCT00808067|450440478|FG000|Overall Study|Physician Decision|47|||
125222190|NCT00808067|450440479|FG001|Overall Study|Physician Decision|38|||
125222191|NCT00808067|450440478|FG000|Overall Study|Protocol Violation|3|||
125138940|NCT00112437|450131227|FG023|Years 6-10 (60-Month Extension)|Other|0|||
125222192|NCT00808067|450440479|FG001|Overall Study|Protocol Violation|11|||
125222193|NCT00808067|450440478|FG000|Overall Study|Patient elected|7|||
125222194|NCT00808067|450440479|FG001|Overall Study|Patient elected|9|||
125222195|NCT00808067|450440478|FG000|Overall Study|Site closed for cause|19|||
125138941|NCT00112437|450131228|FG024|Years 6-10 (60-Month Extension)|Other|1|||
125138942|NCT00112437|450131229|FG025|Years 6-10 (60-Month Extension)|Other|0|||
125385439|NCT01602380|451044861|FG000|Overall Study|Lost to Follow-up|15|||
125385440|NCT01602380|451044862|FG001|Overall Study|Lost to Follow-up|12|||
125385441|NCT01602380|451044861|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125385442|NCT01602380|451044862|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
125385443|NCT01602380|451044861|FG000|Overall Study|Other|2|||
125385444|NCT01602380|451044862|FG001|Overall Study|Other|0|||
125385445|NCT03333044|451044863|FG000|Overall Study|Pregnancy|1|||
125385446|NCT03333044|451044864|FG001|Overall Study|Pregnancy|0|||
125385447|NCT03333044|451044865|FG002|Overall Study|Pregnancy|0|||
125385448|NCT03333044|451044863|FG000|Overall Study|Lost to Follow-up|0|||
125385449|NCT03333044|451044864|FG001|Overall Study|Lost to Follow-up|14|||
125385450|NCT03333044|451044865|FG002|Overall Study|Lost to Follow-up|6|||
125385451|NCT03188094|451044866|FG000|Overall Study|Screen failure|1|||
125385452|NCT03188094|451044867|FG001|Overall Study|Screen failure|0|||
125385453|NCT03188094|451044868|FG002|Overall Study|Screen failure|0|||
125385454|NCT03188094|451044866|FG000|Overall Study|Pregnancy|3|||
125385455|NCT03188094|451044867|FG001|Overall Study|Pregnancy|0|||
125385456|NCT03188094|451044868|FG002|Overall Study|Pregnancy|0|||
125385457|NCT03188094|451044866|FG000|Overall Study|Ineligible|1|||
125385458|NCT03188094|451044867|FG001|Overall Study|Ineligible|0|||
125385459|NCT03188094|451044868|FG002|Overall Study|Ineligible|0|||
125385460|NCT03188094|451044866|FG000|Overall Study|Lost to Follow-up|0|||
125385461|NCT03188094|451044867|FG001|Overall Study|Lost to Follow-up|0|||
125385462|NCT03188094|451044868|FG002|Overall Study|Lost to Follow-up|17|||
125385463|NCT04537234|451044872|FG000|Overall Study|Withdrawal by Subject|2|||
125385464|NCT04537234|451044873|FG001|Overall Study|Withdrawal by Subject|0|||
125385465|NCT04199117|451044876|FG000|Overall Study|Withdrawal by Subject|3|||
125385466|NCT04199117|451044877|FG001|Overall Study|Withdrawal by Subject|0|||
125385467|NCT04199117|451044878|FG002|Overall Study|Withdrawal by Subject|0|||
125385468|NCT04199117|451044879|FG003|Overall Study|Withdrawal by Subject|1|||
125385469|NCT04199117|451044880|FG004|Overall Study|Withdrawal by Subject|1|||
125385470|NCT04199117|451044881|FG005|Overall Study|Withdrawal by Subject|0|||
125385471|NCT04199117|451044882|FG006|Overall Study|Withdrawal by Subject|0|||
125385472|NCT04199117|451044883|FG007|Overall Study|Withdrawal by Subject|2|||
125222196|NCT00808067|450440479|FG001|Overall Study|Site closed for cause|19|||
125222197|NCT00808067|450440478|FG000|Overall Study|Other reason not defined above|5|||
125385473|NCT04199117|451044884|FG008|Overall Study|Withdrawal by Subject|0|||
125385474|NCT04199117|451044885|FG009|Overall Study|Withdrawal by Subject|0|||
125385475|NCT04199117|451044886|FG010|Overall Study|Withdrawal by Subject|1|||
125385476|NCT04199117|451044887|FG011|Overall Study|Withdrawal by Subject|1|||
125385477|NCT04199117|451044888|FG012|Overall Study|Withdrawal by Subject|2|||
125385478|NCT04199117|451044889|FG013|Overall Study|Withdrawal by Subject|1|||
125385479|NCT04199117|451044890|FG014|Overall Study|Withdrawal by Subject|1|||
125385480|NCT04199117|451044891|FG015|Overall Study|Withdrawal by Subject|1|||
125385481|NCT04199117|451044876|FG000|Overall Study|Death|1|||
125385482|NCT04199117|451044877|FG001|Overall Study|Death|1|||
125385483|NCT04199117|451044878|FG002|Overall Study|Death|0|||
125385484|NCT04199117|451044879|FG003|Overall Study|Death|0|||
125385485|NCT04199117|451044880|FG004|Overall Study|Death|0|||
125385486|NCT04199117|451044881|FG005|Overall Study|Death|0|||
125385487|NCT04199117|451044882|FG006|Overall Study|Death|0|||
125385488|NCT04199117|451044883|FG007|Overall Study|Death|0|||
125385489|NCT04199117|451044884|FG008|Overall Study|Death|0|||
125385490|NCT04199117|451044885|FG009|Overall Study|Death|0|||
125385491|NCT04199117|451044886|FG010|Overall Study|Death|0|||
125385492|NCT04199117|451044887|FG011|Overall Study|Death|1|||
125385493|NCT04199117|451044888|FG012|Overall Study|Death|0|||
125385494|NCT04199117|451044889|FG013|Overall Study|Death|1|||
125385495|NCT04199117|451044890|FG014|Overall Study|Death|0|||
125222198|NCT00808067|450440479|FG001|Overall Study|Other reason not defined above|5|||
125222199|NCT00808067|450440478|FG000|Overall Study|Excluded from analysis|13|||
125385496|NCT04199117|451044891|FG015|Overall Study|Death|0|||
125385497|NCT04199117|451044876|FG000|Overall Study|Withdrawal by PI|0|||
125385498|NCT04199117|451044877|FG001|Overall Study|Withdrawal by PI|0|||
125385499|NCT04199117|451044878|FG002|Overall Study|Withdrawal by PI|0|||
125385500|NCT04199117|451044879|FG003|Overall Study|Withdrawal by PI|0|||
125385501|NCT04199117|451044880|FG004|Overall Study|Withdrawal by PI|0|||
125438409|NCT01799720|451232247|FG001|Overall Study|Withdrawal by Subject|0|||
125438410|NCT01799720|451232248|FG002|Overall Study|Withdrawal by Subject|0|||
125385502|NCT04199117|451044881|FG005|Overall Study|Withdrawal by PI|0|||
125385503|NCT04199117|451044882|FG006|Overall Study|Withdrawal by PI|0|||
125385504|NCT04199117|451044883|FG007|Overall Study|Withdrawal by PI|0|||
125385505|NCT04199117|451044884|FG008|Overall Study|Withdrawal by PI|0|||
125385506|NCT04199117|451044885|FG009|Overall Study|Withdrawal by PI|0|||
125385507|NCT04199117|451044886|FG010|Overall Study|Withdrawal by PI|0|||
125385508|NCT04199117|451044887|FG011|Overall Study|Withdrawal by PI|0|||
125385509|NCT04199117|451044888|FG012|Overall Study|Withdrawal by PI|1|||
125385510|NCT04199117|451044889|FG013|Overall Study|Withdrawal by PI|0|||
125138943|NCT00112437|450131204|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138944|NCT00112437|450131205|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138945|NCT00112437|450131206|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138946|NCT00112437|450131207|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125385511|NCT04199117|451044890|FG014|Overall Study|Withdrawal by PI|0|||
125385512|NCT04199117|451044891|FG015|Overall Study|Withdrawal by PI|0|||
125385513|NCT05478252|451044892|FG000|Overall Study|Withdrawal by Subject|2|||
125385514|NCT05478252|451044893|FG001|Overall Study|Withdrawal by Subject|3|||
125385515|NCT05478252|451044892|FG000|Overall Study|Lost to Follow-up|4|||
125385516|NCT05478252|451044893|FG001|Overall Study|Lost to Follow-up|2|||
125385517|NCT05478252|451044892|FG000|Overall Study|Physician Decision|1|||
125385518|NCT05478252|451044893|FG001|Overall Study|Physician Decision|1|||
125385519|NCT05478252|451044892|FG000|Overall Study|Death|1|||
125385520|NCT05478252|451044893|FG001|Overall Study|Death|0|||
125385521|NCT07114198|451044900|FG000|Overall Study|Protocol Violation|1|||
125385522|NCT07114198|451044901|FG001|Overall Study|Protocol Violation|1|||
125138947|NCT00112437|450131208|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138948|NCT00112437|450131209|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125385523|NCT00939809|451046651|FG000|Overall Study|Adverse Event|2|||
125385524|NCT00939809|451046651|FG000|Overall Study|Death|1|||
125385525|NCT00773292|451046652|FG000|Treatment 48 Weeks|Adverse Event|1|||
125222200|NCT00808067|450440479|FG001|Overall Study|Excluded from analysis|19|||
125222201|NCT05027815|450440488|FG000|Overall Study|Death|2|||
125222202|NCT05027815|450440489|FG001|Overall Study|Death|1|||
125222203|NCT03677869|450440490|FG000|Overall Study|Withdrawal by Subject|1|||
125222204|NCT03877224|450440491|FG000|Overall Study|Death|3|||
125222205|NCT03877224|450440492|FG001|Overall Study|Death|2|||
125222206|NCT03877224|450440491|FG000|Overall Study|Withdrawal by Subject|1|||
125385526|NCT00773292|451046652|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
125385527|NCT01859494|451046653|FG000|Overall Study|Adverse Event|1|||
125385528|NCT00518323|451046659|FG000|Overall Study|Lack of Efficacy|14|||
125385529|NCT00518323|451046660|FG001|Overall Study|Lack of Efficacy|2|||
125385530|NCT00518323|451046661|FG002|Overall Study|Lack of Efficacy|4|||
125385531|NCT00518323|451046662|FG003|Overall Study|Lack of Efficacy|20|||
125385532|NCT00518323|451046659|FG000|Overall Study|Withdrawal by Subject|1|||
125385533|NCT00518323|451046660|FG001|Overall Study|Withdrawal by Subject|2|||
125385534|NCT00518323|451046661|FG002|Overall Study|Withdrawal by Subject|4|||
125385535|NCT00518323|451046662|FG003|Overall Study|Withdrawal by Subject|2|||
125385536|NCT00518323|451046659|FG000|Overall Study|Lost to Follow-up|0|||
125222207|NCT03877224|450440492|FG001|Overall Study|Withdrawal by Subject|6|||
125222208|NCT03877224|450440491|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
125222209|NCT03877224|450440492|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
125222210|NCT00447902|450440493|FG000|Overall Study|Adverse Event|0|||
125222211|NCT00447902|450440494|FG001|Overall Study|Adverse Event|3|||
125222212|NCT00447902|450440493|FG000|Overall Study|Protocol Violation|1|||
125222213|NCT00447902|450440494|FG001|Overall Study|Protocol Violation|0|||
125222214|NCT00447902|450440493|FG000|Overall Study|Withdrawal by Subject|0|||
125222215|NCT00447902|450440494|FG001|Overall Study|Withdrawal by Subject|1|||
125222216|NCT00447902|450440493|FG000|Overall Study|included patients who discontinued|1|||
125222217|NCT00447902|450440494|FG001|Overall Study|included patients who discontinued|1|||
125222218|NCT00447902|450440493|FG000|Overall Study|Lack of Efficacy|2|||
125222219|NCT00447902|450440494|FG001|Overall Study|Lack of Efficacy|1|||
125222220|NCT04754542|450440495|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
125222221|NCT04754542|450440496|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
125222222|NCT04771013|450442667|FG000|Overall Study|Withdrawal by Subject|2|||
125222223|NCT04771013|450442668|FG001|Overall Study|Withdrawal by Subject|0|||
125222224|NCT04771013|450442667|FG000|Overall Study|Death|0|||
125222225|NCT04771013|450442668|FG001|Overall Study|Death|5|||
125222226|NCT04771013|450442667|FG000|Overall Study|Referred to another hospital before day 20|0|||
125222227|NCT04771013|450442668|FG001|Overall Study|Referred to another hospital before day 20|1|||
125222228|NCT01519817|450442670|FG000|Overall Study|Withdrawal by Subject|1|||
125222229|NCT01519817|450442671|FG001|Overall Study|Withdrawal by Subject|0|||
125222230|NCT01519817|450442672|FG002|Overall Study|Withdrawal by Subject|0|||
125222231|NCT01519817|450442673|FG003|Overall Study|Withdrawal by Subject|0|||
125222232|NCT01519817|450442670|FG000|Overall Study|Off study due to infection|0|||
125222233|NCT01519817|450442671|FG001|Overall Study|Off study due to infection|0|||
125222234|NCT01519817|450442672|FG002|Overall Study|Off study due to infection|0|||
125222235|NCT01519817|450442673|FG003|Overall Study|Off study due to infection|1|||
125222236|NCT02999789|450442676|FG000|Overall Study|Withdrawal by Subject|0|||
125222237|NCT02999789|450442677|FG001|Overall Study|Withdrawal by Subject|1|||
125222238|NCT02999789|450442676|FG000|Overall Study|Became ineligible|1|||
125222239|NCT02999789|450442677|FG001|Overall Study|Became ineligible|2|||
125222240|NCT00737100|450442686|FG000|Overall Study|Adverse Event|6|||
125222241|NCT00737100|450442687|FG001|Overall Study|Adverse Event|5|||
125222242|NCT00737100|450442688|FG002|Overall Study|Adverse Event|3|||
125222243|NCT00737100|450442686|FG000|Overall Study|Lost to Follow-up|0|||
125222244|NCT00737100|450442687|FG001|Overall Study|Lost to Follow-up|1|||
125222245|NCT00737100|450442688|FG002|Overall Study|Lost to Follow-up|0|||
125222246|NCT00737100|450442686|FG000|Overall Study|Withdrawal by Subject|0|||
125222247|NCT00737100|450442687|FG001|Overall Study|Withdrawal by Subject|0|||
125222248|NCT00737100|450442688|FG002|Overall Study|Withdrawal by Subject|3|||
125222249|NCT00737100|450442686|FG000|Overall Study|Reason discontinued not explained above|1|||
125222250|NCT00737100|450442687|FG001|Overall Study|Reason discontinued not explained above|1|||
125222251|NCT00737100|450442688|FG002|Overall Study|Reason discontinued not explained above|1|||
125222252|NCT01447407|450442689|FG000|Overall Study|Withdrawal by Subject|2|||
125222253|NCT01447407|450442690|FG001|Overall Study|Withdrawal by Subject|0|||
125385537|NCT00518323|451046660|FG001|Overall Study|Lost to Follow-up|2|||
125222254|NCT01447407|450442691|FG002|Overall Study|Withdrawal by Subject|0|||
125222255|NCT01447407|450442692|FG003|Overall Study|Withdrawal by Subject|1|||
125222256|NCT01447407|450442689|FG000|Overall Study|Physician Decision|0|||
125222257|NCT01447407|450442690|FG001|Overall Study|Physician Decision|0|||
125222258|NCT01447407|450442691|FG002|Overall Study|Physician Decision|1|||
125222259|NCT01447407|450442692|FG003|Overall Study|Physician Decision|1|||
125222260|NCT01265394|450442693|FG000|Overall Study|Subjects withdrawn|37|||
125385538|NCT00518323|451046661|FG002|Overall Study|Lost to Follow-up|1|||
125385539|NCT00518323|451046662|FG003|Overall Study|Lost to Follow-up|3|||
125222261|NCT03131167|450442694|FG000|Overall Study|Other (Unspecified)|0|||
125222262|NCT03131167|450442695|FG001|Overall Study|Other (Unspecified)|0|||
125222263|NCT03131167|450442696|FG002|Overall Study|Other (Unspecified)|0|||
125222264|NCT03131167|450442697|FG003|Overall Study|Other (Unspecified)|0|||
125222265|NCT03131167|450442698|FG004|Overall Study|Other (Unspecified)|0|||
125222266|NCT03131167|450442699|FG005|Overall Study|Other (Unspecified)|1|||
125222267|NCT03131167|450442700|FG006|Overall Study|Other (Unspecified)|0|||
125222268|NCT03131167|450442701|FG007|Overall Study|Other (Unspecified)|0|||
125222269|NCT03131167|450442702|FG008|Overall Study|Other (Unspecified)|0|||
125222270|NCT03131167|450442703|FG009|Overall Study|Other (Unspecified)|0|||
125222271|NCT03131167|450442704|FG010|Overall Study|Other (Unspecified)|0|||
125222272|NCT03131167|450442705|FG011|Overall Study|Other (Unspecified)|0|||
125222273|NCT03131167|450442706|FG012|Overall Study|Other (Unspecified)|0|||
125222274|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Death|20|||
125222275|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Death|26|||
125222276|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
125222277|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
125222278|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
125222279|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
125222280|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
125222281|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
125222282|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
125222283|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
125222284|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
125222285|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
125222286|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
125222287|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
125222288|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
125222289|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
125222290|NCT00643201|450442707|FG000|Randomized, Completed 6 Months of Study|Other|107|||
125222291|NCT00643201|450442708|FG001|Randomized, Completed 6 Months of Study|Other|107|||
125222292|NCT00643201|450442707|FG000|Completed Study Follow Up|Death|28|||
125222293|NCT00643201|450442708|FG001|Completed Study Follow Up|Death|34|||
125222294|NCT00643201|450442707|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
125222295|NCT00643201|450442708|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
125222296|NCT00643201|450442707|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
125222297|NCT00643201|450442708|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
125222298|NCT00643201|450442707|FG000|Completed Study Follow Up|non-specified|1|||
125222299|NCT00643201|450442708|FG001|Completed Study Follow Up|non-specified|0|||
125222300|NCT00165503|450442709|FG000|Overall Study|Death|1|||
125222301|NCT00165503|450442709|FG000|Overall Study|Lost to Follow-up|12|||
125222302|NCT00165503|450442709|FG000|Overall Study|Unresectable|3|||
125222303|NCT02346708|450442710|FG000|Overall Study|Adverse Event|2|||
125222304|NCT02346708|450442711|FG001|Overall Study|Adverse Event|0|||
125222305|NCT02346708|450442710|FG000|Overall Study|Protocol Violation|0|||
125222306|NCT02346708|450442711|FG001|Overall Study|Protocol Violation|1|||
125222307|NCT02976519|450442712|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
125222308|NCT02976519|450442713|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
125222309|NCT02976519|450442714|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
125222310|NCT02976519|450442715|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
125222311|NCT02976519|450442716|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
125222312|NCT02976519|450442717|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
125222313|NCT02976519|450442718|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
125222314|NCT02976519|450442712|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
125222315|NCT02976519|450442713|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
125222316|NCT02976519|450442714|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
125222317|NCT02976519|450442715|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
125222318|NCT02976519|450442716|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
125222319|NCT02976519|450442717|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
125222320|NCT02976519|450442718|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
125222321|NCT02976519|450442712|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
125222322|NCT02976519|450442713|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
125222323|NCT02976519|450442714|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
125222324|NCT02976519|450442715|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
125222325|NCT02976519|450442716|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
125385540|NCT00518323|451046659|FG000|Overall Study|Adverse Event|1|||
125385541|NCT00518323|451046660|FG001|Overall Study|Adverse Event|1|||
125385542|NCT00518323|451046661|FG002|Overall Study|Adverse Event|1|||
125385543|NCT00518323|451046662|FG003|Overall Study|Adverse Event|0|||
125385544|NCT00518323|451046659|FG000|Overall Study|Prohibited medication and others|3|||
125385545|NCT00518323|451046660|FG001|Overall Study|Prohibited medication and others|1|||
125385546|NCT00518323|451046661|FG002|Overall Study|Prohibited medication and others|1|||
125385547|NCT00518323|451046662|FG003|Overall Study|Prohibited medication and others|0|||
125385548|NCT02255981|451046663|FG000|Overall Study|Lost to Follow-up|3|||
125385549|NCT02255981|451046663|FG000|Overall Study|Withdrawal by Subject|1|||
125385550|NCT02418468|451046664|FG000|Overall Study|Adverse Event|1|||
125385551|NCT02418468|451046665|FG001|Overall Study|Adverse Event|0|||
125385552|NCT02418468|451046664|FG000|Overall Study|Withdrawal of informed consent|1|||
125385553|NCT02418468|451046665|FG001|Overall Study|Withdrawal of informed consent|1|||
125385554|NCT02914769|451046666|FG000|Overall Study|Protocol Violation|3|||
125385555|NCT02914769|451046667|FG001|Overall Study|Protocol Violation|2|||
125385556|NCT02914769|451046666|FG000|Overall Study|Withdrawal by Subject|0|||
125385557|NCT02914769|451046667|FG001|Overall Study|Withdrawal by Subject|1|||
125385558|NCT02337907|451046670|FG000|Overall Study|Other than listed|1|||
125385559|NCT02337907|451046671|FG001|Overall Study|Other than listed|0|||
125385560|NCT02337907|451046672|FG002|Overall Study|Other than listed|0|||
125385561|NCT02337907|451046673|FG003|Overall Study|Other than listed|1|||
125385562|NCT02337907|451046674|FG004|Overall Study|Other than listed|1|||
125385563|NCT02337907|451046675|FG005|Overall Study|Other than listed|0|||
125385564|NCT02337907|451046670|FG000|Overall Study|Withdrawal by Subject|2|||
125385565|NCT02337907|451046671|FG001|Overall Study|Withdrawal by Subject|3|||
125385566|NCT02337907|451046672|FG002|Overall Study|Withdrawal by Subject|0|||
125385567|NCT02337907|451046673|FG003|Overall Study|Withdrawal by Subject|2|||
125385568|NCT02337907|451046674|FG004|Overall Study|Withdrawal by Subject|5|||
125385569|NCT02337907|451046675|FG005|Overall Study|Withdrawal by Subject|0|||
125385570|NCT02337907|451046670|FG000|Overall Study|Lost to Follow-up|0|||
125385571|NCT02337907|451046671|FG001|Overall Study|Lost to Follow-up|0|||
125385572|NCT02337907|451046672|FG002|Overall Study|Lost to Follow-up|0|||
125385573|NCT02337907|451046673|FG003|Overall Study|Lost to Follow-up|0|||
125385574|NCT02337907|451046674|FG004|Overall Study|Lost to Follow-up|0|||
125385575|NCT02337907|451046675|FG005|Overall Study|Lost to Follow-up|1|||
125385576|NCT02337907|451046670|FG000|Overall Study|Adverse Event|1|||
125385577|NCT02337907|451046671|FG001|Overall Study|Adverse Event|1|||
125385578|NCT02337907|451046672|FG002|Overall Study|Adverse Event|1|||
125385579|NCT02337907|451046673|FG003|Overall Study|Adverse Event|1|||
125385580|NCT02337907|451046674|FG004|Overall Study|Adverse Event|4|||
125385581|NCT02337907|451046675|FG005|Overall Study|Adverse Event|0|||
125385582|NCT01592344|451046679|FG000|Overall Study|Adverse Event|1|||
125385583|NCT01592344|451046680|FG001|Overall Study|Adverse Event|1|||
125385584|NCT01592344|451046679|FG000|Overall Study|Lack of Efficacy|1|||
125385585|NCT01592344|451046680|FG001|Overall Study|Lack of Efficacy|0|||
125385586|NCT01592344|451046679|FG000|Overall Study|not available at primary outcome visit|2|||
125385587|NCT01592344|451046680|FG001|Overall Study|not available at primary outcome visit|4|||
125385588|NCT00613015|451046687|FG000|Overall Study|Lost to Follow-up|0|||
125385589|NCT00613015|451046688|FG001|Overall Study|Lost to Follow-up|1|||
125385590|NCT00613015|451046689|FG002|Overall Study|Lost to Follow-up|3|||
125385591|NCT00613015|451046690|FG003|Overall Study|Lost to Follow-up|3|||
125385592|NCT00613015|451046691|FG004|Overall Study|Lost to Follow-up|2|||
125385593|NCT00613015|451046692|FG005|Overall Study|Lost to Follow-up|3|||
125385594|NCT04120974|451046693|FG000|Overall Study|Death|1|||
125385595|NCT04120974|451046693|FG000|Overall Study|Physician Decision|1|||
125385596|NCT04120974|451046693|FG000|Overall Study|Lost to Follow-up|6|||
125385597|NCT03338062|451046694|FG000|Overall Study|Alternative Therapy|1|||
125385598|NCT03338062|451046695|FG001|Overall Study|Alternative Therapy|0|||
125385599|NCT04256785|451046696|FG000|Overall Study|Adverse Event|8|||
125385600|NCT04256785|451046697|FG001|Overall Study|Adverse Event|6|||
125385601|NCT04256785|451046696|FG000|Overall Study|Lack of Efficacy|3|||
125385602|NCT04256785|451046697|FG001|Overall Study|Lack of Efficacy|4|||
125385603|NCT04256785|451046696|FG000|Overall Study|Lost to Follow-up|7|||
125385604|NCT04256785|451046697|FG001|Overall Study|Lost to Follow-up|7|||
125385605|NCT04256785|451046696|FG000|Overall Study|Protocol Violation|1|||
125385606|NCT04256785|451046697|FG001|Overall Study|Protocol Violation|0|||
125138949|NCT00112437|450131210|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138950|NCT00112437|450131211|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138951|NCT00112437|450131212|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138952|NCT00112437|450131213|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138953|NCT00112437|450131214|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138954|NCT00112437|450131215|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138955|NCT00112437|450131216|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138956|NCT00112437|450131217|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138957|NCT00112437|450131218|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138958|NCT00112437|450131219|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138959|NCT00112437|450131220|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138960|NCT00112437|450131221|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138961|NCT00112437|450131222|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138962|NCT00112437|450131223|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138963|NCT00112437|450131224|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138964|NCT00112437|450131225|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138965|NCT00112437|450131226|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138966|NCT00112437|450131227|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
125138967|NCT00112437|450131228|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138968|NCT00112437|450131229|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
125138969|NCT00112437|450131204|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138970|NCT00112437|450131205|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138971|NCT00112437|450131206|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138972|NCT00112437|450131207|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138973|NCT00112437|450131208|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138974|NCT00112437|450131209|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138975|NCT00112437|450131210|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125385607|NCT04256785|451046696|FG000|Overall Study|Withdrawal by Subject|4|||
125385608|NCT04256785|451046697|FG001|Overall Study|Withdrawal by Subject|1|||
125385609|NCT04256785|451046696|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
125138976|NCT00112437|450131211|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138977|NCT00112437|450131212|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138978|NCT00112437|450131213|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138979|NCT00112437|450131214|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138980|NCT00112437|450131215|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138981|NCT00112437|450131216|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138982|NCT00112437|450131217|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138983|NCT00112437|450131218|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138984|NCT00112437|450131219|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138985|NCT00112437|450131220|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138986|NCT00112437|450131221|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138987|NCT00112437|450131222|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138988|NCT00112437|450131223|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138989|NCT00112437|450131224|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138990|NCT00112437|450131225|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138991|NCT00112437|450131226|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
125138992|NCT00112437|450131227|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
125222326|NCT02976519|450442717|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
125222327|NCT02976519|450442718|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
125222328|NCT02976519|450442712|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
125222329|NCT02976519|450442713|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
125222330|NCT02976519|450442714|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
125222331|NCT02976519|450442715|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
125222332|NCT02976519|450442716|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
125222333|NCT02976519|450442717|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
125222334|NCT02976519|450442718|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
125222335|NCT02976519|450442712|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125222336|NCT02976519|450442713|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125222337|NCT02976519|450442714|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125222338|NCT02976519|450442715|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125222339|NCT02976519|450442716|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125138993|NCT00112437|450131228|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
125138994|NCT00112437|450131229|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
125138995|NCT01960296|450131230|FG000|Overall Study|Postponed surgery|1|||
125222340|NCT02976519|450442717|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
125138996|NCT01960296|450131231|FG001|Overall Study|Postponed surgery|0|||
125138997|NCT01960296|450131230|FG000|Overall Study|Received different procedure|1|||
125385610|NCT04256785|451046697|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
125385611|NCT01170091|451046698|FG000|Overall Study|Missing efficacy evaluation|3|||
125385612|NCT01170091|451046698|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
125385613|NCT00391274|451046706|FG000|Overall Study|Death Due to Study Disease|55|||
125385614|NCT00391274|451046707|FG001|Overall Study|Death Due to Study Disease|45|||
125385615|NCT00391274|451046706|FG000|Overall Study|Lost to Follow-up|0|||
125385616|NCT00391274|451046707|FG001|Overall Study|Lost to Follow-up|3|||
125385617|NCT00391274|451046706|FG000|Overall Study|Physician Decision|4|||
125385618|NCT00391274|451046707|FG001|Overall Study|Physician Decision|2|||
125138998|NCT01960296|450131231|FG001|Overall Study|Received different procedure|3|||
125385619|NCT00391274|451046706|FG000|Overall Study|Withdrawal by Subject|0|||
125385620|NCT00391274|451046707|FG001|Overall Study|Withdrawal by Subject|3|||
125385621|NCT00391274|451046706|FG000|Overall Study|Death Due to Adverse Event|1|||
125385622|NCT00391274|451046707|FG001|Overall Study|Death Due to Adverse Event|3|||
125385623|NCT00391274|451046706|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
125385624|NCT00391274|451046707|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
125385625|NCT00391274|451046706|FG000|Overall Study|Death Not Study Related|0|||
125385626|NCT00391274|451046707|FG001|Overall Study|Death Not Study Related|1|||
125385627|NCT03559257|451046708|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
125385628|NCT03559257|451046709|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
125385629|NCT03559257|451046708|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125385630|NCT03559257|451046709|FG001|Double Blind Treatment Period|Protocol Violation|4|||
125385631|NCT03559257|451046708|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
125385632|NCT03559257|451046709|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
125385633|NCT03559257|451046708|FG000|Double Blind Treatment Period|Adverse Event|0|||
125385634|NCT03559257|451046709|FG001|Double Blind Treatment Period|Adverse Event|1|||
125385635|NCT03559257|451046708|FG000|Double Blind Treatment Period|Screen Failure|0|||
125385636|NCT03559257|451046709|FG001|Double Blind Treatment Period|Screen Failure|1|||
125385637|NCT03559257|451046708|FG000|Open-label Treatment Period|Adverse Event|1|||
125385638|NCT03559257|451046709|FG001|Open-label Treatment Period|Adverse Event|4|||
125385639|NCT03559257|451046708|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
125385640|NCT03559257|451046709|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
125385641|NCT03559257|451046708|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
125385642|NCT03559257|451046709|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
125385643|NCT03559257|451046708|FG000|Open-label Treatment Period|Protocol Violation|2|||
125385644|NCT03559257|451046709|FG001|Open-label Treatment Period|Protocol Violation|0|||
125385645|NCT03559257|451046708|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
125385646|NCT03559257|451046709|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
125385647|NCT03559257|451046708|FG000|Open-label Treatment Period|Physician Decision|0|||
125138999|NCT02003391|450131232|FG000|Overall Study|Withdrawal by Subject|2|||
125139000|NCT02003391|450131233|FG001|Overall Study|Withdrawal by Subject|1|||
125385648|NCT03559257|451046709|FG001|Open-label Treatment Period|Physician Decision|1|||
125385649|NCT03630120|451046710|FG000|Overall Study|Disease progression|0|||
125385650|NCT03630120|451046711|FG001|Overall Study|Disease progression|1|||
125385651|NCT03630120|451046712|FG002|Overall Study|Disease progression|1|||
125385652|NCT03630120|451046713|FG003|Overall Study|Disease progression|1|||
125385653|NCT01519960|451046714|FG000|Overall Study|Withdrawal from the study|26|||
125438411|NCT01799720|451232246|FG000|Overall Study|Protocol Violation|0|||
125222341|NCT02976519|450442718|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
125222342|NCT01781962|450442721|FG000|Overall Study|Other Miscellaneous Reasons|5|||
125222343|NCT00928434|450442722|FG000|Overall Study|Adverse Event|14|||
125222344|NCT00928434|450442723|FG001|Overall Study|Adverse Event|5|||
125222345|NCT00928434|450442724|FG002|Overall Study|Adverse Event|18|||
125222346|NCT00928434|450442722|FG000|Overall Study|Protocol Violation|5|||
125222347|NCT00928434|450442723|FG001|Overall Study|Protocol Violation|0|||
125222348|NCT00928434|450442724|FG002|Overall Study|Protocol Violation|8|||
125222349|NCT00928434|450442722|FG000|Overall Study|Physician Decision|2|||
125222350|NCT00928434|450442723|FG001|Overall Study|Physician Decision|0|||
125222351|NCT00928434|450442724|FG002|Overall Study|Physician Decision|3|||
125222352|NCT00928434|450442722|FG000|Overall Study|Lost to Follow-up|1|||
125222353|NCT00928434|450442723|FG001|Overall Study|Lost to Follow-up|0|||
125222354|NCT00928434|450442724|FG002|Overall Study|Lost to Follow-up|3|||
125222355|NCT00928434|450442722|FG000|Overall Study|Withdrawal by Subject|5|||
125222356|NCT00928434|450442723|FG001|Overall Study|Withdrawal by Subject|3|||
125222357|NCT00928434|450442724|FG002|Overall Study|Withdrawal by Subject|2|||
125222358|NCT00928434|450442722|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
125222359|NCT00928434|450442723|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
125222360|NCT00928434|450442724|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
125222361|NCT00928434|450442722|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
125222362|NCT00928434|450442723|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
125385654|NCT01519960|451046715|FG001|Overall Study|Withdrawal from the study|22|||
125385655|NCT01519960|451046716|FG002|Overall Study|Withdrawal from the study|5|||
125385656|NCT01387347|451046717|FG000|Overall Study|Lost to Follow-up|2|||
125385657|NCT01387347|451046718|FG001|Overall Study|Lost to Follow-up|1|||
125385658|NCT02153112|451046721|FG000|Overall Study|Adverse Event|0|||
125385659|NCT02153112|451046722|FG001|Overall Study|Adverse Event|0|||
125385660|NCT02153112|451046723|FG002|Overall Study|Adverse Event|1|||
125385661|NCT02153112|451046724|FG003|Overall Study|Adverse Event|0|||
125385662|NCT02153112|451046725|FG004|Overall Study|Adverse Event|0|||
125385663|NCT02153112|451046726|FG005|Overall Study|Adverse Event|0|||
125385664|NCT02153112|451046727|FG006|Overall Study|Adverse Event|0|||
125385665|NCT02153112|451046728|FG007|Overall Study|Adverse Event|0|||
125385666|NCT02153112|451046729|FG008|Overall Study|Adverse Event|0|||
125385667|NCT02153112|451046730|FG009|Overall Study|Adverse Event|0|||
125385668|NCT02153112|451046721|FG000|Overall Study|Lost to Follow-up|1|||
125385669|NCT02153112|451046722|FG001|Overall Study|Lost to Follow-up|1|||
125385670|NCT02153112|451046723|FG002|Overall Study|Lost to Follow-up|0|||
125385671|NCT02153112|451046724|FG003|Overall Study|Lost to Follow-up|0|||
125385672|NCT02153112|451046725|FG004|Overall Study|Lost to Follow-up|2|||
125385673|NCT02153112|451046726|FG005|Overall Study|Lost to Follow-up|1|||
125385674|NCT02153112|451046727|FG006|Overall Study|Lost to Follow-up|1|||
125385675|NCT02153112|451046728|FG007|Overall Study|Lost to Follow-up|0|||
125385676|NCT02153112|451046729|FG008|Overall Study|Lost to Follow-up|1|||
125385677|NCT02153112|451046730|FG009|Overall Study|Lost to Follow-up|1|||
125385678|NCT02153112|451046721|FG000|Overall Study|Withdrawal by Subject|3|||
125385679|NCT02153112|451046722|FG001|Overall Study|Withdrawal by Subject|1|||
125385680|NCT02153112|451046723|FG002|Overall Study|Withdrawal by Subject|2|||
125385681|NCT02153112|451046724|FG003|Overall Study|Withdrawal by Subject|2|||
125385682|NCT02153112|451046725|FG004|Overall Study|Withdrawal by Subject|1|||
125385683|NCT02153112|451046726|FG005|Overall Study|Withdrawal by Subject|1|||
125385684|NCT02153112|451046727|FG006|Overall Study|Withdrawal by Subject|7|||
125385685|NCT02153112|451046728|FG007|Overall Study|Withdrawal by Subject|2|||
125385686|NCT02153112|451046729|FG008|Overall Study|Withdrawal by Subject|13|||
125385687|NCT02153112|451046730|FG009|Overall Study|Withdrawal by Subject|12|||
125385688|NCT02153112|451046721|FG000|Overall Study|Reason not Specified|0|||
125385689|NCT02153112|451046722|FG001|Overall Study|Reason not Specified|0|||
125385690|NCT02153112|451046723|FG002|Overall Study|Reason not Specified|0|||
125385691|NCT02153112|451046724|FG003|Overall Study|Reason not Specified|0|||
125385692|NCT02153112|451046725|FG004|Overall Study|Reason not Specified|0|||
125385693|NCT02153112|451046726|FG005|Overall Study|Reason not Specified|0|||
125385694|NCT02153112|451046727|FG006|Overall Study|Reason not Specified|0|||
125385695|NCT02153112|451046728|FG007|Overall Study|Reason not Specified|0|||
125385696|NCT02153112|451046729|FG008|Overall Study|Reason not Specified|1|||
125385697|NCT02153112|451046730|FG009|Overall Study|Reason not Specified|1|||
125385698|NCT00561080|451046731|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
125385699|NCT00561080|451046732|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
125385700|NCT00561080|451046733|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
125385701|NCT00561080|451046731|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
125385702|NCT00561080|451046732|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
125385703|NCT00561080|451046733|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
125385704|NCT00561080|451046731|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
125385705|NCT00561080|451046732|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
125385706|NCT00561080|451046733|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
125385707|NCT00561080|451046731|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
125385708|NCT00561080|451046732|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
125385709|NCT00561080|451046733|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
125385710|NCT00561080|451046731|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
125385711|NCT00561080|451046732|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
125385712|NCT00561080|451046733|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
125385713|NCT00561080|451046731|FG000|Vaccination Period (up to Month 4)|Other|0|||
125385714|NCT00561080|451046732|FG001|Vaccination Period (up to Month 4)|Other|2|||
125385715|NCT00561080|451046733|FG002|Vaccination Period (up to Month 4)|Other|1|||
125385716|NCT00561080|451046731|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
125139001|NCT02003391|450131232|FG000|Overall Study|Protocol Violation|0|||
125139002|NCT02003391|450131233|FG001|Overall Study|Protocol Violation|1|||
125139003|NCT02003391|450131232|FG000|Overall Study|Adverse Event|1|||
125139004|NCT02003391|450131233|FG001|Overall Study|Adverse Event|0|||
125139005|NCT02272803|450131234|FG000|Overall Study|Disease progression|16|||
125139006|NCT02272803|450131235|FG001|Overall Study|Disease progression|8|||
125139007|NCT02272803|450131234|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
125139008|NCT02272803|450131235|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
125139009|NCT02272803|450131234|FG000|Overall Study|Study drug toxicity|4|||
125139010|NCT02272803|450131235|FG001|Overall Study|Study drug toxicity|9|||
125139011|NCT02272803|450131234|FG000|Overall Study|Participant request to discontinue study treatment|3|||
125139012|NCT02272803|450131235|FG001|Overall Study|Participant request to discontinue study treatment|7|||
125139013|NCT02272803|450131234|FG000|Overall Study|Maximum clinical benefit|4|||
125139014|NCT02272803|450131235|FG001|Overall Study|Maximum clinical benefit|2|||
125139015|NCT02272803|450131234|FG000|Overall Study|Poor/non-compliance|2|||
125139016|NCT02272803|450131235|FG001|Overall Study|Poor/non-compliance|2|||
125139017|NCT02272803|450131234|FG000|Overall Study|Withdrawal by Subject|2|||
125139018|NCT02272803|450131235|FG001|Overall Study|Withdrawal by Subject|1|||
125139019|NCT02272803|450131234|FG000|Overall Study|Death|0|||
125139020|NCT02272803|450131235|FG001|Overall Study|Death|1|||
125139021|NCT02272803|450131234|FG000|Overall Study|Other reasons|1|||
125139022|NCT02272803|450131235|FG001|Overall Study|Other reasons|3|||
125139023|NCT02272803|450131234|FG000|Overall Study|Administrative reason by sponsor|5|||
125139024|NCT02272803|450131235|FG001|Overall Study|Administrative reason by sponsor|4|||
125139025|NCT03573544|450131236|FG000|Overall Study|Adverse Event|0|||
125139026|NCT03573544|450131237|FG001|Overall Study|Adverse Event|0|||
125139027|NCT03573544|450131238|FG002|Overall Study|Adverse Event|0|||
125139028|NCT03573544|450131239|FG003|Overall Study|Adverse Event|3|||
125139029|NCT03573544|450131240|FG004|Overall Study|Adverse Event|1|||
125139030|NCT03573544|450131241|FG005|Overall Study|Adverse Event|0|||
125139031|NCT03573544|450131242|FG006|Overall Study|Adverse Event|2|||
125139032|NCT03573544|450131243|FG007|Overall Study|Adverse Event|0|||
125139033|NCT03573544|450131236|FG000|Overall Study|Physician Decision|0|||
125139034|NCT03573544|450131237|FG001|Overall Study|Physician Decision|0|||
125139035|NCT03573544|450131238|FG002|Overall Study|Physician Decision|0|||
125139036|NCT03573544|450131239|FG003|Overall Study|Physician Decision|0|||
125139037|NCT03573544|450131240|FG004|Overall Study|Physician Decision|0|||
125139038|NCT03573544|450131241|FG005|Overall Study|Physician Decision|0|||
125139039|NCT03573544|450131242|FG006|Overall Study|Physician Decision|1|||
125139040|NCT03573544|450131243|FG007|Overall Study|Physician Decision|0|||
125139041|NCT03573544|450131236|FG000|Overall Study|Withdrawal by Subject|2|||
125139042|NCT03573544|450131237|FG001|Overall Study|Withdrawal by Subject|0|||
125139043|NCT03573544|450131238|FG002|Overall Study|Withdrawal by Subject|0|||
125139044|NCT03573544|450131239|FG003|Overall Study|Withdrawal by Subject|1|||
125139045|NCT03573544|450131240|FG004|Overall Study|Withdrawal by Subject|1|||
125139046|NCT03573544|450131241|FG005|Overall Study|Withdrawal by Subject|1|||
125139047|NCT03573544|450131242|FG006|Overall Study|Withdrawal by Subject|0|||
125139048|NCT03573544|450131243|FG007|Overall Study|Withdrawal by Subject|1|||
125139049|NCT03573544|450131236|FG000|Overall Study|Disease progression|3|||
125139050|NCT03573544|450131237|FG001|Overall Study|Disease progression|3|||
125438412|NCT01799720|451232247|FG001|Overall Study|Protocol Violation|1|||
125139051|NCT03573544|450131238|FG002|Overall Study|Disease progression|6|||
125139052|NCT03573544|450131239|FG003|Overall Study|Disease progression|4|||
125139053|NCT03573544|450131240|FG004|Overall Study|Disease progression|5|||
125139054|NCT03573544|450131241|FG005|Overall Study|Disease progression|7|||
125139055|NCT03573544|450131242|FG006|Overall Study|Disease progression|6|||
125139056|NCT03573544|450131243|FG007|Overall Study|Disease progression|7|||
125139057|NCT03846193|450131244|FG000|Overall Study|Physician Decision|0|||
125139058|NCT03846193|450131245|FG001|Overall Study|Physician Decision|0|||
125139059|NCT03846193|450131246|FG002|Overall Study|Physician Decision|1|||
125139060|NCT03846193|450131247|FG003|Overall Study|Physician Decision|0|||
125139061|NCT03846193|450131248|FG004|Overall Study|Physician Decision|0|||
125222363|NCT00928434|450442724|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
125385717|NCT00561080|451046732|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
125385718|NCT00561080|451046733|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
125385719|NCT00561080|451046731|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
125385720|NCT00561080|451046732|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
125385721|NCT00561080|451046733|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
125385722|NCT00561080|451046731|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
125385723|NCT00561080|451046732|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
125385724|NCT00561080|451046733|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
125385725|NCT00561080|451046731|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
125385726|NCT00561080|451046732|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
125385727|NCT00561080|451046733|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
125385728|NCT00238121|451046734|FG000|Overall Study|Withdrawal by Subject|1|||
125385729|NCT00238121|451046735|FG001|Overall Study|Withdrawal by Subject|1|||
125385730|NCT00238121|451046734|FG000|Overall Study|Adverse Event|2|||
125385731|NCT00238121|451046735|FG001|Overall Study|Adverse Event|1|||
125385732|NCT01675128|451046740|FG000|Overall Study|Disease progression on study|1|||
125438413|NCT01799720|451232248|FG002|Overall Study|Protocol Violation|0|||
125139062|NCT03846193|450131244|FG000|Overall Study|Lost to Follow-up|0|||
125139063|NCT03846193|450131245|FG001|Overall Study|Lost to Follow-up|0|||
125438414|NCT01799720|451232246|FG000|Overall Study|Pregnancy|0|||
125139064|NCT03846193|450131246|FG002|Overall Study|Lost to Follow-up|0|||
125139065|NCT03846193|450131247|FG003|Overall Study|Lost to Follow-up|0|||
125139066|NCT03846193|450131248|FG004|Overall Study|Lost to Follow-up|1|||
125385733|NCT01675128|451046741|FG001|Overall Study|Disease progression on study|1|||
125438415|NCT01799720|451232247|FG001|Overall Study|Pregnancy|0|||
125139067|NCT03846193|450131244|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
125139068|NCT03846193|450131245|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
125139069|NCT03846193|450131246|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
125139070|NCT03846193|450131247|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
125139071|NCT03846193|450131248|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
125139072|NCT00902538|450131250|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
125139073|NCT00902538|450131251|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
125139074|NCT00902538|450131252|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
125139075|NCT00902538|450131253|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
125139076|NCT00902538|450131254|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
125139077|NCT00902538|450131255|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
125139078|NCT00902538|450131250|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
125139079|NCT00902538|450131251|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
125139080|NCT00902538|450131252|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
125385734|NCT01675128|451046742|FG002|Overall Study|Disease progression on study|1|||
125385735|NCT01675128|451046740|FG000|Overall Study|Refused further treatment|1|||
125385736|NCT01675128|451046741|FG001|Overall Study|Refused further treatment|0|||
125385737|NCT01675128|451046742|FG002|Overall Study|Refused further treatment|0|||
125385738|NCT01675128|451046740|FG000|Overall Study|Pulmonary complication; off study|0|||
125222364|NCT00928434|450442722|FG000|Overall Study|Other (not meeting above criteria)|5|||
125385739|NCT01675128|451046741|FG001|Overall Study|Pulmonary complication; off study|1|||
125139081|NCT00902538|450131253|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
125139082|NCT00902538|450131254|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
125222365|NCT00928434|450442723|FG001|Overall Study|Other (not meeting above criteria)|1|||
125139083|NCT00902538|450131255|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
125139084|NCT00902538|450131250|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
125139085|NCT00902538|450131251|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
125222366|NCT00928434|450442724|FG002|Overall Study|Other (not meeting above criteria)|2|||
125139086|NCT00902538|450131252|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
125139087|NCT00902538|450131253|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
125385740|NCT01675128|451046742|FG002|Overall Study|Pulmonary complication; off study|0|||
125385741|NCT00832585|451046751|FG000|Overall Study|Withdrawal by Subject|1|||
125385742|NCT00832585|451046751|FG000|Overall Study|Lost to Follow-up|1|||
125385743|NCT01374087|451046753|FG000|Overall Study|Adverse Event|1|||
125385744|NCT01374087|451046754|FG001|Overall Study|Adverse Event|0|||
125385745|NCT01374087|451046753|FG000|Overall Study|Disease progression|2|||
125385746|NCT01374087|451046754|FG001|Overall Study|Disease progression|2|||
125385747|NCT01374087|451046753|FG000|Overall Study|Study discontinued|13|||
125385748|NCT01374087|451046754|FG001|Overall Study|Study discontinued|13|||
125385749|NCT03526458|451046755|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
125385750|NCT03526458|451046756|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
125385751|NCT03526458|451046755|FG000|Overall Study|Stone passed, surgery cancelled|2|||
125385752|NCT03526458|451046756|FG001|Overall Study|Stone passed, surgery cancelled|1|||
125385753|NCT03526458|451046755|FG000|Overall Study|Withdrawal by Subject|1|||
125385754|NCT03526458|451046756|FG001|Overall Study|Withdrawal by Subject|0|||
125385755|NCT03526458|451046755|FG000|Overall Study|Physician Decision|2|||
125385756|NCT03526458|451046756|FG001|Overall Study|Physician Decision|1|||
125385757|NCT03526458|451046755|FG000|Overall Study|Lack of equipment|1|||
125385758|NCT03526458|451046756|FG001|Overall Study|Lack of equipment|1|||
125385759|NCT02466555|451046757|FG000|Overall Study|Lost to Follow-up|2|||
125385760|NCT01082965|451046758|FG000|Overall Study|Protocol Violation|0|||
125385761|NCT01082965|451046759|FG001|Overall Study|Protocol Violation|1|||
125385762|NCT01082965|451046758|FG000|Overall Study|Other|1|||
125385763|NCT01082965|451046759|FG001|Overall Study|Other|1|||
125385764|NCT02587065|451046761|FG000|Overall Study|Adverse Event|14|||
125385765|NCT02587065|451046761|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
125385766|NCT02587065|451046761|FG000|Overall Study|Non-adherence to the Protocol|3|||
125385767|NCT02587065|451046761|FG000|Overall Study|Discontinuation of Study Medication|2|||
125385768|NCT02587065|451046761|FG000|Overall Study|Reason not Specified|3|||
125385769|NCT00445965|451046764|FG000|Overall Study|Adverse Event|2|||
125385770|NCT00445965|451046764|FG000|Overall Study|Physician Decision|1|||
125385771|NCT00445965|451046764|FG000|Overall Study|Enrolled but not treated|1|||
125385772|NCT00445965|451046764|FG000|Overall Study|Removed due to progressive disease|29|||
125385773|NCT01498458|451046774|FG000|Overall Study|Adverse Event|4|||
125385774|NCT01498458|451046774|FG000|Overall Study|Physician Decision|3|||
125385775|NCT02446990|451046778|FG000|Overall Study|Death|485|||
125385776|NCT02446990|451046779|FG001|Overall Study|Death|458|||
125222367|NCT01278342|450442727|FG000|Overall Study|Physician Decision|0|||
125222368|NCT01278342|450442728|FG001|Overall Study|Physician Decision|1|||
125222369|NCT01278342|450442729|FG002|Overall Study|Physician Decision|0|||
125222370|NCT01278342|450442727|FG000|Overall Study|Lost to Follow-up|1|||
125222371|NCT01278342|450442728|FG001|Overall Study|Lost to Follow-up|0|||
125222372|NCT01278342|450442729|FG002|Overall Study|Lost to Follow-up|0|||
125222373|NCT01278342|450442727|FG000|Overall Study|Administrative problems|2|||
125222374|NCT01278342|450442728|FG001|Overall Study|Administrative problems|0|||
125222375|NCT01278342|450442729|FG002|Overall Study|Administrative problems|0|||
125222376|NCT01278342|450442727|FG000|Overall Study|Other|1|||
125222377|NCT01278342|450442728|FG001|Overall Study|Other|0|||
125222378|NCT01278342|450442729|FG002|Overall Study|Other|0|||
125222379|NCT00313846|450442735|FG000|Overall Study|Withdrawal by Subject|2|||
125222380|NCT00313846|450442736|FG001|Overall Study|Withdrawal by Subject|0|||
125222381|NCT00313846|450442735|FG000|Overall Study|Adverse Event|1|||
125222382|NCT00313846|450442736|FG001|Overall Study|Adverse Event|8|||
125222383|NCT00313846|450442735|FG000|Overall Study|Administrative|2|||
125222384|NCT00313846|450442736|FG001|Overall Study|Administrative|3|||
125222385|NCT01462630|450442738|FG000|Overall Study|Did not initiate therapy|3|||
125222386|NCT01462630|450442738|FG000|Overall Study|Death|1|||
125222387|NCT01462630|450442738|FG000|Overall Study|Protocol Violation|2|||
125222388|NCT01462630|450442738|FG000|Overall Study|Adverse Event|1|||
125222389|NCT01765296|450442739|FG000|Overall Study|Protocol Violation|0|||
125222390|NCT01765296|450442740|FG001|Overall Study|Protocol Violation|5|||
125139088|NCT00902538|450131254|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
125139089|NCT00902538|450131255|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
125139090|NCT00902538|450131250|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
125139091|NCT00902538|450131251|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
125139092|NCT00902538|450131252|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
125139093|NCT00902538|450131253|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
125139094|NCT00902538|450131254|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
125222391|NCT01765296|450442741|FG002|Overall Study|Protocol Violation|4|||
125222392|NCT01765296|450442739|FG000|Overall Study|Withdrawal by Subject|4|||
125222393|NCT01765296|450442740|FG001|Overall Study|Withdrawal by Subject|2|||
125139095|NCT00902538|450131255|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
125222394|NCT01765296|450442741|FG002|Overall Study|Withdrawal by Subject|2|||
125139096|NCT00902538|450131250|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
125139097|NCT00902538|450131251|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
125139098|NCT00902538|450131252|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
125139099|NCT00902538|450131253|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
125139100|NCT00902538|450131254|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
125222395|NCT01765296|450442739|FG000|Overall Study|Adverse Event|1|||
125139101|NCT00902538|450131255|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
125222396|NCT01765296|450442740|FG001|Overall Study|Adverse Event|13|||
125139102|NCT00902538|450131250|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
125139103|NCT00902538|450131251|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
125139104|NCT00902538|450131252|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
125139105|NCT00902538|450131253|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
125139106|NCT00902538|450131254|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
125139107|NCT00902538|450131255|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
125139108|NCT00902538|450131250|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
125139109|NCT00902538|450131251|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
125139110|NCT00902538|450131252|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
125139111|NCT00902538|450131253|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
125139112|NCT00902538|450131254|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
125139113|NCT00902538|450131255|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
125139114|NCT00902538|450131250|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
125139115|NCT00902538|450131251|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
125139116|NCT00902538|450131252|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
125139117|NCT00902538|450131253|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
125139118|NCT00902538|450131254|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
125139119|NCT00902538|450131255|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
125139120|NCT00902538|450131250|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
125139121|NCT00902538|450131251|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
125139122|NCT00902538|450131252|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
125139123|NCT00902538|450131253|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
125222397|NCT01765296|450442741|FG002|Overall Study|Adverse Event|5|||
125222398|NCT01765296|450442739|FG000|Overall Study|Lack of Efficacy|0|||
125222399|NCT01765296|450442740|FG001|Overall Study|Lack of Efficacy|0|||
125222400|NCT01765296|450442741|FG002|Overall Study|Lack of Efficacy|2|||
125222401|NCT03933449|450442742|FG000|Overall Study|Adverse Event|6|||
125222402|NCT03933449|450442743|FG001|Overall Study|Adverse Event|4|||
125222403|NCT03933449|450442742|FG000|Overall Study|Death|55|||
125222404|NCT03933449|450442743|FG001|Overall Study|Death|57|||
125222405|NCT03933449|450442742|FG000|Overall Study|Sponsor Decision|1|||
125222406|NCT03933449|450442743|FG001|Overall Study|Sponsor Decision|0|||
125222407|NCT02659943|450442744|FG000|Overall Study|Switched to alternative treatment|1|||
125139124|NCT00902538|450131254|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
125139125|NCT00902538|450131255|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
125139126|NCT00902538|450131250|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
125139127|NCT00902538|450131251|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
125139128|NCT00902538|450131252|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
125139129|NCT00902538|450131253|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
125139130|NCT00902538|450131254|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
125139131|NCT00902538|450131255|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
125139132|NCT00902538|450131250|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
125139133|NCT00902538|450131251|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
125139134|NCT00902538|450131252|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
125139135|NCT00902538|450131253|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
125139136|NCT00902538|450131254|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
125139137|NCT00902538|450131255|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
125139138|NCT00902538|450131250|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
125139139|NCT00902538|450131251|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
125139140|NCT00902538|450131252|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
125139141|NCT00902538|450131253|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
125139142|NCT00902538|450131254|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
125139143|NCT00902538|450131255|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
125139144|NCT00902538|450131250|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
125139145|NCT00902538|450131251|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
125139146|NCT00902538|450131252|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
125139147|NCT00902538|450131253|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
125139148|NCT00902538|450131254|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
125139149|NCT00902538|450131255|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
125139150|NCT00902538|450131250|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
125139151|NCT00902538|450131251|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
125139152|NCT00902538|450131252|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
125139153|NCT00902538|450131253|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
125139154|NCT00902538|450131254|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
125139155|NCT00902538|450131255|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
125139156|NCT00902538|450131250|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
125139157|NCT00902538|450131251|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
125139158|NCT00902538|450131252|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
125139159|NCT00902538|450131253|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
125139160|NCT00902538|450131254|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
125139161|NCT00902538|450131255|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
125139162|NCT00902538|450131250|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
125139163|NCT00902538|450131251|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
125139164|NCT00902538|450131252|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
125139165|NCT00902538|450131253|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
125139166|NCT00902538|450131254|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
125139167|NCT00902538|450131255|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
125139168|NCT00902538|450131250|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
125139169|NCT00902538|450131251|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
125139170|NCT00902538|450131252|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
125139171|NCT00902538|450131253|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
125139172|NCT00902538|450131254|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
125139173|NCT00902538|450131255|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
125139174|NCT00725322|450131256|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
125139175|NCT00725322|450131257|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
125139176|NCT00725322|450131256|FG000|Washout (28 Days)|Protocol Violation|0|||
125139177|NCT00725322|450131257|FG001|Washout (28 Days)|Protocol Violation|1|||
125139178|NCT00660660|450132791|FG000|Overall Study|Adverse Event|1|||
125139179|NCT00660660|450132792|FG001|Overall Study|Adverse Event|0|||
125139180|NCT00660660|450132791|FG000|Overall Study|Lost to Follow-up|0|||
125139181|NCT00660660|450132792|FG001|Overall Study|Lost to Follow-up|6|||
125139182|NCT00660660|450132791|FG000|Overall Study|Lack of Efficacy|0|||
125139183|NCT00660660|450132792|FG001|Overall Study|Lack of Efficacy|2|||
125139184|NCT00660660|450132791|FG000|Overall Study|Withdrawal by Subject|3|||
125222408|NCT02659943|450442745|FG001|Overall Study|Switched to alternative treatment|1|||
125438416|NCT01799720|451232248|FG002|Overall Study|Pregnancy|1|||
125139185|NCT00660660|450132792|FG001|Overall Study|Withdrawal by Subject|0|||
125139186|NCT00660660|450132791|FG000|Overall Study|Incorrect enrollment and other|0|||
125139187|NCT00660660|450132792|FG001|Overall Study|Incorrect enrollment and other|1|||
125139188|NCT00660660|450132791|FG000|Overall Study|New medication after randomization|1|||
125139189|NCT00660660|450132792|FG001|Overall Study|New medication after randomization|0|||
125139190|NCT00081653|450132802|FG000|Overall Study|Adverse Event|23|||
125139191|NCT00081653|450132803|FG001|Overall Study|Adverse Event|17|||
125139192|NCT00081653|450132802|FG000|Overall Study|Lost to Follow-up|2|||
125139193|NCT00081653|450132803|FG001|Overall Study|Lost to Follow-up|4|||
125139194|NCT00081653|450132802|FG000|Overall Study|Refused Treatment|18|||
125139195|NCT00081653|450132803|FG001|Overall Study|Refused Treatment|14|||
125139196|NCT00081653|450132802|FG000|Overall Study|Low bone mineral density|1|||
125139197|NCT00081653|450132803|FG001|Overall Study|Low bone mineral density|0|||
125139198|NCT00081653|450132802|FG000|Overall Study|Bone loss|2|||
125139199|NCT00081653|450132803|FG001|Overall Study|Bone loss|0|||
125139200|NCT00081653|450132802|FG000|Overall Study|Participant leaving country|1|||
125139201|NCT00081653|450132803|FG001|Overall Study|Participant leaving country|0|||
125139202|NCT00081653|450132802|FG000|Overall Study|Loss of bone mass|0|||
125139203|NCT00081653|450132803|FG001|Overall Study|Loss of bone mass|2|||
125139204|NCT02694536|450132811|FG000|Overall Study|Progressive Disease|40|||
125139205|NCT02694536|450132811|FG000|Overall Study|Lost to Follow-up|1|||
125139206|NCT02694536|450132811|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
125139207|NCT02694536|450132811|FG000|Overall Study|Withdrawal by Subject|8|||
125139208|NCT02694536|450132811|FG000|Overall Study|Death|8|||
125139209|NCT02694536|450132811|FG000|Overall Study|Other|22|||
125139210|NCT00385736|450132812|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
125139211|NCT00385736|450132813|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
125139212|NCT00385736|450132814|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
125139213|NCT00385736|450132812|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
125139214|NCT00385736|450132813|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
125139215|NCT00385736|450132814|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
125139216|NCT00385736|450132812|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
125139217|NCT00385736|450132813|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
125139218|NCT00385736|450132814|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
125139219|NCT00385736|450132812|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
125139220|NCT00385736|450132813|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
125139221|NCT00385736|450132814|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
125139222|NCT00385736|450132812|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
125139223|NCT00385736|450132813|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
125139224|NCT00385736|450132814|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
125139225|NCT00385736|450132812|FG000|Efficacy Analysis Set - Induction|Other|0|||
125139226|NCT00385736|450132813|FG001|Efficacy Analysis Set - Induction|Other|0|||
125139227|NCT00385736|450132814|FG002|Efficacy Analysis Set - Induction|Other|1|||
125139228|NCT00385736|450132812|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
125139229|NCT00385736|450132813|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
125139230|NCT00385736|450132814|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
125139231|NCT00385736|450132812|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
125139232|NCT00385736|450132813|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
125139233|NCT00385736|450132814|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
125139234|NCT00385736|450132812|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
125139235|NCT00385736|450132813|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
125139236|NCT00385736|450132814|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
125139237|NCT00385736|450132812|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
125139238|NCT00385736|450132813|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
125139239|NCT00385736|450132814|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
125139240|NCT00385736|450132812|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
125139241|NCT00385736|450132813|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
125139242|NCT00385736|450132814|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
125385777|NCT02446990|451046778|FG000|Overall Study|Lost to Follow-up|3|||
125139243|NCT00385736|450132812|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
125222409|NCT02659943|450442746|FG002|Overall Study|Switched to alternative treatment|0|||
125139244|NCT00385736|450132813|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
125222410|NCT02659943|450442747|FG003|Overall Study|Switched to alternative treatment|2|||
125139245|NCT00385736|450132814|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
125139246|NCT00385736|450132812|FG000|Safety Analysis Set|Adverse Event|23|||
125139247|NCT00385736|450132813|FG001|Safety Analysis Set|Adverse Event|15|||
125139248|NCT00385736|450132814|FG002|Safety Analysis Set|Adverse Event|23|||
125139249|NCT00385736|450132812|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
125139250|NCT00385736|450132813|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
125139251|NCT00385736|450132814|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
125139252|NCT00385736|450132812|FG000|Safety Analysis Set|Lost to Follow-up|0|||
125139253|NCT00385736|450132813|FG001|Safety Analysis Set|Lost to Follow-up|2|||
125139254|NCT00385736|450132814|FG002|Safety Analysis Set|Lost to Follow-up|2|||
125139255|NCT00385736|450132812|FG000|Safety Analysis Set|Lack of Efficacy|38|||
125139256|NCT00385736|450132813|FG001|Safety Analysis Set|Lack of Efficacy|16|||
125139257|NCT00385736|450132814|FG002|Safety Analysis Set|Lack of Efficacy|31|||
125139258|NCT00385736|450132812|FG000|Safety Analysis Set|Protocol Violation|2|||
125139259|NCT00385736|450132813|FG001|Safety Analysis Set|Protocol Violation|1|||
125139260|NCT00385736|450132814|FG002|Safety Analysis Set|Protocol Violation|6|||
125139261|NCT00385736|450132812|FG000|Safety Analysis Set|Other|1|||
125139262|NCT00385736|450132813|FG001|Safety Analysis Set|Other|4|||
125139263|NCT00385736|450132814|FG002|Safety Analysis Set|Other|4|||
125139264|NCT02727192|450132822|FG000|Overall Study|Lost to Follow-up|1|||
125139265|NCT02727192|450132823|FG001|Overall Study|Lost to Follow-up|0|||
125139266|NCT02727192|450132824|FG002|Overall Study|Lost to Follow-up|0|||
125139267|NCT00928057|450132825|FG000|Overall Study|Adverse Event|1|||
125139268|NCT00928057|450132826|FG001|Overall Study|Adverse Event|2|||
125139269|NCT00928057|450132825|FG000|Overall Study|Withdrawal by Subject|1|||
125139270|NCT00928057|450132826|FG001|Overall Study|Withdrawal by Subject|0|||
125139271|NCT00928057|450132825|FG000|Overall Study|Lost to Follow-up|0|||
125139272|NCT00928057|450132826|FG001|Overall Study|Lost to Follow-up|1|||
125139273|NCT00928057|450132825|FG000|Overall Study|Protocol Violation|0|||
125139274|NCT00928057|450132826|FG001|Overall Study|Protocol Violation|1|||
125139275|NCT05497557|450132829|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
125139276|NCT05497557|450132830|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
125139277|NCT05497557|450132831|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
125139278|NCT01380782|450132836|FG000|Overall Study|Adverse Event|0|||
125139279|NCT01380782|450132837|FG001|Overall Study|Adverse Event|1|||
125139280|NCT01380782|450132838|FG002|Overall Study|Adverse Event|0|||
125139281|NCT01380782|450132839|FG003|Overall Study|Adverse Event|0|||
125139282|NCT01380782|450132836|FG000|Overall Study|Death|1|||
125139283|NCT01380782|450132837|FG001|Overall Study|Death|0|||
125139284|NCT01380782|450132838|FG002|Overall Study|Death|0|||
125139285|NCT01380782|450132839|FG003|Overall Study|Death|0|||
125139286|NCT01380782|450132836|FG000|Overall Study|Lack of Efficacy|10|||
125139287|NCT01380782|450132837|FG001|Overall Study|Lack of Efficacy|9|||
125139288|NCT01380782|450132838|FG002|Overall Study|Lack of Efficacy|10|||
125139289|NCT01380782|450132839|FG003|Overall Study|Lack of Efficacy|3|||
125139290|NCT01380782|450132836|FG000|Overall Study|Physician Decision|1|||
125139291|NCT01380782|450132837|FG001|Overall Study|Physician Decision|0|||
125139292|NCT01380782|450132838|FG002|Overall Study|Physician Decision|0|||
125139293|NCT01380782|450132839|FG003|Overall Study|Physician Decision|0|||
125139294|NCT01380782|450132836|FG000|Overall Study|Withdrawal by Subject|0|||
125139295|NCT01380782|450132837|FG001|Overall Study|Withdrawal by Subject|0|||
125139296|NCT01380782|450132838|FG002|Overall Study|Withdrawal by Subject|1|||
125139297|NCT01380782|450132839|FG003|Overall Study|Withdrawal by Subject|1|||
125139298|NCT05387408|450132840|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
125139299|NCT03428750|450132841|FG000|Overall Study|Withdrawal by Subject|11|||
125139300|NCT03428750|450132842|FG001|Overall Study|Withdrawal by Subject|10|||
125139301|NCT03428750|450132841|FG000|Overall Study|Lost to Follow-up|3|||
125139302|NCT03428750|450132842|FG001|Overall Study|Lost to Follow-up|9|||
125139303|NCT03428750|450132841|FG000|Overall Study|Adverse Event|9|||
125139304|NCT03428750|450132842|FG001|Overall Study|Adverse Event|1|||
125139305|NCT03428750|450132841|FG000|Overall Study|Protocol Violation|1|||
125139306|NCT03428750|450132842|FG001|Overall Study|Protocol Violation|0|||
125139307|NCT03428750|450132841|FG000|Overall Study|Administrative|0|||
125139308|NCT03428750|450132842|FG001|Overall Study|Administrative|1|||
125139309|NCT01919112|450132843|FG000|Secondary Analysis-day 30|Death|1|||
125139310|NCT01919112|450132844|FG001|Secondary Analysis-day 30|Death|1|||
125139311|NCT01919112|450132845|FG002|Secondary Analysis-day 30|Death|1|||
125139312|NCT01919112|450132843|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
125139313|NCT01919112|450132844|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
125139314|NCT01919112|450132845|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
125139315|NCT00635648|450132846|FG000|Overall Study|Adverse Event|12|||
125139316|NCT00635648|450132846|FG000|Overall Study|Withdrawal by Subject|9|||
125139317|NCT00635648|450132846|FG000|Overall Study|Physician Decision|4|||
125139318|NCT00635648|450132846|FG000|Overall Study|Rapid progression of baseline disease|4|||
125139319|NCT00635648|450132846|FG000|Overall Study|Use of other antifungal agent needed|1|||
125139320|NCT00635648|450132846|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
125139321|NCT00635648|450132846|FG000|Overall Study|Noncompliance with protocol|1|||
125139322|NCT00635648|450132846|FG000|Overall Study|Other reason|2|||
125139323|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
125385778|NCT02446990|451046779|FG001|Overall Study|Lost to Follow-up|1|||
125385779|NCT02446990|451046778|FG000|Overall Study|Physician Decision|1|||
125385780|NCT02446990|451046779|FG001|Overall Study|Physician Decision|0|||
125385781|NCT02446990|451046778|FG000|Overall Study|Withdrawal by Subject|231|||
125385782|NCT02446990|451046779|FG001|Overall Study|Withdrawal by Subject|199|||
125385783|NCT03158051|451046780|FG000|Overall Study|Lost to Follow-up|41|||
125385784|NCT03158051|451046781|FG001|Overall Study|Lost to Follow-up|47|||
125385785|NCT03158051|451046780|FG000|Overall Study|Physician Decision|6|||
125385786|NCT03158051|451046781|FG001|Overall Study|Physician Decision|7|||
125222411|NCT02659943|450442748|FG004|Overall Study|Switched to alternative treatment|1|||
125385787|NCT03158051|451046780|FG000|Overall Study|Withdrawal by Subject|24|||
125385788|NCT03158051|451046781|FG001|Overall Study|Withdrawal by Subject|15|||
125385789|NCT03158051|451046780|FG000|Overall Study|Death|0|||
125222412|NCT02659943|450442749|FG005|Overall Study|Switched to alternative treatment|0|||
125385790|NCT03158051|451046781|FG001|Overall Study|Death|1|||
125385791|NCT02005250|451046782|FG000|Overall Study|Lost to Follow-up|15|||
125385792|NCT02005250|451046783|FG001|Overall Study|Lost to Follow-up|5|||
125385793|NCT02588833|451046784|FG000|Part 1|Withdrawal by Subject|1|||
125485300|NCT03523572|451412495|FG003|Dose Expansion|Progressive Disease|11|||
125139324|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
125385794|NCT02588833|451046785|FG001|Part 1|Withdrawal by Subject|0|||
125385795|NCT02588833|451046784|FG000|Part 2A|Physician Decision|0|||
125385796|NCT02588833|451046785|FG001|Part 2A|Physician Decision|1|||
125385797|NCT02588833|451046784|FG000|Part 2A|Withdrawal by Subject|0|||
125385798|NCT02588833|451046785|FG001|Part 2A|Withdrawal by Subject|1|||
125385799|NCT02588833|451046784|FG000|Part 2B|Adverse Event|0|||
125385800|NCT02588833|451046785|FG001|Part 2B|Adverse Event|1|||
125385801|NCT02588833|451046784|FG000|Part 2C|Adverse Event|0|||
125385802|NCT02588833|451046785|FG001|Part 2C|Adverse Event|1|||
125139325|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
125139326|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
125139327|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
125139328|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
125139329|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
125385803|NCT02588833|451046784|FG000|Part 2C|Withdrawal by Subject|0|||
125485301|NCT03523572|451412496|FG004|Dose Expansion|Progressive Disease|15|||
125385804|NCT02588833|451046785|FG001|Part 2C|Withdrawal by Subject|1|||
125385805|NCT02588833|451046784|FG000|Part 3 (Safety Follow-up)|Other|0|||
125385806|NCT02588833|451046785|FG001|Part 3 (Safety Follow-up)|Other|2|||
125139330|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
125139331|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
125139332|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
125139333|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
125139334|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
125139335|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
125139336|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
125385807|NCT02738151|451046786|FG000|Overall Study|Randomized but not treated|4|||
125385808|NCT02738151|451046787|FG001|Overall Study|Randomized but not treated|1|||
125385809|NCT02738151|451046786|FG000|Overall Study|Adverse Event|4|||
125385810|NCT02738151|451046787|FG001|Overall Study|Adverse Event|5|||
125139337|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
125139338|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
125139339|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
125139340|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
125139341|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
125139342|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
125139343|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
125139344|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
125139345|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
125222413|NCT02659943|450442750|FG006|Overall Study|Switched to alternative treatment|1|||
125385811|NCT02738151|451046786|FG000|Overall Study|Hypoglycemia|0|||
125385812|NCT02738151|451046787|FG001|Overall Study|Hypoglycemia|1|||
125385813|NCT02738151|451046786|FG000|Overall Study|Poor Compliance to Protocol|4|||
125385814|NCT02738151|451046787|FG001|Overall Study|Poor Compliance to Protocol|3|||
125385815|NCT02738151|451046786|FG000|Overall Study|Other than specified above|11|||
125385816|NCT02738151|451046787|FG001|Overall Study|Other than specified above|21|||
125385817|NCT03649711|451046789|FG000|Overall Study|Adverse Event|0|||
125385818|NCT03649711|451046790|FG001|Overall Study|Adverse Event|1|||
125139346|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
125139347|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
125139348|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
125139349|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
125139350|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
125139351|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
125139352|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
125139353|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
125139354|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
125139355|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
125139356|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
125139357|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
125385819|NCT03649711|451046791|FG002|Overall Study|Adverse Event|0|||
125385820|NCT03649711|451046789|FG000|Overall Study|Kidney Transplant|1|||
125139358|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
125385821|NCT03649711|451046790|FG001|Overall Study|Kidney Transplant|0|||
125385822|NCT03649711|451046791|FG002|Overall Study|Kidney Transplant|0|||
125139359|NCT04194801|450132847|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
125139360|NCT04194801|450132848|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
125139361|NCT04194801|450132849|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
125139362|NCT04194801|450132847|FG000|Part Ib/II End of Study|Death|2|||
125139363|NCT04194801|450132848|FG001|Part Ib/II End of Study|Death|3|||
125139364|NCT04194801|450132849|FG002|Part Ib/II End of Study|Death|3|||
125139365|NCT04194801|450132847|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
125139366|NCT04194801|450132848|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
125139367|NCT04194801|450132849|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
125139368|NCT04194801|450132847|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
125139369|NCT04194801|450132848|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
125485302|NCT03523572|451412497|FG005|Dose Expansion|Progressive Disease|2|||
125139370|NCT04194801|450132849|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
125139371|NCT04194801|450132847|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
125485303|NCT03523572|451412492|FG000|Dose Expansion|Clinical Progression|0|||
125139372|NCT04194801|450132848|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
125139373|NCT04194801|450132849|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
125139374|NCT04194801|450132847|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
125139375|NCT04194801|450132848|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
125139376|NCT04194801|450132849|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
125139377|NCT00294047|450132850|FG000|Month 48|Adverse Event|28|||
125139378|NCT00294047|450132851|FG001|Month 48|Adverse Event|13|||
125139379|NCT00294047|450132850|FG000|Month 48|Protocol Violation|4|||
125139380|NCT00294047|450132851|FG001|Month 48|Protocol Violation|4|||
125139381|NCT00294047|450132850|FG000|Month 48|Withdrawal by Subject|111|||
125139382|NCT00294047|450132851|FG001|Month 48|Withdrawal by Subject|115|||
125139383|NCT00294047|450132850|FG000|Month 48|Lost to Follow-up|272|||
125139384|NCT00294047|450132851|FG001|Month 48|Lost to Follow-up|287|||
125139385|NCT00294047|450132850|FG000|Month 48|Other|10|||
125139386|NCT00294047|450132851|FG001|Month 48|Other|14|||
125222414|NCT02659943|450442744|FG000|Overall Study|Disease progression on study|0|||
125139387|NCT00294047|450132850|FG000|Month 84|Adverse Event|4|||
125139388|NCT00294047|450132851|FG001|Month 84|Adverse Event|2|||
125385823|NCT02921776|451046796|FG000|Overall Study|patient deterioration, fatigue|2|||
125385824|NCT02921776|451046797|FG001|Overall Study|patient deterioration, fatigue|6|||
125385825|NCT02921776|451046798|FG002|Overall Study|patient deterioration, fatigue|0|||
125385826|NCT02921776|451046799|FG003|Overall Study|patient deterioration, fatigue|0|||
125385827|NCT02921776|451046800|FG004|Overall Study|patient deterioration, fatigue|0|||
125385828|NCT02921776|451046801|FG005|Overall Study|patient deterioration, fatigue|0|||
125385829|NCT02921776|451046802|FG006|Overall Study|patient deterioration, fatigue|0|||
125385830|NCT02921776|451046803|FG007|Overall Study|patient deterioration, fatigue|0|||
125385831|NCT02921776|451046796|FG000|Overall Study|Withdrawal by Subject|0|||
125139389|NCT00294047|450132850|FG000|Month 84|Protocol Violation|1|||
125139390|NCT00294047|450132851|FG001|Month 84|Protocol Violation|1|||
125385832|NCT02921776|451046797|FG001|Overall Study|Withdrawal by Subject|2|||
125385833|NCT02921776|451046798|FG002|Overall Study|Withdrawal by Subject|0|||
125139391|NCT00294047|450132850|FG000|Month 84|Withdrawal by Subject|33|||
125385834|NCT02921776|451046799|FG003|Overall Study|Withdrawal by Subject|1|||
125139392|NCT00294047|450132851|FG001|Month 84|Withdrawal by Subject|31|||
125139393|NCT00294047|450132850|FG000|Month 84|Lost to Follow-up|187|||
125139394|NCT00294047|450132851|FG001|Month 84|Lost to Follow-up|190|||
125139395|NCT00294047|450132850|FG000|Month 84|Absent Cervix|2|||
125139396|NCT00294047|450132851|FG001|Month 84|Absent Cervix|0|||
125139397|NCT00294047|450132850|FG000|Month 84|Work related reasons|4|||
125139398|NCT00294047|450132851|FG001|Month 84|Work related reasons|2|||
125139399|NCT00294047|450132850|FG000|Month 84|Center closed, subject did not transfer|1|||
125139400|NCT00294047|450132851|FG001|Month 84|Center closed, subject did not transfer|0|||
125385835|NCT02921776|451046800|FG004|Overall Study|Withdrawal by Subject|1|||
125385836|NCT02921776|451046801|FG005|Overall Study|Withdrawal by Subject|0|||
125385837|NCT02921776|451046802|FG006|Overall Study|Withdrawal by Subject|8|||
125385838|NCT02921776|451046803|FG007|Overall Study|Withdrawal by Subject|1|||
125385839|NCT02921776|451046796|FG000|Overall Study|Death|0|||
125385840|NCT02921776|451046797|FG001|Overall Study|Death|0|||
125385841|NCT02921776|451046798|FG002|Overall Study|Death|0|||
125385842|NCT02921776|451046799|FG003|Overall Study|Death|2|||
125385843|NCT02921776|451046800|FG004|Overall Study|Death|0|||
125385844|NCT02921776|451046801|FG005|Overall Study|Death|0|||
125485304|NCT03523572|451412493|FG001|Dose Expansion|Clinical Progression|0|||
125139401|NCT00294047|450132850|FG000|Month 84|Family problems|2|||
125139402|NCT00294047|450132851|FG001|Month 84|Family problems|2|||
125139403|NCT00294047|450132850|FG000|Month 84|Lack of time|3|||
125139404|NCT00294047|450132851|FG001|Month 84|Lack of time|1|||
125139405|NCT00294047|450132850|FG000|Month 84|Personal reason|2|||
125385845|NCT02921776|451046802|FG006|Overall Study|Death|0|||
125139406|NCT00294047|450132851|FG001|Month 84|Personal reason|4|||
125385846|NCT02921776|451046803|FG007|Overall Study|Death|0|||
125385847|NCT02921776|451046796|FG000|Overall Study|extubation or early discharge|0|||
125385848|NCT02921776|451046797|FG001|Overall Study|extubation or early discharge|0|||
125222415|NCT02659943|450442745|FG001|Overall Study|Disease progression on study|1|||
125385849|NCT02921776|451046798|FG002|Overall Study|extubation or early discharge|0|||
125385850|NCT02921776|451046799|FG003|Overall Study|extubation or early discharge|5|||
125385851|NCT02921776|451046800|FG004|Overall Study|extubation or early discharge|5|||
125385852|NCT02921776|451046801|FG005|Overall Study|extubation or early discharge|0|||
125385853|NCT02921776|451046802|FG006|Overall Study|extubation or early discharge|0|||
125385854|NCT02921776|451046803|FG007|Overall Study|extubation or early discharge|0|||
125385855|NCT02921776|451046796|FG000|Overall Study|Lost to Follow-up|0|||
125385856|NCT02921776|451046797|FG001|Overall Study|Lost to Follow-up|0|||
125385857|NCT02921776|451046798|FG002|Overall Study|Lost to Follow-up|0|||
125385858|NCT02921776|451046799|FG003|Overall Study|Lost to Follow-up|0|||
125385859|NCT02921776|451046800|FG004|Overall Study|Lost to Follow-up|0|||
125385860|NCT02921776|451046801|FG005|Overall Study|Lost to Follow-up|2|||
125385861|NCT02921776|451046802|FG006|Overall Study|Lost to Follow-up|3|||
125385862|NCT02921776|451046803|FG007|Overall Study|Lost to Follow-up|6|||
125385863|NCT02946047|451046804|FG000|Overall Study|Adverse Event|1|||
125385864|NCT02946047|451046805|FG001|Overall Study|Adverse Event|0|||
125385865|NCT02946047|451046806|FG002|Overall Study|Adverse Event|0|||
125385866|NCT02946047|451046807|FG003|Overall Study|Adverse Event|0|||
125385867|NCT04814433|451046811|FG000|Overall Study|Survey not returned|4|||
125385868|NCT04814433|451046812|FG001|Overall Study|Survey not returned|8|||
125385869|NCT04814433|451046813|FG002|Overall Study|Survey not returned|4|||
125385870|NCT04814433|451046814|FG003|Overall Study|Survey not returned|5|||
125385871|NCT02496533|451046815|FG000|Overall Study|Lack of data on outcome|3|||
125385872|NCT02496533|451046816|FG001|Overall Study|Lack of data on outcome|0|||
125385873|NCT02496533|451046815|FG000|Overall Study|Patient did not complete all measures|0|||
125385874|NCT02496533|451046816|FG001|Overall Study|Patient did not complete all measures|4|||
125385875|NCT02496533|451046815|FG000|Overall Study|Late for radiologic testing|0|||
125385876|NCT02496533|451046816|FG001|Overall Study|Late for radiologic testing|2|||
125385877|NCT01816893|451046818|FG000|Washout Period|Withdrawal by Subject|2|||
125385878|NCT01816893|451046819|FG001|Washout Period|Withdrawal by Subject|0|||
125385879|NCT00702403|451048692|FG000|From Consent to Engraftment|Progressive leukemia|6|||
125385880|NCT00702403|451048692|FG000|From Consent to Engraftment|Critically ill|2|||
125385881|NCT00702403|451048692|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
125385882|NCT00702403|451048692|FG000|From Consent to Engraftment|Myocardial infarction|1|||
125385883|NCT00702403|451048692|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
125385884|NCT00702403|451048692|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
125385885|NCT00702403|451048692|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
125385886|NCT00702403|451048692|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
125385887|NCT00702403|451048692|FG000|From Engraftment to Study Completion|Non-compliance|2|||
125385888|NCT00702403|451048692|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
125385889|NCT00702403|451048692|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
125385890|NCT00702403|451048692|FG000|From Engraftment to Study Completion|Suicide|1|||
125139407|NCT00294047|450132850|FG000|Month 84|Subject does not want male physician|1|||
125139408|NCT00294047|450132851|FG001|Month 84|Subject does not want male physician|0|||
125139409|NCT00294047|450132850|FG000|Month 84|Transport reimbursement delayed|0|||
125139410|NCT00294047|450132851|FG001|Month 84|Transport reimbursement delayed|1|||
125139411|NCT00294047|450132850|FG000|Month 84|Unable to reach study site|1|||
125139412|NCT00294047|450132851|FG001|Month 84|Unable to reach study site|0|||
125139413|NCT00294047|450132850|FG000|Month 84|Under investigation locally|1|||
125139414|NCT00294047|450132851|FG001|Month 84|Under investigation locally|0|||
125139415|NCT00294047|450132850|FG000|Month 84|Visit missed|0|||
125222416|NCT02659943|450442746|FG002|Overall Study|Disease progression on study|1|||
125222417|NCT02659943|450442747|FG003|Overall Study|Disease progression on study|1|||
125222418|NCT02659943|450442748|FG004|Overall Study|Disease progression on study|1|||
125222419|NCT02659943|450442749|FG005|Overall Study|Disease progression on study|4|||
125222420|NCT02659943|450442750|FG006|Overall Study|Disease progression on study|0|||
125222421|NCT02659943|450442744|FG000|Overall Study|Patient's condition per principal investigator|0|||
125222422|NCT02659943|450442745|FG001|Overall Study|Patient's condition per principal investigator|0|||
125222423|NCT02659943|450442746|FG002|Overall Study|Patient's condition per principal investigator|0|||
125222424|NCT02659943|450442747|FG003|Overall Study|Patient's condition per principal investigator|0|||
125222425|NCT02659943|450442748|FG004|Overall Study|Patient's condition per principal investigator|0|||
125222426|NCT02659943|450442749|FG005|Overall Study|Patient's condition per principal investigator|1|||
125222427|NCT02659943|450442750|FG006|Overall Study|Patient's condition per principal investigator|0|||
125222428|NCT02659943|450442744|FG000|Overall Study|Ineligible|0|||
125222429|NCT02659943|450442745|FG001|Overall Study|Ineligible|0|||
125222430|NCT02659943|450442746|FG002|Overall Study|Ineligible|0|||
125222431|NCT02659943|450442747|FG003|Overall Study|Ineligible|0|||
125222432|NCT02659943|450442748|FG004|Overall Study|Ineligible|0|||
125222433|NCT02659943|450442749|FG005|Overall Study|Ineligible|0|||
125222434|NCT02659943|450442750|FG006|Overall Study|Ineligible|1|||
125222435|NCT02659943|450442744|FG000|Overall Study|No longer meets eligibility|0|||
125222436|NCT02659943|450442745|FG001|Overall Study|No longer meets eligibility|0|||
125222437|NCT02659943|450442746|FG002|Overall Study|No longer meets eligibility|0|||
125222438|NCT02659943|450442747|FG003|Overall Study|No longer meets eligibility|0|||
125222439|NCT02659943|450442748|FG004|Overall Study|No longer meets eligibility|0|||
125222440|NCT02659943|450442749|FG005|Overall Study|No longer meets eligibility|0|||
125222441|NCT02659943|450442750|FG006|Overall Study|No longer meets eligibility|1|||
125222442|NCT02659943|450442744|FG000|Overall Study|No treatment, per protocol|0|||
125222443|NCT02659943|450442745|FG001|Overall Study|No treatment, per protocol|0|||
125222444|NCT02659943|450442746|FG002|Overall Study|No treatment, per protocol|0|||
125222445|NCT02659943|450442747|FG003|Overall Study|No treatment, per protocol|0|||
125385891|NCT00702403|451048692|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
125385892|NCT00702403|451048692|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
125385893|NCT00702403|451048692|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
125385894|NCT02016625|451048693|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
125385895|NCT02016625|451048694|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
125385896|NCT02016625|451048693|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
125385897|NCT02016625|451048694|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
125385898|NCT02016625|451048693|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
125222446|NCT02659943|450442748|FG004|Overall Study|No treatment, per protocol|0|||
125438417|NCT04276090|451232249|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
125139416|NCT00294047|450132851|FG001|Month 84|Visit missed|1|||
125222447|NCT02659943|450442749|FG005|Overall Study|No treatment, per protocol|0|||
125222448|NCT02659943|450442750|FG006|Overall Study|No treatment, per protocol|3|||
125385899|NCT02016625|451048694|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
125385900|NCT02356783|451048696|FG000|Overall Study|Lost to Follow-up|1|||
125385901|NCT02356783|451048697|FG001|Overall Study|Lost to Follow-up|3|||
125385902|NCT00380978|451048698|FG000|Overall Study|Refused allocated intervention|0|||
125385903|NCT00380978|451048699|FG001|Overall Study|Refused allocated intervention|6|||
125385904|NCT00380978|451048698|FG000|Overall Study|Wrong study envelope|0|||
125385905|NCT00380978|451048699|FG001|Overall Study|Wrong study envelope|2|||
125385906|NCT00380978|451048698|FG000|Overall Study|Allocation prior to analgesia request|1|||
125385907|NCT00380978|451048699|FG001|Overall Study|Allocation prior to analgesia request|2|||
125139417|NCT00294047|450132850|FG000|Month 84|No consent for Month 84 Follow-up|731|||
125139418|NCT00294047|450132851|FG001|Month 84|No consent for Month 84 Follow-up|754|||
125139419|NCT02157974|450132852|FG000|Overall Study|Withdrawal by Subject|0|||
125139420|NCT02157974|450132853|FG001|Overall Study|Withdrawal by Subject|1|||
125139421|NCT02157974|450132854|FG002|Overall Study|Withdrawal by Subject|0|||
125139422|NCT02157974|450132855|FG003|Overall Study|Withdrawal by Subject|0|||
125139423|NCT02157974|450132856|FG004|Overall Study|Withdrawal by Subject|0|||
125139424|NCT02157974|450132852|FG000|Overall Study|Screen Failure|0|||
125139425|NCT02157974|450132853|FG001|Overall Study|Screen Failure|1|||
125139426|NCT02157974|450132854|FG002|Overall Study|Screen Failure|0|||
125139427|NCT02157974|450132855|FG003|Overall Study|Screen Failure|0|||
125139428|NCT02157974|450132856|FG004|Overall Study|Screen Failure|0|||
125139429|NCT02157974|450132852|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
125139430|NCT02157974|450132853|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
125139431|NCT02157974|450132854|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
125139432|NCT02157974|450132855|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
125139433|NCT02157974|450132856|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
125139434|NCT00985439|450132859|FG000|Overall Study|Adverse Event|0|||
125139435|NCT00985439|450132860|FG001|Overall Study|Adverse Event|0|||
125139436|NCT00985439|450132861|FG002|Overall Study|Adverse Event|1|||
125139437|NCT00985439|450132862|FG003|Overall Study|Adverse Event|0|||
125139438|NCT01174186|450132863|FG000|Overall Study|Lost to Follow-up|0|||
125139439|NCT01174186|450132864|FG001|Overall Study|Lost to Follow-up|1|||
125139440|NCT01174186|450132863|FG000|Overall Study|Withdrawal by Subject|0|||
125139441|NCT01174186|450132864|FG001|Overall Study|Withdrawal by Subject|2|||
125139442|NCT05274763|450132865|FG000|Overall Study|Lost to Follow-up|1|||
125139443|NCT01051349|450132867|FG000|Overall Study|Adverse Event|88|||
125139444|NCT01051349|450132867|FG000|Overall Study|Consent Withdrawn|54|||
125139445|NCT01051349|450132867|FG000|Overall Study|Investigator Decision|6|||
125139446|NCT01051349|450132867|FG000|Overall Study|Lost to Follow-up|6|||
125139447|NCT01051349|450132867|FG000|Overall Study|Subject non-compliance|7|||
125139448|NCT01051349|450132867|FG000|Overall Study|Reason not Specified|12|||
125139449|NCT01647828|450132868|FG000|Overall Study|Death|3|||
125139450|NCT01647828|450132869|FG001|Overall Study|Death|4|||
125139451|NCT01647828|450132870|FG002|Overall Study|Death|4|||
125139452|NCT01647828|450132871|FG003|Overall Study|Death|5|||
125139453|NCT01647828|450132872|FG004|Overall Study|Death|6|||
125139454|NCT01647828|450132873|FG005|Overall Study|Death|3|||
125139455|NCT01647828|450132874|FG006|Overall Study|Death|10|||
125139456|NCT01647828|450132875|FG007|Overall Study|Death|60|||
125385908|NCT00380978|451048698|FG000|Overall Study|Parous patient|1|||
125385909|NCT00380978|451048699|FG001|Overall Study|Parous patient|0|||
125385910|NCT04146545|451048700|FG000|Overall Study|deemed ineligible after randomization|1|||
125385911|NCT04146545|451048701|FG001|Overall Study|deemed ineligible after randomization|0|||
125385912|NCT01729754|451048702|FG000|Part 1|Adverse Event|2|||
125385913|NCT01729754|451048703|FG001|Part 1|Adverse Event|0|||
125385914|NCT01729754|451048704|FG002|Part 1|Adverse Event|0|||
125385915|NCT01729754|451048705|FG003|Part 1|Adverse Event|1|||
125385916|NCT01729754|451048706|FG004|Part 1|Adverse Event|0|||
125385917|NCT01729754|451048707|FG005|Part 1|Adverse Event|0|||
125385918|NCT01729754|451048708|FG006|Part 1|Adverse Event|2|||
125385919|NCT01729754|451048709|FG007|Part 1|Adverse Event|0|||
125385920|NCT01729754|451048710|FG008|Part 1|Adverse Event|0|||
125385921|NCT01729754|451048711|FG009|Part 1|Adverse Event|5|||
125385922|NCT01729754|451048702|FG000|Part 1|Lack of Efficacy|1|||
125385923|NCT01729754|451048703|FG001|Part 1|Lack of Efficacy|0|||
125222449|NCT01576575|450442751|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
125139457|NCT01647828|450132876|FG008|Overall Study|Death|71|||
125139458|NCT01647828|450132868|FG000|Overall Study|Withdrawal by Subject|2|||
125139459|NCT01647828|450132869|FG001|Overall Study|Withdrawal by Subject|0|||
125139460|NCT01647828|450132870|FG002|Overall Study|Withdrawal by Subject|0|||
125139461|NCT01647828|450132871|FG003|Overall Study|Withdrawal by Subject|1|||
125139462|NCT01647828|450132872|FG004|Overall Study|Withdrawal by Subject|0|||
125139463|NCT01647828|450132873|FG005|Overall Study|Withdrawal by Subject|0|||
125139464|NCT01647828|450132874|FG006|Overall Study|Withdrawal by Subject|1|||
125139465|NCT01647828|450132875|FG007|Overall Study|Withdrawal by Subject|0|||
125139466|NCT01647828|450132876|FG008|Overall Study|Withdrawal by Subject|2|||
125139467|NCT01647828|450132868|FG000|Overall Study|Study terminated by Sponsor|0|||
125139468|NCT01647828|450132869|FG001|Overall Study|Study terminated by Sponsor|0|||
125385924|NCT01729754|451048704|FG002|Part 1|Lack of Efficacy|0|||
125385925|NCT01729754|451048705|FG003|Part 1|Lack of Efficacy|0|||
125139469|NCT01647828|450132870|FG002|Overall Study|Study terminated by Sponsor|0|||
125139470|NCT01647828|450132871|FG003|Overall Study|Study terminated by Sponsor|0|||
125139471|NCT01647828|450132872|FG004|Overall Study|Study terminated by Sponsor|0|||
125139472|NCT01647828|450132873|FG005|Overall Study|Study terminated by Sponsor|0|||
125139473|NCT01647828|450132874|FG006|Overall Study|Study terminated by Sponsor|1|||
125139474|NCT01647828|450132875|FG007|Overall Study|Study terminated by Sponsor|26|||
125139475|NCT01647828|450132876|FG008|Overall Study|Study terminated by Sponsor|16|||
125139476|NCT01647828|450132868|FG000|Overall Study|Lost to Follow-up|0|||
125385926|NCT01729754|451048706|FG004|Part 1|Lack of Efficacy|0|||
125385927|NCT01729754|451048707|FG005|Part 1|Lack of Efficacy|0|||
125139477|NCT01647828|450132869|FG001|Overall Study|Lost to Follow-up|0|||
125139478|NCT01647828|450132870|FG002|Overall Study|Lost to Follow-up|0|||
125139479|NCT01647828|450132871|FG003|Overall Study|Lost to Follow-up|0|||
125139480|NCT01647828|450132872|FG004|Overall Study|Lost to Follow-up|0|||
125139481|NCT01647828|450132873|FG005|Overall Study|Lost to Follow-up|0|||
125139482|NCT01647828|450132874|FG006|Overall Study|Lost to Follow-up|0|||
125139483|NCT01647828|450132875|FG007|Overall Study|Lost to Follow-up|2|||
125385928|NCT01729754|451048708|FG006|Part 1|Lack of Efficacy|2|||
125139484|NCT01647828|450132876|FG008|Overall Study|Lost to Follow-up|0|||
125385929|NCT01729754|451048709|FG007|Part 1|Lack of Efficacy|0|||
125139485|NCT01906372|450132877|FG000|Overall Study|Withdrawal by Subject|2|||
125139486|NCT00847535|450132881|FG000|Overall Study|Withdrawal by Subject|2|||
125139487|NCT00847535|450132882|FG001|Overall Study|Withdrawal by Subject|1|||
125139488|NCT00847535|450132883|FG002|Overall Study|Withdrawal by Subject|1|||
125139489|NCT00847535|450132881|FG000|Overall Study|Lost to Follow-up|0|||
125139490|NCT00847535|450132882|FG001|Overall Study|Lost to Follow-up|1|||
125139491|NCT00847535|450132883|FG002|Overall Study|Lost to Follow-up|0|||
125385930|NCT01729754|451048710|FG008|Part 1|Lack of Efficacy|0|||
125139492|NCT05604014|450132884|FG000|Overall Study|Lost to Follow-up|13|||
125139493|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Refused|1|||
125139494|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Refused|3|||
125385931|NCT01729754|451048711|FG009|Part 1|Lack of Efficacy|0|||
125385932|NCT01729754|451048702|FG000|Part 1|Lost to Follow-up|1|||
125385933|NCT01729754|451048703|FG001|Part 1|Lost to Follow-up|0|||
125139495|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Medical|0|||
125139496|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Medical|1|||
125385934|NCT01729754|451048704|FG002|Part 1|Lost to Follow-up|0|||
125385935|NCT01729754|451048705|FG003|Part 1|Lost to Follow-up|2|||
125385936|NCT01729754|451048706|FG004|Part 1|Lost to Follow-up|0|||
125139497|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
125385937|NCT01729754|451048707|FG005|Part 1|Lost to Follow-up|0|||
125222450|NCT01576575|450442751|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
125385938|NCT01729754|451048708|FG006|Part 1|Lost to Follow-up|3|||
125385939|NCT01729754|451048709|FG007|Part 1|Lost to Follow-up|0|||
125385940|NCT01729754|451048710|FG008|Part 1|Lost to Follow-up|0|||
125385941|NCT01729754|451048711|FG009|Part 1|Lost to Follow-up|3|||
125385942|NCT01729754|451048702|FG000|Part 1|Non-compliance with Study Drug|1|||
125385943|NCT01729754|451048703|FG001|Part 1|Non-compliance with Study Drug|0|||
125385944|NCT01729754|451048704|FG002|Part 1|Non-compliance with Study Drug|0|||
125385945|NCT01729754|451048705|FG003|Part 1|Non-compliance with Study Drug|0|||
125385946|NCT01729754|451048706|FG004|Part 1|Non-compliance with Study Drug|0|||
125385947|NCT01729754|451048707|FG005|Part 1|Non-compliance with Study Drug|0|||
125385948|NCT01729754|451048708|FG006|Part 1|Non-compliance with Study Drug|0|||
125385949|NCT01729754|451048709|FG007|Part 1|Non-compliance with Study Drug|0|||
125385950|NCT01729754|451048710|FG008|Part 1|Non-compliance with Study Drug|0|||
125385951|NCT01729754|451048711|FG009|Part 1|Non-compliance with Study Drug|0|||
125385952|NCT01729754|451048702|FG000|Part 1|Physician Decision|0|||
125385953|NCT01729754|451048703|FG001|Part 1|Physician Decision|0|||
125385954|NCT01729754|451048704|FG002|Part 1|Physician Decision|0|||
125385955|NCT01729754|451048705|FG003|Part 1|Physician Decision|0|||
125385956|NCT01729754|451048706|FG004|Part 1|Physician Decision|0|||
125385957|NCT01729754|451048707|FG005|Part 1|Physician Decision|0|||
125385958|NCT01729754|451048708|FG006|Part 1|Physician Decision|0|||
125385959|NCT01729754|451048709|FG007|Part 1|Physician Decision|0|||
125385960|NCT01729754|451048710|FG008|Part 1|Physician Decision|0|||
125385961|NCT01729754|451048711|FG009|Part 1|Physician Decision|4|||
125385962|NCT01729754|451048702|FG000|Part 1|Pregnancy|0|||
125385963|NCT01729754|451048703|FG001|Part 1|Pregnancy|0|||
125385964|NCT01729754|451048704|FG002|Part 1|Pregnancy|0|||
125385965|NCT01729754|451048705|FG003|Part 1|Pregnancy|1|||
125385966|NCT01729754|451048706|FG004|Part 1|Pregnancy|0|||
125385967|NCT01729754|451048707|FG005|Part 1|Pregnancy|0|||
125385968|NCT01729754|451048708|FG006|Part 1|Pregnancy|0|||
125385969|NCT01729754|451048709|FG007|Part 1|Pregnancy|0|||
125385970|NCT01729754|451048710|FG008|Part 1|Pregnancy|0|||
125385971|NCT01729754|451048711|FG009|Part 1|Pregnancy|1|||
125385972|NCT01729754|451048702|FG000|Part 1|Progressive Disease|0|||
125385973|NCT01729754|451048703|FG001|Part 1|Progressive Disease|0|||
125385974|NCT01729754|451048704|FG002|Part 1|Progressive Disease|0|||
125385975|NCT01729754|451048705|FG003|Part 1|Progressive Disease|0|||
125222451|NCT01576575|450442751|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
125385976|NCT01729754|451048706|FG004|Part 1|Progressive Disease|0|||
125385977|NCT01729754|451048707|FG005|Part 1|Progressive Disease|0|||
125385978|NCT01729754|451048708|FG006|Part 1|Progressive Disease|0|||
125385979|NCT01729754|451048709|FG007|Part 1|Progressive Disease|0|||
125385980|NCT01729754|451048710|FG008|Part 1|Progressive Disease|0|||
125139498|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
125139499|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
125139500|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
125139501|NCT02054715|450132896|FG000|Baseline/Follow-up 1|No Reason|0|||
125139502|NCT02054715|450132897|FG001|Baseline/Follow-up 1|No Reason|1|||
125139503|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
125139504|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
125139505|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Ineligible|3|||
125139506|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Ineligible|0|||
125139507|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Hospitalization|1|||
125139508|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Hospitalization|0|||
125139509|NCT02054715|450132896|FG000|Baseline/Follow-up 1|Changed Mind|1|||
125139510|NCT02054715|450132897|FG001|Baseline/Follow-up 1|Changed Mind|0|||
125139511|NCT02054715|450132896|FG000|Follow-up 2|Lost to Followup|3|||
125139512|NCT02054715|450132897|FG001|Follow-up 2|Lost to Followup|1|||
125139513|NCT02054715|450132896|FG000|Follow-up 2|Refused|3|||
125139514|NCT02054715|450132897|FG001|Follow-up 2|Refused|2|||
125139515|NCT02054715|450132896|FG000|Follow-up 2|Followup Not Completed|3|||
125385981|NCT01729754|451048711|FG009|Part 1|Progressive Disease|1|||
125139516|NCT02054715|450132897|FG001|Follow-up 2|Followup Not Completed|4|||
125139517|NCT02054715|450132896|FG000|Follow-up 2|Ineligible|4|||
125139518|NCT02054715|450132897|FG001|Follow-up 2|Ineligible|5|||
125139519|NCT02054715|450132896|FG000|Follow-up 2|Death|3|||
125139520|NCT02054715|450132897|FG001|Follow-up 2|Death|3|||
125222452|NCT01723072|450442752|FG000|Overall Study|Withdrawal by Subject|7|||
125222453|NCT01723072|450442753|FG001|Overall Study|Withdrawal by Subject|13|||
125222454|NCT01723072|450442752|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
125222455|NCT01723072|450442753|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
125222456|NCT01723072|450442752|FG000|Overall Study|Other|4|||
125222457|NCT01723072|450442753|FG001|Overall Study|Other|3|||
125222458|NCT03428100|450442754|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
125222459|NCT03428100|450442755|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222460|NCT03428100|450442756|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
125222461|NCT03428100|450442757|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
125222462|NCT03428100|450442758|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222463|NCT03428100|450442759|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222464|NCT03428100|450442760|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222465|NCT03428100|450442761|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222466|NCT03428100|450442762|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222467|NCT03428100|450442763|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222468|NCT03428100|450442764|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222469|NCT03428100|450442765|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222470|NCT03428100|450442766|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222471|NCT03428100|450442767|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222472|NCT03428100|450442768|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222473|NCT03428100|450442769|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222474|NCT03428100|450442770|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222475|NCT03428100|450442771|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222476|NCT03428100|450442772|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
125222477|NCT03428100|450442754|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
125222478|NCT03428100|450442755|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
125222479|NCT03428100|450442756|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
125222480|NCT03428100|450442757|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
125222481|NCT03428100|450442758|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222482|NCT03428100|450442759|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222483|NCT03428100|450442760|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222484|NCT03428100|450442761|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222485|NCT03428100|450442762|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222486|NCT03428100|450442763|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222487|NCT03428100|450442764|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222488|NCT03428100|450442765|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222489|NCT03428100|450442766|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125139521|NCT02054715|450132896|FG000|Follow-up 2|Hospitalization|0|||
125139522|NCT02054715|450132897|FG001|Follow-up 2|Hospitalization|2|||
125139523|NCT02054715|450132896|FG000|Follow-up 2|Changed MD/Facility|0|||
125139524|NCT02054715|450132897|FG001|Follow-up 2|Changed MD/Facility|1|||
125139525|NCT02054715|450132896|FG000|Follow-up 2|Changed Mind|0|||
125139526|NCT02054715|450132897|FG001|Follow-up 2|Changed Mind|1|||
125139527|NCT02054715|450132896|FG000|Follow-up 2|No Reason|2|||
125222490|NCT03428100|450442767|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222491|NCT03428100|450442768|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125139528|NCT02054715|450132897|FG001|Follow-up 2|No Reason|0|||
125139529|NCT02054715|450132896|FG000|Follow-up 2|Treatment Change or Delay|1|||
125139530|NCT02054715|450132897|FG001|Follow-up 2|Treatment Change or Delay|0|||
125139531|NCT01442376|450132899|FG000|Overall Study|Adverse Event|0|||
125385982|NCT01729754|451048702|FG000|Part 1|Protocol Violation|2|||
125385983|NCT01729754|451048703|FG001|Part 1|Protocol Violation|0|||
125385984|NCT01729754|451048704|FG002|Part 1|Protocol Violation|0|||
125385985|NCT01729754|451048705|FG003|Part 1|Protocol Violation|1|||
125385986|NCT01729754|451048706|FG004|Part 1|Protocol Violation|0|||
125385987|NCT01729754|451048707|FG005|Part 1|Protocol Violation|0|||
125385988|NCT01729754|451048708|FG006|Part 1|Protocol Violation|1|||
125385989|NCT01729754|451048709|FG007|Part 1|Protocol Violation|0|||
125385990|NCT01729754|451048710|FG008|Part 1|Protocol Violation|0|||
125385991|NCT01729754|451048711|FG009|Part 1|Protocol Violation|0|||
125385992|NCT01729754|451048702|FG000|Part 1|Withdrawal by Subject|5|||
125139532|NCT01442376|450132900|FG001|Overall Study|Adverse Event|3|||
125139533|NCT01442376|450132901|FG002|Overall Study|Adverse Event|2|||
125139534|NCT01442376|450132899|FG000|Overall Study|Death|0|||
125139535|NCT01442376|450132900|FG001|Overall Study|Death|1|||
125139536|NCT01442376|450132901|FG002|Overall Study|Death|1|||
125139537|NCT01442376|450132899|FG000|Overall Study|Withdrawal of consent|0|||
125139538|NCT01442376|450132900|FG001|Overall Study|Withdrawal of consent|0|||
125139539|NCT01442376|450132901|FG002|Overall Study|Withdrawal of consent|1|||
125139540|NCT01442376|450132899|FG000|Overall Study|Patients not treated|2|||
125139541|NCT01442376|450132900|FG001|Overall Study|Patients not treated|3|||
125139542|NCT01442376|450132901|FG002|Overall Study|Patients not treated|1|||
125139543|NCT01442376|450132899|FG000|Overall Study|Not eligible for subsequent cycles|1|||
125139544|NCT01442376|450132900|FG001|Overall Study|Not eligible for subsequent cycles|2|||
125139545|NCT01442376|450132901|FG002|Overall Study|Not eligible for subsequent cycles|0|||
125139546|NCT01964950|450132902|FG000|Overall Study|Protocol Violation|25|||
125139547|NCT03499873|450132903|FG000|Overall Study|Withdrawal by Subject|4|||
125139548|NCT03499873|450132904|FG001|Overall Study|Withdrawal by Subject|6|||
125139549|NCT03499873|450132905|FG002|Overall Study|Withdrawal by Subject|1|||
125139550|NCT03499873|450132903|FG000|Overall Study|Subjects condition worsened|0|||
125385993|NCT01729754|451048703|FG001|Part 1|Withdrawal by Subject|0|||
125139551|NCT03499873|450132904|FG001|Overall Study|Subjects condition worsened|3|||
125139552|NCT03499873|450132905|FG002|Overall Study|Subjects condition worsened|11|||
125385994|NCT01729754|451048704|FG002|Part 1|Withdrawal by Subject|0|||
125385995|NCT01729754|451048705|FG003|Part 1|Withdrawal by Subject|7|||
125385996|NCT01729754|451048706|FG004|Part 1|Withdrawal by Subject|0|||
125385997|NCT01729754|451048707|FG005|Part 1|Withdrawal by Subject|0|||
125385998|NCT01729754|451048708|FG006|Part 1|Withdrawal by Subject|5|||
125385999|NCT01729754|451048709|FG007|Part 1|Withdrawal by Subject|0|||
125386000|NCT01729754|451048710|FG008|Part 1|Withdrawal by Subject|0|||
125386001|NCT01729754|451048711|FG009|Part 1|Withdrawal by Subject|6|||
125386002|NCT01729754|451048702|FG000|Part 1|Other Protocol Specified Criteria|2|||
125139553|NCT03499873|450132903|FG000|Overall Study|Adverse Event|8|||
125139554|NCT03499873|450132904|FG001|Overall Study|Adverse Event|3|||
125139555|NCT03499873|450132905|FG002|Overall Study|Adverse Event|6|||
125139556|NCT03499873|450132903|FG000|Overall Study|Physician Decision|1|||
125139557|NCT03499873|450132904|FG001|Overall Study|Physician Decision|0|||
125139558|NCT03499873|450132905|FG002|Overall Study|Physician Decision|0|||
125139559|NCT03499873|450132903|FG000|Overall Study|Administrative reasons|0|||
125139560|NCT03499873|450132904|FG001|Overall Study|Administrative reasons|1|||
125139561|NCT03499873|450132905|FG002|Overall Study|Administrative reasons|0|||
125139562|NCT03499873|450132903|FG000|Overall Study|Concomitant therapy|5|||
125139563|NCT03499873|450132904|FG001|Overall Study|Concomitant therapy|4|||
125386003|NCT01729754|451048703|FG001|Part 1|Other Protocol Specified Criteria|0|||
125139564|NCT03499873|450132905|FG002|Overall Study|Concomitant therapy|7|||
125386004|NCT01729754|451048704|FG002|Part 1|Other Protocol Specified Criteria|0|||
125139565|NCT03499873|450132903|FG000|Overall Study|Miscellaneous|1|||
125139566|NCT03499873|450132904|FG001|Overall Study|Miscellaneous|2|||
125139567|NCT03499873|450132905|FG002|Overall Study|Miscellaneous|2|||
125139568|NCT03499873|450132903|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
125386005|NCT01729754|451048705|FG003|Part 1|Other Protocol Specified Criteria|0|||
125386006|NCT01729754|451048706|FG004|Part 1|Other Protocol Specified Criteria|0|||
125386007|NCT01729754|451048707|FG005|Part 1|Other Protocol Specified Criteria|0|||
125386008|NCT01729754|451048708|FG006|Part 1|Other Protocol Specified Criteria|1|||
125386009|NCT01729754|451048709|FG007|Part 1|Other Protocol Specified Criteria|0|||
125386010|NCT01729754|451048710|FG008|Part 1|Other Protocol Specified Criteria|0|||
125386011|NCT01729754|451048711|FG009|Part 1|Other Protocol Specified Criteria|4|||
125386012|NCT01729754|451048702|FG000|Part 2|Adverse Event|2|||
125386013|NCT01729754|451048703|FG001|Part 2|Adverse Event|0|||
125386014|NCT01729754|451048704|FG002|Part 2|Adverse Event|0|||
125386015|NCT01729754|451048705|FG003|Part 2|Adverse Event|0|||
125386016|NCT01729754|451048706|FG004|Part 2|Adverse Event|0|||
125386017|NCT01729754|451048707|FG005|Part 2|Adverse Event|0|||
125386018|NCT01729754|451048708|FG006|Part 2|Adverse Event|0|||
125386019|NCT01729754|451048709|FG007|Part 2|Adverse Event|0|||
125386020|NCT01729754|451048710|FG008|Part 2|Adverse Event|1|||
125386021|NCT01729754|451048711|FG009|Part 2|Adverse Event|2|||
125386022|NCT01729754|451048702|FG000|Part 2|Lack of Efficacy|0|||
125139569|NCT03499873|450132904|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
125139570|NCT03499873|450132905|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
125139571|NCT01075516|450132906|FG000|Overall Study|Death|5|||
125139572|NCT01075516|450132907|FG001|Overall Study|Death|9|||
125139573|NCT01075516|450132906|FG000|Overall Study|Lost to Follow-up|10|||
125139574|NCT01075516|450132907|FG001|Overall Study|Lost to Follow-up|2|||
125139575|NCT01075516|450132906|FG000|Overall Study|Withdrawal by Subject|3|||
125139576|NCT01075516|450132907|FG001|Overall Study|Withdrawal by Subject|5|||
125139577|NCT02252016|450132908|FG000|Overall Study|Lost to Follow-up|2|||
125139578|NCT02252016|450132909|FG001|Overall Study|Lost to Follow-up|1|||
125139579|NCT02252016|450132908|FG000|Overall Study|Physician Decision|1|||
125139580|NCT02252016|450132909|FG001|Overall Study|Physician Decision|0|||
125139581|NCT02252016|450132908|FG000|Overall Study|Withdrawal by Subject|0|||
125139582|NCT02252016|450132909|FG001|Overall Study|Withdrawal by Subject|2|||
125139583|NCT04631562|450132912|FG000|Overall Study|Withdrawal by Subject|0|||
125139584|NCT04631562|450132913|FG001|Overall Study|Withdrawal by Subject|0|||
125139585|NCT04631562|450132914|FG002|Overall Study|Withdrawal by Subject|0|||
125139586|NCT04631562|450132915|FG003|Overall Study|Withdrawal by Subject|0|||
125139587|NCT04631562|450132916|FG004|Overall Study|Withdrawal by Subject|0|||
125139588|NCT04631562|450132917|FG005|Overall Study|Withdrawal by Subject|0|||
125139589|NCT04631562|450132918|FG006|Overall Study|Withdrawal by Subject|0|||
125139590|NCT04631562|450132919|FG007|Overall Study|Withdrawal by Subject|1|||
125139591|NCT04631562|450132920|FG008|Overall Study|Withdrawal by Subject|0|||
125139592|NCT04631562|450132912|FG000|Overall Study|Other|0|||
125139593|NCT04631562|450132913|FG001|Overall Study|Other|0|||
125386023|NCT01729754|451048703|FG001|Part 2|Lack of Efficacy|0|||
125386024|NCT01729754|451048704|FG002|Part 2|Lack of Efficacy|0|||
125386025|NCT01729754|451048705|FG003|Part 2|Lack of Efficacy|0|||
125386026|NCT01729754|451048706|FG004|Part 2|Lack of Efficacy|0|||
125386027|NCT01729754|451048707|FG005|Part 2|Lack of Efficacy|0|||
125386028|NCT01729754|451048708|FG006|Part 2|Lack of Efficacy|0|||
125139594|NCT04631562|450132914|FG002|Overall Study|Other|0|||
125139595|NCT04631562|450132915|FG003|Overall Study|Other|0|||
125139596|NCT04631562|450132916|FG004|Overall Study|Other|0|||
125139597|NCT04631562|450132917|FG005|Overall Study|Other|0|||
125139598|NCT04631562|450132918|FG006|Overall Study|Other|0|||
125139599|NCT04631562|450132919|FG007|Overall Study|Other|0|||
125139600|NCT04631562|450132920|FG008|Overall Study|Other|1|||
125139601|NCT04631562|450132912|FG000|Overall Study|Lost to Follow-up|0|||
125139602|NCT04631562|450132913|FG001|Overall Study|Lost to Follow-up|0|||
125139603|NCT04631562|450132914|FG002|Overall Study|Lost to Follow-up|0|||
125139604|NCT04631562|450132915|FG003|Overall Study|Lost to Follow-up|1|||
125139605|NCT04631562|450132916|FG004|Overall Study|Lost to Follow-up|0|||
125139606|NCT04631562|450132917|FG005|Overall Study|Lost to Follow-up|0|||
125139607|NCT04631562|450132918|FG006|Overall Study|Lost to Follow-up|0|||
125139608|NCT04631562|450132919|FG007|Overall Study|Lost to Follow-up|0|||
125139609|NCT04631562|450132920|FG008|Overall Study|Lost to Follow-up|0|||
125139610|NCT04631562|450132912|FG000|Overall Study|Adverse Event|0|||
125139611|NCT04631562|450132913|FG001|Overall Study|Adverse Event|0|||
125222492|NCT03428100|450442769|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125139612|NCT04631562|450132914|FG002|Overall Study|Adverse Event|0|||
125139613|NCT04631562|450132915|FG003|Overall Study|Adverse Event|0|||
125222493|NCT03428100|450442770|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125139614|NCT04631562|450132916|FG004|Overall Study|Adverse Event|0|||
125139615|NCT04631562|450132917|FG005|Overall Study|Adverse Event|0|||
125139616|NCT04631562|450132918|FG006|Overall Study|Adverse Event|1|||
125139617|NCT04631562|450132919|FG007|Overall Study|Adverse Event|0|||
125386029|NCT01729754|451048709|FG007|Part 2|Lack of Efficacy|0|||
125386030|NCT01729754|451048710|FG008|Part 2|Lack of Efficacy|2|||
125139618|NCT04631562|450132920|FG008|Overall Study|Adverse Event|0|||
125139619|NCT02471807|450132926|FG000|Overall Study|Death|14|||
125139620|NCT02471807|450132926|FG000|Overall Study|Withdrawal by Subject|2|||
125139621|NCT02471807|450132926|FG000|Overall Study|Explant|5|||
125139622|NCT02471807|450132926|FG000|Overall Study|Lost to Follow-up|1|||
125139623|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
125139624|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
125386031|NCT01729754|451048711|FG009|Part 2|Lack of Efficacy|2|||
125222494|NCT03428100|450442771|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222495|NCT03428100|450442772|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
125222496|NCT03428100|450442754|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222497|NCT03428100|450442755|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
125222498|NCT03428100|450442756|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
125222499|NCT03428100|450442757|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222500|NCT03428100|450442758|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222501|NCT03428100|450442759|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222502|NCT03428100|450442760|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125139625|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
125139626|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
125139627|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
125139628|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
125139629|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
125139630|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
125139631|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
125139632|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
125139633|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
125139634|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
125139635|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
125139636|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
125139637|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
125386032|NCT01729754|451048702|FG000|Part 2|Lost to Follow-up|0|||
125386033|NCT01729754|451048703|FG001|Part 2|Lost to Follow-up|0|||
125386034|NCT01729754|451048704|FG002|Part 2|Lost to Follow-up|0|||
125386035|NCT01729754|451048705|FG003|Part 2|Lost to Follow-up|2|||
125386036|NCT01729754|451048706|FG004|Part 2|Lost to Follow-up|0|||
125386037|NCT01729754|451048707|FG005|Part 2|Lost to Follow-up|0|||
125386038|NCT01729754|451048708|FG006|Part 2|Lost to Follow-up|0|||
125386039|NCT01729754|451048709|FG007|Part 2|Lost to Follow-up|1|||
125386040|NCT01729754|451048710|FG008|Part 2|Lost to Follow-up|0|||
125386041|NCT01729754|451048711|FG009|Part 2|Lost to Follow-up|2|||
125386042|NCT01729754|451048702|FG000|Part 2|Non-Compliance with Study Drug|0|||
125386043|NCT01729754|451048703|FG001|Part 2|Non-Compliance with Study Drug|0|||
125386044|NCT01729754|451048704|FG002|Part 2|Non-Compliance with Study Drug|0|||
125386045|NCT01729754|451048705|FG003|Part 2|Non-Compliance with Study Drug|0|||
125386046|NCT01729754|451048706|FG004|Part 2|Non-Compliance with Study Drug|0|||
125386047|NCT01729754|451048707|FG005|Part 2|Non-Compliance with Study Drug|0|||
125386048|NCT01729754|451048708|FG006|Part 2|Non-Compliance with Study Drug|0|||
125386049|NCT01729754|451048709|FG007|Part 2|Non-Compliance with Study Drug|0|||
125386050|NCT01729754|451048710|FG008|Part 2|Non-Compliance with Study Drug|0|||
125386051|NCT01729754|451048711|FG009|Part 2|Non-Compliance with Study Drug|1|||
125386052|NCT01729754|451048702|FG000|Part 2|Pregnancy|0|||
125386053|NCT01729754|451048703|FG001|Part 2|Pregnancy|0|||
125386054|NCT01729754|451048704|FG002|Part 2|Pregnancy|0|||
125386055|NCT01729754|451048705|FG003|Part 2|Pregnancy|1|||
125386056|NCT01729754|451048706|FG004|Part 2|Pregnancy|0|||
125386057|NCT01729754|451048707|FG005|Part 2|Pregnancy|0|||
125386058|NCT01729754|451048708|FG006|Part 2|Pregnancy|0|||
125386059|NCT01729754|451048709|FG007|Part 2|Pregnancy|0|||
125386060|NCT01729754|451048710|FG008|Part 2|Pregnancy|0|||
125139638|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
125139639|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
125139640|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
125139641|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
125139642|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
125139643|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
125139644|NCT02227238|450132938|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
125139645|NCT02227238|450132939|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
125139646|NCT02227238|450132940|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
125139647|NCT02227238|450132938|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
125139648|NCT02227238|450132939|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
125139649|NCT02227238|450132940|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
125139650|NCT02227238|450132938|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
125139651|NCT02227238|450132939|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
125139652|NCT02227238|450132940|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
125139653|NCT02227238|450132938|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
125139654|NCT02227238|450132939|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
125139655|NCT02227238|450132940|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
125139656|NCT02227238|450132938|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
125139657|NCT02227238|450132939|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
125139658|NCT02227238|450132940|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
125139659|NCT02227238|450132938|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
125139660|NCT02227238|450132939|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
125139661|NCT02227238|450132940|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
125139662|NCT02227238|450132938|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
125139663|NCT02227238|450132939|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
125139664|NCT02227238|450132940|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
125139665|NCT04025021|450132941|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
125139666|NCT04025021|450132942|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
125139667|NCT03966911|450132943|FG000|Overall Study|Adverse Event|1|||
125222503|NCT03428100|450442761|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222504|NCT03428100|450442762|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222505|NCT03428100|450442763|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125386061|NCT01729754|451048711|FG009|Part 2|Pregnancy|1|||
125139668|NCT03966911|450132944|FG001|Overall Study|Adverse Event|1|||
125139669|NCT03966911|450132943|FG000|Overall Study|Withdrawal by Subject|8|||
125139670|NCT03966911|450132944|FG001|Overall Study|Withdrawal by Subject|2|||
125139671|NCT03966911|450132943|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
125139672|NCT03966911|450132944|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
125139673|NCT01986647|450132945|FG000|Overall Study|Lost to Follow-up|4|||
125139674|NCT01986647|450132946|FG001|Overall Study|Lost to Follow-up|1|||
125139675|NCT01986647|450132947|FG002|Overall Study|Lost to Follow-up|4|||
125139676|NCT01986647|450132948|FG003|Overall Study|Lost to Follow-up|4|||
125139677|NCT01986647|450132945|FG000|Overall Study|Withdrawal by Subject|1|||
125139678|NCT01986647|450132946|FG001|Overall Study|Withdrawal by Subject|3|||
125139679|NCT01986647|450132947|FG002|Overall Study|Withdrawal by Subject|2|||
125139680|NCT01986647|450132948|FG003|Overall Study|Withdrawal by Subject|3|||
125139681|NCT01986647|450132945|FG000|Overall Study|Health|5|||
125139682|NCT01986647|450132946|FG001|Overall Study|Health|3|||
125139683|NCT01986647|450132947|FG002|Overall Study|Health|6|||
125139684|NCT01986647|450132948|FG003|Overall Study|Health|4|||
125139685|NCT00868998|450132949|FG000|Overall Study|Screen Failure|1|||
125139686|NCT00868998|450132949|FG000|Overall Study|Withdrawal by Subject|1|||
125139687|NCT00868998|450132949|FG000|Overall Study|Progression of disease|2|||
125139688|NCT00868998|450132949|FG000|Overall Study|Death|1|||
125139689|NCT03498560|450132953|FG000|Overall Study|Found Ineligible|2|||
125139690|NCT03498560|450132953|FG000|Overall Study|Withdrawal by Subject|14|||
125139691|NCT03498560|450132953|FG000|Overall Study|Lost to Follow-up|4|||
125139692|NCT03498560|450132953|FG000|Overall Study|Death|1|||
125139693|NCT01004510|450132958|FG000|Overall Study|Adverse Event|1|||
125139694|NCT00474188|450132961|FG000|Overall Study|Withdrawal by Subject|1|||
125139695|NCT00474188|450132961|FG000|Overall Study|Study discontinued by sponsor|5|||
125139696|NCT03541252|450132962|FG000|Overall Study|Withdrawal by Subject|1|||
125139697|NCT01952691|450134257|FG000|Overall Study|Lost to Follow-up|2|||
125139698|NCT00199901|450134258|FG000|Overall Study|Protocol Violation|2|||
125139699|NCT00199901|450134259|FG001|Overall Study|Protocol Violation|0|||
125139700|NCT00199901|450134258|FG000|Overall Study|Withdrawal by Subject|1|||
125139701|NCT00199901|450134259|FG001|Overall Study|Withdrawal by Subject|0|||
125139702|NCT00199901|450134258|FG000|Overall Study|Progressive Disease|24|||
125139703|NCT00199901|450134259|FG001|Overall Study|Progressive Disease|24|||
125139704|NCT05776901|450134262|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
125139705|NCT02302716|450134265|FG000|Overall Study|Adverse Event|1|||
125139706|NCT02302716|450134266|FG001|Overall Study|Adverse Event|1|||
125139707|NCT02302716|450134265|FG000|Overall Study|Death|0|||
125139708|NCT02302716|450134266|FG001|Overall Study|Death|1|||
125139709|NCT02302716|450134265|FG000|Overall Study|Lack of Efficacy|0|||
125139710|NCT02302716|450134266|FG001|Overall Study|Lack of Efficacy|1|||
125139711|NCT02302716|450134265|FG000|Overall Study|Lost to Follow-up|2|||
125139712|NCT02302716|450134266|FG001|Overall Study|Lost to Follow-up|4|||
125139713|NCT02302716|450134265|FG000|Overall Study|Physician Decision|3|||
125139714|NCT02302716|450134266|FG001|Overall Study|Physician Decision|4|||
125139715|NCT02302716|450134265|FG000|Overall Study|Withdrawal by Subject|13|||
125139716|NCT02302716|450134266|FG001|Overall Study|Withdrawal by Subject|7|||
125139717|NCT02302716|450134265|FG000|Overall Study|Protocol Violation|0|||
125139718|NCT02302716|450134266|FG001|Overall Study|Protocol Violation|1|||
125139719|NCT04523480|450134268|FG000|Overall Study|Lost to Follow-up|30|||
125139720|NCT04523480|450134269|FG001|Overall Study|Lost to Follow-up|35|||
125139721|NCT04523480|450134270|FG002|Overall Study|Lost to Follow-up|0|||
125139722|NCT01911429|450134273|FG000|Overall Study|Adverse Event|5|||
125139723|NCT01911429|450134274|FG001|Overall Study|Adverse Event|3|||
125139724|NCT01911429|450134275|FG002|Overall Study|Adverse Event|9|||
125139725|NCT01911429|450134273|FG000|Overall Study|Lack of Efficacy|1|||
125139726|NCT01911429|450134274|FG001|Overall Study|Lack of Efficacy|2|||
125139727|NCT01911429|450134275|FG002|Overall Study|Lack of Efficacy|4|||
125139728|NCT01911429|450134273|FG000|Overall Study|Lost to Follow-up|0|||
125139729|NCT01911429|450134274|FG001|Overall Study|Lost to Follow-up|0|||
125139730|NCT01911429|450134275|FG002|Overall Study|Lost to Follow-up|1|||
125139731|NCT01911429|450134273|FG000|Overall Study|Protocol Violation|0|||
125139732|NCT01911429|450134274|FG001|Overall Study|Protocol Violation|0|||
125139733|NCT01911429|450134275|FG002|Overall Study|Protocol Violation|1|||
125139734|NCT01911429|450134273|FG000|Overall Study|Withdrawal by Subject|5|||
125139735|NCT01911429|450134274|FG001|Overall Study|Withdrawal by Subject|5|||
125139736|NCT01911429|450134275|FG002|Overall Study|Withdrawal by Subject|4|||
125139737|NCT01911429|450134273|FG000|Overall Study|Accidental randomization|0|||
125139738|NCT01911429|450134274|FG001|Overall Study|Accidental randomization|0|||
125139739|NCT01911429|450134275|FG002|Overall Study|Accidental randomization|1|||
125139740|NCT01911429|450134273|FG000|Overall Study|subject left study|1|||
125139741|NCT01911429|450134274|FG001|Overall Study|subject left study|0|||
125139742|NCT01911429|450134275|FG002|Overall Study|subject left study|0|||
125139743|NCT01557751|450134276|FG000|Overall Study|Physician Decision|3|||
125139744|NCT02043132|450134277|FG000|Overall Study|Lost to Follow-up|1|||
125139745|NCT02043132|450134278|FG001|Overall Study|Lost to Follow-up|1|||
125139746|NCT02043132|450134277|FG000|Overall Study|screen failures|4|||
125139747|NCT02043132|450134278|FG001|Overall Study|screen failures|8|||
125139748|NCT01923740|450134279|FG000|Overall Study|Lost to Follow-up|4|||
125222506|NCT03428100|450442764|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222507|NCT03428100|450442765|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125386062|NCT01729754|451048702|FG000|Part 2|Withdrawal by Subject|3|||
125139749|NCT01923740|450134280|FG001|Overall Study|Lost to Follow-up|9|||
125139750|NCT01923740|450134279|FG000|Overall Study|Withdrawal by Subject|2|||
125139751|NCT01923740|450134280|FG001|Overall Study|Withdrawal by Subject|0|||
125139752|NCT00472212|450134282|FG000|Overall Study|Lost to Follow-up|6|||
125139753|NCT00472212|450134283|FG001|Overall Study|Lost to Follow-up|4|||
125139754|NCT02462837|450134284|FG000|Overall Study|pt developed hives|1|||
125139755|NCT02462837|450134285|FG001|Overall Study|pt developed hives|0|||
125139756|NCT02462837|450134284|FG000|Overall Study|Withdrawal by Subject|1|||
125386063|NCT01729754|451048703|FG001|Part 2|Withdrawal by Subject|0|||
125386064|NCT01729754|451048704|FG002|Part 2|Withdrawal by Subject|0|||
125139757|NCT02462837|450134285|FG001|Overall Study|Withdrawal by Subject|0|||
125139758|NCT00958724|450134288|FG000|Overall Study|Disease Progression|6|||
125139759|NCT00840203|450134306|FG000|First Intervention|Protocol Violation|1|||
125139760|NCT00840203|450134307|FG001|First Intervention|Protocol Violation|1|||
125139761|NCT00840203|450134306|FG000|Washout|Protocol Violation|1|||
125139762|NCT00840203|450134307|FG001|Washout|Protocol Violation|0|||
125139763|NCT02121184|450134311|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
125139764|NCT02121184|450134312|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
125139765|NCT02121184|450134311|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
125139766|NCT02121184|450134312|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
125139767|NCT02121184|450134311|FG000|Overall Study|Emergency cesarean section required|0|||
125386065|NCT01729754|451048705|FG003|Part 2|Withdrawal by Subject|2|||
125386066|NCT01729754|451048706|FG004|Part 2|Withdrawal by Subject|0|||
125386067|NCT01729754|451048707|FG005|Part 2|Withdrawal by Subject|0|||
125139768|NCT02121184|450134312|FG001|Overall Study|Emergency cesarean section required|2|||
125139769|NCT02121184|450134311|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
125139770|NCT02121184|450134312|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
125139771|NCT05562011|450134313|FG000|Overall Study|Withdrawal by Subject|3|||
125139772|NCT05562011|450134313|FG000|Overall Study|Lost to Follow-up|1|||
125139773|NCT05562011|450134313|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
125139774|NCT05562011|450134313|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
125139775|NCT05562011|450134313|FG000|Overall Study|Device malfunction|13|||
125139776|NCT00487435|450134322|FG000|Overall Study|Adverse Event|146|||
125139777|NCT00487435|450134322|FG000|Overall Study|Death|2|||
125139778|NCT00487435|450134322|FG000|Overall Study|Lack of Efficacy|33|||
125139779|NCT00487435|450134322|FG000|Overall Study|Lost to Follow-up|54|||
125139780|NCT00487435|450134322|FG000|Overall Study|Pregnancy|2|||
125139781|NCT00487435|450134322|FG000|Overall Study|Withdrawal by Subject|132|||
125139782|NCT00487435|450134322|FG000|Overall Study|Resolution Of Pain|1|||
125139783|NCT00487435|450134322|FG000|Overall Study|Study Medication Non-Compliant|32|||
125139784|NCT00487435|450134322|FG000|Overall Study|Other|83|||
125139785|NCT02705716|450134323|FG000|Overall Study|Adverse Event|0|||
125139786|NCT02705716|450134324|FG001|Overall Study|Adverse Event|1|||
125139787|NCT02705716|450134323|FG000|Overall Study|Protocol Violation|3|||
125139788|NCT02705716|450134324|FG001|Overall Study|Protocol Violation|0|||
125139789|NCT02705716|450134323|FG000|Overall Study|Withdrawal of Consent|1|||
125139790|NCT02705716|450134324|FG001|Overall Study|Withdrawal of Consent|1|||
125139791|NCT00562718|450134325|FG000|Overall Study|Death|1|||
125139792|NCT00562718|450134325|FG000|Overall Study|Withdrawal by Subject|3|||
125139793|NCT00562718|450134325|FG000|Overall Study|Adverse Event|4|||
125139794|NCT00562718|450134325|FG000|Overall Study|Lack of Efficacy|2|||
125139795|NCT00562718|450134325|FG000|Overall Study|not stated|1|||
125139796|NCT01868243|450134326|FG000|Overall Study|Death|0|||
125139797|NCT01868243|450134327|FG001|Overall Study|Death|1|||
125386068|NCT01729754|451048708|FG006|Part 2|Withdrawal by Subject|0|||
125386069|NCT01729754|451048709|FG007|Part 2|Withdrawal by Subject|1|||
125139798|NCT02905435|450134329|FG000|Overall Study|Death|2|||
125139799|NCT02905435|450134329|FG000|Overall Study|Physician Decision|1|||
125139800|NCT02905435|450134329|FG000|Overall Study|Lost to Follow-up|4|||
125139801|NCT01507662|450134330|FG000|Overall Study|Death|26|||
125386070|NCT01729754|451048710|FG008|Part 2|Withdrawal by Subject|1|||
125139802|NCT01507662|450134331|FG001|Overall Study|Death|18|||
125139803|NCT01507662|450134330|FG000|Overall Study|Withdrawal by Subject|290|||
125139804|NCT01507662|450134331|FG001|Overall Study|Withdrawal by Subject|287|||
125139805|NCT01507662|450134330|FG000|Overall Study|Lost to Follow-up|498|||
125139806|NCT01507662|450134331|FG001|Overall Study|Lost to Follow-up|523|||
125139807|NCT01507662|450134330|FG000|Overall Study|Proxy interview done|2|||
125139808|NCT01507662|450134331|FG001|Overall Study|Proxy interview done|3|||
125139809|NCT01395017|450134332|FG000|Overall Study|Lost to Follow-up|1|||
125139810|NCT01395017|450134333|FG001|Overall Study|Lost to Follow-up|0|||
125139811|NCT01395017|450134332|FG000|Overall Study|Adverse Event|26|||
125139812|NCT01395017|450134333|FG001|Overall Study|Adverse Event|12|||
125139813|NCT01395017|450134332|FG000|Overall Study|Physician Decision|11|||
125139814|NCT01395017|450134333|FG001|Overall Study|Physician Decision|15|||
125139815|NCT01395017|450134332|FG000|Overall Study|Withdrawal by Subject|14|||
125139816|NCT01395017|450134333|FG001|Overall Study|Withdrawal by Subject|8|||
125139817|NCT01395017|450134332|FG000|Overall Study|Protocol deviation|1|||
125139818|NCT01395017|450134333|FG001|Overall Study|Protocol deviation|2|||
125139819|NCT01395017|450134332|FG000|Overall Study|Death|4|||
125139820|NCT01395017|450134333|FG001|Overall Study|Death|3|||
125139821|NCT01395017|450134332|FG000|Overall Study|Disease progression|42|||
125139822|NCT01395017|450134333|FG001|Overall Study|Disease progression|58|||
125139823|NCT01395017|450134332|FG000|Overall Study|Sponsor discontinued study|1|||
125139824|NCT01395017|450134333|FG001|Overall Study|Sponsor discontinued study|4|||
125139825|NCT03961204|450134336|FG000|Overall Study|Withdrawal by Subject|2|||
125139826|NCT03961204|450134336|FG000|Overall Study|Lost to Follow-up|3|||
125139827|NCT03961204|450134336|FG000|Overall Study|Other|1|||
125139828|NCT03961204|450134336|FG000|Overall Study|Missing|1|||
125139829|NCT01566435|450134340|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
125139830|NCT03684928|450134341|FG000|First Intervention|Lost to Follow-up|0|||
125139831|NCT03684928|450134342|FG001|First Intervention|Lost to Follow-up|1|||
125139832|NCT03684928|450134341|FG000|First Intervention|Withdrawal by Subject|0|||
125139833|NCT03684928|450134342|FG001|First Intervention|Withdrawal by Subject|2|||
125139834|NCT03684928|450134341|FG000|Second Intervention|Soft Tissue Injury|1|||
125139835|NCT03684928|450134342|FG001|Second Intervention|Soft Tissue Injury|0|||
125139836|NCT03733145|450134348|FG000|Overall Study|screenfail|3|||
125139837|NCT03733145|450134349|FG001|Overall Study|screenfail|3|||
125139838|NCT03733145|450134350|FG002|Overall Study|screenfail|2|||
125139839|NCT04236596|450134351|FG000|Overall Study|Withdrawal by Subject|1|||
125139840|NCT04236596|450134351|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
125139841|NCT04236596|450134351|FG000|Overall Study|Participants did not receive implant at all|4|||
125139842|NCT00557245|450135794|FG000|Overall Study|Lost to Follow-up|7|||
125139843|NCT00557245|450135795|FG001|Overall Study|Lost to Follow-up|8|||
125139844|NCT00557245|450135796|FG002|Overall Study|Lost to Follow-up|10|||
125139845|NCT00557245|450135794|FG000|Overall Study|Ineligible|5|||
125139846|NCT00557245|450135795|FG001|Overall Study|Ineligible|4|||
125139847|NCT00557245|450135796|FG002|Overall Study|Ineligible|2|||
125139848|NCT00798603|450135799|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
125139849|NCT00798603|450135799|FG000|Overall Study|Withdrawal by Subject|10|||
125139850|NCT00798603|450135799|FG000|Overall Study|Adverse Event|22|||
125139851|NCT00798603|450135799|FG000|Overall Study|Physician Decision|1|||
125139852|NCT00798603|450135799|FG000|Overall Study|Lack of insurance coverage|1|||
125139853|NCT02316223|450135802|FG000|Overall Study|Lack of Efficacy|0|||
125139854|NCT02316223|450135803|FG001|Overall Study|Lack of Efficacy|1|||
125139855|NCT02316223|450135804|FG002|Overall Study|Lack of Efficacy|1|||
125139856|NCT02316223|450135802|FG000|Overall Study|Lost to Follow-up|27|||
125139857|NCT02316223|450135803|FG001|Overall Study|Lost to Follow-up|34|||
125139858|NCT02316223|450135804|FG002|Overall Study|Lost to Follow-up|36|||
125139859|NCT02316223|450135802|FG000|Overall Study|COPD Diagnosis|3|||
125139860|NCT02316223|450135803|FG001|Overall Study|COPD Diagnosis|2|||
125139861|NCT02316223|450135804|FG002|Overall Study|COPD Diagnosis|3|||
125139862|NCT02316223|450135802|FG000|Overall Study|Reside outside study area|1|||
125139863|NCT02316223|450135803|FG001|Overall Study|Reside outside study area|1|||
125139864|NCT02316223|450135804|FG002|Overall Study|Reside outside study area|1|||
125139865|NCT02316223|450135802|FG000|Overall Study|No asthma|2|||
125139866|NCT02316223|450135803|FG001|Overall Study|No asthma|0|||
125139867|NCT02316223|450135804|FG002|Overall Study|No asthma|0|||
125139868|NCT02316223|450135802|FG000|Overall Study|Discontinued by PI|11|||
125139869|NCT02316223|450135803|FG001|Overall Study|Discontinued by PI|19|||
125139870|NCT02316223|450135804|FG002|Overall Study|Discontinued by PI|3|||
125139871|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Subject request|8|||
125139872|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Subject request|11|||
125139873|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
125386071|NCT01729754|451048711|FG009|Part 2|Withdrawal by Subject|4|||
125139874|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
125139875|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
125139876|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
125139877|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
125139878|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
125139879|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
125139880|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
125139881|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
125139882|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
125139883|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Death|1|||
125139884|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Death|0|||
125139885|NCT00521586|450135806|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
125386072|NCT01729754|451048702|FG000|Part 2|Other Protocol Specified Criteria|1|||
125386073|NCT01729754|451048703|FG001|Part 2|Other Protocol Specified Criteria|0|||
125386074|NCT01729754|451048704|FG002|Part 2|Other Protocol Specified Criteria|0|||
125386075|NCT01729754|451048705|FG003|Part 2|Other Protocol Specified Criteria|0|||
125386076|NCT01729754|451048706|FG004|Part 2|Other Protocol Specified Criteria|0|||
125386077|NCT01729754|451048707|FG005|Part 2|Other Protocol Specified Criteria|0|||
125386078|NCT01729754|451048708|FG006|Part 2|Other Protocol Specified Criteria|0|||
125386079|NCT01729754|451048709|FG007|Part 2|Other Protocol Specified Criteria|1|||
125386080|NCT01729754|451048710|FG008|Part 2|Other Protocol Specified Criteria|0|||
125386081|NCT01729754|451048711|FG009|Part 2|Other Protocol Specified Criteria|0|||
125386082|NCT01729754|451048702|FG000|Part 3|Adverse Event|0|||
125386083|NCT01729754|451048703|FG001|Part 3|Adverse Event|0|||
125386084|NCT01729754|451048704|FG002|Part 3|Adverse Event|1|||
125386085|NCT01729754|451048705|FG003|Part 3|Adverse Event|0|||
125139886|NCT00521586|450135807|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
125386086|NCT01729754|451048706|FG004|Part 3|Adverse Event|0|||
125386087|NCT01729754|451048707|FG005|Part 3|Adverse Event|5|||
125386088|NCT01729754|451048708|FG006|Part 3|Adverse Event|0|||
125386089|NCT01729754|451048709|FG007|Part 3|Adverse Event|0|||
125386090|NCT01729754|451048710|FG008|Part 3|Adverse Event|0|||
125386091|NCT01729754|451048711|FG009|Part 3|Adverse Event|3|||
125386092|NCT01729754|451048702|FG000|Part 3|Death|0|||
125386093|NCT01729754|451048703|FG001|Part 3|Death|0|||
125386094|NCT01729754|451048704|FG002|Part 3|Death|0|||
125386095|NCT01729754|451048705|FG003|Part 3|Death|0|||
125386096|NCT01729754|451048706|FG004|Part 3|Death|0|||
125222508|NCT03428100|450442766|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222509|NCT03428100|450442767|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222510|NCT03428100|450442768|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222511|NCT03428100|450442769|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222512|NCT03428100|450442770|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222513|NCT03428100|450442771|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125386097|NCT01729754|451048707|FG005|Part 3|Death|2|||
125386098|NCT01729754|451048708|FG006|Part 3|Death|0|||
125386099|NCT01729754|451048709|FG007|Part 3|Death|0|||
125386100|NCT01729754|451048710|FG008|Part 3|Death|0|||
125386101|NCT01729754|451048711|FG009|Part 3|Death|0|||
125139887|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
125139888|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
125139889|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
125139890|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
125139891|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
125139892|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
125222514|NCT03428100|450442772|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
125222515|NCT03428100|450442754|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
125222516|NCT03428100|450442755|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222517|NCT03428100|450442756|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222518|NCT03428100|450442757|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222519|NCT03428100|450442758|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222520|NCT03428100|450442759|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222521|NCT03428100|450442760|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222522|NCT03428100|450442761|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222523|NCT03428100|450442762|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222524|NCT03428100|450442763|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222525|NCT03428100|450442764|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222526|NCT03428100|450442765|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222527|NCT03428100|450442766|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222528|NCT03428100|450442767|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222529|NCT03428100|450442768|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222530|NCT03428100|450442769|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222531|NCT03428100|450442770|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222532|NCT03428100|450442771|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222533|NCT03428100|450442772|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
125222534|NCT03428100|450442754|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222535|NCT03428100|450442755|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
125222536|NCT03428100|450442756|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222537|NCT03428100|450442757|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222538|NCT03428100|450442758|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222539|NCT03428100|450442759|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222540|NCT03428100|450442760|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222541|NCT03428100|450442761|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222542|NCT03428100|450442762|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125386102|NCT01729754|451048702|FG000|Part 3|Lack of Efficacy|0|||
125139893|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
125139894|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
125139895|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
125139896|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
125139897|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
125139898|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
125139899|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
125139900|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
125139901|NCT00521586|450135806|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
125139902|NCT00521586|450135807|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
125139903|NCT00521586|450135806|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
125139904|NCT00521586|450135807|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
125139905|NCT00521586|450135806|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
125139906|NCT00521586|450135807|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
125139907|NCT00521586|450135806|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
125139908|NCT00521586|450135807|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
125139909|NCT00529763|450135808|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
125139910|NCT00529763|450135809|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
125139911|NCT00529763|450135810|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
125139912|NCT00529763|450135808|FG000|Overall Study|Death|1|||
125139913|NCT00529763|450135809|FG001|Overall Study|Death|1|||
125139914|NCT00529763|450135810|FG002|Overall Study|Death|1|||
125139915|NCT00529763|450135808|FG000|Overall Study|Disease Progression|10|||
125139916|NCT00529763|450135809|FG001|Overall Study|Disease Progression|16|||
125139917|NCT00529763|450135810|FG002|Overall Study|Disease Progression|11|||
125139918|NCT00529763|450135808|FG000|Overall Study|Lost to Follow-up|1|||
125222543|NCT03428100|450442763|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222544|NCT03428100|450442764|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222545|NCT03428100|450442765|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222546|NCT03428100|450442766|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222547|NCT03428100|450442767|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222548|NCT03428100|450442768|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222549|NCT03428100|450442769|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222550|NCT03428100|450442770|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222551|NCT03428100|450442771|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222552|NCT03428100|450442772|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
125222553|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222554|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222555|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222556|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222557|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222558|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
125222559|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
125222560|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
125222561|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
125222562|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125386103|NCT01729754|451048703|FG001|Part 3|Lack of Efficacy|0|||
125139919|NCT00529763|450135809|FG001|Overall Study|Lost to Follow-up|2|||
125139920|NCT00529763|450135810|FG002|Overall Study|Lost to Follow-up|3|||
125139921|NCT00529763|450135808|FG000|Overall Study|Stem Cell Transplant|0|||
125139922|NCT00529763|450135809|FG001|Overall Study|Stem Cell Transplant|3|||
125139923|NCT00529763|450135810|FG002|Overall Study|Stem Cell Transplant|1|||
125139924|NCT00529763|450135808|FG000|Overall Study|Study Drug Toxicity|3|||
125139925|NCT00529763|450135809|FG001|Overall Study|Study Drug Toxicity|6|||
125139926|NCT00529763|450135810|FG002|Overall Study|Study Drug Toxicity|4|||
125139927|NCT00529763|450135808|FG000|Overall Study|Participant Withdrew Consent|2|||
125139928|NCT00529763|450135809|FG001|Overall Study|Participant Withdrew Consent|3|||
125139929|NCT00529763|450135810|FG002|Overall Study|Participant Withdrew Consent|4|||
125139930|NCT00529763|450135808|FG000|Overall Study|Other reasons|2|||
125139931|NCT00529763|450135809|FG001|Overall Study|Other reasons|0|||
125139932|NCT00529763|450135810|FG002|Overall Study|Other reasons|2|||
125139933|NCT00529763|450135808|FG000|Overall Study|Participant request to discontinue treatment|1|||
125139934|NCT00529763|450135809|FG001|Overall Study|Participant request to discontinue treatment|1|||
125139935|NCT00529763|450135810|FG002|Overall Study|Participant request to discontinue treatment|3|||
125139936|NCT03669250|450135811|FG000|Overall Study|Adverse Event|0|||
125139937|NCT03669250|450135812|FG001|Overall Study|Adverse Event|0|||
125139938|NCT03669250|450135813|FG002|Overall Study|Adverse Event|0|||
125139939|NCT03669250|450135814|FG003|Overall Study|Adverse Event|0|||
125139940|NCT03669250|450135815|FG004|Overall Study|Adverse Event|1|||
125139941|NCT03669250|450135816|FG005|Overall Study|Adverse Event|0|||
125139942|NCT03669250|450135811|FG000|Overall Study|Withdrawal by Subject|0|||
125139943|NCT03669250|450135812|FG001|Overall Study|Withdrawal by Subject|1|||
125139944|NCT03669250|450135813|FG002|Overall Study|Withdrawal by Subject|0|||
125139945|NCT03669250|450135814|FG003|Overall Study|Withdrawal by Subject|1|||
125139946|NCT03669250|450135815|FG004|Overall Study|Withdrawal by Subject|0|||
125139947|NCT03669250|450135816|FG005|Overall Study|Withdrawal by Subject|0|||
125139948|NCT00828321|450135817|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
125386104|NCT01729754|451048704|FG002|Part 3|Lack of Efficacy|0|||
125386105|NCT01729754|451048705|FG003|Part 3|Lack of Efficacy|0|||
125386106|NCT01729754|451048706|FG004|Part 3|Lack of Efficacy|2|||
125139949|NCT00828321|450135818|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
125139950|NCT00828321|450135817|FG000|Second Intervention|Protocol Violation|0|||
125139951|NCT00828321|450135818|FG001|Second Intervention|Protocol Violation|1|||
125139952|NCT03234907|450135819|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
125139953|NCT03234907|450135820|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
125139954|NCT03234907|450135821|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
125139955|NCT03234907|450135822|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
125139956|NCT03234907|450135823|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
125139957|NCT03234907|450135824|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
125139958|NCT03234907|450135819|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
125139959|NCT03234907|450135820|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
125386107|NCT01729754|451048707|FG005|Part 3|Lack of Efficacy|0|||
125386108|NCT01729754|451048708|FG006|Part 3|Lack of Efficacy|0|||
125386109|NCT01729754|451048709|FG007|Part 3|Lack of Efficacy|0|||
125139960|NCT03234907|450135821|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
125139961|NCT03234907|450135822|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
125139962|NCT03234907|450135823|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
125139963|NCT03234907|450135824|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
125139964|NCT03234907|450135819|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
125139965|NCT03234907|450135820|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
125386110|NCT01729754|451048710|FG008|Part 3|Lack of Efficacy|0|||
125139966|NCT03234907|450135821|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
125139967|NCT03234907|450135822|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
125139968|NCT03234907|450135823|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
125139969|NCT03234907|450135824|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
125139970|NCT03234907|450135819|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
125139971|NCT03234907|450135820|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
125139972|NCT03234907|450135821|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
125139973|NCT03234907|450135822|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
125139974|NCT03234907|450135823|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
125139975|NCT03234907|450135824|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
125139976|NCT03234907|450135819|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
125139977|NCT03234907|450135820|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
125139978|NCT03234907|450135821|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
125139979|NCT03234907|450135822|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
125139980|NCT03234907|450135823|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
125139981|NCT03234907|450135824|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
125139982|NCT03234907|450135819|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
125139983|NCT03234907|450135820|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
125139984|NCT03234907|450135821|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
125139985|NCT03234907|450135822|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
125386111|NCT01729754|451048711|FG009|Part 3|Lack of Efficacy|4|||
125139986|NCT03234907|450135823|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
125139987|NCT03234907|450135824|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
125139988|NCT03234907|450135819|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
125139989|NCT03234907|450135820|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
125139990|NCT03234907|450135821|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
125139991|NCT03234907|450135822|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
125139992|NCT03234907|450135823|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
125139993|NCT03234907|450135824|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
125139994|NCT02664415|450135825|FG000|Overall Study|Adverse Event|1|||
125139995|NCT02664415|450135826|FG001|Overall Study|Adverse Event|0|||
125139996|NCT00642993|450135827|FG000|Overall Study|Adverse Event|85|||
125139997|NCT00642993|450135828|FG001|Overall Study|Adverse Event|4|||
125139998|NCT00642993|450135827|FG000|Overall Study|Lost to Follow-up|8|||
125139999|NCT00642993|450135828|FG001|Overall Study|Lost to Follow-up|4|||
125140000|NCT00642993|450135827|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
125140001|NCT00642993|450135828|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
125140002|NCT00642993|450135827|FG000|Overall Study|Protocol Violation|1|||
125140003|NCT00642993|450135828|FG001|Overall Study|Protocol Violation|4|||
125222563|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
125222564|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222565|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
125222566|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
125140004|NCT00642993|450135827|FG000|Overall Study|Did not meet protocol eligibility|0|||
125140005|NCT00642993|450135828|FG001|Overall Study|Did not meet protocol eligibility|1|||
125140006|NCT00642993|450135827|FG000|Overall Study|Administrative|1|||
125140007|NCT00642993|450135828|FG001|Overall Study|Administrative|0|||
125140008|NCT02986139|450135830|FG000|Overall Study|Sponsor Decision|1|||
125140009|NCT02986139|450135831|FG001|Overall Study|Sponsor Decision|2|||
125140010|NCT02986139|450135830|FG000|Overall Study|Withdrawal by Subject|0|||
125140011|NCT02986139|450135831|FG001|Overall Study|Withdrawal by Subject|1|||
125140012|NCT02986139|450135830|FG000|Overall Study|Lost to Follow-up|0|||
125140013|NCT02986139|450135831|FG001|Overall Study|Lost to Follow-up|1|||
125140014|NCT00414726|450135835|FG000|Overall Study|Withdrawal by Subject|0|||
125140015|NCT00414726|450135836|FG001|Overall Study|Withdrawal by Subject|1|||
125140016|NCT02107196|450135837|FG000|12-week Treatment Period|Adverse Event|6|||
125140017|NCT02107196|450135838|FG001|12-week Treatment Period|Adverse Event|3|||
125140018|NCT02107196|450135837|FG000|12-week Treatment Period|Lack of Efficacy|2|||
125140019|NCT02107196|450135838|FG001|12-week Treatment Period|Lack of Efficacy|1|||
125140020|NCT02107196|450135837|FG000|12-week Treatment Period|Lost to Follow-up|3|||
125140021|NCT02107196|450135838|FG001|12-week Treatment Period|Lost to Follow-up|6|||
125140022|NCT02107196|450135837|FG000|12-week Treatment Period|Physician Decision|0|||
125140023|NCT02107196|450135838|FG001|12-week Treatment Period|Physician Decision|1|||
125140024|NCT02107196|450135837|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
125140025|NCT02107196|450135838|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
125140026|NCT02107196|450135837|FG000|12-week Treatment Period|Protocol Violation|7|||
125140027|NCT02107196|450135838|FG001|12-week Treatment Period|Protocol Violation|8|||
125140028|NCT02107196|450135837|FG000|12-week Treatment Period|Reason Missing|11|||
125140029|NCT02107196|450135838|FG001|12-week Treatment Period|Reason Missing|8|||
125140030|NCT02107196|450135837|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
125222567|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
125140031|NCT02107196|450135838|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
125140032|NCT02107196|450135837|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
125140033|NCT02107196|450135838|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
125140034|NCT02107196|450135837|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
125140035|NCT02107196|450135838|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
125140036|NCT02107196|450135837|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
125140037|NCT02107196|450135838|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
125140038|NCT00516295|450135839|FG000|Overall Study|Lack of Efficacy|2|||
125140039|NCT00516295|450135840|FG001|Overall Study|Lack of Efficacy|0|||
125140040|NCT00516295|450135841|FG002|Overall Study|Lack of Efficacy|0|||
125140041|NCT00516295|450135839|FG000|Overall Study|Ineligible|1|||
125140042|NCT00516295|450135840|FG001|Overall Study|Ineligible|0|||
125140043|NCT00516295|450135841|FG002|Overall Study|Ineligible|0|||
125140044|NCT01243151|450135844|FG000|Overall Study|Adverse Event|0|||
125140045|NCT01243151|450135845|FG001|Overall Study|Adverse Event|1|||
125140046|NCT01243151|450135846|FG002|Overall Study|Adverse Event|0|||
125140047|NCT01243151|450135847|FG003|Overall Study|Adverse Event|0|||
125140048|NCT01243151|450135848|FG004|Overall Study|Adverse Event|0|||
125140049|NCT01243151|450135844|FG000|Overall Study|Protocol Violation|0|||
125140050|NCT01243151|450135845|FG001|Overall Study|Protocol Violation|0|||
125140051|NCT01243151|450135846|FG002|Overall Study|Protocol Violation|1|||
125140052|NCT01243151|450135847|FG003|Overall Study|Protocol Violation|0|||
125140053|NCT01243151|450135848|FG004|Overall Study|Protocol Violation|0|||
125140054|NCT01243151|450135844|FG000|Overall Study|Other|0|||
125140055|NCT01243151|450135845|FG001|Overall Study|Other|0|||
125140056|NCT01243151|450135846|FG002|Overall Study|Other|0|||
125140057|NCT01243151|450135847|FG003|Overall Study|Other|1|||
125140058|NCT01243151|450135848|FG004|Overall Study|Other|0|||
125140059|NCT01243151|450135844|FG000|Overall Study|Randomized but not treated|0|||
125140060|NCT01243151|450135845|FG001|Overall Study|Randomized but not treated|0|||
125140061|NCT01243151|450135846|FG002|Overall Study|Randomized but not treated|0|||
125140062|NCT01243151|450135847|FG003|Overall Study|Randomized but not treated|1|||
125140063|NCT01243151|450135848|FG004|Overall Study|Randomized but not treated|0|||
125140064|NCT03119662|450135849|FG000|Overall Study|Withdrawal by Subject|0|||
125140065|NCT03119662|450135850|FG001|Overall Study|Withdrawal by Subject|1|||
125140066|NCT01630616|450135854|FG000|Overall Study|Adverse Event|0|||
125140067|NCT01630616|450135855|FG001|Overall Study|Adverse Event|0|||
125140068|NCT01630616|450135856|FG002|Overall Study|Adverse Event|0|||
125140069|NCT01630616|450135857|FG003|Overall Study|Adverse Event|1|||
125140070|NCT01630616|450135858|FG004|Overall Study|Adverse Event|0|||
125140071|NCT01630616|450135859|FG005|Overall Study|Adverse Event|0|||
125140072|NCT01630616|450135854|FG000|Overall Study|Withdrawal by Subject|0|||
125140073|NCT01630616|450135855|FG001|Overall Study|Withdrawal by Subject|0|||
125140074|NCT01630616|450135856|FG002|Overall Study|Withdrawal by Subject|0|||
125140075|NCT01630616|450135857|FG003|Overall Study|Withdrawal by Subject|2|||
125140076|NCT01630616|450135858|FG004|Overall Study|Withdrawal by Subject|0|||
125140077|NCT01630616|450135859|FG005|Overall Study|Withdrawal by Subject|0|||
125140078|NCT02218541|450135860|FG000|Overall Study|Lost to Follow-up|2|||
125140079|NCT02218541|450135861|FG001|Overall Study|Lost to Follow-up|1|||
125386112|NCT01729754|451048702|FG000|Part 3|Lost to Follow-up|0|||
125140080|NCT02218541|450135860|FG000|Overall Study|Implant Failure|4|||
125140081|NCT02218541|450135861|FG001|Overall Study|Implant Failure|1|||
125140082|NCT01993186|450135862|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
125140083|NCT01993186|450135863|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
125140084|NCT01993186|450135862|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
125140085|NCT01993186|450135863|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
125140086|NCT01993186|450135862|FG000|Open-Label Extension Period|Other, Not Specified|0|||
125140087|NCT01993186|450135863|FG001|Open-Label Extension Period|Other, Not Specified|1|||
125140088|NCT01993186|450135862|FG000|Open-Label Extension Period|Adverse Event|1|||
125140089|NCT01993186|450135863|FG001|Open-Label Extension Period|Adverse Event|0|||
125140090|NCT01993186|450135862|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
125140091|NCT01993186|450135863|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
125140092|NCT01993186|450135862|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
125140093|NCT01993186|450135863|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
125140094|NCT01993186|450135862|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
125140095|NCT01993186|450135863|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
125140096|NCT01853176|450135865|FG000|Overall Study|Study terminated|4|||
125140097|NCT01853176|450135866|FG001|Overall Study|Study terminated|0|||
125140098|NCT00198133|450135867|FG000|Overall Study|Disease progression|2|||
125140099|NCT00198133|450135868|FG001|Overall Study|Disease progression|5|||
125140100|NCT00198133|450135867|FG000|Overall Study|Adverse Event|1|||
125140101|NCT00198133|450135868|FG001|Overall Study|Adverse Event|3|||
125140102|NCT00198133|450135867|FG000|Overall Study|Withdrawal by Subject|1|||
125386113|NCT01729754|451048703|FG001|Part 3|Lost to Follow-up|1|||
125386114|NCT01729754|451048704|FG002|Part 3|Lost to Follow-up|2|||
125386115|NCT01729754|451048705|FG003|Part 3|Lost to Follow-up|0|||
125386116|NCT01729754|451048706|FG004|Part 3|Lost to Follow-up|0|||
125386117|NCT01729754|451048707|FG005|Part 3|Lost to Follow-up|3|||
125386118|NCT01729754|451048708|FG006|Part 3|Lost to Follow-up|0|||
125140103|NCT00198133|450135868|FG001|Overall Study|Withdrawal by Subject|0|||
125140104|NCT00198133|450135867|FG000|Overall Study|Physician Decision|1|||
125140105|NCT00198133|450135868|FG001|Overall Study|Physician Decision|0|||
125140106|NCT03827395|450135869|FG000|Overall Study|Lost to Follow-up|1|||
125386119|NCT01729754|451048709|FG007|Part 3|Lost to Follow-up|0|||
125386120|NCT01729754|451048710|FG008|Part 3|Lost to Follow-up|1|||
125386121|NCT01729754|451048711|FG009|Part 3|Lost to Follow-up|0|||
125386122|NCT01729754|451048702|FG000|Part 3|Physician Decision|0|||
125386123|NCT01729754|451048703|FG001|Part 3|Physician Decision|0|||
125386124|NCT01729754|451048704|FG002|Part 3|Physician Decision|1|||
125140107|NCT03827395|450135870|FG001|Overall Study|Lost to Follow-up|0|||
125386125|NCT01729754|451048705|FG003|Part 3|Physician Decision|0|||
125140108|NCT03827395|450135869|FG000|Overall Study|Protocol Violation|1|||
125140109|NCT03827395|450135870|FG001|Overall Study|Protocol Violation|0|||
125140110|NCT03827395|450135869|FG000|Overall Study|Became ineligible after enrollment|1|||
125140111|NCT03827395|450135870|FG001|Overall Study|Became ineligible after enrollment|2|||
125140112|NCT00731939|450135871|FG000|Overall Study|Adverse Event|6|||
125140113|NCT00731939|450135871|FG000|Overall Study|Lost to Follow-up|15|||
125140114|NCT00731939|450135871|FG000|Overall Study|Not implanted with study device|9|||
125140115|NCT00731939|450135871|FG000|Overall Study|Withdrawal by Subject|2|||
125140116|NCT00731939|450135871|FG000|Overall Study|Did not meet enrollment criteria|2|||
125140117|NCT02072096|450135874|FG000|Overall Study|Lack of Efficacy|18|||
125140118|NCT02072096|450135875|FG001|Overall Study|Lack of Efficacy|29|||
125140119|NCT02072096|450135874|FG000|Overall Study|Protocol Violation|7|||
125140120|NCT02072096|450135875|FG001|Overall Study|Protocol Violation|7|||
125140121|NCT02072096|450135874|FG000|Overall Study|Withdrawal by Subject|5|||
125140122|NCT02072096|450135875|FG001|Overall Study|Withdrawal by Subject|7|||
125140123|NCT02072096|450135874|FG000|Overall Study|Adverse Event|5|||
125140124|NCT02072096|450135875|FG001|Overall Study|Adverse Event|2|||
125140125|NCT02072096|450135874|FG000|Overall Study|No Reason Provided|4|||
125140126|NCT02072096|450135875|FG001|Overall Study|No Reason Provided|2|||
125140127|NCT02072096|450135874|FG000|Overall Study|Death|2|||
125140128|NCT02072096|450135875|FG001|Overall Study|Death|0|||
125140129|NCT02072096|450135874|FG000|Overall Study|Physician Decision|0|||
125140130|NCT02072096|450135875|FG001|Overall Study|Physician Decision|1|||
125140131|NCT02072096|450135874|FG000|Overall Study|Study Terminated by Sponsor|43|||
125140132|NCT02072096|450135875|FG001|Overall Study|Study Terminated by Sponsor|30|||
125140133|NCT02072096|450135874|FG000|Overall Study|Lost to Follow-up|1|||
125140134|NCT02072096|450135875|FG001|Overall Study|Lost to Follow-up|0|||
125140135|NCT01634139|450135880|FG000|Overall Study|Non compliant with protocol|1|||
125140136|NCT01634139|450135881|FG001|Overall Study|Non compliant with protocol|0|||
125140137|NCT01634139|450135882|FG002|Overall Study|Non compliant with protocol|0|||
125140138|NCT01634139|450135880|FG000|Overall Study|Consent withdrawn not due to AE|4|||
125140139|NCT01634139|450135881|FG001|Overall Study|Consent withdrawn not due to AE|3|||
125140140|NCT01634139|450135882|FG002|Overall Study|Consent withdrawn not due to AE|2|||
125140141|NCT01634139|450135880|FG000|Overall Study|Other|4|||
125140142|NCT01634139|450135881|FG001|Overall Study|Other|0|||
125140143|NCT01634139|450135882|FG002|Overall Study|Other|3|||
125140144|NCT01634139|450135880|FG000|Overall Study|Lost to Follow-up|0|||
125386126|NCT01729754|451048706|FG004|Part 3|Physician Decision|0|||
125140145|NCT01634139|450135881|FG001|Overall Study|Lost to Follow-up|2|||
125140146|NCT01634139|450135882|FG002|Overall Study|Lost to Follow-up|0|||
125386127|NCT01729754|451048707|FG005|Part 3|Physician Decision|0|||
125140147|NCT01634139|450135880|FG000|Overall Study|Not treated|1|||
125140148|NCT01634139|450135881|FG001|Overall Study|Not treated|1|||
125140149|NCT01634139|450135882|FG002|Overall Study|Not treated|0|||
125140150|NCT01168856|450135884|FG000|Overall Study|Lost to Follow-up|4|||
125140151|NCT01168856|450135885|FG001|Overall Study|Lost to Follow-up|34|||
125140152|NCT01168856|450135884|FG000|Overall Study|Withdrawal by Subject|6|||
125140153|NCT01168856|450135885|FG001|Overall Study|Withdrawal by Subject|8|||
125140154|NCT01168856|450135884|FG000|Overall Study|Physician Decision|2|||
125386128|NCT01729754|451048708|FG006|Part 3|Physician Decision|0|||
125140155|NCT01168856|450135885|FG001|Overall Study|Physician Decision|1|||
125140156|NCT01168856|450135884|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
125140157|NCT01168856|450135885|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
125140158|NCT01168856|450135884|FG000|Overall Study|Participant received anti-HCV treatment|1|||
125140159|NCT01168856|450135885|FG001|Overall Study|Participant received anti-HCV treatment|0|||
125140160|NCT01168856|450135884|FG000|Overall Study|Death|0|||
125140161|NCT01168856|450135885|FG001|Overall Study|Death|2|||
125140162|NCT01168856|450135884|FG000|Overall Study|Other|1|||
125140163|NCT01168856|450135885|FG001|Overall Study|Other|291|||
125222568|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
125222569|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
125222570|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222571|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
125222572|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
125222573|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
125222574|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
125222575|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
125222576|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
125222577|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
125222578|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
125222579|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
125222580|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
125222581|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
125222582|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
125222583|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
125222584|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
125222585|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
125222586|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
125222587|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
125222588|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
125222589|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
125222590|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
125222591|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
125222592|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
125222593|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
125140164|NCT01168856|450135884|FG000|Overall Study|Protocol Violation|4|||
125140165|NCT01168856|450135885|FG001|Overall Study|Protocol Violation|6|||
125222594|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
125222595|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
125222596|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
125222597|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
125222598|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
125222599|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
125222600|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
125222601|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
125222602|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
125222603|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
125222604|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
125222605|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
125222606|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
125222607|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
125222608|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
125222609|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
125222610|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222611|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222612|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222613|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222614|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222615|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125386129|NCT01729754|451048709|FG007|Part 3|Physician Decision|0|||
125386130|NCT01729754|451048710|FG008|Part 3|Physician Decision|0|||
125386131|NCT01729754|451048711|FG009|Part 3|Physician Decision|0|||
125386132|NCT01729754|451048702|FG000|Part 3|Withdrawal by Subject|0|||
125386133|NCT01729754|451048703|FG001|Part 3|Withdrawal by Subject|4|||
125386134|NCT01729754|451048704|FG002|Part 3|Withdrawal by Subject|1|||
125386135|NCT01729754|451048705|FG003|Part 3|Withdrawal by Subject|0|||
125386136|NCT01729754|451048706|FG004|Part 3|Withdrawal by Subject|2|||
125386137|NCT01729754|451048707|FG005|Part 3|Withdrawal by Subject|1|||
125386138|NCT01729754|451048708|FG006|Part 3|Withdrawal by Subject|0|||
125386139|NCT01729754|451048709|FG007|Part 3|Withdrawal by Subject|2|||
125386140|NCT01729754|451048710|FG008|Part 3|Withdrawal by Subject|0|||
125386141|NCT01729754|451048711|FG009|Part 3|Withdrawal by Subject|0|||
125386142|NCT01729754|451048702|FG000|Part 3|Other Protocol Specified Criteria|0|||
125386143|NCT01729754|451048703|FG001|Part 3|Other Protocol Specified Criteria|0|||
125386144|NCT01729754|451048704|FG002|Part 3|Other Protocol Specified Criteria|0|||
125386145|NCT01729754|451048705|FG003|Part 3|Other Protocol Specified Criteria|0|||
125386146|NCT01729754|451048706|FG004|Part 3|Other Protocol Specified Criteria|0|||
125386147|NCT01729754|451048707|FG005|Part 3|Other Protocol Specified Criteria|2|||
125386148|NCT01729754|451048708|FG006|Part 3|Other Protocol Specified Criteria|0|||
125140166|NCT01266902|450135886|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
125140167|NCT01266902|450135887|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
125140168|NCT01266902|450135888|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
125140169|NCT01266902|450135886|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
125140170|NCT01266902|450135887|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
125140171|NCT01266902|450135888|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
125140172|NCT01266902|450135886|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
125140173|NCT01266902|450135887|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
125140174|NCT01266902|450135888|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
125140175|NCT01266902|450135886|FG000|Period 1 (Main Study)|Adverse Event|3|||
125140176|NCT01266902|450135887|FG001|Period 1 (Main Study)|Adverse Event|11|||
125140177|NCT01266902|450135888|FG002|Period 1 (Main Study)|Adverse Event|0|||
125140178|NCT01266902|450135886|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
125140179|NCT01266902|450135887|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
125140180|NCT01266902|450135888|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
125140181|NCT01266902|450135886|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
125140182|NCT01266902|450135887|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
125140183|NCT01266902|450135888|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
125140184|NCT01266902|450135886|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
125140185|NCT01266902|450135887|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
125140186|NCT01266902|450135888|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
125140187|NCT01266902|450135886|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
125140188|NCT01266902|450135887|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
125140189|NCT01266902|450135888|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
125140190|NCT01266902|450135886|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
125140191|NCT01266902|450135887|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
125140192|NCT01266902|450135888|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
125140193|NCT01266902|450135886|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
125140194|NCT01266902|450135887|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
125140195|NCT01266902|450135888|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
125140196|NCT00387153|450135893|FG000|Overall Study|Adverse Event|1|||
125386149|NCT01729754|451048709|FG007|Part 3|Other Protocol Specified Criteria|1|||
125386150|NCT01729754|451048710|FG008|Part 3|Other Protocol Specified Criteria|0|||
125386151|NCT01729754|451048711|FG009|Part 3|Other Protocol Specified Criteria|0|||
125386152|NCT00192504|451048716|FG000|Overall Study|Lost to Follow-up|1|||
125386153|NCT00192504|451048717|FG001|Overall Study|Lost to Follow-up|0|||
125386154|NCT00192504|451048718|FG002|Overall Study|Lost to Follow-up|0|||
125386155|NCT00192504|451048719|FG003|Overall Study|Lost to Follow-up|0|||
125140197|NCT00387153|450135893|FG000|Overall Study|Disease Progression|3|||
125140198|NCT00387153|450135893|FG000|Overall Study|Lack of Response|4|||
125140199|NCT04567329|450135894|FG000|Overall Study|Withdrawal by Subject|5|||
125386156|NCT00192504|451048716|FG000|Overall Study|Dosing window missed|0|||
125140200|NCT04567329|450135895|FG001|Overall Study|Withdrawal by Subject|6|||
125222616|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125386157|NCT00192504|451048717|FG001|Overall Study|Dosing window missed|0|||
125140201|NCT04567329|450135894|FG000|Overall Study|Protocol Violation|2|||
125140202|NCT04567329|450135895|FG001|Overall Study|Protocol Violation|3|||
125140203|NCT04567329|450135894|FG000|Overall Study|Discontinued|2|||
125140204|NCT04567329|450135895|FG001|Overall Study|Discontinued|2|||
125140205|NCT04567329|450135894|FG000|Overall Study|Lost to Follow-up|0|||
125140206|NCT04567329|450135895|FG001|Overall Study|Lost to Follow-up|1|||
125140207|NCT04567329|450135894|FG000|Overall Study|Lack of Efficacy|0|||
125140208|NCT04567329|450135895|FG001|Overall Study|Lack of Efficacy|1|||
125140209|NCT01087502|450135896|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
125140210|NCT01087502|450135897|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
125140211|NCT01087502|450135896|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
125140212|NCT01087502|450135897|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
125140213|NCT01087502|450135896|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
125140214|NCT01087502|450135897|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
125140215|NCT01087502|450135896|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
125140216|NCT01087502|450135897|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
125140217|NCT01087502|450135896|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
125140218|NCT01087502|450135897|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
125140219|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
125140220|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
125140221|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
125140222|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
125140223|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
125140224|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
125140225|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
125140226|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
125140227|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
125140228|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
125140229|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
125140230|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
125140231|NCT01087502|450135896|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
125140232|NCT01087502|450135897|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
125140233|NCT00985751|450135899|FG000|Overall Study|Adverse Event|0|||
125140234|NCT00985751|450135900|FG001|Overall Study|Adverse Event|0|||
125140235|NCT00985751|450135901|FG002|Overall Study|Adverse Event|0|||
125140236|NCT00985751|450135902|FG003|Overall Study|Adverse Event|0|||
125140237|NCT00985751|450135903|FG004|Overall Study|Adverse Event|1|||
125140238|NCT00380588|450135904|FG000|Overall Study|Unequivocal Disease Progression|25|||
125140239|NCT00380588|450135905|FG001|Overall Study|Unequivocal Disease Progression|34|||
125140240|NCT00380588|450135904|FG000|Overall Study|Next Cycle Not Started|4|||
125140241|NCT00380588|450135905|FG001|Overall Study|Next Cycle Not Started|0|||
125140242|NCT00380588|450135904|FG000|Overall Study|Adverse Event|7|||
125140243|NCT00380588|450135905|FG001|Overall Study|Adverse Event|3|||
125140244|NCT00380588|450135904|FG000|Overall Study|Withdrawal by Subject|1|||
125140245|NCT00380588|450135905|FG001|Overall Study|Withdrawal by Subject|3|||
125140246|NCT00380588|450135904|FG000|Overall Study|Physician Decision|2|||
125140247|NCT00380588|450135905|FG001|Overall Study|Physician Decision|0|||
125140248|NCT01451541|450135907|FG000|Overall Study|Adverse Event|4|||
125140249|NCT01451541|450135908|FG001|Overall Study|Adverse Event|3|||
125140250|NCT01451541|450135909|FG002|Overall Study|Adverse Event|6|||
125140251|NCT01451541|450135907|FG000|Overall Study|Lack of Efficacy|2|||
125140252|NCT01451541|450135908|FG001|Overall Study|Lack of Efficacy|0|||
125140253|NCT01451541|450135909|FG002|Overall Study|Lack of Efficacy|0|||
125222617|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
125222618|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222619|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222620|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222621|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
125386158|NCT00192504|451048718|FG002|Overall Study|Dosing window missed|1|||
125222622|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
125222623|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125140254|NCT01451541|450135907|FG000|Overall Study|Lost to Follow-up|4|||
125140255|NCT01451541|450135908|FG001|Overall Study|Lost to Follow-up|4|||
125140256|NCT01451541|450135909|FG002|Overall Study|Lost to Follow-up|7|||
125140257|NCT01451541|450135907|FG000|Overall Study|Withdrawal by Subject|15|||
125140258|NCT01451541|450135908|FG001|Overall Study|Withdrawal by Subject|8|||
125140259|NCT01451541|450135909|FG002|Overall Study|Withdrawal by Subject|6|||
125140260|NCT01451541|450135907|FG000|Overall Study|randomization error, noncompliance|11|||
125140261|NCT01451541|450135908|FG001|Overall Study|randomization error, noncompliance|10|||
125140262|NCT01451541|450135909|FG002|Overall Study|randomization error, noncompliance|8|||
125140263|NCT03366428|450135911|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
125140264|NCT03366428|450135911|FG000|Overall Study|Adverse Event|12|||
125140265|NCT03366428|450135911|FG000|Overall Study|Clinical progression|2|||
125140266|NCT03366428|450135911|FG000|Overall Study|Withdrawal by Subject|4|||
125140267|NCT00999687|450135918|FG000|First Intervention|Withdrawal by Subject|1|||
125140268|NCT00999687|450135918|FG000|Second Intervention|Withdrawal by Subject|2|||
125140269|NCT00999687|450135918|FG000|Second Intervention|Lack of Efficacy|1|||
125140270|NCT01120028|450135920|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
125140271|NCT01120028|450135921|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
125140272|NCT01120028|450135922|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
125140273|NCT01120028|450135923|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
125140274|NCT01120028|450135920|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
125140275|NCT01120028|450135921|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
125140276|NCT01120028|450135922|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
125140277|NCT01120028|450135923|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
125140278|NCT01253564|450135925|FG000|Overall Study|Disease Progression|22|||
125140279|NCT01253564|450135925|FG000|Overall Study|Withdrawal by Subject|1|||
125140280|NCT01253564|450135925|FG000|Overall Study|Serious Adverse Event|1|||
125140281|NCT02034513|450137568|FG000|Overall Study|Adverse Event|11|||
125140282|NCT02034513|450137569|FG001|Overall Study|Adverse Event|10|||
125140283|NCT02034513|450137568|FG000|Overall Study|Lack of Efficacy|0|||
125140284|NCT02034513|450137569|FG001|Overall Study|Lack of Efficacy|1|||
125140285|NCT02034513|450137568|FG000|Overall Study|Lost to Follow-up|6|||
125140286|NCT02034513|450137569|FG001|Overall Study|Lost to Follow-up|7|||
125140287|NCT02034513|450137568|FG000|Overall Study|Pregnancy|0|||
125140288|NCT02034513|450137569|FG001|Overall Study|Pregnancy|3|||
125140289|NCT02034513|450137568|FG000|Overall Study|Protocol Violation|7|||
125386159|NCT00192504|451048719|FG003|Overall Study|Dosing window missed|0|||
125386160|NCT01139450|451048720|FG000|Overall Study|Withdrawal by Subject|7|||
125386161|NCT01139450|451048721|FG001|Overall Study|Withdrawal by Subject|10|||
125386162|NCT01139450|451048722|FG002|Overall Study|Withdrawal by Subject|13|||
125386163|NCT01139450|451048720|FG000|Overall Study|Lack of Efficacy|3|||
125386164|NCT01139450|451048721|FG001|Overall Study|Lack of Efficacy|1|||
125386165|NCT01139450|451048722|FG002|Overall Study|Lack of Efficacy|8|||
125386166|NCT01139450|451048720|FG000|Overall Study|Protocol Violation|6|||
125386167|NCT01139450|451048721|FG001|Overall Study|Protocol Violation|5|||
125386168|NCT01139450|451048722|FG002|Overall Study|Protocol Violation|2|||
125386169|NCT01139450|451048720|FG000|Overall Study|Lost to Follow-up|9|||
125140290|NCT02034513|450137569|FG001|Overall Study|Protocol Violation|10|||
125140291|NCT02034513|450137568|FG000|Overall Study|Withdrawal by Subject|25|||
125140292|NCT02034513|450137569|FG001|Overall Study|Withdrawal by Subject|25|||
125140293|NCT02034513|450137568|FG000|Overall Study|Unclassified|0|||
125140294|NCT02034513|450137569|FG001|Overall Study|Unclassified|1|||
125140295|NCT02308241|450137570|FG000|Overall Study|Withdrawal by Subject|3|||
125140296|NCT04408924|450137571|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
125140297|NCT04408924|450137571|FG000|Overall Study|Lost to Follow-up|3|||
125140298|NCT04408924|450137571|FG000|Overall Study|Withdrawal by Subject|5|||
125386170|NCT01139450|451048721|FG001|Overall Study|Lost to Follow-up|7|||
125386171|NCT01139450|451048722|FG002|Overall Study|Lost to Follow-up|11|||
125386172|NCT01139450|451048720|FG000|Overall Study|Administrative|0|||
125386173|NCT01139450|451048721|FG001|Overall Study|Administrative|0|||
125222624|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
125140299|NCT04408924|450137571|FG000|Overall Study|Sponsor Decision|2|||
125140300|NCT00691704|450137572|FG000|Induction Therapy|Disease Progression|1|||
125140301|NCT00691704|450137572|FG000|Induction Therapy|Active Hepatitis|1|||
125140302|NCT00691704|450137572|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
125140303|NCT00691704|450137572|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
125140304|NCT00691704|450137572|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
125140305|NCT04661202|450137573|FG000|Overall Study|Withdrawal by Subject|1|||
125140306|NCT04661202|450137574|FG001|Overall Study|Withdrawal by Subject|1|||
125140307|NCT04661202|450137573|FG000|Overall Study|Lack of Efficacy|2|||
125140308|NCT04661202|450137574|FG001|Overall Study|Lack of Efficacy|0|||
125140309|NCT04158687|450137575|FG000|Overall Study|Adverse Event|2|||
125140310|NCT04158687|450137576|FG001|Overall Study|Adverse Event|3|||
125140311|NCT04158687|450137577|FG002|Overall Study|Adverse Event|0|||
125140312|NCT04158687|450137578|FG003|Overall Study|Adverse Event|3|||
125140313|NCT04158687|450137575|FG000|Overall Study|Lost to Follow-up|5|||
125140314|NCT04158687|450137576|FG001|Overall Study|Lost to Follow-up|12|||
125140315|NCT04158687|450137577|FG002|Overall Study|Lost to Follow-up|4|||
125140316|NCT04158687|450137578|FG003|Overall Study|Lost to Follow-up|5|||
125140317|NCT04158687|450137575|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
125140318|NCT04158687|450137576|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
125140319|NCT04158687|450137577|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
125140320|NCT04158687|450137578|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
125140321|NCT04158687|450137575|FG000|Overall Study|Non-Compliance with Study Medication|2|||
125140322|NCT04158687|450137576|FG001|Overall Study|Non-Compliance with Study Medication|2|||
125140323|NCT04158687|450137577|FG002|Overall Study|Non-Compliance with Study Medication|3|||
125140324|NCT04158687|450137578|FG003|Overall Study|Non-Compliance with Study Medication|0|||
125140325|NCT04158687|450137575|FG000|Overall Study|Investigator Decision|0|||
125140326|NCT04158687|450137576|FG001|Overall Study|Investigator Decision|0|||
125140327|NCT04158687|450137577|FG002|Overall Study|Investigator Decision|2|||
125140328|NCT04158687|450137578|FG003|Overall Study|Investigator Decision|0|||
125140329|NCT04158687|450137575|FG000|Overall Study|Protocol Violation|0|||
125140330|NCT04158687|450137576|FG001|Overall Study|Protocol Violation|2|||
125140331|NCT04158687|450137577|FG002|Overall Study|Protocol Violation|1|||
125140332|NCT04158687|450137578|FG003|Overall Study|Protocol Violation|0|||
125140333|NCT04158687|450137575|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
125140334|NCT04158687|450137576|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
125140335|NCT04158687|450137577|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
125140336|NCT04158687|450137578|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
125140337|NCT04158687|450137575|FG000|Overall Study|Reason not Specified|3|||
125140338|NCT04158687|450137576|FG001|Overall Study|Reason not Specified|2|||
125140339|NCT04158687|450137577|FG002|Overall Study|Reason not Specified|4|||
125140340|NCT04158687|450137578|FG003|Overall Study|Reason not Specified|4|||
125140341|NCT04102345|450137581|FG000|Overall Study|Withdrawal by Subject|1|||
125140342|NCT04102345|450137582|FG001|Overall Study|Withdrawal by Subject|0|||
125140343|NCT00835666|450137588|FG000|Washout|Protocol Violation|1|||
125140344|NCT00835666|450137589|FG001|Washout|Protocol Violation|0|||
125140345|NCT00835666|450137588|FG000|Washout|Withdrawal by Subject|1|||
125140346|NCT00835666|450137589|FG001|Washout|Withdrawal by Subject|0|||
125140347|NCT03599362|450137590|FG000|Overall Study|Screen Failure|3|||
125140348|NCT03707587|450137594|FG000|Overall Study|Death|0|||
125140349|NCT03707587|450137595|FG001|Overall Study|Death|1|||
125140350|NCT01537887|450137596|FG000|Period 1|Physician Decision|0|||
125140351|NCT01537887|450137597|FG001|Period 1|Physician Decision|0|||
125140352|NCT01537887|450137598|FG002|Period 1|Physician Decision|0|||
125140353|NCT01537887|450137599|FG003|Period 1|Physician Decision|0|||
125140354|NCT01537887|450137600|FG004|Period 1|Physician Decision|1|||
125140355|NCT01537887|450137601|FG005|Period 1|Physician Decision|1|||
125140356|NCT01537887|450137596|FG000|Period 1|Did not receive treatment|0|||
125140357|NCT01537887|450137597|FG001|Period 1|Did not receive treatment|0|||
125140358|NCT01537887|450137598|FG002|Period 1|Did not receive treatment|1|||
125140359|NCT01537887|450137599|FG003|Period 1|Did not receive treatment|0|||
125140360|NCT01537887|450137600|FG004|Period 1|Did not receive treatment|0|||
125140361|NCT01537887|450137601|FG005|Period 1|Did not receive treatment|0|||
125140362|NCT01537887|450137596|FG000|Period 2|Withdrawal by Subject|0|||
125140363|NCT01537887|450137597|FG001|Period 2|Withdrawal by Subject|1|||
125140364|NCT01537887|450137598|FG002|Period 2|Withdrawal by Subject|0|||
125140365|NCT01537887|450137599|FG003|Period 2|Withdrawal by Subject|0|||
125140366|NCT01537887|450137600|FG004|Period 2|Withdrawal by Subject|0|||
125140367|NCT01537887|450137601|FG005|Period 2|Withdrawal by Subject|0|||
125140368|NCT01537887|450137596|FG000|Period 3|Adverse Event|0|||
125140369|NCT01537887|450137597|FG001|Period 3|Adverse Event|0|||
125140370|NCT01537887|450137598|FG002|Period 3|Adverse Event|1|||
125140371|NCT01537887|450137599|FG003|Period 3|Adverse Event|0|||
125140372|NCT01537887|450137600|FG004|Period 3|Adverse Event|0|||
125140373|NCT01537887|450137601|FG005|Period 3|Adverse Event|0|||
125140374|NCT01537887|450137596|FG000|Period 3|Withdrawal by Subject|0|||
125140375|NCT01537887|450137597|FG001|Period 3|Withdrawal by Subject|1|||
125140376|NCT01537887|450137598|FG002|Period 3|Withdrawal by Subject|0|||
125140377|NCT01537887|450137599|FG003|Period 3|Withdrawal by Subject|0|||
125140378|NCT01537887|450137600|FG004|Period 3|Withdrawal by Subject|0|||
125140379|NCT01537887|450137601|FG005|Period 3|Withdrawal by Subject|0|||
125140380|NCT01370083|450137603|FG000|Overall Study|Lost to Follow-up|2|||
125140381|NCT01370083|450137604|FG001|Overall Study|Lost to Follow-up|0|||
125140382|NCT01370083|450137603|FG000|Overall Study|Adverse Event|0|||
125140383|NCT01370083|450137604|FG001|Overall Study|Adverse Event|1|||
125140384|NCT03358147|450137606|FG000|Overall Study|Withdrawal by Subject|13|||
125140385|NCT03358147|450137607|FG001|Overall Study|Withdrawal by Subject|19|||
125140386|NCT03358147|450137608|FG002|Overall Study|Withdrawal by Subject|16|||
125140387|NCT03358147|450137609|FG003|Overall Study|Withdrawal by Subject|10|||
125140388|NCT03358147|450137610|FG004|Overall Study|Withdrawal by Subject|5|||
125140389|NCT03358147|450137606|FG000|Overall Study|Adverse Event|3|||
125140390|NCT03358147|450137607|FG001|Overall Study|Adverse Event|9|||
125140391|NCT03358147|450137608|FG002|Overall Study|Adverse Event|7|||
125140392|NCT03358147|450137609|FG003|Overall Study|Adverse Event|5|||
125140393|NCT03358147|450137610|FG004|Overall Study|Adverse Event|2|||
125140394|NCT03358147|450137606|FG000|Overall Study|Lost to Follow-up|4|||
125140395|NCT03358147|450137607|FG001|Overall Study|Lost to Follow-up|3|||
125140396|NCT03358147|450137608|FG002|Overall Study|Lost to Follow-up|7|||
125140397|NCT03358147|450137609|FG003|Overall Study|Lost to Follow-up|6|||
125140398|NCT03358147|450137610|FG004|Overall Study|Lost to Follow-up|4|||
125140399|NCT03358147|450137606|FG000|Overall Study|Major Protocol Deviation|11|||
125140400|NCT03358147|450137607|FG001|Overall Study|Major Protocol Deviation|3|||
125140401|NCT03358147|450137608|FG002|Overall Study|Major Protocol Deviation|2|||
125140402|NCT03358147|450137609|FG003|Overall Study|Major Protocol Deviation|3|||
125140403|NCT03358147|450137610|FG004|Overall Study|Major Protocol Deviation|1|||
125222625|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125140404|NCT03358147|450137606|FG000|Overall Study|Protocol specified criteria|2|||
125140405|NCT03358147|450137607|FG001|Overall Study|Protocol specified criteria|3|||
125140406|NCT03358147|450137608|FG002|Overall Study|Protocol specified criteria|0|||
125140407|NCT03358147|450137609|FG003|Overall Study|Protocol specified criteria|3|||
125140408|NCT03358147|450137610|FG004|Overall Study|Protocol specified criteria|1|||
125140409|NCT03358147|450137606|FG000|Overall Study|Physician Decision|1|||
125140410|NCT03358147|450137607|FG001|Overall Study|Physician Decision|0|||
125140411|NCT03358147|450137608|FG002|Overall Study|Physician Decision|1|||
125386174|NCT01139450|451048722|FG002|Overall Study|Administrative|1|||
125386175|NCT01139450|451048720|FG000|Overall Study|Adverse Event|2|||
125140412|NCT03358147|450137609|FG003|Overall Study|Physician Decision|6|||
125140413|NCT03358147|450137610|FG004|Overall Study|Physician Decision|1|||
125140414|NCT03358147|450137606|FG000|Overall Study|Administrative reasons|0|||
125140415|NCT03358147|450137607|FG001|Overall Study|Administrative reasons|1|||
125140416|NCT03358147|450137608|FG002|Overall Study|Administrative reasons|0|||
125140417|NCT03358147|450137609|FG003|Overall Study|Administrative reasons|3|||
125140418|NCT03358147|450137610|FG004|Overall Study|Administrative reasons|0|||
125140419|NCT03358147|450137606|FG000|Overall Study|Lack of Efficacy|0|||
125140420|NCT03358147|450137607|FG001|Overall Study|Lack of Efficacy|1|||
125140421|NCT03358147|450137608|FG002|Overall Study|Lack of Efficacy|1|||
125386176|NCT01139450|451048721|FG001|Overall Study|Adverse Event|2|||
125386177|NCT01139450|451048722|FG002|Overall Study|Adverse Event|3|||
125140422|NCT03358147|450137609|FG003|Overall Study|Lack of Efficacy|0|||
125140423|NCT03358147|450137610|FG004|Overall Study|Lack of Efficacy|0|||
125386178|NCT04608500|451048723|FG000|Overall Study|Adverse Event|2|||
125386179|NCT04608500|451048724|FG001|Overall Study|Adverse Event|0|||
125386180|NCT04608500|451048723|FG000|Overall Study|Lost to Follow-up|15|||
125386181|NCT04608500|451048724|FG001|Overall Study|Lost to Follow-up|9|||
125386182|NCT04608500|451048723|FG000|Overall Study|Participant request|11|||
125386183|NCT04608500|451048724|FG001|Overall Study|Participant request|7|||
125386184|NCT04608500|451048723|FG000|Overall Study|Protocol Violation|1|||
125386185|NCT04608500|451048724|FG001|Overall Study|Protocol Violation|0|||
125386186|NCT04608500|451048723|FG000|Overall Study|Other|6|||
125386187|NCT04608500|451048724|FG001|Overall Study|Other|2|||
125386188|NCT00542919|451048725|FG000|Overall Study|Adverse Event|1|||
125386189|NCT00542919|451048726|FG001|Overall Study|Adverse Event|5|||
125386190|NCT00542919|451048727|FG002|Overall Study|Adverse Event|1|||
125386191|NCT00542919|451048725|FG000|Overall Study|Withdrawal by Subject|1|||
125386192|NCT00542919|451048726|FG001|Overall Study|Withdrawal by Subject|0|||
125386193|NCT00542919|451048727|FG002|Overall Study|Withdrawal by Subject|3|||
125386194|NCT00542919|451048725|FG000|Overall Study|Physician Decision|2|||
125386195|NCT00542919|451048726|FG001|Overall Study|Physician Decision|2|||
125386196|NCT00542919|451048727|FG002|Overall Study|Physician Decision|1|||
125386197|NCT00542919|451048725|FG000|Overall Study|Sponsor Decision|1|||
125386198|NCT00542919|451048726|FG001|Overall Study|Sponsor Decision|0|||
125386199|NCT00542919|451048727|FG002|Overall Study|Sponsor Decision|0|||
125386200|NCT00542919|451048725|FG000|Overall Study|Lost to Follow-up|2|||
125386201|NCT00542919|451048726|FG001|Overall Study|Lost to Follow-up|0|||
125386202|NCT00542919|451048727|FG002|Overall Study|Lost to Follow-up|1|||
125386203|NCT01881230|451048739|FG000|Overall Study|Death|2|||
125386204|NCT01881230|451048740|FG001|Overall Study|Death|0|||
125386205|NCT01881230|451048741|FG002|Overall Study|Death|1|||
125386206|NCT01881230|451048739|FG000|Overall Study|Adverse Event|9|||
125386207|NCT01881230|451048740|FG001|Overall Study|Adverse Event|13|||
125386208|NCT01881230|451048741|FG002|Overall Study|Adverse Event|12|||
125386209|NCT01881230|451048739|FG000|Overall Study|Progressive Disease|31|||
125386210|NCT01881230|451048740|FG001|Overall Study|Progressive Disease|35|||
125386211|NCT01881230|451048741|FG002|Overall Study|Progressive Disease|36|||
125386212|NCT01881230|451048739|FG000|Overall Study|Symptomatic Deterioration|3|||
125386213|NCT01881230|451048740|FG001|Overall Study|Symptomatic Deterioration|3|||
125386214|NCT01881230|451048741|FG002|Overall Study|Symptomatic Deterioration|1|||
125386215|NCT01881230|451048739|FG000|Overall Study|Withdrawal by Subject|6|||
125386216|NCT01881230|451048740|FG001|Overall Study|Withdrawal by Subject|4|||
125386217|NCT01881230|451048741|FG002|Overall Study|Withdrawal by Subject|6|||
125386218|NCT01881230|451048739|FG000|Overall Study|Physician Decision|4|||
125386219|NCT01881230|451048740|FG001|Overall Study|Physician Decision|3|||
125386220|NCT01881230|451048741|FG002|Overall Study|Physician Decision|6|||
125386221|NCT01881230|451048739|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125386222|NCT01881230|451048740|FG001|Overall Study|Non-Compliance with Study Drug|2|||
125386223|NCT01881230|451048741|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125386224|NCT01881230|451048739|FG000|Overall Study|Given Commercially Available Drug|0|||
125386225|NCT01881230|451048740|FG001|Overall Study|Given Commercially Available Drug|0|||
125386226|NCT01881230|451048741|FG002|Overall Study|Given Commercially Available Drug|2|||
125386227|NCT01881230|451048739|FG000|Overall Study|Protocol Violation|1|||
125386228|NCT01881230|451048740|FG001|Overall Study|Protocol Violation|1|||
125386229|NCT01881230|451048741|FG002|Overall Study|Protocol Violation|0|||
125386230|NCT01881230|451048739|FG000|Overall Study|Miscellaneous|3|||
125386231|NCT01881230|451048740|FG001|Overall Study|Miscellaneous|3|||
125386232|NCT01881230|451048741|FG002|Overall Study|Miscellaneous|0|||
125386233|NCT01881230|451048739|FG000|Overall Study|Untreated: Other|0|||
125386234|NCT01881230|451048740|FG001|Overall Study|Untreated: Other|0|||
125386235|NCT01881230|451048741|FG002|Overall Study|Untreated: Other|1|||
125386236|NCT01881230|451048739|FG000|Overall Study|Untreated: Death|0|||
125386237|NCT01881230|451048740|FG001|Overall Study|Untreated: Death|0|||
125386238|NCT01881230|451048741|FG002|Overall Study|Untreated: Death|1|||
125386239|NCT01881230|451048739|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
125386240|NCT01881230|451048740|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
125386241|NCT01881230|451048741|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
125386242|NCT00112502|451048742|FG000|Overall Study|Withdrawal by Subject|0|||
125386243|NCT00112502|451048743|FG001|Overall Study|Withdrawal by Subject|1|||
125386244|NCT00112502|451048744|FG002|Overall Study|Withdrawal by Subject|1|||
125386245|NCT00112502|451048745|FG003|Overall Study|Withdrawal by Subject|4|||
125386246|NCT00112502|451048746|FG004|Overall Study|Withdrawal by Subject|2|||
125386247|NCT00112502|451048747|FG005|Overall Study|Withdrawal by Subject|5|||
125386248|NCT00112502|451048748|FG006|Overall Study|Withdrawal by Subject|3|||
125386249|NCT00112502|451048749|FG007|Overall Study|Withdrawal by Subject|7|||
125386250|NCT02385266|451048750|FG000|Overall Study|Withdrawal by Subject|1|||
125386251|NCT02385266|451048751|FG001|Overall Study|Withdrawal by Subject|3|||
125386252|NCT02747420|451048752|FG000|Overall Study|Lost to Follow-up|4|||
125386253|NCT02747420|451048753|FG001|Overall Study|Lost to Follow-up|2|||
125386254|NCT02747420|451048752|FG000|Overall Study|Withdrawal by Subject|3|||
125386255|NCT02747420|451048753|FG001|Overall Study|Withdrawal by Subject|2|||
125386256|NCT03662542|451048758|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
125386257|NCT03662542|451048759|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125140424|NCT00425308|450137618|FG000|Overall Study|Adverse Event|2|||
125140425|NCT00425308|450137619|FG001|Overall Study|Adverse Event|1|||
125140426|NCT00425308|450137618|FG000|Overall Study|Withdrawal by Subject|1|||
125140427|NCT00425308|450137619|FG001|Overall Study|Withdrawal by Subject|0|||
125140428|NCT00425308|450137618|FG000|Overall Study|Death|1|||
125140429|NCT00425308|450137619|FG001|Overall Study|Death|0|||
125140430|NCT04442503|450137620|FG000|Overall Study|Adverse Event|1|||
125140431|NCT04442503|450137621|FG001|Overall Study|Adverse Event|1|||
125140432|NCT04442503|450137620|FG000|Overall Study|Lost to Follow-up|8|||
125140433|NCT04442503|450137621|FG001|Overall Study|Lost to Follow-up|6|||
125140434|NCT04442503|450137620|FG000|Overall Study|Physician Decision|0|||
125140435|NCT04442503|450137621|FG001|Overall Study|Physician Decision|2|||
125140436|NCT04442503|450137620|FG000|Overall Study|Withdrawal by Subject|3|||
125140437|NCT04442503|450137621|FG001|Overall Study|Withdrawal by Subject|4|||
125140438|NCT04442503|450137620|FG000|Overall Study|Reason not Specified|0|||
125140439|NCT04442503|450137621|FG001|Overall Study|Reason not Specified|1|||
125140440|NCT04442503|450137620|FG000|Overall Study|Randomized but not Treated|3|||
125140441|NCT04442503|450137621|FG001|Overall Study|Randomized but not Treated|1|||
125140442|NCT01945580|450137625|FG000|Overall Study|Withdrawal by Subject|13|||
125140443|NCT01945580|450137626|FG001|Overall Study|Withdrawal by Subject|35|||
125140444|NCT01945580|450137625|FG000|Overall Study|Physician Decision|3|||
125140445|NCT01945580|450137626|FG001|Overall Study|Physician Decision|2|||
125140446|NCT01945580|450137625|FG000|Overall Study|Lost to Follow-up|26|||
125140447|NCT01945580|450137626|FG001|Overall Study|Lost to Follow-up|39|||
125140448|NCT01945580|450137625|FG000|Overall Study|Death|7|||
125140449|NCT01945580|450137626|FG001|Overall Study|Death|2|||
125140450|NCT01945580|450137625|FG000|Overall Study|Patient moved out of state|0|||
125140451|NCT01945580|450137626|FG001|Overall Study|Patient moved out of state|1|||
125140452|NCT01945580|450137625|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
125140453|NCT01945580|450137626|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
125140454|NCT01945580|450137625|FG000|Overall Study|Family illness - unable to return|0|||
125140455|NCT01945580|450137626|FG001|Overall Study|Family illness - unable to return|1|||
125140456|NCT01945580|450137625|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
125140457|NCT01945580|450137626|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
125140458|NCT01945580|450137625|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
125140459|NCT01945580|450137626|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
125140460|NCT01945580|450137625|FG000|Overall Study|Noncompliance with 36 month visit|1|||
125140461|NCT01945580|450137626|FG001|Overall Study|Noncompliance with 36 month visit|0|||
125140462|NCT01945580|450137625|FG000|Overall Study|The patient moved.|1|||
125140463|NCT01945580|450137626|FG001|Overall Study|The patient moved.|0|||
125140464|NCT01945580|450137625|FG000|Overall Study|No data available|0|||
125140465|NCT01945580|450137626|FG001|Overall Study|No data available|2|||
125140466|NCT02933060|450137629|FG000|Overall Study|Withdrawal by Subject|0|||
125140467|NCT02933060|450137630|FG001|Overall Study|Withdrawal by Subject|1|||
125140468|NCT05034874|450137633|FG000|Overall Study|Withdrawal by Subject|6|||
125140469|NCT05034874|450137634|FG001|Overall Study|Withdrawal by Subject|6|||
125140470|NCT05034874|450137633|FG000|Overall Study|Lost to Follow-up|18|||
125140471|NCT05034874|450137634|FG001|Overall Study|Lost to Follow-up|8|||
125140472|NCT05034874|450137633|FG000|Overall Study|Physician Decision|0|||
125386258|NCT03662542|451048760|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125386259|NCT03662542|451048761|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125386260|NCT03662542|451048762|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125386261|NCT03662542|451048763|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125386262|NCT03662542|451048764|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125386263|NCT03662542|451048765|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125386264|NCT03662542|451048766|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
125222626|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222627|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
125222628|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
125222629|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
125222630|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
125222631|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
125222632|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
125222633|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
125222634|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
125222635|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
125222636|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
125222637|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
125222638|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
125222639|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
125222640|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
125222641|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
125222642|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
125222643|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
125222644|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
125222645|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
125222646|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
125222647|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
125222648|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222649|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222650|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222651|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222652|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222653|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222654|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
125222655|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222656|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222657|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222658|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222659|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222660|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222661|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222662|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222663|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222664|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222665|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
125222666|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
125222667|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
125222668|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
125222669|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
125222670|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
125222671|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
125222672|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
125222673|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
125222674|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
125222675|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
125222676|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
125222677|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
125222678|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
125222679|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
125222680|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
125222681|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
125222682|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
125222683|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
125386265|NCT03662542|451048758|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125386266|NCT03662542|451048759|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
125140473|NCT05034874|450137634|FG001|Overall Study|Physician Decision|1|||
125140474|NCT05034874|450137633|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
125140475|NCT05034874|450137634|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
125140476|NCT00989950|450137635|FG000|Randomized Phase|Protocol Violation|1|||
125140477|NCT00989950|450137636|FG001|Randomized Phase|Protocol Violation|0|||
125140478|NCT00989950|450137637|FG002|Randomized Phase|Protocol Violation|0|||
125140479|NCT00989950|450137638|FG003|Randomized Phase|Protocol Violation|0|||
125140480|NCT00989950|450137635|FG000|Randomized Phase|Adverse Event|0|||
125140481|NCT00989950|450137636|FG001|Randomized Phase|Adverse Event|1|||
125140482|NCT00989950|450137637|FG002|Randomized Phase|Adverse Event|0|||
125140483|NCT00989950|450137638|FG003|Randomized Phase|Adverse Event|0|||
125140484|NCT00101439|450137639|FG000|Period 2|Withdrawal by Subject|0|||
125140485|NCT00101439|450137640|FG001|Period 2|Withdrawal by Subject|2|||
125140486|NCT01867658|450137642|FG000|Overall Study|Withdrawal by Subject|6|||
125140487|NCT01867658|450137642|FG000|Overall Study|Death|2|||
125140488|NCT01867658|450137642|FG000|Overall Study|Subject could not be contacted|1|||
125140489|NCT00840658|450137643|FG000|Overall Study|Death|2|||
125140490|NCT00840658|450137644|FG001|Overall Study|Death|2|||
125140491|NCT00840658|450137645|FG002|Overall Study|Death|3|||
125140492|NCT00840658|450137646|FG003|Overall Study|Death|3|||
125140493|NCT00840658|450137643|FG000|Overall Study|Lost to Follow-up|3|||
125140494|NCT00840658|450137644|FG001|Overall Study|Lost to Follow-up|1|||
125140495|NCT00840658|450137645|FG002|Overall Study|Lost to Follow-up|2|||
125140496|NCT00840658|450137646|FG003|Overall Study|Lost to Follow-up|1|||
125140497|NCT03101358|450137647|FG000|Overall Study|Non-compliance with study schedule|1|||
125140498|NCT03101358|450137648|FG001|Overall Study|Non-compliance with study schedule|0|||
125140499|NCT03101358|450137649|FG002|Overall Study|Non-compliance with study schedule|0|||
125140500|NCT03101358|450137650|FG003|Overall Study|Non-compliance with study schedule|1|||
125140501|NCT03101358|450137647|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
125140502|NCT03101358|450137648|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
125140503|NCT03101358|450137649|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
125140504|NCT03101358|450137650|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
125140505|NCT03101358|450137647|FG000|Overall Study|Physician Decision|1|||
125140506|NCT03101358|450137648|FG001|Overall Study|Physician Decision|0|||
125140507|NCT03101358|450137649|FG002|Overall Study|Physician Decision|0|||
125386267|NCT03662542|451048760|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125386268|NCT03662542|451048761|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125222684|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
125386269|NCT03662542|451048762|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125386270|NCT03662542|451048763|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125222685|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
125386271|NCT03662542|451048764|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125386272|NCT03662542|451048765|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125386273|NCT03662542|451048766|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
125386274|NCT03662542|451048758|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
125386275|NCT03662542|451048759|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
125386276|NCT03662542|451048760|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
125386277|NCT03662542|451048761|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
125386278|NCT03662542|451048762|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
125386279|NCT03662542|451048763|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
125386280|NCT03662542|451048764|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
125386281|NCT03662542|451048765|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
125386282|NCT03662542|451048766|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
125386283|NCT03662542|451048758|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
125386284|NCT03662542|451048759|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125386285|NCT03662542|451048760|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125386286|NCT03662542|451048761|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125386287|NCT03662542|451048762|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125386288|NCT03662542|451048763|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125386289|NCT03662542|451048764|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125386290|NCT03662542|451048765|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125386291|NCT03662542|451048766|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
125386292|NCT03662542|451048758|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125386293|NCT03662542|451048759|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125386294|NCT03662542|451048760|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125386295|NCT03662542|451048761|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125386296|NCT03662542|451048762|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125386297|NCT03662542|451048763|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
125386298|NCT03662542|451048764|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125386299|NCT03662542|451048765|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125386300|NCT03662542|451048766|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
125386301|NCT03662542|451048758|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125386302|NCT03662542|451048759|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125386303|NCT03662542|451048760|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125386304|NCT03662542|451048761|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
125386305|NCT03662542|451048762|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
125386306|NCT03662542|451048763|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125386307|NCT03662542|451048764|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125386308|NCT03662542|451048765|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125386309|NCT03662542|451048766|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
125386310|NCT03662542|451048758|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
125386311|NCT03662542|451048759|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
125386312|NCT03662542|451048760|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
125386313|NCT03662542|451048761|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
125386314|NCT03662542|451048762|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
125140508|NCT03101358|450137650|FG003|Overall Study|Physician Decision|3|||
125140509|NCT03101358|450137647|FG000|Overall Study|Adverse Event|0|||
125140510|NCT03101358|450137648|FG001|Overall Study|Adverse Event|0|||
125140511|NCT03101358|450137649|FG002|Overall Study|Adverse Event|1|||
125140512|NCT03101358|450137650|FG003|Overall Study|Adverse Event|0|||
125140513|NCT03101358|450137647|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
125140514|NCT03101358|450137648|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
125140515|NCT03101358|450137649|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
125140516|NCT03101358|450137650|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
125140517|NCT03101358|450137647|FG000|Overall Study|Lost to Follow-up|1|||
125140518|NCT03101358|450137648|FG001|Overall Study|Lost to Follow-up|0|||
125140519|NCT03101358|450137649|FG002|Overall Study|Lost to Follow-up|0|||
125140520|NCT03101358|450137650|FG003|Overall Study|Lost to Follow-up|1|||
125140521|NCT00474058|450137651|FG000|Overall Study|Adverse Event|11|||
125140522|NCT00474058|450137652|FG001|Overall Study|Adverse Event|6|||
125140523|NCT00474058|450137651|FG000|Overall Study|Lack of Efficacy|0|||
125140524|NCT00474058|450137652|FG001|Overall Study|Lack of Efficacy|4|||
125140525|NCT00474058|450137651|FG000|Overall Study|Withdrawal by Subject|11|||
125140526|NCT00474058|450137652|FG001|Overall Study|Withdrawal by Subject|7|||
125140527|NCT00474058|450137651|FG000|Overall Study|Other|2|||
125386315|NCT03662542|451048763|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
125386316|NCT03662542|451048764|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
125386317|NCT03662542|451048765|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
125140528|NCT00474058|450137652|FG001|Overall Study|Other|0|||
125140529|NCT02426918|450137657|FG000|Overall Study|Adverse Event|2|||
125140530|NCT02426918|450137658|FG001|Overall Study|Adverse Event|2|||
125140531|NCT02426918|450137659|FG002|Overall Study|Adverse Event|0|||
125386318|NCT03662542|451048766|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
125386319|NCT03662542|451048758|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
125386320|NCT03662542|451048759|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
125386321|NCT03662542|451048760|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
125386322|NCT03662542|451048761|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
125386323|NCT03662542|451048762|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
125386324|NCT03662542|451048763|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
125386325|NCT03662542|451048764|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
125386326|NCT03662542|451048765|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
125386327|NCT03662542|451048766|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
125386328|NCT03662542|451048758|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125386329|NCT03662542|451048759|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125386330|NCT03662542|451048760|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125386331|NCT03662542|451048761|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125386332|NCT03662542|451048762|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125386333|NCT03662542|451048763|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
125386334|NCT03662542|451048764|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125386335|NCT03662542|451048765|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125386336|NCT03662542|451048766|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
125386337|NCT03662542|451048758|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
125222686|NCT03428100|450442754|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125386338|NCT03662542|451048759|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
125386339|NCT03662542|451048760|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
125386340|NCT03662542|451048761|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
125386341|NCT03662542|451048762|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
125386342|NCT03662542|451048763|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
125386343|NCT03662542|451048764|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
125386344|NCT03662542|451048765|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
125386345|NCT03662542|451048766|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
125386346|NCT03662542|451048758|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125386347|NCT03662542|451048759|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125386348|NCT03662542|451048760|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125386349|NCT03662542|451048761|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125386350|NCT03662542|451048762|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125386351|NCT03662542|451048763|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125140532|NCT02426918|450137657|FG000|Overall Study|Physician Decision|1|||
125140533|NCT02426918|450137658|FG001|Overall Study|Physician Decision|1|||
125140534|NCT02426918|450137659|FG002|Overall Study|Physician Decision|1|||
125140535|NCT02426918|450137657|FG000|Overall Study|Withdrawal by Subject|5|||
125140536|NCT02426918|450137658|FG001|Overall Study|Withdrawal by Subject|5|||
125140537|NCT02426918|450137659|FG002|Overall Study|Withdrawal by Subject|4|||
125140538|NCT02426918|450137657|FG000|Overall Study|Other|9|||
125140539|NCT02426918|450137658|FG001|Overall Study|Other|11|||
125386352|NCT03662542|451048764|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
125386353|NCT03662542|451048765|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
125386354|NCT03662542|451048766|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
125386355|NCT03662542|451048758|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125386356|NCT03662542|451048759|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125386357|NCT03662542|451048760|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125386358|NCT03662542|451048761|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125386359|NCT03662542|451048762|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125386360|NCT03662542|451048763|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125386361|NCT03662542|451048764|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
125386362|NCT03662542|451048765|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
125386363|NCT03662542|451048766|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
125386364|NCT03662542|451048758|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
125386365|NCT03662542|451048759|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
125386366|NCT03662542|451048760|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
125386367|NCT03662542|451048761|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
125222687|NCT03428100|450442755|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125140540|NCT02426918|450137659|FG002|Overall Study|Other|9|||
125140541|NCT02845336|450137660|FG000|Overall Study|Lost to Follow-up|3|||
125140542|NCT02845336|450137661|FG001|Overall Study|Lost to Follow-up|1|||
125140543|NCT02845336|450137660|FG000|Overall Study|Inability to get medication|2|||
125140544|NCT02845336|450137661|FG001|Overall Study|Inability to get medication|0|||
125140545|NCT00654186|450137668|FG000|Overall Study|Withdrawal by Subject|5|||
125140546|NCT05616728|450137669|FG000|Overall Study|Lost to Follow-up|0|||
125140547|NCT05616728|450137670|FG001|Overall Study|Lost to Follow-up|0|||
125140548|NCT05616728|450137671|FG002|Overall Study|Lost to Follow-up|1|||
125140549|NCT05616728|450137669|FG000|Overall Study|Withdrawal by Subject|1|||
125140550|NCT05616728|450137670|FG001|Overall Study|Withdrawal by Subject|1|||
125140551|NCT05616728|450137671|FG002|Overall Study|Withdrawal by Subject|0|||
125140552|NCT05616728|450137669|FG000|Overall Study|Physician Decision|1|||
125140553|NCT05616728|450137670|FG001|Overall Study|Physician Decision|1|||
125140554|NCT05616728|450137671|FG002|Overall Study|Physician Decision|1|||
125140555|NCT05616728|450137669|FG000|Overall Study|Other|0|||
125140556|NCT05616728|450137670|FG001|Overall Study|Other|2|||
125140557|NCT05616728|450137671|FG002|Overall Study|Other|0|||
125140558|NCT01024855|450137674|FG000|Overall Study|Inclusion/exclusion criteria|1|||
125140559|NCT03306277|450137681|FG000|Overall Study|Death|1|||
125386368|NCT03662542|451048762|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
125386369|NCT03662542|451048763|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
125386370|NCT03662542|451048764|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
125386371|NCT03662542|451048765|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
125386372|NCT03662542|451048766|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
125386373|NCT01217060|451048768|FG000|Overall Study|Withdrawal by Subject|1|||
125386374|NCT03739112|451048769|FG000|Overall Study|Adverse Event|2|||
125386375|NCT03739112|451048770|FG001|Overall Study|Adverse Event|2|||
125140560|NCT03306277|450137681|FG000|Overall Study|Adverse Event|1|||
125140561|NCT03306277|450137681|FG000|Overall Study|Withdrawal by Subject|1|||
125140562|NCT00674128|450137682|FG000|Overall Study|Withdrawal by Subject|25|||
125222688|NCT03428100|450442756|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125140563|NCT00674128|450137683|FG001|Overall Study|Withdrawal by Subject|23|||
125140564|NCT00829452|450137687|FG000|First Intervention|Withdrawal by Subject|0|||
125386376|NCT03739112|451048769|FG000|Overall Study|Withdrawal by Subject|38|||
125386377|NCT03739112|451048770|FG001|Overall Study|Withdrawal by Subject|19|||
125386378|NCT03739112|451048769|FG000|Overall Study|Lost to Follow-up|31|||
125386379|NCT03739112|451048770|FG001|Overall Study|Lost to Follow-up|33|||
125386380|NCT03739112|451048769|FG000|Overall Study|Protocol Deviation|12|||
125386381|NCT03739112|451048770|FG001|Overall Study|Protocol Deviation|9|||
125140565|NCT00829452|450137688|FG001|First Intervention|Withdrawal by Subject|1|||
125140566|NCT00829452|450137687|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
125386382|NCT03739112|451048769|FG000|Overall Study|Physician Decision|1|||
125386383|NCT03739112|451048770|FG001|Overall Study|Physician Decision|0|||
125420828|NCT01260350|451166145|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125140567|NCT00829452|450137688|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
125222689|NCT03428100|450442757|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125222690|NCT03428100|450442758|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
125222691|NCT03428100|450442759|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125222692|NCT03428100|450442760|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
125222693|NCT03428100|450442761|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
125222694|NCT03428100|450442762|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125222695|NCT03428100|450442763|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
125386384|NCT03739112|451048769|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
125386385|NCT03739112|451048770|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
125386386|NCT03739112|451048769|FG000|Overall Study|Site went on hold|65|||
125386387|NCT03739112|451048770|FG001|Overall Study|Site went on hold|67|||
125222696|NCT03428100|450442764|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
125222697|NCT03428100|450442765|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
125222698|NCT03428100|450442766|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
125222699|NCT03428100|450442767|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
125222700|NCT03428100|450442768|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
125222701|NCT03428100|450442769|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125222702|NCT03428100|450442770|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
125222703|NCT03428100|450442771|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
125222704|NCT03428100|450442772|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
125222705|NCT04556760|450442773|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
125222706|NCT04556760|450442774|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
125222707|NCT04556760|450442775|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
125222708|NCT04556760|450442776|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
125222709|NCT04556760|450442777|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
125222710|NCT04556760|450442778|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
125222711|NCT04556760|450442773|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
125222712|NCT04556760|450442774|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
125222713|NCT04556760|450442775|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
125222714|NCT04556760|450442776|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
125222715|NCT04556760|450442777|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
125222716|NCT04556760|450442778|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
125222717|NCT02221648|450442785|FG000|Overall Study|Withdrawal by Subject|3|||
125222718|NCT02221648|450442786|FG001|Overall Study|Withdrawal by Subject|3|||
125222719|NCT03489343|450442790|FG000|Overall Study|Documented progressive disease|1|||
125222720|NCT03489343|450442791|FG001|Overall Study|Documented progressive disease|0|||
125222721|NCT03489343|450442792|FG002|Overall Study|Documented progressive disease|3|||
125222722|NCT03489343|450442793|FG003|Overall Study|Documented progressive disease|1|||
125222723|NCT03489343|450442794|FG004|Overall Study|Documented progressive disease|3|||
125222724|NCT03489343|450442795|FG005|Overall Study|Documented progressive disease|5|||
125222725|NCT03489343|450442796|FG006|Overall Study|Documented progressive disease|4|||
125140568|NCT00829452|450137687|FG000|Second Intervention|Physician Decision|0|||
125140569|NCT00829452|450137688|FG001|Second Intervention|Physician Decision|1|||
125140570|NCT00881751|450137697|FG000|Overall Study|Physician Decision|0|||
125140571|NCT00881751|450137698|FG001|Overall Study|Physician Decision|1|||
125140572|NCT00881751|450137697|FG000|Overall Study|Adverse Event|0|||
125140573|NCT00881751|450137698|FG001|Overall Study|Adverse Event|2|||
125140574|NCT00881751|450137697|FG000|Overall Study|Withdrawal by Subject|0|||
125140575|NCT00881751|450137698|FG001|Overall Study|Withdrawal by Subject|2|||
125140576|NCT00301964|450137701|FG000|Overall Study|Second primary|2|||
125140577|NCT00301964|450137701|FG000|Overall Study|Wrong primary|1|||
125140578|NCT00301964|450137701|FG000|Overall Study|Inadequate pathology|1|||
125140579|NCT02385708|450137703|FG000|Overall Study|Withdrawal by Subject|0|||
125140580|NCT02385708|450137704|FG001|Overall Study|Withdrawal by Subject|2|||
125140581|NCT02385708|450137703|FG000|Overall Study|Withdrawn - surgery canceled|2|||
125140582|NCT02385708|450137704|FG001|Overall Study|Withdrawn - surgery canceled|5|||
125140583|NCT02385708|450137703|FG000|Overall Study|Investigator decision|5|||
125140584|NCT02385708|450137704|FG001|Overall Study|Investigator decision|7|||
125140585|NCT02385708|450137703|FG000|Overall Study|Protocol Violation|1|||
125140586|NCT02385708|450137704|FG001|Overall Study|Protocol Violation|1|||
125140587|NCT01559363|450137711|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
125140588|NCT01559363|450137712|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
125140589|NCT01559363|450137713|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
125140590|NCT01559363|450137714|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
125140591|NCT01559363|450137715|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
125140592|NCT01559363|450137716|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
125140593|NCT01559363|450137711|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
125140594|NCT01559363|450137712|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
125140595|NCT01559363|450137713|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
125140596|NCT01559363|450137714|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
125140597|NCT01559363|450137715|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
125140598|NCT01559363|450137716|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
125140599|NCT01559363|450137711|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
125140600|NCT01559363|450137712|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
125140601|NCT01559363|450137713|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
125140602|NCT01559363|450137714|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
125140603|NCT01559363|450137715|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
125140604|NCT01559363|450137716|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
125140605|NCT01559363|450137711|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
125140606|NCT01559363|450137712|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
125140607|NCT01559363|450137713|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
125140608|NCT01559363|450137714|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
125140609|NCT01559363|450137715|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
125140610|NCT01559363|450137716|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
125140611|NCT01559363|450137711|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
125140612|NCT01559363|450137712|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
125140613|NCT01559363|450137713|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
125140614|NCT01559363|450137714|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
125140615|NCT01559363|450137715|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
125140616|NCT01559363|450137716|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
125140617|NCT01559363|450137711|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
125140618|NCT01559363|450137712|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
125140619|NCT01559363|450137713|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
125140620|NCT01559363|450137714|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
125140621|NCT01559363|450137715|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
125140622|NCT01559363|450137716|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
125140623|NCT01559363|450137711|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
125140624|NCT01559363|450137712|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
125140625|NCT01559363|450137713|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
125140626|NCT01559363|450137714|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
125140627|NCT01559363|450137715|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
125140628|NCT01559363|450137716|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
125140629|NCT00672984|450137717|FG000|First Intervention|Adverse Event|5|||
125140630|NCT00672984|450137718|FG001|First Intervention|Adverse Event|0|||
125140631|NCT00672984|450137719|FG002|First Intervention|Adverse Event|0|||
125140632|NCT00672984|450137717|FG000|First Intervention|Withdrawal by Subject|1|||
125140633|NCT00672984|450137718|FG001|First Intervention|Withdrawal by Subject|2|||
125140634|NCT00672984|450137719|FG002|First Intervention|Withdrawal by Subject|2|||
125140635|NCT00672984|450137717|FG000|First Intervention|Sponsor decision|3|||
125140636|NCT00672984|450137718|FG001|First Intervention|Sponsor decision|0|||
125140637|NCT00672984|450137719|FG002|First Intervention|Sponsor decision|0|||
125140638|NCT00672984|450137717|FG000|Second Intervention|Non-compliance with facility policies|0|||
125140639|NCT00672984|450137718|FG001|Second Intervention|Non-compliance with facility policies|2|||
125140640|NCT00672984|450137719|FG002|Second Intervention|Non-compliance with facility policies|0|||
125140641|NCT00672984|450137717|FG000|Second Intervention|Withdrawal by Subject|0|||
125140642|NCT00672984|450137718|FG001|Second Intervention|Withdrawal by Subject|3|||
125140643|NCT00672984|450137719|FG002|Second Intervention|Withdrawal by Subject|0|||
125140644|NCT00672984|450137717|FG000|Second Intervention|Protocol Violation|0|||
125140645|NCT00672984|450137718|FG001|Second Intervention|Protocol Violation|1|||
125140646|NCT00672984|450137719|FG002|Second Intervention|Protocol Violation|1|||
125140647|NCT00672984|450137717|FG000|Third Intervention|Adverse Event|1|||
125140648|NCT00672984|450137718|FG001|Third Intervention|Adverse Event|0|||
125140649|NCT00672984|450137719|FG002|Third Intervention|Adverse Event|1|||
125140650|NCT00645853|450137720|FG000|Overall Study|Adverse Event|18|||
125140651|NCT00645853|450137721|FG001|Overall Study|Adverse Event|7|||
125140652|NCT00645853|450137720|FG000|Overall Study|AZ study closure in Hungary|60|||
125140653|NCT00645853|450137721|FG001|Overall Study|AZ study closure in Hungary|40|||
125140654|NCT00645853|450137720|FG000|Overall Study|Withdrawal by Subject|5|||
125140655|NCT00645853|450137721|FG001|Overall Study|Withdrawal by Subject|2|||
125140656|NCT00645853|450137720|FG000|Overall Study|Protocol Violation|0|||
125140657|NCT00645853|450137721|FG001|Overall Study|Protocol Violation|2|||
125140658|NCT00645853|450137720|FG000|Overall Study|Discontinuation criteria|2|||
125140659|NCT00645853|450137721|FG001|Overall Study|Discontinuation criteria|2|||
125140660|NCT00645853|450137720|FG000|Overall Study|recall of ICF, planned operation, death|7|||
125140661|NCT00645853|450137721|FG001|Overall Study|recall of ICF, planned operation, death|4|||
125140662|NCT04060251|450137722|FG000|Overall Study|Study terminated due to low enrollment.|7|||
125140663|NCT04060251|450137723|FG001|Overall Study|Study terminated due to low enrollment.|5|||
125140664|NCT04060251|450137724|FG002|Overall Study|Study terminated due to low enrollment.|7|||
125140665|NCT04060251|450137722|FG000|Overall Study|Adverse Event|1|||
125140666|NCT04060251|450137723|FG001|Overall Study|Adverse Event|1|||
125140667|NCT04060251|450137724|FG002|Overall Study|Adverse Event|0|||
125140668|NCT01151618|450137725|FG000|Overall Study|Adverse Event|2|||
125140669|NCT01151618|450137725|FG000|Overall Study|Withdrawal by Subject|7|||
125140670|NCT01632306|450137726|FG000|Overall Study|Protocol Violation|1|||
125140671|NCT01632306|450137727|FG001|Overall Study|Protocol Violation|0|||
125140672|NCT01632306|450137728|FG002|Overall Study|Protocol Violation|0|||
125140673|NCT00858403|450137735|FG000|Overall Study|Withdrawal by Subject|1|||
125140674|NCT00858403|450137735|FG000|Overall Study|Death|3|||
125140675|NCT00858403|450137735|FG000|Overall Study|Disease Progression|1|||
125140676|NCT03867760|450137736|FG000|Overall Study|Lost to Follow-up|2|||
125140677|NCT03867760|450137737|FG001|Overall Study|Lost to Follow-up|3|||
125140678|NCT03867760|450137736|FG000|Overall Study|Withdrawal by Subject|1|||
125140679|NCT03867760|450137737|FG001|Overall Study|Withdrawal by Subject|2|||
125140680|NCT03867760|450137736|FG000|Overall Study|subject could not meet study logistics|3|||
125140681|NCT03867760|450137737|FG001|Overall Study|subject could not meet study logistics|3|||
125140682|NCT02286466|450137739|FG000|Overall Study|Death|1|||
125140683|NCT02286466|450137740|FG001|Overall Study|Death|3|||
125140684|NCT02286466|450137739|FG000|Overall Study|Withdrawal by Subject|5|||
125140685|NCT02286466|450137740|FG001|Overall Study|Withdrawal by Subject|2|||
125140686|NCT02286466|450137739|FG000|Overall Study|Lost to Follow-up|1|||
125140687|NCT02286466|450137740|FG001|Overall Study|Lost to Follow-up|4|||
125140688|NCT02286466|450137739|FG000|Overall Study|Declined Clinician Assessment|0|||
125140689|NCT02286466|450137740|FG001|Overall Study|Declined Clinician Assessment|1|||
125140690|NCT00874276|450137744|FG000|Overall Study|Withdrawal by Subject|1|||
125140691|NCT00874276|450137745|FG001|Overall Study|Withdrawal by Subject|1|||
125140692|NCT03694197|450137748|FG000|Overall Study|Adverse Event|9|||
125140693|NCT03694197|450137748|FG000|Overall Study|Protocol became inconvenient to participate|1|||
125140694|NCT03694197|450137748|FG000|Overall Study|Physician Decision|4|||
125140695|NCT03694197|450137748|FG000|Overall Study|Study terminated by sponsor|1350|||
125140696|NCT03694197|450137748|FG000|Overall Study|Participant moved|5|||
125140697|NCT03694197|450137748|FG000|Overall Study|Participant withdrew consent|10|||
125140698|NCT03694197|450137748|FG000|Overall Study|Related to IMP administration|1|||
125140699|NCT03694197|450137748|FG000|Overall Study|Not disclosed|5|||
125140700|NCT02957331|450137749|FG000|Overall Study|Protocol Violation|1|||
125140701|NCT02957331|450137750|FG001|Overall Study|Protocol Violation|0|||
125140702|NCT03247686|450139503|FG000|Overall Study|Withdrawal by Subject|1|||
125140703|NCT03247686|450139504|FG001|Overall Study|Withdrawal by Subject|2|||
125140704|NCT02583048|450139512|FG000|Overall Study|Withdrawal by Subject|0|||
125140705|NCT02583048|450139513|FG001|Overall Study|Withdrawal by Subject|1|||
125140706|NCT02583048|450139514|FG002|Overall Study|Withdrawal by Subject|0|||
125222726|NCT03489343|450442790|FG000|Overall Study|Adverse Event|0|||
125140707|NCT02583048|450139512|FG000|Overall Study|Failed to meet eligibility criterion|0|||
125140708|NCT02583048|450139513|FG001|Overall Study|Failed to meet eligibility criterion|0|||
125140709|NCT02583048|450139514|FG002|Overall Study|Failed to meet eligibility criterion|1|||
125140710|NCT01151280|450139517|FG000|Overall Study|Adverse Event|1|||
125140711|NCT01151280|450139517|FG000|Overall Study|Lack of Efficacy|3|||
125140712|NCT00757705|450139518|FG000|Overall Study|Adverse Event|19|||
125222727|NCT03489343|450442791|FG001|Overall Study|Adverse Event|1|||
125140713|NCT00757705|450139518|FG000|Overall Study|Lost to Follow-up|16|||
125140714|NCT00757705|450139518|FG000|Overall Study|Withdrawal by Subject|25|||
125222728|NCT03489343|450442792|FG002|Overall Study|Adverse Event|0|||
125222729|NCT03489343|450442793|FG003|Overall Study|Adverse Event|0|||
125222730|NCT03489343|450442794|FG004|Overall Study|Adverse Event|0|||
125222731|NCT03489343|450442795|FG005|Overall Study|Adverse Event|1|||
125222732|NCT03489343|450442796|FG006|Overall Study|Adverse Event|0|||
125222733|NCT03489343|450442790|FG000|Overall Study|Withdrawal by Subject|0|||
125222734|NCT03489343|450442791|FG001|Overall Study|Withdrawal by Subject|0|||
125222735|NCT03489343|450442792|FG002|Overall Study|Withdrawal by Subject|0|||
125222736|NCT03489343|450442793|FG003|Overall Study|Withdrawal by Subject|1|||
125222737|NCT03489343|450442794|FG004|Overall Study|Withdrawal by Subject|0|||
125222738|NCT03489343|450442795|FG005|Overall Study|Withdrawal by Subject|1|||
125222739|NCT03489343|450442796|FG006|Overall Study|Withdrawal by Subject|1|||
125222740|NCT03489343|450442790|FG000|Overall Study|Clinical progression|0|||
125222741|NCT03489343|450442791|FG001|Overall Study|Clinical progression|0|||
125222742|NCT03489343|450442792|FG002|Overall Study|Clinical progression|0|||
125222743|NCT03489343|450442793|FG003|Overall Study|Clinical progression|1|||
125140715|NCT00757705|450139518|FG000|Overall Study|Insufficient Response|26|||
125222744|NCT03489343|450442794|FG004|Overall Study|Clinical progression|0|||
125222745|NCT03489343|450442795|FG005|Overall Study|Clinical progression|0|||
125222746|NCT03489343|450442796|FG006|Overall Study|Clinical progression|1|||
125222747|NCT01166750|450442800|FG000|Overall Study|Lost to Follow-up|1|||
125222748|NCT01166750|450442801|FG001|Overall Study|Lost to Follow-up|0|||
125222749|NCT01585246|450442802|FG000|Overall Study|Lost to Follow-up|0|||
125222750|NCT01585246|450442803|FG001|Overall Study|Lost to Follow-up|0|||
125222751|NCT01585246|450442804|FG002|Overall Study|Lost to Follow-up|2|||
125222752|NCT01585246|450442805|FG003|Overall Study|Lost to Follow-up|1|||
125222753|NCT01585246|450442806|FG004|Overall Study|Lost to Follow-up|0|||
125222754|NCT01585246|450442802|FG000|Overall Study|Protocol Violation|0|||
125222755|NCT01585246|450442803|FG001|Overall Study|Protocol Violation|0|||
125222756|NCT01585246|450442804|FG002|Overall Study|Protocol Violation|0|||
125222757|NCT01585246|450442805|FG003|Overall Study|Protocol Violation|0|||
125222758|NCT01585246|450442806|FG004|Overall Study|Protocol Violation|1|||
125222759|NCT01585246|450442802|FG000|Overall Study|Withdrawal by Subject|0|||
125222760|NCT01585246|450442803|FG001|Overall Study|Withdrawal by Subject|0|||
125222761|NCT01585246|450442804|FG002|Overall Study|Withdrawal by Subject|1|||
125222762|NCT01585246|450442805|FG003|Overall Study|Withdrawal by Subject|2|||
125222763|NCT01585246|450442806|FG004|Overall Study|Withdrawal by Subject|1|||
125222764|NCT01585246|450442802|FG000|Overall Study|Other|0|||
125222765|NCT01585246|450442803|FG001|Overall Study|Other|1|||
125222766|NCT01585246|450442804|FG002|Overall Study|Other|1|||
125222767|NCT01585246|450442805|FG003|Overall Study|Other|1|||
125222768|NCT01585246|450442806|FG004|Overall Study|Other|0|||
125222769|NCT04396626|450442807|FG000|Overall Study|Premature termination of study|975|||
125222770|NCT02111174|450442810|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
125222771|NCT02111174|450442811|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
125222772|NCT02111174|450442810|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
125222773|NCT02111174|450442811|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
125222774|NCT02111174|450442810|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
125222775|NCT02111174|450442811|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
125222776|NCT02111174|450442810|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
125222777|NCT02111174|450442811|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
125222778|NCT00838097|450442814|FG000|Overall Study|Ineligibility determined|6|||
125222779|NCT00838097|450442814|FG000|Overall Study|Adverse Event|2|||
125222780|NCT00838097|450442814|FG000|Overall Study|Withdrawal by Subject|3|||
125222781|NCT00838097|450442814|FG000|Overall Study|Requirement for alternative therapy|2|||
125222782|NCT00838097|450442814|FG000|Overall Study|Physician Decision|4|||
125222783|NCT00838097|450442814|FG000|Overall Study|Lost to Follow-up|11|||
125222784|NCT00838097|450442814|FG000|Overall Study|Death|6|||
125140716|NCT00757705|450139518|FG000|Overall Study|Ineligible to continue|8|||
125140717|NCT00757705|450139518|FG000|Overall Study|Non-compliant|9|||
125140718|NCT00757705|450139518|FG000|Overall Study|Other|18|||
125140719|NCT02578641|450139522|FG000|Overall Study|Adverse Event|5|||
125140720|NCT02578641|450139523|FG001|Overall Study|Adverse Event|15|||
125140721|NCT02578641|450139522|FG000|Overall Study|Death|16|||
125140722|NCT02578641|450139523|FG001|Overall Study|Death|8|||
125140723|NCT02578641|450139522|FG000|Overall Study|Lost to Follow-up|0|||
125140724|NCT02578641|450139523|FG001|Overall Study|Lost to Follow-up|1|||
125140725|NCT02578641|450139522|FG000|Overall Study|Withdrawal by Subject|14|||
125222785|NCT00838097|450442814|FG000|Overall Study|Protocol-specified criteria|142|||
125140726|NCT02578641|450139523|FG001|Overall Study|Withdrawal by Subject|7|||
125222786|NCT00871234|450442815|FG000|Overall Study|Adverse Event|2|||
125222787|NCT00871234|450442815|FG000|Overall Study|Lost to Follow-up|3|||
125222788|NCT03380377|450442818|FG000|Overall Study|Physician Decision|1|||
125222789|NCT03380377|450442818|FG000|Overall Study|Withdrawal by Subject|1|||
125222790|NCT02600923|450442821|FG000|Overall Study|Death|10|||
125222791|NCT02600923|450442821|FG000|Overall Study|Adverse Event|3|||
125140727|NCT02578641|450139522|FG000|Overall Study|Progressive Disease|69|||
125222792|NCT02600923|450442821|FG000|Overall Study|Global deterioration of health status|2|||
125222793|NCT02600923|450442821|FG000|Overall Study|Insufficient clinical response|6|||
125222794|NCT02600923|450442821|FG000|Overall Study|Lost to Follow-up|1|||
125222795|NCT02600923|450442821|FG000|Overall Study|Withdrawal by Subject|5|||
125222796|NCT02600923|450442821|FG000|Overall Study|Objective progression or relapse|50|||
125222797|NCT02600923|450442821|FG000|Overall Study|Study terminated by Sponsor|53|||
125222798|NCT02600923|450442821|FG000|Overall Study|Not treated|1|||
125222799|NCT00792909|450442822|FG000|Overall Study|Withdrawal by Subject|0|||
125222800|NCT00792909|450442823|FG001|Overall Study|Withdrawal by Subject|1|||
125222801|NCT00792909|450442824|FG002|Overall Study|Withdrawal by Subject|0|||
125222802|NCT00128661|450442827|FG000|Overall Study|Adverse Event|14|||
125222803|NCT00128661|450442828|FG001|Overall Study|Adverse Event|11|||
125222804|NCT00128661|450442827|FG000|Overall Study|Lost to Follow-up|10|||
125222805|NCT00128661|450442828|FG001|Overall Study|Lost to Follow-up|7|||
125222806|NCT00128661|450442827|FG000|Overall Study|Withdrawal by Subject|243|||
125222807|NCT00128661|450442828|FG001|Overall Study|Withdrawal by Subject|232|||
125222808|NCT00128661|450442827|FG000|Overall Study|Other|7|||
125222809|NCT00128661|450442828|FG001|Overall Study|Other|8|||
125222810|NCT01261390|450442830|FG000|Overall Study|Significant Concurrent Illness|1|||
125222811|NCT01261390|450442831|FG001|Overall Study|Significant Concurrent Illness|0|||
125222812|NCT01261390|450442832|FG002|Overall Study|Significant Concurrent Illness|1|||
125222813|NCT01261390|450442833|FG003|Overall Study|Significant Concurrent Illness|0|||
125222814|NCT01261390|450442830|FG000|Overall Study|Dissatisfaction with Treatment|2|||
125222815|NCT01261390|450442831|FG001|Overall Study|Dissatisfaction with Treatment|1|||
125222816|NCT01261390|450442832|FG002|Overall Study|Dissatisfaction with Treatment|1|||
125222817|NCT01261390|450442833|FG003|Overall Study|Dissatisfaction with Treatment|2|||
125222818|NCT01261390|450442830|FG000|Overall Study|Relocation|0|||
125222819|NCT01261390|450442831|FG001|Overall Study|Relocation|1|||
125222820|NCT01261390|450442832|FG002|Overall Study|Relocation|0|||
125222821|NCT01261390|450442833|FG003|Overall Study|Relocation|0|||
125222822|NCT01261390|450442830|FG000|Overall Study|Loss of Interest in the Study|3|||
125222823|NCT01261390|450442831|FG001|Overall Study|Loss of Interest in the Study|1|||
125222824|NCT01261390|450442832|FG002|Overall Study|Loss of Interest in the Study|0|||
125222825|NCT01261390|450442833|FG003|Overall Study|Loss of Interest in the Study|0|||
125222826|NCT01261390|450442830|FG000|Overall Study|Lost to Follow-up|1|||
125222827|NCT01261390|450442831|FG001|Overall Study|Lost to Follow-up|6|||
125222828|NCT01261390|450442832|FG002|Overall Study|Lost to Follow-up|5|||
125222829|NCT01261390|450442833|FG003|Overall Study|Lost to Follow-up|6|||
125222830|NCT00977613|450442834|FG000|Overall Study|Lost to Follow-up|16|||
125222831|NCT04001803|450442839|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
125222832|NCT04001803|450442839|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
125222833|NCT04001803|450442839|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
125222834|NCT04001803|450442839|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
125222835|NCT04001803|450442839|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
125222836|NCT04001803|450442839|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
125222837|NCT04001803|450442839|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
125222838|NCT04001803|450442839|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
125222839|NCT04001803|450442839|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
125222840|NCT04001803|450442839|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
125222841|NCT05404711|450442840|FG000|Completed Study Visit|Withdrawal by Subject|1|||
125222842|NCT05404711|450442840|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
125222843|NCT05404711|450442840|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
125222844|NCT05404711|450442840|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
125222845|NCT05404711|450442840|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
125222846|NCT05404711|450442840|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
125222847|NCT02346877|450442843|FG000|Overall Study|Adverse Event|1|||
125222848|NCT02346877|450442844|FG001|Overall Study|Adverse Event|0|||
125222849|NCT02346877|450442843|FG000|Overall Study|Administrative Decision|1|||
125140728|NCT02578641|450139523|FG001|Overall Study|Progressive Disease|21|||
125386388|NCT03739112|451048769|FG000|Overall Study|Other than specified|8|||
125386389|NCT03739112|451048770|FG001|Overall Study|Other than specified|5|||
125386390|NCT03739112|451048769|FG000|Overall Study|Randomized but not vaccinated|31|||
125386391|NCT03739112|451048770|FG001|Overall Study|Randomized but not vaccinated|25|||
125386392|NCT03388138|451048774|FG000|Overall Study|Protocol Violation|1|||
125386393|NCT03388138|451048775|FG001|Overall Study|Protocol Violation|0|||
125386394|NCT01528072|451048776|FG000|Overall Study|Withdrawal by Subject|5|||
125386395|NCT01528072|451048776|FG000|Overall Study|Physician Decision|1|||
125386396|NCT01528072|451048776|FG000|Overall Study|Determined not eligible by AEAC|1|||
125386397|NCT01528072|451048776|FG000|Overall Study|Missed Visit|2|||
125386398|NCT01528072|451048776|FG000|Overall Study|Lost to Follow-up|5|||
125386399|NCT01528072|451048776|FG000|Overall Study|Explanted|2|||
125386400|NCT01528072|451048776|FG000|Overall Study|Site Closure|4|||
125386401|NCT01528072|451048776|FG000|Overall Study|Death|2|||
125386402|NCT01528072|451048776|FG000|Overall Study|Early Termination of Study|52|||
125386403|NCT02529137|451048779|FG000|Overall Study|Discontinuation for different reasons|8|||
125386404|NCT02063854|451048780|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
125386405|NCT02063854|451048781|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
125386406|NCT02063854|451048782|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
125386407|NCT02063854|451048783|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
125386408|NCT02063854|451048784|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
125386409|NCT02063854|451048785|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
125386410|NCT02063854|451048786|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
125386411|NCT02063854|451048780|FG000|Overall Study|Major Protocol Deviation|0|||
125386412|NCT02063854|451048781|FG001|Overall Study|Major Protocol Deviation|0|||
125386413|NCT02063854|451048782|FG002|Overall Study|Major Protocol Deviation|3|||
125386414|NCT02063854|451048783|FG003|Overall Study|Major Protocol Deviation|0|||
125386415|NCT02063854|451048784|FG004|Overall Study|Major Protocol Deviation|0|||
125386416|NCT02063854|451048785|FG005|Overall Study|Major Protocol Deviation|0|||
125386417|NCT02063854|451048786|FG006|Overall Study|Major Protocol Deviation|0|||
125386418|NCT02063854|451048780|FG000|Overall Study|Voluntary Withdrawal|2|||
125386419|NCT02063854|451048781|FG001|Overall Study|Voluntary Withdrawal|0|||
125386420|NCT02063854|451048782|FG002|Overall Study|Voluntary Withdrawal|8|||
125386421|NCT02063854|451048783|FG003|Overall Study|Voluntary Withdrawal|1|||
125386422|NCT02063854|451048784|FG004|Overall Study|Voluntary Withdrawal|3|||
125386423|NCT02063854|451048785|FG005|Overall Study|Voluntary Withdrawal|6|||
125386424|NCT02063854|451048786|FG006|Overall Study|Voluntary Withdrawal|1|||
125386425|NCT02063854|451048780|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
125386426|NCT02063854|451048781|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
125386427|NCT02063854|451048782|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
125386428|NCT02063854|451048783|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
125386429|NCT02063854|451048784|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
125386430|NCT02063854|451048785|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
125386431|NCT02063854|451048786|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
125386432|NCT02063854|451048780|FG000|Overall Study|Reason Not Specified|1|||
125386433|NCT02063854|451048781|FG001|Overall Study|Reason Not Specified|0|||
125386434|NCT02063854|451048782|FG002|Overall Study|Reason Not Specified|0|||
125386435|NCT02063854|451048783|FG003|Overall Study|Reason Not Specified|0|||
125386436|NCT02063854|451048784|FG004|Overall Study|Reason Not Specified|0|||
125386437|NCT02063854|451048785|FG005|Overall Study|Reason Not Specified|0|||
125386438|NCT02063854|451048786|FG006|Overall Study|Reason Not Specified|0|||
125386439|NCT02063854|451048780|FG000|Overall Study|Did Not Receive Study Drug|0|||
125386440|NCT02063854|451048781|FG001|Overall Study|Did Not Receive Study Drug|0|||
125386441|NCT02063854|451048782|FG002|Overall Study|Did Not Receive Study Drug|0|||
125386442|NCT02063854|451048783|FG003|Overall Study|Did Not Receive Study Drug|0|||
125386443|NCT02063854|451048784|FG004|Overall Study|Did Not Receive Study Drug|0|||
125386444|NCT02063854|451048785|FG005|Overall Study|Did Not Receive Study Drug|1|||
125140729|NCT02578641|450139522|FG000|Overall Study|No Study Drug|2|||
125140730|NCT02578641|450139523|FG001|Overall Study|No Study Drug|0|||
125140731|NCT02578641|450139522|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
125140732|NCT02578641|450139523|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
125140733|NCT02578641|450139522|FG000|Overall Study|Non-compliance with Study Schedule|1|||
125140734|NCT02578641|450139523|FG001|Overall Study|Non-compliance with Study Schedule|0|||
125140735|NCT02578641|450139522|FG000|Overall Study|Other|1|||
125140736|NCT02578641|450139523|FG001|Overall Study|Other|10|||
125140737|NCT02578641|450139522|FG000|Overall Study|Not treated|1|||
125140738|NCT02578641|450139523|FG001|Overall Study|Not treated|4|||
125140739|NCT02313558|450139524|FG000|Overall Study|Withdrawal by Subject|2|||
125140740|NCT02313558|450139525|FG001|Overall Study|Withdrawal by Subject|0|||
125140741|NCT02313558|450139524|FG000|Overall Study|Lost to Follow-up|4|||
125140742|NCT02313558|450139525|FG001|Overall Study|Lost to Follow-up|4|||
125386445|NCT02063854|451048786|FG006|Overall Study|Did Not Receive Study Drug|0|||
125386446|NCT01462084|451048787|FG000|Overall Study|Withdrawal by Subject|1|||
125386447|NCT01462084|451048788|FG001|Overall Study|Withdrawal by Subject|0|||
125386448|NCT01462084|451048787|FG000|Overall Study|Protocol Violation|1|||
125386449|NCT01462084|451048788|FG001|Overall Study|Protocol Violation|1|||
125386450|NCT03538158|451048789|FG000|Overall Study|Lost to Follow-up|13|||
125386451|NCT03538158|451048790|FG001|Overall Study|Lost to Follow-up|7|||
125386452|NCT03538158|451048789|FG000|Overall Study|Withdrawal by Subject|2|||
125386453|NCT03538158|451048790|FG001|Overall Study|Withdrawal by Subject|1|||
125386454|NCT00930579|451048791|FG000|Overall Study|Withdrawal by Subject|1|||
125386455|NCT00930579|451048791|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
125386456|NCT00695396|451048792|FG000|Overall Study|Study Closed Prematurely|5|||
125386457|NCT00695396|451048793|FG001|Overall Study|Study Closed Prematurely|6|||
125386458|NCT00695396|451048794|FG002|Overall Study|Study Closed Prematurely|8|||
125386459|NCT00695396|451048792|FG000|Overall Study|Withdrawal by Subject|2|||
125386460|NCT00695396|451048793|FG001|Overall Study|Withdrawal by Subject|2|||
125386461|NCT00695396|451048794|FG002|Overall Study|Withdrawal by Subject|0|||
125386462|NCT00772707|451048795|FG000|Overall Study|Withdrawn|3|||
125386463|NCT02726074|451048800|FG000|Overall Study|Withdrawal by Subject|4|||
125386464|NCT02726074|451048800|FG000|Overall Study|Adverse Event|14|||
125386465|NCT02726074|451048800|FG000|Overall Study|Protocol Violation|3|||
125222850|NCT02346877|450442844|FG001|Overall Study|Administrative Decision|0|||
125222851|NCT02346877|450442843|FG000|Overall Study|Sponsor Decision|12|||
125222852|NCT02346877|450442844|FG001|Overall Study|Sponsor Decision|0|||
125222853|NCT02346877|450442843|FG000|Overall Study|Missing|5|||
125140743|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
125140744|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
125140745|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
125140746|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
125140747|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
125140748|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
125140749|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
125140750|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
125140751|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
125140752|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
125140753|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
125222854|NCT02346877|450442844|FG001|Overall Study|Missing|0|||
125222855|NCT01212094|450444406|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
125222856|NCT01212094|450444407|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
125222857|NCT01212094|450444408|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
125222858|NCT01212094|450444406|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
125386466|NCT02726074|451048800|FG000|Overall Study|Lost to Follow-up|2|||
125386467|NCT02726074|451048800|FG000|Overall Study|Others|3|||
125386468|NCT01679002|451048801|FG000|Overall Study|Adverse Event|1|||
125386469|NCT01679002|451048802|FG001|Overall Study|Adverse Event|1|||
125386470|NCT01679002|451048803|FG002|Overall Study|Adverse Event|0|||
125386471|NCT01176266|451048804|FG000|Overall Study|Death|6|||
125386472|NCT01176266|451048804|FG000|Overall Study|Withdrawal by Subject|3|||
125386473|NCT05075850|451048805|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
125386474|NCT03194321|451048806|FG000|Overall Study|Withdrawal by Subject|1|||
125386475|NCT03194321|451048806|FG000|Overall Study|Lost to Follow-up|1|||
125386476|NCT03194321|451048806|FG000|Overall Study|Travel for Follow-up|1|||
125386477|NCT01288287|451048810|FG000|Overall Study|Lost to Follow-up|8|||
125386478|NCT01288287|451048810|FG000|Overall Study|Withdrawal by Subject|4|||
125386479|NCT01288287|451048810|FG000|Overall Study|Lack of Efficacy|13|||
125386480|NCT01288287|451048810|FG000|Overall Study|Other Reason|13|||
125386481|NCT01288287|451048810|FG000|Overall Study|Unknown Reason|1|||
125386482|NCT01288287|451048810|FG000|Overall Study|Unknown Status|7|||
125386483|NCT03255382|451048814|FG000|Overall Study|Adverse Event|3|||
125386484|NCT03255382|451048815|FG001|Overall Study|Adverse Event|0|||
125386485|NCT03255382|451048814|FG000|Overall Study|Lost to Follow-up|2|||
125386486|NCT03255382|451048815|FG001|Overall Study|Lost to Follow-up|0|||
125386487|NCT03255382|451048814|FG000|Overall Study|Withdrawal by Subject|2|||
125386488|NCT03255382|451048815|FG001|Overall Study|Withdrawal by Subject|0|||
125386489|NCT03255382|451048814|FG000|Overall Study|Other|6|||
125140754|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
125386490|NCT03255382|451048815|FG001|Overall Study|Other|0|||
125140755|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
125140756|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
125140757|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
125140758|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
125140759|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
125140760|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
125140761|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
125140762|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
125140763|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
125140764|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
125140765|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
125140766|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
125140767|NCT01710358|450139527|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
125140768|NCT01710358|450139528|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
125140769|NCT01710358|450139529|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
125140770|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
125222859|NCT01212094|450444407|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
125222860|NCT01212094|450444408|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
125222861|NCT01212094|450444406|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
125222862|NCT01212094|450444407|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
125140771|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
125140772|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
125140773|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
125140774|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
125140775|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
125140776|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
125140777|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
125140778|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
125140779|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
125140780|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
125140781|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
125140782|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
125140783|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
125140784|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
125140785|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
125140786|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
125140787|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
125140788|NCT01710358|450139527|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
125140789|NCT01710358|450139528|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
125140790|NCT01710358|450139529|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
125140791|NCT01710358|450139527|FG000|Rescue Period|Adverse Event|0|||
125140792|NCT01710358|450139528|FG001|Rescue Period|Adverse Event|15|||
125386491|NCT02221284|451048816|FG000|Overall Study|Case Report Forms Uncollected|56|||
125386492|NCT02221284|451048816|FG000|Overall Study|Protocol Deviation|5|||
125386493|NCT03011307|451048821|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
125386494|NCT03011307|451048822|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
125386495|NCT03011307|451048821|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
125386496|NCT03011307|451048822|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
125386497|NCT03011307|451048821|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
125386498|NCT03011307|451048822|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
125386499|NCT00271947|451048823|FG000|Overall Study|Lost to Follow-up|1|||
125386500|NCT01782664|451048824|FG000|Overall Study|Adverse Event|2|||
125386501|NCT01782664|451048825|FG001|Overall Study|Adverse Event|2|||
125386502|NCT01782664|451048826|FG002|Overall Study|Adverse Event|2|||
125386503|NCT01782664|451048827|FG003|Overall Study|Adverse Event|2|||
125386504|NCT01782664|451048828|FG004|Overall Study|Adverse Event|0|||
125386505|NCT01782664|451048829|FG005|Overall Study|Adverse Event|0|||
125386506|NCT01782664|451048824|FG000|Overall Study|Lack of Efficacy|2|||
125386507|NCT01782664|451048825|FG001|Overall Study|Lack of Efficacy|0|||
125386508|NCT01782664|451048826|FG002|Overall Study|Lack of Efficacy|2|||
125386509|NCT01782664|451048827|FG003|Overall Study|Lack of Efficacy|2|||
125386510|NCT01782664|451048828|FG004|Overall Study|Lack of Efficacy|0|||
125386511|NCT01782664|451048829|FG005|Overall Study|Lack of Efficacy|0|||
125386512|NCT01782664|451048824|FG000|Overall Study|Protocol Violation|0|||
125386513|NCT01782664|451048825|FG001|Overall Study|Protocol Violation|1|||
125386514|NCT01782664|451048826|FG002|Overall Study|Protocol Violation|0|||
125386515|NCT01782664|451048827|FG003|Overall Study|Protocol Violation|1|||
125386516|NCT01782664|451048828|FG004|Overall Study|Protocol Violation|0|||
125386517|NCT01782664|451048829|FG005|Overall Study|Protocol Violation|0|||
125386518|NCT01782664|451048824|FG000|Overall Study|Withdrawal by Subject|2|||
125386519|NCT01782664|451048825|FG001|Overall Study|Withdrawal by Subject|2|||
125386520|NCT01782664|451048826|FG002|Overall Study|Withdrawal by Subject|0|||
125386521|NCT01782664|451048827|FG003|Overall Study|Withdrawal by Subject|0|||
125386522|NCT01782664|451048828|FG004|Overall Study|Withdrawal by Subject|0|||
125386523|NCT01782664|451048829|FG005|Overall Study|Withdrawal by Subject|0|||
125386524|NCT02677987|451048830|FG000|Overall Study|Withdrawal by Subject|3|||
125386525|NCT02677987|451048831|FG001|Overall Study|Withdrawal by Subject|0|||
125386526|NCT02677987|451048830|FG000|Overall Study|Lost to Follow-up|1|||
125386527|NCT02677987|451048831|FG001|Overall Study|Lost to Follow-up|0|||
125386528|NCT01522365|451048835|FG000|Overall Study|Withdrawal by Subject|1|||
125386529|NCT01522365|451048836|FG001|Overall Study|Withdrawal by Subject|1|||
125386530|NCT01522365|451048835|FG000|Overall Study|Lost to Follow-up|1|||
125386531|NCT01522365|451048836|FG001|Overall Study|Lost to Follow-up|1|||
125140793|NCT01710358|450139529|FG002|Rescue Period|Adverse Event|0|||
125140794|NCT01710358|450139527|FG000|Rescue Period|Death|0|||
125386532|NCT00673179|451048837|FG000|Overall Study|Toxicity/Complications|3|||
125386533|NCT00673179|451048838|FG001|Overall Study|Toxicity/Complications|0|||
125386534|NCT00651755|451048839|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
125386535|NCT00651755|451048840|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
125386536|NCT00651755|451048839|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
125386537|NCT00651755|451048840|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
125438418|NCT04276090|451232250|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
125438419|NCT04986982|451232251|FG000|Overall Study|Withdrawal by Subject|3|||
125438420|NCT04986982|451232252|FG001|Overall Study|Withdrawal by Subject|1|||
125438421|NCT04986982|451232251|FG000|Overall Study|Lack of Efficacy|0|||
125386538|NCT00624052|451048841|FG000|Overall Study|Adverse Event|7|||
125386539|NCT00624052|451048842|FG001|Overall Study|Adverse Event|6|||
125386540|NCT00624052|451048843|FG002|Overall Study|Adverse Event|0|||
125386541|NCT00624052|451048844|FG003|Overall Study|Adverse Event|3|||
125386542|NCT00624052|451048841|FG000|Overall Study|Lack of Efficacy|1|||
125386543|NCT00624052|451048842|FG001|Overall Study|Lack of Efficacy|1|||
125386544|NCT00624052|451048843|FG002|Overall Study|Lack of Efficacy|0|||
125438422|NCT04986982|451232252|FG001|Overall Study|Lack of Efficacy|2|||
125386545|NCT00624052|451048844|FG003|Overall Study|Lack of Efficacy|0|||
125386546|NCT00624052|451048841|FG000|Overall Study|Lost to Follow-up|2|||
125140795|NCT01710358|450139528|FG001|Rescue Period|Death|1|||
125140796|NCT01710358|450139529|FG002|Rescue Period|Death|0|||
125140797|NCT01710358|450139527|FG000|Rescue Period|Lack of Efficacy|0|||
125140798|NCT01710358|450139528|FG001|Rescue Period|Lack of Efficacy|7|||
125140799|NCT01710358|450139529|FG002|Rescue Period|Lack of Efficacy|0|||
125140800|NCT01710358|450139527|FG000|Rescue Period|Withdrawal by Subject|0|||
125140801|NCT01710358|450139528|FG001|Rescue Period|Withdrawal by Subject|8|||
125140802|NCT01710358|450139529|FG002|Rescue Period|Withdrawal by Subject|0|||
125140803|NCT00735696|450139536|FG000|Overall Study|Withdrawal by Subject|1|||
125140804|NCT00735696|450139536|FG000|Overall Study|Enrolled but never Treated|1|||
125140805|NCT00084864|450139537|FG000|Overall Study|Adverse Event|1|||
125140806|NCT00084864|450139538|FG001|Overall Study|Adverse Event|0|||
125140807|NCT00084864|450139539|FG002|Overall Study|Adverse Event|0|||
125140808|NCT00084864|450139540|FG003|Overall Study|Adverse Event|0|||
125140809|NCT04406194|450139541|FG000|Period 1|Withdrawal by Subject|0|||
125140810|NCT04406194|450139542|FG001|Period 1|Withdrawal by Subject|1|||
125140811|NCT01741545|450139543|FG000|Treatment Period|Lack of Efficacy|0|||
125140812|NCT01741545|450139544|FG001|Treatment Period|Lack of Efficacy|1|||
125140813|NCT01741545|450139543|FG000|Treatment Period|Adverse event, non-fatal|1|||
125140814|NCT01741545|450139544|FG001|Treatment Period|Adverse event, non-fatal|3|||
125140815|NCT01741545|450139543|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
125140816|NCT01741545|450139544|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
125140817|NCT01741545|450139543|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
125140818|NCT01741545|450139544|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
125140819|NCT01456962|450139545|FG000|Overall Study|Lost to Follow-up|2|||
125140820|NCT01456962|450139546|FG001|Overall Study|Lost to Follow-up|1|||
125140821|NCT02704091|450139549|FG000|Overall Study|Adverse Event|4|||
125140822|NCT02704091|450139550|FG001|Overall Study|Adverse Event|3|||
125140823|NCT02704091|450139549|FG000|Overall Study|Protocol Violation|5|||
125140824|NCT02704091|450139550|FG001|Overall Study|Protocol Violation|3|||
125140825|NCT02704091|450139549|FG000|Overall Study|Consent withdrawn|4|||
125140826|NCT02704091|450139550|FG001|Overall Study|Consent withdrawn|4|||
125140827|NCT02704091|450139549|FG000|Overall Study|Lost to Follow-up|13|||
125140828|NCT02704091|450139550|FG001|Overall Study|Lost to Follow-up|5|||
125140829|NCT02704091|450139549|FG000|Overall Study|Other|2|||
125140830|NCT02704091|450139550|FG001|Overall Study|Other|8|||
125140831|NCT03073798|450139551|FG000|Overall Study|Adverse Event|1|||
125140832|NCT03073798|450139551|FG000|Overall Study|Withdrawal by Subject|1|||
125140833|NCT01186458|450139552|FG000|Overall Study|Adverse Event|1|||
125140834|NCT01496118|450139553|FG000|Overall Study|Disease progression|3|||
125140835|NCT01496118|450139554|FG001|Overall Study|Disease progression|2|||
125140836|NCT01496118|450139555|FG002|Overall Study|Disease progression|3|||
125140837|NCT01496118|450139556|FG003|Overall Study|Disease progression|1|||
125140838|NCT01496118|450139557|FG004|Overall Study|Disease progression|2|||
125140839|NCT01496118|450139558|FG005|Overall Study|Disease progression|2|||
125140840|NCT01496118|450139559|FG006|Overall Study|Disease progression|14|||
125140841|NCT01496118|450139560|FG007|Overall Study|Disease progression|10|||
125140842|NCT01496118|450139553|FG000|Overall Study|Physician Decision|0|||
125140843|NCT01496118|450139554|FG001|Overall Study|Physician Decision|0|||
125140844|NCT01496118|450139555|FG002|Overall Study|Physician Decision|0|||
125140845|NCT01496118|450139556|FG003|Overall Study|Physician Decision|0|||
125222863|NCT01212094|450444408|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
125222864|NCT01212094|450444406|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
125222865|NCT01212094|450444407|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
125222866|NCT01212094|450444408|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
125222867|NCT01212094|450444406|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
125222868|NCT01212094|450444407|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
125222869|NCT01212094|450444408|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
125222870|NCT01212094|450444406|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
125222871|NCT01212094|450444407|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
125222872|NCT01212094|450444408|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
125222873|NCT02019550|450444410|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
125222874|NCT02019550|450444411|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
125222875|NCT00823134|450444413|FG000|Overall Study|Invalid measurement|1|||
125222876|NCT02291029|450444417|FG000|Overall Study|Withdrawal by Subject|0|||
125222877|NCT02291029|450444418|FG001|Overall Study|Withdrawal by Subject|0|||
125222878|NCT02291029|450444419|FG002|Overall Study|Withdrawal by Subject|1|||
125222879|NCT02291029|450444420|FG003|Overall Study|Withdrawal by Subject|0|||
125222880|NCT02291029|450444421|FG004|Overall Study|Withdrawal by Subject|0|||
125222881|NCT02291029|450444422|FG005|Overall Study|Withdrawal by Subject|0|||
125222882|NCT02291029|450444417|FG000|Overall Study|Adverse Event|0|||
125222883|NCT02291029|450444418|FG001|Overall Study|Adverse Event|1|||
125222884|NCT02291029|450444419|FG002|Overall Study|Adverse Event|0|||
125222885|NCT02291029|450444420|FG003|Overall Study|Adverse Event|0|||
125222886|NCT02291029|450444421|FG004|Overall Study|Adverse Event|0|||
125222887|NCT02291029|450444422|FG005|Overall Study|Adverse Event|0|||
125222888|NCT02922153|450444423|FG000|Overall Study|Death|8|||
125222889|NCT02922153|450444424|FG001|Overall Study|Death|1|||
125222890|NCT02922153|450444423|FG000|Overall Study|Lost to Follow-up|1|||
125222891|NCT02922153|450444424|FG001|Overall Study|Lost to Follow-up|0|||
125222892|NCT02922153|450444423|FG000|Overall Study|Physician Decision|1|||
125222893|NCT02922153|450444424|FG001|Overall Study|Physician Decision|1|||
125222894|NCT02692586|450444427|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
125222895|NCT02692586|450444427|FG000|Overall Study|Received adjunctive thrombolytics|2|||
125222896|NCT03316586|450444429|FG000|Overall Study|Adverse Event|2|||
125222897|NCT03316586|450444429|FG000|Overall Study|Physician Decision|3|||
125386547|NCT00624052|451048842|FG001|Overall Study|Lost to Follow-up|3|||
125386548|NCT00624052|451048843|FG002|Overall Study|Lost to Follow-up|1|||
125140846|NCT01496118|450139557|FG004|Overall Study|Physician Decision|1|||
125140847|NCT01496118|450139558|FG005|Overall Study|Physician Decision|0|||
125140848|NCT01496118|450139559|FG006|Overall Study|Physician Decision|3|||
125140849|NCT01496118|450139560|FG007|Overall Study|Physician Decision|6|||
125140850|NCT01496118|450139553|FG000|Overall Study|Adverse Event|1|||
125140851|NCT01496118|450139554|FG001|Overall Study|Adverse Event|1|||
125140852|NCT01496118|450139555|FG002|Overall Study|Adverse Event|0|||
125140853|NCT01496118|450139556|FG003|Overall Study|Adverse Event|0|||
125140854|NCT01496118|450139557|FG004|Overall Study|Adverse Event|0|||
125140855|NCT01496118|450139558|FG005|Overall Study|Adverse Event|0|||
125140856|NCT01496118|450139559|FG006|Overall Study|Adverse Event|6|||
125140857|NCT01496118|450139560|FG007|Overall Study|Adverse Event|10|||
125140858|NCT01496118|450139553|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125140859|NCT01496118|450139554|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125140860|NCT01496118|450139555|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125438423|NCT04986982|451232251|FG000|Overall Study|Ineligibility|3|||
125386549|NCT00624052|451048844|FG003|Overall Study|Lost to Follow-up|0|||
125386550|NCT00624052|451048841|FG000|Overall Study|Non compliant with the protocol|2|||
125438424|NCT04986982|451232252|FG001|Overall Study|Ineligibility|0|||
125140861|NCT01496118|450139556|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125140862|NCT01496118|450139557|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125386551|NCT00624052|451048842|FG001|Overall Study|Non compliant with the protocol|1|||
125386552|NCT00624052|451048843|FG002|Overall Study|Non compliant with the protocol|1|||
125386553|NCT00624052|451048844|FG003|Overall Study|Non compliant with the protocol|1|||
125386554|NCT00624052|451048841|FG000|Overall Study|Consent withdrawn|3|||
125386555|NCT00624052|451048842|FG001|Overall Study|Consent withdrawn|1|||
125386556|NCT00624052|451048843|FG002|Overall Study|Consent withdrawn|1|||
125140863|NCT01496118|450139558|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125222898|NCT03316586|450444429|FG000|Overall Study|Lack of Efficacy|10|||
125386557|NCT00624052|451048844|FG003|Overall Study|Consent withdrawn|0|||
125386558|NCT00624052|451048841|FG000|Overall Study|Changed job/ran out if meds|0|||
125386559|NCT00624052|451048842|FG001|Overall Study|Changed job/ran out if meds|2|||
125386560|NCT00624052|451048843|FG002|Overall Study|Changed job/ran out if meds|0|||
125386561|NCT00624052|451048844|FG003|Overall Study|Changed job/ran out if meds|0|||
125386562|NCT00281684|451048847|FG000|Overall Study|Lost to Follow-up|0|||
125386563|NCT00281684|451048848|FG001|Overall Study|Lost to Follow-up|0|||
125386564|NCT00281684|451048849|FG002|Overall Study|Lost to Follow-up|1|||
125386565|NCT00281684|451048850|FG003|Overall Study|Lost to Follow-up|0|||
125140864|NCT01496118|450139559|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
125140865|NCT01496118|450139560|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
125140866|NCT01496118|450139553|FG000|Overall Study|Death|0|||
125140867|NCT01496118|450139554|FG001|Overall Study|Death|0|||
125140868|NCT01496118|450139555|FG002|Overall Study|Death|0|||
125140869|NCT01496118|450139556|FG003|Overall Study|Death|0|||
125140870|NCT01496118|450139557|FG004|Overall Study|Death|0|||
125438425|NCT04986982|451232251|FG000|Overall Study|Adverse Event|4|||
125140871|NCT01496118|450139558|FG005|Overall Study|Death|0|||
125140872|NCT01496118|450139559|FG006|Overall Study|Death|1|||
125140873|NCT01496118|450139560|FG007|Overall Study|Death|1|||
125140874|NCT01496118|450139553|FG000|Overall Study|Withdrawal by Subject|0|||
125140875|NCT01496118|450139554|FG001|Overall Study|Withdrawal by Subject|0|||
125140876|NCT01496118|450139555|FG002|Overall Study|Withdrawal by Subject|0|||
125140877|NCT01496118|450139556|FG003|Overall Study|Withdrawal by Subject|2|||
125140878|NCT01496118|450139557|FG004|Overall Study|Withdrawal by Subject|0|||
125140879|NCT01496118|450139558|FG005|Overall Study|Withdrawal by Subject|1|||
125140880|NCT01496118|450139559|FG006|Overall Study|Withdrawal by Subject|6|||
125140881|NCT01496118|450139560|FG007|Overall Study|Withdrawal by Subject|3|||
125140882|NCT02420353|450139561|FG000|Overall Study|Withdrawal by Subject|0|||
125140883|NCT02420353|450139562|FG001|Overall Study|Withdrawal by Subject|1|||
125140884|NCT01149057|450139563|FG000|Overall Study|Lack of Efficacy|16|||
125140885|NCT01149057|450139563|FG000|Overall Study|Adverse Event|13|||
125140886|NCT01149057|450139563|FG000|Overall Study|Withdrawal by Subject|9|||
125140887|NCT01149057|450139563|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
125140888|NCT01149057|450139563|FG000|Overall Study|B Cell Depletion|4|||
125140889|NCT01149057|450139563|FG000|Overall Study|Participant Non-Compliance|2|||
125140890|NCT01149057|450139563|FG000|Overall Study|Lost to Follow-up|1|||
125140891|NCT01149057|450139563|FG000|Overall Study|High Parathyroid Hormone Value|1|||
125140892|NCT01149057|450139563|FG000|Overall Study|Other|6|||
125140893|NCT04608448|450139564|FG000|Overall Study|Withdrawal by Subject|1|||
125140894|NCT04608448|450139564|FG000|Overall Study|Adverse Event|1|||
125140895|NCT00577655|450139565|FG000|Overall Study|Patient Request|0|||
125140896|NCT00577655|450139566|FG001|Overall Study|Patient Request|2|||
125140897|NCT00577655|450139565|FG000|Overall Study|Protocol Violation|0|||
125140898|NCT00577655|450139566|FG001|Overall Study|Protocol Violation|1|||
125140899|NCT00577655|450139565|FG000|Overall Study|Lost to Follow-up|1|||
125386566|NCT00281684|451048847|FG000|Overall Study|Withdrawal by Subject|1|||
125386567|NCT00281684|451048848|FG001|Overall Study|Withdrawal by Subject|0|||
125386568|NCT00281684|451048849|FG002|Overall Study|Withdrawal by Subject|0|||
125386569|NCT00281684|451048850|FG003|Overall Study|Withdrawal by Subject|0|||
125386570|NCT01464346|451048854|FG000|Overall Study|Withdrawal by Subject|0|||
125386571|NCT01464346|451048855|FG001|Overall Study|Withdrawal by Subject|0|||
125386572|NCT01464346|451048856|FG002|Overall Study|Withdrawal by Subject|1|||
125386573|NCT02295995|451048857|FG000|Overall Study|Lost to Follow-up|5|||
125386574|NCT02295995|451048858|FG001|Overall Study|Lost to Follow-up|1|||
125386575|NCT02447081|451048859|FG000|Overall Study|Death|161|||
125386576|NCT02447081|451048859|FG000|Overall Study|Lost to Follow-up|36|||
125386577|NCT02447081|451048859|FG000|Overall Study|Visit not completed|17|||
125386578|NCT02447081|451048859|FG000|Overall Study|unsuccessful implant procedure|10|||
125386579|NCT02113956|451048863|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
125386580|NCT02113956|451048864|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
125386581|NCT02113956|451048863|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
125386582|NCT02113956|451048864|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
125386583|NCT02113956|451048863|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
125386584|NCT02113956|451048864|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
125386585|NCT02406651|451048865|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
125386586|NCT00718328|451048866|FG000|Overall Study|Lost to Follow-up|1|||
125386587|NCT00718328|451048867|FG001|Overall Study|Lost to Follow-up|0|||
125386588|NCT01064401|451048868|FG000|Overall Study|Adverse Event|47|||
125386589|NCT01064401|451048869|FG001|Overall Study|Adverse Event|56|||
125386590|NCT01064401|451048868|FG000|Overall Study|Lack of Efficacy|46|||
125386591|NCT01064401|451048869|FG001|Overall Study|Lack of Efficacy|23|||
125386592|NCT01064401|451048868|FG000|Overall Study|Lost to Follow-up|12|||
125140900|NCT00577655|450139566|FG001|Overall Study|Lost to Follow-up|1|||
125140901|NCT00875524|450139567|FG000|Overall Study|Serious adverse event|0|||
125140902|NCT00875524|450139568|FG001|Overall Study|Serious adverse event|1|||
125140903|NCT00875524|450139567|FG000|Overall Study|Protocol Violation|4|||
125140904|NCT00875524|450139568|FG001|Overall Study|Protocol Violation|0|||
125140905|NCT00875524|450139567|FG000|Overall Study|Lost to Follow-up|1|||
125140906|NCT00875524|450139568|FG001|Overall Study|Lost to Follow-up|0|||
125140907|NCT00875524|450139567|FG000|Overall Study|Withdrawal by Subject|3|||
125140908|NCT00875524|450139568|FG001|Overall Study|Withdrawal by Subject|5|||
125140909|NCT01370863|450139569|FG000|Overall Study|Adverse Event|1|||
125140910|NCT01370863|450139570|FG001|Overall Study|Adverse Event|1|||
125140911|NCT01370863|450139569|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
125140912|NCT01370863|450139570|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
125140913|NCT01370863|450139569|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
125140914|NCT01370863|450139570|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
125140915|NCT01143337|450139571|FG000|Overall Study|Adverse Event|3|||
125140916|NCT01143337|450139572|FG001|Overall Study|Adverse Event|9|||
125140917|NCT01143337|450139573|FG002|Overall Study|Adverse Event|5|||
125140918|NCT01143337|450139571|FG000|Overall Study|Lack of Efficacy|6|||
125140919|NCT01143337|450139572|FG001|Overall Study|Lack of Efficacy|2|||
125140920|NCT01143337|450139573|FG002|Overall Study|Lack of Efficacy|1|||
125140921|NCT01143337|450139571|FG000|Overall Study|Protocol Violation|1|||
125140922|NCT01143337|450139572|FG001|Overall Study|Protocol Violation|0|||
125140923|NCT01143337|450139573|FG002|Overall Study|Protocol Violation|0|||
125140924|NCT01143337|450139571|FG000|Overall Study|Withdrawal by Subject|0|||
125140925|NCT01143337|450139572|FG001|Overall Study|Withdrawal by Subject|0|||
125140926|NCT01143337|450139573|FG002|Overall Study|Withdrawal by Subject|1|||
125140927|NCT01143337|450139571|FG000|Overall Study|Other reason|0|||
125140928|NCT01143337|450139572|FG001|Overall Study|Other reason|0|||
125386593|NCT01064401|451048869|FG001|Overall Study|Lost to Follow-up|9|||
125386594|NCT01064401|451048868|FG000|Overall Study|Consent Withdrawn|98|||
125140929|NCT01143337|450139573|FG002|Overall Study|Other reason|5|||
125140930|NCT02761915|450139574|FG000|Overall Study|Death|3|||
125140931|NCT02761915|450139575|FG001|Overall Study|Death|1|||
125386595|NCT01064401|451048869|FG001|Overall Study|Consent Withdrawn|80|||
125386596|NCT01064401|451048868|FG000|Overall Study|Investigator Decision|4|||
125386597|NCT01064401|451048869|FG001|Overall Study|Investigator Decision|6|||
125386598|NCT01064401|451048868|FG000|Overall Study|Death|4|||
125140932|NCT02761915|450139576|FG002|Overall Study|Death|1|||
125140933|NCT02761915|450139577|FG003|Overall Study|Death|1|||
125140934|NCT02761915|450139578|FG004|Overall Study|Death|0|||
125140935|NCT02761915|450139579|FG005|Overall Study|Death|1|||
125140936|NCT02761915|450139574|FG000|Overall Study|Withdrawal by Subject|1|||
125140937|NCT02761915|450139575|FG001|Overall Study|Withdrawal by Subject|0|||
125140938|NCT02761915|450139576|FG002|Overall Study|Withdrawal by Subject|0|||
125140939|NCT02761915|450139577|FG003|Overall Study|Withdrawal by Subject|0|||
125140940|NCT02761915|450139578|FG004|Overall Study|Withdrawal by Subject|1|||
125140941|NCT02761915|450139579|FG005|Overall Study|Withdrawal by Subject|2|||
125140942|NCT02761915|450139574|FG000|Overall Study|Disease Progression|0|||
125140943|NCT02761915|450139575|FG001|Overall Study|Disease Progression|0|||
125140944|NCT02761915|450139576|FG002|Overall Study|Disease Progression|0|||
125140945|NCT02761915|450139577|FG003|Overall Study|Disease Progression|2|||
125140946|NCT02761915|450139578|FG004|Overall Study|Disease Progression|2|||
125140947|NCT02761915|450139579|FG005|Overall Study|Disease Progression|2|||
125140948|NCT00819169|450139588|FG000|Overall Study|Withdrawal by Subject|2|||
125140949|NCT00819169|450139589|FG001|Overall Study|Withdrawal by Subject|0|||
125140950|NCT00819169|450139590|FG002|Overall Study|Withdrawal by Subject|0|||
125140951|NCT00819169|450139591|FG003|Overall Study|Withdrawal by Subject|1|||
125140952|NCT00819169|450139592|FG004|Overall Study|Withdrawal by Subject|1|||
125140953|NCT00819169|450139593|FG005|Overall Study|Withdrawal by Subject|1|||
125140954|NCT00819169|450139594|FG006|Overall Study|Withdrawal by Subject|5|||
125140955|NCT00819169|450139595|FG007|Overall Study|Withdrawal by Subject|1|||
125140956|NCT00819169|450139596|FG008|Overall Study|Withdrawal by Subject|4|||
125140957|NCT00819169|450139588|FG000|Overall Study|Lost to Follow-up|0|||
125140958|NCT00819169|450139589|FG001|Overall Study|Lost to Follow-up|2|||
125140959|NCT00819169|450139590|FG002|Overall Study|Lost to Follow-up|0|||
125140960|NCT00819169|450139591|FG003|Overall Study|Lost to Follow-up|1|||
125140961|NCT00819169|450139592|FG004|Overall Study|Lost to Follow-up|0|||
125140962|NCT00819169|450139593|FG005|Overall Study|Lost to Follow-up|6|||
125140963|NCT00819169|450139594|FG006|Overall Study|Lost to Follow-up|2|||
125140964|NCT00819169|450139595|FG007|Overall Study|Lost to Follow-up|2|||
125140965|NCT00819169|450139596|FG008|Overall Study|Lost to Follow-up|1|||
125140966|NCT00819169|450139588|FG000|Overall Study|Death|1|||
125140967|NCT00819169|450139589|FG001|Overall Study|Death|1|||
125140968|NCT00819169|450139590|FG002|Overall Study|Death|3|||
125140969|NCT00819169|450139591|FG003|Overall Study|Death|8|||
125140970|NCT00819169|450139592|FG004|Overall Study|Death|5|||
125140971|NCT00819169|450139593|FG005|Overall Study|Death|7|||
125140972|NCT00819169|450139594|FG006|Overall Study|Death|9|||
125140973|NCT00819169|450139595|FG007|Overall Study|Death|4|||
125140974|NCT00819169|450139596|FG008|Overall Study|Death|7|||
125140975|NCT00819169|450139588|FG000|Overall Study|Ineligibility determined|0|||
125140976|NCT00819169|450139589|FG001|Overall Study|Ineligibility determined|0|||
125140977|NCT00819169|450139590|FG002|Overall Study|Ineligibility determined|0|||
125140978|NCT00819169|450139591|FG003|Overall Study|Ineligibility determined|2|||
125140979|NCT00819169|450139592|FG004|Overall Study|Ineligibility determined|0|||
125222899|NCT03316586|450444429|FG000|Overall Study|still on treatment|1|||
125140980|NCT00819169|450139593|FG005|Overall Study|Ineligibility determined|0|||
125140981|NCT00819169|450139594|FG006|Overall Study|Ineligibility determined|0|||
125140982|NCT00819169|450139595|FG007|Overall Study|Ineligibility determined|0|||
125140983|NCT00819169|450139596|FG008|Overall Study|Ineligibility determined|1|||
125140984|NCT00819169|450139588|FG000|Overall Study|Adverse Event|0|||
125140985|NCT00819169|450139589|FG001|Overall Study|Adverse Event|0|||
125140986|NCT00819169|450139590|FG002|Overall Study|Adverse Event|0|||
125140987|NCT00819169|450139591|FG003|Overall Study|Adverse Event|0|||
125140988|NCT00819169|450139592|FG004|Overall Study|Adverse Event|1|||
125140989|NCT00819169|450139593|FG005|Overall Study|Adverse Event|0|||
125140990|NCT00819169|450139594|FG006|Overall Study|Adverse Event|0|||
125140991|NCT00819169|450139595|FG007|Overall Study|Adverse Event|0|||
125140992|NCT00819169|450139596|FG008|Overall Study|Adverse Event|0|||
125140993|NCT00819169|450139588|FG000|Overall Study|Administrative Decision|0|||
125140994|NCT00819169|450139589|FG001|Overall Study|Administrative Decision|0|||
125140995|NCT00819169|450139590|FG002|Overall Study|Administrative Decision|0|||
125140996|NCT00819169|450139591|FG003|Overall Study|Administrative Decision|0|||
125140997|NCT00819169|450139592|FG004|Overall Study|Administrative Decision|1|||
125140998|NCT00819169|450139593|FG005|Overall Study|Administrative Decision|2|||
125140999|NCT00819169|450139594|FG006|Overall Study|Administrative Decision|0|||
125141000|NCT00819169|450139595|FG007|Overall Study|Administrative Decision|2|||
125141001|NCT00819169|450139596|FG008|Overall Study|Administrative Decision|0|||
125141002|NCT00406393|450139597|FG000|Overall Study|Did not undergo transplantation|2|||
125141003|NCT00406393|450139598|FG001|Overall Study|Did not undergo transplantation|1|||
125141004|NCT03277248|450139601|FG000|Overall Study|Adverse Event|3|||
125141005|NCT03277248|450139602|FG001|Overall Study|Adverse Event|1|||
125141006|NCT03277248|450139601|FG000|Overall Study|Subject Withdrawal of Consent|6|||
125141007|NCT03277248|450139602|FG001|Overall Study|Subject Withdrawal of Consent|23|||
125141008|NCT03277248|450139601|FG000|Overall Study|Investigator/Sponsor Decision|2|||
125141009|NCT03277248|450139602|FG001|Overall Study|Investigator/Sponsor Decision|2|||
125141010|NCT03277248|450139601|FG000|Overall Study|Pregnancy|4|||
125141011|NCT03277248|450139602|FG001|Overall Study|Pregnancy|1|||
125141012|NCT03277248|450139601|FG000|Overall Study|Lost to Follow-up|0|||
125141013|NCT03277248|450139602|FG001|Overall Study|Lost to Follow-up|2|||
125141014|NCT03277248|450139601|FG000|Overall Study|Lack of Efficacy|0|||
125141015|NCT03277248|450139602|FG001|Overall Study|Lack of Efficacy|2|||
125141016|NCT03277248|450139601|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
125141017|NCT03277248|450139602|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
125141018|NCT01663896|450139603|FG000|Overall Study|Various reasons|43|||
125141019|NCT00379353|450139607|FG000|Overall Study|Hospitalization|3|||
125141020|NCT00379353|450139608|FG001|Overall Study|Hospitalization|3|||
125141021|NCT00379353|450139607|FG000|Overall Study|Withdrawal by Subject|5|||
125141022|NCT00379353|450139608|FG001|Overall Study|Withdrawal by Subject|2|||
125141023|NCT00379353|450139607|FG000|Overall Study|Death|1|||
125141024|NCT00379353|450139608|FG001|Overall Study|Death|0|||
125141025|NCT00379353|450139607|FG000|Overall Study|Cardiac Tamponade|1|||
125141026|NCT00379353|450139608|FG001|Overall Study|Cardiac Tamponade|0|||
125141027|NCT00379353|450139607|FG000|Overall Study|Non-compliance|1|||
125141028|NCT00379353|450139608|FG001|Overall Study|Non-compliance|0|||
125141029|NCT00379353|450139607|FG000|Overall Study|Conflicting drug treatment|0|||
125141030|NCT00379353|450139608|FG001|Overall Study|Conflicting drug treatment|1|||
125141031|NCT03614728|450139609|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
125141032|NCT03614728|450139610|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
125141033|NCT03614728|450139611|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
125141034|NCT03614728|450139612|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
125141035|NCT03614728|450139609|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
125141036|NCT03614728|450139610|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
125141037|NCT03614728|450139611|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
125386599|NCT01064401|451048869|FG001|Overall Study|Death|0|||
125386600|NCT01064401|451048868|FG000|Overall Study|Pregnancy|4|||
125386601|NCT01064401|451048869|FG001|Overall Study|Pregnancy|7|||
125386602|NCT01064401|451048868|FG000|Overall Study|Noncompliance|7|||
125386603|NCT01064401|451048869|FG001|Overall Study|Noncompliance|8|||
125386604|NCT01064401|451048868|FG000|Overall Study|Site Closure|4|||
125386605|NCT01064401|451048869|FG001|Overall Study|Site Closure|5|||
125386606|NCT01064401|451048868|FG000|Overall Study|Other|2|||
125386607|NCT01064401|451048869|FG001|Overall Study|Other|1|||
125386608|NCT04007094|451048870|FG000|Overall Study|Lost to Follow-up|1|||
125386609|NCT04007094|451048871|FG001|Overall Study|Lost to Follow-up|1|||
125386610|NCT01581307|451048872|FG000|Overall Study|Withdrawal by Subject|1|||
125386611|NCT00378209|451048877|FG000|Overall Study|Progressive disease|11|||
125386612|NCT00378209|451048877|FG000|Overall Study|Adverse Event|3|||
125386613|NCT00378209|451048877|FG000|Overall Study|Initiation of non-protocol therapy|3|||
125386614|NCT00378209|451048877|FG000|Overall Study|Physician Decision|3|||
125386615|NCT00378209|451048877|FG000|Overall Study|Death|1|||
125386616|NCT00378209|451048877|FG000|Overall Study|Treatment delay|1|||
125386617|NCT01536379|451050690|FG000|Overall Study|Adverse Event|1|||
125386618|NCT01536379|451050691|FG001|Overall Study|Adverse Event|2|||
125386619|NCT01536379|451050690|FG000|Overall Study|Withdrawal by Subject|1|||
125386620|NCT01536379|451050691|FG001|Overall Study|Withdrawal by Subject|1|||
125386621|NCT04447417|451050695|FG000|Overall Study|Withdrawal by Subject|1|||
125386622|NCT04447417|451050696|FG001|Overall Study|Withdrawal by Subject|0|||
125386623|NCT04447417|451050695|FG000|Overall Study|Failure to meet inclusion criteria|1|||
125386624|NCT04447417|451050696|FG001|Overall Study|Failure to meet inclusion criteria|0|||
125386625|NCT04447417|451050695|FG000|Overall Study|Lost to Follow-up|1|||
125386626|NCT04447417|451050696|FG001|Overall Study|Lost to Follow-up|0|||
125386627|NCT02155738|451050700|FG000|Overall Study|Missing critical information|1|||
125386628|NCT02155738|451050701|FG001|Overall Study|Missing critical information|0|||
125386629|NCT02155738|451050702|FG002|Overall Study|Missing critical information|0|||
125386630|NCT02155738|451050703|FG003|Overall Study|Missing critical information|1|||
125386631|NCT01190254|451050704|FG000|Overall Study|Adverse Event|3|||
125386632|NCT01190254|451050705|FG001|Overall Study|Adverse Event|6|||
125386633|NCT01190254|451050706|FG002|Overall Study|Adverse Event|8|||
125386634|NCT01190254|451050704|FG000|Overall Study|Lack of Efficacy|7|||
125141038|NCT03614728|450139612|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
125141039|NCT01824576|450139613|FG000|Overall Study|Device deficiency|2|||
125141040|NCT01691612|450139616|FG000|Overall Study|deemed ineligible after 1st visit|6|||
125141041|NCT01691612|450139616|FG000|Overall Study|Adverse Event|1|||
125141042|NCT05315713|450139621|FG000|Overall Study|Death|5|||
125141043|NCT05315713|450139621|FG000|Overall Study|Progressive disease|1|||
125141044|NCT05315713|450139621|FG000|Overall Study|Withdrawal by Subject|1|||
125141045|NCT05315713|450139621|FG000|Overall Study|Study terminated by sponsor|1|||
125141046|NCT00556673|450139622|FG000|Overall Study|Protocol deviation|3|||
125141047|NCT00556673|450139623|FG001|Overall Study|Protocol deviation|2|||
125141048|NCT01131260|450139624|FG000|Overall Study|Randomization error|5|||
125141049|NCT01131260|450139625|FG001|Overall Study|Randomization error|1|||
125141050|NCT01131260|450139624|FG000|Overall Study|Declined to continue participation|8|||
125141051|NCT01131260|450139625|FG001|Overall Study|Declined to continue participation|13|||
125386635|NCT01190254|451050705|FG001|Overall Study|Lack of Efficacy|4|||
125386636|NCT01190254|451050706|FG002|Overall Study|Lack of Efficacy|5|||
125386637|NCT01190254|451050704|FG000|Overall Study|Lost to Follow-up|4|||
125386638|NCT01190254|451050705|FG001|Overall Study|Lost to Follow-up|2|||
125386639|NCT01190254|451050706|FG002|Overall Study|Lost to Follow-up|0|||
125386640|NCT01190254|451050704|FG000|Overall Study|Withdrawal by Subject|4|||
125141052|NCT01131260|450139624|FG000|Overall Study|Physician Decision|22|||
125141053|NCT01131260|450139625|FG001|Overall Study|Physician Decision|24|||
125141054|NCT01131260|450139624|FG000|Overall Study|Technical problems|7|||
125141055|NCT01131260|450139625|FG001|Overall Study|Technical problems|6|||
125386641|NCT01190254|451050705|FG001|Overall Study|Withdrawal by Subject|5|||
125386642|NCT01190254|451050706|FG002|Overall Study|Withdrawal by Subject|7|||
125386643|NCT01190254|451050704|FG000|Overall Study|Protocol Violation|2|||
125141056|NCT01131260|450139624|FG000|Overall Study|Staff error|2|||
125386644|NCT01190254|451050705|FG001|Overall Study|Protocol Violation|0|||
125386645|NCT01190254|451050706|FG002|Overall Study|Protocol Violation|2|||
125386646|NCT01190254|451050704|FG000|Overall Study|Did not meet protocol eligibility|1|||
125141057|NCT01131260|450139625|FG001|Overall Study|Staff error|1|||
125141058|NCT01131260|450139624|FG000|Overall Study|Ineligible|0|||
125141059|NCT01131260|450139625|FG001|Overall Study|Ineligible|2|||
125141060|NCT00835081|450139628|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125141061|NCT00835081|450139629|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125141062|NCT00421304|450139630|FG000|Overall Study|Lost to Follow-up|5|||
125141063|NCT00421304|450139631|FG001|Overall Study|Lost to Follow-up|2|||
125141064|NCT00421304|450139632|FG002|Overall Study|Lost to Follow-up|5|||
125141065|NCT00421304|450139630|FG000|Overall Study|Withdrawal by Subject|2|||
125141066|NCT00421304|450139631|FG001|Overall Study|Withdrawal by Subject|2|||
125141067|NCT00421304|450139632|FG002|Overall Study|Withdrawal by Subject|2|||
125141068|NCT00421304|450139630|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
125141069|NCT00421304|450139631|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
125141070|NCT00421304|450139632|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
125141071|NCT00421304|450139630|FG000|Overall Study|Did not attend Day 360 visit|0|||
125141072|NCT00421304|450139631|FG001|Overall Study|Did not attend Day 360 visit|0|||
125141073|NCT00421304|450139632|FG002|Overall Study|Did not attend Day 360 visit|1|||
125141074|NCT03196284|450139633|FG000|Main Part|Withdrawal by Subject|0|||
125141075|NCT03196284|450139634|FG001|Main Part|Withdrawal by Subject|1|||
125141076|NCT03196284|450139635|FG002|Main Part|Withdrawal by Subject|0|||
125141077|NCT03196284|450139633|FG000|Extension Part|Lack of Efficacy|0|||
125141078|NCT03196284|450139634|FG001|Extension Part|Lack of Efficacy|0|||
125141079|NCT03196284|450139635|FG002|Extension Part|Lack of Efficacy|1|||
125141080|NCT03196284|450139633|FG000|Extension Part|Withdrawal by Subject|0|||
125141081|NCT03196284|450139634|FG001|Extension Part|Withdrawal by Subject|0|||
125141082|NCT03196284|450139635|FG002|Extension Part|Withdrawal by Subject|1|||
125141083|NCT03196284|450139633|FG000|Extension Part|Physician Decision|0|||
125141084|NCT03196284|450139634|FG001|Extension Part|Physician Decision|0|||
125141085|NCT03196284|450139635|FG002|Extension Part|Physician Decision|1|||
125141086|NCT02535923|450139640|FG000|Overall Study|Lost to Follow-up|5|||
125141087|NCT02535923|450139641|FG001|Overall Study|Lost to Follow-up|5|||
125141088|NCT02535923|450139640|FG000|Overall Study|Withdrawal by Subject|4|||
125141089|NCT02535923|450139641|FG001|Overall Study|Withdrawal by Subject|3|||
125141090|NCT01018862|450139642|FG000|Overall Study|Adverse Event|2|||
125141091|NCT01018862|450139643|FG001|Overall Study|Adverse Event|0|||
125141092|NCT01018862|450139644|FG002|Overall Study|Adverse Event|6|||
125141093|NCT01018862|450139642|FG000|Overall Study|Lack of Efficacy|1|||
125141094|NCT01018862|450139643|FG001|Overall Study|Lack of Efficacy|0|||
125141095|NCT01018862|450139644|FG002|Overall Study|Lack of Efficacy|2|||
125386647|NCT01190254|451050705|FG001|Overall Study|Did not meet protocol eligibility|0|||
125386648|NCT01190254|451050706|FG002|Overall Study|Did not meet protocol eligibility|0|||
125386649|NCT04729127|451050707|FG000|Overall Study|Suspended/Terminated EI Services|4|||
125141096|NCT01018862|450139642|FG000|Overall Study|Lost to Follow-up|3|||
125141097|NCT01018862|450139643|FG001|Overall Study|Lost to Follow-up|1|||
125141098|NCT01018862|450139644|FG002|Overall Study|Lost to Follow-up|0|||
125141099|NCT01018862|450139642|FG000|Overall Study|Protocol Violation|1|||
125141100|NCT01018862|450139643|FG001|Overall Study|Protocol Violation|3|||
125141101|NCT01018862|450139644|FG002|Overall Study|Protocol Violation|3|||
125141102|NCT01018862|450139642|FG000|Overall Study|Withdrawal by Subject|1|||
125141103|NCT01018862|450139643|FG001|Overall Study|Withdrawal by Subject|2|||
125141104|NCT01018862|450139644|FG002|Overall Study|Withdrawal by Subject|1|||
125141105|NCT01018862|450139642|FG000|Overall Study|administrative problems|5|||
125141106|NCT01018862|450139643|FG001|Overall Study|administrative problems|4|||
125141107|NCT01018862|450139644|FG002|Overall Study|administrative problems|4|||
125141108|NCT01968031|450139647|FG000|Overall Study|Adverse Event|13|||
125141109|NCT01968031|450139648|FG001|Overall Study|Adverse Event|10|||
125141110|NCT01968031|450139649|FG002|Overall Study|Adverse Event|22|||
125141111|NCT01968031|450139647|FG000|Overall Study|Withdrawal by Subject|3|||
125141112|NCT01968031|450139648|FG001|Overall Study|Withdrawal by Subject|7|||
125141113|NCT01968031|450139649|FG002|Overall Study|Withdrawal by Subject|3|||
125141114|NCT01968031|450139647|FG000|Overall Study|Did not meet entry criteria|1|||
125141115|NCT01968031|450139648|FG001|Overall Study|Did not meet entry criteria|1|||
125222900|NCT03316586|450444429|FG000|Overall Study|Patient needed radiation therapy|1|||
125222901|NCT03316586|450444429|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
125141116|NCT01968031|450139649|FG002|Overall Study|Did not meet entry criteria|1|||
125141117|NCT01968031|450139647|FG000|Overall Study|Noncompliance|0|||
125141118|NCT01968031|450139648|FG001|Overall Study|Noncompliance|0|||
125222902|NCT01396083|450444430|FG000|Overall Study|Adverse Event|2|||
125222903|NCT01396083|450444431|FG001|Overall Study|Adverse Event|28|||
125222904|NCT01396083|450444430|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125386650|NCT04729127|451050708|FG001|Overall Study|Suspended/Terminated EI Services|0|||
125386651|NCT04729127|451050709|FG002|Overall Study|Suspended/Terminated EI Services|4|||
125386652|NCT04729127|451050710|FG003|Overall Study|Suspended/Terminated EI Services|6|||
125386653|NCT04729127|451050711|FG004|Overall Study|Suspended/Terminated EI Services|0|||
125386654|NCT04729127|451050712|FG005|Overall Study|Suspended/Terminated EI Services|6|||
125386655|NCT04729127|451050713|FG006|Overall Study|Suspended/Terminated EI Services|2|||
125438426|NCT04986982|451232252|FG001|Overall Study|Adverse Event|4|||
125141119|NCT01968031|450139649|FG002|Overall Study|Noncompliance|2|||
125141120|NCT01968031|450139647|FG000|Overall Study|Failed inclusion criteria|0|||
125141121|NCT01968031|450139648|FG001|Overall Study|Failed inclusion criteria|2|||
125141122|NCT01968031|450139649|FG002|Overall Study|Failed inclusion criteria|0|||
125141123|NCT01968031|450139647|FG000|Overall Study|Death|0|||
125141124|NCT01968031|450139648|FG001|Overall Study|Death|0|||
125141125|NCT01968031|450139649|FG002|Overall Study|Death|1|||
125141126|NCT01968031|450139647|FG000|Overall Study|Prohibited concomitant medication|1|||
125141127|NCT01968031|450139648|FG001|Overall Study|Prohibited concomitant medication|0|||
125141128|NCT01968031|450139649|FG002|Overall Study|Prohibited concomitant medication|0|||
125141129|NCT00840879|450139653|FG000|Second Intervention|Withdrawal by Subject|1|||
125141130|NCT00840879|450139654|FG001|Second Intervention|Withdrawal by Subject|0|||
125141131|NCT01109849|450140856|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
125141132|NCT01109849|450140857|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
125141133|NCT01109849|450140858|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
125141134|NCT01109849|450140859|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
125141135|NCT01109849|450140860|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
125141136|NCT01109849|450140856|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
125141137|NCT01109849|450140857|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
125141138|NCT01109849|450140858|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
125141139|NCT01109849|450140859|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
125141140|NCT01109849|450140860|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
125141141|NCT01109849|450140856|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
125141142|NCT01109849|450140857|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
125141143|NCT01109849|450140858|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
125141144|NCT01109849|450140859|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
125141145|NCT01109849|450140860|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
125141146|NCT01109849|450140856|FG000|Initial Randomization: ADHD Treatment|move away|2|||
125141147|NCT01109849|450140857|FG001|Initial Randomization: ADHD Treatment|move away|7|||
125141148|NCT01109849|450140858|FG002|Initial Randomization: ADHD Treatment|move away|0|||
125141149|NCT01109849|450140859|FG003|Initial Randomization: ADHD Treatment|move away|0|||
125141150|NCT01109849|450140860|FG004|Initial Randomization: ADHD Treatment|move away|0|||
125141151|NCT01109849|450140856|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
125386656|NCT04729127|451050714|FG007|Overall Study|Suspended/Terminated EI Services|0|||
125386657|NCT04729127|451050715|FG008|Overall Study|Suspended/Terminated EI Services|2|||
125386658|NCT04729127|451050707|FG000|Overall Study|Withdrawal by Subject|1|||
125386659|NCT04729127|451050708|FG001|Overall Study|Withdrawal by Subject|0|||
125141152|NCT01109849|450140857|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
125141153|NCT01109849|450140858|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
125141154|NCT01109849|450140859|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
125141155|NCT01109849|450140860|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
125141156|NCT01109849|450140856|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
125141157|NCT01109849|450140857|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
125141158|NCT01109849|450140858|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
125141159|NCT01109849|450140859|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
125141160|NCT01109849|450140860|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
125141161|NCT00754052|450140867|FG000|Overall Study|Study terminated by Sponsor|5|||
125141162|NCT00754052|450140868|FG001|Overall Study|Study terminated by Sponsor|3|||
125141163|NCT04364854|450140872|FG000|Overall Study|Withdrawal by Subject|1|||
125141164|NCT04364854|450140873|FG001|Overall Study|Withdrawal by Subject|0|||
125141165|NCT04364854|450140874|FG002|Overall Study|Withdrawal by Subject|1|||
125141166|NCT04364854|450140875|FG003|Overall Study|Withdrawal by Subject|3|||
125141167|NCT04364854|450140872|FG000|Overall Study|Death|1|||
125386660|NCT04729127|451050709|FG002|Overall Study|Withdrawal by Subject|1|||
125141168|NCT04364854|450140873|FG001|Overall Study|Death|0|||
125386661|NCT04729127|451050710|FG003|Overall Study|Withdrawal by Subject|0|||
125141169|NCT04364854|450140874|FG002|Overall Study|Death|0|||
125141170|NCT04364854|450140875|FG003|Overall Study|Death|0|||
125141171|NCT04364854|450140872|FG000|Overall Study|Lost to Follow-up|0|||
125141172|NCT04364854|450140873|FG001|Overall Study|Lost to Follow-up|0|||
125141173|NCT04364854|450140874|FG002|Overall Study|Lost to Follow-up|0|||
125141174|NCT04364854|450140875|FG003|Overall Study|Lost to Follow-up|1|||
125141175|NCT02435433|450140876|FG000|Overall Study|Withdrawal by Subject|2|||
125141176|NCT02435433|450140877|FG001|Overall Study|Withdrawal by Subject|3|||
125141177|NCT02435433|450140878|FG002|Overall Study|Withdrawal by Subject|1|||
125141178|NCT02435433|450140879|FG003|Overall Study|Withdrawal by Subject|0|||
125141179|NCT02435433|450140880|FG004|Overall Study|Withdrawal by Subject|0|||
125141180|NCT02435433|450140876|FG000|Overall Study|Lost to Follow-up|2|||
125141181|NCT02435433|450140877|FG001|Overall Study|Lost to Follow-up|2|||
125141182|NCT02435433|450140878|FG002|Overall Study|Lost to Follow-up|4|||
125141183|NCT02435433|450140879|FG003|Overall Study|Lost to Follow-up|1|||
125141184|NCT02435433|450140880|FG004|Overall Study|Lost to Follow-up|0|||
125141185|NCT00659815|450140881|FG000|Overall Study|Study related symptoms and complaints|2|||
125141186|NCT00659815|450140882|FG001|Overall Study|Study related symptoms and complaints|1|||
125222905|NCT01396083|450444431|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
125222906|NCT01396083|450444430|FG000|Overall Study|Consent withdrawn|4|||
125222907|NCT01396083|450444431|FG001|Overall Study|Consent withdrawn|5|||
125222908|NCT01396083|450444430|FG000|Overall Study|Protocol deviation(s)|0|||
125222909|NCT01396083|450444431|FG001|Overall Study|Protocol deviation(s)|1|||
125222910|NCT01396083|450444430|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125222911|NCT01396083|450444431|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125222912|NCT01396083|450444430|FG000|Overall Study|Administrative problems|1|||
125222913|NCT01396083|450444431|FG001|Overall Study|Administrative problems|0|||
125222914|NCT01396083|450444430|FG000|Overall Study|Lost to Follow-up|1|||
125222915|NCT01396083|450444431|FG001|Overall Study|Lost to Follow-up|0|||
125222916|NCT02806713|450444432|FG000|Overall Study|Urethral injury during procedure|1|||
125222917|NCT02806713|450444433|FG001|Overall Study|Urethral injury during procedure|0|||
125222918|NCT02806713|450444432|FG000|Overall Study|cancelled surgery|1|||
125222919|NCT02806713|450444433|FG001|Overall Study|cancelled surgery|2|||
125222920|NCT00735709|450444434|FG000|Overall Study|Adverse Event|2|||
125222921|NCT00735709|450444435|FG001|Overall Study|Adverse Event|3|||
125222922|NCT00735709|450444436|FG002|Overall Study|Adverse Event|1|||
125222923|NCT00735709|450444437|FG003|Overall Study|Adverse Event|5|||
125141187|NCT00659815|450140881|FG000|Overall Study|Inability to maintain wearing schedule|1|||
125141188|NCT00659815|450140882|FG001|Overall Study|Inability to maintain wearing schedule|2|||
125141189|NCT00659815|450140881|FG000|Overall Study|Withdrawal by Subject|1|||
125222924|NCT00735709|450444434|FG000|Overall Study|Lack of Efficacy|8|||
125222925|NCT00735709|450444435|FG001|Overall Study|Lack of Efficacy|4|||
125141190|NCT00659815|450140882|FG001|Overall Study|Withdrawal by Subject|1|||
125141191|NCT02651987|450140883|FG000|Overall Study|Adverse Event|2|||
125141192|NCT02651987|450140884|FG001|Overall Study|Adverse Event|2|||
125141193|NCT02651987|450140883|FG000|Overall Study|Consent Withdrawn|2|||
125141194|NCT02651987|450140884|FG001|Overall Study|Consent Withdrawn|0|||
125141195|NCT02651987|450140883|FG000|Overall Study|Local PD|0|||
125141196|NCT02651987|450140884|FG001|Overall Study|Local PD|2|||
125141197|NCT02651987|450140883|FG000|Overall Study|Investigator Decision|1|||
125141198|NCT02651987|450140884|FG001|Overall Study|Investigator Decision|1|||
125141199|NCT00522041|450140885|FG000|Overall Study|Adverse Event|9|||
125141200|NCT00522041|450140886|FG001|Overall Study|Adverse Event|3|||
125141201|NCT00522041|450140885|FG000|Overall Study|Protocol Violation|2|||
125141202|NCT00522041|450140886|FG001|Overall Study|Protocol Violation|0|||
125141203|NCT00522041|450140885|FG000|Overall Study|Lost to Follow-up|1|||
125141204|NCT00522041|450140886|FG001|Overall Study|Lost to Follow-up|4|||
125141205|NCT00522041|450140885|FG000|Overall Study|Voluntary withdrawal|5|||
125141206|NCT00522041|450140886|FG001|Overall Study|Voluntary withdrawal|4|||
125141207|NCT00522041|450140885|FG000|Overall Study|Did not receive treatment|0|||
125141208|NCT00522041|450140886|FG001|Overall Study|Did not receive treatment|1|||
125141209|NCT03540160|450140887|FG000|Overall Study|Protocol Violation|1|||
125141210|NCT03540160|450140887|FG000|Overall Study|Physician Decision|8|||
125141211|NCT03540160|450140887|FG000|Overall Study|Lack of Efficacy|60|||
125141212|NCT03540160|450140887|FG000|Overall Study|Pregnancy|1|||
125141213|NCT03540160|450140887|FG000|Overall Study|Adverse Event|20|||
125141214|NCT03540160|450140887|FG000|Overall Study|Withdrawal by Subject|68|||
125141215|NCT03540160|450140887|FG000|Overall Study|COVID-19|2|||
125141216|NCT03540160|450140887|FG000|Overall Study|Study Closure|10|||
125141217|NCT03540160|450140887|FG000|Overall Study|Lost to Follow-up|18|||
125141218|NCT03540160|450140887|FG000|Overall Study|Sponsor decision|191|||
125141219|NCT01664039|450140888|FG000|Overall Study|Adverse Event|3|||
125141220|NCT01664039|450140889|FG001|Overall Study|Adverse Event|4|||
125141221|NCT01664039|450140888|FG000|Overall Study|Lost to Follow-up|1|||
125141222|NCT01664039|450140889|FG001|Overall Study|Lost to Follow-up|1|||
125141223|NCT01664039|450140888|FG000|Overall Study|Withdrawal by Subject|1|||
125141224|NCT01664039|450140889|FG001|Overall Study|Withdrawal by Subject|3|||
125141225|NCT01664039|450140888|FG000|Overall Study|Noncompliance|1|||
125141226|NCT01664039|450140889|FG001|Overall Study|Noncompliance|1|||
125141227|NCT02640235|450140895|FG000|Overall Study|Withdrawal by Subject|7|||
125141228|NCT02640235|450140896|FG001|Overall Study|Withdrawal by Subject|6|||
125141229|NCT02640235|450140895|FG000|Overall Study|Lost to Follow-up|4|||
125141230|NCT02640235|450140896|FG001|Overall Study|Lost to Follow-up|3|||
125141231|NCT02640235|450140895|FG000|Overall Study|Death|2|||
125141232|NCT02640235|450140896|FG001|Overall Study|Death|3|||
125141233|NCT02640235|450140895|FG000|Overall Study|Other|1|||
125438427|NCT04986982|451232251|FG000|Overall Study|Lost to Follow-up|0|||
125141234|NCT02640235|450140896|FG001|Overall Study|Other|2|||
125141235|NCT02372006|450140900|FG000|Overall Study|Progressive disease|8|||
125141236|NCT02372006|450140901|FG001|Overall Study|Progressive disease|7|||
125141237|NCT02372006|450140902|FG002|Overall Study|Progressive disease|34|||
125141238|NCT02372006|450140900|FG000|Overall Study|Dose limiting toxicity|0|||
125141239|NCT02372006|450140901|FG001|Overall Study|Dose limiting toxicity|1|||
125141240|NCT02372006|450140902|FG002|Overall Study|Dose limiting toxicity|0|||
125141241|NCT02372006|450140900|FG000|Overall Study|Adverse Event|0|||
125141242|NCT02372006|450140901|FG001|Overall Study|Adverse Event|0|||
125141243|NCT02372006|450140902|FG002|Overall Study|Adverse Event|3|||
125141244|NCT02372006|450140900|FG000|Overall Study|Withdrawal by Subject|0|||
125141245|NCT02372006|450140901|FG001|Overall Study|Withdrawal by Subject|1|||
125386662|NCT04729127|451050711|FG004|Overall Study|Withdrawal by Subject|0|||
125386663|NCT04729127|451050712|FG005|Overall Study|Withdrawal by Subject|0|||
125386664|NCT04729127|451050713|FG006|Overall Study|Withdrawal by Subject|0|||
125386665|NCT04729127|451050714|FG007|Overall Study|Withdrawal by Subject|0|||
125386666|NCT04729127|451050715|FG008|Overall Study|Withdrawal by Subject|0|||
125386667|NCT04729127|451050707|FG000|Overall Study|Switched Agency/Setting|1|||
125386668|NCT04729127|451050708|FG001|Overall Study|Switched Agency/Setting|0|||
125386669|NCT04729127|451050709|FG002|Overall Study|Switched Agency/Setting|1|||
125386670|NCT04729127|451050710|FG003|Overall Study|Switched Agency/Setting|1|||
125386671|NCT04729127|451050711|FG004|Overall Study|Switched Agency/Setting|0|||
125386672|NCT04729127|451050712|FG005|Overall Study|Switched Agency/Setting|1|||
125386673|NCT04729127|451050713|FG006|Overall Study|Switched Agency/Setting|1|||
125386674|NCT04729127|451050714|FG007|Overall Study|Switched Agency/Setting|0|||
125386675|NCT04729127|451050715|FG008|Overall Study|Switched Agency/Setting|1|||
125222926|NCT00735709|450444436|FG002|Overall Study|Lack of Efficacy|2|||
125386676|NCT00887354|451050716|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
125386677|NCT00887354|451050717|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
125386678|NCT00887354|451050716|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
125386679|NCT00887354|451050717|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
125386680|NCT00887354|451050716|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
125386681|NCT00887354|451050717|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
125438428|NCT04986982|451232252|FG001|Overall Study|Lost to Follow-up|1|||
125386682|NCT00887354|451050716|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
125386683|NCT00887354|451050717|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
125141246|NCT02372006|450140902|FG002|Overall Study|Withdrawal by Subject|1|||
125141247|NCT02372006|450140900|FG000|Overall Study|Other reason for not completing|0|||
125141248|NCT02372006|450140901|FG001|Overall Study|Other reason for not completing|0|||
125141249|NCT02372006|450140902|FG002|Overall Study|Other reason for not completing|1|||
125141250|NCT00467597|450140910|FG000|Overall Study|Withdrawal by Subject|2|||
125141251|NCT00467597|450140911|FG001|Overall Study|Withdrawal by Subject|0|||
125141252|NCT01046084|450140914|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
125141253|NCT01046084|450140915|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
125141254|NCT02166606|450140916|FG000|Overall Study|Adverse Event|3|||
125222927|NCT00735709|450444437|FG003|Overall Study|Lack of Efficacy|3|||
125222928|NCT00735709|450444434|FG000|Overall Study|Noncompliance|0|||
125222929|NCT00735709|450444435|FG001|Overall Study|Noncompliance|0|||
125222930|NCT00735709|450444436|FG002|Overall Study|Noncompliance|1|||
125222931|NCT00735709|450444437|FG003|Overall Study|Noncompliance|0|||
125222932|NCT00735709|450444434|FG000|Overall Study|Protocol deviations|1|||
125222933|NCT00735709|450444435|FG001|Overall Study|Protocol deviations|2|||
125222934|NCT00735709|450444436|FG002|Overall Study|Protocol deviations|1|||
125141255|NCT02166606|450140916|FG000|Overall Study|Death|31|||
125141256|NCT02166606|450140916|FG000|Overall Study|Protocol Violation|7|||
125141257|NCT02166606|450140916|FG000|Overall Study|Lost to Follow-up|30|||
125222935|NCT00735709|450444437|FG003|Overall Study|Protocol deviations|1|||
125222936|NCT00735709|450444434|FG000|Overall Study|Voluntary Withdrawal|1|||
125222937|NCT00735709|450444435|FG001|Overall Study|Voluntary Withdrawal|3|||
125222938|NCT00735709|450444436|FG002|Overall Study|Voluntary Withdrawal|5|||
125222939|NCT00735709|450444437|FG003|Overall Study|Voluntary Withdrawal|7|||
125222940|NCT00735709|450444434|FG000|Overall Study|Lost to Follow-up|0|||
125222941|NCT00735709|450444435|FG001|Overall Study|Lost to Follow-up|1|||
125386684|NCT00887354|451050716|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
125386685|NCT00887354|451050717|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
125386686|NCT00887354|451050716|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
125141258|NCT02166606|450140916|FG000|Overall Study|Withdrawal by Subject|1|||
125141259|NCT02166606|450140916|FG000|Overall Study|Physician Decision|1|||
125386687|NCT00887354|451050717|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
125386688|NCT00887354|451050716|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
125141260|NCT02166606|450140916|FG000|Overall Study|Device upgrade|1|||
125141261|NCT02166606|450140916|FG000|Overall Study|Enrolled after End of Enrollment|4|||
125141262|NCT01958476|450140917|FG000|Overall Study|Parent requested exclusion from analysis|1|||
125386689|NCT00887354|451050717|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
125386690|NCT00887354|451050716|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
125141263|NCT01958476|450140918|FG001|Overall Study|Parent requested exclusion from analysis|0|||
125141264|NCT05412121|450140921|FG000|Overall Study|Withdrawal by Subject|4|||
125141265|NCT05412121|450140921|FG000|Overall Study|Physician Decision|1|||
125141266|NCT05412121|450140921|FG000|Overall Study|Lost to Follow-up|5|||
125386691|NCT00887354|451050717|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
125141267|NCT02670551|450140922|FG000|Overall Study|Adverse Event|4|||
125141268|NCT02670551|450140923|FG001|Overall Study|Adverse Event|7|||
125141269|NCT02670551|450140924|FG002|Overall Study|Adverse Event|9|||
125141270|NCT02670551|450140922|FG000|Overall Study|Lack of Efficacy|2|||
125141271|NCT02670551|450140923|FG001|Overall Study|Lack of Efficacy|0|||
125141272|NCT02670551|450140924|FG002|Overall Study|Lack of Efficacy|3|||
125141273|NCT02670551|450140922|FG000|Overall Study|Withdrawal of Consent|6|||
125222942|NCT00735709|450444436|FG002|Overall Study|Lost to Follow-up|1|||
125222943|NCT00735709|450444437|FG003|Overall Study|Lost to Follow-up|1|||
125222944|NCT00735709|450444434|FG000|Overall Study|Excluded medication|1|||
125222945|NCT00735709|450444435|FG001|Overall Study|Excluded medication|0|||
125222946|NCT00735709|450444436|FG002|Overall Study|Excluded medication|0|||
125222947|NCT00735709|450444437|FG003|Overall Study|Excluded medication|1|||
125222948|NCT01165307|450444439|FG000|Overall Study|Lost to Follow-up|11|||
125222949|NCT01165307|450444440|FG001|Overall Study|Lost to Follow-up|3|||
125222950|NCT01165307|450444439|FG000|Overall Study|Withdrawal by Subject|2|||
125222951|NCT01165307|450444440|FG001|Overall Study|Withdrawal by Subject|0|||
125222952|NCT01165307|450444439|FG000|Overall Study|Subject not available for contact|1|||
125222953|NCT01165307|450444440|FG001|Overall Study|Subject not available for contact|0|||
125222954|NCT00521365|450444444|FG000|Overall Study|Adverse Event|3|||
125222955|NCT00521365|450444444|FG000|Overall Study|Lost to Follow-up|6|||
125222956|NCT00521365|450444444|FG000|Overall Study|Protocol deviation|2|||
125222957|NCT00521365|450444444|FG000|Overall Study|Drug compliance|3|||
125222958|NCT00521365|450444444|FG000|Overall Study|Usage of not allowed drugs|6|||
125222959|NCT03627832|450444445|FG000|Overall Study|Withdrawal by Subject|10|||
125222960|NCT03627832|450444446|FG001|Overall Study|Withdrawal by Subject|1|||
125222961|NCT03150082|450444447|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
125222962|NCT03150082|450444448|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
125222963|NCT01718483|450444449|FG000|Overall Study|Withdrawal by Subject|14|||
125222964|NCT01718483|450444450|FG001|Overall Study|Withdrawal by Subject|12|||
125222965|NCT01718483|450444449|FG000|Overall Study|Adverse Event|5|||
125222966|NCT01718483|450444450|FG001|Overall Study|Adverse Event|12|||
125222967|NCT01718483|450444449|FG000|Overall Study|Lost to Follow-up|8|||
125222968|NCT01718483|450444450|FG001|Overall Study|Lost to Follow-up|3|||
125222969|NCT01718483|450444449|FG000|Overall Study|Protocol Violation|4|||
125222970|NCT01718483|450444450|FG001|Overall Study|Protocol Violation|2|||
125222971|NCT01718483|450444449|FG000|Overall Study|Other|1|||
125222972|NCT01718483|450444450|FG001|Overall Study|Other|4|||
125222973|NCT01718483|450444449|FG000|Overall Study|Pregnancy|1|||
125222974|NCT01718483|450444450|FG001|Overall Study|Pregnancy|1|||
125222975|NCT01718483|450444449|FG000|Overall Study|Lack of Efficacy|1|||
125222976|NCT01718483|450444450|FG001|Overall Study|Lack of Efficacy|0|||
125222977|NCT01051557|450444453|FG000|Overall Study|Physician Decision|1|||
125222978|NCT01051557|450444454|FG001|Overall Study|Physician Decision|0|||
125222979|NCT01051557|450444455|FG002|Overall Study|Physician Decision|0|||
125222980|NCT01051557|450444456|FG003|Overall Study|Physician Decision|0|||
125222981|NCT01051557|450444457|FG004|Overall Study|Physician Decision|0|||
125222982|NCT01051557|450444458|FG005|Overall Study|Physician Decision|0|||
125222983|NCT01051557|450444459|FG006|Overall Study|Physician Decision|0|||
125222984|NCT01051557|450444453|FG000|Overall Study|disease progression|3|||
125222985|NCT01051557|450444454|FG001|Overall Study|disease progression|3|||
125222986|NCT01051557|450444455|FG002|Overall Study|disease progression|5|||
125222987|NCT01051557|450444456|FG003|Overall Study|disease progression|2|||
125222988|NCT01051557|450444457|FG004|Overall Study|disease progression|4|||
125222989|NCT01051557|450444458|FG005|Overall Study|disease progression|3|||
125222990|NCT01051557|450444459|FG006|Overall Study|disease progression|1|||
125222991|NCT01051557|450444453|FG000|Overall Study|Withdrawal by Subject|0|||
125222992|NCT01051557|450444454|FG001|Overall Study|Withdrawal by Subject|0|||
125222993|NCT01051557|450444455|FG002|Overall Study|Withdrawal by Subject|1|||
125222994|NCT01051557|450444456|FG003|Overall Study|Withdrawal by Subject|0|||
125222995|NCT01051557|450444457|FG004|Overall Study|Withdrawal by Subject|2|||
125222996|NCT01051557|450444458|FG005|Overall Study|Withdrawal by Subject|0|||
125222997|NCT01051557|450444459|FG006|Overall Study|Withdrawal by Subject|1|||
125222998|NCT01051557|450444453|FG000|Overall Study|Adverse Event|0|||
125141274|NCT02670551|450140923|FG001|Overall Study|Withdrawal of Consent|3|||
125141275|NCT02670551|450140924|FG002|Overall Study|Withdrawal of Consent|8|||
125141276|NCT02670551|450140922|FG000|Overall Study|Lost to Follow-up|5|||
125141277|NCT02670551|450140923|FG001|Overall Study|Lost to Follow-up|7|||
125141278|NCT02670551|450140924|FG002|Overall Study|Lost to Follow-up|6|||
125141279|NCT02670551|450140922|FG000|Overall Study|Protocol Violation|1|||
125141280|NCT02670551|450140923|FG001|Overall Study|Protocol Violation|0|||
125141281|NCT02670551|450140924|FG002|Overall Study|Protocol Violation|0|||
125141282|NCT02670551|450140922|FG000|Overall Study|Noncompliance with study drug|3|||
125141283|NCT02670551|450140923|FG001|Overall Study|Noncompliance with study drug|3|||
125141284|NCT02670551|450140924|FG002|Overall Study|Noncompliance with study drug|2|||
125141285|NCT02670551|450140922|FG000|Overall Study|Other Miscellaneous Reasons|2|||
125141286|NCT02670551|450140923|FG001|Overall Study|Other Miscellaneous Reasons|3|||
125141287|NCT02670551|450140924|FG002|Overall Study|Other Miscellaneous Reasons|3|||
125141288|NCT02670551|450140922|FG000|Overall Study|Did Not Receive Treatment|5|||
125141289|NCT02670551|450140923|FG001|Overall Study|Did Not Receive Treatment|3|||
125141290|NCT02670551|450140924|FG002|Overall Study|Did Not Receive Treatment|0|||
125141291|NCT04476277|450140925|FG000|Overall Study|Withdrawal by Subject|0|||
125141292|NCT04476277|450140926|FG001|Overall Study|Withdrawal by Subject|0|||
125141293|NCT04476277|450140927|FG002|Overall Study|Withdrawal by Subject|1|||
125141294|NCT04476277|450140928|FG003|Overall Study|Withdrawal by Subject|0|||
125141295|NCT01962298|450140929|FG000|Overall Study|Protocol Violation|1|||
125141296|NCT01962298|450140930|FG001|Overall Study|Protocol Violation|0|||
125141297|NCT01962298|450140931|FG002|Overall Study|Protocol Violation|1|||
125141298|NCT01962298|450140932|FG003|Overall Study|Protocol Violation|1|||
125141299|NCT01962298|450140933|FG004|Overall Study|Protocol Violation|0|||
125141300|NCT01962298|450140929|FG000|Overall Study|Data quality insufficient|2|||
125141301|NCT01962298|450140930|FG001|Overall Study|Data quality insufficient|0|||
125141302|NCT01962298|450140931|FG002|Overall Study|Data quality insufficient|3|||
125141303|NCT01962298|450140932|FG003|Overall Study|Data quality insufficient|1|||
125141304|NCT01962298|450140933|FG004|Overall Study|Data quality insufficient|4|||
125141305|NCT01962298|450140929|FG000|Overall Study|Insufficient data|0|||
125141306|NCT01962298|450140930|FG001|Overall Study|Insufficient data|2|||
125141307|NCT01962298|450140931|FG002|Overall Study|Insufficient data|1|||
125141308|NCT01962298|450140932|FG003|Overall Study|Insufficient data|0|||
125141309|NCT01962298|450140933|FG004|Overall Study|Insufficient data|1|||
125141310|NCT01962298|450140929|FG000|Overall Study|Incorrect data recorded|0|||
125141311|NCT01962298|450140930|FG001|Overall Study|Incorrect data recorded|1|||
125141312|NCT01962298|450140931|FG002|Overall Study|Incorrect data recorded|0|||
125141313|NCT01962298|450140932|FG003|Overall Study|Incorrect data recorded|0|||
125141314|NCT01962298|450140933|FG004|Overall Study|Incorrect data recorded|0|||
125141315|NCT01962298|450140929|FG000|Overall Study|Physician Decision|0|||
125141316|NCT01962298|450140930|FG001|Overall Study|Physician Decision|1|||
125141317|NCT01962298|450140931|FG002|Overall Study|Physician Decision|0|||
125141318|NCT01962298|450140932|FG003|Overall Study|Physician Decision|0|||
125141319|NCT01962298|450140933|FG004|Overall Study|Physician Decision|1|||
125141320|NCT01971645|450140934|FG000|Overall Study|Adverse Event|1|||
125222999|NCT01051557|450444454|FG001|Overall Study|Adverse Event|0|||
125223000|NCT01051557|450444455|FG002|Overall Study|Adverse Event|0|||
125223001|NCT01051557|450444456|FG003|Overall Study|Adverse Event|1|||
125223002|NCT01051557|450444457|FG004|Overall Study|Adverse Event|1|||
125223003|NCT01051557|450444458|FG005|Overall Study|Adverse Event|3|||
125223004|NCT01051557|450444459|FG006|Overall Study|Adverse Event|4|||
125223005|NCT04110314|450444460|FG000|Overall Study|Did not meet inclusion criteria|35255|||
125223006|NCT04110314|450444461|FG001|Overall Study|Did not meet inclusion criteria|35104|||
125223007|NCT04110314|450444462|FG002|Overall Study|Did not meet inclusion criteria|35636|||
125223008|NCT04110314|450444463|FG003|Overall Study|Did not meet inclusion criteria|35135|||
125223009|NCT04110314|450444464|FG004|Overall Study|Did not meet inclusion criteria|35247|||
125223010|NCT04110314|450444465|FG005|Overall Study|Did not meet inclusion criteria|35727|||
125223011|NCT01178125|450444472|FG000|Overall Study|Lost to Follow-up|397|||
125223012|NCT01178125|450444472|FG000|Overall Study|Adverse Event|244|||
125223013|NCT01178125|450444472|FG000|Overall Study|Withdrawal by Subject|209|||
125223014|NCT01178125|450444472|FG000|Overall Study|Noncompliance|184|||
125223015|NCT01178125|450444472|FG000|Overall Study|Pregnancy|55|||
125223016|NCT01178125|450444472|FG000|Overall Study|Other Reason|39|||
125223017|NCT01178125|450444472|FG000|Overall Study|Sponsor Decision|28|||
125223018|NCT01178125|450444472|FG000|Overall Study|Protocol Violation|17|||
125223019|NCT01178125|450444472|FG000|Overall Study|Investigator Decision|5|||
125223020|NCT02948829|450444473|FG000|Overall Study|Lost to Follow-up|2|||
125223021|NCT02948829|450444473|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
125223022|NCT02948829|450444473|FG000|Overall Study|Pregnancy|1|||
125223023|NCT02948829|450444473|FG000|Overall Study|Other: Reason not Specified|8|||
125223024|NCT01004978|450444474|FG000|Overall Study|Disease progression|31|||
125223025|NCT01004978|450444475|FG001|Overall Study|Disease progression|48|||
125223026|NCT01004978|450444474|FG000|Overall Study|Adverse Event|42|||
125223027|NCT01004978|450444475|FG001|Overall Study|Adverse Event|22|||
125223028|NCT01004978|450444474|FG000|Overall Study|Death|3|||
125223029|NCT01004978|450444475|FG001|Overall Study|Death|2|||
125223030|NCT01004978|450444474|FG000|Overall Study|Withdrawal by Subject|16|||
125223031|NCT01004978|450444475|FG001|Overall Study|Withdrawal by Subject|16|||
125223032|NCT01004978|450444474|FG000|Overall Study|Alternative therapy|4|||
125223033|NCT01004978|450444475|FG001|Overall Study|Alternative therapy|8|||
125223034|NCT01004978|450444474|FG000|Overall Study|Physician Decision|6|||
125223035|NCT01004978|450444475|FG001|Overall Study|Physician Decision|3|||
125223036|NCT01004978|450444474|FG000|Overall Study|Other complicating disease|2|||
125223037|NCT01004978|450444475|FG001|Overall Study|Other complicating disease|2|||
125223038|NCT01004978|450444474|FG000|Overall Study|Protocol Violation|2|||
125223039|NCT01004978|450444475|FG001|Overall Study|Protocol Violation|3|||
125223040|NCT01004978|450444474|FG000|Overall Study|Non-compliance|3|||
125223041|NCT01004978|450444475|FG001|Overall Study|Non-compliance|2|||
125223042|NCT01004978|450444474|FG000|Overall Study|Ineligible|1|||
125223043|NCT01004978|450444475|FG001|Overall Study|Ineligible|0|||
125223044|NCT01004978|450444474|FG000|Overall Study|Unblinded|0|||
125223045|NCT01004978|450444475|FG001|Overall Study|Unblinded|1|||
125223046|NCT01004978|450444474|FG000|Overall Study|Performance status worsening|0|||
125223047|NCT01004978|450444475|FG001|Overall Study|Performance status worsening|1|||
125223048|NCT01004978|450444474|FG000|Overall Study|Never started treatment|8|||
125223049|NCT01004978|450444475|FG001|Overall Study|Never started treatment|9|||
125223050|NCT00369915|450444476|FG000|Overall Study|expected side effects|2|||
125223051|NCT00369915|450444477|FG001|Overall Study|expected side effects|1|||
125223052|NCT00369915|450444476|FG000|Overall Study|Withdrawal by Subject|4|||
125223053|NCT00369915|450444477|FG001|Overall Study|Withdrawal by Subject|1|||
125223054|NCT00369915|450444476|FG000|Overall Study|W/drawl by investigators|0|||
125223055|NCT00369915|450444477|FG001|Overall Study|W/drawl by investigators|1|||
125223056|NCT01711983|450444478|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
125141321|NCT01971645|450140935|FG001|Overall Study|Adverse Event|0|||
125141322|NCT01971645|450140936|FG002|Overall Study|Adverse Event|0|||
125141323|NCT01971645|450140934|FG000|Overall Study|Lost to Follow-up|1|||
125141324|NCT01971645|450140935|FG001|Overall Study|Lost to Follow-up|0|||
125141325|NCT01971645|450140936|FG002|Overall Study|Lost to Follow-up|1|||
125386692|NCT00887354|451050716|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
125386693|NCT00887354|451050717|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
125141326|NCT01971645|450140934|FG000|Overall Study|Protocol Violation|0|||
125141327|NCT01971645|450140935|FG001|Overall Study|Protocol Violation|0|||
125141328|NCT01971645|450140936|FG002|Overall Study|Protocol Violation|1|||
125141329|NCT00537095|450140937|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
125141330|NCT00537095|450140938|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
125141331|NCT00537095|450140937|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
125141332|NCT00537095|450140938|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
125141333|NCT00537095|450140937|FG000|Randomized Treatment Period (433 Days)|Death|3|||
125141334|NCT00537095|450140938|FG001|Randomized Treatment Period (433 Days)|Death|1|||
125141335|NCT00537095|450140937|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
125141336|NCT00537095|450140938|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
125141337|NCT00537095|450140937|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
125141338|NCT00537095|450140938|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
125141339|NCT00537095|450140937|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
125141340|NCT00537095|450140938|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
125141341|NCT00537095|450140937|FG000|Open-label Period (590 Days)|Adverse Event|2|||
125141342|NCT00537095|450140938|FG001|Open-label Period (590 Days)|Adverse Event|11|||
125141343|NCT00537095|450140937|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
125141344|NCT00537095|450140938|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
125141345|NCT00537095|450140937|FG000|Open-label Period (590 Days)|Death|2|||
125141346|NCT00537095|450140938|FG001|Open-label Period (590 Days)|Death|2|||
125141347|NCT00537095|450140937|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
125141348|NCT00537095|450140938|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
125141349|NCT00537095|450140937|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
125141350|NCT00537095|450140938|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
125141351|NCT00533507|450140939|FG000|Overall Study|Withdrawal by Subject|1|||
125141352|NCT01576705|450140940|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
125141353|NCT01576705|450140941|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
125141354|NCT01576705|450140942|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
125141355|NCT01576705|450140943|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
125141356|NCT01576705|450140940|FG000|Overall Study|invalid ICF|0|||
125141357|NCT01576705|450140941|FG001|Overall Study|invalid ICF|1|||
125141358|NCT01576705|450140942|FG002|Overall Study|invalid ICF|0|||
125141359|NCT01576705|450140943|FG003|Overall Study|invalid ICF|0|||
125141360|NCT03727139|450140944|FG000|Overall Study|Protocol Violation|60|||
125386694|NCT00887354|451050716|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
125141361|NCT00566722|450140945|FG000|Overall Study|Adverse Event|0|||
125141362|NCT00566722|450140946|FG001|Overall Study|Adverse Event|1|||
125141363|NCT00566722|450140947|FG002|Overall Study|Adverse Event|0|||
125141364|NCT00566722|450140945|FG000|Overall Study|Withdrawal by Subject|0|||
125141365|NCT00566722|450140946|FG001|Overall Study|Withdrawal by Subject|0|||
125141366|NCT00566722|450140947|FG002|Overall Study|Withdrawal by Subject|1|||
125141367|NCT00566722|450140945|FG000|Overall Study|Lost to Follow-up|1|||
125141368|NCT00566722|450140946|FG001|Overall Study|Lost to Follow-up|1|||
125141369|NCT00566722|450140947|FG002|Overall Study|Lost to Follow-up|1|||
125141370|NCT00566722|450140945|FG000|Overall Study|Lack of Efficacy|1|||
125141371|NCT00566722|450140946|FG001|Overall Study|Lack of Efficacy|2|||
125141372|NCT00566722|450140947|FG002|Overall Study|Lack of Efficacy|4|||
125141373|NCT00566722|450140945|FG000|Overall Study|Did not meet exclusion criteria|0|||
125141374|NCT00566722|450140946|FG001|Overall Study|Did not meet exclusion criteria|0|||
125141375|NCT00566722|450140947|FG002|Overall Study|Did not meet exclusion criteria|2|||
125141376|NCT00566722|450140945|FG000|Overall Study|Serious adverse event|0|||
125141377|NCT00566722|450140946|FG001|Overall Study|Serious adverse event|1|||
125223057|NCT01711983|450444478|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
125223058|NCT01711983|450444478|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
125141378|NCT00566722|450140947|FG002|Overall Study|Serious adverse event|0|||
125141379|NCT00566722|450140945|FG000|Overall Study|Noncompliant with drug administration|0|||
125141380|NCT00566722|450140946|FG001|Overall Study|Noncompliant with drug administration|0|||
125141381|NCT00566722|450140947|FG002|Overall Study|Noncompliant with drug administration|1|||
125141382|NCT02896296|450140948|FG000|Overall Study|Adverse Event|1|||
125141383|NCT02896296|450140948|FG000|Overall Study|Lost to Follow-up|19|||
125141384|NCT02896296|450140948|FG000|Overall Study|Pregnancy|1|||
125141385|NCT02896296|450140948|FG000|Overall Study|Physician Decision|2|||
125141386|NCT02896296|450140948|FG000|Overall Study|Withdrawal by Subject|10|||
125141387|NCT02896296|450140948|FG000|Overall Study|Site closing|7|||
125141388|NCT02896296|450140948|FG000|Overall Study|Incarceration|1|||
125141389|NCT02896296|450140948|FG000|Overall Study|Relocation|1|||
125141390|NCT01874535|450140949|FG000|Overall Study|Lost to Follow-up|10|||
125141391|NCT01874535|450140950|FG001|Overall Study|Lost to Follow-up|9|||
125386695|NCT00887354|451050717|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
125141392|NCT01874535|450140949|FG000|Overall Study|incomplete symptom resolution|45|||
125141393|NCT01874535|450140950|FG001|Overall Study|incomplete symptom resolution|35|||
125141394|NCT02597049|450140951|FG000|Overall Study|Lost to Follow-up|0|||
125141395|NCT02597049|450140952|FG001|Overall Study|Lost to Follow-up|3|||
125141396|NCT02597049|450140953|FG002|Overall Study|Lost to Follow-up|2|||
125141397|NCT02597049|450140951|FG000|Overall Study|Withdrawal by Subject|2|||
125141398|NCT02597049|450140952|FG001|Overall Study|Withdrawal by Subject|2|||
125141399|NCT02597049|450140953|FG002|Overall Study|Withdrawal by Subject|1|||
125141400|NCT02597049|450140951|FG000|Overall Study|Adverse Event|2|||
125141401|NCT02597049|450140952|FG001|Overall Study|Adverse Event|0|||
125141402|NCT02597049|450140953|FG002|Overall Study|Adverse Event|0|||
125141403|NCT02597049|450140951|FG000|Overall Study|Death|2|||
125141404|NCT02597049|450140952|FG001|Overall Study|Death|0|||
125141405|NCT02597049|450140953|FG002|Overall Study|Death|0|||
125141406|NCT02597049|450140951|FG000|Overall Study|Noncompliant with Study Visits|1|||
125141407|NCT02597049|450140952|FG001|Overall Study|Noncompliant with Study Visits|0|||
125141408|NCT02597049|450140953|FG002|Overall Study|Noncompliant with Study Visits|0|||
125141409|NCT00243347|450140957|FG000|Overall Study|Lack of Efficacy|4|||
125141410|NCT00243347|450140957|FG000|Overall Study|Adverse Event|2|||
125141411|NCT00243347|450140957|FG000|Overall Study|Death|1|||
125141412|NCT00243347|450140957|FG000|Overall Study|Withdrawal by Subject|5|||
125141413|NCT00243347|450140957|FG000|Overall Study|Condition worsened|7|||
125141414|NCT01044433|450140958|FG000|Overall Study|Lost to Follow-up|3|||
125141415|NCT01044433|450140958|FG000|Overall Study|Withdrawal by Subject|3|||
125141416|NCT05065619|450140960|FG000|Up to Day 42|Lost to Follow-up|1|||
125141417|NCT05065619|450140961|FG001|Up to Day 42|Lost to Follow-up|0|||
125141418|NCT05065619|450140960|FG000|Up to Day 42|Withdrawal by Subject|1|||
125141419|NCT05065619|450140961|FG001|Up to Day 42|Withdrawal by Subject|0|||
125141420|NCT05065619|450140960|FG000|After Day 43|Lost to Follow-up|1|||
125141421|NCT05065619|450140961|FG001|After Day 43|Lost to Follow-up|0|||
125141422|NCT05065619|450140960|FG000|After Day 43|Physician Decision|3|||
125141423|NCT05065619|450140961|FG001|After Day 43|Physician Decision|0|||
125141424|NCT05065619|450140960|FG000|After Day 43|Withdrawal by Subject|1|||
125141425|NCT05065619|450140961|FG001|After Day 43|Withdrawal by Subject|2|||
125141426|NCT05065619|450140960|FG000|After Day 43|Public vaccination|6|||
125141427|NCT05065619|450140961|FG001|After Day 43|Public vaccination|8|||
125141428|NCT05065619|450140960|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
125141429|NCT05065619|450140961|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
125141430|NCT05065619|450140960|FG000|After Day 43|Study Terminated by Sponsor|88|||
125141431|NCT05065619|450140961|FG001|After Day 43|Study Terminated by Sponsor|16|||
125141432|NCT01390948|450140962|FG000|Overall Study|End of Study|1|||
125141433|NCT01390948|450140963|FG001|Overall Study|End of Study|0|||
125141434|NCT01390948|450140964|FG002|Overall Study|End of Study|0|||
125141435|NCT01390948|450140962|FG000|Overall Study|Withdrew consent|2|||
125141436|NCT01390948|450140963|FG001|Overall Study|Withdrew consent|2|||
125141437|NCT01390948|450140964|FG002|Overall Study|Withdrew consent|0|||
125141438|NCT01390948|450140962|FG000|Overall Study|Progressive Disease|2|||
125141439|NCT01390948|450140963|FG001|Overall Study|Progressive Disease|5|||
125141440|NCT01390948|450140964|FG002|Overall Study|Progressive Disease|0|||
125141441|NCT01390948|450140962|FG000|Overall Study|Death during follow-up|10|||
125141442|NCT01390948|450140963|FG001|Overall Study|Death during follow-up|11|||
125141443|NCT01390948|450140964|FG002|Overall Study|Death during follow-up|1|||
125141444|NCT05740098|450140967|FG000|Overall Study|Lost to Follow-up|26|||
125141445|NCT05740098|450140968|FG001|Overall Study|Lost to Follow-up|17|||
125141446|NCT05740098|450140969|FG002|Overall Study|Lost to Follow-up|21|||
125141447|NCT02452463|450140970|FG000|Overall Study|Death|1|||
125141448|NCT02452463|450140971|FG001|Overall Study|Death|0|||
125141449|NCT02452463|450140972|FG002|Overall Study|Death|0|||
125141450|NCT02452463|450140970|FG000|Overall Study|Study Suspended|1|||
125141451|NCT02452463|450140971|FG001|Overall Study|Study Suspended|0|||
125141452|NCT02452463|450140972|FG002|Overall Study|Study Suspended|0|||
125141453|NCT02452463|450140970|FG000|Overall Study|Recommended by DSMB|0|||
125223059|NCT01711983|450444478|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
125223060|NCT00268983|450444479|FG000|Overall Study|Death|3|||
125223061|NCT00268983|450444480|FG001|Overall Study|Death|0|||
125223062|NCT00321906|450444487|FG000|Overall Study|Adverse Event|36|||
125223063|NCT00321906|450444488|FG001|Overall Study|Adverse Event|44|||
125223064|NCT00321906|450444487|FG000|Overall Study|Death|9|||
125223065|NCT00321906|450444488|FG001|Overall Study|Death|6|||
125141454|NCT02452463|450140971|FG001|Overall Study|Recommended by DSMB|1|||
125141455|NCT02452463|450140972|FG002|Overall Study|Recommended by DSMB|0|||
125141456|NCT02452463|450140970|FG000|Overall Study|Withdrawal by Subject|0|||
125141457|NCT02452463|450140971|FG001|Overall Study|Withdrawal by Subject|1|||
125141458|NCT02452463|450140972|FG002|Overall Study|Withdrawal by Subject|0|||
125141459|NCT01528735|450140973|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
125141460|NCT01528735|450140974|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
125141461|NCT01528735|450140973|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
125141462|NCT01528735|450140974|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
125141463|NCT01401062|450140977|FG000|Overall Study|Death|9|||
125141464|NCT01401062|450140978|FG001|Overall Study|Death|7|||
125223066|NCT00321906|450444487|FG000|Overall Study|Lost to Follow-up|1|||
125141465|NCT01401062|450140977|FG000|Overall Study|Physician Decision|1|||
125141466|NCT01401062|450140978|FG001|Overall Study|Physician Decision|0|||
125141467|NCT01401062|450140977|FG000|Overall Study|Withdrawal by Subject|1|||
125141468|NCT01401062|450140978|FG001|Overall Study|Withdrawal by Subject|1|||
125141469|NCT00757172|450140979|FG000|Overall Study|Withdrawal by Subject|4|||
125141470|NCT00757172|450140979|FG000|Overall Study|Physician Decision|3|||
125141471|NCT00757172|450140979|FG000|Overall Study|Progression|4|||
125141472|NCT03555695|450140980|FG000|Overall Study|Withdrawal by Subject|1|||
125141473|NCT03555695|450140980|FG000|Overall Study|Lost to Follow-up|1|||
125141474|NCT03555695|450140980|FG000|Overall Study|appendicitis (unrelated)|1|||
125141475|NCT03555695|450140980|FG000|Overall Study|pre-existing sciatica|1|||
125141476|NCT04194151|450140981|FG000|Overall Study|Physician Decision|1|||
125141477|NCT04194151|450140982|FG001|Overall Study|Physician Decision|1|||
125141478|NCT04194151|450140983|FG002|Overall Study|Physician Decision|1|||
125141479|NCT04194151|450140984|FG003|Overall Study|Physician Decision|1|||
125141480|NCT04194151|450140985|FG004|Overall Study|Physician Decision|0|||
125141481|NCT04194151|450140986|FG005|Overall Study|Physician Decision|1|||
125141482|NCT04194151|450140981|FG000|Overall Study|Monitorization problem|0|||
125141483|NCT04194151|450140982|FG001|Overall Study|Monitorization problem|1|||
125141484|NCT04194151|450140983|FG002|Overall Study|Monitorization problem|0|||
125141485|NCT04194151|450140984|FG003|Overall Study|Monitorization problem|0|||
125141486|NCT04194151|450140985|FG004|Overall Study|Monitorization problem|0|||
125223067|NCT00321906|450444488|FG001|Overall Study|Lost to Follow-up|2|||
125223068|NCT00321906|450444487|FG000|Overall Study|Withdrawal by Subject|0|||
125223069|NCT00321906|450444488|FG001|Overall Study|Withdrawal by Subject|4|||
125141487|NCT04194151|450140986|FG005|Overall Study|Monitorization problem|0|||
125141488|NCT04203823|450140988|FG000|Overall Study|Withdrawal by Subject|2|||
125141489|NCT04203823|450140989|FG001|Overall Study|Withdrawal by Subject|2|||
125141490|NCT04203823|450140988|FG000|Overall Study|Adverse Event|1|||
125141491|NCT04203823|450140989|FG001|Overall Study|Adverse Event|1|||
125141492|NCT04203823|450140988|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125141493|NCT04203823|450140989|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
125141494|NCT01499043|450140990|FG000|Overall Study|Progressive disease (radiographic)|2|||
125141495|NCT01499043|450140990|FG000|Overall Study|Progressive disease (clinical)|1|||
125141496|NCT01499043|450140990|FG000|Overall Study|Withdrawal by Subject|2|||
125141497|NCT01499043|450140990|FG000|Overall Study|Adverse Event|1|||
125141498|NCT00438633|450140991|FG000|Overall Study|Withdrawal by Subject|1|||
125141499|NCT00438633|450140992|FG001|Overall Study|Withdrawal by Subject|0|||
125141500|NCT00438633|450140991|FG000|Overall Study|Lost to Follow-up|15|||
125141501|NCT00438633|450140992|FG001|Overall Study|Lost to Follow-up|17|||
125141502|NCT01912807|450140993|FG000|Overall Study|Did not meet elegibility criteria|6|||
125141503|NCT01912807|450140994|FG001|Overall Study|Did not meet elegibility criteria|4|||
125141504|NCT01912807|450140993|FG000|Overall Study|Lost to Follow-up|36|||
125141505|NCT01912807|450140994|FG001|Overall Study|Lost to Follow-up|37|||
125141506|NCT03506633|450142983|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
125141507|NCT03506633|450142984|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
125141508|NCT01894230|450142985|FG000|Overall Study|Lost to Follow-up|2|||
125141509|NCT01894230|450142986|FG001|Overall Study|Lost to Follow-up|2|||
125141510|NCT01894230|450142985|FG000|Overall Study|Withdrawal by Subject|4|||
125141511|NCT01894230|450142986|FG001|Overall Study|Withdrawal by Subject|4|||
125141512|NCT01894230|450142985|FG000|Overall Study|Non-adherent|0|||
125141513|NCT01894230|450142986|FG001|Overall Study|Non-adherent|1|||
125141514|NCT01894230|450142985|FG000|Overall Study|Death|1|||
125141515|NCT01894230|450142986|FG001|Overall Study|Death|0|||
125141516|NCT00640393|450142988|FG000|Part 1|Lost to Follow-up|2|||
125141517|NCT00640393|450142989|FG001|Part 1|Lost to Follow-up|0|||
125223070|NCT01272908|450444489|FG000|Initial Treatment Period|Adverse Event|1|||
125223071|NCT01272908|450444489|FG000|Initial Treatment Period|Lack of Efficacy|5|||
125223072|NCT01272908|450444489|FG000|Initial Treatment Period|Protocol Violation|1|||
125223073|NCT01272908|450444489|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
125223074|NCT01272908|450444489|FG000|Re-Treatment Period|Adverse Event|2|||
125223075|NCT01272908|450444489|FG000|Re-Treatment Period|Lack of Efficacy|3|||
125141518|NCT00640393|450142990|FG002|Part 1|Lost to Follow-up|0|||
125141519|NCT00640393|450142988|FG000|Part 1|Withdrawal by Subject|3|||
125141520|NCT00640393|450142989|FG001|Part 1|Withdrawal by Subject|0|||
125141521|NCT00640393|450142990|FG002|Part 1|Withdrawal by Subject|0|||
125223076|NCT01272908|450444489|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
125223077|NCT01158261|450444490|FG000|Overall Study|Lost to Follow-up|9|||
125223078|NCT01158261|450444490|FG000|Overall Study|Death|7|||
125141522|NCT00640393|450142988|FG000|Randomization|Withdrawn per protocol|17|||
125141523|NCT00640393|450142989|FG001|Randomization|Withdrawn per protocol|0|||
125141524|NCT00640393|450142990|FG002|Randomization|Withdrawn per protocol|0|||
125141525|NCT00640393|450142988|FG000|Randomization|Never randomized by site|2|||
125141526|NCT00640393|450142989|FG001|Randomization|Never randomized by site|0|||
125141527|NCT00640393|450142990|FG002|Randomization|Never randomized by site|0|||
125141528|NCT00640393|450142988|FG000|Part 2|Lost to Follow-up|0|||
125141529|NCT00640393|450142989|FG001|Part 2|Lost to Follow-up|2|||
125141530|NCT00640393|450142990|FG002|Part 2|Lost to Follow-up|2|||
125141531|NCT00640393|450142988|FG000|Part 2|Withdrawal by Subject|0|||
125141532|NCT00640393|450142989|FG001|Part 2|Withdrawal by Subject|6|||
125141533|NCT00640393|450142990|FG002|Part 2|Withdrawal by Subject|1|||
125141534|NCT00640393|450142988|FG000|Part 2|Non-adherence|0|||
125141535|NCT00640393|450142989|FG001|Part 2|Non-adherence|1|||
125141536|NCT00640393|450142990|FG002|Part 2|Non-adherence|0|||
125141537|NCT00640393|450142988|FG000|Part 2|Adverse Event|0|||
125141538|NCT00640393|450142989|FG001|Part 2|Adverse Event|1|||
125141539|NCT00640393|450142990|FG002|Part 2|Adverse Event|0|||
125141540|NCT00396162|450142996|FG000|Overall Study|Withdrawal by Subject|2|||
125141541|NCT00396162|450142997|FG001|Overall Study|Withdrawal by Subject|3|||
125141542|NCT03387462|450143000|FG000|Overall Study|Lost to Follow-up|1|||
125141543|NCT01460628|450143003|FG000|Overall Study|Adverse Event|3|||
125141544|NCT01460628|450143003|FG000|Overall Study|Withdrawal by Subject|2|||
125141545|NCT01944722|450143005|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
125141546|NCT01944722|450143005|FG000|Overall Study|Specimen Shipping Issues|34|||
125141547|NCT01944722|450143005|FG000|Overall Study|Improper Storage/Transport|5|||
125141548|NCT01944722|450143005|FG000|Overall Study|Insufficient Volume for Test|1|||
125141549|NCT01944722|450143005|FG000|Overall Study|Missing Specimens|3|||
125141550|NCT01944722|450143005|FG000|Overall Study|Specimens Mislabeled|2|||
125141551|NCT01944722|450143005|FG000|Overall Study|Withdrawal by Subject|8|||
125141552|NCT01944722|450143005|FG000|Overall Study|NILM Subjects <30 years old|8106|||
125141553|NCT01944722|450143005|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
125141554|NCT01944722|450143005|FG000|Overall Study|>ASCUS Cytology|1122|||
125141555|NCT00210639|450143006|FG000|Overall Study|Lost to Follow-up|37|||
125141556|NCT00210639|450143007|FG001|Overall Study|Lost to Follow-up|29|||
125141557|NCT00210639|450143006|FG000|Overall Study|Withdrawal by Subject|8|||
125141558|NCT00210639|450143007|FG001|Overall Study|Withdrawal by Subject|1|||
125141559|NCT00210639|450143006|FG000|Overall Study|Other|18|||
125141560|NCT00210639|450143007|FG001|Overall Study|Other|12|||
125141561|NCT02854800|450143009|FG000|Overall Study|Protocol Violation|16|||
125141562|NCT02854800|450143010|FG001|Overall Study|Protocol Violation|11|||
125141563|NCT02854800|450143011|FG002|Overall Study|Protocol Violation|3|||
125141564|NCT02854800|450143009|FG000|Overall Study|Withdrawal by Subject|4|||
125141565|NCT02854800|450143010|FG001|Overall Study|Withdrawal by Subject|2|||
125141566|NCT02854800|450143011|FG002|Overall Study|Withdrawal by Subject|3|||
125141567|NCT02627963|450143017|FG000|Overall Study|Randomized but not treated|2|||
125141568|NCT02627963|450143018|FG001|Overall Study|Randomized but not treated|6|||
125141569|NCT00152451|450143021|FG000|Overall Study|Adverse Event|4|||
125141570|NCT00503867|450143024|FG000|Overall Study|Lost to Follow-up|1|||
125141571|NCT00503867|450143024|FG000|Overall Study|Adverse Event|1|||
125141572|NCT04697173|450143027|FG000|Overall Study|Withdrawal by Subject|34|||
125141573|NCT04697173|450143028|FG001|Overall Study|Withdrawal by Subject|38|||
125141574|NCT03807440|450143029|FG000|Overall Study|No documentation of index date 2|320|||
125141575|NCT03807440|450143029|FG000|Overall Study|No informed consent for index date 2|117|||
125141576|NCT00323258|450143030|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
125141577|NCT00323258|450143031|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
125141578|NCT00323258|450143030|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
125141579|NCT00323258|450143031|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
125141580|NCT00323258|450143030|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
125141581|NCT00323258|450143031|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
125141582|NCT00323258|450143030|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
125141583|NCT00323258|450143031|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
125141584|NCT00323258|450143030|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
125141585|NCT00323258|450143031|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
125141586|NCT00323258|450143030|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
125141587|NCT00323258|450143031|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
125141588|NCT00323258|450143030|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
125141589|NCT00323258|450143031|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
125141590|NCT01859598|450143044|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
125141591|NCT00354835|450143045|FG000|Overall Study|Death|1|||
125223079|NCT01158261|450444490|FG000|Overall Study|Withdrawal by Subject|1|||
125223080|NCT03143101|450444491|FG000|Overall Study|Withdrawal by Subject|0|||
125141592|NCT00354835|450143046|FG001|Overall Study|Death|1|||
125223081|NCT03143101|450444492|FG001|Overall Study|Withdrawal by Subject|1|||
125223082|NCT03143101|450444493|FG002|Overall Study|Withdrawal by Subject|0|||
125141593|NCT00354835|450143045|FG000|Overall Study|Physician Decision|8|||
125141594|NCT00354835|450143046|FG001|Overall Study|Physician Decision|13|||
125141595|NCT00354835|450143045|FG000|Overall Study|Withdrawal by Subject|2|||
125141596|NCT00354835|450143046|FG001|Overall Study|Withdrawal by Subject|1|||
125141597|NCT00354835|450143045|FG000|Overall Study|Ineligible|17|||
125141598|NCT00354835|450143046|FG001|Overall Study|Ineligible|16|||
125141599|NCT00354835|450143045|FG000|Overall Study|Disease progression or relapse|15|||
125141600|NCT00354835|450143046|FG001|Overall Study|Disease progression or relapse|22|||
125141601|NCT00354835|450143045|FG000|Overall Study|Adverse Event|6|||
125141602|NCT00354835|450143046|FG001|Overall Study|Adverse Event|0|||
125141603|NCT00354835|450143045|FG000|Overall Study|Refusal of further therapy|3|||
125141604|NCT00354835|450143046|FG001|Overall Study|Refusal of further therapy|8|||
125141605|NCT01968551|450143047|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
125141606|NCT01968551|450143048|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
125141607|NCT01968551|450143049|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
125141608|NCT01968551|450143047|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
125141609|NCT01968551|450143048|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
125141610|NCT01968551|450143049|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
125141611|NCT01968551|450143047|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
125141612|NCT01968551|450143048|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
125141613|NCT01968551|450143049|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
125141614|NCT01968551|450143047|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
125141615|NCT01968551|450143048|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
125141616|NCT01968551|450143049|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
125141617|NCT01968551|450143047|FG000|Extension Phase|Adverse Event|0|||
125141618|NCT01968551|450143048|FG001|Extension Phase|Adverse Event|0|||
125141619|NCT01968551|450143049|FG002|Extension Phase|Adverse Event|2|||
125141620|NCT01968551|450143047|FG000|Extension Phase|Death|0|||
125141621|NCT01968551|450143048|FG001|Extension Phase|Death|1|||
125141622|NCT01968551|450143049|FG002|Extension Phase|Death|0|||
125141623|NCT01968551|450143047|FG000|Extension Phase|Withdrew Consent|0|||
125141624|NCT01968551|450143048|FG001|Extension Phase|Withdrew Consent|0|||
125141625|NCT01968551|450143049|FG002|Extension Phase|Withdrew Consent|1|||
125141626|NCT01968551|450143047|FG000|Extension Phase|Lost to Follow-up|1|||
125141627|NCT01968551|450143048|FG001|Extension Phase|Lost to Follow-up|0|||
125141628|NCT01968551|450143049|FG002|Extension Phase|Lost to Follow-up|1|||
125141629|NCT00573313|450143052|FG000|Overall Study|Protocol Violation|5|||
125141630|NCT00573313|450143053|FG001|Overall Study|Protocol Violation|0|||
125141631|NCT00573313|450143054|FG002|Overall Study|Protocol Violation|6|||
125141632|NCT00573313|450143055|FG003|Overall Study|Protocol Violation|0|||
125141633|NCT03255980|450143056|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
125141634|NCT03255980|450143057|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
125141635|NCT03255980|450143058|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
125141636|NCT03255980|450143059|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
125141637|NCT03255980|450143056|FG000|Overall Study|Adverse Event|1|||
125141638|NCT03255980|450143057|FG001|Overall Study|Adverse Event|1|||
125141639|NCT03255980|450143058|FG002|Overall Study|Adverse Event|0|||
125141640|NCT03255980|450143059|FG003|Overall Study|Adverse Event|1|||
125141641|NCT03255980|450143056|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
125141642|NCT03255980|450143057|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
125141643|NCT03255980|450143058|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
125141644|NCT03255980|450143059|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
125141645|NCT03255980|450143056|FG000|Overall Study|Lost to Follow-up|1|||
125141646|NCT03255980|450143057|FG001|Overall Study|Lost to Follow-up|1|||
125141647|NCT03255980|450143058|FG002|Overall Study|Lost to Follow-up|0|||
125141648|NCT03255980|450143059|FG003|Overall Study|Lost to Follow-up|3|||
125141649|NCT03255980|450143056|FG000|Overall Study|Withdrawal by Subject|0|||
125141650|NCT03255980|450143057|FG001|Overall Study|Withdrawal by Subject|1|||
125141651|NCT03255980|450143058|FG002|Overall Study|Withdrawal by Subject|0|||
125141652|NCT03255980|450143059|FG003|Overall Study|Withdrawal by Subject|3|||
125141653|NCT01597791|450143060|FG000|Overall Study|Physician Decision|2|||
125141654|NCT01597791|450143061|FG001|Overall Study|Physician Decision|1|||
125141655|NCT01597791|450143060|FG000|Overall Study|Cesarean Section|6|||
125141656|NCT01597791|450143061|FG001|Overall Study|Cesarean Section|7|||
125141657|NCT01597791|450143060|FG000|Overall Study|Subject withdrawal|0|||
125141658|NCT01597791|450143061|FG001|Overall Study|Subject withdrawal|1|||
125141659|NCT01597791|450143060|FG000|Overall Study|Protocol Violation|0|||
125141660|NCT01597791|450143061|FG001|Overall Study|Protocol Violation|1|||
125141661|NCT02096705|450143066|FG000|Treatment|Adverse Event|6|||
125141662|NCT02096705|450143067|FG001|Treatment|Adverse Event|3|||
125141663|NCT02096705|450143066|FG000|Treatment|Subject request to discontinue treatment|1|||
125141664|NCT02096705|450143067|FG001|Treatment|Subject request to discontinue treatment|1|||
125141665|NCT02096705|450143066|FG000|Treatment|Withdrawal by Subject|1|||
125141666|NCT02096705|450143067|FG001|Treatment|Withdrawal by Subject|0|||
125141667|NCT02096705|450143066|FG000|Treatment|Other|1|||
125141668|NCT02096705|450143067|FG001|Treatment|Other|1|||
125141669|NCT02096705|450143066|FG000|Follow-up|Withdrawal by Subject|1|||
125141670|NCT02096705|450143067|FG001|Follow-up|Withdrawal by Subject|0|||
125141671|NCT02096705|450143066|FG000|Follow-up|Adverse Event|2|||
125141672|NCT02096705|450143067|FG001|Follow-up|Adverse Event|2|||
125141673|NCT02096705|450143066|FG000|Follow-up|Subjects not reporting status|1|||
125141674|NCT02096705|450143067|FG001|Follow-up|Subjects not reporting status|2|||
125141675|NCT01949532|450143068|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
125141676|NCT01949532|450143069|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
125141677|NCT00884390|450143070|FG000|Overall Study|Adverse Event|0|||
125141678|NCT00884390|450143071|FG001|Overall Study|Adverse Event|1|||
125141679|NCT00884390|450143070|FG000|Overall Study|Lost to Follow-up|0|||
125141680|NCT00884390|450143071|FG001|Overall Study|Lost to Follow-up|1|||
125141681|NCT00884390|450143070|FG000|Overall Study|Physician Decision|2|||
125223083|NCT03143101|450444491|FG000|Overall Study|Lost to Follow-up|2|||
125223084|NCT03143101|450444492|FG001|Overall Study|Lost to Follow-up|2|||
125141682|NCT00884390|450143071|FG001|Overall Study|Physician Decision|1|||
125141683|NCT00884390|450143070|FG000|Overall Study|Protocol Violation|4|||
125141684|NCT00884390|450143071|FG001|Overall Study|Protocol Violation|1|||
125141685|NCT00884390|450143070|FG000|Overall Study|Withdrawal by Subject|4|||
125141686|NCT00884390|450143071|FG001|Overall Study|Withdrawal by Subject|1|||
125141687|NCT00884390|450143070|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
125141688|NCT00884390|450143071|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
125141689|NCT00884390|450143070|FG000|Overall Study|Other|11|||
125141690|NCT00884390|450143071|FG001|Overall Study|Other|1|||
125141691|NCT02611323|450143075|FG000|Overall Study|Death|3|||
125141692|NCT02611323|450143076|FG001|Overall Study|Death|1|||
125141693|NCT02611323|450143077|FG002|Overall Study|Death|0|||
125141694|NCT02611323|450143078|FG003|Overall Study|Death|0|||
125141695|NCT02611323|450143079|FG004|Overall Study|Death|1|||
125141696|NCT02611323|450143080|FG005|Overall Study|Death|1|||
125141697|NCT02611323|450143081|FG006|Overall Study|Death|8|||
125141698|NCT02611323|450143082|FG007|Overall Study|Death|0|||
125141699|NCT02611323|450143083|FG008|Overall Study|Death|4|||
125141700|NCT02611323|450143084|FG009|Overall Study|Death|6|||
125438429|NCT04986982|451232251|FG000|Overall Study|Sponsor's discretion|1|||
125141701|NCT02611323|450143085|FG010|Overall Study|Death|26|||
125141702|NCT02611323|450143075|FG000|Overall Study|Lost to Follow-up|1|||
125141703|NCT02611323|450143076|FG001|Overall Study|Lost to Follow-up|0|||
125141704|NCT02611323|450143077|FG002|Overall Study|Lost to Follow-up|0|||
125141705|NCT02611323|450143078|FG003|Overall Study|Lost to Follow-up|0|||
125141706|NCT02611323|450143079|FG004|Overall Study|Lost to Follow-up|0|||
125141707|NCT02611323|450143080|FG005|Overall Study|Lost to Follow-up|0|||
125141708|NCT02611323|450143081|FG006|Overall Study|Lost to Follow-up|3|||
125141709|NCT02611323|450143082|FG007|Overall Study|Lost to Follow-up|0|||
125141710|NCT02611323|450143083|FG008|Overall Study|Lost to Follow-up|0|||
125141711|NCT02611323|450143084|FG009|Overall Study|Lost to Follow-up|0|||
125141712|NCT02611323|450143085|FG010|Overall Study|Lost to Follow-up|2|||
125141713|NCT02611323|450143075|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141714|NCT02611323|450143076|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141715|NCT02611323|450143077|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141716|NCT02611323|450143078|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141717|NCT02611323|450143079|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141718|NCT02611323|450143080|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141719|NCT02611323|450143081|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141720|NCT02611323|450143082|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141721|NCT02611323|450143083|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
125386696|NCT00887354|451050716|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
125386697|NCT00887354|451050717|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
125141722|NCT02611323|450143084|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
125141723|NCT02611323|450143085|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
125141724|NCT02611323|450143075|FG000|Overall Study|Progressive Disease|0|||
125141725|NCT02611323|450143076|FG001|Overall Study|Progressive Disease|0|||
125141726|NCT02611323|450143077|FG002|Overall Study|Progressive Disease|0|||
125141727|NCT02611323|450143078|FG003|Overall Study|Progressive Disease|0|||
125141728|NCT02611323|450143079|FG004|Overall Study|Progressive Disease|0|||
125141729|NCT02611323|450143080|FG005|Overall Study|Progressive Disease|0|||
125141730|NCT02611323|450143081|FG006|Overall Study|Progressive Disease|0|||
125141731|NCT02611323|450143082|FG007|Overall Study|Progressive Disease|0|||
125141732|NCT02611323|450143083|FG008|Overall Study|Progressive Disease|0|||
125141733|NCT02611323|450143084|FG009|Overall Study|Progressive Disease|0|||
125141734|NCT02611323|450143085|FG010|Overall Study|Progressive Disease|1|||
125141735|NCT02611323|450143075|FG000|Overall Study|Withdrawal by Subject|1|||
125141736|NCT02611323|450143076|FG001|Overall Study|Withdrawal by Subject|0|||
125141737|NCT02611323|450143077|FG002|Overall Study|Withdrawal by Subject|0|||
125141738|NCT02611323|450143078|FG003|Overall Study|Withdrawal by Subject|0|||
125141739|NCT02611323|450143079|FG004|Overall Study|Withdrawal by Subject|0|||
125141740|NCT02611323|450143080|FG005|Overall Study|Withdrawal by Subject|0|||
125141741|NCT02611323|450143081|FG006|Overall Study|Withdrawal by Subject|0|||
125141742|NCT02611323|450143082|FG007|Overall Study|Withdrawal by Subject|1|||
125141743|NCT02611323|450143083|FG008|Overall Study|Withdrawal by Subject|0|||
125141744|NCT02611323|450143084|FG009|Overall Study|Withdrawal by Subject|1|||
125141745|NCT02611323|450143085|FG010|Overall Study|Withdrawal by Subject|0|||
125141746|NCT01215721|450143086|FG000|Overall Study|Adverse Event|2|||
125141747|NCT00045162|450143087|FG000|Overall Study|Ineligible|12|||
125141748|NCT00045162|450143088|FG001|Overall Study|Ineligible|8|||
125141749|NCT00045162|450143087|FG000|Overall Study|Not treated|7|||
125141750|NCT00045162|450143088|FG001|Overall Study|Not treated|2|||
125141751|NCT00045162|450143087|FG000|Overall Study|Adverse Event|55|||
125141752|NCT00045162|450143088|FG001|Overall Study|Adverse Event|50|||
125141753|NCT00045162|450143087|FG000|Overall Study|Lack of Efficacy|32|||
125141754|NCT00045162|450143088|FG001|Overall Study|Lack of Efficacy|29|||
125141755|NCT00045162|450143087|FG000|Overall Study|Death|10|||
125141756|NCT00045162|450143088|FG001|Overall Study|Death|10|||
125141757|NCT00045162|450143087|FG000|Overall Study|Withdrawal by Subject|5|||
125386698|NCT00887354|451050716|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
125386699|NCT00887354|451050717|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
125386700|NCT00887354|451050716|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
125386701|NCT00887354|451050717|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
125386702|NCT00887354|451050716|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
125386703|NCT00887354|451050717|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
125141758|NCT00045162|450143088|FG001|Overall Study|Withdrawal by Subject|3|||
125141759|NCT00045162|450143087|FG000|Overall Study|Other|21|||
125141760|NCT00045162|450143088|FG001|Overall Study|Other|16|||
125141761|NCT01899053|450143089|FG000|Overall Study|Progressive Disease|4|||
125141762|NCT01899053|450143090|FG001|Overall Study|Progressive Disease|0|||
125141763|NCT01899053|450143091|FG002|Overall Study|Progressive Disease|3|||
125141764|NCT01899053|450143092|FG003|Overall Study|Progressive Disease|0|||
125141765|NCT01899053|450143093|FG004|Overall Study|Progressive Disease|3|||
125141766|NCT01899053|450143094|FG005|Overall Study|Progressive Disease|1|||
125141767|NCT01899053|450143095|FG006|Overall Study|Progressive Disease|1|||
125141768|NCT01899053|450143096|FG007|Overall Study|Progressive Disease|1|||
125141769|NCT01899053|450143097|FG008|Overall Study|Progressive Disease|4|||
125141770|NCT01899053|450143098|FG009|Overall Study|Progressive Disease|3|||
125141771|NCT01899053|450143099|FG010|Overall Study|Progressive Disease|12|||
125141772|NCT01899053|450143100|FG011|Overall Study|Progressive Disease|5|||
125141773|NCT01899053|450143101|FG012|Overall Study|Progressive Disease|8|||
125141774|NCT01899053|450143102|FG013|Overall Study|Progressive Disease|17|||
125141775|NCT01899053|450143089|FG000|Overall Study|Adverse Event|1|||
125141776|NCT01899053|450143090|FG001|Overall Study|Adverse Event|1|||
125141777|NCT01899053|450143091|FG002|Overall Study|Adverse Event|1|||
125141778|NCT01899053|450143092|FG003|Overall Study|Adverse Event|3|||
125141779|NCT01899053|450143093|FG004|Overall Study|Adverse Event|1|||
125141780|NCT01899053|450143094|FG005|Overall Study|Adverse Event|1|||
125141781|NCT01899053|450143095|FG006|Overall Study|Adverse Event|1|||
125141782|NCT01899053|450143096|FG007|Overall Study|Adverse Event|0|||
125141783|NCT01899053|450143097|FG008|Overall Study|Adverse Event|2|||
125141784|NCT01899053|450143098|FG009|Overall Study|Adverse Event|0|||
125141785|NCT01899053|450143099|FG010|Overall Study|Adverse Event|3|||
125141786|NCT01899053|450143100|FG011|Overall Study|Adverse Event|1|||
125141787|NCT01899053|450143101|FG012|Overall Study|Adverse Event|2|||
125141788|NCT01899053|450143102|FG013|Overall Study|Adverse Event|2|||
125141789|NCT01899053|450143089|FG000|Overall Study|Reason Not Specified|0|||
125141790|NCT01899053|450143090|FG001|Overall Study|Reason Not Specified|0|||
125141791|NCT01899053|450143091|FG002|Overall Study|Reason Not Specified|0|||
125141792|NCT01899053|450143092|FG003|Overall Study|Reason Not Specified|0|||
125141793|NCT01899053|450143093|FG004|Overall Study|Reason Not Specified|0|||
125141794|NCT01899053|450143094|FG005|Overall Study|Reason Not Specified|0|||
125141795|NCT01899053|450143095|FG006|Overall Study|Reason Not Specified|1|||
125141796|NCT01899053|450143096|FG007|Overall Study|Reason Not Specified|0|||
125141797|NCT01899053|450143097|FG008|Overall Study|Reason Not Specified|0|||
125141798|NCT01899053|450143098|FG009|Overall Study|Reason Not Specified|0|||
125141799|NCT01899053|450143099|FG010|Overall Study|Reason Not Specified|0|||
125141800|NCT01899053|450143100|FG011|Overall Study|Reason Not Specified|0|||
125141801|NCT01899053|450143101|FG012|Overall Study|Reason Not Specified|1|||
125141802|NCT01899053|450143102|FG013|Overall Study|Reason Not Specified|0|||
125141803|NCT01899053|450143089|FG000|Overall Study|Withdrawal by Subject|1|||
125141804|NCT01899053|450143090|FG001|Overall Study|Withdrawal by Subject|1|||
125141805|NCT01899053|450143091|FG002|Overall Study|Withdrawal by Subject|2|||
125141806|NCT01899053|450143092|FG003|Overall Study|Withdrawal by Subject|0|||
125141807|NCT01899053|450143093|FG004|Overall Study|Withdrawal by Subject|2|||
125141808|NCT01899053|450143094|FG005|Overall Study|Withdrawal by Subject|0|||
125141809|NCT01899053|450143095|FG006|Overall Study|Withdrawal by Subject|0|||
125141810|NCT01899053|450143096|FG007|Overall Study|Withdrawal by Subject|1|||
125141811|NCT01899053|450143097|FG008|Overall Study|Withdrawal by Subject|0|||
125141812|NCT01899053|450143098|FG009|Overall Study|Withdrawal by Subject|0|||
125141813|NCT01899053|450143099|FG010|Overall Study|Withdrawal by Subject|0|||
125141814|NCT01899053|450143100|FG011|Overall Study|Withdrawal by Subject|0|||
125141815|NCT01899053|450143101|FG012|Overall Study|Withdrawal by Subject|1|||
125141816|NCT01899053|450143102|FG013|Overall Study|Withdrawal by Subject|1|||
125141817|NCT01899053|450143089|FG000|Overall Study|Protocol Violation|0|||
125141818|NCT01899053|450143090|FG001|Overall Study|Protocol Violation|0|||
125141819|NCT01899053|450143091|FG002|Overall Study|Protocol Violation|1|||
125141820|NCT01899053|450143092|FG003|Overall Study|Protocol Violation|0|||
125141821|NCT01899053|450143093|FG004|Overall Study|Protocol Violation|0|||
125141822|NCT01899053|450143094|FG005|Overall Study|Protocol Violation|0|||
125141823|NCT01899053|450143095|FG006|Overall Study|Protocol Violation|0|||
125141824|NCT01899053|450143096|FG007|Overall Study|Protocol Violation|0|||
125386704|NCT00887354|451050716|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
125386705|NCT00887354|451050717|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
125141825|NCT01899053|450143097|FG008|Overall Study|Protocol Violation|0|||
125141826|NCT01899053|450143098|FG009|Overall Study|Protocol Violation|0|||
125141827|NCT01899053|450143099|FG010|Overall Study|Protocol Violation|0|||
125141828|NCT01899053|450143100|FG011|Overall Study|Protocol Violation|0|||
125141829|NCT01899053|450143101|FG012|Overall Study|Protocol Violation|0|||
125141830|NCT01899053|450143102|FG013|Overall Study|Protocol Violation|0|||
125141831|NCT01899053|450143089|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
125141832|NCT01899053|450143090|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
125141833|NCT01899053|450143091|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
125223085|NCT03143101|450444493|FG002|Overall Study|Lost to Follow-up|0|||
125223086|NCT01630135|450444495|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
125223087|NCT01630135|450444496|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
125223088|NCT03243305|450444499|FG000|Overall Study|Lost to Follow-up|250|||
125223089|NCT03243305|450444499|FG000|Overall Study|Withdrawal by Subject|170|||
125223090|NCT03243305|450444499|FG000|Overall Study|Pregnancy|104|||
125386706|NCT01365507|451050718|FG000|Overall Study|Withdrawal Criteria|8|||
125141834|NCT01899053|450143092|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141835|NCT01899053|450143093|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
125386707|NCT01365507|451050719|FG001|Overall Study|Withdrawal Criteria|5|||
125386708|NCT01365507|451050718|FG000|Overall Study|Unclassified|1|||
125141836|NCT01899053|450143094|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141837|NCT01899053|450143095|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141838|NCT01899053|450143096|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141839|NCT01899053|450143097|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141840|NCT01899053|450143098|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141841|NCT01899053|450143099|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
125141842|NCT01899053|450143100|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141843|NCT01899053|450143101|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141844|NCT01899053|450143102|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
125141845|NCT01899053|450143089|FG000|Overall Study|Symptomatic Deterioration|0|||
125141846|NCT01899053|450143090|FG001|Overall Study|Symptomatic Deterioration|0|||
125141847|NCT01899053|450143091|FG002|Overall Study|Symptomatic Deterioration|0|||
125141848|NCT01899053|450143092|FG003|Overall Study|Symptomatic Deterioration|0|||
125141849|NCT01899053|450143093|FG004|Overall Study|Symptomatic Deterioration|0|||
125141850|NCT01899053|450143094|FG005|Overall Study|Symptomatic Deterioration|1|||
125141851|NCT01899053|450143095|FG006|Overall Study|Symptomatic Deterioration|0|||
125141852|NCT01899053|450143096|FG007|Overall Study|Symptomatic Deterioration|1|||
125141853|NCT01899053|450143097|FG008|Overall Study|Symptomatic Deterioration|0|||
125141854|NCT01899053|450143098|FG009|Overall Study|Symptomatic Deterioration|0|||
125141855|NCT01899053|450143099|FG010|Overall Study|Symptomatic Deterioration|0|||
125141856|NCT01899053|450143100|FG011|Overall Study|Symptomatic Deterioration|1|||
125141857|NCT01899053|450143101|FG012|Overall Study|Symptomatic Deterioration|2|||
125141858|NCT01899053|450143102|FG013|Overall Study|Symptomatic Deterioration|0|||
125141859|NCT03105297|450143103|FG000|Baseline Phase (Day 1)|Other|21|||
125141860|NCT03105297|450143103|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
125141861|NCT03105297|450143103|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
125141862|NCT00714051|450143108|FG000|Overall Study|Withdrawal by Subject|1|||
125141863|NCT00714051|450143109|FG001|Overall Study|Withdrawal by Subject|0|||
125141864|NCT00714051|450143108|FG000|Overall Study|Death|0|||
125141865|NCT00714051|450143109|FG001|Overall Study|Death|1|||
125141866|NCT03868631|450143110|FG000|Baseline to Week 6|Adverse Event|0|||
125141867|NCT03868631|450143111|FG001|Baseline to Week 6|Adverse Event|3|||
125141868|NCT03868631|450143110|FG000|Baseline to Week 6|Protocol Violation|1|||
125141869|NCT03868631|450143111|FG001|Baseline to Week 6|Protocol Violation|1|||
125141870|NCT03868631|450143110|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
125141871|NCT03868631|450143111|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
125141872|NCT03868631|450143110|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
125141873|NCT03868631|450143111|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
125141874|NCT03868631|450143110|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
125141875|NCT03868631|450143111|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
125141876|NCT03868631|450143110|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
125141877|NCT03868631|450143111|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
125141878|NCT01929681|450143114|FG000|Overall Study|Withdrawal by Subject|1|||
125141879|NCT01929681|450143115|FG001|Overall Study|Withdrawal by Subject|0|||
125141880|NCT01929681|450143114|FG000|Overall Study|Physician Decision|1|||
125141881|NCT01929681|450143115|FG001|Overall Study|Physician Decision|1|||
125141882|NCT03250117|450143116|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
125141883|NCT03250117|450143117|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
125223091|NCT03243305|450444499|FG000|Overall Study|Non-Compliance with Study Drug|38|||
125223092|NCT03243305|450444499|FG000|Overall Study|Adverse Event|23|||
125223093|NCT03243305|450444499|FG000|Overall Study|No sexually active|26|||
125223094|NCT03243305|450444499|FG000|Overall Study|Physician Decision|22|||
125223095|NCT03243305|450444499|FG000|Overall Study|Protocol Violation|22|||
125141884|NCT03250117|450143118|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
125141885|NCT03250117|450143119|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
125141886|NCT01073631|450143122|FG000|Overall Study|Death|82|||
125141887|NCT01073631|450143122|FG000|Overall Study|Adverse Event|24|||
125141888|NCT01073631|450143122|FG000|Overall Study|Other|63|||
125141889|NCT01971554|450143123|FG000|Overall Study|Lost to Follow-up|1|||
125141890|NCT01971554|450143124|FG001|Overall Study|Lost to Follow-up|0|||
125141891|NCT01971554|450143125|FG002|Overall Study|Lost to Follow-up|0|||
125141892|NCT01971554|450143126|FG003|Overall Study|Lost to Follow-up|0|||
125141893|NCT01426854|450143127|FG000|Overall Study|Adverse Event|1|||
125141894|NCT01426854|450143128|FG001|Overall Study|Adverse Event|5|||
125141895|NCT01426854|450143127|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
125141896|NCT01426854|450143128|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
125141897|NCT01426854|450143127|FG000|Overall Study|Lost to Follow-up|3|||
125141898|NCT01426854|450143128|FG001|Overall Study|Lost to Follow-up|0|||
125141899|NCT01426854|450143127|FG000|Overall Study|Noncompliance|0|||
125141900|NCT01426854|450143128|FG001|Overall Study|Noncompliance|1|||
125141901|NCT01426854|450143127|FG000|Overall Study|Treatment Failure|0|||
125141902|NCT01426854|450143128|FG001|Overall Study|Treatment Failure|16|||
125141903|NCT01426854|450143127|FG000|Overall Study|Protocol Deviation|0|||
125141904|NCT01426854|450143128|FG001|Overall Study|Protocol Deviation|1|||
125141905|NCT01426854|450143127|FG000|Overall Study|Other|3|||
125141906|NCT01426854|450143128|FG001|Overall Study|Other|2|||
125141907|NCT01942135|450143134|FG000|Overall Study|Adverse Event|21|||
125141908|NCT01942135|450143135|FG001|Overall Study|Adverse Event|7|||
125141909|NCT01942135|450143134|FG000|Overall Study|Global Deterioration of Health Status|9|||
125141910|NCT01942135|450143135|FG001|Overall Study|Global Deterioration of Health Status|6|||
125141911|NCT01942135|450143134|FG000|Overall Study|Randomized Not Treated|2|||
125141912|NCT01942135|450143135|FG001|Overall Study|Randomized Not Treated|2|||
125141913|NCT01942135|450143134|FG000|Overall Study|Death|2|||
125141914|NCT01942135|450143135|FG001|Overall Study|Death|1|||
125141915|NCT01942135|450143134|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
125141916|NCT01942135|450143135|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
125141917|NCT01942135|450143134|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
125141918|NCT01942135|450143135|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
125141919|NCT01942135|450143134|FG000|Overall Study|Withdrawal by Subject|4|||
125141920|NCT01942135|450143135|FG001|Overall Study|Withdrawal by Subject|3|||
125141921|NCT01942135|450143134|FG000|Overall Study|Protocol Violation|1|||
125141922|NCT01942135|450143135|FG001|Overall Study|Protocol Violation|0|||
125141923|NCT01942135|450143134|FG000|Overall Study|Other|19|||
125141924|NCT01942135|450143135|FG001|Overall Study|Other|4|||
125141925|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
125223096|NCT03243305|450444499|FG000|Overall Study|Study method no longer primary method|12|||
125223097|NCT03243305|450444499|FG000|Overall Study|Study Terminated by Sponsor|1|||
125223098|NCT03243305|450444499|FG000|Overall Study|Early terminations|267|||
125223099|NCT01497067|450444505|FG000|Overall Study|Lost to Follow-up|56|||
125223100|NCT01497067|450444505|FG000|Overall Study|Adverse Event|3|||
125223101|NCT01497067|450444505|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
125223102|NCT01497067|450444505|FG000|Overall Study|Other|13|||
125386709|NCT01365507|451050719|FG001|Overall Study|Unclassified|4|||
125386710|NCT02794103|451050720|FG000|Overall Study|Loss to follow up due to high sedation|3|||
125386711|NCT00914810|451050721|FG000|Overall Study|Withdrawal by Subject|1|||
125386712|NCT00914810|451050722|FG001|Overall Study|Withdrawal by Subject|0|||
125386713|NCT00914810|451050721|FG000|Overall Study|Relocated out of state|1|||
125386714|NCT00914810|451050722|FG001|Overall Study|Relocated out of state|0|||
125386715|NCT00914810|451050721|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
125386716|NCT00914810|451050722|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
125386717|NCT04782856|451050725|FG000|Overall Study|Withdrawal by Subject|0|||
125386718|NCT04782856|451050726|FG001|Overall Study|Withdrawal by Subject|1|||
125386719|NCT01465022|451050727|FG000|Overall Study|Lost to Follow-up|15|||
125386720|NCT01465022|451050728|FG001|Overall Study|Lost to Follow-up|14|||
125386721|NCT01465022|451050729|FG002|Overall Study|Lost to Follow-up|0|||
125386722|NCT01465022|451050727|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
125386723|NCT01465022|451050728|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
125386724|NCT01465022|451050729|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
125386725|NCT01465022|451050727|FG000|Overall Study|Not Randomized|0|||
125386726|NCT01465022|451050728|FG001|Overall Study|Not Randomized|0|||
125386727|NCT01465022|451050729|FG002|Overall Study|Not Randomized|70|||
125141926|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
125141927|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
125141928|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
125141929|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
125141930|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
125141931|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
125141932|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
125141933|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
125141934|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
125141935|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
125141936|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
125141937|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
125141938|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
125141939|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
125141940|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
125223103|NCT01598610|450444508|FG000|Overall Study|Adverse Event|1|||
125223104|NCT04346199|450444509|FG000|Overall Study|Death|8|||
125223105|NCT04346199|450444510|FG001|Overall Study|Death|9|||
125223106|NCT04346199|450444509|FG000|Overall Study|Lost to Follow-up|0|||
125223107|NCT04346199|450444510|FG001|Overall Study|Lost to Follow-up|1|||
125223108|NCT04346199|450444509|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
125223109|NCT04346199|450444510|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
125223110|NCT04346199|450444509|FG000|Overall Study|Withdrawal by Subject|5|||
125223111|NCT04346199|450444510|FG001|Overall Study|Withdrawal by Subject|1|||
125223112|NCT00485069|450444511|FG000|Overall Study|Adverse Event|10|||
125141941|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
125141942|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
125141943|NCT00950300|450143136|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
125141944|NCT00950300|450143137|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
125141945|NCT00950300|450143136|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
125141946|NCT00950300|450143137|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
125141947|NCT00950300|450143136|FG000|TFFU Period|Death|4|||
125141948|NCT00950300|450143137|FG001|TFFU Period|Death|1|||
125141949|NCT00950300|450143136|FG000|TFFU Period|Refused Treatment|10|||
125141950|NCT00950300|450143137|FG001|TFFU Period|Refused Treatment|11|||
125141951|NCT00950300|450143136|FG000|TFFU Period|Failure to Return|16|||
125141952|NCT00950300|450143137|FG001|TFFU Period|Failure to Return|16|||
125141953|NCT00950300|450143136|FG000|TFFU Period|Recurrence of Disease|63|||
125141954|NCT00950300|450143137|FG001|TFFU Period|Recurrence of Disease|72|||
125141955|NCT00950300|450143136|FG000|TFFU Period|Other|4|||
125141956|NCT00950300|450143137|FG001|TFFU Period|Other|3|||
125141957|NCT00950300|450143136|FG000|SFU Period|Death|44|||
125141958|NCT00950300|450143137|FG001|SFU Period|Death|42|||
125141959|NCT00950300|450143136|FG000|SFU Period|Lost to Follow-up|30|||
125141960|NCT00950300|450143137|FG001|SFU Period|Lost to Follow-up|28|||
125141961|NCT00950300|450143136|FG000|SFU Period|Withdrawal by Subject|4|||
125141962|NCT00950300|450143137|FG001|SFU Period|Withdrawal by Subject|8|||
125141963|NCT01717040|450143138|FG000|Overall Study|Lost to Follow-up|2|||
125141964|NCT01717040|450143139|FG001|Overall Study|Lost to Follow-up|3|||
125141965|NCT01717040|450143138|FG000|Overall Study|Lack of Efficacy|1|||
125141966|NCT01717040|450143139|FG001|Overall Study|Lack of Efficacy|1|||
125141967|NCT01717040|450143138|FG000|Overall Study|Adverse Event|1|||
125141968|NCT01717040|450143139|FG001|Overall Study|Adverse Event|0|||
125141969|NCT01717040|450143138|FG000|Overall Study|Required Medication Change|0|||
125141970|NCT01717040|450143139|FG001|Overall Study|Required Medication Change|1|||
125141971|NCT01717040|450143138|FG000|Overall Study|New Substance Use Disorder|1|||
125141972|NCT01717040|450143139|FG001|Overall Study|New Substance Use Disorder|0|||
125141973|NCT00494013|450143140|FG000|Overall Study|Adverse Event|0|||
125141974|NCT00494013|450143141|FG001|Overall Study|Adverse Event|1|||
125141975|NCT00494013|450143140|FG000|Overall Study|Entry Criteria Not Met|1|||
125141976|NCT00494013|450143141|FG001|Overall Study|Entry Criteria Not Met|4|||
125141977|NCT00494013|450143140|FG000|Overall Study|Lost to Follow-up|5|||
125141978|NCT00494013|450143141|FG001|Overall Study|Lost to Follow-up|6|||
125141979|NCT00494013|450143140|FG000|Overall Study|Physician Decision|3|||
125141980|NCT00494013|450143141|FG001|Overall Study|Physician Decision|5|||
125141981|NCT00494013|450143140|FG000|Overall Study|Protocol Violation|8|||
125141982|NCT00494013|450143141|FG001|Overall Study|Protocol Violation|5|||
125141983|NCT00494013|450143140|FG000|Overall Study|Withdrawal by Subject|13|||
125141984|NCT00494013|450143141|FG001|Overall Study|Withdrawal by Subject|14|||
125141985|NCT00494013|450143140|FG000|Overall Study|Sponsor Decision|0|||
125141986|NCT00494013|450143141|FG001|Overall Study|Sponsor Decision|1|||
125223113|NCT00485069|450444512|FG001|Overall Study|Adverse Event|4|||
125223114|NCT00485069|450444511|FG000|Overall Study|Lack of Efficacy|2|||
125223115|NCT00485069|450444512|FG001|Overall Study|Lack of Efficacy|1|||
125223116|NCT00485069|450444511|FG000|Overall Study|Protocol Violation|0|||
125223117|NCT00485069|450444512|FG001|Overall Study|Protocol Violation|1|||
125223118|NCT00485069|450444511|FG000|Overall Study|Withdrawal by Subject|6|||
125386728|NCT01327300|451050730|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
125386729|NCT01327300|451050731|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
125386730|NCT03020823|451050732|FG000|Overall Study|Physician Decision|4|||
125386731|NCT03020823|451050732|FG000|Overall Study|Lack of Efficacy|4|||
125386732|NCT03020823|451050732|FG000|Overall Study|Adverse Event|2|||
125223119|NCT00485069|450444512|FG001|Overall Study|Withdrawal by Subject|6|||
125386733|NCT04307446|451050745|FG000|Overall Study|Lost to Follow-up|2|||
125141987|NCT04750239|450143142|FG000|Overall Study|Withdrawal by Subject|2|||
125141988|NCT04750239|450143142|FG000|Overall Study|Trial terminated by sponsor|1|||
125141989|NCT00903877|450143143|FG000|Overall Study|Did not meet study criteria|33|||
125141990|NCT00903877|450143143|FG000|Overall Study|Withdrawal by Subject|3|||
125141991|NCT00903877|450143143|FG000|Overall Study|Adverse Event|2|||
125141992|NCT00903877|450143143|FG000|Overall Study|Lost to Follow-up|1|||
125141993|NCT00903877|450143143|FG000|Overall Study|Participation put on hold|4|||
125141994|NCT00919711|450143144|FG000|Overall Study|Withdrawal by Subject|15|||
125223120|NCT02989402|450444513|FG000|Overall Study|Adverse event, or serious adverse event|4|||
125223121|NCT02989402|450444513|FG000|Overall Study|Death|2|||
125223122|NCT02989402|450444513|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
125223123|NCT02989402|450444513|FG000|Overall Study|Lost to Follow-up|8|||
125223124|NCT02989402|450444513|FG000|Overall Study|Patient no longer on monotherapy|1|||
125223125|NCT02989402|450444513|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
125223126|NCT02989402|450444513|FG000|Overall Study|Withdrawal by Subject|7|||
125223127|NCT02989402|450444513|FG000|Overall Study|Other|2|||
125223128|NCT03066830|450444514|FG000|Overall Study|At the Participant's own Request|16|||
125223129|NCT03066830|450444515|FG001|Overall Study|At the Participant's own Request|17|||
125223130|NCT03066830|450444514|FG000|Overall Study|Other|3|||
125223131|NCT03066830|450444515|FG001|Overall Study|Other|0|||
125223132|NCT03066830|450444514|FG000|Overall Study|Poor Compliance to Protocol|1|||
125223133|NCT03066830|450444515|FG001|Overall Study|Poor Compliance to Protocol|0|||
125223134|NCT03066830|450444514|FG000|Overall Study|Adverse Event|2|||
125223135|NCT03066830|450444515|FG001|Overall Study|Adverse Event|2|||
125223136|NCT03066830|450444514|FG000|Overall Study|Lost to Follow-up|11|||
125223137|NCT03066830|450444515|FG001|Overall Study|Lost to Follow-up|3|||
125223138|NCT02039778|450444517|FG000|Overall Study|Death|2|||
125223139|NCT02039778|450444517|FG000|Overall Study|Withdrawal by Subject|1|||
125223140|NCT02039778|450444517|FG000|Overall Study|Never started the protocol treatment|1|||
125223141|NCT00992017|450444533|FG000|Overall Study|Lost to Follow-up|2|||
125223142|NCT00992017|450444533|FG000|Overall Study|Withdrawal by Subject|2|||
125223143|NCT00992017|450444533|FG000|Overall Study|Unable to get to clinic|5|||
125223144|NCT00992017|450444533|FG000|Overall Study|Not adhere to study requirements|1|||
125223145|NCT02864407|450444534|FG000|Overall Study|Protocol Violation|3|||
125223146|NCT02864407|450444534|FG000|Overall Study|Lost to Follow-up|115|||
125223147|NCT02864407|450444534|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
125141995|NCT00919711|450143145|FG001|Overall Study|Withdrawal by Subject|7|||
125141996|NCT00919711|450143144|FG000|Overall Study|Adverse Event|13|||
125141997|NCT00919711|450143145|FG001|Overall Study|Adverse Event|3|||
125223148|NCT02864407|450444534|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
125386734|NCT04307446|451050746|FG001|Overall Study|Lost to Follow-up|0|||
125386735|NCT03257631|451050749|FG000|Overall Study|Death|1|||
125223149|NCT02864407|450444534|FG000|Overall Study|Consent prior to the contract date|1|||
125141998|NCT00919711|450143144|FG000|Overall Study|Other|1|||
125223150|NCT01827592|450444544|FG000|Overall Study|Adverse Event|11|||
125223151|NCT01827592|450444545|FG001|Overall Study|Adverse Event|9|||
125223152|NCT01827592|450444546|FG002|Overall Study|Adverse Event|2|||
125223153|NCT01827592|450444544|FG000|Overall Study|Physician Decision|0|||
125223154|NCT01827592|450444545|FG001|Overall Study|Physician Decision|2|||
125141999|NCT00919711|450143145|FG001|Overall Study|Other|2|||
125142000|NCT00919711|450143144|FG000|Overall Study|Administrative Decision|0|||
125142001|NCT00919711|450143145|FG001|Overall Study|Administrative Decision|1|||
125142002|NCT00919711|450143144|FG000|Overall Study|Lost to Follow-up|2|||
125142003|NCT00919711|450143145|FG001|Overall Study|Lost to Follow-up|0|||
125142004|NCT00919711|450143144|FG000|Overall Study|Death|1|||
125142005|NCT00919711|450143145|FG001|Overall Study|Death|0|||
125142006|NCT00919711|450143144|FG000|Overall Study|Noncompliance|1|||
125142007|NCT00919711|450143145|FG001|Overall Study|Noncompliance|0|||
125142008|NCT00087529|450143146|FG000|Overall Study|Death|1|||
125142009|NCT00087529|450143147|FG001|Overall Study|Death|0|||
125142010|NCT00087529|450143146|FG000|Overall Study|Adverse Event|0|||
125386736|NCT03257631|451050750|FG001|Overall Study|Death|0|||
125386737|NCT03257631|451050751|FG002|Overall Study|Death|1|||
125386738|NCT03257631|451050752|FG003|Overall Study|Death|1|||
125386739|NCT03257631|451050749|FG000|Overall Study|Progressive Disease|10|||
125386740|NCT03257631|451050750|FG001|Overall Study|Progressive Disease|9|||
125386741|NCT03257631|451050751|FG002|Overall Study|Progressive Disease|17|||
125386742|NCT03257631|451050752|FG003|Overall Study|Progressive Disease|8|||
125386743|NCT03257631|451050749|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125142011|NCT00087529|450143147|FG001|Overall Study|Adverse Event|8|||
125386744|NCT03257631|451050750|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125386745|NCT03257631|451050751|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
125142012|NCT00087529|450143146|FG000|Overall Study|Pregnancy|0|||
125142013|NCT00087529|450143147|FG001|Overall Study|Pregnancy|1|||
125142014|NCT00087529|450143146|FG000|Overall Study|Lost to Follow-up|2|||
125142015|NCT00087529|450143147|FG001|Overall Study|Lost to Follow-up|3|||
125142016|NCT00087529|450143146|FG000|Overall Study|Participant Decision|14|||
125142017|NCT00087529|450143147|FG001|Overall Study|Participant Decision|37|||
125142018|NCT00087529|450143146|FG000|Overall Study|Physician Decision|4|||
125142019|NCT00087529|450143147|FG001|Overall Study|Physician Decision|8|||
125142020|NCT00087529|450143146|FG000|Overall Study|Initiation of Excluded Therapy|0|||
125142021|NCT00087529|450143147|FG001|Overall Study|Initiation of Excluded Therapy|1|||
125142022|NCT00087529|450143146|FG000|Overall Study|Participant Noncompliance|0|||
125142023|NCT00087529|450143147|FG001|Overall Study|Participant Noncompliance|1|||
125223155|NCT01827592|450444546|FG002|Overall Study|Physician Decision|1|||
125142024|NCT00087529|450143146|FG000|Overall Study|Disease Progression|5|||
125142025|NCT00087529|450143147|FG001|Overall Study|Disease Progression|4|||
125223156|NCT01827592|450444544|FG000|Overall Study|Protocol Violation|2|||
125142026|NCT00087529|450143146|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
125142027|NCT00087529|450143147|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
125142028|NCT00685334|450143150|FG000|Overall Study|Withdrawal by Subject|5|||
125142029|NCT00685334|450143151|FG001|Overall Study|Withdrawal by Subject|6|||
125142030|NCT00685334|450143150|FG000|Overall Study|Lost to Follow-up|4|||
125142031|NCT00685334|450143151|FG001|Overall Study|Lost to Follow-up|0|||
125142032|NCT00685334|450143150|FG000|Overall Study|Chose to enter hospital|1|||
125142033|NCT00685334|450143151|FG001|Overall Study|Chose to enter hospital|1|||
125142034|NCT01891357|450143152|FG000|Overall Study|Protocol Violation|3|||
125142035|NCT04573309|450144458|FG000|Overall Study|Protocol Violation|1|||
125142036|NCT04573309|450144459|FG001|Overall Study|Protocol Violation|0|||
125142037|NCT02300987|450144460|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
125142038|NCT02300987|450144461|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
125142039|NCT02300987|450144460|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
125142040|NCT02300987|450144461|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
125223157|NCT01827592|450444545|FG001|Overall Study|Protocol Violation|1|||
125223158|NCT01827592|450444546|FG002|Overall Study|Protocol Violation|0|||
125386746|NCT03257631|451050752|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
125386747|NCT03257631|451050749|FG000|Overall Study|Adverse Event|0|||
125142041|NCT02300987|450144460|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
125142042|NCT02300987|450144461|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
125142043|NCT02300987|450144460|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
125386748|NCT03257631|451050750|FG001|Overall Study|Adverse Event|0|||
125386749|NCT03257631|451050751|FG002|Overall Study|Adverse Event|2|||
125386750|NCT03257631|451050752|FG003|Overall Study|Adverse Event|0|||
125386751|NCT01290666|451050760|FG000|Overall Study|Lost to Follow-up|11|||
125142044|NCT02300987|450144461|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
125142045|NCT02300987|450144460|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
125142046|NCT02300987|450144461|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
125142047|NCT02488109|450144462|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
125142048|NCT02488109|450144463|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
125142049|NCT02488109|450144462|FG000|12-month Follow-Up|Lost to Follow-up|4|||
125142050|NCT02488109|450144463|FG001|12-month Follow-Up|Lost to Follow-up|7|||
125142051|NCT03969641|450144464|FG000|Overall Study|Lost to Follow-up|5|||
125142052|NCT03969641|450144465|FG001|Overall Study|Lost to Follow-up|3|||
125142053|NCT03969641|450144464|FG000|Overall Study|Withdrawal by Subject|1|||
125142054|NCT03969641|450144465|FG001|Overall Study|Withdrawal by Subject|2|||
125142055|NCT03969641|450144464|FG000|Overall Study|Found to be ineligible|1|||
125142056|NCT03969641|450144465|FG001|Overall Study|Found to be ineligible|1|||
125142057|NCT03969641|450144464|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
125386752|NCT01290666|451050760|FG000|Overall Study|Withdrawal by Subject|23|||
125142058|NCT03969641|450144465|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
125142059|NCT03969641|450144464|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
125142060|NCT03969641|450144465|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
125142061|NCT03969641|450144464|FG000|Overall Study|Elective termination|0|||
125142062|NCT03969641|450144465|FG001|Overall Study|Elective termination|1|||
125142063|NCT01541215|450144466|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
125142064|NCT01541215|450144467|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
125142065|NCT01541215|450144466|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
125142066|NCT01541215|450144467|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
125142067|NCT01541215|450144466|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
125142068|NCT01541215|450144467|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
125142069|NCT01541215|450144466|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
125142070|NCT01541215|450144467|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
125142071|NCT01541215|450144466|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
125142072|NCT01541215|450144467|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
125142073|NCT01541215|450144466|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
125142074|NCT01541215|450144467|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
125386753|NCT01290666|451050760|FG000|Overall Study|Early Termination of Study|4|||
125386754|NCT02672423|451050768|FG000|Period 1|Adverse Event|0|||
125386755|NCT02672423|451050769|FG001|Period 1|Adverse Event|0|||
125386756|NCT02672423|451050770|FG002|Period 1|Adverse Event|0|||
125142075|NCT02658019|450144476|FG000|Overall Study|Adverse Event|1|||
125142076|NCT00820599|450144477|FG000|Overall Study|Death|129|||
125142077|NCT00820599|450144477|FG000|Overall Study|Withdrawal by Subject|2|||
125142078|NCT01098851|450144478|FG000|Overall Study|Equipment failure|1|||
125142079|NCT01098851|450144479|FG001|Overall Study|Equipment failure|0|||
125142080|NCT00452348|450144481|FG000|Overall Study|Adverse Event|6|||
125386757|NCT02672423|451050771|FG003|Period 1|Adverse Event|0|||
125142081|NCT00452348|450144482|FG001|Overall Study|Adverse Event|9|||
125142082|NCT00452348|450144481|FG000|Overall Study|Lack of Efficacy|10|||
125142083|NCT00452348|450144482|FG001|Overall Study|Lack of Efficacy|9|||
125142084|NCT00452348|450144481|FG000|Overall Study|Lost to Follow-up|14|||
125142085|NCT00452348|450144482|FG001|Overall Study|Lost to Follow-up|8|||
125142086|NCT00452348|450144481|FG000|Overall Study|Protocol Violation|22|||
125142087|NCT00452348|450144482|FG001|Overall Study|Protocol Violation|28|||
125142088|NCT00452348|450144481|FG000|Overall Study|Withdrawal by Subject|18|||
125142089|NCT00452348|450144482|FG001|Overall Study|Withdrawal by Subject|21|||
125386758|NCT02672423|451050772|FG004|Period 1|Adverse Event|1|||
125386759|NCT02672423|451050773|FG005|Period 1|Adverse Event|0|||
125386760|NCT02672423|451050774|FG006|Period 1|Adverse Event|0|||
125386761|NCT02672423|451050775|FG007|Period 1|Adverse Event|0|||
125386762|NCT02672423|451050776|FG008|Period 1|Adverse Event|0|||
125386763|NCT02672423|451050777|FG009|Period 1|Adverse Event|0|||
125386764|NCT02672423|451050768|FG000|Period 2|Withdrawal by Subject|0|||
125386765|NCT02672423|451050769|FG001|Period 2|Withdrawal by Subject|0|||
125386766|NCT02672423|451050770|FG002|Period 2|Withdrawal by Subject|1|||
125142090|NCT00452348|450144481|FG000|Overall Study|Other|9|||
125142091|NCT00452348|450144482|FG001|Overall Study|Other|9|||
125142092|NCT00960154|450144483|FG000|Overall Study|Study termination|25|||
125142093|NCT00960154|450144484|FG001|Overall Study|Study termination|25|||
125142094|NCT00486434|450144485|FG000|Overall Study|Withdrawal by Subject|34|||
125142095|NCT00486434|450144486|FG001|Overall Study|Withdrawal by Subject|39|||
125142096|NCT00486434|450144485|FG000|Overall Study|Adverse Event|118|||
125142097|NCT00486434|450144486|FG001|Overall Study|Adverse Event|44|||
125142098|NCT00486434|450144485|FG000|Overall Study|Protocol Violation|22|||
125142099|NCT00486434|450144486|FG001|Overall Study|Protocol Violation|21|||
125142100|NCT00486434|450144485|FG000|Overall Study|Lack of Efficacy|12|||
125142101|NCT00486434|450144486|FG001|Overall Study|Lack of Efficacy|19|||
125142102|NCT00486434|450144485|FG000|Overall Study|Lost to Follow-up|2|||
125142103|NCT00486434|450144486|FG001|Overall Study|Lost to Follow-up|3|||
125142104|NCT00486434|450144485|FG000|Overall Study|Death|1|||
125142105|NCT00486434|450144486|FG001|Overall Study|Death|2|||
125142106|NCT00486434|450144485|FG000|Overall Study|Personal reasons|5|||
125142107|NCT00486434|450144486|FG001|Overall Study|Personal reasons|6|||
125142108|NCT00544167|450144487|FG000|Overall Study|Adverse Event|21|||
125142109|NCT00544167|450144487|FG000|Overall Study|Physician Decision|8|||
125142110|NCT02725515|450144488|FG000|Overall Study|Refused infusion (no study treatment)|1|||
125142111|NCT02725515|450144489|FG001|Overall Study|Refused infusion (no study treatment)|0|||
125142112|NCT02725515|450144488|FG000|Overall Study|Loss of Improvement per Protocol|14|||
125142113|NCT02725515|450144489|FG001|Overall Study|Loss of Improvement per Protocol|25|||
125142114|NCT02725515|450144488|FG000|Overall Study|Withdrawal by Subject|2|||
125142115|NCT02725515|450144489|FG001|Overall Study|Withdrawal by Subject|1|||
125142116|NCT02725515|450144488|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125142117|NCT02725515|450144489|FG001|Overall Study|Non-Compliance With Study Drug|3|||
125142118|NCT02725515|450144488|FG000|Overall Study|Lost to Follow-up|1|||
125142119|NCT02725515|450144489|FG001|Overall Study|Lost to Follow-up|1|||
125142120|NCT02725515|450144488|FG000|Overall Study|Adverse Event|7|||
125142121|NCT02725515|450144489|FG001|Overall Study|Adverse Event|2|||
125142122|NCT02725515|450144488|FG000|Overall Study|No Documented Disease Improvement|0|||
125142123|NCT02725515|450144489|FG001|Overall Study|No Documented Disease Improvement|1|||
125223159|NCT01827592|450444544|FG000|Overall Study|Lost to Follow-up|1|||
125223160|NCT01827592|450444545|FG001|Overall Study|Lost to Follow-up|2|||
125223161|NCT01827592|450444546|FG002|Overall Study|Lost to Follow-up|2|||
125223162|NCT01827592|450444544|FG000|Overall Study|Withdrawal by Subject|12|||
125223163|NCT01827592|450444545|FG001|Overall Study|Withdrawal by Subject|11|||
125223164|NCT01827592|450444546|FG002|Overall Study|Withdrawal by Subject|11|||
125223165|NCT01827592|450444544|FG000|Overall Study|Patient's substantial non-compliance|1|||
125386767|NCT02672423|451050771|FG003|Period 2|Withdrawal by Subject|0|||
125386768|NCT02672423|451050772|FG004|Period 2|Withdrawal by Subject|0|||
125386769|NCT02672423|451050773|FG005|Period 2|Withdrawal by Subject|0|||
125386770|NCT02672423|451050774|FG006|Period 2|Withdrawal by Subject|0|||
125386771|NCT02672423|451050775|FG007|Period 2|Withdrawal by Subject|0|||
125386772|NCT02672423|451050776|FG008|Period 2|Withdrawal by Subject|0|||
125386773|NCT02672423|451050777|FG009|Period 2|Withdrawal by Subject|0|||
125386774|NCT02672423|451050768|FG000|Period 3|Withdrawal by Subject|0|||
125386775|NCT02672423|451050769|FG001|Period 3|Withdrawal by Subject|0|||
125386776|NCT02672423|451050770|FG002|Period 3|Withdrawal by Subject|0|||
125223166|NCT01827592|450444545|FG001|Overall Study|Patient's substantial non-compliance|1|||
125386777|NCT02672423|451050771|FG003|Period 3|Withdrawal by Subject|0|||
125386778|NCT02672423|451050772|FG004|Period 3|Withdrawal by Subject|0|||
125386779|NCT02672423|451050773|FG005|Period 3|Withdrawal by Subject|0|||
125386780|NCT02672423|451050774|FG006|Period 3|Withdrawal by Subject|0|||
125142124|NCT02725515|450144488|FG000|Overall Study|Completed Study Under Original Protocol|0|||
125142125|NCT02725515|450144489|FG001|Overall Study|Completed Study Under Original Protocol|1|||
125142126|NCT02725515|450144488|FG000|Overall Study|Lack of Response|0|||
125142127|NCT02725515|450144489|FG001|Overall Study|Lack of Response|1|||
125142128|NCT00874549|450144490|FG000|Overall Study|Adverse Event|0|||
125142129|NCT00874549|450144491|FG001|Overall Study|Adverse Event|0|||
125142130|NCT00874549|450144492|FG002|Overall Study|Adverse Event|1|||
125142131|NCT00874549|450144493|FG003|Overall Study|Adverse Event|0|||
125142132|NCT00874549|450144490|FG000|Overall Study|Protocol Violation|1|||
125142133|NCT00874549|450144491|FG001|Overall Study|Protocol Violation|0|||
125142134|NCT00874549|450144492|FG002|Overall Study|Protocol Violation|2|||
125142135|NCT00874549|450144493|FG003|Overall Study|Protocol Violation|1|||
125142136|NCT00874549|450144490|FG000|Overall Study|Lost to Follow-up|0|||
125142137|NCT00874549|450144491|FG001|Overall Study|Lost to Follow-up|0|||
125142138|NCT00874549|450144492|FG002|Overall Study|Lost to Follow-up|1|||
125142139|NCT00874549|450144493|FG003|Overall Study|Lost to Follow-up|0|||
125142140|NCT00874549|450144490|FG000|Overall Study|Withdrawal by Subject|0|||
125142141|NCT00874549|450144491|FG001|Overall Study|Withdrawal by Subject|1|||
125142142|NCT00874549|450144492|FG002|Overall Study|Withdrawal by Subject|0|||
125142143|NCT00874549|450144493|FG003|Overall Study|Withdrawal by Subject|1|||
125142144|NCT02998541|450144503|FG000|Overall Study|Adverse Event|4|||
125142145|NCT02998541|450144504|FG001|Overall Study|Adverse Event|5|||
125142146|NCT02998541|450144505|FG002|Overall Study|Adverse Event|1|||
125142147|NCT02998541|450144503|FG000|Overall Study|Protocol Violation|1|||
125142148|NCT02998541|450144504|FG001|Overall Study|Protocol Violation|0|||
125142149|NCT02998541|450144505|FG002|Overall Study|Protocol Violation|0|||
125142150|NCT02998541|450144503|FG000|Overall Study|Withdrawal by Subject|3|||
125142151|NCT02998541|450144504|FG001|Overall Study|Withdrawal by Subject|1|||
125142152|NCT02998541|450144505|FG002|Overall Study|Withdrawal by Subject|0|||
125142153|NCT02998541|450144503|FG000|Overall Study|Lost to Follow-up|0|||
125142154|NCT02998541|450144504|FG001|Overall Study|Lost to Follow-up|3|||
125142155|NCT02998541|450144505|FG002|Overall Study|Lost to Follow-up|1|||
125142156|NCT02998541|450144503|FG000|Overall Study|Physician Decision|0|||
125142157|NCT02998541|450144504|FG001|Overall Study|Physician Decision|0|||
125142158|NCT02998541|450144505|FG002|Overall Study|Physician Decision|3|||
125142159|NCT02998541|450144503|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125142160|NCT02998541|450144504|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125142161|NCT02998541|450144505|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
125142162|NCT01513239|450144506|FG000|Period 1: Main Phase|Adverse Event|1|||
125142163|NCT01513239|450144507|FG001|Period 1: Main Phase|Adverse Event|1|||
125142164|NCT01513239|450144508|FG002|Period 1: Main Phase|Adverse Event|2|||
125223167|NCT01827592|450444546|FG002|Overall Study|Patient's substantial non-compliance|6|||
125142165|NCT01513239|450144509|FG003|Period 1: Main Phase|Adverse Event|0|||
125142166|NCT01513239|450144510|FG004|Period 1: Main Phase|Adverse Event|0|||
125142167|NCT01513239|450144511|FG005|Period 1: Main Phase|Adverse Event|0|||
125142168|NCT01513239|450144506|FG000|Period 1: Main Phase|Death|29|||
125142169|NCT01513239|450144507|FG001|Period 1: Main Phase|Death|22|||
125142170|NCT01513239|450144508|FG002|Period 1: Main Phase|Death|32|||
125142171|NCT01513239|450144509|FG003|Period 1: Main Phase|Death|0|||
125386781|NCT02672423|451050775|FG007|Period 3|Withdrawal by Subject|1|||
125142172|NCT01513239|450144510|FG004|Period 1: Main Phase|Death|0|||
125142173|NCT01513239|450144511|FG005|Period 1: Main Phase|Death|0|||
125142174|NCT01513239|450144506|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
125142175|NCT01513239|450144507|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
125142176|NCT01513239|450144508|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
125142177|NCT01513239|450144509|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
125142178|NCT01513239|450144510|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
125142179|NCT01513239|450144511|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
125142180|NCT01513239|450144506|FG000|Period 1: Main Phase|Physician Decision|4|||
125142181|NCT01513239|450144507|FG001|Period 1: Main Phase|Physician Decision|4|||
125142182|NCT01513239|450144508|FG002|Period 1: Main Phase|Physician Decision|4|||
125142183|NCT01513239|450144509|FG003|Period 1: Main Phase|Physician Decision|0|||
125142184|NCT01513239|450144510|FG004|Period 1: Main Phase|Physician Decision|0|||
125142185|NCT01513239|450144511|FG005|Period 1: Main Phase|Physician Decision|0|||
125142186|NCT01513239|450144506|FG000|Period 1: Main Phase|Protocol Violation|2|||
125142187|NCT01513239|450144507|FG001|Period 1: Main Phase|Protocol Violation|2|||
125142188|NCT01513239|450144508|FG002|Period 1: Main Phase|Protocol Violation|2|||
125142189|NCT01513239|450144509|FG003|Period 1: Main Phase|Protocol Violation|0|||
125142190|NCT01513239|450144510|FG004|Period 1: Main Phase|Protocol Violation|0|||
125142191|NCT01513239|450144511|FG005|Period 1: Main Phase|Protocol Violation|0|||
125142192|NCT01513239|450144506|FG000|Period 1: Main Phase|Technical Problems|1|||
125142193|NCT01513239|450144507|FG001|Period 1: Main Phase|Technical Problems|2|||
125142194|NCT01513239|450144508|FG002|Period 1: Main Phase|Technical Problems|0|||
125142195|NCT01513239|450144509|FG003|Period 1: Main Phase|Technical Problems|0|||
125142196|NCT01513239|450144510|FG004|Period 1: Main Phase|Technical Problems|0|||
125142197|NCT01513239|450144511|FG005|Period 1: Main Phase|Technical Problems|0|||
125142198|NCT01513239|450144506|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
125142199|NCT01513239|450144507|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
125142200|NCT01513239|450144508|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
125142201|NCT01513239|450144509|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
125142202|NCT01513239|450144510|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
125142203|NCT01513239|450144511|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
125142204|NCT01513239|450144506|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
125142205|NCT01513239|450144507|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
125142206|NCT01513239|450144508|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
125142207|NCT01513239|450144509|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
125142208|NCT01513239|450144510|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
125142209|NCT01513239|450144511|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
125142210|NCT01513239|450144506|FG000|Period 2: 9 Month Extension Phase|Death|0|||
125142211|NCT01513239|450144507|FG001|Period 2: 9 Month Extension Phase|Death|0|||
125142212|NCT01513239|450144508|FG002|Period 2: 9 Month Extension Phase|Death|0|||
125142213|NCT01513239|450144509|FG003|Period 2: 9 Month Extension Phase|Death|2|||
125142214|NCT01513239|450144510|FG004|Period 2: 9 Month Extension Phase|Death|5|||
125142215|NCT01513239|450144511|FG005|Period 2: 9 Month Extension Phase|Death|2|||
125142216|NCT01513239|450144506|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
125142217|NCT01513239|450144507|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
125142218|NCT01513239|450144508|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
125142219|NCT01513239|450144509|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
125142220|NCT01513239|450144510|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
125142221|NCT01513239|450144511|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
125142222|NCT01513239|450144506|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
125142223|NCT01513239|450144507|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
125142224|NCT01513239|450144508|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
125142225|NCT01513239|450144509|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
125142226|NCT01513239|450144510|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
125142227|NCT01513239|450144511|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
125223168|NCT01827592|450444544|FG000|Overall Study|Trial terminated by Sponsor|47|||
125223169|NCT01827592|450444545|FG001|Overall Study|Trial terminated by Sponsor|53|||
125223170|NCT01827592|450444546|FG002|Overall Study|Trial terminated by Sponsor|51|||
125223171|NCT01827592|450444544|FG000|Overall Study|Others|0|||
125223172|NCT01827592|450444545|FG001|Overall Study|Others|1|||
125223173|NCT01827592|450444546|FG002|Overall Study|Others|3|||
125223174|NCT02493517|450444547|FG000|Overall Study|Protocol Violation|1|||
125223175|NCT02493517|450444548|FG001|Overall Study|Protocol Violation|2|||
125223176|NCT02493517|450444547|FG000|Overall Study|Withdrawal by Subject|1|||
125223177|NCT02493517|450444548|FG001|Overall Study|Withdrawal by Subject|2|||
125142228|NCT01513239|450144506|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
125142229|NCT01513239|450144507|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
125142230|NCT01513239|450144508|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
125142231|NCT01513239|450144509|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
125142232|NCT01513239|450144510|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
125223178|NCT02493517|450444547|FG000|Overall Study|Adverse Event|0|||
125142233|NCT01513239|450144511|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
125142234|NCT03167606|450144514|FG000|Overall Study|Lost to Follow-up|73|||
125142235|NCT03167606|450144515|FG001|Overall Study|Lost to Follow-up|64|||
125142236|NCT03167606|450144514|FG000|Overall Study|Withdrawal by Subject|6|||
125142237|NCT03167606|450144515|FG001|Overall Study|Withdrawal by Subject|5|||
125142238|NCT03167606|450144514|FG000|Overall Study|Withdrawal by Investigator|0|||
125142239|NCT03167606|450144515|FG001|Overall Study|Withdrawal by Investigator|2|||
125142240|NCT00059332|450144516|FG000|Overall Study|Withdrawal by Subject|2|||
125142241|NCT00059332|450144517|FG001|Overall Study|Withdrawal by Subject|1|||
125142242|NCT00059332|450144516|FG000|Overall Study|Lost to Follow-up|1|||
125142243|NCT00059332|450144517|FG001|Overall Study|Lost to Follow-up|1|||
125142244|NCT00413049|450144518|FG000|Overall Study|Adverse Event|10|||
125142245|NCT00413049|450144519|FG001|Overall Study|Adverse Event|8|||
125142246|NCT00413049|450144518|FG000|Overall Study|Withdrawal by Subject|7|||
125142247|NCT00413049|450144519|FG001|Overall Study|Withdrawal by Subject|5|||
125142248|NCT00413049|450144518|FG000|Overall Study|Lost to Follow-up|2|||
125142249|NCT00413049|450144519|FG001|Overall Study|Lost to Follow-up|3|||
125142250|NCT00413049|450144518|FG000|Overall Study|Protocol Violation|3|||
125142251|NCT00413049|450144519|FG001|Overall Study|Protocol Violation|1|||
125142252|NCT00413049|450144518|FG000|Overall Study|Subject no longer requires study drug|0|||
125142253|NCT00413049|450144519|FG001|Overall Study|Subject no longer requires study drug|1|||
125142254|NCT00413049|450144518|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125142255|NCT00413049|450144519|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125142256|NCT00413049|450144518|FG000|Overall Study|Lack of Efficacy|1|||
125142257|NCT00413049|450144519|FG001|Overall Study|Lack of Efficacy|0|||
125142258|NCT02587143|450144520|FG000|Overall Study|Adverse Event|1|||
125142259|NCT02587143|450144521|FG001|Overall Study|Adverse Event|0|||
125142260|NCT03314857|450144526|FG000|Overall Study|Death|4|||
125142261|NCT03314857|450144526|FG000|Overall Study|Physician Decision|1|||
125142262|NCT02906917|450144527|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
125142263|NCT02906917|450144528|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
125142264|NCT02906917|450144527|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
125142265|NCT02906917|450144528|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
125142266|NCT02906917|450144527|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
125142267|NCT02906917|450144528|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
125142268|NCT02906917|450144527|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
125142269|NCT02906917|450144528|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
125142270|NCT02906917|450144527|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
125142271|NCT02906917|450144528|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
125142272|NCT02906917|450144527|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
125142273|NCT02906917|450144528|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
125142274|NCT02906917|450144527|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
125142275|NCT02906917|450144528|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
125223179|NCT02493517|450444548|FG001|Overall Study|Adverse Event|2|||
125223180|NCT02493517|450444547|FG000|Overall Study|Missed study visit|0|||
125223181|NCT02493517|450444548|FG001|Overall Study|Missed study visit|1|||
125223182|NCT01817075|450444549|FG000|Overall Study|Adverse Event|7|||
125223183|NCT01817075|450444550|FG001|Overall Study|Adverse Event|5|||
125223184|NCT01817075|450444549|FG000|Overall Study|Physician Decision|9|||
125223185|NCT01817075|450444550|FG001|Overall Study|Physician Decision|12|||
125142276|NCT02906917|450144527|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
125142277|NCT02906917|450144528|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
125142278|NCT00874822|450144531|FG000|Overall Study|excluded by criteria|8|||
125142279|NCT04281472|450144533|FG000|Stage A|Lack of Efficacy|8|||
125142280|NCT04281472|450144534|FG001|Stage A|Lack of Efficacy|0|||
125142281|NCT04281472|450144535|FG002|Stage A|Lack of Efficacy|0|||
125142282|NCT04281472|450144533|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
125223186|NCT01817075|450444549|FG000|Overall Study|Withdrawal by Subject|31|||
125223187|NCT01817075|450444550|FG001|Overall Study|Withdrawal by Subject|15|||
125223188|NCT01817075|450444549|FG000|Overall Study|Received Sorafenib after enrollment|0|||
125142283|NCT04281472|450144534|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
125142284|NCT04281472|450144535|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
125142285|NCT04281472|450144533|FG000|Stage A|Adverse Event|20|||
125142286|NCT04281472|450144534|FG001|Stage A|Adverse Event|0|||
125142287|NCT04281472|450144535|FG002|Stage A|Adverse Event|0|||
125223189|NCT01817075|450444550|FG001|Overall Study|Received Sorafenib after enrollment|1|||
125223190|NCT01817075|450444549|FG000|Overall Study|Ineligible|0|||
125223191|NCT01817075|450444550|FG001|Overall Study|Ineligible|2|||
125223192|NCT00419757|450446130|FG000|Overall Study|Adverse Event|1|||
125142288|NCT04281472|450144533|FG000|Stage A|Death|1|||
125142289|NCT04281472|450144534|FG001|Stage A|Death|0|||
125142290|NCT04281472|450144535|FG002|Stage A|Death|0|||
125223193|NCT00419757|450446131|FG001|Overall Study|Adverse Event|4|||
125142291|NCT04281472|450144533|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
125142292|NCT04281472|450144534|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
125142293|NCT04281472|450144535|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
125142294|NCT04281472|450144533|FG000|Stage A|Lost to Follow-up|2|||
125142295|NCT04281472|450144534|FG001|Stage A|Lost to Follow-up|0|||
125142296|NCT04281472|450144535|FG002|Stage A|Lost to Follow-up|0|||
125142297|NCT04281472|450144533|FG000|Stage A|Non-compliance with study drug|1|||
125142298|NCT04281472|450144534|FG001|Stage A|Non-compliance with study drug|0|||
125386782|NCT02672423|451050776|FG008|Period 3|Withdrawal by Subject|0|||
125386783|NCT02672423|451050777|FG009|Period 3|Withdrawal by Subject|0|||
125386784|NCT02672423|451050768|FG000|Period 3|Physician Decision|0|||
125386785|NCT02672423|451050769|FG001|Period 3|Physician Decision|0|||
125142299|NCT04281472|450144535|FG002|Stage A|Non-compliance with study drug|0|||
125142300|NCT04281472|450144533|FG000|Stage A|Physician Decision|1|||
125142301|NCT04281472|450144534|FG001|Stage A|Physician Decision|0|||
125142302|NCT04281472|450144535|FG002|Stage A|Physician Decision|0|||
125142303|NCT04281472|450144533|FG000|Stage A|Prohibited medications|2|||
125142304|NCT04281472|450144534|FG001|Stage A|Prohibited medications|0|||
125142305|NCT04281472|450144535|FG002|Stage A|Prohibited medications|0|||
125142306|NCT04281472|450144533|FG000|Stage A|Withdrawal by Subject|11|||
125142307|NCT04281472|450144534|FG001|Stage A|Withdrawal by Subject|0|||
125142308|NCT04281472|450144535|FG002|Stage A|Withdrawal by Subject|0|||
125142309|NCT04281472|450144533|FG000|Stage A|Other|5|||
125142310|NCT04281472|450144534|FG001|Stage A|Other|0|||
125142311|NCT04281472|450144535|FG002|Stage A|Other|0|||
125142312|NCT04281472|450144533|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
125142313|NCT04281472|450144534|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
125142314|NCT04281472|450144535|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
125142315|NCT04281472|450144533|FG000|Stage B|Adverse Event|0|||
125142316|NCT04281472|450144534|FG001|Stage B|Adverse Event|3|||
125142317|NCT04281472|450144535|FG002|Stage B|Adverse Event|0|||
125223194|NCT00419757|450446130|FG000|Overall Study|Lost to Follow-up|1|||
125223195|NCT00419757|450446131|FG001|Overall Study|Lost to Follow-up|4|||
125223196|NCT00419757|450446130|FG000|Overall Study|Withdrawal by Subject|7|||
125142318|NCT04281472|450144533|FG000|Stage B|Death|0|||
125142319|NCT04281472|450144534|FG001|Stage B|Death|0|||
125142320|NCT04281472|450144535|FG002|Stage B|Death|1|||
125223197|NCT00419757|450446131|FG001|Overall Study|Withdrawal by Subject|1|||
125142321|NCT04281472|450144533|FG000|Stage B|Lack of Efficacy|0|||
125142322|NCT04281472|450144534|FG001|Stage B|Lack of Efficacy|0|||
125142323|NCT04281472|450144535|FG002|Stage B|Lack of Efficacy|1|||
125142324|NCT04281472|450144533|FG000|Stage B|Lost to Follow-up|0|||
125142325|NCT04281472|450144534|FG001|Stage B|Lost to Follow-up|0|||
125142326|NCT04281472|450144535|FG002|Stage B|Lost to Follow-up|2|||
125142327|NCT04281472|450144533|FG000|Stage B|Prohibited medications|0|||
125142328|NCT04281472|450144534|FG001|Stage B|Prohibited medications|2|||
125142329|NCT04281472|450144535|FG002|Stage B|Prohibited medications|1|||
125142330|NCT04281472|450144533|FG000|Stage B|Protocol Violation|0|||
125142331|NCT04281472|450144534|FG001|Stage B|Protocol Violation|1|||
125142332|NCT04281472|450144535|FG002|Stage B|Protocol Violation|1|||
125142333|NCT04281472|450144533|FG000|Stage B|Sponsor decision|0|||
125142334|NCT04281472|450144534|FG001|Stage B|Sponsor decision|0|||
125142335|NCT04281472|450144535|FG002|Stage B|Sponsor decision|1|||
125142336|NCT04281472|450144533|FG000|Stage B|Withdrawal by Subject|0|||
125142337|NCT04281472|450144534|FG001|Stage B|Withdrawal by Subject|3|||
125142338|NCT04281472|450144535|FG002|Stage B|Withdrawal by Subject|3|||
125142339|NCT04281472|450144533|FG000|Stage B|Other|0|||
125142340|NCT04281472|450144534|FG001|Stage B|Other|3|||
125142341|NCT04281472|450144535|FG002|Stage B|Other|0|||
125142342|NCT05278858|450144536|FG000|Overall Study|Withdrawal by Subject|1|||
125142343|NCT03504085|450144539|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
125142344|NCT03504085|450144540|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
125142345|NCT03504085|450144539|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
125142346|NCT03504085|450144540|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
125142347|NCT04133311|450144541|FG000|Period 1 Double Masked Treatment Period|Death|1|||
125142348|NCT04133311|450144542|FG001|Period 1 Double Masked Treatment Period|Death|0|||
125142349|NCT04133311|450144543|FG002|Period 1 Double Masked Treatment Period|Death|0|||
125142350|NCT04133311|450144544|FG003|Period 1 Double Masked Treatment Period|Death|0|||
125142351|NCT04133311|450144541|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
125142352|NCT04133311|450144542|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
125142353|NCT04133311|450144543|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
125142354|NCT04133311|450144544|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
125142355|NCT04133311|450144541|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
125142356|NCT04133311|450144542|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
125142357|NCT04133311|450144543|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
125142358|NCT04133311|450144544|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
125142359|NCT04133311|450144541|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
125142360|NCT04133311|450144542|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
125142361|NCT04133311|450144543|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
125142362|NCT04133311|450144544|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
125142363|NCT04133311|450144541|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
125142364|NCT04133311|450144542|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
125142365|NCT04133311|450144543|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
125142366|NCT04133311|450144544|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
125142367|NCT04133311|450144541|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
125142368|NCT04133311|450144542|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
125142369|NCT04133311|450144543|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
125142370|NCT04133311|450144544|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
125142371|NCT04133311|450144541|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
125142372|NCT04133311|450144542|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
125142373|NCT04133311|450144543|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
125142374|NCT04133311|450144544|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
125142375|NCT04133311|450144541|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
125142376|NCT04133311|450144542|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
125142377|NCT04133311|450144543|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
125142378|NCT04133311|450144544|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
125142379|NCT00728754|450144547|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
125142380|NCT00728754|450144548|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
125142381|NCT00728754|450144547|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
125142382|NCT00728754|450144548|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
125142383|NCT00728754|450144547|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
125142384|NCT00728754|450144548|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
125142385|NCT01926119|450144549|FG000|Overall Study|Withdrawal by Subject|1|||
125142386|NCT00009945|450144552|FG000|Overall Study|no follow up data|7|||
125142387|NCT00009945|450144553|FG001|Overall Study|no follow up data|5|||
125142388|NCT00295490|450144556|FG000|Overall Study|Protocol Violation|0|||
125142389|NCT00295490|450144557|FG001|Overall Study|Protocol Violation|0|||
125142390|NCT00295490|450144558|FG002|Overall Study|Protocol Violation|3|||
125142391|NCT00295490|450144559|FG003|Overall Study|Protocol Violation|3|||
125142392|NCT00295490|450144556|FG000|Overall Study|Withdrawal by Subject|0|||
125142393|NCT00295490|450144557|FG001|Overall Study|Withdrawal by Subject|2|||
125223198|NCT00419757|450446130|FG000|Overall Study|Protocol Violation|2|||
125142394|NCT00295490|450144558|FG002|Overall Study|Withdrawal by Subject|0|||
125142395|NCT00295490|450144559|FG003|Overall Study|Withdrawal by Subject|1|||
125142396|NCT00295490|450144556|FG000|Overall Study|Lost to Follow-up|0|||
125142397|NCT00295490|450144557|FG001|Overall Study|Lost to Follow-up|0|||
125142398|NCT00295490|450144558|FG002|Overall Study|Lost to Follow-up|1|||
125142399|NCT00295490|450144559|FG003|Overall Study|Lost to Follow-up|0|||
125142400|NCT00295490|450144556|FG000|Overall Study|Adverse Event|1|||
125142401|NCT00295490|450144557|FG001|Overall Study|Adverse Event|0|||
125142402|NCT00295490|450144558|FG002|Overall Study|Adverse Event|0|||
125142403|NCT00295490|450144559|FG003|Overall Study|Adverse Event|0|||
125142404|NCT00295490|450144556|FG000|Overall Study|Other|0|||
125142405|NCT00295490|450144557|FG001|Overall Study|Other|2|||
125142406|NCT00295490|450144558|FG002|Overall Study|Other|0|||
125142407|NCT00295490|450144559|FG003|Overall Study|Other|1|||
125142408|NCT01196390|450144560|FG000|Overall Study|Protocol Violation|4|||
125142409|NCT01196390|450144561|FG001|Overall Study|Protocol Violation|5|||
125142410|NCT03141151|450144568|FG000|Overall Study|Lost to Follow-up|3|||
125142411|NCT03141151|450144569|FG001|Overall Study|Lost to Follow-up|2|||
125142412|NCT03141151|450144568|FG000|Overall Study|Withdrawal by Subject|3|||
125142413|NCT03141151|450144569|FG001|Overall Study|Withdrawal by Subject|2|||
125142414|NCT02218216|450144581|FG000|Overall Study|Study terminated before completed|6|||
125142415|NCT02218216|450144582|FG001|Overall Study|Study terminated before completed|0|||
125142416|NCT02218216|450144583|FG002|Overall Study|Study terminated before completed|0|||
125142417|NCT01691430|450146064|FG000|Overall Study|Death|17|||
125142418|NCT01691430|450146065|FG001|Overall Study|Death|16|||
125142419|NCT01691430|450146064|FG000|Overall Study|Withdrawal by Subject|5|||
125142420|NCT01691430|450146065|FG001|Overall Study|Withdrawal by Subject|1|||
125142421|NCT01691430|450146064|FG000|Overall Study|Lost to Follow-up|0|||
125142422|NCT01691430|450146065|FG001|Overall Study|Lost to Follow-up|3|||
125142423|NCT00660387|450146069|FG000|Overall Study|Adverse Event|1|||
125142424|NCT00660387|450146070|FG001|Overall Study|Adverse Event|2|||
125142425|NCT00660387|450146069|FG000|Overall Study|Lack of Efficacy|0|||
125142426|NCT00660387|450146070|FG001|Overall Study|Lack of Efficacy|1|||
125142427|NCT00660387|450146069|FG000|Overall Study|Protocol Violation|1|||
125142428|NCT00660387|450146070|FG001|Overall Study|Protocol Violation|0|||
125142429|NCT04729101|450146073|FG000|Overall Study|Adverse Event|1|||
125142430|NCT04729101|450146074|FG001|Overall Study|Adverse Event|0|||
125142431|NCT04729101|450146073|FG000|Overall Study|Physician Decision|1|||
125142432|NCT04729101|450146074|FG001|Overall Study|Physician Decision|0|||
125142433|NCT04729101|450146073|FG000|Overall Study|Withdrawal by Subject|1|||
125142434|NCT04729101|450146074|FG001|Overall Study|Withdrawal by Subject|0|||
125142435|NCT03086135|450146075|FG000|Overall Study|Adverse Event|1|||
125142436|NCT03086135|450146075|FG000|Overall Study|Lost to Follow-up|2|||
125142437|NCT00762411|450146078|FG000|Initial Treatment|Death|7|||
125142438|NCT00762411|450146079|FG001|Initial Treatment|Death|6|||
125142439|NCT00762411|450146078|FG000|Initial Treatment|Adverse Event|132|||
125142440|NCT00762411|450146079|FG001|Initial Treatment|Adverse Event|40|||
125142441|NCT00762411|450146078|FG000|Initial Treatment|Protocol Violation|4|||
125142442|NCT00762411|450146079|FG001|Initial Treatment|Protocol Violation|1|||
125142443|NCT00762411|450146078|FG000|Initial Treatment|Withdrawal by Subject|65|||
125142444|NCT00762411|450146079|FG001|Initial Treatment|Withdrawal by Subject|52|||
125142445|NCT00762411|450146078|FG000|Initial Treatment|Physician Decision|1|||
125142446|NCT00762411|450146079|FG001|Initial Treatment|Physician Decision|0|||
125142447|NCT00762411|450146078|FG000|Initial Treatment|Sponsor Decision|293|||
125142448|NCT00762411|450146079|FG001|Initial Treatment|Sponsor Decision|401|||
125142449|NCT00762411|450146078|FG000|Initial Treatment|Lost to Follow-up|5|||
125142450|NCT00762411|450146079|FG001|Initial Treatment|Lost to Follow-up|0|||
125142451|NCT00762411|450146078|FG000|Initial Treatment|Caregiver Decision|21|||
125142452|NCT00762411|450146079|FG001|Initial Treatment|Caregiver Decision|16|||
125142453|NCT00762411|450146078|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
125142454|NCT00762411|450146079|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
125142455|NCT00762411|450146078|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
125142456|NCT00762411|450146079|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
125142457|NCT00762411|450146078|FG000|Delayed Start|Adverse Event|0|||
125142458|NCT00762411|450146079|FG001|Delayed Start|Adverse Event|4|||
125142459|NCT00762411|450146078|FG000|Delayed Start|Protocol Violation|0|||
125142460|NCT00762411|450146079|FG001|Delayed Start|Protocol Violation|1|||
125142461|NCT00762411|450146078|FG000|Delayed Start|Sponsor Decision|16|||
125142462|NCT00762411|450146079|FG001|Delayed Start|Sponsor Decision|20|||
125142463|NCT00762411|450146078|FG000|Delayed Start|Caregiver Decision|1|||
125142464|NCT00762411|450146079|FG001|Delayed Start|Caregiver Decision|1|||
125142465|NCT00762411|450146078|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
125142466|NCT00762411|450146079|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
125142467|NCT00762411|450146078|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
125142468|NCT00762411|450146079|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
125142469|NCT00762411|450146078|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
125142470|NCT00762411|450146079|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
125142471|NCT00762411|450146078|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
125142472|NCT00762411|450146079|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
125142473|NCT00762411|450146078|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
125142474|NCT00762411|450146079|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
125142475|NCT00762411|450146078|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
125142476|NCT00762411|450146079|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
125142477|NCT01023061|450146080|FG000|Overall Study|Withdrawal prior to treatment|2|||
125142478|NCT02259348|450146084|FG000|Overall Study|Donors|6|||
125142479|NCT02259348|450146084|FG000|Overall Study|Death|4|||
125142480|NCT04812548|450146085|FG000|Overall Study|Adverse Event|2|||
125142481|NCT04812548|450146086|FG001|Overall Study|Adverse Event|7|||
125142482|NCT04812548|450146085|FG000|Overall Study|HSCT Planned|2|||
125142483|NCT04812548|450146086|FG001|Overall Study|HSCT Planned|3|||
125142484|NCT04812548|450146085|FG000|Overall Study|Progressive Disease|0|||
125142485|NCT04812548|450146086|FG001|Overall Study|Progressive Disease|2|||
125142486|NCT04812548|450146085|FG000|Overall Study|Death|0|||
125142487|NCT04812548|450146086|FG001|Overall Study|Death|1|||
125142488|NCT04812548|450146085|FG000|Overall Study|Post Study Access to Treatment|0|||
125142489|NCT04812548|450146086|FG001|Overall Study|Post Study Access to Treatment|1|||
125223199|NCT00419757|450446131|FG001|Overall Study|Protocol Violation|3|||
125223200|NCT00419757|450446130|FG000|Overall Study|Study specific discontinuation criteria|4|||
125223201|NCT00419757|450446131|FG001|Overall Study|Study specific discontinuation criteria|8|||
125223202|NCT00419757|450446130|FG000|Overall Study|Multiple reasons|3|||
125223203|NCT00419757|450446131|FG001|Overall Study|Multiple reasons|1|||
125223204|NCT00327340|450446132|FG000|Overall Study|Withdrawal by Subject|1|||
125223205|NCT00327340|450446133|FG001|Overall Study|Withdrawal by Subject|5|||
125223206|NCT00327340|450446132|FG000|Overall Study|Physician Decision|1|||
125223207|NCT00327340|450446133|FG001|Overall Study|Physician Decision|1|||
125223208|NCT00327340|450446132|FG000|Overall Study|Disease Progression|10|||
125223209|NCT00327340|450446133|FG001|Overall Study|Disease Progression|19|||
125386786|NCT02672423|451050770|FG002|Period 3|Physician Decision|0|||
125142490|NCT04812548|450146085|FG000|Overall Study|Withdrawal by Subject|0|||
125142491|NCT04812548|450146086|FG001|Overall Study|Withdrawal by Subject|1|||
125386787|NCT02672423|451050771|FG003|Period 3|Physician Decision|0|||
125142492|NCT04812548|450146085|FG000|Overall Study|Physician Decision|1|||
125142493|NCT04812548|450146086|FG001|Overall Study|Physician Decision|0|||
125223210|NCT00327340|450446132|FG000|Overall Study|Symptomatic Disease|0|||
125223211|NCT00327340|450446133|FG001|Overall Study|Symptomatic Disease|2|||
125223212|NCT00327340|450446132|FG000|Overall Study|Adverse Event|3|||
125142494|NCT04211766|450146087|FG000|Overall Study|Withdrawal by Subject|5|||
125223213|NCT00327340|450446133|FG001|Overall Study|Adverse Event|3|||
125223214|NCT03506438|450446138|FG000|Overall Study|Lost to Follow-up|8|||
125223215|NCT03506438|450446139|FG001|Overall Study|Lost to Follow-up|7|||
125386788|NCT02672423|451050772|FG004|Period 3|Physician Decision|0|||
125223216|NCT03506438|450446140|FG002|Overall Study|Lost to Follow-up|8|||
125223217|NCT03506438|450446141|FG003|Overall Study|Lost to Follow-up|7|||
125223218|NCT03506438|450446142|FG004|Overall Study|Lost to Follow-up|0|||
125223219|NCT03506438|450446143|FG005|Overall Study|Lost to Follow-up|0|||
125223220|NCT01128296|450446144|FG000|Overall Study|Physician Decision|0|||
125223221|NCT01128296|450446145|FG001|Overall Study|Physician Decision|0|||
125223222|NCT01128296|450446146|FG002|Overall Study|Physician Decision|0|||
125223223|NCT01128296|450446147|FG003|Overall Study|Physician Decision|0|||
125223224|NCT01128296|450446148|FG004|Overall Study|Physician Decision|0|||
125223225|NCT01128296|450446149|FG005|Overall Study|Physician Decision|3|||
125223226|NCT01128296|450446144|FG000|Overall Study|Withdrawal by Subject|0|||
125223227|NCT01128296|450446145|FG001|Overall Study|Withdrawal by Subject|0|||
125223228|NCT01128296|450446146|FG002|Overall Study|Withdrawal by Subject|0|||
125223229|NCT01128296|450446147|FG003|Overall Study|Withdrawal by Subject|0|||
125223230|NCT01128296|450446148|FG004|Overall Study|Withdrawal by Subject|0|||
125223231|NCT01128296|450446149|FG005|Overall Study|Withdrawal by Subject|2|||
125223232|NCT01831427|450446150|FG000|Overall Study|Adverse Event|0|||
125223233|NCT01831427|450446151|FG001|Overall Study|Adverse Event|1|||
125223234|NCT01831427|450446152|FG002|Overall Study|Adverse Event|0|||
125223235|NCT01831427|450446153|FG003|Overall Study|Adverse Event|0|||
125223236|NCT01831427|450446154|FG004|Overall Study|Adverse Event|0|||
125223237|NCT01831427|450446155|FG005|Overall Study|Adverse Event|1|||
125223238|NCT01831427|450446156|FG006|Overall Study|Adverse Event|0|||
125223239|NCT01831427|450446157|FG007|Overall Study|Adverse Event|1|||
125223240|NCT01831427|450446158|FG008|Overall Study|Adverse Event|0|||
125223241|NCT01831427|450446159|FG009|Overall Study|Adverse Event|0|||
125223242|NCT01831427|450446160|FG010|Overall Study|Adverse Event|2|||
125223243|NCT01831427|450446150|FG000|Overall Study|Investigator's Discretion|0|||
125223244|NCT01831427|450446151|FG001|Overall Study|Investigator's Discretion|0|||
125223245|NCT01831427|450446152|FG002|Overall Study|Investigator's Discretion|0|||
125223246|NCT01831427|450446153|FG003|Overall Study|Investigator's Discretion|1|||
125223247|NCT01831427|450446154|FG004|Overall Study|Investigator's Discretion|0|||
125223248|NCT01831427|450446155|FG005|Overall Study|Investigator's Discretion|0|||
125223249|NCT01831427|450446156|FG006|Overall Study|Investigator's Discretion|0|||
125223250|NCT01831427|450446157|FG007|Overall Study|Investigator's Discretion|0|||
125223251|NCT01831427|450446158|FG008|Overall Study|Investigator's Discretion|0|||
125223252|NCT01831427|450446159|FG009|Overall Study|Investigator's Discretion|0|||
125223253|NCT01831427|450446160|FG010|Overall Study|Investigator's Discretion|0|||
125223254|NCT01831427|450446150|FG000|Overall Study|Withdrew Consent|0|||
125223255|NCT01831427|450446151|FG001|Overall Study|Withdrew Consent|0|||
125223256|NCT01831427|450446152|FG002|Overall Study|Withdrew Consent|0|||
125223257|NCT01831427|450446153|FG003|Overall Study|Withdrew Consent|0|||
125223258|NCT01831427|450446154|FG004|Overall Study|Withdrew Consent|0|||
125223259|NCT01831427|450446155|FG005|Overall Study|Withdrew Consent|0|||
125223260|NCT01831427|450446156|FG006|Overall Study|Withdrew Consent|2|||
125223261|NCT01831427|450446157|FG007|Overall Study|Withdrew Consent|0|||
125223262|NCT01831427|450446158|FG008|Overall Study|Withdrew Consent|0|||
125223263|NCT01831427|450446159|FG009|Overall Study|Withdrew Consent|1|||
125223264|NCT01831427|450446160|FG010|Overall Study|Withdrew Consent|1|||
125386789|NCT02672423|451050773|FG005|Period 3|Physician Decision|1|||
125386790|NCT02672423|451050774|FG006|Period 3|Physician Decision|0|||
125386791|NCT02672423|451050775|FG007|Period 3|Physician Decision|0|||
125386792|NCT02672423|451050776|FG008|Period 3|Physician Decision|0|||
125386793|NCT02672423|451050777|FG009|Period 3|Physician Decision|0|||
125386794|NCT01046682|451050779|FG000|Overall Study|Adverse Event|2|||
125223265|NCT00536510|450446161|FG000|Overall Study|Adverse Event|27|||
125223266|NCT00536510|450446162|FG001|Overall Study|Adverse Event|4|||
125223267|NCT00536510|450446161|FG000|Overall Study|Lost to Follow-up|11|||
125223268|NCT00536510|450446162|FG001|Overall Study|Lost to Follow-up|8|||
125223269|NCT00536510|450446161|FG000|Overall Study|Protocol Violation|4|||
125223270|NCT00536510|450446162|FG001|Overall Study|Protocol Violation|5|||
125223271|NCT00536510|450446161|FG000|Overall Study|Withdrawal by Subject|16|||
125386795|NCT01046682|451050780|FG001|Overall Study|Adverse Event|0|||
125386796|NCT01454570|451050783|FG000|Overall Study|Withdrawal by Subject|2|||
125223272|NCT00536510|450446162|FG001|Overall Study|Withdrawal by Subject|9|||
125223273|NCT00536510|450446161|FG000|Overall Study|Flushing with Product|20|||
125223274|NCT00536510|450446162|FG001|Overall Study|Flushing with Product|0|||
125223275|NCT00536510|450446161|FG000|Overall Study|Laboratory Adverse Event|2|||
125386797|NCT01454570|451050783|FG000|Overall Study|Screen Failure|7|||
125386798|NCT00536107|451050784|FG000|Overall Study|Death|5|||
125386799|NCT00536107|451050785|FG001|Overall Study|Death|1|||
125142495|NCT04211766|450146088|FG001|Overall Study|Withdrawal by Subject|1|||
125142496|NCT03686215|450146089|FG000|Overall Study|Adverse Event|0|||
125142497|NCT03686215|450146090|FG001|Overall Study|Adverse Event|0|||
125142498|NCT03686215|450146091|FG002|Overall Study|Adverse Event|7|||
125142499|NCT03686215|450146089|FG000|Overall Study|Physician Decision|0|||
125142500|NCT03686215|450146090|FG001|Overall Study|Physician Decision|0|||
125142501|NCT03686215|450146091|FG002|Overall Study|Physician Decision|1|||
125142502|NCT03686215|450146089|FG000|Overall Study|Protocol Violation|0|||
125142503|NCT03686215|450146090|FG001|Overall Study|Protocol Violation|0|||
125142504|NCT03686215|450146091|FG002|Overall Study|Protocol Violation|4|||
125142505|NCT03686215|450146089|FG000|Overall Study|Device issue|1|||
125142506|NCT03686215|450146090|FG001|Overall Study|Device issue|0|||
125142507|NCT03686215|450146091|FG002|Overall Study|Device issue|2|||
125142508|NCT02485158|450146092|FG000|Overall Study|Withdrawal by Subject|3|||
125142509|NCT02485158|450146092|FG000|Overall Study|expected drug side effect|1|||
125142510|NCT01813435|450146095|FG000|Overall Study|did not finish experimental regimen|1902|||
125142511|NCT01813435|450146096|FG001|Overall Study|did not finish experimental regimen|770|||
125142512|NCT01813435|450146095|FG000|Overall Study|Lost to Follow-up|268|||
125142513|NCT01813435|450146096|FG001|Overall Study|Lost to Follow-up|237|||
125142514|NCT03035890|450146097|FG000|Overall Study|Death|1|||
125223276|NCT00536510|450446162|FG001|Overall Study|Laboratory Adverse Event|1|||
125142515|NCT01490190|450146098|FG000|Overall Study|Withdrawal by Subject|9|||
125142516|NCT01490190|450146098|FG000|Overall Study|Adverse Event|17|||
125142517|NCT01490190|450146098|FG000|Overall Study|Protocol Violation|5|||
125142518|NCT01490190|450146098|FG000|Overall Study|Lost to Follow-up|13|||
125223277|NCT00536510|450446161|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
125386800|NCT00536107|451050784|FG000|Overall Study|Incorrect enrolment|1|||
125142519|NCT01490190|450146098|FG000|Overall Study|Relocation|1|||
125142520|NCT01490190|450146098|FG000|Overall Study|Inconvenience|1|||
125142521|NCT01490190|450146098|FG000|Overall Study|Ring expulsion|2|||
125142522|NCT02817828|450146104|FG000|Overall Study|Lost to Follow-up|41|||
125142523|NCT02817828|450146104|FG000|Overall Study|Adverse event not related to bleeding|104|||
125142524|NCT02817828|450146104|FG000|Overall Study|Adverse event related to bleeding|53|||
125386801|NCT00536107|451050785|FG001|Overall Study|Incorrect enrolment|0|||
125386802|NCT00536107|451050784|FG000|Overall Study|Withdrawal by Subject|0|||
125386803|NCT00536107|451050785|FG001|Overall Study|Withdrawal by Subject|1|||
125386804|NCT00536107|451050784|FG000|Overall Study|Study Termination|2|||
125386805|NCT00536107|451050785|FG001|Overall Study|Study Termination|4|||
125386806|NCT00371254|451050787|FG000|Overall Study|Disease progression|13|||
125386807|NCT00371254|451050788|FG001|Overall Study|Disease progression|13|||
125386808|NCT00371254|451050787|FG000|Overall Study|Study drug toxicity|3|||
125386809|NCT00371254|451050788|FG001|Overall Study|Study drug toxicity|5|||
125223278|NCT00536510|450446162|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
125223279|NCT02169505|450446163|FG000|Overall Study|Withdrawal by Subject|1|||
125223280|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223281|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
125223282|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
125223283|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223284|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223285|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223286|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223287|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223288|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223289|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223290|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223291|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223292|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125386810|NCT00371254|451050787|FG000|Overall Study|Subject request|5|||
125386811|NCT00371254|451050788|FG001|Overall Study|Subject request|0|||
125386812|NCT00371254|451050787|FG000|Overall Study|Investigator Decision|2|||
125386813|NCT00371254|451050788|FG001|Overall Study|Investigator Decision|0|||
125386814|NCT00371254|451050787|FG000|Overall Study|Adverse event unrelated to study drug|0|||
125386815|NCT00371254|451050788|FG001|Overall Study|Adverse event unrelated to study drug|1|||
125386816|NCT00371254|451050787|FG000|Overall Study|Lost to Follow-up|0|||
125386817|NCT00371254|451050788|FG001|Overall Study|Lost to Follow-up|1|||
125386818|NCT00371254|451050787|FG000|Overall Study|Withdrawal by Subject|0|||
125386819|NCT00371254|451050788|FG001|Overall Study|Withdrawal by Subject|1|||
125386820|NCT02246673|451050791|FG000|Overall Study|Sponsor Decision|1|||
125223293|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125386821|NCT02246673|451050792|FG001|Overall Study|Sponsor Decision|0|||
125386822|NCT02246673|451050793|FG002|Overall Study|Sponsor Decision|0|||
125386823|NCT02246673|451050794|FG003|Overall Study|Sponsor Decision|0|||
125142525|NCT02817828|450146104|FG000|Overall Study|Protocol Violation|11|||
125142526|NCT02817828|450146104|FG000|Overall Study|Pregnancy|7|||
125142527|NCT02817828|450146104|FG000|Overall Study|Pregnancy wish|15|||
125142528|NCT02817828|450146104|FG000|Overall Study|Withdrawal by Subject|78|||
125142529|NCT02817828|450146104|FG000|Overall Study|Other|26|||
125142530|NCT00856349|450146108|FG000|Overall Study|Death|418|||
125142531|NCT00856349|450146108|FG000|Overall Study|Withdrawal by Subject|116|||
125142532|NCT00856349|450146108|FG000|Overall Study|Lost to Follow-up|91|||
125142533|NCT00856349|450146108|FG000|Overall Study|Protocol Violation|38|||
125142534|NCT00856349|450146108|FG000|Overall Study|Physician Decision|13|||
125142535|NCT00856349|450146108|FG000|Overall Study|Subject relocation|104|||
125142536|NCT00856349|450146108|FG000|Overall Study|Device explant|33|||
125142537|NCT00856349|450146108|FG000|Overall Study|Site closure|78|||
125142538|NCT00856349|450146108|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
125142539|NCT05061992|450146109|FG000|Overall Study|Excess bowel movements|1|||
125142540|NCT05061992|450146110|FG001|Overall Study|Excess bowel movements|0|||
125142541|NCT05061992|450146109|FG000|Overall Study|Complications of Medical Care|1|||
125142542|NCT05061992|450146110|FG001|Overall Study|Complications of Medical Care|0|||
125142543|NCT05061992|450146109|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
125142544|NCT05061992|450146110|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
125142545|NCT05061992|450146109|FG000|Overall Study|Withdrawal by Subject|0|||
125142546|NCT05061992|450146110|FG001|Overall Study|Withdrawal by Subject|1|||
125142547|NCT01157234|450146111|FG000|Overall Study|Withdrawal by Subject|1|||
125142548|NCT01157234|450146112|FG001|Overall Study|Withdrawal by Subject|0|||
125142549|NCT00397254|450146121|FG000|Overall Study|Lost to Follow-up|2|||
125142550|NCT00397254|450146122|FG001|Overall Study|Lost to Follow-up|2|||
125142551|NCT02340780|450146123|FG000|Overall Study|Ineligible|1|||
125142552|NCT01055834|450146128|FG000|Treatment Period I|Adverse Event|1|||
125142553|NCT01055834|450146129|FG001|Treatment Period I|Adverse Event|0|||
125142554|NCT01717313|450146130|FG000|Phase A (Weeks 0 to 24)|Death|0|||
125142555|NCT01717313|450146131|FG001|Phase A (Weeks 0 to 24)|Death|1|||
125142556|NCT01717313|450146130|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
125142557|NCT01717313|450146131|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
125142558|NCT01717313|450146130|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
125142559|NCT01717313|450146131|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
125142560|NCT01717313|450146130|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
125142561|NCT01717313|450146131|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
125386824|NCT02246673|451050795|FG004|Overall Study|Sponsor Decision|0|||
125142562|NCT01717313|450146130|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
125142563|NCT01717313|450146131|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
125142564|NCT01717313|450146130|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
125142565|NCT01717313|450146131|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
125142566|NCT01717313|450146130|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
125142567|NCT01717313|450146131|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
125142568|NCT01717313|450146130|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
125142569|NCT01717313|450146131|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
125142570|NCT01717313|450146130|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
125142571|NCT01717313|450146131|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
125142572|NCT01617096|450146142|FG000|Overall Study|Withdrawal by Subject|96|||
125142573|NCT01617096|450146143|FG001|Overall Study|Withdrawal by Subject|81|||
125142574|NCT01617096|450146142|FG000|Overall Study|Lost to Follow-up|37|||
125142575|NCT01617096|450146143|FG001|Overall Study|Lost to Follow-up|32|||
125142576|NCT01617096|450146142|FG000|Overall Study|Physician Decision|10|||
125142577|NCT01617096|450146143|FG001|Overall Study|Physician Decision|18|||
125142578|NCT01617096|450146142|FG000|Overall Study|Death|4|||
125142579|NCT01617096|450146143|FG001|Overall Study|Death|3|||
125142580|NCT01617096|450146142|FG000|Overall Study|Other|1|||
125142581|NCT01617096|450146143|FG001|Overall Study|Other|3|||
125142582|NCT04473326|450146146|FG000|Overall Study|Death|0|||
125142583|NCT04473326|450146147|FG001|Overall Study|Death|1|||
125142584|NCT04473326|450146146|FG000|Overall Study|Withdrawal by Subject|1|||
125142585|NCT04473326|450146147|FG001|Overall Study|Withdrawal by Subject|2|||
125142586|NCT02611362|450146148|FG000|Overall Study|Withdrawal by Subject|7|||
125142587|NCT02611362|450146149|FG001|Overall Study|Withdrawal by Subject|2|||
125142588|NCT02611362|450146148|FG000|Overall Study|Lost to Follow-up|2|||
125142589|NCT02611362|450146149|FG001|Overall Study|Lost to Follow-up|4|||
125142590|NCT01155531|450146150|FG000|Overall Study|Adverse Event|0|||
125142591|NCT01155531|450146151|FG001|Overall Study|Adverse Event|0|||
125142592|NCT01155531|450146152|FG002|Overall Study|Adverse Event|1|||
125142593|NCT01155531|450146153|FG003|Overall Study|Adverse Event|0|||
125142594|NCT01155531|450146150|FG000|Overall Study|Lost to Follow-up|0|||
125142595|NCT01155531|450146151|FG001|Overall Study|Lost to Follow-up|0|||
125142596|NCT01155531|450146152|FG002|Overall Study|Lost to Follow-up|0|||
125142597|NCT01155531|450146153|FG003|Overall Study|Lost to Follow-up|1|||
125142598|NCT01155531|450146150|FG000|Overall Study|Withdrawal by Subject|1|||
125142599|NCT01155531|450146151|FG001|Overall Study|Withdrawal by Subject|0|||
125142600|NCT01155531|450146152|FG002|Overall Study|Withdrawal by Subject|1|||
125142601|NCT01155531|450146153|FG003|Overall Study|Withdrawal by Subject|0|||
125142602|NCT00354159|450146154|FG000|Randomized Study Period|Withdrawal by Subject|5|||
125386825|NCT02246673|451050791|FG000|Overall Study|Withdrawal by Subject|0|||
125386826|NCT02246673|451050792|FG001|Overall Study|Withdrawal by Subject|0|||
125386827|NCT02246673|451050793|FG002|Overall Study|Withdrawal by Subject|0|||
125386828|NCT02246673|451050794|FG003|Overall Study|Withdrawal by Subject|0|||
125386829|NCT02246673|451050795|FG004|Overall Study|Withdrawal by Subject|1|||
125386830|NCT02246673|451050791|FG000|Overall Study|Lost to Follow-up|0|||
125386831|NCT02246673|451050792|FG001|Overall Study|Lost to Follow-up|0|||
125142603|NCT00354159|450146155|FG001|Randomized Study Period|Withdrawal by Subject|3|||
125142604|NCT00354159|450146154|FG000|Randomized Study Period|Physician Decision|6|||
125142605|NCT00354159|450146155|FG001|Randomized Study Period|Physician Decision|10|||
125142606|NCT00354159|450146154|FG000|Randomized Study Period|Lost to Follow-up|4|||
125142607|NCT00354159|450146155|FG001|Randomized Study Period|Lost to Follow-up|0|||
125142608|NCT00354159|450146154|FG000|Randomized Study Period|Death|7|||
125142609|NCT00354159|450146155|FG001|Randomized Study Period|Death|9|||
125142610|NCT00354159|450146154|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
125142611|NCT00354159|450146155|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
125142612|NCT00354159|450146154|FG000|Long-term Follow-up|Physician Decision|127|||
125142613|NCT00354159|450146155|FG001|Long-term Follow-up|Physician Decision|122|||
125142614|NCT00354159|450146154|FG000|Long-term Follow-up|Lost to Follow-up|1|||
125142615|NCT00354159|450146155|FG001|Long-term Follow-up|Lost to Follow-up|0|||
125142616|NCT00354159|450146154|FG000|Long-term Follow-up|Death|14|||
125142617|NCT00354159|450146155|FG001|Long-term Follow-up|Death|11|||
125142618|NCT00354159|450146154|FG000|Long-term Follow-up|Study Closed|29|||
125142619|NCT00354159|450146155|FG001|Long-term Follow-up|Study Closed|34|||
125142620|NCT02046122|450146156|FG000|Overall Study|Physician Decision|8|||
125142621|NCT02046122|450146156|FG000|Overall Study|Withdrawal by Subject|1|||
125142622|NCT01653704|450146157|FG000|Overall Study|Technical failure during recording|1|||
125142623|NCT01653704|450146158|FG001|Overall Study|Technical failure during recording|1|||
125142624|NCT01653704|450146157|FG000|Overall Study|Performance not reflective of training|1|||
125142625|NCT01653704|450146158|FG001|Overall Study|Performance not reflective of training|0|||
125142626|NCT01728116|450146161|FG000|Overall Study|Sponsor Terminated Study|106|||
125142627|NCT01728116|450146162|FG001|Overall Study|Sponsor Terminated Study|35|||
125142628|NCT01728116|450146161|FG000|Overall Study|Withdrawal by Subject|16|||
125142629|NCT01728116|450146162|FG001|Overall Study|Withdrawal by Subject|9|||
125142630|NCT01728116|450146161|FG000|Overall Study|Adverse Event|13|||
125142631|NCT01728116|450146162|FG001|Overall Study|Adverse Event|0|||
125142632|NCT01728116|450146161|FG000|Overall Study|Procedure/device failure|7|||
125142633|NCT01728116|450146162|FG001|Overall Study|Procedure/device failure|0|||
125142634|NCT01728116|450146161|FG000|Overall Study|Lost to Follow-up|9|||
125142635|NCT01728116|450146162|FG001|Overall Study|Lost to Follow-up|2|||
125142636|NCT01728116|450146161|FG000|Overall Study|Physician Decision|2|||
125142637|NCT01728116|450146162|FG001|Overall Study|Physician Decision|0|||
125142638|NCT01728116|450146161|FG000|Overall Study|Subject Non-Compliance|2|||
125142639|NCT01728116|450146162|FG001|Overall Study|Subject Non-Compliance|0|||
125142640|NCT01728116|450146161|FG000|Overall Study|Inter-current finding at procedure|1|||
125142641|NCT01728116|450146162|FG001|Overall Study|Inter-current finding at procedure|0|||
125142642|NCT01728116|450146161|FG000|Overall Study|Incorrectly enrolled in Study|0|||
125142643|NCT01728116|450146162|FG001|Overall Study|Incorrectly enrolled in Study|1|||
125142644|NCT01728116|450146161|FG000|Overall Study|various not noted previously|5|||
125142645|NCT01728116|450146162|FG001|Overall Study|various not noted previously|0|||
125142646|NCT01532908|450146163|FG000|Overall Study|Not Transplanted|1|||
125142647|NCT01532908|450146164|FG001|Overall Study|Not Transplanted|0|||
125142648|NCT04610580|450146165|FG000|Two-way Crossover Period|Adverse Event|1|||
125142649|NCT04610580|450146166|FG001|Two-way Crossover Period|Adverse Event|0|||
125142650|NCT04610580|450146167|FG002|Two-way Crossover Period|Adverse Event|0|||
125142651|NCT04610580|450146168|FG003|Two-way Crossover Period|Adverse Event|0|||
125142652|NCT04610580|450146169|FG004|Two-way Crossover Period|Adverse Event|0|||
125142653|NCT04610580|450146170|FG005|Two-way Crossover Period|Adverse Event|0|||
125142654|NCT04610580|450146165|FG000|Two-way Crossover Period|Physician Decision|1|||
125386832|NCT02246673|451050793|FG002|Overall Study|Lost to Follow-up|0|||
125386833|NCT02246673|451050794|FG003|Overall Study|Lost to Follow-up|1|||
125386834|NCT02246673|451050795|FG004|Overall Study|Lost to Follow-up|0|||
125142655|NCT04610580|450146166|FG001|Two-way Crossover Period|Physician Decision|0|||
125142656|NCT04610580|450146167|FG002|Two-way Crossover Period|Physician Decision|0|||
125142657|NCT04610580|450146168|FG003|Two-way Crossover Period|Physician Decision|0|||
125386835|NCT02246673|451050791|FG000|Overall Study|Protocol Violation|0|||
125142658|NCT04610580|450146169|FG004|Two-way Crossover Period|Physician Decision|0|||
125142659|NCT04610580|450146170|FG005|Two-way Crossover Period|Physician Decision|0|||
125142660|NCT04610580|450146165|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
125142661|NCT04610580|450146166|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
125142662|NCT04610580|450146167|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
125142663|NCT04610580|450146168|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
125142664|NCT04610580|450146169|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
125142665|NCT04610580|450146170|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
125142666|NCT04610580|450146165|FG000|Two-way Crossover Period|Other than specified|0|||
125142667|NCT04610580|450146166|FG001|Two-way Crossover Period|Other than specified|1|||
125142668|NCT04610580|450146167|FG002|Two-way Crossover Period|Other than specified|0|||
125142669|NCT04610580|450146168|FG003|Two-way Crossover Period|Other than specified|0|||
125142670|NCT04610580|450146169|FG004|Two-way Crossover Period|Other than specified|0|||
125142671|NCT04610580|450146170|FG005|Two-way Crossover Period|Other than specified|0|||
125142672|NCT04610580|450146165|FG000|Washout Before Extension Period|Other than specified|0|||
125142673|NCT04610580|450146166|FG001|Washout Before Extension Period|Other than specified|1|||
125142674|NCT04610580|450146167|FG002|Washout Before Extension Period|Other than specified|0|||
125142675|NCT04610580|450146168|FG003|Washout Before Extension Period|Other than specified|0|||
125142676|NCT04610580|450146169|FG004|Washout Before Extension Period|Other than specified|0|||
125142677|NCT04610580|450146170|FG005|Washout Before Extension Period|Other than specified|0|||
125142678|NCT04610580|450146165|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
125142679|NCT04610580|450146166|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
125142680|NCT04610580|450146167|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
125142681|NCT04610580|450146168|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
125142682|NCT04610580|450146169|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
125142683|NCT04610580|450146170|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
125142684|NCT04610580|450146165|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
125142685|NCT04610580|450146166|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
125142686|NCT04610580|450146167|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
125142687|NCT04610580|450146168|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
125142688|NCT04610580|450146169|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
125142689|NCT04610580|450146170|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
125142690|NCT01097694|450146171|FG000|Overall Study|Adverse Event|5|||
125142691|NCT01097694|450146172|FG001|Overall Study|Adverse Event|0|||
125223294|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
125223295|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
125142692|NCT01097694|450146171|FG000|Overall Study|Lost to Follow-up|0|||
125223296|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
125386836|NCT02246673|451050792|FG001|Overall Study|Protocol Violation|0|||
125386837|NCT02246673|451050793|FG002|Overall Study|Protocol Violation|0|||
125142693|NCT01097694|450146172|FG001|Overall Study|Lost to Follow-up|3|||
125142694|NCT01097694|450146171|FG000|Overall Study|Withdrawal by Subject|3|||
125386838|NCT02246673|451050794|FG003|Overall Study|Protocol Violation|1|||
125223297|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223298|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223299|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223300|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223301|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223302|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223303|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223304|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223305|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223306|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223307|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223308|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125223309|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
125142695|NCT01097694|450146172|FG001|Overall Study|Withdrawal by Subject|1|||
125142696|NCT04320745|450146173|FG000|Overall Study|Adverse Event|26|||
125142697|NCT04320745|450146173|FG000|Overall Study|Withdrawal by Subject|4|||
125142698|NCT04320745|450146173|FG000|Overall Study|Lost to Follow-up|12|||
125142699|NCT04320745|450146173|FG000|Overall Study|Protocol Deviation|2|||
125142700|NCT04320745|450146173|FG000|Overall Study|Non-compliance With Study Drug|2|||
125142701|NCT04320745|450146173|FG000|Overall Study|Reason Not Specified|1|||
125142702|NCT02004691|450146174|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
125142703|NCT02004691|450146175|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
125142704|NCT02004691|450146174|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
125142705|NCT02004691|450146175|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
125142706|NCT02004691|450146174|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
125142707|NCT02004691|450146175|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
125142708|NCT02004691|450146174|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
125142709|NCT02004691|450146175|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
125142710|NCT02004691|450146174|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
125142711|NCT02004691|450146175|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
125142712|NCT02004691|450146174|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
125142713|NCT02004691|450146175|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
125142714|NCT01320722|450146176|FG000|Overall Study|Did not Receive Intervention|3|||
125142715|NCT01320722|450146177|FG001|Overall Study|Did not Receive Intervention|2|||
125142716|NCT01320722|450146178|FG002|Overall Study|Did not Receive Intervention|1|||
125142717|NCT01320722|450146179|FG003|Overall Study|Did not Receive Intervention|1|||
125142718|NCT01320722|450146180|FG004|Overall Study|Did not Receive Intervention|2|||
125142719|NCT01320722|450146176|FG000|Overall Study|Lost to Follow-up|0|||
125142720|NCT01320722|450146177|FG001|Overall Study|Lost to Follow-up|1|||
125142721|NCT01320722|450146178|FG002|Overall Study|Lost to Follow-up|0|||
125142722|NCT01320722|450146179|FG003|Overall Study|Lost to Follow-up|1|||
125142723|NCT01320722|450146180|FG004|Overall Study|Lost to Follow-up|3|||
125142724|NCT01320722|450146176|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
125142725|NCT01320722|450146177|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
125142726|NCT01320722|450146178|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
125142727|NCT01320722|450146179|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
125142728|NCT01320722|450146180|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
125142729|NCT01320722|450146176|FG000|Overall Study|Participant Developed a Rash|0|||
125142730|NCT01320722|450146177|FG001|Overall Study|Participant Developed a Rash|0|||
125142731|NCT01320722|450146178|FG002|Overall Study|Participant Developed a Rash|2|||
125142732|NCT01320722|450146179|FG003|Overall Study|Participant Developed a Rash|1|||
125142733|NCT01320722|450146180|FG004|Overall Study|Participant Developed a Rash|1|||
125142734|NCT01320722|450146176|FG000|Overall Study|Non-compliant with Medication|0|||
125142735|NCT01320722|450146177|FG001|Overall Study|Non-compliant with Medication|0|||
125142736|NCT01320722|450146178|FG002|Overall Study|Non-compliant with Medication|1|||
125142737|NCT01320722|450146179|FG003|Overall Study|Non-compliant with Medication|0|||
125142738|NCT01320722|450146180|FG004|Overall Study|Non-compliant with Medication|0|||
125142739|NCT01320722|450146176|FG000|Overall Study|Adverse Event|0|||
125142740|NCT01320722|450146177|FG001|Overall Study|Adverse Event|0|||
125142741|NCT01320722|450146178|FG002|Overall Study|Adverse Event|3|||
125142742|NCT01320722|450146179|FG003|Overall Study|Adverse Event|6|||
125142743|NCT01320722|450146180|FG004|Overall Study|Adverse Event|0|||
125142744|NCT01320722|450146176|FG000|Overall Study|Not Compliant with Study Procedures|0|||
125142745|NCT01320722|450146177|FG001|Overall Study|Not Compliant with Study Procedures|0|||
125142746|NCT01320722|450146178|FG002|Overall Study|Not Compliant with Study Procedures|0|||
125142747|NCT01320722|450146179|FG003|Overall Study|Not Compliant with Study Procedures|4|||
125142748|NCT01320722|450146180|FG004|Overall Study|Not Compliant with Study Procedures|0|||
125142749|NCT01320722|450146176|FG000|Overall Study|Pregnancy|0|||
125142750|NCT01320722|450146177|FG001|Overall Study|Pregnancy|0|||
125142751|NCT01320722|450146178|FG002|Overall Study|Pregnancy|0|||
125142752|NCT01320722|450146179|FG003|Overall Study|Pregnancy|1|||
125142753|NCT01320722|450146180|FG004|Overall Study|Pregnancy|0|||
125142754|NCT01320722|450146176|FG000|Overall Study|Started an Exclusionary Medication|0|||
125142755|NCT01320722|450146177|FG001|Overall Study|Started an Exclusionary Medication|0|||
125142756|NCT01320722|450146178|FG002|Overall Study|Started an Exclusionary Medication|0|||
125142757|NCT01320722|450146179|FG003|Overall Study|Started an Exclusionary Medication|0|||
125142758|NCT01320722|450146180|FG004|Overall Study|Started an Exclusionary Medication|1|||
125142759|NCT01320722|450146176|FG000|Overall Study|Withdrew due to Health Condition|0|||
125142760|NCT01320722|450146177|FG001|Overall Study|Withdrew due to Health Condition|0|||
125142761|NCT01320722|450146178|FG002|Overall Study|Withdrew due to Health Condition|0|||
125142762|NCT01320722|450146179|FG003|Overall Study|Withdrew due to Health Condition|0|||
125142763|NCT01320722|450146180|FG004|Overall Study|Withdrew due to Health Condition|1|||
125142764|NCT00021541|450146181|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
125142765|NCT00021541|450146182|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
125142766|NCT00021541|450146181|FG000|Period 1-First Treatment|Adverse Event|2|||
125142767|NCT00021541|450146182|FG001|Period 1-First Treatment|Adverse Event|1|||
125142768|NCT00021541|450146181|FG000|Period 1-First Treatment|non-adherence|3|||
125142769|NCT00021541|450146182|FG001|Period 1-First Treatment|non-adherence|0|||
125142770|NCT00021541|450146181|FG000|Period 1-First Treatment|Death|1|||
125142771|NCT00021541|450146182|FG001|Period 1-First Treatment|Death|0|||
125142772|NCT00021541|450146181|FG000|Period 1-First Treatment|Pts that did not progress|2|||
125142773|NCT00021541|450146182|FG001|Period 1-First Treatment|Pts that did not progress|2|||
125142774|NCT00021541|450146181|FG000|Period 1-First Treatment|Ineligible|0|||
125142775|NCT00021541|450146182|FG001|Period 1-First Treatment|Ineligible|2|||
125142776|NCT00021541|450146181|FG000|Period 2-crossover|refused phase B|2|||
125142777|NCT00021541|450146182|FG001|Period 2-crossover|refused phase B|2|||
125142778|NCT00021541|450146181|FG000|Period 2-crossover|Withdrawal by Subject|3|||
125142779|NCT00021541|450146182|FG001|Period 2-crossover|Withdrawal by Subject|4|||
125142780|NCT00021541|450146181|FG000|Period 2-crossover|Adverse Event|2|||
125142781|NCT00021541|450146182|FG001|Period 2-crossover|Adverse Event|2|||
125142782|NCT00021541|450146181|FG000|Period 2-crossover|non-adherence|1|||
125142783|NCT00021541|450146182|FG001|Period 2-crossover|non-adherence|0|||
125142784|NCT00021541|450146181|FG000|Period 2-crossover|Pts that did not progress|2|||
125142785|NCT00021541|450146182|FG001|Period 2-crossover|Pts that did not progress|3|||
125142786|NCT03407729|450146183|FG000|Overall Study|Lost to Follow-up|2|||
125142787|NCT03407729|450146184|FG001|Overall Study|Lost to Follow-up|0|||
125142788|NCT03407729|450146183|FG000|Overall Study|Unable to schedule|0|||
125142789|NCT03407729|450146184|FG001|Overall Study|Unable to schedule|3|||
125142790|NCT04142658|450146185|FG000|Overall Study|Death|2|||
125142791|NCT04142658|450146186|FG001|Overall Study|Death|1|||
125142792|NCT04142658|450146185|FG000|Overall Study|Lost to Follow-up|4|||
125142793|NCT04142658|450146186|FG001|Overall Study|Lost to Follow-up|13|||
125142794|NCT04142658|450146185|FG000|Overall Study|Withdrawal by Subject|9|||
125142795|NCT04142658|450146186|FG001|Overall Study|Withdrawal by Subject|16|||
125142796|NCT02943096|450146187|FG000|Overall Study|Lack of Efficacy|0|||
125142797|NCT02943096|450146188|FG001|Overall Study|Lack of Efficacy|1|||
125142798|NCT00939523|450146193|FG000|Overall Study|Lack of Efficacy|1|||
125142799|NCT00939523|450146193|FG000|Overall Study|Physician Decision|2|||
125142800|NCT00024258|450146194|FG000|Overall Study|Withdrawal by Subject|1|||
125142801|NCT00024258|450146194|FG000|Overall Study|Disease Progression|8|||
125142802|NCT01050764|450146195|FG000|Overall Study|Death, before HSCT|1|||
125142803|NCT01050764|450146195|FG000|Overall Study|Donor mobilization failure, death|1|||
125142804|NCT01050764|450146195|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
125142805|NCT02119936|450146196|FG000|Overall Study|Lost to Follow-up|10|||
125142806|NCT00570128|450146197|FG000|Overall Study|Adverse Event|1|||
125142807|NCT00570128|450146198|FG001|Overall Study|Adverse Event|0|||
125142808|NCT00570128|450146197|FG000|Overall Study|Lost to Follow-up|1|||
125142809|NCT00570128|450146198|FG001|Overall Study|Lost to Follow-up|0|||
125142810|NCT00570128|450146197|FG000|Overall Study|Withdrawal by Subject|2|||
125142811|NCT00570128|450146198|FG001|Overall Study|Withdrawal by Subject|0|||
125142812|NCT04194008|450146199|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
125142813|NCT04194008|450146199|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
125142814|NCT04194008|450146199|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
125142815|NCT04194008|450146199|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
125142816|NCT04194008|450146199|FG000|Treatment Phase With Nerivio|Missing data|4|||
125142817|NCT04194008|450146199|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
125142818|NCT03193021|450146200|FG000|Overall Study|Lost to Follow-up|1|||
125142819|NCT03193021|450146201|FG001|Overall Study|Lost to Follow-up|1|||
125142820|NCT01139762|450146202|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
125142821|NCT01139762|450146203|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
125142822|NCT01139762|450146204|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
125142823|NCT01139762|450146202|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
125142824|NCT01139762|450146203|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
125142825|NCT01139762|450146204|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
125142826|NCT01139762|450146202|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
125142827|NCT01139762|450146203|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
125142828|NCT01139762|450146204|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
125142829|NCT01139762|450146202|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
125142830|NCT01139762|450146203|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
125142831|NCT01139762|450146204|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
125142832|NCT01139762|450146202|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
125142833|NCT01139762|450146203|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
125142834|NCT01139762|450146204|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
125142835|NCT01139762|450146202|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
125142836|NCT01139762|450146203|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
125142837|NCT01139762|450146204|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
125142838|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
125142839|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
125142840|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
125142841|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Death|0|||
125142842|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Death|1|||
125142843|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Death|1|||
125142844|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
125142845|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
125142846|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
125142847|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
125223310|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
125223311|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
125223312|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
125223313|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223314|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223315|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223316|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223317|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223318|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223319|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223320|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223321|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223322|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125142848|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
125142849|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
125142850|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
125142851|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
125142852|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
125142853|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
125142854|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
125142855|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
125142856|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
125142857|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
125386839|NCT02246673|451050795|FG004|Overall Study|Protocol Violation|0|||
125386840|NCT04356963|451050797|FG000|First Session|Withdrawal by Subject|1|||
125142858|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
125142859|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
125142860|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
125386841|NCT04356963|451050797|FG000|Second Session|Withdrawal by Subject|3|||
125386842|NCT04356963|451050797|FG000|Second Session|Lost to Follow-up|1|||
125386843|NCT04356963|451050797|FG000|Third Session|Lost to Follow-up|6|||
125386844|NCT04356963|451050797|FG000|Third Session|Withdrawal by Subject|1|||
125386845|NCT01179477|451050799|FG000|Overall Study|Death|542|||
125386846|NCT01179477|451050799|FG000|Overall Study|Unsuccessful implant|80|||
125386847|NCT01179477|451050799|FG000|Overall Study|Non-death withdrawal|438|||
125386848|NCT01179477|451050799|FG000|Overall Study|Did not complete final visit|27|||
125386849|NCT01265849|451050807|FG000|Overall Study|Randomized//Treatment not initiated|1|||
125386850|NCT01265849|451050808|FG001|Overall Study|Randomized//Treatment not initiated|4|||
125386851|NCT01265849|451050809|FG002|Overall Study|Randomized//Treatment not initiated|0|||
125386852|NCT01265849|451050807|FG000|Overall Study|Physician Decision|1|||
125386853|NCT01265849|451050808|FG001|Overall Study|Physician Decision|2|||
125386854|NCT01265849|451050809|FG002|Overall Study|Physician Decision|0|||
125386855|NCT01265849|451050807|FG000|Overall Study|Lost to Follow-up|18|||
125386856|NCT01265849|451050808|FG001|Overall Study|Lost to Follow-up|15|||
125386857|NCT01265849|451050809|FG002|Overall Study|Lost to Follow-up|5|||
125386858|NCT01265849|451050807|FG000|Overall Study|Not otherwise specified|1|||
125386859|NCT01265849|451050808|FG001|Overall Study|Not otherwise specified|6|||
125223323|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125386860|NCT01265849|451050809|FG002|Overall Study|Not otherwise specified|1|||
125386861|NCT01265849|451050807|FG000|Overall Study|Withdrawal by Subject|25|||
125386862|NCT01265849|451050808|FG001|Overall Study|Withdrawal by Subject|34|||
125386863|NCT01265849|451050809|FG002|Overall Study|Withdrawal by Subject|13|||
125386864|NCT00975481|451050811|FG000|Second Intervention Period|Adverse Event|2|||
125223324|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
125223325|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223326|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223327|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
125223328|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223329|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223330|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223331|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223332|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223333|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223334|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223335|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223336|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223337|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223338|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125386865|NCT00975481|451050812|FG001|Second Intervention Period|Adverse Event|1|||
125386866|NCT00975481|451050813|FG002|Second Intervention Period|Adverse Event|0|||
125142861|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
125142862|NCT01139762|450146202|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
125142863|NCT01139762|450146203|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
125142864|NCT01139762|450146204|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
125142865|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Adverse Event|8|||
125142866|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Adverse Event|5|||
125142867|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Adverse Event|9|||
125142868|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Adverse Event|0|||
125142869|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Adverse Event|0|||
125142870|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Adverse Event|0|||
125142871|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
125142872|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
125142873|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
125142874|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
125142875|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
125142876|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
125142877|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
125142878|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
125142879|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
125142880|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
125142881|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
125142882|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
125142883|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Physician Decision|4|||
125142884|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Physician Decision|0|||
125142885|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Physician Decision|2|||
125142886|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Physician Decision|0|||
125142887|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Physician Decision|0|||
125142888|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Physician Decision|0|||
125142889|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Pregnancy|1|||
125142890|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Pregnancy|2|||
125142891|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Pregnancy|0|||
125142892|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Pregnancy|0|||
125142893|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Pregnancy|0|||
125142894|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Pregnancy|0|||
125142895|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
125142896|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
125142897|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
125142898|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
125142899|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
125142900|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
125142901|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
125142902|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
125142903|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
125142904|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
125142905|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
125142906|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
125438430|NCT04986982|451232252|FG001|Overall Study|Sponsor's discretion|0|||
125142907|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
125142908|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
125142909|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
125438431|NCT01155661|451232253|FG000|Overall Study|Adverse Event|101|||
125386867|NCT00975481|451050814|FG003|Second Intervention Period|Adverse Event|0|||
125386868|NCT00975481|451050815|FG004|Second Intervention Period|Adverse Event|0|||
125142910|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
125142911|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
125142912|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
125142913|NCT02614196|450146205|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
125142914|NCT02614196|450146206|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
125142915|NCT02614196|450146207|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
125142916|NCT02614196|450146208|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
125142917|NCT02614196|450146209|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
125142918|NCT02614196|450146210|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
125142919|NCT02614196|450146205|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
125142920|NCT02614196|450146206|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
125142921|NCT02614196|450146207|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
125142922|NCT02614196|450146208|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
125142923|NCT02614196|450146209|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
125142924|NCT02614196|450146210|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
125142925|NCT02614196|450146205|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
125142926|NCT02614196|450146206|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
125142927|NCT02614196|450146207|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
125142928|NCT02614196|450146208|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
125142929|NCT02614196|450146209|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
125142930|NCT02614196|450146210|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
125142931|NCT02614196|450146205|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
125142932|NCT02614196|450146206|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
125142933|NCT02614196|450146207|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
125142934|NCT02614196|450146208|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
125142935|NCT02614196|450146209|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
125142936|NCT02614196|450146210|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
125142937|NCT02614196|450146205|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
125386869|NCT00975481|451050816|FG005|Second Intervention Period|Adverse Event|0|||
125386870|NCT00975481|451050811|FG000|Second Intervention Period|Withdrawal by Subject|0|||
125386871|NCT00975481|451050812|FG001|Second Intervention Period|Withdrawal by Subject|0|||
125386872|NCT00975481|451050813|FG002|Second Intervention Period|Withdrawal by Subject|1|||
125386873|NCT00975481|451050814|FG003|Second Intervention Period|Withdrawal by Subject|0|||
125386874|NCT00975481|451050815|FG004|Second Intervention Period|Withdrawal by Subject|0|||
125386875|NCT00975481|451050816|FG005|Second Intervention Period|Withdrawal by Subject|0|||
125386876|NCT00975481|451050811|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
125386877|NCT00975481|451050812|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
125386878|NCT00975481|451050813|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
125386879|NCT00975481|451050814|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
125386880|NCT00975481|451050815|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
125386881|NCT00975481|451050816|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
125386882|NCT00975481|451050811|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
125386883|NCT00975481|451050812|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
125386884|NCT00975481|451050813|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
125386885|NCT00975481|451050814|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
125142938|NCT02614196|450146206|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
125142939|NCT02614196|450146207|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
125142940|NCT02614196|450146208|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
125142941|NCT02614196|450146209|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
125142942|NCT02614196|450146210|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
125142943|NCT01539239|450146211|FG000|Overall Study|Death|5|||
125142944|NCT01539239|450146212|FG001|Overall Study|Death|5|||
125142945|NCT01539239|450146211|FG000|Overall Study|Lost to Follow-up|7|||
125142946|NCT01539239|450146212|FG001|Overall Study|Lost to Follow-up|12|||
125142947|NCT00640341|450147870|FG000|Overall Study|Adverse Event|0|||
125223339|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
125223340|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223341|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223342|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
125223343|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223344|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223345|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223346|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223347|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223348|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223349|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223350|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223351|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223352|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223353|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223354|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
125223355|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223356|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223357|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
125223358|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223359|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223360|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223361|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223362|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223363|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223364|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223365|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223366|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223367|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223368|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125386886|NCT00975481|451050815|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
125386887|NCT00975481|451050816|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
125386888|NCT00643682|451050817|FG000|Overall Study|did not keep appointment|522|||
125386889|NCT00643682|451050818|FG001|Overall Study|did not keep appointment|509|||
125386890|NCT02154581|451050829|FG000|Overall Study|Lost to Follow-up|7|||
125386891|NCT02154581|451050830|FG001|Overall Study|Lost to Follow-up|8|||
125142948|NCT00640341|450147871|FG001|Overall Study|Adverse Event|0|||
125142949|NCT00640341|450147872|FG002|Overall Study|Adverse Event|1|||
125142950|NCT00640341|450147870|FG000|Overall Study|Positive Slit Lamp Findings|0|||
125142951|NCT00640341|450147871|FG001|Overall Study|Positive Slit Lamp Findings|0|||
125142952|NCT00640341|450147872|FG002|Overall Study|Positive Slit Lamp Findings|1|||
125142953|NCT00640341|450147870|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
125142954|NCT00640341|450147871|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
125142955|NCT00640341|450147872|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
125142956|NCT00640341|450147870|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
125142957|NCT00640341|450147871|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
125142958|NCT00640341|450147872|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
125142959|NCT00640341|450147870|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
125142960|NCT00640341|450147871|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
125142961|NCT00640341|450147872|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
125142962|NCT00640341|450147870|FG000|Overall Study|Lost to Follow-up|2|||
125142963|NCT00640341|450147871|FG001|Overall Study|Lost to Follow-up|0|||
125142964|NCT00640341|450147872|FG002|Overall Study|Lost to Follow-up|0|||
125142965|NCT00640341|450147870|FG000|Overall Study|Withdrawal by Subject|4|||
125142966|NCT00640341|450147871|FG001|Overall Study|Withdrawal by Subject|0|||
125142967|NCT00640341|450147872|FG002|Overall Study|Withdrawal by Subject|1|||
125142968|NCT00640341|450147870|FG000|Overall Study|Unacceptable Lens Movement|1|||
125142969|NCT00640341|450147871|FG001|Overall Study|Unacceptable Lens Movement|0|||
125142970|NCT00640341|450147872|FG002|Overall Study|Unacceptable Lens Movement|0|||
125142971|NCT00640341|450147870|FG000|Overall Study|Poor fit/Uncomfortable|4|||
125142972|NCT00640341|450147871|FG001|Overall Study|Poor fit/Uncomfortable|0|||
125142973|NCT00640341|450147872|FG002|Overall Study|Poor fit/Uncomfortable|0|||
125142974|NCT00640341|450147870|FG000|Overall Study|Ineligable at Baseline|5|||
125142975|NCT00640341|450147871|FG001|Overall Study|Ineligable at Baseline|3|||
125142976|NCT00640341|450147872|FG002|Overall Study|Ineligable at Baseline|2|||
125142977|NCT00640341|450147870|FG000|Overall Study|Adverse event and positive slit lamp|1|||
125142978|NCT00640341|450147871|FG001|Overall Study|Adverse event and positive slit lamp|0|||
125142979|NCT00640341|450147872|FG002|Overall Study|Adverse event and positive slit lamp|0|||
125142980|NCT01520987|450147875|FG000|Overall Study|Withdrawal by Subject|1|||
125142981|NCT01520987|450147876|FG001|Overall Study|Withdrawal by Subject|0|||
125142982|NCT01520987|450147877|FG002|Overall Study|Withdrawal by Subject|0|||
125142983|NCT01520987|450147878|FG003|Overall Study|Withdrawal by Subject|0|||
125142984|NCT01520987|450147879|FG004|Overall Study|Withdrawal by Subject|0|||
125142985|NCT01520987|450147880|FG005|Overall Study|Withdrawal by Subject|1|||
125142986|NCT01520987|450147881|FG006|Overall Study|Withdrawal by Subject|0|||
125142987|NCT01520987|450147882|FG007|Overall Study|Withdrawal by Subject|0|||
125142988|NCT02005562|450147883|FG000|Overall Study|Death|2|||
125142989|NCT02005562|450147884|FG001|Overall Study|Death|2|||
125142990|NCT02005562|450147883|FG000|Overall Study|Graft loss|7|||
125142991|NCT02005562|450147884|FG001|Overall Study|Graft loss|6|||
125142992|NCT02005562|450147883|FG000|Overall Study|Withdrawal by Subject|2|||
125142993|NCT02005562|450147884|FG001|Overall Study|Withdrawal by Subject|2|||
125223369|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
125223370|NCT02326272|450446164|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125386892|NCT00741039|451050831|FG000|Overall Study|Patient non-compliance|2|||
125142994|NCT02005562|450147883|FG000|Overall Study|No transplant|1|||
125142995|NCT02005562|450147884|FG001|Overall Study|No transplant|4|||
125386893|NCT00741039|451050832|FG001|Overall Study|Patient non-compliance|0|||
125386894|NCT01092182|451050833|FG000|Overall Study|Death|0|||
125386895|NCT01092182|451050834|FG001|Overall Study|Death|5|||
125142996|NCT02005562|450147883|FG000|Overall Study|Physician Decision|0|||
125223371|NCT02326272|450446165|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125142997|NCT02005562|450147884|FG001|Overall Study|Physician Decision|1|||
125142998|NCT02966340|450147887|FG000|Overall Study|Adverse Event|0|||
125386896|NCT01092182|451050835|FG002|Overall Study|Death|3|||
125142999|NCT02966340|450147888|FG001|Overall Study|Adverse Event|1|||
125143000|NCT02966340|450147887|FG000|Overall Study|Lost to Follow-up|0|||
125223372|NCT02326272|450446166|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
125223373|NCT02326272|450446167|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125143001|NCT02966340|450147888|FG001|Overall Study|Lost to Follow-up|1|||
125143002|NCT02966340|450147887|FG000|Overall Study|Withdrawal by Subject|1|||
125143003|NCT02966340|450147888|FG001|Overall Study|Withdrawal by Subject|0|||
125143004|NCT02966340|450147887|FG000|Overall Study|data acquisition error|1|||
125143005|NCT02966340|450147888|FG001|Overall Study|data acquisition error|0|||
125143006|NCT02966340|450147887|FG000|Overall Study|startle non-responder|1|||
125143007|NCT02966340|450147888|FG001|Overall Study|startle non-responder|1|||
125143008|NCT01622660|450147889|FG000|Overall Study|Adverse Event|1|||
125143009|NCT04590781|450147890|FG000|Overall Study|Death|0|||
125143010|NCT04590781|450147891|FG001|Overall Study|Death|2|||
125143011|NCT04590781|450147890|FG000|Overall Study|Withdrawal by Subject|2|||
125143012|NCT04590781|450147891|FG001|Overall Study|Withdrawal by Subject|0|||
125143013|NCT01680016|450147892|FG000|Overall Study|Adverse Event|0|||
125143014|NCT01680016|450147893|FG001|Overall Study|Adverse Event|0|||
125143015|NCT01680016|450147894|FG002|Overall Study|Adverse Event|1|||
125143016|NCT01680016|450147895|FG003|Overall Study|Adverse Event|4|||
125143017|NCT01680016|450147892|FG000|Overall Study|The Subject went out of The Trial|1|||
125143018|NCT01680016|450147893|FG001|Overall Study|The Subject went out of The Trial|0|||
125143019|NCT01680016|450147894|FG002|Overall Study|The Subject went out of The Trial|3|||
125143020|NCT01680016|450147895|FG003|Overall Study|The Subject went out of The Trial|0|||
125143021|NCT01680016|450147892|FG000|Overall Study|Protocol Violation|0|||
125143022|NCT01680016|450147893|FG001|Overall Study|Protocol Violation|1|||
125143023|NCT01680016|450147894|FG002|Overall Study|Protocol Violation|0|||
125143024|NCT01680016|450147895|FG003|Overall Study|Protocol Violation|0|||
125143025|NCT01680016|450147892|FG000|Overall Study|Withdrawal by Subject|5|||
125143026|NCT01680016|450147893|FG001|Overall Study|Withdrawal by Subject|7|||
125143027|NCT01680016|450147894|FG002|Overall Study|Withdrawal by Subject|1|||
125143028|NCT01680016|450147895|FG003|Overall Study|Withdrawal by Subject|1|||
125143029|NCT01120899|450147896|FG000|Overall Study|Withdrawal by Subject|3|||
125143030|NCT00202839|450147899|FG000|Overall Study|Adverse Event|1|||
125143031|NCT00202839|450147900|FG001|Overall Study|Adverse Event|5|||
125143032|NCT00202839|450147899|FG000|Overall Study|Physician Decision|12|||
125143033|NCT00202839|450147900|FG001|Overall Study|Physician Decision|0|||
125143034|NCT00202839|450147899|FG000|Overall Study|Withdrawal by Subject|6|||
125143035|NCT00202839|450147900|FG001|Overall Study|Withdrawal by Subject|2|||
125143036|NCT00202839|450147899|FG000|Overall Study|Protocol Violation|2|||
125143037|NCT00202839|450147900|FG001|Overall Study|Protocol Violation|1|||
125143038|NCT00202839|450147899|FG000|Overall Study|Lost to Follow-up|3|||
125143039|NCT00202839|450147900|FG001|Overall Study|Lost to Follow-up|2|||
125143040|NCT00442351|450147901|FG000|Overall Study|Administrative|6|||
125143041|NCT00442351|450147902|FG001|Overall Study|Administrative|5|||
125143042|NCT00442351|450147901|FG000|Overall Study|Did not meet protocol eligibility|1|||
125143043|NCT00442351|450147902|FG001|Overall Study|Did not meet protocol eligibility|0|||
125143044|NCT00442351|450147901|FG000|Overall Study|Other|0|||
125143045|NCT00442351|450147902|FG001|Overall Study|Other|1|||
125143046|NCT00377156|450147907|FG000|Overall Study|Death|23|||
125143047|NCT00377156|450147908|FG001|Overall Study|Death|19|||
125143048|NCT00377156|450147907|FG000|Overall Study|Withdrawal by Subject|16|||
125143049|NCT00377156|450147908|FG001|Overall Study|Withdrawal by Subject|24|||
125143050|NCT00377156|450147907|FG000|Overall Study|Had follow-up <90 d|3|||
125143051|NCT00377156|450147908|FG001|Overall Study|Had follow-up <90 d|6|||
125143052|NCT00377156|450147907|FG000|Overall Study|Cancellation|1|||
125143053|NCT00377156|450147908|FG001|Overall Study|Cancellation|0|||
125143054|NCT00377156|450147907|FG000|Overall Study|Refused testing|0|||
125143055|NCT00377156|450147908|FG001|Overall Study|Refused testing|1|||
125143056|NCT00377156|450147907|FG000|Overall Study|Ineligible|0|||
125143057|NCT00377156|450147908|FG001|Overall Study|Ineligible|1|||
125143058|NCT00377156|450147907|FG000|Overall Study|Disability or language problem|0|||
125143059|NCT00377156|450147908|FG001|Overall Study|Disability or language problem|1|||
125143060|NCT00377156|450147907|FG000|Overall Study|Other|5|||
125143061|NCT00377156|450147908|FG001|Overall Study|Other|2|||
125143062|NCT00288704|450147909|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
125143063|NCT00288704|450147910|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
125143064|NCT00288704|450147911|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
125143065|NCT00288704|450147909|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
125143066|NCT00288704|450147910|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
125143067|NCT00288704|450147911|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
125386897|NCT01092182|451050833|FG000|Overall Study|participant safety|1|||
125143068|NCT00288704|450147909|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
125143069|NCT00288704|450147910|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
125143070|NCT00288704|450147911|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
125143071|NCT00288704|450147909|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
125143072|NCT00288704|450147910|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
125143073|NCT00288704|450147911|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
125143074|NCT00288704|450147909|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
125143075|NCT00288704|450147910|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
125386898|NCT01092182|451050834|FG001|Overall Study|participant safety|2|||
125386899|NCT01092182|451050835|FG002|Overall Study|participant safety|0|||
125386900|NCT01092182|451050833|FG000|Overall Study|Physician Decision|0|||
125386901|NCT01092182|451050834|FG001|Overall Study|Physician Decision|6|||
125386902|NCT01092182|451050835|FG002|Overall Study|Physician Decision|0|||
125386903|NCT01092182|451050833|FG000|Overall Study|Did not meet criteria|0|||
125386904|NCT01092182|451050834|FG001|Overall Study|Did not meet criteria|0|||
125386905|NCT01092182|451050835|FG002|Overall Study|Did not meet criteria|25|||
125386906|NCT01092182|451050833|FG000|Overall Study|Non-compliance|0|||
125386907|NCT01092182|451050834|FG001|Overall Study|Non-compliance|3|||
125143076|NCT00288704|450147911|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
125143077|NCT00288704|450147909|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
125143078|NCT00288704|450147910|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
125143079|NCT00288704|450147911|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
125143080|NCT00288704|450147909|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
125143081|NCT00288704|450147910|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
125143082|NCT00288704|450147911|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
125143083|NCT01579006|450147912|FG000|Overall Study|Lack of Efficacy|10|||
125143084|NCT01579006|450147912|FG000|Overall Study|Adverse Event|13|||
125143085|NCT01579006|450147912|FG000|Overall Study|Withdrawal by Subject|5|||
125143086|NCT01579006|450147912|FG000|Overall Study|Non-compliance|3|||
125143087|NCT01579006|450147912|FG000|Overall Study|Due to participant's health fund|1|||
125143088|NCT01579006|450147912|FG000|Overall Study|Scheduled surgery|1|||
125143089|NCT02473393|450147915|FG000|Overall Study|Adverse Event|0|||
125143090|NCT02473393|450147916|FG001|Overall Study|Adverse Event|0|||
125143091|NCT02473393|450147917|FG002|Overall Study|Adverse Event|1|||
125143092|NCT02473393|450147918|FG003|Overall Study|Adverse Event|0|||
125143093|NCT02473393|450147915|FG000|Overall Study|Withdrawal by Subject|0|||
125143094|NCT02473393|450147916|FG001|Overall Study|Withdrawal by Subject|0|||
125143095|NCT02473393|450147917|FG002|Overall Study|Withdrawal by Subject|1|||
125143096|NCT02473393|450147918|FG003|Overall Study|Withdrawal by Subject|1|||
125143097|NCT02697617|450147919|FG000|Overall Study|Withdrawal by Subject|0|||
125143098|NCT02697617|450147920|FG001|Overall Study|Withdrawal by Subject|2|||
125143099|NCT02697617|450147919|FG000|Overall Study|Pregnancy|1|||
125143100|NCT02697617|450147920|FG001|Overall Study|Pregnancy|0|||
125143101|NCT02460835|450147921|FG000|Overall Study|Disease progression prior to treatment|3|||
125143102|NCT02460835|450147921|FG000|Overall Study|Unable to complete planning scans|2|||
125143103|NCT02460835|450147921|FG000|Overall Study|Decrease in performance status|1|||
125143104|NCT02460835|450147921|FG000|Overall Study|Withdrawal by Subject|3|||
125143105|NCT02460835|450147921|FG000|Overall Study|Underwent fractionated RT|10|||
125143106|NCT02460835|450147921|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
125143107|NCT00517192|450147925|FG000|Overall Study|Adverse Event|1|||
125143108|NCT00517192|450147926|FG001|Overall Study|Adverse Event|1|||
125143109|NCT00517192|450147925|FG000|Overall Study|Lost to Follow-up|1|||
125143110|NCT00517192|450147926|FG001|Overall Study|Lost to Follow-up|1|||
125143111|NCT00517192|450147925|FG000|Overall Study|Withdrawal by Subject|1|||
125143112|NCT00517192|450147926|FG001|Overall Study|Withdrawal by Subject|0|||
125143113|NCT00517192|450147925|FG000|Overall Study|Early termination of the trial|16|||
125143114|NCT00517192|450147926|FG001|Overall Study|Early termination of the trial|18|||
125143115|NCT02733627|450147928|FG000|Overall Study|Adverse Event|0|||
125143116|NCT02733627|450147929|FG001|Overall Study|Adverse Event|1|||
125143117|NCT02733627|450147930|FG002|Overall Study|Adverse Event|1|||
125143118|NCT02733627|450147931|FG003|Overall Study|Adverse Event|0|||
125143119|NCT02733627|450147928|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
125143120|NCT02733627|450147929|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
125143121|NCT02733627|450147930|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
125143122|NCT02733627|450147931|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
125143123|NCT00183196|450147932|FG000|Overall Study|Withdrawal by Subject|18|||
125143124|NCT00183196|450147933|FG001|Overall Study|Withdrawal by Subject|11|||
125223374|NCT02326272|450446168|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125223375|NCT02326272|450446169|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125223376|NCT02326272|450446170|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125143125|NCT00183196|450147934|FG002|Overall Study|Withdrawal by Subject|13|||
125143126|NCT00183196|450147932|FG000|Overall Study|Adverse Event|1|||
125143127|NCT00183196|450147933|FG001|Overall Study|Adverse Event|2|||
125143128|NCT00183196|450147934|FG002|Overall Study|Adverse Event|2|||
125143129|NCT00183196|450147932|FG000|Overall Study|Legal event|1|||
125143130|NCT00183196|450147933|FG001|Overall Study|Legal event|1|||
125143131|NCT00183196|450147934|FG002|Overall Study|Legal event|1|||
125143132|NCT00183196|450147932|FG000|Overall Study|Required more intensive care|0|||
125143133|NCT00183196|450147933|FG001|Overall Study|Required more intensive care|1|||
125143134|NCT00183196|450147934|FG002|Overall Study|Required more intensive care|2|||
125143135|NCT01119625|450147935|FG000|Overall Study|Lost to Follow-up|1|||
125143136|NCT01119625|450147936|FG001|Overall Study|Lost to Follow-up|2|||
125143137|NCT01119625|450147935|FG000|Overall Study|Withdrawal by Subject|2|||
125143138|NCT01119625|450147936|FG001|Overall Study|Withdrawal by Subject|1|||
125143139|NCT01119625|450147935|FG000|Overall Study|Other|0|||
125143140|NCT01119625|450147936|FG001|Overall Study|Other|1|||
125143141|NCT01721772|450147941|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
125143142|NCT01721772|450147942|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
125143143|NCT01721772|450147941|FG000|Pre-Treatment|Poor/non-compliance|0|||
125143144|NCT01721772|450147942|FG001|Pre-Treatment|Poor/non-compliance|1|||
125143145|NCT01721772|450147941|FG000|Pre-Treatment|Participant withdrew consent|0|||
125143146|NCT01721772|450147942|FG001|Pre-Treatment|Participant withdrew consent|1|||
125143147|NCT01721772|450147941|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
125143148|NCT01721772|450147942|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
125143149|NCT01721772|450147941|FG000|Treatment|Disease progression|119|||
125143150|NCT01721772|450147942|FG001|Treatment|Disease progression|168|||
125143151|NCT01721772|450147941|FG000|Treatment|Study drug toxicity|19|||
125143152|NCT01721772|450147942|FG001|Treatment|Study drug toxicity|10|||
125143153|NCT01721772|450147941|FG000|Treatment|Adverse event unrelated to study drug|7|||
125143154|NCT01721772|450147942|FG001|Treatment|Adverse event unrelated to study drug|7|||
125143155|NCT01721772|450147941|FG000|Treatment|Maximum clinical benefit|16|||
125143156|NCT01721772|450147942|FG001|Treatment|Maximum clinical benefit|4|||
125143157|NCT01721772|450147941|FG000|Treatment|Other|19|||
125143158|NCT01721772|450147942|FG001|Treatment|Other|2|||
125143159|NCT01721772|450147941|FG000|Treatment|Participant withdrew consent|2|||
125143160|NCT01721772|450147942|FG001|Treatment|Participant withdrew consent|5|||
125143161|NCT01721772|450147941|FG000|Treatment|Participant request to discontinue study treatment|21|||
125143162|NCT01721772|450147942|FG001|Treatment|Participant request to discontinue study treatment|8|||
125143163|NCT01721772|450147941|FG000|Treatment|Death|1|||
125143164|NCT01721772|450147942|FG001|Treatment|Death|0|||
125143165|NCT01721772|450147941|FG000|Treatment|Not reported|1|||
125143166|NCT01721772|450147942|FG001|Treatment|Not reported|0|||
125143167|NCT01721772|450147941|FG000|Treatment|Poor/non-compliance|1|||
125143168|NCT01721772|450147942|FG001|Treatment|Poor/non-compliance|0|||
125143169|NCT01721772|450147941|FG000|Treatment|Lost to Follow-up|0|||
125143170|NCT01721772|450147942|FG001|Treatment|Lost to Follow-up|1|||
125143171|NCT05004649|450147948|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
125143172|NCT05004649|450147948|FG000|Overall Study|Lost to Follow-up|1|||
125143173|NCT05004649|450147948|FG000|Overall Study|Withdrawal by Subject|2|||
125143174|NCT05004649|450147948|FG000|Overall Study|COVID-19|1|||
125143175|NCT01698554|450147949|FG000|Overall Study|Adverse Event|2|||
125143176|NCT01698554|450147950|FG001|Overall Study|Adverse Event|5|||
125143177|NCT01698554|450147951|FG002|Overall Study|Adverse Event|0|||
125143178|NCT01698554|450147952|FG003|Overall Study|Adverse Event|1|||
125143179|NCT01698554|450147949|FG000|Overall Study|Lost to Follow-up|1|||
125143180|NCT01698554|450147950|FG001|Overall Study|Lost to Follow-up|0|||
125223377|NCT02326272|450446171|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125223378|NCT02326272|450446172|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125386908|NCT01092182|451050835|FG002|Overall Study|Non-compliance|0|||
125143181|NCT01698554|450147951|FG002|Overall Study|Lost to Follow-up|0|||
125143182|NCT01698554|450147952|FG003|Overall Study|Lost to Follow-up|0|||
125143183|NCT01698554|450147949|FG000|Overall Study|Personal Reasons|0|||
125143184|NCT01698554|450147950|FG001|Overall Study|Personal Reasons|5|||
125143185|NCT01698554|450147951|FG002|Overall Study|Personal Reasons|1|||
125143186|NCT01698554|450147952|FG003|Overall Study|Personal Reasons|1|||
125143187|NCT01698554|450147949|FG000|Overall Study|Protocol Violation|2|||
125143188|NCT01698554|450147950|FG001|Overall Study|Protocol Violation|0|||
125143189|NCT01698554|450147951|FG002|Overall Study|Protocol Violation|1|||
125143190|NCT01698554|450147952|FG003|Overall Study|Protocol Violation|0|||
125143191|NCT01698554|450147949|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125143192|NCT01698554|450147950|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125143193|NCT01698554|450147951|FG002|Overall Study|Other Miscellaneous Reasons|0|||
125143194|NCT01698554|450147952|FG003|Overall Study|Other Miscellaneous Reasons|0|||
125143195|NCT02654145|450147953|FG000|Overall Study|Lack of Efficacy|1|||
125143196|NCT02654145|450147953|FG000|Overall Study|Protocol Violation|1|||
125143197|NCT02654145|450147953|FG000|Overall Study|Withdrawal by Subject|5|||
125143198|NCT02637141|450147954|FG000|Overall Study|Adverse Event|1|||
125143199|NCT02637141|450147955|FG001|Overall Study|Adverse Event|1|||
125143200|NCT02637141|450147956|FG002|Overall Study|Adverse Event|0|||
125143201|NCT02637141|450147954|FG000|Overall Study|Withdrawal by Subject|1|||
125143202|NCT02637141|450147955|FG001|Overall Study|Withdrawal by Subject|1|||
125143203|NCT02637141|450147956|FG002|Overall Study|Withdrawal by Subject|1|||
125143204|NCT01943435|450147958|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
125143205|NCT01943435|450147959|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
125143206|NCT01943435|450147960|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
125143207|NCT01943435|450147958|FG000|Intervention Period|Withdrawal by Subject|3|||
125143208|NCT01943435|450147959|FG001|Intervention Period|Withdrawal by Subject|3|||
125143209|NCT01943435|450147960|FG002|Intervention Period|Withdrawal by Subject|4|||
125143210|NCT01943435|450147958|FG000|2 Month Follow up|Lost to Follow-up|2|||
125143211|NCT01943435|450147959|FG001|2 Month Follow up|Lost to Follow-up|3|||
125143212|NCT01943435|450147960|FG002|2 Month Follow up|Lost to Follow-up|0|||
125143213|NCT01943435|450147958|FG000|6 Month Follow up|Lost to Follow-up|12|||
125143214|NCT01943435|450147959|FG001|6 Month Follow up|Lost to Follow-up|7|||
125143215|NCT01943435|450147960|FG002|6 Month Follow up|Lost to Follow-up|15|||
125143216|NCT03885934|450147961|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
125143217|NCT03885934|450147962|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
125143218|NCT03885934|450147963|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
125143219|NCT03885934|450147964|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
125143220|NCT03885934|450147965|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
125143221|NCT03885934|450147966|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
125143222|NCT04535986|450147974|FG000|Overall Study|Death|4|||
125143223|NCT04535986|450147975|FG001|Overall Study|Death|5|||
125143224|NCT04535986|450147974|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
125143225|NCT04535986|450147975|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
125143226|NCT04535986|450147974|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
125143227|NCT04535986|450147975|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
125143228|NCT04535986|450147974|FG000|Overall Study|Adverse Event|10|||
125143229|NCT04535986|450147975|FG001|Overall Study|Adverse Event|1|||
125143230|NCT04535986|450147974|FG000|Overall Study|Lack of Efficacy|3|||
125143231|NCT04535986|450147975|FG001|Overall Study|Lack of Efficacy|2|||
125143232|NCT04535986|450147974|FG000|Overall Study|Investigator discretion|3|||
125143233|NCT04535986|450147975|FG001|Overall Study|Investigator discretion|0|||
125143234|NCT04535986|450147974|FG000|Overall Study|Withdrawal by Subject|32|||
125143235|NCT04535986|450147975|FG001|Overall Study|Withdrawal by Subject|14|||
125143236|NCT04535986|450147974|FG000|Overall Study|Lost to Follow-up|5|||
125143237|NCT04535986|450147975|FG001|Overall Study|Lost to Follow-up|3|||
125143238|NCT04535986|450147974|FG000|Overall Study|Other|7|||
125143239|NCT04535986|450147975|FG001|Overall Study|Other|3|||
125143240|NCT01559116|450147978|FG000|Overall Study|Adverse Event|10|||
125143241|NCT01559116|450147978|FG000|Overall Study|Lack of Efficacy|1|||
125143242|NCT01559116|450147978|FG000|Overall Study|Lost to Follow-up|1|||
125143243|NCT01559116|450147978|FG000|Overall Study|Protocol Violation|1|||
125143244|NCT01559116|450147978|FG000|Overall Study|Withdrawal by Subject|4|||
125143245|NCT01559116|450147978|FG000|Overall Study|other than stated above|9|||
125143246|NCT02377349|450147979|FG000|Overall Study|Serious Adverse Event|1|||
125143247|NCT02377349|450147980|FG001|Overall Study|Serious Adverse Event|0|||
125143248|NCT02377349|450147979|FG000|Overall Study|Protocol Violation|3|||
125143249|NCT02377349|450147980|FG001|Overall Study|Protocol Violation|2|||
125143250|NCT02377349|450147979|FG000|Overall Study|Withdrawal by Subject|5|||
125143251|NCT02377349|450147980|FG001|Overall Study|Withdrawal by Subject|3|||
125223379|NCT02326272|450446173|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125386909|NCT01092182|451050833|FG000|Overall Study|Participant refused follow-up|0|||
125143252|NCT02377349|450147979|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
125143253|NCT02377349|450147980|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
125143254|NCT02377349|450147979|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
125143255|NCT02377349|450147980|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
125143256|NCT02377349|450147979|FG000|Overall Study|Other|0|||
125143257|NCT02377349|450147980|FG001|Overall Study|Other|1|||
125143258|NCT03259165|450147981|FG000|Overall Study|COVID 19 pandemic|1|||
125143259|NCT03259165|450147982|FG001|Overall Study|COVID 19 pandemic|1|||
125143260|NCT00550147|450147985|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
125143261|NCT00550147|450147985|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
125143262|NCT00550147|450147985|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
125143263|NCT00550147|450147985|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
125143264|NCT00550147|450147985|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
125143265|NCT01824498|450147986|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
125143266|NCT01824498|450147987|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
125386910|NCT01092182|451050834|FG001|Overall Study|Participant refused follow-up|2|||
125386911|NCT01092182|451050835|FG002|Overall Study|Participant refused follow-up|0|||
125386912|NCT02515045|451050847|FG000|Overall Study|Adverse Event|0|||
125386913|NCT02515045|451050848|FG001|Overall Study|Adverse Event|3|||
125143267|NCT01824498|450147988|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
125143268|NCT01824498|450147989|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
125386914|NCT02515045|451050849|FG002|Overall Study|Adverse Event|3|||
125143269|NCT01824498|450147990|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
125143270|NCT01824498|450147991|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
125143271|NCT01567527|450147992|FG000|Conversion Phase.|Protocol deviation|3|||
125143272|NCT01567527|450147993|FG001|Conversion Phase.|Protocol deviation|0|||
125143273|NCT01567527|450147994|FG002|Conversion Phase.|Protocol deviation|0|||
125143274|NCT01567527|450147995|FG003|Conversion Phase.|Protocol deviation|0|||
125143275|NCT01567527|450147996|FG004|Conversion Phase.|Protocol deviation|0|||
125143276|NCT01567527|450147992|FG000|Conversion Phase.|Met withdrawal criteria|10|||
125143277|NCT01567527|450147993|FG001|Conversion Phase.|Met withdrawal criteria|0|||
125143278|NCT01567527|450147994|FG002|Conversion Phase.|Met withdrawal criteria|0|||
125143279|NCT01567527|450147995|FG003|Conversion Phase.|Met withdrawal criteria|0|||
125143280|NCT01567527|450147996|FG004|Conversion Phase.|Met withdrawal criteria|0|||
125143281|NCT01567527|450147992|FG000|Conversion Phase.|Withdrawal by Subject|32|||
125143282|NCT01567527|450147993|FG001|Conversion Phase.|Withdrawal by Subject|0|||
125143283|NCT01567527|450147994|FG002|Conversion Phase.|Withdrawal by Subject|0|||
125143284|NCT01567527|450147995|FG003|Conversion Phase.|Withdrawal by Subject|0|||
125143285|NCT01567527|450147996|FG004|Conversion Phase.|Withdrawal by Subject|0|||
125143286|NCT01567527|450147992|FG000|Conversion Phase.|Lost to Follow-up|16|||
125143287|NCT01567527|450147993|FG001|Conversion Phase.|Lost to Follow-up|0|||
125143288|NCT01567527|450147994|FG002|Conversion Phase.|Lost to Follow-up|0|||
125143289|NCT01567527|450147995|FG003|Conversion Phase.|Lost to Follow-up|0|||
125143290|NCT01567527|450147996|FG004|Conversion Phase.|Lost to Follow-up|0|||
125143291|NCT01567527|450147992|FG000|Conversion Phase.|Lack of Efficacy|2|||
125143292|NCT01567527|450147993|FG001|Conversion Phase.|Lack of Efficacy|0|||
125143293|NCT01567527|450147994|FG002|Conversion Phase.|Lack of Efficacy|0|||
125143294|NCT01567527|450147995|FG003|Conversion Phase.|Lack of Efficacy|0|||
125143295|NCT01567527|450147996|FG004|Conversion Phase.|Lack of Efficacy|0|||
125143296|NCT01567527|450147992|FG000|Conversion Phase.|Adverse Event|33|||
125143297|NCT01567527|450147993|FG001|Conversion Phase.|Adverse Event|0|||
125143298|NCT01567527|450147994|FG002|Conversion Phase.|Adverse Event|0|||
125143299|NCT01567527|450147995|FG003|Conversion Phase.|Adverse Event|0|||
125143300|NCT01567527|450147996|FG004|Conversion Phase.|Adverse Event|0|||
125143301|NCT01567527|450147992|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
125143302|NCT01567527|450147993|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
125143303|NCT01567527|450147994|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
125143304|NCT01567527|450147995|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
125143305|NCT01567527|450147996|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
125143306|NCT01567527|450147992|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
125143307|NCT01567527|450147993|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
125143308|NCT01567527|450147994|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
125143309|NCT01567527|450147995|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
125143310|NCT01567527|450147996|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
125143311|NCT01567527|450147992|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
125143312|NCT01567527|450147993|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
125143313|NCT01567527|450147994|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
125143314|NCT01567527|450147995|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
125143315|NCT01567527|450147996|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
125143316|NCT01567527|450147992|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
125143317|NCT01567527|450147993|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
125143318|NCT01567527|450147994|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
125143319|NCT01567527|450147995|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
125143320|NCT01567527|450147996|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
125143321|NCT01567527|450147992|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
125143322|NCT01567527|450147993|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
125143323|NCT01567527|450147994|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
125143324|NCT01567527|450147995|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
125143325|NCT01567527|450147996|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
125143326|NCT01567527|450147992|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
125143327|NCT01567527|450147993|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
125143328|NCT01567527|450147994|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
125143329|NCT01567527|450147995|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
125143330|NCT01567527|450147996|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
125143331|NCT01567527|450147992|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
125143332|NCT01567527|450147993|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
125143333|NCT01567527|450147994|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
125143334|NCT01567527|450147995|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
125143335|NCT01567527|450147996|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
125143336|NCT01567527|450147992|FG000|IM Depot Stabilization.|Protocol deviation|0|||
125143337|NCT01567527|450147993|FG001|IM Depot Stabilization.|Protocol deviation|0|||
125143338|NCT01567527|450147994|FG002|IM Depot Stabilization.|Protocol deviation|5|||
125143339|NCT01567527|450147995|FG003|IM Depot Stabilization.|Protocol deviation|0|||
125143340|NCT01567527|450147996|FG004|IM Depot Stabilization.|Protocol deviation|0|||
125143341|NCT01567527|450147992|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
125143342|NCT01567527|450147993|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
125143343|NCT01567527|450147994|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
125143344|NCT01567527|450147995|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
125143345|NCT01567527|450147996|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
125143346|NCT01567527|450147992|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
125143347|NCT01567527|450147993|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
125143348|NCT01567527|450147994|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
125143349|NCT01567527|450147995|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
125143350|NCT01567527|450147996|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
125143351|NCT01567527|450147992|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
125143352|NCT01567527|450147993|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
125143353|NCT01567527|450147994|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
125143354|NCT01567527|450147995|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
125143355|NCT01567527|450147996|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
125143356|NCT01567527|450147992|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
125143357|NCT01567527|450147993|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
125143358|NCT01567527|450147994|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
125143359|NCT01567527|450147995|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
125143360|NCT01567527|450147996|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
125143361|NCT01567527|450147992|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
125143362|NCT01567527|450147993|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
125143363|NCT01567527|450147994|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
125143364|NCT01567527|450147995|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
125143365|NCT01567527|450147996|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
125143366|NCT01567527|450147992|FG000|IM Depot Stabilization.|Adverse Event|0|||
125143367|NCT01567527|450147993|FG001|IM Depot Stabilization.|Adverse Event|0|||
125143368|NCT01567527|450147994|FG002|IM Depot Stabilization.|Adverse Event|37|||
125143369|NCT01567527|450147995|FG003|IM Depot Stabilization.|Adverse Event|0|||
125143370|NCT01567527|450147996|FG004|IM Depot Stabilization.|Adverse Event|0|||
125143371|NCT01567527|450147992|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
125143372|NCT01567527|450147993|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
125143373|NCT01567527|450147994|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
125143374|NCT01567527|450147995|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
125143375|NCT01567527|450147996|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
125143376|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
125143377|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
125143378|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
125143379|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
125143380|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
125143381|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
125386915|NCT02515045|451050847|FG000|Overall Study|Lost to Follow-up|0|||
125386916|NCT02515045|451050848|FG001|Overall Study|Lost to Follow-up|1|||
125386917|NCT02515045|451050849|FG002|Overall Study|Lost to Follow-up|1|||
125143382|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
125143383|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
125143384|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
125143385|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
125143386|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
125143387|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
125143388|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
125143389|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
125143390|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
125143391|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
125143392|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
125143393|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
125143394|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
125438432|NCT01155661|451232253|FG000|Overall Study|Death|1|||
125223380|NCT02326272|450446174|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125223381|NCT02326272|450446175|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125223382|NCT02326272|450446176|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125223383|NCT02326272|450446177|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125223384|NCT02326272|450446178|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
125143395|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
125143396|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125143397|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125143398|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
125143399|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
125143400|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
125143401|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
125143402|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
125143403|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
125143404|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
125143405|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
125143406|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
125143407|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
125143408|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
125143409|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
125143410|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
125143411|NCT01567527|450147992|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125143412|NCT01567527|450147993|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125143413|NCT01567527|450147994|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
125143414|NCT01567527|450147995|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
125143415|NCT01567527|450147996|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
125143416|NCT02623218|450147997|FG000|Overall Study|Lost to Follow-up|0|||
125143417|NCT02623218|450147998|FG001|Overall Study|Lost to Follow-up|1|||
125143418|NCT02623218|450147999|FG002|Overall Study|Lost to Follow-up|0|||
125143419|NCT02623218|450148000|FG003|Overall Study|Lost to Follow-up|0|||
125143420|NCT02623218|450148001|FG004|Overall Study|Lost to Follow-up|0|||
125143421|NCT01726803|450148002|FG000|Overall Study|Lost to Follow-up|6|||
125143422|NCT01726803|450148003|FG001|Overall Study|Lost to Follow-up|1|||
125143423|NCT01726803|450148002|FG000|Overall Study|Withdrawal by Subject|1|||
125143424|NCT01726803|450148003|FG001|Overall Study|Withdrawal by Subject|0|||
125143425|NCT01547728|450148010|FG000|Overall Study|Change in procedure and equipment|1|||
125143426|NCT01547728|450148010|FG000|Overall Study|Drug not ready for subject|1|||
125143427|NCT01547728|450148010|FG000|Overall Study|Screen failure|39|||
125143428|NCT03828539|450148011|FG000|Overall Study|Adverse Event|3|||
125143429|NCT03828539|450148012|FG001|Overall Study|Adverse Event|12|||
125143430|NCT03828539|450148011|FG000|Overall Study|Patient's/guardian's decision|3|||
125143431|NCT03828539|450148012|FG001|Overall Study|Patient's/guardian's decision|5|||
125143432|NCT03828539|450148011|FG000|Overall Study|Lost to Follow-up|4|||
125143433|NCT03828539|450148012|FG001|Overall Study|Lost to Follow-up|2|||
125143434|NCT03828539|450148011|FG000|Overall Study|Protocol Violation|3|||
125143435|NCT03828539|450148012|FG001|Overall Study|Protocol Violation|2|||
125143436|NCT03828539|450148011|FG000|Overall Study|Withdrawal of informed consent|2|||
125143437|NCT03828539|450148012|FG001|Overall Study|Withdrawal of informed consent|1|||
125143438|NCT03828539|450148011|FG000|Overall Study|New therapy for study indication|1|||
125143439|NCT03828539|450148012|FG001|Overall Study|New therapy for study indication|0|||
125143440|NCT01341405|450148013|FG000|Overall Study|Adverse Event|0|||
125143441|NCT01341405|450148014|FG001|Overall Study|Adverse Event|1|||
125143442|NCT01341405|450148015|FG002|Overall Study|Adverse Event|1|||
125143443|NCT01341405|450148013|FG000|Overall Study|Withdrawal by Subject|3|||
125143444|NCT01341405|450148014|FG001|Overall Study|Withdrawal by Subject|2|||
125143445|NCT01341405|450148015|FG002|Overall Study|Withdrawal by Subject|1|||
125143446|NCT02616380|450148016|FG000|Overall Study|Lost to Follow-up|1|||
125143447|NCT02616380|450148016|FG000|Overall Study|Other|2|||
125143448|NCT00826241|450148017|FG000|Overall Study|Withdrawal from Follow-up|1|||
125143449|NCT00826241|450148017|FG000|Overall Study|Withdrew consent|2|||
125143450|NCT00826241|450148017|FG000|Overall Study|Death|4|||
125143451|NCT00826241|450148017|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
125143452|NCT00826241|450148017|FG000|Overall Study|Non-compliance|1|||
125143453|NCT00826241|450148017|FG000|Overall Study|Progression of disease|1|||
125143454|NCT00826241|450148017|FG000|Overall Study|Patient refused follow-up|3|||
125143455|NCT00826241|450148017|FG000|Overall Study|Lost to Follow-up|9|||
125143456|NCT00826241|450148017|FG000|Overall Study|Could not obtain records|1|||
125143457|NCT00826241|450148017|FG000|Overall Study|Screen failure|2|||
125143458|NCT00826241|450148017|FG000|Overall Study|Pt unable to proceed to registration|1|||
125143459|NCT00826241|450148017|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
125143460|NCT03950674|450148022|FG000|Overall Study|Death|16|||
125143461|NCT03950674|450148023|FG001|Overall Study|Death|15|||
125143462|NCT03950674|450148022|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
125143463|NCT03950674|450148023|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
125143464|NCT00830167|450148026|FG000|Overall Study|Lack of Efficacy|26|||
125143465|NCT00830167|450148027|FG001|Overall Study|Lack of Efficacy|10|||
125143466|NCT00830167|450148026|FG000|Overall Study|Adverse Event|8|||
125143467|NCT00830167|450148027|FG001|Overall Study|Adverse Event|24|||
125143468|NCT00830167|450148026|FG000|Overall Study|Not meeting entrance criteria|2|||
125143469|NCT00830167|450148027|FG001|Overall Study|Not meeting entrance criteria|5|||
125143470|NCT00830167|450148026|FG000|Overall Study|Withdrawal by Subject|2|||
125143471|NCT00830167|450148027|FG001|Overall Study|Withdrawal by Subject|0|||
125143472|NCT00830167|450148026|FG000|Overall Study|Lost to Follow-up|0|||
125143473|NCT00830167|450148027|FG001|Overall Study|Lost to Follow-up|1|||
125143474|NCT00830167|450148026|FG000|Overall Study|Protocol Violation|0|||
125143475|NCT00830167|450148027|FG001|Overall Study|Protocol Violation|1|||
125143476|NCT00830167|450148026|FG000|Overall Study|Other|2|||
125143477|NCT00830167|450148027|FG001|Overall Study|Other|2|||
125386918|NCT01120756|451050850|FG000|Overall Study|Withdrawal by Subject|1|||
125386919|NCT01120756|451050851|FG001|Overall Study|Withdrawal by Subject|1|||
125386920|NCT03760146|451050856|FG000|Overall Study|Adverse Event|11|||
125386921|NCT03760146|451050857|FG001|Overall Study|Adverse Event|8|||
125386922|NCT03760146|451050858|FG002|Overall Study|Adverse Event|0|||
125386923|NCT03760146|451050859|FG003|Overall Study|Adverse Event|0|||
125386924|NCT03760146|451050860|FG004|Overall Study|Adverse Event|0|||
125386925|NCT03760146|451050861|FG005|Overall Study|Adverse Event|0|||
125143478|NCT02224053|450148028|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
125143479|NCT02224053|450148028|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
125143480|NCT02224053|450148028|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
125143481|NCT02224053|450148028|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
125143482|NCT02224053|450148028|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
125143483|NCT00609154|450148029|FG000|Overall Study|Protocol Violation|1|||
125143484|NCT00609154|450148030|FG001|Overall Study|Protocol Violation|2|||
125143485|NCT00609154|450148029|FG000|Overall Study|Unable to establish IV access|0|||
125143486|NCT00609154|450148030|FG001|Overall Study|Unable to establish IV access|4|||
125143487|NCT00609154|450148029|FG000|Overall Study|Adverse Event|0|||
125143488|NCT00609154|450148030|FG001|Overall Study|Adverse Event|2|||
125143489|NCT00860262|450148035|FG000|Overall Study|Adverse Event|9|||
125143490|NCT00860262|450148036|FG001|Overall Study|Adverse Event|6|||
125143491|NCT00860262|450148037|FG002|Overall Study|Adverse Event|7|||
125143492|NCT00860262|450148035|FG000|Overall Study|Protocol Violation|0|||
125143493|NCT00860262|450148036|FG001|Overall Study|Protocol Violation|1|||
125143494|NCT00860262|450148037|FG002|Overall Study|Protocol Violation|0|||
125143495|NCT00860262|450148035|FG000|Overall Study|Lost to Follow-up|2|||
125143496|NCT00860262|450148036|FG001|Overall Study|Lost to Follow-up|0|||
125143497|NCT00860262|450148037|FG002|Overall Study|Lost to Follow-up|1|||
125143498|NCT00860262|450148035|FG000|Overall Study|Withdrawal by Subject|4|||
125143499|NCT00860262|450148036|FG001|Overall Study|Withdrawal by Subject|8|||
125143500|NCT00860262|450148037|FG002|Overall Study|Withdrawal by Subject|6|||
125143501|NCT00860262|450148035|FG000|Overall Study|Lack of Efficacy|0|||
125143502|NCT00860262|450148036|FG001|Overall Study|Lack of Efficacy|4|||
125143503|NCT00860262|450148037|FG002|Overall Study|Lack of Efficacy|3|||
125143504|NCT00860262|450148035|FG000|Overall Study|Other|5|||
125143505|NCT00860262|450148036|FG001|Overall Study|Other|3|||
125143506|NCT00860262|450148037|FG002|Overall Study|Other|1|||
125143507|NCT00124618|450148038|FG000|Overall Study|Ineligible|1|||
125143508|NCT00593827|450148039|FG000|Overall Study|On Active Treatment/Pending|0|||
125143509|NCT00593827|450148040|FG001|Overall Study|On Active Treatment/Pending|2|||
125143510|NCT01675596|450148041|FG000|Overall Study|Death|6|||
125143511|NCT01675596|450148041|FG000|Overall Study|Exit with other reason|1|||
125143512|NCT01675596|450148041|FG000|Overall Study|Missed Visit|1|||
125143513|NCT01751087|450148042|FG000|Overall Study|Withdrawal by Subject|1|||
125143514|NCT01751087|450148043|FG001|Overall Study|Withdrawal by Subject|0|||
125143515|NCT01751087|450148044|FG002|Overall Study|Withdrawal by Subject|0|||
125143516|NCT01751087|450148042|FG000|Overall Study|Physician Decision|0|||
125143517|NCT01751087|450148043|FG001|Overall Study|Physician Decision|0|||
125143518|NCT01751087|450148044|FG002|Overall Study|Physician Decision|1|||
125143519|NCT02219009|450149435|FG000|Overall Study|Withdrawal by Subject|5|||
125143520|NCT02219009|450149436|FG001|Overall Study|Withdrawal by Subject|1|||
125143521|NCT02219009|450149435|FG000|Overall Study|Adverse Event|2|||
125143522|NCT02219009|450149436|FG001|Overall Study|Adverse Event|4|||
125143523|NCT02219009|450149435|FG000|Overall Study|Lost to Follow-up|2|||
125143524|NCT02219009|450149436|FG001|Overall Study|Lost to Follow-up|2|||
125143525|NCT02219009|450149435|FG000|Overall Study|Protocol deviation|1|||
125143526|NCT02219009|450149436|FG001|Overall Study|Protocol deviation|0|||
125143527|NCT02219009|450149435|FG000|Overall Study|Physician Decision|0|||
125143528|NCT02219009|450149436|FG001|Overall Study|Physician Decision|1|||
125143529|NCT00274625|450149437|FG000|Overall Study|Lost to Follow-up|46|||
125143530|NCT00274625|450149438|FG001|Overall Study|Lost to Follow-up|54|||
125143531|NCT00274625|450149437|FG000|Overall Study|Excluded from analysis|14|||
125143532|NCT00274625|450149438|FG001|Overall Study|Excluded from analysis|8|||
125143533|NCT03087786|450149440|FG000|Overall Study|Withdrawal by Subject|2|||
125143534|NCT03087786|450149441|FG001|Overall Study|Withdrawal by Subject|0|||
125143535|NCT00880334|450149442|FG000|Randomized Phase|Physician Decision|1|||
125143536|NCT00880334|450149443|FG001|Randomized Phase|Physician Decision|0|||
125143537|NCT00880334|450149442|FG000|Randomized Phase|Withdrawal by Subject|2|||
125143538|NCT00880334|450149443|FG001|Randomized Phase|Withdrawal by Subject|1|||
125143539|NCT00880334|450149442|FG000|Randomized Phase|Inadequate Labs|1|||
125143540|NCT00880334|450149443|FG001|Randomized Phase|Inadequate Labs|1|||
125143541|NCT00880334|450149442|FG000|Randomized Phase|Brain Metastasis|0|||
125143542|NCT00880334|450149443|FG001|Randomized Phase|Brain Metastasis|1|||
125143543|NCT00880334|450149442|FG000|Randomized Phase|Crossover Participants|0|||
125143544|NCT00880334|450149443|FG001|Randomized Phase|Crossover Participants|37|||
125143545|NCT02419573|450149451|FG000|Overall Study|Lost to Follow-up|3|||
125143546|NCT02419573|450149452|FG001|Overall Study|Lost to Follow-up|0|||
125143547|NCT02419573|450149451|FG000|Overall Study|Withdrawal by Subject|1|||
125143548|NCT02419573|450149452|FG001|Overall Study|Withdrawal by Subject|0|||
125143549|NCT02229084|450149453|FG000|Overall Study|Adverse Event|1|||
125143550|NCT02229084|450149454|FG001|Overall Study|Adverse Event|0|||
125143551|NCT02229084|450149455|FG002|Overall Study|Adverse Event|0|||
125143552|NCT02229084|450149456|FG003|Overall Study|Adverse Event|0|||
125143553|NCT02229084|450149457|FG004|Overall Study|Adverse Event|0|||
125143554|NCT02229084|450149458|FG005|Overall Study|Adverse Event|0|||
125143555|NCT02229084|450149459|FG006|Overall Study|Adverse Event|0|||
125143556|NCT02229084|450149453|FG000|Overall Study|Lost to Follow-up|0|||
125143557|NCT02229084|450149454|FG001|Overall Study|Lost to Follow-up|0|||
125143558|NCT02229084|450149455|FG002|Overall Study|Lost to Follow-up|1|||
125143559|NCT02229084|450149456|FG003|Overall Study|Lost to Follow-up|1|||
125143560|NCT02229084|450149457|FG004|Overall Study|Lost to Follow-up|0|||
125143561|NCT02229084|450149458|FG005|Overall Study|Lost to Follow-up|0|||
125386926|NCT03760146|451050856|FG000|Overall Study|Death|1|||
125386927|NCT03760146|451050857|FG001|Overall Study|Death|0|||
125386928|NCT03760146|451050858|FG002|Overall Study|Death|0|||
125143562|NCT02229084|450149459|FG006|Overall Study|Lost to Follow-up|1|||
125143563|NCT02229084|450149453|FG000|Overall Study|Physician Decision|0|||
125143564|NCT02229084|450149454|FG001|Overall Study|Physician Decision|0|||
125143565|NCT02229084|450149455|FG002|Overall Study|Physician Decision|0|||
125143566|NCT02229084|450149456|FG003|Overall Study|Physician Decision|1|||
125143567|NCT02229084|450149457|FG004|Overall Study|Physician Decision|3|||
125143568|NCT02229084|450149458|FG005|Overall Study|Physician Decision|0|||
125143569|NCT02229084|450149459|FG006|Overall Study|Physician Decision|1|||
125143570|NCT02229084|450149453|FG000|Overall Study|Withdrawal by Subject|0|||
125143571|NCT02229084|450149454|FG001|Overall Study|Withdrawal by Subject|0|||
125143572|NCT02229084|450149455|FG002|Overall Study|Withdrawal by Subject|1|||
125143573|NCT02229084|450149456|FG003|Overall Study|Withdrawal by Subject|0|||
125143574|NCT02229084|450149457|FG004|Overall Study|Withdrawal by Subject|1|||
125143575|NCT02229084|450149458|FG005|Overall Study|Withdrawal by Subject|1|||
125143576|NCT02229084|450149459|FG006|Overall Study|Withdrawal by Subject|1|||
125143577|NCT02229084|450149453|FG000|Overall Study|Death|0|||
125143578|NCT02229084|450149454|FG001|Overall Study|Death|0|||
125143579|NCT02229084|450149455|FG002|Overall Study|Death|0|||
125143580|NCT02229084|450149456|FG003|Overall Study|Death|0|||
125143581|NCT02229084|450149457|FG004|Overall Study|Death|0|||
125143582|NCT02229084|450149458|FG005|Overall Study|Death|0|||
125143583|NCT02229084|450149459|FG006|Overall Study|Death|1|||
125143584|NCT02179190|450149463|FG000|Enrollment|Exit Prior to Device Attempt|11|||
125143585|NCT02179190|450149463|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
125143586|NCT02179190|450149463|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
125143587|NCT02179190|450149463|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
125143588|NCT02179190|450149463|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
125143589|NCT02179190|450149463|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
125143590|NCT00881569|450149466|FG000|Overall Study|Disease progression|1|||
125143591|NCT00881569|450149467|FG001|Overall Study|Disease progression|1|||
125143592|NCT01993940|450149478|FG000|Overall Study|Adverse Event|16|||
125143593|NCT01993940|450149479|FG001|Overall Study|Adverse Event|11|||
125143594|NCT01993940|450149478|FG000|Overall Study|Withdrawal by Subject|15|||
125143595|NCT01993940|450149479|FG001|Overall Study|Withdrawal by Subject|19|||
125143596|NCT01993940|450149478|FG000|Overall Study|Lost to Follow-up|2|||
125143597|NCT01993940|450149479|FG001|Overall Study|Lost to Follow-up|5|||
125386929|NCT03760146|451050859|FG003|Overall Study|Death|0|||
125386930|NCT03760146|451050860|FG004|Overall Study|Death|0|||
125143598|NCT01993940|450149478|FG000|Overall Study|Protocol Violation|5|||
125143599|NCT01993940|450149479|FG001|Overall Study|Protocol Violation|8|||
125143600|NCT01993940|450149478|FG000|Overall Study|Death|1|||
125143601|NCT01993940|450149479|FG001|Overall Study|Death|0|||
125143602|NCT01993940|450149478|FG000|Overall Study|Other - Miscellaneous|1|||
125143603|NCT01993940|450149479|FG001|Overall Study|Other - Miscellaneous|1|||
125143604|NCT04164758|450149480|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
125143605|NCT04164758|450149481|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
125143606|NCT04164758|450149482|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
125143607|NCT04164758|450149480|FG000|Overall Study|Adverse Event|0|||
125143608|NCT04164758|450149481|FG001|Overall Study|Adverse Event|1|||
125143609|NCT04164758|450149482|FG002|Overall Study|Adverse Event|0|||
125143610|NCT02858037|450149489|FG000|Overall Study|Death|1|||
125143611|NCT02858037|450149489|FG000|Overall Study|Withdrawal by Subject|18|||
125143612|NCT02858037|450149489|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
125143613|NCT02858037|450149489|FG000|Overall Study|Lost to Follow-up|3|||
125143614|NCT02858037|450149489|FG000|Overall Study|Other|4|||
125143615|NCT01670097|450149490|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
125143616|NCT01670097|450149491|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
125143617|NCT01670097|450149490|FG000|Overall Study|Study burden|1|||
125143618|NCT01670097|450149491|FG001|Overall Study|Study burden|0|||
125143619|NCT01670097|450149490|FG000|Overall Study|COPD exacerbation|0|||
125143620|NCT01670097|450149491|FG001|Overall Study|COPD exacerbation|1|||
125143621|NCT01670097|450149490|FG000|Overall Study|Neutropenia|0|||
125143622|NCT01670097|450149491|FG001|Overall Study|Neutropenia|1|||
125143623|NCT01670097|450149490|FG000|Overall Study|Clinical deterioration|0|||
125143624|NCT01670097|450149491|FG001|Overall Study|Clinical deterioration|1|||
125143625|NCT01670097|450149490|FG000|Overall Study|Disease progression|0|||
125143626|NCT01670097|450149491|FG001|Overall Study|Disease progression|1|||
125143627|NCT00697827|450149492|FG000|Overall Study|enrolled but not treated|2|||
125143628|NCT00697827|450149493|FG001|Overall Study|enrolled but not treated|1|||
125143629|NCT03732833|450149494|FG000|Overall Study|Adverse Event|0|||
125143630|NCT03732833|450149495|FG001|Overall Study|Adverse Event|3|||
125143631|NCT03732833|450149496|FG002|Overall Study|Adverse Event|1|||
125143632|NCT03732833|450149494|FG000|Overall Study|Withdrawal by Subject|11|||
125143633|NCT03732833|450149495|FG001|Overall Study|Withdrawal by Subject|13|||
125143634|NCT03732833|450149496|FG002|Overall Study|Withdrawal by Subject|8|||
125143635|NCT03732833|450149494|FG000|Overall Study|Lost to Follow-up|3|||
125143636|NCT03732833|450149495|FG001|Overall Study|Lost to Follow-up|5|||
125143637|NCT03732833|450149496|FG002|Overall Study|Lost to Follow-up|4|||
125143638|NCT03732833|450149494|FG000|Overall Study|Pregnancy|0|||
125143639|NCT03732833|450149495|FG001|Overall Study|Pregnancy|2|||
125143640|NCT03732833|450149496|FG002|Overall Study|Pregnancy|0|||
125143641|NCT03732833|450149494|FG000|Overall Study|Physician Decision|2|||
125143642|NCT03732833|450149495|FG001|Overall Study|Physician Decision|3|||
125143643|NCT03732833|450149496|FG002|Overall Study|Physician Decision|1|||
125143644|NCT03732833|450149494|FG000|Overall Study|Covid-19 related and other reasons|2|||
125143645|NCT03732833|450149495|FG001|Overall Study|Covid-19 related and other reasons|7|||
125143646|NCT03732833|450149496|FG002|Overall Study|Covid-19 related and other reasons|3|||
125143647|NCT02311894|450149498|FG000|Overall Study|Discontinued in error|1|||
125143648|NCT02311894|450149498|FG000|Overall Study|Lost to Follow-up|1|||
125143649|NCT02311894|450149498|FG000|Overall Study|Adverse Event|1|||
125143650|NCT02311894|450149498|FG000|Overall Study|Withdrawal by Subject|1|||
125143651|NCT00702507|450149501|FG000|Initial Treatment Phase|Adverse Event|2|||
125143652|NCT00702507|450149501|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
125143653|NCT00702507|450149501|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
125143654|NCT00702507|450149501|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
125143655|NCT00702507|450149501|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
125143656|NCT00702507|450149501|FG000|Follow-up Phase|Protocol Violation|2|||
125143657|NCT00702507|450149501|FG000|Follow-up Phase|Lost to Follow-up|23|||
125386931|NCT03760146|451050861|FG005|Overall Study|Death|0|||
125386932|NCT03760146|451050856|FG000|Overall Study|Lost to Follow-up|41|||
125143658|NCT00702507|450149501|FG000|Follow-up Phase|Late Enrollment|1|||
125143659|NCT01277510|450149502|FG000|Double-blind Phase|Non-compliance|0|||
125143660|NCT01277510|450149503|FG001|Double-blind Phase|Non-compliance|1|||
125143661|NCT01277510|450149502|FG000|Double-blind Phase|Adverse Event|1|||
125143662|NCT01277510|450149503|FG001|Double-blind Phase|Adverse Event|0|||
125143663|NCT01277510|450149502|FG000|Double-blind Phase|Withdrawal by Subject|2|||
125143664|NCT01277510|450149503|FG001|Double-blind Phase|Withdrawal by Subject|0|||
125143665|NCT01277510|450149502|FG000|Double-blind Phase|Administrative decision|7|||
125143666|NCT01277510|450149503|FG001|Double-blind Phase|Administrative decision|9|||
125143667|NCT01277510|450149502|FG000|Double-blind Phase|Death|0|||
125143668|NCT01277510|450149503|FG001|Double-blind Phase|Death|1|||
125143669|NCT01277510|450149502|FG000|Double-blind Phase|Protocol-specified criteria|2|||
125143670|NCT01277510|450149503|FG001|Double-blind Phase|Protocol-specified criteria|6|||
125386933|NCT03760146|451050857|FG001|Overall Study|Lost to Follow-up|28|||
125386934|NCT03760146|451050858|FG002|Overall Study|Lost to Follow-up|9|||
125143671|NCT01277510|450149502|FG000|Double-blind Phase|Other|1|||
125143672|NCT01277510|450149503|FG001|Double-blind Phase|Other|1|||
125143673|NCT01277510|450149502|FG000|Open-label Phase|Administrative decision|4|||
125143674|NCT01277510|450149503|FG001|Open-label Phase|Administrative decision|3|||
125143675|NCT01277510|450149502|FG000|Open-label Phase|Protocol-specified criteria|1|||
125143676|NCT01277510|450149503|FG001|Open-label Phase|Protocol-specified criteria|0|||
125143677|NCT01277510|450149502|FG000|Open-label Phase|Never received investigational product|2|||
125143678|NCT01277510|450149503|FG001|Open-label Phase|Never received investigational product|0|||
125143679|NCT01685008|450149504|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
125143680|NCT01685008|450149505|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
125143681|NCT01685008|450149506|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
125143682|NCT01685008|450149507|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
125386935|NCT03760146|451050859|FG003|Overall Study|Lost to Follow-up|2|||
125386936|NCT03760146|451050860|FG004|Overall Study|Lost to Follow-up|14|||
125143683|NCT01685008|450149504|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
125143684|NCT01685008|450149505|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
125143685|NCT01685008|450149506|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
125143686|NCT01685008|450149507|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
125143687|NCT01685008|450149504|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
125143688|NCT01685008|450149505|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
125143689|NCT01685008|450149506|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
125143690|NCT01685008|450149507|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
125143691|NCT01685008|450149504|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
125143692|NCT01685008|450149505|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
125143693|NCT01685008|450149506|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
125143694|NCT01685008|450149507|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
125143695|NCT01685008|450149504|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
125143696|NCT01685008|450149505|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
125143697|NCT01685008|450149506|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
125143698|NCT01685008|450149507|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
125143699|NCT00057941|450149519|FG000|Overall Study|Death|1|||
125143700|NCT00057941|450149520|FG001|Overall Study|Death|2|||
125143701|NCT00057941|450149519|FG000|Overall Study|Adverse Event|7|||
125143702|NCT00057941|450149520|FG001|Overall Study|Adverse Event|9|||
125143703|NCT00057941|450149519|FG000|Overall Study|Lack of Efficacy|54|||
125143704|NCT00057941|450149520|FG001|Overall Study|Lack of Efficacy|53|||
125143705|NCT00057941|450149519|FG000|Overall Study|Withdrawal by Subject|6|||
125143706|NCT00057941|450149520|FG001|Overall Study|Withdrawal by Subject|1|||
125143707|NCT00057941|450149519|FG000|Overall Study|still on treatment|3|||
125143708|NCT00057941|450149520|FG001|Overall Study|still on treatment|1|||
125143709|NCT00057941|450149519|FG000|Overall Study|insurance, symptomatic deterioration|1|||
125143710|NCT00057941|450149520|FG001|Overall Study|insurance, symptomatic deterioration|3|||
125143711|NCT00057941|450149519|FG000|Overall Study|Ineligible|2|||
125143712|NCT00057941|450149520|FG001|Overall Study|Ineligible|5|||
125143713|NCT01898598|450149522|FG000|Overall Study|Adverse Event|1|||
125143714|NCT01898598|450149523|FG001|Overall Study|Adverse Event|0|||
125143715|NCT01898598|450149522|FG000|Overall Study|Withdrawal by Subject|3|||
125143716|NCT01898598|450149523|FG001|Overall Study|Withdrawal by Subject|0|||
125143717|NCT01898598|450149522|FG000|Overall Study|Lost to Follow-up|0|||
125143718|NCT01898598|450149523|FG001|Overall Study|Lost to Follow-up|1|||
125143719|NCT01898598|450149522|FG000|Overall Study|Other|0|||
125143720|NCT01898598|450149523|FG001|Overall Study|Other|1|||
125143721|NCT03833427|450149524|FG000|Overall Study|Death|4|||
125143722|NCT03833427|450149525|FG001|Overall Study|Death|2|||
125143723|NCT03833427|450149526|FG002|Overall Study|Death|9|||
125143724|NCT03833427|450149527|FG003|Overall Study|Death|11|||
125143725|NCT03833427|450149528|FG004|Overall Study|Death|0|||
125143726|NCT03833427|450149529|FG005|Overall Study|Death|0|||
125143727|NCT03833427|450149530|FG006|Overall Study|Death|0|||
125143728|NCT03833427|450149524|FG000|Overall Study|Withdrawal by Subject|0|||
125143729|NCT03833427|450149525|FG001|Overall Study|Withdrawal by Subject|1|||
125143730|NCT03833427|450149526|FG002|Overall Study|Withdrawal by Subject|1|||
125143731|NCT03833427|450149527|FG003|Overall Study|Withdrawal by Subject|0|||
125143732|NCT03833427|450149528|FG004|Overall Study|Withdrawal by Subject|0|||
125143733|NCT03833427|450149529|FG005|Overall Study|Withdrawal by Subject|0|||
125143734|NCT03833427|450149530|FG006|Overall Study|Withdrawal by Subject|0|||
125143735|NCT03833427|450149524|FG000|Overall Study|Sponsor Decision|0|||
125143736|NCT03833427|450149525|FG001|Overall Study|Sponsor Decision|0|||
125143737|NCT03833427|450149526|FG002|Overall Study|Sponsor Decision|1|||
125143738|NCT03833427|450149527|FG003|Overall Study|Sponsor Decision|3|||
125143739|NCT03833427|450149528|FG004|Overall Study|Sponsor Decision|0|||
125143740|NCT03833427|450149529|FG005|Overall Study|Sponsor Decision|0|||
125143741|NCT03833427|450149530|FG006|Overall Study|Sponsor Decision|0|||
125143742|NCT01499160|450149532|FG000|Overall Study|Adverse Event|1|||
125143743|NCT01499160|450149532|FG000|Overall Study|Withdrawal by Subject|1|||
125143744|NCT02387762|450149535|FG000|Overall Study|Withdrawal by Subject|1|||
125143745|NCT02387762|450149536|FG001|Overall Study|Withdrawal by Subject|0|||
125143746|NCT01596127|450149537|FG000|Overall Study|Patient Ineligible|1|||
125143747|NCT00688844|450149539|FG000|Overall Study|Lost to Follow-up|10|||
125143748|NCT01374451|450149540|FG000|Overall Study|Administrative problems|1|||
125143749|NCT01374451|450149541|FG001|Overall Study|Administrative problems|0|||
125143750|NCT01223027|450149542|FG000|Overall Study|Adverse Event|20|||
125143751|NCT01223027|450149543|FG001|Overall Study|Adverse Event|10|||
125143752|NCT01223027|450149542|FG000|Overall Study|Death|42|||
125143753|NCT01223027|450149543|FG001|Overall Study|Death|42|||
125143754|NCT01223027|450149542|FG000|Overall Study|Lost to Follow-up|2|||
125143755|NCT01223027|450149543|FG001|Overall Study|Lost to Follow-up|1|||
125143756|NCT01223027|450149542|FG000|Overall Study|Physician Decision|4|||
125143757|NCT01223027|450149543|FG001|Overall Study|Physician Decision|8|||
125143758|NCT01223027|450149542|FG000|Overall Study|Progressive Disease|167|||
125143759|NCT01223027|450149543|FG001|Overall Study|Progressive Disease|183|||
125143760|NCT01223027|450149542|FG000|Overall Study|Protocol Violation|2|||
125143761|NCT01223027|450149543|FG001|Overall Study|Protocol Violation|1|||
125143762|NCT01223027|450149542|FG000|Overall Study|Subject/guardian decicion|18|||
125143763|NCT01223027|450149543|FG001|Overall Study|Subject/guardian decicion|16|||
125143764|NCT01223027|450149542|FG000|Overall Study|New therapy for study indication|17|||
125143765|NCT01223027|450149543|FG001|Overall Study|New therapy for study indication|8|||
125143766|NCT01223027|450149542|FG000|Overall Study|Study terminated by sponsor|2|||
125143767|NCT01223027|450149543|FG001|Overall Study|Study terminated by sponsor|8|||
125143768|NCT03201003|450149547|FG000|Overall Study|Adverse Event|14|||
125143769|NCT03201003|450149548|FG001|Overall Study|Adverse Event|1|||
125143770|NCT03201003|450149547|FG000|Overall Study|Other reasons|5|||
125143771|NCT03201003|450149548|FG001|Overall Study|Other reasons|1|||
125143772|NCT03201003|450149547|FG000|Overall Study|Withdrawal by Subject|4|||
125143773|NCT03201003|450149548|FG001|Overall Study|Withdrawal by Subject|1|||
125143774|NCT03201003|450149547|FG000|Overall Study|Lost to Follow-up|2|||
125143775|NCT03201003|450149548|FG001|Overall Study|Lost to Follow-up|0|||
125143776|NCT03201003|450149547|FG000|Overall Study|Protocol Violation|1|||
125143777|NCT03201003|450149548|FG001|Overall Study|Protocol Violation|0|||
125143778|NCT00834613|450149549|FG000|First Intervention|Protocol Violation|1|||
125143779|NCT00834613|450149550|FG001|First Intervention|Protocol Violation|0|||
125143780|NCT00663234|450149551|FG000|Overall Study|Not willing to adhere to requirements|1|||
125143781|NCT01709903|450149554|FG000|Overall Study|administrative problems|2|||
125143782|NCT01709903|450149555|FG001|Overall Study|administrative problems|6|||
125143783|NCT01709903|450149554|FG000|Overall Study|Abnormal test procedure results|1|||
125143784|NCT01709903|450149555|FG001|Overall Study|Abnormal test procedure results|0|||
125143785|NCT01709903|450149554|FG000|Overall Study|In ability to use device|1|||
125143786|NCT01709903|450149555|FG001|Overall Study|In ability to use device|1|||
125143787|NCT01709903|450149554|FG000|Overall Study|no longer needed study drug|0|||
125143788|NCT01709903|450149555|FG001|Overall Study|no longer needed study drug|1|||
125143789|NCT01709903|450149554|FG000|Overall Study|Lost to Follow-up|0|||
125143790|NCT01709903|450149555|FG001|Overall Study|Lost to Follow-up|2|||
125143791|NCT01709903|450149554|FG000|Overall Study|Death|2|||
125143792|NCT01709903|450149555|FG001|Overall Study|Death|0|||
125143793|NCT01709903|450149554|FG000|Overall Study|Protocol Violation|3|||
125143794|NCT01709903|450149555|FG001|Overall Study|Protocol Violation|2|||
125143795|NCT01709903|450149554|FG000|Overall Study|Lack of Efficacy|3|||
125143796|NCT01709903|450149555|FG001|Overall Study|Lack of Efficacy|3|||
125143797|NCT01709903|450149554|FG000|Overall Study|Withdrawal by Subject|6|||
125143798|NCT01709903|450149555|FG001|Overall Study|Withdrawal by Subject|6|||
125143799|NCT01709903|450149554|FG000|Overall Study|Adverse Event|11|||
125143800|NCT01709903|450149555|FG001|Overall Study|Adverse Event|18|||
125143801|NCT02061280|450149556|FG000|Overall Study|Protocol Violation|12|||
125143802|NCT02061280|450149557|FG001|Overall Study|Protocol Violation|8|||
125143803|NCT02061280|450149556|FG000|Overall Study|moved out of state|0|||
125143804|NCT02061280|450149557|FG001|Overall Study|moved out of state|1|||
125143805|NCT02061280|450149556|FG000|Overall Study|Withdrawal by Subject|1|||
125143806|NCT02061280|450149557|FG001|Overall Study|Withdrawal by Subject|2|||
125143807|NCT02061280|450149556|FG000|Overall Study|Lost to Follow-up|5|||
125143808|NCT02061280|450149557|FG001|Overall Study|Lost to Follow-up|1|||
125143809|NCT00724958|450149571|FG000|Overall Study|Adverse Event|28|||
125143810|NCT00724958|450149571|FG000|Overall Study|Loss of Response|40|||
125143811|NCT00724958|450149571|FG000|Overall Study|No Response|18|||
125143812|NCT00724958|450149571|FG000|Overall Study|Remission|7|||
125143813|NCT00724958|450149571|FG000|Overall Study|Other Reason|76|||
125143814|NCT00724958|450149571|FG000|Overall Study|No documentation for end of therapy|13|||
125143815|NCT00697619|450149572|FG000|Overall Study|Lack of Efficacy|2|||
125143816|NCT00697619|450149573|FG001|Overall Study|Lack of Efficacy|2|||
125143817|NCT00697619|450149572|FG000|Overall Study|Adverse Event|4|||
125143818|NCT00697619|450149573|FG001|Overall Study|Adverse Event|6|||
125223385|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125223386|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125223387|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125223388|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125223389|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
125223390|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
125223391|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
125223392|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
125386937|NCT03760146|451050861|FG005|Overall Study|Lost to Follow-up|8|||
125143819|NCT00258856|450151329|FG000|Overall Study|Lost to Follow-up|1|||
125143820|NCT00258856|450151330|FG001|Overall Study|Lost to Follow-up|0|||
125143821|NCT00258856|450151331|FG002|Overall Study|Lost to Follow-up|2|||
125143822|NCT00258856|450151332|FG003|Overall Study|Lost to Follow-up|0|||
125143823|NCT00258856|450151329|FG000|Overall Study|Non-compliance|2|||
125143824|NCT00258856|450151330|FG001|Overall Study|Non-compliance|0|||
125143825|NCT00258856|450151331|FG002|Overall Study|Non-compliance|0|||
125143826|NCT00258856|450151332|FG003|Overall Study|Non-compliance|1|||
125143827|NCT01754376|450151338|FG000|Overall Study|Adverse Event|1|||
125143828|NCT01754376|450151338|FG000|Overall Study|Lack of Efficacy|2|||
125143829|NCT04556734|450151339|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
125143830|NCT04556734|450151340|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
125143831|NCT04556734|450151341|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
125143832|NCT04556734|450151342|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125143833|NCT04556734|450151343|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125143834|NCT04556734|450151344|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125143835|NCT04556734|450151345|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125143836|NCT04556734|450151346|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125143837|NCT04556734|450151339|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
125143838|NCT04556734|450151340|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125143839|NCT04556734|450151341|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125143840|NCT04556734|450151342|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125143841|NCT04556734|450151343|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125143842|NCT04556734|450151344|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125438433|NCT01155661|451232253|FG000|Overall Study|Lack of Efficacy|32|||
125143843|NCT04556734|450151345|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125143844|NCT04556734|450151346|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125143845|NCT04556734|450151339|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125143846|NCT04556734|450151340|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125143847|NCT04556734|450151341|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125143848|NCT04556734|450151342|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125143849|NCT04556734|450151343|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125143850|NCT04556734|450151344|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125143851|NCT04556734|450151345|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125143852|NCT04556734|450151346|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125143853|NCT04556734|450151339|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
125143854|NCT04556734|450151340|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143855|NCT04556734|450151341|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143856|NCT04556734|450151342|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143857|NCT04556734|450151343|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143858|NCT04556734|450151344|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143859|NCT04556734|450151345|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143860|NCT04556734|450151346|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125143861|NCT04556734|450151339|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143862|NCT04556734|450151340|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143863|NCT04556734|450151341|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
125143864|NCT04556734|450151342|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143865|NCT04556734|450151343|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143866|NCT04556734|450151344|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143867|NCT04556734|450151345|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143868|NCT04556734|450151346|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
125143869|NCT04556734|450151339|FG000|OLE Period (28 Weeks)|Not reported|0|||
125143870|NCT04556734|450151340|FG001|OLE Period (28 Weeks)|Not reported|0|||
125143871|NCT04556734|450151341|FG002|OLE Period (28 Weeks)|Not reported|0|||
125143872|NCT04556734|450151342|FG003|OLE Period (28 Weeks)|Not reported|0|||
125143873|NCT04556734|450151343|FG004|OLE Period (28 Weeks)|Not reported|0|||
125143874|NCT04556734|450151344|FG005|OLE Period (28 Weeks)|Not reported|1|||
125143875|NCT04556734|450151345|FG006|OLE Period (28 Weeks)|Not reported|0|||
125143876|NCT04556734|450151346|FG007|OLE Period (28 Weeks)|Not reported|0|||
125143877|NCT04556734|450151339|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143878|NCT04556734|450151340|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143879|NCT04556734|450151341|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143880|NCT04556734|450151342|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143881|NCT04556734|450151343|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143882|NCT04556734|450151344|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143883|NCT04556734|450151345|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
125143884|NCT04556734|450151346|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
125143885|NCT04556734|450151339|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
125143886|NCT04556734|450151340|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
125143887|NCT04556734|450151341|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
125143888|NCT04556734|450151342|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
125143889|NCT04556734|450151343|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
125143890|NCT04556734|450151344|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
125143891|NCT04556734|450151345|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
125143892|NCT04556734|450151346|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
125143893|NCT04556734|450151339|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125143894|NCT04556734|450151340|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125143895|NCT04556734|450151341|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125143896|NCT04556734|450151342|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
125143897|NCT04556734|450151343|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
125143898|NCT04556734|450151344|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
125143899|NCT04556734|450151345|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
125143900|NCT04556734|450151346|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
125143901|NCT04264819|450151347|FG000|Overall Study|Physician Decision|19|||
125143902|NCT04264819|450151347|FG000|Overall Study|Adverse Event|12|||
125143903|NCT04264819|450151347|FG000|Overall Study|Withdrawal by Subject|11|||
125386938|NCT03760146|451050856|FG000|Overall Study|No longer met eligibility criteria|3|||
125143904|NCT04264819|450151347|FG000|Overall Study|Lost to Follow-up|2|||
125143905|NCT04264819|450151347|FG000|Overall Study|Death|2|||
125143906|NCT01705717|450151353|FG000|Overall Study|Adverse Event|2|||
125143907|NCT01705717|450151354|FG001|Overall Study|Adverse Event|2|||
125143908|NCT01705717|450151353|FG000|Overall Study|Lack of Efficacy|0|||
125143909|NCT01705717|450151354|FG001|Overall Study|Lack of Efficacy|1|||
125143910|NCT01705717|450151353|FG000|Overall Study|Other|0|||
125143911|NCT01705717|450151354|FG001|Overall Study|Other|2|||
125143912|NCT01188226|450151358|FG000|Overall Study|Withdrawal by Subject|4|||
125143913|NCT01662024|450151359|FG000|Overall Study|Pregnancy|2|||
125143914|NCT01662024|450151359|FG000|Overall Study|Withdrawal by Subject|3|||
125143915|NCT02846883|450151360|FG000|Overall Study|Death|0|||
125223393|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
125223394|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125223395|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125143916|NCT02846883|450151361|FG001|Overall Study|Death|1|||
125143917|NCT02846883|450151362|FG002|Overall Study|Death|1|||
125143918|NCT02846883|450151360|FG000|Overall Study|Lost to Follow-up|0|||
125143919|NCT02846883|450151361|FG001|Overall Study|Lost to Follow-up|0|||
125143920|NCT02846883|450151362|FG002|Overall Study|Lost to Follow-up|1|||
125143921|NCT02846883|450151360|FG000|Overall Study|Withdrawal by Subject|1|||
125143922|NCT02846883|450151361|FG001|Overall Study|Withdrawal by Subject|0|||
125143923|NCT02846883|450151362|FG002|Overall Study|Withdrawal by Subject|0|||
125143924|NCT02846883|450151360|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
125143925|NCT02846883|450151361|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
125143926|NCT02846883|450151362|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
125143927|NCT02846883|450151360|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
125143928|NCT02846883|450151361|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
125143929|NCT02846883|450151362|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
125143930|NCT04768296|450151363|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
125143931|NCT04768296|450151364|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
125143932|NCT01453153|450151371|FG000|Overall Study|Physician Decision|0|||
125143933|NCT01453153|450151372|FG001|Overall Study|Physician Decision|0|||
125143934|NCT01453153|450151373|FG002|Overall Study|Physician Decision|1|||
125143935|NCT01453153|450151371|FG000|Overall Study|Progressive Disease|3|||
125143936|NCT01453153|450151372|FG001|Overall Study|Progressive Disease|2|||
125143937|NCT01453153|450151373|FG002|Overall Study|Progressive Disease|16|||
125143938|NCT01453153|450151371|FG000|Overall Study|Withdrawal by Subject|0|||
125143939|NCT01453153|450151372|FG001|Overall Study|Withdrawal by Subject|1|||
125143940|NCT01453153|450151373|FG002|Overall Study|Withdrawal by Subject|2|||
125143941|NCT01453153|450151371|FG000|Overall Study|Adverse Event|1|||
125143942|NCT01453153|450151372|FG001|Overall Study|Adverse Event|1|||
125143943|NCT01453153|450151373|FG002|Overall Study|Adverse Event|1|||
125143944|NCT01802216|450151378|FG000|4 Month Visit|Participant did not show to visit|3|||
125143945|NCT01802216|450151379|FG001|4 Month Visit|Participant did not show to visit|4|||
125143946|NCT01802216|450151378|FG000|8 Month Visit|Participant did not show to visit|3|||
125143947|NCT01802216|450151379|FG001|8 Month Visit|Participant did not show to visit|5|||
125143948|NCT01802216|450151378|FG000|12 Month Visit|Participant did not show to visit|3|||
125143949|NCT01802216|450151379|FG001|12 Month Visit|Participant did not show to visit|4|||
125143950|NCT00799708|450151380|FG000|Overall Study|non-compliance|1|||
125143951|NCT00799708|450151381|FG001|Overall Study|non-compliance|0|||
125143952|NCT00799708|450151382|FG002|Overall Study|non-compliance|0|||
125143953|NCT03343639|450151383|FG000|Overall Study|Withdrawal by Subject|10|||
125143954|NCT03343639|450151384|FG001|Overall Study|Withdrawal by Subject|6|||
125143955|NCT03343639|450151383|FG000|Overall Study|Lost to Follow-up|4|||
125143956|NCT03343639|450151384|FG001|Overall Study|Lost to Follow-up|5|||
125143957|NCT03343639|450151383|FG000|Overall Study|Protocol Violation|0|||
125143958|NCT03343639|450151384|FG001|Overall Study|Protocol Violation|1|||
125143959|NCT02274558|450151390|FG000|Overall Study|Adverse Event|2|||
125143960|NCT02274558|450151391|FG001|Overall Study|Adverse Event|4|||
125143961|NCT02274558|450151392|FG002|Overall Study|Adverse Event|2|||
125143962|NCT02274558|450151390|FG000|Overall Study|Non-compliance|2|||
125143963|NCT02274558|450151391|FG001|Overall Study|Non-compliance|1|||
125438434|NCT01155661|451232253|FG000|Overall Study|Lost to Follow-up|22|||
125143964|NCT02274558|450151392|FG002|Overall Study|Non-compliance|0|||
125143965|NCT02274558|450151390|FG000|Overall Study|Withdrawal by Subject|1|||
125143966|NCT02274558|450151391|FG001|Overall Study|Withdrawal by Subject|5|||
125143967|NCT02274558|450151392|FG002|Overall Study|Withdrawal by Subject|4|||
125143968|NCT02274558|450151390|FG000|Overall Study|Death|0|||
125143969|NCT02274558|450151391|FG001|Overall Study|Death|0|||
125143970|NCT02274558|450151392|FG002|Overall Study|Death|1|||
125143971|NCT02274558|450151390|FG000|Overall Study|Lost to Follow-up|2|||
125143972|NCT02274558|450151391|FG001|Overall Study|Lost to Follow-up|1|||
125143973|NCT02274558|450151392|FG002|Overall Study|Lost to Follow-up|1|||
125143974|NCT02274558|450151390|FG000|Overall Study|Physician Decision|0|||
125143975|NCT02274558|450151391|FG001|Overall Study|Physician Decision|2|||
125143976|NCT02274558|450151392|FG002|Overall Study|Physician Decision|1|||
125143977|NCT02655224|450151393|FG000|Overall Study|Adverse Event|1|||
125143978|NCT02655224|450151394|FG001|Overall Study|Adverse Event|1|||
125143979|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
125143980|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
125143981|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
125143982|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
125143983|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
125143984|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
125143985|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
125143986|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
125143987|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
125143988|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
125143989|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
125143990|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
125143991|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
125143992|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
125143993|NCT04592419|450151397|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
125143994|NCT04592419|450151398|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
125143995|NCT04592419|450151397|FG000|Open-Label Extension Period|Adverse Event|1|||
125143996|NCT04592419|450151398|FG001|Open-Label Extension Period|Adverse Event|2|||
125143997|NCT04592419|450151397|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
125143998|NCT04592419|450151398|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
125143999|NCT04592419|450151397|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
125144000|NCT04592419|450151398|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
125144001|NCT04592419|450151397|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
125144002|NCT04592419|450151398|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
125144003|NCT04592419|450151397|FG000|Open-Label Extension Period|Sponsor Request|73|||
125144004|NCT04592419|450151398|FG001|Open-Label Extension Period|Sponsor Request|84|||
125144005|NCT05393271|450151403|FG000|Overall Study|Physician Decision|0|||
125144006|NCT05393271|450151404|FG001|Overall Study|Physician Decision|0|||
125144007|NCT05393271|450151405|FG002|Overall Study|Physician Decision|0|||
125144008|NCT05393271|450151406|FG003|Overall Study|Physician Decision|0|||
125144009|NCT05393271|450151407|FG004|Overall Study|Physician Decision|0|||
125144010|NCT05393271|450151408|FG005|Overall Study|Physician Decision|0|||
125144011|NCT05393271|450151409|FG006|Overall Study|Physician Decision|1|||
125144012|NCT05393271|450151410|FG007|Overall Study|Physician Decision|0|||
125144013|NCT05393271|450151411|FG008|Overall Study|Physician Decision|0|||
125144014|NCT05393271|450151412|FG009|Overall Study|Physician Decision|0|||
125144015|NCT05393271|450151413|FG010|Overall Study|Physician Decision|0|||
125144016|NCT02943993|450151414|FG000|Overall Study|Withdrawal by Subject|52|||
125144017|NCT02943993|450151414|FG000|Overall Study|Transfer to another institution|6|||
125144018|NCT02943993|450151414|FG000|Overall Study|Lost to Follow-up|135|||
125144019|NCT02943993|450151414|FG000|Overall Study|Death|98|||
125144020|NCT02943993|450151414|FG000|Overall Study|Other reason for premature termination|32|||
125144021|NCT02943993|450151414|FG000|Overall Study|Missing reason for termination|7|||
125144022|NCT02483416|450151415|FG000|Overall Study|Other reason|0|||
125144023|NCT02483416|450151416|FG001|Overall Study|Other reason|1|||
125144024|NCT02483416|450151415|FG000|Overall Study|Treatment stop|3|||
125144025|NCT02483416|450151416|FG001|Overall Study|Treatment stop|0|||
125144026|NCT04968925|450151417|FG000|Phase I- Period 1|COVID-19 related|0|||
125144027|NCT04968925|450151418|FG001|Phase I- Period 1|COVID-19 related|1|||
125144028|NCT04968925|450151419|FG002|Phase I- Period 1|COVID-19 related|0|||
125144029|NCT04968925|450151420|FG003|Phase I- Period 1|COVID-19 related|0|||
125144030|NCT04968925|450151417|FG000|Phase I- Period 1|Subject enrolled in error|1|||
125144031|NCT04968925|450151418|FG001|Phase I- Period 1|Subject enrolled in error|1|||
125144032|NCT04968925|450151419|FG002|Phase I- Period 1|Subject enrolled in error|0|||
125223396|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125386939|NCT03760146|451050857|FG001|Overall Study|No longer met eligibility criteria|9|||
125144033|NCT04968925|450151420|FG003|Phase I- Period 1|Subject enrolled in error|0|||
125144034|NCT04968925|450151417|FG000|Phase II- Period 1|COVID-19 Related|0|||
125386940|NCT03760146|451050858|FG002|Overall Study|No longer met eligibility criteria|0|||
125386941|NCT03760146|451050859|FG003|Overall Study|No longer met eligibility criteria|0|||
125386942|NCT03760146|451050860|FG004|Overall Study|No longer met eligibility criteria|1|||
125386943|NCT03760146|451050861|FG005|Overall Study|No longer met eligibility criteria|0|||
125144035|NCT04968925|450151418|FG001|Phase II- Period 1|COVID-19 Related|0|||
125144036|NCT04968925|450151419|FG002|Phase II- Period 1|COVID-19 Related|6|||
125144037|NCT04968925|450151420|FG003|Phase II- Period 1|COVID-19 Related|6|||
125144038|NCT04968925|450151417|FG000|Phase II- Period 1|Subject enrolled in error|0|||
125144039|NCT04968925|450151418|FG001|Phase II- Period 1|Subject enrolled in error|0|||
125144040|NCT04968925|450151419|FG002|Phase II- Period 1|Subject enrolled in error|1|||
125144041|NCT04968925|450151420|FG003|Phase II- Period 1|Subject enrolled in error|0|||
125144042|NCT04968925|450151417|FG000|Phase II -Period 2|COVID-19 related|0|||
125144043|NCT04968925|450151418|FG001|Phase II -Period 2|COVID-19 related|0|||
125144044|NCT04968925|450151419|FG002|Phase II -Period 2|COVID-19 related|4|||
125144045|NCT04968925|450151420|FG003|Phase II -Period 2|COVID-19 related|3|||
125144046|NCT04968925|450151417|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
125144047|NCT04968925|450151418|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
125223397|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125386944|NCT03760146|451050856|FG000|Overall Study|Protocol Violation|21|||
125223398|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125223399|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125386945|NCT03760146|451050857|FG001|Overall Study|Protocol Violation|13|||
125144048|NCT04968925|450151419|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
125144049|NCT04968925|450151420|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
125144050|NCT00876265|450151425|FG000|Overall Study|Miscellaneous reasons|4|||
125144051|NCT00876265|450151425|FG000|Overall Study|Lost to Follow-up|6|||
125144052|NCT00876265|450151425|FG000|Overall Study|Withdrawal by Subject|2|||
125144053|NCT02754492|450151426|FG000|Overall Study|Protocol Violation|2|||
125144054|NCT02754492|450151427|FG001|Overall Study|Protocol Violation|2|||
125144055|NCT02754492|450151428|FG002|Overall Study|Protocol Violation|0|||
125144056|NCT02754492|450151429|FG003|Overall Study|Protocol Violation|1|||
125144057|NCT02754492|450151426|FG000|Overall Study|Withdrawal by Subject|2|||
125144058|NCT02754492|450151427|FG001|Overall Study|Withdrawal by Subject|0|||
125144059|NCT02754492|450151428|FG002|Overall Study|Withdrawal by Subject|0|||
125144060|NCT02754492|450151429|FG003|Overall Study|Withdrawal by Subject|0|||
125144061|NCT02754492|450151426|FG000|Overall Study|Equipment malfuntion|0|||
125144062|NCT02754492|450151427|FG001|Overall Study|Equipment malfuntion|0|||
125144063|NCT02754492|450151428|FG002|Overall Study|Equipment malfuntion|2|||
125144064|NCT02754492|450151429|FG003|Overall Study|Equipment malfuntion|5|||
125144065|NCT02754492|450151426|FG000|Overall Study|Adverse Event|0|||
125144066|NCT02754492|450151427|FG001|Overall Study|Adverse Event|0|||
125144067|NCT02754492|450151428|FG002|Overall Study|Adverse Event|0|||
125144068|NCT02754492|450151429|FG003|Overall Study|Adverse Event|13|||
125144069|NCT02754492|450151426|FG000|Overall Study|Venous access issues not resulting in AE|0|||
125144070|NCT02754492|450151427|FG001|Overall Study|Venous access issues not resulting in AE|0|||
125144071|NCT02754492|450151428|FG002|Overall Study|Venous access issues not resulting in AE|0|||
125144072|NCT02754492|450151429|FG003|Overall Study|Venous access issues not resulting in AE|4|||
125144073|NCT01408888|450151430|FG000|First Intervention|Adverse Event|0|||
125144074|NCT01408888|450151431|FG001|First Intervention|Adverse Event|1|||
125144075|NCT01408888|450151430|FG000|First Intervention|Withdrawal by Subject|0|||
125144076|NCT01408888|450151431|FG001|First Intervention|Withdrawal by Subject|2|||
125144077|NCT01408888|450151430|FG000|Second Intervention|Withdrawal by Subject|1|||
125144078|NCT01408888|450151431|FG001|Second Intervention|Withdrawal by Subject|0|||
125144079|NCT01408888|450151430|FG000|Second Intervention|Adverse Event|1|||
125144080|NCT01408888|450151431|FG001|Second Intervention|Adverse Event|0|||
125144081|NCT00487695|450151434|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
125144082|NCT00487695|450151435|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
125144083|NCT00487695|450151434|FG000|First Procedure|active wheezing (did not have procedure)|1|||
125144084|NCT00487695|450151435|FG001|First Procedure|active wheezing (did not have procedure)|0|||
125144085|NCT00487695|450151434|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
125144086|NCT00487695|450151435|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
125144087|NCT00487695|450151434|FG000|Second Procedure|active wheezing|0|||
125144088|NCT00487695|450151435|FG001|Second Procedure|active wheezing|1|||
125144089|NCT00487695|450151434|FG000|Second Procedure|Withdrawal by Subject|1|||
125144090|NCT00487695|450151435|FG001|Second Procedure|Withdrawal by Subject|2|||
125144091|NCT00695110|450151436|FG000|Treatment Period 1|Adverse Event|1|||
125144092|NCT00695110|450151436|FG000|Treatment Period 1|Withdrawal by Subject|2|||
125386946|NCT03760146|451050858|FG002|Overall Study|Protocol Violation|1|||
125386947|NCT03760146|451050859|FG003|Overall Study|Protocol Violation|0|||
125144093|NCT00695110|450151436|FG000|Treatment Period 3|Withdrawal by Subject|1|||
125144094|NCT00695110|450151436|FG000|Treatment Period 4|Adverse Event|1|||
125144095|NCT04542694|450151437|FG000|Overall Study|The need for prohibited therapy|2|||
125144096|NCT04542694|450151438|FG001|Overall Study|The need for prohibited therapy|0|||
125144097|NCT04542694|450151437|FG000|Overall Study|Adverse Event|1|||
125144098|NCT04542694|450151438|FG001|Overall Study|Adverse Event|0|||
125144099|NCT04542694|450151437|FG000|Overall Study|Protocol Violation|1|||
125144100|NCT04542694|450151438|FG001|Overall Study|Protocol Violation|0|||
125144101|NCT02167594|450151439|FG000|Overall Study|Withdrawal by Subject|2|||
125144102|NCT02167594|450151440|FG001|Overall Study|Withdrawal by Subject|0|||
125144103|NCT02167594|450151441|FG002|Overall Study|Withdrawal by Subject|0|||
125144104|NCT02167594|450151439|FG000|Overall Study|Death|0|||
125144105|NCT02167594|450151440|FG001|Overall Study|Death|1|||
125144106|NCT02167594|450151441|FG002|Overall Study|Death|0|||
125144107|NCT03433703|450151442|FG000|Overall Study|Study terminated by Sponsor|2|||
125144108|NCT01957150|450151443|FG000|Overall Study|Adverse Event|23|||
125144109|NCT01957150|450151444|FG001|Overall Study|Adverse Event|20|||
125144110|NCT01957150|450151443|FG000|Overall Study|Withdrawal by Subject|13|||
125144111|NCT01957150|450151444|FG001|Overall Study|Withdrawal by Subject|17|||
125144112|NCT01957150|450151443|FG000|Overall Study|Physician Decision|3|||
125144113|NCT01957150|450151444|FG001|Overall Study|Physician Decision|6|||
125144114|NCT01957150|450151443|FG000|Overall Study|Lost to Follow-up|4|||
125386948|NCT03760146|451050860|FG004|Overall Study|Protocol Violation|1|||
125386949|NCT03760146|451050861|FG005|Overall Study|Protocol Violation|0|||
125386950|NCT03760146|451050856|FG000|Overall Study|Withdrawal by Subject|19|||
125386951|NCT03760146|451050857|FG001|Overall Study|Withdrawal by Subject|20|||
125386952|NCT03760146|451050858|FG002|Overall Study|Withdrawal by Subject|1|||
125144115|NCT01957150|450151444|FG001|Overall Study|Lost to Follow-up|4|||
125144116|NCT01957150|450151443|FG000|Overall Study|Protocol Violation|1|||
125386953|NCT03760146|451050859|FG003|Overall Study|Withdrawal by Subject|0|||
125144117|NCT01957150|450151444|FG001|Overall Study|Protocol Violation|0|||
125386954|NCT03760146|451050860|FG004|Overall Study|Withdrawal by Subject|1|||
125144118|NCT01957150|450151443|FG000|Overall Study|Lack of Efficacy|11|||
125144119|NCT01957150|450151444|FG001|Overall Study|Lack of Efficacy|11|||
125144120|NCT02786953|450151449|FG000|Overall Study|Withdrawal by Subject|3|||
125144121|NCT02786953|450151450|FG001|Overall Study|Withdrawal by Subject|0|||
125144122|NCT02786953|450151449|FG000|Overall Study|Physician Decision|0|||
125144123|NCT02786953|450151450|FG001|Overall Study|Physician Decision|1|||
125144124|NCT01745094|450151453|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
125144125|NCT01745094|450151454|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
125144126|NCT01745094|450151455|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
125144127|NCT01745094|450151456|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
125144128|NCT01745094|450151453|FG000|Overall Study|Adverse Event|0|||
125144129|NCT01745094|450151454|FG001|Overall Study|Adverse Event|0|||
125144130|NCT01745094|450151455|FG002|Overall Study|Adverse Event|3|||
125144131|NCT01745094|450151456|FG003|Overall Study|Adverse Event|0|||
125144132|NCT01745094|450151453|FG000|Overall Study|Withdrawal by Subject|2|||
125144133|NCT01745094|450151454|FG001|Overall Study|Withdrawal by Subject|0|||
125144134|NCT01745094|450151455|FG002|Overall Study|Withdrawal by Subject|1|||
125144135|NCT01745094|450151456|FG003|Overall Study|Withdrawal by Subject|2|||
125144136|NCT01745094|450151453|FG000|Overall Study|Protocol Violation|1|||
125144137|NCT01745094|450151454|FG001|Overall Study|Protocol Violation|0|||
125144138|NCT01745094|450151455|FG002|Overall Study|Protocol Violation|3|||
125144139|NCT01745094|450151456|FG003|Overall Study|Protocol Violation|1|||
125144140|NCT01745094|450151453|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
125144141|NCT01745094|450151454|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
125144142|NCT01745094|450151455|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
125144143|NCT01745094|450151456|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
125144144|NCT01745094|450151453|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
125144145|NCT01745094|450151454|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
125144146|NCT01745094|450151455|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
125144147|NCT01745094|450151456|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
125144148|NCT01745094|450151453|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
125223400|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125386955|NCT03760146|451050861|FG005|Overall Study|Withdrawal by Subject|0|||
125144149|NCT01745094|450151454|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
125144150|NCT01745094|450151455|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
125144151|NCT01745094|450151456|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
125144152|NCT03414034|450151457|FG000|Overall Study|Adverse Event|6|||
125144153|NCT03414034|450151458|FG001|Overall Study|Adverse Event|1|||
125144154|NCT03414034|450151459|FG002|Overall Study|Adverse Event|1|||
125144155|NCT03414034|450151457|FG000|Overall Study|Death|0|||
125144156|NCT03414034|450151458|FG001|Overall Study|Death|0|||
125144157|NCT03414034|450151459|FG002|Overall Study|Death|1|||
125144158|NCT03414034|450151457|FG000|Overall Study|Non-compliance With Study Drug|0|||
125386956|NCT00449644|451050862|FG000|Overall Study|Adverse Event|0|||
125386957|NCT00449644|451050863|FG001|Overall Study|Adverse Event|0|||
125144159|NCT03414034|450151458|FG001|Overall Study|Non-compliance With Study Drug|0|||
125386958|NCT00449644|451050864|FG002|Overall Study|Adverse Event|3|||
125386959|NCT00449644|451050865|FG003|Overall Study|Adverse Event|5|||
125386960|NCT00449644|451050862|FG000|Overall Study|Death|1|||
125386961|NCT00449644|451050863|FG001|Overall Study|Death|0|||
125386962|NCT00449644|451050864|FG002|Overall Study|Death|6|||
125386963|NCT00449644|451050865|FG003|Overall Study|Death|1|||
125386964|NCT00449644|451050862|FG000|Overall Study|Lost to Follow-up|1|||
125386965|NCT00449644|451050863|FG001|Overall Study|Lost to Follow-up|1|||
125144160|NCT03414034|450151459|FG002|Overall Study|Non-compliance With Study Drug|1|||
125144161|NCT03414034|450151457|FG000|Overall Study|Physician Decision|1|||
125144162|NCT03414034|450151458|FG001|Overall Study|Physician Decision|3|||
125386966|NCT00449644|451050864|FG002|Overall Study|Lost to Follow-up|5|||
125386967|NCT00449644|451050865|FG003|Overall Study|Lost to Follow-up|3|||
125144163|NCT03414034|450151459|FG002|Overall Study|Physician Decision|2|||
125386968|NCT00449644|451050862|FG000|Overall Study|Pregnancy|0|||
125386969|NCT00449644|451050863|FG001|Overall Study|Pregnancy|0|||
125386970|NCT00449644|451050864|FG002|Overall Study|Pregnancy|3|||
125386971|NCT00449644|451050865|FG003|Overall Study|Pregnancy|2|||
125386972|NCT00449644|451050862|FG000|Overall Study|Protocol Violation|4|||
125386973|NCT00449644|451050863|FG001|Overall Study|Protocol Violation|4|||
125386974|NCT00449644|451050864|FG002|Overall Study|Protocol Violation|3|||
125386975|NCT00449644|451050865|FG003|Overall Study|Protocol Violation|7|||
125386976|NCT00449644|451050862|FG000|Overall Study|Withdrawal by Subject|3|||
125386977|NCT00449644|451050863|FG001|Overall Study|Withdrawal by Subject|4|||
125386978|NCT00449644|451050864|FG002|Overall Study|Withdrawal by Subject|6|||
125386979|NCT00449644|451050865|FG003|Overall Study|Withdrawal by Subject|7|||
125386980|NCT00449644|451050862|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
125386981|NCT00449644|451050863|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
125386982|NCT00449644|451050864|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
125386983|NCT00449644|451050865|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
125223401|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223402|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223403|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223404|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223405|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
125223406|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
125223407|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125144164|NCT03414034|450151457|FG000|Overall Study|Withdrawal of Informed Consent|2|||
125144165|NCT03414034|450151458|FG001|Overall Study|Withdrawal of Informed Consent|1|||
125144166|NCT03414034|450151459|FG002|Overall Study|Withdrawal of Informed Consent|4|||
125144167|NCT03414034|450151457|FG000|Overall Study|Progressive Disease|15|||
125144168|NCT03414034|450151458|FG001|Overall Study|Progressive Disease|15|||
125223408|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
125223409|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
125223410|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223411|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223412|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223413|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125144169|NCT03414034|450151459|FG002|Overall Study|Progressive Disease|17|||
125144170|NCT03414034|450151457|FG000|Overall Study|Miscellaneous|0|||
125144171|NCT03414034|450151458|FG001|Overall Study|Miscellaneous|0|||
125144172|NCT03414034|450151459|FG002|Overall Study|Miscellaneous|2|||
125223414|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125223415|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223416|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223417|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223418|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223419|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223420|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
125386984|NCT00449644|451050862|FG000|Overall Study|Other|1|||
125144173|NCT04010227|450151461|FG000|Overall Study|Death|1|||
125144174|NCT04010227|450151462|FG001|Overall Study|Death|2|||
125144175|NCT04010227|450151461|FG000|Overall Study|Medical Reasons|4|||
125144176|NCT04010227|450151462|FG001|Overall Study|Medical Reasons|3|||
125144177|NCT04010227|450151461|FG000|Overall Study|Withdrawal by Subject|2|||
125144178|NCT04010227|450151462|FG001|Overall Study|Withdrawal by Subject|0|||
125223421|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223422|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
125223423|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223424|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223425|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223426|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223427|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223428|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223429|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125223430|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223431|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223432|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223433|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125223434|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223435|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
125223436|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125223437|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125223438|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223439|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125223440|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223441|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223442|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223443|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223444|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125223445|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223446|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223447|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223448|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223449|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223450|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223451|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223452|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
125223453|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125386985|NCT00449644|451050863|FG001|Overall Study|Other|4|||
125386986|NCT00449644|451050864|FG002|Overall Study|Other|1|||
125386987|NCT00449644|451050865|FG003|Overall Study|Other|0|||
125386988|NCT00449644|451050862|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
125386989|NCT00449644|451050863|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
125386990|NCT00449644|451050864|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
125386991|NCT00449644|451050865|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
125386992|NCT03642717|451050866|FG000|Overall Study|Lost to Follow-up|2|||
125386993|NCT03642717|451050866|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
125386994|NCT03642717|451050866|FG000|Overall Study|Taken study drug prior to contract date|3|||
125386995|NCT01559012|451050869|FG000|Overall Study|Withdrawal by Subject|0|||
125386996|NCT01559012|451050870|FG001|Overall Study|Withdrawal by Subject|1|||
125386997|NCT00946712|451050871|FG000|Overall Study|Adverse Event|118|||
125386998|NCT00946712|451050872|FG001|Overall Study|Adverse Event|124|||
125144179|NCT04010227|450151461|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
125144180|NCT04010227|450151462|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
125144181|NCT00640926|450151463|FG000|Overall Study|Adverse Event|2|||
125144182|NCT00640926|450151464|FG001|Overall Study|Adverse Event|3|||
125386999|NCT00946712|451050871|FG000|Overall Study|Disease progression|308|||
125387000|NCT00946712|451050872|FG001|Overall Study|Disease progression|404|||
125387001|NCT00946712|451050871|FG000|Overall Study|Death|21|||
125387002|NCT00946712|451050872|FG001|Overall Study|Death|22|||
125387003|NCT00946712|451050871|FG000|Overall Study|No treatment given|25|||
125223454|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125387004|NCT00946712|451050872|FG001|Overall Study|No treatment given|29|||
125387005|NCT00946712|451050871|FG000|Overall Study|Other reasons|61|||
125223455|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125387006|NCT00946712|451050872|FG001|Overall Study|Other reasons|73|||
125387007|NCT00946712|451050871|FG000|Overall Study|On Treatment|0|||
125387008|NCT00946712|451050872|FG001|Overall Study|On Treatment|4|||
125387009|NCT00946712|451050871|FG000|Overall Study|Ineligible|14|||
125387010|NCT00946712|451050872|FG001|Overall Study|Ineligible|6|||
125387011|NCT02291055|451050873|FG000|Overall Study|Death|2|||
125387012|NCT02291055|451050874|FG001|Overall Study|Death|2|||
125387013|NCT02291055|451050875|FG002|Overall Study|Death|5|||
125387014|NCT02291055|451050876|FG003|Overall Study|Death|8|||
125144183|NCT00640926|450151465|FG002|Overall Study|Adverse Event|2|||
125144184|NCT00640926|450151463|FG000|Overall Study|Lack of Efficacy|0|||
125387015|NCT02291055|451050877|FG004|Overall Study|Death|12|||
125387016|NCT02291055|451050873|FG000|Overall Study|Lost to Follow-up|0|||
125387017|NCT02291055|451050874|FG001|Overall Study|Lost to Follow-up|0|||
125387018|NCT02291055|451050875|FG002|Overall Study|Lost to Follow-up|0|||
125387019|NCT02291055|451050876|FG003|Overall Study|Lost to Follow-up|1|||
125387020|NCT02291055|451050877|FG004|Overall Study|Lost to Follow-up|2|||
125387021|NCT02291055|451050873|FG000|Overall Study|Withdrawal by Subject|3|||
125387022|NCT02291055|451050874|FG001|Overall Study|Withdrawal by Subject|1|||
125387023|NCT02291055|451050875|FG002|Overall Study|Withdrawal by Subject|1|||
125144185|NCT00640926|450151464|FG001|Overall Study|Lack of Efficacy|2|||
125144186|NCT00640926|450151465|FG002|Overall Study|Lack of Efficacy|1|||
125144187|NCT00640926|450151463|FG000|Overall Study|Protocol Violation|2|||
125144188|NCT00640926|450151464|FG001|Overall Study|Protocol Violation|0|||
125144189|NCT00640926|450151465|FG002|Overall Study|Protocol Violation|2|||
125144190|NCT00640926|450151463|FG000|Overall Study|Lost to Follow-up|3|||
125144191|NCT00640926|450151464|FG001|Overall Study|Lost to Follow-up|1|||
125144192|NCT00640926|450151465|FG002|Overall Study|Lost to Follow-up|2|||
125144193|NCT00640926|450151463|FG000|Overall Study|Withdrawal by Subject|1|||
125144194|NCT00640926|450151464|FG001|Overall Study|Withdrawal by Subject|0|||
125144195|NCT00640926|450151465|FG002|Overall Study|Withdrawal by Subject|1|||
125144196|NCT03922750|450151466|FG000|Overall Study|Unclassified|0|||
125223456|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125387024|NCT02291055|451050876|FG003|Overall Study|Withdrawal by Subject|5|||
125387025|NCT02291055|451050877|FG004|Overall Study|Withdrawal by Subject|10|||
125387026|NCT02291055|451050873|FG000|Overall Study|Progressive Disease|0|||
125144197|NCT03922750|450151467|FG001|Overall Study|Unclassified|0|||
125144198|NCT03922750|450151468|FG002|Overall Study|Unclassified|1|||
125144199|NCT03922750|450151466|FG000|Overall Study|Adverse Event|0|||
125144200|NCT03922750|450151467|FG001|Overall Study|Adverse Event|1|||
125387027|NCT02291055|451050874|FG001|Overall Study|Progressive Disease|0|||
125387028|NCT02291055|451050875|FG002|Overall Study|Progressive Disease|1|||
125387029|NCT02291055|451050876|FG003|Overall Study|Progressive Disease|4|||
125387030|NCT02291055|451050877|FG004|Overall Study|Progressive Disease|2|||
125144201|NCT03922750|450151468|FG002|Overall Study|Adverse Event|0|||
125144202|NCT02985398|450151469|FG000|Overall Study|Adverse Event|1|||
125144203|NCT02985398|450151469|FG000|Overall Study|Lost to Follow-up|4|||
125223457|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223458|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125144204|NCT02985398|450151469|FG000|Overall Study|Withdrawal by Subject|8|||
125144205|NCT02985398|450151469|FG000|Overall Study|Study Burden|9|||
125144206|NCT01841073|450151470|FG000|Overall Study|Adverse Event|1|||
125144207|NCT01841073|450151471|FG001|Overall Study|Adverse Event|1|||
125144208|NCT01841073|450151470|FG000|Overall Study|Physician Decision|1|||
125144209|NCT01841073|450151471|FG001|Overall Study|Physician Decision|0|||
125387031|NCT02291055|451050873|FG000|Overall Study|Study Terminated by Sponsor|0|||
125387032|NCT02291055|451050874|FG001|Overall Study|Study Terminated by Sponsor|0|||
125387033|NCT02291055|451050875|FG002|Overall Study|Study Terminated by Sponsor|0|||
125387034|NCT02291055|451050876|FG003|Overall Study|Study Terminated by Sponsor|5|||
125387035|NCT02291055|451050877|FG004|Overall Study|Study Terminated by Sponsor|1|||
125387036|NCT02291055|451050873|FG000|Overall Study|Other|0|||
125387037|NCT02291055|451050874|FG001|Overall Study|Other|2|||
125387038|NCT02291055|451050875|FG002|Overall Study|Other|1|||
125387039|NCT02291055|451050876|FG003|Overall Study|Other|4|||
125387040|NCT02291055|451050877|FG004|Overall Study|Other|0|||
125387041|NCT03839212|451050878|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
125387042|NCT00679263|451050879|FG000|Visit 2/Dose 1|Adverse Event|1|||
125144210|NCT01841073|450151470|FG000|Overall Study|Lost to Follow-up|0|||
125144211|NCT01841073|450151471|FG001|Overall Study|Lost to Follow-up|2|||
125144212|NCT00668395|450151472|FG000|Overall Study|Withdrawal by Subject|4|||
125144213|NCT00668395|450151473|FG001|Overall Study|Withdrawal by Subject|4|||
125144214|NCT00668395|450151474|FG002|Overall Study|Withdrawal by Subject|1|||
125144215|NCT00668395|450151472|FG000|Overall Study|Adverse Event|1|||
125144216|NCT00668395|450151473|FG001|Overall Study|Adverse Event|1|||
125144217|NCT00668395|450151474|FG002|Overall Study|Adverse Event|0|||
125144218|NCT00668395|450151472|FG000|Overall Study|Physician Decision|1|||
125144219|NCT00668395|450151473|FG001|Overall Study|Physician Decision|1|||
125144220|NCT00668395|450151474|FG002|Overall Study|Physician Decision|0|||
125144221|NCT05665387|450151479|FG000|Overall Study|Withdrawal by Subject|1|||
125144222|NCT05665387|450151480|FG001|Overall Study|Withdrawal by Subject|0|||
125144223|NCT05665387|450151481|FG002|Overall Study|Withdrawal by Subject|1|||
125144224|NCT01211262|450151484|FG000|Overall Study|Progressive Disease|18|||
125144225|NCT01211262|450151485|FG001|Overall Study|Progressive Disease|9|||
125144226|NCT01211262|450151484|FG000|Overall Study|Adverse Event|4|||
125144227|NCT01211262|450151485|FG001|Overall Study|Adverse Event|0|||
125144228|NCT01211262|450151484|FG000|Overall Study|Withdrawal of Consent|1|||
125144229|NCT01211262|450151485|FG001|Overall Study|Withdrawal of Consent|0|||
125144230|NCT01211262|450151484|FG000|Overall Study|Other|0|||
125144231|NCT01211262|450151485|FG001|Overall Study|Other|1|||
125144232|NCT04049097|450151488|FG000|Overall Study|Adverse Event|18|||
125144233|NCT04049097|450151488|FG000|Overall Study|Death|2|||
125144234|NCT04049097|450151488|FG000|Overall Study|Lost to Follow-up|1|||
125144235|NCT04049097|450151488|FG000|Overall Study|Physician Decision|2|||
125144236|NCT04049097|450151488|FG000|Overall Study|Withdrawal by Subject|9|||
125144237|NCT04049097|450151488|FG000|Overall Study|Protocol Violation|2|||
125223459|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
125223460|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223461|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223462|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223463|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223464|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223465|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223466|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
125223467|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223468|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125144238|NCT04049097|450151488|FG000|Overall Study|Other|1|||
125144239|NCT04049097|450151488|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
125223469|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125144240|NCT01970592|450151489|FG000|Overall Study|Withdrawal by Subject|4|||
125144241|NCT01970592|450151489|FG000|Overall Study|Physician Decision|1|||
125144242|NCT01970592|450151489|FG000|Overall Study|Adverse Event|1|||
125144243|NCT00160524|450151490|FG000|Overall Study|Adverse Event|119|||
125144244|NCT00160524|450151490|FG000|Overall Study|Adverse Event and Other|94|||
125144245|NCT00160524|450151490|FG000|Overall Study|Protocol Violation|16|||
125144246|NCT00160524|450151490|FG000|Overall Study|Protocol Violation and Other|2|||
125144247|NCT00160524|450151490|FG000|Overall Study|Withdrawal by Subject|141|||
125144248|NCT00160524|450151490|FG000|Overall Study|Withdrawal by Subject and Other|17|||
125144249|NCT00160524|450151490|FG000|Overall Study|Physician Decision|27|||
125144250|NCT00160524|450151490|FG000|Overall Study|Physician Decision and Other|6|||
125144251|NCT00160524|450151490|FG000|Overall Study|Lost to Follow-up|13|||
125144252|NCT00160524|450151490|FG000|Overall Study|Lost to Follow-up and Other|1|||
125144253|NCT00160524|450151490|FG000|Overall Study|Lack of Efficacy|21|||
125144254|NCT00160524|450151490|FG000|Overall Study|Lack of Efficacy and Other|1|||
125144255|NCT00160524|450151490|FG000|Overall Study|Other|20|||
125144256|NCT02661022|450151491|FG000|Overall Study|Withdrawal by Subject|3|||
125144257|NCT02661022|450151492|FG001|Overall Study|Withdrawal by Subject|0|||
125144258|NCT02661022|450151491|FG000|Overall Study|Adverse Event|1|||
125144259|NCT02661022|450151492|FG001|Overall Study|Adverse Event|1|||
125144260|NCT02661022|450151491|FG000|Overall Study|Physician Decision|1|||
125144261|NCT02661022|450151492|FG001|Overall Study|Physician Decision|0|||
125144262|NCT02661022|450151491|FG000|Overall Study|Progressive Disease|2|||
125144263|NCT02661022|450151492|FG001|Overall Study|Progressive Disease|1|||
125144264|NCT03448692|450151493|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
125144265|NCT03448692|450151494|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
125144266|NCT03448692|450151493|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
125144267|NCT03448692|450151494|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
125144268|NCT03448692|450151493|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
125144269|NCT03448692|450151494|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
125144270|NCT03448692|450151493|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
125144271|NCT03448692|450151494|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
125144272|NCT03448692|450151493|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
125144273|NCT03448692|450151494|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
125144274|NCT01598896|450151503|FG000|Overall Study|Withdrawal by Subject|0|||
125144275|NCT01598896|450151504|FG001|Overall Study|Withdrawal by Subject|1|||
125144276|NCT01598896|450151503|FG000|Overall Study|Lack of Efficacy|0|||
125144277|NCT01598896|450151504|FG001|Overall Study|Lack of Efficacy|1|||
125144278|NCT04553406|450151507|FG000|Overall Study|Study Discontinuation|0|||
125144279|NCT04553406|450151508|FG001|Overall Study|Study Discontinuation|1|||
125144280|NCT00772148|450151509|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
125144281|NCT00772148|450151510|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
125144282|NCT00772148|450151509|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
125144283|NCT00772148|450151510|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
125144284|NCT00772148|450151509|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
125144285|NCT00772148|450151510|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
125144286|NCT00772148|450151509|FG000|Maintenance Phase (Week 52)|Death|2|||
125144287|NCT00772148|450151510|FG001|Maintenance Phase (Week 52)|Death|2|||
125144288|NCT00772148|450151509|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
125144289|NCT00772148|450151510|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
125144290|NCT00772148|450151509|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
125144291|NCT00772148|450151510|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
125144292|NCT00772148|450151509|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
125144293|NCT00772148|450151510|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
125144294|NCT00633022|450151513|FG000|Overall Study|Adverse Event|1|||
125144295|NCT00633022|450151514|FG001|Overall Study|Adverse Event|0|||
125144296|NCT00633022|450151515|FG002|Overall Study|Adverse Event|5|||
125144297|NCT00633022|450151513|FG000|Overall Study|Physician Decision|0|||
125144298|NCT00633022|450151514|FG001|Overall Study|Physician Decision|1|||
125144299|NCT00633022|450151515|FG002|Overall Study|Physician Decision|0|||
125144300|NCT03573336|450151516|FG000|Overall Study|Study terminated|2|||
125144301|NCT03573336|450151517|FG001|Overall Study|Study terminated|4|||
125144302|NCT03573336|450151518|FG002|Overall Study|Study terminated|2|||
125144303|NCT04388787|450151519|FG000|Blinded Period|Patient could not follow instructions|1|||
125144304|NCT04388787|450151519|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
125144305|NCT02940522|450153040|FG000|Overall Study|Lost to Follow-up|1|||
125144306|NCT02940522|450153041|FG001|Overall Study|Lost to Follow-up|2|||
125144307|NCT02940522|450153040|FG000|Overall Study|Withdrawal by Subject|1|||
125144308|NCT02940522|450153041|FG001|Overall Study|Withdrawal by Subject|0|||
125144309|NCT02710214|450153042|FG000|Overall Study|Lost to Follow-up|1|||
125387043|NCT00679263|451050880|FG001|Visit 2/Dose 1|Adverse Event|0|||
125144310|NCT02710214|450153043|FG001|Overall Study|Lost to Follow-up|0|||
125144311|NCT02710214|450153042|FG000|Overall Study|Lack of Efficacy|0|||
125387044|NCT00679263|451050881|FG002|Visit 2/Dose 1|Adverse Event|0|||
125387045|NCT00679263|451050879|FG000|Visit 2/Dose 1|subject not compliance|1|||
125387046|NCT00679263|451050880|FG001|Visit 2/Dose 1|subject not compliance|1|||
125387047|NCT00679263|451050881|FG002|Visit 2/Dose 1|subject not compliance|0|||
125387048|NCT03999892|451050882|FG000|Overall Study|Lost to Follow-up|1|||
125387049|NCT00733746|451050883|FG000|Overall Study|Ineligible|5|||
125387050|NCT03245008|451050884|FG000|Overall Study|Adverse Event|15|||
125387051|NCT03245008|451050885|FG001|Overall Study|Adverse Event|18|||
125387052|NCT03245008|451050886|FG002|Overall Study|Adverse Event|15|||
125144312|NCT02710214|450153043|FG001|Overall Study|Lack of Efficacy|1|||
125144313|NCT02710214|450153042|FG000|Overall Study|Death|0|||
125144314|NCT02710214|450153043|FG001|Overall Study|Death|1|||
125144315|NCT04980456|450153049|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
125387053|NCT03245008|451050887|FG003|Overall Study|Adverse Event|0|||
125387054|NCT03245008|451050888|FG004|Overall Study|Adverse Event|1|||
125387055|NCT03245008|451050884|FG000|Overall Study|Lack of Efficacy|0|||
125387056|NCT03245008|451050885|FG001|Overall Study|Lack of Efficacy|1|||
125387057|NCT03245008|451050886|FG002|Overall Study|Lack of Efficacy|0|||
125387058|NCT03245008|451050887|FG003|Overall Study|Lack of Efficacy|0|||
125387059|NCT03245008|451050888|FG004|Overall Study|Lack of Efficacy|0|||
125144316|NCT04980456|450153050|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
125144317|NCT04980456|450153049|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
125144318|NCT04980456|450153050|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
125144319|NCT04980456|450153049|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
125144320|NCT04980456|450153050|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
125144321|NCT04980456|450153049|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
125144322|NCT04980456|450153050|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
125144323|NCT04832971|450153051|FG000|Overall Study|Death|1|||
125144324|NCT04832971|450153052|FG001|Overall Study|Death|0|||
125144325|NCT04832971|450153053|FG002|Overall Study|Death|0|||
125144326|NCT04832971|450153054|FG003|Overall Study|Death|0|||
125144327|NCT04832971|450153051|FG000|Overall Study|Lost to Follow-up|1|||
125144328|NCT04832971|450153052|FG001|Overall Study|Lost to Follow-up|1|||
125144329|NCT04832971|450153053|FG002|Overall Study|Lost to Follow-up|1|||
125144330|NCT04832971|450153054|FG003|Overall Study|Lost to Follow-up|0|||
125144331|NCT04832971|450153051|FG000|Overall Study|Withdrawal by Subject|1|||
125387060|NCT03245008|451050884|FG000|Overall Study|Lost to Follow-up|4|||
125387061|NCT03245008|451050885|FG001|Overall Study|Lost to Follow-up|1|||
125387062|NCT03245008|451050886|FG002|Overall Study|Lost to Follow-up|0|||
125387063|NCT03245008|451050887|FG003|Overall Study|Lost to Follow-up|0|||
125387064|NCT03245008|451050888|FG004|Overall Study|Lost to Follow-up|1|||
125144332|NCT04832971|450153052|FG001|Overall Study|Withdrawal by Subject|3|||
125144333|NCT04832971|450153053|FG002|Overall Study|Withdrawal by Subject|2|||
125144334|NCT04832971|450153054|FG003|Overall Study|Withdrawal by Subject|2|||
125387065|NCT03245008|451050884|FG000|Overall Study|Physician Decision|1|||
125387066|NCT03245008|451050885|FG001|Overall Study|Physician Decision|3|||
125387067|NCT03245008|451050886|FG002|Overall Study|Physician Decision|4|||
125387068|NCT03245008|451050887|FG003|Overall Study|Physician Decision|0|||
125387069|NCT03245008|451050888|FG004|Overall Study|Physician Decision|0|||
125387070|NCT03245008|451050884|FG000|Overall Study|Protocol Violation|0|||
125387071|NCT03245008|451050885|FG001|Overall Study|Protocol Violation|1|||
125387072|NCT03245008|451050886|FG002|Overall Study|Protocol Violation|0|||
125387073|NCT03245008|451050887|FG003|Overall Study|Protocol Violation|0|||
125387074|NCT03245008|451050888|FG004|Overall Study|Protocol Violation|0|||
125387075|NCT03245008|451050884|FG000|Overall Study|Withdrawal by Subject|20|||
125387076|NCT03245008|451050885|FG001|Overall Study|Withdrawal by Subject|19|||
125387077|NCT03245008|451050886|FG002|Overall Study|Withdrawal by Subject|11|||
125387078|NCT03245008|451050887|FG003|Overall Study|Withdrawal by Subject|0|||
125387079|NCT03245008|451050888|FG004|Overall Study|Withdrawal by Subject|0|||
125387080|NCT03245008|451050884|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
125387081|NCT03245008|451050885|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
125387082|NCT03245008|451050886|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
125387083|NCT03245008|451050887|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
125387084|NCT03245008|451050888|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
125387085|NCT03245008|451050884|FG000|Overall Study|Failure to meet randomization criteria|0|||
125387086|NCT03245008|451050885|FG001|Overall Study|Failure to meet randomization criteria|1|||
125387087|NCT03245008|451050886|FG002|Overall Study|Failure to meet randomization criteria|0|||
125387088|NCT03245008|451050887|FG003|Overall Study|Failure to meet randomization criteria|1|||
125387089|NCT03245008|451050888|FG004|Overall Study|Failure to meet randomization criteria|0|||
125387090|NCT02075658|451050889|FG000|Overall Study|Physician Decision|2|||
125387091|NCT02075658|451050890|FG001|Overall Study|Physician Decision|2|||
125387092|NCT01286012|451050891|FG000|Overall Study|Adverse Event|3|||
125387093|NCT01286012|451050892|FG001|Overall Study|Adverse Event|3|||
125387094|NCT01286012|451050891|FG000|Overall Study|Death|2|||
125387095|NCT01286012|451050892|FG001|Overall Study|Death|3|||
125387096|NCT01286012|451050891|FG000|Overall Study|Protocol Violation|1|||
125387097|NCT01286012|451050892|FG001|Overall Study|Protocol Violation|1|||
125387098|NCT01286012|451050891|FG000|Overall Study|Withdrawal by Subject|4|||
125387099|NCT01286012|451050892|FG001|Overall Study|Withdrawal by Subject|4|||
125387100|NCT01286012|451050891|FG000|Overall Study|Physician Decision|2|||
125387101|NCT01286012|451050892|FG001|Overall Study|Physician Decision|0|||
125387102|NCT01286012|451050891|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
125387103|NCT01286012|451050892|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
125387104|NCT04439253|451052198|FG000|Overall Study|Adverse Event|1|||
125387105|NCT04439253|451052198|FG000|Overall Study|Disease progression|2|||
125387106|NCT04439253|451052198|FG000|Overall Study|Complicating disease|1|||
125387107|NCT03971695|451052199|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125387108|NCT03971695|451052200|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125387109|NCT03971695|451052201|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125387110|NCT03971695|451052202|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
125387111|NCT03971695|451052203|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
125387112|NCT03971695|451052204|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125387113|NCT03971695|451052205|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125387114|NCT03971695|451052206|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125387115|NCT03971695|451052207|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
125387116|NCT03971695|451052208|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
125387117|NCT03971695|451052209|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
125387118|NCT03971695|451052210|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
125387119|NCT03971695|451052211|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
125387120|NCT02603809|451052216|FG000|Overall Study|Withdrawal by Subject|4|||
125387121|NCT02603809|451052217|FG001|Overall Study|Withdrawal by Subject|1|||
125387122|NCT02603809|451052218|FG002|Overall Study|Withdrawal by Subject|2|||
125387123|NCT02603809|451052219|FG003|Overall Study|Withdrawal by Subject|3|||
125387124|NCT02603809|451052220|FG004|Overall Study|Withdrawal by Subject|3|||
125387125|NCT02603809|451052221|FG005|Overall Study|Withdrawal by Subject|4|||
125387126|NCT02603809|451052216|FG000|Overall Study|Lost to Follow-up|2|||
125387127|NCT02603809|451052217|FG001|Overall Study|Lost to Follow-up|3|||
125387128|NCT02603809|451052218|FG002|Overall Study|Lost to Follow-up|1|||
125387129|NCT02603809|451052219|FG003|Overall Study|Lost to Follow-up|4|||
125387130|NCT02603809|451052220|FG004|Overall Study|Lost to Follow-up|2|||
125387131|NCT02603809|451052221|FG005|Overall Study|Lost to Follow-up|2|||
125387132|NCT02603809|451052216|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
125387133|NCT02603809|451052217|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
125387134|NCT02603809|451052218|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
125223470|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125387135|NCT02603809|451052219|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
125144335|NCT04832971|450153051|FG000|Overall Study|Other, Not Specified|0|||
125144336|NCT04832971|450153052|FG001|Overall Study|Other, Not Specified|0|||
125144337|NCT04832971|450153053|FG002|Overall Study|Other, Not Specified|1|||
125144338|NCT04832971|450153054|FG003|Overall Study|Other, Not Specified|0|||
125144339|NCT00927251|450153055|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
125144340|NCT03687242|450153060|FG000|Overall Study|Adverse Event|1|||
125144341|NCT00969124|450153081|FG000|Overall Study|Protocol Violation|2|||
125144342|NCT00969124|450153081|FG000|Overall Study|Inadequate bowel preparation|15|||
125144343|NCT00969124|450153081|FG000|Overall Study|Inability to reach cecum|9|||
125144344|NCT00969124|450153081|FG000|Overall Study|Previously unrecognized disease|3|||
125144345|NCT00969124|450153081|FG000|Overall Study|Technical error|1|||
125144346|NCT02575339|450153084|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
125144347|NCT02575339|450153085|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
125223471|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223472|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223473|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223474|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
125223475|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223476|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223477|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223478|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223479|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223480|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223481|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223482|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223483|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
125223484|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223485|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223486|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223487|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223488|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223489|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
125223490|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223491|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223492|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223493|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223494|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223495|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
125223496|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
125223497|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
125223498|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
125223499|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223500|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223501|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223502|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223503|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223504|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125223505|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125438435|NCT01155661|451232253|FG000|Overall Study|Physician Decision|3|||
125144348|NCT02575339|450153086|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
125144349|NCT02575339|450153084|FG000|Study Treatment|Disease Progression|5|||
125144350|NCT02575339|450153085|FG001|Study Treatment|Disease Progression|2|||
125144351|NCT02575339|450153086|FG002|Study Treatment|Disease Progression|0|||
125144352|NCT02575339|450153084|FG000|Study Treatment|Adverse Event|1|||
125144353|NCT02575339|450153085|FG001|Study Treatment|Adverse Event|2|||
125144354|NCT02575339|450153086|FG002|Study Treatment|Adverse Event|0|||
125144355|NCT02575339|450153084|FG000|Follow up|Death|6|||
125144356|NCT02575339|450153085|FG001|Follow up|Death|2|||
125144357|NCT02575339|450153086|FG002|Follow up|Death|0|||
125144358|NCT02575339|450153084|FG000|Follow up|Study Terminated|0|||
125144359|NCT02575339|450153085|FG001|Follow up|Study Terminated|2|||
125144360|NCT02575339|450153086|FG002|Follow up|Study Terminated|0|||
125144361|NCT02575339|450153084|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
125144362|NCT02575339|450153085|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
125144363|NCT02575339|450153086|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
125144364|NCT04633642|450153087|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
125144365|NCT04633642|450153088|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
125144366|NCT04675775|450153089|FG000|Overall Study|Withdrawal by Subject|7|||
125144367|NCT02451358|450153094|FG000|Overall Study|Withdrawal by Subject|1|||
125144368|NCT02451358|450153095|FG001|Overall Study|Withdrawal by Subject|1|||
125144369|NCT02451358|450153096|FG002|Overall Study|Withdrawal by Subject|0|||
125144370|NCT02451358|450153097|FG003|Overall Study|Withdrawal by Subject|0|||
125144371|NCT02451358|450153094|FG000|Overall Study|Protocol Violation|0|||
125144372|NCT02451358|450153095|FG001|Overall Study|Protocol Violation|1|||
125144373|NCT02451358|450153096|FG002|Overall Study|Protocol Violation|1|||
125144374|NCT02451358|450153097|FG003|Overall Study|Protocol Violation|0|||
125144375|NCT01344018|450153104|FG000|Overall Study|Death|22|||
125144376|NCT01344018|450153105|FG001|Overall Study|Death|25|||
125144377|NCT01344018|450153104|FG000|Overall Study|Lost to Follow-up|4|||
125144378|NCT01344018|450153105|FG001|Overall Study|Lost to Follow-up|7|||
125144379|NCT05070754|450153106|FG000|Overall Study|Withdrawal by Subject|0|||
125144380|NCT05070754|450153107|FG001|Overall Study|Withdrawal by Subject|0|||
125144381|NCT05070754|450153108|FG002|Overall Study|Withdrawal by Subject|0|||
125144382|NCT05070754|450153109|FG003|Overall Study|Withdrawal by Subject|1|||
125144383|NCT05070754|450153106|FG000|Overall Study|Protocol Violation|0|||
125144384|NCT05070754|450153107|FG001|Overall Study|Protocol Violation|0|||
125144385|NCT05070754|450153108|FG002|Overall Study|Protocol Violation|0|||
125144386|NCT05070754|450153109|FG003|Overall Study|Protocol Violation|1|||
125144387|NCT00252564|450153110|FG000|Overall Study|Adverse Event|17|||
125144388|NCT00252564|450153111|FG001|Overall Study|Adverse Event|13|||
125144389|NCT00252564|450153110|FG000|Overall Study|Unrelated Complication|2|||
125144390|NCT00252564|450153111|FG001|Overall Study|Unrelated Complication|1|||
125144391|NCT00252564|450153110|FG000|Overall Study|Disease Progression|14|||
125144392|NCT00252564|450153111|FG001|Overall Study|Disease Progression|20|||
125144393|NCT00252564|450153110|FG000|Overall Study|Death|0|||
125144394|NCT00252564|450153111|FG001|Overall Study|Death|3|||
125144395|NCT00252564|450153110|FG000|Overall Study|Physician Decision|1|||
125144396|NCT00252564|450153111|FG001|Overall Study|Physician Decision|0|||
125144397|NCT00252564|450153110|FG000|Overall Study|Lost to Follow-up|1|||
125144398|NCT00252564|450153111|FG001|Overall Study|Lost to Follow-up|0|||
125144399|NCT00252564|450153110|FG000|Overall Study|Patient Request|4|||
125144400|NCT00252564|450153111|FG001|Overall Study|Patient Request|5|||
125144401|NCT00252564|450153110|FG000|Overall Study|Withdrawal by Subject|0|||
125144402|NCT00252564|450153111|FG001|Overall Study|Withdrawal by Subject|2|||
125144403|NCT04561115|450153113|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
125144404|NCT04561115|450153114|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
125144405|NCT04561115|450153113|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
125144406|NCT04561115|450153114|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
125144407|NCT04561115|450153113|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
125144408|NCT04561115|450153114|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
125144409|NCT00743145|450153115|FG000|Overall Study|Withdrawal by Subject|1|||
125144410|NCT00743145|450153115|FG000|Overall Study|Adverse Event|2|||
125144411|NCT00743145|450153115|FG000|Overall Study|Pregnancy|1|||
125144412|NCT01583530|450153116|FG000|Overall Study|Adverse Event|0|||
125144413|NCT01583530|450153117|FG001|Overall Study|Adverse Event|0|||
125144414|NCT01583530|450153118|FG002|Overall Study|Adverse Event|0|||
125144415|NCT01583530|450153119|FG003|Overall Study|Adverse Event|0|||
125144416|NCT01583530|450153120|FG004|Overall Study|Adverse Event|0|||
125144417|NCT01583530|450153121|FG005|Overall Study|Adverse Event|1|||
125144418|NCT01583530|450153116|FG000|Overall Study|Withdrawal by Subject|0|||
125144419|NCT01583530|450153117|FG001|Overall Study|Withdrawal by Subject|3|||
125144420|NCT01583530|450153118|FG002|Overall Study|Withdrawal by Subject|0|||
125144421|NCT01583530|450153119|FG003|Overall Study|Withdrawal by Subject|1|||
125144422|NCT01583530|450153120|FG004|Overall Study|Withdrawal by Subject|1|||
125144423|NCT01583530|450153121|FG005|Overall Study|Withdrawal by Subject|2|||
125144424|NCT01583530|450153116|FG000|Overall Study|Lost to Follow-up|0|||
125387136|NCT02603809|451052220|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
125387137|NCT02603809|451052221|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
125387138|NCT02603809|451052216|FG000|Overall Study|Physician Decision|0|||
125387139|NCT02603809|451052217|FG001|Overall Study|Physician Decision|0|||
125387140|NCT02603809|451052218|FG002|Overall Study|Physician Decision|0|||
125387141|NCT02603809|451052219|FG003|Overall Study|Physician Decision|1|||
125144425|NCT01583530|450153117|FG001|Overall Study|Lost to Follow-up|0|||
125144426|NCT01583530|450153118|FG002|Overall Study|Lost to Follow-up|0|||
125144427|NCT01583530|450153119|FG003|Overall Study|Lost to Follow-up|0|||
125387142|NCT02603809|451052220|FG004|Overall Study|Physician Decision|2|||
125387143|NCT02603809|451052221|FG005|Overall Study|Physician Decision|1|||
125387144|NCT02603809|451052216|FG000|Overall Study|Adverse Event|3|||
125387145|NCT02603809|451052217|FG001|Overall Study|Adverse Event|0|||
125387146|NCT02603809|451052218|FG002|Overall Study|Adverse Event|2|||
125387147|NCT02603809|451052219|FG003|Overall Study|Adverse Event|2|||
125387148|NCT02603809|451052220|FG004|Overall Study|Adverse Event|1|||
125387149|NCT02603809|451052221|FG005|Overall Study|Adverse Event|1|||
125387150|NCT02603809|451052216|FG000|Overall Study|Lack of Efficacy|0|||
125387151|NCT02603809|451052217|FG001|Overall Study|Lack of Efficacy|1|||
125387152|NCT02603809|451052218|FG002|Overall Study|Lack of Efficacy|0|||
125387153|NCT02603809|451052219|FG003|Overall Study|Lack of Efficacy|0|||
125387154|NCT02603809|451052220|FG004|Overall Study|Lack of Efficacy|0|||
125387155|NCT02603809|451052221|FG005|Overall Study|Lack of Efficacy|1|||
125387156|NCT00156533|451052222|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
125387157|NCT00156533|451052223|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
125223506|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125387158|NCT00156533|451052224|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
125387159|NCT00156533|451052225|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
125387160|NCT00156533|451052222|FG000|Overall Study|Withdrawal by Subject|1|||
125387161|NCT00156533|451052223|FG001|Overall Study|Withdrawal by Subject|0|||
125387162|NCT00156533|451052224|FG002|Overall Study|Withdrawal by Subject|0|||
125387163|NCT00156533|451052225|FG003|Overall Study|Withdrawal by Subject|1|||
125387164|NCT00156533|451052222|FG000|Overall Study|Failed Screening|1|||
125387165|NCT00156533|451052223|FG001|Overall Study|Failed Screening|0|||
125144428|NCT01583530|450153120|FG004|Overall Study|Lost to Follow-up|3|||
125144429|NCT01583530|450153121|FG005|Overall Study|Lost to Follow-up|0|||
125144430|NCT01583530|450153116|FG000|Overall Study|Lack of compliance|0|||
125144431|NCT01583530|450153117|FG001|Overall Study|Lack of compliance|0|||
125144432|NCT01583530|450153118|FG002|Overall Study|Lack of compliance|0|||
125144433|NCT01583530|450153119|FG003|Overall Study|Lack of compliance|0|||
125144434|NCT01583530|450153120|FG004|Overall Study|Lack of compliance|1|||
125144435|NCT01583530|450153121|FG005|Overall Study|Lack of compliance|0|||
125144436|NCT02416180|450153122|FG000|Overall Study|Withdrawal by Subject|1|||
125144437|NCT03480022|450153127|FG000|Overall Study|Pregnancy|2|||
125144438|NCT03480022|450153128|FG001|Overall Study|Pregnancy|0|||
125144439|NCT03480022|450153127|FG000|Overall Study|Adverse Event|6|||
125144440|NCT03480022|450153128|FG001|Overall Study|Adverse Event|0|||
125144441|NCT03480022|450153127|FG000|Overall Study|Lack of Efficacy|0|||
125144442|NCT03480022|450153128|FG001|Overall Study|Lack of Efficacy|2|||
125144443|NCT03480022|450153127|FG000|Overall Study|Physician Decision|0|||
125144444|NCT03480022|450153128|FG001|Overall Study|Physician Decision|1|||
125144445|NCT03480022|450153127|FG000|Overall Study|Withdrawal by Subject|2|||
125144446|NCT03480022|450153128|FG001|Overall Study|Withdrawal by Subject|0|||
125387166|NCT00156533|451052224|FG002|Overall Study|Failed Screening|1|||
125387167|NCT00156533|451052225|FG003|Overall Study|Failed Screening|1|||
125387168|NCT03265249|451052228|FG000|Overall Study|Withdrawal by Subject|0|||
125387169|NCT03265249|451052229|FG001|Overall Study|Withdrawal by Subject|1|||
125387170|NCT03446040|451052233|FG000|Overall Study|Disease progression|3|||
125387171|NCT03446040|451052234|FG001|Overall Study|Disease progression|3|||
125387172|NCT03446040|451052235|FG002|Overall Study|Disease progression|3|||
125387173|NCT03446040|451052236|FG003|Overall Study|Disease progression|4|||
125387174|NCT03446040|451052237|FG004|Overall Study|Disease progression|4|||
125387175|NCT03446040|451052238|FG005|Overall Study|Disease progression|6|||
125387176|NCT03446040|451052239|FG006|Overall Study|Disease progression|3|||
125387177|NCT03446040|451052240|FG007|Overall Study|Disease progression|4|||
125387178|NCT03446040|451052241|FG008|Overall Study|Disease progression|2|||
125387179|NCT03446040|451052242|FG009|Overall Study|Disease progression|4|||
125144447|NCT03480022|450153127|FG000|Overall Study|Medication concerns|1|||
125144448|NCT03480022|450153128|FG001|Overall Study|Medication concerns|0|||
125144449|NCT03480022|450153127|FG000|Overall Study|Family member COVID exposure|0|||
125144450|NCT03480022|450153128|FG001|Overall Study|Family member COVID exposure|1|||
125144451|NCT00283842|450153129|FG000|Overall Study|Adverse Event|8|||
125387180|NCT03446040|451052243|FG010|Overall Study|Disease progression|9|||
125387181|NCT03446040|451052244|FG011|Overall Study|Disease progression|3|||
125387182|NCT03446040|451052245|FG012|Overall Study|Disease progression|7|||
125387183|NCT03446040|451052246|FG013|Overall Study|Disease progression|7|||
125387184|NCT03446040|451052233|FG000|Overall Study|Study drug toxicity|0|||
125387185|NCT03446040|451052234|FG001|Overall Study|Study drug toxicity|0|||
125387186|NCT03446040|451052235|FG002|Overall Study|Study drug toxicity|0|||
125387187|NCT03446040|451052236|FG003|Overall Study|Study drug toxicity|0|||
125387188|NCT03446040|451052237|FG004|Overall Study|Study drug toxicity|0|||
125387189|NCT03446040|451052238|FG005|Overall Study|Study drug toxicity|0|||
125144452|NCT00283842|450153130|FG001|Overall Study|Adverse Event|7|||
125144453|NCT00283842|450153131|FG002|Overall Study|Adverse Event|21|||
125144454|NCT00283842|450153132|FG003|Overall Study|Adverse Event|21|||
125144455|NCT00283842|450153133|FG004|Overall Study|Adverse Event|5|||
125144456|NCT00283842|450153129|FG000|Overall Study|Protocol Violation|1|||
125144457|NCT00283842|450153130|FG001|Overall Study|Protocol Violation|5|||
125144458|NCT00283842|450153131|FG002|Overall Study|Protocol Violation|4|||
125144459|NCT00283842|450153132|FG003|Overall Study|Protocol Violation|0|||
125144460|NCT00283842|450153133|FG004|Overall Study|Protocol Violation|0|||
125144461|NCT00283842|450153129|FG000|Overall Study|Protocol deviation|0|||
125144462|NCT00283842|450153130|FG001|Overall Study|Protocol deviation|0|||
125144463|NCT00283842|450153131|FG002|Overall Study|Protocol deviation|0|||
125144464|NCT00283842|450153132|FG003|Overall Study|Protocol deviation|0|||
125144465|NCT00283842|450153133|FG004|Overall Study|Protocol deviation|2|||
125144466|NCT00283842|450153129|FG000|Overall Study|Withdrawal by Subject|2|||
125144467|NCT00283842|450153130|FG001|Overall Study|Withdrawal by Subject|1|||
125144468|NCT00283842|450153131|FG002|Overall Study|Withdrawal by Subject|1|||
125144469|NCT00283842|450153132|FG003|Overall Study|Withdrawal by Subject|5|||
125387190|NCT03446040|451052239|FG006|Overall Study|Study drug toxicity|0|||
125144470|NCT00283842|450153133|FG004|Overall Study|Withdrawal by Subject|4|||
125144471|NCT00283842|450153129|FG000|Overall Study|Lack of Efficacy|1|||
125144472|NCT00283842|450153130|FG001|Overall Study|Lack of Efficacy|3|||
125144473|NCT00283842|450153131|FG002|Overall Study|Lack of Efficacy|1|||
125144474|NCT00283842|450153132|FG003|Overall Study|Lack of Efficacy|0|||
125144475|NCT00283842|450153133|FG004|Overall Study|Lack of Efficacy|3|||
125387191|NCT03446040|451052240|FG007|Overall Study|Study drug toxicity|0|||
125223507|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125144476|NCT00283842|450153129|FG000|Overall Study|Lost to Follow-up|0|||
125144477|NCT00283842|450153130|FG001|Overall Study|Lost to Follow-up|2|||
125144478|NCT00283842|450153131|FG002|Overall Study|Lost to Follow-up|4|||
125144479|NCT00283842|450153132|FG003|Overall Study|Lost to Follow-up|1|||
125144480|NCT00283842|450153133|FG004|Overall Study|Lost to Follow-up|1|||
125144481|NCT02472639|450153136|FG000|Overall Study|Physician Decision|4|||
125144482|NCT02472639|450153137|FG001|Overall Study|Physician Decision|3|||
125144483|NCT00751023|450153139|FG000|Overall Study|Lost to Follow-up|11|||
125144484|NCT00751023|450153140|FG001|Overall Study|Lost to Follow-up|7|||
125144485|NCT02308696|450153142|FG000|Overall Study|Lost to Follow-up|28|||
125144486|NCT02308696|450153143|FG001|Overall Study|Lost to Follow-up|21|||
125144487|NCT02308696|450153142|FG000|Overall Study|Death|8|||
125144488|NCT02308696|450153143|FG001|Overall Study|Death|4|||
125144489|NCT02308696|450153142|FG000|Overall Study|Moved to a Higher Level of Care|17|||
125144490|NCT02308696|450153143|FG001|Overall Study|Moved to a Higher Level of Care|6|||
125144491|NCT04768114|450153144|FG000|Overall Study|Lost to Follow-up|5|||
125144492|NCT04768114|450153145|FG001|Overall Study|Lost to Follow-up|10|||
125144493|NCT04768114|450153144|FG000|Overall Study|Withdrawal by Subject|0|||
125144494|NCT04768114|450153145|FG001|Overall Study|Withdrawal by Subject|1|||
125144495|NCT03980522|450153152|FG000|Treatment Period|Adverse Event|1|||
125144496|NCT03980522|450153153|FG001|Treatment Period|Adverse Event|0|||
125144497|NCT03980522|450153154|FG002|Treatment Period|Adverse Event|0|||
125144498|NCT03980522|450153155|FG003|Treatment Period|Adverse Event|0|||
125144499|NCT03980522|450153156|FG004|Treatment Period|Adverse Event|0|||
125144500|NCT04892147|450153157|FG000|Overall Study|Withdrawal by Subject|2|||
125144501|NCT04892147|450153158|FG001|Overall Study|Withdrawal by Subject|0|||
125144502|NCT05263505|450153159|FG000|Overall Study|Adverse Event|0|||
125144503|NCT05263505|450153160|FG001|Overall Study|Adverse Event|1|||
125144504|NCT01785615|450153167|FG000|Dietary Phase|Lost to Follow-up|0|||
125144505|NCT01785615|450153168|FG001|Dietary Phase|Lost to Follow-up|0|||
125144506|NCT01785615|450153169|FG002|Dietary Phase|Lost to Follow-up|0|||
125144507|NCT01785615|450153170|FG003|Dietary Phase|Lost to Follow-up|24|||
125144508|NCT03428945|450153171|FG000|Overall Study|Lost to Follow-up|5|||
125144509|NCT03428945|450153172|FG001|Overall Study|Lost to Follow-up|3|||
125144510|NCT03428945|450153171|FG000|Overall Study|Withdrawal by Subject|10|||
125144511|NCT03428945|450153172|FG001|Overall Study|Withdrawal by Subject|10|||
125144512|NCT00360490|450153175|FG000|Overall Study|Adverse Event|4|||
125144513|NCT00360490|450153176|FG001|Overall Study|Adverse Event|2|||
125144514|NCT00360490|450153175|FG000|Overall Study|Lost to Follow-up|2|||
125144515|NCT00360490|450153176|FG001|Overall Study|Lost to Follow-up|1|||
125144516|NCT00360490|450153175|FG000|Overall Study|Physician Decision|2|||
125144517|NCT00360490|450153176|FG001|Overall Study|Physician Decision|1|||
125144518|NCT00360490|450153175|FG000|Overall Study|Protocol Violation|0|||
125144519|NCT00360490|450153176|FG001|Overall Study|Protocol Violation|4|||
125144520|NCT00360490|450153175|FG000|Overall Study|Withdrawal by Subject|1|||
125144521|NCT00360490|450153176|FG001|Overall Study|Withdrawal by Subject|3|||
125144522|NCT03294317|450153177|FG000|Overall Study|Physician Decision|1|||
125144523|NCT03294317|450153177|FG000|Overall Study|Withdrawal by Subject|6|||
125144524|NCT03294317|450153177|FG000|Overall Study|Lost to Follow-up|1|||
125144525|NCT03294317|450153177|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
125144526|NCT03294317|450153177|FG000|Overall Study|Failed HB lead implant|8|||
125144527|NCT03294317|450153177|FG000|Overall Study|Received CRT instead|1|||
125144528|NCT03294317|450153177|FG000|Overall Study|Exited after lead revision|2|||
125144529|NCT01160640|450153178|FG000|Overall Study|Physician Decision|3|||
125144530|NCT01160640|450153179|FG001|Overall Study|Physician Decision|3|||
125144531|NCT01160640|450153178|FG000|Overall Study|Incarceration|1|||
125144532|NCT01160640|450153179|FG001|Overall Study|Incarceration|0|||
125144533|NCT01160640|450153178|FG000|Overall Study|Withdrawal by Subject|0|||
125144534|NCT01160640|450153179|FG001|Overall Study|Withdrawal by Subject|3|||
125144535|NCT00642811|450153184|FG000|Overall Study|Adverse Event|2|||
125144536|NCT00642811|450153185|FG001|Overall Study|Adverse Event|3|||
125144537|NCT00642811|450153186|FG002|Overall Study|Adverse Event|0|||
125144538|NCT00642811|450153187|FG003|Overall Study|Adverse Event|0|||
125144539|NCT00642811|450153188|FG004|Overall Study|Adverse Event|0|||
125144540|NCT00642811|450153189|FG005|Overall Study|Adverse Event|1|||
125144541|NCT00642811|450153184|FG000|Overall Study|Developement of discontinuation criteria|0|||
125144542|NCT00642811|450153185|FG001|Overall Study|Developement of discontinuation criteria|0|||
125144543|NCT00642811|450153186|FG002|Overall Study|Developement of discontinuation criteria|0|||
125144544|NCT00642811|450153187|FG003|Overall Study|Developement of discontinuation criteria|0|||
125144545|NCT00642811|450153188|FG004|Overall Study|Developement of discontinuation criteria|1|||
125144546|NCT00642811|450153189|FG005|Overall Study|Developement of discontinuation criteria|0|||
125144547|NCT00642811|450153184|FG000|Overall Study|Severe Non-compliance to protocol|1|||
125144548|NCT00642811|450153185|FG001|Overall Study|Severe Non-compliance to protocol|0|||
125144549|NCT00642811|450153186|FG002|Overall Study|Severe Non-compliance to protocol|0|||
125144550|NCT00642811|450153187|FG003|Overall Study|Severe Non-compliance to protocol|0|||
125144551|NCT00642811|450153188|FG004|Overall Study|Severe Non-compliance to protocol|0|||
125144552|NCT00642811|450153189|FG005|Overall Study|Severe Non-compliance to protocol|0|||
125144553|NCT00642811|450153184|FG000|Overall Study|Other|0|||
125144554|NCT00642811|450153185|FG001|Overall Study|Other|1|||
125144555|NCT00642811|450153186|FG002|Overall Study|Other|0|||
125144556|NCT00642811|450153187|FG003|Overall Study|Other|1|||
125144557|NCT00642811|450153188|FG004|Overall Study|Other|0|||
125144558|NCT00642811|450153189|FG005|Overall Study|Other|0|||
125144559|NCT01562613|450153191|FG000|Overall Study|Lost to Follow-up|2|||
125144560|NCT01562613|450153191|FG000|Overall Study|Withdrawal by Subject|2|||
125144561|NCT02614898|450153192|FG000|Overall Study|Participated until study termination|10|||
125144562|NCT02614898|450153193|FG001|Overall Study|Participated until study termination|26|||
125223508|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125144563|NCT02614898|450153192|FG000|Overall Study|Lost to Follow-up|0|||
125144564|NCT02614898|450153193|FG001|Overall Study|Lost to Follow-up|2|||
125303056|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
125144565|NCT02614898|450153192|FG000|Overall Study|Physician Decision|1|||
125144566|NCT02614898|450153193|FG001|Overall Study|Physician Decision|8|||
125144567|NCT02614898|450153192|FG000|Overall Study|Study Terminated by Sponsor|3|||
125144568|NCT02614898|450153193|FG001|Overall Study|Study Terminated by Sponsor|0|||
125144569|NCT02614898|450153192|FG000|Overall Study|Withdrawal by Subject|0|||
125144570|NCT02614898|450153193|FG001|Overall Study|Withdrawal by Subject|2|||
125144571|NCT02614898|450153192|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125144572|NCT02614898|450153193|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125144573|NCT02614898|450153192|FG000|Overall Study|Other-Additional Information Unavailable|0|||
125144574|NCT02614898|450153193|FG001|Overall Study|Other-Additional Information Unavailable|11|||
125144575|NCT02614898|450153192|FG000|Overall Study|Missing|0|||
125144576|NCT02614898|450153193|FG001|Overall Study|Missing|1|||
125144577|NCT00239005|450153194|FG000|Overall Study|Adverse Event|6|||
125144578|NCT00239005|450153195|FG001|Overall Study|Adverse Event|6|||
125144579|NCT00239005|450153194|FG000|Overall Study|Withdrawal by Subject|3|||
125144580|NCT00239005|450153195|FG001|Overall Study|Withdrawal by Subject|4|||
125144581|NCT00239005|450153194|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
125144582|NCT00239005|450153195|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
125144583|NCT00239005|450153194|FG000|Overall Study|Protocol Violation|1|||
125144584|NCT00239005|450153195|FG001|Overall Study|Protocol Violation|0|||
125144585|NCT00239005|450153194|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
125144586|NCT00239005|450153195|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
125144587|NCT00239005|450153194|FG000|Overall Study|Lost to Follow-up|0|||
125144588|NCT00239005|450153195|FG001|Overall Study|Lost to Follow-up|1|||
125144589|NCT00787605|450153196|FG000|Overall Study|Administrative Problems|3|||
125144590|NCT00787605|450153197|FG001|Overall Study|Administrative Problems|0|||
125144591|NCT00787605|450153196|FG000|Overall Study|Adverse Event|14|||
125144592|NCT00787605|450153197|FG001|Overall Study|Adverse Event|25|||
125144593|NCT00787605|450153196|FG000|Overall Study|Lost to Follow-up|3|||
125144594|NCT00787605|450153197|FG001|Overall Study|Lost to Follow-up|6|||
125144595|NCT00787605|450153196|FG000|Overall Study|Protocol Violation|7|||
125144596|NCT00787605|450153197|FG001|Overall Study|Protocol Violation|3|||
125144597|NCT00787605|450153196|FG000|Overall Study|Withdrawal by Subject|6|||
125144598|NCT00787605|450153197|FG001|Overall Study|Withdrawal by Subject|13|||
125144599|NCT00787605|450153196|FG000|Overall Study|Lack of Efficacy|13|||
125144600|NCT00787605|450153197|FG001|Overall Study|Lack of Efficacy|9|||
125144601|NCT03108820|450153198|FG000|Overall Study|Lost to Follow-up|30|||
125144602|NCT03108820|450153199|FG001|Overall Study|Lost to Follow-up|28|||
125144603|NCT03108820|450153198|FG000|Overall Study|Withdrawal by Subject|32|||
125144604|NCT03108820|450153199|FG001|Overall Study|Withdrawal by Subject|24|||
125144605|NCT03108820|450153198|FG000|Overall Study|Death|6|||
125144606|NCT03108820|450153199|FG001|Overall Study|Death|11|||
125144607|NCT03382041|450153200|FG000|Overall Study|Consent Form Lost|2|||
125144608|NCT03382041|450153201|FG001|Overall Study|Consent Form Lost|1|||
125144609|NCT03382041|450153200|FG000|Overall Study|Withdrawal by Subject|1|||
125144610|NCT03382041|450153201|FG001|Overall Study|Withdrawal by Subject|4|||
125144611|NCT03382041|450153200|FG000|Overall Study|Lost to Follow-up|1|||
125144612|NCT03382041|450153201|FG001|Overall Study|Lost to Follow-up|4|||
125144613|NCT03493919|450153206|FG000|Overall Study|Other|2|||
125144614|NCT03493919|450153207|FG001|Overall Study|Other|0|||
125144615|NCT03493919|450153208|FG002|Overall Study|Other|1|||
125144616|NCT03493919|450153209|FG003|Overall Study|Other|0|||
125144617|NCT03493919|450153206|FG000|Overall Study|Withdrawal by Subject|9|||
125144618|NCT03493919|450153207|FG001|Overall Study|Withdrawal by Subject|3|||
125144619|NCT03493919|450153208|FG002|Overall Study|Withdrawal by Subject|1|||
125144620|NCT03493919|450153209|FG003|Overall Study|Withdrawal by Subject|1|||
125144621|NCT03493919|450153206|FG000|Overall Study|Lost to Follow-up|5|||
125144622|NCT03493919|450153207|FG001|Overall Study|Lost to Follow-up|0|||
125144623|NCT03493919|450153208|FG002|Overall Study|Lost to Follow-up|0|||
125144624|NCT03493919|450153209|FG003|Overall Study|Lost to Follow-up|3|||
125144625|NCT03493919|450153206|FG000|Overall Study|Adverse Event|0|||
125144626|NCT03493919|450153207|FG001|Overall Study|Adverse Event|1|||
125144627|NCT03493919|450153208|FG002|Overall Study|Adverse Event|0|||
125144628|NCT03493919|450153209|FG003|Overall Study|Adverse Event|0|||
125144629|NCT04640194|450153210|FG000|Overall Study|Adverse Event|3|||
125144630|NCT04640194|450153211|FG001|Overall Study|Adverse Event|7|||
125144631|NCT04640194|450153212|FG002|Overall Study|Adverse Event|0|||
125144632|NCT04640194|450153213|FG003|Overall Study|Adverse Event|5|||
125144633|NCT04640194|450153214|FG004|Overall Study|Adverse Event|0|||
125144634|NCT04640194|450153215|FG005|Overall Study|Adverse Event|4|||
125144635|NCT04640194|450153216|FG006|Overall Study|Adverse Event|0|||
125144636|NCT04640194|450153210|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
125144637|NCT04640194|450153211|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
125144638|NCT04640194|450153212|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
125144639|NCT04640194|450153213|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
125387192|NCT03446040|451052241|FG008|Overall Study|Study drug toxicity|1|||
125144640|NCT04640194|450153214|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
125144641|NCT04640194|450153215|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
125144642|NCT04640194|450153216|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
125144643|NCT04640194|450153210|FG000|Overall Study|fibrinogen level too low|0|||
125387193|NCT03446040|451052242|FG009|Overall Study|Study drug toxicity|0|||
125144644|NCT04640194|450153211|FG001|Overall Study|fibrinogen level too low|0|||
125387194|NCT03446040|451052243|FG010|Overall Study|Study drug toxicity|0|||
125387195|NCT03446040|451052244|FG011|Overall Study|Study drug toxicity|0|||
125387196|NCT03446040|451052245|FG012|Overall Study|Study drug toxicity|0|||
125387197|NCT03446040|451052246|FG013|Overall Study|Study drug toxicity|0|||
125387198|NCT03446040|451052233|FG000|Overall Study|Adverse Event|0|||
125387199|NCT03446040|451052234|FG001|Overall Study|Adverse Event|0|||
125387200|NCT03446040|451052235|FG002|Overall Study|Adverse Event|0|||
125387201|NCT03446040|451052236|FG003|Overall Study|Adverse Event|0|||
125387202|NCT03446040|451052237|FG004|Overall Study|Adverse Event|0|||
125387203|NCT03446040|451052238|FG005|Overall Study|Adverse Event|2|||
125144645|NCT04640194|450153212|FG002|Overall Study|fibrinogen level too low|0|||
125144646|NCT04640194|450153213|FG003|Overall Study|fibrinogen level too low|1|||
125144647|NCT04640194|450153214|FG004|Overall Study|fibrinogen level too low|0|||
125144648|NCT04640194|450153215|FG005|Overall Study|fibrinogen level too low|0|||
125144649|NCT04640194|450153216|FG006|Overall Study|fibrinogen level too low|0|||
125144650|NCT04640194|450153210|FG000|Overall Study|mild bleeding|0|||
125144651|NCT04640194|450153211|FG001|Overall Study|mild bleeding|0|||
125144652|NCT04640194|450153212|FG002|Overall Study|mild bleeding|0|||
125144653|NCT04640194|450153213|FG003|Overall Study|mild bleeding|1|||
125144654|NCT04640194|450153214|FG004|Overall Study|mild bleeding|0|||
125144655|NCT04640194|450153215|FG005|Overall Study|mild bleeding|0|||
125144656|NCT04640194|450153216|FG006|Overall Study|mild bleeding|0|||
125144657|NCT04640194|450153210|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
125144658|NCT04640194|450153211|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
125144659|NCT04640194|450153212|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
125144660|NCT04640194|450153213|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
125144661|NCT04640194|450153214|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
125144662|NCT04640194|450153215|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
125144663|NCT04640194|450153216|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
125144664|NCT04428645|450153217|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
125144665|NCT04773600|450153222|FG000|Overall Study|Withdrawal by Subject|15|||
125144666|NCT04773600|450153223|FG001|Overall Study|Withdrawal by Subject|9|||
125144667|NCT04773600|450153222|FG000|Overall Study|Lost to Follow-up|10|||
125144668|NCT04773600|450153223|FG001|Overall Study|Lost to Follow-up|6|||
125144669|NCT04773600|450153222|FG000|Overall Study|Adverse Event|8|||
125144670|NCT04773600|450153223|FG001|Overall Study|Adverse Event|2|||
125144671|NCT04773600|450153222|FG000|Overall Study|Lack of Efficacy|2|||
125144672|NCT04773600|450153223|FG001|Overall Study|Lack of Efficacy|3|||
125144673|NCT04773600|450153222|FG000|Overall Study|Noncompliance|2|||
125144674|NCT04773600|450153223|FG001|Overall Study|Noncompliance|0|||
125144675|NCT04773600|450153222|FG000|Overall Study|Protocol Violation|2|||
125144676|NCT04773600|450153223|FG001|Overall Study|Protocol Violation|0|||
125144677|NCT04773600|450153222|FG000|Overall Study|Physician Decision|0|||
125144678|NCT04773600|450153223|FG001|Overall Study|Physician Decision|1|||
125144679|NCT04773600|450153222|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
125144680|NCT04773600|450153223|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
125144681|NCT04773600|450153222|FG000|Overall Study|Emergency Travel Out of Country|1|||
125144682|NCT04773600|450153223|FG001|Overall Study|Emergency Travel Out of Country|0|||
125144683|NCT00500318|450155876|FG000|Overall Study|Adverse Event|3|||
125144684|NCT00500318|450155877|FG001|Overall Study|Adverse Event|8|||
125144685|NCT00500318|450155876|FG000|Overall Study|Protocol Violation|1|||
125144686|NCT00500318|450155877|FG001|Overall Study|Protocol Violation|3|||
125144687|NCT00500318|450155876|FG000|Overall Study|Withdrawal by Subject|1|||
125144688|NCT00500318|450155877|FG001|Overall Study|Withdrawal by Subject|2|||
125144689|NCT00500318|450155876|FG000|Overall Study|Lack of Efficacy|0|||
125144690|NCT00500318|450155877|FG001|Overall Study|Lack of Efficacy|3|||
125303057|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
125223509|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223510|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
125223511|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223512|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223513|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125144691|NCT00500318|450155876|FG000|Overall Study|Other Reason|0|||
125144692|NCT00500318|450155877|FG001|Overall Study|Other Reason|1|||
125144693|NCT03243396|450155878|FG000|Overall Study|Lost to Follow-up|2|||
125144694|NCT03243396|450155879|FG001|Overall Study|Lost to Follow-up|3|||
125144695|NCT03243396|450155880|FG002|Overall Study|Lost to Follow-up|15|||
125144696|NCT03243396|450155881|FG003|Overall Study|Lost to Follow-up|8|||
125144697|NCT03243396|450155882|FG004|Overall Study|Lost to Follow-up|1|||
125144698|NCT03243396|450155883|FG005|Overall Study|Lost to Follow-up|4|||
125144699|NCT03243396|450155884|FG006|Overall Study|Lost to Follow-up|9|||
125144700|NCT01257581|450155885|FG000|Overall Study|Early Termination|3|||
125144701|NCT01257581|450155886|FG001|Overall Study|Early Termination|1|||
125144702|NCT01257581|450155887|FG002|Overall Study|Early Termination|2|||
125144703|NCT01257581|450155885|FG000|Overall Study|Death|2|||
125144704|NCT01257581|450155886|FG001|Overall Study|Death|2|||
125144705|NCT01257581|450155887|FG002|Overall Study|Death|4|||
125144706|NCT02246764|450155890|FG000|Overall Study|Adverse Event|15|||
125144707|NCT02246764|450155891|FG001|Overall Study|Adverse Event|29|||
125144708|NCT02246764|450155892|FG002|Overall Study|Adverse Event|1|||
125144709|NCT02246764|450155890|FG000|Overall Study|Withdrawal by Subject|0|||
125144710|NCT02246764|450155891|FG001|Overall Study|Withdrawal by Subject|0|||
125144711|NCT02246764|450155892|FG002|Overall Study|Withdrawal by Subject|1|||
125144712|NCT02246764|450155890|FG000|Overall Study|Disallowed Concomitant Medication|1|||
125144713|NCT02246764|450155891|FG001|Overall Study|Disallowed Concomitant Medication|0|||
125144714|NCT02246764|450155892|FG002|Overall Study|Disallowed Concomitant Medication|0|||
125144715|NCT02246764|450155890|FG000|Overall Study|Physician Decision|0|||
125144716|NCT02246764|450155891|FG001|Overall Study|Physician Decision|2|||
125387204|NCT03446040|451052239|FG006|Overall Study|Adverse Event|0|||
125387205|NCT03446040|451052240|FG007|Overall Study|Adverse Event|0|||
125387206|NCT03446040|451052241|FG008|Overall Study|Adverse Event|1|||
125144717|NCT02246764|450155892|FG002|Overall Study|Physician Decision|1|||
125144718|NCT02246764|450155890|FG000|Overall Study|Protocol Violation|2|||
125144719|NCT02246764|450155891|FG001|Overall Study|Protocol Violation|1|||
125144720|NCT02246764|450155892|FG002|Overall Study|Protocol Violation|1|||
125144721|NCT04982445|450155893|FG000|Overall Study|Protocol Violation|1|||
125387207|NCT03446040|451052242|FG009|Overall Study|Adverse Event|0|||
125144722|NCT04982445|450155893|FG000|Overall Study|Withdrawal by Subject|4|||
125144723|NCT04982445|450155893|FG000|Overall Study|Lost to Follow-up|1|||
125144724|NCT02161549|450155899|FG000|Overall Study|Physician Decision|6|||
125144725|NCT02161549|450155900|FG001|Overall Study|Physician Decision|2|||
125144726|NCT03223909|450155901|FG000|Overall Study|Protocol Violation|48|||
125144727|NCT03223909|450155902|FG001|Overall Study|Protocol Violation|45|||
125387208|NCT03446040|451052243|FG010|Overall Study|Adverse Event|0|||
125144728|NCT03223909|450155903|FG002|Overall Study|Protocol Violation|16|||
125144729|NCT01628549|450155906|FG000|Overall Study|Adverse Event|1|||
125387209|NCT03446040|451052244|FG011|Overall Study|Adverse Event|0|||
125387210|NCT03446040|451052245|FG012|Overall Study|Adverse Event|0|||
125223514|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223515|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223516|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223517|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223518|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223519|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
125223520|NCT02326272|450446164|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125387211|NCT03446040|451052246|FG013|Overall Study|Adverse Event|0|||
125387212|NCT03446040|451052233|FG000|Overall Study|Death|0|||
125387213|NCT03446040|451052234|FG001|Overall Study|Death|0|||
125223521|NCT02326272|450446165|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223522|NCT02326272|450446166|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223523|NCT02326272|450446167|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223524|NCT02326272|450446168|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223525|NCT02326272|450446169|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125144730|NCT01628549|450155907|FG001|Overall Study|Adverse Event|1|||
125144731|NCT01628549|450155908|FG002|Overall Study|Adverse Event|0|||
125144732|NCT01628549|450155909|FG003|Overall Study|Adverse Event|4|||
125144733|NCT01628549|450155906|FG000|Overall Study|Lost to Follow-up|3|||
125144734|NCT01628549|450155907|FG001|Overall Study|Lost to Follow-up|4|||
125144735|NCT01628549|450155908|FG002|Overall Study|Lost to Follow-up|3|||
125144736|NCT01628549|450155909|FG003|Overall Study|Lost to Follow-up|3|||
125144737|NCT01628549|450155906|FG000|Overall Study|Withdrawal by Subject|3|||
125144738|NCT01628549|450155907|FG001|Overall Study|Withdrawal by Subject|4|||
125144739|NCT01628549|450155908|FG002|Overall Study|Withdrawal by Subject|4|||
125144740|NCT01628549|450155909|FG003|Overall Study|Withdrawal by Subject|1|||
125144741|NCT01628549|450155906|FG000|Overall Study|Protocol Violation|2|||
125387214|NCT03446040|451052235|FG002|Overall Study|Death|0|||
125387215|NCT03446040|451052236|FG003|Overall Study|Death|0|||
125387216|NCT03446040|451052237|FG004|Overall Study|Death|0|||
125387217|NCT03446040|451052238|FG005|Overall Study|Death|0|||
125387218|NCT03446040|451052239|FG006|Overall Study|Death|0|||
125387219|NCT03446040|451052240|FG007|Overall Study|Death|0|||
125387220|NCT03446040|451052241|FG008|Overall Study|Death|0|||
125387221|NCT03446040|451052242|FG009|Overall Study|Death|0|||
125144742|NCT01628549|450155907|FG001|Overall Study|Protocol Violation|1|||
125144743|NCT01628549|450155908|FG002|Overall Study|Protocol Violation|1|||
125144744|NCT01628549|450155909|FG003|Overall Study|Protocol Violation|0|||
125144745|NCT01628549|450155906|FG000|Overall Study|withdrawn for noncompliance|0|||
125144746|NCT01628549|450155907|FG001|Overall Study|withdrawn for noncompliance|2|||
125144747|NCT01628549|450155908|FG002|Overall Study|withdrawn for noncompliance|1|||
125144748|NCT01628549|450155909|FG003|Overall Study|withdrawn for noncompliance|0|||
125144749|NCT01628549|450155906|FG000|Overall Study|abnormal laboratory test results|0|||
125144750|NCT01628549|450155907|FG001|Overall Study|abnormal laboratory test results|0|||
125144751|NCT01628549|450155908|FG002|Overall Study|abnormal laboratory test results|1|||
125144752|NCT01628549|450155909|FG003|Overall Study|abnormal laboratory test results|0|||
125144753|NCT01628549|450155906|FG000|Overall Study|positive pregnancy test|0|||
125144754|NCT01628549|450155907|FG001|Overall Study|positive pregnancy test|0|||
125144755|NCT01628549|450155908|FG002|Overall Study|positive pregnancy test|0|||
125144756|NCT01628549|450155909|FG003|Overall Study|positive pregnancy test|1|||
125144757|NCT00177164|450155910|FG000|Overall Study|Protocol Violation|0|||
125144758|NCT00177164|450155911|FG001|Overall Study|Protocol Violation|7|||
125144759|NCT00177164|450155910|FG000|Overall Study|Lost to Follow-up|4|||
125387222|NCT03446040|451052243|FG010|Overall Study|Death|1|||
125144760|NCT00177164|450155911|FG001|Overall Study|Lost to Follow-up|5|||
125144761|NCT00177164|450155910|FG000|Overall Study|increase in alcohol and drug use|1|||
125144762|NCT00177164|450155911|FG001|Overall Study|increase in alcohol and drug use|2|||
125144763|NCT00177164|450155910|FG000|Overall Study|Adverse Event|1|||
125144764|NCT00177164|450155911|FG001|Overall Study|Adverse Event|0|||
125144765|NCT00177164|450155910|FG000|Overall Study|discharge from hospital|1|||
125144766|NCT00177164|450155911|FG001|Overall Study|discharge from hospital|0|||
125144767|NCT00177164|450155910|FG000|Overall Study|Lack of Efficacy|2|||
125144768|NCT00177164|450155911|FG001|Overall Study|Lack of Efficacy|1|||
125144769|NCT00177164|450155910|FG000|Overall Study|Pregnancy|0|||
125144770|NCT00177164|450155911|FG001|Overall Study|Pregnancy|1|||
125223526|NCT02326272|450446170|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
125387223|NCT03446040|451052244|FG011|Overall Study|Death|0|||
125144771|NCT00965757|450155912|FG000|Double-blind Phase|Progression of concomitant disease|1|||
125144772|NCT00965757|450155913|FG001|Double-blind Phase|Progression of concomitant disease|2|||
125144773|NCT00965757|450155914|FG002|Double-blind Phase|Progression of concomitant disease|0|||
125144774|NCT00965757|450155915|FG003|Double-blind Phase|Progression of concomitant disease|0|||
125144775|NCT00965757|450155912|FG000|Double-blind Phase|Adverse drug reaction|2|||
125144776|NCT00965757|450155913|FG001|Double-blind Phase|Adverse drug reaction|1|||
125144777|NCT00965757|450155914|FG002|Double-blind Phase|Adverse drug reaction|0|||
125144778|NCT00965757|450155915|FG003|Double-blind Phase|Adverse drug reaction|0|||
125144779|NCT00965757|450155912|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
125144780|NCT00965757|450155913|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
125144781|NCT00965757|450155914|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
125144782|NCT00965757|450155915|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
125387224|NCT03446040|451052245|FG012|Overall Study|Death|0|||
125387225|NCT03446040|451052246|FG013|Overall Study|Death|2|||
125387226|NCT03446040|451052233|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
125387227|NCT03446040|451052234|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
125387228|NCT03446040|451052235|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
125387229|NCT03446040|451052236|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
125387230|NCT03446040|451052237|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
125387231|NCT03446040|451052238|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
125387232|NCT03446040|451052239|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
125387233|NCT03446040|451052240|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
125387234|NCT03446040|451052241|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
125387235|NCT03446040|451052242|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
125387236|NCT03446040|451052243|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
125387237|NCT03446040|451052244|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
125387238|NCT03446040|451052245|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
125387239|NCT03446040|451052246|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
125387240|NCT03446040|451052233|FG000|Overall Study|Participant withdrew consent|0|||
125144783|NCT00965757|450155912|FG000|Double-blind Phase|Lack of Efficacy|7|||
125144784|NCT00965757|450155913|FG001|Double-blind Phase|Lack of Efficacy|11|||
125387241|NCT03446040|451052234|FG001|Overall Study|Participant withdrew consent|0|||
125438436|NCT01155661|451232253|FG000|Overall Study|Protocol Violation|35|||
125303058|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
125303059|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
125303060|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303061|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
125303062|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
125144785|NCT00965757|450155914|FG002|Double-blind Phase|Lack of Efficacy|0|||
125144786|NCT00965757|450155915|FG003|Double-blind Phase|Lack of Efficacy|0|||
125144787|NCT00965757|450155912|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
125144788|NCT00965757|450155913|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
125144789|NCT00965757|450155914|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
125144790|NCT00965757|450155915|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
125144791|NCT00965757|450155912|FG000|Double-blind Phase|Lost to Follow-up|0|||
125144792|NCT00965757|450155913|FG001|Double-blind Phase|Lost to Follow-up|1|||
125144793|NCT00965757|450155914|FG002|Double-blind Phase|Lost to Follow-up|0|||
125144794|NCT00965757|450155915|FG003|Double-blind Phase|Lost to Follow-up|0|||
125144795|NCT00965757|450155912|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
125144796|NCT00965757|450155913|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
125144797|NCT00965757|450155914|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
125144798|NCT00965757|450155915|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
125144799|NCT00965757|450155912|FG000|Double-blind Phase|Other|1|||
125144800|NCT00965757|450155913|FG001|Double-blind Phase|Other|0|||
125144801|NCT00965757|450155914|FG002|Double-blind Phase|Other|0|||
125144802|NCT00965757|450155915|FG003|Double-blind Phase|Other|0|||
125144803|NCT00965757|450155912|FG000|Extension Phase|Progression of concomitant disease|0|||
125144804|NCT00965757|450155913|FG001|Extension Phase|Progression of concomitant disease|0|||
125144805|NCT00965757|450155914|FG002|Extension Phase|Progression of concomitant disease|4|||
125144806|NCT00965757|450155915|FG003|Extension Phase|Progression of concomitant disease|2|||
125144807|NCT00965757|450155912|FG000|Extension Phase|Adverse drug reaction|0|||
125144808|NCT00965757|450155913|FG001|Extension Phase|Adverse drug reaction|0|||
125144809|NCT00965757|450155914|FG002|Extension Phase|Adverse drug reaction|6|||
125144810|NCT00965757|450155915|FG003|Extension Phase|Adverse drug reaction|3|||
125144811|NCT00965757|450155912|FG000|Extension Phase|Abnormal Laboratory Value|0|||
125144812|NCT00965757|450155913|FG001|Extension Phase|Abnormal Laboratory Value|0|||
125144813|NCT00965757|450155914|FG002|Extension Phase|Abnormal Laboratory Value|6|||
125144814|NCT00965757|450155915|FG003|Extension Phase|Abnormal Laboratory Value|1|||
125144815|NCT00965757|450155912|FG000|Extension Phase|Lack of Efficacy|0|||
125144816|NCT00965757|450155913|FG001|Extension Phase|Lack of Efficacy|0|||
125144817|NCT00965757|450155914|FG002|Extension Phase|Lack of Efficacy|8|||
125144818|NCT00965757|450155915|FG003|Extension Phase|Lack of Efficacy|12|||
125144819|NCT00965757|450155912|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
125144820|NCT00965757|450155913|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
125144821|NCT00965757|450155914|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
125144822|NCT00965757|450155915|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
125144823|NCT00965757|450155912|FG000|Extension Phase|Lost to Follow-up|0|||
125144824|NCT00965757|450155913|FG001|Extension Phase|Lost to Follow-up|0|||
125144825|NCT00965757|450155914|FG002|Extension Phase|Lost to Follow-up|0|||
125144826|NCT00965757|450155915|FG003|Extension Phase|Lost to Follow-up|1|||
125144827|NCT00965757|450155912|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
125144828|NCT00965757|450155913|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
125144829|NCT00965757|450155914|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
125144830|NCT00965757|450155915|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
125144831|NCT00965757|450155912|FG000|Extension Phase|Protocol Violation|0|||
125144832|NCT00965757|450155913|FG001|Extension Phase|Protocol Violation|0|||
125144833|NCT00965757|450155914|FG002|Extension Phase|Protocol Violation|0|||
125144834|NCT00965757|450155915|FG003|Extension Phase|Protocol Violation|1|||
125144835|NCT00965757|450155912|FG000|Extension Phase|Other|0|||
125144836|NCT00965757|450155913|FG001|Extension Phase|Other|0|||
125144837|NCT00965757|450155914|FG002|Extension Phase|Other|2|||
125144838|NCT00965757|450155915|FG003|Extension Phase|Other|1|||
125144839|NCT01398787|450155920|FG000|Overall Study|Adverse Event|1|||
125144840|NCT02351167|450155921|FG000|Overall Study|Withdrawal by Subject|19|||
125144841|NCT02351167|450155922|FG001|Overall Study|Withdrawal by Subject|18|||
125144842|NCT02351167|450155923|FG002|Overall Study|Withdrawal by Subject|21|||
125144843|NCT01332968|450155924|FG000|Induction Period|Adverse Event|23|||
125144844|NCT01332968|450155925|FG001|Induction Period|Adverse Event|26|||
125144845|NCT01332968|450155926|FG002|Induction Period|Adverse Event|0|||
125144846|NCT01332968|450155927|FG003|Induction Period|Adverse Event|0|||
125144847|NCT01332968|450155928|FG004|Induction Period|Adverse Event|0|||
125144848|NCT01332968|450155929|FG005|Induction Period|Adverse Event|0|||
125144849|NCT01332968|450155930|FG006|Induction Period|Adverse Event|0|||
125144850|NCT01332968|450155931|FG007|Induction Period|Adverse Event|0|||
125144851|NCT01332968|450155924|FG000|Induction Period|Death|1|||
125144852|NCT01332968|450155925|FG001|Induction Period|Death|4|||
125144853|NCT01332968|450155926|FG002|Induction Period|Death|0|||
125144854|NCT01332968|450155927|FG003|Induction Period|Death|0|||
125144855|NCT01332968|450155928|FG004|Induction Period|Death|0|||
125144856|NCT01332968|450155929|FG005|Induction Period|Death|0|||
125144857|NCT01332968|450155930|FG006|Induction Period|Death|0|||
125144858|NCT01332968|450155931|FG007|Induction Period|Death|0|||
125144859|NCT01332968|450155924|FG000|Induction Period|Non-compliance|1|||
125144860|NCT01332968|450155925|FG001|Induction Period|Non-compliance|0|||
125144861|NCT01332968|450155926|FG002|Induction Period|Non-compliance|0|||
125144862|NCT01332968|450155927|FG003|Induction Period|Non-compliance|0|||
125144863|NCT01332968|450155928|FG004|Induction Period|Non-compliance|0|||
125144864|NCT01332968|450155929|FG005|Induction Period|Non-compliance|0|||
125144865|NCT01332968|450155930|FG006|Induction Period|Non-compliance|0|||
125144866|NCT01332968|450155931|FG007|Induction Period|Non-compliance|0|||
125144867|NCT01332968|450155924|FG000|Induction Period|Other|2|||
125144868|NCT01332968|450155925|FG001|Induction Period|Other|2|||
125144869|NCT01332968|450155926|FG002|Induction Period|Other|0|||
125144870|NCT01332968|450155927|FG003|Induction Period|Other|0|||
125144871|NCT01332968|450155928|FG004|Induction Period|Other|0|||
125144872|NCT01332968|450155929|FG005|Induction Period|Other|0|||
125144873|NCT01332968|450155930|FG006|Induction Period|Other|0|||
125144874|NCT01332968|450155931|FG007|Induction Period|Other|0|||
125144875|NCT01332968|450155924|FG000|Induction Period|Physician Decision|6|||
125144876|NCT01332968|450155925|FG001|Induction Period|Physician Decision|1|||
125144877|NCT01332968|450155926|FG002|Induction Period|Physician Decision|0|||
125144878|NCT01332968|450155927|FG003|Induction Period|Physician Decision|0|||
125144879|NCT01332968|450155928|FG004|Induction Period|Physician Decision|0|||
125144880|NCT01332968|450155929|FG005|Induction Period|Physician Decision|0|||
125144881|NCT01332968|450155930|FG006|Induction Period|Physician Decision|0|||
125144882|NCT01332968|450155931|FG007|Induction Period|Physician Decision|0|||
125144883|NCT01332968|450155924|FG000|Induction Period|Progressive Disease|15|||
125144884|NCT01332968|450155925|FG001|Induction Period|Progressive Disease|7|||
125144885|NCT01332968|450155926|FG002|Induction Period|Progressive Disease|0|||
125223527|NCT02326272|450446171|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223528|NCT02326272|450446172|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223529|NCT02326272|450446173|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223530|NCT02326272|450446174|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125144886|NCT01332968|450155927|FG003|Induction Period|Progressive Disease|0|||
125144887|NCT01332968|450155928|FG004|Induction Period|Progressive Disease|0|||
125144888|NCT01332968|450155929|FG005|Induction Period|Progressive Disease|0|||
125144889|NCT01332968|450155930|FG006|Induction Period|Progressive Disease|0|||
125144890|NCT01332968|450155931|FG007|Induction Period|Progressive Disease|0|||
125144891|NCT01332968|450155924|FG000|Induction Period|Protocol Violation|3|||
125144892|NCT01332968|450155925|FG001|Induction Period|Protocol Violation|4|||
125144893|NCT01332968|450155926|FG002|Induction Period|Protocol Violation|0|||
125144894|NCT01332968|450155927|FG003|Induction Period|Protocol Violation|0|||
125144895|NCT01332968|450155928|FG004|Induction Period|Protocol Violation|0|||
125144896|NCT01332968|450155929|FG005|Induction Period|Protocol Violation|0|||
125144897|NCT01332968|450155930|FG006|Induction Period|Protocol Violation|0|||
125144898|NCT01332968|450155931|FG007|Induction Period|Protocol Violation|0|||
125144899|NCT01332968|450155924|FG000|Induction Period|Withdrawal by Subject|3|||
125144900|NCT01332968|450155925|FG001|Induction Period|Withdrawal by Subject|5|||
125144901|NCT01332968|450155926|FG002|Induction Period|Withdrawal by Subject|0|||
125144902|NCT01332968|450155927|FG003|Induction Period|Withdrawal by Subject|0|||
125144903|NCT01332968|450155928|FG004|Induction Period|Withdrawal by Subject|0|||
125144904|NCT01332968|450155929|FG005|Induction Period|Withdrawal by Subject|0|||
125144905|NCT01332968|450155930|FG006|Induction Period|Withdrawal by Subject|0|||
125144906|NCT01332968|450155931|FG007|Induction Period|Withdrawal by Subject|0|||
125144907|NCT01332968|450155924|FG000|Induction Period|Randomised but not treated|4|||
125144908|NCT01332968|450155925|FG001|Induction Period|Randomised but not treated|7|||
125144909|NCT01332968|450155926|FG002|Induction Period|Randomised but not treated|0|||
125144910|NCT01332968|450155927|FG003|Induction Period|Randomised but not treated|0|||
125144911|NCT01332968|450155928|FG004|Induction Period|Randomised but not treated|0|||
125144912|NCT01332968|450155929|FG005|Induction Period|Randomised but not treated|0|||
125144913|NCT01332968|450155930|FG006|Induction Period|Randomised but not treated|0|||
125144914|NCT01332968|450155931|FG007|Induction Period|Randomised but not treated|0|||
125387242|NCT03446040|451052235|FG002|Overall Study|Participant withdrew consent|0|||
125387243|NCT03446040|451052236|FG003|Overall Study|Participant withdrew consent|0|||
125387244|NCT03446040|451052237|FG004|Overall Study|Participant withdrew consent|0|||
125387245|NCT03446040|451052238|FG005|Overall Study|Participant withdrew consent|1|||
125387246|NCT03446040|451052239|FG006|Overall Study|Participant withdrew consent|0|||
125387247|NCT03446040|451052240|FG007|Overall Study|Participant withdrew consent|1|||
125387248|NCT03446040|451052241|FG008|Overall Study|Participant withdrew consent|0|||
125387249|NCT03446040|451052242|FG009|Overall Study|Participant withdrew consent|0|||
125144915|NCT01332968|450155924|FG000|Maintenance/Observation Period|Adverse Event|0|||
125144916|NCT01332968|450155925|FG001|Maintenance/Observation Period|Adverse Event|0|||
125144917|NCT01332968|450155926|FG002|Maintenance/Observation Period|Adverse Event|53|||
125144918|NCT01332968|450155927|FG003|Maintenance/Observation Period|Adverse Event|66|||
125144919|NCT01332968|450155928|FG004|Maintenance/Observation Period|Adverse Event|0|||
125144920|NCT01332968|450155929|FG005|Maintenance/Observation Period|Adverse Event|0|||
125144921|NCT01332968|450155930|FG006|Maintenance/Observation Period|Adverse Event|0|||
125223531|NCT02326272|450446175|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125303178|NCT03100058|450736662|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125387250|NCT03446040|451052243|FG010|Overall Study|Participant withdrew consent|0|||
125387251|NCT03446040|451052244|FG011|Overall Study|Participant withdrew consent|0|||
125387252|NCT03446040|451052245|FG012|Overall Study|Participant withdrew consent|0|||
125387253|NCT03446040|451052246|FG013|Overall Study|Participant withdrew consent|0|||
125387254|NCT03446040|451052233|FG000|Overall Study|Not reported|0|||
125144922|NCT01332968|450155931|FG007|Maintenance/Observation Period|Adverse Event|0|||
125223532|NCT02326272|450446176|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125387255|NCT03446040|451052234|FG001|Overall Study|Not reported|0|||
125387256|NCT03446040|451052235|FG002|Overall Study|Not reported|1|||
125144923|NCT01332968|450155924|FG000|Maintenance/Observation Period|Death|0|||
125144924|NCT01332968|450155925|FG001|Maintenance/Observation Period|Death|0|||
125144925|NCT01332968|450155926|FG002|Maintenance/Observation Period|Death|5|||
125144926|NCT01332968|450155927|FG003|Maintenance/Observation Period|Death|6|||
125144927|NCT01332968|450155928|FG004|Maintenance/Observation Period|Death|0|||
125144928|NCT01332968|450155929|FG005|Maintenance/Observation Period|Death|0|||
125144929|NCT01332968|450155930|FG006|Maintenance/Observation Period|Death|0|||
125387257|NCT03446040|451052236|FG003|Overall Study|Not reported|0|||
125387258|NCT03446040|451052237|FG004|Overall Study|Not reported|0|||
125144930|NCT01332968|450155931|FG007|Maintenance/Observation Period|Death|0|||
125144931|NCT01332968|450155924|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
125144932|NCT01332968|450155925|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
125144933|NCT01332968|450155926|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
125144934|NCT01332968|450155927|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
125144935|NCT01332968|450155928|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
125144936|NCT01332968|450155929|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
125387259|NCT03446040|451052238|FG005|Overall Study|Not reported|0|||
125387260|NCT03446040|451052239|FG006|Overall Study|Not reported|0|||
125387261|NCT03446040|451052240|FG007|Overall Study|Not reported|0|||
125387262|NCT03446040|451052241|FG008|Overall Study|Not reported|0|||
125144937|NCT01332968|450155930|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
125223533|NCT02326272|450446177|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125223534|NCT02326272|450446178|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
125387263|NCT03446040|451052242|FG009|Overall Study|Not reported|0|||
125387264|NCT03446040|451052243|FG010|Overall Study|Not reported|0|||
125387265|NCT03446040|451052244|FG011|Overall Study|Not reported|0|||
125387266|NCT03446040|451052245|FG012|Overall Study|Not reported|0|||
125387267|NCT03446040|451052246|FG013|Overall Study|Not reported|0|||
125387268|NCT03036098|451052247|FG000|Pre-Treatment|Other Reasons|1|||
125387269|NCT03036098|451052248|FG001|Pre-Treatment|Other Reasons|2|||
125387270|NCT03036098|451052249|FG002|Pre-Treatment|Other Reasons|0|||
125387271|NCT03036098|451052250|FG003|Pre-Treatment|Other Reasons|5|||
125387272|NCT03036098|451052247|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
125387273|NCT03036098|451052248|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
125387274|NCT03036098|451052249|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
125387275|NCT03036098|451052250|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
125387276|NCT03036098|451052247|FG000|Pre-Treatment|Withdrawal by Subject|1|||
125387277|NCT03036098|451052248|FG001|Pre-Treatment|Withdrawal by Subject|14|||
125387278|NCT03036098|451052249|FG002|Pre-Treatment|Withdrawal by Subject|0|||
125387279|NCT03036098|451052250|FG003|Pre-Treatment|Withdrawal by Subject|5|||
125387280|NCT03036098|451052247|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
125387281|NCT03036098|451052248|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
125144938|NCT01332968|450155931|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
125144939|NCT01332968|450155924|FG000|Maintenance/Observation Period|Non-compliance|0|||
125144940|NCT01332968|450155925|FG001|Maintenance/Observation Period|Non-compliance|0|||
125144941|NCT01332968|450155926|FG002|Maintenance/Observation Period|Non-compliance|4|||
125144942|NCT01332968|450155927|FG003|Maintenance/Observation Period|Non-compliance|3|||
125144943|NCT01332968|450155928|FG004|Maintenance/Observation Period|Non-compliance|0|||
125144944|NCT01332968|450155929|FG005|Maintenance/Observation Period|Non-compliance|0|||
125144945|NCT01332968|450155930|FG006|Maintenance/Observation Period|Non-compliance|0|||
125144946|NCT01332968|450155931|FG007|Maintenance/Observation Period|Non-compliance|0|||
125387282|NCT03036098|451052249|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
125387283|NCT03036098|451052250|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
125144947|NCT01332968|450155924|FG000|Maintenance/Observation Period|Other|0|||
125387284|NCT03036098|451052247|FG000|Treatment|Disease Progression|130|||
125387285|NCT03036098|451052248|FG001|Treatment|Disease Progression|77|||
125387286|NCT03036098|451052249|FG002|Treatment|Disease Progression|168|||
125387287|NCT03036098|451052250|FG003|Treatment|Disease Progression|50|||
125387288|NCT03036098|451052247|FG000|Treatment|Study Drug Toxicity|95|||
125387289|NCT03036098|451052248|FG001|Treatment|Study Drug Toxicity|45|||
125387290|NCT03036098|451052249|FG002|Treatment|Study Drug Toxicity|26|||
125387291|NCT03036098|451052250|FG003|Treatment|Study Drug Toxicity|22|||
125387292|NCT03036098|451052247|FG000|Treatment|Death|9|||
125387293|NCT03036098|451052248|FG001|Treatment|Death|3|||
125387294|NCT03036098|451052249|FG002|Treatment|Death|1|||
125387295|NCT03036098|451052250|FG003|Treatment|Death|2|||
125387296|NCT03036098|451052247|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
125387297|NCT03036098|451052248|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
125144948|NCT01332968|450155925|FG001|Maintenance/Observation Period|Other|0|||
125144949|NCT01332968|450155926|FG002|Maintenance/Observation Period|Other|4|||
125144950|NCT01332968|450155927|FG003|Maintenance/Observation Period|Other|7|||
125144951|NCT01332968|450155928|FG004|Maintenance/Observation Period|Other|0|||
125144952|NCT01332968|450155929|FG005|Maintenance/Observation Period|Other|0|||
125144953|NCT01332968|450155930|FG006|Maintenance/Observation Period|Other|0|||
125144954|NCT01332968|450155931|FG007|Maintenance/Observation Period|Other|0|||
125144955|NCT01332968|450155924|FG000|Maintenance/Observation Period|Physician Decision|0|||
125144956|NCT01332968|450155925|FG001|Maintenance/Observation Period|Physician Decision|0|||
125144957|NCT01332968|450155926|FG002|Maintenance/Observation Period|Physician Decision|14|||
125144958|NCT01332968|450155927|FG003|Maintenance/Observation Period|Physician Decision|19|||
125144959|NCT01332968|450155928|FG004|Maintenance/Observation Period|Physician Decision|0|||
125144960|NCT01332968|450155929|FG005|Maintenance/Observation Period|Physician Decision|1|||
125144961|NCT01332968|450155930|FG006|Maintenance/Observation Period|Physician Decision|0|||
125144962|NCT01332968|450155931|FG007|Maintenance/Observation Period|Physician Decision|0|||
125144963|NCT01332968|450155924|FG000|Maintenance/Observation Period|Progressive Disease|0|||
125144964|NCT01332968|450155925|FG001|Maintenance/Observation Period|Progressive Disease|0|||
125144965|NCT01332968|450155926|FG002|Maintenance/Observation Period|Progressive Disease|72|||
125144966|NCT01332968|450155927|FG003|Maintenance/Observation Period|Progressive Disease|40|||
125144967|NCT01332968|450155928|FG004|Maintenance/Observation Period|Progressive Disease|0|||
125144968|NCT01332968|450155929|FG005|Maintenance/Observation Period|Progressive Disease|0|||
125144969|NCT01332968|450155930|FG006|Maintenance/Observation Period|Progressive Disease|0|||
125144970|NCT01332968|450155931|FG007|Maintenance/Observation Period|Progressive Disease|0|||
125144971|NCT01332968|450155924|FG000|Maintenance/Observation Period|Protocol Violation|0|||
125144972|NCT01332968|450155925|FG001|Maintenance/Observation Period|Protocol Violation|0|||
125144973|NCT01332968|450155926|FG002|Maintenance/Observation Period|Protocol Violation|1|||
125144974|NCT01332968|450155927|FG003|Maintenance/Observation Period|Protocol Violation|1|||
125144975|NCT01332968|450155928|FG004|Maintenance/Observation Period|Protocol Violation|0|||
125144976|NCT01332968|450155929|FG005|Maintenance/Observation Period|Protocol Violation|0|||
125144977|NCT01332968|450155930|FG006|Maintenance/Observation Period|Protocol Violation|0|||
125144978|NCT01332968|450155931|FG007|Maintenance/Observation Period|Protocol Violation|0|||
125144979|NCT01332968|450155924|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
125144980|NCT01332968|450155925|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
125144981|NCT01332968|450155926|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
125144982|NCT01332968|450155927|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
125144983|NCT01332968|450155928|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
125144984|NCT01332968|450155929|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
125144985|NCT01332968|450155930|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
125144986|NCT01332968|450155931|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
125144987|NCT01332968|450155924|FG000|Follow-Up Period|Adverse Event|0|||
125144988|NCT01332968|450155925|FG001|Follow-Up Period|Adverse Event|0|||
125144989|NCT01332968|450155926|FG002|Follow-Up Period|Adverse Event|0|||
125144990|NCT01332968|450155927|FG003|Follow-Up Period|Adverse Event|0|||
125144991|NCT01332968|450155928|FG004|Follow-Up Period|Adverse Event|0|||
125144992|NCT01332968|450155929|FG005|Follow-Up Period|Adverse Event|0|||
125144993|NCT01332968|450155930|FG006|Follow-Up Period|Adverse Event|0|||
125144994|NCT01332968|450155931|FG007|Follow-Up Period|Adverse Event|4|||
125223535|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
125144995|NCT01332968|450155924|FG000|Follow-Up Period|Death|0|||
125144996|NCT01332968|450155925|FG001|Follow-Up Period|Death|0|||
125144997|NCT01332968|450155926|FG002|Follow-Up Period|Death|0|||
125144998|NCT01332968|450155927|FG003|Follow-Up Period|Death|0|||
125144999|NCT01332968|450155928|FG004|Follow-Up Period|Death|0|||
125145000|NCT01332968|450155929|FG005|Follow-Up Period|Death|0|||
125145001|NCT01332968|450155930|FG006|Follow-Up Period|Death|27|||
125145002|NCT01332968|450155931|FG007|Follow-Up Period|Death|30|||
125145003|NCT01332968|450155924|FG000|Follow-Up Period|Lost to Follow-up|0|||
125145004|NCT01332968|450155925|FG001|Follow-Up Period|Lost to Follow-up|0|||
125145005|NCT01332968|450155926|FG002|Follow-Up Period|Lost to Follow-up|0|||
125145006|NCT01332968|450155927|FG003|Follow-Up Period|Lost to Follow-up|0|||
125145007|NCT01332968|450155928|FG004|Follow-Up Period|Lost to Follow-up|0|||
125145008|NCT01332968|450155929|FG005|Follow-Up Period|Lost to Follow-up|0|||
125387298|NCT03036098|451052249|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
125387299|NCT03036098|451052250|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
125387300|NCT03036098|451052247|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
125387301|NCT03036098|451052248|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
125387302|NCT03036098|451052249|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
125387303|NCT03036098|451052250|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
125145009|NCT01332968|450155930|FG006|Follow-Up Period|Lost to Follow-up|11|||
125145010|NCT01332968|450155931|FG007|Follow-Up Period|Lost to Follow-up|15|||
125387304|NCT03036098|451052247|FG000|Treatment|Withdrawal by Subject|2|||
125387305|NCT03036098|451052248|FG001|Treatment|Withdrawal by Subject|9|||
125387306|NCT03036098|451052249|FG002|Treatment|Withdrawal by Subject|2|||
125387307|NCT03036098|451052250|FG003|Treatment|Withdrawal by Subject|4|||
125387308|NCT03036098|451052247|FG000|Treatment|Maximum Clinical Benefit|6|||
125387309|NCT03036098|451052248|FG001|Treatment|Maximum Clinical Benefit|1|||
125387310|NCT03036098|451052249|FG002|Treatment|Maximum Clinical Benefit|6|||
125387311|NCT03036098|451052250|FG003|Treatment|Maximum Clinical Benefit|10|||
125387312|NCT03036098|451052247|FG000|Treatment|Poor/Non Compliance|1|||
125387313|NCT03036098|451052248|FG001|Treatment|Poor/Non Compliance|2|||
125387314|NCT03036098|451052249|FG002|Treatment|Poor/Non Compliance|0|||
125387315|NCT03036098|451052250|FG003|Treatment|Poor/Non Compliance|1|||
125387316|NCT03036098|451052247|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
125387317|NCT03036098|451052248|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
125387318|NCT03036098|451052249|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
125387319|NCT03036098|451052250|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
125387320|NCT03036098|451052247|FG000|Treatment|Administrative Reason by Sponsor|1|||
125387321|NCT03036098|451052248|FG001|Treatment|Administrative Reason by Sponsor|0|||
125387322|NCT03036098|451052249|FG002|Treatment|Administrative Reason by Sponsor|2|||
125387323|NCT03036098|451052250|FG003|Treatment|Administrative Reason by Sponsor|1|||
125387324|NCT03036098|451052247|FG000|Treatment|Other Reasons|31|||
125387325|NCT03036098|451052248|FG001|Treatment|Other Reasons|5|||
125387326|NCT03036098|451052249|FG002|Treatment|Other Reasons|21|||
125387327|NCT03036098|451052250|FG003|Treatment|Other Reasons|8|||
125387328|NCT03036098|451052247|FG000|Treatment|Ongoing Treatment|0|||
125387329|NCT03036098|451052248|FG001|Treatment|Ongoing Treatment|0|||
125387330|NCT03036098|451052249|FG002|Treatment|Ongoing Treatment|23|||
125387331|NCT03036098|451052250|FG003|Treatment|Ongoing Treatment|0|||
125387332|NCT00507442|451052251|FG000|Overall Study|Adverse Event|8|||
125387333|NCT00507442|451052252|FG001|Overall Study|Adverse Event|11|||
125387334|NCT00507442|451052253|FG002|Overall Study|Adverse Event|4|||
125387335|NCT00507442|451052254|FG003|Overall Study|Adverse Event|1|||
125145011|NCT01332968|450155924|FG000|Follow-Up Period|Non-compliance|0|||
125145012|NCT01332968|450155925|FG001|Follow-Up Period|Non-compliance|0|||
125387336|NCT00507442|451052251|FG000|Overall Study|Protocol Violation|0|||
125145013|NCT01332968|450155926|FG002|Follow-Up Period|Non-compliance|0|||
125387337|NCT00507442|451052252|FG001|Overall Study|Protocol Violation|1|||
125145014|NCT01332968|450155927|FG003|Follow-Up Period|Non-compliance|0|||
125145015|NCT01332968|450155928|FG004|Follow-Up Period|Non-compliance|0|||
125223536|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
125223537|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
125223538|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
125387338|NCT00507442|451052253|FG002|Overall Study|Protocol Violation|0|||
125387339|NCT00507442|451052254|FG003|Overall Study|Protocol Violation|0|||
125387340|NCT00507442|451052251|FG000|Overall Study|Lost to Follow-up|0|||
125387341|NCT00507442|451052252|FG001|Overall Study|Lost to Follow-up|0|||
125387342|NCT00507442|451052253|FG002|Overall Study|Lost to Follow-up|1|||
125387343|NCT00507442|451052254|FG003|Overall Study|Lost to Follow-up|0|||
125387344|NCT00507442|451052251|FG000|Overall Study|Physician Decision|0|||
125387345|NCT00507442|451052252|FG001|Overall Study|Physician Decision|2|||
125387346|NCT00507442|451052253|FG002|Overall Study|Physician Decision|4|||
125387347|NCT00507442|451052254|FG003|Overall Study|Physician Decision|1|||
125387348|NCT00507442|451052251|FG000|Overall Study|Progressive Disease|2|||
125387349|NCT00507442|451052252|FG001|Overall Study|Progressive Disease|4|||
125387350|NCT00507442|451052253|FG002|Overall Study|Progressive Disease|2|||
125387351|NCT00507442|451052254|FG003|Overall Study|Progressive Disease|0|||
125387352|NCT00507442|451052251|FG000|Overall Study|Withdrawal by Subject|4|||
125387353|NCT00507442|451052252|FG001|Overall Study|Withdrawal by Subject|4|||
125387354|NCT00507442|451052253|FG002|Overall Study|Withdrawal by Subject|2|||
125387355|NCT00507442|451052254|FG003|Overall Study|Withdrawal by Subject|1|||
125387356|NCT00507442|451052251|FG000|Overall Study|Other|2|||
125387357|NCT00507442|451052252|FG001|Overall Study|Other|5|||
125387358|NCT00507442|451052253|FG002|Overall Study|Other|2|||
125387359|NCT00507442|451052254|FG003|Overall Study|Other|2|||
125387360|NCT02410954|451052261|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
125387361|NCT02410954|451052262|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
125387362|NCT02410954|451052261|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
125387363|NCT02410954|451052262|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
125387364|NCT00271609|451052263|FG000|Overall Study|Adverse Event|11|||
125387365|NCT00271609|451052264|FG001|Overall Study|Adverse Event|3|||
125387366|NCT00271609|451052263|FG000|Overall Study|Withdrawal by Subject|2|||
125387367|NCT00271609|451052264|FG001|Overall Study|Withdrawal by Subject|0|||
125387368|NCT02188589|451052265|FG000|Overall Study|Withdrawal by Subject|5|||
125387369|NCT01826487|451052269|FG000|Overall Study|Adverse Event|1|||
125387370|NCT01826487|451052270|FG001|Overall Study|Adverse Event|1|||
125387371|NCT01826487|451052269|FG000|Overall Study|Lost to Follow-up|1|||
125387372|NCT01826487|451052270|FG001|Overall Study|Lost to Follow-up|0|||
125387373|NCT01826487|451052269|FG000|Overall Study|Withdrawal by Subject|1|||
125387374|NCT01826487|451052270|FG001|Overall Study|Withdrawal by Subject|3|||
125387375|NCT01826487|451052269|FG000|Overall Study|Protocol Violation|1|||
125387376|NCT01826487|451052270|FG001|Overall Study|Protocol Violation|1|||
125387377|NCT01408030|451052271|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
125387378|NCT01408030|451052272|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
125387379|NCT01408030|451052273|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
125387380|NCT01408030|451052274|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
125387381|NCT01408030|451052271|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
125387382|NCT01408030|451052272|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
125387383|NCT01408030|451052273|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
125387384|NCT01408030|451052274|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
125387385|NCT01408030|451052271|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
125387386|NCT01408030|451052272|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
125387387|NCT01408030|451052273|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
125387388|NCT01408030|451052274|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
125387389|NCT01408030|451052271|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
125387390|NCT01408030|451052272|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
125387391|NCT01408030|451052273|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
125387392|NCT01408030|451052274|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
125387393|NCT01408030|451052271|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
125387394|NCT01408030|451052272|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
125387395|NCT01408030|451052273|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
125387396|NCT01408030|451052274|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
125387397|NCT01408030|451052271|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
125387398|NCT01408030|451052272|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
125387399|NCT01408030|451052273|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
125145016|NCT01332968|450155929|FG005|Follow-Up Period|Non-compliance|0|||
125387400|NCT01408030|451052274|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
125145017|NCT01332968|450155930|FG006|Follow-Up Period|Non-compliance|4|||
125145018|NCT01332968|450155931|FG007|Follow-Up Period|Non-compliance|9|||
125145019|NCT01332968|450155924|FG000|Follow-Up Period|Other|0|||
125145020|NCT01332968|450155925|FG001|Follow-Up Period|Other|0|||
125145021|NCT01332968|450155926|FG002|Follow-Up Period|Other|0|||
125145022|NCT01332968|450155927|FG003|Follow-Up Period|Other|0|||
125145023|NCT01332968|450155928|FG004|Follow-Up Period|Other|0|||
125145024|NCT01332968|450155929|FG005|Follow-Up Period|Other|0|||
125145025|NCT01332968|450155930|FG006|Follow-Up Period|Other|18|||
125145026|NCT01332968|450155931|FG007|Follow-Up Period|Other|21|||
125145027|NCT01332968|450155924|FG000|Follow-Up Period|Physician Decision|0|||
125145028|NCT01332968|450155925|FG001|Follow-Up Period|Physician Decision|0|||
125145029|NCT01332968|450155926|FG002|Follow-Up Period|Physician Decision|0|||
125145030|NCT01332968|450155927|FG003|Follow-Up Period|Physician Decision|0|||
125145031|NCT01332968|450155928|FG004|Follow-Up Period|Physician Decision|0|||
125145032|NCT01332968|450155929|FG005|Follow-Up Period|Physician Decision|0|||
125145033|NCT01332968|450155930|FG006|Follow-Up Period|Physician Decision|12|||
125145034|NCT01332968|450155931|FG007|Follow-Up Period|Physician Decision|15|||
125145035|NCT01332968|450155924|FG000|Follow-Up Period|Progressive Disease|0|||
125145036|NCT01332968|450155925|FG001|Follow-Up Period|Progressive Disease|0|||
125145037|NCT01332968|450155926|FG002|Follow-Up Period|Progressive Disease|0|||
125145038|NCT01332968|450155927|FG003|Follow-Up Period|Progressive Disease|0|||
125145039|NCT01332968|450155928|FG004|Follow-Up Period|Progressive Disease|0|||
125145040|NCT01332968|450155929|FG005|Follow-Up Period|Progressive Disease|0|||
125145041|NCT01332968|450155930|FG006|Follow-Up Period|Progressive Disease|126|||
125145042|NCT01332968|450155931|FG007|Follow-Up Period|Progressive Disease|106|||
125145043|NCT01332968|450155924|FG000|Follow-Up Period|Protocol Violation|0|||
125145044|NCT01332968|450155925|FG001|Follow-Up Period|Protocol Violation|0|||
125145045|NCT01332968|450155926|FG002|Follow-Up Period|Protocol Violation|0|||
125145046|NCT01332968|450155927|FG003|Follow-Up Period|Protocol Violation|0|||
125145047|NCT01332968|450155928|FG004|Follow-Up Period|Protocol Violation|0|||
125387401|NCT01408030|451052271|FG000|Observation Phase (Off Drug)|Other|1|||
125387402|NCT01408030|451052272|FG001|Observation Phase (Off Drug)|Other|1|||
125387403|NCT01408030|451052273|FG002|Observation Phase (Off Drug)|Other|1|||
125387404|NCT01408030|451052274|FG003|Observation Phase (Off Drug)|Other|1|||
125387405|NCT03755414|451052276|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
125387406|NCT03755414|451052277|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
125145048|NCT01332968|450155929|FG005|Follow-Up Period|Protocol Violation|0|||
125387407|NCT03755414|451052278|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
125387408|NCT03755414|451052276|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
125387409|NCT03755414|451052277|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
125387410|NCT03755414|451052278|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
125387411|NCT03755414|451052276|FG000|Overall Study|Non-compliance|0|||
125387412|NCT03755414|451052277|FG001|Overall Study|Non-compliance|1|||
125387413|NCT03755414|451052278|FG002|Overall Study|Non-compliance|0|||
125387414|NCT02081079|451052279|FG000|Overall Study|Lack of Efficacy|3|||
125387415|NCT02081079|451052280|FG001|Overall Study|Lack of Efficacy|2|||
125387416|NCT02081079|451052279|FG000|Overall Study|Lost to Follow-up|1|||
125387417|NCT02081079|451052280|FG001|Overall Study|Lost to Follow-up|0|||
125145049|NCT01332968|450155930|FG006|Follow-Up Period|Protocol Violation|1|||
125145050|NCT01332968|450155931|FG007|Follow-Up Period|Protocol Violation|0|||
125145051|NCT01332968|450155924|FG000|Follow-Up Period|Withdrawal by Subject|0|||
125145052|NCT01332968|450155925|FG001|Follow-Up Period|Withdrawal by Subject|0|||
125145053|NCT01332968|450155926|FG002|Follow-Up Period|Withdrawal by Subject|0|||
125145054|NCT01332968|450155927|FG003|Follow-Up Period|Withdrawal by Subject|0|||
125145055|NCT01332968|450155928|FG004|Follow-Up Period|Withdrawal by Subject|0|||
125145056|NCT01332968|450155929|FG005|Follow-Up Period|Withdrawal by Subject|0|||
125145057|NCT01332968|450155930|FG006|Follow-Up Period|Withdrawal by Subject|29|||
125145058|NCT01332968|450155931|FG007|Follow-Up Period|Withdrawal by Subject|32|||
125145059|NCT01332968|450155924|FG000|Follow-Up Period|No reason provided|0|||
125145060|NCT01332968|450155925|FG001|Follow-Up Period|No reason provided|0|||
125145061|NCT01332968|450155926|FG002|Follow-Up Period|No reason provided|0|||
125145062|NCT01332968|450155927|FG003|Follow-Up Period|No reason provided|0|||
125145063|NCT01332968|450155928|FG004|Follow-Up Period|No reason provided|0|||
125145064|NCT01332968|450155929|FG005|Follow-Up Period|No reason provided|0|||
125145065|NCT01332968|450155930|FG006|Follow-Up Period|No reason provided|2|||
125145066|NCT01332968|450155931|FG007|Follow-Up Period|No reason provided|3|||
125145067|NCT00113919|450155938|FG000|Overall Study|Physician Decision|8|||
125145068|NCT00113919|450155938|FG000|Overall Study|Death|6|||
125145069|NCT00715676|450155942|FG000|Overall Study|Adverse Event|3|||
125145070|NCT00715676|450155943|FG001|Overall Study|Adverse Event|5|||
125145071|NCT00715676|450155944|FG002|Overall Study|Adverse Event|21|||
125145072|NCT00715676|450155942|FG000|Overall Study|Withdrawal by Subject|1|||
125145073|NCT00715676|450155943|FG001|Overall Study|Withdrawal by Subject|3|||
125145074|NCT00715676|450155944|FG002|Overall Study|Withdrawal by Subject|8|||
125145075|NCT00715676|450155942|FG000|Overall Study|Lost to Follow-up|1|||
125145076|NCT00715676|450155943|FG001|Overall Study|Lost to Follow-up|2|||
125145077|NCT00715676|450155944|FG002|Overall Study|Lost to Follow-up|1|||
125145078|NCT00715676|450155942|FG000|Overall Study|Terminated by Sponsor|1|||
125145079|NCT00715676|450155943|FG001|Overall Study|Terminated by Sponsor|0|||
125145080|NCT00715676|450155944|FG002|Overall Study|Terminated by Sponsor|0|||
125145081|NCT00715676|450155942|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
125145082|NCT00715676|450155943|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
125145083|NCT00715676|450155944|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
125387418|NCT01712854|451052281|FG000|Overall Study|Physician Decision|1|||
125387419|NCT02225743|451052282|FG000|Overall Study|Withdrawal by Subject|18|||
125387420|NCT03886220|451052283|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
125387421|NCT03886220|451052284|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
125387422|NCT03886220|451052283|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
125145084|NCT00715676|450155942|FG000|Overall Study|Use of Exclusionary Medication|0|||
125145085|NCT00715676|450155943|FG001|Overall Study|Use of Exclusionary Medication|0|||
125145086|NCT00715676|450155944|FG002|Overall Study|Use of Exclusionary Medication|1|||
125145087|NCT00715676|450155942|FG000|Overall Study|Elevated Blood Glucose|0|||
125145088|NCT00715676|450155943|FG001|Overall Study|Elevated Blood Glucose|1|||
125145089|NCT00715676|450155944|FG002|Overall Study|Elevated Blood Glucose|0|||
125145090|NCT00372996|450155945|FG000|Overall Study|Death|11|||
125145091|NCT00372996|450155946|FG001|Overall Study|Death|4|||
125145092|NCT00372996|450155947|FG002|Overall Study|Death|8|||
125145093|NCT00372996|450155948|FG003|Overall Study|Death|7|||
125145094|NCT00372996|450155945|FG000|Overall Study|Lost to Follow-up|0|||
125145095|NCT00372996|450155946|FG001|Overall Study|Lost to Follow-up|2|||
125145096|NCT00372996|450155947|FG002|Overall Study|Lost to Follow-up|0|||
125145097|NCT00372996|450155948|FG003|Overall Study|Lost to Follow-up|1|||
125145098|NCT00372996|450155945|FG000|Overall Study|Withdrawal by Subject|12|||
125145099|NCT00372996|450155946|FG001|Overall Study|Withdrawal by Subject|6|||
125145100|NCT00372996|450155947|FG002|Overall Study|Withdrawal by Subject|9|||
125145101|NCT00372996|450155948|FG003|Overall Study|Withdrawal by Subject|5|||
125145102|NCT00372996|450155945|FG000|Overall Study|Study Terminated by Sponsor|4|||
125145103|NCT00372996|450155946|FG001|Overall Study|Study Terminated by Sponsor|0|||
125145104|NCT00372996|450155947|FG002|Overall Study|Study Terminated by Sponsor|4|||
125145105|NCT00372996|450155948|FG003|Overall Study|Study Terminated by Sponsor|0|||
125145106|NCT00372996|450155945|FG000|Overall Study|Other|10|||
125145107|NCT00372996|450155946|FG001|Overall Study|Other|2|||
125145108|NCT00372996|450155947|FG002|Overall Study|Other|7|||
125145109|NCT00372996|450155948|FG003|Overall Study|Other|7|||
125223539|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
125387423|NCT03886220|451052284|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
125387424|NCT03886220|451052283|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
125387425|NCT03886220|451052284|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
125387426|NCT00768300|451052289|FG000|Overall Study|Randomized but not treated|1|||
125387427|NCT00768300|451052290|FG001|Overall Study|Randomized but not treated|1|||
125387428|NCT00768300|451052289|FG000|Overall Study|Adverse Event|10|||
125387429|NCT00768300|451052290|FG001|Overall Study|Adverse Event|2|||
125387430|NCT00768300|451052289|FG000|Overall Study|Protocol Violation|6|||
125387431|NCT00768300|451052290|FG001|Overall Study|Protocol Violation|1|||
125387432|NCT00768300|451052289|FG000|Overall Study|Withdrawal by Subject|13|||
125387433|NCT00768300|451052290|FG001|Overall Study|Withdrawal by Subject|7|||
125387434|NCT00768300|451052289|FG000|Overall Study|Physician Decision|2|||
125387435|NCT00768300|451052290|FG001|Overall Study|Physician Decision|3|||
125387436|NCT00768300|451052289|FG000|Overall Study|Study discontinued by Sponsor|271|||
125387437|NCT00768300|451052290|FG001|Overall Study|Study discontinued by Sponsor|140|||
125387438|NCT00768300|451052289|FG000|Overall Study|Death|21|||
125387439|NCT00768300|451052290|FG001|Overall Study|Death|5|||
125387440|NCT00768300|451052289|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
125387441|NCT00768300|451052290|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
125387442|NCT00768300|451052289|FG000|Overall Study|Screen failure following randomization|1|||
125387443|NCT00768300|451052290|FG001|Overall Study|Screen failure following randomization|0|||
125387444|NCT00768300|451052289|FG000|Overall Study|Received lung transplant|1|||
125387445|NCT00768300|451052290|FG001|Overall Study|Received lung transplant|1|||
125387446|NCT00768300|451052289|FG000|Overall Study|Lost to Follow-up|0|||
125387447|NCT00768300|451052290|FG001|Overall Study|Lost to Follow-up|1|||
125387448|NCT00768300|451052289|FG000|Overall Study|Began prohibited concomitant medication|0|||
125387449|NCT00768300|451052290|FG001|Overall Study|Began prohibited concomitant medication|1|||
125387450|NCT00768300|451052289|FG000|Overall Study|Treated but never dosed with Study drug|1|||
125387451|NCT00768300|451052290|FG001|Overall Study|Treated but never dosed with Study drug|0|||
125387452|NCT00768300|451052289|FG000|Overall Study|Missing data|1|||
125387453|NCT00768300|451052290|FG001|Overall Study|Missing data|0|||
125387454|NCT02068222|451052291|FG000|Overall Study|Lost to Follow-up|1|||
125387455|NCT00698581|451052294|FG000|Overall Study|Lack of Efficacy|23|||
125387456|NCT00698581|451052295|FG001|Overall Study|Lack of Efficacy|11|||
125387457|NCT00698581|451052294|FG000|Overall Study|Withdrawal by Subject|6|||
125387458|NCT00698581|451052295|FG001|Overall Study|Withdrawal by Subject|0|||
125387459|NCT00698581|451052294|FG000|Overall Study|Other reason|9|||
125387460|NCT00698581|451052295|FG001|Overall Study|Other reason|1|||
125387461|NCT00698581|451052294|FG000|Overall Study|SAE, non-fatal|1|||
125387462|NCT00698581|451052295|FG001|Overall Study|SAE, non-fatal|0|||
125387463|NCT00698581|451052294|FG000|Overall Study|AE, non-serious non-fatal|4|||
125387464|NCT00698581|451052295|FG001|Overall Study|AE, non-serious non-fatal|0|||
125387465|NCT00698581|451052294|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125387466|NCT00698581|451052295|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
125387467|NCT00698581|451052294|FG000|Overall Study|AE of unknown type|1|||
125387468|NCT00698581|451052295|FG001|Overall Study|AE of unknown type|0|||
125387469|NCT00302458|451052296|FG000|Overall Study|Lost to Follow-up|1|||
125387470|NCT00302458|451052296|FG000|Overall Study|Ineligible after screening|1|||
125387471|NCT00302458|451052296|FG000|Overall Study|Withdrawal by Subject|1|||
125387472|NCT00853723|451052299|FG000|Overall Study|Adverse Event|3|||
125387473|NCT00853723|451052300|FG001|Overall Study|Adverse Event|4|||
125387474|NCT00853723|451052301|FG002|Overall Study|Adverse Event|1|||
125387475|NCT00853723|451052299|FG000|Overall Study|Withdrawal by Subject|2|||
125387476|NCT00853723|451052300|FG001|Overall Study|Withdrawal by Subject|1|||
125387477|NCT00853723|451052301|FG002|Overall Study|Withdrawal by Subject|0|||
125387478|NCT00853723|451052299|FG000|Overall Study|Protocol Violation|1|||
125387479|NCT00853723|451052300|FG001|Overall Study|Protocol Violation|2|||
125387480|NCT00853723|451052301|FG002|Overall Study|Protocol Violation|1|||
125387481|NCT01531387|451052302|FG000|Overall Study|Early termination of study|11|||
125387482|NCT01531387|451052303|FG001|Overall Study|Early termination of study|11|||
125387483|NCT02642432|451052306|FG000|Overall Study|Adverse Event|2|||
125387484|NCT02642432|451052306|FG000|Overall Study|Withdrew Consent|1|||
125387485|NCT02642432|451052306|FG000|Overall Study|Lost to Follow-up|2|||
125387486|NCT02642432|451052306|FG000|Overall Study|Other|3|||
125387487|NCT01848756|451052307|FG000|Overall Study|Adverse Event|1|||
125387488|NCT01848756|451052307|FG000|Overall Study|Withdrawal by Subject|1|||
125387489|NCT01848756|451052307|FG000|Overall Study|Enrolled in Error|1|||
125387490|NCT02865915|451052311|FG000|Overall Study|Pregnancy|1|||
125387491|NCT02865915|451052312|FG001|Overall Study|Pregnancy|0|||
125387492|NCT02865915|451052311|FG000|Overall Study|Withdrawal by Subject|1|||
125387493|NCT02865915|451052312|FG001|Overall Study|Withdrawal by Subject|1|||
125387494|NCT02865915|451052311|FG000|Overall Study|Adverse Event|0|||
125387495|NCT02865915|451052312|FG001|Overall Study|Adverse Event|4|||
125387496|NCT02865915|451052311|FG000|Overall Study|Lost to Follow-up|0|||
125387497|NCT02865915|451052312|FG001|Overall Study|Lost to Follow-up|1|||
125387498|NCT02865915|451052311|FG000|Overall Study|Protocol Violation|0|||
125387499|NCT02865915|451052312|FG001|Overall Study|Protocol Violation|1|||
125387500|NCT02865915|451052311|FG000|Overall Study|Study terminated by sponsor|23|||
125387501|NCT02865915|451052312|FG001|Overall Study|Study terminated by sponsor|18|||
125387502|NCT02865915|451052311|FG000|Overall Study|Dosing group discontinued|0|||
125387503|NCT02865915|451052312|FG001|Overall Study|Dosing group discontinued|5|||
125387504|NCT00663052|451052313|FG000|Overall Study|Adverse Event|6|||
125387505|NCT00663052|451052314|FG001|Overall Study|Adverse Event|3|||
125387506|NCT00663052|451052313|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
125387507|NCT00663052|451052314|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
125387508|NCT00663052|451052313|FG000|Overall Study|Protocol Violation|1|||
125387509|NCT00663052|451052314|FG001|Overall Study|Protocol Violation|0|||
125387510|NCT00663052|451052313|FG000|Overall Study|Withdrawal by Subject|2|||
125387511|NCT00663052|451052314|FG001|Overall Study|Withdrawal by Subject|5|||
125387512|NCT00663052|451052313|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
125387513|NCT00663052|451052314|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
125387514|NCT00663052|451052313|FG000|Overall Study|Other|0|||
125387515|NCT00663052|451052314|FG001|Overall Study|Other|1|||
125145110|NCT01091363|450155949|FG000|Overall Study|Withdrawal by Subject|11|||
125387516|NCT05760300|451052315|FG000|Overall Study|Adverse Event|0|||
125223540|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
125387517|NCT05760300|451052316|FG001|Overall Study|Adverse Event|0|||
125387518|NCT05760300|451052317|FG002|Overall Study|Adverse Event|1|||
125387519|NCT05760300|451052318|FG003|Overall Study|Adverse Event|0|||
125387520|NCT05760300|451052315|FG000|Overall Study|Participant Decision|1|||
125387521|NCT05760300|451052316|FG001|Overall Study|Participant Decision|0|||
125387522|NCT05760300|451052317|FG002|Overall Study|Participant Decision|0|||
125387523|NCT05760300|451052318|FG003|Overall Study|Participant Decision|0|||
125387524|NCT04350788|451052332|FG000|Overall Study|Lost to Follow-up|6|||
125387525|NCT04350788|451052333|FG001|Overall Study|Lost to Follow-up|2|||
125387526|NCT04350788|451052332|FG000|Overall Study|Withdrawal by Subject|2|||
125387527|NCT04350788|451052333|FG001|Overall Study|Withdrawal by Subject|4|||
125387528|NCT04350788|451052332|FG000|Overall Study|Protocol Violation|4|||
125387529|NCT04350788|451052333|FG001|Overall Study|Protocol Violation|0|||
125387530|NCT01894581|451052334|FG000|Overall Study|Withdrawal by Subject|2|||
125387531|NCT01894581|451052335|FG001|Overall Study|Withdrawal by Subject|3|||
125387532|NCT01894581|451052334|FG000|Overall Study|Screen Failure|3|||
125387533|NCT01894581|451052335|FG001|Overall Study|Screen Failure|4|||
125387534|NCT03313804|451052336|FG000|Treatment|Death|5|||
125387535|NCT03313804|451052336|FG000|Treatment|still on treatment|2|||
125387536|NCT03313804|451052336|FG000|Follow Up|still on follow up|3|||
125387537|NCT01252940|451052337|FG000|Main Study Phase|Randomized but not treated|4|||
125387538|NCT01252940|451052338|FG001|Main Study Phase|Randomized but not treated|2|||
125387539|NCT01252940|451052337|FG000|Main Study Phase|Adverse Event|3|||
125387540|NCT01252940|451052338|FG001|Main Study Phase|Adverse Event|1|||
125387541|NCT01252940|451052337|FG000|Main Study Phase|Lack of Efficacy|1|||
125387542|NCT01252940|451052338|FG001|Main Study Phase|Lack of Efficacy|0|||
125387543|NCT01252940|451052337|FG000|Main Study Phase|Lost to Follow-up|6|||
125387544|NCT01252940|451052338|FG001|Main Study Phase|Lost to Follow-up|1|||
125387545|NCT01252940|451052337|FG000|Main Study Phase|Physician Decision|1|||
125387546|NCT01252940|451052338|FG001|Main Study Phase|Physician Decision|0|||
125387547|NCT01252940|451052337|FG000|Main Study Phase|Protocol Violation|4|||
125387548|NCT01252940|451052338|FG001|Main Study Phase|Protocol Violation|2|||
125387549|NCT01252940|451052337|FG000|Main Study Phase|Withdrawal by Subject|6|||
125387550|NCT01252940|451052338|FG001|Main Study Phase|Withdrawal by Subject|5|||
125387551|NCT01252940|451052337|FG000|Main Study Phase|Subject Non-compliance|1|||
125387552|NCT01252940|451052338|FG001|Main Study Phase|Subject Non-compliance|1|||
125387553|NCT01252940|451052337|FG000|Extension Phase|Adverse Event|2|||
125387554|NCT01252940|451052338|FG001|Extension Phase|Adverse Event|1|||
125387555|NCT01252940|451052337|FG000|Extension Phase|Lack of Efficacy|1|||
125387556|NCT01252940|451052338|FG001|Extension Phase|Lack of Efficacy|0|||
125387557|NCT01252940|451052337|FG000|Extension Phase|Lost to Follow-up|5|||
125387558|NCT01252940|451052338|FG001|Extension Phase|Lost to Follow-up|0|||
125387559|NCT01252940|451052337|FG000|Extension Phase|Physician Decision|0|||
125223541|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
125223542|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
125223543|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
125223544|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
125145111|NCT01091363|450155950|FG001|Overall Study|Withdrawal by Subject|15|||
125145112|NCT01091363|450155949|FG000|Overall Study|Lost to Follow-up|2|||
125145113|NCT01091363|450155950|FG001|Overall Study|Lost to Follow-up|2|||
125145114|NCT02760433|450155953|FG000|Overall Study|Lost to Follow-up|1|||
125145115|NCT02760433|450155954|FG001|Overall Study|Lost to Follow-up|0|||
125145116|NCT02760433|450155955|FG002|Overall Study|Lost to Follow-up|1|||
125145117|NCT02760433|450155956|FG003|Overall Study|Lost to Follow-up|0|||
125145118|NCT02760433|450155957|FG004|Overall Study|Lost to Follow-up|0|||
125145119|NCT02760433|450155953|FG000|Overall Study|Withdrawal by Subject|23|||
125145120|NCT02760433|450155954|FG001|Overall Study|Withdrawal by Subject|9|||
125145121|NCT02760433|450155955|FG002|Overall Study|Withdrawal by Subject|0|||
125145122|NCT02760433|450155956|FG003|Overall Study|Withdrawal by Subject|2|||
125145123|NCT02760433|450155957|FG004|Overall Study|Withdrawal by Subject|9|||
125145124|NCT02760433|450155953|FG000|Overall Study|Lack of Response At Week 14|0|||
125145125|NCT02760433|450155954|FG001|Overall Study|Lack of Response At Week 14|0|||
125145126|NCT02760433|450155955|FG002|Overall Study|Lack of Response At Week 14|0|||
125145127|NCT02760433|450155956|FG003|Overall Study|Lack of Response At Week 14|0|||
125145128|NCT02760433|450155957|FG004|Overall Study|Lack of Response At Week 14|1|||
125145129|NCT02760433|450155953|FG000|Overall Study|Subject refused to continue the study|1|||
125145130|NCT02760433|450155954|FG001|Overall Study|Subject refused to continue the study|0|||
125145131|NCT02760433|450155955|FG002|Overall Study|Subject refused to continue the study|0|||
125145132|NCT02760433|450155956|FG003|Overall Study|Subject refused to continue the study|0|||
125145133|NCT02760433|450155957|FG004|Overall Study|Subject refused to continue the study|0|||
125145134|NCT02760433|450155953|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
125145135|NCT02760433|450155954|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
125145136|NCT02760433|450155955|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
125145137|NCT02760433|450155956|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
125145138|NCT02760433|450155957|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
125387560|NCT01252940|451052338|FG001|Extension Phase|Physician Decision|1|||
125387561|NCT01252940|451052337|FG000|Extension Phase|Subject Non-compliance|1|||
125387562|NCT01252940|451052338|FG001|Extension Phase|Subject Non-compliance|0|||
125145139|NCT02760433|450155953|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
125145140|NCT02760433|450155954|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
125145141|NCT02760433|450155955|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
125145142|NCT02760433|450155956|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
125145143|NCT02760433|450155957|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
125145144|NCT02151149|450155958|FG000|Treatment Period|Death|2|||
125145145|NCT02151149|450155959|FG001|Treatment Period|Death|3|||
125145146|NCT02151149|450155958|FG000|Treatment Period|Adverse Event|17|||
125145147|NCT02151149|450155959|FG001|Treatment Period|Adverse Event|14|||
125145148|NCT02151149|450155958|FG000|Treatment Period|Progressive Disease|25|||
125387563|NCT01252940|451052337|FG000|Extension Phase|Withdrawal by Subject|1|||
125387564|NCT01252940|451052338|FG001|Extension Phase|Withdrawal by Subject|1|||
125387565|NCT03759379|451053906|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
125387566|NCT03759379|451053907|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
125387567|NCT03759379|451053906|FG000|Treatment Period|Death|2|||
125387568|NCT03759379|451053907|FG001|Treatment Period|Death|3|||
125387569|NCT03759379|451053906|FG000|Treatment Period|Lost to Follow-up|1|||
125387570|NCT03759379|451053907|FG001|Treatment Period|Lost to Follow-up|0|||
125387571|NCT03759379|451053906|FG000|Treatment Period|Physician Decision|0|||
125387572|NCT03759379|451053907|FG001|Treatment Period|Physician Decision|1|||
125387573|NCT01254227|451053910|FG000|Overall Study|Withdrawal by Subject|6|||
125387574|NCT01254227|451053910|FG000|Overall Study|Lost to Follow-up|6|||
125387575|NCT01254227|451053910|FG000|Overall Study|Adverse Event|5|||
125387576|NCT01254227|451053910|FG000|Overall Study|Abnormal test procedure result|5|||
125387577|NCT01254227|451053910|FG000|Overall Study|Administrative problems|2|||
125387578|NCT01254227|451053910|FG000|Overall Study|Death|1|||
125387579|NCT01254227|451053910|FG000|Overall Study|Protocol deviation|1|||
125387580|NCT03873987|451053915|FG000|Overall Study|Adverse Event|1|||
125387581|NCT03873987|451053916|FG001|Overall Study|Adverse Event|0|||
125387582|NCT03873987|451053915|FG000|Overall Study|staff was unable to start a new IV line|1|||
125145149|NCT02151149|450155959|FG001|Treatment Period|Progressive Disease|24|||
125145150|NCT02151149|450155958|FG000|Treatment Period|Symptomatic Deterioration|2|||
125387583|NCT03873987|451053916|FG001|Overall Study|staff was unable to start a new IV line|0|||
125387584|NCT03873987|451053915|FG000|Overall Study|Lost to Follow-up|0|||
125387585|NCT03873987|451053916|FG001|Overall Study|Lost to Follow-up|1|||
125145151|NCT02151149|450155959|FG001|Treatment Period|Symptomatic Deterioration|10|||
125145152|NCT02151149|450155958|FG000|Treatment Period|Withdrawal by Subject|13|||
125145153|NCT02151149|450155959|FG001|Treatment Period|Withdrawal by Subject|11|||
125145154|NCT02151149|450155958|FG000|Treatment Period|Miscellaneous|8|||
125145155|NCT02151149|450155959|FG001|Treatment Period|Miscellaneous|7|||
125145156|NCT02151149|450155958|FG000|Treatment Period|Participants randomized but not treated|3|||
125145157|NCT02151149|450155959|FG001|Treatment Period|Participants randomized but not treated|2|||
125145158|NCT02151149|450155958|FG000|Follow-Up Period|Lost to Follow-up|2|||
125145159|NCT02151149|450155959|FG001|Follow-Up Period|Lost to Follow-up|3|||
125145160|NCT02151149|450155958|FG000|Follow-Up Period|Death|37|||
125145161|NCT02151149|450155959|FG001|Follow-Up Period|Death|34|||
125145162|NCT05889039|450155965|FG000|Overall Study|error in completing survey|0|||
125145163|NCT05889039|450155966|FG001|Overall Study|error in completing survey|2|||
125145164|NCT05889039|450155967|FG002|Overall Study|error in completing survey|0|||
125145165|NCT05889039|450155968|FG003|Overall Study|error in completing survey|0|||
125145166|NCT05889039|450155965|FG000|Overall Study|Lost to Follow-up|4|||
125145167|NCT05889039|450155966|FG001|Overall Study|Lost to Follow-up|0|||
125145168|NCT05889039|450155967|FG002|Overall Study|Lost to Follow-up|0|||
125145169|NCT05889039|450155968|FG003|Overall Study|Lost to Follow-up|0|||
125387586|NCT02535741|451053917|FG000|Overall Study|Adverse Event|3|||
125387587|NCT02535741|451053917|FG000|Overall Study|Withdrawal by Subject|9|||
125387588|NCT02535741|451053917|FG000|Overall Study|Lost to Follow-up|10|||
125387589|NCT02535741|451053917|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
125145170|NCT00982228|450155969|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
125145171|NCT00982228|450155970|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
125145172|NCT00982228|450155969|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
125145173|NCT00982228|450155970|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
125145174|NCT00982228|450155969|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
125145175|NCT00982228|450155970|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
125145176|NCT00982228|450155969|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
125145177|NCT00982228|450155970|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
125145178|NCT00982228|450155969|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
125145179|NCT00982228|450155970|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
125145180|NCT00982228|450155969|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
125145181|NCT00982228|450155970|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
125145182|NCT00982228|450155969|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
125145183|NCT00982228|450155970|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
125145184|NCT00982228|450155969|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
125145185|NCT00982228|450155970|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
125145186|NCT00982228|450155969|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
125145187|NCT00982228|450155970|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
125145188|NCT00982228|450155969|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
125145189|NCT00982228|450155970|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
125145190|NCT01438476|450155971|FG000|Overall Study|Protocol Violation|1|||
125145191|NCT01438476|450155972|FG001|Overall Study|Protocol Violation|0|||
125145192|NCT01438476|450155971|FG000|Overall Study|Withdrawal by Subject|1|||
125145193|NCT01438476|450155972|FG001|Overall Study|Withdrawal by Subject|0|||
125145194|NCT01438476|450155971|FG000|Overall Study|No Surgery- Disease|8|||
125145195|NCT01438476|450155972|FG001|Overall Study|No Surgery- Disease|10|||
125145196|NCT01438476|450155971|FG000|Overall Study|Communication barrier|0|||
125145197|NCT01438476|450155972|FG001|Overall Study|Communication barrier|1|||
125145198|NCT02522780|450155975|FG000|Overall Study|Consent withdrawn by subject|5|||
125145199|NCT02522780|450155976|FG001|Overall Study|Consent withdrawn by subject|7|||
125145200|NCT02522780|450155975|FG000|Overall Study|Protocol deviation|1|||
125145201|NCT02522780|450155976|FG001|Overall Study|Protocol deviation|3|||
125145202|NCT02522780|450155975|FG000|Overall Study|Subject refused endoscopic procedure|0|||
125145203|NCT02522780|450155976|FG001|Overall Study|Subject refused endoscopic procedure|1|||
125145204|NCT02522780|450155975|FG000|Overall Study|Adverse event, non-fatal|11|||
125145205|NCT02522780|450155976|FG001|Overall Study|Adverse event, non-fatal|16|||
125145206|NCT02058160|450155977|FG000|Overall Study|Randomized but not treated|2|||
125145207|NCT02058160|450155978|FG001|Overall Study|Randomized but not treated|4|||
125145208|NCT02058160|450155977|FG000|Overall Study|Poor compliance to protocol|4|||
125145209|NCT02058160|450155978|FG001|Overall Study|Poor compliance to protocol|1|||
125145210|NCT02058160|450155977|FG000|Overall Study|Adverse Event|12|||
125145211|NCT02058160|450155978|FG001|Overall Study|Adverse Event|3|||
125145212|NCT02058160|450155977|FG000|Overall Study|Lost to Follow-up|1|||
125145213|NCT02058160|450155978|FG001|Overall Study|Lost to Follow-up|0|||
125145214|NCT02058160|450155977|FG000|Overall Study|Other than specified above|12|||
125145215|NCT02058160|450155978|FG001|Overall Study|Other than specified above|6|||
125145216|NCT03310619|450155979|FG000|Pre-Treatment Period|Death|1|||
125145217|NCT03310619|450155980|FG001|Pre-Treatment Period|Death|0|||
125145218|NCT03310619|450155981|FG002|Pre-Treatment Period|Death|0|||
125145219|NCT03310619|450155982|FG003|Pre-Treatment Period|Death|0|||
125145220|NCT03310619|450155983|FG004|Pre-Treatment Period|Death|1|||
125145221|NCT03310619|450155984|FG005|Pre-Treatment Period|Death|0|||
125145222|NCT03310619|450155985|FG006|Pre-Treatment Period|Death|0|||
125145223|NCT03310619|450155986|FG007|Pre-Treatment Period|Death|0|||
125145224|NCT03310619|450155979|FG000|Pre-Treatment Period|Other reasons|2|||
125145225|NCT03310619|450155980|FG001|Pre-Treatment Period|Other reasons|1|||
125145226|NCT03310619|450155981|FG002|Pre-Treatment Period|Other reasons|2|||
125145227|NCT03310619|450155982|FG003|Pre-Treatment Period|Other reasons|0|||
125145228|NCT03310619|450155983|FG004|Pre-Treatment Period|Other reasons|0|||
125145229|NCT03310619|450155984|FG005|Pre-Treatment Period|Other reasons|0|||
125145230|NCT03310619|450155985|FG006|Pre-Treatment Period|Other reasons|2|||
125145231|NCT03310619|450155986|FG007|Pre-Treatment Period|Other reasons|0|||
125145232|NCT03310619|450155979|FG000|Treatment Period|Death|1|||
125145233|NCT03310619|450155980|FG001|Treatment Period|Death|2|||
125145234|NCT03310619|450155981|FG002|Treatment Period|Death|0|||
125145235|NCT03310619|450155982|FG003|Treatment Period|Death|0|||
125145236|NCT03310619|450155983|FG004|Treatment Period|Death|1|||
125145237|NCT03310619|450155984|FG005|Treatment Period|Death|0|||
125145238|NCT03310619|450155985|FG006|Treatment Period|Death|2|||
125145239|NCT03310619|450155986|FG007|Treatment Period|Death|0|||
125145240|NCT03310619|450155979|FG000|Treatment Period|Adverse Event|0|||
125145241|NCT03310619|450155980|FG001|Treatment Period|Adverse Event|1|||
125387590|NCT02535741|451053917|FG000|Overall Study|Missing data|6|||
125387591|NCT00798369|451053918|FG000|Overall Study|Subject withdrew consent|0|||
125387592|NCT00798369|451053919|FG001|Overall Study|Subject withdrew consent|0|||
125387593|NCT00798369|451053920|FG002|Overall Study|Subject withdrew consent|1|||
125387594|NCT00798369|451053921|FG003|Overall Study|Subject withdrew consent|1|||
125145242|NCT03310619|450155981|FG002|Treatment Period|Adverse Event|4|||
125145243|NCT03310619|450155982|FG003|Treatment Period|Adverse Event|1|||
125145244|NCT03310619|450155983|FG004|Treatment Period|Adverse Event|0|||
125145245|NCT03310619|450155984|FG005|Treatment Period|Adverse Event|0|||
125145246|NCT03310619|450155985|FG006|Treatment Period|Adverse Event|0|||
125145247|NCT03310619|450155986|FG007|Treatment Period|Adverse Event|0|||
125145248|NCT03310619|450155979|FG000|Treatment Period|Withdrawal by participant|0|||
125145249|NCT03310619|450155980|FG001|Treatment Period|Withdrawal by participant|0|||
125145250|NCT03310619|450155981|FG002|Treatment Period|Withdrawal by participant|1|||
125387595|NCT00798369|451053922|FG004|Overall Study|Subject withdrew consent|0|||
125387596|NCT00798369|451053923|FG005|Overall Study|Subject withdrew consent|2|||
125387597|NCT00798369|451053918|FG000|Overall Study|Lost to Follow-up|1|||
125145251|NCT03310619|450155982|FG003|Treatment Period|Withdrawal by participant|0|||
125145252|NCT03310619|450155983|FG004|Treatment Period|Withdrawal by participant|0|||
125145253|NCT03310619|450155984|FG005|Treatment Period|Withdrawal by participant|0|||
125145254|NCT03310619|450155985|FG006|Treatment Period|Withdrawal by participant|0|||
125145255|NCT03310619|450155986|FG007|Treatment Period|Withdrawal by participant|0|||
125387598|NCT00798369|451053919|FG001|Overall Study|Lost to Follow-up|1|||
125145256|NCT03310619|450155979|FG000|Treatment Period|Lost to Follow-up|0|||
125145257|NCT03310619|450155980|FG001|Treatment Period|Lost to Follow-up|0|||
125387599|NCT00798369|451053920|FG002|Overall Study|Lost to Follow-up|1|||
125387600|NCT00798369|451053921|FG003|Overall Study|Lost to Follow-up|0|||
125387601|NCT00798369|451053922|FG004|Overall Study|Lost to Follow-up|1|||
125387602|NCT00798369|451053923|FG005|Overall Study|Lost to Follow-up|0|||
125387603|NCT00798369|451053918|FG000|Overall Study|Adminstrative problems|0|||
125387604|NCT00798369|451053919|FG001|Overall Study|Adminstrative problems|0|||
125387605|NCT00798369|451053920|FG002|Overall Study|Adminstrative problems|0|||
125387606|NCT00798369|451053921|FG003|Overall Study|Adminstrative problems|0|||
125387607|NCT00798369|451053922|FG004|Overall Study|Adminstrative problems|0|||
125387608|NCT00798369|451053923|FG005|Overall Study|Adminstrative problems|1|||
125387609|NCT04475588|451053924|FG000|Overall Study|Adverse Event|2|||
125387610|NCT04475588|451053925|FG001|Overall Study|Adverse Event|0|||
125387611|NCT00588822|451053926|FG000|Overall Study|progression of disease|8|||
125387612|NCT04762680|451053928|FG000|Phase 2|Adverse Event|0|||
125387613|NCT04762680|451053929|FG001|Phase 2|Adverse Event|1|||
125387614|NCT04762680|451053930|FG002|Phase 2|Adverse Event|0|||
125387615|NCT04762680|451053931|FG003|Phase 2|Adverse Event|0|||
125387616|NCT04762680|451053932|FG004|Phase 2|Adverse Event|0|||
125387617|NCT04762680|451053933|FG005|Phase 2|Adverse Event|0|||
125387618|NCT04762680|451053934|FG006|Phase 2|Adverse Event|0|||
125387619|NCT04762680|451053935|FG007|Phase 2|Adverse Event|0|||
125387620|NCT04762680|451053936|FG008|Phase 2|Adverse Event|0|||
125387621|NCT04762680|451053937|FG009|Phase 2|Adverse Event|0|||
125387622|NCT04762680|451053938|FG010|Phase 2|Adverse Event|0|||
125387623|NCT04762680|451053939|FG011|Phase 2|Adverse Event|0|||
125387624|NCT04762680|451053940|FG012|Phase 2|Adverse Event|0|||
125387625|NCT04762680|451053941|FG013|Phase 2|Adverse Event|0|||
125387626|NCT04762680|451053942|FG014|Phase 2|Adverse Event|0|||
125387627|NCT04762680|451053943|FG015|Phase 2|Adverse Event|0|||
125387628|NCT04762680|451053944|FG016|Phase 2|Adverse Event|0|||
125387629|NCT04762680|451053945|FG017|Phase 2|Adverse Event|0|||
125387630|NCT04762680|451053946|FG018|Phase 2|Adverse Event|0|||
125387631|NCT04762680|451053947|FG019|Phase 2|Adverse Event|0|||
125387632|NCT04762680|451053948|FG020|Phase 2|Adverse Event|0|||
125387633|NCT04762680|451053949|FG021|Phase 2|Adverse Event|0|||
125387634|NCT04762680|451053928|FG000|Phase 2|Protocol Violation|5|||
125387635|NCT04762680|451053929|FG001|Phase 2|Protocol Violation|5|||
125387636|NCT04762680|451053930|FG002|Phase 2|Protocol Violation|1|||
125387637|NCT04762680|451053931|FG003|Phase 2|Protocol Violation|0|||
125387638|NCT04762680|451053932|FG004|Phase 2|Protocol Violation|0|||
125387639|NCT04762680|451053933|FG005|Phase 2|Protocol Violation|0|||
125387640|NCT04762680|451053934|FG006|Phase 2|Protocol Violation|0|||
125387641|NCT04762680|451053935|FG007|Phase 2|Protocol Violation|0|||
125387642|NCT04762680|451053936|FG008|Phase 2|Protocol Violation|0|||
125387643|NCT04762680|451053937|FG009|Phase 2|Protocol Violation|0|||
125387644|NCT04762680|451053938|FG010|Phase 2|Protocol Violation|0|||
125387645|NCT04762680|451053939|FG011|Phase 2|Protocol Violation|0|||
125387646|NCT04762680|451053940|FG012|Phase 2|Protocol Violation|0|||
125145258|NCT03310619|450155981|FG002|Treatment Period|Lost to Follow-up|0|||
125145259|NCT03310619|450155982|FG003|Treatment Period|Lost to Follow-up|0|||
125145260|NCT03310619|450155983|FG004|Treatment Period|Lost to Follow-up|0|||
125145261|NCT03310619|450155984|FG005|Treatment Period|Lost to Follow-up|0|||
125145262|NCT03310619|450155985|FG006|Treatment Period|Lost to Follow-up|0|||
125145263|NCT03310619|450155986|FG007|Treatment Period|Lost to Follow-up|1|||
125145264|NCT03310619|450155979|FG000|Treatment Period|Study terminated by sponsor|0|||
125145265|NCT03310619|450155980|FG001|Treatment Period|Study terminated by sponsor|0|||
125145266|NCT03310619|450155981|FG002|Treatment Period|Study terminated by sponsor|0|||
125145267|NCT03310619|450155982|FG003|Treatment Period|Study terminated by sponsor|0|||
125145268|NCT03310619|450155983|FG004|Treatment Period|Study terminated by sponsor|0|||
125145269|NCT03310619|450155984|FG005|Treatment Period|Study terminated by sponsor|0|||
125145270|NCT03310619|450155985|FG006|Treatment Period|Study terminated by sponsor|0|||
125145271|NCT03310619|450155986|FG007|Treatment Period|Study terminated by sponsor|1|||
125145272|NCT03310619|450155979|FG000|Treatment Period|Physician Decision|0|||
125145273|NCT03310619|450155980|FG001|Treatment Period|Physician Decision|0|||
125145274|NCT03310619|450155981|FG002|Treatment Period|Physician Decision|0|||
125145275|NCT03310619|450155982|FG003|Treatment Period|Physician Decision|0|||
125145276|NCT03310619|450155983|FG004|Treatment Period|Physician Decision|3|||
125145277|NCT03310619|450155984|FG005|Treatment Period|Physician Decision|0|||
125145278|NCT03310619|450155985|FG006|Treatment Period|Physician Decision|0|||
125145279|NCT03310619|450155986|FG007|Treatment Period|Physician Decision|0|||
125387647|NCT04762680|451053941|FG013|Phase 2|Protocol Violation|0|||
125387648|NCT04762680|451053942|FG014|Phase 2|Protocol Violation|0|||
125387649|NCT04762680|451053943|FG015|Phase 2|Protocol Violation|0|||
125387650|NCT04762680|451053944|FG016|Phase 2|Protocol Violation|0|||
125387651|NCT04762680|451053945|FG017|Phase 2|Protocol Violation|0|||
125387652|NCT04762680|451053946|FG018|Phase 2|Protocol Violation|0|||
125387653|NCT04762680|451053947|FG019|Phase 2|Protocol Violation|0|||
125387654|NCT04762680|451053948|FG020|Phase 2|Protocol Violation|0|||
125387655|NCT04762680|451053949|FG021|Phase 2|Protocol Violation|0|||
125387656|NCT04762680|451053928|FG000|Phase 2|Withdrawal by Subject|23|||
125387657|NCT04762680|451053929|FG001|Phase 2|Withdrawal by Subject|21|||
125387658|NCT04762680|451053930|FG002|Phase 2|Withdrawal by Subject|28|||
125387659|NCT04762680|451053931|FG003|Phase 2|Withdrawal by Subject|0|||
125387660|NCT04762680|451053932|FG004|Phase 2|Withdrawal by Subject|0|||
125387661|NCT04762680|451053933|FG005|Phase 2|Withdrawal by Subject|0|||
125387662|NCT04762680|451053934|FG006|Phase 2|Withdrawal by Subject|0|||
125387663|NCT04762680|451053935|FG007|Phase 2|Withdrawal by Subject|0|||
125387664|NCT04762680|451053936|FG008|Phase 2|Withdrawal by Subject|0|||
125387665|NCT04762680|451053937|FG009|Phase 2|Withdrawal by Subject|0|||
125387666|NCT04762680|451053938|FG010|Phase 2|Withdrawal by Subject|0|||
125387667|NCT04762680|451053939|FG011|Phase 2|Withdrawal by Subject|0|||
125387668|NCT04762680|451053940|FG012|Phase 2|Withdrawal by Subject|0|||
125387669|NCT04762680|451053941|FG013|Phase 2|Withdrawal by Subject|0|||
125387670|NCT04762680|451053942|FG014|Phase 2|Withdrawal by Subject|0|||
125145280|NCT03310619|450155979|FG000|Treatment Period|Other reasons|1|||
125387671|NCT04762680|451053943|FG015|Phase 2|Withdrawal by Subject|0|||
125387672|NCT04762680|451053944|FG016|Phase 2|Withdrawal by Subject|0|||
125145281|NCT03310619|450155980|FG001|Treatment Period|Other reasons|0|||
125387673|NCT04762680|451053945|FG017|Phase 2|Withdrawal by Subject|0|||
125387674|NCT04762680|451053946|FG018|Phase 2|Withdrawal by Subject|0|||
125145282|NCT03310619|450155981|FG002|Treatment Period|Other reasons|2|||
125145283|NCT03310619|450155982|FG003|Treatment Period|Other reasons|0|||
125145284|NCT03310619|450155983|FG004|Treatment Period|Other reasons|0|||
125145285|NCT03310619|450155984|FG005|Treatment Period|Other reasons|0|||
125145286|NCT03310619|450155985|FG006|Treatment Period|Other reasons|0|||
125145287|NCT03310619|450155986|FG007|Treatment Period|Other reasons|0|||
125145288|NCT01115933|450155987|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
125145289|NCT00926367|450155989|FG000|Overall Study|Withdrawal by Subject|0|||
125145290|NCT00926367|450155990|FG001|Overall Study|Withdrawal by Subject|1|||
125387675|NCT04762680|451053947|FG019|Phase 2|Withdrawal by Subject|0|||
125387676|NCT04762680|451053948|FG020|Phase 2|Withdrawal by Subject|0|||
125387677|NCT04762680|451053949|FG021|Phase 2|Withdrawal by Subject|0|||
125387678|NCT04762680|451053928|FG000|Phase 2|Lost to Follow-up|14|||
125387679|NCT04762680|451053929|FG001|Phase 2|Lost to Follow-up|8|||
125387680|NCT04762680|451053930|FG002|Phase 2|Lost to Follow-up|9|||
125387681|NCT04762680|451053931|FG003|Phase 2|Lost to Follow-up|0|||
125387682|NCT04762680|451053932|FG004|Phase 2|Lost to Follow-up|0|||
125145291|NCT00926367|450155989|FG000|Overall Study|Lost to Follow-up|1|||
125145292|NCT00926367|450155990|FG001|Overall Study|Lost to Follow-up|0|||
125145293|NCT00926367|450155989|FG000|Overall Study|Skin Irritation|1|||
125145294|NCT00926367|450155990|FG001|Overall Study|Skin Irritation|2|||
125145295|NCT01517867|450155991|FG000|Overall Study|never started treatment|29|||
125145296|NCT01517867|450155992|FG001|Overall Study|never started treatment|32|||
125145297|NCT01517867|450155991|FG000|Overall Study|Withdrawal by Subject|34|||
125145298|NCT01517867|450155992|FG001|Overall Study|Withdrawal by Subject|30|||
125145299|NCT01517867|450155991|FG000|Overall Study|Still in treatment at study end|0|||
125145300|NCT01517867|450155992|FG001|Overall Study|Still in treatment at study end|3|||
125145301|NCT01266603|450155994|FG000|Overall Study|Adverse Event|1|||
125145302|NCT01266603|450155994|FG000|Overall Study|Lack of Efficacy|14|||
125145303|NCT01266603|450155994|FG000|Overall Study|Withdrawal by Subject|1|||
125145304|NCT01266603|450155994|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
125145305|NCT02725411|450156001|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
125145306|NCT02725411|450156002|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
125145307|NCT02725411|450156003|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
125145308|NCT02725411|450156001|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
125145309|NCT02725411|450156002|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
125145310|NCT02725411|450156003|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
125145311|NCT02725411|450156001|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
125145312|NCT02725411|450156002|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
125145313|NCT02725411|450156003|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
125145314|NCT02725411|450156001|FG000|Treatment Period (56 Weeks)|Other|1|||
125145315|NCT02725411|450156002|FG001|Treatment Period (56 Weeks)|Other|4|||
125145316|NCT02725411|450156003|FG002|Treatment Period (56 Weeks)|Other|5|||
125145317|NCT02725411|450156001|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
125145318|NCT02725411|450156002|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
125145319|NCT02725411|450156003|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
125145320|NCT02725411|450156001|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
125145321|NCT02725411|450156002|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
125145322|NCT02725411|450156003|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
125145323|NCT02725411|450156001|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
125145324|NCT02725411|450156002|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
125145325|NCT02725411|450156003|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
125145326|NCT02725411|450156001|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
125145327|NCT02725411|450156002|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
125145328|NCT02725411|450156003|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
125145329|NCT02725411|450156001|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
125145330|NCT02725411|450156002|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
125145331|NCT02725411|450156003|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
125145332|NCT02725411|450156001|FG000|Follow-up Period (24 Weeks)|Other|1|||
125145333|NCT02725411|450156002|FG001|Follow-up Period (24 Weeks)|Other|4|||
125145334|NCT02725411|450156003|FG002|Follow-up Period (24 Weeks)|Other|2|||
125145335|NCT02725411|450156001|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
125145336|NCT02725411|450156002|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
125145337|NCT02725411|450156003|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
125145338|NCT02911935|450156006|FG000|Overall Study|Lost to Follow-up|5|||
125223545|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
125387683|NCT04762680|451053933|FG005|Phase 2|Lost to Follow-up|0|||
125387684|NCT04762680|451053934|FG006|Phase 2|Lost to Follow-up|0|||
125387685|NCT04762680|451053935|FG007|Phase 2|Lost to Follow-up|0|||
125387686|NCT04762680|451053936|FG008|Phase 2|Lost to Follow-up|0|||
125387687|NCT04762680|451053937|FG009|Phase 2|Lost to Follow-up|0|||
125387688|NCT04762680|451053938|FG010|Phase 2|Lost to Follow-up|0|||
125387689|NCT04762680|451053939|FG011|Phase 2|Lost to Follow-up|0|||
125387690|NCT04762680|451053940|FG012|Phase 2|Lost to Follow-up|0|||
125387691|NCT04762680|451053941|FG013|Phase 2|Lost to Follow-up|0|||
125387692|NCT04762680|451053942|FG014|Phase 2|Lost to Follow-up|0|||
125387693|NCT04762680|451053943|FG015|Phase 2|Lost to Follow-up|0|||
125387694|NCT04762680|451053944|FG016|Phase 2|Lost to Follow-up|0|||
125387695|NCT04762680|451053945|FG017|Phase 2|Lost to Follow-up|0|||
125387696|NCT04762680|451053946|FG018|Phase 2|Lost to Follow-up|0|||
125387697|NCT04762680|451053947|FG019|Phase 2|Lost to Follow-up|0|||
125387698|NCT04762680|451053948|FG020|Phase 2|Lost to Follow-up|0|||
125387699|NCT04762680|451053949|FG021|Phase 2|Lost to Follow-up|0|||
125387700|NCT04762680|451053928|FG000|Phase 3|Adverse Event|0|||
125387701|NCT04762680|451053929|FG001|Phase 3|Adverse Event|0|||
125387702|NCT04762680|451053930|FG002|Phase 3|Adverse Event|0|||
125387703|NCT04762680|451053931|FG003|Phase 3|Adverse Event|1|||
125387704|NCT04762680|451053932|FG004|Phase 3|Adverse Event|0|||
125387705|NCT04762680|451053933|FG005|Phase 3|Adverse Event|0|||
125387706|NCT04762680|451053934|FG006|Phase 3|Adverse Event|0|||
125387707|NCT04762680|451053935|FG007|Phase 3|Adverse Event|0|||
125387708|NCT04762680|451053936|FG008|Phase 3|Adverse Event|0|||
125387709|NCT04762680|451053937|FG009|Phase 3|Adverse Event|0|||
125387710|NCT04762680|451053938|FG010|Phase 3|Adverse Event|0|||
125387711|NCT04762680|451053939|FG011|Phase 3|Adverse Event|0|||
125387712|NCT04762680|451053940|FG012|Phase 3|Adverse Event|0|||
125387713|NCT04762680|451053941|FG013|Phase 3|Adverse Event|0|||
125387714|NCT04762680|451053942|FG014|Phase 3|Adverse Event|0|||
125387715|NCT04762680|451053943|FG015|Phase 3|Adverse Event|0|||
125387716|NCT04762680|451053944|FG016|Phase 3|Adverse Event|0|||
125387717|NCT04762680|451053945|FG017|Phase 3|Adverse Event|3|||
125387718|NCT04762680|451053946|FG018|Phase 3|Adverse Event|0|||
125387719|NCT04762680|451053947|FG019|Phase 3|Adverse Event|0|||
125387720|NCT04762680|451053948|FG020|Phase 3|Adverse Event|0|||
125387721|NCT04762680|451053949|FG021|Phase 3|Adverse Event|0|||
125387722|NCT04762680|451053928|FG000|Phase 3|Protocol Violation|0|||
125387723|NCT04762680|451053929|FG001|Phase 3|Protocol Violation|0|||
125145339|NCT02911935|450156007|FG001|Overall Study|Lost to Follow-up|7|||
125145340|NCT00603512|450156008|FG000|Overall Study|Adverse Event|0|||
125145341|NCT00603512|450156009|FG001|Overall Study|Adverse Event|2|||
125145342|NCT00603512|450156010|FG002|Overall Study|Adverse Event|4|||
125145343|NCT00603512|450156011|FG003|Overall Study|Adverse Event|4|||
125145344|NCT00603512|450156012|FG004|Overall Study|Adverse Event|2|||
125145345|NCT00603512|450156008|FG000|Overall Study|Lack of Efficacy|0|||
125145346|NCT00603512|450156009|FG001|Overall Study|Lack of Efficacy|1|||
125145347|NCT00603512|450156010|FG002|Overall Study|Lack of Efficacy|0|||
125145348|NCT00603512|450156011|FG003|Overall Study|Lack of Efficacy|0|||
125145349|NCT00603512|450156012|FG004|Overall Study|Lack of Efficacy|1|||
125145350|NCT00603512|450156008|FG000|Overall Study|Other|2|||
125145351|NCT00603512|450156009|FG001|Overall Study|Other|1|||
125145352|NCT00603512|450156010|FG002|Overall Study|Other|0|||
125223546|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
125387724|NCT04762680|451053930|FG002|Phase 3|Protocol Violation|0|||
125387725|NCT04762680|451053931|FG003|Phase 3|Protocol Violation|4|||
125387726|NCT04762680|451053932|FG004|Phase 3|Protocol Violation|1|||
125145353|NCT00603512|450156011|FG003|Overall Study|Other|1|||
125145354|NCT00603512|450156012|FG004|Overall Study|Other|1|||
125145355|NCT00603512|450156008|FG000|Overall Study|Withdrawal by Subject|0|||
125223547|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
125223548|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
125223549|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
125387727|NCT04762680|451053933|FG005|Phase 3|Protocol Violation|5|||
125387728|NCT04762680|451053934|FG006|Phase 3|Protocol Violation|1|||
125387729|NCT04762680|451053935|FG007|Phase 3|Protocol Violation|0|||
125387730|NCT04762680|451053936|FG008|Phase 3|Protocol Violation|0|||
125387731|NCT04762680|451053937|FG009|Phase 3|Protocol Violation|0|||
125387732|NCT04762680|451053938|FG010|Phase 3|Protocol Violation|0|||
125387733|NCT04762680|451053939|FG011|Phase 3|Protocol Violation|2|||
125387734|NCT04762680|451053940|FG012|Phase 3|Protocol Violation|3|||
125387735|NCT04762680|451053941|FG013|Phase 3|Protocol Violation|0|||
125387736|NCT04762680|451053942|FG014|Phase 3|Protocol Violation|0|||
125387737|NCT04762680|451053943|FG015|Phase 3|Protocol Violation|1|||
125387738|NCT04762680|451053944|FG016|Phase 3|Protocol Violation|0|||
125387739|NCT04762680|451053945|FG017|Phase 3|Protocol Violation|10|||
125387740|NCT04762680|451053946|FG018|Phase 3|Protocol Violation|0|||
125145356|NCT00603512|450156009|FG001|Overall Study|Withdrawal by Subject|0|||
125387741|NCT04762680|451053947|FG019|Phase 3|Protocol Violation|0|||
125387742|NCT04762680|451053948|FG020|Phase 3|Protocol Violation|0|||
125387743|NCT04762680|451053949|FG021|Phase 3|Protocol Violation|0|||
125387744|NCT04762680|451053928|FG000|Phase 3|Withdrawal by Subject|0|||
125145357|NCT00603512|450156010|FG002|Overall Study|Withdrawal by Subject|0|||
125145358|NCT00603512|450156011|FG003|Overall Study|Withdrawal by Subject|0|||
125145359|NCT00603512|450156012|FG004|Overall Study|Withdrawal by Subject|1|||
125145360|NCT00603512|450156008|FG000|Overall Study|Randomized but not treated|0|||
125145361|NCT00603512|450156009|FG001|Overall Study|Randomized but not treated|1|||
125145362|NCT00603512|450156010|FG002|Overall Study|Randomized but not treated|1|||
125145363|NCT00603512|450156011|FG003|Overall Study|Randomized but not treated|2|||
125145364|NCT00603512|450156012|FG004|Overall Study|Randomized but not treated|0|||
125145365|NCT00685750|450156013|FG000|Overall Study|Tumor sampling failure|0|||
125145366|NCT00685750|450156014|FG001|Overall Study|Tumor sampling failure|0|||
125145367|NCT00685750|450156015|FG002|Overall Study|Tumor sampling failure|1|||
125145368|NCT00685750|450156016|FG003|Overall Study|Tumor sampling failure|0|||
125145369|NCT00685750|450156017|FG004|Overall Study|Tumor sampling failure|0|||
125145370|NCT00685750|450156018|FG005|Overall Study|Tumor sampling failure|0|||
125145371|NCT00685750|450156019|FG006|Overall Study|Tumor sampling failure|0|||
125145372|NCT00685750|450156013|FG000|Overall Study|Patient didn't receive the treatment|0|||
125145373|NCT00685750|450156014|FG001|Overall Study|Patient didn't receive the treatment|0|||
125145374|NCT00685750|450156015|FG002|Overall Study|Patient didn't receive the treatment|0|||
125145375|NCT00685750|450156016|FG003|Overall Study|Patient didn't receive the treatment|0|||
125145376|NCT00685750|450156017|FG004|Overall Study|Patient didn't receive the treatment|0|||
125145377|NCT00685750|450156018|FG005|Overall Study|Patient didn't receive the treatment|0|||
125145378|NCT00685750|450156019|FG006|Overall Study|Patient didn't receive the treatment|1|||
125145379|NCT00685750|450156013|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125145380|NCT00685750|450156014|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125145381|NCT00685750|450156015|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
125145382|NCT00685750|450156016|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
125145383|NCT00685750|450156017|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
125145384|NCT00685750|450156018|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
125145385|NCT00685750|450156019|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
125145386|NCT04979858|450156020|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
125145387|NCT04979858|450156021|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
125145388|NCT02654015|450156022|FG000|Overall Study|Death|12|||
125145389|NCT02654015|450156022|FG000|Overall Study|Lost to Follow-up|3|||
125145390|NCT01896505|450156025|FG000|Overall Study|Adverse Event|1|||
125145391|NCT01896505|450156026|FG001|Overall Study|Adverse Event|0|||
125145392|NCT01896505|450156027|FG002|Overall Study|Adverse Event|2|||
125145393|NCT01896505|450156028|FG003|Overall Study|Adverse Event|1|||
125145394|NCT01896505|450156029|FG004|Overall Study|Adverse Event|1|||
125145395|NCT01896505|450156030|FG005|Overall Study|Adverse Event|0|||
125145396|NCT01896505|450156025|FG000|Overall Study|Physician Decision|1|||
125145397|NCT01896505|450156026|FG001|Overall Study|Physician Decision|3|||
125145398|NCT01896505|450156027|FG002|Overall Study|Physician Decision|2|||
125145399|NCT01896505|450156028|FG003|Overall Study|Physician Decision|0|||
125145400|NCT01896505|450156029|FG004|Overall Study|Physician Decision|0|||
125145401|NCT01896505|450156030|FG005|Overall Study|Physician Decision|1|||
125145402|NCT01896505|450156025|FG000|Overall Study|Withdrawal by Subject|1|||
125145403|NCT01896505|450156026|FG001|Overall Study|Withdrawal by Subject|0|||
125145404|NCT01896505|450156027|FG002|Overall Study|Withdrawal by Subject|3|||
125145405|NCT01896505|450156028|FG003|Overall Study|Withdrawal by Subject|1|||
125145406|NCT01896505|450156029|FG004|Overall Study|Withdrawal by Subject|0|||
125145407|NCT01896505|450156030|FG005|Overall Study|Withdrawal by Subject|0|||
125145408|NCT01896505|450156025|FG000|Overall Study|Disease Progression|7|||
125145409|NCT01896505|450156026|FG001|Overall Study|Disease Progression|5|||
125145410|NCT01896505|450156027|FG002|Overall Study|Disease Progression|8|||
125145411|NCT01896505|450156028|FG003|Overall Study|Disease Progression|4|||
125145412|NCT01896505|450156029|FG004|Overall Study|Disease Progression|4|||
125145413|NCT01896505|450156030|FG005|Overall Study|Disease Progression|4|||
125145414|NCT01896505|450156025|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
125145415|NCT01896505|450156026|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
125145416|NCT01896505|450156027|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
125145417|NCT01896505|450156028|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
125145418|NCT01896505|450156029|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
125145419|NCT01896505|450156030|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
125145420|NCT01896505|450156025|FG000|Overall Study|Intercurrent illness|0|||
125223550|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125145421|NCT01896505|450156026|FG001|Overall Study|Intercurrent illness|1|||
125145422|NCT01896505|450156027|FG002|Overall Study|Intercurrent illness|0|||
125145423|NCT01896505|450156028|FG003|Overall Study|Intercurrent illness|0|||
125145424|NCT01896505|450156029|FG004|Overall Study|Intercurrent illness|0|||
125145425|NCT01896505|450156030|FG005|Overall Study|Intercurrent illness|0|||
125145426|NCT01896505|450156025|FG000|Overall Study|Death|0|||
125145427|NCT01896505|450156026|FG001|Overall Study|Death|0|||
125145428|NCT01896505|450156027|FG002|Overall Study|Death|1|||
125145429|NCT01896505|450156028|FG003|Overall Study|Death|1|||
125387745|NCT04762680|451053929|FG001|Phase 3|Withdrawal by Subject|0|||
125145430|NCT01896505|450156029|FG004|Overall Study|Death|0|||
125223551|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125387746|NCT04762680|451053930|FG002|Phase 3|Withdrawal by Subject|0|||
125145431|NCT01896505|450156030|FG005|Overall Study|Death|1|||
125387747|NCT04762680|451053931|FG003|Phase 3|Withdrawal by Subject|13|||
125145432|NCT04974580|450156031|FG000|Overall Study|Lost to Follow-up|33|||
125145433|NCT04974580|450156032|FG001|Overall Study|Lost to Follow-up|39|||
125223552|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125387748|NCT04762680|451053932|FG004|Phase 3|Withdrawal by Subject|17|||
125387749|NCT04762680|451053933|FG005|Phase 3|Withdrawal by Subject|12|||
125387750|NCT04762680|451053934|FG006|Phase 3|Withdrawal by Subject|8|||
125387751|NCT04762680|451053935|FG007|Phase 3|Withdrawal by Subject|3|||
125387752|NCT04762680|451053936|FG008|Phase 3|Withdrawal by Subject|2|||
125387753|NCT04762680|451053937|FG009|Phase 3|Withdrawal by Subject|4|||
125387754|NCT04762680|451053938|FG010|Phase 3|Withdrawal by Subject|3|||
125387755|NCT04762680|451053939|FG011|Phase 3|Withdrawal by Subject|1|||
125387756|NCT04762680|451053940|FG012|Phase 3|Withdrawal by Subject|3|||
125387757|NCT04762680|451053941|FG013|Phase 3|Withdrawal by Subject|2|||
125387758|NCT04762680|451053942|FG014|Phase 3|Withdrawal by Subject|1|||
125387759|NCT04762680|451053943|FG015|Phase 3|Withdrawal by Subject|4|||
125387760|NCT04762680|451053944|FG016|Phase 3|Withdrawal by Subject|6|||
125387761|NCT04762680|451053945|FG017|Phase 3|Withdrawal by Subject|32|||
125387762|NCT04762680|451053946|FG018|Phase 3|Withdrawal by Subject|0|||
125387763|NCT04762680|451053947|FG019|Phase 3|Withdrawal by Subject|0|||
125387764|NCT04762680|451053948|FG020|Phase 3|Withdrawal by Subject|0|||
125387765|NCT04762680|451053949|FG021|Phase 3|Withdrawal by Subject|0|||
125387766|NCT04762680|451053928|FG000|Phase 3|Lost to Follow-up|0|||
125387767|NCT04762680|451053929|FG001|Phase 3|Lost to Follow-up|0|||
125387768|NCT04762680|451053930|FG002|Phase 3|Lost to Follow-up|0|||
125387769|NCT04762680|451053931|FG003|Phase 3|Lost to Follow-up|9|||
125387770|NCT04762680|451053932|FG004|Phase 3|Lost to Follow-up|22|||
125387771|NCT04762680|451053933|FG005|Phase 3|Lost to Follow-up|24|||
125387772|NCT04762680|451053934|FG006|Phase 3|Lost to Follow-up|2|||
125387773|NCT04762680|451053935|FG007|Phase 3|Lost to Follow-up|4|||
125387774|NCT04762680|451053936|FG008|Phase 3|Lost to Follow-up|6|||
125387775|NCT04762680|451053937|FG009|Phase 3|Lost to Follow-up|4|||
125387776|NCT04762680|451053938|FG010|Phase 3|Lost to Follow-up|3|||
125387777|NCT04762680|451053939|FG011|Phase 3|Lost to Follow-up|0|||
125387778|NCT04762680|451053940|FG012|Phase 3|Lost to Follow-up|5|||
125387779|NCT04762680|451053941|FG013|Phase 3|Lost to Follow-up|4|||
125387780|NCT04762680|451053942|FG014|Phase 3|Lost to Follow-up|6|||
125387781|NCT04762680|451053943|FG015|Phase 3|Lost to Follow-up|1|||
125387782|NCT04762680|451053944|FG016|Phase 3|Lost to Follow-up|1|||
125387783|NCT04762680|451053945|FG017|Phase 3|Lost to Follow-up|66|||
125387784|NCT04762680|451053946|FG018|Phase 3|Lost to Follow-up|0|||
125387785|NCT04762680|451053947|FG019|Phase 3|Lost to Follow-up|0|||
125387786|NCT04762680|451053948|FG020|Phase 3|Lost to Follow-up|0|||
125387787|NCT04762680|451053949|FG021|Phase 3|Lost to Follow-up|0|||
125387788|NCT04762680|451053928|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387789|NCT04762680|451053929|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387790|NCT04762680|451053930|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387791|NCT04762680|451053931|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387792|NCT04762680|451053932|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387793|NCT04762680|451053933|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387794|NCT04762680|451053934|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125145434|NCT04974580|450156033|FG002|Overall Study|Lost to Follow-up|30|||
125145435|NCT04974580|450156034|FG003|Overall Study|Lost to Follow-up|29|||
125145436|NCT05317195|450156040|FG000|Randomization|Withdrawal by Subject|1|||
125145437|NCT05317195|450156040|FG000|Randomization|Discontinued|6|||
125145438|NCT05317195|450156040|FG000|Admission|Withdrawal by Subject|2|||
125145439|NCT03919695|450156041|FG000|3-month Follow-up|Death|1|||
125145440|NCT03919695|450156042|FG001|3-month Follow-up|Death|1|||
125145441|NCT03919695|450156041|FG000|3-month Follow-up|unable to contact|0|||
125145442|NCT03919695|450156042|FG001|3-month Follow-up|unable to contact|3|||
125145443|NCT03919695|450156041|FG000|3-month Follow-up|in prison|0|||
125145444|NCT03919695|450156042|FG001|3-month Follow-up|in prison|1|||
125145445|NCT03919695|450156041|FG000|6-month Follow-up|Death|0|||
125145446|NCT03919695|450156042|FG001|6-month Follow-up|Death|1|||
125145447|NCT03919695|450156041|FG000|6-month Follow-up|Lost to Follow-up|1|||
125145448|NCT03919695|450156042|FG001|6-month Follow-up|Lost to Follow-up|2|||
125145449|NCT03919695|450156041|FG000|6-month Follow-up|in prison|0|||
125145450|NCT03919695|450156042|FG001|6-month Follow-up|in prison|2|||
125145451|NCT03919695|450156041|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
125145452|NCT03919695|450156042|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
125145453|NCT03919695|450156041|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
125145454|NCT03919695|450156042|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
125223553|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125145455|NCT02063217|450156044|FG000|Overall Study|Withdrawal by Subject|1|||
125145456|NCT02063217|450156045|FG001|Overall Study|Withdrawal by Subject|0|||
125145457|NCT02063217|450156046|FG002|Overall Study|Withdrawal by Subject|0|||
125145458|NCT01020526|450156047|FG000|Overall Study|Withdrawal by Subject|5|||
125145459|NCT01020526|450156047|FG000|Overall Study|Other reasons|3|||
125145460|NCT01020526|450156047|FG000|Overall Study|Insufficient clinical response|3|||
125145461|NCT01020526|450156047|FG000|Overall Study|Lost to Follow-up|1|||
125145462|NCT01020526|450156047|FG000|Overall Study|Adverse Event|2|||
125145463|NCT02212457|450156053|FG000|Overall Study|Adverse Event|1|||
125145464|NCT02212457|450156054|FG001|Overall Study|Adverse Event|2|||
125145465|NCT02212457|450156055|FG002|Overall Study|Adverse Event|2|||
125145466|NCT02212457|450156056|FG003|Overall Study|Adverse Event|2|||
125145467|NCT02212457|450156057|FG004|Overall Study|Adverse Event|0|||
125145468|NCT02212457|450156058|FG005|Overall Study|Adverse Event|1|||
125145469|NCT02212457|450156053|FG000|Overall Study|Withdrawal by Subject|8|||
125145470|NCT02212457|450156054|FG001|Overall Study|Withdrawal by Subject|10|||
125145471|NCT02212457|450156055|FG002|Overall Study|Withdrawal by Subject|8|||
125145472|NCT02212457|450156056|FG003|Overall Study|Withdrawal by Subject|6|||
125145473|NCT02212457|450156057|FG004|Overall Study|Withdrawal by Subject|5|||
125145474|NCT02212457|450156058|FG005|Overall Study|Withdrawal by Subject|4|||
125145475|NCT02212457|450156053|FG000|Overall Study|Lost to Follow-up|6|||
125145476|NCT02212457|450156054|FG001|Overall Study|Lost to Follow-up|7|||
125145477|NCT02212457|450156055|FG002|Overall Study|Lost to Follow-up|4|||
125145478|NCT02212457|450156056|FG003|Overall Study|Lost to Follow-up|1|||
125145479|NCT02212457|450156057|FG004|Overall Study|Lost to Follow-up|8|||
125145480|NCT02212457|450156058|FG005|Overall Study|Lost to Follow-up|4|||
125145481|NCT02212457|450156053|FG000|Overall Study|Protocol Violation|2|||
125145482|NCT02212457|450156054|FG001|Overall Study|Protocol Violation|1|||
125145483|NCT02212457|450156055|FG002|Overall Study|Protocol Violation|0|||
125145484|NCT02212457|450156056|FG003|Overall Study|Protocol Violation|1|||
125145485|NCT02212457|450156057|FG004|Overall Study|Protocol Violation|2|||
125145486|NCT02212457|450156058|FG005|Overall Study|Protocol Violation|3|||
125145487|NCT02212457|450156053|FG000|Overall Study|Other|2|||
125145488|NCT02212457|450156054|FG001|Overall Study|Other|1|||
125145489|NCT02212457|450156055|FG002|Overall Study|Other|2|||
125145490|NCT02212457|450156056|FG003|Overall Study|Other|1|||
125145491|NCT02212457|450156057|FG004|Overall Study|Other|0|||
125145492|NCT02212457|450156058|FG005|Overall Study|Other|1|||
125145493|NCT01120691|450156059|FG000|Overall Study|Adverse Event|59|||
125145494|NCT01120691|450156060|FG001|Overall Study|Adverse Event|67|||
125145495|NCT01120691|450156061|FG002|Overall Study|Adverse Event|47|||
125145496|NCT01120691|450156059|FG000|Overall Study|Subject withdrew consent|33|||
125145497|NCT01120691|450156060|FG001|Overall Study|Subject withdrew consent|50|||
125145498|NCT01120691|450156061|FG002|Overall Study|Subject withdrew consent|44|||
125145499|NCT01120691|450156059|FG000|Overall Study|Death|21|||
125145500|NCT01120691|450156060|FG001|Overall Study|Death|22|||
125145501|NCT01120691|450156061|FG002|Overall Study|Death|24|||
125145502|NCT01120691|450156059|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
125145503|NCT01120691|450156060|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
125145504|NCT01120691|450156061|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
125145505|NCT01120691|450156059|FG000|Overall Study|Administrative problems|15|||
125145506|NCT01120691|450156060|FG001|Overall Study|Administrative problems|8|||
125145507|NCT01120691|450156061|FG002|Overall Study|Administrative problems|9|||
125145508|NCT01120691|450156059|FG000|Overall Study|Protocol deviation|13|||
125145509|NCT01120691|450156060|FG001|Overall Study|Protocol deviation|12|||
125145510|NCT01120691|450156061|FG002|Overall Study|Protocol deviation|12|||
125145511|NCT01120691|450156059|FG000|Overall Study|Lost to Follow-up|5|||
125145512|NCT01120691|450156060|FG001|Overall Study|Lost to Follow-up|6|||
125145513|NCT01120691|450156061|FG002|Overall Study|Lost to Follow-up|4|||
125145514|NCT01120691|450156059|FG000|Overall Study|Abnormal test procedure result(s)|3|||
125145515|NCT01120691|450156060|FG001|Overall Study|Abnormal test procedure result(s)|2|||
125145516|NCT01120691|450156061|FG002|Overall Study|Abnormal test procedure result(s)|1|||
125145517|NCT01120691|450156059|FG000|Overall Study|Patient's inability to use the device|3|||
125145518|NCT01120691|450156060|FG001|Overall Study|Patient's inability to use the device|1|||
125145519|NCT01120691|450156061|FG002|Overall Study|Patient's inability to use the device|0|||
125145520|NCT01120691|450156059|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125145521|NCT01120691|450156060|FG001|Overall Study|Abnormal laboratory value(s)|3|||
125145522|NCT01120691|450156061|FG002|Overall Study|Abnormal laboratory value(s)|4|||
125145523|NCT03370510|450156064|FG000|Overall Study|COVID-19|2|||
125145524|NCT03370510|450156065|FG001|Overall Study|COVID-19|0|||
125145525|NCT01525628|450156070|FG000|Overall Study|Adverse Event|1|||
125438437|NCT01155661|451232253|FG000|Overall Study|Withdrawal by Subject|73|||
125438438|NCT01155661|451232253|FG000|Overall Study|Sponsor Decision|13|||
125438439|NCT01370005|451232254|FG000|Overall Study|Not treated|1|||
125438440|NCT01370005|451232255|FG001|Overall Study|Not treated|0|||
125438441|NCT01370005|451232256|FG002|Overall Study|Not treated|0|||
125438442|NCT01370005|451232254|FG000|Overall Study|Adverse Event|5|||
125438443|NCT01370005|451232255|FG001|Overall Study|Adverse Event|5|||
125438444|NCT01370005|451232256|FG002|Overall Study|Adverse Event|6|||
125438445|NCT01370005|451232254|FG000|Overall Study|Lack of Efficacy|1|||
125438446|NCT01370005|451232255|FG001|Overall Study|Lack of Efficacy|0|||
125438447|NCT01370005|451232256|FG002|Overall Study|Lack of Efficacy|0|||
125438448|NCT01370005|451232254|FG000|Overall Study|Non compliant with protocol|0|||
125438449|NCT01370005|451232255|FG001|Overall Study|Non compliant with protocol|1|||
125438450|NCT01370005|451232256|FG002|Overall Study|Non compliant with protocol|2|||
125438451|NCT01370005|451232254|FG000|Overall Study|Lost to Follow-up|1|||
125438452|NCT01370005|451232255|FG001|Overall Study|Lost to Follow-up|1|||
125438453|NCT01370005|451232256|FG002|Overall Study|Lost to Follow-up|1|||
125438454|NCT01370005|451232254|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
125438455|NCT01370005|451232255|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
125438456|NCT01370005|451232256|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
125438457|NCT01370005|451232254|FG000|Overall Study|Other reason not defined above|3|||
125438458|NCT01370005|451232255|FG001|Overall Study|Other reason not defined above|0|||
125438459|NCT01370005|451232256|FG002|Overall Study|Other reason not defined above|2|||
125438460|NCT01871558|451232257|FG000|Overall Study|Other reason|0|||
125438461|NCT01871558|451232258|FG001|Overall Study|Other reason|1|||
125438462|NCT01871558|451232257|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
125438463|NCT01871558|451232258|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
125438464|NCT01871558|451232257|FG000|Overall Study|Withdrawal by Subject|2|||
125438465|NCT01871558|451232258|FG001|Overall Study|Withdrawal by Subject|0|||
125438466|NCT02401308|451232259|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
125438467|NCT02401308|451232260|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
125438468|NCT02736968|451232261|FG000|Overall Study|Lost to Follow-up|0|||
125438469|NCT02736968|451232262|FG001|Overall Study|Lost to Follow-up|0|||
125438470|NCT02736968|451232263|FG002|Overall Study|Lost to Follow-up|0|||
125438471|NCT02736968|451232264|FG003|Overall Study|Lost to Follow-up|0|||
125438472|NCT02736968|451232265|FG004|Overall Study|Lost to Follow-up|0|||
125438473|NCT02736968|451232266|FG005|Overall Study|Lost to Follow-up|0|||
125438474|NCT02736968|451232267|FG006|Overall Study|Lost to Follow-up|5|||
125438475|NCT02736968|451232268|FG007|Overall Study|Lost to Follow-up|2|||
125438476|NCT02736968|451232261|FG000|Overall Study|COVID-19 Pandemic|0|||
125438477|NCT02736968|451232262|FG001|Overall Study|COVID-19 Pandemic|0|||
125438478|NCT02736968|451232263|FG002|Overall Study|COVID-19 Pandemic|0|||
125438479|NCT02736968|451232264|FG003|Overall Study|COVID-19 Pandemic|0|||
125438480|NCT02736968|451232265|FG004|Overall Study|COVID-19 Pandemic|0|||
125438481|NCT02736968|451232266|FG005|Overall Study|COVID-19 Pandemic|0|||
125438482|NCT02736968|451232267|FG006|Overall Study|COVID-19 Pandemic|2|||
125438483|NCT02736968|451232268|FG007|Overall Study|COVID-19 Pandemic|0|||
125438484|NCT02736968|451232261|FG000|Overall Study|Withdrawal by Subject|0|||
125438485|NCT02736968|451232262|FG001|Overall Study|Withdrawal by Subject|0|||
125438486|NCT02736968|451232263|FG002|Overall Study|Withdrawal by Subject|0|||
125438487|NCT02736968|451232264|FG003|Overall Study|Withdrawal by Subject|0|||
125438488|NCT02736968|451232265|FG004|Overall Study|Withdrawal by Subject|0|||
125145526|NCT01525628|450156071|FG001|Overall Study|Adverse Event|1|||
125145527|NCT01525628|450156072|FG002|Overall Study|Adverse Event|2|||
125145528|NCT01525628|450156073|FG003|Overall Study|Adverse Event|0|||
125145529|NCT01525628|450156074|FG004|Overall Study|Adverse Event|1|||
125145530|NCT01525628|450156070|FG000|Overall Study|Lack of Efficacy|0|||
125145531|NCT01525628|450156071|FG001|Overall Study|Lack of Efficacy|2|||
125145532|NCT01525628|450156072|FG002|Overall Study|Lack of Efficacy|2|||
125438489|NCT02736968|451232266|FG005|Overall Study|Withdrawal by Subject|0|||
125438490|NCT02736968|451232267|FG006|Overall Study|Withdrawal by Subject|1|||
125438491|NCT02736968|451232268|FG007|Overall Study|Withdrawal by Subject|0|||
125438492|NCT02041923|451232269|FG000|Overall Study|Lost to Follow-up|26|||
125145533|NCT01525628|450156073|FG003|Overall Study|Lack of Efficacy|1|||
125438493|NCT02041923|451232270|FG001|Overall Study|Lost to Follow-up|30|||
125438494|NCT01734434|451232273|FG000|Overall Study|Death Infant|3|||
125223554|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125145534|NCT01525628|450156074|FG004|Overall Study|Lack of Efficacy|2|||
125145535|NCT01525628|450156070|FG000|Overall Study|Protocol Violation|0|||
125145536|NCT01525628|450156071|FG001|Overall Study|Protocol Violation|0|||
125145537|NCT01525628|450156072|FG002|Overall Study|Protocol Violation|1|||
125145538|NCT01525628|450156073|FG003|Overall Study|Protocol Violation|0|||
125145539|NCT01525628|450156074|FG004|Overall Study|Protocol Violation|0|||
125145540|NCT01525628|450156070|FG000|Overall Study|Lost to Follow-up|1|||
125145541|NCT01525628|450156071|FG001|Overall Study|Lost to Follow-up|1|||
125145542|NCT01525628|450156072|FG002|Overall Study|Lost to Follow-up|0|||
125145543|NCT01525628|450156073|FG003|Overall Study|Lost to Follow-up|0|||
125145544|NCT01525628|450156074|FG004|Overall Study|Lost to Follow-up|0|||
125145545|NCT01525628|450156070|FG000|Overall Study|Withdrawal by Subject|0|||
125145546|NCT01525628|450156071|FG001|Overall Study|Withdrawal by Subject|1|||
125145547|NCT01525628|450156072|FG002|Overall Study|Withdrawal by Subject|0|||
125145548|NCT01525628|450156073|FG003|Overall Study|Withdrawal by Subject|0|||
125145549|NCT01525628|450156074|FG004|Overall Study|Withdrawal by Subject|0|||
125145550|NCT01525628|450156070|FG000|Overall Study|Other reason not defined above|0|||
125145551|NCT01525628|450156071|FG001|Overall Study|Other reason not defined above|0|||
125145552|NCT01525628|450156072|FG002|Overall Study|Other reason not defined above|0|||
125145553|NCT01525628|450156073|FG003|Overall Study|Other reason not defined above|3|||
125145554|NCT01525628|450156074|FG004|Overall Study|Other reason not defined above|0|||
125145555|NCT00089973|450156075|FG000|Overall Study|Adverse Event|3|||
125145556|NCT00089973|450156075|FG000|Overall Study|Withdrawal by Subject|1|||
125145557|NCT00089973|450156075|FG000|Overall Study|Disease progression|45|||
125145558|NCT00089973|450156075|FG000|Overall Study|Death|1|||
125145559|NCT01992094|450156076|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
125145560|NCT01992094|450156077|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
125145561|NCT01992094|450156078|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
125145562|NCT01992094|450156076|FG000|Overall Study|Adverse Event|1|||
125145563|NCT01992094|450156077|FG001|Overall Study|Adverse Event|0|||
125145564|NCT01992094|450156078|FG002|Overall Study|Adverse Event|0|||
125145565|NCT01992094|450156076|FG000|Overall Study|Death|5|||
125145566|NCT01992094|450156077|FG001|Overall Study|Death|5|||
125145567|NCT01992094|450156078|FG002|Overall Study|Death|2|||
125145568|NCT01992094|450156076|FG000|Overall Study|Lost to Follow-up|26|||
125145569|NCT01992094|450156077|FG001|Overall Study|Lost to Follow-up|9|||
125145570|NCT01992094|450156078|FG002|Overall Study|Lost to Follow-up|13|||
125145571|NCT01992094|450156076|FG000|Overall Study|OTHER|4|||
125223555|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125223556|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125145572|NCT01992094|450156077|FG001|Overall Study|OTHER|0|||
125145573|NCT01992094|450156078|FG002|Overall Study|OTHER|0|||
125145574|NCT01992094|450156076|FG000|Overall Study|Protocol Violation|1|||
125145575|NCT01992094|450156077|FG001|Overall Study|Protocol Violation|0|||
125145576|NCT01992094|450156078|FG002|Overall Study|Protocol Violation|1|||
125145577|NCT01992094|450156076|FG000|Overall Study|Withdrawal by Subject|7|||
125145578|NCT01992094|450156077|FG001|Overall Study|Withdrawal by Subject|3|||
125145579|NCT01992094|450156078|FG002|Overall Study|Withdrawal by Subject|4|||
125145580|NCT01214239|450156079|FG000|Overall Study|Adverse Event|3|||
125145581|NCT01214239|450156080|FG001|Overall Study|Adverse Event|4|||
125145582|NCT01214239|450156079|FG000|Overall Study|Protocol Violation|2|||
125145583|NCT01214239|450156080|FG001|Overall Study|Protocol Violation|1|||
125145584|NCT01214239|450156079|FG000|Overall Study|Lost to Follow-up|1|||
125145585|NCT01214239|450156080|FG001|Overall Study|Lost to Follow-up|1|||
125145586|NCT01214239|450156079|FG000|Overall Study|Withdrawal by Subject|4|||
125145587|NCT01214239|450156080|FG001|Overall Study|Withdrawal by Subject|9|||
125145588|NCT01214239|450156079|FG000|Overall Study|Lack of Efficacy|1|||
125438495|NCT01734434|451232274|FG001|Overall Study|Death Infant|1|||
125438496|NCT01734434|451232275|FG002|Overall Study|Death Infant|17|||
125438497|NCT01734434|451232276|FG003|Overall Study|Death Infant|5|||
125438498|NCT01734434|451232273|FG000|Overall Study|Lost to Follow-up|2|||
125438499|NCT01734434|451232274|FG001|Overall Study|Lost to Follow-up|9|||
125438500|NCT01734434|451232275|FG002|Overall Study|Lost to Follow-up|67|||
125438501|NCT01734434|451232276|FG003|Overall Study|Lost to Follow-up|11|||
125438502|NCT01734434|451232273|FG000|Overall Study|No Live Birth|1|||
125438503|NCT01734434|451232274|FG001|Overall Study|No Live Birth|2|||
125438504|NCT01734434|451232275|FG002|Overall Study|No Live Birth|32|||
125438505|NCT01734434|451232276|FG003|Overall Study|No Live Birth|6|||
125438506|NCT01734434|451232273|FG000|Overall Study|Withdrawal by Subject|4|||
125438507|NCT01734434|451232274|FG001|Overall Study|Withdrawal by Subject|0|||
125438508|NCT01734434|451232275|FG002|Overall Study|Withdrawal by Subject|8|||
125438509|NCT01734434|451232276|FG003|Overall Study|Withdrawal by Subject|1|||
125438510|NCT01734434|451232273|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
125438511|NCT01734434|451232274|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
125438512|NCT01734434|451232275|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
125438513|NCT01734434|451232276|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
125438514|NCT01734434|451232273|FG000|Overall Study|Subject Not Reachable|0|||
125438515|NCT01734434|451232274|FG001|Overall Study|Subject Not Reachable|0|||
125438516|NCT01734434|451232275|FG002|Overall Study|Subject Not Reachable|1|||
125438517|NCT01734434|451232276|FG003|Overall Study|Subject Not Reachable|0|||
125438518|NCT01734434|451232273|FG000|Overall Study|Treatment Defaulter|0|||
125438519|NCT01734434|451232274|FG001|Overall Study|Treatment Defaulter|0|||
125438520|NCT01734434|451232275|FG002|Overall Study|Treatment Defaulter|1|||
125438521|NCT01734434|451232276|FG003|Overall Study|Treatment Defaulter|0|||
125438522|NCT01734434|451232273|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
125438523|NCT01734434|451232274|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
125438524|NCT01734434|451232275|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
125438525|NCT01734434|451232276|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
125438526|NCT01734434|451232273|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
125438527|NCT01734434|451232274|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
125438528|NCT01734434|451232275|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
125438529|NCT01734434|451232276|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
125438530|NCT03391960|451232280|FG000|Overall Study|Protocol Violation|0|||
125438531|NCT03391960|451232281|FG001|Overall Study|Protocol Violation|0|||
125438532|NCT03518658|451233863|FG000|Overall Study|Other|51|||
125438533|NCT03518658|451233864|FG001|Overall Study|Other|0|||
125438534|NCT02105636|451233868|FG000|Pre-Treatment|Disease Progression|1|||
125438535|NCT02105636|451233869|FG001|Pre-Treatment|Disease Progression|0|||
125438536|NCT02105636|451233868|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
125438537|NCT02105636|451233869|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
125223557|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125223558|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125438538|NCT02105636|451233868|FG000|Pre-Treatment|Participant withdrew consent|0|||
125438539|NCT02105636|451233869|FG001|Pre-Treatment|Participant withdrew consent|6|||
125438540|NCT02105636|451233868|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
125438541|NCT02105636|451233869|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
125438542|NCT02105636|451233868|FG000|Treatment|Study Drug Toxicity|14|||
125438543|NCT02105636|451233869|FG001|Treatment|Study Drug Toxicity|10|||
125438544|NCT02105636|451233868|FG000|Treatment|Adverse event unrelated to study drug|19|||
125387795|NCT04762680|451053935|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387796|NCT04762680|451053936|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387797|NCT04762680|451053937|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387798|NCT04762680|451053938|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387799|NCT04762680|451053939|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387800|NCT04762680|451053940|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387801|NCT04762680|451053941|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387802|NCT04762680|451053942|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387803|NCT04762680|451053943|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387804|NCT04762680|451053944|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387805|NCT04762680|451053945|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387806|NCT04762680|451053946|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387807|NCT04762680|451053947|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387808|NCT04762680|451053948|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
125387809|NCT04762680|451053949|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
125387810|NCT04762680|451053928|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387811|NCT04762680|451053929|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387812|NCT04762680|451053930|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387813|NCT04762680|451053931|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387814|NCT04762680|451053932|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387815|NCT04762680|451053933|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387816|NCT04762680|451053934|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387817|NCT04762680|451053935|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387818|NCT04762680|451053936|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387819|NCT04762680|451053937|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387820|NCT04762680|451053938|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387821|NCT04762680|451053939|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387822|NCT04762680|451053940|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387823|NCT04762680|451053941|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387824|NCT04762680|451053942|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387825|NCT04762680|451053943|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387826|NCT04762680|451053944|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387827|NCT04762680|451053945|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387828|NCT04762680|451053946|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387829|NCT04762680|451053947|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
125387830|NCT04762680|451053948|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387831|NCT04762680|451053949|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
125387832|NCT02082210|451053950|FG000|Overall Study|Death|0|||
125387833|NCT02082210|451053951|FG001|Overall Study|Death|0|||
125387834|NCT02082210|451053952|FG002|Overall Study|Death|1|||
125387835|NCT02082210|451053953|FG003|Overall Study|Death|1|||
125387836|NCT02082210|451053954|FG004|Overall Study|Death|1|||
125387837|NCT02082210|451053955|FG005|Overall Study|Death|0|||
125387838|NCT02082210|451053950|FG000|Overall Study|Withdrawal by Subject|0|||
125387839|NCT02082210|451053951|FG001|Overall Study|Withdrawal by Subject|0|||
125387840|NCT02082210|451053952|FG002|Overall Study|Withdrawal by Subject|0|||
125387841|NCT02082210|451053953|FG003|Overall Study|Withdrawal by Subject|1|||
125387842|NCT02082210|451053954|FG004|Overall Study|Withdrawal by Subject|2|||
125387843|NCT02082210|451053955|FG005|Overall Study|Withdrawal by Subject|2|||
125387844|NCT02082210|451053950|FG000|Overall Study|Clinical Progression|0|||
125387845|NCT02082210|451053951|FG001|Overall Study|Clinical Progression|0|||
125387846|NCT02082210|451053952|FG002|Overall Study|Clinical Progression|0|||
125387847|NCT02082210|451053953|FG003|Overall Study|Clinical Progression|1|||
125387848|NCT02082210|451053954|FG004|Overall Study|Clinical Progression|0|||
125387849|NCT02082210|451053955|FG005|Overall Study|Clinical Progression|0|||
125387850|NCT02082210|451053950|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
125387851|NCT02082210|451053951|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
125387852|NCT02082210|451053952|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
125387853|NCT02082210|451053953|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
125387854|NCT02082210|451053954|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
125387855|NCT02082210|451053955|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
125223559|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125387856|NCT02082210|451053950|FG000|Overall Study|Physician Decision|0|||
125387857|NCT02082210|451053951|FG001|Overall Study|Physician Decision|0|||
125387858|NCT02082210|451053952|FG002|Overall Study|Physician Decision|1|||
125387859|NCT02082210|451053953|FG003|Overall Study|Physician Decision|1|||
125387860|NCT02082210|451053954|FG004|Overall Study|Physician Decision|0|||
125387861|NCT02082210|451053955|FG005|Overall Study|Physician Decision|0|||
125387862|NCT02520011|451053956|FG000|Overall Study|Adverse Event|0|||
125387863|NCT02520011|451053957|FG001|Overall Study|Adverse Event|1|||
125387864|NCT02520011|451053958|FG002|Overall Study|Adverse Event|2|||
125387865|NCT02520011|451053956|FG000|Overall Study|Death|0|||
125387866|NCT02520011|451053957|FG001|Overall Study|Death|8|||
125387867|NCT02520011|451053958|FG002|Overall Study|Death|1|||
125387868|NCT02520011|451053956|FG000|Overall Study|Lack of Efficacy|4|||
125387869|NCT02520011|451053957|FG001|Overall Study|Lack of Efficacy|26|||
125145589|NCT01214239|450156080|FG001|Overall Study|Lack of Efficacy|2|||
125145590|NCT01214239|450156079|FG000|Overall Study|patient's private reason|1|||
125145591|NCT01214239|450156080|FG001|Overall Study|patient's private reason|1|||
125145592|NCT01049581|450156081|FG000|Overall Study|Lost to Follow-up|2|||
125145593|NCT01049581|450156082|FG001|Overall Study|Lost to Follow-up|1|||
125145594|NCT05068284|450156093|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
125145595|NCT05068284|450156094|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
125145596|NCT05068284|450156095|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
125145597|NCT05068284|450156096|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
125145598|NCT05068284|450156097|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
125145599|NCT05068284|450156098|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
125145600|NCT05068284|450156099|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
125145601|NCT05068284|450156100|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
125145602|NCT05068284|450156093|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145603|NCT05068284|450156094|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145604|NCT05068284|450156095|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
125145605|NCT05068284|450156096|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145606|NCT05068284|450156097|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145607|NCT05068284|450156098|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145608|NCT05068284|450156099|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145609|NCT05068284|450156100|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
125145610|NCT05068284|450156093|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
125145611|NCT05068284|450156094|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
125145612|NCT05068284|450156095|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
125145613|NCT05068284|450156096|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
125145614|NCT05068284|450156097|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
125145615|NCT05068284|450156098|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
125145616|NCT05068284|450156099|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
125145617|NCT05068284|450156100|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
125145618|NCT05068284|450156093|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
125145619|NCT05068284|450156094|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
125145620|NCT05068284|450156095|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
125145621|NCT05068284|450156096|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
125145622|NCT05068284|450156097|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
125145623|NCT05068284|450156098|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
125145624|NCT05068284|450156099|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
125145625|NCT05068284|450156100|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
125145626|NCT05068284|450156093|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145627|NCT05068284|450156094|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145628|NCT05068284|450156095|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145629|NCT05068284|450156096|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
125145630|NCT05068284|450156097|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145631|NCT05068284|450156098|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145632|NCT05068284|450156099|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145633|NCT05068284|450156100|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
125145634|NCT05068284|450156093|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
125145635|NCT05068284|450156094|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
125145636|NCT05068284|450156095|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
125145637|NCT05068284|450156096|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
125145638|NCT05068284|450156097|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
125145639|NCT05068284|450156098|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
125145640|NCT05068284|450156099|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
125145641|NCT05068284|450156100|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
125145642|NCT05068284|450156093|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145643|NCT05068284|450156094|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145644|NCT05068284|450156095|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
125145645|NCT05068284|450156096|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145646|NCT05068284|450156097|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145647|NCT05068284|450156098|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145648|NCT05068284|450156099|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145649|NCT05068284|450156100|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
125145650|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
125145651|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125145652|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125145653|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125145654|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125145655|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125145656|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125145657|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
125145658|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
125145659|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
125145660|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
125145661|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
125223560|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
125438545|NCT02105636|451233869|FG001|Treatment|Adverse event unrelated to study drug|3|||
125438546|NCT02105636|451233868|FG000|Treatment|Participant request to discontinue study treatment|8|||
125438547|NCT02105636|451233869|FG001|Treatment|Participant request to discontinue study treatment|6|||
125438548|NCT02105636|451233868|FG000|Treatment|Participant withdrew consent|5|||
125438549|NCT02105636|451233869|FG001|Treatment|Participant withdrew consent|1|||
125438550|NCT02105636|451233868|FG000|Treatment|Lost to Follow-up|1|||
125438551|NCT02105636|451233869|FG001|Treatment|Lost to Follow-up|0|||
125438552|NCT02105636|451233868|FG000|Treatment|Maximum Clinical Benefit|1|||
125438553|NCT02105636|451233869|FG001|Treatment|Maximum Clinical Benefit|3|||
125438554|NCT02105636|451233868|FG000|Treatment|Poor/Non-compliance|0|||
125438555|NCT02105636|451233869|FG001|Treatment|Poor/Non-compliance|1|||
125438556|NCT02105636|451233868|FG000|Treatment|Participant no longer meets study criteria|1|||
125438557|NCT02105636|451233869|FG001|Treatment|Participant no longer meets study criteria|0|||
125438558|NCT02105636|451233868|FG000|Treatment|Other reasons|1|||
125438559|NCT02105636|451233869|FG001|Treatment|Other reasons|0|||
125438560|NCT02105636|451233868|FG000|Treatment|Disease Progression|185|||
125438561|NCT02105636|451233869|FG001|Treatment|Disease Progression|87|||
125438562|NCT00802659|451233871|FG000|Overall Study|Physician Decision|0|||
125438563|NCT00802659|451233872|FG001|Overall Study|Physician Decision|1|||
125438564|NCT00802659|451233873|FG002|Overall Study|Physician Decision|0|||
125438565|NCT00802659|451233874|FG003|Overall Study|Physician Decision|0|||
125438566|NCT00423293|451233875|FG000|Overall Study|Ineligible / No protocol treatment|11|||
125438567|NCT01912222|451233876|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
125438568|NCT01912222|451233877|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
125438569|NCT01912222|451233878|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
125438570|NCT01912222|451233876|FG000|Part B: Treatment Period|Progressive disease|10|||
125438571|NCT01912222|451233877|FG001|Part B: Treatment Period|Progressive disease|12|||
125438572|NCT01912222|451233878|FG002|Part B: Treatment Period|Progressive disease|15|||
125438573|NCT01912222|451233876|FG000|Part B: Treatment Period|Adverse Event|1|||
125438574|NCT01912222|451233877|FG001|Part B: Treatment Period|Adverse Event|2|||
125438575|NCT01912222|451233878|FG002|Part B: Treatment Period|Adverse Event|3|||
125438576|NCT01912222|451233876|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
125438577|NCT01912222|451233877|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
125438578|NCT01912222|451233878|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
125438579|NCT01014975|451233879|FG000|Overall Study|Withdrawal by Subject|1|||
125438580|NCT01014975|451233880|FG001|Overall Study|Withdrawal by Subject|0|||
125438581|NCT01014975|451233881|FG002|Overall Study|Withdrawal by Subject|1|||
125438582|NCT01014975|451233879|FG000|Overall Study|Death|3|||
125438583|NCT01014975|451233880|FG001|Overall Study|Death|3|||
125438584|NCT01014975|451233881|FG002|Overall Study|Death|4|||
125438585|NCT01014975|451233879|FG000|Overall Study|Lost to Follow-up|0|||
125438586|NCT01014975|451233880|FG001|Overall Study|Lost to Follow-up|0|||
125438587|NCT01014975|451233881|FG002|Overall Study|Lost to Follow-up|1|||
125438588|NCT01336634|451233884|FG000|Overall Study|Study closed/terminated|5|||
125438589|NCT01336634|451233885|FG001|Overall Study|Study closed/terminated|6|||
125438590|NCT01336634|451233886|FG002|Overall Study|Study closed/terminated|6|||
125438591|NCT01336634|451233884|FG000|Overall Study|Lost to Follow-up|2|||
125438592|NCT01336634|451233885|FG001|Overall Study|Lost to Follow-up|1|||
125438593|NCT01336634|451233886|FG002|Overall Study|Lost to Follow-up|1|||
125438594|NCT01336634|451233884|FG000|Overall Study|Physician Decision|1|||
125438595|NCT01336634|451233885|FG001|Overall Study|Physician Decision|1|||
125438596|NCT01336634|451233886|FG002|Overall Study|Physician Decision|0|||
125438597|NCT01336634|451233884|FG000|Overall Study|Withdrawal by Subject|6|||
125438598|NCT01336634|451233885|FG001|Overall Study|Withdrawal by Subject|0|||
125438599|NCT01336634|451233886|FG002|Overall Study|Withdrawal by Subject|2|||
125438600|NCT01863043|451233887|FG000|Overall Study|Death|6|||
125438601|NCT01863043|451233888|FG001|Overall Study|Death|1|||
125438602|NCT01863043|451233887|FG000|Overall Study|Withdrawal by Subject|0|||
125438603|NCT01863043|451233888|FG001|Overall Study|Withdrawal by Subject|2|||
125438604|NCT01863043|451233887|FG000|Overall Study|Adverse Event|7|||
125438605|NCT01863043|451233888|FG001|Overall Study|Adverse Event|8|||
125438606|NCT01863043|451233887|FG000|Overall Study|exclusion criteria found after enrollment|0|||
125438607|NCT01863043|451233888|FG001|Overall Study|exclusion criteria found after enrollment|1|||
125438608|NCT01912781|451233889|FG000|Overall Study|Withdrawal by Subject|2|||
125438609|NCT01912781|451233890|FG001|Overall Study|Withdrawal by Subject|0|||
125438610|NCT00854295|451233891|FG000|Overall Study|Death|7|||
125438611|NCT00854295|451233892|FG001|Overall Study|Death|0|||
125438612|NCT00854295|451233893|FG002|Overall Study|Death|1|||
125438613|NCT00854295|451233894|FG003|Overall Study|Death|1|||
125438614|NCT00854295|451233891|FG000|Overall Study|Adverse Event|6|||
125438615|NCT00854295|451233892|FG001|Overall Study|Adverse Event|1|||
125438616|NCT00854295|451233893|FG002|Overall Study|Adverse Event|1|||
125438617|NCT00854295|451233894|FG003|Overall Study|Adverse Event|3|||
125438618|NCT00854295|451233891|FG000|Overall Study|Lost to Follow-up|18|||
125438619|NCT00854295|451233892|FG001|Overall Study|Lost to Follow-up|5|||
125223561|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
125223562|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
125223563|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
125145662|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
125145663|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
125145664|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
125145665|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
125145666|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
125145667|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
125145668|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
125145669|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
125145670|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
125145671|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
125145672|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
125145673|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
125145674|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
125145675|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145676|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145677|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145678|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145679|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145680|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145681|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
125145682|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
125145683|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145684|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145685|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145686|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145687|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145688|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145689|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
125145690|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
125145691|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
125145692|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
125145693|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
125145694|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
125145695|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
125145696|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
125145697|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
125145698|NCT05068284|450156093|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145699|NCT05068284|450156094|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145700|NCT05068284|450156095|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145701|NCT05068284|450156096|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145702|NCT05068284|450156097|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145703|NCT05068284|450156098|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145704|NCT05068284|450156099|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
125145705|NCT05068284|450156100|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
125145706|NCT00965731|450156101|FG000|Overall Study|Death|0|||
125145707|NCT00965731|450156102|FG001|Overall Study|Death|4|||
125145708|NCT00965731|450156101|FG000|Overall Study|Withdrawal by Subject|0|||
125145709|NCT00965731|450156102|FG001|Overall Study|Withdrawal by Subject|1|||
125145710|NCT00965731|450156101|FG000|Overall Study|Other|7|||
125145711|NCT00965731|450156102|FG001|Overall Study|Other|15|||
125145712|NCT05135273|450158008|FG000|Overall Study|Recruited into the army|0|||
125145713|NCT05135273|450158009|FG001|Overall Study|Recruited into the army|0|||
125145714|NCT05135273|450158010|FG002|Overall Study|Recruited into the army|0|||
125145715|NCT05135273|450158011|FG003|Overall Study|Recruited into the army|0|||
125145716|NCT05135273|450158012|FG004|Overall Study|Recruited into the army|1|||
125145717|NCT05135273|450158013|FG005|Overall Study|Recruited into the army|0|||
125387870|NCT02520011|451053958|FG002|Overall Study|Lack of Efficacy|4|||
125387871|NCT02520011|451053956|FG000|Overall Study|Physician Decision|0|||
125387872|NCT02520011|451053957|FG001|Overall Study|Physician Decision|2|||
125387873|NCT02520011|451053958|FG002|Overall Study|Physician Decision|0|||
125387874|NCT02520011|451053956|FG000|Overall Study|Withdrawal by Subject|1|||
125387875|NCT02520011|451053957|FG001|Overall Study|Withdrawal by Subject|3|||
125145718|NCT05135273|450158014|FG006|Overall Study|Recruited into the army|0|||
125145719|NCT05135273|450158015|FG007|Overall Study|Recruited into the army|0|||
125145720|NCT05135273|450158008|FG000|Overall Study|Moved away from study site|0|||
125145721|NCT05135273|450158009|FG001|Overall Study|Moved away from study site|0|||
125145722|NCT05135273|450158010|FG002|Overall Study|Moved away from study site|0|||
125145723|NCT05135273|450158011|FG003|Overall Study|Moved away from study site|0|||
125145724|NCT05135273|450158012|FG004|Overall Study|Moved away from study site|0|||
125145725|NCT05135273|450158013|FG005|Overall Study|Moved away from study site|1|||
125145726|NCT05135273|450158014|FG006|Overall Study|Moved away from study site|1|||
125145727|NCT05135273|450158015|FG007|Overall Study|Moved away from study site|0|||
125145728|NCT05135273|450158008|FG000|Overall Study|Travel|0|||
125145729|NCT05135273|450158009|FG001|Overall Study|Travel|0|||
125145730|NCT05135273|450158010|FG002|Overall Study|Travel|0|||
125145731|NCT05135273|450158011|FG003|Overall Study|Travel|0|||
125145732|NCT05135273|450158012|FG004|Overall Study|Travel|0|||
125145733|NCT05135273|450158013|FG005|Overall Study|Travel|0|||
125145734|NCT05135273|450158014|FG006|Overall Study|Travel|0|||
125145735|NCT05135273|450158015|FG007|Overall Study|Travel|1|||
125145736|NCT04129944|450158017|FG000|Overall Study|Death|0|||
125145737|NCT04129944|450158018|FG001|Overall Study|Death|0|||
125145738|NCT04129944|450158019|FG002|Overall Study|Death|0|||
125145739|NCT04129944|450158020|FG003|Overall Study|Death|1|||
125145740|NCT04129944|450158017|FG000|Overall Study|Lost to Follow-up|1|||
125145741|NCT04129944|450158018|FG001|Overall Study|Lost to Follow-up|0|||
125145742|NCT04129944|450158019|FG002|Overall Study|Lost to Follow-up|0|||
125145743|NCT04129944|450158020|FG003|Overall Study|Lost to Follow-up|0|||
125145744|NCT04129944|450158017|FG000|Overall Study|Withdrawal by Subject|1|||
125145745|NCT04129944|450158018|FG001|Overall Study|Withdrawal by Subject|0|||
125145746|NCT04129944|450158019|FG002|Overall Study|Withdrawal by Subject|1|||
125145747|NCT04129944|450158020|FG003|Overall Study|Withdrawal by Subject|2|||
125145748|NCT00493792|450158021|FG000|Overall Study|Death|55|||
125145749|NCT00493792|450158022|FG001|Overall Study|Death|50|||
125145750|NCT00493792|450158021|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
125145751|NCT00493792|450158022|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
125145752|NCT00685035|450158023|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
125223564|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
125145753|NCT00685035|450158024|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
125145754|NCT04241133|450158025|FG000|Overall Study|COVID19 Precautions|14|||
125145755|NCT04241133|450158026|FG001|Overall Study|COVID19 Precautions|34|||
125145756|NCT02104817|450158027|FG000|Overall Study|Death|363|||
125145757|NCT02104817|450158028|FG001|Overall Study|Death|330|||
125145758|NCT02104817|450158027|FG000|Overall Study|Lost to Follow-up|3|||
125145759|NCT02104817|450158028|FG001|Overall Study|Lost to Follow-up|2|||
125145760|NCT02104817|450158027|FG000|Overall Study|Protocol Violation|0|||
125145761|NCT02104817|450158028|FG001|Overall Study|Protocol Violation|1|||
125145762|NCT02104817|450158027|FG000|Overall Study|Study terminated by sponsor|5854|||
125145763|NCT02104817|450158028|FG001|Overall Study|Study terminated by sponsor|5901|||
125145764|NCT02104817|450158027|FG000|Overall Study|Withdrawal by Subject|111|||
125145765|NCT02104817|450158028|FG001|Overall Study|Withdrawal by Subject|78|||
125145766|NCT02104817|450158027|FG000|Overall Study|Other reasons|128|||
125438620|NCT00854295|451233893|FG002|Overall Study|Lost to Follow-up|21|||
125438621|NCT00854295|451233894|FG003|Overall Study|Lost to Follow-up|21|||
125145767|NCT02104817|450158028|FG001|Overall Study|Other reasons|135|||
125145768|NCT00611884|450158033|FG000|Overall Study|Adverse Event|1|||
125145769|NCT00611884|450158034|FG001|Overall Study|Adverse Event|0|||
125145770|NCT00611884|450158035|FG002|Overall Study|Adverse Event|0|||
125145771|NCT00611884|450158036|FG003|Overall Study|Adverse Event|1|||
125145772|NCT00611884|450158033|FG000|Overall Study|Non-Compliance|1|||
125145773|NCT00611884|450158034|FG001|Overall Study|Non-Compliance|4|||
125145774|NCT00611884|450158035|FG002|Overall Study|Non-Compliance|2|||
125145775|NCT00611884|450158036|FG003|Overall Study|Non-Compliance|2|||
125145776|NCT00611884|450158033|FG000|Overall Study|Lack of Efficacy|0|||
125145777|NCT00611884|450158034|FG001|Overall Study|Lack of Efficacy|1|||
125145778|NCT00611884|450158035|FG002|Overall Study|Lack of Efficacy|0|||
125145779|NCT00611884|450158036|FG003|Overall Study|Lack of Efficacy|0|||
125145780|NCT00611884|450158033|FG000|Overall Study|Unclassified|7|||
125145781|NCT00611884|450158034|FG001|Overall Study|Unclassified|4|||
125145782|NCT00611884|450158035|FG002|Overall Study|Unclassified|2|||
125145783|NCT00611884|450158036|FG003|Overall Study|Unclassified|3|||
125145784|NCT00981799|450158037|FG000|Overall Study|Adverse Event|1|||
125145785|NCT00981799|450158038|FG001|Overall Study|Adverse Event|1|||
125145786|NCT00981799|450158039|FG002|Overall Study|Adverse Event|0|||
125145787|NCT00981799|450158040|FG003|Overall Study|Adverse Event|0|||
125145788|NCT00348816|450158041|FG000|Overall Study|Noncompliance with radiation treatment|1|||
125145789|NCT00687739|450158042|FG000|Overall Study|Lost to Follow-up|2|||
125145790|NCT00687739|450158043|FG001|Overall Study|Lost to Follow-up|2|||
125145791|NCT00687739|450158044|FG002|Overall Study|Lost to Follow-up|1|||
125438622|NCT00854295|451233891|FG000|Overall Study|Physician Decision|10|||
125438623|NCT00854295|451233892|FG001|Overall Study|Physician Decision|0|||
125438624|NCT00854295|451233893|FG002|Overall Study|Physician Decision|0|||
125438625|NCT00854295|451233894|FG003|Overall Study|Physician Decision|0|||
125438626|NCT05033743|451233900|FG000|Overall Study|Lost to Follow-up|1|||
125438627|NCT05033743|451233900|FG000|Overall Study|Protocol Violation|2|||
125438628|NCT05033743|451233900|FG000|Overall Study|Withdrawal by Subject|1|||
125438629|NCT04537897|451233901|FG000|Overall Study|Other than listed|0|||
125438630|NCT04537897|451233902|FG001|Overall Study|Other than listed|0|||
125438631|NCT04537897|451233903|FG002|Overall Study|Other than listed|0|||
125438632|NCT04537897|451233904|FG003|Overall Study|Other than listed|0|||
125438633|NCT04537897|451233905|FG004|Overall Study|Other than listed|0|||
125438634|NCT04537897|451233906|FG005|Overall Study|Other than listed|0|||
125438635|NCT04537897|451233907|FG006|Overall Study|Other than listed|1|||
125438636|NCT04537897|451233908|FG007|Overall Study|Other than listed|0|||
125438637|NCT04537897|451233909|FG008|Overall Study|Other than listed|0|||
125438638|NCT04537897|451233901|FG000|Overall Study|Adverse Event|0|||
125438639|NCT04537897|451233902|FG001|Overall Study|Adverse Event|0|||
125438640|NCT04537897|451233903|FG002|Overall Study|Adverse Event|0|||
125438641|NCT04537897|451233904|FG003|Overall Study|Adverse Event|1|||
125438642|NCT04537897|451233905|FG004|Overall Study|Adverse Event|0|||
125438643|NCT04537897|451233906|FG005|Overall Study|Adverse Event|0|||
125438644|NCT04537897|451233907|FG006|Overall Study|Adverse Event|0|||
125438645|NCT04537897|451233908|FG007|Overall Study|Adverse Event|0|||
125438646|NCT04537897|451233909|FG008|Overall Study|Adverse Event|0|||
125438647|NCT04537897|451233901|FG000|Overall Study|Withdrawal by Subject|0|||
125438648|NCT04537897|451233902|FG001|Overall Study|Withdrawal by Subject|1|||
125438649|NCT04537897|451233903|FG002|Overall Study|Withdrawal by Subject|0|||
125438650|NCT04537897|451233904|FG003|Overall Study|Withdrawal by Subject|0|||
125438651|NCT04537897|451233905|FG004|Overall Study|Withdrawal by Subject|0|||
125438652|NCT04537897|451233906|FG005|Overall Study|Withdrawal by Subject|0|||
125438653|NCT04537897|451233907|FG006|Overall Study|Withdrawal by Subject|0|||
125438654|NCT04537897|451233908|FG007|Overall Study|Withdrawal by Subject|0|||
125438655|NCT04537897|451233909|FG008|Overall Study|Withdrawal by Subject|0|||
125438656|NCT00197028|451233913|FG000|Overall Study|Adverse Event|2|||
125438657|NCT00197028|451233914|FG001|Overall Study|Adverse Event|2|||
125438658|NCT00197028|451233913|FG000|Overall Study|Protocol Violation|2|||
125438659|NCT00197028|451233914|FG001|Overall Study|Protocol Violation|1|||
125438660|NCT00197028|451233913|FG000|Overall Study|Withdrawal by Subject|8|||
125438661|NCT00197028|451233914|FG001|Overall Study|Withdrawal by Subject|12|||
125438662|NCT00197028|451233913|FG000|Overall Study|Lost to Follow-up|1|||
125438663|NCT00197028|451233914|FG001|Overall Study|Lost to Follow-up|0|||
125438664|NCT00197028|451233913|FG000|Overall Study|Other|3|||
125438665|NCT00197028|451233914|FG001|Overall Study|Other|6|||
125438666|NCT00885352|451233919|FG000|Overall Study|Adverse Event|2|||
125438667|NCT00885352|451233920|FG001|Overall Study|Adverse Event|3|||
125438668|NCT00885352|451233919|FG000|Overall Study|Lost to Follow-up|2|||
125145792|NCT00687739|450158045|FG003|Overall Study|Lost to Follow-up|2|||
125145793|NCT00687739|450158042|FG000|Overall Study|Adverse Event|0|||
125145794|NCT00687739|450158043|FG001|Overall Study|Adverse Event|1|||
125145795|NCT00687739|450158044|FG002|Overall Study|Adverse Event|1|||
125145796|NCT00687739|450158045|FG003|Overall Study|Adverse Event|0|||
125145797|NCT01190930|450158046|FG000|Induction|Adverse Event|17|||
125145798|NCT01190930|450158047|FG001|Induction|Adverse Event|0|||
125145799|NCT01190930|450158048|FG002|Induction|Adverse Event|0|||
125145800|NCT01190930|450158049|FG003|Induction|Adverse Event|0|||
125145801|NCT01190930|450158050|FG004|Induction|Adverse Event|0|||
125145802|NCT01190930|450158051|FG005|Induction|Adverse Event|0|||
125145803|NCT01190930|450158052|FG006|Induction|Adverse Event|0|||
125145804|NCT01190930|450158053|FG007|Induction|Adverse Event|0|||
125145805|NCT01190930|450158054|FG008|Induction|Adverse Event|0|||
125145806|NCT01190930|450158055|FG009|Induction|Adverse Event|0|||
125145807|NCT01190930|450158046|FG000|Induction|Death|34|||
125145808|NCT01190930|450158047|FG001|Induction|Death|0|||
125145809|NCT01190930|450158048|FG002|Induction|Death|0|||
125145810|NCT01190930|450158049|FG003|Induction|Death|0|||
125145811|NCT01190930|450158050|FG004|Induction|Death|0|||
125145812|NCT01190930|450158051|FG005|Induction|Death|0|||
125145813|NCT01190930|450158052|FG006|Induction|Death|0|||
125145814|NCT01190930|450158053|FG007|Induction|Death|0|||
125145815|NCT01190930|450158054|FG008|Induction|Death|0|||
125145816|NCT01190930|450158055|FG009|Induction|Death|0|||
125145817|NCT01190930|450158046|FG000|Induction|Lost to Follow-up|1|||
125145818|NCT01190930|450158047|FG001|Induction|Lost to Follow-up|0|||
125145819|NCT01190930|450158048|FG002|Induction|Lost to Follow-up|0|||
125145820|NCT01190930|450158049|FG003|Induction|Lost to Follow-up|0|||
125145821|NCT01190930|450158050|FG004|Induction|Lost to Follow-up|0|||
125145822|NCT01190930|450158051|FG005|Induction|Lost to Follow-up|0|||
125145823|NCT01190930|450158052|FG006|Induction|Lost to Follow-up|0|||
125145824|NCT01190930|450158053|FG007|Induction|Lost to Follow-up|0|||
125145825|NCT01190930|450158054|FG008|Induction|Lost to Follow-up|0|||
125145826|NCT01190930|450158055|FG009|Induction|Lost to Follow-up|0|||
125145827|NCT01190930|450158046|FG000|Induction|Physician Decision|125|||
125145828|NCT01190930|450158047|FG001|Induction|Physician Decision|3|||
125223565|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223566|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223567|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223568|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223569|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223570|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223571|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223572|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125145829|NCT01190930|450158048|FG002|Induction|Physician Decision|0|||
125145830|NCT01190930|450158049|FG003|Induction|Physician Decision|0|||
125145831|NCT01190930|450158050|FG004|Induction|Physician Decision|0|||
125145832|NCT01190930|450158051|FG005|Induction|Physician Decision|0|||
125145833|NCT01190930|450158052|FG006|Induction|Physician Decision|0|||
125145834|NCT01190930|450158053|FG007|Induction|Physician Decision|0|||
125145835|NCT01190930|450158054|FG008|Induction|Physician Decision|0|||
125145836|NCT01190930|450158055|FG009|Induction|Physician Decision|0|||
125145837|NCT01190930|450158046|FG000|Induction|Withdrawal by Subject|9|||
125145838|NCT01190930|450158047|FG001|Induction|Withdrawal by Subject|0|||
125145839|NCT01190930|450158048|FG002|Induction|Withdrawal by Subject|0|||
125145840|NCT01190930|450158049|FG003|Induction|Withdrawal by Subject|0|||
125145841|NCT01190930|450158050|FG004|Induction|Withdrawal by Subject|0|||
125145842|NCT01190930|450158051|FG005|Induction|Withdrawal by Subject|0|||
125145843|NCT01190930|450158052|FG006|Induction|Withdrawal by Subject|0|||
125145844|NCT01190930|450158053|FG007|Induction|Withdrawal by Subject|0|||
125145845|NCT01190930|450158054|FG008|Induction|Withdrawal by Subject|0|||
125145846|NCT01190930|450158055|FG009|Induction|Withdrawal by Subject|0|||
125145847|NCT01190930|450158046|FG000|Induction|Refusal|235|||
125223573|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223574|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125145848|NCT01190930|450158047|FG001|Induction|Refusal|0|||
125145849|NCT01190930|450158048|FG002|Induction|Refusal|0|||
125145850|NCT01190930|450158049|FG003|Induction|Refusal|0|||
125145851|NCT01190930|450158050|FG004|Induction|Refusal|0|||
125145852|NCT01190930|450158051|FG005|Induction|Refusal|0|||
125145853|NCT01190930|450158052|FG006|Induction|Refusal|0|||
125145854|NCT01190930|450158053|FG007|Induction|Refusal|0|||
125145855|NCT01190930|450158054|FG008|Induction|Refusal|0|||
125145856|NCT01190930|450158055|FG009|Induction|Refusal|0|||
125145857|NCT01190930|450158046|FG000|Induction|Inevaluable|23|||
125145858|NCT01190930|450158047|FG001|Induction|Inevaluable|1|||
125145859|NCT01190930|450158048|FG002|Induction|Inevaluable|0|||
125145860|NCT01190930|450158049|FG003|Induction|Inevaluable|0|||
125145861|NCT01190930|450158050|FG004|Induction|Inevaluable|0|||
125145862|NCT01190930|450158051|FG005|Induction|Inevaluable|0|||
125145863|NCT01190930|450158052|FG006|Induction|Inevaluable|0|||
125145864|NCT01190930|450158053|FG007|Induction|Inevaluable|0|||
125145865|NCT01190930|450158054|FG008|Induction|Inevaluable|0|||
125145866|NCT01190930|450158055|FG009|Induction|Inevaluable|0|||
125145867|NCT01190930|450158046|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
125145868|NCT01190930|450158047|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145869|NCT01190930|450158048|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145870|NCT01190930|450158049|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145871|NCT01190930|450158050|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145872|NCT01190930|450158051|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145873|NCT01190930|450158052|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145874|NCT01190930|450158053|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145875|NCT01190930|450158054|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145876|NCT01190930|450158055|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
125145877|NCT01190930|450158046|FG000|Induction|High Risk Downs|80|||
125145878|NCT01190930|450158047|FG001|Induction|High Risk Downs|0|||
125145879|NCT01190930|450158048|FG002|Induction|High Risk Downs|0|||
125145880|NCT01190930|450158049|FG003|Induction|High Risk Downs|0|||
125145881|NCT01190930|450158050|FG004|Induction|High Risk Downs|0|||
125145882|NCT01190930|450158051|FG005|Induction|High Risk Downs|0|||
125145883|NCT01190930|450158052|FG006|Induction|High Risk Downs|0|||
125145884|NCT01190930|450158053|FG007|Induction|High Risk Downs|0|||
125145885|NCT01190930|450158054|FG008|Induction|High Risk Downs|0|||
125145886|NCT01190930|450158055|FG009|Induction|High Risk Downs|0|||
125145887|NCT01190930|450158046|FG000|Induction|Enrollment onto another COG Protocol|1|||
125145888|NCT01190930|450158047|FG001|Induction|Enrollment onto another COG Protocol|0|||
125145889|NCT01190930|450158048|FG002|Induction|Enrollment onto another COG Protocol|0|||
125145890|NCT01190930|450158049|FG003|Induction|Enrollment onto another COG Protocol|0|||
125145891|NCT01190930|450158050|FG004|Induction|Enrollment onto another COG Protocol|0|||
125145892|NCT01190930|450158051|FG005|Induction|Enrollment onto another COG Protocol|0|||
125145893|NCT01190930|450158052|FG006|Induction|Enrollment onto another COG Protocol|0|||
125145894|NCT01190930|450158053|FG007|Induction|Enrollment onto another COG Protocol|0|||
125145895|NCT01190930|450158054|FG008|Induction|Enrollment onto another COG Protocol|0|||
125145896|NCT01190930|450158055|FG009|Induction|Enrollment onto another COG Protocol|0|||
125145897|NCT01190930|450158046|FG000|Induction|Average Risk|1847|||
125145898|NCT01190930|450158047|FG001|Induction|Average Risk|0|||
125145899|NCT01190930|450158048|FG002|Induction|Average Risk|0|||
125145900|NCT01190930|450158049|FG003|Induction|Average Risk|0|||
125145901|NCT01190930|450158050|FG004|Induction|Average Risk|0|||
125145902|NCT01190930|450158051|FG005|Induction|Average Risk|0|||
125145903|NCT01190930|450158052|FG006|Induction|Average Risk|0|||
125145904|NCT01190930|450158053|FG007|Induction|Average Risk|0|||
125145905|NCT01190930|450158054|FG008|Induction|Average Risk|0|||
125145906|NCT01190930|450158055|FG009|Induction|Average Risk|0|||
125145907|NCT01190930|450158046|FG000|Induction|High Risk|1227|||
125145908|NCT01190930|450158047|FG001|Induction|High Risk|0|||
125145909|NCT01190930|450158048|FG002|Induction|High Risk|0|||
125145910|NCT01190930|450158049|FG003|Induction|High Risk|0|||
125145911|NCT01190930|450158050|FG004|Induction|High Risk|0|||
125145912|NCT01190930|450158051|FG005|Induction|High Risk|0|||
125145913|NCT01190930|450158052|FG006|Induction|High Risk|0|||
125145914|NCT01190930|450158053|FG007|Induction|High Risk|0|||
125145915|NCT01190930|450158054|FG008|Induction|High Risk|0|||
125145916|NCT01190930|450158055|FG009|Induction|High Risk|0|||
125145917|NCT01190930|450158046|FG000|Induction|Low Risk|443|||
125145918|NCT01190930|450158047|FG001|Induction|Low Risk|0|||
125145919|NCT01190930|450158048|FG002|Induction|Low Risk|0|||
125145920|NCT01190930|450158049|FG003|Induction|Low Risk|0|||
125145921|NCT01190930|450158050|FG004|Induction|Low Risk|0|||
125145922|NCT01190930|450158051|FG005|Induction|Low Risk|0|||
125145923|NCT01190930|450158052|FG006|Induction|Low Risk|0|||
125145924|NCT01190930|450158053|FG007|Induction|Low Risk|0|||
125145925|NCT01190930|450158054|FG008|Induction|Low Risk|0|||
125145926|NCT01190930|450158055|FG009|Induction|Low Risk|0|||
125145927|NCT01190930|450158046|FG000|Induction|Very High Risk|1012|||
125145928|NCT01190930|450158047|FG001|Induction|Very High Risk|0|||
125145929|NCT01190930|450158048|FG002|Induction|Very High Risk|0|||
125145930|NCT01190930|450158049|FG003|Induction|Very High Risk|0|||
125145931|NCT01190930|450158050|FG004|Induction|Very High Risk|0|||
125145932|NCT01190930|450158051|FG005|Induction|Very High Risk|0|||
125145933|NCT01190930|450158052|FG006|Induction|Very High Risk|0|||
125145934|NCT01190930|450158053|FG007|Induction|Very High Risk|0|||
125145935|NCT01190930|450158054|FG008|Induction|Very High Risk|0|||
125145936|NCT01190930|450158055|FG009|Induction|Very High Risk|0|||
125145937|NCT01190930|450158046|FG000|Induction|Philadelphia chromosome-positive|99|||
125145938|NCT01190930|450158047|FG001|Induction|Philadelphia chromosome-positive|0|||
125145939|NCT01190930|450158048|FG002|Induction|Philadelphia chromosome-positive|0|||
125145940|NCT01190930|450158049|FG003|Induction|Philadelphia chromosome-positive|0|||
125145941|NCT01190930|450158050|FG004|Induction|Philadelphia chromosome-positive|0|||
125145942|NCT01190930|450158051|FG005|Induction|Philadelphia chromosome-positive|0|||
125145943|NCT01190930|450158052|FG006|Induction|Philadelphia chromosome-positive|0|||
125145944|NCT01190930|450158053|FG007|Induction|Philadelphia chromosome-positive|0|||
125145945|NCT01190930|450158054|FG008|Induction|Philadelphia chromosome-positive|0|||
125145946|NCT01190930|450158055|FG009|Induction|Philadelphia chromosome-positive|0|||
125145947|NCT01190930|450158046|FG000|Induction|Incomplete Induction data|63|||
125145948|NCT01190930|450158047|FG001|Induction|Incomplete Induction data|0|||
125145949|NCT01190930|450158048|FG002|Induction|Incomplete Induction data|0|||
125145950|NCT01190930|450158049|FG003|Induction|Incomplete Induction data|0|||
125145951|NCT01190930|450158050|FG004|Induction|Incomplete Induction data|0|||
125145952|NCT01190930|450158051|FG005|Induction|Incomplete Induction data|0|||
125145953|NCT01190930|450158052|FG006|Induction|Incomplete Induction data|0|||
125145954|NCT01190930|450158053|FG007|Induction|Incomplete Induction data|0|||
125145955|NCT01190930|450158054|FG008|Induction|Incomplete Induction data|0|||
125145956|NCT01190930|450158055|FG009|Induction|Incomplete Induction data|0|||
125145957|NCT01190930|450158046|FG000|Induction|Progressive disease|0|||
125145958|NCT01190930|450158047|FG001|Induction|Progressive disease|1|||
125145959|NCT01190930|450158048|FG002|Induction|Progressive disease|0|||
125145960|NCT01190930|450158049|FG003|Induction|Progressive disease|0|||
125145961|NCT01190930|450158050|FG004|Induction|Progressive disease|0|||
125145962|NCT01190930|450158051|FG005|Induction|Progressive disease|0|||
125145963|NCT01190930|450158052|FG006|Induction|Progressive disease|0|||
125145964|NCT01190930|450158053|FG007|Induction|Progressive disease|0|||
125145965|NCT01190930|450158054|FG008|Induction|Progressive disease|0|||
125145966|NCT01190930|450158055|FG009|Induction|Progressive disease|0|||
125145967|NCT01190930|450158046|FG000|Induction|No treatment|3|||
125145968|NCT01190930|450158047|FG001|Induction|No treatment|0|||
125145969|NCT01190930|450158048|FG002|Induction|No treatment|0|||
125145970|NCT01190930|450158049|FG003|Induction|No treatment|0|||
125145971|NCT01190930|450158050|FG004|Induction|No treatment|0|||
125145972|NCT01190930|450158051|FG005|Induction|No treatment|0|||
125145973|NCT01190930|450158052|FG006|Induction|No treatment|0|||
125145974|NCT01190930|450158053|FG007|Induction|No treatment|0|||
125145975|NCT01190930|450158054|FG008|Induction|No treatment|0|||
125145976|NCT01190930|450158055|FG009|Induction|No treatment|0|||
125145977|NCT01190930|450158046|FG000|Induction|Ineligible|69|||
125145978|NCT01190930|450158047|FG001|Induction|Ineligible|4|||
125145979|NCT01190930|450158048|FG002|Induction|Ineligible|0|||
125145980|NCT01190930|450158049|FG003|Induction|Ineligible|0|||
125145981|NCT01190930|450158050|FG004|Induction|Ineligible|0|||
125145982|NCT01190930|450158051|FG005|Induction|Ineligible|0|||
125145983|NCT01190930|450158052|FG006|Induction|Ineligible|0|||
125145984|NCT01190930|450158053|FG007|Induction|Ineligible|0|||
125145985|NCT01190930|450158054|FG008|Induction|Ineligible|0|||
125145986|NCT01190930|450158055|FG009|Induction|Ineligible|0|||
125145987|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
125145988|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
125145989|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
125145990|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
125145991|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
125145992|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
125145993|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
125145994|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
125145995|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
125145996|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
125145997|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Death|0|||
125145998|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Death|0|||
125145999|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Death|8|||
125146000|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Death|4|||
125146001|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Death|0|||
125146002|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Death|0|||
125146003|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Death|0|||
125146004|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Death|0|||
125146005|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Death|0|||
125146006|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Death|0|||
125146007|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
125146008|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
125146009|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
125146010|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
125146011|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
125146012|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
125146013|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
125223575|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
125146014|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
125146015|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
125146016|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
125146017|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146018|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
125146019|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
125146020|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
125146021|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146022|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146023|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146024|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146025|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146026|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
125146027|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Refusal|0|||
125146028|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Refusal|2|||
125146029|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Refusal|694|||
125146030|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Refusal|4|||
125146031|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Refusal|0|||
125146032|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Refusal|3|||
125146033|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Refusal|0|||
125146034|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Refusal|0|||
125146035|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Refusal|0|||
125146036|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Refusal|0|||
125146037|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
125146038|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
125146039|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
125146040|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
125146041|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
125146042|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
125146043|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
125146044|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
125146045|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
125146046|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
125146047|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146048|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
125146049|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146050|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146051|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146052|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146053|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146054|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146055|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146056|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
125146057|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
125146058|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
125146059|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
125146060|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
125146061|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
125146062|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
125146063|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
125146064|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
125146065|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
125146066|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
125146067|NCT01190930|450158046|FG000|Post Induction Pre-Maintenance|Relapse|0|||
125146068|NCT01190930|450158047|FG001|Post Induction Pre-Maintenance|Relapse|0|||
125146069|NCT01190930|450158048|FG002|Post Induction Pre-Maintenance|Relapse|1|||
125146070|NCT01190930|450158049|FG003|Post Induction Pre-Maintenance|Relapse|0|||
125146071|NCT01190930|450158050|FG004|Post Induction Pre-Maintenance|Relapse|0|||
125146072|NCT01190930|450158051|FG005|Post Induction Pre-Maintenance|Relapse|0|||
125146073|NCT01190930|450158052|FG006|Post Induction Pre-Maintenance|Relapse|0|||
125146074|NCT01190930|450158053|FG007|Post Induction Pre-Maintenance|Relapse|0|||
125146075|NCT01190930|450158054|FG008|Post Induction Pre-Maintenance|Relapse|0|||
125146076|NCT01190930|450158055|FG009|Post Induction Pre-Maintenance|Relapse|0|||
125146077|NCT01190930|450158046|FG000|Maintenance|Adverse Event|0|||
125146078|NCT01190930|450158047|FG001|Maintenance|Adverse Event|0|||
125146079|NCT01190930|450158048|FG002|Maintenance|Adverse Event|0|||
125387876|NCT02520011|451053958|FG002|Overall Study|Withdrawal by Subject|0|||
125387877|NCT02520011|451053956|FG000|Overall Study|Protocol Deviation|0|||
125387878|NCT02520011|451053957|FG001|Overall Study|Protocol Deviation|1|||
125387879|NCT02520011|451053958|FG002|Overall Study|Protocol Deviation|0|||
125387880|NCT02520011|451053956|FG000|Overall Study|Patient went to hospice|0|||
125387881|NCT02520011|451053957|FG001|Overall Study|Patient went to hospice|1|||
125387882|NCT02520011|451053958|FG002|Overall Study|Patient went to hospice|0|||
125387883|NCT02520011|451053956|FG000|Overall Study|Progressive disease following response|0|||
125387884|NCT02520011|451053957|FG001|Overall Study|Progressive disease following response|4|||
125387885|NCT02520011|451053958|FG002|Overall Study|Progressive disease following response|2|||
125387886|NCT02436759|451053959|FG000|Overall Study|Adverse Event|3|||
125387887|NCT02436759|451053960|FG001|Overall Study|Adverse Event|0|||
125387888|NCT02436759|451053959|FG000|Overall Study|Protocol Violation|1|||
125146080|NCT01190930|450158049|FG003|Maintenance|Adverse Event|0|||
125146081|NCT01190930|450158050|FG004|Maintenance|Adverse Event|0|||
125146082|NCT01190930|450158051|FG005|Maintenance|Adverse Event|1|||
125146083|NCT01190930|450158052|FG006|Maintenance|Adverse Event|1|||
125146084|NCT01190930|450158053|FG007|Maintenance|Adverse Event|3|||
125146085|NCT01190930|450158054|FG008|Maintenance|Adverse Event|3|||
125146086|NCT01190930|450158055|FG009|Maintenance|Adverse Event|0|||
125146087|NCT01190930|450158046|FG000|Maintenance|Death|0|||
125146088|NCT01190930|450158047|FG001|Maintenance|Death|0|||
125146089|NCT01190930|450158048|FG002|Maintenance|Death|0|||
125146090|NCT01190930|450158049|FG003|Maintenance|Death|1|||
125146091|NCT01190930|450158050|FG004|Maintenance|Death|0|||
125146092|NCT01190930|450158051|FG005|Maintenance|Death|0|||
125146093|NCT01190930|450158052|FG006|Maintenance|Death|2|||
125146094|NCT01190930|450158053|FG007|Maintenance|Death|2|||
125146095|NCT01190930|450158054|FG008|Maintenance|Death|2|||
125146096|NCT01190930|450158055|FG009|Maintenance|Death|2|||
125146097|NCT01190930|450158046|FG000|Maintenance|Lost to Follow-up|0|||
125146098|NCT01190930|450158047|FG001|Maintenance|Lost to Follow-up|0|||
125146099|NCT01190930|450158048|FG002|Maintenance|Lost to Follow-up|0|||
125146100|NCT01190930|450158049|FG003|Maintenance|Lost to Follow-up|0|||
125146101|NCT01190930|450158050|FG004|Maintenance|Lost to Follow-up|0|||
125146102|NCT01190930|450158051|FG005|Maintenance|Lost to Follow-up|0|||
125146103|NCT01190930|450158052|FG006|Maintenance|Lost to Follow-up|1|||
125146104|NCT01190930|450158053|FG007|Maintenance|Lost to Follow-up|1|||
125146105|NCT01190930|450158054|FG008|Maintenance|Lost to Follow-up|1|||
125146106|NCT01190930|450158055|FG009|Maintenance|Lost to Follow-up|0|||
125146107|NCT01190930|450158046|FG000|Maintenance|Physician Decision|0|||
125146108|NCT01190930|450158047|FG001|Maintenance|Physician Decision|1|||
125146109|NCT01190930|450158048|FG002|Maintenance|Physician Decision|0|||
125146110|NCT01190930|450158049|FG003|Maintenance|Physician Decision|5|||
125146111|NCT01190930|450158050|FG004|Maintenance|Physician Decision|9|||
125146112|NCT01190930|450158051|FG005|Maintenance|Physician Decision|4|||
125146113|NCT01190930|450158052|FG006|Maintenance|Physician Decision|8|||
125146114|NCT01190930|450158053|FG007|Maintenance|Physician Decision|8|||
125146115|NCT01190930|450158054|FG008|Maintenance|Physician Decision|10|||
125146116|NCT01190930|450158055|FG009|Maintenance|Physician Decision|17|||
125146117|NCT01190930|450158046|FG000|Maintenance|Withdrawal by Subject|0|||
125146118|NCT01190930|450158047|FG001|Maintenance|Withdrawal by Subject|0|||
125146119|NCT01190930|450158048|FG002|Maintenance|Withdrawal by Subject|0|||
125146120|NCT01190930|450158049|FG003|Maintenance|Withdrawal by Subject|0|||
125146121|NCT01190930|450158050|FG004|Maintenance|Withdrawal by Subject|0|||
125146122|NCT01190930|450158051|FG005|Maintenance|Withdrawal by Subject|0|||
125146123|NCT01190930|450158052|FG006|Maintenance|Withdrawal by Subject|2|||
125146124|NCT01190930|450158053|FG007|Maintenance|Withdrawal by Subject|1|||
125146125|NCT01190930|450158054|FG008|Maintenance|Withdrawal by Subject|4|||
125146126|NCT01190930|450158055|FG009|Maintenance|Withdrawal by Subject|1|||
125146127|NCT01190930|450158046|FG000|Maintenance|Refusal|0|||
125146128|NCT01190930|450158047|FG001|Maintenance|Refusal|1|||
125146129|NCT01190930|450158048|FG002|Maintenance|Refusal|0|||
125146130|NCT01190930|450158049|FG003|Maintenance|Refusal|2|||
125146131|NCT01190930|450158050|FG004|Maintenance|Refusal|0|||
125146132|NCT01190930|450158051|FG005|Maintenance|Refusal|4|||
125146133|NCT01190930|450158052|FG006|Maintenance|Refusal|5|||
125146134|NCT01190930|450158053|FG007|Maintenance|Refusal|17|||
125146135|NCT01190930|450158054|FG008|Maintenance|Refusal|13|||
125146136|NCT01190930|450158055|FG009|Maintenance|Refusal|6|||
125146137|NCT01190930|450158046|FG000|Maintenance|second malignant neoplasm|0|||
125146138|NCT01190930|450158047|FG001|Maintenance|second malignant neoplasm|0|||
125387889|NCT02436759|451053960|FG001|Overall Study|Protocol Violation|0|||
125146139|NCT01190930|450158048|FG002|Maintenance|second malignant neoplasm|0|||
125146140|NCT01190930|450158049|FG003|Maintenance|second malignant neoplasm|1|||
125146141|NCT01190930|450158050|FG004|Maintenance|second malignant neoplasm|0|||
125146142|NCT01190930|450158051|FG005|Maintenance|second malignant neoplasm|1|||
125146143|NCT01190930|450158052|FG006|Maintenance|second malignant neoplasm|0|||
125146144|NCT01190930|450158053|FG007|Maintenance|second malignant neoplasm|0|||
125146145|NCT01190930|450158054|FG008|Maintenance|second malignant neoplasm|1|||
125146146|NCT01190930|450158055|FG009|Maintenance|second malignant neoplasm|0|||
125146147|NCT01190930|450158046|FG000|Maintenance|Inevaluable|0|||
125146148|NCT01190930|450158047|FG001|Maintenance|Inevaluable|0|||
125146149|NCT01190930|450158048|FG002|Maintenance|Inevaluable|0|||
125146150|NCT01190930|450158049|FG003|Maintenance|Inevaluable|0|||
125146151|NCT01190930|450158050|FG004|Maintenance|Inevaluable|0|||
125146152|NCT01190930|450158051|FG005|Maintenance|Inevaluable|1|||
125146153|NCT01190930|450158052|FG006|Maintenance|Inevaluable|1|||
125387890|NCT02436759|451053959|FG000|Overall Study|Withdrawal by Subject|0|||
125387891|NCT02436759|451053960|FG001|Overall Study|Withdrawal by Subject|1|||
125387892|NCT01727141|451053961|FG000|Overall Study|Physician Decision|0|||
125146154|NCT01190930|450158053|FG007|Maintenance|Inevaluable|1|||
125146155|NCT01190930|450158054|FG008|Maintenance|Inevaluable|0|||
125146156|NCT01190930|450158055|FG009|Maintenance|Inevaluable|0|||
125146157|NCT01190930|450158046|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
125146158|NCT01190930|450158047|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
125146159|NCT01190930|450158048|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
125146160|NCT01190930|450158049|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
125146161|NCT01190930|450158050|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
125146162|NCT01190930|450158051|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
125387893|NCT01727141|451053962|FG001|Overall Study|Physician Decision|1|||
125146163|NCT01190930|450158052|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
125146164|NCT01190930|450158053|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
125146165|NCT01190930|450158054|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
125146166|NCT01190930|450158055|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
125146167|NCT01190930|450158046|FG000|Maintenance|Relapse|0|||
125146168|NCT01190930|450158047|FG001|Maintenance|Relapse|0|||
125146169|NCT01190930|450158048|FG002|Maintenance|Relapse|0|||
125146170|NCT01190930|450158049|FG003|Maintenance|Relapse|2|||
125146171|NCT01190930|450158050|FG004|Maintenance|Relapse|0|||
125146172|NCT01190930|450158051|FG005|Maintenance|Relapse|1|||
125146173|NCT01190930|450158052|FG006|Maintenance|Relapse|6|||
125146174|NCT01190930|450158053|FG007|Maintenance|Relapse|13|||
125146175|NCT01190930|450158054|FG008|Maintenance|Relapse|11|||
125146176|NCT01190930|450158055|FG009|Maintenance|Relapse|11|||
125146177|NCT01190930|450158046|FG000|Maintenance|Still on therapy|0|||
125146178|NCT01190930|450158047|FG001|Maintenance|Still on therapy|8|||
125146179|NCT01190930|450158048|FG002|Maintenance|Still on therapy|0|||
125146180|NCT01190930|450158049|FG003|Maintenance|Still on therapy|29|||
125146181|NCT01190930|450158050|FG004|Maintenance|Still on therapy|0|||
125146182|NCT01190930|450158051|FG005|Maintenance|Still on therapy|0|||
125146183|NCT01190930|450158052|FG006|Maintenance|Still on therapy|0|||
125146184|NCT01190930|450158053|FG007|Maintenance|Still on therapy|0|||
125146185|NCT01190930|450158054|FG008|Maintenance|Still on therapy|0|||
125146186|NCT01190930|450158055|FG009|Maintenance|Still on therapy|0|||
125146187|NCT00046839|450158058|FG000|Overall Study|Ineligible / No protocol treatment|0|||
125146188|NCT00046839|450158059|FG001|Overall Study|Ineligible / No protocol treatment|2|||
125146189|NCT00046839|450158058|FG000|Overall Study|Withdrawal of consent|1|||
125146190|NCT00046839|450158059|FG001|Overall Study|Withdrawal of consent|0|||
125146191|NCT02050321|450158060|FG000|Overall Study|Withdrawal by Subject|1|||
125146192|NCT02050321|450158060|FG000|Overall Study|Adverse Event|1|||
125146193|NCT00766493|450158061|FG000|30 Days Post-Procedure|Discontinued|7|||
125146194|NCT00766493|450158061|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
125146195|NCT00766493|450158061|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
125146196|NCT00721955|450158064|FG000|Overall Study|Adverse Event|0|||
125146197|NCT00721955|450158065|FG001|Overall Study|Adverse Event|0|||
125146198|NCT00721955|450158066|FG002|Overall Study|Adverse Event|2|||
125146199|NCT01292837|450158067|FG000|Overall Study|Adverse Event|1|||
125146200|NCT01292837|450158067|FG000|Overall Study|Further treatment determined|1|||
125146201|NCT04531527|450158070|FG000|Overall Study|Found to be Ineligible|3|||
125146202|NCT01077258|450158079|FG000|Overall Study|Lost to Follow-up|1390|||
125146203|NCT01077258|450158079|FG000|Overall Study|Adverse drug reaction|218|||
125146204|NCT01077258|450158079|FG000|Overall Study|Lack of Efficacy|663|||
125146205|NCT01077258|450158079|FG000|Overall Study|Clinical remission|37|||
125146206|NCT01077258|450158079|FG000|Overall Study|Other reasons|260|||
125146207|NCT00434837|450158080|FG000|Overall Study|Lost to Follow-up|20|||
125146208|NCT00434837|450158081|FG001|Overall Study|Lost to Follow-up|23|||
125146209|NCT00434837|450158082|FG002|Overall Study|Lost to Follow-up|30|||
125146210|NCT00726895|450158084|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
125146211|NCT00726895|450158085|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125146212|NCT01881737|450158088|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
125146213|NCT01881737|450158088|FG000|Overall Study|Withdrawal by Subject|1|||
125146214|NCT01881737|450158088|FG000|Overall Study|Worsening of baseline behavior|1|||
125146215|NCT02250651|450158101|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
125146216|NCT02250651|450158102|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
125146217|NCT02250651|450158103|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
125146218|NCT02250651|450158101|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
125146219|NCT02250651|450158102|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
125146220|NCT02250651|450158103|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
125146221|NCT02250651|450158101|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
125146222|NCT02250651|450158102|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
125146223|NCT02250651|450158103|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
125146224|NCT02250651|450158101|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
125146225|NCT02250651|450158102|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
125146226|NCT02250651|450158103|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
125146227|NCT02250651|450158101|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
125146228|NCT02250651|450158102|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
125146229|NCT02250651|450158103|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
125146230|NCT02250651|450158101|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
125146231|NCT02250651|450158102|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
125146232|NCT02250651|450158103|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
125146233|NCT02250651|450158101|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
125146234|NCT02250651|450158102|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
125146235|NCT02250651|450158103|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
125387894|NCT01727141|451053963|FG002|Overall Study|Physician Decision|0|||
125146236|NCT02250651|450158101|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
125146237|NCT02250651|450158102|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
125146238|NCT02250651|450158103|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
125146239|NCT02250651|450158101|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
125146240|NCT02250651|450158102|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
125146241|NCT02250651|450158103|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
125146242|NCT02250651|450158101|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
125146243|NCT02250651|450158102|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
125146244|NCT02250651|450158103|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
125146245|NCT02250651|450158101|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
125146246|NCT02250651|450158102|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
125146247|NCT02250651|450158103|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
125146248|NCT02250651|450158101|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
125146249|NCT02250651|450158102|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
125146250|NCT02250651|450158103|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
125146251|NCT02250651|450158101|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
125387895|NCT01727141|451053964|FG003|Overall Study|Physician Decision|2|||
125387896|NCT01727141|451053961|FG000|Overall Study|Lost to Follow-up|0|||
125387897|NCT01727141|451053962|FG001|Overall Study|Lost to Follow-up|2|||
125387898|NCT01727141|451053963|FG002|Overall Study|Lost to Follow-up|0|||
125387899|NCT01727141|451053964|FG003|Overall Study|Lost to Follow-up|0|||
125387900|NCT01727141|451053961|FG000|Overall Study|Death|0|||
125387901|NCT01727141|451053962|FG001|Overall Study|Death|1|||
125387902|NCT01727141|451053963|FG002|Overall Study|Death|1|||
125387903|NCT01727141|451053964|FG003|Overall Study|Death|1|||
125387904|NCT01727141|451053961|FG000|Overall Study|Protocol deviation|1|||
125387905|NCT01727141|451053962|FG001|Overall Study|Protocol deviation|1|||
125387906|NCT01727141|451053963|FG002|Overall Study|Protocol deviation|0|||
125387907|NCT01727141|451053964|FG003|Overall Study|Protocol deviation|1|||
125387908|NCT01727141|451053961|FG000|Overall Study|Withdrawal by Subject|4|||
125387909|NCT01727141|451053962|FG001|Overall Study|Withdrawal by Subject|4|||
125387910|NCT01727141|451053963|FG002|Overall Study|Withdrawal by Subject|2|||
125387911|NCT01727141|451053964|FG003|Overall Study|Withdrawal by Subject|11|||
125387912|NCT04014075|451053967|FG000|Overall Study|Progressive Disease|53|||
125387913|NCT04014075|451053967|FG000|Overall Study|Adverse Event|15|||
125387914|NCT04014075|451053967|FG000|Overall Study|Clinical Progression|4|||
125387915|NCT04014075|451053967|FG000|Overall Study|Death|2|||
125387916|NCT04014075|451053967|FG000|Overall Study|Withdrawal by Subject|2|||
125387917|NCT04014075|451053967|FG000|Overall Study|Miscellaneous|2|||
125146252|NCT02250651|450158102|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
125146253|NCT02250651|450158103|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
125146254|NCT02250651|450158101|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
125146255|NCT02250651|450158102|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
125146256|NCT02250651|450158103|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
125146257|NCT02250651|450158101|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
125146258|NCT02250651|450158102|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
125146259|NCT02250651|450158103|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
125146260|NCT03496298|450158104|FG000|Overall Study|Adverse Event|49|||
125146261|NCT03496298|450158105|FG001|Overall Study|Adverse Event|68|||
125146262|NCT03496298|450158106|FG002|Overall Study|Adverse Event|79|||
125146263|NCT03496298|450158104|FG000|Overall Study|Study terminated by Sponsor|1050|||
125146264|NCT03496298|450158105|FG001|Overall Study|Study terminated by Sponsor|1063|||
125146265|NCT03496298|450158106|FG002|Overall Study|Study terminated by Sponsor|1071|||
125146266|NCT03496298|450158104|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
125146267|NCT03496298|450158105|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
125146268|NCT03496298|450158106|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
125146269|NCT03496298|450158104|FG000|Overall Study|Withdrawal by Subject|176|||
125146270|NCT03496298|450158105|FG001|Overall Study|Withdrawal by Subject|154|||
125146271|NCT03496298|450158106|FG002|Overall Study|Withdrawal by Subject|151|||
125146272|NCT03496298|450158104|FG000|Overall Study|Other|29|||
125146273|NCT03496298|450158105|FG001|Overall Study|Other|20|||
125146274|NCT03496298|450158106|FG002|Overall Study|Other|23|||
125146275|NCT03496298|450158104|FG000|Overall Study|Randomized and not treated|1|||
125387918|NCT04014075|451053967|FG000|Overall Study|Physician Decision|1|||
125387919|NCT03616912|451053971|FG000|Overall Study|Adverse Event|17|||
125387920|NCT03616912|451053972|FG001|Overall Study|Adverse Event|21|||
125387921|NCT03616912|451053973|FG002|Overall Study|Adverse Event|9|||
125146276|NCT03496298|450158105|FG001|Overall Study|Randomized and not treated|1|||
125223576|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125387922|NCT03616912|451053974|FG003|Overall Study|Adverse Event|0|||
125387923|NCT03616912|451053975|FG004|Overall Study|Adverse Event|0|||
125387924|NCT03616912|451053976|FG005|Overall Study|Adverse Event|0|||
125387925|NCT03616912|451053971|FG000|Overall Study|Death|1|||
125146277|NCT03496298|450158106|FG002|Overall Study|Randomized and not treated|1|||
125146278|NCT02260635|450158111|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
125146279|NCT02260635|450158112|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
125146280|NCT02260635|450158111|FG000|Open-Label Extension|Study Termination|25|||
125146281|NCT02260635|450158112|FG001|Open-Label Extension|Study Termination|25|||
125146282|NCT02260635|450158111|FG000|Open-Label Extension|Withdrawal by Subject|1|||
125146283|NCT02260635|450158112|FG001|Open-Label Extension|Withdrawal by Subject|0|||
125146284|NCT04106817|450158113|FG000|Overall Study|Lost to Follow-up|1|||
125146285|NCT04106817|450158114|FG001|Overall Study|Lost to Follow-up|0|||
125146286|NCT04106817|450158115|FG002|Overall Study|Lost to Follow-up|0|||
125146287|NCT00152516|450158116|FG000|Overall Study|Adverse Event|18|||
125146288|NCT00152516|450158116|FG000|Overall Study|Lack and Loss of Efficacy|30|||
125146289|NCT00152516|450158116|FG000|Overall Study|Lost to Follow-up|5|||
125146290|NCT00152516|450158116|FG000|Overall Study|Withdrawal by Subject|8|||
125146291|NCT00152516|450158116|FG000|Overall Study|Protocol Violation|3|||
125146292|NCT00152516|450158116|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
125146293|NCT00152516|450158116|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
125146294|NCT00152516|450158116|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
125146295|NCT00152516|450158116|FG000|Overall Study|Other: Non-Compliance|2|||
125146296|NCT00152516|450158116|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
125146297|NCT00152516|450158116|FG000|Overall Study|Other: Moved Out Of State|1|||
125146298|NCT00152516|450158116|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
125146299|NCT00152516|450158116|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
125146300|NCT02427399|450158117|FG000|Overall Study|Protocol Violation|14|||
125146301|NCT02427399|450158118|FG001|Overall Study|Protocol Violation|16|||
125146302|NCT02427399|450158119|FG002|Overall Study|Protocol Violation|12|||
125146303|NCT02427399|450158120|FG003|Overall Study|Protocol Violation|18|||
125146304|NCT02427399|450158121|FG004|Overall Study|Protocol Violation|15|||
125146305|NCT02289820|450158122|FG000|Overall Study|Withdrawal by Subject|2|||
125146306|NCT02289820|450158123|FG001|Overall Study|Withdrawal by Subject|1|||
125146307|NCT02289820|450158124|FG002|Overall Study|Withdrawal by Subject|2|||
125146308|NCT02289820|450158125|FG003|Overall Study|Withdrawal by Subject|1|||
125146309|NCT02289820|450158126|FG004|Overall Study|Withdrawal by Subject|0|||
125146310|NCT02289820|450158127|FG005|Overall Study|Withdrawal by Subject|0|||
125146311|NCT02289820|450158128|FG006|Overall Study|Withdrawal by Subject|1|||
125146312|NCT02289820|450158122|FG000|Overall Study|Death|0|||
125146313|NCT02289820|450158123|FG001|Overall Study|Death|0|||
125146314|NCT02289820|450158124|FG002|Overall Study|Death|1|||
125146315|NCT02289820|450158125|FG003|Overall Study|Death|0|||
125146316|NCT02289820|450158126|FG004|Overall Study|Death|0|||
125146317|NCT02289820|450158127|FG005|Overall Study|Death|0|||
125146318|NCT02289820|450158128|FG006|Overall Study|Death|0|||
125146319|NCT02289820|450158122|FG000|Overall Study|Lost to Follow-up|0|||
125146320|NCT02289820|450158123|FG001|Overall Study|Lost to Follow-up|0|||
125146321|NCT02289820|450158124|FG002|Overall Study|Lost to Follow-up|3|||
125146322|NCT02289820|450158125|FG003|Overall Study|Lost to Follow-up|1|||
125146323|NCT02289820|450158126|FG004|Overall Study|Lost to Follow-up|0|||
125146324|NCT02289820|450158127|FG005|Overall Study|Lost to Follow-up|1|||
125146325|NCT02289820|450158128|FG006|Overall Study|Lost to Follow-up|1|||
125146326|NCT02289820|450158122|FG000|Overall Study|withdrawal of consent|0|||
125146327|NCT02289820|450158123|FG001|Overall Study|withdrawal of consent|1|||
125146328|NCT02289820|450158124|FG002|Overall Study|withdrawal of consent|0|||
125146329|NCT02289820|450158125|FG003|Overall Study|withdrawal of consent|0|||
125146330|NCT02289820|450158126|FG004|Overall Study|withdrawal of consent|0|||
125146331|NCT02289820|450158127|FG005|Overall Study|withdrawal of consent|0|||
125146332|NCT02289820|450158128|FG006|Overall Study|withdrawal of consent|0|||
125146333|NCT03847974|450158131|FG000|Overall Study|relocated out of region|3|||
125146334|NCT03847974|450158131|FG000|Overall Study|Withdrawal by Subject|2|||
125146335|NCT03847974|450158131|FG000|Overall Study|Adverse Event|1|||
125146336|NCT01924364|450158132|FG000|Overall Study|Physician Decision|3|||
125146337|NCT01685216|450158133|FG000|Overall Study|Did not receive study drug|1|||
125146338|NCT00756717|450158134|FG000|Overall Study|Withdrawal by Subject|2|||
125146339|NCT02418754|450158135|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
125146340|NCT02418754|450158136|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
125146341|NCT02418754|450158137|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
125146342|NCT02418754|450158138|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
125146343|NCT02418754|450158139|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
125146344|NCT02418754|450158135|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
125146345|NCT02418754|450158136|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
125146346|NCT02418754|450158137|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
125146347|NCT02418754|450158138|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
125146348|NCT02418754|450158139|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
125146349|NCT02418754|450158135|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
125146350|NCT02418754|450158136|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
125146351|NCT02418754|450158137|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
125146352|NCT02418754|450158138|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
125387926|NCT03616912|451053972|FG001|Overall Study|Death|1|||
125387927|NCT03616912|451053973|FG002|Overall Study|Death|0|||
125387928|NCT03616912|451053974|FG003|Overall Study|Death|0|||
125387929|NCT03616912|451053975|FG004|Overall Study|Death|0|||
125387930|NCT03616912|451053976|FG005|Overall Study|Death|0|||
125387931|NCT03616912|451053971|FG000|Overall Study|Lack of Efficacy|13|||
125387932|NCT03616912|451053972|FG001|Overall Study|Lack of Efficacy|6|||
125387933|NCT03616912|451053973|FG002|Overall Study|Lack of Efficacy|8|||
125387934|NCT03616912|451053974|FG003|Overall Study|Lack of Efficacy|4|||
125387935|NCT03616912|451053975|FG004|Overall Study|Lack of Efficacy|5|||
125387936|NCT03616912|451053976|FG005|Overall Study|Lack of Efficacy|1|||
125387937|NCT03616912|451053971|FG000|Overall Study|Lost to Follow-up|1|||
125387938|NCT03616912|451053972|FG001|Overall Study|Lost to Follow-up|2|||
125387939|NCT03616912|451053973|FG002|Overall Study|Lost to Follow-up|3|||
125387940|NCT03616912|451053974|FG003|Overall Study|Lost to Follow-up|0|||
125387941|NCT03616912|451053975|FG004|Overall Study|Lost to Follow-up|0|||
125387942|NCT03616912|451053976|FG005|Overall Study|Lost to Follow-up|0|||
125387943|NCT03616912|451053971|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
125387944|NCT03616912|451053972|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
125387945|NCT03616912|451053973|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
125387946|NCT03616912|451053974|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
125387947|NCT03616912|451053975|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
125387948|NCT03616912|451053976|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
125387949|NCT03616912|451053971|FG000|Overall Study|Withdrawal by Subject|12|||
125438669|NCT00885352|451233920|FG001|Overall Study|Lost to Follow-up|2|||
125146353|NCT02418754|450158139|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
125146354|NCT02418754|450158135|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
125146355|NCT02418754|450158136|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
125146356|NCT02418754|450158137|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
125146357|NCT02418754|450158138|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
125146358|NCT02418754|450158139|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
125146359|NCT02418754|450158135|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
125146360|NCT02418754|450158136|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
125146361|NCT02418754|450158137|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
125146362|NCT02418754|450158138|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
125146363|NCT02418754|450158139|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
125146364|NCT02418754|450158135|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
125146365|NCT02418754|450158136|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
125146366|NCT02418754|450158137|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
125146367|NCT02418754|450158138|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
125146368|NCT02418754|450158139|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
125146369|NCT02418754|450158135|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
125146370|NCT02418754|450158136|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
125146371|NCT02418754|450158137|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
125146372|NCT02418754|450158138|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
125146373|NCT02418754|450158139|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
125146374|NCT02418754|450158135|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
125146375|NCT02418754|450158136|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
125146376|NCT02418754|450158137|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
125223577|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
125223578|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223579|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125223580|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223581|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223582|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223583|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223584|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223585|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223586|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223587|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223588|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223589|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223590|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223591|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
125223592|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125223593|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125387950|NCT03616912|451053972|FG001|Overall Study|Withdrawal by Subject|12|||
125387951|NCT03616912|451053973|FG002|Overall Study|Withdrawal by Subject|15|||
125387952|NCT03616912|451053974|FG003|Overall Study|Withdrawal by Subject|2|||
125387953|NCT03616912|451053975|FG004|Overall Study|Withdrawal by Subject|0|||
125387954|NCT03616912|451053976|FG005|Overall Study|Withdrawal by Subject|2|||
125146377|NCT02418754|450158138|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
125146378|NCT02418754|450158139|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
125146379|NCT02418754|450158135|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
125146380|NCT02418754|450158136|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
125146381|NCT02418754|450158137|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
125146382|NCT02418754|450158138|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
125146383|NCT02418754|450158139|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
125146384|NCT02418754|450158135|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
125146385|NCT02418754|450158136|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
125146386|NCT02418754|450158137|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
125146387|NCT02418754|450158138|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
125146388|NCT02418754|450158139|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
125146389|NCT02418754|450158135|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
125146390|NCT02418754|450158136|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
125146391|NCT02418754|450158137|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
125146392|NCT02418754|450158138|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
125146393|NCT02418754|450158139|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
125146394|NCT00250705|450158140|FG000|Overall Study|Lack of Efficacy|2|||
125146395|NCT02466386|450158148|FG000|Overall Study|Adverse Event|5|||
125146396|NCT02466386|450158148|FG000|Overall Study|Protocol Violation|2|||
125146397|NCT02466386|450158148|FG000|Overall Study|Withdrawal by Subject|14|||
125146398|NCT02466386|450158148|FG000|Overall Study|Lost to Follow-up|5|||
125146399|NCT02466386|450158148|FG000|Overall Study|Lack of Efficacy|8|||
125146400|NCT02466386|450158148|FG000|Overall Study|Other|10|||
125146401|NCT01688882|450158151|FG000|Overall Study|Adverse Event|1|||
125146402|NCT01688882|450158152|FG001|Overall Study|Adverse Event|0|||
125146403|NCT01688882|450158151|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125146404|NCT01688882|450158152|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125146405|NCT01688882|450158151|FG000|Overall Study|Administrative problems|1|||
125146406|NCT01688882|450158152|FG001|Overall Study|Administrative problems|0|||
125146407|NCT03259789|450158153|FG000|Overall Study|Adverse Event|3|||
125146408|NCT03259789|450158154|FG001|Overall Study|Adverse Event|2|||
125146409|NCT03259789|450158155|FG002|Overall Study|Adverse Event|1|||
125146410|NCT03259789|450158153|FG000|Overall Study|Withdrawal by Subject|9|||
125146411|NCT03259789|450158154|FG001|Overall Study|Withdrawal by Subject|5|||
125146412|NCT03259789|450158155|FG002|Overall Study|Withdrawal by Subject|1|||
125146413|NCT03259789|450158153|FG000|Overall Study|Lost to Follow-up|5|||
125146414|NCT03259789|450158154|FG001|Overall Study|Lost to Follow-up|9|||
125146415|NCT03259789|450158155|FG002|Overall Study|Lost to Follow-up|4|||
125146416|NCT03259789|450158153|FG000|Overall Study|Physician Decision|0|||
125146417|NCT03259789|450158154|FG001|Overall Study|Physician Decision|1|||
125146418|NCT03259789|450158155|FG002|Overall Study|Physician Decision|0|||
125146419|NCT00889252|450158156|FG000|Overall Study|Adverse Event|2|||
125146420|NCT00889252|450158157|FG001|Overall Study|Adverse Event|4|||
125146421|NCT00889252|450158156|FG000|Overall Study|Withdrawal by Subject|3|||
125146422|NCT00889252|450158157|FG001|Overall Study|Withdrawal by Subject|0|||
125146423|NCT00889252|450158156|FG000|Overall Study|Protocol Violation|2|||
125146424|NCT00889252|450158157|FG001|Overall Study|Protocol Violation|0|||
125146425|NCT02416934|450158158|FG000|Overall Study|given steroids|1|||
125146426|NCT02416934|450158159|FG001|Overall Study|given steroids|2|||
125146427|NCT02416934|450158158|FG000|Overall Study|Lost to Follow-up|0|||
125146428|NCT02416934|450158159|FG001|Overall Study|Lost to Follow-up|2|||
125146429|NCT02416934|450158158|FG000|Overall Study|Withdrawal by Subject|1|||
125146430|NCT02416934|450158159|FG001|Overall Study|Withdrawal by Subject|0|||
125146431|NCT02416934|450158158|FG000|Overall Study|recruited during continuing renewal proc|0|||
125387955|NCT03616912|451053971|FG000|Overall Study|Study Terminated by Sponsor|0|||
125146432|NCT02416934|450158159|FG001|Overall Study|recruited during continuing renewal proc|1|||
125146433|NCT02416934|450158158|FG000|Overall Study|Protocol Violation|0|||
125146434|NCT02416934|450158159|FG001|Overall Study|Protocol Violation|1|||
125387956|NCT03616912|451053972|FG001|Overall Study|Study Terminated by Sponsor|0|||
125387957|NCT03616912|451053973|FG002|Overall Study|Study Terminated by Sponsor|0|||
125387958|NCT03616912|451053974|FG003|Overall Study|Study Terminated by Sponsor|10|||
125146435|NCT02416934|450158158|FG000|Overall Study|surgery started late|0|||
125146436|NCT02416934|450158159|FG001|Overall Study|surgery started late|1|||
125146437|NCT02416934|450158158|FG000|Overall Study|re-operation|1|||
125146438|NCT02416934|450158159|FG001|Overall Study|re-operation|0|||
125146439|NCT00398073|450158162|FG000|Overall Study|Withdrawal by Subject|1|||
125146440|NCT00398073|450158163|FG001|Overall Study|Withdrawal by Subject|0|||
125146441|NCT01833169|450158166|FG000|Overall Study|Disease Progression|99|||
125146442|NCT01833169|450158166|FG000|Overall Study|Adverse Event|33|||
125146443|NCT01833169|450158166|FG000|Overall Study|Withdrawal by Subject|9|||
125146444|NCT01833169|450158166|FG000|Overall Study|Death|3|||
125387959|NCT03616912|451053975|FG004|Overall Study|Study Terminated by Sponsor|9|||
125146445|NCT01833169|450158166|FG000|Overall Study|Physician Decision|2|||
125146446|NCT00879684|450158170|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
125146447|NCT00879684|450158171|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
125146448|NCT00879684|450158172|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
125146449|NCT00879684|450158173|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
125146450|NCT00879684|450158174|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
125146451|NCT00879684|450158175|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
125146452|NCT00879684|450158176|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
125146453|NCT00879684|450158170|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
125146454|NCT00879684|450158171|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
125146455|NCT00879684|450158172|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
125146456|NCT00879684|450158173|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
125146457|NCT00879684|450158174|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
125146458|NCT00879684|450158175|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
125146459|NCT00879684|450158176|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
125146460|NCT00879684|450158170|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
125146461|NCT00879684|450158171|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
125146462|NCT00879684|450158172|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
125146463|NCT00879684|450158173|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
125146464|NCT00879684|450158174|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
125146465|NCT00879684|450158175|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
125146466|NCT00879684|450158176|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
125146467|NCT00879684|450158170|FG000|Stage 1: Dose Escalation|Death|0|||
125146468|NCT00879684|450158171|FG001|Stage 1: Dose Escalation|Death|0|||
125146469|NCT00879684|450158172|FG002|Stage 1: Dose Escalation|Death|1|||
125146470|NCT00879684|450158173|FG003|Stage 1: Dose Escalation|Death|0|||
125146471|NCT00879684|450158174|FG004|Stage 1: Dose Escalation|Death|0|||
125146472|NCT00879684|450158175|FG005|Stage 1: Dose Escalation|Death|0|||
125146473|NCT00879684|450158176|FG006|Stage 1: Dose Escalation|Death|0|||
125146474|NCT00879684|450158170|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
125146475|NCT00879684|450158171|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
125146476|NCT00879684|450158172|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
125146477|NCT00879684|450158173|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
125146478|NCT00879684|450158174|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
125146479|NCT00879684|450158175|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
125146480|NCT00879684|450158176|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
125146481|NCT00879684|450158170|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
125146482|NCT00879684|450158171|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
125146483|NCT00879684|450158172|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
125146484|NCT00879684|450158173|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
125146485|NCT00879684|450158174|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
125146486|NCT00879684|450158175|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
125146487|NCT00879684|450158176|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
125146488|NCT00879684|450158170|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
125146489|NCT00879684|450158171|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
125146490|NCT00879684|450158172|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
125146491|NCT00879684|450158173|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
125146492|NCT00879684|450158174|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
125146493|NCT00879684|450158175|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
125146494|NCT00879684|450158176|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
125146495|NCT00127166|450158177|FG000|Period I|Protocol Violation|0|||
125146496|NCT00127166|450158178|FG001|Period I|Protocol Violation|2|||
125146497|NCT00127166|450158177|FG000|Period I|Withdrawal by Subject|2|||
125146498|NCT00127166|450158178|FG001|Period I|Withdrawal by Subject|0|||
125146499|NCT00127166|450158177|FG000|Period I|Patient did not meet inclusion criteria|1|||
125146500|NCT00127166|450158178|FG001|Period I|Patient did not meet inclusion criteria|0|||
125146501|NCT00127166|450158177|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
125146502|NCT00127166|450158178|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
125146503|NCT00127166|450158177|FG000|Period II|Withdrawal by Subject|2|||
125146504|NCT00127166|450158178|FG001|Period II|Withdrawal by Subject|0|||
125146505|NCT00127166|450158177|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
125146506|NCT00127166|450158178|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
125146507|NCT00105157|450158179|FG000|Double-Blind (DB)|Never Treated|1|||
125146508|NCT00105157|450158180|FG001|Double-Blind (DB)|Never Treated|0|||
125146509|NCT00105157|450158181|FG002|Double-Blind (DB)|Never Treated|0|||
125146510|NCT00105157|450158182|FG003|Double-Blind (DB)|Never Treated|0|||
125146511|NCT00105157|450158179|FG000|Double-Blind (DB)|Adverse Event|2|||
125223594|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
125146512|NCT00105157|450158180|FG001|Double-Blind (DB)|Adverse Event|0|||
125146513|NCT00105157|450158181|FG002|Double-Blind (DB)|Adverse Event|1|||
125146514|NCT00105157|450158182|FG003|Double-Blind (DB)|Adverse Event|1|||
125146515|NCT00105157|450158179|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
125146516|NCT00105157|450158180|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
125146517|NCT00105157|450158181|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
125146518|NCT00105157|450158182|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
125146519|NCT00105157|450158179|FG000|Open-Label Continuation of DB|Adverse Event|3|||
125146520|NCT00105157|450158180|FG001|Open-Label Continuation of DB|Adverse Event|1|||
125146521|NCT00105157|450158181|FG002|Open-Label Continuation of DB|Adverse Event|0|||
125146522|NCT00105157|450158182|FG003|Open-Label Continuation of DB|Adverse Event|0|||
125146523|NCT00105157|450158179|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
125146524|NCT00105157|450158180|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
125146525|NCT00105157|450158181|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
125146526|NCT00105157|450158182|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
125146527|NCT00105157|450158179|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
125146528|NCT00105157|450158180|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
125146529|NCT00105157|450158181|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
125146530|NCT00105157|450158182|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
125146531|NCT00105157|450158179|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
125146532|NCT00105157|450158180|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
125146533|NCT00105157|450158181|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
125146534|NCT00105157|450158182|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
125146535|NCT00105157|450158179|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
125146536|NCT00105157|450158180|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
125146537|NCT00105157|450158181|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
125146538|NCT00105157|450158182|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
125146539|NCT00105157|450158179|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
125146540|NCT00105157|450158180|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
125146541|NCT00105157|450158181|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
125146542|NCT00105157|450158182|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
125146543|NCT00105157|450158179|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
125146544|NCT00105157|450158180|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
125146545|NCT00105157|450158181|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
125146546|NCT00105157|450158182|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
125146547|NCT00105157|450158179|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
125146548|NCT00105157|450158180|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
125146549|NCT00105157|450158181|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
125146550|NCT00105157|450158182|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
125146551|NCT00105157|450158179|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
125146552|NCT00105157|450158180|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
125146553|NCT00105157|450158181|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
125146554|NCT00105157|450158182|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
125146555|NCT00105157|450158179|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
125146556|NCT00105157|450158180|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
125146557|NCT00105157|450158181|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
125146558|NCT00105157|450158182|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
125146559|NCT00105157|450158179|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
125146560|NCT00105157|450158180|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
125146561|NCT00105157|450158181|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
125146562|NCT00105157|450158182|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
125146563|NCT02169336|450158185|FG000|Overall Study|Lack of Efficacy|1|||
125146564|NCT02169336|450158186|FG001|Overall Study|Lack of Efficacy|1|||
125146565|NCT02169336|450158187|FG002|Overall Study|Lack of Efficacy|0|||
125146566|NCT02169336|450158185|FG000|Overall Study|Adverse Event|2|||
125146567|NCT02169336|450158186|FG001|Overall Study|Adverse Event|3|||
125146568|NCT02169336|450158187|FG002|Overall Study|Adverse Event|1|||
125146569|NCT02169336|450158185|FG000|Overall Study|Withdrawal by Subject|1|||
125146570|NCT02169336|450158186|FG001|Overall Study|Withdrawal by Subject|0|||
125146571|NCT02169336|450158187|FG002|Overall Study|Withdrawal by Subject|0|||
125146572|NCT02169336|450158185|FG000|Overall Study|Physician Decision|0|||
125146573|NCT02169336|450158186|FG001|Overall Study|Physician Decision|0|||
125146574|NCT02169336|450158187|FG002|Overall Study|Physician Decision|1|||
125146575|NCT02169336|450158185|FG000|Overall Study|Subject declined to continue dosing|0|||
125146576|NCT02169336|450158186|FG001|Overall Study|Subject declined to continue dosing|0|||
125223595|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125223596|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125223597|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125223598|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125223599|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125146577|NCT02169336|450158187|FG002|Overall Study|Subject declined to continue dosing|1|||
125146578|NCT01148225|450158188|FG000|Overall Study|Other|185|||
125146579|NCT00393705|450158189|FG000|Overall Study|Adverse Event|0|||
125146580|NCT00393705|450158190|FG001|Overall Study|Adverse Event|2|||
125146581|NCT00393705|450158189|FG000|Overall Study|Death|0|||
125146582|NCT00393705|450158190|FG001|Overall Study|Death|1|||
125146583|NCT00393705|450158189|FG000|Overall Study|Lost to Follow-up|2|||
125146584|NCT00393705|450158190|FG001|Overall Study|Lost to Follow-up|2|||
125146585|NCT00393705|450158189|FG000|Overall Study|Entry Criteria Not Met|10|||
125146586|NCT00393705|450158190|FG001|Overall Study|Entry Criteria Not Met|10|||
125146587|NCT00393705|450158189|FG000|Overall Study|Protocol Violation|4|||
125146588|NCT00393705|450158190|FG001|Overall Study|Protocol Violation|3|||
125146589|NCT00393705|450158189|FG000|Overall Study|Withdrawal by Subject|5|||
125146590|NCT00393705|450158190|FG001|Overall Study|Withdrawal by Subject|3|||
125146591|NCT00393705|450158189|FG000|Overall Study|Physician Decision|2|||
125146592|NCT00393705|450158190|FG001|Overall Study|Physician Decision|2|||
125146593|NCT02490800|450158191|FG000|Overall Study|Adverse Event|0|||
125146594|NCT02490800|450158192|FG001|Overall Study|Adverse Event|0|||
125146595|NCT02490800|450158193|FG002|Overall Study|Adverse Event|0|||
125146596|NCT02490800|450158194|FG003|Overall Study|Adverse Event|2|||
125146597|NCT02490800|450158195|FG004|Overall Study|Adverse Event|3|||
125146598|NCT02490800|450158196|FG005|Overall Study|Adverse Event|2|||
125146599|NCT02490800|450158197|FG006|Overall Study|Adverse Event|0|||
125146600|NCT02490800|450158198|FG007|Overall Study|Adverse Event|0|||
125146601|NCT02490800|450158199|FG008|Overall Study|Adverse Event|0|||
125146602|NCT02490800|450158200|FG009|Overall Study|Adverse Event|0|||
125146603|NCT02490800|450158201|FG010|Overall Study|Adverse Event|0|||
125146604|NCT02490800|450158202|FG011|Overall Study|Adverse Event|2|||
125146605|NCT02490800|450158203|FG012|Overall Study|Adverse Event|2|||
125146606|NCT02490800|450158191|FG000|Overall Study|Withdrawal by Subject|0|||
125146607|NCT02490800|450158192|FG001|Overall Study|Withdrawal by Subject|0|||
125146608|NCT02490800|450158193|FG002|Overall Study|Withdrawal by Subject|0|||
125146609|NCT02490800|450158194|FG003|Overall Study|Withdrawal by Subject|1|||
125146610|NCT02490800|450158195|FG004|Overall Study|Withdrawal by Subject|0|||
125146611|NCT02490800|450158196|FG005|Overall Study|Withdrawal by Subject|0|||
125146612|NCT02490800|450158197|FG006|Overall Study|Withdrawal by Subject|0|||
125146613|NCT02490800|450158198|FG007|Overall Study|Withdrawal by Subject|0|||
125146614|NCT02490800|450158199|FG008|Overall Study|Withdrawal by Subject|1|||
125146615|NCT02490800|450158200|FG009|Overall Study|Withdrawal by Subject|0|||
125146616|NCT02490800|450158201|FG010|Overall Study|Withdrawal by Subject|0|||
125146617|NCT02490800|450158202|FG011|Overall Study|Withdrawal by Subject|0|||
125146618|NCT02490800|450158203|FG012|Overall Study|Withdrawal by Subject|0|||
125146619|NCT02490800|450158191|FG000|Overall Study|Progressive disease|3|||
125146620|NCT02490800|450158192|FG001|Overall Study|Progressive disease|3|||
125146621|NCT02490800|450158193|FG002|Overall Study|Progressive disease|3|||
125146622|NCT02490800|450158194|FG003|Overall Study|Progressive disease|4|||
125146623|NCT02490800|450158195|FG004|Overall Study|Progressive disease|4|||
125146624|NCT02490800|450158196|FG005|Overall Study|Progressive disease|1|||
125146625|NCT02490800|450158197|FG006|Overall Study|Progressive disease|4|||
125146626|NCT02490800|450158198|FG007|Overall Study|Progressive disease|3|||
125146627|NCT02490800|450158199|FG008|Overall Study|Progressive disease|6|||
125146628|NCT02490800|450158200|FG009|Overall Study|Progressive disease|2|||
125146629|NCT02490800|450158201|FG010|Overall Study|Progressive disease|7|||
125146630|NCT02490800|450158202|FG011|Overall Study|Progressive disease|1|||
125146631|NCT02490800|450158203|FG012|Overall Study|Progressive disease|10|||
125146632|NCT02490800|450158191|FG000|Overall Study|Patient enrolled in post-trial access|0|||
125146633|NCT02490800|450158192|FG001|Overall Study|Patient enrolled in post-trial access|0|||
125146634|NCT02490800|450158193|FG002|Overall Study|Patient enrolled in post-trial access|0|||
125146635|NCT02490800|450158194|FG003|Overall Study|Patient enrolled in post-trial access|0|||
125146636|NCT02490800|450158195|FG004|Overall Study|Patient enrolled in post-trial access|0|||
125146637|NCT02490800|450158196|FG005|Overall Study|Patient enrolled in post-trial access|0|||
125146638|NCT02490800|450158197|FG006|Overall Study|Patient enrolled in post-trial access|0|||
125146639|NCT02490800|450158198|FG007|Overall Study|Patient enrolled in post-trial access|0|||
125146640|NCT02490800|450158199|FG008|Overall Study|Patient enrolled in post-trial access|0|||
125146641|NCT02490800|450158200|FG009|Overall Study|Patient enrolled in post-trial access|1|||
125146642|NCT02490800|450158201|FG010|Overall Study|Patient enrolled in post-trial access|1|||
125146643|NCT02490800|450158202|FG011|Overall Study|Patient enrolled in post-trial access|0|||
125146644|NCT02490800|450158203|FG012|Overall Study|Patient enrolled in post-trial access|6|||
125146645|NCT03365791|450158204|FG000|Overall Study|Adverse Event|5|||
125146646|NCT03365791|450158204|FG000|Overall Study|Death|1|||
125146647|NCT03365791|450158204|FG000|Overall Study|Lost to Follow-up|1|||
125146648|NCT03365791|450158204|FG000|Overall Study|Physician Decision|9|||
125146649|NCT03365791|450158204|FG000|Overall Study|Progressive disease|51|||
125146650|NCT03365791|450158204|FG000|Overall Study|Subject/guardian decision|5|||
125146651|NCT03693950|450158205|FG000|Overall Study|Withdrawal by Subject|1|||
125146652|NCT03693950|450158206|FG001|Overall Study|Withdrawal by Subject|0|||
125438670|NCT00885352|451233919|FG000|Overall Study|Physician Decision|0|||
125146653|NCT01475487|450158207|FG000|Overall Study|had to leave early for personal reasons|2|||
125146654|NCT01475487|450158208|FG001|Overall Study|had to leave early for personal reasons|1|||
125146655|NCT03203642|450158209|FG000|Overall Study|Adverse Event|3|||
125146656|NCT03203642|450158210|FG001|Overall Study|Adverse Event|1|||
125146657|NCT03203642|450158209|FG000|Overall Study|Withdrawal by Subject|6|||
125146658|NCT03203642|450158210|FG001|Overall Study|Withdrawal by Subject|6|||
125146659|NCT03203642|450158209|FG000|Overall Study|Lost to Follow-up|2|||
125146660|NCT03203642|450158210|FG001|Overall Study|Lost to Follow-up|1|||
125146661|NCT03203642|450158209|FG000|Overall Study|Termination of the study by sponsor|1|||
125146662|NCT03203642|450158210|FG001|Overall Study|Termination of the study by sponsor|1|||
125146663|NCT03203642|450158209|FG000|Overall Study|Participant moved|0|||
125146664|NCT03203642|450158210|FG001|Overall Study|Participant moved|1|||
125146665|NCT03203642|450158209|FG000|Overall Study|Investigator's decision|3|||
125146666|NCT03203642|450158210|FG001|Overall Study|Investigator's decision|0|||
125146667|NCT03203642|450158209|FG000|Overall Study|Other than above specified|0|||
125146668|NCT03203642|450158210|FG001|Overall Study|Other than above specified|1|||
125146669|NCT00559637|450159711|FG000|Overall Study|Adverse Event|22|||
125146670|NCT00559637|450159711|FG000|Overall Study|Withdrawal by Subject|4|||
125146671|NCT00559637|450159711|FG000|Overall Study|Protocol Violation|6|||
125146672|NCT00559637|450159711|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
125146673|NCT00559637|450159711|FG000|Overall Study|Failure to return|6|||
125146674|NCT00559637|450159711|FG000|Overall Study|Insufficient response|3|||
125146675|NCT00559637|450159711|FG000|Overall Study|Started requiring dialysis after month 7|2|||
125146676|NCT00559637|450159711|FG000|Overall Study|Suspected lung cancer|1|||
125146677|NCT00559637|450159711|FG000|Overall Study|Participation in another study|1|||
125146678|NCT00559637|450159711|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
125146679|NCT00559637|450159711|FG000|Overall Study|Change of center|1|||
125146680|NCT00559637|450159711|FG000|Overall Study|Change of home|1|||
125146681|NCT00559637|450159711|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
125146682|NCT02832167|450159712|FG000|Treatment Period 1|Disease progression|90|||
125146683|NCT02832167|450159712|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
125146684|NCT02832167|450159712|FG000|Treatment Period 1|Death|2|||
125146685|NCT02832167|450159712|FG000|Treatment Period 1|Study Drug Toxicity|6|||
125146686|NCT02832167|450159712|FG000|Treatment Period 1|Participant request to discontinue|9|||
125146687|NCT02832167|450159712|FG000|Treatment Period 1|No longer meet study criteria|1|||
125146688|NCT02832167|450159712|FG000|Treatment Period 1|Participant withdrew consent|3|||
125146689|NCT02832167|450159712|FG000|Treatment Period 1|Other reasons|6|||
125146690|NCT02832167|450159712|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
125146691|NCT02832167|450159712|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
125146692|NCT02832167|450159712|FG000|Transition From Period 1 to Period 2|Death|2|||
125146693|NCT02832167|450159712|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
125146694|NCT02832167|450159712|FG000|Treatment Period 2|Disease progression|69|||
125146695|NCT02832167|450159712|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
125146696|NCT02832167|450159712|FG000|Treatment Period 2|Maximum clinical benefit|1|||
125146697|NCT02832167|450159712|FG000|Treatment Period 2|Study Drug Toxicity|5|||
125146698|NCT02832167|450159712|FG000|Treatment Period 2|Participant request to discontinue|2|||
125146699|NCT02832167|450159712|FG000|Treatment Period 2|Participant withdrew consent|3|||
125146700|NCT02832167|450159712|FG000|Treatment Period 2|Other reasons|3|||
125146701|NCT01958060|450159715|FG000|Overall Study|Not treated|2|||
125146702|NCT01958060|450159716|FG001|Overall Study|Not treated|0|||
125146703|NCT01958060|450159717|FG002|Overall Study|Not treated|0|||
125146704|NCT01958060|450159718|FG003|Overall Study|Not treated|0|||
125146705|NCT01958060|450159719|FG004|Overall Study|Not treated|1|||
125146706|NCT01958060|450159720|FG005|Overall Study|Not treated|0|||
125146707|NCT02293460|450159722|FG000|Overall Study|Protocol Violation|1|||
125146708|NCT02293460|450159722|FG000|Overall Study|Lack of Efficacy|2|||
125146709|NCT02293460|450159722|FG000|Overall Study|Adverse Event|2|||
125146710|NCT02293460|450159722|FG000|Overall Study|Withdrawal by Subject|1|||
125146711|NCT00224484|450159742|FG000|Overall Study|Serious Adverse Event|1|||
125146712|NCT00224484|450159743|FG001|Overall Study|Serious Adverse Event|1|||
125146713|NCT00224484|450159744|FG002|Overall Study|Serious Adverse Event|0|||
125146714|NCT00224484|450159742|FG000|Overall Study|Non-Serious Adverse Event|5|||
125146715|NCT00224484|450159743|FG001|Overall Study|Non-Serious Adverse Event|7|||
125146716|NCT00224484|450159744|FG002|Overall Study|Non-Serious Adverse Event|3|||
125146717|NCT00224484|450159742|FG000|Overall Study|Protocol Violation|2|||
125146718|NCT00224484|450159743|FG001|Overall Study|Protocol Violation|2|||
125146719|NCT00224484|450159744|FG002|Overall Study|Protocol Violation|0|||
125146720|NCT00224484|450159742|FG000|Overall Study|Withdrawal by Subject|49|||
125146721|NCT00224484|450159743|FG001|Overall Study|Withdrawal by Subject|18|||
125146722|NCT00224484|450159744|FG002|Overall Study|Withdrawal by Subject|16|||
125146723|NCT00224484|450159742|FG000|Overall Study|Migrated/moved from study area|18|||
125146724|NCT00224484|450159743|FG001|Overall Study|Migrated/moved from study area|5|||
125146725|NCT00224484|450159744|FG002|Overall Study|Migrated/moved from study area|5|||
125146726|NCT00224484|450159742|FG000|Overall Study|Lost to Follow-up|66|||
125146727|NCT00224484|450159743|FG001|Overall Study|Lost to Follow-up|28|||
125387960|NCT03616912|451053976|FG005|Overall Study|Study Terminated by Sponsor|11|||
125387961|NCT03616912|451053971|FG000|Overall Study|Protocol Deviation|1|||
125387962|NCT03616912|451053972|FG001|Overall Study|Protocol Deviation|1|||
125387963|NCT03616912|451053973|FG002|Overall Study|Protocol Deviation|0|||
125387964|NCT03616912|451053974|FG003|Overall Study|Protocol Deviation|0|||
125146728|NCT00224484|450159744|FG002|Overall Study|Lost to Follow-up|36|||
125146729|NCT00224484|450159742|FG000|Overall Study|Reason not specified|5|||
125146730|NCT00224484|450159743|FG001|Overall Study|Reason not specified|4|||
125146731|NCT00224484|450159744|FG002|Overall Study|Reason not specified|2|||
125146732|NCT01074008|450159747|FG000|Overall Study|Adverse Event|0|||
125146733|NCT01074008|450159748|FG001|Overall Study|Adverse Event|1|||
125146734|NCT01074008|450159749|FG002|Overall Study|Adverse Event|0|||
125146735|NCT01074008|450159750|FG003|Overall Study|Adverse Event|0|||
125146736|NCT01074008|450159751|FG004|Overall Study|Adverse Event|0|||
125146737|NCT01074008|450159752|FG005|Overall Study|Adverse Event|0|||
125146738|NCT01074008|450159753|FG006|Overall Study|Adverse Event|0|||
125146739|NCT01074008|450159754|FG007|Overall Study|Adverse Event|0|||
125146740|NCT01074008|450159755|FG008|Overall Study|Adverse Event|0|||
125146741|NCT01074008|450159747|FG000|Overall Study|Withdrawal by Subject|1|||
125146742|NCT01074008|450159748|FG001|Overall Study|Withdrawal by Subject|1|||
125146743|NCT01074008|450159749|FG002|Overall Study|Withdrawal by Subject|1|||
125146744|NCT01074008|450159750|FG003|Overall Study|Withdrawal by Subject|0|||
125146745|NCT01074008|450159751|FG004|Overall Study|Withdrawal by Subject|1|||
125146746|NCT01074008|450159752|FG005|Overall Study|Withdrawal by Subject|0|||
125146747|NCT01074008|450159753|FG006|Overall Study|Withdrawal by Subject|0|||
125146748|NCT01074008|450159754|FG007|Overall Study|Withdrawal by Subject|0|||
125146749|NCT01074008|450159755|FG008|Overall Study|Withdrawal by Subject|0|||
125146750|NCT01074008|450159747|FG000|Overall Study|Lost to Follow-up|0|||
125146751|NCT01074008|450159748|FG001|Overall Study|Lost to Follow-up|1|||
125146752|NCT01074008|450159749|FG002|Overall Study|Lost to Follow-up|1|||
125146753|NCT01074008|450159750|FG003|Overall Study|Lost to Follow-up|1|||
125146754|NCT01074008|450159751|FG004|Overall Study|Lost to Follow-up|1|||
125146755|NCT01074008|450159752|FG005|Overall Study|Lost to Follow-up|0|||
125146756|NCT01074008|450159753|FG006|Overall Study|Lost to Follow-up|1|||
125146757|NCT01074008|450159754|FG007|Overall Study|Lost to Follow-up|0|||
125146758|NCT01074008|450159755|FG008|Overall Study|Lost to Follow-up|4|||
125146759|NCT02805309|450159756|FG000|Overall Study|Lost to Follow-up|2|||
125146760|NCT02805309|450159757|FG001|Overall Study|Lost to Follow-up|2|||
125146761|NCT02805309|450159758|FG002|Overall Study|Lost to Follow-up|2|||
125146762|NCT02805309|450159756|FG000|Overall Study|Post-Randomization Exclusion|0|||
125146763|NCT02805309|450159757|FG001|Overall Study|Post-Randomization Exclusion|2|||
125146764|NCT02805309|450159758|FG002|Overall Study|Post-Randomization Exclusion|1|||
125146765|NCT01350934|450159763|FG000|Base Study|Adverse Event|6|||
125146766|NCT01350934|450159764|FG001|Base Study|Adverse Event|0|||
125146767|NCT01350934|450159763|FG000|Base Study|Lost to Follow-up|1|||
125146768|NCT01350934|450159764|FG001|Base Study|Lost to Follow-up|0|||
125146769|NCT01350934|450159763|FG000|Base Study|Protocol Violation|1|||
125146770|NCT01350934|450159764|FG001|Base Study|Protocol Violation|1|||
125146771|NCT01350934|450159763|FG000|Base Study|Withdrawal by Subject|1|||
125146772|NCT01350934|450159764|FG001|Base Study|Withdrawal by Subject|2|||
125146773|NCT01350934|450159763|FG000|Base Study|Non-Compliance With Study Drug|2|||
125146774|NCT01350934|450159764|FG001|Base Study|Non-Compliance With Study Drug|0|||
125146775|NCT01350934|450159763|FG000|Extension Study|Adverse Event|2|||
125146776|NCT01350934|450159764|FG001|Extension Study|Adverse Event|1|||
125146777|NCT01350934|450159763|FG000|Extension Study|Lost to Follow-up|2|||
125146778|NCT01350934|450159764|FG001|Extension Study|Lost to Follow-up|0|||
125146779|NCT01350934|450159763|FG000|Extension Study|Protocol Violation|1|||
125146780|NCT01350934|450159764|FG001|Extension Study|Protocol Violation|1|||
125146781|NCT01350934|450159763|FG000|Extension Study|Lack of Efficacy|0|||
125146782|NCT01350934|450159764|FG001|Extension Study|Lack of Efficacy|1|||
125146783|NCT01350934|450159763|FG000|Extension Study|Withdrawal by Subject|0|||
125146784|NCT01350934|450159764|FG001|Extension Study|Withdrawal by Subject|1|||
125146785|NCT03547635|450159767|FG000|Overall Study|Adverse Event|5|||
125146786|NCT03547635|450159768|FG001|Overall Study|Adverse Event|2|||
125146787|NCT03547635|450159769|FG002|Overall Study|Adverse Event|3|||
125146788|NCT03547635|450159767|FG000|Overall Study|Lost to Follow-up|1|||
125146789|NCT03547635|450159768|FG001|Overall Study|Lost to Follow-up|3|||
125146790|NCT03547635|450159769|FG002|Overall Study|Lost to Follow-up|4|||
125146791|NCT03547635|450159767|FG000|Overall Study|Withdrawal by Subject|1|||
125146792|NCT03547635|450159768|FG001|Overall Study|Withdrawal by Subject|0|||
125146793|NCT03547635|450159769|FG002|Overall Study|Withdrawal by Subject|0|||
125146794|NCT03547635|450159767|FG000|Overall Study|Withdrawal By PI|0|||
125146795|NCT03547635|450159768|FG001|Overall Study|Withdrawal By PI|1|||
125223600|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125146796|NCT03547635|450159769|FG002|Overall Study|Withdrawal By PI|0|||
125146797|NCT03547635|450159767|FG000|Overall Study|Withdrawal by Sponsor|0|||
125146798|NCT03547635|450159768|FG001|Overall Study|Withdrawal by Sponsor|0|||
125387965|NCT03616912|451053975|FG004|Overall Study|Protocol Deviation|0|||
125387966|NCT03616912|451053976|FG005|Overall Study|Protocol Deviation|0|||
125146799|NCT03547635|450159769|FG002|Overall Study|Withdrawal by Sponsor|1|||
125146800|NCT03547635|450159767|FG000|Overall Study|Errant Randomization before Treatment|0|||
125146801|NCT03547635|450159768|FG001|Overall Study|Errant Randomization before Treatment|1|||
125146802|NCT03547635|450159769|FG002|Overall Study|Errant Randomization before Treatment|0|||
125146803|NCT03547635|450159767|FG000|Overall Study|Withdrawal by Subject|1|||
125146804|NCT03547635|450159768|FG001|Overall Study|Withdrawal by Subject|0|||
125146805|NCT03547635|450159769|FG002|Overall Study|Withdrawal by Subject|0|||
125146806|NCT02415387|450159779|FG000|Overall Study|Withdrawal by Subject|6|||
125146807|NCT02415387|450159780|FG001|Overall Study|Withdrawal by Subject|1|||
125146808|NCT02415387|450159779|FG000|Overall Study|blood draw problem|0|||
125146809|NCT02415387|450159780|FG001|Overall Study|blood draw problem|1|||
125146810|NCT02415387|450159779|FG000|Overall Study|Protocol Violation|1|||
125146811|NCT02415387|450159780|FG001|Overall Study|Protocol Violation|0|||
125146812|NCT00676650|450159784|FG000|Overall Study|Death|45|||
125146813|NCT00676650|450159785|FG001|Overall Study|Death|14|||
125146814|NCT00676650|450159784|FG000|Overall Study|Adverse Event|159|||
125146815|NCT00676650|450159785|FG001|Overall Study|Adverse Event|21|||
125146816|NCT00676650|450159784|FG000|Overall Study|Global deterioration of health status|66|||
125146817|NCT00676650|450159785|FG001|Overall Study|Global deterioration of health status|31|||
125146818|NCT00676650|450159784|FG000|Overall Study|Lost to Follow-up|0|||
125146819|NCT00676650|450159785|FG001|Overall Study|Lost to Follow-up|1|||
125146820|NCT00676650|450159784|FG000|Overall Study|Objective progression or relapse|189|||
125146821|NCT00676650|450159785|FG001|Overall Study|Objective progression or relapse|140|||
125146822|NCT00676650|450159784|FG000|Overall Study|Other|14|||
125146823|NCT00676650|450159785|FG001|Overall Study|Other|10|||
125146824|NCT00676650|450159784|FG000|Overall Study|Protocol Violation|3|||
125146825|NCT00676650|450159785|FG001|Overall Study|Protocol Violation|1|||
125146826|NCT00676650|450159784|FG000|Overall Study|Study terminated by sponsor|57|||
125146827|NCT00676650|450159785|FG001|Overall Study|Study terminated by sponsor|43|||
125146828|NCT00676650|450159784|FG000|Overall Study|Withdrawal by Subject|48|||
125146829|NCT00676650|450159785|FG001|Overall Study|Withdrawal by Subject|24|||
125146830|NCT00676650|450159784|FG000|Overall Study|Randomized but not treated|3|||
125146831|NCT00676650|450159785|FG001|Overall Study|Randomized but not treated|4|||
125146832|NCT00683592|450159786|FG000|Overall Study|Adverse Event|12|||
125146833|NCT00683592|450159787|FG001|Overall Study|Adverse Event|4|||
125146834|NCT00683592|450159786|FG000|Overall Study|Withdrawal by Subject|11|||
125146835|NCT00683592|450159787|FG001|Overall Study|Withdrawal by Subject|11|||
125146836|NCT00683592|450159786|FG000|Overall Study|Lost to Follow-up|17|||
125387967|NCT03616912|451053971|FG000|Overall Study|Pregnancy|1|||
125387968|NCT03616912|451053972|FG001|Overall Study|Pregnancy|0|||
125387969|NCT03616912|451053973|FG002|Overall Study|Pregnancy|4|||
125387970|NCT03616912|451053974|FG003|Overall Study|Pregnancy|0|||
125387971|NCT03616912|451053975|FG004|Overall Study|Pregnancy|0|||
125387972|NCT03616912|451053976|FG005|Overall Study|Pregnancy|0|||
125387973|NCT03616912|451053971|FG000|Overall Study|Protocol Violation|1|||
125387974|NCT03616912|451053972|FG001|Overall Study|Protocol Violation|0|||
125387975|NCT03616912|451053973|FG002|Overall Study|Protocol Violation|2|||
125387976|NCT03616912|451053974|FG003|Overall Study|Protocol Violation|0|||
125146837|NCT00683592|450159787|FG001|Overall Study|Lost to Follow-up|17|||
125146838|NCT00683592|450159786|FG000|Overall Study|Lack of Efficacy|3|||
125146839|NCT00683592|450159787|FG001|Overall Study|Lack of Efficacy|7|||
125146840|NCT00683592|450159786|FG000|Overall Study|Physician Decision|0|||
125146841|NCT00683592|450159787|FG001|Overall Study|Physician Decision|1|||
125146842|NCT00683592|450159786|FG000|Overall Study|Non-compliance|3|||
125146843|NCT00683592|450159787|FG001|Overall Study|Non-compliance|5|||
125146844|NCT00683592|450159786|FG000|Overall Study|Other|1|||
125387977|NCT03616912|451053975|FG004|Overall Study|Protocol Violation|0|||
125387978|NCT03616912|451053976|FG005|Overall Study|Protocol Violation|0|||
125387979|NCT03616912|451053971|FG000|Overall Study|Physician Decision|2|||
125146845|NCT00683592|450159787|FG001|Overall Study|Other|1|||
125146846|NCT03653026|450159788|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
125146847|NCT03653026|450159789|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
125146848|NCT03653026|450159790|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
125146849|NCT03653026|450159791|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
125146850|NCT03653026|450159788|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
125146851|NCT03653026|450159789|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
125146852|NCT03653026|450159790|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125146853|NCT03653026|450159791|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125146854|NCT03653026|450159788|FG000|Part 1: Placebo-controlled Period|Other|0|||
125146855|NCT03653026|450159789|FG001|Part 1: Placebo-controlled Period|Other|3|||
125146856|NCT03653026|450159790|FG002|Part 1: Placebo-controlled Period|Other|0|||
125146857|NCT03653026|450159791|FG003|Part 1: Placebo-controlled Period|Other|0|||
125146858|NCT03653026|450159788|FG000|Part 2: Open-label Extension|Adverse Event|0|||
125146859|NCT03653026|450159789|FG001|Part 2: Open-label Extension|Adverse Event|0|||
125387980|NCT03616912|451053972|FG001|Overall Study|Physician Decision|0|||
125387981|NCT03616912|451053973|FG002|Overall Study|Physician Decision|0|||
125387982|NCT03616912|451053974|FG003|Overall Study|Physician Decision|0|||
125146860|NCT03653026|450159790|FG002|Part 2: Open-label Extension|Adverse Event|1|||
125146861|NCT03653026|450159791|FG003|Part 2: Open-label Extension|Adverse Event|1|||
125146862|NCT03653026|450159788|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
125146863|NCT03653026|450159789|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
125146864|NCT03653026|450159790|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
125146865|NCT03653026|450159791|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
125146866|NCT03653026|450159788|FG000|Part 2: Open-label Extension|Other|0|||
125146867|NCT03653026|450159789|FG001|Part 2: Open-label Extension|Other|0|||
125146868|NCT03653026|450159790|FG002|Part 2: Open-label Extension|Other|1|||
125146869|NCT03653026|450159791|FG003|Part 2: Open-label Extension|Other|2|||
125146870|NCT01201759|450159792|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
125146871|NCT01201759|450159793|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
125146872|NCT01201759|450159792|FG000|Visit 3 - Washout|Adverse Event|0|||
125146873|NCT01201759|450159793|FG001|Visit 3 - Washout|Adverse Event|3|||
125146874|NCT01201759|450159792|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
125146875|NCT01201759|450159793|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
125146876|NCT01201759|450159792|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
125146877|NCT01201759|450159793|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
125146878|NCT02005276|450159800|FG000|Overall Study|No longer interested|5|||
125146879|NCT02005276|450159801|FG001|Overall Study|No longer interested|2|||
125146880|NCT02005276|450159802|FG002|Overall Study|No longer interested|3|||
125146881|NCT02005276|450159803|FG003|Overall Study|No longer interested|3|||
125146882|NCT01963260|450159804|FG000|Overall Study|Withdrawal by Subject|2|||
125146883|NCT01963260|450159805|FG001|Overall Study|Withdrawal by Subject|0|||
125146884|NCT01963260|450159806|FG002|Overall Study|Withdrawal by Subject|0|||
125146885|NCT01963260|450159807|FG003|Overall Study|Withdrawal by Subject|1|||
125146886|NCT01963260|450159808|FG004|Overall Study|Withdrawal by Subject|2|||
125146887|NCT01963260|450159809|FG005|Overall Study|Withdrawal by Subject|0|||
125146888|NCT01963260|450159810|FG006|Overall Study|Withdrawal by Subject|0|||
125146889|NCT01963260|450159811|FG007|Overall Study|Withdrawal by Subject|0|||
125146890|NCT01963260|450159812|FG008|Overall Study|Withdrawal by Subject|0|||
125146891|NCT01963260|450159813|FG009|Overall Study|Withdrawal by Subject|0|||
125146892|NCT04994431|450159814|FG000|Overall Study|Adverse Event|1|||
125146893|NCT04994431|450159815|FG001|Overall Study|Adverse Event|0|||
125146894|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
125146895|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
125146896|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
125146897|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
125146898|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
125146899|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
125146900|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
125146901|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
125146902|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
125146903|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
125146904|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
125146905|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
125146906|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
125146907|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
125146908|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
125146909|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
125146910|NCT01067521|450159818|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
125146911|NCT01067521|450159819|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
125146912|NCT01067521|450159818|FG000|Open-Label Period|Death|3|||
125146913|NCT01067521|450159819|FG001|Open-Label Period|Death|1|||
125146914|NCT01067521|450159818|FG000|Open-Label Period|Adverse Event|30|||
125146915|NCT01067521|450159819|FG001|Open-Label Period|Adverse Event|28|||
125146916|NCT01067521|450159818|FG000|Open-Label Period|Withdrawal by Subject|160|||
125146917|NCT01067521|450159819|FG001|Open-Label Period|Withdrawal by Subject|88|||
125146918|NCT01067521|450159818|FG000|Open-Label Period|Physician Decision|13|||
125146919|NCT01067521|450159819|FG001|Open-Label Period|Physician Decision|11|||
125146920|NCT01067521|450159818|FG000|Open-Label Period|Non-compliance with study drug|5|||
125146921|NCT01067521|450159819|FG001|Open-Label Period|Non-compliance with study drug|0|||
125146922|NCT01067521|450159818|FG000|Open-Label Period|Protocol Violation|3|||
125146923|NCT01067521|450159819|FG001|Open-Label Period|Protocol Violation|0|||
125146924|NCT01067521|450159818|FG000|Open-Label Period|Pregnancy|14|||
125146925|NCT01067521|450159819|FG001|Open-Label Period|Pregnancy|8|||
125146926|NCT01067521|450159818|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
125146927|NCT01067521|450159819|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
125146928|NCT01067521|450159818|FG000|Open-Label Period|Lost to Follow-up|21|||
125146929|NCT01067521|450159819|FG001|Open-Label Period|Lost to Follow-up|20|||
125146930|NCT03419962|450159822|FG000|Overall Study|Change to other medication|1|||
125387983|NCT03616912|451053975|FG004|Overall Study|Physician Decision|1|||
125146931|NCT03419962|450159822|FG000|Overall Study|Refusal of continuing with trial drug|1|||
125146932|NCT03419962|450159822|FG000|Overall Study|Lost to Follow-up|3|||
125146933|NCT03419962|450159822|FG000|Overall Study|Difficulty in inhaling the doses|1|||
125146934|NCT03419962|450159822|FG000|Overall Study|Missing completion data|31|||
125146935|NCT02914457|450159823|FG000|Overall Study|Withdrawal by Subject|1|||
125146936|NCT02914457|450159823|FG000|Overall Study|Physician Decision|1|||
125146937|NCT02914457|450159823|FG000|Overall Study|No veins available for lead placement|1|||
125146938|NCT02914457|450159823|FG000|Overall Study|Electrical instability of patient|1|||
125146939|NCT02914457|450159823|FG000|Overall Study|ECG acquisition error due to sweating|1|||
125146940|NCT02914457|450159823|FG000|Overall Study|Protocol Violation|1|||
125146941|NCT01098539|450159826|FG000|Overall Study|Adverse Event|26|||
125146942|NCT01098539|450159827|FG001|Overall Study|Adverse Event|26|||
125146943|NCT01098539|450159826|FG000|Overall Study|Protocol Violation|1|||
125146944|NCT01098539|450159827|FG001|Overall Study|Protocol Violation|4|||
125146945|NCT01098539|450159826|FG000|Overall Study|Noncompliance|3|||
125146946|NCT01098539|450159827|FG001|Overall Study|Noncompliance|5|||
125146947|NCT01098539|450159826|FG000|Overall Study|Lost to Follow-up|4|||
125146948|NCT01098539|450159827|FG001|Overall Study|Lost to Follow-up|4|||
125387984|NCT03616912|451053976|FG005|Overall Study|Physician Decision|0|||
125387985|NCT03616912|451053971|FG000|Overall Study|Randomized But Never Treated|0|||
125387986|NCT03616912|451053972|FG001|Overall Study|Randomized But Never Treated|2|||
125387987|NCT03616912|451053973|FG002|Overall Study|Randomized But Never Treated|0|||
125387988|NCT03616912|451053974|FG003|Overall Study|Randomized But Never Treated|0|||
125387989|NCT03616912|451053975|FG004|Overall Study|Randomized But Never Treated|0|||
125387990|NCT03616912|451053976|FG005|Overall Study|Randomized But Never Treated|0|||
125387991|NCT02584504|451053977|FG000|Double-blind Treatment|Participant withdrew consent|0|||
125387992|NCT02584504|451053978|FG001|Double-blind Treatment|Participant withdrew consent|0|||
125387993|NCT02584504|451053979|FG002|Double-blind Treatment|Participant withdrew consent|1|||
125387994|NCT02584504|451053977|FG000|Double-blind Treatment|Adverse Event|0|||
125387995|NCT02584504|451053978|FG001|Double-blind Treatment|Adverse Event|1|||
125387996|NCT02584504|451053979|FG002|Double-blind Treatment|Adverse Event|0|||
125387997|NCT02584504|451053977|FG000|Double-blind Treatment|Family Matter|0|||
125387998|NCT02584504|451053978|FG001|Double-blind Treatment|Family Matter|1|||
125387999|NCT02584504|451053979|FG002|Double-blind Treatment|Family Matter|0|||
125146949|NCT01098539|450159826|FG000|Overall Study|Withdrawal by Subject|12|||
125146950|NCT01098539|450159827|FG001|Overall Study|Withdrawal by Subject|26|||
125146951|NCT01098539|450159826|FG000|Overall Study|Physician Decision|5|||
125146952|NCT01098539|450159827|FG001|Overall Study|Physician Decision|3|||
125146953|NCT01849458|450159828|FG000|Overall Study|Lost to Follow-up|4|||
125146954|NCT01781234|450159829|FG000|Overall Study|Adverse Event|2|||
125146955|NCT01781234|450159830|FG001|Overall Study|Adverse Event|0|||
125146956|NCT01781234|450159829|FG000|Overall Study|Protocol Violation|3|||
125146957|NCT01781234|450159830|FG001|Overall Study|Protocol Violation|0|||
125146958|NCT01781234|450159829|FG000|Overall Study|Withdrawal by Subject|4|||
125146959|NCT01781234|450159830|FG001|Overall Study|Withdrawal by Subject|3|||
125146960|NCT03439085|450159831|FG000|Overall Study|Death|2|||
125146961|NCT03439085|450159831|FG000|Overall Study|Screen Failure|20|||
125146962|NCT01863433|450159832|FG000|Overall Study|Protocol Violation|1|||
125146963|NCT02174276|450159833|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
125146964|NCT02174276|450159834|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
125146965|NCT02174276|450159835|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
125146966|NCT02174276|450159836|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
125146967|NCT02174276|450159833|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
125146968|NCT02174276|450159834|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
125146969|NCT02174276|450159835|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
125146970|NCT02174276|450159836|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
125146971|NCT02174276|450159833|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
125146972|NCT02174276|450159834|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
125146973|NCT02174276|450159835|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
125146974|NCT02174276|450159836|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
125146975|NCT02174276|450159833|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
125146976|NCT02174276|450159834|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
125388000|NCT02584504|451053977|FG000|Open-label Treatment|Participant withdrew consent|0|||
125388001|NCT02584504|451053978|FG001|Open-label Treatment|Participant withdrew consent|0|||
125146977|NCT02174276|450159835|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
125146978|NCT02174276|450159836|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
125146979|NCT02174276|450159833|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
125146980|NCT02174276|450159834|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
125146981|NCT02174276|450159835|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
125146982|NCT02174276|450159836|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
125146983|NCT02174276|450159833|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
125146984|NCT02174276|450159834|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
125146985|NCT02174276|450159835|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
125146986|NCT02174276|450159836|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
125146987|NCT01206439|450159837|FG000|Overall Study|subject did not meet inclusion criteria|1|||
125146988|NCT00515216|450159840|FG000|Overall Study|Withdrawal by Subject|1|||
125146989|NCT02786927|450159841|FG000|Overall Study|Adverse Event|1|||
125146990|NCT02786927|450159841|FG000|Overall Study|Protocol Violation|4|||
125146991|NCT01801917|450159842|FG000|Period 1 - Randomized|Adverse Event|1|||
125146992|NCT01801917|450159843|FG001|Period 1 - Randomized|Adverse Event|0|||
125146993|NCT01801917|450159844|FG002|Period 1 - Randomized|Adverse Event|1|||
125146994|NCT01801917|450159845|FG003|Period 1 - Randomized|Adverse Event|0|||
125146995|NCT04307849|450159846|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
125146996|NCT04307849|450159847|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
125146997|NCT04307849|450159848|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
125146998|NCT04307849|450159849|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
125146999|NCT04307849|450159850|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
125147000|NCT04307849|450159851|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
125147001|NCT04307849|450159846|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
125147002|NCT04307849|450159847|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
125147003|NCT04307849|450159848|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
125147004|NCT04307849|450159849|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
125147005|NCT04307849|450159850|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
125147006|NCT04307849|450159851|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
125147007|NCT04307849|450159846|FG000|Overall Study|Family member did not want them to continue|0|||
125147008|NCT04307849|450159847|FG001|Overall Study|Family member did not want them to continue|0|||
125147009|NCT04307849|450159848|FG002|Overall Study|Family member did not want them to continue|1|||
125147010|NCT04307849|450159849|FG003|Overall Study|Family member did not want them to continue|0|||
125147011|NCT04307849|450159850|FG004|Overall Study|Family member did not want them to continue|0|||
125147012|NCT04307849|450159851|FG005|Overall Study|Family member did not want them to continue|0|||
125147013|NCT04307849|450159846|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
125147014|NCT04307849|450159847|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
125147015|NCT04307849|450159848|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
125147016|NCT04307849|450159849|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
125147017|NCT04307849|450159850|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
125147018|NCT04307849|450159851|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
125147019|NCT05467982|450159852|FG000|Overall Study|Death|0|||
125147020|NCT05467982|450159853|FG001|Overall Study|Death|1|||
125147021|NCT05467982|450159852|FG000|Overall Study|Lost to Follow-up|3|||
125147022|NCT05467982|450159853|FG001|Overall Study|Lost to Follow-up|1|||
125147023|NCT00708682|450159873|FG000|Infant Series|Adverse Event|1|||
125147024|NCT00708682|450159873|FG000|Infant Series|Lost to Follow-up|4|||
125147025|NCT00708682|450159873|FG000|Infant Series|Protocol Violation|1|||
125147026|NCT00708682|450159873|FG000|Infant Series|Parent/legal guardian request|6|||
125147027|NCT00708682|450159873|FG000|Infant Series|Failed to return|2|||
125147028|NCT00708682|450159873|FG000|Infant Series|Other|19|||
125147029|NCT00708682|450159873|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
125147030|NCT00708682|450159873|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
125147031|NCT00708682|450159873|FG000|Toddler Dose|Lost to Follow-up|3|||
125147032|NCT00708682|450159873|FG000|Toddler Dose|Failed to Return|4|||
125147033|NCT00420095|450159874|FG000|Overall Study|Adverse Event|1|||
125147034|NCT00420095|450159875|FG001|Overall Study|Adverse Event|0|||
125147035|NCT00420095|450159874|FG000|Overall Study|Protocol Violation|1|||
125147036|NCT00420095|450159875|FG001|Overall Study|Protocol Violation|1|||
125147037|NCT00420095|450159874|FG000|Overall Study|Lost to Follow-up|1|||
125147038|NCT00420095|450159875|FG001|Overall Study|Lost to Follow-up|0|||
125147039|NCT03185741|450159876|FG000|Baseline|Withdrawal by Subject|1|||
125147040|NCT03185741|450159877|FG001|Baseline|Withdrawal by Subject|3|||
125147041|NCT03185741|450159878|FG002|Baseline|Withdrawal by Subject|2|||
125147042|NCT03185741|450159876|FG000|Baseline|Lost to Follow-up|1|||
125147043|NCT03185741|450159877|FG001|Baseline|Lost to Follow-up|2|||
125147044|NCT03185741|450159878|FG002|Baseline|Lost to Follow-up|3|||
125147045|NCT03185741|450159876|FG000|3Month|Death|1|||
125147046|NCT03185741|450159877|FG001|3Month|Death|1|||
125147047|NCT03185741|450159878|FG002|3Month|Death|2|||
125147048|NCT03185741|450159876|FG000|3Month|Withdrawal by Subject|1|||
125147049|NCT03185741|450159877|FG001|3Month|Withdrawal by Subject|5|||
125147050|NCT03185741|450159878|FG002|3Month|Withdrawal by Subject|1|||
125147051|NCT03185741|450159876|FG000|3Month|Lost to Follow-up|7|||
125147052|NCT03185741|450159877|FG001|3Month|Lost to Follow-up|9|||
125147053|NCT03185741|450159878|FG002|3Month|Lost to Follow-up|8|||
125223601|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125147054|NCT03185741|450159876|FG000|3Month|Unavailable for 3Month|11|||
125147055|NCT03185741|450159877|FG001|3Month|Unavailable for 3Month|10|||
125147056|NCT03185741|450159878|FG002|3Month|Unavailable for 3Month|11|||
125147057|NCT03185741|450159876|FG000|3Month|Protocol Violation|0|||
125147058|NCT03185741|450159877|FG001|3Month|Protocol Violation|0|||
125147059|NCT03185741|450159878|FG002|3Month|Protocol Violation|3|||
125147060|NCT03185741|450159876|FG000|6Month|Death|1|||
125147061|NCT03185741|450159877|FG001|6Month|Death|1|||
125147062|NCT03185741|450159878|FG002|6Month|Death|2|||
125147063|NCT03185741|450159876|FG000|6Month|Withdrawal by Subject|2|||
125147064|NCT03185741|450159877|FG001|6Month|Withdrawal by Subject|3|||
125147065|NCT03185741|450159878|FG002|6Month|Withdrawal by Subject|1|||
125147066|NCT03185741|450159876|FG000|6Month|Lost to Follow-up|16|||
125147067|NCT03185741|450159877|FG001|6Month|Lost to Follow-up|15|||
125147068|NCT03185741|450159878|FG002|6Month|Lost to Follow-up|16|||
125147069|NCT01634854|450159879|FG000|Overall Study|Cesarean delivery|2|||
125388002|NCT02584504|451053979|FG002|Open-label Treatment|Participant withdrew consent|4|||
125388003|NCT02584504|451053977|FG000|Open-label Treatment|Adverse Event|2|||
125388004|NCT02584504|451053978|FG001|Open-label Treatment|Adverse Event|2|||
125388005|NCT02584504|451053979|FG002|Open-label Treatment|Adverse Event|3|||
125388006|NCT02584504|451053977|FG000|Open-label Treatment|Physician Decision|0|||
125388007|NCT02584504|451053978|FG001|Open-label Treatment|Physician Decision|1|||
125388008|NCT02584504|451053979|FG002|Open-label Treatment|Physician Decision|0|||
125388009|NCT02584504|451053977|FG000|Open-label Treatment|Entered but not treated|0|||
125388010|NCT02584504|451053978|FG001|Open-label Treatment|Entered but not treated|1|||
125147070|NCT01634854|450159880|FG001|Overall Study|Cesarean delivery|7|||
125147071|NCT00654641|450159881|FG000|Overall Study|Lost to Follow-up|2|||
125147072|NCT00654641|450159882|FG001|Overall Study|Lost to Follow-up|3|||
125147073|NCT01337596|450159883|FG000|Overall Study|Withdrawal by Subject|0|||
125147074|NCT01337596|450159884|FG001|Overall Study|Withdrawal by Subject|0|||
125147075|NCT01337596|450159885|FG002|Overall Study|Withdrawal by Subject|0|||
125147076|NCT01337596|450159886|FG003|Overall Study|Withdrawal by Subject|0|||
125147077|NCT01337596|450159887|FG004|Overall Study|Withdrawal by Subject|2|||
125147078|NCT01337596|450159888|FG005|Overall Study|Withdrawal by Subject|0|||
125147079|NCT01337596|450159889|FG006|Overall Study|Withdrawal by Subject|0|||
125147080|NCT01337596|450159890|FG007|Overall Study|Withdrawal by Subject|0|||
125147081|NCT01337596|450159891|FG008|Overall Study|Withdrawal by Subject|0|||
125147082|NCT00108628|450161255|FG000|Overall Study|Withdrawal by Subject|17|||
125147083|NCT00108628|450161256|FG001|Overall Study|Withdrawal by Subject|9|||
125147084|NCT00108628|450161255|FG000|Overall Study|Lack of Efficacy|2|||
125147085|NCT00108628|450161256|FG001|Overall Study|Lack of Efficacy|1|||
125147086|NCT00108628|450161255|FG000|Overall Study|Death|1|||
125147087|NCT00108628|450161256|FG001|Overall Study|Death|0|||
125147088|NCT01636934|450161257|FG000|Overall Study|Withdrawal by Subject|3|||
125147089|NCT01636934|450161258|FG001|Overall Study|Withdrawal by Subject|2|||
125147090|NCT01636934|450161257|FG000|Overall Study|Chemo cancel|1|||
125147091|NCT01636934|450161258|FG001|Overall Study|Chemo cancel|0|||
125388011|NCT02584504|451053979|FG002|Open-label Treatment|Entered but not treated|1|||
125388012|NCT01652664|451053982|FG000|Overall Study|Treatment Failure|5|||
125147092|NCT01636934|450161257|FG000|Overall Study|Too ill to continue|1|||
125147093|NCT01636934|450161258|FG001|Overall Study|Too ill to continue|0|||
125147094|NCT01636934|450161257|FG000|Overall Study|Never started study medication|1|||
125147095|NCT01636934|450161258|FG001|Overall Study|Never started study medication|1|||
125147096|NCT02297841|450161262|FG000|Overall Study|Withdrawal by Subject|1|||
125147097|NCT02297841|450161262|FG000|Overall Study|Protocol Violation|7|||
125147098|NCT03429049|450161263|FG000|Overall Study|Adverse Event|2|||
125147099|NCT03429049|450161264|FG001|Overall Study|Adverse Event|3|||
125147100|NCT03429049|450161263|FG000|Overall Study|Death|0|||
125147101|NCT03429049|450161264|FG001|Overall Study|Death|1|||
125147102|NCT03429049|450161263|FG000|Overall Study|Lack of Efficacy|4|||
125147103|NCT03429049|450161264|FG001|Overall Study|Lack of Efficacy|2|||
125147104|NCT03429049|450161263|FG000|Overall Study|Lost to Follow-up|9|||
125147105|NCT03429049|450161264|FG001|Overall Study|Lost to Follow-up|8|||
125147106|NCT03429049|450161263|FG000|Overall Study|Physician Decision|1|||
125147107|NCT03429049|450161264|FG001|Overall Study|Physician Decision|0|||
125147108|NCT03429049|450161263|FG000|Overall Study|Protocol Violation|3|||
125147109|NCT03429049|450161264|FG001|Overall Study|Protocol Violation|0|||
125147110|NCT03429049|450161263|FG000|Overall Study|Sponsor Decision|2|||
125147111|NCT03429049|450161264|FG001|Overall Study|Sponsor Decision|0|||
125147112|NCT03429049|450161263|FG000|Overall Study|Withdrawal by Subject|4|||
125147113|NCT03429049|450161264|FG001|Overall Study|Withdrawal by Subject|20|||
125147114|NCT03429049|450161263|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
125388013|NCT01652664|451053983|FG001|Overall Study|Treatment Failure|1|||
125147115|NCT03429049|450161264|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
125223602|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125388014|NCT01652664|451053982|FG000|Overall Study|Inadequate IOP control|1|||
125147116|NCT01841060|450161268|FG000|Overall Study|Protocol Violation|10|||
125147117|NCT01872715|450161272|FG000|Overall Study|Adverse Event|1|||
125147118|NCT01872715|450161272|FG000|Overall Study|Protocol Violation|1|||
125147119|NCT01872715|450161272|FG000|Overall Study|Withdrawal by Subject|2|||
125147120|NCT01765270|450161282|FG000|Overall Study|Physician Decision|1|||
125147121|NCT01765270|450161283|FG001|Overall Study|Physician Decision|0|||
125147122|NCT01765270|450161282|FG000|Overall Study|Withdrawal by Subject|0|||
125147123|NCT01765270|450161283|FG001|Overall Study|Withdrawal by Subject|1|||
125147124|NCT03431337|450161286|FG000|Overall Study|Lost to Follow-up|21|||
125147125|NCT03431337|450161287|FG001|Overall Study|Lost to Follow-up|19|||
125147126|NCT03431337|450161286|FG000|Overall Study|Withdrawal by Subject|8|||
125147127|NCT03431337|450161287|FG001|Overall Study|Withdrawal by Subject|3|||
125147128|NCT00329160|450161288|FG000|Overall Study|Adverse Event|27|||
125147129|NCT00329160|450161288|FG000|Overall Study|Withdrawal by Subject|13|||
125147130|NCT00329160|450161288|FG000|Overall Study|Protocol Violation|2|||
125147131|NCT00329160|450161288|FG000|Overall Study|Did not Receive Study Drug|1|||
125147132|NCT00329160|450161288|FG000|Overall Study|Incomplete IVUS|45|||
125147133|NCT04501094|450161289|FG000|Overall Study|Death (unrelated to research)|1|||
125147134|NCT04501094|450161290|FG001|Overall Study|Death (unrelated to research)|0|||
125147135|NCT00063258|450161294|FG000|Overall Study|Physician Decision|2|||
125147136|NCT00063258|450161295|FG001|Overall Study|Physician Decision|0|||
125147137|NCT00063258|450161294|FG000|Overall Study|Lack of Efficacy|2|||
125147138|NCT00063258|450161295|FG001|Overall Study|Lack of Efficacy|0|||
125147139|NCT00784979|450161298|FG000|Overall Study|incomplete data|6|||
125147140|NCT00894933|450161299|FG000|Overall Study|Lost to Follow-up|2|||
125147141|NCT00894933|450161299|FG000|Overall Study|Cancelled Procedure|1|||
125147142|NCT00894933|450161299|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
125147143|NCT01235715|450161304|FG000|Overall Study|Physician Decision|0|||
125147144|NCT01235715|450161305|FG001|Overall Study|Physician Decision|2|||
125147145|NCT03619876|450161306|FG000|Overall Study|Withdrawal by Subject|1|||
125147146|NCT03619876|450161307|FG001|Overall Study|Withdrawal by Subject|2|||
125147147|NCT03619876|450161306|FG000|Overall Study|Withdrawal due to incidental finding|0|||
125147148|NCT03619876|450161307|FG001|Overall Study|Withdrawal due to incidental finding|2|||
125147149|NCT00396630|450161310|FG000|Overall Study|Lost to Follow-up|1|||
125147150|NCT00396630|450161311|FG001|Overall Study|Lost to Follow-up|1|||
125147151|NCT00396630|450161310|FG000|Overall Study|Withdrawal by Subject|1|||
125147152|NCT00396630|450161311|FG001|Overall Study|Withdrawal by Subject|1|||
125147153|NCT00396630|450161310|FG000|Overall Study|Not vaccinated at Visit 3|3|||
125147154|NCT00396630|450161311|FG001|Overall Study|Not vaccinated at Visit 3|3|||
125147155|NCT00996437|450161314|FG000|Overall Study|Death|1|||
125147156|NCT00996437|450161315|FG001|Overall Study|Death|0|||
125147157|NCT00996437|450161314|FG000|Overall Study|Dropped|2|||
125147158|NCT00996437|450161315|FG001|Overall Study|Dropped|2|||
125147159|NCT00996437|450161314|FG000|Overall Study|Missed|2|||
125147160|NCT00996437|450161315|FG001|Overall Study|Missed|5|||
125147161|NCT02576717|450161318|FG000|Overall Study|Other Reasons|16|||
125147162|NCT02576717|450161319|FG001|Overall Study|Other Reasons|18|||
125147163|NCT02576717|450161320|FG002|Overall Study|Other Reasons|15|||
125147164|NCT02576717|450161318|FG000|Overall Study|Covid-19 Pandemic|0|||
125147165|NCT02576717|450161319|FG001|Overall Study|Covid-19 Pandemic|1|||
125147166|NCT02576717|450161320|FG002|Overall Study|Covid-19 Pandemic|1|||
125147167|NCT02576717|450161318|FG000|Overall Study|Sponsor Decision|0|||
125147168|NCT02576717|450161319|FG001|Overall Study|Sponsor Decision|0|||
125147169|NCT02576717|450161320|FG002|Overall Study|Sponsor Decision|1|||
125147170|NCT02576717|450161318|FG000|Overall Study|Physician Decision|3|||
125147171|NCT02576717|450161319|FG001|Overall Study|Physician Decision|8|||
125147172|NCT02576717|450161320|FG002|Overall Study|Physician Decision|9|||
125388015|NCT01652664|451053983|FG001|Overall Study|Inadequate IOP control|0|||
125147173|NCT02576717|450161318|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
125147174|NCT02576717|450161319|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
125147175|NCT02576717|450161320|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
125147176|NCT02576717|450161318|FG000|Overall Study|Death|3|||
125147177|NCT02576717|450161319|FG001|Overall Study|Death|5|||
125147178|NCT02576717|450161320|FG002|Overall Study|Death|3|||
125147179|NCT02576717|450161318|FG000|Overall Study|Lost to Follow-up|9|||
125147180|NCT02576717|450161319|FG001|Overall Study|Lost to Follow-up|10|||
125147181|NCT02576717|450161320|FG002|Overall Study|Lost to Follow-up|19|||
125147182|NCT02576717|450161318|FG000|Overall Study|Protocol Violation|4|||
125147183|NCT02576717|450161319|FG001|Overall Study|Protocol Violation|0|||
125147184|NCT02576717|450161320|FG002|Overall Study|Protocol Violation|5|||
125147185|NCT02576717|450161318|FG000|Overall Study|Lack of Efficacy|24|||
125147186|NCT02576717|450161319|FG001|Overall Study|Lack of Efficacy|28|||
125147187|NCT02576717|450161320|FG002|Overall Study|Lack of Efficacy|20|||
125147188|NCT02576717|450161318|FG000|Overall Study|Adverse Event|26|||
125147189|NCT02576717|450161319|FG001|Overall Study|Adverse Event|32|||
125147190|NCT02576717|450161320|FG002|Overall Study|Adverse Event|26|||
125147191|NCT01755975|450161321|FG000|Overall Study|Adverse Event|0|||
125147192|NCT01755975|450161322|FG001|Overall Study|Adverse Event|0|||
125147193|NCT01755975|450161323|FG002|Overall Study|Adverse Event|1|||
125388016|NCT00464568|451053989|FG000|Overall Study|Adverse Event|2|||
125147194|NCT01755975|450161324|FG003|Overall Study|Adverse Event|0|||
125147195|NCT01755975|450161325|FG004|Overall Study|Adverse Event|2|||
125147196|NCT00399893|450161326|FG000|Overall Study|Withdrawal by Subject|1|||
125147197|NCT00399893|450161327|FG001|Overall Study|Withdrawal by Subject|0|||
125147198|NCT01729026|450161329|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
125147199|NCT01729026|450161330|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
125147200|NCT01729026|450161329|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
125147201|NCT01729026|450161330|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
125147202|NCT00906373|450161331|FG000|Overall Study|Withdrawal by Subject|0|||
125147203|NCT00906373|450161332|FG001|Overall Study|Withdrawal by Subject|5|||
125147204|NCT00906373|450161331|FG000|Overall Study|Other|0|||
125147205|NCT00906373|450161332|FG001|Overall Study|Other|1|||
125147206|NCT00906373|450161331|FG000|Overall Study|Still on treatment at cutoff date|0|||
125147207|NCT00906373|450161332|FG001|Overall Study|Still on treatment at cutoff date|2|||
125147208|NCT01597479|450161333|FG000|Overall Study|Protocol Violation|1|||
125147209|NCT01597479|450161334|FG001|Overall Study|Protocol Violation|0|||
125147210|NCT01597479|450161333|FG000|Overall Study|Lost to Follow-up|1|||
125147211|NCT01597479|450161334|FG001|Overall Study|Lost to Follow-up|0|||
125147212|NCT00848042|450161335|FG000|Overall Study|Death|1|||
125147213|NCT00848042|450161336|FG001|Overall Study|Death|2|||
125147214|NCT00848042|450161337|FG002|Overall Study|Death|0|||
125147215|NCT00848042|450161335|FG000|Overall Study|Other Therapy|3|||
125147216|NCT00848042|450161336|FG001|Overall Study|Other Therapy|0|||
125147217|NCT00848042|450161337|FG002|Overall Study|Other Therapy|0|||
125147218|NCT00979212|450161340|FG000|Overall Study|Protocol Violation|1|||
125147219|NCT00979212|450161341|FG001|Overall Study|Protocol Violation|8|||
125147220|NCT00979212|450161340|FG000|Overall Study|No protocol therapy received|1|||
125147221|NCT00979212|450161341|FG001|Overall Study|No protocol therapy received|0|||
125147222|NCT04886063|450161344|FG000|Overall Study|Adverse Event|50|||
125147223|NCT04886063|450161344|FG000|Overall Study|Lack of Efficacy|31|||
125147224|NCT04886063|450161344|FG000|Overall Study|Withdrawal by Subject|45|||
125147225|NCT04886063|450161344|FG000|Overall Study|Physician Decision|3|||
125147226|NCT04886063|450161344|FG000|Overall Study|Protocol Violation|3|||
125147227|NCT04886063|450161344|FG000|Overall Study|Site closure|4|||
125147228|NCT04886063|450161344|FG000|Overall Study|Nursing home replacement|3|||
125147229|NCT04886063|450161344|FG000|Overall Study|Lost to Follow-up|5|||
125147230|NCT04886063|450161344|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
125147231|NCT04886063|450161344|FG000|Overall Study|>1 reason|20|||
125147232|NCT00309985|450161345|FG000|Overall Study|Disease progression|12|||
125147233|NCT00309985|450161346|FG001|Overall Study|Disease progression|0|||
125147234|NCT00309985|450161345|FG000|Overall Study|Adverse Event|30|||
125147235|NCT00309985|450161346|FG001|Overall Study|Adverse Event|0|||
125147236|NCT00309985|450161345|FG000|Overall Study|Death|2|||
125147237|NCT00309985|450161346|FG001|Overall Study|Death|0|||
125147238|NCT00309985|450161345|FG000|Overall Study|Withdrawal by Subject|5|||
125147239|NCT00309985|450161346|FG001|Overall Study|Withdrawal by Subject|1|||
125147240|NCT00309985|450161345|FG000|Overall Study|Physician Decision|3|||
125147241|NCT00309985|450161346|FG001|Overall Study|Physician Decision|0|||
125147242|NCT00309985|450161345|FG000|Overall Study|Never started treatment|7|||
125147243|NCT00309985|450161346|FG001|Overall Study|Never started treatment|0|||
125147244|NCT00309985|450161345|FG000|Overall Study|Complicating disease|1|||
125147245|NCT00309985|450161346|FG001|Overall Study|Complicating disease|0|||
125147246|NCT00309985|450161345|FG000|Overall Study|Non-compliance|1|||
125147247|NCT00309985|450161346|FG001|Overall Study|Non-compliance|0|||
125147248|NCT00309985|450161345|FG000|Overall Study|Chemotherapy discontinued only|1|||
125147249|NCT00309985|450161346|FG001|Overall Study|Chemotherapy discontinued only|0|||
125147250|NCT02448563|450161347|FG000|Overall Study|Lost to Follow-up|16|||
125147251|NCT02448563|450161348|FG001|Overall Study|Lost to Follow-up|10|||
125147252|NCT02448563|450161347|FG000|Overall Study|Withdrawal by Subject|0|||
125147253|NCT02448563|450161348|FG001|Overall Study|Withdrawal by Subject|1|||
125147254|NCT02340962|450161350|FG000|Overall Study|Lost to Follow-up|1|||
125147255|NCT02340962|450161351|FG001|Overall Study|Lost to Follow-up|0|||
125147256|NCT01450800|450161352|FG000|Overall Study|Protocol Violation|1|||
125147257|NCT01450800|450161353|FG001|Overall Study|Protocol Violation|3|||
125147258|NCT00265785|450161354|FG000|Overall Study|Adverse Event|4|||
125147259|NCT00265785|450161354|FG000|Overall Study|Withdrawal by Subject|3|||
125147260|NCT00265785|450161354|FG000|Overall Study|Progression/Relapse|15|||
125147261|NCT00265785|450161354|FG000|Overall Study|Not protocol specified|2|||
125223603|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125147262|NCT00265785|450161354|FG000|Overall Study|Ineligible|1|||
125147263|NCT00265785|450161354|FG000|Overall Study|Did not receive protocol treatment|2|||
125147264|NCT01294449|450161357|FG000|Overall Study|Death|11|||
125438671|NCT00885352|451233920|FG001|Overall Study|Physician Decision|3|||
125147265|NCT01294449|450161358|FG001|Overall Study|Death|12|||
125147266|NCT01294449|450161357|FG000|Overall Study|Withdrawal by Subject|1|||
125147267|NCT01294449|450161358|FG001|Overall Study|Withdrawal by Subject|3|||
125147268|NCT04291508|450161365|FG000|Overall Study|Withdrawal by Subject|1|||
125147269|NCT04291508|450161366|FG001|Overall Study|Withdrawal by Subject|0|||
125147270|NCT04291508|450161367|FG002|Overall Study|Withdrawal by Subject|1|||
125147271|NCT04291508|450161368|FG003|Overall Study|Withdrawal by Subject|0|||
125147272|NCT04291508|450161365|FG000|Overall Study|lost to follow up|4|||
125147273|NCT04291508|450161366|FG001|Overall Study|lost to follow up|0|||
125147274|NCT04291508|450161367|FG002|Overall Study|lost to follow up|1|||
125147275|NCT04291508|450161368|FG003|Overall Study|lost to follow up|0|||
125147276|NCT02329431|450161369|FG000|Overall Study|Lost to Follow-up|20|||
125147277|NCT02329431|450161370|FG001|Overall Study|Lost to Follow-up|13|||
125147278|NCT02625974|450161371|FG000|Part 1|Lost to Follow-up|9|||
125147279|NCT02625974|450161372|FG001|Part 1|Lost to Follow-up|3|||
125147280|NCT02625974|450161371|FG000|Part 2|Lost to Follow-up|4|||
125147281|NCT02625974|450161372|FG001|Part 2|Lost to Follow-up|6|||
125147282|NCT02625974|450161371|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
125147283|NCT02625974|450161372|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
125147284|NCT01977456|450161373|FG000|Overall Study|Death|5|||
125147285|NCT01142661|450161374|FG000|Overall Study|Adverse Event|2|||
125147286|NCT01142661|450161374|FG000|Overall Study|Withdrawal by Subject|1|||
125147287|NCT01142661|450161374|FG000|Overall Study|Physician Decision|1|||
125147288|NCT00434590|450161375|FG000|Overall Study|Administrative problems|5|||
125147289|NCT00434590|450161376|FG001|Overall Study|Administrative problems|5|||
125147290|NCT02129062|450162870|FG000|Overall Study|Death|1|||
125147291|NCT02129062|450162870|FG000|Overall Study|Disease Progression|2|||
125147292|NCT02722616|450162871|FG000|Overall Study|Sponsor closed study after one month|2|||
125147293|NCT02722616|450162872|FG001|Overall Study|Sponsor closed study after one month|0|||
125147294|NCT02722616|450162873|FG002|Overall Study|Sponsor closed study after one month|0|||
125147295|NCT01923311|450162876|FG000|Overall Study|Pregnancy|1|||
125147296|NCT01923311|450162877|FG001|Overall Study|Pregnancy|0|||
125147297|NCT01923311|450162876|FG000|Overall Study|Investigator's Discretion|1|||
125147298|NCT01923311|450162877|FG001|Overall Study|Investigator's Discretion|0|||
125147299|NCT01923311|450162876|FG000|Overall Study|Non-Compliance with Study Drug|2|||
125147300|NCT01923311|450162877|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125147301|NCT01923311|450162876|FG000|Overall Study|Withdrew Consent|1|||
125147302|NCT01923311|450162877|FG001|Overall Study|Withdrew Consent|0|||
125388017|NCT03425331|451053992|FG000|Overall Study|Withdrawal by Subject|1|||
125388018|NCT03425331|451053992|FG000|Overall Study|Death|1|||
125388019|NCT03425331|451053992|FG000|Overall Study|Adverse Event|1|||
125388020|NCT03425331|451053992|FG000|Overall Study|Disease Progression|2|||
125388021|NCT02864251|451053994|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
125388022|NCT02864251|451053995|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
125388023|NCT02864251|451053996|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
125388024|NCT02864251|451053994|FG000|Pre-Treatment|Withdrawal by Participant|0|||
125388025|NCT02864251|451053995|FG001|Pre-Treatment|Withdrawal by Participant|0|||
125388026|NCT02864251|451053996|FG002|Pre-Treatment|Withdrawal by Participant|4|||
125388027|NCT02864251|451053994|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
125388028|NCT02864251|451053995|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
125388029|NCT02864251|451053996|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
125388030|NCT02864251|451053994|FG000|Pre-Treatment|Other Reasons|0|||
125388031|NCT02864251|451053995|FG001|Pre-Treatment|Other Reasons|1|||
125388032|NCT02864251|451053996|FG002|Pre-Treatment|Other Reasons|1|||
125388033|NCT02864251|451053994|FG000|Treatment|Disease Progression|109|||
125388034|NCT02864251|451053995|FG001|Treatment|Disease Progression|52|||
125388035|NCT02864251|451053996|FG002|Treatment|Disease Progression|101|||
125388036|NCT02864251|451053994|FG000|Treatment|Study Drug Toxicity|9|||
125388037|NCT02864251|451053995|FG001|Treatment|Study Drug Toxicity|4|||
125388038|NCT02864251|451053996|FG002|Treatment|Study Drug Toxicity|10|||
125388039|NCT02864251|451053994|FG000|Treatment|Death|0|||
125388040|NCT02864251|451053995|FG001|Treatment|Death|2|||
125388041|NCT02864251|451053996|FG002|Treatment|Death|3|||
125388042|NCT02864251|451053994|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
125388043|NCT02864251|451053995|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
125388044|NCT02864251|451053996|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
125147303|NCT01923311|450162876|FG000|Overall Study|Study Terminated by Sponsor|12|||
125147304|NCT01923311|450162877|FG001|Overall Study|Study Terminated by Sponsor|0|||
125147305|NCT02031237|450162878|FG000|Overall Study|Death|1|||
125147306|NCT02031237|450162879|FG001|Overall Study|Death|5|||
125147307|NCT02031237|450162880|FG002|Overall Study|Death|0|||
125147308|NCT02031237|450162878|FG000|Overall Study|Physician Decision|0|||
125147309|NCT02031237|450162879|FG001|Overall Study|Physician Decision|1|||
125147310|NCT02031237|450162880|FG002|Overall Study|Physician Decision|0|||
125147311|NCT02031237|450162878|FG000|Overall Study|Withdrawal by Subject|2|||
125147312|NCT02031237|450162879|FG001|Overall Study|Withdrawal by Subject|2|||
125147313|NCT02031237|450162880|FG002|Overall Study|Withdrawal by Subject|0|||
125147314|NCT02031237|450162878|FG000|Overall Study|Protocol Violation|2|||
125147315|NCT02031237|450162879|FG001|Overall Study|Protocol Violation|6|||
125147316|NCT02031237|450162880|FG002|Overall Study|Protocol Violation|0|||
125147317|NCT02031237|450162878|FG000|Overall Study|Alternate Treatment Given|0|||
125147318|NCT02031237|450162879|FG001|Overall Study|Alternate Treatment Given|0|||
125223604|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125147319|NCT02031237|450162880|FG002|Overall Study|Alternate Treatment Given|3|||
125147320|NCT01011335|450162883|FG000|Overall Study|Lost to Follow-up|0|||
125147321|NCT01011335|450162884|FG001|Overall Study|Lost to Follow-up|0|||
125147322|NCT01011335|450162885|FG002|Overall Study|Lost to Follow-up|1|||
125147323|NCT01011335|450162886|FG003|Overall Study|Lost to Follow-up|1|||
125147324|NCT01011335|450162887|FG004|Overall Study|Lost to Follow-up|1|||
125147325|NCT01011335|450162888|FG005|Overall Study|Lost to Follow-up|1|||
125147326|NCT01011335|450162889|FG006|Overall Study|Lost to Follow-up|2|||
125147327|NCT01011335|450162890|FG007|Overall Study|Lost to Follow-up|2|||
125147328|NCT01011335|450162891|FG008|Overall Study|Lost to Follow-up|1|||
125147329|NCT01011335|450162892|FG009|Overall Study|Lost to Follow-up|0|||
125147330|NCT01011335|450162893|FG010|Overall Study|Lost to Follow-up|0|||
125147331|NCT01011335|450162894|FG011|Overall Study|Lost to Follow-up|1|||
125147332|NCT01011335|450162895|FG012|Overall Study|Lost to Follow-up|2|||
125147333|NCT01011335|450162883|FG000|Overall Study|Protocol Violation|0|||
125147334|NCT01011335|450162884|FG001|Overall Study|Protocol Violation|1|||
125147335|NCT01011335|450162885|FG002|Overall Study|Protocol Violation|0|||
125147336|NCT01011335|450162886|FG003|Overall Study|Protocol Violation|0|||
125147337|NCT01011335|450162887|FG004|Overall Study|Protocol Violation|0|||
125147338|NCT01011335|450162888|FG005|Overall Study|Protocol Violation|0|||
125147339|NCT01011335|450162889|FG006|Overall Study|Protocol Violation|0|||
125147340|NCT01011335|450162890|FG007|Overall Study|Protocol Violation|0|||
125147341|NCT01011335|450162891|FG008|Overall Study|Protocol Violation|0|||
125147342|NCT01011335|450162892|FG009|Overall Study|Protocol Violation|0|||
125147343|NCT01011335|450162893|FG010|Overall Study|Protocol Violation|0|||
125147344|NCT01011335|450162894|FG011|Overall Study|Protocol Violation|0|||
125147345|NCT01011335|450162895|FG012|Overall Study|Protocol Violation|0|||
125147346|NCT01011335|450162883|FG000|Overall Study|Moved/deployed or no booster|1|||
125147347|NCT01011335|450162884|FG001|Overall Study|Moved/deployed or no booster|0|||
125147348|NCT01011335|450162885|FG002|Overall Study|Moved/deployed or no booster|0|||
125147349|NCT01011335|450162886|FG003|Overall Study|Moved/deployed or no booster|1|||
125147350|NCT01011335|450162887|FG004|Overall Study|Moved/deployed or no booster|0|||
125147351|NCT01011335|450162888|FG005|Overall Study|Moved/deployed or no booster|0|||
125147352|NCT01011335|450162889|FG006|Overall Study|Moved/deployed or no booster|1|||
125147353|NCT01011335|450162890|FG007|Overall Study|Moved/deployed or no booster|0|||
125147354|NCT01011335|450162891|FG008|Overall Study|Moved/deployed or no booster|1|||
125147355|NCT01011335|450162892|FG009|Overall Study|Moved/deployed or no booster|0|||
125147356|NCT01011335|450162893|FG010|Overall Study|Moved/deployed or no booster|2|||
125147357|NCT01011335|450162894|FG011|Overall Study|Moved/deployed or no booster|0|||
125147358|NCT01011335|450162895|FG012|Overall Study|Moved/deployed or no booster|0|||
125147359|NCT01011335|450162883|FG000|Overall Study|Adverse Event|0|||
125147360|NCT01011335|450162884|FG001|Overall Study|Adverse Event|0|||
125147361|NCT01011335|450162885|FG002|Overall Study|Adverse Event|0|||
125147362|NCT01011335|450162886|FG003|Overall Study|Adverse Event|0|||
125147363|NCT01011335|450162887|FG004|Overall Study|Adverse Event|0|||
125147364|NCT01011335|450162888|FG005|Overall Study|Adverse Event|0|||
125147365|NCT01011335|450162889|FG006|Overall Study|Adverse Event|0|||
125147366|NCT01011335|450162890|FG007|Overall Study|Adverse Event|0|||
125147367|NCT01011335|450162891|FG008|Overall Study|Adverse Event|0|||
125147368|NCT01011335|450162892|FG009|Overall Study|Adverse Event|0|||
125147369|NCT01011335|450162893|FG010|Overall Study|Adverse Event|4|||
125147370|NCT01011335|450162894|FG011|Overall Study|Adverse Event|0|||
125147371|NCT01011335|450162895|FG012|Overall Study|Adverse Event|1|||
125147372|NCT01765751|450162902|FG000|Overall Study|Lost to Follow-up|0|||
125147373|NCT01765751|450162903|FG001|Overall Study|Lost to Follow-up|2|||
125147374|NCT01765751|450162904|FG002|Overall Study|Lost to Follow-up|1|||
125147375|NCT02459418|450162905|FG000|Overall Study|Exclusion Criteria|4|||
125147376|NCT02459418|450162906|FG001|Overall Study|Exclusion Criteria|0|||
125147377|NCT02459418|450162905|FG000|Overall Study|Protocol Violation|0|||
125147378|NCT02459418|450162906|FG001|Overall Study|Protocol Violation|2|||
125147379|NCT02459418|450162905|FG000|Overall Study|Physician Decision|0|||
125147380|NCT02459418|450162906|FG001|Overall Study|Physician Decision|2|||
125147381|NCT02459418|450162905|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
125147382|NCT02459418|450162906|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
125147383|NCT02459418|450162905|FG000|Overall Study|Adverse Event|0|||
125147384|NCT02459418|450162906|FG001|Overall Study|Adverse Event|1|||
125147385|NCT02459418|450162905|FG000|Overall Study|Withdrawal by Subject|1|||
125147386|NCT02459418|450162906|FG001|Overall Study|Withdrawal by Subject|1|||
125147387|NCT02459418|450162905|FG000|Overall Study|Elevated Creatine Kinase|1|||
125147388|NCT02459418|450162906|FG001|Overall Study|Elevated Creatine Kinase|0|||
125147389|NCT02459418|450162905|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
125147390|NCT02459418|450162906|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
125147391|NCT05258630|450162907|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
125147392|NCT05258630|450162908|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
125147393|NCT05258630|450162907|FG000|Overall Study|Lost to Follow-up|0|||
125147394|NCT05258630|450162908|FG001|Overall Study|Lost to Follow-up|2|||
125147395|NCT03303417|450162909|FG000|Overall Study|Withdrawal by Subject|1|||
125147396|NCT03303417|450162910|FG001|Overall Study|Withdrawal by Subject|1|||
125147397|NCT01848210|450162911|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
125147398|NCT01848210|450162912|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
125147399|NCT01848210|450162911|FG000|Overall Study|Lost to Follow-up|24|||
125147400|NCT01848210|450162912|FG001|Overall Study|Lost to Follow-up|12|||
125147401|NCT01848210|450162911|FG000|Overall Study|Protocol Violation|3|||
125147402|NCT01848210|450162912|FG001|Overall Study|Protocol Violation|5|||
125147403|NCT01848210|450162911|FG000|Overall Study|Use of Forbidden Drugs|9|||
125147404|NCT01848210|450162912|FG001|Overall Study|Use of Forbidden Drugs|10|||
125147405|NCT01848210|450162911|FG000|Overall Study|Impedition Condition|5|||
125147406|NCT01848210|450162912|FG001|Overall Study|Impedition Condition|9|||
125147407|NCT01848210|450162911|FG000|Overall Study|Adverse Event|7|||
125147408|NCT01848210|450162912|FG001|Overall Study|Adverse Event|9|||
125147409|NCT01848210|450162911|FG000|Overall Study|Discontinuation Criterion|5|||
125147410|NCT01848210|450162912|FG001|Overall Study|Discontinuation Criterion|7|||
125147411|NCT01848210|450162911|FG000|Overall Study|Hypesensitivity|1|||
125147412|NCT01848210|450162912|FG001|Overall Study|Hypesensitivity|0|||
125147413|NCT01848210|450162911|FG000|Overall Study|Hepatic Function Alteration|4|||
125147414|NCT01848210|450162912|FG001|Overall Study|Hepatic Function Alteration|0|||
125147415|NCT01848210|450162911|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
125147416|NCT01848210|450162912|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
125147417|NCT01848210|450162911|FG000|Overall Study|Administrative|1|||
125147418|NCT01848210|450162912|FG001|Overall Study|Administrative|0|||
125147419|NCT02426541|450162916|FG000|Overall Study|Protocol Violation|1|||
125147420|NCT02426541|450162917|FG001|Overall Study|Protocol Violation|0|||
125147421|NCT00631007|450162920|FG000|Overall Study|Adverse Event|0|||
125147422|NCT00631007|450162921|FG001|Overall Study|Adverse Event|2|||
125147423|NCT00631007|450162922|FG002|Overall Study|Adverse Event|0|||
125147424|NCT00631007|450162923|FG003|Overall Study|Adverse Event|2|||
125147425|NCT00631007|450162924|FG004|Overall Study|Adverse Event|3|||
125147426|NCT00631007|450162925|FG005|Overall Study|Adverse Event|2|||
125147427|NCT00631007|450162920|FG000|Overall Study|Lost to Follow-up|2|||
125147428|NCT00631007|450162921|FG001|Overall Study|Lost to Follow-up|1|||
125147429|NCT00631007|450162922|FG002|Overall Study|Lost to Follow-up|2|||
125147430|NCT00631007|450162923|FG003|Overall Study|Lost to Follow-up|4|||
125147431|NCT00631007|450162924|FG004|Overall Study|Lost to Follow-up|5|||
125147432|NCT00631007|450162925|FG005|Overall Study|Lost to Follow-up|3|||
125147433|NCT00631007|450162920|FG000|Overall Study|Physician Decision|1|||
125147434|NCT00631007|450162921|FG001|Overall Study|Physician Decision|0|||
125147435|NCT00631007|450162922|FG002|Overall Study|Physician Decision|1|||
125147436|NCT00631007|450162923|FG003|Overall Study|Physician Decision|0|||
125147437|NCT00631007|450162924|FG004|Overall Study|Physician Decision|0|||
125147438|NCT00631007|450162925|FG005|Overall Study|Physician Decision|2|||
125147439|NCT00631007|450162920|FG000|Overall Study|Persistent Hyperglycemia|2|||
125147440|NCT00631007|450162921|FG001|Overall Study|Persistent Hyperglycemia|2|||
125147441|NCT00631007|450162922|FG002|Overall Study|Persistent Hyperglycemia|5|||
125147442|NCT00631007|450162923|FG003|Overall Study|Persistent Hyperglycemia|1|||
125147443|NCT00631007|450162924|FG004|Overall Study|Persistent Hyperglycemia|2|||
125147444|NCT00631007|450162925|FG005|Overall Study|Persistent Hyperglycemia|5|||
125147445|NCT00631007|450162920|FG000|Overall Study|Withdrawal by Subject|4|||
125147446|NCT00631007|450162921|FG001|Overall Study|Withdrawal by Subject|5|||
125147447|NCT00631007|450162922|FG002|Overall Study|Withdrawal by Subject|2|||
125147448|NCT00631007|450162923|FG003|Overall Study|Withdrawal by Subject|2|||
125147449|NCT00631007|450162924|FG004|Overall Study|Withdrawal by Subject|1|||
125147450|NCT00631007|450162925|FG005|Overall Study|Withdrawal by Subject|3|||
125147451|NCT00631007|450162920|FG000|Overall Study|Other|2|||
125147452|NCT00631007|450162921|FG001|Overall Study|Other|1|||
125147453|NCT00631007|450162922|FG002|Overall Study|Other|0|||
125147454|NCT00631007|450162923|FG003|Overall Study|Other|0|||
125147455|NCT00631007|450162924|FG004|Overall Study|Other|1|||
125147456|NCT00631007|450162925|FG005|Overall Study|Other|0|||
125147457|NCT00683787|450162926|FG000|Overall Study|Progression|3|||
125147458|NCT00683787|450162927|FG001|Overall Study|Progression|3|||
125147459|NCT00683787|450162928|FG002|Overall Study|Progression|0|||
125147460|NCT00683787|450162926|FG000|Overall Study|Adverse Event|0|||
125147461|NCT00683787|450162927|FG001|Overall Study|Adverse Event|0|||
125147462|NCT00683787|450162928|FG002|Overall Study|Adverse Event|2|||
125147463|NCT02674633|450162929|FG000|Overall Study|Lost to Follow-up|3|||
125147464|NCT02674633|450162930|FG001|Overall Study|Lost to Follow-up|2|||
125147465|NCT02674633|450162929|FG000|Overall Study|Physician Decision|1|||
125147466|NCT02674633|450162930|FG001|Overall Study|Physician Decision|0|||
125147467|NCT02674633|450162929|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125147468|NCT02674633|450162930|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
125223605|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
125147469|NCT00460109|450162931|FG000|Overall Study|Death|1|||
125147470|NCT02994394|450162932|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
125147471|NCT02994394|450162933|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
125147472|NCT02994394|450162934|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
125147473|NCT02994394|450162935|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
125147474|NCT02994394|450162936|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
125147475|NCT02994394|450162937|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
125147476|NCT02994394|450162932|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
125147477|NCT02994394|450162933|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
125223606|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125147478|NCT02994394|450162934|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
125147479|NCT02994394|450162935|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
125147480|NCT02994394|450162936|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
125147481|NCT02994394|450162937|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
125147482|NCT02327325|450162938|FG000|Overall Study|Withdrawal by Subject|1|||
125147483|NCT02327325|450162939|FG001|Overall Study|Withdrawal by Subject|4|||
125147484|NCT02327325|450162940|FG002|Overall Study|Withdrawal by Subject|4|||
125147485|NCT02327325|450162938|FG000|Overall Study|Excluded by Study Team|0|||
125147486|NCT02327325|450162939|FG001|Overall Study|Excluded by Study Team|0|||
125147487|NCT02327325|450162940|FG002|Overall Study|Excluded by Study Team|1|||
125147488|NCT02457819|450162945|FG000|Overall Study|reason not given|8|||
125147489|NCT02457819|450162945|FG000|Overall Study|Withdrawal by Subject|24|||
125147490|NCT02457819|450162945|FG000|Overall Study|Protocol Violation|1|||
125147491|NCT02457819|450162945|FG000|Overall Study|non compliance with study drug|4|||
125147492|NCT02457819|450162945|FG000|Overall Study|Lost to Follow-up|10|||
125147493|NCT02457819|450162945|FG000|Overall Study|Lack of Efficacy|19|||
125147494|NCT02457819|450162945|FG000|Overall Study|Adverse Event|33|||
125147495|NCT03330236|450162947|FG000|Overall Study|Death|2|||
125147496|NCT03330236|450162948|FG001|Overall Study|Death|1|||
125147497|NCT03330236|450162947|FG000|Overall Study|Withdrawal by Subject|2|||
125147498|NCT03330236|450162948|FG001|Overall Study|Withdrawal by Subject|4|||
125147499|NCT03330236|450162947|FG000|Overall Study|Lost to Follow-up|0|||
125388045|NCT02864251|451053994|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
125147500|NCT03330236|450162948|FG001|Overall Study|Lost to Follow-up|2|||
125147501|NCT03330236|450162947|FG000|Overall Study|Physician Decision|2|||
125147502|NCT03330236|450162948|FG001|Overall Study|Physician Decision|0|||
125147503|NCT03330236|450162947|FG000|Overall Study|Protocol Violation|4|||
125147504|NCT03330236|450162948|FG001|Overall Study|Protocol Violation|3|||
125147505|NCT03330236|450162947|FG000|Overall Study|SedLine malfunction/blinding|19|||
125147506|NCT03330236|450162948|FG001|Overall Study|SedLine malfunction/blinding|14|||
125147507|NCT03330236|450162947|FG000|Overall Study|Volatile anesthetics used|11|||
125147508|NCT03330236|450162948|FG001|Overall Study|Volatile anesthetics used|8|||
125147509|NCT03330236|450162947|FG000|Overall Study|Surgery aborted/converted to open|60|||
125147510|NCT03330236|450162948|FG001|Overall Study|Surgery aborted/converted to open|52|||
125147511|NCT01901848|450162952|FG000|Randomized and Treated|Lost to Follow-up|3|||
125147512|NCT01901848|450162953|FG001|Randomized and Treated|Lost to Follow-up|6|||
125147513|NCT01901848|450162952|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
125147514|NCT01901848|450162953|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
125147515|NCT00763555|450162954|FG000|Overall Study|Adverse Event|2|||
125147516|NCT00763555|450162955|FG001|Overall Study|Adverse Event|1|||
125147517|NCT00763555|450162954|FG000|Overall Study|Withdrawal by Subject|2|||
125147518|NCT00763555|450162955|FG001|Overall Study|Withdrawal by Subject|6|||
125147519|NCT00763555|450162954|FG000|Overall Study|Lost to Follow-up|0|||
125147520|NCT00763555|450162955|FG001|Overall Study|Lost to Follow-up|3|||
125147521|NCT00852917|450162956|FG000|Overall Study|Adverse Event|13|||
125147522|NCT00852917|450162957|FG001|Overall Study|Adverse Event|20|||
125147523|NCT00852917|450162958|FG002|Overall Study|Adverse Event|35|||
125147524|NCT00852917|450162959|FG003|Overall Study|Adverse Event|17|||
125147525|NCT00852917|450162956|FG000|Overall Study|Lack of Efficacy|21|||
125147526|NCT00852917|450162957|FG001|Overall Study|Lack of Efficacy|11|||
125147527|NCT00852917|450162958|FG002|Overall Study|Lack of Efficacy|11|||
125147528|NCT00852917|450162959|FG003|Overall Study|Lack of Efficacy|47|||
125147529|NCT00852917|450162956|FG000|Overall Study|Withdrawal by Subject|4|||
125147530|NCT00852917|450162957|FG001|Overall Study|Withdrawal by Subject|8|||
125147531|NCT00852917|450162958|FG002|Overall Study|Withdrawal by Subject|10|||
125147532|NCT00852917|450162959|FG003|Overall Study|Withdrawal by Subject|9|||
125147533|NCT00852917|450162956|FG000|Overall Study|Physician Decision|6|||
125147534|NCT00852917|450162957|FG001|Overall Study|Physician Decision|7|||
125147535|NCT00852917|450162958|FG002|Overall Study|Physician Decision|2|||
125147536|NCT00852917|450162959|FG003|Overall Study|Physician Decision|19|||
125147537|NCT00852917|450162956|FG000|Overall Study|Death|0|||
125147538|NCT00852917|450162957|FG001|Overall Study|Death|0|||
125147539|NCT00852917|450162958|FG002|Overall Study|Death|0|||
125147540|NCT00852917|450162959|FG003|Overall Study|Death|1|||
125147541|NCT03710590|450162960|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
125147542|NCT03710590|450162961|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
125388046|NCT02864251|451053995|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
125147543|NCT02488824|450162962|FG000|Overall Study|Adverse Event|1|||
125147544|NCT02488824|450162963|FG001|Overall Study|Adverse Event|1|||
125147545|NCT01045707|450162966|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
125147546|NCT01045707|450162967|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
125147547|NCT01045707|450162966|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
125147548|NCT01045707|450162967|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
125147549|NCT01045707|450162966|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
125147550|NCT01045707|450162967|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
125147551|NCT01045707|450162966|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
125147552|NCT01045707|450162967|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
125147553|NCT01045707|450162966|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
125147554|NCT01045707|450162967|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
125147555|NCT01045707|450162966|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
125147556|NCT01045707|450162967|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
125147557|NCT01045707|450162966|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
125147558|NCT01045707|450162967|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
125147559|NCT01045707|450162966|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
125147560|NCT01045707|450162967|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
125147561|NCT01045707|450162966|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
125147562|NCT01045707|450162967|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
125147563|NCT04317599|450162971|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
125147564|NCT04317599|450162971|FG000|Overall Study|treatment outside standard of care|4|||
125147565|NCT00809965|450162972|FG000|Overall Study|Death|194|||
125147566|NCT00809965|450162973|FG001|Overall Study|Death|147|||
125147567|NCT00809965|450162974|FG002|Overall Study|Death|196|||
125147568|NCT00809965|450162972|FG000|Overall Study|Lost to Follow-up|17|||
125147569|NCT00809965|450162973|FG001|Overall Study|Lost to Follow-up|10|||
125147570|NCT00809965|450162974|FG002|Overall Study|Lost to Follow-up|18|||
125147571|NCT00809965|450162972|FG000|Overall Study|Withdrawal by Subject|405|||
125147572|NCT00809965|450162973|FG001|Overall Study|Withdrawal by Subject|448|||
125147573|NCT00809965|450162974|FG002|Overall Study|Withdrawal by Subject|441|||
125147574|NCT00809965|450162972|FG000|Overall Study|Other Reason|167|||
125147575|NCT00809965|450162973|FG001|Overall Study|Other Reason|170|||
125147576|NCT00809965|450162974|FG002|Overall Study|Other Reason|189|||
125147577|NCT02315066|450162975|FG000|Overall Study|Lost to Follow-up|0|||
125147578|NCT02315066|450162976|FG001|Overall Study|Lost to Follow-up|1|||
125147579|NCT02315066|450162977|FG002|Overall Study|Lost to Follow-up|1|||
125147580|NCT02315066|450162978|FG003|Overall Study|Lost to Follow-up|0|||
125147581|NCT02315066|450162979|FG004|Overall Study|Lost to Follow-up|1|||
125147582|NCT02315066|450162980|FG005|Overall Study|Lost to Follow-up|0|||
125147583|NCT02315066|450162981|FG006|Overall Study|Lost to Follow-up|2|||
125147584|NCT02315066|450162982|FG007|Overall Study|Lost to Follow-up|1|||
125147585|NCT02315066|450162983|FG008|Overall Study|Lost to Follow-up|0|||
125147586|NCT02315066|450162984|FG009|Overall Study|Lost to Follow-up|0|||
125147587|NCT02315066|450162985|FG010|Overall Study|Lost to Follow-up|1|||
125147588|NCT02315066|450162986|FG011|Overall Study|Lost to Follow-up|2|||
125147589|NCT02315066|450162987|FG012|Overall Study|Lost to Follow-up|0|||
125147590|NCT02315066|450162988|FG013|Overall Study|Lost to Follow-up|4|||
125147591|NCT02315066|450162975|FG000|Overall Study|Death|2|||
125388047|NCT02864251|451053996|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
125147592|NCT02315066|450162976|FG001|Overall Study|Death|7|||
125147593|NCT02315066|450162977|FG002|Overall Study|Death|6|||
125147594|NCT02315066|450162978|FG003|Overall Study|Death|11|||
125147595|NCT02315066|450162979|FG004|Overall Study|Death|10|||
125147596|NCT02315066|450162980|FG005|Overall Study|Death|3|||
125147597|NCT02315066|450162981|FG006|Overall Study|Death|9|||
125147598|NCT02315066|450162982|FG007|Overall Study|Death|9|||
125147599|NCT02315066|450162983|FG008|Overall Study|Death|10|||
125147600|NCT02315066|450162984|FG009|Overall Study|Death|8|||
125147601|NCT02315066|450162985|FG010|Overall Study|Death|10|||
125147602|NCT02315066|450162986|FG011|Overall Study|Death|7|||
125147603|NCT02315066|450162987|FG012|Overall Study|Death|8|||
125147604|NCT02315066|450162988|FG013|Overall Study|Death|21|||
125147605|NCT02315066|450162975|FG000|Overall Study|Other|0|||
125147606|NCT02315066|450162976|FG001|Overall Study|Other|0|||
125147607|NCT02315066|450162977|FG002|Overall Study|Other|0|||
125147608|NCT02315066|450162978|FG003|Overall Study|Other|0|||
125147609|NCT02315066|450162979|FG004|Overall Study|Other|0|||
125147610|NCT02315066|450162980|FG005|Overall Study|Other|0|||
125147611|NCT02315066|450162981|FG006|Overall Study|Other|0|||
125147612|NCT02315066|450162982|FG007|Overall Study|Other|1|||
125147613|NCT02315066|450162983|FG008|Overall Study|Other|1|||
125388048|NCT02864251|451053994|FG000|Treatment|Withdrawal by Participant|8|||
125388049|NCT02864251|451053995|FG001|Treatment|Withdrawal by Participant|5|||
125147614|NCT02315066|450162984|FG009|Overall Study|Other|2|||
125147615|NCT02315066|450162985|FG010|Overall Study|Other|0|||
125147616|NCT02315066|450162986|FG011|Overall Study|Other|0|||
125147617|NCT02315066|450162987|FG012|Overall Study|Other|0|||
125147618|NCT02315066|450162988|FG013|Overall Study|Other|0|||
125147619|NCT02315066|450162975|FG000|Overall Study|Subject refused further follow-up|0|||
125147620|NCT02315066|450162976|FG001|Overall Study|Subject refused further follow-up|2|||
125147621|NCT02315066|450162977|FG002|Overall Study|Subject refused further follow-up|2|||
125147622|NCT02315066|450162978|FG003|Overall Study|Subject refused further follow-up|0|||
125147623|NCT02315066|450162979|FG004|Overall Study|Subject refused further follow-up|0|||
125147624|NCT02315066|450162980|FG005|Overall Study|Subject refused further follow-up|0|||
125147625|NCT02315066|450162981|FG006|Overall Study|Subject refused further follow-up|2|||
125147626|NCT02315066|450162982|FG007|Overall Study|Subject refused further follow-up|3|||
125438672|NCT00885352|451233919|FG000|Overall Study|Protocol Violation|0|||
125147627|NCT02315066|450162983|FG008|Overall Study|Subject refused further follow-up|0|||
125147628|NCT02315066|450162984|FG009|Overall Study|Subject refused further follow-up|1|||
125147629|NCT02315066|450162985|FG010|Overall Study|Subject refused further follow-up|1|||
125147630|NCT02315066|450162986|FG011|Overall Study|Subject refused further follow-up|2|||
125147631|NCT02315066|450162987|FG012|Overall Study|Subject refused further follow-up|2|||
125147632|NCT02315066|450162988|FG013|Overall Study|Subject refused further follow-up|4|||
125147633|NCT02315066|450162975|FG000|Overall Study|Study ongoing at date of cut-off|0|||
125147634|NCT02315066|450162976|FG001|Overall Study|Study ongoing at date of cut-off|0|||
125147635|NCT02315066|450162977|FG002|Overall Study|Study ongoing at date of cut-off|0|||
125147636|NCT02315066|450162978|FG003|Overall Study|Study ongoing at date of cut-off|0|||
125147637|NCT02315066|450162979|FG004|Overall Study|Study ongoing at date of cut-off|0|||
125147638|NCT02315066|450162980|FG005|Overall Study|Study ongoing at date of cut-off|0|||
125147639|NCT02315066|450162981|FG006|Overall Study|Study ongoing at date of cut-off|0|||
125147640|NCT02315066|450162982|FG007|Overall Study|Study ongoing at date of cut-off|0|||
125147641|NCT02315066|450162983|FG008|Overall Study|Study ongoing at date of cut-off|0|||
125147642|NCT02315066|450162984|FG009|Overall Study|Study ongoing at date of cut-off|0|||
125147643|NCT02315066|450162985|FG010|Overall Study|Study ongoing at date of cut-off|0|||
125147644|NCT02315066|450162986|FG011|Overall Study|Study ongoing at date of cut-off|0|||
125147645|NCT02315066|450162987|FG012|Overall Study|Study ongoing at date of cut-off|0|||
125147646|NCT02315066|450162988|FG013|Overall Study|Study ongoing at date of cut-off|1|||
125147647|NCT00112294|450162989|FG000|Overall Study|Still on study|5|||
125147648|NCT00112294|450162990|FG001|Overall Study|Still on study|0|||
125147649|NCT01142908|450162991|FG000|Overall Study|Lost to Follow-up|19|||
125147650|NCT01142908|450162992|FG001|Overall Study|Lost to Follow-up|13|||
125147651|NCT01142908|450162991|FG000|Overall Study|Death|1|||
125147652|NCT01142908|450162992|FG001|Overall Study|Death|4|||
125147653|NCT01142908|450162991|FG000|Overall Study|Excluded - did not meet criteria|9|||
125147654|NCT01142908|450162992|FG001|Overall Study|Excluded - did not meet criteria|5|||
125147655|NCT01142908|450162991|FG000|Overall Study|Withdrawal by Subject|3|||
125147656|NCT01142908|450162992|FG001|Overall Study|Withdrawal by Subject|0|||
125147657|NCT00035555|450162993|FG000|Overall Study|Adverse Event|5|||
125147658|NCT00035555|450162994|FG001|Overall Study|Adverse Event|8|||
125147659|NCT00035555|450162995|FG002|Overall Study|Adverse Event|9|||
125147660|NCT00035555|450162993|FG000|Overall Study|Allograft loss|1|||
125147661|NCT00035555|450162994|FG001|Overall Study|Allograft loss|1|||
125147662|NCT00035555|450162995|FG002|Overall Study|Allograft loss|2|||
125147663|NCT00035555|450162993|FG000|Overall Study|Death|0|||
125147664|NCT00035555|450162994|FG001|Overall Study|Death|0|||
125147665|NCT00035555|450162995|FG002|Overall Study|Death|2|||
125147666|NCT00035555|450162993|FG000|Overall Study|Lost to Follow-up|0|||
125147667|NCT00035555|450162994|FG001|Overall Study|Lost to Follow-up|0|||
125147668|NCT00035555|450162995|FG002|Overall Study|Lost to Follow-up|1|||
125147669|NCT00035555|450162993|FG000|Overall Study|Noncompliance|0|||
125147670|NCT00035555|450162994|FG001|Overall Study|Noncompliance|1|||
125147671|NCT00035555|450162995|FG002|Overall Study|Noncompliance|1|||
125147672|NCT00035555|450162993|FG000|Overall Study|Prohibited medication|1|||
125147673|NCT00035555|450162994|FG001|Overall Study|Prohibited medication|1|||
125147674|NCT00035555|450162995|FG002|Overall Study|Prohibited medication|0|||
125147675|NCT00035555|450162993|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
125147676|NCT00035555|450162994|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
125147677|NCT00035555|450162995|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
125147678|NCT00035555|450162993|FG000|Overall Study|Withdrawal by Subject|2|||
125147679|NCT00035555|450162994|FG001|Overall Study|Withdrawal by Subject|0|||
125147680|NCT00035555|450162995|FG002|Overall Study|Withdrawal by Subject|2|||
125147681|NCT00035555|450162993|FG000|Overall Study|Investigator deemed not a good candidate|0|||
125147682|NCT00035555|450162994|FG001|Overall Study|Investigator deemed not a good candidate|0|||
125147683|NCT00035555|450162995|FG002|Overall Study|Investigator deemed not a good candidate|1|||
125147684|NCT00035555|450162993|FG000|Overall Study|Received cyclosporin in error|0|||
125147685|NCT00035555|450162994|FG001|Overall Study|Received cyclosporin in error|0|||
125147686|NCT00035555|450162995|FG002|Overall Study|Received cyclosporin in error|1|||
125147687|NCT01186016|450162998|FG000|Overall Study|Withdrawal by Subject|46|||
125147688|NCT01186016|450162999|FG001|Overall Study|Withdrawal by Subject|29|||
125147689|NCT01055886|450163001|FG000|Overall Study|Withdrawal by Subject|4|||
125147690|NCT01055886|450163002|FG001|Overall Study|Withdrawal by Subject|9|||
125147691|NCT01055886|450163001|FG000|Overall Study|Lost to Follow-up|1|||
125147692|NCT01055886|450163002|FG001|Overall Study|Lost to Follow-up|1|||
125147693|NCT01055886|450163001|FG000|Overall Study|Withdrawal by PI|0|||
125147694|NCT01055886|450163002|FG001|Overall Study|Withdrawal by PI|1|||
125147695|NCT02972515|450163005|FG000|Overall Study|Lost to Follow-up|78|||
125147696|NCT01086969|450163006|FG000|Overall Study|Withdrawal by Subject|1|||
125147697|NCT01086969|450163007|FG001|Overall Study|Withdrawal by Subject|2|||
125147698|NCT01086969|450163008|FG002|Overall Study|Withdrawal by Subject|0|||
125147699|NCT00585312|450163019|FG000|Overall Study|Adverse Event|3|||
125147700|NCT00585312|450163020|FG001|Overall Study|Adverse Event|0|||
125147701|NCT00585312|450163019|FG000|Overall Study|Lack of Efficacy|6|||
125147702|NCT00585312|450163020|FG001|Overall Study|Lack of Efficacy|11|||
125147703|NCT00585312|450163019|FG000|Overall Study|Lost to Follow-up|1|||
125147704|NCT00585312|450163020|FG001|Overall Study|Lost to Follow-up|1|||
125147705|NCT00585312|450163019|FG000|Overall Study|Reason not specified|2|||
125147706|NCT00585312|450163020|FG001|Overall Study|Reason not specified|0|||
125147707|NCT00585312|450163019|FG000|Overall Study|Withdrawal by Subject|5|||
125147708|NCT00585312|450163020|FG001|Overall Study|Withdrawal by Subject|1|||
125147709|NCT00585312|450163019|FG000|Overall Study|Study terminated by the sponsor|34|||
125147710|NCT00585312|450163020|FG001|Overall Study|Study terminated by the sponsor|31|||
125147711|NCT04203667|450163023|FG000|Overall Study|Withdrawal by Subject|1|||
125147712|NCT04203667|450163023|FG000|Overall Study|Lost to Follow-up|1|||
125147713|NCT04203667|450163023|FG000|Overall Study|Death|1|||
125147714|NCT04203667|450163023|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
125147715|NCT01362296|450163024|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
125147716|NCT01362296|450163025|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
125147717|NCT01362296|450163026|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
125147718|NCT01362296|450163027|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
125147719|NCT01362296|450163024|FG000|Randomized Phase (RP)|Physician Decision|1|||
125147720|NCT01362296|450163025|FG001|Randomized Phase (RP)|Physician Decision|9|||
125147721|NCT01362296|450163026|FG002|Randomized Phase (RP)|Physician Decision|0|||
125147722|NCT01362296|450163027|FG003|Randomized Phase (RP)|Physician Decision|0|||
125147723|NCT01362296|450163024|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
125147724|NCT01362296|450163025|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
125147725|NCT01362296|450163026|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
125147726|NCT01362296|450163027|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
125147727|NCT01362296|450163024|FG000|Randomized Phase (RP)|Adverse Event|20|||
125147728|NCT01362296|450163025|FG001|Randomized Phase (RP)|Adverse Event|4|||
125147729|NCT01362296|450163026|FG002|Randomized Phase (RP)|Adverse Event|0|||
125147730|NCT01362296|450163027|FG003|Randomized Phase (RP)|Adverse Event|0|||
125147731|NCT01362296|450163024|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
125147732|NCT01362296|450163025|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
125147733|NCT01362296|450163026|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
125147734|NCT01362296|450163027|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
125147735|NCT01362296|450163024|FG000|Crossover Phase|PD including Death due to PD|0|||
125147736|NCT01362296|450163025|FG001|Crossover Phase|PD including Death due to PD|0|||
125147737|NCT01362296|450163026|FG002|Crossover Phase|PD including Death due to PD|16|||
125147738|NCT01362296|450163027|FG003|Crossover Phase|PD including Death due to PD|1|||
125147739|NCT01362296|450163024|FG000|Crossover Phase|Withdrawal by Subject|0|||
125147740|NCT01362296|450163025|FG001|Crossover Phase|Withdrawal by Subject|0|||
125147741|NCT01362296|450163026|FG002|Crossover Phase|Withdrawal by Subject|2|||
125147742|NCT01362296|450163027|FG003|Crossover Phase|Withdrawal by Subject|1|||
125147743|NCT01362296|450163024|FG000|Crossover Phase|Adverse Event|0|||
125147744|NCT01362296|450163025|FG001|Crossover Phase|Adverse Event|0|||
125147745|NCT01362296|450163026|FG002|Crossover Phase|Adverse Event|4|||
125147746|NCT01362296|450163027|FG003|Crossover Phase|Adverse Event|0|||
125147747|NCT01362296|450163024|FG000|Crossover Phase|Study Closed/Terminated|0|||
125147748|NCT01362296|450163025|FG001|Crossover Phase|Study Closed/Terminated|0|||
125147749|NCT01362296|450163026|FG002|Crossover Phase|Study Closed/Terminated|1|||
125147750|NCT01362296|450163027|FG003|Crossover Phase|Study Closed/Terminated|0|||
125147751|NCT00653159|450164329|FG000|Overall Study|Adverse Event|4|||
125147752|NCT00653159|450164330|FG001|Overall Study|Adverse Event|1|||
125147753|NCT00653159|450164329|FG000|Overall Study|Lost to Follow-up|1|||
125147754|NCT00653159|450164330|FG001|Overall Study|Lost to Follow-up|2|||
125147755|NCT00109837|450164331|FG000|Overall Study|Adverse Event|2|||
125147756|NCT00109837|450164331|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
125147757|NCT00109837|450164331|FG000|Overall Study|Death|1|||
125147758|NCT00109837|450164331|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
125147759|NCT00109837|450164331|FG000|Overall Study|Not treated|1|||
125147760|NCT00109837|450164331|FG000|Overall Study|Ineligible|1|||
125147761|NCT00381849|450164332|FG000|Wash Out|Withdrawal by Subject|0|||
125147762|NCT00381849|450164333|FG001|Wash Out|Withdrawal by Subject|1|||
125147763|NCT04167618|450164334|FG000|Overall Study|Trial terminated by sponsor|1|||
125147764|NCT04167618|450164335|FG001|Overall Study|Trial terminated by sponsor|1|||
125147765|NCT05996198|450164336|FG000|Overall Study|Withdrawal by Subject|1|||
125147766|NCT05996198|450164337|FG001|Overall Study|Withdrawal by Subject|0|||
125147767|NCT00835796|450164339|FG000|First Intervention|Withdrawal by Subject|0|||
125147768|NCT00835796|450164340|FG001|First Intervention|Withdrawal by Subject|1|||
125147769|NCT00651183|450164343|FG000|Overall Study|Lack of Efficacy|1|||
125147770|NCT00651183|450164344|FG001|Overall Study|Lack of Efficacy|0|||
125147771|NCT00651183|450164343|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
125147772|NCT00651183|450164344|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
125147773|NCT00651183|450164343|FG000|Overall Study|Tolerability insufficient|5|||
125438673|NCT00885352|451233920|FG001|Overall Study|Protocol Violation|2|||
125147774|NCT00651183|450164344|FG001|Overall Study|Tolerability insufficient|2|||
125147775|NCT00651183|450164343|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
125147776|NCT00651183|450164344|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
125147777|NCT00651183|450164343|FG000|Overall Study|Withdrawal by Subject|6|||
125147778|NCT00651183|450164344|FG001|Overall Study|Withdrawal by Subject|3|||
125147779|NCT00651183|450164343|FG000|Overall Study|Lost to Follow-up|3|||
125147780|NCT00651183|450164344|FG001|Overall Study|Lost to Follow-up|1|||
125147781|NCT00651183|450164343|FG000|Overall Study|Other reasons|4|||
125147782|NCT00651183|450164344|FG001|Overall Study|Other reasons|2|||
125147783|NCT00651183|450164343|FG000|Overall Study|missing|1|||
125147784|NCT00651183|450164344|FG001|Overall Study|missing|0|||
125147785|NCT01363011|450164346|FG000|Main Study|Adverse Event|2|||
125147786|NCT01363011|450164347|FG001|Main Study|Adverse Event|3|||
125147787|NCT01363011|450164346|FG000|Main Study|Investigator's Discretion|1|||
125147788|NCT01363011|450164347|FG001|Main Study|Investigator's Discretion|1|||
125147789|NCT01363011|450164346|FG000|Main Study|Withdrew Consent|1|||
125147790|NCT01363011|450164347|FG001|Main Study|Withdrew Consent|4|||
125147791|NCT01363011|450164346|FG000|Main Study|Protocol Violation|0|||
125147792|NCT01363011|450164347|FG001|Main Study|Protocol Violation|1|||
125147793|NCT01363011|450164346|FG000|Extension Phase|Adverse Event|1|||
125147794|NCT01363011|450164347|FG001|Extension Phase|Adverse Event|1|||
125147795|NCT01363011|450164346|FG000|Extension Phase|Lack of Efficacy|0|||
125147796|NCT01363011|450164347|FG001|Extension Phase|Lack of Efficacy|1|||
125147797|NCT01363011|450164346|FG000|Extension Phase|Investigator's Discretion|2|||
125147798|NCT01363011|450164347|FG001|Extension Phase|Investigator's Discretion|2|||
125147799|NCT01363011|450164346|FG000|Extension Phase|Withdrew Consent|0|||
125147800|NCT01363011|450164347|FG001|Extension Phase|Withdrew Consent|1|||
125147801|NCT01363011|450164346|FG000|Extension Phase|Lost to Follow-up|0|||
125147802|NCT01363011|450164347|FG001|Extension Phase|Lost to Follow-up|2|||
125147803|NCT01363011|450164346|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
125147804|NCT01363011|450164347|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
125147805|NCT04412057|450164348|FG000|Overall Study|Death|3|||
125147806|NCT04412057|450164349|FG001|Overall Study|Death|7|||
125147807|NCT04412057|450164348|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
125147808|NCT04412057|450164349|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
125147809|NCT01961882|450164353|FG000|Overall Study|Adverse Event|3|||
125147810|NCT01961882|450164354|FG001|Overall Study|Adverse Event|2|||
125147811|NCT01961882|450164353|FG000|Overall Study|Physician Decision|1|||
125147812|NCT01961882|450164354|FG001|Overall Study|Physician Decision|0|||
125147813|NCT01961882|450164353|FG000|Overall Study|Withdrawal by Subject|4|||
125147814|NCT01961882|450164354|FG001|Overall Study|Withdrawal by Subject|1|||
125147815|NCT01961882|450164353|FG000|Overall Study|Relapse of AML|39|||
125147816|NCT01961882|450164354|FG001|Overall Study|Relapse of AML|37|||
125147817|NCT01961882|450164353|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
125147818|NCT01961882|450164354|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
125147819|NCT01961882|450164353|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
125147820|NCT01961882|450164354|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
125147821|NCT00407745|450164355|FG000|Overall Study|Lack of Efficacy|1|||
125147822|NCT00407745|450164356|FG001|Overall Study|Lack of Efficacy|2|||
125147823|NCT00407745|450164355|FG000|Overall Study|Withdrawal by Subject|3|||
125147824|NCT00407745|450164356|FG001|Overall Study|Withdrawal by Subject|3|||
125147825|NCT00407745|450164355|FG000|Overall Study|Protocol Violation|5|||
125147826|NCT00407745|450164356|FG001|Overall Study|Protocol Violation|3|||
125147827|NCT00407745|450164355|FG000|Overall Study|Adverse Event|8|||
125147828|NCT00407745|450164356|FG001|Overall Study|Adverse Event|8|||
125147829|NCT00407745|450164355|FG000|Overall Study|Other|2|||
125147830|NCT00407745|450164356|FG001|Overall Study|Other|0|||
125147831|NCT00407745|450164355|FG000|Overall Study|Randomized, unknown if treated|0|||
125147832|NCT00407745|450164356|FG001|Overall Study|Randomized, unknown if treated|1|||
125147833|NCT00108082|450164357|FG000|Overall Study|Adverse Event|14|||
125147834|NCT00108082|450164358|FG001|Overall Study|Adverse Event|12|||
125147835|NCT00108082|450164359|FG002|Overall Study|Adverse Event|17|||
125223607|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
125223608|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125223609|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
125147836|NCT00108082|450164357|FG000|Overall Study|Lost to Follow-up|6|||
125147837|NCT00108082|450164358|FG001|Overall Study|Lost to Follow-up|3|||
125147838|NCT00108082|450164359|FG002|Overall Study|Lost to Follow-up|7|||
125147839|NCT00108082|450164357|FG000|Overall Study|Consent Withdrawn|3|||
125147840|NCT00108082|450164358|FG001|Overall Study|Consent Withdrawn|3|||
125147841|NCT00108082|450164359|FG002|Overall Study|Consent Withdrawn|5|||
125147842|NCT00108082|450164357|FG000|Overall Study|Protocol Violation|1|||
125147843|NCT00108082|450164358|FG001|Overall Study|Protocol Violation|2|||
125147844|NCT00108082|450164359|FG002|Overall Study|Protocol Violation|0|||
125147845|NCT00108082|450164357|FG000|Overall Study|Lack of Efficacy|3|||
125147846|NCT00108082|450164358|FG001|Overall Study|Lack of Efficacy|1|||
125147847|NCT00108082|450164359|FG002|Overall Study|Lack of Efficacy|2|||
125147848|NCT00108082|450164357|FG000|Overall Study|Amendment 4: > Month 12|5|||
125147849|NCT00108082|450164358|FG001|Overall Study|Amendment 4: > Month 12|7|||
125147850|NCT00108082|450164359|FG002|Overall Study|Amendment 4: > Month 12|5|||
125147851|NCT00108082|450164357|FG000|Overall Study|Woman of Child-bearing Potential|2|||
125147852|NCT00108082|450164358|FG001|Overall Study|Woman of Child-bearing Potential|0|||
125147853|NCT00108082|450164359|FG002|Overall Study|Woman of Child-bearing Potential|2|||
125147854|NCT00108082|450164357|FG000|Overall Study|Incorrectly Randomized|0|||
125147855|NCT00108082|450164358|FG001|Overall Study|Incorrectly Randomized|0|||
125147856|NCT00108082|450164359|FG002|Overall Study|Incorrectly Randomized|2|||
125147857|NCT00108082|450164357|FG000|Overall Study|Non-compliance|1|||
125147858|NCT00108082|450164358|FG001|Overall Study|Non-compliance|0|||
125147859|NCT00108082|450164359|FG002|Overall Study|Non-compliance|2|||
125147860|NCT00108082|450164357|FG000|Overall Study|Stopped Study Medication|0|||
125147861|NCT00108082|450164358|FG001|Overall Study|Stopped Study Medication|0|||
125147862|NCT00108082|450164359|FG002|Overall Study|Stopped Study Medication|1|||
125147863|NCT00108082|450164357|FG000|Overall Study|Site Closed Study|0|||
125147864|NCT00108082|450164358|FG001|Overall Study|Site Closed Study|2|||
125147865|NCT00108082|450164359|FG002|Overall Study|Site Closed Study|0|||
125147866|NCT00108082|450164357|FG000|Overall Study|Protocol Amendment|0|||
125147867|NCT00108082|450164358|FG001|Overall Study|Protocol Amendment|1|||
125147868|NCT00108082|450164359|FG002|Overall Study|Protocol Amendment|0|||
125147869|NCT00108082|450164357|FG000|Overall Study|Study Medication Not Tapered|0|||
125147870|NCT00108082|450164358|FG001|Overall Study|Study Medication Not Tapered|1|||
125147871|NCT00108082|450164359|FG002|Overall Study|Study Medication Not Tapered|0|||
125147872|NCT00108082|450164357|FG000|Overall Study|Subject Left Site Location|1|||
125147873|NCT00108082|450164358|FG001|Overall Study|Subject Left Site Location|0|||
125147874|NCT00108082|450164359|FG002|Overall Study|Subject Left Site Location|0|||
125147875|NCT00108082|450164357|FG000|Overall Study|Investigator Not at Site|1|||
125147876|NCT00108082|450164358|FG001|Overall Study|Investigator Not at Site|0|||
125147877|NCT00108082|450164359|FG002|Overall Study|Investigator Not at Site|0|||
125147878|NCT00108082|450164357|FG000|Overall Study|Blood Pressure Not Controlled|1|||
125147879|NCT00108082|450164358|FG001|Overall Study|Blood Pressure Not Controlled|0|||
125147880|NCT00108082|450164359|FG002|Overall Study|Blood Pressure Not Controlled|0|||
125147881|NCT01563237|450164360|FG000|Overall Study|Lost to Follow-up|6|||
125147882|NCT01563237|450164361|FG001|Overall Study|Lost to Follow-up|0|||
125147883|NCT01563237|450164360|FG000|Overall Study|Withdrawal by Subject|1|||
125147884|NCT01563237|450164361|FG001|Overall Study|Withdrawal by Subject|0|||
125147885|NCT01563237|450164360|FG000|Overall Study|Adverse Event|1|||
125147886|NCT01563237|450164361|FG001|Overall Study|Adverse Event|0|||
125147887|NCT01563237|450164360|FG000|Overall Study|Medical Reasons|1|||
125147888|NCT01563237|450164361|FG001|Overall Study|Medical Reasons|0|||
125147889|NCT01563237|450164360|FG000|Overall Study|Death|1|||
125147890|NCT01563237|450164361|FG001|Overall Study|Death|0|||
125147891|NCT02940730|450164367|FG000|Intervention 2|Physician Decision|7|||
125147892|NCT02940730|450164368|FG001|Intervention 2|Physician Decision|0|||
125147893|NCT03036839|450164370|FG000|Overall Study|Adverse Event|0|||
125147894|NCT03036839|450164371|FG001|Overall Study|Adverse Event|0|||
125147895|NCT03036839|450164372|FG002|Overall Study|Adverse Event|1|||
125147896|NCT03036839|450164370|FG000|Overall Study|Death|3|||
125147897|NCT03036839|450164371|FG001|Overall Study|Death|0|||
125147898|NCT03036839|450164372|FG002|Overall Study|Death|3|||
125147899|NCT03036839|450164370|FG000|Overall Study|Withdrew Consent|0|||
125147900|NCT03036839|450164371|FG001|Overall Study|Withdrew Consent|0|||
125147901|NCT03036839|450164372|FG002|Overall Study|Withdrew Consent|1|||
125147902|NCT00412737|450164373|FG000|Overall Study|Death|1|||
125147903|NCT00412737|450164374|FG001|Overall Study|Death|0|||
125147904|NCT00412737|450164373|FG000|Overall Study|Adverse Event|3|||
125147905|NCT00412737|450164374|FG001|Overall Study|Adverse Event|2|||
125147906|NCT00412737|450164373|FG000|Overall Study|Refused Treatment|6|||
125147907|NCT00412737|450164374|FG001|Overall Study|Refused Treatment|2|||
125147908|NCT00412737|450164373|FG000|Overall Study|Failure to Return|6|||
125147909|NCT00412737|450164374|FG001|Overall Study|Failure to Return|2|||
125147910|NCT01064531|450164376|FG000|Overall Study|Lost to Follow-up|0|||
125147911|NCT01064531|450164377|FG001|Overall Study|Lost to Follow-up|2|||
125147912|NCT01064531|450164376|FG000|Overall Study|Physician Decision|0|||
125147913|NCT01064531|450164377|FG001|Overall Study|Physician Decision|1|||
125147914|NCT01064531|450164376|FG000|Overall Study|Withdrawal by Subject|2|||
125147915|NCT01064531|450164377|FG001|Overall Study|Withdrawal by Subject|2|||
125147916|NCT01064531|450164376|FG000|Overall Study|Revision due to femoral stem loosening|1|||
125147917|NCT01064531|450164377|FG001|Overall Study|Revision due to femoral stem loosening|0|||
125147918|NCT01064531|450164376|FG000|Overall Study|Revision due to dislocation|0|||
125147919|NCT01064531|450164377|FG001|Overall Study|Revision due to dislocation|1|||
125147920|NCT01064531|450164376|FG000|Overall Study|Death|0|||
125147921|NCT01064531|450164377|FG001|Overall Study|Death|1|||
125147922|NCT03449199|450164382|FG000|Overall Study|Lost to Follow-up|1|||
125147923|NCT03449199|450164383|FG001|Overall Study|Lost to Follow-up|1|||
125147924|NCT03449199|450164384|FG002|Overall Study|Lost to Follow-up|0|||
125147925|NCT03449199|450164382|FG000|Overall Study|Protocol Deviation|0|||
125147926|NCT03449199|450164383|FG001|Overall Study|Protocol Deviation|0|||
125147927|NCT03449199|450164384|FG002|Overall Study|Protocol Deviation|1|||
125147928|NCT03449199|450164382|FG000|Overall Study|Withdrawal by Subject|0|||
125147929|NCT03449199|450164383|FG001|Overall Study|Withdrawal by Subject|0|||
125147930|NCT03449199|450164384|FG002|Overall Study|Withdrawal by Subject|1|||
125147931|NCT01091103|450164385|FG000|Overall Study|Adverse Event|1|||
125147932|NCT01091103|450164385|FG000|Overall Study|Progressive Disease|3|||
125147933|NCT01270620|450164386|FG000|Overall Study|Withdrawal by Subject|1|||
125147934|NCT01270620|450164387|FG001|Overall Study|Withdrawal by Subject|3|||
125147935|NCT00684567|450164388|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
125147936|NCT00684567|450164388|FG000|Monotherapy Period|Adverse Event|2|||
125147937|NCT00684567|450164388|FG000|Monotherapy Period|Death|1|||
125147938|NCT00684567|450164388|FG000|Monotherapy Period|Progression of primary disease|11|||
125147939|NCT03136406|450164389|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
125147940|NCT00988208|450164392|FG000|Overall Study|Adverse Event|71|||
125147941|NCT00988208|450164393|FG001|Overall Study|Adverse Event|122|||
125147942|NCT00988208|450164392|FG000|Overall Study|Disease Progression|103|||
125147943|NCT00988208|450164393|FG001|Overall Study|Disease Progression|89|||
125147944|NCT00988208|450164392|FG000|Overall Study|Withdrawal by Subject|50|||
125147945|NCT00988208|450164393|FG001|Overall Study|Withdrawal by Subject|57|||
125147946|NCT00988208|450164392|FG000|Overall Study|Death|9|||
125147947|NCT00988208|450164393|FG001|Overall Study|Death|15|||
125147948|NCT00988208|450164392|FG000|Overall Study|Lost to Follow-up|2|||
125147949|NCT00988208|450164393|FG001|Overall Study|Lost to Follow-up|3|||
125147950|NCT00988208|450164392|FG000|Overall Study|Protocol Violation|9|||
125147951|NCT00988208|450164393|FG001|Overall Study|Protocol Violation|2|||
125147952|NCT00988208|450164392|FG000|Overall Study|Sponsor Decision|102|||
125147953|NCT00988208|450164393|FG001|Overall Study|Sponsor Decision|78|||
125147954|NCT00988208|450164392|FG000|Overall Study|Clinical Progression|17|||
125147955|NCT00988208|450164393|FG001|Overall Study|Clinical Progression|16|||
125147956|NCT00988208|450164392|FG000|Overall Study|Biochemical Progression|21|||
125147957|NCT00988208|450164393|FG001|Overall Study|Biochemical Progression|7|||
125147958|NCT00988208|450164392|FG000|Overall Study|Clinical Deterioration|7|||
125147959|NCT00988208|450164393|FG001|Overall Study|Clinical Deterioration|14|||
125147960|NCT00988208|450164392|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
125147961|NCT00988208|450164393|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
125147962|NCT00988208|450164392|FG000|Overall Study|Other|8|||
125147963|NCT00988208|450164393|FG001|Overall Study|Other|3|||
125147964|NCT02618382|450164401|FG000|Overall Study|Physician Decision|1|||
125147965|NCT02618382|450164401|FG000|Overall Study|Withdrawal by Subject|1|||
125147966|NCT02618382|450164401|FG000|Overall Study|Protocol Violation|1|||
125147967|NCT03843125|450164402|FG000|Overall Study|Adverse Event|17|||
125147968|NCT03843125|450164403|FG001|Overall Study|Adverse Event|13|||
125147969|NCT03843125|450164404|FG002|Overall Study|Adverse Event|5|||
125147970|NCT03843125|450164405|FG003|Overall Study|Adverse Event|9|||
125147971|NCT03843125|450164402|FG000|Overall Study|Death|0|||
125147972|NCT03843125|450164403|FG001|Overall Study|Death|6|||
125147973|NCT03843125|450164404|FG002|Overall Study|Death|2|||
125147974|NCT03843125|450164405|FG003|Overall Study|Death|0|||
125147975|NCT03843125|450164402|FG000|Overall Study|Lack of Efficacy|14|||
125147976|NCT03843125|450164403|FG001|Overall Study|Lack of Efficacy|11|||
125147977|NCT03843125|450164404|FG002|Overall Study|Lack of Efficacy|9|||
125147978|NCT03843125|450164405|FG003|Overall Study|Lack of Efficacy|4|||
125147979|NCT03843125|450164402|FG000|Overall Study|Lost to Follow-up|3|||
125147980|NCT03843125|450164403|FG001|Overall Study|Lost to Follow-up|4|||
125147981|NCT03843125|450164404|FG002|Overall Study|Lost to Follow-up|0|||
125147982|NCT03843125|450164405|FG003|Overall Study|Lost to Follow-up|2|||
125147983|NCT03843125|450164402|FG000|Overall Study|Other|12|||
125147984|NCT03843125|450164403|FG001|Overall Study|Other|14|||
125147985|NCT03843125|450164404|FG002|Overall Study|Other|3|||
125147986|NCT03843125|450164405|FG003|Overall Study|Other|4|||
125147987|NCT03843125|450164402|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
125147988|NCT03843125|450164403|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
125147989|NCT03843125|450164404|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
125147990|NCT03843125|450164405|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
125147991|NCT03843125|450164402|FG000|Overall Study|Study Terminated by Sponsor|318|||
125147992|NCT03843125|450164403|FG001|Overall Study|Study Terminated by Sponsor|318|||
125147993|NCT03843125|450164404|FG002|Overall Study|Study Terminated by Sponsor|163|||
125147994|NCT03843125|450164405|FG003|Overall Study|Study Terminated by Sponsor|163|||
125147995|NCT03843125|450164402|FG000|Overall Study|Withdrawal by Subject|23|||
125147996|NCT03843125|450164403|FG001|Overall Study|Withdrawal by Subject|12|||
125147997|NCT03843125|450164404|FG002|Overall Study|Withdrawal by Subject|6|||
125147998|NCT03843125|450164405|FG003|Overall Study|Withdrawal by Subject|9|||
125147999|NCT03843125|450164402|FG000|Overall Study|Missing data|0|||
125148000|NCT03843125|450164403|FG001|Overall Study|Missing data|1|||
125148001|NCT03843125|450164404|FG002|Overall Study|Missing data|1|||
125148002|NCT03843125|450164405|FG003|Overall Study|Missing data|0|||
125148003|NCT03173560|450164406|FG000|Overall Study|Death|70|||
125148004|NCT03173560|450164407|FG001|Overall Study|Death|60|||
125148005|NCT03173560|450164406|FG000|Overall Study|Lost to Follow-up|1|||
125148006|NCT03173560|450164407|FG001|Overall Study|Lost to Follow-up|4|||
125148007|NCT03173560|450164406|FG000|Overall Study|Withdrawal by Subject|10|||
125148008|NCT03173560|450164407|FG001|Overall Study|Withdrawal by Subject|5|||
125148009|NCT03173560|450164406|FG000|Overall Study|Other|0|||
125148010|NCT03173560|450164407|FG001|Overall Study|Other|1|||
125148011|NCT04254809|450164408|FG000|Overall Study|Lost to Follow-up|5|||
125148012|NCT04254809|450164409|FG001|Overall Study|Lost to Follow-up|10|||
125148013|NCT03023137|450164410|FG000|Overall Study|Multiple pregnancy|2|||
125148014|NCT03023137|450164411|FG001|Overall Study|Multiple pregnancy|4|||
125148015|NCT03023137|450164410|FG000|Overall Study|Lost to Follow-up|1|||
125148016|NCT03023137|450164411|FG001|Overall Study|Lost to Follow-up|1|||
125148017|NCT03023137|450164410|FG000|Overall Study|Protocol Violation|0|||
125148018|NCT03023137|450164411|FG001|Overall Study|Protocol Violation|4|||
125148019|NCT03023137|450164410|FG000|Overall Study|Lost the baby in a car accident|1|||
125148020|NCT03023137|450164411|FG001|Overall Study|Lost the baby in a car accident|0|||
125148021|NCT02608476|450164412|FG000|Overall Study|Withdrawal by Subject|30|||
125148022|NCT02608476|450164413|FG001|Overall Study|Withdrawal by Subject|37|||
125148023|NCT02608476|450164412|FG000|Overall Study|Lost to Follow-up|24|||
125148024|NCT02608476|450164413|FG001|Overall Study|Lost to Follow-up|24|||
125148025|NCT02608476|450164412|FG000|Overall Study|Adverse Event|2|||
125148026|NCT02608476|450164413|FG001|Overall Study|Adverse Event|8|||
125148027|NCT02608476|450164412|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
125148028|NCT02608476|450164413|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
125148029|NCT02608476|450164412|FG000|Overall Study|Noncompliance with treatment|1|||
125148030|NCT02608476|450164413|FG001|Overall Study|Noncompliance with treatment|5|||
125148031|NCT02608476|450164412|FG000|Overall Study|Lack of Efficacy|3|||
125148032|NCT02608476|450164413|FG001|Overall Study|Lack of Efficacy|1|||
125148033|NCT02608476|450164412|FG000|Overall Study|Other|0|||
125148034|NCT02608476|450164413|FG001|Overall Study|Other|1|||
125148035|NCT02608476|450164412|FG000|Overall Study|Physician Decision|1|||
125223610|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223611|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223612|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223613|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223614|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223615|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223616|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223617|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223618|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223619|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223620|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223621|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
125223622|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223623|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125223624|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
125223625|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223626|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223627|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223628|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223629|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223630|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223631|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125148036|NCT02608476|450164413|FG001|Overall Study|Physician Decision|0|||
125148037|NCT02608476|450164412|FG000|Overall Study|Pregnancy|0|||
125148038|NCT02608476|450164413|FG001|Overall Study|Pregnancy|1|||
125148039|NCT02608476|450164412|FG000|Overall Study|Progressive disease|1|||
125148040|NCT02608476|450164413|FG001|Overall Study|Progressive disease|0|||
125148041|NCT02795676|450164414|FG000|Overall Study|Adverse Event|2|||
125148042|NCT02795676|450164415|FG001|Overall Study|Adverse Event|0|||
125148043|NCT02795676|450164414|FG000|Overall Study|Withdrawal by Subject|3|||
125148044|NCT02795676|450164415|FG001|Overall Study|Withdrawal by Subject|1|||
125148045|NCT00605176|450164416|FG000|Overall Study|Adverse Event|2|||
125148046|NCT00605176|450164417|FG001|Overall Study|Adverse Event|1|||
125148047|NCT00605176|450164418|FG002|Overall Study|Adverse Event|3|||
125148048|NCT00605176|450164416|FG000|Overall Study|Withdrawal by Subject|4|||
125148049|NCT00605176|450164417|FG001|Overall Study|Withdrawal by Subject|2|||
125148050|NCT00605176|450164418|FG002|Overall Study|Withdrawal by Subject|4|||
125148051|NCT00605176|450164416|FG000|Overall Study|Lost to Follow-up|2|||
125148052|NCT00605176|450164417|FG001|Overall Study|Lost to Follow-up|2|||
125148053|NCT00605176|450164418|FG002|Overall Study|Lost to Follow-up|1|||
125148054|NCT00605176|450164416|FG000|Overall Study|Non-complicance with study procedures|1|||
125148055|NCT00605176|450164417|FG001|Overall Study|Non-complicance with study procedures|0|||
125148056|NCT00605176|450164418|FG002|Overall Study|Non-complicance with study procedures|0|||
125148057|NCT00605176|450164416|FG000|Overall Study|Use of concomitant therapy|1|||
125148058|NCT00605176|450164417|FG001|Overall Study|Use of concomitant therapy|0|||
125148059|NCT00605176|450164418|FG002|Overall Study|Use of concomitant therapy|1|||
125148060|NCT00605176|450164416|FG000|Overall Study|Other (not due to AE)|1|||
125148061|NCT00605176|450164417|FG001|Overall Study|Other (not due to AE)|1|||
125148062|NCT00605176|450164418|FG002|Overall Study|Other (not due to AE)|0|||
125148063|NCT04253236|450164434|FG000|Overall Study|Adverse Event|1|||
125148064|NCT04253236|450164435|FG001|Overall Study|Adverse Event|0|||
125148065|NCT04253236|450164434|FG000|Overall Study|Safety Concerns|1|||
125148066|NCT04253236|450164435|FG001|Overall Study|Safety Concerns|0|||
125148067|NCT04253236|450164434|FG000|Overall Study|Study Terminated by Sponsor|1|||
125148068|NCT04253236|450164435|FG001|Overall Study|Study Terminated by Sponsor|0|||
125148069|NCT00587431|450164436|FG000|Overall Study|Adverse Event|1|||
125148070|NCT00587431|450164437|FG001|Overall Study|Adverse Event|0|||
125148071|NCT00587431|450164436|FG000|Overall Study|Withdrawal by Subject|0|||
125148072|NCT00587431|450164437|FG001|Overall Study|Withdrawal by Subject|1|||
125148073|NCT02169791|450164438|FG000|Overall Study|Death|6|||
125148074|NCT02169791|450164438|FG000|Overall Study|patient withdrew consent|1|||
125148075|NCT03566238|450164439|FG000|Overall Study|Adverse Event|0|||
125148076|NCT03566238|450164440|FG001|Overall Study|Adverse Event|1|||
125148077|NCT03566238|450164441|FG002|Overall Study|Adverse Event|0|||
125148078|NCT03566238|450164439|FG000|Overall Study|Lack of Efficacy|4|||
125148079|NCT03566238|450164440|FG001|Overall Study|Lack of Efficacy|2|||
125148080|NCT03566238|450164441|FG002|Overall Study|Lack of Efficacy|5|||
125148081|NCT03566238|450164439|FG000|Overall Study|Other|1|||
125148082|NCT03566238|450164440|FG001|Overall Study|Other|0|||
125148083|NCT03566238|450164441|FG002|Overall Study|Other|0|||
125148084|NCT00373425|450164448|FG000|Overall Study|Relapse of NSCLC|116|||
125148085|NCT00373425|450164449|FG001|Overall Study|Relapse of NSCLC|104|||
125148086|NCT00373425|450164450|FG002|Overall Study|Relapse of NSCLC|19|||
125148087|NCT00373425|450164451|FG003|Overall Study|Relapse of NSCLC|2|||
125148088|NCT00373425|450164452|FG004|Overall Study|Relapse of NSCLC|26|||
125148089|NCT00373425|450164448|FG000|Overall Study|Adverse Event|191|||
125148090|NCT00373425|450164449|FG001|Overall Study|Adverse Event|22|||
125148091|NCT00373425|450164450|FG002|Overall Study|Adverse Event|59|||
125148092|NCT00373425|450164451|FG003|Overall Study|Adverse Event|0|||
125148093|NCT00373425|450164452|FG004|Overall Study|Adverse Event|34|||
125148094|NCT00373425|450164448|FG000|Overall Study|Patient request|35|||
125148095|NCT00373425|450164449|FG001|Overall Study|Patient request|18|||
125148096|NCT00373425|450164450|FG002|Overall Study|Patient request|43|||
125148097|NCT00373425|450164451|FG003|Overall Study|Patient request|6|||
125148098|NCT00373425|450164452|FG004|Overall Study|Patient request|7|||
125148099|NCT00373425|450164448|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
125148100|NCT00373425|450164449|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
125148101|NCT00373425|450164450|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
125148102|NCT00373425|450164451|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
125148103|NCT00373425|450164452|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
125148104|NCT00373425|450164448|FG000|Overall Study|Death|7|||
125148105|NCT00373425|450164449|FG001|Overall Study|Death|0|||
125148106|NCT00373425|450164450|FG002|Overall Study|Death|3|||
125148107|NCT00373425|450164451|FG003|Overall Study|Death|1|||
125148108|NCT00373425|450164452|FG004|Overall Study|Death|0|||
125148109|NCT03942211|450164455|FG000|Overall Study|Death|1|||
125148110|NCT03942211|450164456|FG001|Overall Study|Death|0|||
125223632|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223633|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223634|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223635|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223636|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
125223637|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
125223638|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
125223639|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
125223640|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223641|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223642|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223643|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223644|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223645|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125388050|NCT02864251|451053996|FG002|Treatment|Withdrawal by Participant|13|||
125388051|NCT02864251|451053994|FG000|Treatment|Maximum Clinical Benefit|1|||
125148111|NCT03942211|450164455|FG000|Overall Study|Study terminated by sponsor|5|||
125148112|NCT03942211|450164456|FG001|Overall Study|Study terminated by sponsor|3|||
125148113|NCT03942211|450164455|FG000|Overall Study|Adverse Event|0|||
125148114|NCT03942211|450164456|FG001|Overall Study|Adverse Event|1|||
125148115|NCT01183884|450164457|FG000|Overall Study|Progressive Disease|26|||
125148116|NCT01183884|450164457|FG000|Overall Study|Adverse Event|3|||
125148117|NCT01183884|450164457|FG000|Overall Study|Withdrawal by Subject|1|||
125148118|NCT01183884|450164457|FG000|Overall Study|Other Complicating Disease|3|||
125148119|NCT01183884|450164457|FG000|Overall Study|Not Treated|1|||
125148120|NCT01183884|450164457|FG000|Overall Study|Other|4|||
125148121|NCT01835548|450164463|FG000|Dose Optimization Period|Adverse Event|0|||
125148122|NCT01835548|450164464|FG001|Dose Optimization Period|Adverse Event|0|||
125148123|NCT01835548|450164465|FG002|Dose Optimization Period|Adverse Event|1|||
125148124|NCT01835548|450164463|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
125148125|NCT01835548|450164464|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
125148126|NCT01835548|450164465|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
125148127|NCT01835548|450164463|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125148128|NCT01835548|450164464|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125148129|NCT01835548|450164465|FG002|Double-Blind Treatment Period|Adverse Event|0|||
125148130|NCT01835548|450164463|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125148131|NCT01835548|450164464|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
125148132|NCT01835548|450164465|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125148133|NCT01169038|450164466|FG000|Overall Study|Death|1|||
125148134|NCT01169038|450164466|FG000|Overall Study|Adverse Event|5|||
125148135|NCT01169038|450164466|FG000|Overall Study|Required antibiotic administration|1|||
125148136|NCT01488448|450164467|FG000|Overall Study|Withdrawal by Subject|3|||
125148137|NCT01488448|450164468|FG001|Overall Study|Withdrawal by Subject|1|||
125148138|NCT01488448|450164467|FG000|Overall Study|Adverse Event|9|||
125148139|NCT01488448|450164468|FG001|Overall Study|Adverse Event|4|||
125148140|NCT01488448|450164467|FG000|Overall Study|Physician Decision|4|||
125148141|NCT01488448|450164468|FG001|Overall Study|Physician Decision|9|||
125148142|NCT01488448|450164467|FG000|Overall Study|Protocol Violation|4|||
125148143|NCT01488448|450164468|FG001|Overall Study|Protocol Violation|3|||
125148144|NCT00537017|450164469|FG000|Treatment Phase|Adverse Event|19|||
125148145|NCT00537017|450164469|FG000|Treatment Phase|Withdrawal by Subject|13|||
125148146|NCT00537017|450164469|FG000|Treatment Phase|Protocol Violation|2|||
125148147|NCT00537017|450164469|FG000|Follow-up Phase|Withdrawal by Subject|9|||
125148148|NCT03168906|450164472|FG000|Overall Study|Lack of Efficacy|6|||
125148149|NCT03168906|450164473|FG001|Overall Study|Lack of Efficacy|6|||
125148150|NCT02219308|450164476|FG000|Overall Study|Withdrawal by Subject|1|||
125148151|NCT02219308|450164477|FG001|Overall Study|Withdrawal by Subject|2|||
125148152|NCT02839798|450166442|FG000|Overall Study|Withdrawal by Subject|2|||
125148153|NCT02447887|450166443|FG000|Overall Study|Study was terminated|3|||
125148154|NCT00401245|450166444|FG000|Double Blind Titration Phase|Adverse Event|3|||
125148155|NCT00401245|450166445|FG001|Double Blind Titration Phase|Adverse Event|2|||
125148156|NCT00401245|450166446|FG002|Double Blind Titration Phase|Adverse Event|5|||
125148157|NCT00401245|450166447|FG003|Double Blind Titration Phase|Adverse Event|12|||
125148158|NCT00401245|450166448|FG004|Double Blind Titration Phase|Adverse Event|0|||
125148159|NCT00401245|450166449|FG005|Double Blind Titration Phase|Adverse Event|0|||
125148160|NCT00401245|450166450|FG006|Double Blind Titration Phase|Adverse Event|0|||
125148161|NCT00401245|450166451|FG007|Double Blind Titration Phase|Adverse Event|0|||
125148162|NCT00401245|450166444|FG000|Double Blind Titration Phase|Other|0|||
125148163|NCT00401245|450166445|FG001|Double Blind Titration Phase|Other|0|||
125148164|NCT00401245|450166446|FG002|Double Blind Titration Phase|Other|1|||
125148165|NCT00401245|450166447|FG003|Double Blind Titration Phase|Other|0|||
125148166|NCT00401245|450166448|FG004|Double Blind Titration Phase|Other|0|||
125148167|NCT00401245|450166449|FG005|Double Blind Titration Phase|Other|0|||
125148168|NCT00401245|450166450|FG006|Double Blind Titration Phase|Other|0|||
125148169|NCT00401245|450166451|FG007|Double Blind Titration Phase|Other|0|||
125148170|NCT00401245|450166444|FG000|Double Blind Titration Phase|Protocol Violation|0|||
125148171|NCT00401245|450166445|FG001|Double Blind Titration Phase|Protocol Violation|0|||
125148172|NCT00401245|450166446|FG002|Double Blind Titration Phase|Protocol Violation|0|||
125148173|NCT00401245|450166447|FG003|Double Blind Titration Phase|Protocol Violation|1|||
125148174|NCT00401245|450166448|FG004|Double Blind Titration Phase|Protocol Violation|0|||
125148175|NCT00401245|450166449|FG005|Double Blind Titration Phase|Protocol Violation|0|||
125148176|NCT00401245|450166450|FG006|Double Blind Titration Phase|Protocol Violation|0|||
125148177|NCT00401245|450166451|FG007|Double Blind Titration Phase|Protocol Violation|0|||
125148178|NCT00401245|450166444|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
125148179|NCT00401245|450166445|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
125223646|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223647|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223648|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223649|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125148180|NCT00401245|450166446|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
125148181|NCT00401245|450166447|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
125148182|NCT00401245|450166448|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
125148183|NCT00401245|450166449|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
125148184|NCT00401245|450166450|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
125148185|NCT00401245|450166451|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
125148186|NCT00401245|450166444|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
125148187|NCT00401245|450166445|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
125148188|NCT00401245|450166446|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
125148189|NCT00401245|450166447|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
125148190|NCT00401245|450166448|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
125148191|NCT00401245|450166449|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
125148192|NCT00401245|450166450|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
125148193|NCT00401245|450166451|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
125148194|NCT00401245|450166444|FG000|Open Label Phase|Adverse Event|5|||
125148195|NCT00401245|450166445|FG001|Open Label Phase|Adverse Event|14|||
125148196|NCT00401245|450166446|FG002|Open Label Phase|Adverse Event|6|||
125148197|NCT00401245|450166447|FG003|Open Label Phase|Adverse Event|7|||
125148198|NCT00401245|450166448|FG004|Open Label Phase|Adverse Event|0|||
125148199|NCT00401245|450166449|FG005|Open Label Phase|Adverse Event|0|||
125148200|NCT00401245|450166450|FG006|Open Label Phase|Adverse Event|0|||
125148201|NCT00401245|450166451|FG007|Open Label Phase|Adverse Event|0|||
125148202|NCT00401245|450166444|FG000|Open Label Phase|Lost to Follow-up|5|||
125148203|NCT00401245|450166445|FG001|Open Label Phase|Lost to Follow-up|7|||
125148204|NCT00401245|450166446|FG002|Open Label Phase|Lost to Follow-up|5|||
125148205|NCT00401245|450166447|FG003|Open Label Phase|Lost to Follow-up|4|||
125148206|NCT00401245|450166448|FG004|Open Label Phase|Lost to Follow-up|0|||
125148207|NCT00401245|450166449|FG005|Open Label Phase|Lost to Follow-up|0|||
125148208|NCT00401245|450166450|FG006|Open Label Phase|Lost to Follow-up|0|||
125148209|NCT00401245|450166451|FG007|Open Label Phase|Lost to Follow-up|0|||
125148210|NCT00401245|450166444|FG000|Open Label Phase|Other|4|||
125148211|NCT00401245|450166445|FG001|Open Label Phase|Other|8|||
125148212|NCT00401245|450166446|FG002|Open Label Phase|Other|7|||
125148213|NCT00401245|450166447|FG003|Open Label Phase|Other|8|||
125148214|NCT00401245|450166448|FG004|Open Label Phase|Other|0|||
125148215|NCT00401245|450166449|FG005|Open Label Phase|Other|0|||
125148216|NCT00401245|450166450|FG006|Open Label Phase|Other|0|||
125148217|NCT00401245|450166451|FG007|Open Label Phase|Other|0|||
125148218|NCT00401245|450166444|FG000|Open Label Phase|Protocol Violation|0|||
125148219|NCT00401245|450166445|FG001|Open Label Phase|Protocol Violation|1|||
125148220|NCT00401245|450166446|FG002|Open Label Phase|Protocol Violation|0|||
125148221|NCT00401245|450166447|FG003|Open Label Phase|Protocol Violation|1|||
125148222|NCT00401245|450166448|FG004|Open Label Phase|Protocol Violation|0|||
125148223|NCT00401245|450166449|FG005|Open Label Phase|Protocol Violation|0|||
125148224|NCT00401245|450166450|FG006|Open Label Phase|Protocol Violation|0|||
125148225|NCT00401245|450166451|FG007|Open Label Phase|Protocol Violation|0|||
125148226|NCT00401245|450166444|FG000|Open Label Phase|Withdrawal by Subject|3|||
125148227|NCT00401245|450166445|FG001|Open Label Phase|Withdrawal by Subject|3|||
125148228|NCT00401245|450166446|FG002|Open Label Phase|Withdrawal by Subject|2|||
125148229|NCT00401245|450166447|FG003|Open Label Phase|Withdrawal by Subject|1|||
125148230|NCT00401245|450166448|FG004|Open Label Phase|Withdrawal by Subject|0|||
125148231|NCT00401245|450166449|FG005|Open Label Phase|Withdrawal by Subject|0|||
125148232|NCT00401245|450166450|FG006|Open Label Phase|Withdrawal by Subject|0|||
125148233|NCT00401245|450166451|FG007|Open Label Phase|Withdrawal by Subject|0|||
125148234|NCT00401245|450166444|FG000|Open Label Phase|Lack of Efficacy|4|||
125148235|NCT00401245|450166445|FG001|Open Label Phase|Lack of Efficacy|2|||
125148236|NCT00401245|450166446|FG002|Open Label Phase|Lack of Efficacy|3|||
125148237|NCT00401245|450166447|FG003|Open Label Phase|Lack of Efficacy|0|||
125148238|NCT00401245|450166448|FG004|Open Label Phase|Lack of Efficacy|0|||
125148239|NCT00401245|450166449|FG005|Open Label Phase|Lack of Efficacy|0|||
125148240|NCT00401245|450166450|FG006|Open Label Phase|Lack of Efficacy|0|||
125148241|NCT00401245|450166451|FG007|Open Label Phase|Lack of Efficacy|0|||
125148242|NCT00401245|450166444|FG000|Double Blind Tapering Phase|Adverse Event|0|||
125148243|NCT00401245|450166445|FG001|Double Blind Tapering Phase|Adverse Event|0|||
125148244|NCT00401245|450166446|FG002|Double Blind Tapering Phase|Adverse Event|0|||
125148245|NCT00401245|450166447|FG003|Double Blind Tapering Phase|Adverse Event|0|||
125148246|NCT00401245|450166448|FG004|Double Blind Tapering Phase|Adverse Event|1|||
125148247|NCT00401245|450166449|FG005|Double Blind Tapering Phase|Adverse Event|1|||
125148248|NCT00401245|450166450|FG006|Double Blind Tapering Phase|Adverse Event|2|||
125223650|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223651|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
125223652|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125148249|NCT00401245|450166451|FG007|Double Blind Tapering Phase|Adverse Event|4|||
125148250|NCT00401245|450166444|FG000|Double Blind Tapering Phase|Investigator request|0|||
125148251|NCT00401245|450166445|FG001|Double Blind Tapering Phase|Investigator request|0|||
125223653|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223654|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
125223655|NCT02326272|450446164|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125223656|NCT02326272|450446165|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125148252|NCT00401245|450166446|FG002|Double Blind Tapering Phase|Investigator request|0|||
125148253|NCT00401245|450166447|FG003|Double Blind Tapering Phase|Investigator request|0|||
125148254|NCT00401245|450166448|FG004|Double Blind Tapering Phase|Investigator request|0|||
125148255|NCT00401245|450166449|FG005|Double Blind Tapering Phase|Investigator request|0|||
125148256|NCT00401245|450166450|FG006|Double Blind Tapering Phase|Investigator request|0|||
125148257|NCT00401245|450166451|FG007|Double Blind Tapering Phase|Investigator request|1|||
125148258|NCT00401245|450166444|FG000|Double Blind Tapering Phase|Other|0|||
125148259|NCT00401245|450166445|FG001|Double Blind Tapering Phase|Other|0|||
125148260|NCT00401245|450166446|FG002|Double Blind Tapering Phase|Other|0|||
125148261|NCT00401245|450166447|FG003|Double Blind Tapering Phase|Other|0|||
125148262|NCT00401245|450166448|FG004|Double Blind Tapering Phase|Other|1|||
125148263|NCT00401245|450166449|FG005|Double Blind Tapering Phase|Other|0|||
125148264|NCT00401245|450166450|FG006|Double Blind Tapering Phase|Other|2|||
125148265|NCT00401245|450166451|FG007|Double Blind Tapering Phase|Other|2|||
125148266|NCT00401245|450166444|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
125148267|NCT00401245|450166445|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
125148268|NCT00401245|450166446|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
125148269|NCT00401245|450166447|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
125148270|NCT00401245|450166448|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
125148271|NCT00401245|450166449|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
125148272|NCT00401245|450166450|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
125148273|NCT00401245|450166451|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
125148274|NCT00401245|450166444|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148275|NCT00401245|450166445|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148276|NCT00401245|450166446|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148277|NCT00401245|450166447|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148278|NCT00401245|450166448|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148279|NCT00401245|450166449|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
125148280|NCT00401245|450166450|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148281|NCT00401245|450166451|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
125148282|NCT02344745|450166452|FG000|Overall Study|Data collection sheets were lost|2|||
125148283|NCT02344745|450166453|FG001|Overall Study|Data collection sheets were lost|0|||
125148284|NCT02788513|450166454|FG000|Overall Study|Withdrawal by Subject|3|||
125148285|NCT02788513|450166455|FG001|Overall Study|Withdrawal by Subject|0|||
125148286|NCT02788513|450166456|FG002|Overall Study|Withdrawal by Subject|2|||
125148287|NCT02788513|450166457|FG003|Overall Study|Withdrawal by Subject|3|||
125148288|NCT02788513|450166458|FG004|Overall Study|Withdrawal by Subject|1|||
125148289|NCT02788513|450166454|FG000|Overall Study|Lost to Follow-up|1|||
125148290|NCT02788513|450166455|FG001|Overall Study|Lost to Follow-up|0|||
125148291|NCT02788513|450166456|FG002|Overall Study|Lost to Follow-up|0|||
125148292|NCT02788513|450166457|FG003|Overall Study|Lost to Follow-up|0|||
125148293|NCT02788513|450166458|FG004|Overall Study|Lost to Follow-up|1|||
125148294|NCT02788513|450166454|FG000|Overall Study|Adverse Event|5|||
125148295|NCT02788513|450166455|FG001|Overall Study|Adverse Event|8|||
125148296|NCT02788513|450166456|FG002|Overall Study|Adverse Event|4|||
125148297|NCT02788513|450166457|FG003|Overall Study|Adverse Event|2|||
125148298|NCT02788513|450166458|FG004|Overall Study|Adverse Event|2|||
125148299|NCT02788513|450166454|FG000|Overall Study|Protocol Violation|0|||
125148300|NCT02788513|450166455|FG001|Overall Study|Protocol Violation|0|||
125148301|NCT02788513|450166456|FG002|Overall Study|Protocol Violation|1|||
125148302|NCT02788513|450166457|FG003|Overall Study|Protocol Violation|1|||
125148303|NCT02788513|450166458|FG004|Overall Study|Protocol Violation|0|||
125148304|NCT02788513|450166454|FG000|Overall Study|Subject decided to stop taking treatment|0|||
125148305|NCT02788513|450166455|FG001|Overall Study|Subject decided to stop taking treatment|0|||
125148306|NCT02788513|450166456|FG002|Overall Study|Subject decided to stop taking treatment|1|||
125148307|NCT02788513|450166457|FG003|Overall Study|Subject decided to stop taking treatment|0|||
125148308|NCT02788513|450166458|FG004|Overall Study|Subject decided to stop taking treatment|0|||
125148309|NCT02788513|450166454|FG000|Overall Study|Decision by the study team|0|||
125148310|NCT02788513|450166455|FG001|Overall Study|Decision by the study team|0|||
125148311|NCT02788513|450166456|FG002|Overall Study|Decision by the study team|0|||
125148312|NCT02788513|450166457|FG003|Overall Study|Decision by the study team|0|||
125148313|NCT02788513|450166458|FG004|Overall Study|Decision by the study team|1|||
125148314|NCT02014441|450166460|FG000|Overall Study|Withdrawal by Subject|12|||
125148315|NCT01933919|450166461|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
125148316|NCT01933919|450166462|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
125148317|NCT01933919|450166461|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
125148318|NCT01933919|450166462|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
125223657|NCT02326272|450446166|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125148319|NCT01933919|450166461|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
125148320|NCT01933919|450166462|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
125148321|NCT01933919|450166461|FG000|Open-label Long-term Phase|Adverse Event|2|||
125148322|NCT01933919|450166462|FG001|Open-label Long-term Phase|Adverse Event|0|||
125148323|NCT01933919|450166461|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
125148324|NCT01933919|450166462|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
125148325|NCT01933919|450166461|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
125148326|NCT01933919|450166462|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
125148327|NCT01933919|450166461|FG000|Open-label Long-term Phase|Other|1|||
125148328|NCT01933919|450166462|FG001|Open-label Long-term Phase|Other|2|||
125148329|NCT00991510|450166463|FG000|Period I (Days 1-14)|Adverse Event|1|||
125148330|NCT00991510|450166464|FG001|Period I (Days 1-14)|Adverse Event|0|||
125148331|NCT00991510|450166463|FG000|Period III (Days 29-112)|Adverse Event|1|||
125148332|NCT00991510|450166464|FG001|Period III (Days 29-112)|Adverse Event|1|||
125148333|NCT02356211|450166469|FG000|Overall Study|Withdrawal by Subject|2|||
125148334|NCT02356211|450166470|FG001|Overall Study|Withdrawal by Subject|2|||
125148335|NCT02356211|450166469|FG000|Overall Study|ineligible|1|||
125148336|NCT02356211|450166470|FG001|Overall Study|ineligible|8|||
125148337|NCT02510261|450166475|FG000|Overall Study|Adverse Event|5|||
125148338|NCT02510261|450166476|FG001|Overall Study|Adverse Event|8|||
125148339|NCT02510261|450166477|FG002|Overall Study|Adverse Event|0|||
125148340|NCT02510261|450166475|FG000|Overall Study|Physician Decision|1|||
125148341|NCT02510261|450166476|FG001|Overall Study|Physician Decision|5|||
125148342|NCT02510261|450166477|FG002|Overall Study|Physician Decision|0|||
125148343|NCT02510261|450166475|FG000|Overall Study|Death|19|||
125148344|NCT02510261|450166476|FG001|Overall Study|Death|19|||
125148345|NCT02510261|450166477|FG002|Overall Study|Death|0|||
125148346|NCT02510261|450166475|FG000|Overall Study|Withdrawal by Subject|3|||
125148347|NCT02510261|450166476|FG001|Overall Study|Withdrawal by Subject|10|||
125148348|NCT02510261|450166477|FG002|Overall Study|Withdrawal by Subject|3|||
125148349|NCT02443324|450166481|FG000|Overall Study|Death|4|||
125148350|NCT02443324|450166482|FG001|Overall Study|Death|1|||
125148351|NCT02443324|450166483|FG002|Overall Study|Death|0|||
125148352|NCT02443324|450166484|FG003|Overall Study|Death|3|||
125148353|NCT02443324|450166485|FG004|Overall Study|Death|1|||
125148354|NCT02443324|450166486|FG005|Overall Study|Death|3|||
125148355|NCT02443324|450166487|FG006|Overall Study|Death|2|||
125148356|NCT02443324|450166481|FG000|Overall Study|Lost to Follow-up|0|||
125148357|NCT02443324|450166482|FG001|Overall Study|Lost to Follow-up|0|||
125148358|NCT02443324|450166483|FG002|Overall Study|Lost to Follow-up|0|||
125148359|NCT02443324|450166484|FG003|Overall Study|Lost to Follow-up|1|||
125148360|NCT02443324|450166485|FG004|Overall Study|Lost to Follow-up|0|||
125148361|NCT02443324|450166486|FG005|Overall Study|Lost to Follow-up|1|||
125148362|NCT02443324|450166487|FG006|Overall Study|Lost to Follow-up|0|||
125148363|NCT02443324|450166481|FG000|Overall Study|Physician Decision|0|||
125148364|NCT02443324|450166482|FG001|Overall Study|Physician Decision|3|||
125148365|NCT02443324|450166483|FG002|Overall Study|Physician Decision|5|||
125148366|NCT02443324|450166484|FG003|Overall Study|Physician Decision|1|||
125148367|NCT02443324|450166485|FG004|Overall Study|Physician Decision|1|||
125148368|NCT02443324|450166486|FG005|Overall Study|Physician Decision|0|||
125148369|NCT02443324|450166487|FG006|Overall Study|Physician Decision|2|||
125148370|NCT02443324|450166481|FG000|Overall Study|Progressive Disease|20|||
125148371|NCT02443324|450166482|FG001|Overall Study|Progressive Disease|20|||
125148372|NCT02443324|450166483|FG002|Overall Study|Progressive Disease|13|||
125148373|NCT02443324|450166484|FG003|Overall Study|Progressive Disease|10|||
125148374|NCT02443324|450166485|FG004|Overall Study|Progressive Disease|13|||
125148375|NCT02443324|450166486|FG005|Overall Study|Progressive Disease|17|||
125148376|NCT02443324|450166487|FG006|Overall Study|Progressive Disease|10|||
125148377|NCT02443324|450166481|FG000|Overall Study|Withdrawal by Subject|0|||
125148378|NCT02443324|450166482|FG001|Overall Study|Withdrawal by Subject|0|||
125148379|NCT02443324|450166483|FG002|Overall Study|Withdrawal by Subject|3|||
125148380|NCT02443324|450166484|FG003|Overall Study|Withdrawal by Subject|1|||
125148381|NCT02443324|450166485|FG004|Overall Study|Withdrawal by Subject|1|||
125388052|NCT02864251|451053995|FG001|Treatment|Maximum Clinical Benefit|0|||
125148382|NCT02443324|450166486|FG005|Overall Study|Withdrawal by Subject|0|||
125148383|NCT02443324|450166487|FG006|Overall Study|Withdrawal by Subject|1|||
125388053|NCT02864251|451053996|FG002|Treatment|Maximum Clinical Benefit|1|||
125148384|NCT02443324|450166481|FG000|Overall Study|Adverse Event|0|||
125148385|NCT02443324|450166482|FG001|Overall Study|Adverse Event|1|||
125148386|NCT02443324|450166483|FG002|Overall Study|Adverse Event|3|||
125148387|NCT02443324|450166484|FG003|Overall Study|Adverse Event|0|||
125148388|NCT02443324|450166485|FG004|Overall Study|Adverse Event|4|||
125388054|NCT02864251|451053994|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
125148389|NCT02443324|450166486|FG005|Overall Study|Adverse Event|3|||
125148390|NCT02443324|450166487|FG006|Overall Study|Adverse Event|3|||
125148391|NCT02443324|450166481|FG000|Overall Study|Enrolled but Never Treated|0|||
125148392|NCT02443324|450166482|FG001|Overall Study|Enrolled but Never Treated|0|||
125148393|NCT02443324|450166483|FG002|Overall Study|Enrolled but Never Treated|1|||
125148394|NCT02443324|450166484|FG003|Overall Study|Enrolled but Never Treated|0|||
125148395|NCT02443324|450166485|FG004|Overall Study|Enrolled but Never Treated|1|||
125148396|NCT02443324|450166486|FG005|Overall Study|Enrolled but Never Treated|0|||
125148397|NCT02443324|450166487|FG006|Overall Study|Enrolled but Never Treated|1|||
125148398|NCT02780167|450166498|FG000|Overall Study|Adverse Event|9|||
125148399|NCT02780167|450166499|FG001|Overall Study|Adverse Event|8|||
125388055|NCT02864251|451053995|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
125388056|NCT02864251|451053996|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
125388057|NCT02864251|451053994|FG000|Treatment|Other Reasons|1|||
125388058|NCT02864251|451053995|FG001|Treatment|Other Reasons|1|||
125388059|NCT02864251|451053996|FG002|Treatment|Other Reasons|4|||
125388060|NCT02864251|451053994|FG000|Treatment|Administrative Reason by Sponsor|1|||
125148400|NCT02780167|450166500|FG002|Overall Study|Adverse Event|8|||
125388061|NCT02864251|451053995|FG001|Treatment|Administrative Reason by Sponsor|0|||
125388062|NCT02864251|451053996|FG002|Treatment|Administrative Reason by Sponsor|0|||
125388063|NCT00885755|451053997|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
125388064|NCT00885755|451053998|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
125388065|NCT00885755|451053999|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
125388066|NCT00885755|451053997|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
125388067|NCT00885755|451053998|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
125388068|NCT00885755|451053999|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
125388069|NCT00885755|451053997|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
125388070|NCT00885755|451053998|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
125388071|NCT00885755|451053999|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
125388072|NCT00885755|451053997|FG000|Part I: Trastuzumab+Taxane|Death|0|||
125388073|NCT00885755|451053998|FG001|Part I: Trastuzumab+Taxane|Death|0|||
125388074|NCT00885755|451053999|FG002|Part I: Trastuzumab+Taxane|Death|1|||
125388075|NCT00885755|451053997|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
125388076|NCT00885755|451053998|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
125388077|NCT00885755|451053999|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
125388078|NCT04343521|451054000|FG000|Overall Study|Adverse Event|0|||
125388079|NCT04343521|451054001|FG001|Overall Study|Adverse Event|2|||
125388080|NCT04343521|451054000|FG000|Overall Study|Death|1|||
125388081|NCT04343521|451054001|FG001|Overall Study|Death|2|||
125388082|NCT04343521|451054000|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
125388083|NCT04343521|451054001|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
125388084|NCT04343521|451054000|FG000|Overall Study|Withdrawal by Subject|70|||
125388085|NCT04343521|451054001|FG001|Overall Study|Withdrawal by Subject|95|||
125148401|NCT02780167|450166501|FG003|Overall Study|Adverse Event|12|||
125148402|NCT02780167|450166502|FG004|Overall Study|Adverse Event|8|||
125148403|NCT02780167|450166498|FG000|Overall Study|Lack of Efficacy|6|||
125148404|NCT02780167|450166499|FG001|Overall Study|Lack of Efficacy|5|||
125148405|NCT02780167|450166500|FG002|Overall Study|Lack of Efficacy|6|||
125148406|NCT02780167|450166501|FG003|Overall Study|Lack of Efficacy|1|||
125148407|NCT02780167|450166502|FG004|Overall Study|Lack of Efficacy|0|||
125148408|NCT02780167|450166498|FG000|Overall Study|Lost to Follow-up|2|||
125148409|NCT02780167|450166499|FG001|Overall Study|Lost to Follow-up|0|||
125148410|NCT02780167|450166500|FG002|Overall Study|Lost to Follow-up|1|||
125148411|NCT02780167|450166501|FG003|Overall Study|Lost to Follow-up|0|||
125148412|NCT02780167|450166502|FG004|Overall Study|Lost to Follow-up|0|||
125148413|NCT02780167|450166498|FG000|Overall Study|Does not meet entrance criteria|0|||
125148414|NCT02780167|450166499|FG001|Overall Study|Does not meet entrance criteria|0|||
125148415|NCT02780167|450166500|FG002|Overall Study|Does not meet entrance criteria|1|||
125148416|NCT02780167|450166501|FG003|Overall Study|Does not meet entrance criteria|0|||
125148417|NCT02780167|450166502|FG004|Overall Study|Does not meet entrance criteria|0|||
125148418|NCT02780167|450166498|FG000|Overall Study|No longer meets eligibility criteria|0|||
125148419|NCT02780167|450166499|FG001|Overall Study|No longer meets eligibility criteria|0|||
125148420|NCT02780167|450166500|FG002|Overall Study|No longer meets eligibility criteria|0|||
125148421|NCT02780167|450166501|FG003|Overall Study|No longer meets eligibility criteria|1|||
125148422|NCT02780167|450166502|FG004|Overall Study|No longer meets eligibility criteria|1|||
125148423|NCT02780167|450166498|FG000|Overall Study|Protocol Violation|5|||
125148424|NCT02780167|450166499|FG001|Overall Study|Protocol Violation|5|||
125148425|NCT02780167|450166500|FG002|Overall Study|Protocol Violation|1|||
125148426|NCT02780167|450166501|FG003|Overall Study|Protocol Violation|1|||
125148427|NCT02780167|450166502|FG004|Overall Study|Protocol Violation|2|||
125148428|NCT02780167|450166498|FG000|Overall Study|Withdrawal by Subject|6|||
125148429|NCT02780167|450166499|FG001|Overall Study|Withdrawal by Subject|4|||
125148430|NCT02780167|450166500|FG002|Overall Study|Withdrawal by Subject|4|||
125148431|NCT02780167|450166501|FG003|Overall Study|Withdrawal by Subject|3|||
125148432|NCT02780167|450166502|FG004|Overall Study|Withdrawal by Subject|4|||
125388086|NCT04343521|451054000|FG000|Overall Study|Withdrawal by study team|6|||
125388087|NCT04343521|451054001|FG001|Overall Study|Withdrawal by study team|12|||
125388088|NCT00107198|451054002|FG000|Overall Study|Lack of Efficacy|28|||
125388089|NCT00107198|451054002|FG000|Overall Study|Lost to Follow-up|12|||
125388090|NCT00107198|451054002|FG000|Overall Study|Protocol Violation|1|||
125148433|NCT02780167|450166498|FG000|Overall Study|Other|0|||
125148434|NCT02780167|450166499|FG001|Overall Study|Other|0|||
125148435|NCT02780167|450166500|FG002|Overall Study|Other|3|||
125148436|NCT02780167|450166501|FG003|Overall Study|Other|1|||
125148437|NCT02780167|450166502|FG004|Overall Study|Other|2|||
125148438|NCT03180801|450166503|FG000|Overall Study|Physician Decision|3|||
125148439|NCT03180801|450166504|FG001|Overall Study|Physician Decision|3|||
125148440|NCT03180801|450166505|FG002|Overall Study|Physician Decision|1|||
125148441|NCT03180801|450166503|FG000|Overall Study|Non-compliance|1|||
125148442|NCT03180801|450166504|FG001|Overall Study|Non-compliance|4|||
125148443|NCT03180801|450166505|FG002|Overall Study|Non-compliance|0|||
125148444|NCT03180801|450166503|FG000|Overall Study|Inoculation Target Reached|1|||
125148445|NCT03180801|450166504|FG001|Overall Study|Inoculation Target Reached|1|||
125148446|NCT03180801|450166505|FG002|Overall Study|Inoculation Target Reached|3|||
125148447|NCT03180801|450166503|FG000|Overall Study|Adverse Event|1|||
125148448|NCT03180801|450166504|FG001|Overall Study|Adverse Event|0|||
125148449|NCT03180801|450166505|FG002|Overall Study|Adverse Event|2|||
125148450|NCT03180801|450166503|FG000|Overall Study|Withdrawal by Subject|2|||
125148451|NCT03180801|450166504|FG001|Overall Study|Withdrawal by Subject|2|||
125148452|NCT03180801|450166505|FG002|Overall Study|Withdrawal by Subject|1|||
125148453|NCT03180801|450166503|FG000|Overall Study|Lost to Follow-up|0|||
125148454|NCT03180801|450166504|FG001|Overall Study|Lost to Follow-up|2|||
125148455|NCT03180801|450166505|FG002|Overall Study|Lost to Follow-up|3|||
125148456|NCT03756883|450166506|FG000|Overall Study|Adverse Event|2|||
125148457|NCT03756883|450166507|FG001|Overall Study|Adverse Event|2|||
125148458|NCT03756883|450166508|FG002|Overall Study|Adverse Event|2|||
125148459|NCT03756883|450166506|FG000|Overall Study|Lack of Efficacy|0|||
125148460|NCT03756883|450166507|FG001|Overall Study|Lack of Efficacy|1|||
125148461|NCT03756883|450166508|FG002|Overall Study|Lack of Efficacy|2|||
125148462|NCT03756883|450166506|FG000|Overall Study|Lost to Follow-up|3|||
125148463|NCT03756883|450166507|FG001|Overall Study|Lost to Follow-up|3|||
125148464|NCT03756883|450166508|FG002|Overall Study|Lost to Follow-up|0|||
125148465|NCT03756883|450166506|FG000|Overall Study|Protocol Violation|2|||
125148466|NCT03756883|450166507|FG001|Overall Study|Protocol Violation|0|||
125148467|NCT03756883|450166508|FG002|Overall Study|Protocol Violation|1|||
125148468|NCT03756883|450166506|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
125148469|NCT03756883|450166507|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
125148470|NCT03756883|450166508|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
125148471|NCT03756883|450166506|FG000|Overall Study|Withdrawal by Subject|4|||
125148472|NCT03756883|450166507|FG001|Overall Study|Withdrawal by Subject|1|||
125148473|NCT03756883|450166508|FG002|Overall Study|Withdrawal by Subject|0|||
125148474|NCT03756883|450166506|FG000|Overall Study|Other Reasons|2|||
125148475|NCT03756883|450166507|FG001|Overall Study|Other Reasons|4|||
125148476|NCT03756883|450166508|FG002|Overall Study|Other Reasons|0|||
125148477|NCT03235479|450166511|FG000|Overall Study|Lost to Follow-up|8|||
125148478|NCT03235479|450166512|FG001|Overall Study|Lost to Follow-up|11|||
125148479|NCT03235479|450166511|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
125148480|NCT03235479|450166512|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
125148481|NCT03235479|450166511|FG000|Overall Study|Pregnancy|1|||
125148482|NCT03235479|450166512|FG001|Overall Study|Pregnancy|0|||
125148483|NCT03235479|450166511|FG000|Overall Study|Protocol Deviation|1|||
125148484|NCT03235479|450166512|FG001|Overall Study|Protocol Deviation|3|||
125148485|NCT03235479|450166511|FG000|Overall Study|Technical Problems|3|||
125148486|NCT03235479|450166512|FG001|Overall Study|Technical Problems|2|||
125148487|NCT03235479|450166511|FG000|Overall Study|Withdrawal by Subject|2|||
125148488|NCT03235479|450166512|FG001|Overall Study|Withdrawal by Subject|2|||
125148489|NCT03235479|450166511|FG000|Overall Study|Other Reasons|3|||
125148490|NCT03235479|450166512|FG001|Overall Study|Other Reasons|5|||
125148491|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
125148492|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
125148493|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
125148494|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
125148495|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
125148496|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
125148497|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125148498|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125148499|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
125148500|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
125148501|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
125148502|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
125148503|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
125148504|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
125148505|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
125148506|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
125148507|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Death|2|||
125148508|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Death|1|||
125148509|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Death|0|||
125148510|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Death|0|||
125148511|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
125148512|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
125148513|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
125148514|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
125148515|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
125148516|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
125148517|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
125148518|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
125148519|NCT03110380|450166524|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
125148520|NCT03110380|450166525|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
125148521|NCT03110380|450166526|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
125148522|NCT03110380|450166527|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
125148523|NCT03110380|450166524|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
125148524|NCT03110380|450166525|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
125148525|NCT03110380|450166526|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
125148526|NCT03110380|450166527|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
125148527|NCT03110380|450166524|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
125148528|NCT03110380|450166525|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
125148529|NCT03110380|450166526|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
125148530|NCT03110380|450166527|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
125148531|NCT03110380|450166524|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
125148532|NCT03110380|450166525|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
125148533|NCT03110380|450166526|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
125148534|NCT03110380|450166527|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
125148535|NCT01355302|450166530|FG000|Phase 1b|Death|4|||
125148536|NCT01355302|450166531|FG001|Phase 1b|Death|0|||
125148537|NCT01355302|450166532|FG002|Phase 1b|Death|0|||
125148538|NCT01355302|450166530|FG000|Phase 1b|Study terminated by sponsor|2|||
125148539|NCT01355302|450166531|FG001|Phase 1b|Study terminated by sponsor|0|||
125148540|NCT01355302|450166532|FG002|Phase 1b|Study terminated by sponsor|0|||
125148541|NCT02531594|450166533|FG000|Overall Study|Withdrawal by Subject|7|||
125148542|NCT02531594|450166534|FG001|Overall Study|Withdrawal by Subject|8|||
125148543|NCT03750695|450166535|FG000|Overall Study|Lost to Follow-up|0|||
125388091|NCT00107198|451054002|FG000|Overall Study|Withdrawal by Subject|6|||
125148544|NCT03750695|450166536|FG001|Overall Study|Lost to Follow-up|1|||
125148545|NCT04480307|450166539|FG000|Overall Study|Withdrawal by Subject|0|||
125148546|NCT04480307|450166540|FG001|Overall Study|Withdrawal by Subject|1|||
125148547|NCT04480307|450166541|FG002|Overall Study|Withdrawal by Subject|0|||
125148548|NCT04480307|450166542|FG003|Overall Study|Withdrawal by Subject|0|||
125148549|NCT04480307|450166539|FG000|Overall Study|Adverse Event|0|||
125148550|NCT04480307|450166540|FG001|Overall Study|Adverse Event|0|||
125148551|NCT04480307|450166541|FG002|Overall Study|Adverse Event|0|||
125148552|NCT04480307|450166542|FG003|Overall Study|Adverse Event|1|||
125148553|NCT01203917|450166544|FG000|Overall Study|Death|29|||
125148554|NCT01203917|450166544|FG000|Overall Study|Lost to Follow-up|2|||
125148555|NCT01203917|450166544|FG000|Overall Study|Withdrawal by Subject|3|||
125148556|NCT01203917|450166544|FG000|Overall Study|Due to objective disease progression|1|||
125148557|NCT01203917|450166544|FG000|Overall Study|Due to EGFR M+I patient|1|||
125148558|NCT01264835|450166545|FG000|Overall Study|Lost to Follow-up|1|||
125148559|NCT04660032|450166548|FG000|Overall Study|Protocol Violation|1|||
125148560|NCT04660032|450166549|FG001|Overall Study|Protocol Violation|1|||
125148561|NCT01609582|450166558|FG000|Overall Study|Adverse Event|20|||
125148562|NCT01609582|450166559|FG001|Overall Study|Adverse Event|18|||
125148563|NCT01609582|450166558|FG000|Overall Study|Lost to Follow-up|10|||
125148564|NCT01609582|450166559|FG001|Overall Study|Lost to Follow-up|10|||
125148565|NCT01609582|450166558|FG000|Overall Study|Withdrawal by Subject|21|||
125148566|NCT01609582|450166559|FG001|Overall Study|Withdrawal by Subject|15|||
125148567|NCT01609582|450166558|FG000|Overall Study|Study Terminated by Sponsor|1543|||
125148568|NCT01609582|450166559|FG001|Overall Study|Study Terminated by Sponsor|1548|||
125148569|NCT01609582|450166558|FG000|Overall Study|Other|9|||
125148570|NCT01609582|450166559|FG001|Overall Study|Other|10|||
125148571|NCT01609582|450166558|FG000|Overall Study|Randomized, but not treated|0|||
125148572|NCT01609582|450166559|FG001|Overall Study|Randomized, but not treated|3|||
125148573|NCT00819767|450166560|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125388092|NCT00107198|451054002|FG000|Overall Study|Ineligible|5|||
125388093|NCT05442554|451054003|FG000|Overall Study|Adverse Event|1|||
125388094|NCT00751348|451054004|FG000|Overall Study|Withdrawal by Subject|5|||
125148574|NCT00819767|450166561|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125148575|NCT00808509|450166565|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
125148576|NCT00808509|450166566|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
125148577|NCT00808509|450166565|FG000|Randomized Phase|Reduced methotrexate dose|1|||
125148578|NCT00808509|450166566|FG001|Randomized Phase|Reduced methotrexate dose|2|||
125148579|NCT00808509|450166565|FG000|Randomized Phase|Patient refused rescue therapy|0|||
125148580|NCT00808509|450166566|FG001|Randomized Phase|Patient refused rescue therapy|3|||
125148581|NCT02762994|450166569|FG000|Overall Study|Withdrawal by Subject|0|||
125148582|NCT02762994|450166570|FG001|Overall Study|Withdrawal by Subject|1|||
125148583|NCT02762994|450166571|FG002|Overall Study|Withdrawal by Subject|2|||
125148584|NCT02762994|450166572|FG003|Overall Study|Withdrawal by Subject|0|||
125148585|NCT02762994|450166569|FG000|Overall Study|Protocol Violation|1|||
125148586|NCT02762994|450166570|FG001|Overall Study|Protocol Violation|0|||
125148587|NCT02762994|450166571|FG002|Overall Study|Protocol Violation|0|||
125148588|NCT02762994|450166572|FG003|Overall Study|Protocol Violation|2|||
125148589|NCT05103657|450166575|FG000|Overall Study|Other reasons than listed|9|||
125148590|NCT05103657|450166576|FG001|Overall Study|Other reasons than listed|8|||
125148591|NCT05103657|450166575|FG000|Overall Study|Protocol deviation|2|||
125148592|NCT05103657|450166576|FG001|Overall Study|Protocol deviation|2|||
125148593|NCT05103657|450166575|FG000|Overall Study|No reason available|5|||
125148594|NCT05103657|450166576|FG001|Overall Study|No reason available|4|||
125148595|NCT05103657|450166575|FG000|Overall Study|Burden of study procedures|3|||
125148596|NCT05103657|450166576|FG001|Overall Study|Burden of study procedures|1|||
125148597|NCT05103657|450166575|FG000|Overall Study|Perceived lack of efficacy|1|||
125148598|NCT05103657|450166576|FG001|Overall Study|Perceived lack of efficacy|1|||
125148599|NCT05103657|450166575|FG000|Overall Study|Adverse Event|6|||
125148600|NCT05103657|450166576|FG001|Overall Study|Adverse Event|14|||
125148601|NCT05103657|450166575|FG000|Overall Study|Not Treated|1|||
125148602|NCT05103657|450166576|FG001|Overall Study|Not Treated|1|||
125148603|NCT04234464|450166580|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
125148604|NCT04234464|450166581|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
125148605|NCT03635983|450166582|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
125148606|NCT03635983|450166583|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
125148607|NCT03635983|450166582|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
125148608|NCT03635983|450166583|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125148609|NCT03635983|450166582|FG000|Pre-Treatment Period|Other reasons|0|||
125148610|NCT03635983|450166583|FG001|Pre-Treatment Period|Other reasons|1|||
125148611|NCT03635983|450166582|FG000|Pre-Treatment Period|Disease Progression|0|||
125148612|NCT03635983|450166583|FG001|Pre-Treatment Period|Disease Progression|1|||
125148613|NCT03635983|450166582|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
125148614|NCT03635983|450166583|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
125148615|NCT03635983|450166582|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
125148616|NCT03635983|450166583|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
125148617|NCT03635983|450166582|FG000|Treatment Period|Withdrawal by Subject|3|||
125148618|NCT03635983|450166583|FG001|Treatment Period|Withdrawal by Subject|5|||
125148619|NCT03635983|450166582|FG000|Treatment Period|Death|3|||
125148620|NCT03635983|450166583|FG001|Treatment Period|Death|5|||
125148621|NCT03635983|450166582|FG000|Treatment Period|Poor/Non-compliance|2|||
125148622|NCT03635983|450166583|FG001|Treatment Period|Poor/Non-compliance|1|||
125148623|NCT03635983|450166582|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
125148624|NCT03635983|450166583|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
125148625|NCT03635983|450166582|FG000|Treatment Period|Other reasons|7|||
125148626|NCT03635983|450166583|FG001|Treatment Period|Other reasons|4|||
125148627|NCT03635983|450166582|FG000|Treatment Period|Disease progression|230|||
125148628|NCT03635983|450166583|FG001|Treatment Period|Disease progression|201|||
125148629|NCT03635983|450166582|FG000|Treatment Period|Study drug toxicity|35|||
125148630|NCT03635983|450166583|FG001|Treatment Period|Study drug toxicity|36|||
125148631|NCT03635983|450166582|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
125148632|NCT03635983|450166583|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
125148633|NCT03635983|450166582|FG000|Treatment Period|Maximum clinical benefit|3|||
125148634|NCT03635983|450166583|FG001|Treatment Period|Maximum clinical benefit|5|||
125148635|NCT03635983|450166582|FG000|Treatment Period|Administrative reason by the sponsor|1|||
125148636|NCT03635983|450166583|FG001|Treatment Period|Administrative reason by the sponsor|2|||
125148637|NCT03635983|450166582|FG000|Treatment Period|Lost to Follow-up|0|||
125148638|NCT03635983|450166583|FG001|Treatment Period|Lost to Follow-up|1|||
125148639|NCT01235442|450166585|FG000|Overall Study|Lost to Follow-up|12|||
125148640|NCT01235442|450166586|FG001|Overall Study|Lost to Follow-up|10|||
125148641|NCT01235442|450166585|FG000|Overall Study|Death|0|||
125148642|NCT01235442|450166586|FG001|Overall Study|Death|2|||
125148643|NCT01235442|450166585|FG000|Overall Study|Pregnancy|1|||
125148644|NCT01235442|450166586|FG001|Overall Study|Pregnancy|1|||
125148645|NCT01235442|450166585|FG000|Overall Study|Ineligibility determined|5|||
125148646|NCT01235442|450166586|FG001|Overall Study|Ineligibility determined|4|||
125148647|NCT01235442|450166585|FG000|Overall Study|Protocol Violation|3|||
125148648|NCT01235442|450166586|FG001|Overall Study|Protocol Violation|3|||
125148649|NCT01235442|450166585|FG000|Overall Study|Adverse Event|4|||
125148650|NCT01235442|450166586|FG001|Overall Study|Adverse Event|6|||
125148651|NCT01235442|450166585|FG000|Overall Study|Withdrawal by Subject|15|||
125148652|NCT01235442|450166586|FG001|Overall Study|Withdrawal by Subject|9|||
125148653|NCT01235442|450166585|FG000|Overall Study|Lack of Efficacy|1|||
125148654|NCT01235442|450166586|FG001|Overall Study|Lack of Efficacy|3|||
125148655|NCT01235442|450166585|FG000|Overall Study|Noncompliance|1|||
125148656|NCT01235442|450166586|FG001|Overall Study|Noncompliance|2|||
125148657|NCT01235442|450166585|FG000|Overall Study|Administrative decision|1|||
125148658|NCT01235442|450166586|FG001|Overall Study|Administrative decision|2|||
125148659|NCT01235442|450166585|FG000|Overall Study|Other unspecified|1|||
125148660|NCT01235442|450166586|FG001|Overall Study|Other unspecified|2|||
125148661|NCT01701973|450166589|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148662|NCT01701973|450166590|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
125148663|NCT01701973|450166591|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148664|NCT01701973|450166592|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148665|NCT01701973|450166593|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148666|NCT01701973|450166594|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148667|NCT01701973|450166595|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148668|NCT01701973|450166596|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
125148669|NCT02412722|450166599|FG000|Overall Study|Adverse Event|0|||
125148670|NCT02412722|450166600|FG001|Overall Study|Adverse Event|2|||
125148671|NCT02412722|450166601|FG002|Overall Study|Adverse Event|0|||
125148672|NCT02412722|450166602|FG003|Overall Study|Adverse Event|3|||
125148673|NCT02412722|450166603|FG004|Overall Study|Adverse Event|0|||
125148674|NCT02412722|450166604|FG005|Overall Study|Adverse Event|3|||
125148675|NCT02412722|450166599|FG000|Overall Study|Progressive Disease|6|||
125148676|NCT02412722|450166600|FG001|Overall Study|Progressive Disease|4|||
125148677|NCT02412722|450166601|FG002|Overall Study|Progressive Disease|4|||
125148678|NCT02412722|450166602|FG003|Overall Study|Progressive Disease|9|||
125148679|NCT02412722|450166603|FG004|Overall Study|Progressive Disease|3|||
125148680|NCT02412722|450166604|FG005|Overall Study|Progressive Disease|3|||
125148681|NCT02412722|450166599|FG000|Overall Study|Withdrawal by Subject|2|||
125148682|NCT02412722|450166600|FG001|Overall Study|Withdrawal by Subject|0|||
125148683|NCT02412722|450166601|FG002|Overall Study|Withdrawal by Subject|1|||
125148684|NCT02412722|450166602|FG003|Overall Study|Withdrawal by Subject|2|||
125148685|NCT02412722|450166603|FG004|Overall Study|Withdrawal by Subject|1|||
125148686|NCT02412722|450166604|FG005|Overall Study|Withdrawal by Subject|1|||
125148687|NCT02412722|450166599|FG000|Overall Study|Lost to Follow-up|0|||
125148688|NCT02412722|450166600|FG001|Overall Study|Lost to Follow-up|0|||
125148689|NCT02412722|450166601|FG002|Overall Study|Lost to Follow-up|0|||
125148690|NCT02412722|450166602|FG003|Overall Study|Lost to Follow-up|0|||
125148691|NCT02412722|450166603|FG004|Overall Study|Lost to Follow-up|1|||
125148692|NCT02412722|450166604|FG005|Overall Study|Lost to Follow-up|0|||
125148693|NCT02412722|450166599|FG000|Overall Study|Received drug in run-in and discontinued|0|||
125148694|NCT02412722|450166600|FG001|Overall Study|Received drug in run-in and discontinued|2|||
125148695|NCT02412722|450166601|FG002|Overall Study|Received drug in run-in and discontinued|0|||
125148696|NCT02412722|450166602|FG003|Overall Study|Received drug in run-in and discontinued|0|||
125148697|NCT02412722|450166603|FG004|Overall Study|Received drug in run-in and discontinued|0|||
125148698|NCT02412722|450166604|FG005|Overall Study|Received drug in run-in and discontinued|0|||
125148699|NCT02412722|450166599|FG000|Overall Study|Reason not Specified|3|||
125148700|NCT02412722|450166600|FG001|Overall Study|Reason not Specified|0|||
125148701|NCT02412722|450166601|FG002|Overall Study|Reason not Specified|2|||
125148702|NCT02412722|450166602|FG003|Overall Study|Reason not Specified|1|||
125148703|NCT02412722|450166603|FG004|Overall Study|Reason not Specified|2|||
125148704|NCT02412722|450166604|FG005|Overall Study|Reason not Specified|6|||
125148705|NCT02941523|450166605|FG000|Monotherapy|Withdrawal by Subject|0|||
125148706|NCT02941523|450166606|FG001|Monotherapy|Withdrawal by Subject|1|||
125148707|NCT02941523|450166605|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
125148708|NCT02941523|450166606|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
125148709|NCT02941523|450166605|FG000|Carboplatin Combination Therapy|Death|1|||
125148710|NCT02941523|450166606|FG001|Carboplatin Combination Therapy|Death|2|||
125148711|NCT02941523|450166605|FG000|Carboplatin Combination Therapy|Disease progression|2|||
125148712|NCT02941523|450166606|FG001|Carboplatin Combination Therapy|Disease progression|0|||
125148713|NCT02941523|450166605|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
125148714|NCT02941523|450166606|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
125148715|NCT04449341|450166607|FG000|Overall Study|Protocol Violation|1|||
125148716|NCT04449341|450166608|FG001|Overall Study|Protocol Violation|0|||
125148717|NCT04499482|450166609|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
125148718|NCT04330157|450166610|FG000|Overall Study|Protocol Violation|4|||
125148719|NCT04330157|450166610|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
125148720|NCT01899326|450166612|FG000|Overall Study|Withdrawal by Subject|1|||
125148721|NCT01899326|450166612|FG000|Overall Study|Adverse Event|2|||
125148722|NCT01899326|450166612|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
125148723|NCT01263561|450166613|FG000|Overall Study|Death|1|||
125148724|NCT01263561|450166614|FG001|Overall Study|Death|2|||
125148725|NCT01396421|450166615|FG000|Overall Study|Lost to Follow-up|0|||
125148726|NCT01396421|450166616|FG001|Overall Study|Lost to Follow-up|0|||
125148727|NCT01396421|450166617|FG002|Overall Study|Lost to Follow-up|0|||
125148728|NCT01396421|450166618|FG003|Overall Study|Lost to Follow-up|1|||
125148729|NCT01396421|450166615|FG000|Overall Study|Adverse Event|17|||
125148730|NCT01396421|450166616|FG001|Overall Study|Adverse Event|15|||
125148731|NCT01396421|450166617|FG002|Overall Study|Adverse Event|12|||
125388095|NCT00751348|451054005|FG001|Overall Study|Withdrawal by Subject|2|||
125388096|NCT00751348|451054004|FG000|Overall Study|Migration from study area|1|||
125388097|NCT00751348|451054005|FG001|Overall Study|Migration from study area|0|||
125148732|NCT01396421|450166618|FG003|Overall Study|Adverse Event|32|||
125148733|NCT01396421|450166615|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
125148734|NCT01396421|450166616|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
125148735|NCT01396421|450166617|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
125148736|NCT01396421|450166618|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
125148737|NCT01396421|450166615|FG000|Overall Study|Physician Decision|1|||
125148738|NCT01396421|450166616|FG001|Overall Study|Physician Decision|1|||
125148739|NCT01396421|450166617|FG002|Overall Study|Physician Decision|0|||
125148740|NCT01396421|450166618|FG003|Overall Study|Physician Decision|3|||
125148741|NCT01396421|450166615|FG000|Overall Study|Withdrawal by Subject|31|||
125148742|NCT01396421|450166616|FG001|Overall Study|Withdrawal by Subject|24|||
125148743|NCT01396421|450166617|FG002|Overall Study|Withdrawal by Subject|13|||
125148744|NCT01396421|450166618|FG003|Overall Study|Withdrawal by Subject|21|||
125148745|NCT01396421|450166615|FG000|Overall Study|Protocol Deviation|2|||
125148746|NCT01396421|450166616|FG001|Overall Study|Protocol Deviation|1|||
125148747|NCT01396421|450166617|FG002|Overall Study|Protocol Deviation|1|||
125148748|NCT01396421|450166618|FG003|Overall Study|Protocol Deviation|0|||
125148749|NCT01396421|450166615|FG000|Overall Study|Lack of Efficacy|7|||
125148750|NCT01396421|450166616|FG001|Overall Study|Lack of Efficacy|17|||
125148751|NCT01396421|450166617|FG002|Overall Study|Lack of Efficacy|7|||
125148752|NCT01396421|450166618|FG003|Overall Study|Lack of Efficacy|18|||
125148753|NCT03689894|450166623|FG000|Overall Study|Adverse Event|1|||
125148754|NCT01321697|450166629|FG000|Overall Study|Study Terminated|7|||
125148755|NCT00857818|450166630|FG000|Overall Study|Lack of Efficacy|1|||
125148756|NCT00857818|450166631|FG001|Overall Study|Lack of Efficacy|0|||
125148757|NCT00857818|450166630|FG000|Overall Study|Adverse Event|3|||
125148758|NCT00857818|450166631|FG001|Overall Study|Adverse Event|0|||
125148759|NCT00857818|450166630|FG000|Overall Study|Withdrawal by Subject|0|||
125148760|NCT00857818|450166631|FG001|Overall Study|Withdrawal by Subject|4|||
125148761|NCT00857818|450166630|FG000|Overall Study|Sponsor terminated study|6|||
125148762|NCT00857818|450166631|FG001|Overall Study|Sponsor terminated study|4|||
125148763|NCT00857818|450166630|FG000|Overall Study|Investigator decision|1|||
125148764|NCT00857818|450166631|FG001|Overall Study|Investigator decision|0|||
125148765|NCT04149535|450166633|FG000|Overall Study|Death|11|||
125148766|NCT04149535|450166634|FG001|Overall Study|Death|7|||
125148767|NCT04149535|450166633|FG000|Overall Study|Physician Decision|10|||
125148768|NCT04149535|450166634|FG001|Overall Study|Physician Decision|4|||
125148769|NCT04149535|450166633|FG000|Overall Study|Withdrawal by Subject|6|||
125148770|NCT04149535|450166634|FG001|Overall Study|Withdrawal by Subject|7|||
125148771|NCT04149535|450166633|FG000|Overall Study|Not described|2|||
125148772|NCT04149535|450166634|FG001|Overall Study|Not described|0|||
125148773|NCT02175368|450166635|FG000|Overall Study|Lost to Follow-up|1|||
125148774|NCT02875028|450166636|FG000|Washout Period|Withdrawal by Subject|0|||
125148775|NCT02875028|450166637|FG001|Washout Period|Withdrawal by Subject|1|||
125148776|NCT03180528|450168091|FG000|Overall Study|Adverse Event|1|||
125148777|NCT03180528|450168091|FG000|Overall Study|Withdrawal by Subject|1|||
125148778|NCT03180528|450168091|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
125148779|NCT04703855|450168092|FG000|Overall Study|Heart Transplant|1|||
125148780|NCT01989676|450168095|FG000|Overall Study|Death|52|||
125148781|NCT01989676|450168096|FG001|Overall Study|Death|60|||
125148782|NCT01989676|450168095|FG000|Overall Study|Protocol Violation|2|||
125148783|NCT01989676|450168096|FG001|Overall Study|Protocol Violation|1|||
125148784|NCT01989676|450168095|FG000|Overall Study|Lost to Follow-up|8|||
125148785|NCT01989676|450168096|FG001|Overall Study|Lost to Follow-up|18|||
125148786|NCT01989676|450168095|FG000|Overall Study|No longer willing to participate in study|26|||
125148787|NCT01989676|450168096|FG001|Overall Study|No longer willing to participate in study|26|||
125148788|NCT01989676|450168095|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
125148789|NCT01989676|450168096|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
125148790|NCT01989676|450168095|FG000|Overall Study|Other|4|||
125148791|NCT01989676|450168096|FG001|Overall Study|Other|3|||
125388098|NCT04191382|451054010|FG000|Overall Study|Withdrawal by Subject|1|||
125148792|NCT03941834|450168097|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
125388099|NCT04191382|451054011|FG001|Overall Study|Withdrawal by Subject|0|||
125148793|NCT03941834|450168098|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
125148794|NCT03941834|450168099|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
125148795|NCT03941834|450168097|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
125148796|NCT03941834|450168098|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
125148797|NCT03941834|450168099|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
125148798|NCT03941834|450168097|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
125148799|NCT03941834|450168098|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
125148800|NCT03941834|450168099|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
125148801|NCT03941834|450168097|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
125148802|NCT03941834|450168098|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
125148803|NCT03941834|450168099|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
125148804|NCT03941834|450168097|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
125148805|NCT03941834|450168098|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
125148806|NCT03941834|450168099|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
125148807|NCT03941834|450168097|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
125148808|NCT03941834|450168098|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
125148809|NCT03941834|450168099|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
125148810|NCT01560819|450168103|FG000|Overall Study|Physician Decision|1|||
125148811|NCT01560819|450168104|FG001|Overall Study|Physician Decision|0|||
125148812|NCT00114231|450168105|FG000|Overall Study|No consent|2|||
125148813|NCT00114231|450168106|FG001|Overall Study|No consent|0|||
125148814|NCT00114231|450168105|FG000|Overall Study|QARC requirement not met|1|||
125148815|NCT00114231|450168106|FG001|Overall Study|QARC requirement not met|0|||
125148816|NCT00114231|450168105|FG000|Overall Study|Suspected metastatic disease|1|||
125148817|NCT00114231|450168106|FG001|Overall Study|Suspected metastatic disease|0|||
125148818|NCT00114231|450168105|FG000|Overall Study|No adenocarcinoma|1|||
125148819|NCT00114231|450168106|FG001|Overall Study|No adenocarcinoma|0|||
125148820|NCT00114231|450168105|FG000|Overall Study|Low creatinine clearance|0|||
125148821|NCT00114231|450168106|FG001|Overall Study|Low creatinine clearance|1|||
125148822|NCT00114231|450168105|FG000|Overall Study|Tumor size > 4cm|1|||
125148823|NCT00114231|450168106|FG001|Overall Study|Tumor size > 4cm|0|||
125148824|NCT00114231|450168105|FG000|Overall Study|Tumor fixed on digital exam|0|||
125148825|NCT00114231|450168106|FG001|Overall Study|Tumor fixed on digital exam|1|||
125148826|NCT00114231|450168105|FG000|Overall Study|No Absolute Neutrophil Count|2|||
125148827|NCT00114231|450168106|FG001|Overall Study|No Absolute Neutrophil Count|0|||
125148828|NCT00114231|450168105|FG000|Overall Study|Biopsy done after registration|1|||
125148829|NCT00114231|450168106|FG001|Overall Study|Biopsy done after registration|0|||
125148830|NCT01976728|450168109|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
125148831|NCT01976728|450168110|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
125148832|NCT01976728|450168111|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
125148833|NCT01976728|450168112|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
125148834|NCT00966381|450168114|FG000|Overall Study|Withdrawal by Subject|2|||
125148835|NCT00966381|450168115|FG001|Overall Study|Withdrawal by Subject|2|||
125148836|NCT01124695|450168119|FG000|Overall Study|Disease progression|77|||
125148837|NCT01124695|450168119|FG000|Overall Study|Adverse Event|11|||
125148838|NCT01124695|450168119|FG000|Overall Study|Death|1|||
125148839|NCT01124695|450168119|FG000|Overall Study|Withdrawal by Subject|7|||
125148840|NCT01124695|450168119|FG000|Overall Study|Physician Decision|3|||
125148841|NCT01124695|450168119|FG000|Overall Study|Alternative therapy|9|||
125148842|NCT01124695|450168119|FG000|Overall Study|No documentation that patient went off treatment|4|||
125148843|NCT01124695|450168119|FG000|Overall Study|Ineligible|9|||
125148844|NCT01124695|450168119|FG000|Overall Study|Ineligible and never start treatment|2|||
125148845|NCT02668822|450168120|FG000|Overall Study|Protocol Violation|2|||
125148846|NCT02668822|450168121|FG001|Overall Study|Protocol Violation|0|||
125148847|NCT02668822|450168120|FG000|Overall Study|Study Terminated by Sponsor|7|||
125148848|NCT02668822|450168121|FG001|Overall Study|Study Terminated by Sponsor|9|||
125148849|NCT01522950|450168122|FG000|Overall Study|Withdrawal by Subject|3|||
125148850|NCT01522950|450168123|FG001|Overall Study|Withdrawal by Subject|2|||
125148851|NCT01522950|450168124|FG002|Overall Study|Withdrawal by Subject|1|||
125148852|NCT01522950|450168122|FG000|Overall Study|Adverse Event|3|||
125148853|NCT01522950|450168123|FG001|Overall Study|Adverse Event|1|||
125148854|NCT01522950|450168124|FG002|Overall Study|Adverse Event|1|||
125148855|NCT01522950|450168122|FG000|Overall Study|Protocol Violation|0|||
125148856|NCT01522950|450168123|FG001|Overall Study|Protocol Violation|0|||
125148857|NCT01522950|450168124|FG002|Overall Study|Protocol Violation|2|||
125148858|NCT01522950|450168122|FG000|Overall Study|Death|0|||
125148859|NCT01522950|450168123|FG001|Overall Study|Death|1|||
125148860|NCT01522950|450168124|FG002|Overall Study|Death|1|||
125148861|NCT01522950|450168122|FG000|Overall Study|Study Medication Sensitivity|0|||
125148862|NCT01522950|450168123|FG001|Overall Study|Study Medication Sensitivity|1|||
125148863|NCT01522950|450168124|FG002|Overall Study|Study Medication Sensitivity|0|||
125148864|NCT00298740|450168127|FG000|Overall Study|Lack of Efficacy|6|||
125388100|NCT04191382|451054012|FG002|Overall Study|Withdrawal by Subject|0|||
125148865|NCT00298740|450168127|FG000|Overall Study|Withdrawal by Subject|3|||
125148866|NCT01345318|450168129|FG000|Overall Study|Adverse Event|16|||
125148867|NCT01345318|450168129|FG000|Overall Study|Lack of Efficacy|17|||
125148868|NCT01345318|450168129|FG000|Overall Study|Lost to Follow-up|2|||
125148869|NCT01345318|450168129|FG000|Overall Study|Protocol Violation|1|||
125148870|NCT01345318|450168129|FG000|Overall Study|Withdrawal by Subject|41|||
125148871|NCT01345318|450168129|FG000|Overall Study|Other|3|||
125148872|NCT00317642|450168130|FG000|Overall Study|Not Received Either Study Drug|1|||
125148873|NCT00317642|450168131|FG001|Overall Study|Not Received Either Study Drug|3|||
125388101|NCT05237206|451054013|FG000|Overall Study|screen failure-did not receive treatment|8|||
125148874|NCT00317642|450168130|FG000|Overall Study|Physician Decision|15|||
125388102|NCT05237206|451054013|FG000|Overall Study|did not receive treatment|3|||
125148875|NCT00317642|450168131|FG001|Overall Study|Physician Decision|7|||
125148876|NCT00317642|450168130|FG000|Overall Study|Participant declined treatment|14|||
125148877|NCT00317642|450168131|FG001|Overall Study|Participant declined treatment|3|||
125148878|NCT00317642|450168130|FG000|Overall Study|Adverse Event|17|||
125148879|NCT00317642|450168131|FG001|Overall Study|Adverse Event|5|||
125148880|NCT00317642|450168130|FG000|Overall Study|Treatment Failure|56|||
125148881|NCT00317642|450168131|FG001|Overall Study|Treatment Failure|102|||
125148882|NCT00317642|450168130|FG000|Overall Study|Disease Recurrence|1|||
125148883|NCT00317642|450168131|FG001|Overall Study|Disease Recurrence|2|||
125148884|NCT00317642|450168130|FG000|Overall Study|Death|14|||
125148885|NCT00317642|450168131|FG001|Overall Study|Death|7|||
125148886|NCT00317642|450168130|FG000|Overall Study|Not Continue to Consolidation|2|||
125148887|NCT00317642|450168131|FG001|Overall Study|Not Continue to Consolidation|0|||
125148888|NCT00317642|450168130|FG000|Overall Study|Withdrawal by Subject|0|||
125148889|NCT00317642|450168131|FG001|Overall Study|Withdrawal by Subject|1|||
125148890|NCT00317642|450168130|FG000|Overall Study|Referred For Transplantation|1|||
125148891|NCT00317642|450168131|FG001|Overall Study|Referred For Transplantation|0|||
125148892|NCT00317642|450168130|FG000|Overall Study|AML Not Centrally Confirmed|1|||
125148893|NCT00317642|450168131|FG001|Overall Study|AML Not Centrally Confirmed|5|||
125148894|NCT01049412|450168133|FG000|Period I|Withdrawal by Subject|4|||
125148895|NCT01049412|450168134|FG001|Period I|Withdrawal by Subject|6|||
125148896|NCT01049412|450168133|FG000|Period I|Lost to Follow-up|2|||
125148897|NCT01049412|450168134|FG001|Period I|Lost to Follow-up|2|||
125148898|NCT01049412|450168133|FG000|Period I|Physician Decision|0|||
125148899|NCT01049412|450168134|FG001|Period I|Physician Decision|3|||
125148900|NCT01049412|450168133|FG000|Period I|Protocol Violation|1|||
125148901|NCT01049412|450168134|FG001|Period I|Protocol Violation|2|||
125148902|NCT01049412|450168133|FG000|Period I|Adverse Event|1|||
125148903|NCT01049412|450168134|FG001|Period I|Adverse Event|0|||
125148904|NCT01049412|450168133|FG000|Period II|Withdrawal by Subject|2|||
125148905|NCT01049412|450168134|FG001|Period II|Withdrawal by Subject|3|||
125148906|NCT01049412|450168133|FG000|Period II|Adverse Event|1|||
125388103|NCT05172544|451054014|FG000|Overall Study|Withdrawal by Subject|1|||
125388104|NCT05172544|451054015|FG001|Overall Study|Withdrawal by Subject|0|||
125388105|NCT05172544|451054016|FG002|Overall Study|Withdrawal by Subject|0|||
125148907|NCT01049412|450168134|FG001|Period II|Adverse Event|0|||
125148908|NCT01049412|450168133|FG000|Period II|Lost to Follow-up|1|||
125148909|NCT01049412|450168134|FG001|Period II|Lost to Follow-up|0|||
125148910|NCT04205162|450168142|FG000|Overall Study|Lost to Follow-up|1|||
125148911|NCT04205162|450168143|FG001|Overall Study|Lost to Follow-up|0|||
125148912|NCT04205162|450168142|FG000|Overall Study|Withdrawal by Subject|2|||
125148913|NCT04205162|450168143|FG001|Overall Study|Withdrawal by Subject|0|||
125148914|NCT04205162|450168142|FG000|Overall Study|University closure due to COVID-19|1|||
125148915|NCT04205162|450168143|FG001|Overall Study|University closure due to COVID-19|0|||
125148916|NCT01011556|450168144|FG000|Overall Study|Adverse Event|1|||
125148917|NCT01011556|450168145|FG001|Overall Study|Adverse Event|3|||
125148918|NCT01011556|450168146|FG002|Overall Study|Adverse Event|2|||
125148919|NCT01011556|450168147|FG003|Overall Study|Adverse Event|1|||
125148920|NCT01011556|450168144|FG000|Overall Study|Lost to Follow-up|1|||
125148921|NCT01011556|450168145|FG001|Overall Study|Lost to Follow-up|0|||
125148922|NCT01011556|450168146|FG002|Overall Study|Lost to Follow-up|0|||
125148923|NCT01011556|450168147|FG003|Overall Study|Lost to Follow-up|0|||
125148924|NCT01011556|450168144|FG000|Overall Study|Physician Decision|1|||
125148925|NCT01011556|450168145|FG001|Overall Study|Physician Decision|0|||
125148926|NCT01011556|450168146|FG002|Overall Study|Physician Decision|0|||
125148927|NCT01011556|450168147|FG003|Overall Study|Physician Decision|1|||
125148928|NCT01011556|450168144|FG000|Overall Study|Protocol Violation|0|||
125148929|NCT01011556|450168145|FG001|Overall Study|Protocol Violation|1|||
125148930|NCT01011556|450168146|FG002|Overall Study|Protocol Violation|0|||
125148931|NCT01011556|450168147|FG003|Overall Study|Protocol Violation|0|||
125148932|NCT01011556|450168144|FG000|Overall Study|Withdrawal by Subject|1|||
125148933|NCT01011556|450168145|FG001|Overall Study|Withdrawal by Subject|2|||
125148934|NCT01011556|450168146|FG002|Overall Study|Withdrawal by Subject|4|||
125148935|NCT01011556|450168147|FG003|Overall Study|Withdrawal by Subject|4|||
125148936|NCT01011556|450168144|FG000|Overall Study|Sponsor decision|0|||
125148937|NCT01011556|450168145|FG001|Overall Study|Sponsor decision|1|||
125148938|NCT01011556|450168146|FG002|Overall Study|Sponsor decision|1|||
125148939|NCT01011556|450168147|FG003|Overall Study|Sponsor decision|2|||
125148940|NCT01011556|450168144|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
125148941|NCT01011556|450168145|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
125148942|NCT01011556|450168146|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
125148943|NCT01011556|450168147|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
125148944|NCT00263887|450168148|FG000|Overall Study|Withdrawal by Subject|1|||
125148945|NCT00263887|450168149|FG001|Overall Study|Withdrawal by Subject|1|||
125148946|NCT00263887|450168148|FG000|Overall Study|Lung transplantation|1|||
125148947|NCT00263887|450168149|FG001|Overall Study|Lung transplantation|2|||
125148948|NCT00263887|450168148|FG000|Overall Study|Too ill to attend visit|1|||
125148949|NCT00263887|450168149|FG001|Overall Study|Too ill to attend visit|0|||
125148950|NCT00263887|450168148|FG000|Overall Study|Adverse Event|0|||
125148951|NCT00263887|450168149|FG001|Overall Study|Adverse Event|2|||
125148952|NCT00263887|450168148|FG000|Overall Study|Disease progression|0|||
125148953|NCT00263887|450168149|FG001|Overall Study|Disease progression|1|||
125148954|NCT00263887|450168148|FG000|Overall Study|Lack of Efficacy|0|||
125148955|NCT00263887|450168149|FG001|Overall Study|Lack of Efficacy|1|||
125148956|NCT00779402|450168150|FG000|Treatment Phase 1|Disease Progression|1|||
125148957|NCT00779402|450168151|FG001|Treatment Phase 1|Disease Progression|0|||
125148958|NCT00779402|450168150|FG000|Treatment Phase 1|Adverse Event|2|||
125148959|NCT00779402|450168151|FG001|Treatment Phase 1|Adverse Event|0|||
125148960|NCT00779402|450168150|FG000|Treatment Phase 1|Protocol Violation|1|||
125148961|NCT00779402|450168151|FG001|Treatment Phase 1|Protocol Violation|0|||
125148962|NCT00779402|450168150|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
125148963|NCT00779402|450168151|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
125148964|NCT00779402|450168150|FG000|Treatment Phase 1|Lost to Follow-up|0|||
125148965|NCT00779402|450168151|FG001|Treatment Phase 1|Lost to Follow-up|1|||
125148966|NCT00779402|450168150|FG000|Treatment Phase 1|Death|0|||
125148967|NCT00779402|450168151|FG001|Treatment Phase 1|Death|1|||
125148968|NCT00779402|450168150|FG000|Treatment Phase 1|Intercurrent Illness|1|||
125148969|NCT00779402|450168151|FG001|Treatment Phase 1|Intercurrent Illness|1|||
125148970|NCT00779402|450168150|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
125148971|NCT00779402|450168151|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
125148972|NCT00779402|450168150|FG000|Treatment Phase 1|Other|4|||
125148973|NCT00779402|450168151|FG001|Treatment Phase 1|Other|2|||
125148974|NCT00779402|450168150|FG000|Treatment Phase 1|Closure of Study|3|||
125148975|NCT00779402|450168151|FG001|Treatment Phase 1|Closure of Study|2|||
125148976|NCT00779402|450168150|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
125148977|NCT00779402|450168151|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
125148978|NCT00779402|450168150|FG000|Surveillance Phase|Protocol Violation|0|||
125148979|NCT00779402|450168151|FG001|Surveillance Phase|Protocol Violation|1|||
125148980|NCT00779402|450168150|FG000|Surveillance Phase|Patient refused to continue|22|||
125148981|NCT00779402|450168151|FG001|Surveillance Phase|Patient refused to continue|14|||
125148982|NCT00779402|450168150|FG000|Surveillance Phase|Lost to Follow-up|2|||
125148983|NCT00779402|450168151|FG001|Surveillance Phase|Lost to Follow-up|1|||
125148984|NCT00779402|450168150|FG000|Surveillance Phase|Death|0|||
125148985|NCT00779402|450168151|FG001|Surveillance Phase|Death|1|||
125148986|NCT00779402|450168150|FG000|Surveillance Phase|Intercurrent Illness|2|||
125148987|NCT00779402|450168151|FG001|Surveillance Phase|Intercurrent Illness|0|||
125148988|NCT00779402|450168150|FG000|Surveillance Phase|Other|5|||
125148989|NCT00779402|450168151|FG001|Surveillance Phase|Other|5|||
125148990|NCT00779402|450168150|FG000|Surveillance Phase|Withdrawal by Subject|4|||
125148991|NCT00779402|450168151|FG001|Surveillance Phase|Withdrawal by Subject|1|||
125148992|NCT00779402|450168150|FG000|Surveillance Phase|Closure of study|5|||
125148993|NCT00779402|450168151|FG001|Surveillance Phase|Closure of study|6|||
125148994|NCT00779402|450168150|FG000|Surveillance Phase|Completed Protocol Visits|3|||
125148995|NCT00779402|450168151|FG001|Surveillance Phase|Completed Protocol Visits|2|||
125148996|NCT00779402|450168150|FG000|Long-term Follow-up|Patient refused to continue|2|||
125148997|NCT00779402|450168151|FG001|Long-term Follow-up|Patient refused to continue|0|||
125148998|NCT00779402|450168150|FG000|Long-term Follow-up|Other|5|||
125148999|NCT00779402|450168151|FG001|Long-term Follow-up|Other|0|||
125149000|NCT00779402|450168150|FG000|Long-term Follow-up|Closure of Study|8|||
125149001|NCT00779402|450168151|FG001|Long-term Follow-up|Closure of Study|4|||
125149002|NCT00779402|450168150|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
125149003|NCT00779402|450168151|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
125149004|NCT00693225|450168152|FG000|Overall Study|Lost to Follow-up|1|||
125149005|NCT00693225|450168153|FG001|Overall Study|Lost to Follow-up|2|||
125149006|NCT00693225|450168152|FG000|Overall Study|Adverse Event|1|||
125149007|NCT00693225|450168153|FG001|Overall Study|Adverse Event|3|||
125149008|NCT01315028|450168154|FG000|Overall Study|Lost to Follow-up|1|||
125149009|NCT01315028|450168155|FG001|Overall Study|Lost to Follow-up|0|||
125149010|NCT01315028|450168154|FG000|Overall Study|Death|0|||
125149011|NCT01315028|450168155|FG001|Overall Study|Death|1|||
125149012|NCT02359864|450168156|FG000|Overall Study|Withdrawal by Subject|1|||
125149013|NCT02359864|450168157|FG001|Overall Study|Withdrawal by Subject|0|||
125149014|NCT00725764|450168158|FG000|Overall Study|Withdrawal by Subject|2|||
125149015|NCT00725764|450168158|FG000|Overall Study|Physician Decision|1|||
125149016|NCT00725764|450168158|FG000|Overall Study|Progressive Disease|7|||
125149017|NCT00725764|450168158|FG000|Overall Study|Lost to Follow-up|1|||
125149018|NCT00725764|450168158|FG000|Overall Study|Death|1|||
125149019|NCT00725764|450168158|FG000|Overall Study|Participant non compliant with protocol|1|||
125149020|NCT00725764|450168158|FG000|Overall Study|Decline in performance status|1|||
125149021|NCT01928615|450168159|FG000|Overall Study|Study Terminated by Sponsor|2|||
125149022|NCT00090753|450168160|FG000|First Treatment Period|Adverse Event|20|||
125149023|NCT00090753|450168161|FG001|First Treatment Period|Adverse Event|8|||
125149024|NCT00090753|450168160|FG000|First Treatment Period|Death|88|||
125149025|NCT00090753|450168161|FG001|First Treatment Period|Death|62|||
125149026|NCT00090753|450168160|FG000|First Treatment Period|Lack of Efficacy|2|||
125149027|NCT00090753|450168161|FG001|First Treatment Period|Lack of Efficacy|1|||
125149028|NCT00090753|450168160|FG000|First Treatment Period|Refused Treatment|32|||
125149029|NCT00090753|450168161|FG001|First Treatment Period|Refused Treatment|25|||
125149030|NCT00090753|450168160|FG000|First Treatment Period|Lost to Follow-up|4|||
125149031|NCT00090753|450168161|FG001|First Treatment Period|Lost to Follow-up|4|||
125149032|NCT00090753|450168160|FG000|First Treatment Period|Renal Transplant|70|||
125149033|NCT00090753|450168161|FG001|First Treatment Period|Renal Transplant|50|||
125149034|NCT00090753|450168160|FG000|First Treatment Period|Mircera Commercialization|1|||
125149035|NCT00090753|450168161|FG001|First Treatment Period|Mircera Commercialization|0|||
125149036|NCT00090753|450168160|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
125149037|NCT00090753|450168161|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
125149038|NCT00090753|450168160|FG000|Extended Treatment Period|Adverse Event|11|||
125149039|NCT00090753|450168161|FG001|Extended Treatment Period|Adverse Event|0|||
125149040|NCT00090753|450168160|FG000|Extended Treatment Period|Death|58|||
125149041|NCT00090753|450168161|FG001|Extended Treatment Period|Death|30|||
125149042|NCT00090753|450168160|FG000|Extended Treatment Period|Lack of Efficacy|1|||
125149043|NCT00090753|450168161|FG001|Extended Treatment Period|Lack of Efficacy|0|||
125149044|NCT00090753|450168160|FG000|Extended Treatment Period|Refused Treatment|18|||
125149045|NCT00090753|450168161|FG001|Extended Treatment Period|Refused Treatment|12|||
125149046|NCT00090753|450168160|FG000|Extended Treatment Period|Lost to Follow-up|3|||
125149047|NCT00090753|450168161|FG001|Extended Treatment Period|Lost to Follow-up|1|||
125149048|NCT00090753|450168160|FG000|Extended Treatment Period|Renal Transplant|15|||
125149049|NCT00090753|450168161|FG001|Extended Treatment Period|Renal Transplant|12|||
125149050|NCT00090753|450168160|FG000|Extended Treatment Period|Mircera Commercialization|188|||
125149051|NCT00090753|450168161|FG001|Extended Treatment Period|Mircera Commercialization|93|||
125149052|NCT00090753|450168160|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
125149053|NCT00090753|450168161|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
125149054|NCT01256060|450168164|FG000|Overall Study|Lost to Follow-up|0|||
125149055|NCT01256060|450168165|FG001|Overall Study|Lost to Follow-up|1|||
125149056|NCT01256060|450168166|FG002|Overall Study|Lost to Follow-up|0|||
125149057|NCT01256060|450168167|FG003|Overall Study|Lost to Follow-up|0|||
125149058|NCT01466036|450168168|FG000|Overall Study|Death|1|||
125149059|NCT01466036|450168169|FG001|Overall Study|Death|1|||
125149060|NCT01466036|450168168|FG000|Overall Study|Physician Decision|0|||
125149061|NCT01466036|450168169|FG001|Overall Study|Physician Decision|4|||
125149062|NCT01466036|450168168|FG000|Overall Study|Adverse Event|2|||
125149063|NCT01466036|450168169|FG001|Overall Study|Adverse Event|6|||
125149064|NCT01466036|450168168|FG000|Overall Study|Withdrawal by Subject|2|||
125149065|NCT01466036|450168169|FG001|Overall Study|Withdrawal by Subject|8|||
125149066|NCT01466036|450168168|FG000|Overall Study|progression/relapse|14|||
125149067|NCT01466036|450168169|FG001|Overall Study|progression/relapse|21|||
125149068|NCT01466036|450168168|FG000|Overall Study|prolonged treatment delay|1|||
125149069|NCT01466036|450168169|FG001|Overall Study|prolonged treatment delay|1|||
125149070|NCT01808248|450168170|FG000|Overall Study|Lack of Efficacy|3|||
125149071|NCT01808248|450168170|FG000|Overall Study|Withdrawal by Subject|1|||
125149072|NCT01808248|450168170|FG000|Overall Study|Lost to Follow-up|1|||
125149073|NCT00761176|450168171|FG000|Overall Study|Death|1|||
125149074|NCT00761176|450168172|FG001|Overall Study|Death|0|||
125149075|NCT00761176|450168171|FG000|Overall Study|Withdrawal by Subject|1|||
125149076|NCT00761176|450168172|FG001|Overall Study|Withdrawal by Subject|1|||
125149077|NCT00109850|450168173|FG000|Overall Study|Adverse Event|1|||
125149078|NCT00109850|450168173|FG000|Overall Study|Death|2|||
125149079|NCT00109850|450168173|FG000|Overall Study|Ineligible|1|||
125149080|NCT00476593|450168174|FG000|Overall Study|Lost to Follow-up|10|||
125149081|NCT00476593|450168175|FG001|Overall Study|Lost to Follow-up|2|||
125149082|NCT00476593|450168176|FG002|Overall Study|Lost to Follow-up|8|||
125149083|NCT00476593|450168177|FG003|Overall Study|Lost to Follow-up|22|||
125149084|NCT03430011|450168178|FG000|Pre-Treatment|Death|1|||
125149085|NCT03430011|450168179|FG001|Pre-Treatment|Death|0|||
125149086|NCT03430011|450168180|FG002|Pre-Treatment|Death|0|||
125149087|NCT03430011|450168181|FG003|Pre-Treatment|Death|0|||
125149088|NCT03430011|450168182|FG004|Pre-Treatment|Death|1|||
125149089|NCT03430011|450168183|FG005|Pre-Treatment|Death|0|||
125149090|NCT03430011|450168184|FG006|Pre-Treatment|Death|1|||
125149091|NCT03430011|450168185|FG007|Pre-Treatment|Death|0|||
125149092|NCT03430011|450168178|FG000|Pre-Treatment|Screen Fail|0|||
125149093|NCT03430011|450168179|FG001|Pre-Treatment|Screen Fail|0|||
125149094|NCT03430011|450168180|FG002|Pre-Treatment|Screen Fail|0|||
125149095|NCT03430011|450168181|FG003|Pre-Treatment|Screen Fail|0|||
125149096|NCT03430011|450168182|FG004|Pre-Treatment|Screen Fail|1|||
125223658|NCT02326272|450446167|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125149097|NCT03430011|450168183|FG005|Pre-Treatment|Screen Fail|0|||
125149098|NCT03430011|450168184|FG006|Pre-Treatment|Screen Fail|0|||
125149099|NCT03430011|450168185|FG007|Pre-Treatment|Screen Fail|0|||
125149100|NCT03430011|450168178|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149101|NCT03430011|450168179|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149102|NCT03430011|450168180|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
125149103|NCT03430011|450168181|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149104|NCT03430011|450168182|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149105|NCT03430011|450168183|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149106|NCT03430011|450168184|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149107|NCT03430011|450168185|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
125149108|NCT03430011|450168178|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
125149109|NCT03430011|450168179|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
125149110|NCT03430011|450168180|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
125149111|NCT03430011|450168181|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
125149112|NCT03430011|450168182|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
125149113|NCT03430011|450168183|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
125149114|NCT03430011|450168184|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
125149115|NCT03430011|450168185|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
125149116|NCT03430011|450168178|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
125149117|NCT03430011|450168179|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
125149118|NCT03430011|450168180|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
125149119|NCT03430011|450168181|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
125149120|NCT03430011|450168182|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
125149121|NCT03430011|450168183|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
125149122|NCT03430011|450168184|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
125149123|NCT03430011|450168185|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
125149124|NCT03430011|450168178|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
125149125|NCT03430011|450168179|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
125149126|NCT03430011|450168180|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
125149127|NCT03430011|450168181|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
125149128|NCT03430011|450168182|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
125149129|NCT03430011|450168183|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
125149130|NCT03430011|450168184|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
125149131|NCT03430011|450168185|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
125149132|NCT03430011|450168178|FG000|JCARH125 Treatment|Death|4|||
125149133|NCT03430011|450168179|FG001|JCARH125 Treatment|Death|19|||
125149134|NCT03430011|450168180|FG002|JCARH125 Treatment|Death|10|||
125149135|NCT03430011|450168181|FG003|JCARH125 Treatment|Death|8|||
125149136|NCT03430011|450168182|FG004|JCARH125 Treatment|Death|5|||
125149137|NCT03430011|450168183|FG005|JCARH125 Treatment|Death|3|||
125149138|NCT03430011|450168184|FG006|JCARH125 Treatment|Death|4|||
125149139|NCT03430011|450168185|FG007|JCARH125 Treatment|Death|2|||
125149140|NCT03430011|450168178|FG000|JCARH125 Treatment|Other reasons|1|||
125149141|NCT03430011|450168179|FG001|JCARH125 Treatment|Other reasons|0|||
125149142|NCT03430011|450168180|FG002|JCARH125 Treatment|Other reasons|4|||
125149143|NCT03430011|450168181|FG003|JCARH125 Treatment|Other reasons|2|||
125149144|NCT03430011|450168182|FG004|JCARH125 Treatment|Other reasons|2|||
125149145|NCT03430011|450168183|FG005|JCARH125 Treatment|Other reasons|1|||
125149146|NCT03430011|450168184|FG006|JCARH125 Treatment|Other reasons|3|||
125149147|NCT03430011|450168185|FG007|JCARH125 Treatment|Other reasons|2|||
125149148|NCT04126343|450168186|FG000|Overall Study|Adverse Event|0|||
125149149|NCT04126343|450168187|FG001|Overall Study|Adverse Event|0|||
125149150|NCT04126343|450168188|FG002|Overall Study|Adverse Event|0|||
125149151|NCT04126343|450168189|FG003|Overall Study|Adverse Event|0|||
125149152|NCT04126343|450168190|FG004|Overall Study|Adverse Event|0|||
125149153|NCT04126343|450168191|FG005|Overall Study|Adverse Event|1|||
125149154|NCT04126343|450168186|FG000|Overall Study|Withdrawal by Subject|0|||
125149155|NCT04126343|450168187|FG001|Overall Study|Withdrawal by Subject|0|||
125149156|NCT04126343|450168188|FG002|Overall Study|Withdrawal by Subject|0|||
125149157|NCT04126343|450168189|FG003|Overall Study|Withdrawal by Subject|1|||
125149158|NCT04126343|450168190|FG004|Overall Study|Withdrawal by Subject|0|||
125149159|NCT04126343|450168191|FG005|Overall Study|Withdrawal by Subject|0|||
125149160|NCT04126343|450168186|FG000|Overall Study|Related to COVID-19 pandemic|3|||
125149161|NCT04126343|450168187|FG001|Overall Study|Related to COVID-19 pandemic|4|||
125149162|NCT04126343|450168188|FG002|Overall Study|Related to COVID-19 pandemic|3|||
125149163|NCT04126343|450168189|FG003|Overall Study|Related to COVID-19 pandemic|3|||
125149164|NCT04126343|450168190|FG004|Overall Study|Related to COVID-19 pandemic|3|||
125149165|NCT04126343|450168191|FG005|Overall Study|Related to COVID-19 pandemic|3|||
125149166|NCT00084799|450168192|FG000|Overall Study|Disease Progression|1|||
125149167|NCT00084799|450168193|FG001|Overall Study|Disease Progression|0|||
125149168|NCT03712124|450168194|FG000|Overall Study|Protocol Violation|1|||
125149169|NCT03712124|450168195|FG001|Overall Study|Protocol Violation|0|||
125149170|NCT04314843|450168197|FG000|Overall Study|Death|2|||
125149171|NCT04314843|450168198|FG001|Overall Study|Death|2|||
125149172|NCT04314843|450168197|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
125149173|NCT04314843|450168198|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
125149174|NCT00551616|450168199|FG000|Overall Study|Lost to Follow-up|48|||
125149175|NCT00551616|450168200|FG001|Overall Study|Lost to Follow-up|40|||
125149176|NCT00569777|450168201|FG000|Overall Study|Withdrawal by Subject|4|||
125223659|NCT02326272|450446168|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125149177|NCT00569777|450168202|FG001|Overall Study|Withdrawal by Subject|0|||
125149178|NCT00569777|450168201|FG000|Overall Study|Adverse Event|3|||
125149179|NCT00569777|450168202|FG001|Overall Study|Adverse Event|0|||
125149180|NCT00569777|450168201|FG000|Overall Study|Lost to Follow-up|1|||
125149181|NCT00569777|450168202|FG001|Overall Study|Lost to Follow-up|0|||
125149182|NCT00569777|450168201|FG000|Overall Study|scheduled eye surgery|0|||
125149183|NCT00569777|450168202|FG001|Overall Study|scheduled eye surgery|1|||
125149184|NCT00569777|450168201|FG000|Overall Study|did not meet exclusion criteria|1|||
125149185|NCT00569777|450168202|FG001|Overall Study|did not meet exclusion criteria|2|||
125149186|NCT00569777|450168201|FG000|Overall Study|pregnant|1|||
125149187|NCT00569777|450168202|FG001|Overall Study|pregnant|0|||
125149188|NCT04718129|450168207|FG000|Overall Study|Lost to Follow-up|6|||
125149189|NCT04718129|450168208|FG001|Overall Study|Lost to Follow-up|7|||
125149190|NCT01378962|450168209|FG000|Overall Study|Death|14|||
125149191|NCT01378962|450168209|FG000|Overall Study|Lost to Follow-up|1|||
125149192|NCT01378962|450168209|FG000|Overall Study|Other|2|||
125149193|NCT02030535|450168210|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
125149194|NCT01588548|450168211|FG000|Overall Study|Withdrawal by Subject|0|||
125149195|NCT01588548|450168212|FG001|Overall Study|Withdrawal by Subject|1|||
125149196|NCT01588548|450168213|FG002|Overall Study|Withdrawal by Subject|1|||
125149197|NCT01588548|450168214|FG003|Overall Study|Withdrawal by Subject|1|||
125149198|NCT01588548|450168215|FG004|Overall Study|Withdrawal by Subject|2|||
125149199|NCT01588548|450168216|FG005|Overall Study|Withdrawal by Subject|3|||
125149200|NCT01588548|450168211|FG000|Overall Study|Adverse Event|0|||
125149201|NCT01588548|450168212|FG001|Overall Study|Adverse Event|0|||
125149202|NCT01588548|450168213|FG002|Overall Study|Adverse Event|1|||
125149203|NCT01588548|450168214|FG003|Overall Study|Adverse Event|2|||
125149204|NCT01588548|450168215|FG004|Overall Study|Adverse Event|1|||
125149205|NCT01588548|450168216|FG005|Overall Study|Adverse Event|0|||
125388106|NCT05172544|451054014|FG000|Overall Study|Physician Decision|0|||
125388107|NCT05172544|451054015|FG001|Overall Study|Physician Decision|0|||
125388108|NCT05172544|451054016|FG002|Overall Study|Physician Decision|1|||
125388109|NCT04829318|451054017|FG000|Overall Study|Adverse Event|6|||
125388110|NCT04829318|451054017|FG000|Overall Study|Death|1|||
125388111|NCT04829318|451054017|FG000|Overall Study|Lost to Follow-up|1|||
125388112|NCT04829318|451054017|FG000|Overall Study|Physician Decision|1|||
125388113|NCT04829318|451054017|FG000|Overall Study|Withdrawal by Subject|19|||
125388114|NCT04829318|451054017|FG000|Overall Study|Site terminated by sponsor|1|||
125388115|NCT04829318|451054017|FG000|Overall Study|Sponsor decision|5|||
125388116|NCT04829318|451054017|FG000|Overall Study|Other|1|||
125388117|NCT03659916|451054021|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
125388118|NCT03659916|451054022|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
125388119|NCT03659916|451054023|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
125388120|NCT03659916|451054021|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
125388121|NCT03659916|451054022|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
125388122|NCT03659916|451054023|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
125388123|NCT03659916|451054021|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
125388124|NCT03659916|451054022|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
125388125|NCT03659916|451054023|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
125388126|NCT03659916|451054021|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
125388127|NCT03659916|451054022|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
125149206|NCT01588548|450168211|FG000|Overall Study|Condition Under Investigation Worsened|3|||
125388128|NCT03659916|451054023|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
125149207|NCT01588548|450168212|FG001|Overall Study|Condition Under Investigation Worsened|6|||
125149208|NCT01588548|450168213|FG002|Overall Study|Condition Under Investigation Worsened|4|||
125149209|NCT01588548|450168214|FG003|Overall Study|Condition Under Investigation Worsened|4|||
125149210|NCT01588548|450168215|FG004|Overall Study|Condition Under Investigation Worsened|3|||
125149211|NCT01588548|450168216|FG005|Overall Study|Condition Under Investigation Worsened|3|||
125149212|NCT00292227|450168217|FG000|Patch Period|Adverse Event|1|||
125388129|NCT03659916|451054021|FG000|Treatment Period (72 Weeks)|Other|1|||
125149213|NCT00292227|450168218|FG001|Patch Period|Adverse Event|0|||
125388130|NCT03659916|451054022|FG001|Treatment Period (72 Weeks)|Other|3|||
125388131|NCT03659916|451054023|FG002|Treatment Period (72 Weeks)|Other|9|||
125388132|NCT03659916|451054021|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
125388133|NCT03659916|451054022|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
125388134|NCT03659916|451054023|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
125388135|NCT03659916|451054021|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
125149214|NCT00292227|450168219|FG002|Patch Period|Adverse Event|2|||
125149215|NCT00292227|450168217|FG000|Patch Period|Withdrawal by Subject|0|||
125149216|NCT00292227|450168218|FG001|Patch Period|Withdrawal by Subject|0|||
125149217|NCT00292227|450168219|FG002|Patch Period|Withdrawal by Subject|1|||
125149218|NCT03257254|450168220|FG000|Overall Study|Withdrawal by Subject|7|||
125149219|NCT03257254|450168220|FG000|Overall Study|Lost to Follow-up|9|||
125149220|NCT03257254|450168220|FG000|Overall Study|Study discontinued by sponsor|5|||
125149221|NCT00442546|450168221|FG000|Overall Study|Adverse Event|11|||
125149222|NCT00442546|450168222|FG001|Overall Study|Adverse Event|17|||
125388136|NCT03659916|451054022|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
125388137|NCT03659916|451054023|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
125388138|NCT03659916|451054021|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
125388139|NCT03659916|451054022|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
125388140|NCT03659916|451054023|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
125388141|NCT03659916|451054021|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
125388142|NCT03659916|451054022|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
125388143|NCT03659916|451054023|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
125388144|NCT03659916|451054021|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
125388145|NCT03659916|451054022|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
125388146|NCT03659916|451054023|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
125388147|NCT03659916|451054021|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
125388148|NCT03659916|451054022|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
125388149|NCT03659916|451054023|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
125388150|NCT00322842|451054024|FG000|Overall Study|Withdrawal by Subject|0|||
125388151|NCT00322842|451054025|FG001|Overall Study|Withdrawal by Subject|1|||
125388152|NCT00322842|451054024|FG000|Overall Study|Lost to Follow-up|0|||
125149223|NCT00442546|450168223|FG002|Overall Study|Adverse Event|13|||
125149224|NCT00442546|450168221|FG000|Overall Study|Lost to Follow-up|1|||
125149225|NCT00442546|450168222|FG001|Overall Study|Lost to Follow-up|2|||
125149226|NCT00442546|450168223|FG002|Overall Study|Lost to Follow-up|1|||
125149227|NCT00442546|450168221|FG000|Overall Study|Other|4|||
125149228|NCT00442546|450168222|FG001|Overall Study|Other|9|||
125149229|NCT00442546|450168223|FG002|Overall Study|Other|6|||
125388153|NCT00322842|451054025|FG001|Overall Study|Lost to Follow-up|1|||
125388154|NCT00322842|451054024|FG000|Overall Study|Refused transplant|1|||
125388155|NCT00322842|451054025|FG001|Overall Study|Refused transplant|0|||
125388156|NCT00322842|451054024|FG000|Overall Study|Death|1|||
125388157|NCT00322842|451054025|FG001|Overall Study|Death|0|||
125388158|NCT02867709|451054026|FG000|Treatment Period|Adverse Event|1|||
125388159|NCT02867709|451054027|FG001|Treatment Period|Adverse Event|1|||
125388160|NCT02867709|451054028|FG002|Treatment Period|Adverse Event|2|||
125388161|NCT02867709|451054026|FG000|Treatment Period|Withdrawal of Consent|7|||
125388162|NCT02867709|451054027|FG001|Treatment Period|Withdrawal of Consent|9|||
125388163|NCT02867709|451054028|FG002|Treatment Period|Withdrawal of Consent|8|||
125149230|NCT00442546|450168221|FG000|Overall Study|Withdrawal by Subject|5|||
125149231|NCT00442546|450168222|FG001|Overall Study|Withdrawal by Subject|5|||
125149232|NCT00442546|450168223|FG002|Overall Study|Withdrawal by Subject|7|||
125149233|NCT00442546|450168221|FG000|Overall Study|Randomized But Not Treated|5|||
125388164|NCT02867709|451054026|FG000|Treatment Period|Lost to Follow-up|17|||
125388165|NCT02867709|451054027|FG001|Treatment Period|Lost to Follow-up|20|||
125388166|NCT02867709|451054028|FG002|Treatment Period|Lost to Follow-up|20|||
125388167|NCT02867709|451054026|FG000|Treatment Period|Lack of Qualifying Event|42|||
125388168|NCT02867709|451054027|FG001|Treatment Period|Lack of Qualifying Event|55|||
125388169|NCT02867709|451054028|FG002|Treatment Period|Lack of Qualifying Event|42|||
125388170|NCT02867709|451054026|FG000|Treatment Period|Protocol Violation|3|||
125388171|NCT02867709|451054027|FG001|Treatment Period|Protocol Violation|2|||
125388172|NCT02867709|451054028|FG002|Treatment Period|Protocol Violation|3|||
125388173|NCT02867709|451054026|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
125388174|NCT02867709|451054027|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
125388175|NCT02867709|451054028|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
125388176|NCT02867709|451054026|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
125388177|NCT02867709|451054027|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
125388178|NCT02867709|451054028|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
125388179|NCT02867709|451054026|FG000|Safety Follow-up Period|Pregnancy|0|||
125388180|NCT02867709|451054027|FG001|Safety Follow-up Period|Pregnancy|1|||
125388181|NCT02867709|451054028|FG002|Safety Follow-up Period|Pregnancy|0|||
125388182|NCT02867709|451054026|FG000|Safety Follow-up Period|Protocol Violation|0|||
125388183|NCT02867709|451054027|FG001|Safety Follow-up Period|Protocol Violation|1|||
125388184|NCT02867709|451054028|FG002|Safety Follow-up Period|Protocol Violation|1|||
125438674|NCT00885352|451233919|FG000|Overall Study|Withdrawal by Subject|1|||
125438675|NCT00885352|451233920|FG001|Overall Study|Withdrawal by Subject|5|||
125438676|NCT00885352|451233919|FG000|Overall Study|Contradiction to study medication|0|||
125438677|NCT00885352|451233920|FG001|Overall Study|Contradiction to study medication|2|||
125438678|NCT00885352|451233919|FG000|Overall Study|Excluded medication|2|||
125438679|NCT00885352|451233920|FG001|Overall Study|Excluded medication|2|||
125438680|NCT00885352|451233919|FG000|Overall Study|Lab abnormalities|1|||
125438681|NCT00885352|451233920|FG001|Overall Study|Lab abnormalities|1|||
125149234|NCT00442546|450168222|FG001|Overall Study|Randomized But Not Treated|4|||
125149235|NCT00442546|450168223|FG002|Overall Study|Randomized But Not Treated|6|||
125149236|NCT03840382|450168224|FG000|Overall Study|Lost to Follow-up|11|||
125149237|NCT00802178|450169194|FG000|Overall Study|Lack of Efficacy|36|||
125149238|NCT00802178|450169194|FG000|Overall Study|Insufficient tolerability (IT)|17|||
125388185|NCT03615105|451054033|FG000|Overall Study|Protocol Violation|1|||
125388186|NCT03615105|451054034|FG001|Overall Study|Protocol Violation|0|||
125388187|NCT03615105|451054035|FG002|Overall Study|Protocol Violation|0|||
125388188|NCT03615105|451054033|FG000|Overall Study|Death|0|||
125388189|NCT03615105|451054034|FG001|Overall Study|Death|2|||
125388190|NCT03615105|451054035|FG002|Overall Study|Death|0|||
125388191|NCT04383743|451054036|FG000|Overall Study|Withdrawal by Subject|1|||
125388192|NCT04383743|451054036|FG000|Overall Study|Adverse Event|1|||
125388193|NCT04837131|451054037|FG000|Overall Study|Death|1|||
125388194|NCT04837131|451054037|FG000|Overall Study|Withdrawal by Subject|1|||
125388195|NCT04837131|451054037|FG000|Overall Study|Adverse Event|1|||
125388196|NCT04837131|451054037|FG000|Overall Study|Protocol Violation|1|||
125388197|NCT03482791|451054038|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
125388198|NCT03482791|451054039|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
125149239|NCT00802178|450169194|FG000|Overall Study|Withdrawal by Subject|18|||
125149240|NCT00802178|450169194|FG000|Overall Study|Other|32|||
125149241|NCT00802178|450169194|FG000|Overall Study|Lack of efficacy and patient wish|1|||
125149242|NCT00802178|450169194|FG000|Overall Study|IT and patient wish|8|||
125149243|NCT00802178|450169194|FG000|Overall Study|Patients wish and other reason|1|||
125149244|NCT00097786|450169195|FG000|Overall Study|lost to follow-up for all-cause death|296|||
125149245|NCT00097786|450169196|FG001|Overall Study|lost to follow-up for all-cause death|292|||
125149246|NCT00097786|450169197|FG002|Overall Study|lost to follow-up for all-cause death|313|||
125149247|NCT00097786|450169198|FG003|Overall Study|lost to follow-up for all-cause death|310|||
125149248|NCT02000531|450169199|FG000|Overall Study|Lost to Follow-up|1|||
125149249|NCT02000531|450169200|FG001|Overall Study|Lost to Follow-up|0|||
125149250|NCT02000531|450169199|FG000|Overall Study|Discontinued due to data cut-off|3|||
125149251|NCT02000531|450169200|FG001|Overall Study|Discontinued due to data cut-off|8|||
125149252|NCT01239472|450169203|FG000|Overall Study|Withdrawal by Subject|5|||
125149253|NCT01239472|450169204|FG001|Overall Study|Withdrawal by Subject|1|||
125149254|NCT01239472|450169203|FG000|Overall Study|Adverse Event|0|||
125149255|NCT01239472|450169204|FG001|Overall Study|Adverse Event|1|||
125149256|NCT01239472|450169203|FG000|Overall Study|Lack of Efficacy|0|||
125149257|NCT01239472|450169204|FG001|Overall Study|Lack of Efficacy|1|||
125149258|NCT01280617|450169207|FG000|Overall Study|Adverse Event|0|||
125149259|NCT01280617|450169208|FG001|Overall Study|Adverse Event|1|||
125149260|NCT05966090|450169209|FG000|Overall Study|Lost to Follow-up|6|||
125149261|NCT05966090|450169210|FG001|Overall Study|Lost to Follow-up|6|||
125149262|NCT05966090|450169209|FG000|Overall Study|Adverse Event|1|||
125149263|NCT05966090|450169210|FG001|Overall Study|Adverse Event|1|||
125149264|NCT05966090|450169209|FG000|Overall Study|Withdrawal by Subject|1|||
125149265|NCT05966090|450169210|FG001|Overall Study|Withdrawal by Subject|1|||
125149266|NCT05966090|450169209|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125149267|NCT05966090|450169210|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
125149268|NCT05966090|450169209|FG000|Overall Study|Other|1|||
125149269|NCT05966090|450169210|FG001|Overall Study|Other|1|||
125149270|NCT02001051|450169211|FG000|Overall Study|Deemed not eligible following enrollment|0|||
125149271|NCT02001051|450169212|FG001|Overall Study|Deemed not eligible following enrollment|1|||
125149272|NCT00529217|450169217|FG000|Overall Study|Lack of Efficacy|2|||
125149273|NCT00529217|450169217|FG000|Overall Study|Unable to adhere to study schedule|2|||
125149274|NCT01098110|450169219|FG000|Overall Study|Withdrawal by Subject|14|||
125149275|NCT01098110|450169220|FG001|Overall Study|Withdrawal by Subject|24|||
125149276|NCT01098110|450169221|FG002|Overall Study|Withdrawal by Subject|19|||
125149277|NCT01098110|450169219|FG000|Overall Study|Adverse Event|30|||
125149278|NCT01098110|450169220|FG001|Overall Study|Adverse Event|32|||
125149279|NCT01098110|450169221|FG002|Overall Study|Adverse Event|43|||
125149280|NCT01098110|450169219|FG000|Overall Study|Lack of Efficacy|13|||
125149281|NCT01098110|450169220|FG001|Overall Study|Lack of Efficacy|9|||
125149282|NCT01098110|450169221|FG002|Overall Study|Lack of Efficacy|27|||
125149283|NCT01098110|450169219|FG000|Overall Study|Other|4|||
125149284|NCT01098110|450169220|FG001|Overall Study|Other|7|||
125149285|NCT01098110|450169221|FG002|Overall Study|Other|5|||
125149286|NCT01098110|450169219|FG000|Overall Study|Untreated|1|||
125388199|NCT04690751|451054041|FG000|Overall Study|Protocol Violation|0|||
125149287|NCT01098110|450169220|FG001|Overall Study|Untreated|1|||
125149288|NCT01098110|450169221|FG002|Overall Study|Untreated|0|||
125149289|NCT02147587|450169222|FG000|Overall Study|Adverse Event|9|||
125149290|NCT02147587|450169223|FG001|Overall Study|Adverse Event|4|||
125149291|NCT02147587|450169222|FG000|Overall Study|Lack of Efficacy|2|||
125149292|NCT02147587|450169223|FG001|Overall Study|Lack of Efficacy|1|||
125149293|NCT01546519|450169224|FG000|Overall Study|Adverse Event|0|||
125388200|NCT04690751|451054042|FG001|Overall Study|Protocol Violation|1|||
125388201|NCT04690751|451054043|FG002|Overall Study|Protocol Violation|0|||
125388202|NCT04690751|451054044|FG003|Overall Study|Protocol Violation|1|||
125388203|NCT04690751|451054045|FG004|Overall Study|Protocol Violation|2|||
125149294|NCT01546519|450169225|FG001|Overall Study|Adverse Event|0|||
125149295|NCT01546519|450169226|FG002|Overall Study|Adverse Event|1|||
125149296|NCT01546519|450169227|FG003|Overall Study|Adverse Event|1|||
125388204|NCT04690751|451054046|FG005|Overall Study|Protocol Violation|0|||
125149297|NCT01546519|450169224|FG000|Overall Study|Death|0|||
125149298|NCT01546519|450169225|FG001|Overall Study|Death|1|||
125149299|NCT01546519|450169226|FG002|Overall Study|Death|3|||
125149300|NCT01546519|450169227|FG003|Overall Study|Death|1|||
125149301|NCT01546519|450169224|FG000|Overall Study|related to disease progression|2|||
125149302|NCT01546519|450169225|FG001|Overall Study|related to disease progression|2|||
125149303|NCT01546519|450169226|FG002|Overall Study|related to disease progression|2|||
125149304|NCT01546519|450169227|FG003|Overall Study|related to disease progression|1|||
125149305|NCT01546519|450169224|FG000|Overall Study|Physician Decision|6|||
125149306|NCT01546519|450169225|FG001|Overall Study|Physician Decision|5|||
125149307|NCT01546519|450169226|FG002|Overall Study|Physician Decision|2|||
125149308|NCT01546519|450169227|FG003|Overall Study|Physician Decision|3|||
125149309|NCT01546519|450169224|FG000|Overall Study|Withdrawal by Subject|1|||
125149310|NCT01546519|450169225|FG001|Overall Study|Withdrawal by Subject|0|||
125149311|NCT01546519|450169226|FG002|Overall Study|Withdrawal by Subject|0|||
125149312|NCT01546519|450169227|FG003|Overall Study|Withdrawal by Subject|0|||
125149313|NCT01519947|450169234|FG000|Overall Study|Death|0|||
125149314|NCT01519947|450169235|FG001|Overall Study|Death|0|||
125149315|NCT01519947|450169236|FG002|Overall Study|Death|0|||
125149316|NCT01519947|450169237|FG003|Overall Study|Death|1|||
125149317|NCT01519947|450169234|FG000|Overall Study|Protocol Violation|0|||
125149318|NCT01519947|450169235|FG001|Overall Study|Protocol Violation|0|||
125149319|NCT01519947|450169236|FG002|Overall Study|Protocol Violation|2|||
125149320|NCT01519947|450169237|FG003|Overall Study|Protocol Violation|1|||
125149321|NCT01519947|450169234|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
125149322|NCT01519947|450169235|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
125149323|NCT01519947|450169236|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
125149324|NCT01519947|450169237|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
125149325|NCT01519947|450169234|FG000|Overall Study|Development of Anemia|0|||
125149326|NCT01519947|450169235|FG001|Overall Study|Development of Anemia|1|||
125149327|NCT01519947|450169236|FG002|Overall Study|Development of Anemia|0|||
125149328|NCT01519947|450169237|FG003|Overall Study|Development of Anemia|1|||
125149329|NCT01519947|450169234|FG000|Overall Study|Blood Transfusion|0|||
125149330|NCT01519947|450169235|FG001|Overall Study|Blood Transfusion|1|||
125149331|NCT01519947|450169236|FG002|Overall Study|Blood Transfusion|1|||
125149332|NCT01519947|450169237|FG003|Overall Study|Blood Transfusion|0|||
125149333|NCT01519947|450169234|FG000|Overall Study|Withdrawal by Subject|0|||
125149334|NCT01519947|450169235|FG001|Overall Study|Withdrawal by Subject|1|||
125149335|NCT01519947|450169236|FG002|Overall Study|Withdrawal by Subject|0|||
125149336|NCT01519947|450169237|FG003|Overall Study|Withdrawal by Subject|1|||
125149337|NCT01519947|450169234|FG000|Overall Study|Lost to Follow-up|0|||
125149338|NCT01519947|450169235|FG001|Overall Study|Lost to Follow-up|0|||
125149339|NCT01519947|450169236|FG002|Overall Study|Lost to Follow-up|3|||
125149340|NCT01519947|450169237|FG003|Overall Study|Lost to Follow-up|2|||
125149341|NCT01519947|450169234|FG000|Overall Study|Poor Response|1|||
125149342|NCT01519947|450169235|FG001|Overall Study|Poor Response|0|||
125149343|NCT01519947|450169236|FG002|Overall Study|Poor Response|0|||
125149344|NCT01519947|450169237|FG003|Overall Study|Poor Response|1|||
125149345|NCT01519947|450169234|FG000|Overall Study|Adverse Event|1|||
125149346|NCT01519947|450169235|FG001|Overall Study|Adverse Event|0|||
125149347|NCT01519947|450169236|FG002|Overall Study|Adverse Event|1|||
125149348|NCT01519947|450169237|FG003|Overall Study|Adverse Event|1|||
125149349|NCT02274948|450169244|FG000|Overall Study|Lost to Follow-up|28|||
125149350|NCT02274948|450169245|FG001|Overall Study|Lost to Follow-up|25|||
125149351|NCT02274948|450169244|FG000|Overall Study|Withdrawal by Subject|64|||
125149352|NCT02274948|450169245|FG001|Overall Study|Withdrawal by Subject|58|||
125149353|NCT02274948|450169244|FG000|Overall Study|Stopped on family Practitioner advice|2|||
125149354|NCT02274948|450169245|FG001|Overall Study|Stopped on family Practitioner advice|5|||
125149355|NCT02274948|450169244|FG000|Overall Study|Left the area|4|||
125149356|NCT02274948|450169245|FG001|Overall Study|Left the area|3|||
125149357|NCT00707434|450169246|FG000|Overall Study|Adverse Event|1|||
125149358|NCT00530348|450169248|FG000|Overall Study|Adverse Event|5|||
125149359|NCT00530348|450169249|FG001|Overall Study|Adverse Event|1|||
125149360|NCT00530348|450169248|FG000|Overall Study|Death|0|||
125388205|NCT04690751|451054041|FG000|Overall Study|Adverse Event|0|||
125149361|NCT00530348|450169249|FG001|Overall Study|Death|1|||
125149362|NCT00530348|450169248|FG000|Overall Study|Lack of Efficacy|2|||
125149363|NCT00530348|450169249|FG001|Overall Study|Lack of Efficacy|0|||
125149364|NCT00530348|450169248|FG000|Overall Study|Lost to Follow-up|0|||
125149365|NCT00530348|450169249|FG001|Overall Study|Lost to Follow-up|2|||
125149366|NCT00530348|450169248|FG000|Overall Study|Physician Decision|1|||
125149367|NCT00530348|450169249|FG001|Overall Study|Physician Decision|2|||
125149368|NCT00530348|450169248|FG000|Overall Study|Pregnancy|1|||
125388206|NCT04690751|451054042|FG001|Overall Study|Adverse Event|0|||
125149369|NCT00530348|450169249|FG001|Overall Study|Pregnancy|0|||
125149370|NCT00530348|450169248|FG000|Overall Study|Withdrawal by Subject|12|||
125149371|NCT00530348|450169249|FG001|Overall Study|Withdrawal by Subject|12|||
125149372|NCT00530348|450169248|FG000|Overall Study|Randomised in error|1|||
125149373|NCT00530348|450169249|FG001|Overall Study|Randomised in error|0|||
125149374|NCT00530348|450169248|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
125149375|NCT00530348|450169249|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
125149376|NCT04364763|450169250|FG000|Overall Study|Death|1|||
125149377|NCT04364763|450169251|FG001|Overall Study|Death|2|||
125149378|NCT04364763|450169250|FG000|Overall Study|Lost to Follow-up|1|||
125149379|NCT04364763|450169251|FG001|Overall Study|Lost to Follow-up|0|||
125149380|NCT01386125|450169252|FG000|Overall Study|Lost to Follow-up|3|||
125149381|NCT01386125|450169253|FG001|Overall Study|Lost to Follow-up|9|||
125149382|NCT01386125|450169252|FG000|Overall Study|Physician Decision|0|||
125149383|NCT01386125|450169253|FG001|Overall Study|Physician Decision|1|||
125149384|NCT01386125|450169252|FG000|Overall Study|Protocol Violation|5|||
125149385|NCT01386125|450169253|FG001|Overall Study|Protocol Violation|7|||
125149386|NCT01386125|450169252|FG000|Overall Study|Disease Progress|1|||
125149387|NCT01386125|450169253|FG001|Overall Study|Disease Progress|2|||
125149388|NCT01386125|450169252|FG000|Overall Study|Withdrawal by Subject|13|||
125149389|NCT01386125|450169253|FG001|Overall Study|Withdrawal by Subject|12|||
125149390|NCT01386125|450169252|FG000|Overall Study|Adverse Event|2|||
125149391|NCT01386125|450169253|FG001|Overall Study|Adverse Event|5|||
125149392|NCT01386125|450169252|FG000|Overall Study|Lack of Efficacy|0|||
125149393|NCT01386125|450169253|FG001|Overall Study|Lack of Efficacy|1|||
125149394|NCT01386125|450169252|FG000|Overall Study|Participant Leaving Country|1|||
125149395|NCT01386125|450169253|FG001|Overall Study|Participant Leaving Country|0|||
125149396|NCT00732160|450169258|FG000|Overall Study|Adverse Event|1|||
125149397|NCT00732160|450169259|FG001|Overall Study|Adverse Event|0|||
125149398|NCT00732160|450169260|FG002|Overall Study|Adverse Event|1|||
125149399|NCT00732160|450169261|FG003|Overall Study|Adverse Event|1|||
125149400|NCT00732160|450169258|FG000|Overall Study|scheduling|4|||
125149401|NCT00732160|450169259|FG001|Overall Study|scheduling|4|||
125149402|NCT00732160|450169260|FG002|Overall Study|scheduling|2|||
125149403|NCT00732160|450169261|FG003|Overall Study|scheduling|1|||
125149404|NCT00676494|450169262|FG000|Overall Study|Missed Visit|8|||
125149405|NCT00676494|450169262|FG000|Overall Study|Withdrawal by Subject|6|||
125149406|NCT00985231|450169283|FG000|Overall Study|ineligible|1|||
125149407|NCT00985231|450169284|FG001|Overall Study|ineligible|0|||
125149408|NCT00985231|450169283|FG000|Overall Study|Protocol Violation|1|||
125149409|NCT00985231|450169284|FG001|Overall Study|Protocol Violation|0|||
125149410|NCT00985231|450169283|FG000|Overall Study|Withdrawal by Subject|1|||
125149411|NCT00985231|450169284|FG001|Overall Study|Withdrawal by Subject|0|||
125149412|NCT00985231|450169283|FG000|Overall Study|Lost to Follow-up|0|||
125149413|NCT00985231|450169284|FG001|Overall Study|Lost to Follow-up|1|||
125149414|NCT00985231|450169283|FG000|Overall Study|Study related symptoms & complaints|0|||
125149415|NCT00985231|450169284|FG001|Overall Study|Study related symptoms & complaints|2|||
125149416|NCT01463982|450169285|FG000|Overall Study|Withdrawal by Subject|0|||
125149417|NCT01463982|450169286|FG001|Overall Study|Withdrawal by Subject|1|||
125149418|NCT01463982|450169287|FG002|Overall Study|Withdrawal by Subject|1|||
125149419|NCT01463982|450169288|FG003|Overall Study|Withdrawal by Subject|0|||
125149420|NCT01463982|450169285|FG000|Overall Study|Treatment delay over 5 week|0|||
125149421|NCT01463982|450169286|FG001|Overall Study|Treatment delay over 5 week|0|||
125149422|NCT01463982|450169287|FG002|Overall Study|Treatment delay over 5 week|1|||
125149423|NCT01463982|450169288|FG003|Overall Study|Treatment delay over 5 week|0|||
125149424|NCT04220775|450169289|FG000|Overall Study|Adverse Event|1|||
125149425|NCT04220775|450169290|FG001|Overall Study|Adverse Event|0|||
125149426|NCT04220775|450169289|FG000|Overall Study|Disease Progression|1|||
125149427|NCT04220775|450169290|FG001|Overall Study|Disease Progression|0|||
125149428|NCT00931463|450169291|FG000|Overall Study|Death|8|||
125149429|NCT00931463|450169292|FG001|Overall Study|Death|4|||
125149430|NCT00931463|450169291|FG000|Overall Study|Withdrawal by Subject|5|||
125149431|NCT00931463|450169292|FG001|Overall Study|Withdrawal by Subject|0|||
125149432|NCT00931463|450169291|FG000|Overall Study|Lost to Follow-up|4|||
125149433|NCT00931463|450169292|FG001|Overall Study|Lost to Follow-up|1|||
125149434|NCT00436917|450169293|FG000|Overall Study|Withdrawal by Subject|13|||
125149435|NCT00436917|450169293|FG000|Overall Study|Adverse Event|2|||
125149436|NCT00436917|450169293|FG000|Overall Study|Physician Decision|1|||
125149437|NCT00436917|450169293|FG000|Overall Study|Death|1|||
125149438|NCT00436917|450169293|FG000|Overall Study|Lost to Follow-up|1|||
125149439|NCT00436917|450169293|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
125149440|NCT00436917|450169293|FG000|Overall Study|Increased creatinine|1|||
125149441|NCT00436917|450169293|FG000|Overall Study|Personal conflicts of patient|1|||
125149442|NCT01083680|450169298|FG000|Overall Study|Lost to Follow-up|2758|||
125149443|NCT01083680|450169298|FG000|Overall Study|Withdrawal by Subject|1086|||
125149444|NCT05766787|450169299|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
125149445|NCT05766787|450169300|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
125149446|NCT05766787|450169299|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
125149447|NCT05766787|450169300|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
125149448|NCT05766787|450169299|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
125149449|NCT05766787|450169300|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
125149450|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
125388207|NCT04690751|451054043|FG002|Overall Study|Adverse Event|1|||
125149451|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
125149452|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
125149453|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
125149454|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
125149455|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
125149456|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
125149457|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
125149458|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
125149459|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
125149460|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
125149461|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
125149462|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
125149463|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
125149464|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
125149465|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
125149466|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
125149467|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
125149468|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
125149469|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
125149470|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
125149471|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
125149472|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
125149473|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
125149474|NCT01435928|450169301|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
125149475|NCT01435928|450169302|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
125149476|NCT01435928|450169303|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
125149477|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
125149478|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
125149479|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
125149480|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
125149481|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
125149482|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
125149483|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
125149484|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
125149485|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
125149486|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
125388208|NCT04690751|451054044|FG003|Overall Study|Adverse Event|0|||
125388209|NCT04690751|451054045|FG004|Overall Study|Adverse Event|0|||
125388210|NCT04690751|451054046|FG005|Overall Study|Adverse Event|0|||
125388211|NCT04690751|451054041|FG000|Overall Study|Positive urine drug screen test|0|||
125388212|NCT04690751|451054042|FG001|Overall Study|Positive urine drug screen test|0|||
125388213|NCT04690751|451054043|FG002|Overall Study|Positive urine drug screen test|0|||
125388214|NCT04690751|451054044|FG003|Overall Study|Positive urine drug screen test|0|||
125388215|NCT04690751|451054045|FG004|Overall Study|Positive urine drug screen test|1|||
125388216|NCT04690751|451054046|FG005|Overall Study|Positive urine drug screen test|0|||
125388217|NCT04364620|451054047|FG000|Overall Study|Disease Progression|20|||
125388218|NCT04364620|451054047|FG000|Overall Study|Adverse Event|5|||
125388219|NCT04364620|451054047|FG000|Overall Study|Physician Decision|4|||
125388220|NCT04364620|451054047|FG000|Overall Study|Death|3|||
125388221|NCT04364620|451054047|FG000|Overall Study|Other|2|||
125388222|NCT04364620|451054047|FG000|Overall Study|Withdrawal by Subject|1|||
125388223|NCT01239368|451056545|FG000|Overall Study|Principal investigator discretion|1|||
125388224|NCT01239368|451056546|FG001|Overall Study|Principal investigator discretion|0|||
125388225|NCT01239368|451056547|FG002|Overall Study|Principal investigator discretion|0|||
125388226|NCT01239368|451056548|FG003|Overall Study|Principal investigator discretion|0|||
125388227|NCT01239368|451056549|FG004|Overall Study|Principal investigator discretion|1|||
125149487|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
125149488|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
125149489|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
125223660|NCT02326272|450446169|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125223661|NCT02326272|450446170|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125388228|NCT01239368|451056550|FG005|Overall Study|Principal investigator discretion|2|||
125388229|NCT01239368|451056551|FG006|Overall Study|Principal investigator discretion|0|||
125388230|NCT01239368|451056552|FG007|Overall Study|Principal investigator discretion|0|||
125388231|NCT01239368|451056553|FG008|Overall Study|Principal investigator discretion|0|||
125388232|NCT01239368|451056554|FG009|Overall Study|Principal investigator discretion|1|||
125388233|NCT01239368|451056545|FG000|Overall Study|Disease progression on study|1|||
125388234|NCT01239368|451056546|FG001|Overall Study|Disease progression on study|1|||
125388235|NCT01239368|451056547|FG002|Overall Study|Disease progression on study|1|||
125388236|NCT01239368|451056548|FG003|Overall Study|Disease progression on study|1|||
125388237|NCT01239368|451056549|FG004|Overall Study|Disease progression on study|4|||
125388238|NCT01239368|451056550|FG005|Overall Study|Disease progression on study|2|||
125149490|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
125149491|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
125149492|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
125149493|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
125149494|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
125149495|NCT01435928|450169301|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
125149496|NCT01435928|450169302|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
125149497|NCT01435928|450169303|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
125149498|NCT01619579|450171236|FG000|Overall Study|Withdrawal by Subject|0|||
125149499|NCT01619579|450171237|FG001|Overall Study|Withdrawal by Subject|3|||
125149500|NCT02124902|450171238|FG000|Overall Study|Adverse Event|7|||
125149501|NCT02124902|450171239|FG001|Overall Study|Adverse Event|2|||
125149502|NCT02124902|450171238|FG000|Overall Study|Went to alternative treatment|4|||
125149503|NCT02124902|450171239|FG001|Overall Study|Went to alternative treatment|0|||
125149504|NCT02124902|450171238|FG000|Overall Study|Withdrawal by Subject|2|||
125149505|NCT02124902|450171239|FG001|Overall Study|Withdrawal by Subject|1|||
125149506|NCT02124902|450171238|FG000|Overall Study|Physician Decision|2|||
125149507|NCT02124902|450171239|FG001|Overall Study|Physician Decision|0|||
125149508|NCT02124902|450171238|FG000|Overall Study|Not eligible|1|||
125149509|NCT02124902|450171239|FG001|Overall Study|Not eligible|0|||
125149510|NCT02124902|450171238|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
125149511|NCT02124902|450171239|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
125149512|NCT02938442|450171240|FG000|Overall Study|Death|0|||
125149513|NCT02938442|450171241|FG001|Overall Study|Death|1|||
125149514|NCT02938442|450171240|FG000|Overall Study|Lost to Follow-up|0|||
125149515|NCT02938442|450171241|FG001|Overall Study|Lost to Follow-up|1|||
125149516|NCT02938442|450171240|FG000|Overall Study|Physician Decision|0|||
125149517|NCT02938442|450171241|FG001|Overall Study|Physician Decision|1|||
125149518|NCT02938442|450171240|FG000|Overall Study|Withdrawal by Subject|2|||
125149519|NCT02938442|450171241|FG001|Overall Study|Withdrawal by Subject|0|||
125149520|NCT04100096|450171244|FG000|Overall Study|Adverse Event|19|||
125149521|NCT04100096|450171245|FG001|Overall Study|Adverse Event|7|||
125149522|NCT04100096|450171244|FG000|Overall Study|Lack of Efficacy|0|||
125149523|NCT04100096|450171245|FG001|Overall Study|Lack of Efficacy|1|||
125149524|NCT04100096|450171244|FG000|Overall Study|Lost to Follow-up|13|||
125149525|NCT04100096|450171245|FG001|Overall Study|Lost to Follow-up|11|||
125149526|NCT04100096|450171244|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125149527|NCT04100096|450171245|FG001|Overall Study|Non-Compliance With Study Drug|3|||
125149528|NCT04100096|450171244|FG000|Overall Study|Protocol Deviation|1|||
125149529|NCT04100096|450171245|FG001|Overall Study|Protocol Deviation|1|||
125149530|NCT04100096|450171244|FG000|Overall Study|Withdrawal by Participant|13|||
125149531|NCT04100096|450171245|FG001|Overall Study|Withdrawal by Participant|15|||
125149532|NCT00831233|450171249|FG000|Overall Study|Adverse Event|0|||
125149533|NCT00831233|450171250|FG001|Overall Study|Adverse Event|1|||
125149534|NCT00831233|450171249|FG000|Overall Study|Protocol Violation|1|||
125149535|NCT00831233|450171250|FG001|Overall Study|Protocol Violation|0|||
125149536|NCT00831233|450171249|FG000|Overall Study|Selection Criteria Not Met|2|||
125149537|NCT00831233|450171250|FG001|Overall Study|Selection Criteria Not Met|0|||
125149538|NCT02211014|450171251|FG000|Overall Study|Adverse Event|0|||
125149539|NCT02211014|450171252|FG001|Overall Study|Adverse Event|2|||
125149540|NCT02211014|450171251|FG000|Overall Study|Physician Decision|1|||
125149541|NCT02211014|450171252|FG001|Overall Study|Physician Decision|2|||
125149542|NCT02211014|450171251|FG000|Overall Study|Started another cancer therapy|1|||
125149543|NCT02211014|450171252|FG001|Overall Study|Started another cancer therapy|0|||
125149544|NCT02211014|450171251|FG000|Overall Study|Withdrawal by Subject|0|||
125149545|NCT02211014|450171252|FG001|Overall Study|Withdrawal by Subject|1|||
125388239|NCT01239368|451056551|FG006|Overall Study|Disease progression on study|5|||
125388240|NCT01239368|451056552|FG007|Overall Study|Disease progression on study|0|||
125388241|NCT01239368|451056553|FG008|Overall Study|Disease progression on study|0|||
125388242|NCT01239368|451056554|FG009|Overall Study|Disease progression on study|2|||
125388243|NCT01239368|451056545|FG000|Overall Study|Refused further treatment|0|||
125149546|NCT02211014|450171251|FG000|Overall Study|In agreement with patient, no benefit|0|||
125149547|NCT02211014|450171252|FG001|Overall Study|In agreement with patient, no benefit|1|||
125149548|NCT01915940|450171253|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
125149549|NCT01915940|450171254|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
125149550|NCT01915940|450171255|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
125149551|NCT01915940|450171253|FG000|Treatment Period|Decision of Participant|0|||
125149552|NCT01915940|450171254|FG001|Treatment Period|Decision of Participant|1|||
125149553|NCT01915940|450171255|FG002|Treatment Period|Decision of Participant|3|||
125149554|NCT01915940|450171253|FG000|Treatment Period|Adverse Event|0|||
125149555|NCT01915940|450171254|FG001|Treatment Period|Adverse Event|9|||
125149556|NCT01915940|450171255|FG002|Treatment Period|Adverse Event|1|||
125149557|NCT01915940|450171253|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
125149558|NCT01915940|450171254|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
125149559|NCT01915940|450171255|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
125149560|NCT02960438|450171256|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
125149561|NCT02960438|450171257|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
125149562|NCT02960438|450171258|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
125149563|NCT02960438|450171259|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
125149564|NCT02960438|450171256|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
125149565|NCT02960438|450171257|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
125149566|NCT02960438|450171258|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
125149567|NCT02960438|450171259|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
125149568|NCT02960438|450171256|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
125149569|NCT02960438|450171257|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
125149570|NCT02960438|450171258|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
125149571|NCT02960438|450171259|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
125149572|NCT02960438|450171256|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
125149573|NCT02960438|450171257|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
125149574|NCT02960438|450171258|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
125149575|NCT02960438|450171259|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
125149576|NCT02960438|450171256|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
125149577|NCT02960438|450171257|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
125149578|NCT02960438|450171258|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
125149579|NCT02960438|450171259|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
125149580|NCT02960438|450171256|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
125149581|NCT02960438|450171257|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
125149582|NCT02960438|450171258|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
125149583|NCT02960438|450171259|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
125149584|NCT02960438|450171256|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
125149585|NCT02960438|450171257|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
125149586|NCT02960438|450171258|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
125149587|NCT02960438|450171259|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
125149588|NCT02960438|450171256|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
125149589|NCT02960438|450171257|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
125149590|NCT02960438|450171258|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
125149591|NCT02960438|450171259|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
125149592|NCT02960438|450171256|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
125149593|NCT02960438|450171257|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
125149594|NCT02960438|450171258|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
125149595|NCT02960438|450171259|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
125149596|NCT02960438|450171256|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
125149597|NCT02960438|450171257|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
125149598|NCT02960438|450171258|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
125149599|NCT02960438|450171259|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
125149600|NCT02960438|450171256|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
125149601|NCT02960438|450171257|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
125149602|NCT02960438|450171258|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
125149603|NCT02960438|450171259|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
125149604|NCT02960438|450171256|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
125149605|NCT02960438|450171257|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
125149606|NCT02960438|450171258|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
125149607|NCT02960438|450171259|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
125149608|NCT01647711|450171261|FG000|Overall Study|Progressive disease|6|||
125149609|NCT01647711|450171262|FG001|Overall Study|Progressive disease|2|||
125149610|NCT01647711|450171263|FG002|Overall Study|Progressive disease|6|||
125149611|NCT01647711|450171264|FG003|Overall Study|Progressive disease|8|||
125149612|NCT01647711|450171265|FG004|Overall Study|Progressive disease|2|||
125149613|NCT01647711|450171261|FG000|Overall Study|Other adverse event|0|||
125149614|NCT01647711|450171262|FG001|Overall Study|Other adverse event|0|||
125149615|NCT01647711|450171263|FG002|Overall Study|Other adverse event|2|||
125149616|NCT01647711|450171264|FG003|Overall Study|Other adverse event|0|||
125149617|NCT01647711|450171265|FG004|Overall Study|Other adverse event|2|||
125149618|NCT01647711|450171261|FG000|Overall Study|Protocol Violation|0|||
125149619|NCT01647711|450171262|FG001|Overall Study|Protocol Violation|0|||
125149620|NCT01647711|450171263|FG002|Overall Study|Protocol Violation|0|||
125149621|NCT01647711|450171264|FG003|Overall Study|Protocol Violation|0|||
125149622|NCT01647711|450171265|FG004|Overall Study|Protocol Violation|1|||
125149623|NCT01647711|450171261|FG000|Overall Study|Refused to continue taking medication|0|||
125149624|NCT01647711|450171262|FG001|Overall Study|Refused to continue taking medication|0|||
125149625|NCT01647711|450171263|FG002|Overall Study|Refused to continue taking medication|0|||
125149626|NCT01647711|450171264|FG003|Overall Study|Refused to continue taking medication|2|||
125149627|NCT01647711|450171265|FG004|Overall Study|Refused to continue taking medication|1|||
125149628|NCT01647711|450171261|FG000|Overall Study|Other reason not defined|0|||
125149629|NCT01647711|450171262|FG001|Overall Study|Other reason not defined|1|||
125149630|NCT01647711|450171263|FG002|Overall Study|Other reason not defined|1|||
125149631|NCT01647711|450171264|FG003|Overall Study|Other reason not defined|1|||
125149632|NCT01647711|450171265|FG004|Overall Study|Other reason not defined|0|||
125149633|NCT01796964|450171283|FG000|Overall Study|Adverse Event|1|||
125149634|NCT01796964|450171284|FG001|Overall Study|Adverse Event|1|||
125149635|NCT01796964|450171283|FG000|Overall Study|Death|1|||
125149636|NCT01796964|450171284|FG001|Overall Study|Death|0|||
125149637|NCT01796964|450171283|FG000|Overall Study|Protocol Violation|0|||
125149638|NCT01796964|450171284|FG001|Overall Study|Protocol Violation|1|||
125149639|NCT01796964|450171283|FG000|Overall Study|Withdrawal by Subject|1|||
125149640|NCT01796964|450171284|FG001|Overall Study|Withdrawal by Subject|1|||
125149641|NCT04025684|450171285|FG000|Overall Study|Withdrawal by Subject|1|||
125149642|NCT04025684|450171286|FG001|Overall Study|Withdrawal by Subject|1|||
125149643|NCT04025684|450171287|FG002|Overall Study|Withdrawal by Subject|0|||
125149644|NCT04025684|450171288|FG003|Overall Study|Withdrawal by Subject|0|||
125149645|NCT04025684|450171285|FG000|Overall Study|Multiple reasons|1|||
125149646|NCT04025684|450171286|FG001|Overall Study|Multiple reasons|3|||
125149647|NCT04025684|450171287|FG002|Overall Study|Multiple reasons|0|||
125149648|NCT04025684|450171288|FG003|Overall Study|Multiple reasons|1|||
125149649|NCT01844531|450171289|FG000|Overall Study|Withdrawal by Subject|0|||
125149650|NCT01844531|450171290|FG001|Overall Study|Withdrawal by Subject|1|||
125149651|NCT01844531|450171291|FG002|Overall Study|Withdrawal by Subject|0|||
125149652|NCT01844531|450171292|FG003|Overall Study|Withdrawal by Subject|0|||
125149653|NCT02744755|450171293|FG000|Study Period 1|Protocol Violation|2|||
125149654|NCT02744755|450171294|FG001|Study Period 1|Protocol Violation|1|||
125149655|NCT02744755|450171293|FG000|Study Period 1|not defined|0|||
125149656|NCT02744755|450171294|FG001|Study Period 1|not defined|1|||
125149657|NCT02744755|450171293|FG000|Study Period 1|Pregnancy|1|||
125149658|NCT02744755|450171294|FG001|Study Period 1|Pregnancy|0|||
125149659|NCT02744755|450171293|FG000|Study Period 1|Adverse Event|1|||
125149660|NCT02744755|450171294|FG001|Study Period 1|Adverse Event|1|||
125149661|NCT02744755|450171293|FG000|Study Period 1|Lost to Follow-up|1|||
125149662|NCT02744755|450171294|FG001|Study Period 1|Lost to Follow-up|1|||
125149663|NCT02744755|450171293|FG000|Study Period 1|Lack of Efficacy|1|||
125149664|NCT02744755|450171294|FG001|Study Period 1|Lack of Efficacy|0|||
125149665|NCT02744755|450171293|FG000|Study Period 1|Withdrawal by Subject|8|||
125149666|NCT02744755|450171294|FG001|Study Period 1|Withdrawal by Subject|4|||
125149667|NCT02744755|450171293|FG000|Study Period 2|Adverse Event|5|||
125149668|NCT02744755|450171294|FG001|Study Period 2|Adverse Event|0|||
125149669|NCT02744755|450171293|FG000|Study Period 2|Protocol Violation|1|||
125149670|NCT02744755|450171294|FG001|Study Period 2|Protocol Violation|0|||
125149671|NCT02744755|450171293|FG000|Study Period 2|not defined|3|||
125149672|NCT02744755|450171294|FG001|Study Period 2|not defined|2|||
125149673|NCT02744755|450171293|FG000|Study Period 2|Lost to Follow-up|0|||
125149674|NCT02744755|450171294|FG001|Study Period 2|Lost to Follow-up|2|||
125149675|NCT02744755|450171293|FG000|Study Period 2|Withdrawal by Subject|2|||
125149676|NCT02744755|450171294|FG001|Study Period 2|Withdrawal by Subject|2|||
125149677|NCT02744755|450171293|FG000|Study Period 2|Lack of Efficacy|3|||
125149678|NCT02744755|450171294|FG001|Study Period 2|Lack of Efficacy|2|||
125149679|NCT02916693|450171297|FG000|Overall Study|Lost to Follow-up|7|||
125149680|NCT00337428|450171298|FG000|Overall Study|Withdrawal by Subject|1|||
125149681|NCT00337428|450171299|FG001|Overall Study|Withdrawal by Subject|2|||
125149682|NCT00337428|450171298|FG000|Overall Study|Lack of Time|1|||
125149683|NCT00337428|450171299|FG001|Overall Study|Lack of Time|1|||
125149684|NCT00337428|450171298|FG000|Overall Study|Unwilling to Continue|1|||
125438682|NCT00669903|451233923|FG000|Overall Study|Adverse Event|0|||
125438683|NCT00669903|451233924|FG001|Overall Study|Adverse Event|1|||
125438684|NCT00669903|451233925|FG002|Overall Study|Adverse Event|3|||
125438685|NCT00669903|451233926|FG003|Overall Study|Adverse Event|1|||
125438686|NCT00669903|451233923|FG000|Overall Study|Withdrawal by Subject|0|||
125438687|NCT00669903|451233924|FG001|Overall Study|Withdrawal by Subject|2|||
125438688|NCT00669903|451233925|FG002|Overall Study|Withdrawal by Subject|2|||
125149685|NCT00337428|450171299|FG001|Overall Study|Unwilling to Continue|0|||
125149686|NCT00337428|450171298|FG000|Overall Study|Anorexia|1|||
125149687|NCT00337428|450171299|FG001|Overall Study|Anorexia|0|||
125149688|NCT01999894|450171300|FG000|Overall Study|Adverse Event|9|||
125149689|NCT01999894|450171300|FG000|Overall Study|Lack of Efficacy|5|||
125149690|NCT01999894|450171300|FG000|Overall Study|Protocol Violation|1|||
125149691|NCT01999894|450171300|FG000|Overall Study|Withdrawal by Subject|7|||
125149692|NCT01999894|450171300|FG000|Overall Study|Lost to Follow-up|10|||
125149693|NCT01999894|450171300|FG000|Overall Study|Other Reason|3|||
125388244|NCT01239368|451056546|FG001|Overall Study|Refused further treatment|0|||
125388245|NCT01239368|451056547|FG002|Overall Study|Refused further treatment|0|||
125388246|NCT01239368|451056548|FG003|Overall Study|Refused further treatment|0|||
125388247|NCT01239368|451056549|FG004|Overall Study|Refused further treatment|0|||
125388248|NCT01239368|451056550|FG005|Overall Study|Refused further treatment|0|||
125388249|NCT01239368|451056551|FG006|Overall Study|Refused further treatment|0|||
125388250|NCT01239368|451056552|FG007|Overall Study|Refused further treatment|0|||
125388251|NCT01239368|451056553|FG008|Overall Study|Refused further treatment|0|||
125388252|NCT01239368|451056554|FG009|Overall Study|Refused further treatment|1|||
125388253|NCT01239368|451056545|FG000|Overall Study|Death|0|||
125388254|NCT01239368|451056546|FG001|Overall Study|Death|0|||
125388255|NCT01239368|451056547|FG002|Overall Study|Death|0|||
125388256|NCT01239368|451056548|FG003|Overall Study|Death|0|||
125388257|NCT01239368|451056549|FG004|Overall Study|Death|0|||
125388258|NCT01239368|451056550|FG005|Overall Study|Death|0|||
125388259|NCT01239368|451056551|FG006|Overall Study|Death|1|||
125388260|NCT01239368|451056552|FG007|Overall Study|Death|0|||
125388261|NCT01239368|451056553|FG008|Overall Study|Death|0|||
125388262|NCT01239368|451056554|FG009|Overall Study|Death|0|||
125388263|NCT04579380|451056555|FG000|Overall Study|Death|9|||
125388264|NCT04579380|451056556|FG001|Overall Study|Death|22|||
125149694|NCT01999894|450171300|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
125149695|NCT01740791|450171302|FG000|Overall Study|Randomized but never treated|5|||
125149696|NCT01740791|450171303|FG001|Overall Study|Randomized but never treated|3|||
125149697|NCT01740791|450171304|FG002|Overall Study|Randomized but never treated|2|||
125149698|NCT01740791|450171305|FG003|Overall Study|Randomized but never treated|2|||
125149699|NCT01740791|450171306|FG004|Overall Study|Randomized but never treated|1|||
125149700|NCT01740791|450171307|FG005|Overall Study|Randomized but never treated|3|||
125149701|NCT01740791|450171302|FG000|Overall Study|Lost to Follow-up|2|||
125149702|NCT01740791|450171303|FG001|Overall Study|Lost to Follow-up|0|||
125149703|NCT01740791|450171304|FG002|Overall Study|Lost to Follow-up|2|||
125149704|NCT01740791|450171305|FG003|Overall Study|Lost to Follow-up|3|||
125149705|NCT01740791|450171306|FG004|Overall Study|Lost to Follow-up|2|||
125149706|NCT01740791|450171307|FG005|Overall Study|Lost to Follow-up|3|||
125149707|NCT01740791|450171302|FG000|Overall Study|Withdrew Consent|4|||
125149708|NCT01740791|450171303|FG001|Overall Study|Withdrew Consent|0|||
125149709|NCT01740791|450171304|FG002|Overall Study|Withdrew Consent|1|||
125149710|NCT01740791|450171305|FG003|Overall Study|Withdrew Consent|2|||
125149711|NCT01740791|450171306|FG004|Overall Study|Withdrew Consent|0|||
125149712|NCT01740791|450171307|FG005|Overall Study|Withdrew Consent|3|||
125149713|NCT01740791|450171302|FG000|Overall Study|Investigator's discretion|1|||
125149714|NCT01740791|450171303|FG001|Overall Study|Investigator's discretion|0|||
125149715|NCT01740791|450171304|FG002|Overall Study|Investigator's discretion|1|||
125149716|NCT01740791|450171305|FG003|Overall Study|Investigator's discretion|0|||
125149717|NCT01740791|450171306|FG004|Overall Study|Investigator's discretion|0|||
125149718|NCT01740791|450171307|FG005|Overall Study|Investigator's discretion|1|||
125149719|NCT01740791|450171302|FG000|Overall Study|Adverse Event|0|||
125149720|NCT01740791|450171303|FG001|Overall Study|Adverse Event|0|||
125149721|NCT01740791|450171304|FG002|Overall Study|Adverse Event|0|||
125149722|NCT01740791|450171305|FG003|Overall Study|Adverse Event|0|||
125149723|NCT01740791|450171306|FG004|Overall Study|Adverse Event|0|||
125149724|NCT01740791|450171307|FG005|Overall Study|Adverse Event|1|||
125149725|NCT03170869|450171308|FG000|Overall Study|Protocol Violation|5|||
125149726|NCT03170869|450171308|FG000|Overall Study|Early study termination|3|||
125149727|NCT00220727|450171311|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
125149728|NCT00220727|450171312|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
125149729|NCT02020967|450171313|FG000|Overall Study|Withdrawal by Subject|51|||
125149730|NCT03507686|450171314|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
125149731|NCT03507686|450171315|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
125149732|NCT03507686|450171314|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
125149733|NCT03507686|450171315|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
125149734|NCT03507686|450171314|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
125149735|NCT03507686|450171315|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
125149736|NCT03507686|450171314|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
125149737|NCT03507686|450171315|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
125149738|NCT03507686|450171314|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
125149739|NCT03507686|450171315|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
125149740|NCT03507686|450171314|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
125149741|NCT03507686|450171315|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
125223662|NCT02326272|450446171|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125388265|NCT04579380|451056557|FG002|Overall Study|Death|22|||
125388266|NCT04579380|451056558|FG003|Overall Study|Death|17|||
125388267|NCT04579380|451056559|FG004|Overall Study|Death|6|||
125223663|NCT02326272|450446172|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125388268|NCT04579380|451056560|FG005|Overall Study|Death|21|||
125149742|NCT02508116|450171316|FG000|Overall Study|Lost to Follow-up|2|||
125149743|NCT02508116|450171317|FG001|Overall Study|Lost to Follow-up|3|||
125149744|NCT02508116|450171316|FG000|Overall Study|Withdrawal by Subject|3|||
125149745|NCT02508116|450171317|FG001|Overall Study|Withdrawal by Subject|2|||
125149746|NCT02508116|450171316|FG000|Overall Study|Protocol Violation|1|||
125149747|NCT02508116|450171317|FG001|Overall Study|Protocol Violation|2|||
125149748|NCT02508116|450171316|FG000|Overall Study|Physician Decision|2|||
125149749|NCT02508116|450171317|FG001|Overall Study|Physician Decision|0|||
125149750|NCT00983528|450171320|FG000|Overall Study|Death|4|||
125149751|NCT00983528|450171320|FG000|Overall Study|Lost to Follow-up|1|||
125388269|NCT04579380|451056561|FG006|Overall Study|Death|10|||
125149752|NCT00983528|450171320|FG000|Overall Study|Study Terminated|1|||
125149753|NCT00575380|450171321|FG000|Overall Study|Withdrawal by Subject|1|||
125149754|NCT00575380|450171322|FG001|Overall Study|Withdrawal by Subject|0|||
125149755|NCT00575380|450171321|FG000|Overall Study|Adverse Event|0|||
125149756|NCT00575380|450171322|FG001|Overall Study|Adverse Event|1|||
125149757|NCT00575380|450171321|FG000|Overall Study|Various|0|||
125149758|NCT00575380|450171322|FG001|Overall Study|Various|2|||
125149759|NCT00559364|450171323|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
125149760|NCT00559364|450171324|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
125149761|NCT00330460|450171331|FG000|Overall Study|Physician Decision|1|||
125149762|NCT00330460|450171332|FG001|Overall Study|Physician Decision|0|||
125149763|NCT00330460|450171331|FG000|Overall Study|Adverse Event|10|||
125149764|NCT00330460|450171332|FG001|Overall Study|Adverse Event|8|||
125149765|NCT00330460|450171331|FG000|Overall Study|Withdrawal by Subject|18|||
125149766|NCT00330460|450171332|FG001|Overall Study|Withdrawal by Subject|17|||
125149767|NCT00330460|450171331|FG000|Overall Study|Death|1|||
125149768|NCT00330460|450171332|FG001|Overall Study|Death|1|||
125149769|NCT00330460|450171331|FG000|Overall Study|Ineligibility determined|1|||
125149770|NCT00330460|450171332|FG001|Overall Study|Ineligibility determined|3|||
125149771|NCT00330460|450171331|FG000|Overall Study|Lost to Follow-up|8|||
125149772|NCT00330460|450171332|FG001|Overall Study|Lost to Follow-up|3|||
125149773|NCT00330460|450171331|FG000|Overall Study|Noncompliance|2|||
125149774|NCT00330460|450171332|FG001|Overall Study|Noncompliance|1|||
125149775|NCT00330460|450171331|FG000|Overall Study|Other|1|||
125149776|NCT00330460|450171332|FG001|Overall Study|Other|0|||
125149777|NCT02663882|450171333|FG000|Overall Study|Lost to Follow-up|4|||
125149778|NCT02663882|450171334|FG001|Overall Study|Lost to Follow-up|2|||
125149779|NCT00388037|450171335|FG000|Overall Study|Protocol Violation|1|||
125149780|NCT02539368|450171342|FG000|Overall Study|Death|4|||
125149781|NCT02539368|450171343|FG001|Overall Study|Death|2|||
125149782|NCT02539368|450171344|FG002|Overall Study|Death|1|||
125149783|NCT02539368|450171345|FG003|Overall Study|Death|0|||
125149784|NCT02539368|450171346|FG004|Overall Study|Death|0|||
125149785|NCT02539368|450171342|FG000|Overall Study|Withdrawal by Subject|44|||
125149786|NCT02539368|450171343|FG001|Overall Study|Withdrawal by Subject|35|||
125149787|NCT02539368|450171344|FG002|Overall Study|Withdrawal by Subject|9|||
125149788|NCT02539368|450171345|FG003|Overall Study|Withdrawal by Subject|1|||
125149789|NCT02539368|450171346|FG004|Overall Study|Withdrawal by Subject|3|||
125149790|NCT02539368|450171342|FG000|Overall Study|Physician Decision|49|||
125149791|NCT02539368|450171343|FG001|Overall Study|Physician Decision|15|||
125149792|NCT02539368|450171344|FG002|Overall Study|Physician Decision|7|||
125149793|NCT02539368|450171345|FG003|Overall Study|Physician Decision|0|||
125388270|NCT04579380|451056562|FG007|Overall Study|Death|11|||
125388271|NCT04579380|451056563|FG008|Overall Study|Death|25|||
125149794|NCT02539368|450171346|FG004|Overall Study|Physician Decision|2|||
125149795|NCT02539368|450171342|FG000|Overall Study|Lost to Follow-up|96|||
125149796|NCT02539368|450171343|FG001|Overall Study|Lost to Follow-up|21|||
125149797|NCT02539368|450171344|FG002|Overall Study|Lost to Follow-up|16|||
125149798|NCT02539368|450171345|FG003|Overall Study|Lost to Follow-up|4|||
125149799|NCT02539368|450171346|FG004|Overall Study|Lost to Follow-up|3|||
125388272|NCT04579380|451056555|FG000|Overall Study|Withdrawal by Subject|0|||
125388273|NCT04579380|451056556|FG001|Overall Study|Withdrawal by Subject|3|||
125149800|NCT02539368|450171342|FG000|Overall Study|Adverse Event|44|||
125149801|NCT02539368|450171343|FG001|Overall Study|Adverse Event|5|||
125149802|NCT02539368|450171344|FG002|Overall Study|Adverse Event|9|||
125149803|NCT02539368|450171345|FG003|Overall Study|Adverse Event|0|||
125149804|NCT02539368|450171346|FG004|Overall Study|Adverse Event|3|||
125149805|NCT02539368|450171342|FG000|Overall Study|Participant Non-compliant|13|||
125149806|NCT02539368|450171343|FG001|Overall Study|Participant Non-compliant|2|||
125149807|NCT02539368|450171344|FG002|Overall Study|Participant Non-compliant|1|||
125149808|NCT02539368|450171345|FG003|Overall Study|Participant Non-compliant|1|||
125388274|NCT04579380|451056557|FG002|Overall Study|Withdrawal by Subject|4|||
125149809|NCT02539368|450171346|FG004|Overall Study|Participant Non-compliant|0|||
125149810|NCT02539368|450171342|FG000|Overall Study|Other|145|||
125149811|NCT02539368|450171343|FG001|Overall Study|Other|18|||
125149812|NCT02539368|450171344|FG002|Overall Study|Other|24|||
125149813|NCT02539368|450171345|FG003|Overall Study|Other|1|||
125149814|NCT02539368|450171346|FG004|Overall Study|Other|3|||
125149815|NCT02539368|450171342|FG000|Overall Study|Missing|10|||
125149816|NCT02539368|450171343|FG001|Overall Study|Missing|3|||
125388275|NCT04579380|451056558|FG003|Overall Study|Withdrawal by Subject|0|||
125388276|NCT04579380|451056559|FG004|Overall Study|Withdrawal by Subject|1|||
125388277|NCT04579380|451056560|FG005|Overall Study|Withdrawal by Subject|2|||
125388278|NCT04579380|451056561|FG006|Overall Study|Withdrawal by Subject|0|||
125388279|NCT04579380|451056562|FG007|Overall Study|Withdrawal by Subject|1|||
125388280|NCT04579380|451056563|FG008|Overall Study|Withdrawal by Subject|2|||
125388281|NCT04579380|451056555|FG000|Overall Study|Ongoing|2|||
125388282|NCT04579380|451056556|FG001|Overall Study|Ongoing|6|||
125388283|NCT04579380|451056557|FG002|Overall Study|Ongoing|4|||
125388284|NCT04579380|451056558|FG003|Overall Study|Ongoing|8|||
125388285|NCT04579380|451056559|FG004|Overall Study|Ongoing|5|||
125388286|NCT04579380|451056560|FG005|Overall Study|Ongoing|8|||
125388287|NCT04579380|451056561|FG006|Overall Study|Ongoing|3|||
125388288|NCT04579380|451056562|FG007|Overall Study|Ongoing|19|||
125388289|NCT04579380|451056563|FG008|Overall Study|Ongoing|6|||
125388290|NCT02967692|451056564|FG000|Overall Study|Progressive disease|3|||
125388291|NCT02967692|451056565|FG001|Overall Study|Progressive disease|15|||
125388292|NCT02967692|451056566|FG002|Overall Study|Progressive disease|114|||
125388293|NCT02967692|451056567|FG003|Overall Study|Progressive disease|151|||
125388294|NCT02967692|451056564|FG000|Overall Study|Subject/guardian decision|1|||
125388295|NCT02967692|451056565|FG001|Overall Study|Subject/guardian decision|1|||
125388296|NCT02967692|451056566|FG002|Overall Study|Subject/guardian decision|14|||
125388297|NCT02967692|451056567|FG003|Overall Study|Subject/guardian decision|22|||
125388298|NCT02967692|451056564|FG000|Overall Study|Death|0|||
125388299|NCT02967692|451056565|FG001|Overall Study|Death|1|||
125388300|NCT02967692|451056566|FG002|Overall Study|Death|13|||
125149817|NCT02539368|450171344|FG002|Overall Study|Missing|0|||
125149818|NCT02539368|450171345|FG003|Overall Study|Missing|0|||
125149819|NCT02539368|450171346|FG004|Overall Study|Missing|0|||
125149820|NCT00869440|450171347|FG000|Overall Study|Withdrawal by Subject|1|||
125149821|NCT00869440|450171348|FG001|Overall Study|Withdrawal by Subject|0|||
125149822|NCT00869440|450171349|FG002|Overall Study|Withdrawal by Subject|0|||
125149823|NCT00869440|450171350|FG003|Overall Study|Withdrawal by Subject|0|||
125149824|NCT00869440|450171347|FG000|Overall Study|Physician Decision|1|||
125149825|NCT00869440|450171348|FG001|Overall Study|Physician Decision|1|||
125149826|NCT00869440|450171349|FG002|Overall Study|Physician Decision|0|||
125149827|NCT00869440|450171350|FG003|Overall Study|Physician Decision|0|||
125149828|NCT03558139|450171353|FG000|Overall Study|Consent Withdrawn|1|||
125149829|NCT03558139|450171354|FG001|Overall Study|Consent Withdrawn|1|||
125149830|NCT03558139|450171355|FG002|Overall Study|Consent Withdrawn|4|||
125149831|NCT03558139|450171353|FG000|Overall Study|Death|5|||
125149832|NCT03558139|450171354|FG001|Overall Study|Death|3|||
125149833|NCT03558139|450171355|FG002|Overall Study|Death|8|||
125149834|NCT03558139|450171353|FG000|Overall Study|Lost to Follow-up|0|||
125149835|NCT03558139|450171354|FG001|Overall Study|Lost to Follow-up|0|||
125149836|NCT03558139|450171355|FG002|Overall Study|Lost to Follow-up|3|||
125149837|NCT03558139|450171353|FG000|Overall Study|Study Ended Per Protocol|0|||
125149838|NCT03558139|450171354|FG001|Overall Study|Study Ended Per Protocol|3|||
125149839|NCT03558139|450171355|FG002|Overall Study|Study Ended Per Protocol|6|||
125149840|NCT02752802|450171356|FG000|Overall Study|Contrast Volume Not Collected|1|||
125149841|NCT02752802|450171357|FG001|Overall Study|Contrast Volume Not Collected|0|||
125149842|NCT02808819|450171358|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
125149843|NCT02808819|450171359|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
125149844|NCT02808819|450171358|FG000|Overall Study|Withdrawal by Subject|10|||
125149845|NCT02808819|450171359|FG001|Overall Study|Withdrawal by Subject|13|||
125149846|NCT02808819|450171358|FG000|Overall Study|Site terminated by sponsor|2|||
125149847|NCT02808819|450171359|FG001|Overall Study|Site terminated by sponsor|0|||
125149848|NCT02808819|450171358|FG000|Overall Study|Pregnancy|1|||
125149849|NCT02808819|450171359|FG001|Overall Study|Pregnancy|0|||
125149850|NCT02808819|450171358|FG000|Overall Study|Lost to Follow-up|1|||
125388301|NCT02967692|451056567|FG003|Overall Study|Death|13|||
125388302|NCT02967692|451056564|FG000|Overall Study|Protocol deviation|1|||
125438689|NCT00669903|451233926|FG003|Overall Study|Withdrawal by Subject|2|||
125149851|NCT02808819|450171359|FG001|Overall Study|Lost to Follow-up|6|||
125388303|NCT02967692|451056565|FG001|Overall Study|Protocol deviation|0|||
125388304|NCT02967692|451056566|FG002|Overall Study|Protocol deviation|1|||
125388305|NCT02967692|451056567|FG003|Overall Study|Protocol deviation|1|||
125388306|NCT02967692|451056564|FG000|Overall Study|Lost to Follow-up|0|||
125149852|NCT02808819|450171358|FG000|Overall Study|Protocol Violation|0|||
125149853|NCT02808819|450171359|FG001|Overall Study|Protocol Violation|1|||
125149854|NCT02808819|450171358|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
125149855|NCT02808819|450171359|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
125149856|NCT02808819|450171358|FG000|Overall Study|Death|1|||
125149857|NCT02808819|450171359|FG001|Overall Study|Death|0|||
125149858|NCT02808819|450171358|FG000|Overall Study|Adverse Event|3|||
125149859|NCT02808819|450171359|FG001|Overall Study|Adverse Event|4|||
125388307|NCT02967692|451056565|FG001|Overall Study|Lost to Follow-up|0|||
125388308|NCT02967692|451056566|FG002|Overall Study|Lost to Follow-up|1|||
125388309|NCT02967692|451056567|FG003|Overall Study|Lost to Follow-up|0|||
125388310|NCT02967692|451056564|FG000|Overall Study|Physician Decision|0|||
125149860|NCT03573817|450171360|FG000|Overall Study|Adverse Event|0|||
125149861|NCT03573817|450171361|FG001|Overall Study|Adverse Event|2|||
125149862|NCT03573817|450171360|FG000|Overall Study|Protocol Violation|0|||
125149863|NCT03573817|450171361|FG001|Overall Study|Protocol Violation|1|||
125149864|NCT03573817|450171360|FG000|Overall Study|Withdrawal by Subject|1|||
125149865|NCT03573817|450171361|FG001|Overall Study|Withdrawal by Subject|1|||
125149866|NCT02013531|450171362|FG000|Overall Study|Lost to Follow-up|3|||
125149867|NCT02013531|450171362|FG000|Overall Study|Met Withdrawal Criteria|1|||
125149868|NCT02013531|450171362|FG000|Overall Study|Withdrawal by Subject|1|||
125149869|NCT03546647|450171363|FG000|Overall Study|Adverse Event|1|||
125149870|NCT03546647|450171364|FG001|Overall Study|Adverse Event|0|||
125149871|NCT02400476|450171365|FG000|Overall Study|Adverse Event|57|||
125149872|NCT02400476|450171366|FG001|Overall Study|Adverse Event|10|||
125149873|NCT02400476|450171367|FG002|Overall Study|Adverse Event|22|||
125149874|NCT02400476|450171368|FG003|Overall Study|Adverse Event|19|||
125149875|NCT02400476|450171369|FG004|Overall Study|Adverse Event|5|||
125149876|NCT02400476|450171370|FG005|Overall Study|Adverse Event|8|||
125149877|NCT02400476|450171365|FG000|Overall Study|Withdrawal by Subject|4|||
125149878|NCT02400476|450171366|FG001|Overall Study|Withdrawal by Subject|1|||
125149879|NCT02400476|450171367|FG002|Overall Study|Withdrawal by Subject|12|||
125149880|NCT02400476|450171368|FG003|Overall Study|Withdrawal by Subject|7|||
125149881|NCT02400476|450171369|FG004|Overall Study|Withdrawal by Subject|5|||
125149882|NCT02400476|450171370|FG005|Overall Study|Withdrawal by Subject|5|||
125149883|NCT02400476|450171365|FG000|Overall Study|Lost to Follow-up|0|||
125149884|NCT02400476|450171366|FG001|Overall Study|Lost to Follow-up|0|||
125149885|NCT02400476|450171367|FG002|Overall Study|Lost to Follow-up|0|||
125149886|NCT02400476|450171368|FG003|Overall Study|Lost to Follow-up|1|||
125149887|NCT02400476|450171369|FG004|Overall Study|Lost to Follow-up|3|||
125149888|NCT02400476|450171370|FG005|Overall Study|Lost to Follow-up|1|||
125149889|NCT02400476|450171365|FG000|Overall Study|Physician Decision|0|||
125149890|NCT02400476|450171366|FG001|Overall Study|Physician Decision|0|||
125149891|NCT02400476|450171367|FG002|Overall Study|Physician Decision|1|||
125149892|NCT02400476|450171368|FG003|Overall Study|Physician Decision|1|||
125149893|NCT02400476|450171369|FG004|Overall Study|Physician Decision|0|||
125149894|NCT02400476|450171370|FG005|Overall Study|Physician Decision|1|||
125149895|NCT02400476|450171365|FG000|Overall Study|Other, Disease Progression|0|||
125149896|NCT02400476|450171366|FG001|Overall Study|Other, Disease Progression|1|||
125149897|NCT02400476|450171367|FG002|Overall Study|Other, Disease Progression|2|||
125149898|NCT02400476|450171368|FG003|Overall Study|Other, Disease Progression|1|||
125149899|NCT02400476|450171369|FG004|Overall Study|Other, Disease Progression|2|||
125149900|NCT02400476|450171370|FG005|Overall Study|Other, Disease Progression|1|||
125149901|NCT02400476|450171365|FG000|Overall Study|Other, Decreased Quality of Life|0|||
125149902|NCT02400476|450171366|FG001|Overall Study|Other, Decreased Quality of Life|0|||
125149903|NCT02400476|450171367|FG002|Overall Study|Other, Decreased Quality of Life|2|||
125149904|NCT02400476|450171368|FG003|Overall Study|Other, Decreased Quality of Life|0|||
125149905|NCT02400476|450171369|FG004|Overall Study|Other, Decreased Quality of Life|0|||
125149906|NCT02400476|450171370|FG005|Overall Study|Other, Decreased Quality of Life|0|||
125149907|NCT02400476|450171365|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
125149908|NCT02400476|450171366|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
125149909|NCT02400476|450171367|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
125149910|NCT02400476|450171368|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
125149911|NCT02400476|450171369|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
125149912|NCT02400476|450171370|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
125149913|NCT00588731|450171373|FG000|Overall Study|Withdrawal by Subject|3|||
125149914|NCT00588731|450171374|FG001|Overall Study|Withdrawal by Subject|2|||
125149915|NCT00612677|450171377|FG000|Overall Study|study closed before treatment started|1|||
125149916|NCT00613730|450171380|FG000|Overall Study|Disease progression|2|||
125149917|NCT00613730|450171380|FG000|Overall Study|Administrative decision|1|||
125149918|NCT02056652|450171383|FG000|Overall Study|Withdrawal by Subject|1|||
125149919|NCT02056652|450171384|FG001|Overall Study|Withdrawal by Subject|0|||
125149920|NCT02056652|450171383|FG000|Overall Study|Lost to Follow-up|0|||
125149921|NCT02056652|450171384|FG001|Overall Study|Lost to Follow-up|3|||
125149922|NCT02093923|450171385|FG000|Overall Study|Lost to Follow-up|0|||
125223664|NCT02326272|450446173|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125149923|NCT02093923|450171386|FG001|Overall Study|Lost to Follow-up|0|||
125149924|NCT02093923|450171387|FG002|Overall Study|Lost to Follow-up|0|||
125149925|NCT02093923|450171388|FG003|Overall Study|Lost to Follow-up|1|||
125149926|NCT02093923|450171389|FG004|Overall Study|Lost to Follow-up|0|||
125149927|NCT02093923|450171385|FG000|Overall Study|Screen failure after randomization|0|||
125149928|NCT02093923|450171386|FG001|Overall Study|Screen failure after randomization|0|||
125149929|NCT02093923|450171387|FG002|Overall Study|Screen failure after randomization|0|||
125149930|NCT02093923|450171388|FG003|Overall Study|Screen failure after randomization|1|||
125149931|NCT02093923|450171389|FG004|Overall Study|Screen failure after randomization|0|||
125149932|NCT03253094|450171390|FG000|Overall Study|Adverse Event|2|||
125149933|NCT03253094|450171391|FG001|Overall Study|Adverse Event|0|||
125149934|NCT03253094|450171392|FG002|Overall Study|Adverse Event|0|||
125149935|NCT03253094|450171393|FG003|Overall Study|Adverse Event|0|||
125149936|NCT03253094|450171394|FG004|Overall Study|Adverse Event|0|||
125149937|NCT03253094|450171395|FG005|Overall Study|Adverse Event|0|||
125149938|NCT03253094|450171390|FG000|Overall Study|Lack of Efficacy|0|||
125149939|NCT03253094|450171391|FG001|Overall Study|Lack of Efficacy|0|||
125149940|NCT03253094|450171392|FG002|Overall Study|Lack of Efficacy|2|||
125149941|NCT03253094|450171393|FG003|Overall Study|Lack of Efficacy|1|||
125149942|NCT03253094|450171394|FG004|Overall Study|Lack of Efficacy|2|||
125149943|NCT03253094|450171395|FG005|Overall Study|Lack of Efficacy|1|||
125149944|NCT03253094|450171390|FG000|Overall Study|Lost to Follow-up|0|||
125149945|NCT03253094|450171391|FG001|Overall Study|Lost to Follow-up|0|||
125149946|NCT03253094|450171392|FG002|Overall Study|Lost to Follow-up|1|||
125149947|NCT03253094|450171393|FG003|Overall Study|Lost to Follow-up|1|||
125149948|NCT03253094|450171394|FG004|Overall Study|Lost to Follow-up|0|||
125149949|NCT03253094|450171395|FG005|Overall Study|Lost to Follow-up|1|||
125149950|NCT03253094|450171390|FG000|Overall Study|Physician Decision|1|||
125149951|NCT03253094|450171391|FG001|Overall Study|Physician Decision|0|||
125149952|NCT03253094|450171392|FG002|Overall Study|Physician Decision|0|||
125149953|NCT03253094|450171393|FG003|Overall Study|Physician Decision|1|||
125149954|NCT03253094|450171394|FG004|Overall Study|Physician Decision|0|||
125149955|NCT03253094|450171395|FG005|Overall Study|Physician Decision|2|||
125149956|NCT03253094|450171390|FG000|Overall Study|Withdrawal by Subject|1|||
125149957|NCT03253094|450171391|FG001|Overall Study|Withdrawal by Subject|2|||
125149958|NCT03253094|450171392|FG002|Overall Study|Withdrawal by Subject|1|||
125149959|NCT03253094|450171393|FG003|Overall Study|Withdrawal by Subject|0|||
125149960|NCT03253094|450171394|FG004|Overall Study|Withdrawal by Subject|3|||
125149961|NCT03253094|450171395|FG005|Overall Study|Withdrawal by Subject|0|||
125149962|NCT03253094|450171390|FG000|Overall Study|Other|0|||
125149963|NCT03253094|450171391|FG001|Overall Study|Other|1|||
125149964|NCT03253094|450171392|FG002|Overall Study|Other|2|||
125149965|NCT03253094|450171393|FG003|Overall Study|Other|1|||
125149966|NCT03253094|450171394|FG004|Overall Study|Other|0|||
125149967|NCT03253094|450171395|FG005|Overall Study|Other|0|||
125149968|NCT00248170|450171396|FG000|Overall Study|Withdrawal by Subject|71|||
125149969|NCT00248170|450171397|FG001|Overall Study|Withdrawal by Subject|79|||
125149970|NCT00248170|450171396|FG000|Overall Study|Protocol Violation|35|||
125149971|NCT00248170|450171397|FG001|Overall Study|Protocol Violation|30|||
125149972|NCT00248170|450171396|FG000|Overall Study|Lost to Follow-up|28|||
125149973|NCT00248170|450171397|FG001|Overall Study|Lost to Follow-up|35|||
125149974|NCT00248170|450171396|FG000|Overall Study|Disease progression|196|||
125149975|NCT00248170|450171397|FG001|Overall Study|Disease progression|216|||
125149976|NCT00248170|450171396|FG000|Overall Study|Death|28|||
125149977|NCT00248170|450171397|FG001|Overall Study|Death|47|||
125149978|NCT00248170|450171396|FG000|Overall Study|Adverse Event|311|||
125149979|NCT00248170|450171397|FG001|Overall Study|Adverse Event|296|||
125149980|NCT00248170|450171396|FG000|Overall Study|Administrative problems|22|||
125149981|NCT00248170|450171397|FG001|Overall Study|Administrative problems|25|||
125149982|NCT00248170|450171396|FG000|Overall Study|Abnormal test procedure(s) result|49|||
125149983|NCT00248170|450171397|FG001|Overall Study|Abnormal test procedure(s) result|61|||
125149984|NCT00248170|450171396|FG000|Overall Study|Abnormal laboratory values|4|||
125149985|NCT00248170|450171397|FG001|Overall Study|Abnormal laboratory values|0|||
125149986|NCT00248170|450171396|FG000|Overall Study|Protocol deviation|17|||
125149987|NCT00248170|450171397|FG001|Overall Study|Protocol deviation|19|||
125149988|NCT01557582|450171398|FG000|Overall Study|Protocol Violation|4|||
125149989|NCT01557582|450171398|FG000|Overall Study|Operator error|2|||
125149990|NCT02843659|450171402|FG000|Overall Study|Subject Withdrew Consent|0|||
125149991|NCT02843659|450171403|FG001|Overall Study|Subject Withdrew Consent|0|||
125149992|NCT02843659|450171404|FG002|Overall Study|Subject Withdrew Consent|1|||
125149993|NCT02843659|450171402|FG000|Overall Study|Administrative Reason by Sponsor|4|||
125149994|NCT02843659|450171403|FG001|Overall Study|Administrative Reason by Sponsor|5|||
125149995|NCT02843659|450171404|FG002|Overall Study|Administrative Reason by Sponsor|4|||
125149996|NCT02843659|450171402|FG000|Overall Study|Adverse Event|0|||
125149997|NCT02843659|450171403|FG001|Overall Study|Adverse Event|1|||
125149998|NCT02843659|450171404|FG002|Overall Study|Adverse Event|0|||
125149999|NCT02413294|450171405|FG000|Overall Study|Withdrawal by Subject|1|||
125150000|NCT01253317|450171415|FG000|Overall Study|Adverse Event|2|||
125150001|NCT02012452|450174648|FG000|Overall Study|Lost to Follow-up|2|||
125150002|NCT02012452|450174649|FG001|Overall Study|Lost to Follow-up|1|||
125150003|NCT02012452|450174648|FG000|Overall Study|Withdrawal by Subject|4|||
125150004|NCT02012452|450174649|FG001|Overall Study|Withdrawal by Subject|0|||
125150005|NCT02688387|450174650|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150006|NCT02688387|450174651|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150007|NCT02688387|450174652|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
125150008|NCT02688387|450174653|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150009|NCT02688387|450174654|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150010|NCT02688387|450174655|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150011|NCT02688387|450174656|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150012|NCT02688387|450174657|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150013|NCT02688387|450174658|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150014|NCT02688387|450174659|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150015|NCT02688387|450174660|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150016|NCT02688387|450174661|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150017|NCT02688387|450174662|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150018|NCT02688387|450174663|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150019|NCT02688387|450174664|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150020|NCT02688387|450174665|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150021|NCT02688387|450174666|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150022|NCT02688387|450174667|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150023|NCT02688387|450174668|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150024|NCT02688387|450174669|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150025|NCT02688387|450174670|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150026|NCT02688387|450174671|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
125150027|NCT02688387|450174650|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150028|NCT02688387|450174651|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150029|NCT02688387|450174652|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150030|NCT02688387|450174653|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
125150031|NCT02688387|450174654|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150032|NCT02688387|450174655|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150033|NCT02688387|450174656|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150034|NCT02688387|450174657|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150035|NCT02688387|450174658|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150036|NCT02688387|450174659|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150037|NCT02688387|450174660|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150038|NCT02688387|450174661|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150039|NCT02688387|450174662|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150040|NCT02688387|450174663|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150041|NCT02688387|450174664|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150042|NCT02688387|450174665|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150043|NCT02688387|450174666|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150044|NCT02688387|450174667|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150045|NCT02688387|450174668|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150046|NCT02688387|450174669|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150047|NCT02688387|450174670|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150048|NCT02688387|450174671|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150049|NCT02688387|450174650|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150050|NCT02688387|450174651|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
125150051|NCT02688387|450174652|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150052|NCT02688387|450174653|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150053|NCT02688387|450174654|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150054|NCT02688387|450174655|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150055|NCT02688387|450174656|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150056|NCT02688387|450174657|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150057|NCT02688387|450174658|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150058|NCT02688387|450174659|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150059|NCT02688387|450174660|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150060|NCT02688387|450174661|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150061|NCT02688387|450174662|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150062|NCT02688387|450174663|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150063|NCT02688387|450174664|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150064|NCT02688387|450174665|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150065|NCT02688387|450174666|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150066|NCT02688387|450174667|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150067|NCT02688387|450174668|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150068|NCT02688387|450174669|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150069|NCT02688387|450174670|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125150070|NCT02688387|450174671|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
125388311|NCT02967692|451056565|FG001|Overall Study|Physician Decision|0|||
125388312|NCT02967692|451056566|FG002|Overall Study|Physician Decision|22|||
125388313|NCT02967692|451056567|FG003|Overall Study|Physician Decision|13|||
125388314|NCT02967692|451056564|FG000|Overall Study|Adverse Event|2|||
125388315|NCT02967692|451056565|FG001|Overall Study|Adverse Event|9|||
125388316|NCT02967692|451056566|FG002|Overall Study|Adverse Event|60|||
125150071|NCT02688387|450174650|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150072|NCT02688387|450174651|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150073|NCT02688387|450174652|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
125150074|NCT02688387|450174653|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150075|NCT02688387|450174654|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
125150076|NCT02688387|450174655|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150077|NCT02688387|450174656|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150078|NCT02688387|450174657|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150079|NCT02688387|450174658|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150080|NCT02688387|450174659|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150081|NCT02688387|450174660|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150082|NCT02688387|450174661|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150083|NCT02688387|450174662|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150084|NCT02688387|450174663|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150085|NCT02688387|450174664|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150086|NCT02688387|450174665|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150087|NCT02688387|450174666|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150088|NCT02688387|450174667|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150089|NCT02688387|450174668|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150090|NCT02688387|450174669|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150091|NCT02688387|450174670|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150092|NCT02688387|450174671|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
125150093|NCT02688387|450174650|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
125150094|NCT02688387|450174651|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150095|NCT02688387|450174652|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150096|NCT02688387|450174653|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150097|NCT02688387|450174654|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150098|NCT02688387|450174655|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150099|NCT02688387|450174656|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150100|NCT02688387|450174657|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150101|NCT02688387|450174658|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150102|NCT02688387|450174659|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150103|NCT02688387|450174660|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150104|NCT02688387|450174661|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150105|NCT02688387|450174662|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150106|NCT02688387|450174663|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150107|NCT02688387|450174664|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150108|NCT02688387|450174665|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150109|NCT02688387|450174666|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150110|NCT02688387|450174667|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150111|NCT02688387|450174668|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150112|NCT02688387|450174669|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150113|NCT02688387|450174670|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150114|NCT02688387|450174671|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
125150115|NCT02688387|450174650|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150116|NCT02688387|450174651|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150117|NCT02688387|450174652|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150118|NCT02688387|450174653|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150119|NCT02688387|450174654|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150120|NCT02688387|450174655|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150121|NCT02688387|450174656|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150122|NCT02688387|450174657|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150123|NCT02688387|450174658|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150124|NCT02688387|450174659|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150125|NCT02688387|450174660|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
125150126|NCT02688387|450174661|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150127|NCT02688387|450174662|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150128|NCT02688387|450174663|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150129|NCT02688387|450174664|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150130|NCT02688387|450174665|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150131|NCT02688387|450174666|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150132|NCT02688387|450174667|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150133|NCT02688387|450174668|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150134|NCT02688387|450174669|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150135|NCT02688387|450174670|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150136|NCT02688387|450174671|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
125150137|NCT02688387|450174650|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150138|NCT02688387|450174651|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150139|NCT02688387|450174652|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150140|NCT02688387|450174653|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150141|NCT02688387|450174654|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150142|NCT02688387|450174655|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150143|NCT02688387|450174656|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150144|NCT02688387|450174657|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150145|NCT02688387|450174658|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150146|NCT02688387|450174659|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150147|NCT02688387|450174660|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150148|NCT02688387|450174661|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150149|NCT02688387|450174662|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150150|NCT02688387|450174663|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150151|NCT02688387|450174664|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
125150152|NCT02688387|450174665|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150153|NCT02688387|450174666|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150154|NCT02688387|450174667|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150155|NCT02688387|450174668|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150156|NCT02688387|450174669|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150157|NCT02688387|450174670|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150158|NCT02688387|450174671|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
125150159|NCT02688387|450174650|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150160|NCT02688387|450174651|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150161|NCT02688387|450174652|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150162|NCT02688387|450174653|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150163|NCT02688387|450174654|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150164|NCT02688387|450174655|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150165|NCT02688387|450174656|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150166|NCT02688387|450174657|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150167|NCT02688387|450174658|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150168|NCT02688387|450174659|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150169|NCT02688387|450174660|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150170|NCT02688387|450174661|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150171|NCT02688387|450174662|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150172|NCT02688387|450174663|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150173|NCT02688387|450174664|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150174|NCT02688387|450174665|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150175|NCT02688387|450174666|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150176|NCT02688387|450174667|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150177|NCT02688387|450174668|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150178|NCT02688387|450174669|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150179|NCT02688387|450174670|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
125150180|NCT02688387|450174671|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
125150181|NCT02688387|450174650|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150182|NCT02688387|450174651|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150183|NCT02688387|450174652|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150184|NCT02688387|450174653|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150185|NCT02688387|450174654|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150186|NCT02688387|450174655|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150187|NCT02688387|450174656|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150188|NCT02688387|450174657|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150189|NCT02688387|450174658|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150190|NCT02688387|450174659|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150191|NCT02688387|450174660|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150192|NCT02688387|450174661|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150193|NCT02688387|450174662|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150194|NCT02688387|450174663|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150195|NCT02688387|450174664|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150196|NCT02688387|450174665|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150197|NCT02688387|450174666|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150198|NCT02688387|450174667|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150199|NCT02688387|450174668|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
125150200|NCT02688387|450174669|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125223665|NCT02326272|450446174|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125150201|NCT02688387|450174670|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
125150202|NCT02688387|450174671|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
125150203|NCT02688387|450174650|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150204|NCT02688387|450174651|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150205|NCT02688387|450174652|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150206|NCT02688387|450174653|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150207|NCT02688387|450174654|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150208|NCT02688387|450174655|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150209|NCT02688387|450174656|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150210|NCT02688387|450174657|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150211|NCT02688387|450174658|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150212|NCT02688387|450174659|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150213|NCT02688387|450174660|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150214|NCT02688387|450174661|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150215|NCT02688387|450174662|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150216|NCT02688387|450174663|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150217|NCT02688387|450174664|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150218|NCT02688387|450174665|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150219|NCT02688387|450174666|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150220|NCT02688387|450174667|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150221|NCT02688387|450174668|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150222|NCT02688387|450174669|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
125150223|NCT02688387|450174670|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150224|NCT02688387|450174671|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
125150225|NCT04403399|450174674|FG000|Period 2|Physician Decision|0|||
125150226|NCT04403399|450174675|FG001|Period 2|Physician Decision|1|||
125150227|NCT01606228|450174676|FG000|Overall Study|Lost to Follow-up|20|||
125150228|NCT01606228|450174676|FG000|Overall Study|Withdrawal by Subject|3|||
125150229|NCT01606228|450174676|FG000|Overall Study|Non-compliant|3|||
125150230|NCT01606228|450174676|FG000|Overall Study|Lack of Efficacy|2|||
125150231|NCT01606228|450174676|FG000|Overall Study|Adverse Event|1|||
125150232|NCT00546910|450174677|FG000|Overall Study|Adverse Event|2|||
125150233|NCT00546910|450174678|FG001|Overall Study|Adverse Event|3|||
125150234|NCT00546910|450174677|FG000|Overall Study|Lack of Efficacy|5|||
125150235|NCT00546910|450174678|FG001|Overall Study|Lack of Efficacy|7|||
125150236|NCT00546910|450174677|FG000|Overall Study|Physician Decision|0|||
125150237|NCT00546910|450174678|FG001|Overall Study|Physician Decision|1|||
125150238|NCT00546910|450174677|FG000|Overall Study|Withdrawal by Subject|2|||
125150239|NCT00546910|450174678|FG001|Overall Study|Withdrawal by Subject|0|||
125150240|NCT01115855|450174679|FG000|Overall Study|Adverse Event|16|||
125150241|NCT01115855|450174680|FG001|Overall Study|Adverse Event|18|||
125150242|NCT01115855|450174679|FG000|Overall Study|Death|6|||
125150243|NCT01115855|450174680|FG001|Overall Study|Death|5|||
125150244|NCT01115855|450174679|FG000|Overall Study|Lab Abnormality|1|||
125150245|NCT01115855|450174680|FG001|Overall Study|Lab Abnormality|1|||
125150246|NCT01115855|450174679|FG000|Overall Study|Protocol Violation|0|||
125150247|NCT01115855|450174680|FG001|Overall Study|Protocol Violation|1|||
125150248|NCT01115855|450174679|FG000|Overall Study|Withdrawal by Subject|5|||
125150249|NCT01115855|450174680|FG001|Overall Study|Withdrawal by Subject|5|||
125150250|NCT01115855|450174679|FG000|Overall Study|Other|8|||
125150251|NCT01115855|450174680|FG001|Overall Study|Other|6|||
125150252|NCT00089076|450174705|FG000|Overall Study|Alternate Therapy|1|||
125150253|NCT00089076|450174705|FG000|Overall Study|Withdrawal by Subject|2|||
125150254|NCT00089076|450174705|FG000|Overall Study|Progression|7|||
125150255|NCT01009515|450174707|FG000|Overall Study|Withdrawal by Subject|3|||
125150256|NCT00983476|450174711|FG000|Overall Study|Did not receive intervention|17|||
125150257|NCT00983476|450174712|FG001|Overall Study|Did not receive intervention|22|||
125150258|NCT00983476|450174713|FG002|Overall Study|Did not receive intervention|0|||
125150259|NCT01175473|450174715|FG000|Overall Study|Adverse Event|2|||
125150260|NCT01175473|450174716|FG001|Overall Study|Adverse Event|2|||
125150261|NCT01857973|450174719|FG000|Overall Study|Subject did not meet required BG range|3|||
125150262|NCT01857973|450174719|FG000|Overall Study|drop out after 3 failed attempts|1|||
125150263|NCT01857973|450174719|FG000|Overall Study|Physician Decision|1|||
125150264|NCT01731886|450174728|FG000|Overall Study|Death|1|||
125150265|NCT01731886|450174729|FG001|Overall Study|Death|0|||
125150266|NCT01731886|450174728|FG000|Overall Study|Never started treatment|0|||
125150267|NCT01731886|450174729|FG001|Overall Study|Never started treatment|1|||
125150268|NCT01731886|450174728|FG000|Overall Study|Non-compliant|1|||
125150269|NCT01731886|450174729|FG001|Overall Study|Non-compliant|0|||
125150270|NCT00271024|450174730|FG000|Overall Study|Lost Interest|3|||
125150271|NCT00271024|450174731|FG001|Overall Study|Lost Interest|4|||
125150272|NCT00271024|450174732|FG002|Overall Study|Lost Interest|2|||
125223666|NCT02326272|450446175|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125223667|NCT02326272|450446176|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
125388317|NCT02967692|451056567|FG003|Overall Study|Adverse Event|28|||
125388318|NCT02967692|451056564|FG000|Overall Study|Study terminated by sponsor|2|||
125388319|NCT02967692|451056565|FG001|Overall Study|Study terminated by sponsor|1|||
125388320|NCT02967692|451056566|FG002|Overall Study|Study terminated by sponsor|42|||
125150273|NCT00271024|450174733|FG003|Overall Study|Lost Interest|3|||
125150274|NCT00271024|450174730|FG000|Overall Study|Unknown/Unspecified|11|||
125150275|NCT00271024|450174731|FG001|Overall Study|Unknown/Unspecified|11|||
125150276|NCT00271024|450174732|FG002|Overall Study|Unknown/Unspecified|8|||
125150277|NCT00271024|450174733|FG003|Overall Study|Unknown/Unspecified|4|||
125150278|NCT00271024|450174730|FG000|Overall Study|Protocol Violation|1|||
125150279|NCT00271024|450174731|FG001|Overall Study|Protocol Violation|6|||
125150280|NCT00271024|450174732|FG002|Overall Study|Protocol Violation|5|||
125150281|NCT00271024|450174733|FG003|Overall Study|Protocol Violation|11|||
125150282|NCT00271024|450174730|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
125150283|NCT00271024|450174731|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
125150284|NCT00271024|450174732|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
125150285|NCT00271024|450174733|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
125150286|NCT00271024|450174730|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
125150287|NCT00271024|450174731|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
125150288|NCT00271024|450174732|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
125150289|NCT00271024|450174733|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
125150290|NCT00129116|450174734|FG000|Primary Phase|Lost to Follow-up|1|||
125150291|NCT00129116|450174735|FG001|Primary Phase|Lost to Follow-up|1|||
125150292|NCT00129116|450174736|FG002|Primary Phase|Lost to Follow-up|0|||
125150293|NCT00129116|450174737|FG003|Primary Phase|Lost to Follow-up|1|||
125388321|NCT02967692|451056567|FG003|Overall Study|Study terminated by sponsor|37|||
125388322|NCT00066066|451056570|FG000|Overall Study|Lost to Follow-up|6|||
125388323|NCT00066066|451056571|FG001|Overall Study|Lost to Follow-up|4|||
125388324|NCT00066066|451056572|FG002|Overall Study|Lost to Follow-up|7|||
125388325|NCT00066066|451056573|FG003|Overall Study|Lost to Follow-up|4|||
125388326|NCT00066066|451056574|FG004|Overall Study|Lost to Follow-up|3|||
125388327|NCT00066066|451056575|FG005|Overall Study|Lost to Follow-up|5|||
125388328|NCT02268409|451056576|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
125388329|NCT02268409|451056576|FG000|Overall Study|Death|1|||
125388330|NCT02268409|451056576|FG000|Overall Study|Lost to Follow-up|1|||
125388331|NCT02268409|451056576|FG000|Overall Study|Protocol Violation|3|||
125388332|NCT02268409|451056576|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
125388333|NCT02268409|451056576|FG000|Overall Study|Withdrawal by Subject|5|||
125388334|NCT00489853|451056581|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
125388335|NCT00489853|451056582|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
125388336|NCT00489853|451056583|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
125388337|NCT00489853|451056581|FG000|Wash-out Period 1|Adverse Event|0|||
125388338|NCT00489853|451056582|FG001|Wash-out Period 1|Adverse Event|1|||
125388339|NCT00489853|451056583|FG002|Wash-out Period 1|Adverse Event|1|||
125388340|NCT00489853|451056581|FG000|Wash-out Period 1|Protocol Violation|0|||
125388341|NCT00489853|451056582|FG001|Wash-out Period 1|Protocol Violation|1|||
125388342|NCT00489853|451056583|FG002|Wash-out Period 1|Protocol Violation|1|||
125388343|NCT00489853|451056581|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
125388344|NCT00489853|451056582|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
125388345|NCT00489853|451056583|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
125388346|NCT00489853|451056581|FG000|Wash-out Period 2|Adverse Event|1|||
125388347|NCT00489853|451056582|FG001|Wash-out Period 2|Adverse Event|1|||
125388348|NCT00489853|451056583|FG002|Wash-out Period 2|Adverse Event|0|||
125388349|NCT00489853|451056581|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
125388350|NCT00489853|451056582|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
125388351|NCT00489853|451056583|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
125388352|NCT00489853|451056581|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
125388353|NCT00489853|451056582|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
125388354|NCT00489853|451056583|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
125388355|NCT01541969|451056587|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
125388356|NCT01541969|451056588|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
125388357|NCT01541969|451056587|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
125388358|NCT01541969|451056588|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
125388359|NCT01541969|451056587|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
125388360|NCT01541969|451056588|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
125150294|NCT00129116|450174738|FG004|Primary Phase|Lost to Follow-up|1|||
125150295|NCT00129116|450174734|FG000|Primary Phase|Protocol Violation|0|||
125388361|NCT01541969|451056587|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
125388362|NCT01541969|451056588|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
125388363|NCT01541969|451056587|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
125388364|NCT01541969|451056588|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
125150296|NCT00129116|450174735|FG001|Primary Phase|Protocol Violation|1|||
125150297|NCT00129116|450174736|FG002|Primary Phase|Protocol Violation|0|||
125388365|NCT01541969|451056587|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
125388366|NCT01541969|451056588|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
125388367|NCT01541969|451056587|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
125150298|NCT00129116|450174737|FG003|Primary Phase|Protocol Violation|0|||
125150299|NCT00129116|450174738|FG004|Primary Phase|Protocol Violation|0|||
125150300|NCT00129116|450174734|FG000|Primary Phase|Adverse Event|1|||
125150301|NCT00129116|450174735|FG001|Primary Phase|Adverse Event|1|||
125150302|NCT00129116|450174736|FG002|Primary Phase|Adverse Event|0|||
125150303|NCT00129116|450174737|FG003|Primary Phase|Adverse Event|0|||
125150304|NCT00129116|450174738|FG004|Primary Phase|Adverse Event|0|||
125150305|NCT00129116|450174734|FG000|Primary Phase|Withdrawal by Subject|0|||
125150306|NCT00129116|450174735|FG001|Primary Phase|Withdrawal by Subject|1|||
125150307|NCT00129116|450174736|FG002|Primary Phase|Withdrawal by Subject|0|||
125150308|NCT00129116|450174737|FG003|Primary Phase|Withdrawal by Subject|0|||
125150309|NCT00129116|450174738|FG004|Primary Phase|Withdrawal by Subject|0|||
125150310|NCT00129116|450174734|FG000|Primary Phase|Other|0|||
125150311|NCT00129116|450174735|FG001|Primary Phase|Other|0|||
125150312|NCT00129116|450174736|FG002|Primary Phase|Other|1|||
125150313|NCT00129116|450174737|FG003|Primary Phase|Other|0|||
125150314|NCT00129116|450174738|FG004|Primary Phase|Other|0|||
125150315|NCT00129116|450174734|FG000|Booster Phase|Lost to Follow-up|2|||
125150316|NCT00129116|450174735|FG001|Booster Phase|Lost to Follow-up|0|||
125150317|NCT00129116|450174736|FG002|Booster Phase|Lost to Follow-up|0|||
125150318|NCT00129116|450174737|FG003|Booster Phase|Lost to Follow-up|0|||
125150319|NCT00129116|450174738|FG004|Booster Phase|Lost to Follow-up|1|||
125150320|NCT00602537|450174739|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
125150321|NCT00602537|450174740|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
125150322|NCT00602537|450174739|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
125150323|NCT00602537|450174740|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
125150324|NCT00602537|450174739|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
125150325|NCT00602537|450174740|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
125150326|NCT00602537|450174739|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
125150327|NCT00602537|450174740|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
125150328|NCT00602537|450174739|FG000|Follow Up Study Comparison|Adverse Event|1|||
125150329|NCT00602537|450174740|FG001|Follow Up Study Comparison|Adverse Event|0|||
125150330|NCT00602537|450174739|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
125150331|NCT00602537|450174740|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
125150332|NCT00602537|450174739|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
125150333|NCT00602537|450174740|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
125150334|NCT03417830|450174743|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
125150335|NCT03417830|450174744|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
125150336|NCT00823199|450174745|FG000|Overall Study|Withdrawal by Subject|2|||
125150337|NCT00268892|450174746|FG000|Overall Study|Adverse Event|14|||
125150338|NCT00268892|450174747|FG001|Overall Study|Adverse Event|17|||
125150339|NCT00268892|450174748|FG002|Overall Study|Adverse Event|20|||
125150340|NCT00268892|450174746|FG000|Overall Study|Lack of Efficacy|1|||
125150341|NCT00268892|450174747|FG001|Overall Study|Lack of Efficacy|3|||
125150342|NCT00268892|450174748|FG002|Overall Study|Lack of Efficacy|0|||
125150343|NCT00268892|450174746|FG000|Overall Study|Withdrawal by Subject|14|||
125150344|NCT00268892|450174747|FG001|Overall Study|Withdrawal by Subject|15|||
125150345|NCT00268892|450174748|FG002|Overall Study|Withdrawal by Subject|13|||
125150346|NCT00268892|450174746|FG000|Overall Study|Physician Decision|0|||
125150347|NCT00268892|450174747|FG001|Overall Study|Physician Decision|1|||
125388368|NCT01541969|451056588|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
125388369|NCT01541969|451056587|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
125438690|NCT00669903|451233923|FG000|Overall Study|Lost to Follow-up|1|||
125150348|NCT00268892|450174748|FG002|Overall Study|Physician Decision|0|||
125150349|NCT00268892|450174746|FG000|Overall Study|Lost to Follow-up|5|||
125150350|NCT00268892|450174747|FG001|Overall Study|Lost to Follow-up|2|||
125150351|NCT00268892|450174748|FG002|Overall Study|Lost to Follow-up|4|||
125150352|NCT00268892|450174746|FG000|Overall Study|Protocol Violation|0|||
125150353|NCT00268892|450174747|FG001|Overall Study|Protocol Violation|1|||
125150354|NCT00268892|450174748|FG002|Overall Study|Protocol Violation|0|||
125150355|NCT00268892|450174746|FG000|Overall Study|Disease Progression|1|||
125150356|NCT00268892|450174747|FG001|Overall Study|Disease Progression|1|||
125150357|NCT00268892|450174748|FG002|Overall Study|Disease Progression|0|||
125150358|NCT00268892|450174746|FG000|Overall Study|Trial Site Closed|4|||
125150359|NCT00268892|450174747|FG001|Overall Study|Trial Site Closed|2|||
125150360|NCT00268892|450174748|FG002|Overall Study|Trial Site Closed|2|||
125150361|NCT01640184|450174755|FG000|Overall Study|Death|1|||
125150362|NCT01640184|450174756|FG001|Overall Study|Death|0|||
125150363|NCT01640184|450174757|FG002|Overall Study|Death|0|||
125150364|NCT01640184|450174755|FG000|Overall Study|Lost to Follow-up|4|||
125150365|NCT01640184|450174756|FG001|Overall Study|Lost to Follow-up|1|||
125150366|NCT01640184|450174757|FG002|Overall Study|Lost to Follow-up|0|||
125150367|NCT01640184|450174755|FG000|Overall Study|Physician Decision|3|||
125150368|NCT01640184|450174756|FG001|Overall Study|Physician Decision|0|||
125150369|NCT01640184|450174757|FG002|Overall Study|Physician Decision|0|||
125150370|NCT01640184|450174755|FG000|Overall Study|Withdrawal by Subject|0|||
125150371|NCT01640184|450174756|FG001|Overall Study|Withdrawal by Subject|1|||
125150372|NCT01640184|450174757|FG002|Overall Study|Withdrawal by Subject|1|||
125150373|NCT01640184|450174755|FG000|Overall Study|Protocol Violation|0|||
125150374|NCT01640184|450174756|FG001|Overall Study|Protocol Violation|0|||
125150375|NCT01640184|450174757|FG002|Overall Study|Protocol Violation|1|||
125150376|NCT01684878|450174761|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
125150377|NCT01684878|450174762|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
125150378|NCT01684878|450174763|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
125150379|NCT01684878|450174764|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
125150380|NCT01684878|450174761|FG000|Part 1: Safety Run in Phase|Death|15|||
125150381|NCT01684878|450174762|FG001|Part 1: Safety Run in Phase|Death|20|||
125150382|NCT01684878|450174763|FG002|Part 1: Safety Run in Phase|Death|0|||
125150383|NCT01684878|450174764|FG003|Part 1: Safety Run in Phase|Death|0|||
125150384|NCT01684878|450174761|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
125150385|NCT01684878|450174762|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
125150386|NCT01684878|450174763|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
125150387|NCT01684878|450174764|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
125150388|NCT01684878|450174761|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
125150389|NCT01684878|450174762|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
125150390|NCT01684878|450174763|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
125150391|NCT01684878|450174764|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
125150392|NCT01684878|450174761|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
125150393|NCT01684878|450174762|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
125150394|NCT01684878|450174763|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
125150395|NCT01684878|450174764|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
125150396|NCT01684878|450174761|FG000|Part 2: Randomized Phase|Death|0|||
125223668|NCT02326272|450446177|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125223669|NCT02326272|450446178|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
125223670|NCT00468585|450446182|FG000|Overall Study|Patient not treated|1|||
125223671|NCT00468585|450446183|FG001|Overall Study|Patient not treated|0|||
125223672|NCT00468585|450446184|FG002|Overall Study|Patient not treated|1|||
125223673|NCT00468585|450446185|FG003|Overall Study|Patient not treated|0|||
125223674|NCT00468585|450446182|FG000|Overall Study|Patient found to be ineligible|0|||
125223675|NCT00468585|450446183|FG001|Overall Study|Patient found to be ineligible|0|||
125223676|NCT00468585|450446184|FG002|Overall Study|Patient found to be ineligible|1|||
125223677|NCT00468585|450446185|FG003|Overall Study|Patient found to be ineligible|0|||
125223678|NCT00468585|450446182|FG000|Overall Study|Adverse Event|0|||
125223679|NCT00468585|450446183|FG001|Overall Study|Adverse Event|0|||
125223680|NCT00468585|450446184|FG002|Overall Study|Adverse Event|1|||
125223681|NCT00468585|450446185|FG003|Overall Study|Adverse Event|0|||
125223682|NCT00468585|450446182|FG000|Overall Study|Withdrawal by Subject|0|||
125223683|NCT00468585|450446183|FG001|Overall Study|Withdrawal by Subject|0|||
125223684|NCT00468585|450446184|FG002|Overall Study|Withdrawal by Subject|2|||
125223685|NCT00468585|450446185|FG003|Overall Study|Withdrawal by Subject|1|||
125223686|NCT02154139|450446186|FG000|Overall Study|Injection not administered|2|||
125223687|NCT02154139|450446186|FG000|Overall Study|Other|2|||
125223688|NCT02154139|450446186|FG000|Overall Study|Investigator transferred|3|||
125223689|NCT00809445|450446188|FG000|1 Month Follow-up|Lost contact|1|||
125223690|NCT00809445|450446189|FG001|1 Month Follow-up|Lost contact|2|||
125223691|NCT00809445|450446190|FG002|1 Month Follow-up|Lost contact|1|||
125223692|NCT00809445|450446188|FG000|1 Month Follow-up|Withdrew consent|1|||
125223693|NCT00809445|450446189|FG001|1 Month Follow-up|Withdrew consent|1|||
125223694|NCT00809445|450446190|FG002|1 Month Follow-up|Withdrew consent|1|||
125223695|NCT00809445|450446188|FG000|1 Month Follow-up|Death|0|||
125223696|NCT00809445|450446189|FG001|1 Month Follow-up|Death|1|||
125223697|NCT00809445|450446190|FG002|1 Month Follow-up|Death|1|||
125223698|NCT00809445|450446188|FG000|1 Month Follow-up|Incarcerated|0|||
125223699|NCT00809445|450446189|FG001|1 Month Follow-up|Incarcerated|0|||
125223700|NCT00809445|450446190|FG002|1 Month Follow-up|Incarcerated|1|||
125223701|NCT00809445|450446188|FG000|6 Month Follow-up|Lost contact|16|||
125223702|NCT00809445|450446189|FG001|6 Month Follow-up|Lost contact|14|||
125223703|NCT00809445|450446190|FG002|6 Month Follow-up|Lost contact|14|||
125388370|NCT01541969|451056588|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
125388371|NCT01541969|451056587|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
125388372|NCT01541969|451056588|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
125150397|NCT01684878|450174762|FG001|Part 2: Randomized Phase|Death|0|||
125150398|NCT01684878|450174763|FG002|Part 2: Randomized Phase|Death|62|||
125150399|NCT01684878|450174764|FG003|Part 2: Randomized Phase|Death|68|||
125150400|NCT01684878|450174761|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
125223704|NCT00809445|450446188|FG000|6 Month Follow-up|Death|2|||
125223705|NCT00809445|450446189|FG001|6 Month Follow-up|Death|1|||
125223706|NCT00809445|450446190|FG002|6 Month Follow-up|Death|1|||
125223707|NCT00809445|450446188|FG000|6 Month Follow-up|Incarcerated|6|||
125388373|NCT01541969|451056587|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
125388374|NCT01541969|451056588|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
125388375|NCT01614990|451056589|FG000|Overall Study|Protocol Violation|1|||
125388376|NCT01614990|451056590|FG001|Overall Study|Protocol Violation|1|||
125388377|NCT05129488|451056591|FG000|Overall Study|Protocol Violation|3|||
125388378|NCT02608268|451056592|FG000|Overall Study|Adverse Event|0|||
125388379|NCT02608268|451056593|FG001|Overall Study|Adverse Event|0|||
125150401|NCT01684878|450174762|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
125388380|NCT02608268|451056594|FG002|Overall Study|Adverse Event|1|||
125388381|NCT02608268|451056595|FG003|Overall Study|Adverse Event|0|||
125388382|NCT02608268|451056596|FG004|Overall Study|Adverse Event|0|||
125388383|NCT02608268|451056597|FG005|Overall Study|Adverse Event|0|||
125388384|NCT02608268|451056598|FG006|Overall Study|Adverse Event|0|||
125388385|NCT02608268|451056599|FG007|Overall Study|Adverse Event|0|||
125388386|NCT02608268|451056600|FG008|Overall Study|Adverse Event|0|||
125388387|NCT02608268|451056601|FG009|Overall Study|Adverse Event|0|||
125388388|NCT02608268|451056602|FG010|Overall Study|Adverse Event|0|||
125388389|NCT02608268|451056603|FG011|Overall Study|Adverse Event|0|||
125388390|NCT02608268|451056604|FG012|Overall Study|Adverse Event|2|||
125150402|NCT01684878|450174763|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
125150403|NCT01684878|450174764|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
125150404|NCT01684878|450174761|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
125150405|NCT01684878|450174762|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
125150406|NCT01684878|450174763|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
125150407|NCT01684878|450174764|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
125150408|NCT02692482|450174765|FG000|Overall Study|Death|2|||
125150409|NCT02692482|450174766|FG001|Overall Study|Death|2|||
125150410|NCT02692482|450174765|FG000|Overall Study|Withdrawal by Subject|1|||
125150411|NCT02692482|450174766|FG001|Overall Study|Withdrawal by Subject|2|||
125150412|NCT01435031|450174767|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
125150413|NCT01435031|450174767|FG000|ITT at 1 Month|Death|1|||
125150414|NCT01435031|450174767|FG000|ITT at 1 Month|Lost to Follow-up|4|||
125150415|NCT01435031|450174767|FG000|ITT at 6 Months|Death|2|||
125150416|NCT01435031|450174767|FG000|ITT at 6 Months|Lost to Follow-up|3|||
125150417|NCT01435031|450174767|FG000|ITT at 1 Year|Death|1|||
125150418|NCT01435031|450174767|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
125150419|NCT01435031|450174767|FG000|ITT at 1 Year|Lost to Follow-up|6|||
125150420|NCT01435031|450174767|FG000|ITT at 2 Years|Death|7|||
125150421|NCT01435031|450174767|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
125150422|NCT01435031|450174767|FG000|ITT at 2 Years|Lost to Follow-up|4|||
125150423|NCT01435031|450174767|FG000|ITT at 3 Years|Death|5|||
125150424|NCT01435031|450174767|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
125150425|NCT01435031|450174767|FG000|ITT at 3 Years|Lost to Follow-up|4|||
125150426|NCT01435031|450174767|FG000|ITT at 4 Years|Death|4|||
125150427|NCT01435031|450174767|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
125150428|NCT01435031|450174767|FG000|ITT at 4 Years|Lost to Follow-up|1|||
125150429|NCT02927834|450174768|FG000|Overall Study|Lost to Follow-up|1|||
125150430|NCT02927834|450174769|FG001|Overall Study|Lost to Follow-up|2|||
125150431|NCT02927834|450174770|FG002|Overall Study|Lost to Follow-up|2|||
125150432|NCT00479388|450174771|FG000|Overall Study|Adverse Event|90|||
125150433|NCT00479388|450174772|FG001|Overall Study|Adverse Event|45|||
125150434|NCT00479388|450174771|FG000|Overall Study|Lost to Follow-up|0|||
125150435|NCT00479388|450174772|FG001|Overall Study|Lost to Follow-up|2|||
125150436|NCT00479388|450174771|FG000|Overall Study|Protocol Violation|10|||
125150437|NCT00479388|450174772|FG001|Overall Study|Protocol Violation|9|||
125150438|NCT00479388|450174771|FG000|Overall Study|Withdrawal by Subject|32|||
125150439|NCT00479388|450174772|FG001|Overall Study|Withdrawal by Subject|17|||
125150440|NCT01876368|450174775|FG000|Overall Study|Adverse Event|2|||
125150441|NCT01876368|450174776|FG001|Overall Study|Adverse Event|5|||
125150442|NCT01876368|450174775|FG000|Overall Study|Lack of Efficacy|1|||
125150443|NCT01876368|450174776|FG001|Overall Study|Lack of Efficacy|0|||
125150444|NCT01876368|450174775|FG000|Overall Study|Lost to Follow-up|0|||
125150445|NCT01876368|450174776|FG001|Overall Study|Lost to Follow-up|1|||
125150446|NCT01876368|450174775|FG000|Overall Study|Non-compliance with study treatment|0|||
125150447|NCT01876368|450174776|FG001|Overall Study|Non-compliance with study treatment|1|||
125388391|NCT02608268|451056605|FG013|Overall Study|Adverse Event|0|||
125388392|NCT02608268|451056606|FG014|Overall Study|Adverse Event|0|||
125388393|NCT02608268|451056607|FG015|Overall Study|Adverse Event|0|||
125438691|NCT00669903|451233924|FG001|Overall Study|Lost to Follow-up|1|||
125150448|NCT01876368|450174775|FG000|Overall Study|Physician Decision|0|||
125150449|NCT01876368|450174776|FG001|Overall Study|Physician Decision|2|||
125150450|NCT01876368|450174775|FG000|Overall Study|Protocol deviation|3|||
125150451|NCT01876368|450174776|FG001|Overall Study|Protocol deviation|3|||
125150452|NCT01876368|450174775|FG000|Overall Study|Subject/guardian decision|3|||
125150453|NCT01876368|450174776|FG001|Overall Study|Subject/guardian decision|1|||
125150454|NCT01955044|450174777|FG000|Overall Study|Death|1|||
125150455|NCT01955044|450174778|FG001|Overall Study|Death|1|||
125150456|NCT01955044|450174779|FG002|Overall Study|Death|0|||
125223708|NCT00809445|450446189|FG001|6 Month Follow-up|Incarcerated|8|||
125388394|NCT02608268|451056608|FG016|Overall Study|Adverse Event|0|||
125388395|NCT02608268|451056609|FG017|Overall Study|Adverse Event|0|||
125388396|NCT02608268|451056610|FG018|Overall Study|Adverse Event|0|||
125388397|NCT02608268|451056611|FG019|Overall Study|Adverse Event|0|||
125388398|NCT02608268|451056612|FG020|Overall Study|Adverse Event|1|||
125388399|NCT02608268|451056613|FG021|Overall Study|Adverse Event|1|||
125388400|NCT02608268|451056614|FG022|Overall Study|Adverse Event|0|||
125150457|NCT02260258|450174780|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
125150458|NCT02260258|450174781|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
125150459|NCT01644149|450174782|FG000|Overall Study|Withdrawal by Subject|1|||
125150460|NCT01644149|450174783|FG001|Overall Study|Withdrawal by Subject|0|||
125388401|NCT02608268|451056615|FG023|Overall Study|Adverse Event|0|||
125150461|NCT01644149|450174782|FG000|Overall Study|Lost to Follow-up|3|||
125150462|NCT01644149|450174783|FG001|Overall Study|Lost to Follow-up|1|||
125150463|NCT01610063|450174786|FG000|Overall Study|Lost to Follow-up|42|||
125150464|NCT01610063|450174787|FG001|Overall Study|Lost to Follow-up|20|||
125150465|NCT04405739|450174788|FG000|Overall Study|Adverse Event|0|||
125150466|NCT04405739|450174789|FG001|Overall Study|Adverse Event|1|||
125150467|NCT04405739|450174790|FG002|Overall Study|Adverse Event|0|||
125150468|NCT04405739|450174791|FG003|Overall Study|Adverse Event|0|||
125150469|NCT04405739|450174788|FG000|Overall Study|Lost to Follow-up|0|||
125150470|NCT04405739|450174789|FG001|Overall Study|Lost to Follow-up|2|||
125150471|NCT04405739|450174790|FG002|Overall Study|Lost to Follow-up|1|||
125150472|NCT04405739|450174791|FG003|Overall Study|Lost to Follow-up|3|||
125150473|NCT04405739|450174788|FG000|Overall Study|Withdrawal by Subject|0|||
125150474|NCT04405739|450174789|FG001|Overall Study|Withdrawal by Subject|2|||
125150475|NCT04405739|450174790|FG002|Overall Study|Withdrawal by Subject|1|||
125150476|NCT04405739|450174791|FG003|Overall Study|Withdrawal by Subject|1|||
125150477|NCT04405739|450174788|FG000|Overall Study|Death|0|||
125150478|NCT04405739|450174789|FG001|Overall Study|Death|0|||
125150479|NCT04405739|450174790|FG002|Overall Study|Death|1|||
125150480|NCT04405739|450174791|FG003|Overall Study|Death|0|||
125150481|NCT04405739|450174788|FG000|Overall Study|Transferred to rehab|0|||
125150482|NCT04405739|450174789|FG001|Overall Study|Transferred to rehab|0|||
125150483|NCT04405739|450174790|FG002|Overall Study|Transferred to rehab|0|||
125150484|NCT04405739|450174791|FG003|Overall Study|Transferred to rehab|1|||
125150485|NCT04405739|450174788|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
125150486|NCT04405739|450174789|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
125150487|NCT04405739|450174790|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
125150488|NCT04405739|450174791|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
125150489|NCT01436643|450174792|FG000|2-week Pre-treatment|Abnormal test result|0|||
125150490|NCT01436643|450174793|FG001|2-week Pre-treatment|Abnormal test result|0|||
125150491|NCT01436643|450174794|FG002|2-week Pre-treatment|Abnormal test result|0|||
125150492|NCT01436643|450174795|FG003|2-week Pre-treatment|Abnormal test result|1|||
125150493|NCT01436643|450174792|FG000|2-week Pre-treatment|Adverse Event|0|||
125150494|NCT01436643|450174793|FG001|2-week Pre-treatment|Adverse Event|0|||
125150495|NCT01436643|450174794|FG002|2-week Pre-treatment|Adverse Event|0|||
125150496|NCT01436643|450174795|FG003|2-week Pre-treatment|Adverse Event|5|||
125150497|NCT01436643|450174792|FG000|2-week Pre-treatment|Protocol Violation|0|||
125150498|NCT01436643|450174793|FG001|2-week Pre-treatment|Protocol Violation|0|||
125150499|NCT01436643|450174794|FG002|2-week Pre-treatment|Protocol Violation|0|||
125150500|NCT01436643|450174795|FG003|2-week Pre-treatment|Protocol Violation|4|||
125150501|NCT01436643|450174792|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
125150502|NCT01436643|450174793|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
125150503|NCT01436643|450174794|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
125150504|NCT01436643|450174795|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
125150505|NCT01436643|450174792|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
125150506|NCT01436643|450174793|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
125150507|NCT01436643|450174794|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
125150508|NCT01436643|450174795|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
125150509|NCT01436643|450174792|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
125150510|NCT01436643|450174793|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
125150511|NCT01436643|450174794|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
125388402|NCT02608268|451056616|FG024|Overall Study|Adverse Event|1|||
125150512|NCT01436643|450174795|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
125150513|NCT03718117|450174796|FG000|Overall Study|Death|12|||
125150514|NCT03718117|450174797|FG001|Overall Study|Death|11|||
125150515|NCT03718117|450174798|FG002|Overall Study|Death|0|||
125150516|NCT03718117|450174796|FG000|Overall Study|Other|0|||
125150517|NCT03718117|450174797|FG001|Overall Study|Other|1|||
125150518|NCT03718117|450174798|FG002|Overall Study|Other|0|||
125150519|NCT03718117|450174796|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
125388403|NCT02608268|451056617|FG025|Overall Study|Adverse Event|0|||
125388404|NCT02608268|451056618|FG026|Overall Study|Adverse Event|0|||
125388405|NCT02608268|451056619|FG027|Overall Study|Adverse Event|0|||
125150520|NCT03718117|450174797|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
125388406|NCT02608268|451056620|FG028|Overall Study|Adverse Event|1|||
125150521|NCT03718117|450174798|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
125150522|NCT03718117|450174796|FG000|Overall Study|Participant not met eligibility criteria|0|||
125150523|NCT03718117|450174797|FG001|Overall Study|Participant not met eligibility criteria|0|||
125150524|NCT03718117|450174798|FG002|Overall Study|Participant not met eligibility criteria|2|||
125150525|NCT03069417|450174799|FG000|Overall Study|Lost to Follow-up|2|||
125150526|NCT03069417|450174800|FG001|Overall Study|Lost to Follow-up|0|||
125150527|NCT03069417|450174799|FG000|Overall Study|Reason Unknown|4|||
125150528|NCT03069417|450174800|FG001|Overall Study|Reason Unknown|7|||
125150529|NCT01867606|450174801|FG000|Overall Study|Withdrawal by Subject|10|||
125150530|NCT01867606|450174802|FG001|Overall Study|Withdrawal by Subject|14|||
125150531|NCT01867606|450174801|FG000|Overall Study|Protocol Violation|0|||
125150532|NCT01867606|450174802|FG001|Overall Study|Protocol Violation|1|||
125150533|NCT00402025|450174808|FG000|Overall Study|Adverse Event|0|||
125150534|NCT00402025|450174809|FG001|Overall Study|Adverse Event|0|||
125150535|NCT00402025|450174810|FG002|Overall Study|Adverse Event|2|||
125150536|NCT00402025|450174808|FG000|Overall Study|Death|0|||
125150537|NCT00402025|450174809|FG001|Overall Study|Death|1|||
125150538|NCT00402025|450174810|FG002|Overall Study|Death|5|||
125150539|NCT00402025|450174808|FG000|Overall Study|Disease Progression|1|||
125150540|NCT00402025|450174809|FG001|Overall Study|Disease Progression|1|||
125150541|NCT00402025|450174810|FG002|Overall Study|Disease Progression|2|||
125150542|NCT00402025|450174808|FG000|Overall Study|Physician Decision|1|||
125150543|NCT00402025|450174809|FG001|Overall Study|Physician Decision|1|||
125150544|NCT00402025|450174810|FG002|Overall Study|Physician Decision|0|||
125150545|NCT00402025|450174808|FG000|Overall Study|Participant Decision|0|||
125150546|NCT00402025|450174809|FG001|Overall Study|Participant Decision|0|||
125150547|NCT00402025|450174810|FG002|Overall Study|Participant Decision|1|||
125150548|NCT03234608|450174816|FG000|Overall Study|Lost to Follow-up|23|||
125150549|NCT03234608|450174817|FG001|Overall Study|Lost to Follow-up|21|||
125150550|NCT02105701|450174818|FG000|Overall Study|Lost to Follow-up|1|||
125150551|NCT02105701|450174819|FG001|Overall Study|Lost to Follow-up|0|||
125150552|NCT02105701|450174820|FG002|Overall Study|Lost to Follow-up|2|||
125150553|NCT02105701|450174821|FG003|Overall Study|Lost to Follow-up|1|||
125150554|NCT02105701|450174818|FG000|Overall Study|Protocol Violation|0|||
125150555|NCT02105701|450174819|FG001|Overall Study|Protocol Violation|0|||
125150556|NCT02105701|450174820|FG002|Overall Study|Protocol Violation|1|||
125150557|NCT02105701|450174821|FG003|Overall Study|Protocol Violation|0|||
125150558|NCT02105701|450174818|FG000|Overall Study|Withdrawal by Subject|2|||
125150559|NCT02105701|450174819|FG001|Overall Study|Withdrawal by Subject|1|||
125150560|NCT02105701|450174820|FG002|Overall Study|Withdrawal by Subject|0|||
125150561|NCT02105701|450174821|FG003|Overall Study|Withdrawal by Subject|1|||
125150562|NCT02105701|450174818|FG000|Overall Study|Death|1|||
125150563|NCT02105701|450174819|FG001|Overall Study|Death|0|||
125150564|NCT02105701|450174820|FG002|Overall Study|Death|0|||
125150565|NCT02105701|450174821|FG003|Overall Study|Death|0|||
125150566|NCT02148445|450174822|FG000|Overall Study|Death|1|||
125150567|NCT02148445|450174823|FG001|Overall Study|Death|3|||
125150568|NCT03450629|450174824|FG000|Overall Study|Adverse Event|15|||
125150569|NCT03450629|450174825|FG001|Overall Study|Adverse Event|14|||
125150570|NCT03450629|450174824|FG000|Overall Study|Physician Decision|2|||
125150571|NCT03450629|450174825|FG001|Overall Study|Physician Decision|2|||
125150572|NCT03450629|450174824|FG000|Overall Study|Lack of Efficacy|2|||
125150573|NCT03450629|450174825|FG001|Overall Study|Lack of Efficacy|0|||
125150574|NCT03450629|450174824|FG000|Overall Study|Lost to Follow-up|4|||
125150575|NCT03450629|450174825|FG001|Overall Study|Lost to Follow-up|2|||
125150576|NCT03450629|450174824|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125150577|NCT03450629|450174825|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
125150578|NCT03450629|450174824|FG000|Overall Study|Non-Compliance With Study Drug|2|||
125150579|NCT03450629|450174825|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125150580|NCT03450629|450174824|FG000|Overall Study|Protocol Violation|11|||
125150581|NCT03450629|450174825|FG001|Overall Study|Protocol Violation|8|||
125150582|NCT03450629|450174824|FG000|Overall Study|Withdrawal by Subject|12|||
125150583|NCT03450629|450174825|FG001|Overall Study|Withdrawal by Subject|6|||
125150584|NCT04230876|450174827|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
125150585|NCT04230876|450174828|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
125150586|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
125150587|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150588|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150589|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150590|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150591|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150592|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150593|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150594|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
125150595|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
125150596|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150597|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150598|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150599|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150600|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150601|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150602|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150603|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
125150604|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
125150605|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150606|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150607|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150608|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150609|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150610|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150611|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150612|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
125150613|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
125150614|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150615|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150616|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150617|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150618|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150619|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150620|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150621|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
125150622|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
125150623|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150624|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150625|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150626|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150627|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150628|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150629|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150630|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
125150631|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
125150632|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150633|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150634|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150635|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150636|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125223709|NCT00809445|450446190|FG002|6 Month Follow-up|Incarcerated|8|||
125223710|NCT00809445|450446188|FG000|6 Month Follow-up|Withdrew consent|0|||
125223711|NCT00809445|450446189|FG001|6 Month Follow-up|Withdrew consent|0|||
125223712|NCT00809445|450446190|FG002|6 Month Follow-up|Withdrew consent|1|||
125223713|NCT00676403|450446191|FG000|Overall Study|Adverse Event|1|||
125150637|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150638|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150639|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
125150640|NCT00739973|450174829|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
125150641|NCT00739973|450174830|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150642|NCT00739973|450174831|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150643|NCT00739973|450174832|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150644|NCT00739973|450174833|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150645|NCT00739973|450174834|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150646|NCT00739973|450174835|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150647|NCT00739973|450174836|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150648|NCT00739973|450174837|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
125150649|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
125150650|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
125150651|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
125150652|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
125150653|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
125223714|NCT00676403|450446192|FG001|Overall Study|Adverse Event|2|||
125223715|NCT00676403|450446193|FG002|Overall Study|Adverse Event|0|||
125150654|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
125150655|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
125150656|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
125150657|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
125150658|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150659|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150660|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150661|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150662|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
125150663|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150664|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150665|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
125150666|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
125150667|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
125150668|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
125150669|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150670|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150671|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150672|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150673|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150674|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150675|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
125150676|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
125150677|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
125150678|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
125150679|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
125150680|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
125150681|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
125150682|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
125150683|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
125150684|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
125150685|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150686|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150687|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
125150688|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150689|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150690|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150691|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150692|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150693|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
125150694|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
125150695|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
125150696|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
125150697|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
125150698|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
125150699|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
125150700|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
125150701|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
125150702|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
125150703|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
125150704|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
125150705|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
125150706|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
125150707|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
125150708|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
125150709|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
125150710|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
125223716|NCT00676403|450446194|FG003|Overall Study|Adverse Event|5|||
125223717|NCT00676403|450446195|FG004|Overall Study|Adverse Event|1|||
125150711|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
125150712|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150713|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150714|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150715|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150716|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150717|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150718|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
125150719|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150720|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
125150721|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
125150722|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
125150723|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
125150724|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
125150725|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
125150726|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
125150727|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
125150728|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
125150729|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
125150730|NCT00739973|450174829|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150731|NCT00739973|450174830|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
125150732|NCT00739973|450174831|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150733|NCT00739973|450174832|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150734|NCT00739973|450174833|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150735|NCT00739973|450174834|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150736|NCT00739973|450174835|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
125150737|NCT00739973|450174836|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150738|NCT00739973|450174837|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
125150739|NCT01662362|450174838|FG000|Overall Study|Lost to Follow-up|38|||
125150740|NCT01181531|450174839|FG000|Overall Study|Other|17|||
125150741|NCT01181531|450174840|FG001|Overall Study|Other|12|||
125150742|NCT01181531|450174839|FG000|Overall Study|Partial consent by subject withdrawn|0|||
125150743|NCT01181531|450174840|FG001|Overall Study|Partial consent by subject withdrawn|1|||
125150744|NCT01181531|450174839|FG000|Overall Study|Physician Decision|3|||
125150745|NCT01181531|450174840|FG001|Overall Study|Physician Decision|1|||
125150746|NCT01181531|450174839|FG000|Overall Study|Noncompliance|2|||
125150747|NCT01181531|450174840|FG001|Overall Study|Noncompliance|2|||
125150748|NCT01181531|450174839|FG000|Overall Study|Ineligibility determined|1|||
125150749|NCT01181531|450174840|FG001|Overall Study|Ineligibility determined|2|||
125150750|NCT01181531|450174839|FG000|Overall Study|Protocol Specified Criteria|15|||
125150751|NCT01181531|450174840|FG001|Overall Study|Protocol Specified Criteria|8|||
125150752|NCT01181531|450174839|FG000|Overall Study|Pregnancy|0|||
125150753|NCT01181531|450174840|FG001|Overall Study|Pregnancy|1|||
125150754|NCT01181531|450174839|FG000|Overall Study|Withdrawal by Subject|8|||
125150755|NCT01181531|450174840|FG001|Overall Study|Withdrawal by Subject|7|||
125150756|NCT01181531|450174839|FG000|Overall Study|Protocol Violation|6|||
125150757|NCT01181531|450174840|FG001|Overall Study|Protocol Violation|6|||
125150758|NCT01181531|450174839|FG000|Overall Study|Death|9|||
125150759|NCT01181531|450174840|FG001|Overall Study|Death|12|||
125150760|NCT01181531|450174839|FG000|Overall Study|Adverse Event|0|||
125150761|NCT01181531|450174840|FG001|Overall Study|Adverse Event|1|||
125150762|NCT00987831|450174841|FG000|Overall Study|Never flared in 12 months|1|||
125150763|NCT00987831|450174842|FG001|Overall Study|Never flared in 12 months|0|||
125150764|NCT00987831|450174843|FG002|Overall Study|Never flared in 12 months|0|||
125150765|NCT00987831|450174841|FG000|Overall Study|Lost to Follow-up|0|||
125150766|NCT00987831|450174842|FG001|Overall Study|Lost to Follow-up|3|||
125150767|NCT00987831|450174843|FG002|Overall Study|Lost to Follow-up|0|||
125150768|NCT00576303|450174844|FG000|Dose Titration Period|Early withdrawal|17|||
125150769|NCT00576303|450174844|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
125150770|NCT00576303|450174844|FG000|Long Term Safety Period|Early withdrawal|16|||
125150771|NCT00810602|450174845|FG000|Overall Study|Withdrawal by Subject|8|||
125150772|NCT00810602|450174846|FG001|Overall Study|Withdrawal by Subject|3|||
125150773|NCT02792218|450174847|FG000|Overall Study|Patient/guardian decision|15|||
125150774|NCT02792218|450174848|FG001|Overall Study|Patient/guardian decision|42|||
125150775|NCT02792218|450174847|FG000|Overall Study|Adverse Event|15|||
125150776|NCT02792218|450174848|FG001|Overall Study|Adverse Event|14|||
125150777|NCT02792218|450174847|FG000|Overall Study|Lost to Follow-up|10|||
125150778|NCT02792218|450174848|FG001|Overall Study|Lost to Follow-up|5|||
125150779|NCT02792218|450174847|FG000|Overall Study|Lack of Efficacy|1|||
125150780|NCT02792218|450174848|FG001|Overall Study|Lack of Efficacy|12|||
125150781|NCT02792218|450174847|FG000|Overall Study|Physician Decision|4|||
125150782|NCT02792218|450174848|FG001|Overall Study|Physician Decision|4|||
125150783|NCT02792218|450174847|FG000|Overall Study|Protocol deviation|3|||
125150784|NCT02792218|450174848|FG001|Overall Study|Protocol deviation|2|||
125150785|NCT02792218|450174847|FG000|Overall Study|New therapy for study indication|0|||
125150786|NCT02792218|450174848|FG001|Overall Study|New therapy for study indication|1|||
125150787|NCT02792218|450174847|FG000|Overall Study|Non-compliance with study treatment|0|||
125150788|NCT02792218|450174848|FG001|Overall Study|Non-compliance with study treatment|1|||
125150789|NCT02792218|450174847|FG000|Overall Study|Pregnancy|1|||
125150790|NCT02792218|450174848|FG001|Overall Study|Pregnancy|0|||
125150791|NCT00824369|450174849|FG000|Overall Study|Nolonger willing to participate in study|1|||
125150792|NCT00824369|450174850|FG001|Overall Study|Nolonger willing to participate in study|0|||
125150793|NCT00824369|450174851|FG002|Overall Study|Nolonger willing to participate in study|1|||
125150794|NCT00824369|450174852|FG003|Overall Study|Nolonger willing to participate in study|2|||
125150795|NCT00824369|450174853|FG004|Overall Study|Nolonger willing to participate in study|0|||
125150796|NCT00824369|450174854|FG005|Overall Study|Nolonger willing to participate in study|1|||
125150797|NCT00824369|450174849|FG000|Overall Study|Lost to Follow-up|0|||
125150798|NCT00824369|450174850|FG001|Overall Study|Lost to Follow-up|0|||
125150799|NCT00824369|450174851|FG002|Overall Study|Lost to Follow-up|0|||
125150800|NCT00824369|450174852|FG003|Overall Study|Lost to Follow-up|0|||
125150801|NCT00824369|450174853|FG004|Overall Study|Lost to Follow-up|1|||
125150802|NCT00824369|450174854|FG005|Overall Study|Lost to Follow-up|0|||
125150803|NCT00749411|450174864|FG000|Overall Study|Adverse Event|0|||
125150804|NCT00749411|450174865|FG001|Overall Study|Adverse Event|2|||
125150805|NCT00749411|450174864|FG000|Overall Study|Lack of Efficacy|0|||
125150806|NCT00749411|450174865|FG001|Overall Study|Lack of Efficacy|1|||
125150807|NCT00749411|450174864|FG000|Overall Study|Protocol Violation|1|||
125150808|NCT00749411|450174865|FG001|Overall Study|Protocol Violation|1|||
125150809|NCT00749411|450174864|FG000|Overall Study|Protocol-defined stopping criteria|0|||
125150810|NCT00749411|450174865|FG001|Overall Study|Protocol-defined stopping criteria|1|||
125150811|NCT03183141|450174867|FG000|Overall Study|Withdrawal by Subject|2|||
125150812|NCT03183141|450174868|FG001|Overall Study|Withdrawal by Subject|4|||
125150813|NCT03183141|450174867|FG000|Overall Study|Death|0|||
125150814|NCT03183141|450174868|FG001|Overall Study|Death|8|||
125150815|NCT02756637|450174870|FG000|Overall Study|Not eligible for initial SWOG study|10|||
125150816|NCT02756637|450174871|FG001|Overall Study|Not eligible for initial SWOG study|10|||
125150817|NCT02756637|450174870|FG000|Overall Study|No available NLR value|44|||
125150818|NCT02756637|450174871|FG001|Overall Study|No available NLR value|44|||
125150819|NCT02756637|450174870|FG000|Overall Study|Did not complete curative therapy|33|||
125150820|NCT02756637|450174871|FG001|Overall Study|Did not complete curative therapy|0|||
125150821|NCT01507090|450174872|FG000|Overall Study|incomplete dataset|18|||
125150822|NCT04034355|450174891|FG000|Overall Study|Study terminated by Sponsor|10|||
125150823|NCT04034355|450174892|FG001|Overall Study|Study terminated by Sponsor|17|||
125150824|NCT04034355|450174891|FG000|Overall Study|Withdrawal by Subject|12|||
125150825|NCT04034355|450174892|FG001|Overall Study|Withdrawal by Subject|11|||
125150826|NCT04034355|450174891|FG000|Overall Study|Site terminated by Sponsor|4|||
125150827|NCT04034355|450174892|FG001|Overall Study|Site terminated by Sponsor|5|||
125150828|NCT04034355|450174891|FG000|Overall Study|Adverse Event|2|||
125150829|NCT04034355|450174892|FG001|Overall Study|Adverse Event|0|||
125150830|NCT04034355|450174891|FG000|Overall Study|Death|1|||
125150831|NCT04034355|450174892|FG001|Overall Study|Death|1|||
125150832|NCT04034355|450174891|FG000|Overall Study|Not reported|2|||
125150833|NCT04034355|450174892|FG001|Overall Study|Not reported|0|||
125150834|NCT04034355|450174891|FG000|Overall Study|Lost to Follow-up|1|||
125150835|NCT04034355|450174892|FG001|Overall Study|Lost to Follow-up|0|||
125150836|NCT04034355|450174891|FG000|Overall Study|Physician Decision|1|||
125150837|NCT04034355|450174892|FG001|Overall Study|Physician Decision|0|||
125150838|NCT04034355|450174891|FG000|Overall Study|Protocol Violation|0|||
125150839|NCT04034355|450174892|FG001|Overall Study|Protocol Violation|1|||
125150840|NCT04034355|450174891|FG000|Overall Study|Progressive disease|1|||
125150841|NCT04034355|450174892|FG001|Overall Study|Progressive disease|0|||
125150842|NCT02190279|450176530|FG000|Overall Study|Withdrawal consent|1|||
125150843|NCT02190279|450176531|FG001|Overall Study|Withdrawal consent|0|||
125150844|NCT02190279|450176532|FG002|Overall Study|Withdrawal consent|1|||
125150845|NCT02190279|450176530|FG000|Overall Study|Lost to Follow-up|2|||
125150846|NCT02190279|450176531|FG001|Overall Study|Lost to Follow-up|0|||
125150847|NCT02190279|450176532|FG002|Overall Study|Lost to Follow-up|0|||
125150848|NCT02190279|450176530|FG000|Overall Study|Refused further treatment|0|||
125150849|NCT02190279|450176531|FG001|Overall Study|Refused further treatment|0|||
125150850|NCT02190279|450176532|FG002|Overall Study|Refused further treatment|1|||
125150851|NCT02190279|450176530|FG000|Overall Study|Screening failure|0|||
125150852|NCT02190279|450176531|FG001|Overall Study|Screening failure|0|||
125150853|NCT02190279|450176532|FG002|Overall Study|Screening failure|1|||
125150854|NCT01467479|450176533|FG000|Overall Study|No Study Medication|1|||
125150855|NCT01467479|450176534|FG001|Overall Study|No Study Medication|0|||
125150856|NCT01467479|450176535|FG002|Overall Study|No Study Medication|2|||
125150857|NCT01467479|450176533|FG000|Overall Study|Adverse Event|1|||
125150858|NCT01467479|450176534|FG001|Overall Study|Adverse Event|2|||
125150859|NCT01467479|450176535|FG002|Overall Study|Adverse Event|0|||
125150860|NCT01467479|450176533|FG000|Overall Study|Death|0|||
125150861|NCT01467479|450176534|FG001|Overall Study|Death|0|||
125150862|NCT01467479|450176535|FG002|Overall Study|Death|1|||
125150863|NCT01467479|450176533|FG000|Overall Study|Lost to Follow-up|2|||
125150864|NCT01467479|450176534|FG001|Overall Study|Lost to Follow-up|5|||
125150865|NCT01467479|450176535|FG002|Overall Study|Lost to Follow-up|3|||
125150866|NCT01467479|450176533|FG000|Overall Study|Withdrawal of Consent|3|||
125150867|NCT01467479|450176534|FG001|Overall Study|Withdrawal of Consent|7|||
125150868|NCT01467479|450176535|FG002|Overall Study|Withdrawal of Consent|7|||
125150869|NCT01467479|450176533|FG000|Overall Study|Study Terminated by Sponsor|1|||
125150870|NCT01467479|450176534|FG001|Overall Study|Study Terminated by Sponsor|3|||
125150871|NCT01467479|450176535|FG002|Overall Study|Study Terminated by Sponsor|3|||
125150872|NCT01467479|450176533|FG000|Overall Study|Other|1|||
125150873|NCT01467479|450176534|FG001|Overall Study|Other|0|||
125150874|NCT01467479|450176535|FG002|Overall Study|Other|0|||
125150875|NCT01197417|450176541|FG000|Overall Study|Physician Decision|3|||
125150876|NCT01197417|450176542|FG001|Overall Study|Physician Decision|2|||
125150877|NCT01197417|450176541|FG000|Overall Study|Withdrawal by Subject|2|||
125150878|NCT01197417|450176542|FG001|Overall Study|Withdrawal by Subject|4|||
125150879|NCT01197417|450176541|FG000|Overall Study|Site miscommunication|0|||
125150880|NCT01197417|450176542|FG001|Overall Study|Site miscommunication|1|||
125150881|NCT01197417|450176541|FG000|Overall Study|Subject transferred to intensive care|0|||
125150882|NCT01197417|450176542|FG001|Overall Study|Subject transferred to intensive care|1|||
125150883|NCT01197417|450176541|FG000|Overall Study|Not consented in time to receive drug|0|||
125150884|NCT01197417|450176542|FG001|Overall Study|Not consented in time to receive drug|1|||
125150885|NCT01197417|450176541|FG000|Overall Study|Hypotension|1|||
125150886|NCT01197417|450176542|FG001|Overall Study|Hypotension|2|||
125150887|NCT01197417|450176541|FG000|Overall Study|Found to be ineligible|2|||
125150888|NCT01197417|450176542|FG001|Overall Study|Found to be ineligible|5|||
125150889|NCT01197417|450176541|FG000|Overall Study|No 25-hour magnesium level|0|||
125150890|NCT01197417|450176542|FG001|Overall Study|No 25-hour magnesium level|2|||
125150891|NCT01652729|450176543|FG000|Overall Study|Withdrawal by Subject|14|||
125150892|NCT01652729|450176544|FG001|Overall Study|Withdrawal by Subject|7|||
125150893|NCT01652729|450176545|FG002|Overall Study|Withdrawal by Subject|7|||
125150894|NCT01652729|450176543|FG000|Overall Study|Adverse Event|4|||
125150895|NCT01652729|450176544|FG001|Overall Study|Adverse Event|0|||
125150896|NCT01652729|450176545|FG002|Overall Study|Adverse Event|3|||
125150897|NCT01652729|450176543|FG000|Overall Study|Physician Decision|1|||
125150898|NCT01652729|450176544|FG001|Overall Study|Physician Decision|0|||
125150899|NCT01652729|450176545|FG002|Overall Study|Physician Decision|1|||
125150900|NCT01652729|450176543|FG000|Overall Study|Protocol Violation|1|||
125150901|NCT01652729|450176544|FG001|Overall Study|Protocol Violation|0|||
125150902|NCT01652729|450176545|FG002|Overall Study|Protocol Violation|0|||
125150903|NCT01652729|450176543|FG000|Overall Study|Lost to Follow-up|6|||
125150904|NCT01652729|450176544|FG001|Overall Study|Lost to Follow-up|6|||
125150905|NCT01652729|450176545|FG002|Overall Study|Lost to Follow-up|3|||
125150906|NCT01652729|450176543|FG000|Overall Study|Administrative|1|||
125150907|NCT01652729|450176544|FG001|Overall Study|Administrative|0|||
125150908|NCT01652729|450176545|FG002|Overall Study|Administrative|0|||
125150909|NCT01311557|450176546|FG000|Overall Study|Serious adverse event|0|||
125150910|NCT01311557|450176547|FG001|Overall Study|Serious adverse event|1|||
125150911|NCT01311557|450176546|FG000|Overall Study|Protocol Violation|4|||
125150912|NCT01311557|450176547|FG001|Overall Study|Protocol Violation|2|||
125150913|NCT01311557|450176546|FG000|Overall Study|Lost to Follow-up|0|||
125150914|NCT01311557|450176547|FG001|Overall Study|Lost to Follow-up|1|||
125150915|NCT01311557|450176546|FG000|Overall Study|Withdrawal by Subject|1|||
125388407|NCT02608268|451056621|FG029|Overall Study|Adverse Event|0|||
125150916|NCT01311557|450176547|FG001|Overall Study|Withdrawal by Subject|2|||
125150917|NCT01470417|450176550|FG000|Overall Study|Disease progression|0|||
125150918|NCT01470417|450176551|FG001|Overall Study|Disease progression|2|||
125150919|NCT02418455|450176552|FG000|48-Week Treatment Period|Other- Not Specified|1|||
125150920|NCT02418455|450176552|FG000|Continuation Period|Sponsor Decision|7|||
125150921|NCT02973321|450176553|FG000|Overall Study|Other than specified|0|||
125388408|NCT02608268|451056592|FG000|Overall Study|Death|1|||
125150922|NCT02973321|450176554|FG001|Overall Study|Other than specified|5|||
125150923|NCT02973321|450176555|FG002|Overall Study|Other than specified|3|||
125150924|NCT02973321|450176556|FG003|Overall Study|Other than specified|3|||
125150925|NCT02973321|450176557|FG004|Overall Study|Other than specified|1|||
125150926|NCT02973321|450176553|FG000|Overall Study|Lack of Efficacy|0|||
125150927|NCT02973321|450176554|FG001|Overall Study|Lack of Efficacy|0|||
125150928|NCT02973321|450176555|FG002|Overall Study|Lack of Efficacy|0|||
125150929|NCT02973321|450176556|FG003|Overall Study|Lack of Efficacy|0|||
125150930|NCT02973321|450176557|FG004|Overall Study|Lack of Efficacy|1|||
125150931|NCT02973321|450176553|FG000|Overall Study|Adverse Event|1|||
125150932|NCT02973321|450176554|FG001|Overall Study|Adverse Event|10|||
125150933|NCT02973321|450176555|FG002|Overall Study|Adverse Event|11|||
125150934|NCT02973321|450176556|FG003|Overall Study|Adverse Event|13|||
125223718|NCT00676403|450446196|FG005|Overall Study|Adverse Event|2|||
125150935|NCT02973321|450176557|FG004|Overall Study|Adverse Event|3|||
125150936|NCT00194792|450176564|FG000|Overall Study|Withdrawal by Subject|1|||
125150937|NCT01714739|450176565|FG000|Overall Study|Disease progression|3|||
125150938|NCT01714739|450176566|FG001|Overall Study|Disease progression|5|||
125150939|NCT01714739|450176567|FG002|Overall Study|Disease progression|5|||
125150940|NCT01714739|450176568|FG003|Overall Study|Disease progression|204|||
125150941|NCT01714739|450176569|FG004|Overall Study|Disease progression|1|||
125150942|NCT01714739|450176570|FG005|Overall Study|Disease progression|3|||
125150943|NCT01714739|450176571|FG006|Overall Study|Disease progression|5|||
125150944|NCT01714739|450176565|FG000|Overall Study|Study drug toxicity|1|||
125150945|NCT01714739|450176566|FG001|Overall Study|Study drug toxicity|1|||
125150946|NCT01714739|450176567|FG002|Overall Study|Study drug toxicity|1|||
125150947|NCT01714739|450176568|FG003|Overall Study|Study drug toxicity|15|||
125150948|NCT01714739|450176569|FG004|Overall Study|Study drug toxicity|0|||
125150949|NCT01714739|450176570|FG005|Overall Study|Study drug toxicity|0|||
125150950|NCT01714739|450176571|FG006|Overall Study|Study drug toxicity|5|||
125150951|NCT01714739|450176565|FG000|Overall Study|Death|0|||
125150952|NCT01714739|450176566|FG001|Overall Study|Death|0|||
125150953|NCT01714739|450176567|FG002|Overall Study|Death|0|||
125150954|NCT01714739|450176568|FG003|Overall Study|Death|1|||
125150955|NCT01714739|450176569|FG004|Overall Study|Death|0|||
125150956|NCT01714739|450176570|FG005|Overall Study|Death|0|||
125150957|NCT01714739|450176571|FG006|Overall Study|Death|0|||
125150958|NCT01714739|450176565|FG000|Overall Study|Adverse Event unrelated to drug|0|||
125150959|NCT01714739|450176566|FG001|Overall Study|Adverse Event unrelated to drug|0|||
125150960|NCT01714739|450176567|FG002|Overall Study|Adverse Event unrelated to drug|3|||
125150961|NCT01714739|450176568|FG003|Overall Study|Adverse Event unrelated to drug|21|||
125150962|NCT01714739|450176569|FG004|Overall Study|Adverse Event unrelated to drug|0|||
125150963|NCT01714739|450176570|FG005|Overall Study|Adverse Event unrelated to drug|0|||
125150964|NCT01714739|450176571|FG006|Overall Study|Adverse Event unrelated to drug|0|||
125150965|NCT01714739|450176565|FG000|Overall Study|Participant request to stop therapy|0|||
125150966|NCT01714739|450176566|FG001|Overall Study|Participant request to stop therapy|1|||
125150967|NCT01714739|450176567|FG002|Overall Study|Participant request to stop therapy|0|||
125150968|NCT01714739|450176568|FG003|Overall Study|Participant request to stop therapy|6|||
125150969|NCT01714739|450176569|FG004|Overall Study|Participant request to stop therapy|0|||
125150970|NCT01714739|450176570|FG005|Overall Study|Participant request to stop therapy|0|||
125150971|NCT01714739|450176571|FG006|Overall Study|Participant request to stop therapy|0|||
125150972|NCT01714739|450176565|FG000|Overall Study|Participant withdrew consent|0|||
125150973|NCT01714739|450176566|FG001|Overall Study|Participant withdrew consent|1|||
125150974|NCT01714739|450176567|FG002|Overall Study|Participant withdrew consent|0|||
125150975|NCT01714739|450176568|FG003|Overall Study|Participant withdrew consent|8|||
125150976|NCT01714739|450176569|FG004|Overall Study|Participant withdrew consent|0|||
125150977|NCT01714739|450176570|FG005|Overall Study|Participant withdrew consent|0|||
125150978|NCT01714739|450176571|FG006|Overall Study|Participant withdrew consent|0|||
125150979|NCT01714739|450176565|FG000|Overall Study|Lost to Follow-up|0|||
125150980|NCT01714739|450176566|FG001|Overall Study|Lost to Follow-up|0|||
125150981|NCT01714739|450176567|FG002|Overall Study|Lost to Follow-up|0|||
125150982|NCT01714739|450176568|FG003|Overall Study|Lost to Follow-up|1|||
125150983|NCT01714739|450176569|FG004|Overall Study|Lost to Follow-up|0|||
125150984|NCT01714739|450176570|FG005|Overall Study|Lost to Follow-up|0|||
125150985|NCT01714739|450176571|FG006|Overall Study|Lost to Follow-up|0|||
125150986|NCT01714739|450176565|FG000|Overall Study|Maximum clinical benefit|0|||
125150987|NCT01714739|450176566|FG001|Overall Study|Maximum clinical benefit|1|||
125150988|NCT01714739|450176567|FG002|Overall Study|Maximum clinical benefit|1|||
125150989|NCT01714739|450176568|FG003|Overall Study|Maximum clinical benefit|3|||
125150990|NCT01714739|450176569|FG004|Overall Study|Maximum clinical benefit|0|||
125150991|NCT01714739|450176570|FG005|Overall Study|Maximum clinical benefit|0|||
125150992|NCT01714739|450176571|FG006|Overall Study|Maximum clinical benefit|0|||
125150993|NCT01714739|450176565|FG000|Overall Study|Poor/non-comliance|0|||
125150994|NCT01714739|450176566|FG001|Overall Study|Poor/non-comliance|1|||
125150995|NCT01714739|450176567|FG002|Overall Study|Poor/non-comliance|0|||
125150996|NCT01714739|450176568|FG003|Overall Study|Poor/non-comliance|1|||
125150997|NCT01714739|450176569|FG004|Overall Study|Poor/non-comliance|0|||
125150998|NCT01714739|450176570|FG005|Overall Study|Poor/non-comliance|0|||
125150999|NCT01714739|450176571|FG006|Overall Study|Poor/non-comliance|0|||
125151000|NCT01714739|450176565|FG000|Overall Study|No longer meets study criteria|0|||
125151001|NCT01714739|450176566|FG001|Overall Study|No longer meets study criteria|0|||
125151002|NCT01714739|450176567|FG002|Overall Study|No longer meets study criteria|0|||
125151003|NCT01714739|450176568|FG003|Overall Study|No longer meets study criteria|1|||
125223719|NCT00676403|450446191|FG000|Overall Study|Lost to Follow-up|0|||
125151004|NCT01714739|450176569|FG004|Overall Study|No longer meets study criteria|0|||
125151005|NCT01714739|450176570|FG005|Overall Study|No longer meets study criteria|0|||
125151006|NCT01714739|450176571|FG006|Overall Study|No longer meets study criteria|0|||
125151007|NCT01714739|450176565|FG000|Overall Study|Other reason|0|||
125151008|NCT01714739|450176566|FG001|Overall Study|Other reason|0|||
125223720|NCT00676403|450446192|FG001|Overall Study|Lost to Follow-up|0|||
125151009|NCT01714739|450176567|FG002|Overall Study|Other reason|0|||
125151010|NCT01714739|450176568|FG003|Overall Study|Other reason|3|||
125151011|NCT01714739|450176569|FG004|Overall Study|Other reason|1|||
125151012|NCT01714739|450176570|FG005|Overall Study|Other reason|0|||
125151013|NCT01714739|450176571|FG006|Overall Study|Other reason|0|||
125151014|NCT00865514|450176572|FG000|Overall Study|Infusion cost exceeded funding|2|||
125151015|NCT03920280|450176573|FG000|Overall Study|Adverse Event|2|||
125151016|NCT03920280|450176574|FG001|Overall Study|Adverse Event|3|||
125151017|NCT03920280|450176573|FG000|Overall Study|Lost to Follow-up|0|||
125151018|NCT03920280|450176574|FG001|Overall Study|Lost to Follow-up|1|||
125151019|NCT03920280|450176573|FG000|Overall Study|Withdrawal by Subject|1|||
125151020|NCT03920280|450176574|FG001|Overall Study|Withdrawal by Subject|1|||
125151021|NCT03920280|450176573|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
125151022|NCT03920280|450176574|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
125151023|NCT01557920|450176575|FG000|Overall Study|Withdrawal by Subject|2|||
125151024|NCT01557920|450176576|FG001|Overall Study|Withdrawal by Subject|3|||
125151025|NCT01557920|450176575|FG000|Overall Study|Lack of Efficacy|1|||
125223721|NCT00676403|450446193|FG002|Overall Study|Lost to Follow-up|0|||
125223722|NCT00676403|450446194|FG003|Overall Study|Lost to Follow-up|0|||
125223723|NCT00676403|450446195|FG004|Overall Study|Lost to Follow-up|0|||
125223724|NCT00676403|450446196|FG005|Overall Study|Lost to Follow-up|1|||
125223725|NCT00676403|450446191|FG000|Overall Study|Reason Unspecified|1|||
125223726|NCT00676403|450446192|FG001|Overall Study|Reason Unspecified|0|||
125223727|NCT00676403|450446193|FG002|Overall Study|Reason Unspecified|1|||
125223728|NCT00676403|450446194|FG003|Overall Study|Reason Unspecified|0|||
125223729|NCT00676403|450446195|FG004|Overall Study|Reason Unspecified|0|||
125223730|NCT00676403|450446196|FG005|Overall Study|Reason Unspecified|1|||
125223731|NCT00676403|450446191|FG000|Overall Study|Withdrawal by Subject|0|||
125223732|NCT00676403|450446192|FG001|Overall Study|Withdrawal by Subject|0|||
125223733|NCT00676403|450446193|FG002|Overall Study|Withdrawal by Subject|0|||
125223734|NCT00676403|450446194|FG003|Overall Study|Withdrawal by Subject|0|||
125223735|NCT00676403|450446195|FG004|Overall Study|Withdrawal by Subject|0|||
125223736|NCT00676403|450446196|FG005|Overall Study|Withdrawal by Subject|1|||
125223737|NCT02048722|450446200|FG000|2 Cycles of Treatment|Adverse Event|2|||
125223738|NCT02048722|450446200|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
125223739|NCT02048722|450446200|FG000|2 Cycles of Treatment|Progressive Disease|2|||
125223740|NCT02048722|450446200|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
125223741|NCT02048722|450446200|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
125223742|NCT02048722|450446200|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
125223743|NCT05209880|450446201|FG000|1-Month Follow-up|Spoke with Doctor|5|||
125223744|NCT05209880|450446202|FG001|1-Month Follow-up|Spoke with Doctor|5|||
125223745|NCT05209880|450446201|FG000|1-Month Follow-up|Lost to Follow-up|7|||
125223746|NCT05209880|450446202|FG001|1-Month Follow-up|Lost to Follow-up|9|||
125223747|NCT05209880|450446201|FG000|1-Month Follow-up|Discontinued|0|||
125223748|NCT05209880|450446202|FG001|1-Month Follow-up|Discontinued|1|||
125223749|NCT05209880|450446201|FG000|3-Month Follow-up|Spoke with Doctor|17|||
125223750|NCT05209880|450446202|FG001|3-Month Follow-up|Spoke with Doctor|7|||
125223751|NCT05209880|450446201|FG000|3-Month Follow-up|Lost to Follow-up|8|||
125223752|NCT05209880|450446202|FG001|3-Month Follow-up|Lost to Follow-up|10|||
125223753|NCT05209880|450446201|FG000|3-Month Follow-up|Discontinued|1|||
125223754|NCT05209880|450446202|FG001|3-Month Follow-up|Discontinued|3|||
125223755|NCT05209880|450446201|FG000|6-Month Follow-up|Spoke with Doctor|25|||
125223756|NCT05209880|450446202|FG001|6-Month Follow-up|Spoke with Doctor|14|||
125223757|NCT05209880|450446201|FG000|6-Month Follow-up|Lost to Follow-up|9|||
125223758|NCT05209880|450446202|FG001|6-Month Follow-up|Lost to Follow-up|14|||
125223759|NCT05209880|450446201|FG000|6-Month Follow-up|Discontinued|1|||
125223760|NCT05209880|450446202|FG001|6-Month Follow-up|Discontinued|3|||
125223761|NCT04073303|450446203|FG000|Overall Study|Adverse Event|0|||
125223762|NCT04073303|450446204|FG001|Overall Study|Adverse Event|2|||
125223763|NCT04073303|450446203|FG000|Overall Study|Withdrawal by Subject|16|||
125223764|NCT04073303|450446204|FG001|Overall Study|Withdrawal by Subject|36|||
125151026|NCT01557920|450176576|FG001|Overall Study|Lack of Efficacy|0|||
125223765|NCT04073303|450446203|FG000|Overall Study|Lost to Follow-up|6|||
125223766|NCT04073303|450446204|FG001|Overall Study|Lost to Follow-up|1|||
125223767|NCT04073303|450446203|FG000|Overall Study|Protocol Deviation|0|||
125151027|NCT01857206|450176579|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
125151028|NCT01857206|450176580|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
125151029|NCT01857206|450176579|FG000|Overall Study|Lost to Follow-up|9|||
125223768|NCT04073303|450446204|FG001|Overall Study|Protocol Deviation|4|||
125388409|NCT02608268|451056593|FG001|Overall Study|Death|0|||
125151030|NCT01857206|450176580|FG001|Overall Study|Lost to Follow-up|6|||
125151031|NCT01857206|450176579|FG000|Overall Study|Unclassified|3|||
125151032|NCT01857206|450176580|FG001|Overall Study|Unclassified|3|||
125151033|NCT01857206|450176579|FG000|Overall Study|Withdrawal by Subject|1|||
125223769|NCT04073303|450446203|FG000|Overall Study|Other|1|||
125223770|NCT04073303|450446204|FG001|Overall Study|Other|1|||
125223771|NCT02899065|450446208|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
125223772|NCT02899065|450446209|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
125223773|NCT02899065|450446208|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
125223774|NCT02899065|450446209|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
125223775|NCT02899065|450446208|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
125223776|NCT02899065|450446209|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
125223777|NCT05227118|450446212|FG000|Overall Study|Adverse Event|0|||
125223778|NCT05227118|450446213|FG001|Overall Study|Adverse Event|0|||
125223779|NCT05227118|450446214|FG002|Overall Study|Adverse Event|1|||
125223780|NCT05227118|450446215|FG003|Overall Study|Adverse Event|0|||
125223781|NCT05227118|450446212|FG000|Overall Study|Withdrawal by Subject|0|||
125223782|NCT05227118|450446213|FG001|Overall Study|Withdrawal by Subject|0|||
125223783|NCT05227118|450446214|FG002|Overall Study|Withdrawal by Subject|2|||
125223784|NCT05227118|450446215|FG003|Overall Study|Withdrawal by Subject|0|||
125223785|NCT02689804|450446216|FG000|Overall Study|Withdrawal by Subject|2|||
125223786|NCT02689804|450446217|FG001|Overall Study|Withdrawal by Subject|0|||
125223787|NCT02417753|450446218|FG000|Overall Study|Death|1|||
125223788|NCT03113968|450446221|FG000|Overall Study|Withdrawal by Subject|31|||
125223789|NCT03113968|450446222|FG001|Overall Study|Withdrawal by Subject|4|||
125223790|NCT04805671|450446223|FG000|Overall Study|Death|2|||
125223791|NCT04805671|450446224|FG001|Overall Study|Death|7|||
125223792|NCT04805671|450446223|FG000|Overall Study|Lost to Follow-up|1|||
125223793|NCT04805671|450446224|FG001|Overall Study|Lost to Follow-up|0|||
125223794|NCT04805671|450446223|FG000|Overall Study|Withdrawal by Subject|9|||
125223795|NCT04805671|450446224|FG001|Overall Study|Withdrawal by Subject|7|||
125223796|NCT04805671|450446223|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
125223797|NCT04805671|450446224|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
125223798|NCT01657162|450446231|FG000|Overall Study|Adverse Event|26|||
125223799|NCT01657162|450446232|FG001|Overall Study|Adverse Event|36|||
125223800|NCT01657162|450446231|FG000|Overall Study|Withdrawal by Subject|13|||
125223801|NCT01657162|450446232|FG001|Overall Study|Withdrawal by Subject|13|||
125223802|NCT01657162|450446231|FG000|Overall Study|Continuing Significant Deterioration|9|||
125223803|NCT01657162|450446232|FG001|Overall Study|Continuing Significant Deterioration|3|||
125223804|NCT01657162|450446231|FG000|Overall Study|Refusal of Treatment|4|||
125223805|NCT01657162|450446232|FG001|Overall Study|Refusal of Treatment|6|||
125223806|NCT01657162|450446231|FG000|Overall Study|Lost to Follow-up|3|||
125223807|NCT01657162|450446232|FG001|Overall Study|Lost to Follow-up|4|||
125223808|NCT01657162|450446231|FG000|Overall Study|Death|2|||
125223809|NCT01657162|450446232|FG001|Overall Study|Death|3|||
125223810|NCT01657162|450446231|FG000|Overall Study|Inability to Complete Study Procedures|1|||
125223811|NCT01657162|450446232|FG001|Overall Study|Inability to Complete Study Procedures|7|||
125223812|NCT01657162|450446231|FG000|Overall Study|Protocol Violation|1|||
125223813|NCT01657162|450446232|FG001|Overall Study|Protocol Violation|0|||
125151034|NCT01857206|450176580|FG001|Overall Study|Withdrawal by Subject|0|||
125151035|NCT00003531|450176584|FG000|Overall Study|Not evaluable|10|||
125151036|NCT02487082|450176585|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
125151037|NCT02487082|450176586|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
125151038|NCT02487082|450176585|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
125151039|NCT02487082|450176586|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
125151040|NCT00251316|450176587|FG000|Overall Study|Physician Decision|2|||
125151041|NCT00251316|450176588|FG001|Overall Study|Physician Decision|3|||
125151042|NCT00346164|450176589|FG000|Overall Study|Adverse Event|0|||
125151043|NCT00346164|450176590|FG001|Overall Study|Adverse Event|0|||
125151044|NCT00346164|450176591|FG002|Overall Study|Adverse Event|0|||
125151045|NCT00346164|450176592|FG003|Overall Study|Adverse Event|1|||
125151046|NCT00346164|450176589|FG000|Overall Study|Lack of Efficacy|0|||
125151047|NCT00346164|450176590|FG001|Overall Study|Lack of Efficacy|1|||
125151048|NCT00346164|450176591|FG002|Overall Study|Lack of Efficacy|7|||
125151049|NCT00346164|450176592|FG003|Overall Study|Lack of Efficacy|25|||
125151050|NCT00346164|450176589|FG000|Overall Study|Physician Decision|0|||
125151051|NCT00346164|450176590|FG001|Overall Study|Physician Decision|1|||
125151052|NCT00346164|450176591|FG002|Overall Study|Physician Decision|2|||
125151053|NCT00346164|450176592|FG003|Overall Study|Physician Decision|27|||
125151054|NCT00346164|450176589|FG000|Overall Study|Protocol Violation|6|||
125151055|NCT00346164|450176590|FG001|Overall Study|Protocol Violation|2|||
125151056|NCT00346164|450176591|FG002|Overall Study|Protocol Violation|10|||
125151057|NCT00346164|450176592|FG003|Overall Study|Protocol Violation|4|||
125151058|NCT00346164|450176589|FG000|Overall Study|Withdrawal by Subject|0|||
125151059|NCT00346164|450176590|FG001|Overall Study|Withdrawal by Subject|0|||
125151060|NCT00346164|450176591|FG002|Overall Study|Withdrawal by Subject|2|||
125151061|NCT00346164|450176592|FG003|Overall Study|Withdrawal by Subject|0|||
125151062|NCT00346164|450176589|FG000|Overall Study|Ineligible|11|||
125151063|NCT00346164|450176590|FG001|Overall Study|Ineligible|2|||
125151064|NCT00346164|450176591|FG002|Overall Study|Ineligible|2|||
125151065|NCT00346164|450176592|FG003|Overall Study|Ineligible|23|||
125223814|NCT01657162|450446231|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
125223815|NCT01657162|450446232|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
125151066|NCT00346164|450176589|FG000|Overall Study|Refusal of further protocol therapy|0|||
125151067|NCT00346164|450176590|FG001|Overall Study|Refusal of further protocol therapy|1|||
125151068|NCT00346164|450176591|FG002|Overall Study|Refusal of further protocol therapy|3|||
125151069|NCT00346164|450176592|FG003|Overall Study|Refusal of further protocol therapy|15|||
125151070|NCT00346164|450176589|FG000|Overall Study|Inability to start week 16 tx on time|0|||
125151071|NCT00346164|450176590|FG001|Overall Study|Inability to start week 16 tx on time|0|||
125151072|NCT00346164|450176591|FG002|Overall Study|Inability to start week 16 tx on time|0|||
125151073|NCT00346164|450176592|FG003|Overall Study|Inability to start week 16 tx on time|11|||
125151074|NCT02039063|450176593|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
125151075|NCT02039063|450176594|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
125151076|NCT02039063|450176595|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
125151077|NCT02039063|450176596|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
125151078|NCT02039063|450176593|FG000|Treatment Phase|Progression of disease|0|||
125151079|NCT02039063|450176594|FG001|Treatment Phase|Progression of disease|0|||
125151080|NCT02039063|450176595|FG002|Treatment Phase|Progression of disease|1|||
125151081|NCT02039063|450176596|FG003|Treatment Phase|Progression of disease|1|||
125151082|NCT02039063|450176593|FG000|Extension Phase|Inadequate therapeutic effect|0|||
125151083|NCT02039063|450176594|FG001|Extension Phase|Inadequate therapeutic effect|1|||
125151084|NCT02039063|450176595|FG002|Extension Phase|Inadequate therapeutic effect|2|||
125151085|NCT02039063|450176596|FG003|Extension Phase|Inadequate therapeutic effect|0|||
125151086|NCT02039063|450176593|FG000|Extension Phase|Progression of disease|0|||
125151087|NCT02039063|450176594|FG001|Extension Phase|Progression of disease|0|||
125151088|NCT02039063|450176595|FG002|Extension Phase|Progression of disease|0|||
125151089|NCT02039063|450176596|FG003|Extension Phase|Progression of disease|1|||
125151090|NCT02039063|450176593|FG000|Extension Phase|Adverse Event|0|||
125151091|NCT02039063|450176594|FG001|Extension Phase|Adverse Event|0|||
125151092|NCT02039063|450176595|FG002|Extension Phase|Adverse Event|1|||
125151093|NCT02039063|450176596|FG003|Extension Phase|Adverse Event|0|||
125151094|NCT00467831|450176598|FG000|Overall Study|Death|2|||
125151095|NCT00467831|450176598|FG000|Overall Study|Withdrawal by Subject|1|||
125151096|NCT01198873|450176599|FG000|Overall Study|Adverse Event|4|||
125151097|NCT01198873|450176600|FG001|Overall Study|Adverse Event|7|||
125151098|NCT01198873|450176599|FG000|Overall Study|Study closure|29|||
125151099|NCT01198873|450176600|FG001|Overall Study|Study closure|23|||
125151100|NCT01198873|450176599|FG000|Overall Study|Other than above|4|||
125151101|NCT01198873|450176600|FG001|Overall Study|Other than above|2|||
125151102|NCT03139240|450176601|FG000|Overall Study|Lost to Follow-up|0|||
125223816|NCT01657162|450446231|FG000|Overall Study|Other than Specified|0|||
125223817|NCT01657162|450446232|FG001|Overall Study|Other than Specified|2|||
125223818|NCT00901342|450446233|FG000|Overall Study|Adverse Event|1|||
125223819|NCT00901342|450446233|FG000|Overall Study|Death|4|||
125223820|NCT00901342|450446233|FG000|Overall Study|Disease progression|1|||
125223821|NCT00901342|450446233|FG000|Overall Study|Withdrawal by Subject|9|||
125223822|NCT03421379|450446235|FG000|Period 1|Withdrawal by Subject|0|||
125223823|NCT03421379|450446236|FG001|Period 1|Withdrawal by Subject|1|||
125223824|NCT03421379|450446235|FG000|Period 1|Physician Decision|1|||
125223825|NCT03421379|450446236|FG001|Period 1|Physician Decision|1|||
125223826|NCT03421379|450446235|FG000|Period 1|Did not receive treatment|1|||
125223827|NCT03421379|450446236|FG001|Period 1|Did not receive treatment|2|||
125223828|NCT02782741|450446237|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
125223829|NCT02782741|450446238|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
125223830|NCT02782741|450446239|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
125223831|NCT02782741|450446237|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
125223832|NCT02782741|450446238|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
125223833|NCT02782741|450446239|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
125223834|NCT02782741|450446237|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
125151103|NCT03139240|450176602|FG001|Overall Study|Lost to Follow-up|1|||
125151104|NCT03139240|450176603|FG002|Overall Study|Lost to Follow-up|1|||
125151105|NCT03139240|450176604|FG003|Overall Study|Lost to Follow-up|0|||
125151106|NCT00171340|450176605|FG000|Overall Study|Adverse Event|46|||
125151107|NCT00171340|450176606|FG001|Overall Study|Adverse Event|42|||
125151108|NCT00171340|450176605|FG000|Overall Study|Lack of Efficacy|29|||
125151109|NCT00171340|450176606|FG001|Overall Study|Lack of Efficacy|41|||
125151110|NCT00171340|450176605|FG000|Overall Study|Protocol Violation|7|||
125151111|NCT00171340|450176606|FG001|Overall Study|Protocol Violation|8|||
125151112|NCT00171340|450176605|FG000|Overall Study|Withdrawal by Subject|22|||
125151113|NCT00171340|450176606|FG001|Overall Study|Withdrawal by Subject|19|||
125151114|NCT00171340|450176605|FG000|Overall Study|Lost to Follow-up|0|||
125151115|NCT00171340|450176606|FG001|Overall Study|Lost to Follow-up|5|||
125151116|NCT00171340|450176605|FG000|Overall Study|Abnormal Laboratory Results|2|||
125151117|NCT00171340|450176606|FG001|Overall Study|Abnormal Laboratory Results|0|||
125151118|NCT00171340|450176605|FG000|Overall Study|Abnormal Test Procedure Results|6|||
125151119|NCT00171340|450176606|FG001|Overall Study|Abnormal Test Procedure Results|11|||
125151120|NCT00171340|450176605|FG000|Overall Study|No Longer Required Study Drug|1|||
125151121|NCT00171340|450176606|FG001|Overall Study|No Longer Required Study Drug|1|||
125151122|NCT00171340|450176605|FG000|Overall Study|Administrative Problems|5|||
125151123|NCT00171340|450176606|FG001|Overall Study|Administrative Problems|2|||
125151124|NCT00171340|450176605|FG000|Overall Study|Death|6|||
125151125|NCT00171340|450176606|FG001|Overall Study|Death|6|||
125151126|NCT01998243|450176607|FG000|Overall Study|Pregnancy|0|||
125151127|NCT01998243|450176608|FG001|Overall Study|Pregnancy|1|||
125151128|NCT01998243|450176607|FG000|Overall Study|Protocol Violation|5|||
125151129|NCT01998243|450176608|FG001|Overall Study|Protocol Violation|2|||
125151130|NCT01998243|450176607|FG000|Overall Study|Withdrawal by Subject|3|||
125151131|NCT01998243|450176608|FG001|Overall Study|Withdrawal by Subject|4|||
125151132|NCT01056640|450176609|FG000|Overall Study|Withdrawal by Subject|11|||
125151133|NCT01056640|450176610|FG001|Overall Study|Withdrawal by Subject|8|||
125151134|NCT01056640|450176609|FG000|Overall Study|Death|15|||
125151135|NCT01056640|450176610|FG001|Overall Study|Death|4|||
125151136|NCT04569786|450176611|FG000|Overall Study|Lost to Follow-up|1|||
125151137|NCT04569786|450176612|FG001|Overall Study|Lost to Follow-up|0|||
125151138|NCT04569786|450176613|FG002|Overall Study|Lost to Follow-up|4|||
125151139|NCT04569786|450176614|FG003|Overall Study|Lost to Follow-up|1|||
125151140|NCT04569786|450176615|FG004|Overall Study|Lost to Follow-up|0|||
125151141|NCT04569786|450176611|FG000|Overall Study|Withdrawal by Subject|0|||
125151142|NCT04569786|450176612|FG001|Overall Study|Withdrawal by Subject|0|||
125151143|NCT04569786|450176613|FG002|Overall Study|Withdrawal by Subject|0|||
125151144|NCT04569786|450176614|FG003|Overall Study|Withdrawal by Subject|5|||
125151145|NCT04569786|450176615|FG004|Overall Study|Withdrawal by Subject|1|||
125151146|NCT04569786|450176611|FG000|Overall Study|Physician Decision|0|||
125151147|NCT04569786|450176612|FG001|Overall Study|Physician Decision|0|||
125151148|NCT04569786|450176613|FG002|Overall Study|Physician Decision|0|||
125151149|NCT04569786|450176614|FG003|Overall Study|Physician Decision|1|||
125151150|NCT04569786|450176615|FG004|Overall Study|Physician Decision|0|||
125151151|NCT02492841|450176616|FG000|Overall Study|Lost to Follow-up|34|||
125151152|NCT02492841|450176617|FG001|Overall Study|Lost to Follow-up|31|||
125151153|NCT02492841|450176618|FG002|Overall Study|Lost to Follow-up|35|||
125151154|NCT02563769|450176628|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
125151155|NCT02563769|450176629|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
125151156|NCT02563769|450176630|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
125151157|NCT00690482|450176631|FG000|Overall Study|Adverse Event|2|||
125151158|NCT00690482|450176632|FG001|Overall Study|Adverse Event|1|||
125151159|NCT00690482|450176631|FG000|Overall Study|Incorrect enrolment|0|||
125151160|NCT00690482|450176632|FG001|Overall Study|Incorrect enrolment|1|||
125151161|NCT00690482|450176631|FG000|Overall Study|Study-specific discontinuation criteria|1|||
125151162|NCT00690482|450176632|FG001|Overall Study|Study-specific discontinuation criteria|0|||
125151163|NCT00690482|450176631|FG000|Overall Study|Intake of prohibited medicine|1|||
125151164|NCT00690482|450176632|FG001|Overall Study|Intake of prohibited medicine|0|||
125151165|NCT00690482|450176631|FG000|Overall Study|withdrew consent at rand.day|0|||
125151166|NCT00690482|450176632|FG001|Overall Study|withdrew consent at rand.day|1|||
125151167|NCT02820740|450176633|FG000|Overall Study|Did not have procedure|2|||
125151168|NCT00925301|450176637|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
125151169|NCT00925301|450176638|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
125151170|NCT00925301|450176639|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
125151171|NCT00925301|450176640|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
125151172|NCT00925301|450176637|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
125151173|NCT00925301|450176638|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
125151174|NCT00925301|450176639|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
125151175|NCT00925301|450176640|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
125151176|NCT00925301|450176637|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
125151177|NCT00925301|450176638|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
125151178|NCT00925301|450176639|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
125151179|NCT00925301|450176640|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
125151180|NCT00925301|450176637|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
125151181|NCT00925301|450176638|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
125151182|NCT00925301|450176639|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
125151183|NCT00925301|450176640|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
125151184|NCT00925301|450176637|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
125151185|NCT00925301|450176638|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
125151186|NCT00925301|450176639|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
125151187|NCT00925301|450176640|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
125151188|NCT00925301|450176637|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
125151189|NCT00925301|450176638|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
125151190|NCT00925301|450176639|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
125151191|NCT00925301|450176640|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
125151192|NCT00925301|450176637|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
125151193|NCT00925301|450176638|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
125151194|NCT00925301|450176639|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
125388410|NCT02608268|451056594|FG002|Overall Study|Death|0|||
125388411|NCT02608268|451056595|FG003|Overall Study|Death|0|||
125388412|NCT02608268|451056596|FG004|Overall Study|Death|0|||
125388413|NCT02608268|451056597|FG005|Overall Study|Death|0|||
125388414|NCT02608268|451056598|FG006|Overall Study|Death|0|||
125388415|NCT02608268|451056599|FG007|Overall Study|Death|0|||
125388416|NCT02608268|451056600|FG008|Overall Study|Death|1|||
125388417|NCT02608268|451056601|FG009|Overall Study|Death|1|||
125388418|NCT02608268|451056602|FG010|Overall Study|Death|0|||
125388419|NCT02608268|451056603|FG011|Overall Study|Death|0|||
125151195|NCT00925301|450176640|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
125388420|NCT02608268|451056604|FG012|Overall Study|Death|0|||
125388421|NCT02608268|451056605|FG013|Overall Study|Death|0|||
125388422|NCT02608268|451056606|FG014|Overall Study|Death|0|||
125388423|NCT02608268|451056607|FG015|Overall Study|Death|1|||
125388424|NCT02608268|451056608|FG016|Overall Study|Death|0|||
125388425|NCT02608268|451056609|FG017|Overall Study|Death|1|||
125388426|NCT02608268|451056610|FG018|Overall Study|Death|0|||
125388427|NCT02608268|451056611|FG019|Overall Study|Death|1|||
125388428|NCT02608268|451056612|FG020|Overall Study|Death|1|||
125388429|NCT02608268|451056613|FG021|Overall Study|Death|0|||
125388430|NCT02608268|451056614|FG022|Overall Study|Death|0|||
125388431|NCT02608268|451056615|FG023|Overall Study|Death|0|||
125388432|NCT02608268|451056616|FG024|Overall Study|Death|1|||
125388433|NCT02608268|451056617|FG025|Overall Study|Death|2|||
125388434|NCT02608268|451056618|FG026|Overall Study|Death|0|||
125388435|NCT02608268|451056619|FG027|Overall Study|Death|1|||
125388436|NCT02608268|451056620|FG028|Overall Study|Death|4|||
125388437|NCT02608268|451056621|FG029|Overall Study|Death|0|||
125388438|NCT02608268|451056592|FG000|Overall Study|Physician Decision|0|||
125388439|NCT02608268|451056593|FG001|Overall Study|Physician Decision|0|||
125388440|NCT02608268|451056594|FG002|Overall Study|Physician Decision|0|||
125388441|NCT02608268|451056595|FG003|Overall Study|Physician Decision|0|||
125388442|NCT02608268|451056596|FG004|Overall Study|Physician Decision|0|||
125388443|NCT02608268|451056597|FG005|Overall Study|Physician Decision|0|||
125388444|NCT02608268|451056598|FG006|Overall Study|Physician Decision|0|||
125388445|NCT02608268|451056599|FG007|Overall Study|Physician Decision|0|||
125388446|NCT02608268|451056600|FG008|Overall Study|Physician Decision|0|||
125388447|NCT02608268|451056601|FG009|Overall Study|Physician Decision|0|||
125388448|NCT02608268|451056602|FG010|Overall Study|Physician Decision|1|||
125388449|NCT02608268|451056603|FG011|Overall Study|Physician Decision|0|||
125388450|NCT02608268|451056604|FG012|Overall Study|Physician Decision|0|||
125388451|NCT02608268|451056605|FG013|Overall Study|Physician Decision|1|||
125388452|NCT02608268|451056606|FG014|Overall Study|Physician Decision|0|||
125388453|NCT02608268|451056607|FG015|Overall Study|Physician Decision|0|||
125388454|NCT02608268|451056608|FG016|Overall Study|Physician Decision|0|||
125388455|NCT02608268|451056609|FG017|Overall Study|Physician Decision|0|||
125388456|NCT02608268|451056610|FG018|Overall Study|Physician Decision|0|||
125388457|NCT02608268|451056611|FG019|Overall Study|Physician Decision|0|||
125388458|NCT02608268|451056612|FG020|Overall Study|Physician Decision|0|||
125388459|NCT02608268|451056613|FG021|Overall Study|Physician Decision|0|||
125388460|NCT02608268|451056614|FG022|Overall Study|Physician Decision|1|||
125388461|NCT02608268|451056615|FG023|Overall Study|Physician Decision|1|||
125388462|NCT02608268|451056616|FG024|Overall Study|Physician Decision|1|||
125388463|NCT02608268|451056617|FG025|Overall Study|Physician Decision|0|||
125388464|NCT02608268|451056618|FG026|Overall Study|Physician Decision|0|||
125388465|NCT02608268|451056619|FG027|Overall Study|Physician Decision|2|||
125388466|NCT02608268|451056620|FG028|Overall Study|Physician Decision|1|||
125388467|NCT02608268|451056621|FG029|Overall Study|Physician Decision|1|||
125388468|NCT02608268|451056592|FG000|Overall Study|Progressive disease|12|||
125388469|NCT02608268|451056593|FG001|Overall Study|Progressive disease|8|||
125388470|NCT02608268|451056594|FG002|Overall Study|Progressive disease|13|||
125438692|NCT00669903|451233925|FG002|Overall Study|Lost to Follow-up|0|||
125151196|NCT01117987|450176641|FG000|Overall Study|Protocol deviation|0|||
125388471|NCT02608268|451056595|FG003|Overall Study|Progressive disease|5|||
125388472|NCT02608268|451056596|FG004|Overall Study|Progressive disease|2|||
125388473|NCT02608268|451056597|FG005|Overall Study|Progressive disease|4|||
125151197|NCT01117987|450176642|FG001|Overall Study|Protocol deviation|1|||
125388474|NCT02608268|451056598|FG006|Overall Study|Progressive disease|6|||
125388475|NCT02608268|451056599|FG007|Overall Study|Progressive disease|2|||
125388476|NCT02608268|451056600|FG008|Overall Study|Progressive disease|5|||
125388477|NCT02608268|451056601|FG009|Overall Study|Progressive disease|6|||
125388478|NCT02608268|451056602|FG010|Overall Study|Progressive disease|5|||
125388479|NCT02608268|451056603|FG011|Overall Study|Progressive disease|5|||
125388480|NCT02608268|451056604|FG012|Overall Study|Progressive disease|4|||
125388481|NCT02608268|451056605|FG013|Overall Study|Progressive disease|11|||
125388482|NCT02608268|451056606|FG014|Overall Study|Progressive disease|6|||
125151198|NCT01117987|450176641|FG000|Overall Study|Subject no longer requires study drug|1|||
125388483|NCT02608268|451056607|FG015|Overall Study|Progressive disease|3|||
125388484|NCT02608268|451056608|FG016|Overall Study|Progressive disease|5|||
125388485|NCT02608268|451056609|FG017|Overall Study|Progressive disease|5|||
125388486|NCT02608268|451056610|FG018|Overall Study|Progressive disease|5|||
125388487|NCT02608268|451056611|FG019|Overall Study|Progressive disease|2|||
125151199|NCT01117987|450176642|FG001|Overall Study|Subject no longer requires study drug|0|||
125151200|NCT01117987|450176641|FG000|Overall Study|Lost to Follow-up|1|||
125151201|NCT01117987|450176642|FG001|Overall Study|Lost to Follow-up|1|||
125151202|NCT01117987|450176641|FG000|Overall Study|Abnormal test procedure result|2|||
125151203|NCT01117987|450176642|FG001|Overall Study|Abnormal test procedure result|0|||
125151204|NCT01117987|450176641|FG000|Overall Study|Lack of Efficacy|3|||
125151205|NCT01117987|450176642|FG001|Overall Study|Lack of Efficacy|4|||
125151206|NCT01117987|450176641|FG000|Overall Study|Death|5|||
125151207|NCT01117987|450176642|FG001|Overall Study|Death|10|||
125151208|NCT01117987|450176641|FG000|Overall Study|Withdrawal by Subject|5|||
125151209|NCT01117987|450176642|FG001|Overall Study|Withdrawal by Subject|10|||
125151210|NCT01117987|450176641|FG000|Overall Study|Adverse Event|19|||
125151211|NCT01117987|450176642|FG001|Overall Study|Adverse Event|26|||
125151212|NCT01117987|450176641|FG000|Overall Study|Administrative problems|25|||
125151213|NCT01117987|450176642|FG001|Overall Study|Administrative problems|22|||
125151214|NCT04117945|450176643|FG000|Overall Study|Death|1|||
125151215|NCT04117945|450176644|FG001|Overall Study|Death|0|||
125151216|NCT04117945|450176643|FG000|Overall Study|Withdrawal by Subject|3|||
125151217|NCT04117945|450176644|FG001|Overall Study|Withdrawal by Subject|1|||
125151218|NCT04117945|450176643|FG000|Overall Study|Disease Progression|0|||
125151219|NCT04117945|450176644|FG001|Overall Study|Disease Progression|2|||
125151220|NCT04117945|450176643|FG000|Overall Study|Ineligible|8|||
125151221|NCT04117945|450176644|FG001|Overall Study|Ineligible|7|||
125151222|NCT01917968|450176646|FG000|Overall Study|Death|3|||
125151223|NCT01917968|450176647|FG001|Overall Study|Death|2|||
125151224|NCT01917968|450176646|FG000|Overall Study|Lost to Follow-up|21|||
125151225|NCT01917968|450176647|FG001|Overall Study|Lost to Follow-up|39|||
125151226|NCT01917968|450176646|FG000|Overall Study|Physician Decision|1|||
125151227|NCT01917968|450176647|FG001|Overall Study|Physician Decision|2|||
125151228|NCT01917968|450176646|FG000|Overall Study|Withdrawal by Subject|20|||
125151229|NCT01917968|450176647|FG001|Overall Study|Withdrawal by Subject|35|||
125151230|NCT01917968|450176646|FG000|Overall Study|Subject Relocation|5|||
125151231|NCT01917968|450176647|FG001|Overall Study|Subject Relocation|1|||
125151232|NCT01917968|450176646|FG000|Overall Study|36M Missed Visit|3|||
125151233|NCT01917968|450176647|FG001|Overall Study|36M Missed Visit|2|||
125151234|NCT01917968|450176646|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
125151235|NCT01917968|450176647|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
125151236|NCT01917968|450176646|FG000|Overall Study|Change in Family Circumstances|0|||
125151237|NCT01917968|450176647|FG001|Overall Study|Change in Family Circumstances|1|||
125151238|NCT01917968|450176646|FG000|Overall Study|No Data Available|0|||
125151239|NCT01917968|450176647|FG001|Overall Study|No Data Available|2|||
125151240|NCT04232540|450176653|FG000|Overall Study|Lost to Follow-up|1|||
125151241|NCT04232540|450176654|FG001|Overall Study|Lost to Follow-up|0|||
125151242|NCT03438006|450176655|FG000|Overall Study|Adverse Event|1|||
125151243|NCT03438006|450176655|FG000|Overall Study|Lost to Follow-up|67|||
125151244|NCT03438006|450176655|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
125151245|NCT03438006|450176655|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
125151246|NCT03078478|450176674|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
125151247|NCT03078478|450176675|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
125151248|NCT03078478|450176674|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
125151249|NCT03078478|450176675|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
125151250|NCT03078478|450176674|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
125151251|NCT03078478|450176675|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
125151252|NCT03078478|450176674|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
125151253|NCT03078478|450176675|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
125151254|NCT03078478|450176674|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
125151255|NCT03078478|450176675|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
125151256|NCT03078478|450176674|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
125151257|NCT03078478|450176675|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
125151258|NCT03078478|450176674|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
125151259|NCT03078478|450176675|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
125151260|NCT03078478|450176674|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
125151261|NCT03078478|450176675|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
125388488|NCT02608268|451056612|FG020|Overall Study|Progressive disease|10|||
125151262|NCT02339090|450176677|FG000|Overall Study|Adverse Event|1|||
125151263|NCT02339090|450176678|FG001|Overall Study|Adverse Event|0|||
125151264|NCT02339090|450176677|FG000|Overall Study|Lost to Follow-up|0|||
125151265|NCT02339090|450176678|FG001|Overall Study|Lost to Follow-up|1|||
125151266|NCT02339090|450176677|FG000|Overall Study|Non-compliance With Study Drug|0|||
125151267|NCT02339090|450176678|FG001|Overall Study|Non-compliance With Study Drug|1|||
125151268|NCT02339090|450176677|FG000|Overall Study|Withdrawal by Subject|2|||
125151269|NCT02339090|450176678|FG001|Overall Study|Withdrawal by Subject|1|||
125151270|NCT02339090|450176677|FG000|Overall Study|Poor Growth|3|||
125151271|NCT02339090|450176678|FG001|Overall Study|Poor Growth|0|||
125151272|NCT02339090|450176677|FG000|Overall Study|Randomized but not treated|0|||
125151273|NCT02339090|450176678|FG001|Overall Study|Randomized but not treated|2|||
125151274|NCT02737592|450176682|FG000|Overall Study|Withdrawal by Subject|1|||
125151275|NCT00955721|450176684|FG000|Overall Study|Physician Decision|1|||
125151276|NCT00955721|450176685|FG001|Overall Study|Physician Decision|0|||
125151277|NCT00955721|450176684|FG000|Overall Study|Death|1|||
125151278|NCT00955721|450176685|FG001|Overall Study|Death|0|||
125151279|NCT00955721|450176684|FG000|Overall Study|Withdrawal by Subject|1|||
125151280|NCT00955721|450176685|FG001|Overall Study|Withdrawal by Subject|0|||
125151281|NCT03581188|450178098|FG000|Overall Study|Inclusion criteria not met|3|||
125151282|NCT03581188|450178099|FG001|Overall Study|Inclusion criteria not met|2|||
125151283|NCT03581188|450178098|FG000|Overall Study|Lost to Follow-up|5|||
125151284|NCT03581188|450178099|FG001|Overall Study|Lost to Follow-up|5|||
125151285|NCT03581188|450178098|FG000|Overall Study|Discontinued intervention|11|||
125151286|NCT03581188|450178099|FG001|Overall Study|Discontinued intervention|8|||
125151287|NCT03064438|450178100|FG000|Overall Study|Lost to Follow-up|1|||
125151288|NCT03064438|450178101|FG001|Overall Study|Lost to Follow-up|0|||
125151289|NCT03064438|450178100|FG000|Overall Study|Withdrawal by Subject|0|||
125151290|NCT03064438|450178101|FG001|Overall Study|Withdrawal by Subject|1|||
125151291|NCT01937351|450178102|FG000|Overall Study|Withdrawal by Subject|4|||
125151292|NCT01937351|450178103|FG001|Overall Study|Withdrawal by Subject|2|||
125151293|NCT01937351|450178102|FG000|Overall Study|Death|1|||
125151294|NCT01937351|450178103|FG001|Overall Study|Death|0|||
125151295|NCT01937351|450178102|FG000|Overall Study|Not treated w device, per protocol fail|4|||
125151296|NCT01937351|450178103|FG001|Overall Study|Not treated w device, per protocol fail|0|||
125151297|NCT01961687|450178104|FG000|Overall Study|Lost to Follow-up|19|||
125151298|NCT01961687|450178104|FG000|Overall Study|Re-operation|17|||
125151299|NCT01961687|450178104|FG000|Overall Study|Death|7|||
125151300|NCT01961687|450178104|FG000|Overall Study|Withdrawal by Subject|6|||
125151301|NCT01961687|450178104|FG000|Overall Study|Adverse Event|6|||
125151302|NCT01961687|450178104|FG000|Overall Study|Moved to area without study site|2|||
125151303|NCT01961687|450178104|FG000|Overall Study|Sponsor decision|2|||
125151304|NCT01961687|450178104|FG000|Overall Study|Physician Decision|1|||
125151305|NCT01961687|450178104|FG000|Overall Study|Unable to meet follow-up requirements|1|||
125151306|NCT02284347|450178105|FG000|Overall Study|Lost to Follow-up|2|||
125151307|NCT02284347|450178105|FG000|Overall Study|Withdrawn prior to treatment|1|||
125151308|NCT01301482|450178107|FG000|Overall Study|Withdrawal by Subject|1|||
125151309|NCT00480324|450178108|FG000|Overall Study|Adverse Event|1|||
125151310|NCT00480324|450178109|FG001|Overall Study|Adverse Event|1|||
125151311|NCT00480324|450178108|FG000|Overall Study|Protocol Violation|0|||
125151312|NCT00480324|450178109|FG001|Overall Study|Protocol Violation|1|||
125151313|NCT00480324|450178108|FG000|Overall Study|Withdrawal by Subject|14|||
125151314|NCT00480324|450178109|FG001|Overall Study|Withdrawal by Subject|5|||
125151315|NCT00480324|450178108|FG000|Overall Study|Lost to Follow-up|17|||
125151316|NCT00480324|450178109|FG001|Overall Study|Lost to Follow-up|8|||
125151317|NCT00480324|450178108|FG000|Overall Study|Subject's mother pregnant|0|||
125151318|NCT00480324|450178109|FG001|Overall Study|Subject's mother pregnant|1|||
125151319|NCT01552369|450178110|FG000|Overall Study|Did not consent to extended follow up|8|||
125151320|NCT01552369|450178111|FG001|Overall Study|Did not consent to extended follow up|9|||
125151321|NCT01316419|450178112|FG000|Overall Study|Not treated|103|||
125151322|NCT01316419|450178112|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
125151323|NCT01316419|450178112|FG000|Overall Study|Lost to Follow-up|19|||
125151324|NCT02999984|450178113|FG000|Overall Study|Treatment Failure|1|||
125151325|NCT04039919|450178114|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125151326|NCT04039919|450178115|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125151327|NCT04039919|450178116|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125151328|NCT04039919|450178117|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125151329|NCT04039919|450178118|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125151330|NCT04039919|450178114|FG000|Treatment Period 1|Sponsor's decision|0|||
125151331|NCT04039919|450178115|FG001|Treatment Period 1|Sponsor's decision|0|||
125151332|NCT04039919|450178116|FG002|Treatment Period 1|Sponsor's decision|0|||
125151333|NCT04039919|450178117|FG003|Treatment Period 1|Sponsor's decision|0|||
125151334|NCT04039919|450178118|FG004|Treatment Period 1|Sponsor's decision|16|||
125151335|NCT04039919|450178114|FG000|Treatment Period 5|Withdrawal by Subject|1|||
125151336|NCT04039919|450178115|FG001|Treatment Period 5|Withdrawal by Subject|0|||
125151337|NCT04039919|450178116|FG002|Treatment Period 5|Withdrawal by Subject|0|||
125388489|NCT02608268|451056613|FG021|Overall Study|Progressive disease|4|||
125151338|NCT04039919|450178117|FG003|Treatment Period 5|Withdrawal by Subject|0|||
125151339|NCT04039919|450178118|FG004|Treatment Period 5|Withdrawal by Subject|0|||
125151340|NCT00754013|450178119|FG000|Overall Study|Lost to Follow-up|1|||
125151341|NCT00754013|450178120|FG001|Overall Study|Lost to Follow-up|1|||
125151342|NCT00754013|450178119|FG000|Overall Study|didn't return after study termed|3|||
125151343|NCT00754013|450178120|FG001|Overall Study|didn't return after study termed|4|||
125151344|NCT02310789|450178121|FG000|Overall Study|Adverse Event|1|||
125151345|NCT00983918|450178122|FG000|Overall Study|conversion to open cholecystectomy|0|||
125151346|NCT00983918|450178123|FG001|Overall Study|conversion to open cholecystectomy|2|||
125151347|NCT00983918|450178124|FG002|Overall Study|conversion to open cholecystectomy|2|||
125388490|NCT02608268|451056614|FG022|Overall Study|Progressive disease|5|||
125151348|NCT00983918|450178125|FG003|Overall Study|conversion to open cholecystectomy|2|||
125151349|NCT00977548|450178127|FG000|Overall Study|Ineligible|4|||
125151350|NCT00977548|450178127|FG000|Overall Study|Adverse Event|8|||
125151351|NCT00977548|450178127|FG000|Overall Study|Withdrawal by Subject|1|||
125151352|NCT02070757|450178128|FG000|Overall Study|Adverse Event|107|||
125151353|NCT02070757|450178129|FG001|Overall Study|Adverse Event|99|||
125151354|NCT02070757|450178128|FG000|Overall Study|Lost to Follow-up|7|||
125151355|NCT02070757|450178129|FG001|Overall Study|Lost to Follow-up|4|||
125151356|NCT02070757|450178128|FG000|Overall Study|Protocol Violation|0|||
125151357|NCT02070757|450178129|FG001|Overall Study|Protocol Violation|4|||
125151358|NCT02070757|450178128|FG000|Overall Study|Withdrawal by Subject|1|||
125151359|NCT02070757|450178129|FG001|Overall Study|Withdrawal by Subject|3|||
125151360|NCT02070757|450178128|FG000|Overall Study|Investigator Decision|0|||
125151361|NCT02070757|450178129|FG001|Overall Study|Investigator Decision|2|||
125151362|NCT02070757|450178128|FG000|Overall Study|Discharged from Study Hospital|2|||
125151363|NCT02070757|450178129|FG001|Overall Study|Discharged from Study Hospital|2|||
125151364|NCT01546922|450178130|FG000|First Period of 10 Weeks|Protocol Violation|3|||
125151365|NCT01546922|450178131|FG001|First Period of 10 Weeks|Protocol Violation|1|||
125151366|NCT01546922|450178130|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
125151367|NCT01546922|450178131|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
125151368|NCT01546922|450178130|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
125151369|NCT01546922|450178131|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
125151370|NCT01546922|450178130|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
125151371|NCT01546922|450178131|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
125151372|NCT01546922|450178130|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
125151373|NCT01546922|450178131|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
125151374|NCT04086641|450178134|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
125151375|NCT04086641|450178135|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
125151376|NCT01613378|450178138|FG000|Overall Study|Lack of Efficacy|13|||
125151377|NCT01613378|450178138|FG000|Overall Study|Adverse Event|11|||
125151378|NCT01613378|450178138|FG000|Overall Study|Withdrawal by Subject|8|||
125151379|NCT01613378|450178138|FG000|Overall Study|Death|2|||
125151380|NCT01613378|450178138|FG000|Overall Study|Lost to Follow-up|1|||
125151381|NCT01613378|450178138|FG000|Overall Study|Other Reason|4|||
125151382|NCT00794417|450178139|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
125151383|NCT00794417|450178140|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
125151384|NCT00794417|450178141|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
125151385|NCT00794417|450178142|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
125151386|NCT00794417|450178139|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
125151387|NCT00794417|450178140|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
125151388|NCT00794417|450178141|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
125151389|NCT00794417|450178142|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
125151390|NCT00794417|450178139|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
125151391|NCT00794417|450178140|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
125151392|NCT00794417|450178141|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
125151393|NCT00794417|450178142|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
125151394|NCT00794417|450178139|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
125151395|NCT00794417|450178140|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
125151396|NCT00794417|450178141|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
125151397|NCT00794417|450178142|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
125151398|NCT00794417|450178139|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
125151399|NCT00794417|450178140|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
125151400|NCT00794417|450178141|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
125151401|NCT00794417|450178142|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
125151402|NCT00794417|450178139|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
125151403|NCT00794417|450178140|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
125151404|NCT00794417|450178141|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
125151405|NCT00794417|450178142|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
125151406|NCT00792623|450178143|FG000|Overall Study|Adverse Event|2|||
125151407|NCT00792623|450178143|FG000|Overall Study|Withdrawal by Subject|5|||
125151408|NCT00880087|450178151|FG000|Overall Study|Lost to Follow-up|0|||
125151409|NCT00880087|450178152|FG001|Overall Study|Lost to Follow-up|2|||
125388491|NCT02608268|451056615|FG023|Overall Study|Progressive disease|5|||
125388492|NCT02608268|451056616|FG024|Overall Study|Progressive disease|3|||
125388493|NCT02608268|451056617|FG025|Overall Study|Progressive disease|11|||
125151410|NCT02065713|450178153|FG000|Overall Study|Adverse Event|0|||
125151411|NCT02065713|450178154|FG001|Overall Study|Adverse Event|1|||
125388494|NCT02608268|451056618|FG026|Overall Study|Progressive disease|16|||
125151412|NCT02065713|450178153|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125151413|NCT02065713|450178154|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125151414|NCT00483548|450178157|FG000|Overall Study|Randomized; not treated with study drug|1|||
125151415|NCT00483548|450178158|FG001|Overall Study|Randomized; not treated with study drug|3|||
125151416|NCT00483548|450178157|FG000|Overall Study|Adverse Event|25|||
125151417|NCT00483548|450178158|FG001|Overall Study|Adverse Event|14|||
125151418|NCT00483548|450178157|FG000|Overall Study|Laboratory abnormality|1|||
125151419|NCT00483548|450178158|FG001|Overall Study|Laboratory abnormality|2|||
125151420|NCT00483548|450178157|FG000|Overall Study|Lack of Efficacy|4|||
125151421|NCT00483548|450178158|FG001|Overall Study|Lack of Efficacy|8|||
125151422|NCT00483548|450178157|FG000|Overall Study|Protocol Violation|11|||
125151423|NCT00483548|450178158|FG001|Overall Study|Protocol Violation|7|||
125151424|NCT00483548|450178157|FG000|Overall Study|Pregnancy|1|||
125151425|NCT00483548|450178158|FG001|Overall Study|Pregnancy|0|||
125151426|NCT00483548|450178157|FG000|Overall Study|Protocol required discontinuation|6|||
125151427|NCT00483548|450178158|FG001|Overall Study|Protocol required discontinuation|6|||
125151428|NCT00483548|450178157|FG000|Overall Study|Unable to comply with protocol schedule|1|||
125151429|NCT00483548|450178158|FG001|Overall Study|Unable to comply with protocol schedule|0|||
125151430|NCT00483548|450178157|FG000|Overall Study|Non-compliance with medication|2|||
125151431|NCT00483548|450178158|FG001|Overall Study|Non-compliance with medication|0|||
125151432|NCT00483548|450178157|FG000|Overall Study|Lost to Follow-up|3|||
125151433|NCT00483548|450178158|FG001|Overall Study|Lost to Follow-up|4|||
125151434|NCT00483548|450178157|FG000|Overall Study|Withdrawal by Subject|5|||
125151435|NCT00483548|450178158|FG001|Overall Study|Withdrawal by Subject|2|||
125151436|NCT02694549|450178161|FG000|Overall Study|screen failures|2|||
125151437|NCT01534078|450178162|FG000|Overall Study|Death|1|||
125151438|NCT01534078|450178162|FG000|Overall Study|Withdrawal by Subject|1|||
125151439|NCT02459665|450178163|FG000|Overall Study|Withdrawal by Subject|0|||
125151440|NCT02459665|450178164|FG001|Overall Study|Withdrawal by Subject|1|||
125151441|NCT02459665|450178165|FG002|Overall Study|Withdrawal by Subject|1|||
125151442|NCT02459665|450178166|FG003|Overall Study|Withdrawal by Subject|2|||
125151443|NCT01220609|450178167|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
125151444|NCT01220609|450178167|FG000|Overall Study|Ineligible- Wrong cell type|1|||
125151445|NCT01220609|450178167|FG000|Overall Study|Ineligible-Never treated|1|||
125151446|NCT02225665|450178168|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
125151447|NCT02225665|450178169|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
125151448|NCT02225665|450178168|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
125151449|NCT02225665|450178169|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
125151450|NCT00572039|450178170|FG000|Overall Study|Withdrawal by Subject|9|||
125151451|NCT00572039|450178171|FG001|Overall Study|Withdrawal by Subject|6|||
125151452|NCT00572039|450178170|FG000|Overall Study|Death|2|||
125151453|NCT00572039|450178171|FG001|Overall Study|Death|3|||
125151454|NCT00572039|450178170|FG000|Overall Study|Ill|5|||
125151455|NCT00572039|450178171|FG001|Overall Study|Ill|1|||
125151456|NCT01790113|450178176|FG000|Overall Study|Adverse Event|2|||
125151457|NCT01790113|450178177|FG001|Overall Study|Adverse Event|7|||
125151458|NCT01790113|450178176|FG000|Overall Study|Study ended due to FDA clearance|1|||
125151459|NCT01790113|450178177|FG001|Overall Study|Study ended due to FDA clearance|68|||
125151460|NCT03585959|450178178|FG000|Overall Study|Physician Decision|1|||
125151461|NCT03585959|450178178|FG000|Overall Study|Unsuccessful Procedure|2|||
125151462|NCT00614822|450178180|FG000|Overall Study|Adverse Event|3|||
125151463|NCT02674386|450178183|FG000|Overall Study|Lost to Follow-up|0|||
125151464|NCT02674386|450178184|FG001|Overall Study|Lost to Follow-up|1|||
125151465|NCT02674386|450178185|FG002|Overall Study|Lost to Follow-up|1|||
125151466|NCT02674386|450178183|FG000|Overall Study|Withdrawal by Subject|0|||
125151467|NCT02674386|450178184|FG001|Overall Study|Withdrawal by Subject|4|||
125151468|NCT02674386|450178185|FG002|Overall Study|Withdrawal by Subject|0|||
125151469|NCT02674386|450178183|FG000|Overall Study|Other|0|||
125151470|NCT02674386|450178184|FG001|Overall Study|Other|1|||
125151471|NCT02674386|450178185|FG002|Overall Study|Other|0|||
125151472|NCT02674386|450178183|FG000|Overall Study|Enrolled but not evaluated|0|||
125151473|NCT02674386|450178184|FG001|Overall Study|Enrolled but not evaluated|4|||
125151474|NCT02674386|450178185|FG002|Overall Study|Enrolled but not evaluated|0|||
125151475|NCT01439724|450178190|FG000|Overall Study|missing consultation|9|||
125151476|NCT01439724|450178191|FG001|Overall Study|missing consultation|8|||
125151477|NCT01040793|450178196|FG000|Overall Study|Adverse Event|5|||
125151478|NCT01040793|450178197|FG001|Overall Study|Adverse Event|3|||
125151479|NCT01040793|450178198|FG002|Overall Study|Adverse Event|0|||
125151480|NCT01040793|450178199|FG003|Overall Study|Adverse Event|2|||
125151481|NCT01040793|450178200|FG004|Overall Study|Adverse Event|2|||
125151482|NCT01040793|450178201|FG005|Overall Study|Adverse Event|1|||
125151483|NCT01040793|450178196|FG000|Overall Study|Protocol Violation|1|||
125151484|NCT01040793|450178197|FG001|Overall Study|Protocol Violation|1|||
125151485|NCT01040793|450178198|FG002|Overall Study|Protocol Violation|1|||
125151486|NCT01040793|450178199|FG003|Overall Study|Protocol Violation|0|||
125151487|NCT01040793|450178200|FG004|Overall Study|Protocol Violation|1|||
125151488|NCT01040793|450178201|FG005|Overall Study|Protocol Violation|0|||
125438693|NCT00669903|451233926|FG003|Overall Study|Lost to Follow-up|1|||
125151489|NCT01040793|450178196|FG000|Overall Study|Lost to Follow-up|0|||
125151490|NCT01040793|450178197|FG001|Overall Study|Lost to Follow-up|1|||
125151491|NCT01040793|450178198|FG002|Overall Study|Lost to Follow-up|1|||
125151492|NCT01040793|450178199|FG003|Overall Study|Lost to Follow-up|0|||
125151493|NCT01040793|450178200|FG004|Overall Study|Lost to Follow-up|0|||
125151494|NCT01040793|450178201|FG005|Overall Study|Lost to Follow-up|0|||
125151495|NCT01040793|450178196|FG000|Overall Study|Withdrawal by Subject|0|||
125151496|NCT01040793|450178197|FG001|Overall Study|Withdrawal by Subject|0|||
125151497|NCT01040793|450178198|FG002|Overall Study|Withdrawal by Subject|0|||
125151498|NCT01040793|450178199|FG003|Overall Study|Withdrawal by Subject|2|||
125151499|NCT01040793|450178200|FG004|Overall Study|Withdrawal by Subject|0|||
125151500|NCT01040793|450178201|FG005|Overall Study|Withdrawal by Subject|0|||
125151501|NCT01040793|450178196|FG000|Overall Study|Other reasons not listed above|0|||
125151502|NCT01040793|450178197|FG001|Overall Study|Other reasons not listed above|0|||
125151503|NCT01040793|450178198|FG002|Overall Study|Other reasons not listed above|1|||
125151504|NCT01040793|450178199|FG003|Overall Study|Other reasons not listed above|0|||
125151505|NCT01040793|450178200|FG004|Overall Study|Other reasons not listed above|1|||
125151506|NCT01040793|450178201|FG005|Overall Study|Other reasons not listed above|0|||
125151507|NCT00939627|450178206|FG000|Overall Study|Disease Progression|16|||
125151508|NCT00939627|450178207|FG001|Overall Study|Disease Progression|12|||
125151509|NCT00939627|450178208|FG002|Overall Study|Disease Progression|0|||
125151510|NCT00939627|450178206|FG000|Overall Study|Adverse Event|6|||
125151511|NCT00939627|450178207|FG001|Overall Study|Adverse Event|7|||
125151512|NCT00939627|450178208|FG002|Overall Study|Adverse Event|0|||
125151513|NCT00939627|450178206|FG000|Overall Study|Death|0|||
125151514|NCT00939627|450178207|FG001|Overall Study|Death|2|||
125151515|NCT00939627|450178208|FG002|Overall Study|Death|0|||
125151516|NCT00939627|450178206|FG000|Overall Study|Withdrawal by Subject|2|||
125151517|NCT00939627|450178207|FG001|Overall Study|Withdrawal by Subject|4|||
125151518|NCT00939627|450178208|FG002|Overall Study|Withdrawal by Subject|0|||
125151519|NCT00939627|450178206|FG000|Overall Study|Other complicating disease|1|||
125151520|NCT00939627|450178207|FG001|Overall Study|Other complicating disease|1|||
125151521|NCT00939627|450178208|FG002|Overall Study|Other complicating disease|0|||
125151522|NCT00939627|450178206|FG000|Overall Study|Not compliant|2|||
125151523|NCT00939627|450178207|FG001|Overall Study|Not compliant|0|||
125151524|NCT00939627|450178208|FG002|Overall Study|Not compliant|0|||
125151525|NCT00939627|450178206|FG000|Overall Study|No off-tx reason given|0|||
125151526|NCT00939627|450178207|FG001|Overall Study|No off-tx reason given|2|||
125151527|NCT00939627|450178208|FG002|Overall Study|No off-tx reason given|0|||
125151528|NCT03297294|450178209|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
125151529|NCT03297294|450178210|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
125151530|NCT03297294|450178211|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125151531|NCT03297294|450178212|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125151532|NCT03297294|450178213|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
125151533|NCT03297294|450178209|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
125151534|NCT03297294|450178210|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
125151535|NCT03297294|450178211|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125151536|NCT03297294|450178212|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125151537|NCT03297294|450178213|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
125151538|NCT03297294|450178209|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
125151539|NCT03297294|450178210|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
125151540|NCT03297294|450178211|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125151541|NCT03297294|450178212|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125151542|NCT03297294|450178213|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
125151543|NCT03297294|450178209|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
125151544|NCT03297294|450178210|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
125151545|NCT03297294|450178211|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125151546|NCT03297294|450178212|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125151547|NCT03297294|450178213|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
125151548|NCT03297294|450178209|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
125151549|NCT03297294|450178210|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
125151550|NCT03297294|450178211|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
125151551|NCT03297294|450178212|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
125151552|NCT03297294|450178213|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
125151553|NCT02776553|450178219|FG000|Overall Study|Lost to Follow-up|1|||
125151554|NCT02776553|450178220|FG001|Overall Study|Lost to Follow-up|0|||
125151555|NCT02776553|450178219|FG000|Overall Study|got liver transplant|1|||
125151556|NCT02776553|450178220|FG001|Overall Study|got liver transplant|2|||
125151557|NCT02776553|450178219|FG000|Overall Study|had other surgery|1|||
125151558|NCT02776553|450178220|FG001|Overall Study|had other surgery|0|||
125151559|NCT02776553|450178219|FG000|Overall Study|Protocol Violation|0|||
125151560|NCT02776553|450178220|FG001|Overall Study|Protocol Violation|1|||
125151561|NCT00104247|450178230|FG000|Overall Study|Withdrawal by Subject|1|||
125151562|NCT00104247|450178231|FG001|Overall Study|Withdrawal by Subject|0|||
125388495|NCT02608268|451056619|FG027|Overall Study|Progressive disease|11|||
125438694|NCT00669903|451233923|FG000|Overall Study|Protocol Violation|0|||
125151563|NCT00104247|450178230|FG000|Overall Study|Noncompliant with dosing|0|||
125151564|NCT00104247|450178231|FG001|Overall Study|Noncompliant with dosing|1|||
125151565|NCT00063882|450178234|FG000|Overall Study|Protocol Violation|3|||
125151566|NCT00063882|450178235|FG001|Overall Study|Protocol Violation|3|||
125151567|NCT00063882|450178234|FG000|Overall Study|Withdrawal by Subject|2|||
125151568|NCT00063882|450178235|FG001|Overall Study|Withdrawal by Subject|1|||
125151569|NCT01930175|450178236|FG000|Core Study|Lost to Follow-up|0|||
125151570|NCT01930175|450178237|FG001|Core Study|Lost to Follow-up|1|||
125151571|NCT01930175|450178238|FG002|Core Study|Lost to Follow-up|0|||
125151572|NCT01930175|450178236|FG000|Core Study|Adverse Event|0|||
125151573|NCT01930175|450178237|FG001|Core Study|Adverse Event|0|||
125151574|NCT01930175|450178238|FG002|Core Study|Adverse Event|1|||
125151575|NCT00834899|450178239|FG000|Overall Study|Withdrawal by Subject|1|||
125151576|NCT00834899|450178240|FG001|Overall Study|Withdrawal by Subject|1|||
125151577|NCT03314662|450178243|FG000|Overall Study|Withdrawal by Subject|1|||
125151578|NCT03314662|450178244|FG001|Overall Study|Withdrawal by Subject|1|||
125151579|NCT03314662|450178245|FG002|Overall Study|Withdrawal by Subject|1|||
125151580|NCT03314662|450178243|FG000|Overall Study|Lost to Follow-up|5|||
125151581|NCT03314662|450178244|FG001|Overall Study|Lost to Follow-up|4|||
125151582|NCT03314662|450178245|FG002|Overall Study|Lost to Follow-up|4|||
125151583|NCT03314662|450178243|FG000|Overall Study|Death|2|||
125151584|NCT03314662|450178244|FG001|Overall Study|Death|0|||
125151585|NCT03314662|450178245|FG002|Overall Study|Death|0|||
125151586|NCT01117766|450178250|FG000|First Intervention|Adverse Event|0|||
125151587|NCT01117766|450178251|FG001|First Intervention|Adverse Event|1|||
125151588|NCT01117766|450178250|FG000|First Intervention|Protocol Violation|1|||
125151589|NCT01117766|450178251|FG001|First Intervention|Protocol Violation|0|||
125151590|NCT01117766|450178250|FG000|Washout Period|Protocol Violation|0|||
125151591|NCT01117766|450178251|FG001|Washout Period|Protocol Violation|2|||
125151592|NCT01117766|450178250|FG000|Second Intervention|Lost to Follow-up|1|||
125151593|NCT01117766|450178251|FG001|Second Intervention|Lost to Follow-up|0|||
125151594|NCT01117766|450178250|FG000|Second Intervention|Other|1|||
125151595|NCT01117766|450178251|FG001|Second Intervention|Other|2|||
125151596|NCT01117766|450178250|FG000|Second Intervention|Adverse Event|0|||
125151597|NCT01117766|450178251|FG001|Second Intervention|Adverse Event|2|||
125151598|NCT01117766|450178250|FG000|Second Intervention|Withdrawal by Subject|0|||
125151599|NCT01117766|450178251|FG001|Second Intervention|Withdrawal by Subject|1|||
125151600|NCT00438659|450178252|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
125151601|NCT00438659|450178253|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
125151602|NCT00438659|450178252|FG000|Overall Study|Cancel|5|||
125151603|NCT00438659|450178253|FG001|Overall Study|Cancel|2|||
125151604|NCT02244424|450178254|FG000|Overall Study|Lost to Follow-up|20|||
125151605|NCT02244424|450178255|FG001|Overall Study|Lost to Follow-up|10|||
125151606|NCT03366194|450178259|FG000|Overall Study|Lost to Follow-up|2|||
125151607|NCT01684215|450179458|FG000|Phase 1, Part 1|Adverse Event|1|||
125151608|NCT01684215|450179459|FG001|Phase 1, Part 1|Adverse Event|0|||
125151609|NCT01684215|450179460|FG002|Phase 1, Part 1|Adverse Event|0|||
125151610|NCT01684215|450179461|FG003|Phase 1, Part 1|Adverse Event|0|||
125151611|NCT01684215|450179458|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
125151612|NCT01684215|450179459|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
125151613|NCT01684215|450179460|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
125151614|NCT01684215|450179461|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
125151615|NCT01684215|450179458|FG000|Phase 1, Part 2|Adverse Event|0|||
125151616|NCT01684215|450179459|FG001|Phase 1, Part 2|Adverse Event|0|||
125151617|NCT01684215|450179460|FG002|Phase 1, Part 2|Adverse Event|1|||
125151618|NCT01684215|450179461|FG003|Phase 1, Part 2|Adverse Event|0|||
125151619|NCT01684215|450179458|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
125151620|NCT01684215|450179459|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
125151621|NCT01684215|450179460|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
125151622|NCT01684215|450179461|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
125151623|NCT01684215|450179458|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
125151624|NCT01684215|450179459|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
125151625|NCT01684215|450179460|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
125151626|NCT01684215|450179461|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
125151627|NCT01684215|450179458|FG000|Phase 2|Death|0|||
125151628|NCT01684215|450179459|FG001|Phase 2|Death|0|||
125151629|NCT01684215|450179460|FG002|Phase 2|Death|0|||
125151630|NCT01684215|450179461|FG003|Phase 2|Death|8|||
125151631|NCT01684215|450179458|FG000|Phase 2|Study terminated by sponsor|0|||
125151632|NCT01684215|450179459|FG001|Phase 2|Study terminated by sponsor|0|||
125151633|NCT01684215|450179460|FG002|Phase 2|Study terminated by sponsor|0|||
125151634|NCT01684215|450179461|FG003|Phase 2|Study terminated by sponsor|30|||
125151635|NCT01684215|450179458|FG000|Phase 2|Enrolled but not treated|0|||
125151636|NCT01684215|450179459|FG001|Phase 2|Enrolled but not treated|0|||
125151637|NCT01684215|450179460|FG002|Phase 2|Enrolled but not treated|0|||
125151638|NCT01684215|450179461|FG003|Phase 2|Enrolled but not treated|1|||
125151639|NCT01684215|450179458|FG000|Phase 2|Lost to Follow-up|0|||
125151640|NCT01684215|450179459|FG001|Phase 2|Lost to Follow-up|0|||
125151641|NCT01684215|450179460|FG002|Phase 2|Lost to Follow-up|0|||
125151642|NCT01684215|450179461|FG003|Phase 2|Lost to Follow-up|4|||
125151643|NCT03919448|450179466|FG000|Overall Study|Withdrawal by Subject|1|||
125151644|NCT03919448|450179467|FG001|Overall Study|Withdrawal by Subject|0|||
125388496|NCT02608268|451056620|FG028|Overall Study|Progressive disease|10|||
125388497|NCT02608268|451056621|FG029|Overall Study|Progressive disease|15|||
125151645|NCT03919448|450179468|FG002|Overall Study|Withdrawal by Subject|0|||
125151646|NCT03438539|450179469|FG000|Overall Study|Lost to Follow-up|8|||
125151647|NCT03438539|450179470|FG001|Overall Study|Lost to Follow-up|4|||
125151648|NCT03438539|450179471|FG002|Overall Study|Lost to Follow-up|10|||
125151649|NCT03438539|450179472|FG003|Overall Study|Lost to Follow-up|9|||
125151650|NCT03438539|450179473|FG004|Overall Study|Lost to Follow-up|3|||
125151651|NCT03438539|450179474|FG005|Overall Study|Lost to Follow-up|8|||
125151652|NCT04213209|450179478|FG000|Overall Study|Protocol Violation|1|||
125151653|NCT04213209|450179479|FG001|Overall Study|Protocol Violation|0|||
125151654|NCT04213209|450179480|FG002|Overall Study|Protocol Violation|0|||
125151655|NCT04213209|450179481|FG003|Overall Study|Protocol Violation|0|||
125151656|NCT04213209|450179482|FG004|Overall Study|Protocol Violation|0|||
125151657|NCT04213209|450179483|FG005|Overall Study|Protocol Violation|0|||
125151658|NCT01005329|450179486|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
125151659|NCT01272921|450179489|FG000|Overall Study|Protocol Violation|2|||
125151660|NCT01272921|450179490|FG001|Overall Study|Protocol Violation|1|||
125151661|NCT01132664|450179491|FG000|Phase lb|Adverse Event|0|||
125151662|NCT01132664|450179492|FG001|Phase lb|Adverse Event|1|||
125151663|NCT01132664|450179493|FG002|Phase lb|Adverse Event|0|||
125151664|NCT01132664|450179494|FG003|Phase lb|Adverse Event|0|||
125151665|NCT01132664|450179495|FG004|Phase lb|Adverse Event|0|||
125151666|NCT01132664|450179491|FG000|Phase lb|Withdrawal by Subject|1|||
125151667|NCT01132664|450179492|FG001|Phase lb|Withdrawal by Subject|2|||
125151668|NCT01132664|450179493|FG002|Phase lb|Withdrawal by Subject|0|||
125151669|NCT01132664|450179494|FG003|Phase lb|Withdrawal by Subject|0|||
125151670|NCT01132664|450179495|FG004|Phase lb|Withdrawal by Subject|0|||
125151671|NCT01132664|450179491|FG000|Phase lb|Disease Progression|4|||
125151672|NCT01132664|450179492|FG001|Phase lb|Disease Progression|9|||
125151673|NCT01132664|450179493|FG002|Phase lb|Disease Progression|0|||
125151674|NCT01132664|450179494|FG003|Phase lb|Disease Progression|0|||
125151675|NCT01132664|450179495|FG004|Phase lb|Disease Progression|0|||
125151676|NCT01132664|450179491|FG000|Phase ll|Death|0|||
125151677|NCT01132664|450179492|FG001|Phase ll|Death|0|||
125151678|NCT01132664|450179493|FG002|Phase ll|Death|2|||
125151679|NCT01132664|450179494|FG003|Phase ll|Death|0|||
125151680|NCT01132664|450179495|FG004|Phase ll|Death|0|||
125151681|NCT01132664|450179491|FG000|Phase ll|Adverse Event|0|||
125151682|NCT01132664|450179492|FG001|Phase ll|Adverse Event|0|||
125151683|NCT01132664|450179493|FG002|Phase ll|Adverse Event|10|||
125151684|NCT01132664|450179494|FG003|Phase ll|Adverse Event|0|||
125151685|NCT01132664|450179495|FG004|Phase ll|Adverse Event|0|||
125151686|NCT01132664|450179491|FG000|Phase ll|Withdrawal by Subject|0|||
125151687|NCT01132664|450179492|FG001|Phase ll|Withdrawal by Subject|0|||
125151688|NCT01132664|450179493|FG002|Phase ll|Withdrawal by Subject|3|||
125151689|NCT01132664|450179494|FG003|Phase ll|Withdrawal by Subject|0|||
125151690|NCT01132664|450179495|FG004|Phase ll|Withdrawal by Subject|0|||
125151691|NCT01132664|450179491|FG000|Phase ll|Disease progression|0|||
125151692|NCT01132664|450179492|FG001|Phase ll|Disease progression|0|||
125151693|NCT01132664|450179493|FG002|Phase ll|Disease progression|35|||
125151694|NCT01132664|450179494|FG003|Phase ll|Disease progression|0|||
125388498|NCT02608268|451056592|FG000|Overall Study|Subject/guardian decision|1|||
125388499|NCT02608268|451056593|FG001|Overall Study|Subject/guardian decision|1|||
125388500|NCT02608268|451056594|FG002|Overall Study|Subject/guardian decision|2|||
125388501|NCT02608268|451056595|FG003|Overall Study|Subject/guardian decision|0|||
125388502|NCT02608268|451056596|FG004|Overall Study|Subject/guardian decision|0|||
125388503|NCT02608268|451056597|FG005|Overall Study|Subject/guardian decision|0|||
125388504|NCT02608268|451056598|FG006|Overall Study|Subject/guardian decision|0|||
125438695|NCT00669903|451233924|FG001|Overall Study|Protocol Violation|1|||
125151695|NCT01132664|450179495|FG004|Phase ll|Disease progression|0|||
125151696|NCT01132664|450179491|FG000|BM Cohort|Disease progression|0|||
125151697|NCT01132664|450179492|FG001|BM Cohort|Disease progression|0|||
125151698|NCT01132664|450179493|FG002|BM Cohort|Disease progression|0|||
125151699|NCT01132664|450179494|FG003|BM Cohort|Disease progression|3|||
125388505|NCT02608268|451056599|FG007|Overall Study|Subject/guardian decision|0|||
125388506|NCT02608268|451056600|FG008|Overall Study|Subject/guardian decision|2|||
125388507|NCT02608268|451056601|FG009|Overall Study|Subject/guardian decision|2|||
125438696|NCT00669903|451233925|FG002|Overall Study|Protocol Violation|0|||
125151700|NCT01132664|450179495|FG004|BM Cohort|Disease progression|4|||
125151701|NCT01132664|450179491|FG000|BM Cohort|Adverse Event|0|||
125151702|NCT01132664|450179492|FG001|BM Cohort|Adverse Event|0|||
125151703|NCT01132664|450179493|FG002|BM Cohort|Adverse Event|0|||
125151704|NCT01132664|450179494|FG003|BM Cohort|Adverse Event|0|||
125151705|NCT01132664|450179495|FG004|BM Cohort|Adverse Event|1|||
125151706|NCT01132664|450179491|FG000|BM Cohort|Withdrawal by Subject|0|||
125151707|NCT01132664|450179492|FG001|BM Cohort|Withdrawal by Subject|0|||
125151708|NCT01132664|450179493|FG002|BM Cohort|Withdrawal by Subject|0|||
125151709|NCT01132664|450179494|FG003|BM Cohort|Withdrawal by Subject|0|||
125151710|NCT01132664|450179495|FG004|BM Cohort|Withdrawal by Subject|1|||
125151711|NCT00126126|450179496|FG000|Overall Study|Lost to Follow-up|0|||
125151712|NCT00126126|450179497|FG001|Overall Study|Lost to Follow-up|2|||
125151713|NCT01567826|450179500|FG000|Overall Study|Lost to Follow-up|3|||
125151714|NCT01567826|450179501|FG001|Overall Study|Lost to Follow-up|2|||
125151715|NCT01223235|450179504|FG000|Overall Study|Withdrawal by Subject|1|||
125151716|NCT04364737|450179508|FG000|Overall Study|Withdrawal by Subject|4|||
125151717|NCT04364737|450179509|FG001|Overall Study|Withdrawal by Subject|9|||
125151718|NCT04364737|450179508|FG000|Overall Study|Lost to Follow-up|1|||
125151719|NCT04364737|450179509|FG001|Overall Study|Lost to Follow-up|1|||
125151720|NCT00868296|450179513|FG000|Overall Study|Adverse Event|0|||
125151721|NCT00868296|450179514|FG001|Overall Study|Adverse Event|2|||
125151722|NCT00868296|450179513|FG000|Overall Study|Withdrawal by Subject|0|||
125151723|NCT00868296|450179514|FG001|Overall Study|Withdrawal by Subject|1|||
125151724|NCT00804141|450179519|FG000|Overall Study|Adverse Event|157|||
125151725|NCT00804141|450179519|FG000|Overall Study|Death|4|||
125151726|NCT00804141|450179519|FG000|Overall Study|Failed to return|96|||
125151727|NCT00804141|450179519|FG000|Overall Study|Investigator request|8|||
125151728|NCT00804141|450179519|FG000|Overall Study|Protocol Violation|85|||
125151729|NCT00804141|450179519|FG000|Overall Study|Withdrawal by Subject|131|||
125151730|NCT00804141|450179519|FG000|Overall Study|Lack of Efficacy|46|||
125151731|NCT00804141|450179519|FG000|Overall Study|Other than specified|30|||
125151732|NCT00804141|450179519|FG000|Overall Study|Enrolled but not treated|6|||
125151733|NCT02075606|450179520|FG000|Overall Study|Adverse Event|5|||
125151734|NCT02075606|450179520|FG000|Overall Study|Withdrawal by Subject|1|||
125151735|NCT02075606|450179520|FG000|Overall Study|Death|1|||
125151736|NCT02075606|450179520|FG000|Overall Study|Investigator's decision|1|||
125151737|NCT02075606|450179520|FG000|Overall Study|Symptom management|1|||
125151738|NCT02075606|450179520|FG000|Overall Study|Increasing Symptoms|1|||
125151739|NCT02462486|450179521|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
125151740|NCT02462486|450179522|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
125151741|NCT02462486|450179523|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
125151742|NCT02462486|450179521|FG000|Overall Study|Adverse Event|53|||
125151743|NCT02462486|450179522|FG001|Overall Study|Adverse Event|48|||
125151744|NCT02462486|450179523|FG002|Overall Study|Adverse Event|21|||
125151745|NCT02462486|450179521|FG000|Overall Study|Lack of Efficacy|6|||
125151746|NCT02462486|450179522|FG001|Overall Study|Lack of Efficacy|12|||
125151747|NCT02462486|450179523|FG002|Overall Study|Lack of Efficacy|3|||
125151748|NCT02462486|450179521|FG000|Overall Study|Lost to Follow-up|3|||
125151749|NCT02462486|450179522|FG001|Overall Study|Lost to Follow-up|4|||
125151750|NCT02462486|450179523|FG002|Overall Study|Lost to Follow-up|2|||
125151751|NCT02462486|450179521|FG000|Overall Study|Withdrawal by Subject|25|||
125151752|NCT02462486|450179522|FG001|Overall Study|Withdrawal by Subject|22|||
125151753|NCT02462486|450179523|FG002|Overall Study|Withdrawal by Subject|19|||
125151754|NCT02462486|450179521|FG000|Overall Study|Protocol Violation|3|||
125151755|NCT02462486|450179522|FG001|Overall Study|Protocol Violation|1|||
125151756|NCT02462486|450179523|FG002|Overall Study|Protocol Violation|1|||
125151757|NCT02462486|450179521|FG000|Overall Study|Reason not Specified|3|||
125151758|NCT02462486|450179522|FG001|Overall Study|Reason not Specified|4|||
125151759|NCT02462486|450179523|FG002|Overall Study|Reason not Specified|3|||
125151760|NCT00941720|450179527|FG000|Overall Study|Withdrawal by Subject|1|||
125151761|NCT00941720|450179527|FG000|Overall Study|Insurance denied participation|11|||
125151762|NCT00941720|450179527|FG000|Overall Study|ineligible|2|||
125151763|NCT01682148|450179528|FG000|Overall Study|Withdrawal by Subject|2|||
125151764|NCT01682148|450179529|FG001|Overall Study|Withdrawal by Subject|0|||
125151765|NCT01682148|450179528|FG000|Overall Study|Lost to Follow-up|1|||
125151766|NCT01682148|450179529|FG001|Overall Study|Lost to Follow-up|2|||
125151767|NCT01682148|450179528|FG000|Overall Study|Protocol Violation|1|||
125151768|NCT01682148|450179529|FG001|Overall Study|Protocol Violation|1|||
125151769|NCT00775528|450179530|FG000|Overall Study|Protocol Violation|1|||
125151770|NCT02087176|450179531|FG000|Overall Study|Withdrawal by Subject|1|||
125438697|NCT00669903|451233926|FG003|Overall Study|Protocol Violation|0|||
125151771|NCT02087176|450179531|FG000|Overall Study|Death|10|||
125223835|NCT02782741|450446238|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
125223836|NCT02782741|450446239|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
125223837|NCT02782741|450446237|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
125223838|NCT02782741|450446238|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
125438698|NCT01827254|451233929|FG000|Overall Study|Death|10|||
125438699|NCT01827254|451233929|FG000|Overall Study|Case report form not completed|4|||
125151772|NCT02087176|450179531|FG000|Overall Study|Censored|19|||
125151773|NCT02087176|450179531|FG000|Overall Study|Study Terminated by Sponsor|2|||
125151774|NCT03648879|450179532|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
125151775|NCT03812991|450179535|FG000|Overall Study|Lost to Follow-up|3|||
125151776|NCT03812991|450179536|FG001|Overall Study|Lost to Follow-up|1|||
125151777|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
125151778|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
125223839|NCT02782741|450446239|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
125223840|NCT02782741|450446237|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
125223841|NCT02782741|450446238|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
125223842|NCT02782741|450446239|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
125438700|NCT01827254|451233929|FG000|Overall Study|Invalidated centre|3|||
125151779|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
125151780|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
125151781|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
125151782|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
125151783|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
125151784|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
125151785|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
125151786|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
125151787|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
125151788|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
125151789|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
125151790|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
125151791|NCT04740931|450179537|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
125151792|NCT04740931|450179538|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
125151793|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
125151794|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
125151795|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
125151796|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
125151797|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
125151798|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
125151799|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
125151800|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
125151801|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
125151802|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
125151803|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
125151804|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
125151805|NCT04740931|450179537|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
125151806|NCT04740931|450179538|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
125151807|NCT00895037|450179539|FG000|Overall Study|Death|0|||
125151808|NCT00895037|450179540|FG001|Overall Study|Death|2|||
125151809|NCT00895037|450179541|FG002|Overall Study|Death|1|||
125151810|NCT01029392|450179547|FG000|Overall Study|Withdrawal by Subject|18|||
125151811|NCT01029392|450179548|FG001|Overall Study|Withdrawal by Subject|11|||
125151812|NCT01029392|450179547|FG000|Overall Study|Physician Decision|2|||
125151813|NCT01029392|450179548|FG001|Overall Study|Physician Decision|0|||
125151814|NCT01103479|450179549|FG000|Overall Study|Up to date with CRC screening|1|||
125151815|NCT01103479|450179550|FG001|Overall Study|Up to date with CRC screening|9|||
125151816|NCT01103479|450179551|FG002|Overall Study|Up to date with CRC screening|12|||
125151817|NCT01103479|450179549|FG000|Overall Study|Family history of CRC|1|||
125151818|NCT01103479|450179550|FG001|Overall Study|Family history of CRC|0|||
125151819|NCT01103479|450179551|FG002|Overall Study|Family history of CRC|2|||
125151820|NCT01103479|450179549|FG000|Overall Study|Active cancer|1|||
125151821|NCT01103479|450179550|FG001|Overall Study|Active cancer|0|||
125151822|NCT01103479|450179551|FG002|Overall Study|Active cancer|0|||
125151823|NCT01103479|450179549|FG000|Overall Study|Saw non-study physician|2|||
125151824|NCT01103479|450179550|FG001|Overall Study|Saw non-study physician|0|||
125151825|NCT01103479|450179551|FG002|Overall Study|Saw non-study physician|0|||
125151826|NCT01534637|450179552|FG000|Overall Study|Physician Decision|3|||
125151827|NCT01534637|450179552|FG000|Overall Study|Lack of Efficacy|3|||
125151828|NCT01534637|450179552|FG000|Overall Study|Withdrawal by Subject|1|||
125151829|NCT01534637|450179552|FG000|Overall Study|Adverse Event|1|||
125151830|NCT01534637|450179552|FG000|Overall Study|Liver Mets before treatment|1|||
125151831|NCT00605917|450179553|FG000|Overall Study|Protocol Violation|79|||
125151832|NCT00890552|450179554|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
125151833|NCT00890552|450179554|FG000|On-treatment|Early prog disease/ death|10|||
125151834|NCT00724373|450179555|FG000|Overall Study|Adverse Event|41|||
125151835|NCT00724373|450179555|FG000|Overall Study|Lack of Efficacy|82|||
125151836|NCT00724373|450179555|FG000|Overall Study|Lost to Follow-up|7|||
125151837|NCT00724373|450179555|FG000|Overall Study|Non-compliance|2|||
125151838|NCT00724373|450179555|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
125151839|NCT00724373|450179555|FG000|Overall Study|Participant moved away|1|||
125151840|NCT00724373|450179555|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
125151841|NCT00724373|450179555|FG000|Overall Study|Only to have 24 week regimen|1|||
125151842|NCT00724373|450179555|FG000|Overall Study|Viral Relapse|1|||
125151843|NCT00724373|450179555|FG000|Overall Study|Acute HCV infection|1|||
125151844|NCT00724373|450179555|FG000|Overall Study|Drug Relapse|1|||
125151845|NCT00724373|450179555|FG000|Overall Study|Tolerability|23|||
125151846|NCT02549573|450179556|FG000|Overall Study|Withdrawal by Subject|0|||
125151847|NCT02549573|450179557|FG001|Overall Study|Withdrawal by Subject|2|||
125388508|NCT02608268|451056602|FG010|Overall Study|Subject/guardian decision|0|||
125388509|NCT02608268|451056603|FG011|Overall Study|Subject/guardian decision|1|||
125388510|NCT02608268|451056604|FG012|Overall Study|Subject/guardian decision|0|||
125388511|NCT02608268|451056605|FG013|Overall Study|Subject/guardian decision|1|||
125388512|NCT02608268|451056606|FG014|Overall Study|Subject/guardian decision|0|||
125388513|NCT02608268|451056607|FG015|Overall Study|Subject/guardian decision|1|||
125388514|NCT02608268|451056608|FG016|Overall Study|Subject/guardian decision|0|||
125388515|NCT02608268|451056609|FG017|Overall Study|Subject/guardian decision|0|||
125151848|NCT02549573|450179556|FG000|Overall Study|Protocol Violation|0|||
125151849|NCT02549573|450179557|FG001|Overall Study|Protocol Violation|1|||
125151850|NCT03043560|450179560|FG000|Overall Study|Discontinued Intervention|1|||
125151851|NCT03043560|450179561|FG001|Overall Study|Discontinued Intervention|2|||
125151852|NCT03043560|450179560|FG000|Overall Study|Lost to Follow-up|0|||
125151853|NCT03043560|450179561|FG001|Overall Study|Lost to Follow-up|1|||
125151854|NCT00440115|450179562|FG000|Overall Study|Death|7|||
125151855|NCT00440115|450179563|FG001|Overall Study|Death|9|||
125151856|NCT00440115|450179564|FG002|Overall Study|Death|5|||
125151857|NCT00440115|450179562|FG000|Overall Study|Incarceration|0|||
125151858|NCT00440115|450179563|FG001|Overall Study|Incarceration|2|||
125151859|NCT00440115|450179564|FG002|Overall Study|Incarceration|1|||
125151860|NCT00206102|450179566|FG000|Overall Study|Adverse Event|119|||
125151861|NCT00206102|450179567|FG001|Overall Study|Adverse Event|82|||
125151862|NCT00206102|450179566|FG000|Overall Study|Protocol Violation|0|||
125151863|NCT00206102|450179567|FG001|Overall Study|Protocol Violation|2|||
125151864|NCT00206102|450179566|FG000|Overall Study|Lack of therapeutic response|16|||
125151865|NCT00206102|450179567|FG001|Overall Study|Lack of therapeutic response|11|||
125151866|NCT00206102|450179566|FG000|Overall Study|Lost to Follow-up|95|||
125151867|NCT00206102|450179567|FG001|Overall Study|Lost to Follow-up|66|||
125151868|NCT00206102|450179566|FG000|Overall Study|Withdrawal by Subject|118|||
125151869|NCT00206102|450179567|FG001|Overall Study|Withdrawal by Subject|101|||
125151870|NCT00206102|450179566|FG000|Overall Study|Study-specific discontinuation criteria|18|||
125151871|NCT00206102|450179567|FG001|Overall Study|Study-specific discontinuation criteria|17|||
125151872|NCT00206102|450179566|FG000|Overall Study|None of those categories|42|||
125151873|NCT00206102|450179567|FG001|Overall Study|None of those categories|36|||
125151874|NCT03123783|450179568|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
125151875|NCT03123783|450179569|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
125151876|NCT03123783|450179570|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
125151877|NCT03123783|450179571|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
125151878|NCT03123783|450179572|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
125151879|NCT03123783|450179573|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
125151880|NCT03123783|450179574|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
125151881|NCT03123783|450179568|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
125151882|NCT03123783|450179569|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
125388516|NCT02608268|451056610|FG018|Overall Study|Subject/guardian decision|1|||
125388517|NCT02608268|451056611|FG019|Overall Study|Subject/guardian decision|0|||
125388518|NCT02608268|451056612|FG020|Overall Study|Subject/guardian decision|0|||
125151883|NCT03123783|450179570|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
125151884|NCT03123783|450179571|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
125151885|NCT03123783|450179572|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
125151886|NCT03123783|450179573|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
125151887|NCT03123783|450179574|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
125151888|NCT03123783|450179568|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
125151889|NCT03123783|450179569|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
125151890|NCT03123783|450179570|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
125151891|NCT03123783|450179571|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
125151892|NCT03123783|450179572|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
125151893|NCT03123783|450179573|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
125151894|NCT03123783|450179574|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
125151895|NCT03123783|450179568|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
125151896|NCT03123783|450179569|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
125151897|NCT03123783|450179570|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
125151898|NCT03123783|450179571|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
125388519|NCT02608268|451056613|FG021|Overall Study|Subject/guardian decision|0|||
125388520|NCT02608268|451056614|FG022|Overall Study|Subject/guardian decision|1|||
125388521|NCT02608268|451056615|FG023|Overall Study|Subject/guardian decision|0|||
125151899|NCT03123783|450179572|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
125388522|NCT02608268|451056616|FG024|Overall Study|Subject/guardian decision|0|||
125388523|NCT02608268|451056617|FG025|Overall Study|Subject/guardian decision|1|||
125388524|NCT02608268|451056618|FG026|Overall Study|Subject/guardian decision|1|||
125388525|NCT02608268|451056619|FG027|Overall Study|Subject/guardian decision|1|||
125388526|NCT02608268|451056620|FG028|Overall Study|Subject/guardian decision|1|||
125151900|NCT03123783|450179573|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
125151901|NCT03123783|450179574|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
125151902|NCT02953678|450179577|FG000|Overall Study|Adverse Event|20|||
125151903|NCT02953678|450179577|FG000|Overall Study|Death|7|||
125151904|NCT02953678|450179577|FG000|Overall Study|Physician Decision|23|||
125151905|NCT02953678|450179577|FG000|Overall Study|Progressive Disease of GVHD|7|||
125151906|NCT02953678|450179577|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
125151907|NCT02953678|450179577|FG000|Overall Study|Withdrawal by participant|3|||
125151908|NCT02953678|450179577|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
125151909|NCT02953678|450179577|FG000|Overall Study|Participants were transferred to commercial product.|3|||
125151910|NCT01730040|450181083|FG000|Overall Study|Randomized but not treated|0|||
125151911|NCT01730040|450181084|FG001|Overall Study|Randomized but not treated|0|||
125151912|NCT01730040|450181085|FG002|Overall Study|Randomized but not treated|0|||
125151913|NCT01730040|450181086|FG003|Overall Study|Randomized but not treated|0|||
125151914|NCT01730040|450181087|FG004|Overall Study|Randomized but not treated|0|||
125151915|NCT01730040|450181088|FG005|Overall Study|Randomized but not treated|1|||
125151916|NCT01730040|450181089|FG006|Overall Study|Randomized but not treated|0|||
125151917|NCT01730040|450181083|FG000|Overall Study|Subject moved|0|||
125151918|NCT01730040|450181084|FG001|Overall Study|Subject moved|0|||
125151919|NCT01730040|450181085|FG002|Overall Study|Subject moved|1|||
125151920|NCT01730040|450181086|FG003|Overall Study|Subject moved|0|||
125151921|NCT01730040|450181087|FG004|Overall Study|Subject moved|0|||
125151922|NCT01730040|450181088|FG005|Overall Study|Subject moved|0|||
125151923|NCT01730040|450181089|FG006|Overall Study|Subject moved|1|||
125151924|NCT01730040|450181083|FG000|Overall Study|Physician Decision|0|||
125151925|NCT01730040|450181084|FG001|Overall Study|Physician Decision|0|||
125151926|NCT01730040|450181085|FG002|Overall Study|Physician Decision|0|||
125388527|NCT02608268|451056621|FG029|Overall Study|Subject/guardian decision|0|||
125388528|NCT01012622|451056622|FG000|Overall Study|Withdrawal by Subject|6|||
125388529|NCT01012622|451056622|FG000|Overall Study|Lost to Follow-up|5|||
125388530|NCT01012622|451056622|FG000|Overall Study|Adverse Event|7|||
125388531|NCT01012622|451056622|FG000|Overall Study|non-compliance with the drug|9|||
125388532|NCT01012622|451056622|FG000|Overall Study|Other|1|||
125388533|NCT01012622|451056622|FG000|Overall Study|screening failure|1|||
125388534|NCT01012622|451056622|FG000|Overall Study|withdrawal of consent by a parent|2|||
125388535|NCT01063764|451056626|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
125388536|NCT01063764|451056626|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
125388537|NCT01063764|451056626|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
125388538|NCT01063764|451056626|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
125388539|NCT01063764|451056626|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
125388540|NCT01063764|451056626|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
125388541|NCT01063764|451056626|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
125388542|NCT00697515|451056629|FG000|Dose Optimization Period|Adverse Event|4|||
125388543|NCT00697515|451056630|FG001|Dose Optimization Period|Adverse Event|0|||
125388544|NCT00697515|451056629|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
125388545|NCT00697515|451056630|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
125388546|NCT00697515|451056629|FG000|Dose Optimization Period|Lost to Follow-up|2|||
125388547|NCT00697515|451056630|FG001|Dose Optimization Period|Lost to Follow-up|0|||
125388548|NCT00697515|451056629|FG000|Dose Optimization Period|sponsor request|2|||
125388549|NCT00697515|451056630|FG001|Dose Optimization Period|sponsor request|0|||
125388550|NCT00697515|451056629|FG000|Dose Optimization Period|called to active duty|1|||
125388551|NCT00697515|451056630|FG001|Dose Optimization Period|called to active duty|0|||
125388552|NCT00697515|451056629|FG000|Dose Optimization Period|elevated QTc|1|||
125388553|NCT00697515|451056630|FG001|Dose Optimization Period|elevated QTc|0|||
125388554|NCT00697515|451056629|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
125388555|NCT00697515|451056630|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
125388556|NCT00697515|451056629|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
125151927|NCT01730040|450181086|FG003|Overall Study|Physician Decision|0|||
125151928|NCT01730040|450181087|FG004|Overall Study|Physician Decision|0|||
125151929|NCT01730040|450181088|FG005|Overall Study|Physician Decision|1|||
125151930|NCT01730040|450181089|FG006|Overall Study|Physician Decision|1|||
125388557|NCT00697515|451056630|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
125151931|NCT01730040|450181083|FG000|Overall Study|Other than specified|7|||
125151932|NCT01730040|450181084|FG001|Overall Study|Other than specified|8|||
125151933|NCT01730040|450181085|FG002|Overall Study|Other than specified|5|||
125388558|NCT00697515|451056629|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
125151934|NCT01730040|450181086|FG003|Overall Study|Other than specified|5|||
125151935|NCT01730040|450181087|FG004|Overall Study|Other than specified|5|||
125151936|NCT01730040|450181088|FG005|Overall Study|Other than specified|4|||
125151937|NCT01730040|450181089|FG006|Overall Study|Other than specified|4|||
125151938|NCT01730040|450181083|FG000|Overall Study|Adverse Event|4|||
125151939|NCT01730040|450181084|FG001|Overall Study|Adverse Event|3|||
125151940|NCT01730040|450181085|FG002|Overall Study|Adverse Event|5|||
125151941|NCT01730040|450181086|FG003|Overall Study|Adverse Event|3|||
125151942|NCT01730040|450181087|FG004|Overall Study|Adverse Event|1|||
125151943|NCT01730040|450181088|FG005|Overall Study|Adverse Event|1|||
125151944|NCT01730040|450181089|FG006|Overall Study|Adverse Event|2|||
125151945|NCT01730040|450181083|FG000|Overall Study|Poor compliance to protocol|2|||
125151946|NCT01730040|450181084|FG001|Overall Study|Poor compliance to protocol|4|||
125151947|NCT01730040|450181085|FG002|Overall Study|Poor compliance to protocol|0|||
125388559|NCT00697515|451056630|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
125388560|NCT00697515|451056629|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
125388561|NCT00697515|451056630|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
125388562|NCT02603432|451056631|FG000|Overall Study|Adverse Event|1|||
125388563|NCT02603432|451056632|FG001|Overall Study|Adverse Event|0|||
125388564|NCT02603432|451056631|FG000|Overall Study|Death|221|||
125388565|NCT02603432|451056632|FG001|Overall Study|Death|242|||
125388566|NCT02603432|451056631|FG000|Overall Study|Lost to Follow-up|3|||
125388567|NCT02603432|451056632|FG001|Overall Study|Lost to Follow-up|9|||
125388568|NCT02603432|451056631|FG000|Overall Study|Progressive Disease|7|||
125388569|NCT02603432|451056632|FG001|Overall Study|Progressive Disease|5|||
125388570|NCT02603432|451056631|FG000|Overall Study|Withdrawal by Subject|12|||
125388571|NCT02603432|451056632|FG001|Overall Study|Withdrawal by Subject|18|||
125388572|NCT02603432|451056631|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
125388573|NCT02603432|451056632|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125388574|NCT02603432|451056631|FG000|Overall Study|Study terminated by sponsor|74|||
125388575|NCT02603432|451056632|FG001|Overall Study|Study terminated by sponsor|75|||
125388576|NCT02603432|451056631|FG000|Overall Study|Other|13|||
125388577|NCT02603432|451056632|FG001|Overall Study|Other|0|||
125151948|NCT01730040|450181086|FG003|Overall Study|Poor compliance to protocol|0|||
125151949|NCT01730040|450181087|FG004|Overall Study|Poor compliance to protocol|0|||
125151950|NCT01730040|450181088|FG005|Overall Study|Poor compliance to protocol|0|||
125151951|NCT01730040|450181089|FG006|Overall Study|Poor compliance to protocol|1|||
125151952|NCT01042535|450181090|FG000|Overall Study|disease progression prior to treatment|3|||
125151953|NCT01042535|450181090|FG000|Overall Study|disease progression during treatment|3|||
125151954|NCT01042535|450181090|FG000|Overall Study|complications from other disease|2|||
125151955|NCT01546142|450181091|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
125151956|NCT01546142|450181092|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
125151957|NCT01546142|450181091|FG000|Overall Study|Subject Noncompliance|1|||
125151958|NCT01546142|450181092|FG001|Overall Study|Subject Noncompliance|1|||
125151959|NCT01546142|450181091|FG000|Overall Study|Adverse Event|6|||
125151960|NCT01546142|450181092|FG001|Overall Study|Adverse Event|3|||
125151961|NCT01546142|450181091|FG000|Overall Study|Lost to Follow-up|20|||
125151962|NCT01546142|450181092|FG001|Overall Study|Lost to Follow-up|15|||
125151963|NCT01546142|450181091|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
125151964|NCT01546142|450181092|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
125151965|NCT01546142|450181091|FG000|Overall Study|Subject Randomized but Not Treated|1|||
125151966|NCT01546142|450181092|FG001|Overall Study|Subject Randomized but Not Treated|0|||
125151967|NCT01213836|450181095|FG000|Period 1, First Intervention|Adverse Event|2|||
125151968|NCT01213836|450181096|FG001|Period 1, First Intervention|Adverse Event|1|||
125151969|NCT01213836|450181095|FG000|Period 1, First Intervention|Protocol Violation|0|||
125151970|NCT01213836|450181096|FG001|Period 1, First Intervention|Protocol Violation|1|||
125151971|NCT01213836|450181095|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
125151972|NCT01213836|450181096|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
125151973|NCT00255151|450181097|FG000|Overall Study|Adverse Event|10|||
125151974|NCT00255151|450181098|FG001|Overall Study|Adverse Event|6|||
125151975|NCT00255151|450181099|FG002|Overall Study|Adverse Event|9|||
125151976|NCT00255151|450181097|FG000|Overall Study|Lost to Follow-up|4|||
125151977|NCT00255151|450181098|FG001|Overall Study|Lost to Follow-up|3|||
125151978|NCT00255151|450181099|FG002|Overall Study|Lost to Follow-up|4|||
125151979|NCT00255151|450181097|FG000|Overall Study|Withdrawal by Subject|18|||
125151980|NCT00255151|450181098|FG001|Overall Study|Withdrawal by Subject|17|||
125151981|NCT00255151|450181099|FG002|Overall Study|Withdrawal by Subject|8|||
125151982|NCT00255151|450181097|FG000|Overall Study|Noncompliance|0|||
125151983|NCT00255151|450181098|FG001|Overall Study|Noncompliance|1|||
125151984|NCT00255151|450181099|FG002|Overall Study|Noncompliance|2|||
125151985|NCT00255151|450181097|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
125151986|NCT00255151|450181098|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
125151987|NCT00255151|450181099|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
125151988|NCT00255151|450181097|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
125151989|NCT00255151|450181098|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
125151990|NCT00255151|450181099|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
125151991|NCT00255151|450181097|FG000|Overall Study|Possible Barrett's Esophagus|1|||
125151992|NCT00255151|450181098|FG001|Overall Study|Possible Barrett's Esophagus|3|||
125388578|NCT01957462|451056633|FG000|Test Period 1|Withdrawal by Subject|1|||
125388579|NCT01957462|451056634|FG001|Test Period 1|Withdrawal by Subject|0|||
125388580|NCT01957462|451056633|FG000|Test Period 1|Adverse Event|1|||
125388581|NCT01957462|451056634|FG001|Test Period 1|Adverse Event|0|||
125151993|NCT00255151|450181099|FG002|Overall Study|Possible Barrett's Esophagus|8|||
125151994|NCT00255151|450181097|FG000|Overall Study|Esophageal Stricture|0|||
125151995|NCT00255151|450181098|FG001|Overall Study|Esophageal Stricture|0|||
125151996|NCT00255151|450181099|FG002|Overall Study|Esophageal Stricture|1|||
125151997|NCT00255151|450181097|FG000|Overall Study|Therapeutic Failure|11|||
125151998|NCT00255151|450181098|FG001|Overall Study|Therapeutic Failure|2|||
125151999|NCT00255151|450181099|FG002|Overall Study|Therapeutic Failure|3|||
125152000|NCT00107042|450181100|FG000|Overall Study|Lost to Follow-up|9|||
125388582|NCT05954052|451056635|FG000|Overall Study|Adverse Event|1|||
125388583|NCT01124604|451056636|FG000|Overall Study|Adverse Event|10|||
125388584|NCT01124604|451056637|FG001|Overall Study|Adverse Event|1|||
125388585|NCT01124604|451056636|FG000|Overall Study|Lack of Efficacy|1|||
125388586|NCT01124604|451056637|FG001|Overall Study|Lack of Efficacy|0|||
125388587|NCT01124604|451056636|FG000|Overall Study|Withdrawal by Subject|4|||
125388588|NCT01124604|451056637|FG001|Overall Study|Withdrawal by Subject|0|||
125388589|NCT01124604|451056636|FG000|Overall Study|Disease Progression|0|||
125388590|NCT01124604|451056637|FG001|Overall Study|Disease Progression|1|||
125388591|NCT01856790|451056638|FG000|Closed Loop Control|Withdrawal by Subject|2|||
125388592|NCT01856790|451056638|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
125152001|NCT00107042|450181101|FG001|Overall Study|Lost to Follow-up|7|||
125152002|NCT00107042|450181100|FG000|Overall Study|Withdrawal by Subject|6|||
125152003|NCT00107042|450181101|FG001|Overall Study|Withdrawal by Subject|1|||
125152004|NCT00107042|450181100|FG000|Overall Study|Moved out of area|5|||
125152005|NCT00107042|450181101|FG001|Overall Study|Moved out of area|3|||
125152006|NCT00107042|450181100|FG000|Overall Study|Pregnancy|1|||
125152007|NCT00107042|450181101|FG001|Overall Study|Pregnancy|1|||
125152008|NCT00107042|450181100|FG000|Overall Study|Inadvertent enrollment|0|||
125388593|NCT04091646|451056639|FG000|Overall Study|Adverse Event|2|||
125388594|NCT04091646|451056640|FG001|Overall Study|Adverse Event|1|||
125388595|NCT04091646|451056639|FG000|Overall Study|Lost to Follow-up|6|||
125388596|NCT04091646|451056640|FG001|Overall Study|Lost to Follow-up|2|||
125388597|NCT04091646|451056639|FG000|Overall Study|Protocol Violation|0|||
125388598|NCT04091646|451056640|FG001|Overall Study|Protocol Violation|1|||
125388599|NCT04091646|451056639|FG000|Overall Study|Withdrawal by Subject|4|||
125388600|NCT04091646|451056640|FG001|Overall Study|Withdrawal by Subject|1|||
125388601|NCT04091646|451056639|FG000|Overall Study|Participant Incarcerated|1|||
125388602|NCT04091646|451056640|FG001|Overall Study|Participant Incarcerated|0|||
125388603|NCT03102918|451056641|FG000|Overall Study|Protocol Violation|1|||
125388604|NCT03102918|451056642|FG001|Overall Study|Protocol Violation|0|||
125388605|NCT01316276|451056645|FG000|Overall Study|Death|1|||
125388606|NCT01316276|451056645|FG000|Overall Study|Adverse Event|19|||
125388607|NCT01316276|451056645|FG000|Overall Study|Withdrawal of consent|24|||
125388608|NCT01316276|451056645|FG000|Overall Study|Lost to Follow-up|1|||
125388609|NCT01316276|451056645|FG000|Overall Study|Other|22|||
125388610|NCT00605475|451056646|FG000|Overall Study|Abnormal Laboratory Values|0|||
125388611|NCT00605475|451056647|FG001|Overall Study|Abnormal Laboratory Values|0|||
125388612|NCT00605475|451056648|FG002|Overall Study|Abnormal Laboratory Values|0|||
125388613|NCT00605475|451056649|FG003|Overall Study|Abnormal Laboratory Values|0|||
125388614|NCT00605475|451056650|FG004|Overall Study|Abnormal Laboratory Values|0|||
125388615|NCT00605475|451056651|FG005|Overall Study|Abnormal Laboratory Values|0|||
125388616|NCT00605475|451056652|FG006|Overall Study|Abnormal Laboratory Values|0|||
125388617|NCT00605475|451056653|FG007|Overall Study|Abnormal Laboratory Values|0|||
125388618|NCT00605475|451056654|FG008|Overall Study|Abnormal Laboratory Values|1|||
125152009|NCT00107042|450181101|FG001|Overall Study|Inadvertent enrollment|1|||
125152010|NCT00107042|450181100|FG000|Overall Study|vaccinated outside window|1|||
125152011|NCT00107042|450181101|FG001|Overall Study|vaccinated outside window|1|||
125152012|NCT00107042|450181100|FG000|Overall Study|Disallowed medications|0|||
125152013|NCT00107042|450181101|FG001|Overall Study|Disallowed medications|2|||
125152014|NCT01286558|450181104|FG000|Overall Study|Adverse Event|1|||
125152015|NCT01286558|450181105|FG001|Overall Study|Adverse Event|1|||
125152016|NCT01286558|450181104|FG000|Overall Study|Withdrawal by Subject|0|||
125388619|NCT00605475|451056655|FG009|Overall Study|Abnormal Laboratory Values|0|||
125388620|NCT00605475|451056646|FG000|Overall Study|Administrative problems|0|||
125388621|NCT00605475|451056647|FG001|Overall Study|Administrative problems|0|||
125388622|NCT00605475|451056648|FG002|Overall Study|Administrative problems|0|||
125388623|NCT00605475|451056649|FG003|Overall Study|Administrative problems|0|||
125388624|NCT00605475|451056650|FG004|Overall Study|Administrative problems|0|||
125388625|NCT00605475|451056651|FG005|Overall Study|Administrative problems|0|||
125152017|NCT01286558|450181105|FG001|Overall Study|Withdrawal by Subject|1|||
125152018|NCT04109313|450181111|FG000|Overall Study|Pregnancy|1|||
125388626|NCT00605475|451056652|FG006|Overall Study|Administrative problems|1|||
125388627|NCT00605475|451056653|FG007|Overall Study|Administrative problems|0|||
125388628|NCT00605475|451056654|FG008|Overall Study|Administrative problems|0|||
125388629|NCT00605475|451056655|FG009|Overall Study|Administrative problems|0|||
125388630|NCT00605475|451056646|FG000|Overall Study|Lost to Follow-up|0|||
125152019|NCT04109313|450181111|FG000|Overall Study|Adverse Event|11|||
125152020|NCT04109313|450181111|FG000|Overall Study|Lack of Efficacy|11|||
125152021|NCT04109313|450181111|FG000|Overall Study|Lost to Follow-up|1|||
125152022|NCT04109313|450181111|FG000|Overall Study|Physician Decision|2|||
125152023|NCT04109313|450181111|FG000|Overall Study|Subject Decision|13|||
125152024|NCT04109313|450181111|FG000|Overall Study|Covid-19 situation|2|||
125152025|NCT00655850|450181114|FG000|Overall Study|Death|2|||
125152026|NCT00655850|450181114|FG000|Overall Study|Withdrawal by Subject|1|||
125152027|NCT03702049|450181115|FG000|Overall Study|Lost to Follow-up|4|||
125152028|NCT03702049|450181115|FG000|Overall Study|Physician Decision|1|||
125152029|NCT00573170|450181116|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
125152030|NCT00573170|450181117|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
125152031|NCT00573170|450181118|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
125152032|NCT00573170|450181119|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
125152033|NCT00573170|450181120|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
125152034|NCT00573170|450181121|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
125152035|NCT00573170|450181116|FG000|First Washout Period|Adverse Event|1|||
125152036|NCT00573170|450181117|FG001|First Washout Period|Adverse Event|1|||
125152037|NCT00573170|450181118|FG002|First Washout Period|Adverse Event|0|||
125152038|NCT00573170|450181119|FG003|First Washout Period|Adverse Event|0|||
125152039|NCT00573170|450181120|FG004|First Washout Period|Adverse Event|0|||
125152040|NCT00573170|450181121|FG005|First Washout Period|Adverse Event|1|||
125152041|NCT00573170|450181116|FG000|First Washout Period|Lack of Efficacy|0|||
125152042|NCT00573170|450181117|FG001|First Washout Period|Lack of Efficacy|0|||
125152043|NCT00573170|450181118|FG002|First Washout Period|Lack of Efficacy|0|||
125152044|NCT00573170|450181119|FG003|First Washout Period|Lack of Efficacy|0|||
125152045|NCT00573170|450181120|FG004|First Washout Period|Lack of Efficacy|0|||
125152046|NCT00573170|450181121|FG005|First Washout Period|Lack of Efficacy|1|||
125152047|NCT00573170|450181116|FG000|First Washout Period|Lost to Follow-up|1|||
125152048|NCT00573170|450181117|FG001|First Washout Period|Lost to Follow-up|1|||
125152049|NCT00573170|450181118|FG002|First Washout Period|Lost to Follow-up|0|||
125152050|NCT00573170|450181119|FG003|First Washout Period|Lost to Follow-up|2|||
125152051|NCT00573170|450181120|FG004|First Washout Period|Lost to Follow-up|0|||
125152052|NCT00573170|450181121|FG005|First Washout Period|Lost to Follow-up|2|||
125152053|NCT00573170|450181116|FG000|First Washout Period|Withdrawal by Subject|2|||
125152054|NCT00573170|450181117|FG001|First Washout Period|Withdrawal by Subject|0|||
125152055|NCT00573170|450181118|FG002|First Washout Period|Withdrawal by Subject|0|||
125152056|NCT00573170|450181119|FG003|First Washout Period|Withdrawal by Subject|2|||
125152057|NCT00573170|450181120|FG004|First Washout Period|Withdrawal by Subject|3|||
125152058|NCT00573170|450181121|FG005|First Washout Period|Withdrawal by Subject|3|||
125152059|NCT00573170|450181116|FG000|First Washout Period|Other|4|||
125152060|NCT00573170|450181117|FG001|First Washout Period|Other|0|||
125152061|NCT00573170|450181118|FG002|First Washout Period|Other|1|||
125152062|NCT00573170|450181119|FG003|First Washout Period|Other|1|||
125152063|NCT00573170|450181120|FG004|First Washout Period|Other|0|||
125152064|NCT00573170|450181121|FG005|First Washout Period|Other|0|||
125152065|NCT00573170|450181116|FG000|Second Washout Period|Adverse Event|1|||
125152066|NCT00573170|450181117|FG001|Second Washout Period|Adverse Event|0|||
125152067|NCT00573170|450181118|FG002|Second Washout Period|Adverse Event|0|||
125152068|NCT00573170|450181119|FG003|Second Washout Period|Adverse Event|0|||
125152069|NCT00573170|450181120|FG004|Second Washout Period|Adverse Event|1|||
125152070|NCT00573170|450181121|FG005|Second Washout Period|Adverse Event|0|||
125152071|NCT00573170|450181116|FG000|Second Washout Period|Protocol Violation|2|||
125152072|NCT00573170|450181117|FG001|Second Washout Period|Protocol Violation|1|||
125152073|NCT00573170|450181118|FG002|Second Washout Period|Protocol Violation|1|||
125152074|NCT00573170|450181119|FG003|Second Washout Period|Protocol Violation|0|||
125152075|NCT00573170|450181120|FG004|Second Washout Period|Protocol Violation|0|||
125152076|NCT00573170|450181121|FG005|Second Washout Period|Protocol Violation|0|||
125152077|NCT00573170|450181116|FG000|Second Washout Period|Withdrawal by Subject|1|||
125152078|NCT00573170|450181117|FG001|Second Washout Period|Withdrawal by Subject|1|||
125152079|NCT00573170|450181118|FG002|Second Washout Period|Withdrawal by Subject|2|||
125152080|NCT00573170|450181119|FG003|Second Washout Period|Withdrawal by Subject|0|||
125152081|NCT00573170|450181120|FG004|Second Washout Period|Withdrawal by Subject|1|||
125152082|NCT00573170|450181121|FG005|Second Washout Period|Withdrawal by Subject|0|||
125152083|NCT00573170|450181116|FG000|Second Washout Period|Lost to Follow-up|0|||
125152084|NCT00573170|450181117|FG001|Second Washout Period|Lost to Follow-up|0|||
125152085|NCT00573170|450181118|FG002|Second Washout Period|Lost to Follow-up|0|||
125152086|NCT00573170|450181119|FG003|Second Washout Period|Lost to Follow-up|1|||
125152087|NCT00573170|450181120|FG004|Second Washout Period|Lost to Follow-up|0|||
125152088|NCT00573170|450181121|FG005|Second Washout Period|Lost to Follow-up|0|||
125152089|NCT00573170|450181116|FG000|Second Washout Period|Other|1|||
125152090|NCT00573170|450181117|FG001|Second Washout Period|Other|2|||
125152091|NCT00573170|450181118|FG002|Second Washout Period|Other|1|||
125152092|NCT00573170|450181119|FG003|Second Washout Period|Other|4|||
125152093|NCT00573170|450181120|FG004|Second Washout Period|Other|6|||
125152094|NCT00573170|450181121|FG005|Second Washout Period|Other|2|||
125152095|NCT00573170|450181116|FG000|Third Treatment Period|Withdrawal by Subject|1|||
125152096|NCT00573170|450181117|FG001|Third Treatment Period|Withdrawal by Subject|0|||
125152097|NCT00573170|450181118|FG002|Third Treatment Period|Withdrawal by Subject|0|||
125152098|NCT00573170|450181119|FG003|Third Treatment Period|Withdrawal by Subject|0|||
125152099|NCT00573170|450181120|FG004|Third Treatment Period|Withdrawal by Subject|0|||
125152100|NCT00573170|450181121|FG005|Third Treatment Period|Withdrawal by Subject|0|||
125152101|NCT00573170|450181116|FG000|Third Treatment Period|Lost to Follow-up|0|||
125152102|NCT00573170|450181117|FG001|Third Treatment Period|Lost to Follow-up|0|||
125152103|NCT00573170|450181118|FG002|Third Treatment Period|Lost to Follow-up|0|||
125152104|NCT00573170|450181119|FG003|Third Treatment Period|Lost to Follow-up|0|||
125152105|NCT00573170|450181120|FG004|Third Treatment Period|Lost to Follow-up|0|||
125152106|NCT00573170|450181121|FG005|Third Treatment Period|Lost to Follow-up|2|||
125152107|NCT00986570|450181122|FG000|Overall Study|Lost to Follow-up|6|||
125152108|NCT00986570|450181122|FG000|Overall Study|Potential bias for objective assessment|1|||
125152109|NCT00608517|450181124|FG000|Overall Study|Death|1|||
125152110|NCT00608517|450181125|FG001|Overall Study|Death|0|||
125152111|NCT00608517|450181126|FG002|Overall Study|Death|0|||
125152112|NCT01833533|450181128|FG000|Overall Study|Adverse Event|0|||
125152113|NCT01833533|450181129|FG001|Overall Study|Adverse Event|1|||
125152114|NCT01833533|450181128|FG000|Overall Study|Lost to Follow-up|4|||
125152115|NCT01833533|450181129|FG001|Overall Study|Lost to Follow-up|9|||
125152116|NCT01833533|450181128|FG000|Overall Study|To Enter an Extension Study|0|||
125152117|NCT01833533|450181129|FG001|Overall Study|To Enter an Extension Study|4|||
125152118|NCT01833533|450181128|FG000|Overall Study|Other|2|||
125152119|NCT01833533|450181129|FG001|Overall Study|Other|7|||
125152120|NCT02457611|450181131|FG000|Overall Study|Lost to Follow-up|3|||
125152121|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
125152122|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
125152123|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
125152124|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
125152125|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
125152126|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
125152127|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
125152128|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
125152129|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
125152130|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
125152131|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
125152132|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
125152133|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
125152134|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
125152135|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
125152136|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
125152137|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
125152138|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
125152139|NCT00384293|450181132|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
125152140|NCT00384293|450181133|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
125152141|NCT00384293|450181134|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
125152142|NCT00384293|450181132|FG000|Post-randomization Period|Adverse Event|0|||
125152143|NCT00384293|450181133|FG001|Post-randomization Period|Adverse Event|23|||
125152144|NCT00384293|450181134|FG002|Post-randomization Period|Adverse Event|7|||
125152145|NCT00384293|450181132|FG000|Post-randomization Period|Lost to Follow-up|0|||
125152146|NCT00384293|450181133|FG001|Post-randomization Period|Lost to Follow-up|2|||
125152147|NCT00384293|450181134|FG002|Post-randomization Period|Lost to Follow-up|1|||
125152148|NCT00384293|450181132|FG000|Post-randomization Period|Protocol Violation|0|||
125152149|NCT00384293|450181133|FG001|Post-randomization Period|Protocol Violation|1|||
125152150|NCT00384293|450181134|FG002|Post-randomization Period|Protocol Violation|0|||
125152151|NCT00384293|450181132|FG000|Post-randomization Period|Withdrawal by Subject|0|||
125152152|NCT00384293|450181133|FG001|Post-randomization Period|Withdrawal by Subject|8|||
125152153|NCT00384293|450181134|FG002|Post-randomization Period|Withdrawal by Subject|6|||
125152154|NCT00384293|450181132|FG000|Post-randomization Period|Trial Termination|0|||
125152155|NCT00384293|450181133|FG001|Post-randomization Period|Trial Termination|180|||
125152156|NCT00384293|450181134|FG002|Post-randomization Period|Trial Termination|204|||
125152157|NCT00384293|450181132|FG000|Post-randomization Period|Patient Randomized in Error|0|||
125152158|NCT00384293|450181133|FG001|Post-randomization Period|Patient Randomized in Error|0|||
125152159|NCT00384293|450181134|FG002|Post-randomization Period|Patient Randomized in Error|1|||
125152160|NCT00493454|450181135|FG000|Overall Study|Withdrawal by Subject|1|||
125152161|NCT00103038|450181136|FG000|Overall Study|Withdrawal by Subject|8|||
125152162|NCT00103038|450181136|FG000|Overall Study|Screen failure|3|||
125152163|NCT00103038|450181136|FG000|Overall Study|Death|1|||
125152164|NCT00103038|450181136|FG000|Overall Study|Physician Decision|1|||
125152165|NCT02865395|450181143|FG000|Overall Study|Physician Decision|6|||
125152166|NCT02865395|450181144|FG001|Overall Study|Physician Decision|10|||
125152167|NCT02865395|450181145|FG002|Overall Study|Physician Decision|7|||
125152168|NCT01501110|450181146|FG000|Overall Study|Death|0|||
125152169|NCT01501110|450181147|FG001|Overall Study|Death|1|||
125152170|NCT01483625|450181148|FG000|Overall Study|Adverse Event|1|||
125152171|NCT01483625|450181149|FG001|Overall Study|Adverse Event|1|||
125152172|NCT01483625|450181148|FG000|Overall Study|Refused to continue medication|2|||
125152173|NCT01483625|450181149|FG001|Overall Study|Refused to continue medication|1|||
125152174|NCT01483625|450181148|FG000|Overall Study|Due to other reason|1|||
125152175|NCT01483625|450181149|FG001|Overall Study|Due to other reason|0|||
125152176|NCT02310763|450181153|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
125152177|NCT02310763|450181154|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
125152178|NCT02310763|450181155|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
125152179|NCT02310763|450181153|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
125152180|NCT02310763|450181154|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
125152181|NCT02310763|450181155|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
125152182|NCT02310763|450181153|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
125152183|NCT02310763|450181154|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
125152184|NCT02310763|450181155|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
125152185|NCT02310763|450181153|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
125152186|NCT02310763|450181154|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
125152187|NCT02310763|450181155|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
125152188|NCT02310763|450181153|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
125152189|NCT02310763|450181154|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
125152190|NCT02310763|450181155|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
125152191|NCT04019054|450181156|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
125152192|NCT04019054|450181157|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
125152193|NCT04019054|450181156|FG000|Overall Study|Withdrawal by Subject|3|||
125152194|NCT04019054|450181157|FG001|Overall Study|Withdrawal by Subject|1|||
125152195|NCT05444543|450181158|FG000|Overall Study|Withdrawal by Subject|1|||
125152196|NCT05444543|450181159|FG001|Overall Study|Withdrawal by Subject|0|||
125152197|NCT05444543|450181158|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
125152198|NCT05444543|450181159|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
125152199|NCT05444543|450181158|FG000|Overall Study|Adverse Event|0|||
125152200|NCT05444543|450181159|FG001|Overall Study|Adverse Event|1|||
125152201|NCT05444543|450181158|FG000|Overall Study|Family relocating at a distance from study site|0|||
125152202|NCT05444543|450181159|FG001|Overall Study|Family relocating at a distance from study site|1|||
125152203|NCT01261624|450181160|FG000|Week 0 to Week 12|Disease Progression|1|||
125152204|NCT01261624|450181161|FG001|Week 0 to Week 12|Disease Progression|1|||
125152205|NCT01261624|450181160|FG000|Week 0 to Week 12|Insufficient Response|0|||
125152206|NCT01261624|450181161|FG001|Week 0 to Week 12|Insufficient Response|2|||
125152207|NCT01261624|450181160|FG000|Week 13 to Week 24|Insufficient Response|0|||
125152208|NCT01261624|450181161|FG001|Week 13 to Week 24|Insufficient Response|1|||
125152209|NCT02094261|450181164|FG000|Overall Study|Death|24|||
125152210|NCT02094261|450181164|FG000|Overall Study|Lost to Follow-up|1|||
125152211|NCT02094261|450181164|FG000|Overall Study|Withdrawal by Subject|4|||
125152212|NCT02094261|450181164|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
125152213|NCT03877926|450181167|FG000|Overall Study|Adverse Event|1|||
125152214|NCT03877926|450181168|FG001|Overall Study|Adverse Event|0|||
125152215|NCT03877926|450181169|FG002|Overall Study|Adverse Event|0|||
125152216|NCT03877926|450181170|FG003|Overall Study|Adverse Event|0|||
125152217|NCT03877926|450181167|FG000|Overall Study|Death|2|||
125152218|NCT03877926|450181168|FG001|Overall Study|Death|2|||
125152219|NCT03877926|450181169|FG002|Overall Study|Death|2|||
125152220|NCT03877926|450181170|FG003|Overall Study|Death|0|||
125152221|NCT03877926|450181167|FG000|Overall Study|Lost to Follow-up|41|||
125152222|NCT03877926|450181168|FG001|Overall Study|Lost to Follow-up|52|||
125152223|NCT03877926|450181169|FG002|Overall Study|Lost to Follow-up|45|||
125152224|NCT03877926|450181170|FG003|Overall Study|Lost to Follow-up|17|||
125152225|NCT03877926|450181167|FG000|Overall Study|Physician Decision|2|||
125152226|NCT03877926|450181168|FG001|Overall Study|Physician Decision|0|||
125152227|NCT03877926|450181169|FG002|Overall Study|Physician Decision|2|||
125152228|NCT03877926|450181170|FG003|Overall Study|Physician Decision|0|||
125152229|NCT03877926|450181167|FG000|Overall Study|Withdrawal by Subject|18|||
125152230|NCT03877926|450181168|FG001|Overall Study|Withdrawal by Subject|21|||
125152231|NCT03877926|450181169|FG002|Overall Study|Withdrawal by Subject|12|||
125152232|NCT03877926|450181170|FG003|Overall Study|Withdrawal by Subject|4|||
125152233|NCT03877926|450181167|FG000|Overall Study|Other - Various|4|||
125152234|NCT03877926|450181168|FG001|Overall Study|Other - Various|1|||
125152235|NCT03877926|450181169|FG002|Overall Study|Other - Various|1|||
125152236|NCT03877926|450181170|FG003|Overall Study|Other - Various|0|||
125152237|NCT03877926|450181167|FG000|Overall Study|Not Treated|3|||
125152238|NCT03877926|450181168|FG001|Overall Study|Not Treated|1|||
125152239|NCT03877926|450181169|FG002|Overall Study|Not Treated|1|||
125152240|NCT03877926|450181170|FG003|Overall Study|Not Treated|0|||
125152241|NCT03554317|450181171|FG000|Overall Study|Withdrawal by Subject|1|||
125152242|NCT03554317|450181171|FG000|Overall Study|PSA Progression|3|||
125152243|NCT03554317|450181171|FG000|Overall Study|Radiographic Progression|4|||
125152244|NCT00124462|450181174|FG000|Overall Study|Lost to Follow-up|3|||
125152245|NCT00124462|450181175|FG001|Overall Study|Lost to Follow-up|3|||
125152246|NCT00124462|450181174|FG000|Overall Study|Physician Decision|3|||
125152247|NCT00124462|450181175|FG001|Overall Study|Physician Decision|4|||
125152248|NCT00124462|450181174|FG000|Overall Study|Withdrawal by Subject|4|||
125152249|NCT00124462|450181175|FG001|Overall Study|Withdrawal by Subject|5|||
125152250|NCT00124462|450181174|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
125152251|NCT00124462|450181175|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
125152252|NCT00537199|450181176|FG000|Overall Study|Study Terminated|1|||
125152253|NCT00860743|450181179|FG000|Overall Study|Withdrawal by Subject|3|||
125152254|NCT00860743|450181180|FG001|Overall Study|Withdrawal by Subject|0|||
125152255|NCT03827018|450181182|FG000|Overall Study|Adverse Event|1|||
125152256|NCT03827018|450181183|FG001|Overall Study|Adverse Event|0|||
125152257|NCT03827018|450181182|FG000|Overall Study|Withdrawal by Subject|2|||
125152258|NCT03827018|450181183|FG001|Overall Study|Withdrawal by Subject|2|||
125152259|NCT03827018|450181182|FG000|Overall Study|Lack of Efficacy|0|||
125152260|NCT03827018|450181183|FG001|Overall Study|Lack of Efficacy|1|||
125152261|NCT00350402|450181188|FG000|Overall Study|Lost to Follow-up|1|||
125152262|NCT00350402|450181189|FG001|Overall Study|Lost to Follow-up|1|||
125152263|NCT01884688|450181192|FG000|Overall Study|Screen Failure|2|||
125152264|NCT04099641|450181196|FG000|Overall Study|Death|46|||
125152265|NCT04099641|450181197|FG001|Overall Study|Death|12|||
125152266|NCT04099641|450181196|FG000|Overall Study|Lost to Follow-up|1|||
125152267|NCT04099641|450181197|FG001|Overall Study|Lost to Follow-up|0|||
125152268|NCT04099641|450181196|FG000|Overall Study|Withdrawal by Subject|2|||
125152269|NCT04099641|450181197|FG001|Overall Study|Withdrawal by Subject|0|||
125152270|NCT04798482|450181213|FG000|Overall Study|Physician Decision|1|||
125152271|NCT04798482|450181213|FG000|Overall Study|Lost eligibility|1|||
125152272|NCT01192399|450181214|FG000|Overall Study|Lack of Efficacy|2|||
125152273|NCT03903159|450181216|FG000|Overall Study|Discharged with Staff Approval|2|||
125152274|NCT03903159|450181216|FG000|Overall Study|Discharged at Staff Request|2|||
125152275|NCT03903159|450181216|FG000|Overall Study|Discharged Against Staff Advice|1|||
125152276|NCT02443545|450181217|FG000|Overall Study|Adverse Event|1|||
125152277|NCT02443545|450181218|FG001|Overall Study|Adverse Event|1|||
125152278|NCT02443545|450181217|FG000|Overall Study|Lost to Follow-up|0|||
125152279|NCT02443545|450181218|FG001|Overall Study|Lost to Follow-up|2|||
125152280|NCT02443545|450181217|FG000|Overall Study|Physician Decision|3|||
125152281|NCT02443545|450181218|FG001|Overall Study|Physician Decision|0|||
125152282|NCT02443545|450181217|FG000|Overall Study|Protocol Violation|8|||
125152283|NCT02443545|450181218|FG001|Overall Study|Protocol Violation|1|||
125152284|NCT02443545|450181217|FG000|Overall Study|Pregnancy|1|||
125152285|NCT02443545|450181218|FG001|Overall Study|Pregnancy|1|||
125152286|NCT02443545|450181217|FG000|Overall Study|Withdrawal by Subject|6|||
125152287|NCT02443545|450181218|FG001|Overall Study|Withdrawal by Subject|3|||
125152288|NCT02443545|450181217|FG000|Overall Study|Termination of study|20|||
125152289|NCT02443545|450181218|FG001|Overall Study|Termination of study|11|||
125152290|NCT00536484|450181219|FG000|Overall Study|Adverse Event|21|||
125152291|NCT00536484|450181220|FG001|Overall Study|Adverse Event|34|||
125152292|NCT00536484|450181219|FG000|Overall Study|Withdrawal by Subject|11|||
125152293|NCT00536484|450181220|FG001|Overall Study|Withdrawal by Subject|11|||
125152294|NCT00536484|450181219|FG000|Overall Study|Lost to Follow-up|8|||
125152295|NCT00536484|450181220|FG001|Overall Study|Lost to Follow-up|6|||
125152296|NCT00536484|450181219|FG000|Overall Study|Lack of Efficacy|16|||
125152297|NCT00536484|450181220|FG001|Overall Study|Lack of Efficacy|5|||
125152298|NCT00536484|450181219|FG000|Overall Study|Other|4|||
125152299|NCT00536484|450181220|FG001|Overall Study|Other|0|||
125152300|NCT01506908|450181221|FG000|Overall Study|Adverse Event|1|||
125152301|NCT01506908|450181222|FG001|Overall Study|Adverse Event|0|||
125152302|NCT01382251|450181224|FG000|Overall Study|Surgeries cancelled or delayed|16|||
125152303|NCT01382251|450181225|FG001|Overall Study|Surgeries cancelled or delayed|16|||
125152304|NCT01382251|450181224|FG000|Overall Study|Lost to Follow-up|4|||
125152305|NCT01382251|450181225|FG001|Overall Study|Lost to Follow-up|4|||
125152306|NCT01382251|450181224|FG000|Overall Study|Contacted after study closed|1|||
125152307|NCT01382251|450181225|FG001|Overall Study|Contacted after study closed|1|||
125152308|NCT00562120|450181226|FG000|First Intervention Period|Adverse Event|1|||
125152309|NCT00562120|450181227|FG001|First Intervention Period|Adverse Event|0|||
125152310|NCT00562120|450181228|FG002|First Intervention Period|Adverse Event|0|||
125152311|NCT00562120|450181229|FG003|First Intervention Period|Adverse Event|0|||
125152312|NCT00562120|450181226|FG000|First Intervention Period|Randomized but not Treated|1|||
125152313|NCT00562120|450181227|FG001|First Intervention Period|Randomized but not Treated|0|||
125152314|NCT00562120|450181228|FG002|First Intervention Period|Randomized but not Treated|0|||
125152315|NCT00562120|450181229|FG003|First Intervention Period|Randomized but not Treated|0|||
125152316|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
125152317|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
125152318|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
125152319|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
125152320|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
125152321|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
125152322|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
125152323|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
125152324|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
125152325|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
125152326|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
125152327|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
125152328|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Death|0|||
125152329|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Death|1|||
125152330|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Death|0|||
125152331|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Death|0|||
125152332|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
125152333|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
125152334|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
125152335|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
125152336|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
125152337|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
125152338|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
125152339|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
125152340|NCT00545688|450181230|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
125152341|NCT00545688|450181231|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
125152342|NCT00545688|450181232|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
125152343|NCT00545688|450181233|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
125152344|NCT00545688|450181230|FG000|Adjuvant Treatment Period|Disease Progression|3|||
125152345|NCT00545688|450181231|FG001|Adjuvant Treatment Period|Disease Progression|3|||
125152346|NCT00545688|450181232|FG002|Adjuvant Treatment Period|Disease Progression|0|||
125152347|NCT00545688|450181233|FG003|Adjuvant Treatment Period|Disease Progression|7|||
125152348|NCT00545688|450181230|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
125152349|NCT00545688|450181231|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
125152350|NCT00545688|450181232|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
125152351|NCT00545688|450181233|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
125152352|NCT00545688|450181230|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
125152353|NCT00545688|450181231|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
125152354|NCT00545688|450181232|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
125152355|NCT00545688|450181233|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
125152356|NCT00545688|450181230|FG000|Adjuvant Treatment Period|Adverse Event|0|||
125152357|NCT00545688|450181231|FG001|Adjuvant Treatment Period|Adverse Event|3|||
125152358|NCT00545688|450181232|FG002|Adjuvant Treatment Period|Adverse Event|2|||
125152359|NCT00545688|450181233|FG003|Adjuvant Treatment Period|Adverse Event|2|||
125152360|NCT00545688|450181230|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
125152361|NCT00545688|450181231|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
125152362|NCT00545688|450181232|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
125152363|NCT00545688|450181233|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
125152364|NCT00545688|450181230|FG000|Follow-Up Period|Death|4|||
125152365|NCT00545688|450181231|FG001|Follow-Up Period|Death|2|||
125152366|NCT00545688|450181232|FG002|Follow-Up Period|Death|2|||
125152367|NCT00545688|450181233|FG003|Follow-Up Period|Death|6|||
125152368|NCT00545688|450181230|FG000|Follow-Up Period|Disease Progression|6|||
125152369|NCT00545688|450181231|FG001|Follow-Up Period|Disease Progression|5|||
125152370|NCT00545688|450181232|FG002|Follow-Up Period|Disease Progression|9|||
125152371|NCT00545688|450181233|FG003|Follow-Up Period|Disease Progression|9|||
125152372|NCT00545688|450181230|FG000|Follow-Up Period|Refused Treatment|6|||
125152373|NCT00545688|450181231|FG001|Follow-Up Period|Refused Treatment|2|||
125152374|NCT00545688|450181232|FG002|Follow-Up Period|Refused Treatment|0|||
125152375|NCT00545688|450181233|FG003|Follow-Up Period|Refused Treatment|2|||
125388631|NCT00605475|451056647|FG001|Overall Study|Lost to Follow-up|0|||
125152376|NCT00545688|450181230|FG000|Follow-Up Period|Lost to Follow-up|3|||
125388632|NCT00605475|451056648|FG002|Overall Study|Lost to Follow-up|0|||
125152377|NCT00545688|450181231|FG001|Follow-Up Period|Lost to Follow-up|3|||
125152378|NCT00545688|450181232|FG002|Follow-Up Period|Lost to Follow-up|3|||
125152379|NCT00545688|450181233|FG003|Follow-Up Period|Lost to Follow-up|1|||
125152380|NCT00545688|450181230|FG000|Follow-Up Period|Unspecified Reason|2|||
125152381|NCT00545688|450181231|FG001|Follow-Up Period|Unspecified Reason|5|||
125152382|NCT00545688|450181232|FG002|Follow-Up Period|Unspecified Reason|6|||
125388633|NCT00605475|451056649|FG003|Overall Study|Lost to Follow-up|0|||
125152383|NCT00545688|450181233|FG003|Follow-Up Period|Unspecified Reason|8|||
125388634|NCT00605475|451056650|FG004|Overall Study|Lost to Follow-up|0|||
125152384|NCT00545688|450181230|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
125152385|NCT00545688|450181231|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
125152386|NCT00545688|450181232|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
125152387|NCT00545688|450181233|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
125152388|NCT04678817|450183209|FG000|Overall Study|Lost to Follow-up|28|||
125152389|NCT04678817|450183210|FG001|Overall Study|Lost to Follow-up|0|||
125152390|NCT04678817|450183211|FG002|Overall Study|Lost to Follow-up|0|||
125152391|NCT01010126|450183220|FG000|Overall Study|Withdrawal by Subject|1|||
125152392|NCT01010126|450183221|FG001|Overall Study|Withdrawal by Subject|0|||
125152393|NCT01010126|450183222|FG002|Overall Study|Withdrawal by Subject|1|||
125152394|NCT01010126|450183223|FG003|Overall Study|Withdrawal by Subject|0|||
125152395|NCT01010126|450183224|FG004|Overall Study|Withdrawal by Subject|3|||
125152396|NCT01010126|450183225|FG005|Overall Study|Withdrawal by Subject|0|||
125152397|NCT00784134|450183235|FG000|Overall Study|Lost to Follow-up|3|||
125152398|NCT00784134|450183236|FG001|Overall Study|Lost to Follow-up|6|||
125152399|NCT03785145|450183237|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
125152400|NCT03785145|450183238|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
125152401|NCT03785145|450183237|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
125152402|NCT03785145|450183238|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
125152403|NCT03785145|450183237|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
125152404|NCT03785145|450183238|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
125152405|NCT03785145|450183237|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
125152406|NCT03785145|450183238|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
125152407|NCT03785145|450183237|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
125152408|NCT03785145|450183238|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
125152409|NCT03785145|450183237|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
125152410|NCT03785145|450183238|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
125152411|NCT03785145|450183237|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
125152412|NCT03785145|450183238|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
125152413|NCT03785145|450183237|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
125152414|NCT03785145|450183238|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
125152415|NCT03785145|450183237|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
125152416|NCT03785145|450183238|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
125152417|NCT03785145|450183237|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
125152418|NCT03785145|450183238|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
125152419|NCT03785145|450183237|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
125152420|NCT03785145|450183238|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
125152421|NCT03250299|450183243|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
125152422|NCT03250299|450183244|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
125152423|NCT03250299|450183245|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
125152424|NCT03250299|450183246|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
125152425|NCT03250299|450183247|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
125152426|NCT03250299|450183243|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
125152427|NCT03250299|450183244|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
125152428|NCT03250299|450183245|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
125152429|NCT03250299|450183246|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
125152430|NCT03250299|450183247|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
125152431|NCT03250299|450183243|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
125152432|NCT03250299|450183244|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
125152433|NCT03250299|450183245|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
125152434|NCT03250299|450183246|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
125152435|NCT03250299|450183247|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
125152436|NCT03250299|450183243|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
125152437|NCT03250299|450183244|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
125152438|NCT03250299|450183245|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
125152439|NCT03250299|450183246|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
125152440|NCT03250299|450183247|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
125152441|NCT03346070|450183248|FG000|Overall Study|Death|0|||
125152442|NCT03346070|450183249|FG001|Overall Study|Death|0|||
125152443|NCT03346070|450183250|FG002|Overall Study|Death|0|||
125152444|NCT03346070|450183251|FG003|Overall Study|Death|0|||
125152445|NCT03346070|450183252|FG004|Overall Study|Death|1|||
125152446|NCT03346070|450183248|FG000|Overall Study|Lost to Follow-up|0|||
125152447|NCT03346070|450183249|FG001|Overall Study|Lost to Follow-up|1|||
125152448|NCT03346070|450183250|FG002|Overall Study|Lost to Follow-up|2|||
125152449|NCT03346070|450183251|FG003|Overall Study|Lost to Follow-up|0|||
125152450|NCT03346070|450183252|FG004|Overall Study|Lost to Follow-up|0|||
125152451|NCT03346070|450183248|FG000|Overall Study|Physician Decision|0|||
125152452|NCT03346070|450183249|FG001|Overall Study|Physician Decision|0|||
125152453|NCT03346070|450183250|FG002|Overall Study|Physician Decision|0|||
125152454|NCT03346070|450183251|FG003|Overall Study|Physician Decision|1|||
125152455|NCT03346070|450183252|FG004|Overall Study|Physician Decision|1|||
125152456|NCT03346070|450183248|FG000|Overall Study|Withdrawal by Subject|1|||
125152457|NCT03346070|450183249|FG001|Overall Study|Withdrawal by Subject|0|||
125152458|NCT03346070|450183250|FG002|Overall Study|Withdrawal by Subject|0|||
125152459|NCT03346070|450183251|FG003|Overall Study|Withdrawal by Subject|1|||
125152460|NCT03346070|450183252|FG004|Overall Study|Withdrawal by Subject|0|||
125152461|NCT03346070|450183248|FG000|Overall Study|Study medication not received as planned|2|||
125152462|NCT03346070|450183249|FG001|Overall Study|Study medication not received as planned|3|||
125152463|NCT03346070|450183250|FG002|Overall Study|Study medication not received as planned|2|||
125152464|NCT03346070|450183251|FG003|Overall Study|Study medication not received as planned|3|||
125152465|NCT03346070|450183252|FG004|Overall Study|Study medication not received as planned|2|||
125152466|NCT03346070|450183248|FG000|Overall Study|Screen Failure|0|||
125152467|NCT03346070|450183249|FG001|Overall Study|Screen Failure|0|||
125152468|NCT03346070|450183250|FG002|Overall Study|Screen Failure|0|||
125152469|NCT03346070|450183251|FG003|Overall Study|Screen Failure|1|||
125152470|NCT03346070|450183252|FG004|Overall Study|Screen Failure|1|||
125152471|NCT01221090|450183263|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
125152472|NCT01221090|450183264|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
125152473|NCT01221090|450183265|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
125152474|NCT01221090|450183266|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
125152475|NCT01221090|450183263|FG000|Overall Study|Withdrawal by Subject|0|||
125152476|NCT01221090|450183264|FG001|Overall Study|Withdrawal by Subject|22|||
125152477|NCT01221090|450183265|FG002|Overall Study|Withdrawal by Subject|27|||
125152478|NCT01221090|450183266|FG003|Overall Study|Withdrawal by Subject|2|||
125152479|NCT00708708|450183267|FG000|Overall Study|Another therapy instead of Enbrel|141|||
125152480|NCT00708708|450183267|FG000|Overall Study|Lost to Follow-up|52|||
125152481|NCT00708708|450183267|FG000|Overall Study|Withdrawal by Subject|51|||
125152482|NCT00708708|450183267|FG000|Overall Study|Intolerance|42|||
125152483|NCT00708708|450183267|FG000|Overall Study|Another therapy along with Enbrel|15|||
125152484|NCT00708708|450183267|FG000|Overall Study|Other unspecified|11|||
125152485|NCT00708708|450183267|FG000|Overall Study|Good effectiveness|9|||
125152486|NCT00708708|450183267|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
125152487|NCT00708708|450183267|FG000|Overall Study|Administrative reasons|7|||
125152488|NCT00708708|450183267|FG000|Overall Study|Lack of effectiveness|4|||
125152489|NCT00708708|450183267|FG000|Overall Study|Lack of compliance|3|||
125152490|NCT00708708|450183267|FG000|Overall Study|Pregnancy|3|||
125152491|NCT00708708|450183267|FG000|Overall Study|Adverse Event|3|||
125152492|NCT00708708|450183267|FG000|Overall Study|Missing values|392|||
125152493|NCT04776746|450183271|FG000|Overall Study|Study terminated by sponsor|61|||
125152494|NCT04776746|450183271|FG000|Overall Study|Adverse Event|5|||
125152495|NCT04776746|450183271|FG000|Overall Study|Death|4|||
125152496|NCT04776746|450183271|FG000|Overall Study|Lack of Efficacy|3|||
125152497|NCT04776746|450183271|FG000|Overall Study|Noncompliance with study drug|2|||
125152498|NCT04776746|450183271|FG000|Overall Study|Not related to COVID-19|2|||
125152499|NCT00440466|450183272|FG000|Overall Study|Death|3|||
125152500|NCT00440466|450183273|FG001|Overall Study|Death|2|||
125152501|NCT00440466|450183274|FG002|Overall Study|Death|9|||
125152502|NCT00440466|450183272|FG000|Overall Study|Adverse Event|3|||
125152503|NCT00440466|450183273|FG001|Overall Study|Adverse Event|4|||
125152504|NCT00440466|450183274|FG002|Overall Study|Adverse Event|11|||
125152505|NCT00440466|450183272|FG000|Overall Study|Lost to Follow-up|1|||
125152506|NCT00440466|450183273|FG001|Overall Study|Lost to Follow-up|0|||
125152507|NCT00440466|450183274|FG002|Overall Study|Lost to Follow-up|2|||
125152508|NCT00440466|450183272|FG000|Overall Study|Physician Decision|2|||
125152509|NCT00440466|450183273|FG001|Overall Study|Physician Decision|0|||
125152510|NCT00440466|450183274|FG002|Overall Study|Physician Decision|1|||
125152511|NCT00440466|450183272|FG000|Overall Study|Protocol Violation|2|||
125152512|NCT00440466|450183273|FG001|Overall Study|Protocol Violation|0|||
125152513|NCT00440466|450183274|FG002|Overall Study|Protocol Violation|4|||
125152514|NCT00440466|450183272|FG000|Overall Study|Withdrawal by Subject|2|||
125152515|NCT00440466|450183273|FG001|Overall Study|Withdrawal by Subject|5|||
125152516|NCT00440466|450183274|FG002|Overall Study|Withdrawal by Subject|9|||
125152517|NCT00440466|450183272|FG000|Overall Study|Began Dialysis|0|||
125152518|NCT00440466|450183273|FG001|Overall Study|Began Dialysis|0|||
125152519|NCT00440466|450183274|FG002|Overall Study|Began Dialysis|1|||
125152520|NCT00440466|450183272|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
125152521|NCT00440466|450183273|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
125152522|NCT00440466|450183274|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
125152523|NCT00418522|450183275|FG000|Overall Study|Adverse Event|7|||
125152524|NCT00418522|450183276|FG001|Overall Study|Adverse Event|1|||
125152525|NCT00418522|450183275|FG000|Overall Study|Lack of Efficacy|1|||
125152526|NCT00418522|450183276|FG001|Overall Study|Lack of Efficacy|3|||
125152527|NCT00418522|450183275|FG000|Overall Study|Lost to Follow-up|10|||
125152528|NCT00418522|450183276|FG001|Overall Study|Lost to Follow-up|4|||
125152529|NCT00418522|450183275|FG000|Overall Study|Withdrawal by Subject|31|||
125152530|NCT00418522|450183276|FG001|Overall Study|Withdrawal by Subject|7|||
125152531|NCT00418522|450183275|FG000|Overall Study|Other|27|||
125152532|NCT00418522|450183276|FG001|Overall Study|Other|23|||
125152533|NCT00418522|450183275|FG000|Overall Study|Randomized but did not receive treatment|7|||
125152534|NCT00418522|450183276|FG001|Overall Study|Randomized but did not receive treatment|4|||
125152535|NCT00892281|450183280|FG000|Overall Study|Adverse Event|65|||
125152536|NCT00892281|450183281|FG001|Overall Study|Adverse Event|8|||
125152537|NCT00892281|450183280|FG000|Overall Study|Lost to Follow-up|81|||
125152538|NCT00892281|450183281|FG001|Overall Study|Lost to Follow-up|8|||
125152539|NCT00892281|450183280|FG000|Overall Study|Pregnancy|1|||
125152540|NCT00892281|450183281|FG001|Overall Study|Pregnancy|0|||
125152541|NCT00892281|450183280|FG000|Overall Study|Protocol Violation|7|||
125152542|NCT00892281|450183281|FG001|Overall Study|Protocol Violation|2|||
125152543|NCT00892281|450183280|FG000|Overall Study|Withdrawal by Subject|86|||
125152544|NCT00892281|450183281|FG001|Overall Study|Withdrawal by Subject|14|||
125152545|NCT00892281|450183280|FG000|Overall Study|Subject failed to return for final visit|2|||
125152546|NCT00892281|450183281|FG001|Overall Study|Subject failed to return for final visit|0|||
125152547|NCT00892281|450183280|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
125152548|NCT00892281|450183281|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
125152549|NCT00892281|450183280|FG000|Overall Study|Final visit completed 4 weeks late|0|||
125152550|NCT00892281|450183281|FG001|Overall Study|Final visit completed 4 weeks late|1|||
125152551|NCT00892281|450183280|FG000|Overall Study|Subject completed day after study closed|1|||
125152552|NCT00892281|450183281|FG001|Overall Study|Subject completed day after study closed|0|||
125152553|NCT00892281|450183280|FG000|Overall Study|Family emergency|1|||
125152554|NCT00892281|450183281|FG001|Overall Study|Family emergency|0|||
125152555|NCT00892281|450183280|FG000|Overall Study|Last visit not done - death in family|1|||
125152556|NCT00892281|450183281|FG001|Overall Study|Last visit not done - death in family|0|||
125152557|NCT00892281|450183280|FG000|Overall Study|Did not meet incl/excl criteria|1|||
125152558|NCT00892281|450183281|FG001|Overall Study|Did not meet incl/excl criteria|0|||
125152559|NCT00892281|450183280|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
125152560|NCT00892281|450183281|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
125152561|NCT00892281|450183280|FG000|Overall Study|Unable to redeem the drug voucher|1|||
125152562|NCT00892281|450183281|FG001|Overall Study|Unable to redeem the drug voucher|0|||
125152563|NCT00892281|450183280|FG000|Overall Study|Subject not good candidate for study|1|||
125152564|NCT00892281|450183281|FG001|Overall Study|Subject not good candidate for study|0|||
125152565|NCT00892281|450183280|FG000|Overall Study|Subject did not return for any visits|1|||
125152566|NCT00892281|450183281|FG001|Overall Study|Subject did not return for any visits|0|||
125152567|NCT00892281|450183280|FG000|Overall Study|Subject missed several visits/lost meds|1|||
125152568|NCT00892281|450183281|FG001|Overall Study|Subject missed several visits/lost meds|0|||
125152569|NCT00892281|450183280|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
125152570|NCT00892281|450183281|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
125152571|NCT00892281|450183280|FG000|Overall Study|Scheduled for knee replacement|0|||
125152572|NCT00892281|450183281|FG001|Overall Study|Scheduled for knee replacement|1|||
125152573|NCT00892281|450183280|FG000|Overall Study|PI complained of inadequate compensation|3|||
125152574|NCT00892281|450183281|FG001|Overall Study|PI complained of inadequate compensation|0|||
125152575|NCT00892281|450183280|FG000|Overall Study|Subject lost interest in program|0|||
125388635|NCT00605475|451056651|FG005|Overall Study|Lost to Follow-up|0|||
125388636|NCT00605475|451056652|FG006|Overall Study|Lost to Follow-up|0|||
125388637|NCT00605475|451056653|FG007|Overall Study|Lost to Follow-up|0|||
125388638|NCT00605475|451056654|FG008|Overall Study|Lost to Follow-up|1|||
125388639|NCT00605475|451056655|FG009|Overall Study|Lost to Follow-up|1|||
125388640|NCT00605475|451056646|FG000|Overall Study|Protocol Violation|0|||
125152576|NCT00892281|450183281|FG001|Overall Study|Subject lost interest in program|1|||
125152577|NCT00892281|450183280|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
125388641|NCT00605475|451056647|FG001|Overall Study|Protocol Violation|0|||
125388642|NCT00605475|451056648|FG002|Overall Study|Protocol Violation|0|||
125388643|NCT00605475|451056649|FG003|Overall Study|Protocol Violation|0|||
125388644|NCT00605475|451056650|FG004|Overall Study|Protocol Violation|1|||
125152578|NCT00892281|450183281|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
125152579|NCT00892281|450183280|FG000|Overall Study|Death in family|1|||
125152580|NCT00892281|450183281|FG001|Overall Study|Death in family|0|||
125152581|NCT00892281|450183280|FG000|Overall Study|Lack of efficacy of study product|2|||
125152582|NCT00892281|450183281|FG001|Overall Study|Lack of efficacy of study product|0|||
125152583|NCT00892281|450183280|FG000|Overall Study|Subject not seen by PI at final visit|1|||
125388645|NCT00605475|451056651|FG005|Overall Study|Protocol Violation|0|||
125152584|NCT00892281|450183281|FG001|Overall Study|Subject not seen by PI at final visit|0|||
125152585|NCT00892281|450183280|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
125152586|NCT00892281|450183281|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
125152587|NCT00892281|450183280|FG000|Overall Study|Missed multiple visits|1|||
125152588|NCT00892281|450183281|FG001|Overall Study|Missed multiple visits|0|||
125152589|NCT00892281|450183280|FG000|Overall Study|Missed visits rescheduled out of window|1|||
125388646|NCT00605475|451056652|FG006|Overall Study|Protocol Violation|0|||
125388647|NCT00605475|451056653|FG007|Overall Study|Protocol Violation|0|||
125388648|NCT00605475|451056654|FG008|Overall Study|Protocol Violation|0|||
125152590|NCT00892281|450183281|FG001|Overall Study|Missed visits rescheduled out of window|0|||
125152591|NCT00892281|450183280|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
125152592|NCT00892281|450183281|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
125152593|NCT00892281|450183280|FG000|Overall Study|Subject had history of drug abuse|1|||
125152594|NCT00892281|450183281|FG001|Overall Study|Subject had history of drug abuse|0|||
125152595|NCT00892281|450183280|FG000|Overall Study|Rash on hand|1|||
125152596|NCT00892281|450183281|FG001|Overall Study|Rash on hand|0|||
125152597|NCT00892281|450183280|FG000|Overall Study|Visit 4 date out of window|1|||
125152598|NCT00892281|450183281|FG001|Overall Study|Visit 4 date out of window|0|||
125152599|NCT00865098|450183284|FG000|Overall Study|Progressive disease|1|||
125152600|NCT01048502|450183291|FG000|Overall Study|Lost to Follow-up|2|||
125152601|NCT01048502|450183292|FG001|Overall Study|Lost to Follow-up|0|||
125152602|NCT01048502|450183293|FG002|Overall Study|Lost to Follow-up|0|||
125152603|NCT01048502|450183294|FG003|Overall Study|Lost to Follow-up|0|||
125152604|NCT01048502|450183291|FG000|Overall Study|Adverse Event|1|||
125152605|NCT01048502|450183292|FG001|Overall Study|Adverse Event|0|||
125152606|NCT01048502|450183293|FG002|Overall Study|Adverse Event|0|||
125152607|NCT01048502|450183294|FG003|Overall Study|Adverse Event|0|||
125152608|NCT01048502|450183291|FG000|Overall Study|Withdrawal by Subject|1|||
125152609|NCT01048502|450183292|FG001|Overall Study|Withdrawal by Subject|4|||
125152610|NCT01048502|450183293|FG002|Overall Study|Withdrawal by Subject|5|||
125152611|NCT01048502|450183294|FG003|Overall Study|Withdrawal by Subject|3|||
125152612|NCT01048502|450183291|FG000|Overall Study|Physician Decision|0|||
125152613|NCT01048502|450183292|FG001|Overall Study|Physician Decision|3|||
125152614|NCT01048502|450183293|FG002|Overall Study|Physician Decision|0|||
125152615|NCT01048502|450183294|FG003|Overall Study|Physician Decision|1|||
125152616|NCT01138826|450183295|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
125152617|NCT01138826|450183296|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
125152618|NCT01138826|450183297|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
125152619|NCT01138826|450183298|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
125152620|NCT01138826|450183299|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
125152621|NCT01138826|450183300|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
125152622|NCT05206448|450183301|FG000|Overall Study|Lost to Follow-up|2|||
125152623|NCT05206448|450183302|FG001|Overall Study|Lost to Follow-up|2|||
125152624|NCT05206448|450183301|FG000|Overall Study|Withdrawal by Subject|2|||
125152625|NCT05206448|450183302|FG001|Overall Study|Withdrawal by Subject|0|||
125152626|NCT05206448|450183301|FG000|Overall Study|found ineligible after randomization|1|||
125152627|NCT05206448|450183302|FG001|Overall Study|found ineligible after randomization|1|||
125152628|NCT05206448|450183301|FG000|Overall Study|unable to complete study due to personal constraints|1|||
125152629|NCT05206448|450183302|FG001|Overall Study|unable to complete study due to personal constraints|0|||
125152630|NCT05206448|450183301|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
125152631|NCT05206448|450183302|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
125152632|NCT01333072|450183306|FG000|Overall Study|Lost to Follow-up|3|||
125152633|NCT01333072|450183307|FG001|Overall Study|Lost to Follow-up|0|||
125152634|NCT01333072|450183306|FG000|Overall Study|Adverse Event|2|||
125152635|NCT01333072|450183307|FG001|Overall Study|Adverse Event|4|||
125152636|NCT01333072|450183306|FG000|Overall Study|Physician Decision|1|||
125152637|NCT01333072|450183307|FG001|Overall Study|Physician Decision|0|||
125152638|NCT00619359|450183308|FG000|Overall Study|Adverse Event|32|||
125152639|NCT00619359|450183309|FG001|Overall Study|Adverse Event|36|||
125152640|NCT00619359|450183308|FG000|Overall Study|Lost to Follow-up|12|||
125152641|NCT00619359|450183309|FG001|Overall Study|Lost to Follow-up|16|||
125152642|NCT00619359|450183308|FG000|Overall Study|Physician Decision|0|||
125152643|NCT00619359|450183309|FG001|Overall Study|Physician Decision|7|||
125152644|NCT00619359|450183308|FG000|Overall Study|Protocol Violation|1|||
125152645|NCT00619359|450183309|FG001|Overall Study|Protocol Violation|1|||
125152646|NCT00619359|450183308|FG000|Overall Study|Withdrawal by Subject|19|||
125152647|NCT00619359|450183309|FG001|Overall Study|Withdrawal by Subject|20|||
125152648|NCT00619359|450183308|FG000|Overall Study|Progressive Disease|3|||
125152649|NCT00619359|450183309|FG001|Overall Study|Progressive Disease|1|||
125152650|NCT02502734|450183310|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
125152651|NCT02502734|450183311|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
125152652|NCT02502734|450183310|FG000|Washout Period|Adverse Event|1|||
125152653|NCT02502734|450183311|FG001|Washout Period|Adverse Event|0|||
125152654|NCT03649412|450183314|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
125152655|NCT03649412|450183315|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
125152656|NCT03649412|450183314|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
125152657|NCT03649412|450183315|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
125152658|NCT03649412|450183314|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
125152659|NCT03649412|450183315|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
125152660|NCT03649412|450183314|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
125152661|NCT03649412|450183315|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
125152662|NCT03649412|450183314|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
125152663|NCT03649412|450183315|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
125152664|NCT03649412|450183314|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
125152665|NCT03649412|450183315|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
125152666|NCT02280187|450183316|FG000|Overall Study|Lost to Follow-up|218|||
125152667|NCT04668274|450183317|FG000|Part 1 Study Period 1|Adverse Event|3|||
125152668|NCT04668274|450183318|FG001|Part 1 Study Period 1|Adverse Event|0|||
125152669|NCT04668274|450183319|FG002|Part 1 Study Period 1|Adverse Event|0|||
125152670|NCT04668274|450183320|FG003|Part 1 Study Period 1|Adverse Event|0|||
125152671|NCT04668274|450183317|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
125152672|NCT04668274|450183318|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
125152673|NCT04668274|450183319|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
125152674|NCT04668274|450183320|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
125152675|NCT04668274|450183317|FG000|Part 1 Study Period 2|Other|0|||
125152676|NCT04668274|450183318|FG001|Part 1 Study Period 2|Other|1|||
125152677|NCT04668274|450183319|FG002|Part 1 Study Period 2|Other|0|||
125152678|NCT04668274|450183320|FG003|Part 1 Study Period 2|Other|0|||
125152679|NCT04668274|450183317|FG000|Part 1 Study Period 3|Adverse Event|0|||
125152680|NCT04668274|450183318|FG001|Part 1 Study Period 3|Adverse Event|0|||
125152681|NCT04668274|450183319|FG002|Part 1 Study Period 3|Adverse Event|1|||
125152682|NCT04668274|450183320|FG003|Part 1 Study Period 3|Adverse Event|0|||
125152683|NCT04668274|450183317|FG000|Part 1 Study Period 3|Other|0|||
125152684|NCT04668274|450183318|FG001|Part 1 Study Period 3|Other|0|||
125152685|NCT04668274|450183319|FG002|Part 1 Study Period 3|Other|2|||
125152686|NCT04668274|450183320|FG003|Part 1 Study Period 3|Other|0|||
125152687|NCT04668274|450183317|FG000|Part 2 Study Period 4|Other|0|||
125152688|NCT04668274|450183318|FG001|Part 2 Study Period 4|Other|0|||
125152689|NCT04668274|450183319|FG002|Part 2 Study Period 4|Other|0|||
125152690|NCT04668274|450183320|FG003|Part 2 Study Period 4|Other|1|||
125152691|NCT02363439|450183321|FG000|Overall Study|Lack of Efficacy|4|||
125152692|NCT00508027|450183330|FG000|Dose Level 1|Lost to Follow-up|4|||
125152693|NCT00508027|450183330|FG000|Dose Level 1|Withdrawal by Subject|2|||
125152694|NCT00508027|450183330|FG000|Dose Level 1|Physician Decision|2|||
125152695|NCT00508027|450183330|FG000|Dose Level 2|Lost to Follow-up|2|||
125152696|NCT00508027|450183330|FG000|Dose Level 2|Withdrawal by Subject|2|||
125152697|NCT01719562|450183331|FG000|Overall Study|Lost to Follow-up|1|||
125152698|NCT01719562|450183332|FG001|Overall Study|Lost to Follow-up|0|||
125152699|NCT01719562|450183331|FG000|Overall Study|Death|1|||
125152700|NCT01719562|450183332|FG001|Overall Study|Death|0|||
125152701|NCT01719562|450183331|FG000|Overall Study|New cancer diagnosis|1|||
125152702|NCT01719562|450183332|FG001|Overall Study|New cancer diagnosis|0|||
125152703|NCT03891329|450183337|FG000|Overall Study|Death|5|||
125152704|NCT03891329|450183337|FG000|Overall Study|Lost to Follow-up|4|||
125152705|NCT03891329|450183337|FG000|Overall Study|Physician Decision|4|||
125152706|NCT03891329|450183337|FG000|Overall Study|Device explanted|3|||
125152707|NCT03891329|450183337|FG000|Overall Study|No study device implanted|3|||
125152708|NCT01832402|450183342|FG000|Overall Study|Lost to Follow-up|2|||
125152709|NCT01832402|450183343|FG001|Overall Study|Lost to Follow-up|0|||
125152710|NCT01832402|450183342|FG000|Overall Study|Withdrawal by Subject|3|||
125152711|NCT01832402|450183343|FG001|Overall Study|Withdrawal by Subject|3|||
125152712|NCT01832402|450183342|FG000|Overall Study|Declining Performance status|2|||
125152713|NCT01832402|450183343|FG001|Overall Study|Declining Performance status|1|||
125152714|NCT01202877|450183344|FG000|Overall Study|Disease Progression|0|||
125152715|NCT01202877|450183345|FG001|Overall Study|Disease Progression|1|||
125152716|NCT01202877|450183346|FG002|Overall Study|Disease Progression|2|||
125152717|NCT01202877|450183344|FG000|Overall Study|Adverse Event|0|||
125152718|NCT01202877|450183345|FG001|Overall Study|Adverse Event|0|||
125152719|NCT01202877|450183346|FG002|Overall Study|Adverse Event|2|||
125152720|NCT01202877|450183344|FG000|Overall Study|Withdrawal by Subject|0|||
125152721|NCT01202877|450183345|FG001|Overall Study|Withdrawal by Subject|0|||
125152722|NCT01202877|450183346|FG002|Overall Study|Withdrawal by Subject|1|||
125152723|NCT01202877|450183344|FG000|Overall Study|Death|0|||
125152724|NCT01202877|450183345|FG001|Overall Study|Death|0|||
125152725|NCT01202877|450183346|FG002|Overall Study|Death|1|||
125152726|NCT00396331|450183347|FG000|Overall Study|Failed to mobilize - no transplant|8|||
125152727|NCT00396331|450183347|FG000|Overall Study|Did not go on to transplant|5|||
125152728|NCT00396331|450183347|FG000|Overall Study|Lost to Follow-up|3|||
125152729|NCT00396331|450183347|FG000|Overall Study|Death|16|||
125152730|NCT01351350|450183348|FG000|Overall Study|Disease Progression|5|||
125152731|NCT01351350|450183349|FG001|Overall Study|Disease Progression|13|||
125152732|NCT01351350|450183350|FG002|Overall Study|Disease Progression|6|||
125152733|NCT01351350|450183351|FG003|Overall Study|Disease Progression|8|||
125152734|NCT01351350|450183352|FG004|Overall Study|Disease Progression|5|||
125152735|NCT01351350|450183348|FG000|Overall Study|Adverse Event|1|||
125152736|NCT01351350|450183349|FG001|Overall Study|Adverse Event|10|||
125152737|NCT01351350|450183350|FG002|Overall Study|Adverse Event|1|||
125152738|NCT01351350|450183351|FG003|Overall Study|Adverse Event|2|||
125152739|NCT01351350|450183352|FG004|Overall Study|Adverse Event|0|||
125152740|NCT01351350|450183348|FG000|Overall Study|Participant Decision|2|||
125152741|NCT01351350|450183349|FG001|Overall Study|Participant Decision|6|||
125152742|NCT01351350|450183350|FG002|Overall Study|Participant Decision|3|||
125152743|NCT01351350|450183351|FG003|Overall Study|Participant Decision|3|||
125152744|NCT01351350|450183352|FG004|Overall Study|Participant Decision|2|||
125152745|NCT01351350|450183348|FG000|Overall Study|Enrolled but not Treated|0|||
125152746|NCT01351350|450183349|FG001|Overall Study|Enrolled but not Treated|0|||
125152747|NCT01351350|450183350|FG002|Overall Study|Enrolled but not Treated|1|||
125152748|NCT01351350|450183351|FG003|Overall Study|Enrolled but not Treated|0|||
125152749|NCT01351350|450183352|FG004|Overall Study|Enrolled but not Treated|0|||
125152750|NCT02339740|450183355|FG000|Overall Study|Death|1|||
125152751|NCT02339740|450183356|FG001|Overall Study|Death|0|||
125152752|NCT02339740|450183355|FG000|Overall Study|Physician Decision|0|||
125152753|NCT02339740|450183356|FG001|Overall Study|Physician Decision|2|||
125152754|NCT02339740|450183355|FG000|Overall Study|Withdrawal by Subject|5|||
125152755|NCT02339740|450183356|FG001|Overall Study|Withdrawal by Subject|1|||
125152756|NCT02339740|450183355|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
125152757|NCT02339740|450183356|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
125152758|NCT02096588|450183357|FG000|Overall Study|Lack of Efficacy|2|||
125152759|NCT02096588|450183358|FG001|Overall Study|Lack of Efficacy|0|||
125152760|NCT02096588|450183357|FG000|Overall Study|Withdrawal by Subject|0|||
125152761|NCT02096588|450183358|FG001|Overall Study|Withdrawal by Subject|1|||
125152762|NCT00303667|450183359|FG000|Overall Study|Death|0|||
125152763|NCT00303667|450183360|FG001|Overall Study|Death|4|||
125152764|NCT02377921|450183363|FG000|Overall Study|Subject non-compliance|1|||
125152765|NCT02377921|450183364|FG001|Overall Study|Subject non-compliance|1|||
125152766|NCT00706355|450183370|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
125152767|NCT00706355|450183371|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
125152768|NCT00706355|450183372|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
125152769|NCT00706355|450183373|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
125152770|NCT00706355|450183370|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
125152771|NCT00706355|450183371|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
125152772|NCT00706355|450183372|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
125152773|NCT00706355|450183373|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
125152774|NCT00706355|450183370|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
125152775|NCT00706355|450183371|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
125152776|NCT00706355|450183372|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
125152777|NCT00706355|450183373|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
125152778|NCT00706355|450183370|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
125152779|NCT00706355|450183371|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
125152780|NCT00706355|450183372|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
125152781|NCT00706355|450183373|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
125152782|NCT00706355|450183370|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
125152783|NCT00706355|450183371|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
125152784|NCT00706355|450183372|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
125152785|NCT00706355|450183373|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
125152786|NCT00706355|450183370|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
125152787|NCT00706355|450183371|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
125152788|NCT00706355|450183372|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
125152789|NCT00706355|450183373|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
125152790|NCT00706355|450183370|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
125152791|NCT00706355|450183371|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
125152792|NCT00706355|450183372|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
125152793|NCT00706355|450183373|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
125152794|NCT00706355|450183370|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
125152795|NCT00706355|450183371|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
125152796|NCT00706355|450183372|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
125152797|NCT00706355|450183373|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
125152798|NCT00706355|450183370|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
125152799|NCT00706355|450183371|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
125152800|NCT00706355|450183372|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
125152801|NCT00706355|450183373|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
125152802|NCT01020799|450183374|FG000|Overall Study|Adverse Event|4|||
125152803|NCT01020799|450183375|FG001|Overall Study|Adverse Event|3|||
125152804|NCT01020799|450183376|FG002|Overall Study|Adverse Event|2|||
125152805|NCT01020799|450183374|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
125152806|NCT01020799|450183375|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
125152807|NCT01020799|450183376|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
125152808|NCT01020799|450183374|FG000|Overall Study|Protocol Violation|3|||
125152809|NCT01020799|450183375|FG001|Overall Study|Protocol Violation|2|||
125152810|NCT01020799|450183376|FG002|Overall Study|Protocol Violation|0|||
125152811|NCT01020799|450183374|FG000|Overall Study|Withdrawal by Subject|2|||
125152812|NCT01020799|450183375|FG001|Overall Study|Withdrawal by Subject|2|||
125388649|NCT00605475|451056655|FG009|Overall Study|Protocol Violation|0|||
125388650|NCT00605475|451056646|FG000|Overall Study|Withdrawal by Subject|0|||
125388651|NCT00605475|451056647|FG001|Overall Study|Withdrawal by Subject|0|||
125152813|NCT01020799|450183376|FG002|Overall Study|Withdrawal by Subject|3|||
125152814|NCT01020799|450183374|FG000|Overall Study|Lost to Follow-up|6|||
125152815|NCT01020799|450183375|FG001|Overall Study|Lost to Follow-up|4|||
125152816|NCT01020799|450183376|FG002|Overall Study|Lost to Follow-up|2|||
125152817|NCT01425528|450183377|FG000|Overall Study|Withdrawal by Subject|1|||
125152818|NCT01425528|450183378|FG001|Overall Study|Withdrawal by Subject|1|||
125152819|NCT00952276|450183383|FG000|Overall Study|Withdrawal by Subject|1|||
125152820|NCT00952276|450183384|FG001|Overall Study|Withdrawal by Subject|0|||
125152821|NCT00952276|450183385|FG002|Overall Study|Withdrawal by Subject|0|||
125152822|NCT00952276|450183386|FG003|Overall Study|Withdrawal by Subject|1|||
125152823|NCT00952276|450183387|FG004|Overall Study|Withdrawal by Subject|0|||
125152824|NCT02985879|450183388|FG000|Overall Study|Adverse Event|7|||
125152825|NCT02985879|450183389|FG001|Overall Study|Adverse Event|9|||
125152826|NCT02985879|450183390|FG002|Overall Study|Adverse Event|7|||
125152827|NCT02985879|450183388|FG000|Overall Study|Withdrew consent|6|||
125152828|NCT02985879|450183389|FG001|Overall Study|Withdrew consent|8|||
125152829|NCT02985879|450183390|FG002|Overall Study|Withdrew consent|10|||
125152830|NCT02985879|450183388|FG000|Overall Study|Lost to Follow-up|1|||
125152831|NCT02985879|450183389|FG001|Overall Study|Lost to Follow-up|0|||
125152832|NCT02985879|450183390|FG002|Overall Study|Lost to Follow-up|2|||
125152833|NCT02985879|450183388|FG000|Overall Study|Other, not specified|62|||
125152834|NCT02985879|450183389|FG001|Overall Study|Other, not specified|58|||
125152835|NCT02985879|450183390|FG002|Overall Study|Other, not specified|58|||
125152836|NCT00595335|450184966|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
125152837|NCT00595335|450184967|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
125152838|NCT00595335|450184966|FG000|Baseline to Six Months|Disease Progression|1|||
125152839|NCT00595335|450184967|FG001|Baseline to Six Months|Disease Progression|1|||
125152840|NCT00595335|450184966|FG000|Baseline to Six Months|Adverse Event|1|||
125152841|NCT00595335|450184967|FG001|Baseline to Six Months|Adverse Event|0|||
125152842|NCT00595335|450184966|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
125152843|NCT00595335|450184967|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
125152844|NCT00595335|450184966|FG000|Six Months to Twelve Months|Disease Progression|1|||
125152845|NCT00595335|450184967|FG001|Six Months to Twelve Months|Disease Progression|0|||
125152846|NCT01647958|450184972|FG000|Initial Study|Lost to Follow-up|2|||
125152847|NCT01647958|450184973|FG001|Initial Study|Lost to Follow-up|3|||
125152848|NCT01647958|450184972|FG000|Continuation Phase|treatment received during Overall Study|39|||
125152849|NCT01647958|450184973|FG001|Continuation Phase|treatment received during Overall Study|0|||
125152850|NCT01647958|450184972|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
125152851|NCT01647958|450184973|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
125152852|NCT00544817|450184974|FG000|Combined Modality|Lack of Efficacy|2|||
125152853|NCT00544817|450184974|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
125152854|NCT00544817|450184974|FG000|Combined Modality|Adverse Event|2|||
125152855|NCT00544817|450184974|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
125152856|NCT00544817|450184974|FG000|No Treatment Interval|Lack of Efficacy|8|||
125152857|NCT00544817|450184974|FG000|No Treatment Interval|Physician Decision|3|||
125152858|NCT00544817|450184974|FG000|No Treatment Interval|Adverse Event|1|||
125152859|NCT00544817|450184974|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
125152860|NCT00544817|450184974|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
125152861|NCT00544817|450184974|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
125152862|NCT01131299|450184975|FG000|Overall Study|Withdrawal by Subject|4|||
125152863|NCT01131299|450184976|FG001|Overall Study|Withdrawal by Subject|7|||
125152864|NCT01885182|450184983|FG000|Overall Study|Adverse Event|11|||
125152865|NCT01885182|450184984|FG001|Overall Study|Adverse Event|13|||
125152866|NCT01885182|450184983|FG000|Overall Study|Withdrawal by Subject|13|||
125152867|NCT01885182|450184984|FG001|Overall Study|Withdrawal by Subject|6|||
125152868|NCT01885182|450184983|FG000|Overall Study|Lost to Follow-up|2|||
125152869|NCT01885182|450184984|FG001|Overall Study|Lost to Follow-up|2|||
125152870|NCT01885182|450184983|FG000|Overall Study|Lack of Efficacy|8|||
125152871|NCT01885182|450184984|FG001|Overall Study|Lack of Efficacy|1|||
125152872|NCT03686150|450184985|FG000|Overall Study|Withdrawal by Subject|1|||
125152873|NCT03686150|450184986|FG001|Overall Study|Withdrawal by Subject|1|||
125152874|NCT03686150|450184987|FG002|Overall Study|Withdrawal by Subject|1|||
125152875|NCT03686150|450184988|FG003|Overall Study|Withdrawal by Subject|0|||
125152876|NCT03686150|450184989|FG004|Overall Study|Withdrawal by Subject|1|||
125152877|NCT03686150|450184990|FG005|Overall Study|Withdrawal by Subject|2|||
125152878|NCT03686150|450184985|FG000|Overall Study|Physician Decision|1|||
125152879|NCT03686150|450184986|FG001|Overall Study|Physician Decision|0|||
125152880|NCT03686150|450184987|FG002|Overall Study|Physician Decision|0|||
125388652|NCT00605475|451056648|FG002|Overall Study|Withdrawal by Subject|0|||
125152881|NCT03686150|450184988|FG003|Overall Study|Physician Decision|0|||
125152882|NCT03686150|450184989|FG004|Overall Study|Physician Decision|0|||
125152883|NCT03686150|450184990|FG005|Overall Study|Physician Decision|1|||
125152884|NCT03686150|450184985|FG000|Overall Study|Lost to Follow-up|0|||
125223843|NCT04157088|450446240|FG000|Overall Study|Study terminated by sponsor|23|||
125223844|NCT04157088|450446240|FG000|Overall Study|Withdrawal by Subject|4|||
125152885|NCT03686150|450184986|FG001|Overall Study|Lost to Follow-up|1|||
125152886|NCT03686150|450184987|FG002|Overall Study|Lost to Follow-up|0|||
125152887|NCT03686150|450184988|FG003|Overall Study|Lost to Follow-up|0|||
125152888|NCT03686150|450184989|FG004|Overall Study|Lost to Follow-up|0|||
125152889|NCT03686150|450184990|FG005|Overall Study|Lost to Follow-up|0|||
125152890|NCT01207440|450184991|FG000|Overall Study|Adverse Event|46|||
125152891|NCT01207440|450184992|FG001|Overall Study|Adverse Event|11|||
125152892|NCT01207440|450184993|FG002|Overall Study|Adverse Event|7|||
125152893|NCT01207440|450184994|FG003|Overall Study|Adverse Event|2|||
125152894|NCT01207440|450184995|FG004|Overall Study|Adverse Event|6|||
125152895|NCT01207440|450184996|FG005|Overall Study|Adverse Event|6|||
125152896|NCT01207440|450184997|FG006|Overall Study|Adverse Event|2|||
125152897|NCT01207440|450184991|FG000|Overall Study|Death|6|||
125152898|NCT01207440|450184992|FG001|Overall Study|Death|3|||
125152899|NCT01207440|450184993|FG002|Overall Study|Death|2|||
125152900|NCT01207440|450184994|FG003|Overall Study|Death|2|||
125152901|NCT01207440|450184995|FG004|Overall Study|Death|7|||
125152902|NCT01207440|450184996|FG005|Overall Study|Death|5|||
125152903|NCT01207440|450184997|FG006|Overall Study|Death|1|||
125152904|NCT01207440|450184991|FG000|Overall Study|Lack of Efficacy|13|||
125152905|NCT01207440|450184992|FG001|Overall Study|Lack of Efficacy|2|||
125152906|NCT01207440|450184993|FG002|Overall Study|Lack of Efficacy|5|||
125152907|NCT01207440|450184994|FG003|Overall Study|Lack of Efficacy|1|||
125152908|NCT01207440|450184995|FG004|Overall Study|Lack of Efficacy|2|||
125152909|NCT01207440|450184996|FG005|Overall Study|Lack of Efficacy|3|||
125152910|NCT01207440|450184997|FG006|Overall Study|Lack of Efficacy|0|||
125152911|NCT01207440|450184991|FG000|Overall Study|Lost to Follow-up|0|||
125152912|NCT01207440|450184992|FG001|Overall Study|Lost to Follow-up|0|||
125152913|NCT01207440|450184993|FG002|Overall Study|Lost to Follow-up|2|||
125152914|NCT01207440|450184994|FG003|Overall Study|Lost to Follow-up|1|||
125152915|NCT01207440|450184995|FG004|Overall Study|Lost to Follow-up|0|||
125152916|NCT01207440|450184996|FG005|Overall Study|Lost to Follow-up|0|||
125152917|NCT01207440|450184997|FG006|Overall Study|Lost to Follow-up|0|||
125152918|NCT01207440|450184991|FG000|Overall Study|Non-compliance with Study Drug|3|||
125152919|NCT01207440|450184992|FG001|Overall Study|Non-compliance with Study Drug|0|||
125152920|NCT01207440|450184993|FG002|Overall Study|Non-compliance with Study Drug|1|||
125152921|NCT01207440|450184994|FG003|Overall Study|Non-compliance with Study Drug|0|||
125152922|NCT01207440|450184995|FG004|Overall Study|Non-compliance with Study Drug|0|||
125152923|NCT01207440|450184996|FG005|Overall Study|Non-compliance with Study Drug|0|||
125152924|NCT01207440|450184997|FG006|Overall Study|Non-compliance with Study Drug|0|||
125152925|NCT01207440|450184991|FG000|Overall Study|Physician Decision|6|||
125152926|NCT01207440|450184992|FG001|Overall Study|Physician Decision|5|||
125152927|NCT01207440|450184993|FG002|Overall Study|Physician Decision|5|||
125152928|NCT01207440|450184994|FG003|Overall Study|Physician Decision|0|||
125152929|NCT01207440|450184995|FG004|Overall Study|Physician Decision|1|||
125152930|NCT01207440|450184996|FG005|Overall Study|Physician Decision|0|||
125152931|NCT01207440|450184997|FG006|Overall Study|Physician Decision|0|||
125152932|NCT01207440|450184991|FG000|Overall Study|Progressive Disease|19|||
125152933|NCT01207440|450184992|FG001|Overall Study|Progressive Disease|10|||
125152934|NCT01207440|450184993|FG002|Overall Study|Progressive Disease|19|||
125152935|NCT01207440|450184994|FG003|Overall Study|Progressive Disease|7|||
125152936|NCT01207440|450184995|FG004|Overall Study|Progressive Disease|23|||
125152937|NCT01207440|450184996|FG005|Overall Study|Progressive Disease|27|||
125152938|NCT01207440|450184997|FG006|Overall Study|Progressive Disease|0|||
125152939|NCT01207440|450184991|FG000|Overall Study|Protocol Violation|2|||
125152940|NCT01207440|450184992|FG001|Overall Study|Protocol Violation|0|||
125152941|NCT01207440|450184993|FG002|Overall Study|Protocol Violation|0|||
125152942|NCT01207440|450184994|FG003|Overall Study|Protocol Violation|0|||
125152943|NCT01207440|450184995|FG004|Overall Study|Protocol Violation|0|||
125152944|NCT01207440|450184996|FG005|Overall Study|Protocol Violation|0|||
125152945|NCT01207440|450184997|FG006|Overall Study|Protocol Violation|0|||
125152946|NCT01207440|450184991|FG000|Overall Study|Site Terminated by Sponsor|69|||
125152947|NCT01207440|450184992|FG001|Overall Study|Site Terminated by Sponsor|19|||
125152948|NCT01207440|450184993|FG002|Overall Study|Site Terminated by Sponsor|12|||
125152949|NCT01207440|450184994|FG003|Overall Study|Site Terminated by Sponsor|2|||
125152950|NCT01207440|450184995|FG004|Overall Study|Site Terminated by Sponsor|3|||
125152951|NCT01207440|450184996|FG005|Overall Study|Site Terminated by Sponsor|0|||
125152952|NCT01207440|450184997|FG006|Overall Study|Site Terminated by Sponsor|2|||
125152953|NCT01207440|450184991|FG000|Overall Study|Withdrawal by Subject|29|||
125152954|NCT01207440|450184992|FG001|Overall Study|Withdrawal by Subject|4|||
125152955|NCT01207440|450184993|FG002|Overall Study|Withdrawal by Subject|5|||
125152956|NCT01207440|450184994|FG003|Overall Study|Withdrawal by Subject|3|||
125152957|NCT01207440|450184995|FG004|Overall Study|Withdrawal by Subject|2|||
125152958|NCT01207440|450184996|FG005|Overall Study|Withdrawal by Subject|2|||
125152959|NCT01207440|450184997|FG006|Overall Study|Withdrawal by Subject|0|||
125152960|NCT01207440|450184991|FG000|Overall Study|Reason Not Specified|10|||
125388653|NCT00605475|451056649|FG003|Overall Study|Withdrawal by Subject|0|||
125388654|NCT00605475|451056650|FG004|Overall Study|Withdrawal by Subject|0|||
125388655|NCT00605475|451056651|FG005|Overall Study|Withdrawal by Subject|2|||
125388656|NCT00605475|451056652|FG006|Overall Study|Withdrawal by Subject|0|||
125388657|NCT00605475|451056653|FG007|Overall Study|Withdrawal by Subject|0|||
125388658|NCT00605475|451056654|FG008|Overall Study|Withdrawal by Subject|0|||
125388659|NCT00605475|451056655|FG009|Overall Study|Withdrawal by Subject|1|||
125388660|NCT02596854|451056658|FG000|Overall Study|Withdrawn|8|||
125388661|NCT06027866|451056663|FG000|Overall Study|Withdrawal by Subject|2|||
125388662|NCT01852812|451056665|FG000|Overall Study|Adverse Event|0|||
125152961|NCT01207440|450184992|FG001|Overall Study|Reason Not Specified|10|||
125152962|NCT01207440|450184993|FG002|Overall Study|Reason Not Specified|7|||
125152963|NCT01207440|450184994|FG003|Overall Study|Reason Not Specified|0|||
125152964|NCT01207440|450184995|FG004|Overall Study|Reason Not Specified|4|||
125152965|NCT01207440|450184996|FG005|Overall Study|Reason Not Specified|3|||
125152966|NCT01207440|450184997|FG006|Overall Study|Reason Not Specified|0|||
125152967|NCT03341000|450184998|FG000|Overall Study|Adverse Event|1|||
125152968|NCT02813421|450185001|FG000|Overall Study|Withdrawal by Subject|1|||
125152969|NCT02813421|450185002|FG001|Overall Study|Withdrawal by Subject|2|||
125152970|NCT02813421|450185001|FG000|Overall Study|Lost to Follow-up|1|||
125152971|NCT02813421|450185002|FG001|Overall Study|Lost to Follow-up|1|||
125152972|NCT03135899|450185003|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152973|NCT03135899|450185004|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152974|NCT03135899|450185005|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152975|NCT03135899|450185006|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152976|NCT03135899|450185007|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152977|NCT03135899|450185008|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152978|NCT03135899|450185009|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
125152979|NCT03135899|450185010|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
125152980|NCT03135899|450185003|FG000|Overall Study|Withdrawal by Subject|0|||
125152981|NCT03135899|450185004|FG001|Overall Study|Withdrawal by Subject|0|||
125152982|NCT03135899|450185005|FG002|Overall Study|Withdrawal by Subject|0|||
125152983|NCT03135899|450185006|FG003|Overall Study|Withdrawal by Subject|0|||
125152984|NCT03135899|450185007|FG004|Overall Study|Withdrawal by Subject|0|||
125152985|NCT03135899|450185008|FG005|Overall Study|Withdrawal by Subject|2|||
125152986|NCT03135899|450185009|FG006|Overall Study|Withdrawal by Subject|0|||
125152987|NCT03135899|450185010|FG007|Overall Study|Withdrawal by Subject|0|||
125152988|NCT04146363|450185011|FG000|Induction Period|Adverse Event|1|||
125152989|NCT04146363|450185012|FG001|Induction Period|Adverse Event|2|||
125152990|NCT04146363|450185013|FG002|Induction Period|Adverse Event|0|||
125152991|NCT04146363|450185014|FG003|Induction Period|Adverse Event|0|||
125152992|NCT04146363|450185015|FG004|Induction Period|Adverse Event|0|||
125152993|NCT04146363|450185016|FG005|Induction Period|Adverse Event|0|||
125152994|NCT04146363|450185017|FG006|Induction Period|Adverse Event|0|||
125152995|NCT04146363|450185018|FG007|Induction Period|Adverse Event|0|||
125152996|NCT04146363|450185019|FG008|Induction Period|Adverse Event|0|||
125152997|NCT04146363|450185020|FG009|Induction Period|Adverse Event|0|||
125152998|NCT04146363|450185021|FG010|Induction Period|Adverse Event|0|||
125152999|NCT04146363|450185011|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
125153000|NCT04146363|450185012|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
125153001|NCT04146363|450185013|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
125153002|NCT04146363|450185014|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
125153003|NCT04146363|450185015|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
125153004|NCT04146363|450185016|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
125153005|NCT04146363|450185017|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
125153006|NCT04146363|450185018|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
125153007|NCT04146363|450185019|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
125153008|NCT04146363|450185020|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
125153009|NCT04146363|450185021|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
125153010|NCT04146363|450185011|FG000|Induction Period|Lack of Efficacy|7|||
125153011|NCT04146363|450185012|FG001|Induction Period|Lack of Efficacy|2|||
125153012|NCT04146363|450185013|FG002|Induction Period|Lack of Efficacy|0|||
125153013|NCT04146363|450185014|FG003|Induction Period|Lack of Efficacy|0|||
125153014|NCT04146363|450185015|FG004|Induction Period|Lack of Efficacy|0|||
125153015|NCT04146363|450185016|FG005|Induction Period|Lack of Efficacy|0|||
125153016|NCT04146363|450185017|FG006|Induction Period|Lack of Efficacy|0|||
125153017|NCT04146363|450185018|FG007|Induction Period|Lack of Efficacy|0|||
125153018|NCT04146363|450185019|FG008|Induction Period|Lack of Efficacy|0|||
125388663|NCT01852812|451056666|FG001|Overall Study|Adverse Event|0|||
125388664|NCT01852812|451056667|FG002|Overall Study|Adverse Event|1|||
125153019|NCT04146363|450185020|FG009|Induction Period|Lack of Efficacy|0|||
125153020|NCT04146363|450185021|FG010|Induction Period|Lack of Efficacy|0|||
125153021|NCT04146363|450185011|FG000|Induction Period|Lost to Follow-up|1|||
125153022|NCT04146363|450185012|FG001|Induction Period|Lost to Follow-up|4|||
125153023|NCT04146363|450185013|FG002|Induction Period|Lost to Follow-up|0|||
125223845|NCT04157088|450446240|FG000|Overall Study|Lost to Follow-up|2|||
125153024|NCT04146363|450185014|FG003|Induction Period|Lost to Follow-up|0|||
125153025|NCT04146363|450185015|FG004|Induction Period|Lost to Follow-up|0|||
125153026|NCT04146363|450185016|FG005|Induction Period|Lost to Follow-up|0|||
125153027|NCT04146363|450185017|FG006|Induction Period|Lost to Follow-up|0|||
125153028|NCT04146363|450185018|FG007|Induction Period|Lost to Follow-up|0|||
125153029|NCT04146363|450185019|FG008|Induction Period|Lost to Follow-up|0|||
125153030|NCT04146363|450185020|FG009|Induction Period|Lost to Follow-up|0|||
125153031|NCT04146363|450185021|FG010|Induction Period|Lost to Follow-up|0|||
125153032|NCT04146363|450185011|FG000|Induction Period|Positive quantiferon test|0|||
125153033|NCT04146363|450185012|FG001|Induction Period|Positive quantiferon test|1|||
125153034|NCT04146363|450185013|FG002|Induction Period|Positive quantiferon test|0|||
125153035|NCT04146363|450185014|FG003|Induction Period|Positive quantiferon test|0|||
125153036|NCT04146363|450185015|FG004|Induction Period|Positive quantiferon test|0|||
125153037|NCT04146363|450185016|FG005|Induction Period|Positive quantiferon test|0|||
125153038|NCT04146363|450185017|FG006|Induction Period|Positive quantiferon test|0|||
125153039|NCT04146363|450185018|FG007|Induction Period|Positive quantiferon test|0|||
125153040|NCT04146363|450185019|FG008|Induction Period|Positive quantiferon test|0|||
125153041|NCT04146363|450185020|FG009|Induction Period|Positive quantiferon test|0|||
125153042|NCT04146363|450185021|FG010|Induction Period|Positive quantiferon test|0|||
125153043|NCT04146363|450185011|FG000|Induction Period|Protocol Deviation|5|||
125153044|NCT04146363|450185012|FG001|Induction Period|Protocol Deviation|6|||
125153045|NCT04146363|450185013|FG002|Induction Period|Protocol Deviation|0|||
125153046|NCT04146363|450185014|FG003|Induction Period|Protocol Deviation|0|||
125153047|NCT04146363|450185015|FG004|Induction Period|Protocol Deviation|0|||
125153048|NCT04146363|450185016|FG005|Induction Period|Protocol Deviation|0|||
125153049|NCT04146363|450185017|FG006|Induction Period|Protocol Deviation|0|||
125153050|NCT04146363|450185018|FG007|Induction Period|Protocol Deviation|0|||
125153051|NCT04146363|450185019|FG008|Induction Period|Protocol Deviation|0|||
125153052|NCT04146363|450185020|FG009|Induction Period|Protocol Deviation|0|||
125153053|NCT04146363|450185021|FG010|Induction Period|Protocol Deviation|0|||
125153054|NCT04146363|450185011|FG000|Induction Period|Withdrawal by Subject|6|||
125153055|NCT04146363|450185012|FG001|Induction Period|Withdrawal by Subject|3|||
125153056|NCT04146363|450185013|FG002|Induction Period|Withdrawal by Subject|0|||
125153057|NCT04146363|450185014|FG003|Induction Period|Withdrawal by Subject|0|||
125153058|NCT04146363|450185015|FG004|Induction Period|Withdrawal by Subject|0|||
125153059|NCT04146363|450185016|FG005|Induction Period|Withdrawal by Subject|0|||
125153060|NCT04146363|450185017|FG006|Induction Period|Withdrawal by Subject|0|||
125153061|NCT04146363|450185018|FG007|Induction Period|Withdrawal by Subject|0|||
125153062|NCT04146363|450185019|FG008|Induction Period|Withdrawal by Subject|0|||
125153063|NCT04146363|450185020|FG009|Induction Period|Withdrawal by Subject|0|||
125153064|NCT04146363|450185021|FG010|Induction Period|Withdrawal by Subject|0|||
125153065|NCT04146363|450185011|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153066|NCT04146363|450185012|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153067|NCT04146363|450185013|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153068|NCT04146363|450185014|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153069|NCT04146363|450185015|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153070|NCT04146363|450185016|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153071|NCT04146363|450185017|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
125153072|NCT04146363|450185018|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
125153073|NCT04146363|450185019|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153074|NCT04146363|450185020|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153075|NCT04146363|450185021|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
125153076|NCT04146363|450185011|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153077|NCT04146363|450185012|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153078|NCT04146363|450185013|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153079|NCT04146363|450185014|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153080|NCT04146363|450185015|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153081|NCT04146363|450185016|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153082|NCT04146363|450185017|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153083|NCT04146363|450185018|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
125153084|NCT04146363|450185019|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153085|NCT04146363|450185020|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153086|NCT04146363|450185021|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
125153087|NCT04146363|450185011|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153088|NCT04146363|450185012|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153089|NCT04146363|450185013|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153090|NCT04146363|450185014|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153091|NCT04146363|450185015|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153092|NCT04146363|450185016|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153093|NCT04146363|450185017|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
125388665|NCT01852812|451056665|FG000|Overall Study|Non-compliance With Study Drug|0|||
125388666|NCT01852812|451056666|FG001|Overall Study|Non-compliance With Study Drug|1|||
125388667|NCT01852812|451056667|FG002|Overall Study|Non-compliance With Study Drug|0|||
125388668|NCT02250443|451056668|FG000|Overall Study|Administrative problems|7|||
125388669|NCT02250443|451056668|FG000|Overall Study|Adverse Event|3|||
125388670|NCT01549964|451056669|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
125153094|NCT04146363|450185018|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
125153095|NCT04146363|450185019|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153096|NCT04146363|450185020|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153097|NCT04146363|450185021|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
125153098|NCT04146363|450185011|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153099|NCT04146363|450185012|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153100|NCT04146363|450185013|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
125153101|NCT04146363|450185014|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153102|NCT04146363|450185015|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153103|NCT04146363|450185016|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
125153104|NCT04146363|450185017|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153105|NCT04146363|450185018|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153106|NCT04146363|450185019|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153107|NCT04146363|450185020|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153108|NCT04146363|450185021|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
125153109|NCT04146363|450185011|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153110|NCT04146363|450185012|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153111|NCT04146363|450185013|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153112|NCT04146363|450185014|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153113|NCT04146363|450185015|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
125153114|NCT04146363|450185016|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
125153115|NCT04146363|450185017|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
125153116|NCT04146363|450185018|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
125153117|NCT04146363|450185019|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153118|NCT04146363|450185020|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153119|NCT04146363|450185021|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
125153120|NCT04146363|450185011|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153121|NCT04146363|450185012|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153122|NCT04146363|450185013|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
125153123|NCT04146363|450185014|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153124|NCT04146363|450185015|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153125|NCT04146363|450185016|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
125153126|NCT04146363|450185017|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
125153127|NCT04146363|450185018|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
125153128|NCT04146363|450185019|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153129|NCT04146363|450185020|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153130|NCT04146363|450185021|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
125153131|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153132|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153133|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153134|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153135|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153136|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153137|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153138|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153139|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
125153140|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
125153141|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
125153142|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153143|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153144|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153145|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153146|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153147|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153148|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153149|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
125153150|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
125153151|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
125153152|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
125388671|NCT01549964|451056670|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
125153153|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153154|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153155|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153156|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153157|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153158|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153159|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153160|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153161|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
125153162|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
125153163|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
125153164|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153165|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153166|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153167|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153168|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153169|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153170|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153171|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153172|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
125153173|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
125153174|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
125153175|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153176|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153177|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153178|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153179|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153180|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153181|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153182|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
125153183|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
125153184|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
125153185|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
125153186|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153187|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153188|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153189|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153190|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153191|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153192|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153193|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153194|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153195|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
125153196|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
125153197|NCT04146363|450185011|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153198|NCT04146363|450185012|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153199|NCT04146363|450185013|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153200|NCT04146363|450185014|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153201|NCT04146363|450185015|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153202|NCT04146363|450185016|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153203|NCT04146363|450185017|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153204|NCT04146363|450185018|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153205|NCT04146363|450185019|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153206|NCT04146363|450185020|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
125153207|NCT04146363|450185021|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
125153208|NCT02914236|450185030|FG000|Overall Study|Lost to Follow-up|1|||
125153209|NCT00706095|450185037|FG000|Overall Study|Progressive Disease|4|||
125153210|NCT00706095|450185038|FG001|Overall Study|Progressive Disease|5|||
125153211|NCT00706095|450185039|FG002|Overall Study|Progressive Disease|3|||
125153212|NCT00706095|450185037|FG000|Overall Study|Clinical Progression|1|||
125153213|NCT00706095|450185038|FG001|Overall Study|Clinical Progression|2|||
125153214|NCT00706095|450185039|FG002|Overall Study|Clinical Progression|2|||
125153215|NCT00706095|450185037|FG000|Overall Study|Withdrawal by Subject|1|||
125153216|NCT00706095|450185038|FG001|Overall Study|Withdrawal by Subject|0|||
125153217|NCT00706095|450185039|FG002|Overall Study|Withdrawal by Subject|0|||
125153218|NCT02676284|450185040|FG000|Overall Study|Withdrawal by Subject|1|||
125153219|NCT01685073|450185041|FG000|Overall Study|Lost to Follow-up|6|||
125438701|NCT01827254|451233929|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
125153220|NCT01685073|450185042|FG001|Overall Study|Lost to Follow-up|8|||
125153221|NCT01685073|450185041|FG000|Overall Study|Withdrawal by Subject|24|||
125153222|NCT01685073|450185042|FG001|Overall Study|Withdrawal by Subject|24|||
125153223|NCT00743509|450185045|FG000|Overall Study|Withdrawal by Subject|2|||
125153224|NCT03768726|450185050|FG000|Treatment Phase|Adverse Event|2|||
125153225|NCT03768726|450185051|FG001|Treatment Phase|Adverse Event|2|||
125153226|NCT03768726|450185050|FG000|Treatment Phase|Lost to Follow-up|1|||
125153227|NCT03768726|450185051|FG001|Treatment Phase|Lost to Follow-up|0|||
125153228|NCT03768726|450185050|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
125153229|NCT03768726|450185051|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
125153230|NCT03768726|450185050|FG000|Treatment Phase|Withdrawal by Subject|3|||
125153231|NCT03768726|450185051|FG001|Treatment Phase|Withdrawal by Subject|1|||
125153232|NCT03768726|450185050|FG000|Follow-Up|Adverse Event|2|||
125153233|NCT03768726|450185051|FG001|Follow-Up|Adverse Event|2|||
125153234|NCT03768726|450185050|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
125153235|NCT03768726|450185051|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
125153236|NCT03768726|450185050|FG000|Follow-Up|Withdrawal by Subject|2|||
125153237|NCT03768726|450185051|FG001|Follow-Up|Withdrawal by Subject|0|||
125153238|NCT03768726|450185050|FG000|Follow-Up|Other|1|||
125153239|NCT03768726|450185051|FG001|Follow-Up|Other|0|||
125153240|NCT01787279|450185052|FG000|Overall Study|Lost to Follow-up|2|||
125153241|NCT01787279|450185052|FG000|Overall Study|Lack of Efficacy|1|||
125153242|NCT02695719|450185053|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
125153243|NCT02695719|450185054|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
125153244|NCT02695719|450185053|FG000|Overall Study|Significant Protocol Deviation|0|||
125153245|NCT02695719|450185054|FG001|Overall Study|Significant Protocol Deviation|1|||
125153246|NCT02695719|450185053|FG000|Overall Study|Voluntary Withdrawal|1|||
125153247|NCT02695719|450185054|FG001|Overall Study|Voluntary Withdrawal|0|||
125153248|NCT00140413|450185055|FG000|Overall Study|Lost to Follow-up|1|||
125153249|NCT00140413|450185056|FG001|Overall Study|Lost to Follow-up|0|||
125153250|NCT00140413|450185055|FG000|Overall Study|Withdrawal by Subject|2|||
125153251|NCT00140413|450185056|FG001|Overall Study|Withdrawal by Subject|0|||
125153252|NCT01360866|450185061|FG000|Overall Study|Lost to Follow-up|11|||
125153253|NCT01360866|450185062|FG001|Overall Study|Lost to Follow-up|28|||
125153254|NCT01360866|450185063|FG002|Overall Study|Lost to Follow-up|41|||
125153255|NCT01360866|450185064|FG003|Overall Study|Lost to Follow-up|0|||
125153256|NCT01360866|450185061|FG000|Overall Study|Adverse Event|56|||
125153257|NCT01360866|450185062|FG001|Overall Study|Adverse Event|61|||
125153258|NCT01360866|450185063|FG002|Overall Study|Adverse Event|134|||
125153259|NCT01360866|450185064|FG003|Overall Study|Adverse Event|6|||
125153260|NCT01360866|450185061|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
125153261|NCT01360866|450185062|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
125153262|NCT01360866|450185063|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
125153263|NCT01360866|450185064|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
125153264|NCT01360866|450185061|FG000|Overall Study|Withdrawn by Investigator|9|||
125153265|NCT01360866|450185062|FG001|Overall Study|Withdrawn by Investigator|8|||
125153266|NCT01360866|450185063|FG002|Overall Study|Withdrawn by Investigator|31|||
125153267|NCT01360866|450185064|FG003|Overall Study|Withdrawn by Investigator|2|||
125153268|NCT01360866|450185061|FG000|Overall Study|Withdrawal by participant|79|||
125153269|NCT01360866|450185062|FG001|Overall Study|Withdrawal by participant|89|||
125153270|NCT01360866|450185063|FG002|Overall Study|Withdrawal by participant|168|||
125153271|NCT01360866|450185064|FG003|Overall Study|Withdrawal by participant|8|||
125153272|NCT01360866|450185061|FG000|Overall Study|Protocol Deviation|25|||
125153273|NCT01360866|450185062|FG001|Overall Study|Protocol Deviation|33|||
125153274|NCT01360866|450185063|FG002|Overall Study|Protocol Deviation|61|||
125153275|NCT01360866|450185064|FG003|Overall Study|Protocol Deviation|2|||
125153276|NCT01360866|450185061|FG000|Overall Study|Lack of Efficacy|30|||
125153277|NCT01360866|450185062|FG001|Overall Study|Lack of Efficacy|40|||
125153278|NCT01360866|450185063|FG002|Overall Study|Lack of Efficacy|30|||
125153279|NCT01360866|450185064|FG003|Overall Study|Lack of Efficacy|4|||
125153280|NCT01304693|450185065|FG000|Overall Study|Adverse Event|0|||
125153281|NCT01304693|450185066|FG001|Overall Study|Adverse Event|0|||
125153282|NCT01304693|450185067|FG002|Overall Study|Adverse Event|0|||
125153283|NCT01304693|450185068|FG003|Overall Study|Adverse Event|0|||
125153284|NCT01304693|450185069|FG004|Overall Study|Adverse Event|1|||
125153285|NCT01304693|450185065|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
125153286|NCT01304693|450185066|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
125153287|NCT01304693|450185067|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
125153288|NCT01304693|450185068|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
125153289|NCT01304693|450185069|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
125153290|NCT02129647|450185070|FG000|Overall Study|Adverse Event|2|||
125153291|NCT02129647|450185070|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
125153292|NCT00918463|450185072|FG000|Overall Study|Death|1|||
125153293|NCT00918463|450185072|FG000|Overall Study|Lack of Efficacy|1|||
125153294|NCT01014624|450185076|FG000|Overall Study|Adverse Event|0|||
125153295|NCT01014624|450185077|FG001|Overall Study|Adverse Event|1|||
125153296|NCT01014624|450185076|FG000|Overall Study|Protocol Violation|1|||
125153297|NCT01014624|450185077|FG001|Overall Study|Protocol Violation|0|||
125153298|NCT01014624|450185076|FG000|Overall Study|Withdrawal by Subject|1|||
125153299|NCT01014624|450185077|FG001|Overall Study|Withdrawal by Subject|0|||
125153300|NCT01715896|450185081|FG000|Overall Study|Lost to Follow-up|0|||
125153301|NCT01715896|450185082|FG001|Overall Study|Lost to Follow-up|2|||
125153302|NCT01715896|450185081|FG000|Overall Study|Withdrawal by Subject|1|||
125153303|NCT01715896|450185082|FG001|Overall Study|Withdrawal by Subject|4|||
125153304|NCT01715896|450185081|FG000|Overall Study|Other|2|||
125153305|NCT01715896|450185082|FG001|Overall Study|Other|5|||
125153306|NCT01173471|450185086|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125153307|NCT01173471|450185087|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125153308|NCT01173471|450185088|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
125153309|NCT01173471|450185089|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
125153310|NCT01173471|450185086|FG000|Overall Study|Condition under investigation worsened|2|||
125153311|NCT01173471|450185087|FG001|Overall Study|Condition under investigation worsened|0|||
125153312|NCT01173471|450185088|FG002|Overall Study|Condition under investigation worsened|0|||
125153313|NCT01173471|450185089|FG003|Overall Study|Condition under investigation worsened|0|||
125153314|NCT01173471|450185086|FG000|Overall Study|Lost to Follow-up|0|||
125153315|NCT01173471|450185087|FG001|Overall Study|Lost to Follow-up|0|||
125153316|NCT01173471|450185088|FG002|Overall Study|Lost to Follow-up|1|||
125153317|NCT01173471|450185089|FG003|Overall Study|Lost to Follow-up|0|||
125153318|NCT01173471|450185086|FG000|Overall Study|Reason given as Other|0|||
125153319|NCT01173471|450185087|FG001|Overall Study|Reason given as Other|0|||
125153320|NCT01173471|450185088|FG002|Overall Study|Reason given as Other|1|||
125153321|NCT01173471|450185089|FG003|Overall Study|Reason given as Other|0|||
125153322|NCT03028740|450185090|FG000|Overall Study|Did not Receive Study Drug|4|||
125153323|NCT03028740|450185091|FG001|Overall Study|Did not Receive Study Drug|5|||
125153324|NCT03028740|450185090|FG000|Overall Study|Adverse Event|8|||
125153325|NCT03028740|450185091|FG001|Overall Study|Adverse Event|26|||
125153326|NCT03028740|450185090|FG000|Overall Study|Lack of Efficacy|0|||
125153327|NCT03028740|450185091|FG001|Overall Study|Lack of Efficacy|1|||
125153328|NCT03028740|450185090|FG000|Overall Study|Withdrawal by Subject|48|||
125153329|NCT03028740|450185091|FG001|Overall Study|Withdrawal by Subject|101|||
125153330|NCT03028740|450185090|FG000|Overall Study|Lost to Follow-up|30|||
125153331|NCT03028740|450185091|FG001|Overall Study|Lost to Follow-up|54|||
125153332|NCT03028740|450185090|FG000|Overall Study|Physician Decision|4|||
125153333|NCT03028740|450185091|FG001|Overall Study|Physician Decision|11|||
125153334|NCT03028740|450185090|FG000|Overall Study|Protocol Violation|4|||
125153335|NCT03028740|450185091|FG001|Overall Study|Protocol Violation|8|||
125153336|NCT03028740|450185090|FG000|Overall Study|Non-compliance with Study Drug|0|||
125153337|NCT03028740|450185091|FG001|Overall Study|Non-compliance with Study Drug|2|||
125153338|NCT03028740|450185090|FG000|Overall Study|Study Terminated by Sponsor|467|||
125153339|NCT03028740|450185091|FG001|Overall Study|Study Terminated by Sponsor|917|||
125153340|NCT03028740|450185090|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
125153341|NCT03028740|450185091|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
125153342|NCT03028740|450185090|FG000|Overall Study|Reason not Specified|1|||
125153343|NCT03028740|450185091|FG001|Overall Study|Reason not Specified|5|||
125153344|NCT03336242|450185097|FG000|Overall Study|Adverse Event|0|||
125153345|NCT03336242|450185098|FG001|Overall Study|Adverse Event|1|||
125153346|NCT02224573|450185100|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
125153347|NCT02224573|450185101|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
125153348|NCT02224573|450185100|FG000|Treatment Phase|Started on Other IMP|1|||
125153349|NCT02224573|450185101|FG001|Treatment Phase|Started on Other IMP|0|||
125153350|NCT02224573|450185100|FG000|Treatment Phase|Participant Discontinued IMP|0|||
125153351|NCT02224573|450185101|FG001|Treatment Phase|Participant Discontinued IMP|1|||
125153352|NCT02224573|450185100|FG000|Treatment Phase|Lack of Efficacy|15|||
125153353|NCT02224573|450185101|FG001|Treatment Phase|Lack of Efficacy|8|||
125153354|NCT02224573|450185100|FG000|Treatment Phase|Began Commercial Product|1|||
125153355|NCT02224573|450185101|FG001|Treatment Phase|Began Commercial Product|0|||
125153356|NCT02224573|450185100|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
125153357|NCT02224573|450185101|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
125153358|NCT02224573|450185100|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
125153359|NCT02224573|450185101|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
125153360|NCT02224573|450185100|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
125153361|NCT02224573|450185101|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
125153362|NCT02224573|450185100|FG000|Treatment Phase|Continued Compassionate Use|1|||
125153363|NCT02224573|450185101|FG001|Treatment Phase|Continued Compassionate Use|0|||
125153364|NCT02224573|450185100|FG000|Treatment Phase|Lack of Efficiency|2|||
125153365|NCT02224573|450185101|FG001|Treatment Phase|Lack of Efficiency|1|||
125153366|NCT02224573|450185100|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
125153367|NCT02224573|450185101|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
125153368|NCT02224573|450185100|FG000|Treatment Phase|Participant Moved|2|||
125153369|NCT02224573|450185101|FG001|Treatment Phase|Participant Moved|0|||
125153370|NCT02224573|450185100|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
125153371|NCT02224573|450185101|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
125153372|NCT02224573|450185100|FG000|Treatment Phase|Refused Medication|1|||
125153373|NCT02224573|450185101|FG001|Treatment Phase|Refused Medication|1|||
125153374|NCT02224573|450185100|FG000|Treatment Phase|Adverse Event|26|||
125153375|NCT02224573|450185101|FG001|Treatment Phase|Adverse Event|38|||
125153376|NCT02224573|450185100|FG000|Treatment Phase|Placed in Group Home|0|||
125153377|NCT02224573|450185101|FG001|Treatment Phase|Placed in Group Home|1|||
125153378|NCT02224573|450185100|FG000|Treatment Phase|Pursued Other Trials|1|||
125153379|NCT02224573|450185101|FG001|Treatment Phase|Pursued Other Trials|0|||
125153380|NCT02224573|450185100|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
125153381|NCT02224573|450185101|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
125153382|NCT02224573|450185100|FG000|Treatment Phase|Lost to Follow-up|2|||
125153383|NCT02224573|450185101|FG001|Treatment Phase|Lost to Follow-up|1|||
125153384|NCT02224573|450185100|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
125153385|NCT02224573|450185101|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
125153386|NCT02224573|450185100|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
125153387|NCT02224573|450185101|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
125153388|NCT02224573|450185100|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
125153389|NCT02224573|450185101|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
125153390|NCT02224573|450185100|FG000|Taper Phase|Adverse Event|1|||
125153391|NCT02224573|450185101|FG001|Taper Phase|Adverse Event|1|||
125153392|NCT02546362|450185102|FG000|4-week Treatment Period|Lost to Follow-up|1|||
125153393|NCT02546362|450185102|FG000|4-week Treatment Period|Change in medication|2|||
125153394|NCT02546362|450185102|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
125153395|NCT02546362|450185102|FG000|12-week Treatment Period|Lost to Follow-up|2|||
125153396|NCT02546362|450185102|FG000|12-week Treatment Period|Change in medication|1|||
125153397|NCT01557842|450185103|FG000|Overall Study|Lost to Follow-up|0|||
125153398|NCT01557842|450185104|FG001|Overall Study|Lost to Follow-up|1|||
125153399|NCT01557842|450185103|FG000|Overall Study|Death|1|||
125153400|NCT01557842|450185104|FG001|Overall Study|Death|0|||
125153401|NCT01557842|450185103|FG000|Overall Study|Lack of Efficacy|0|||
125153402|NCT01557842|450185104|FG001|Overall Study|Lack of Efficacy|1|||
125153403|NCT01557842|450185103|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
125153404|NCT01557842|450185104|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
125153405|NCT01557842|450185103|FG000|Overall Study|Study Terminated by Sponsor|3|||
125153406|NCT01557842|450185104|FG001|Overall Study|Study Terminated by Sponsor|4|||
125153407|NCT01557842|450185103|FG000|Overall Study|Not Ablated|2|||
125153408|NCT01557842|450185104|FG001|Overall Study|Not Ablated|0|||
125153409|NCT03005067|450185108|FG000|Overall Study|Withdrawal by Subject|3|||
125153410|NCT03005067|450185109|FG001|Overall Study|Withdrawal by Subject|2|||
125153411|NCT03005067|450185108|FG000|Overall Study|Adverse Event|4|||
125153412|NCT03005067|450185109|FG001|Overall Study|Adverse Event|3|||
125153413|NCT03005067|450185108|FG000|Overall Study|Other (reason not specified)|3|||
125153414|NCT03005067|450185109|FG001|Overall Study|Other (reason not specified)|1|||
125153415|NCT03005067|450185108|FG000|Overall Study|Protocol Violation|0|||
125153416|NCT03005067|450185109|FG001|Overall Study|Protocol Violation|1|||
125153417|NCT01661881|450185115|FG000|Overall Study|Disease Progression|1|||
125153418|NCT00355472|450185122|FG000|Overall Study|Physician Decision|1|||
125153419|NCT01803269|450185125|FG000|Overall Study|Withdrawal by Subject|3|||
125153420|NCT01803269|450185126|FG001|Overall Study|Withdrawal by Subject|0|||
125153421|NCT01803269|450185127|FG002|Overall Study|Withdrawal by Subject|0|||
125153422|NCT04647383|450185128|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
125153423|NCT04647383|450185129|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
125153424|NCT04647383|450185130|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
125153425|NCT04647383|450185131|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
125153426|NCT00873119|450185132|FG000|Overall Study|Patient request|4|||
125153427|NCT00873119|450185133|FG001|Overall Study|Patient request|2|||
125153428|NCT00873119|450185132|FG000|Overall Study|Adverse Event|8|||
125153429|NCT00873119|450185133|FG001|Overall Study|Adverse Event|0|||
125153430|NCT00873119|450185132|FG000|Overall Study|Progressive disease|26|||
125153431|NCT00873119|450185133|FG001|Overall Study|Progressive disease|18|||
125153432|NCT00873119|450185132|FG000|Overall Study|Death|2|||
125153433|NCT00873119|450185133|FG001|Overall Study|Death|1|||
125153434|NCT00873119|450185132|FG000|Overall Study|Other|2|||
125153435|NCT00873119|450185133|FG001|Overall Study|Other|5|||
125153436|NCT00873119|450185132|FG000|Overall Study|Not treated|2|||
125153437|NCT00873119|450185133|FG001|Overall Study|Not treated|0|||
125153438|NCT01258101|450185136|FG000|Overall Study|Adverse Event|5|||
125153439|NCT01258101|450185137|FG001|Overall Study|Adverse Event|6|||
125153440|NCT01258101|450185138|FG002|Overall Study|Adverse Event|0|||
125153441|NCT01258101|450185139|FG003|Overall Study|Adverse Event|0|||
125153442|NCT01258101|450185136|FG000|Overall Study|Extra exclusion criterion amended|2|||
125153443|NCT01258101|450185137|FG001|Overall Study|Extra exclusion criterion amended|1|||
125153444|NCT01258101|450185138|FG002|Overall Study|Extra exclusion criterion amended|1|||
125153445|NCT01258101|450185139|FG003|Overall Study|Extra exclusion criterion amended|1|||
125388672|NCT01549964|451056671|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
125388673|NCT01549964|451056672|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
125388674|NCT01549964|451056669|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
125388675|NCT01549964|451056670|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
125388676|NCT01549964|451056671|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
125388677|NCT01549964|451056672|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
125388678|NCT01549964|451056669|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
125388679|NCT01549964|451056670|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
125388680|NCT01549964|451056671|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
125388681|NCT01549964|451056672|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
125388682|NCT01549964|451056669|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
125388683|NCT01549964|451056670|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
125388684|NCT01549964|451056671|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
125388685|NCT01549964|451056672|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
125388686|NCT01549964|451056669|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
125388687|NCT01549964|451056670|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
125388688|NCT01549964|451056671|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
125388689|NCT01549964|451056672|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
125388690|NCT01549964|451056669|FG000|24-Week Treatment Period|Other|1|||
125388691|NCT01549964|451056670|FG001|24-Week Treatment Period|Other|0|||
125388692|NCT01549964|451056671|FG002|24-Week Treatment Period|Other|1|||
125388693|NCT01549964|451056672|FG003|24-Week Treatment Period|Other|0|||
125388694|NCT01549964|451056669|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
125388695|NCT01549964|451056670|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
125388696|NCT01549964|451056671|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
125388697|NCT01549964|451056672|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
125388698|NCT01549964|451056669|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
125388699|NCT01549964|451056670|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
125388700|NCT01549964|451056671|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
125388701|NCT01549964|451056672|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
125388702|NCT01549964|451056669|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
125388703|NCT01549964|451056670|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
125388704|NCT01549964|451056671|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
125388705|NCT01549964|451056672|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
125388706|NCT01549964|451056669|FG000|80-Week Extension Period|Pregnancy|0|||
125388707|NCT01549964|451056670|FG001|80-Week Extension Period|Pregnancy|0|||
125388708|NCT01549964|451056671|FG002|80-Week Extension Period|Pregnancy|1|||
125388709|NCT01549964|451056672|FG003|80-Week Extension Period|Pregnancy|0|||
125388710|NCT01549964|451056669|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
125388711|NCT01549964|451056670|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
125388712|NCT01549964|451056671|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
125153446|NCT01258101|450185136|FG000|Overall Study|Informed consent has been withdrawn|2|||
125153447|NCT01258101|450185137|FG001|Overall Study|Informed consent has been withdrawn|2|||
125153448|NCT01258101|450185138|FG002|Overall Study|Informed consent has been withdrawn|1|||
125153449|NCT01258101|450185139|FG003|Overall Study|Informed consent has been withdrawn|1|||
125153450|NCT01258101|450185136|FG000|Overall Study|Patient is not able to attend visits|8|||
125153451|NCT01258101|450185137|FG001|Overall Study|Patient is not able to attend visits|9|||
125153452|NCT01258101|450185138|FG002|Overall Study|Patient is not able to attend visits|7|||
125153453|NCT01258101|450185139|FG003|Overall Study|Patient is not able to attend visits|6|||
125153454|NCT01258101|450185136|FG000|Overall Study|Patient´s compliance|4|||
125153455|NCT01258101|450185137|FG001|Overall Study|Patient´s compliance|3|||
125153456|NCT01258101|450185138|FG002|Overall Study|Patient´s compliance|1|||
125153457|NCT01258101|450185139|FG003|Overall Study|Patient´s compliance|2|||
125153458|NCT01258101|450185136|FG000|Overall Study|Lost to Follow-up|5|||
125153459|NCT01258101|450185137|FG001|Overall Study|Lost to Follow-up|5|||
125153460|NCT01258101|450185138|FG002|Overall Study|Lost to Follow-up|0|||
125153461|NCT01258101|450185139|FG003|Overall Study|Lost to Follow-up|6|||
125153462|NCT01258101|450185136|FG000|Overall Study|PCR positive at week 24|0|||
125153463|NCT01258101|450185137|FG001|Overall Study|PCR positive at week 24|0|||
125153464|NCT01258101|450185138|FG002|Overall Study|PCR positive at week 24|0|||
125153465|NCT01258101|450185139|FG003|Overall Study|PCR positive at week 24|1|||
125153466|NCT01258101|450185136|FG000|Overall Study|Other reason|7|||
125153467|NCT01258101|450185137|FG001|Overall Study|Other reason|8|||
125153468|NCT01258101|450185138|FG002|Overall Study|Other reason|1|||
125153469|NCT01258101|450185139|FG003|Overall Study|Other reason|8|||
125153470|NCT01807117|450185140|FG000|Overall Study|Physician Decision|2|||
125388713|NCT01549964|451056672|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
125388714|NCT01549964|451056669|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
125388715|NCT01549964|451056670|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
125153471|NCT01807117|450185140|FG000|Overall Study|Disease diagnosis not a study disease|1|||
125223846|NCT04157088|450446240|FG000|Overall Study|Death|1|||
125388716|NCT01549964|451056671|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
125388717|NCT01549964|451056672|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
125388718|NCT01549964|451056669|FG000|80-Week Extension Period|Lost to Follow-up|1|||
125388719|NCT01549964|451056670|FG001|80-Week Extension Period|Lost to Follow-up|0|||
125388720|NCT01549964|451056671|FG002|80-Week Extension Period|Lost to Follow-up|2|||
125388721|NCT01549964|451056672|FG003|80-Week Extension Period|Lost to Follow-up|1|||
125388722|NCT01549964|451056669|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
125388723|NCT01549964|451056670|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
125388724|NCT01549964|451056671|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
125388725|NCT01549964|451056672|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
125388726|NCT02290821|451056673|FG000|Overall Study|Withdrawal by Subject|1|||
125388727|NCT02290821|451056674|FG001|Overall Study|Withdrawal by Subject|1|||
125388728|NCT02290821|451056673|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
125388729|NCT02290821|451056674|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
125388730|NCT02290821|451056673|FG000|Overall Study|Lost to Follow-up|3|||
125388731|NCT02290821|451056674|FG001|Overall Study|Lost to Follow-up|2|||
125388732|NCT02438722|451056675|FG000|Overall Study|Adverse Event|12|||
125388733|NCT02438722|451056676|FG001|Overall Study|Adverse Event|9|||
125388734|NCT02438722|451056675|FG000|Overall Study|Refusal unrelated to AE|2|||
125388735|NCT02438722|451056676|FG001|Overall Study|Refusal unrelated to AE|5|||
125388736|NCT02438722|451056675|FG000|Overall Study|Disease progression/relapse|46|||
125388737|NCT02438722|451056676|FG001|Overall Study|Disease progression/relapse|51|||
125388738|NCT02438722|451056675|FG000|Overall Study|Death|0|||
125388739|NCT02438722|451056676|FG001|Overall Study|Death|3|||
125388740|NCT02438722|451056675|FG000|Overall Study|Physician Decision|2|||
125388741|NCT02438722|451056676|FG001|Overall Study|Physician Decision|2|||
125388742|NCT02438722|451056675|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
125388743|NCT02438722|451056676|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
125388744|NCT02438722|451056675|FG000|Overall Study|Withdrawal by Subject|0|||
125388745|NCT02438722|451056676|FG001|Overall Study|Withdrawal by Subject|1|||
125388746|NCT02438722|451056675|FG000|Overall Study|On protocol treatment|15|||
125388747|NCT02438722|451056676|FG001|Overall Study|On protocol treatment|14|||
125388748|NCT02438722|451056675|FG000|Overall Study|Did not receive protocol treatment|5|||
125388749|NCT02438722|451056676|FG001|Overall Study|Did not receive protocol treatment|0|||
125388750|NCT00728130|451056677|FG000|Overall Study|Withdrawal by Subject|1|||
125388751|NCT00728130|451056677|FG000|Overall Study|Paperwork not completed in time|1|||
125388752|NCT00728130|451056677|FG000|Overall Study|Physician Decision|1|||
125388753|NCT01737047|451056678|FG000|Overall Study|Death|10|||
125388754|NCT01737047|451056679|FG001|Overall Study|Death|0|||
125388755|NCT01737047|451056680|FG002|Overall Study|Death|1|||
125153472|NCT02243293|450185143|FG000|Overall Study|Adverse Event|1|||
125153473|NCT02243293|450185144|FG001|Overall Study|Adverse Event|0|||
125153474|NCT02243293|450185145|FG002|Overall Study|Adverse Event|0|||
125153475|NCT02243293|450185146|FG003|Overall Study|Adverse Event|0|||
125153476|NCT02243293|450185147|FG004|Overall Study|Adverse Event|0|||
125153477|NCT02243293|450185148|FG005|Overall Study|Adverse Event|0|||
125153478|NCT02243293|450185149|FG006|Overall Study|Adverse Event|0|||
125153479|NCT02243293|450185150|FG007|Overall Study|Adverse Event|0|||
125153480|NCT02243293|450185151|FG008|Overall Study|Adverse Event|0|||
125153481|NCT02243293|450185152|FG009|Overall Study|Adverse Event|0|||
125153482|NCT02243293|450185153|FG010|Overall Study|Adverse Event|0|||
125153483|NCT02243293|450185154|FG011|Overall Study|Adverse Event|0|||
125153484|NCT02243293|450185155|FG012|Overall Study|Adverse Event|0|||
125153485|NCT02243293|450185156|FG013|Overall Study|Adverse Event|0|||
125153486|NCT02243293|450185157|FG014|Overall Study|Adverse Event|0|||
125153487|NCT02243293|450185158|FG015|Overall Study|Adverse Event|1|||
125153488|NCT02243293|450185159|FG016|Overall Study|Adverse Event|0|||
125153489|NCT02243293|450185160|FG017|Overall Study|Adverse Event|0|||
125153490|NCT02243293|450185161|FG018|Overall Study|Adverse Event|0|||
125153491|NCT02243293|450185162|FG019|Overall Study|Adverse Event|0|||
125153492|NCT02243293|450185163|FG020|Overall Study|Adverse Event|1|||
125153493|NCT02243293|450185164|FG021|Overall Study|Adverse Event|0|||
125153494|NCT02243293|450185143|FG000|Overall Study|Withdrawal by Subject|1|||
125153495|NCT02243293|450185144|FG001|Overall Study|Withdrawal by Subject|0|||
125153496|NCT02243293|450185145|FG002|Overall Study|Withdrawal by Subject|0|||
125153497|NCT02243293|450185146|FG003|Overall Study|Withdrawal by Subject|0|||
125153498|NCT02243293|450185147|FG004|Overall Study|Withdrawal by Subject|0|||
125153499|NCT02243293|450185148|FG005|Overall Study|Withdrawal by Subject|0|||
125388756|NCT01737047|451056678|FG000|Overall Study|Withdrawal by Subject|17|||
125153500|NCT02243293|450185149|FG006|Overall Study|Withdrawal by Subject|0|||
125153501|NCT02243293|450185150|FG007|Overall Study|Withdrawal by Subject|0|||
125153502|NCT02243293|450185151|FG008|Overall Study|Withdrawal by Subject|0|||
125153503|NCT02243293|450185152|FG009|Overall Study|Withdrawal by Subject|1|||
125153504|NCT02243293|450185153|FG010|Overall Study|Withdrawal by Subject|0|||
125153505|NCT02243293|450185154|FG011|Overall Study|Withdrawal by Subject|1|||
125153506|NCT02243293|450185155|FG012|Overall Study|Withdrawal by Subject|0|||
125153507|NCT02243293|450185156|FG013|Overall Study|Withdrawal by Subject|0|||
125153508|NCT02243293|450185157|FG014|Overall Study|Withdrawal by Subject|0|||
125153509|NCT02243293|450185158|FG015|Overall Study|Withdrawal by Subject|0|||
125153510|NCT02243293|450185159|FG016|Overall Study|Withdrawal by Subject|0|||
125153511|NCT02243293|450185160|FG017|Overall Study|Withdrawal by Subject|0|||
125153512|NCT02243293|450185161|FG018|Overall Study|Withdrawal by Subject|0|||
125153513|NCT02243293|450185162|FG019|Overall Study|Withdrawal by Subject|0|||
125153514|NCT02243293|450185163|FG020|Overall Study|Withdrawal by Subject|0|||
125153515|NCT02243293|450185164|FG021|Overall Study|Withdrawal by Subject|1|||
125153516|NCT02243293|450185143|FG000|Overall Study|Lost to Follow-up|0|||
125153517|NCT02243293|450185144|FG001|Overall Study|Lost to Follow-up|1|||
125153518|NCT02243293|450185145|FG002|Overall Study|Lost to Follow-up|1|||
125153519|NCT02243293|450185146|FG003|Overall Study|Lost to Follow-up|1|||
125153520|NCT02243293|450185147|FG004|Overall Study|Lost to Follow-up|0|||
125153521|NCT02243293|450185148|FG005|Overall Study|Lost to Follow-up|0|||
125153522|NCT02243293|450185149|FG006|Overall Study|Lost to Follow-up|3|||
125153523|NCT02243293|450185150|FG007|Overall Study|Lost to Follow-up|0|||
125153524|NCT02243293|450185151|FG008|Overall Study|Lost to Follow-up|0|||
125153525|NCT02243293|450185152|FG009|Overall Study|Lost to Follow-up|0|||
125153526|NCT02243293|450185153|FG010|Overall Study|Lost to Follow-up|0|||
125153527|NCT02243293|450185154|FG011|Overall Study|Lost to Follow-up|2|||
125153528|NCT02243293|450185155|FG012|Overall Study|Lost to Follow-up|0|||
125153529|NCT02243293|450185156|FG013|Overall Study|Lost to Follow-up|0|||
125153530|NCT02243293|450185157|FG014|Overall Study|Lost to Follow-up|0|||
125153531|NCT02243293|450185158|FG015|Overall Study|Lost to Follow-up|0|||
125153532|NCT02243293|450185159|FG016|Overall Study|Lost to Follow-up|3|||
125153533|NCT02243293|450185160|FG017|Overall Study|Lost to Follow-up|1|||
125153534|NCT02243293|450185161|FG018|Overall Study|Lost to Follow-up|0|||
125153535|NCT02243293|450185162|FG019|Overall Study|Lost to Follow-up|0|||
125153536|NCT02243293|450185163|FG020|Overall Study|Lost to Follow-up|1|||
125153537|NCT02243293|450185164|FG021|Overall Study|Lost to Follow-up|2|||
125153538|NCT02243293|450185143|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
125153539|NCT02243293|450185144|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
125153540|NCT02243293|450185145|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
125153541|NCT02243293|450185146|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
125153542|NCT02243293|450185147|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
125153543|NCT02243293|450185148|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
125153544|NCT02243293|450185149|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
125153545|NCT02243293|450185150|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
125153546|NCT02243293|450185151|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
125153547|NCT02243293|450185152|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
125153548|NCT02243293|450185153|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
125153549|NCT02243293|450185154|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
125153550|NCT02243293|450185155|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
125153551|NCT02243293|450185156|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
125153552|NCT02243293|450185157|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
125153553|NCT02243293|450185158|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
125153554|NCT02243293|450185159|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
125153555|NCT02243293|450185160|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
125153556|NCT02243293|450185161|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
125153557|NCT02243293|450185162|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
125153558|NCT02243293|450185163|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
125153559|NCT02243293|450185164|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
125153560|NCT02243293|450185143|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
125153561|NCT02243293|450185144|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
125153562|NCT02243293|450185145|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
125153563|NCT02243293|450185146|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
125153564|NCT02243293|450185147|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
125153565|NCT02243293|450185148|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
125153566|NCT02243293|450185149|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
125153567|NCT02243293|450185150|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
125153568|NCT02243293|450185151|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
125153569|NCT02243293|450185152|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
125153570|NCT02243293|450185153|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
125153571|NCT02243293|450185154|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
125153572|NCT02243293|450185155|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
125153573|NCT02243293|450185156|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
125153574|NCT02243293|450185157|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
125153575|NCT02243293|450185158|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
125153576|NCT02243293|450185159|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
125153577|NCT02243293|450185160|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
125153578|NCT02243293|450185161|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
125153579|NCT02243293|450185162|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
125153580|NCT02243293|450185163|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
125153581|NCT02243293|450185164|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
125153582|NCT02181296|450185165|FG000|Overall Study|Lost to Follow-up|7|||
125153583|NCT02181296|450185166|FG001|Overall Study|Lost to Follow-up|6|||
125153584|NCT02658487|450186687|FG000|Overall Study|Death|2|||
125388757|NCT01737047|451056679|FG001|Overall Study|Withdrawal by Subject|11|||
125388758|NCT01737047|451056680|FG002|Overall Study|Withdrawal by Subject|4|||
125388759|NCT01154218|451056681|FG000|Third Intervention Period|Adverse Event|0|||
125388760|NCT01154218|451056682|FG001|Third Intervention Period|Adverse Event|1|||
125388761|NCT01154218|451056683|FG002|Third Intervention Period|Adverse Event|0|||
125388762|NCT01154218|451056684|FG003|Third Intervention Period|Adverse Event|0|||
125388763|NCT01154218|451056681|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
125388764|NCT01154218|451056682|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
125388765|NCT01154218|451056683|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
125388766|NCT01154218|451056684|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
125388767|NCT01154218|451056681|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
125388768|NCT01154218|451056682|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
125153585|NCT02658487|450186687|FG000|Overall Study|Disease progression|10|||
125153586|NCT02658487|450186687|FG000|Overall Study|Alternative therapy|1|||
125153587|NCT02658487|450186687|FG000|Overall Study|Adverse Event|1|||
125153588|NCT02658487|450186687|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
125153589|NCT02658487|450186687|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
125153590|NCT00614926|450186695|FG000|Overall Study|Burden of travel|1|||
125153591|NCT00614926|450186696|FG001|Overall Study|Burden of travel|0|||
125153592|NCT00614926|450186695|FG000|Overall Study|Adverse Event|3|||
125153593|NCT00614926|450186696|FG001|Overall Study|Adverse Event|0|||
125153594|NCT00856830|450186699|FG000|Irinotecan & Bendamustine|Death|0|||
125153595|NCT00856830|450186700|FG001|Irinotecan & Bendamustine|Death|0|||
125153596|NCT00856830|450186701|FG002|Irinotecan & Bendamustine|Death|0|||
125153597|NCT00856830|450186702|FG003|Irinotecan & Bendamustine|Death|2|||
125153598|NCT00856830|450186699|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
125153599|NCT00856830|450186700|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
125153600|NCT00856830|450186701|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
125153601|NCT00856830|450186702|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
125153602|NCT02954159|450186704|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
125153603|NCT02954159|450186705|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
125153604|NCT02954159|450186704|FG000|Overall Study|Withdrawal by Subject|0|||
125153605|NCT02954159|450186705|FG001|Overall Study|Withdrawal by Subject|1|||
125153606|NCT01117337|450186712|FG000|Overall Study|Lost to Follow-up|4|||
125153607|NCT01117337|450186713|FG001|Overall Study|Lost to Follow-up|0|||
125153608|NCT03575871|450186714|FG000|Overall Study|Adverse Event|5|||
125153609|NCT03575871|450186715|FG001|Overall Study|Adverse Event|5|||
125153610|NCT03575871|450186716|FG002|Overall Study|Adverse Event|8|||
125153611|NCT03575871|450186714|FG000|Overall Study|Death|1|||
125153612|NCT03575871|450186715|FG001|Overall Study|Death|0|||
125153613|NCT03575871|450186716|FG002|Overall Study|Death|0|||
125153614|NCT03575871|450186714|FG000|Overall Study|Lack of Efficacy|5|||
125153615|NCT03575871|450186715|FG001|Overall Study|Lack of Efficacy|4|||
125153616|NCT03575871|450186716|FG002|Overall Study|Lack of Efficacy|7|||
125153617|NCT03575871|450186714|FG000|Overall Study|Lost to Follow-up|1|||
125153618|NCT03575871|450186715|FG001|Overall Study|Lost to Follow-up|1|||
125153619|NCT03575871|450186716|FG002|Overall Study|Lost to Follow-up|1|||
125153620|NCT03575871|450186714|FG000|Overall Study|Protocol Deviation|1|||
125153621|NCT03575871|450186715|FG001|Overall Study|Protocol Deviation|1|||
125153622|NCT03575871|450186716|FG002|Overall Study|Protocol Deviation|1|||
125153623|NCT03575871|450186714|FG000|Overall Study|Withdrawal by Subject|6|||
125153624|NCT03575871|450186715|FG001|Overall Study|Withdrawal by Subject|1|||
125153625|NCT03575871|450186716|FG002|Overall Study|Withdrawal by Subject|9|||
125388769|NCT01154218|451056683|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
125388770|NCT01154218|451056684|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
125438702|NCT01827254|451233929|FG000|Overall Study|Did not complete re-challenge|1|||
125153626|NCT03575871|450186714|FG000|Overall Study|Other than specified|2|||
125153627|NCT03575871|450186715|FG001|Overall Study|Other than specified|2|||
125388771|NCT00362115|451056687|FG000|Overall Study|Adverse Event|0|||
125388772|NCT00362115|451056688|FG001|Overall Study|Adverse Event|1|||
125438703|NCT01827254|451233929|FG000|Overall Study|Disease progression|36|||
125438704|NCT01827254|451233929|FG000|Overall Study|Intolerance to treatment|4|||
125438705|NCT01923389|451233930|FG000|Overall Study|Protocol Violation|1|||
125153628|NCT03575871|450186716|FG002|Overall Study|Other than specified|0|||
125153629|NCT02791893|450186719|FG000|Blinded Phase|Lost to Follow-up|2|||
125153630|NCT02791893|450186720|FG001|Blinded Phase|Lost to Follow-up|2|||
125153631|NCT02791893|450186719|FG000|Blinded Phase|Withdrawal by Subject|1|||
125153632|NCT02791893|450186720|FG001|Blinded Phase|Withdrawal by Subject|2|||
125153633|NCT02791893|450186719|FG000|Open Label Phase|Lost to Follow-up|3|||
125153634|NCT02791893|450186720|FG001|Open Label Phase|Lost to Follow-up|0|||
125153635|NCT02791893|450186719|FG000|Open Label Phase|Withdrawal by Subject|0|||
125153636|NCT02791893|450186720|FG001|Open Label Phase|Withdrawal by Subject|2|||
125153637|NCT01744093|450186724|FG000|Overall Study|Withdrawal by Subject|6|||
125153638|NCT01744093|450186725|FG001|Overall Study|Withdrawal by Subject|1|||
125153639|NCT01570283|450186726|FG000|Cohort 1: Dose Level 1|Death|0|||
125153640|NCT01570283|450186727|FG001|Cohort 1: Dose Level 1|Death|1|||
125153641|NCT01570283|450186728|FG002|Cohort 1: Dose Level 1|Death|0|||
125153642|NCT01570283|450186729|FG003|Cohort 1: Dose Level 1|Death|0|||
125153643|NCT01570283|450186730|FG004|Cohort 1: Dose Level 1|Death|0|||
125153644|NCT01570283|450186731|FG005|Cohort 1: Dose Level 1|Death|0|||
125153645|NCT01570283|450186726|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
125153646|NCT01570283|450186727|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
125153647|NCT01570283|450186728|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
125153648|NCT01570283|450186729|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
125153649|NCT01570283|450186730|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
125153650|NCT01570283|450186731|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
125153651|NCT01570283|450186726|FG000|Cohort 2: Dose Level 2|Death|0|||
125153652|NCT01570283|450186727|FG001|Cohort 2: Dose Level 2|Death|0|||
125153653|NCT01570283|450186728|FG002|Cohort 2: Dose Level 2|Death|1|||
125153654|NCT01570283|450186729|FG003|Cohort 2: Dose Level 2|Death|0|||
125153655|NCT01570283|450186730|FG004|Cohort 2: Dose Level 2|Death|0|||
125153656|NCT01570283|450186731|FG005|Cohort 2: Dose Level 2|Death|0|||
125153657|NCT01570283|450186726|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
125153658|NCT01570283|450186727|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
125153659|NCT01570283|450186728|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
125153660|NCT01570283|450186729|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
125153661|NCT01570283|450186730|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
125153662|NCT01570283|450186731|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
125153663|NCT01570283|450186726|FG000|Cohort 3: Dose Level 3|Death|0|||
125153664|NCT01570283|450186727|FG001|Cohort 3: Dose Level 3|Death|0|||
125153665|NCT01570283|450186728|FG002|Cohort 3: Dose Level 3|Death|0|||
125153666|NCT01570283|450186729|FG003|Cohort 3: Dose Level 3|Death|0|||
125153667|NCT01570283|450186730|FG004|Cohort 3: Dose Level 3|Death|0|||
125153668|NCT01570283|450186731|FG005|Cohort 3: Dose Level 3|Death|1|||
125153669|NCT01570283|450186726|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
125153670|NCT01570283|450186727|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
125153671|NCT01570283|450186728|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
125153672|NCT01570283|450186729|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
125153673|NCT01570283|450186730|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
125153674|NCT01570283|450186731|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
125153675|NCT00685802|450186736|FG000|Washout Period of 7 Days|Protocol Violation|2|||
125153676|NCT00685802|450186737|FG001|Washout Period of 7 Days|Protocol Violation|0|||
125153677|NCT00685802|450186736|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
125153678|NCT00685802|450186737|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125153679|NCT02025010|450186741|FG000|Overall Study|Symptomatic or radiographic progression|36|||
125153680|NCT02025010|450186741|FG000|Overall Study|Adverse Event|6|||
125153681|NCT02025010|450186741|FG000|Overall Study|Physician Decision|7|||
125153682|NCT02025010|450186741|FG000|Overall Study|Withdrawal by Subject|3|||
125438706|NCT01923389|451233931|FG001|Overall Study|Protocol Violation|0|||
125438707|NCT03292146|451233932|FG000|Baseline to 12 Months|Relocation|1|||
125438708|NCT03292146|451233933|FG001|Baseline to 12 Months|Relocation|0|||
125438709|NCT03292146|451233932|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
125438710|NCT03292146|451233933|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
125438711|NCT03292146|451233932|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
125438712|NCT03292146|451233933|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
125438713|NCT03292146|451233932|FG000|12 Months to 24 Months|Planning pregnancy|2|||
125438714|NCT03292146|451233933|FG001|12 Months to 24 Months|Planning pregnancy|2|||
125438715|NCT03292146|451233932|FG000|12 Months to 24 Months|Personal reasons|1|||
125438716|NCT03292146|451233933|FG001|12 Months to 24 Months|Personal reasons|0|||
125153683|NCT02025010|450186741|FG000|Overall Study|Intercurrent illness|3|||
125153684|NCT02025010|450186741|FG000|Overall Study|Patients still on treatment|3|||
125153685|NCT02025010|450186741|FG000|Overall Study|Never initiate the treatment|2|||
125153686|NCT00949988|450186742|FG000|Overall Study|Withdrawal by Subject|3|||
125438717|NCT03292146|451233932|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
125438718|NCT03292146|451233933|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
125438719|NCT00545363|451233936|FG000|Overall Study|Adverse Event|6|||
125153687|NCT05212883|450186746|FG000|Overall Study|Invalid test result|125|||
125153688|NCT03095118|450186750|FG000|Overall Study|Adverse Event|1|||
125153689|NCT03095118|450186750|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
125153690|NCT03847194|450186751|FG000|Overall Study|Lost to Follow-up|2|||
125153691|NCT03847194|450186752|FG001|Overall Study|Lost to Follow-up|5|||
125153692|NCT03847194|450186751|FG000|Overall Study|Withdrawal by Subject|1|||
125438720|NCT00545363|451233937|FG001|Overall Study|Adverse Event|7|||
125153693|NCT03847194|450186752|FG001|Overall Study|Withdrawal by Subject|2|||
125153694|NCT03847194|450186751|FG000|Overall Study|Death|0|||
125153695|NCT03847194|450186752|FG001|Overall Study|Death|1|||
125153696|NCT02408120|450186753|FG000|Overall Study|Withdrawal by Subject|0|||
125153697|NCT02408120|450186754|FG001|Overall Study|Withdrawal by Subject|1|||
125153698|NCT02408120|450186753|FG000|Overall Study|Treatment Refusal|1|||
125153699|NCT02408120|450186754|FG001|Overall Study|Treatment Refusal|0|||
125153700|NCT02408120|450186753|FG000|Overall Study|Received Steroids|1|||
125153701|NCT02408120|450186754|FG001|Overall Study|Received Steroids|1|||
125153702|NCT02408120|450186753|FG000|Overall Study|Discharged same day|1|||
125153703|NCT02408120|450186754|FG001|Overall Study|Discharged same day|1|||
125153704|NCT02408120|450186753|FG000|Overall Study|Did not receive insulin|1|||
125153705|NCT02408120|450186754|FG001|Overall Study|Did not receive insulin|2|||
125153706|NCT01144403|450186755|FG000|Overall Study|Lost to Follow-up|3|||
125153707|NCT01144403|450186755|FG000|Overall Study|Death|1|||
125153708|NCT01144403|450186755|FG000|Overall Study|Adverse Event|1|||
125153709|NCT03176784|450186756|FG000|Overall Study|Lost to Follow-up|77|||
125153710|NCT03176784|450186757|FG001|Overall Study|Lost to Follow-up|79|||
125153711|NCT03176784|450186758|FG002|Overall Study|Lost to Follow-up|79|||
125153712|NCT03176784|450186759|FG003|Overall Study|Lost to Follow-up|49|||
125153713|NCT03176784|450186756|FG000|Overall Study|Withdrawal by Subject|28|||
125153714|NCT03176784|450186757|FG001|Overall Study|Withdrawal by Subject|34|||
125153715|NCT03176784|450186758|FG002|Overall Study|Withdrawal by Subject|34|||
125153716|NCT03176784|450186759|FG003|Overall Study|Withdrawal by Subject|21|||
125153717|NCT01825837|450186760|FG000|PART I|Withdrawal by Subject|0|||
125153718|NCT01825837|450186761|FG001|PART I|Withdrawal by Subject|0|||
125153719|NCT01825837|450186762|FG002|PART I|Withdrawal by Subject|0|||
125153720|NCT01825837|450186763|FG003|PART I|Withdrawal by Subject|6|||
125153721|NCT01825837|450186760|FG000|PART I|Patient non-compliance|0|||
125153722|NCT01825837|450186761|FG001|PART I|Patient non-compliance|0|||
125153723|NCT01825837|450186762|FG002|PART I|Patient non-compliance|0|||
125153724|NCT01825837|450186763|FG003|PART I|Patient non-compliance|1|||
125153725|NCT01825837|450186760|FG000|PART I|Treatment failure|0|||
125153726|NCT01825837|450186761|FG001|PART I|Treatment failure|0|||
125153727|NCT01825837|450186762|FG002|PART I|Treatment failure|0|||
125153728|NCT01825837|450186763|FG003|PART I|Treatment failure|7|||
125153729|NCT01825837|450186760|FG000|PART I|reason unspecified|0|||
125153730|NCT01825837|450186761|FG001|PART I|reason unspecified|0|||
125153731|NCT01825837|450186762|FG002|PART I|reason unspecified|0|||
125153732|NCT01825837|450186763|FG003|PART I|reason unspecified|3|||
125153733|NCT01825837|450186760|FG000|PART II|Withdrawal by Subject|3|||
125153734|NCT01825837|450186761|FG001|PART II|Withdrawal by Subject|3|||
125153735|NCT01825837|450186762|FG002|PART II|Withdrawal by Subject|7|||
125153736|NCT01825837|450186763|FG003|PART II|Withdrawal by Subject|0|||
125153737|NCT01825837|450186760|FG000|PART II|Patient non-compliance|5|||
125153738|NCT01825837|450186761|FG001|PART II|Patient non-compliance|2|||
125153739|NCT01825837|450186762|FG002|PART II|Patient non-compliance|4|||
125153740|NCT01825837|450186763|FG003|PART II|Patient non-compliance|0|||
125153741|NCT01825837|450186760|FG000|PART II|Adverse Event|3|||
125153742|NCT01825837|450186761|FG001|PART II|Adverse Event|3|||
125153743|NCT01825837|450186762|FG002|PART II|Adverse Event|1|||
125153744|NCT01825837|450186763|FG003|PART II|Adverse Event|0|||
125153745|NCT01825837|450186760|FG000|PART II|Treatment failure|6|||
125153746|NCT01825837|450186761|FG001|PART II|Treatment failure|4|||
125153747|NCT01825837|450186762|FG002|PART II|Treatment failure|5|||
125153748|NCT01825837|450186763|FG003|PART II|Treatment failure|0|||
125153749|NCT01825837|450186760|FG000|PART II|reason unspecified|2|||
125153750|NCT01825837|450186761|FG001|PART II|reason unspecified|2|||
125153751|NCT01825837|450186762|FG002|PART II|reason unspecified|2|||
125153752|NCT01825837|450186763|FG003|PART II|reason unspecified|0|||
125153753|NCT00904748|450186764|FG000|Overall Study|Withdrawal by Subject|1|||
125153754|NCT00904748|450186765|FG001|Overall Study|Withdrawal by Subject|1|||
125153755|NCT00904748|450186766|FG002|Overall Study|Withdrawal by Subject|1|||
125153756|NCT00904748|450186767|FG003|Overall Study|Withdrawal by Subject|2|||
125153757|NCT00904748|450186768|FG004|Overall Study|Withdrawal by Subject|0|||
125153758|NCT00904748|450186769|FG005|Overall Study|Withdrawal by Subject|0|||
125153759|NCT00904748|450186764|FG000|Overall Study|Adverse Event|0|||
125153760|NCT00904748|450186765|FG001|Overall Study|Adverse Event|0|||
125153761|NCT00904748|450186766|FG002|Overall Study|Adverse Event|0|||
125153762|NCT00904748|450186767|FG003|Overall Study|Adverse Event|0|||
125153763|NCT00904748|450186768|FG004|Overall Study|Adverse Event|1|||
125153764|NCT00904748|450186769|FG005|Overall Study|Adverse Event|0|||
125153765|NCT00680186|450186775|FG000|Overall Study|Adverse Event|47|||
125153766|NCT00680186|450186776|FG001|Overall Study|Adverse Event|44|||
125153767|NCT00680186|450186775|FG000|Overall Study|Protocol Violation|31|||
125153768|NCT00680186|450186776|FG001|Overall Study|Protocol Violation|26|||
125153769|NCT00680186|450186775|FG000|Overall Study|Lost to Follow-up|11|||
125153770|NCT00680186|450186776|FG001|Overall Study|Lost to Follow-up|6|||
125153771|NCT00680186|450186775|FG000|Overall Study|Withdrawal by Subject|32|||
125153772|NCT00680186|450186776|FG001|Overall Study|Withdrawal by Subject|39|||
125153773|NCT00680186|450186775|FG000|Overall Study|Other|4|||
125153774|NCT00680186|450186776|FG001|Overall Study|Other|1|||
125153775|NCT00285584|450186784|FG000|Month 3|Lost to Follow-up|3|||
125153776|NCT00285584|450186785|FG001|Month 3|Lost to Follow-up|3|||
125153777|NCT00285584|450186784|FG000|Month 3|Withdrawal by Subject|1|||
125153778|NCT00285584|450186785|FG001|Month 3|Withdrawal by Subject|0|||
125153779|NCT00285584|450186784|FG000|Month 6|Lost to Follow-up|0|||
125153780|NCT00285584|450186785|FG001|Month 6|Lost to Follow-up|1|||
125153781|NCT00645944|450186786|FG000|Randomized|Withdrawal by Subject|1|||
125153782|NCT00645944|450186787|FG001|Randomized|Withdrawal by Subject|2|||
125153783|NCT00645944|450186786|FG000|Received Medication|Adverse Event|2|||
125153784|NCT00645944|450186787|FG001|Received Medication|Adverse Event|1|||
125153785|NCT00645944|450186786|FG000|Received Medication|Withdrawal by Subject|1|||
125153786|NCT00645944|450186787|FG001|Received Medication|Withdrawal by Subject|1|||
125153787|NCT00645944|450186786|FG000|Received Medication|Lost to Follow-up|1|||
125153788|NCT00645944|450186787|FG001|Received Medication|Lost to Follow-up|0|||
125153789|NCT00645944|450186786|FG000|Received Medication|Protocol Violation|2|||
125153790|NCT00645944|450186787|FG001|Received Medication|Protocol Violation|1|||
125153791|NCT01523587|450186789|FG000|Overall Study|Other than listed|5|||
125153792|NCT01523587|450186790|FG001|Overall Study|Other than listed|5|||
125153793|NCT01523587|450186789|FG000|Overall Study|Worsening of underlying cancer disease|19|||
125153794|NCT01523587|450186790|FG001|Overall Study|Worsening of underlying cancer disease|34|||
125153795|NCT01523587|450186789|FG000|Overall Study|Adverse Event|68|||
125153796|NCT01523587|450186790|FG001|Overall Study|Adverse Event|52|||
125153797|NCT01523587|450186789|FG000|Overall Study|Protocol Violation|5|||
125153798|NCT01523587|450186790|FG001|Overall Study|Protocol Violation|3|||
125153799|NCT01523587|450186789|FG000|Overall Study|Lost to Follow-up|2|||
125153800|NCT01523587|450186790|FG001|Overall Study|Lost to Follow-up|2|||
125153801|NCT01523587|450186789|FG000|Overall Study|Withdrawal by Subject|28|||
125153802|NCT01523587|450186790|FG001|Overall Study|Withdrawal by Subject|20|||
125153803|NCT01523587|450186789|FG000|Overall Study|Withdrew due to Progressive disease|265|||
125153804|NCT01523587|450186790|FG001|Overall Study|Withdrew due to Progressive disease|279|||
125153805|NCT01523587|450186789|FG000|Overall Study|Randomised but bot treated|6|||
125153806|NCT01523587|450186790|FG001|Overall Study|Randomised but bot treated|2|||
125153807|NCT01298778|450186791|FG000|Overall Study|Lost to Follow-up|2|||
125153808|NCT01298778|450186792|FG001|Overall Study|Lost to Follow-up|3|||
125153809|NCT01298778|450186791|FG000|Overall Study|Incorrect use of VAS|1|||
125153810|NCT01298778|450186792|FG001|Overall Study|Incorrect use of VAS|0|||
125153811|NCT01298778|450186791|FG000|Overall Study|Withdrawal by Subject|0|||
125153812|NCT01298778|450186792|FG001|Overall Study|Withdrawal by Subject|1|||
125153813|NCT01298778|450186791|FG000|Overall Study|Protocol Violation|0|||
125153814|NCT01298778|450186792|FG001|Overall Study|Protocol Violation|1|||
125153815|NCT01298778|450186791|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
125153816|NCT01298778|450186792|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
125153817|NCT04965389|450186793|FG000|Overall Study|Other reasons|1|||
125153818|NCT04965389|450186794|FG001|Overall Study|Other reasons|0|||
125153819|NCT04965389|450186795|FG002|Overall Study|Other reasons|0|||
125153820|NCT04965389|450186796|FG003|Overall Study|Other reasons|0|||
125153821|NCT04965389|450186793|FG000|Overall Study|Participant withdrew consent|0|||
125153822|NCT04965389|450186794|FG001|Overall Study|Participant withdrew consent|1|||
125153823|NCT04965389|450186795|FG002|Overall Study|Participant withdrew consent|0|||
125153824|NCT04965389|450186796|FG003|Overall Study|Participant withdrew consent|0|||
125153825|NCT04965389|450186793|FG000|Overall Study|Poor/Non-compliance|0|||
125153826|NCT04965389|450186794|FG001|Overall Study|Poor/Non-compliance|1|||
125153827|NCT04965389|450186795|FG002|Overall Study|Poor/Non-compliance|0|||
125153828|NCT04965389|450186796|FG003|Overall Study|Poor/Non-compliance|0|||
125153829|NCT02709486|450186799|FG000|Overall Study|Adverse Event|2|||
125153830|NCT02709486|450186800|FG001|Overall Study|Adverse Event|5|||
125153831|NCT02709486|450186801|FG002|Overall Study|Adverse Event|3|||
125153832|NCT02709486|450186799|FG000|Overall Study|Death|0|||
125153833|NCT02709486|450186800|FG001|Overall Study|Death|0|||
125153834|NCT02709486|450186801|FG002|Overall Study|Death|2|||
125153835|NCT02709486|450186799|FG000|Overall Study|Insufficient clinical response|7|||
125153836|NCT02709486|450186800|FG001|Overall Study|Insufficient clinical response|3|||
125153837|NCT02709486|450186801|FG002|Overall Study|Insufficient clinical response|3|||
125153838|NCT02709486|450186799|FG000|Overall Study|Lost to Follow-up|3|||
125153839|NCT02709486|450186800|FG001|Overall Study|Lost to Follow-up|2|||
125153840|NCT02709486|450186801|FG002|Overall Study|Lost to Follow-up|2|||
125153841|NCT02709486|450186799|FG000|Overall Study|Other|0|||
125153842|NCT02709486|450186800|FG001|Overall Study|Other|2|||
125153843|NCT02709486|450186801|FG002|Overall Study|Other|3|||
125153844|NCT02709486|450186799|FG000|Overall Study|Withdrawal by Subject|32|||
125153845|NCT02709486|450186800|FG001|Overall Study|Withdrawal by Subject|22|||
125153846|NCT02709486|450186801|FG002|Overall Study|Withdrawal by Subject|32|||
125153847|NCT01855048|450186811|FG000|Overall Study|Withdrawal by Subject|0|||
125153848|NCT01855048|450186812|FG001|Overall Study|Withdrawal by Subject|1|||
125153849|NCT01855048|450186813|FG002|Overall Study|Withdrawal by Subject|0|||
125153850|NCT01855048|450186814|FG003|Overall Study|Withdrawal by Subject|0|||
125153851|NCT01855048|450186815|FG004|Overall Study|Withdrawal by Subject|1|||
125153852|NCT01855048|450186816|FG005|Overall Study|Withdrawal by Subject|0|||
125153853|NCT02139124|450186817|FG000|Overall Study|Adverse Event|2|||
125153854|NCT02139124|450186818|FG001|Overall Study|Adverse Event|0|||
125153855|NCT02139124|450186819|FG002|Overall Study|Adverse Event|1|||
125153856|NCT02139124|450186820|FG003|Overall Study|Adverse Event|2|||
125153857|NCT02139124|450186821|FG004|Overall Study|Adverse Event|5|||
125153858|NCT02139124|450186817|FG000|Overall Study|Withdrawal by Subject|2|||
125153859|NCT02139124|450186818|FG001|Overall Study|Withdrawal by Subject|2|||
125153860|NCT02139124|450186819|FG002|Overall Study|Withdrawal by Subject|2|||
125153861|NCT02139124|450186820|FG003|Overall Study|Withdrawal by Subject|2|||
125153862|NCT02139124|450186821|FG004|Overall Study|Withdrawal by Subject|3|||
125153863|NCT02139124|450186817|FG000|Overall Study|Protocol Violation|0|||
125153864|NCT02139124|450186818|FG001|Overall Study|Protocol Violation|0|||
125153865|NCT02139124|450186819|FG002|Overall Study|Protocol Violation|0|||
125153866|NCT02139124|450186820|FG003|Overall Study|Protocol Violation|1|||
125153867|NCT02139124|450186821|FG004|Overall Study|Protocol Violation|1|||
125153868|NCT02139124|450186817|FG000|Overall Study|non-compliant|1|||
125153869|NCT02139124|450186818|FG001|Overall Study|non-compliant|0|||
125153870|NCT02139124|450186819|FG002|Overall Study|non-compliant|0|||
125153871|NCT02139124|450186820|FG003|Overall Study|non-compliant|2|||
125153872|NCT02139124|450186821|FG004|Overall Study|non-compliant|0|||
125153873|NCT02139124|450186817|FG000|Overall Study|incarceration|0|||
125153874|NCT02139124|450186818|FG001|Overall Study|incarceration|0|||
125153875|NCT02139124|450186819|FG002|Overall Study|incarceration|1|||
125153876|NCT02139124|450186820|FG003|Overall Study|incarceration|0|||
125153877|NCT02139124|450186821|FG004|Overall Study|incarceration|0|||
125153878|NCT02139124|450186817|FG000|Overall Study|subject moved|1|||
125153879|NCT02139124|450186818|FG001|Overall Study|subject moved|0|||
125153880|NCT02139124|450186819|FG002|Overall Study|subject moved|0|||
125153881|NCT02139124|450186820|FG003|Overall Study|subject moved|0|||
125153882|NCT02139124|450186821|FG004|Overall Study|subject moved|0|||
125153883|NCT02139124|450186817|FG000|Overall Study|Lost to Follow-up|3|||
125153884|NCT02139124|450186818|FG001|Overall Study|Lost to Follow-up|2|||
125153885|NCT02139124|450186819|FG002|Overall Study|Lost to Follow-up|0|||
125153886|NCT02139124|450186820|FG003|Overall Study|Lost to Follow-up|5|||
125153887|NCT02139124|450186821|FG004|Overall Study|Lost to Follow-up|4|||
125153888|NCT02691741|450186822|FG000|Overall Study|Adverse Event|0|||
125153889|NCT02691741|450186823|FG001|Overall Study|Adverse Event|2|||
125153890|NCT02691741|450186822|FG000|Overall Study|Lost to Follow-up|1|||
125153891|NCT02691741|450186823|FG001|Overall Study|Lost to Follow-up|0|||
125153892|NCT02691741|450186822|FG000|Overall Study|Physician Decision|0|||
125153893|NCT02691741|450186823|FG001|Overall Study|Physician Decision|1|||
125153894|NCT02691741|450186822|FG000|Overall Study|Withdrawal by Subject|0|||
125153895|NCT02691741|450186823|FG001|Overall Study|Withdrawal by Subject|4|||
125153896|NCT03465436|450186824|FG000|Period 1|Protocol Violation|0|||
125153897|NCT03465436|450186825|FG001|Period 1|Protocol Violation|0|||
125153898|NCT03465436|450186826|FG002|Period 1|Protocol Violation|1|||
125153899|NCT03465436|450186827|FG003|Period 1|Protocol Violation|0|||
125153900|NCT03465436|450186824|FG000|Period 2|Protocol Violation|0|||
125153901|NCT03465436|450186825|FG001|Period 2|Protocol Violation|1|||
125153902|NCT03465436|450186826|FG002|Period 2|Protocol Violation|0|||
125153903|NCT03465436|450186827|FG003|Period 2|Protocol Violation|0|||
125153904|NCT03465436|450186824|FG000|Period 3|Protocol Violation|1|||
125153905|NCT03465436|450186825|FG001|Period 3|Protocol Violation|1|||
125153906|NCT03465436|450186826|FG002|Period 3|Protocol Violation|0|||
125153907|NCT03465436|450186827|FG003|Period 3|Protocol Violation|0|||
125153908|NCT03465436|450186824|FG000|Period 4|Protocol Violation|0|||
125153909|NCT03465436|450186825|FG001|Period 4|Protocol Violation|0|||
125153910|NCT03465436|450186826|FG002|Period 4|Protocol Violation|1|||
125153911|NCT03465436|450186827|FG003|Period 4|Protocol Violation|0|||
125153912|NCT02697773|450186828|FG000|Overall Study|Adverse Event|2|||
125153913|NCT02697773|450186829|FG001|Overall Study|Adverse Event|1|||
125153914|NCT02697773|450186830|FG002|Overall Study|Adverse Event|2|||
125153915|NCT02697773|450186828|FG000|Overall Study|Death|0|||
125153916|NCT02697773|450186829|FG001|Overall Study|Death|0|||
125153917|NCT02697773|450186830|FG002|Overall Study|Death|2|||
125153918|NCT02697773|450186828|FG000|Overall Study|Lack of Efficacy|4|||
125153919|NCT02697773|450186829|FG001|Overall Study|Lack of Efficacy|6|||
125153920|NCT02697773|450186830|FG002|Overall Study|Lack of Efficacy|6|||
125438721|NCT00545363|451233936|FG000|Overall Study|Withdrawal by Subject|6|||
125153921|NCT02697773|450186828|FG000|Overall Study|Lost to Follow-up|5|||
125153922|NCT02697773|450186829|FG001|Overall Study|Lost to Follow-up|5|||
125153923|NCT02697773|450186830|FG002|Overall Study|Lost to Follow-up|7|||
125153924|NCT02697773|450186828|FG000|Overall Study|Other|15|||
125153925|NCT02697773|450186829|FG001|Overall Study|Other|11|||
125223847|NCT02421419|450446241|FG000|Overall Study|Physician Decision|0|||
125153926|NCT02697773|450186830|FG002|Overall Study|Other|10|||
125153927|NCT02697773|450186828|FG000|Overall Study|Protocol Violation|1|||
125153928|NCT02697773|450186829|FG001|Overall Study|Protocol Violation|1|||
125153929|NCT02697773|450186830|FG002|Overall Study|Protocol Violation|0|||
125153930|NCT02697773|450186828|FG000|Overall Study|Withdrawal by Subject|10|||
125153931|NCT02697773|450186829|FG001|Overall Study|Withdrawal by Subject|13|||
125438722|NCT00545363|451233937|FG001|Overall Study|Withdrawal by Subject|5|||
125438723|NCT00545363|451233936|FG000|Overall Study|Non-compliance|3|||
125153932|NCT02697773|450186830|FG002|Overall Study|Withdrawal by Subject|13|||
125153933|NCT02697773|450186828|FG000|Overall Study|Randomized but not treated|1|||
125153934|NCT02697773|450186829|FG001|Overall Study|Randomized but not treated|1|||
125153935|NCT02697773|450186830|FG002|Overall Study|Randomized but not treated|0|||
125153936|NCT01118117|450186831|FG000|Overall Study|Death|8|||
125153937|NCT01118117|450186832|FG001|Overall Study|Death|0|||
125153938|NCT01118117|450186831|FG000|Overall Study|Lost to Follow-up|6|||
125153939|NCT01118117|450186832|FG001|Overall Study|Lost to Follow-up|0|||
125153940|NCT01118117|450186831|FG000|Overall Study|Missed 12 Month Visit|7|||
125153941|NCT01118117|450186832|FG001|Overall Study|Missed 12 Month Visit|0|||
125153942|NCT02149121|450186834|FG000|Main Study Period|Lack of Efficacy|2|||
125153943|NCT02149121|450186835|FG001|Main Study Period|Lack of Efficacy|2|||
125153944|NCT02149121|450186836|FG002|Main Study Period|Lack of Efficacy|1|||
125153945|NCT02149121|450186837|FG003|Main Study Period|Lack of Efficacy|0|||
125153946|NCT02149121|450186838|FG004|Main Study Period|Lack of Efficacy|0|||
125153947|NCT02149121|450186839|FG005|Main Study Period|Lack of Efficacy|0|||
125153948|NCT02149121|450186840|FG006|Main Study Period|Lack of Efficacy|0|||
125153949|NCT02149121|450186834|FG000|Main Study Period|Withdrawal by Subject|9|||
125153950|NCT02149121|450186835|FG001|Main Study Period|Withdrawal by Subject|5|||
125153951|NCT02149121|450186836|FG002|Main Study Period|Withdrawal by Subject|1|||
125153952|NCT02149121|450186837|FG003|Main Study Period|Withdrawal by Subject|0|||
125153953|NCT02149121|450186838|FG004|Main Study Period|Withdrawal by Subject|0|||
125153954|NCT02149121|450186839|FG005|Main Study Period|Withdrawal by Subject|0|||
125153955|NCT02149121|450186840|FG006|Main Study Period|Withdrawal by Subject|0|||
125153956|NCT02149121|450186834|FG000|Main Study Period|Adverse Event|2|||
125153957|NCT02149121|450186835|FG001|Main Study Period|Adverse Event|5|||
125153958|NCT02149121|450186836|FG002|Main Study Period|Adverse Event|1|||
125153959|NCT02149121|450186837|FG003|Main Study Period|Adverse Event|0|||
125153960|NCT02149121|450186838|FG004|Main Study Period|Adverse Event|0|||
125153961|NCT02149121|450186839|FG005|Main Study Period|Adverse Event|0|||
125153962|NCT02149121|450186840|FG006|Main Study Period|Adverse Event|0|||
125153963|NCT02149121|450186834|FG000|Main Study Period|Protocol Violation|2|||
125153964|NCT02149121|450186835|FG001|Main Study Period|Protocol Violation|0|||
125153965|NCT02149121|450186836|FG002|Main Study Period|Protocol Violation|0|||
125153966|NCT02149121|450186837|FG003|Main Study Period|Protocol Violation|0|||
125153967|NCT02149121|450186838|FG004|Main Study Period|Protocol Violation|0|||
125153968|NCT02149121|450186839|FG005|Main Study Period|Protocol Violation|0|||
125153969|NCT02149121|450186840|FG006|Main Study Period|Protocol Violation|0|||
125153970|NCT02149121|450186834|FG000|Main Study Period|Lost to Follow-up|2|||
125153971|NCT02149121|450186835|FG001|Main Study Period|Lost to Follow-up|1|||
125153972|NCT02149121|450186836|FG002|Main Study Period|Lost to Follow-up|0|||
125153973|NCT02149121|450186837|FG003|Main Study Period|Lost to Follow-up|0|||
125153974|NCT02149121|450186838|FG004|Main Study Period|Lost to Follow-up|0|||
125153975|NCT02149121|450186839|FG005|Main Study Period|Lost to Follow-up|0|||
125153976|NCT02149121|450186840|FG006|Main Study Period|Lost to Follow-up|0|||
125153977|NCT02149121|450186834|FG000|Main Study Period|Death|1|||
125153978|NCT02149121|450186835|FG001|Main Study Period|Death|0|||
125153979|NCT02149121|450186836|FG002|Main Study Period|Death|0|||
125153980|NCT02149121|450186837|FG003|Main Study Period|Death|0|||
125153981|NCT02149121|450186838|FG004|Main Study Period|Death|0|||
125153982|NCT02149121|450186839|FG005|Main Study Period|Death|0|||
125153983|NCT02149121|450186840|FG006|Main Study Period|Death|0|||
125153984|NCT02149121|450186834|FG000|Main Study Period|Physician Decision|1|||
125153985|NCT02149121|450186835|FG001|Main Study Period|Physician Decision|0|||
125153986|NCT02149121|450186836|FG002|Main Study Period|Physician Decision|0|||
125153987|NCT02149121|450186837|FG003|Main Study Period|Physician Decision|0|||
125153988|NCT02149121|450186838|FG004|Main Study Period|Physician Decision|0|||
125153989|NCT02149121|450186839|FG005|Main Study Period|Physician Decision|0|||
125153990|NCT02149121|450186840|FG006|Main Study Period|Physician Decision|0|||
125153991|NCT02149121|450186834|FG000|Main Study Period|Developed any malignancy|0|||
125153992|NCT02149121|450186835|FG001|Main Study Period|Developed any malignancy|1|||
125438724|NCT00545363|451233937|FG001|Overall Study|Non-compliance|1|||
125153993|NCT02149121|450186836|FG002|Main Study Period|Developed any malignancy|1|||
125153994|NCT02149121|450186837|FG003|Main Study Period|Developed any malignancy|0|||
125153995|NCT02149121|450186838|FG004|Main Study Period|Developed any malignancy|0|||
125153996|NCT02149121|450186839|FG005|Main Study Period|Developed any malignancy|0|||
125153997|NCT02149121|450186840|FG006|Main Study Period|Developed any malignancy|0|||
125153998|NCT02149121|450186834|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
125153999|NCT02149121|450186835|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
125154000|NCT02149121|450186836|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
125154001|NCT02149121|450186837|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
125154002|NCT02149121|450186838|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
125154003|NCT02149121|450186839|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
125438725|NCT00545363|451233936|FG000|Overall Study|Did not meet entry criteria|1|||
125154004|NCT02149121|450186840|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
125154005|NCT02149121|450186834|FG000|Main Study Period|Disease progression|0|||
125154006|NCT02149121|450186835|FG001|Main Study Period|Disease progression|1|||
125154007|NCT02149121|450186836|FG002|Main Study Period|Disease progression|0|||
125154008|NCT02149121|450186837|FG003|Main Study Period|Disease progression|0|||
125154009|NCT02149121|450186838|FG004|Main Study Period|Disease progression|0|||
125154010|NCT02149121|450186839|FG005|Main Study Period|Disease progression|0|||
125154011|NCT02149121|450186840|FG006|Main Study Period|Disease progression|0|||
125154012|NCT02149121|450186834|FG000|Extension Study Period|Withdrawal by Subject|0|||
125154013|NCT02149121|450186835|FG001|Extension Study Period|Withdrawal by Subject|0|||
125154014|NCT02149121|450186836|FG002|Extension Study Period|Withdrawal by Subject|0|||
125154015|NCT02149121|450186837|FG003|Extension Study Period|Withdrawal by Subject|1|||
125154016|NCT02149121|450186838|FG004|Extension Study Period|Withdrawal by Subject|0|||
125154017|NCT02149121|450186839|FG005|Extension Study Period|Withdrawal by Subject|2|||
125154018|NCT02149121|450186840|FG006|Extension Study Period|Withdrawal by Subject|0|||
125154019|NCT03166124|450186841|FG000|Treatment Period 1|Adverse Event|0|||
125154020|NCT03166124|450186842|FG001|Treatment Period 1|Adverse Event|0|||
125154021|NCT03166124|450186843|FG002|Treatment Period 1|Adverse Event|1|||
125154022|NCT03166124|450186844|FG003|Treatment Period 1|Adverse Event|0|||
125154023|NCT03166124|450186841|FG000|Wash-out Period|Withdrawal by Subject|0|||
125154024|NCT03166124|450186842|FG001|Wash-out Period|Withdrawal by Subject|1|||
125154025|NCT03166124|450186843|FG002|Wash-out Period|Withdrawal by Subject|0|||
125154026|NCT03166124|450186844|FG003|Wash-out Period|Withdrawal by Subject|1|||
125154027|NCT03166124|450186841|FG000|Wash-out Period|Adverse Event|0|||
125154028|NCT03166124|450186842|FG001|Wash-out Period|Adverse Event|1|||
125154029|NCT03166124|450186843|FG002|Wash-out Period|Adverse Event|1|||
125154030|NCT03166124|450186844|FG003|Wash-out Period|Adverse Event|0|||
125154031|NCT00094094|450186850|FG000|Overall Study|Death|2|||
125154032|NCT00094094|450186850|FG000|Overall Study|Lack of Efficacy|23|||
125154033|NCT00094094|450186850|FG000|Overall Study|Adverse Event|7|||
125154034|NCT04974619|450188806|FG000|Overall Study|Lost to Follow-up|0|||
125154035|NCT04974619|450188807|FG001|Overall Study|Lost to Follow-up|0|||
125154036|NCT04974619|450188808|FG002|Overall Study|Lost to Follow-up|1|||
125154037|NCT04974619|450188806|FG000|Overall Study|Withdrawal by Subject|0|||
125154038|NCT04974619|450188807|FG001|Overall Study|Withdrawal by Subject|0|||
125154039|NCT04974619|450188808|FG002|Overall Study|Withdrawal by Subject|1|||
125154040|NCT04974619|450188806|FG000|Overall Study|Protocol Violation|0|||
125154041|NCT04974619|450188807|FG001|Overall Study|Protocol Violation|1|||
125154042|NCT04974619|450188808|FG002|Overall Study|Protocol Violation|0|||
125154043|NCT00493779|450188809|FG000|Overall Study|Logistical issue at site|1|||
125154044|NCT01475253|450188810|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
125154045|NCT01475253|450188811|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
125154046|NCT01475253|450188812|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
125154047|NCT01475253|450188813|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
125154048|NCT01475253|450188810|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
125154049|NCT01475253|450188811|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
125154050|NCT01475253|450188812|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
125154051|NCT01475253|450188813|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
125154052|NCT02148913|450188815|FG000|Overall Study|Death|0|||
125154053|NCT02148913|450188816|FG001|Overall Study|Death|1|||
125154054|NCT02148913|450188817|FG002|Overall Study|Death|0|||
125154055|NCT02148913|450188818|FG003|Overall Study|Death|0|||
125154056|NCT01045993|450188821|FG000|Overall Study|Treated-later found eligibility not met|0|||
125154057|NCT01045993|450188822|FG001|Overall Study|Treated-later found eligibility not met|1|||
125154058|NCT01045993|450188823|FG002|Overall Study|Treated-later found eligibility not met|0|||
125154059|NCT01045993|450188824|FG003|Overall Study|Treated-later found eligibility not met|0|||
125154060|NCT05506358|450188825|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
125154061|NCT05506358|450188826|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
125154062|NCT05506358|450188827|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
125154063|NCT05506358|450188828|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
125154064|NCT05506358|450188829|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
125154065|NCT05506358|450188825|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
125154066|NCT05506358|450188826|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
125154067|NCT05506358|450188827|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
125154068|NCT05506358|450188828|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
125154069|NCT05506358|450188829|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
125154070|NCT05506358|450188825|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
125154071|NCT05506358|450188826|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
125154072|NCT05506358|450188827|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
125223848|NCT02421419|450446242|FG001|Overall Study|Physician Decision|0|||
125154073|NCT05506358|450188828|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
125154074|NCT05506358|450188829|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
125154075|NCT05506358|450188825|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
125154076|NCT05506358|450188826|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
125154077|NCT05506358|450188827|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
125154078|NCT05506358|450188828|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
125154079|NCT05506358|450188829|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
125154080|NCT05506358|450188825|FG000|Overall Study|HbE trait|0|||
125154081|NCT05506358|450188826|FG001|Overall Study|HbE trait|0|||
125154082|NCT05506358|450188827|FG002|Overall Study|HbE trait|0|||
125154083|NCT05506358|450188828|FG003|Overall Study|HbE trait|1|||
125154084|NCT05506358|450188829|FG004|Overall Study|HbE trait|0|||
125154085|NCT01659736|450188830|FG000|Treatment Period|Adverse Event|1|||
125154086|NCT01659736|450188831|FG001|Treatment Period|Adverse Event|1|||
125154087|NCT01659736|450188830|FG000|Treatment Period|Protocol Violation|3|||
125154088|NCT01659736|450188831|FG001|Treatment Period|Protocol Violation|1|||
125154089|NCT01659736|450188830|FG000|Treatment Period|Withdrawal by Subject|1|||
125154090|NCT01659736|450188831|FG001|Treatment Period|Withdrawal by Subject|0|||
125154091|NCT01659736|450188830|FG000|3-month Follow-up|Lost to Follow-up|0|||
125154092|NCT01659736|450188831|FG001|3-month Follow-up|Lost to Follow-up|1|||
125154093|NCT00262041|450188837|FG000|Overall Study|Withdrawal by Subject|0|||
125154094|NCT00262041|450188838|FG001|Overall Study|Withdrawal by Subject|3|||
125154095|NCT00262041|450188839|FG002|Overall Study|Withdrawal by Subject|1|||
125154096|NCT00262041|450188837|FG000|Overall Study|Lost to Follow-up|1|||
125154097|NCT00262041|450188838|FG001|Overall Study|Lost to Follow-up|1|||
125154098|NCT00262041|450188839|FG002|Overall Study|Lost to Follow-up|5|||
125154099|NCT00262041|450188837|FG000|Overall Study|Unable to classify|1|||
125154100|NCT00262041|450188838|FG001|Overall Study|Unable to classify|0|||
125154101|NCT00262041|450188839|FG002|Overall Study|Unable to classify|0|||
125154102|NCT02384941|450188842|FG000|Overall Study|Adverse Event|11|||
125154103|NCT02384941|450188843|FG001|Overall Study|Adverse Event|13|||
125154104|NCT02384941|450188844|FG002|Overall Study|Adverse Event|17|||
125154105|NCT02384941|450188842|FG000|Overall Study|Lost to Follow-up|3|||
125154106|NCT02384941|450188843|FG001|Overall Study|Lost to Follow-up|2|||
125154107|NCT02384941|450188844|FG002|Overall Study|Lost to Follow-up|1|||
125154108|NCT02384941|450188842|FG000|Overall Study|Non-Compliance With Study Drug|2|||
125438726|NCT00545363|451233937|FG001|Overall Study|Did not meet entry criteria|1|||
125154109|NCT02384941|450188843|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125154110|NCT02384941|450188844|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125154111|NCT02384941|450188842|FG000|Overall Study|Physician Decision|1|||
125154112|NCT02384941|450188843|FG001|Overall Study|Physician Decision|1|||
125154113|NCT02384941|450188844|FG002|Overall Study|Physician Decision|0|||
125154114|NCT02384941|450188842|FG000|Overall Study|Protocol Violation|3|||
125154115|NCT02384941|450188843|FG001|Overall Study|Protocol Violation|0|||
125154116|NCT02384941|450188844|FG002|Overall Study|Protocol Violation|0|||
125154117|NCT02384941|450188842|FG000|Overall Study|Withdrawal by Subject|26|||
125154118|NCT02384941|450188843|FG001|Overall Study|Withdrawal by Subject|19|||
125154119|NCT02384941|450188844|FG002|Overall Study|Withdrawal by Subject|20|||
125154120|NCT02384941|450188842|FG000|Overall Study|Pregnancy|0|||
125154121|NCT02384941|450188843|FG001|Overall Study|Pregnancy|0|||
125154122|NCT02384941|450188844|FG002|Overall Study|Pregnancy|1|||
125154123|NCT02384941|450188842|FG000|Overall Study|Other than specified above|4|||
125154124|NCT02384941|450188843|FG001|Overall Study|Other than specified above|0|||
125154125|NCT02384941|450188844|FG002|Overall Study|Other than specified above|1|||
125154126|NCT00252174|450188847|FG000|Overall Study|Withdrawal by Subject|0|||
125154127|NCT00252174|450188848|FG001|Overall Study|Withdrawal by Subject|1|||
125154128|NCT00252174|450188849|FG002|Overall Study|Withdrawal by Subject|0|||
125154129|NCT00484419|450188853|FG000|Overall Study|Adverse Event|3|||
125154130|NCT00484419|450188854|FG001|Overall Study|Adverse Event|0|||
125154131|NCT00484419|450188855|FG002|Overall Study|Adverse Event|0|||
125154132|NCT00484419|450188853|FG000|Overall Study|Lost to Follow-up|1|||
125154133|NCT00484419|450188854|FG001|Overall Study|Lost to Follow-up|0|||
125154134|NCT00484419|450188855|FG002|Overall Study|Lost to Follow-up|2|||
125154135|NCT00484419|450188853|FG000|Overall Study|Withdrawal by Subject|3|||
125154136|NCT00484419|450188854|FG001|Overall Study|Withdrawal by Subject|1|||
125154137|NCT00484419|450188855|FG002|Overall Study|Withdrawal by Subject|1|||
125154138|NCT00484419|450188853|FG000|Overall Study|subject met discontinuation criteria|2|||
125154139|NCT00484419|450188854|FG001|Overall Study|subject met discontinuation criteria|2|||
125154140|NCT00484419|450188855|FG002|Overall Study|subject met discontinuation criteria|4|||
125438727|NCT00545363|451233936|FG000|Overall Study|Lost to Follow-up|2|||
125154141|NCT00484419|450188853|FG000|Overall Study|required restricted medication|1|||
125154142|NCT00484419|450188854|FG001|Overall Study|required restricted medication|0|||
125154143|NCT00484419|450188855|FG002|Overall Study|required restricted medication|1|||
125154144|NCT00484419|450188853|FG000|Overall Study|Physician Decision|1|||
125154145|NCT00484419|450188854|FG001|Overall Study|Physician Decision|1|||
125154146|NCT00484419|450188855|FG002|Overall Study|Physician Decision|1|||
125388773|NCT00362115|451056689|FG002|Overall Study|Adverse Event|1|||
125388774|NCT00362115|451056690|FG003|Overall Study|Adverse Event|1|||
125154147|NCT00484419|450188853|FG000|Overall Study|subject unable to receive medication|1|||
125154148|NCT00484419|450188854|FG001|Overall Study|subject unable to receive medication|0|||
125154149|NCT00484419|450188855|FG002|Overall Study|subject unable to receive medication|0|||
125154150|NCT00484419|450188853|FG000|Overall Study|subject relocated|0|||
125154151|NCT00484419|450188854|FG001|Overall Study|subject relocated|1|||
125154152|NCT00484419|450188855|FG002|Overall Study|subject relocated|0|||
125154153|NCT00484419|450188853|FG000|Overall Study|sponsor decision, randomized in error|0|||
125154154|NCT00484419|450188854|FG001|Overall Study|sponsor decision, randomized in error|0|||
125154155|NCT00484419|450188855|FG002|Overall Study|sponsor decision, randomized in error|2|||
125154156|NCT00102687|450188856|FG000|Initial Period|Withdrawal by Subject|6|||
125154157|NCT00102687|450188857|FG001|Initial Period|Withdrawal by Subject|3|||
125154158|NCT00102687|450188858|FG002|Initial Period|Withdrawal by Subject|5|||
125154159|NCT00102687|450188859|FG003|Initial Period|Withdrawal by Subject|0|||
125154160|NCT00102687|450188860|FG004|Initial Period|Withdrawal by Subject|0|||
125154161|NCT00102687|450188856|FG000|Initial Period|Adverse Event|4|||
125154162|NCT00102687|450188857|FG001|Initial Period|Adverse Event|7|||
125154163|NCT00102687|450188858|FG002|Initial Period|Adverse Event|9|||
125154164|NCT00102687|450188859|FG003|Initial Period|Adverse Event|0|||
125154165|NCT00102687|450188860|FG004|Initial Period|Adverse Event|0|||
125154166|NCT00102687|450188856|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
125154167|NCT00102687|450188857|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
125154168|NCT00102687|450188858|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
125154169|NCT00102687|450188859|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
125154170|NCT00102687|450188860|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
125154171|NCT00102687|450188856|FG000|Initial Period|Protocol Violation|0|||
125154172|NCT00102687|450188857|FG001|Initial Period|Protocol Violation|0|||
125154173|NCT00102687|450188858|FG002|Initial Period|Protocol Violation|2|||
125154174|NCT00102687|450188859|FG003|Initial Period|Protocol Violation|0|||
125154175|NCT00102687|450188860|FG004|Initial Period|Protocol Violation|0|||
125154176|NCT00102687|450188856|FG000|Initial Period|Physician Decision|2|||
125154177|NCT00102687|450188857|FG001|Initial Period|Physician Decision|9|||
125154178|NCT00102687|450188858|FG002|Initial Period|Physician Decision|6|||
125154179|NCT00102687|450188859|FG003|Initial Period|Physician Decision|0|||
125154180|NCT00102687|450188860|FG004|Initial Period|Physician Decision|0|||
125154181|NCT00102687|450188856|FG000|Initial Period|Sponsor's decision|0|||
125154182|NCT00102687|450188857|FG001|Initial Period|Sponsor's decision|1|||
125154183|NCT00102687|450188858|FG002|Initial Period|Sponsor's decision|1|||
125154184|NCT00102687|450188859|FG003|Initial Period|Sponsor's decision|0|||
125154185|NCT00102687|450188860|FG004|Initial Period|Sponsor's decision|0|||
125154186|NCT00102687|450188856|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
125154187|NCT00102687|450188857|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
125154188|NCT00102687|450188858|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
125154189|NCT00102687|450188859|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
125154190|NCT00102687|450188860|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
125154191|NCT00102687|450188856|FG000|Initial Period|Death|1|||
125154192|NCT00102687|450188857|FG001|Initial Period|Death|1|||
125154193|NCT00102687|450188858|FG002|Initial Period|Death|1|||
125154194|NCT00102687|450188859|FG003|Initial Period|Death|0|||
125154195|NCT00102687|450188860|FG004|Initial Period|Death|0|||
125154196|NCT00102687|450188856|FG000|Maintenance Period|Withdrawal by Subject|4|||
125154197|NCT00102687|450188857|FG001|Maintenance Period|Withdrawal by Subject|0|||
125154198|NCT00102687|450188858|FG002|Maintenance Period|Withdrawal by Subject|2|||
125154199|NCT00102687|450188859|FG003|Maintenance Period|Withdrawal by Subject|3|||
125154200|NCT00102687|450188860|FG004|Maintenance Period|Withdrawal by Subject|1|||
125154201|NCT00102687|450188856|FG000|Maintenance Period|Adverse Event|1|||
125154202|NCT00102687|450188857|FG001|Maintenance Period|Adverse Event|0|||
125154203|NCT00102687|450188858|FG002|Maintenance Period|Adverse Event|0|||
125154204|NCT00102687|450188859|FG003|Maintenance Period|Adverse Event|1|||
125154205|NCT00102687|450188860|FG004|Maintenance Period|Adverse Event|3|||
125154206|NCT00102687|450188856|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
125154207|NCT00102687|450188857|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
125154208|NCT00102687|450188858|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
125154209|NCT00102687|450188859|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
125154210|NCT00102687|450188860|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
125154211|NCT00102687|450188856|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
125154212|NCT00102687|450188857|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
125154213|NCT00102687|450188858|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
125388775|NCT00362115|451056691|FG004|Overall Study|Adverse Event|2|||
125154214|NCT00102687|450188859|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
125154215|NCT00102687|450188860|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
125154216|NCT00102687|450188856|FG000|Maintenance Period|Death|0|||
125154217|NCT00102687|450188857|FG001|Maintenance Period|Death|0|||
125154218|NCT00102687|450188858|FG002|Maintenance Period|Death|0|||
125154219|NCT00102687|450188859|FG003|Maintenance Period|Death|1|||
125154220|NCT00102687|450188860|FG004|Maintenance Period|Death|1|||
125154221|NCT00102687|450188856|FG000|Maintenance Period|Physician Decision|1|||
125154222|NCT00102687|450188857|FG001|Maintenance Period|Physician Decision|2|||
125154223|NCT00102687|450188858|FG002|Maintenance Period|Physician Decision|3|||
125154224|NCT00102687|450188859|FG003|Maintenance Period|Physician Decision|0|||
125154225|NCT00102687|450188860|FG004|Maintenance Period|Physician Decision|4|||
125154226|NCT01341587|450188861|FG000|Overall Study|Lost to Follow-up|2|||
125154227|NCT01341587|450188862|FG001|Overall Study|Lost to Follow-up|0|||
125154228|NCT01341587|450188861|FG000|Overall Study|stopped using the meters|2|||
125154229|NCT01341587|450188862|FG001|Overall Study|stopped using the meters|10|||
125154230|NCT03739138|450188864|FG000|Overall Study|Death|0|||
125154231|NCT03739138|450188865|FG001|Overall Study|Death|7|||
125154232|NCT03739138|450188866|FG002|Overall Study|Death|4|||
125154233|NCT03739138|450188867|FG003|Overall Study|Death|13|||
125154234|NCT03739138|450188868|FG004|Overall Study|Death|0|||
125154235|NCT03739138|450188864|FG000|Overall Study|Lost to Follow-up|0|||
125154236|NCT03739138|450188865|FG001|Overall Study|Lost to Follow-up|0|||
125154237|NCT03739138|450188866|FG002|Overall Study|Lost to Follow-up|1|||
125154238|NCT03739138|450188867|FG003|Overall Study|Lost to Follow-up|0|||
125154239|NCT03739138|450188868|FG004|Overall Study|Lost to Follow-up|0|||
125154240|NCT03739138|450188864|FG000|Overall Study|Study Terminated By Sponsor|0|||
125154241|NCT03739138|450188865|FG001|Overall Study|Study Terminated By Sponsor|0|||
125154242|NCT03739138|450188866|FG002|Overall Study|Study Terminated By Sponsor|0|||
125154243|NCT03739138|450188867|FG003|Overall Study|Study Terminated By Sponsor|4|||
125154244|NCT03739138|450188868|FG004|Overall Study|Study Terminated By Sponsor|0|||
125154245|NCT03739138|450188864|FG000|Overall Study|Withdrawal by Subject|0|||
125154246|NCT03739138|450188865|FG001|Overall Study|Withdrawal by Subject|0|||
125154247|NCT03739138|450188866|FG002|Overall Study|Withdrawal by Subject|0|||
125154248|NCT03739138|450188867|FG003|Overall Study|Withdrawal by Subject|1|||
125154249|NCT03739138|450188868|FG004|Overall Study|Withdrawal by Subject|0|||
125154250|NCT00466726|450188869|FG000|Overall Study|Not evaluable for response|14|||
125154251|NCT04403763|450188870|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
125154252|NCT04403763|450188871|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
125154253|NCT04403763|450188872|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
125154254|NCT04403763|450188873|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
125154255|NCT04403763|450188874|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
125154256|NCT04403763|450188875|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
125154257|NCT04403763|450188876|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
125154258|NCT04403763|450188870|FG000|Stage 1|Early termination due to PK tube failure|0|||
125154259|NCT04403763|450188871|FG001|Stage 1|Early termination due to PK tube failure|0|||
125154260|NCT04403763|450188872|FG002|Stage 1|Early termination due to PK tube failure|1|||
125154261|NCT04403763|450188873|FG003|Stage 1|Early termination due to PK tube failure|0|||
125154262|NCT04403763|450188874|FG004|Stage 1|Early termination due to PK tube failure|0|||
125154263|NCT04403763|450188875|FG005|Stage 1|Early termination due to PK tube failure|0|||
125154264|NCT04403763|450188876|FG006|Stage 1|Early termination due to PK tube failure|0|||
125154265|NCT04403763|450188870|FG000|Stage 2A|Adverse Event|0|||
125154266|NCT04403763|450188871|FG001|Stage 2A|Adverse Event|0|||
125154267|NCT04403763|450188872|FG002|Stage 2A|Adverse Event|0|||
125154268|NCT04403763|450188873|FG003|Stage 2A|Adverse Event|0|||
125154269|NCT04403763|450188874|FG004|Stage 2A|Adverse Event|0|||
125154270|NCT04403763|450188875|FG005|Stage 2A|Adverse Event|0|||
125154271|NCT04403763|450188876|FG006|Stage 2A|Adverse Event|1|||
125154272|NCT01376310|450188877|FG000|Overall Study|Study closed/terminated|1|||
125154273|NCT01376310|450188878|FG001|Overall Study|Study closed/terminated|2|||
125154274|NCT01376310|450188877|FG000|Overall Study|Withdrawal by Subject|8|||
125154275|NCT01376310|450188878|FG001|Overall Study|Withdrawal by Subject|2|||
125154276|NCT01376310|450188877|FG000|Overall Study|Physician Decision|26|||
125154277|NCT01376310|450188878|FG001|Overall Study|Physician Decision|7|||
125154278|NCT01376310|450188877|FG000|Overall Study|Lost to Follow-up|1|||
125154279|NCT01376310|450188878|FG001|Overall Study|Lost to Follow-up|0|||
125154280|NCT02470091|450188879|FG000|Overall Study|Withdrawal by Subject|1|||
125154281|NCT02470091|450188880|FG001|Overall Study|Withdrawal by Subject|0|||
125154282|NCT02470091|450188879|FG000|Overall Study|Ineligible|0|||
125154283|NCT02470091|450188880|FG001|Overall Study|Ineligible|2|||
125388776|NCT00362115|451056692|FG005|Overall Study|Adverse Event|2|||
125388777|NCT00362115|451056693|FG006|Overall Study|Adverse Event|1|||
125388778|NCT00362115|451056687|FG000|Overall Study|Protocol Violation|0|||
125388779|NCT00362115|451056688|FG001|Overall Study|Protocol Violation|0|||
125388780|NCT00362115|451056689|FG002|Overall Study|Protocol Violation|0|||
125388781|NCT00362115|451056690|FG003|Overall Study|Protocol Violation|0|||
125388782|NCT00362115|451056691|FG004|Overall Study|Protocol Violation|0|||
125388783|NCT00362115|451056692|FG005|Overall Study|Protocol Violation|1|||
125388784|NCT00362115|451056693|FG006|Overall Study|Protocol Violation|0|||
125388785|NCT00362115|451056687|FG000|Overall Study|Lost to Follow-up|0|||
125388786|NCT00362115|451056688|FG001|Overall Study|Lost to Follow-up|1|||
125388787|NCT00362115|451056689|FG002|Overall Study|Lost to Follow-up|0|||
125388788|NCT00362115|451056690|FG003|Overall Study|Lost to Follow-up|0|||
125388789|NCT00362115|451056691|FG004|Overall Study|Lost to Follow-up|2|||
125154284|NCT00767520|450188893|FG000|Overall Study|Participants still on treatment|11|||
125154285|NCT00767520|450188894|FG001|Overall Study|Participants still on treatment|15|||
125154286|NCT00767520|450188893|FG000|Overall Study|Randomized in error and Never treated|0|||
125154287|NCT00767520|450188894|FG001|Overall Study|Randomized in error and Never treated|2|||
125154288|NCT00720226|450188895|FG000|Overall Study|Withdrawal by Subject|7|||
125154289|NCT00720226|450188896|FG001|Overall Study|Withdrawal by Subject|4|||
125154290|NCT00958126|450188897|FG000|Overall Study|Serious Adverse Event|0|||
125154291|NCT00958126|450188898|FG001|Overall Study|Serious Adverse Event|2|||
125154292|NCT00958126|450188899|FG002|Overall Study|Serious Adverse Event|0|||
125154293|NCT00958126|450188900|FG003|Overall Study|Serious Adverse Event|0|||
125154294|NCT00958126|450188901|FG004|Overall Study|Serious Adverse Event|0|||
125154295|NCT00958126|450188902|FG005|Overall Study|Serious Adverse Event|0|||
125154296|NCT00958126|450188903|FG006|Overall Study|Serious Adverse Event|1|||
125154297|NCT00958126|450188904|FG007|Overall Study|Serious Adverse Event|0|||
125154298|NCT00958126|450188897|FG000|Overall Study|Withdrawal by Subject|0|||
125154299|NCT00958126|450188898|FG001|Overall Study|Withdrawal by Subject|2|||
125154300|NCT00958126|450188899|FG002|Overall Study|Withdrawal by Subject|0|||
125154301|NCT00958126|450188900|FG003|Overall Study|Withdrawal by Subject|0|||
125154302|NCT00958126|450188901|FG004|Overall Study|Withdrawal by Subject|0|||
125154303|NCT00958126|450188902|FG005|Overall Study|Withdrawal by Subject|0|||
125154304|NCT00958126|450188903|FG006|Overall Study|Withdrawal by Subject|0|||
125154305|NCT00958126|450188904|FG007|Overall Study|Withdrawal by Subject|0|||
125154306|NCT00958126|450188897|FG000|Overall Study|Moved away from study area|0|||
125154307|NCT00958126|450188898|FG001|Overall Study|Moved away from study area|0|||
125154308|NCT00958126|450188899|FG002|Overall Study|Moved away from study area|1|||
125154309|NCT00958126|450188900|FG003|Overall Study|Moved away from study area|1|||
125154310|NCT00958126|450188901|FG004|Overall Study|Moved away from study area|0|||
125154311|NCT00958126|450188902|FG005|Overall Study|Moved away from study area|0|||
125154312|NCT00958126|450188903|FG006|Overall Study|Moved away from study area|0|||
125154313|NCT00958126|450188904|FG007|Overall Study|Moved away from study area|0|||
125154314|NCT00958126|450188897|FG000|Overall Study|Lost to Follow-up|1|||
125154315|NCT00958126|450188898|FG001|Overall Study|Lost to Follow-up|5|||
125154316|NCT00958126|450188899|FG002|Overall Study|Lost to Follow-up|9|||
125154317|NCT00958126|450188900|FG003|Overall Study|Lost to Follow-up|8|||
125154318|NCT00958126|450188901|FG004|Overall Study|Lost to Follow-up|0|||
125154319|NCT00958126|450188902|FG005|Overall Study|Lost to Follow-up|0|||
125154320|NCT00958126|450188903|FG006|Overall Study|Lost to Follow-up|0|||
125154321|NCT00958126|450188904|FG007|Overall Study|Lost to Follow-up|0|||
125154322|NCT00958126|450188897|FG000|Overall Study|Sponsor/Investigator decision|0|||
125154323|NCT00958126|450188898|FG001|Overall Study|Sponsor/Investigator decision|0|||
125154324|NCT00958126|450188899|FG002|Overall Study|Sponsor/Investigator decision|0|||
125154325|NCT00958126|450188900|FG003|Overall Study|Sponsor/Investigator decision|1|||
125154326|NCT00958126|450188901|FG004|Overall Study|Sponsor/Investigator decision|0|||
125154327|NCT00958126|450188902|FG005|Overall Study|Sponsor/Investigator decision|0|||
125154328|NCT00958126|450188903|FG006|Overall Study|Sponsor/Investigator decision|0|||
125154329|NCT00958126|450188904|FG007|Overall Study|Sponsor/Investigator decision|0|||
125154330|NCT00958126|450188897|FG000|Overall Study|Other Reason|0|||
125154331|NCT00958126|450188898|FG001|Overall Study|Other Reason|0|||
125154332|NCT00958126|450188899|FG002|Overall Study|Other Reason|0|||
125154333|NCT00958126|450188900|FG003|Overall Study|Other Reason|1|||
125154334|NCT00958126|450188901|FG004|Overall Study|Other Reason|0|||
125154335|NCT00958126|450188902|FG005|Overall Study|Other Reason|1|||
125154336|NCT00958126|450188903|FG006|Overall Study|Other Reason|0|||
125154337|NCT00958126|450188904|FG007|Overall Study|Other Reason|0|||
125154338|NCT00733369|450188905|FG000|Overall Study|Lost to Follow-up|2|||
125154339|NCT00733369|450188906|FG001|Overall Study|Lost to Follow-up|1|||
125154340|NCT00733369|450188905|FG000|Overall Study|Adverse Event|4|||
125154341|NCT00733369|450188906|FG001|Overall Study|Adverse Event|4|||
125154342|NCT00733369|450188905|FG000|Overall Study|Protocol Violation|4|||
125154343|NCT00733369|450188906|FG001|Overall Study|Protocol Violation|4|||
125154344|NCT03401073|450188907|FG000|Overall Study|Lost to Follow-up|1|||
125154345|NCT03401073|450188908|FG001|Overall Study|Lost to Follow-up|2|||
125154346|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
125154347|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
125154348|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
125154349|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
125154350|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
125154351|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
125154352|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
125154353|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
125154354|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
125154355|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
125223849|NCT02421419|450446243|FG002|Overall Study|Physician Decision|1|||
125154356|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
125154357|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
125154358|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
125154359|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
125154360|NCT02510014|450188914|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
125154361|NCT02510014|450188915|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
125154362|NCT02510014|450188914|FG000|Treatment Period|Adverse Event|11|||
125154363|NCT02510014|450188915|FG001|Treatment Period|Adverse Event|4|||
125154364|NCT02510014|450188914|FG000|Treatment Period|Withdrawal symptoms|3|||
125154365|NCT02510014|450188915|FG001|Treatment Period|Withdrawal symptoms|0|||
125154366|NCT02510014|450188914|FG000|Treatment Period|Lost to Follow-up|80|||
125154367|NCT02510014|450188915|FG001|Treatment Period|Lost to Follow-up|19|||
125154368|NCT02510014|450188914|FG000|Treatment Period|Physician Decision|5|||
125154369|NCT02510014|450188915|FG001|Treatment Period|Physician Decision|0|||
125154370|NCT02510014|450188914|FG000|Treatment Period|Withdrawal by Subject|67|||
125154371|NCT02510014|450188915|FG001|Treatment Period|Withdrawal by Subject|24|||
125154372|NCT02510014|450188914|FG000|Treatment Period|Withdrawn by the investigator|7|||
125154373|NCT02510014|450188915|FG001|Treatment Period|Withdrawn by the investigator|1|||
125154374|NCT02510014|450188914|FG000|Treatment Period|Protocol Violation|4|||
125154375|NCT02510014|450188915|FG001|Treatment Period|Protocol Violation|4|||
125154376|NCT02510014|450188914|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
125154377|NCT02510014|450188915|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
125154378|NCT01875471|450188919|FG000|Overall Study|Adverse Event|0|||
125154379|NCT01875471|450188920|FG001|Overall Study|Adverse Event|1|||
125154380|NCT01875471|450188919|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
125154381|NCT01875471|450188920|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
125154382|NCT04179019|450188922|FG000|Overall Study|Lost to Follow-up|2|||
125154383|NCT04179019|450188922|FG000|Overall Study|Physician Decision|2|||
125154384|NCT04179019|450188922|FG000|Overall Study|Withdrawal by Subject|5|||
125154385|NCT04179019|450188922|FG000|Overall Study|Adverse Event|4|||
125154386|NCT02083926|450188923|FG000|Overall Study|Withdrawal by Subject|1|||
125154387|NCT02083926|450188924|FG001|Overall Study|Withdrawal by Subject|0|||
125154388|NCT02610816|450188925|FG000|Phase 1|Withdrawal by Subject|2|||
125154389|NCT02610816|450188926|FG001|Phase 1|Withdrawal by Subject|6|||
125154390|NCT02610816|450188927|FG002|Phase 1|Withdrawal by Subject|0|||
125154391|NCT02610816|450188928|FG003|Phase 1|Withdrawal by Subject|0|||
125154392|NCT02610816|450188925|FG000|Phase 1|Lost to Follow-up|2|||
125154393|NCT02610816|450188926|FG001|Phase 1|Lost to Follow-up|1|||
125154394|NCT02610816|450188927|FG002|Phase 1|Lost to Follow-up|0|||
125154395|NCT02610816|450188928|FG003|Phase 1|Lost to Follow-up|0|||
125154396|NCT02610816|450188925|FG000|Phase 1|Physician Decision|0|||
125154397|NCT02610816|450188926|FG001|Phase 1|Physician Decision|1|||
125154398|NCT02610816|450188927|FG002|Phase 1|Physician Decision|0|||
125154399|NCT02610816|450188928|FG003|Phase 1|Physician Decision|0|||
125154400|NCT02610816|450188925|FG000|Phase 2|Withdrawal by Subject|0|||
125154401|NCT02610816|450188926|FG001|Phase 2|Withdrawal by Subject|0|||
125154402|NCT02610816|450188927|FG002|Phase 2|Withdrawal by Subject|9|||
125154403|NCT02610816|450188928|FG003|Phase 2|Withdrawal by Subject|3|||
125154404|NCT02610816|450188925|FG000|Phase 2|Lost to Follow-up|0|||
125154405|NCT02610816|450188926|FG001|Phase 2|Lost to Follow-up|0|||
125154406|NCT02610816|450188927|FG002|Phase 2|Lost to Follow-up|2|||
125154407|NCT02610816|450188928|FG003|Phase 2|Lost to Follow-up|0|||
125154408|NCT02610816|450188925|FG000|Phase 2|Physician Decision|0|||
125154409|NCT02610816|450188926|FG001|Phase 2|Physician Decision|0|||
125154410|NCT02610816|450188927|FG002|Phase 2|Physician Decision|0|||
125154411|NCT02610816|450188928|FG003|Phase 2|Physician Decision|2|||
125154412|NCT02610816|450188925|FG000|Phase 2|Pregnancy|0|||
125154413|NCT02610816|450188926|FG001|Phase 2|Pregnancy|0|||
125154414|NCT02610816|450188927|FG002|Phase 2|Pregnancy|0|||
125154415|NCT02610816|450188928|FG003|Phase 2|Pregnancy|1|||
125154416|NCT01949116|450188929|FG000|Overall Study|Death|2|||
125154417|NCT01949116|450188930|FG001|Overall Study|Death|0|||
125154418|NCT01949116|450188929|FG000|Overall Study|Lost to Follow-up|1|||
125154419|NCT01949116|450188930|FG001|Overall Study|Lost to Follow-up|3|||
125154420|NCT01949116|450188929|FG000|Overall Study|Withdrawal by Subject|5|||
125154421|NCT01949116|450188930|FG001|Overall Study|Withdrawal by Subject|3|||
125154422|NCT03438227|450188931|FG000|Overall Study|Withdrawal by Subject|10|||
125154423|NCT03438227|450188932|FG001|Overall Study|Withdrawal by Subject|5|||
125154424|NCT00049842|450188934|FG000|Treatment Phase|Adverse Event|47|||
125154425|NCT00049842|450188935|FG001|Treatment Phase|Adverse Event|12|||
125154426|NCT00049842|450188934|FG000|Treatment Phase|Withdrawal by Subject|35|||
125154427|NCT00049842|450188935|FG001|Treatment Phase|Withdrawal by Subject|46|||
125154428|NCT00049842|450188934|FG000|Treatment Phase|Non-compliance with protocol|7|||
125154429|NCT00049842|450188935|FG001|Treatment Phase|Non-compliance with protocol|8|||
125154430|NCT00049842|450188934|FG000|Treatment Phase|Lost to Follow-up|4|||
125154431|NCT00049842|450188935|FG001|Treatment Phase|Lost to Follow-up|8|||
125154432|NCT00049842|450188934|FG000|Treatment Phase|Administrative|0|||
125154433|NCT00049842|450188935|FG001|Treatment Phase|Administrative|3|||
125154434|NCT00049842|450188934|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
125154435|NCT00049842|450188935|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
125154436|NCT00049842|450188934|FG000|Follow-up Phase|Adverse Event|6|||
125154437|NCT00049842|450188935|FG001|Follow-up Phase|Adverse Event|1|||
125154438|NCT00049842|450188934|FG000|Follow-up Phase|Other|1|||
125154439|NCT00049842|450188935|FG001|Follow-up Phase|Other|4|||
125154440|NCT01813071|450188936|FG000|Overall Study|Protocol Violation|0|||
125154441|NCT01813071|450188937|FG001|Overall Study|Protocol Violation|0|||
125154442|NCT01813071|450188938|FG002|Overall Study|Protocol Violation|0|||
125388790|NCT00362115|451056692|FG005|Overall Study|Lost to Follow-up|0|||
125388791|NCT00362115|451056693|FG006|Overall Study|Lost to Follow-up|1|||
125388792|NCT00362115|451056687|FG000|Overall Study|Withdrawal by Subject|1|||
125388793|NCT00362115|451056688|FG001|Overall Study|Withdrawal by Subject|3|||
125388794|NCT00362115|451056689|FG002|Overall Study|Withdrawal by Subject|1|||
125154443|NCT01813071|450188939|FG003|Overall Study|Protocol Violation|0|||
125154444|NCT01813071|450188940|FG004|Overall Study|Protocol Violation|1|||
125154445|NCT01813071|450188941|FG005|Overall Study|Protocol Violation|4|||
125154446|NCT01813071|450188942|FG006|Overall Study|Protocol Violation|2|||
125154447|NCT01813071|450188943|FG007|Overall Study|Protocol Violation|4|||
125154448|NCT01813071|450188944|FG008|Overall Study|Protocol Violation|2|||
125154449|NCT01813071|450188936|FG000|Overall Study|Withdrawal by Subject|0|||
125154450|NCT01813071|450188937|FG001|Overall Study|Withdrawal by Subject|0|||
125154451|NCT01813071|450188938|FG002|Overall Study|Withdrawal by Subject|0|||
125154452|NCT01813071|450188939|FG003|Overall Study|Withdrawal by Subject|0|||
125154453|NCT01813071|450188940|FG004|Overall Study|Withdrawal by Subject|0|||
125154454|NCT01813071|450188941|FG005|Overall Study|Withdrawal by Subject|1|||
125154455|NCT01813071|450188942|FG006|Overall Study|Withdrawal by Subject|0|||
125154456|NCT01813071|450188943|FG007|Overall Study|Withdrawal by Subject|0|||
125154457|NCT01813071|450188944|FG008|Overall Study|Withdrawal by Subject|0|||
125154458|NCT01813071|450188936|FG000|Overall Study|Adverse Event|0|||
125154459|NCT01813071|450188937|FG001|Overall Study|Adverse Event|0|||
125154460|NCT01813071|450188938|FG002|Overall Study|Adverse Event|0|||
125154461|NCT01813071|450188939|FG003|Overall Study|Adverse Event|0|||
125154462|NCT01813071|450188940|FG004|Overall Study|Adverse Event|0|||
125154463|NCT01813071|450188941|FG005|Overall Study|Adverse Event|1|||
125154464|NCT01813071|450188942|FG006|Overall Study|Adverse Event|0|||
125154465|NCT01813071|450188943|FG007|Overall Study|Adverse Event|0|||
125154466|NCT01813071|450188944|FG008|Overall Study|Adverse Event|0|||
125154467|NCT01813071|450188936|FG000|Overall Study|Physician Decision|0|||
125154468|NCT01813071|450188937|FG001|Overall Study|Physician Decision|0|||
125154469|NCT01813071|450188938|FG002|Overall Study|Physician Decision|0|||
125154470|NCT01813071|450188939|FG003|Overall Study|Physician Decision|0|||
125154471|NCT01813071|450188940|FG004|Overall Study|Physician Decision|0|||
125154472|NCT01813071|450188941|FG005|Overall Study|Physician Decision|0|||
125154473|NCT01813071|450188942|FG006|Overall Study|Physician Decision|1|||
125154474|NCT01813071|450188943|FG007|Overall Study|Physician Decision|0|||
125154475|NCT01813071|450188944|FG008|Overall Study|Physician Decision|0|||
125154476|NCT01813071|450188936|FG000|Overall Study|Met inc/exc criteria|0|||
125154477|NCT01813071|450188937|FG001|Overall Study|Met inc/exc criteria|0|||
125154478|NCT01813071|450188938|FG002|Overall Study|Met inc/exc criteria|0|||
125154479|NCT01813071|450188939|FG003|Overall Study|Met inc/exc criteria|0|||
125154480|NCT01813071|450188940|FG004|Overall Study|Met inc/exc criteria|0|||
125154481|NCT01813071|450188941|FG005|Overall Study|Met inc/exc criteria|1|||
125154482|NCT01813071|450188942|FG006|Overall Study|Met inc/exc criteria|0|||
125154483|NCT01813071|450188943|FG007|Overall Study|Met inc/exc criteria|1|||
125154484|NCT01813071|450188944|FG008|Overall Study|Met inc/exc criteria|1|||
125154485|NCT00613834|450188945|FG000|Overall Study|Withdrawal by Subject|0|||
125154486|NCT00613834|450188946|FG001|Overall Study|Withdrawal by Subject|3|||
125154487|NCT00842530|450188947|FG000|Overall Study|Serious adverse event|0|||
125154488|NCT00842530|450188948|FG001|Overall Study|Serious adverse event|6|||
125154489|NCT00842530|450188947|FG000|Overall Study|Other adverse event|6|||
125154490|NCT00842530|450188948|FG001|Overall Study|Other adverse event|1|||
125154491|NCT00842530|450188947|FG000|Overall Study|Protocol Violation|32|||
125154492|NCT00842530|450188948|FG001|Overall Study|Protocol Violation|14|||
125154493|NCT00842530|450188947|FG000|Overall Study|Lost to Follow-up|6|||
125388795|NCT00362115|451056690|FG003|Overall Study|Withdrawal by Subject|0|||
125154494|NCT00842530|450188948|FG001|Overall Study|Lost to Follow-up|8|||
125154495|NCT00842530|450188947|FG000|Overall Study|Withdrawal by Subject|73|||
125388796|NCT00362115|451056691|FG004|Overall Study|Withdrawal by Subject|1|||
125154496|NCT00842530|450188948|FG001|Overall Study|Withdrawal by Subject|28|||
125154497|NCT02939950|450188951|FG000|Overall Study|Lost to Follow-up|13|||
125154498|NCT02939950|450188952|FG001|Overall Study|Lost to Follow-up|16|||
125154499|NCT02939950|450188951|FG000|Overall Study|Positive slit lamp findings|0|||
125154500|NCT02939950|450188952|FG001|Overall Study|Positive slit lamp findings|1|||
125154501|NCT02939950|450188951|FG000|Overall Study|Chalazion upper lid|0|||
125154502|NCT02939950|450188952|FG001|Overall Study|Chalazion upper lid|1|||
125154503|NCT02939950|450188951|FG000|Overall Study|Lack of motivation|0|||
125154504|NCT02939950|450188952|FG001|Overall Study|Lack of motivation|2|||
125154505|NCT02939950|450188951|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
125154506|NCT02939950|450188952|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
125154507|NCT02939950|450188951|FG000|Overall Study|Military orders|1|||
125154508|NCT02939950|450188952|FG001|Overall Study|Military orders|0|||
125154509|NCT02939950|450188951|FG000|Overall Study|Participant Relocated|5|||
125154510|NCT02939950|450188952|FG001|Overall Study|Participant Relocated|3|||
125154511|NCT02939950|450188951|FG000|Overall Study|Study related symptoms|8|||
125154512|NCT02939950|450188952|FG001|Overall Study|Study related symptoms|8|||
125154513|NCT02939950|450188951|FG000|Overall Study|Unacceptable lens movement|2|||
125154514|NCT02939950|450188952|FG001|Overall Study|Unacceptable lens movement|0|||
125154515|NCT02939950|450188951|FG000|Overall Study|Protocol Violation|6|||
125154516|NCT02939950|450188952|FG001|Overall Study|Protocol Violation|3|||
125154517|NCT02939950|450188951|FG000|Overall Study|Physician Decision|2|||
125154518|NCT02939950|450188952|FG001|Overall Study|Physician Decision|0|||
125154519|NCT02939950|450188951|FG000|Overall Study|Pregnancy|6|||
125154520|NCT02939950|450188952|FG001|Overall Study|Pregnancy|7|||
125154521|NCT02939950|450188951|FG000|Overall Study|Withdrawal by Subject|12|||
125154522|NCT02939950|450188952|FG001|Overall Study|Withdrawal by Subject|28|||
125154523|NCT02939950|450188951|FG000|Overall Study|Adverse Event|7|||
125154524|NCT02939950|450188952|FG001|Overall Study|Adverse Event|3|||
125154525|NCT02939950|450188951|FG000|Overall Study|Randomized, not dispensed|1|||
125154526|NCT02939950|450188952|FG001|Overall Study|Randomized, not dispensed|0|||
125154527|NCT02939950|450188951|FG000|Overall Study|Ineligible at Baseline|2|||
125154528|NCT02939950|450188952|FG001|Overall Study|Ineligible at Baseline|8|||
125154529|NCT01660022|450188956|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
125154530|NCT01660022|450188957|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
125154531|NCT01660022|450188958|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
125154532|NCT01660022|450188959|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
125154533|NCT01660022|450188960|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
125154534|NCT01660022|450188961|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
125154535|NCT01660022|450188956|FG000|First Sequence (7 Days)|Adverse Event|0|||
125154536|NCT01660022|450188957|FG001|First Sequence (7 Days)|Adverse Event|0|||
125154537|NCT01660022|450188958|FG002|First Sequence (7 Days)|Adverse Event|0|||
125154538|NCT01660022|450188959|FG003|First Sequence (7 Days)|Adverse Event|0|||
125154539|NCT01660022|450188960|FG004|First Sequence (7 Days)|Adverse Event|1|||
125154540|NCT01660022|450188961|FG005|First Sequence (7 Days)|Adverse Event|3|||
125154541|NCT01660022|450188956|FG000|First Sequence (7 Days)|Protocol Violation|0|||
125154542|NCT01660022|450188957|FG001|First Sequence (7 Days)|Protocol Violation|0|||
125154543|NCT01660022|450188958|FG002|First Sequence (7 Days)|Protocol Violation|0|||
125154544|NCT01660022|450188959|FG003|First Sequence (7 Days)|Protocol Violation|0|||
125154545|NCT01660022|450188960|FG004|First Sequence (7 Days)|Protocol Violation|0|||
125154546|NCT01660022|450188961|FG005|First Sequence (7 Days)|Protocol Violation|1|||
125154547|NCT00766831|450188966|FG000|Overall Study|Withdrawal by Subject|4|||
125154548|NCT00766831|450188966|FG000|Overall Study|Lost to Follow-up|3|||
125154549|NCT00766831|450188966|FG000|Overall Study|Adverse Event|20|||
125154550|NCT00766831|450188966|FG000|Overall Study|Protocol Violation|15|||
125154551|NCT00766831|450188966|FG000|Overall Study|Physician Decision|5|||
125154552|NCT00766831|450188966|FG000|Overall Study|Withdrawal of consent|26|||
125154553|NCT00766831|450188966|FG000|Overall Study|Non cooperation by participants|14|||
125154554|NCT00766831|450188966|FG000|Overall Study|Other|28|||
125154555|NCT00788593|450188967|FG000|Placebo Run-in Phase|Adverse Event|2|||
125154556|NCT00788593|450188968|FG001|Placebo Run-in Phase|Adverse Event|0|||
125154557|NCT00788593|450188969|FG002|Placebo Run-in Phase|Adverse Event|0|||
125154558|NCT00788593|450188967|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
125154559|NCT00788593|450188968|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
125154560|NCT00788593|450188969|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
125154561|NCT00788593|450188967|FG000|Placebo Run-in Phase|Protocol Violation|2|||
125154562|NCT00788593|450188968|FG001|Placebo Run-in Phase|Protocol Violation|0|||
125154563|NCT00788593|450188969|FG002|Placebo Run-in Phase|Protocol Violation|0|||
125154564|NCT00788593|450188967|FG000|First Intervention Period|Adverse Event|0|||
125154565|NCT00788593|450188968|FG001|First Intervention Period|Adverse Event|1|||
125154566|NCT00788593|450188969|FG002|First Intervention Period|Adverse Event|0|||
125154567|NCT00788593|450188967|FG000|Second Intervention Period|Lost to Follow-up|0|||
125154568|NCT00788593|450188968|FG001|Second Intervention Period|Lost to Follow-up|1|||
125154569|NCT00788593|450188969|FG002|Second Intervention Period|Lost to Follow-up|0|||
125154570|NCT00788593|450188967|FG000|Second Intervention Period|Other|0|||
125154571|NCT00788593|450188968|FG001|Second Intervention Period|Other|0|||
125438728|NCT00545363|451233937|FG001|Overall Study|Lost to Follow-up|0|||
125154572|NCT00788593|450188969|FG002|Second Intervention Period|Other|1|||
125438729|NCT00545363|451233936|FG000|Overall Study|Other|1|||
125154573|NCT04553913|450188976|FG000|Overall Study|patient's block resolved prior to PACU|1|||
125154574|NCT04553913|450188976|FG000|Overall Study|did not use the device properly|5|||
125154575|NCT00710749|450188977|FG000|First Intervention|Withdrawal by Subject|1|||
125154576|NCT00710749|450188978|FG001|First Intervention|Withdrawal by Subject|0|||
125154577|NCT01000610|450191479|FG000|Overall Study|Adverse Event|1|||
125154578|NCT01000610|450191479|FG000|Overall Study|Lost to Follow-up|4|||
125154579|NCT01000610|450191479|FG000|Overall Study|Treatment failure|1|||
125154580|NCT02631876|450191486|FG000|Overall Study|Death|96|||
125154581|NCT02631876|450191487|FG001|Overall Study|Death|50|||
125154582|NCT02631876|450191486|FG000|Overall Study|Investigator's discretion|1|||
125154583|NCT02631876|450191487|FG001|Overall Study|Investigator's discretion|0|||
125154584|NCT02631876|450191486|FG000|Overall Study|Lost to Follow-up|2|||
125154585|NCT02631876|450191487|FG001|Overall Study|Lost to Follow-up|0|||
125154586|NCT02631876|450191486|FG000|Overall Study|Withdrawal by Subject|16|||
125154587|NCT02631876|450191487|FG001|Overall Study|Withdrawal by Subject|9|||
125154588|NCT02631876|450191486|FG000|Overall Study|Other than specified|4|||
125154589|NCT02631876|450191487|FG001|Overall Study|Other than specified|4|||
125154590|NCT01592721|450191488|FG000|Long-term Follow-up|Death|1|||
125154591|NCT01408563|450191493|FG000|Overall Study|Ineligible after consent/ registration|2|||
125154592|NCT02516410|450191494|FG000|Overall Study|Adverse Event|0|||
125154593|NCT02516410|450191495|FG001|Overall Study|Adverse Event|1|||
125154594|NCT02516410|450191494|FG000|Overall Study|Withdrawal by Subject|0|||
125154595|NCT02516410|450191495|FG001|Overall Study|Withdrawal by Subject|1|||
125154596|NCT01432574|450191496|FG000|Overall Study|Moved|2|||
125154597|NCT01432574|450191496|FG000|Overall Study|Not interested|1|||
125154598|NCT02698865|450191505|FG000|Overall Study|Other|11|||
125154599|NCT02698865|450191506|FG001|Overall Study|Other|11|||
125154600|NCT02698865|450191505|FG000|Overall Study|Withdrawal by Subject|20|||
125154601|NCT02698865|450191506|FG001|Overall Study|Withdrawal by Subject|16|||
125154602|NCT02698865|450191505|FG000|Overall Study|Physician Decision|0|||
125154603|NCT02698865|450191506|FG001|Overall Study|Physician Decision|4|||
125154604|NCT02698865|450191505|FG000|Overall Study|Lost to Follow-up|4|||
125154605|NCT02698865|450191506|FG001|Overall Study|Lost to Follow-up|2|||
125154606|NCT03861481|450191507|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
125154607|NCT03861481|450191508|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
125154608|NCT03861481|450191507|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
125154609|NCT03861481|450191508|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
125154610|NCT03861481|450191507|FG000|Overall Study|Relapse|1|||
125154611|NCT03861481|450191508|FG001|Overall Study|Relapse|0|||
125154612|NCT03861481|450191507|FG000|Overall Study|Withdrawal by Subject|0|||
125154613|NCT03861481|450191508|FG001|Overall Study|Withdrawal by Subject|1|||
125154614|NCT03861481|450191507|FG000|Overall Study|Lack of Efficacy|4|||
125154615|NCT03861481|450191508|FG001|Overall Study|Lack of Efficacy|5|||
125154616|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
125154617|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
125154618|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
125154619|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
125154620|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
125154621|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
125154622|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
125154623|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
125154624|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
125154625|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
125154626|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
125154627|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
125154628|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
125154629|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
125154630|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
125154631|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
125154632|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
125154633|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
125154634|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
125154635|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
125154636|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
125154637|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
125154638|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
125154639|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
125154640|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
125154641|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
125154642|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
125154643|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
125154644|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
125154645|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
125154646|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
125154647|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
125154648|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
125154649|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
125388797|NCT00362115|451056692|FG005|Overall Study|Withdrawal by Subject|3|||
125388798|NCT00362115|451056693|FG006|Overall Study|Withdrawal by Subject|4|||
125388799|NCT00362115|451056687|FG000|Overall Study|Lack of Efficacy|1|||
125154650|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
125154651|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
125154652|NCT00773734|450191509|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
125154653|NCT00773734|450191510|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
125154654|NCT00773734|450191511|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
125154655|NCT00773734|450191512|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
125154656|NCT00773734|450191513|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
125154657|NCT00773734|450191514|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
125154658|NCT00773734|450191509|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
125154659|NCT00773734|450191510|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
125154660|NCT00773734|450191511|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
125154661|NCT00773734|450191512|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
125154662|NCT00773734|450191513|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
125154663|NCT00773734|450191514|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
125154664|NCT00773734|450191509|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
125154665|NCT00773734|450191510|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
125154666|NCT00773734|450191511|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
125154667|NCT00773734|450191512|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
125154668|NCT00773734|450191513|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
125154669|NCT00773734|450191514|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
125154670|NCT00773734|450191509|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
125154671|NCT00773734|450191510|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
125154672|NCT00773734|450191511|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
125154673|NCT00773734|450191512|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
125154674|NCT00773734|450191513|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
125154675|NCT00773734|450191514|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
125154676|NCT00773734|450191509|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
125154677|NCT00773734|450191510|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
125154678|NCT00773734|450191511|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
125154679|NCT00773734|450191512|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
125154680|NCT00773734|450191513|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
125154681|NCT00773734|450191514|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
125154682|NCT00773734|450191509|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
125154683|NCT00773734|450191510|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
125154684|NCT00773734|450191511|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
125154685|NCT00773734|450191512|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
125154686|NCT00773734|450191513|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
125154687|NCT00773734|450191514|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
125154688|NCT00773734|450191509|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
125154689|NCT00773734|450191510|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
125154690|NCT00773734|450191511|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
125154691|NCT00773734|450191512|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
125154692|NCT00773734|450191513|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
125154693|NCT00773734|450191514|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
125154694|NCT00773734|450191509|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
125154695|NCT00773734|450191510|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
125154696|NCT00773734|450191511|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
125154697|NCT00773734|450191512|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
125154698|NCT00773734|450191513|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
125154699|NCT00773734|450191514|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
125154700|NCT00773734|450191509|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
125154701|NCT00773734|450191510|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
125154702|NCT00773734|450191511|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
125154703|NCT00773734|450191512|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
125154704|NCT00773734|450191513|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
125154705|NCT00773734|450191514|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
125154706|NCT00773734|450191509|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
125154707|NCT00773734|450191510|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
125154708|NCT00773734|450191511|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
125154709|NCT00773734|450191512|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
125154710|NCT00773734|450191513|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
125223850|NCT00196105|450446249|FG000|Overall Study|Lost to Follow-up|4|||
125388800|NCT00362115|451056688|FG001|Overall Study|Lack of Efficacy|0|||
125154711|NCT00773734|450191514|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
125154712|NCT00773734|450191509|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
125154713|NCT00773734|450191510|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
125154714|NCT00773734|450191511|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
125154715|NCT00773734|450191512|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
125154716|NCT00773734|450191513|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
125154717|NCT00773734|450191514|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
125154718|NCT00773734|450191509|FG000|Extension: Active Treatment Week 24-52|Other|0|||
125154719|NCT00773734|450191510|FG001|Extension: Active Treatment Week 24-52|Other|0|||
125154720|NCT00773734|450191511|FG002|Extension: Active Treatment Week 24-52|Other|1|||
125154721|NCT00773734|450191512|FG003|Extension: Active Treatment Week 24-52|Other|2|||
125154722|NCT00773734|450191513|FG004|Extension: Active Treatment Week 24-52|Other|0|||
125154723|NCT00773734|450191514|FG005|Extension: Active Treatment Week 24-52|Other|1|||
125154724|NCT00773734|450191509|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
125154725|NCT00773734|450191510|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
125154726|NCT00773734|450191511|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
125154727|NCT00773734|450191512|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
125154728|NCT00773734|450191513|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
125154729|NCT00773734|450191514|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
125154730|NCT00773734|450191509|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
125154731|NCT00773734|450191510|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
125154732|NCT00773734|450191511|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
125154733|NCT00773734|450191512|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
125154734|NCT00773734|450191513|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
125154735|NCT00773734|450191514|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
125154736|NCT00773734|450191509|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
125154737|NCT00773734|450191510|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
125154738|NCT00773734|450191511|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
125154739|NCT00773734|450191512|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
125154740|NCT00773734|450191513|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
125154741|NCT00773734|450191514|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
125154742|NCT00773734|450191509|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
125154743|NCT00773734|450191510|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
125154744|NCT00773734|450191511|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
125154745|NCT00773734|450191512|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
125154746|NCT00773734|450191513|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
125154747|NCT00773734|450191514|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
125154748|NCT01220297|450191517|FG000|Overall Study|Death|2|||
125154749|NCT01220297|450191517|FG000|Overall Study|Lost to Follow-up|1|||
125154750|NCT01287039|450191518|FG000|Overall Study|Noncompliance with study procedures|0|||
125154751|NCT01287039|450191519|FG001|Overall Study|Noncompliance with study procedures|1|||
125154752|NCT01287039|450191518|FG000|Overall Study|Change of location/residence|0|||
125154753|NCT01287039|450191519|FG001|Overall Study|Change of location/residence|3|||
125154754|NCT01287039|450191518|FG000|Overall Study|Elective surgery|0|||
125154755|NCT01287039|450191519|FG001|Overall Study|Elective surgery|1|||
125154756|NCT01287039|450191518|FG000|Overall Study|Protocol Violation|2|||
125154757|NCT01287039|450191519|FG001|Overall Study|Protocol Violation|3|||
125154758|NCT01287039|450191518|FG000|Overall Study|Excluded medication taken|1|||
125154759|NCT01287039|450191519|FG001|Overall Study|Excluded medication taken|0|||
125154760|NCT01287039|450191518|FG000|Overall Study|Noncompliance with study medication|0|||
125154761|NCT01287039|450191519|FG001|Overall Study|Noncompliance with study medication|1|||
125154762|NCT01287039|450191518|FG000|Overall Study|Problem with travel|0|||
125154763|NCT01287039|450191519|FG001|Overall Study|Problem with travel|1|||
125154764|NCT01287039|450191518|FG000|Overall Study|Death|1|||
125154765|NCT01287039|450191519|FG001|Overall Study|Death|0|||
125154766|NCT01287039|450191518|FG000|Overall Study|Change of residence|1|||
125154767|NCT01287039|450191519|FG001|Overall Study|Change of residence|0|||
125154768|NCT01287039|450191518|FG000|Overall Study|Adverse Event|7|||
125154769|NCT01287039|450191519|FG001|Overall Study|Adverse Event|4|||
125154770|NCT01287039|450191518|FG000|Overall Study|Withdrawal by Subject|14|||
125154771|NCT01287039|450191519|FG001|Overall Study|Withdrawal by Subject|11|||
125154772|NCT01287039|450191518|FG000|Overall Study|Lost to Follow-up|3|||
125154773|NCT01287039|450191519|FG001|Overall Study|Lost to Follow-up|2|||
125154774|NCT00099268|450191520|FG000|Overall Study|Withdrawal by Subject|46|||
125154775|NCT00099268|450191521|FG001|Overall Study|Withdrawal by Subject|28|||
125438730|NCT00545363|451233937|FG001|Overall Study|Other|1|||
125438731|NCT03125941|451233940|FG000|Overall Study|did not receive intervention|1|||
125154776|NCT00099268|450191520|FG000|Overall Study|Adverse Event|19|||
125154777|NCT00099268|450191521|FG001|Overall Study|Adverse Event|19|||
125154778|NCT00099268|450191520|FG000|Overall Study|Protocol Violation|9|||
125154779|NCT00099268|450191521|FG001|Overall Study|Protocol Violation|8|||
125154780|NCT00099268|450191520|FG000|Overall Study|Lost to Follow-up|6|||
125154781|NCT00099268|450191521|FG001|Overall Study|Lost to Follow-up|4|||
125154782|NCT00099268|450191520|FG000|Overall Study|Lack of Efficacy|5|||
125154783|NCT00099268|450191521|FG001|Overall Study|Lack of Efficacy|18|||
125154784|NCT00099268|450191520|FG000|Overall Study|Administrative problems|4|||
125154785|NCT00099268|450191521|FG001|Overall Study|Administrative problems|4|||
125154786|NCT00099268|450191520|FG000|Overall Study|Death|3|||
125154787|NCT00099268|450191521|FG001|Overall Study|Death|1|||
125154788|NCT05016622|450191522|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
125154789|NCT05016622|450191522|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
125154790|NCT02581163|450191524|FG000|Overall Study|Failure to return|15|||
125154791|NCT02581163|450191524|FG000|Overall Study|Insufficient virological response|3|||
125154792|NCT02581163|450191524|FG000|Overall Study|Withdrew consent|1|||
125154793|NCT02581163|450191524|FG000|Overall Study|Death|1|||
125154794|NCT02581163|450191524|FG000|Overall Study|Other, not specified|9|||
125154795|NCT03438396|450191525|FG000|Overall Study|Reason Not Specified|9|||
125154796|NCT03438396|450191525|FG000|Overall Study|Withdrawal by Subject|5|||
125154797|NCT03438396|450191525|FG000|Overall Study|Lost to Follow-up|2|||
125154798|NCT03438396|450191525|FG000|Overall Study|Death|85|||
125154799|NCT03438396|450191525|FG000|Overall Study|Not treated|1|||
125154800|NCT02006628|450191526|FG000|Overall Study|Adverse Event|1|||
125154801|NCT02006628|450191527|FG001|Overall Study|Adverse Event|1|||
125154802|NCT02006628|450191526|FG000|Overall Study|Withdrawal by Subject|2|||
125154803|NCT02006628|450191527|FG001|Overall Study|Withdrawal by Subject|1|||
125154804|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
125154805|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
125154806|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
125154807|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
125154808|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
125154809|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
125154810|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
125154811|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
125154812|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
125154813|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
125154814|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
125154815|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
125154816|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
125154817|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
125154818|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
125154819|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
125154820|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
125154821|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
125154822|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
125154823|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
125154824|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
125154825|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
125154826|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
125154827|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
125154828|NCT01421342|450191528|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
125154829|NCT01421342|450191529|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
125154830|NCT01421342|450191530|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
125154831|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
125154832|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
125154833|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
125154834|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
125154835|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
125154836|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
125154837|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
125154838|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
125154839|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
125154840|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
125154841|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
125154842|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
125154843|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
125154844|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
125154845|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
125154846|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
125154847|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
125154848|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
125154849|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
125154850|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
125223851|NCT00196105|450446250|FG001|Overall Study|Lost to Follow-up|5|||
125223852|NCT00196105|450446251|FG002|Overall Study|Lost to Follow-up|7|||
125223853|NCT04863872|450446252|FG000|Overall Study|Withdrawal by Subject|4|||
125223854|NCT04863872|450446253|FG001|Overall Study|Withdrawal by Subject|15|||
125223855|NCT04863872|450446252|FG000|Overall Study|Death|5|||
125154851|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
125154852|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
125154853|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
125154854|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
125154855|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
125154856|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
125154857|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
125154858|NCT01421342|450191528|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
125154859|NCT01421342|450191529|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
125154860|NCT01421342|450191530|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
125154861|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
125154862|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
125154863|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
125154864|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
125154865|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
125154866|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
125154867|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
125154868|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
125154869|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
125154870|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
125154871|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
125154872|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
125154873|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
125154874|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
125154875|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
125154876|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
125154877|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
125154878|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
125154879|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
125154880|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
125154881|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
125154882|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
125154883|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
125154884|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
125154885|NCT01421342|450191528|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
125154886|NCT01421342|450191529|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
125154887|NCT01421342|450191530|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
125154888|NCT03578237|450191531|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
125154889|NCT03578237|450191532|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
125154890|NCT02488330|450191533|FG000|Overall Study|Adverse Event|1|||
125154891|NCT02488330|450191533|FG000|Overall Study|Physician Decision|2|||
125154892|NCT02488330|450191533|FG000|Overall Study|Death|2|||
125154893|NCT02488330|450191533|FG000|Overall Study|Disease Progression|3|||
125154894|NCT02488330|450191533|FG000|Overall Study|Study Termination by Sponsor|4|||
125154895|NCT01206816|450191535|FG000|Overall Study|Protocol Violation|0|||
125154896|NCT01206816|450191536|FG001|Overall Study|Protocol Violation|0|||
125154897|NCT01206816|450191537|FG002|Overall Study|Protocol Violation|1|||
125154898|NCT01206816|450191538|FG003|Overall Study|Protocol Violation|0|||
125154899|NCT01206816|450191539|FG004|Overall Study|Protocol Violation|0|||
125154900|NCT01206816|450191540|FG005|Overall Study|Protocol Violation|0|||
125154901|NCT01206816|450191541|FG006|Overall Study|Protocol Violation|0|||
125154902|NCT01206816|450191535|FG000|Overall Study|Withdrawal by Subject|0|||
125154903|NCT01206816|450191536|FG001|Overall Study|Withdrawal by Subject|0|||
125154904|NCT01206816|450191537|FG002|Overall Study|Withdrawal by Subject|1|||
125154905|NCT01206816|450191538|FG003|Overall Study|Withdrawal by Subject|0|||
125154906|NCT01206816|450191539|FG004|Overall Study|Withdrawal by Subject|0|||
125154907|NCT01206816|450191540|FG005|Overall Study|Withdrawal by Subject|0|||
125154908|NCT01206816|450191541|FG006|Overall Study|Withdrawal by Subject|0|||
125154909|NCT01206816|450191535|FG000|Overall Study|Progressive disease|3|||
125154910|NCT01206816|450191536|FG001|Overall Study|Progressive disease|3|||
125154911|NCT01206816|450191537|FG002|Overall Study|Progressive disease|13|||
125154912|NCT01206816|450191538|FG003|Overall Study|Progressive disease|3|||
125438732|NCT03125941|451233941|FG001|Overall Study|did not receive intervention|2|||
125154913|NCT01206816|450191539|FG004|Overall Study|Progressive disease|3|||
125154914|NCT01206816|450191540|FG005|Overall Study|Progressive disease|16|||
125154915|NCT01206816|450191541|FG006|Overall Study|Progressive disease|3|||
125154916|NCT01206816|450191535|FG000|Overall Study|Other AE|0|||
125154917|NCT01206816|450191536|FG001|Overall Study|Other AE|0|||
125154918|NCT01206816|450191537|FG002|Overall Study|Other AE|4|||
125154919|NCT01206816|450191538|FG003|Overall Study|Other AE|0|||
125154920|NCT01206816|450191539|FG004|Overall Study|Other AE|0|||
125154921|NCT01206816|450191540|FG005|Overall Study|Other AE|3|||
125154922|NCT01206816|450191541|FG006|Overall Study|Other AE|2|||
125154923|NCT01206816|450191535|FG000|Overall Study|other than stated above|0|||
125154924|NCT01206816|450191536|FG001|Overall Study|other than stated above|0|||
125154925|NCT01206816|450191537|FG002|Overall Study|other than stated above|1|||
125154926|NCT01206816|450191538|FG003|Overall Study|other than stated above|0|||
125154927|NCT01206816|450191539|FG004|Overall Study|other than stated above|0|||
125154928|NCT01206816|450191540|FG005|Overall Study|other than stated above|0|||
125154929|NCT01206816|450191541|FG006|Overall Study|other than stated above|1|||
125154930|NCT02493777|450191544|FG000|Overall Study|Lost to Follow-up|0|||
125154931|NCT02493777|450191545|FG001|Overall Study|Lost to Follow-up|1|||
125154932|NCT01642914|450191546|FG000|Overall Study|Adverse Event|11|||
125154933|NCT01642914|450191547|FG001|Overall Study|Adverse Event|7|||
125154934|NCT01642914|450191548|FG002|Overall Study|Adverse Event|15|||
125154935|NCT01642914|450191546|FG000|Overall Study|Lack of Efficacy|9|||
125154936|NCT01642914|450191547|FG001|Overall Study|Lack of Efficacy|4|||
125154937|NCT01642914|450191548|FG002|Overall Study|Lack of Efficacy|2|||
125154938|NCT01642914|450191546|FG000|Overall Study|Protocol Violation|15|||
125154939|NCT01642914|450191547|FG001|Overall Study|Protocol Violation|13|||
125154940|NCT01642914|450191548|FG002|Overall Study|Protocol Violation|6|||
125154941|NCT01642914|450191546|FG000|Overall Study|Withdrawal by Subject|5|||
125154942|NCT01642914|450191547|FG001|Overall Study|Withdrawal by Subject|5|||
125154943|NCT01642914|450191548|FG002|Overall Study|Withdrawal by Subject|10|||
125154944|NCT01642914|450191546|FG000|Overall Study|Lost to Follow-up|5|||
125154945|NCT01642914|450191547|FG001|Overall Study|Lost to Follow-up|3|||
125154946|NCT01642914|450191548|FG002|Overall Study|Lost to Follow-up|7|||
125154947|NCT01642914|450191546|FG000|Overall Study|Other Reason|1|||
125154948|NCT01642914|450191547|FG001|Overall Study|Other Reason|0|||
125154949|NCT01642914|450191548|FG002|Overall Study|Other Reason|0|||
125154950|NCT01705236|450191549|FG000|Overall Study|Lost to Follow-up|1|||
125154951|NCT01705236|450191549|FG000|Overall Study|Administrative problems|2|||
125154952|NCT01705236|450191549|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
125154953|NCT01705236|450191549|FG000|Overall Study|Protocol Violation|3|||
125154954|NCT01705236|450191549|FG000|Overall Study|Abnormal test procedure result(s)|4|||
125154955|NCT01705236|450191549|FG000|Overall Study|Abnormal laboratory value(s)|4|||
125154956|NCT01705236|450191549|FG000|Overall Study|Withdrawal by Subject|5|||
125154957|NCT01705236|450191549|FG000|Overall Study|Adverse Event|5|||
125154958|NCT00171301|450191550|FG000|Overall Study|Death|1|||
125154959|NCT00171301|450191551|FG001|Overall Study|Death|2|||
125154960|NCT00171301|450191550|FG000|Overall Study|Adverse Event|1|||
125154961|NCT00171301|450191551|FG001|Overall Study|Adverse Event|2|||
125154962|NCT00171301|450191550|FG000|Overall Study|Lost to Follow-up|6|||
125154963|NCT00171301|450191551|FG001|Overall Study|Lost to Follow-up|2|||
125154964|NCT00171301|450191550|FG000|Overall Study|Protocol Violation|0|||
125154965|NCT00171301|450191551|FG001|Overall Study|Protocol Violation|2|||
125154966|NCT00171301|450191550|FG000|Overall Study|Withdrawal by Subject|0|||
125154967|NCT00171301|450191551|FG001|Overall Study|Withdrawal by Subject|1|||
125154968|NCT04319159|450191552|FG000|Overall Study|Screening failure|13|||
125154969|NCT04319159|450191552|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
125154970|NCT04319159|450191552|FG000|Overall Study|Withdrawal by Subject|1|||
125154971|NCT02100319|450191553|FG000|Overall Study|Case Report Forms Uncollected|11|||
125154972|NCT02100319|450191553|FG000|Overall Study|Protocol Deviation|5|||
125154973|NCT02370914|450191554|FG000|Overall Study|Protocol Violation|2|||
125438733|NCT00582491|451233942|FG000|Overall Study|Withdrawal by Subject|1|||
125154974|NCT00754442|450191555|FG000|Overall Study|Withdrawal by Subject|5|||
125154975|NCT00754442|450191556|FG001|Overall Study|Withdrawal by Subject|3|||
125154976|NCT00296491|450191557|FG000|Overall Study|Low Pollen Counts|18|||
125154977|NCT00296491|450191558|FG001|Overall Study|Low Pollen Counts|26|||
125154978|NCT00296491|450191559|FG002|Overall Study|Low Pollen Counts|25|||
125154979|NCT00296491|450191560|FG003|Overall Study|Low Pollen Counts|16|||
125154980|NCT00296491|450191557|FG000|Overall Study|Protocol Violation|4|||
125154981|NCT00296491|450191558|FG001|Overall Study|Protocol Violation|6|||
125154982|NCT00296491|450191559|FG002|Overall Study|Protocol Violation|2|||
125154983|NCT00296491|450191560|FG003|Overall Study|Protocol Violation|3|||
125154984|NCT00296491|450191557|FG000|Overall Study|Adverse Event|1|||
125154985|NCT00296491|450191558|FG001|Overall Study|Adverse Event|3|||
125154986|NCT00296491|450191559|FG002|Overall Study|Adverse Event|1|||
125154987|NCT00296491|450191560|FG003|Overall Study|Adverse Event|4|||
125154988|NCT00296491|450191557|FG000|Overall Study|Withdrawn due to Asthma|0|||
125154989|NCT00296491|450191558|FG001|Overall Study|Withdrawn due to Asthma|0|||
125154990|NCT00296491|450191559|FG002|Overall Study|Withdrawn due to Asthma|0|||
125154991|NCT00296491|450191560|FG003|Overall Study|Withdrawn due to Asthma|4|||
125154992|NCT00296491|450191557|FG000|Overall Study|Withdrawal by Subject|7|||
125154993|NCT00296491|450191558|FG001|Overall Study|Withdrawal by Subject|3|||
125154994|NCT00296491|450191559|FG002|Overall Study|Withdrawal by Subject|3|||
125438734|NCT00582491|451233943|FG001|Overall Study|Withdrawal by Subject|0|||
125438735|NCT04192630|451233944|FG000|Overall Study|Discontinued before surgery|2|||
125154995|NCT00296491|450191560|FG003|Overall Study|Withdrawal by Subject|2|||
125154996|NCT00296491|450191557|FG000|Overall Study|Non-Compliance|12|||
125154997|NCT00296491|450191558|FG001|Overall Study|Non-Compliance|13|||
125154998|NCT00296491|450191559|FG002|Overall Study|Non-Compliance|10|||
125154999|NCT00296491|450191560|FG003|Overall Study|Non-Compliance|14|||
125155000|NCT00296491|450191557|FG000|Overall Study|Lost to Follow-up|0|||
125155001|NCT00296491|450191558|FG001|Overall Study|Lost to Follow-up|2|||
125155002|NCT00296491|450191559|FG002|Overall Study|Lost to Follow-up|2|||
125155003|NCT00296491|450191560|FG003|Overall Study|Lost to Follow-up|0|||
125155004|NCT01300052|450191561|FG000|Overall Study|Adverse Event|3|||
125155005|NCT01300052|450191562|FG001|Overall Study|Adverse Event|0|||
125155006|NCT01300052|450191561|FG000|Overall Study|Withdrawal by Subject|2|||
125155007|NCT01300052|450191562|FG001|Overall Study|Withdrawal by Subject|2|||
125155008|NCT01300052|450191561|FG000|Overall Study|Protocol Violation|1|||
125155009|NCT01300052|450191562|FG001|Overall Study|Protocol Violation|1|||
125155010|NCT01231373|450191563|FG000|Overall Study|Withdrew consent prior to randomization|2|||
125155011|NCT01231373|450191564|FG001|Overall Study|Withdrew consent prior to randomization|1|||
125155012|NCT01231373|450191565|FG002|Overall Study|Withdrew consent prior to randomization|0|||
125155013|NCT01231373|450191566|FG003|Overall Study|Withdrew consent prior to randomization|0|||
125155014|NCT01231373|450191563|FG000|Overall Study|Lost to Follow-up|0|||
125155015|NCT01231373|450191564|FG001|Overall Study|Lost to Follow-up|0|||
125155016|NCT01231373|450191565|FG002|Overall Study|Lost to Follow-up|0|||
125155017|NCT01231373|450191566|FG003|Overall Study|Lost to Follow-up|1|||
125155018|NCT01231373|450191563|FG000|Overall Study|Withdrew Consent|1|||
125155019|NCT01231373|450191564|FG001|Overall Study|Withdrew Consent|0|||
125155020|NCT01231373|450191565|FG002|Overall Study|Withdrew Consent|0|||
125155021|NCT01231373|450191566|FG003|Overall Study|Withdrew Consent|0|||
125155022|NCT03451006|450191567|FG000|Overall Study|Withdrawal by Subject|2|||
125155023|NCT03451006|450191568|FG001|Overall Study|Withdrawal by Subject|2|||
125155024|NCT02547766|450191569|FG000|Overall Study|Withdrawal by Subject|1|||
125155025|NCT01929395|450191570|FG000|Overall Study|Did not complete - non-related toxicity|1|||
125155026|NCT01929395|450191571|FG001|Overall Study|Did not complete - non-related toxicity|0|||
125155027|NCT01929395|450191572|FG002|Overall Study|Did not complete - non-related toxicity|0|||
125155028|NCT01929395|450191570|FG000|Overall Study|Withdrawal by Subject|0|||
125155029|NCT01929395|450191571|FG001|Overall Study|Withdrawal by Subject|1|||
125155030|NCT01929395|450191572|FG002|Overall Study|Withdrawal by Subject|0|||
125155031|NCT01929395|450191570|FG000|Overall Study|Screen Fail|0|||
125155032|NCT01929395|450191571|FG001|Overall Study|Screen Fail|0|||
125155033|NCT01929395|450191572|FG002|Overall Study|Screen Fail|1|||
125155034|NCT03604341|450191573|FG000|Overall Study|Withdrawal by Subject|1|||
125155035|NCT03604341|450191574|FG001|Overall Study|Withdrawal by Subject|1|||
125155036|NCT03604341|450191573|FG000|Overall Study|Adverse Event|1|||
125155037|NCT03604341|450191574|FG001|Overall Study|Adverse Event|0|||
125155038|NCT03604341|450191573|FG000|Overall Study|Protocol Violation|0|||
125155039|NCT03604341|450191574|FG001|Overall Study|Protocol Violation|1|||
125155040|NCT00897949|450191578|FG000|Overall Study|Adverse Event|1|||
125155041|NCT00897949|450191579|FG001|Overall Study|Adverse Event|1|||
125155042|NCT00897949|450191580|FG002|Overall Study|Adverse Event|0|||
125155043|NCT00897949|450191578|FG000|Overall Study|Lost to Follow-up|0|||
125155044|NCT00897949|450191579|FG001|Overall Study|Lost to Follow-up|2|||
125155045|NCT00897949|450191580|FG002|Overall Study|Lost to Follow-up|1|||
125155046|NCT00897949|450191578|FG000|Overall Study|Protocol Violation|6|||
125155047|NCT00897949|450191579|FG001|Overall Study|Protocol Violation|3|||
125155048|NCT00897949|450191580|FG002|Overall Study|Protocol Violation|1|||
125155049|NCT00897949|450191578|FG000|Overall Study|Withdrawal by Subject|1|||
125155050|NCT00897949|450191579|FG001|Overall Study|Withdrawal by Subject|2|||
125155051|NCT00897949|450191580|FG002|Overall Study|Withdrawal by Subject|0|||
125155052|NCT00897949|450191578|FG000|Overall Study|Patient Uncoorperative|0|||
125155053|NCT00897949|450191579|FG001|Overall Study|Patient Uncoorperative|2|||
125155054|NCT00897949|450191580|FG002|Overall Study|Patient Uncoorperative|1|||
125155055|NCT00897949|450191578|FG000|Overall Study|Lost to Follow-up|30|||
125155056|NCT00897949|450191579|FG001|Overall Study|Lost to Follow-up|23|||
125155057|NCT00897949|450191580|FG002|Overall Study|Lost to Follow-up|17|||
125155058|NCT00897949|450191578|FG000|Overall Study|Withdrawal by Subject|24|||
125155059|NCT00897949|450191579|FG001|Overall Study|Withdrawal by Subject|31|||
125155060|NCT00897949|450191580|FG002|Overall Study|Withdrawal by Subject|17|||
125155061|NCT00897949|450191578|FG000|Overall Study|Abnormal Prestudy Labs|2|||
125155062|NCT00897949|450191579|FG001|Overall Study|Abnormal Prestudy Labs|3|||
125155063|NCT00897949|450191580|FG002|Overall Study|Abnormal Prestudy Labs|4|||
125155064|NCT00897949|450191578|FG000|Overall Study|Abnormal Baseline ECG|2|||
125155065|NCT00897949|450191579|FG001|Overall Study|Abnormal Baseline ECG|2|||
125155066|NCT00897949|450191580|FG002|Overall Study|Abnormal Baseline ECG|4|||
125155067|NCT00897949|450191578|FG000|Overall Study|Need for Concom. Med.|0|||
125155068|NCT00897949|450191579|FG001|Overall Study|Need for Concom. Med.|1|||
125155069|NCT00897949|450191580|FG002|Overall Study|Need for Concom. Med.|1|||
125155070|NCT00897949|450191578|FG000|Overall Study|Lack of Migraine Attack|29|||
125155071|NCT00897949|450191579|FG001|Overall Study|Lack of Migraine Attack|30|||
125155072|NCT00897949|450191580|FG002|Overall Study|Lack of Migraine Attack|19|||
125155073|NCT00897949|450191578|FG000|Overall Study|Did not take study drug|9|||
125155074|NCT00897949|450191579|FG001|Overall Study|Did not take study drug|3|||
125155075|NCT00897949|450191580|FG002|Overall Study|Did not take study drug|4|||
125155076|NCT01553747|450191581|FG000|Overall Study|Protocol Violation|0|||
125155077|NCT01553747|450191582|FG001|Overall Study|Protocol Violation|2|||
125155078|NCT01553747|450191583|FG002|Overall Study|Protocol Violation|0|||
125155079|NCT01553747|450191581|FG000|Overall Study|Voluntarily withdrew|70|||
125155080|NCT01553747|450191582|FG001|Overall Study|Voluntarily withdrew|66|||
125155081|NCT01553747|450191583|FG002|Overall Study|Voluntarily withdrew|74|||
125155082|NCT01553747|450191581|FG000|Overall Study|Adverse event or SAE|32|||
125155083|NCT01553747|450191582|FG001|Overall Study|Adverse event or SAE|28|||
125155084|NCT01553747|450191583|FG002|Overall Study|Adverse event or SAE|19|||
125155085|NCT01553747|450191581|FG000|Overall Study|Physician decision: other|10|||
125155086|NCT01553747|450191582|FG001|Overall Study|Physician decision: other|8|||
125155087|NCT01553747|450191583|FG002|Overall Study|Physician decision: other|7|||
125155088|NCT01553747|450191581|FG000|Overall Study|Lost to Follow-up|11|||
125155089|NCT01553747|450191582|FG001|Overall Study|Lost to Follow-up|5|||
125155090|NCT01553747|450191583|FG002|Overall Study|Lost to Follow-up|6|||
125155091|NCT01553747|450191581|FG000|Overall Study|Sponsor decision, specify|7|||
125155092|NCT01553747|450191582|FG001|Overall Study|Sponsor decision, specify|5|||
125155093|NCT01553747|450191583|FG002|Overall Study|Sponsor decision, specify|0|||
125155094|NCT01553747|450191581|FG000|Overall Study|Physician decision: lack of efficacy|1|||
125155095|NCT01553747|450191582|FG001|Overall Study|Physician decision: lack of efficacy|5|||
125155096|NCT01553747|450191583|FG002|Overall Study|Physician decision: lack of efficacy|3|||
125155097|NCT01134627|450191584|FG000|Overall Study|Adverse Event|47|||
125155098|NCT01134627|450191585|FG001|Overall Study|Adverse Event|31|||
125155099|NCT01134627|450191584|FG000|Overall Study|Lost to Follow-up|1|||
125155100|NCT01134627|450191585|FG001|Overall Study|Lost to Follow-up|2|||
125155101|NCT01134627|450191584|FG000|Overall Study|Protocol Violation|3|||
125155102|NCT01134627|450191585|FG001|Overall Study|Protocol Violation|5|||
125155103|NCT01134627|450191584|FG000|Overall Study|Lack of Efficacy|2|||
125155104|NCT01134627|450191585|FG001|Overall Study|Lack of Efficacy|12|||
125155105|NCT01134627|450191584|FG000|Overall Study|Withdrawal by Subject|4|||
125155106|NCT01134627|450191585|FG001|Overall Study|Withdrawal by Subject|3|||
125155107|NCT01134627|450191584|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
125155108|NCT01134627|450191585|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
125155109|NCT01134627|450191584|FG000|Overall Study|Other|11|||
125155110|NCT01134627|450191585|FG001|Overall Study|Other|14|||
125155111|NCT00351351|450191586|FG000|Overall Study|surgical access pbs; device issues|9|||
125155112|NCT00351351|450191587|FG001|Overall Study|surgical access pbs; device issues|4|||
125155113|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
125155114|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
125155115|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
125155116|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
125155117|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
125155118|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
125155119|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
125155120|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
125155121|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
125155122|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
125155123|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
125155124|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
125155125|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
125155126|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
125155127|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
125155128|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
125155129|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
125155130|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
125155131|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
125155132|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
125155133|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
125155134|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
125155135|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
125155136|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
125155137|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
125155138|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
125155139|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
125155140|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
125155141|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Death|0|||
125155142|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Death|1|||
125155143|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Death|0|||
125155144|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Death|0|||
125155145|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
125155146|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
125155147|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
125155148|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
125155149|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
125155150|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
125155151|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
125155152|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
125155153|NCT02990806|450191591|FG000|Stage 1 (22 Weeks)|Other|1|||
125155154|NCT02990806|450191592|FG001|Stage 1 (22 Weeks)|Other|3|||
125155155|NCT02990806|450191593|FG002|Stage 1 (22 Weeks)|Other|0|||
125155156|NCT02990806|450191594|FG003|Stage 1 (22 Weeks)|Other|0|||
125155157|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
125155158|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
125155159|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
125155160|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
125155161|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Death|1|||
125155162|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Death|0|||
125155163|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Death|0|||
125155164|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Death|0|||
125155165|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
125155166|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
125155167|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
125155168|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
125155169|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
125155170|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
125155171|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
125155172|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
125155173|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
125155174|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
125155175|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
125155176|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
125155177|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
125155178|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
125155179|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
125155180|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
125155181|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
125155182|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
125155183|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
125155184|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
125155185|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
125155186|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
125155187|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
125155188|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
125155189|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
125155190|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
125155191|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
125155192|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
125155193|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
125155194|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
125155195|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
125155196|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
125155197|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
125155198|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
125155199|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
125155200|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
125155201|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Other|3|||
125155202|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Other|0|||
125155203|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Other|4|||
125155204|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Other|1|||
125155205|NCT02990806|450191591|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
125155206|NCT02990806|450191592|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
125155207|NCT02990806|450191593|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
125155208|NCT02990806|450191594|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
125155209|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
125155210|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
125155211|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
125155212|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
125155213|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
125155214|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
125155215|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
125155216|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
125155217|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
125155218|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
125155219|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
125155220|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
125155221|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
125155222|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
125155223|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
125155224|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
125155225|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
125155226|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
125155227|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
125155228|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
125155229|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
125155230|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
125155231|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
125155232|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
125155233|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
125155234|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
125155235|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
125155236|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
125155237|NCT02990806|450191591|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
125155238|NCT02990806|450191592|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
125155239|NCT02990806|450191593|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
125155240|NCT02990806|450191594|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
125155241|NCT02903238|450191595|FG000|Overall Study|Lost to Follow-up|4|||
125155242|NCT00700817|450191596|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
125155243|NCT00700817|450191597|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
125155244|NCT00700817|450191598|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
125155245|NCT00700817|450191599|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
125155246|NCT00700817|450191600|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
125155247|NCT00700817|450191596|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
125155248|NCT00700817|450191597|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
125155249|NCT00700817|450191598|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
125155250|NCT00700817|450191599|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
125155251|NCT00700817|450191600|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
125155252|NCT00700817|450191596|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
125155253|NCT00700817|450191597|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
125155254|NCT00700817|450191598|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
125155255|NCT00700817|450191599|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
125155256|NCT00700817|450191600|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
125155257|NCT00700817|450191596|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
125155258|NCT00700817|450191597|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
125155259|NCT00700817|450191598|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
125155260|NCT00700817|450191599|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
125155261|NCT00700817|450191600|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
125155262|NCT00700817|450191596|FG000|Week 0-26 (Main Period)|Unclassified|14|||
125155263|NCT00700817|450191597|FG001|Week 0-26 (Main Period)|Unclassified|4|||
125155264|NCT00700817|450191598|FG002|Week 0-26 (Main Period)|Unclassified|8|||
125155265|NCT00700817|450191599|FG003|Week 0-26 (Main Period)|Unclassified|0|||
125155266|NCT00700817|450191600|FG004|Week 0-26 (Main Period)|Unclassified|0|||
125155267|NCT00700817|450191596|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
125155268|NCT00700817|450191597|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
125155269|NCT00700817|450191598|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
125155270|NCT00700817|450191599|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
125155271|NCT00700817|450191600|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
125155272|NCT00700817|450191596|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
125155273|NCT00700817|450191597|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
125155274|NCT00700817|450191598|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
125155275|NCT00700817|450191599|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
125155276|NCT00700817|450191600|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
125155277|NCT00700817|450191596|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
125155278|NCT00700817|450191597|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
125155279|NCT00700817|450191598|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
125155280|NCT00700817|450191599|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
125155281|NCT00700817|450191600|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
125155282|NCT00700817|450191596|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
125155283|NCT00700817|450191597|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
125155284|NCT00700817|450191598|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
125155285|NCT00700817|450191599|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
125155286|NCT00700817|450191600|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
125155287|NCT00700817|450191596|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
125155288|NCT00700817|450191597|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
125155289|NCT00700817|450191598|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
125155290|NCT00700817|450191599|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
125155291|NCT00700817|450191600|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
125155292|NCT00700817|450191596|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
125155293|NCT00700817|450191597|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
125155294|NCT00700817|450191598|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
125155295|NCT00700817|450191599|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
125155296|NCT00700817|450191600|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
125155297|NCT00700817|450191596|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
125155298|NCT00700817|450191597|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
125155299|NCT00700817|450191598|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
125155300|NCT00700817|450191599|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
125155301|NCT00700817|450191600|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
125155302|NCT00700817|450191596|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
125155303|NCT00700817|450191597|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
125155304|NCT00700817|450191598|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
125155305|NCT00700817|450191599|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
125155306|NCT00700817|450191600|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
125155307|NCT00700817|450191596|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
125155308|NCT00700817|450191597|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
125155309|NCT00700817|450191598|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
125155310|NCT00700817|450191599|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
125155311|NCT00700817|450191600|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
125155312|NCT00700817|450191596|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
125155313|NCT00700817|450191597|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
125155314|NCT00700817|450191598|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
125155315|NCT00700817|450191599|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
125155316|NCT00700817|450191600|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
125155317|NCT01338987|450191601|FG000|Overall Study|enrolled on new protocol|0|||
125155318|NCT01338987|450191602|FG001|Overall Study|enrolled on new protocol|0|||
125155319|NCT01338987|450191603|FG002|Overall Study|enrolled on new protocol|1|||
125155320|NCT01338987|450191604|FG003|Overall Study|enrolled on new protocol|0|||
125155321|NCT01338987|450191605|FG004|Overall Study|enrolled on new protocol|0|||
125155322|NCT01338987|450191601|FG000|Overall Study|Disease progression on study|2|||
125155323|NCT01338987|450191602|FG001|Overall Study|Disease progression on study|1|||
125155324|NCT01338987|450191603|FG002|Overall Study|Disease progression on study|1|||
125155325|NCT01338987|450191604|FG003|Overall Study|Disease progression on study|0|||
125155326|NCT01338987|450191605|FG004|Overall Study|Disease progression on study|0|||
125155327|NCT00606502|450191608|FG000|Randomization|Randomized but not treated|3|||
125155328|NCT00606502|450191609|FG001|Randomization|Randomized but not treated|0|||
125155329|NCT00606502|450191608|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
125155330|NCT00606502|450191609|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
125155331|NCT01470612|450191618|FG000|Overall Study|Adverse Event|20|||
125155332|NCT01470612|450191619|FG001|Overall Study|Adverse Event|80|||
125155333|NCT01470612|450191618|FG000|Overall Study|Death|0|||
125155334|NCT01470612|450191619|FG001|Overall Study|Death|1|||
125155335|NCT01470612|450191618|FG000|Overall Study|Lack of Efficacy|20|||
125155336|NCT01470612|450191619|FG001|Overall Study|Lack of Efficacy|326|||
125155337|NCT01470612|450191618|FG000|Overall Study|Lost to Follow-up|2|||
125155338|NCT01470612|450191619|FG001|Overall Study|Lost to Follow-up|5|||
125155339|NCT01470612|450191618|FG000|Overall Study|Did not meet entrance criteria|0|||
125155340|NCT01470612|450191619|FG001|Overall Study|Did not meet entrance criteria|1|||
125155341|NCT01470612|450191618|FG000|Overall Study|Pregnancy|2|||
125155342|NCT01470612|450191619|FG001|Overall Study|Pregnancy|10|||
125155343|NCT01470612|450191618|FG000|Overall Study|Protocol Violation|2|||
125155344|NCT01470612|450191619|FG001|Overall Study|Protocol Violation|7|||
125155345|NCT01470612|450191618|FG000|Overall Study|Withdrawal by Subject|24|||
125155346|NCT01470612|450191619|FG001|Overall Study|Withdrawal by Subject|79|||
125155347|NCT01470612|450191618|FG000|Overall Study|Other|14|||
125155348|NCT01470612|450191619|FG001|Overall Study|Other|156|||
125155349|NCT03407118|450191623|FG000|Period 2|Withdrawal by Subject|1|||
125155350|NCT03407118|450191624|FG001|Period 2|Withdrawal by Subject|0|||
125155351|NCT02556307|450191625|FG000|Overall Study|Premature treatment interruption|11|||
125155352|NCT02556307|450191625|FG000|Overall Study|Lost to Follow-up|36|||
125155353|NCT02556307|450191625|FG000|Overall Study|Change to triple therapy|4|||
125155354|NCT02556307|450191625|FG000|Overall Study|Enrolled but not treated|2|||
125155355|NCT00384176|450191628|FG000|Overall Study|Death|239|||
125155356|NCT00384176|450191629|FG001|Overall Study|Death|247|||
125155357|NCT00384176|450191630|FG002|Overall Study|Death|105|||
125155358|NCT00384176|450191628|FG000|Overall Study|Withdrawal by Subject|52|||
125155359|NCT00384176|450191629|FG001|Overall Study|Withdrawal by Subject|48|||
125155360|NCT00384176|450191630|FG002|Overall Study|Withdrawal by Subject|22|||
125155361|NCT00384176|450191628|FG000|Overall Study|Lost to Follow-up|16|||
125155362|NCT00384176|450191629|FG001|Overall Study|Lost to Follow-up|18|||
125155363|NCT00384176|450191630|FG002|Overall Study|Lost to Follow-up|4|||
125155364|NCT00384176|450191628|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
125155365|NCT00384176|450191629|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
125155366|NCT00384176|450191630|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
125155367|NCT00384176|450191628|FG000|Overall Study|Longer QTC as Visit 1|1|||
125155368|NCT00384176|450191629|FG001|Overall Study|Longer QTC as Visit 1|0|||
125155369|NCT00384176|450191630|FG002|Overall Study|Longer QTC as Visit 1|0|||
125155370|NCT00384176|450191628|FG000|Overall Study|Toxicity of treatment|1|||
125155371|NCT00384176|450191629|FG001|Overall Study|Toxicity of treatment|0|||
125155372|NCT00384176|450191630|FG002|Overall Study|Toxicity of treatment|0|||
125155373|NCT00384176|450191628|FG000|Overall Study|Did not receive study treatment|0|||
125155374|NCT00384176|450191629|FG001|Overall Study|Did not receive study treatment|1|||
125155375|NCT00384176|450191630|FG002|Overall Study|Did not receive study treatment|1|||
125155376|NCT00384176|450191628|FG000|Overall Study|Physician Decision|0|||
125155377|NCT00384176|450191629|FG001|Overall Study|Physician Decision|2|||
125155378|NCT00384176|450191630|FG002|Overall Study|Physician Decision|0|||
125155379|NCT00384176|450191628|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
125155380|NCT00384176|450191629|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
125155381|NCT00384176|450191630|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
125155382|NCT00854373|450191631|FG000|Overall Study|Withdrawal by Subject|1|||
125155383|NCT00854373|450191632|FG001|Overall Study|Withdrawal by Subject|3|||
125155384|NCT00854373|450191631|FG000|Overall Study|Forgot to take study drug|1|||
125155385|NCT00854373|450191632|FG001|Overall Study|Forgot to take study drug|1|||
125155386|NCT00307931|450191633|FG000|Overall Study|Adverse Event|1|||
125155387|NCT00515034|450191634|FG000|Overall Study|Adverse Event|2|||
125155388|NCT00515034|450191635|FG001|Overall Study|Adverse Event|0|||
125155389|NCT00515034|450191636|FG002|Overall Study|Adverse Event|1|||
125155390|NCT00515034|450191637|FG003|Overall Study|Adverse Event|0|||
125155391|NCT00515034|450191634|FG000|Overall Study|Death|4|||
125155392|NCT00515034|450191635|FG001|Overall Study|Death|2|||
125155393|NCT00515034|450191636|FG002|Overall Study|Death|1|||
125155394|NCT00515034|450191637|FG003|Overall Study|Death|3|||
125155395|NCT00515034|450191634|FG000|Overall Study|Withdrawal by Subject|1|||
125155396|NCT00515034|450191635|FG001|Overall Study|Withdrawal by Subject|0|||
125155397|NCT00515034|450191636|FG002|Overall Study|Withdrawal by Subject|3|||
125155398|NCT00515034|450191637|FG003|Overall Study|Withdrawal by Subject|0|||
125155399|NCT00515034|450191634|FG000|Overall Study|Physician Decision|0|||
125155400|NCT00515034|450191635|FG001|Overall Study|Physician Decision|0|||
125155401|NCT00515034|450191636|FG002|Overall Study|Physician Decision|1|||
125155402|NCT00515034|450191637|FG003|Overall Study|Physician Decision|1|||
125155403|NCT00515034|450191634|FG000|Overall Study|Other|1|||
125155404|NCT00515034|450191635|FG001|Overall Study|Other|0|||
125155405|NCT00515034|450191636|FG002|Overall Study|Other|2|||
125155406|NCT00515034|450191637|FG003|Overall Study|Other|1|||
125155407|NCT01392326|450191638|FG000|Overall Study|Death|2|||
125155408|NCT01392326|450191639|FG001|Overall Study|Death|0|||
125155409|NCT01392326|450191640|FG002|Overall Study|Death|0|||
125155410|NCT01392326|450191638|FG000|Overall Study|Withdrawal by Subject|12|||
125155411|NCT01392326|450191639|FG001|Overall Study|Withdrawal by Subject|11|||
125155412|NCT01392326|450191640|FG002|Overall Study|Withdrawal by Subject|15|||
125155413|NCT01392326|450191638|FG000|Overall Study|Protocol Violation|2|||
125155414|NCT01392326|450191639|FG001|Overall Study|Protocol Violation|0|||
125155415|NCT01392326|450191640|FG002|Overall Study|Protocol Violation|0|||
125155416|NCT01392326|450191638|FG000|Overall Study|Pregnancy|0|||
125155417|NCT01392326|450191639|FG001|Overall Study|Pregnancy|0|||
125155418|NCT01392326|450191640|FG002|Overall Study|Pregnancy|1|||
125155419|NCT01392326|450191638|FG000|Overall Study|Physician Decision|7|||
125155420|NCT01392326|450191639|FG001|Overall Study|Physician Decision|5|||
125155421|NCT01392326|450191640|FG002|Overall Study|Physician Decision|2|||
125155422|NCT01392326|450191638|FG000|Overall Study|Lost to Follow-up|1|||
125155423|NCT01392326|450191639|FG001|Overall Study|Lost to Follow-up|3|||
125155424|NCT01392326|450191640|FG002|Overall Study|Lost to Follow-up|4|||
125155425|NCT01392326|450191638|FG000|Overall Study|Lack of Efficacy|14|||
125155426|NCT01392326|450191639|FG001|Overall Study|Lack of Efficacy|10|||
125155427|NCT01392326|450191640|FG002|Overall Study|Lack of Efficacy|15|||
125155428|NCT01392326|450191638|FG000|Overall Study|Adverse Event|9|||
125155429|NCT01392326|450191639|FG001|Overall Study|Adverse Event|6|||
125155430|NCT01392326|450191640|FG002|Overall Study|Adverse Event|11|||
125155431|NCT05626803|450194095|FG000|Overall Study|Lost to Follow-up|0|||
125155432|NCT05626803|450194096|FG001|Overall Study|Lost to Follow-up|1|||
125155433|NCT05626803|450194097|FG002|Overall Study|Lost to Follow-up|0|||
125155434|NCT05626803|450194098|FG003|Overall Study|Lost to Follow-up|0|||
125155435|NCT00493246|450194099|FG000|Overall Study|Withdrawal by Subject|0|||
125155436|NCT00493246|450194100|FG001|Overall Study|Withdrawal by Subject|0|||
125155437|NCT00493246|450194101|FG002|Overall Study|Withdrawal by Subject|0|||
125155438|NCT00493246|450194102|FG003|Overall Study|Withdrawal by Subject|0|||
125155439|NCT00493246|450194103|FG004|Overall Study|Withdrawal by Subject|1|||
125388801|NCT00362115|451056689|FG002|Overall Study|Lack of Efficacy|5|||
125155440|NCT00493246|450194104|FG005|Overall Study|Withdrawal by Subject|0|||
125155441|NCT00493246|450194105|FG006|Overall Study|Withdrawal by Subject|0|||
125155442|NCT00493246|450194106|FG007|Overall Study|Withdrawal by Subject|0|||
125155443|NCT00493246|450194099|FG000|Overall Study|No access to draw blood|0|||
125155444|NCT00493246|450194100|FG001|Overall Study|No access to draw blood|0|||
125155445|NCT00493246|450194101|FG002|Overall Study|No access to draw blood|0|||
125155446|NCT00493246|450194102|FG003|Overall Study|No access to draw blood|0|||
125155447|NCT00493246|450194103|FG004|Overall Study|No access to draw blood|0|||
125155448|NCT00493246|450194104|FG005|Overall Study|No access to draw blood|1|||
125155449|NCT00493246|450194105|FG006|Overall Study|No access to draw blood|0|||
125155450|NCT00493246|450194106|FG007|Overall Study|No access to draw blood|0|||
125155451|NCT00493246|450194099|FG000|Overall Study|Lost to Follow-up|0|||
125155452|NCT00493246|450194100|FG001|Overall Study|Lost to Follow-up|0|||
125155453|NCT00493246|450194101|FG002|Overall Study|Lost to Follow-up|0|||
125155454|NCT00493246|450194102|FG003|Overall Study|Lost to Follow-up|0|||
125155455|NCT00493246|450194103|FG004|Overall Study|Lost to Follow-up|0|||
125155456|NCT00493246|450194104|FG005|Overall Study|Lost to Follow-up|0|||
125155457|NCT00493246|450194105|FG006|Overall Study|Lost to Follow-up|1|||
125155458|NCT00493246|450194106|FG007|Overall Study|Lost to Follow-up|0|||
125155459|NCT02054130|450194111|FG000|Overall Study|Withdrawal by Subject|4|||
125155460|NCT02054130|450194112|FG001|Overall Study|Withdrawal by Subject|4|||
125155461|NCT02054130|450194113|FG002|Overall Study|Withdrawal by Subject|7|||
125155462|NCT02054130|450194114|FG003|Overall Study|Withdrawal by Subject|10|||
125155463|NCT02054130|450194111|FG000|Overall Study|Death|0|||
125155464|NCT02054130|450194112|FG001|Overall Study|Death|1|||
125155465|NCT02054130|450194113|FG002|Overall Study|Death|0|||
125155466|NCT02054130|450194114|FG003|Overall Study|Death|0|||
125155467|NCT02054130|450194111|FG000|Overall Study|Lost to Follow-up|0|||
125155468|NCT02054130|450194112|FG001|Overall Study|Lost to Follow-up|0|||
125155469|NCT02054130|450194113|FG002|Overall Study|Lost to Follow-up|1|||
125155470|NCT02054130|450194114|FG003|Overall Study|Lost to Follow-up|2|||
125155471|NCT02054130|450194111|FG000|Overall Study|Missed dose|4|||
125155472|NCT02054130|450194112|FG001|Overall Study|Missed dose|6|||
125155473|NCT02054130|450194113|FG002|Overall Study|Missed dose|7|||
125155474|NCT02054130|450194114|FG003|Overall Study|Missed dose|10|||
125155475|NCT00094458|450194115|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
125388802|NCT00362115|451056690|FG003|Overall Study|Lack of Efficacy|2|||
125388803|NCT00362115|451056691|FG004|Overall Study|Lack of Efficacy|2|||
125388804|NCT00362115|451056692|FG005|Overall Study|Lack of Efficacy|0|||
125388805|NCT00362115|451056693|FG006|Overall Study|Lack of Efficacy|3|||
125388806|NCT00362115|451056687|FG000|Overall Study|Physician Decision|0|||
125388807|NCT00362115|451056688|FG001|Overall Study|Physician Decision|0|||
125388808|NCT00362115|451056689|FG002|Overall Study|Physician Decision|0|||
125388809|NCT00362115|451056690|FG003|Overall Study|Physician Decision|0|||
125388810|NCT00362115|451056691|FG004|Overall Study|Physician Decision|0|||
125388811|NCT00362115|451056692|FG005|Overall Study|Physician Decision|0|||
125388812|NCT00362115|451056693|FG006|Overall Study|Physician Decision|3|||
125388813|NCT00362115|451056687|FG000|Overall Study|Other|0|||
125388814|NCT00362115|451056688|FG001|Overall Study|Other|1|||
125388815|NCT00362115|451056689|FG002|Overall Study|Other|0|||
125388816|NCT00362115|451056690|FG003|Overall Study|Other|1|||
125388817|NCT00362115|451056691|FG004|Overall Study|Other|0|||
125388818|NCT00362115|451056692|FG005|Overall Study|Other|1|||
125388819|NCT00362115|451056693|FG006|Overall Study|Other|0|||
125388820|NCT03965962|451056694|FG000|Overall Study|Adverse Event|1|||
125388821|NCT03965962|451056695|FG001|Overall Study|Adverse Event|0|||
125438736|NCT04192630|451233945|FG001|Overall Study|Discontinued before surgery|0|||
125155476|NCT00094458|450194116|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
125155477|NCT00094458|450194117|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
125155478|NCT00094458|450194118|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
125155479|NCT00094458|450194119|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
125388822|NCT03965962|451056696|FG002|Overall Study|Adverse Event|0|||
125388823|NCT03965962|451056697|FG003|Overall Study|Adverse Event|0|||
125388824|NCT03965962|451056694|FG000|Overall Study|Protocol Violation|21|||
125388825|NCT03965962|451056695|FG001|Overall Study|Protocol Violation|4|||
125438737|NCT04192630|451233944|FG000|Overall Study|Discontinued after surgery|5|||
125155480|NCT00094458|450194120|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
125155481|NCT00094458|450194115|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
125155482|NCT00094458|450194116|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
125155483|NCT00094458|450194117|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
125155484|NCT00094458|450194118|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
125155485|NCT00094458|450194119|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
125155486|NCT00094458|450194120|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
125155487|NCT00094458|450194115|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
125155488|NCT00094458|450194116|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
125155489|NCT00094458|450194117|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
125155490|NCT00094458|450194118|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
125155491|NCT00094458|450194119|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
125155492|NCT00094458|450194120|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
125155493|NCT00094458|450194115|FG000|Main Study: Through Week 30|Adverse Event|38|||
125155494|NCT00094458|450194116|FG001|Main Study: Through Week 30|Adverse Event|20|||
125155495|NCT00094458|450194117|FG002|Main Study: Through Week 30|Adverse Event|28|||
125155496|NCT00094458|450194118|FG003|Main Study: Through Week 30|Adverse Event|0|||
125155497|NCT00094458|450194119|FG004|Main Study: Through Week 30|Adverse Event|0|||
125155498|NCT00094458|450194120|FG005|Main Study: Through Week 30|Adverse Event|0|||
125155499|NCT00094458|450194115|FG000|Main Study: Through Week 30|Death|1|||
125155500|NCT00094458|450194116|FG001|Main Study: Through Week 30|Death|0|||
125155501|NCT00094458|450194117|FG002|Main Study: Through Week 30|Death|0|||
125155502|NCT00094458|450194118|FG003|Main Study: Through Week 30|Death|0|||
125155503|NCT00094458|450194119|FG004|Main Study: Through Week 30|Death|0|||
125155504|NCT00094458|450194120|FG005|Main Study: Through Week 30|Death|0|||
125155505|NCT00094458|450194115|FG000|Main Study: Through Week 30|Other|19|||
125155506|NCT00094458|450194116|FG001|Main Study: Through Week 30|Other|16|||
125155507|NCT00094458|450194117|FG002|Main Study: Through Week 30|Other|9|||
125155508|NCT00094458|450194118|FG003|Main Study: Through Week 30|Other|0|||
125155509|NCT00094458|450194119|FG004|Main Study: Through Week 30|Other|0|||
125155510|NCT00094458|450194120|FG005|Main Study: Through Week 30|Other|0|||
125155511|NCT00094458|450194115|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
125155512|NCT00094458|450194116|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
125155513|NCT00094458|450194117|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
125155514|NCT00094458|450194118|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
125155515|NCT00094458|450194119|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
125155516|NCT00094458|450194120|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
125155517|NCT00094458|450194115|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
125155518|NCT00094458|450194116|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
125155519|NCT00094458|450194117|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
125155520|NCT00094458|450194118|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
125155521|NCT00094458|450194119|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
125155522|NCT00094458|450194120|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
125155523|NCT00094458|450194115|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
125155524|NCT00094458|450194116|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
125155525|NCT00094458|450194117|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
125155526|NCT00094458|450194118|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
125155527|NCT00094458|450194119|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
125155528|NCT00094458|450194120|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
125155529|NCT00094458|450194115|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
125155530|NCT00094458|450194116|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
125155531|NCT00094458|450194117|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
125155532|NCT00094458|450194118|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
125155533|NCT00094458|450194119|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
125155534|NCT00094458|450194120|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
125155535|NCT00094458|450194115|FG000|OLE: Open-Label Extension|Adverse Event|0|||
125155536|NCT00094458|450194116|FG001|OLE: Open-Label Extension|Adverse Event|0|||
125155537|NCT00094458|450194117|FG002|OLE: Open-Label Extension|Adverse Event|0|||
125155538|NCT00094458|450194118|FG003|OLE: Open-Label Extension|Adverse Event|0|||
125155539|NCT00094458|450194119|FG004|OLE: Open-Label Extension|Adverse Event|3|||
125388826|NCT03965962|451056696|FG002|Overall Study|Protocol Violation|10|||
125388827|NCT03965962|451056697|FG003|Overall Study|Protocol Violation|5|||
125388828|NCT03965962|451056694|FG000|Overall Study|Lost to Follow-up|0|||
125388829|NCT03965962|451056695|FG001|Overall Study|Lost to Follow-up|1|||
125388830|NCT03965962|451056696|FG002|Overall Study|Lost to Follow-up|0|||
125155540|NCT00094458|450194120|FG005|OLE: Open-Label Extension|Adverse Event|4|||
125155541|NCT00094458|450194115|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
125155542|NCT00094458|450194116|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
125155543|NCT00094458|450194117|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
125155544|NCT00094458|450194118|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
125155545|NCT00094458|450194119|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
125388831|NCT03965962|451056697|FG003|Overall Study|Lost to Follow-up|0|||
125155546|NCT00094458|450194120|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
125155547|NCT00094458|450194115|FG000|OLE: Open-Label Extension|Patient decision|0|||
125155548|NCT00094458|450194116|FG001|OLE: Open-Label Extension|Patient decision|0|||
125155549|NCT00094458|450194117|FG002|OLE: Open-Label Extension|Patient decision|0|||
125155550|NCT00094458|450194118|FG003|OLE: Open-Label Extension|Patient decision|0|||
125155551|NCT00094458|450194119|FG004|OLE: Open-Label Extension|Patient decision|1|||
125155552|NCT00094458|450194120|FG005|OLE: Open-Label Extension|Patient decision|0|||
125155553|NCT02017860|450194125|FG000|Overall Study|Adverse Event|1|||
125155554|NCT02017860|450194125|FG000|Overall Study|Withdrawal by Subject|1|||
125155555|NCT01829113|450194128|FG000|Overall Study|Disease Progression|37|||
125155556|NCT01829113|450194129|FG001|Overall Study|Disease Progression|48|||
125155557|NCT01829113|450194128|FG000|Overall Study|Adverse Event|14|||
125155558|NCT01829113|450194129|FG001|Overall Study|Adverse Event|10|||
125155559|NCT01829113|450194128|FG000|Overall Study|Withdrawal by Subject|17|||
125155560|NCT01829113|450194129|FG001|Overall Study|Withdrawal by Subject|10|||
125155561|NCT01829113|450194128|FG000|Overall Study|Death|4|||
125155562|NCT01829113|450194129|FG001|Overall Study|Death|6|||
125155563|NCT01829113|450194128|FG000|Overall Study|Sponsor Decision|1|||
125155564|NCT01829113|450194129|FG001|Overall Study|Sponsor Decision|1|||
125155565|NCT01829113|450194128|FG000|Overall Study|No Study Treatment Received|3|||
125155566|NCT01829113|450194129|FG001|Overall Study|No Study Treatment Received|2|||
125155567|NCT01829113|450194128|FG000|Overall Study|Physician Decision|1|||
125155568|NCT01829113|450194129|FG001|Overall Study|Physician Decision|1|||
125155569|NCT02010255|450194136|FG000|Overall Study|Death|0|||
125155570|NCT02010255|450194137|FG001|Overall Study|Death|1|||
125155571|NCT02010255|450194138|FG002|Overall Study|Death|4|||
125155572|NCT02010255|450194139|FG003|Overall Study|Death|4|||
125155573|NCT02010255|450194140|FG004|Overall Study|Death|2|||
125155574|NCT02010255|450194141|FG005|Overall Study|Death|0|||
125155575|NCT02010255|450194142|FG006|Overall Study|Death|1|||
125155576|NCT02010255|450194143|FG007|Overall Study|Death|1|||
125155577|NCT02010255|450194144|FG008|Overall Study|Death|1|||
125155578|NCT02010255|450194145|FG009|Overall Study|Death|0|||
125155579|NCT02010255|450194146|FG010|Overall Study|Death|1|||
125155580|NCT02010255|450194147|FG011|Overall Study|Death|1|||
125155581|NCT02010255|450194148|FG012|Overall Study|Death|0|||
125155582|NCT02010255|450194149|FG013|Overall Study|Death|0|||
125155583|NCT02010255|450194136|FG000|Overall Study|Lack of Efficacy|4|||
125155584|NCT02010255|450194137|FG001|Overall Study|Lack of Efficacy|1|||
125155585|NCT02010255|450194138|FG002|Overall Study|Lack of Efficacy|2|||
125155586|NCT02010255|450194139|FG003|Overall Study|Lack of Efficacy|1|||
125155587|NCT02010255|450194140|FG004|Overall Study|Lack of Efficacy|1|||
125155588|NCT02010255|450194141|FG005|Overall Study|Lack of Efficacy|0|||
125155589|NCT02010255|450194142|FG006|Overall Study|Lack of Efficacy|0|||
125155590|NCT02010255|450194143|FG007|Overall Study|Lack of Efficacy|0|||
125155591|NCT02010255|450194144|FG008|Overall Study|Lack of Efficacy|0|||
125155592|NCT02010255|450194145|FG009|Overall Study|Lack of Efficacy|0|||
125155593|NCT02010255|450194146|FG010|Overall Study|Lack of Efficacy|1|||
125155594|NCT02010255|450194147|FG011|Overall Study|Lack of Efficacy|0|||
125155595|NCT02010255|450194148|FG012|Overall Study|Lack of Efficacy|0|||
125155596|NCT02010255|450194149|FG013|Overall Study|Lack of Efficacy|0|||
125155597|NCT02010255|450194136|FG000|Overall Study|Withdrew Consent|1|||
125155598|NCT02010255|450194137|FG001|Overall Study|Withdrew Consent|0|||
125155599|NCT02010255|450194138|FG002|Overall Study|Withdrew Consent|0|||
125155600|NCT02010255|450194139|FG003|Overall Study|Withdrew Consent|1|||
125155601|NCT02010255|450194140|FG004|Overall Study|Withdrew Consent|0|||
125155602|NCT02010255|450194141|FG005|Overall Study|Withdrew Consent|0|||
125155603|NCT02010255|450194142|FG006|Overall Study|Withdrew Consent|0|||
125155604|NCT02010255|450194143|FG007|Overall Study|Withdrew Consent|0|||
125155605|NCT02010255|450194144|FG008|Overall Study|Withdrew Consent|0|||
125155606|NCT02010255|450194145|FG009|Overall Study|Withdrew Consent|0|||
125155607|NCT02010255|450194146|FG010|Overall Study|Withdrew Consent|0|||
125155608|NCT02010255|450194147|FG011|Overall Study|Withdrew Consent|0|||
125155609|NCT02010255|450194148|FG012|Overall Study|Withdrew Consent|0|||
125155610|NCT02010255|450194149|FG013|Overall Study|Withdrew Consent|0|||
125155611|NCT02010255|450194136|FG000|Overall Study|Adverse Event|1|||
125155612|NCT02010255|450194137|FG001|Overall Study|Adverse Event|0|||
125155613|NCT02010255|450194138|FG002|Overall Study|Adverse Event|0|||
125155614|NCT02010255|450194139|FG003|Overall Study|Adverse Event|0|||
125155615|NCT02010255|450194140|FG004|Overall Study|Adverse Event|0|||
125155616|NCT02010255|450194141|FG005|Overall Study|Adverse Event|0|||
125155617|NCT02010255|450194142|FG006|Overall Study|Adverse Event|0|||
125155618|NCT02010255|450194143|FG007|Overall Study|Adverse Event|0|||
125155619|NCT02010255|450194144|FG008|Overall Study|Adverse Event|0|||
125155620|NCT02010255|450194145|FG009|Overall Study|Adverse Event|0|||
125155621|NCT02010255|450194146|FG010|Overall Study|Adverse Event|0|||
125155622|NCT02010255|450194147|FG011|Overall Study|Adverse Event|0|||
125155623|NCT02010255|450194148|FG012|Overall Study|Adverse Event|0|||
125155624|NCT02010255|450194149|FG013|Overall Study|Adverse Event|0|||
125155625|NCT02010255|450194136|FG000|Overall Study|Lost to Follow-up|0|||
125155626|NCT02010255|450194137|FG001|Overall Study|Lost to Follow-up|0|||
125155627|NCT02010255|450194138|FG002|Overall Study|Lost to Follow-up|1|||
125155628|NCT02010255|450194139|FG003|Overall Study|Lost to Follow-up|0|||
125155629|NCT02010255|450194140|FG004|Overall Study|Lost to Follow-up|1|||
125155630|NCT02010255|450194141|FG005|Overall Study|Lost to Follow-up|0|||
125438738|NCT04192630|451233945|FG001|Overall Study|Discontinued after surgery|3|||
125438739|NCT01425632|451233946|FG000|Overall Study|Adverse Event|0|||
125438740|NCT01425632|451233947|FG001|Overall Study|Adverse Event|1|||
125438741|NCT01425632|451233948|FG002|Overall Study|Adverse Event|1|||
125438742|NCT01425632|451233946|FG000|Overall Study|Physician Decision|1|||
125155631|NCT02010255|450194142|FG006|Overall Study|Lost to Follow-up|0|||
125155632|NCT02010255|450194143|FG007|Overall Study|Lost to Follow-up|0|||
125155633|NCT02010255|450194144|FG008|Overall Study|Lost to Follow-up|0|||
125155634|NCT02010255|450194145|FG009|Overall Study|Lost to Follow-up|0|||
125155635|NCT02010255|450194146|FG010|Overall Study|Lost to Follow-up|0|||
125155636|NCT02010255|450194147|FG011|Overall Study|Lost to Follow-up|0|||
125155637|NCT02010255|450194148|FG012|Overall Study|Lost to Follow-up|0|||
125155638|NCT02010255|450194149|FG013|Overall Study|Lost to Follow-up|0|||
125155639|NCT02010255|450194136|FG000|Overall Study|Randomized but Not Treated|0|||
125155640|NCT02010255|450194137|FG001|Overall Study|Randomized but Not Treated|0|||
125155641|NCT02010255|450194138|FG002|Overall Study|Randomized but Not Treated|0|||
125155642|NCT02010255|450194139|FG003|Overall Study|Randomized but Not Treated|0|||
125155643|NCT02010255|450194140|FG004|Overall Study|Randomized but Not Treated|0|||
125155644|NCT02010255|450194141|FG005|Overall Study|Randomized but Not Treated|0|||
125155645|NCT02010255|450194142|FG006|Overall Study|Randomized but Not Treated|0|||
125155646|NCT02010255|450194143|FG007|Overall Study|Randomized but Not Treated|0|||
125155647|NCT02010255|450194144|FG008|Overall Study|Randomized but Not Treated|0|||
125155648|NCT02010255|450194145|FG009|Overall Study|Randomized but Not Treated|0|||
125155649|NCT02010255|450194146|FG010|Overall Study|Randomized but Not Treated|0|||
125155650|NCT02010255|450194147|FG011|Overall Study|Randomized but Not Treated|0|||
125155651|NCT02010255|450194148|FG012|Overall Study|Randomized but Not Treated|0|||
125155652|NCT02010255|450194149|FG013|Overall Study|Randomized but Not Treated|1|||
125155653|NCT00977431|450194152|FG000|Overall Study|Other than listed|1|||
125155654|NCT00977431|450194153|FG001|Overall Study|Other than listed|0|||
125155655|NCT00977431|450194154|FG002|Overall Study|Other than listed|0|||
125155656|NCT00977431|450194155|FG003|Overall Study|Other than listed|0|||
125155657|NCT00977431|450194156|FG004|Overall Study|Other than listed|2|||
125155658|NCT00977431|450194152|FG000|Overall Study|Protocol Violation|0|||
125155659|NCT00977431|450194153|FG001|Overall Study|Protocol Violation|0|||
125155660|NCT00977431|450194154|FG002|Overall Study|Protocol Violation|1|||
125155661|NCT00977431|450194155|FG003|Overall Study|Protocol Violation|0|||
125155662|NCT00977431|450194156|FG004|Overall Study|Protocol Violation|0|||
125155663|NCT00977431|450194152|FG000|Overall Study|Adverse Event|3|||
125155664|NCT00977431|450194153|FG001|Overall Study|Adverse Event|0|||
125155665|NCT00977431|450194154|FG002|Overall Study|Adverse Event|4|||
125155666|NCT00977431|450194155|FG003|Overall Study|Adverse Event|0|||
125155667|NCT00977431|450194156|FG004|Overall Study|Adverse Event|6|||
125155668|NCT00977431|450194152|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
125155669|NCT00977431|450194153|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
125155670|NCT00977431|450194154|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
125155671|NCT00977431|450194155|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
125155672|NCT00977431|450194156|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
125155673|NCT00977431|450194152|FG000|Overall Study|Progressive disease|2|||
125155674|NCT00977431|450194153|FG001|Overall Study|Progressive disease|6|||
125155675|NCT00977431|450194154|FG002|Overall Study|Progressive disease|1|||
125155676|NCT00977431|450194155|FG003|Overall Study|Progressive disease|3|||
125155677|NCT00977431|450194156|FG004|Overall Study|Progressive disease|5|||
125155678|NCT01010750|450194157|FG000|Second Intervention|Adverse Event|0|||
125155679|NCT01010750|450194158|FG001|Second Intervention|Adverse Event|1|||
125155680|NCT01010750|450194159|FG002|Second Intervention|Adverse Event|0|||
125155681|NCT01010750|450194160|FG003|Second Intervention|Adverse Event|0|||
125155682|NCT01010750|450194161|FG004|Second Intervention|Adverse Event|0|||
125155683|NCT01010750|450194162|FG005|Second Intervention|Adverse Event|0|||
125155684|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
125155685|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
125155686|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
125155687|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
125438743|NCT01425632|451233947|FG001|Overall Study|Physician Decision|0|||
125438744|NCT01425632|451233948|FG002|Overall Study|Physician Decision|0|||
125155688|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
125155689|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
125155690|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
125155691|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
125155692|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
125438745|NCT01425632|451233946|FG000|Overall Study|Protocol Violation|0|||
125155693|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
125155694|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Subject decision|1|||
125155695|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Subject decision|1|||
125155696|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
125155697|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
125155698|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
125155699|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
125155700|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
125155701|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
125155702|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
125155703|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
125155704|NCT00518882|450194165|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
125155705|NCT00518882|450194166|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
125155706|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
125155707|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
125155708|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
125155709|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
125155710|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
125155711|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
125155712|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
125155713|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
125155714|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
125155715|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
125155716|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
125155717|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
125155718|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
125155719|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
125155720|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
125155721|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
125155722|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
125155723|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
125155724|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
125155725|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
125155726|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
125155727|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
125155728|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
125155729|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
125155730|NCT00518882|450194165|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
125155731|NCT00518882|450194166|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
125155732|NCT00567476|450194170|FG000|Overall Study|Adverse Event|2|||
125155733|NCT00567476|450194171|FG001|Overall Study|Adverse Event|0|||
125155734|NCT00567476|450194170|FG000|Overall Study|Pregnancy|1|||
125155735|NCT00567476|450194171|FG001|Overall Study|Pregnancy|0|||
125155736|NCT00567476|450194170|FG000|Overall Study|Protocol Violation|4|||
125155737|NCT00567476|450194171|FG001|Overall Study|Protocol Violation|1|||
125155738|NCT00567476|450194170|FG000|Overall Study|Lost to Follow-up|0|||
125155739|NCT00567476|450194171|FG001|Overall Study|Lost to Follow-up|1|||
125155740|NCT00567476|450194170|FG000|Overall Study|Administrative issues|1|||
125155741|NCT00567476|450194171|FG001|Overall Study|Administrative issues|0|||
125155742|NCT00567476|450194170|FG000|Overall Study|Medical Decision|0|||
125155743|NCT00567476|450194171|FG001|Overall Study|Medical Decision|1|||
125155744|NCT00567476|450194170|FG000|Overall Study|Non-adherence to protocol|0|||
125155745|NCT00567476|450194171|FG001|Overall Study|Non-adherence to protocol|1|||
125155746|NCT02696031|450194172|FG000|Up to Week 24|Adverse Event|2|||
125155747|NCT02696031|450194173|FG001|Up to Week 24|Adverse Event|4|||
125155748|NCT02696031|450194174|FG002|Up to Week 24|Adverse Event|2|||
125155749|NCT02696031|450194175|FG003|Up to Week 24|Adverse Event|0|||
125155750|NCT02696031|450194176|FG004|Up to Week 24|Adverse Event|0|||
125155751|NCT02696031|450194177|FG005|Up to Week 24|Adverse Event|0|||
125155752|NCT02696031|450194172|FG000|Up to Week 24|Lack of Efficacy|2|||
125155753|NCT02696031|450194173|FG001|Up to Week 24|Lack of Efficacy|1|||
125155754|NCT02696031|450194174|FG002|Up to Week 24|Lack of Efficacy|2|||
125155755|NCT02696031|450194175|FG003|Up to Week 24|Lack of Efficacy|0|||
125155756|NCT02696031|450194176|FG004|Up to Week 24|Lack of Efficacy|0|||
125155757|NCT02696031|450194177|FG005|Up to Week 24|Lack of Efficacy|0|||
125155758|NCT02696031|450194172|FG000|Up to Week 24|Lost to Follow-up|0|||
125155759|NCT02696031|450194173|FG001|Up to Week 24|Lost to Follow-up|1|||
125155760|NCT02696031|450194174|FG002|Up to Week 24|Lost to Follow-up|1|||
125155761|NCT02696031|450194175|FG003|Up to Week 24|Lost to Follow-up|0|||
125155762|NCT02696031|450194176|FG004|Up to Week 24|Lost to Follow-up|0|||
125155763|NCT02696031|450194177|FG005|Up to Week 24|Lost to Follow-up|0|||
125155764|NCT02696031|450194172|FG000|Up to Week 24|Physician Decision|1|||
125155765|NCT02696031|450194173|FG001|Up to Week 24|Physician Decision|0|||
125155766|NCT02696031|450194174|FG002|Up to Week 24|Physician Decision|1|||
125155767|NCT02696031|450194175|FG003|Up to Week 24|Physician Decision|0|||
125155768|NCT02696031|450194176|FG004|Up to Week 24|Physician Decision|0|||
125155769|NCT02696031|450194177|FG005|Up to Week 24|Physician Decision|0|||
125155770|NCT02696031|450194172|FG000|Up to Week 24|Protocol Violation|1|||
125155771|NCT02696031|450194173|FG001|Up to Week 24|Protocol Violation|0|||
125155772|NCT02696031|450194174|FG002|Up to Week 24|Protocol Violation|0|||
125155773|NCT02696031|450194175|FG003|Up to Week 24|Protocol Violation|0|||
125155774|NCT02696031|450194176|FG004|Up to Week 24|Protocol Violation|0|||
125155775|NCT02696031|450194177|FG005|Up to Week 24|Protocol Violation|0|||
125155776|NCT02696031|450194172|FG000|Up to Week 24|Withdrawal by Subject|4|||
125155777|NCT02696031|450194173|FG001|Up to Week 24|Withdrawal by Subject|1|||
125155778|NCT02696031|450194174|FG002|Up to Week 24|Withdrawal by Subject|5|||
125155779|NCT02696031|450194175|FG003|Up to Week 24|Withdrawal by Subject|0|||
125155780|NCT02696031|450194176|FG004|Up to Week 24|Withdrawal by Subject|0|||
125155781|NCT02696031|450194177|FG005|Up to Week 24|Withdrawal by Subject|0|||
125155782|NCT02696031|450194172|FG000|Up to Week 52|Adverse Event|4|||
125155783|NCT02696031|450194173|FG001|Up to Week 52|Adverse Event|5|||
125155784|NCT02696031|450194174|FG002|Up to Week 52|Adverse Event|3|||
125155785|NCT02696031|450194175|FG003|Up to Week 52|Adverse Event|0|||
125155786|NCT02696031|450194176|FG004|Up to Week 52|Adverse Event|0|||
125155787|NCT02696031|450194177|FG005|Up to Week 52|Adverse Event|0|||
125155788|NCT02696031|450194172|FG000|Up to Week 52|Lack of Efficacy|10|||
125155789|NCT02696031|450194173|FG001|Up to Week 52|Lack of Efficacy|7|||
125155790|NCT02696031|450194174|FG002|Up to Week 52|Lack of Efficacy|11|||
125155791|NCT02696031|450194175|FG003|Up to Week 52|Lack of Efficacy|0|||
125155792|NCT02696031|450194176|FG004|Up to Week 52|Lack of Efficacy|0|||
125155793|NCT02696031|450194177|FG005|Up to Week 52|Lack of Efficacy|0|||
125155794|NCT02696031|450194172|FG000|Up to Week 52|Lost to Follow-up|1|||
125155795|NCT02696031|450194173|FG001|Up to Week 52|Lost to Follow-up|1|||
125155796|NCT02696031|450194174|FG002|Up to Week 52|Lost to Follow-up|1|||
125155797|NCT02696031|450194175|FG003|Up to Week 52|Lost to Follow-up|0|||
125155798|NCT02696031|450194176|FG004|Up to Week 52|Lost to Follow-up|0|||
125155799|NCT02696031|450194177|FG005|Up to Week 52|Lost to Follow-up|0|||
125155800|NCT02696031|450194172|FG000|Up to Week 52|Physician Decision|1|||
125155801|NCT02696031|450194173|FG001|Up to Week 52|Physician Decision|1|||
125155802|NCT02696031|450194174|FG002|Up to Week 52|Physician Decision|2|||
125155803|NCT02696031|450194175|FG003|Up to Week 52|Physician Decision|0|||
125155804|NCT02696031|450194176|FG004|Up to Week 52|Physician Decision|0|||
125155805|NCT02696031|450194177|FG005|Up to Week 52|Physician Decision|0|||
125155806|NCT02696031|450194172|FG000|Up to Week 52|Pregnancy|0|||
125155807|NCT02696031|450194173|FG001|Up to Week 52|Pregnancy|2|||
125155808|NCT02696031|450194174|FG002|Up to Week 52|Pregnancy|0|||
125155809|NCT02696031|450194175|FG003|Up to Week 52|Pregnancy|0|||
125155810|NCT02696031|450194176|FG004|Up to Week 52|Pregnancy|0|||
125155811|NCT02696031|450194177|FG005|Up to Week 52|Pregnancy|0|||
125155812|NCT02696031|450194172|FG000|Up to Week 52|Protocol Violation|1|||
125155813|NCT02696031|450194173|FG001|Up to Week 52|Protocol Violation|0|||
125155814|NCT02696031|450194174|FG002|Up to Week 52|Protocol Violation|0|||
125155815|NCT02696031|450194175|FG003|Up to Week 52|Protocol Violation|0|||
125155816|NCT02696031|450194176|FG004|Up to Week 52|Protocol Violation|0|||
125155817|NCT02696031|450194177|FG005|Up to Week 52|Protocol Violation|0|||
125155818|NCT02696031|450194172|FG000|Up to Week 52|Withdrawal by Subject|12|||
125155819|NCT02696031|450194173|FG001|Up to Week 52|Withdrawal by Subject|3|||
125155820|NCT02696031|450194174|FG002|Up to Week 52|Withdrawal by Subject|9|||
125155821|NCT02696031|450194175|FG003|Up to Week 52|Withdrawal by Subject|0|||
125155822|NCT02696031|450194176|FG004|Up to Week 52|Withdrawal by Subject|0|||
125155823|NCT02696031|450194177|FG005|Up to Week 52|Withdrawal by Subject|0|||
125155824|NCT02696031|450194172|FG000|Up to Week 104|Pregnancy|0|||
125155825|NCT02696031|450194173|FG001|Up to Week 104|Pregnancy|2|||
125155826|NCT02696031|450194174|FG002|Up to Week 104|Pregnancy|1|||
125155827|NCT02696031|450194175|FG003|Up to Week 104|Pregnancy|0|||
125155828|NCT02696031|450194176|FG004|Up to Week 104|Pregnancy|0|||
125155829|NCT02696031|450194177|FG005|Up to Week 104|Pregnancy|0|||
125155830|NCT02696031|450194172|FG000|Up to Week 104|Withdrawal by Subject|15|||
125155831|NCT02696031|450194173|FG001|Up to Week 104|Withdrawal by Subject|10|||
125155832|NCT02696031|450194174|FG002|Up to Week 104|Withdrawal by Subject|16|||
125155833|NCT02696031|450194175|FG003|Up to Week 104|Withdrawal by Subject|0|||
125155834|NCT02696031|450194176|FG004|Up to Week 104|Withdrawal by Subject|0|||
125155835|NCT02696031|450194177|FG005|Up to Week 104|Withdrawal by Subject|0|||
125155836|NCT02696031|450194172|FG000|Up to Week 104|Protocol Violation|1|||
125155837|NCT02696031|450194173|FG001|Up to Week 104|Protocol Violation|0|||
125155838|NCT02696031|450194174|FG002|Up to Week 104|Protocol Violation|0|||
125155839|NCT02696031|450194175|FG003|Up to Week 104|Protocol Violation|0|||
125155840|NCT02696031|450194176|FG004|Up to Week 104|Protocol Violation|0|||
125155841|NCT02696031|450194177|FG005|Up to Week 104|Protocol Violation|0|||
125155842|NCT02696031|450194172|FG000|Up to Week 104|Physician Decision|1|||
125155843|NCT02696031|450194173|FG001|Up to Week 104|Physician Decision|2|||
125155844|NCT02696031|450194174|FG002|Up to Week 104|Physician Decision|3|||
125155845|NCT02696031|450194175|FG003|Up to Week 104|Physician Decision|0|||
125155846|NCT02696031|450194176|FG004|Up to Week 104|Physician Decision|0|||
125155847|NCT02696031|450194177|FG005|Up to Week 104|Physician Decision|0|||
125155848|NCT02696031|450194172|FG000|Up to Week 104|Lost to Follow-up|2|||
125155849|NCT02696031|450194173|FG001|Up to Week 104|Lost to Follow-up|3|||
125155850|NCT02696031|450194174|FG002|Up to Week 104|Lost to Follow-up|1|||
125155851|NCT02696031|450194175|FG003|Up to Week 104|Lost to Follow-up|0|||
125155852|NCT02696031|450194176|FG004|Up to Week 104|Lost to Follow-up|0|||
125155853|NCT02696031|450194177|FG005|Up to Week 104|Lost to Follow-up|0|||
125155854|NCT02696031|450194172|FG000|Up to Week 104|Lack of Efficacy|13|||
125155855|NCT02696031|450194173|FG001|Up to Week 104|Lack of Efficacy|12|||
125155856|NCT02696031|450194174|FG002|Up to Week 104|Lack of Efficacy|11|||
125155857|NCT02696031|450194175|FG003|Up to Week 104|Lack of Efficacy|0|||
125155858|NCT02696031|450194176|FG004|Up to Week 104|Lack of Efficacy|0|||
125155859|NCT02696031|450194177|FG005|Up to Week 104|Lack of Efficacy|0|||
125155860|NCT02696031|450194172|FG000|Up to Week 104|Adverse Event|7|||
125155861|NCT02696031|450194173|FG001|Up to Week 104|Adverse Event|11|||
125155862|NCT02696031|450194174|FG002|Up to Week 104|Adverse Event|5|||
125155863|NCT02696031|450194175|FG003|Up to Week 104|Adverse Event|0|||
125155864|NCT02696031|450194176|FG004|Up to Week 104|Adverse Event|0|||
125155865|NCT02696031|450194177|FG005|Up to Week 104|Adverse Event|0|||
125155866|NCT02696031|450194172|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
125155867|NCT02696031|450194173|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
125155868|NCT02696031|450194174|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
125155869|NCT02696031|450194175|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
125155870|NCT02696031|450194176|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
125155871|NCT02696031|450194177|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
125155872|NCT02696031|450194172|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
125155873|NCT02696031|450194173|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
125155874|NCT02696031|450194174|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
125155875|NCT02696031|450194175|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
125155876|NCT02696031|450194176|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
125155877|NCT02696031|450194177|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
125155878|NCT02696031|450194172|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
125155879|NCT02696031|450194173|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
125155880|NCT02696031|450194174|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
125155881|NCT02696031|450194175|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
125155882|NCT02696031|450194176|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
125155883|NCT02696031|450194177|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
125155884|NCT02696031|450194172|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
125155885|NCT02696031|450194173|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
125155886|NCT02696031|450194174|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
125155887|NCT02696031|450194175|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
125155888|NCT02696031|450194176|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
125155889|NCT02696031|450194177|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
125155890|NCT02696031|450194172|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
125155891|NCT02696031|450194173|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
125155892|NCT02696031|450194174|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
125155893|NCT02696031|450194175|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
125155894|NCT02696031|450194176|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
125155895|NCT02696031|450194177|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
125155896|NCT02696031|450194172|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
125155897|NCT02696031|450194173|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
125155898|NCT02696031|450194174|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
125155899|NCT02696031|450194175|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
125155900|NCT02696031|450194176|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
125155901|NCT02696031|450194177|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
125155902|NCT02696031|450194172|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
125155903|NCT02696031|450194173|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
125155904|NCT02696031|450194174|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
125155905|NCT02696031|450194175|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
125155906|NCT02696031|450194176|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
125155907|NCT02696031|450194177|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
125155908|NCT02777918|450194178|FG000|Overall Study|Medical reasons|1|||
125155909|NCT02777918|450194179|FG001|Overall Study|Medical reasons|2|||
125155910|NCT02777918|450194178|FG000|Overall Study|Too busy / stressed|1|||
125155911|NCT02777918|450194179|FG001|Overall Study|Too busy / stressed|1|||
125155912|NCT02777918|450194178|FG000|Overall Study|Withdrawal by Subject|1|||
125155913|NCT02777918|450194179|FG001|Overall Study|Withdrawal by Subject|1|||
125155914|NCT00058214|450194180|FG000|Overall Study|Adverse Event|1|||
125155915|NCT03856593|450194184|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
125155916|NCT03856593|450194185|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
125155917|NCT03978091|450194189|FG000|Overall Study|Lost to Follow-up|0|||
125155918|NCT03978091|450194190|FG001|Overall Study|Lost to Follow-up|0|||
125155919|NCT03978091|450194191|FG002|Overall Study|Lost to Follow-up|1|||
125155920|NCT03978091|450194192|FG003|Overall Study|Lost to Follow-up|0|||
125155921|NCT03978091|450194193|FG004|Overall Study|Lost to Follow-up|0|||
125155922|NCT03978091|450194194|FG005|Overall Study|Lost to Follow-up|0|||
125155923|NCT03978091|450194189|FG000|Overall Study|Withdrawal by Subject|0|||
125155924|NCT03978091|450194190|FG001|Overall Study|Withdrawal by Subject|0|||
125155925|NCT03978091|450194191|FG002|Overall Study|Withdrawal by Subject|0|||
125155926|NCT03978091|450194192|FG003|Overall Study|Withdrawal by Subject|1|||
125155927|NCT03978091|450194193|FG004|Overall Study|Withdrawal by Subject|1|||
125155928|NCT03978091|450194194|FG005|Overall Study|Withdrawal by Subject|0|||
125155929|NCT02595008|450194199|FG000|Overall Study|Enrolled In Error|1|||
125155930|NCT02595008|450194200|FG001|Overall Study|Enrolled In Error|0|||
125155931|NCT03078582|450194203|FG000|Overall Study|Adverse Event|0|||
125155932|NCT03078582|450194204|FG001|Overall Study|Adverse Event|8|||
125155933|NCT02972502|450194215|FG000|Overall Study|Lost to Follow-up|3|||
125155934|NCT02972502|450194216|FG001|Overall Study|Lost to Follow-up|1|||
125155935|NCT02972502|450194215|FG000|Overall Study|Withdrawal by Subject|1|||
125155936|NCT02972502|450194216|FG001|Overall Study|Withdrawal by Subject|1|||
125155937|NCT01347866|450194219|FG000|Overall Study|Death|0|||
125155938|NCT01347866|450194220|FG001|Overall Study|Death|0|||
125155939|NCT01347866|450194221|FG002|Overall Study|Death|0|||
125155940|NCT01347866|450194222|FG003|Overall Study|Death|1|||
125155941|NCT01347866|450194223|FG004|Overall Study|Death|2|||
125155942|NCT01347866|450194224|FG005|Overall Study|Death|2|||
125155943|NCT01347866|450194225|FG006|Overall Study|Death|1|||
125155944|NCT01347866|450194226|FG007|Overall Study|Death|0|||
125155945|NCT01347866|450194227|FG008|Overall Study|Death|4|||
125155946|NCT01347866|450194228|FG009|Overall Study|Death|1|||
125155947|NCT01347866|450194229|FG010|Overall Study|Death|3|||
125155948|NCT01347866|450194230|FG011|Overall Study|Death|1|||
125155949|NCT01347866|450194231|FG012|Overall Study|Death|2|||
125155950|NCT01347866|450194232|FG013|Overall Study|Death|0|||
125155951|NCT01347866|450194233|FG014|Overall Study|Death|0|||
125155952|NCT01347866|450194234|FG015|Overall Study|Death|1|||
125155953|NCT01347866|450194235|FG016|Overall Study|Death|0|||
125155954|NCT01347866|450194219|FG000|Overall Study|Lost to Follow-up|0|||
125155955|NCT01347866|450194220|FG001|Overall Study|Lost to Follow-up|0|||
125155956|NCT01347866|450194221|FG002|Overall Study|Lost to Follow-up|0|||
125155957|NCT01347866|450194222|FG003|Overall Study|Lost to Follow-up|0|||
125155958|NCT01347866|450194223|FG004|Overall Study|Lost to Follow-up|0|||
125155959|NCT01347866|450194224|FG005|Overall Study|Lost to Follow-up|0|||
125155960|NCT01347866|450194225|FG006|Overall Study|Lost to Follow-up|0|||
125155961|NCT01347866|450194226|FG007|Overall Study|Lost to Follow-up|1|||
125155962|NCT01347866|450194227|FG008|Overall Study|Lost to Follow-up|1|||
125155963|NCT01347866|450194228|FG009|Overall Study|Lost to Follow-up|0|||
125155964|NCT01347866|450194229|FG010|Overall Study|Lost to Follow-up|0|||
125155965|NCT01347866|450194230|FG011|Overall Study|Lost to Follow-up|0|||
125155966|NCT01347866|450194231|FG012|Overall Study|Lost to Follow-up|0|||
125155967|NCT01347866|450194232|FG013|Overall Study|Lost to Follow-up|0|||
125155968|NCT01347866|450194233|FG014|Overall Study|Lost to Follow-up|0|||
125155969|NCT01347866|450194234|FG015|Overall Study|Lost to Follow-up|0|||
125155970|NCT01347866|450194235|FG016|Overall Study|Lost to Follow-up|0|||
125155971|NCT01347866|450194219|FG000|Overall Study|Other|3|||
125155972|NCT01347866|450194220|FG001|Overall Study|Other|1|||
125155973|NCT01347866|450194221|FG002|Overall Study|Other|1|||
125155974|NCT01347866|450194222|FG003|Overall Study|Other|4|||
125155975|NCT01347866|450194223|FG004|Overall Study|Other|5|||
125155976|NCT01347866|450194224|FG005|Overall Study|Other|0|||
125155977|NCT01347866|450194225|FG006|Overall Study|Other|5|||
125155978|NCT01347866|450194226|FG007|Overall Study|Other|3|||
125155979|NCT01347866|450194227|FG008|Overall Study|Other|22|||
125155980|NCT01347866|450194228|FG009|Overall Study|Other|5|||
125155981|NCT01347866|450194229|FG010|Overall Study|Other|0|||
125155982|NCT01347866|450194230|FG011|Overall Study|Other|3|||
125155983|NCT01347866|450194231|FG012|Overall Study|Other|4|||
125155984|NCT01347866|450194232|FG013|Overall Study|Other|4|||
125155985|NCT01347866|450194233|FG014|Overall Study|Other|2|||
125155986|NCT01347866|450194234|FG015|Overall Study|Other|3|||
125155987|NCT01347866|450194235|FG016|Overall Study|Other|0|||
125155988|NCT01347866|450194219|FG000|Overall Study|Subject refused further follow-up|2|||
125155989|NCT01347866|450194220|FG001|Overall Study|Subject refused further follow-up|0|||
125155990|NCT01347866|450194221|FG002|Overall Study|Subject refused further follow-up|0|||
125155991|NCT01347866|450194222|FG003|Overall Study|Subject refused further follow-up|2|||
125155992|NCT01347866|450194223|FG004|Overall Study|Subject refused further follow-up|0|||
125155993|NCT01347866|450194224|FG005|Overall Study|Subject refused further follow-up|1|||
125155994|NCT01347866|450194225|FG006|Overall Study|Subject refused further follow-up|0|||
125155995|NCT01347866|450194226|FG007|Overall Study|Subject refused further follow-up|0|||
125155996|NCT01347866|450194227|FG008|Overall Study|Subject refused further follow-up|4|||
125155997|NCT01347866|450194228|FG009|Overall Study|Subject refused further follow-up|1|||
125155998|NCT01347866|450194229|FG010|Overall Study|Subject refused further follow-up|0|||
125155999|NCT01347866|450194230|FG011|Overall Study|Subject refused further follow-up|0|||
125156000|NCT01347866|450194231|FG012|Overall Study|Subject refused further follow-up|1|||
125156001|NCT01347866|450194232|FG013|Overall Study|Subject refused further follow-up|3|||
125156002|NCT01347866|450194233|FG014|Overall Study|Subject refused further follow-up|1|||
125388832|NCT03965962|451056694|FG000|Overall Study|Withdrawal by Subject|3|||
125388833|NCT03965962|451056695|FG001|Overall Study|Withdrawal by Subject|0|||
125388834|NCT03965962|451056696|FG002|Overall Study|Withdrawal by Subject|0|||
125388835|NCT03965962|451056697|FG003|Overall Study|Withdrawal by Subject|1|||
125388836|NCT03803774|451056698|FG000|Dose Escalation|Withdrawal by Subject|0|||
125388837|NCT03803774|451056699|FG001|Dose Escalation|Withdrawal by Subject|0|||
125388838|NCT03803774|451056700|FG002|Dose Escalation|Withdrawal by Subject|0|||
125388839|NCT03803774|451056701|FG003|Dose Escalation|Withdrawal by Subject|1|||
125388840|NCT03803774|451056702|FG004|Dose Escalation|Withdrawal by Subject|0|||
125388841|NCT00003641|451056703|FG000|Overall Study|Withdrawal by Subject|0|||
125388842|NCT00003641|451056704|FG001|Overall Study|Withdrawal by Subject|100|||
125388843|NCT00003641|451056703|FG000|Overall Study|Adverse Event|0|||
125388844|NCT00003641|451056704|FG001|Overall Study|Adverse Event|38|||
125388845|NCT00003641|451056703|FG000|Overall Study|Disease progression|0|||
125388846|NCT00003641|451056704|FG001|Overall Study|Disease progression|2|||
125388847|NCT00003641|451056703|FG000|Overall Study|Unknown/missing|0|||
125388848|NCT00003641|451056704|FG001|Overall Study|Unknown/missing|22|||
125388849|NCT00003641|451056703|FG000|Overall Study|Should not receive interferon therapy|2|||
125388850|NCT00003641|451056704|FG001|Overall Study|Should not receive interferon therapy|0|||
125388851|NCT00003641|451056703|FG000|Overall Study|Never started interferon|567|||
125388852|NCT00003641|451056704|FG001|Overall Study|Never started interferon|12|||
125388853|NCT00878709|451056705|FG000|Overall Study|Withdrawal by Subject|197|||
125388854|NCT00878709|451056706|FG001|Overall Study|Withdrawal by Subject|120|||
125388855|NCT00878709|451056705|FG000|Overall Study|Lost to Follow-up|35|||
125388856|NCT00878709|451056706|FG001|Overall Study|Lost to Follow-up|33|||
125388857|NCT00878709|451056705|FG000|Overall Study|Other Reasons|93|||
125388858|NCT00878709|451056706|FG001|Overall Study|Other Reasons|84|||
125388859|NCT05214768|451056714|FG000|Induction Period|Withdrawal by Subject|1|||
125388860|NCT05214768|451056715|FG001|Induction Period|Withdrawal by Subject|0|||
125388861|NCT05214768|451056716|FG002|Induction Period|Withdrawal by Subject|0|||
125388862|NCT05214768|451056717|FG003|Induction Period|Withdrawal by Subject|0|||
125388863|NCT05214768|451056718|FG004|Induction Period|Withdrawal by Subject|0|||
125156003|NCT01347866|450194234|FG015|Overall Study|Subject refused further follow-up|0|||
125156004|NCT01347866|450194235|FG016|Overall Study|Subject refused further follow-up|2|||
125156005|NCT00869024|450194236|FG000|Overall Study|Death|2|||
125156006|NCT00869024|450194237|FG001|Overall Study|Death|3|||
125156007|NCT00869024|450194236|FG000|Overall Study|Lost to Follow-up|0|||
125156008|NCT00869024|450194237|FG001|Overall Study|Lost to Follow-up|1|||
125156009|NCT00869024|450194236|FG000|Overall Study|Protocol Violation|0|||
125156010|NCT00869024|450194237|FG001|Overall Study|Protocol Violation|1|||
125156011|NCT00293202|450194238|FG000|Overall Study|Withdrawal by Subject|1|||
125156012|NCT00293202|450194239|FG001|Overall Study|Withdrawal by Subject|2|||
125156013|NCT00293202|450194238|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
125156014|NCT00293202|450194239|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
125156015|NCT00293202|450194238|FG000|Overall Study|on-hold due to fistula maturation time|1|||
125156016|NCT00293202|450194239|FG001|Overall Study|on-hold due to fistula maturation time|0|||
125156017|NCT02442271|450194240|FG000|Overall Study|Adverse Event|1|||
125156018|NCT02442271|450194240|FG000|Overall Study|Withdrew Consent|1|||
125156019|NCT02442271|450194240|FG000|Overall Study|Lost to Follow-up|1|||
125156020|NCT02442271|450194240|FG000|Overall Study|Other|1|||
125156021|NCT01560507|450194242|FG000|Overall Study|Lost to Follow-up|3|||
125156022|NCT01560507|450194243|FG001|Overall Study|Lost to Follow-up|1|||
125156023|NCT01560507|450194244|FG002|Overall Study|Lost to Follow-up|2|||
125156024|NCT01560507|450194242|FG000|Overall Study|Withdrawal by Subject|1|||
125388864|NCT05214768|451056719|FG005|Induction Period|Withdrawal by Subject|0|||
125388865|NCT05214768|451056714|FG000|Induction Period|Physician Decision|1|||
125388866|NCT05214768|451056715|FG001|Induction Period|Physician Decision|0|||
125156025|NCT01560507|450194243|FG001|Overall Study|Withdrawal by Subject|1|||
125156026|NCT01560507|450194244|FG002|Overall Study|Withdrawal by Subject|0|||
125156027|NCT02080832|450194245|FG000|Overall Study|Excluded from analysis by MRI|9|||
125156028|NCT02080832|450194246|FG001|Overall Study|Excluded from analysis by MRI|10|||
125388867|NCT05214768|451056716|FG002|Induction Period|Physician Decision|0|||
125388868|NCT05214768|451056717|FG003|Induction Period|Physician Decision|0|||
125156029|NCT02080832|450194247|FG002|Overall Study|Excluded from analysis by MRI|14|||
125156030|NCT02080832|450194245|FG000|Overall Study|Lost to Follow-up|0|||
125156031|NCT02080832|450194246|FG001|Overall Study|Lost to Follow-up|2|||
125156032|NCT02080832|450194247|FG002|Overall Study|Lost to Follow-up|2|||
125388869|NCT05214768|451056718|FG004|Induction Period|Physician Decision|0|||
125388870|NCT05214768|451056719|FG005|Induction Period|Physician Decision|0|||
125388871|NCT05214768|451056714|FG000|Maintenance Period|Other Reasons|0|||
125156033|NCT02427984|450194248|FG000|Overall Study|Lost to Follow-up|13|||
125156034|NCT02427984|450194249|FG001|Overall Study|Lost to Follow-up|5|||
125156035|NCT02427984|450194250|FG002|Overall Study|Lost to Follow-up|18|||
125156036|NCT01491035|450194255|FG000|Overall Study|Lost to Follow-up|0|||
125156037|NCT01491035|450194256|FG001|Overall Study|Lost to Follow-up|0|||
125156038|NCT01491035|450194257|FG002|Overall Study|Lost to Follow-up|0|||
125156039|NCT01491035|450194258|FG003|Overall Study|Lost to Follow-up|0|||
125156040|NCT01491035|450194259|FG004|Overall Study|Lost to Follow-up|1|||
125156041|NCT01491035|450194260|FG005|Overall Study|Lost to Follow-up|0|||
125156042|NCT01491035|450194261|FG006|Overall Study|Lost to Follow-up|0|||
125156043|NCT01491035|450194262|FG007|Overall Study|Lost to Follow-up|0|||
125156044|NCT01277718|450194267|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
125156045|NCT01277718|450194268|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
125156046|NCT01277718|450194267|FG000|Period 2 - Second Intervention|Physician Decision|0|||
125156047|NCT01277718|450194268|FG001|Period 2 - Second Intervention|Physician Decision|2|||
125156048|NCT01524913|450194269|FG000|Overall Study|Lost to Follow-up|4|||
125156049|NCT01524913|450194270|FG001|Overall Study|Lost to Follow-up|0|||
125156050|NCT01524913|450194271|FG002|Overall Study|Lost to Follow-up|0|||
125156051|NCT03351231|450194285|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
125156052|NCT03351231|450194285|FG000|Combination Therapy Period|Disease progression|2|||
125156053|NCT03351231|450194285|FG000|Combination Therapy Period|Study drug toxicity|1|||
125156054|NCT03351231|450194285|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
125156055|NCT03351231|450194285|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
125156056|NCT03351231|450194285|FG000|Safety Follow-Up Period|Other reason|2|||
125156057|NCT02858726|450194286|FG000|Overall Study|Adverse Event|4|||
125156058|NCT02858726|450194287|FG001|Overall Study|Adverse Event|4|||
125156059|NCT02858726|450194288|FG002|Overall Study|Adverse Event|9|||
125156060|NCT02858726|450194289|FG003|Overall Study|Adverse Event|1|||
125156061|NCT02858726|450194286|FG000|Overall Study|Physician Decision|0|||
125156062|NCT02858726|450194287|FG001|Overall Study|Physician Decision|0|||
125156063|NCT02858726|450194288|FG002|Overall Study|Physician Decision|1|||
125156064|NCT02858726|450194289|FG003|Overall Study|Physician Decision|0|||
125156065|NCT02858726|450194286|FG000|Overall Study|Protocol Violation|0|||
125156066|NCT02858726|450194287|FG001|Overall Study|Protocol Violation|0|||
125156067|NCT02858726|450194288|FG002|Overall Study|Protocol Violation|0|||
125156068|NCT02858726|450194289|FG003|Overall Study|Protocol Violation|1|||
125156069|NCT02858726|450194286|FG000|Overall Study|Study Terminated by Sponsor|0|||
125156070|NCT02858726|450194287|FG001|Overall Study|Study Terminated by Sponsor|0|||
125156071|NCT02858726|450194288|FG002|Overall Study|Study Terminated by Sponsor|0|||
125156072|NCT02858726|450194289|FG003|Overall Study|Study Terminated by Sponsor|1|||
125156073|NCT02858726|450194286|FG000|Overall Study|Withdrawal by Subject|1|||
125156074|NCT02858726|450194287|FG001|Overall Study|Withdrawal by Subject|2|||
125156075|NCT02858726|450194288|FG002|Overall Study|Withdrawal by Subject|1|||
125156076|NCT02858726|450194289|FG003|Overall Study|Withdrawal by Subject|0|||
125156077|NCT02858726|450194286|FG000|Overall Study|Noncompliance|0|||
125156078|NCT02858726|450194287|FG001|Overall Study|Noncompliance|1|||
125156079|NCT02858726|450194288|FG002|Overall Study|Noncompliance|0|||
125156080|NCT02858726|450194289|FG003|Overall Study|Noncompliance|0|||
125156081|NCT00233987|450194292|FG000|Overall Study|Withdrawal by Subject|1|||
125156082|NCT00233987|450194292|FG000|Overall Study|Lack of Efficacy|2|||
125156083|NCT00233987|450194292|FG000|Overall Study|Reason Under Review|1|||
125156084|NCT00233987|450194292|FG000|Overall Study|Other - Not Protocol Specified|5|||
125156085|NCT00233987|450194292|FG000|Overall Study|Eligible but No Treatment Received|2|||
125156086|NCT00233987|450194292|FG000|Overall Study|Ineligible|4|||
125156087|NCT00518622|450194295|FG000|Overall Study|Lost to Follow-up|0|||
125156088|NCT00518622|450194296|FG001|Overall Study|Lost to Follow-up|0|||
125156089|NCT00518622|450194297|FG002|Overall Study|Lost to Follow-up|1|||
125156090|NCT00518622|450194298|FG003|Overall Study|Lost to Follow-up|0|||
125156091|NCT00518622|450194299|FG004|Overall Study|Lost to Follow-up|0|||
125156092|NCT00518622|450194300|FG005|Overall Study|Lost to Follow-up|0|||
125156093|NCT00518622|450194301|FG006|Overall Study|Lost to Follow-up|0|||
125156094|NCT00518622|450194302|FG007|Overall Study|Lost to Follow-up|0|||
125156095|NCT00518622|450194295|FG000|Overall Study|Study medication taken incorrectly|0|||
125156096|NCT00518622|450194296|FG001|Overall Study|Study medication taken incorrectly|1|||
125156097|NCT00518622|450194297|FG002|Overall Study|Study medication taken incorrectly|0|||
125156098|NCT00518622|450194298|FG003|Overall Study|Study medication taken incorrectly|0|||
125156099|NCT00518622|450194299|FG004|Overall Study|Study medication taken incorrectly|0|||
125156100|NCT00518622|450194300|FG005|Overall Study|Study medication taken incorrectly|0|||
125156101|NCT00518622|450194301|FG006|Overall Study|Study medication taken incorrectly|0|||
125156102|NCT00518622|450194302|FG007|Overall Study|Study medication taken incorrectly|0|||
125156103|NCT01688726|450194303|FG000|Overall Study|Adverse Event|1|||
125156104|NCT01688726|450194304|FG001|Overall Study|Adverse Event|0|||
125156105|NCT01688726|450194303|FG000|Overall Study|Relocated abroad|0|||
125156106|NCT01688726|450194304|FG001|Overall Study|Relocated abroad|1|||
125156107|NCT02177136|450195823|FG000|DB Phase|Withdrawal by Subject|2|||
125156108|NCT02177136|450195824|FG001|DB Phase|Withdrawal by Subject|0|||
125156109|NCT02177136|450195825|FG002|DB Phase|Withdrawal by Subject|0|||
125156110|NCT02177136|450195826|FG003|DB Phase|Withdrawal by Subject|0|||
125156111|NCT02177136|450195823|FG000|DB Phase|Discontinued Due to Pruritus|1|||
125156112|NCT02177136|450195824|FG001|DB Phase|Discontinued Due to Pruritus|3|||
125156113|NCT02177136|450195825|FG002|DB Phase|Discontinued Due to Pruritus|0|||
125156114|NCT02177136|450195826|FG003|DB Phase|Discontinued Due to Pruritus|0|||
125156115|NCT02177136|450195823|FG000|DB Phase|Adverse Event|3|||
125156116|NCT02177136|450195824|FG001|DB Phase|Adverse Event|2|||
125156117|NCT02177136|450195825|FG002|DB Phase|Adverse Event|3|||
125156118|NCT02177136|450195826|FG003|DB Phase|Adverse Event|0|||
125156119|NCT02177136|450195823|FG000|DB Phase|Protocol Violation|0|||
125156120|NCT02177136|450195824|FG001|DB Phase|Protocol Violation|0|||
125156121|NCT02177136|450195825|FG002|DB Phase|Protocol Violation|1|||
125156122|NCT02177136|450195826|FG003|DB Phase|Protocol Violation|0|||
125156123|NCT02177136|450195823|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
125156124|NCT02177136|450195824|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
125156125|NCT02177136|450195825|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
125156126|NCT02177136|450195826|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
125156127|NCT02177136|450195823|FG000|LTSE Phase|Withdrawal by Subject|0|||
125156128|NCT02177136|450195824|FG001|LTSE Phase|Withdrawal by Subject|0|||
125156129|NCT02177136|450195825|FG002|LTSE Phase|Withdrawal by Subject|0|||
125156130|NCT02177136|450195826|FG003|LTSE Phase|Withdrawal by Subject|6|||
125156131|NCT02177136|450195823|FG000|LTSE Phase|Adverse Event|0|||
125156132|NCT02177136|450195824|FG001|LTSE Phase|Adverse Event|0|||
125156133|NCT02177136|450195825|FG002|LTSE Phase|Adverse Event|0|||
125156134|NCT02177136|450195826|FG003|LTSE Phase|Adverse Event|10|||
125156135|NCT02177136|450195823|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
125156136|NCT02177136|450195824|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
125156137|NCT02177136|450195825|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
125156138|NCT02177136|450195826|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
125156139|NCT02177136|450195823|FG000|LTSE Phase|Physician Decision|0|||
125156140|NCT02177136|450195824|FG001|LTSE Phase|Physician Decision|0|||
125156141|NCT02177136|450195825|FG002|LTSE Phase|Physician Decision|0|||
125156142|NCT02177136|450195826|FG003|LTSE Phase|Physician Decision|2|||
125156143|NCT02177136|450195823|FG000|LTSE Phase|Lost to Follow-up|0|||
125156144|NCT02177136|450195824|FG001|LTSE Phase|Lost to Follow-up|0|||
125156145|NCT02177136|450195825|FG002|LTSE Phase|Lost to Follow-up|0|||
125156146|NCT02177136|450195826|FG003|LTSE Phase|Lost to Follow-up|1|||
125156147|NCT02177136|450195823|FG000|LTSE Phase|Participant Moved|0|||
125156148|NCT02177136|450195824|FG001|LTSE Phase|Participant Moved|0|||
125156149|NCT02177136|450195825|FG002|LTSE Phase|Participant Moved|0|||
125156150|NCT02177136|450195826|FG003|LTSE Phase|Participant Moved|1|||
125156151|NCT01386684|450195827|FG000|Overall Study|Lost to Follow-up|51|||
125156152|NCT01386684|450195827|FG000|Overall Study|Other|51|||
125156153|NCT01386684|450195827|FG000|Overall Study|Death|47|||
125156154|NCT01386684|450195827|FG000|Overall Study|Withdrawal of Consent|44|||
125156155|NCT01386684|450195827|FG000|Overall Study|Alternative Therapy Required|37|||
125156156|NCT01386684|450195827|FG000|Overall Study|Disease Progression|28|||
125156157|NCT01386684|450195827|FG000|Overall Study|Adverse Event|20|||
125156158|NCT01386684|450195827|FG000|Overall Study|Noncompliance|8|||
125156159|NCT01386684|450195827|FG000|Overall Study|Protocol Violation|4|||
125156160|NCT01386684|450195827|FG000|Overall Study|Missing|3|||
125156161|NCT03197558|450195832|FG000|Overall Study|Tubes not placed|1|||
125156162|NCT02072148|450195843|FG000|Overall Study|withdrew prior to surgery|23|||
125156163|NCT02072148|450195844|FG001|Overall Study|withdrew prior to surgery|0|||
125156164|NCT02072148|450195845|FG002|Overall Study|withdrew prior to surgery|0|||
125156165|NCT02072148|450195843|FG000|Overall Study|Death|0|||
125156166|NCT02072148|450195844|FG001|Overall Study|Death|0|||
125156167|NCT02072148|450195845|FG002|Overall Study|Death|1|||
125156168|NCT02072148|450195843|FG000|Overall Study|Withdrawal by Subject|0|||
125156169|NCT02072148|450195844|FG001|Overall Study|Withdrawal by Subject|13|||
125156170|NCT02072148|450195845|FG002|Overall Study|Withdrawal by Subject|12|||
125156171|NCT02528123|450195851|FG000|Overall Study|Lost to Follow-up|1|||
125156172|NCT01892657|450195855|FG000|Overall Study|Withdrawal by Subject|6|||
125156173|NCT01892657|450195855|FG000|Overall Study|Protocol Violation|12|||
125156174|NCT03463993|450195861|FG000|Overall Study|Lost to Follow-up|7|||
125156175|NCT03463993|450195862|FG001|Overall Study|Lost to Follow-up|8|||
125156176|NCT03463993|450195861|FG000|Overall Study|Withdrawal by Subject|2|||
125156177|NCT03463993|450195862|FG001|Overall Study|Withdrawal by Subject|0|||
125438746|NCT01425632|451233947|FG001|Overall Study|Protocol Violation|0|||
125438747|NCT01425632|451233948|FG002|Overall Study|Protocol Violation|2|||
125156178|NCT03463993|450195861|FG000|Overall Study|Protocol Violation|4|||
125156179|NCT03463993|450195862|FG001|Overall Study|Protocol Violation|1|||
125156180|NCT03463993|450195861|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
125156181|NCT03463993|450195862|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
125156182|NCT03463993|450195861|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
125156183|NCT03463993|450195862|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
125156184|NCT01478828|450195863|FG000|Overall Study|Adverse Event|1|||
125156185|NCT00136318|450195864|FG000|Overall Study|Adverse Event|5|||
125156186|NCT00136318|450195865|FG001|Overall Study|Adverse Event|5|||
125156187|NCT00136318|450195864|FG000|Overall Study|Withdrawal by Subject|2|||
125156188|NCT00136318|450195865|FG001|Overall Study|Withdrawal by Subject|2|||
125223856|NCT04863872|450446253|FG001|Overall Study|Death|2|||
125156189|NCT02654587|450195885|FG000|Overall Study|patient alive at end of study|22|||
125156190|NCT02654587|450195886|FG001|Overall Study|patient alive at end of study|8|||
125156191|NCT02654587|450195885|FG000|Overall Study|Withdrawal by Subject|1|||
125156192|NCT02654587|450195886|FG001|Overall Study|Withdrawal by Subject|7|||
125156193|NCT01843348|450195889|FG000|Overall Study|Withdrawal by Subject|4|||
125156194|NCT01843348|450195890|FG001|Overall Study|Withdrawal by Subject|16|||
125156195|NCT01843348|450195891|FG002|Overall Study|Withdrawal by Subject|18|||
125156196|NCT01843348|450195889|FG000|Overall Study|Lost to Follow-up|5|||
125156197|NCT01843348|450195890|FG001|Overall Study|Lost to Follow-up|4|||
125156198|NCT01843348|450195891|FG002|Overall Study|Lost to Follow-up|2|||
125156199|NCT01843348|450195889|FG000|Overall Study|Death|5|||
125156200|NCT01843348|450195890|FG001|Overall Study|Death|3|||
125156201|NCT01843348|450195891|FG002|Overall Study|Death|4|||
125388872|NCT05214768|451056715|FG001|Maintenance Period|Other Reasons|0|||
125388873|NCT05214768|451056716|FG002|Maintenance Period|Other Reasons|1|||
125388874|NCT05214768|451056717|FG003|Maintenance Period|Other Reasons|1|||
125388875|NCT05214768|451056718|FG004|Maintenance Period|Other Reasons|0|||
125388876|NCT05214768|451056719|FG005|Maintenance Period|Other Reasons|0|||
125388877|NCT05214768|451056714|FG000|Maintenance Period|Withdrawal by Subject|0|||
125388878|NCT05214768|451056715|FG001|Maintenance Period|Withdrawal by Subject|0|||
125388879|NCT05214768|451056716|FG002|Maintenance Period|Withdrawal by Subject|0|||
125388880|NCT05214768|451056717|FG003|Maintenance Period|Withdrawal by Subject|1|||
125388881|NCT05214768|451056718|FG004|Maintenance Period|Withdrawal by Subject|0|||
125388882|NCT05214768|451056719|FG005|Maintenance Period|Withdrawal by Subject|0|||
125388883|NCT05214768|451056714|FG000|Maintenance Period|Lack of Efficacy|0|||
125388884|NCT05214768|451056715|FG001|Maintenance Period|Lack of Efficacy|0|||
125388885|NCT05214768|451056716|FG002|Maintenance Period|Lack of Efficacy|1|||
125388886|NCT05214768|451056717|FG003|Maintenance Period|Lack of Efficacy|0|||
125388887|NCT05214768|451056718|FG004|Maintenance Period|Lack of Efficacy|1|||
125388888|NCT05214768|451056719|FG005|Maintenance Period|Lack of Efficacy|0|||
125388889|NCT05214768|451056714|FG000|Open Label Extension Period|Physician Decision|0|||
125388890|NCT05214768|451056715|FG001|Open Label Extension Period|Physician Decision|0|||
125388891|NCT05214768|451056716|FG002|Open Label Extension Period|Physician Decision|0|||
125388892|NCT05214768|451056717|FG003|Open Label Extension Period|Physician Decision|0|||
125388893|NCT05214768|451056718|FG004|Open Label Extension Period|Physician Decision|0|||
125388894|NCT05214768|451056719|FG005|Open Label Extension Period|Physician Decision|1|||
125388895|NCT05214768|451056714|FG000|Open Label Extension Period|Lack of Efficacy|0|||
125388896|NCT05214768|451056715|FG001|Open Label Extension Period|Lack of Efficacy|0|||
125388897|NCT05214768|451056716|FG002|Open Label Extension Period|Lack of Efficacy|0|||
125388898|NCT05214768|451056717|FG003|Open Label Extension Period|Lack of Efficacy|0|||
125388899|NCT05214768|451056718|FG004|Open Label Extension Period|Lack of Efficacy|0|||
125388900|NCT05214768|451056719|FG005|Open Label Extension Period|Lack of Efficacy|1|||
125388901|NCT05214768|451056714|FG000|Open Label Extension Period|Ongoing Study|0|||
125388902|NCT05214768|451056715|FG001|Open Label Extension Period|Ongoing Study|0|||
125388903|NCT05214768|451056716|FG002|Open Label Extension Period|Ongoing Study|0|||
125388904|NCT05214768|451056717|FG003|Open Label Extension Period|Ongoing Study|0|||
125388905|NCT05214768|451056718|FG004|Open Label Extension Period|Ongoing Study|0|||
125388906|NCT05214768|451056719|FG005|Open Label Extension Period|Ongoing Study|42|||
125388907|NCT05041322|451056720|FG000|Baseline|Withdrawal by Subject|1|||
125156202|NCT01843348|450195889|FG000|Overall Study|Graft loss/retransplantation|5|||
125156203|NCT01843348|450195890|FG001|Overall Study|Graft loss/retransplantation|8|||
125156204|NCT01843348|450195891|FG002|Overall Study|Graft loss/retransplantation|11|||
125156205|NCT01843348|450195889|FG000|Overall Study|Various reasons|4|||
125156206|NCT01843348|450195890|FG001|Overall Study|Various reasons|9|||
125156207|NCT01843348|450195891|FG002|Overall Study|Various reasons|6|||
125156208|NCT02039414|450195892|FG000|Overall Study|Delivered|1|||
125156209|NCT02039414|450195893|FG001|Overall Study|Delivered|1|||
125156210|NCT02039414|450195892|FG000|Overall Study|Lost to Follow-up|2|||
125156211|NCT02039414|450195893|FG001|Overall Study|Lost to Follow-up|0|||
125388908|NCT05041322|451056721|FG001|Baseline|Withdrawal by Subject|0|||
125388909|NCT05041322|451056720|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
125388910|NCT05041322|451056721|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
125156212|NCT02039414|450195892|FG000|Overall Study|Protocol Violation|3|||
125388911|NCT05041322|451056720|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
125388912|NCT05041322|451056721|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
125388913|NCT03795298|451056722|FG000|Overall Study|Death|34|||
125388914|NCT03795298|451056723|FG001|Overall Study|Death|29|||
125388915|NCT03795298|451056722|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
125388916|NCT03795298|451056723|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
125388917|NCT03795298|451056722|FG000|Overall Study|Lost to Follow-up|28|||
125156213|NCT02039414|450195893|FG001|Overall Study|Protocol Violation|1|||
125156214|NCT00430950|450195894|FG000|Overall Study|Adverse Event|7|||
125156215|NCT00430950|450195895|FG001|Overall Study|Adverse Event|6|||
125156216|NCT00430950|450195894|FG000|Overall Study|Withdrawal by Subject|1|||
125156217|NCT00430950|450195895|FG001|Overall Study|Withdrawal by Subject|0|||
125156218|NCT00430950|450195894|FG000|Overall Study|concomitant medication,etc.|5|||
125156219|NCT00430950|450195895|FG001|Overall Study|concomitant medication,etc.|7|||
125156220|NCT02429934|450195898|FG000|Overall Study|Withdrawal by Subject|0|||
125156221|NCT02429934|450195899|FG001|Overall Study|Withdrawal by Subject|2|||
125156222|NCT02429934|450195898|FG000|Overall Study|Adverse Event|2|||
125156223|NCT02429934|450195899|FG001|Overall Study|Adverse Event|0|||
125156224|NCT02429934|450195898|FG000|Overall Study|Lost to Follow-up|1|||
125156225|NCT02429934|450195899|FG001|Overall Study|Lost to Follow-up|1|||
125156226|NCT02429934|450195898|FG000|Overall Study|Physician Decision|1|||
125156227|NCT02429934|450195899|FG001|Overall Study|Physician Decision|0|||
125156228|NCT00831623|450195903|FG000|Overall Study|Withdrawal by Subject|9|||
125156229|NCT00831623|450195903|FG000|Overall Study|Lost to Follow-up|1|||
125156230|NCT00831623|450195903|FG000|Overall Study|Not 2 years post-treatment|12|||
125156231|NCT01564459|450195907|FG000|Run-In|Adverse Event|7|||
125156232|NCT01564459|450195908|FG001|Run-In|Adverse Event|0|||
125156233|NCT01564459|450195909|FG002|Run-In|Adverse Event|0|||
125156234|NCT01564459|450195907|FG000|Run-In|Lost to Follow-up|1|||
125156235|NCT01564459|450195908|FG001|Run-In|Lost to Follow-up|0|||
125156236|NCT01564459|450195909|FG002|Run-In|Lost to Follow-up|0|||
125156237|NCT01564459|450195907|FG000|Run-In|Non-compliance with study drug|2|||
125156238|NCT01564459|450195908|FG001|Run-In|Non-compliance with study drug|0|||
125156239|NCT01564459|450195909|FG002|Run-In|Non-compliance with study drug|0|||
125156240|NCT01564459|450195907|FG000|Run-In|Protocol Violation|1|||
125156241|NCT01564459|450195908|FG001|Run-In|Protocol Violation|0|||
125156242|NCT01564459|450195909|FG002|Run-In|Protocol Violation|0|||
125156243|NCT01564459|450195907|FG000|Run-In|Withdrawal by Subject|1|||
125156244|NCT01564459|450195908|FG001|Run-In|Withdrawal by Subject|0|||
125156245|NCT01564459|450195909|FG002|Run-In|Withdrawal by Subject|0|||
125156246|NCT01564459|450195907|FG000|Double-blind Treatment|Adverse Event|0|||
125156247|NCT01564459|450195908|FG001|Double-blind Treatment|Adverse Event|0|||
125156248|NCT01564459|450195909|FG002|Double-blind Treatment|Adverse Event|1|||
125156249|NCT00706992|450195915|FG000|Overall Study|Study termination|5|||
125156250|NCT00706992|450195916|FG001|Overall Study|Study termination|5|||
125156251|NCT00706992|450195917|FG002|Overall Study|Study termination|6|||
125156252|NCT00706992|450195918|FG003|Overall Study|Study termination|2|||
125156253|NCT00706992|450195919|FG004|Overall Study|Study termination|3|||
125156254|NCT00706992|450195920|FG005|Overall Study|Study termination|2|||
125156255|NCT00706992|450195921|FG006|Overall Study|Study termination|3|||
125156256|NCT00706992|450195915|FG000|Overall Study|Disease progression before treatment|0|||
125156257|NCT00706992|450195916|FG001|Overall Study|Disease progression before treatment|0|||
125156258|NCT00706992|450195917|FG002|Overall Study|Disease progression before treatment|0|||
125156259|NCT00706992|450195918|FG003|Overall Study|Disease progression before treatment|0|||
125156260|NCT00706992|450195919|FG004|Overall Study|Disease progression before treatment|1|||
125156261|NCT00706992|450195920|FG005|Overall Study|Disease progression before treatment|0|||
125156262|NCT00706992|450195921|FG006|Overall Study|Disease progression before treatment|0|||
125156263|NCT03545191|450195922|FG000|Overall Study|Death|1|||
125156264|NCT03545191|450195923|FG001|Overall Study|Death|0|||
125156265|NCT03545191|450195924|FG002|Overall Study|Death|0|||
125156266|NCT03545191|450195922|FG000|Overall Study|Adverse Event|4|||
125156267|NCT03545191|450195923|FG001|Overall Study|Adverse Event|2|||
125156268|NCT03545191|450195924|FG002|Overall Study|Adverse Event|7|||
125156269|NCT03545191|450195922|FG000|Overall Study|Other reasons|3|||
125156270|NCT03545191|450195923|FG001|Overall Study|Other reasons|11|||
125156271|NCT03545191|450195924|FG002|Overall Study|Other reasons|8|||
125156272|NCT03545191|450195922|FG000|Overall Study|Withdrawal by Subject|13|||
125156273|NCT03545191|450195923|FG001|Overall Study|Withdrawal by Subject|10|||
125156274|NCT03545191|450195924|FG002|Overall Study|Withdrawal by Subject|12|||
125156275|NCT03545191|450195922|FG000|Overall Study|Lost to Follow-up|1|||
125156276|NCT03545191|450195923|FG001|Overall Study|Lost to Follow-up|2|||
125156277|NCT03545191|450195924|FG002|Overall Study|Lost to Follow-up|3|||
125156278|NCT02377063|450195928|FG000|Overall Study|Non-compliance|5|||
125156279|NCT02746627|450195934|FG000|Overall Study|Withdrawal by Subject|1|||
125156280|NCT02746627|450195935|FG001|Overall Study|Withdrawal by Subject|1|||
125156281|NCT02746627|450195936|FG002|Overall Study|Withdrawal by Subject|1|||
125156282|NCT02340221|450195939|FG000|Overall Study|Death|100|||
125156283|NCT02340221|450195940|FG001|Overall Study|Death|197|||
125156284|NCT02340221|450195939|FG000|Overall Study|Withdrawal by Participant|24|||
125156285|NCT02340221|450195940|FG001|Overall Study|Withdrawal by Participant|37|||
125156286|NCT02340221|450195939|FG000|Overall Study|Lost to Follow-up|4|||
125156287|NCT02340221|450195940|FG001|Overall Study|Lost to Follow-up|15|||
125156288|NCT02340221|450195939|FG000|Overall Study|Reason Not Specified|85|||
125156289|NCT02340221|450195940|FG001|Overall Study|Reason Not Specified|165|||
125156290|NCT02340221|450195939|FG000|Overall Study|Study Terminated by Sponsor|1|||
125156291|NCT02340221|450195940|FG001|Overall Study|Study Terminated by Sponsor|3|||
125156292|NCT03499119|450195941|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
125156293|NCT03499119|450195942|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
125156294|NCT03499119|450195943|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
125156295|NCT03499119|450195944|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
125156296|NCT03499119|450195941|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
125156297|NCT03499119|450195942|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
125156298|NCT03499119|450195943|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
125156299|NCT03499119|450195944|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
125156300|NCT03499119|450195941|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
125156301|NCT03499119|450195942|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
125156302|NCT03499119|450195943|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
125156303|NCT03499119|450195944|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
125156304|NCT03499119|450195941|FG000|Optional Extension Phase|Lost to Follow-up|0|||
125156305|NCT03499119|450195942|FG001|Optional Extension Phase|Lost to Follow-up|0|||
125156306|NCT03499119|450195943|FG002|Optional Extension Phase|Lost to Follow-up|0|||
125156307|NCT03499119|450195944|FG003|Optional Extension Phase|Lost to Follow-up|1|||
125156308|NCT03499119|450195941|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
125156309|NCT03499119|450195942|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
125156310|NCT03499119|450195943|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
125156311|NCT03499119|450195944|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
125156312|NCT03499119|450195941|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
125156313|NCT03499119|450195942|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
125156314|NCT03499119|450195943|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
125156315|NCT03499119|450195944|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
125156316|NCT00588640|450195945|FG000|Overall Study|Physician Decision|1|||
125156317|NCT00588640|450195945|FG000|Overall Study|Ineligible Patient|1|||
125156318|NCT00103402|450195946|FG000|Overall Study|Adverse Event|3|||
125156319|NCT00103402|450195947|FG001|Overall Study|Adverse Event|4|||
125156320|NCT00103402|450195946|FG000|Overall Study|Lost to Follow-up|8|||
125156321|NCT00103402|450195947|FG001|Overall Study|Lost to Follow-up|7|||
125156322|NCT00103402|450195946|FG000|Overall Study|Dissatisfied/No longer interested|6|||
125156323|NCT00103402|450195947|FG001|Overall Study|Dissatisfied/No longer interested|6|||
125156324|NCT00103402|450195946|FG000|Overall Study|Personal constraints/Other|5|||
125156325|NCT00103402|450195947|FG001|Overall Study|Personal constraints/Other|0|||
125156326|NCT01393730|450195948|FG000|Overall Study|Withdrawal by Subject|3|||
125156327|NCT01393730|450195948|FG000|Overall Study|Other|2|||
125156328|NCT01393730|450195948|FG000|Overall Study|Adverse Event|1|||
125156329|NCT01481324|450195951|FG000|Overall Study|Missing Data|0|||
125156330|NCT01481324|450195952|FG001|Overall Study|Missing Data|2|||
125156331|NCT01481324|450195953|FG002|Overall Study|Missing Data|2|||
125156332|NCT01172821|450195955|FG000|Overall Study|Adverse Event|5|||
125156333|NCT01172821|450195956|FG001|Overall Study|Adverse Event|2|||
125156334|NCT01172821|450195957|FG002|Overall Study|Adverse Event|2|||
125156335|NCT01172821|450195958|FG003|Overall Study|Adverse Event|7|||
125156336|NCT01172821|450195955|FG000|Overall Study|Protocol Violation|0|||
125156337|NCT01172821|450195956|FG001|Overall Study|Protocol Violation|2|||
125156338|NCT01172821|450195957|FG002|Overall Study|Protocol Violation|1|||
125156339|NCT01172821|450195958|FG003|Overall Study|Protocol Violation|2|||
125156340|NCT01172821|450195955|FG000|Overall Study|Lost to Follow-up|4|||
125156341|NCT01172821|450195956|FG001|Overall Study|Lost to Follow-up|1|||
125156342|NCT01172821|450195957|FG002|Overall Study|Lost to Follow-up|2|||
125156343|NCT01172821|450195958|FG003|Overall Study|Lost to Follow-up|2|||
125156344|NCT01172821|450195955|FG000|Overall Study|Withdrawal by Subject|2|||
125156345|NCT01172821|450195956|FG001|Overall Study|Withdrawal by Subject|3|||
125156346|NCT01172821|450195957|FG002|Overall Study|Withdrawal by Subject|3|||
125156347|NCT01172821|450195958|FG003|Overall Study|Withdrawal by Subject|3|||
125156348|NCT01172821|450195955|FG000|Overall Study|Other|3|||
125156349|NCT01172821|450195956|FG001|Overall Study|Other|4|||
125156350|NCT01172821|450195957|FG002|Overall Study|Other|5|||
125156351|NCT01172821|450195958|FG003|Overall Study|Other|3|||
125156352|NCT00123955|450195959|FG000|Overall Study|Adverse Event|1|||
125156353|NCT00123955|450195960|FG001|Overall Study|Adverse Event|0|||
125156354|NCT00123955|450195959|FG000|Overall Study|Withdrawal by Subject|4|||
125156355|NCT00123955|450195960|FG001|Overall Study|Withdrawal by Subject|3|||
125156356|NCT00123955|450195959|FG000|Overall Study|Death|0|||
125156357|NCT00123955|450195960|FG001|Overall Study|Death|1|||
125156358|NCT01663727|450195962|FG000|Overall Study|Death|161|||
125156359|NCT01663727|450195963|FG001|Overall Study|Death|155|||
125156360|NCT01663727|450195962|FG000|Overall Study|Lost to Follow-up|10|||
125156361|NCT01663727|450195963|FG001|Overall Study|Lost to Follow-up|8|||
125156362|NCT01663727|450195962|FG000|Overall Study|Withdrawal by Subject|18|||
125156363|NCT01663727|450195963|FG001|Overall Study|Withdrawal by Subject|25|||
125156364|NCT01663727|450195962|FG000|Overall Study|Study Terminated|51|||
125156365|NCT01663727|450195963|FG001|Overall Study|Study Terminated|50|||
125156366|NCT01663727|450195962|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
125156367|NCT01663727|450195963|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
125156368|NCT01663727|450195962|FG000|Overall Study|Withdrawal prior to dosing.|1|||
125156369|NCT01663727|450195963|FG001|Overall Study|Withdrawal prior to dosing.|0|||
125156370|NCT00003138|450197678|FG000|Step 1|Reasons off treatment not documented|60|||
125156371|NCT00003138|450197679|FG001|Step 1|Reasons off treatment not documented|57|||
125156372|NCT00003138|450197678|FG000|Step 1|Never started treatment|1|||
125156373|NCT00003138|450197679|FG001|Step 1|Never started treatment|0|||
125156374|NCT00003138|450197678|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
125156375|NCT00003138|450197679|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
125156376|NCT00003138|450197678|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
125156377|NCT00003138|450197679|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
125156378|NCT00003138|450197678|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
125156379|NCT00003138|450197679|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
125156380|NCT00003138|450197678|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
125156381|NCT00003138|450197679|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
125156382|NCT04495283|450197681|FG000|Overall Study|Physician Decision|0|||
125156383|NCT04495283|450197682|FG001|Overall Study|Physician Decision|0|||
125156384|NCT04495283|450197683|FG002|Overall Study|Physician Decision|1|||
125156385|NCT04495283|450197681|FG000|Overall Study|Withdrawal by Subject|0|||
125156386|NCT04495283|450197682|FG001|Overall Study|Withdrawal by Subject|1|||
125156387|NCT04495283|450197683|FG002|Overall Study|Withdrawal by Subject|1|||
125156388|NCT04495283|450197681|FG000|Overall Study|Other|1|||
125156389|NCT04495283|450197682|FG001|Overall Study|Other|0|||
125156390|NCT04495283|450197683|FG002|Overall Study|Other|1|||
125156391|NCT05142566|450197686|FG000|Overall Study|Protocol Violation|1|||
125156392|NCT02246439|450197687|FG000|Overall Study|Adverse Event|3|||
125156393|NCT02246439|450197688|FG001|Overall Study|Adverse Event|0|||
125156394|NCT02246439|450197687|FG000|Overall Study|Lost to Follow-up|7|||
125156395|NCT02246439|450197688|FG001|Overall Study|Lost to Follow-up|5|||
125156396|NCT02246439|450197687|FG000|Overall Study|Protocol Violation|0|||
125156397|NCT02246439|450197688|FG001|Overall Study|Protocol Violation|2|||
125156398|NCT02246439|450197687|FG000|Overall Study|Physician Decision|0|||
125156399|NCT02246439|450197688|FG001|Overall Study|Physician Decision|1|||
125156400|NCT02246439|450197687|FG000|Overall Study|Unkonwn|1|||
125156401|NCT02246439|450197688|FG001|Overall Study|Unkonwn|3|||
125223857|NCT04863872|450446252|FG000|Overall Study|Lost to Follow-up|2|||
125223858|NCT04863872|450446253|FG001|Overall Study|Lost to Follow-up|1|||
125156402|NCT02246439|450197687|FG000|Overall Study|Withdrawal by Subject|1|||
125156403|NCT02246439|450197688|FG001|Overall Study|Withdrawal by Subject|0|||
125156404|NCT01553279|450197689|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
125156405|NCT01553279|450197690|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
125156406|NCT01553279|450197689|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
125156407|NCT01553279|450197690|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
125156408|NCT01553279|450197689|FG000|Interim Period|Withdrawal by Subject|2|||
125156409|NCT01553279|450197690|FG001|Interim Period|Withdrawal by Subject|2|||
125156410|NCT01553279|450197689|FG000|Interim Period|Lost to Follow-up|1|||
125156411|NCT01553279|450197690|FG001|Interim Period|Lost to Follow-up|0|||
125156412|NCT01553279|450197689|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
125156413|NCT01553279|450197690|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
125156414|NCT01553279|450197689|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
125156415|NCT01553279|450197690|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
125156416|NCT00380692|450197691|FG000|Study Period II - Double Blind|Adverse Event|1|||
125156417|NCT00380692|450197692|FG001|Study Period II - Double Blind|Adverse Event|0|||
125388918|NCT03795298|451056723|FG001|Overall Study|Lost to Follow-up|17|||
125388919|NCT03795298|451056722|FG000|Overall Study|Physician Decision|5|||
125388920|NCT03795298|451056723|FG001|Overall Study|Physician Decision|4|||
125388921|NCT03795298|451056722|FG000|Overall Study|Withdrawal by Subject|43|||
125388922|NCT03795298|451056723|FG001|Overall Study|Withdrawal by Subject|28|||
125388923|NCT03795298|451056722|FG000|Overall Study|Reason not reported|7|||
125156418|NCT00380692|450197691|FG000|Study Period II - Double Blind|Protocol Violation|2|||
125156419|NCT00380692|450197692|FG001|Study Period II - Double Blind|Protocol Violation|2|||
125156420|NCT00380692|450197691|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
125156421|NCT00380692|450197692|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
125156422|NCT00380692|450197691|FG000|Study Period II - Double Blind|Physician Decision|0|||
125156423|NCT00380692|450197692|FG001|Study Period II - Double Blind|Physician Decision|1|||
125156424|NCT00380692|450197691|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
125156425|NCT00380692|450197692|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
125156426|NCT00380692|450197691|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
125156427|NCT00380692|450197692|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
125156428|NCT00380692|450197691|FG000|Study Period III - Open Label|Adverse Event|5|||
125156429|NCT00380692|450197692|FG001|Study Period III - Open Label|Adverse Event|3|||
125156430|NCT00380692|450197691|FG000|Study Period III - Open Label|Protocol Violation|0|||
125156431|NCT00380692|450197692|FG001|Study Period III - Open Label|Protocol Violation|0|||
125156432|NCT00380692|450197691|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
125156433|NCT00380692|450197692|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
125223859|NCT04058028|450446254|FG000|Overall Study|Withdrawal of Consent from Study|12|||
125388924|NCT03795298|451056723|FG001|Overall Study|Reason not reported|9|||
125388925|NCT04303780|451056724|FG000|Overall Study|Death|104|||
125156434|NCT00380692|450197691|FG000|Study Period III - Open Label|Physician Decision|0|||
125156435|NCT00380692|450197692|FG001|Study Period III - Open Label|Physician Decision|3|||
125156436|NCT00380692|450197691|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
125156437|NCT00380692|450197692|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
125156438|NCT00380692|450197691|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
125156439|NCT00380692|450197692|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
125156440|NCT01388166|450197693|FG000|Overall Study|Adverse Event|16|||
125156441|NCT01388166|450197693|FG000|Overall Study|Lost to Follow-up|30|||
125156442|NCT01388166|450197693|FG000|Overall Study|Others than specified above|13|||
125156443|NCT00158756|450197694|FG000|Overall Study|Withdrawal by Subject|5|||
125388926|NCT04303780|451056725|FG001|Overall Study|Death|85|||
125388927|NCT04303780|451056724|FG000|Overall Study|Lost to Follow-up|5|||
125156444|NCT00158756|450197695|FG001|Overall Study|Withdrawal by Subject|0|||
125156445|NCT00158756|450197696|FG002|Overall Study|Withdrawal by Subject|6|||
125156446|NCT00158756|450197697|FG003|Overall Study|Withdrawal by Subject|1|||
125156447|NCT00158756|450197698|FG004|Overall Study|Withdrawal by Subject|3|||
125156448|NCT00158756|450197694|FG000|Overall Study|Adverse Event|0|||
125156449|NCT00158756|450197695|FG001|Overall Study|Adverse Event|0|||
125156450|NCT00158756|450197696|FG002|Overall Study|Adverse Event|1|||
125156451|NCT00158756|450197697|FG003|Overall Study|Adverse Event|0|||
125156452|NCT00158756|450197698|FG004|Overall Study|Adverse Event|0|||
125156453|NCT00158756|450197694|FG000|Overall Study|Serious adverse event|0|||
125156454|NCT00158756|450197695|FG001|Overall Study|Serious adverse event|0|||
125156455|NCT00158756|450197696|FG002|Overall Study|Serious adverse event|1|||
125156456|NCT00158756|450197697|FG003|Overall Study|Serious adverse event|0|||
125156457|NCT00158756|450197698|FG004|Overall Study|Serious adverse event|0|||
125156458|NCT01429051|450197699|FG000|Titration Phase|Death|1|||
125156459|NCT01429051|450197699|FG000|Titration Phase|Withdrawal by Subject|7|||
125156460|NCT01429051|450197699|FG000|Titration Phase|Physician Decision|1|||
125156461|NCT01429051|450197699|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
125156462|NCT01429051|450197699|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
125156463|NCT01429051|450197699|FG000|Efficacy Phase|Adverse Event|1|||
125156464|NCT01429051|450197699|FG000|Efficacy Phase|Death|1|||
125156465|NCT01429051|450197699|FG000|Tolerability Phase|Death|5|||
125156466|NCT01429051|450197699|FG000|Tolerability Phase|Adverse Event|2|||
125156467|NCT01429051|450197699|FG000|Tolerability Phase|Withdrawal by Subject|5|||
125156468|NCT01429051|450197699|FG000|Tolerability Phase|Physician Decision|1|||
125156469|NCT01429051|450197699|FG000|Tolerability Phase|Other|2|||
125156470|NCT04132336|450197700|FG000|Overall Study|Investigator Decision|0|||
125156471|NCT04132336|450197701|FG001|Overall Study|Investigator Decision|1|||
125156472|NCT04132336|450197702|FG002|Overall Study|Investigator Decision|0|||
125156473|NCT04132336|450197703|FG003|Overall Study|Investigator Decision|0|||
125156474|NCT04132336|450197704|FG004|Overall Study|Investigator Decision|0|||
125156475|NCT04132336|450197705|FG005|Overall Study|Investigator Decision|0|||
125156476|NCT04132336|450197706|FG006|Overall Study|Investigator Decision|0|||
125156477|NCT01939496|450197707|FG000|Overall Study|Adverse Event|2|||
125156478|NCT01939496|450197708|FG001|Overall Study|Adverse Event|0|||
125156479|NCT01939496|450197709|FG002|Overall Study|Adverse Event|0|||
125156480|NCT01939496|450197707|FG000|Overall Study|Lost to Follow-up|1|||
125156481|NCT01939496|450197708|FG001|Overall Study|Lost to Follow-up|1|||
125156482|NCT01939496|450197709|FG002|Overall Study|Lost to Follow-up|0|||
125156483|NCT01939496|450197707|FG000|Overall Study|Physician Decision|1|||
125156484|NCT01939496|450197708|FG001|Overall Study|Physician Decision|0|||
125156485|NCT01939496|450197709|FG002|Overall Study|Physician Decision|0|||
125156486|NCT01939496|450197707|FG000|Overall Study|Protocol Violation|3|||
125156487|NCT01939496|450197708|FG001|Overall Study|Protocol Violation|0|||
125156488|NCT01939496|450197709|FG002|Overall Study|Protocol Violation|0|||
125156489|NCT01939496|450197707|FG000|Overall Study|Withdrawal by Subject|0|||
125156490|NCT01939496|450197708|FG001|Overall Study|Withdrawal by Subject|1|||
125156491|NCT01939496|450197709|FG002|Overall Study|Withdrawal by Subject|1|||
125156492|NCT01939496|450197707|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
125156493|NCT01939496|450197708|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
125156494|NCT01939496|450197709|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
125156495|NCT01939496|450197707|FG000|Overall Study|Other|2|||
125156496|NCT01939496|450197708|FG001|Overall Study|Other|0|||
125156497|NCT01939496|450197709|FG002|Overall Study|Other|1|||
125156498|NCT03052322|450197710|FG000|Overall Study|Other un-specified|1|||
125388928|NCT04303780|451056725|FG001|Overall Study|Lost to Follow-up|2|||
125156499|NCT03052322|450197711|FG001|Overall Study|Other un-specified|2|||
125156500|NCT03052322|450197710|FG000|Overall Study|Withdrawal by Subject|10|||
125156501|NCT03052322|450197711|FG001|Overall Study|Withdrawal by Subject|9|||
125156502|NCT03052322|450197710|FG000|Overall Study|Death|0|||
125156503|NCT03052322|450197711|FG001|Overall Study|Death|2|||
125156504|NCT03052322|450197710|FG000|Overall Study|Lack of Efficacy|1|||
125156505|NCT03052322|450197711|FG001|Overall Study|Lack of Efficacy|2|||
125156506|NCT03052322|450197710|FG000|Overall Study|Protocol Violation|1|||
125156507|NCT03052322|450197711|FG001|Overall Study|Protocol Violation|0|||
125156508|NCT03052322|450197710|FG000|Overall Study|Lost to Follow-up|2|||
125156509|NCT03052322|450197711|FG001|Overall Study|Lost to Follow-up|4|||
125156510|NCT03052322|450197710|FG000|Overall Study|Adverse Event|6|||
125156511|NCT03052322|450197711|FG001|Overall Study|Adverse Event|13|||
125156512|NCT04920916|450197712|FG000|Phase IIa 60 Day Study|Death|2|||
125156513|NCT04920916|450197713|FG001|Phase IIa 60 Day Study|Death|5|||
125156514|NCT04920916|450197712|FG000|1 Year Follow up (Phone Call)|Death|1|||
125156515|NCT04920916|450197713|FG001|1 Year Follow up (Phone Call)|Death|3|||
125156516|NCT04920916|450197712|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
125156517|NCT04920916|450197713|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
125156518|NCT00973765|450197714|FG000|Overall Study|Lost to Follow-up|8|||
125156519|NCT00973765|450197715|FG001|Overall Study|Lost to Follow-up|14|||
125156520|NCT02011113|450197716|FG000|Overall Study|Adverse Event|4|||
125156521|NCT02011113|450197716|FG000|Overall Study|Disease Progression (DP)|16|||
125156522|NCT02011113|450197716|FG000|Overall Study|Death|1|||
125156523|NCT02011113|450197716|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
125156524|NCT02011113|450197716|FG000|Overall Study|Investigator's judgement- DP|3|||
125156525|NCT02011113|450197716|FG000|Overall Study|Study terminated by sponsor|11|||
125156526|NCT00468728|450197723|FG000|Treatment|criteria for mITT population|4|||
125156527|NCT00468728|450197724|FG001|Treatment|criteria for mITT population|11|||
125156528|NCT00468728|450197723|FG000|Follow-up|mITT failure|34|||
125156529|NCT00468728|450197724|FG001|Follow-up|mITT failure|31|||
125156530|NCT03251963|450197725|FG000|Overall Study|inappropriate Xa level timing|6|||
125156531|NCT03251963|450197726|FG001|Overall Study|inappropriate Xa level timing|3|||
125156532|NCT03251963|450197725|FG000|Overall Study|no peak Xa level drawn|2|||
125156533|NCT03251963|450197726|FG001|Overall Study|no peak Xa level drawn|0|||
125156534|NCT03251963|450197725|FG000|Overall Study|bled prior to Xa level|1|||
125156535|NCT03251963|450197726|FG001|Overall Study|bled prior to Xa level|2|||
125156536|NCT04505293|450197727|FG000|Overall Study|Lost to Follow-up|2|||
125156537|NCT04505293|450197727|FG000|Overall Study|Withdrawal by Subject|6|||
125156538|NCT04505293|450197727|FG000|Overall Study|CT scan unreadable|277|||
125156539|NCT02712333|450197729|FG000|First Period|Withdrawal by Subject|3|||
125156540|NCT02712333|450197730|FG001|First Period|Withdrawal by Subject|2|||
125156541|NCT00775606|450197731|FG000|Overall Study|Study sponsor terminated funding|3|||
125156542|NCT00775606|450197732|FG001|Overall Study|Study sponsor terminated funding|0|||
125156543|NCT02278718|450197733|FG000|Overall Study|Adverse Event|1|||
125156544|NCT02278718|450197734|FG001|Overall Study|Adverse Event|0|||
125156545|NCT02278718|450197733|FG000|Overall Study|Lost to Follow-up|2|||
125156546|NCT02278718|450197734|FG001|Overall Study|Lost to Follow-up|4|||
125156547|NCT02278718|450197733|FG000|Overall Study|Withdrawal by Subject|1|||
125156548|NCT02278718|450197734|FG001|Overall Study|Withdrawal by Subject|4|||
125156549|NCT02278718|450197733|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
125156550|NCT02278718|450197734|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
125156551|NCT02278718|450197733|FG000|Overall Study|Missing|0|||
125156552|NCT02278718|450197734|FG001|Overall Study|Missing|1|||
125156553|NCT01546649|450197735|FG000|Overall Study|Adverse Event|4|||
125156554|NCT01546649|450197736|FG001|Overall Study|Adverse Event|5|||
125156555|NCT01546649|450197735|FG000|Overall Study|Protocol Violation|1|||
125156556|NCT01546649|450197736|FG001|Overall Study|Protocol Violation|0|||
125156557|NCT01546649|450197735|FG000|Overall Study|Lack of Efficacy|1|||
125156558|NCT01546649|450197736|FG001|Overall Study|Lack of Efficacy|0|||
125156559|NCT01546649|450197735|FG000|Overall Study|Recurrence|1|||
125156560|NCT01546649|450197736|FG001|Overall Study|Recurrence|1|||
125156561|NCT01546649|450197735|FG000|Overall Study|Discovery of secondary cancer|0|||
125223860|NCT04058028|450446255|FG001|Overall Study|Withdrawal of Consent from Study|8|||
125223861|NCT04058028|450446256|FG002|Overall Study|Withdrawal of Consent from Study|6|||
125223862|NCT04058028|450446257|FG003|Overall Study|Withdrawal of Consent from Study|7|||
125223863|NCT04058028|450446254|FG000|Overall Study|Decision by Sponsor|13|||
125223864|NCT04058028|450446255|FG001|Overall Study|Decision by Sponsor|4|||
125156562|NCT01546649|450197736|FG001|Overall Study|Discovery of secondary cancer|1|||
125156563|NCT01546649|450197735|FG000|Overall Study|Withdrawal by Subject|1|||
125156564|NCT01546649|450197736|FG001|Overall Study|Withdrawal by Subject|2|||
125156565|NCT04440449|450197737|FG000|Overall Study|Lost to Follow-up|2|||
125223865|NCT04058028|450446256|FG002|Overall Study|Decision by Sponsor|1|||
125223866|NCT04058028|450446257|FG003|Overall Study|Decision by Sponsor|35|||
125223867|NCT04058028|450446254|FG000|Overall Study|Lost to Follow-up|1|||
125223868|NCT04058028|450446255|FG001|Overall Study|Lost to Follow-up|1|||
125223869|NCT04058028|450446256|FG002|Overall Study|Lost to Follow-up|1|||
125223870|NCT04058028|450446257|FG003|Overall Study|Lost to Follow-up|0|||
125223871|NCT04058028|450446254|FG000|Overall Study|Death|0|||
125223872|NCT04058028|450446255|FG001|Overall Study|Death|1|||
125156566|NCT04440449|450197738|FG001|Overall Study|Lost to Follow-up|0|||
125156567|NCT03212794|450197739|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
125156568|NCT03212794|450197740|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
125156569|NCT03212794|450197739|FG000|Overall Study|Lost to Follow-up|5|||
125156570|NCT03212794|450197740|FG001|Overall Study|Lost to Follow-up|6|||
125223873|NCT04058028|450446256|FG002|Overall Study|Death|0|||
125388929|NCT04303780|451056724|FG000|Overall Study|Withdrawal by Subject|12|||
125388930|NCT04303780|451056725|FG001|Overall Study|Withdrawal by Subject|39|||
125388931|NCT04303780|451056724|FG000|Overall Study|Ongoing in study|50|||
125388932|NCT04303780|451056725|FG001|Overall Study|Ongoing in study|45|||
125388933|NCT01344161|451056726|FG000|Overall Study|Lost to Follow-up|4|||
125388934|NCT01344161|451056727|FG001|Overall Study|Lost to Follow-up|1|||
125388935|NCT01344161|451056726|FG000|Overall Study|Pregnancy|0|||
125388936|NCT01344161|451056727|FG001|Overall Study|Pregnancy|1|||
125388937|NCT01344161|451056726|FG000|Overall Study|Protocol Violation|1|||
125388938|NCT01344161|451056727|FG001|Overall Study|Protocol Violation|1|||
125388939|NCT02255500|451058004|FG000|Overall Study|Withdrawal by Subject|1|||
125388940|NCT02255500|451058005|FG001|Overall Study|Withdrawal by Subject|0|||
125388941|NCT04765358|451058013|FG000|Overall Study|Withdrawal by Subject|1|||
125388942|NCT02731729|451058014|FG000|Overall Study|Death|2|||
125388943|NCT02731729|451058015|FG001|Overall Study|Death|2|||
125388944|NCT02731729|451058014|FG000|Overall Study|Study terminated by Sponsor|6|||
125388945|NCT02731729|451058015|FG001|Overall Study|Study terminated by Sponsor|6|||
125388946|NCT02731729|451058014|FG000|Overall Study|Withdrawal by Subject|1|||
125388947|NCT02731729|451058015|FG001|Overall Study|Withdrawal by Subject|0|||
125388948|NCT00159588|451058016|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
125388949|NCT00159588|451058017|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
125388950|NCT00159588|451058018|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
125388951|NCT02066467|451058020|FG000|Overall Study|Did not undergo implant procedure|24|||
125388952|NCT02066467|451058020|FG000|Overall Study|Attempted to implant withoput success|43|||
125388953|NCT02066467|451058020|FG000|Overall Study|Consent ineligible|1|||
125388954|NCT02066467|451058020|FG000|Overall Study|Death|54|||
125388955|NCT02066467|451058020|FG000|Overall Study|Lost to Follow-up|51|||
125388956|NCT02066467|451058020|FG000|Overall Study|Adverse Event|20|||
125388957|NCT02066467|451058020|FG000|Overall Study|Withdrawal by Subject|16|||
125388958|NCT02066467|451058020|FG000|Overall Study|Physician Decision|2|||
125388959|NCT02066467|451058020|FG000|Overall Study|Not defined|4|||
125388960|NCT00456521|451058021|FG000|Overall Study|Adverse Event|150|||
125388961|NCT00456521|451058022|FG001|Overall Study|Adverse Event|25|||
125388962|NCT00456521|451058021|FG000|Overall Study|Withdrawal by Subject|43|||
125388963|NCT00456521|451058022|FG001|Overall Study|Withdrawal by Subject|24|||
125388964|NCT00456521|451058021|FG000|Overall Study|Lost to Follow-up|22|||
125388965|NCT00456521|451058022|FG001|Overall Study|Lost to Follow-up|17|||
125388966|NCT00456521|451058021|FG000|Overall Study|Lack of Efficacy|3|||
125388967|NCT00456521|451058022|FG001|Overall Study|Lack of Efficacy|6|||
125156571|NCT03212794|450197739|FG000|Overall Study|Incarcerated; unable to participate|2|||
125156572|NCT03212794|450197740|FG001|Overall Study|Incarcerated; unable to participate|0|||
125156573|NCT03212794|450197739|FG000|Overall Study|Withdrawal by Subject|1|||
125156574|NCT03212794|450197740|FG001|Overall Study|Withdrawal by Subject|0|||
125156575|NCT03212794|450197739|FG000|Overall Study|Death|0|||
125156576|NCT03212794|450197740|FG001|Overall Study|Death|1|||
125156577|NCT03212794|450197739|FG000|Overall Study|Found to be ineligible after allocation|0|||
125156578|NCT03212794|450197740|FG001|Overall Study|Found to be ineligible after allocation|1|||
125156579|NCT03212794|450197739|FG000|Overall Study|Relocated out of area|2|||
125156580|NCT03212794|450197740|FG001|Overall Study|Relocated out of area|0|||
125156581|NCT01763918|450197741|FG000|Overall Study|Withdrawal by Subject|2|||
125156582|NCT01763918|450197742|FG001|Overall Study|Withdrawal by Subject|1|||
125156583|NCT01763918|450197743|FG002|Overall Study|Withdrawal by Subject|1|||
125156584|NCT01763918|450197744|FG003|Overall Study|Withdrawal by Subject|2|||
125156585|NCT01763918|450197741|FG000|Overall Study|Sponsor Decision|4|||
125156586|NCT01763918|450197742|FG001|Overall Study|Sponsor Decision|0|||
125156587|NCT01763918|450197743|FG002|Overall Study|Sponsor Decision|9|||
125156588|NCT01763918|450197744|FG003|Overall Study|Sponsor Decision|0|||
125156589|NCT03395639|450197745|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
125156590|NCT03395639|450197746|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
125156591|NCT03395639|450197747|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
125156592|NCT03395639|450197745|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
125156593|NCT03395639|450197746|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
125156594|NCT03395639|450197747|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
125156595|NCT03395639|450197745|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
125156596|NCT03395639|450197746|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
125388968|NCT00456521|451058021|FG000|Overall Study|Protocol Violation|4|||
125388969|NCT00456521|451058022|FG001|Overall Study|Protocol Violation|0|||
125388970|NCT00456521|451058021|FG000|Overall Study|Pregnancy|1|||
125388971|NCT00456521|451058022|FG001|Overall Study|Pregnancy|1|||
125388972|NCT00456521|451058021|FG000|Overall Study|Drug non-compliance, moved, other|26|||
125388973|NCT00456521|451058022|FG001|Overall Study|Drug non-compliance, moved, other|11|||
125388974|NCT00297037|451058023|FG000|Overall Study|Withdrawal by Subject|2|||
125388975|NCT00297037|451058024|FG001|Overall Study|Withdrawal by Subject|0|||
125156597|NCT03395639|450197747|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
125388976|NCT00076011|451058025|FG000|Overall Study|Death|1|||
125388977|NCT00076011|451058025|FG000|Overall Study|Adverse Event|10|||
125388978|NCT00076011|451058025|FG000|Overall Study|Lack of Efficacy|25|||
125388979|NCT00076011|451058025|FG000|Overall Study|Withdrawal by Subject|1|||
125388980|NCT00076011|451058025|FG000|Overall Study|Study terminated by sponsor|3|||
125388981|NCT00076011|451058025|FG000|Overall Study|Other|11|||
125388982|NCT00076011|451058025|FG000|Overall Study|Ongoing|1|||
125388983|NCT00581776|451058026|FG000|Overall Study|Disease progression or no response|3|||
125388984|NCT03056755|451058031|FG000|Treatment- Core Phase|Progressive disease|89|||
125388985|NCT03056755|451058032|FG001|Treatment- Core Phase|Progressive disease|88|||
125388986|NCT03056755|451058033|FG002|Treatment- Core Phase|Progressive disease|90|||
125388987|NCT03056755|451058031|FG000|Treatment- Core Phase|Adverse Event|20|||
125388988|NCT03056755|451058032|FG001|Treatment- Core Phase|Adverse Event|14|||
125388989|NCT03056755|451058033|FG002|Treatment- Core Phase|Adverse Event|13|||
125388990|NCT03056755|451058031|FG000|Treatment- Core Phase|Physician Decision|7|||
125388991|NCT03056755|451058032|FG001|Treatment- Core Phase|Physician Decision|13|||
125388992|NCT03056755|451058033|FG002|Treatment- Core Phase|Physician Decision|5|||
125388993|NCT03056755|451058031|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
125388994|NCT03056755|451058032|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
125388995|NCT03056755|451058033|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
125388996|NCT03056755|451058031|FG000|Treatment- Core Phase|Death|3|||
125388997|NCT03056755|451058032|FG001|Treatment- Core Phase|Death|2|||
125388998|NCT03056755|451058033|FG002|Treatment- Core Phase|Death|4|||
125156598|NCT03395639|450197745|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
125156599|NCT03395639|450197746|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
125156600|NCT03395639|450197747|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
125156601|NCT03395639|450197745|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
125156602|NCT03395639|450197746|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
125156603|NCT03395639|450197747|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
125156604|NCT00942331|450197748|FG000|Overall Study|Did not start treatment|15|||
125156605|NCT00942331|450197749|FG001|Overall Study|Did not start treatment|22|||
125156606|NCT00597116|450197752|FG000|Overall Study|Adverse Event|2|||
125156607|NCT00597116|450197753|FG001|Overall Study|Adverse Event|1|||
125156608|NCT00597116|450197752|FG000|Overall Study|Withdrawal by Subject|0|||
125156609|NCT00597116|450197753|FG001|Overall Study|Withdrawal by Subject|2|||
125156610|NCT00597116|450197752|FG000|Overall Study|Physician Decision|0|||
125156611|NCT00597116|450197753|FG001|Overall Study|Physician Decision|1|||
125156612|NCT00597116|450197752|FG000|Overall Study|Death|0|||
125156613|NCT00597116|450197753|FG001|Overall Study|Death|1|||
125156614|NCT00597116|450197752|FG000|Overall Study|Lost to Follow-up|1|||
125156615|NCT00597116|450197753|FG001|Overall Study|Lost to Follow-up|0|||
125156616|NCT00597116|450197752|FG000|Overall Study|Progressive disease|11|||
125156617|NCT00597116|450197753|FG001|Overall Study|Progressive disease|6|||
125156618|NCT00757848|450197757|FG000|Overall Study|Voluntary discontinuation|1|||
125156619|NCT00757848|450197758|FG001|Overall Study|Voluntary discontinuation|0|||
125156620|NCT00757848|450197757|FG000|Overall Study|Adverse Event|1|||
125156621|NCT00757848|450197758|FG001|Overall Study|Adverse Event|2|||
125156622|NCT00757848|450197757|FG000|Overall Study|Incorrect enrolment|1|||
125156623|NCT00757848|450197758|FG001|Overall Study|Incorrect enrolment|0|||
125156624|NCT01901874|450197761|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
125156625|NCT01901874|450197761|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
125156626|NCT01901874|450197761|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
125156627|NCT01901874|450197761|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
125156628|NCT01901874|450197761|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
125156629|NCT01901874|450197761|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
125156630|NCT03832738|450197767|FG000|Overall Study|Withdrawal by Subject|6|||
125156631|NCT03832738|450197768|FG001|Overall Study|Withdrawal by Subject|7|||
125156632|NCT03832738|450197769|FG002|Overall Study|Withdrawal by Subject|16|||
125156633|NCT03832738|450197767|FG000|Overall Study|Physician Decision|0|||
125156634|NCT03832738|450197768|FG001|Overall Study|Physician Decision|1|||
125156635|NCT03832738|450197769|FG002|Overall Study|Physician Decision|2|||
125156636|NCT03832738|450197767|FG000|Overall Study|Adverse Event|2|||
125156637|NCT03832738|450197768|FG001|Overall Study|Adverse Event|3|||
125156638|NCT03832738|450197769|FG002|Overall Study|Adverse Event|1|||
125156639|NCT03832738|450197767|FG000|Overall Study|Pregnancy|0|||
125388999|NCT03056755|451058031|FG000|Treatment- Core Phase|Protocol deviation|1|||
125389000|NCT03056755|451058032|FG001|Treatment- Core Phase|Protocol deviation|1|||
125389001|NCT03056755|451058033|FG002|Treatment- Core Phase|Protocol deviation|0|||
125389002|NCT03056755|451058031|FG000|Treatment- Core Phase|Technical problems|1|||
125389003|NCT03056755|451058032|FG001|Treatment- Core Phase|Technical problems|0|||
125389004|NCT03056755|451058033|FG002|Treatment- Core Phase|Technical problems|0|||
125156640|NCT03832738|450197768|FG001|Overall Study|Pregnancy|1|||
125156641|NCT03832738|450197769|FG002|Overall Study|Pregnancy|0|||
125156642|NCT03977701|450197770|FG000|Overall Study|COVID-19 pandemic|0|||
125156643|NCT03977701|450197771|FG001|Overall Study|COVID-19 pandemic|0|||
125156644|NCT03977701|450197772|FG002|Overall Study|COVID-19 pandemic|0|||
125389005|NCT03056755|451058031|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
125438748|NCT01425632|451233946|FG000|Overall Study|Withdrawal by Subject|0|||
125438749|NCT01425632|451233947|FG001|Overall Study|Withdrawal by Subject|0|||
125438750|NCT01425632|451233948|FG002|Overall Study|Withdrawal by Subject|1|||
125438751|NCT01208415|451233951|FG000|Overall Study|Death|1|||
125438752|NCT01208415|451233951|FG000|Overall Study|Lost to Follow-up|2|||
125438753|NCT01208415|451233951|FG000|Overall Study|Withdrawal by Subject|3|||
125438754|NCT01208415|451233951|FG000|Overall Study|Device not placed|1|||
125438755|NCT01208415|451233951|FG000|Overall Study|Still be eligible for follow-up|33|||
125438756|NCT01115491|451233952|FG000|Overall Study|Death|22|||
125438757|NCT01115491|451233952|FG000|Overall Study|Adverse Event|3|||
125438758|NCT01115491|451233952|FG000|Overall Study|Lost to Follow-up|3|||
125438759|NCT01115491|451233952|FG000|Overall Study|Withdrawal by Subject|1|||
125156645|NCT03977701|450197773|FG003|Overall Study|COVID-19 pandemic|0|||
125156646|NCT03977701|450197774|FG004|Overall Study|COVID-19 pandemic|0|||
125156647|NCT03977701|450197775|FG005|Overall Study|COVID-19 pandemic|1|||
125156648|NCT03977701|450197776|FG006|Overall Study|COVID-19 pandemic|0|||
125156649|NCT03977701|450197777|FG007|Overall Study|COVID-19 pandemic|1|||
125156650|NCT03977701|450197778|FG008|Overall Study|COVID-19 pandemic|0|||
125156651|NCT03977701|450197779|FG009|Overall Study|COVID-19 pandemic|0|||
125156652|NCT00702208|450197780|FG000|Overall Study|Lost to Follow-up|28|||
125156653|NCT00702208|450197780|FG000|Overall Study|Did not self-lavage|1|||
125156654|NCT00702208|450197780|FG000|Overall Study|Unsatisfactory colposcopy|2|||
125156655|NCT02025751|450197781|FG000|Overall Study|Lost to Follow-up|1|||
125156656|NCT02025751|450197782|FG001|Overall Study|Lost to Follow-up|0|||
125156657|NCT02025751|450197781|FG000|Overall Study|Adverse Event|0|||
125156658|NCT02025751|450197782|FG001|Overall Study|Adverse Event|1|||
125156659|NCT02025751|450197781|FG000|Overall Study|Physician Decision|0|||
125156660|NCT02025751|450197782|FG001|Overall Study|Physician Decision|1|||
125156661|NCT02025751|450197781|FG000|Overall Study|Withdrawal by Subject|0|||
125156662|NCT02025751|450197782|FG001|Overall Study|Withdrawal by Subject|1|||
125156663|NCT03864042|450197783|FG000|DDI Phase|Adverse Event|2|||
125156664|NCT03864042|450197784|FG001|DDI Phase|Adverse Event|0|||
125156665|NCT03864042|450197785|FG002|DDI Phase|Adverse Event|0|||
125156666|NCT03864042|450197783|FG000|DDI Phase|Physician Decision|1|||
125156667|NCT03864042|450197784|FG001|DDI Phase|Physician Decision|0|||
125156668|NCT03864042|450197785|FG002|DDI Phase|Physician Decision|0|||
125156669|NCT03864042|450197783|FG000|DDI Phase|Progressive Disease|1|||
125156670|NCT03864042|450197784|FG001|DDI Phase|Progressive Disease|0|||
125156671|NCT03864042|450197785|FG002|DDI Phase|Progressive Disease|0|||
125156672|NCT03864042|450197783|FG000|Post-DDI Phase|Adverse Event|5|||
125156673|NCT03864042|450197784|FG001|Post-DDI Phase|Adverse Event|3|||
125156674|NCT03864042|450197785|FG002|Post-DDI Phase|Adverse Event|2|||
125156675|NCT03864042|450197783|FG000|Post-DDI Phase|Progressive Disease|11|||
125156676|NCT03864042|450197784|FG001|Post-DDI Phase|Progressive Disease|6|||
125156677|NCT03864042|450197785|FG002|Post-DDI Phase|Progressive Disease|13|||
125156678|NCT03864042|450197783|FG000|Post-DDI Phase|Discretion of investigator|1|||
125156679|NCT03864042|450197784|FG001|Post-DDI Phase|Discretion of investigator|1|||
125156680|NCT03864042|450197785|FG002|Post-DDI Phase|Discretion of investigator|0|||
125156681|NCT03864042|450197783|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
125156682|NCT03864042|450197784|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
125156683|NCT03864042|450197785|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
125156684|NCT03864042|450197783|FG000|Post-DDI Phase|Withdrawal of consent|1|||
125156685|NCT03864042|450197784|FG001|Post-DDI Phase|Withdrawal of consent|2|||
125156686|NCT03864042|450197785|FG002|Post-DDI Phase|Withdrawal of consent|0|||
125156687|NCT02220725|450197786|FG000|Overall Study|Lost to Follow-up|0|||
125156688|NCT02220725|450197787|FG001|Overall Study|Lost to Follow-up|0|||
125156689|NCT02220725|450197788|FG002|Overall Study|Lost to Follow-up|0|||
125156690|NCT02220725|450197789|FG003|Overall Study|Lost to Follow-up|1|||
125156691|NCT02220725|450197786|FG000|Overall Study|Withdrawal by Subject|0|||
125156692|NCT02220725|450197787|FG001|Overall Study|Withdrawal by Subject|0|||
125156693|NCT02220725|450197788|FG002|Overall Study|Withdrawal by Subject|0|||
125156694|NCT02220725|450197789|FG003|Overall Study|Withdrawal by Subject|1|||
125156695|NCT03487848|450197790|FG000|Overall Study|Lost to Follow-up|1|||
125156696|NCT00731549|450197791|FG000|Overall Study|Lost to Follow-up|19|||
125156697|NCT00731549|450197791|FG000|Overall Study|Met withdrawal criteria|24|||
125438760|NCT01115491|451233952|FG000|Overall Study|Physician Decision|1|||
125156698|NCT00731549|450197791|FG000|Overall Study|Physician Decision|16|||
125156699|NCT00731549|450197791|FG000|Overall Study|Withdrawal by Subject|89|||
125156700|NCT00731549|450197791|FG000|Overall Study|Protocol deviation|1|||
125156701|NCT00731549|450197791|FG000|Overall Study|Adverse Event|31|||
125156702|NCT00731549|450197791|FG000|Overall Study|Lack of efficacy with AE|37|||
125156703|NCT00731549|450197791|FG000|Overall Study|Lack of efficacy without AE|6|||
125438761|NCT04297241|451233953|FG000|Overall Study|Withdrawal by Subject|1|||
125438762|NCT04297241|451233953|FG000|Overall Study|Adverse Event|1|||
125438763|NCT04297241|451233953|FG000|Overall Study|Physician Decision|3|||
125156704|NCT02333487|450197792|FG000|Overall Study|Adverse Event|0|||
125156705|NCT02333487|450197793|FG001|Overall Study|Adverse Event|2|||
125156706|NCT02333487|450197794|FG002|Overall Study|Adverse Event|0|||
125438764|NCT01003639|451233954|FG000|Overall Study|Lost to Follow-up|6|||
125156707|NCT01297322|450197795|FG000|Overall Study|Lost to Follow-up|1|||
125156708|NCT01297322|450197796|FG001|Overall Study|Lost to Follow-up|0|||
125156709|NCT01297322|450197795|FG000|Overall Study|Withdrawal by Subject|0|||
125156710|NCT01297322|450197796|FG001|Overall Study|Withdrawal by Subject|1|||
125156711|NCT01297322|450197795|FG000|Overall Study|Protocol Violation|0|||
125156712|NCT01297322|450197796|FG001|Overall Study|Protocol Violation|3|||
125156713|NCT01111019|450197797|FG000|Overall Study|Withdrew Prematurely|2|||
125156714|NCT01111019|450197797|FG000|Overall Study|Other|1|||
125156715|NCT01583218|450197800|FG000|Overall Study|Withdrawal by Subject|43|||
125156716|NCT01583218|450197801|FG001|Overall Study|Withdrawal by Subject|29|||
125156717|NCT01583218|450197800|FG000|Overall Study|Death|206|||
125156718|NCT01583218|450197801|FG001|Overall Study|Death|211|||
125156719|NCT01583218|450197800|FG000|Overall Study|Lost to Follow-up|11|||
125156720|NCT01583218|450197801|FG001|Overall Study|Lost to Follow-up|17|||
125156721|NCT01583218|450197800|FG000|Overall Study|Adverse event or serious adverse event|3|||
125156722|NCT01583218|450197801|FG001|Overall Study|Adverse event or serious adverse event|3|||
125156723|NCT01583218|450197800|FG000|Overall Study|Patient /Family decision|3|||
125156724|NCT01583218|450197801|FG001|Overall Study|Patient /Family decision|0|||
125156725|NCT01583218|450197800|FG000|Overall Study|Cannot contact patient directly|1|||
125156726|NCT01583218|450197801|FG001|Overall Study|Cannot contact patient directly|2|||
125156727|NCT01583218|450197800|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
125156728|NCT01583218|450197801|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
125156729|NCT01583218|450197800|FG000|Overall Study|Patient did not wish to attend visits|0|||
125156730|NCT01583218|450197801|FG001|Overall Study|Patient did not wish to attend visits|1|||
125223874|NCT04058028|450446257|FG003|Overall Study|Death|0|||
125223875|NCT01691378|450446261|FG000|Overall Study|Withdrawal by Subject|2|||
125223876|NCT01691378|450446262|FG001|Overall Study|Withdrawal by Subject|0|||
125223877|NCT01691378|450446261|FG000|Overall Study|Lost to Follow-up|5|||
125156731|NCT01583218|450197800|FG000|Overall Study|Patient randomized but not dosed|17|||
125156732|NCT01583218|450197801|FG001|Overall Study|Patient randomized but not dosed|16|||
125156733|NCT01583218|450197800|FG000|Overall Study|Patient was assessed via phone in person|1|||
125156734|NCT01583218|450197801|FG001|Overall Study|Patient was assessed via phone in person|0|||
125156735|NCT01583218|450197800|FG000|Overall Study|Patient deemed ineligible after random|2|||
125156736|NCT01583218|450197801|FG001|Overall Study|Patient deemed ineligible after random|0|||
125156737|NCT01583218|450197800|FG000|Overall Study|Patient was early terminated from study|0|||
125156738|NCT01583218|450197801|FG001|Overall Study|Patient was early terminated from study|1|||
125156739|NCT01583218|450197800|FG000|Overall Study|Patient was randomized due to mistake|1|||
125156740|NCT01583218|450197801|FG001|Overall Study|Patient was randomized due to mistake|0|||
125156741|NCT01583218|450197800|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
125223878|NCT01691378|450446262|FG001|Overall Study|Lost to Follow-up|2|||
125156742|NCT01583218|450197801|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
125156743|NCT01583218|450197800|FG000|Overall Study|Withdraw of consent on day of random|1|||
125156744|NCT01583218|450197801|FG001|Overall Study|Withdraw of consent on day of random|0|||
125156745|NCT00712985|450197805|FG000|Overall Study|1 withdrew prior to start of drug|1|||
125156746|NCT00712985|450197805|FG000|Overall Study|1 patient moved out of state|1|||
125156747|NCT00712985|450197805|FG000|Overall Study|Lack of Efficacy|3|||
125156748|NCT01299805|450197808|FG000|Overall Study|Adverse Event|2|||
125156749|NCT01299805|450197809|FG001|Overall Study|Adverse Event|0|||
125156750|NCT03334721|450197810|FG000|Overall Study|Withdrawal by Subject|1|||
125156751|NCT03334721|450197811|FG001|Overall Study|Withdrawal by Subject|0|||
125156752|NCT03334721|450197810|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
125156753|NCT03334721|450197811|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
125156754|NCT01902628|450197812|FG000|Overall Study|Withdrawal of participant's consent|7|||
125156755|NCT01902628|450197812|FG000|Overall Study|Adverse Event|41|||
125156756|NCT01902628|450197812|FG000|Overall Study|Lost to Follow-up|35|||
125156757|NCT04969861|450197814|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
125156758|NCT04969861|450197815|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
125156759|NCT02522403|450199202|FG000|Overall Study|Lost to Follow-up|2|||
125156760|NCT02522403|450199203|FG001|Overall Study|Lost to Follow-up|2|||
125438765|NCT01003639|451233955|FG001|Overall Study|Lost to Follow-up|9|||
125438766|NCT01003639|451233954|FG000|Overall Study|Withdrawal by Subject|9|||
125438767|NCT01003639|451233955|FG001|Overall Study|Withdrawal by Subject|5|||
125156761|NCT02522403|450199202|FG000|Overall Study|Withdrawal by Subject|2|||
125156762|NCT02522403|450199203|FG001|Overall Study|Withdrawal by Subject|4|||
125438768|NCT01003639|451233954|FG000|Overall Study|Lack of Efficacy|1|||
125438769|NCT01003639|451233955|FG001|Overall Study|Lack of Efficacy|6|||
125438770|NCT01003639|451233954|FG000|Overall Study|Adverse Event|0|||
125156763|NCT04718194|450199208|FG000|Overall Study|Withdrawal by Subject|3|||
125156764|NCT04718194|450199209|FG001|Overall Study|Withdrawal by Subject|0|||
125156765|NCT04718194|450199208|FG000|Overall Study|Lost to Follow-up|3|||
125156766|NCT04718194|450199209|FG001|Overall Study|Lost to Follow-up|0|||
125438771|NCT01003639|451233955|FG001|Overall Study|Adverse Event|1|||
125438772|NCT01003639|451233954|FG000|Overall Study|Protocol Violation|0|||
125156767|NCT02091141|450199211|FG000|Overall Study|Death|280|||
125156768|NCT02091141|450199212|FG001|Overall Study|Death|118|||
125156769|NCT02091141|450199213|FG002|Overall Study|Death|46|||
125156770|NCT02091141|450199214|FG003|Overall Study|Death|13|||
125156771|NCT02091141|450199215|FG004|Overall Study|Death|31|||
125156772|NCT02091141|450199216|FG005|Overall Study|Death|16|||
125156773|NCT02091141|450199217|FG006|Overall Study|Death|12|||
125156774|NCT02091141|450199211|FG000|Overall Study|Withdrawal by Subject|21|||
125156775|NCT02091141|450199212|FG001|Overall Study|Withdrawal by Subject|13|||
125156776|NCT02091141|450199213|FG002|Overall Study|Withdrawal by Subject|3|||
125156777|NCT02091141|450199214|FG003|Overall Study|Withdrawal by Subject|2|||
125156778|NCT02091141|450199215|FG004|Overall Study|Withdrawal by Subject|2|||
125156779|NCT02091141|450199216|FG005|Overall Study|Withdrawal by Subject|3|||
125156780|NCT02091141|450199217|FG006|Overall Study|Withdrawal by Subject|0|||
125156781|NCT02091141|450199211|FG000|Overall Study|Lost to Follow-up|21|||
125156782|NCT02091141|450199212|FG001|Overall Study|Lost to Follow-up|5|||
125156783|NCT02091141|450199213|FG002|Overall Study|Lost to Follow-up|1|||
125156784|NCT02091141|450199214|FG003|Overall Study|Lost to Follow-up|0|||
125156785|NCT02091141|450199215|FG004|Overall Study|Lost to Follow-up|1|||
125156786|NCT02091141|450199216|FG005|Overall Study|Lost to Follow-up|2|||
125156787|NCT02091141|450199217|FG006|Overall Study|Lost to Follow-up|0|||
125156788|NCT02091141|450199211|FG000|Overall Study|Reason Not Specified|6|||
125156789|NCT02091141|450199212|FG001|Overall Study|Reason Not Specified|5|||
125156790|NCT02091141|450199213|FG002|Overall Study|Reason Not Specified|2|||
125156791|NCT02091141|450199214|FG003|Overall Study|Reason Not Specified|0|||
125156792|NCT02091141|450199215|FG004|Overall Study|Reason Not Specified|0|||
125156793|NCT02091141|450199216|FG005|Overall Study|Reason Not Specified|0|||
125156794|NCT02091141|450199217|FG006|Overall Study|Reason Not Specified|1|||
125156795|NCT02091141|450199211|FG000|Overall Study|Study Ended by Sponsor|1|||
125156796|NCT02091141|450199212|FG001|Overall Study|Study Ended by Sponsor|9|||
125156797|NCT02091141|450199213|FG002|Overall Study|Study Ended by Sponsor|0|||
125156798|NCT02091141|450199214|FG003|Overall Study|Study Ended by Sponsor|0|||
125156799|NCT02091141|450199215|FG004|Overall Study|Study Ended by Sponsor|0|||
125156800|NCT02091141|450199216|FG005|Overall Study|Study Ended by Sponsor|0|||
125156801|NCT02091141|450199217|FG006|Overall Study|Study Ended by Sponsor|0|||
125156802|NCT02091141|450199211|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
125156803|NCT02091141|450199212|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
125156804|NCT02091141|450199213|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
125156805|NCT02091141|450199214|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
125156806|NCT02091141|450199215|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
125156807|NCT02091141|450199216|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
125156808|NCT02091141|450199217|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
125156809|NCT00605865|450199218|FG000|Overall Study|Protocol Violation|115|||
125156810|NCT03955471|450199219|FG000|Overall Study|Death|22|||
125156811|NCT03955471|450199219|FG000|Overall Study|Lost to Follow-up|1|||
125156812|NCT03955471|450199219|FG000|Overall Study|Withdrawal by Subject|6|||
125156813|NCT03955471|450199219|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
125156814|NCT01032018|450199230|FG000|Overall Study|Lost to Follow-up|6|||
125156815|NCT01032018|450199231|FG001|Overall Study|Lost to Follow-up|5|||
125156816|NCT01032018|450199230|FG000|Overall Study|Death|0|||
125156817|NCT01032018|450199231|FG001|Overall Study|Death|1|||
125156818|NCT02119286|450199234|FG000|Overall Study|Adverse Event|9|||
125156819|NCT02119286|450199235|FG001|Overall Study|Adverse Event|7|||
125156820|NCT02119286|450199236|FG002|Overall Study|Adverse Event|2|||
125156821|NCT02119286|450199234|FG000|Overall Study|Lack of Efficacy|11|||
125389006|NCT03056755|451058032|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
125389007|NCT03056755|451058033|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
125156822|NCT02119286|450199235|FG001|Overall Study|Lack of Efficacy|3|||
125156823|NCT02119286|450199236|FG002|Overall Study|Lack of Efficacy|4|||
125156824|NCT02119286|450199234|FG000|Overall Study|Lost to Follow-up|2|||
125156825|NCT02119286|450199235|FG001|Overall Study|Lost to Follow-up|0|||
125156826|NCT02119286|450199236|FG002|Overall Study|Lost to Follow-up|1|||
125156827|NCT02119286|450199234|FG000|Overall Study|Withdrawal by Subject|4|||
125156828|NCT02119286|450199235|FG001|Overall Study|Withdrawal by Subject|1|||
125389008|NCT03056755|451058031|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
125156829|NCT02119286|450199236|FG002|Overall Study|Withdrawal by Subject|0|||
125156830|NCT03247517|450199237|FG000|Overall Study|Adverse Event|0|||
125156831|NCT03247517|450199238|FG001|Overall Study|Adverse Event|4|||
125156832|NCT03247517|450199239|FG002|Overall Study|Adverse Event|2|||
125156833|NCT03247517|450199237|FG000|Overall Study|Lost to Follow-up|2|||
125156834|NCT03247517|450199238|FG001|Overall Study|Lost to Follow-up|6|||
125156835|NCT03247517|450199239|FG002|Overall Study|Lost to Follow-up|4|||
125156836|NCT03247517|450199237|FG000|Overall Study|Consent withdrawn by caregiver|1|||
125156837|NCT03247517|450199238|FG001|Overall Study|Consent withdrawn by caregiver|4|||
125156838|NCT03247517|450199239|FG002|Overall Study|Consent withdrawn by caregiver|7|||
125156839|NCT03247517|450199237|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
125156840|NCT03247517|450199238|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
125156841|NCT03247517|450199239|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
125156842|NCT03247517|450199237|FG000|Overall Study|Protocol Violation|0|||
125156843|NCT03247517|450199238|FG001|Overall Study|Protocol Violation|2|||
125156844|NCT03247517|450199239|FG002|Overall Study|Protocol Violation|0|||
125156845|NCT03247517|450199237|FG000|Overall Study|Multiple reasons|3|||
125156846|NCT03247517|450199238|FG001|Overall Study|Multiple reasons|1|||
125156847|NCT03247517|450199239|FG002|Overall Study|Multiple reasons|0|||
125156848|NCT00619112|450199240|FG000|Overall Study|Adverse Event|1|||
125156849|NCT00619112|450199241|FG001|Overall Study|Adverse Event|2|||
125156850|NCT01996332|450199242|FG000|Overall Study|Adverse Event|117|||
125156851|NCT01996332|450199242|FG000|Overall Study|Lack of Efficacy|1245|||
125156852|NCT01996332|450199242|FG000|Overall Study|Death|264|||
125156853|NCT01996332|450199242|FG000|Overall Study|Protocol Violation|9|||
125156854|NCT01996332|450199242|FG000|Overall Study|Withdrawal by Subject|71|||
125156855|NCT01996332|450199242|FG000|Overall Study|Other|20|||
125156856|NCT01996332|450199242|FG000|Overall Study|Clinical Deterioration|28|||
125156857|NCT01996332|450199242|FG000|Overall Study|Physician Decision|17|||
125156858|NCT01996332|450199242|FG000|Overall Study|Lost to Follow-up|34|||
125156859|NCT02113189|450199243|FG000|Overall Study|Lost to follow up|2|||
125156860|NCT02113189|450199244|FG001|Overall Study|Lost to follow up|1|||
125156861|NCT02113189|450199245|FG002|Overall Study|Lost to follow up|3|||
125156862|NCT03265288|450199246|FG000|Overall Study|Adverse Event|0|||
125156863|NCT03265288|450199247|FG001|Overall Study|Adverse Event|1|||
125156864|NCT03265288|450199246|FG000|Overall Study|Withdrawal by Subject|13|||
125156865|NCT03265288|450199247|FG001|Overall Study|Withdrawal by Subject|5|||
125156866|NCT03265288|450199246|FG000|Overall Study|Drug Withdrawn|3|||
125156867|NCT03265288|450199247|FG001|Overall Study|Drug Withdrawn|3|||
125156868|NCT03265288|450199246|FG000|Overall Study|Any Other Reason|7|||
125156869|NCT03265288|450199247|FG001|Overall Study|Any Other Reason|3|||
125156870|NCT00652028|450199248|FG000|Overall Study|Adverse Event|1|||
125156871|NCT00652028|450199249|FG001|Overall Study|Adverse Event|0|||
125156872|NCT00652028|450199250|FG002|Overall Study|Adverse Event|0|||
125156873|NCT00652028|450199251|FG003|Overall Study|Adverse Event|0|||
125156874|NCT00652028|450199248|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
125156875|NCT00652028|450199249|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
125156876|NCT00652028|450199250|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
125156877|NCT00652028|450199251|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
125156878|NCT00652028|450199248|FG000|Overall Study|Physician Decision|0|||
125156879|NCT00652028|450199249|FG001|Overall Study|Physician Decision|0|||
125156880|NCT00652028|450199250|FG002|Overall Study|Physician Decision|1|||
125156881|NCT00652028|450199251|FG003|Overall Study|Physician Decision|0|||
125156882|NCT00931268|450199255|FG000|Overall Study|Lost to Follow-up|6|||
125156883|NCT00430495|450199256|FG000|Overall Study|Adverse Event|2|||
125156884|NCT00430495|450199257|FG001|Overall Study|Adverse Event|3|||
125156885|NCT00430495|450199258|FG002|Overall Study|Adverse Event|2|||
125156886|NCT00430495|450199259|FG003|Overall Study|Adverse Event|0|||
125156887|NCT00430495|450199256|FG000|Overall Study|Death|0|||
125156888|NCT00430495|450199257|FG001|Overall Study|Death|0|||
125156889|NCT00430495|450199258|FG002|Overall Study|Death|1|||
125156890|NCT00430495|450199259|FG003|Overall Study|Death|0|||
125156891|NCT00430495|450199256|FG000|Overall Study|Lost to Follow-up|0|||
125156892|NCT00430495|450199257|FG001|Overall Study|Lost to Follow-up|1|||
125156893|NCT00430495|450199258|FG002|Overall Study|Lost to Follow-up|4|||
125156894|NCT00430495|450199259|FG003|Overall Study|Lost to Follow-up|0|||
125156895|NCT00430495|450199256|FG000|Overall Study|Protocol Violation|1|||
125156896|NCT00430495|450199257|FG001|Overall Study|Protocol Violation|0|||
125156897|NCT00430495|450199258|FG002|Overall Study|Protocol Violation|1|||
125156898|NCT00430495|450199259|FG003|Overall Study|Protocol Violation|0|||
125156899|NCT00430495|450199256|FG000|Overall Study|Disease Progression|1|||
125156900|NCT00430495|450199257|FG001|Overall Study|Disease Progression|1|||
125156901|NCT00430495|450199258|FG002|Overall Study|Disease Progression|0|||
125156902|NCT00430495|450199259|FG003|Overall Study|Disease Progression|0|||
125156903|NCT00430495|450199256|FG000|Overall Study|Other|8|||
125156904|NCT00430495|450199257|FG001|Overall Study|Other|2|||
125156905|NCT00430495|450199258|FG002|Overall Study|Other|5|||
125156906|NCT00430495|450199259|FG003|Overall Study|Other|4|||
125156907|NCT00430495|450199256|FG000|Overall Study|Randomized but not Treated|2|||
125156908|NCT00430495|450199257|FG001|Overall Study|Randomized but not Treated|0|||
125156909|NCT00430495|450199258|FG002|Overall Study|Randomized but not Treated|0|||
125156910|NCT00430495|450199259|FG003|Overall Study|Randomized but not Treated|0|||
125156911|NCT02751359|450199260|FG000|Overall Study|Lost to Follow-up|1|||
125156912|NCT02400671|450199261|FG000|Overall Study|Death|5|||
125389009|NCT03056755|451058032|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
125156913|NCT02400671|450199262|FG001|Overall Study|Death|3|||
125156914|NCT02400671|450199263|FG002|Overall Study|Death|4|||
125156915|NCT02400671|450199261|FG000|Overall Study|Lost to Follow-up|20|||
125156916|NCT02400671|450199262|FG001|Overall Study|Lost to Follow-up|27|||
125156917|NCT02400671|450199263|FG002|Overall Study|Lost to Follow-up|24|||
125156918|NCT02400671|450199261|FG000|Overall Study|Withdrawal by Subject|2|||
125156919|NCT02400671|450199262|FG001|Overall Study|Withdrawal by Subject|2|||
125156920|NCT02400671|450199263|FG002|Overall Study|Withdrawal by Subject|0|||
125156921|NCT02145026|450199264|FG000|Overall Study|Adverse Event|2|||
125156922|NCT02145026|450199264|FG000|Overall Study|Death|4|||
125156923|NCT02145026|450199264|FG000|Overall Study|Withdrawal by Subject|2|||
125156924|NCT02145026|450199264|FG000|Overall Study|Physician Decision|4|||
125156925|NCT00857792|450199265|FG000|Overall Study|inadequate image quality for analysis|12|||
125156926|NCT01797835|450199266|FG000|Overall Study|Lost to Follow-up|31|||
125156927|NCT01797835|450199267|FG001|Overall Study|Lost to Follow-up|27|||
125156928|NCT04421586|450199275|FG000|Overall Study|Death|0|||
125156929|NCT04421586|450199276|FG001|Overall Study|Death|1|||
125156930|NCT04421586|450199275|FG000|Overall Study|Lost to Follow-up|2|||
125156931|NCT04421586|450199276|FG001|Overall Study|Lost to Follow-up|2|||
125156932|NCT04421586|450199275|FG000|Overall Study|Withdrawn by PI|1|||
125156933|NCT04421586|450199276|FG001|Overall Study|Withdrawn by PI|0|||
125156934|NCT04421586|450199275|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
125156935|NCT04421586|450199276|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
125156936|NCT00076804|450199278|FG000|Overall Study|Death|9|||
125156937|NCT00076804|450199279|FG001|Overall Study|Death|20|||
125156938|NCT00076804|450199278|FG000|Overall Study|Lost to Follow-up|9|||
125389010|NCT03056755|451058033|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
125156939|NCT00076804|450199279|FG001|Overall Study|Lost to Follow-up|9|||
125389011|NCT03056755|451058031|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
125389012|NCT03056755|451058032|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
125389013|NCT03056755|451058033|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
125389014|NCT03056755|451058031|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
125389015|NCT03056755|451058032|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
125389016|NCT03056755|451058033|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
125389017|NCT03615326|451058037|FG000|Overall Study|Death|266|||
125389018|NCT03615326|451058038|FG001|Overall Study|Death|286|||
125389019|NCT03615326|451058039|FG002|Overall Study|Death|14|||
125389020|NCT03615326|451058040|FG003|Overall Study|Death|17|||
125389021|NCT03615326|451058037|FG000|Overall Study|Lost to Follow-up|0|||
125389022|NCT03615326|451058038|FG001|Overall Study|Lost to Follow-up|1|||
125389023|NCT03615326|451058039|FG002|Overall Study|Lost to Follow-up|0|||
125156940|NCT00076804|450199278|FG000|Overall Study|Withdrawal by Subject|10|||
125156941|NCT00076804|450199279|FG001|Overall Study|Withdrawal by Subject|8|||
125156942|NCT00076804|450199278|FG000|Overall Study|Early study Closure|32|||
125156943|NCT00076804|450199279|FG001|Overall Study|Early study Closure|32|||
125389024|NCT03615326|451058040|FG003|Overall Study|Lost to Follow-up|0|||
125389025|NCT03615326|451058037|FG000|Overall Study|Withdrawal by Subject|1|||
125389026|NCT03615326|451058038|FG001|Overall Study|Withdrawal by Subject|3|||
125156944|NCT04295135|450199281|FG000|Overall Study|Withdrawal by Subject|2|||
125156945|NCT04295135|450199282|FG001|Overall Study|Withdrawal by Subject|1|||
125156946|NCT04295135|450199281|FG000|Overall Study|Subject left organization|8|||
125156947|NCT04295135|450199282|FG001|Overall Study|Subject left organization|4|||
125156948|NCT03484117|450199283|FG000|Overall Study|Lost to Follow-up|1|||
125156949|NCT03484117|450199284|FG001|Overall Study|Lost to Follow-up|3|||
125156950|NCT03484117|450199283|FG000|Overall Study|Declined participation in exit assess|1|||
125156951|NCT03484117|450199284|FG001|Overall Study|Declined participation in exit assess|1|||
125156952|NCT00289874|450199285|FG000|Overall Study|Adverse Event|1|||
125156953|NCT00289874|450199286|FG001|Overall Study|Adverse Event|5|||
125156954|NCT00289874|450199285|FG000|Overall Study|Lost to Follow-up|1|||
125156955|NCT00289874|450199286|FG001|Overall Study|Lost to Follow-up|1|||
125156956|NCT00289874|450199285|FG000|Overall Study|Protocol Violation|3|||
125156957|NCT00289874|450199286|FG001|Overall Study|Protocol Violation|2|||
125389027|NCT03615326|451058039|FG002|Overall Study|Withdrawal by Subject|0|||
125156958|NCT00289874|450199285|FG000|Overall Study|Did not meet eligibility|1|||
125156959|NCT00289874|450199286|FG001|Overall Study|Did not meet eligibility|0|||
125156960|NCT03835325|450199287|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
125156961|NCT03835325|450199287|FG000|Overall Study|Selection failure|1|||
125156962|NCT03852459|450199288|FG000|Overall Study|Adverse Event|2|||
125156963|NCT03852459|450199289|FG001|Overall Study|Adverse Event|2|||
125389028|NCT03615326|451058040|FG003|Overall Study|Withdrawal by Subject|0|||
125389029|NCT03615326|451058037|FG000|Overall Study|Participants Ongoing|83|||
125156964|NCT03852459|450199288|FG000|Overall Study|Withdrawal by Subject|1|||
125156965|NCT03852459|450199289|FG001|Overall Study|Withdrawal by Subject|1|||
125156966|NCT00770692|450199291|FG000|Overall Study|Withdrawal by Subject|7|||
125389030|NCT03615326|451058038|FG001|Overall Study|Participants Ongoing|58|||
125156967|NCT00770692|450199292|FG001|Overall Study|Withdrawal by Subject|9|||
125156968|NCT00770692|450199293|FG002|Overall Study|Withdrawal by Subject|9|||
125156969|NCT00770692|450199294|FG003|Overall Study|Withdrawal by Subject|6|||
125389031|NCT03615326|451058039|FG002|Overall Study|Participants Ongoing|6|||
125389032|NCT03615326|451058040|FG003|Overall Study|Participants Ongoing|3|||
125389033|NCT00405587|451058047|FG000|Overall Study|Death|0|||
125156970|NCT00770692|450199291|FG000|Overall Study|Adverse Event|3|||
125156971|NCT00770692|450199292|FG001|Overall Study|Adverse Event|0|||
125156972|NCT00770692|450199293|FG002|Overall Study|Adverse Event|4|||
125156973|NCT00770692|450199294|FG003|Overall Study|Adverse Event|4|||
125156974|NCT00770692|450199291|FG000|Overall Study|Investigator judgment|2|||
125156975|NCT00770692|450199292|FG001|Overall Study|Investigator judgment|0|||
125156976|NCT00770692|450199293|FG002|Overall Study|Investigator judgment|1|||
125389034|NCT00405587|451058048|FG001|Overall Study|Death|0|||
125389035|NCT00405587|451058049|FG002|Overall Study|Death|0|||
125389036|NCT00405587|451058050|FG003|Overall Study|Death|1|||
125389037|NCT00405587|451058047|FG000|Overall Study|Disease Progression|22|||
125389038|NCT00405587|451058048|FG001|Overall Study|Disease Progression|23|||
125389039|NCT00405587|451058049|FG002|Overall Study|Disease Progression|21|||
125156977|NCT00770692|450199294|FG003|Overall Study|Investigator judgment|1|||
125156978|NCT01138111|450199296|FG000|Overall Study|Withdrawal by Subject|5|||
125156979|NCT01138111|450199296|FG000|Overall Study|Adverse Event|1|||
125156980|NCT01138111|450199296|FG000|Overall Study|Death|1|||
125156981|NCT01138111|450199296|FG000|Overall Study|Lost to Follow-up|2|||
125156982|NCT00560937|450199299|FG000|Overall Study|Withdrawal by Subject|0|||
125156983|NCT00560937|450199300|FG001|Overall Study|Withdrawal by Subject|1|||
125156984|NCT00560937|450199299|FG000|Overall Study|Physician Decision|1|||
125156985|NCT00560937|450199300|FG001|Overall Study|Physician Decision|1|||
125156986|NCT03629028|450199301|FG000|Overall Study|Lost to Follow-up|26|||
125156987|NCT03629028|450199302|FG001|Overall Study|Lost to Follow-up|23|||
125156988|NCT03629028|450199301|FG000|Overall Study|Pregnancy|4|||
125156989|NCT03629028|450199302|FG001|Overall Study|Pregnancy|2|||
125156990|NCT03629028|450199301|FG000|Overall Study|intolerance to examination|2|||
125156991|NCT03629028|450199302|FG001|Overall Study|intolerance to examination|0|||
125156992|NCT02687360|450199307|FG000|Overall Study|Withdrawal by Subject|3|||
125156993|NCT02687360|450199308|FG001|Overall Study|Withdrawal by Subject|0|||
125156994|NCT02989168|450199309|FG000|Overall Study|Withdrawal by Subject|2|||
125156995|NCT02989168|450199310|FG001|Overall Study|Withdrawal by Subject|0|||
125156996|NCT02989168|450199309|FG000|Overall Study|Physician Decision|0|||
125156997|NCT02989168|450199310|FG001|Overall Study|Physician Decision|1|||
125156998|NCT02989168|450199309|FG000|Overall Study|Adverse Event|1|||
125156999|NCT02989168|450199310|FG001|Overall Study|Adverse Event|2|||
125157000|NCT02989168|450199309|FG000|Overall Study|Sponsor stopped study.|1|||
125157001|NCT02989168|450199310|FG001|Overall Study|Sponsor stopped study.|0|||
125157002|NCT01846273|450199311|FG000|Overall Study|Adverse Event|9|||
125157003|NCT01846273|450199312|FG001|Overall Study|Adverse Event|7|||
125157004|NCT01846273|450199313|FG002|Overall Study|Adverse Event|0|||
125157005|NCT01846273|450199311|FG000|Overall Study|Subject withdrew consent|5|||
125157006|NCT01846273|450199312|FG001|Overall Study|Subject withdrew consent|8|||
125157007|NCT01846273|450199313|FG002|Overall Study|Subject withdrew consent|0|||
125157008|NCT01846273|450199311|FG000|Overall Study|Lost to Follow-up|2|||
125157009|NCT01846273|450199312|FG001|Overall Study|Lost to Follow-up|1|||
125157010|NCT01846273|450199313|FG002|Overall Study|Lost to Follow-up|0|||
125157011|NCT01846273|450199311|FG000|Overall Study|Administrative problems|1|||
125157012|NCT01846273|450199312|FG001|Overall Study|Administrative problems|0|||
125157013|NCT01846273|450199313|FG002|Overall Study|Administrative problems|0|||
125157014|NCT01846273|450199311|FG000|Overall Study|Death|2|||
125157015|NCT01846273|450199312|FG001|Overall Study|Death|1|||
125157016|NCT01846273|450199313|FG002|Overall Study|Death|0|||
125157017|NCT01846273|450199311|FG000|Overall Study|Disease Progression|0|||
125157018|NCT01846273|450199312|FG001|Overall Study|Disease Progression|4|||
125157019|NCT01846273|450199313|FG002|Overall Study|Disease Progression|0|||
125157020|NCT01846273|450199311|FG000|Overall Study|Protocol Deviation|2|||
125157021|NCT01846273|450199312|FG001|Overall Study|Protocol Deviation|3|||
125157022|NCT01846273|450199313|FG002|Overall Study|Protocol Deviation|0|||
125157023|NCT01846273|450199311|FG000|Overall Study|Physician Decision|1|||
125157024|NCT01846273|450199312|FG001|Overall Study|Physician Decision|2|||
125157025|NCT01846273|450199313|FG002|Overall Study|Physician Decision|0|||
125157026|NCT00456495|450199316|FG000|Overall Study|Physician Decision|2|||
125157027|NCT02939014|450199317|FG000|Overall Study|Lost to Follow-up|1|||
125157028|NCT02939014|450199318|FG001|Overall Study|Lost to Follow-up|0|||
125157029|NCT02939014|450199317|FG000|Overall Study|Death|4|||
125157030|NCT02939014|450199318|FG001|Overall Study|Death|3|||
125157031|NCT05069155|450199319|FG000|Overall Study|Withdrawal by Subject|1|||
125157032|NCT05069155|450199320|FG001|Overall Study|Withdrawal by Subject|3|||
125157033|NCT02674061|450199321|FG000|Overall Study|Death|229|||
125157034|NCT02674061|450199322|FG001|Overall Study|Death|77|||
125157035|NCT02674061|450199321|FG000|Overall Study|Lost to Follow-up|3|||
125157036|NCT02674061|450199322|FG001|Overall Study|Lost to Follow-up|3|||
125157037|NCT02674061|450199321|FG000|Overall Study|Withdrawal by Subject|9|||
125157038|NCT02674061|450199322|FG001|Overall Study|Withdrawal by Subject|1|||
125157039|NCT02674061|450199321|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
125157040|NCT02674061|450199322|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
125157041|NCT01558297|450199328|FG000|Overall Study|Withdrawal by Subject|2|||
125157042|NCT01558297|450199329|FG001|Overall Study|Withdrawal by Subject|2|||
125389040|NCT00405587|451058050|FG003|Overall Study|Disease Progression|17|||
125157043|NCT01558297|450199330|FG002|Overall Study|Withdrawal by Subject|1|||
125157044|NCT01334710|450199331|FG000|Overall Study|Trial was terminated|3|||
125157045|NCT00375492|450199332|FG000|Overall Study|Adverse Event|4|||
125157046|NCT00375492|450199333|FG001|Overall Study|Adverse Event|5|||
125157047|NCT00375492|450199332|FG000|Overall Study|Entry Criteria Not Met|0|||
125157048|NCT00375492|450199333|FG001|Overall Study|Entry Criteria Not Met|1|||
125157049|NCT00375492|450199332|FG000|Overall Study|Loss of Glucose Control|0|||
125157050|NCT00375492|450199333|FG001|Overall Study|Loss of Glucose Control|1|||
125157051|NCT00375492|450199332|FG000|Overall Study|Lost to Follow-up|10|||
125157052|NCT00375492|450199333|FG001|Overall Study|Lost to Follow-up|5|||
125157053|NCT00375492|450199332|FG000|Overall Study|Physician Decision|0|||
125157054|NCT00375492|450199333|FG001|Overall Study|Physician Decision|4|||
125157055|NCT00375492|450199332|FG000|Overall Study|Protocol Violation|6|||
125157056|NCT00375492|450199333|FG001|Overall Study|Protocol Violation|3|||
125157057|NCT00375492|450199332|FG000|Overall Study|Sponsor Decision|0|||
125157058|NCT00375492|450199333|FG001|Overall Study|Sponsor Decision|1|||
125157059|NCT00375492|450199332|FG000|Overall Study|Withdrawal by Subject|6|||
125157060|NCT00375492|450199333|FG001|Overall Study|Withdrawal by Subject|6|||
125157061|NCT01232491|450199334|FG000|Overall Study|Adverse Event|13|||
125157062|NCT01232491|450199335|FG001|Overall Study|Adverse Event|8|||
125157063|NCT01232491|450199334|FG000|Overall Study|Lack of Efficacy|1|||
125157064|NCT01232491|450199335|FG001|Overall Study|Lack of Efficacy|5|||
125157065|NCT01232491|450199334|FG000|Overall Study|Protocol Violation|13|||
125157066|NCT01232491|450199335|FG001|Overall Study|Protocol Violation|11|||
125157067|NCT01232491|450199334|FG000|Overall Study|Withdrawal Criteria|12|||
125157068|NCT01232491|450199335|FG001|Overall Study|Withdrawal Criteria|21|||
125157069|NCT01232491|450199334|FG000|Overall Study|Other|21|||
125157070|NCT01232491|450199335|FG001|Overall Study|Other|18|||
125157071|NCT03340064|450200742|FG000|First Period|Adverse Event, non-fatal|2|||
125157072|NCT03340064|450200743|FG001|First Period|Adverse Event, non-fatal|0|||
125157073|NCT03340064|450200742|FG000|First Period|Lack of Efficacy|3|||
125157074|NCT03340064|450200743|FG001|First Period|Lack of Efficacy|0|||
125157075|NCT03340064|450200742|FG000|Second Period|Adverse Event, non-fatal|1|||
125157076|NCT03340064|450200743|FG001|Second Period|Adverse Event, non-fatal|1|||
125157077|NCT03340064|450200742|FG000|Second Period|Lack of Efficacy|11|||
125157078|NCT03340064|450200743|FG001|Second Period|Lack of Efficacy|0|||
125157079|NCT03340064|450200742|FG000|Second Period|Physician Decision|3|||
125157080|NCT03340064|450200743|FG001|Second Period|Physician Decision|0|||
125157081|NCT03340064|450200742|FG000|Second Period|Withdrawal by Subject|2|||
125157082|NCT03340064|450200743|FG001|Second Period|Withdrawal by Subject|1|||
125157083|NCT03340064|450200742|FG000|Second Period|Approved Drug Available For Indication|1|||
125157084|NCT03340064|450200743|FG001|Second Period|Approved Drug Available For Indication|0|||
125157085|NCT03340064|450200742|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
125157086|NCT03340064|450200743|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
125157087|NCT00856973|450200746|FG000|Overall Study|Adverse Event|5|||
125157088|NCT00856973|450200747|FG001|Overall Study|Adverse Event|5|||
125157089|NCT00856973|450200748|FG002|Overall Study|Adverse Event|3|||
125157090|NCT00856973|450200746|FG000|Overall Study|Lost to Follow-up|6|||
125157091|NCT00856973|450200747|FG001|Overall Study|Lost to Follow-up|3|||
125157092|NCT00856973|450200748|FG002|Overall Study|Lost to Follow-up|5|||
125157093|NCT00856973|450200746|FG000|Overall Study|Physician Decision|0|||
125157094|NCT00856973|450200747|FG001|Overall Study|Physician Decision|3|||
125157095|NCT00856973|450200748|FG002|Overall Study|Physician Decision|1|||
125157096|NCT00856973|450200746|FG000|Overall Study|Protocol Violation|1|||
125157097|NCT00856973|450200747|FG001|Overall Study|Protocol Violation|2|||
125157098|NCT00856973|450200748|FG002|Overall Study|Protocol Violation|1|||
125157099|NCT00856973|450200746|FG000|Overall Study|Withdrawal by Subject|13|||
125157100|NCT00856973|450200747|FG001|Overall Study|Withdrawal by Subject|16|||
125157101|NCT00856973|450200748|FG002|Overall Study|Withdrawal by Subject|15|||
125157102|NCT00856973|450200746|FG000|Overall Study|Other|11|||
125157103|NCT00856973|450200747|FG001|Overall Study|Other|12|||
125157104|NCT00856973|450200748|FG002|Overall Study|Other|13|||
125157105|NCT03439852|450200750|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
125157106|NCT03439852|450200751|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
125157107|NCT03439852|450200750|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
125157108|NCT03439852|450200751|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
125157109|NCT03439852|450200750|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
125157110|NCT03439852|450200751|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
125157111|NCT04556552|450200754|FG000|Overall Study|Lost to Follow-up|1|||
125157112|NCT04556552|450200755|FG001|Overall Study|Lost to Follow-up|0|||
125157113|NCT04556552|450200754|FG000|Overall Study|Claustrophobia|0|||
125157114|NCT04556552|450200755|FG001|Overall Study|Claustrophobia|1|||
125157115|NCT04556552|450200754|FG000|Overall Study|Inability to continue|0|||
125157116|NCT04556552|450200755|FG001|Overall Study|Inability to continue|1|||
125157117|NCT01215513|450200756|FG000|Overall Study|Not completed CS42|9|||
125157118|NCT01215513|450200756|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
125157119|NCT01215513|450200756|FG000|Overall Study|Adverse event (CS42A)|2|||
125389041|NCT00405587|451058047|FG000|Overall Study|Physician Decision|3|||
125389042|NCT00405587|451058048|FG001|Overall Study|Physician Decision|2|||
125389043|NCT00405587|451058049|FG002|Overall Study|Physician Decision|0|||
125157120|NCT01215513|450200756|FG000|Overall Study|Physician decision (CS42A)|6|||
125157121|NCT01215513|450200756|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
125157122|NCT01215513|450200756|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
125157123|NCT00793780|450200759|FG000|Overall Study|Withdrawal by Subject|2|||
125157124|NCT00793780|450200760|FG001|Overall Study|Withdrawal by Subject|1|||
125157125|NCT02858492|450200761|FG000|Overall Study|Withdrawal by Subject|0|||
125157126|NCT02858492|450200762|FG001|Overall Study|Withdrawal by Subject|1|||
125157127|NCT02858492|450200763|FG002|Overall Study|Withdrawal by Subject|0|||
125157128|NCT02858492|450200764|FG003|Overall Study|Withdrawal by Subject|1|||
125157129|NCT02858492|450200761|FG000|Overall Study|Adverse Event|0|||
125157130|NCT02858492|450200762|FG001|Overall Study|Adverse Event|0|||
125157131|NCT02858492|450200763|FG002|Overall Study|Adverse Event|0|||
125157132|NCT02858492|450200764|FG003|Overall Study|Adverse Event|3|||
125157133|NCT02858492|450200761|FG000|Overall Study|Lack of Efficacy|0|||
125157134|NCT02858492|450200762|FG001|Overall Study|Lack of Efficacy|0|||
125157135|NCT02858492|450200763|FG002|Overall Study|Lack of Efficacy|0|||
125157136|NCT02858492|450200764|FG003|Overall Study|Lack of Efficacy|1|||
125157137|NCT02858492|450200761|FG000|Overall Study|Protocol defined stopping criteria|0|||
125157138|NCT02858492|450200762|FG001|Overall Study|Protocol defined stopping criteria|0|||
125157139|NCT02858492|450200763|FG002|Overall Study|Protocol defined stopping criteria|0|||
125157140|NCT02858492|450200764|FG003|Overall Study|Protocol defined stopping criteria|1|||
125157141|NCT02040779|450200769|FG000|Overall Study|Adverse Event|1|||
125157142|NCT02040779|450200770|FG001|Overall Study|Adverse Event|0|||
125157143|NCT02040779|450200771|FG002|Overall Study|Adverse Event|0|||
125157144|NCT02040779|450200769|FG000|Overall Study|Withdrawal by Subject|4|||
125157145|NCT02040779|450200770|FG001|Overall Study|Withdrawal by Subject|1|||
125157146|NCT02040779|450200771|FG002|Overall Study|Withdrawal by Subject|3|||
125157147|NCT02040779|450200769|FG000|Overall Study|Non-compliance|0|||
125157148|NCT02040779|450200770|FG001|Overall Study|Non-compliance|1|||
125157149|NCT02040779|450200771|FG002|Overall Study|Non-compliance|0|||
125157150|NCT02040779|450200769|FG000|Overall Study|Protocol Violation|2|||
125157151|NCT02040779|450200770|FG001|Overall Study|Protocol Violation|1|||
125157152|NCT02040779|450200771|FG002|Overall Study|Protocol Violation|0|||
125157153|NCT02040779|450200769|FG000|Overall Study|Lost to Follow-up|1|||
125157154|NCT02040779|450200770|FG001|Overall Study|Lost to Follow-up|2|||
125157155|NCT02040779|450200771|FG002|Overall Study|Lost to Follow-up|1|||
125157156|NCT02040779|450200769|FG000|Overall Study|Lack of Efficacy|4|||
125157157|NCT02040779|450200770|FG001|Overall Study|Lack of Efficacy|2|||
125157158|NCT02040779|450200771|FG002|Overall Study|Lack of Efficacy|0|||
125157159|NCT02132637|450200772|FG000|Study Period 1|Withdrawal by Subject|0|||
125157160|NCT02132637|450200773|FG001|Study Period 1|Withdrawal by Subject|4|||
125157161|NCT02132637|450200772|FG000|Study Period 1|Physician Decision|1|||
125157162|NCT02132637|450200773|FG001|Study Period 1|Physician Decision|0|||
125157163|NCT02132637|450200772|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
125157164|NCT02132637|450200773|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
125157165|NCT02132637|450200772|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
125157166|NCT02132637|450200773|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
125157167|NCT00127036|450200781|FG000|Overall Study|Insufficient Data for Analysis|6|||
125157168|NCT00127036|450200782|FG001|Overall Study|Insufficient Data for Analysis|11|||
125157169|NCT00127036|450200781|FG000|Overall Study|Screen Failure|2|||
125157170|NCT00127036|450200782|FG001|Overall Study|Screen Failure|0|||
125157171|NCT03656874|450200785|FG000|Overall Study|Lost to Follow-up|3|||
125157172|NCT03656874|450200786|FG001|Overall Study|Lost to Follow-up|17|||
125157173|NCT00584844|450200787|FG000|Overall Study|Withdrawal by Subject|59|||
125157174|NCT00584844|450200787|FG000|Overall Study|Screen Failure|20|||
125157175|NCT01195103|450200788|FG000|Overall Study|Withdrawal by Subject|1|||
125157176|NCT01195103|450200789|FG001|Overall Study|Withdrawal by Subject|0|||
125157177|NCT01195103|450200790|FG002|Overall Study|Withdrawal by Subject|0|||
125157178|NCT03760250|450200791|FG000|Overall Study|Withdrawal by Subject|1|||
125157179|NCT03760250|450200791|FG000|Overall Study|Physician Decision|1|||
125157180|NCT01615263|450200792|FG000|Overall Study|Post-randomization exclusion|0|||
125157181|NCT01615263|450200793|FG001|Overall Study|Post-randomization exclusion|2|||
125157182|NCT00857259|450200794|FG000|Overall Study|Protocol Violation|1|||
125157183|NCT00857259|450200795|FG001|Overall Study|Protocol Violation|0|||
125389044|NCT00405587|451058050|FG003|Overall Study|Physician Decision|0|||
125157184|NCT00857259|450200796|FG002|Overall Study|Protocol Violation|1|||
125157185|NCT02701413|450200797|FG000|Overall Study|Withdrawal by Subject|7|||
125157186|NCT02701413|450200798|FG001|Overall Study|Withdrawal by Subject|11|||
125157187|NCT01370213|450200799|FG000|Overall Study|Early Death|1|||
125157188|NCT01370213|450200800|FG001|Overall Study|Early Death|0|||
125157189|NCT01370213|450200801|FG002|Overall Study|Early Death|0|||
125157190|NCT01370213|450200799|FG000|Overall Study|Not evaluable|0|||
125157191|NCT01370213|450200800|FG001|Overall Study|Not evaluable|2|||
125157192|NCT01370213|450200801|FG002|Overall Study|Not evaluable|0|||
125157193|NCT01621191|450200807|FG000|Overall Study|Adverse Event|9|||
125157194|NCT01621191|450200807|FG000|Overall Study|Withdrawal by Subject|8|||
125157195|NCT01621191|450200807|FG000|Overall Study|Lack of Efficacy|6|||
125157196|NCT01621191|450200807|FG000|Overall Study|Lost to Follow-up|1|||
125157197|NCT01621191|450200807|FG000|Overall Study|Site Removed From Study|1|||
125157198|NCT01782482|450200812|FG000|Overall Study|Adverse Event|2|||
125157199|NCT01782482|450200813|FG001|Overall Study|Adverse Event|1|||
125157200|NCT01782482|450200812|FG000|Overall Study|Lost to Follow-up|2|||
125157201|NCT01782482|450200813|FG001|Overall Study|Lost to Follow-up|3|||
125157202|NCT01782482|450200812|FG000|Overall Study|Physician Decision|1|||
125157203|NCT01782482|450200813|FG001|Overall Study|Physician Decision|0|||
125157204|NCT01782482|450200812|FG000|Overall Study|Protocol Violation|1|||
125157205|NCT01782482|450200813|FG001|Overall Study|Protocol Violation|0|||
125157206|NCT01782482|450200812|FG000|Overall Study|Withdrawal by Subject|2|||
125157207|NCT01782482|450200813|FG001|Overall Study|Withdrawal by Subject|3|||
125157208|NCT01782482|450200812|FG000|Overall Study|Randomized in Error|2|||
125157209|NCT01782482|450200813|FG001|Overall Study|Randomized in Error|2|||
125157210|NCT01782482|450200812|FG000|Overall Study|Habitually wearing toric lens OS|0|||
125157211|NCT01782482|450200813|FG001|Overall Study|Habitually wearing toric lens OS|1|||
125157212|NCT00038649|450200815|FG000|Overall Study|Adverse Event|9|||
125157213|NCT01321008|450200816|FG000|Overall Study|Early Study Termination|1|||
125157214|NCT02749292|450200821|FG000|Overall Study|Physician Decision|1|||
125157215|NCT02749292|450200822|FG001|Overall Study|Physician Decision|0|||
125157216|NCT02749292|450200821|FG000|Overall Study|Withdrawal by Subject|5|||
125157217|NCT02749292|450200822|FG001|Overall Study|Withdrawal by Subject|7|||
125157218|NCT02749292|450200821|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
125157219|NCT02749292|450200822|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
125157220|NCT02749292|450200821|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
125157221|NCT02749292|450200822|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
125157222|NCT02749292|450200821|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
125157223|NCT02749292|450200822|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
125157224|NCT02749292|450200821|FG000|Overall Study|Adverse Event|4|||
125157225|NCT02749292|450200822|FG001|Overall Study|Adverse Event|1|||
125157226|NCT02749292|450200821|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
125157227|NCT02749292|450200822|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
125157228|NCT02749292|450200821|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
125157229|NCT02749292|450200822|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
125157230|NCT02749292|450200821|FG000|Overall Study|Requiring glucocorticoids|0|||
125157231|NCT02749292|450200822|FG001|Overall Study|Requiring glucocorticoids|3|||
125157232|NCT02749292|450200821|FG000|Overall Study|Cancer|1|||
125157233|NCT02749292|450200822|FG001|Overall Study|Cancer|0|||
125157234|NCT02458092|450200823|FG000|Overall Study|Withdrawal by Subject|1|||
125157235|NCT02458092|450200824|FG001|Overall Study|Withdrawal by Subject|0|||
125157236|NCT00251641|450200827|FG000|Overall Study|Adverse Event|80|||
125157237|NCT00251641|450200828|FG001|Overall Study|Adverse Event|8|||
125157238|NCT00251641|450200827|FG000|Overall Study|Lack of Efficacy|2|||
125157239|NCT00251641|450200828|FG001|Overall Study|Lack of Efficacy|1|||
125157240|NCT00251641|450200827|FG000|Overall Study|Progression of Disease|0|||
125157241|NCT00251641|450200828|FG001|Overall Study|Progression of Disease|2|||
125157242|NCT00251641|450200827|FG000|Overall Study|Lost to Follow-up|3|||
125157243|NCT00251641|450200828|FG001|Overall Study|Lost to Follow-up|3|||
125157244|NCT00251641|450200827|FG000|Overall Study|Withdrawal by Subject|6|||
125157245|NCT00251641|450200828|FG001|Overall Study|Withdrawal by Subject|8|||
125157246|NCT00251641|450200827|FG000|Overall Study|Protocol Violation|10|||
125157247|NCT00251641|450200828|FG001|Overall Study|Protocol Violation|2|||
125157248|NCT00251641|450200827|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
125157249|NCT00251641|450200828|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
125157250|NCT00251641|450200827|FG000|Overall Study|Switched Treatment|9|||
125157251|NCT00251641|450200828|FG001|Overall Study|Switched Treatment|63|||
125157252|NCT02093221|450200831|FG000|Overall Study|Adverse Event|1|||
125157253|NCT02093221|450200832|FG001|Overall Study|Adverse Event|0|||
125157254|NCT02093221|450200833|FG002|Overall Study|Adverse Event|0|||
125157255|NCT02093221|450200834|FG003|Overall Study|Adverse Event|0|||
125157256|NCT02093221|450200835|FG004|Overall Study|Adverse Event|0|||
125157257|NCT02093221|450200831|FG000|Overall Study|Withdrawal by Subject|1|||
125157258|NCT02093221|450200832|FG001|Overall Study|Withdrawal by Subject|1|||
125157259|NCT02093221|450200833|FG002|Overall Study|Withdrawal by Subject|4|||
125157260|NCT02093221|450200834|FG003|Overall Study|Withdrawal by Subject|1|||
125157261|NCT02093221|450200835|FG004|Overall Study|Withdrawal by Subject|1|||
125157262|NCT02093221|450200831|FG000|Overall Study|Lost to Follow-up|2|||
125157263|NCT02093221|450200832|FG001|Overall Study|Lost to Follow-up|0|||
125157264|NCT02093221|450200833|FG002|Overall Study|Lost to Follow-up|1|||
125157265|NCT02093221|450200834|FG003|Overall Study|Lost to Follow-up|1|||
125157266|NCT02093221|450200835|FG004|Overall Study|Lost to Follow-up|0|||
125157267|NCT02093221|450200831|FG000|Overall Study|Death|0|||
125157268|NCT02093221|450200832|FG001|Overall Study|Death|1|||
125157269|NCT02093221|450200833|FG002|Overall Study|Death|0|||
125157270|NCT02093221|450200834|FG003|Overall Study|Death|0|||
125157271|NCT02093221|450200835|FG004|Overall Study|Death|0|||
125157272|NCT02093221|450200831|FG000|Overall Study|Protocol Violation|0|||
125157273|NCT02093221|450200832|FG001|Overall Study|Protocol Violation|1|||
125157274|NCT02093221|450200833|FG002|Overall Study|Protocol Violation|0|||
125157275|NCT02093221|450200834|FG003|Overall Study|Protocol Violation|0|||
125157276|NCT02093221|450200835|FG004|Overall Study|Protocol Violation|0|||
125157277|NCT02093221|450200831|FG000|Overall Study|Study termination|6|||
125157278|NCT02093221|450200832|FG001|Overall Study|Study termination|5|||
125157279|NCT02093221|450200833|FG002|Overall Study|Study termination|4|||
125157280|NCT02093221|450200834|FG003|Overall Study|Study termination|6|||
125157281|NCT02093221|450200835|FG004|Overall Study|Study termination|7|||
125157282|NCT00257920|450200838|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
125157283|NCT00257920|450200839|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
125157284|NCT00257920|450200838|FG000|Period: Second Intervention|Other|2|||
125157285|NCT00257920|450200839|FG001|Period: Second Intervention|Other|1|||
125157286|NCT03097588|450200847|FG000|Overall Study|Adverse Event|1|||
125157287|NCT03456960|450200848|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
125157288|NCT03456960|450200849|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
125157289|NCT03456960|450200850|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
125157290|NCT03456960|450200851|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
125157291|NCT03456960|450200852|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
125157292|NCT03456960|450200853|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
125157293|NCT03456960|450200848|FG000|Period 2 (1 Day)|Adverse Event|1|||
125157294|NCT03456960|450200849|FG001|Period 2 (1 Day)|Adverse Event|0|||
125157295|NCT03456960|450200850|FG002|Period 2 (1 Day)|Adverse Event|0|||
125157296|NCT03456960|450200851|FG003|Period 2 (1 Day)|Adverse Event|1|||
125157297|NCT03456960|450200852|FG004|Period 2 (1 Day)|Adverse Event|0|||
125157298|NCT03456960|450200853|FG005|Period 2 (1 Day)|Adverse Event|0|||
125157299|NCT00653991|450200854|FG000|3 Month Follow-up|Participant would not respond|150|||
125157300|NCT00653991|450200855|FG001|3 Month Follow-up|Participant would not respond|157|||
125157301|NCT00653991|450200854|FG000|6 Month Follow-up|Participant would not respond|133|||
125157302|NCT00653991|450200855|FG001|6 Month Follow-up|Participant would not respond|141|||
125157303|NCT00891839|450200856|FG000|Overall Study|Adverse Event|2|||
125157304|NCT00891839|450200856|FG000|Overall Study|Withdrawal by Subject|2|||
125157305|NCT00891839|450200856|FG000|Overall Study|Disease progression|3|||
125157306|NCT03828448|450200857|FG000|Overall Study|Sponsor's Discretion|34|||
125157307|NCT02037165|450200858|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
125157308|NCT02037165|450200859|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
125157309|NCT02037165|450200860|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
125157310|NCT02037165|450200861|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
125157311|NCT02037165|450200862|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
125157312|NCT00532935|450200863|FG000|Overall Study|Adverse Event|11|||
125157313|NCT00532935|450200864|FG001|Overall Study|Adverse Event|12|||
125157314|NCT00532935|450200863|FG000|Overall Study|Lack of Efficacy|0|||
125157315|NCT00532935|450200864|FG001|Overall Study|Lack of Efficacy|3|||
125157316|NCT00532935|450200863|FG000|Overall Study|Lost to Follow-up|10|||
125157317|NCT00532935|450200864|FG001|Overall Study|Lost to Follow-up|6|||
125157318|NCT00532935|450200863|FG000|Overall Study|Physician Decision|4|||
125157319|NCT00532935|450200864|FG001|Overall Study|Physician Decision|5|||
125157320|NCT00532935|450200863|FG000|Overall Study|Pregnancy|1|||
125157321|NCT00532935|450200864|FG001|Overall Study|Pregnancy|0|||
125157322|NCT00532935|450200863|FG000|Overall Study|Protocol Violation|4|||
125157323|NCT00532935|450200864|FG001|Overall Study|Protocol Violation|2|||
125157324|NCT00532935|450200863|FG000|Overall Study|Withdrawal by Subject|10|||
125157325|NCT00532935|450200864|FG001|Overall Study|Withdrawal by Subject|9|||
125157326|NCT00532935|450200863|FG000|Overall Study|Protocol Specific Criteria|11|||
125157327|NCT00532935|450200864|FG001|Overall Study|Protocol Specific Criteria|15|||
125157328|NCT01300923|450200865|FG000|Overall Study|Physician Decision|0|||
125157329|NCT01300923|450200866|FG001|Overall Study|Physician Decision|2|||
125157330|NCT01568866|450200867|FG000|Overall Study|Disease Progression|208|||
125157331|NCT01568866|450200868|FG001|Overall Study|Disease Progression|183|||
125157332|NCT01568866|450200867|FG000|Overall Study|Adverse Event|94|||
125157333|NCT01568866|450200868|FG001|Overall Study|Adverse Event|96|||
125157334|NCT01568866|450200867|FG000|Overall Study|Patient Request|55|||
125157335|NCT01568866|450200868|FG001|Overall Study|Patient Request|71|||
125157336|NCT01568866|450200867|FG000|Overall Study|Physician Decision|40|||
125157337|NCT01568866|450200868|FG001|Overall Study|Physician Decision|32|||
125157338|NCT01568866|450200867|FG000|Overall Study|Withdrawal by Subject|19|||
125157339|NCT01568866|450200868|FG001|Overall Study|Withdrawal by Subject|11|||
125157340|NCT01568866|450200867|FG000|Overall Study|Death|10|||
125157341|NCT01568866|450200868|FG001|Overall Study|Death|18|||
125157342|NCT01568866|450200867|FG000|Overall Study|Protocol Non-compliance|2|||
125157343|NCT01568866|450200868|FG001|Overall Study|Protocol Non-compliance|4|||
125157344|NCT01568866|450200867|FG000|Overall Study|Lost to Follow-up|1|||
125157345|NCT01568866|450200868|FG001|Overall Study|Lost to Follow-up|0|||
125157346|NCT01568866|450200867|FG000|Overall Study|Randomized but Not Dosed|9|||
125157347|NCT01568866|450200868|FG001|Overall Study|Randomized but Not Dosed|1|||
125157348|NCT01698775|450200869|FG000|Phase A|Adverse Event|2|||
125157349|NCT01698775|450200870|FG001|Phase A|Adverse Event|1|||
125157350|NCT01698775|450200869|FG000|Phase A|Death|1|||
125157351|NCT01698775|450200870|FG001|Phase A|Death|1|||
125157352|NCT01698775|450200869|FG000|Phase A|Lack of Efficacy|1|||
125157353|NCT01698775|450200870|FG001|Phase A|Lack of Efficacy|0|||
125157354|NCT01698775|450200869|FG000|Phase A|Lost to Follow-up|1|||
125157355|NCT01698775|450200870|FG001|Phase A|Lost to Follow-up|2|||
125157356|NCT01698775|450200869|FG000|Phase A|Protocol Violation|1|||
125157357|NCT01698775|450200870|FG001|Phase A|Protocol Violation|0|||
125157358|NCT01698775|450200869|FG000|Phase A|Withdrawal by Subject|3|||
125157359|NCT01698775|450200870|FG001|Phase A|Withdrawal by Subject|4|||
125157360|NCT01698775|450200869|FG000|Phase A|Kidney [transplant]|0|||
125157361|NCT01698775|450200870|FG001|Phase A|Kidney [transplant]|1|||
125157362|NCT01698775|450200869|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
125157363|NCT01698775|450200870|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
125157364|NCT01698775|450200869|FG000|Phase B|Adverse Event|6|||
125157365|NCT01698775|450200870|FG001|Phase B|Adverse Event|3|||
125157366|NCT01698775|450200869|FG000|Phase B|Death|0|||
125157367|NCT01698775|450200870|FG001|Phase B|Death|1|||
125157368|NCT01698775|450200869|FG000|Phase B|Lack of Efficacy|0|||
125157369|NCT01698775|450200870|FG001|Phase B|Lack of Efficacy|1|||
125157370|NCT01698775|450200869|FG000|Phase B|Lost to Follow-up|0|||
125157371|NCT01698775|450200870|FG001|Phase B|Lost to Follow-up|1|||
125157372|NCT01698775|450200869|FG000|Phase B|Physician Decision|1|||
125157373|NCT01698775|450200870|FG001|Phase B|Physician Decision|1|||
125157374|NCT01698775|450200869|FG000|Phase B|Protocol Violation|1|||
125157375|NCT01698775|450200870|FG001|Phase B|Protocol Violation|1|||
125157376|NCT01698775|450200869|FG000|Phase B|Withdrawal by Subject|6|||
125157377|NCT01698775|450200870|FG001|Phase B|Withdrawal by Subject|2|||
125157378|NCT01244061|450200873|FG000|Overall Study|Death|1|||
125157379|NCT01244061|450200874|FG001|Overall Study|Death|0|||
125157380|NCT01244061|450200873|FG000|Overall Study|Did not meet entrance criteria|1|||
125157381|NCT01244061|450200874|FG001|Overall Study|Did not meet entrance criteria|0|||
125157382|NCT01244061|450200873|FG000|Overall Study|Lack of Efficacy|1|||
125157383|NCT01244061|450200874|FG001|Overall Study|Lack of Efficacy|3|||
125157384|NCT01244061|450200873|FG000|Overall Study|Lost to Follow-up|34|||
125157385|NCT01244061|450200874|FG001|Overall Study|Lost to Follow-up|30|||
125157386|NCT01244061|450200873|FG000|Overall Study|Withdrawal by Subject|29|||
125157387|NCT01244061|450200874|FG001|Overall Study|Withdrawal by Subject|46|||
125157388|NCT01244061|450200873|FG000|Overall Study|Other|8|||
125157389|NCT01244061|450200874|FG001|Overall Study|Other|19|||
125157390|NCT01244061|450200873|FG000|Overall Study|Protocol Violation|1|||
125157391|NCT01244061|450200874|FG001|Overall Study|Protocol Violation|1|||
125157392|NCT01244061|450200873|FG000|Overall Study|Adverse Event|5|||
125157393|NCT01244061|450200874|FG001|Overall Study|Adverse Event|2|||
125157394|NCT01244061|450200873|FG000|Overall Study|Randomized but not treated|2|||
125157395|NCT01244061|450200874|FG001|Overall Study|Randomized but not treated|2|||
125157396|NCT02384850|450200877|FG000|Overall Study|Withdrawal by Subject|2|||
125157397|NCT02384850|450200878|FG001|Overall Study|Withdrawal by Subject|2|||
125157398|NCT02013375|450200879|FG000|Overall Study|Did not engraft|1|||
125157399|NCT02013375|450200879|FG000|Overall Study|Did not engraft|1|||
125438773|NCT01003639|451233955|FG001|Overall Study|Protocol Violation|1|||
125438774|NCT01003639|451233954|FG000|Overall Study|Physician Decision|1|||
125438775|NCT01003639|451233955|FG001|Overall Study|Physician Decision|0|||
125438776|NCT01076088|451233959|FG000|Overall Study|Adverse Event|1|||
125438777|NCT01076088|451233960|FG001|Overall Study|Adverse Event|6|||
125438778|NCT01076088|451233961|FG002|Overall Study|Adverse Event|3|||
125438779|NCT01076088|451233962|FG003|Overall Study|Adverse Event|2|||
125438780|NCT01076088|451233963|FG004|Overall Study|Adverse Event|3|||
125438781|NCT01076088|451233964|FG005|Overall Study|Adverse Event|3|||
125438782|NCT01076088|451233959|FG000|Overall Study|Lost to Follow-up|1|||
125438783|NCT01076088|451233960|FG001|Overall Study|Lost to Follow-up|1|||
125438784|NCT01076088|451233961|FG002|Overall Study|Lost to Follow-up|0|||
125438785|NCT01076088|451233962|FG003|Overall Study|Lost to Follow-up|1|||
125438786|NCT01076088|451233963|FG004|Overall Study|Lost to Follow-up|1|||
125438787|NCT01076088|451233964|FG005|Overall Study|Lost to Follow-up|2|||
125438788|NCT01076088|451233959|FG000|Overall Study|Non-compliance with study drug|0|||
125438789|NCT01076088|451233960|FG001|Overall Study|Non-compliance with study drug|0|||
125438790|NCT01076088|451233961|FG002|Overall Study|Non-compliance with study drug|0|||
125438791|NCT01076088|451233962|FG003|Overall Study|Non-compliance with study drug|1|||
125438792|NCT01076088|451233963|FG004|Overall Study|Non-compliance with study drug|0|||
125438793|NCT01076088|451233964|FG005|Overall Study|Non-compliance with study drug|0|||
125157421|NCT02932228|450200886|FG000|Overall Study|Death|8|||
125157422|NCT02932228|450200887|FG001|Overall Study|Death|23|||
125157423|NCT02932228|450200886|FG000|Overall Study|not eligible upon chart review|2|||
125157424|NCT02932228|450200887|FG001|Overall Study|not eligible upon chart review|5|||
125157425|NCT00821873|450202621|FG000|Overall Study|Lost to Follow-up|4|||
125157426|NCT03310411|450202622|FG000|Period 1|Adverse Event|0|||
125157427|NCT03310411|450202623|FG001|Period 1|Adverse Event|0|||
125223879|NCT02849080|450446263|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
125223880|NCT02849080|450446264|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
125223881|NCT02849080|450446265|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
125223882|NCT02849080|450446266|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
125223883|NCT02849080|450446263|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
125223884|NCT02849080|450446264|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
125223885|NCT02849080|450446265|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
125223886|NCT02849080|450446266|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
125223887|NCT02849080|450446263|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
125223888|NCT02849080|450446264|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
125223889|NCT02849080|450446265|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
125223890|NCT02849080|450446266|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
125223891|NCT02849080|450446263|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
125223892|NCT02849080|450446264|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
125223893|NCT02849080|450446265|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
125223894|NCT02849080|450446266|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
125223895|NCT02849080|450446263|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
125223896|NCT02849080|450446264|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
125223897|NCT02849080|450446265|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
125223898|NCT02849080|450446266|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
125223899|NCT02849080|450446263|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
125223900|NCT02849080|450446264|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
125223901|NCT02849080|450446265|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
125223902|NCT02849080|450446266|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
125223903|NCT01819727|450446267|FG000|Overall Study|Adverse Event|8|||
125223904|NCT01819727|450446268|FG001|Overall Study|Adverse Event|9|||
125223905|NCT01819727|450446267|FG000|Overall Study|Death|1|||
125223906|NCT01819727|450446268|FG001|Overall Study|Death|0|||
125223907|NCT01819727|450446267|FG000|Overall Study|Lost to Follow-up|1|||
125223908|NCT01819727|450446268|FG001|Overall Study|Lost to Follow-up|1|||
125223909|NCT01819727|450446267|FG000|Overall Study|Physician Decision|3|||
125223910|NCT01819727|450446268|FG001|Overall Study|Physician Decision|2|||
125223911|NCT01819727|450446267|FG000|Overall Study|Pregnancy|1|||
125223912|NCT01819727|450446268|FG001|Overall Study|Pregnancy|0|||
125223913|NCT01819727|450446267|FG000|Overall Study|Protocol Violation|0|||
125223914|NCT01819727|450446268|FG001|Overall Study|Protocol Violation|2|||
125223915|NCT01819727|450446267|FG000|Overall Study|Study Terminated by Sponsor|0|||
125223916|NCT01819727|450446268|FG001|Overall Study|Study Terminated by Sponsor|1|||
125223917|NCT01819727|450446267|FG000|Overall Study|Withdrawal by Subject|6|||
125223918|NCT01819727|450446268|FG001|Overall Study|Withdrawal by Subject|11|||
125223919|NCT01819727|450446267|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
125223920|NCT01819727|450446268|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
125223921|NCT01819727|450446267|FG000|Overall Study|Quit due to lack of health benifits|0|||
125223922|NCT01819727|450446268|FG001|Overall Study|Quit due to lack of health benifits|1|||
125223923|NCT02155985|450446269|FG000|Overall Study|Withdrawal by Subject|0|||
125223924|NCT02155985|450446270|FG001|Overall Study|Withdrawal by Subject|0|||
125223925|NCT02155985|450446271|FG002|Overall Study|Withdrawal by Subject|1|||
125223926|NCT02155985|450446269|FG000|Overall Study|Lost to Follow-up|1|||
125389045|NCT00405587|451058047|FG000|Overall Study|Adverse Event|1|||
125389046|NCT00405587|451058048|FG001|Overall Study|Adverse Event|0|||
125389047|NCT00405587|451058049|FG002|Overall Study|Adverse Event|0|||
125389048|NCT00405587|451058050|FG003|Overall Study|Adverse Event|0|||
125389049|NCT00405587|451058047|FG000|Overall Study|Lost to Follow-up|0|||
125157428|NCT03310411|450202624|FG002|Period 1|Adverse Event|0|||
125157429|NCT03310411|450202625|FG003|Period 1|Adverse Event|1|||
125157430|NCT03623386|450202628|FG000|Overall Study|Protocol Violation|3|||
125157431|NCT03623386|450202629|FG001|Overall Study|Protocol Violation|2|||
125157432|NCT03623386|450202630|FG002|Overall Study|Protocol Violation|0|||
125157433|NCT03623386|450202628|FG000|Overall Study|Physician Decision|1|||
125157434|NCT03623386|450202629|FG001|Overall Study|Physician Decision|1|||
125157435|NCT03623386|450202630|FG002|Overall Study|Physician Decision|0|||
125157436|NCT03623386|450202628|FG000|Overall Study|Lost to Follow-up|0|||
125157437|NCT03623386|450202629|FG001|Overall Study|Lost to Follow-up|2|||
125157438|NCT03623386|450202630|FG002|Overall Study|Lost to Follow-up|0|||
125157439|NCT03623386|450202628|FG000|Overall Study|COVID-19|0|||
125157440|NCT03623386|450202629|FG001|Overall Study|COVID-19|1|||
125157441|NCT03623386|450202630|FG002|Overall Study|COVID-19|0|||
125157442|NCT04271735|450202633|FG000|Overall Study|Physician Decision|2|||
125157443|NCT04271735|450202634|FG001|Overall Study|Physician Decision|0|||
125157444|NCT00515541|450202635|FG000|Overall Study|Physician Decision|0|||
125157445|NCT00515541|450202636|FG001|Overall Study|Physician Decision|2|||
125157446|NCT00515541|450202637|FG002|Overall Study|Physician Decision|0|||
125157447|NCT00515541|450202638|FG003|Overall Study|Physician Decision|1|||
125157448|NCT00515541|450202635|FG000|Overall Study|No show for appointments|0|||
125157449|NCT00515541|450202636|FG001|Overall Study|No show for appointments|1|||
125157450|NCT00515541|450202637|FG002|Overall Study|No show for appointments|0|||
125157451|NCT00515541|450202638|FG003|Overall Study|No show for appointments|2|||
125157452|NCT00515541|450202635|FG000|Overall Study|Withdrawal by Subject|0|||
125157453|NCT00515541|450202636|FG001|Overall Study|Withdrawal by Subject|2|||
125389050|NCT00405587|451058048|FG001|Overall Study|Lost to Follow-up|1|||
125389051|NCT00405587|451058049|FG002|Overall Study|Lost to Follow-up|1|||
125389052|NCT00405587|451058050|FG003|Overall Study|Lost to Follow-up|0|||
125157454|NCT00515541|450202637|FG002|Overall Study|Withdrawal by Subject|0|||
125157455|NCT00515541|450202638|FG003|Overall Study|Withdrawal by Subject|2|||
125157456|NCT00922272|450202639|FG000|Open-label Phase|Adverse Event|5|||
125157457|NCT00922272|450202640|FG001|Open-label Phase|Adverse Event|0|||
125157458|NCT00922272|450202639|FG000|Open-label Phase|Protocol Violation|1|||
125157459|NCT00922272|450202640|FG001|Open-label Phase|Protocol Violation|0|||
125157460|NCT00922272|450202639|FG000|Open-label Phase|Withdrawal by Subject|11|||
125157461|NCT00922272|450202640|FG001|Open-label Phase|Withdrawal by Subject|0|||
125157462|NCT00922272|450202639|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
125157463|NCT00922272|450202640|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
125157464|NCT00922272|450202639|FG000|Open-label Phase|Withdrawal criteria met|5|||
125157465|NCT00922272|450202640|FG001|Open-label Phase|Withdrawal criteria met|0|||
125157466|NCT00922272|450202639|FG000|Double-blind Phase|Adverse Event|1|||
125157467|NCT00922272|450202640|FG001|Double-blind Phase|Adverse Event|1|||
125157468|NCT00922272|450202639|FG000|Double-blind Phase|Withdrawal by Subject|1|||
125157469|NCT00922272|450202640|FG001|Double-blind Phase|Withdrawal by Subject|1|||
125157470|NCT00922272|450202639|FG000|Double-blind Phase|Lost to Follow-up|2|||
125157471|NCT00922272|450202640|FG001|Double-blind Phase|Lost to Follow-up|1|||
125157472|NCT00922272|450202639|FG000|Double-blind Phase|Withdrawal criteria met|1|||
125157473|NCT00922272|450202640|FG001|Double-blind Phase|Withdrawal criteria met|1|||
125157474|NCT00922272|450202639|FG000|Double-blind Phase|Noncompliance|1|||
125157475|NCT00922272|450202640|FG001|Double-blind Phase|Noncompliance|1|||
125157476|NCT00922272|450202639|FG000|Double-blind Phase|Positive urine drug screen|1|||
125157477|NCT00922272|450202640|FG001|Double-blind Phase|Positive urine drug screen|1|||
125157478|NCT02588950|450202641|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
125157479|NCT02588950|450202642|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
125157480|NCT02588950|450202643|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
125157481|NCT02588950|450202644|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
125157482|NCT02588950|450202641|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
125157483|NCT02588950|450202642|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
125157484|NCT02588950|450202643|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
125157485|NCT02588950|450202644|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
125157486|NCT03188718|450202645|FG000|Overall Study|Participant noncompliance|4|||
125157487|NCT03188718|450202645|FG000|Overall Study|Withdrawal by Subject|1|||
125157488|NCT03188718|450202645|FG000|Overall Study|Device failure|3|||
125157489|NCT02072824|450202646|FG000|Overall Study|Insufficient clinical response|1|||
125157490|NCT02072824|450202647|FG001|Overall Study|Insufficient clinical response|0|||
125157491|NCT02072824|450202648|FG002|Overall Study|Insufficient clinical response|1|||
125157492|NCT02072824|450202646|FG000|Overall Study|No longer willing to participate|1|||
125157493|NCT02072824|450202647|FG001|Overall Study|No longer willing to participate|0|||
125157494|NCT02072824|450202648|FG002|Overall Study|No longer willing to participate|1|||
125157495|NCT02072824|450202646|FG000|Overall Study|Medication error|0|||
125157496|NCT02072824|450202647|FG001|Overall Study|Medication error|1|||
125157497|NCT02072824|450202648|FG002|Overall Study|Medication error|0|||
125157498|NCT02072824|450202646|FG000|Overall Study|Adverse Event|0|||
125157499|NCT02072824|450202647|FG001|Overall Study|Adverse Event|0|||
125157500|NCT02072824|450202648|FG002|Overall Study|Adverse Event|1|||
125157501|NCT03084367|450202649|FG000|Overall Study|Lost to Follow-up|32|||
125157502|NCT03084367|450202649|FG000|Overall Study|Withdrawal by Subject|4|||
125157503|NCT03084367|450202649|FG000|Overall Study|Other|1|||
125157504|NCT00841906|450202650|FG000|Overall Study|Withdrawal by Subject|2|||
125157505|NCT00841906|450202651|FG001|Overall Study|Withdrawal by Subject|0|||
125157506|NCT02667288|450202654|FG000|Overall Study|Protocol Violation|5|||
125157507|NCT02667288|450202654|FG000|Overall Study|Lost to Follow-up|3|||
125157508|NCT02667288|450202654|FG000|Overall Study|Withdrawal by Subject|5|||
125157509|NCT00912093|450202655|FG000|The Controlled Phase|Death|0|||
125157510|NCT00912093|450202656|FG001|The Controlled Phase|Death|1|||
125157511|NCT00912093|450202657|FG002|The Controlled Phase|Death|0|||
125157512|NCT00912093|450202658|FG003|The Controlled Phase|Death|0|||
125157513|NCT00912093|450202659|FG004|The Controlled Phase|Death|0|||
125157514|NCT00912093|450202655|FG000|The Controlled Phase|Medical Condition|0|||
125157515|NCT00912093|450202656|FG001|The Controlled Phase|Medical Condition|1|||
125157516|NCT00912093|450202657|FG002|The Controlled Phase|Medical Condition|0|||
125157517|NCT00912093|450202658|FG003|The Controlled Phase|Medical Condition|0|||
125157518|NCT00912093|450202659|FG004|The Controlled Phase|Medical Condition|0|||
125157519|NCT00912093|450202655|FG000|The Controlled Phase|Lost to Follow-up|0|||
125157520|NCT00912093|450202656|FG001|The Controlled Phase|Lost to Follow-up|0|||
125157521|NCT00912093|450202657|FG002|The Controlled Phase|Lost to Follow-up|0|||
125157522|NCT00912093|450202658|FG003|The Controlled Phase|Lost to Follow-up|0|||
125157523|NCT00912093|450202659|FG004|The Controlled Phase|Lost to Follow-up|1|||
125389053|NCT00405587|451058047|FG000|Overall Study|Radiation induced necrosis|0|||
125389054|NCT00405587|451058048|FG001|Overall Study|Radiation induced necrosis|1|||
125389055|NCT00405587|451058049|FG002|Overall Study|Radiation induced necrosis|0|||
125389056|NCT00405587|451058050|FG003|Overall Study|Radiation induced necrosis|0|||
125389057|NCT00405587|451058047|FG000|Overall Study|Withdrawal by Subject|0|||
125389058|NCT00405587|451058048|FG001|Overall Study|Withdrawal by Subject|0|||
125389059|NCT00405587|451058049|FG002|Overall Study|Withdrawal by Subject|0|||
125389060|NCT00405587|451058050|FG003|Overall Study|Withdrawal by Subject|2|||
125389061|NCT00405587|451058047|FG000|Overall Study|Participant not dosed|0|||
125389062|NCT00405587|451058048|FG001|Overall Study|Participant not dosed|1|||
125389063|NCT00405587|451058049|FG002|Overall Study|Participant not dosed|0|||
125389064|NCT00405587|451058050|FG003|Overall Study|Participant not dosed|0|||
125389065|NCT02419742|451058051|FG000|Overall Study|Adverse Event|2|||
125389066|NCT02419742|451058052|FG001|Overall Study|Adverse Event|0|||
125389067|NCT02419742|451058051|FG000|Overall Study|Disease Progression|0|||
125389068|NCT02419742|451058052|FG001|Overall Study|Disease Progression|1|||
125389069|NCT02419742|451058051|FG000|Overall Study|Withdrew Consent|2|||
125389070|NCT02419742|451058052|FG001|Overall Study|Withdrew Consent|1|||
125389071|NCT02419742|451058051|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
125389072|NCT02419742|451058052|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
125389073|NCT03506373|451058057|FG000|Overall Study|Adverse Event|6|||
125389074|NCT03506373|451058057|FG000|Overall Study|Withdrawal by Subject|2|||
125389075|NCT03506373|451058057|FG000|Overall Study|Disease progression|5|||
125389076|NCT03506373|451058057|FG000|Overall Study|Other|3|||
125389077|NCT02211131|451058058|FG000|Overall Study|Death|26|||
125389078|NCT02211131|451058059|FG001|Overall Study|Death|16|||
125389079|NCT02211131|451058058|FG000|Overall Study|Lost to Follow-up|4|||
125389080|NCT02211131|451058059|FG001|Overall Study|Lost to Follow-up|3|||
125389081|NCT02211131|451058058|FG000|Overall Study|Decision by Sponsor|1|||
125389082|NCT02211131|451058059|FG001|Overall Study|Decision by Sponsor|1|||
125389083|NCT02211131|451058058|FG000|Overall Study|Withdrawal by Subject|3|||
125389084|NCT02211131|451058059|FG001|Overall Study|Withdrawal by Subject|8|||
125389085|NCT03340025|451058060|FG000|Overall Study|Lost to Follow-up|2|||
125389086|NCT03340025|451058061|FG001|Overall Study|Lost to Follow-up|2|||
125389087|NCT02120950|451058062|FG000|Overall Study|Adverse Event|5|||
125389088|NCT02120950|451058063|FG001|Overall Study|Adverse Event|4|||
125389089|NCT02120950|451058064|FG002|Overall Study|Adverse Event|3|||
125389090|NCT02120950|451058062|FG000|Overall Study|Death|3|||
125389091|NCT02120950|451058063|FG001|Overall Study|Death|0|||
125389092|NCT02120950|451058064|FG002|Overall Study|Death|1|||
125389093|NCT02120950|451058062|FG000|Overall Study|Withdrawal by Subject|6|||
125389094|NCT02120950|451058063|FG001|Overall Study|Withdrawal by Subject|3|||
125389095|NCT02120950|451058064|FG002|Overall Study|Withdrawal by Subject|2|||
125389096|NCT02120950|451058062|FG000|Overall Study|Protocol Violation|1|||
125389097|NCT02120950|451058063|FG001|Overall Study|Protocol Violation|1|||
125389098|NCT02120950|451058064|FG002|Overall Study|Protocol Violation|7|||
125389099|NCT02120950|451058062|FG000|Overall Study|Other reasons|5|||
125389100|NCT02120950|451058063|FG001|Overall Study|Other reasons|4|||
125389101|NCT02120950|451058064|FG002|Overall Study|Other reasons|1|||
125389102|NCT02120950|451058062|FG000|Overall Study|Lost to Follow-up|0|||
125389103|NCT02120950|451058063|FG001|Overall Study|Lost to Follow-up|2|||
125389104|NCT02120950|451058064|FG002|Overall Study|Lost to Follow-up|1|||
125389105|NCT02424383|451058065|FG000|Overall Study|Withdrawal by Subject|32|||
125389106|NCT02424383|451058065|FG000|Overall Study|Death|170|||
125389107|NCT02424383|451058065|FG000|Overall Study|Sponsor's decision|3|||
125389108|NCT02424383|451058065|FG000|Overall Study|Investigator's decision|44|||
125157524|NCT04397445|450202662|FG000|Overall Study|Withdrawal by Subject|1|||
125389109|NCT02424383|451058065|FG000|Overall Study|Lost to Follow-up|81|||
125438794|NCT01076088|451233959|FG000|Overall Study|Physician Decision|1|||
125438795|NCT01076088|451233960|FG001|Overall Study|Physician Decision|3|||
125157525|NCT04397445|450202663|FG001|Overall Study|Withdrawal by Subject|0|||
125157526|NCT04397445|450202664|FG002|Overall Study|Withdrawal by Subject|0|||
125157527|NCT04397445|450202665|FG003|Overall Study|Withdrawal by Subject|0|||
125157528|NCT03921151|450202666|FG000|Overall Study|Withdrawal by Subject|11|||
125389110|NCT02424383|451058065|FG000|Overall Study|Other|7|||
125389111|NCT02424383|451058065|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
125389112|NCT00909779|451058066|FG000|Overall Study|Adverse Event|53|||
125389113|NCT00909779|451058067|FG001|Overall Study|Adverse Event|55|||
125389114|NCT00909779|451058066|FG000|Overall Study|Lack of Efficacy|7|||
125389115|NCT00909779|451058067|FG001|Overall Study|Lack of Efficacy|4|||
125389116|NCT00909779|451058066|FG000|Overall Study|Lost to Follow-up|19|||
125389117|NCT00909779|451058067|FG001|Overall Study|Lost to Follow-up|15|||
125438796|NCT01076088|451233961|FG002|Overall Study|Physician Decision|0|||
125389118|NCT00909779|451058066|FG000|Overall Study|Physician Decision|8|||
125389119|NCT00909779|451058067|FG001|Overall Study|Physician Decision|2|||
125389120|NCT00909779|451058066|FG000|Overall Study|Protocol Violation|2|||
125389121|NCT00909779|451058067|FG001|Overall Study|Protocol Violation|5|||
125389122|NCT00909779|451058066|FG000|Overall Study|Withdrawal by Subject|116|||
125389123|NCT00909779|451058067|FG001|Overall Study|Withdrawal by Subject|80|||
125157529|NCT03921151|450202667|FG001|Overall Study|Withdrawal by Subject|16|||
125157530|NCT00270257|450202669|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
125157531|NCT00270257|450202670|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
125157532|NCT03001219|450202675|FG000|Proof of Concept|Study Termination by Sponsor|0|||
125157533|NCT03001219|450202676|FG001|Proof of Concept|Study Termination by Sponsor|1|||
125157534|NCT03001219|450202675|FG000|Proof of Concept|Withdrawal by Subject|0|||
125157535|NCT03001219|450202676|FG001|Proof of Concept|Withdrawal by Subject|4|||
125157536|NCT03001219|450202675|FG000|Proof of Concept|Protocol Deviation|0|||
125157537|NCT03001219|450202676|FG001|Proof of Concept|Protocol Deviation|1|||
125157538|NCT03001219|450202675|FG000|Proof of Concept|Adverse Event|1|||
125157539|NCT03001219|450202676|FG001|Proof of Concept|Adverse Event|1|||
125157540|NCT03001219|450202675|FG000|Proof of Concept|Physician Decision|1|||
125157541|NCT03001219|450202676|FG001|Proof of Concept|Physician Decision|0|||
125157542|NCT03001219|450202675|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
125157543|NCT03001219|450202676|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
125157544|NCT03001219|450202675|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
125157545|NCT03001219|450202676|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
125157546|NCT03001219|450202675|FG000|Extension Period Analysis|Physician Decision|0|||
125157547|NCT03001219|450202676|FG001|Extension Period Analysis|Physician Decision|1|||
125157548|NCT03001219|450202675|FG000|Extension Period Analysis|Adverse Event|1|||
125157549|NCT03001219|450202676|FG001|Extension Period Analysis|Adverse Event|1|||
125157550|NCT03001219|450202675|FG000|Extension Period Analysis|Protocol Deviation|0|||
125157551|NCT03001219|450202676|FG001|Extension Period Analysis|Protocol Deviation|1|||
125157552|NCT03001219|450202675|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
125157553|NCT03001219|450202676|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
125157554|NCT03733210|450202677|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
125157555|NCT03733210|450202678|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
125157556|NCT02621034|450202679|FG000|Overall Study|Lost to Follow-up|3|||
125157557|NCT02621034|450202680|FG001|Overall Study|Lost to Follow-up|2|||
125157558|NCT02621034|450202681|FG002|Overall Study|Lost to Follow-up|5|||
125157559|NCT02963441|450202682|FG000|Overall Study|Protocol violation or withdrawn|8|||
125157560|NCT02963441|450202682|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
125157561|NCT02963441|450202682|FG000|Overall Study|IDx-DR insufficient quality|33|||
125157562|NCT02669940|450202685|FG000|Overall Study|Failure to return|0|||
125157563|NCT02669940|450202686|FG001|Overall Study|Failure to return|3|||
125157564|NCT02669940|450202685|FG000|Overall Study|Insufficient follow-up data|1|||
125157565|NCT02669940|450202686|FG001|Overall Study|Insufficient follow-up data|0|||
125157566|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Adverse Event|9|||
125157567|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Adverse Event|4|||
125157568|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Adverse Event|5|||
125157569|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Adverse Event|9|||
125157570|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Adverse Event|8|||
125157571|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Adverse Event|0|||
125157572|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Adverse Event|0|||
125157573|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
125157574|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
125157575|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
125157576|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
125157577|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
125157578|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
125157579|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
125157580|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Death|1|||
125157581|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Death|1|||
125157582|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Death|1|||
125157583|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Death|1|||
125157584|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Death|0|||
125157585|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Death|0|||
125157586|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Death|0|||
125157587|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
125157588|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
125157589|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
125157590|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
125157591|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
125157592|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
125157593|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
125157594|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
125157595|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
125157596|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
125157597|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
125157598|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
125157599|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
125157600|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
125157601|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
125157602|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
125157603|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
125157604|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
125157605|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
125157606|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
125157607|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
125157608|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Other|2|||
125157609|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Other|9|||
125157610|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Other|9|||
125157611|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Other|3|||
125157612|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Other|2|||
125157613|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Other|0|||
125157614|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Other|0|||
125157615|NCT00361335|450202687|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
125157616|NCT00361335|450202688|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
125157617|NCT00361335|450202689|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
125157618|NCT00361335|450202690|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
125157619|NCT00361335|450202691|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
125157620|NCT00361335|450202692|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
125157621|NCT00361335|450202693|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
125157622|NCT00361335|450202687|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
125157623|NCT00361335|450202688|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
125157624|NCT00361335|450202689|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
125157625|NCT00361335|450202690|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
125157626|NCT00361335|450202691|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
125157627|NCT00361335|450202692|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
125157628|NCT00361335|450202693|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
125157629|NCT00361335|450202687|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
125157630|NCT00361335|450202688|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
125157631|NCT00361335|450202689|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
125157632|NCT00361335|450202690|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
125157633|NCT00361335|450202691|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
125157634|NCT00361335|450202692|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
125157635|NCT00361335|450202693|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
125157636|NCT00361335|450202687|FG000|SC Period: Week E0 to Week E24|Death|0|||
125157637|NCT00361335|450202688|FG001|SC Period: Week E0 to Week E24|Death|0|||
125157638|NCT00361335|450202689|FG002|SC Period: Week E0 to Week E24|Death|0|||
125157639|NCT00361335|450202690|FG003|SC Period: Week E0 to Week E24|Death|0|||
125157640|NCT00361335|450202691|FG004|SC Period: Week E0 to Week E24|Death|0|||
125157641|NCT00361335|450202692|FG005|SC Period: Week E0 to Week E24|Death|0|||
125157642|NCT00361335|450202693|FG006|SC Period: Week E0 to Week E24|Death|1|||
125157643|NCT00361335|450202687|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
125157644|NCT00361335|450202688|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
125157645|NCT00361335|450202689|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
125157646|NCT00361335|450202690|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
125157647|NCT00361335|450202691|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
125157648|NCT00361335|450202692|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
125157649|NCT00361335|450202693|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
125157650|NCT00361335|450202687|FG000|SC Period: Week E0 to Week E24|Other|1|||
125157651|NCT00361335|450202688|FG001|SC Period: Week E0 to Week E24|Other|0|||
125157652|NCT00361335|450202689|FG002|SC Period: Week E0 to Week E24|Other|0|||
125157653|NCT00361335|450202690|FG003|SC Period: Week E0 to Week E24|Other|1|||
125157654|NCT00361335|450202691|FG004|SC Period: Week E0 to Week E24|Other|0|||
125157655|NCT00361335|450202692|FG005|SC Period: Week E0 to Week E24|Other|1|||
125157656|NCT00361335|450202693|FG006|SC Period: Week E0 to Week E24|Other|2|||
125157657|NCT00361335|450202687|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
125157658|NCT00361335|450202688|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
125157659|NCT00361335|450202689|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
125157660|NCT00361335|450202690|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
125157661|NCT00361335|450202691|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
125157662|NCT00361335|450202692|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
125157663|NCT00361335|450202693|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
125157664|NCT05065983|450202694|FG000|Overall Study|Lost to Follow-up|2|||
125157665|NCT00986180|450202695|FG000|Overall Study|Adverse Event|21|||
125157666|NCT00986180|450202696|FG001|Overall Study|Adverse Event|23|||
125157667|NCT00986180|450202695|FG000|Overall Study|Lack of Efficacy|4|||
125157668|NCT00986180|450202696|FG001|Overall Study|Lack of Efficacy|3|||
125157669|NCT00986180|450202695|FG000|Overall Study|Lost to Follow-up|5|||
125157670|NCT00986180|450202696|FG001|Overall Study|Lost to Follow-up|7|||
125157671|NCT00986180|450202695|FG000|Overall Study|Physician Decision|1|||
125157672|NCT00986180|450202696|FG001|Overall Study|Physician Decision|3|||
125157673|NCT00986180|450202695|FG000|Overall Study|Protocol Violation|2|||
125157674|NCT00986180|450202696|FG001|Overall Study|Protocol Violation|0|||
125438797|NCT01076088|451233962|FG003|Overall Study|Physician Decision|1|||
125438798|NCT01076088|451233963|FG004|Overall Study|Physician Decision|1|||
125438799|NCT01076088|451233964|FG005|Overall Study|Physician Decision|0|||
125157675|NCT00986180|450202695|FG000|Overall Study|Withdrawal by Subject|1|||
125157676|NCT00986180|450202696|FG001|Overall Study|Withdrawal by Subject|9|||
125157677|NCT00986180|450202695|FG000|Overall Study|Miscellanies|10|||
125157678|NCT00986180|450202696|FG001|Overall Study|Miscellanies|11|||
125157679|NCT01765582|450202697|FG000|Overall Study|Other|3|||
125157680|NCT01765582|450202698|FG001|Overall Study|Other|6|||
125157681|NCT01765582|450202699|FG002|Overall Study|Other|9|||
125157682|NCT01765582|450202697|FG000|Overall Study|Lost to Follow-up|2|||
125157683|NCT01765582|450202698|FG001|Overall Study|Lost to Follow-up|2|||
125157684|NCT01765582|450202699|FG002|Overall Study|Lost to Follow-up|1|||
125157685|NCT01765582|450202697|FG000|Overall Study|Death|31|||
125157686|NCT01765582|450202698|FG001|Overall Study|Death|36|||
125157687|NCT01765582|450202699|FG002|Overall Study|Death|33|||
125157688|NCT01765582|450202697|FG000|Overall Study|Sponsor Decision|46|||
125157689|NCT01765582|450202698|FG001|Overall Study|Sponsor Decision|42|||
125157690|NCT01765582|450202699|FG002|Overall Study|Sponsor Decision|42|||
125157691|NCT01765582|450202697|FG000|Overall Study|Withdrawal of Consent|11|||
125157692|NCT01765582|450202698|FG001|Overall Study|Withdrawal of Consent|6|||
125157693|NCT01765582|450202699|FG002|Overall Study|Withdrawal of Consent|10|||
125157694|NCT01691820|450202700|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
125157695|NCT01691820|450202701|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
125157696|NCT01691820|450202700|FG000|Overall Study|Migrated/moved from study area|7|||
125157697|NCT01691820|450202701|FG001|Overall Study|Migrated/moved from study area|4|||
125157698|NCT01691820|450202700|FG000|Overall Study|Lost to Follow-up|6|||
125157699|NCT01691820|450202701|FG001|Overall Study|Lost to Follow-up|17|||
125157700|NCT01691820|450202700|FG000|Overall Study|Other (unspecified)|4|||
125157701|NCT01691820|450202701|FG001|Overall Study|Other (unspecified)|1|||
125157702|NCT00616941|450202706|FG000|Overall Study|Progressive Disease|1|||
125157703|NCT00616941|450202707|FG001|Overall Study|Progressive Disease|2|||
125157704|NCT00616941|450202708|FG002|Overall Study|Progressive Disease|1|||
125157705|NCT00616941|450202706|FG000|Overall Study|Adverse Event|0|||
125157706|NCT00616941|450202707|FG001|Overall Study|Adverse Event|1|||
125157707|NCT00616941|450202708|FG002|Overall Study|Adverse Event|1|||
125157708|NCT00616941|450202706|FG000|Overall Study|Subject Non-compliance|0|||
125157709|NCT00616941|450202707|FG001|Overall Study|Subject Non-compliance|0|||
125157710|NCT00616941|450202708|FG002|Overall Study|Subject Non-compliance|1|||
125157711|NCT00616941|450202706|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
125157712|NCT00616941|450202707|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
125157713|NCT00616941|450202708|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
125157714|NCT00616941|450202706|FG000|Overall Study|Vaccination Suspended|0|||
125157715|NCT00616941|450202707|FG001|Overall Study|Vaccination Suspended|0|||
125157716|NCT00616941|450202708|FG002|Overall Study|Vaccination Suspended|3|||
125157717|NCT00714493|450202709|FG000|Overall Study|Adverse Event|11|||
125157718|NCT00714493|450202709|FG000|Overall Study|Death|3|||
125157719|NCT00714493|450202709|FG000|Overall Study|Lack of Efficacy|10|||
125157720|NCT00714493|450202709|FG000|Overall Study|Lost to Follow-up|3|||
125157721|NCT00714493|450202709|FG000|Overall Study|Protocol Violation|12|||
125157722|NCT00714493|450202709|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
125157723|NCT00714493|450202709|FG000|Overall Study|OTHER|2|||
125157724|NCT02372071|450202710|FG000|Overall Study|Protocol Violation|18|||
125157725|NCT00506129|450202711|FG000|Overall Study|Disease Progression/Relapse|15|||
125157726|NCT00506129|450202711|FG000|Overall Study|Death|7|||
125157727|NCT00557076|450202716|FG000|Overall Study|Unblinding|0|||
125157728|NCT00557076|450202717|FG001|Overall Study|Unblinding|1|||
125157729|NCT02408068|450202719|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
125157730|NCT02408068|450202720|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
125157731|NCT02408068|450202721|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
125157732|NCT02408068|450202722|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
125157733|NCT02408068|450202723|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
125157734|NCT02408068|450202724|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
125157735|NCT02138136|450202733|FG000|Overall Study|Protocol Violation|4|||
125157736|NCT02138136|450202733|FG000|Overall Study|Physician Decision|7|||
125157737|NCT02138136|450202733|FG000|Overall Study|Lack of Efficacy|35|||
125157738|NCT02138136|450202733|FG000|Overall Study|Pregnancy|2|||
125157739|NCT02138136|450202733|FG000|Overall Study|Adverse Event|18|||
125157740|NCT02138136|450202733|FG000|Overall Study|Withdrawal by Subject|36|||
125157741|NCT02138136|450202733|FG000|Overall Study|Lost to Follow-up|32|||
125157742|NCT02138136|450202733|FG000|Overall Study|Withdrawn by Sponsor|5|||
125157743|NCT00706381|450202736|FG000|Overall Study|Lost to Follow-up|0|||
125157744|NCT00706381|450202737|FG001|Overall Study|Lost to Follow-up|1|||
125157745|NCT00706381|450202738|FG002|Overall Study|Lost to Follow-up|1|||
125157746|NCT00706381|450202739|FG003|Overall Study|Lost to Follow-up|0|||
125157747|NCT00995085|450202743|FG000|Overall Study|Withdrawal by Subject|5|||
125157748|NCT03096847|450202749|FG000|Overall Study|Other|2|||
125157749|NCT03096847|450202750|FG001|Overall Study|Other|1|||
125157750|NCT03096847|450202751|FG002|Overall Study|Other|2|||
125389124|NCT00909779|451058066|FG000|Overall Study|Site Ceasing Operation|2|||
125389125|NCT00909779|451058067|FG001|Overall Study|Site Ceasing Operation|2|||
125389126|NCT00909779|451058066|FG000|Overall Study|Medical Monitor Decision|1|||
125389127|NCT00909779|451058067|FG001|Overall Study|Medical Monitor Decision|0|||
125389128|NCT00909779|451058066|FG000|Overall Study|Noncompliance|1|||
125157751|NCT03096847|450202749|FG000|Overall Study|Lost to Follow-up|1|||
125157752|NCT03096847|450202750|FG001|Overall Study|Lost to Follow-up|0|||
125157753|NCT03096847|450202751|FG002|Overall Study|Lost to Follow-up|1|||
125157754|NCT03096847|450202749|FG000|Overall Study|Death|6|||
125157755|NCT03096847|450202750|FG001|Overall Study|Death|0|||
125157756|NCT03096847|450202751|FG002|Overall Study|Death|2|||
125157757|NCT03096847|450202749|FG000|Overall Study|Protocol Violation|3|||
125157758|NCT03096847|450202750|FG001|Overall Study|Protocol Violation|0|||
125157759|NCT03096847|450202751|FG002|Overall Study|Protocol Violation|6|||
125157760|NCT03096847|450202749|FG000|Overall Study|Physician Decision|12|||
125157761|NCT03096847|450202750|FG001|Overall Study|Physician Decision|2|||
125157762|NCT03096847|450202751|FG002|Overall Study|Physician Decision|8|||
125157763|NCT03096847|450202749|FG000|Overall Study|Withdrawal by Subject|24|||
125157764|NCT03096847|450202750|FG001|Overall Study|Withdrawal by Subject|1|||
125157765|NCT03096847|450202751|FG002|Overall Study|Withdrawal by Subject|12|||
125157766|NCT03096847|450202749|FG000|Overall Study|Adverse Event|72|||
125157767|NCT03096847|450202750|FG001|Overall Study|Adverse Event|6|||
125157768|NCT03096847|450202751|FG002|Overall Study|Adverse Event|28|||
125157769|NCT03096847|450202749|FG000|Overall Study|Progressive disease|97|||
125157770|NCT03096847|450202750|FG001|Overall Study|Progressive disease|10|||
125157771|NCT03096847|450202751|FG002|Overall Study|Progressive disease|78|||
125157772|NCT03096847|450202749|FG000|Overall Study|Non-compliance with study medication|1|||
125157773|NCT03096847|450202750|FG001|Overall Study|Non-compliance with study medication|0|||
125157774|NCT03096847|450202751|FG002|Overall Study|Non-compliance with study medication|0|||
125157775|NCT03096847|450202749|FG000|Overall Study|New therapy for study indication|1|||
125157776|NCT03096847|450202750|FG001|Overall Study|New therapy for study indication|0|||
125157777|NCT03096847|450202751|FG002|Overall Study|New therapy for study indication|1|||
125157778|NCT01640873|450202752|FG000|Overall Study|Protocol Violation|2|||
125157779|NCT01640873|450202753|FG001|Overall Study|Protocol Violation|1|||
125157780|NCT02192164|450202754|FG000|Overall Study|Other|8|||
125157781|NCT02192164|450202754|FG000|Overall Study|Withdrawal by Subject|1|||
125157782|NCT02192164|450202754|FG000|Overall Study|Physician Decision|4|||
125157783|NCT02192164|450202754|FG000|Overall Study|Did not meet the exclusion criteria|1|||
125157784|NCT00359788|450202757|FG000|Overall Study|Adverse Event|11|||
125157785|NCT00359788|450202758|FG001|Overall Study|Adverse Event|10|||
125157786|NCT00359788|450202757|FG000|Overall Study|Lack of Efficacy|1|||
125157787|NCT00359788|450202758|FG001|Overall Study|Lack of Efficacy|2|||
125157788|NCT00359788|450202757|FG000|Overall Study|Lost to Follow-up|3|||
125157789|NCT00359788|450202758|FG001|Overall Study|Lost to Follow-up|2|||
125157790|NCT00359788|450202757|FG000|Overall Study|Withdrawal by Subject|4|||
125157791|NCT00359788|450202758|FG001|Overall Study|Withdrawal by Subject|1|||
125157792|NCT00359788|450202757|FG000|Overall Study|Protocol Violation|4|||
125157793|NCT00359788|450202758|FG001|Overall Study|Protocol Violation|2|||
125157794|NCT02143583|450202759|FG000|Overall Study|Withdrawal by Subject|1|||
125157795|NCT02143583|450202760|FG001|Overall Study|Withdrawal by Subject|0|||
125157796|NCT02143583|450202761|FG002|Overall Study|Withdrawal by Subject|1|||
125157797|NCT02143583|450202759|FG000|Overall Study|husband illness|0|||
125157798|NCT02143583|450202760|FG001|Overall Study|husband illness|0|||
125157799|NCT02143583|450202761|FG002|Overall Study|husband illness|1|||
125157800|NCT00673933|450202762|FG000|Overall Study|Withdrawal by Subject|2|||
125157801|NCT00673933|450202762|FG000|Overall Study|Lost to Follow-up|1|||
125157802|NCT04932941|450202763|FG000|Overall Study|Lost to Follow-up|3|||
125157803|NCT04932941|450202764|FG001|Overall Study|Lost to Follow-up|1|||
125157804|NCT04932941|450202763|FG000|Overall Study|Withdrawal by Subject|7|||
125157805|NCT04932941|450202764|FG001|Overall Study|Withdrawal by Subject|4|||
125157806|NCT04932941|450202763|FG000|Overall Study|Other|4|||
125389129|NCT00909779|451058067|FG001|Overall Study|Noncompliance|1|||
125157807|NCT04932941|450202764|FG001|Overall Study|Other|2|||
125157808|NCT01929031|450202767|FG000|Overall Study|Adverse Event|3|||
125157809|NCT01929031|450202768|FG001|Overall Study|Adverse Event|1|||
125157810|NCT01929031|450202769|FG002|Overall Study|Adverse Event|1|||
125157811|NCT01929031|450202770|FG003|Overall Study|Adverse Event|0|||
125157812|NCT01929031|450202771|FG004|Overall Study|Adverse Event|0|||
125157813|NCT01929031|450202772|FG005|Overall Study|Adverse Event|0|||
125157814|NCT01929031|450202767|FG000|Overall Study|Protocol Violation|1|||
125157815|NCT01929031|450202768|FG001|Overall Study|Protocol Violation|0|||
125157816|NCT01929031|450202769|FG002|Overall Study|Protocol Violation|0|||
125157817|NCT01929031|450202770|FG003|Overall Study|Protocol Violation|0|||
125157818|NCT01929031|450202771|FG004|Overall Study|Protocol Violation|0|||
125157819|NCT01929031|450202772|FG005|Overall Study|Protocol Violation|1|||
125389130|NCT00909779|451058066|FG000|Overall Study|Randomized in error|1|||
125157820|NCT01929031|450202767|FG000|Overall Study|Reason other than specified above|0|||
125157821|NCT01929031|450202768|FG001|Overall Study|Reason other than specified above|1|||
125389131|NCT00909779|451058067|FG001|Overall Study|Randomized in error|1|||
125438800|NCT01076088|451233959|FG000|Overall Study|Withdrawal by Subject|8|||
125438801|NCT01076088|451233960|FG001|Overall Study|Withdrawal by Subject|8|||
125438802|NCT01076088|451233961|FG002|Overall Study|Withdrawal by Subject|14|||
125438803|NCT01076088|451233962|FG003|Overall Study|Withdrawal by Subject|10|||
125157822|NCT01929031|450202769|FG002|Overall Study|Reason other than specified above|0|||
125157823|NCT01929031|450202770|FG003|Overall Study|Reason other than specified above|0|||
125438804|NCT01076088|451233963|FG004|Overall Study|Withdrawal by Subject|11|||
125157824|NCT01929031|450202771|FG004|Overall Study|Reason other than specified above|1|||
125157825|NCT01929031|450202772|FG005|Overall Study|Reason other than specified above|0|||
125157826|NCT02394730|450202778|FG000|Overall Study|Lost to Follow-up|1|||
125157827|NCT02394730|450202779|FG001|Overall Study|Lost to Follow-up|0|||
125157828|NCT02394730|450202778|FG000|Overall Study|Withdrawal by Subject|0|||
125157829|NCT02394730|450202779|FG001|Overall Study|Withdrawal by Subject|1|||
125157830|NCT03510182|450202783|FG000|Overall Study|Withdrawal by Subject|2|||
125157831|NCT01195272|450202784|FG000|Overall Study|Adverse Event|1|||
125157832|NCT01195272|450202784|FG000|Overall Study|Lack of Efficacy|3|||
125157833|NCT04905290|450204521|FG000|Overall Study|Adverse Event|4|||
125157834|NCT04905290|450204521|FG000|Overall Study|Death|2|||
125157835|NCT04905290|450204521|FG000|Overall Study|Withdrawal by Subject|4|||
125157836|NCT04905290|450204521|FG000|Overall Study|Physician Decision|2|||
125157837|NCT04905290|450204521|FG000|Overall Study|Lost to Follow-up|2|||
125157838|NCT04905290|450204521|FG000|Overall Study|Screen Failure|2|||
125157839|NCT04905290|450204521|FG000|Overall Study|Unsuccessful Procedure|2|||
125157840|NCT03295318|450204522|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
125157841|NCT03295318|450204523|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
125157842|NCT03295318|450204524|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
125157843|NCT03295318|450204522|FG000|Overall Study|Death|1|||
125157844|NCT03295318|450204523|FG001|Overall Study|Death|1|||
125157845|NCT03295318|450204524|FG002|Overall Study|Death|1|||
125157846|NCT03295318|450204522|FG000|Overall Study|Protocol Violation|4|||
125157847|NCT03295318|450204523|FG001|Overall Study|Protocol Violation|3|||
125157848|NCT03295318|450204524|FG002|Overall Study|Protocol Violation|3|||
125157849|NCT03295318|450204522|FG000|Overall Study|Withdrawal by Subject|0|||
125157850|NCT03295318|450204523|FG001|Overall Study|Withdrawal by Subject|0|||
125157851|NCT03295318|450204524|FG002|Overall Study|Withdrawal by Subject|1|||
125157852|NCT03295318|450204522|FG000|Overall Study|Subject discontinued due to travel|0|||
125157853|NCT03295318|450204523|FG001|Overall Study|Subject discontinued due to travel|1|||
125157854|NCT03295318|450204524|FG002|Overall Study|Subject discontinued due to travel|0|||
125157855|NCT04319718|450204525|FG000|Overall Study|Adverse Event|0|||
125157856|NCT04319718|450204526|FG001|Overall Study|Adverse Event|2|||
125157857|NCT04319718|450204525|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
125157858|NCT04319718|450204526|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
125157859|NCT01288053|450204527|FG000|Overall Study|Death|1|||
125157860|NCT00144781|450204528|FG000|Overall Study|Adverse Event|0|||
125157861|NCT00144781|450204529|FG001|Overall Study|Adverse Event|1|||
125157862|NCT00144781|450204530|FG002|Overall Study|Adverse Event|0|||
125157863|NCT00144781|450204531|FG003|Overall Study|Adverse Event|0|||
125157864|NCT00144781|450204528|FG000|Overall Study|Non-compliant|0|||
125157865|NCT00144781|450204529|FG001|Overall Study|Non-compliant|1|||
125157866|NCT00144781|450204530|FG002|Overall Study|Non-compliant|0|||
125157867|NCT00144781|450204531|FG003|Overall Study|Non-compliant|0|||
125157868|NCT02068092|450204532|FG000|Overall Study|Physician Decision|2|||
125157869|NCT02068092|450204532|FG000|Overall Study|Adverse Event|2|||
125157870|NCT02068092|450204532|FG000|Overall Study|Lost to Follow-up|4|||
125157871|NCT02068092|450204532|FG000|Overall Study|Withdrawal by Subject|2|||
125157872|NCT01045421|450204533|FG000|Phase 1|Progressive Disease|0|||
125157873|NCT01045421|450204534|FG001|Phase 1|Progressive Disease|0|||
125157874|NCT01045421|450204535|FG002|Phase 1|Progressive Disease|0|||
125438805|NCT01076088|451233964|FG005|Overall Study|Withdrawal by Subject|17|||
125438806|NCT01076088|451233959|FG000|Overall Study|Other protocol specified criteria|0|||
125157875|NCT01045421|450204536|FG003|Phase 1|Progressive Disease|0|||
125157876|NCT01045421|450204537|FG004|Phase 1|Progressive Disease|1|||
125157877|NCT01045421|450204538|FG005|Phase 1|Progressive Disease|0|||
125157878|NCT01045421|450204539|FG006|Phase 1|Progressive Disease|0|||
125157879|NCT01045421|450204540|FG007|Phase 1|Progressive Disease|0|||
125157880|NCT01045421|450204541|FG008|Phase 1|Progressive Disease|0|||
125157881|NCT01045421|450204542|FG009|Phase 1|Progressive Disease|0|||
125157882|NCT01045421|450204543|FG010|Phase 1|Progressive Disease|0|||
125157883|NCT01045421|450204533|FG000|Phase 1|Withdrawal by Subject|0|||
125157884|NCT01045421|450204534|FG001|Phase 1|Withdrawal by Subject|0|||
125157885|NCT01045421|450204535|FG002|Phase 1|Withdrawal by Subject|0|||
125157886|NCT01045421|450204536|FG003|Phase 1|Withdrawal by Subject|1|||
125157887|NCT01045421|450204537|FG004|Phase 1|Withdrawal by Subject|0|||
125157888|NCT01045421|450204538|FG005|Phase 1|Withdrawal by Subject|0|||
125157889|NCT01045421|450204539|FG006|Phase 1|Withdrawal by Subject|0|||
125157890|NCT01045421|450204540|FG007|Phase 1|Withdrawal by Subject|0|||
125438807|NCT01076088|451233960|FG001|Overall Study|Other protocol specified criteria|0|||
125157891|NCT01045421|450204541|FG008|Phase 1|Withdrawal by Subject|0|||
125157892|NCT01045421|450204542|FG009|Phase 1|Withdrawal by Subject|0|||
125157893|NCT01045421|450204543|FG010|Phase 1|Withdrawal by Subject|0|||
125157894|NCT01045421|450204533|FG000|Phase 2|Progressive Disease|0|||
125157895|NCT01045421|450204534|FG001|Phase 2|Progressive Disease|0|||
125157896|NCT01045421|450204535|FG002|Phase 2|Progressive Disease|0|||
125157897|NCT01045421|450204536|FG003|Phase 2|Progressive Disease|0|||
125389132|NCT02738333|451058069|FG000|Overall Study|Death|1|||
125389133|NCT02738333|451058070|FG001|Overall Study|Death|0|||
125389134|NCT02738333|451058071|FG002|Overall Study|Death|0|||
125157898|NCT01045421|450204537|FG004|Phase 2|Progressive Disease|0|||
125157899|NCT01045421|450204538|FG005|Phase 2|Progressive Disease|0|||
125157900|NCT01045421|450204539|FG006|Phase 2|Progressive Disease|0|||
125157901|NCT01045421|450204540|FG007|Phase 2|Progressive Disease|1|||
125157902|NCT01045421|450204541|FG008|Phase 2|Progressive Disease|1|||
125157903|NCT01045421|450204542|FG009|Phase 2|Progressive Disease|1|||
125157904|NCT01045421|450204543|FG010|Phase 2|Progressive Disease|1|||
125157905|NCT01045421|450204533|FG000|Phase 2|Death|0|||
125157906|NCT01045421|450204534|FG001|Phase 2|Death|0|||
125157907|NCT01045421|450204535|FG002|Phase 2|Death|0|||
125157908|NCT01045421|450204536|FG003|Phase 2|Death|0|||
125157909|NCT01045421|450204537|FG004|Phase 2|Death|0|||
125157910|NCT01045421|450204538|FG005|Phase 2|Death|0|||
125157911|NCT01045421|450204539|FG006|Phase 2|Death|0|||
125157912|NCT01045421|450204540|FG007|Phase 2|Death|1|||
125157913|NCT01045421|450204541|FG008|Phase 2|Death|1|||
125157914|NCT01045421|450204542|FG009|Phase 2|Death|2|||
125157915|NCT01045421|450204543|FG010|Phase 2|Death|0|||
125157916|NCT01045421|450204533|FG000|Phase 2|Other|0|||
125157917|NCT01045421|450204534|FG001|Phase 2|Other|0|||
125157918|NCT01045421|450204535|FG002|Phase 2|Other|0|||
125157919|NCT01045421|450204536|FG003|Phase 2|Other|0|||
125157920|NCT01045421|450204537|FG004|Phase 2|Other|0|||
125157921|NCT01045421|450204538|FG005|Phase 2|Other|0|||
125157922|NCT01045421|450204539|FG006|Phase 2|Other|0|||
125157923|NCT01045421|450204540|FG007|Phase 2|Other|3|||
125157924|NCT01045421|450204541|FG008|Phase 2|Other|0|||
125157925|NCT01045421|450204542|FG009|Phase 2|Other|0|||
125157926|NCT01045421|450204543|FG010|Phase 2|Other|1|||
125157927|NCT02221037|450204544|FG000|Overall Study|Physician Decision|0|||
125157928|NCT02221037|450204545|FG001|Overall Study|Physician Decision|0|||
125157929|NCT02221037|450204546|FG002|Overall Study|Physician Decision|1|||
125157930|NCT02221037|450204547|FG003|Overall Study|Physician Decision|0|||
125157931|NCT02307266|450204548|FG000|Overall Study|Adverse Event|3|||
125157932|NCT02307266|450204549|FG001|Overall Study|Adverse Event|1|||
125157933|NCT02307266|450204550|FG002|Overall Study|Adverse Event|5|||
125157934|NCT02307266|450204548|FG000|Overall Study|Withdrawal by Subject|2|||
125157935|NCT02307266|450204549|FG001|Overall Study|Withdrawal by Subject|0|||
125157936|NCT02307266|450204550|FG002|Overall Study|Withdrawal by Subject|1|||
125157937|NCT02307266|450204548|FG000|Overall Study|Lost to Follow-up|3|||
125157938|NCT02307266|450204549|FG001|Overall Study|Lost to Follow-up|0|||
125157939|NCT02307266|450204550|FG002|Overall Study|Lost to Follow-up|0|||
125157940|NCT01995266|450204559|FG000|Overall Study|Death|1|||
125157941|NCT01995266|450204559|FG000|Overall Study|Lack of Efficacy|6|||
125157942|NCT01995266|450204559|FG000|Overall Study|Adverse Event|2|||
125157943|NCT03596151|450204563|FG000|Overall Study|Withdrawal by Subject|1|||
125157944|NCT00729248|450204566|FG000|Overall Study|Physician Decision|2|||
125157945|NCT03573505|450204572|FG000|Overall Study|Adverse Event|1|||
125157946|NCT03573505|450204573|FG001|Overall Study|Adverse Event|1|||
125157947|NCT03573505|450204572|FG000|Overall Study|Consent withdrawn|0|||
125157948|NCT03573505|450204573|FG001|Overall Study|Consent withdrawn|1|||
125389135|NCT02738333|451058069|FG000|Overall Study|Lost to Follow-up|1|||
125389136|NCT02738333|451058070|FG001|Overall Study|Lost to Follow-up|0|||
125389137|NCT02738333|451058071|FG002|Overall Study|Lost to Follow-up|0|||
125157949|NCT03573505|450204572|FG000|Overall Study|Disease progression|0|||
125157950|NCT03573505|450204573|FG001|Overall Study|Disease progression|1|||
125157951|NCT03573505|450204572|FG000|Overall Study|Site Terminated by Sponsor|1|||
125157952|NCT03573505|450204573|FG001|Overall Study|Site Terminated by Sponsor|1|||
125157953|NCT03573505|450204572|FG000|Overall Study|Study terminated by sponsor|50|||
125157954|NCT03573505|450204573|FG001|Overall Study|Study terminated by sponsor|45|||
125157955|NCT03573505|450204572|FG000|Overall Study|Reason not specified|0|||
125157956|NCT03573505|450204573|FG001|Overall Study|Reason not specified|1|||
125389138|NCT01520363|451058072|FG000|Overall Study|Withdrawal by Subject|2|||
125157957|NCT03573505|450204572|FG000|Overall Study|Death|0|||
125157958|NCT03573505|450204573|FG001|Overall Study|Death|4|||
125157959|NCT03222583|450204574|FG000|Overall Study|Withdrawal by Subject|3|||
125157960|NCT03222583|450204575|FG001|Overall Study|Withdrawal by Subject|3|||
125157961|NCT03222583|450204574|FG000|Overall Study|Lost to Follow-up|1|||
125157962|NCT03222583|450204575|FG001|Overall Study|Lost to Follow-up|0|||
125157963|NCT03222583|450204574|FG000|Overall Study|Other|1|||
125157964|NCT03222583|450204575|FG001|Overall Study|Other|3|||
125157965|NCT04280705|450204576|FG000|Overall Study|Enrolled but not treated|4|||
125157966|NCT04280705|450204577|FG001|Overall Study|Enrolled but not treated|10|||
125157967|NCT04280705|450204576|FG000|Overall Study|Physician Decision|1|||
125389139|NCT01520363|451058073|FG001|Overall Study|Withdrawal by Subject|0|||
125389140|NCT01498952|451058075|FG000|Overall Study|Death|2|||
125389141|NCT01498952|451058076|FG001|Overall Study|Death|2|||
125389142|NCT01498952|451058077|FG002|Overall Study|Death|0|||
125389143|NCT01498952|451058078|FG003|Overall Study|Death|0|||
125389144|NCT01498952|451058079|FG004|Overall Study|Death|0|||
125389145|NCT00579826|451058080|FG000|Overall Study|Withdrawal by Subject|5|||
125389146|NCT00579826|451058081|FG001|Overall Study|Withdrawal by Subject|3|||
125389147|NCT02073279|451058089|FG000|Double-blind Period|Adverse Event|1|||
125389148|NCT02073279|451058090|FG001|Double-blind Period|Adverse Event|1|||
125389149|NCT02073279|451058089|FG000|Double-blind Period|Switched to another treatment|1|||
125438808|NCT01076088|451233961|FG002|Overall Study|Other protocol specified criteria|0|||
125438809|NCT01076088|451233962|FG003|Overall Study|Other protocol specified criteria|0|||
125438810|NCT01076088|451233963|FG004|Overall Study|Other protocol specified criteria|0|||
125438811|NCT01076088|451233964|FG005|Overall Study|Other protocol specified criteria|1|||
125438812|NCT04362137|451233965|FG000|Overall Study|Death|9|||
125438813|NCT04362137|451233966|FG001|Overall Study|Death|3|||
125438814|NCT04362137|451233965|FG000|Overall Study|Patient decision|6|||
125438815|NCT04362137|451233966|FG001|Overall Study|Patient decision|3|||
125438816|NCT04362137|451233965|FG000|Overall Study|Adverse Event|1|||
125438817|NCT04362137|451233966|FG001|Overall Study|Adverse Event|0|||
125438818|NCT04362137|451233965|FG000|Overall Study|Lost to Follow-up|1|||
125438819|NCT04362137|451233966|FG001|Overall Study|Lost to Follow-up|0|||
125438820|NCT04362137|451233965|FG000|Overall Study|Protocol deviation|1|||
125438821|NCT04362137|451233966|FG001|Overall Study|Protocol deviation|0|||
125438822|NCT03306043|451233970|FG000|Overall Study|Adverse Event|1|||
125438823|NCT03306043|451233970|FG000|Overall Study|Lost to Follow-up|1|||
125438824|NCT03306043|451233970|FG000|Overall Study|Withdrawal by Subject|2|||
125438825|NCT00785538|451233971|FG000|Treatment Period|Adverse Event|1|||
125438826|NCT00785538|451233972|FG001|Treatment Period|Adverse Event|2|||
125438827|NCT00785538|451233973|FG002|Treatment Period|Adverse Event|2|||
125438828|NCT00785538|451233974|FG003|Treatment Period|Adverse Event|0|||
125438829|NCT00785538|451233971|FG000|Treatment Period|Withdrawal by Subject|0|||
125438830|NCT00785538|451233972|FG001|Treatment Period|Withdrawal by Subject|0|||
125438831|NCT00785538|451233973|FG002|Treatment Period|Withdrawal by Subject|0|||
125157968|NCT04280705|450204577|FG001|Overall Study|Physician Decision|0|||
125157969|NCT04280705|450204576|FG000|Overall Study|Withdrawal by Subject|7|||
125157970|NCT04280705|450204577|FG001|Overall Study|Withdrawal by Subject|9|||
125157971|NCT04280705|450204576|FG000|Overall Study|Adverse Event|0|||
125157972|NCT04280705|450204577|FG001|Overall Study|Adverse Event|4|||
125157973|NCT04280705|450204576|FG000|Overall Study|Transferred to another hospital|1|||
125157974|NCT04280705|450204577|FG001|Overall Study|Transferred to another hospital|1|||
125389150|NCT02073279|451058090|FG001|Double-blind Period|Switched to another treatment|2|||
125157975|NCT04268316|450204580|FG000|Overall Study|Withdrawal by Subject|2|||
125157976|NCT04268316|450204581|FG001|Overall Study|Withdrawal by Subject|1|||
125157977|NCT04268316|450204582|FG002|Overall Study|Withdrawal by Subject|0|||
125157978|NCT05855616|450204592|FG000|Overall Study|Lost to Follow-up|1|||
125157979|NCT05855616|450204593|FG001|Overall Study|Lost to Follow-up|2|||
125157980|NCT04032158|450204594|FG000|Overall Study|Study Termination|2|||
125157981|NCT04032158|450204595|FG001|Overall Study|Study Termination|1|||
125157982|NCT00059787|450204596|FG000|Overall Study|Adverse Event|13|||
125157983|NCT00059787|450204596|FG000|Overall Study|disease progression|2|||
125157984|NCT00059787|450204596|FG000|Overall Study|ineligible|1|||
125157985|NCT00059787|450204596|FG000|Overall Study|Other|4|||
125157986|NCT00103311|450204603|FG000|Overall Study|Lost to Follow-up|1|||
125157987|NCT00103311|450204604|FG001|Overall Study|Lost to Follow-up|0|||
125157988|NCT00103311|450204603|FG000|Overall Study|Withdrawal by Subject|2|||
125157989|NCT00103311|450204604|FG001|Overall Study|Withdrawal by Subject|1|||
125389151|NCT02073279|451058089|FG000|Double-blind Period|Protocol Violation|0|||
125389152|NCT02073279|451058090|FG001|Double-blind Period|Protocol Violation|1|||
125438832|NCT00785538|451233974|FG003|Treatment Period|Withdrawal by Subject|1|||
125438833|NCT01234649|451233975|FG000|Overall Study|Withdrawal by Subject|32|||
125438834|NCT01234649|451233976|FG001|Overall Study|Withdrawal by Subject|26|||
125438835|NCT01234649|451233975|FG000|Overall Study|Pregnancy|6|||
125438836|NCT01234649|451233976|FG001|Overall Study|Pregnancy|6|||
125438837|NCT01234649|451233975|FG000|Overall Study|intolerant to side effects|4|||
125438838|NCT01234649|451233976|FG001|Overall Study|intolerant to side effects|3|||
125157990|NCT00103311|450204603|FG000|Overall Study|Adverse Event|1|||
125157991|NCT00103311|450204604|FG001|Overall Study|Adverse Event|0|||
125157992|NCT01196078|450204605|FG000|Overall Study|Withdrawal by Subject|3|||
125438839|NCT01234649|451233975|FG000|Overall Study|Allergic reaction|1|||
125157993|NCT01196078|450204606|FG001|Overall Study|Withdrawal by Subject|5|||
125157994|NCT01196078|450204605|FG000|Overall Study|Adverse Event|4|||
125157995|NCT01196078|450204606|FG001|Overall Study|Adverse Event|4|||
125157996|NCT01196078|450204605|FG000|Overall Study|Protocol Violation|2|||
125157997|NCT01196078|450204606|FG001|Overall Study|Protocol Violation|1|||
125438840|NCT01234649|451233976|FG001|Overall Study|Allergic reaction|0|||
125438841|NCT01234649|451233975|FG000|Overall Study|Lack of Efficacy|0|||
125438842|NCT01234649|451233976|FG001|Overall Study|Lack of Efficacy|3|||
125157998|NCT01196078|450204605|FG000|Overall Study|Lack of Efficacy|17|||
125157999|NCT01196078|450204606|FG001|Overall Study|Lack of Efficacy|23|||
125158000|NCT01196078|450204605|FG000|Overall Study|Lost to Follow-up|1|||
125158001|NCT01196078|450204606|FG001|Overall Study|Lost to Follow-up|0|||
125158002|NCT01196078|450204605|FG000|Overall Study|Death|6|||
125158003|NCT01196078|450204606|FG001|Overall Study|Death|4|||
125158004|NCT01403064|450204607|FG000|Overall Study|Death|0|||
125158005|NCT01403064|450204608|FG001|Overall Study|Death|0|||
125158006|NCT01403064|450204609|FG002|Overall Study|Death|1|||
125158007|NCT01403064|450204610|FG003|Overall Study|Death|1|||
125158008|NCT01403064|450204607|FG000|Overall Study|Withdrawal by Subject|0|||
125158009|NCT01403064|450204608|FG001|Overall Study|Withdrawal by Subject|0|||
125158010|NCT01403064|450204609|FG002|Overall Study|Withdrawal by Subject|1|||
125158011|NCT01403064|450204610|FG003|Overall Study|Withdrawal by Subject|1|||
125158012|NCT01403064|450204607|FG000|Overall Study|Other|1|||
125158013|NCT01403064|450204608|FG001|Overall Study|Other|0|||
125158014|NCT01403064|450204609|FG002|Overall Study|Other|2|||
125158015|NCT01403064|450204610|FG003|Overall Study|Other|1|||
125158016|NCT04688931|450204620|FG000|Overall Study|Adverse Event|4|||
125158017|NCT04688931|450204621|FG001|Overall Study|Adverse Event|1|||
125158018|NCT04688931|450204620|FG000|Overall Study|Withdrawal by Subject|5|||
125389153|NCT02073279|451058089|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
125389154|NCT02073279|451058090|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
125389155|NCT02073279|451058089|FG000|Double-blind Period|Withdrawal by Subject|2|||
125389156|NCT02073279|451058090|FG001|Double-blind Period|Withdrawal by Subject|2|||
125389157|NCT02073279|451058089|FG000|Open-label Extension Period|Adverse Event|1|||
125389158|NCT02073279|451058090|FG001|Open-label Extension Period|Adverse Event|0|||
125389159|NCT02073279|451058089|FG000|Open-label Extension Period|Lack of Efficacy|1|||
125389160|NCT02073279|451058090|FG001|Open-label Extension Period|Lack of Efficacy|0|||
125389161|NCT02073279|451058089|FG000|Open-label Extension Period|Lost to Follow-up|0|||
125389162|NCT02073279|451058090|FG001|Open-label Extension Period|Lost to Follow-up|4|||
125389163|NCT02073279|451058089|FG000|Open-label Extension Period|Switched to another treatment|1|||
125389164|NCT02073279|451058090|FG001|Open-label Extension Period|Switched to another treatment|4|||
125389165|NCT02073279|451058089|FG000|Open-label Extension Period|Protocol Violation|0|||
125389166|NCT02073279|451058090|FG001|Open-label Extension Period|Protocol Violation|1|||
125389167|NCT02073279|451058089|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
125389168|NCT02073279|451058090|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
125389169|NCT02073279|451058089|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
125389170|NCT02073279|451058090|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
125389171|NCT00304356|451058091|FG000|Nitazoxanide|Physician Decision|5|||
125389172|NCT00304356|451058091|FG000|Nitazoxanide|Physician Decision|1|||
125389173|NCT00304356|451058091|FG000|Nitazoxanide|number is 0|1|||
125389174|NCT00304356|451058091|FG000|Nitazoxanide|Physician Decision|1|||
125389175|NCT00304356|451058091|FG000|Nitazoxanide|Physician Decision|1|||
125389176|NCT00304356|451058091|FG000|Nitazoxanide|Physician Decision|1|||
125389177|NCT00335972|451058092|FG000|Overall Study|not given treatments|0|||
125389178|NCT00335972|451058093|FG001|Overall Study|not given treatments|3|||
125389179|NCT00729183|451058095|FG000|Overall Study|Adverse Event|11|||
125389180|NCT00729183|451058096|FG001|Overall Study|Adverse Event|5|||
125389181|NCT00729183|451058095|FG000|Overall Study|Lack of Efficacy|0|||
125389182|NCT00729183|451058096|FG001|Overall Study|Lack of Efficacy|1|||
125389183|NCT00729183|451058095|FG000|Overall Study|Lost to Follow-up|3|||
125389184|NCT00729183|451058096|FG001|Overall Study|Lost to Follow-up|1|||
125389185|NCT00729183|451058095|FG000|Overall Study|Physician Decision|1|||
125389186|NCT00729183|451058096|FG001|Overall Study|Physician Decision|1|||
125389187|NCT00729183|451058095|FG000|Overall Study|Protocol Violation|1|||
125389188|NCT00729183|451058096|FG001|Overall Study|Protocol Violation|0|||
125389189|NCT00729183|451058095|FG000|Overall Study|Withdrawal by Subject|9|||
125389190|NCT00729183|451058096|FG001|Overall Study|Withdrawal by Subject|7|||
125389191|NCT05497284|451058097|FG000|Overall Study|Adverse Event|1|||
125389192|NCT05497284|451058098|FG001|Overall Study|Adverse Event|0|||
125158019|NCT04688931|450204621|FG001|Overall Study|Withdrawal by Subject|16|||
125158020|NCT04688931|450204620|FG000|Overall Study|Physician Decision|3|||
125158021|NCT04688931|450204621|FG001|Overall Study|Physician Decision|5|||
125389193|NCT05497284|451058097|FG000|Overall Study|Physician Decision|0|||
125389194|NCT05497284|451058098|FG001|Overall Study|Physician Decision|1|||
125389195|NCT05497284|451058097|FG000|Overall Study|Study terminated by sponsor|7|||
125389196|NCT05497284|451058098|FG001|Overall Study|Study terminated by sponsor|4|||
125389197|NCT05497284|451058097|FG000|Overall Study|Subject Decision|0|||
125389198|NCT05497284|451058098|FG001|Overall Study|Subject Decision|1|||
125389199|NCT03878446|451058099|FG000|Overall Study|Withdrawn by parent or guardian|1|||
125158022|NCT04688931|450204620|FG000|Overall Study|Noncompliance|0|||
125158023|NCT04688931|450204621|FG001|Overall Study|Noncompliance|1|||
125158024|NCT04688931|450204620|FG000|Overall Study|Lost to Follow-up|1|||
125158025|NCT04688931|450204621|FG001|Overall Study|Lost to Follow-up|3|||
125158026|NCT04688931|450204620|FG000|Overall Study|Randomization Error|3|||
125389200|NCT03878446|451058100|FG001|Overall Study|Withdrawn by parent or guardian|0|||
125438843|NCT00318149|451233979|FG000|Overall Study|Adverse Event|0|||
125158027|NCT04688931|450204621|FG001|Overall Study|Randomization Error|0|||
125158028|NCT04688931|450204620|FG000|Overall Study|Not Eligible|1|||
125158029|NCT04688931|450204621|FG001|Overall Study|Not Eligible|3|||
125158030|NCT04688931|450204620|FG000|Overall Study|Disease Progression|0|||
125158031|NCT04688931|450204621|FG001|Overall Study|Disease Progression|2|||
125158032|NCT04688931|450204620|FG000|Overall Study|Sponsor Requirement|1|||
125158033|NCT04688931|450204621|FG001|Overall Study|Sponsor Requirement|1|||
125158034|NCT04688931|450204620|FG000|Overall Study|Other Reason|1|||
125158035|NCT04688931|450204621|FG001|Overall Study|Other Reason|2|||
125158036|NCT00450619|450204622|FG000|Overall Study|refused treatment after randomization|2|||
125158037|NCT00450619|450204623|FG001|Overall Study|refused treatment after randomization|0|||
125158038|NCT00450619|450204622|FG000|Overall Study|did not progress; refused further trmt|1|||
125158039|NCT00450619|450204623|FG001|Overall Study|did not progress; refused further trmt|1|||
125158040|NCT00450619|450204622|FG000|Overall Study|Adverse Event|1|||
125158041|NCT00450619|450204623|FG001|Overall Study|Adverse Event|0|||
125158042|NCT02034058|450204624|FG000|Overall Study|Death|3|||
125158043|NCT02963311|450204629|FG000|Overall Study|Withdrawal by Subject|1|||
125158044|NCT02963311|450204629|FG000|Overall Study|Screen Failure|4|||
125158045|NCT01968694|450204649|FG000|Washout (1 Month)|Lost to Follow-up|0|||
125158046|NCT01968694|450204650|FG001|Washout (1 Month)|Lost to Follow-up|1|||
125158047|NCT02836496|450204653|FG000|Overall Study|Adverse Event|2|||
125158048|NCT02836496|450204654|FG001|Overall Study|Adverse Event|1|||
125158049|NCT02836496|450204653|FG000|Overall Study|Withdrawal by Subject|0|||
125158050|NCT02836496|450204654|FG001|Overall Study|Withdrawal by Subject|1|||
125158051|NCT00354341|450204655|FG000|Overall Study|Adverse Event|1|||
125158052|NCT00354341|450204656|FG001|Overall Study|Adverse Event|0|||
125158053|NCT00354341|450204655|FG000|Overall Study|Death|0|||
125158054|NCT00354341|450204656|FG001|Overall Study|Death|2|||
125158055|NCT00354341|450204655|FG000|Overall Study|Refused treatment|1|||
125158056|NCT00354341|450204656|FG001|Overall Study|Refused treatment|2|||
125158057|NCT00354341|450204655|FG000|Overall Study|Failure to return|0|||
125158058|NCT00354341|450204656|FG001|Overall Study|Failure to return|1|||
125158059|NCT00354341|450204655|FG000|Overall Study|Other|1|||
125158060|NCT00354341|450204656|FG001|Overall Study|Other|2|||
125158061|NCT01400919|450204657|FG000|Overall Study|Withdrawal by Subject|4|||
125158062|NCT01400919|450204657|FG000|Overall Study|Lost to Follow-up|2|||
125158063|NCT01400919|450204657|FG000|Overall Study|Missed visit|2|||
125158064|NCT00251719|450204658|FG000|Overall Study|Adverse Event|14|||
125158065|NCT00251719|450204659|FG001|Overall Study|Adverse Event|8|||
125158066|NCT00251719|450204660|FG002|Overall Study|Adverse Event|7|||
125158067|NCT00251719|450204658|FG000|Overall Study|Protocol Violation|1|||
125158068|NCT00251719|450204659|FG001|Overall Study|Protocol Violation|1|||
125158069|NCT00251719|450204660|FG002|Overall Study|Protocol Violation|1|||
125158070|NCT00251719|450204658|FG000|Overall Study|Lost to Follow-up|5|||
125158071|NCT00251719|450204659|FG001|Overall Study|Lost to Follow-up|11|||
125158072|NCT00251719|450204660|FG002|Overall Study|Lost to Follow-up|8|||
125158073|NCT00251719|450204658|FG000|Overall Study|Withdrawal by Subject|14|||
125158074|NCT00251719|450204659|FG001|Overall Study|Withdrawal by Subject|12|||
125158075|NCT00251719|450204660|FG002|Overall Study|Withdrawal by Subject|11|||
125158076|NCT00251719|450204658|FG000|Overall Study|Lack of Efficacy|2|||
125158077|NCT00251719|450204659|FG001|Overall Study|Lack of Efficacy|1|||
125158078|NCT00251719|450204660|FG002|Overall Study|Lack of Efficacy|0|||
125158079|NCT00251719|450204658|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
125158080|NCT00251719|450204659|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
125158081|NCT00251719|450204660|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
125158082|NCT00251719|450204658|FG000|Overall Study|Investigator decision|1|||
125158083|NCT00251719|450204659|FG001|Overall Study|Investigator decision|1|||
125158084|NCT00251719|450204660|FG002|Overall Study|Investigator decision|0|||
125158085|NCT00251719|450204658|FG000|Overall Study|Noncompliance|2|||
125158086|NCT00251719|450204659|FG001|Overall Study|Noncompliance|3|||
125158087|NCT00251719|450204660|FG002|Overall Study|Noncompliance|1|||
125158088|NCT00251719|450204658|FG000|Overall Study|Barrett's esophagus|2|||
125158089|NCT00251719|450204659|FG001|Overall Study|Barrett's esophagus|2|||
125158090|NCT00251719|450204660|FG002|Overall Study|Barrett's esophagus|0|||
125158091|NCT03822832|450204661|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
125158092|NCT03822832|450204662|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
125158093|NCT03822832|450204661|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
125158094|NCT03822832|450204662|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
125158095|NCT03822832|450204661|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
125158096|NCT03822832|450204662|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
125158097|NCT03822832|450204661|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
125158098|NCT03822832|450204662|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
125158099|NCT03822832|450204661|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
125158100|NCT03822832|450204662|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
125158101|NCT03822832|450204661|FG000|Re-allocation|Not re-allocated to open label period|2|||
125158102|NCT03822832|450204662|FG001|Re-allocation|Not re-allocated to open label period|6|||
125158103|NCT03822832|450204661|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
125158104|NCT03822832|450204662|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
125158105|NCT03822832|450204661|FG000|Period 2 - Open Label Period|Adverse Event|0|||
125158106|NCT03822832|450204662|FG001|Period 2 - Open Label Period|Adverse Event|3|||
125158107|NCT01732874|450204663|FG000|Overall Study|Withdrawal by Subject|5|||
125158108|NCT01732874|450204664|FG001|Overall Study|Withdrawal by Subject|1|||
125158109|NCT01732874|450204663|FG000|Overall Study|Death of Infant|3|||
125158110|NCT01732874|450204664|FG001|Overall Study|Death of Infant|2|||
125158111|NCT00846521|450204667|FG000|Overall Study|Withdrawal by Subject|5|||
125158112|NCT00846521|450204667|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
125158113|NCT00846521|450204667|FG000|Overall Study|Protocol Violation|1|||
125158114|NCT01246011|450204668|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
125158115|NCT01246011|450204669|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
125158116|NCT01246011|450204670|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
125158117|NCT01246011|450204668|FG000|Overall Study|Withdrawal by Subject|0|||
125158118|NCT01246011|450204669|FG001|Overall Study|Withdrawal by Subject|0|||
125158119|NCT01246011|450204670|FG002|Overall Study|Withdrawal by Subject|1|||
125158120|NCT04392583|450204671|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
125158121|NCT02303041|450204672|FG000|Overall Study|Adverse Event|1|||
125158122|NCT02303041|450204673|FG001|Overall Study|Adverse Event|2|||
125158123|NCT03979820|450204674|FG000|Overall Study|Protocol Violation|1|||
125158124|NCT03979820|450204675|FG001|Overall Study|Protocol Violation|0|||
125158125|NCT03979820|450204676|FG002|Overall Study|Protocol Violation|0|||
125158126|NCT03979820|450204677|FG003|Overall Study|Protocol Violation|0|||
125158127|NCT03979820|450204674|FG000|Overall Study|Withdrawal by Subject|0|||
125158128|NCT03979820|450204675|FG001|Overall Study|Withdrawal by Subject|0|||
125158129|NCT03979820|450204676|FG002|Overall Study|Withdrawal by Subject|1|||
125158130|NCT03979820|450204677|FG003|Overall Study|Withdrawal by Subject|0|||
125158131|NCT03979820|450204674|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
125158132|NCT03979820|450204675|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
125158133|NCT03979820|450204676|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
125158134|NCT03979820|450204677|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
125158135|NCT00160641|450204678|FG000|Overall Study|Adverse Event|102|||
125158136|NCT00160641|450204678|FG000|Overall Study|Withdrawal by Subject|87|||
125158137|NCT00160641|450204678|FG000|Overall Study|Lost to Follow-up|8|||
125158138|NCT00160641|450204678|FG000|Overall Study|Lack of Efficacy|12|||
125158139|NCT00160641|450204678|FG000|Overall Study|Protocol Violation|3|||
125158140|NCT00160641|450204678|FG000|Overall Study|Other|9|||
125158141|NCT05816200|450204692|FG000|Overall Study|Lost to Follow-up|2|||
125158142|NCT05816200|450204693|FG001|Overall Study|Lost to Follow-up|1|||
125158143|NCT01366443|450204694|FG000|Overall Study|Lost to Follow-up|2|||
125158144|NCT01366443|450204694|FG000|Overall Study|Under 18 yo|1|||
125158145|NCT00369382|450204695|FG000|Overall Study|Death|0|||
125158146|NCT00369382|450204696|FG001|Overall Study|Death|2|||
125158147|NCT00369382|450204695|FG000|Overall Study|Physician Decision|2|||
125158148|NCT00369382|450204696|FG001|Overall Study|Physician Decision|1|||
125158149|NCT00369382|450204695|FG000|Overall Study|Withdrawal by Subject|5|||
125158150|NCT00369382|450204696|FG001|Overall Study|Withdrawal by Subject|0|||
125158151|NCT00369382|450204695|FG000|Overall Study|Randomized, not treated|2|||
125158152|NCT00369382|450204696|FG001|Overall Study|Randomized, not treated|0|||
125158153|NCT00369382|450204695|FG000|Overall Study|Other|1|||
125158154|NCT00369382|450204696|FG001|Overall Study|Other|0|||
125158155|NCT01673698|450204699|FG000|Overall Study|Lost to Follow-up|51|||
125158156|NCT01673698|450204700|FG001|Overall Study|Lost to Follow-up|13|||
125158157|NCT00507546|450204701|FG000|Overall Study|Withdrawal by Subject|1|||
125158158|NCT00507546|450204702|FG001|Overall Study|Withdrawal by Subject|0|||
125158159|NCT00507546|450204701|FG000|Overall Study|Protocol Violation|1|||
125158160|NCT00507546|450204702|FG001|Overall Study|Protocol Violation|0|||
125158161|NCT00507546|450204701|FG000|Overall Study|Physician Decision|0|||
125158162|NCT00507546|450204702|FG001|Overall Study|Physician Decision|1|||
125158163|NCT00448136|450204703|FG000|Overall Study|Death|3|||
125158164|NCT00448136|450204704|FG001|Overall Study|Death|8|||
125158165|NCT00448136|450204703|FG000|Overall Study|Investigator's decision (progression)|1|||
125158166|NCT00448136|450204704|FG001|Overall Study|Investigator's decision (progression)|0|||
125158167|NCT00609466|450204705|FG000|Overall Study|Withdrawal by Subject|0|||
125158168|NCT00609466|450204706|FG001|Overall Study|Withdrawal by Subject|1|||
125158169|NCT00609466|450204707|FG002|Overall Study|Withdrawal by Subject|1|||
125158170|NCT00609466|450204705|FG000|Overall Study|Adverse Event|2|||
125158171|NCT00609466|450204706|FG001|Overall Study|Adverse Event|3|||
125158172|NCT00609466|450204707|FG002|Overall Study|Adverse Event|1|||
125389201|NCT03878446|451058101|FG002|Overall Study|Withdrawn by parent or guardian|0|||
125389202|NCT03878446|451058102|FG003|Overall Study|Withdrawn by parent or guardian|0|||
125158173|NCT00609466|450204705|FG000|Overall Study|Lack of Efficacy|0|||
125158174|NCT00609466|450204706|FG001|Overall Study|Lack of Efficacy|2|||
125389203|NCT03878446|451058103|FG004|Overall Study|Withdrawn by parent or guardian|0|||
125158175|NCT00609466|450204707|FG002|Overall Study|Lack of Efficacy|2|||
125158176|NCT03512262|450204708|FG000|Overall Study|Adverse Event|8|||
125158177|NCT03512262|450204709|FG001|Overall Study|Adverse Event|3|||
125158178|NCT03512262|450204708|FG000|Overall Study|Death (non-treatment emergent)|1|||
125158179|NCT03512262|450204709|FG001|Overall Study|Death (non-treatment emergent)|0|||
125158180|NCT03512262|450204708|FG000|Overall Study|Withdrawal by Subject|17|||
125158181|NCT03512262|450204709|FG001|Overall Study|Withdrawal by Subject|9|||
125158182|NCT03512262|450204708|FG000|Overall Study|Lost to Follow-up|7|||
125158183|NCT03512262|450204709|FG001|Overall Study|Lost to Follow-up|1|||
125158184|NCT03512262|450204708|FG000|Overall Study|Other than Specified|2|||
125158185|NCT03512262|450204709|FG001|Overall Study|Other than Specified|2|||
125158186|NCT03407430|450204710|FG000|Washout|Protocol Violation|1|||
125158187|NCT03407430|450204711|FG001|Washout|Protocol Violation|0|||
125158188|NCT03502707|450206211|FG000|Overall Study|Adverse Event|0|||
125158189|NCT03502707|450206212|FG001|Overall Study|Adverse Event|0|||
125158190|NCT03502707|450206213|FG002|Overall Study|Adverse Event|0|||
125158191|NCT03502707|450206214|FG003|Overall Study|Adverse Event|0|||
125158192|NCT03502707|450206215|FG004|Overall Study|Adverse Event|0|||
125158193|NCT03502707|450206216|FG005|Overall Study|Adverse Event|0|||
125158194|NCT03502707|450206217|FG006|Overall Study|Adverse Event|0|||
125158195|NCT03502707|450206218|FG007|Overall Study|Adverse Event|0|||
125158196|NCT03502707|450206219|FG008|Overall Study|Adverse Event|0|||
125158197|NCT03502707|450206220|FG009|Overall Study|Adverse Event|0|||
125158198|NCT03502707|450206221|FG010|Overall Study|Adverse Event|0|||
125158199|NCT03502707|450206222|FG011|Overall Study|Adverse Event|0|||
125158200|NCT03502707|450206223|FG012|Overall Study|Adverse Event|0|||
125158201|NCT03502707|450206224|FG013|Overall Study|Adverse Event|0|||
125158202|NCT03502707|450206225|FG014|Overall Study|Adverse Event|0|||
125158203|NCT03502707|450206226|FG015|Overall Study|Adverse Event|1|||
125158204|NCT03502707|450206227|FG016|Overall Study|Adverse Event|5|||
125158205|NCT03502707|450206228|FG017|Overall Study|Adverse Event|0|||
125158206|NCT03502707|450206211|FG000|Overall Study|Death|0|||
125158207|NCT03502707|450206212|FG001|Overall Study|Death|0|||
125158208|NCT03502707|450206213|FG002|Overall Study|Death|0|||
125158209|NCT03502707|450206214|FG003|Overall Study|Death|1|||
125158210|NCT03502707|450206215|FG004|Overall Study|Death|0|||
125158211|NCT03502707|450206216|FG005|Overall Study|Death|0|||
125158212|NCT03502707|450206217|FG006|Overall Study|Death|0|||
125158213|NCT03502707|450206218|FG007|Overall Study|Death|0|||
125158214|NCT03502707|450206219|FG008|Overall Study|Death|1|||
125158215|NCT03502707|450206220|FG009|Overall Study|Death|1|||
125158216|NCT03502707|450206221|FG010|Overall Study|Death|0|||
125158217|NCT03502707|450206222|FG011|Overall Study|Death|0|||
125158218|NCT03502707|450206223|FG012|Overall Study|Death|1|||
125158219|NCT03502707|450206224|FG013|Overall Study|Death|0|||
125158220|NCT03502707|450206225|FG014|Overall Study|Death|0|||
125158221|NCT03502707|450206226|FG015|Overall Study|Death|1|||
125158222|NCT03502707|450206227|FG016|Overall Study|Death|0|||
125158223|NCT03502707|450206228|FG017|Overall Study|Death|0|||
125158224|NCT03502707|450206211|FG000|Overall Study|Lost to Follow-up|0|||
125158225|NCT03502707|450206212|FG001|Overall Study|Lost to Follow-up|0|||
125158226|NCT03502707|450206213|FG002|Overall Study|Lost to Follow-up|0|||
125158227|NCT03502707|450206214|FG003|Overall Study|Lost to Follow-up|0|||
125158228|NCT03502707|450206215|FG004|Overall Study|Lost to Follow-up|0|||
125158229|NCT03502707|450206216|FG005|Overall Study|Lost to Follow-up|0|||
125158230|NCT03502707|450206217|FG006|Overall Study|Lost to Follow-up|0|||
125158231|NCT03502707|450206218|FG007|Overall Study|Lost to Follow-up|5|||
125158232|NCT03502707|450206219|FG008|Overall Study|Lost to Follow-up|0|||
125158233|NCT03502707|450206220|FG009|Overall Study|Lost to Follow-up|2|||
125158234|NCT03502707|450206221|FG010|Overall Study|Lost to Follow-up|1|||
125158235|NCT03502707|450206222|FG011|Overall Study|Lost to Follow-up|2|||
125389204|NCT04365556|451058104|FG000|Overall Study|No longer eligible due to treatment plan|1|||
125389205|NCT04365556|451058105|FG001|Overall Study|No longer eligible due to treatment plan|0|||
125389206|NCT04365556|451058104|FG000|Overall Study|Lost to Follow-up|3|||
125389207|NCT04365556|451058105|FG001|Overall Study|Lost to Follow-up|2|||
125158236|NCT03502707|450206223|FG012|Overall Study|Lost to Follow-up|1|||
125158237|NCT03502707|450206224|FG013|Overall Study|Lost to Follow-up|1|||
125158238|NCT03502707|450206225|FG014|Overall Study|Lost to Follow-up|0|||
125158239|NCT03502707|450206226|FG015|Overall Study|Lost to Follow-up|4|||
125158240|NCT03502707|450206227|FG016|Overall Study|Lost to Follow-up|9|||
125389208|NCT01502423|451058106|FG000|Overall Study|Withdrawal by Subject|0|||
125389209|NCT01502423|451058107|FG001|Overall Study|Withdrawal by Subject|1|||
125158241|NCT03502707|450206228|FG017|Overall Study|Lost to Follow-up|2|||
125158242|NCT03502707|450206211|FG000|Overall Study|Physician Decision|0|||
125158243|NCT03502707|450206212|FG001|Overall Study|Physician Decision|0|||
125158244|NCT03502707|450206213|FG002|Overall Study|Physician Decision|0|||
125158245|NCT03502707|450206214|FG003|Overall Study|Physician Decision|0|||
125158246|NCT03502707|450206215|FG004|Overall Study|Physician Decision|0|||
125158247|NCT03502707|450206216|FG005|Overall Study|Physician Decision|0|||
125158248|NCT03502707|450206217|FG006|Overall Study|Physician Decision|0|||
125158249|NCT03502707|450206218|FG007|Overall Study|Physician Decision|0|||
125158250|NCT03502707|450206219|FG008|Overall Study|Physician Decision|2|||
125158251|NCT03502707|450206220|FG009|Overall Study|Physician Decision|1|||
125158252|NCT03502707|450206221|FG010|Overall Study|Physician Decision|0|||
125158253|NCT03502707|450206222|FG011|Overall Study|Physician Decision|0|||
125158254|NCT03502707|450206223|FG012|Overall Study|Physician Decision|0|||
125158255|NCT03502707|450206224|FG013|Overall Study|Physician Decision|0|||
125158256|NCT03502707|450206225|FG014|Overall Study|Physician Decision|1|||
125158257|NCT03502707|450206226|FG015|Overall Study|Physician Decision|3|||
125158258|NCT03502707|450206227|FG016|Overall Study|Physician Decision|0|||
125158259|NCT03502707|450206228|FG017|Overall Study|Physician Decision|0|||
125158260|NCT03502707|450206211|FG000|Overall Study|Protocol Violation|0|||
125158261|NCT03502707|450206212|FG001|Overall Study|Protocol Violation|0|||
125438844|NCT00318149|451233980|FG001|Overall Study|Adverse Event|0|||
125438845|NCT00318149|451233981|FG002|Overall Study|Adverse Event|0|||
125438846|NCT00318149|451233982|FG003|Overall Study|Adverse Event|0|||
125438847|NCT00318149|451233983|FG004|Overall Study|Adverse Event|0|||
125438848|NCT00318149|451233984|FG005|Overall Study|Adverse Event|2|||
125438849|NCT00785707|451233991|FG000|Overall Study|Lost to Follow-up|7|||
125438850|NCT02262260|451233992|FG000|Overall Study|Adverse Event|4|||
125438851|NCT02262260|451233993|FG001|Overall Study|Adverse Event|1|||
125438852|NCT02262260|451233992|FG000|Overall Study|Withdrawal of consent|4|||
125438853|NCT02262260|451233993|FG001|Overall Study|Withdrawal of consent|2|||
125438854|NCT02262260|451233992|FG000|Overall Study|Lost to Follow-up|1|||
125438855|NCT02262260|451233993|FG001|Overall Study|Lost to Follow-up|2|||
125438856|NCT02262260|451233992|FG000|Overall Study|Protocol deviation|2|||
125438857|NCT02262260|451233993|FG001|Overall Study|Protocol deviation|5|||
125438858|NCT01794117|451233995|FG000|Overall Study|Adverse Event|1|||
125438859|NCT01794117|451233996|FG001|Overall Study|Adverse Event|0|||
125438860|NCT01794117|451233997|FG002|Overall Study|Adverse Event|0|||
125438861|NCT01794117|451233998|FG003|Overall Study|Adverse Event|0|||
125438862|NCT01794117|451233995|FG000|Overall Study|Participant noncompliance|0|||
125438863|NCT01794117|451233996|FG001|Overall Study|Participant noncompliance|1|||
125438864|NCT01794117|451233997|FG002|Overall Study|Participant noncompliance|0|||
125438865|NCT01794117|451233998|FG003|Overall Study|Participant noncompliance|0|||
125438866|NCT01794117|451233995|FG000|Overall Study|Refused further treatment|0|||
125438867|NCT01794117|451233996|FG001|Overall Study|Refused further treatment|2|||
125438868|NCT01794117|451233997|FG002|Overall Study|Refused further treatment|0|||
125438869|NCT01794117|451233998|FG003|Overall Study|Refused further treatment|0|||
125438870|NCT02322814|451233999|FG000|Overall Study|Death|7|||
125438871|NCT02322814|451234000|FG001|Overall Study|Death|29|||
125438872|NCT02322814|451234001|FG002|Overall Study|Death|32|||
125438873|NCT02322814|451234002|FG003|Overall Study|Death|23|||
125438874|NCT02322814|451234003|FG004|Overall Study|Death|14|||
125438875|NCT02322814|451233999|FG000|Overall Study|Lost to Follow-up|1|||
125438876|NCT02322814|451234000|FG001|Overall Study|Lost to Follow-up|3|||
125438877|NCT02322814|451234001|FG002|Overall Study|Lost to Follow-up|3|||
125438878|NCT02322814|451234002|FG003|Overall Study|Lost to Follow-up|1|||
125438879|NCT02322814|451234003|FG004|Overall Study|Lost to Follow-up|0|||
125438880|NCT02322814|451233999|FG000|Overall Study|Various Reasons|2|||
125158262|NCT03502707|450206213|FG002|Overall Study|Protocol Violation|0|||
125158263|NCT03502707|450206214|FG003|Overall Study|Protocol Violation|0|||
125158264|NCT03502707|450206215|FG004|Overall Study|Protocol Violation|0|||
125158265|NCT03502707|450206216|FG005|Overall Study|Protocol Violation|0|||
125158266|NCT03502707|450206217|FG006|Overall Study|Protocol Violation|0|||
125158267|NCT03502707|450206218|FG007|Overall Study|Protocol Violation|0|||
125158268|NCT03502707|450206219|FG008|Overall Study|Protocol Violation|0|||
125158269|NCT03502707|450206220|FG009|Overall Study|Protocol Violation|0|||
125158270|NCT03502707|450206221|FG010|Overall Study|Protocol Violation|0|||
125158271|NCT03502707|450206222|FG011|Overall Study|Protocol Violation|0|||
125158272|NCT03502707|450206223|FG012|Overall Study|Protocol Violation|0|||
125158273|NCT03502707|450206224|FG013|Overall Study|Protocol Violation|0|||
125158274|NCT03502707|450206225|FG014|Overall Study|Protocol Violation|0|||
125158275|NCT03502707|450206226|FG015|Overall Study|Protocol Violation|1|||
125158276|NCT03502707|450206227|FG016|Overall Study|Protocol Violation|0|||
125158277|NCT03502707|450206228|FG017|Overall Study|Protocol Violation|0|||
125158278|NCT03502707|450206211|FG000|Overall Study|Withdrawal by Subject|1|||
125438881|NCT02322814|451234000|FG001|Overall Study|Various Reasons|0|||
125438882|NCT02322814|451234001|FG002|Overall Study|Various Reasons|1|||
125438883|NCT02322814|451234002|FG003|Overall Study|Various Reasons|1|||
125158279|NCT03502707|450206212|FG001|Overall Study|Withdrawal by Subject|1|||
125158280|NCT03502707|450206213|FG002|Overall Study|Withdrawal by Subject|0|||
125438884|NCT02322814|451234003|FG004|Overall Study|Various Reasons|0|||
125438885|NCT02322814|451233999|FG000|Overall Study|Progressive Disease|0|||
125158281|NCT03502707|450206214|FG003|Overall Study|Withdrawal by Subject|0|||
125438886|NCT02322814|451234000|FG001|Overall Study|Progressive Disease|0|||
125158282|NCT03502707|450206215|FG004|Overall Study|Withdrawal by Subject|0|||
125158283|NCT03502707|450206216|FG005|Overall Study|Withdrawal by Subject|2|||
125158284|NCT03502707|450206217|FG006|Overall Study|Withdrawal by Subject|0|||
125438887|NCT02322814|451234001|FG002|Overall Study|Progressive Disease|0|||
125438888|NCT02322814|451234002|FG003|Overall Study|Progressive Disease|1|||
125438889|NCT02322814|451234003|FG004|Overall Study|Progressive Disease|1|||
125438890|NCT02322814|451233999|FG000|Overall Study|Protocol Violation|1|||
125158285|NCT03502707|450206218|FG007|Overall Study|Withdrawal by Subject|3|||
125158286|NCT03502707|450206219|FG008|Overall Study|Withdrawal by Subject|1|||
125158287|NCT03502707|450206220|FG009|Overall Study|Withdrawal by Subject|2|||
125158288|NCT03502707|450206221|FG010|Overall Study|Withdrawal by Subject|12|||
125158289|NCT03502707|450206222|FG011|Overall Study|Withdrawal by Subject|23|||
125158290|NCT03502707|450206223|FG012|Overall Study|Withdrawal by Subject|5|||
125158291|NCT03502707|450206224|FG013|Overall Study|Withdrawal by Subject|3|||
125158292|NCT03502707|450206225|FG014|Overall Study|Withdrawal by Subject|3|||
125158293|NCT03502707|450206226|FG015|Overall Study|Withdrawal by Subject|43|||
125158294|NCT03502707|450206227|FG016|Overall Study|Withdrawal by Subject|44|||
125158295|NCT03502707|450206228|FG017|Overall Study|Withdrawal by Subject|18|||
125158296|NCT03502707|450206211|FG000|Overall Study|Sponsor's Decision|1|||
125158297|NCT03502707|450206212|FG001|Overall Study|Sponsor's Decision|0|||
125158298|NCT03502707|450206213|FG002|Overall Study|Sponsor's Decision|0|||
125158299|NCT03502707|450206214|FG003|Overall Study|Sponsor's Decision|0|||
125158300|NCT03502707|450206215|FG004|Overall Study|Sponsor's Decision|0|||
125158301|NCT03502707|450206216|FG005|Overall Study|Sponsor's Decision|0|||
125158302|NCT03502707|450206217|FG006|Overall Study|Sponsor's Decision|0|||
125158303|NCT03502707|450206218|FG007|Overall Study|Sponsor's Decision|0|||
125158304|NCT03502707|450206219|FG008|Overall Study|Sponsor's Decision|0|||
125158305|NCT03502707|450206220|FG009|Overall Study|Sponsor's Decision|1|||
125158306|NCT03502707|450206221|FG010|Overall Study|Sponsor's Decision|0|||
125158307|NCT03502707|450206222|FG011|Overall Study|Sponsor's Decision|0|||
125158308|NCT03502707|450206223|FG012|Overall Study|Sponsor's Decision|0|||
125158309|NCT03502707|450206224|FG013|Overall Study|Sponsor's Decision|0|||
125158310|NCT03502707|450206225|FG014|Overall Study|Sponsor's Decision|0|||
125158311|NCT03502707|450206226|FG015|Overall Study|Sponsor's Decision|2|||
125158312|NCT03502707|450206227|FG016|Overall Study|Sponsor's Decision|1|||
125158313|NCT03502707|450206228|FG017|Overall Study|Sponsor's Decision|0|||
125158314|NCT03502707|450206211|FG000|Overall Study|Initiated Prohibited Medication|0|||
125158315|NCT03502707|450206212|FG001|Overall Study|Initiated Prohibited Medication|0|||
125158316|NCT03502707|450206213|FG002|Overall Study|Initiated Prohibited Medication|0|||
125158317|NCT03502707|450206214|FG003|Overall Study|Initiated Prohibited Medication|0|||
125158318|NCT03502707|450206215|FG004|Overall Study|Initiated Prohibited Medication|0|||
125158319|NCT03502707|450206216|FG005|Overall Study|Initiated Prohibited Medication|0|||
125158320|NCT03502707|450206217|FG006|Overall Study|Initiated Prohibited Medication|0|||
125158321|NCT03502707|450206218|FG007|Overall Study|Initiated Prohibited Medication|0|||
125158322|NCT03502707|450206219|FG008|Overall Study|Initiated Prohibited Medication|0|||
125158323|NCT03502707|450206220|FG009|Overall Study|Initiated Prohibited Medication|0|||
125158324|NCT03502707|450206221|FG010|Overall Study|Initiated Prohibited Medication|0|||
125158325|NCT03502707|450206222|FG011|Overall Study|Initiated Prohibited Medication|0|||
125158326|NCT03502707|450206223|FG012|Overall Study|Initiated Prohibited Medication|0|||
125158327|NCT03502707|450206224|FG013|Overall Study|Initiated Prohibited Medication|0|||
125158328|NCT03502707|450206225|FG014|Overall Study|Initiated Prohibited Medication|0|||
125158329|NCT03502707|450206226|FG015|Overall Study|Initiated Prohibited Medication|0|||
125158330|NCT03502707|450206227|FG016|Overall Study|Initiated Prohibited Medication|1|||
125158331|NCT03502707|450206228|FG017|Overall Study|Initiated Prohibited Medication|0|||
125158332|NCT03502707|450206211|FG000|Overall Study|Other|0|||
125158333|NCT03502707|450206212|FG001|Overall Study|Other|0|||
125158334|NCT03502707|450206213|FG002|Overall Study|Other|0|||
125158335|NCT03502707|450206214|FG003|Overall Study|Other|0|||
125158336|NCT03502707|450206215|FG004|Overall Study|Other|0|||
125158337|NCT03502707|450206216|FG005|Overall Study|Other|0|||
125158338|NCT03502707|450206217|FG006|Overall Study|Other|0|||
125158339|NCT03502707|450206218|FG007|Overall Study|Other|0|||
125158340|NCT03502707|450206219|FG008|Overall Study|Other|1|||
125158341|NCT03502707|450206220|FG009|Overall Study|Other|1|||
125158342|NCT03502707|450206221|FG010|Overall Study|Other|2|||
125389210|NCT03181399|451060327|FG000|6 Months on Treatment|Protocol non-compliance|7|||
125389211|NCT03181399|451060327|FG000|6 Months on Treatment|Adverse Event|4|||
125389212|NCT03181399|451060327|FG000|6 Months on Treatment|Tried alternative treatment|2|||
125389213|NCT03181399|451060327|FG000|6 Months on Treatment|Lost to Follow-up|2|||
125158343|NCT03502707|450206222|FG011|Overall Study|Other|0|||
125158344|NCT03502707|450206223|FG012|Overall Study|Other|0|||
125158345|NCT03502707|450206224|FG013|Overall Study|Other|0|||
125158346|NCT03502707|450206225|FG014|Overall Study|Other|0|||
125158347|NCT03502707|450206226|FG015|Overall Study|Other|4|||
125158348|NCT03502707|450206227|FG016|Overall Study|Other|1|||
125158349|NCT03502707|450206228|FG017|Overall Study|Other|0|||
125158350|NCT03502707|450206211|FG000|Overall Study|Randomized but not vaccinated|0|||
125158351|NCT03502707|450206212|FG001|Overall Study|Randomized but not vaccinated|0|||
125158352|NCT03502707|450206213|FG002|Overall Study|Randomized but not vaccinated|0|||
125158353|NCT03502707|450206214|FG003|Overall Study|Randomized but not vaccinated|0|||
125158354|NCT03502707|450206215|FG004|Overall Study|Randomized but not vaccinated|0|||
125158355|NCT03502707|450206216|FG005|Overall Study|Randomized but not vaccinated|0|||
125158356|NCT03502707|450206217|FG006|Overall Study|Randomized but not vaccinated|0|||
125158357|NCT03502707|450206218|FG007|Overall Study|Randomized but not vaccinated|0|||
125158358|NCT03502707|450206219|FG008|Overall Study|Randomized but not vaccinated|0|||
125158359|NCT03502707|450206220|FG009|Overall Study|Randomized but not vaccinated|0|||
125158360|NCT03502707|450206221|FG010|Overall Study|Randomized but not vaccinated|0|||
125158361|NCT03502707|450206222|FG011|Overall Study|Randomized but not vaccinated|1|||
125158362|NCT03502707|450206223|FG012|Overall Study|Randomized but not vaccinated|0|||
125158363|NCT03502707|450206224|FG013|Overall Study|Randomized but not vaccinated|0|||
125158364|NCT03502707|450206225|FG014|Overall Study|Randomized but not vaccinated|0|||
125158365|NCT03502707|450206226|FG015|Overall Study|Randomized but not vaccinated|0|||
125158366|NCT03502707|450206227|FG016|Overall Study|Randomized but not vaccinated|0|||
125158367|NCT03502707|450206228|FG017|Overall Study|Randomized but not vaccinated|1|||
125158368|NCT04551911|450206229|FG000|Overall Study|Lost to Follow-up|2|||
125158369|NCT04551911|450206230|FG001|Overall Study|Lost to Follow-up|1|||
125158370|NCT04551911|450206229|FG000|Overall Study|Withdrawal by Subject|10|||
125158371|NCT04551911|450206230|FG001|Overall Study|Withdrawal by Subject|10|||
125158372|NCT04551911|450206229|FG000|Overall Study|Did not receive the study drug|3|||
125158373|NCT04551911|450206230|FG001|Overall Study|Did not receive the study drug|4|||
125158374|NCT01030341|450206231|FG000|Overall Study|Withdrawal by Subject|1|||
125158375|NCT01030341|450206231|FG000|Overall Study|Lost to Follow-up|2|||
125158376|NCT01884311|450206232|FG000|Overall Study|Withdrawal by Subject|3|||
125158377|NCT01884311|450206232|FG000|Overall Study|withdrew consent due to AEs|1|||
125158378|NCT01884311|450206232|FG000|Overall Study|Precautionary measure|1|||
125158379|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Death|89|||
125158380|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Death|193|||
125158381|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Death|198|||
125158382|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
125158383|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
125158384|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
125158385|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
125158386|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
125158387|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
125158388|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
125158389|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
125158390|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
125158391|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
125158392|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
125158393|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
125158394|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
125158395|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
125158396|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
125158397|NCT02031458|450206235|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
125158398|NCT02031458|450206236|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
125158399|NCT02031458|450206237|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
125158400|NCT02031458|450206235|FG000|Baseline to May 8, 2015|Death|36|||
125158401|NCT02031458|450206236|FG001|Baseline to May 8, 2015|Death|87|||
125158402|NCT02031458|450206237|FG002|Baseline to May 8, 2015|Death|100|||
125158403|NCT02031458|450206235|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
125158404|NCT02031458|450206236|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
125158405|NCT02031458|450206237|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
125158406|NCT02031458|450206235|FG000|Baseline to May 8, 2015|Physician Decision|0|||
125389214|NCT03181399|451060327|FG000|6 Months on Treatment|Personal reasons|1|||
125389215|NCT03181399|451060327|FG000|3 Months Off-treatment|Parent unable to travel|1|||
125389216|NCT05123222|451060328|FG000|Overall Study|Lost to Follow-up|2|||
125389217|NCT05123222|451060329|FG001|Overall Study|Lost to Follow-up|0|||
125389218|NCT05123222|451060330|FG002|Overall Study|Lost to Follow-up|0|||
125158407|NCT02031458|450206236|FG001|Baseline to May 8, 2015|Physician Decision|1|||
125158408|NCT02031458|450206237|FG002|Baseline to May 8, 2015|Physician Decision|0|||
125158409|NCT02031458|450206235|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
125158410|NCT02031458|450206236|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
125158411|NCT02031458|450206237|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
125223927|NCT02155985|450446270|FG001|Overall Study|Lost to Follow-up|0|||
125223928|NCT02155985|450446271|FG002|Overall Study|Lost to Follow-up|0|||
125223929|NCT02998151|450446272|FG000|Overall Study|Withdrawal by Subject|3|||
125223930|NCT02998151|450446272|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
125223931|NCT02998151|450446272|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
125223932|NCT02573259|450446275|FG000|Overall Study|Death|1|||
125223933|NCT02573259|450446276|FG001|Overall Study|Death|6|||
125223934|NCT02573259|450446277|FG002|Overall Study|Death|5|||
125223935|NCT02573259|450446278|FG003|Overall Study|Death|6|||
125223936|NCT02573259|450446279|FG004|Overall Study|Death|9|||
125223937|NCT02573259|450446280|FG005|Overall Study|Death|32|||
125223938|NCT02573259|450446281|FG006|Overall Study|Death|21|||
125389219|NCT05123222|451060331|FG003|Overall Study|Lost to Follow-up|0|||
125389220|NCT05123222|451060328|FG000|Overall Study|Protocol Violation|0|||
125389221|NCT05123222|451060329|FG001|Overall Study|Protocol Violation|0|||
125389222|NCT05123222|451060330|FG002|Overall Study|Protocol Violation|1|||
125389223|NCT05123222|451060331|FG003|Overall Study|Protocol Violation|0|||
125389224|NCT00265343|451060332|FG000|Overall Study|Adverse Event|10|||
125389225|NCT00265343|451060333|FG001|Overall Study|Adverse Event|7|||
125389226|NCT00265343|451060332|FG000|Overall Study|Withdrawal by Subject|3|||
125389227|NCT00265343|451060333|FG001|Overall Study|Withdrawal by Subject|9|||
125389228|NCT00265343|451060332|FG000|Overall Study|Other|8|||
125389229|NCT00265343|451060333|FG001|Overall Study|Other|3|||
125389230|NCT04865354|451060334|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
125389231|NCT04865354|451060335|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
125389232|NCT04865354|451060334|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
125158412|NCT02031458|450206235|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
125158413|NCT02031458|450206236|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
125158414|NCT02031458|450206237|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
125223939|NCT02573259|450446275|FG000|Overall Study|Lost to Follow-up|0|||
125223940|NCT02573259|450446276|FG001|Overall Study|Lost to Follow-up|0|||
125223941|NCT02573259|450446277|FG002|Overall Study|Lost to Follow-up|0|||
125223942|NCT02573259|450446278|FG003|Overall Study|Lost to Follow-up|0|||
125223943|NCT02573259|450446279|FG004|Overall Study|Lost to Follow-up|0|||
125223944|NCT02573259|450446280|FG005|Overall Study|Lost to Follow-up|2|||
125223945|NCT02573259|450446281|FG006|Overall Study|Lost to Follow-up|1|||
125223946|NCT02573259|450446275|FG000|Overall Study|Participant refused further follow-up|0|||
125223947|NCT02573259|450446276|FG001|Overall Study|Participant refused further follow-up|2|||
125223948|NCT02573259|450446277|FG002|Overall Study|Participant refused further follow-up|1|||
125223949|NCT02573259|450446278|FG003|Overall Study|Participant refused further follow-up|0|||
125223950|NCT02573259|450446279|FG004|Overall Study|Participant refused further follow-up|3|||
125223951|NCT02573259|450446280|FG005|Overall Study|Participant refused further follow-up|20|||
125223952|NCT02573259|450446281|FG006|Overall Study|Participant refused further follow-up|7|||
125223953|NCT02573259|450446275|FG000|Overall Study|Other|0|||
125223954|NCT02573259|450446276|FG001|Overall Study|Other|0|||
125223955|NCT02573259|450446277|FG002|Overall Study|Other|0|||
125223956|NCT02573259|450446278|FG003|Overall Study|Other|0|||
125223957|NCT02573259|450446279|FG004|Overall Study|Other|1|||
125223958|NCT02573259|450446280|FG005|Overall Study|Other|4|||
125223959|NCT02573259|450446281|FG006|Overall Study|Other|5|||
125223960|NCT00751140|450446282|FG000|Overall Study|benign angioma excluded from analysis|1|||
125223961|NCT03718429|450446286|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
125223962|NCT03718429|450446287|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
125223963|NCT03718429|450446288|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
125223964|NCT03718429|450446289|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
125223965|NCT04632225|450446292|FG000|Overall Study|Withdrawal by Subject|2|||
125223966|NCT04632225|450446293|FG001|Overall Study|Withdrawal by Subject|2|||
125389233|NCT04865354|451060335|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
125389234|NCT04865354|451060334|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
125158415|NCT02031458|450206235|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
125389235|NCT04865354|451060335|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
125158416|NCT02031458|450206236|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
125158417|NCT02031458|450206237|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
125158418|NCT02031458|450206235|FG000|Baseline to May 8, 2015|On Treatment|43|||
125158419|NCT02031458|450206236|FG001|Baseline to May 8, 2015|On Treatment|81|||
125158420|NCT02031458|450206237|FG002|Baseline to May 8, 2015|On Treatment|73|||
125158421|NCT02031458|450206235|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
125158422|NCT02031458|450206236|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
125158423|NCT02031458|450206237|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
125158424|NCT00609518|450206239|FG000|Overall Study|Death from Study Disease|32|||
125158425|NCT00609518|450206240|FG001|Overall Study|Death from Study Disease|32|||
125158426|NCT00609518|450206239|FG000|Overall Study|Withdrawal by Subject|5|||
125158427|NCT00609518|450206240|FG001|Overall Study|Withdrawal by Subject|3|||
125158428|NCT00609518|450206239|FG000|Overall Study|Lost to Follow-up|3|||
125158429|NCT00609518|450206240|FG001|Overall Study|Lost to Follow-up|0|||
125158430|NCT00609518|450206239|FG000|Overall Study|Physician Decision|1|||
125158431|NCT00609518|450206240|FG001|Overall Study|Physician Decision|3|||
125158432|NCT00609518|450206239|FG000|Overall Study|Death from Adverse Event|2|||
125223967|NCT00325819|450446294|FG000|Overall Study|Study product lost in mail|2|||
125389236|NCT00706641|451060336|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
125438891|NCT02322814|451234000|FG001|Overall Study|Protocol Violation|0|||
125158433|NCT00609518|450206240|FG001|Overall Study|Death from Adverse Event|2|||
125223968|NCT00325819|450446295|FG001|Overall Study|Study product lost in mail|1|||
125223969|NCT00325819|450446294|FG000|Overall Study|Did not take a dose of study product|4|||
125223970|NCT00325819|450446295|FG001|Overall Study|Did not take a dose of study product|9|||
125223971|NCT00325819|450446294|FG000|Overall Study|Lost to Follow-up|3|||
125223972|NCT00325819|450446295|FG001|Overall Study|Lost to Follow-up|3|||
125438892|NCT02322814|451234001|FG002|Overall Study|Protocol Violation|0|||
125158434|NCT00292188|450206244|FG000|Single-Blind|Adverse Event|14|||
125158435|NCT00292188|450206245|FG001|Single-Blind|Adverse Event|0|||
125158436|NCT00292188|450206246|FG002|Single-Blind|Adverse Event|0|||
125158437|NCT00292188|450206244|FG000|Single-Blind|Lack of Efficacy|2|||
125158438|NCT00292188|450206245|FG001|Single-Blind|Lack of Efficacy|0|||
125158439|NCT00292188|450206246|FG002|Single-Blind|Lack of Efficacy|0|||
125158440|NCT00292188|450206244|FG000|Single-Blind|Laboratory Abnormality|5|||
125158441|NCT00292188|450206245|FG001|Single-Blind|Laboratory Abnormality|0|||
125158442|NCT00292188|450206246|FG002|Single-Blind|Laboratory Abnormality|0|||
125158443|NCT00292188|450206244|FG000|Single-Blind|Lost to Follow-up|3|||
125158444|NCT00292188|450206245|FG001|Single-Blind|Lost to Follow-up|0|||
125158445|NCT00292188|450206246|FG002|Single-Blind|Lost to Follow-up|0|||
125158446|NCT00292188|450206244|FG000|Single-Blind|Other|77|||
125158447|NCT00292188|450206245|FG001|Single-Blind|Other|0|||
125158448|NCT00292188|450206246|FG002|Single-Blind|Other|0|||
125158449|NCT00292188|450206244|FG000|Single-Blind|Withdrawal by Subject|12|||
125158450|NCT00292188|450206245|FG001|Single-Blind|Withdrawal by Subject|0|||
125158451|NCT00292188|450206246|FG002|Single-Blind|Withdrawal by Subject|0|||
125158452|NCT00292188|450206244|FG000|Single-Blind|Did not receive treatment|1|||
125158453|NCT00292188|450206245|FG001|Single-Blind|Did not receive treatment|0|||
125158454|NCT00292188|450206246|FG002|Single-Blind|Did not receive treatment|0|||
125158455|NCT00292188|450206244|FG000|Double-Blind|Adverse Event|0|||
125158456|NCT00292188|450206245|FG001|Double-Blind|Adverse Event|25|||
125158457|NCT00292188|450206246|FG002|Double-Blind|Adverse Event|9|||
125158458|NCT00292188|450206244|FG000|Double-Blind|Lack of Efficacy|0|||
125158459|NCT00292188|450206245|FG001|Double-Blind|Lack of Efficacy|2|||
125158460|NCT00292188|450206246|FG002|Double-Blind|Lack of Efficacy|12|||
125158461|NCT00292188|450206244|FG000|Double-Blind|Lost to Follow-up|0|||
125158462|NCT00292188|450206245|FG001|Double-Blind|Lost to Follow-up|1|||
125158463|NCT00292188|450206246|FG002|Double-Blind|Lost to Follow-up|0|||
125158464|NCT00292188|450206244|FG000|Double-Blind|Other|0|||
125158465|NCT00292188|450206245|FG001|Double-Blind|Other|3|||
125158466|NCT00292188|450206246|FG002|Double-Blind|Other|4|||
125158467|NCT00292188|450206244|FG000|Double-Blind|Withdrawal by Subject|0|||
125158468|NCT00292188|450206245|FG001|Double-Blind|Withdrawal by Subject|0|||
125158469|NCT00292188|450206246|FG002|Double-Blind|Withdrawal by Subject|3|||
125158470|NCT00292188|450206244|FG000|Double-Blind|Laboratory Abnormality|0|||
125158471|NCT00292188|450206245|FG001|Double-Blind|Laboratory Abnormality|0|||
125158472|NCT00292188|450206246|FG002|Double-Blind|Laboratory Abnormality|1|||
125158473|NCT00824616|450206247|FG000|Overall Study|Adverse Event|2|||
125158474|NCT00824616|450206248|FG001|Overall Study|Adverse Event|1|||
125158475|NCT00824616|450206247|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
125158476|NCT00824616|450206248|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
125158477|NCT00824616|450206247|FG000|Overall Study|Hyperglycemia|1|||
125158478|NCT00824616|450206248|FG001|Overall Study|Hyperglycemia|1|||
125158479|NCT00824616|450206247|FG000|Overall Study|Lack of Efficacy|2|||
125158480|NCT00824616|450206248|FG001|Overall Study|Lack of Efficacy|1|||
125158481|NCT00824616|450206247|FG000|Overall Study|Lost to Follow-up|0|||
125158482|NCT00824616|450206248|FG001|Overall Study|Lost to Follow-up|1|||
125158483|NCT00824616|450206247|FG000|Overall Study|Withdrawal by Subject|1|||
125158484|NCT00824616|450206248|FG001|Overall Study|Withdrawal by Subject|1|||
125158485|NCT00974974|450206258|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
125158486|NCT00974974|450206259|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
125158487|NCT00974974|450206258|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
125158488|NCT00974974|450206259|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
125158489|NCT00974974|450206258|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
125158490|NCT00974974|450206259|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
125158491|NCT00974974|450206258|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
125158492|NCT00974974|450206259|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
125158493|NCT00974974|450206258|FG000|IR CD-LD Dose Adjustment|Various|0|||
125158494|NCT00974974|450206259|FG001|IR CD-LD Dose Adjustment|Various|9|||
125158495|NCT00974974|450206258|FG000|IPX066 Dose Conversion|Adverse Event|23|||
125158496|NCT00974974|450206259|FG001|IPX066 Dose Conversion|Adverse Event|0|||
125158497|NCT00974974|450206258|FG000|IPX066 Dose Conversion|Death|2|||
125158498|NCT00974974|450206259|FG001|IPX066 Dose Conversion|Death|0|||
125158499|NCT00974974|450206258|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
125158500|NCT00974974|450206259|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
125158501|NCT00974974|450206258|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
125158502|NCT00974974|450206259|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
125158503|NCT00974974|450206258|FG000|IPX066 Dose Conversion|Various|3|||
125389237|NCT00706641|451060336|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
125389238|NCT00706641|451060336|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
125389239|NCT00004888|451060337|FG000|Overall Study|Adverse Event|5|||
125158504|NCT00974974|450206259|FG001|IPX066 Dose Conversion|Various|0|||
125158505|NCT00974974|450206258|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
125158506|NCT00974974|450206259|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
125223973|NCT05212168|450446296|FG000|Overall Study|Lost to Follow-up|0|||
125158507|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
125158508|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
125158509|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
125158510|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
125158511|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
125158512|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
125158513|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
125158514|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
125158515|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
125158516|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
125158517|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
125158518|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
125158519|NCT00974974|450206258|FG000|Maintenance - Double Blind Treatment|Various|4|||
125158520|NCT00974974|450206259|FG001|Maintenance - Double Blind Treatment|Various|0|||
125158521|NCT01959035|450206260|FG000|Overall Study|Adverse Event|5|||
125158522|NCT01959035|450206260|FG000|Overall Study|Withdrawal by Subject|4|||
125158523|NCT01959035|450206260|FG000|Overall Study|Lost to Follow-up|1|||
125158524|NCT01959035|450206260|FG000|Overall Study|Other (no primary reason given)|1|||
125158525|NCT03254602|450206261|FG000|Overall Study|Lost to Follow-up|4|||
125158526|NCT00688376|450206265|FG000|Double-Blind Phase|Adverse Event|4|||
125158527|NCT00688376|450206266|FG001|Double-Blind Phase|Adverse Event|4|||
125158528|NCT00688376|450206265|FG000|Double-Blind Phase|Protocol Violation|1|||
125158529|NCT00688376|450206266|FG001|Double-Blind Phase|Protocol Violation|2|||
125158530|NCT00688376|450206265|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
125158531|NCT00688376|450206266|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
125158532|NCT00688376|450206265|FG000|Double-Blind Phase|Not treated|0|||
125158533|NCT00688376|450206266|FG001|Double-Blind Phase|Not treated|1|||
125158534|NCT00688376|450206265|FG000|Blinded Extension Phase|Adverse Event|3|||
125158535|NCT00688376|450206266|FG001|Blinded Extension Phase|Adverse Event|4|||
125158536|NCT00688376|450206265|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
125158537|NCT00688376|450206266|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
125158538|NCT00688376|450206265|FG000|Blinded Extension Phase|Physician Decision|1|||
125158539|NCT00688376|450206266|FG001|Blinded Extension Phase|Physician Decision|0|||
125158540|NCT00688376|450206265|FG000|Blinded Extension Phase|Other|1|||
125158541|NCT00688376|450206266|FG001|Blinded Extension Phase|Other|0|||
125158542|NCT04492020|450206273|FG000|Overall Study|Adverse Event|1|||
125158543|NCT04492020|450206274|FG001|Overall Study|Adverse Event|3|||
125158544|NCT04492020|450206273|FG000|Overall Study|Withdrawal by Subject|4|||
125158545|NCT04492020|450206274|FG001|Overall Study|Withdrawal by Subject|3|||
125158546|NCT04492020|450206273|FG000|Overall Study|Lost to Follow-up|4|||
125158547|NCT04492020|450206274|FG001|Overall Study|Lost to Follow-up|3|||
125158548|NCT04492020|450206273|FG000|Overall Study|Protocol Violation|5|||
125158549|NCT04492020|450206274|FG001|Overall Study|Protocol Violation|2|||
125158550|NCT04492020|450206273|FG000|Overall Study|Lack of Qualifying Event|25|||
125158551|NCT04492020|450206274|FG001|Overall Study|Lack of Qualifying Event|27|||
125158552|NCT04492020|450206273|FG000|Overall Study|Non-compliance with Study Drug|2|||
125158553|NCT04492020|450206274|FG001|Overall Study|Non-compliance with Study Drug|1|||
125158554|NCT02792959|450206279|FG000|Overall Study|Protocol Violation|1|||
125158555|NCT03914950|450206283|FG000|Overall Study|Physician Decision|54|||
125158556|NCT00003875|450206292|FG000|Overall Study|Screen Failed|1|||
125158557|NCT01780987|450206293|FG000|Overall Study|Adverse Event|0|||
125158558|NCT01780987|450206294|FG001|Overall Study|Adverse Event|4|||
125158559|NCT01780987|450206293|FG000|Overall Study|Withdrawal by Subject|2|||
125158560|NCT01780987|450206294|FG001|Overall Study|Withdrawal by Subject|0|||
125158561|NCT01780987|450206293|FG000|Overall Study|Request of Changing Hospital|0|||
125158562|NCT01780987|450206294|FG001|Overall Study|Request of Changing Hospital|1|||
125158563|NCT01780987|450206293|FG000|Overall Study|Changing Residence|1|||
125158564|NCT01780987|450206294|FG001|Overall Study|Changing Residence|0|||
125158565|NCT01780987|450206293|FG000|Overall Study|Not Receiving any Study Medication|0|||
125158566|NCT01780987|450206294|FG001|Overall Study|Not Receiving any Study Medication|1|||
125158567|NCT04168190|450206295|FG000|Overall Study|Lost to Follow-up|0|||
125158568|NCT04168190|450206296|FG001|Overall Study|Lost to Follow-up|1|||
125158569|NCT04168190|450206297|FG002|Overall Study|Lost to Follow-up|0|||
125158570|NCT04168190|450206298|FG003|Overall Study|Lost to Follow-up|7|||
125158571|NCT04168190|450206299|FG004|Overall Study|Lost to Follow-up|5|||
125158572|NCT04168190|450206295|FG000|Overall Study|Withdrawal by Subject|1|||
125158573|NCT04168190|450206296|FG001|Overall Study|Withdrawal by Subject|0|||
125158574|NCT04168190|450206297|FG002|Overall Study|Withdrawal by Subject|0|||
125158575|NCT04168190|450206298|FG003|Overall Study|Withdrawal by Subject|2|||
125158576|NCT04168190|450206299|FG004|Overall Study|Withdrawal by Subject|4|||
125158577|NCT04168190|450206295|FG000|Overall Study|Death|0|||
125158578|NCT04168190|450206296|FG001|Overall Study|Death|0|||
125158579|NCT04168190|450206297|FG002|Overall Study|Death|0|||
125223974|NCT05212168|450446297|FG001|Overall Study|Lost to Follow-up|3|||
125389240|NCT00004888|451060338|FG001|Overall Study|Adverse Event|10|||
125158580|NCT04168190|450206298|FG003|Overall Study|Death|1|||
125158581|NCT04168190|450206299|FG004|Overall Study|Death|0|||
125158582|NCT01070771|450206300|FG000|Overall Study|Adverse Event|2|||
125158583|NCT01070771|450206300|FG000|Overall Study|Protocol Violation|1|||
125158584|NCT00629265|450206301|FG000|Overall Study|Lost to Follow-up|4|||
125158585|NCT00629265|450206302|FG001|Overall Study|Lost to Follow-up|5|||
125158586|NCT00629265|450206301|FG000|Overall Study|Withdrawal by Subject|11|||
125158587|NCT00629265|450206302|FG001|Overall Study|Withdrawal by Subject|8|||
125158588|NCT00629265|450206301|FG000|Overall Study|Death|1|||
125158589|NCT00629265|450206302|FG001|Overall Study|Death|0|||
125158590|NCT00629265|450206301|FG000|Overall Study|Adverse Event|2|||
125158591|NCT00629265|450206302|FG001|Overall Study|Adverse Event|0|||
125158592|NCT00629265|450206301|FG000|Overall Study|HNC Recurrence|4|||
125158593|NCT00629265|450206302|FG001|Overall Study|HNC Recurrence|0|||
125158594|NCT00629265|450206301|FG000|Overall Study|Other CA Requiring Treatment|1|||
125158595|NCT00629265|450206302|FG001|Overall Study|Other CA Requiring Treatment|3|||
125158596|NCT00629265|450206301|FG000|Overall Study|Needed Esophageal Dilation|4|||
125158597|NCT00629265|450206302|FG001|Overall Study|Needed Esophageal Dilation|1|||
125158598|NCT00629265|450206301|FG000|Overall Study|Unrelated Medical Complications|3|||
125158599|NCT00629265|450206302|FG001|Overall Study|Unrelated Medical Complications|1|||
125158600|NCT00629265|450206301|FG000|Overall Study|Unknown Reason|2|||
125158601|NCT00629265|450206302|FG001|Overall Study|Unknown Reason|2|||
125158602|NCT04465630|450206303|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
125158603|NCT04465630|450206303|FG000|Overall Study|Screen failure|8|||
125158604|NCT04465630|450206303|FG000|Overall Study|Baseline failure|16|||
125158605|NCT01169532|450206304|FG000|Overall Study|Withdrawal by Subject|1|||
125158606|NCT04355663|450206309|FG000|Overall Study|Physician Decision|2|||
125158607|NCT04355663|450206310|FG001|Overall Study|Physician Decision|7|||
125158608|NCT04355663|450206311|FG002|Overall Study|Physician Decision|0|||
125158609|NCT04355663|450206309|FG000|Overall Study|Adverse Event|0|||
125158610|NCT04355663|450206310|FG001|Overall Study|Adverse Event|0|||
125158611|NCT04355663|450206311|FG002|Overall Study|Adverse Event|1|||
125158612|NCT04355663|450206309|FG000|Overall Study|Withdrawal by Subject|0|||
125158613|NCT04355663|450206310|FG001|Overall Study|Withdrawal by Subject|8|||
125158614|NCT04355663|450206311|FG002|Overall Study|Withdrawal by Subject|3|||
125158615|NCT00876018|450206314|FG000|Overall Study|Lost to Follow-up|0|||
125158616|NCT00876018|450206315|FG001|Overall Study|Lost to Follow-up|1|||
125158617|NCT00876018|450206316|FG002|Overall Study|Lost to Follow-up|1|||
125158618|NCT00876018|450206314|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
125158619|NCT00876018|450206315|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
125158620|NCT00876018|450206316|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
125158621|NCT01230892|450206317|FG000|Overall Study|Withdrawal by Subject|1|||
125158622|NCT01230892|450206318|FG001|Overall Study|Withdrawal by Subject|1|||
125158623|NCT01230892|450206317|FG000|Overall Study|Lost to Follow-up|2|||
125158624|NCT01230892|450206318|FG001|Overall Study|Lost to Follow-up|0|||
125158625|NCT00679913|450206319|FG000|Overall Study|Protocol Violation|18|||
125158626|NCT00679913|450206320|FG001|Overall Study|Protocol Violation|13|||
125158627|NCT00725621|450206321|FG000|Overall Study|Adverse Event|25|||
125158628|NCT00725621|450206321|FG000|Overall Study|Lack of Efficacy|46|||
125158629|NCT00725621|450206321|FG000|Overall Study|Withdrawal by Subject|57|||
125158630|NCT00725621|450206321|FG000|Overall Study|Physician Decision|19|||
125158631|NCT00725621|450206321|FG000|Overall Study|Lost to Follow-up|52|||
125158632|NCT00725621|450206321|FG000|Overall Study|Non-compliance|8|||
125158633|NCT00725621|450206321|FG000|Overall Study|Continued treatment by other physician|6|||
125158634|NCT00725621|450206321|FG000|Overall Study|Switched to other study|1|||
125158635|NCT00725621|450206321|FG000|Overall Study|Switched to other drug|1|||
125158636|NCT00725621|450206321|FG000|Overall Study|Prepared for elective surgery|1|||
125223975|NCT05212168|450446296|FG000|Overall Study|Study terminated by sponsor|30|||
125223976|NCT05212168|450446297|FG001|Overall Study|Study terminated by sponsor|27|||
125158637|NCT00725621|450206321|FG000|Overall Study|Reason not specified|55|||
125158638|NCT01189500|450206322|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
125158639|NCT01189500|450206322|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
125158640|NCT00062751|450206323|FG000|Overall Study|Disease progression|24|||
125158641|NCT00062751|450206324|FG001|Overall Study|Disease progression|17|||
125158642|NCT00062751|450206325|FG002|Overall Study|Disease progression|24|||
125158643|NCT00062751|450206326|FG003|Overall Study|Disease progression|2|||
125158644|NCT00062751|450206327|FG004|Overall Study|Disease progression|2|||
125158645|NCT00062751|450206323|FG000|Overall Study|Adverse Event|4|||
125158646|NCT00062751|450206324|FG001|Overall Study|Adverse Event|7|||
125158647|NCT00062751|450206325|FG002|Overall Study|Adverse Event|2|||
125158648|NCT00062751|450206326|FG003|Overall Study|Adverse Event|2|||
125158649|NCT00062751|450206327|FG004|Overall Study|Adverse Event|2|||
125158650|NCT00062751|450206323|FG000|Overall Study|Other|2|||
125158651|NCT00062751|450206324|FG001|Overall Study|Other|3|||
125158652|NCT00062751|450206325|FG002|Overall Study|Other|1|||
125158653|NCT00062751|450206326|FG003|Overall Study|Other|0|||
125158654|NCT00062751|450206327|FG004|Overall Study|Other|1|||
125158655|NCT00062751|450206323|FG000|Overall Study|Withdrawal by Subject|1|||
125223977|NCT05212168|450446296|FG000|Overall Study|Other|4|||
125223978|NCT05212168|450446297|FG001|Overall Study|Other|7|||
125223979|NCT03811821|450446298|FG000|Overall Study|Adverse Event|1|||
125223980|NCT03811821|450446299|FG001|Overall Study|Adverse Event|1|||
125223981|NCT03811821|450446298|FG000|Overall Study|Withdrawal by Subject|5|||
125223982|NCT03811821|450446299|FG001|Overall Study|Withdrawal by Subject|4|||
125223983|NCT03811821|450446298|FG000|Overall Study|Lost to Follow-up|2|||
125223984|NCT03811821|450446299|FG001|Overall Study|Lost to Follow-up|2|||
125223985|NCT03811821|450446298|FG000|Overall Study|Contraindication for treatment|0|||
125438893|NCT02322814|451234002|FG003|Overall Study|Protocol Violation|0|||
125438894|NCT02322814|451234003|FG004|Overall Study|Protocol Violation|0|||
125438895|NCT02322814|451233999|FG000|Overall Study|Study Terminated by Sponsor|0|||
125158656|NCT00062751|450206324|FG001|Overall Study|Withdrawal by Subject|2|||
125158657|NCT00062751|450206325|FG002|Overall Study|Withdrawal by Subject|2|||
125158658|NCT00062751|450206326|FG003|Overall Study|Withdrawal by Subject|1|||
125158659|NCT00062751|450206327|FG004|Overall Study|Withdrawal by Subject|0|||
125158660|NCT00062751|450206323|FG000|Overall Study|Symptomatic deterioration|1|||
125158661|NCT00062751|450206324|FG001|Overall Study|Symptomatic deterioration|1|||
125158662|NCT00062751|450206325|FG002|Overall Study|Symptomatic deterioration|0|||
125158663|NCT00062751|450206326|FG003|Overall Study|Symptomatic deterioration|0|||
125158664|NCT00062751|450206327|FG004|Overall Study|Symptomatic deterioration|1|||
125158665|NCT00062751|450206323|FG000|Overall Study|Death|1|||
125158666|NCT00062751|450206324|FG001|Overall Study|Death|0|||
125158667|NCT00062751|450206325|FG002|Overall Study|Death|1|||
125158668|NCT00062751|450206326|FG003|Overall Study|Death|0|||
125158669|NCT00062751|450206327|FG004|Overall Study|Death|0|||
125158670|NCT01144364|450206330|FG000|Induction Phase|Disease progression|14|||
125158671|NCT01144364|450206331|FG001|Induction Phase|Disease progression|0|||
125158672|NCT01144364|450206332|FG002|Induction Phase|Disease progression|0|||
125158673|NCT01144364|450206330|FG000|Induction Phase|Adverse Event|9|||
125158674|NCT01144364|450206331|FG001|Induction Phase|Adverse Event|0|||
125158675|NCT01144364|450206332|FG002|Induction Phase|Adverse Event|0|||
125158676|NCT01144364|450206330|FG000|Induction Phase|Death|1|||
125158677|NCT01144364|450206331|FG001|Induction Phase|Death|0|||
125158678|NCT01144364|450206332|FG002|Induction Phase|Death|0|||
125158679|NCT01144364|450206330|FG000|Induction Phase|Withdrawal by Subject|1|||
125158680|NCT01144364|450206331|FG001|Induction Phase|Withdrawal by Subject|0|||
125158681|NCT01144364|450206332|FG002|Induction Phase|Withdrawal by Subject|0|||
125158682|NCT01144364|450206330|FG000|Induction Phase|Lost to Follow-up|2|||
125158683|NCT01144364|450206331|FG001|Induction Phase|Lost to Follow-up|0|||
125158684|NCT01144364|450206332|FG002|Induction Phase|Lost to Follow-up|0|||
125158685|NCT01144364|450206330|FG000|Induction Phase|Physician Decision|1|||
125158686|NCT01144364|450206331|FG001|Induction Phase|Physician Decision|0|||
125158687|NCT01144364|450206332|FG002|Induction Phase|Physician Decision|0|||
125158688|NCT01144364|450206330|FG000|Induction Phase|Stable disease|2|||
125158689|NCT01144364|450206331|FG001|Induction Phase|Stable disease|0|||
125158690|NCT01144364|450206332|FG002|Induction Phase|Stable disease|0|||
125158691|NCT01144364|450206330|FG000|Induction Phase|Secondary neoplasia|1|||
125158692|NCT01144364|450206331|FG001|Induction Phase|Secondary neoplasia|0|||
125158693|NCT01144364|450206332|FG002|Induction Phase|Secondary neoplasia|0|||
125158694|NCT01144364|450206330|FG000|Induction Phase|Protocol Violation|1|||
125158695|NCT01144364|450206331|FG001|Induction Phase|Protocol Violation|0|||
125158696|NCT01144364|450206332|FG002|Induction Phase|Protocol Violation|0|||
125158697|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
125158698|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
125158699|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
125158700|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
125158701|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
125158702|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
125158703|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Death|0|||
125158704|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Death|2|||
125158705|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Death|0|||
125158706|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
125158707|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
125158708|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
125158709|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
125223986|NCT03811821|450446299|FG001|Overall Study|Contraindication for treatment|1|||
125158710|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
125158711|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
125158712|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
125158713|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
125158714|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
125158715|NCT01144364|450206330|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
125158716|NCT01144364|450206331|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
125158717|NCT01144364|450206332|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
125223987|NCT03811821|450446298|FG000|Overall Study|Tolerability|0|||
125223988|NCT03811821|450446299|FG001|Overall Study|Tolerability|3|||
125158718|NCT01301508|450206335|FG000|Overall Study|Withdrawal by Subject|1|||
125158719|NCT01301508|450206336|FG001|Overall Study|Withdrawal by Subject|2|||
125158720|NCT01301508|450206335|FG000|Overall Study|Lost to Follow-up|0|||
125158721|NCT01301508|450206336|FG001|Overall Study|Lost to Follow-up|1|||
125158722|NCT00851643|450206337|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
125158723|NCT00851643|450206338|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
125158724|NCT00851643|450206339|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
125158725|NCT00851643|450206340|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
125158726|NCT00851643|450206341|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
125158727|NCT00851643|450206342|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
125158728|NCT00851643|450206337|FG000|Base Study (Up to 12 Months)|Other|0|||
125158729|NCT00851643|450206338|FG001|Base Study (Up to 12 Months)|Other|0|||
125158730|NCT00851643|450206339|FG002|Base Study (Up to 12 Months)|Other|0|||
125158731|NCT00851643|450206340|FG003|Base Study (Up to 12 Months)|Other|0|||
125158732|NCT00851643|450206341|FG004|Base Study (Up to 12 Months)|Other|0|||
125158733|NCT00851643|450206342|FG005|Base Study (Up to 12 Months)|Other|1|||
125158734|NCT00851643|450206337|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
125158735|NCT00851643|450206338|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
125158736|NCT00851643|450206339|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
125158737|NCT00851643|450206340|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
125158738|NCT00851643|450206341|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
125158739|NCT00851643|450206342|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
125158740|NCT00851643|450206337|FG000|Extension Study (Up to 36 Months)|Moved|0|||
125158741|NCT00851643|450206338|FG001|Extension Study (Up to 36 Months)|Moved|2|||
125158742|NCT00851643|450206339|FG002|Extension Study (Up to 36 Months)|Moved|1|||
125158743|NCT00851643|450206340|FG003|Extension Study (Up to 36 Months)|Moved|1|||
125158744|NCT00851643|450206341|FG004|Extension Study (Up to 36 Months)|Moved|0|||
125158745|NCT00851643|450206342|FG005|Extension Study (Up to 36 Months)|Moved|1|||
125158746|NCT02707861|450206345|FG000|Overall Study|Went onto commercial drug|30|||
125158747|NCT02707861|450206346|FG001|Overall Study|Went onto commercial drug|23|||
125158748|NCT02707861|450206345|FG000|Overall Study|Adverse Event|2|||
125158749|NCT02707861|450206346|FG001|Overall Study|Adverse Event|3|||
125158750|NCT02707861|450206345|FG000|Overall Study|Death|5|||
125158751|NCT02707861|450206346|FG001|Overall Study|Death|2|||
125158752|NCT02707861|450206345|FG000|Overall Study|Lack of Efficacy|0|||
125158753|NCT02707861|450206346|FG001|Overall Study|Lack of Efficacy|2|||
125158754|NCT02707861|450206345|FG000|Overall Study|Physician Decision|1|||
125158755|NCT02707861|450206346|FG001|Overall Study|Physician Decision|4|||
125158756|NCT02707861|450206345|FG000|Overall Study|Withdrawal by Subject|2|||
125158757|NCT02707861|450206346|FG001|Overall Study|Withdrawal by Subject|1|||
125158758|NCT02707861|450206345|FG000|Overall Study|Lost to Follow-up|1|||
125158759|NCT02707861|450206346|FG001|Overall Study|Lost to Follow-up|3|||
125158760|NCT01940497|450206347|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
125158761|NCT01940497|450206348|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
125158762|NCT01940497|450206347|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
125158763|NCT01940497|450206348|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
125158764|NCT01940497|450206347|FG000|Overall Study|Violation of Entry Criteria|1|||
125158765|NCT01940497|450206348|FG001|Overall Study|Violation of Entry Criteria|1|||
125158766|NCT01940497|450206347|FG000|Overall Study|Refused Treatment|1|||
125158767|NCT01940497|450206348|FG001|Overall Study|Refused Treatment|3|||
125158768|NCT01940497|450206347|FG000|Overall Study|Withdrew Consent|6|||
125158769|NCT01940497|450206348|FG001|Overall Study|Withdrew Consent|2|||
125158770|NCT01940497|450206347|FG000|Overall Study|Administrative/Other|1|||
125158771|NCT01940497|450206348|FG001|Overall Study|Administrative/Other|1|||
125158772|NCT01641133|450206349|FG000|Overall Study|Protocol Violation|0|||
125158773|NCT01641133|450206350|FG001|Overall Study|Protocol Violation|1|||
125158774|NCT01641133|450206351|FG002|Overall Study|Protocol Violation|1|||
125158775|NCT01641133|450206349|FG000|Overall Study|Migrated/moved from study area|5|||
125158776|NCT01641133|450206350|FG001|Overall Study|Migrated/moved from study area|3|||
125158777|NCT01641133|450206351|FG002|Overall Study|Migrated/moved from study area|1|||
125158778|NCT01641133|450206349|FG000|Overall Study|Adverse Event|0|||
125158779|NCT01641133|450206350|FG001|Overall Study|Adverse Event|0|||
125158780|NCT01641133|450206351|FG002|Overall Study|Adverse Event|1|||
125158781|NCT01641133|450206349|FG000|Overall Study|Withdrawal by Subject|5|||
125158782|NCT01641133|450206350|FG001|Overall Study|Withdrawal by Subject|3|||
125158783|NCT01641133|450206351|FG002|Overall Study|Withdrawal by Subject|3|||
125223989|NCT03811821|450446298|FG000|Overall Study|Comorbidities|0|||
125158784|NCT01641133|450206349|FG000|Overall Study|Lost to Follow-up|0|||
125158785|NCT01641133|450206350|FG001|Overall Study|Lost to Follow-up|2|||
125158786|NCT01641133|450206351|FG002|Overall Study|Lost to Follow-up|2|||
125158787|NCT00444457|450206355|FG000|Infant Series|Other|0|||
125158788|NCT00444457|450206356|FG001|Infant Series|Other|1|||
125158789|NCT00444457|450206357|FG002|Infant Series|Other|0|||
125158790|NCT00444457|450206358|FG003|Infant Series|Other|0|||
125223990|NCT03811821|450446299|FG001|Overall Study|Comorbidities|2|||
125438896|NCT02322814|451234000|FG001|Overall Study|Study Terminated by Sponsor|7|||
125438897|NCT02322814|451234001|FG002|Overall Study|Study Terminated by Sponsor|9|||
125438898|NCT02322814|451234002|FG003|Overall Study|Study Terminated by Sponsor|5|||
125438899|NCT02322814|451234003|FG004|Overall Study|Study Terminated by Sponsor|13|||
125438900|NCT02322814|451233999|FG000|Overall Study|Withdrawal by Subject|5|||
125438901|NCT02322814|451234000|FG001|Overall Study|Withdrawal by Subject|4|||
125438902|NCT02322814|451234001|FG002|Overall Study|Withdrawal by Subject|2|||
125438903|NCT02322814|451234002|FG003|Overall Study|Withdrawal by Subject|1|||
125438904|NCT02322814|451234003|FG004|Overall Study|Withdrawal by Subject|3|||
125438905|NCT02459093|451234004|FG000|Overall Study|Protocol Violation|6|||
125438906|NCT02459093|451234005|FG001|Overall Study|Protocol Violation|11|||
125438907|NCT02459093|451234004|FG000|Overall Study|Lost to Follow-up|6|||
125438908|NCT02459093|451234005|FG001|Overall Study|Lost to Follow-up|7|||
125438909|NCT00118092|451234006|FG000|Overall Study|Withdrawal by Subject|1|||
125438910|NCT00118092|451234006|FG000|Overall Study|Protocol Violation|1|||
125438911|NCT00591864|451234007|FG000|Overall Study|Incomplete Imaging|5|||
125438912|NCT01567865|451234015|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
125438913|NCT01567865|451234016|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
125438914|NCT01567865|451234017|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
125438915|NCT01567865|451234018|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
125438916|NCT01567865|451234015|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
125438917|NCT01567865|451234016|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
125438918|NCT01567865|451234017|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
125438919|NCT01567865|451234018|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
125438920|NCT00309608|451234019|FG000|Overall Study|Adverse Event|1|||
125438921|NCT00309608|451234020|FG001|Overall Study|Adverse Event|5|||
125438922|NCT00309608|451234021|FG002|Overall Study|Adverse Event|3|||
125438923|NCT00309608|451234022|FG003|Overall Study|Adverse Event|2|||
125438924|NCT00309608|451234023|FG004|Overall Study|Adverse Event|3|||
125438925|NCT00309608|451234019|FG000|Overall Study|Protocol Violation|2|||
125438926|NCT00309608|451234020|FG001|Overall Study|Protocol Violation|0|||
125438927|NCT00309608|451234021|FG002|Overall Study|Protocol Violation|0|||
125438928|NCT00309608|451234022|FG003|Overall Study|Protocol Violation|0|||
125438929|NCT00309608|451234023|FG004|Overall Study|Protocol Violation|0|||
125438930|NCT00309608|451234019|FG000|Overall Study|Lost to Follow-up|0|||
125438931|NCT00309608|451234020|FG001|Overall Study|Lost to Follow-up|0|||
125438932|NCT00309608|451234021|FG002|Overall Study|Lost to Follow-up|2|||
125438933|NCT00309608|451234022|FG003|Overall Study|Lost to Follow-up|0|||
125438934|NCT00309608|451234023|FG004|Overall Study|Lost to Follow-up|1|||
125438935|NCT00309608|451234019|FG000|Overall Study|Withdrawal by Subject|1|||
125438936|NCT00309608|451234020|FG001|Overall Study|Withdrawal by Subject|4|||
125438937|NCT00309608|451234021|FG002|Overall Study|Withdrawal by Subject|2|||
125438938|NCT00309608|451234022|FG003|Overall Study|Withdrawal by Subject|0|||
125438939|NCT00309608|451234023|FG004|Overall Study|Withdrawal by Subject|0|||
125438940|NCT00309608|451234019|FG000|Overall Study|Other incl. Lack of efficacy|10|||
125438941|NCT00309608|451234020|FG001|Overall Study|Other incl. Lack of efficacy|4|||
125438942|NCT00309608|451234021|FG002|Overall Study|Other incl. Lack of efficacy|3|||
125158791|NCT00444457|450206355|FG000|Infant Series|Parent or legal guardian request|18|||
125158792|NCT00444457|450206356|FG001|Infant Series|Parent or legal guardian request|29|||
125158793|NCT00444457|450206357|FG002|Infant Series|Parent or legal guardian request|34|||
125158794|NCT00444457|450206358|FG003|Infant Series|Parent or legal guardian request|14|||
125158795|NCT00444457|450206355|FG000|Infant Series|Lost to Follow-up|10|||
125158796|NCT00444457|450206356|FG001|Infant Series|Lost to Follow-up|11|||
125158797|NCT00444457|450206357|FG002|Infant Series|Lost to Follow-up|7|||
125158798|NCT00444457|450206358|FG003|Infant Series|Lost to Follow-up|6|||
125158799|NCT00444457|450206355|FG000|Infant Series|Protocol Violation|16|||
125158800|NCT00444457|450206356|FG001|Infant Series|Protocol Violation|8|||
125158801|NCT00444457|450206357|FG002|Infant Series|Protocol Violation|6|||
125158802|NCT00444457|450206358|FG003|Infant Series|Protocol Violation|3|||
125158803|NCT00444457|450206355|FG000|Infant Series|Failed to return|5|||
125158804|NCT00444457|450206356|FG001|Infant Series|Failed to return|4|||
125158805|NCT00444457|450206357|FG002|Infant Series|Failed to return|4|||
125158806|NCT00444457|450206358|FG003|Infant Series|Failed to return|2|||
125158807|NCT00444457|450206355|FG000|Infant Series|Investigator request|4|||
125158808|NCT00444457|450206356|FG001|Infant Series|Investigator request|3|||
125158809|NCT00444457|450206357|FG002|Infant Series|Investigator request|3|||
125438943|NCT00309608|451234022|FG003|Overall Study|Other incl. Lack of efficacy|4|||
125438944|NCT00309608|451234023|FG004|Overall Study|Other incl. Lack of efficacy|0|||
125438945|NCT00621296|451234030|FG000|Overall Study|Adverse Event|2|||
125438946|NCT00621296|451234030|FG000|Overall Study|Lack of Efficacy|1|||
125158810|NCT00444457|450206358|FG003|Infant Series|Investigator request|2|||
125158811|NCT00444457|450206355|FG000|Infant Series|Other|0|||
125438947|NCT00621296|451234030|FG000|Overall Study|Physician Decision|7|||
125438948|NCT00621296|451234030|FG000|Overall Study|Unmatch Criteria|1|||
125438949|NCT00621296|451234030|FG000|Overall Study|Stopping Criteria|3|||
125438950|NCT04921969|451234031|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
125158812|NCT00444457|450206356|FG001|Infant Series|Other|2|||
125158813|NCT00444457|450206357|FG002|Infant Series|Other|4|||
125158814|NCT00444457|450206358|FG003|Infant Series|Other|0|||
125158815|NCT00444457|450206355|FG000|Infant Series|Adverse Event|1|||
125158816|NCT00444457|450206356|FG001|Infant Series|Adverse Event|2|||
125158817|NCT00444457|450206357|FG002|Infant Series|Adverse Event|2|||
125158818|NCT00444457|450206358|FG003|Infant Series|Adverse Event|0|||
125158819|NCT00444457|450206355|FG000|Infant Series|Death|0|||
125158820|NCT00444457|450206356|FG001|Infant Series|Death|1|||
125158821|NCT00444457|450206357|FG002|Infant Series|Death|1|||
125158822|NCT00444457|450206358|FG003|Infant Series|Death|1|||
125158823|NCT00444457|450206355|FG000|After Infant Series|Other|0|||
125158824|NCT00444457|450206356|FG001|After Infant Series|Other|1|||
125158825|NCT00444457|450206357|FG002|After Infant Series|Other|1|||
125158826|NCT00444457|450206358|FG003|After Infant Series|Other|1|||
125158827|NCT00444457|450206355|FG000|After Infant Series|Parent or legal guardian request|4|||
125158828|NCT00444457|450206356|FG001|After Infant Series|Parent or legal guardian request|11|||
125158829|NCT00444457|450206357|FG002|After Infant Series|Parent or legal guardian request|6|||
125158830|NCT00444457|450206358|FG003|After Infant Series|Parent or legal guardian request|3|||
125158831|NCT00444457|450206355|FG000|After Infant Series|Failed to return|7|||
125158832|NCT00444457|450206356|FG001|After Infant Series|Failed to return|6|||
125158833|NCT00444457|450206357|FG002|After Infant Series|Failed to return|5|||
125158834|NCT00444457|450206358|FG003|After Infant Series|Failed to return|1|||
125158835|NCT00444457|450206355|FG000|After Infant Series|Lost to Follow-up|5|||
125158836|NCT00444457|450206356|FG001|After Infant Series|Lost to Follow-up|5|||
125158837|NCT00444457|450206357|FG002|After Infant Series|Lost to Follow-up|5|||
125158838|NCT00444457|450206358|FG003|After Infant Series|Lost to Follow-up|2|||
125158839|NCT00444457|450206355|FG000|After Infant Series|Protocol Violation|2|||
125158840|NCT00444457|450206356|FG001|After Infant Series|Protocol Violation|4|||
125158841|NCT00444457|450206357|FG002|After Infant Series|Protocol Violation|2|||
125158842|NCT00444457|450206358|FG003|After Infant Series|Protocol Violation|2|||
125158843|NCT00444457|450206355|FG000|After Infant Series|Adverse Event|2|||
125158844|NCT00444457|450206356|FG001|After Infant Series|Adverse Event|2|||
125158845|NCT00444457|450206357|FG002|After Infant Series|Adverse Event|0|||
125158846|NCT00444457|450206358|FG003|After Infant Series|Adverse Event|0|||
125158847|NCT00444457|450206355|FG000|After Infant Series|Investigator request|0|||
125158848|NCT00444457|450206356|FG001|After Infant Series|Investigator request|0|||
125158849|NCT00444457|450206357|FG002|After Infant Series|Investigator request|0|||
125158850|NCT00444457|450206358|FG003|After Infant Series|Investigator request|1|||
125158851|NCT00444457|450206355|FG000|After Infant Series|Other|0|||
125158852|NCT00444457|450206356|FG001|After Infant Series|Other|1|||
125158853|NCT00444457|450206357|FG002|After Infant Series|Other|0|||
125158854|NCT00444457|450206358|FG003|After Infant Series|Other|0|||
125158855|NCT00444457|450206355|FG000|Toddler Dose|Lost to Follow-up|4|||
125158856|NCT00444457|450206356|FG001|Toddler Dose|Lost to Follow-up|1|||
125158857|NCT00444457|450206357|FG002|Toddler Dose|Lost to Follow-up|1|||
125158858|NCT00444457|450206358|FG003|Toddler Dose|Lost to Follow-up|3|||
125223991|NCT04888494|450446302|FG000|Overall Study|Lost to Follow-up|2|||
125223992|NCT04888494|450446303|FG001|Overall Study|Lost to Follow-up|3|||
125223993|NCT04888494|450446302|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
125223994|NCT04888494|450446303|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
125223995|NCT00611806|450448026|FG000|Overall Study|Withdrawal by Subject|8|||
125223996|NCT00611806|450448027|FG001|Overall Study|Withdrawal by Subject|2|||
125223997|NCT00611806|450448026|FG000|Overall Study|Adverse Event|2|||
125158859|NCT00444457|450206355|FG000|Toddler Dose|Failed to return|2|||
125158860|NCT00444457|450206356|FG001|Toddler Dose|Failed to return|2|||
125158861|NCT00444457|450206357|FG002|Toddler Dose|Failed to return|1|||
125158862|NCT00444457|450206358|FG003|Toddler Dose|Failed to return|3|||
125158863|NCT00444457|450206355|FG000|Toddler Dose|Parent or legal guardian request|0|||
125158864|NCT00444457|450206356|FG001|Toddler Dose|Parent or legal guardian request|3|||
125158865|NCT00444457|450206357|FG002|Toddler Dose|Parent or legal guardian request|2|||
125158866|NCT00444457|450206358|FG003|Toddler Dose|Parent or legal guardian request|1|||
125158867|NCT00444457|450206355|FG000|Toddler Dose|Protocol Violation|1|||
125223998|NCT00611806|450448027|FG001|Overall Study|Adverse Event|1|||
125158868|NCT00444457|450206356|FG001|Toddler Dose|Protocol Violation|0|||
125158869|NCT00444457|450206357|FG002|Toddler Dose|Protocol Violation|0|||
125158870|NCT00444457|450206358|FG003|Toddler Dose|Protocol Violation|1|||
125158871|NCT02518919|450207431|FG000|Overall Study|Protocol Violation|1|||
125158872|NCT02518919|450207432|FG001|Overall Study|Protocol Violation|1|||
125158873|NCT02518919|450207433|FG002|Overall Study|Protocol Violation|2|||
125158874|NCT02227147|450207435|FG000|Controlled Treatment Period|Adverse Event|4|||
125158875|NCT02227147|450207436|FG001|Controlled Treatment Period|Adverse Event|3|||
125158876|NCT02227147|450207435|FG000|Controlled Treatment Period|Other|2|||
125158877|NCT02227147|450207436|FG001|Controlled Treatment Period|Other|0|||
125158878|NCT02227147|450207435|FG000|Follow-up Period|Other|3|||
125158879|NCT02227147|450207436|FG001|Follow-up Period|Other|5|||
125158880|NCT02923674|450207437|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
125223999|NCT00611806|450448026|FG000|Overall Study|Lost to Follow-up|6|||
125438951|NCT04921969|451234032|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
125438952|NCT04921969|451234033|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
125438953|NCT04921969|451234034|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
125438954|NCT04921969|451234035|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
125438955|NCT04921969|451234036|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
125438956|NCT04921969|451234037|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
125438957|NCT04921969|451234031|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
125438958|NCT04921969|451234032|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125438959|NCT04921969|451234033|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125438960|NCT04921969|451234034|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125438961|NCT04921969|451234035|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125438962|NCT04921969|451234036|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125438963|NCT04921969|451234037|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125438964|NCT04921969|451234031|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
125438965|NCT04921969|451234032|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
125438966|NCT04921969|451234033|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
125438967|NCT04921969|451234034|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125438968|NCT04921969|451234035|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125438969|NCT04921969|451234036|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125438970|NCT04921969|451234037|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125438971|NCT04921969|451234031|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
125438972|NCT04921969|451234032|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
125438973|NCT04921969|451234033|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
125438974|NCT04921969|451234034|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
125438975|NCT04921969|451234035|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
125438976|NCT04921969|451234036|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
125438977|NCT04921969|451234037|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
125438978|NCT04921969|451234031|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
125438979|NCT04921969|451234032|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
125438980|NCT04921969|451234033|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
125438981|NCT04921969|451234034|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
125438982|NCT04921969|451234035|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
125438983|NCT04921969|451234036|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
125438984|NCT04921969|451234037|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
125158881|NCT02923674|450207438|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
125158882|NCT02923674|450207439|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
125158883|NCT02923674|450207437|FG000|Overall Study|Lost to Follow-up|7|||
125158884|NCT02923674|450207438|FG001|Overall Study|Lost to Follow-up|12|||
125158885|NCT02923674|450207439|FG002|Overall Study|Lost to Follow-up|7|||
125158886|NCT02923674|450207437|FG000|Overall Study|Problem with intervention|2|||
125158887|NCT02923674|450207438|FG001|Overall Study|Problem with intervention|2|||
125158888|NCT02923674|450207439|FG002|Overall Study|Problem with intervention|1|||
125158889|NCT02923674|450207437|FG000|Overall Study|Adverse Event|3|||
125158890|NCT02923674|450207438|FG001|Overall Study|Adverse Event|1|||
125158891|NCT02923674|450207439|FG002|Overall Study|Adverse Event|1|||
125158892|NCT02923674|450207437|FG000|Overall Study|Withdrawal by Subject|2|||
125158893|NCT02923674|450207438|FG001|Overall Study|Withdrawal by Subject|2|||
125158894|NCT02923674|450207439|FG002|Overall Study|Withdrawal by Subject|2|||
125158895|NCT03709823|450207440|FG000|Overall Study|Adverse Event|0|||
125158896|NCT03709823|450207441|FG001|Overall Study|Adverse Event|0|||
125158897|NCT03709823|450207442|FG002|Overall Study|Adverse Event|1|||
125158898|NCT03709823|450207443|FG003|Overall Study|Adverse Event|0|||
125158899|NCT03709823|450207444|FG004|Overall Study|Adverse Event|0|||
125158900|NCT03709823|450207445|FG005|Overall Study|Adverse Event|0|||
125158901|NCT03709823|450207440|FG000|Overall Study|Lost to Follow-up|2|||
125158902|NCT03709823|450207441|FG001|Overall Study|Lost to Follow-up|2|||
125158903|NCT03709823|450207442|FG002|Overall Study|Lost to Follow-up|2|||
125158904|NCT03709823|450207443|FG003|Overall Study|Lost to Follow-up|1|||
125158905|NCT03709823|450207444|FG004|Overall Study|Lost to Follow-up|1|||
125158906|NCT03709823|450207445|FG005|Overall Study|Lost to Follow-up|0|||
125158907|NCT03709823|450207440|FG000|Overall Study|Withdrawal by Subject|1|||
125158908|NCT03709823|450207441|FG001|Overall Study|Withdrawal by Subject|3|||
125158909|NCT03709823|450207442|FG002|Overall Study|Withdrawal by Subject|0|||
125158910|NCT03709823|450207443|FG003|Overall Study|Withdrawal by Subject|0|||
125158911|NCT03709823|450207444|FG004|Overall Study|Withdrawal by Subject|0|||
125158912|NCT03709823|450207445|FG005|Overall Study|Withdrawal by Subject|0|||
125158913|NCT03709823|450207440|FG000|Overall Study|Other, Not Specified|0|||
125158914|NCT03709823|450207441|FG001|Overall Study|Other, Not Specified|0|||
125438985|NCT04921969|451234031|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
125438986|NCT04921969|451234032|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
125438987|NCT04921969|451234033|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
125438988|NCT04921969|451234034|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125158915|NCT03709823|450207442|FG002|Overall Study|Other, Not Specified|0|||
125158916|NCT03709823|450207443|FG003|Overall Study|Other, Not Specified|1|||
125158917|NCT03709823|450207444|FG004|Overall Study|Other, Not Specified|0|||
125158918|NCT03709823|450207445|FG005|Overall Study|Other, Not Specified|0|||
125158919|NCT01055132|450207446|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
125158920|NCT01055132|450207447|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
125158921|NCT01055132|450207446|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
125158922|NCT01055132|450207447|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
125158923|NCT00158600|450207448|FG000|Overall Study|unable to commit time to study|0|||
125158924|NCT00158600|450207449|FG001|Overall Study|unable to commit time to study|1|||
125158925|NCT00158600|450207448|FG000|Overall Study|Adverse Event|2|||
125158926|NCT00158600|450207449|FG001|Overall Study|Adverse Event|1|||
125158927|NCT00158600|450207448|FG000|Overall Study|Death|1|||
125158928|NCT00158600|450207449|FG001|Overall Study|Death|0|||
125158929|NCT00158600|450207448|FG000|Overall Study|Withdrawal by Subject|2|||
125158930|NCT00158600|450207449|FG001|Overall Study|Withdrawal by Subject|2|||
125158931|NCT02618408|450207450|FG000|Overall Study|Withdrawal by Subject|1|||
125158932|NCT02618408|450207451|FG001|Overall Study|Withdrawal by Subject|0|||
125158933|NCT02618408|450207452|FG002|Overall Study|Withdrawal by Subject|4|||
125158934|NCT02618408|450207450|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
125158935|NCT02618408|450207451|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
125158936|NCT02618408|450207452|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
125158937|NCT02618408|450207450|FG000|Overall Study|Lost to Follow-up|4|||
125158938|NCT02618408|450207451|FG001|Overall Study|Lost to Follow-up|2|||
125158939|NCT02618408|450207452|FG002|Overall Study|Lost to Follow-up|6|||
125158940|NCT02618408|450207450|FG000|Overall Study|Adverse Event|4|||
125158941|NCT02618408|450207451|FG001|Overall Study|Adverse Event|0|||
125158942|NCT02618408|450207452|FG002|Overall Study|Adverse Event|10|||
125158943|NCT02618408|450207450|FG000|Overall Study|Physician Decision|1|||
125158944|NCT02618408|450207451|FG001|Overall Study|Physician Decision|1|||
125158945|NCT02618408|450207452|FG002|Overall Study|Physician Decision|2|||
125158946|NCT02618408|450207450|FG000|Overall Study|Protocol Violation|1|||
125158947|NCT02618408|450207451|FG001|Overall Study|Protocol Violation|1|||
125158948|NCT02618408|450207452|FG002|Overall Study|Protocol Violation|2|||
125158949|NCT02618408|450207450|FG000|Overall Study|Other, Multiple Categories|0|||
125158950|NCT02618408|450207451|FG001|Overall Study|Other, Multiple Categories|0|||
125158951|NCT02618408|450207452|FG002|Overall Study|Other, Multiple Categories|4|||
125158952|NCT02575911|450207456|FG000|Overall Study|Lost to Follow-up|1|||
125158953|NCT01249365|450207457|FG000|Overall Study|Lost to Follow-up|1|||
125158954|NCT01460901|450207458|FG000|Overall Study|Withdrawal by Subject|2|||
125158955|NCT02566993|450207459|FG000|Overall Study|Randomized but not treated|5|||
125158956|NCT02566993|450207460|FG001|Overall Study|Randomized but not treated|16|||
125158957|NCT02566993|450207459|FG000|Overall Study|Progressive disease|213|||
125158958|NCT02566993|450207460|FG001|Overall Study|Progressive disease|152|||
125158959|NCT02566993|450207459|FG000|Overall Study|Withdrawal by Subject|12|||
125158960|NCT02566993|450207460|FG001|Overall Study|Withdrawal by Subject|28|||
125158961|NCT02566993|450207459|FG000|Overall Study|Death|17|||
125158962|NCT02566993|450207460|FG001|Overall Study|Death|23|||
125158963|NCT02566993|450207459|FG000|Overall Study|Physician Decision|10|||
125158964|NCT02566993|450207460|FG001|Overall Study|Physician Decision|17|||
125158965|NCT02566993|450207459|FG000|Overall Study|Study drug-related adverse event|20|||
125158966|NCT02566993|450207460|FG001|Overall Study|Study drug-related adverse event|41|||
125158967|NCT02566993|450207459|FG000|Overall Study|Non study drug-related adverse event|9|||
125158968|NCT02566993|450207460|FG001|Overall Study|Non study drug-related adverse event|9|||
125158969|NCT02566993|450207459|FG000|Overall Study|Symptomatic deterioration|9|||
125158970|NCT02566993|450207460|FG001|Overall Study|Symptomatic deterioration|16|||
125158971|NCT02566993|450207459|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
125158972|NCT02566993|450207460|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
125158973|NCT02566993|450207459|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
125158974|NCT02566993|450207460|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
125158975|NCT02566993|450207459|FG000|Overall Study|Screening failure|2|||
125158976|NCT02566993|450207460|FG001|Overall Study|Screening failure|0|||
125158977|NCT02566993|450207459|FG000|Overall Study|Lost to Follow-up|0|||
125158978|NCT02566993|450207460|FG001|Overall Study|Lost to Follow-up|1|||
125158979|NCT02566993|450207459|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
125158980|NCT02566993|450207460|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
125158981|NCT03127644|450207470|FG000|Overall Study|Study-specific withdrawal criteria|0|||
125158982|NCT03127644|450207471|FG001|Overall Study|Study-specific withdrawal criteria|0|||
125158983|NCT03127644|450207472|FG002|Overall Study|Study-specific withdrawal criteria|2|||
125158984|NCT02032706|450207473|FG000|Overall Study|Did not qualify|5|||
125158985|NCT02032706|450207473|FG000|Overall Study|Protocol Violation|1|||
125158986|NCT01156142|450207476|FG000|Overall Study|Withdrawal by Subject|8|||
125158987|NCT01156142|450207477|FG001|Overall Study|Withdrawal by Subject|6|||
125158988|NCT01156142|450207476|FG000|Overall Study|Ineligible|0|||
125158989|NCT01156142|450207477|FG001|Overall Study|Ineligible|1|||
125158990|NCT00893737|450207478|FG000|Overall Study|Adverse Event|4|||
125158991|NCT00893737|450207478|FG000|Overall Study|Withdrawal by Subject|2|||
125158992|NCT00893737|450207478|FG000|Overall Study|Lost to Follow-up|6|||
125158993|NCT02140411|450207479|FG000|Overall Study|Adverse Event|1|||
125158994|NCT03981419|450207482|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
125158995|NCT03981419|450207483|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
125158996|NCT01330459|450207488|FG000|Overall Study|Physician Decision|0|||
125158997|NCT01330459|450207489|FG001|Overall Study|Physician Decision|2|||
125158998|NCT00895947|450207490|FG000|Overall Study|Adverse Event|3|||
125158999|NCT00895947|450207491|FG001|Overall Study|Adverse Event|4|||
125159000|NCT00895947|450207490|FG000|Overall Study|Lost to Follow-up|3|||
125159001|NCT00895947|450207491|FG001|Overall Study|Lost to Follow-up|4|||
125159002|NCT00895947|450207490|FG000|Overall Study|Protocol Violation|4|||
125159003|NCT00895947|450207491|FG001|Overall Study|Protocol Violation|2|||
125159004|NCT00895947|450207490|FG000|Overall Study|Withdrawal by Subject|2|||
125159005|NCT00895947|450207491|FG001|Overall Study|Withdrawal by Subject|0|||
125159006|NCT04620135|450207495|FG000|Study Completion|Adverse Event|2|||
125159007|NCT04620135|450207496|FG001|Study Completion|Adverse Event|3|||
125159008|NCT04620135|450207495|FG000|Study Completion|Withdrawal by Subject|2|||
125159009|NCT04620135|450207496|FG001|Study Completion|Withdrawal by Subject|0|||
125159010|NCT02005887|450207505|FG000|Overall Study|Protocol Violation|0|||
125159011|NCT02005887|450207506|FG001|Overall Study|Protocol Violation|2|||
125159012|NCT01550744|450207507|FG000|Open-Label|Lost to Follow-up|7|||
125159013|NCT01550744|450207508|FG001|Open-Label|Lost to Follow-up|0|||
125159014|NCT01550744|450207509|FG002|Open-Label|Lost to Follow-up|0|||
125438989|NCT04921969|451234035|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125438990|NCT04921969|451234036|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125438991|NCT04921969|451234037|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125438992|NCT04921969|451234031|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
125438993|NCT04921969|451234032|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
125159015|NCT01550744|450207507|FG000|Open-Label|Withdrawal by Subject|13|||
125159016|NCT01550744|450207508|FG001|Open-Label|Withdrawal by Subject|0|||
125159017|NCT01550744|450207509|FG002|Open-Label|Withdrawal by Subject|0|||
125159018|NCT01550744|450207507|FG000|Open-Label|Adverse Event|11|||
125159019|NCT01550744|450207508|FG001|Open-Label|Adverse Event|0|||
125159020|NCT01550744|450207509|FG002|Open-Label|Adverse Event|0|||
125159021|NCT01550744|450207507|FG000|Open-Label|Lack of Efficacy|4|||
125159022|NCT01550744|450207508|FG001|Open-Label|Lack of Efficacy|0|||
125159023|NCT01550744|450207509|FG002|Open-Label|Lack of Efficacy|0|||
125159024|NCT01550744|450207507|FG000|Open-Label|Protocol Violation|4|||
125159025|NCT01550744|450207508|FG001|Open-Label|Protocol Violation|0|||
125159026|NCT01550744|450207509|FG002|Open-Label|Protocol Violation|0|||
125159027|NCT01550744|450207507|FG000|Open-Label|Not all 3 study drug injections received|2|||
125159028|NCT01550744|450207508|FG001|Open-Label|Not all 3 study drug injections received|0|||
125159029|NCT01550744|450207509|FG002|Open-Label|Not all 3 study drug injections received|0|||
125159030|NCT01550744|450207507|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
125159031|NCT01550744|450207508|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
125159032|NCT01550744|450207509|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
125224000|NCT00611806|450448027|FG001|Overall Study|Lost to Follow-up|0|||
125224001|NCT02317991|450448028|FG000|Overall Study|Adverse Event|12|||
125224002|NCT02317991|450448028|FG000|Overall Study|Death|4|||
125224003|NCT02317991|450448028|FG000|Overall Study|Withdrawal by Subject|8|||
125224004|NCT02317991|450448028|FG000|Overall Study|Progressive Disease|41|||
125224005|NCT01921517|450448029|FG000|Overall Study|Lost to Follow-up|5|||
125224006|NCT01921517|450448030|FG001|Overall Study|Lost to Follow-up|0|||
125224007|NCT01921517|450448029|FG000|Overall Study|Newly diagnosed health concern|2|||
125224008|NCT01921517|450448030|FG001|Overall Study|Newly diagnosed health concern|0|||
125224009|NCT01921517|450448029|FG000|Overall Study|Physician Decision|0|||
125224010|NCT01921517|450448030|FG001|Overall Study|Physician Decision|2|||
125224011|NCT01921517|450448029|FG000|Overall Study|Withdrawal by Subject|7|||
125224012|NCT01921517|450448030|FG001|Overall Study|Withdrawal by Subject|3|||
125159033|NCT01550744|450207507|FG000|Open-Label|Other|1|||
125224013|NCT01921517|450448029|FG000|Overall Study|Subject missed final imaging|1|||
125159034|NCT01550744|450207508|FG001|Open-Label|Other|0|||
125159035|NCT01550744|450207509|FG002|Open-Label|Other|0|||
125159036|NCT01550744|450207507|FG000|Double-Blind|Lost to Follow-up|0|||
125159037|NCT01550744|450207508|FG001|Double-Blind|Lost to Follow-up|6|||
125159038|NCT01550744|450207509|FG002|Double-Blind|Lost to Follow-up|12|||
125159039|NCT01550744|450207507|FG000|Double-Blind|Withdrawal by Subject|0|||
125224014|NCT01921517|450448030|FG001|Overall Study|Subject missed final imaging|4|||
125224015|NCT01325350|450448031|FG000|Overall Study|Adverse Event|3|||
125159040|NCT01550744|450207508|FG001|Double-Blind|Withdrawal by Subject|2|||
125159041|NCT01550744|450207509|FG002|Double-Blind|Withdrawal by Subject|15|||
125159042|NCT01550744|450207507|FG000|Double-Blind|Adverse Event|0|||
125224016|NCT01325350|450448032|FG001|Overall Study|Adverse Event|3|||
125224017|NCT01325350|450448033|FG002|Overall Study|Adverse Event|3|||
125224018|NCT01325350|450448034|FG003|Overall Study|Adverse Event|1|||
125159043|NCT01550744|450207508|FG001|Double-Blind|Adverse Event|4|||
125159044|NCT01550744|450207509|FG002|Double-Blind|Adverse Event|15|||
125159045|NCT01550744|450207507|FG000|Double-Blind|Death|0|||
125159046|NCT01550744|450207508|FG001|Double-Blind|Death|1|||
125159047|NCT01550744|450207509|FG002|Double-Blind|Death|0|||
125159048|NCT01550744|450207507|FG000|Double-Blind|Lack of Efficacy|0|||
125159049|NCT01550744|450207508|FG001|Double-Blind|Lack of Efficacy|2|||
125159050|NCT01550744|450207509|FG002|Double-Blind|Lack of Efficacy|8|||
125159051|NCT01550744|450207507|FG000|Double-Blind|Protocol Violation|0|||
125159052|NCT01550744|450207508|FG001|Double-Blind|Protocol Violation|0|||
125159053|NCT01550744|450207509|FG002|Double-Blind|Protocol Violation|4|||
125159054|NCT01550744|450207507|FG000|Double-Blind|Pregnancy|0|||
125159055|NCT01550744|450207508|FG001|Double-Blind|Pregnancy|0|||
125159056|NCT01550744|450207509|FG002|Double-Blind|Pregnancy|3|||
125159057|NCT01550744|450207507|FG000|Double-Blind|Other|0|||
125159058|NCT01550744|450207508|FG001|Double-Blind|Other|2|||
125159059|NCT01550744|450207509|FG002|Double-Blind|Other|10|||
125159060|NCT01660334|450207510|FG000|Overall Study|Lost to Follow-up|1|||
125159061|NCT00311311|450207511|FG000|Overall Study|Adverse Event|3|||
125159062|NCT00311311|450207512|FG001|Overall Study|Adverse Event|2|||
125159063|NCT00311311|450207511|FG000|Overall Study|Withdrawal by Subject|1|||
125159064|NCT00311311|450207512|FG001|Overall Study|Withdrawal by Subject|1|||
125159065|NCT00311311|450207511|FG000|Overall Study|Noncompliance|0|||
125159066|NCT00311311|450207512|FG001|Overall Study|Noncompliance|1|||
125159067|NCT00311311|450207511|FG000|Overall Study|Study Termination by Sponsor|3|||
125159068|NCT00311311|450207512|FG001|Overall Study|Study Termination by Sponsor|4|||
125159069|NCT00311311|450207511|FG000|Overall Study|Death|1|||
125159070|NCT00311311|450207512|FG001|Overall Study|Death|0|||
125159071|NCT00311311|450207511|FG000|Overall Study|Lack of ancillary assistance|0|||
125159072|NCT00311311|450207512|FG001|Overall Study|Lack of ancillary assistance|1|||
125159073|NCT00988065|450207514|FG000|Overall Study|Adverse Event|4|||
125159074|NCT00988065|450207515|FG001|Overall Study|Adverse Event|10|||
125159075|NCT00988065|450207516|FG002|Overall Study|Adverse Event|2|||
125159076|NCT00988065|450207514|FG000|Overall Study|Lost to Follow-up|1|||
125159077|NCT00988065|450207515|FG001|Overall Study|Lost to Follow-up|2|||
125159078|NCT00988065|450207516|FG002|Overall Study|Lost to Follow-up|2|||
125159079|NCT00988065|450207514|FG000|Overall Study|Subject withdrew consent|3|||
125159080|NCT00988065|450207515|FG001|Overall Study|Subject withdrew consent|5|||
125159081|NCT00988065|450207516|FG002|Overall Study|Subject withdrew consent|2|||
125159082|NCT00988065|450207514|FG000|Overall Study|Noncompliance with protocol|5|||
125159083|NCT00988065|450207515|FG001|Overall Study|Noncompliance with protocol|6|||
125159084|NCT00988065|450207516|FG002|Overall Study|Noncompliance with protocol|9|||
125159085|NCT01229735|450207517|FG000|Overall Study|Lack of Efficacy|8|||
125159086|NCT01229735|450207518|FG001|Overall Study|Lack of Efficacy|8|||
125159087|NCT01229735|450207517|FG000|Overall Study|Protocol Violation|13|||
125159088|NCT01229735|450207518|FG001|Overall Study|Protocol Violation|8|||
125159089|NCT01229735|450207517|FG000|Overall Study|Lost to Follow-up|0|||
125159090|NCT01229735|450207518|FG001|Overall Study|Lost to Follow-up|2|||
125159091|NCT01229735|450207517|FG000|Overall Study|Withdrawal by Subject|18|||
125159092|NCT01229735|450207518|FG001|Overall Study|Withdrawal by Subject|17|||
125159093|NCT01229735|450207517|FG000|Overall Study|Other Reason|13|||
125159094|NCT01229735|450207518|FG001|Overall Study|Other Reason|10|||
125159095|NCT01229735|450207517|FG000|Overall Study|SAE, non-fatal|0|||
125159096|NCT01229735|450207518|FG001|Overall Study|SAE, non-fatal|4|||
125159097|NCT01229735|450207517|FG000|Overall Study|AE, non-serious non-fatal|13|||
125159098|NCT01229735|450207518|FG001|Overall Study|AE, non-serious non-fatal|17|||
125159099|NCT01229735|450207517|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125159100|NCT01229735|450207518|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
125159101|NCT02685202|450207519|FG000|Overall Study|Lost to Follow-up|9|||
125159102|NCT02787408|450207526|FG000|Overall Study|Death|16|||
125159103|NCT02787408|450207526|FG000|Overall Study|Withdrawal by Subject|1|||
125159104|NCT02787408|450207526|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
125159105|NCT00985712|450207529|FG000|Overall Study|Adverse Event|0|||
125159106|NCT00985712|450207530|FG001|Overall Study|Adverse Event|1|||
125159107|NCT00985712|450207529|FG000|Overall Study|Lost to Follow-up|2|||
125159108|NCT00985712|450207530|FG001|Overall Study|Lost to Follow-up|2|||
125159109|NCT00985712|450207529|FG000|Overall Study|Protocol Violation|0|||
125159110|NCT00985712|450207530|FG001|Overall Study|Protocol Violation|1|||
125159111|NCT00985712|450207529|FG000|Overall Study|Withdrawal by Subject|4|||
125159112|NCT00985712|450207530|FG001|Overall Study|Withdrawal by Subject|1|||
125159113|NCT00985712|450207529|FG000|Overall Study|Sponsor decision|0|||
125159114|NCT00985712|450207530|FG001|Overall Study|Sponsor decision|2|||
125159115|NCT03123861|450207533|FG000|Overall Study|Protocol Violation|1|||
125159116|NCT03123861|450207534|FG001|Overall Study|Protocol Violation|1|||
125159117|NCT03123861|450207533|FG000|Overall Study|Withdrawal by Subject|2|||
125159118|NCT03123861|450207534|FG001|Overall Study|Withdrawal by Subject|2|||
125159119|NCT02206620|450207535|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
125159120|NCT02206620|450207536|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
125159121|NCT02206620|450207535|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
125159122|NCT02206620|450207536|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
125159123|NCT01346774|450207537|FG000|Overall Study|Did not take a single dose|6|||
125159124|NCT01346774|450207538|FG001|Overall Study|Did not take a single dose|4|||
125159125|NCT01346774|450207537|FG000|Overall Study|Lost to Follow-up|3|||
125159126|NCT01346774|450207538|FG001|Overall Study|Lost to Follow-up|4|||
125159127|NCT01346774|450207537|FG000|Overall Study|Withdrawal by Subject|1|||
125159128|NCT01346774|450207538|FG001|Overall Study|Withdrawal by Subject|4|||
125159129|NCT01346774|450207537|FG000|Overall Study|Protocol Violation|2|||
125159130|NCT01346774|450207538|FG001|Overall Study|Protocol Violation|3|||
125159131|NCT01346774|450207537|FG000|Overall Study|Adverse Event|1|||
125159132|NCT01346774|450207538|FG001|Overall Study|Adverse Event|2|||
125159133|NCT00502801|450207539|FG000|Treatment Period|Withdrawal by Subject|3|||
125159134|NCT00502801|450207539|FG000|Treatment Period|Adverse Event|7|||
125159135|NCT00502801|450207539|FG000|Treatment Period|Death|14|||
125159136|NCT00502801|450207539|FG000|Treatment Period|OTHER|30|||
125159137|NCT00502801|450207539|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
125159138|NCT00502801|450207539|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
125159139|NCT00502801|450207539|FG000|End of Therapy to Test of Cure|Death|3|||
125159140|NCT00502801|450207539|FG000|End of Therapy to Test of Cure|OTHER|2|||
125159141|NCT03212521|450207543|FG000|Overall Study|Adverse Event|1|||
125159142|NCT03212521|450207543|FG000|Overall Study|Lost to Follow-up|4|||
125159143|NCT03212521|450207543|FG000|Overall Study|Withdrawal by Subject|1|||
125159144|NCT03212521|450207543|FG000|Overall Study|Other|1|||
125159145|NCT01602965|450207548|FG000|Overall Study|Lost to Follow-up|4|||
125159146|NCT01602965|450207549|FG001|Overall Study|Lost to Follow-up|2|||
125159147|NCT00321737|450207550|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
125159148|NCT00321737|450207551|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
125159149|NCT00321737|450207552|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
125159150|NCT00321737|450207550|FG000|Overall Study|Adverse Event|11|||
125159151|NCT00321737|450207551|FG001|Overall Study|Adverse Event|3|||
125159152|NCT00321737|450207552|FG002|Overall Study|Adverse Event|6|||
125159153|NCT00321737|450207550|FG000|Overall Study|Lost to Follow-up|5|||
125159154|NCT00321737|450207551|FG001|Overall Study|Lost to Follow-up|5|||
125159155|NCT00321737|450207552|FG002|Overall Study|Lost to Follow-up|6|||
125159156|NCT00321737|450207550|FG000|Overall Study|Withdrawal by Subject|19|||
125159157|NCT00321737|450207551|FG001|Overall Study|Withdrawal by Subject|12|||
125159158|NCT00321737|450207552|FG002|Overall Study|Withdrawal by Subject|17|||
125159159|NCT00321737|450207550|FG000|Overall Study|Protocol Violation|0|||
125159160|NCT00321737|450207551|FG001|Overall Study|Protocol Violation|0|||
125159161|NCT00321737|450207552|FG002|Overall Study|Protocol Violation|1|||
125159162|NCT00321737|450207550|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
125159163|NCT00321737|450207551|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
125159164|NCT00321737|450207552|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
125159165|NCT00321737|450207550|FG000|Overall Study|Possible Barrett's Esophagus|2|||
125159166|NCT00321737|450207551|FG001|Overall Study|Possible Barrett's Esophagus|1|||
125159167|NCT00321737|450207552|FG002|Overall Study|Possible Barrett's Esophagus|1|||
125159168|NCT00321737|450207550|FG000|Overall Study|Therapeutic Failure|6|||
125159169|NCT00321737|450207551|FG001|Overall Study|Therapeutic Failure|0|||
125159170|NCT00321737|450207552|FG002|Overall Study|Therapeutic Failure|2|||
125159171|NCT00321737|450207550|FG000|Overall Study|Pregnancy|0|||
125159172|NCT00321737|450207551|FG001|Overall Study|Pregnancy|2|||
125159173|NCT00321737|450207552|FG002|Overall Study|Pregnancy|0|||
125159174|NCT00321737|450207550|FG000|Overall Study|Noncompliance|2|||
125159175|NCT00321737|450207551|FG001|Overall Study|Noncompliance|0|||
125159176|NCT00321737|450207552|FG002|Overall Study|Noncompliance|0|||
125159177|NCT00321737|450207550|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
125159178|NCT00321737|450207551|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
125159179|NCT00321737|450207552|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
125159180|NCT02283294|450207553|FG000|Overall Study|Lost to Follow-up|1|||
125159181|NCT02283294|450207554|FG001|Overall Study|Lost to Follow-up|1|||
125159182|NCT02283294|450207553|FG000|Overall Study|Withdrawal by Subject|1|||
125159183|NCT02283294|450207554|FG001|Overall Study|Withdrawal by Subject|6|||
125159184|NCT02283294|450207553|FG000|Overall Study|Protocol Violation|1|||
125159185|NCT02283294|450207554|FG001|Overall Study|Protocol Violation|0|||
125159186|NCT02283294|450207553|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
125159187|NCT02283294|450207554|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
125159188|NCT01769339|450207555|FG000|Overall Study|Lost to Follow-up|42|||
125159189|NCT01769339|450207555|FG000|Overall Study|Adverse Event|1|||
125159190|NCT00290251|450207556|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
125159191|NCT00290251|450207557|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
125159192|NCT00290251|450207558|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
125159193|NCT00290251|450207559|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
125159194|NCT00290251|450207560|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
125159195|NCT00290251|450207561|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
125159196|NCT00290251|450207556|FG000|Treatment 1 (Months 2-4)|headache|0|||
125159197|NCT00290251|450207557|FG001|Treatment 1 (Months 2-4)|headache|0|||
125159198|NCT00290251|450207558|FG002|Treatment 1 (Months 2-4)|headache|0|||
125159199|NCT00290251|450207559|FG003|Treatment 1 (Months 2-4)|headache|0|||
125159200|NCT00290251|450207560|FG004|Treatment 1 (Months 2-4)|headache|1|||
125159201|NCT00290251|450207561|FG005|Treatment 1 (Months 2-4)|headache|0|||
125159202|NCT00290251|450207556|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
125159203|NCT00290251|450207557|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
125159204|NCT00290251|450207558|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
125159205|NCT00290251|450207559|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
125159206|NCT00290251|450207560|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
125159207|NCT00290251|450207561|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
125159208|NCT04062448|450210026|FG000|Overall Study|Lost to Follow-up|1|||
125159209|NCT04062448|450210026|FG000|Overall Study|Withdrawal by Subject|2|||
125159210|NCT05101486|450210027|FG000|Overall Study|Death|1|||
125159211|NCT05101486|450210028|FG001|Overall Study|Death|0|||
125159212|NCT05101486|450210029|FG002|Overall Study|Death|1|||
125159213|NCT05101486|450210027|FG000|Overall Study|Lost to Follow-up|12|||
125159214|NCT05101486|450210028|FG001|Overall Study|Lost to Follow-up|8|||
125159215|NCT05101486|450210029|FG002|Overall Study|Lost to Follow-up|17|||
125159216|NCT05101486|450210027|FG000|Overall Study|Physician Decision|1|||
125159217|NCT05101486|450210028|FG001|Overall Study|Physician Decision|0|||
125159218|NCT05101486|450210029|FG002|Overall Study|Physician Decision|0|||
125159219|NCT05101486|450210027|FG000|Overall Study|Protocol Violation|0|||
125159220|NCT05101486|450210028|FG001|Overall Study|Protocol Violation|0|||
125159221|NCT05101486|450210029|FG002|Overall Study|Protocol Violation|1|||
125159222|NCT05101486|450210027|FG000|Overall Study|Withdrawal by Subject|5|||
125159223|NCT05101486|450210028|FG001|Overall Study|Withdrawal by Subject|2|||
125159224|NCT05101486|450210029|FG002|Overall Study|Withdrawal by Subject|4|||
125159225|NCT05101486|450210027|FG000|Overall Study|Randomized but not vaccinated|1|||
125159226|NCT05101486|450210028|FG001|Overall Study|Randomized but not vaccinated|1|||
125159227|NCT05101486|450210029|FG002|Overall Study|Randomized but not vaccinated|1|||
125159228|NCT02788045|450210030|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
125159229|NCT02788045|450210031|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
125159230|NCT02788045|450210032|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
125159231|NCT02788045|450210030|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
125159232|NCT02788045|450210031|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
125159233|NCT02788045|450210032|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
125159234|NCT02788045|450210030|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
125159235|NCT02788045|450210031|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
125159236|NCT02788045|450210032|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
125159237|NCT02788045|450210030|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
125159238|NCT02788045|450210031|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
125159239|NCT02788045|450210032|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
125159240|NCT02788045|450210030|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
125159241|NCT02788045|450210031|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
125159242|NCT02788045|450210032|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
125159243|NCT02788045|450210030|FG000|Main Study (Up to Week 72)|Other|3|||
125159244|NCT02788045|450210031|FG001|Main Study (Up to Week 72)|Other|0|||
125159245|NCT02788045|450210032|FG002|Main Study (Up to Week 72)|Other|0|||
125159246|NCT02788045|450210030|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
125159247|NCT02788045|450210031|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
125159248|NCT02788045|450210032|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
125438994|NCT04921969|451234033|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
125438995|NCT04921969|451234034|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
125438996|NCT04921969|451234035|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
125438997|NCT04921969|451234036|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
125438998|NCT04921969|451234037|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
125438999|NCT04921969|451234031|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
125159249|NCT02788045|450210030|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
125159250|NCT02788045|450210031|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
125159251|NCT02788045|450210032|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
125159252|NCT02788045|450210030|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
125159253|NCT02788045|450210031|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
125159254|NCT02788045|450210032|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
125159255|NCT03188666|450210033|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
125159256|NCT03188666|450210034|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
125159257|NCT03188666|450210035|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
125159258|NCT03188666|450210036|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
125159259|NCT03188666|450210033|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
125159260|NCT03188666|450210034|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
125159261|NCT03188666|450210035|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
125159262|NCT03188666|450210036|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
125224019|NCT01325350|450448035|FG004|Overall Study|Adverse Event|2|||
125389241|NCT00004888|451060337|FG000|Overall Study|Withdrawal by Subject|0|||
125159263|NCT03188666|450210033|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
125159264|NCT03188666|450210034|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
125159265|NCT03188666|450210035|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
125159266|NCT03188666|450210036|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
125159267|NCT03188666|450210033|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
125159268|NCT03188666|450210034|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
125159269|NCT03188666|450210035|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
125159270|NCT03188666|450210036|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
125159271|NCT03696953|450210037|FG000|Overall Study|Withdrawal by Subject|6|||
125159272|NCT03696953|450210038|FG001|Overall Study|Withdrawal by Subject|1|||
125159273|NCT03696953|450210037|FG000|Overall Study|missed GBS swabs|2|||
125159274|NCT03696953|450210038|FG001|Overall Study|missed GBS swabs|2|||
125159275|NCT03696953|450210037|FG000|Overall Study|lost study bottle containing capsules|2|||
125159276|NCT03696953|450210038|FG001|Overall Study|lost study bottle containing capsules|0|||
125159277|NCT03696953|450210037|FG000|Overall Study|Premature birth|1|||
125159278|NCT03696953|450210038|FG001|Overall Study|Premature birth|4|||
125159279|NCT03696953|450210037|FG000|Overall Study|Gestational hypertension|1|||
125159280|NCT03696953|450210038|FG001|Overall Study|Gestational hypertension|1|||
125159281|NCT03696953|450210037|FG000|Overall Study|Gestational diabetes|2|||
125159282|NCT03696953|450210038|FG001|Overall Study|Gestational diabetes|1|||
125159283|NCT03696953|450210037|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
125159284|NCT03696953|450210038|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
125159285|NCT03696953|450210037|FG000|Overall Study|Changed prenatal provider|1|||
125159286|NCT03696953|450210038|FG001|Overall Study|Changed prenatal provider|1|||
125159287|NCT05104476|450210039|FG000|Overall Study|Randomized But Not Treated|1|||
125159288|NCT05104476|450210040|FG001|Overall Study|Randomized But Not Treated|2|||
125159289|NCT05104476|450210039|FG000|Overall Study|Adverse Event|2|||
125159290|NCT05104476|450210040|FG001|Overall Study|Adverse Event|2|||
125159291|NCT05104476|450210039|FG000|Overall Study|Withdrawal by Subject|3|||
125159292|NCT05104476|450210040|FG001|Overall Study|Withdrawal by Subject|3|||
125159293|NCT05104476|450210039|FG000|Overall Study|Other Than Specified|0|||
125159294|NCT05104476|450210040|FG001|Overall Study|Other Than Specified|3|||
125159295|NCT04908683|450210041|FG000|Overall Study|Failure to meet continuation criteria|34|||
125159296|NCT04908683|450210042|FG001|Overall Study|Failure to meet continuation criteria|22|||
125159297|NCT04908683|450210041|FG000|Overall Study|Initiated prohibited medication|3|||
125159298|NCT04908683|450210042|FG001|Overall Study|Initiated prohibited medication|0|||
125159299|NCT04908683|450210041|FG000|Overall Study|Randomized by mistake|1|||
125159300|NCT04908683|450210042|FG001|Overall Study|Randomized by mistake|0|||
125159301|NCT04908683|450210041|FG000|Overall Study|Lost to Follow-up|679|||
125159302|NCT04908683|450210042|FG001|Overall Study|Lost to Follow-up|341|||
125159303|NCT04908683|450210041|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
125159304|NCT04908683|450210042|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
125159305|NCT04908683|450210041|FG000|Overall Study|Physician Decision|44|||
125159306|NCT04908683|450210042|FG001|Overall Study|Physician Decision|35|||
125159307|NCT04908683|450210041|FG000|Overall Study|Technical problems|12|||
125159308|NCT04908683|450210042|FG001|Overall Study|Technical problems|9|||
125159309|NCT04908683|450210041|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
125159310|NCT04908683|450210042|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
125159311|NCT04908683|450210041|FG000|Overall Study|Protocol Violation|2|||
125159312|NCT04908683|450210042|FG001|Overall Study|Protocol Violation|0|||
125159313|NCT04908683|450210041|FG000|Overall Study|Withdrawal by Subject|1188|||
125159314|NCT04908683|450210042|FG001|Overall Study|Withdrawal by Subject|570|||
125159315|NCT04908683|450210041|FG000|Overall Study|Site Closure by Sponsor|6|||
125159316|NCT04908683|450210042|FG001|Overall Study|Site Closure by Sponsor|3|||
125159317|NCT04908683|450210041|FG000|Overall Study|Adverse Event|21|||
125159318|NCT04908683|450210042|FG001|Overall Study|Adverse Event|11|||
125159319|NCT04908683|450210041|FG000|Overall Study|Death|101|||
125159320|NCT04908683|450210042|FG001|Overall Study|Death|61|||
125159321|NCT04908683|450210041|FG000|Overall Study|Sponsor's decision|14398|||
125159322|NCT04908683|450210042|FG001|Overall Study|Sponsor's decision|7205|||
125389242|NCT00004888|451060338|FG001|Overall Study|Withdrawal by Subject|3|||
125389243|NCT00004888|451060337|FG000|Overall Study|Physician Decision|1|||
125389244|NCT00004888|451060338|FG001|Overall Study|Physician Decision|1|||
125389245|NCT00004888|451060337|FG000|Overall Study|Progressive Disease|4|||
125389246|NCT00004888|451060338|FG001|Overall Study|Progressive Disease|9|||
125389247|NCT00004888|451060337|FG000|Overall Study|Death without progressive disease|0|||
125389248|NCT00004888|451060338|FG001|Overall Study|Death without progressive disease|1|||
125389249|NCT00004888|451060337|FG000|Overall Study|Toxic death|1|||
125389250|NCT00004888|451060338|FG001|Overall Study|Toxic death|0|||
125389251|NCT02579265|451060339|FG000|Overall Study|Weaned off earlier than 28 days|44|||
125159323|NCT04908683|450210041|FG000|Overall Study|Other|92|||
125159324|NCT04908683|450210042|FG001|Overall Study|Other|50|||
125224020|NCT01325350|450448031|FG000|Overall Study|Pregnancy|0|||
125159325|NCT04908683|450210041|FG000|Overall Study|Randomized not vaccinated|108|||
125159326|NCT04908683|450210042|FG001|Overall Study|Randomized not vaccinated|52|||
125159327|NCT03047473|450210044|FG000|Overall Study|Lost to Follow-up|2|||
125159328|NCT06204887|450210045|FG000|Overall Study|Lost to Follow-up|3|||
125159329|NCT06204887|450210046|FG001|Overall Study|Lost to Follow-up|4|||
125159330|NCT06204887|450210047|FG002|Overall Study|Lost to Follow-up|1|||
125159331|NCT06204887|450210048|FG003|Overall Study|Lost to Follow-up|6|||
125159332|NCT02935686|450210049|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
125159333|NCT02935686|450210050|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
125159334|NCT02935686|450210051|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
125159335|NCT02935686|450210052|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
125159336|NCT02935686|450210053|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
125159337|NCT02935686|450210049|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
125159338|NCT02935686|450210050|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
125159339|NCT02935686|450210051|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
125159340|NCT02935686|450210052|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
125159341|NCT02935686|450210053|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
125159342|NCT02935686|450210049|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
125159343|NCT02935686|450210050|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
125159344|NCT02935686|450210051|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
125159345|NCT02935686|450210052|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
125159346|NCT02935686|450210053|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
125159347|NCT02935686|450210049|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
125159348|NCT02935686|450210050|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
125159349|NCT02935686|450210051|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
125159350|NCT02935686|450210052|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
125159351|NCT02935686|450210053|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
125159352|NCT02935686|450210049|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
125159353|NCT02935686|450210050|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
125159354|NCT02935686|450210051|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
125159355|NCT02935686|450210052|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
125159356|NCT02935686|450210053|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
125159357|NCT02935686|450210049|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
125159358|NCT02935686|450210050|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
125159359|NCT02935686|450210051|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
125159360|NCT02935686|450210052|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
125159361|NCT02935686|450210053|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
125159362|NCT02935686|450210049|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
125159363|NCT02935686|450210050|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
125159364|NCT02935686|450210051|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
125159365|NCT02935686|450210052|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
125159366|NCT02935686|450210053|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
125159367|NCT02935686|450210049|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
125159368|NCT02935686|450210050|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
125159369|NCT02935686|450210051|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
125224021|NCT01325350|450448032|FG001|Overall Study|Pregnancy|0|||
125224022|NCT01325350|450448033|FG002|Overall Study|Pregnancy|1|||
125224023|NCT01325350|450448034|FG003|Overall Study|Pregnancy|0|||
125224024|NCT01325350|450448035|FG004|Overall Study|Pregnancy|1|||
125224025|NCT01325350|450448031|FG000|Overall Study|Lost to Follow-up|1|||
125224026|NCT01325350|450448032|FG001|Overall Study|Lost to Follow-up|0|||
125224027|NCT01325350|450448033|FG002|Overall Study|Lost to Follow-up|5|||
125224028|NCT01325350|450448034|FG003|Overall Study|Lost to Follow-up|1|||
125224029|NCT01325350|450448035|FG004|Overall Study|Lost to Follow-up|5|||
125224030|NCT01325350|450448031|FG000|Overall Study|Personal Reasons|2|||
125224031|NCT01325350|450448032|FG001|Overall Study|Personal Reasons|1|||
125224032|NCT01325350|450448033|FG002|Overall Study|Personal Reasons|6|||
125224033|NCT01325350|450448034|FG003|Overall Study|Personal Reasons|5|||
125159370|NCT02935686|450210052|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
125159371|NCT02935686|450210053|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
125159372|NCT02935686|450210049|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
125159373|NCT02935686|450210050|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
125159374|NCT02935686|450210051|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
125389252|NCT02579265|451060340|FG001|Overall Study|Weaned off earlier than 28 days|43|||
125159375|NCT02935686|450210052|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
125224034|NCT01325350|450448035|FG004|Overall Study|Personal Reasons|3|||
125224035|NCT01325350|450448031|FG000|Overall Study|Protocol Violation|0|||
125224036|NCT01325350|450448032|FG001|Overall Study|Protocol Violation|0|||
125224037|NCT01325350|450448033|FG002|Overall Study|Protocol Violation|0|||
125224038|NCT01325350|450448034|FG003|Overall Study|Protocol Violation|1|||
125224039|NCT01325350|450448035|FG004|Overall Study|Protocol Violation|0|||
125389253|NCT02579265|451060339|FG000|Overall Study|Adverse Event|2|||
125159376|NCT02935686|450210053|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
125159377|NCT02935686|450210049|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
125159378|NCT02935686|450210050|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
125159379|NCT02935686|450210051|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
125159380|NCT02935686|450210052|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
125159381|NCT02935686|450210053|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
125159382|NCT02935686|450210049|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
125159383|NCT02935686|450210050|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
125159384|NCT02935686|450210051|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
125159385|NCT02935686|450210052|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
125159386|NCT02935686|450210053|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
125159387|NCT00062010|450210055|FG000|Overall Study|Ineligible|3|||
125159388|NCT02856880|450210056|FG000|Overall Study|Withdrawal of consent|1|||
125159389|NCT00573157|450210057|FG000|Overall Study|Adverse Event|3|||
125159390|NCT00573157|450210058|FG001|Overall Study|Adverse Event|1|||
125159391|NCT00573157|450210057|FG000|Overall Study|Other|1|||
125159392|NCT00573157|450210058|FG001|Overall Study|Other|1|||
125159393|NCT02944383|450210059|FG000|Overall Study|Lost to Follow-up|0|||
125159394|NCT02944383|450210060|FG001|Overall Study|Lost to Follow-up|0|||
125159395|NCT02944383|450210061|FG002|Overall Study|Lost to Follow-up|1|||
125159396|NCT02944383|450210059|FG000|Overall Study|Withdrawal by Subject|1|||
125159397|NCT02944383|450210060|FG001|Overall Study|Withdrawal by Subject|0|||
125159398|NCT02944383|450210061|FG002|Overall Study|Withdrawal by Subject|0|||
125159399|NCT01183221|450210064|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
125159400|NCT01183221|450210065|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
125159401|NCT00807248|450210069|FG000|Overall Study|Adverse Event|1|||
125159402|NCT00807248|450210070|FG001|Overall Study|Adverse Event|2|||
125159403|NCT00807248|450210071|FG002|Overall Study|Adverse Event|2|||
125389254|NCT02579265|451060340|FG001|Overall Study|Adverse Event|0|||
125159404|NCT00807248|450210072|FG003|Overall Study|Adverse Event|6|||
125159405|NCT00807248|450210069|FG000|Overall Study|Lack of Efficacy|14|||
125389255|NCT02579265|451060339|FG000|Overall Study|Any other reason not specified|0|||
125389256|NCT02579265|451060340|FG001|Overall Study|Any other reason not specified|2|||
125389257|NCT02579265|451060339|FG000|Overall Study|Withdrawal by Subject|2|||
125389258|NCT02579265|451060340|FG001|Overall Study|Withdrawal by Subject|0|||
125389259|NCT02579265|451060339|FG000|Overall Study|Physician Decision|1|||
125389260|NCT02579265|451060340|FG001|Overall Study|Physician Decision|0|||
125389261|NCT02579265|451060339|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
125389262|NCT02579265|451060340|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
125389263|NCT02174848|451060341|FG000|Overall Study|Adverse Event|2|||
125389264|NCT02174848|451060342|FG001|Overall Study|Adverse Event|1|||
125389265|NCT02174848|451060341|FG000|Overall Study|Withdrawal by Subject|3|||
125389266|NCT02174848|451060342|FG001|Overall Study|Withdrawal by Subject|3|||
125389267|NCT02174848|451060341|FG000|Overall Study|Lost to Follow-up|0|||
125389268|NCT02174848|451060342|FG001|Overall Study|Lost to Follow-up|1|||
125389269|NCT02174848|451060341|FG000|Overall Study|Worsening of disease|1|||
125389270|NCT02174848|451060342|FG001|Overall Study|Worsening of disease|1|||
125389271|NCT02174848|451060341|FG000|Overall Study|Unable to comply with study requirements|1|||
125389272|NCT02174848|451060342|FG001|Overall Study|Unable to comply with study requirements|0|||
125389273|NCT00644969|451060347|FG000|Treatment Phase|Randomized, not treated|1|||
125389274|NCT00644969|451060348|FG001|Treatment Phase|Randomized, not treated|0|||
125389275|NCT00644969|451060347|FG000|Treatment Phase|Adverse Event|3|||
125389276|NCT00644969|451060348|FG001|Treatment Phase|Adverse Event|0|||
125389277|NCT00644969|451060347|FG000|Treatment Phase|Withdrawal by Subject|4|||
125389278|NCT00644969|451060348|FG001|Treatment Phase|Withdrawal by Subject|0|||
125389279|NCT00644969|451060347|FG000|Treatment Phase|Lost to Follow-up|2|||
125389280|NCT00644969|451060348|FG001|Treatment Phase|Lost to Follow-up|2|||
125389281|NCT00644969|451060347|FG000|Treatment Phase|Other|4|||
125389282|NCT00644969|451060348|FG001|Treatment Phase|Other|1|||
125389283|NCT00644969|451060347|FG000|Post Treatment Phase|Death|1|||
125389284|NCT00644969|451060348|FG001|Post Treatment Phase|Death|0|||
125389285|NCT00644969|451060347|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
125389286|NCT00644969|451060348|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
125389287|NCT00644969|451060347|FG000|Post Treatment Phase|Lost to Follow-up|4|||
125389288|NCT00644969|451060348|FG001|Post Treatment Phase|Lost to Follow-up|1|||
125389289|NCT00644969|451060347|FG000|Post Treatment Phase|Other|1|||
125389290|NCT00644969|451060348|FG001|Post Treatment Phase|Other|0|||
125389291|NCT02515942|451060349|FG000|Overall Study|Adverse Event|5|||
125389292|NCT02515942|451060350|FG001|Overall Study|Adverse Event|0|||
125389293|NCT02515942|451060351|FG002|Overall Study|Adverse Event|0|||
125389294|NCT02515942|451060349|FG000|Overall Study|Death|0|||
125389295|NCT02515942|451060350|FG001|Overall Study|Death|0|||
125389296|NCT02515942|451060351|FG002|Overall Study|Death|1|||
125389297|NCT02515942|451060349|FG000|Overall Study|Lack of Efficacy|0|||
125224040|NCT01325350|450448031|FG000|Overall Study|Withdrawal by Subject|0|||
125224041|NCT01325350|450448032|FG001|Overall Study|Withdrawal by Subject|0|||
125224042|NCT01325350|450448033|FG002|Overall Study|Withdrawal by Subject|1|||
125224043|NCT01325350|450448034|FG003|Overall Study|Withdrawal by Subject|1|||
125224044|NCT01325350|450448035|FG004|Overall Study|Withdrawal by Subject|0|||
125224045|NCT01325350|450448031|FG000|Overall Study|Did Not Receive Treatment|0|||
125224046|NCT01325350|450448032|FG001|Overall Study|Did Not Receive Treatment|1|||
125159406|NCT00807248|450210070|FG001|Overall Study|Lack of Efficacy|4|||
125159407|NCT00807248|450210071|FG002|Overall Study|Lack of Efficacy|8|||
125159408|NCT00807248|450210072|FG003|Overall Study|Lack of Efficacy|3|||
125159409|NCT00807248|450210069|FG000|Overall Study|Protocol Violation|0|||
125159410|NCT00807248|450210070|FG001|Overall Study|Protocol Violation|1|||
125159411|NCT00807248|450210071|FG002|Overall Study|Protocol Violation|1|||
125159412|NCT00807248|450210072|FG003|Overall Study|Protocol Violation|0|||
125159413|NCT00807248|450210069|FG000|Overall Study|Withdrawal of Consent|5|||
125159414|NCT00807248|450210070|FG001|Overall Study|Withdrawal of Consent|5|||
125159415|NCT00807248|450210071|FG002|Overall Study|Withdrawal of Consent|5|||
125159416|NCT00807248|450210072|FG003|Overall Study|Withdrawal of Consent|5|||
125159417|NCT00807248|450210069|FG000|Overall Study|Lost to Follow-up|1|||
125159418|NCT00807248|450210070|FG001|Overall Study|Lost to Follow-up|0|||
125159419|NCT00807248|450210071|FG002|Overall Study|Lost to Follow-up|0|||
125159420|NCT00807248|450210072|FG003|Overall Study|Lost to Follow-up|0|||
125159421|NCT00807248|450210069|FG000|Overall Study|Other Reason|0|||
125159422|NCT00807248|450210070|FG001|Overall Study|Other Reason|0|||
125159423|NCT00807248|450210071|FG002|Overall Study|Other Reason|2|||
125159424|NCT00807248|450210072|FG003|Overall Study|Other Reason|0|||
125159425|NCT02504671|450210074|FG000|Overall Study|Withdrawal by Subject|1|||
125159426|NCT02504671|450210075|FG001|Overall Study|Withdrawal by Subject|5|||
125159427|NCT02504671|450210076|FG002|Overall Study|Withdrawal by Subject|4|||
125159428|NCT02504671|450210077|FG003|Overall Study|Withdrawal by Subject|4|||
125159429|NCT02504671|450210078|FG004|Overall Study|Withdrawal by Subject|5|||
125159430|NCT02504671|450210079|FG005|Overall Study|Withdrawal by Subject|3|||
125159431|NCT02504671|450210074|FG000|Overall Study|Lack of Efficacy|1|||
125159432|NCT02504671|450210075|FG001|Overall Study|Lack of Efficacy|3|||
125159433|NCT02504671|450210076|FG002|Overall Study|Lack of Efficacy|1|||
125159434|NCT02504671|450210077|FG003|Overall Study|Lack of Efficacy|0|||
125159435|NCT02504671|450210078|FG004|Overall Study|Lack of Efficacy|4|||
125159436|NCT02504671|450210079|FG005|Overall Study|Lack of Efficacy|4|||
125159437|NCT02504671|450210074|FG000|Overall Study|Adverse Event|1|||
125159438|NCT02504671|450210075|FG001|Overall Study|Adverse Event|1|||
125159439|NCT02504671|450210076|FG002|Overall Study|Adverse Event|0|||
125159440|NCT02504671|450210077|FG003|Overall Study|Adverse Event|1|||
125159441|NCT02504671|450210078|FG004|Overall Study|Adverse Event|0|||
125159442|NCT02504671|450210079|FG005|Overall Study|Adverse Event|2|||
125159443|NCT02504671|450210074|FG000|Overall Study|Protocol Violation|2|||
125159444|NCT02504671|450210075|FG001|Overall Study|Protocol Violation|1|||
125159445|NCT02504671|450210076|FG002|Overall Study|Protocol Violation|0|||
125159446|NCT02504671|450210077|FG003|Overall Study|Protocol Violation|0|||
125159447|NCT02504671|450210078|FG004|Overall Study|Protocol Violation|0|||
125159448|NCT02504671|450210079|FG005|Overall Study|Protocol Violation|1|||
125159449|NCT02504671|450210074|FG000|Overall Study|Lost to Follow-up|0|||
125159450|NCT02504671|450210075|FG001|Overall Study|Lost to Follow-up|0|||
125159451|NCT02504671|450210076|FG002|Overall Study|Lost to Follow-up|2|||
125159452|NCT02504671|450210077|FG003|Overall Study|Lost to Follow-up|0|||
125159453|NCT02504671|450210078|FG004|Overall Study|Lost to Follow-up|0|||
125159454|NCT02504671|450210079|FG005|Overall Study|Lost to Follow-up|1|||
125159455|NCT02504671|450210074|FG000|Overall Study|Protocol defined stopping criteria|7|||
125159456|NCT02504671|450210075|FG001|Overall Study|Protocol defined stopping criteria|4|||
125159457|NCT02504671|450210076|FG002|Overall Study|Protocol defined stopping criteria|3|||
125159458|NCT02504671|450210077|FG003|Overall Study|Protocol defined stopping criteria|5|||
125159459|NCT02504671|450210078|FG004|Overall Study|Protocol defined stopping criteria|3|||
125159460|NCT02504671|450210079|FG005|Overall Study|Protocol defined stopping criteria|3|||
125159461|NCT00210249|450210080|FG000|Overall Study|Lost to Follow-up|5|||
125159462|NCT00210249|450210080|FG000|Overall Study|Protocol Violation|11|||
125159463|NCT00599521|450210081|FG000|Overall Study|Lack of Efficacy|4|||
125159464|NCT00599521|450210082|FG001|Overall Study|Lack of Efficacy|8|||
125159465|NCT00599521|450210081|FG000|Overall Study|Adverse Event|4|||
125159466|NCT00599521|450210082|FG001|Overall Study|Adverse Event|1|||
125159467|NCT00599521|450210081|FG000|Overall Study|Withdrawal by Subject|28|||
125159468|NCT00599521|450210082|FG001|Overall Study|Withdrawal by Subject|34|||
125389298|NCT02515942|451060350|FG001|Overall Study|Lack of Efficacy|0|||
125389299|NCT02515942|451060351|FG002|Overall Study|Lack of Efficacy|1|||
125159469|NCT00599521|450210081|FG000|Overall Study|Protocol Violation|1|||
125159470|NCT00599521|450210082|FG001|Overall Study|Protocol Violation|1|||
125159471|NCT00599521|450210081|FG000|Overall Study|Lost to Follow-up|23|||
125159472|NCT00599521|450210082|FG001|Overall Study|Lost to Follow-up|23|||
125159473|NCT00599521|450210081|FG000|Overall Study|Pregnancy|0|||
125159474|NCT00599521|450210082|FG001|Overall Study|Pregnancy|2|||
125224047|NCT01325350|450448033|FG002|Overall Study|Did Not Receive Treatment|1|||
125439000|NCT04921969|451234032|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
125439001|NCT04921969|451234033|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
125439002|NCT04921969|451234034|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
125439003|NCT04921969|451234035|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
125439004|NCT04921969|451234036|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
125439005|NCT04921969|451234037|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
125439006|NCT04921969|451234031|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125439007|NCT04921969|451234032|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125439008|NCT04921969|451234033|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125439009|NCT04921969|451234034|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
125439010|NCT04921969|451234035|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125439011|NCT04921969|451234036|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
125439012|NCT04921969|451234037|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
125439013|NCT04921969|451234031|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125439014|NCT04921969|451234032|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125439015|NCT04921969|451234033|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125439016|NCT04921969|451234034|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
125439017|NCT04921969|451234035|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
125439018|NCT04921969|451234036|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
125439019|NCT04921969|451234037|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
125439020|NCT04921969|451234031|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
125439021|NCT04921969|451234032|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
125439022|NCT04921969|451234033|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
125439023|NCT04921969|451234034|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
125439024|NCT04921969|451234035|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
125439025|NCT04921969|451234036|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
125439026|NCT04921969|451234037|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
125439027|NCT04921969|451234031|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125439028|NCT04921969|451234032|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125439029|NCT04921969|451234033|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125439030|NCT04921969|451234034|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
125439031|NCT04921969|451234035|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
125439032|NCT04921969|451234036|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
125439033|NCT04921969|451234037|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
125439034|NCT04921969|451234031|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
125439035|NCT04921969|451234032|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
125439036|NCT04921969|451234033|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
125439037|NCT04921969|451234034|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
125439038|NCT04921969|451234035|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
125439039|NCT04921969|451234036|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
125439040|NCT04921969|451234037|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
125439041|NCT04921969|451234031|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
125439042|NCT04921969|451234032|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
125439043|NCT04921969|451234033|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
125439044|NCT04921969|451234034|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
125439045|NCT04921969|451234035|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
125159475|NCT01293539|450210083|FG000|Overall Study|Physician Decision|1|||
125159476|NCT01687478|450210086|FG000|Overall Study|Adverse Event|3|||
125159477|NCT01687478|450210087|FG001|Overall Study|Adverse Event|10|||
125159478|NCT01687478|450210086|FG000|Overall Study|Lost to Follow-up|1|||
125159479|NCT01687478|450210087|FG001|Overall Study|Lost to Follow-up|3|||
125159480|NCT01687478|450210086|FG000|Overall Study|Protocol Violation|0|||
125159481|NCT01687478|450210087|FG001|Overall Study|Protocol Violation|2|||
125159482|NCT01687478|450210086|FG000|Overall Study|Withdrawal by Subject|21|||
125159483|NCT01687478|450210087|FG001|Overall Study|Withdrawal by Subject|19|||
125159484|NCT01687478|450210086|FG000|Overall Study|Physician Decision|1|||
125159485|NCT01687478|450210087|FG001|Overall Study|Physician Decision|3|||
125159486|NCT01687478|450210086|FG000|Overall Study|Entry Criteria Not Met|6|||
125159487|NCT01687478|450210087|FG001|Overall Study|Entry Criteria Not Met|2|||
125159488|NCT04322149|450210088|FG000|Overall Study|Adverse Event|1|||
125159489|NCT04322149|450210089|FG001|Overall Study|Adverse Event|1|||
125159490|NCT04322149|450210090|FG002|Overall Study|Adverse Event|0|||
125159491|NCT04322149|450210091|FG003|Overall Study|Adverse Event|0|||
125159492|NCT04322149|450210088|FG000|Overall Study|Withdrawal by Subject|0|||
125159493|NCT04322149|450210089|FG001|Overall Study|Withdrawal by Subject|0|||
125159494|NCT04322149|450210090|FG002|Overall Study|Withdrawal by Subject|0|||
125159495|NCT04322149|450210091|FG003|Overall Study|Withdrawal by Subject|2|||
125159496|NCT04322149|450210088|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
125159497|NCT04322149|450210089|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
125224048|NCT01325350|450448034|FG003|Overall Study|Did Not Receive Treatment|0|||
125159498|NCT04322149|450210090|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
125159499|NCT04322149|450210091|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
125159500|NCT01700049|450210092|FG000|Overall Study|Withdrawal by Subject|1|||
125159501|NCT01206101|450210093|FG000|Overall Study|Adverse Event|1|||
125159502|NCT01206101|450210094|FG001|Overall Study|Adverse Event|0|||
125159503|NCT01206101|450210093|FG000|Overall Study|Physician Decision|0|||
125159504|NCT01206101|450210094|FG001|Overall Study|Physician Decision|1|||
125159505|NCT01206101|450210093|FG000|Overall Study|Unclassified|1|||
125159506|NCT01206101|450210094|FG001|Overall Study|Unclassified|0|||
125159507|NCT01248013|450210095|FG000|Overall Study|Withdrawal by Subject|14|||
125159508|NCT00307034|450210099|FG000|Overall Study|Adverse Event|1|||
125159509|NCT00307034|450210100|FG001|Overall Study|Adverse Event|2|||
125159510|NCT00307034|450210099|FG000|Overall Study|Withdrawal by Subject|1|||
125159511|NCT00307034|450210100|FG001|Overall Study|Withdrawal by Subject|2|||
125159512|NCT00307034|450210099|FG000|Overall Study|Lost to Follow-up|0|||
125159513|NCT00307034|450210100|FG001|Overall Study|Lost to Follow-up|3|||
125159514|NCT00667810|450210101|FG000|Overall Study|Adverse Event|13|||
125159515|NCT00667810|450210102|FG001|Overall Study|Adverse Event|14|||
125159516|NCT00667810|450210103|FG002|Overall Study|Adverse Event|19|||
125159517|NCT00667810|450210104|FG003|Overall Study|Adverse Event|1|||
125159518|NCT00667810|450210101|FG000|Overall Study|Death|1|||
125159519|NCT00667810|450210102|FG001|Overall Study|Death|1|||
125159520|NCT00667810|450210103|FG002|Overall Study|Death|3|||
125159521|NCT00667810|450210104|FG003|Overall Study|Death|0|||
125159522|NCT00667810|450210101|FG000|Overall Study|Lack of Efficacy|1|||
125159523|NCT00667810|450210102|FG001|Overall Study|Lack of Efficacy|0|||
125159524|NCT00667810|450210103|FG002|Overall Study|Lack of Efficacy|2|||
125159525|NCT00667810|450210104|FG003|Overall Study|Lack of Efficacy|0|||
125159526|NCT00667810|450210101|FG000|Overall Study|Lost to Follow-up|1|||
125159527|NCT00667810|450210102|FG001|Overall Study|Lost to Follow-up|4|||
125159528|NCT00667810|450210103|FG002|Overall Study|Lost to Follow-up|2|||
125159529|NCT00667810|450210104|FG003|Overall Study|Lost to Follow-up|0|||
125159530|NCT00667810|450210101|FG000|Overall Study|Physician Decision|1|||
125159531|NCT00667810|450210102|FG001|Overall Study|Physician Decision|1|||
125159532|NCT00667810|450210103|FG002|Overall Study|Physician Decision|2|||
125159533|NCT00667810|450210104|FG003|Overall Study|Physician Decision|0|||
125159534|NCT00667810|450210101|FG000|Overall Study|Protocol Violation|0|||
125159535|NCT00667810|450210102|FG001|Overall Study|Protocol Violation|2|||
125159536|NCT00667810|450210103|FG002|Overall Study|Protocol Violation|0|||
125159537|NCT00667810|450210104|FG003|Overall Study|Protocol Violation|0|||
125159538|NCT00667810|450210101|FG000|Overall Study|Withdrawal by Subject|14|||
125159539|NCT00667810|450210102|FG001|Overall Study|Withdrawal by Subject|20|||
125159540|NCT00667810|450210103|FG002|Overall Study|Withdrawal by Subject|29|||
125159541|NCT00667810|450210104|FG003|Overall Study|Withdrawal by Subject|1|||
125159542|NCT00667810|450210101|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
125159543|NCT00667810|450210102|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
125159544|NCT00667810|450210103|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
125159545|NCT00667810|450210104|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
125159546|NCT00667810|450210101|FG000|Overall Study|Failed to Return|0|||
125159547|NCT00667810|450210102|FG001|Overall Study|Failed to Return|0|||
125159548|NCT00667810|450210103|FG002|Overall Study|Failed to Return|2|||
125159549|NCT00667810|450210104|FG003|Overall Study|Failed to Return|0|||
125159550|NCT00667810|450210101|FG000|Overall Study|Loss of Caregiver|0|||
125159551|NCT00667810|450210102|FG001|Overall Study|Loss of Caregiver|1|||
125159552|NCT00667810|450210103|FG002|Overall Study|Loss of Caregiver|3|||
125159553|NCT00667810|450210104|FG003|Overall Study|Loss of Caregiver|0|||
125159554|NCT00667810|450210101|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
125159555|NCT00667810|450210102|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
125159556|NCT00667810|450210103|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
125159557|NCT00667810|450210104|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
125159558|NCT00667810|450210101|FG000|Overall Study|Other|6|||
125159559|NCT00667810|450210102|FG001|Overall Study|Other|6|||
125159560|NCT00667810|450210103|FG002|Overall Study|Other|5|||
125159561|NCT00667810|450210104|FG003|Overall Study|Other|0|||
125159562|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
125159563|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
125159564|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
125159565|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
125159566|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
125159567|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
125159568|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
125159569|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
125159570|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
125159571|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
125159572|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
125159573|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
125439046|NCT04921969|451234036|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
125439047|NCT04921969|451234037|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
125439048|NCT04921969|451234031|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
125439049|NCT04921969|451234032|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
125439050|NCT04921969|451234033|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
125439051|NCT04921969|451234034|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
125439052|NCT04921969|451234035|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
125439053|NCT04921969|451234036|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
125439054|NCT04921969|451234037|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
125439055|NCT00386308|451235380|FG000|Overall Study|Adverse Event|3|||
125439056|NCT00386308|451235381|FG001|Overall Study|Adverse Event|3|||
125439057|NCT00386308|451235380|FG000|Overall Study|Protocol Violation|2|||
125439058|NCT00386308|451235381|FG001|Overall Study|Protocol Violation|5|||
125439059|NCT00386308|451235380|FG000|Overall Study|Lack of Efficacy|0|||
125439060|NCT00386308|451235381|FG001|Overall Study|Lack of Efficacy|2|||
125439061|NCT00386308|451235380|FG000|Overall Study|Lost to Follow-up|10|||
125439062|NCT00386308|451235381|FG001|Overall Study|Lost to Follow-up|6|||
125439063|NCT00386308|451235380|FG000|Overall Study|Withdrawal by Subject|6|||
125439064|NCT00386308|451235381|FG001|Overall Study|Withdrawal by Subject|2|||
125439065|NCT00386308|451235380|FG000|Overall Study|Other Event|8|||
125439066|NCT00386308|451235381|FG001|Overall Study|Other Event|1|||
125439067|NCT02906683|451235382|FG000|Overall Study|Adverse Event|0|||
125439068|NCT02906683|451235383|FG001|Overall Study|Adverse Event|1|||
125439069|NCT02906683|451235384|FG002|Overall Study|Adverse Event|0|||
125439070|NCT02906683|451235382|FG000|Overall Study|Physician Decision|0|||
125439071|NCT02906683|451235383|FG001|Overall Study|Physician Decision|1|||
125439072|NCT02906683|451235384|FG002|Overall Study|Physician Decision|1|||
125439073|NCT02906683|451235382|FG000|Overall Study|Withdrawal by Subject|0|||
125439074|NCT02906683|451235383|FG001|Overall Study|Withdrawal by Subject|2|||
125439075|NCT02906683|451235384|FG002|Overall Study|Withdrawal by Subject|1|||
125439076|NCT02906683|451235382|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
125439077|NCT02906683|451235383|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
125439078|NCT02906683|451235384|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
125439079|NCT02906683|451235382|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
125439080|NCT02906683|451235383|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
125439081|NCT02906683|451235384|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
125439082|NCT02781506|451235385|FG000|Overall Study|Adverse Event|5|||
125439083|NCT01340482|451235386|FG000|Overall Study|Adverse Event|2|||
125439084|NCT01340482|451235387|FG001|Overall Study|Adverse Event|0|||
125439085|NCT01340482|451235388|FG002|Overall Study|Adverse Event|0|||
125439086|NCT00744237|451235389|FG000|Overall Study|Lack of Efficacy|1|||
125439087|NCT00744237|451235390|FG001|Overall Study|Lack of Efficacy|1|||
125439088|NCT00744237|451235391|FG002|Overall Study|Lack of Efficacy|0|||
125439089|NCT00744237|451235389|FG000|Overall Study|Withdrawal by Subject|9|||
125439090|NCT00744237|451235390|FG001|Overall Study|Withdrawal by Subject|5|||
125439091|NCT00744237|451235391|FG002|Overall Study|Withdrawal by Subject|3|||
125439092|NCT00744237|451235389|FG000|Overall Study|Lost to Follow-up|1|||
125439093|NCT00744237|451235390|FG001|Overall Study|Lost to Follow-up|1|||
125159574|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
125159575|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
125159576|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
125159577|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
125159578|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
125159579|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
125159580|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
125159581|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
125159582|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
125159583|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
125159584|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
125159585|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
125159586|NCT03514641|450210105|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
125159587|NCT03514641|450210106|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
125159588|NCT03514641|450210107|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
125159589|NCT03514641|450210108|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
125159590|NCT03514641|450210105|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
125159591|NCT03514641|450210106|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
125159592|NCT03514641|450210107|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
125439094|NCT00744237|451235391|FG002|Overall Study|Lost to Follow-up|1|||
125439095|NCT00744237|451235389|FG000|Overall Study|Protocol Violation|3|||
125439096|NCT00744237|451235390|FG001|Overall Study|Protocol Violation|4|||
125439097|NCT00744237|451235391|FG002|Overall Study|Protocol Violation|3|||
125159593|NCT03514641|450210108|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
125159594|NCT03514641|450210105|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
125159595|NCT03514641|450210106|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
125159596|NCT03514641|450210107|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
125159597|NCT03514641|450210108|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
125159598|NCT03514641|450210105|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
125159599|NCT03514641|450210106|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
125159600|NCT03514641|450210107|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
125159601|NCT03514641|450210108|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
125159602|NCT03514641|450210105|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
125159603|NCT03514641|450210106|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
125159604|NCT03514641|450210107|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
125159605|NCT03514641|450210108|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
125159606|NCT03514641|450210105|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
125159607|NCT03514641|450210106|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
125159608|NCT03514641|450210107|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
125159609|NCT03514641|450210108|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
125159610|NCT04234984|450210109|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
125159611|NCT04234984|450210109|FG000|Follow-up at the Second Time Point|Death|1|||
125159612|NCT04234984|450210109|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
125159613|NCT02038907|450210110|FG000|Overall Study|Protocol Violation|0|||
125159614|NCT02038907|450210111|FG001|Overall Study|Protocol Violation|0|||
125159615|NCT02038907|450210112|FG002|Overall Study|Protocol Violation|0|||
125159616|NCT02038907|450210113|FG003|Overall Study|Protocol Violation|0|||
125159617|NCT02038907|450210114|FG004|Overall Study|Protocol Violation|0|||
125159618|NCT02038907|450210115|FG005|Overall Study|Protocol Violation|0|||
125159619|NCT02038907|450210116|FG006|Overall Study|Protocol Violation|0|||
125159620|NCT02038907|450210117|FG007|Overall Study|Protocol Violation|0|||
125159621|NCT02038907|450210118|FG008|Overall Study|Protocol Violation|0|||
125159622|NCT02038907|450210119|FG009|Overall Study|Protocol Violation|0|||
125159623|NCT02038907|450210120|FG010|Overall Study|Protocol Violation|1|||
125159624|NCT02038907|450210121|FG011|Overall Study|Protocol Violation|0|||
125159625|NCT02038907|450210122|FG012|Overall Study|Protocol Violation|0|||
125159626|NCT02038907|450210123|FG013|Overall Study|Protocol Violation|0|||
125159627|NCT02038907|450210110|FG000|Overall Study|Withdrawal by Subject|0|||
125159628|NCT02038907|450210111|FG001|Overall Study|Withdrawal by Subject|0|||
125159629|NCT02038907|450210112|FG002|Overall Study|Withdrawal by Subject|0|||
125159630|NCT02038907|450210113|FG003|Overall Study|Withdrawal by Subject|0|||
125159631|NCT02038907|450210114|FG004|Overall Study|Withdrawal by Subject|0|||
125159632|NCT02038907|450210115|FG005|Overall Study|Withdrawal by Subject|0|||
125159633|NCT02038907|450210116|FG006|Overall Study|Withdrawal by Subject|0|||
125159634|NCT02038907|450210117|FG007|Overall Study|Withdrawal by Subject|0|||
125159635|NCT02038907|450210118|FG008|Overall Study|Withdrawal by Subject|0|||
125159636|NCT02038907|450210119|FG009|Overall Study|Withdrawal by Subject|0|||
125159637|NCT02038907|450210120|FG010|Overall Study|Withdrawal by Subject|1|||
125159638|NCT02038907|450210121|FG011|Overall Study|Withdrawal by Subject|0|||
125159639|NCT02038907|450210122|FG012|Overall Study|Withdrawal by Subject|0|||
125159640|NCT02038907|450210123|FG013|Overall Study|Withdrawal by Subject|0|||
125159641|NCT01732484|450210130|FG000|Overall Study|Death|7|||
125159642|NCT01732484|450210130|FG000|Overall Study|Lost to Follow-up|14|||
125159643|NCT01732484|450210130|FG000|Overall Study|chronical illness|5|||
125159644|NCT02272634|450210131|FG000|Overall Study|Adverse Event|1|||
125159645|NCT02272634|450210132|FG001|Overall Study|Adverse Event|0|||
125159646|NCT02272634|450210133|FG002|Overall Study|Adverse Event|0|||
125159647|NCT02272634|450210131|FG000|Overall Study|Protocol Violation|0|||
125159648|NCT02272634|450210132|FG001|Overall Study|Protocol Violation|0|||
125159649|NCT02272634|450210133|FG002|Overall Study|Protocol Violation|1|||
125159650|NCT02272634|450210131|FG000|Overall Study|Withdrawal by Subject|0|||
125159651|NCT02272634|450210132|FG001|Overall Study|Withdrawal by Subject|1|||
125159652|NCT02272634|450210133|FG002|Overall Study|Withdrawal by Subject|0|||
125159653|NCT05070546|450210134|FG000|Overall Study|Death|0|||
125159654|NCT05070546|450210135|FG001|Overall Study|Death|0|||
125159655|NCT05070546|450210136|FG002|Overall Study|Death|0|||
125159656|NCT05070546|450210137|FG003|Overall Study|Death|0|||
125159657|NCT05070546|450210138|FG004|Overall Study|Death|0|||
125159658|NCT05070546|450210139|FG005|Overall Study|Death|1|||
125159659|NCT05070546|450210134|FG000|Overall Study|Lost to Follow-up|8|||
125159660|NCT05070546|450210135|FG001|Overall Study|Lost to Follow-up|2|||
125159661|NCT05070546|450210136|FG002|Overall Study|Lost to Follow-up|7|||
125159662|NCT05070546|450210137|FG003|Overall Study|Lost to Follow-up|1|||
125159663|NCT05070546|450210138|FG004|Overall Study|Lost to Follow-up|2|||
125159664|NCT05070546|450210139|FG005|Overall Study|Lost to Follow-up|0|||
125159665|NCT05070546|450210134|FG000|Overall Study|Withdrawal by Subject|1|||
125159666|NCT05070546|450210135|FG001|Overall Study|Withdrawal by Subject|1|||
125159667|NCT05070546|450210136|FG002|Overall Study|Withdrawal by Subject|3|||
125159668|NCT05070546|450210137|FG003|Overall Study|Withdrawal by Subject|0|||
125224049|NCT01325350|450448035|FG004|Overall Study|Did Not Receive Treatment|1|||
125224050|NCT01716806|450448036|FG000|Overall Study|Patient withdrawal of consent|4|||
125224051|NCT01716806|450448037|FG001|Overall Study|Patient withdrawal of consent|2|||
125224052|NCT01716806|450448038|FG002|Overall Study|Patient withdrawal of consent|4|||
125224053|NCT01716806|450448039|FG003|Overall Study|Patient withdrawal of consent|3|||
125224054|NCT01716806|450448040|FG004|Overall Study|Patient withdrawal of consent|2|||
125224055|NCT01716806|450448041|FG005|Overall Study|Patient withdrawal of consent|0|||
125224056|NCT01716806|450448036|FG000|Overall Study|Lost to Follow-up|3|||
125224057|NCT01716806|450448037|FG001|Overall Study|Lost to Follow-up|3|||
125224058|NCT01716806|450448038|FG002|Overall Study|Lost to Follow-up|0|||
125224059|NCT01716806|450448039|FG003|Overall Study|Lost to Follow-up|2|||
125224060|NCT01716806|450448040|FG004|Overall Study|Lost to Follow-up|1|||
125224061|NCT01716806|450448041|FG005|Overall Study|Lost to Follow-up|0|||
125224062|NCT01716806|450448036|FG000|Overall Study|Death|13|||
125224063|NCT01716806|450448037|FG001|Overall Study|Death|9|||
125224064|NCT01716806|450448038|FG002|Overall Study|Death|12|||
125224065|NCT01716806|450448039|FG003|Overall Study|Death|4|||
125224066|NCT01716806|450448040|FG004|Overall Study|Death|10|||
125224067|NCT01716806|450448041|FG005|Overall Study|Death|5|||
125224068|NCT01716806|450448036|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
125224069|NCT01716806|450448037|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
125224070|NCT01716806|450448038|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
125224071|NCT01716806|450448039|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
125224072|NCT01716806|450448040|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
125224073|NCT01716806|450448041|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
125224074|NCT01716806|450448036|FG000|Overall Study|PI decision|0|||
125224075|NCT01716806|450448037|FG001|Overall Study|PI decision|0|||
125224076|NCT01716806|450448038|FG002|Overall Study|PI decision|0|||
125224077|NCT01716806|450448039|FG003|Overall Study|PI decision|0|||
125224078|NCT01716806|450448040|FG004|Overall Study|PI decision|1|||
125224079|NCT01716806|450448041|FG005|Overall Study|PI decision|0|||
125224080|NCT01716806|450448036|FG000|Overall Study|Change in performance status|1|||
125224081|NCT01716806|450448037|FG001|Overall Study|Change in performance status|0|||
125224082|NCT01716806|450448038|FG002|Overall Study|Change in performance status|0|||
125224083|NCT01716806|450448039|FG003|Overall Study|Change in performance status|0|||
125224084|NCT01716806|450448040|FG004|Overall Study|Change in performance status|0|||
125224085|NCT01716806|450448041|FG005|Overall Study|Change in performance status|0|||
125224086|NCT01716806|450448036|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
125389300|NCT02515942|451060349|FG000|Overall Study|Lost to Follow-up|2|||
125159669|NCT05070546|450210138|FG004|Overall Study|Withdrawal by Subject|0|||
125159670|NCT05070546|450210139|FG005|Overall Study|Withdrawal by Subject|0|||
125159671|NCT05070546|450210134|FG000|Overall Study|Other|0|||
125159672|NCT05070546|450210135|FG001|Overall Study|Other|0|||
125159673|NCT05070546|450210136|FG002|Overall Study|Other|0|||
125159674|NCT05070546|450210137|FG003|Overall Study|Other|0|||
125159675|NCT05070546|450210138|FG004|Overall Study|Other|3|||
125159676|NCT05070546|450210139|FG005|Overall Study|Other|0|||
125159677|NCT05070546|450210134|FG000|Overall Study|Randomized but not vaccinated|1|||
125159678|NCT05070546|450210135|FG001|Overall Study|Randomized but not vaccinated|0|||
125159679|NCT05070546|450210136|FG002|Overall Study|Randomized but not vaccinated|1|||
125159680|NCT05070546|450210137|FG003|Overall Study|Randomized but not vaccinated|1|||
125159681|NCT05070546|450210138|FG004|Overall Study|Randomized but not vaccinated|3|||
125159682|NCT05070546|450210139|FG005|Overall Study|Randomized but not vaccinated|0|||
125159683|NCT01359644|450210140|FG000|Treatment Period|Lack of Efficacy|0|||
125389301|NCT02515942|451060350|FG001|Overall Study|Lost to Follow-up|0|||
125389302|NCT02515942|451060351|FG002|Overall Study|Lost to Follow-up|0|||
125389303|NCT02515942|451060349|FG000|Overall Study|Withdrawal by Subject|0|||
125389304|NCT02515942|451060350|FG001|Overall Study|Withdrawal by Subject|3|||
125159684|NCT01359644|450210141|FG001|Treatment Period|Lack of Efficacy|1|||
125389305|NCT02515942|451060351|FG002|Overall Study|Withdrawal by Subject|2|||
125389306|NCT00902564|451060353|FG000|Overall Study|Withdrawal by Subject|2|||
125389307|NCT00922766|451060354|FG000|Overall Study|Death|3|||
125389308|NCT00922766|451060354|FG000|Overall Study|Withdrawal by Subject|2|||
125389309|NCT00922766|451060354|FG000|Overall Study|Other|1|||
125389310|NCT00922766|451060354|FG000|Overall Study|Adverse Event|1|||
125389311|NCT01649375|451060357|FG000|Up to Week 16|Adverse Event|2|||
125159685|NCT01359644|450210142|FG002|Treatment Period|Lack of Efficacy|0|||
125159686|NCT01359644|450210143|FG003|Treatment Period|Lack of Efficacy|0|||
125224087|NCT01716806|450448037|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
125224088|NCT01716806|450448038|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
125389312|NCT01649375|451060358|FG001|Up to Week 16|Adverse Event|5|||
125389313|NCT01649375|451060359|FG002|Up to Week 16|Adverse Event|4|||
125389314|NCT01649375|451060360|FG003|Up to Week 16|Adverse Event|0|||
125159687|NCT01359644|450210144|FG004|Treatment Period|Lack of Efficacy|0|||
125389315|NCT01649375|451060361|FG004|Up to Week 16|Adverse Event|0|||
125389316|NCT01649375|451060357|FG000|Up to Week 16|Lack of Efficacy|0|||
125389317|NCT01649375|451060358|FG001|Up to Week 16|Lack of Efficacy|0|||
125389318|NCT01649375|451060359|FG002|Up to Week 16|Lack of Efficacy|1|||
125389319|NCT01649375|451060360|FG003|Up to Week 16|Lack of Efficacy|0|||
125389320|NCT01649375|451060361|FG004|Up to Week 16|Lack of Efficacy|0|||
125389321|NCT01649375|451060357|FG000|Up to Week 16|Physician Decision|0|||
125389322|NCT01649375|451060358|FG001|Up to Week 16|Physician Decision|0|||
125389323|NCT01649375|451060359|FG002|Up to Week 16|Physician Decision|1|||
125389324|NCT01649375|451060360|FG003|Up to Week 16|Physician Decision|0|||
125389325|NCT01649375|451060361|FG004|Up to Week 16|Physician Decision|0|||
125389326|NCT01649375|451060357|FG000|Up to Week 16|Withdrawal by Subject|2|||
125389327|NCT01649375|451060358|FG001|Up to Week 16|Withdrawal by Subject|1|||
125389328|NCT01649375|451060359|FG002|Up to Week 16|Withdrawal by Subject|2|||
125389329|NCT01649375|451060360|FG003|Up to Week 16|Withdrawal by Subject|0|||
125389330|NCT01649375|451060361|FG004|Up to Week 16|Withdrawal by Subject|0|||
125389331|NCT01649375|451060357|FG000|Up to Week 16|Death|1|||
125389332|NCT01649375|451060358|FG001|Up to Week 16|Death|0|||
125389333|NCT01649375|451060359|FG002|Up to Week 16|Death|0|||
125389334|NCT01649375|451060360|FG003|Up to Week 16|Death|0|||
125389335|NCT01649375|451060361|FG004|Up to Week 16|Death|0|||
125389336|NCT01649375|451060357|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
125389337|NCT01649375|451060358|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
125389338|NCT01649375|451060359|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
125389339|NCT01649375|451060360|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
125389340|NCT01649375|451060361|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
125389341|NCT01649375|451060357|FG000|Week 16 up to Week 260|Non-compliance|0|||
125389342|NCT01649375|451060358|FG001|Week 16 up to Week 260|Non-compliance|1|||
125389343|NCT01649375|451060359|FG002|Week 16 up to Week 260|Non-compliance|0|||
125389344|NCT01649375|451060360|FG003|Week 16 up to Week 260|Non-compliance|1|||
125389345|NCT01649375|451060361|FG004|Week 16 up to Week 260|Non-compliance|0|||
125389346|NCT01649375|451060357|FG000|Week 16 up to Week 260|Physician Decision|0|||
125389347|NCT01649375|451060358|FG001|Week 16 up to Week 260|Physician Decision|2|||
125389348|NCT01649375|451060359|FG002|Week 16 up to Week 260|Physician Decision|0|||
125389349|NCT01649375|451060360|FG003|Week 16 up to Week 260|Physician Decision|0|||
125389350|NCT01649375|451060361|FG004|Week 16 up to Week 260|Physician Decision|0|||
125389351|NCT01649375|451060357|FG000|Week 16 up to Week 260|Technical issues|0|||
125389352|NCT01649375|451060358|FG001|Week 16 up to Week 260|Technical issues|1|||
125389353|NCT01649375|451060359|FG002|Week 16 up to Week 260|Technical issues|0|||
125389354|NCT01649375|451060360|FG003|Week 16 up to Week 260|Technical issues|1|||
125389355|NCT01649375|451060361|FG004|Week 16 up to Week 260|Technical issues|0|||
125389356|NCT01649375|451060357|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
125389357|NCT01649375|451060358|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
125389358|NCT01649375|451060359|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
125389359|NCT01649375|451060360|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
125389360|NCT01649375|451060361|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
125389361|NCT01649375|451060357|FG000|Week 16 up to Week 260|Death|1|||
125389362|NCT01649375|451060358|FG001|Week 16 up to Week 260|Death|1|||
125389363|NCT01649375|451060359|FG002|Week 16 up to Week 260|Death|0|||
125389364|NCT01649375|451060360|FG003|Week 16 up to Week 260|Death|0|||
125389365|NCT01649375|451060361|FG004|Week 16 up to Week 260|Death|0|||
125389366|NCT01649375|451060357|FG000|Week 16 up to Week 260|Adverse Event|5|||
125389367|NCT01649375|451060358|FG001|Week 16 up to Week 260|Adverse Event|2|||
125389368|NCT01649375|451060359|FG002|Week 16 up to Week 260|Adverse Event|0|||
125389369|NCT01649375|451060360|FG003|Week 16 up to Week 260|Adverse Event|3|||
125389370|NCT01649375|451060361|FG004|Week 16 up to Week 260|Adverse Event|2|||
125389371|NCT01762943|451060364|FG000|Overall Study|Physician Decision|1|||
125389372|NCT01762943|451060365|FG001|Overall Study|Physician Decision|1|||
125389373|NCT01762943|451060364|FG000|Overall Study|Protocol Violation|1|||
125389374|NCT01762943|451060365|FG001|Overall Study|Protocol Violation|0|||
125389375|NCT01762943|451060364|FG000|Overall Study|Withdrawal by Subject|2|||
125389376|NCT01762943|451060365|FG001|Overall Study|Withdrawal by Subject|1|||
125389377|NCT00539838|451060366|FG000|Overall Study|Fail to return|2|||
125389378|NCT00539838|451060367|FG001|Overall Study|Fail to return|0|||
125389379|NCT00539838|451060368|FG002|Overall Study|Fail to return|0|||
125389380|NCT00539838|451060366|FG000|Overall Study|Withdrawal by Subject|0|||
125389381|NCT00539838|451060367|FG001|Overall Study|Withdrawal by Subject|4|||
125389382|NCT00539838|451060368|FG002|Overall Study|Withdrawal by Subject|0|||
125389383|NCT00539838|451060366|FG000|Overall Study|Death|0|||
125389384|NCT00539838|451060367|FG001|Overall Study|Death|2|||
125389385|NCT00539838|451060368|FG002|Overall Study|Death|0|||
125389386|NCT00539838|451060366|FG000|Overall Study|Did not cooperate|1|||
125389387|NCT00539838|451060367|FG001|Overall Study|Did not cooperate|0|||
125389388|NCT00539838|451060368|FG002|Overall Study|Did not cooperate|1|||
125389389|NCT00539838|451060366|FG000|Overall Study|Administrative|4|||
125389390|NCT00539838|451060367|FG001|Overall Study|Administrative|0|||
125389391|NCT00539838|451060368|FG002|Overall Study|Administrative|8|||
125389392|NCT02658890|451060369|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125159688|NCT01359644|450210145|FG005|Treatment Period|Lack of Efficacy|0|||
125159689|NCT01359644|450210146|FG006|Treatment Period|Lack of Efficacy|0|||
125159690|NCT01359644|450210147|FG007|Treatment Period|Lack of Efficacy|0|||
125439098|NCT00744237|451235389|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
125439099|NCT00744237|451235390|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
125439100|NCT00744237|451235391|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
125439101|NCT00744237|451235389|FG000|Overall Study|Dosing Error|1|||
125439102|NCT00744237|451235390|FG001|Overall Study|Dosing Error|0|||
125439103|NCT00744237|451235391|FG002|Overall Study|Dosing Error|1|||
125439104|NCT00744237|451235389|FG000|Overall Study|Study Drug Error|1|||
125439105|NCT00744237|451235390|FG001|Overall Study|Study Drug Error|0|||
125439106|NCT00744237|451235391|FG002|Overall Study|Study Drug Error|0|||
125439107|NCT00744237|451235389|FG000|Overall Study|Prohibited Concomitant Medication|0|||
125439108|NCT00744237|451235390|FG001|Overall Study|Prohibited Concomitant Medication|0|||
125439109|NCT00744237|451235391|FG002|Overall Study|Prohibited Concomitant Medication|1|||
125439110|NCT00744237|451235389|FG000|Overall Study|Poor Compliance|0|||
125439111|NCT00744237|451235390|FG001|Overall Study|Poor Compliance|2|||
125439112|NCT00744237|451235391|FG002|Overall Study|Poor Compliance|0|||
125439113|NCT00744237|451235389|FG000|Overall Study|Administrative. Site Closed|1|||
125439114|NCT00744237|451235390|FG001|Overall Study|Administrative. Site Closed|1|||
125439115|NCT00744237|451235391|FG002|Overall Study|Administrative. Site Closed|1|||
125439116|NCT00744237|451235389|FG000|Overall Study|Adverse Event|9|||
125439117|NCT00744237|451235390|FG001|Overall Study|Adverse Event|13|||
125439118|NCT00744237|451235391|FG002|Overall Study|Adverse Event|5|||
125439119|NCT02802319|451235392|FG000|Overall Study|Physician Decision|2|||
125439120|NCT02802319|451235393|FG001|Overall Study|Physician Decision|1|||
125439121|NCT02802319|451235392|FG000|Overall Study|Lost to Follow-up|0|||
125159691|NCT01359644|450210148|FG008|Treatment Period|Lack of Efficacy|0|||
125159692|NCT01359644|450210149|FG009|Treatment Period|Lack of Efficacy|0|||
125159693|NCT01359644|450210140|FG000|Treatment Period|Adverse Event|0|||
125159694|NCT01359644|450210141|FG001|Treatment Period|Adverse Event|0|||
125159695|NCT01359644|450210142|FG002|Treatment Period|Adverse Event|1|||
125159696|NCT01359644|450210143|FG003|Treatment Period|Adverse Event|0|||
125159697|NCT01359644|450210144|FG004|Treatment Period|Adverse Event|0|||
125389393|NCT02658890|451060370|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389394|NCT02658890|451060371|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389395|NCT02658890|451060372|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389396|NCT02658890|451060373|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389397|NCT02658890|451060374|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389398|NCT02658890|451060375|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389399|NCT02658890|451060376|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389400|NCT02658890|451060377|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
125389401|NCT02658890|451060378|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389402|NCT02658890|451060379|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389403|NCT02658890|451060380|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389404|NCT02658890|451060381|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389405|NCT02658890|451060382|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389406|NCT02658890|451060383|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389407|NCT02658890|451060384|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389408|NCT02658890|451060385|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389409|NCT02658890|451060386|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389410|NCT02658890|451060387|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389411|NCT02658890|451060388|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389412|NCT02658890|451060389|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389413|NCT02658890|451060390|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389414|NCT02658890|451060391|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389415|NCT02658890|451060392|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389416|NCT02658890|451060393|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389417|NCT02658890|451060394|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389418|NCT02658890|451060395|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389419|NCT02658890|451060369|FG000|Treatment Phase|Adverse Event|0|||
125389420|NCT02658890|451060370|FG001|Treatment Phase|Adverse Event|1|||
125389421|NCT02658890|451060371|FG002|Treatment Phase|Adverse Event|2|||
125389422|NCT02658890|451060372|FG003|Treatment Phase|Adverse Event|2|||
125439122|NCT02802319|451235393|FG001|Overall Study|Lost to Follow-up|4|||
125439123|NCT03545113|451235394|FG000|Overall Study|Surgery Cancelled|1|||
125439124|NCT03545113|451235395|FG001|Overall Study|Surgery Cancelled|0|||
125439125|NCT03545113|451235394|FG000|Overall Study|Death|1|||
125159698|NCT01359644|450210145|FG005|Treatment Period|Adverse Event|1|||
125159699|NCT01359644|450210146|FG006|Treatment Period|Adverse Event|0|||
125159700|NCT01359644|450210147|FG007|Treatment Period|Adverse Event|0|||
125439126|NCT03545113|451235395|FG001|Overall Study|Death|0|||
125439127|NCT03545113|451235394|FG000|Overall Study|Adverse Event|2|||
125439128|NCT03545113|451235395|FG001|Overall Study|Adverse Event|0|||
125439129|NCT03545113|451235394|FG000|Overall Study|Received different surgery|1|||
125439130|NCT03545113|451235395|FG001|Overall Study|Received different surgery|0|||
125439131|NCT00999661|451235398|FG000|Overall Study|Lost to Follow-up|59|||
125439132|NCT00999661|451235398|FG000|Overall Study|Adverse Event|1|||
125439133|NCT00999661|451235398|FG000|Overall Study|Withdrawal by Subject|1|||
125439134|NCT00999661|451235398|FG000|Overall Study|Not meeting eligibility criteria|9|||
125439135|NCT03638635|451235400|FG000|Initial Hospitalization|Study terminated prematurely|0|||
125439136|NCT03638635|451235401|FG001|Initial Hospitalization|Study terminated prematurely|1|||
125439137|NCT03638635|451235400|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
125439138|NCT03638635|451235401|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
125159701|NCT01359644|450210148|FG008|Treatment Period|Adverse Event|0|||
125439139|NCT03638635|451235400|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
125439140|NCT03638635|451235401|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
125439141|NCT00313911|451235405|FG000|Overall Study|Serious adverse event|6|||
125439142|NCT00313911|451235406|FG001|Overall Study|Serious adverse event|1|||
125439143|NCT00313911|451235405|FG000|Overall Study|Adverse Event|2|||
125439144|NCT00313911|451235406|FG001|Overall Study|Adverse Event|3|||
125439145|NCT00313911|451235405|FG000|Overall Study|Protocol Violation|19|||
125439146|NCT00313911|451235406|FG001|Overall Study|Protocol Violation|10|||
125439147|NCT00313911|451235405|FG000|Overall Study|Lost to Follow-up|27|||
125439148|NCT00313911|451235406|FG001|Overall Study|Lost to Follow-up|14|||
125439149|NCT00313911|451235405|FG000|Overall Study|Withdrawal by Subject|39|||
125439150|NCT00313911|451235406|FG001|Overall Study|Withdrawal by Subject|12|||
125439151|NCT00313911|451235405|FG000|Overall Study|Did not meet age criteria|1|||
125439152|NCT00313911|451235406|FG001|Overall Study|Did not meet age criteria|1|||
125439153|NCT02406261|451235414|FG000|Period 1|Lost to Follow-up|2|||
125439154|NCT02406261|451235415|FG001|Period 1|Lost to Follow-up|0|||
125439155|NCT02406261|451235414|FG000|Period 1|Adverse Event|1|||
125439156|NCT02406261|451235415|FG001|Period 1|Adverse Event|0|||
125439157|NCT02406261|451235414|FG000|Period 2|Physician Decision|0|||
125439158|NCT02406261|451235415|FG001|Period 2|Physician Decision|1|||
125439159|NCT02406261|451235414|FG000|Period 2|Protocol Violation|0|||
125439160|NCT02406261|451235415|FG001|Period 2|Protocol Violation|1|||
125439161|NCT02406261|451235414|FG000|Period 2|Withdrawal by Subject|0|||
125439162|NCT02406261|451235415|FG001|Period 2|Withdrawal by Subject|1|||
125439163|NCT02222896|451235416|FG000|Abdomen|Did not qualify|34|||
125439164|NCT02222896|451235417|FG001|Abdomen|Did not qualify|10|||
125439165|NCT02222896|451235418|FG002|Abdomen|Did not qualify|32|||
125439166|NCT02222896|451235416|FG000|Groin|Did not qualify|43|||
125439167|NCT02222896|451235417|FG001|Groin|Did not qualify|9|||
125439168|NCT02222896|451235418|FG002|Groin|Did not qualify|40|||
125439169|NCT02226172|451235425|FG000|Overall Study|Participant refused further follow-up|4|||
125439170|NCT02226172|451235425|FG000|Overall Study|Other|5|||
125439171|NCT02226172|451235425|FG000|Overall Study|Death|1|||
125439172|NCT02226172|451235425|FG000|Overall Study|Study terminated by sponsor|1|||
125439173|NCT02226172|451235425|FG000|Overall Study|Adverse Event|6|||
125439174|NCT01865617|451235426|FG000|Overall Study|Death|27|||
125439175|NCT01865617|451235427|FG001|Overall Study|Death|3|||
125439176|NCT01865617|451235428|FG002|Overall Study|Death|1|||
125439177|NCT01865617|451235429|FG003|Overall Study|Death|1|||
125439178|NCT01865617|451235430|FG004|Overall Study|Death|5|||
125439179|NCT01865617|451235431|FG005|Overall Study|Death|1|||
125439180|NCT01865617|451235432|FG006|Overall Study|Death|11|||
125439181|NCT01865617|451235433|FG007|Overall Study|Death|1|||
125439182|NCT01865617|451235434|FG008|Overall Study|Death|11|||
125439183|NCT01865617|451235435|FG009|Overall Study|Death|3|||
125439184|NCT01865617|451235436|FG010|Overall Study|Death|32|||
125439185|NCT01865617|451235437|FG011|Overall Study|Death|6|||
125159702|NCT01359644|450210149|FG009|Treatment Period|Adverse Event|0|||
125439186|NCT01865617|451235438|FG012|Overall Study|Death|13|||
125439187|NCT01865617|451235426|FG000|Overall Study|Lost to Follow-up|2|||
125439188|NCT01865617|451235427|FG001|Overall Study|Lost to Follow-up|0|||
125439189|NCT01865617|451235428|FG002|Overall Study|Lost to Follow-up|0|||
125439190|NCT01865617|451235429|FG003|Overall Study|Lost to Follow-up|0|||
125439191|NCT01865617|451235430|FG004|Overall Study|Lost to Follow-up|0|||
125439192|NCT01865617|451235431|FG005|Overall Study|Lost to Follow-up|0|||
125439193|NCT01865617|451235432|FG006|Overall Study|Lost to Follow-up|0|||
125439194|NCT01865617|451235433|FG007|Overall Study|Lost to Follow-up|0|||
125439195|NCT01865617|451235434|FG008|Overall Study|Lost to Follow-up|0|||
125439196|NCT01865617|451235435|FG009|Overall Study|Lost to Follow-up|0|||
125439197|NCT01865617|451235436|FG010|Overall Study|Lost to Follow-up|0|||
125439198|NCT01865617|451235437|FG011|Overall Study|Lost to Follow-up|0|||
125439199|NCT01865617|451235438|FG012|Overall Study|Lost to Follow-up|0|||
125439200|NCT01865617|451235426|FG000|Overall Study|Withdrawal by Subject|1|||
125439201|NCT01865617|451235427|FG001|Overall Study|Withdrawal by Subject|0|||
125439202|NCT01865617|451235428|FG002|Overall Study|Withdrawal by Subject|0|||
125159703|NCT01359644|450210140|FG000|Treatment Period|Lost to Follow-up|0|||
125224089|NCT01716806|450448039|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
125224090|NCT01716806|450448040|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
125224091|NCT01716806|450448041|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
125224092|NCT01716806|450448036|FG000|Overall Study|Sponsor direction|7|||
125224093|NCT01716806|450448037|FG001|Overall Study|Sponsor direction|8|||
125224094|NCT01716806|450448038|FG002|Overall Study|Sponsor direction|5|||
125224095|NCT01716806|450448039|FG003|Overall Study|Sponsor direction|12|||
125224096|NCT01716806|450448040|FG004|Overall Study|Sponsor direction|16|||
125224097|NCT01716806|450448041|FG005|Overall Study|Sponsor direction|1|||
125224098|NCT00956839|450448042|FG000|Overall Study|Lost to Follow-up|3|||
125224099|NCT00956839|450448043|FG001|Overall Study|Lost to Follow-up|0|||
125224100|NCT00956839|450448044|FG002|Overall Study|Lost to Follow-up|3|||
125224101|NCT03527277|450448045|FG000|Overall Study|Withdrawal by Subject|5|||
125224102|NCT03527277|450448046|FG001|Overall Study|Withdrawal by Subject|0|||
125224103|NCT03527277|450448045|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
125224104|NCT03527277|450448046|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
125224105|NCT03527277|450448045|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
125224106|NCT03527277|450448046|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
125224107|NCT04155463|450448047|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
125224108|NCT04155463|450448048|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
125224109|NCT01914393|450448053|FG000|Overall Study|Protocol Violation|11|||
125224110|NCT01914393|450448054|FG001|Overall Study|Protocol Violation|3|||
125224111|NCT01914393|450448055|FG002|Overall Study|Protocol Violation|19|||
125224112|NCT01914393|450448053|FG000|Overall Study|Lack of Efficacy|11|||
125224113|NCT01914393|450448054|FG001|Overall Study|Lack of Efficacy|16|||
125224114|NCT01914393|450448055|FG002|Overall Study|Lack of Efficacy|5|||
125224115|NCT01914393|450448053|FG000|Overall Study|no reason given|14|||
125224116|NCT01914393|450448054|FG001|Overall Study|no reason given|8|||
125224117|NCT01914393|450448055|FG002|Overall Study|no reason given|16|||
125224118|NCT01914393|450448053|FG000|Overall Study|Adverse Event|29|||
125224119|NCT01914393|450448054|FG001|Overall Study|Adverse Event|18|||
125224120|NCT01914393|450448055|FG002|Overall Study|Adverse Event|31|||
125224121|NCT01914393|450448053|FG000|Overall Study|Withdrawal by Subject|38|||
125224122|NCT01914393|450448054|FG001|Overall Study|Withdrawal by Subject|20|||
125224123|NCT01914393|450448055|FG002|Overall Study|Withdrawal by Subject|47|||
125224124|NCT01914393|450448053|FG000|Overall Study|Lost to Follow-up|12|||
125224125|NCT01914393|450448054|FG001|Overall Study|Lost to Follow-up|6|||
125224126|NCT01914393|450448055|FG002|Overall Study|Lost to Follow-up|19|||
125224127|NCT01914393|450448053|FG000|Overall Study|subject never dosed|0|||
125224128|NCT01914393|450448054|FG001|Overall Study|subject never dosed|0|||
125224129|NCT01914393|450448055|FG002|Overall Study|subject never dosed|1|||
125224130|NCT01063855|450448056|FG000|Overall Study|Adverse Event|4|||
125224131|NCT01063855|450448057|FG001|Overall Study|Adverse Event|4|||
125224132|NCT01063855|450448056|FG000|Overall Study|Death|0|||
125224133|NCT01063855|450448057|FG001|Overall Study|Death|1|||
125224134|NCT01063855|450448056|FG000|Overall Study|Lost to Follow-up|8|||
125224135|NCT01063855|450448057|FG001|Overall Study|Lost to Follow-up|4|||
125224136|NCT01063855|450448056|FG000|Overall Study|Pregnancy|1|||
125159704|NCT01359644|450210141|FG001|Treatment Period|Lost to Follow-up|0|||
125159705|NCT01359644|450210142|FG002|Treatment Period|Lost to Follow-up|0|||
125159706|NCT01359644|450210143|FG003|Treatment Period|Lost to Follow-up|0|||
125159707|NCT01359644|450210144|FG004|Treatment Period|Lost to Follow-up|0|||
125159708|NCT01359644|450210145|FG005|Treatment Period|Lost to Follow-up|1|||
125159709|NCT01359644|450210146|FG006|Treatment Period|Lost to Follow-up|0|||
125159710|NCT01359644|450210147|FG007|Treatment Period|Lost to Follow-up|0|||
125159711|NCT01359644|450210148|FG008|Treatment Period|Lost to Follow-up|0|||
125159712|NCT01359644|450210149|FG009|Treatment Period|Lost to Follow-up|0|||
125159713|NCT01359644|450210140|FG000|Follow-up Period|Withdrawal by Subject|0|||
125159714|NCT01359644|450210141|FG001|Follow-up Period|Withdrawal by Subject|0|||
125159715|NCT01359644|450210142|FG002|Follow-up Period|Withdrawal by Subject|0|||
125159716|NCT01359644|450210143|FG003|Follow-up Period|Withdrawal by Subject|0|||
125159717|NCT01359644|450210144|FG004|Follow-up Period|Withdrawal by Subject|0|||
125159718|NCT01359644|450210145|FG005|Follow-up Period|Withdrawal by Subject|1|||
125159719|NCT01359644|450210146|FG006|Follow-up Period|Withdrawal by Subject|0|||
125159720|NCT01359644|450210147|FG007|Follow-up Period|Withdrawal by Subject|0|||
125159721|NCT01359644|450210148|FG008|Follow-up Period|Withdrawal by Subject|0|||
125159722|NCT01359644|450210149|FG009|Follow-up Period|Withdrawal by Subject|0|||
125159723|NCT01359644|450210140|FG000|Follow-up Period|Lost to Follow-up|0|||
125159724|NCT01359644|450210141|FG001|Follow-up Period|Lost to Follow-up|0|||
125224137|NCT01063855|450448057|FG001|Overall Study|Pregnancy|0|||
125224138|NCT01063855|450448056|FG000|Overall Study|Lack of Efficacy|0|||
125159725|NCT01359644|450210142|FG002|Follow-up Period|Lost to Follow-up|0|||
125224139|NCT01063855|450448057|FG001|Overall Study|Lack of Efficacy|1|||
125224140|NCT01063855|450448056|FG000|Overall Study|Withdrawal by Subject|11|||
125224141|NCT01063855|450448057|FG001|Overall Study|Withdrawal by Subject|8|||
125389423|NCT02658890|451060373|FG004|Treatment Phase|Adverse Event|1|||
125389424|NCT02658890|451060374|FG005|Treatment Phase|Adverse Event|0|||
125389425|NCT02658890|451060375|FG006|Treatment Phase|Adverse Event|0|||
125389426|NCT02658890|451060376|FG007|Treatment Phase|Adverse Event|2|||
125389427|NCT02658890|451060377|FG008|Treatment Phase|Adverse Event|1|||
125389428|NCT02658890|451060378|FG009|Treatment Phase|Adverse Event|2|||
125389429|NCT02658890|451060379|FG010|Treatment Phase|Adverse Event|3|||
125389430|NCT02658890|451060380|FG011|Treatment Phase|Adverse Event|0|||
125389431|NCT02658890|451060381|FG012|Treatment Phase|Adverse Event|1|||
125389432|NCT02658890|451060382|FG013|Treatment Phase|Adverse Event|4|||
125389433|NCT02658890|451060383|FG014|Treatment Phase|Adverse Event|0|||
125159726|NCT01359644|450210143|FG003|Follow-up Period|Lost to Follow-up|0|||
125159727|NCT01359644|450210144|FG004|Follow-up Period|Lost to Follow-up|0|||
125159728|NCT01359644|450210145|FG005|Follow-up Period|Lost to Follow-up|0|||
125159729|NCT01359644|450210146|FG006|Follow-up Period|Lost to Follow-up|1|||
125159730|NCT01359644|450210147|FG007|Follow-up Period|Lost to Follow-up|2|||
125159731|NCT01359644|450210148|FG008|Follow-up Period|Lost to Follow-up|0|||
125159732|NCT01359644|450210149|FG009|Follow-up Period|Lost to Follow-up|0|||
125159733|NCT02130882|450210150|FG000|Overall Study|Withdrawal by Subject|0|||
125159734|NCT02130882|450210151|FG001|Overall Study|Withdrawal by Subject|1|||
125159735|NCT00669071|450210154|FG000|Overall Study|Lost to Follow-up|3|||
125159736|NCT00669071|450210154|FG000|Overall Study|Final visit 40 days out of window|1|||
125159737|NCT01194973|450210155|FG000|Screening Period|Screen Failure|3|||
125159738|NCT01194973|450210155|FG000|26 Week Treatment Period|Adverse Event|1|||
125159739|NCT01194973|450210155|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
125159740|NCT01194973|450210155|FG000|26 Week Treatment Period|Pregnancy|1|||
125159741|NCT00359632|450210158|FG000|Overall Study|Death|2|||
125159742|NCT00359632|450210159|FG001|Overall Study|Death|0|||
125159743|NCT00359632|450210158|FG000|Overall Study|Adverse Event|1|||
125159744|NCT00359632|450210159|FG001|Overall Study|Adverse Event|0|||
125159745|NCT00359632|450210158|FG000|Overall Study|Non-compliance with visit schedule|1|||
125159746|NCT00359632|450210159|FG001|Overall Study|Non-compliance with visit schedule|0|||
125159747|NCT02615171|450210160|FG000|Overall Study|Lost to Follow-up|2|||
125159748|NCT02615171|450210161|FG001|Overall Study|Lost to Follow-up|1|||
125224142|NCT01063855|450448056|FG000|Overall Study|Reason not specified|13|||
125224143|NCT01063855|450448057|FG001|Overall Study|Reason not specified|11|||
125224144|NCT02163395|450448060|FG000|Overall Study|Withdrawal by Subject|1|||
125224145|NCT02163395|450448060|FG000|Overall Study|Lost to Follow-up|3|||
125224146|NCT02163395|450448060|FG000|Overall Study|Adverse Event|1|||
125224147|NCT05137717|450448081|FG000|Overall Study|Death|2|||
125224148|NCT05137717|450448081|FG000|Overall Study|Withdrawal by Subject|6|||
125224149|NCT02035553|450448082|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
125224150|NCT02035553|450448083|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
125224151|NCT02035553|450448082|FG000|Overall Study|Adverse Event|10|||
125224152|NCT02035553|450448083|FG001|Overall Study|Adverse Event|6|||
125224153|NCT02035553|450448082|FG000|Overall Study|Physician Decision|3|||
125224154|NCT02035553|450448083|FG001|Overall Study|Physician Decision|2|||
125224155|NCT02035553|450448082|FG000|Overall Study|Lack of Efficacy|1|||
125224156|NCT02035553|450448083|FG001|Overall Study|Lack of Efficacy|1|||
125224157|NCT02035553|450448082|FG000|Overall Study|Withdrawal by Subject|4|||
125224158|NCT02035553|450448083|FG001|Overall Study|Withdrawal by Subject|7|||
125224159|NCT02035553|450448082|FG000|Overall Study|Non-compliance with Study Drug|0|||
125224160|NCT02035553|450448083|FG001|Overall Study|Non-compliance with Study Drug|1|||
125224161|NCT02035553|450448082|FG000|Overall Study|Lost to Follow-up|0|||
125224162|NCT02035553|450448083|FG001|Overall Study|Lost to Follow-up|1|||
125224163|NCT02035553|450448082|FG000|Overall Study|Other Reason|0|||
125224164|NCT02035553|450448083|FG001|Overall Study|Other Reason|4|||
125224165|NCT02619617|450448084|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
125224166|NCT02619617|450448085|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
125224167|NCT02619617|450448084|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
125224168|NCT02619617|450448085|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
125224169|NCT01854697|450448086|FG000|Overall Study|Adverse Event|1|||
125224170|NCT01854697|450448087|FG001|Overall Study|Adverse Event|0|||
125224171|NCT01854697|450448088|FG002|Overall Study|Adverse Event|0|||
125224172|NCT01854697|450448089|FG003|Overall Study|Adverse Event|0|||
125224173|NCT01854697|450448090|FG004|Overall Study|Adverse Event|1|||
125389434|NCT02658890|451060384|FG015|Treatment Phase|Adverse Event|0|||
125389435|NCT02658890|451060385|FG016|Treatment Phase|Adverse Event|0|||
125389436|NCT02658890|451060386|FG017|Treatment Phase|Adverse Event|0|||
125159749|NCT01000493|450210169|FG000|Overall Study|Adverse Event|3|||
125159750|NCT01000493|450210170|FG001|Overall Study|Adverse Event|6|||
125159751|NCT01000493|450210169|FG000|Overall Study|Lack of Efficacy|1|||
125224174|NCT01854697|450448086|FG000|Overall Study|Lost to Follow-up|4|||
125224175|NCT01854697|450448087|FG001|Overall Study|Lost to Follow-up|1|||
125224176|NCT01854697|450448088|FG002|Overall Study|Lost to Follow-up|1|||
125389437|NCT02658890|451060387|FG018|Treatment Phase|Adverse Event|5|||
125224177|NCT01854697|450448089|FG003|Overall Study|Lost to Follow-up|2|||
125224178|NCT01854697|450448090|FG004|Overall Study|Lost to Follow-up|0|||
125389438|NCT02658890|451060388|FG019|Treatment Phase|Adverse Event|1|||
125439203|NCT01865617|451235429|FG003|Overall Study|Withdrawal by Subject|0|||
125439204|NCT01865617|451235430|FG004|Overall Study|Withdrawal by Subject|0|||
125439205|NCT01865617|451235431|FG005|Overall Study|Withdrawal by Subject|0|||
125439206|NCT01865617|451235432|FG006|Overall Study|Withdrawal by Subject|0|||
125439207|NCT01865617|451235433|FG007|Overall Study|Withdrawal by Subject|0|||
125439208|NCT01865617|451235434|FG008|Overall Study|Withdrawal by Subject|0|||
125439209|NCT01865617|451235435|FG009|Overall Study|Withdrawal by Subject|0|||
125439210|NCT01865617|451235436|FG010|Overall Study|Withdrawal by Subject|0|||
125439211|NCT01865617|451235437|FG011|Overall Study|Withdrawal by Subject|0|||
125439212|NCT01865617|451235438|FG012|Overall Study|Withdrawal by Subject|0|||
125439213|NCT01865617|451235426|FG000|Overall Study|Patient proceeded to new therapy|0|||
125439214|NCT01865617|451235427|FG001|Overall Study|Patient proceeded to new therapy|0|||
125439215|NCT01865617|451235428|FG002|Overall Study|Patient proceeded to new therapy|0|||
125439216|NCT01865617|451235429|FG003|Overall Study|Patient proceeded to new therapy|0|||
125439217|NCT01865617|451235430|FG004|Overall Study|Patient proceeded to new therapy|2|||
125439218|NCT01865617|451235431|FG005|Overall Study|Patient proceeded to new therapy|0|||
125439219|NCT01865617|451235432|FG006|Overall Study|Patient proceeded to new therapy|0|||
125439220|NCT01865617|451235433|FG007|Overall Study|Patient proceeded to new therapy|0|||
125439221|NCT01865617|451235434|FG008|Overall Study|Patient proceeded to new therapy|0|||
125439222|NCT01865617|451235435|FG009|Overall Study|Patient proceeded to new therapy|0|||
125439223|NCT01865617|451235436|FG010|Overall Study|Patient proceeded to new therapy|0|||
125439224|NCT01865617|451235437|FG011|Overall Study|Patient proceeded to new therapy|0|||
125439225|NCT01865617|451235438|FG012|Overall Study|Patient proceeded to new therapy|0|||
125439226|NCT01865617|451235426|FG000|Overall Study|Other|0|||
125439227|NCT01865617|451235427|FG001|Overall Study|Other|0|||
125439228|NCT01865617|451235428|FG002|Overall Study|Other|0|||
125439229|NCT01865617|451235429|FG003|Overall Study|Other|0|||
125439230|NCT01865617|451235430|FG004|Overall Study|Other|0|||
125439231|NCT01865617|451235431|FG005|Overall Study|Other|0|||
125439232|NCT01865617|451235432|FG006|Overall Study|Other|1|||
125439233|NCT01865617|451235433|FG007|Overall Study|Other|0|||
125439234|NCT01865617|451235434|FG008|Overall Study|Other|0|||
125439235|NCT01865617|451235435|FG009|Overall Study|Other|0|||
125439236|NCT01865617|451235436|FG010|Overall Study|Other|0|||
125439237|NCT01865617|451235437|FG011|Overall Study|Other|0|||
125439238|NCT01865617|451235438|FG012|Overall Study|Other|0|||
125439239|NCT00258440|451235444|FG000|Overall Study|Withdrawal by Subject|0|||
125439240|NCT00258440|451235445|FG001|Overall Study|Withdrawal by Subject|0|||
125439241|NCT00258440|451235446|FG002|Overall Study|Withdrawal by Subject|1|||
125439242|NCT00737061|451235447|FG000|Waiting Period|Lost to Follow-up|6|||
125439243|NCT00737061|451235447|FG000|Waiting Period|Withdrawal by Subject|1|||
125439244|NCT00737061|451235447|FG000|Waiting Period|Bilateral placement failure|34|||
125439245|NCT00737061|451235447|FG000|Waiting Period|Deemed patent following HSG|26|||
125439246|NCT00737061|451235447|FG000|Waiting Period|Alternative contraception failure|3|||
125439247|NCT00737061|451235447|FG000|Waiting Period|Elected surgical tubal ligation|5|||
125439248|NCT00737061|451235447|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
125439249|NCT00737061|451235447|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
125439250|NCT00737061|451235447|FG000|1 Year Wearing Period|Discontinued reilance|3|||
125439251|NCT00737061|451235447|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
125439252|NCT00439179|451235449|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
125439253|NCT00439179|451235450|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
125439254|NCT00439179|451235451|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
125439255|NCT00439179|451235452|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
125439256|NCT01844115|451235456|FG000|Overall Study|Adverse Event|4|||
125439257|NCT01844115|451235457|FG001|Overall Study|Adverse Event|22|||
125159752|NCT01000493|450210170|FG001|Overall Study|Lack of Efficacy|1|||
125159753|NCT01000493|450210169|FG000|Overall Study|Protocol Violation|1|||
125159754|NCT01000493|450210170|FG001|Overall Study|Protocol Violation|8|||
125159755|NCT01000493|450210169|FG000|Overall Study|Study closed/terminated|25|||
125159756|NCT01000493|450210170|FG001|Overall Study|Study closed/terminated|23|||
125159757|NCT01000493|450210169|FG000|Overall Study|Lost to Follow-up|5|||
125159758|NCT01000493|450210170|FG001|Overall Study|Lost to Follow-up|9|||
125439258|NCT01844115|451235456|FG000|Overall Study|Lack of Efficacy|1|||
125439259|NCT01844115|451235457|FG001|Overall Study|Lack of Efficacy|4|||
125439260|NCT01844115|451235456|FG000|Overall Study|Protocol Violation|12|||
125439261|NCT01844115|451235457|FG001|Overall Study|Protocol Violation|10|||
125439262|NCT01844115|451235456|FG000|Overall Study|Withdrawal by Subject|11|||
125439263|NCT01844115|451235457|FG001|Overall Study|Withdrawal by Subject|11|||
125439264|NCT01844115|451235456|FG000|Overall Study|Lost to Follow-up|11|||
125439265|NCT01844115|451235457|FG001|Overall Study|Lost to Follow-up|10|||
125439266|NCT01844115|451235456|FG000|Overall Study|Pregnancy|0|||
125439267|NCT01844115|451235457|FG001|Overall Study|Pregnancy|1|||
125159759|NCT01000493|450210169|FG000|Overall Study|Physician Decision|1|||
125159760|NCT01000493|450210170|FG001|Overall Study|Physician Decision|1|||
125159761|NCT01000493|450210169|FG000|Overall Study|Withdrawal by Subject|3|||
125439268|NCT00758160|451235458|FG000|Overall Study|No Longer Requires Study Medication|4|||
125439269|NCT00758160|451235458|FG000|Overall Study|Administration Problems|3|||
125389439|NCT02658890|451060389|FG020|Treatment Phase|Adverse Event|3|||
125389440|NCT02658890|451060390|FG021|Treatment Phase|Adverse Event|0|||
125389441|NCT02658890|451060391|FG022|Treatment Phase|Adverse Event|5|||
125159762|NCT01000493|450210170|FG001|Overall Study|Withdrawal by Subject|7|||
125159763|NCT01408628|450210171|FG000|Consented|Withdrawal by Subject|12|||
125159764|NCT01408628|450210171|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
125159765|NCT01408628|450210171|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
125159766|NCT01408628|450210171|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
125159767|NCT01941940|450210172|FG000|Overall Study|Adverse Event|11|||
125159768|NCT01941940|450210172|FG000|Overall Study|Lost to Follow-up|2|||
125159769|NCT01941940|450210172|FG000|Overall Study|Physician Decision|2|||
125159770|NCT01941940|450210172|FG000|Overall Study|Withdrawal by Subject|15|||
125159771|NCT01941940|450210172|FG000|Overall Study|Death|1|||
125159772|NCT01941940|450210172|FG000|Overall Study|Other|1|||
125159773|NCT01941940|450210172|FG000|Overall Study|Other|1|||
125159774|NCT00750308|450210173|FG000|First Treatment|Adverse Event|0|||
125159775|NCT00750308|450210174|FG001|First Treatment|Adverse Event|1|||
125159776|NCT00750308|450210175|FG002|First Treatment|Adverse Event|0|||
125159777|NCT00750308|450210176|FG003|First Treatment|Adverse Event|0|||
125159778|NCT00750308|450210177|FG004|First Treatment|Adverse Event|0|||
125159779|NCT00750308|450210178|FG005|First Treatment|Adverse Event|0|||
125159780|NCT00750308|450210179|FG006|First Treatment|Adverse Event|0|||
125159781|NCT00750308|450210180|FG007|First Treatment|Adverse Event|0|||
125159782|NCT00750308|450210181|FG008|First Treatment|Adverse Event|0|||
125159783|NCT00750308|450210182|FG009|First Treatment|Adverse Event|0|||
125159784|NCT00750308|450210183|FG010|First Treatment|Adverse Event|1|||
125159785|NCT00750308|450210184|FG011|First Treatment|Adverse Event|1|||
125159786|NCT00750308|450210173|FG000|First Treatment|Withdrawal by Subject|0|||
125159787|NCT00750308|450210174|FG001|First Treatment|Withdrawal by Subject|0|||
125159788|NCT00750308|450210175|FG002|First Treatment|Withdrawal by Subject|0|||
125159789|NCT00750308|450210176|FG003|First Treatment|Withdrawal by Subject|1|||
125159790|NCT00750308|450210177|FG004|First Treatment|Withdrawal by Subject|0|||
125159791|NCT00750308|450210178|FG005|First Treatment|Withdrawal by Subject|0|||
125159792|NCT00750308|450210179|FG006|First Treatment|Withdrawal by Subject|0|||
125159793|NCT00750308|450210180|FG007|First Treatment|Withdrawal by Subject|1|||
125159794|NCT00750308|450210181|FG008|First Treatment|Withdrawal by Subject|0|||
125159795|NCT00750308|450210182|FG009|First Treatment|Withdrawal by Subject|0|||
125159796|NCT00750308|450210183|FG010|First Treatment|Withdrawal by Subject|0|||
125159797|NCT00750308|450210184|FG011|First Treatment|Withdrawal by Subject|0|||
125159798|NCT00750308|450210173|FG000|Second Treatment|Adverse Event|0|||
125159799|NCT00750308|450210174|FG001|Second Treatment|Adverse Event|0|||
125159800|NCT00750308|450210175|FG002|Second Treatment|Adverse Event|0|||
125159801|NCT00750308|450210176|FG003|Second Treatment|Adverse Event|0|||
125159802|NCT00750308|450210177|FG004|Second Treatment|Adverse Event|0|||
125159803|NCT00750308|450210178|FG005|Second Treatment|Adverse Event|1|||
125159804|NCT00750308|450210179|FG006|Second Treatment|Adverse Event|0|||
125159805|NCT00750308|450210180|FG007|Second Treatment|Adverse Event|0|||
125159806|NCT00750308|450210181|FG008|Second Treatment|Adverse Event|1|||
125159807|NCT00750308|450210182|FG009|Second Treatment|Adverse Event|0|||
125159808|NCT00750308|450210183|FG010|Second Treatment|Adverse Event|0|||
125159809|NCT00750308|450210184|FG011|Second Treatment|Adverse Event|0|||
125159810|NCT00750308|450210173|FG000|Second Treatment|Withdrawal by Subject|0|||
125159811|NCT00750308|450210174|FG001|Second Treatment|Withdrawal by Subject|0|||
125159812|NCT00750308|450210175|FG002|Second Treatment|Withdrawal by Subject|0|||
125159813|NCT00750308|450210176|FG003|Second Treatment|Withdrawal by Subject|0|||
125159814|NCT00750308|450210177|FG004|Second Treatment|Withdrawal by Subject|1|||
125159815|NCT00750308|450210178|FG005|Second Treatment|Withdrawal by Subject|0|||
125159816|NCT00750308|450210179|FG006|Second Treatment|Withdrawal by Subject|0|||
125159817|NCT00750308|450210180|FG007|Second Treatment|Withdrawal by Subject|0|||
125159818|NCT00750308|450210181|FG008|Second Treatment|Withdrawal by Subject|0|||
125159819|NCT00750308|450210182|FG009|Second Treatment|Withdrawal by Subject|0|||
125159820|NCT00750308|450210183|FG010|Second Treatment|Withdrawal by Subject|0|||
125159821|NCT00750308|450210184|FG011|Second Treatment|Withdrawal by Subject|0|||
125159822|NCT00750308|450210173|FG000|Third Treatment|Withdrawal by Subject|0|||
125159823|NCT00750308|450210174|FG001|Third Treatment|Withdrawal by Subject|1|||
125159824|NCT00750308|450210175|FG002|Third Treatment|Withdrawal by Subject|0|||
125159825|NCT00750308|450210176|FG003|Third Treatment|Withdrawal by Subject|0|||
125159826|NCT00750308|450210177|FG004|Third Treatment|Withdrawal by Subject|0|||
125389442|NCT02658890|451060392|FG023|Treatment Phase|Adverse Event|0|||
125159827|NCT00750308|450210178|FG005|Third Treatment|Withdrawal by Subject|0|||
125159828|NCT00750308|450210179|FG006|Third Treatment|Withdrawal by Subject|0|||
125159829|NCT00750308|450210180|FG007|Third Treatment|Withdrawal by Subject|0|||
125159830|NCT00750308|450210181|FG008|Third Treatment|Withdrawal by Subject|0|||
125159831|NCT00750308|450210182|FG009|Third Treatment|Withdrawal by Subject|0|||
125159832|NCT00750308|450210183|FG010|Third Treatment|Withdrawal by Subject|0|||
125389443|NCT02658890|451060393|FG024|Treatment Phase|Adverse Event|0|||
125389444|NCT02658890|451060394|FG025|Treatment Phase|Adverse Event|2|||
125389445|NCT02658890|451060395|FG026|Treatment Phase|Adverse Event|1|||
125159833|NCT00750308|450210184|FG011|Third Treatment|Withdrawal by Subject|0|||
125159834|NCT00513682|450210185|FG000|Washout Phase|Adverse Event|2|||
125159835|NCT01121666|450210187|FG000|Overall Study|Protocol Violation|29|||
125159836|NCT01121666|450210188|FG001|Overall Study|Protocol Violation|10|||
125159837|NCT03176459|450210189|FG000|Overall Study|Lost to Follow-up|5|||
125159838|NCT03176459|450210190|FG001|Overall Study|Lost to Follow-up|7|||
125159839|NCT06077487|450212869|FG000|Overall Study|Withdrawal by Subject|0|||
125159840|NCT06077487|450212870|FG001|Overall Study|Withdrawal by Subject|1|||
125159841|NCT00759902|450212873|FG000|Overall Study|Adverse Event|0|||
125159842|NCT00759902|450212874|FG001|Overall Study|Adverse Event|1|||
125159843|NCT02128217|450212879|FG000|Overall Study|Lost to Follow-up|0|||
125159844|NCT02128217|450212880|FG001|Overall Study|Lost to Follow-up|1|||
125159845|NCT05071313|450212881|FG000|Overall Study|Lost to Follow-up|17|||
125159846|NCT05071313|450212882|FG001|Overall Study|Lost to Follow-up|10|||
125159847|NCT05071313|450212881|FG000|Overall Study|Physician Decision|1|||
125159848|NCT05071313|450212882|FG001|Overall Study|Physician Decision|6|||
125159849|NCT05071313|450212881|FG000|Overall Study|Death|1|||
125159850|NCT05071313|450212882|FG001|Overall Study|Death|0|||
125159851|NCT05071313|450212881|FG000|Overall Study|Withdrawal by Subject|10|||
125159852|NCT05071313|450212882|FG001|Overall Study|Withdrawal by Subject|15|||
125159853|NCT05071313|450212881|FG000|Overall Study|Other|1|||
125159854|NCT05071313|450212882|FG001|Overall Study|Other|0|||
125159855|NCT05071313|450212881|FG000|Overall Study|Randomized but not vaccinated|4|||
125159856|NCT05071313|450212882|FG001|Overall Study|Randomized but not vaccinated|2|||
125159857|NCT00541970|450212883|FG000|Month 7|Protocol Violation|9|||
125159858|NCT00541970|450212884|FG001|Month 7|Protocol Violation|13|||
125159859|NCT00541970|450212885|FG002|Month 7|Protocol Violation|11|||
125159860|NCT00541970|450212886|FG003|Month 7|Protocol Violation|5|||
125159861|NCT00541970|450212883|FG000|Month 12|Adverse Event|0|||
125159862|NCT00541970|450212884|FG001|Month 12|Adverse Event|1|||
125159863|NCT00541970|450212885|FG002|Month 12|Adverse Event|1|||
125159864|NCT00541970|450212886|FG003|Month 12|Adverse Event|1|||
125159865|NCT00541970|450212883|FG000|Month 12|Protocol Violation|12|||
125159866|NCT00541970|450212884|FG001|Month 12|Protocol Violation|21|||
125159867|NCT00541970|450212885|FG002|Month 12|Protocol Violation|20|||
125159868|NCT00541970|450212886|FG003|Month 12|Protocol Violation|15|||
125159869|NCT00541970|450212883|FG000|Month 18|Adverse Event|0|||
125159870|NCT00541970|450212884|FG001|Month 18|Adverse Event|1|||
125159871|NCT00541970|450212885|FG002|Month 18|Adverse Event|1|||
125159872|NCT00541970|450212886|FG003|Month 18|Adverse Event|1|||
125159873|NCT00541970|450212883|FG000|Month 18|Protocol Violation|14|||
125159874|NCT00541970|450212884|FG001|Month 18|Protocol Violation|23|||
125159875|NCT00541970|450212885|FG002|Month 18|Protocol Violation|24|||
125159876|NCT00541970|450212886|FG003|Month 18|Protocol Violation|16|||
125159877|NCT00541970|450212883|FG000|Month 24|Adverse Event|0|||
125159878|NCT00541970|450212884|FG001|Month 24|Adverse Event|1|||
125159879|NCT00541970|450212885|FG002|Month 24|Adverse Event|1|||
125159880|NCT00541970|450212886|FG003|Month 24|Adverse Event|1|||
125159881|NCT00541970|450212883|FG000|Month 24|Protocol Violation|29|||
125159882|NCT00541970|450212884|FG001|Month 24|Protocol Violation|31|||
125159883|NCT00541970|450212885|FG002|Month 24|Protocol Violation|31|||
125159884|NCT00541970|450212886|FG003|Month 24|Protocol Violation|21|||
125159885|NCT00541970|450212883|FG000|Month 36|Protocol Violation|61|||
125159886|NCT00541970|450212884|FG001|Month 36|Protocol Violation|66|||
125159887|NCT00541970|450212885|FG002|Month 36|Protocol Violation|66|||
125159888|NCT00541970|450212886|FG003|Month 36|Protocol Violation|60|||
125159889|NCT00541970|450212883|FG000|Month 48|Withdrawal by Subject|2|||
125159890|NCT00541970|450212884|FG001|Month 48|Withdrawal by Subject|4|||
125159891|NCT00541970|450212885|FG002|Month 48|Withdrawal by Subject|4|||
125159892|NCT00541970|450212886|FG003|Month 48|Withdrawal by Subject|2|||
125159893|NCT00541970|450212883|FG000|Month 48|Other|3|||
125159894|NCT00541970|450212884|FG001|Month 48|Other|1|||
125159895|NCT00541970|450212885|FG002|Month 48|Other|1|||
125159896|NCT00541970|450212886|FG003|Month 48|Other|0|||
125159897|NCT00541970|450212883|FG000|Month 48|Lost to Follow-up|66|||
125159898|NCT00541970|450212884|FG001|Month 48|Lost to Follow-up|68|||
125159899|NCT00541970|450212885|FG002|Month 48|Lost to Follow-up|68|||
125159900|NCT00541970|450212886|FG003|Month 48|Lost to Follow-up|73|||
125159901|NCT00541970|450212883|FG000|Month 60|Protocol Violation|78|||
125159902|NCT00541970|450212884|FG001|Month 60|Protocol Violation|77|||
125159903|NCT00541970|450212885|FG002|Month 60|Protocol Violation|82|||
125159904|NCT00541970|450212886|FG003|Month 60|Protocol Violation|72|||
125159905|NCT00321828|450212887|FG000|Overall Study|Ineligible|3|||
125159906|NCT00321828|450212887|FG000|Overall Study|No follow up data|1|||
125159907|NCT00858143|450212892|FG000|Overall Study|Adverse Event|16|||
125159908|NCT00858143|450212892|FG000|Overall Study|Lack of Efficacy|4|||
125159909|NCT00858143|450212892|FG000|Overall Study|Death|7|||
125159910|NCT00858143|450212892|FG000|Overall Study|Other|23|||
125159911|NCT00852969|450212893|FG000|Overall Study|Adverse Event|0|||
125159912|NCT00852969|450212894|FG001|Overall Study|Adverse Event|1|||
125159913|NCT00852969|450212893|FG000|Overall Study|Lost to Follow-up|0|||
125159914|NCT00852969|450212894|FG001|Overall Study|Lost to Follow-up|1|||
125389446|NCT02658890|451060369|FG000|Treatment Phase|Death|0|||
125389447|NCT02658890|451060370|FG001|Treatment Phase|Death|0|||
125159915|NCT03853148|450212895|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
125159916|NCT03853148|450212896|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
125159917|NCT03853148|450212897|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
125159918|NCT03853148|450212898|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
125159919|NCT00658658|450212901|FG000|Overall Study|Withdrawal by Subject|0|||
125159920|NCT00658658|450212902|FG001|Overall Study|Withdrawal by Subject|1|||
125159921|NCT00658658|450212903|FG002|Overall Study|Withdrawal by Subject|0|||
125159922|NCT00658658|450212904|FG003|Overall Study|Withdrawal by Subject|0|||
125159923|NCT00658658|450212905|FG004|Overall Study|Withdrawal by Subject|0|||
125159924|NCT00658658|450212901|FG000|Overall Study|Death|4|||
125159925|NCT00658658|450212902|FG001|Overall Study|Death|0|||
125159926|NCT00658658|450212903|FG002|Overall Study|Death|0|||
125159927|NCT00658658|450212904|FG003|Overall Study|Death|1|||
125159928|NCT00658658|450212905|FG004|Overall Study|Death|1|||
125159929|NCT00658658|450212901|FG000|Overall Study|Disease Progression|0|||
125159930|NCT00658658|450212902|FG001|Overall Study|Disease Progression|1|||
125159931|NCT00658658|450212903|FG002|Overall Study|Disease Progression|0|||
125159932|NCT00658658|450212904|FG003|Overall Study|Disease Progression|1|||
125159933|NCT00658658|450212905|FG004|Overall Study|Disease Progression|3|||
125159934|NCT00658658|450212901|FG000|Overall Study|Protocol-specified Criteria|1|||
125159935|NCT00658658|450212902|FG001|Overall Study|Protocol-specified Criteria|0|||
125159936|NCT00658658|450212903|FG002|Overall Study|Protocol-specified Criteria|0|||
125159937|NCT00658658|450212904|FG003|Overall Study|Protocol-specified Criteria|0|||
125159938|NCT00658658|450212905|FG004|Overall Study|Protocol-specified Criteria|0|||
125159939|NCT00658658|450212901|FG000|Overall Study|Other|0|||
125159940|NCT00658658|450212902|FG001|Overall Study|Other|0|||
125159941|NCT00658658|450212903|FG002|Overall Study|Other|0|||
125159942|NCT00658658|450212904|FG003|Overall Study|Other|0|||
125159943|NCT00658658|450212905|FG004|Overall Study|Other|1|||
125159944|NCT00678041|450212906|FG000|Overall Study|Physician Decision|5|||
125159945|NCT00678041|450212907|FG001|Overall Study|Physician Decision|5|||
125159946|NCT02358343|450212908|FG000|Screening Intervention|Death|0|||
125159947|NCT02358343|450212909|FG001|Screening Intervention|Death|2|||
125159948|NCT02358343|450212910|FG002|Screening Intervention|Death|0|||
125159949|NCT02358343|450212911|FG003|Screening Intervention|Death|0|||
125159950|NCT02358343|450212912|FG004|Screening Intervention|Death|0|||
125159951|NCT02358343|450212908|FG000|Screening Intervention|Withdrawal by Subject|1|||
125159952|NCT02358343|450212909|FG001|Screening Intervention|Withdrawal by Subject|0|||
125159953|NCT02358343|450212910|FG002|Screening Intervention|Withdrawal by Subject|0|||
125159954|NCT02358343|450212911|FG003|Screening Intervention|Withdrawal by Subject|0|||
125159955|NCT02358343|450212912|FG004|Screening Intervention|Withdrawal by Subject|0|||
125159956|NCT02358343|450212908|FG000|Screening Intervention|Determined Ineligible|5|||
125159957|NCT02358343|450212909|FG001|Screening Intervention|Determined Ineligible|6|||
125159958|NCT02358343|450212910|FG002|Screening Intervention|Determined Ineligible|0|||
125159959|NCT02358343|450212911|FG003|Screening Intervention|Determined Ineligible|0|||
125159960|NCT02358343|450212912|FG004|Screening Intervention|Determined Ineligible|0|||
125159961|NCT02358343|450212908|FG000|Comparative Efficacy Trial / Observation|Death|0|||
125159962|NCT02358343|450212909|FG001|Comparative Efficacy Trial / Observation|Death|0|||
125159963|NCT02358343|450212910|FG002|Comparative Efficacy Trial / Observation|Death|2|||
125159964|NCT02358343|450212911|FG003|Comparative Efficacy Trial / Observation|Death|0|||
125159965|NCT02358343|450212912|FG004|Comparative Efficacy Trial / Observation|Death|0|||
125159966|NCT02358343|450212908|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
125159967|NCT02358343|450212909|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
125159968|NCT02358343|450212910|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
125159969|NCT02358343|450212911|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
125159970|NCT02358343|450212912|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
125159971|NCT02358343|450212908|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
125159972|NCT02358343|450212909|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
125159973|NCT02358343|450212910|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
125159974|NCT02358343|450212911|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
125159975|NCT02358343|450212912|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
125159976|NCT00090610|450212915|FG000|Overall Study|Withdrawal by Subject|1|||
125159977|NCT00090610|450212916|FG001|Overall Study|Withdrawal by Subject|1|||
125159978|NCT02444793|450212917|FG000|Overall Study|Lost to Follow-up|2|||
125159979|NCT02444793|450212918|FG001|Overall Study|Lost to Follow-up|2|||
125159980|NCT02444793|450212919|FG002|Overall Study|Lost to Follow-up|0|||
125159981|NCT02444793|450212920|FG003|Overall Study|Lost to Follow-up|0|||
125159982|NCT02444793|450212917|FG000|Overall Study|Death|0|||
125159983|NCT02444793|450212918|FG001|Overall Study|Death|3|||
125159984|NCT02444793|450212919|FG002|Overall Study|Death|0|||
125224179|NCT01854697|450448086|FG000|Overall Study|To enter another AbbVie study|1|||
125159985|NCT02444793|450212920|FG003|Overall Study|Death|0|||
125159986|NCT02444793|450212917|FG000|Overall Study|Other|0|||
125159987|NCT02444793|450212918|FG001|Overall Study|Other|0|||
125159988|NCT02444793|450212919|FG002|Overall Study|Other|2|||
125159989|NCT02444793|450212920|FG003|Overall Study|Other|0|||
125159990|NCT02444793|450212917|FG000|Overall Study|Objective progression or relapse|9|||
125389448|NCT02658890|451060371|FG002|Treatment Phase|Death|0|||
125389449|NCT02658890|451060372|FG003|Treatment Phase|Death|0|||
125389450|NCT02658890|451060373|FG004|Treatment Phase|Death|0|||
125389451|NCT02658890|451060374|FG005|Treatment Phase|Death|0|||
125159991|NCT02444793|450212918|FG001|Overall Study|Objective progression or relapse|1|||
125159992|NCT02444793|450212919|FG002|Overall Study|Objective progression or relapse|2|||
125159993|NCT02444793|450212920|FG003|Overall Study|Objective progression or relapse|3|||
125159994|NCT04498403|450212923|FG000|Overall Study|Adverse Event|1|||
125389452|NCT02658890|451060375|FG006|Treatment Phase|Death|0|||
125389453|NCT02658890|451060376|FG007|Treatment Phase|Death|0|||
125389454|NCT02658890|451060377|FG008|Treatment Phase|Death|0|||
125389455|NCT02658890|451060378|FG009|Treatment Phase|Death|0|||
125389456|NCT02658890|451060379|FG010|Treatment Phase|Death|0|||
125389457|NCT02658890|451060380|FG011|Treatment Phase|Death|0|||
125389458|NCT02658890|451060381|FG012|Treatment Phase|Death|0|||
125389459|NCT02658890|451060382|FG013|Treatment Phase|Death|0|||
125389460|NCT02658890|451060383|FG014|Treatment Phase|Death|0|||
125389461|NCT02658890|451060384|FG015|Treatment Phase|Death|0|||
125389462|NCT02658890|451060385|FG016|Treatment Phase|Death|0|||
125389463|NCT02658890|451060386|FG017|Treatment Phase|Death|0|||
125389464|NCT02658890|451060387|FG018|Treatment Phase|Death|1|||
125389465|NCT02658890|451060388|FG019|Treatment Phase|Death|0|||
125389466|NCT02658890|451060389|FG020|Treatment Phase|Death|0|||
125389467|NCT02658890|451060390|FG021|Treatment Phase|Death|0|||
125389468|NCT02658890|451060391|FG022|Treatment Phase|Death|0|||
125389469|NCT02658890|451060392|FG023|Treatment Phase|Death|0|||
125389470|NCT02658890|451060393|FG024|Treatment Phase|Death|0|||
125389471|NCT02658890|451060394|FG025|Treatment Phase|Death|0|||
125389472|NCT02658890|451060395|FG026|Treatment Phase|Death|0|||
125389473|NCT02658890|451060369|FG000|Treatment Phase|Lost to Follow-up|0|||
125389474|NCT02658890|451060370|FG001|Treatment Phase|Lost to Follow-up|0|||
125389475|NCT02658890|451060371|FG002|Treatment Phase|Lost to Follow-up|0|||
125389476|NCT02658890|451060372|FG003|Treatment Phase|Lost to Follow-up|0|||
125389477|NCT02658890|451060373|FG004|Treatment Phase|Lost to Follow-up|0|||
125389478|NCT02658890|451060374|FG005|Treatment Phase|Lost to Follow-up|0|||
125159995|NCT04498403|450212924|FG001|Overall Study|Adverse Event|0|||
125159996|NCT04498403|450212923|FG000|Overall Study|Study Terminated By Sponsor|29|||
125159997|NCT04498403|450212924|FG001|Overall Study|Study Terminated By Sponsor|10|||
125159998|NCT01951885|450212925|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
125159999|NCT01951885|450212926|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
125160000|NCT01951885|450212925|FG000|Overall Study|Adverse Event|1|||
125160001|NCT01951885|450212926|FG001|Overall Study|Adverse Event|0|||
125160002|NCT01951885|450212925|FG000|Overall Study|Withdrawal by Subject|0|||
125160003|NCT01951885|450212926|FG001|Overall Study|Withdrawal by Subject|1|||
125160004|NCT01951885|450212925|FG000|Overall Study|ineligible due to a change in donor|0|||
125160005|NCT01951885|450212926|FG001|Overall Study|ineligible due to a change in donor|1|||
125160006|NCT01951885|450212925|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
125160007|NCT01951885|450212926|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
125160008|NCT00866658|450212927|FG000|Overall Study|Adverse Event|5|||
125160009|NCT00866658|450212928|FG001|Overall Study|Adverse Event|14|||
125160010|NCT00866658|450212927|FG000|Overall Study|Lack of Efficacy|2|||
125160011|NCT00866658|450212928|FG001|Overall Study|Lack of Efficacy|1|||
125160012|NCT00866658|450212927|FG000|Overall Study|Withdrawal by Subject|1|||
125160013|NCT00866658|450212928|FG001|Overall Study|Withdrawal by Subject|0|||
125160014|NCT00866658|450212927|FG000|Overall Study|Protocol Violation|1|||
125160015|NCT00866658|450212928|FG001|Overall Study|Protocol Violation|1|||
125160016|NCT00866658|450212927|FG000|Overall Study|Familial and Personal Reasons|4|||
125160017|NCT00866658|450212928|FG001|Overall Study|Familial and Personal Reasons|5|||
125160018|NCT01859130|450212931|FG000|Overall Study|Death|4|||
125160019|NCT01859130|450212931|FG000|Overall Study|Lost to Follow-up|16|||
125160020|NCT01859130|450212931|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
125160021|NCT01859130|450212931|FG000|Overall Study|Physician Decision|6|||
125160022|NCT01859130|450212931|FG000|Overall Study|Withdrawal by Subject|17|||
125389479|NCT02658890|451060375|FG006|Treatment Phase|Lost to Follow-up|1|||
125389480|NCT02658890|451060376|FG007|Treatment Phase|Lost to Follow-up|0|||
125389481|NCT02658890|451060377|FG008|Treatment Phase|Lost to Follow-up|0|||
125389482|NCT02658890|451060378|FG009|Treatment Phase|Lost to Follow-up|0|||
125389483|NCT02658890|451060379|FG010|Treatment Phase|Lost to Follow-up|0|||
125389484|NCT02658890|451060380|FG011|Treatment Phase|Lost to Follow-up|0|||
125389485|NCT02658890|451060381|FG012|Treatment Phase|Lost to Follow-up|0|||
125389486|NCT02658890|451060382|FG013|Treatment Phase|Lost to Follow-up|0|||
125389487|NCT02658890|451060383|FG014|Treatment Phase|Lost to Follow-up|0|||
125389488|NCT02658890|451060384|FG015|Treatment Phase|Lost to Follow-up|0|||
125389489|NCT02658890|451060385|FG016|Treatment Phase|Lost to Follow-up|0|||
125160023|NCT01859130|450212931|FG000|Overall Study|Adverse Event|11|||
125160024|NCT01462318|450212934|FG000|Main Study / TP-DI Study|Other|2|||
125160025|NCT01462318|450212935|FG001|Main Study / TP-DI Study|Other|0|||
125160026|NCT01462318|450212936|FG002|Main Study / TP-DI Study|Other|0|||
125160027|NCT01462318|450212934|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
125160028|NCT01462318|450212935|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
125160029|NCT01462318|450212936|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
125160030|NCT01462318|450212934|FG000|Main Study / TP-DI Study|Adverse Event|4|||
125160031|NCT01462318|450212935|FG001|Main Study / TP-DI Study|Adverse Event|0|||
125160032|NCT01462318|450212936|FG002|Main Study / TP-DI Study|Adverse Event|0|||
125160033|NCT01462318|450212934|FG000|Extension Phase|Lost to Follow-up|0|||
125160034|NCT01462318|450212935|FG001|Extension Phase|Lost to Follow-up|0|||
125160035|NCT01462318|450212936|FG002|Extension Phase|Lost to Follow-up|1|||
125160036|NCT01462318|450212934|FG000|Extension Phase|Other|0|||
125160037|NCT01462318|450212935|FG001|Extension Phase|Other|0|||
125160038|NCT01462318|450212936|FG002|Extension Phase|Other|1|||
125160039|NCT01462318|450212934|FG000|Extension Phase|Disease Progression|0|||
125160040|NCT01462318|450212935|FG001|Extension Phase|Disease Progression|0|||
125160041|NCT01462318|450212936|FG002|Extension Phase|Disease Progression|1|||
125160042|NCT01462318|450212934|FG000|Extension Phase|Withdrawal by Subject|0|||
125160043|NCT01462318|450212935|FG001|Extension Phase|Withdrawal by Subject|0|||
125160044|NCT01462318|450212936|FG002|Extension Phase|Withdrawal by Subject|15|||
125160045|NCT01462318|450212934|FG000|Extension Phase|Investigator Decision|0|||
125160046|NCT01462318|450212935|FG001|Extension Phase|Investigator Decision|0|||
125160047|NCT01462318|450212936|FG002|Extension Phase|Investigator Decision|5|||
125160048|NCT01462318|450212934|FG000|Extension Phase|Adverse Event|0|||
125160049|NCT01462318|450212935|FG001|Extension Phase|Adverse Event|0|||
125160050|NCT01462318|450212936|FG002|Extension Phase|Adverse Event|22|||
125160051|NCT03827564|450212937|FG000|Overall Study|Discontinued due to Study Termination|1|||
125160052|NCT03827564|450212938|FG001|Overall Study|Discontinued due to Study Termination|0|||
125160053|NCT00891371|450212939|FG000|Pre-assignment|Inclusion/exclusion|5|||
125160054|NCT00891371|450212939|FG000|Pre-assignment|Consent withdrawal|1|||
125160055|NCT00891371|450212939|FG000|Treatment|Lack of Efficacy|5|||
125160056|NCT00891371|450212939|FG000|Treatment|Adverse Event|2|||
125160057|NCT00891371|450212939|FG000|Treatment|Death|1|||
125160058|NCT00891371|450212939|FG000|Treatment|Lost to Follow-up|1|||
125160059|NCT02238626|450212940|FG000|Overall Study|Adverse Event|3|||
125160060|NCT02238626|450212941|FG001|Overall Study|Adverse Event|5|||
125160061|NCT02238626|450212942|FG002|Overall Study|Adverse Event|0|||
125160062|NCT02238626|450212943|FG003|Overall Study|Adverse Event|3|||
125160063|NCT02238626|450212940|FG000|Overall Study|Lost to Follow-up|2|||
125160064|NCT02238626|450212941|FG001|Overall Study|Lost to Follow-up|4|||
125160065|NCT02238626|450212942|FG002|Overall Study|Lost to Follow-up|2|||
125160066|NCT02238626|450212943|FG003|Overall Study|Lost to Follow-up|2|||
125160067|NCT02238626|450212940|FG000|Overall Study|Withdrawal by Subject|0|||
125160068|NCT02238626|450212941|FG001|Overall Study|Withdrawal by Subject|3|||
125160069|NCT02238626|450212942|FG002|Overall Study|Withdrawal by Subject|0|||
125160070|NCT02238626|450212943|FG003|Overall Study|Withdrawal by Subject|1|||
125160071|NCT02238626|450212940|FG000|Overall Study|Death|0|||
125160072|NCT02238626|450212941|FG001|Overall Study|Death|0|||
125160073|NCT02238626|450212942|FG002|Overall Study|Death|1|||
125160074|NCT02238626|450212943|FG003|Overall Study|Death|1|||
125160075|NCT02238626|450212940|FG000|Overall Study|Other|0|||
125160076|NCT02238626|450212941|FG001|Overall Study|Other|2|||
125160077|NCT02238626|450212942|FG002|Overall Study|Other|0|||
125160078|NCT02238626|450212943|FG003|Overall Study|Other|0|||
125160079|NCT02622113|450212946|FG000|Overall Study|Adverse Event|4|||
125160080|NCT02622113|450212947|FG001|Overall Study|Adverse Event|4|||
125160081|NCT02622113|450212946|FG000|Overall Study|Physician Decision|0|||
125160082|NCT02622113|450212947|FG001|Overall Study|Physician Decision|1|||
125160083|NCT02622113|450212946|FG000|Overall Study|Withdrawal by Subject|0|||
125160084|NCT02622113|450212947|FG001|Overall Study|Withdrawal by Subject|2|||
125160085|NCT02622113|450212946|FG000|Overall Study|Stopping Criteria|1|||
125160086|NCT02622113|450212947|FG001|Overall Study|Stopping Criteria|3|||
125160087|NCT04442490|450212954|FG000|Overall Study|Withdrawal by Subject|18|||
125160088|NCT04442490|450212955|FG001|Overall Study|Withdrawal by Subject|10|||
125160089|NCT04442490|450212954|FG000|Overall Study|Lost to Follow-up|7|||
125160090|NCT04442490|450212955|FG001|Overall Study|Lost to Follow-up|7|||
125224180|NCT01854697|450448087|FG001|Overall Study|To enter another AbbVie study|0|||
125160091|NCT04442490|450212954|FG000|Overall Study|Adverse Event|2|||
125160092|NCT04442490|450212955|FG001|Overall Study|Adverse Event|6|||
125160093|NCT04442490|450212954|FG000|Overall Study|Noncompliance|3|||
125160094|NCT04442490|450212955|FG001|Overall Study|Noncompliance|1|||
125160095|NCT04442490|450212954|FG000|Overall Study|Physician Decision|2|||
125160096|NCT04442490|450212955|FG001|Overall Study|Physician Decision|1|||
125160097|NCT04442490|450212954|FG000|Overall Study|Reason not Specified|2|||
125160098|NCT04442490|450212955|FG001|Overall Study|Reason not Specified|1|||
125160099|NCT04442490|450212954|FG000|Overall Study|Randomized but not Treated|3|||
125160100|NCT04442490|450212955|FG001|Overall Study|Randomized but not Treated|3|||
125439270|NCT00758160|451235458|FG000|Overall Study|Adverse Event|15|||
125439271|NCT00758160|451235458|FG000|Overall Study|Lack of Efficacy|10|||
125439272|NCT00758160|451235458|FG000|Overall Study|Lost to Follow-up|14|||
125439273|NCT00758160|451235458|FG000|Overall Study|Protocol Violation|12|||
125439274|NCT00758160|451235458|FG000|Overall Study|Withdrawal by Subject|8|||
125439275|NCT01613027|451235459|FG000|Overall Study|Lost to Follow-up|5|||
125439276|NCT01613027|451235459|FG000|Overall Study|Switched Physician|1|||
125439277|NCT01613027|451235459|FG000|Overall Study|Lack of Efficacy|1|||
125439278|NCT01613027|451235459|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
125439279|NCT00993317|451235460|FG000|Overall Study|Adverse Event|2|||
125439280|NCT00993317|451235461|FG001|Overall Study|Adverse Event|4|||
125439281|NCT00993317|451235460|FG000|Overall Study|Lack of Efficacy|18|||
125439282|NCT00993317|451235461|FG001|Overall Study|Lack of Efficacy|18|||
125439283|NCT00993317|451235460|FG000|Overall Study|Withdrawal by Subject|0|||
125439284|NCT00993317|451235461|FG001|Overall Study|Withdrawal by Subject|2|||
125439285|NCT00993317|451235460|FG000|Overall Study|Investigator's opinion|0|||
125439286|NCT00993317|451235461|FG001|Overall Study|Investigator's opinion|1|||
125439287|NCT00993317|451235460|FG000|Overall Study|Early study termination at the site|1|||
125439288|NCT00993317|451235461|FG001|Overall Study|Early study termination at the site|0|||
125439289|NCT02153359|451235462|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
125439290|NCT02153359|451235463|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
125439291|NCT04422639|451235464|FG000|Overall Study|Death|1|||
125439292|NCT04422639|451235465|FG001|Overall Study|Death|0|||
125439293|NCT04422639|451235464|FG000|Overall Study|study closed prior to completion of FU visits|0|||
125439294|NCT04422639|451235465|FG001|Overall Study|study closed prior to completion of FU visits|2|||
125439295|NCT01964521|451235466|FG000|Overall Study|Lost to Follow-up|4|||
125439296|NCT01372605|451235467|FG000|Overall Study|Death|1|||
125439297|NCT01372605|451235468|FG001|Overall Study|Death|2|||
125439298|NCT01372605|451235467|FG000|Overall Study|Lost to Follow-up|2|||
125439299|NCT01372605|451235468|FG001|Overall Study|Lost to Follow-up|1|||
125439300|NCT01372605|451235467|FG000|Overall Study|Withdrawal by Subject|4|||
125439301|NCT01372605|451235468|FG001|Overall Study|Withdrawal by Subject|7|||
125439302|NCT01372605|451235467|FG000|Overall Study|Moved|3|||
125439303|NCT01372605|451235468|FG001|Overall Study|Moved|0|||
125439304|NCT01372605|451235467|FG000|Overall Study|Changed medical home|2|||
125439305|NCT01372605|451235468|FG001|Overall Study|Changed medical home|0|||
125439306|NCT01108510|451235469|FG000|Overall Study|Randomized but Not Treated|5|||
125439307|NCT01108510|451235470|FG001|Overall Study|Randomized but Not Treated|1|||
125439308|NCT01108510|451235469|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
125439309|NCT01108510|451235470|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
125439310|NCT01108510|451235469|FG000|Overall Study|Adverse Event|26|||
125439311|NCT01108510|451235470|FG001|Overall Study|Adverse Event|19|||
125439312|NCT01108510|451235469|FG000|Overall Study|Lost to Follow-up|20|||
125439313|NCT01108510|451235470|FG001|Overall Study|Lost to Follow-up|17|||
125439314|NCT01108510|451235469|FG000|Overall Study|Withdrew Consent|21|||
125439315|NCT01108510|451235470|FG001|Overall Study|Withdrew Consent|15|||
125439316|NCT01108510|451235469|FG000|Overall Study|Investigator's Discretion|12|||
125439317|NCT01108510|451235470|FG001|Overall Study|Investigator's Discretion|10|||
125439318|NCT01108510|451235469|FG000|Overall Study|Participant Noncompliance|5|||
125439319|NCT01108510|451235470|FG001|Overall Study|Participant Noncompliance|7|||
125439320|NCT01108510|451235469|FG000|Overall Study|Lack of Efficacy|3|||
125439321|NCT01108510|451235470|FG001|Overall Study|Lack of Efficacy|0|||
125439322|NCT01108510|451235469|FG000|Overall Study|Pregnancy|0|||
125439323|NCT01108510|451235470|FG001|Overall Study|Pregnancy|3|||
125439324|NCT01108510|451235469|FG000|Overall Study|Death|1|||
125439325|NCT01108510|451235470|FG001|Overall Study|Death|1|||
125439326|NCT02796963|451235471|FG000|Overall Study|Lost to Follow-up|89|||
125439327|NCT02796963|451235472|FG001|Overall Study|Lost to Follow-up|76|||
125439328|NCT02796963|451235473|FG002|Overall Study|Lost to Follow-up|69|||
125439329|NCT02796963|451235474|FG003|Overall Study|Lost to Follow-up|72|||
125439330|NCT00951509|451235475|FG000|Overall Study|Withdrawal by Subject|2|||
125160101|NCT01449279|450212956|FG000|Overall Study|Lack of Efficacy|5|||
125439331|NCT01258660|451235477|FG000|Overall Study|Adverse Event|2|||
125439332|NCT01258660|451235478|FG001|Overall Study|Adverse Event|4|||
125439333|NCT01258660|451235477|FG000|Overall Study|Withdrawal by Subject|3|||
125439334|NCT01258660|451235478|FG001|Overall Study|Withdrawal by Subject|0|||
125439335|NCT01258660|451235477|FG000|Overall Study|due to relocation|2|||
125439336|NCT01258660|451235478|FG001|Overall Study|due to relocation|0|||
125439337|NCT01258660|451235477|FG000|Overall Study|Protocol Violation|0|||
125439338|NCT01258660|451235478|FG001|Overall Study|Protocol Violation|1|||
125439339|NCT01258660|451235477|FG000|Overall Study|Invalid for primary analysis data set|4|||
125439340|NCT01258660|451235478|FG001|Overall Study|Invalid for primary analysis data set|6|||
125439341|NCT01193582|451235479|FG000|Vaccination Series|Withdrawal by Subject|11|||
125439342|NCT01193582|451235480|FG001|Vaccination Series|Withdrawal by Subject|13|||
125439343|NCT01193582|451235481|FG002|Vaccination Series|Withdrawal by Subject|8|||
125439344|NCT01193582|451235482|FG003|Vaccination Series|Withdrawal by Subject|3|||
125160102|NCT01449279|450212956|FG000|Overall Study|Toxicity|2|||
125160103|NCT00505375|450212957|FG000|Overall Study|Death|1|||
125439345|NCT01193582|451235479|FG000|12 Month Follow-up|Death|0|||
125439346|NCT01193582|451235480|FG001|12 Month Follow-up|Death|0|||
125439347|NCT01193582|451235481|FG002|12 Month Follow-up|Death|1|||
125439348|NCT01193582|451235482|FG003|12 Month Follow-up|Death|0|||
125439349|NCT01193582|451235479|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
125439350|NCT01193582|451235480|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
125439351|NCT01193582|451235481|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
125439352|NCT01193582|451235482|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
125439353|NCT03632434|451235495|FG000|Overall Study|Withdrawal by Subject|2|||
125439354|NCT01751113|451235496|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
125439355|NCT01751113|451235497|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
125439356|NCT01751113|451235498|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
125439357|NCT01751113|451235499|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
125439358|NCT01751113|451235500|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
125439359|NCT01751113|451235501|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
125439360|NCT01751113|451235496|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
125439361|NCT01751113|451235497|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
125439362|NCT01751113|451235498|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
125439363|NCT01751113|451235499|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
125439364|NCT01751113|451235500|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
125439365|NCT01751113|451235501|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
125439366|NCT01775930|451235502|FG000|Overall Study|Futility stopping boundary met|1|||
125439367|NCT01551303|451235504|FG000|Overall Study|failed awareness check on vision test|4|||
125439368|NCT01551303|451235505|FG001|Overall Study|failed awareness check on vision test|7|||
125439369|NCT00363896|451235506|FG000|Overall Study|Withdrawal by Subject|29|||
125439370|NCT00363896|451235507|FG001|Overall Study|Withdrawal by Subject|16|||
125439371|NCT00363896|451235506|FG000|Overall Study|Adverse Event|24|||
125439372|NCT00363896|451235507|FG001|Overall Study|Adverse Event|13|||
125439373|NCT00363896|451235506|FG000|Overall Study|COPD exacerbation|13|||
125439374|NCT00363896|451235507|FG001|Overall Study|COPD exacerbation|7|||
125439375|NCT00363896|451235506|FG000|Overall Study|Lack of Efficacy|12|||
125439376|NCT00363896|451235507|FG001|Overall Study|Lack of Efficacy|8|||
125439377|NCT00363896|451235506|FG000|Overall Study|Protocol Violation|6|||
125439378|NCT00363896|451235507|FG001|Overall Study|Protocol Violation|1|||
125439379|NCT00363896|451235506|FG000|Overall Study|Lost to Follow-up|3|||
125439380|NCT00363896|451235507|FG001|Overall Study|Lost to Follow-up|0|||
125439381|NCT00363896|451235506|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
125439382|NCT00363896|451235507|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
125439383|NCT00363896|451235506|FG000|Overall Study|Other|1|||
125439384|NCT00363896|451235507|FG001|Overall Study|Other|2|||
125439385|NCT03856996|451235515|FG000|Overall Study|Withdrawal by Subject|1|||
125439386|NCT03856996|451235516|FG001|Overall Study|Withdrawal by Subject|0|||
125439387|NCT03856996|451235515|FG000|Overall Study|Lost to Follow-up|0|||
125439388|NCT03856996|451235516|FG001|Overall Study|Lost to Follow-up|1|||
125439389|NCT03856996|451235515|FG000|Overall Study|Adverse Event|1|||
125439390|NCT03856996|451235516|FG001|Overall Study|Adverse Event|1|||
125439391|NCT03856996|451235515|FG000|Overall Study|Other|1|||
125439392|NCT03856996|451235516|FG001|Overall Study|Other|0|||
125439393|NCT00786474|451235517|FG000|Overall Study|Death|5|||
125439394|NCT00786474|451235518|FG001|Overall Study|Death|4|||
125439395|NCT00786474|451235517|FG000|Overall Study|Withdrawal by Subject|23|||
125439396|NCT00786474|451235518|FG001|Overall Study|Withdrawal by Subject|31|||
125439397|NCT00786474|451235517|FG000|Overall Study|Lost to Follow-up|3|||
125439398|NCT00786474|451235518|FG001|Overall Study|Lost to Follow-up|3|||
125439399|NCT00786474|451235517|FG000|Overall Study|Physician Decision|2|||
125439400|NCT00786474|451235518|FG001|Overall Study|Physician Decision|1|||
125160104|NCT00505375|450212958|FG001|Overall Study|Death|0|||
125160105|NCT00505375|450212957|FG000|Overall Study|Withdrawal by Subject|2|||
125160106|NCT00505375|450212958|FG001|Overall Study|Withdrawal by Subject|2|||
125439401|NCT00786474|451235517|FG000|Overall Study|Other|4|||
125439402|NCT00786474|451235518|FG001|Overall Study|Other|4|||
125439403|NCT02180438|451235519|FG000|Overall Study|Lost to Follow-up|1|||
125439404|NCT00514046|451235525|FG000|Overall Study|transferred to another protocol|2|||
125439405|NCT00514046|451235526|FG001|Overall Study|transferred to another protocol|1|||
125439406|NCT00514046|451235527|FG002|Overall Study|transferred to another protocol|3|||
125439407|NCT00514046|451235528|FG003|Overall Study|transferred to another protocol|0|||
125439408|NCT00514046|451235529|FG004|Overall Study|transferred to another protocol|1|||
125439409|NCT00514046|451235530|FG005|Overall Study|transferred to another protocol|0|||
125439410|NCT00514046|451235531|FG006|Overall Study|transferred to another protocol|0|||
125439411|NCT00514046|451235532|FG007|Overall Study|transferred to another protocol|0|||
125439412|NCT00514046|451235533|FG008|Overall Study|transferred to another protocol|0|||
125439413|NCT00514046|451235525|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
125439414|NCT00514046|451235526|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
125439415|NCT00514046|451235527|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
125439416|NCT00514046|451235528|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
125439417|NCT00514046|451235529|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
125439418|NCT00514046|451235530|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
125439419|NCT00514046|451235531|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
125439420|NCT00514046|451235532|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
125439421|NCT00514046|451235533|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
125439422|NCT00514046|451235525|FG000|Overall Study|Disease progression on study|0|||
125439423|NCT00514046|451235526|FG001|Overall Study|Disease progression on study|0|||
125439424|NCT00514046|451235527|FG002|Overall Study|Disease progression on study|2|||
125439425|NCT00514046|451235528|FG003|Overall Study|Disease progression on study|0|||
125439426|NCT00514046|451235529|FG004|Overall Study|Disease progression on study|0|||
125439427|NCT00514046|451235530|FG005|Overall Study|Disease progression on study|1|||
125439428|NCT00514046|451235531|FG006|Overall Study|Disease progression on study|0|||
125439429|NCT00514046|451235532|FG007|Overall Study|Disease progression on study|0|||
125160107|NCT00505375|450212957|FG000|Overall Study|Lost to Follow-up|0|||
125160108|NCT00505375|450212958|FG001|Overall Study|Lost to Follow-up|2|||
125160109|NCT00505375|450212957|FG000|Overall Study|Pregnancy|1|||
125160110|NCT00505375|450212958|FG001|Overall Study|Pregnancy|0|||
125160111|NCT00505375|450212957|FG000|Overall Study|Travel issues|0|||
125160112|NCT00505375|450212958|FG001|Overall Study|Travel issues|1|||
125160113|NCT03347422|450212959|FG000|Part A (26 Weeks)|Adverse Event|3|||
125160114|NCT03347422|450212960|FG001|Part A (26 Weeks)|Adverse Event|0|||
125160115|NCT03347422|450212959|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
125160116|NCT03347422|450212960|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
125160117|NCT03347422|450212959|FG000|Part B (149 Weeks)|Adverse Event|0|||
125160118|NCT03347422|450212960|FG001|Part B (149 Weeks)|Adverse Event|1|||
125160119|NCT03347422|450212959|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
125160120|NCT03347422|450212960|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
125160121|NCT03347422|450212959|FG000|Part B (149 Weeks)|Other|1|||
125160122|NCT03347422|450212960|FG001|Part B (149 Weeks)|Other|0|||
125160123|NCT02746471|450212961|FG000|Overall Study|Death|43|||
125160124|NCT02746471|450212961|FG000|Overall Study|Exited before 36 months|1119|||
125160125|NCT00910091|450212962|FG000|Pre-assignment|Withdrawal by Subject|0|||
125160126|NCT00910091|450212963|FG001|Pre-assignment|Withdrawal by Subject|2|||
125160127|NCT00910091|450212962|FG000|Treatment and Survival|Withdrawal by Subject|3|||
125160128|NCT00910091|450212963|FG001|Treatment and Survival|Withdrawal by Subject|4|||
125160129|NCT00910091|450212962|FG000|Treatment and Survival|Adverse Event|1|||
125160130|NCT00910091|450212963|FG001|Treatment and Survival|Adverse Event|0|||
125160131|NCT04594707|450212967|FG000|Overall Study|Adverse Event|0|||
125160132|NCT04594707|450212968|FG001|Overall Study|Adverse Event|0|||
125160133|NCT04594707|450212969|FG002|Overall Study|Adverse Event|1|||
125160134|NCT04594707|450212967|FG000|Overall Study|Death|0|||
125160135|NCT04594707|450212968|FG001|Overall Study|Death|2|||
125160136|NCT04594707|450212969|FG002|Overall Study|Death|2|||
125160137|NCT04594707|450212967|FG000|Overall Study|Lung Transplant|0|||
125160138|NCT04594707|450212968|FG001|Overall Study|Lung Transplant|0|||
125160139|NCT04594707|450212969|FG002|Overall Study|Lung Transplant|1|||
125160140|NCT04594707|450212967|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
125160141|NCT04594707|450212968|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
125160142|NCT04594707|450212969|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
125160143|NCT04594707|450212967|FG000|Overall Study|Study Terminated By Sponsor|19|||
125160144|NCT04594707|450212968|FG001|Overall Study|Study Terminated By Sponsor|47|||
125224181|NCT01854697|450448088|FG002|Overall Study|To enter another AbbVie study|0|||
125224182|NCT01854697|450448089|FG003|Overall Study|To enter another AbbVie study|0|||
125224183|NCT01854697|450448090|FG004|Overall Study|To enter another AbbVie study|1|||
125224184|NCT01854697|450448086|FG000|Overall Study|Withdrew Consent|0|||
125224185|NCT01854697|450448087|FG001|Overall Study|Withdrew Consent|1|||
125224186|NCT01854697|450448088|FG002|Overall Study|Withdrew Consent|0|||
125224187|NCT01854697|450448089|FG003|Overall Study|Withdrew Consent|1|||
125224188|NCT01854697|450448090|FG004|Overall Study|Withdrew Consent|0|||
125224189|NCT01854697|450448086|FG000|Overall Study|Other|0|||
125224190|NCT01854697|450448087|FG001|Overall Study|Other|1|||
125224191|NCT01854697|450448088|FG002|Overall Study|Other|1|||
125224192|NCT01854697|450448089|FG003|Overall Study|Other|0|||
125224193|NCT01854697|450448090|FG004|Overall Study|Other|0|||
125224194|NCT03713684|450448091|FG000|Overall Study|Adverse Event|1|||
125224195|NCT03713684|450448092|FG001|Overall Study|Adverse Event|3|||
125224196|NCT03713684|450448093|FG002|Overall Study|Adverse Event|1|||
125224197|NCT03713684|450448094|FG003|Overall Study|Adverse Event|0|||
125224198|NCT03713684|450448091|FG000|Overall Study|Poor compliance to protocol|2|||
125160145|NCT04594707|450212969|FG002|Overall Study|Study Terminated By Sponsor|41|||
125160146|NCT04594707|450212967|FG000|Overall Study|Withdrawal by Subject|1|||
125160147|NCT04594707|450212968|FG001|Overall Study|Withdrawal by Subject|0|||
125160148|NCT04594707|450212969|FG002|Overall Study|Withdrawal by Subject|2|||
125160149|NCT01155024|450212970|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
125160150|NCT01155024|450212971|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
125224199|NCT03713684|450448092|FG001|Overall Study|Poor compliance to protocol|1|||
125224200|NCT03713684|450448093|FG002|Overall Study|Poor compliance to protocol|0|||
125160151|NCT01155024|450212970|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
125160152|NCT01155024|450212971|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
125160153|NCT01155024|450212970|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
125160154|NCT01155024|450212971|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
125160155|NCT01593696|450212972|FG000|Dose Escalation|Progressive Disease|2|||
125160156|NCT01593696|450212973|FG001|Dose Escalation|Progressive Disease|0|||
125389490|NCT02658890|451060386|FG017|Treatment Phase|Lost to Follow-up|0|||
125389491|NCT02658890|451060387|FG018|Treatment Phase|Lost to Follow-up|0|||
125389492|NCT02658890|451060388|FG019|Treatment Phase|Lost to Follow-up|0|||
125389493|NCT02658890|451060389|FG020|Treatment Phase|Lost to Follow-up|0|||
125389494|NCT02658890|451060390|FG021|Treatment Phase|Lost to Follow-up|0|||
125389495|NCT02658890|451060391|FG022|Treatment Phase|Lost to Follow-up|0|||
125389496|NCT02658890|451060392|FG023|Treatment Phase|Lost to Follow-up|0|||
125389497|NCT02658890|451060393|FG024|Treatment Phase|Lost to Follow-up|0|||
125389498|NCT02658890|451060394|FG025|Treatment Phase|Lost to Follow-up|0|||
125389499|NCT02658890|451060395|FG026|Treatment Phase|Lost to Follow-up|0|||
125389500|NCT02658890|451060369|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
125389501|NCT02658890|451060370|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
125389502|NCT02658890|451060371|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
125389503|NCT02658890|451060372|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
125389504|NCT02658890|451060373|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
125389505|NCT02658890|451060374|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
125389506|NCT02658890|451060375|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
125389507|NCT02658890|451060376|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
125389508|NCT02658890|451060377|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
125389509|NCT02658890|451060378|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
125389510|NCT02658890|451060379|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
125389511|NCT02658890|451060380|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
125389512|NCT02658890|451060381|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
125389513|NCT02658890|451060382|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
125389514|NCT02658890|451060383|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
125389515|NCT02658890|451060384|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
125389516|NCT02658890|451060385|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
125389517|NCT02658890|451060386|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
125389518|NCT02658890|451060387|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
125389519|NCT02658890|451060388|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
125389520|NCT02658890|451060389|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
125389521|NCT02658890|451060390|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
125389522|NCT02658890|451060391|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
125389523|NCT02658890|451060392|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
125389524|NCT02658890|451060393|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
125389525|NCT02658890|451060394|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
125389526|NCT02658890|451060395|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
125389527|NCT02658890|451060369|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
125389528|NCT02658890|451060370|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
125389529|NCT02658890|451060371|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
125389530|NCT02658890|451060372|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
125389531|NCT02658890|451060373|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
125389532|NCT02658890|451060374|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
125389533|NCT02658890|451060375|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
125389534|NCT02658890|451060376|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
125389535|NCT02658890|451060377|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
125389536|NCT02658890|451060378|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
125389537|NCT02658890|451060379|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
125389538|NCT02658890|451060380|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
125389539|NCT02658890|451060381|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
125389540|NCT02658890|451060382|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
125389541|NCT02658890|451060383|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
125389542|NCT02658890|451060384|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
125389543|NCT02658890|451060385|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
125389544|NCT02658890|451060386|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
125389545|NCT02658890|451060387|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
125389546|NCT02658890|451060388|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
125389547|NCT02658890|451060389|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
125439430|NCT00514046|451235533|FG008|Overall Study|Disease progression on study|0|||
125439431|NCT00655551|451235534|FG000|All Periods Combined|Adverse Event|0|||
125389548|NCT02658890|451060390|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
125389549|NCT02658890|451060391|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
125389550|NCT02658890|451060392|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
125389551|NCT02658890|451060393|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
125389552|NCT02658890|451060394|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
125389553|NCT02658890|451060395|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
125389554|NCT02658890|451060369|FG000|Treatment Phase|Other Reasons|0|||
125160157|NCT01593696|450212974|FG002|Dose Escalation|Progressive Disease|0|||
125160158|NCT01593696|450212975|FG003|Dose Escalation|Progressive Disease|0|||
125160159|NCT01593696|450212972|FG000|Dose Expansion|Fungal infection|0|||
125160160|NCT01593696|450212973|FG001|Dose Expansion|Fungal infection|0|||
125160161|NCT01593696|450212974|FG002|Dose Expansion|Fungal infection|1|||
125160162|NCT01593696|450212975|FG003|Dose Expansion|Fungal infection|0|||
125160163|NCT01936623|450212978|FG000|Overall Study|Lost to Follow-up|0|||
125160164|NCT01936623|450212979|FG001|Overall Study|Lost to Follow-up|5|||
125160165|NCT03167723|450212980|FG000|Overall Study|Protocol Violation|4|||
125160166|NCT03167723|450212981|FG001|Overall Study|Protocol Violation|6|||
125160167|NCT01175811|450212983|FG000|Overall Study|Adverse Event|1|||
125160168|NCT01175811|450212984|FG001|Overall Study|Adverse Event|1|||
125160169|NCT01175811|450212983|FG000|Overall Study|Entry criteria not met|3|||
125160170|NCT01175811|450212984|FG001|Overall Study|Entry criteria not met|1|||
125160171|NCT01175811|450212983|FG000|Overall Study|Lack of Efficacy|1|||
125160172|NCT01175811|450212984|FG001|Overall Study|Lack of Efficacy|0|||
125160173|NCT01175811|450212983|FG000|Overall Study|Lost to Follow-up|3|||
125160174|NCT01175811|450212984|FG001|Overall Study|Lost to Follow-up|2|||
125160175|NCT01175811|450212983|FG000|Overall Study|Physician Decision|1|||
125160176|NCT01175811|450212984|FG001|Overall Study|Physician Decision|1|||
125160177|NCT01175811|450212983|FG000|Overall Study|Protocol Violation|1|||
125160178|NCT01175811|450212984|FG001|Overall Study|Protocol Violation|2|||
125160179|NCT01175811|450212983|FG000|Overall Study|Withdrawal by Subject|6|||
125160180|NCT01175811|450212984|FG001|Overall Study|Withdrawal by Subject|7|||
125160181|NCT03579966|450212985|FG000|Overall Study|Adverse Event|6|||
125160182|NCT03579966|450212985|FG000|Overall Study|Lost to Follow-up|4|||
125160183|NCT03579966|450212985|FG000|Overall Study|Physician Decision|10|||
125160184|NCT03579966|450212985|FG000|Overall Study|Pregnancy|1|||
125160185|NCT03579966|450212985|FG000|Overall Study|Withdrawal by Subject|16|||
125160186|NCT03579966|450212985|FG000|Overall Study|Study terminated by Sponsor|22|||
125160187|NCT03579966|450212985|FG000|Overall Study|Protocol Violation|1|||
125160188|NCT01340768|450212988|FG000|Overall Study|Lost to Follow-up|10|||
125160189|NCT01340768|450212989|FG001|Overall Study|Lost to Follow-up|4|||
125160190|NCT01340768|450212988|FG000|Overall Study|Withdrawal by Subject|5|||
125160191|NCT01340768|450212989|FG001|Overall Study|Withdrawal by Subject|1|||
125160192|NCT01340768|450212988|FG000|Overall Study|Other|2|||
125160193|NCT01340768|450212989|FG001|Overall Study|Other|0|||
125160194|NCT03052959|450212990|FG000|Overall Study|Lost to Follow-up|4|||
125160195|NCT03052959|450212991|FG001|Overall Study|Lost to Follow-up|5|||
125160196|NCT00950963|450212992|FG000|Overall Study|Lost to Follow-up|29|||
125160197|NCT00950963|450212993|FG001|Overall Study|Lost to Follow-up|24|||
125160198|NCT00848107|450212994|FG000|Overall Study|Lost to Follow-up|2|||
125160199|NCT00848107|450212994|FG000|Overall Study|Withdrawal by Subject|8|||
125160200|NCT00848107|450212994|FG000|Overall Study|Adverse Event|9|||
125160201|NCT00848107|450212994|FG000|Overall Study|Death|1|||
125160202|NCT00848107|450212994|FG000|Overall Study|Pregnancy|1|||
125160203|NCT00326963|450212995|FG000|Overall Study|Adverse Event|2|||
125160204|NCT00326963|450212995|FG000|Overall Study|Injection site reaction|1|||
125160205|NCT00326963|450212995|FG000|Overall Study|Death|1|||
125160206|NCT00326963|450212995|FG000|Overall Study|Failure to return|10|||
125160207|NCT00326963|450212995|FG000|Overall Study|Withdrawal by Subject|10|||
125160208|NCT00326963|450212995|FG000|Overall Study|Refused treatment / did not cooperate|5|||
125160209|NCT00326963|450212995|FG000|Overall Study|Violation of selection criteria at entry|2|||
125160210|NCT00326963|450212995|FG000|Overall Study|Other protocol violation|1|||
125160211|NCT00326963|450212995|FG000|Overall Study|Administrative / other|1|||
125160212|NCT00859586|450212996|FG000|Overall Study|Donors|4|||
125160213|NCT02992418|450212997|FG000|Overall Study|Withdrawal by Subject|11|||
125160214|NCT02992418|450212998|FG001|Overall Study|Withdrawal by Subject|12|||
125160215|NCT02992418|450212997|FG000|Overall Study|Non-compliance with the protocol|308|||
125160216|NCT02992418|450212998|FG001|Overall Study|Non-compliance with the protocol|308|||
125160217|NCT02992418|450212997|FG000|Overall Study|Lost to Follow-up|27|||
125160218|NCT02992418|450212998|FG001|Overall Study|Lost to Follow-up|22|||
125160219|NCT03246126|450213003|FG000|Overall Study|Withdrawal by Subject|0|||
125160220|NCT03246126|450213004|FG001|Overall Study|Withdrawal by Subject|1|||
125160221|NCT01006135|450213007|FG000|Overall Study|Adverse Event|22|||
125160222|NCT01006135|450213007|FG000|Overall Study|Protocol Violation|14|||
125160223|NCT01006135|450213007|FG000|Overall Study|Lost to Follow-up|32|||
125160224|NCT01006135|450213007|FG000|Overall Study|Other|72|||
125160225|NCT00928707|450213009|FG000|Overall Study|Protocol Violation|1|||
125160226|NCT00928707|450213010|FG001|Overall Study|Protocol Violation|0|||
125160227|NCT00132028|450213011|FG000|Overall Study|Adverse Event|7|||
125160228|NCT00132028|450213011|FG000|Overall Study|Death|2|||
125160229|NCT00132028|450213011|FG000|Overall Study|Lack of Efficacy|11|||
125160230|NCT00132028|450213011|FG000|Overall Study|Withdrawal by Subject|2|||
125160231|NCT00132028|450213011|FG000|Overall Study|not eligible|2|||
125160232|NCT00132028|450213011|FG000|Overall Study|Physician Decision|3|||
125160233|NCT02731326|450213017|FG000|Overall Study|Withdrawal by Subject|4|||
125160234|NCT02731326|450213018|FG001|Overall Study|Withdrawal by Subject|1|||
125160235|NCT02731326|450213017|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
125160236|NCT02731326|450213018|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
125160237|NCT02731326|450213017|FG000|Overall Study|Discharged without AliveCor|10|||
125160238|NCT02731326|450213018|FG001|Overall Study|Discharged without AliveCor|0|||
125160239|NCT02731326|450213017|FG000|Overall Study|Duplicate Participant|1|||
125160240|NCT02731326|450213018|FG001|Overall Study|Duplicate Participant|1|||
125160241|NCT00302081|450213020|FG000|Overall Study|Adverse Event|6|||
125160242|NCT00302081|450213021|FG001|Overall Study|Adverse Event|5|||
125160243|NCT00302081|450213022|FG002|Overall Study|Adverse Event|4|||
125389555|NCT02658890|451060370|FG001|Treatment Phase|Other Reasons|0|||
125389556|NCT02658890|451060371|FG002|Treatment Phase|Other Reasons|0|||
125389557|NCT02658890|451060372|FG003|Treatment Phase|Other Reasons|0|||
125389558|NCT02658890|451060373|FG004|Treatment Phase|Other Reasons|0|||
125389559|NCT02658890|451060374|FG005|Treatment Phase|Other Reasons|0|||
125389560|NCT02658890|451060375|FG006|Treatment Phase|Other Reasons|1|||
125389561|NCT02658890|451060376|FG007|Treatment Phase|Other Reasons|0|||
125389562|NCT02658890|451060377|FG008|Treatment Phase|Other Reasons|1|||
125389563|NCT02658890|451060378|FG009|Treatment Phase|Other Reasons|0|||
125389564|NCT02658890|451060379|FG010|Treatment Phase|Other Reasons|0|||
125389565|NCT02658890|451060380|FG011|Treatment Phase|Other Reasons|0|||
125389566|NCT02658890|451060381|FG012|Treatment Phase|Other Reasons|0|||
125389567|NCT02658890|451060382|FG013|Treatment Phase|Other Reasons|2|||
125389568|NCT02658890|451060383|FG014|Treatment Phase|Other Reasons|0|||
125389569|NCT02658890|451060384|FG015|Treatment Phase|Other Reasons|0|||
125389570|NCT02658890|451060385|FG016|Treatment Phase|Other Reasons|0|||
125389571|NCT02658890|451060386|FG017|Treatment Phase|Other Reasons|0|||
125389572|NCT02658890|451060387|FG018|Treatment Phase|Other Reasons|1|||
125389573|NCT02658890|451060388|FG019|Treatment Phase|Other Reasons|0|||
125389574|NCT02658890|451060389|FG020|Treatment Phase|Other Reasons|0|||
125389575|NCT02658890|451060390|FG021|Treatment Phase|Other Reasons|0|||
125389576|NCT02658890|451060391|FG022|Treatment Phase|Other Reasons|0|||
125389577|NCT02658890|451060392|FG023|Treatment Phase|Other Reasons|0|||
125389578|NCT02658890|451060393|FG024|Treatment Phase|Other Reasons|1|||
125389579|NCT02658890|451060394|FG025|Treatment Phase|Other Reasons|0|||
125389580|NCT02658890|451060395|FG026|Treatment Phase|Other Reasons|1|||
125389581|NCT02658890|451060369|FG000|Treatment Phase|Progressive Disease|6|||
125389582|NCT02658890|451060370|FG001|Treatment Phase|Progressive Disease|7|||
125389583|NCT02658890|451060371|FG002|Treatment Phase|Progressive Disease|6|||
125389584|NCT02658890|451060372|FG003|Treatment Phase|Progressive Disease|12|||
125389585|NCT02658890|451060373|FG004|Treatment Phase|Progressive Disease|6|||
125389586|NCT02658890|451060374|FG005|Treatment Phase|Progressive Disease|18|||
125389587|NCT02658890|451060375|FG006|Treatment Phase|Progressive Disease|12|||
125389588|NCT02658890|451060376|FG007|Treatment Phase|Progressive Disease|19|||
125389589|NCT02658890|451060377|FG008|Treatment Phase|Progressive Disease|26|||
125389590|NCT02658890|451060378|FG009|Treatment Phase|Progressive Disease|8|||
125389591|NCT02658890|451060379|FG010|Treatment Phase|Progressive Disease|7|||
125439432|NCT00655551|451235535|FG001|All Periods Combined|Adverse Event|3|||
125439433|NCT00655551|451235536|FG002|All Periods Combined|Adverse Event|4|||
125439434|NCT00655551|451235534|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
125439435|NCT00655551|451235535|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
125439436|NCT00655551|451235536|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
125439437|NCT00655551|451235534|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
125439438|NCT00655551|451235535|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
125439439|NCT00655551|451235536|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
125439440|NCT00655551|451235534|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
125439441|NCT00655551|451235535|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
125439442|NCT00655551|451235536|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
125439443|NCT00876460|451235538|FG000|Combination Therapy Phase|Progressive disease|2|||
125439444|NCT00876460|451235539|FG001|Combination Therapy Phase|Progressive disease|3|||
125439445|NCT00876460|451235540|FG002|Combination Therapy Phase|Progressive disease|3|||
125439446|NCT00876460|451235541|FG003|Combination Therapy Phase|Progressive disease|3|||
125439447|NCT00876460|451235542|FG004|Combination Therapy Phase|Progressive disease|3|||
125439448|NCT00876460|451235543|FG005|Combination Therapy Phase|Progressive disease|1|||
125160244|NCT00302081|450213020|FG000|Overall Study|Lost to Follow-up|21|||
125160245|NCT00302081|450213021|FG001|Overall Study|Lost to Follow-up|18|||
125389592|NCT02658890|451060380|FG011|Treatment Phase|Progressive Disease|9|||
125160246|NCT00302081|450213022|FG002|Overall Study|Lost to Follow-up|28|||
125389593|NCT02658890|451060381|FG012|Treatment Phase|Progressive Disease|8|||
125389594|NCT02658890|451060382|FG013|Treatment Phase|Progressive Disease|29|||
125389595|NCT02658890|451060383|FG014|Treatment Phase|Progressive Disease|6|||
125389596|NCT02658890|451060384|FG015|Treatment Phase|Progressive Disease|2|||
125389597|NCT02658890|451060385|FG016|Treatment Phase|Progressive Disease|32|||
125389598|NCT02658890|451060386|FG017|Treatment Phase|Progressive Disease|14|||
125389599|NCT02658890|451060387|FG018|Treatment Phase|Progressive Disease|40|||
125439449|NCT00876460|451235544|FG006|Combination Therapy Phase|Progressive disease|1|||
125439450|NCT00876460|451235545|FG007|Combination Therapy Phase|Progressive disease|1|||
125439451|NCT00876460|451235538|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
125160247|NCT00302081|450213020|FG000|Overall Study|Withdrawal by Subject|8|||
125160248|NCT00302081|450213021|FG001|Overall Study|Withdrawal by Subject|12|||
125160249|NCT00302081|450213022|FG002|Overall Study|Withdrawal by Subject|8|||
125160250|NCT00302081|450213020|FG000|Overall Study|Protocol Violation|5|||
125160251|NCT00302081|450213021|FG001|Overall Study|Protocol Violation|1|||
125160252|NCT00302081|450213022|FG002|Overall Study|Protocol Violation|2|||
125160253|NCT00302081|450213020|FG000|Overall Study|Lack of Efficacy|1|||
125160254|NCT00302081|450213021|FG001|Overall Study|Lack of Efficacy|0|||
125160255|NCT00302081|450213022|FG002|Overall Study|Lack of Efficacy|5|||
125160256|NCT00302081|450213020|FG000|Overall Study|Death|2|||
125160257|NCT00302081|450213021|FG001|Overall Study|Death|1|||
125160258|NCT00302081|450213022|FG002|Overall Study|Death|0|||
125389600|NCT02658890|451060388|FG019|Treatment Phase|Progressive Disease|32|||
125389601|NCT02658890|451060389|FG020|Treatment Phase|Progressive Disease|19|||
125389602|NCT02658890|451060390|FG021|Treatment Phase|Progressive Disease|30|||
125389603|NCT02658890|451060391|FG022|Treatment Phase|Progressive Disease|15|||
125389604|NCT02658890|451060392|FG023|Treatment Phase|Progressive Disease|0|||
125389605|NCT02658890|451060393|FG024|Treatment Phase|Progressive Disease|0|||
125389606|NCT02658890|451060394|FG025|Treatment Phase|Progressive Disease|14|||
125389607|NCT02658890|451060395|FG026|Treatment Phase|Progressive Disease|11|||
125389608|NCT02658890|451060369|FG000|Treatment Phase|Study Drug Toxicity|0|||
125389609|NCT02658890|451060370|FG001|Treatment Phase|Study Drug Toxicity|0|||
125389610|NCT02658890|451060371|FG002|Treatment Phase|Study Drug Toxicity|2|||
125389611|NCT02658890|451060372|FG003|Treatment Phase|Study Drug Toxicity|0|||
125389612|NCT02658890|451060373|FG004|Treatment Phase|Study Drug Toxicity|0|||
125389613|NCT02658890|451060374|FG005|Treatment Phase|Study Drug Toxicity|0|||
125389614|NCT02658890|451060375|FG006|Treatment Phase|Study Drug Toxicity|0|||
125389615|NCT02658890|451060376|FG007|Treatment Phase|Study Drug Toxicity|0|||
125389616|NCT02658890|451060377|FG008|Treatment Phase|Study Drug Toxicity|3|||
125389617|NCT02658890|451060378|FG009|Treatment Phase|Study Drug Toxicity|0|||
125389618|NCT02658890|451060379|FG010|Treatment Phase|Study Drug Toxicity|1|||
125389619|NCT02658890|451060380|FG011|Treatment Phase|Study Drug Toxicity|1|||
125389620|NCT02658890|451060381|FG012|Treatment Phase|Study Drug Toxicity|2|||
125389621|NCT02658890|451060382|FG013|Treatment Phase|Study Drug Toxicity|9|||
125389622|NCT02658890|451060383|FG014|Treatment Phase|Study Drug Toxicity|0|||
125389623|NCT02658890|451060384|FG015|Treatment Phase|Study Drug Toxicity|1|||
125389624|NCT02658890|451060385|FG016|Treatment Phase|Study Drug Toxicity|1|||
125389625|NCT02658890|451060386|FG017|Treatment Phase|Study Drug Toxicity|0|||
125389626|NCT02658890|451060387|FG018|Treatment Phase|Study Drug Toxicity|8|||
125389627|NCT02658890|451060388|FG019|Treatment Phase|Study Drug Toxicity|3|||
125389628|NCT02658890|451060389|FG020|Treatment Phase|Study Drug Toxicity|2|||
125389629|NCT02658890|451060390|FG021|Treatment Phase|Study Drug Toxicity|0|||
125389630|NCT02658890|451060391|FG022|Treatment Phase|Study Drug Toxicity|8|||
125389631|NCT02658890|451060392|FG023|Treatment Phase|Study Drug Toxicity|0|||
125389632|NCT02658890|451060393|FG024|Treatment Phase|Study Drug Toxicity|0|||
125389633|NCT02658890|451060394|FG025|Treatment Phase|Study Drug Toxicity|2|||
125389634|NCT02658890|451060395|FG026|Treatment Phase|Study Drug Toxicity|0|||
125389635|NCT02658890|451060369|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389636|NCT02658890|451060370|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389637|NCT02658890|451060371|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389638|NCT02658890|451060372|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
125389639|NCT02658890|451060373|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389640|NCT02658890|451060374|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389641|NCT02658890|451060375|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389642|NCT02658890|451060376|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389643|NCT02658890|451060377|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389644|NCT02658890|451060378|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
125389645|NCT02658890|451060379|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389646|NCT02658890|451060380|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125160259|NCT00302081|450213020|FG000|Overall Study|Other|13|||
125160260|NCT00302081|450213021|FG001|Overall Study|Other|6|||
125160261|NCT00302081|450213022|FG002|Overall Study|Other|5|||
125160262|NCT01616953|450213023|FG000|Overall Study|Lost to Follow-up|1|||
125160263|NCT01616953|450213024|FG001|Overall Study|Lost to Follow-up|0|||
125160264|NCT01616953|450213023|FG000|Overall Study|lack of bone and soft tissue|1|||
125160265|NCT01616953|450213024|FG001|Overall Study|lack of bone and soft tissue|0|||
125160266|NCT02500641|450213027|FG000|Overall Study|Adverse Event|0|||
125160267|NCT02500641|450213028|FG001|Overall Study|Adverse Event|2|||
125160268|NCT02500641|450213027|FG000|Overall Study|Withdrawal by Subject|4|||
125160269|NCT02500641|450213028|FG001|Overall Study|Withdrawal by Subject|5|||
125160270|NCT02500641|450213027|FG000|Overall Study|Unable to follow study procedures|3|||
125160271|NCT02500641|450213028|FG001|Overall Study|Unable to follow study procedures|2|||
125389647|NCT02658890|451060381|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125160272|NCT02500641|450213027|FG000|Overall Study|Protocol Violation|1|||
125160273|NCT02500641|450213028|FG001|Overall Study|Protocol Violation|2|||
125439452|NCT00876460|451235539|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
125439453|NCT00876460|451235540|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
125439454|NCT00876460|451235541|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
125439455|NCT00876460|451235542|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
125439456|NCT00876460|451235543|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
125439457|NCT00876460|451235544|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
125439458|NCT00876460|451235545|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
125160274|NCT02500641|450213027|FG000|Overall Study|Lost to Follow-up|1|||
125160275|NCT02500641|450213028|FG001|Overall Study|Lost to Follow-up|0|||
125160276|NCT02500641|450213027|FG000|Overall Study|Sponsor decision|1|||
125160277|NCT02500641|450213028|FG001|Overall Study|Sponsor decision|0|||
125160278|NCT02500641|450213027|FG000|Overall Study|Non compliance to study drug|0|||
125160279|NCT02500641|450213028|FG001|Overall Study|Non compliance to study drug|1|||
125160280|NCT00643565|450213030|FG000|Overall Study|Death|12|||
125160281|NCT00643565|450213031|FG001|Overall Study|Death|11|||
125160282|NCT00643565|450213030|FG000|Overall Study|Withdrawal by Subject|4|||
125160283|NCT00643565|450213031|FG001|Overall Study|Withdrawal by Subject|1|||
125160284|NCT00643565|450213030|FG000|Overall Study|Lost to Follow-up|0|||
125389648|NCT02658890|451060382|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389649|NCT02658890|451060383|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389650|NCT02658890|451060384|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389651|NCT02658890|451060385|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389652|NCT02658890|451060386|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389653|NCT02658890|451060387|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
125389654|NCT02658890|451060388|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389655|NCT02658890|451060389|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389656|NCT02658890|451060390|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389657|NCT02658890|451060391|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
125389658|NCT02658890|451060392|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389659|NCT02658890|451060393|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389660|NCT02658890|451060394|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389661|NCT02658890|451060395|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
125389662|NCT02658890|451060369|FG000|Treatment Phase|Withdrawal by Subject|0|||
125389663|NCT02658890|451060370|FG001|Treatment Phase|Withdrawal by Subject|1|||
125160285|NCT00643565|450213031|FG001|Overall Study|Lost to Follow-up|6|||
125160286|NCT00643565|450213030|FG000|Overall Study|Other|7|||
125160287|NCT00643565|450213031|FG001|Overall Study|Other|8|||
125160288|NCT00643565|450213030|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
125160289|NCT00643565|450213031|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
125160290|NCT00643565|450213030|FG000|Overall Study|Recurrence of Disease|2|||
125160291|NCT00643565|450213031|FG001|Overall Study|Recurrence of Disease|1|||
125160292|NCT00643565|450213030|FG000|Overall Study|Progression of Disease|18|||
125160293|NCT00643565|450213031|FG001|Overall Study|Progression of Disease|14|||
125160294|NCT00643565|450213030|FG000|Overall Study|Protocol Violation|3|||
125160295|NCT00643565|450213031|FG001|Overall Study|Protocol Violation|0|||
125160296|NCT00643565|450213030|FG000|Overall Study|Did Not Cooperate|0|||
125160297|NCT00643565|450213031|FG001|Overall Study|Did Not Cooperate|1|||
125160298|NCT00643565|450213030|FG000|Overall Study|Administrative|22|||
125160299|NCT00643565|450213031|FG001|Overall Study|Administrative|16|||
125160300|NCT00643565|450213030|FG000|Overall Study|Adverse Event|5|||
125160301|NCT00643565|450213031|FG001|Overall Study|Adverse Event|8|||
125160302|NCT02317614|450213032|FG000|Overall Study|Lost to Follow-up|1|||
125160303|NCT02317614|450213033|FG001|Overall Study|Lost to Follow-up|1|||
125160304|NCT02317614|450213032|FG000|Overall Study|Withdrawal by Subject|1|||
125160305|NCT02317614|450213033|FG001|Overall Study|Withdrawal by Subject|0|||
125160306|NCT02317614|450213032|FG000|Overall Study|Death|1|||
125160307|NCT02317614|450213033|FG001|Overall Study|Death|1|||
125160308|NCT01355159|450213034|FG000|Overall Study|Withdrew consent|39|||
125160309|NCT01355159|450213035|FG001|Overall Study|Withdrew consent|47|||
125160310|NCT01355159|450213034|FG000|Overall Study|No primary outcome data|17|||
125160311|NCT01355159|450213035|FG001|Overall Study|No primary outcome data|11|||
125160312|NCT01355159|450213034|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
125160313|NCT01355159|450213035|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
125160314|NCT01355159|450213034|FG000|Overall Study|Early intrauterine fetal death|6|||
125160315|NCT01355159|450213035|FG001|Overall Study|Early intrauterine fetal death|6|||
125160316|NCT04700280|450213036|FG000|Overall Study|Adverse Event|4|||
125160317|NCT04700280|450213037|FG001|Overall Study|Adverse Event|0|||
125160318|NCT04700280|450213036|FG000|Overall Study|Lack of Efficacy|1|||
125160319|NCT04700280|450213037|FG001|Overall Study|Lack of Efficacy|0|||
125160320|NCT04700280|450213036|FG000|Overall Study|Study terminated by sponsor|5|||
125160321|NCT04700280|450213037|FG001|Overall Study|Study terminated by sponsor|3|||
125160322|NCT04700280|450213036|FG000|Overall Study|Other than specified|1|||
125439459|NCT00876460|451235538|FG000|Combination Therapy Phase|Adverse Event|0|||
125439460|NCT00876460|451235539|FG001|Combination Therapy Phase|Adverse Event|2|||
125439461|NCT00876460|451235540|FG002|Combination Therapy Phase|Adverse Event|0|||
125439462|NCT00876460|451235541|FG003|Combination Therapy Phase|Adverse Event|2|||
125439463|NCT00876460|451235542|FG004|Combination Therapy Phase|Adverse Event|2|||
125439464|NCT00876460|451235543|FG005|Combination Therapy Phase|Adverse Event|0|||
125439465|NCT00876460|451235544|FG006|Combination Therapy Phase|Adverse Event|3|||
125439466|NCT00876460|451235545|FG007|Combination Therapy Phase|Adverse Event|2|||
125439467|NCT00876460|451235538|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
125439468|NCT00876460|451235539|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
125439469|NCT00876460|451235540|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
125439470|NCT00876460|451235541|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
125439471|NCT00876460|451235542|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
125439472|NCT00876460|451235543|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
125439473|NCT00876460|451235544|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
125439474|NCT00876460|451235545|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
125439475|NCT00876460|451235538|FG000|Combination Therapy Phase|Other reason not defined above|0|||
125439476|NCT00876460|451235539|FG001|Combination Therapy Phase|Other reason not defined above|0|||
125439477|NCT00876460|451235540|FG002|Combination Therapy Phase|Other reason not defined above|0|||
125439478|NCT00876460|451235541|FG003|Combination Therapy Phase|Other reason not defined above|0|||
125439479|NCT00876460|451235542|FG004|Combination Therapy Phase|Other reason not defined above|0|||
125439480|NCT00876460|451235543|FG005|Combination Therapy Phase|Other reason not defined above|0|||
125439481|NCT00876460|451235544|FG006|Combination Therapy Phase|Other reason not defined above|1|||
125439482|NCT00876460|451235545|FG007|Combination Therapy Phase|Other reason not defined above|2|||
125439483|NCT00876460|451235538|FG000|Combination Therapy Phase|Not treated|0|||
125439484|NCT00876460|451235539|FG001|Combination Therapy Phase|Not treated|0|||
125439485|NCT00876460|451235540|FG002|Combination Therapy Phase|Not treated|0|||
125439486|NCT00876460|451235541|FG003|Combination Therapy Phase|Not treated|0|||
125439487|NCT00876460|451235542|FG004|Combination Therapy Phase|Not treated|0|||
125439488|NCT00876460|451235543|FG005|Combination Therapy Phase|Not treated|0|||
125439489|NCT00876460|451235544|FG006|Combination Therapy Phase|Not treated|1|||
125439490|NCT00876460|451235545|FG007|Combination Therapy Phase|Not treated|0|||
125439491|NCT00876460|451235538|FG000|Mono Therapy Phase|Progressive disease|0|||
125439492|NCT00876460|451235539|FG001|Mono Therapy Phase|Progressive disease|0|||
125439493|NCT00876460|451235540|FG002|Mono Therapy Phase|Progressive disease|0|||
125439494|NCT00876460|451235541|FG003|Mono Therapy Phase|Progressive disease|0|||
125439495|NCT00876460|451235542|FG004|Mono Therapy Phase|Progressive disease|2|||
125439496|NCT00876460|451235543|FG005|Mono Therapy Phase|Progressive disease|0|||
125439497|NCT00876460|451235544|FG006|Mono Therapy Phase|Progressive disease|1|||
125439498|NCT00876460|451235545|FG007|Mono Therapy Phase|Progressive disease|3|||
125439499|NCT00876460|451235538|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
125439500|NCT00876460|451235539|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
125439501|NCT00876460|451235540|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
125439502|NCT00876460|451235541|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
125160323|NCT04700280|450213037|FG001|Overall Study|Other than specified|0|||
125160324|NCT00741936|450213041|FG000|Overall Study|Lost to Follow-up|1|||
125160325|NCT00741936|450213042|FG001|Overall Study|Lost to Follow-up|1|||
125160326|NCT00741936|450213041|FG000|Overall Study|Adverse Event|3|||
125160327|NCT00741936|450213042|FG001|Overall Study|Adverse Event|4|||
125160328|NCT00741936|450213041|FG000|Overall Study|Pregnancy|0|||
125160329|NCT00741936|450213042|FG001|Overall Study|Pregnancy|1|||
125160330|NCT00741936|450213041|FG000|Overall Study|Protocol Violation|2|||
125160331|NCT00741936|450213042|FG001|Overall Study|Protocol Violation|0|||
125160332|NCT00741936|450213041|FG000|Overall Study|Lack of Efficacy|0|||
125160333|NCT00741936|450213042|FG001|Overall Study|Lack of Efficacy|2|||
125160334|NCT00741936|450213041|FG000|Overall Study|Low compliance|3|||
125160335|NCT00741936|450213042|FG001|Overall Study|Low compliance|0|||
125160336|NCT02450526|450213043|FG000|DB Period (Cycle 1)|Adverse Event|0|||
125160337|NCT02450526|450213044|FG001|DB Period (Cycle 1)|Adverse Event|0|||
125160338|NCT02450526|450213045|FG002|DB Period (Cycle 1)|Adverse Event|2|||
125160339|NCT02450526|450213046|FG003|DB Period (Cycle 1)|Adverse Event|0|||
125160340|NCT02450526|450213047|FG004|DB Period (Cycle 1)|Adverse Event|0|||
125160341|NCT02450526|450213043|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
125160342|NCT02450526|450213044|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
125160343|NCT02450526|450213045|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
125160344|NCT02450526|450213046|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
125160345|NCT02450526|450213047|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
125160346|NCT02450526|450213043|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
125160347|NCT02450526|450213044|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
125160348|NCT02450526|450213045|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
125160349|NCT02450526|450213046|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
125439503|NCT00876460|451235542|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
125160350|NCT02450526|450213047|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
125160351|NCT02450526|450213043|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
125160352|NCT02450526|450213044|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
125439504|NCT00876460|451235543|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
125224201|NCT03713684|450448094|FG003|Overall Study|Poor compliance to protocol|1|||
125224202|NCT03713684|450448091|FG000|Overall Study|Withdrawal by Subject|14|||
125389664|NCT02658890|451060371|FG002|Treatment Phase|Withdrawal by Subject|0|||
125389665|NCT02658890|451060372|FG003|Treatment Phase|Withdrawal by Subject|0|||
125389666|NCT02658890|451060373|FG004|Treatment Phase|Withdrawal by Subject|0|||
125389667|NCT02658890|451060374|FG005|Treatment Phase|Withdrawal by Subject|0|||
125389668|NCT02658890|451060375|FG006|Treatment Phase|Withdrawal by Subject|1|||
125389669|NCT02658890|451060376|FG007|Treatment Phase|Withdrawal by Subject|0|||
125389670|NCT02658890|451060377|FG008|Treatment Phase|Withdrawal by Subject|0|||
125389671|NCT02658890|451060378|FG009|Treatment Phase|Withdrawal by Subject|1|||
125389672|NCT02658890|451060379|FG010|Treatment Phase|Withdrawal by Subject|0|||
125389673|NCT02658890|451060380|FG011|Treatment Phase|Withdrawal by Subject|0|||
125389674|NCT02658890|451060381|FG012|Treatment Phase|Withdrawal by Subject|1|||
125389675|NCT02658890|451060382|FG013|Treatment Phase|Withdrawal by Subject|3|||
125389676|NCT02658890|451060383|FG014|Treatment Phase|Withdrawal by Subject|0|||
125389677|NCT02658890|451060384|FG015|Treatment Phase|Withdrawal by Subject|0|||
125389678|NCT02658890|451060385|FG016|Treatment Phase|Withdrawal by Subject|1|||
125389679|NCT02658890|451060386|FG017|Treatment Phase|Withdrawal by Subject|0|||
125389680|NCT02658890|451060387|FG018|Treatment Phase|Withdrawal by Subject|4|||
125389681|NCT02658890|451060388|FG019|Treatment Phase|Withdrawal by Subject|3|||
125389682|NCT02658890|451060389|FG020|Treatment Phase|Withdrawal by Subject|0|||
125389683|NCT02658890|451060390|FG021|Treatment Phase|Withdrawal by Subject|4|||
125389684|NCT02658890|451060391|FG022|Treatment Phase|Withdrawal by Subject|1|||
125389685|NCT02658890|451060392|FG023|Treatment Phase|Withdrawal by Subject|1|||
125389686|NCT02658890|451060393|FG024|Treatment Phase|Withdrawal by Subject|0|||
125389687|NCT02658890|451060394|FG025|Treatment Phase|Withdrawal by Subject|0|||
125389688|NCT02658890|451060395|FG026|Treatment Phase|Withdrawal by Subject|0|||
125389689|NCT02474199|451060396|FG000|Overall Study|Lost to Follow-up|1|||
125389690|NCT02474199|451060397|FG001|Overall Study|Lost to Follow-up|0|||
125389691|NCT02474199|451060398|FG002|Overall Study|Lost to Follow-up|0|||
125389692|NCT02474199|451060399|FG003|Overall Study|Lost to Follow-up|0|||
125389693|NCT02474199|451060396|FG000|Overall Study|Withdrawal by Subject|1|||
125389694|NCT02474199|451060397|FG001|Overall Study|Withdrawal by Subject|2|||
125389695|NCT02474199|451060398|FG002|Overall Study|Withdrawal by Subject|0|||
125389696|NCT02474199|451060399|FG003|Overall Study|Withdrawal by Subject|1|||
125389697|NCT02474199|451060396|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
125389698|NCT02474199|451060397|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
125389699|NCT02474199|451060398|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
125389700|NCT02474199|451060399|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
125389701|NCT02474199|451060396|FG000|Overall Study|Did not meet eligibility criteria|0|||
125389702|NCT02474199|451060397|FG001|Overall Study|Did not meet eligibility criteria|0|||
125389703|NCT02474199|451060398|FG002|Overall Study|Did not meet eligibility criteria|2|||
125389704|NCT02474199|451060399|FG003|Overall Study|Did not meet eligibility criteria|2|||
125389705|NCT00952341|451060400|FG000|Cycle 1|Adverse Event|4|||
125389706|NCT00952341|451060401|FG001|Cycle 1|Adverse Event|1|||
125389707|NCT00952341|451060400|FG000|Cycle 1|Withdrawal by Subject|3|||
125389708|NCT00952341|451060401|FG001|Cycle 1|Withdrawal by Subject|8|||
125389709|NCT00952341|451060400|FG000|Cycle 1|Protocol Violation|2|||
125389710|NCT00952341|451060401|FG001|Cycle 1|Protocol Violation|1|||
125389711|NCT00952341|451060400|FG000|Cycle 1|Lost to Follow-up|11|||
125389712|NCT00952341|451060401|FG001|Cycle 1|Lost to Follow-up|2|||
125389713|NCT00952341|451060400|FG000|Cycle 1|Physician Decision|0|||
125389714|NCT00952341|451060401|FG001|Cycle 1|Physician Decision|1|||
125389715|NCT00952341|451060400|FG000|Cycle 2|Withdrawal by Subject|1|||
125389716|NCT00952341|451060401|FG001|Cycle 2|Withdrawal by Subject|1|||
125389717|NCT00952341|451060400|FG000|Cycle 2|Protocol Violation|1|||
125389718|NCT00952341|451060401|FG001|Cycle 2|Protocol Violation|0|||
125389719|NCT00952341|451060400|FG000|Cycle 2|Lost to Follow-up|6|||
125389720|NCT00952341|451060401|FG001|Cycle 2|Lost to Follow-up|9|||
125389721|NCT00952341|451060400|FG000|Cycle 2|Physician Decision|1|||
125389722|NCT00952341|451060401|FG001|Cycle 2|Physician Decision|1|||
125389723|NCT00952341|451060400|FG000|Cycle 2|Progressive Disease|0|||
125389724|NCT00952341|451060401|FG001|Cycle 2|Progressive Disease|1|||
125389725|NCT03253848|451060404|FG000|Overall Study|Adverse Event|7|||
125389726|NCT03253848|451060404|FG000|Overall Study|Death|5|||
125389727|NCT03253848|451060404|FG000|Overall Study|initiation of other treatments|3|||
125389728|NCT03253848|451060404|FG000|Overall Study|Other complicating disease|1|||
125389729|NCT03253848|451060404|FG000|Overall Study|Withdrawal by Subject|1|||
125389730|NCT03253848|451060404|FG000|Overall Study|Declining health|1|||
125389731|NCT05352815|451060405|FG000|Overall Study|Withdrawal by Subject|28|||
125389732|NCT05352815|451060406|FG001|Overall Study|Withdrawal by Subject|24|||
125389733|NCT05352815|451060405|FG000|Overall Study|Lost to Follow-up|4|||
125389734|NCT05352815|451060406|FG001|Overall Study|Lost to Follow-up|7|||
125389735|NCT05352815|451060405|FG000|Overall Study|Death|2|||
125389736|NCT05352815|451060406|FG001|Overall Study|Death|3|||
125389737|NCT05352815|451060405|FG000|Overall Study|Site closure|1|||
125389738|NCT05352815|451060406|FG001|Overall Study|Site closure|0|||
125224203|NCT03713684|450448092|FG001|Overall Study|Withdrawal by Subject|6|||
125224204|NCT03713684|450448093|FG002|Overall Study|Withdrawal by Subject|14|||
125160353|NCT02450526|450213045|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
125160354|NCT02450526|450213046|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
125160355|NCT02450526|450213047|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
125160356|NCT02450526|450213043|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
125160357|NCT02450526|450213044|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
125160358|NCT02450526|450213045|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
125160359|NCT02450526|450213046|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
125160360|NCT02450526|450213047|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
125160361|NCT02450526|450213043|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
125160362|NCT02450526|450213044|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
125160363|NCT02450526|450213045|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
125160364|NCT02450526|450213046|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
125160365|NCT02450526|450213047|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
125160366|NCT02450526|450213043|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
125160367|NCT02450526|450213044|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
125160368|NCT02450526|450213045|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
125160369|NCT02450526|450213046|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
125160370|NCT02450526|450213047|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
125160371|NCT02450526|450213043|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
125160372|NCT02450526|450213044|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
125160373|NCT02450526|450213045|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
125160374|NCT02450526|450213046|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
125160375|NCT02450526|450213047|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
125160376|NCT01970865|450213048|FG000|Overall Study|Death|3|||
125160377|NCT01970865|450213049|FG001|Overall Study|Death|2|||
125160378|NCT01970865|450213050|FG002|Overall Study|Death|3|||
125160379|NCT01970865|450213051|FG003|Overall Study|Death|6|||
125160380|NCT01970865|450213052|FG004|Overall Study|Death|9|||
125160381|NCT01970865|450213053|FG005|Overall Study|Death|3|||
125160382|NCT01970865|450213054|FG006|Overall Study|Death|2|||
125160383|NCT01970865|450213055|FG007|Overall Study|Death|3|||
125160384|NCT01970865|450213056|FG008|Overall Study|Death|2|||
125160385|NCT01970865|450213057|FG009|Overall Study|Death|2|||
125160386|NCT01970865|450213058|FG010|Overall Study|Death|8|||
125160387|NCT01970865|450213059|FG011|Overall Study|Death|13|||
125160388|NCT01970865|450213060|FG012|Overall Study|Death|25|||
125160389|NCT01970865|450213061|FG013|Overall Study|Death|46|||
125160390|NCT01970865|450213062|FG014|Overall Study|Death|37|||
125160391|NCT01970865|450213063|FG015|Overall Study|Death|22|||
125160392|NCT01970865|450213064|FG016|Overall Study|Death|1|||
125160393|NCT01970865|450213065|FG017|Overall Study|Death|17|||
125160394|NCT01970865|450213048|FG000|Overall Study|Lost to Follow-up|0|||
125160395|NCT01970865|450213049|FG001|Overall Study|Lost to Follow-up|0|||
125160396|NCT01970865|450213050|FG002|Overall Study|Lost to Follow-up|0|||
125160397|NCT01970865|450213051|FG003|Overall Study|Lost to Follow-up|1|||
125160398|NCT01970865|450213052|FG004|Overall Study|Lost to Follow-up|1|||
125160399|NCT01970865|450213053|FG005|Overall Study|Lost to Follow-up|0|||
125160400|NCT01970865|450213054|FG006|Overall Study|Lost to Follow-up|0|||
125160401|NCT01970865|450213055|FG007|Overall Study|Lost to Follow-up|0|||
125160402|NCT01970865|450213056|FG008|Overall Study|Lost to Follow-up|0|||
125160403|NCT01970865|450213057|FG009|Overall Study|Lost to Follow-up|0|||
125160404|NCT01970865|450213058|FG010|Overall Study|Lost to Follow-up|1|||
125160405|NCT01970865|450213059|FG011|Overall Study|Lost to Follow-up|0|||
125160406|NCT01970865|450213060|FG012|Overall Study|Lost to Follow-up|2|||
125160407|NCT01970865|450213061|FG013|Overall Study|Lost to Follow-up|0|||
125160408|NCT01970865|450213062|FG014|Overall Study|Lost to Follow-up|1|||
125160409|NCT01970865|450213063|FG015|Overall Study|Lost to Follow-up|4|||
125160410|NCT01970865|450213064|FG016|Overall Study|Lost to Follow-up|0|||
125160411|NCT01970865|450213065|FG017|Overall Study|Lost to Follow-up|1|||
125160412|NCT01970865|450213048|FG000|Overall Study|Other|0|||
125160413|NCT01970865|450213049|FG001|Overall Study|Other|1|||
125160414|NCT01970865|450213050|FG002|Overall Study|Other|0|||
125160415|NCT01970865|450213051|FG003|Overall Study|Other|1|||
125160416|NCT01970865|450213052|FG004|Overall Study|Other|1|||
125160417|NCT01970865|450213053|FG005|Overall Study|Other|0|||
125160418|NCT01970865|450213054|FG006|Overall Study|Other|1|||
125160419|NCT01970865|450213055|FG007|Overall Study|Other|0|||
125160420|NCT01970865|450213056|FG008|Overall Study|Other|0|||
125160421|NCT01970865|450213057|FG009|Overall Study|Other|0|||
125160422|NCT01970865|450213058|FG010|Overall Study|Other|2|||
125224205|NCT03713684|450448094|FG003|Overall Study|Withdrawal by Subject|16|||
125160423|NCT01970865|450213059|FG011|Overall Study|Other|3|||
125160424|NCT01970865|450213060|FG012|Overall Study|Other|8|||
125160425|NCT01970865|450213061|FG013|Overall Study|Other|3|||
125160426|NCT01970865|450213062|FG014|Overall Study|Other|2|||
125160427|NCT01970865|450213063|FG015|Overall Study|Other|3|||
125160428|NCT01970865|450213064|FG016|Overall Study|Other|0|||
125160429|NCT01970865|450213065|FG017|Overall Study|Other|2|||
125160430|NCT01970865|450213048|FG000|Overall Study|Participant refused further follow-up|0|||
125439505|NCT00876460|451235544|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
125439506|NCT00876460|451235545|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
125439507|NCT00876460|451235538|FG000|Mono Therapy Phase|Adverse Event|0|||
125439508|NCT00876460|451235539|FG001|Mono Therapy Phase|Adverse Event|0|||
125439509|NCT00876460|451235540|FG002|Mono Therapy Phase|Adverse Event|0|||
125439510|NCT00876460|451235541|FG003|Mono Therapy Phase|Adverse Event|1|||
125439511|NCT00876460|451235542|FG004|Mono Therapy Phase|Adverse Event|0|||
125439512|NCT00876460|451235543|FG005|Mono Therapy Phase|Adverse Event|0|||
125439513|NCT00876460|451235544|FG006|Mono Therapy Phase|Adverse Event|0|||
125439514|NCT00876460|451235545|FG007|Mono Therapy Phase|Adverse Event|0|||
125439515|NCT01051063|451235548|FG000|Overall Study|Death|2|||
125439516|NCT01051063|451235549|FG001|Overall Study|Death|2|||
125439517|NCT01051063|451235548|FG000|Overall Study|Withdrawal by Subject|1|||
125439518|NCT01051063|451235549|FG001|Overall Study|Withdrawal by Subject|1|||
125439519|NCT01051063|451235548|FG000|Overall Study|Termination of the study|5|||
125439520|NCT01051063|451235549|FG001|Overall Study|Termination of the study|0|||
125439521|NCT01051063|451235548|FG000|Overall Study|Moved from the study site area|1|||
125439522|NCT01051063|451235549|FG001|Overall Study|Moved from the study site area|0|||
125439523|NCT01051063|451235548|FG000|Overall Study|Other|1|||
125439524|NCT01051063|451235549|FG001|Overall Study|Other|0|||
125439525|NCT01051063|451235548|FG000|Overall Study|Lost to Follow-up|0|||
125439526|NCT01051063|451235549|FG001|Overall Study|Lost to Follow-up|1|||
125439527|NCT03857841|451235551|FG000|Overall Study|Death|1|||
125439528|NCT03857841|451235552|FG001|Overall Study|Death|0|||
125439529|NCT03857841|451235553|FG002|Overall Study|Death|0|||
125439530|NCT03857841|451235554|FG003|Overall Study|Death|0|||
125439531|NCT03857841|451235551|FG000|Overall Study|Study Terminated by Sponsor|1|||
125439532|NCT03857841|451235552|FG001|Overall Study|Study Terminated by Sponsor|0|||
125160431|NCT01970865|450213049|FG001|Overall Study|Participant refused further follow-up|0|||
125160432|NCT01970865|450213050|FG002|Overall Study|Participant refused further follow-up|0|||
125160433|NCT01970865|450213051|FG003|Overall Study|Participant refused further follow-up|2|||
125160434|NCT01970865|450213052|FG004|Overall Study|Participant refused further follow-up|3|||
125160435|NCT01970865|450213053|FG005|Overall Study|Participant refused further follow-up|0|||
125160436|NCT01970865|450213054|FG006|Overall Study|Participant refused further follow-up|0|||
125160437|NCT01970865|450213055|FG007|Overall Study|Participant refused further follow-up|0|||
125160438|NCT01970865|450213056|FG008|Overall Study|Participant refused further follow-up|0|||
125160439|NCT01970865|450213057|FG009|Overall Study|Participant refused further follow-up|0|||
125160440|NCT01970865|450213058|FG010|Overall Study|Participant refused further follow-up|1|||
125160441|NCT01970865|450213059|FG011|Overall Study|Participant refused further follow-up|4|||
125160442|NCT01970865|450213060|FG012|Overall Study|Participant refused further follow-up|7|||
125160443|NCT01970865|450213061|FG013|Overall Study|Participant refused further follow-up|8|||
125160444|NCT01970865|450213062|FG014|Overall Study|Participant refused further follow-up|3|||
125160445|NCT01970865|450213063|FG015|Overall Study|Participant refused further follow-up|11|||
125160446|NCT01970865|450213064|FG016|Overall Study|Participant refused further follow-up|0|||
125160447|NCT01970865|450213065|FG017|Overall Study|Participant refused further follow-up|6|||
125160448|NCT01855074|450213068|FG000|Overall Study|Adverse Event|1|||
125160449|NCT01855074|450213068|FG000|Overall Study|Lost to Follow-up|4|||
125160450|NCT01855074|450213068|FG000|Overall Study|Withdrawal by Subject|8|||
125160451|NCT01855074|450213068|FG000|Overall Study|Started but not treated|1|||
125160452|NCT01150890|450213069|FG000|Overall Study|Other|0|||
125160453|NCT01150890|450213070|FG001|Overall Study|Other|1|||
125160454|NCT01150890|450213071|FG002|Overall Study|Other|0|||
125160455|NCT01150890|450213072|FG003|Overall Study|Other|2|||
125160456|NCT01150890|450213069|FG000|Overall Study|Pregnancy|0|||
125439533|NCT03857841|451235553|FG002|Overall Study|Study Terminated by Sponsor|0|||
125439534|NCT03857841|451235554|FG003|Overall Study|Study Terminated by Sponsor|0|||
125439535|NCT01242176|451237479|FG000|Washout Period of 7 Days|Adverse Event|0|||
125160457|NCT01150890|450213070|FG001|Overall Study|Pregnancy|0|||
125160458|NCT01150890|450213071|FG002|Overall Study|Pregnancy|0|||
125160459|NCT01150890|450213072|FG003|Overall Study|Pregnancy|1|||
125160460|NCT01150890|450213069|FG000|Overall Study|Administrative Decision|4|||
125160461|NCT01150890|450213070|FG001|Overall Study|Administrative Decision|4|||
125160462|NCT01150890|450213071|FG002|Overall Study|Administrative Decision|5|||
125160463|NCT01150890|450213072|FG003|Overall Study|Administrative Decision|6|||
125160464|NCT01150890|450213069|FG000|Overall Study|Ineligibility determined|0|||
125160465|NCT01150890|450213070|FG001|Overall Study|Ineligibility determined|1|||
125160466|NCT01150890|450213071|FG002|Overall Study|Ineligibility determined|0|||
125160467|NCT01150890|450213072|FG003|Overall Study|Ineligibility determined|0|||
125160468|NCT01150890|450213069|FG000|Overall Study|Adverse Event|0|||
125439536|NCT01242176|451237480|FG001|Washout Period of 7 Days|Adverse Event|2|||
125439537|NCT01242176|451237479|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
125160469|NCT01150890|450213070|FG001|Overall Study|Adverse Event|0|||
125160470|NCT01150890|450213071|FG002|Overall Study|Adverse Event|2|||
125439538|NCT01242176|451237480|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
125439539|NCT01683994|451237483|FG000|Overall Study|Withdrawal by Subject|1|||
125439540|NCT01683994|451237484|FG001|Overall Study|Withdrawal by Subject|0|||
125160471|NCT01150890|450213072|FG003|Overall Study|Adverse Event|0|||
125389739|NCT02759120|451060407|FG000|Overall Study|Death|34|||
125389740|NCT02759120|451060408|FG001|Overall Study|Death|36|||
125389741|NCT02759120|451060407|FG000|Overall Study|Lost to Follow-up|4|||
125389742|NCT02759120|451060408|FG001|Overall Study|Lost to Follow-up|7|||
125389743|NCT02759120|451060407|FG000|Overall Study|Physician Decision|3|||
125389744|NCT02759120|451060408|FG001|Overall Study|Physician Decision|0|||
125389745|NCT02759120|451060407|FG000|Overall Study|Withdrawal by Subject|28|||
125389746|NCT02759120|451060408|FG001|Overall Study|Withdrawal by Subject|15|||
125389747|NCT02759120|451060407|FG000|Overall Study|Moved out of area|3|||
125389748|NCT02759120|451060408|FG001|Overall Study|Moved out of area|4|||
125389749|NCT02759120|451060407|FG000|Overall Study|Lung transplant|3|||
125389750|NCT02759120|451060408|FG001|Overall Study|Lung transplant|5|||
125389751|NCT02759120|451060407|FG000|Overall Study|Other reason not completed|10|||
125160472|NCT01150890|450213069|FG000|Overall Study|Withdrawal by Subject|0|||
125160473|NCT01150890|450213070|FG001|Overall Study|Withdrawal by Subject|0|||
125160474|NCT01150890|450213071|FG002|Overall Study|Withdrawal by Subject|2|||
125160475|NCT01150890|450213072|FG003|Overall Study|Withdrawal by Subject|1|||
125160476|NCT01150890|450213069|FG000|Overall Study|Disease progression|0|||
125160477|NCT01150890|450213070|FG001|Overall Study|Disease progression|7|||
125160478|NCT01150890|450213071|FG002|Overall Study|Disease progression|3|||
125160479|NCT01150890|450213072|FG003|Overall Study|Disease progression|7|||
125160480|NCT03071094|450213076|FG000|Overall Study|Death|1|||
125160481|NCT03071094|450213077|FG001|Overall Study|Death|1|||
125160482|NCT03071094|450213076|FG000|Overall Study|Adverse Event|1|||
125160483|NCT03071094|450213077|FG001|Overall Study|Adverse Event|0|||
125160484|NCT02312063|450213078|FG000|Overall Study|Withdrawal by Subject|0|||
125160485|NCT02312063|450213079|FG001|Overall Study|Withdrawal by Subject|1|||
125160486|NCT01079832|450213080|FG000|Overall Study|Withdrawal by Subject|1|||
125160487|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
125160488|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
125160489|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160490|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160491|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160492|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160493|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160494|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160495|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160496|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160497|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160498|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160499|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160500|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
125160501|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
125160502|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
125160503|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160504|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160505|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160506|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160507|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160508|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160509|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160510|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160511|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160512|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160513|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160514|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
125160515|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
125160516|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
125160517|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160518|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160519|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160520|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125224206|NCT03713684|450448091|FG000|Overall Study|Other than specified|69|||
125224207|NCT03713684|450448092|FG001|Overall Study|Other than specified|77|||
125389752|NCT02759120|451060408|FG001|Overall Study|Other reason not completed|12|||
125389753|NCT04461015|451060410|FG000|Overall Study|IV access lost during the study|0|||
125389754|NCT04461015|451060411|FG001|Overall Study|IV access lost during the study|1|||
125389755|NCT04461015|451060410|FG000|Overall Study|Withdrawal by Subject|0|||
125389756|NCT04461015|451060411|FG001|Overall Study|Withdrawal by Subject|1|||
125389757|NCT05071183|451060418|FG000|Overall Study|Death|1|||
125389758|NCT05071183|451060419|FG001|Overall Study|Death|2|||
125439541|NCT01683994|451237485|FG002|Overall Study|Withdrawal by Subject|0|||
125439542|NCT01683994|451237486|FG003|Overall Study|Withdrawal by Subject|1|||
125439543|NCT01683994|451237487|FG004|Overall Study|Withdrawal by Subject|0|||
125439544|NCT01683994|451237483|FG000|Overall Study|Intercurrent illness|0|||
125439545|NCT01683994|451237484|FG001|Overall Study|Intercurrent illness|0|||
125439546|NCT01683994|451237485|FG002|Overall Study|Intercurrent illness|0|||
125439547|NCT01683994|451237486|FG003|Overall Study|Intercurrent illness|2|||
125439548|NCT01683994|451237487|FG004|Overall Study|Intercurrent illness|1|||
125439549|NCT00806624|451237488|FG000|Overall Study|Adverse Event|2|||
125439550|NCT00806624|451237489|FG001|Overall Study|Adverse Event|8|||
125439551|NCT00806624|451237490|FG002|Overall Study|Adverse Event|0|||
125439552|NCT00806624|451237488|FG000|Overall Study|Death|0|||
125439553|NCT00806624|451237489|FG001|Overall Study|Death|1|||
125439554|NCT00806624|451237490|FG002|Overall Study|Death|1|||
125439555|NCT00806624|451237488|FG000|Overall Study|Lost to Follow-up|1|||
125439556|NCT00806624|451237489|FG001|Overall Study|Lost to Follow-up|0|||
125439557|NCT00806624|451237490|FG002|Overall Study|Lost to Follow-up|1|||
125439558|NCT00806624|451237488|FG000|Overall Study|Withdrawal by Subject|6|||
125439559|NCT00806624|451237489|FG001|Overall Study|Withdrawal by Subject|3|||
125439560|NCT00806624|451237490|FG002|Overall Study|Withdrawal by Subject|3|||
125439561|NCT00806624|451237488|FG000|Overall Study|discontinued before start of treatment|0|||
125439562|NCT00806624|451237489|FG001|Overall Study|discontinued before start of treatment|0|||
125439563|NCT00806624|451237490|FG002|Overall Study|discontinued before start of treatment|1|||
125439564|NCT01987596|451237497|FG000|Overall Study|Physician Decision|1|||
125439565|NCT01987596|451237498|FG001|Overall Study|Physician Decision|0|||
125439566|NCT01987596|451237497|FG000|Overall Study|Progressive Disease; missing all period|0|||
125439567|NCT01987596|451237498|FG001|Overall Study|Progressive Disease; missing all period|1|||
125439568|NCT01533714|451237500|FG000|Overall Study|Adverse Event|0|||
125439569|NCT01533714|451237501|FG001|Overall Study|Adverse Event|1|||
125439570|NCT01533714|451237502|FG002|Overall Study|Adverse Event|2|||
125439571|NCT01533714|451237503|FG003|Overall Study|Adverse Event|2|||
125439572|NCT01533714|451237504|FG004|Overall Study|Adverse Event|2|||
125439573|NCT01533714|451237505|FG005|Overall Study|Adverse Event|1|||
125439574|NCT01533714|451237500|FG000|Overall Study|Lack of Efficacy|0|||
125439575|NCT01533714|451237501|FG001|Overall Study|Lack of Efficacy|0|||
125439576|NCT01533714|451237502|FG002|Overall Study|Lack of Efficacy|0|||
125439577|NCT01533714|451237503|FG003|Overall Study|Lack of Efficacy|0|||
125439578|NCT01533714|451237504|FG004|Overall Study|Lack of Efficacy|0|||
125439579|NCT01533714|451237505|FG005|Overall Study|Lack of Efficacy|1|||
125439580|NCT01533714|451237500|FG000|Overall Study|Withdrawal by Subject|0|||
125439581|NCT01533714|451237501|FG001|Overall Study|Withdrawal by Subject|1|||
125439582|NCT01533714|451237502|FG002|Overall Study|Withdrawal by Subject|0|||
125439583|NCT01533714|451237503|FG003|Overall Study|Withdrawal by Subject|1|||
125439584|NCT01533714|451237504|FG004|Overall Study|Withdrawal by Subject|1|||
125439585|NCT01533714|451237505|FG005|Overall Study|Withdrawal by Subject|0|||
125439586|NCT01533714|451237500|FG000|Overall Study|Exclusion criteria|0|||
125439587|NCT01533714|451237501|FG001|Overall Study|Exclusion criteria|1|||
125439588|NCT01533714|451237502|FG002|Overall Study|Exclusion criteria|0|||
125439589|NCT01533714|451237503|FG003|Overall Study|Exclusion criteria|0|||
125439590|NCT01533714|451237504|FG004|Overall Study|Exclusion criteria|0|||
125439591|NCT01533714|451237505|FG005|Overall Study|Exclusion criteria|0|||
125439592|NCT01533714|451237500|FG000|Overall Study|Positive for purified protein derivative|0|||
125439593|NCT01533714|451237501|FG001|Overall Study|Positive for purified protein derivative|0|||
125439594|NCT01533714|451237502|FG002|Overall Study|Positive for purified protein derivative|1|||
125439595|NCT01533714|451237503|FG003|Overall Study|Positive for purified protein derivative|0|||
125439596|NCT01533714|451237504|FG004|Overall Study|Positive for purified protein derivative|1|||
125439597|NCT01533714|451237505|FG005|Overall Study|Positive for purified protein derivative|0|||
125439598|NCT01533714|451237500|FG000|Overall Study|Withdrawal criteria|0|||
125439599|NCT01533714|451237501|FG001|Overall Study|Withdrawal criteria|0|||
125439600|NCT01533714|451237502|FG002|Overall Study|Withdrawal criteria|1|||
125439601|NCT01533714|451237503|FG003|Overall Study|Withdrawal criteria|0|||
125439602|NCT01533714|451237504|FG004|Overall Study|Withdrawal criteria|3|||
125160521|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160522|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160523|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160524|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160525|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160526|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160527|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125160528|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
125439603|NCT01533714|451237505|FG005|Overall Study|Withdrawal criteria|1|||
125439604|NCT01533714|451237500|FG000|Overall Study|Ineligibility reason|0|||
125439605|NCT01533714|451237501|FG001|Overall Study|Ineligibility reason|0|||
125439606|NCT01533714|451237502|FG002|Overall Study|Ineligibility reason|0|||
125439607|NCT01533714|451237503|FG003|Overall Study|Ineligibility reason|1|||
125439608|NCT01533714|451237504|FG004|Overall Study|Ineligibility reason|0|||
125439609|NCT01533714|451237505|FG005|Overall Study|Ineligibility reason|0|||
125439610|NCT00467142|451237506|FG000|Overall Study|Withdrawal by Subject|1|||
125160529|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
125160530|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
125439611|NCT00467142|451237506|FG000|Overall Study|Adverse Event|1|||
125439612|NCT00467142|451237506|FG000|Overall Study|Protocol Violation|1|||
125439613|NCT00251927|451237508|FG000|Overall Study|Adverse Event|3|||
125439614|NCT00251927|451237509|FG001|Overall Study|Adverse Event|15|||
125439615|NCT00251927|451237508|FG000|Overall Study|Lack of Efficacy|22|||
125439616|NCT00251927|451237509|FG001|Overall Study|Lack of Efficacy|16|||
125439617|NCT00251927|451237508|FG000|Overall Study|Lost to Follow-up|22|||
125439618|NCT00251927|451237509|FG001|Overall Study|Lost to Follow-up|8|||
125439619|NCT00251927|451237508|FG000|Overall Study|Protocol Violation|1|||
125439620|NCT00251927|451237509|FG001|Overall Study|Protocol Violation|2|||
125439621|NCT00251927|451237508|FG000|Overall Study|Pregnancy|2|||
125439622|NCT00251927|451237509|FG001|Overall Study|Pregnancy|0|||
125439623|NCT00251927|451237508|FG000|Overall Study|Withdrawal by Subject|40|||
125439624|NCT00251927|451237509|FG001|Overall Study|Withdrawal by Subject|25|||
125439625|NCT00251927|451237508|FG000|Overall Study|Study-specific discont. achieved|13|||
125439626|NCT00251927|451237509|FG001|Overall Study|Study-specific discont. achieved|2|||
125439627|NCT00251927|451237508|FG000|Overall Study|Study procedure non-compliance|5|||
125439628|NCT00251927|451237509|FG001|Overall Study|Study procedure non-compliance|6|||
125439629|NCT02771210|451237510|FG000|Period 1|Adverse Event|5|||
125439630|NCT02771210|451237511|FG001|Period 1|Adverse Event|3|||
125439631|NCT02771210|451237510|FG000|Period 1|Lack of Efficacy|3|||
125439632|NCT02771210|451237511|FG001|Period 1|Lack of Efficacy|6|||
125439633|NCT02771210|451237510|FG000|Period 1|Lost to Follow-up|2|||
125439634|NCT02771210|451237511|FG001|Period 1|Lost to Follow-up|0|||
125439635|NCT02771210|451237510|FG000|Period 1|Physician Decision|0|||
125439636|NCT02771210|451237511|FG001|Period 1|Physician Decision|1|||
125439637|NCT02771210|451237510|FG000|Period 1|Withdrawal by Subject|0|||
125439638|NCT02771210|451237511|FG001|Period 1|Withdrawal by Subject|3|||
125439639|NCT02771210|451237510|FG000|Period 1|Withdrawal of informed consent|1|||
125439640|NCT02771210|451237511|FG001|Period 1|Withdrawal of informed consent|5|||
125439641|NCT02771210|451237510|FG000|Period 2|Adverse Event|1|||
125439642|NCT02771210|451237511|FG001|Period 2|Adverse Event|0|||
125439643|NCT02771210|451237510|FG000|Period 2|Lack of Efficacy|0|||
125439644|NCT02771210|451237511|FG001|Period 2|Lack of Efficacy|1|||
125439645|NCT02771210|451237510|FG000|Period 2|Withdrawal by Subject|1|||
125439646|NCT02771210|451237511|FG001|Period 2|Withdrawal by Subject|0|||
125439647|NCT02771210|451237510|FG000|Period 2|Withdrawal of informed consent|0|||
125439648|NCT02771210|451237511|FG001|Period 2|Withdrawal of informed consent|2|||
125439649|NCT00684762|451237518|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
125439650|NCT00684762|451237519|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
125439651|NCT02572817|451237520|FG000|Overall Study|Death|6|||
125439652|NCT02572817|451237521|FG001|Overall Study|Death|3|||
125439653|NCT02572817|451237520|FG000|Overall Study|Lost to Follow-up|3|||
125439654|NCT02572817|451237521|FG001|Overall Study|Lost to Follow-up|3|||
125439655|NCT02441946|451237526|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
125439656|NCT02441946|451237527|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
125439657|NCT02441946|451237528|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
125160531|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160532|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160533|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160534|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160535|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160536|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160537|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160538|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160539|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160540|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125439658|NCT02441946|451237526|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
125439659|NCT02441946|451237527|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
125439660|NCT02441946|451237528|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
125439661|NCT02441946|451237526|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
125439662|NCT02441946|451237527|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
125439663|NCT02441946|451237528|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
125439664|NCT02441946|451237526|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
125439665|NCT02441946|451237527|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
125439666|NCT02441946|451237528|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
125439667|NCT02441946|451237526|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
125439668|NCT02441946|451237527|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
125439669|NCT02441946|451237528|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
125439670|NCT02441946|451237526|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
125439671|NCT02441946|451237527|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
125160541|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160542|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
125160543|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
125160544|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
125160545|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160546|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160547|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160548|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160549|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160550|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160551|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160552|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160553|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160554|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160555|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160556|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
125160557|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
125160558|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
125160559|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160560|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160561|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160562|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160563|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160564|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160565|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160566|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160567|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160568|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160569|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160570|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
125160571|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
125160572|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
125160573|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160574|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160575|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160576|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160577|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160578|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160579|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125389759|NCT05071183|451060420|FG002|Overall Study|Death|0|||
125389760|NCT05071183|451060418|FG000|Overall Study|Other Reasons|1|||
125389761|NCT05071183|451060419|FG001|Overall Study|Other Reasons|3|||
125389762|NCT05071183|451060420|FG002|Overall Study|Other Reasons|2|||
125389763|NCT03897179|451060433|FG000|Overall Study|Withdrawal by Subject|1|||
125389764|NCT00704535|451060434|FG000|Overall Study|Adverse Event|2|||
125389765|NCT00704535|451060434|FG000|Overall Study|Death|2|||
125389766|NCT00704535|451060434|FG000|Overall Study|Lost to Follow-up|8|||
125389767|NCT00704535|451060434|FG000|Overall Study|Protocol Violation|10|||
125389768|NCT00704535|451060434|FG000|Overall Study|Completed status not on Case Report Form|124|||
125389769|NCT01480076|451060435|FG000|Overall Study|Run-in Failure|52|||
125389770|NCT01480076|451060435|FG000|Overall Study|Adverse Event|39|||
125389771|NCT01480076|451060435|FG000|Overall Study|Death|2|||
125389772|NCT01480076|451060435|FG000|Overall Study|Disease Progression|5|||
125389773|NCT01480076|451060435|FG000|Overall Study|Non-compliance With Study Protocol|15|||
125389774|NCT01480076|451060435|FG000|Overall Study|Withdrawal by Subject|105|||
125389775|NCT01480076|451060435|FG000|Overall Study|Lost to Follow-up|7|||
125389776|NCT01480076|451060435|FG000|Overall Study|Investigator Decision|13|||
125389777|NCT01480076|451060435|FG000|Overall Study|Other|52|||
125389778|NCT02503332|451060436|FG000|Overall Study|Adverse Event|17|||
125389779|NCT02503332|451060437|FG001|Overall Study|Adverse Event|5|||
125389780|NCT02503332|451060438|FG002|Overall Study|Adverse Event|3|||
125389781|NCT02503332|451060439|FG003|Overall Study|Adverse Event|1|||
125389782|NCT02503332|451060436|FG000|Overall Study|Investigator's Decision|5|||
125389783|NCT02503332|451060437|FG001|Overall Study|Investigator's Decision|1|||
125389784|NCT02503332|451060438|FG002|Overall Study|Investigator's Decision|0|||
125160580|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160581|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160582|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160583|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125160584|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
125389785|NCT02503332|451060439|FG003|Overall Study|Investigator's Decision|0|||
125224208|NCT03713684|450448093|FG002|Overall Study|Other than specified|73|||
125224209|NCT03713684|450448094|FG003|Overall Study|Other than specified|70|||
125224210|NCT02185417|450448095|FG000|Overall Study|Death|448|||
125224211|NCT02185417|450448096|FG001|Overall Study|Death|446|||
125224212|NCT02185417|450448097|FG002|Overall Study|Death|0|||
125224213|NCT02185417|450448095|FG000|Overall Study|Withdrawal by Subject|7|||
125389786|NCT02503332|451060436|FG000|Overall Study|Sponsor's Decision|1|||
125389787|NCT02503332|451060437|FG001|Overall Study|Sponsor's Decision|0|||
125389788|NCT02503332|451060438|FG002|Overall Study|Sponsor's Decision|0|||
125389789|NCT02503332|451060439|FG003|Overall Study|Sponsor's Decision|1|||
125389790|NCT02503332|451060436|FG000|Overall Study|Subject Request|6|||
125389791|NCT02503332|451060437|FG001|Overall Study|Subject Request|5|||
125389792|NCT02503332|451060438|FG002|Overall Study|Subject Request|2|||
125389793|NCT02503332|451060439|FG003|Overall Study|Subject Request|1|||
125389794|NCT02503332|451060436|FG000|Overall Study|Death|0|||
125389795|NCT02503332|451060437|FG001|Overall Study|Death|2|||
125389796|NCT02503332|451060438|FG002|Overall Study|Death|2|||
125389797|NCT02503332|451060439|FG003|Overall Study|Death|0|||
125389798|NCT02503332|451060436|FG000|Overall Study|Other|5|||
125389799|NCT02503332|451060437|FG001|Overall Study|Other|6|||
125389800|NCT02503332|451060438|FG002|Overall Study|Other|1|||
125389801|NCT02503332|451060439|FG003|Overall Study|Other|1|||
125389802|NCT01413360|451060440|FG000|Overall Study|Lost to Follow-up|2|||
125389803|NCT01413360|451060440|FG000|Overall Study|Adverse Event|1|||
125389804|NCT02625090|451060450|FG000|Overall Study|Participant wants to be pregnant|2|||
125389805|NCT02625090|451060450|FG000|Overall Study|For the Promoter|1|||
125389806|NCT02625090|451060450|FG000|Overall Study|Sponsor's Decision|9|||
125389807|NCT02625090|451060450|FG000|Overall Study|Somnolence|1|||
125389808|NCT02625090|451060450|FG000|Overall Study|Study terminated by Sponsor|7|||
125389809|NCT02625090|451060450|FG000|Overall Study|Negative Benefit/Risk|1|||
125389810|NCT02625090|451060450|FG000|Overall Study|Protocol Deviation|2|||
125389811|NCT02625090|451060450|FG000|Overall Study|Lack of Efficacy|16|||
125389812|NCT02625090|451060450|FG000|Overall Study|Adverse Event|3|||
125389813|NCT02439320|451060455|FG000|Overall Study|Adverse Event|0|||
125389814|NCT02439320|451060456|FG001|Overall Study|Adverse Event|2|||
125389815|NCT02439320|451060457|FG002|Overall Study|Adverse Event|0|||
125389816|NCT02439320|451060455|FG000|Overall Study|Lost to Follow-up|37|||
125389817|NCT02439320|451060456|FG001|Overall Study|Lost to Follow-up|34|||
125389818|NCT02439320|451060457|FG002|Overall Study|Lost to Follow-up|42|||
125389819|NCT02439320|451060455|FG000|Overall Study|Death|0|||
125389820|NCT02439320|451060456|FG001|Overall Study|Death|1|||
125389821|NCT02439320|451060457|FG002|Overall Study|Death|0|||
125389822|NCT02439320|451060455|FG000|Overall Study|Noncompliance with Protocol|10|||
125389823|NCT02439320|451060456|FG001|Overall Study|Noncompliance with Protocol|11|||
125389824|NCT02439320|451060457|FG002|Overall Study|Noncompliance with Protocol|7|||
125389825|NCT02439320|451060455|FG000|Overall Study|Pregnancy|0|||
125389826|NCT02439320|451060456|FG001|Overall Study|Pregnancy|1|||
125389827|NCT02439320|451060457|FG002|Overall Study|Pregnancy|1|||
125389828|NCT02439320|451060455|FG000|Overall Study|Withdrawal by Subject|12|||
125389829|NCT02439320|451060456|FG001|Overall Study|Withdrawal by Subject|16|||
125389830|NCT02439320|451060457|FG002|Overall Study|Withdrawal by Subject|14|||
125389831|NCT02439320|451060455|FG000|Overall Study|Physician Decision|2|||
125389832|NCT02439320|451060456|FG001|Overall Study|Physician Decision|1|||
125389833|NCT02439320|451060457|FG002|Overall Study|Physician Decision|0|||
125389834|NCT02439320|451060455|FG000|Overall Study|Sponsor Request|0|||
125389835|NCT02439320|451060456|FG001|Overall Study|Sponsor Request|2|||
125389836|NCT02439320|451060457|FG002|Overall Study|Sponsor Request|1|||
125439672|NCT02441946|451237528|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
125439673|NCT02441946|451237526|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
125439674|NCT02441946|451237527|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
125439675|NCT02441946|451237528|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
125439676|NCT02441946|451237526|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
125439677|NCT02441946|451237527|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
125439678|NCT02441946|451237528|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
125439679|NCT02441946|451237526|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
125439680|NCT02441946|451237527|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
125439681|NCT02441946|451237528|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
125439682|NCT02441946|451237526|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
125439683|NCT02441946|451237527|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
125439684|NCT02441946|451237528|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
125439685|NCT02441946|451237526|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
125439686|NCT02441946|451237527|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125439687|NCT02441946|451237528|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
125389837|NCT02439320|451060455|FG000|Overall Study|Randomization Failure|35|||
125389838|NCT02439320|451060456|FG001|Overall Study|Randomization Failure|46|||
125224214|NCT02185417|450448096|FG001|Overall Study|Withdrawal by Subject|12|||
125389839|NCT02439320|451060457|FG002|Overall Study|Randomization Failure|34|||
125389840|NCT02016482|451060460|FG000|Period A|Adverse Event|3|||
125389841|NCT02016482|451060461|FG001|Period A|Adverse Event|5|||
125439688|NCT02111213|451237529|FG000|Overall Study|Withdrawal by Subject|3|||
125439689|NCT02111213|451237530|FG001|Overall Study|Withdrawal by Subject|2|||
125439690|NCT02111213|451237529|FG000|Overall Study|Lost to Follow-up|3|||
125439691|NCT02111213|451237530|FG001|Overall Study|Lost to Follow-up|4|||
125439692|NCT00119262|451237531|FG000|Overall Study|Lack of Efficacy|0|||
125439693|NCT00119262|451237532|FG001|Overall Study|Lack of Efficacy|3|||
125439694|NCT00119262|451237531|FG000|Overall Study|Withdrawal by Subject|12|||
125439695|NCT00119262|451237532|FG001|Overall Study|Withdrawal by Subject|11|||
125439696|NCT00119262|451237531|FG000|Overall Study|Adverse Event|33|||
125439697|NCT00119262|451237532|FG001|Overall Study|Adverse Event|35|||
125439698|NCT00119262|451237531|FG000|Overall Study|other disease|0|||
125439699|NCT00119262|451237532|FG001|Overall Study|other disease|2|||
125439700|NCT00119262|451237531|FG000|Overall Study|ineligble|1|||
125439701|NCT00119262|451237532|FG001|Overall Study|ineligble|2|||
125439702|NCT00119262|451237531|FG000|Overall Study|others|0|||
125439703|NCT00119262|451237532|FG001|Overall Study|others|5|||
125439704|NCT00734214|451237533|FG000|Overall Study|Withdrawal by Subject|3|||
125439705|NCT00734214|451237534|FG001|Overall Study|Withdrawal by Subject|4|||
125439706|NCT00734214|451237533|FG000|Overall Study|MD withdrawal|1|||
125439707|NCT00734214|451237534|FG001|Overall Study|MD withdrawal|0|||
125439708|NCT00924469|451237540|FG000|Overall Study|Adverse Event|2|||
125439709|NCT00924469|451237541|FG001|Overall Study|Adverse Event|0|||
125439710|NCT00924469|451237540|FG000|Overall Study|Withdrawal by Subject|0|||
125439711|NCT00924469|451237541|FG001|Overall Study|Withdrawal by Subject|1|||
125439712|NCT00924469|451237540|FG000|Overall Study|Lost to Follow-up|0|||
125439713|NCT00924469|451237541|FG001|Overall Study|Lost to Follow-up|1|||
125439714|NCT00630058|451237543|FG000|Overall Study|Adverse Event|1|||
125439715|NCT00630058|451237544|FG001|Overall Study|Adverse Event|1|||
125439716|NCT00630058|451237543|FG000|Overall Study|Withdrawal by Subject|0|||
125439717|NCT00630058|451237544|FG001|Overall Study|Withdrawal by Subject|1|||
125439718|NCT00630058|451237543|FG000|Overall Study|stopping criteria|3|||
125439719|NCT00630058|451237544|FG001|Overall Study|stopping criteria|2|||
125439720|NCT01651936|451237545|FG000|Base Study|Adverse Event|3|||
125439721|NCT01651936|451237546|FG001|Base Study|Adverse Event|0|||
125439722|NCT01651936|451237547|FG002|Base Study|Adverse Event|0|||
125439723|NCT01651936|451237545|FG000|Base Study|Withdrawal by Subject|1|||
125439724|NCT01651936|451237546|FG001|Base Study|Withdrawal by Subject|1|||
125439725|NCT01651936|451237547|FG002|Base Study|Withdrawal by Subject|0|||
125439726|NCT01651936|451237545|FG000|Base Study|Early Escape|2|||
125439727|NCT01651936|451237546|FG001|Base Study|Early Escape|8|||
125439728|NCT01651936|451237547|FG002|Base Study|Early Escape|0|||
125439729|NCT01651936|451237545|FG000|Base Study|Study terminated by sponsor|21|||
125439730|NCT01651936|451237546|FG001|Base Study|Study terminated by sponsor|16|||
125439731|NCT01651936|451237547|FG002|Base Study|Study terminated by sponsor|0|||
125439732|NCT01651936|451237545|FG000|Extension Study|Lack of Efficacy|0|||
125439733|NCT01651936|451237546|FG001|Extension Study|Lack of Efficacy|0|||
125439734|NCT01651936|451237547|FG002|Extension Study|Lack of Efficacy|1|||
125439735|NCT01651936|451237545|FG000|Extension Study|Study terminated by sponsor|0|||
125439736|NCT01651936|451237546|FG001|Extension Study|Study terminated by sponsor|0|||
125439737|NCT01651936|451237547|FG002|Extension Study|Study terminated by sponsor|13|||
125439738|NCT03044353|451237551|FG000|Overall Study|Adverse Event|0|||
125439739|NCT03044353|451237552|FG001|Overall Study|Adverse Event|1|||
125439740|NCT03044353|451237553|FG002|Overall Study|Adverse Event|0|||
125439741|NCT02141659|451237560|FG000|Overall Study|Major Protocol Deviation|0|||
125439742|NCT02141659|451237561|FG001|Overall Study|Major Protocol Deviation|1|||
125439743|NCT02141659|451237562|FG002|Overall Study|Major Protocol Deviation|0|||
125439744|NCT02141659|451237563|FG003|Overall Study|Major Protocol Deviation|0|||
125439745|NCT02141659|451237564|FG004|Overall Study|Major Protocol Deviation|0|||
125439746|NCT02141659|451237565|FG005|Overall Study|Major Protocol Deviation|0|||
125439747|NCT02141659|451237560|FG000|Overall Study|Lack of Efficacy|0|||
125439748|NCT02141659|451237561|FG001|Overall Study|Lack of Efficacy|0|||
125439749|NCT02141659|451237562|FG002|Overall Study|Lack of Efficacy|0|||
125439750|NCT02141659|451237563|FG003|Overall Study|Lack of Efficacy|0|||
125439751|NCT02141659|451237564|FG004|Overall Study|Lack of Efficacy|0|||
125439752|NCT02141659|451237565|FG005|Overall Study|Lack of Efficacy|1|||
125439753|NCT02141659|451237560|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
125439754|NCT02141659|451237561|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
125160585|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
125439755|NCT02141659|451237562|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
125439756|NCT02141659|451237563|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
125439757|NCT02141659|451237564|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
125439758|NCT02141659|451237565|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
125439759|NCT02340520|451237568|FG000|Overall Study|Lost to Follow-up|1|||
125439760|NCT02340520|451237568|FG000|Overall Study|Patient did not take drug as specified|1|||
125439761|NCT02340520|451237568|FG000|Overall Study|Withdrawal by Subject|1|||
125439762|NCT01464255|451237569|FG000|Overall Study|unresolve corneal staining|0|||
125439763|NCT01464255|451237570|FG001|Overall Study|unresolve corneal staining|1|||
125439764|NCT01231503|451237571|FG000|Overall Study|Adverse Event|0|||
125224215|NCT02185417|450448097|FG002|Overall Study|Withdrawal by Subject|0|||
125224216|NCT02595502|450448098|FG000|Period 1|Adverse Event|0|||
125224217|NCT02595502|450448099|FG001|Period 1|Adverse Event|1|||
125224218|NCT02595502|450448098|FG000|Period 1|Withdrawal by Subject|1|||
125224219|NCT02595502|450448099|FG001|Period 1|Withdrawal by Subject|0|||
125224220|NCT02595502|450448098|FG000|Period 1|Lost to Follow-up|0|||
125224221|NCT02595502|450448099|FG001|Period 1|Lost to Follow-up|1|||
125224222|NCT02595502|450448098|FG000|Period 2|Adverse Event|1|||
125224223|NCT02595502|450448099|FG001|Period 2|Adverse Event|1|||
125224224|NCT02595502|450448098|FG000|Period 2|Received incorrect lens at Period 1|0|||
125224225|NCT02595502|450448099|FG001|Period 2|Received incorrect lens at Period 1|1|||
125224226|NCT02595502|450448098|FG000|Period 3|Protocol Violation|0|||
125224227|NCT02595502|450448099|FG001|Period 3|Protocol Violation|1|||
125224228|NCT02595502|450448098|FG000|Period 3|Lost to Follow-up|1|||
125224229|NCT02595502|450448099|FG001|Period 3|Lost to Follow-up|0|||
125224230|NCT02595502|450448098|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
125224231|NCT02595502|450448099|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
125224232|NCT00974311|450448100|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
125224233|NCT00974311|450448101|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
125224234|NCT00974311|450448100|FG000|DB Phase (up to 24 Months)|Death|561|||
125224235|NCT00974311|450448101|FG001|DB Phase (up to 24 Months)|Death|298|||
125224236|NCT00974311|450448100|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
125224237|NCT00974311|450448101|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
125224238|NCT00974311|450448100|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
125224239|NCT00974311|450448101|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
125224240|NCT00974311|450448100|FG000|DB Phase (up to 24 Months)|Other|1|||
125224241|NCT00974311|450448101|FG001|DB Phase (up to 24 Months)|Other|0|||
125224242|NCT00974311|450448100|FG000|OLE Phase (up to 77 Months)|Death|14|||
125224243|NCT00974311|450448101|FG001|OLE Phase (up to 77 Months)|Death|21|||
125224244|NCT00974311|450448100|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
125224245|NCT00974311|450448101|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
125224246|NCT00974311|450448100|FG000|OLE Phase (up to 77 Months)|Other|15|||
125224247|NCT00974311|450448101|FG001|OLE Phase (up to 77 Months)|Other|2|||
125224248|NCT00974311|450448100|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
125224249|NCT00974311|450448101|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
125224250|NCT05556148|450448104|FG000|Overall Study|Early Termination|29|||
125224251|NCT05556148|450448104|FG000|Overall Study|Baseline Tasks Expired|4|||
125224252|NCT05556148|450448104|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
125224253|NCT05556148|450448104|FG000|Overall Study|No Longer Wished to Participate|1|||
125224254|NCT05556148|450448104|FG000|Overall Study|Bacterial Conjunctivitis|1|||
125224255|NCT00458003|450448105|FG000|Overall Study|Non protocol spinal anesthesia|1|||
125224256|NCT00458003|450448106|FG001|Overall Study|Non protocol spinal anesthesia|1|||
125224257|NCT04176939|450448109|FG000|Overall Study|Withdrawal by Subject|5|||
125224258|NCT04176939|450448109|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
125224259|NCT04176939|450448109|FG000|Overall Study|Lost to Follow-up|2|||
125224260|NCT04176939|450448109|FG000|Overall Study|Unspecified reason|4|||
125224261|NCT04176939|450448109|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
125224262|NCT01529606|450448112|FG000|Overall Study|Lost to Follow-up|21|||
125224263|NCT01529606|450448113|FG001|Overall Study|Lost to Follow-up|18|||
125224264|NCT01746862|450448116|FG000|Overall Study|Withdrawal by Subject|1|||
125224265|NCT01746862|450448117|FG001|Overall Study|Withdrawal by Subject|1|||
125224266|NCT01746862|450448116|FG000|Overall Study|Protocol Violation|1|||
125224267|NCT01746862|450448117|FG001|Overall Study|Protocol Violation|0|||
125389842|NCT02016482|451060460|FG000|Period A|Withdrawal by Subject|3|||
125389843|NCT02016482|451060461|FG001|Period A|Withdrawal by Subject|4|||
125389844|NCT02016482|451060460|FG000|Period A|Lost to Follow-up|3|||
125389845|NCT02016482|451060461|FG001|Period A|Lost to Follow-up|3|||
125389846|NCT02016482|451060460|FG000|Period A|Lack of Efficacy|2|||
125389847|NCT02016482|451060461|FG001|Period A|Lack of Efficacy|1|||
125389848|NCT02016482|451060460|FG000|Period A|Other|3|||
125389849|NCT02016482|451060461|FG001|Period A|Other|0|||
125389850|NCT02016482|451060460|FG000|Period A|Protocol Violation|0|||
125389851|NCT02016482|451060461|FG001|Period A|Protocol Violation|1|||
125389852|NCT02016482|451060460|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
125389853|NCT02016482|451060461|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
125389854|NCT02016482|451060460|FG000|Period B|Withdrawal by Subject|1|||
125389855|NCT02016482|451060461|FG001|Period B|Withdrawal by Subject|1|||
125224268|NCT01746862|450448116|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
125224269|NCT01746862|450448117|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
125224270|NCT01746862|450448116|FG000|Overall Study|Entered puberty during the study|1|||
125224271|NCT01746862|450448117|FG001|Overall Study|Entered puberty during the study|0|||
125224272|NCT04742673|450448118|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
125224273|NCT04742673|450448119|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
125224274|NCT01900444|450448120|FG000|Overall Study|Protocol Violation|2|||
125224275|NCT01900444|450448120|FG000|Overall Study|Lost to Follow-up|1|||
125389856|NCT02016482|451060460|FG000|Period B|Lost to Follow-up|2|||
125160586|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
125160587|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160588|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160589|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160590|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160591|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160592|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160593|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160594|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160595|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160596|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160597|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160598|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
125160599|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
125160600|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
125160601|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160602|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160603|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160604|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160605|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160606|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160607|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160608|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160609|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160610|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160611|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160612|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
125160613|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
125160614|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
125160615|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160616|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160617|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160618|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160619|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160620|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160621|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160622|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160623|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160624|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160625|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160626|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
125160627|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
125160628|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
125160629|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160630|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160631|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160632|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160633|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160634|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160635|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160636|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160637|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160638|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125389857|NCT02016482|451060461|FG001|Period B|Lost to Follow-up|0|||
125389858|NCT02016482|451060460|FG000|Period B|Lack of Efficacy|6|||
125389859|NCT02016482|451060461|FG001|Period B|Lack of Efficacy|4|||
125389860|NCT02016482|451060460|FG000|Period B|Other|4|||
125389861|NCT02016482|451060461|FG001|Period B|Other|0|||
125389862|NCT02016482|451060460|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
125389863|NCT02016482|451060461|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
125389864|NCT00949325|451060462|FG000|Overall Study|Adverse Event|0|||
125389865|NCT00949325|451060463|FG001|Overall Study|Adverse Event|2|||
125160639|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125160640|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
125389866|NCT00949325|451060464|FG002|Overall Study|Adverse Event|0|||
125389867|NCT00791518|451060465|FG000|Overall Study|Protocol Violation|93|||
125389868|NCT01251380|451060468|FG000|Overall Study|Other (Not otherwise specified)|12|||
125389869|NCT01251380|451060468|FG000|Overall Study|Withdrawal by Subject|6|||
125160641|NCT03982199|450213081|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
125160642|NCT03982199|450213082|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
125389870|NCT01251380|451060468|FG000|Overall Study|Lack of Efficacy|1|||
125389871|NCT01251380|451060468|FG000|Overall Study|Adverse Event|1|||
125389872|NCT01251380|451060468|FG000|Overall Study|Lost to Follow-up|2|||
125389873|NCT02205333|451060474|FG000|Overall Study|Death|5|||
125389874|NCT02205333|451060475|FG001|Overall Study|Death|6|||
125389875|NCT02205333|451060476|FG002|Overall Study|Death|2|||
125389876|NCT02205333|451060477|FG003|Overall Study|Death|6|||
125389877|NCT02205333|451060478|FG004|Overall Study|Death|5|||
125389878|NCT02205333|451060479|FG005|Overall Study|Death|3|||
125389879|NCT02205333|451060480|FG006|Overall Study|Death|3|||
125389880|NCT02205333|451060481|FG007|Overall Study|Death|2|||
125389881|NCT02205333|451060482|FG008|Overall Study|Death|0|||
125389882|NCT02205333|451060474|FG000|Overall Study|Withdrawal by Subject|1|||
125389883|NCT02205333|451060475|FG001|Overall Study|Withdrawal by Subject|0|||
125389884|NCT02205333|451060476|FG002|Overall Study|Withdrawal by Subject|0|||
125389885|NCT02205333|451060477|FG003|Overall Study|Withdrawal by Subject|1|||
125389886|NCT02205333|451060478|FG004|Overall Study|Withdrawal by Subject|0|||
125389887|NCT02205333|451060479|FG005|Overall Study|Withdrawal by Subject|0|||
125389888|NCT02205333|451060480|FG006|Overall Study|Withdrawal by Subject|2|||
125389889|NCT02205333|451060481|FG007|Overall Study|Withdrawal by Subject|0|||
125389890|NCT02205333|451060482|FG008|Overall Study|Withdrawal by Subject|0|||
125389891|NCT00454987|451060483|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
125389892|NCT00454987|451060484|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
125389893|NCT00454987|451060485|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
125389894|NCT00454987|451060483|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
125389895|NCT00454987|451060484|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
125389896|NCT00454987|451060485|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
125389897|NCT00454987|451060483|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
125389898|NCT00454987|451060484|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
125389899|NCT00454987|451060485|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
125389900|NCT01476696|451060486|FG000|Overall Study|Sponsor decision|2|||
125389901|NCT01476696|451060487|FG001|Overall Study|Sponsor decision|1|||
125389902|NCT01476696|451060488|FG002|Overall Study|Sponsor decision|0|||
125389903|NCT01476696|451060486|FG000|Overall Study|Withdrawal by Subject|1|||
125389904|NCT01476696|451060487|FG001|Overall Study|Withdrawal by Subject|0|||
125389905|NCT01476696|451060488|FG002|Overall Study|Withdrawal by Subject|0|||
125389906|NCT02009046|451060489|FG000|Overall Study|Lost to Follow-up|256|||
125389907|NCT02009046|451060490|FG001|Overall Study|Lost to Follow-up|206|||
125389908|NCT00973479|451060493|FG000|Overall Study|Lost to Follow-up|0|||
125389909|NCT00973479|451060494|FG001|Overall Study|Lost to Follow-up|3|||
125389910|NCT00973479|451060493|FG000|Overall Study|Death|2|||
125389911|NCT00973479|451060494|FG001|Overall Study|Death|2|||
125389912|NCT00973479|451060493|FG000|Overall Study|Withdrawal by Subject|15|||
125389913|NCT00973479|451060494|FG001|Overall Study|Withdrawal by Subject|16|||
125389914|NCT00973479|451060493|FG000|Overall Study|Lack of Efficacy|5|||
125389915|NCT00973479|451060494|FG001|Overall Study|Lack of Efficacy|7|||
125389916|NCT00973479|451060493|FG000|Overall Study|Adverse Event|12|||
125389917|NCT00973479|451060494|FG001|Overall Study|Adverse Event|32|||
125389918|NCT00973479|451060493|FG000|Overall Study|Protocol Violation|2|||
125389919|NCT00973479|451060494|FG001|Overall Study|Protocol Violation|2|||
125389920|NCT00973479|451060493|FG000|Overall Study|Other|1|||
125389921|NCT00973479|451060494|FG001|Overall Study|Other|7|||
125389922|NCT02136576|451060497|FG000|Overall Study|Lost to Follow-up|2|||
125389923|NCT02136576|451060498|FG001|Overall Study|Lost to Follow-up|0|||
125389924|NCT02136576|451060499|FG002|Overall Study|Lost to Follow-up|0|||
125389925|NCT03082599|451060502|FG000|Overall Study|Lost to Follow-up|1|||
125389926|NCT03082599|451060503|FG001|Overall Study|Lost to Follow-up|0|||
125389927|NCT00735878|451060504|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
125389928|NCT00735878|451060505|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
125389929|NCT00735878|451060506|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
125389930|NCT00549562|451060507|FG000|Overall Study|Adverse Event|1|||
125389931|NCT00549562|451060507|FG000|Overall Study|Lack of Efficacy|1|||
125389932|NCT00323115|451060510|FG000|Vaccine Administration|Adverse Event|1|||
125389933|NCT00323115|451060510|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
125389934|NCT00567892|451060512|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
125389935|NCT00567892|451060513|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
125389936|NCT00567892|451060514|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
125389937|NCT00567892|451060515|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
125389938|NCT00567892|451060512|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
125389939|NCT00567892|451060513|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
125389940|NCT00567892|451060514|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
125389941|NCT00567892|451060515|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
125389942|NCT04709575|451061891|FG000|Overall Study|Withdrawal by Subject|6|||
125389943|NCT04709575|451061892|FG001|Overall Study|Withdrawal by Subject|2|||
125160643|NCT03982199|450213083|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160644|NCT03982199|450213084|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160645|NCT03982199|450213085|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160646|NCT03982199|450213086|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160647|NCT03982199|450213087|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160648|NCT03982199|450213088|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160649|NCT03982199|450213089|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160650|NCT03982199|450213090|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160651|NCT03982199|450213091|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160652|NCT03982199|450213092|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160653|NCT03982199|450213093|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160654|NCT03982199|450213094|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
125160655|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160656|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160657|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160658|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
125160659|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160660|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160661|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160662|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160663|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160664|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160665|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160666|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160667|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160668|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
125160669|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125389944|NCT04709575|451061891|FG000|Overall Study|Lost to Follow-up|2|||
125389945|NCT04709575|451061892|FG001|Overall Study|Lost to Follow-up|2|||
125389946|NCT04709575|451061891|FG000|Overall Study|Adverse Event|1|||
125389947|NCT04709575|451061892|FG001|Overall Study|Adverse Event|0|||
125389948|NCT04709575|451061891|FG000|Overall Study|Protocol Violation|1|||
125389949|NCT04709575|451061892|FG001|Overall Study|Protocol Violation|1|||
125389950|NCT04254978|451061895|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
125389951|NCT04254978|451061895|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
125389952|NCT04254978|451061895|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
125389953|NCT04254978|451061895|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
125389954|NCT04254978|451061895|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
125389955|NCT04254978|451061895|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
125389956|NCT00277212|451061896|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
125389957|NCT00277212|451061897|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
125389958|NCT00277212|451061898|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
125389959|NCT00277212|451061896|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
125389960|NCT00277212|451061897|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
125389961|NCT00277212|451061898|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
125389962|NCT00277212|451061896|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
125389963|NCT00277212|451061897|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
125389964|NCT00277212|451061898|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
125389965|NCT00277212|451061896|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
125389966|NCT00277212|451061897|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
125389967|NCT00277212|451061898|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
125389968|NCT00277212|451061896|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
125389969|NCT00277212|451061897|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
125389970|NCT00277212|451061898|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
125389971|NCT00277212|451061896|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
125389972|NCT00277212|451061897|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
125389973|NCT00277212|451061898|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
125389974|NCT00277212|451061896|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
125389975|NCT00277212|451061897|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
125389976|NCT00277212|451061898|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
125389977|NCT00277212|451061896|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
125389978|NCT00277212|451061897|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
125389979|NCT00277212|451061898|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
125389980|NCT00277212|451061896|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
125389981|NCT00277212|451061897|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
125389982|NCT00277212|451061898|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
125439765|NCT01231503|451237572|FG001|Overall Study|Adverse Event|0|||
125439766|NCT01231503|451237573|FG002|Overall Study|Adverse Event|0|||
125439767|NCT01231503|451237574|FG003|Overall Study|Adverse Event|0|||
125439768|NCT01231503|451237575|FG004|Overall Study|Adverse Event|0|||
125439769|NCT01231503|451237576|FG005|Overall Study|Adverse Event|1|||
125439770|NCT01231503|451237577|FG006|Overall Study|Adverse Event|0|||
125439771|NCT01231503|451237578|FG007|Overall Study|Adverse Event|0|||
125439772|NCT01231503|451237571|FG000|Overall Study|Adverse event, serious fatal|0|||
125439773|NCT01231503|451237572|FG001|Overall Study|Adverse event, serious fatal|0|||
125439774|NCT01231503|451237573|FG002|Overall Study|Adverse event, serious fatal|1|||
125439775|NCT01231503|451237574|FG003|Overall Study|Adverse event, serious fatal|1|||
125439776|NCT01231503|451237575|FG004|Overall Study|Adverse event, serious fatal|0|||
125439777|NCT01231503|451237576|FG005|Overall Study|Adverse event, serious fatal|1|||
125439778|NCT01231503|451237577|FG006|Overall Study|Adverse event, serious fatal|0|||
125439779|NCT01231503|451237578|FG007|Overall Study|Adverse event, serious fatal|0|||
125439780|NCT01231503|451237571|FG000|Overall Study|Withdrawal by Subject|6|||
125439781|NCT01231503|451237572|FG001|Overall Study|Withdrawal by Subject|3|||
125439782|NCT01231503|451237573|FG002|Overall Study|Withdrawal by Subject|3|||
125439783|NCT01231503|451237574|FG003|Overall Study|Withdrawal by Subject|1|||
125439784|NCT01231503|451237575|FG004|Overall Study|Withdrawal by Subject|3|||
125439785|NCT01231503|451237576|FG005|Overall Study|Withdrawal by Subject|5|||
125439786|NCT01231503|451237577|FG006|Overall Study|Withdrawal by Subject|1|||
125439787|NCT01231503|451237578|FG007|Overall Study|Withdrawal by Subject|2|||
125439788|NCT01231503|451237571|FG000|Overall Study|Lost to Follow-up|8|||
125439789|NCT01231503|451237572|FG001|Overall Study|Lost to Follow-up|10|||
125439790|NCT01231503|451237573|FG002|Overall Study|Lost to Follow-up|8|||
125439791|NCT01231503|451237574|FG003|Overall Study|Lost to Follow-up|5|||
125439792|NCT01231503|451237575|FG004|Overall Study|Lost to Follow-up|7|||
125439793|NCT01231503|451237576|FG005|Overall Study|Lost to Follow-up|9|||
125439794|NCT01231503|451237577|FG006|Overall Study|Lost to Follow-up|6|||
125439795|NCT01231503|451237578|FG007|Overall Study|Lost to Follow-up|6|||
125439796|NCT01231503|451237571|FG000|Overall Study|Protocol Violation|0|||
125439797|NCT01231503|451237572|FG001|Overall Study|Protocol Violation|0|||
125439798|NCT01231503|451237573|FG002|Overall Study|Protocol Violation|0|||
125439799|NCT01231503|451237574|FG003|Overall Study|Protocol Violation|1|||
125439800|NCT01231503|451237575|FG004|Overall Study|Protocol Violation|0|||
125439801|NCT01231503|451237576|FG005|Overall Study|Protocol Violation|0|||
125439802|NCT01231503|451237577|FG006|Overall Study|Protocol Violation|0|||
125439803|NCT01231503|451237578|FG007|Overall Study|Protocol Violation|0|||
125439804|NCT01586338|451237579|FG000|Overall Study|Adverse Event|3|||
125224276|NCT00072384|450448124|FG000|Overall Study|Physician Decision|1|||
125224277|NCT00072384|450448124|FG000|Overall Study|Ineligible|8|||
125224278|NCT01825200|450448125|FG000|Overall Study|Lost to Follow-up|5|||
125224279|NCT01825200|450448126|FG001|Overall Study|Lost to Follow-up|6|||
125224280|NCT01825200|450448125|FG000|Overall Study|Withdrawal by Subject|0|||
125224281|NCT01825200|450448126|FG001|Overall Study|Withdrawal by Subject|1|||
125224282|NCT00490035|450448127|FG000|Overall Study|AE, non-serious non-fatal|3|||
125224283|NCT00490035|450448128|FG001|Overall Study|AE, non-serious non-fatal|4|||
125224284|NCT00490035|450448129|FG002|Overall Study|AE, non-serious non-fatal|4|||
125224285|NCT00490035|450448130|FG003|Overall Study|AE, non-serious non-fatal|5|||
125224286|NCT00490035|450448127|FG000|Overall Study|Lost to Follow-up|2|||
125224287|NCT00490035|450448128|FG001|Overall Study|Lost to Follow-up|0|||
125224288|NCT00490035|450448129|FG002|Overall Study|Lost to Follow-up|1|||
125224289|NCT00490035|450448130|FG003|Overall Study|Lost to Follow-up|0|||
125224290|NCT00490035|450448127|FG000|Overall Study|Withdrawal by Subject|2|||
125224291|NCT00490035|450448128|FG001|Overall Study|Withdrawal by Subject|1|||
125224292|NCT00490035|450448129|FG002|Overall Study|Withdrawal by Subject|1|||
125439805|NCT01586338|451237579|FG000|Overall Study|Lost to Follow-up|1|||
125439806|NCT01586338|451237579|FG000|Overall Study|Withdrawal by participant|3|||
125439807|NCT01586338|451237579|FG000|Overall Study|Other|1|||
125439808|NCT00284089|451237580|FG000|Multiple Dose Phase|Adverse Event|1|||
125439809|NCT00284089|451237581|FG001|Multiple Dose Phase|Adverse Event|0|||
125439810|NCT00284089|451237582|FG002|Multiple Dose Phase|Adverse Event|1|||
125224293|NCT00490035|450448130|FG003|Overall Study|Withdrawal by Subject|0|||
125224294|NCT00490035|450448127|FG000|Overall Study|Other reason|0|||
125439811|NCT00284089|451237583|FG003|Multiple Dose Phase|Adverse Event|1|||
125224295|NCT00490035|450448128|FG001|Overall Study|Other reason|1|||
125439812|NCT00284089|451237580|FG000|Multiple Dose Phase|Protocol Violation|0|||
125439813|NCT00284089|451237581|FG001|Multiple Dose Phase|Protocol Violation|0|||
125439814|NCT00284089|451237582|FG002|Multiple Dose Phase|Protocol Violation|1|||
125439815|NCT00284089|451237583|FG003|Multiple Dose Phase|Protocol Violation|0|||
125439816|NCT00284089|451237580|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
125439817|NCT00284089|451237581|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
125224296|NCT00490035|450448129|FG002|Overall Study|Other reason|3|||
125224297|NCT00490035|450448130|FG003|Overall Study|Other reason|1|||
125224298|NCT00490035|450448127|FG000|Overall Study|AE, serious fatal|1|||
125224299|NCT00490035|450448128|FG001|Overall Study|AE, serious fatal|0|||
125224300|NCT00490035|450448129|FG002|Overall Study|AE, serious fatal|0|||
125389983|NCT00277212|451061896|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
125389984|NCT00277212|451061897|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
125389985|NCT00277212|451061898|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
125389986|NCT00277212|451061896|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
125389987|NCT00277212|451061897|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
125389988|NCT00277212|451061898|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
125389989|NCT00277212|451061896|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
125389990|NCT00277212|451061897|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
125389991|NCT00277212|451061898|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
125389992|NCT00277212|451061896|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
125389993|NCT00277212|451061897|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
125389994|NCT00277212|451061898|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
125389995|NCT00277212|451061896|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
125389996|NCT00277212|451061897|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
125389997|NCT00277212|451061898|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
125389998|NCT00277212|451061896|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
125389999|NCT00277212|451061897|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
125390000|NCT00277212|451061898|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
125390001|NCT00277212|451061896|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
125390002|NCT00277212|451061897|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
125390003|NCT00277212|451061898|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
125390004|NCT00277212|451061896|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
125390005|NCT00277212|451061897|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
125390006|NCT00277212|451061898|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
125390007|NCT00277212|451061896|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
125390008|NCT00277212|451061897|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
125390009|NCT00277212|451061898|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
125390010|NCT03336216|451061899|FG000|Randomization|Not reported|2|||
125390011|NCT03336216|451061900|FG001|Randomization|Not reported|0|||
125390012|NCT03336216|451061901|FG002|Randomization|Not reported|1|||
125390013|NCT03336216|451061902|FG003|Randomization|Not reported|0|||
125390014|NCT03336216|451061899|FG000|Randomization|Other reasons|1|||
125390015|NCT03336216|451061900|FG001|Randomization|Other reasons|1|||
125390016|NCT03336216|451061901|FG002|Randomization|Other reasons|1|||
125390017|NCT03336216|451061902|FG003|Randomization|Other reasons|0|||
125390018|NCT03336216|451061899|FG000|Randomization|Participant no longer meets study criteria|0|||
125390019|NCT03336216|451061900|FG001|Randomization|Participant no longer meets study criteria|2|||
125390020|NCT03336216|451061901|FG002|Randomization|Participant no longer meets study criteria|4|||
125390021|NCT03336216|451061902|FG003|Randomization|Participant no longer meets study criteria|1|||
125390022|NCT03336216|451061899|FG000|Randomization|Lost to Follow-up|1|||
125390023|NCT03336216|451061900|FG001|Randomization|Lost to Follow-up|0|||
125390024|NCT03336216|451061901|FG002|Randomization|Lost to Follow-up|0|||
125390025|NCT03336216|451061902|FG003|Randomization|Lost to Follow-up|0|||
125390026|NCT03336216|451061899|FG000|Randomization|Participant withdrew consent|9|||
125390027|NCT03336216|451061900|FG001|Randomization|Participant withdrew consent|1|||
125390028|NCT03336216|451061901|FG002|Randomization|Participant withdrew consent|0|||
125390029|NCT03336216|451061902|FG003|Randomization|Participant withdrew consent|0|||
125390030|NCT03336216|451061899|FG000|Randomization|Adverse Event|1|||
125390031|NCT03336216|451061900|FG001|Randomization|Adverse Event|1|||
125390032|NCT03336216|451061901|FG002|Randomization|Adverse Event|0|||
125390033|NCT03336216|451061902|FG003|Randomization|Adverse Event|0|||
125390034|NCT03336216|451061899|FG000|Treatment|Adverse Event|2|||
125390035|NCT03336216|451061900|FG001|Treatment|Adverse Event|3|||
125390036|NCT03336216|451061901|FG002|Treatment|Adverse Event|4|||
125390037|NCT03336216|451061902|FG003|Treatment|Adverse Event|4|||
125390038|NCT03336216|451061899|FG000|Treatment|Participant request to discontinue treatment|2|||
125390039|NCT03336216|451061900|FG001|Treatment|Participant request to discontinue treatment|1|||
125390040|NCT03336216|451061901|FG002|Treatment|Participant request to discontinue treatment|2|||
125390041|NCT03336216|451061902|FG003|Treatment|Participant request to discontinue treatment|2|||
125390042|NCT03336216|451061899|FG000|Treatment|Participant withdrew consent|7|||
125390043|NCT03336216|451061900|FG001|Treatment|Participant withdrew consent|2|||
125439818|NCT00284089|451237582|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
125439819|NCT00284089|451237583|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
125390044|NCT03336216|451061901|FG002|Treatment|Participant withdrew consent|3|||
125390045|NCT03336216|451061902|FG003|Treatment|Participant withdrew consent|2|||
125390046|NCT03336216|451061899|FG000|Treatment|Death|2|||
125390047|NCT03336216|451061900|FG001|Treatment|Death|3|||
125390048|NCT03336216|451061901|FG002|Treatment|Death|3|||
125390049|NCT03336216|451061902|FG003|Treatment|Death|4|||
125390050|NCT03336216|451061899|FG000|Treatment|Participant no longer meets study criteria|0|||
125390051|NCT03336216|451061900|FG001|Treatment|Participant no longer meets study criteria|1|||
125390052|NCT03336216|451061901|FG002|Treatment|Participant no longer meets study criteria|0|||
125224301|NCT00490035|450448130|FG003|Overall Study|AE, serious fatal|0|||
125224302|NCT00490035|450448127|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
125224303|NCT00490035|450448128|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
125224304|NCT00490035|450448129|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
125224305|NCT00490035|450448130|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
125224306|NCT00490035|450448127|FG000|Overall Study|AE of unknown type|0|||
125224307|NCT00490035|450448128|FG001|Overall Study|AE of unknown type|0|||
125224308|NCT00490035|450448129|FG002|Overall Study|AE of unknown type|2|||
125224309|NCT00490035|450448130|FG003|Overall Study|AE of unknown type|0|||
125224310|NCT06058390|450448134|FG000|Overall Study|Lost to Follow-up|0|||
125224311|NCT06058390|450448135|FG001|Overall Study|Lost to Follow-up|0|||
125224312|NCT06058390|450448136|FG002|Overall Study|Lost to Follow-up|2|||
125224313|NCT06058390|450448137|FG003|Overall Study|Lost to Follow-up|1|||
125224314|NCT06058390|450448134|FG000|Overall Study|Physician Decision|0|||
125224315|NCT06058390|450448135|FG001|Overall Study|Physician Decision|0|||
125224316|NCT06058390|450448136|FG002|Overall Study|Physician Decision|0|||
125224317|NCT06058390|450448137|FG003|Overall Study|Physician Decision|1|||
125224318|NCT06058390|450448134|FG000|Overall Study|Participants did not receive any study intervention|0|||
125224319|NCT06058390|450448135|FG001|Overall Study|Participants did not receive any study intervention|0|||
125224320|NCT06058390|450448136|FG002|Overall Study|Participants did not receive any study intervention|0|||
125224321|NCT06058390|450448137|FG003|Overall Study|Participants did not receive any study intervention|1|||
125224322|NCT03361306|450448140|FG000|Overall Study|Death|6|||
125224323|NCT04817332|450448143|FG000|Overall Study|Lost to Follow-up|3|||
125224324|NCT04817332|450448144|FG001|Overall Study|Lost to Follow-up|3|||
125224325|NCT04817332|450448143|FG000|Overall Study|Protocol Violation|2|||
125224326|NCT04817332|450448144|FG001|Overall Study|Protocol Violation|0|||
125224327|NCT04795466|450448150|FG000|Overall Study|Adverse Event|3|||
125224328|NCT04795466|450448151|FG001|Overall Study|Adverse Event|1|||
125224329|NCT04795466|450448150|FG000|Overall Study|Physician Decision|1|||
125390053|NCT03336216|451061902|FG003|Treatment|Participant no longer meets study criteria|0|||
125390054|NCT03336216|451061899|FG000|Treatment|Other reasons|2|||
125390055|NCT03336216|451061900|FG001|Treatment|Other reasons|0|||
125390056|NCT03336216|451061901|FG002|Treatment|Other reasons|0|||
125390057|NCT03336216|451061902|FG003|Treatment|Other reasons|3|||
125390058|NCT03336216|451061899|FG000|Treatment|Disease progression|23|||
125390059|NCT03336216|451061900|FG001|Treatment|Disease progression|34|||
125390060|NCT03336216|451061901|FG002|Treatment|Disease progression|33|||
125390061|NCT03336216|451061902|FG003|Treatment|Disease progression|26|||
125390062|NCT03336216|451061899|FG000|Treatment|Study drug toxicity|0|||
125390063|NCT03336216|451061900|FG001|Treatment|Study drug toxicity|3|||
125390064|NCT03336216|451061901|FG002|Treatment|Study drug toxicity|2|||
125390065|NCT03336216|451061902|FG003|Treatment|Study drug toxicity|0|||
125390066|NCT03336216|451061899|FG000|Treatment|Adverse Event unrelated to study drug|1|||
125390067|NCT03336216|451061900|FG001|Treatment|Adverse Event unrelated to study drug|1|||
125390068|NCT03336216|451061901|FG002|Treatment|Adverse Event unrelated to study drug|1|||
125390069|NCT03336216|451061902|FG003|Treatment|Adverse Event unrelated to study drug|0|||
125390070|NCT03336216|451061899|FG000|Treatment|Disease Recurrence|1|||
125390071|NCT03336216|451061900|FG001|Treatment|Disease Recurrence|0|||
125390072|NCT03336216|451061901|FG002|Treatment|Disease Recurrence|0|||
125390073|NCT03336216|451061902|FG003|Treatment|Disease Recurrence|0|||
125390074|NCT03239470|451061908|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
125390075|NCT03239470|451061909|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
125390076|NCT01023581|451061912|FG000|Overall Study|Adverse Event|4|||
125390077|NCT01023581|451061913|FG001|Overall Study|Adverse Event|4|||
125390078|NCT01023581|451061914|FG002|Overall Study|Adverse Event|7|||
125390079|NCT01023581|451061915|FG003|Overall Study|Adverse Event|3|||
125390080|NCT01023581|451061916|FG004|Overall Study|Adverse Event|2|||
125390081|NCT01023581|451061917|FG005|Overall Study|Adverse Event|5|||
125390082|NCT01023581|451061918|FG006|Overall Study|Adverse Event|11|||
125390083|NCT01023581|451061912|FG000|Overall Study|Major protocol deviation|2|||
125390084|NCT01023581|451061913|FG001|Overall Study|Major protocol deviation|0|||
125390085|NCT01023581|451061914|FG002|Overall Study|Major protocol deviation|3|||
125390086|NCT01023581|451061915|FG003|Overall Study|Major protocol deviation|0|||
125390087|NCT01023581|451061916|FG004|Overall Study|Major protocol deviation|0|||
125439820|NCT00284089|451237580|FG000|Multiple Dose Phase|Death|0|||
125224330|NCT04795466|450448151|FG001|Overall Study|Physician Decision|0|||
125224331|NCT04795466|450448150|FG000|Overall Study|Withdrawal by Subject|2|||
125224332|NCT04795466|450448151|FG001|Overall Study|Withdrawal by Subject|1|||
125390088|NCT01023581|451061917|FG005|Overall Study|Major protocol deviation|0|||
125390089|NCT01023581|451061918|FG006|Overall Study|Major protocol deviation|0|||
125390090|NCT01023581|451061912|FG000|Overall Study|Lost to Follow-up|4|||
125390091|NCT01023581|451061913|FG001|Overall Study|Lost to Follow-up|8|||
125390092|NCT01023581|451061914|FG002|Overall Study|Lost to Follow-up|7|||
125224333|NCT05635045|450448152|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
125390093|NCT01023581|451061915|FG003|Overall Study|Lost to Follow-up|2|||
125439821|NCT00284089|451237581|FG001|Multiple Dose Phase|Death|0|||
125439822|NCT00284089|451237582|FG002|Multiple Dose Phase|Death|1|||
125439823|NCT00284089|451237583|FG003|Multiple Dose Phase|Death|1|||
125439824|NCT00284089|451237580|FG000|Extension Phase|Adverse Event|0|||
125439825|NCT00284089|451237581|FG001|Extension Phase|Adverse Event|0|||
125160670|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160671|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
125390094|NCT01023581|451061916|FG004|Overall Study|Lost to Follow-up|5|||
125390095|NCT01023581|451061917|FG005|Overall Study|Lost to Follow-up|2|||
125390096|NCT01023581|451061918|FG006|Overall Study|Lost to Follow-up|2|||
125390097|NCT01023581|451061912|FG000|Overall Study|Withdrawal by Subject|13|||
125390098|NCT01023581|451061913|FG001|Overall Study|Withdrawal by Subject|8|||
125390099|NCT01023581|451061914|FG002|Overall Study|Withdrawal by Subject|16|||
125390100|NCT01023581|451061915|FG003|Overall Study|Withdrawal by Subject|10|||
125160672|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125390101|NCT01023581|451061916|FG004|Overall Study|Withdrawal by Subject|6|||
125390102|NCT01023581|451061917|FG005|Overall Study|Withdrawal by Subject|8|||
125390103|NCT01023581|451061918|FG006|Overall Study|Withdrawal by Subject|5|||
125390104|NCT01023581|451061912|FG000|Overall Study|Pregnancy|0|||
125390105|NCT01023581|451061913|FG001|Overall Study|Pregnancy|0|||
125390106|NCT01023581|451061914|FG002|Overall Study|Pregnancy|0|||
125390107|NCT01023581|451061915|FG003|Overall Study|Pregnancy|2|||
125390108|NCT01023581|451061916|FG004|Overall Study|Pregnancy|0|||
125390109|NCT01023581|451061917|FG005|Overall Study|Pregnancy|1|||
125390110|NCT01023581|451061918|FG006|Overall Study|Pregnancy|0|||
125390111|NCT01023581|451061912|FG000|Overall Study|Lack of Efficacy|9|||
125390112|NCT01023581|451061913|FG001|Overall Study|Lack of Efficacy|3|||
125390113|NCT01023581|451061914|FG002|Overall Study|Lack of Efficacy|6|||
125390114|NCT01023581|451061915|FG003|Overall Study|Lack of Efficacy|2|||
125390115|NCT01023581|451061916|FG004|Overall Study|Lack of Efficacy|1|||
125390116|NCT01023581|451061917|FG005|Overall Study|Lack of Efficacy|2|||
125390117|NCT01023581|451061918|FG006|Overall Study|Lack of Efficacy|1|||
125390118|NCT01023581|451061912|FG000|Overall Study|Physician Decision|2|||
125390119|NCT01023581|451061913|FG001|Overall Study|Physician Decision|0|||
125390120|NCT01023581|451061914|FG002|Overall Study|Physician Decision|2|||
125390121|NCT01023581|451061915|FG003|Overall Study|Physician Decision|1|||
125390122|NCT01023581|451061916|FG004|Overall Study|Physician Decision|1|||
125390123|NCT01023581|451061917|FG005|Overall Study|Physician Decision|1|||
125390124|NCT01023581|451061918|FG006|Overall Study|Physician Decision|1|||
125390125|NCT01023581|451061912|FG000|Overall Study|Other|1|||
125390126|NCT01023581|451061913|FG001|Overall Study|Other|0|||
125390127|NCT01023581|451061914|FG002|Overall Study|Other|1|||
125390128|NCT01023581|451061915|FG003|Overall Study|Other|0|||
125390129|NCT01023581|451061916|FG004|Overall Study|Other|1|||
125390130|NCT01023581|451061917|FG005|Overall Study|Other|0|||
125390131|NCT01023581|451061918|FG006|Overall Study|Other|0|||
125390132|NCT00666757|451061919|FG000|Overall Study|Lost to Follow-up|39|||
125390133|NCT00666757|451061920|FG001|Overall Study|Lost to Follow-up|35|||
125390134|NCT00666757|451061919|FG000|Overall Study|Protocol Violation|23|||
125390135|NCT00666757|451061920|FG001|Overall Study|Protocol Violation|24|||
125390136|NCT00666757|451061919|FG000|Overall Study|Adverse Event|22|||
125390137|NCT00666757|451061920|FG001|Overall Study|Adverse Event|12|||
125390138|NCT00666757|451061919|FG000|Overall Study|Withdrawal by Subject|13|||
125390139|NCT00666757|451061920|FG001|Overall Study|Withdrawal by Subject|17|||
125390140|NCT00666757|451061919|FG000|Overall Study|Lack of Efficacy|3|||
125390141|NCT00666757|451061920|FG001|Overall Study|Lack of Efficacy|6|||
125390142|NCT00666757|451061919|FG000|Overall Study|Physician Decision|0|||
125390143|NCT00666757|451061920|FG001|Overall Study|Physician Decision|2|||
125390144|NCT00666757|451061919|FG000|Overall Study|Sponsor decision|0|||
125390145|NCT00666757|451061920|FG001|Overall Study|Sponsor decision|1|||
125390146|NCT01231581|451061921|FG000|Overall Study|Lost to Follow-up|2|||
125160673|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160674|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160675|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160676|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125390147|NCT01231581|451061922|FG001|Overall Study|Lost to Follow-up|2|||
125390148|NCT01231581|451061921|FG000|Overall Study|Withdrawal by Subject|6|||
125390149|NCT01231581|451061922|FG001|Overall Study|Withdrawal by Subject|9|||
125439826|NCT00284089|451237582|FG002|Extension Phase|Adverse Event|2|||
125390150|NCT01231581|451061921|FG000|Overall Study|Study Closed/Terminated|6|||
125390151|NCT01231581|451061922|FG001|Overall Study|Study Closed/Terminated|5|||
125390152|NCT01231581|451061921|FG000|Overall Study|Death|65|||
125390153|NCT01231581|451061922|FG001|Overall Study|Death|64|||
125390154|NCT01231581|451061921|FG000|Overall Study|Ongoing|1|||
125390155|NCT01231581|451061922|FG001|Overall Study|Ongoing|0|||
125390156|NCT02510794|451061923|FG000|Overall Study|Adverse Event|0|||
125390157|NCT02510794|451061924|FG001|Overall Study|Adverse Event|1|||
125390158|NCT02510794|451061925|FG002|Overall Study|Adverse Event|0|||
125390159|NCT02510794|451061926|FG003|Overall Study|Adverse Event|0|||
125439827|NCT00284089|451237583|FG003|Extension Phase|Adverse Event|2|||
125390160|NCT02510794|451061923|FG000|Overall Study|Death|1|||
125390161|NCT02510794|451061924|FG001|Overall Study|Death|2|||
125390162|NCT02510794|451061925|FG002|Overall Study|Death|1|||
125390163|NCT02510794|451061926|FG003|Overall Study|Death|1|||
125390164|NCT02510794|451061923|FG000|Overall Study|Lack of Efficacy|3|||
125390165|NCT02510794|451061924|FG001|Overall Study|Lack of Efficacy|1|||
125390166|NCT02510794|451061925|FG002|Overall Study|Lack of Efficacy|1|||
125390167|NCT02510794|451061926|FG003|Overall Study|Lack of Efficacy|0|||
125390168|NCT02510794|451061923|FG000|Overall Study|Participant moved out of the area|0|||
125390169|NCT02510794|451061924|FG001|Overall Study|Participant moved out of the area|0|||
125390170|NCT02510794|451061925|FG002|Overall Study|Participant moved out of the area|0|||
125390171|NCT02510794|451061926|FG003|Overall Study|Participant moved out of the area|1|||
125390172|NCT02510794|451061923|FG000|Overall Study|Physician Decision|3|||
125390173|NCT02510794|451061924|FG001|Overall Study|Physician Decision|0|||
125390174|NCT02510794|451061925|FG002|Overall Study|Physician Decision|0|||
125390175|NCT02510794|451061926|FG003|Overall Study|Physician Decision|0|||
125390176|NCT02510794|451061923|FG000|Overall Study|Protocol Violation|0|||
125390177|NCT02510794|451061924|FG001|Overall Study|Protocol Violation|0|||
125390178|NCT02510794|451061925|FG002|Overall Study|Protocol Violation|1|||
125390179|NCT02510794|451061926|FG003|Overall Study|Protocol Violation|0|||
125390180|NCT02510794|451061923|FG000|Overall Study|Withdrawal by Subject|1|||
125390181|NCT02510794|451061924|FG001|Overall Study|Withdrawal by Subject|2|||
125390182|NCT02510794|451061925|FG002|Overall Study|Withdrawal by Subject|4|||
125390183|NCT02510794|451061926|FG003|Overall Study|Withdrawal by Subject|3|||
125390184|NCT03090100|451061927|FG000|Overall Study|Adverse Event|9|||
125390185|NCT03090100|451061928|FG001|Overall Study|Adverse Event|11|||
125390186|NCT03090100|451061927|FG000|Overall Study|Pregnancy|1|||
125390187|NCT03090100|451061928|FG001|Overall Study|Pregnancy|1|||
125390188|NCT03090100|451061927|FG000|Overall Study|Lack of Efficacy|2|||
125390189|NCT03090100|451061928|FG001|Overall Study|Lack of Efficacy|7|||
125390190|NCT03090100|451061927|FG000|Overall Study|Lost to Follow-up|2|||
125390191|NCT03090100|451061928|FG001|Overall Study|Lost to Follow-up|2|||
125390192|NCT03090100|451061927|FG000|Overall Study|Withdrawal by Subject|7|||
125390193|NCT03090100|451061928|FG001|Overall Study|Withdrawal by Subject|19|||
125390194|NCT03090100|451061927|FG000|Overall Study|Protocol Violation|2|||
125390195|NCT03090100|451061928|FG001|Overall Study|Protocol Violation|6|||
125390196|NCT03090100|451061927|FG000|Overall Study|Non-compliance|2|||
125390197|NCT03090100|451061928|FG001|Overall Study|Non-compliance|0|||
125390198|NCT03090100|451061927|FG000|Overall Study|Other|2|||
125390199|NCT03090100|451061928|FG001|Overall Study|Other|2|||
125390200|NCT01660711|451061929|FG000|Overall Study|Adverse Event|7|||
125390201|NCT01660711|451061929|FG000|Overall Study|Withdrawal by Subject|1|||
125390202|NCT02532647|451061937|FG000|Overall Study|Did not receive trial medication|1|||
125390203|NCT02532647|451061938|FG001|Overall Study|Did not receive trial medication|0|||
125390204|NCT02532647|451061939|FG002|Overall Study|Did not receive trial medication|1|||
125390205|NCT02420691|451061945|FG000|Overall Study|Adverse Event|3|||
125390206|NCT02420691|451061945|FG000|Overall Study|Withdrawal by Subject|3|||
125390207|NCT05694546|451061948|FG000|Overall Study|Lost to Follow-up|11|||
125390208|NCT01589445|451061949|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
125390209|NCT01589445|451061949|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
125390210|NCT01589445|451061949|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
125390211|NCT01589445|451061949|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
125390212|NCT01589445|451061949|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
125390213|NCT01589445|451061949|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
125390214|NCT01589445|451061949|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
125390215|NCT01589445|451061949|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
125390216|NCT01589445|451061949|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
125390217|NCT01589445|451061949|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
125390218|NCT00325754|451061950|FG000|Overall Study|Adverse Event|4|||
125390219|NCT00325754|451061951|FG001|Overall Study|Adverse Event|1|||
125390220|NCT02972632|451061957|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
125390221|NCT02972632|451061957|FG000|Overall Study|Lost to Follow-up|4|||
125390222|NCT02972632|451061957|FG000|Overall Study|Voluntary Withdrawal|10|||
125160677|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160678|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160679|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160680|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160681|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125390223|NCT01488097|451061967|FG000|Overall Study|Lost to Follow-up|1|||
125390224|NCT03054870|451061988|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
125390225|NCT03054870|451061988|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
125390226|NCT01324388|451061989|FG000|Part 1 of Study|Adverse Event|2|||
125390227|NCT01324388|451061990|FG001|Part 1 of Study|Adverse Event|0|||
125390228|NCT01324388|451061991|FG002|Part 1 of Study|Adverse Event|0|||
125390229|NCT01324388|451061992|FG003|Part 1 of Study|Adverse Event|0|||
125390230|NCT01324388|451061989|FG000|Part 1 of Study|Protocol Violation|1|||
125160682|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
125160683|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160684|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160685|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
125160686|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125390231|NCT01324388|451061990|FG001|Part 1 of Study|Protocol Violation|2|||
125390232|NCT01324388|451061991|FG002|Part 1 of Study|Protocol Violation|0|||
125390233|NCT01324388|451061992|FG003|Part 1 of Study|Protocol Violation|0|||
125390234|NCT01324388|451061989|FG000|Part 1 of Study|Physician Decision|1|||
125390235|NCT01324388|451061990|FG001|Part 1 of Study|Physician Decision|0|||
125390236|NCT01324388|451061991|FG002|Part 1 of Study|Physician Decision|0|||
125390237|NCT01324388|451061992|FG003|Part 1 of Study|Physician Decision|0|||
125390238|NCT01324388|451061989|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
125390239|NCT01324388|451061990|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
125390240|NCT01324388|451061991|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
125390241|NCT01324388|451061992|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
125390242|NCT01324388|451061989|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
125390243|NCT01324388|451061990|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
125390244|NCT01324388|451061991|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
125390245|NCT01324388|451061992|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
125390246|NCT03089606|451061993|FG000|Overall Study|Progression after Cycle 1|1|||
125390247|NCT02140567|451061995|FG000|Overall Study|Problems with recording equipment|6|||
125390248|NCT01709695|451061997|FG000|Overall Study|Withdrawal by Subject|1|||
125390249|NCT01709695|451061998|FG001|Overall Study|Withdrawal by Subject|1|||
125390250|NCT02802592|451061999|FG000|Overall Study|Study terminated due to loss of funding|4|||
125390251|NCT02882854|451062000|FG000|Overall Study|Lost to Follow-up|1|||
125390252|NCT02882854|451062001|FG001|Overall Study|Lost to Follow-up|2|||
125390253|NCT02882854|451062000|FG000|Overall Study|Physician Decision|0|||
125390254|NCT02882854|451062001|FG001|Overall Study|Physician Decision|1|||
125390255|NCT02039674|451062005|FG000|Overall Study|Adverse Event|0|||
125390256|NCT02039674|451062006|FG001|Overall Study|Adverse Event|0|||
125390257|NCT02039674|451062007|FG002|Overall Study|Adverse Event|0|||
125390258|NCT02039674|451062008|FG003|Overall Study|Adverse Event|1|||
125390259|NCT02039674|451062009|FG004|Overall Study|Adverse Event|0|||
125390260|NCT02039674|451062010|FG005|Overall Study|Adverse Event|0|||
125390261|NCT02039674|451062011|FG006|Overall Study|Adverse Event|0|||
125390262|NCT02039674|451062012|FG007|Overall Study|Adverse Event|0|||
125390263|NCT02039674|451062013|FG008|Overall Study|Adverse Event|2|||
125390264|NCT02039674|451062014|FG009|Overall Study|Adverse Event|1|||
125390265|NCT02039674|451062015|FG010|Overall Study|Adverse Event|0|||
125390266|NCT02039674|451062016|FG011|Overall Study|Adverse Event|2|||
125390267|NCT02039674|451062017|FG012|Overall Study|Adverse Event|3|||
125390268|NCT02039674|451062018|FG013|Overall Study|Adverse Event|1|||
125390269|NCT02039674|451062005|FG000|Overall Study|Death|2|||
125390270|NCT02039674|451062006|FG001|Overall Study|Death|0|||
125160687|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160688|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160689|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160690|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160691|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160692|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160693|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160694|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160695|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160696|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
125160697|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160698|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160699|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
125160700|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
125160701|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160702|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160703|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160704|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160705|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160706|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160707|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125390271|NCT02039674|451062007|FG002|Overall Study|Death|2|||
125390272|NCT02039674|451062008|FG003|Overall Study|Death|3|||
125390273|NCT02039674|451062009|FG004|Overall Study|Death|0|||
125390274|NCT02039674|451062010|FG005|Overall Study|Death|0|||
125390275|NCT02039674|451062011|FG006|Overall Study|Death|1|||
125390276|NCT02039674|451062012|FG007|Overall Study|Death|0|||
125390277|NCT02039674|451062013|FG008|Overall Study|Death|2|||
125390278|NCT02039674|451062014|FG009|Overall Study|Death|0|||
125390279|NCT02039674|451062015|FG010|Overall Study|Death|1|||
125390280|NCT02039674|451062016|FG011|Overall Study|Death|3|||
125390281|NCT02039674|451062017|FG012|Overall Study|Death|2|||
125390282|NCT02039674|451062018|FG013|Overall Study|Death|8|||
125390283|NCT02039674|451062005|FG000|Overall Study|Excluded Medication|1|||
125390284|NCT02039674|451062006|FG001|Overall Study|Excluded Medication|1|||
125390285|NCT02039674|451062007|FG002|Overall Study|Excluded Medication|0|||
125390286|NCT02039674|451062008|FG003|Overall Study|Excluded Medication|1|||
125390287|NCT02039674|451062009|FG004|Overall Study|Excluded Medication|0|||
125390288|NCT02039674|451062010|FG005|Overall Study|Excluded Medication|1|||
125390289|NCT02039674|451062011|FG006|Overall Study|Excluded Medication|0|||
125390290|NCT02039674|451062012|FG007|Overall Study|Excluded Medication|0|||
125390291|NCT02039674|451062013|FG008|Overall Study|Excluded Medication|2|||
125390292|NCT02039674|451062014|FG009|Overall Study|Excluded Medication|3|||
125390293|NCT02039674|451062015|FG010|Overall Study|Excluded Medication|5|||
125390294|NCT02039674|451062016|FG011|Overall Study|Excluded Medication|6|||
125390295|NCT02039674|451062017|FG012|Overall Study|Excluded Medication|8|||
125390296|NCT02039674|451062018|FG013|Overall Study|Excluded Medication|3|||
125390297|NCT02039674|451062005|FG000|Overall Study|Lost to Follow-up|0|||
125390298|NCT02039674|451062006|FG001|Overall Study|Lost to Follow-up|0|||
125390299|NCT02039674|451062007|FG002|Overall Study|Lost to Follow-up|0|||
125390300|NCT02039674|451062008|FG003|Overall Study|Lost to Follow-up|0|||
125390301|NCT02039674|451062009|FG004|Overall Study|Lost to Follow-up|1|||
125390302|NCT02039674|451062010|FG005|Overall Study|Lost to Follow-up|1|||
125390303|NCT02039674|451062011|FG006|Overall Study|Lost to Follow-up|0|||
125390304|NCT02039674|451062012|FG007|Overall Study|Lost to Follow-up|0|||
125390305|NCT02039674|451062013|FG008|Overall Study|Lost to Follow-up|0|||
125390306|NCT02039674|451062014|FG009|Overall Study|Lost to Follow-up|0|||
125390307|NCT02039674|451062015|FG010|Overall Study|Lost to Follow-up|0|||
125390308|NCT02039674|451062016|FG011|Overall Study|Lost to Follow-up|2|||
125390309|NCT02039674|451062017|FG012|Overall Study|Lost to Follow-up|2|||
125160708|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160709|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160710|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
125160711|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160712|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160713|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160714|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
125160715|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160716|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160717|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160718|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160719|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160720|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160721|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160722|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160723|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160724|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
125160725|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160726|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160727|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
125160728|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
125160729|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160730|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160731|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160732|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160733|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160734|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160735|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160736|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160737|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125160738|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
125390310|NCT02039674|451062018|FG013|Overall Study|Lost to Follow-up|1|||
125390311|NCT02039674|451062005|FG000|Overall Study|Physician Decision|0|||
125390312|NCT02039674|451062006|FG001|Overall Study|Physician Decision|0|||
125390313|NCT02039674|451062007|FG002|Overall Study|Physician Decision|0|||
125390314|NCT02039674|451062008|FG003|Overall Study|Physician Decision|0|||
125390315|NCT02039674|451062009|FG004|Overall Study|Physician Decision|0|||
125439828|NCT00284089|451237580|FG000|Extension Phase|condition no longer requires study drug|2|||
125390316|NCT02039674|451062010|FG005|Overall Study|Physician Decision|0|||
125224334|NCT05635045|450448153|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
125224335|NCT05635045|450448154|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
125224336|NCT05635045|450448155|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
125224337|NCT02131064|450448163|FG000|Overall Study|Death|5|||
125224338|NCT02131064|450448164|FG001|Overall Study|Death|6|||
125224339|NCT02131064|450448163|FG000|Overall Study|Lost to Follow-up|4|||
125224340|NCT02131064|450448164|FG001|Overall Study|Lost to Follow-up|8|||
125224341|NCT02131064|450448163|FG000|Overall Study|Withdrawal by Subject|14|||
125224342|NCT02131064|450448164|FG001|Overall Study|Withdrawal by Subject|18|||
125224343|NCT02131064|450448163|FG000|Overall Study|Other|2|||
125224344|NCT02131064|450448164|FG001|Overall Study|Other|2|||
125224345|NCT00810069|450448165|FG000|Lead-in Period I|Adverse Event|43|||
125224346|NCT00810069|450448166|FG001|Lead-in Period I|Adverse Event|0|||
125224347|NCT00810069|450448167|FG002|Lead-in Period I|Adverse Event|0|||
125224348|NCT00810069|450448165|FG000|Lead-in Period I|Lack of Efficacy|1|||
125224349|NCT00810069|450448166|FG001|Lead-in Period I|Lack of Efficacy|0|||
125224350|NCT00810069|450448167|FG002|Lead-in Period I|Lack of Efficacy|0|||
125224351|NCT00810069|450448165|FG000|Lead-in Period I|Lost to Follow-up|19|||
125224352|NCT00810069|450448166|FG001|Lead-in Period I|Lost to Follow-up|0|||
125224353|NCT00810069|450448167|FG002|Lead-in Period I|Lost to Follow-up|0|||
125224354|NCT00810069|450448165|FG000|Lead-in Period I|Physician Decision|1|||
125224355|NCT00810069|450448166|FG001|Lead-in Period I|Physician Decision|0|||
125224356|NCT00810069|450448167|FG002|Lead-in Period I|Physician Decision|0|||
125224357|NCT00810069|450448165|FG000|Lead-in Period I|Protocol Violation|1|||
125224358|NCT00810069|450448166|FG001|Lead-in Period I|Protocol Violation|0|||
125224359|NCT00810069|450448167|FG002|Lead-in Period I|Protocol Violation|0|||
125224360|NCT00810069|450448165|FG000|Lead-in Period I|Withdrawal by Subject|46|||
125224361|NCT00810069|450448166|FG001|Lead-in Period I|Withdrawal by Subject|0|||
125224362|NCT00810069|450448167|FG002|Lead-in Period I|Withdrawal by Subject|0|||
125224363|NCT00810069|450448165|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
125224364|NCT00810069|450448166|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
125224365|NCT00810069|450448167|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
125224366|NCT00810069|450448165|FG000|Lead-in Period I|Randomization criteria not met|158|||
125224367|NCT00810069|450448166|FG001|Lead-in Period I|Randomization criteria not met|0|||
125224368|NCT00810069|450448167|FG002|Lead-in Period I|Randomization criteria not met|0|||
125224369|NCT00810069|450448165|FG000|Double-Blind Period II|Adverse Event|0|||
125224370|NCT00810069|450448166|FG001|Double-Blind Period II|Adverse Event|9|||
125224371|NCT00810069|450448167|FG002|Double-Blind Period II|Adverse Event|8|||
125224372|NCT00810069|450448165|FG000|Double-Blind Period II|Lack of Efficacy|0|||
125224373|NCT00810069|450448166|FG001|Double-Blind Period II|Lack of Efficacy|7|||
125224374|NCT00810069|450448167|FG002|Double-Blind Period II|Lack of Efficacy|12|||
125224375|NCT00810069|450448165|FG000|Double-Blind Period II|Lost to Follow-up|0|||
125224376|NCT00810069|450448166|FG001|Double-Blind Period II|Lost to Follow-up|9|||
125224377|NCT00810069|450448167|FG002|Double-Blind Period II|Lost to Follow-up|9|||
125224378|NCT00810069|450448165|FG000|Double-Blind Period II|Physician Decision|0|||
125224379|NCT00810069|450448166|FG001|Double-Blind Period II|Physician Decision|0|||
125224380|NCT00810069|450448167|FG002|Double-Blind Period II|Physician Decision|1|||
125224381|NCT00810069|450448165|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
125224382|NCT00810069|450448166|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
125224383|NCT00810069|450448167|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
125224384|NCT00810069|450448165|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
125390317|NCT02039674|451062011|FG006|Overall Study|Physician Decision|0|||
125390318|NCT02039674|451062012|FG007|Overall Study|Physician Decision|0|||
125390319|NCT02039674|451062013|FG008|Overall Study|Physician Decision|0|||
125390320|NCT02039674|451062014|FG009|Overall Study|Physician Decision|0|||
125390321|NCT02039674|451062015|FG010|Overall Study|Physician Decision|0|||
125390322|NCT02039674|451062016|FG011|Overall Study|Physician Decision|1|||
125390323|NCT02039674|451062017|FG012|Overall Study|Physician Decision|1|||
125390324|NCT02039674|451062018|FG013|Overall Study|Physician Decision|0|||
125390325|NCT02039674|451062005|FG000|Overall Study|Progressive Disease|8|||
125390326|NCT02039674|451062006|FG001|Overall Study|Progressive Disease|8|||
125390327|NCT02039674|451062007|FG002|Overall Study|Progressive Disease|6|||
125390328|NCT02039674|451062008|FG003|Overall Study|Progressive Disease|7|||
125390329|NCT02039674|451062009|FG004|Overall Study|Progressive Disease|9|||
125224385|NCT00810069|450448166|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
125224386|NCT00810069|450448167|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
125224387|NCT00810069|450448165|FG000|Double-Blind Period II|Clinical relapse|0|||
125224388|NCT00810069|450448166|FG001|Double-Blind Period II|Clinical relapse|3|||
125224389|NCT00810069|450448167|FG002|Double-Blind Period II|Clinical relapse|0|||
125224390|NCT00810069|450448165|FG000|Double-Blind Period II|Protocol Violation|0|||
125390330|NCT02039674|451062010|FG005|Overall Study|Progressive Disease|10|||
125390331|NCT02039674|451062011|FG006|Overall Study|Progressive Disease|1|||
125224391|NCT00810069|450448166|FG001|Double-Blind Period II|Protocol Violation|7|||
125224392|NCT00810069|450448167|FG002|Double-Blind Period II|Protocol Violation|6|||
125390332|NCT02039674|451062012|FG007|Overall Study|Progressive Disease|3|||
125224393|NCT00971867|450448171|FG000|Overall Study|Adverse Event|4|||
125224394|NCT00971867|450448171|FG000|Overall Study|Participant Withdrew Consent|1|||
125224395|NCT00971867|450448171|FG000|Overall Study|Disease Progression|6|||
125224396|NCT04767373|450448172|FG000|Overall Study|Death|6|||
125224397|NCT04767373|450448173|FG001|Overall Study|Death|3|||
125224398|NCT04767373|450448172|FG000|Overall Study|Lost to Follow-up|67|||
125224399|NCT04767373|450448173|FG001|Overall Study|Lost to Follow-up|35|||
125224400|NCT04767373|450448172|FG000|Overall Study|Physician Decision|15|||
125224401|NCT04767373|450448173|FG001|Overall Study|Physician Decision|4|||
125224402|NCT04767373|450448172|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125224403|NCT04767373|450448173|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125224404|NCT04767373|450448172|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
125224405|NCT04767373|450448173|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
125224406|NCT04767373|450448172|FG000|Overall Study|Other|1|||
125224407|NCT04767373|450448173|FG001|Overall Study|Other|2|||
125224408|NCT00593918|450448175|FG000|Overall Study|Withdrawal by Subject|5|||
125224409|NCT00593918|450448176|FG001|Overall Study|Withdrawal by Subject|24|||
125224410|NCT02983045|450448177|FG000|Overall Study|Withdrawal by Subject|0|||
125224411|NCT02983045|450448178|FG001|Overall Study|Withdrawal by Subject|1|||
125224412|NCT02983045|450448179|FG002|Overall Study|Withdrawal by Subject|0|||
125439829|NCT00284089|451237581|FG001|Extension Phase|condition no longer requires study drug|0|||
125439830|NCT00284089|451237582|FG002|Extension Phase|condition no longer requires study drug|2|||
125224413|NCT02983045|450448180|FG003|Overall Study|Withdrawal by Subject|5|||
125224414|NCT02983045|450448181|FG004|Overall Study|Withdrawal by Subject|0|||
125224415|NCT02983045|450448182|FG005|Overall Study|Withdrawal by Subject|72|||
125224416|NCT02983045|450448183|FG006|Overall Study|Withdrawal by Subject|0|||
125224417|NCT02983045|450448184|FG007|Overall Study|Withdrawal by Subject|0|||
125224418|NCT02983045|450448185|FG008|Overall Study|Withdrawal by Subject|0|||
125224419|NCT02983045|450448186|FG009|Overall Study|Withdrawal by Subject|2|||
125224420|NCT02983045|450448177|FG000|Overall Study|Lost to Follow-up|0|||
125224421|NCT02983045|450448178|FG001|Overall Study|Lost to Follow-up|0|||
125224422|NCT02983045|450448179|FG002|Overall Study|Lost to Follow-up|0|||
125224423|NCT02983045|450448180|FG003|Overall Study|Lost to Follow-up|0|||
125224424|NCT02983045|450448181|FG004|Overall Study|Lost to Follow-up|0|||
125224425|NCT02983045|450448182|FG005|Overall Study|Lost to Follow-up|10|||
125224426|NCT02983045|450448183|FG006|Overall Study|Lost to Follow-up|0|||
125224427|NCT02983045|450448184|FG007|Overall Study|Lost to Follow-up|0|||
125224428|NCT02983045|450448185|FG008|Overall Study|Lost to Follow-up|0|||
125224429|NCT02983045|450448186|FG009|Overall Study|Lost to Follow-up|0|||
125224430|NCT02658669|450448187|FG000|Overall Study|Lost to Follow-up|7|||
125439831|NCT00284089|451237583|FG003|Extension Phase|condition no longer requires study drug|7|||
125439832|NCT00284089|451237580|FG000|Extension Phase|Protocol Violation|0|||
125439833|NCT00284089|451237581|FG001|Extension Phase|Protocol Violation|0|||
125439834|NCT00284089|451237582|FG002|Extension Phase|Protocol Violation|1|||
125160739|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160740|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160741|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160742|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160743|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160744|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160745|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160746|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160747|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
125160748|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160749|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160750|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160751|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160752|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
125160753|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160754|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160755|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160756|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160757|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160758|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160759|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160760|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125224431|NCT02658669|450448188|FG001|Overall Study|Lost to Follow-up|5|||
125224432|NCT03727841|450448189|FG000|Overall Study|Physician Decision|3|||
125224433|NCT03727841|450448190|FG001|Overall Study|Physician Decision|1|||
125224434|NCT01601496|450448191|FG000|Overall Study|Physician Decision|1|||
125224435|NCT01601496|450448191|FG000|Overall Study|Withdrawal by Subject|1|||
125224436|NCT01601496|450448191|FG000|Overall Study|Lost to Follow-up|6|||
125224437|NCT01601496|450448191|FG000|Overall Study|Death|4|||
125439835|NCT00284089|451237583|FG003|Extension Phase|Protocol Violation|0|||
125439836|NCT00284089|451237580|FG000|Extension Phase|Withdrawal by Subject|0|||
125439837|NCT00284089|451237581|FG001|Extension Phase|Withdrawal by Subject|0|||
125439838|NCT00284089|451237582|FG002|Extension Phase|Withdrawal by Subject|1|||
125439839|NCT00284089|451237583|FG003|Extension Phase|Withdrawal by Subject|3|||
125439840|NCT01146574|451237586|FG000|Overall Study|Death|0|||
125439841|NCT01146574|451237587|FG001|Overall Study|Death|1|||
125439842|NCT01146574|451237588|FG002|Overall Study|Death|1|||
125439843|NCT01146574|451237589|FG003|Overall Study|Death|0|||
125439844|NCT01146574|451237590|FG004|Overall Study|Death|0|||
125439845|NCT01146574|451237591|FG005|Overall Study|Death|0|||
125439846|NCT01146574|451237592|FG006|Overall Study|Death|0|||
125439847|NCT01146574|451237586|FG000|Overall Study|Other reasons|0|||
125439848|NCT01146574|451237587|FG001|Overall Study|Other reasons|0|||
125439849|NCT01146574|451237588|FG002|Overall Study|Other reasons|3|||
125439850|NCT01146574|451237589|FG003|Overall Study|Other reasons|0|||
125439851|NCT01146574|451237590|FG004|Overall Study|Other reasons|0|||
125439852|NCT01146574|451237591|FG005|Overall Study|Other reasons|0|||
125439853|NCT01146574|451237592|FG006|Overall Study|Other reasons|0|||
125439854|NCT01146574|451237586|FG000|Overall Study|Kidney transplant|0|||
125439855|NCT01146574|451237587|FG001|Overall Study|Kidney transplant|0|||
125439856|NCT01146574|451237588|FG002|Overall Study|Kidney transplant|1|||
125439857|NCT01146574|451237589|FG003|Overall Study|Kidney transplant|1|||
125439858|NCT01146574|451237590|FG004|Overall Study|Kidney transplant|0|||
125439859|NCT01146574|451237591|FG005|Overall Study|Kidney transplant|0|||
125439860|NCT01146574|451237592|FG006|Overall Study|Kidney transplant|0|||
125439861|NCT01146574|451237586|FG000|Overall Study|Withdrew consent|0|||
125439862|NCT01146574|451237587|FG001|Overall Study|Withdrew consent|0|||
125439863|NCT01146574|451237588|FG002|Overall Study|Withdrew consent|1|||
125439864|NCT01146574|451237589|FG003|Overall Study|Withdrew consent|1|||
125439865|NCT01146574|451237590|FG004|Overall Study|Withdrew consent|2|||
125439866|NCT01146574|451237591|FG005|Overall Study|Withdrew consent|1|||
125439867|NCT01146574|451237592|FG006|Overall Study|Withdrew consent|1|||
125439868|NCT03051659|451237593|FG000|Treatment Period|Withdrawal by Subject|0|||
125439869|NCT03051659|451237594|FG001|Treatment Period|Withdrawal by Subject|2|||
125439870|NCT03051659|451237593|FG000|Survival Follow-up|Lost to Follow-up|23|||
125439871|NCT03051659|451237594|FG001|Survival Follow-up|Lost to Follow-up|22|||
125439872|NCT03053492|451237595|FG000|Overall Study|Adverse Event|1|||
125439873|NCT03053492|451237596|FG001|Overall Study|Adverse Event|1|||
125439874|NCT03053492|451237595|FG000|Overall Study|Withdrawal by Subject|7|||
125439875|NCT03053492|451237596|FG001|Overall Study|Withdrawal by Subject|5|||
125439876|NCT01868074|451237597|FG000|Overall Study|Lost to Follow-up|3|||
125439877|NCT01868074|451237598|FG001|Overall Study|Lost to Follow-up|2|||
125439878|NCT01868074|451237597|FG000|Overall Study|Withdrawal by Subject|4|||
125439879|NCT01868074|451237598|FG001|Overall Study|Withdrawal by Subject|2|||
125439880|NCT01544491|451237599|FG000|Overall Study|Withdrawal by Subject|3|||
125439881|NCT01544491|451237600|FG001|Overall Study|Withdrawal by Subject|2|||
125439882|NCT01544491|451237599|FG000|Overall Study|Lost to Follow-up|0|||
125439883|NCT01544491|451237600|FG001|Overall Study|Lost to Follow-up|1|||
125439884|NCT01544491|451237599|FG000|Overall Study|administrative problems|2|||
125439885|NCT01544491|451237600|FG001|Overall Study|administrative problems|0|||
125439886|NCT00967018|451237601|FG000|Overall Study|Adverse Event|2|||
125439887|NCT00967018|451237601|FG000|Overall Study|Physician Decision|7|||
125439888|NCT00967018|451237601|FG000|Overall Study|Lost to Follow-up|2|||
125439889|NCT00967018|451237601|FG000|Overall Study|Withdrawal by Subject|1|||
125439890|NCT00967018|451237601|FG000|Overall Study|Miscellaneous Reasons|9|||
125439891|NCT04642469|451237607|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
125439892|NCT04642469|451237608|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
125439893|NCT04642469|451237607|FG000|Overall Study|Death|1|||
125439894|NCT04642469|451237608|FG001|Overall Study|Death|2|||
125439895|NCT04642469|451237607|FG000|Overall Study|Study/site closed following amendment 1|11|||
125160761|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
125160762|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160763|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125439896|NCT04642469|451237608|FG001|Overall Study|Study/site closed following amendment 1|11|||
125439897|NCT04642469|451237607|FG000|Overall Study|Other|1|||
125439898|NCT04642469|451237608|FG001|Overall Study|Other|1|||
125439899|NCT04642469|451237607|FG000|Overall Study|Withdrawal by Subject|1|||
125439900|NCT04642469|451237608|FG001|Overall Study|Withdrawal by Subject|0|||
125439901|NCT00680056|451237610|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
125160764|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125439902|NCT00680056|451237611|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
125439903|NCT00680056|451237610|FG000|Second Intervention|Protocol Violation|3|||
125439904|NCT00680056|451237611|FG001|Second Intervention|Protocol Violation|1|||
125439905|NCT02733042|451237612|FG000|Overall Study|Adverse Event|1|||
125439906|NCT02733042|451237613|FG001|Overall Study|Adverse Event|0|||
125439907|NCT02733042|451237614|FG002|Overall Study|Adverse Event|1|||
125390333|NCT02039674|451062013|FG008|Overall Study|Progressive Disease|6|||
125390334|NCT02039674|451062014|FG009|Overall Study|Progressive Disease|4|||
125390335|NCT02039674|451062015|FG010|Overall Study|Progressive Disease|0|||
125160765|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160766|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
125160767|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160768|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160769|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160770|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160771|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160772|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160773|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160774|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160775|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
125160776|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160777|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160778|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160779|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160780|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
125160781|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160782|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160783|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160784|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160785|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160786|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160787|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160788|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160789|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
125160790|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160791|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160792|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160793|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160794|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
125160795|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160796|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160797|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160798|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160799|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160800|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160801|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160802|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160803|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
125160804|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160805|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160806|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160807|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160808|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
125160809|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160810|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160811|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125390336|NCT02039674|451062016|FG011|Overall Study|Progressive Disease|34|||
125390337|NCT02039674|451062017|FG012|Overall Study|Progressive Disease|34|||
125390338|NCT02039674|451062018|FG013|Overall Study|Progressive Disease|18|||
125390339|NCT02039674|451062005|FG000|Overall Study|Withdrawal by Subject|1|||
125390340|NCT02039674|451062006|FG001|Overall Study|Withdrawal by Subject|2|||
125390341|NCT02039674|451062007|FG002|Overall Study|Withdrawal by Subject|3|||
125390342|NCT02039674|451062008|FG003|Overall Study|Withdrawal by Subject|0|||
125390343|NCT02039674|451062009|FG004|Overall Study|Withdrawal by Subject|1|||
125390344|NCT02039674|451062010|FG005|Overall Study|Withdrawal by Subject|0|||
125390345|NCT02039674|451062011|FG006|Overall Study|Withdrawal by Subject|0|||
125390346|NCT02039674|451062012|FG007|Overall Study|Withdrawal by Subject|0|||
125160812|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160813|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160814|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
125390347|NCT02039674|451062013|FG008|Overall Study|Withdrawal by Subject|0|||
125390348|NCT02039674|451062014|FG009|Overall Study|Withdrawal by Subject|1|||
125390349|NCT02039674|451062015|FG010|Overall Study|Withdrawal by Subject|1|||
125390350|NCT02039674|451062016|FG011|Overall Study|Withdrawal by Subject|4|||
125390351|NCT02039674|451062017|FG012|Overall Study|Withdrawal by Subject|6|||
125390352|NCT02039674|451062018|FG013|Overall Study|Withdrawal by Subject|2|||
125390353|NCT02039674|451062005|FG000|Overall Study|Clinical Progression|0|||
125390354|NCT02039674|451062006|FG001|Overall Study|Clinical Progression|0|||
125390355|NCT02039674|451062007|FG002|Overall Study|Clinical Progression|0|||
125390356|NCT02039674|451062008|FG003|Overall Study|Clinical Progression|0|||
125390357|NCT02039674|451062009|FG004|Overall Study|Clinical Progression|0|||
125390358|NCT02039674|451062010|FG005|Overall Study|Clinical Progression|0|||
125390359|NCT02039674|451062011|FG006|Overall Study|Clinical Progression|1|||
125390360|NCT02039674|451062012|FG007|Overall Study|Clinical Progression|0|||
125390361|NCT02039674|451062013|FG008|Overall Study|Clinical Progression|0|||
125390362|NCT02039674|451062014|FG009|Overall Study|Clinical Progression|0|||
125390363|NCT02039674|451062015|FG010|Overall Study|Clinical Progression|0|||
125390364|NCT02039674|451062016|FG011|Overall Study|Clinical Progression|0|||
125390365|NCT02039674|451062017|FG012|Overall Study|Clinical Progression|1|||
125390366|NCT02039674|451062018|FG013|Overall Study|Clinical Progression|0|||
125390367|NCT02039674|451062005|FG000|Overall Study|Sponsor Decision|1|||
125390368|NCT02039674|451062006|FG001|Overall Study|Sponsor Decision|1|||
125390369|NCT02039674|451062007|FG002|Overall Study|Sponsor Decision|1|||
125390370|NCT02039674|451062008|FG003|Overall Study|Sponsor Decision|1|||
125390371|NCT02039674|451062009|FG004|Overall Study|Sponsor Decision|1|||
125390372|NCT02039674|451062010|FG005|Overall Study|Sponsor Decision|0|||
125390373|NCT02039674|451062011|FG006|Overall Study|Sponsor Decision|0|||
125390374|NCT02039674|451062012|FG007|Overall Study|Sponsor Decision|0|||
125390375|NCT02039674|451062013|FG008|Overall Study|Sponsor Decision|0|||
125390376|NCT02039674|451062014|FG009|Overall Study|Sponsor Decision|3|||
125390377|NCT02039674|451062015|FG010|Overall Study|Sponsor Decision|0|||
125390378|NCT02039674|451062016|FG011|Overall Study|Sponsor Decision|8|||
125390379|NCT02039674|451062017|FG012|Overall Study|Sponsor Decision|5|||
125390380|NCT02039674|451062018|FG013|Overall Study|Sponsor Decision|0|||
125390381|NCT02039674|451062005|FG000|Overall Study|Other|0|||
125390382|NCT02039674|451062006|FG001|Overall Study|Other|0|||
125390383|NCT02039674|451062007|FG002|Overall Study|Other|0|||
125390384|NCT02039674|451062008|FG003|Overall Study|Other|0|||
125390385|NCT02039674|451062009|FG004|Overall Study|Other|0|||
125390386|NCT02039674|451062010|FG005|Overall Study|Other|0|||
125390387|NCT02039674|451062011|FG006|Overall Study|Other|0|||
125390388|NCT02039674|451062012|FG007|Overall Study|Other|0|||
125390389|NCT02039674|451062013|FG008|Overall Study|Other|0|||
125390390|NCT02039674|451062014|FG009|Overall Study|Other|0|||
125390391|NCT02039674|451062015|FG010|Overall Study|Other|0|||
125390392|NCT02039674|451062016|FG011|Overall Study|Other|0|||
125390393|NCT02039674|451062017|FG012|Overall Study|Other|1|||
125390394|NCT02039674|451062018|FG013|Overall Study|Other|0|||
125390395|NCT01358357|451062019|FG000|Open Label Phase|Adverse Event|0|||
125390396|NCT01358357|451062020|FG001|Open Label Phase|Adverse Event|0|||
125390397|NCT01358357|451062021|FG002|Open Label Phase|Adverse Event|59|||
125390398|NCT01358357|451062019|FG000|Open Label Phase|Lack of Efficacy|0|||
125390399|NCT01358357|451062020|FG001|Open Label Phase|Lack of Efficacy|0|||
125390400|NCT01358357|451062021|FG002|Open Label Phase|Lack of Efficacy|107|||
125390401|NCT01358357|451062019|FG000|Open Label Phase|Lost to Follow-up|0|||
125390402|NCT01358357|451062020|FG001|Open Label Phase|Lost to Follow-up|0|||
125390403|NCT01358357|451062021|FG002|Open Label Phase|Lost to Follow-up|76|||
125390404|NCT01358357|451062019|FG000|Open Label Phase|Protocol Violation|0|||
125390405|NCT01358357|451062020|FG001|Open Label Phase|Protocol Violation|0|||
125390406|NCT01358357|451062021|FG002|Open Label Phase|Protocol Violation|45|||
125390407|NCT01358357|451062019|FG000|Open Label Phase|Withdrawal by Subject|0|||
125390408|NCT01358357|451062020|FG001|Open Label Phase|Withdrawal by Subject|0|||
125390409|NCT01358357|451062021|FG002|Open Label Phase|Withdrawal by Subject|112|||
125160815|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160816|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
125390410|NCT01358357|451062019|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
125390411|NCT01358357|451062020|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
125390412|NCT01358357|451062021|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
125390413|NCT01358357|451062019|FG000|Open Label Phase|Terminated at study completion|0|||
125390414|NCT01358357|451062020|FG001|Open Label Phase|Terminated at study completion|0|||
125390415|NCT01358357|451062021|FG002|Open Label Phase|Terminated at study completion|5|||
125390416|NCT01358357|451062019|FG000|Open Label Phase|Mood episode|0|||
125390417|NCT01358357|451062020|FG001|Open Label Phase|Mood episode|0|||
125390418|NCT01358357|451062021|FG002|Open Label Phase|Mood episode|42|||
125160817|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
125390419|NCT01358357|451062019|FG000|Double-Blind Phase|Adverse Event|8|||
125390420|NCT01358357|451062020|FG001|Double-Blind Phase|Adverse Event|5|||
125390421|NCT01358357|451062021|FG002|Double-Blind Phase|Adverse Event|0|||
125390422|NCT01358357|451062019|FG000|Double-Blind Phase|Lost to Follow-up|5|||
125390423|NCT01358357|451062020|FG001|Double-Blind Phase|Lost to Follow-up|7|||
125390424|NCT01358357|451062021|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125390425|NCT01358357|451062019|FG000|Double-Blind Phase|Protocol Violation|1|||
125390426|NCT01358357|451062020|FG001|Double-Blind Phase|Protocol Violation|11|||
125390427|NCT01358357|451062021|FG002|Double-Blind Phase|Protocol Violation|0|||
125390428|NCT01358357|451062019|FG000|Double-Blind Phase|Protocol Violation|16|||
125390429|NCT01358357|451062020|FG001|Double-Blind Phase|Protocol Violation|12|||
125390430|NCT01358357|451062021|FG002|Double-Blind Phase|Protocol Violation|0|||
125390431|NCT01358357|451062019|FG000|Double-Blind Phase|Terminated at study completion|2|||
125390432|NCT01358357|451062020|FG001|Double-Blind Phase|Terminated at study completion|0|||
125390433|NCT01358357|451062021|FG002|Double-Blind Phase|Terminated at study completion|0|||
125390434|NCT01358357|451062019|FG000|Double-Blind Phase|Recurrence of mood event|48|||
125390435|NCT01358357|451062020|FG001|Double-Blind Phase|Recurrence of mood event|64|||
125390436|NCT01358357|451062021|FG002|Double-Blind Phase|Recurrence of mood event|0|||
125390437|NCT01358357|451062019|FG000|Double-Blind Phase|Administrative|0|||
125390438|NCT01358357|451062020|FG001|Double-Blind Phase|Administrative|1|||
125390439|NCT01358357|451062021|FG002|Double-Blind Phase|Administrative|0|||
125390440|NCT00537381|451062022|FG000|Overall Study|Adverse Event|13|||
125390441|NCT00537381|451062023|FG001|Overall Study|Adverse Event|9|||
125390442|NCT00537381|451062022|FG000|Overall Study|Death|3|||
125390443|NCT00537381|451062023|FG001|Overall Study|Death|3|||
125390444|NCT00537381|451062022|FG000|Overall Study|Withdrawal by Subject|5|||
125390445|NCT00537381|451062023|FG001|Overall Study|Withdrawal by Subject|14|||
125390446|NCT00537381|451062022|FG000|Overall Study|Physician Decision|7|||
125390447|NCT00537381|451062023|FG001|Overall Study|Physician Decision|6|||
125390448|NCT00537381|451062022|FG000|Overall Study|Disease Progression|9|||
125390449|NCT00537381|451062023|FG001|Overall Study|Disease Progression|18|||
125390450|NCT00537381|451062022|FG000|Overall Study|Sponsor decision|14|||
125390451|NCT00537381|451062023|FG001|Overall Study|Sponsor decision|9|||
125390452|NCT00537381|451062022|FG000|Overall Study|Other|5|||
125390453|NCT00537381|451062023|FG001|Overall Study|Other|3|||
125390454|NCT02590939|451062024|FG000|Overall Study|Withdrawal by Subject|3|||
125390455|NCT02590939|451062025|FG001|Overall Study|Withdrawal by Subject|1|||
125390456|NCT02590939|451062024|FG000|Overall Study|Failed the nociceptive test|2|||
125390457|NCT02590939|451062025|FG001|Overall Study|Failed the nociceptive test|1|||
125390458|NCT02347189|451062030|FG000|Overall Study|No implant attempted of study device|9|||
125390459|NCT02347189|451062030|FG000|Overall Study|No primary outcome data available|2|||
125390460|NCT00994240|451062032|FG000|Overall Study|Lost to Follow-up|3|||
125390461|NCT00994240|451062033|FG001|Overall Study|Lost to Follow-up|2|||
125390462|NCT00994240|451062032|FG000|Overall Study|Withdrawal by Subject|1|||
125390463|NCT00994240|451062033|FG001|Overall Study|Withdrawal by Subject|0|||
125390464|NCT00994240|451062032|FG000|Overall Study|study termination|2|||
125390465|NCT00994240|451062033|FG001|Overall Study|study termination|3|||
125390466|NCT00352846|451062034|FG000|Overall Study|Disease progression|0|||
125390467|NCT00352846|451062035|FG001|Overall Study|Disease progression|2|||
125390468|NCT00352846|451062034|FG000|Overall Study|Withdrawal by Subject|3|||
125390469|NCT00352846|451062035|FG001|Overall Study|Withdrawal by Subject|8|||
125390470|NCT00352846|451062034|FG000|Overall Study|Ineligible|3|||
125390471|NCT00352846|451062035|FG001|Overall Study|Ineligible|2|||
125390472|NCT00352846|451062034|FG000|Overall Study|Non-compliance|2|||
125390473|NCT00352846|451062035|FG001|Overall Study|Non-compliance|0|||
125390474|NCT00352846|451062034|FG000|Overall Study|Death|0|||
125390475|NCT00352846|451062035|FG001|Overall Study|Death|1|||
125390476|NCT01527682|451062036|FG000|Overall Study|Protocol Violation|8|||
125390477|NCT00600938|451062039|FG000|Core Study|Abnormal test procedure result(s)|3|||
125390478|NCT00600938|451062040|FG001|Core Study|Abnormal test procedure result(s)|2|||
125390479|NCT00600938|451062041|FG002|Core Study|Abnormal test procedure result(s)|0|||
125390480|NCT00600938|451062042|FG003|Core Study|Abnormal test procedure result(s)|0|||
125390481|NCT00600938|451062039|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
125390482|NCT00600938|451062040|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
125390483|NCT00600938|451062041|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
125390484|NCT00600938|451062042|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
125390485|NCT00600938|451062039|FG000|Core Study|Patient withdrew consent|7|||
125390486|NCT00600938|451062040|FG001|Core Study|Patient withdrew consent|12|||
125390487|NCT00600938|451062041|FG002|Core Study|Patient withdrew consent|0|||
125390488|NCT00600938|451062042|FG003|Core Study|Patient withdrew consent|0|||
125390489|NCT00600938|451062039|FG000|Core Study|Lost to Follow-up|3|||
125390490|NCT00600938|451062040|FG001|Core Study|Lost to Follow-up|2|||
125390491|NCT00600938|451062041|FG002|Core Study|Lost to Follow-up|0|||
125390492|NCT00600938|451062042|FG003|Core Study|Lost to Follow-up|0|||
125390493|NCT00600938|451062039|FG000|Core Study|Death|1|||
125439908|NCT02733042|451237615|FG003|Overall Study|Adverse Event|1|||
125390494|NCT00600938|451062040|FG001|Core Study|Death|1|||
125390495|NCT00600938|451062041|FG002|Core Study|Death|0|||
125439909|NCT02733042|451237616|FG004|Overall Study|Adverse Event|0|||
125390496|NCT00600938|451062042|FG003|Core Study|Death|0|||
125390497|NCT00600938|451062039|FG000|Core Study|Protocol Violation|1|||
125390498|NCT00600938|451062040|FG001|Core Study|Protocol Violation|2|||
125390499|NCT00600938|451062041|FG002|Core Study|Protocol Violation|0|||
125390500|NCT00600938|451062042|FG003|Core Study|Protocol Violation|0|||
125390501|NCT00600938|451062039|FG000|Extension Study|Adverse Event|1|||
125390502|NCT00600938|451062040|FG001|Extension Study|Adverse Event|0|||
125390503|NCT00600938|451062041|FG002|Extension Study|Adverse Event|2|||
125390504|NCT00600938|451062042|FG003|Extension Study|Adverse Event|0|||
125390505|NCT00600938|451062039|FG000|Extension Study|Abnormal test procedure results|0|||
125390506|NCT00600938|451062040|FG001|Extension Study|Abnormal test procedure results|1|||
125390507|NCT00600938|451062041|FG002|Extension Study|Abnormal test procedure results|1|||
125390508|NCT00600938|451062042|FG003|Extension Study|Abnormal test procedure results|1|||
125390509|NCT00600938|451062039|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
125390510|NCT00600938|451062040|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
125390511|NCT00600938|451062041|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
125390512|NCT00600938|451062042|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
125390513|NCT00600938|451062039|FG000|Extension Study|Withdrawal by Subject|2|||
125390514|NCT00600938|451062040|FG001|Extension Study|Withdrawal by Subject|2|||
125390515|NCT00600938|451062041|FG002|Extension Study|Withdrawal by Subject|3|||
125390516|NCT00600938|451062042|FG003|Extension Study|Withdrawal by Subject|0|||
125390517|NCT00600938|451062039|FG000|Extension Study|Lost to Follow-up|1|||
125390518|NCT00600938|451062040|FG001|Extension Study|Lost to Follow-up|1|||
125390519|NCT00600938|451062041|FG002|Extension Study|Lost to Follow-up|2|||
125390520|NCT00600938|451062042|FG003|Extension Study|Lost to Follow-up|0|||
125390521|NCT00600938|451062039|FG000|Extension Study|Death|1|||
125390522|NCT00600938|451062040|FG001|Extension Study|Death|0|||
125390523|NCT00600938|451062041|FG002|Extension Study|Death|0|||
125390524|NCT00600938|451062042|FG003|Extension Study|Death|0|||
125390525|NCT00278954|451063476|FG000|Overall Study|Adverse Event|3|||
125390526|NCT00278954|451063476|FG000|Overall Study|Lost to Follow-up|1|||
125390527|NCT00278954|451063476|FG000|Overall Study|Withdrawal by Subject|1|||
125390528|NCT05664490|451063481|FG000|Overall Study|Withdrawal by Subject|0|||
125390529|NCT05664490|451063482|FG001|Overall Study|Withdrawal by Subject|1|||
125390530|NCT05664490|451063481|FG000|Overall Study|Lost to Follow-up|14|||
125390531|NCT05664490|451063482|FG001|Overall Study|Lost to Follow-up|22|||
125390532|NCT02939560|451063483|FG000|Overall Study|Withdrawal by Subject|2|||
125390533|NCT02939560|451063483|FG000|Overall Study|Protocol Violation|1|||
125390534|NCT01817725|451063491|FG000|Overall Study|Withdrawal by Subject|1|||
125390535|NCT03412084|451063492|FG000|Overall Study|Withdrawal by Subject|2|||
125390536|NCT03412084|451063493|FG001|Overall Study|Withdrawal by Subject|0|||
125390537|NCT03412084|451063492|FG000|Overall Study|Participant moved|1|||
125390538|NCT03412084|451063493|FG001|Overall Study|Participant moved|0|||
125390539|NCT03412084|451063492|FG000|Overall Study|Lost to Follow-up|1|||
125390540|NCT03412084|451063493|FG001|Overall Study|Lost to Follow-up|1|||
125390541|NCT01505608|451063494|FG000|Phase I|Lack of Efficacy|0|||
125390542|NCT01505608|451063495|FG001|Phase I|Lack of Efficacy|4|||
125390543|NCT01505608|451063494|FG000|Phase I|Adverse Event|0|||
125390544|NCT01505608|451063495|FG001|Phase I|Adverse Event|1|||
125390545|NCT01505608|451063494|FG000|Phase I|Withdrawal by Subject|0|||
125390546|NCT01505608|451063495|FG001|Phase I|Withdrawal by Subject|1|||
125390547|NCT01505608|451063494|FG000|Phase II|Lack of Efficacy|2|||
125390548|NCT01505608|451063495|FG001|Phase II|Lack of Efficacy|1|||
125390549|NCT01505608|451063494|FG000|Phase II|Protocol Violation|0|||
125390550|NCT01505608|451063495|FG001|Phase II|Protocol Violation|1|||
125390551|NCT02319031|451063501|FG000|Treatment Period|Death|1|||
125390552|NCT02319031|451063502|FG001|Treatment Period|Death|0|||
125390553|NCT03519971|451063507|FG000|Overall Study|Death|142|||
125390554|NCT03519971|451063508|FG001|Overall Study|Death|69|||
125390555|NCT03519971|451063507|FG000|Overall Study|Lost to Follow-up|0|||
125390556|NCT03519971|451063508|FG001|Overall Study|Lost to Follow-up|1|||
125390557|NCT03519971|451063507|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
125390558|NCT03519971|451063508|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
125390559|NCT03519971|451063507|FG000|Overall Study|Withdrawal by Subject|3|||
125390560|NCT03519971|451063508|FG001|Overall Study|Withdrawal by Subject|2|||
125390561|NCT03519971|451063507|FG000|Overall Study|Other|1|||
125390562|NCT03519971|451063508|FG001|Overall Study|Other|0|||
125390563|NCT00129129|451063509|FG000|Primary Phase|Adverse Event|2|||
125390564|NCT00129129|451063510|FG001|Primary Phase|Adverse Event|1|||
125390565|NCT00129129|451063511|FG002|Primary Phase|Adverse Event|0|||
125390566|NCT00129129|451063512|FG003|Primary Phase|Adverse Event|0|||
125390567|NCT00129129|451063513|FG004|Primary Phase|Adverse Event|0|||
125390568|NCT00129129|451063509|FG000|Primary Phase|Withdrawal by Subject|12|||
125390569|NCT00129129|451063510|FG001|Primary Phase|Withdrawal by Subject|10|||
125390570|NCT00129129|451063511|FG002|Primary Phase|Withdrawal by Subject|0|||
125390571|NCT00129129|451063512|FG003|Primary Phase|Withdrawal by Subject|0|||
125390572|NCT00129129|451063513|FG004|Primary Phase|Withdrawal by Subject|0|||
125390573|NCT00129129|451063509|FG000|Primary Phase|Migration from study area|1|||
125390574|NCT00129129|451063510|FG001|Primary Phase|Migration from study area|3|||
125390575|NCT00129129|451063511|FG002|Primary Phase|Migration from study area|0|||
125390576|NCT00129129|451063512|FG003|Primary Phase|Migration from study area|0|||
125390577|NCT00129129|451063513|FG004|Primary Phase|Migration from study area|0|||
125390578|NCT00129129|451063509|FG000|Primary Phase|Lost to Follow-up|8|||
125439910|NCT02733042|451237617|FG005|Overall Study|Adverse Event|0|||
125439911|NCT02733042|451237618|FG006|Overall Study|Adverse Event|0|||
125439912|NCT02733042|451237619|FG007|Overall Study|Adverse Event|0|||
125439913|NCT02733042|451237620|FG008|Overall Study|Adverse Event|0|||
125439914|NCT02733042|451237621|FG009|Overall Study|Adverse Event|0|||
125439915|NCT02733042|451237622|FG010|Overall Study|Adverse Event|2|||
125439916|NCT02733042|451237623|FG011|Overall Study|Adverse Event|2|||
125439917|NCT02733042|451237624|FG012|Overall Study|Adverse Event|0|||
125439918|NCT02733042|451237625|FG013|Overall Study|Adverse Event|2|||
125439919|NCT02733042|451237626|FG014|Overall Study|Adverse Event|0|||
125439920|NCT02733042|451237627|FG015|Overall Study|Adverse Event|0|||
125439921|NCT02733042|451237628|FG016|Overall Study|Adverse Event|0|||
125439922|NCT02733042|451237629|FG017|Overall Study|Adverse Event|1|||
125439923|NCT02733042|451237630|FG018|Overall Study|Adverse Event|0|||
125439924|NCT02733042|451237612|FG000|Overall Study|Progressive Disease|2|||
125439925|NCT02733042|451237613|FG001|Overall Study|Progressive Disease|1|||
125439926|NCT02733042|451237614|FG002|Overall Study|Progressive Disease|3|||
125439927|NCT02733042|451237615|FG003|Overall Study|Progressive Disease|1|||
125439928|NCT02733042|451237616|FG004|Overall Study|Progressive Disease|2|||
125439929|NCT02733042|451237617|FG005|Overall Study|Progressive Disease|3|||
125439930|NCT02733042|451237618|FG006|Overall Study|Progressive Disease|0|||
125439931|NCT02733042|451237619|FG007|Overall Study|Progressive Disease|3|||
125439932|NCT02733042|451237620|FG008|Overall Study|Progressive Disease|3|||
125439933|NCT02733042|451237621|FG009|Overall Study|Progressive Disease|2|||
125439934|NCT02733042|451237622|FG010|Overall Study|Progressive Disease|2|||
125439935|NCT02733042|451237623|FG011|Overall Study|Progressive Disease|2|||
125439936|NCT02733042|451237624|FG012|Overall Study|Progressive Disease|8|||
125439937|NCT02733042|451237625|FG013|Overall Study|Progressive Disease|1|||
125160818|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160819|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160820|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160821|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160822|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
125160823|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160824|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160825|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160826|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160827|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160828|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160829|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160830|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160831|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
125160832|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160833|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160834|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160835|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160836|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
125160837|NCT03982199|450213081|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160838|NCT03982199|450213082|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160839|NCT03982199|450213083|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160840|NCT03982199|450213084|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160841|NCT03982199|450213085|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160842|NCT03982199|450213086|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
125160843|NCT03982199|450213087|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160844|NCT03982199|450213088|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
125439938|NCT02733042|451237626|FG014|Overall Study|Progressive Disease|4|||
125160845|NCT03982199|450213089|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
125160846|NCT03982199|450213090|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160847|NCT03982199|450213091|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160848|NCT03982199|450213092|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160849|NCT03982199|450213093|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160850|NCT03982199|450213094|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
125160851|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125439939|NCT02733042|451237627|FG015|Overall Study|Progressive Disease|7|||
125439940|NCT02733042|451237628|FG016|Overall Study|Progressive Disease|2|||
125439941|NCT02733042|451237629|FG017|Overall Study|Progressive Disease|3|||
125439942|NCT02733042|451237630|FG018|Overall Study|Progressive Disease|4|||
125439943|NCT02733042|451237612|FG000|Overall Study|Withdrawal by Subject|0|||
125439944|NCT02733042|451237613|FG001|Overall Study|Withdrawal by Subject|1|||
125439945|NCT02733042|451237614|FG002|Overall Study|Withdrawal by Subject|2|||
125439946|NCT02733042|451237615|FG003|Overall Study|Withdrawal by Subject|1|||
125439947|NCT02733042|451237616|FG004|Overall Study|Withdrawal by Subject|1|||
125439948|NCT02733042|451237617|FG005|Overall Study|Withdrawal by Subject|0|||
125439949|NCT02733042|451237618|FG006|Overall Study|Withdrawal by Subject|0|||
125439950|NCT02733042|451237619|FG007|Overall Study|Withdrawal by Subject|0|||
125224438|NCT01601496|450448191|FG000|Overall Study|Other: patient refusal to continue|3|||
125224439|NCT03771963|450448199|FG000|Overall Study|Lost to Follow-up|22|||
125224440|NCT03771963|450448199|FG000|Overall Study|Withdrawal of Consent|10|||
125224441|NCT03014206|450448200|FG000|Overall Study|Registration Violation|12|||
125224442|NCT05502302|450448201|FG000|Overall Study|Lost to Follow-up|6|||
125224443|NCT05502302|450448201|FG000|Overall Study|Death|2|||
125224444|NCT02358031|450450091|FG000|Overall Study|Death|253|||
125224445|NCT02358031|450450092|FG001|Overall Study|Death|237|||
125224446|NCT02358031|450450093|FG002|Overall Study|Death|266|||
125224447|NCT02358031|450450091|FG000|Overall Study|Lost to Follow-up|1|||
125224448|NCT02358031|450450092|FG001|Overall Study|Lost to Follow-up|1|||
125224449|NCT02358031|450450093|FG002|Overall Study|Lost to Follow-up|0|||
125224450|NCT02358031|450450091|FG000|Overall Study|Withdrawal by Subject|19|||
125224451|NCT02358031|450450092|FG001|Overall Study|Withdrawal by Subject|14|||
125224452|NCT02358031|450450093|FG002|Overall Study|Withdrawal by Subject|18|||
125224453|NCT02358031|450450091|FG000|Overall Study|Sponsor Decision|26|||
125224454|NCT02358031|450450092|FG001|Overall Study|Sponsor Decision|28|||
125224455|NCT02358031|450450093|FG002|Overall Study|Sponsor Decision|16|||
125224456|NCT05664581|450450094|FG000|Overall Study|Withdrawal by Subject|2|||
125224457|NCT03101150|450450097|FG000|Overall Study|Lost to Follow-up|2|||
125224458|NCT03101150|450450098|FG001|Overall Study|Lost to Follow-up|4|||
125224459|NCT03101150|450450097|FG000|Overall Study|Miscarriage|3|||
125224460|NCT03101150|450450098|FG001|Overall Study|Miscarriage|6|||
125224461|NCT03163446|450450099|FG000|Overall Study|Unable to return for Day 180 visit|2|||
125224462|NCT03163446|450450100|FG001|Overall Study|Unable to return for Day 180 visit|0|||
125224463|NCT03163446|450450099|FG000|Overall Study|Withdrawal by Subject|2|||
125224464|NCT03163446|450450100|FG001|Overall Study|Withdrawal by Subject|6|||
125224465|NCT03163446|450450099|FG000|Overall Study|Death|16|||
125224466|NCT03163446|450450100|FG001|Overall Study|Death|5|||
125224467|NCT03163446|450450099|FG000|Overall Study|Lost to Follow-up|6|||
125224468|NCT03163446|450450100|FG001|Overall Study|Lost to Follow-up|5|||
125224469|NCT03163446|450450099|FG000|Overall Study|Physician Decision|1|||
125224470|NCT03163446|450450100|FG001|Overall Study|Physician Decision|1|||
125224471|NCT03163446|450450099|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
125224472|NCT03163446|450450100|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
125224473|NCT01317641|450450101|FG000|Overall Study|Not treated|0|||
125224474|NCT01317641|450450102|FG001|Overall Study|Not treated|0|||
125224475|NCT01317641|450450103|FG002|Overall Study|Not treated|0|||
125224476|NCT01317641|450450104|FG003|Overall Study|Not treated|0|||
125224477|NCT01317641|450450105|FG004|Overall Study|Not treated|0|||
125224478|NCT01317641|450450106|FG005|Overall Study|Not treated|0|||
125224479|NCT01317641|450450107|FG006|Overall Study|Not treated|0|||
125224480|NCT01317641|450450108|FG007|Overall Study|Not treated|1|||
125224481|NCT01317641|450450109|FG008|Overall Study|Not treated|1|||
125224482|NCT01317641|450450101|FG000|Overall Study|Adverse Event|0|||
125224483|NCT01317641|450450102|FG001|Overall Study|Adverse Event|1|||
125224484|NCT01317641|450450103|FG002|Overall Study|Adverse Event|0|||
125224485|NCT01317641|450450104|FG003|Overall Study|Adverse Event|1|||
125224486|NCT01317641|450450105|FG004|Overall Study|Adverse Event|0|||
125224487|NCT01317641|450450106|FG005|Overall Study|Adverse Event|0|||
125224488|NCT01317641|450450107|FG006|Overall Study|Adverse Event|2|||
125224489|NCT01317641|450450108|FG007|Overall Study|Adverse Event|1|||
125439951|NCT02733042|451237620|FG008|Overall Study|Withdrawal by Subject|1|||
125439952|NCT02733042|451237621|FG009|Overall Study|Withdrawal by Subject|1|||
125439953|NCT02733042|451237622|FG010|Overall Study|Withdrawal by Subject|0|||
125439954|NCT02733042|451237623|FG011|Overall Study|Withdrawal by Subject|2|||
125439955|NCT02733042|451237624|FG012|Overall Study|Withdrawal by Subject|1|||
125224490|NCT01317641|450450109|FG008|Overall Study|Adverse Event|0|||
125224491|NCT01317641|450450101|FG000|Overall Study|Protocol Violation|1|||
125224492|NCT01317641|450450102|FG001|Overall Study|Protocol Violation|0|||
125224493|NCT01317641|450450103|FG002|Overall Study|Protocol Violation|0|||
125224494|NCT01317641|450450104|FG003|Overall Study|Protocol Violation|0|||
125224495|NCT01317641|450450105|FG004|Overall Study|Protocol Violation|0|||
125224496|NCT01317641|450450106|FG005|Overall Study|Protocol Violation|0|||
125439956|NCT02733042|451237625|FG013|Overall Study|Withdrawal by Subject|1|||
125224497|NCT01317641|450450107|FG006|Overall Study|Protocol Violation|0|||
125224498|NCT01317641|450450108|FG007|Overall Study|Protocol Violation|0|||
125224499|NCT01317641|450450109|FG008|Overall Study|Protocol Violation|0|||
125224500|NCT01317641|450450101|FG000|Overall Study|Disease progression|0|||
125224501|NCT01317641|450450102|FG001|Overall Study|Disease progression|0|||
125439957|NCT02733042|451237626|FG014|Overall Study|Withdrawal by Subject|0|||
125224502|NCT01317641|450450103|FG002|Overall Study|Disease progression|0|||
125224503|NCT01317641|450450104|FG003|Overall Study|Disease progression|0|||
125224504|NCT01317641|450450105|FG004|Overall Study|Disease progression|0|||
125390579|NCT00129129|451063510|FG001|Primary Phase|Lost to Follow-up|6|||
125390580|NCT00129129|451063511|FG002|Primary Phase|Lost to Follow-up|0|||
125390581|NCT00129129|451063512|FG003|Primary Phase|Lost to Follow-up|0|||
125390582|NCT00129129|451063513|FG004|Primary Phase|Lost to Follow-up|0|||
125390583|NCT00129129|451063509|FG000|Primary Phase|Other|2|||
125390584|NCT00129129|451063510|FG001|Primary Phase|Other|5|||
125390585|NCT00129129|451063511|FG002|Primary Phase|Other|0|||
125390586|NCT00129129|451063512|FG003|Primary Phase|Other|0|||
125390587|NCT00129129|451063513|FG004|Primary Phase|Other|0|||
125390588|NCT00129129|451063509|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
125390589|NCT00129129|451063510|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
125390590|NCT00129129|451063511|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
125390591|NCT00129129|451063512|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
125224505|NCT01317641|450450106|FG005|Overall Study|Disease progression|0|||
125224506|NCT01317641|450450107|FG006|Overall Study|Disease progression|0|||
125224507|NCT01317641|450450108|FG007|Overall Study|Disease progression|3|||
125224508|NCT01317641|450450109|FG008|Overall Study|Disease progression|4|||
125224509|NCT01317641|450450101|FG000|Overall Study|Withdrawal by Subject|0|||
125224510|NCT01317641|450450102|FG001|Overall Study|Withdrawal by Subject|0|||
125224511|NCT01317641|450450103|FG002|Overall Study|Withdrawal by Subject|0|||
125224512|NCT01317641|450450104|FG003|Overall Study|Withdrawal by Subject|0|||
125390592|NCT00129129|451063513|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
125160852|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160853|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160854|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160855|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160856|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160857|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160858|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160859|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
125160860|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
125160861|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
125160862|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
125160863|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
125160864|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
125160865|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160866|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160867|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160868|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160869|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160870|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160871|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160872|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160873|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160874|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
125224513|NCT01317641|450450105|FG004|Overall Study|Withdrawal by Subject|0|||
125224514|NCT01317641|450450106|FG005|Overall Study|Withdrawal by Subject|0|||
125224515|NCT01317641|450450107|FG006|Overall Study|Withdrawal by Subject|1|||
125224516|NCT01317641|450450108|FG007|Overall Study|Withdrawal by Subject|0|||
125224517|NCT01317641|450450109|FG008|Overall Study|Withdrawal by Subject|0|||
125390593|NCT00129129|451063509|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
125390594|NCT00129129|451063510|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
125390595|NCT00129129|451063511|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
125390596|NCT00129129|451063512|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
125390597|NCT00129129|451063513|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
125390598|NCT00129129|451063509|FG000|Fourth Dose Phase|Migration from study area|0|||
125390599|NCT00129129|451063510|FG001|Fourth Dose Phase|Migration from study area|0|||
125390600|NCT00129129|451063511|FG002|Fourth Dose Phase|Migration from study area|0|||
125390601|NCT00129129|451063512|FG003|Fourth Dose Phase|Migration from study area|0|||
125390602|NCT00129129|451063513|FG004|Fourth Dose Phase|Migration from study area|2|||
125390603|NCT00129129|451063509|FG000|Fourth Dose Phase|Other|0|||
125390604|NCT00129129|451063510|FG001|Fourth Dose Phase|Other|0|||
125390605|NCT00129129|451063511|FG002|Fourth Dose Phase|Other|0|||
125390606|NCT00129129|451063512|FG003|Fourth Dose Phase|Other|1|||
125390607|NCT00129129|451063513|FG004|Fourth Dose Phase|Other|1|||
125390608|NCT00129129|451063509|FG000|Fourth Dose Phase|Protocol Violation|0|||
125390609|NCT00129129|451063510|FG001|Fourth Dose Phase|Protocol Violation|0|||
125390610|NCT00129129|451063511|FG002|Fourth Dose Phase|Protocol Violation|0|||
125390611|NCT00129129|451063512|FG003|Fourth Dose Phase|Protocol Violation|1|||
125390612|NCT00129129|451063513|FG004|Fourth Dose Phase|Protocol Violation|0|||
125390613|NCT01524692|451063518|FG000|Overall Study|Withdrawal by Subject|3|||
125390614|NCT03774433|451063519|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
125390615|NCT00108160|451063520|FG000|Overall Study|Lost to Follow-up|25|||
125390616|NCT00108160|451063521|FG001|Overall Study|Lost to Follow-up|12|||
125390617|NCT00108160|451063520|FG000|Overall Study|Death|1|||
125390618|NCT00108160|451063521|FG001|Overall Study|Death|2|||
125390619|NCT00108160|451063520|FG000|Overall Study|Withdrawal by Subject|4|||
125390620|NCT00108160|451063521|FG001|Overall Study|Withdrawal by Subject|2|||
125390621|NCT00108160|451063520|FG000|Overall Study|Protocol Violation|9|||
125390622|NCT00108160|451063521|FG001|Overall Study|Protocol Violation|5|||
125390623|NCT01150123|451063523|FG000|Overall Study|Withdrawal by Subject|1|||
125390624|NCT01150123|451063524|FG001|Overall Study|Withdrawal by Subject|1|||
125390625|NCT01150123|451063525|FG002|Overall Study|Withdrawal by Subject|2|||
125390626|NCT01150123|451063526|FG003|Overall Study|Withdrawal by Subject|1|||
125390627|NCT01150123|451063527|FG004|Overall Study|Withdrawal by Subject|1|||
125160875|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160876|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160877|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160878|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
125160879|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160880|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160881|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160882|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160883|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160884|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160885|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160886|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160887|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160888|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160889|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160890|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160891|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
125160892|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
125160893|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160894|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160895|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160896|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160897|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160898|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160899|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160900|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160901|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160902|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160903|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
125160904|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
125160905|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
125160906|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
125160907|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160908|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160909|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160910|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160911|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160912|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160913|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160914|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160915|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160916|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160917|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160918|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160919|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
125160920|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
125160921|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160922|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160923|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125390628|NCT01150123|451063528|FG005|Overall Study|Withdrawal by Subject|1|||
125439958|NCT02733042|451237627|FG015|Overall Study|Withdrawal by Subject|0|||
125439959|NCT02733042|451237628|FG016|Overall Study|Withdrawal by Subject|0|||
125439960|NCT02733042|451237629|FG017|Overall Study|Withdrawal by Subject|0|||
125439961|NCT02733042|451237630|FG018|Overall Study|Withdrawal by Subject|0|||
125439962|NCT02733042|451237612|FG000|Overall Study|Other Reasons|0|||
125439963|NCT02733042|451237613|FG001|Overall Study|Other Reasons|0|||
125439964|NCT02733042|451237614|FG002|Overall Study|Other Reasons|1|||
125439965|NCT02733042|451237615|FG003|Overall Study|Other Reasons|0|||
125439966|NCT02733042|451237616|FG004|Overall Study|Other Reasons|0|||
125439967|NCT02733042|451237617|FG005|Overall Study|Other Reasons|0|||
125439968|NCT02733042|451237618|FG006|Overall Study|Other Reasons|0|||
125439969|NCT02733042|451237619|FG007|Overall Study|Other Reasons|0|||
125439970|NCT02733042|451237620|FG008|Overall Study|Other Reasons|0|||
125439971|NCT02733042|451237621|FG009|Overall Study|Other Reasons|1|||
125439972|NCT02733042|451237622|FG010|Overall Study|Other Reasons|1|||
125439973|NCT02733042|451237623|FG011|Overall Study|Other Reasons|0|||
125439974|NCT02733042|451237624|FG012|Overall Study|Other Reasons|0|||
125439975|NCT02733042|451237625|FG013|Overall Study|Other Reasons|0|||
125439976|NCT02733042|451237626|FG014|Overall Study|Other Reasons|0|||
125224518|NCT01228591|450450112|FG000|Baseline|Lack of Efficacy|1|||
125224519|NCT01228591|450450113|FG001|Baseline|Lack of Efficacy|2|||
125224520|NCT01298700|450450114|FG000|Overall Study|Adverse Event|50|||
125224521|NCT01298700|450450115|FG001|Overall Study|Adverse Event|51|||
125224522|NCT01298700|450450114|FG000|Overall Study|Lack of Efficacy|9|||
125224523|NCT01298700|450450115|FG001|Overall Study|Lack of Efficacy|14|||
125224524|NCT01298700|450450114|FG000|Overall Study|Lost to Follow-up|5|||
125224525|NCT01298700|450450115|FG001|Overall Study|Lost to Follow-up|2|||
125224526|NCT01298700|450450114|FG000|Overall Study|Withdrawal by Subject|12|||
125224527|NCT01298700|450450115|FG001|Overall Study|Withdrawal by Subject|9|||
125224528|NCT01298700|450450114|FG000|Overall Study|Protocol Violation|6|||
125224529|NCT01298700|450450115|FG001|Overall Study|Protocol Violation|4|||
125224530|NCT01298700|450450114|FG000|Overall Study|Other Miscellaneous Reasons|16|||
125224531|NCT01298700|450450115|FG001|Overall Study|Other Miscellaneous Reasons|15|||
125224532|NCT01298700|450450114|FG000|Overall Study|Did not Receive Study Drug|3|||
125224533|NCT01298700|450450115|FG001|Overall Study|Did not Receive Study Drug|5|||
125224534|NCT00643760|450450120|FG000|Overall Study|Adverse Event|11|||
125224535|NCT00643760|450450121|FG001|Overall Study|Adverse Event|5|||
125224536|NCT00643760|450450122|FG002|Overall Study|Adverse Event|12|||
125224537|NCT00643760|450450123|FG003|Overall Study|Adverse Event|21|||
125224538|NCT00643760|450450124|FG004|Overall Study|Adverse Event|6|||
125224539|NCT00643760|450450120|FG000|Overall Study|Lack of Efficacy|3|||
125224540|NCT00643760|450450121|FG001|Overall Study|Lack of Efficacy|1|||
125224541|NCT00643760|450450122|FG002|Overall Study|Lack of Efficacy|0|||
125224542|NCT00643760|450450123|FG003|Overall Study|Lack of Efficacy|4|||
125224543|NCT00643760|450450124|FG004|Overall Study|Lack of Efficacy|3|||
125224544|NCT00643760|450450120|FG000|Overall Study|Protocol Violation|7|||
125224545|NCT00643760|450450121|FG001|Overall Study|Protocol Violation|6|||
125224546|NCT00643760|450450122|FG002|Overall Study|Protocol Violation|4|||
125224547|NCT00643760|450450123|FG003|Overall Study|Protocol Violation|4|||
125224548|NCT00643760|450450124|FG004|Overall Study|Protocol Violation|6|||
125224549|NCT00643760|450450120|FG000|Overall Study|Lost to Follow-up|6|||
125224550|NCT00643760|450450121|FG001|Overall Study|Lost to Follow-up|2|||
125224551|NCT00643760|450450122|FG002|Overall Study|Lost to Follow-up|1|||
125224552|NCT00643760|450450123|FG003|Overall Study|Lost to Follow-up|3|||
125224553|NCT00643760|450450124|FG004|Overall Study|Lost to Follow-up|3|||
125224554|NCT00643760|450450120|FG000|Overall Study|Investigator Discretion|0|||
125224555|NCT00643760|450450121|FG001|Overall Study|Investigator Discretion|0|||
125224556|NCT00643760|450450122|FG002|Overall Study|Investigator Discretion|0|||
125224557|NCT00643760|450450123|FG003|Overall Study|Investigator Discretion|2|||
125224558|NCT00643760|450450124|FG004|Overall Study|Investigator Discretion|0|||
125224559|NCT00643760|450450120|FG000|Overall Study|Withdrawal by Subject|3|||
125224560|NCT00643760|450450121|FG001|Overall Study|Withdrawal by Subject|1|||
125224561|NCT00643760|450450122|FG002|Overall Study|Withdrawal by Subject|2|||
125439977|NCT02733042|451237627|FG015|Overall Study|Other Reasons|1|||
125439978|NCT02733042|451237628|FG016|Overall Study|Other Reasons|0|||
125439979|NCT02733042|451237629|FG017|Overall Study|Other Reasons|1|||
125224562|NCT00643760|450450123|FG003|Overall Study|Withdrawal by Subject|4|||
125224563|NCT00643760|450450124|FG004|Overall Study|Withdrawal by Subject|1|||
125224564|NCT03934216|450450125|FG000|Overall Study|Other Reasons|5|||
125224565|NCT03934216|450450126|FG001|Overall Study|Other Reasons|5|||
125224566|NCT03934216|450450125|FG000|Overall Study|Adverse Event|22|||
125224567|NCT03934216|450450126|FG001|Overall Study|Adverse Event|11|||
125224568|NCT03934216|450450125|FG000|Overall Study|Lack of Efficacy|8|||
125224569|NCT03934216|450450126|FG001|Overall Study|Lack of Efficacy|7|||
125224570|NCT03934216|450450125|FG000|Overall Study|Lost to Follow-up|2|||
125439980|NCT02733042|451237630|FG018|Overall Study|Other Reasons|0|||
125224571|NCT03934216|450450126|FG001|Overall Study|Lost to Follow-up|0|||
125224572|NCT03934216|450450125|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125224573|NCT03934216|450450126|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125439981|NCT02733042|451237612|FG000|Overall Study|Death|0|||
125439982|NCT02733042|451237613|FG001|Overall Study|Death|0|||
125439983|NCT02733042|451237614|FG002|Overall Study|Death|0|||
125439984|NCT02733042|451237615|FG003|Overall Study|Death|0|||
125439985|NCT02733042|451237616|FG004|Overall Study|Death|0|||
125439986|NCT02733042|451237617|FG005|Overall Study|Death|0|||
125439987|NCT02733042|451237618|FG006|Overall Study|Death|1|||
125439988|NCT02733042|451237619|FG007|Overall Study|Death|0|||
125439989|NCT02733042|451237620|FG008|Overall Study|Death|1|||
125439990|NCT02733042|451237621|FG009|Overall Study|Death|0|||
125439991|NCT02733042|451237622|FG010|Overall Study|Death|1|||
125439992|NCT02733042|451237623|FG011|Overall Study|Death|0|||
125439993|NCT02733042|451237624|FG012|Overall Study|Death|0|||
125439994|NCT02733042|451237625|FG013|Overall Study|Death|0|||
125439995|NCT02733042|451237626|FG014|Overall Study|Death|1|||
125439996|NCT02733042|451237627|FG015|Overall Study|Death|2|||
125439997|NCT02733042|451237628|FG016|Overall Study|Death|0|||
125439998|NCT02733042|451237629|FG017|Overall Study|Death|0|||
125439999|NCT02733042|451237630|FG018|Overall Study|Death|0|||
125440000|NCT01821898|451237631|FG000|Overall Study|Withdrawal by Subject|2|||
125440001|NCT01821898|451237632|FG001|Overall Study|Withdrawal by Subject|1|||
125440002|NCT00337662|451237635|FG000|Study Period II|Lost to Follow-up|0|||
125440003|NCT00337662|451237636|FG001|Study Period II|Lost to Follow-up|0|||
125440004|NCT00337662|451237637|FG002|Study Period II|Lost to Follow-up|0|||
125440005|NCT00337662|451237638|FG003|Study Period II|Lost to Follow-up|35|||
125440006|NCT00337662|451237635|FG000|Study Period II|Withdrawal by Subject|0|||
125440007|NCT00337662|451237636|FG001|Study Period II|Withdrawal by Subject|0|||
125440008|NCT00337662|451237637|FG002|Study Period II|Withdrawal by Subject|0|||
125440009|NCT00337662|451237638|FG003|Study Period II|Withdrawal by Subject|20|||
125440010|NCT00337662|451237635|FG000|Study Period II|Adverse Event|0|||
125440011|NCT00337662|451237636|FG001|Study Period II|Adverse Event|0|||
125440012|NCT00337662|451237637|FG002|Study Period II|Adverse Event|0|||
125440013|NCT00337662|451237638|FG003|Study Period II|Adverse Event|16|||
125440014|NCT00337662|451237635|FG000|Study Period II|Physician Decision|0|||
125440015|NCT00337662|451237636|FG001|Study Period II|Physician Decision|0|||
125440016|NCT00337662|451237637|FG002|Study Period II|Physician Decision|0|||
125440017|NCT00337662|451237638|FG003|Study Period II|Physician Decision|13|||
125440018|NCT00337662|451237635|FG000|Study Period II|Entry Criteria Not Met|0|||
125440019|NCT00337662|451237636|FG001|Study Period II|Entry Criteria Not Met|0|||
125440020|NCT00337662|451237637|FG002|Study Period II|Entry Criteria Not Met|0|||
125440021|NCT00337662|451237638|FG003|Study Period II|Entry Criteria Not Met|6|||
125440022|NCT00337662|451237635|FG000|Study Period II|Protocol Violation|0|||
125440023|NCT00337662|451237636|FG001|Study Period II|Protocol Violation|0|||
125440024|NCT00337662|451237637|FG002|Study Period II|Protocol Violation|0|||
125440025|NCT00337662|451237638|FG003|Study Period II|Protocol Violation|6|||
125440026|NCT00337662|451237635|FG000|Study Period II|Lack of Efficacy|0|||
125440027|NCT00337662|451237636|FG001|Study Period II|Lack of Efficacy|0|||
125440028|NCT00337662|451237637|FG002|Study Period II|Lack of Efficacy|0|||
125440029|NCT00337662|451237638|FG003|Study Period II|Lack of Efficacy|7|||
125440030|NCT00337662|451237635|FG000|Study Period II|Sponsor Decision|0|||
125440031|NCT00337662|451237636|FG001|Study Period II|Sponsor Decision|0|||
125440032|NCT00337662|451237637|FG002|Study Period II|Sponsor Decision|0|||
125440033|NCT00337662|451237638|FG003|Study Period II|Sponsor Decision|2|||
125440034|NCT00337662|451237635|FG000|Study Period II|Parent/Caregiver Decision|0|||
125440035|NCT00337662|451237636|FG001|Study Period II|Parent/Caregiver Decision|0|||
125440036|NCT00337662|451237637|FG002|Study Period II|Parent/Caregiver Decision|0|||
125440037|NCT00337662|451237638|FG003|Study Period II|Parent/Caregiver Decision|1|||
125440038|NCT00337662|451237635|FG000|Study Period III|Lost to Follow-up|14|||
125440039|NCT00337662|451237636|FG001|Study Period III|Lost to Follow-up|16|||
125440040|NCT00337662|451237637|FG002|Study Period III|Lost to Follow-up|14|||
125440041|NCT00337662|451237638|FG003|Study Period III|Lost to Follow-up|0|||
125440042|NCT00337662|451237635|FG000|Study Period III|Withdrawal by Subject|18|||
125440043|NCT00337662|451237636|FG001|Study Period III|Withdrawal by Subject|14|||
125440044|NCT00337662|451237637|FG002|Study Period III|Withdrawal by Subject|12|||
125160924|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160925|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160926|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160927|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125440045|NCT00337662|451237638|FG003|Study Period III|Withdrawal by Subject|0|||
125440046|NCT00337662|451237635|FG000|Study Period III|Adverse Event|9|||
125440047|NCT00337662|451237636|FG001|Study Period III|Adverse Event|10|||
125440048|NCT00337662|451237637|FG002|Study Period III|Adverse Event|8|||
125440049|NCT00337662|451237638|FG003|Study Period III|Adverse Event|0|||
125160928|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125440050|NCT00337662|451237635|FG000|Study Period III|Protocol Violation|3|||
125440051|NCT00337662|451237636|FG001|Study Period III|Protocol Violation|8|||
125440052|NCT00337662|451237637|FG002|Study Period III|Protocol Violation|2|||
125440053|NCT00337662|451237638|FG003|Study Period III|Protocol Violation|0|||
125440054|NCT00337662|451237635|FG000|Study Period III|Physician Decision|6|||
125440055|NCT00337662|451237636|FG001|Study Period III|Physician Decision|5|||
125224574|NCT03934216|450450125|FG000|Overall Study|Pregnancy|1|||
125224575|NCT03934216|450450126|FG001|Overall Study|Pregnancy|0|||
125224576|NCT03934216|450450125|FG000|Overall Study|Withdrawal by Subject|18|||
125224577|NCT03934216|450450126|FG001|Overall Study|Withdrawal by Subject|6|||
125224578|NCT03934216|450450125|FG000|Overall Study|Randomized but not treated|1|||
125224579|NCT03934216|450450126|FG001|Overall Study|Randomized but not treated|1|||
125224580|NCT00048035|450450129|FG000|Core Period|Early Withdrawals|4|||
125224581|NCT00048035|450450130|FG001|Core Period|Early Withdrawals|2|||
125224582|NCT00048035|450450131|FG002|Core Period|Early Withdrawals|1|||
125224583|NCT00048035|450450132|FG003|Core Period|Early Withdrawals|1|||
125224584|NCT00048035|450450133|FG004|Core Period|Early Withdrawals|1|||
125224585|NCT00048035|450450134|FG005|Core Period|Early Withdrawals|1|||
125224586|NCT00048035|450450135|FG006|Core Period|Early Withdrawals|0|||
125224587|NCT00048035|450450136|FG007|Core Period|Early Withdrawals|0|||
125224588|NCT00048035|450450129|FG000|Extension Year 1|Early Withdrawals|0|||
125224589|NCT00048035|450450130|FG001|Extension Year 1|Early Withdrawals|0|||
125224590|NCT00048035|450450131|FG002|Extension Year 1|Early Withdrawals|0|||
125224591|NCT00048035|450450132|FG003|Extension Year 1|Early Withdrawals|0|||
125224592|NCT00048035|450450133|FG004|Extension Year 1|Early Withdrawals|0|||
125224593|NCT00048035|450450134|FG005|Extension Year 1|Early Withdrawals|0|||
125224594|NCT00048035|450450135|FG006|Extension Year 1|Early Withdrawals|11|||
125224595|NCT00048035|450450136|FG007|Extension Year 1|Early Withdrawals|11|||
125224596|NCT00048035|450450129|FG000|Extension Year 2|Early Withdrawals|0|||
125224597|NCT00048035|450450130|FG001|Extension Year 2|Early Withdrawals|0|||
125224598|NCT00048035|450450131|FG002|Extension Year 2|Early Withdrawals|0|||
125224599|NCT00048035|450450132|FG003|Extension Year 2|Early Withdrawals|0|||
125224600|NCT00048035|450450133|FG004|Extension Year 2|Early Withdrawals|0|||
125224601|NCT00048035|450450134|FG005|Extension Year 2|Early Withdrawals|0|||
125224602|NCT00048035|450450135|FG006|Extension Year 2|Early Withdrawals|3|||
125224603|NCT00048035|450450136|FG007|Extension Year 2|Early Withdrawals|3|||
125224604|NCT02735980|450450137|FG000|Overall Study|Adverse Event|0|||
125224605|NCT02735980|450450138|FG001|Overall Study|Adverse Event|4|||
125224606|NCT02735980|450450139|FG002|Overall Study|Adverse Event|1|||
125224607|NCT02735980|450450137|FG000|Overall Study|Death|5|||
125224608|NCT02735980|450450138|FG001|Overall Study|Death|4|||
125224609|NCT02735980|450450139|FG002|Overall Study|Death|0|||
125224610|NCT02735980|450450137|FG000|Overall Study|Physician Decision|3|||
125224611|NCT02735980|450450138|FG001|Overall Study|Physician Decision|1|||
125224612|NCT02735980|450450139|FG002|Overall Study|Physician Decision|0|||
125224613|NCT02735980|450450137|FG000|Overall Study|Screen failure|1|||
125224614|NCT02735980|450450138|FG001|Overall Study|Screen failure|0|||
125224615|NCT02735980|450450139|FG002|Overall Study|Screen failure|0|||
125224616|NCT02735980|450450137|FG000|Overall Study|Withdrawal by Subject|1|||
125224617|NCT02735980|450450138|FG001|Overall Study|Withdrawal by Subject|2|||
125224618|NCT02735980|450450139|FG002|Overall Study|Withdrawal by Subject|0|||
125224619|NCT00509899|450450140|FG000|Overall Study|Progressive disease|1|||
125224620|NCT00509899|450450141|FG001|Overall Study|Progressive disease|3|||
125224621|NCT00509899|450450142|FG002|Overall Study|Progressive disease|5|||
125224622|NCT00509899|450450143|FG003|Overall Study|Progressive disease|1|||
125224623|NCT00509899|450450144|FG004|Overall Study|Progressive disease|0|||
125224624|NCT00509899|450450145|FG005|Overall Study|Progressive disease|1|||
125224625|NCT00509899|450450146|FG006|Overall Study|Progressive disease|0|||
125224626|NCT00509899|450450147|FG007|Overall Study|Progressive disease|0|||
125224627|NCT00509899|450450140|FG000|Overall Study|Unacceptable Toxicity|1|||
125224628|NCT00509899|450450141|FG001|Overall Study|Unacceptable Toxicity|0|||
125224629|NCT00509899|450450142|FG002|Overall Study|Unacceptable Toxicity|0|||
125224630|NCT00509899|450450143|FG003|Overall Study|Unacceptable Toxicity|2|||
125224631|NCT00509899|450450144|FG004|Overall Study|Unacceptable Toxicity|0|||
125224632|NCT00509899|450450145|FG005|Overall Study|Unacceptable Toxicity|0|||
125224633|NCT00509899|450450146|FG006|Overall Study|Unacceptable Toxicity|0|||
125224634|NCT00509899|450450147|FG007|Overall Study|Unacceptable Toxicity|0|||
125224635|NCT00509899|450450140|FG000|Overall Study|Withdrawal by Subject|6|||
125224636|NCT00509899|450450141|FG001|Overall Study|Withdrawal by Subject|2|||
125224637|NCT00509899|450450142|FG002|Overall Study|Withdrawal by Subject|3|||
125224638|NCT00509899|450450143|FG003|Overall Study|Withdrawal by Subject|0|||
125224639|NCT00509899|450450144|FG004|Overall Study|Withdrawal by Subject|3|||
125224640|NCT00509899|450450145|FG005|Overall Study|Withdrawal by Subject|2|||
125224641|NCT00509899|450450146|FG006|Overall Study|Withdrawal by Subject|0|||
125224642|NCT00509899|450450147|FG007|Overall Study|Withdrawal by Subject|0|||
125224643|NCT00509899|450450140|FG000|Overall Study|Physician Decision|4|||
125224644|NCT00509899|450450141|FG001|Overall Study|Physician Decision|2|||
125224645|NCT00509899|450450142|FG002|Overall Study|Physician Decision|7|||
125224646|NCT00509899|450450143|FG003|Overall Study|Physician Decision|0|||
125224647|NCT00509899|450450144|FG004|Overall Study|Physician Decision|1|||
125224648|NCT00509899|450450145|FG005|Overall Study|Physician Decision|4|||
125224649|NCT00509899|450450146|FG006|Overall Study|Physician Decision|0|||
125224650|NCT00509899|450450147|FG007|Overall Study|Physician Decision|0|||
125224651|NCT00509899|450450140|FG000|Overall Study|Intercurrent Illness|1|||
125160929|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160930|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160931|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160932|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
125160933|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
125160934|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
125160935|NCT03982199|450213081|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160936|NCT03982199|450213082|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160937|NCT03982199|450213083|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160938|NCT03982199|450213084|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160939|NCT03982199|450213085|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160940|NCT03982199|450213086|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160941|NCT03982199|450213087|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160942|NCT03982199|450213088|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160943|NCT03982199|450213089|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160944|NCT03982199|450213090|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160945|NCT03982199|450213091|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160946|NCT03982199|450213092|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160947|NCT03982199|450213093|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
125160948|NCT03982199|450213094|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
125160949|NCT00594646|450213095|FG000|Overall Study|Withdrawal by Subject|1|||
125160950|NCT00594646|450213095|FG000|Overall Study|Lost to Follow-up|15|||
125160951|NCT03907462|450213098|FG000|Overall Study|Physician Decision|1|||
125160952|NCT03907462|450213099|FG001|Overall Study|Physician Decision|3|||
125160953|NCT03907462|450213100|FG002|Overall Study|Physician Decision|1|||
125160954|NCT03907462|450213098|FG000|Overall Study|Withdrawal by Subject|6|||
125160955|NCT03907462|450213099|FG001|Overall Study|Withdrawal by Subject|3|||
125160956|NCT03907462|450213100|FG002|Overall Study|Withdrawal by Subject|3|||
125160957|NCT03907462|450213098|FG000|Overall Study|Pregnancy|4|||
125160958|NCT03907462|450213099|FG001|Overall Study|Pregnancy|2|||
125160959|NCT03907462|450213100|FG002|Overall Study|Pregnancy|6|||
125160960|NCT03907462|450213098|FG000|Overall Study|Lost to Follow-up|16|||
125160961|NCT03907462|450213099|FG001|Overall Study|Lost to Follow-up|18|||
125160962|NCT03907462|450213100|FG002|Overall Study|Lost to Follow-up|22|||
125160963|NCT03107026|450215280|FG000|Overall Study|Adverse Event|2|||
125160964|NCT03107026|450215281|FG001|Overall Study|Adverse Event|14|||
125160965|NCT03107026|450215282|FG002|Overall Study|Adverse Event|23|||
125160966|NCT03107026|450215280|FG000|Overall Study|Lost to Follow-up|12|||
125160967|NCT03107026|450215281|FG001|Overall Study|Lost to Follow-up|12|||
125160968|NCT03107026|450215282|FG002|Overall Study|Lost to Follow-up|13|||
125160969|NCT03107026|450215280|FG000|Overall Study|Protocol Violation|1|||
125160970|NCT03107026|450215281|FG001|Overall Study|Protocol Violation|2|||
125160971|NCT03107026|450215282|FG002|Overall Study|Protocol Violation|0|||
125160972|NCT03107026|450215280|FG000|Overall Study|Pregnancy|1|||
125160973|NCT03107026|450215281|FG001|Overall Study|Pregnancy|0|||
125160974|NCT03107026|450215282|FG002|Overall Study|Pregnancy|0|||
125160975|NCT03107026|450215280|FG000|Overall Study|Withdrawal by Subject|13|||
125160976|NCT03107026|450215281|FG001|Overall Study|Withdrawal by Subject|5|||
125160977|NCT03107026|450215282|FG002|Overall Study|Withdrawal by Subject|17|||
125160978|NCT03107026|450215280|FG000|Overall Study|non compliance with study visits|1|||
125160979|NCT03107026|450215281|FG001|Overall Study|non compliance with study visits|2|||
125160980|NCT03107026|450215282|FG002|Overall Study|non compliance with study visits|0|||
125160981|NCT03107026|450215280|FG000|Overall Study|non-compliance with study drug|2|||
125160982|NCT03107026|450215281|FG001|Overall Study|non-compliance with study drug|2|||
125160983|NCT03107026|450215282|FG002|Overall Study|non-compliance with study drug|3|||
125160984|NCT03107026|450215280|FG000|Overall Study|Physician Decision|0|||
125160985|NCT03107026|450215281|FG001|Overall Study|Physician Decision|1|||
125160986|NCT03107026|450215282|FG002|Overall Study|Physician Decision|0|||
125160987|NCT02049450|450215283|FG000|Overall Study|Adverse Event|2|||
125160988|NCT02049450|450215283|FG000|Overall Study|Withdrawal by Subject|1|||
125160989|NCT02049450|450215283|FG000|Overall Study|Patients/guardian decision|1|||
125160990|NCT00577395|450215284|FG000|Overall Study|Study was terminated early by Sponsor|7|||
125160991|NCT00577395|450215285|FG001|Overall Study|Study was terminated early by Sponsor|6|||
125160992|NCT00554190|450215288|FG000|Overall Study|Termination forms not completed|10|||
125160993|NCT04709835|450215292|FG000|Overall Study|Withdrawal by Subject|0|||
125160994|NCT04709835|450215293|FG001|Overall Study|Withdrawal by Subject|1|||
125160995|NCT04709835|450215294|FG002|Overall Study|Withdrawal by Subject|0|||
125160996|NCT04325204|450215295|FG000|Overall Study|Death|0|||
125160997|NCT04325204|450215296|FG001|Overall Study|Death|1|||
125160998|NCT04325204|450215295|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
125160999|NCT04325204|450215296|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
125161000|NCT04325204|450215295|FG000|Overall Study|Lost to Follow-up|8|||
125161001|NCT04325204|450215296|FG001|Overall Study|Lost to Follow-up|8|||
125440056|NCT00337662|451237637|FG002|Study Period III|Physician Decision|0|||
125440057|NCT00337662|451237638|FG003|Study Period III|Physician Decision|0|||
125440058|NCT00337662|451237635|FG000|Study Period III|Entry Criteria Not Met|4|||
125440059|NCT00337662|451237636|FG001|Study Period III|Entry Criteria Not Met|1|||
125440060|NCT00337662|451237637|FG002|Study Period III|Entry Criteria Not Met|3|||
125440061|NCT00337662|451237638|FG003|Study Period III|Entry Criteria Not Met|0|||
125440062|NCT00337662|451237635|FG000|Study Period III|Lack of Efficacy|4|||
125440063|NCT00337662|451237636|FG001|Study Period III|Lack of Efficacy|4|||
125440064|NCT00337662|451237637|FG002|Study Period III|Lack of Efficacy|2|||
125440065|NCT00337662|451237638|FG003|Study Period III|Lack of Efficacy|0|||
125440066|NCT00337662|451237635|FG000|Study Period III|Parent/Caregiver Decision|0|||
125440067|NCT00337662|451237636|FG001|Study Period III|Parent/Caregiver Decision|0|||
125440068|NCT00337662|451237637|FG002|Study Period III|Parent/Caregiver Decision|2|||
125440069|NCT00337662|451237638|FG003|Study Period III|Parent/Caregiver Decision|0|||
125440070|NCT00337662|451237635|FG000|Study Period III|Sponsor Decision|1|||
125440071|NCT00337662|451237636|FG001|Study Period III|Sponsor Decision|0|||
125440072|NCT00337662|451237637|FG002|Study Period III|Sponsor Decision|1|||
125440073|NCT00337662|451237638|FG003|Study Period III|Sponsor Decision|0|||
125440074|NCT00337662|451237635|FG000|Study Period III|Clinical Relapse|1|||
125440075|NCT00337662|451237636|FG001|Study Period III|Clinical Relapse|0|||
125440076|NCT00337662|451237637|FG002|Study Period III|Clinical Relapse|0|||
125440077|NCT00337662|451237638|FG003|Study Period III|Clinical Relapse|0|||
125440078|NCT03691948|451237640|FG000|Overall Study|Lost to Follow-up|1|||
125440079|NCT03691948|451237641|FG001|Overall Study|Lost to Follow-up|3|||
125440080|NCT02344537|451237642|FG000|Overall Study|Protocol Violation|1|||
125440081|NCT02344537|451237643|FG001|Overall Study|Protocol Violation|1|||
125440082|NCT02344537|451237642|FG000|Overall Study|Subject started another treatment after wk 6|1|||
125440083|NCT02344537|451237643|FG001|Overall Study|Subject started another treatment after wk 6|0|||
125440084|NCT02344537|451237642|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
125440085|NCT02344537|451237643|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
125440086|NCT00960752|451237645|FG000|Overall Study|Adverse Event|0|||
125440087|NCT00960752|451237646|FG001|Overall Study|Adverse Event|0|||
125440088|NCT00960752|451237647|FG002|Overall Study|Adverse Event|1|||
125440089|NCT00960752|451237645|FG000|Overall Study|Progression|0|||
125440090|NCT00960752|451237646|FG001|Overall Study|Progression|0|||
125440091|NCT00960752|451237647|FG002|Overall Study|Progression|1|||
125440092|NCT00180713|451237655|FG000|Overall Study|Withdrawal by Subject|2|||
125440093|NCT00180713|451237656|FG001|Overall Study|Withdrawal by Subject|0|||
125440094|NCT00180713|451237655|FG000|Overall Study|Adverse Event|3|||
125440095|NCT00180713|451237656|FG001|Overall Study|Adverse Event|3|||
125440096|NCT01091428|451239641|FG000|Phase 1|Progressive Disease|24|||
125440097|NCT01091428|451239642|FG001|Phase 1|Progressive Disease|8|||
125440098|NCT01091428|451239643|FG002|Phase 1|Progressive Disease|0|||
125440099|NCT01091428|451239644|FG003|Phase 1|Progressive Disease|0|||
125440100|NCT01091428|451239641|FG000|Phase 1|Symptomatic Deterioration|3|||
125440101|NCT01091428|451239642|FG001|Phase 1|Symptomatic Deterioration|2|||
125440102|NCT01091428|451239643|FG002|Phase 1|Symptomatic Deterioration|0|||
125440103|NCT01091428|451239644|FG003|Phase 1|Symptomatic Deterioration|0|||
125440104|NCT01091428|451239641|FG000|Phase 1|Adverse Event|2|||
125440105|NCT01091428|451239642|FG001|Phase 1|Adverse Event|0|||
125440106|NCT01091428|451239643|FG002|Phase 1|Adverse Event|0|||
125440107|NCT01091428|451239644|FG003|Phase 1|Adverse Event|0|||
125440108|NCT01091428|451239641|FG000|Phase 1|Withdrawal by Subject|7|||
125440109|NCT01091428|451239642|FG001|Phase 1|Withdrawal by Subject|0|||
125440110|NCT01091428|451239643|FG002|Phase 1|Withdrawal by Subject|0|||
125440111|NCT01091428|451239644|FG003|Phase 1|Withdrawal by Subject|0|||
125440112|NCT01091428|451239641|FG000|Phase 1|Reason not specified|0|||
125440113|NCT01091428|451239642|FG001|Phase 1|Reason not specified|1|||
125440114|NCT01091428|451239643|FG002|Phase 1|Reason not specified|0|||
125440115|NCT01091428|451239644|FG003|Phase 1|Reason not specified|0|||
125440116|NCT01091428|451239641|FG000|Phase 1|Single-Patient IND|2|||
125440117|NCT01091428|451239642|FG001|Phase 1|Single-Patient IND|0|||
125440118|NCT01091428|451239643|FG002|Phase 1|Single-Patient IND|0|||
125440119|NCT01091428|451239644|FG003|Phase 1|Single-Patient IND|0|||
125440120|NCT01091428|451239641|FG000|Phase 2|Progressive Disease|0|||
125440121|NCT01091428|451239642|FG001|Phase 2|Progressive Disease|0|||
125440122|NCT01091428|451239643|FG002|Phase 2|Progressive Disease|44|||
125440123|NCT01091428|451239644|FG003|Phase 2|Progressive Disease|46|||
125440124|NCT01091428|451239641|FG000|Phase 2|Symptomatic Deterioration|0|||
125440125|NCT01091428|451239642|FG001|Phase 2|Symptomatic Deterioration|0|||
125440126|NCT01091428|451239643|FG002|Phase 2|Symptomatic Deterioration|1|||
125440127|NCT01091428|451239644|FG003|Phase 2|Symptomatic Deterioration|6|||
125440128|NCT01091428|451239641|FG000|Phase 2|Adverse Event|0|||
125440129|NCT01091428|451239642|FG001|Phase 2|Adverse Event|0|||
125440130|NCT01091428|451239643|FG002|Phase 2|Adverse Event|12|||
125440131|NCT01091428|451239644|FG003|Phase 2|Adverse Event|5|||
125440132|NCT01091428|451239641|FG000|Phase 2|Withdrawal by Subject|0|||
125440133|NCT01091428|451239642|FG001|Phase 2|Withdrawal by Subject|0|||
125440134|NCT01091428|451239643|FG002|Phase 2|Withdrawal by Subject|9|||
125161002|NCT04325204|450215295|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
125161003|NCT04325204|450215296|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
125161004|NCT04711902|450215298|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
125161005|NCT04711902|450215299|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
125161006|NCT04711902|450215300|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
125161007|NCT04711902|450215301|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
125161008|NCT04711902|450215302|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
125161009|NCT04711902|450215303|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
125161010|NCT04710979|450215304|FG000|Overall Study|Lost to Follow-up|2|||
125161011|NCT04710979|450215305|FG001|Overall Study|Lost to Follow-up|4|||
125161012|NCT04710979|450215304|FG000|Overall Study|Withdrawal by Subject|1|||
125161013|NCT04710979|450215305|FG001|Overall Study|Withdrawal by Subject|0|||
125161014|NCT01561430|450215311|FG000|Overall Study|Adverse Event|0|||
125161015|NCT01561430|450215312|FG001|Overall Study|Adverse Event|0|||
125161016|NCT01561430|450215313|FG002|Overall Study|Adverse Event|3|||
125161017|NCT01561430|450215314|FG003|Overall Study|Adverse Event|1|||
125390629|NCT01150123|451063529|FG006|Overall Study|Withdrawal by Subject|0|||
125390630|NCT01150123|451063530|FG007|Overall Study|Withdrawal by Subject|3|||
125390631|NCT01150123|451063531|FG008|Overall Study|Withdrawal by Subject|2|||
125390632|NCT01150123|451063532|FG009|Overall Study|Withdrawal by Subject|0|||
125390633|NCT01150123|451063533|FG010|Overall Study|Withdrawal by Subject|1|||
125390634|NCT01150123|451063534|FG011|Overall Study|Withdrawal by Subject|0|||
125390635|NCT01150123|451063535|FG012|Overall Study|Withdrawal by Subject|1|||
125390636|NCT01150123|451063536|FG013|Overall Study|Withdrawal by Subject|0|||
125390637|NCT01150123|451063537|FG014|Overall Study|Withdrawal by Subject|0|||
125390638|NCT01150123|451063538|FG015|Overall Study|Withdrawal by Subject|1|||
125390639|NCT01150123|451063539|FG016|Overall Study|Withdrawal by Subject|0|||
125390640|NCT01150123|451063540|FG017|Overall Study|Withdrawal by Subject|1|||
125390641|NCT01150123|451063523|FG000|Overall Study|Lost to Follow-up|2|||
125390642|NCT01150123|451063524|FG001|Overall Study|Lost to Follow-up|1|||
125390643|NCT01150123|451063525|FG002|Overall Study|Lost to Follow-up|2|||
125390644|NCT01150123|451063526|FG003|Overall Study|Lost to Follow-up|2|||
125390645|NCT01150123|451063527|FG004|Overall Study|Lost to Follow-up|2|||
125390646|NCT01150123|451063528|FG005|Overall Study|Lost to Follow-up|5|||
125390647|NCT01150123|451063529|FG006|Overall Study|Lost to Follow-up|0|||
125390648|NCT01150123|451063530|FG007|Overall Study|Lost to Follow-up|0|||
125390649|NCT01150123|451063531|FG008|Overall Study|Lost to Follow-up|3|||
125390650|NCT01150123|451063532|FG009|Overall Study|Lost to Follow-up|1|||
125390651|NCT01150123|451063533|FG010|Overall Study|Lost to Follow-up|1|||
125390652|NCT01150123|451063534|FG011|Overall Study|Lost to Follow-up|1|||
125390653|NCT01150123|451063535|FG012|Overall Study|Lost to Follow-up|2|||
125390654|NCT01150123|451063536|FG013|Overall Study|Lost to Follow-up|0|||
125390655|NCT01150123|451063537|FG014|Overall Study|Lost to Follow-up|0|||
125390656|NCT01150123|451063538|FG015|Overall Study|Lost to Follow-up|0|||
125390657|NCT01150123|451063539|FG016|Overall Study|Lost to Follow-up|0|||
125390658|NCT01150123|451063540|FG017|Overall Study|Lost to Follow-up|0|||
125390659|NCT02486042|451063545|FG000|Overall Study|Physician Decision|1|||
125390660|NCT02486042|451063546|FG001|Overall Study|Physician Decision|7|||
125390661|NCT02486042|451063545|FG000|Overall Study|Hospital transfer|2|||
125390662|NCT02486042|451063546|FG001|Overall Study|Hospital transfer|2|||
125390663|NCT02486042|451063545|FG000|Overall Study|Withdrawal by Subject|0|||
125390664|NCT02486042|451063546|FG001|Overall Study|Withdrawal by Subject|2|||
125390665|NCT01466387|451063547|FG000|Overall Study|Adverse Event|0|||
125390666|NCT01466387|451063548|FG001|Overall Study|Adverse Event|0|||
125390667|NCT01466387|451063549|FG002|Overall Study|Adverse Event|1|||
125390668|NCT01466387|451063550|FG003|Overall Study|Adverse Event|1|||
125390669|NCT01466387|451063551|FG004|Overall Study|Adverse Event|0|||
125390670|NCT01466387|451063552|FG005|Overall Study|Adverse Event|0|||
125390671|NCT01466387|451063547|FG000|Overall Study|Lost to Follow-up|0|||
125390672|NCT01466387|451063548|FG001|Overall Study|Lost to Follow-up|0|||
125390673|NCT01466387|451063549|FG002|Overall Study|Lost to Follow-up|0|||
125390674|NCT01466387|451063550|FG003|Overall Study|Lost to Follow-up|0|||
125390675|NCT01466387|451063551|FG004|Overall Study|Lost to Follow-up|0|||
125390676|NCT01466387|451063552|FG005|Overall Study|Lost to Follow-up|1|||
125390677|NCT01466387|451063547|FG000|Overall Study|Protocol Violation|1|||
125390678|NCT01466387|451063548|FG001|Overall Study|Protocol Violation|0|||
125390679|NCT01466387|451063549|FG002|Overall Study|Protocol Violation|0|||
125390680|NCT01466387|451063550|FG003|Overall Study|Protocol Violation|1|||
125390681|NCT01466387|451063551|FG004|Overall Study|Protocol Violation|0|||
125390682|NCT01466387|451063552|FG005|Overall Study|Protocol Violation|0|||
125390683|NCT02968979|451063555|FG000|Overall Study|Protocol Violation|7|||
125390684|NCT02968979|451063555|FG000|Overall Study|Withdrawal by Subject|1|||
125390685|NCT04404855|451063556|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
125390686|NCT04404855|451063557|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
125161018|NCT01561430|450215311|FG000|Overall Study|Withdrawal by Subject|0|||
125440135|NCT01091428|451239644|FG003|Phase 2|Withdrawal by Subject|8|||
125440136|NCT01091428|451239641|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
125440137|NCT01091428|451239642|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
125440138|NCT01091428|451239643|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
125440139|NCT01091428|451239644|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
125440140|NCT01091428|451239641|FG000|Phase 2|Reason not specified|0|||
125440141|NCT01091428|451239642|FG001|Phase 2|Reason not specified|0|||
125440142|NCT01091428|451239643|FG002|Phase 2|Reason not specified|4|||
125440143|NCT01091428|451239644|FG003|Phase 2|Reason not specified|3|||
125440144|NCT01091428|451239641|FG000|Phase 2|Physician Decision|0|||
125440145|NCT01091428|451239642|FG001|Phase 2|Physician Decision|0|||
125440146|NCT01091428|451239643|FG002|Phase 2|Physician Decision|2|||
125161019|NCT01561430|450215312|FG001|Overall Study|Withdrawal by Subject|0|||
125161020|NCT01561430|450215313|FG002|Overall Study|Withdrawal by Subject|1|||
125161021|NCT01561430|450215314|FG003|Overall Study|Withdrawal by Subject|0|||
125161022|NCT01561430|450215311|FG000|Overall Study|Physician Decision|0|||
125161023|NCT01561430|450215312|FG001|Overall Study|Physician Decision|1|||
125161024|NCT01561430|450215313|FG002|Overall Study|Physician Decision|0|||
125161025|NCT01561430|450215314|FG003|Overall Study|Physician Decision|0|||
125161026|NCT01561430|450215311|FG000|Overall Study|Sponsor Decision|1|||
125161027|NCT01561430|450215312|FG001|Overall Study|Sponsor Decision|14|||
125161028|NCT01561430|450215313|FG002|Overall Study|Sponsor Decision|13|||
125161029|NCT01561430|450215314|FG003|Overall Study|Sponsor Decision|12|||
125161030|NCT02570113|450215315|FG000|Overall Study|Withdrawal by Subject|3|||
125161031|NCT02564211|450215316|FG000|Overall Study|Adverse Event|4|||
125161032|NCT01908816|450215317|FG000|Overall Study|Subject's no longer requires study drug|0|||
125161033|NCT01908816|450215318|FG001|Overall Study|Subject's no longer requires study drug|0|||
125161034|NCT01908816|450215319|FG002|Overall Study|Subject's no longer requires study drug|0|||
125161035|NCT01908816|450215320|FG003|Overall Study|Subject's no longer requires study drug|1|||
125161036|NCT01908816|450215317|FG000|Overall Study|Protocol deviation|1|||
125161037|NCT01908816|450215318|FG001|Overall Study|Protocol deviation|2|||
125161038|NCT01908816|450215319|FG002|Overall Study|Protocol deviation|1|||
125161039|NCT01908816|450215320|FG003|Overall Study|Protocol deviation|1|||
125161040|NCT01908816|450215317|FG000|Overall Study|Withdrawal by Subject|0|||
125161041|NCT01908816|450215318|FG001|Overall Study|Withdrawal by Subject|4|||
125161042|NCT01908816|450215319|FG002|Overall Study|Withdrawal by Subject|2|||
125161043|NCT01908816|450215320|FG003|Overall Study|Withdrawal by Subject|2|||
125161044|NCT01908816|450215317|FG000|Overall Study|Lost to Follow-up|3|||
125161045|NCT01908816|450215318|FG001|Overall Study|Lost to Follow-up|5|||
125161046|NCT01908816|450215319|FG002|Overall Study|Lost to Follow-up|4|||
125161047|NCT01908816|450215320|FG003|Overall Study|Lost to Follow-up|2|||
125161048|NCT01908816|450215317|FG000|Overall Study|Death|1|||
125161049|NCT01908816|450215318|FG001|Overall Study|Death|0|||
125161050|NCT01908816|450215319|FG002|Overall Study|Death|7|||
125161051|NCT01908816|450215320|FG003|Overall Study|Death|1|||
125161052|NCT01908816|450215317|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125161053|NCT01908816|450215318|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
125161054|NCT01908816|450215319|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
125161055|NCT01908816|450215320|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
125161056|NCT01908816|450215317|FG000|Overall Study|Early termination|87|||
125161057|NCT01908816|450215318|FG001|Overall Study|Early termination|60|||
125161058|NCT01908816|450215319|FG002|Overall Study|Early termination|43|||
125161059|NCT01908816|450215320|FG003|Overall Study|Early termination|28|||
125161060|NCT05183217|450215321|FG000|Overall Study|Withdrawal by Subject|1|||
125161061|NCT05183217|450215322|FG001|Overall Study|Withdrawal by Subject|1|||
125440147|NCT01091428|451239644|FG003|Phase 2|Physician Decision|0|||
125440148|NCT02531295|451239645|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
125161062|NCT03201250|450215323|FG000|Overall Study|screen failures|3|||
125161063|NCT03201250|450215324|FG001|Overall Study|screen failures|0|||
125161064|NCT03201250|450215325|FG002|Overall Study|screen failures|0|||
125161065|NCT00415194|450215326|FG000|Overall Study|Adverse Event|37|||
125161066|NCT00415194|450215327|FG001|Overall Study|Adverse Event|32|||
125161067|NCT00415194|450215326|FG000|Overall Study|Entry Criteria Not Met|4|||
125161068|NCT00415194|450215327|FG001|Overall Study|Entry Criteria Not Met|8|||
125161069|NCT00415194|450215326|FG000|Overall Study|Lost to Follow-up|1|||
125161070|NCT00415194|450215327|FG001|Overall Study|Lost to Follow-up|0|||
125161071|NCT00415194|450215326|FG000|Overall Study|Physician Decision|10|||
125440149|NCT02531295|451239646|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
125161072|NCT00415194|450215327|FG001|Overall Study|Physician Decision|16|||
125161073|NCT00415194|450215326|FG000|Overall Study|Progressive Disease|180|||
125161074|NCT00415194|450215327|FG001|Overall Study|Progressive Disease|217|||
125161075|NCT00415194|450215326|FG000|Overall Study|Protocol Violation|4|||
125161076|NCT00415194|450215327|FG001|Overall Study|Protocol Violation|2|||
125440150|NCT02531295|451239647|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
125440151|NCT02531295|451239648|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
125161077|NCT00415194|450215326|FG000|Overall Study|Withdrawal by Subject|28|||
125161078|NCT00415194|450215327|FG001|Overall Study|Withdrawal by Subject|21|||
125161079|NCT00415194|450215326|FG000|Overall Study|Death Due to Study Disease|26|||
125161080|NCT00415194|450215327|FG001|Overall Study|Death Due to Study Disease|29|||
125161081|NCT00415194|450215326|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
125161082|NCT00415194|450215327|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
125161083|NCT00415194|450215326|FG000|Overall Study|Death Due to Procedural Related AE|0|||
125161084|NCT00415194|450215327|FG001|Overall Study|Death Due to Procedural Related AE|1|||
125161085|NCT00415194|450215326|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
125161086|NCT00415194|450215327|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
125161087|NCT01297465|450215328|FG000|Overall Study|Lack of Ovarian Response|1|||
125161088|NCT01297465|450215329|FG001|Overall Study|Lack of Ovarian Response|1|||
125161089|NCT01297465|450215328|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
125161090|NCT01297465|450215329|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
125161091|NCT01297465|450215328|FG000|Overall Study|No Oocytes Retrieved|1|||
125161092|NCT01297465|450215329|FG001|Overall Study|No Oocytes Retrieved|1|||
125161093|NCT01297465|450215328|FG000|Overall Study|Poor oocyte quality|0|||
125161094|NCT01297465|450215329|FG001|Overall Study|Poor oocyte quality|1|||
125161095|NCT01297465|450215328|FG000|Overall Study|No Fertilization|6|||
125161096|NCT01297465|450215329|FG001|Overall Study|No Fertilization|4|||
125161097|NCT01297465|450215328|FG000|Overall Study|All Embryos Discarded|0|||
125161098|NCT01297465|450215329|FG001|Overall Study|All Embryos Discarded|1|||
125161099|NCT01297465|450215328|FG000|Overall Study|Intention to Freeze all Embryos|0|||
125161100|NCT01297465|450215329|FG001|Overall Study|Intention to Freeze all Embryos|1|||
125161101|NCT00969540|450215330|FG000|Overall Study|Lost to Follow-up|1|||
125161102|NCT00969540|450215331|FG001|Overall Study|Lost to Follow-up|1|||
125161103|NCT02397408|450215332|FG000|Overall Study|Physician Decision|4|||
125161104|NCT02397408|450215332|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
125161105|NCT00369655|450215333|FG000|Overall Study|Refusal of further treatment|2|||
125161106|NCT01683838|450215334|FG000|Overall Study|Adverse Event|12|||
125161107|NCT01683838|450215335|FG001|Overall Study|Adverse Event|2|||
125161108|NCT01683838|450215334|FG000|Overall Study|Protocol Violation|3|||
125161109|NCT01683838|450215335|FG001|Overall Study|Protocol Violation|1|||
125161110|NCT01683838|450215334|FG000|Overall Study|Withdrawal by Subject|6|||
125161111|NCT01683838|450215335|FG001|Overall Study|Withdrawal by Subject|5|||
125161112|NCT01683838|450215334|FG000|Overall Study|Lost to Follow-up|1|||
125161113|NCT01683838|450215335|FG001|Overall Study|Lost to Follow-up|1|||
125161114|NCT01683838|450215334|FG000|Overall Study|Other|4|||
125161115|NCT01683838|450215335|FG001|Overall Study|Other|3|||
125161116|NCT01646138|450215336|FG000|Overall Study|Lost to Follow-up|0|||
125161117|NCT01646138|450215337|FG001|Overall Study|Lost to Follow-up|0|||
125161118|NCT01646138|450215338|FG002|Overall Study|Lost to Follow-up|0|||
125161119|NCT01646138|450215339|FG003|Overall Study|Lost to Follow-up|0|||
125161120|NCT01646138|450215340|FG004|Overall Study|Lost to Follow-up|2|||
125161121|NCT04049617|450215341|FG000|Overall Study|Adverse Event|0|||
125161122|NCT04049617|450215342|FG001|Overall Study|Adverse Event|0|||
125161123|NCT04049617|450215343|FG002|Overall Study|Adverse Event|0|||
125161124|NCT04049617|450215344|FG003|Overall Study|Adverse Event|1|||
125161125|NCT04049617|450215345|FG004|Overall Study|Adverse Event|0|||
125161126|NCT04049617|450215346|FG005|Overall Study|Adverse Event|0|||
125161127|NCT04049617|450215341|FG000|Overall Study|Death|0|||
125161128|NCT04049617|450215342|FG001|Overall Study|Death|0|||
125161129|NCT04049617|450215343|FG002|Overall Study|Death|0|||
125161130|NCT04049617|450215344|FG003|Overall Study|Death|0|||
125161131|NCT04049617|450215345|FG004|Overall Study|Death|0|||
125161132|NCT04049617|450215346|FG005|Overall Study|Death|1|||
125161133|NCT04049617|450215341|FG000|Overall Study|Lost to Follow-up|0|||
125161134|NCT04049617|450215342|FG001|Overall Study|Lost to Follow-up|0|||
125161135|NCT04049617|450215343|FG002|Overall Study|Lost to Follow-up|0|||
125161136|NCT04049617|450215344|FG003|Overall Study|Lost to Follow-up|1|||
125161137|NCT04049617|450215345|FG004|Overall Study|Lost to Follow-up|0|||
125161138|NCT04049617|450215346|FG005|Overall Study|Lost to Follow-up|0|||
125161139|NCT04049617|450215341|FG000|Overall Study|Withdrew consent|0|||
125161140|NCT04049617|450215342|FG001|Overall Study|Withdrew consent|0|||
125161141|NCT04049617|450215343|FG002|Overall Study|Withdrew consent|1|||
125161142|NCT04049617|450215344|FG003|Overall Study|Withdrew consent|0|||
125161143|NCT04049617|450215345|FG004|Overall Study|Withdrew consent|0|||
125161144|NCT04049617|450215346|FG005|Overall Study|Withdrew consent|0|||
125161145|NCT03551496|450215347|FG000|Overall Study|Death|11|||
125161146|NCT03551496|450215348|FG001|Overall Study|Death|7|||
125161147|NCT03551496|450215347|FG000|Overall Study|Withdrawal by Subject|4|||
125161148|NCT03551496|450215348|FG001|Overall Study|Withdrawal by Subject|3|||
125161149|NCT03551496|450215347|FG000|Overall Study|Other Reasons|1|||
125161150|NCT03551496|450215348|FG001|Overall Study|Other Reasons|0|||
125161151|NCT01524679|450215349|FG000|Overall Study|Lost to Follow-up|1|||
125161152|NCT01524679|450215350|FG001|Overall Study|Lost to Follow-up|4|||
125161153|NCT01524679|450215349|FG000|Overall Study|Withdrawal by Subject|4|||
125161154|NCT01524679|450215350|FG001|Overall Study|Withdrawal by Subject|4|||
125161155|NCT01524679|450215349|FG000|Overall Study|Adverse Event|9|||
125161156|NCT01524679|450215350|FG001|Overall Study|Adverse Event|0|||
125161157|NCT01524679|450215349|FG000|Overall Study|Protocol Violation|1|||
125161158|NCT01524679|450215350|FG001|Overall Study|Protocol Violation|0|||
125161159|NCT01524679|450215349|FG000|Overall Study|Lack of Efficacy|2|||
125161160|NCT01524679|450215350|FG001|Overall Study|Lack of Efficacy|0|||
125161161|NCT01524679|450215349|FG000|Overall Study|e.g.wish for children, relocation|6|||
125161162|NCT01524679|450215350|FG001|Overall Study|e.g.wish for children, relocation|1|||
125161163|NCT00801099|450215351|FG000|Overall Study|Lost to Follow-up|101|||
125161164|NCT00140426|450215354|FG000|Overall Study|Withdrawal by Subject|0|||
125161165|NCT00140426|450215355|FG001|Overall Study|Withdrawal by Subject|3|||
125161166|NCT02149108|450215356|FG000|Overall Study|Not treated|1|||
125161167|NCT02149108|450215357|FG001|Overall Study|Not treated|2|||
125161168|NCT02149108|450215356|FG000|Overall Study|Progressive Disease (PD)|324|||
125161169|NCT02149108|450215357|FG001|Overall Study|Progressive Disease (PD)|318|||
125161170|NCT02149108|450215356|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
125161171|NCT02149108|450215357|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
125161172|NCT02149108|450215356|FG000|Overall Study|Other Adverse Event (AE)|8|||
125161173|NCT02149108|450215357|FG001|Overall Study|Other Adverse Event (AE)|18|||
125161174|NCT02149108|450215356|FG000|Overall Study|Other not defined above|0|||
125161175|NCT02149108|450215357|FG001|Overall Study|Other not defined above|2|||
125161176|NCT02149108|450215356|FG000|Overall Study|Refusal to continue trial medication|15|||
125161177|NCT02149108|450215357|FG001|Overall Study|Refusal to continue trial medication|11|||
125161178|NCT02149108|450215356|FG000|Overall Study|Lost to Follow-up|1|||
125161179|NCT02149108|450215357|FG001|Overall Study|Lost to Follow-up|0|||
125161180|NCT02981303|450215358|FG000|Overall Study|Progressive Disease|17|||
125161181|NCT02981303|450215359|FG001|Overall Study|Progressive Disease|37|||
125161182|NCT02981303|450215358|FG000|Overall Study|Adverse Event|1|||
125161183|NCT02981303|450215359|FG001|Overall Study|Adverse Event|4|||
125161184|NCT02981303|450215358|FG000|Overall Study|Withdrawal by Subject|0|||
125161185|NCT02981303|450215359|FG001|Overall Study|Withdrawal by Subject|1|||
125161186|NCT02393248|450215360|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161187|NCT02393248|450215361|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
125161188|NCT02393248|450215362|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161189|NCT02393248|450215363|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161190|NCT02393248|450215364|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161191|NCT02393248|450215365|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
125161192|NCT02393248|450215366|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
125161193|NCT02393248|450215367|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161194|NCT02393248|450215368|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161195|NCT02393248|450215369|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161196|NCT02393248|450215370|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161197|NCT02393248|450215371|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161198|NCT02393248|450215372|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161199|NCT02393248|450215373|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161200|NCT02393248|450215374|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161201|NCT02393248|450215375|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161202|NCT02393248|450215376|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161203|NCT02393248|450215377|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161204|NCT02393248|450215378|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161205|NCT02393248|450215379|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161206|NCT02393248|450215380|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161207|NCT02393248|450215381|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161208|NCT02393248|450215382|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161209|NCT02393248|450215383|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161210|NCT02393248|450215384|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
125161211|NCT02393248|450215360|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161212|NCT02393248|450215361|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
125161213|NCT02393248|450215362|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161214|NCT02393248|450215363|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161215|NCT02393248|450215364|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125390687|NCT03320564|451063558|FG000|Overall Study|Protocol Violation|1|||
125390688|NCT00788827|451063559|FG000|Overall Study|Lack of Efficacy|2|||
125390689|NCT03745144|451063566|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
125390690|NCT03745144|451063567|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
125390691|NCT03745144|451063568|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
125390692|NCT03745144|451063566|FG000|Period 1|Other|0|||
125390693|NCT03745144|451063567|FG001|Period 1|Other|0|||
125390694|NCT03745144|451063568|FG002|Period 1|Other|1|||
125390695|NCT00896337|451063569|FG000|Overall Study|Death|7|||
125390696|NCT00896337|451063569|FG000|Overall Study|Withdrawal by Subject|7|||
125390697|NCT00896337|451063569|FG000|Overall Study|Lost to Follow-up|11|||
125390698|NCT01586819|451063570|FG000|Overall Study|Withdrawal by Subject|1|||
125390699|NCT01586819|451063571|FG001|Overall Study|Withdrawal by Subject|0|||
125390700|NCT01359254|451063572|FG000|Overall Study|Death|1|||
125161216|NCT02393248|450215365|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161217|NCT02393248|450215366|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161218|NCT02393248|450215367|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161219|NCT02393248|450215368|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161220|NCT02393248|450215369|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161221|NCT02393248|450215370|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161222|NCT02393248|450215371|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161223|NCT02393248|450215372|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161224|NCT02393248|450215373|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161225|NCT02393248|450215374|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125224652|NCT00509899|450450141|FG001|Overall Study|Intercurrent Illness|0|||
125390701|NCT01359254|451063573|FG001|Overall Study|Death|0|||
125390702|NCT04668950|451063574|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
125390703|NCT04668950|451063575|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
125390704|NCT04668950|451063574|FG000|Overall Study|Could not confirm started study medication|15|||
125390705|NCT04668950|451063575|FG001|Overall Study|Could not confirm started study medication|15|||
125390706|NCT04668950|451063574|FG000|Overall Study|Could not confirm baseline status|6|||
125390707|NCT04668950|451063575|FG001|Overall Study|Could not confirm baseline status|2|||
125390708|NCT04668950|451063574|FG000|Overall Study|Drop out and did not start medication|15|||
125390709|NCT04668950|451063575|FG001|Overall Study|Drop out and did not start medication|17|||
125390710|NCT04668950|451063574|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
125390711|NCT04668950|451063575|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
125390712|NCT04668950|451063574|FG000|Overall Study|Other|2|||
125390713|NCT04668950|451063575|FG001|Overall Study|Other|4|||
125390714|NCT03979638|451063578|FG000|Period 1|Physician Decision|1|||
125390715|NCT03979638|451063579|FG001|Period 1|Physician Decision|1|||
125390716|NCT03979638|451063578|FG000|Period 1|Withdrawal by Subject|4|||
125390717|NCT03979638|451063579|FG001|Period 1|Withdrawal by Subject|3|||
125390718|NCT03979638|451063578|FG000|Period 1|Study terminated by Sponsor|1|||
125390719|NCT03979638|451063579|FG001|Period 1|Study terminated by Sponsor|3|||
125390720|NCT03979638|451063578|FG000|Period 1|Protocol Violation|1|||
125390721|NCT03979638|451063579|FG001|Period 1|Protocol Violation|0|||
125390722|NCT03979638|451063578|FG000|Period 2|Study terminated by Sponsor|1|||
125390723|NCT03979638|451063579|FG001|Period 2|Study terminated by Sponsor|1|||
125390724|NCT04248933|451063580|FG000|Overall Study|Lost to Follow-up|9|||
125390725|NCT04248933|451063580|FG000|Overall Study|Withdrawal by Subject|2|||
125390726|NCT00578942|451063581|FG000|Overall Study|Lost to Follow-up|1|||
125390727|NCT01124643|451063595|FG000|Overall Study|Death|1|||
125390728|NCT02910167|451063596|FG000|Overall Study|Adverse Event|1|||
125390729|NCT02910167|451063596|FG000|Overall Study|Lost to Follow-up|18|||
125390730|NCT04220411|451063597|FG000|Overall Study|Adverse Event|0|||
125390731|NCT04220411|451063598|FG001|Overall Study|Adverse Event|0|||
125390732|NCT04220411|451063599|FG002|Overall Study|Adverse Event|0|||
125390733|NCT04220411|451063600|FG003|Overall Study|Adverse Event|1|||
125390734|NCT02028988|451063601|FG000|Overall Study|Withdrawal by Subject|2|||
125390735|NCT02680639|451063604|FG000|Screening Period|Screen Failure|7|||
125390736|NCT02680639|451063605|FG001|Screening Period|Screen Failure|0|||
125390737|NCT02680639|451063606|FG002|Screening Period|Screen Failure|0|||
125390738|NCT01063595|451063607|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
125390739|NCT01063595|451063608|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
125390740|NCT01063595|451063607|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
125390741|NCT01063595|451063608|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
125390742|NCT01063595|451063607|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
125390743|NCT01063595|451063608|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
125390744|NCT01063595|451063607|FG000|First Intervention|Adverse Event|1|||
125390745|NCT01063595|451063608|FG001|First Intervention|Adverse Event|4|||
125390746|NCT01063595|451063607|FG000|First Intervention|Withdrawal by Subject|1|||
125390747|NCT01063595|451063608|FG001|First Intervention|Withdrawal by Subject|0|||
125390748|NCT01063595|451063607|FG000|First Intervention|Reason not Specified|0|||
125390749|NCT01063595|451063608|FG001|First Intervention|Reason not Specified|1|||
125390750|NCT00747435|451063609|FG000|Overall Study|Lost to Follow-up|2|||
125390751|NCT00747435|451063609|FG000|Overall Study|Withdrawal by Subject|3|||
125390752|NCT00747435|451063609|FG000|Overall Study|Still undergoing follow up|1|||
125390753|NCT04059146|451063610|FG000|Overall Study|Withdrawal by Subject|0|||
125390754|NCT04059146|451063611|FG001|Overall Study|Withdrawal by Subject|1|||
125390755|NCT02678676|451063612|FG000|Overall Study|Death|619|||
125390756|NCT02678676|451063613|FG001|Overall Study|Death|649|||
125390757|NCT02678676|451063612|FG000|Overall Study|Withdrawal by Subject|13|||
125390758|NCT02678676|451063613|FG001|Overall Study|Withdrawal by Subject|5|||
125390759|NCT02678676|451063612|FG000|Overall Study|Lost to Follow-up|171|||
125390760|NCT02678676|451063613|FG001|Overall Study|Lost to Follow-up|151|||
125440152|NCT02531295|451239649|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
125161226|NCT02393248|450215375|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125440153|NCT02531295|451239650|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
125440154|NCT04424290|451239652|FG000|Overall Study|Not treated|0|||
125440155|NCT04424290|451239653|FG001|Overall Study|Not treated|0|||
125440156|NCT04424290|451239654|FG002|Overall Study|Not treated|1|||
125440157|NCT04424290|451239655|FG003|Overall Study|Not treated|0|||
125440158|NCT04424290|451239656|FG004|Overall Study|Not treated|1|||
125440159|NCT04424290|451239652|FG000|Overall Study|Adverse Event|0|||
125440160|NCT04424290|451239653|FG001|Overall Study|Adverse Event|0|||
125440161|NCT04424290|451239654|FG002|Overall Study|Adverse Event|0|||
125440162|NCT04424290|451239655|FG003|Overall Study|Adverse Event|2|||
125440163|NCT04424290|451239656|FG004|Overall Study|Adverse Event|0|||
125440164|NCT04424290|451239652|FG000|Overall Study|Withdrawal by Subject|0|||
125440165|NCT04424290|451239653|FG001|Overall Study|Withdrawal by Subject|0|||
125440166|NCT04424290|451239654|FG002|Overall Study|Withdrawal by Subject|0|||
125440167|NCT04424290|451239655|FG003|Overall Study|Withdrawal by Subject|0|||
125161227|NCT02393248|450215376|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161228|NCT02393248|450215377|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161229|NCT02393248|450215378|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161230|NCT02393248|450215379|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161231|NCT02393248|450215380|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161232|NCT02393248|450215381|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161233|NCT02393248|450215382|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161234|NCT02393248|450215383|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161235|NCT02393248|450215384|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
125161236|NCT02393248|450215360|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
125161237|NCT02393248|450215361|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
125161238|NCT02393248|450215362|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
125161239|NCT02393248|450215363|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
125161240|NCT02393248|450215364|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
125161241|NCT02393248|450215365|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
125161242|NCT02393248|450215366|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
125161243|NCT02393248|450215367|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
125161244|NCT02393248|450215368|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
125161245|NCT02393248|450215369|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
125161246|NCT02393248|450215370|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
125161247|NCT02393248|450215371|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
125161248|NCT02393248|450215372|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
125161249|NCT02393248|450215373|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
125161250|NCT02393248|450215374|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
125161251|NCT02393248|450215375|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
125161252|NCT02393248|450215376|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
125161253|NCT02393248|450215377|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
125161254|NCT02393248|450215378|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
125161255|NCT02393248|450215379|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
125161256|NCT02393248|450215380|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
125161257|NCT02393248|450215381|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
125161258|NCT02393248|450215382|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
125161259|NCT02393248|450215383|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
125161260|NCT02393248|450215384|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
125161261|NCT02393248|450215360|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
125161262|NCT02393248|450215361|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161263|NCT02393248|450215362|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161264|NCT02393248|450215363|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161265|NCT02393248|450215364|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161266|NCT02393248|450215365|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161267|NCT02393248|450215366|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161268|NCT02393248|450215367|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161269|NCT02393248|450215368|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161270|NCT02393248|450215369|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161271|NCT02393248|450215370|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161272|NCT02393248|450215371|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161273|NCT02393248|450215372|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161274|NCT02393248|450215373|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161275|NCT02393248|450215374|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161276|NCT02393248|450215375|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125440168|NCT04424290|451239656|FG004|Overall Study|Withdrawal by Subject|1|||
125440169|NCT04424290|451239652|FG000|Overall Study|Other than listed|0|||
125161277|NCT02393248|450215376|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125224653|NCT00509899|450450142|FG002|Overall Study|Intercurrent Illness|0|||
125440170|NCT04424290|451239653|FG001|Overall Study|Other than listed|0|||
125440171|NCT04424290|451239654|FG002|Overall Study|Other than listed|0|||
125440172|NCT04424290|451239655|FG003|Overall Study|Other than listed|1|||
125440173|NCT04424290|451239656|FG004|Overall Study|Other than listed|0|||
125161278|NCT02393248|450215377|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161279|NCT02393248|450215378|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161280|NCT02393248|450215379|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161281|NCT02393248|450215380|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161282|NCT02393248|450215381|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161283|NCT02393248|450215382|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161284|NCT02393248|450215383|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161285|NCT02393248|450215384|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
125161286|NCT02393248|450215360|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161287|NCT02393248|450215361|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161288|NCT02393248|450215362|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161289|NCT02393248|450215363|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161290|NCT02393248|450215364|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161291|NCT02393248|450215365|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
125161292|NCT02393248|450215366|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
125161293|NCT02393248|450215367|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161294|NCT02393248|450215368|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161295|NCT02393248|450215369|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
125161296|NCT02393248|450215370|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161297|NCT02393248|450215371|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161298|NCT02393248|450215372|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161299|NCT02393248|450215373|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161300|NCT02393248|450215374|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161301|NCT02393248|450215375|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161302|NCT02393248|450215376|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161303|NCT02393248|450215377|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161304|NCT02393248|450215378|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161305|NCT02393248|450215379|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161306|NCT02393248|450215380|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161307|NCT02393248|450215381|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161308|NCT02393248|450215382|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161309|NCT02393248|450215383|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161310|NCT02393248|450215384|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
125161311|NCT02393248|450215360|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161312|NCT02393248|450215361|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161313|NCT02393248|450215362|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161314|NCT02393248|450215363|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161315|NCT02393248|450215364|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161316|NCT02393248|450215365|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161317|NCT02393248|450215366|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
125161318|NCT02393248|450215367|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161319|NCT02393248|450215368|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161320|NCT02393248|450215369|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161321|NCT02393248|450215370|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161322|NCT02393248|450215371|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161323|NCT02393248|450215372|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161324|NCT02393248|450215373|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161325|NCT02393248|450215374|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161326|NCT02393248|450215375|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161327|NCT02393248|450215376|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161328|NCT02393248|450215377|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161329|NCT02393248|450215378|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161330|NCT02393248|450215379|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161331|NCT02393248|450215380|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161332|NCT02393248|450215381|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161333|NCT02393248|450215382|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161334|NCT02393248|450215383|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161335|NCT02393248|450215384|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
125161336|NCT02393248|450215360|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125440174|NCT04249336|451239659|FG000|Overall Study|Lost to Follow-up|3|||
125440175|NCT04249336|451239660|FG001|Overall Study|Lost to Follow-up|3|||
125440176|NCT04249336|451239661|FG002|Overall Study|Lost to Follow-up|3|||
125440177|NCT04249336|451239662|FG003|Overall Study|Lost to Follow-up|3|||
125440178|NCT03390036|451239663|FG000|Overall Study|Lost to Follow-up|1|||
125440179|NCT03390036|451239664|FG001|Overall Study|Lost to Follow-up|0|||
125440180|NCT03390036|451239665|FG002|Overall Study|Lost to Follow-up|0|||
125440181|NCT03390036|451239663|FG000|Overall Study|Lack of Efficacy|1|||
125440182|NCT03390036|451239664|FG001|Overall Study|Lack of Efficacy|0|||
125440183|NCT03390036|451239665|FG002|Overall Study|Lack of Efficacy|0|||
125440184|NCT00358215|451239666|FG000|Overall Study|Ineligibility determined|4|||
125440185|NCT00358215|451239667|FG001|Overall Study|Ineligibility determined|3|||
125161337|NCT02393248|450215361|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161338|NCT02393248|450215362|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161339|NCT02393248|450215363|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161340|NCT02393248|450215364|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161341|NCT02393248|450215365|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161342|NCT02393248|450215366|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161343|NCT02393248|450215367|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161344|NCT02393248|450215368|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161345|NCT02393248|450215369|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161346|NCT02393248|450215370|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161347|NCT02393248|450215371|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
125161348|NCT02393248|450215372|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
125161349|NCT02393248|450215373|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
125161350|NCT02393248|450215374|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
125161351|NCT02393248|450215375|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161352|NCT02393248|450215376|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161353|NCT02393248|450215377|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161354|NCT02393248|450215378|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161355|NCT02393248|450215379|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161356|NCT02393248|450215380|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161357|NCT02393248|450215381|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161358|NCT02393248|450215382|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161359|NCT02393248|450215383|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161360|NCT02393248|450215384|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
125161361|NCT02393248|450215360|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161362|NCT02393248|450215361|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161363|NCT02393248|450215362|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161364|NCT02393248|450215363|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161365|NCT02393248|450215364|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161366|NCT02393248|450215365|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161367|NCT02393248|450215366|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161368|NCT02393248|450215367|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161369|NCT02393248|450215368|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161370|NCT02393248|450215369|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161371|NCT02393248|450215370|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
125161372|NCT02393248|450215371|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
125161373|NCT02393248|450215372|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161374|NCT02393248|450215373|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161375|NCT02393248|450215374|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161376|NCT02393248|450215375|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161377|NCT02393248|450215376|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161378|NCT02393248|450215377|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161379|NCT02393248|450215378|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161380|NCT02393248|450215379|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161381|NCT02393248|450215380|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161382|NCT02393248|450215381|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161383|NCT02393248|450215382|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161384|NCT02393248|450215383|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125161385|NCT02393248|450215384|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
125440186|NCT00358215|451239666|FG000|Overall Study|Adverse Event|83|||
125161386|NCT02393248|450215360|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
125161387|NCT02393248|450215361|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
125161388|NCT02393248|450215362|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
125161389|NCT02393248|450215363|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
125161390|NCT02393248|450215364|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
125440187|NCT00358215|451239667|FG001|Overall Study|Adverse Event|65|||
125440188|NCT00358215|451239666|FG000|Overall Study|Withdrawal by Subject|111|||
125224654|NCT00509899|450450143|FG003|Overall Study|Intercurrent Illness|1|||
125224655|NCT00509899|450450144|FG004|Overall Study|Intercurrent Illness|0|||
125224656|NCT00509899|450450145|FG005|Overall Study|Intercurrent Illness|1|||
125224657|NCT00509899|450450146|FG006|Overall Study|Intercurrent Illness|0|||
125224658|NCT00509899|450450147|FG007|Overall Study|Intercurrent Illness|0|||
125224659|NCT00509899|450450140|FG000|Overall Study|Death|2|||
125224660|NCT00509899|450450141|FG001|Overall Study|Death|2|||
125224661|NCT00509899|450450142|FG002|Overall Study|Death|3|||
125224662|NCT00509899|450450143|FG003|Overall Study|Death|0|||
125224663|NCT00509899|450450144|FG004|Overall Study|Death|1|||
125224664|NCT00509899|450450145|FG005|Overall Study|Death|1|||
125224665|NCT00509899|450450146|FG006|Overall Study|Death|1|||
125224666|NCT00509899|450450147|FG007|Overall Study|Death|1|||
125224667|NCT00509899|450450140|FG000|Overall Study|Lack of Efficacy|1|||
125224668|NCT00509899|450450141|FG001|Overall Study|Lack of Efficacy|0|||
125224669|NCT00509899|450450142|FG002|Overall Study|Lack of Efficacy|2|||
125224670|NCT00509899|450450143|FG003|Overall Study|Lack of Efficacy|0|||
125224671|NCT00509899|450450144|FG004|Overall Study|Lack of Efficacy|0|||
125224672|NCT00509899|450450145|FG005|Overall Study|Lack of Efficacy|1|||
125224673|NCT00509899|450450146|FG006|Overall Study|Lack of Efficacy|0|||
125224674|NCT00509899|450450147|FG007|Overall Study|Lack of Efficacy|0|||
125224675|NCT02087774|450450152|FG000|Overall Study|Were absent day of data collection|8|||
125224676|NCT02087774|450450153|FG001|Overall Study|Were absent day of data collection|20|||
125224677|NCT05081388|450450154|FG000|Overall Study|Adverse Event|1|||
125224678|NCT05081388|450450155|FG001|Overall Study|Adverse Event|0|||
125390761|NCT02678676|451063612|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
125390762|NCT02678676|451063613|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
125390763|NCT04439318|451063616|FG000|Overall Study|Ineligible|1|||
125161391|NCT02393248|450215365|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
125161392|NCT02393248|450215366|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
125161393|NCT02393248|450215367|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
125161394|NCT02393248|450215368|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
125161395|NCT02393248|450215369|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
125161396|NCT02393248|450215370|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
125161397|NCT02393248|450215371|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
125161398|NCT02393248|450215372|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
125161399|NCT02393248|450215373|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
125161400|NCT02393248|450215374|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
125161401|NCT02393248|450215375|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
125161402|NCT02393248|450215376|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
125161403|NCT02393248|450215377|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
125161404|NCT02393248|450215378|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
125161405|NCT02393248|450215379|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
125161406|NCT02393248|450215380|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
125161407|NCT02393248|450215381|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
125161408|NCT02393248|450215382|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
125161409|NCT02393248|450215383|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
125161410|NCT02393248|450215384|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
125161411|NCT02393248|450215360|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161412|NCT02393248|450215361|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161413|NCT02393248|450215362|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161414|NCT02393248|450215363|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161415|NCT02393248|450215364|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161416|NCT02393248|450215365|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161417|NCT02393248|450215366|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161418|NCT02393248|450215367|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161419|NCT02393248|450215368|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161420|NCT02393248|450215369|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161421|NCT02393248|450215370|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161422|NCT02393248|450215371|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
125161423|NCT02393248|450215372|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161424|NCT02393248|450215373|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
125161425|NCT02393248|450215374|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161426|NCT02393248|450215375|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161427|NCT02393248|450215376|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161428|NCT02393248|450215377|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161429|NCT02393248|450215378|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125224679|NCT05081388|450450156|FG002|Overall Study|Adverse Event|0|||
125224680|NCT05081388|450450157|FG003|Overall Study|Adverse Event|0|||
125224681|NCT05081388|450450158|FG004|Overall Study|Adverse Event|0|||
125224682|NCT05081388|450450154|FG000|Overall Study|Lost to Follow-up|0|||
125224683|NCT05081388|450450155|FG001|Overall Study|Lost to Follow-up|1|||
125224684|NCT05081388|450450156|FG002|Overall Study|Lost to Follow-up|0|||
125161430|NCT02393248|450215379|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161431|NCT02393248|450215380|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161432|NCT02393248|450215381|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161433|NCT02393248|450215382|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161434|NCT02393248|450215383|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161435|NCT02393248|450215384|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
125161436|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161437|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161438|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161439|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161440|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161441|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161442|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161443|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161444|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161445|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161446|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161447|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161448|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161449|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161450|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161451|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161452|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161453|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161454|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
125161455|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161456|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
125161457|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
125161458|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161459|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
125390764|NCT04439318|451063616|FG000|Overall Study|Never Started Treatment|3|||
125161460|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
125161461|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Death|0|||
125161462|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Death|0|||
125161463|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Death|0|||
125161464|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Death|0|||
125161465|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Death|0|||
125161466|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Death|0|||
125161467|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Death|0|||
125161468|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Death|0|||
125161469|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Death|0|||
125161470|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Death|0|||
125161471|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Death|0|||
125161472|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Death|0|||
125161473|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Death|0|||
125161474|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Death|0|||
125161475|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Death|0|||
125161476|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Death|1|||
125161477|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Death|7|||
125161478|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Death|5|||
125161479|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Death|5|||
125161480|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Death|3|||
125161481|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Death|7|||
125161482|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Death|5|||
125161483|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Death|6|||
125161484|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Death|3|||
125161485|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Death|0|||
125161486|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161487|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161488|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125390765|NCT04439318|451063616|FG000|Overall Study|Adverse Event|10|||
125390766|NCT04439318|451063616|FG000|Overall Study|Death|2|||
125390767|NCT04439318|451063616|FG000|Overall Study|Disease Progression|25|||
125390768|NCT04439318|451063616|FG000|Overall Study|Other Complicating Disease|2|||
125161489|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161490|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161491|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161492|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161493|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161494|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161495|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161496|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125224685|NCT05081388|450450157|FG003|Overall Study|Lost to Follow-up|0|||
125224686|NCT05081388|450450158|FG004|Overall Study|Lost to Follow-up|0|||
125224687|NCT05081388|450450154|FG000|Overall Study|Subject decision|0|||
125224688|NCT05081388|450450155|FG001|Overall Study|Subject decision|0|||
125224689|NCT05081388|450450156|FG002|Overall Study|Subject decision|0|||
125224690|NCT05081388|450450157|FG003|Overall Study|Subject decision|1|||
125224691|NCT05081388|450450158|FG004|Overall Study|Subject decision|0|||
125224692|NCT02157519|450450167|FG000|Overall Study|Death|3|||
125161497|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161498|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161499|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161500|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125224693|NCT02157519|450450168|FG001|Overall Study|Death|1|||
125161501|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161502|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161503|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
125161504|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
125161505|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
125161506|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
125161507|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
125161508|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
125161509|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
125161510|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
125161511|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Disease Progression|0|||
125161512|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Disease Progression|0|||
125161513|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Disease Progression|0|||
125161514|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Disease Progression|0|||
125161515|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Disease Progression|0|||
125161516|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Disease Progression|0|||
125161517|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Disease Progression|0|||
125161518|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Disease Progression|0|||
125161519|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Disease Progression|0|||
125161520|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Disease Progression|0|||
125161521|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Disease Progression|0|||
125161522|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Disease Progression|0|||
125161523|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Disease Progression|0|||
125161524|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Disease Progression|0|||
125161525|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Disease Progression|0|||
125161526|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Disease Progression|0|||
125161527|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Disease Progression|0|||
125161528|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Disease Progression|0|||
125161529|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Disease Progression|0|||
125161530|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Disease Progression|0|||
125161531|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Disease Progression|2|||
125161532|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Disease Progression|1|||
125161533|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Disease Progression|0|||
125161534|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Disease Progression|0|||
125161535|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Disease Progression|0|||
125161536|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161537|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161538|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161539|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161540|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161541|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161542|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161543|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161544|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161545|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161546|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
125224694|NCT02157519|450450167|FG000|Overall Study|Withdrawal by Subject|7|||
125390769|NCT04439318|451063616|FG000|Overall Study|Withdrawal by Subject|4|||
125390770|NCT04439318|451063616|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
125390771|NCT04439318|451063616|FG000|Overall Study|Non-Compliance|1|||
125161547|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161548|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161549|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161550|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161551|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
125224695|NCT02157519|450450168|FG001|Overall Study|Withdrawal by Subject|0|||
125224696|NCT02157519|450450167|FG000|Overall Study|Lost to Follow-up|1|||
125224697|NCT02157519|450450168|FG001|Overall Study|Lost to Follow-up|0|||
125161552|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161553|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161554|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161555|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161556|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
125161557|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
125161558|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161559|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161560|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
125161561|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161562|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161563|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161564|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161565|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161566|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161567|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161568|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161569|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161570|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161571|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161572|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161573|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161574|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161575|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161576|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161577|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161578|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161579|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161580|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161581|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
125161582|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161583|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161584|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161585|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
125161586|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Adverse Event|0|||
125161587|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Adverse Event|0|||
125161588|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Adverse Event|0|||
125161589|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Adverse Event|0|||
125161590|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Adverse Event|0|||
125161591|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Adverse Event|0|||
125161592|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Adverse Event|0|||
125161593|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Adverse Event|0|||
125161594|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Adverse Event|0|||
125161595|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Adverse Event|0|||
125161596|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Adverse Event|0|||
125161597|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Adverse Event|0|||
125161598|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Adverse Event|0|||
125161599|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Adverse Event|0|||
125161600|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Adverse Event|0|||
125161601|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Adverse Event|0|||
125161602|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Adverse Event|0|||
125161603|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Adverse Event|0|||
125161604|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Adverse Event|0|||
125161605|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Adverse Event|0|||
125161606|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Adverse Event|0|||
125161607|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Adverse Event|0|||
125161608|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Adverse Event|0|||
125161609|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Adverse Event|1|||
125161610|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Adverse Event|0|||
125390772|NCT04439318|451063616|FG000|Overall Study|Still on Treatment|1|||
125390773|NCT03509675|451065279|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
125224698|NCT01656395|450450169|FG000|Overall Study|Adverse Event|1|||
125224699|NCT01656395|450450170|FG001|Overall Study|Adverse Event|14|||
125224700|NCT01656395|450450171|FG002|Overall Study|Adverse Event|5|||
125224701|NCT01656395|450450172|FG003|Overall Study|Adverse Event|4|||
125224702|NCT01656395|450450173|FG004|Overall Study|Adverse Event|5|||
125224703|NCT01656395|450450174|FG005|Overall Study|Adverse Event|7|||
125224704|NCT01656395|450450175|FG006|Overall Study|Adverse Event|0|||
125224705|NCT01656395|450450176|FG007|Overall Study|Adverse Event|0|||
125224706|NCT01656395|450450169|FG000|Overall Study|Lack of Efficacy|1|||
125224707|NCT01656395|450450170|FG001|Overall Study|Lack of Efficacy|8|||
125224708|NCT01656395|450450171|FG002|Overall Study|Lack of Efficacy|6|||
125440189|NCT00358215|451239667|FG001|Overall Study|Withdrawal by Subject|102|||
125440190|NCT00358215|451239666|FG000|Overall Study|Participant request|65|||
125440191|NCT00358215|451239667|FG001|Overall Study|Participant request|64|||
125440192|NCT00358215|451239666|FG000|Overall Study|Physician Decision|47|||
125440193|NCT00358215|451239667|FG001|Overall Study|Physician Decision|39|||
125440194|NCT00358215|451239666|FG000|Overall Study|Lost to Follow-up|16|||
125440195|NCT00358215|451239667|FG001|Overall Study|Lost to Follow-up|22|||
125440196|NCT00358215|451239666|FG000|Overall Study|Death|265|||
125440197|NCT00358215|451239667|FG001|Overall Study|Death|281|||
125440198|NCT00358215|451239666|FG000|Overall Study|Protocol Violation|64|||
125440199|NCT00358215|451239667|FG001|Overall Study|Protocol Violation|59|||
125440200|NCT00358215|451239666|FG000|Overall Study|Pregnancy|1|||
125440201|NCT00358215|451239667|FG001|Overall Study|Pregnancy|0|||
125440202|NCT00358215|451239666|FG000|Overall Study|Other|21|||
125440203|NCT00358215|451239667|FG001|Overall Study|Other|14|||
125440204|NCT00358215|451239666|FG000|Overall Study|Did not receive investigational product|2|||
125440205|NCT00358215|451239667|FG001|Overall Study|Did not receive investigational product|3|||
125440206|NCT04329104|451239672|FG000|Efficacy Study|Withdrawal by Subject|0|||
125440207|NCT04329104|451239673|FG001|Efficacy Study|Withdrawal by Subject|0|||
125440208|NCT04329104|451239674|FG002|Efficacy Study|Withdrawal by Subject|0|||
125440209|NCT04329104|451239675|FG003|Efficacy Study|Withdrawal by Subject|5|||
125440210|NCT04329104|451239676|FG004|Efficacy Study|Withdrawal by Subject|6|||
125440211|NCT04329104|451239677|FG005|Efficacy Study|Withdrawal by Subject|8|||
125440212|NCT03884231|451239678|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
125440213|NCT03884231|451239678|FG000|Overall Study|Subject Withdrew Consent|1|||
125440214|NCT03884231|451239678|FG000|Overall Study|MRI Scan Not Performed|1|||
125440215|NCT01853254|451239679|FG000|Overall Study|Abnormal Laboratory Test|1|||
125440216|NCT01853254|451239679|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
125440217|NCT01853254|451239679|FG000|Overall Study|Death|1|||
125440218|NCT01853254|451239679|FG000|Overall Study|Failure to Return|43|||
125440219|NCT01853254|451239679|FG000|Overall Study|Insufficient Therapeutic Response|22|||
125440220|NCT01853254|451239679|FG000|Overall Study|Refusal of Treatment|1|||
125440221|NCT01853254|451239679|FG000|Overall Study|Other Protocol Violation|1|||
125440222|NCT01853254|451239679|FG000|Overall Study|Withdrawal of Consent|16|||
125440223|NCT01853254|451239679|FG000|Overall Study|Administrative/Other|16|||
125440224|NCT01017120|451239690|FG000|Overall Study|Adverse Event|9|||
125440225|NCT01017120|451239691|FG001|Overall Study|Adverse Event|0|||
125440226|NCT01017120|451239690|FG000|Overall Study|Lost to Follow-up|13|||
125440227|NCT01017120|451239691|FG001|Overall Study|Lost to Follow-up|11|||
125440228|NCT01017120|451239690|FG000|Overall Study|Lack of Efficacy|1|||
125440229|NCT01017120|451239691|FG001|Overall Study|Lack of Efficacy|0|||
125440230|NCT01017120|451239690|FG000|Overall Study|Withdrawal by Subject|39|||
125440231|NCT01017120|451239691|FG001|Overall Study|Withdrawal by Subject|21|||
125440232|NCT01017120|451239690|FG000|Overall Study|Pregnancy|1|||
125440233|NCT01017120|451239691|FG001|Overall Study|Pregnancy|1|||
125440234|NCT01017120|451239690|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
125224709|NCT01656395|450450172|FG003|Overall Study|Lack of Efficacy|1|||
125224710|NCT01656395|450450173|FG004|Overall Study|Lack of Efficacy|1|||
125224711|NCT01656395|450450174|FG005|Overall Study|Lack of Efficacy|6|||
125440235|NCT01017120|451239691|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
125440236|NCT01017120|451239690|FG000|Overall Study|Relocated Out of Town|0|||
125440237|NCT01017120|451239691|FG001|Overall Study|Relocated Out of Town|2|||
125440238|NCT01017120|451239690|FG000|Overall Study|Protocol Violation|1|||
125440239|NCT01017120|451239691|FG001|Overall Study|Protocol Violation|0|||
125440240|NCT01017120|451239690|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
125440241|NCT01017120|451239691|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
125440242|NCT01087723|451239693|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
125440243|NCT01087723|451239694|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
125440244|NCT01087723|451239693|FG000|Overall Study|Withdrawal by Subject|10|||
125440245|NCT01087723|451239694|FG001|Overall Study|Withdrawal by Subject|13|||
125440246|NCT01087723|451239693|FG000|Overall Study|Physician Decision|2|||
125224712|NCT01656395|450450175|FG006|Overall Study|Lack of Efficacy|0|||
125224713|NCT01656395|450450176|FG007|Overall Study|Lack of Efficacy|0|||
125224714|NCT01656395|450450169|FG000|Overall Study|Lost to Follow-up|1|||
125224715|NCT01656395|450450170|FG001|Overall Study|Lost to Follow-up|0|||
125440247|NCT01087723|451239694|FG001|Overall Study|Physician Decision|0|||
125440248|NCT01087723|451239693|FG000|Overall Study|Lost to Follow-up|1|||
125161611|NCT02393248|450215360|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161612|NCT02393248|450215361|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161613|NCT02393248|450215362|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161614|NCT02393248|450215363|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161615|NCT02393248|450215364|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161616|NCT02393248|450215365|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161617|NCT02393248|450215366|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161618|NCT02393248|450215367|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161619|NCT02393248|450215368|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161620|NCT02393248|450215369|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161621|NCT02393248|450215370|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161622|NCT02393248|450215371|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161623|NCT02393248|450215372|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161624|NCT02393248|450215373|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161625|NCT02393248|450215374|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161626|NCT02393248|450215375|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161627|NCT02393248|450215376|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161628|NCT02393248|450215377|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161629|NCT02393248|450215378|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161630|NCT02393248|450215379|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161631|NCT02393248|450215380|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161632|NCT02393248|450215381|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161633|NCT02393248|450215382|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161634|NCT02393248|450215383|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
125161635|NCT02393248|450215384|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
125161636|NCT00987389|450215385|FG000|Overall Study|Ineligible|0|||
125161637|NCT00987389|450215386|FG001|Overall Study|Ineligible|3|||
125161638|NCT00987389|450215387|FG002|Overall Study|Ineligible|0|||
125161639|NCT00987389|450215388|FG003|Overall Study|Ineligible|0|||
125161640|NCT00987389|450215385|FG000|Overall Study|Lost to Follow-up|4|||
125161641|NCT00987389|450215386|FG001|Overall Study|Lost to Follow-up|1|||
125161642|NCT00987389|450215387|FG002|Overall Study|Lost to Follow-up|3|||
125161643|NCT00987389|450215388|FG003|Overall Study|Lost to Follow-up|1|||
125161644|NCT00987389|450215385|FG000|Overall Study|Withdrawal by Subject|4|||
125161645|NCT00987389|450215386|FG001|Overall Study|Withdrawal by Subject|3|||
125161646|NCT00987389|450215387|FG002|Overall Study|Withdrawal by Subject|2|||
125161647|NCT00987389|450215388|FG003|Overall Study|Withdrawal by Subject|1|||
125161648|NCT00987389|450215385|FG000|Overall Study|Withdrawn from Treatment|0|||
125161649|NCT00987389|450215386|FG001|Overall Study|Withdrawn from Treatment|1|||
125161650|NCT00987389|450215387|FG002|Overall Study|Withdrawn from Treatment|0|||
125161651|NCT00987389|450215388|FG003|Overall Study|Withdrawn from Treatment|0|||
125161652|NCT00987389|450215385|FG000|Overall Study|Multiple different reasons|1|||
125161653|NCT00987389|450215386|FG001|Overall Study|Multiple different reasons|0|||
125161654|NCT00987389|450215387|FG002|Overall Study|Multiple different reasons|3|||
125161655|NCT00987389|450215388|FG003|Overall Study|Multiple different reasons|1|||
125161656|NCT00507130|450215389|FG000|Overall Study|Lost to Follow-up|0|||
125161657|NCT00507130|450215390|FG001|Overall Study|Lost to Follow-up|0|||
125161658|NCT00507130|450215391|FG002|Overall Study|Lost to Follow-up|1|||
125161659|NCT00507130|450215392|FG003|Overall Study|Lost to Follow-up|1|||
125161660|NCT00507130|450215389|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
125224716|NCT01656395|450450171|FG002|Overall Study|Lost to Follow-up|0|||
125161661|NCT00507130|450215390|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
125161662|NCT00507130|450215391|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
125161663|NCT00507130|450215392|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
125161664|NCT00080938|450215397|FG000|Overall Study|Adverse Event|3|||
125161665|NCT00080938|450215397|FG000|Overall Study|Withdrawal by Subject|6|||
125224717|NCT01656395|450450172|FG003|Overall Study|Lost to Follow-up|0|||
125161666|NCT00080938|450215397|FG000|Overall Study|Death|2|||
125161667|NCT00080938|450215397|FG000|Overall Study|Lack of Efficacy|7|||
125161668|NCT00080938|450215397|FG000|Overall Study|other disease|1|||
125161669|NCT00080938|450215397|FG000|Overall Study|Not started protocol therapy|1|||
125161670|NCT00080938|450215397|FG000|Overall Study|Ineligible|4|||
125390774|NCT03509675|451065280|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
125161671|NCT00338455|450215403|FG000|Overall Study|Death|2|||
125161672|NCT00338455|450215404|FG001|Overall Study|Death|1|||
125161673|NCT00338455|450215403|FG000|Overall Study|Physician Decision|1|||
125161674|NCT00338455|450215404|FG001|Overall Study|Physician Decision|0|||
125224718|NCT01656395|450450173|FG004|Overall Study|Lost to Follow-up|0|||
125224719|NCT01656395|450450174|FG005|Overall Study|Lost to Follow-up|0|||
125224720|NCT01656395|450450175|FG006|Overall Study|Lost to Follow-up|0|||
125224721|NCT01656395|450450176|FG007|Overall Study|Lost to Follow-up|0|||
125224722|NCT01656395|450450169|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125224723|NCT01656395|450450170|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125224724|NCT01656395|450450171|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125224725|NCT01656395|450450172|FG003|Overall Study|Non-Compliance with Study Drug|0|||
125224726|NCT01656395|450450173|FG004|Overall Study|Non-Compliance with Study Drug|1|||
125224727|NCT01656395|450450174|FG005|Overall Study|Non-Compliance with Study Drug|1|||
125224728|NCT01656395|450450175|FG006|Overall Study|Non-Compliance with Study Drug|0|||
125224729|NCT01656395|450450176|FG007|Overall Study|Non-Compliance with Study Drug|0|||
125224730|NCT01656395|450450169|FG000|Overall Study|Other|0|||
125224731|NCT01656395|450450170|FG001|Overall Study|Other|0|||
125224732|NCT01656395|450450171|FG002|Overall Study|Other|1|||
125161675|NCT02266134|450215405|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
125161676|NCT02266134|450215406|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
125161677|NCT02266134|450215407|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
125161678|NCT02266134|450215408|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
125161679|NCT02266134|450215405|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
125161680|NCT02266134|450215406|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
125161681|NCT02266134|450215407|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
125161682|NCT02266134|450215408|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
125161683|NCT02266134|450215405|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
125161684|NCT02266134|450215406|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
125161685|NCT02266134|450215407|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
125161686|NCT02266134|450215408|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
125161687|NCT02266134|450215405|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
125161688|NCT02266134|450215406|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
125161689|NCT02266134|450215407|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
125161690|NCT02266134|450215408|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
125161691|NCT02266134|450215405|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
125224733|NCT01656395|450450172|FG003|Overall Study|Other|0|||
125224734|NCT01656395|450450173|FG004|Overall Study|Other|0|||
125224735|NCT01656395|450450174|FG005|Overall Study|Other|1|||
125390775|NCT03509675|451065279|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
125390776|NCT03509675|451065280|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
125390777|NCT03509675|451065279|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
125390778|NCT03509675|451065280|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
125390779|NCT03509675|451065279|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
125390780|NCT03509675|451065280|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
125390781|NCT05620576|451065283|FG000|Overall Study|Adverse Event|1|||
125390782|NCT05620576|451065284|FG001|Overall Study|Adverse Event|1|||
125390783|NCT05620576|451065283|FG000|Overall Study|Lost to Follow-up|3|||
125390784|NCT05620576|451065284|FG001|Overall Study|Lost to Follow-up|1|||
125390785|NCT05620576|451065283|FG000|Overall Study|Physician Decision|0|||
125390786|NCT05620576|451065284|FG001|Overall Study|Physician Decision|1|||
125390787|NCT05620576|451065283|FG000|Overall Study|Protocol Deviation|1|||
125390788|NCT05620576|451065284|FG001|Overall Study|Protocol Deviation|1|||
125390789|NCT05620576|451065283|FG000|Overall Study|Withdrawal by Subject|2|||
125390790|NCT05620576|451065284|FG001|Overall Study|Withdrawal by Subject|3|||
125390791|NCT02622828|451065285|FG000|Overall Study|participant withdrew|3|||
125390792|NCT04920123|451065293|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
125390793|NCT04920123|451065294|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
125390794|NCT04920123|451065295|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
125390795|NCT03406858|451065298|FG000|Overall Study|Failure to receive treatment drug.|1|||
125390796|NCT03406858|451065298|FG000|Overall Study|ineligible|1|||
125390797|NCT01203072|451065314|FG000|Overall Study|Adverse Event|5|||
125390798|NCT01203072|451065315|FG001|Overall Study|Adverse Event|3|||
125390799|NCT01203072|451065316|FG002|Overall Study|Adverse Event|2|||
125390800|NCT01203072|451065317|FG003|Overall Study|Adverse Event|4|||
125390801|NCT01203072|451065318|FG004|Overall Study|Adverse Event|2|||
125390802|NCT01203072|451065314|FG000|Overall Study|Lack of Efficacy|1|||
125390803|NCT01203072|451065315|FG001|Overall Study|Lack of Efficacy|0|||
125390804|NCT01203072|451065316|FG002|Overall Study|Lack of Efficacy|0|||
125390805|NCT01203072|451065317|FG003|Overall Study|Lack of Efficacy|0|||
125390806|NCT01203072|451065318|FG004|Overall Study|Lack of Efficacy|0|||
125161692|NCT02266134|450215406|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
125161693|NCT02266134|450215407|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
125224736|NCT01656395|450450175|FG006|Overall Study|Other|0|||
125390807|NCT01203072|451065314|FG000|Overall Study|Lost to Follow-up|0|||
125390808|NCT01203072|451065315|FG001|Overall Study|Lost to Follow-up|1|||
125390809|NCT01203072|451065316|FG002|Overall Study|Lost to Follow-up|0|||
125224737|NCT01656395|450450176|FG007|Overall Study|Other|0|||
125224738|NCT01656395|450450169|FG000|Overall Study|Physician Decision|2|||
125224739|NCT01656395|450450170|FG001|Overall Study|Physician Decision|3|||
125440249|NCT01087723|451239694|FG001|Overall Study|Lost to Follow-up|4|||
125440250|NCT01087723|451239693|FG000|Overall Study|Reason Not Specified|1|||
125440251|NCT01087723|451239694|FG001|Overall Study|Reason Not Specified|2|||
125440252|NCT00289770|451239699|FG000|Year 15|Withdrawal by Subject|1|||
125440253|NCT01702428|451239700|FG000|Overall Study|Adverse Event|2|||
125440254|NCT01702428|451239701|FG001|Overall Study|Adverse Event|0|||
125440255|NCT01702428|451239702|FG002|Overall Study|Adverse Event|0|||
125440256|NCT01702428|451239703|FG003|Overall Study|Adverse Event|0|||
125440257|NCT01702428|451239700|FG000|Overall Study|Lost to Follow-up|33|||
125440258|NCT01702428|451239701|FG001|Overall Study|Lost to Follow-up|41|||
125440259|NCT01702428|451239702|FG002|Overall Study|Lost to Follow-up|37|||
125440260|NCT01702428|451239703|FG003|Overall Study|Lost to Follow-up|44|||
125440261|NCT01702428|451239700|FG000|Overall Study|Parents cannot assist to site|1|||
125440262|NCT01702428|451239701|FG001|Overall Study|Parents cannot assist to site|0|||
125440263|NCT01702428|451239702|FG002|Overall Study|Parents cannot assist to site|1|||
125440264|NCT01702428|451239703|FG003|Overall Study|Parents cannot assist to site|0|||
125440265|NCT01702428|451239700|FG000|Overall Study|Lost Coverage|0|||
125440266|NCT01702428|451239701|FG001|Overall Study|Lost Coverage|0|||
125440267|NCT01702428|451239702|FG002|Overall Study|Lost Coverage|0|||
125440268|NCT01702428|451239703|FG003|Overall Study|Lost Coverage|1|||
125440269|NCT01702428|451239700|FG000|Overall Study|Lost Health Plan|3|||
125440270|NCT01702428|451239701|FG001|Overall Study|Lost Health Plan|5|||
125440271|NCT01702428|451239702|FG002|Overall Study|Lost Health Plan|0|||
125440272|NCT01702428|451239703|FG003|Overall Study|Lost Health Plan|2|||
125440273|NCT01702428|451239700|FG000|Overall Study|Mother transferred care|0|||
125440274|NCT01702428|451239701|FG001|Overall Study|Mother transferred care|1|||
125440275|NCT01702428|451239702|FG002|Overall Study|Mother transferred care|0|||
125440276|NCT01702428|451239703|FG003|Overall Study|Mother transferred care|0|||
125440277|NCT01702428|451239700|FG000|Overall Study|Parents too busy|1|||
125440278|NCT01702428|451239701|FG001|Overall Study|Parents too busy|0|||
125440279|NCT01702428|451239702|FG002|Overall Study|Parents too busy|0|||
125440280|NCT01702428|451239703|FG003|Overall Study|Parents too busy|0|||
125440281|NCT01702428|451239700|FG000|Overall Study|Protocol Violation|3|||
125440282|NCT01702428|451239701|FG001|Overall Study|Protocol Violation|0|||
125440283|NCT01702428|451239702|FG002|Overall Study|Protocol Violation|1|||
125440284|NCT01702428|451239703|FG003|Overall Study|Protocol Violation|0|||
125440285|NCT01702428|451239700|FG000|Overall Study|Withdrawal by Subject|21|||
125440286|NCT01702428|451239701|FG001|Overall Study|Withdrawal by Subject|23|||
125440287|NCT01702428|451239702|FG002|Overall Study|Withdrawal by Subject|14|||
125440288|NCT01702428|451239703|FG003|Overall Study|Withdrawal by Subject|10|||
125440289|NCT00154063|451239706|FG000|Overall Study|Adverse Event|4|||
125440290|NCT00154063|451239707|FG001|Overall Study|Adverse Event|8|||
125440291|NCT00154063|451239706|FG000|Overall Study|Protocol Violation|1|||
125440292|NCT00154063|451239707|FG001|Overall Study|Protocol Violation|1|||
125440293|NCT00154063|451239706|FG000|Overall Study|Investigator or Sponsor Request|0|||
125440294|NCT00154063|451239707|FG001|Overall Study|Investigator or Sponsor Request|1|||
125440295|NCT00154063|451239706|FG000|Overall Study|Withdrawal by Subject|4|||
125440296|NCT00154063|451239707|FG001|Overall Study|Withdrawal by Subject|9|||
125440297|NCT00154063|451239706|FG000|Overall Study|Other|3|||
125440298|NCT00154063|451239707|FG001|Overall Study|Other|3|||
125440299|NCT02091869|451239708|FG000|Overall Study|Withdrawal by Subject|0|||
125440300|NCT02091869|451239709|FG001|Overall Study|Withdrawal by Subject|3|||
125440301|NCT01804673|451239710|FG000|Overall Study|Adverse Event|4|||
125440302|NCT01804673|451239710|FG000|Overall Study|Withdrawal by Subject|1|||
125440303|NCT01804673|451239710|FG000|Overall Study|Lack of Efficacy|9|||
125440304|NCT01804673|451239710|FG000|Overall Study|Change to Oral Therapy|37|||
125440305|NCT01804673|451239710|FG000|Overall Study|No Further Therapy Required|84|||
125440306|NCT01804673|451239710|FG000|Overall Study|Use of Prohibited Medication|1|||
125440307|NCT01804673|451239710|FG000|Overall Study|Other|4|||
125440308|NCT00451217|451239720|FG000|Overall Study|Lost to Follow-up|0|||
125440309|NCT00451217|451239721|FG001|Overall Study|Lost to Follow-up|1|||
125440310|NCT00451217|451239722|FG002|Overall Study|Lost to Follow-up|1|||
125440311|NCT00451217|451239723|FG003|Overall Study|Lost to Follow-up|1|||
125440312|NCT00451217|451239720|FG000|Overall Study|Withdrawal by Subject|1|||
125440313|NCT00451217|451239721|FG001|Overall Study|Withdrawal by Subject|0|||
125440314|NCT00451217|451239722|FG002|Overall Study|Withdrawal by Subject|0|||
125440315|NCT00451217|451239723|FG003|Overall Study|Withdrawal by Subject|0|||
125440316|NCT00451217|451239720|FG000|Overall Study|Not Treated|1|||
125440317|NCT00451217|451239721|FG001|Overall Study|Not Treated|1|||
125440318|NCT00451217|451239722|FG002|Overall Study|Not Treated|3|||
125161694|NCT02266134|450215408|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
125161695|NCT02266134|450215405|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
125440319|NCT00451217|451239723|FG003|Overall Study|Not Treated|4|||
125440320|NCT00358150|451239724|FG000|Overall Study|Adverse Event|3|||
125440321|NCT00358150|451239724|FG000|Overall Study|Withdrawal by Subject|1|||
125440322|NCT00358150|451239724|FG000|Overall Study|Undefined|3|||
125440323|NCT04668989|451239725|FG000|First Intervention|Covid-19 related self-isolation|0|||
125440324|NCT04668989|451239726|FG001|First Intervention|Covid-19 related self-isolation|1|||
125161696|NCT02266134|450215406|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
125161697|NCT02266134|450215407|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
125161698|NCT02266134|450215408|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
125161699|NCT01437943|450215411|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
125161700|NCT01437943|450215412|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
125161701|NCT01437943|450215411|FG000|Overall Study|Subject expressed pregnancy plans|1|||
125161702|NCT01437943|450215412|FG001|Overall Study|Subject expressed pregnancy plans|0|||
125161703|NCT01437943|450215411|FG000|Overall Study|Adverse Event|2|||
125161704|NCT01437943|450215412|FG001|Overall Study|Adverse Event|0|||
125161705|NCT04647721|450215413|FG000|Overall Study|Withdrawal by Subject|0|||
125161706|NCT04647721|450215414|FG001|Overall Study|Withdrawal by Subject|2|||
125161707|NCT04647721|450215413|FG000|Overall Study|Lost to Follow-up|2|||
125161708|NCT04647721|450215414|FG001|Overall Study|Lost to Follow-up|0|||
125161709|NCT04771403|450215415|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
125161710|NCT04771403|450215416|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
125161711|NCT04771403|450215415|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
125161712|NCT04771403|450215416|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
125161713|NCT04771403|450215415|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
125161714|NCT04771403|450215416|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
125161715|NCT04771403|450215415|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
125161716|NCT04771403|450215416|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
125161717|NCT04771403|450215415|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
125161718|NCT04771403|450215416|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
125161719|NCT04771403|450215415|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
125161720|NCT04771403|450215416|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
125161721|NCT04771403|450215415|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
125161722|NCT04771403|450215416|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
125161723|NCT04771403|450215415|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
125161724|NCT04771403|450215416|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
125161725|NCT05084963|450215417|FG000|Overall Study|Withdrawal by Subject|0|||
125161726|NCT05084963|450215418|FG001|Overall Study|Withdrawal by Subject|0|||
125161727|NCT05084963|450215419|FG002|Overall Study|Withdrawal by Subject|1|||
125161728|NCT05442866|450215420|FG000|Overall Study|Death|1|||
125161729|NCT05442866|450215420|FG000|Overall Study|Lost to Follow-up|9|||
125161730|NCT05442866|450215420|FG000|Overall Study|Protocol Violation|1|||
125161731|NCT03819049|450215421|FG000|Overall Study|Lost to Follow-up|1|||
125161732|NCT03819049|450215422|FG001|Overall Study|Lost to Follow-up|2|||
125161733|NCT03819049|450215423|FG002|Overall Study|Lost to Follow-up|9|||
125161734|NCT03819049|450215424|FG003|Overall Study|Lost to Follow-up|0|||
125161735|NCT03819049|450215425|FG004|Overall Study|Lost to Follow-up|3|||
125161736|NCT03819049|450215426|FG005|Overall Study|Lost to Follow-up|1|||
125161737|NCT03819049|450215427|FG006|Overall Study|Lost to Follow-up|0|||
125161738|NCT03819049|450215421|FG000|Overall Study|Withdrawal by Subject|0|||
125161739|NCT03819049|450215422|FG001|Overall Study|Withdrawal by Subject|0|||
125161740|NCT03819049|450215423|FG002|Overall Study|Withdrawal by Subject|18|||
125161741|NCT03819049|450215424|FG003|Overall Study|Withdrawal by Subject|0|||
125161742|NCT03819049|450215425|FG004|Overall Study|Withdrawal by Subject|10|||
125161743|NCT03819049|450215426|FG005|Overall Study|Withdrawal by Subject|9|||
125161744|NCT03819049|450215427|FG006|Overall Study|Withdrawal by Subject|1|||
125161745|NCT03819049|450215421|FG000|Overall Study|Ongoing|0|||
125161746|NCT03819049|450215422|FG001|Overall Study|Ongoing|0|||
125161747|NCT03819049|450215423|FG002|Overall Study|Ongoing|75|||
125161748|NCT03819049|450215424|FG003|Overall Study|Ongoing|0|||
125161749|NCT03819049|450215425|FG004|Overall Study|Ongoing|41|||
125161750|NCT03819049|450215426|FG005|Overall Study|Ongoing|0|||
125161751|NCT03819049|450215427|FG006|Overall Study|Ongoing|0|||
125161752|NCT03819049|450215421|FG000|Overall Study|Other|0|||
125161753|NCT03819049|450215422|FG001|Overall Study|Other|0|||
125161754|NCT03819049|450215423|FG002|Overall Study|Other|2|||
125161755|NCT03819049|450215424|FG003|Overall Study|Other|0|||
125161756|NCT03819049|450215425|FG004|Overall Study|Other|0|||
125161757|NCT03819049|450215426|FG005|Overall Study|Other|0|||
125161758|NCT03819049|450215427|FG006|Overall Study|Other|0|||
125161759|NCT03819049|450215421|FG000|Overall Study|Randomized but not vaccinated|0|||
125224740|NCT01656395|450450171|FG002|Overall Study|Physician Decision|3|||
125440325|NCT04668989|451239725|FG000|Second Intervention|Adverse Event|0|||
125440326|NCT04668989|451239726|FG001|Second Intervention|Adverse Event|1|||
125440327|NCT01622348|451239731|FG000|Overall Study|Withdrawal by Subject|1|||
125440328|NCT01622348|451239732|FG001|Overall Study|Withdrawal by Subject|0|||
125440329|NCT01622348|451239733|FG002|Overall Study|Withdrawal by Subject|1|||
125440330|NCT00179010|451239734|FG000|Overall Study|Muscle probe defective|1|||
125440331|NCT00179010|451239735|FG001|Overall Study|Muscle probe defective|1|||
125440332|NCT00179010|451239734|FG000|Overall Study|Failure to place arterial line|0|||
125440333|NCT00179010|451239735|FG001|Overall Study|Failure to place arterial line|1|||
125440334|NCT01592695|451239744|FG000|Overall Study|Lost to Follow-up|8|||
125440335|NCT01592695|451239745|FG001|Overall Study|Lost to Follow-up|4|||
125440336|NCT01763788|451239757|FG000|Overall Study|Lost to Follow-up|0|||
125440337|NCT01763788|451239758|FG001|Overall Study|Lost to Follow-up|0|||
125440338|NCT01763788|451239759|FG002|Overall Study|Lost to Follow-up|1|||
125440339|NCT01763788|451239760|FG003|Overall Study|Lost to Follow-up|0|||
125440340|NCT03893825|451239761|FG000|Overall Study|Death|2|||
125440341|NCT03893825|451239762|FG001|Overall Study|Death|1|||
125440342|NCT03893825|451239761|FG000|Overall Study|Adverse Event|0|||
125161760|NCT03819049|450215422|FG001|Overall Study|Randomized but not vaccinated|0|||
125161761|NCT03819049|450215423|FG002|Overall Study|Randomized but not vaccinated|0|||
125161762|NCT03819049|450215424|FG003|Overall Study|Randomized but not vaccinated|1|||
125161763|NCT03819049|450215425|FG004|Overall Study|Randomized but not vaccinated|0|||
125161764|NCT03819049|450215426|FG005|Overall Study|Randomized but not vaccinated|2|||
125161765|NCT03819049|450215427|FG006|Overall Study|Randomized but not vaccinated|1|||
125161766|NCT03819049|450215421|FG000|Overall Study|Physician Decision|0|||
125161767|NCT03819049|450215422|FG001|Overall Study|Physician Decision|0|||
125161768|NCT03819049|450215423|FG002|Overall Study|Physician Decision|0|||
125161769|NCT03819049|450215424|FG003|Overall Study|Physician Decision|0|||
125161770|NCT03819049|450215425|FG004|Overall Study|Physician Decision|0|||
125161771|NCT03819049|450215426|FG005|Overall Study|Physician Decision|0|||
125161772|NCT03819049|450215427|FG006|Overall Study|Physician Decision|1|||
125161773|NCT01568320|450215432|FG000|Overall Study|Death|20|||
125161774|NCT01568320|450215432|FG000|Overall Study|Lost to Follow-up|9|||
125161775|NCT01568320|450215432|FG000|Overall Study|Withdrawal by Subject|10|||
125161776|NCT01568320|450215432|FG000|Overall Study|Conversion to open repair|1|||
125161777|NCT01568320|450215432|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
125161778|NCT00816361|450215433|FG000|Overall Study|Withdrawal by Subject|0|||
125161779|NCT00816361|450215434|FG001|Overall Study|Withdrawal by Subject|0|||
125161780|NCT00816361|450215435|FG002|Overall Study|Withdrawal by Subject|0|||
125161781|NCT00816361|450215436|FG003|Overall Study|Withdrawal by Subject|0|||
125161782|NCT00816361|450215437|FG004|Overall Study|Withdrawal by Subject|1|||
125161783|NCT00816361|450215438|FG005|Overall Study|Withdrawal by Subject|2|||
125161784|NCT00816361|450215439|FG006|Overall Study|Withdrawal by Subject|0|||
125161785|NCT00816361|450215440|FG007|Overall Study|Withdrawal by Subject|2|||
125161786|NCT00816361|450215441|FG008|Overall Study|Withdrawal by Subject|1|||
125161787|NCT00816361|450215433|FG000|Overall Study|Death|4|||
125161788|NCT00816361|450215434|FG001|Overall Study|Death|3|||
125161789|NCT00816361|450215435|FG002|Overall Study|Death|3|||
125161790|NCT00816361|450215436|FG003|Overall Study|Death|3|||
125161791|NCT00816361|450215437|FG004|Overall Study|Death|1|||
125161792|NCT00816361|450215438|FG005|Overall Study|Death|1|||
125161793|NCT00816361|450215439|FG006|Overall Study|Death|3|||
125161794|NCT00816361|450215440|FG007|Overall Study|Death|7|||
125161795|NCT00816361|450215441|FG008|Overall Study|Death|8|||
125161796|NCT00816361|450215433|FG000|Overall Study|Other|0|||
125161797|NCT00816361|450215434|FG001|Overall Study|Other|0|||
125161798|NCT00816361|450215435|FG002|Overall Study|Other|0|||
125161799|NCT00816361|450215436|FG003|Overall Study|Other|0|||
125161800|NCT00816361|450215437|FG004|Overall Study|Other|0|||
125161801|NCT00816361|450215438|FG005|Overall Study|Other|0|||
125161802|NCT00816361|450215439|FG006|Overall Study|Other|0|||
125161803|NCT00816361|450215440|FG007|Overall Study|Other|0|||
125161804|NCT00816361|450215441|FG008|Overall Study|Other|1|||
125161805|NCT00546572|450215443|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
125440343|NCT03893825|451239762|FG001|Overall Study|Adverse Event|2|||
125161806|NCT00546572|450215444|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
125161807|NCT00546572|450215443|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
125161808|NCT00546572|450215444|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
125161809|NCT00546572|450215443|FG000|Vax 1 / Year 0|Protocol Violation|3|||
125161810|NCT00546572|450215444|FG001|Vax 1 / Year 0|Protocol Violation|4|||
125161811|NCT00546572|450215443|FG000|Vax 1 / Year 0|Death|2|||
125161812|NCT00546572|450215444|FG001|Vax 1 / Year 0|Death|2|||
125440344|NCT03893825|451239761|FG000|Overall Study|Withdrawal by Subject|19|||
125161813|NCT00546572|450215443|FG000|Vax 1 / Year 0|Adverse Event|0|||
125161814|NCT00546572|450215444|FG001|Vax 1 / Year 0|Adverse Event|1|||
125161815|NCT00546572|450215443|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
125440345|NCT03893825|451239762|FG001|Overall Study|Withdrawal by Subject|21|||
125440346|NCT03893825|451239761|FG000|Overall Study|Protocol deviation|1|||
125161816|NCT00546572|450215444|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
125440347|NCT03893825|451239762|FG001|Overall Study|Protocol deviation|0|||
125390810|NCT01203072|451065317|FG003|Overall Study|Lost to Follow-up|0|||
125390811|NCT01203072|451065318|FG004|Overall Study|Lost to Follow-up|0|||
125390812|NCT01203072|451065314|FG000|Overall Study|Protocol Violation|2|||
125390813|NCT01203072|451065315|FG001|Overall Study|Protocol Violation|0|||
125390814|NCT01203072|451065316|FG002|Overall Study|Protocol Violation|0|||
125390815|NCT01203072|451065317|FG003|Overall Study|Protocol Violation|0|||
125390816|NCT01203072|451065318|FG004|Overall Study|Protocol Violation|1|||
125390817|NCT01203072|451065314|FG000|Overall Study|Withdrawal by Subject|2|||
125390818|NCT01203072|451065315|FG001|Overall Study|Withdrawal by Subject|2|||
125390819|NCT01203072|451065316|FG002|Overall Study|Withdrawal by Subject|1|||
125390820|NCT01203072|451065317|FG003|Overall Study|Withdrawal by Subject|2|||
125390821|NCT01203072|451065318|FG004|Overall Study|Withdrawal by Subject|3|||
125390822|NCT02286193|451065324|FG000|Overall Study|Referred: CRS unable to make contact|62|||
125390823|NCT02286193|451065324|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
125390824|NCT02286193|451065324|FG000|Overall Study|Referred: Declined service|38|||
125390825|NCT02023151|451065325|FG000|Overall Study|Lost to Follow-up|4|||
125390826|NCT04064294|451065326|FG000|Overall Study|Adverse Event|1|||
125390827|NCT04064294|451065327|FG001|Overall Study|Adverse Event|0|||
125390828|NCT04064294|451065328|FG002|Overall Study|Adverse Event|0|||
125390829|NCT03450707|451065329|FG000|Overall Study|Outside enrollment window|4|||
125390830|NCT03450707|451065330|FG001|Overall Study|Outside enrollment window|1|||
125390831|NCT03450707|451065329|FG000|Overall Study|Death|1|||
125390832|NCT03450707|451065330|FG001|Overall Study|Death|0|||
125390833|NCT03450707|451065329|FG000|Overall Study|Indication for thiamine|1|||
125390834|NCT03450707|451065330|FG001|Overall Study|Indication for thiamine|1|||
125390835|NCT03450707|451065329|FG000|Overall Study|Evidence of traumatic brain injury|1|||
125390836|NCT03450707|451065330|FG001|Overall Study|Evidence of traumatic brain injury|0|||
125390837|NCT03450707|451065329|FG000|Overall Study|Following commands|0|||
125390838|NCT03450707|451065330|FG001|Overall Study|Following commands|3|||
125390839|NCT03450707|451065329|FG000|Overall Study|Lactate < 3.5|0|||
125390840|NCT03450707|451065330|FG001|Overall Study|Lactate < 3.5|2|||
125390841|NCT03450707|451065329|FG000|Overall Study|Rearrest with ECMO|0|||
125390842|NCT03450707|451065330|FG001|Overall Study|Rearrest with ECMO|1|||
125390843|NCT03450707|451065329|FG000|Overall Study|Indication for thiamine + head CT results|0|||
125390844|NCT03450707|451065330|FG001|Overall Study|Indication for thiamine + head CT results|1|||
125390845|NCT03450707|451065329|FG000|Overall Study|Family/patient goals of care|0|||
125390846|NCT03450707|451065330|FG001|Overall Study|Family/patient goals of care|1|||
125390847|NCT00481195|451065331|FG000|Overall Study|Adverse Event|16|||
125390848|NCT00481195|451065332|FG001|Overall Study|Adverse Event|11|||
125390849|NCT00481195|451065331|FG000|Overall Study|Lack of Efficacy|1|||
125390850|NCT00481195|451065332|FG001|Overall Study|Lack of Efficacy|3|||
125390851|NCT00481195|451065331|FG000|Overall Study|Lost to Follow-up|4|||
125390852|NCT00481195|451065332|FG001|Overall Study|Lost to Follow-up|6|||
125390853|NCT00481195|451065331|FG000|Overall Study|Physician Decision|3|||
125390854|NCT00481195|451065332|FG001|Overall Study|Physician Decision|1|||
125390855|NCT00481195|451065331|FG000|Overall Study|Protocol Violation|10|||
125390856|NCT00481195|451065332|FG001|Overall Study|Protocol Violation|7|||
125390857|NCT00481195|451065331|FG000|Overall Study|Withdrawal by Subject|3|||
125390858|NCT00481195|451065332|FG001|Overall Study|Withdrawal by Subject|9|||
125390859|NCT00481195|451065331|FG000|Overall Study|Miscellaneous|2|||
125390860|NCT00481195|451065332|FG001|Overall Study|Miscellaneous|2|||
125390861|NCT03343483|451065333|FG000|Overall Study|Death|0|||
125390862|NCT03343483|451065334|FG001|Overall Study|Death|3|||
125390863|NCT03343483|451065333|FG000|Overall Study|Lost to Follow-up|9|||
125390864|NCT03343483|451065334|FG001|Overall Study|Lost to Follow-up|13|||
125390865|NCT03343483|451065333|FG000|Overall Study|Withdrawal by Subject|8|||
125390866|NCT03343483|451065334|FG001|Overall Study|Withdrawal by Subject|17|||
125390867|NCT02932904|451065335|FG000|Overall Study|Reason not Specified|1|||
125390868|NCT02932904|451065336|FG001|Overall Study|Reason not Specified|0|||
125390869|NCT02932904|451065337|FG002|Overall Study|Reason not Specified|2|||
125390870|NCT02932904|451065338|FG003|Overall Study|Reason not Specified|2|||
125161817|NCT00546572|450215443|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
125161818|NCT00546572|450215444|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
125161819|NCT00546572|450215443|FG000|Vax 2 / Year 1|Other|1|||
125161820|NCT00546572|450215444|FG001|Vax 2 / Year 1|Other|1|||
125161821|NCT00546572|450215443|FG000|Vax 2 / Year 1|Adverse Event|1|||
125161822|NCT00546572|450215444|FG001|Vax 2 / Year 1|Adverse Event|0|||
125161823|NCT00546572|450215443|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
125161824|NCT00546572|450215444|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
125161825|NCT01394952|450215445|FG000|Overall Study|Lost to Follow-up|0|||
125161826|NCT01394952|450215446|FG001|Overall Study|Lost to Follow-up|5|||
125390871|NCT02932904|451065335|FG000|Overall Study|Noncompliance with Study Drug|2|||
125390872|NCT02932904|451065336|FG001|Overall Study|Noncompliance with Study Drug|3|||
125390873|NCT02932904|451065337|FG002|Overall Study|Noncompliance with Study Drug|3|||
125390874|NCT02932904|451065338|FG003|Overall Study|Noncompliance with Study Drug|4|||
125390875|NCT02932904|451065335|FG000|Overall Study|Pregnancy|0|||
125390876|NCT02932904|451065336|FG001|Overall Study|Pregnancy|1|||
125161827|NCT01394952|450215445|FG000|Overall Study|Withdrawal by Subject|10|||
125161828|NCT01394952|450215446|FG001|Overall Study|Withdrawal by Subject|5|||
125161829|NCT01394952|450215445|FG000|Overall Study|Physician Decision|2|||
125161830|NCT01394952|450215446|FG001|Overall Study|Physician Decision|0|||
125161831|NCT01394952|450215445|FG000|Overall Study|Sponsor Decision|5|||
125161832|NCT01394952|450215446|FG001|Overall Study|Sponsor Decision|7|||
125161833|NCT01986010|450215447|FG000|Overall Study|Adverse Event|0|||
125161834|NCT01986010|450215448|FG001|Overall Study|Adverse Event|1|||
125161835|NCT01986010|450215449|FG002|Overall Study|Adverse Event|0|||
125161836|NCT01986010|450215450|FG003|Overall Study|Adverse Event|0|||
125161837|NCT01986010|450215451|FG004|Overall Study|Adverse Event|0|||
125161838|NCT01986010|450215452|FG005|Overall Study|Adverse Event|0|||
125161839|NCT01986010|450215453|FG006|Overall Study|Adverse Event|0|||
125161840|NCT01986010|450215454|FG007|Overall Study|Adverse Event|0|||
125161841|NCT01986010|450215455|FG008|Overall Study|Adverse Event|0|||
125161842|NCT01986010|450215456|FG009|Overall Study|Adverse Event|0|||
125161843|NCT01986010|450215457|FG010|Overall Study|Adverse Event|0|||
125161844|NCT01986010|450215458|FG011|Overall Study|Adverse Event|0|||
125161845|NCT01986010|450215459|FG012|Overall Study|Adverse Event|0|||
125161846|NCT01986010|450215460|FG013|Overall Study|Adverse Event|0|||
125161847|NCT01986010|450215461|FG014|Overall Study|Adverse Event|0|||
125161848|NCT01986010|450215462|FG015|Overall Study|Adverse Event|1|||
125161849|NCT01986010|450215463|FG016|Overall Study|Adverse Event|0|||
125161850|NCT01986010|450215447|FG000|Overall Study|Lost to Follow-up|2|||
125161851|NCT01986010|450215448|FG001|Overall Study|Lost to Follow-up|1|||
125161852|NCT01986010|450215449|FG002|Overall Study|Lost to Follow-up|2|||
125161853|NCT01986010|450215450|FG003|Overall Study|Lost to Follow-up|2|||
125161854|NCT01986010|450215451|FG004|Overall Study|Lost to Follow-up|2|||
125161855|NCT01986010|450215452|FG005|Overall Study|Lost to Follow-up|2|||
125161856|NCT01986010|450215453|FG006|Overall Study|Lost to Follow-up|0|||
125161857|NCT01986010|450215454|FG007|Overall Study|Lost to Follow-up|0|||
125161858|NCT01986010|450215455|FG008|Overall Study|Lost to Follow-up|4|||
125161859|NCT01986010|450215456|FG009|Overall Study|Lost to Follow-up|2|||
125161860|NCT01986010|450215457|FG010|Overall Study|Lost to Follow-up|0|||
125161861|NCT01986010|450215458|FG011|Overall Study|Lost to Follow-up|1|||
125161862|NCT01986010|450215459|FG012|Overall Study|Lost to Follow-up|1|||
125161863|NCT01986010|450215460|FG013|Overall Study|Lost to Follow-up|1|||
125161864|NCT01986010|450215461|FG014|Overall Study|Lost to Follow-up|2|||
125161865|NCT01986010|450215462|FG015|Overall Study|Lost to Follow-up|0|||
125161866|NCT01986010|450215463|FG016|Overall Study|Lost to Follow-up|0|||
125161867|NCT01986010|450215447|FG000|Overall Study|Physician Decision|0|||
125161868|NCT01986010|450215448|FG001|Overall Study|Physician Decision|0|||
125161869|NCT01986010|450215449|FG002|Overall Study|Physician Decision|0|||
125161870|NCT01986010|450215450|FG003|Overall Study|Physician Decision|0|||
125161871|NCT01986010|450215451|FG004|Overall Study|Physician Decision|0|||
125161872|NCT01986010|450215452|FG005|Overall Study|Physician Decision|0|||
125161873|NCT01986010|450215453|FG006|Overall Study|Physician Decision|0|||
125161874|NCT01986010|450215454|FG007|Overall Study|Physician Decision|0|||
125161875|NCT01986010|450215455|FG008|Overall Study|Physician Decision|0|||
125161876|NCT01986010|450215456|FG009|Overall Study|Physician Decision|0|||
125161877|NCT01986010|450215457|FG010|Overall Study|Physician Decision|0|||
125161878|NCT01986010|450215458|FG011|Overall Study|Physician Decision|0|||
125161879|NCT01986010|450215459|FG012|Overall Study|Physician Decision|0|||
125161880|NCT01986010|450215460|FG013|Overall Study|Physician Decision|0|||
125161881|NCT01986010|450215461|FG014|Overall Study|Physician Decision|1|||
125161882|NCT01986010|450215462|FG015|Overall Study|Physician Decision|0|||
125161883|NCT01986010|450215463|FG016|Overall Study|Physician Decision|0|||
125161884|NCT01986010|450215447|FG000|Overall Study|Withdrawal by Subject|2|||
125161885|NCT01986010|450215448|FG001|Overall Study|Withdrawal by Subject|2|||
125161886|NCT01986010|450215449|FG002|Overall Study|Withdrawal by Subject|3|||
125161887|NCT01986010|450215450|FG003|Overall Study|Withdrawal by Subject|0|||
125161888|NCT01986010|450215451|FG004|Overall Study|Withdrawal by Subject|2|||
125161889|NCT01986010|450215452|FG005|Overall Study|Withdrawal by Subject|4|||
125161890|NCT01986010|450215453|FG006|Overall Study|Withdrawal by Subject|0|||
125161891|NCT01986010|450215454|FG007|Overall Study|Withdrawal by Subject|0|||
125161892|NCT01986010|450215455|FG008|Overall Study|Withdrawal by Subject|0|||
125161893|NCT01986010|450215456|FG009|Overall Study|Withdrawal by Subject|0|||
125161894|NCT01986010|450215457|FG010|Overall Study|Withdrawal by Subject|0|||
125161895|NCT01986010|450215458|FG011|Overall Study|Withdrawal by Subject|2|||
125161896|NCT01986010|450215459|FG012|Overall Study|Withdrawal by Subject|0|||
125161897|NCT01986010|450215460|FG013|Overall Study|Withdrawal by Subject|1|||
125161898|NCT01986010|450215461|FG014|Overall Study|Withdrawal by Subject|2|||
125161899|NCT01986010|450215462|FG015|Overall Study|Withdrawal by Subject|0|||
125161900|NCT01986010|450215463|FG016|Overall Study|Withdrawal by Subject|0|||
125161901|NCT01986010|450215447|FG000|Overall Study|Status Not Recorded|2|||
125161902|NCT01986010|450215448|FG001|Overall Study|Status Not Recorded|4|||
125161903|NCT01986010|450215449|FG002|Overall Study|Status Not Recorded|2|||
125161904|NCT01986010|450215450|FG003|Overall Study|Status Not Recorded|0|||
125161905|NCT01986010|450215451|FG004|Overall Study|Status Not Recorded|1|||
125161906|NCT01986010|450215452|FG005|Overall Study|Status Not Recorded|2|||
125440348|NCT03893825|451239761|FG000|Overall Study|Lost to Follow-up|10|||
125440349|NCT03893825|451239762|FG001|Overall Study|Lost to Follow-up|10|||
125440350|NCT03893825|451239761|FG000|Overall Study|Other than specified|7|||
125440351|NCT03893825|451239762|FG001|Overall Study|Other than specified|6|||
125440352|NCT04397523|451239763|FG000|Overall Study|Lost to Follow-up|3|||
125440353|NCT04397523|451239763|FG000|Overall Study|Transfer from/to other hospital|8|||
125161907|NCT01986010|450215453|FG006|Overall Study|Status Not Recorded|0|||
125161908|NCT01986010|450215454|FG007|Overall Study|Status Not Recorded|0|||
125161909|NCT01986010|450215455|FG008|Overall Study|Status Not Recorded|2|||
125161910|NCT01986010|450215456|FG009|Overall Study|Status Not Recorded|1|||
125161911|NCT01986010|450215457|FG010|Overall Study|Status Not Recorded|7|||
125161912|NCT01986010|450215458|FG011|Overall Study|Status Not Recorded|7|||
125161913|NCT01986010|450215459|FG012|Overall Study|Status Not Recorded|9|||
125161914|NCT01986010|450215460|FG013|Overall Study|Status Not Recorded|9|||
125161915|NCT01986010|450215461|FG014|Overall Study|Status Not Recorded|5|||
125161916|NCT01986010|450215462|FG015|Overall Study|Status Not Recorded|10|||
125161917|NCT01986010|450215463|FG016|Overall Study|Status Not Recorded|4|||
125161918|NCT01335997|450215464|FG000|Period I and II|Adverse Event|63|||
125161919|NCT01335997|450215465|FG001|Period I and II|Adverse Event|43|||
125161920|NCT01335997|450215464|FG000|Period I and II|Noncompliance with Study Drug|1|||
125161921|NCT01335997|450215465|FG001|Period I and II|Noncompliance with Study Drug|1|||
125161922|NCT01335997|450215464|FG000|Period I and II|Lost to Follow-up|3|||
125161923|NCT01335997|450215465|FG001|Period I and II|Lost to Follow-up|5|||
125161924|NCT01335997|450215464|FG000|Period I and II|Withdrawal by Subject|9|||
125161925|NCT01335997|450215465|FG001|Period I and II|Withdrawal by Subject|4|||
125161926|NCT01335997|450215464|FG000|Period I and II|Study Terminated by Sponsor|406|||
125161927|NCT01335997|450215465|FG001|Period I and II|Study Terminated by Sponsor|415|||
125161928|NCT01335997|450215464|FG000|Period I and II|Protocol Violation|9|||
125161929|NCT01335997|450215465|FG001|Period I and II|Protocol Violation|10|||
125161930|NCT01335997|450215464|FG000|Period I and II|Physician Decision|2|||
125161931|NCT01335997|450215465|FG001|Period I and II|Physician Decision|1|||
125161932|NCT01335997|450215464|FG000|Period III|Adverse Event|0|||
125161933|NCT01335997|450215465|FG001|Period III|Adverse Event|2|||
125161934|NCT01335997|450215464|FG000|Period III|Study Terminated by Sponsor|77|||
125161935|NCT01335997|450215465|FG001|Period III|Study Terminated by Sponsor|76|||
125161936|NCT01335997|450215464|FG000|Period III|Protocol Violation|0|||
125161937|NCT01335997|450215465|FG001|Period III|Protocol Violation|1|||
125161938|NCT01335997|450215464|FG000|Period III|Lost to Follow-up|1|||
125161939|NCT01335997|450215465|FG001|Period III|Lost to Follow-up|0|||
125161940|NCT04740814|450215466|FG000|Overall Study|Adverse Event|3|||
125161941|NCT04740814|450215466|FG000|Overall Study|Protocol Violation|2|||
125161942|NCT04740814|450215466|FG000|Overall Study|Lost to Follow-up|2|||
125161943|NCT04740814|450215466|FG000|Overall Study|Withdrawal by Subject|3|||
125161944|NCT01763684|450215467|FG000|Overall Study|Study terminated early due to low enrollment|126|||
125161945|NCT01763684|450215468|FG001|Overall Study|Study terminated early due to low enrollment|127|||
125161946|NCT01763684|450215467|FG000|Overall Study|Study surgery not performed|7|||
125161947|NCT01763684|450215468|FG001|Overall Study|Study surgery not performed|6|||
125161948|NCT04453202|450215473|FG000|Overall Study|Adverse Event|0|||
125161949|NCT04453202|450215474|FG001|Overall Study|Adverse Event|0|||
125161950|NCT04453202|450215475|FG002|Overall Study|Adverse Event|0|||
125161951|NCT04453202|450215476|FG003|Overall Study|Adverse Event|0|||
125161952|NCT04453202|450215477|FG004|Overall Study|Adverse Event|0|||
125161953|NCT04453202|450215478|FG005|Overall Study|Adverse Event|0|||
125161954|NCT04453202|450215479|FG006|Overall Study|Adverse Event|1|||
125161955|NCT04453202|450215480|FG007|Overall Study|Adverse Event|0|||
125161956|NCT04453202|450215481|FG008|Overall Study|Adverse Event|0|||
125161957|NCT04453202|450215482|FG009|Overall Study|Adverse Event|0|||
125161958|NCT04453202|450215483|FG010|Overall Study|Adverse Event|0|||
125161959|NCT04453202|450215473|FG000|Overall Study|Death|0|||
125161960|NCT04453202|450215474|FG001|Overall Study|Death|0|||
125161961|NCT04453202|450215475|FG002|Overall Study|Death|0|||
125161962|NCT04453202|450215476|FG003|Overall Study|Death|0|||
125440354|NCT01275196|451239764|FG000|Overall Study|Adverse Event|3|||
125440355|NCT01275196|451239765|FG001|Overall Study|Adverse Event|5|||
125440356|NCT01275196|451239764|FG000|Overall Study|Withdrawal by Subject|4|||
125440357|NCT01275196|451239765|FG001|Overall Study|Withdrawal by Subject|5|||
125161963|NCT04453202|450215477|FG004|Overall Study|Death|0|||
125440358|NCT01275196|451239764|FG000|Overall Study|Lost to Follow-up|1|||
125161964|NCT04453202|450215478|FG005|Overall Study|Death|0|||
125161965|NCT04453202|450215479|FG006|Overall Study|Death|0|||
125161966|NCT04453202|450215480|FG007|Overall Study|Death|0|||
125161967|NCT04453202|450215481|FG008|Overall Study|Death|0|||
125161968|NCT04453202|450215482|FG009|Overall Study|Death|1|||
125161969|NCT04453202|450215483|FG010|Overall Study|Death|0|||
125161970|NCT04453202|450215473|FG000|Overall Study|Lost to Follow-up|0|||
125161971|NCT04453202|450215474|FG001|Overall Study|Lost to Follow-up|1|||
125161972|NCT04453202|450215475|FG002|Overall Study|Lost to Follow-up|0|||
125161973|NCT04453202|450215476|FG003|Overall Study|Lost to Follow-up|1|||
125161974|NCT04453202|450215477|FG004|Overall Study|Lost to Follow-up|0|||
125161975|NCT04453202|450215478|FG005|Overall Study|Lost to Follow-up|0|||
125224741|NCT01656395|450450172|FG003|Overall Study|Physician Decision|2|||
125161976|NCT04453202|450215479|FG006|Overall Study|Lost to Follow-up|0|||
125161977|NCT04453202|450215480|FG007|Overall Study|Lost to Follow-up|0|||
125161978|NCT04453202|450215481|FG008|Overall Study|Lost to Follow-up|0|||
125161979|NCT04453202|450215482|FG009|Overall Study|Lost to Follow-up|1|||
125161980|NCT04453202|450215483|FG010|Overall Study|Lost to Follow-up|1|||
125161981|NCT04453202|450215473|FG000|Overall Study|Withdrawal by Subject|1|||
125161982|NCT04453202|450215474|FG001|Overall Study|Withdrawal by Subject|2|||
125161983|NCT04453202|450215475|FG002|Overall Study|Withdrawal by Subject|1|||
125161984|NCT04453202|450215476|FG003|Overall Study|Withdrawal by Subject|2|||
125161985|NCT04453202|450215477|FG004|Overall Study|Withdrawal by Subject|1|||
125161986|NCT04453202|450215478|FG005|Overall Study|Withdrawal by Subject|1|||
125161987|NCT04453202|450215479|FG006|Overall Study|Withdrawal by Subject|0|||
125161988|NCT04453202|450215480|FG007|Overall Study|Withdrawal by Subject|0|||
125161989|NCT04453202|450215481|FG008|Overall Study|Withdrawal by Subject|0|||
125161990|NCT04453202|450215482|FG009|Overall Study|Withdrawal by Subject|1|||
125161991|NCT04453202|450215483|FG010|Overall Study|Withdrawal by Subject|0|||
125161992|NCT04453202|450215473|FG000|Overall Study|Adverse Event|0|||
125161993|NCT04453202|450215474|FG001|Overall Study|Adverse Event|0|||
125161994|NCT04453202|450215475|FG002|Overall Study|Adverse Event|0|||
125161995|NCT04453202|450215476|FG003|Overall Study|Adverse Event|0|||
125161996|NCT04453202|450215477|FG004|Overall Study|Adverse Event|0|||
125224742|NCT01656395|450450173|FG004|Overall Study|Physician Decision|3|||
125224743|NCT01656395|450450174|FG005|Overall Study|Physician Decision|3|||
125224744|NCT01656395|450450175|FG006|Overall Study|Physician Decision|0|||
125224745|NCT01656395|450450176|FG007|Overall Study|Physician Decision|0|||
125224746|NCT01656395|450450169|FG000|Overall Study|Pregnancy|0|||
125224747|NCT01656395|450450170|FG001|Overall Study|Pregnancy|0|||
125224748|NCT01656395|450450171|FG002|Overall Study|Pregnancy|1|||
125224749|NCT01656395|450450172|FG003|Overall Study|Pregnancy|0|||
125224750|NCT01656395|450450173|FG004|Overall Study|Pregnancy|0|||
125224751|NCT01656395|450450174|FG005|Overall Study|Pregnancy|0|||
125224752|NCT01656395|450450175|FG006|Overall Study|Pregnancy|0|||
125224753|NCT01656395|450450176|FG007|Overall Study|Pregnancy|0|||
125224754|NCT01656395|450450169|FG000|Overall Study|Progressive Disease|0|||
125224755|NCT01656395|450450170|FG001|Overall Study|Progressive Disease|0|||
125224756|NCT01656395|450450171|FG002|Overall Study|Progressive Disease|0|||
125224757|NCT01656395|450450172|FG003|Overall Study|Progressive Disease|0|||
125224758|NCT01656395|450450173|FG004|Overall Study|Progressive Disease|0|||
125224759|NCT01656395|450450174|FG005|Overall Study|Progressive Disease|1|||
125224760|NCT01656395|450450175|FG006|Overall Study|Progressive Disease|0|||
125224761|NCT01656395|450450176|FG007|Overall Study|Progressive Disease|0|||
125224762|NCT01656395|450450169|FG000|Overall Study|Protocol Violation|6|||
125224763|NCT01656395|450450170|FG001|Overall Study|Protocol Violation|6|||
125224764|NCT01656395|450450171|FG002|Overall Study|Protocol Violation|9|||
125224765|NCT01656395|450450172|FG003|Overall Study|Protocol Violation|2|||
125224766|NCT01656395|450450173|FG004|Overall Study|Protocol Violation|4|||
125224767|NCT01656395|450450174|FG005|Overall Study|Protocol Violation|10|||
125224768|NCT01656395|450450175|FG006|Overall Study|Protocol Violation|0|||
125224769|NCT01656395|450450176|FG007|Overall Study|Protocol Violation|0|||
125224770|NCT01656395|450450169|FG000|Overall Study|Screen Failure|2|||
125224771|NCT01656395|450450170|FG001|Overall Study|Screen Failure|1|||
125224772|NCT01656395|450450171|FG002|Overall Study|Screen Failure|7|||
125224773|NCT01656395|450450172|FG003|Overall Study|Screen Failure|1|||
125224774|NCT01656395|450450173|FG004|Overall Study|Screen Failure|0|||
125224775|NCT01656395|450450174|FG005|Overall Study|Screen Failure|8|||
125224776|NCT01656395|450450175|FG006|Overall Study|Screen Failure|0|||
125224777|NCT01656395|450450176|FG007|Overall Study|Screen Failure|0|||
125224778|NCT01656395|450450169|FG000|Overall Study|Withdrawal by Subject|3|||
125224779|NCT01656395|450450170|FG001|Overall Study|Withdrawal by Subject|1|||
125224780|NCT01656395|450450171|FG002|Overall Study|Withdrawal by Subject|4|||
125224781|NCT01656395|450450172|FG003|Overall Study|Withdrawal by Subject|2|||
125224782|NCT01656395|450450173|FG004|Overall Study|Withdrawal by Subject|0|||
125224783|NCT01656395|450450174|FG005|Overall Study|Withdrawal by Subject|3|||
125224784|NCT01656395|450450175|FG006|Overall Study|Withdrawal by Subject|0|||
125224785|NCT01656395|450450176|FG007|Overall Study|Withdrawal by Subject|0|||
125224786|NCT03075267|450450177|FG000|Overall Study|Protocol Violation|1|||
125390877|NCT02932904|451065337|FG002|Overall Study|Pregnancy|1|||
125161997|NCT04453202|450215478|FG005|Overall Study|Adverse Event|1|||
125161998|NCT04453202|450215479|FG006|Overall Study|Adverse Event|0|||
125390878|NCT02932904|451065338|FG003|Overall Study|Pregnancy|0|||
125390879|NCT02932904|451065335|FG000|Overall Study|Study Termination|0|||
125224787|NCT03075267|450450178|FG001|Overall Study|Protocol Violation|0|||
125224788|NCT03075267|450450179|FG002|Overall Study|Protocol Violation|0|||
125224789|NCT00661089|450450182|FG000|Overall Study|1 subject withdrawal|0|||
125161999|NCT04453202|450215480|FG007|Overall Study|Adverse Event|0|||
125224790|NCT00661089|450450183|FG001|Overall Study|1 subject withdrawal|1|||
125224791|NCT00661089|450450182|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
125224792|NCT00661089|450450183|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
125224793|NCT00274742|450450184|FG000|Overall Study|Adverse Event|0|||
125224794|NCT00274742|450450185|FG001|Overall Study|Adverse Event|4|||
125440359|NCT01275196|451239765|FG001|Overall Study|Lost to Follow-up|0|||
125440360|NCT01275196|451239764|FG000|Overall Study|Disease Progression|6|||
125440361|NCT01275196|451239765|FG001|Overall Study|Disease Progression|5|||
125440362|NCT01275196|451239764|FG000|Overall Study|Protocol Violation|1|||
125440363|NCT01275196|451239765|FG001|Overall Study|Protocol Violation|0|||
125440364|NCT01275196|451239764|FG000|Overall Study|Suboptimal response/treatment failure|5|||
125440365|NCT01275196|451239765|FG001|Overall Study|Suboptimal response/treatment failure|6|||
125440366|NCT01088529|451239795|FG000|Overall Study|Did not receive study treatment|0|||
125440367|NCT01088529|451239796|FG001|Overall Study|Did not receive study treatment|1|||
125440368|NCT02838628|451239798|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
125440369|NCT02838628|451239799|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
125440370|NCT02838628|451239798|FG000|Recurrence Follow-up Period|Adverse Event|1|||
125440371|NCT02838628|451239799|FG001|Recurrence Follow-up Period|Adverse Event|0|||
125440372|NCT02838628|451239798|FG000|Recurrence Follow-up Period|Non-compliance|0|||
125440373|NCT02838628|451239799|FG001|Recurrence Follow-up Period|Non-compliance|1|||
125440374|NCT02838628|451239798|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
125440375|NCT02838628|451239799|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
125440376|NCT02838628|451239798|FG000|Recurrence Follow-up Period|Other un-specified|1|||
125440377|NCT02838628|451239799|FG001|Recurrence Follow-up Period|Other un-specified|1|||
125440378|NCT03560245|451239802|FG000|Overall Study|Withdrawal by Subject|3|||
125440379|NCT03560245|451239803|FG001|Overall Study|Withdrawal by Subject|2|||
125440380|NCT03560245|451239802|FG000|Overall Study|Adverse Event|1|||
125440381|NCT03560245|451239803|FG001|Overall Study|Adverse Event|1|||
125440382|NCT03560245|451239802|FG000|Overall Study|Protocol Violation|1|||
125440383|NCT03560245|451239803|FG001|Overall Study|Protocol Violation|0|||
125440384|NCT03560245|451239802|FG000|Overall Study|Death|0|||
125440385|NCT03560245|451239803|FG001|Overall Study|Death|1|||
125162000|NCT04453202|450215481|FG008|Overall Study|Adverse Event|0|||
125162001|NCT04453202|450215482|FG009|Overall Study|Adverse Event|0|||
125162002|NCT04453202|450215483|FG010|Overall Study|Adverse Event|0|||
125162003|NCT01157897|450215484|FG000|Overall Study|Lost to Follow-up|2|||
125162004|NCT01157897|450215485|FG001|Overall Study|Lost to Follow-up|0|||
125162005|NCT01157897|450215486|FG002|Overall Study|Lost to Follow-up|0|||
125162006|NCT01157897|450215487|FG003|Overall Study|Lost to Follow-up|1|||
125162007|NCT01157897|450215484|FG000|Overall Study|Relocated|0|||
125162008|NCT01157897|450215485|FG001|Overall Study|Relocated|2|||
125162009|NCT01157897|450215486|FG002|Overall Study|Relocated|0|||
125162010|NCT01157897|450215487|FG003|Overall Study|Relocated|0|||
125162011|NCT03276221|450215488|FG000|Overall Study|Lost to Follow-up|6|||
125162012|NCT03276221|450215489|FG001|Overall Study|Lost to Follow-up|2|||
125162013|NCT03276221|450215490|FG002|Overall Study|Lost to Follow-up|0|||
125162014|NCT03276221|450215488|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
125162015|NCT03276221|450215489|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
125162016|NCT03276221|450215490|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
125162017|NCT02912650|450215491|FG000|Overall Study|Withdrawal by Subject|1|||
125162018|NCT02912650|450215492|FG001|Overall Study|Withdrawal by Subject|0|||
125162019|NCT02912650|450215493|FG002|Overall Study|Withdrawal by Subject|1|||
125162020|NCT02912650|450215494|FG003|Overall Study|Withdrawal by Subject|5|||
125162021|NCT02912650|450215491|FG000|Overall Study|Adverse Event|0|||
125162022|NCT02912650|450215492|FG001|Overall Study|Adverse Event|0|||
125162023|NCT02912650|450215493|FG002|Overall Study|Adverse Event|1|||
125162024|NCT02912650|450215494|FG003|Overall Study|Adverse Event|0|||
125162025|NCT02562482|450215496|FG000|Overall Study|Enrolled, but did not receive product|4|||
125162026|NCT02562482|450215497|FG001|Overall Study|Enrolled, but did not receive product|0|||
125162027|NCT02562482|450215496|FG000|Overall Study|Lost to Follow-up|9|||
125162028|NCT02562482|450215497|FG001|Overall Study|Lost to Follow-up|6|||
125162029|NCT02562482|450215496|FG000|Overall Study|Moved from area|2|||
125162030|NCT02562482|450215497|FG001|Overall Study|Moved from area|3|||
125162031|NCT02562482|450215496|FG000|Overall Study|Withdrawal by Subject|5|||
125162032|NCT02562482|450215497|FG001|Overall Study|Withdrawal by Subject|3|||
125162033|NCT02562482|450215496|FG000|Overall Study|Physician Decision|1|||
125162034|NCT02562482|450215497|FG001|Overall Study|Physician Decision|3|||
125162035|NCT02562482|450215496|FG000|Overall Study|Illness/Injury unrelated to product|0|||
125162036|NCT02562482|450215497|FG001|Overall Study|Illness/Injury unrelated to product|1|||
125162037|NCT02435836|450215502|FG000|Overall Study|Lost to Follow-up|21|||
125162038|NCT02435836|450215502|FG000|Overall Study|Lack of Efficacy|1|||
125162039|NCT02435836|450215502|FG000|Overall Study|Withdrawal by Subject|236|||
125162040|NCT02435836|450215502|FG000|Overall Study|Insufficient Clinical Response|26|||
125162041|NCT02435836|450215502|FG000|Overall Study|Adverse Event|44|||
125162042|NCT02435836|450215502|FG000|Overall Study|Sponsor discontinued trial|167|||
125162043|NCT02435836|450215502|FG000|Overall Study|Noncompliance|27|||
125440386|NCT03560245|451239802|FG000|Overall Study|Lost to Follow-up|0|||
125162044|NCT02435836|450215502|FG000|Overall Study|Protocol Violation|6|||
125162045|NCT02435836|450215502|FG000|Overall Study|Met Withdrawal Criteria|7|||
125162046|NCT02435836|450215502|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
125440387|NCT03560245|451239803|FG001|Overall Study|Lost to Follow-up|1|||
125440388|NCT03560245|451239802|FG000|Overall Study|Physician Decision|0|||
125440389|NCT03560245|451239803|FG001|Overall Study|Physician Decision|1|||
125440390|NCT03560245|451239802|FG000|Overall Study|Other|0|||
125440391|NCT03560245|451239803|FG001|Overall Study|Other|1|||
125440392|NCT01265823|451239804|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
125440393|NCT01265823|451239804|FG000|Overall Study|Failure to Return|4|||
125440394|NCT01265823|451239804|FG000|Overall Study|Protocol Violation|1|||
125440395|NCT01265823|451239804|FG000|Overall Study|Participant Request|1|||
125440396|NCT02611830|451239811|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
125440397|NCT02611830|451239812|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
125440398|NCT02611830|451239813|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
125440399|NCT02611830|451239814|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
125440400|NCT02611830|451239811|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
125440401|NCT02611830|451239812|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
125440402|NCT02611830|451239813|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
125440403|NCT02611830|451239814|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
125440404|NCT02611830|451239811|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
125440405|NCT02611830|451239812|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
125440406|NCT02611830|451239813|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
125440407|NCT02611830|451239814|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
125440408|NCT02611830|451239811|FG000|OL Induction Phase|Lack of Efficacy|9|||
125440409|NCT02611830|451239812|FG001|OL Induction Phase|Lack of Efficacy|0|||
125224795|NCT00274742|450450186|FG002|Overall Study|Adverse Event|1|||
125390880|NCT02932904|451065336|FG001|Overall Study|Study Termination|1|||
125390881|NCT02932904|451065337|FG002|Overall Study|Study Termination|0|||
125390882|NCT02932904|451065338|FG003|Overall Study|Study Termination|0|||
125390883|NCT02932904|451065335|FG000|Overall Study|Voluntary Withdrawal|2|||
125390884|NCT02932904|451065336|FG001|Overall Study|Voluntary Withdrawal|1|||
125390885|NCT02932904|451065337|FG002|Overall Study|Voluntary Withdrawal|4|||
125390886|NCT02932904|451065338|FG003|Overall Study|Voluntary Withdrawal|2|||
125390887|NCT02932904|451065335|FG000|Overall Study|Lost to Follow-up|5|||
125390888|NCT02932904|451065336|FG001|Overall Study|Lost to Follow-up|3|||
125390889|NCT02932904|451065337|FG002|Overall Study|Lost to Follow-up|6|||
125390890|NCT02932904|451065338|FG003|Overall Study|Lost to Follow-up|0|||
125390891|NCT02932904|451065335|FG000|Overall Study|Significant Protocol Deviation|2|||
125390892|NCT02932904|451065336|FG001|Overall Study|Significant Protocol Deviation|3|||
125390893|NCT02932904|451065337|FG002|Overall Study|Significant Protocol Deviation|6|||
125390894|NCT02932904|451065338|FG003|Overall Study|Significant Protocol Deviation|1|||
125390895|NCT02932904|451065335|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
125390896|NCT02932904|451065336|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
125390897|NCT02932904|451065337|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
125390898|NCT02932904|451065338|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
125390899|NCT02932904|451065335|FG000|Overall Study|Randomized But Not Treated|1|||
125390900|NCT02932904|451065336|FG001|Overall Study|Randomized But Not Treated|1|||
125390901|NCT02932904|451065337|FG002|Overall Study|Randomized But Not Treated|0|||
125390902|NCT02932904|451065338|FG003|Overall Study|Randomized But Not Treated|2|||
125390903|NCT00337103|451065339|FG000|Overall Study|Progressive Disease|414|||
125390904|NCT00337103|451065340|FG001|Overall Study|Progressive Disease|410|||
125390905|NCT00337103|451065339|FG000|Overall Study|Adverse Event|45|||
125390906|NCT00337103|451065340|FG001|Overall Study|Adverse Event|59|||
125390907|NCT00337103|451065339|FG000|Overall Study|Subject Choice|34|||
125390908|NCT00337103|451065340|FG001|Overall Study|Subject Choice|27|||
125390909|NCT00337103|451065339|FG000|Overall Study|Clinical Progression|27|||
125390910|NCT00337103|451065340|FG001|Overall Study|Clinical Progression|24|||
125390911|NCT00337103|451065339|FG000|Overall Study|Physician Decision|15|||
125390912|NCT00337103|451065340|FG001|Overall Study|Physician Decision|14|||
125390913|NCT00337103|451065339|FG000|Overall Study|Withdrawal by Subject|8|||
125390914|NCT00337103|451065340|FG001|Overall Study|Withdrawal by Subject|5|||
125390915|NCT00337103|451065339|FG000|Overall Study|Other|5|||
125390916|NCT00337103|451065340|FG001|Overall Study|Other|6|||
125390917|NCT00337103|451065339|FG000|Overall Study|Entry Criteria Not Met|4|||
125440410|NCT02611830|451239813|FG002|OL Induction Phase|Lack of Efficacy|0|||
125440411|NCT02611830|451239814|FG003|OL Induction Phase|Lack of Efficacy|0|||
125440412|NCT02611830|451239811|FG000|OL Induction Phase|Reason not specified|3|||
125440413|NCT02611830|451239812|FG001|OL Induction Phase|Reason not specified|0|||
125440414|NCT02611830|451239813|FG002|OL Induction Phase|Reason not specified|0|||
125440415|NCT02611830|451239814|FG003|OL Induction Phase|Reason not specified|0|||
125440416|NCT02611830|451239811|FG000|Maintenance Phase|Lack of Efficacy|0|||
125440417|NCT02611830|451239812|FG001|Maintenance Phase|Lack of Efficacy|29|||
125224796|NCT00274742|450450187|FG003|Overall Study|Adverse Event|4|||
125224797|NCT00274742|450450188|FG004|Overall Study|Adverse Event|12|||
125390918|NCT00337103|451065340|FG001|Overall Study|Entry Criteria Not Met|1|||
125390919|NCT00337103|451065339|FG000|Overall Study|Lost to Follow-up|1|||
125440418|NCT02611830|451239813|FG002|Maintenance Phase|Lack of Efficacy|18|||
125390920|NCT00337103|451065340|FG001|Overall Study|Lost to Follow-up|2|||
125390921|NCT00337103|451065339|FG000|Overall Study|Death|1|||
125224798|NCT00274742|450450189|FG005|Overall Study|Adverse Event|3|||
125224799|NCT00274742|450450184|FG000|Overall Study|Lost to Follow-up|0|||
125224800|NCT00274742|450450185|FG001|Overall Study|Lost to Follow-up|0|||
125224801|NCT00274742|450450186|FG002|Overall Study|Lost to Follow-up|0|||
125224802|NCT00274742|450450187|FG003|Overall Study|Lost to Follow-up|0|||
125224803|NCT00274742|450450188|FG004|Overall Study|Lost to Follow-up|1|||
125224804|NCT00274742|450450189|FG005|Overall Study|Lost to Follow-up|0|||
125224805|NCT00274742|450450184|FG000|Overall Study|End of Study|0|||
125224806|NCT00274742|450450185|FG001|Overall Study|End of Study|0|||
125224807|NCT00274742|450450186|FG002|Overall Study|End of Study|0|||
125224808|NCT00274742|450450187|FG003|Overall Study|End of Study|1|||
125224809|NCT00274742|450450188|FG004|Overall Study|End of Study|0|||
125224810|NCT00274742|450450189|FG005|Overall Study|End of Study|0|||
125224811|NCT00274742|450450184|FG000|Overall Study|Disease Progression|0|||
125224812|NCT00274742|450450185|FG001|Overall Study|Disease Progression|1|||
125224813|NCT00274742|450450186|FG002|Overall Study|Disease Progression|1|||
125224814|NCT00274742|450450187|FG003|Overall Study|Disease Progression|0|||
125224815|NCT00274742|450450188|FG004|Overall Study|Disease Progression|1|||
125224816|NCT00274742|450450189|FG005|Overall Study|Disease Progression|0|||
125224817|NCT00274742|450450184|FG000|Overall Study|Other|0|||
125224818|NCT00274742|450450185|FG001|Overall Study|Other|3|||
125224819|NCT00274742|450450186|FG002|Overall Study|Other|0|||
125224820|NCT00274742|450450187|FG003|Overall Study|Other|0|||
125224821|NCT00274742|450450188|FG004|Overall Study|Other|2|||
125224822|NCT00274742|450450189|FG005|Overall Study|Other|0|||
125224823|NCT04144322|450450197|FG000|Overall Study|Lack of Efficacy|2|||
125224824|NCT04144322|450450198|FG001|Overall Study|Lack of Efficacy|2|||
125224825|NCT00385918|450450201|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
125224826|NCT00385918|450450202|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
125224827|NCT00385918|450450203|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
125224828|NCT00385918|450450201|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
125224829|NCT00385918|450450202|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
125224830|NCT00385918|450450203|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
125224831|NCT00385918|450450201|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
125224832|NCT00385918|450450202|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
125224833|NCT00385918|450450203|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
125224834|NCT00385918|450450201|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
125224835|NCT00385918|450450202|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
125224836|NCT00385918|450450203|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
125224837|NCT00385918|450450201|FG000|Intervention Phase After Randomization|Physician Decision|1|||
125162047|NCT02041091|450215503|FG000|Treatment|Adverse Event|3|||
125162048|NCT02041091|450215504|FG001|Treatment|Adverse Event|3|||
125162049|NCT02041091|450215503|FG000|Treatment|Withdrawal by Subject|2|||
125162050|NCT02041091|450215504|FG001|Treatment|Withdrawal by Subject|4|||
125162051|NCT02041091|450215503|FG000|Treatment|Physician Decision|1|||
125162052|NCT02041091|450215504|FG001|Treatment|Physician Decision|0|||
125162053|NCT02041091|450215503|FG000|Treatment|Sponsor Decision|15|||
125162054|NCT02041091|450215504|FG001|Treatment|Sponsor Decision|16|||
125162055|NCT02041091|450215503|FG000|Treatment|Lost to Follow-up|1|||
125162056|NCT02041091|450215504|FG001|Treatment|Lost to Follow-up|0|||
125162057|NCT02041091|450215503|FG000|Optional Safety Extension Period|Adverse Event|4|||
125162058|NCT02041091|450215504|FG001|Optional Safety Extension Period|Adverse Event|2|||
125162059|NCT02041091|450215503|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
125162060|NCT02041091|450215504|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
125162061|NCT02041091|450215503|FG000|Optional Safety Extension Period|Protocol Violation|2|||
125162062|NCT02041091|450215504|FG001|Optional Safety Extension Period|Protocol Violation|0|||
125162063|NCT02041091|450215503|FG000|Optional Safety Extension Period|Physician Decision|2|||
125162064|NCT02041091|450215504|FG001|Optional Safety Extension Period|Physician Decision|1|||
125224838|NCT00385918|450450202|FG001|Intervention Phase After Randomization|Physician Decision|0|||
125224839|NCT00385918|450450203|FG002|Intervention Phase After Randomization|Physician Decision|0|||
125224840|NCT00385918|450450201|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
125224841|NCT00385918|450450202|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
125224842|NCT00385918|450450203|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
125224843|NCT01676701|450450204|FG000|Overall Study|Protocol Violation|1|||
125162065|NCT02041091|450215503|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
125162066|NCT02041091|450215504|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
125224844|NCT01676701|450450205|FG001|Overall Study|Protocol Violation|0|||
125224845|NCT01676701|450450204|FG000|Overall Study|Sponsor Decision|3|||
125162067|NCT02041091|450215503|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
125162068|NCT02041091|450215504|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
125224846|NCT01676701|450450205|FG001|Overall Study|Sponsor Decision|4|||
125224847|NCT02155699|450450214|FG000|Overall Study|Withdrawal by Subject|0|||
125224848|NCT02155699|450450215|FG001|Overall Study|Withdrawal by Subject|3|||
125224849|NCT02155699|450450216|FG002|Overall Study|Withdrawal by Subject|6|||
125224850|NCT02155699|450450217|FG003|Overall Study|Withdrawal by Subject|1|||
125224851|NCT02155699|450450214|FG000|Overall Study|Lost to Follow-up|0|||
125224852|NCT02155699|450450215|FG001|Overall Study|Lost to Follow-up|0|||
125224853|NCT02155699|450450216|FG002|Overall Study|Lost to Follow-up|0|||
125224854|NCT02155699|450450217|FG003|Overall Study|Lost to Follow-up|3|||
125224855|NCT02155699|450450214|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
125162069|NCT00922987|450215505|FG000|Overall Study|Insufficient clinical response|1|||
125162070|NCT00922987|450215505|FG000|Overall Study|Protocol Violation|2|||
125162071|NCT00922987|450215505|FG000|Overall Study|Adverse Event|1|||
125162072|NCT05091307|450217717|FG000|Overall Study|Death|0|||
125162073|NCT05091307|450217718|FG001|Overall Study|Death|0|||
125162074|NCT05091307|450217719|FG002|Overall Study|Death|1|||
125162075|NCT05091307|450217720|FG003|Overall Study|Death|0|||
125162076|NCT05091307|450217717|FG000|Overall Study|Lost to Follow-up|33|||
125162077|NCT05091307|450217718|FG001|Overall Study|Lost to Follow-up|33|||
125162078|NCT05091307|450217719|FG002|Overall Study|Lost to Follow-up|2|||
125162079|NCT05091307|450217720|FG003|Overall Study|Lost to Follow-up|0|||
125162080|NCT05091307|450217717|FG000|Overall Study|Physician Decision|1|||
125162081|NCT05091307|450217718|FG001|Overall Study|Physician Decision|0|||
125162082|NCT05091307|450217719|FG002|Overall Study|Physician Decision|0|||
125162083|NCT05091307|450217720|FG003|Overall Study|Physician Decision|0|||
125162084|NCT05091307|450217717|FG000|Overall Study|Protocol Violation|1|||
125162085|NCT05091307|450217718|FG001|Overall Study|Protocol Violation|0|||
125162086|NCT05091307|450217719|FG002|Overall Study|Protocol Violation|0|||
125162087|NCT05091307|450217720|FG003|Overall Study|Protocol Violation|0|||
125162088|NCT05091307|450217717|FG000|Overall Study|Withdrawal by Subject|16|||
125162089|NCT05091307|450217718|FG001|Overall Study|Withdrawal by Subject|16|||
125162090|NCT05091307|450217719|FG002|Overall Study|Withdrawal by Subject|0|||
125162091|NCT05091307|450217720|FG003|Overall Study|Withdrawal by Subject|1|||
125162092|NCT05091307|450217717|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
125162093|NCT05091307|450217718|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
125162094|NCT05091307|450217719|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
125162095|NCT05091307|450217720|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
125162096|NCT05091307|450217717|FG000|Overall Study|Initiated Prohibited Medication|1|||
125162097|NCT05091307|450217718|FG001|Overall Study|Initiated Prohibited Medication|0|||
125162098|NCT05091307|450217719|FG002|Overall Study|Initiated Prohibited Medication|0|||
125162099|NCT05091307|450217720|FG003|Overall Study|Initiated Prohibited Medication|0|||
125162100|NCT05091307|450217717|FG000|Overall Study|Other|4|||
125162101|NCT05091307|450217718|FG001|Overall Study|Other|4|||
125162102|NCT05091307|450217719|FG002|Overall Study|Other|0|||
125162103|NCT05091307|450217720|FG003|Overall Study|Other|0|||
125162104|NCT05091307|450217717|FG000|Overall Study|Randomized but not vaccinated|0|||
125162105|NCT05091307|450217718|FG001|Overall Study|Randomized but not vaccinated|2|||
125162106|NCT05091307|450217719|FG002|Overall Study|Randomized but not vaccinated|0|||
125162107|NCT05091307|450217720|FG003|Overall Study|Randomized but not vaccinated|0|||
125162108|NCT03303625|450217721|FG000|Overall Study|Withdrawal by Subject|2|||
125162109|NCT03303625|450217722|FG001|Overall Study|Withdrawal by Subject|0|||
125162110|NCT03303625|450217723|FG002|Overall Study|Withdrawal by Subject|0|||
125162111|NCT03303625|450217724|FG003|Overall Study|Withdrawal by Subject|0|||
125162112|NCT01167257|450217725|FG000|Overall Study|Lost to Follow-up|2|||
125162113|NCT01167257|450217726|FG001|Overall Study|Lost to Follow-up|2|||
125162114|NCT01167257|450217725|FG000|Overall Study|Withdrew consent|1|||
125162115|NCT01167257|450217726|FG001|Overall Study|Withdrew consent|1|||
125162116|NCT02492880|450217727|FG000|Overall Study|Lost to Follow-up|1|||
125162117|NCT02492880|450217727|FG000|Overall Study|Protocol Violation|1|||
125162118|NCT02771795|450217728|FG000|Overall Study|Withdrawal by Subject|47|||
125162119|NCT02771795|450217729|FG001|Overall Study|Withdrawal by Subject|37|||
125162120|NCT02771795|450217728|FG000|Overall Study|Termination by premature discontinuation of study|168|||
125162121|NCT02771795|450217729|FG001|Overall Study|Termination by premature discontinuation of study|185|||
125162122|NCT02906930|450217730|FG000|Overall Study|Withdrawal by Subject|0|||
125162123|NCT02906930|450217731|FG001|Overall Study|Withdrawal by Subject|5|||
125162124|NCT02906930|450217732|FG002|Overall Study|Withdrawal by Subject|5|||
125162125|NCT02906930|450217733|FG003|Overall Study|Withdrawal by Subject|4|||
125162126|NCT02906930|450217730|FG000|Overall Study|Lost to Follow-up|5|||
125390922|NCT00337103|451065340|FG001|Overall Study|Death|0|||
125162127|NCT02906930|450217731|FG001|Overall Study|Lost to Follow-up|7|||
125162128|NCT02906930|450217732|FG002|Overall Study|Lost to Follow-up|5|||
125162129|NCT02906930|450217733|FG003|Overall Study|Lost to Follow-up|2|||
125390923|NCT03387813|451065343|FG000|Overall Study|Death|40|||
125390924|NCT03387813|451065344|FG001|Overall Study|Death|37|||
125390925|NCT03387813|451065345|FG002|Overall Study|Death|190|||
125390926|NCT03387813|451065343|FG000|Overall Study|Withdrawal by Subject|9|||
125390927|NCT03387813|451065344|FG001|Overall Study|Withdrawal by Subject|19|||
125390928|NCT03387813|451065345|FG002|Overall Study|Withdrawal by Subject|32|||
125390929|NCT03387813|451065343|FG000|Overall Study|Lost to Follow-up|3|||
125390930|NCT03387813|451065344|FG001|Overall Study|Lost to Follow-up|9|||
125390931|NCT03387813|451065345|FG002|Overall Study|Lost to Follow-up|15|||
125162130|NCT02906930|450217730|FG000|Overall Study|Death|0|||
125162131|NCT02906930|450217731|FG001|Overall Study|Death|0|||
125162132|NCT02906930|450217732|FG002|Overall Study|Death|1|||
125162133|NCT02906930|450217733|FG003|Overall Study|Death|0|||
125162134|NCT02906930|450217730|FG000|Overall Study|Other|1|||
125162135|NCT02906930|450217731|FG001|Overall Study|Other|2|||
125162136|NCT02906930|450217732|FG002|Overall Study|Other|1|||
125162137|NCT02906930|450217733|FG003|Overall Study|Other|2|||
125162138|NCT00622466|450217743|FG000|Overall Study|Death|1|||
125162139|NCT00622466|450217743|FG000|Overall Study|Adverse Event|1|||
125162140|NCT00622466|450217743|FG000|Overall Study|Withdrawal by Subject|2|||
125162141|NCT04585789|450217747|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
125162142|NCT04585789|450217748|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
125162143|NCT04585789|450217749|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
125162144|NCT04585789|450217747|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
125162145|NCT04585789|450217748|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
125162146|NCT04585789|450217749|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
125162147|NCT01383135|450217752|FG000|Overall Study|Not Scanned / Imaged|1|||
125162148|NCT01383135|450217753|FG001|Overall Study|Not Scanned / Imaged|0|||
125162149|NCT01383135|450217754|FG002|Overall Study|Not Scanned / Imaged|1|||
125162150|NCT01383135|450217755|FG003|Overall Study|Not Scanned / Imaged|0|||
125162151|NCT01154816|450217756|FG000|Overall Study|Withdrawal by Subject|1|||
125162152|NCT01154816|450217757|FG001|Overall Study|Withdrawal by Subject|0|||
125162153|NCT01154816|450217758|FG002|Overall Study|Withdrawal by Subject|0|||
125162154|NCT01154816|450217759|FG003|Overall Study|Withdrawal by Subject|1|||
125162155|NCT01154816|450217760|FG004|Overall Study|Withdrawal by Subject|0|||
125162156|NCT01154816|450217761|FG005|Overall Study|Withdrawal by Subject|0|||
125162157|NCT01154816|450217762|FG006|Overall Study|Withdrawal by Subject|0|||
125162158|NCT01154816|450217763|FG007|Overall Study|Withdrawal by Subject|0|||
125162159|NCT01154816|450217764|FG008|Overall Study|Withdrawal by Subject|1|||
125162160|NCT01154816|450217765|FG009|Overall Study|Withdrawal by Subject|3|||
125162161|NCT01154816|450217766|FG010|Overall Study|Withdrawal by Subject|0|||
125162162|NCT01154816|450217767|FG011|Overall Study|Withdrawal by Subject|0|||
125162163|NCT01154816|450217756|FG000|Overall Study|Progressive Disease|13|||
125162164|NCT01154816|450217757|FG001|Overall Study|Progressive Disease|8|||
125162165|NCT01154816|450217758|FG002|Overall Study|Progressive Disease|9|||
125162166|NCT01154816|450217759|FG003|Overall Study|Progressive Disease|9|||
125162167|NCT01154816|450217760|FG004|Overall Study|Progressive Disease|8|||
125162168|NCT01154816|450217761|FG005|Overall Study|Progressive Disease|8|||
125162169|NCT01154816|450217762|FG006|Overall Study|Progressive Disease|5|||
125162170|NCT01154816|450217763|FG007|Overall Study|Progressive Disease|6|||
125162171|NCT01154816|450217764|FG008|Overall Study|Progressive Disease|8|||
125162172|NCT01154816|450217765|FG009|Overall Study|Progressive Disease|6|||
125162173|NCT01154816|450217766|FG010|Overall Study|Progressive Disease|10|||
125162174|NCT01154816|450217767|FG011|Overall Study|Progressive Disease|3|||
125162175|NCT01154816|450217756|FG000|Overall Study|Physician Decision|1|||
125162176|NCT01154816|450217757|FG001|Overall Study|Physician Decision|0|||
125390932|NCT03387813|451065343|FG000|Overall Study|Non-Compliance|6|||
125390933|NCT03387813|451065344|FG001|Overall Study|Non-Compliance|6|||
125390934|NCT03387813|451065345|FG002|Overall Study|Non-Compliance|31|||
125390935|NCT03387813|451065343|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
125390936|NCT03387813|451065344|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
125390937|NCT03387813|451065345|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
125390938|NCT03792672|451065350|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
125390939|NCT03792672|451065351|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
125390940|NCT03792672|451065352|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
125390941|NCT03792672|451065353|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
125390942|NCT03792672|451065354|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
125390943|NCT03792672|451065355|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
125390944|NCT03792672|451065350|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
125390945|NCT03792672|451065351|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
125390946|NCT03792672|451065352|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
125390947|NCT03792672|451065353|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
125390948|NCT03792672|451065354|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
125390949|NCT03792672|451065355|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
125390950|NCT03792672|451065350|FG000|Treatment Period 4 (2 Days)|Other|1|||
125390951|NCT03792672|451065351|FG001|Treatment Period 4 (2 Days)|Other|0|||
125390952|NCT03792672|451065352|FG002|Treatment Period 4 (2 Days)|Other|0|||
125162177|NCT01154816|450217758|FG002|Overall Study|Physician Decision|1|||
125162178|NCT01154816|450217759|FG003|Overall Study|Physician Decision|0|||
125162179|NCT01154816|450217760|FG004|Overall Study|Physician Decision|2|||
125162180|NCT01154816|450217761|FG005|Overall Study|Physician Decision|0|||
125162181|NCT01154816|450217762|FG006|Overall Study|Physician Decision|0|||
125162182|NCT01154816|450217763|FG007|Overall Study|Physician Decision|0|||
125162183|NCT01154816|450217764|FG008|Overall Study|Physician Decision|0|||
125162184|NCT01154816|450217765|FG009|Overall Study|Physician Decision|1|||
125162185|NCT01154816|450217766|FG010|Overall Study|Physician Decision|1|||
125162186|NCT01154816|450217767|FG011|Overall Study|Physician Decision|1|||
125162187|NCT01154816|450217756|FG000|Overall Study|Adverse Event|5|||
125162188|NCT01154816|450217757|FG001|Overall Study|Adverse Event|2|||
125162189|NCT01154816|450217758|FG002|Overall Study|Adverse Event|0|||
125162190|NCT01154816|450217759|FG003|Overall Study|Adverse Event|0|||
125162191|NCT01154816|450217760|FG004|Overall Study|Adverse Event|0|||
125162192|NCT01154816|450217761|FG005|Overall Study|Adverse Event|0|||
125162193|NCT01154816|450217762|FG006|Overall Study|Adverse Event|1|||
125162194|NCT01154816|450217763|FG007|Overall Study|Adverse Event|1|||
125162195|NCT01154816|450217764|FG008|Overall Study|Adverse Event|0|||
125162196|NCT01154816|450217765|FG009|Overall Study|Adverse Event|0|||
125162197|NCT01154816|450217766|FG010|Overall Study|Adverse Event|0|||
125162198|NCT01154816|450217767|FG011|Overall Study|Adverse Event|0|||
125162199|NCT03397771|450217768|FG000|Overall Study|2 erroneously randomized, never treated|3|||
125162200|NCT03397771|450217769|FG001|Overall Study|2 erroneously randomized, never treated|1|||
125162201|NCT03397771|450217768|FG000|Overall Study|Withdrawal by Subject|1|||
125162202|NCT03397771|450217769|FG001|Overall Study|Withdrawal by Subject|3|||
125162203|NCT03397771|450217768|FG000|Overall Study|Protocol Violation|2|||
125162204|NCT03397771|450217769|FG001|Overall Study|Protocol Violation|2|||
125162205|NCT03397771|450217768|FG000|Overall Study|Adverse Event|2|||
125162206|NCT03397771|450217769|FG001|Overall Study|Adverse Event|1|||
125162207|NCT04078126|450217772|FG000|Washout|Study put on hold due to COVID-19|0|||
125162208|NCT04078126|450217773|FG001|Washout|Study put on hold due to COVID-19|2|||
125162209|NCT04078126|450217772|FG000|Period 2|Study put on hold due to COVID-19|1|||
125162210|NCT04078126|450217773|FG001|Period 2|Study put on hold due to COVID-19|1|||
125162211|NCT03321630|450217774|FG000|Overall Study|Adverse Event|1|||
125440419|NCT02611830|451239814|FG003|Maintenance Phase|Lack of Efficacy|6|||
125440420|NCT02611830|451239811|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
125440421|NCT02611830|451239812|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
125440422|NCT02611830|451239813|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
125440423|NCT02611830|451239814|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
125440424|NCT02611830|451239811|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
125440425|NCT02611830|451239812|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
125440426|NCT02611830|451239813|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
125440427|NCT02611830|451239814|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
125440428|NCT02611830|451239811|FG000|Maintenance Phase|Lost to Follow-up|0|||
125440429|NCT02611830|451239812|FG001|Maintenance Phase|Lost to Follow-up|0|||
125440430|NCT02611830|451239813|FG002|Maintenance Phase|Lost to Follow-up|0|||
125440431|NCT02611830|451239814|FG003|Maintenance Phase|Lost to Follow-up|1|||
125440432|NCT02611830|451239811|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
125440433|NCT02611830|451239812|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
125440434|NCT02611830|451239813|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
125440435|NCT02611830|451239814|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
125440436|NCT02611830|451239811|FG000|Maintenance Phase|Pregnancy|0|||
125440437|NCT02611830|451239812|FG001|Maintenance Phase|Pregnancy|0|||
125440438|NCT02611830|451239813|FG002|Maintenance Phase|Pregnancy|1|||
125440439|NCT02611830|451239814|FG003|Maintenance Phase|Pregnancy|0|||
125440440|NCT02611830|451239811|FG000|Maintenance Phase|Reason not specified|0|||
125440441|NCT02611830|451239812|FG001|Maintenance Phase|Reason not specified|1|||
125162212|NCT03321630|450217774|FG000|Overall Study|Investigator Discretion|2|||
125162213|NCT03321630|450217774|FG000|Overall Study|Withdrawal by Subject|1|||
125162214|NCT02669758|450217775|FG000|Overall Study|Withdrawal by Subject|43|||
125162215|NCT02669758|450217775|FG000|Overall Study|Lost to Follow-up|19|||
125162216|NCT02669758|450217775|FG000|Overall Study|Adverse Event|16|||
125162217|NCT02669758|450217775|FG000|Overall Study|Non-Compliance with Study Drug|8|||
125162218|NCT02669758|450217775|FG000|Overall Study|Lack of Efficacy|5|||
125162219|NCT02669758|450217775|FG000|Overall Study|Pregnancy|1|||
125162220|NCT02669758|450217775|FG000|Overall Study|Study noncompliance|1|||
125162221|NCT02669758|450217775|FG000|Overall Study|Protocol Violation|1|||
125162222|NCT02455050|450217776|FG000|Treatment Period 1|Lost to Follow-up|1|||
125162223|NCT02455050|450217777|FG001|Treatment Period 1|Lost to Follow-up|1|||
125162224|NCT02455050|450217778|FG002|Treatment Period 1|Lost to Follow-up|1|||
125162225|NCT02455050|450217779|FG003|Treatment Period 1|Lost to Follow-up|2|||
125162226|NCT02455050|450217776|FG000|Treatment Period 2|Lost to Follow-up|1|||
125440442|NCT02611830|451239813|FG002|Maintenance Phase|Reason not specified|4|||
125440443|NCT02611830|451239814|FG003|Maintenance Phase|Reason not specified|0|||
125440444|NCT02058290|451239818|FG000|Overall Study|Protocol Violation|2|||
125162227|NCT02455050|450217777|FG001|Treatment Period 2|Lost to Follow-up|0|||
125162228|NCT02455050|450217778|FG002|Treatment Period 2|Lost to Follow-up|2|||
125162229|NCT02455050|450217779|FG003|Treatment Period 2|Lost to Follow-up|1|||
125162230|NCT02325518|450217780|FG000|Overall Study|Adverse Event|4|||
125440445|NCT02058290|451239819|FG001|Overall Study|Protocol Violation|1|||
125162231|NCT02325518|450217781|FG001|Overall Study|Adverse Event|1|||
125162232|NCT02325518|450217780|FG000|Overall Study|Physician Decision|0|||
125440446|NCT02058290|451239818|FG000|Overall Study|Physician Decision|1|||
125440447|NCT02058290|451239819|FG001|Overall Study|Physician Decision|0|||
125162233|NCT02325518|450217781|FG001|Overall Study|Physician Decision|1|||
125162234|NCT02325518|450217780|FG000|Overall Study|Withdrawal by Subject|0|||
125162235|NCT02325518|450217781|FG001|Overall Study|Withdrawal by Subject|1|||
125162236|NCT03393806|450217784|FG000|Overall Study|Physician Decision|1|||
125162237|NCT03393806|450217785|FG001|Overall Study|Physician Decision|0|||
125162238|NCT00886288|450217786|FG000|Overall Study|no respect of the 12 weeks period|657|||
125162239|NCT00886288|450217787|FG001|Overall Study|no respect of the 12 weeks period|227|||
125162240|NCT00886288|450217786|FG000|Overall Study|Lost to Follow-up|86|||
125162241|NCT00886288|450217787|FG001|Overall Study|Lost to Follow-up|0|||
125162242|NCT01675661|450217788|FG000|Overall Study|Lost to Follow-up|22|||
125162243|NCT01675661|450217789|FG001|Overall Study|Lost to Follow-up|23|||
125162244|NCT01675661|450217788|FG000|Overall Study|Practical problems|9|||
125162245|NCT01675661|450217789|FG001|Overall Study|Practical problems|5|||
125162246|NCT01675661|450217788|FG000|Overall Study|Moved away|5|||
125162247|NCT01675661|450217789|FG001|Overall Study|Moved away|6|||
125162248|NCT01675661|450217788|FG000|Overall Study|Withdrawal by Subject|3|||
125162249|NCT01675661|450217789|FG001|Overall Study|Withdrawal by Subject|7|||
125162250|NCT01675661|450217788|FG000|Overall Study|Physician Decision|0|||
125162251|NCT01675661|450217789|FG001|Overall Study|Physician Decision|2|||
125162252|NCT01675661|450217788|FG000|Overall Study|Death|0|||
125162253|NCT01675661|450217789|FG001|Overall Study|Death|1|||
125162254|NCT01675661|450217788|FG000|Overall Study|Other reason|1|||
125162255|NCT01675661|450217789|FG001|Overall Study|Other reason|2|||
125162256|NCT04765384|450217790|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
125162257|NCT04765384|450217791|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
125162258|NCT04765384|450217792|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
125162259|NCT04765384|450217793|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
125162260|NCT04765384|450217794|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
125162261|NCT04765384|450217795|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
125162262|NCT04765384|450217790|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
125162263|NCT04765384|450217791|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
125162264|NCT04765384|450217792|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
125162265|NCT04765384|450217793|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
125162266|NCT04765384|450217794|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
125162267|NCT04765384|450217795|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
125162268|NCT04765384|450217790|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
125162269|NCT04765384|450217791|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
125162270|NCT04765384|450217792|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
125162271|NCT04765384|450217793|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
125162272|NCT04765384|450217794|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
125162273|NCT04765384|450217795|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
125162274|NCT04765384|450217790|FG000|Post-natal: Neonates and Infants|Death|0|||
125162275|NCT04765384|450217791|FG001|Post-natal: Neonates and Infants|Death|0|||
125162276|NCT04765384|450217792|FG002|Post-natal: Neonates and Infants|Death|0|||
125162277|NCT04765384|450217793|FG003|Post-natal: Neonates and Infants|Death|1|||
125162278|NCT04765384|450217794|FG004|Post-natal: Neonates and Infants|Death|0|||
125162279|NCT04765384|450217795|FG005|Post-natal: Neonates and Infants|Death|0|||
125162280|NCT04765384|450217790|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
125162281|NCT04765384|450217791|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
125162282|NCT04765384|450217792|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
125162283|NCT04765384|450217793|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
125162284|NCT04765384|450217794|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
125162285|NCT04765384|450217795|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
125440448|NCT02058290|451239818|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
125440449|NCT02058290|451239819|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
125440450|NCT02058290|451239818|FG000|Overall Study|Withdrawal by Subject|0|||
125440451|NCT02058290|451239819|FG001|Overall Study|Withdrawal by Subject|1|||
125440452|NCT03012061|451239822|FG000|Overall Study|Withdrawal by Subject|1|||
125440453|NCT03012061|451239823|FG001|Overall Study|Withdrawal by Subject|5|||
125440454|NCT03012061|451239824|FG002|Overall Study|Withdrawal by Subject|4|||
125440455|NCT03012061|451239822|FG000|Overall Study|Investigator Site Closed|1|||
125440456|NCT03012061|451239823|FG001|Overall Study|Investigator Site Closed|2|||
125162286|NCT01971970|450217796|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
125162287|NCT01971970|450217797|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
125162288|NCT01971970|450217796|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
125162289|NCT01971970|450217797|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
125162290|NCT01971970|450217796|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
125162291|NCT01971970|450217797|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
125162292|NCT01971970|450217796|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
125162293|NCT01971970|450217797|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
125440457|NCT03012061|451239824|FG002|Overall Study|Investigator Site Closed|0|||
125440458|NCT03012061|451239822|FG000|Overall Study|Lost to Follow-up|2|||
125162294|NCT01971970|450217796|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
125162295|NCT01971970|450217797|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
125162296|NCT01971970|450217796|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
125162297|NCT01971970|450217797|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
125162298|NCT01971970|450217796|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
125162299|NCT01971970|450217797|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
125162300|NCT02335983|450217798|FG000|Overall Study|Sponsor Decision|0|||
125162301|NCT02335983|450217799|FG001|Overall Study|Sponsor Decision|0|||
125162302|NCT02335983|450217800|FG002|Overall Study|Sponsor Decision|1|||
125162303|NCT02335983|450217801|FG003|Overall Study|Sponsor Decision|1|||
125162304|NCT02335983|450217802|FG004|Overall Study|Sponsor Decision|0|||
125162305|NCT02335983|450217803|FG005|Overall Study|Sponsor Decision|1|||
125162306|NCT02335983|450217798|FG000|Overall Study|Withdrawal by Subject|3|||
125162307|NCT02335983|450217799|FG001|Overall Study|Withdrawal by Subject|2|||
125162308|NCT02335983|450217800|FG002|Overall Study|Withdrawal by Subject|2|||
125162309|NCT02335983|450217801|FG003|Overall Study|Withdrawal by Subject|1|||
125162310|NCT02335983|450217802|FG004|Overall Study|Withdrawal by Subject|3|||
125162311|NCT02335983|450217803|FG005|Overall Study|Withdrawal by Subject|9|||
125162312|NCT02335983|450217798|FG000|Overall Study|Death|0|||
125162313|NCT02335983|450217799|FG001|Overall Study|Death|0|||
125162314|NCT02335983|450217800|FG002|Overall Study|Death|2|||
125162315|NCT02335983|450217801|FG003|Overall Study|Death|0|||
125162316|NCT02335983|450217802|FG004|Overall Study|Death|0|||
125162317|NCT02335983|450217803|FG005|Overall Study|Death|0|||
125162318|NCT02335983|450217798|FG000|Overall Study|Lost to Follow-up|0|||
125162319|NCT02335983|450217799|FG001|Overall Study|Lost to Follow-up|0|||
125162320|NCT02335983|450217800|FG002|Overall Study|Lost to Follow-up|0|||
125162321|NCT02335983|450217801|FG003|Overall Study|Lost to Follow-up|0|||
125162322|NCT02335983|450217802|FG004|Overall Study|Lost to Follow-up|0|||
125162323|NCT02335983|450217803|FG005|Overall Study|Lost to Follow-up|1|||
125162324|NCT02335983|450217798|FG000|Overall Study|Protocol Specified Criteria|5|||
125162325|NCT02335983|450217799|FG001|Overall Study|Protocol Specified Criteria|7|||
125162326|NCT02335983|450217800|FG002|Overall Study|Protocol Specified Criteria|27|||
125162327|NCT02335983|450217801|FG003|Overall Study|Protocol Specified Criteria|7|||
125390953|NCT03792672|451065353|FG003|Treatment Period 4 (2 Days)|Other|0|||
125390954|NCT03792672|451065354|FG004|Treatment Period 4 (2 Days)|Other|0|||
125390955|NCT03792672|451065355|FG005|Treatment Period 4 (2 Days)|Other|0|||
125390956|NCT01907828|451065359|FG000|Overall Study|Exclusion criteria not met|0|||
125390957|NCT01907828|451065360|FG001|Overall Study|Exclusion criteria not met|1|||
125390958|NCT01907828|451065359|FG000|Overall Study|Withdrawal by Subject|3|||
125390959|NCT01907828|451065360|FG001|Overall Study|Withdrawal by Subject|4|||
125390960|NCT01907828|451065359|FG000|Overall Study|Lost to Follow-up|3|||
125390961|NCT01907828|451065360|FG001|Overall Study|Lost to Follow-up|0|||
125390962|NCT01907828|451065359|FG000|Overall Study|Participant refused 24-month follow-up|1|||
125390963|NCT01907828|451065360|FG001|Overall Study|Participant refused 24-month follow-up|0|||
125390964|NCT01907828|451065359|FG000|Overall Study|Participant met exclusion criteria|0|||
125390965|NCT01907828|451065360|FG001|Overall Study|Participant met exclusion criteria|1|||
125390966|NCT04414553|451065361|FG000|Overall Study|Lost to Follow-up|20|||
125390967|NCT01085097|451065364|FG000|Overall Study|Adverse Event|0|||
125390968|NCT01085097|451065365|FG001|Overall Study|Adverse Event|0|||
125390969|NCT01085097|451065366|FG002|Overall Study|Adverse Event|2|||
125390970|NCT01085097|451065364|FG000|Overall Study|Treatment failure|2|||
125390971|NCT01085097|451065365|FG001|Overall Study|Treatment failure|0|||
125390972|NCT01085097|451065366|FG002|Overall Study|Treatment failure|0|||
125390973|NCT04007523|451065368|FG000|Overall Study|Withdrawal by Subject|0|||
125390974|NCT04007523|451065369|FG001|Overall Study|Withdrawal by Subject|1|||
125390975|NCT04007523|451065370|FG002|Overall Study|Withdrawal by Subject|1|||
125390976|NCT04007523|451065371|FG003|Overall Study|Withdrawal by Subject|0|||
125390977|NCT04007523|451065368|FG000|Overall Study|ICU Transfer|0|||
125390978|NCT04007523|451065369|FG001|Overall Study|ICU Transfer|1|||
125390979|NCT04007523|451065370|FG002|Overall Study|ICU Transfer|0|||
125390980|NCT04007523|451065371|FG003|Overall Study|ICU Transfer|0|||
125390981|NCT04007523|451065368|FG000|Overall Study|COVID hospital closure|0|||
125390982|NCT04007523|451065369|FG001|Overall Study|COVID hospital closure|0|||
125390983|NCT04007523|451065370|FG002|Overall Study|COVID hospital closure|1|||
125390984|NCT04007523|451065371|FG003|Overall Study|COVID hospital closure|2|||
125390985|NCT04007523|451065368|FG000|Overall Study|Surgery cancelled|0|||
125390986|NCT04007523|451065369|FG001|Overall Study|Surgery cancelled|0|||
125390987|NCT04007523|451065370|FG002|Overall Study|Surgery cancelled|1|||
125162328|NCT02335983|450217802|FG004|Overall Study|Protocol Specified Criteria|5|||
125162329|NCT02335983|450217803|FG005|Overall Study|Protocol Specified Criteria|21|||
125162330|NCT00655876|450217804|FG000|Overall Study|Protocol Violation|9|||
125390988|NCT04007523|451065371|FG003|Overall Study|Surgery cancelled|1|||
125390989|NCT02197806|451065376|FG000|Overall Study|Adverse Event|0|||
125390990|NCT02197806|451065377|FG001|Overall Study|Adverse Event|1|||
125390991|NCT02197806|451065378|FG002|Overall Study|Adverse Event|0|||
125440459|NCT03012061|451239823|FG001|Overall Study|Lost to Follow-up|1|||
125440460|NCT03012061|451239824|FG002|Overall Study|Lost to Follow-up|0|||
125440461|NCT03012061|451239822|FG000|Overall Study|Study closed/ Terminated|0|||
125440462|NCT03012061|451239823|FG001|Overall Study|Study closed/ Terminated|0|||
125440463|NCT03012061|451239824|FG002|Overall Study|Study closed/ Terminated|1|||
125440464|NCT03012061|451239822|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
125440465|NCT03012061|451239823|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
125440466|NCT03012061|451239824|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
125440467|NCT03012061|451239822|FG000|Overall Study|Protocol Violation|0|||
125440468|NCT03012061|451239823|FG001|Overall Study|Protocol Violation|0|||
125440469|NCT03012061|451239824|FG002|Overall Study|Protocol Violation|2|||
125440470|NCT03012061|451239822|FG000|Overall Study|Lack of Efficacy|0|||
125440471|NCT03012061|451239823|FG001|Overall Study|Lack of Efficacy|1|||
125440472|NCT03012061|451239824|FG002|Overall Study|Lack of Efficacy|0|||
125440473|NCT03012061|451239822|FG000|Overall Study|Adverse Event|2|||
125440474|NCT03012061|451239823|FG001|Overall Study|Adverse Event|0|||
125440475|NCT03012061|451239824|FG002|Overall Study|Adverse Event|0|||
125440476|NCT02696902|451239825|FG000|Overall Study|Lost to Follow-up|0|||
125440477|NCT02696902|451239826|FG001|Overall Study|Lost to Follow-up|1|||
125440478|NCT02696902|451239827|FG002|Overall Study|Lost to Follow-up|1|||
125440479|NCT02696902|451239825|FG000|Overall Study|Withdrawal by Subject|0|||
125440480|NCT02696902|451239826|FG001|Overall Study|Withdrawal by Subject|0|||
125440481|NCT02696902|451239827|FG002|Overall Study|Withdrawal by Subject|1|||
125440482|NCT02696902|451239825|FG000|Overall Study|Death|19|||
125440483|NCT02696902|451239826|FG001|Overall Study|Death|3|||
125440484|NCT02696902|451239827|FG002|Overall Study|Death|24|||
125440485|NCT02696902|451239825|FG000|Overall Study|Participant not fit post-randomization|0|||
125440486|NCT02696902|451239826|FG001|Overall Study|Participant not fit post-randomization|0|||
125440487|NCT02696902|451239827|FG002|Overall Study|Participant not fit post-randomization|1|||
125440488|NCT02696902|451239825|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
125440489|NCT02696902|451239826|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
125440490|NCT02696902|451239827|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
125440491|NCT02696902|451239825|FG000|Overall Study|Principal investigator's decision|1|||
125440492|NCT02696902|451239826|FG001|Overall Study|Principal investigator's decision|0|||
125440493|NCT02696902|451239827|FG002|Overall Study|Principal investigator's decision|0|||
125440494|NCT02696902|451239825|FG000|Overall Study|Sponsor's decision|1|||
125440495|NCT02696902|451239826|FG001|Overall Study|Sponsor's decision|0|||
125440496|NCT02696902|451239827|FG002|Overall Study|Sponsor's decision|0|||
125440497|NCT02696902|451239825|FG000|Overall Study|Transferred to other hospital|1|||
125440498|NCT02696902|451239826|FG001|Overall Study|Transferred to other hospital|0|||
125440499|NCT02696902|451239827|FG002|Overall Study|Transferred to other hospital|0|||
125440500|NCT01291225|451239829|FG000|Overall Study|Lost to Follow-up|85|||
125440501|NCT01291225|451239830|FG001|Overall Study|Lost to Follow-up|39|||
125440502|NCT01267253|451239831|FG000|Overall Study|Ineligible - required test not done|1|||
125440503|NCT01267253|451239831|FG000|Overall Study|Inevaluable-never received study treatme|2|||
125440504|NCT02855164|451239834|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
125440505|NCT02855164|451239835|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
125440506|NCT02855164|451239836|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
125440507|NCT02855164|451239837|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
125440508|NCT02855164|451239838|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
125440509|NCT02855164|451239839|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
125440510|NCT02855164|451239840|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
125440511|NCT02855164|451239841|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
125440512|NCT02855164|451239834|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
125440513|NCT02855164|451239835|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
125440514|NCT02855164|451239836|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
125440515|NCT02855164|451239837|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
125440516|NCT02855164|451239838|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
125440517|NCT02855164|451239839|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
125440518|NCT02855164|451239840|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
125440519|NCT02855164|451239841|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
125440520|NCT02855164|451239834|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
125440521|NCT02855164|451239835|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
125440522|NCT02855164|451239836|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
125440523|NCT02855164|451239837|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
125440524|NCT02855164|451239838|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
125440525|NCT02855164|451239839|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
125440526|NCT02855164|451239840|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
125440527|NCT02855164|451239841|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
125440528|NCT02855164|451239834|FG000|Part C (Randomized Set)|Adverse Event|0|||
125440529|NCT02855164|451239835|FG001|Part C (Randomized Set)|Adverse Event|0|||
125440530|NCT02855164|451239836|FG002|Part C (Randomized Set)|Adverse Event|0|||
125162331|NCT00655876|450217805|FG001|Overall Study|Protocol Violation|7|||
125224856|NCT02155699|450450215|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
125162332|NCT01831765|450217806|FG000|Overall Study|Lack of Efficacy|1|||
125162333|NCT01831765|450217807|FG001|Overall Study|Lack of Efficacy|0|||
125162334|NCT01831765|450217808|FG002|Overall Study|Lack of Efficacy|0|||
125162335|NCT01831765|450217806|FG000|Overall Study|Other, sponsor withdrew subject|0|||
125162336|NCT01831765|450217807|FG001|Overall Study|Other, sponsor withdrew subject|1|||
125162337|NCT01831765|450217808|FG002|Overall Study|Other, sponsor withdrew subject|0|||
125162338|NCT01831765|450217806|FG000|Overall Study|Pregnancy|1|||
125162339|NCT01831765|450217807|FG001|Overall Study|Pregnancy|1|||
125162340|NCT01831765|450217808|FG002|Overall Study|Pregnancy|2|||
125162341|NCT01831765|450217806|FG000|Overall Study|Death|0|||
125162342|NCT01831765|450217807|FG001|Overall Study|Death|1|||
125162343|NCT01831765|450217808|FG002|Overall Study|Death|1|||
125162344|NCT01831765|450217806|FG000|Overall Study|Other, site closed|1|||
125162345|NCT01831765|450217807|FG001|Overall Study|Other, site closed|1|||
125162346|NCT01831765|450217808|FG002|Overall Study|Other, site closed|0|||
125162347|NCT01831765|450217806|FG000|Overall Study|Adverse Event|5|||
125162348|NCT01831765|450217807|FG001|Overall Study|Adverse Event|3|||
125162349|NCT01831765|450217808|FG002|Overall Study|Adverse Event|3|||
125162350|NCT01831765|450217806|FG000|Overall Study|Withdrawal by Subject|22|||
125162351|NCT01831765|450217807|FG001|Overall Study|Withdrawal by Subject|7|||
125162352|NCT01831765|450217808|FG002|Overall Study|Withdrawal by Subject|17|||
125162353|NCT01831765|450217806|FG000|Overall Study|Withdrawal criteria|12|||
125162354|NCT01831765|450217807|FG001|Overall Study|Withdrawal criteria|10|||
125162355|NCT01831765|450217808|FG002|Overall Study|Withdrawal criteria|16|||
125162356|NCT01831765|450217806|FG000|Overall Study|Lost to Follow-up|2|||
125162357|NCT01831765|450217807|FG001|Overall Study|Lost to Follow-up|3|||
125162358|NCT01831765|450217808|FG002|Overall Study|Lost to Follow-up|3|||
125162359|NCT00977379|450217811|FG000|Overall Study|Withdrawal by Subject|1|||
125162360|NCT00977379|450217812|FG001|Overall Study|Withdrawal by Subject|1|||
125162361|NCT00977379|450217811|FG000|Overall Study|Death|7|||
125162362|NCT00977379|450217812|FG001|Overall Study|Death|9|||
125162363|NCT00977379|450217811|FG000|Overall Study|Premature Study Termination|4|||
125162364|NCT00977379|450217812|FG001|Overall Study|Premature Study Termination|0|||
125162365|NCT00977379|450217811|FG000|Overall Study|Participant Moving House|0|||
125162366|NCT00977379|450217812|FG001|Overall Study|Participant Moving House|1|||
125162367|NCT00977379|450217811|FG000|Overall Study|Randomization Error|0|||
125162368|NCT00977379|450217812|FG001|Overall Study|Randomization Error|1|||
125162369|NCT00706511|450217815|FG000|Overall Study|Withdrawal by Subject|1|||
125162370|NCT00706511|450217816|FG001|Overall Study|Withdrawal by Subject|0|||
125162371|NCT00706511|450217817|FG002|Overall Study|Withdrawal by Subject|0|||
125162372|NCT00706511|450217818|FG003|Overall Study|Withdrawal by Subject|0|||
125162373|NCT02605993|450217819|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
125162374|NCT02605993|450217820|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
125162375|NCT02605993|450217821|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
125162376|NCT02605993|450217822|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
125162377|NCT02603393|450217823|FG000|Overall Study|Patient/guardian decision|32|||
125162378|NCT02603393|450217824|FG001|Overall Study|Patient/guardian decision|18|||
125162379|NCT02603393|450217823|FG000|Overall Study|Adverse Event|17|||
125162380|NCT02603393|450217824|FG001|Overall Study|Adverse Event|15|||
125162381|NCT02603393|450217823|FG000|Overall Study|Technical problems|4|||
125162382|NCT02603393|450217824|FG001|Overall Study|Technical problems|7|||
125162383|NCT02603393|450217823|FG000|Overall Study|Lack of Efficacy|7|||
125162384|NCT02603393|450217824|FG001|Overall Study|Lack of Efficacy|2|||
125162385|NCT02603393|450217823|FG000|Overall Study|Death|3|||
125162386|NCT02603393|450217824|FG001|Overall Study|Death|4|||
125162387|NCT02603393|450217823|FG000|Overall Study|Physician Decision|3|||
125162388|NCT02603393|450217824|FG001|Overall Study|Physician Decision|3|||
125162389|NCT02603393|450217823|FG000|Overall Study|Protocol deviation|2|||
125162390|NCT02603393|450217824|FG001|Overall Study|Protocol deviation|3|||
125162391|NCT02603393|450217823|FG000|Overall Study|Lost to Follow-up|1|||
125162392|NCT02603393|450217824|FG001|Overall Study|Lost to Follow-up|2|||
125162393|NCT02603393|450217823|FG000|Overall Study|Non-compliance with study treatment|1|||
125162394|NCT02603393|450217824|FG001|Overall Study|Non-compliance with study treatment|0|||
125162395|NCT02603393|450217823|FG000|Overall Study|Sponsor decision|1|||
125162396|NCT02603393|450217824|FG001|Overall Study|Sponsor decision|0|||
125162397|NCT01974440|450217830|FG000|Overall Study|Lost to Follow-up|7|||
125162398|NCT01974440|450217831|FG001|Overall Study|Lost to Follow-up|7|||
125162399|NCT01974440|450217830|FG000|Overall Study|Withdrawal by Subject|24|||
125162400|NCT01974440|450217831|FG001|Overall Study|Withdrawal by Subject|20|||
125162401|NCT01974440|450217830|FG000|Overall Study|Sponsor decision|109|||
125162402|NCT01974440|450217831|FG001|Overall Study|Sponsor decision|110|||
125162403|NCT00762437|450217832|FG000|Overall Study|Lost to Follow-up|7|||
125162404|NCT00762437|450217832|FG000|Overall Study|Missed final study visit|11|||
125162405|NCT00762437|450217832|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
125162406|NCT02387983|450217833|FG000|Overall Study|Adverse Event|4|||
125162407|NCT02387983|450217833|FG000|Overall Study|Protocol Violation|1|||
125162408|NCT02387983|450217833|FG000|Overall Study|Withdrawal by Subject|2|||
125162409|NCT03569228|450217834|FG000|Overall Study|Withdrawal by PI|0|||
125162410|NCT03569228|450217835|FG001|Overall Study|Withdrawal by PI|0|||
125162411|NCT03569228|450217836|FG002|Overall Study|Withdrawal by PI|2|||
125162412|NCT03569228|450217837|FG003|Overall Study|Withdrawal by PI|2|||
125162413|NCT03569228|450217838|FG004|Overall Study|Withdrawal by PI|1|||
125162414|NCT03569228|450217839|FG005|Overall Study|Withdrawal by PI|0|||
125162415|NCT03569228|450217840|FG006|Overall Study|Withdrawal by PI|0|||
125162416|NCT03569228|450217841|FG007|Overall Study|Withdrawal by PI|0|||
125162417|NCT03569228|450217842|FG008|Overall Study|Withdrawal by PI|0|||
125162418|NCT03569228|450217834|FG000|Overall Study|Lost to Follow-up|0|||
125162419|NCT03569228|450217835|FG001|Overall Study|Lost to Follow-up|0|||
125162420|NCT03569228|450217836|FG002|Overall Study|Lost to Follow-up|0|||
125162421|NCT03569228|450217837|FG003|Overall Study|Lost to Follow-up|0|||
125162422|NCT03569228|450217838|FG004|Overall Study|Lost to Follow-up|0|||
125162423|NCT03569228|450217839|FG005|Overall Study|Lost to Follow-up|0|||
125162424|NCT03569228|450217840|FG006|Overall Study|Lost to Follow-up|0|||
125162425|NCT03569228|450217841|FG007|Overall Study|Lost to Follow-up|0|||
125162426|NCT03569228|450217842|FG008|Overall Study|Lost to Follow-up|1|||
125162427|NCT03569228|450217834|FG000|Overall Study|Screen Fail|2|||
125162428|NCT03569228|450217835|FG001|Overall Study|Screen Fail|2|||
125162429|NCT03569228|450217836|FG002|Overall Study|Screen Fail|1|||
125162430|NCT03569228|450217837|FG003|Overall Study|Screen Fail|1|||
125162431|NCT03569228|450217838|FG004|Overall Study|Screen Fail|1|||
125162432|NCT03569228|450217839|FG005|Overall Study|Screen Fail|3|||
125162433|NCT03569228|450217840|FG006|Overall Study|Screen Fail|1|||
125162434|NCT03569228|450217841|FG007|Overall Study|Screen Fail|5|||
125162435|NCT03569228|450217842|FG008|Overall Study|Screen Fail|2|||
125162436|NCT06354998|450217843|FG000|Overall Study|Withdrawal by Subject|3|||
125390992|NCT02197806|451065379|FG003|Overall Study|Adverse Event|1|||
125390993|NCT02268812|451065383|FG000|Overall Study|Adverse Event|8|||
125390994|NCT02268812|451065384|FG001|Overall Study|Adverse Event|26|||
125390995|NCT02268812|451065385|FG002|Overall Study|Adverse Event|7|||
125390996|NCT02268812|451065386|FG003|Overall Study|Adverse Event|10|||
125390997|NCT02268812|451065383|FG000|Overall Study|Protocol deviation|0|||
125390998|NCT02268812|451065384|FG001|Overall Study|Protocol deviation|0|||
125390999|NCT02268812|451065385|FG002|Overall Study|Protocol deviation|1|||
125391000|NCT02268812|451065386|FG003|Overall Study|Protocol deviation|0|||
125391001|NCT02268812|451065383|FG000|Overall Study|Withdrawal by Subject|0|||
125391002|NCT02268812|451065384|FG001|Overall Study|Withdrawal by Subject|1|||
125391003|NCT02268812|451065385|FG002|Overall Study|Withdrawal by Subject|0|||
125391004|NCT02268812|451065386|FG003|Overall Study|Withdrawal by Subject|0|||
125391005|NCT02268812|451065383|FG000|Overall Study|Physician Decision|3|||
125391006|NCT02268812|451065384|FG001|Overall Study|Physician Decision|1|||
125391007|NCT02268812|451065385|FG002|Overall Study|Physician Decision|0|||
125391008|NCT02268812|451065386|FG003|Overall Study|Physician Decision|1|||
125391009|NCT02268812|451065383|FG000|Overall Study|Other|5|||
125391010|NCT02268812|451065384|FG001|Overall Study|Other|4|||
125391011|NCT02268812|451065385|FG002|Overall Study|Other|1|||
125391012|NCT02268812|451065386|FG003|Overall Study|Other|3|||
125391013|NCT00075582|451065387|FG000|Overall Study|Adverse Event|3|||
125391014|NCT00075582|451065388|FG001|Overall Study|Adverse Event|1|||
125391015|NCT00075582|451065387|FG000|Overall Study|Lack of Efficacy|4|||
125391016|NCT00075582|451065388|FG001|Overall Study|Lack of Efficacy|8|||
125391017|NCT00075582|451065387|FG000|Overall Study|Physician Decision|5|||
125391018|NCT00075582|451065388|FG001|Overall Study|Physician Decision|8|||
125391019|NCT00075582|451065387|FG000|Overall Study|Withdrawal by Subject|2|||
125391020|NCT00075582|451065388|FG001|Overall Study|Withdrawal by Subject|2|||
125391021|NCT00075582|451065387|FG000|Overall Study|Ineligible for study|36|||
125391022|NCT00075582|451065388|FG001|Overall Study|Ineligible for study|16|||
125391023|NCT05045144|451065389|FG000|Overall Study|Lost to Follow-up|3|||
125391024|NCT05045144|451065390|FG001|Overall Study|Lost to Follow-up|2|||
125391025|NCT05045144|451065391|FG002|Overall Study|Lost to Follow-up|3|||
125391026|NCT05045144|451065392|FG003|Overall Study|Lost to Follow-up|5|||
125391027|NCT05045144|451065393|FG004|Overall Study|Lost to Follow-up|13|||
125391028|NCT05045144|451065389|FG000|Overall Study|Withdrawal by Subject|0|||
125162437|NCT06354998|450217844|FG001|Overall Study|Withdrawal by Subject|0|||
125162438|NCT02440568|450217845|FG000|Overall Study|Death|1|||
125162439|NCT02440568|450217846|FG001|Overall Study|Death|3|||
125162440|NCT02440568|450217847|FG002|Overall Study|Death|4|||
125162441|NCT02440568|450217848|FG003|Overall Study|Death|2|||
125162442|NCT02440568|450217845|FG000|Overall Study|Lack of Efficacy|2|||
125162443|NCT02440568|450217846|FG001|Overall Study|Lack of Efficacy|0|||
125162444|NCT02440568|450217847|FG002|Overall Study|Lack of Efficacy|1|||
125162445|NCT02440568|450217848|FG003|Overall Study|Lack of Efficacy|0|||
125391029|NCT05045144|451065390|FG001|Overall Study|Withdrawal by Subject|1|||
125391030|NCT05045144|451065391|FG002|Overall Study|Withdrawal by Subject|0|||
125391031|NCT05045144|451065392|FG003|Overall Study|Withdrawal by Subject|0|||
125391032|NCT05045144|451065393|FG004|Overall Study|Withdrawal by Subject|0|||
125391033|NCT05045144|451065389|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125162446|NCT02440568|450217845|FG000|Overall Study|Lost to Follow-up|1|||
125162447|NCT02440568|450217846|FG001|Overall Study|Lost to Follow-up|0|||
125162448|NCT02440568|450217847|FG002|Overall Study|Lost to Follow-up|0|||
125162449|NCT02440568|450217848|FG003|Overall Study|Lost to Follow-up|0|||
125162450|NCT01103466|450217856|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
125162451|NCT01103466|450217857|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
125440531|NCT02855164|451239837|FG003|Part C (Randomized Set)|Adverse Event|0|||
125440532|NCT02855164|451239838|FG004|Part C (Randomized Set)|Adverse Event|0|||
125440533|NCT02855164|451239839|FG005|Part C (Randomized Set)|Adverse Event|5|||
125440534|NCT02855164|451239840|FG006|Part C (Randomized Set)|Adverse Event|9|||
125440535|NCT02855164|451239841|FG007|Part C (Randomized Set)|Adverse Event|2|||
125440536|NCT02855164|451239834|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
125440537|NCT02855164|451239835|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
125440538|NCT02855164|451239836|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
125162452|NCT01103466|450217858|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
125162453|NCT01103466|450217856|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
125162454|NCT01103466|450217857|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
125162455|NCT01103466|450217858|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
125162456|NCT01103466|450217856|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
125162457|NCT01103466|450217857|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
125162458|NCT01103466|450217858|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
125162459|NCT01103466|450217856|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
125162460|NCT01103466|450217857|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
125162461|NCT01103466|450217858|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
125162462|NCT01103466|450217856|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
125162463|NCT01103466|450217857|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
125162464|NCT01103466|450217858|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
125162465|NCT01103466|450217856|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
125162466|NCT01103466|450217857|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
125224857|NCT02155699|450450216|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
125224858|NCT02155699|450450217|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
125224859|NCT02227784|450450218|FG000|Double-Blind Phase|Adverse Event|3|||
125224860|NCT02227784|450450219|FG001|Double-Blind Phase|Adverse Event|2|||
125224861|NCT02227784|450450220|FG002|Double-Blind Phase|Adverse Event|1|||
125224862|NCT02227784|450450221|FG003|Double-Blind Phase|Adverse Event|3|||
125224863|NCT02227784|450450222|FG004|Double-Blind Phase|Adverse Event|0|||
125224864|NCT02227784|450450218|FG000|Double-Blind Phase|Physician Decision|1|||
125224865|NCT02227784|450450219|FG001|Double-Blind Phase|Physician Decision|0|||
125224866|NCT02227784|450450220|FG002|Double-Blind Phase|Physician Decision|0|||
125224867|NCT02227784|450450221|FG003|Double-Blind Phase|Physician Decision|1|||
125224868|NCT02227784|450450222|FG004|Double-Blind Phase|Physician Decision|0|||
125224869|NCT02227784|450450218|FG000|Double-Blind Phase|Protocol Violation|0|||
125224870|NCT02227784|450450219|FG001|Double-Blind Phase|Protocol Violation|0|||
125224871|NCT02227784|450450220|FG002|Double-Blind Phase|Protocol Violation|1|||
125224872|NCT02227784|450450221|FG003|Double-Blind Phase|Protocol Violation|1|||
125224873|NCT02227784|450450222|FG004|Double-Blind Phase|Protocol Violation|0|||
125224874|NCT02227784|450450218|FG000|Double-Blind Phase|Sponsor Decision|34|||
125224875|NCT02227784|450450219|FG001|Double-Blind Phase|Sponsor Decision|15|||
125224876|NCT02227784|450450220|FG002|Double-Blind Phase|Sponsor Decision|14|||
125224877|NCT02227784|450450221|FG003|Double-Blind Phase|Sponsor Decision|32|||
125224878|NCT02227784|450450222|FG004|Double-Blind Phase|Sponsor Decision|0|||
125224879|NCT02227784|450450218|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
125224880|NCT02227784|450450219|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
125224881|NCT02227784|450450220|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
125224882|NCT02227784|450450221|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
125224883|NCT02227784|450450222|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
125224884|NCT02227784|450450218|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
125224885|NCT02227784|450450219|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
125224886|NCT02227784|450450220|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
125224887|NCT02227784|450450221|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
125224888|NCT02227784|450450222|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
125224889|NCT02227784|450450218|FG000|Open-Label Extension Phase (OLE)|Death|0|||
125224890|NCT02227784|450450219|FG001|Open-Label Extension Phase (OLE)|Death|0|||
125224891|NCT02227784|450450220|FG002|Open-Label Extension Phase (OLE)|Death|0|||
125224892|NCT02227784|450450221|FG003|Open-Label Extension Phase (OLE)|Death|0|||
125224893|NCT02227784|450450222|FG004|Open-Label Extension Phase (OLE)|Death|1|||
125224894|NCT02227784|450450218|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
125224895|NCT02227784|450450219|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
125224896|NCT02227784|450450220|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
125224897|NCT02227784|450450221|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
125224898|NCT02227784|450450222|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
125224899|NCT02227784|450450218|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
125440539|NCT02855164|451239837|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
125162467|NCT01103466|450217858|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
125162468|NCT02331368|450217861|FG000|Overall Study|Withdrawal by Subject|3|||
125162469|NCT02302859|450217869|FG000|Overall Study|Lost Phone|1|||
125162470|NCT02302859|450217870|FG001|Overall Study|Lost Phone|1|||
125162471|NCT02302859|450217869|FG000|Overall Study|Withdrawal by Subject|0|||
125162472|NCT02302859|450217870|FG001|Overall Study|Withdrawal by Subject|1|||
125162473|NCT03285308|450217873|FG000|Overall Study|Adverse Event|3|||
125162474|NCT03285308|450217874|FG001|Overall Study|Adverse Event|7|||
125162475|NCT03285308|450217873|FG000|Overall Study|Withdrawal by Subject|8|||
125162476|NCT03285308|450217874|FG001|Overall Study|Withdrawal by Subject|9|||
125162477|NCT03285308|450217873|FG000|Overall Study|Lost to Follow-up|3|||
125162478|NCT03285308|450217874|FG001|Overall Study|Lost to Follow-up|1|||
125162479|NCT03285308|450217873|FG000|Overall Study|Protocol Deviation|6|||
125162480|NCT03285308|450217874|FG001|Overall Study|Protocol Deviation|5|||
125162481|NCT03285308|450217873|FG000|Overall Study|Reason not Specified|0|||
125162482|NCT03285308|450217874|FG001|Overall Study|Reason not Specified|1|||
125162483|NCT02283983|450217875|FG000|Overall Study|Inclusion criteria not met|0|||
125162484|NCT02283983|450217876|FG001|Overall Study|Inclusion criteria not met|1|||
125162485|NCT02283983|450217875|FG000|Overall Study|Withdrawal by Subject|4|||
125162486|NCT02283983|450217876|FG001|Overall Study|Withdrawal by Subject|2|||
125162487|NCT02283983|450217875|FG000|Overall Study|Protocol Violation|0|||
125162488|NCT02283983|450217876|FG001|Overall Study|Protocol Violation|4|||
125162489|NCT02283983|450217875|FG000|Overall Study|Physician Decision|2|||
125162490|NCT02283983|450217876|FG001|Overall Study|Physician Decision|4|||
125162491|NCT02283983|450217875|FG000|Overall Study|Death|1|||
125162492|NCT02283983|450217876|FG001|Overall Study|Death|0|||
125162493|NCT02283983|450217875|FG000|Overall Study|Adverse Event|1|||
125162494|NCT02283983|450217876|FG001|Overall Study|Adverse Event|0|||
125162495|NCT02283983|450217875|FG000|Overall Study|Lost to Follow-up|9|||
125162496|NCT02283983|450217876|FG001|Overall Study|Lost to Follow-up|8|||
125162497|NCT02283983|450217875|FG000|Overall Study|Relapse|1|||
125162498|NCT02283983|450217876|FG001|Overall Study|Relapse|0|||
125162499|NCT00424775|450217883|FG000|Overall Study|Adverse Event|2|||
125162500|NCT00424775|450217884|FG001|Overall Study|Adverse Event|0|||
125162501|NCT00424775|450217883|FG000|Overall Study|Lack of Efficacy|1|||
125162502|NCT00424775|450217884|FG001|Overall Study|Lack of Efficacy|0|||
125162503|NCT00681590|450217885|FG000|Overall Study|Withdrawal by Subject|2|||
125162504|NCT00681590|450217886|FG001|Overall Study|Withdrawal by Subject|12|||
125162505|NCT01898650|450217887|FG000|Overall Study|the subject would not lie still for imaging|1|||
125162506|NCT01791153|450217888|FG000|Part 1: Blinded Period|Adverse Event|7|||
125162507|NCT01791153|450217889|FG001|Part 1: Blinded Period|Adverse Event|3|||
125162508|NCT01791153|450217890|FG002|Part 1: Blinded Period|Adverse Event|2|||
125162509|NCT01791153|450217891|FG003|Part 1: Blinded Period|Adverse Event|0|||
125162510|NCT01791153|450217892|FG004|Part 1: Blinded Period|Adverse Event|0|||
125224900|NCT02227784|450450219|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
125391034|NCT05045144|451065390|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125391035|NCT05045144|451065391|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125391036|NCT05045144|451065392|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125391037|NCT05045144|451065393|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125391038|NCT00851799|451065394|FG000|Overall Study|Death|1|||
125391039|NCT00851799|451065395|FG001|Overall Study|Death|0|||
125391040|NCT00851799|451065396|FG002|Overall Study|Death|1|||
125391041|NCT00851799|451065394|FG000|Overall Study|Lost to Follow-up|5|||
125391042|NCT00851799|451065395|FG001|Overall Study|Lost to Follow-up|3|||
125391043|NCT00851799|451065396|FG002|Overall Study|Lost to Follow-up|10|||
125391044|NCT00851799|451065394|FG000|Overall Study|Not able to get to clinic|8|||
125391045|NCT00851799|451065395|FG001|Overall Study|Not able to get to clinic|5|||
125391046|NCT00851799|451065396|FG002|Overall Study|Not able to get to clinic|9|||
125391047|NCT00851799|451065394|FG000|Overall Study|Not willing to adhere to requirements|1|||
125391048|NCT00851799|451065395|FG001|Overall Study|Not willing to adhere to requirements|2|||
125391049|NCT00851799|451065396|FG002|Overall Study|Not willing to adhere to requirements|2|||
125391050|NCT00851799|451065394|FG000|Overall Study|Withdrew consent prior study completion|1|||
125391051|NCT00851799|451065395|FG001|Overall Study|Withdrew consent prior study completion|2|||
125391052|NCT00851799|451065396|FG002|Overall Study|Withdrew consent prior study completion|1|||
125391053|NCT00851799|451065394|FG000|Overall Study|Severe Debilitation|0|||
125391054|NCT00851799|451065395|FG001|Overall Study|Severe Debilitation|1|||
125391055|NCT00851799|451065396|FG002|Overall Study|Severe Debilitation|0|||
125391056|NCT00851799|451065394|FG000|Overall Study|Completed protocol due to pregnancy|0|||
125391057|NCT00851799|451065395|FG001|Overall Study|Completed protocol due to pregnancy|0|||
125391058|NCT00851799|451065396|FG002|Overall Study|Completed protocol due to pregnancy|1|||
125391059|NCT04056195|451065400|FG000|Overall Study|Adverse Event|1|||
125391060|NCT04056195|451065401|FG001|Overall Study|Adverse Event|0|||
125391061|NCT04056195|451065402|FG002|Overall Study|Adverse Event|0|||
125391062|NCT04056195|451065400|FG000|Overall Study|Withdrawal by Subject|0|||
125391063|NCT04056195|451065401|FG001|Overall Study|Withdrawal by Subject|1|||
125391064|NCT04056195|451065402|FG002|Overall Study|Withdrawal by Subject|1|||
125162511|NCT01791153|450217893|FG005|Part 1: Blinded Period|Adverse Event|0|||
125162512|NCT01791153|450217894|FG006|Part 1: Blinded Period|Adverse Event|0|||
125162513|NCT01791153|450217895|FG007|Part 1: Blinded Period|Adverse Event|0|||
125162514|NCT01791153|450217888|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
125162515|NCT01791153|450217889|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
125162516|NCT01791153|450217890|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
125162517|NCT01791153|450217891|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
125162518|NCT01791153|450217892|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
125162519|NCT01791153|450217893|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
125162520|NCT01791153|450217894|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
125162521|NCT01791153|450217895|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
125162522|NCT01791153|450217888|FG000|Part 1: Blinded Period|Non-Compliance|1|||
125162523|NCT01791153|450217889|FG001|Part 1: Blinded Period|Non-Compliance|0|||
125162524|NCT01791153|450217890|FG002|Part 1: Blinded Period|Non-Compliance|0|||
125162525|NCT01791153|450217891|FG003|Part 1: Blinded Period|Non-Compliance|0|||
125162526|NCT01791153|450217892|FG004|Part 1: Blinded Period|Non-Compliance|0|||
125162527|NCT01791153|450217893|FG005|Part 1: Blinded Period|Non-Compliance|0|||
125162528|NCT01791153|450217894|FG006|Part 1: Blinded Period|Non-Compliance|0|||
125162529|NCT01791153|450217895|FG007|Part 1: Blinded Period|Non-Compliance|0|||
125162530|NCT01791153|450217888|FG000|Part 1: Blinded Period|Physician Decision|0|||
125162531|NCT01791153|450217889|FG001|Part 1: Blinded Period|Physician Decision|0|||
125162532|NCT01791153|450217890|FG002|Part 1: Blinded Period|Physician Decision|0|||
125162533|NCT01791153|450217891|FG003|Part 1: Blinded Period|Physician Decision|1|||
125162534|NCT01791153|450217892|FG004|Part 1: Blinded Period|Physician Decision|0|||
125162535|NCT01791153|450217893|FG005|Part 1: Blinded Period|Physician Decision|0|||
125162536|NCT01791153|450217894|FG006|Part 1: Blinded Period|Physician Decision|0|||
125162537|NCT01791153|450217895|FG007|Part 1: Blinded Period|Physician Decision|0|||
125162538|NCT01791153|450217888|FG000|Part 1: Blinded Period|Protocol Violation|0|||
125162539|NCT01791153|450217889|FG001|Part 1: Blinded Period|Protocol Violation|0|||
125162540|NCT01791153|450217890|FG002|Part 1: Blinded Period|Protocol Violation|0|||
125162541|NCT01791153|450217891|FG003|Part 1: Blinded Period|Protocol Violation|1|||
125162542|NCT01791153|450217892|FG004|Part 1: Blinded Period|Protocol Violation|0|||
125162543|NCT01791153|450217893|FG005|Part 1: Blinded Period|Protocol Violation|0|||
125162544|NCT01791153|450217894|FG006|Part 1: Blinded Period|Protocol Violation|0|||
125162545|NCT01791153|450217895|FG007|Part 1: Blinded Period|Protocol Violation|0|||
125162546|NCT01791153|450217888|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
125162547|NCT01791153|450217889|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
125162548|NCT01791153|450217890|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
125162549|NCT01791153|450217891|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
125162550|NCT01791153|450217892|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
125162551|NCT01791153|450217893|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
125162552|NCT01791153|450217894|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
125162553|NCT01791153|450217895|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
125162554|NCT01791153|450217888|FG000|Part 2: Open-label Period|Adverse Event|0|||
125162555|NCT01791153|450217889|FG001|Part 2: Open-label Period|Adverse Event|0|||
125162556|NCT01791153|450217890|FG002|Part 2: Open-label Period|Adverse Event|0|||
125162557|NCT01791153|450217891|FG003|Part 2: Open-label Period|Adverse Event|0|||
125162558|NCT01791153|450217892|FG004|Part 2: Open-label Period|Adverse Event|0|||
125162559|NCT01791153|450217893|FG005|Part 2: Open-label Period|Adverse Event|1|||
125162560|NCT01791153|450217894|FG006|Part 2: Open-label Period|Adverse Event|1|||
125162561|NCT01791153|450217895|FG007|Part 2: Open-label Period|Adverse Event|2|||
125162562|NCT01791153|450217888|FG000|Part 2: Open-label Period|Death|0|||
125162563|NCT01791153|450217889|FG001|Part 2: Open-label Period|Death|0|||
125162564|NCT01791153|450217890|FG002|Part 2: Open-label Period|Death|0|||
125162565|NCT01791153|450217891|FG003|Part 2: Open-label Period|Death|0|||
125162566|NCT01791153|450217892|FG004|Part 2: Open-label Period|Death|0|||
125162567|NCT01791153|450217893|FG005|Part 2: Open-label Period|Death|1|||
125162568|NCT01791153|450217894|FG006|Part 2: Open-label Period|Death|1|||
125162569|NCT01791153|450217895|FG007|Part 2: Open-label Period|Death|1|||
125162570|NCT01791153|450217888|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
125162571|NCT01791153|450217889|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
125162572|NCT01791153|450217890|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
125162573|NCT01791153|450217891|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
125162574|NCT01791153|450217892|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
125162575|NCT01791153|450217893|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
125162576|NCT01791153|450217894|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
125162577|NCT01791153|450217895|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
125162578|NCT01791153|450217888|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
125162579|NCT01791153|450217889|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
125162580|NCT01791153|450217890|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
125162581|NCT01791153|450217891|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
125162582|NCT01791153|450217892|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
125162583|NCT01791153|450217893|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
125162584|NCT01791153|450217894|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
125162585|NCT01791153|450217895|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
125162586|NCT01791153|450217888|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
125391065|NCT04056195|451065400|FG000|Overall Study|Physician Decision|1|||
125391066|NCT04056195|451065401|FG001|Overall Study|Physician Decision|1|||
125391067|NCT04056195|451065402|FG002|Overall Study|Physician Decision|1|||
125391068|NCT01342510|451065418|FG000|Overall Study|Protocol Violation|12|||
125391069|NCT01342510|451065419|FG001|Overall Study|Protocol Violation|6|||
125391070|NCT01342510|451065420|FG002|Overall Study|Protocol Violation|13|||
125391071|NCT01342510|451065421|FG003|Overall Study|Protocol Violation|11|||
125391072|NCT01400516|451065423|FG000|Primary Trial|Withdrawal by Subject|0|||
125391073|NCT01400516|451065424|FG001|Primary Trial|Withdrawal by Subject|2|||
125391074|NCT01796197|451065432|FG000|Overall Study|Lost to Follow-up|1|||
125391075|NCT01796197|451065432|FG000|Overall Study|Lack of Efficacy|1|||
125391076|NCT01380184|451065433|FG000|Part 1 (19 Days)|Adverse Event|1|||
125391077|NCT01380184|451065433|FG000|Part 2|Adverse Event|5|||
125391078|NCT01380184|451065433|FG000|Part 2|Disease Progression|8|||
125391079|NCT01380184|451065433|FG000|Part 2|Lost to Follow-up|1|||
125391080|NCT04243538|451065434|FG000|Overall Study|Withdrawal by Subject|0|||
125391081|NCT04243538|451065435|FG001|Overall Study|Withdrawal by Subject|2|||
125391082|NCT04243538|451065434|FG000|Overall Study|Lost to Follow-up|0|||
125391083|NCT04243538|451065435|FG001|Overall Study|Lost to Follow-up|3|||
125391084|NCT03532295|451065436|FG000|Overall Study|Did not start treatment|0|||
125391085|NCT03532295|451065437|FG001|Overall Study|Did not start treatment|2|||
125391086|NCT02776917|451065438|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
125391087|NCT00699972|451067000|FG000|Overall Study|Adverse Event|7|||
125391088|NCT00699972|451067001|FG001|Overall Study|Adverse Event|9|||
125391089|NCT00699972|451067002|FG002|Overall Study|Adverse Event|24|||
125391090|NCT00699972|451067000|FG000|Overall Study|Lost to Follow-up|0|||
125391091|NCT00699972|451067001|FG001|Overall Study|Lost to Follow-up|2|||
125391092|NCT00699972|451067002|FG002|Overall Study|Lost to Follow-up|0|||
125391093|NCT00699972|451067000|FG000|Overall Study|Withdrawal by Subject|3|||
125391094|NCT00699972|451067001|FG001|Overall Study|Withdrawal by Subject|7|||
125391095|NCT00699972|451067002|FG002|Overall Study|Withdrawal by Subject|4|||
125391096|NCT00699972|451067000|FG000|Overall Study|Lack of Efficacy|2|||
125391097|NCT00699972|451067001|FG001|Overall Study|Lack of Efficacy|0|||
125391098|NCT00699972|451067002|FG002|Overall Study|Lack of Efficacy|2|||
125391099|NCT00699972|451067000|FG000|Overall Study|Administrative/Other|3|||
125391100|NCT00699972|451067001|FG001|Overall Study|Administrative/Other|1|||
125391101|NCT00699972|451067002|FG002|Overall Study|Administrative/Other|4|||
125391102|NCT00699972|451067000|FG000|Overall Study|Randomized, Not Treated|1|||
125391103|NCT00699972|451067001|FG001|Overall Study|Randomized, Not Treated|0|||
125391104|NCT00699972|451067002|FG002|Overall Study|Randomized, Not Treated|1|||
125391105|NCT02558790|451067009|FG000|Overall Study|Lost to Follow-up|2|||
125391106|NCT02558790|451067009|FG000|Overall Study|Physician Decision|1|||
125391107|NCT02558790|451067009|FG000|Overall Study|Withdrawal by Subject|1|||
125391108|NCT02558790|451067009|FG000|Overall Study|Screen Fail|3|||
125391109|NCT04214288|451067010|FG000|Overall Study|Ongoing in the study|41|||
125391110|NCT04214288|451067011|FG001|Overall Study|Ongoing in the study|51|||
125391111|NCT04214288|451067012|FG002|Overall Study|Ongoing in the study|12|||
125391112|NCT04214288|451067013|FG003|Overall Study|Ongoing in the study|39|||
125391113|NCT04214288|451067010|FG000|Overall Study|Adverse Event|1|||
125391114|NCT04214288|451067011|FG001|Overall Study|Adverse Event|0|||
125391115|NCT04214288|451067012|FG002|Overall Study|Adverse Event|0|||
125391116|NCT04214288|451067013|FG003|Overall Study|Adverse Event|0|||
125391117|NCT04214288|451067010|FG000|Overall Study|Death|22|||
125391118|NCT04214288|451067011|FG001|Overall Study|Death|13|||
125391119|NCT04214288|451067012|FG002|Overall Study|Death|7|||
125391120|NCT04214288|451067013|FG003|Overall Study|Death|19|||
125391121|NCT04214288|451067010|FG000|Overall Study|Lost to Follow-up|1|||
125391122|NCT04214288|451067011|FG001|Overall Study|Lost to Follow-up|2|||
125391123|NCT04214288|451067012|FG002|Overall Study|Lost to Follow-up|1|||
125391124|NCT04214288|451067013|FG003|Overall Study|Lost to Follow-up|0|||
125391125|NCT04214288|451067010|FG000|Overall Study|Other|1|||
125391126|NCT04214288|451067011|FG001|Overall Study|Other|2|||
125391127|NCT04214288|451067012|FG002|Overall Study|Other|0|||
125391128|NCT04214288|451067013|FG003|Overall Study|Other|6|||
125391129|NCT04214288|451067010|FG000|Overall Study|Protocol Violation|0|||
125391130|NCT04214288|451067011|FG001|Overall Study|Protocol Violation|1|||
125391131|NCT04214288|451067012|FG002|Overall Study|Protocol Violation|0|||
125391132|NCT04214288|451067013|FG003|Overall Study|Protocol Violation|0|||
125391133|NCT04214288|451067010|FG000|Overall Study|Withdrawal by Subject|8|||
125391134|NCT04214288|451067011|FG001|Overall Study|Withdrawal by Subject|4|||
125391135|NCT04214288|451067012|FG002|Overall Study|Withdrawal by Subject|0|||
125391136|NCT04214288|451067013|FG003|Overall Study|Withdrawal by Subject|9|||
125391137|NCT01577758|451067020|FG000|Dose Escalation Phase|Adverse Event|0|||
125391138|NCT01577758|451067021|FG001|Dose Escalation Phase|Adverse Event|0|||
125391139|NCT01577758|451067022|FG002|Dose Escalation Phase|Adverse Event|0|||
125391140|NCT01577758|451067023|FG003|Dose Escalation Phase|Adverse Event|0|||
125391141|NCT01577758|451067024|FG004|Dose Escalation Phase|Adverse Event|0|||
125440540|NCT02855164|451239838|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
125440541|NCT02855164|451239839|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
125440542|NCT02855164|451239840|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
125440543|NCT02855164|451239841|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
125440544|NCT02855164|451239834|FG000|Part C (Randomized Set)|Physician Decision|0|||
125440545|NCT02855164|451239835|FG001|Part C (Randomized Set)|Physician Decision|0|||
125440546|NCT02855164|451239836|FG002|Part C (Randomized Set)|Physician Decision|0|||
125440547|NCT02855164|451239837|FG003|Part C (Randomized Set)|Physician Decision|0|||
125440548|NCT02855164|451239838|FG004|Part C (Randomized Set)|Physician Decision|0|||
125440549|NCT02855164|451239839|FG005|Part C (Randomized Set)|Physician Decision|1|||
125440550|NCT02855164|451239840|FG006|Part C (Randomized Set)|Physician Decision|0|||
125440551|NCT02855164|451239841|FG007|Part C (Randomized Set)|Physician Decision|1|||
125440552|NCT02855164|451239834|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
125440553|NCT02855164|451239835|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
125440554|NCT02855164|451239836|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
125440555|NCT02855164|451239837|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
125440556|NCT02855164|451239838|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
125440557|NCT02855164|451239839|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
125440558|NCT02855164|451239840|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
125440559|NCT02855164|451239841|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
125440560|NCT00383240|451239842|FG000|Overall Study|Adverse Event|4|||
125440561|NCT00383240|451239843|FG001|Overall Study|Adverse Event|6|||
125440562|NCT00383240|451239844|FG002|Overall Study|Adverse Event|9|||
125440563|NCT00383240|451239845|FG003|Overall Study|Adverse Event|7|||
125440564|NCT00383240|451239842|FG000|Overall Study|Treatment Failure|8|||
125440565|NCT00383240|451239843|FG001|Overall Study|Treatment Failure|13|||
125440566|NCT00383240|451239844|FG002|Overall Study|Treatment Failure|47|||
125440567|NCT00383240|451239845|FG003|Overall Study|Treatment Failure|46|||
125440568|NCT00383240|451239842|FG000|Overall Study|Lost to Follow-up|3|||
125440569|NCT00383240|451239843|FG001|Overall Study|Lost to Follow-up|0|||
125440570|NCT00383240|451239844|FG002|Overall Study|Lost to Follow-up|0|||
125440571|NCT00383240|451239845|FG003|Overall Study|Lost to Follow-up|2|||
125440572|NCT00383240|451239842|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
125440573|NCT00383240|451239843|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
125440574|NCT00383240|451239844|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
125440575|NCT00383240|451239845|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
125440576|NCT00383240|451239842|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
125440577|NCT00383240|451239843|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
125440578|NCT00383240|451239844|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
125440579|NCT00383240|451239845|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
125440580|NCT00383240|451239842|FG000|Overall Study|Protocol Violation|4|||
125440581|NCT00383240|451239843|FG001|Overall Study|Protocol Violation|5|||
125440582|NCT00383240|451239844|FG002|Overall Study|Protocol Violation|9|||
125440583|NCT00383240|451239845|FG003|Overall Study|Protocol Violation|6|||
125440584|NCT00383240|451239842|FG000|Overall Study|Did not meet protocol eligibility|9|||
125440585|NCT00383240|451239843|FG001|Overall Study|Did not meet protocol eligibility|4|||
125440586|NCT00383240|451239844|FG002|Overall Study|Did not meet protocol eligibility|9|||
125440587|NCT00383240|451239845|FG003|Overall Study|Did not meet protocol eligibility|3|||
125162587|NCT01791153|450217889|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
125162588|NCT01791153|450217890|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
125162589|NCT01791153|450217891|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
125162590|NCT01791153|450217892|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
125162591|NCT01791153|450217893|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
125162592|NCT01791153|450217894|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
125162593|NCT01791153|450217895|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
125224901|NCT02227784|450450220|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
125391142|NCT01577758|451067025|FG005|Dose Escalation Phase|Adverse Event|2|||
125391143|NCT01577758|451067026|FG006|Dose Escalation Phase|Adverse Event|1|||
125391144|NCT01577758|451067027|FG007|Dose Escalation Phase|Adverse Event|0|||
125391145|NCT01577758|451067020|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
125391146|NCT01577758|451067021|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
125391147|NCT01577758|451067022|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
125391148|NCT01577758|451067023|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
125391149|NCT01577758|451067024|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
125391150|NCT01577758|451067025|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
125391151|NCT01577758|451067026|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
125391152|NCT01577758|451067027|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
125391153|NCT01577758|451067020|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
125391154|NCT01577758|451067021|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
125391155|NCT01577758|451067022|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
125224902|NCT02227784|450450221|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
125391156|NCT01577758|451067023|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
125162594|NCT01791153|450217888|FG000|Part 2: Open-label Period|Physician Decision|0|||
125162595|NCT01791153|450217889|FG001|Part 2: Open-label Period|Physician Decision|0|||
125162596|NCT01791153|450217890|FG002|Part 2: Open-label Period|Physician Decision|0|||
125162597|NCT01791153|450217891|FG003|Part 2: Open-label Period|Physician Decision|0|||
125162598|NCT01791153|450217892|FG004|Part 2: Open-label Period|Physician Decision|1|||
125162599|NCT01791153|450217893|FG005|Part 2: Open-label Period|Physician Decision|1|||
125162600|NCT01791153|450217894|FG006|Part 2: Open-label Period|Physician Decision|0|||
125162601|NCT01791153|450217895|FG007|Part 2: Open-label Period|Physician Decision|0|||
125162602|NCT00975286|450217899|FG000|Overall Study|Adverse Event|9|||
125162603|NCT00975286|450217900|FG001|Overall Study|Adverse Event|19|||
125162604|NCT00975286|450217899|FG000|Overall Study|Protocol Violation|1|||
125162605|NCT00975286|450217900|FG001|Overall Study|Protocol Violation|2|||
125162606|NCT00975286|450217899|FG000|Overall Study|Withdrawal by Subject|0|||
125162607|NCT00975286|450217900|FG001|Overall Study|Withdrawal by Subject|2|||
125162608|NCT00975286|450217899|FG000|Overall Study|Familial and Personal Reasons|2|||
125162609|NCT00975286|450217900|FG001|Overall Study|Familial and Personal Reasons|2|||
125162610|NCT00975286|450217899|FG000|Overall Study|Poor Compliance to Protocol|0|||
125224903|NCT02227784|450450222|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
125224904|NCT03834506|450450226|FG000|Overall Study|Death|336|||
125224905|NCT03834506|450450227|FG001|Overall Study|Death|326|||
125224906|NCT03834506|450450226|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125224907|NCT03834506|450450227|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125224908|NCT03834506|450450226|FG000|Overall Study|Withdrawal by Subject|10|||
125224909|NCT03834506|450450227|FG001|Overall Study|Withdrawal by Subject|8|||
125224910|NCT03834506|450450226|FG000|Overall Study|Sponsor decision|165|||
125224911|NCT03834506|450450227|FG001|Overall Study|Sponsor decision|178|||
125224912|NCT03834506|450450226|FG000|Overall Study|Physician Decision|3|||
125162611|NCT00975286|450217900|FG001|Overall Study|Poor Compliance to Protocol|2|||
125162612|NCT00975286|450217899|FG000|Overall Study|Sponsor Decision|0|||
125162613|NCT00975286|450217900|FG001|Overall Study|Sponsor Decision|2|||
125162614|NCT02357342|450217901|FG000|First 6 Months|Death|2|||
125224913|NCT03834506|450450227|FG001|Overall Study|Physician Decision|1|||
125224914|NCT03834506|450450226|FG000|Overall Study|Lost to Follow-up|0|||
125162615|NCT02357342|450217902|FG001|First 6 Months|Death|0|||
125162616|NCT01674647|450217903|FG000|Treatment Period|Death|4|||
125162617|NCT01674647|450217904|FG001|Treatment Period|Death|1|||
125162618|NCT01674647|450217903|FG000|Treatment Period|Efficacy outcome reached|0|||
125162619|NCT01674647|450217904|FG001|Treatment Period|Efficacy outcome reached|1|||
125162620|NCT01674647|450217903|FG000|Treatment Period|Physician Decision|3|||
125162621|NCT01674647|450217904|FG001|Treatment Period|Physician Decision|1|||
125162622|NCT01674647|450217903|FG000|Treatment Period|Adverse Event|60|||
125162623|NCT01674647|450217904|FG001|Treatment Period|Adverse Event|22|||
125162624|NCT01674647|450217903|FG000|Treatment Period|Non-compliance with study drug|3|||
125162625|NCT01674647|450217904|FG001|Treatment Period|Non-compliance with study drug|0|||
125162626|NCT01674647|450217903|FG000|Treatment Period|Lost to Follow-up|1|||
125162627|NCT01674647|450217904|FG001|Treatment Period|Lost to Follow-up|1|||
125162628|NCT01674647|450217903|FG000|Treatment Period|Withdrawal by Subject|19|||
125162629|NCT01674647|450217904|FG001|Treatment Period|Withdrawal by Subject|16|||
125162630|NCT01674647|450217903|FG000|Treatment Period|Switching to other therapy|5|||
125162631|NCT01674647|450217904|FG001|Treatment Period|Switching to other therapy|2|||
125162632|NCT01674647|450217903|FG000|Treatment Period|Logistical difficulties|5|||
125162633|NCT01674647|450217904|FG001|Treatment Period|Logistical difficulties|8|||
125162634|NCT01674647|450217903|FG000|Treatment Period|Treatment failure|0|||
125162635|NCT01674647|450217904|FG001|Treatment Period|Treatment failure|14|||
125162636|NCT01674647|450217903|FG000|Treatment Period|Protocol Violation|56|||
125224915|NCT03834506|450450227|FG001|Overall Study|Lost to Follow-up|1|||
125224916|NCT04577794|450450228|FG000|Overall Study|Adverse Event|1|||
125224917|NCT04577794|450450229|FG001|Overall Study|Adverse Event|1|||
125224918|NCT01628848|450450230|FG000|Overall Study|Adverse Event|9|||
125224919|NCT01628848|450450231|FG001|Overall Study|Adverse Event|7|||
125224920|NCT01628848|450450230|FG000|Overall Study|Lack of Efficacy|0|||
125224921|NCT01628848|450450231|FG001|Overall Study|Lack of Efficacy|4|||
125162637|NCT01674647|450217904|FG001|Treatment Period|Protocol Violation|36|||
125224922|NCT01628848|450450230|FG000|Overall Study|Withdrawal by Subject|0|||
125162638|NCT01674647|450217903|FG000|30-day Safety Follow-up Period|Death|3|||
125162639|NCT01674647|450217904|FG001|30-day Safety Follow-up Period|Death|2|||
125162640|NCT01674647|450217903|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
125162641|NCT01674647|450217904|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
125162642|NCT01674647|450217903|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
125162643|NCT01674647|450217904|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
125162644|NCT01674647|450217903|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
125224923|NCT01628848|450450231|FG001|Overall Study|Withdrawal by Subject|2|||
125224924|NCT01628848|450450230|FG000|Overall Study|Physician Decision|3|||
125224925|NCT01628848|450450231|FG001|Overall Study|Physician Decision|1|||
125224926|NCT00003471|450450232|FG000|Overall Study|Not evaluable|4|||
125224927|NCT02104895|450450233|FG000|Overall Study|Withdrawal by Subject|0|||
125224928|NCT02104895|450450234|FG001|Overall Study|Withdrawal by Subject|14|||
125440588|NCT00383240|451239842|FG000|Overall Study|Administrative|1|||
125440589|NCT00383240|451239843|FG001|Overall Study|Administrative|1|||
125440590|NCT00383240|451239844|FG002|Overall Study|Administrative|0|||
125440591|NCT00383240|451239845|FG003|Overall Study|Administrative|0|||
125440592|NCT02601937|451239847|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
125440593|NCT02601937|451239848|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
125440594|NCT02601937|451239849|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
125440595|NCT02601937|451239850|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
125440596|NCT02601937|451239851|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
125440597|NCT02601937|451239852|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
125440598|NCT02601937|451239853|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
125440599|NCT02601937|451239854|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
125440600|NCT02601937|451239855|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
125440601|NCT02601937|451239856|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
125440602|NCT02601937|451239857|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
125440603|NCT02601937|451239847|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
125440604|NCT02601937|451239848|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125440605|NCT02601937|451239849|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125440606|NCT02601937|451239850|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125440607|NCT02601937|451239851|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125440608|NCT02601937|451239852|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125440609|NCT02601937|451239853|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
125440610|NCT02601937|451239854|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125440611|NCT02601937|451239855|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125440612|NCT02601937|451239856|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125440613|NCT02601937|451239857|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
125440614|NCT02601937|451239847|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125440615|NCT02601937|451239848|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125440616|NCT02601937|451239849|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
125440617|NCT02601937|451239850|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125440618|NCT02601937|451239851|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125440619|NCT02601937|451239852|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125440620|NCT02601937|451239853|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125440621|NCT02601937|451239854|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125440622|NCT02601937|451239855|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125440623|NCT02601937|451239856|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125440624|NCT02601937|451239857|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
125440625|NCT02601937|451239847|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
125440626|NCT02601937|451239848|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
125440627|NCT02601937|451239849|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
125440628|NCT02601937|451239850|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
125440629|NCT02601937|451239851|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
125440630|NCT02601937|451239852|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
125440631|NCT02601937|451239853|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
125440632|NCT02601937|451239854|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
125440633|NCT02601937|451239855|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
125440634|NCT02601937|451239856|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
125440635|NCT02601937|451239857|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
125440636|NCT02601937|451239847|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125440637|NCT02601937|451239848|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125440638|NCT02601937|451239849|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125440639|NCT02601937|451239850|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125440640|NCT02601937|451239851|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125440641|NCT02601937|451239852|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125162645|NCT01674647|450217904|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
125162646|NCT01674647|450217903|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
125162647|NCT01674647|450217904|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
125162648|NCT01674647|450217903|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
125162649|NCT01674647|450217904|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
125162650|NCT01490866|450217905|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
125162651|NCT01490866|450217905|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
125162652|NCT01490866|450217905|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
125162653|NCT01490866|450217905|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
125162654|NCT01490866|450217905|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
125224929|NCT03311945|450450236|FG000|Overall Study|Adverse Event|2|||
125162655|NCT01490866|450217905|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
125440642|NCT02601937|451239853|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125440643|NCT02601937|451239854|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125440644|NCT02601937|451239855|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125440645|NCT02601937|451239856|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
125440646|NCT02601937|451239857|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
125440647|NCT02601937|451239847|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125440648|NCT02601937|451239848|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125440649|NCT02601937|451239849|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125440650|NCT02601937|451239850|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125440651|NCT02601937|451239851|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125440652|NCT02601937|451239852|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125440653|NCT02601937|451239853|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125440654|NCT02601937|451239854|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
125440655|NCT02601937|451239855|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125440656|NCT02601937|451239856|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125440657|NCT02601937|451239857|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
125440658|NCT02601937|451239847|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125440659|NCT02601937|451239848|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125440660|NCT02601937|451239849|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125440661|NCT02601937|451239850|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125440662|NCT02601937|451239851|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125440663|NCT02601937|451239852|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125162656|NCT01490866|450217905|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
125162657|NCT01490866|450217905|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
125162658|NCT01490866|450217905|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
125162659|NCT01490866|450217905|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
125162660|NCT01490866|450217905|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
125162661|NCT01181271|450217906|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
125162662|NCT01181271|450217906|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
125162663|NCT01181271|450217906|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
125162664|NCT01181271|450217906|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
125162665|NCT04156620|450217907|FG000|Overall Study|Adverse event - TP 1|5|||
125162666|NCT04156620|450217908|FG001|Overall Study|Adverse event - TP 1|2|||
125162667|NCT04156620|450217907|FG000|Overall Study|Lost to follow-up TP 1|1|||
125162668|NCT04156620|450217908|FG001|Overall Study|Lost to follow-up TP 1|1|||
125162669|NCT04156620|450217907|FG000|Overall Study|Progressive disease - TP 1|0|||
125162670|NCT04156620|450217908|FG001|Overall Study|Progressive disease - TP 1|1|||
125162671|NCT04156620|450217907|FG000|Overall Study|Subject decision - TP 1|3|||
125162672|NCT04156620|450217908|FG001|Overall Study|Subject decision - TP 1|5|||
125162673|NCT04156620|450217907|FG000|Overall Study|Adverse event - TP 2|5|||
125162674|NCT04156620|450217908|FG001|Overall Study|Adverse event - TP 2|6|||
125162675|NCT04156620|450217907|FG000|Overall Study|Death - TP 2|1|||
125162676|NCT04156620|450217908|FG001|Overall Study|Death - TP 2|0|||
125162677|NCT04156620|450217907|FG000|Overall Study|Lost to follow-up - TP 2|5|||
125162678|NCT04156620|450217908|FG001|Overall Study|Lost to follow-up - TP 2|2|||
125162679|NCT04156620|450217907|FG000|Overall Study|Physician decision - TP 2|4|||
125162680|NCT04156620|450217908|FG001|Overall Study|Physician decision - TP 2|2|||
125162681|NCT04156620|450217907|FG000|Overall Study|Pregnancy - TP 2|1|||
125162682|NCT04156620|450217908|FG001|Overall Study|Pregnancy - TP 2|1|||
125162683|NCT04156620|450217907|FG000|Overall Study|Subject decision - TP 2|11|||
125162684|NCT04156620|450217908|FG001|Overall Study|Subject decision - TP 2|9|||
125162685|NCT04156620|450217907|FG000|Overall Study|New therapy for study indication - TP 2|1|||
125162686|NCT04156620|450217908|FG001|Overall Study|New therapy for study indication - TP 2|0|||
125162687|NCT02980874|450217909|FG000|Overall Study|Adverse Event|2|||
125162688|NCT02980874|450217910|FG001|Overall Study|Adverse Event|7|||
125162689|NCT02980874|450217909|FG000|Overall Study|Withdrawal by Subject|7|||
125162690|NCT02980874|450217910|FG001|Overall Study|Withdrawal by Subject|2|||
125162691|NCT02980874|450217909|FG000|Overall Study|Lost to Follow-up|5|||
125162692|NCT02980874|450217910|FG001|Overall Study|Lost to Follow-up|5|||
125162693|NCT02980874|450217909|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
125162694|NCT02980874|450217910|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
125162695|NCT02980874|450217909|FG000|Overall Study|Unknown study completion status|1|||
125162696|NCT02980874|450217910|FG001|Overall Study|Unknown study completion status|0|||
125162697|NCT02722148|450217911|FG000|Overall Study|Lost to Follow-up|2|||
125162698|NCT02722148|450217911|FG000|Overall Study|Non compliant with treatment regimen|3|||
125162699|NCT01753336|450217912|FG000|Overall Study|Patient decision|12|||
125162700|NCT01753336|450217912|FG000|Overall Study|Lost to Follow-up|3|||
125162701|NCT01753336|450217912|FG000|Overall Study|Physician Decision|2|||
125162702|NCT01753336|450217912|FG000|Overall Study|Sponsor's decision|2|||
125162703|NCT01753336|450217912|FG000|Overall Study|Withdrawal by Subject|1|||
125162704|NCT00446199|450217916|FG000|Overall Study|Adverse Event|7|||
125162705|NCT00446199|450217917|FG001|Overall Study|Adverse Event|4|||
125162706|NCT00446199|450217918|FG002|Overall Study|Adverse Event|6|||
125162707|NCT00446199|450217919|FG003|Overall Study|Adverse Event|4|||
125162708|NCT00446199|450217916|FG000|Overall Study|Lost to Follow-up|4|||
125162709|NCT00446199|450217917|FG001|Overall Study|Lost to Follow-up|5|||
125162710|NCT00446199|450217918|FG002|Overall Study|Lost to Follow-up|2|||
125162711|NCT00446199|450217919|FG003|Overall Study|Lost to Follow-up|6|||
125162712|NCT00446199|450217916|FG000|Overall Study|Protocol Violation|1|||
125162713|NCT00446199|450217917|FG001|Overall Study|Protocol Violation|2|||
125162714|NCT00446199|450217918|FG002|Overall Study|Protocol Violation|1|||
125162715|NCT00446199|450217919|FG003|Overall Study|Protocol Violation|3|||
125162716|NCT00446199|450217916|FG000|Overall Study|Withdrawal by Subject|2|||
125162717|NCT00446199|450217917|FG001|Overall Study|Withdrawal by Subject|5|||
125162718|NCT00446199|450217918|FG002|Overall Study|Withdrawal by Subject|9|||
125162719|NCT00446199|450217919|FG003|Overall Study|Withdrawal by Subject|10|||
125162720|NCT00446199|450217916|FG000|Overall Study|Site termination|2|||
125162721|NCT00446199|450217917|FG001|Overall Study|Site termination|0|||
125162722|NCT00446199|450217918|FG002|Overall Study|Site termination|0|||
125162723|NCT00446199|450217919|FG003|Overall Study|Site termination|1|||
125162724|NCT00446199|450217916|FG000|Overall Study|Randomization in Error|2|||
125162725|NCT00446199|450217917|FG001|Overall Study|Randomization in Error|0|||
125162726|NCT00446199|450217918|FG002|Overall Study|Randomization in Error|1|||
125162727|NCT00446199|450217919|FG003|Overall Study|Randomization in Error|1|||
125162728|NCT00446199|450217916|FG000|Overall Study|Lack of Efficacy|1|||
125162729|NCT00446199|450217917|FG001|Overall Study|Lack of Efficacy|0|||
125162730|NCT00446199|450217918|FG002|Overall Study|Lack of Efficacy|0|||
125162731|NCT00446199|450217919|FG003|Overall Study|Lack of Efficacy|1|||
125162732|NCT00446199|450217916|FG000|Overall Study|Non-compliant with study drug|1|||
125162733|NCT00446199|450217917|FG001|Overall Study|Non-compliant with study drug|0|||
125162734|NCT00446199|450217918|FG002|Overall Study|Non-compliant with study drug|5|||
125162735|NCT00446199|450217919|FG003|Overall Study|Non-compliant with study drug|0|||
125162736|NCT00446199|450217916|FG000|Overall Study|Non-compliant with visit schedule|1|||
125162737|NCT00446199|450217917|FG001|Overall Study|Non-compliant with visit schedule|1|||
125162738|NCT00446199|450217918|FG002|Overall Study|Non-compliant with visit schedule|1|||
125162739|NCT00446199|450217919|FG003|Overall Study|Non-compliant with visit schedule|2|||
125162740|NCT00446199|450217916|FG000|Overall Study|Hormone fear|0|||
125162741|NCT00446199|450217917|FG001|Overall Study|Hormone fear|0|||
125162742|NCT00446199|450217918|FG002|Overall Study|Hormone fear|0|||
125162743|NCT00446199|450217919|FG003|Overall Study|Hormone fear|1|||
125162744|NCT00446199|450217916|FG000|Overall Study|Lost interest in study participation|0|||
125162745|NCT00446199|450217917|FG001|Overall Study|Lost interest in study participation|1|||
125162746|NCT00446199|450217918|FG002|Overall Study|Lost interest in study participation|0|||
125162747|NCT00446199|450217919|FG003|Overall Study|Lost interest in study participation|0|||
125162748|NCT00446199|450217916|FG000|Overall Study|In-/Exclusion criterion violated|2|||
125162749|NCT00446199|450217917|FG001|Overall Study|In-/Exclusion criterion violated|1|||
125162750|NCT00446199|450217918|FG002|Overall Study|In-/Exclusion criterion violated|2|||
125162751|NCT00446199|450217919|FG003|Overall Study|In-/Exclusion criterion violated|1|||
125162752|NCT00446199|450217916|FG000|Overall Study|Move|0|||
125162753|NCT00446199|450217917|FG001|Overall Study|Move|1|||
125162754|NCT00446199|450217918|FG002|Overall Study|Move|0|||
125162755|NCT00446199|450217919|FG003|Overall Study|Move|0|||
125162756|NCT04188301|450217925|FG000|Month 3|Lost to Follow-up|0|||
125162757|NCT04188301|450217926|FG001|Month 3|Lost to Follow-up|0|||
125162758|NCT04188301|450217927|FG002|Month 3|Lost to Follow-up|1|||
125162759|NCT04188301|450217925|FG000|Month 12|Lost to Follow-up|0|||
125162760|NCT04188301|450217926|FG001|Month 12|Lost to Follow-up|0|||
125162761|NCT04188301|450217927|FG002|Month 12|Lost to Follow-up|2|||
125162762|NCT04188301|450217925|FG000|Month 12|Death|1|||
125162763|NCT04188301|450217926|FG001|Month 12|Death|1|||
125162764|NCT04188301|450217927|FG002|Month 12|Death|0|||
125162765|NCT04188301|450217925|FG000|Month 18|Lost to Follow-up|6|||
125162766|NCT04188301|450217926|FG001|Month 18|Lost to Follow-up|0|||
125162767|NCT04188301|450217927|FG002|Month 18|Lost to Follow-up|0|||
125162768|NCT01104779|450217928|FG000|Overall Study|Protocol Violation|1|||
125162769|NCT01104779|450217929|FG001|Overall Study|Protocol Violation|2|||
125162770|NCT01104779|450217930|FG002|Overall Study|Protocol Violation|2|||
125162771|NCT01104779|450217928|FG000|Overall Study|Lack of Efficacy|26|||
125162772|NCT01104779|450217929|FG001|Overall Study|Lack of Efficacy|12|||
125162773|NCT01104779|450217930|FG002|Overall Study|Lack of Efficacy|13|||
125162774|NCT01104779|450217928|FG000|Overall Study|Adverse Event|13|||
125162775|NCT01104779|450217929|FG001|Overall Study|Adverse Event|14|||
125162776|NCT01104779|450217930|FG002|Overall Study|Adverse Event|13|||
125162777|NCT01104779|450217928|FG000|Overall Study|Did not meet inc/exc criteria|1|||
125440664|NCT02601937|451239853|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125440665|NCT02601937|451239854|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125440666|NCT02601937|451239855|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
125440667|NCT02601937|451239856|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
125440668|NCT02601937|451239857|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
125440669|NCT02601937|451239847|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125440670|NCT02601937|451239848|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125440671|NCT02601937|451239849|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125440672|NCT02601937|451239850|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125440673|NCT02601937|451239851|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125440674|NCT02601937|451239852|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125440675|NCT02601937|451239853|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
125440676|NCT02601937|451239854|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
125440677|NCT02601937|451239855|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
125440678|NCT02601937|451239856|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
125440679|NCT02601937|451239857|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
125440680|NCT02601937|451239847|FG000|Period 2: Dose Expansion Cohort|Other|0|||
125440681|NCT02601937|451239848|FG001|Period 2: Dose Expansion Cohort|Other|0|||
125440682|NCT02601937|451239849|FG002|Period 2: Dose Expansion Cohort|Other|0|||
125440683|NCT02601937|451239850|FG003|Period 2: Dose Expansion Cohort|Other|0|||
125440684|NCT02601937|451239851|FG004|Period 2: Dose Expansion Cohort|Other|0|||
125440685|NCT02601937|451239852|FG005|Period 2: Dose Expansion Cohort|Other|0|||
125440686|NCT02601937|451239853|FG006|Period 2: Dose Expansion Cohort|Other|0|||
125440687|NCT02601937|451239854|FG007|Period 2: Dose Expansion Cohort|Other|0|||
125440688|NCT02601937|451239855|FG008|Period 2: Dose Expansion Cohort|Other|2|||
125440689|NCT02601937|451239856|FG009|Period 2: Dose Expansion Cohort|Other|2|||
125440690|NCT02601937|451239857|FG010|Period 2: Dose Expansion Cohort|Other|0|||
125440691|NCT02601937|451239847|FG000|Period 2: Dose Expansion Cohort|Death|0|||
125440692|NCT02601937|451239848|FG001|Period 2: Dose Expansion Cohort|Death|0|||
125440693|NCT02601937|451239849|FG002|Period 2: Dose Expansion Cohort|Death|0|||
125440694|NCT02601937|451239850|FG003|Period 2: Dose Expansion Cohort|Death|0|||
125440695|NCT02601937|451239851|FG004|Period 2: Dose Expansion Cohort|Death|0|||
125440696|NCT02601937|451239852|FG005|Period 2: Dose Expansion Cohort|Death|0|||
125440697|NCT02601937|451239853|FG006|Period 2: Dose Expansion Cohort|Death|0|||
125440698|NCT02601937|451239854|FG007|Period 2: Dose Expansion Cohort|Death|0|||
125440699|NCT02601937|451239855|FG008|Period 2: Dose Expansion Cohort|Death|1|||
125440700|NCT02601937|451239856|FG009|Period 2: Dose Expansion Cohort|Death|0|||
125440701|NCT02601937|451239857|FG010|Period 2: Dose Expansion Cohort|Death|0|||
125440702|NCT02924389|451239858|FG000|Overall Study|Lost to Follow-up|1|||
125440703|NCT02924389|451239859|FG001|Overall Study|Lost to Follow-up|0|||
125162778|NCT01104779|450217929|FG001|Overall Study|Did not meet inc/exc criteria|1|||
125162779|NCT01104779|450217930|FG002|Overall Study|Did not meet inc/exc criteria|1|||
125162780|NCT01104779|450217928|FG000|Overall Study|Other reasons|0|||
125162781|NCT01104779|450217929|FG001|Overall Study|Other reasons|1|||
125162782|NCT01104779|450217930|FG002|Overall Study|Other reasons|0|||
125162783|NCT01104779|450217928|FG000|Overall Study|Lost to Follow-up|2|||
125162784|NCT01104779|450217929|FG001|Overall Study|Lost to Follow-up|0|||
125162785|NCT01104779|450217930|FG002|Overall Study|Lost to Follow-up|1|||
125162786|NCT01104779|450217928|FG000|Overall Study|Withdrawal by Subject|16|||
125162787|NCT01104779|450217929|FG001|Overall Study|Withdrawal by Subject|25|||
125162788|NCT01104779|450217930|FG002|Overall Study|Withdrawal by Subject|32|||
125162789|NCT03548064|450220624|FG000|Overall Study|Withdrawal by Subject|0|||
125162790|NCT03548064|450220625|FG001|Overall Study|Withdrawal by Subject|0|||
125162791|NCT03548064|450220626|FG002|Overall Study|Withdrawal by Subject|0|||
125162792|NCT03548064|450220627|FG003|Overall Study|Withdrawal by Subject|1|||
125162793|NCT03548064|450220628|FG004|Overall Study|Withdrawal by Subject|0|||
125162794|NCT03548064|450220629|FG005|Overall Study|Withdrawal by Subject|0|||
125162795|NCT03548064|450220630|FG006|Overall Study|Withdrawal by Subject|0|||
125162796|NCT03548064|450220631|FG007|Overall Study|Withdrawal by Subject|0|||
125162797|NCT03548064|450220624|FG000|Overall Study|Lost to Follow-up|0|||
125162798|NCT03548064|450220625|FG001|Overall Study|Lost to Follow-up|0|||
125162799|NCT03548064|450220626|FG002|Overall Study|Lost to Follow-up|0|||
125162800|NCT03548064|450220627|FG003|Overall Study|Lost to Follow-up|0|||
125162801|NCT03548064|450220628|FG004|Overall Study|Lost to Follow-up|2|||
125162802|NCT03548064|450220629|FG005|Overall Study|Lost to Follow-up|0|||
125162803|NCT03548064|450220630|FG006|Overall Study|Lost to Follow-up|0|||
125162804|NCT03548064|450220631|FG007|Overall Study|Lost to Follow-up|0|||
125162805|NCT03548064|450220624|FG000|Overall Study|Covid-19 Pandemic|0|||
125162806|NCT03548064|450220625|FG001|Overall Study|Covid-19 Pandemic|0|||
125162807|NCT03548064|450220626|FG002|Overall Study|Covid-19 Pandemic|0|||
125162808|NCT03548064|450220627|FG003|Overall Study|Covid-19 Pandemic|0|||
125162809|NCT03548064|450220628|FG004|Overall Study|Covid-19 Pandemic|10|||
125162810|NCT03548064|450220629|FG005|Overall Study|Covid-19 Pandemic|3|||
125162811|NCT03548064|450220630|FG006|Overall Study|Covid-19 Pandemic|0|||
125162812|NCT03548064|450220631|FG007|Overall Study|Covid-19 Pandemic|0|||
125162813|NCT05011123|450220632|FG000|Overall Study|Withdrawal by Subject|4|||
125162814|NCT05011123|450220633|FG001|Overall Study|Withdrawal by Subject|2|||
125162815|NCT05011123|450220632|FG000|Overall Study|Lost to Follow-up|7|||
125162816|NCT05011123|450220633|FG001|Overall Study|Lost to Follow-up|6|||
125162817|NCT05011123|450220632|FG000|Overall Study|Ongoing at the time of DBL date|36|||
125162818|NCT05011123|450220633|FG001|Overall Study|Ongoing at the time of DBL date|10|||
125162819|NCT05011123|450220632|FG000|Overall Study|Randomized but did not receive vaccination|1|||
125162820|NCT05011123|450220633|FG001|Overall Study|Randomized but did not receive vaccination|0|||
125162821|NCT04221789|450220634|FG000|Overall Study|deviation from protoco|22|||
125162822|NCT04221789|450220635|FG001|Overall Study|deviation from protoco|8|||
125162823|NCT04732221|450220636|FG000|Base Period|Death|2|||
125162824|NCT04732221|450220637|FG001|Base Period|Death|0|||
125162825|NCT04732221|450220638|FG002|Base Period|Death|0|||
125162826|NCT04732221|450220639|FG003|Base Period|Death|0|||
125162827|NCT04732221|450220640|FG004|Base Period|Death|0|||
125162828|NCT04732221|450220641|FG005|Base Period|Death|0|||
125162829|NCT04732221|450220642|FG006|Base Period|Death|0|||
125162830|NCT04732221|450220636|FG000|Base Period|Withdrawal by Subject|0|||
125162831|NCT04732221|450220637|FG001|Base Period|Withdrawal by Subject|1|||
125162832|NCT04732221|450220638|FG002|Base Period|Withdrawal by Subject|1|||
125162833|NCT04732221|450220639|FG003|Base Period|Withdrawal by Subject|0|||
125224930|NCT03311945|450450236|FG000|Overall Study|Lack of Efficacy|1|||
125224931|NCT01107925|450450237|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
125224932|NCT01107925|450450238|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
125224933|NCT01107925|450450239|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
125224934|NCT01107925|450450240|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
125224935|NCT01107925|450450241|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
125224936|NCT01107925|450450242|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
125224937|NCT01107925|450450237|FG000|Period 2|Withdrawal by Subject|0|||
125224938|NCT01107925|450450238|FG001|Period 2|Withdrawal by Subject|1|||
125224939|NCT01107925|450450239|FG002|Period 2|Withdrawal by Subject|0|||
125224940|NCT01107925|450450240|FG003|Period 2|Withdrawal by Subject|0|||
125224941|NCT01107925|450450241|FG004|Period 2|Withdrawal by Subject|0|||
125224942|NCT01107925|450450242|FG005|Period 2|Withdrawal by Subject|1|||
125224943|NCT04877990|450450243|FG000|Treatment|Other reasons|3|||
125224944|NCT04877990|450450244|FG001|Treatment|Other reasons|1|||
125224945|NCT04877990|450450243|FG000|Treatment|Administrative reasons by sponsor|17|||
125224946|NCT04877990|450450244|FG001|Treatment|Administrative reasons by sponsor|33|||
125224947|NCT04877990|450450243|FG000|Treatment|Withdrawal by Subject|2|||
125224948|NCT04877990|450450244|FG001|Treatment|Withdrawal by Subject|6|||
125224949|NCT04877990|450450243|FG000|Treatment|Adverse Event|2|||
125224950|NCT04877990|450450244|FG001|Treatment|Adverse Event|1|||
125224951|NCT01619878|450450245|FG000|6 Week Follow-up Phase|Adverse Event|1|||
125224952|NCT01619878|450450245|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
125224953|NCT01619878|450450245|FG000|Follow-up at 12 Months of Age|Death|2|||
125224954|NCT03839394|450450246|FG000|Overall Study|Lost to Follow-up|6|||
125224955|NCT03839394|450450247|FG001|Overall Study|Lost to Follow-up|8|||
125224956|NCT03839394|450450246|FG000|Overall Study|Withdrawal by Subject|0|||
125224957|NCT03839394|450450247|FG001|Overall Study|Withdrawal by Subject|2|||
125224958|NCT02895295|450450250|FG000|Overall Study|Survey Non-response|71|||
125224959|NCT02895295|450450251|FG001|Overall Study|Survey Non-response|94|||
125224960|NCT02895295|450450252|FG002|Overall Study|Survey Non-response|92|||
125224961|NCT01367249|450450253|FG000|Overall Study|Withdrawal by Subject|6|||
125224962|NCT01367249|450450254|FG001|Overall Study|Withdrawal by Subject|6|||
125224963|NCT01367249|450450253|FG000|Overall Study|Other|3|||
125224964|NCT01367249|450450254|FG001|Overall Study|Other|10|||
125162834|NCT04732221|450220640|FG004|Base Period|Withdrawal by Subject|0|||
125162835|NCT04732221|450220641|FG005|Base Period|Withdrawal by Subject|0|||
125224965|NCT04821830|450450257|FG000|Overall Study|Withdrawal by Subject|1|||
125224966|NCT04821830|450450258|FG001|Overall Study|Withdrawal by Subject|0|||
125224967|NCT00960804|450450264|FG000|Overall Study|Adverse Event|1|||
125224968|NCT00960804|450450265|FG001|Overall Study|Adverse Event|0|||
125224969|NCT00960804|450450266|FG002|Overall Study|Adverse Event|0|||
125224970|NCT00960804|450450264|FG000|Overall Study|Withdrawal by Subject|1|||
125224971|NCT00960804|450450265|FG001|Overall Study|Withdrawal by Subject|0|||
125224972|NCT00960804|450450266|FG002|Overall Study|Withdrawal by Subject|0|||
125440704|NCT02924389|451239858|FG000|Overall Study|Physician Decision|2|||
125162836|NCT04732221|450220642|FG006|Base Period|Withdrawal by Subject|0|||
125162837|NCT04732221|450220636|FG000|Extension Period|Adverse Event|0|||
125162838|NCT04732221|450220637|FG001|Extension Period|Adverse Event|0|||
125162839|NCT04732221|450220638|FG002|Extension Period|Adverse Event|0|||
125162840|NCT04732221|450220639|FG003|Extension Period|Adverse Event|0|||
125162841|NCT04732221|450220640|FG004|Extension Period|Adverse Event|0|||
125162842|NCT04732221|450220641|FG005|Extension Period|Adverse Event|1|||
125162843|NCT04732221|450220642|FG006|Extension Period|Adverse Event|0|||
125162844|NCT04732221|450220636|FG000|Extension Period|Death|0|||
125162845|NCT04732221|450220637|FG001|Extension Period|Death|0|||
125162846|NCT04732221|450220638|FG002|Extension Period|Death|0|||
125162847|NCT04732221|450220639|FG003|Extension Period|Death|0|||
125162848|NCT04732221|450220640|FG004|Extension Period|Death|1|||
125162849|NCT04732221|450220641|FG005|Extension Period|Death|0|||
125162850|NCT04732221|450220642|FG006|Extension Period|Death|2|||
125162851|NCT04732221|450220636|FG000|Extension Period|Pregnancy|0|||
125162852|NCT04732221|450220637|FG001|Extension Period|Pregnancy|0|||
125162853|NCT04732221|450220638|FG002|Extension Period|Pregnancy|0|||
125162854|NCT04732221|450220639|FG003|Extension Period|Pregnancy|0|||
125162855|NCT04732221|450220640|FG004|Extension Period|Pregnancy|1|||
125162856|NCT04732221|450220641|FG005|Extension Period|Pregnancy|0|||
125162857|NCT04732221|450220642|FG006|Extension Period|Pregnancy|0|||
125162858|NCT04732221|450220636|FG000|Extension Period|Sponsors Decision|0|||
125162859|NCT04732221|450220637|FG001|Extension Period|Sponsors Decision|0|||
125162860|NCT04732221|450220638|FG002|Extension Period|Sponsors Decision|0|||
125162861|NCT04732221|450220639|FG003|Extension Period|Sponsors Decision|0|||
125162862|NCT04732221|450220640|FG004|Extension Period|Sponsors Decision|41|||
125162863|NCT04732221|450220641|FG005|Extension Period|Sponsors Decision|40|||
125162864|NCT04732221|450220642|FG006|Extension Period|Sponsors Decision|40|||
125162865|NCT04732221|450220636|FG000|Extension Period|Withdrawal by Subject|0|||
125162866|NCT04732221|450220637|FG001|Extension Period|Withdrawal by Subject|0|||
125162867|NCT04732221|450220638|FG002|Extension Period|Withdrawal by Subject|0|||
125162868|NCT04732221|450220639|FG003|Extension Period|Withdrawal by Subject|0|||
125162869|NCT04732221|450220640|FG004|Extension Period|Withdrawal by Subject|1|||
125162870|NCT04732221|450220641|FG005|Extension Period|Withdrawal by Subject|5|||
125162871|NCT04732221|450220642|FG006|Extension Period|Withdrawal by Subject|2|||
125162872|NCT03747601|450220643|FG000|Overall Study|COVID halt to visits|4|||
125162873|NCT05327816|450220644|FG000|Overall Study|Lost to Follow-up|1|||
125162874|NCT05327816|450220645|FG001|Overall Study|Lost to Follow-up|0|||
125162875|NCT05327816|450220646|FG002|Overall Study|Lost to Follow-up|0|||
125162876|NCT05327816|450220647|FG003|Overall Study|Lost to Follow-up|0|||
125162877|NCT05327816|450220648|FG004|Overall Study|Lost to Follow-up|0|||
125162878|NCT05327816|450220649|FG005|Overall Study|Lost to Follow-up|0|||
125162879|NCT05327816|450220650|FG006|Overall Study|Lost to Follow-up|0|||
125162880|NCT05327816|450220651|FG007|Overall Study|Lost to Follow-up|0|||
125162881|NCT05327816|450220652|FG008|Overall Study|Lost to Follow-up|0|||
125162882|NCT05327816|450220653|FG009|Overall Study|Lost to Follow-up|1|||
125162883|NCT05327816|450220654|FG010|Overall Study|Lost to Follow-up|0|||
125162884|NCT05327816|450220644|FG000|Overall Study|Withdrawal by Subject|0|||
125162885|NCT05327816|450220645|FG001|Overall Study|Withdrawal by Subject|0|||
125224973|NCT00960804|450450264|FG000|Overall Study|Study terminated by the sponsor|5|||
125224974|NCT00960804|450450265|FG001|Overall Study|Study terminated by the sponsor|4|||
125224975|NCT00960804|450450266|FG002|Overall Study|Study terminated by the sponsor|10|||
125224976|NCT00490919|450450267|FG000|Open-label Run-in Period|Adverse Event|239|||
125224977|NCT00490919|450450268|FG001|Open-label Run-in Period|Adverse Event|0|||
125224978|NCT00490919|450450269|FG002|Open-label Run-in Period|Adverse Event|0|||
125224979|NCT00490919|450450267|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
125224980|NCT00490919|450450268|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
125224981|NCT00490919|450450269|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
125224982|NCT00490919|450450267|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
125224983|NCT00490919|450450268|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
125224984|NCT00490919|450450269|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
125440705|NCT02924389|451239859|FG001|Overall Study|Physician Decision|0|||
125440706|NCT02924389|451239858|FG000|Overall Study|Withdrawal by Subject|3|||
125440707|NCT02924389|451239859|FG001|Overall Study|Withdrawal by Subject|0|||
125440708|NCT02924389|451239858|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
125440709|NCT02924389|451239859|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
125440710|NCT03918239|451241557|FG000|Overall Study|Lost to Follow-up|3|||
125440711|NCT03918239|451241558|FG001|Overall Study|Lost to Follow-up|1|||
125440712|NCT03918239|451241557|FG000|Overall Study|Pregnancy|0|||
125440713|NCT03918239|451241558|FG001|Overall Study|Pregnancy|2|||
125224985|NCT00490919|450450267|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
125224986|NCT00490919|450450268|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
125224987|NCT00490919|450450269|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
125440714|NCT03918239|451241557|FG000|Overall Study|Withdrawal by Subject|3|||
125440715|NCT03918239|451241558|FG001|Overall Study|Withdrawal by Subject|3|||
125162886|NCT05327816|450220646|FG002|Overall Study|Withdrawal by Subject|0|||
125224988|NCT00490919|450450267|FG000|Open-label Run-in Period|Administrative|40|||
125162887|NCT05327816|450220647|FG003|Overall Study|Withdrawal by Subject|0|||
125162888|NCT05327816|450220648|FG004|Overall Study|Withdrawal by Subject|1|||
125440716|NCT03918239|451241557|FG000|Overall Study|positive urine drug screening results|4|||
125440717|NCT03918239|451241558|FG001|Overall Study|positive urine drug screening results|1|||
125162889|NCT05327816|450220649|FG005|Overall Study|Withdrawal by Subject|1|||
125162890|NCT05327816|450220650|FG006|Overall Study|Withdrawal by Subject|0|||
125162891|NCT05327816|450220651|FG007|Overall Study|Withdrawal by Subject|0|||
125162892|NCT05327816|450220652|FG008|Overall Study|Withdrawal by Subject|0|||
125162893|NCT05327816|450220653|FG009|Overall Study|Withdrawal by Subject|0|||
125224989|NCT00490919|450450268|FG001|Open-label Run-in Period|Administrative|0|||
125224990|NCT00490919|450450269|FG002|Open-label Run-in Period|Administrative|0|||
125224991|NCT00490919|450450267|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
125224992|NCT00490919|450450268|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
125224993|NCT00490919|450450269|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
125224994|NCT00490919|450450267|FG000|Double-blind Phase|Adverse Event|0|||
125224995|NCT00490919|450450268|FG001|Double-blind Phase|Adverse Event|40|||
125224996|NCT00490919|450450269|FG002|Double-blind Phase|Adverse Event|20|||
125224997|NCT00490919|450450267|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125224998|NCT00490919|450450268|FG001|Double-blind Phase|Withdrawal by Subject|10|||
125224999|NCT00490919|450450269|FG002|Double-blind Phase|Withdrawal by Subject|11|||
125225000|NCT00490919|450450267|FG000|Double-blind Phase|Lost to Follow-up|0|||
125225001|NCT00490919|450450268|FG001|Double-blind Phase|Lost to Follow-up|8|||
125225002|NCT00490919|450450269|FG002|Double-blind Phase|Lost to Follow-up|11|||
125225003|NCT00490919|450450267|FG000|Double-blind Phase|Lack of Efficacy|0|||
125225004|NCT00490919|450450268|FG001|Double-blind Phase|Lack of Efficacy|22|||
125225005|NCT00490919|450450269|FG002|Double-blind Phase|Lack of Efficacy|36|||
125225006|NCT00490919|450450267|FG000|Double-blind Phase|Administrative|0|||
125225007|NCT00490919|450450268|FG001|Double-blind Phase|Administrative|6|||
125225008|NCT00490919|450450269|FG002|Double-blind Phase|Administrative|6|||
125225009|NCT02787304|450451979|FG000|Overall Study|Adverse Event|9|||
125225010|NCT02787304|450451980|FG001|Overall Study|Adverse Event|3|||
125225011|NCT02787304|450451981|FG002|Overall Study|Adverse Event|8|||
125162894|NCT05327816|450220654|FG010|Overall Study|Withdrawal by Subject|0|||
125162895|NCT05327816|450220644|FG000|Overall Study|Study Terminated by Sponsor|11|||
125162896|NCT05327816|450220645|FG001|Overall Study|Study Terminated by Sponsor|12|||
125162897|NCT05327816|450220646|FG002|Overall Study|Study Terminated by Sponsor|12|||
125162898|NCT05327816|450220647|FG003|Overall Study|Study Terminated by Sponsor|12|||
125162899|NCT05327816|450220648|FG004|Overall Study|Study Terminated by Sponsor|11|||
125162900|NCT05327816|450220649|FG005|Overall Study|Study Terminated by Sponsor|11|||
125162901|NCT05327816|450220650|FG006|Overall Study|Study Terminated by Sponsor|11|||
125162902|NCT05327816|450220651|FG007|Overall Study|Study Terminated by Sponsor|11|||
125162903|NCT05327816|450220652|FG008|Overall Study|Study Terminated by Sponsor|11|||
125162904|NCT05327816|450220653|FG009|Overall Study|Study Terminated by Sponsor|11|||
125162905|NCT05327816|450220654|FG010|Overall Study|Study Terminated by Sponsor|12|||
125162906|NCT05327816|450220644|FG000|Overall Study|Randomized but not treated|0|||
125162907|NCT05327816|450220645|FG001|Overall Study|Randomized but not treated|0|||
125162908|NCT05327816|450220646|FG002|Overall Study|Randomized but not treated|0|||
125162909|NCT05327816|450220647|FG003|Overall Study|Randomized but not treated|0|||
125162910|NCT05327816|450220648|FG004|Overall Study|Randomized but not treated|0|||
125225012|NCT02787304|450451982|FG003|Overall Study|Adverse Event|1|||
125225013|NCT02787304|450451979|FG000|Overall Study|Withdrawal by Subject|1|||
125225014|NCT02787304|450451980|FG001|Overall Study|Withdrawal by Subject|4|||
125225015|NCT02787304|450451981|FG002|Overall Study|Withdrawal by Subject|0|||
125225016|NCT02787304|450451982|FG003|Overall Study|Withdrawal by Subject|0|||
125162911|NCT05327816|450220649|FG005|Overall Study|Randomized but not treated|0|||
125162912|NCT05327816|450220650|FG006|Overall Study|Randomized but not treated|1|||
125162913|NCT05327816|450220651|FG007|Overall Study|Randomized but not treated|1|||
125162914|NCT05327816|450220652|FG008|Overall Study|Randomized but not treated|1|||
125162915|NCT05327816|450220653|FG009|Overall Study|Randomized but not treated|0|||
125225017|NCT02787304|450451979|FG000|Overall Study|Lost to Follow-up|1|||
125225018|NCT02787304|450451980|FG001|Overall Study|Lost to Follow-up|0|||
125225019|NCT02787304|450451981|FG002|Overall Study|Lost to Follow-up|0|||
125225020|NCT02787304|450451982|FG003|Overall Study|Lost to Follow-up|1|||
125225021|NCT02787304|450451979|FG000|Overall Study|Noncompliance with study drug|0|||
125225022|NCT02787304|450451980|FG001|Overall Study|Noncompliance with study drug|0|||
125225023|NCT02787304|450451981|FG002|Overall Study|Noncompliance with study drug|1|||
125225024|NCT02787304|450451982|FG003|Overall Study|Noncompliance with study drug|0|||
125225025|NCT02787304|450451979|FG000|Overall Study|Physician Decision|0|||
125225026|NCT02787304|450451980|FG001|Overall Study|Physician Decision|0|||
125225027|NCT02787304|450451981|FG002|Overall Study|Physician Decision|1|||
125225028|NCT02787304|450451982|FG003|Overall Study|Physician Decision|0|||
125391157|NCT01577758|451067024|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
125391158|NCT01577758|451067025|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
125391159|NCT01577758|451067026|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
125391160|NCT01577758|451067027|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
125391161|NCT01577758|451067020|FG000|Dose Escalation Phase|Progression Disease|2|||
125162916|NCT05327816|450220654|FG010|Overall Study|Randomized but not treated|0|||
125162917|NCT00112866|450220655|FG000|Overall Study|Protocol Violation|1|||
125162918|NCT00112866|450220656|FG001|Overall Study|Protocol Violation|0|||
125162919|NCT00112866|450220655|FG000|Overall Study|did not start treatment post-op|1|||
125162920|NCT00112866|450220656|FG001|Overall Study|did not start treatment post-op|2|||
125162921|NCT04305587|450220657|FG000|Overall Study|Withdrawal by Subject|0|||
125225029|NCT02787304|450451979|FG000|Overall Study|Study terminated by sponsor|25|||
125225030|NCT02787304|450451980|FG001|Overall Study|Study terminated by sponsor|31|||
125162922|NCT04305587|450220658|FG001|Overall Study|Withdrawal by Subject|0|||
125162923|NCT04305587|450220659|FG002|Overall Study|Withdrawal by Subject|0|||
125162924|NCT04305587|450220660|FG003|Overall Study|Withdrawal by Subject|1|||
125162925|NCT04305587|450220661|FG004|Overall Study|Withdrawal by Subject|0|||
125162926|NCT04305587|450220662|FG005|Overall Study|Withdrawal by Subject|0|||
125162927|NCT04305587|450220663|FG006|Overall Study|Withdrawal by Subject|0|||
125162928|NCT04305587|450220664|FG007|Overall Study|Withdrawal by Subject|0|||
125162929|NCT04305587|450220665|FG008|Overall Study|Withdrawal by Subject|0|||
125162930|NCT01367665|450220666|FG000|Overall Study|Death|102|||
125162931|NCT01367665|450220667|FG001|Overall Study|Death|19|||
125162932|NCT01367665|450220666|FG000|Overall Study|Lost to Follow-up|222|||
125162933|NCT01367665|450220667|FG001|Overall Study|Lost to Follow-up|22|||
125162934|NCT01367665|450220666|FG000|Overall Study|Not Done|118|||
125162935|NCT01367665|450220667|FG001|Overall Study|Not Done|14|||
125162936|NCT02752906|450220668|FG000|Overall Study|Protocol Violation|2|||
125162937|NCT02752906|450220669|FG001|Overall Study|Protocol Violation|1|||
125162938|NCT02752906|450220668|FG000|Overall Study|Withdrawal by Subject|2|||
125162939|NCT02752906|450220669|FG001|Overall Study|Withdrawal by Subject|2|||
125162940|NCT02752906|450220668|FG000|Overall Study|Lost to Follow-up|3|||
125162941|NCT02752906|450220669|FG001|Overall Study|Lost to Follow-up|2|||
125162942|NCT01345175|450220674|FG000|Overall Study|Physician Decision|0|||
125162943|NCT01345175|450220675|FG001|Overall Study|Physician Decision|1|||
125162944|NCT01345175|450220674|FG000|Overall Study|Withdrawal by Subject|1|||
125162945|NCT01345175|450220675|FG001|Overall Study|Withdrawal by Subject|1|||
125162946|NCT01345175|450220674|FG000|Overall Study|Failed to complete BFI|3|||
125162947|NCT01345175|450220675|FG001|Overall Study|Failed to complete BFI|2|||
125162948|NCT01345175|450220674|FG000|Overall Study|Stopped taking medication|2|||
125162949|NCT01345175|450220675|FG001|Overall Study|Stopped taking medication|2|||
125162950|NCT04112173|450220679|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
125162951|NCT01259115|450220681|FG000|Period 1|Adverse Event|1|||
125162952|NCT01259115|450220682|FG001|Period 1|Adverse Event|0|||
125162953|NCT01259115|450220681|FG000|Period 1|Protocol Violation|2|||
125162954|NCT01259115|450220682|FG001|Period 1|Protocol Violation|0|||
125162955|NCT01259115|450220681|FG000|Period 1|Lost to Follow-up|0|||
125162956|NCT01259115|450220682|FG001|Period 1|Lost to Follow-up|1|||
125162957|NCT01259115|450220681|FG000|Period 2|Adverse Event|1|||
125162958|NCT01259115|450220682|FG001|Period 2|Adverse Event|0|||
125162959|NCT03560986|450220683|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
125162960|NCT03560986|450220684|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
125162961|NCT03560986|450220683|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
125162962|NCT03560986|450220684|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
125162963|NCT03560986|450220683|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
125162964|NCT03560986|450220684|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
125162965|NCT03560986|450220683|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
125162966|NCT03560986|450220684|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
125162967|NCT03560986|450220683|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
125162968|NCT03560986|450220684|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
125162969|NCT03560986|450220683|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
125162970|NCT03560986|450220684|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
125162971|NCT03560986|450220683|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
125162972|NCT03560986|450220684|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
125162973|NCT02524730|450220685|FG000|Overall Study|Lost to Follow-up|5|||
125162974|NCT02524730|450220685|FG000|Overall Study|Withdrawal by Subject|18|||
125162975|NCT02524730|450220685|FG000|Overall Study|Death|10|||
125162976|NCT02524730|450220685|FG000|Overall Study|Adverse Event|8|||
125162977|NCT02524730|450220685|FG000|Overall Study|Protocol Violation|1|||
125162978|NCT02524730|450220685|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
125162979|NCT00593736|450220688|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
125162980|NCT00593736|450220689|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
125162981|NCT00593736|450220690|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
125162982|NCT00593736|450220691|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
125162983|NCT00593736|450220688|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
125162984|NCT00593736|450220689|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
125162985|NCT00593736|450220690|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
125162986|NCT00593736|450220691|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
125162987|NCT00593736|450220688|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
125162988|NCT00593736|450220689|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
125162989|NCT00593736|450220690|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
125162990|NCT00593736|450220691|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
125162991|NCT00593736|450220688|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
125162992|NCT00593736|450220689|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
125162993|NCT00593736|450220690|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
125440718|NCT02930122|451241559|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
125440719|NCT02930122|451241560|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
125440720|NCT01024959|451241563|FG000|Overall Study|ineligible|12|||
125440721|NCT01024959|451241563|FG000|Overall Study|results not evaluable|12|||
125440722|NCT01024959|451241563|FG000|Overall Study|missing results required for analysis|17|||
125440723|NCT00636792|451241564|FG000|Overall Study|Adverse Event|16|||
125440724|NCT00636792|451241564|FG000|Overall Study|Physician Decision|7|||
125440725|NCT00636792|451241564|FG000|Overall Study|Progressive Disease|4|||
125440726|NCT00636792|451241564|FG000|Overall Study|Withdrawal by Subject|3|||
125440727|NCT00636792|451241564|FG000|Overall Study|Other|3|||
125440728|NCT00709592|451241567|FG000|Overall Study|Unable to proceed to transplant|0|||
125440729|NCT00709592|451241568|FG001|Overall Study|Unable to proceed to transplant|1|||
125440730|NCT00178256|451241569|FG000|Overall Study|Adverse Event|2|||
125440731|NCT00178256|451241570|FG001|Overall Study|Adverse Event|0|||
125440732|NCT00178256|451241571|FG002|Overall Study|Adverse Event|0|||
125440733|NCT00178256|451241572|FG003|Overall Study|Adverse Event|0|||
125440734|NCT00178256|451241569|FG000|Overall Study|Death|0|||
125440735|NCT00178256|451241570|FG001|Overall Study|Death|1|||
125440736|NCT00178256|451241571|FG002|Overall Study|Death|0|||
125440737|NCT00178256|451241572|FG003|Overall Study|Death|1|||
125440738|NCT00178256|451241569|FG000|Overall Study|Cancer progression|2|||
125162994|NCT00593736|450220691|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
125162995|NCT00593736|450220688|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
125162996|NCT00593736|450220689|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
125162997|NCT00593736|450220690|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
125162998|NCT00593736|450220691|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
125162999|NCT00593736|450220688|FG000|Screening Period and Placebo Run-in|Various|0|||
125163000|NCT00593736|450220689|FG001|Screening Period and Placebo Run-in|Various|0|||
125163001|NCT00593736|450220690|FG002|Screening Period and Placebo Run-in|Various|0|||
125163002|NCT00593736|450220691|FG003|Screening Period and Placebo Run-in|Various|25|||
125163003|NCT00593736|450220688|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
125163004|NCT00593736|450220689|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
125163005|NCT00593736|450220690|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
125225031|NCT02787304|450451981|FG002|Overall Study|Study terminated by sponsor|31|||
125440739|NCT00178256|451241570|FG001|Overall Study|Cancer progression|0|||
125163006|NCT00593736|450220691|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
125163007|NCT00593736|450220688|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
125163008|NCT00593736|450220689|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
125163009|NCT00593736|450220690|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
125163010|NCT00593736|450220691|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
125163011|NCT00593736|450220688|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
125163012|NCT00593736|450220689|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
125163013|NCT00593736|450220690|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
125163014|NCT00593736|450220691|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
125163015|NCT00593736|450220688|FG000|Treatment Period and Placebo Run-out|Various|1|||
125163016|NCT00593736|450220689|FG001|Treatment Period and Placebo Run-out|Various|1|||
125163017|NCT00593736|450220690|FG002|Treatment Period and Placebo Run-out|Various|1|||
125163018|NCT00593736|450220691|FG003|Treatment Period and Placebo Run-out|Various|0|||
125163019|NCT01868893|450220692|FG000|Overall Study|Adverse Event|2|||
125163020|NCT01868893|450220692|FG000|Overall Study|Commercial availability of study drug|17|||
125163021|NCT01868893|450220692|FG000|Overall Study|Neutropenia|1|||
125163022|NCT01857271|450220693|FG000|Overall Study|Lost to Follow-up|1|||
125163023|NCT01783548|450220694|FG000|Overall Study|Adverse Event|8|||
125163024|NCT01783548|450220695|FG001|Overall Study|Adverse Event|4|||
125163025|NCT01783548|450220694|FG000|Overall Study|Withdrawal by Subject|11|||
125163026|NCT01783548|450220695|FG001|Overall Study|Withdrawal by Subject|8|||
125163027|NCT01783548|450220694|FG000|Overall Study|Non-compliance|4|||
125163028|NCT01783548|450220695|FG001|Overall Study|Non-compliance|0|||
125163029|NCT01783548|450220694|FG000|Overall Study|Protocol Violation|2|||
125163030|NCT01783548|450220695|FG001|Overall Study|Protocol Violation|2|||
125163031|NCT01783548|450220694|FG000|Overall Study|Lost to Follow-up|8|||
125163032|NCT01783548|450220695|FG001|Overall Study|Lost to Follow-up|3|||
125163033|NCT01783548|450220694|FG000|Overall Study|Lack of Efficacy|1|||
125163034|NCT01783548|450220695|FG001|Overall Study|Lack of Efficacy|1|||
125163035|NCT03493386|450220696|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125163036|NCT03493386|450220697|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
125163037|NCT03493386|450220698|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125163038|NCT03493386|450220699|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125440740|NCT00178256|451241571|FG002|Overall Study|Cancer progression|0|||
125440741|NCT00178256|451241572|FG003|Overall Study|Cancer progression|1|||
125440742|NCT02086552|451241575|FG000|Overall Study|Withdrawal by Subject|1|||
125440743|NCT00708305|451241576|FG000|Period 1|Protocol Violation|1|||
125163039|NCT00988442|450220700|FG000|Overall Study|Death|1|||
125163040|NCT00988442|450220701|FG001|Overall Study|Death|2|||
125163041|NCT00988442|450220700|FG000|Overall Study|Lost to Follow-up|0|||
125163042|NCT00988442|450220701|FG001|Overall Study|Lost to Follow-up|1|||
125163043|NCT00988442|450220700|FG000|Overall Study|Early Study Closure|29|||
125163044|NCT00988442|450220701|FG001|Overall Study|Early Study Closure|25|||
125163045|NCT05297578|450220707|FG000|Overall Study|Lost to Follow-up|1|||
125163046|NCT05297578|450220708|FG001|Overall Study|Lost to Follow-up|1|||
125163047|NCT05297578|450220709|FG002|Overall Study|Lost to Follow-up|2|||
125163048|NCT05297578|450220710|FG003|Overall Study|Lost to Follow-up|1|||
125163049|NCT05297578|450220707|FG000|Overall Study|Death|0|||
125163050|NCT05297578|450220708|FG001|Overall Study|Death|1|||
125163051|NCT05297578|450220709|FG002|Overall Study|Death|0|||
125163052|NCT05297578|450220710|FG003|Overall Study|Death|0|||
125163053|NCT05297578|450220707|FG000|Overall Study|Withdrawal by Subject|0|||
125163054|NCT05297578|450220708|FG001|Overall Study|Withdrawal by Subject|0|||
125163055|NCT05297578|450220709|FG002|Overall Study|Withdrawal by Subject|1|||
125163056|NCT05297578|450220710|FG003|Overall Study|Withdrawal by Subject|0|||
125163057|NCT01087489|450220712|FG000|Overall Study|enrolled in another VA study|0|||
125163058|NCT01087489|450220713|FG001|Overall Study|enrolled in another VA study|1|||
125163059|NCT01087489|450220712|FG000|Overall Study|Death|0|||
125163060|NCT01087489|450220713|FG001|Overall Study|Death|1|||
125163061|NCT01087489|450220712|FG000|Overall Study|unable to survey by telephone|0|||
125163062|NCT01087489|450220713|FG001|Overall Study|unable to survey by telephone|1|||
125163063|NCT00117325|450220714|FG000|Overall Study|Adverse Event|3|||
125163064|NCT00117325|450220715|FG001|Overall Study|Adverse Event|3|||
125163065|NCT00117325|450220714|FG000|Overall Study|Lost to Follow-up|1|||
125163066|NCT00117325|450220715|FG001|Overall Study|Lost to Follow-up|1|||
125163067|NCT00117325|450220714|FG000|Overall Study|Protocol Violation|2|||
125163068|NCT00117325|450220715|FG001|Overall Study|Protocol Violation|3|||
125163069|NCT00117325|450220714|FG000|Overall Study|Withdrawal by Subject|3|||
125163070|NCT00117325|450220715|FG001|Overall Study|Withdrawal by Subject|2|||
125163071|NCT00117325|450220714|FG000|Overall Study|Lack of Efficacy|1|||
125163072|NCT00117325|450220715|FG001|Overall Study|Lack of Efficacy|0|||
125163073|NCT00117325|450220714|FG000|Overall Study|Use of prohibited medicine|1|||
125163074|NCT00117325|450220715|FG001|Overall Study|Use of prohibited medicine|2|||
125163075|NCT00117325|450220714|FG000|Overall Study|Early termination|1|||
125163076|NCT00117325|450220715|FG001|Overall Study|Early termination|1|||
125163077|NCT00117325|450220714|FG000|Overall Study|Admisnitrative|1|||
125163078|NCT00117325|450220715|FG001|Overall Study|Admisnitrative|0|||
125163079|NCT01468818|450220718|FG000|Overall Study|Death during treatment|2|||
125163080|NCT01212588|450220720|FG000|Overall Study|Physician Decision|0|||
125163081|NCT01212588|450220721|FG001|Overall Study|Physician Decision|1|||
125163082|NCT01212588|450220720|FG000|Overall Study|Protocol Violation|1|||
125163083|NCT01212588|450220721|FG001|Overall Study|Protocol Violation|1|||
125163084|NCT02338193|450220722|FG000|Overall Study|Withdrawal by Subject|0|||
125163085|NCT02338193|450220723|FG001|Overall Study|Withdrawal by Subject|0|||
125163086|NCT02338193|450220724|FG002|Overall Study|Withdrawal by Subject|2|||
125163087|NCT02338193|450220722|FG000|Overall Study|Pregnancy|0|||
125163088|NCT02338193|450220723|FG001|Overall Study|Pregnancy|1|||
125163089|NCT02338193|450220724|FG002|Overall Study|Pregnancy|1|||
125163090|NCT02338193|450220722|FG000|Overall Study|Noncompliant with visits|2|||
125163091|NCT02338193|450220723|FG001|Overall Study|Noncompliant with visits|2|||
125163092|NCT02338193|450220724|FG002|Overall Study|Noncompliant with visits|7|||
125163093|NCT02338193|450220722|FG000|Overall Study|moved out of state|0|||
125163094|NCT02338193|450220723|FG001|Overall Study|moved out of state|1|||
125163095|NCT02338193|450220724|FG002|Overall Study|moved out of state|0|||
125163096|NCT02338193|450220722|FG000|Overall Study|intolerant of side effects|1|||
125163097|NCT02338193|450220723|FG001|Overall Study|intolerant of side effects|0|||
125163098|NCT02338193|450220724|FG002|Overall Study|intolerant of side effects|0|||
125163099|NCT01735955|450220725|FG000|Overall Study|Administrative problems|1|||
125163100|NCT01735955|450220725|FG000|Overall Study|Patient/guardian decision|1|||
125163101|NCT01735955|450220725|FG000|Overall Study|Patient withdrew consent|2|||
125391162|NCT01577758|451067021|FG001|Dose Escalation Phase|Progression Disease|2|||
125163102|NCT01735955|450220725|FG000|Overall Study|Physician Decision|4|||
125163103|NCT01735955|450220725|FG000|Overall Study|Disease progression|24|||
125163104|NCT01735955|450220725|FG000|Overall Study|Adverse Event|5|||
125163105|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
125163106|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
125163107|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
125163108|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
125163109|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
125163110|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
125163111|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
125163112|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
125163113|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
125163114|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125391163|NCT01577758|451067022|FG002|Dose Escalation Phase|Progression Disease|1|||
125163115|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
125163116|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163117|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163118|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163119|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163120|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163121|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163122|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
125163123|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163124|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
125163125|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163126|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
125163127|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163128|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163129|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163130|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163131|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163132|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163133|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
125163134|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163135|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
125163136|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163137|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163138|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163139|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163140|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
125163141|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
125163142|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
125163143|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
125163144|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163145|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
125163146|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163147|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163148|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163149|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163150|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163151|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
125163152|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163153|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163154|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163155|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163156|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163157|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163158|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
125163159|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125391164|NCT01577758|451067023|FG003|Dose Escalation Phase|Progression Disease|2|||
125391165|NCT01577758|451067024|FG004|Dose Escalation Phase|Progression Disease|5|||
125391166|NCT01577758|451067025|FG005|Dose Escalation Phase|Progression Disease|0|||
125391167|NCT01577758|451067026|FG006|Dose Escalation Phase|Progression Disease|0|||
125391168|NCT01577758|451067027|FG007|Dose Escalation Phase|Progression Disease|0|||
125391169|NCT01577758|451067020|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125391170|NCT01577758|451067021|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125391171|NCT01577758|451067022|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125391172|NCT01577758|451067023|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125391173|NCT01577758|451067024|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125391174|NCT01577758|451067025|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125391175|NCT01577758|451067026|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
125391176|NCT01577758|451067027|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
125391177|NCT01577758|451067020|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
125391178|NCT01577758|451067021|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
125440744|NCT00708305|451241577|FG001|Period 1|Protocol Violation|0|||
125440745|NCT00708305|451241578|FG002|Period 1|Protocol Violation|1|||
125440746|NCT00708305|451241579|FG003|Period 1|Protocol Violation|0|||
125163160|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163161|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163162|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
125163163|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163164|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163165|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163166|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163167|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163168|NCT03893565|450220737|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
125163169|NCT03893565|450220738|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
125163170|NCT03893565|450220739|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
125163171|NCT03893565|450220740|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
125163172|NCT03893565|450220741|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
125163173|NCT03893565|450220742|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
125163174|NCT03893565|450220743|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
125163175|NCT03893565|450220744|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
125163176|NCT03893565|450220745|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
125163177|NCT03893565|450220737|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
125163178|NCT03893565|450220738|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
125163179|NCT03893565|450220739|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
125163180|NCT03893565|450220740|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
125163181|NCT03893565|450220741|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
125163182|NCT03893565|450220742|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
125163183|NCT03893565|450220743|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
125163184|NCT03893565|450220744|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
125163185|NCT03893565|450220745|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
125163186|NCT03893565|450220737|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163187|NCT03893565|450220738|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163188|NCT03893565|450220739|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163189|NCT03893565|450220740|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163190|NCT03893565|450220741|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163191|NCT03893565|450220742|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163192|NCT03893565|450220743|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
125163193|NCT03893565|450220744|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163194|NCT03893565|450220745|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
125163195|NCT03893565|450220737|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163196|NCT03893565|450220738|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163197|NCT03893565|450220739|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163198|NCT03893565|450220740|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163199|NCT03893565|450220741|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163200|NCT03893565|450220742|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
125163201|NCT03893565|450220743|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
125163202|NCT03893565|450220744|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163203|NCT03893565|450220745|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
125163204|NCT03893565|450220737|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
125163205|NCT03893565|450220738|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
125163206|NCT03893565|450220739|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
125163207|NCT03893565|450220740|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
125163208|NCT03893565|450220741|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
125163209|NCT03893565|450220742|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
125163210|NCT03893565|450220743|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
125163211|NCT03893565|450220744|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
125163212|NCT03893565|450220745|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
125163213|NCT03893565|450220737|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163214|NCT03893565|450220738|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163215|NCT03893565|450220739|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163216|NCT03893565|450220740|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163217|NCT03893565|450220741|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163218|NCT03893565|450220742|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163219|NCT03893565|450220743|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163220|NCT03893565|450220744|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
125163221|NCT03893565|450220745|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
125163222|NCT03893565|450220737|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163223|NCT03893565|450220738|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125225032|NCT02787304|450451982|FG003|Overall Study|Study terminated by sponsor|32|||
125391179|NCT01577758|451067022|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
125391180|NCT01577758|451067023|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
125391181|NCT01577758|451067024|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
125391182|NCT01577758|451067025|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
125391183|NCT01577758|451067026|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
125391184|NCT01577758|451067027|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
125391185|NCT01577758|451067020|FG000|mCRC Expansion Phase|Progression Disease|0|||
125391186|NCT01577758|451067021|FG001|mCRC Expansion Phase|Progression Disease|0|||
125391187|NCT01577758|451067022|FG002|mCRC Expansion Phase|Progression Disease|0|||
125391188|NCT01577758|451067023|FG003|mCRC Expansion Phase|Progression Disease|0|||
125391189|NCT01577758|451067024|FG004|mCRC Expansion Phase|Progression Disease|0|||
125391190|NCT01577758|451067025|FG005|mCRC Expansion Phase|Progression Disease|0|||
125391191|NCT01577758|451067026|FG006|mCRC Expansion Phase|Progression Disease|0|||
125391192|NCT01577758|451067027|FG007|mCRC Expansion Phase|Progression Disease|19|||
125391193|NCT01289847|451067028|FG000|Overall Study|Patient could not comply with visits|1|||
125391194|NCT04327999|451067033|FG000|Overall Study|Protocol Violation|1|||
125391195|NCT03975647|451067034|FG000|Overall Study|Death|71|||
125391196|NCT03975647|451067035|FG001|Overall Study|Death|63|||
125391197|NCT03975647|451067034|FG000|Overall Study|Lost to Follow-up|2|||
125391198|NCT03975647|451067035|FG001|Overall Study|Lost to Follow-up|2|||
125391199|NCT03975647|451067034|FG000|Overall Study|Subject withdrawal of consent|7|||
125391200|NCT03975647|451067035|FG001|Overall Study|Subject withdrawal of consent|11|||
125391201|NCT02872116|451067036|FG000|Pre-Treatment|Disease Progression|0|||
125391202|NCT02872116|451067037|FG001|Pre-Treatment|Disease Progression|1|||
125391203|NCT02872116|451067038|FG002|Pre-Treatment|Disease Progression|0|||
125391204|NCT02872116|451067036|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
125391205|NCT02872116|451067037|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
125391206|NCT02872116|451067038|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
125391207|NCT02872116|451067036|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
125391208|NCT02872116|451067037|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
125391209|NCT02872116|451067038|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
125391210|NCT02872116|451067036|FG000|Pre-Treatment|Participant withdrew consent|2|||
125391211|NCT02872116|451067037|FG001|Pre-Treatment|Participant withdrew consent|20|||
125391212|NCT02872116|451067038|FG002|Pre-Treatment|Participant withdrew consent|3|||
125391213|NCT02872116|451067036|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
125391214|NCT02872116|451067037|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
125391215|NCT02872116|451067038|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
125391216|NCT02872116|451067036|FG000|Pre-Treatment|Other reasons|1|||
125391217|NCT02872116|451067037|FG001|Pre-Treatment|Other reasons|2|||
125391218|NCT02872116|451067038|FG002|Pre-Treatment|Other reasons|2|||
125391219|NCT02872116|451067036|FG000|Treatment|Death|121|||
125391220|NCT02872116|451067037|FG001|Treatment|Death|94|||
125391221|NCT02872116|451067038|FG002|Treatment|Death|68|||
125391222|NCT02872116|451067036|FG000|Treatment|Lost to Follow-up|5|||
125391223|NCT02872116|451067037|FG001|Treatment|Lost to Follow-up|7|||
125163224|NCT03893565|450220739|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163225|NCT03893565|450220740|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163226|NCT03893565|450220741|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163227|NCT03893565|450220742|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163228|NCT03893565|450220743|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163229|NCT03893565|450220744|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
125163230|NCT03893565|450220745|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
125163231|NCT03893565|450220737|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163232|NCT03893565|450220738|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163233|NCT03893565|450220739|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163234|NCT03893565|450220740|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163235|NCT03893565|450220741|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163236|NCT03893565|450220742|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163237|NCT03893565|450220743|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125163238|NCT03893565|450220744|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
125163239|NCT03893565|450220745|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
125225033|NCT01051921|450451986|FG000|Overall Study|Physician Decision|9|||
125391224|NCT02872116|451067038|FG002|Treatment|Lost to Follow-up|3|||
125163240|NCT03893565|450220737|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125391225|NCT02872116|451067036|FG000|Treatment|Participant withdrew consent|20|||
125391226|NCT02872116|451067037|FG001|Treatment|Participant withdrew consent|40|||
125391227|NCT02872116|451067038|FG002|Treatment|Participant withdrew consent|8|||
125391228|NCT02872116|451067036|FG000|Treatment|Other reasons|13|||
125391229|NCT02872116|451067037|FG001|Treatment|Other reasons|12|||
125391230|NCT02872116|451067038|FG002|Treatment|Other reasons|5|||
125391231|NCT03735667|451067039|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
125163241|NCT03893565|450220738|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163242|NCT03893565|450220739|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163243|NCT03893565|450220740|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163244|NCT03893565|450220741|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163245|NCT03893565|450220742|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163246|NCT03893565|450220743|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163247|NCT03893565|450220744|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
125163248|NCT03893565|450220745|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
125163249|NCT05788289|450220751|FG000|Overall Study|Death|3|||
125163250|NCT00085423|450220756|FG000|Overall Study|Withdrawal by Subject|1|||
125163251|NCT00085423|450220756|FG000|Overall Study|screen failure|1|||
125163252|NCT00536263|450220759|FG000|Overall Study|Adverse Event|5|||
125163253|NCT00536263|450220760|FG001|Overall Study|Adverse Event|5|||
125163254|NCT00536263|450220761|FG002|Overall Study|Adverse Event|7|||
125163255|NCT00536263|450220759|FG000|Overall Study|Lost to Follow-up|3|||
125163256|NCT00536263|450220760|FG001|Overall Study|Lost to Follow-up|4|||
125163257|NCT00536263|450220761|FG002|Overall Study|Lost to Follow-up|4|||
125163258|NCT00536263|450220759|FG000|Overall Study|Subject withdrew - not treatment related|2|||
125163259|NCT00536263|450220760|FG001|Overall Study|Subject withdrew - not treatment related|0|||
125163260|NCT00536263|450220761|FG002|Overall Study|Subject withdrew - not treatment related|5|||
125163261|NCT00536263|450220759|FG000|Overall Study|Subject withdrew - treatment related|0|||
125163262|NCT00536263|450220760|FG001|Overall Study|Subject withdrew - treatment related|3|||
125163263|NCT00536263|450220761|FG002|Overall Study|Subject withdrew - treatment related|2|||
125163264|NCT00536263|450220759|FG000|Overall Study|Noncompliance with protocol|0|||
125163265|NCT00536263|450220760|FG001|Overall Study|Noncompliance with protocol|0|||
125163266|NCT00536263|450220761|FG002|Overall Study|Noncompliance with protocol|1|||
125163267|NCT00536263|450220759|FG000|Overall Study|Did not meet protocol eligibility|1|||
125163268|NCT00536263|450220760|FG001|Overall Study|Did not meet protocol eligibility|2|||
125163269|NCT00536263|450220761|FG002|Overall Study|Did not meet protocol eligibility|2|||
125163270|NCT03734666|450220763|FG000|Overall Study|Other|7|||
125163271|NCT03734666|450220764|FG001|Overall Study|Other|4|||
125163272|NCT03734666|450220763|FG000|Overall Study|Lost to Follow-up|12|||
125163273|NCT03734666|450220764|FG001|Overall Study|Lost to Follow-up|12|||
125163274|NCT00914459|450220767|FG000|Overall Study|Protocol Violation|0|||
125163275|NCT00914459|450220768|FG001|Overall Study|Protocol Violation|1|||
125163276|NCT00914459|450220767|FG000|Overall Study|Parent/Legal guardian request|1|||
125163277|NCT00914459|450220768|FG001|Overall Study|Parent/Legal guardian request|0|||
125163278|NCT01661179|450220769|FG000|Overall Study|Death|1|||
125163279|NCT01661179|450220769|FG000|Overall Study|Withdrawal by Subject|1|||
125163280|NCT01661179|450220769|FG000|Overall Study|Other Eligibility criteria|4|||
125163281|NCT01946191|450220770|FG000|Allocation|Did not complete orientation|1|||
125163282|NCT01946191|450220771|FG001|Allocation|Did not complete orientation|1|||
125163283|NCT01946191|450220770|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
125163284|NCT01946191|450220771|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
125163285|NCT01946191|450220770|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
125163286|NCT01946191|450220771|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
125163287|NCT01946191|450220770|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
125163288|NCT01946191|450220771|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
125163289|NCT03118570|450220772|FG000|Overall Study|Adverse Event|2|||
125163290|NCT03118570|450220773|FG001|Overall Study|Adverse Event|0|||
125163291|NCT03118570|450220774|FG002|Overall Study|Adverse Event|0|||
125225034|NCT01051921|450451986|FG000|Overall Study|Adverse Event|8|||
125225035|NCT01051921|450451986|FG000|Overall Study|Withdrawal by Subject|7|||
125225036|NCT01051921|450451986|FG000|Overall Study|Lost to Follow-up|4|||
125225037|NCT01051921|450451986|FG000|Overall Study|virological failure|1|||
125225038|NCT01051921|450451986|FG000|Overall Study|patient moved|1|||
125225039|NCT03110354|450451989|FG000|Overall Study|Death|1|||
125225040|NCT03110354|450451990|FG001|Overall Study|Death|0|||
125225041|NCT03110354|450451991|FG002|Overall Study|Death|0|||
125225042|NCT03110354|450451992|FG003|Overall Study|Death|1|||
125225043|NCT03110354|450451993|FG004|Overall Study|Death|0|||
125225044|NCT03110354|450451989|FG000|Overall Study|Start of new therapy|0|||
125440747|NCT00708305|451241576|FG000|Period 1|Other Reason|0|||
125440748|NCT00708305|451241577|FG001|Period 1|Other Reason|0|||
125163292|NCT03118570|450220775|FG003|Overall Study|Adverse Event|0|||
125163293|NCT03118570|450220776|FG004|Overall Study|Adverse Event|3|||
125163294|NCT03118570|450220772|FG000|Overall Study|Withdrawal by Subject|0|||
125163295|NCT03118570|450220773|FG001|Overall Study|Withdrawal by Subject|1|||
125163296|NCT03118570|450220774|FG002|Overall Study|Withdrawal by Subject|4|||
125163297|NCT03118570|450220775|FG003|Overall Study|Withdrawal by Subject|0|||
125163298|NCT03118570|450220776|FG004|Overall Study|Withdrawal by Subject|1|||
125163299|NCT03118570|450220772|FG000|Overall Study|Lost to Follow-up|2|||
125163300|NCT03118570|450220773|FG001|Overall Study|Lost to Follow-up|3|||
125163301|NCT03118570|450220774|FG002|Overall Study|Lost to Follow-up|1|||
125440749|NCT00708305|451241578|FG002|Period 1|Other Reason|0|||
125391232|NCT03735667|451067040|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
125391233|NCT03735667|451067041|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
125391234|NCT03735667|451067039|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
125391235|NCT03735667|451067040|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
125391236|NCT03735667|451067041|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
125391237|NCT03735667|451067039|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
125391238|NCT03735667|451067040|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
125391239|NCT03735667|451067041|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
125391240|NCT03735667|451067039|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
125391241|NCT03735667|451067040|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
125391242|NCT03735667|451067041|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
125391243|NCT03735667|451067039|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
125391244|NCT03735667|451067040|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
125391245|NCT03735667|451067041|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
125391246|NCT03735667|451067039|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
125391247|NCT03735667|451067040|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
125391248|NCT03735667|451067041|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
125391249|NCT03735667|451067039|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
125391250|NCT03735667|451067040|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
125391251|NCT03735667|451067041|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
125391252|NCT03735667|451067039|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
125391253|NCT03735667|451067040|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
125391254|NCT03735667|451067041|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
125391255|NCT03735667|451067039|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
125391256|NCT03735667|451067040|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
125391257|NCT03735667|451067041|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
125391258|NCT03735667|451067039|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
125391259|NCT03735667|451067040|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
125391260|NCT03735667|451067041|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
125391261|NCT03735667|451067039|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
125391262|NCT03735667|451067040|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
125391263|NCT03735667|451067041|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
125391264|NCT03735667|451067039|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
125391265|NCT03735667|451067040|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
125391266|NCT03735667|451067041|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
125391267|NCT00006478|451067042|FG000|Overall Study|Vaccine could not be produced|1|||
125391268|NCT00006478|451067042|FG000|Overall Study|Physician Decision|6|||
125391269|NCT03161483|451067046|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
125391270|NCT03161483|451067047|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
125391271|NCT03161483|451067048|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
125391272|NCT03161483|451067049|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
125391273|NCT03161483|451067046|FG000|Treatment Period|Death|1|||
125391274|NCT03161483|451067047|FG001|Treatment Period|Death|0|||
125391275|NCT03161483|451067048|FG002|Treatment Period|Death|0|||
125391276|NCT03161483|451067049|FG003|Treatment Period|Death|0|||
125391277|NCT03161483|451067046|FG000|Treatment Period|Adverse Event|5|||
125391278|NCT03161483|451067047|FG001|Treatment Period|Adverse Event|2|||
125391279|NCT03161483|451067048|FG002|Treatment Period|Adverse Event|1|||
125391280|NCT03161483|451067049|FG003|Treatment Period|Adverse Event|11|||
125391281|NCT03161483|451067046|FG000|Treatment Period|Pregnancy|1|||
125391282|NCT03161483|451067047|FG001|Treatment Period|Pregnancy|0|||
125391283|NCT03161483|451067048|FG002|Treatment Period|Pregnancy|0|||
125391284|NCT03161483|451067049|FG003|Treatment Period|Pregnancy|0|||
125391285|NCT03161483|451067046|FG000|Treatment Period|Lack of Efficacy|0|||
125391286|NCT03161483|451067047|FG001|Treatment Period|Lack of Efficacy|0|||
125391287|NCT03161483|451067048|FG002|Treatment Period|Lack of Efficacy|0|||
125391288|NCT03161483|451067049|FG003|Treatment Period|Lack of Efficacy|1|||
125391289|NCT03161483|451067046|FG000|Treatment Period|Withdrawal by Subject|2|||
125391290|NCT03161483|451067047|FG001|Treatment Period|Withdrawal by Subject|5|||
125391291|NCT03161483|451067048|FG002|Treatment Period|Withdrawal by Subject|2|||
125391292|NCT03161483|451067049|FG003|Treatment Period|Withdrawal by Subject|6|||
125391293|NCT03161483|451067046|FG000|Treatment Period|Lost to Follow-up|0|||
125391294|NCT03161483|451067047|FG001|Treatment Period|Lost to Follow-up|0|||
125391295|NCT03161483|451067048|FG002|Treatment Period|Lost to Follow-up|0|||
125391296|NCT03161483|451067049|FG003|Treatment Period|Lost to Follow-up|1|||
125391297|NCT03161483|451067046|FG000|Treatment Period|Protocol Violation|0|||
125391298|NCT03161483|451067047|FG001|Treatment Period|Protocol Violation|0|||
125391299|NCT03161483|451067048|FG002|Treatment Period|Protocol Violation|0|||
125391300|NCT03161483|451067049|FG003|Treatment Period|Protocol Violation|1|||
125391301|NCT03161483|451067046|FG000|Treatment Period|Other reasons|1|||
125391302|NCT03161483|451067047|FG001|Treatment Period|Other reasons|1|||
125391303|NCT03161483|451067048|FG002|Treatment Period|Other reasons|0|||
125225045|NCT03110354|450451990|FG001|Overall Study|Start of new therapy|0|||
125225046|NCT03110354|450451991|FG002|Overall Study|Start of new therapy|0|||
125225047|NCT03110354|450451992|FG003|Overall Study|Start of new therapy|0|||
125225048|NCT03110354|450451993|FG004|Overall Study|Start of new therapy|1|||
125225049|NCT03110354|450451989|FG000|Overall Study|Failure to achieve response|2|||
125225050|NCT03110354|450451990|FG001|Overall Study|Failure to achieve response|3|||
125225051|NCT03110354|450451991|FG002|Overall Study|Failure to achieve response|0|||
125225052|NCT03110354|450451992|FG003|Overall Study|Failure to achieve response|2|||
125225053|NCT03110354|450451993|FG004|Overall Study|Failure to achieve response|1|||
125225054|NCT03110354|450451989|FG000|Overall Study|Progressive disease|1|||
125225055|NCT03110354|450451990|FG001|Overall Study|Progressive disease|1|||
125225056|NCT03110354|450451991|FG002|Overall Study|Progressive disease|3|||
125225057|NCT03110354|450451992|FG003|Overall Study|Progressive disease|4|||
125225058|NCT03110354|450451993|FG004|Overall Study|Progressive disease|2|||
125225059|NCT03110354|450451989|FG000|Overall Study|Adverse Event|0|||
125225060|NCT03110354|450451990|FG001|Overall Study|Adverse Event|0|||
125225061|NCT03110354|450451991|FG002|Overall Study|Adverse Event|0|||
125225062|NCT03110354|450451992|FG003|Overall Study|Adverse Event|2|||
125225063|NCT03110354|450451993|FG004|Overall Study|Adverse Event|2|||
125225064|NCT03110354|450451989|FG000|Overall Study|Other|0|||
125225065|NCT03110354|450451990|FG001|Overall Study|Other|0|||
125225066|NCT03110354|450451991|FG002|Overall Study|Other|0|||
125225067|NCT03110354|450451992|FG003|Overall Study|Other|1|||
125225068|NCT03110354|450451993|FG004|Overall Study|Other|1|||
125225069|NCT00379834|450451994|FG000|Overall Study|Time constraints|2|||
125225070|NCT01775670|450452003|FG000|Overall Study|Lost to Follow-up|1|||
125225071|NCT01775670|450452004|FG001|Overall Study|Lost to Follow-up|1|||
125225072|NCT01001429|450452005|FG000|Overall Study|surgery cancelled|0|||
125225073|NCT01001429|450452006|FG001|Overall Study|surgery cancelled|1|||
125225074|NCT01053741|450452013|FG000|2nd Study Intervention|Physician Decision|0|||
125225075|NCT01053741|450452014|FG001|2nd Study Intervention|Physician Decision|1|||
125225076|NCT02063672|450452015|FG000|Overall Study|Ongoing Follow-up|27|||
125225077|NCT02063672|450452016|FG001|Overall Study|Ongoing Follow-up|14|||
125225078|NCT02063672|450452015|FG000|Overall Study|Death|5|||
125225079|NCT02063672|450452016|FG001|Overall Study|Death|3|||
125225080|NCT02063672|450452015|FG000|Overall Study|Lost to Follow-up|1|||
125225081|NCT02063672|450452016|FG001|Overall Study|Lost to Follow-up|3|||
125225082|NCT02063672|450452015|FG000|Overall Study|Withdrawal by Subject|2|||
125225083|NCT02063672|450452016|FG001|Overall Study|Withdrawal by Subject|2|||
125225084|NCT00619827|450452018|FG000|Overall Study|Adverse Event|1|||
125225085|NCT00619827|450452019|FG001|Overall Study|Adverse Event|2|||
125225086|NCT00619827|450452018|FG000|Overall Study|Withdrawal by Subject|2|||
125440750|NCT00708305|451241579|FG003|Period 1|Other Reason|2|||
125440751|NCT00708305|451241576|FG000|Period 2|Lost to Follow-up|0|||
125163302|NCT03118570|450220775|FG003|Overall Study|Lost to Follow-up|0|||
125163303|NCT03118570|450220776|FG004|Overall Study|Lost to Follow-up|1|||
125163304|NCT03118570|450220772|FG000|Overall Study|Other, Not Specified|1|||
125163305|NCT03118570|450220773|FG001|Overall Study|Other, Not Specified|3|||
125163306|NCT03118570|450220774|FG002|Overall Study|Other, Not Specified|0|||
125163307|NCT03118570|450220775|FG003|Overall Study|Other, Not Specified|0|||
125163308|NCT03118570|450220776|FG004|Overall Study|Other, Not Specified|0|||
125163309|NCT03970837|450220777|FG000|Overall Study|Adverse Event|23|||
125163310|NCT03970837|450220778|FG001|Overall Study|Adverse Event|20|||
125163311|NCT03970837|450220779|FG002|Overall Study|Adverse Event|16|||
125163312|NCT03970837|450220780|FG003|Overall Study|Adverse Event|6|||
125163313|NCT03970837|450220781|FG004|Overall Study|Adverse Event|4|||
125163314|NCT03970837|450220782|FG005|Overall Study|Adverse Event|5|||
125163315|NCT03970837|450220783|FG006|Overall Study|Adverse Event|1|||
125163316|NCT03970837|450220784|FG007|Overall Study|Adverse Event|5|||
125163317|NCT03970837|450220785|FG008|Overall Study|Adverse Event|0|||
125163318|NCT03970837|450220786|FG009|Overall Study|Adverse Event|0|||
125163319|NCT03970837|450220787|FG010|Overall Study|Adverse Event|1|||
125163320|NCT03970837|450220788|FG011|Overall Study|Adverse Event|1|||
125163321|NCT03970837|450220777|FG000|Overall Study|Lack of Efficacy|14|||
125163322|NCT03970837|450220778|FG001|Overall Study|Lack of Efficacy|12|||
125225087|NCT00619827|450452019|FG001|Overall Study|Withdrawal by Subject|2|||
125225088|NCT00104052|450452020|FG000|Overall Study|Adverse Event|1|||
125225089|NCT00104052|450452020|FG000|Overall Study|Lack of Efficacy|26|||
125225090|NCT00104052|450452020|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
125225091|NCT02498678|450452021|FG000|Overall Study|interference from the surgical team|0|||
125225092|NCT02498678|450452022|FG001|Overall Study|interference from the surgical team|2|||
125225093|NCT00239720|450452028|FG000|Overall Study|Adverse Event|1|||
125225094|NCT00239720|450452029|FG001|Overall Study|Adverse Event|0|||
125225095|NCT00239720|450452028|FG000|Overall Study|Lost to Follow-up|0|||
125163323|NCT03970837|450220779|FG002|Overall Study|Lack of Efficacy|1|||
125163324|NCT03970837|450220780|FG003|Overall Study|Lack of Efficacy|2|||
125163325|NCT03970837|450220781|FG004|Overall Study|Lack of Efficacy|3|||
125163326|NCT03970837|450220782|FG005|Overall Study|Lack of Efficacy|4|||
125163327|NCT03970837|450220783|FG006|Overall Study|Lack of Efficacy|6|||
125225096|NCT00239720|450452029|FG001|Overall Study|Lost to Follow-up|1|||
125440752|NCT00708305|451241577|FG001|Period 2|Lost to Follow-up|1|||
125440753|NCT00708305|451241578|FG002|Period 2|Lost to Follow-up|0|||
125440754|NCT00708305|451241579|FG003|Period 2|Lost to Follow-up|0|||
125440755|NCT00708305|451241576|FG000|Period 2|Protocol Violation|0|||
125440756|NCT00708305|451241577|FG001|Period 2|Protocol Violation|1|||
125440757|NCT00708305|451241578|FG002|Period 2|Protocol Violation|0|||
125440758|NCT00708305|451241579|FG003|Period 2|Protocol Violation|0|||
125440759|NCT00708305|451241576|FG000|Period 2|Other Reason|1|||
125440760|NCT00708305|451241577|FG001|Period 2|Other Reason|0|||
125440761|NCT00708305|451241578|FG002|Period 2|Other Reason|0|||
125440762|NCT00708305|451241579|FG003|Period 2|Other Reason|1|||
125440763|NCT00708305|451241576|FG000|Period 3|Protocol Violation|0|||
125440764|NCT00708305|451241577|FG001|Period 3|Protocol Violation|2|||
125440765|NCT00708305|451241578|FG002|Period 3|Protocol Violation|0|||
125440766|NCT00708305|451241579|FG003|Period 3|Protocol Violation|0|||
125440767|NCT00708305|451241576|FG000|Period 3|Other Reason|1|||
125440768|NCT00708305|451241577|FG001|Period 3|Other Reason|0|||
125440769|NCT00708305|451241578|FG002|Period 3|Other Reason|0|||
125440770|NCT00708305|451241579|FG003|Period 3|Other Reason|0|||
125440771|NCT02823964|451241584|FG000|Overall Study|Adverse Event|2|||
125440772|NCT02823964|451241584|FG000|Overall Study|Physician Decision|1|||
125440773|NCT02823964|451241584|FG000|Overall Study|Lack of Efficacy|1|||
125440774|NCT02823964|451241584|FG000|Overall Study|Withdrawal by Subject|1|||
125440775|NCT04012814|451241587|FG000|Overall Study|Lost to Follow-up|4|||
125440776|NCT04012814|451241587|FG000|Overall Study|Withdrawal by Subject|2|||
125440777|NCT04012814|451241587|FG000|Overall Study|Protocol Violation|1|||
125440778|NCT04012814|451241587|FG000|Overall Study|Adverse Event|1|||
125440779|NCT00390455|451241588|FG000|Overall Study|Adverse Event|17|||
125440780|NCT00390455|451241589|FG001|Overall Study|Adverse Event|3|||
125440781|NCT00390455|451241588|FG000|Overall Study|Withdrawal by Subject|8|||
125440782|NCT00390455|451241589|FG001|Overall Study|Withdrawal by Subject|8|||
125440783|NCT00390455|451241588|FG000|Overall Study|Alternate Treatment|0|||
125440784|NCT00390455|451241589|FG001|Overall Study|Alternate Treatment|1|||
125440785|NCT00390455|451241588|FG000|Overall Study|Other Medical Reasons|7|||
125440786|NCT00390455|451241589|FG001|Overall Study|Other Medical Reasons|11|||
125440787|NCT02761629|451241594|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
125440788|NCT02761629|451241595|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
125440789|NCT02761629|451241594|FG000|Overall Study|Insufficient Therapeutic Response|2|||
125440790|NCT02761629|451241595|FG001|Overall Study|Insufficient Therapeutic Response|7|||
125440791|NCT02761629|451241594|FG000|Overall Study|Failure to Return|2|||
125440792|NCT02761629|451241595|FG001|Overall Study|Failure to Return|4|||
125440793|NCT02761629|451241594|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
125440794|NCT02761629|451241595|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
125440795|NCT02761629|451241594|FG000|Overall Study|Protocol Violation|2|||
125440796|NCT02761629|451241595|FG001|Overall Study|Protocol Violation|2|||
125440797|NCT02761629|451241594|FG000|Overall Study|Withdrawal by Subject|0|||
125440798|NCT02761629|451241595|FG001|Overall Study|Withdrawal by Subject|3|||
125440799|NCT02761629|451241594|FG000|Overall Study|Other|0|||
125391304|NCT03161483|451067049|FG003|Treatment Period|Other reasons|0|||
125391305|NCT02404350|451067060|FG000|Overall Study|Adverse Event|2|||
125391306|NCT02404350|451067061|FG001|Overall Study|Adverse Event|2|||
125391307|NCT02404350|451067062|FG002|Overall Study|Adverse Event|3|||
125391308|NCT02404350|451067063|FG003|Overall Study|Adverse Event|9|||
125391309|NCT02404350|451067060|FG000|Overall Study|Lack of Efficacy|3|||
125391310|NCT02404350|451067061|FG001|Overall Study|Lack of Efficacy|1|||
125391311|NCT02404350|451067062|FG002|Overall Study|Lack of Efficacy|0|||
125391312|NCT02404350|451067063|FG003|Overall Study|Lack of Efficacy|3|||
125391313|NCT02404350|451067060|FG000|Overall Study|Lost to Follow-up|2|||
125391314|NCT02404350|451067061|FG001|Overall Study|Lost to Follow-up|0|||
125391315|NCT02404350|451067062|FG002|Overall Study|Lost to Follow-up|0|||
125391316|NCT02404350|451067063|FG003|Overall Study|Lost to Follow-up|1|||
125391317|NCT02404350|451067060|FG000|Overall Study|Physician Decision|1|||
125391318|NCT02404350|451067061|FG001|Overall Study|Physician Decision|0|||
125391319|NCT02404350|451067062|FG002|Overall Study|Physician Decision|0|||
125391320|NCT02404350|451067063|FG003|Overall Study|Physician Decision|2|||
125391321|NCT02404350|451067060|FG000|Overall Study|Pregnancy|0|||
125440800|NCT02761629|451241595|FG001|Overall Study|Other|2|||
125440801|NCT02761629|451241594|FG000|Overall Study|Lost to Follow-up|4|||
125391322|NCT02404350|451067061|FG001|Overall Study|Pregnancy|0|||
125391323|NCT02404350|451067062|FG002|Overall Study|Pregnancy|0|||
125391324|NCT02404350|451067063|FG003|Overall Study|Pregnancy|1|||
125391325|NCT02404350|451067060|FG000|Overall Study|Withdrawal by Subject|7|||
125440802|NCT02761629|451241595|FG001|Overall Study|Lost to Follow-up|1|||
125440803|NCT02761629|451241594|FG000|Overall Study|Randomized But Not Treated|8|||
125440804|NCT02761629|451241595|FG001|Overall Study|Randomized But Not Treated|4|||
125440805|NCT02001974|451241598|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
125440806|NCT02001974|451241599|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
125440807|NCT02001974|451241600|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
125440808|NCT02001974|451241598|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
125163328|NCT03970837|450220784|FG007|Overall Study|Lack of Efficacy|1|||
125163329|NCT03970837|450220785|FG008|Overall Study|Lack of Efficacy|1|||
125163330|NCT03970837|450220786|FG009|Overall Study|Lack of Efficacy|0|||
125163331|NCT03970837|450220787|FG010|Overall Study|Lack of Efficacy|0|||
125163332|NCT03970837|450220788|FG011|Overall Study|Lack of Efficacy|0|||
125163333|NCT03970837|450220777|FG000|Overall Study|Lost to Follow-up|6|||
125163334|NCT03970837|450220778|FG001|Overall Study|Lost to Follow-up|5|||
125163335|NCT03970837|450220779|FG002|Overall Study|Lost to Follow-up|5|||
125225097|NCT01484951|450452031|FG000|Overall Study|Adverse Event|3|||
125225098|NCT01484951|450452031|FG000|Overall Study|Personal Reasons|1|||
125225099|NCT01484951|450452031|FG000|Overall Study|Non-Compliance|1|||
125225100|NCT00917124|450452036|FG000|Overall Study|Protocol Violation|4|||
125225101|NCT00917124|450452037|FG001|Overall Study|Protocol Violation|6|||
125225102|NCT00115778|450452038|FG000|Overall Study|Withdrawal by Subject|0|||
125225103|NCT00115778|450452039|FG001|Overall Study|Withdrawal by Subject|1|||
125225104|NCT00528424|450452042|FG000|Overall Study|Lost to Follow-up|13|||
125225105|NCT00528424|450452042|FG000|Overall Study|Withdrew consent|2|||
125225106|NCT00528424|450452042|FG000|Overall Study|Administrative reason|2|||
125225107|NCT00528424|450452042|FG000|Overall Study|Other|12|||
125225108|NCT02515630|450452043|FG000|Overall Study|Withdrawal by Subject|5|||
125225109|NCT02515630|450452043|FG000|Overall Study|Adverse Event|4|||
125225110|NCT02515630|450452043|FG000|Overall Study|Physician Decision|4|||
125225111|NCT02515630|450452043|FG000|Overall Study|Death|2|||
125225112|NCT02515630|450452043|FG000|Overall Study|Disease Progression|1|||
125225113|NCT00483652|450452044|FG000|Double-blind Treatment Period|Protocol Violation|2|||
125225114|NCT00483652|450452045|FG001|Double-blind Treatment Period|Protocol Violation|1|||
125225115|NCT00483652|450452044|FG000|Double-blind Treatment Period|Adverse Event|3|||
125225116|NCT00483652|450452045|FG001|Double-blind Treatment Period|Adverse Event|4|||
125225117|NCT00483652|450452044|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
125225118|NCT00483652|450452045|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
125225119|NCT00483652|450452044|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
125225120|NCT00483652|450452045|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
125225121|NCT00473655|450452050|FG000|Overall Study|Lost to Follow-up|9|||
125225122|NCT00473655|450452051|FG001|Overall Study|Lost to Follow-up|5|||
125225123|NCT00473655|450452052|FG002|Overall Study|Lost to Follow-up|8|||
125225124|NCT02219685|450452053|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
125225125|NCT02219685|450452054|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
125225126|NCT02219685|450452053|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
125225127|NCT02219685|450452054|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
125225128|NCT02869789|450452055|FG000|Overall Study|Disease progression|184|||
125225129|NCT02869789|450452056|FG001|Overall Study|Disease progression|109|||
125225130|NCT02869789|450452057|FG002|Overall Study|Disease progression|260|||
125225131|NCT02869789|450452058|FG003|Overall Study|Disease progression|19|||
125225132|NCT02869789|450452055|FG000|Overall Study|Study drug toxicity|90|||
125225133|NCT02869789|450452056|FG001|Overall Study|Study drug toxicity|32|||
125225134|NCT02869789|450452057|FG002|Overall Study|Study drug toxicity|55|||
125225135|NCT02869789|450452058|FG003|Overall Study|Study drug toxicity|14|||
125225136|NCT02869789|450452055|FG000|Overall Study|Death|7|||
125225137|NCT02869789|450452056|FG001|Overall Study|Death|3|||
125225138|NCT02869789|450452057|FG002|Overall Study|Death|5|||
125225139|NCT02869789|450452058|FG003|Overall Study|Death|1|||
125225140|NCT02869789|450452055|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
125225141|NCT02869789|450452056|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
125225142|NCT02869789|450452057|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
125225143|NCT02869789|450452058|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
125225144|NCT02869789|450452055|FG000|Overall Study|Participant request to discontinue study treatment|10|||
125225145|NCT02869789|450452056|FG001|Overall Study|Participant request to discontinue study treatment|5|||
125225146|NCT02869789|450452057|FG002|Overall Study|Participant request to discontinue study treatment|5|||
125225147|NCT02869789|450452058|FG003|Overall Study|Participant request to discontinue study treatment|3|||
125225148|NCT02869789|450452055|FG000|Overall Study|Withdrawal by Subject|5|||
125225149|NCT02869789|450452056|FG001|Overall Study|Withdrawal by Subject|2|||
125225150|NCT02869789|450452057|FG002|Overall Study|Withdrawal by Subject|7|||
125225151|NCT02869789|450452058|FG003|Overall Study|Withdrawal by Subject|2|||
125391326|NCT02404350|451067061|FG001|Overall Study|Withdrawal by Subject|3|||
125391327|NCT02404350|451067062|FG002|Overall Study|Withdrawal by Subject|3|||
125225152|NCT02869789|450452055|FG000|Overall Study|Lost to Follow-up|0|||
125225153|NCT02869789|450452056|FG001|Overall Study|Lost to Follow-up|0|||
125225154|NCT02869789|450452057|FG002|Overall Study|Lost to Follow-up|2|||
125225155|NCT02869789|450452058|FG003|Overall Study|Lost to Follow-up|0|||
125225156|NCT02869789|450452055|FG000|Overall Study|Maximum clinical benefit|5|||
125225157|NCT02869789|450452056|FG001|Overall Study|Maximum clinical benefit|2|||
125391328|NCT02404350|451067063|FG003|Overall Study|Withdrawal by Subject|19|||
125391329|NCT02404350|451067060|FG000|Overall Study|Due to Non-compliance with treatment|0|||
125163336|NCT03970837|450220780|FG003|Overall Study|Lost to Follow-up|1|||
125163337|NCT03970837|450220781|FG004|Overall Study|Lost to Follow-up|0|||
125163338|NCT03970837|450220782|FG005|Overall Study|Lost to Follow-up|2|||
125225158|NCT02869789|450452057|FG002|Overall Study|Maximum clinical benefit|1|||
125225159|NCT02869789|450452058|FG003|Overall Study|Maximum clinical benefit|0|||
125225160|NCT02869789|450452055|FG000|Overall Study|Poor/Non-compliance|0|||
125225161|NCT02869789|450452056|FG001|Overall Study|Poor/Non-compliance|2|||
125225162|NCT02869789|450452057|FG002|Overall Study|Poor/Non-compliance|1|||
125225163|NCT02869789|450452058|FG003|Overall Study|Poor/Non-compliance|0|||
125225164|NCT02869789|450452055|FG000|Overall Study|Participant no longer meets study criteria|0|||
125225165|NCT02869789|450452056|FG001|Overall Study|Participant no longer meets study criteria|1|||
125163339|NCT03970837|450220783|FG006|Overall Study|Lost to Follow-up|0|||
125163340|NCT03970837|450220784|FG007|Overall Study|Lost to Follow-up|0|||
125440809|NCT02001974|451241599|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
125440810|NCT02001974|451241600|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
125163341|NCT03970837|450220785|FG008|Overall Study|Lost to Follow-up|0|||
125163342|NCT03970837|450220786|FG009|Overall Study|Lost to Follow-up|0|||
125163343|NCT03970837|450220787|FG010|Overall Study|Lost to Follow-up|0|||
125163344|NCT03970837|450220788|FG011|Overall Study|Lost to Follow-up|0|||
125163345|NCT03970837|450220777|FG000|Overall Study|Protocol Violation|1|||
125163346|NCT03970837|450220778|FG001|Overall Study|Protocol Violation|0|||
125163347|NCT03970837|450220779|FG002|Overall Study|Protocol Violation|0|||
125163348|NCT03970837|450220780|FG003|Overall Study|Protocol Violation|0|||
125163349|NCT03970837|450220781|FG004|Overall Study|Protocol Violation|0|||
125163350|NCT03970837|450220782|FG005|Overall Study|Protocol Violation|0|||
125163351|NCT03970837|450220783|FG006|Overall Study|Protocol Violation|0|||
125225166|NCT02869789|450452057|FG002|Overall Study|Participant no longer meets study criteria|1|||
125225167|NCT02869789|450452058|FG003|Overall Study|Participant no longer meets study criteria|0|||
125440811|NCT02001974|451241598|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
125163352|NCT03970837|450220784|FG007|Overall Study|Protocol Violation|0|||
125440812|NCT02001974|451241599|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
125440813|NCT02001974|451241600|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
125440814|NCT02001974|451241598|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
125440815|NCT02001974|451241599|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
125440816|NCT02001974|451241600|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
125440817|NCT00210119|451241601|FG000|Overall Study|Protocol Violation|1|||
125440818|NCT00210119|451241601|FG000|Overall Study|Withdrawal by Subject|1|||
125440819|NCT04827134|451241602|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
125440820|NCT04827134|451241603|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
125440821|NCT04827134|451241604|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
125440822|NCT04827134|451241605|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
125440823|NCT04844918|451241606|FG000|Overall Study|Adverse Event|7|||
125440824|NCT04844918|451241607|FG001|Overall Study|Adverse Event|8|||
125440825|NCT04844918|451241608|FG002|Overall Study|Adverse Event|5|||
125440826|NCT04844918|451241606|FG000|Overall Study|Physician Decision|0|||
125440827|NCT04844918|451241607|FG001|Overall Study|Physician Decision|1|||
125440828|NCT04844918|451241608|FG002|Overall Study|Physician Decision|0|||
125440829|NCT04844918|451241606|FG000|Overall Study|Withdrawal by Subject|6|||
125440830|NCT04844918|451241607|FG001|Overall Study|Withdrawal by Subject|3|||
125440831|NCT04844918|451241608|FG002|Overall Study|Withdrawal by Subject|3|||
125440832|NCT04844918|451241606|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
125440833|NCT04844918|451241607|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
125440834|NCT04844918|451241608|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
125440835|NCT02743793|451241613|FG000|Overall Study|Death|1|||
125440836|NCT02743793|451241614|FG001|Overall Study|Death|1|||
125440837|NCT02743793|451241613|FG000|Overall Study|Withdrawal by Subject|0|||
125440838|NCT02743793|451241614|FG001|Overall Study|Withdrawal by Subject|1|||
125440839|NCT02743793|451241613|FG000|Overall Study|Screen Failure|4|||
125440840|NCT02743793|451241614|FG001|Overall Study|Screen Failure|0|||
125440841|NCT02743793|451241613|FG000|Overall Study|No Primary Care Physician|0|||
125440842|NCT02743793|451241614|FG001|Overall Study|No Primary Care Physician|1|||
125440843|NCT02743793|451241613|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
125163353|NCT03970837|450220785|FG008|Overall Study|Protocol Violation|0|||
125225168|NCT02869789|450452055|FG000|Overall Study|Administrative reason by sponsor|0|||
125225169|NCT02869789|450452056|FG001|Overall Study|Administrative reason by sponsor|0|||
125225170|NCT02869789|450452057|FG002|Overall Study|Administrative reason by sponsor|1|||
125225171|NCT02869789|450452058|FG003|Overall Study|Administrative reason by sponsor|0|||
125225172|NCT02869789|450452055|FG000|Overall Study|Other reasons|4|||
125440844|NCT02743793|451241614|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
125163354|NCT03970837|450220786|FG009|Overall Study|Protocol Violation|0|||
125163355|NCT03970837|450220787|FG010|Overall Study|Protocol Violation|0|||
125163356|NCT03970837|450220788|FG011|Overall Study|Protocol Violation|0|||
125163357|NCT03970837|450220777|FG000|Overall Study|Physician Decision|5|||
125440845|NCT02743793|451241613|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
125440846|NCT02743793|451241614|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
125440847|NCT02293837|451241617|FG000|Overall Study|Lost to Follow-up|0|||
125440848|NCT02293837|451241618|FG001|Overall Study|Lost to Follow-up|2|||
125440849|NCT02293837|451241619|FG002|Overall Study|Lost to Follow-up|1|||
125440850|NCT02293837|451241620|FG003|Overall Study|Lost to Follow-up|0|||
125440851|NCT02293837|451241617|FG000|Overall Study|Withdrawal by Subject|2|||
125440852|NCT02293837|451241618|FG001|Overall Study|Withdrawal by Subject|1|||
125440853|NCT02293837|451241619|FG002|Overall Study|Withdrawal by Subject|2|||
125440854|NCT02293837|451241620|FG003|Overall Study|Withdrawal by Subject|1|||
125440855|NCT02293837|451241617|FG000|Overall Study|COVID-19 Related|1|||
125440856|NCT02293837|451241618|FG001|Overall Study|COVID-19 Related|1|||
125440857|NCT02293837|451241619|FG002|Overall Study|COVID-19 Related|0|||
125440858|NCT02293837|451241620|FG003|Overall Study|COVID-19 Related|0|||
125440859|NCT02293837|451241617|FG000|Overall Study|Participant ill and could not be infused|0|||
125440860|NCT02293837|451241618|FG001|Overall Study|Participant ill and could not be infused|0|||
125440861|NCT02293837|451241619|FG002|Overall Study|Participant ill and could not be infused|1|||
125440862|NCT02293837|451241620|FG003|Overall Study|Participant ill and could not be infused|0|||
125440863|NCT04779242|451241621|FG000|Overall Study|Adverse Event|1|||
125440864|NCT04779242|451241622|FG001|Overall Study|Adverse Event|1|||
125440865|NCT04779242|451241621|FG000|Overall Study|Lost to Follow-up|2|||
125440866|NCT04779242|451241622|FG001|Overall Study|Lost to Follow-up|4|||
125440867|NCT04779242|451241621|FG000|Overall Study|Withdrawal by Subject|7|||
125440868|NCT04779242|451241622|FG001|Overall Study|Withdrawal by Subject|9|||
125440869|NCT04779242|451241621|FG000|Overall Study|Death|6|||
125440870|NCT04779242|451241622|FG001|Overall Study|Death|6|||
125440871|NCT04779242|451241621|FG000|Overall Study|COVID-19 related reasons|2|||
125440872|NCT04779242|451241622|FG001|Overall Study|COVID-19 related reasons|1|||
125440873|NCT04779242|451241621|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
125440874|NCT04779242|451241622|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
125440875|NCT04779242|451241621|FG000|Overall Study|Martial Law in Ukraine|2|||
125440876|NCT04779242|451241622|FG001|Overall Study|Martial Law in Ukraine|3|||
125440877|NCT03285113|451241623|FG000|Overall Study|Unable to implant leads|2|||
125440878|NCT01461993|451241625|FG000|Overall Study|Withdrawal by Subject|60|||
125440879|NCT01461993|451241626|FG001|Overall Study|Withdrawal by Subject|53|||
125440880|NCT01461993|451241627|FG002|Overall Study|Withdrawal by Subject|16|||
125440881|NCT01461993|451241625|FG000|Overall Study|Lost to Follow-up|44|||
125440882|NCT01461993|451241626|FG001|Overall Study|Lost to Follow-up|48|||
125440883|NCT01461993|451241627|FG002|Overall Study|Lost to Follow-up|22|||
125440884|NCT01461993|451241625|FG000|Overall Study|Protocol Violation|10|||
125440885|NCT01461993|451241626|FG001|Overall Study|Protocol Violation|9|||
125440886|NCT01461993|451241627|FG002|Overall Study|Protocol Violation|7|||
125440887|NCT01461993|451241625|FG000|Overall Study|Adverse Event|9|||
125440888|NCT01461993|451241626|FG001|Overall Study|Adverse Event|11|||
125440889|NCT01461993|451241627|FG002|Overall Study|Adverse Event|3|||
125440890|NCT01461993|451241625|FG000|Overall Study|No longer met eligibility criteria|13|||
125440891|NCT01461993|451241626|FG001|Overall Study|No longer met eligibility criteria|18|||
125440892|NCT01461993|451241627|FG002|Overall Study|No longer met eligibility criteria|10|||
125440893|NCT01461993|451241625|FG000|Overall Study|Did not meet entrance criteria|2|||
125440894|NCT01461993|451241626|FG001|Overall Study|Did not meet entrance criteria|3|||
125440895|NCT01461993|451241627|FG002|Overall Study|Did not meet entrance criteria|0|||
125440896|NCT01461993|451241625|FG000|Overall Study|Other|13|||
125440897|NCT01461993|451241626|FG001|Overall Study|Other|15|||
125440898|NCT01461993|451241627|FG002|Overall Study|Other|6|||
125440899|NCT00219141|451241629|FG000|Overall Study|Adverse Event|4|||
125440900|NCT00219141|451241630|FG001|Overall Study|Adverse Event|10|||
125440901|NCT00219141|451241631|FG002|Overall Study|Adverse Event|5|||
125163358|NCT03970837|450220778|FG001|Overall Study|Physician Decision|8|||
125163359|NCT03970837|450220779|FG002|Overall Study|Physician Decision|4|||
125163360|NCT03970837|450220780|FG003|Overall Study|Physician Decision|1|||
125163361|NCT03970837|450220781|FG004|Overall Study|Physician Decision|5|||
125163362|NCT03970837|450220782|FG005|Overall Study|Physician Decision|2|||
125163363|NCT03970837|450220783|FG006|Overall Study|Physician Decision|4|||
125163364|NCT03970837|450220784|FG007|Overall Study|Physician Decision|5|||
125163365|NCT03970837|450220785|FG008|Overall Study|Physician Decision|0|||
125163366|NCT03970837|450220786|FG009|Overall Study|Physician Decision|1|||
125163367|NCT03970837|450220787|FG010|Overall Study|Physician Decision|0|||
125440902|NCT00219141|451241629|FG000|Overall Study|Lack of Efficacy|3|||
125440903|NCT00219141|451241630|FG001|Overall Study|Lack of Efficacy|2|||
125163368|NCT03970837|450220788|FG011|Overall Study|Physician Decision|0|||
125163369|NCT03970837|450220777|FG000|Overall Study|Withdrawal by Subject|32|||
125163370|NCT03970837|450220778|FG001|Overall Study|Withdrawal by Subject|35|||
125440904|NCT00219141|451241631|FG002|Overall Study|Lack of Efficacy|0|||
125440905|NCT00219141|451241629|FG000|Overall Study|Administrative problems|0|||
125440906|NCT00219141|451241630|FG001|Overall Study|Administrative problems|1|||
125440907|NCT00219141|451241631|FG002|Overall Study|Administrative problems|0|||
125440908|NCT00219141|451241629|FG000|Overall Study|Lost to Follow-up|2|||
125440909|NCT00219141|451241630|FG001|Overall Study|Lost to Follow-up|4|||
125440910|NCT00219141|451241631|FG002|Overall Study|Lost to Follow-up|1|||
125440911|NCT00219141|451241629|FG000|Overall Study|Protocol Violation|3|||
125440912|NCT00219141|451241630|FG001|Overall Study|Protocol Violation|1|||
125440913|NCT00219141|451241631|FG002|Overall Study|Protocol Violation|1|||
125440914|NCT00219141|451241629|FG000|Overall Study|Withdrawal by Subject|1|||
125440915|NCT00219141|451241630|FG001|Overall Study|Withdrawal by Subject|3|||
125440916|NCT00219141|451241631|FG002|Overall Study|Withdrawal by Subject|5|||
125225173|NCT02869789|450452056|FG001|Overall Study|Other reasons|8|||
125440917|NCT00219141|451241629|FG000|Overall Study|Condition no longer requires study drug|1|||
125440918|NCT00219141|451241630|FG001|Overall Study|Condition no longer requires study drug|0|||
125440919|NCT00219141|451241631|FG002|Overall Study|Condition no longer requires study drug|0|||
125440920|NCT02066532|451241634|FG000|Phase II|Withdrawal by Subject|1|||
125440921|NCT02066532|451241635|FG001|Phase II|Withdrawal by Subject|0|||
125440922|NCT02066532|451241636|FG002|Phase II|Withdrawal by Subject|0|||
125440923|NCT02066532|451241637|FG003|Phase II|Withdrawal by Subject|0|||
125440924|NCT05033080|451241638|FG000|Overall Study|Adverse Event|4|||
125440925|NCT05033080|451241639|FG001|Overall Study|Adverse Event|4|||
125440926|NCT05033080|451241638|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
125440927|NCT05033080|451241639|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
125440928|NCT05033080|451241638|FG000|Overall Study|Lost to Follow-up|1|||
125440929|NCT05033080|451241639|FG001|Overall Study|Lost to Follow-up|0|||
125440930|NCT05033080|451241638|FG000|Overall Study|Other non-compliance|0|||
125440931|NCT05033080|451241639|FG001|Overall Study|Other non-compliance|1|||
125440932|NCT05033080|451241638|FG000|Overall Study|Physician Decision|0|||
125440933|NCT05033080|451241639|FG001|Overall Study|Physician Decision|1|||
125440934|NCT05033080|451241638|FG000|Overall Study|Other|1|||
125440935|NCT05033080|451241639|FG001|Overall Study|Other|1|||
125440936|NCT01263106|451241646|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
125440937|NCT01263106|451241647|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
125440938|NCT01680458|451241653|FG000|Overall Study|Protocol Violation|3|||
125440939|NCT01018563|451241654|FG000|Overall Study|Termination of the study by Sponsor|2|||
125440940|NCT01018563|451241655|FG001|Overall Study|Termination of the study by Sponsor|1|||
125440941|NCT00903786|451241667|FG000|Overall Study|Physician Decision|6|||
125440942|NCT00903786|451241667|FG000|Overall Study|Lack of Efficacy|5|||
125440943|NCT00903786|451241667|FG000|Overall Study|Reason other than lack of efficacy|4|||
125440944|NCT05822921|451241674|FG000|Overall Study|Lost to Follow-up|1|||
125440945|NCT05822921|451241675|FG001|Overall Study|Lost to Follow-up|1|||
125440946|NCT00544544|451241676|FG000|Overall Study|Withdrawal by Subject|1|||
125440947|NCT00544544|451241676|FG000|Overall Study|Adverse Event|1|||
125440948|NCT00544544|451241676|FG000|Overall Study|Lost to Follow-up|1|||
125440949|NCT03406702|451241677|FG000|Overall Study|Missed Day 27 Dosing|1|||
125440950|NCT01857622|451241680|FG000|Overall Study|Adverse Event|5|||
125440951|NCT01857622|451241681|FG001|Overall Study|Adverse Event|0|||
125440952|NCT01857622|451241682|FG002|Overall Study|Adverse Event|2|||
125440953|NCT01857622|451241680|FG000|Overall Study|Physician Decision|1|||
125440954|NCT01857622|451241681|FG001|Overall Study|Physician Decision|0|||
125440955|NCT01857622|451241682|FG002|Overall Study|Physician Decision|0|||
125440956|NCT01857622|451241680|FG000|Overall Study|Protocol Violation|4|||
125440957|NCT01857622|451241681|FG001|Overall Study|Protocol Violation|1|||
125440958|NCT01857622|451241682|FG002|Overall Study|Protocol Violation|0|||
125440959|NCT01857622|451241680|FG000|Overall Study|Withdrawal by Subject|1|||
125440960|NCT01857622|451241681|FG001|Overall Study|Withdrawal by Subject|0|||
125440961|NCT01857622|451241682|FG002|Overall Study|Withdrawal by Subject|0|||
125440962|NCT04318093|451241683|FG000|Overall Study|Adverse Event|2|||
125440963|NCT04318093|451241684|FG001|Overall Study|Adverse Event|2|||
125440964|NCT04318093|451241683|FG000|Overall Study|Participant withdrew consent|1|||
125440965|NCT04318093|451241684|FG001|Overall Study|Participant withdrew consent|0|||
125440966|NCT04318093|451241683|FG000|Overall Study|Other reasons|0|||
125440967|NCT04318093|451241684|FG001|Overall Study|Other reasons|1|||
125440968|NCT00127413|451241688|FG000|Overall Study|Lost to Follow-up|6|||
125440969|NCT00127413|451241689|FG001|Overall Study|Lost to Follow-up|4|||
125163371|NCT03970837|450220779|FG002|Overall Study|Withdrawal by Subject|12|||
125163372|NCT03970837|450220780|FG003|Overall Study|Withdrawal by Subject|8|||
125163373|NCT03970837|450220781|FG004|Overall Study|Withdrawal by Subject|6|||
125163374|NCT03970837|450220782|FG005|Overall Study|Withdrawal by Subject|8|||
125163375|NCT03970837|450220783|FG006|Overall Study|Withdrawal by Subject|2|||
125163376|NCT03970837|450220784|FG007|Overall Study|Withdrawal by Subject|3|||
125163377|NCT03970837|450220785|FG008|Overall Study|Withdrawal by Subject|0|||
125163378|NCT03970837|450220786|FG009|Overall Study|Withdrawal by Subject|0|||
125440970|NCT00127413|451241690|FG002|Overall Study|Lost to Follow-up|8|||
125163379|NCT03970837|450220787|FG010|Overall Study|Withdrawal by Subject|0|||
125163380|NCT03970837|450220788|FG011|Overall Study|Withdrawal by Subject|1|||
125440971|NCT00127413|451241691|FG003|Overall Study|Lost to Follow-up|2|||
125440972|NCT00547911|451241694|FG000|Overall Study|Adverse Event|0|||
125440973|NCT00547911|451241695|FG001|Overall Study|Adverse Event|0|||
125440974|NCT00547911|451241696|FG002|Overall Study|Adverse Event|0|||
125440975|NCT00547911|451241697|FG003|Overall Study|Adverse Event|1|||
125440976|NCT00547911|451241698|FG004|Overall Study|Adverse Event|0|||
125440977|NCT00547911|451241699|FG005|Overall Study|Adverse Event|0|||
125440978|NCT01644474|451241701|FG000|Overall Study|Poor compliance to protocol|1|||
125440979|NCT01644474|451241702|FG001|Overall Study|Poor compliance to protocol|0|||
125440980|NCT01644474|451241701|FG000|Overall Study|Consent withdrawn by participant|0|||
125440981|NCT01644474|451241702|FG001|Overall Study|Consent withdrawn by participant|1|||
125440982|NCT01644474|451241701|FG000|Overall Study|Participant moved|0|||
125440983|NCT01644474|451241702|FG001|Overall Study|Participant moved|1|||
125440984|NCT01644474|451241701|FG000|Overall Study|Adverse Event|4|||
125440985|NCT01644474|451241702|FG001|Overall Study|Adverse Event|5|||
125440986|NCT01644474|451241701|FG000|Overall Study|Site scheduling error|1|||
125440987|NCT01644474|451241702|FG001|Overall Study|Site scheduling error|1|||
125440988|NCT01644474|451241701|FG000|Overall Study|Protocol Violation|1|||
125440989|NCT01644474|451241702|FG001|Overall Study|Protocol Violation|0|||
125440990|NCT02023879|451241703|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
125440991|NCT02023879|451241704|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
125440992|NCT02023879|451241705|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
125440993|NCT02023879|451241703|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
125440994|NCT02023879|451241704|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
125440995|NCT02023879|451241705|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
125440996|NCT02023879|451241703|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
125440997|NCT02023879|451241704|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
125440998|NCT02023879|451241705|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
125440999|NCT02023879|451241703|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
125441000|NCT02023879|451241704|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
125441001|NCT02023879|451241705|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
125441002|NCT02023879|451241703|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
125441003|NCT02023879|451241704|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
125441004|NCT02023879|451241705|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
125441005|NCT02023879|451241703|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
125163381|NCT03970837|450220777|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
125163382|NCT03970837|450220778|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
125163383|NCT03970837|450220779|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
125163384|NCT03970837|450220780|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
125163385|NCT03970837|450220781|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
125163386|NCT03970837|450220782|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
125163387|NCT03970837|450220783|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
125163388|NCT03970837|450220784|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
125163389|NCT03970837|450220785|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
125163390|NCT03970837|450220786|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
125163391|NCT03970837|450220787|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
125163392|NCT03970837|450220788|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
125163393|NCT03970837|450220777|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125163394|NCT03970837|450220778|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125163395|NCT03970837|450220779|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125163396|NCT03970837|450220780|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125163397|NCT03970837|450220781|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125163398|NCT03970837|450220782|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125163399|NCT03970837|450220783|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
125163400|NCT03970837|450220784|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
125163401|NCT03970837|450220785|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
125163402|NCT03970837|450220786|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
125163403|NCT03970837|450220787|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
125163404|NCT03970837|450220788|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
125163405|NCT01425723|450220791|FG000|Overall Study|Lack of Efficacy|0|||
125163406|NCT01425723|450220792|FG001|Overall Study|Lack of Efficacy|1|||
125163407|NCT01425723|450220791|FG000|Overall Study|Withdrawal by Subject|1|||
125163408|NCT01425723|450220792|FG001|Overall Study|Withdrawal by Subject|4|||
125163409|NCT01425723|450220791|FG000|Overall Study|Lost to Follow-up|0|||
125163410|NCT01425723|450220792|FG001|Overall Study|Lost to Follow-up|3|||
125163411|NCT01425723|450220791|FG000|Overall Study|Physician Decision|2|||
125163412|NCT01425723|450220792|FG001|Overall Study|Physician Decision|0|||
125163413|NCT01425723|450220791|FG000|Overall Study|Other|1|||
125163414|NCT01425723|450220792|FG001|Overall Study|Other|10|||
125163415|NCT00186043|450220793|FG000|Overall Study|Lack of Efficacy|1|||
125163416|NCT00186043|450220794|FG001|Overall Study|Lack of Efficacy|3|||
125163417|NCT00186043|450220793|FG000|Overall Study|Lost to Follow-up|4|||
125163418|NCT00186043|450220794|FG001|Overall Study|Lost to Follow-up|6|||
125163419|NCT00186043|450220793|FG000|Overall Study|Withdrawal by Subject|1|||
125163420|NCT00186043|450220794|FG001|Overall Study|Withdrawal by Subject|0|||
125163421|NCT00186043|450220793|FG000|Overall Study|Adverse Event|7|||
125163422|NCT00186043|450220794|FG001|Overall Study|Adverse Event|3|||
125163423|NCT00186043|450220793|FG000|Overall Study|Protocol Violation|2|||
125163424|NCT00186043|450220794|FG001|Overall Study|Protocol Violation|1|||
125163425|NCT04874636|450220795|FG000|Overall Study|Adverse Event|17|||
125163426|NCT04874636|450220796|FG001|Overall Study|Adverse Event|7|||
125163427|NCT04874636|450220795|FG000|Overall Study|Lost to Follow-up|1|||
125163428|NCT04874636|450220796|FG001|Overall Study|Lost to Follow-up|0|||
125163429|NCT04874636|450220795|FG000|Overall Study|Non-Compliance with Study Drug|2|||
125163430|NCT04874636|450220796|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125163431|NCT04874636|450220795|FG000|Overall Study|Physician Decision|1|||
125163432|NCT04874636|450220796|FG001|Overall Study|Physician Decision|0|||
125163433|NCT04874636|450220795|FG000|Overall Study|Withdrawal by Subject|6|||
125391330|NCT02404350|451067061|FG001|Overall Study|Due to Non-compliance with treatment|0|||
125391331|NCT02404350|451067062|FG002|Overall Study|Due to Non-compliance with treatment|0|||
125391332|NCT02404350|451067063|FG003|Overall Study|Due to Non-compliance with treatment|1|||
125391333|NCT02404350|451067060|FG000|Overall Study|Due to Technical problems|0|||
125391334|NCT02404350|451067061|FG001|Overall Study|Due to Technical problems|0|||
125391335|NCT02404350|451067062|FG002|Overall Study|Due to Technical problems|0|||
125391336|NCT02404350|451067063|FG003|Overall Study|Due to Technical problems|1|||
125391337|NCT04238728|451067064|FG000|Overall Study|Withdrawal by Subject|1|||
125391338|NCT04238728|451067064|FG000|Overall Study|Lost to Follow-up|2|||
125391339|NCT05389657|451067066|FG000|Overall Study|Lost to Follow-up|7|||
125391340|NCT05389657|451067067|FG001|Overall Study|Lost to Follow-up|8|||
125391341|NCT01256593|451067069|FG000|Overall Study|Protocol Violation|26|||
125391342|NCT01256593|451067069|FG000|Overall Study|No Drug Administration Information|2|||
125391343|NCT01256593|451067069|FG000|Overall Study|No Visit After Treatment|186|||
125391344|NCT01498640|451067070|FG000|Overall Study|Lost to Follow-up|1|||
125391345|NCT01498640|451067070|FG000|Overall Study|Death|1|||
125391346|NCT01498640|451067070|FG000|Overall Study|Other|3|||
125391347|NCT03065244|451067077|FG000|Overall Study|Lost to Follow-up|1|||
125391348|NCT03065244|451067078|FG001|Overall Study|Lost to Follow-up|1|||
125391349|NCT03065244|451067077|FG000|Overall Study|Diagnosed with a different disease|1|||
125391350|NCT03065244|451067078|FG001|Overall Study|Diagnosed with a different disease|1|||
125391351|NCT03065244|451067077|FG000|Overall Study|Protocol Violation|0|||
125391352|NCT03065244|451067078|FG001|Overall Study|Protocol Violation|1|||
125391353|NCT03065244|451067077|FG000|Overall Study|Withdrawal by Subject|1|||
125391354|NCT03065244|451067078|FG001|Overall Study|Withdrawal by Subject|1|||
125391355|NCT03717480|451067079|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
125391356|NCT01708174|451067080|FG000|Treatment Period|Withdrawal by Subject|1|||
125391357|NCT01708174|451067081|FG001|Treatment Period|Withdrawal by Subject|0|||
125391358|NCT01708174|451067082|FG002|Treatment Period|Withdrawal by Subject|0|||
125391359|NCT01708174|451067080|FG000|Treatment Period|Progressive disease|0|||
125391360|NCT01708174|451067081|FG001|Treatment Period|Progressive disease|1|||
125391361|NCT01708174|451067082|FG002|Treatment Period|Progressive disease|0|||
125391362|NCT01708174|451067080|FG000|Treatment Period|Death|0|||
125391363|NCT01708174|451067081|FG001|Treatment Period|Death|0|||
125391364|NCT01708174|451067082|FG002|Treatment Period|Death|1|||
125391365|NCT01708174|451067080|FG000|Treatment Period|Adverse Event|0|||
125391366|NCT01708174|451067081|FG001|Treatment Period|Adverse Event|1|||
125391367|NCT01708174|451067082|FG002|Treatment Period|Adverse Event|0|||
125391368|NCT01894152|451067083|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
125391369|NCT01774786|451067084|FG000|Overall Study|Death|300|||
125391370|NCT01774786|451067085|FG001|Overall Study|Death|319|||
125391371|NCT01774786|451067084|FG000|Overall Study|Lost to Follow-up|6|||
125391372|NCT01774786|451067085|FG001|Overall Study|Lost to Follow-up|7|||
125391373|NCT01774786|451067084|FG000|Overall Study|Withdrawal by Subject|18|||
125391374|NCT01774786|451067085|FG001|Overall Study|Withdrawal by Subject|14|||
125391375|NCT01774786|451067084|FG000|Overall Study|Physician Decision|2|||
125391376|NCT01774786|451067085|FG001|Overall Study|Physician Decision|0|||
125391377|NCT01774786|451067084|FG000|Overall Study|Non-compliance|0|||
125391378|NCT01774786|451067085|FG001|Overall Study|Non-compliance|1|||
125391379|NCT01774786|451067084|FG000|Overall Study|Reason Not Specified|2|||
125391380|NCT01774786|451067085|FG001|Overall Study|Reason Not Specified|5|||
125391381|NCT02385084|451067086|FG000|Period 2|Protocol Violation|0|||
125391382|NCT02385084|451067087|FG001|Period 2|Protocol Violation|0|||
125391383|NCT02385084|451067088|FG002|Period 2|Protocol Violation|1|||
125391384|NCT02385084|451067089|FG003|Period 2|Protocol Violation|0|||
125391385|NCT02385084|451067090|FG004|Period 2|Protocol Violation|0|||
125441006|NCT02023879|451241704|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
125163434|NCT04874636|450220796|FG001|Overall Study|Withdrawal by Subject|5|||
125391386|NCT02385084|451067091|FG005|Period 2|Protocol Violation|0|||
125391387|NCT02965703|451067097|FG000|Overall Study|Withdrawal by Subject|6|||
125391388|NCT02965703|451067098|FG001|Overall Study|Withdrawal by Subject|3|||
125391389|NCT02965703|451067099|FG002|Overall Study|Withdrawal by Subject|1|||
125391390|NCT02965703|451067097|FG000|Overall Study|Protocol Violation|1|||
125391391|NCT02965703|451067098|FG001|Overall Study|Protocol Violation|0|||
125391392|NCT02965703|451067099|FG002|Overall Study|Protocol Violation|0|||
125391393|NCT02965703|451067097|FG000|Overall Study|Adverse Event|1|||
125391394|NCT02965703|451067098|FG001|Overall Study|Adverse Event|1|||
125391395|NCT02965703|451067099|FG002|Overall Study|Adverse Event|0|||
125441007|NCT02023879|451241705|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
125441008|NCT02023879|451241703|FG000|Extension Open Label Treatment|Adverse Event|1|||
125441009|NCT02023879|451241704|FG001|Extension Open Label Treatment|Adverse Event|7|||
125441010|NCT02023879|451241705|FG002|Extension Open Label Treatment|Adverse Event|3|||
125441011|NCT02023879|451241703|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
125441012|NCT02023879|451241704|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
125441013|NCT02023879|451241705|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
125441014|NCT02023879|451241703|FG000|Extension Open Label Treatment|Participant moved|1|||
125441015|NCT02023879|451241704|FG001|Extension Open Label Treatment|Participant moved|2|||
125163435|NCT00228423|450220799|FG000|Overall Study|Adverse Event|2|||
125163436|NCT00228423|450220800|FG001|Overall Study|Adverse Event|5|||
125163437|NCT00228423|450220799|FG000|Overall Study|Withdrawal by Subject|7|||
125163438|NCT00228423|450220800|FG001|Overall Study|Withdrawal by Subject|3|||
125163439|NCT00228423|450220799|FG000|Overall Study|Protocol Violation|1|||
125163440|NCT00228423|450220800|FG001|Overall Study|Protocol Violation|3|||
125163441|NCT00228423|450220799|FG000|Overall Study|Physician Decision|0|||
125163442|NCT00228423|450220800|FG001|Overall Study|Physician Decision|1|||
125163443|NCT03845296|450222637|FG000|Overall Study|On Treatment|2|||
125441016|NCT02023879|451241705|FG002|Extension Open Label Treatment|Participant moved|0|||
125441017|NCT02023879|451241703|FG000|Extension Open Label Treatment|Other than specified above|2|||
125163444|NCT03845296|450222638|FG001|Overall Study|On Treatment|1|||
125163445|NCT03845296|450222637|FG000|Overall Study|Adverse Event|4|||
125163446|NCT03845296|450222638|FG001|Overall Study|Adverse Event|11|||
125441018|NCT02023879|451241704|FG001|Extension Open Label Treatment|Other than specified above|7|||
125441019|NCT02023879|451241705|FG002|Extension Open Label Treatment|Other than specified above|2|||
125441020|NCT02044458|451241709|FG000|Overall Study|Protocol Violation|3|||
125441021|NCT02044458|451241710|FG001|Overall Study|Protocol Violation|8|||
125441022|NCT03363659|451241711|FG000|Overall Study|Adverse Event|1|||
125441023|NCT03363659|451241711|FG000|Overall Study|Screen fail|1|||
125441024|NCT03363659|451241711|FG000|Overall Study|Withdrawal by Subject|1|||
125441025|NCT03872388|451241712|FG000|Overall Study|Disease Progression|0|||
125441026|NCT03872388|451241713|FG001|Overall Study|Disease Progression|0|||
125441027|NCT03872388|451241714|FG002|Overall Study|Disease Progression|0|||
125441028|NCT03872388|451241715|FG003|Overall Study|Disease Progression|0|||
125441029|NCT03872388|451241716|FG004|Overall Study|Disease Progression|0|||
125441030|NCT03872388|451241717|FG005|Overall Study|Disease Progression|0|||
125441031|NCT03872388|451241718|FG006|Overall Study|Disease Progression|1|||
125441032|NCT03872388|451241719|FG007|Overall Study|Disease Progression|1|||
125441033|NCT01040780|451244075|FG000|Overall Study|Protocol Violation|1|||
125441034|NCT01040780|451244076|FG001|Overall Study|Protocol Violation|3|||
125441035|NCT00802737|451244077|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
125441036|NCT00802737|451244078|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
125441037|NCT00802737|451244079|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
125441038|NCT00802737|451244077|FG000|Overall Study|Death|6|||
125441039|NCT00802737|451244078|FG001|Overall Study|Death|5|||
125441040|NCT00802737|451244079|FG002|Overall Study|Death|1|||
125441041|NCT00802737|451244077|FG000|Overall Study|Adverse Event|1|||
125441042|NCT00802737|451244078|FG001|Overall Study|Adverse Event|0|||
125441043|NCT00802737|451244079|FG002|Overall Study|Adverse Event|0|||
125163447|NCT03845296|450222637|FG000|Overall Study|Refusal unrelated to adverse event|0|||
125163448|NCT03845296|450222638|FG001|Overall Study|Refusal unrelated to adverse event|1|||
125163449|NCT03845296|450222637|FG000|Overall Study|Progression/relapse|14|||
125163450|NCT03845296|450222638|FG001|Overall Study|Progression/relapse|18|||
125163451|NCT03845296|450222637|FG000|Overall Study|Death|4|||
125163452|NCT03845296|450222638|FG001|Overall Study|Death|0|||
125163453|NCT03845296|450222637|FG000|Overall Study|Other - not protocol specified|1|||
125163454|NCT03845296|450222638|FG001|Overall Study|Other - not protocol specified|3|||
125163455|NCT01200992|450222642|FG000|Overall Study|Study terminated early|35|||
125163456|NCT01200992|450222643|FG001|Overall Study|Study terminated early|41|||
125163457|NCT01200992|450222642|FG000|Overall Study|Randomized but not treated|2|||
125163458|NCT01200992|450222643|FG001|Overall Study|Randomized but not treated|0|||
125163459|NCT02213510|450222652|FG000|Overall Study|Death|0|||
125163460|NCT02213510|450222653|FG001|Overall Study|Death|1|||
125163461|NCT02213510|450222652|FG000|Overall Study|Lost to Follow-up|1|||
125163462|NCT02213510|450222653|FG001|Overall Study|Lost to Follow-up|0|||
125163463|NCT04241315|450222666|FG000|Overall Study|Withdrawal by Subject|0|||
125441044|NCT00802737|451244077|FG000|Overall Study|Received Prohibited Therapy|1|||
125163464|NCT04241315|450222667|FG001|Overall Study|Withdrawal by Subject|1|||
125163465|NCT00699283|450222668|FG000|Overall Study|Lack of Efficacy|15|||
125441045|NCT00802737|451244078|FG001|Overall Study|Received Prohibited Therapy|0|||
125163466|NCT00699283|450222669|FG001|Overall Study|Lack of Efficacy|5|||
125163467|NCT00699283|450222668|FG000|Overall Study|Lost to Follow-up|2|||
125441046|NCT00802737|451244079|FG002|Overall Study|Received Prohibited Therapy|0|||
125441047|NCT00802737|451244077|FG000|Overall Study|Ongoing CLL-Treatment|0|||
125441048|NCT00802737|451244078|FG001|Overall Study|Ongoing CLL-Treatment|1|||
125441049|NCT00802737|451244079|FG002|Overall Study|Ongoing CLL-Treatment|0|||
125441050|NCT00802737|451244077|FG000|Overall Study|Participant too Unwell|0|||
125441051|NCT00802737|451244078|FG001|Overall Study|Participant too Unwell|2|||
125441052|NCT00802737|451244079|FG002|Overall Study|Participant too Unwell|0|||
125441053|NCT03864926|451244087|FG000|Overall Study|Death|0|||
125441054|NCT03864926|451244088|FG001|Overall Study|Death|2|||
125441055|NCT00445601|451244089|FG000|Overall Study|Withdrawal by Subject|11|||
125441056|NCT00445601|451244090|FG001|Overall Study|Withdrawal by Subject|11|||
125441057|NCT00445601|451244089|FG000|Overall Study|TURBT Complication|12|||
125441058|NCT00445601|451244090|FG001|Overall Study|TURBT Complication|8|||
125441059|NCT00445601|451244089|FG000|Overall Study|Incorrect Disease Status|6|||
125441060|NCT00445601|451244090|FG001|Overall Study|Incorrect Disease Status|6|||
125441061|NCT00445601|451244089|FG000|Overall Study|Drug Delivery Issue|2|||
125441062|NCT00445601|451244090|FG001|Overall Study|Drug Delivery Issue|2|||
125441063|NCT00445601|451244089|FG000|Overall Study|Adverse Event|2|||
125441064|NCT00445601|451244090|FG001|Overall Study|Adverse Event|0|||
125441065|NCT00445601|451244089|FG000|Overall Study|Death prior to TURBT|0|||
125441066|NCT00445601|451244090|FG001|Overall Study|Death prior to TURBT|1|||
125441067|NCT01625910|451244097|FG000|Overall Study|Lost to Follow-up|3|||
125441068|NCT01625910|451244098|FG001|Overall Study|Lost to Follow-up|4|||
125441069|NCT02959138|451244099|FG000|Overall Study|Enrolled but Never Treated|0|||
125441070|NCT02959138|451244100|FG001|Overall Study|Enrolled but Never Treated|1|||
125441071|NCT02959138|451244101|FG002|Overall Study|Enrolled but Never Treated|0|||
125441072|NCT02391038|451244102|FG000|Overall Study|Progressive disease|3|||
125441073|NCT02391038|451244103|FG001|Overall Study|Progressive disease|3|||
125441074|NCT02391038|451244104|FG002|Overall Study|Progressive disease|6|||
125441075|NCT04213989|451244110|FG000|Overall Study|Withdrawal by Subject|3|||
125441076|NCT04213989|451244111|FG001|Overall Study|Withdrawal by Subject|2|||
125441077|NCT04213989|451244110|FG000|Overall Study|Physician Decision|1|||
125441078|NCT04213989|451244111|FG001|Overall Study|Physician Decision|0|||
125441079|NCT04213989|451244110|FG000|Overall Study|Lost to Follow-up|0|||
125441080|NCT04213989|451244111|FG001|Overall Study|Lost to Follow-up|4|||
125441081|NCT01681368|451244116|FG000|Overall Study|Refused further treatment|1|||
125441082|NCT01681368|451244116|FG000|Overall Study|Refused further follow up|1|||
125441083|NCT01189890|451244117|FG000|Overall Study|Adverse Event|3|||
125441084|NCT01189890|451244118|FG001|Overall Study|Adverse Event|4|||
125441085|NCT01189890|451244117|FG000|Overall Study|Lack of Efficacy|7|||
125225174|NCT02869789|450452057|FG002|Overall Study|Other reasons|6|||
125225175|NCT02869789|450452058|FG003|Overall Study|Other reasons|0|||
125225176|NCT01566604|450452061|FG000|Overall Study|Patient's inability to use the device|1|||
125225177|NCT01566604|450452062|FG001|Overall Study|Patient's inability to use the device|0|||
125225178|NCT01566604|450452061|FG000|Overall Study|Administrative problems|1|||
125225179|NCT01566604|450452062|FG001|Overall Study|Administrative problems|0|||
125225180|NCT01566604|450452061|FG000|Overall Study|Lack of Efficacy|1|||
125225181|NCT01566604|450452062|FG001|Overall Study|Lack of Efficacy|2|||
125225182|NCT01566604|450452061|FG000|Overall Study|Protocol deviation|2|||
125225183|NCT01566604|450452062|FG001|Overall Study|Protocol deviation|0|||
125225184|NCT01566604|450452061|FG000|Overall Study|Abnormal laboratory value|2|||
125225185|NCT01566604|450452062|FG001|Overall Study|Abnormal laboratory value|0|||
125441086|NCT01189890|451244118|FG001|Overall Study|Lack of Efficacy|2|||
125441087|NCT01189890|451244117|FG000|Overall Study|Lost to Follow-up|1|||
125441088|NCT01189890|451244118|FG001|Overall Study|Lost to Follow-up|7|||
125441089|NCT01189890|451244117|FG000|Overall Study|Protocol Violation|1|||
125163468|NCT00699283|450222669|FG001|Overall Study|Lost to Follow-up|0|||
125163469|NCT00699283|450222668|FG000|Overall Study|Withdrawal by Subject|1|||
125163470|NCT00699283|450222669|FG001|Overall Study|Withdrawal by Subject|0|||
125163471|NCT00699283|450222668|FG000|Overall Study|Other Reason|5|||
125163472|NCT00699283|450222669|FG001|Overall Study|Other Reason|1|||
125163473|NCT00699283|450222668|FG000|Overall Study|SAE, non-fatal|1|||
125163474|NCT00699283|450222669|FG001|Overall Study|SAE, non-fatal|1|||
125163475|NCT00699283|450222668|FG000|Overall Study|AE, non-serious non-fatal|8|||
125163476|NCT00699283|450222669|FG001|Overall Study|AE, non-serious non-fatal|1|||
125163477|NCT00699283|450222668|FG000|Overall Study|AE of unknown type|1|||
125163478|NCT00699283|450222669|FG001|Overall Study|AE of unknown type|0|||
125163479|NCT00394524|450222670|FG000|Overall Study|Protocol Violation|2|||
125441090|NCT01189890|451244118|FG001|Overall Study|Protocol Violation|5|||
125441091|NCT01189890|451244117|FG000|Overall Study|Withdrawal by Subject|15|||
125441092|NCT01189890|451244118|FG001|Overall Study|Withdrawal by Subject|11|||
125163480|NCT00394524|450222671|FG001|Overall Study|Protocol Violation|3|||
125163481|NCT00394524|450222670|FG000|Overall Study|Death|1|||
125225186|NCT01566604|450452061|FG000|Overall Study|Death|4|||
125225187|NCT01566604|450452062|FG001|Overall Study|Death|1|||
125225188|NCT01566604|450452061|FG000|Overall Study|Adverse Event|4|||
125225189|NCT01566604|450452062|FG001|Overall Study|Adverse Event|2|||
125163482|NCT00394524|450222671|FG001|Overall Study|Death|0|||
125225190|NCT01566604|450452061|FG000|Overall Study|Withdrawal by Subject|9|||
125441093|NCT01189890|451244117|FG000|Overall Study|Non Compliance|0|||
125441094|NCT01189890|451244118|FG001|Overall Study|Non Compliance|1|||
125441095|NCT01189890|451244117|FG000|Overall Study|Physician Decision|5|||
125441096|NCT01189890|451244118|FG001|Overall Study|Physician Decision|4|||
125163483|NCT00394524|450222670|FG000|Overall Study|Withdrawal by Subject|0|||
125163484|NCT00394524|450222671|FG001|Overall Study|Withdrawal by Subject|1|||
125163485|NCT01398514|450222672|FG000|Overall Study|Adverse Event|1|||
125163486|NCT01398514|450222673|FG001|Overall Study|Adverse Event|0|||
125163487|NCT01398514|450222672|FG000|Overall Study|Non-compliance with study procedures|2|||
125163488|NCT01398514|450222673|FG001|Overall Study|Non-compliance with study procedures|0|||
125163489|NCT01398514|450222672|FG000|Overall Study|Physiologic non-responsiveness|1|||
125163490|NCT01398514|450222673|FG001|Overall Study|Physiologic non-responsiveness|3|||
125163491|NCT01398514|450222672|FG000|Overall Study|Failure to show a conditioned response|4|||
125163492|NCT01398514|450222673|FG001|Overall Study|Failure to show a conditioned response|3|||
125163493|NCT03537599|450222674|FG000|Overall Study|Disease Progression|2|||
125163494|NCT03537599|450222675|FG001|Overall Study|Disease Progression|1|||
125163495|NCT03537599|450222674|FG000|Overall Study|Death|0|||
125163496|NCT03537599|450222675|FG001|Overall Study|Death|1|||
125163497|NCT01007942|450222676|FG000|Overall Study|Adverse Event|29|||
125163498|NCT01007942|450222677|FG001|Overall Study|Adverse Event|14|||
125163499|NCT01007942|450222676|FG000|Overall Study|Abnormal test procedure|0|||
125163500|NCT01007942|450222677|FG001|Overall Study|Abnormal test procedure|1|||
125163501|NCT01007942|450222676|FG000|Overall Study|Disease progression|217|||
125391396|NCT02965703|451067097|FG000|Overall Study|Lost to Follow-up|2|||
125391397|NCT02965703|451067098|FG001|Overall Study|Lost to Follow-up|1|||
125391398|NCT02965703|451067099|FG002|Overall Study|Lost to Follow-up|1|||
125391399|NCT00744627|451067100|FG000|Overall Study|Adverse Event|6|||
125391400|NCT00744627|451067101|FG001|Overall Study|Adverse Event|9|||
125391401|NCT00744627|451067100|FG000|Overall Study|Lack of Efficacy|7|||
125391402|NCT00744627|451067101|FG001|Overall Study|Lack of Efficacy|3|||
125391403|NCT00744627|451067100|FG000|Overall Study|Noncompliance|0|||
125391404|NCT00744627|451067101|FG001|Overall Study|Noncompliance|1|||
125391405|NCT00744627|451067100|FG000|Overall Study|Protocol Deviations|0|||
125391406|NCT00744627|451067101|FG001|Overall Study|Protocol Deviations|2|||
125391407|NCT00744627|451067100|FG000|Overall Study|Voluntary Withdrawal|9|||
125391408|NCT00744627|451067101|FG001|Overall Study|Voluntary Withdrawal|6|||
125391409|NCT00744627|451067100|FG000|Overall Study|Lost to Follow-up|2|||
125391410|NCT00744627|451067101|FG001|Overall Study|Lost to Follow-up|1|||
125391411|NCT00744627|451067100|FG000|Overall Study|Other|1|||
125391412|NCT00744627|451067101|FG001|Overall Study|Other|0|||
125391413|NCT02268786|451067102|FG000|Overall Study|No Euploid Embryos available|42|||
125391414|NCT02268786|451067103|FG001|Overall Study|No Euploid Embryos available|0|||
125391415|NCT02268786|451067102|FG000|Overall Study|Withdrawal by Subject|7|||
125391416|NCT02268786|451067103|FG001|Overall Study|Withdrawal by Subject|14|||
125391417|NCT02268786|451067102|FG000|Overall Study|Thaw Failure|6|||
125391418|NCT02268786|451067103|FG001|Overall Study|Thaw Failure|4|||
125391419|NCT02268786|451067102|FG000|Overall Study|Protocol Violation|1|||
125391420|NCT02268786|451067103|FG001|Overall Study|Protocol Violation|0|||
125391421|NCT00768144|451067104|FG000|Overall Study|Adverse Event|13|||
125391422|NCT00768144|451067104|FG000|Overall Study|Progressive Disease|21|||
125391423|NCT00768144|451067104|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
125391424|NCT00768144|451067104|FG000|Overall Study|Pt Withdrew Consent|1|||
125391425|NCT04251221|451067105|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
125391426|NCT04251221|451067106|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
125391427|NCT02171260|451067107|FG000|Overall Study|Death|0|||
125391428|NCT02171260|451067108|FG001|Overall Study|Death|0|||
125391429|NCT02171260|451067109|FG002|Overall Study|Death|0|||
125391430|NCT02171260|451067110|FG003|Overall Study|Death|1|||
125391431|NCT02171260|451067107|FG000|Overall Study|Physician Decision|1|||
125391432|NCT02171260|451067108|FG001|Overall Study|Physician Decision|0|||
125391433|NCT02171260|451067109|FG002|Overall Study|Physician Decision|1|||
125391434|NCT02171260|451067110|FG003|Overall Study|Physician Decision|0|||
125391435|NCT02171260|451067107|FG000|Overall Study|Withdrawal by Subject|1|||
125391436|NCT02171260|451067108|FG001|Overall Study|Withdrawal by Subject|0|||
125391437|NCT02171260|451067109|FG002|Overall Study|Withdrawal by Subject|0|||
125391438|NCT02171260|451067110|FG003|Overall Study|Withdrawal by Subject|0|||
125391439|NCT02171260|451067107|FG000|Overall Study|Evidence of progressive disease|4|||
125391440|NCT02171260|451067108|FG001|Overall Study|Evidence of progressive disease|6|||
125391441|NCT02171260|451067109|FG002|Overall Study|Evidence of progressive disease|4|||
125163502|NCT01007942|450222677|FG001|Overall Study|Disease progression|242|||
125163503|NCT01007942|450222676|FG000|Overall Study|New cancer therapy|5|||
125163504|NCT01007942|450222677|FG001|Overall Study|New cancer therapy|1|||
125163505|NCT01007942|450222676|FG000|Overall Study|Protocol Violation|1|||
125391442|NCT02171260|451067110|FG003|Overall Study|Evidence of progressive disease|4|||
125391443|NCT00323492|451067111|FG000|Study Phase 1|Adverse Event|2|||
125391444|NCT00323492|451067112|FG001|Study Phase 1|Adverse Event|0|||
125391445|NCT00323492|451067113|FG002|Study Phase 1|Adverse Event|0|||
125391446|NCT00323492|451067111|FG000|Study Phase 2|Adverse Event|1|||
125391447|NCT00323492|451067112|FG001|Study Phase 2|Adverse Event|0|||
125391448|NCT00323492|451067113|FG002|Study Phase 2|Adverse Event|0|||
125391449|NCT00323492|451067111|FG000|Study Phase 2|Physician Decision|1|||
125391450|NCT00323492|451067112|FG001|Study Phase 2|Physician Decision|0|||
125391451|NCT00323492|451067113|FG002|Study Phase 2|Physician Decision|0|||
125391452|NCT00323492|451067111|FG000|Study Phase 2|Lost to Follow-up|1|||
125391453|NCT00323492|451067112|FG001|Study Phase 2|Lost to Follow-up|0|||
125391454|NCT00323492|451067113|FG002|Study Phase 2|Lost to Follow-up|0|||
125391455|NCT00323492|451067111|FG000|Study Phase 2|Withdrawal by Subject|0|||
125391456|NCT00323492|451067112|FG001|Study Phase 2|Withdrawal by Subject|1|||
125391457|NCT00323492|451067113|FG002|Study Phase 2|Withdrawal by Subject|0|||
125391458|NCT00323492|451067111|FG000|Study Phase 2|Noncompliance with study schedule|0|||
125391459|NCT00323492|451067112|FG001|Study Phase 2|Noncompliance with study schedule|0|||
125391460|NCT00323492|451067113|FG002|Study Phase 2|Noncompliance with study schedule|1|||
125391461|NCT00323492|451067111|FG000|Study Phase 2|Protocol Violation|1|||
125391462|NCT00323492|451067112|FG001|Study Phase 2|Protocol Violation|0|||
125391463|NCT00323492|451067113|FG002|Study Phase 2|Protocol Violation|0|||
125391464|NCT01319877|451067116|FG000|Overall Study|Lost to Follow-up|100|||
125391465|NCT01319877|451067117|FG001|Overall Study|Lost to Follow-up|37|||
125391466|NCT01319877|451067116|FG000|Overall Study|Physician Decision|2|||
125391467|NCT01319877|451067117|FG001|Overall Study|Physician Decision|0|||
125391468|NCT01319877|451067116|FG000|Overall Study|Disease Progression|2|||
125391469|NCT01319877|451067117|FG001|Overall Study|Disease Progression|2|||
125391470|NCT01319877|451067116|FG000|Overall Study|Withdrawal by Subject|0|||
125391471|NCT01319877|451067117|FG001|Overall Study|Withdrawal by Subject|1|||
125391472|NCT01319877|451067116|FG000|Overall Study|Reason Not Specified|4|||
125391473|NCT01319877|451067117|FG001|Overall Study|Reason Not Specified|5|||
125391474|NCT03560531|451067118|FG000|Overall Study|Death|4|||
125391475|NCT03560531|451067119|FG001|Overall Study|Death|1|||
125391476|NCT03560531|451067120|FG002|Overall Study|Death|1|||
125391477|NCT03560531|451067121|FG003|Overall Study|Death|2|||
125391478|NCT03560531|451067122|FG004|Overall Study|Death|6|||
125391479|NCT03560531|451067123|FG005|Overall Study|Death|1|||
125391480|NCT03560531|451067124|FG006|Overall Study|Death|4|||
125391481|NCT03560531|451067125|FG007|Overall Study|Death|8|||
125391482|NCT03560531|451067126|FG008|Overall Study|Death|1|||
125391483|NCT03560531|451067127|FG009|Overall Study|Death|3|||
125391484|NCT03560531|451067128|FG010|Overall Study|Death|2|||
125391485|NCT03560531|451067129|FG011|Overall Study|Death|0|||
125391486|NCT03560531|451067130|FG012|Overall Study|Death|4|||
125391487|NCT03560531|451067131|FG013|Overall Study|Death|1|||
125391488|NCT03560531|451067118|FG000|Overall Study|Lost to Follow-up|1|||
125391489|NCT03560531|451067119|FG001|Overall Study|Lost to Follow-up|1|||
125391490|NCT03560531|451067120|FG002|Overall Study|Lost to Follow-up|0|||
125391491|NCT03560531|451067121|FG003|Overall Study|Lost to Follow-up|0|||
125391492|NCT03560531|451067122|FG004|Overall Study|Lost to Follow-up|0|||
125391493|NCT03560531|451067123|FG005|Overall Study|Lost to Follow-up|0|||
125391494|NCT03560531|451067124|FG006|Overall Study|Lost to Follow-up|1|||
125391495|NCT03560531|451067125|FG007|Overall Study|Lost to Follow-up|0|||
125391496|NCT03560531|451067126|FG008|Overall Study|Lost to Follow-up|0|||
125391497|NCT03560531|451067127|FG009|Overall Study|Lost to Follow-up|0|||
125391498|NCT03560531|451067128|FG010|Overall Study|Lost to Follow-up|0|||
125391499|NCT03560531|451067129|FG011|Overall Study|Lost to Follow-up|0|||
125391500|NCT03560531|451067130|FG012|Overall Study|Lost to Follow-up|0|||
125391501|NCT03560531|451067131|FG013|Overall Study|Lost to Follow-up|0|||
125391502|NCT03560531|451067118|FG000|Overall Study|Withdrawal by Subject|1|||
125391503|NCT03560531|451067119|FG001|Overall Study|Withdrawal by Subject|0|||
125391504|NCT03560531|451067120|FG002|Overall Study|Withdrawal by Subject|0|||
125391505|NCT03560531|451067121|FG003|Overall Study|Withdrawal by Subject|0|||
125391506|NCT03560531|451067122|FG004|Overall Study|Withdrawal by Subject|0|||
125391507|NCT03560531|451067123|FG005|Overall Study|Withdrawal by Subject|0|||
125391508|NCT03560531|451067124|FG006|Overall Study|Withdrawal by Subject|0|||
125391509|NCT03560531|451067125|FG007|Overall Study|Withdrawal by Subject|3|||
125163506|NCT01007942|450222677|FG001|Overall Study|Protocol Violation|1|||
125163507|NCT01007942|450222676|FG000|Overall Study|Withdrawal by Subject|19|||
125163508|NCT01007942|450222677|FG001|Overall Study|Withdrawal by Subject|14|||
125163509|NCT01007942|450222676|FG000|Overall Study|Lost to Follow-up|1|||
125163510|NCT01007942|450222677|FG001|Overall Study|Lost to Follow-up|0|||
125391510|NCT03560531|451067126|FG008|Overall Study|Withdrawal by Subject|2|||
125391511|NCT03560531|451067127|FG009|Overall Study|Withdrawal by Subject|0|||
125391512|NCT03560531|451067128|FG010|Overall Study|Withdrawal by Subject|0|||
125391513|NCT03560531|451067129|FG011|Overall Study|Withdrawal by Subject|0|||
125391514|NCT03560531|451067130|FG012|Overall Study|Withdrawal by Subject|2|||
125391515|NCT03560531|451067131|FG013|Overall Study|Withdrawal by Subject|0|||
125391516|NCT03560531|451067118|FG000|Overall Study|Study end per-protocol|1|||
125391517|NCT03560531|451067119|FG001|Overall Study|Study end per-protocol|1|||
125391518|NCT03560531|451067120|FG002|Overall Study|Study end per-protocol|2|||
125391519|NCT03560531|451067121|FG003|Overall Study|Study end per-protocol|0|||
125391520|NCT03560531|451067122|FG004|Overall Study|Study end per-protocol|1|||
125391521|NCT03560531|451067123|FG005|Overall Study|Study end per-protocol|0|||
125391522|NCT03560531|451067124|FG006|Overall Study|Study end per-protocol|0|||
125391523|NCT03560531|451067125|FG007|Overall Study|Study end per-protocol|0|||
125391524|NCT03560531|451067126|FG008|Overall Study|Study end per-protocol|0|||
125225191|NCT01566604|450452062|FG001|Overall Study|Withdrawal by Subject|6|||
125225192|NCT03225170|450452063|FG000|Overall Study|Lost to Follow-up|4|||
125225193|NCT03225170|450452064|FG001|Overall Study|Lost to Follow-up|4|||
125225194|NCT03225170|450452065|FG002|Overall Study|Lost to Follow-up|0|||
125225195|NCT03225170|450452063|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
125225196|NCT03225170|450452064|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
125225197|NCT03225170|450452065|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
125225198|NCT00549549|450452089|FG000|Overall Study|Adverse Event|5|||
125225199|NCT00549549|450452090|FG001|Overall Study|Adverse Event|3|||
125225200|NCT00549549|450452091|FG002|Overall Study|Adverse Event|1|||
125225201|NCT00549549|450452092|FG003|Overall Study|Adverse Event|9|||
125225202|NCT00549549|450452089|FG000|Overall Study|Lack of Efficacy|9|||
125225203|NCT00549549|450452090|FG001|Overall Study|Lack of Efficacy|6|||
125225204|NCT00549549|450452091|FG002|Overall Study|Lack of Efficacy|4|||
125225205|NCT00549549|450452092|FG003|Overall Study|Lack of Efficacy|2|||
125225206|NCT00549549|450452089|FG000|Overall Study|Lost to Follow-up|1|||
125225207|NCT00549549|450452090|FG001|Overall Study|Lost to Follow-up|0|||
125225208|NCT00549549|450452091|FG002|Overall Study|Lost to Follow-up|1|||
125225209|NCT00549549|450452092|FG003|Overall Study|Lost to Follow-up|2|||
125225210|NCT00549549|450452089|FG000|Overall Study|Withdrawal by Subject|0|||
125225211|NCT00549549|450452090|FG001|Overall Study|Withdrawal by Subject|4|||
125225212|NCT00549549|450452091|FG002|Overall Study|Withdrawal by Subject|1|||
125225213|NCT00549549|450452092|FG003|Overall Study|Withdrawal by Subject|0|||
125225214|NCT00549549|450452089|FG000|Overall Study|Other|9|||
125225215|NCT00549549|450452090|FG001|Overall Study|Other|9|||
125225216|NCT00549549|450452091|FG002|Overall Study|Other|9|||
125225217|NCT00549549|450452092|FG003|Overall Study|Other|11|||
125225218|NCT00549549|450452089|FG000|Overall Study|Randomized but not treated|0|||
125225219|NCT00549549|450452090|FG001|Overall Study|Randomized but not treated|0|||
125225220|NCT00549549|450452091|FG002|Overall Study|Randomized but not treated|1|||
125225221|NCT00549549|450452092|FG003|Overall Study|Randomized but not treated|1|||
125225222|NCT00248651|450452095|FG000|Overall Study|Withdrawal by Subject|28|||
125225223|NCT00248651|450452096|FG001|Overall Study|Withdrawal by Subject|40|||
125225224|NCT00248651|450452097|FG002|Overall Study|Withdrawal by Subject|32|||
125225225|NCT02688933|450452098|FG000|Overall Study|Adverse Event|3|||
125225226|NCT02688933|450452099|FG001|Overall Study|Adverse Event|1|||
125225227|NCT02688933|450452098|FG000|Overall Study|Lack of Efficacy|2|||
125225228|NCT02688933|450452099|FG001|Overall Study|Lack of Efficacy|2|||
125225229|NCT02688933|450452098|FG000|Overall Study|Poor compliance to protocol|7|||
125225230|NCT02688933|450452099|FG001|Overall Study|Poor compliance to protocol|4|||
125391525|NCT03560531|451067127|FG009|Overall Study|Study end per-protocol|0|||
125163511|NCT01007942|450222676|FG000|Overall Study|Administrative problems|2|||
125163512|NCT01007942|450222677|FG001|Overall Study|Administrative problems|0|||
125163513|NCT01007942|450222676|FG000|Overall Study|Death|3|||
125163514|NCT01007942|450222677|FG001|Overall Study|Death|2|||
125163515|NCT01007942|450222676|FG000|Overall Study|Patients untreated|4|||
125163516|NCT01007942|450222677|FG001|Overall Study|Patients untreated|3|||
125163517|NCT05083585|450222682|FG000|Overall Study|Death|1|||
125163518|NCT05083585|450222683|FG001|Overall Study|Death|1|||
125163519|NCT05083585|450222682|FG000|Overall Study|Lost to Follow-up|1|||
125163520|NCT05083585|450222683|FG001|Overall Study|Lost to Follow-up|1|||
125163521|NCT05083585|450222682|FG000|Overall Study|Withdrawal by Subject|2|||
125163522|NCT05083585|450222683|FG001|Overall Study|Withdrawal by Subject|0|||
125163523|NCT05083585|450222682|FG000|Overall Study|Randomized but not vaccinated|2|||
125163524|NCT05083585|450222683|FG001|Overall Study|Randomized but not vaccinated|0|||
125163525|NCT03929757|450222684|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
125163526|NCT03929757|450222685|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
125163527|NCT03929757|450222686|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
125163528|NCT03929757|450222684|FG000|Main Study: Up to Day 365|Other|1|||
125163529|NCT03929757|450222685|FG001|Main Study: Up to Day 365|Other|0|||
125163530|NCT03929757|450222686|FG002|Main Study: Up to Day 365|Other|0|||
125163531|NCT03929757|450222684|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
125163532|NCT03929757|450222685|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
125163533|NCT03929757|450222686|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
125163534|NCT00114166|450222688|FG000|Overall Study|Wrong primary|0|||
125163535|NCT00114166|450222689|FG001|Overall Study|Wrong primary|1|||
125163536|NCT00806286|450222695|FG000|Overall Study|Adverse Event|5|||
125163537|NCT00806286|450222696|FG001|Overall Study|Adverse Event|2|||
125163538|NCT00806286|450222697|FG002|Overall Study|Adverse Event|0|||
125163539|NCT00806286|450222695|FG000|Overall Study|Disease progression|31|||
125163540|NCT00806286|450222696|FG001|Overall Study|Disease progression|38|||
125225231|NCT02688933|450452098|FG000|Overall Study|Hypoglycemia|2|||
125225232|NCT02688933|450452099|FG001|Overall Study|Hypoglycemia|0|||
125225233|NCT02688933|450452098|FG000|Overall Study|Other than Specified|14|||
125225234|NCT02688933|450452099|FG001|Overall Study|Other than Specified|25|||
125225235|NCT02688933|450452098|FG000|Overall Study|Lost to Follow-up|1|||
125163541|NCT00806286|450222697|FG002|Overall Study|Disease progression|1|||
125163542|NCT00806286|450222695|FG000|Overall Study|Death|1|||
125163543|NCT00806286|450222696|FG001|Overall Study|Death|6|||
125163544|NCT00806286|450222697|FG002|Overall Study|Death|0|||
125163545|NCT00806286|450222695|FG000|Overall Study|Lost to Follow-up|0|||
125163546|NCT00806286|450222696|FG001|Overall Study|Lost to Follow-up|1|||
125163547|NCT00806286|450222697|FG002|Overall Study|Lost to Follow-up|0|||
125163548|NCT00806286|450222695|FG000|Overall Study|Withdrawal by Subject|8|||
125163549|NCT00806286|450222696|FG001|Overall Study|Withdrawal by Subject|3|||
125163550|NCT00806286|450222697|FG002|Overall Study|Withdrawal by Subject|1|||
125163551|NCT00806286|450222695|FG000|Overall Study|Physician Decision|2|||
125163552|NCT00806286|450222696|FG001|Overall Study|Physician Decision|2|||
125163553|NCT00806286|450222697|FG002|Overall Study|Physician Decision|0|||
125163554|NCT00806286|450222695|FG000|Overall Study|Due to a variety of reasons|7|||
125163555|NCT00806286|450222696|FG001|Overall Study|Due to a variety of reasons|2|||
125163556|NCT00806286|450222697|FG002|Overall Study|Due to a variety of reasons|1|||
125163557|NCT03402750|450222698|FG000|Overall Study|Lost to Follow-up|2|||
125163558|NCT03402750|450222699|FG001|Overall Study|Lost to Follow-up|1|||
125163559|NCT03469336|450222700|FG000|Overall Study|Adverse Event|1|||
125163560|NCT02628743|450222701|FG000|Overall Study|Other|3|||
125163561|NCT02628743|450222701|FG000|Overall Study|Withdrawal by Subject|50|||
125163562|NCT02628743|450222701|FG000|Overall Study|Study Terminated by Sponsor|76|||
125163563|NCT02628743|450222701|FG000|Overall Study|Physician Decision|2|||
125163564|NCT02534844|450222702|FG000|Part B|Withdrawal by Subject|0|||
125163565|NCT02534844|450222703|FG001|Part B|Withdrawal by Subject|0|||
125163566|NCT02534844|450222704|FG002|Part B|Withdrawal by Subject|0|||
125163567|NCT02534844|450222705|FG003|Part B|Withdrawal by Subject|0|||
125163568|NCT02534844|450222706|FG004|Part B|Withdrawal by Subject|2|||
125163569|NCT02534844|450222707|FG005|Part B|Withdrawal by Subject|1|||
125163570|NCT04645966|450222719|FG000|Vaccination Phase|Adverse Event|1|||
125163571|NCT04645966|450222720|FG001|Vaccination Phase|Adverse Event|0|||
125163572|NCT04645966|450222721|FG002|Vaccination Phase|Adverse Event|0|||
125163573|NCT04645966|450222722|FG003|Vaccination Phase|Adverse Event|0|||
125163574|NCT04645966|450222723|FG004|Vaccination Phase|Adverse Event|0|||
125163575|NCT04645966|450222724|FG005|Vaccination Phase|Adverse Event|0|||
125163576|NCT04645966|450222725|FG006|Vaccination Phase|Adverse Event|1|||
125163577|NCT04645966|450222726|FG007|Vaccination Phase|Adverse Event|0|||
125163578|NCT04645966|450222727|FG008|Vaccination Phase|Adverse Event|0|||
125163579|NCT04645966|450222719|FG000|Vaccination Phase|Death|0|||
125391526|NCT03560531|451067128|FG010|Overall Study|Study end per-protocol|0|||
125391527|NCT03560531|451067129|FG011|Overall Study|Study end per-protocol|0|||
125391528|NCT03560531|451067130|FG012|Overall Study|Study end per-protocol|0|||
125391529|NCT03560531|451067131|FG013|Overall Study|Study end per-protocol|0|||
125391530|NCT03560531|451067118|FG000|Overall Study|Early study termination by sponsor|9|||
125391531|NCT03560531|451067119|FG001|Overall Study|Early study termination by sponsor|0|||
125391532|NCT03560531|451067120|FG002|Overall Study|Early study termination by sponsor|0|||
125391533|NCT03560531|451067121|FG003|Overall Study|Early study termination by sponsor|4|||
125391534|NCT03560531|451067122|FG004|Overall Study|Early study termination by sponsor|8|||
125391535|NCT03560531|451067123|FG005|Overall Study|Early study termination by sponsor|2|||
125391536|NCT03560531|451067124|FG006|Overall Study|Early study termination by sponsor|5|||
125391537|NCT03560531|451067125|FG007|Overall Study|Early study termination by sponsor|64|||
125163580|NCT04645966|450222720|FG001|Vaccination Phase|Death|0|||
125163581|NCT04645966|450222721|FG002|Vaccination Phase|Death|0|||
125163582|NCT04645966|450222722|FG003|Vaccination Phase|Death|0|||
125163583|NCT04645966|450222723|FG004|Vaccination Phase|Death|0|||
125163584|NCT04645966|450222724|FG005|Vaccination Phase|Death|1|||
125163585|NCT04645966|450222725|FG006|Vaccination Phase|Death|0|||
125163586|NCT04645966|450222726|FG007|Vaccination Phase|Death|0|||
125163587|NCT04645966|450222727|FG008|Vaccination Phase|Death|0|||
125163588|NCT04645966|450222719|FG000|Vaccination Phase|Protocol Violation|0|||
125163589|NCT04645966|450222720|FG001|Vaccination Phase|Protocol Violation|0|||
125163590|NCT04645966|450222721|FG002|Vaccination Phase|Protocol Violation|0|||
125163591|NCT04645966|450222722|FG003|Vaccination Phase|Protocol Violation|0|||
125163592|NCT04645966|450222723|FG004|Vaccination Phase|Protocol Violation|1|||
125163593|NCT04645966|450222724|FG005|Vaccination Phase|Protocol Violation|0|||
125163594|NCT04645966|450222725|FG006|Vaccination Phase|Protocol Violation|0|||
125163595|NCT04645966|450222726|FG007|Vaccination Phase|Protocol Violation|0|||
125163596|NCT04645966|450222727|FG008|Vaccination Phase|Protocol Violation|0|||
125163597|NCT04645966|450222719|FG000|Vaccination Phase|Study terminated by sponsor|0|||
125225236|NCT02688933|450452099|FG001|Overall Study|Lost to Follow-up|5|||
125225237|NCT01275144|450452100|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
125391538|NCT03560531|451067126|FG008|Overall Study|Early study termination by sponsor|7|||
125391539|NCT03560531|451067127|FG009|Overall Study|Early study termination by sponsor|2|||
125391540|NCT03560531|451067128|FG010|Overall Study|Early study termination by sponsor|16|||
125163598|NCT04645966|450222720|FG001|Vaccination Phase|Study terminated by sponsor|0|||
125163599|NCT04645966|450222721|FG002|Vaccination Phase|Study terminated by sponsor|14|||
125163600|NCT04645966|450222722|FG003|Vaccination Phase|Study terminated by sponsor|15|||
125391541|NCT03560531|451067129|FG011|Overall Study|Early study termination by sponsor|2|||
125391542|NCT03560531|451067130|FG012|Overall Study|Early study termination by sponsor|6|||
125225238|NCT01275144|450452101|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
125225239|NCT00828113|450452102|FG000|Overall Study|Withdrawal by Subject|27|||
125225240|NCT00828113|450452103|FG001|Overall Study|Withdrawal by Subject|26|||
125225241|NCT00828113|450452102|FG000|Overall Study|Lost to Follow-up|3|||
125225242|NCT00828113|450452103|FG001|Overall Study|Lost to Follow-up|5|||
125225243|NCT01365130|450452104|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
125225244|NCT05547386|450452106|FG000|Overall Study|Withdrawal by Subject|7|||
125225245|NCT04622969|450452107|FG000|Overall Study|Withdrawal by Subject|2|||
125225246|NCT04622969|450452108|FG001|Overall Study|Withdrawal by Subject|3|||
125225247|NCT05607576|450452109|FG000|Overall Study|immediate sensor error|2|||
125225248|NCT05607576|450452109|FG000|Overall Study|Physician Decision|2|||
125225249|NCT04467515|450452110|FG000|Overall Study|Lost to Follow-up|1|||
125225250|NCT04467515|450452111|FG001|Overall Study|Lost to Follow-up|0|||
125225251|NCT04467515|450452112|FG002|Overall Study|Lost to Follow-up|0|||
125225252|NCT04467515|450452110|FG000|Overall Study|Withdrawal by Subject|1|||
125225253|NCT04467515|450452111|FG001|Overall Study|Withdrawal by Subject|0|||
125225254|NCT04467515|450452112|FG002|Overall Study|Withdrawal by Subject|1|||
125225255|NCT04467515|450452110|FG000|Overall Study|Progressive Disease|0|||
125225256|NCT04467515|450452111|FG001|Overall Study|Progressive Disease|1|||
125225257|NCT04467515|450452112|FG002|Overall Study|Progressive Disease|3|||
125163601|NCT04645966|450222723|FG004|Vaccination Phase|Study terminated by sponsor|47|||
125163602|NCT04645966|450222724|FG005|Vaccination Phase|Study terminated by sponsor|43|||
125163603|NCT04645966|450222725|FG006|Vaccination Phase|Study terminated by sponsor|29|||
125163604|NCT04645966|450222726|FG007|Vaccination Phase|Study terminated by sponsor|29|||
125163605|NCT04645966|450222727|FG008|Vaccination Phase|Study terminated by sponsor|12|||
125163606|NCT04645966|450222719|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
125163607|NCT04645966|450222720|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
125163608|NCT04645966|450222721|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
125163609|NCT04645966|450222722|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
125163610|NCT04645966|450222723|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
125163611|NCT04645966|450222724|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
125163612|NCT04645966|450222725|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
125163613|NCT04645966|450222726|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
125163614|NCT04645966|450222727|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
125163615|NCT04645966|450222719|FG000|Vaccination Phase|Other|0|||
125163616|NCT04645966|450222720|FG001|Vaccination Phase|Other|0|||
125163617|NCT04645966|450222721|FG002|Vaccination Phase|Other|0|||
125163618|NCT04645966|450222722|FG003|Vaccination Phase|Other|0|||
125163619|NCT04645966|450222723|FG004|Vaccination Phase|Other|0|||
125163620|NCT04645966|450222724|FG005|Vaccination Phase|Other|2|||
125163621|NCT04645966|450222725|FG006|Vaccination Phase|Other|0|||
125163622|NCT04645966|450222726|FG007|Vaccination Phase|Other|0|||
125163623|NCT04645966|450222727|FG008|Vaccination Phase|Other|0|||
125163624|NCT04645966|450222719|FG000|Vaccination Phase|Lost to Follow-up|0|||
125163625|NCT04645966|450222720|FG001|Vaccination Phase|Lost to Follow-up|0|||
125163626|NCT04645966|450222721|FG002|Vaccination Phase|Lost to Follow-up|0|||
125163627|NCT04645966|450222722|FG003|Vaccination Phase|Lost to Follow-up|0|||
125163628|NCT04645966|450222723|FG004|Vaccination Phase|Lost to Follow-up|0|||
125163629|NCT04645966|450222724|FG005|Vaccination Phase|Lost to Follow-up|0|||
125163630|NCT04645966|450222725|FG006|Vaccination Phase|Lost to Follow-up|0|||
125163631|NCT04645966|450222726|FG007|Vaccination Phase|Lost to Follow-up|1|||
125163632|NCT04645966|450222727|FG008|Vaccination Phase|Lost to Follow-up|0|||
125163633|NCT04645966|450222719|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
125163634|NCT04645966|450222720|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
125163635|NCT04645966|450222721|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
125163636|NCT04645966|450222722|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
125163637|NCT04645966|450222723|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
125163638|NCT04645966|450222724|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
125163639|NCT04645966|450222725|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
125163640|NCT04645966|450222726|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
125163641|NCT04645966|450222727|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
125163642|NCT04645966|450222719|FG000|Follow-up Phase|Lost to Follow-up|0|||
125163643|NCT04645966|450222720|FG001|Follow-up Phase|Lost to Follow-up|0|||
125163644|NCT04645966|450222721|FG002|Follow-up Phase|Lost to Follow-up|0|||
125163645|NCT04645966|450222722|FG003|Follow-up Phase|Lost to Follow-up|0|||
125163646|NCT04645966|450222723|FG004|Follow-up Phase|Lost to Follow-up|0|||
125163647|NCT04645966|450222724|FG005|Follow-up Phase|Lost to Follow-up|0|||
125163648|NCT04645966|450222725|FG006|Follow-up Phase|Lost to Follow-up|0|||
125225258|NCT04467515|450452110|FG000|Overall Study|Death|0|||
125163649|NCT04645966|450222726|FG007|Follow-up Phase|Lost to Follow-up|1|||
125163650|NCT04645966|450222727|FG008|Follow-up Phase|Lost to Follow-up|0|||
125163651|NCT03825341|450222728|FG000|Overall Study|Withdrawal by Subject|0|||
125163652|NCT03825341|450222729|FG001|Overall Study|Withdrawal by Subject|1|||
125163653|NCT00289536|450222731|FG000|Period 3|Lost to Follow-up|0|||
125225259|NCT04467515|450452111|FG001|Overall Study|Death|1|||
125225260|NCT04467515|450452112|FG002|Overall Study|Death|0|||
125225261|NCT04391842|450452115|FG000|Overall Study|Withdrawal by Subject|2|||
125441097|NCT01189890|451244117|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
125441098|NCT01189890|451244118|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
125441099|NCT00593554|451244119|FG000|Overall Study|Death|1|||
125441100|NCT00593554|451244120|FG001|Overall Study|Death|2|||
125441101|NCT00593554|451244119|FG000|Overall Study|Physician Decision|0|||
125441102|NCT00593554|451244120|FG001|Overall Study|Physician Decision|1|||
125441103|NCT00593554|451244119|FG000|Overall Study|Withdrawal by Subject|1|||
125441104|NCT00593554|451244120|FG001|Overall Study|Withdrawal by Subject|0|||
125441105|NCT00593554|451244119|FG000|Overall Study|Disease Progression|1|||
125441106|NCT00593554|451244120|FG001|Overall Study|Disease Progression|2|||
125441107|NCT02254421|451244123|FG000|Overall Study|Randomized but Not Treated|1|||
125441108|NCT02254421|451244124|FG001|Overall Study|Randomized but Not Treated|0|||
125441109|NCT02254421|451244123|FG000|Overall Study|Death|0|||
125441110|NCT02254421|451244124|FG001|Overall Study|Death|2|||
125441111|NCT02254421|451244123|FG000|Overall Study|Withdrew Consent|1|||
125441112|NCT02254421|451244124|FG001|Overall Study|Withdrew Consent|1|||
125441113|NCT00839917|451244127|FG000|Overall Study|Lost to Follow-up|1|||
125441114|NCT00839917|451244128|FG001|Overall Study|Lost to Follow-up|0|||
125441115|NCT00839917|451244127|FG000|Overall Study|Did not receive vaccine|0|||
125441116|NCT00839917|451244128|FG001|Overall Study|Did not receive vaccine|1|||
125441117|NCT00867490|451244129|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
125441118|NCT00867490|451244129|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
125441119|NCT00867490|451244129|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
125441120|NCT00867490|451244129|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
125441121|NCT00867490|451244129|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
125441122|NCT01129336|451244130|FG000|Overall Study|Protocol Violation|1|||
125441123|NCT01129336|451244131|FG001|Overall Study|Protocol Violation|0|||
125441124|NCT01129336|451244130|FG000|Overall Study|Disease Progression|1|||
125441125|NCT01129336|451244131|FG001|Overall Study|Disease Progression|4|||
125441126|NCT01129336|451244130|FG000|Overall Study|Lost to Follow-up|1|||
125441127|NCT01129336|451244131|FG001|Overall Study|Lost to Follow-up|0|||
125441128|NCT01129336|451244130|FG000|Overall Study|Withdrawal by Subject|7|||
125441129|NCT01129336|451244131|FG001|Overall Study|Withdrawal by Subject|4|||
125441130|NCT01129336|451244130|FG000|Overall Study|Adverse Event|0|||
125163654|NCT00289536|450222732|FG001|Period 3|Lost to Follow-up|0|||
125163655|NCT00289536|450222733|FG002|Period 3|Lost to Follow-up|1|||
125163656|NCT02116608|450222738|FG000|Overall Study|Lost to Follow-up|0|||
125163657|NCT02116608|450222739|FG001|Overall Study|Lost to Follow-up|0|||
125163658|NCT02116608|450222740|FG002|Overall Study|Lost to Follow-up|1|||
125163659|NCT02116608|450222738|FG000|Overall Study|Physician Decision|0|||
125163660|NCT02116608|450222739|FG001|Overall Study|Physician Decision|1|||
125163661|NCT02116608|450222740|FG002|Overall Study|Physician Decision|0|||
125163662|NCT02116608|450222738|FG000|Overall Study|Death|0|||
125163663|NCT02116608|450222739|FG001|Overall Study|Death|1|||
125163664|NCT02116608|450222740|FG002|Overall Study|Death|0|||
125163665|NCT04283500|450222741|FG000|Overall Study|Lost to Follow-up|8|||
125163666|NCT04283500|450222741|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
125163667|NCT02006693|450222745|FG000|Overall Study|No Reason Specified|6|||
125163668|NCT02006693|450222746|FG001|Overall Study|No Reason Specified|8|||
125163669|NCT02006693|450222745|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
125163670|NCT02006693|450222746|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
125225262|NCT00810199|450452116|FG000|Overall Study|Adverse Event|24|||
125441131|NCT01129336|451244131|FG001|Overall Study|Adverse Event|1|||
125441132|NCT01129336|451244130|FG000|Overall Study|Missing Study Completion Status|2|||
125163671|NCT02006693|450222745|FG000|Overall Study|XEN Implant Explantation|0|||
125163672|NCT02006693|450222746|FG001|Overall Study|XEN Implant Explantation|1|||
125163673|NCT02006693|450222745|FG000|Overall Study|Death|2|||
125163674|NCT02006693|450222746|FG001|Overall Study|Death|2|||
125163675|NCT02006693|450222745|FG000|Overall Study|Lost to Follow-up|4|||
125163676|NCT02006693|450222746|FG001|Overall Study|Lost to Follow-up|1|||
125163677|NCT02006693|450222745|FG000|Overall Study|Patient Decision|4|||
125163678|NCT02006693|450222746|FG001|Overall Study|Patient Decision|0|||
125163679|NCT01119508|450222749|FG000|Overall Study|Adverse Event|56|||
125163680|NCT01119508|450222749|FG000|Overall Study|Withdrawal by Subject|2|||
125163681|NCT01119508|450222749|FG000|Overall Study|Died before tumor response evaluation|1|||
125163682|NCT00265395|450222750|FG000|Overall Study|Adverse Event|3|||
125163683|NCT00265395|450222751|FG001|Overall Study|Adverse Event|6|||
125163684|NCT00265395|450222750|FG000|Overall Study|Lost to Follow-up|2|||
125163685|NCT00265395|450222751|FG001|Overall Study|Lost to Follow-up|1|||
125163686|NCT00265395|450222750|FG000|Overall Study|Withdrawal by Subject|1|||
125225263|NCT00810199|450452117|FG001|Overall Study|Adverse Event|26|||
125441133|NCT01129336|451244131|FG001|Overall Study|Missing Study Completion Status|3|||
125441134|NCT01129336|451244130|FG000|Overall Study|Death|0|||
125441135|NCT01129336|451244131|FG001|Overall Study|Death|4|||
125441136|NCT01950273|451244132|FG000|Overall Study|Protocol Violation|1|||
125441137|NCT01950273|451244133|FG001|Overall Study|Protocol Violation|0|||
125441138|NCT01950273|451244132|FG000|Overall Study|Withdrawal by Subject|2|||
125441139|NCT01950273|451244133|FG001|Overall Study|Withdrawal by Subject|0|||
125441140|NCT01950273|451244132|FG000|Overall Study|Other not defined above|1|||
125441141|NCT01950273|451244133|FG001|Overall Study|Other not defined above|0|||
125441142|NCT01254565|451244134|FG000|Overall Study|Non-compliance to Study Procedures|0|||
125441143|NCT01254565|451244135|FG001|Overall Study|Non-compliance to Study Procedures|0|||
125441144|NCT01254565|451244136|FG002|Overall Study|Non-compliance to Study Procedures|0|||
125441145|NCT01254565|451244137|FG003|Overall Study|Non-compliance to Study Procedures|0|||
125441146|NCT01254565|451244138|FG004|Overall Study|Non-compliance to Study Procedures|1|||
125441147|NCT01254565|451244139|FG005|Overall Study|Non-compliance to Study Procedures|0|||
125441148|NCT01254565|451244134|FG000|Overall Study|Did not Receive Treatment|1|||
125441149|NCT01254565|451244135|FG001|Overall Study|Did not Receive Treatment|1|||
125441150|NCT01254565|451244136|FG002|Overall Study|Did not Receive Treatment|0|||
125441151|NCT01254565|451244137|FG003|Overall Study|Did not Receive Treatment|0|||
125441152|NCT01254565|451244138|FG004|Overall Study|Did not Receive Treatment|3|||
125441153|NCT01254565|451244139|FG005|Overall Study|Did not Receive Treatment|4|||
125441154|NCT01254565|451244134|FG000|Overall Study|Other|0|||
125441155|NCT01254565|451244135|FG001|Overall Study|Other|0|||
125441156|NCT01254565|451244136|FG002|Overall Study|Other|0|||
125441157|NCT01254565|451244137|FG003|Overall Study|Other|1|||
125441158|NCT01254565|451244138|FG004|Overall Study|Other|0|||
125441159|NCT01254565|451244139|FG005|Overall Study|Other|0|||
125441160|NCT00472186|451244140|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
125441161|NCT00472186|451244141|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
125441162|NCT03354637|451244142|FG000|Double-blind Period|Protocol Violation|2|||
125441163|NCT03354637|451244143|FG001|Double-blind Period|Protocol Violation|0|||
125441164|NCT03354637|451244144|FG002|Double-blind Period|Protocol Violation|0|||
125441165|NCT03354637|451244142|FG000|Double-blind Period|Adverse Event|1|||
125441166|NCT03354637|451244143|FG001|Double-blind Period|Adverse Event|2|||
125441167|NCT03354637|451244144|FG002|Double-blind Period|Adverse Event|0|||
125441168|NCT03354637|451244142|FG000|Double-blind Period|Lost to Follow-up|3|||
125441169|NCT03354637|451244143|FG001|Double-blind Period|Lost to Follow-up|4|||
125441170|NCT03354637|451244144|FG002|Double-blind Period|Lost to Follow-up|3|||
125163687|NCT00265395|450222751|FG001|Overall Study|Withdrawal by Subject|6|||
125391543|NCT03560531|451067131|FG013|Overall Study|Early study termination by sponsor|2|||
125391544|NCT01200797|451067134|FG000|Overall Study|symptomatic deterioration|2|||
125391545|NCT01200797|451067134|FG000|Overall Study|Adverse Event|4|||
125391546|NCT01200797|451067134|FG000|Overall Study|Disease Progression|13|||
125391547|NCT03608774|451067139|FG000|Overall Study|Lost to Follow-up|5|||
125391548|NCT03608774|451067140|FG001|Overall Study|Lost to Follow-up|5|||
125391549|NCT03608774|451067139|FG000|Overall Study|Withdrawal by Subject|1|||
125391550|NCT03608774|451067140|FG001|Overall Study|Withdrawal by Subject|0|||
125391551|NCT03608774|451067139|FG000|Overall Study|Protocol Violation|1|||
125391552|NCT03608774|451067140|FG001|Overall Study|Protocol Violation|0|||
125391553|NCT03608774|451067139|FG000|Overall Study|Not eligible at enrollment|0|||
125391554|NCT03608774|451067140|FG001|Overall Study|Not eligible at enrollment|1|||
125391555|NCT03608774|451067139|FG000|Overall Study|Health related event|0|||
125391556|NCT03608774|451067140|FG001|Overall Study|Health related event|1|||
125391557|NCT00642668|451067141|FG000|Overall Study|Lost to Follow-up|1|||
125391558|NCT00642668|451067141|FG000|Overall Study|Adverse Event|2|||
125391559|NCT00642668|451067141|FG000|Overall Study|Death|2|||
125391560|NCT00642668|451067141|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125391561|NCT00642668|451067141|FG000|Overall Study|Failure to Return|1|||
125391562|NCT00642668|451067141|FG000|Overall Study|Dialysis Initiation|5|||
125391563|NCT00642668|451067141|FG000|Overall Study|Blood Transfusion|2|||
125391564|NCT01177540|451067142|FG000|Overall Study|Adverse Event|1|||
125391565|NCT01177540|451067143|FG001|Overall Study|Adverse Event|0|||
125391566|NCT01623596|451067149|FG000|Overall Study|Abnormal laboratory values|2|||
125391567|NCT01623596|451067150|FG001|Overall Study|Abnormal laboratory values|0|||
125391568|NCT01623596|451067149|FG000|Overall Study|Administrative problems|9|||
125391569|NCT01623596|451067150|FG001|Overall Study|Administrative problems|13|||
125391570|NCT01623596|451067149|FG000|Overall Study|Adverse Event|20|||
125391571|NCT01623596|451067150|FG001|Overall Study|Adverse Event|29|||
125163688|NCT00265395|450222750|FG000|Overall Study|Protocol Violation|2|||
125163689|NCT00265395|450222751|FG001|Overall Study|Protocol Violation|2|||
125163690|NCT00265395|450222750|FG000|Overall Study|Lack of Efficacy|0|||
125391572|NCT01623596|451067149|FG000|Overall Study|Death|0|||
125391573|NCT01623596|451067150|FG001|Overall Study|Death|2|||
125441171|NCT03354637|451244142|FG000|Double-blind Period|Withdrawal by Subject|10|||
125441172|NCT03354637|451244143|FG001|Double-blind Period|Withdrawal by Subject|6|||
125441173|NCT03354637|451244144|FG002|Double-blind Period|Withdrawal by Subject|4|||
125163691|NCT00265395|450222751|FG001|Overall Study|Lack of Efficacy|1|||
125163692|NCT00265395|450222750|FG000|Overall Study|Administrative|0|||
125391574|NCT01623596|451067149|FG000|Overall Study|Lost to Follow-up|12|||
125391575|NCT01623596|451067150|FG001|Overall Study|Lost to Follow-up|16|||
125391576|NCT01623596|451067149|FG000|Overall Study|Withdrawal by Subject|13|||
125391577|NCT01623596|451067150|FG001|Overall Study|Withdrawal by Subject|31|||
125441174|NCT03354637|451244142|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
125441175|NCT03354637|451244143|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
125441176|NCT03354637|451244144|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
125441177|NCT03354637|451244142|FG000|Open Label Extension|Adverse Event|0|||
125441178|NCT03354637|451244143|FG001|Open Label Extension|Adverse Event|0|||
125441179|NCT03354637|451244144|FG002|Open Label Extension|Adverse Event|1|||
125441180|NCT03354637|451244142|FG000|Open Label Extension|Lost to Follow-up|0|||
125441181|NCT03354637|451244143|FG001|Open Label Extension|Lost to Follow-up|0|||
125441182|NCT03354637|451244144|FG002|Open Label Extension|Lost to Follow-up|2|||
125441183|NCT03354637|451244142|FG000|Open Label Extension|Withdrawal by Subject|0|||
125441184|NCT03354637|451244143|FG001|Open Label Extension|Withdrawal by Subject|0|||
125441185|NCT03354637|451244144|FG002|Open Label Extension|Withdrawal by Subject|5|||
125441186|NCT03354637|451244142|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
125441187|NCT03354637|451244143|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
125441188|NCT03354637|451244144|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
125441189|NCT03354637|451244142|FG000|Open Label Extension|Subject Noncompliance|0|||
125441190|NCT03354637|451244143|FG001|Open Label Extension|Subject Noncompliance|0|||
125441191|NCT03354637|451244144|FG002|Open Label Extension|Subject Noncompliance|1|||
125441192|NCT03354637|451244142|FG000|Open Label Extension|Lack of Efficacy|0|||
125441193|NCT03354637|451244143|FG001|Open Label Extension|Lack of Efficacy|0|||
125441194|NCT03354637|451244144|FG002|Open Label Extension|Lack of Efficacy|1|||
125441195|NCT03354637|451244142|FG000|Open Label Extension|Physician Decision|0|||
125441196|NCT03354637|451244143|FG001|Open Label Extension|Physician Decision|0|||
125441197|NCT03354637|451244144|FG002|Open Label Extension|Physician Decision|1|||
125441198|NCT02726399|451244145|FG000|Overall Study|Participant Non-Compliance|1|||
125441199|NCT02726399|451244145|FG000|Overall Study|Adverse Event|2|||
125163693|NCT00265395|450222751|FG001|Overall Study|Administrative|1|||
125163694|NCT04053465|450222754|FG000|Overall Study|Withdrawal by Subject|4|||
125163695|NCT04053465|450222755|FG001|Overall Study|Withdrawal by Subject|4|||
125163696|NCT03317834|450222756|FG000|Overall Study|Death|2|||
125163697|NCT03317834|450222756|FG000|Overall Study|Device Revision|5|||
125163698|NCT03317834|450222756|FG000|Overall Study|Withdrawal by Subject|13|||
125163699|NCT03317834|450222756|FG000|Overall Study|Lost to Follow-up|13|||
125163700|NCT01140503|450222765|FG000|Overall Study|Withdrawal by Subject|1|||
125163701|NCT04135196|450222768|FG000|Overall Study|Lost to Follow-up|8|||
125163702|NCT04135196|450222769|FG001|Overall Study|Lost to Follow-up|7|||
125163703|NCT04135196|450222770|FG002|Overall Study|Lost to Follow-up|8|||
125163704|NCT04135196|450222771|FG003|Overall Study|Lost to Follow-up|9|||
125163705|NCT04135196|450222772|FG004|Overall Study|Lost to Follow-up|1|||
125163706|NCT04135196|450222768|FG000|Overall Study|Pregnancy|0|||
125163707|NCT04135196|450222769|FG001|Overall Study|Pregnancy|0|||
125163708|NCT04135196|450222770|FG002|Overall Study|Pregnancy|1|||
125163709|NCT04135196|450222771|FG003|Overall Study|Pregnancy|0|||
125163710|NCT04135196|450222772|FG004|Overall Study|Pregnancy|0|||
125163711|NCT04135196|450222768|FG000|Overall Study|Withdrawal by Subject|0|||
125163712|NCT04135196|450222769|FG001|Overall Study|Withdrawal by Subject|0|||
125163713|NCT04135196|450222770|FG002|Overall Study|Withdrawal by Subject|0|||
125163714|NCT04135196|450222771|FG003|Overall Study|Withdrawal by Subject|0|||
125163715|NCT04135196|450222772|FG004|Overall Study|Withdrawal by Subject|1|||
125163716|NCT00809159|450222774|FG000|Part 1|Adverse Event|1|||
125163717|NCT00809159|450222775|FG001|Part 1|Adverse Event|1|||
125163718|NCT00809159|450222776|FG002|Part 1|Adverse Event|0|||
125163719|NCT00809159|450222777|FG003|Part 1|Adverse Event|0|||
125163720|NCT00809159|450222778|FG004|Part 1|Adverse Event|0|||
125163721|NCT00809159|450222779|FG005|Part 1|Adverse Event|0|||
125163722|NCT00809159|450222774|FG000|Part 1|Lost to Follow-up|1|||
125163723|NCT00809159|450222775|FG001|Part 1|Lost to Follow-up|0|||
125163724|NCT00809159|450222776|FG002|Part 1|Lost to Follow-up|0|||
125225264|NCT00810199|450452116|FG000|Overall Study|Death|4|||
125225265|NCT00810199|450452117|FG001|Overall Study|Death|6|||
125225266|NCT00810199|450452116|FG000|Overall Study|Withdrew consent|9|||
125225267|NCT00810199|450452117|FG001|Overall Study|Withdrew consent|12|||
125225268|NCT00810199|450452116|FG000|Overall Study|Insufficient therapeutic response|5|||
125225269|NCT00810199|450452117|FG001|Overall Study|Insufficient therapeutic response|14|||
125225270|NCT00810199|450452116|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
125441200|NCT02726399|451244145|FG000|Overall Study|Progression of disease|4|||
125441201|NCT03268590|451244147|FG000|Overall Study|Previously unknown exclusion criteria|1|||
125163725|NCT00809159|450222777|FG003|Part 1|Lost to Follow-up|0|||
125163726|NCT00809159|450222778|FG004|Part 1|Lost to Follow-up|0|||
125225271|NCT00810199|450452117|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
125441202|NCT00919893|451244152|FG000|Overall Study|Protocol Violation|19|||
125163727|NCT00809159|450222779|FG005|Part 1|Lost to Follow-up|0|||
125163728|NCT00809159|450222774|FG000|Part 1|Withdrawal by Subject|3|||
125163729|NCT00809159|450222775|FG001|Part 1|Withdrawal by Subject|1|||
125441203|NCT00919893|451244153|FG001|Overall Study|Protocol Violation|9|||
125163730|NCT00809159|450222776|FG002|Part 1|Withdrawal by Subject|0|||
125163731|NCT00809159|450222777|FG003|Part 1|Withdrawal by Subject|0|||
125163732|NCT00809159|450222778|FG004|Part 1|Withdrawal by Subject|0|||
125163733|NCT00809159|450222779|FG005|Part 1|Withdrawal by Subject|0|||
125163734|NCT00809159|450222774|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
125163735|NCT00809159|450222775|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
125163736|NCT00809159|450222776|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
125163737|NCT00809159|450222777|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
125163738|NCT00809159|450222778|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
125163739|NCT00809159|450222779|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
125163740|NCT00809159|450222774|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
125163741|NCT00809159|450222775|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
125163742|NCT00809159|450222776|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
125163743|NCT00809159|450222777|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
125163744|NCT00809159|450222778|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
125225272|NCT00810199|450452116|FG000|Overall Study|Administrative/Other|5|||
125225273|NCT00810199|450452117|FG001|Overall Study|Administrative/Other|6|||
125225274|NCT00810199|450452116|FG000|Overall Study|Protocol Violation|2|||
125225275|NCT00810199|450452117|FG001|Overall Study|Protocol Violation|6|||
125391578|NCT01623596|451067149|FG000|Overall Study|Patient no longer requires study drug|1|||
125391579|NCT01623596|451067150|FG001|Overall Study|Patient no longer requires study drug|0|||
125391580|NCT01623596|451067149|FG000|Overall Study|Protocol Violation|0|||
125391581|NCT01623596|451067150|FG001|Overall Study|Protocol Violation|6|||
125391582|NCT01623596|451067149|FG000|Overall Study|Lack of Efficacy|5|||
125391583|NCT01623596|451067150|FG001|Overall Study|Lack of Efficacy|3|||
125391584|NCT05756790|451067151|FG000|Overall Study|Withdrawal by Subject|1|||
125391585|NCT05756790|451067152|FG001|Overall Study|Withdrawal by Subject|1|||
125391586|NCT05756790|451067153|FG002|Overall Study|Withdrawal by Subject|1|||
125391587|NCT05756790|451067154|FG003|Overall Study|Withdrawal by Subject|1|||
125391588|NCT05756790|451067155|FG004|Overall Study|Withdrawal by Subject|0|||
125391589|NCT05756790|451067156|FG005|Overall Study|Withdrawal by Subject|0|||
125391590|NCT05756790|451067151|FG000|Overall Study|Protocol Violation|0|||
125391591|NCT05756790|451067152|FG001|Overall Study|Protocol Violation|0|||
125391592|NCT05756790|451067153|FG002|Overall Study|Protocol Violation|1|||
125391593|NCT05756790|451067154|FG003|Overall Study|Protocol Violation|1|||
125391594|NCT05756790|451067155|FG004|Overall Study|Protocol Violation|0|||
125391595|NCT05756790|451067156|FG005|Overall Study|Protocol Violation|0|||
125391596|NCT05756790|451067151|FG000|Overall Study|Ineligible|0|||
125391597|NCT05756790|451067152|FG001|Overall Study|Ineligible|0|||
125391598|NCT05756790|451067153|FG002|Overall Study|Ineligible|0|||
125391599|NCT05756790|451067154|FG003|Overall Study|Ineligible|0|||
125391600|NCT05756790|451067155|FG004|Overall Study|Ineligible|2|||
125391601|NCT05756790|451067156|FG005|Overall Study|Ineligible|2|||
125391602|NCT01545817|451068573|FG000|Pazopanib|Disease progression|51|||
125163745|NCT00809159|450222779|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
125163746|NCT00809159|450222774|FG000|Part 1 and 2|Administrative problems|0|||
125163747|NCT00809159|450222775|FG001|Part 1 and 2|Administrative problems|0|||
125163748|NCT00809159|450222776|FG002|Part 1 and 2|Administrative problems|0|||
125163749|NCT00809159|450222777|FG003|Part 1 and 2|Administrative problems|1|||
125163750|NCT00809159|450222778|FG004|Part 1 and 2|Administrative problems|0|||
125163751|NCT00809159|450222779|FG005|Part 1 and 2|Administrative problems|0|||
125163752|NCT00809159|450222774|FG000|Part 1 and 2|Adverse Event|0|||
125163753|NCT00809159|450222775|FG001|Part 1 and 2|Adverse Event|0|||
125163754|NCT00809159|450222776|FG002|Part 1 and 2|Adverse Event|1|||
125163755|NCT00809159|450222777|FG003|Part 1 and 2|Adverse Event|0|||
125163756|NCT00809159|450222778|FG004|Part 1 and 2|Adverse Event|1|||
125163757|NCT00809159|450222779|FG005|Part 1 and 2|Adverse Event|1|||
125163758|NCT00809159|450222774|FG000|Part 1 and 2|Lost to Follow-up|0|||
125163759|NCT00809159|450222775|FG001|Part 1 and 2|Lost to Follow-up|0|||
125163760|NCT00809159|450222776|FG002|Part 1 and 2|Lost to Follow-up|1|||
125163761|NCT00809159|450222777|FG003|Part 1 and 2|Lost to Follow-up|1|||
125163762|NCT00809159|450222778|FG004|Part 1 and 2|Lost to Follow-up|0|||
125163763|NCT00809159|450222779|FG005|Part 1 and 2|Lost to Follow-up|0|||
125163764|NCT00809159|450222774|FG000|Part 1 and 2|Withdrawal by Subject|0|||
125163765|NCT00809159|450222775|FG001|Part 1 and 2|Withdrawal by Subject|0|||
125163766|NCT00809159|450222776|FG002|Part 1 and 2|Withdrawal by Subject|4|||
125163767|NCT00809159|450222777|FG003|Part 1 and 2|Withdrawal by Subject|0|||
125163768|NCT00809159|450222778|FG004|Part 1 and 2|Withdrawal by Subject|0|||
125163769|NCT00809159|450222779|FG005|Part 1 and 2|Withdrawal by Subject|1|||
125163770|NCT03201211|450222782|FG000|Overall Study|Adverse Event|1|||
125163771|NCT03201211|450222783|FG001|Overall Study|Adverse Event|0|||
125163772|NCT03201211|450222784|FG002|Overall Study|Adverse Event|0|||
125163773|NCT03201211|450222782|FG000|Overall Study|Protocol Violation|1|||
125163774|NCT03201211|450222783|FG001|Overall Study|Protocol Violation|0|||
125163775|NCT03201211|450222784|FG002|Overall Study|Protocol Violation|0|||
125163776|NCT03201211|450222782|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125163777|NCT03201211|450222783|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
125163778|NCT03201211|450222784|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
125391603|NCT01545817|451068574|FG001|Pazopanib|Disease progression|0|||
125391604|NCT01545817|451068573|FG000|Pazopanib|Adverse Event|19|||
125391605|NCT01545817|451068574|FG001|Pazopanib|Adverse Event|0|||
125391606|NCT01545817|451068573|FG000|Pazopanib|Other reason|4|||
125163779|NCT03201211|450222782|FG000|Overall Study|OTHER unknown reasons|0|||
125163780|NCT03201211|450222783|FG001|Overall Study|OTHER unknown reasons|1|||
125163781|NCT03201211|450222784|FG002|Overall Study|OTHER unknown reasons|0|||
125163782|NCT01083810|450222785|FG000|Overall Study|Lost to Follow-up|23|||
125163783|NCT01083810|450222786|FG001|Overall Study|Lost to Follow-up|11|||
125163784|NCT01083810|450222787|FG002|Overall Study|Lost to Follow-up|4|||
125163785|NCT01083810|450222785|FG000|Overall Study|Adverse Event|15|||
125163786|NCT01083810|450222786|FG001|Overall Study|Adverse Event|11|||
125163787|NCT01083810|450222787|FG002|Overall Study|Adverse Event|4|||
125163788|NCT01083810|450222785|FG000|Overall Study|Withdrawal by Subject|7|||
125163789|NCT01083810|450222786|FG001|Overall Study|Withdrawal by Subject|2|||
125163790|NCT01083810|450222787|FG002|Overall Study|Withdrawal by Subject|4|||
125163791|NCT01083810|450222785|FG000|Overall Study|Reason not reported|6|||
125163792|NCT01083810|450222786|FG001|Overall Study|Reason not reported|1|||
125163793|NCT01083810|450222787|FG002|Overall Study|Reason not reported|1|||
125163794|NCT01083810|450222785|FG000|Overall Study|Non-compliance|4|||
125163795|NCT01083810|450222786|FG001|Overall Study|Non-compliance|7|||
125163796|NCT01083810|450222787|FG002|Overall Study|Non-compliance|2|||
125163797|NCT01083810|450222785|FG000|Overall Study|Simplification|4|||
125163798|NCT01083810|450222786|FG001|Overall Study|Simplification|1|||
125163799|NCT01083810|450222787|FG002|Overall Study|Simplification|0|||
125163800|NCT01083810|450222785|FG000|Overall Study|Death|2|||
125163801|NCT01083810|450222786|FG001|Overall Study|Death|2|||
125163802|NCT01083810|450222787|FG002|Overall Study|Death|3|||
125163803|NCT01083810|450222785|FG000|Overall Study|Co-morbidities|1|||
125163804|NCT01083810|450222786|FG001|Overall Study|Co-morbidities|0|||
125163805|NCT01083810|450222787|FG002|Overall Study|Co-morbidities|0|||
125163806|NCT01083810|450222785|FG000|Overall Study|Participation in study|1|||
125163807|NCT01083810|450222786|FG001|Overall Study|Participation in study|0|||
125163808|NCT01083810|450222787|FG002|Overall Study|Participation in study|0|||
125163809|NCT01083810|450222785|FG000|Overall Study|Therapy break|1|||
125163810|NCT01083810|450222786|FG001|Overall Study|Therapy break|2|||
125163811|NCT01083810|450222787|FG002|Overall Study|Therapy break|2|||
125163812|NCT01083810|450222785|FG000|Overall Study|Virologic failure|1|||
125163813|NCT01083810|450222786|FG001|Overall Study|Virologic failure|8|||
125163814|NCT01083810|450222787|FG002|Overall Study|Virologic failure|0|||
125163815|NCT01629966|450222788|FG000|Overall Study|Pregnancy|0|||
125163816|NCT01629966|450222789|FG001|Overall Study|Pregnancy|1|||
125163817|NCT01629966|450222790|FG002|Overall Study|Pregnancy|0|||
125163818|NCT01629966|450222788|FG000|Overall Study|Lost to Follow-up|10|||
125163819|NCT01629966|450222789|FG001|Overall Study|Lost to Follow-up|13|||
125163820|NCT01629966|450222790|FG002|Overall Study|Lost to Follow-up|9|||
125163821|NCT01629966|450222788|FG000|Overall Study|Withdrawal by Subject|8|||
125163822|NCT01629966|450222789|FG001|Overall Study|Withdrawal by Subject|9|||
125163823|NCT01629966|450222790|FG002|Overall Study|Withdrawal by Subject|16|||
125163824|NCT01629966|450222788|FG000|Overall Study|Protocol Violation|7|||
125163825|NCT01629966|450222789|FG001|Overall Study|Protocol Violation|9|||
125163826|NCT01629966|450222790|FG002|Overall Study|Protocol Violation|7|||
125163827|NCT01629966|450222788|FG000|Overall Study|Lack of Efficacy|5|||
125163828|NCT01629966|450222789|FG001|Overall Study|Lack of Efficacy|2|||
125163829|NCT01629966|450222790|FG002|Overall Study|Lack of Efficacy|4|||
125163830|NCT01629966|450222788|FG000|Overall Study|Adverse Event|11|||
125163831|NCT01629966|450222789|FG001|Overall Study|Adverse Event|18|||
125163832|NCT01629966|450222790|FG002|Overall Study|Adverse Event|30|||
125163833|NCT00477295|450222793|FG000|Overall Study|Adverse Event|31|||
125163834|NCT00477295|450222794|FG001|Overall Study|Adverse Event|35|||
125163835|NCT00477295|450222793|FG000|Overall Study|Withdrawal by Subject|35|||
125163836|NCT00477295|450222794|FG001|Overall Study|Withdrawal by Subject|24|||
125163837|NCT00477295|450222793|FG000|Overall Study|Lack of Efficacy|23|||
125163838|NCT00477295|450222794|FG001|Overall Study|Lack of Efficacy|23|||
125163839|NCT00477295|450222793|FG000|Overall Study|Protocol Violation|3|||
125163840|NCT00477295|450222794|FG001|Overall Study|Protocol Violation|8|||
125163841|NCT00477295|450222793|FG000|Overall Study|Physician Decision|4|||
125163842|NCT00477295|450222794|FG001|Overall Study|Physician Decision|5|||
125163843|NCT00477295|450222793|FG000|Overall Study|Lost to Follow-up|21|||
125163844|NCT00477295|450222794|FG001|Overall Study|Lost to Follow-up|11|||
125163845|NCT00477295|450222793|FG000|Overall Study|Other|4|||
125163846|NCT00477295|450222794|FG001|Overall Study|Other|3|||
125163847|NCT04568031|450222795|FG000|Overall Study|Lost to Follow-up|1|||
125163848|NCT04568031|450222796|FG001|Overall Study|Lost to Follow-up|0|||
125163849|NCT04568031|450222797|FG002|Overall Study|Lost to Follow-up|0|||
125163850|NCT04568031|450222798|FG003|Overall Study|Lost to Follow-up|0|||
125163851|NCT04568031|450222795|FG000|Overall Study|Physician Decision|1|||
125163852|NCT04568031|450222796|FG001|Overall Study|Physician Decision|0|||
125163853|NCT04568031|450222797|FG002|Overall Study|Physician Decision|1|||
125163854|NCT04568031|450222798|FG003|Overall Study|Physician Decision|0|||
125163855|NCT04568031|450222795|FG000|Overall Study|Withdrawal by Subject|1|||
125163856|NCT04568031|450222796|FG001|Overall Study|Withdrawal by Subject|0|||
125163857|NCT04568031|450222797|FG002|Overall Study|Withdrawal by Subject|4|||
125163858|NCT04568031|450222798|FG003|Overall Study|Withdrawal by Subject|1|||
125441204|NCT01375959|451244154|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
125441205|NCT01375959|451244155|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
125441206|NCT01375959|451244154|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
125441207|NCT01375959|451244155|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
125441208|NCT01375959|451244154|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
125441209|NCT01375959|451244155|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
125441210|NCT00794820|451244159|FG000|Overall Study|Adverse Event|11|||
125441211|NCT00794820|451244159|FG000|Overall Study|Secondary Malignancies|2|||
125163859|NCT04430855|450222799|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
125163860|NCT04430855|450222800|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
125163861|NCT04430855|450222799|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
125163862|NCT04430855|450222800|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
125163863|NCT04430855|450222799|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
125163864|NCT04430855|450222800|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
125163865|NCT04430855|450222799|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
125163866|NCT04430855|450222800|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
125163867|NCT04430855|450222799|FG000|Period 1 (Weeks 1-12)|Other|0|||
125163868|NCT04430855|450222800|FG001|Period 1 (Weeks 1-12)|Other|1|||
125163869|NCT04430855|450222799|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
125163870|NCT04430855|450222800|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
125163871|NCT04430855|450222799|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
125163872|NCT04430855|450222800|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
125163873|NCT04430855|450222799|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
125163874|NCT04430855|450222800|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
125163875|NCT00390221|450222801|FG000|Overall Study|Lost to Follow-up|0|||
125163876|NCT00390221|450222802|FG001|Overall Study|Lost to Follow-up|3|||
125163877|NCT00390221|450222803|FG002|Overall Study|Lost to Follow-up|0|||
125163878|NCT00390221|450222801|FG000|Overall Study|Adverse Event|1|||
125163879|NCT00390221|450222802|FG001|Overall Study|Adverse Event|4|||
125163880|NCT00390221|450222803|FG002|Overall Study|Adverse Event|3|||
125163881|NCT00390221|450222801|FG000|Overall Study|Investigator Decision|0|||
125163882|NCT00390221|450222802|FG001|Overall Study|Investigator Decision|0|||
125163883|NCT00390221|450222803|FG002|Overall Study|Investigator Decision|1|||
125163884|NCT00390221|450222801|FG000|Overall Study|Withdrawal by Subject|13|||
125163885|NCT00390221|450222802|FG001|Overall Study|Withdrawal by Subject|9|||
125163886|NCT00390221|450222803|FG002|Overall Study|Withdrawal by Subject|7|||
125163887|NCT00390221|450222801|FG000|Overall Study|Subject Non-compliance|1|||
125163888|NCT00390221|450222802|FG001|Overall Study|Subject Non-compliance|0|||
125163889|NCT00390221|450222803|FG002|Overall Study|Subject Non-compliance|2|||
125163890|NCT00390221|450222801|FG000|Overall Study|Other|3|||
125163891|NCT00390221|450222802|FG001|Overall Study|Other|4|||
125163892|NCT00390221|450222803|FG002|Overall Study|Other|2|||
125163893|NCT02533375|450222806|FG000|Overall Study|Lack of Efficacy|3|||
125163894|NCT02533375|450222806|FG000|Overall Study|Adverse Event|2|||
125163895|NCT03258853|450222824|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
125163896|NCT03258853|450222825|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
125163897|NCT03870477|450222826|FG000|Overall Study|Early Study Termination|1|||
125163898|NCT01709838|450222829|FG000|Overall Study|Withdrawal by Subject|21|||
125163899|NCT01709838|450222829|FG000|Overall Study|Lost to Follow-up|16|||
125163900|NCT01709838|450222829|FG000|Overall Study|Pregnancy|10|||
125163901|NCT01709838|450222829|FG000|Overall Study|Subject/guardian decision|8|||
125163902|NCT01709838|450222829|FG000|Overall Study|Adverse Event|4|||
125163903|NCT01709838|450222829|FG000|Overall Study|Physician Decision|4|||
125163904|NCT01709838|450222829|FG000|Overall Study|Death|3|||
125163905|NCT01709838|450222829|FG000|Overall Study|Protocol Violation|1|||
125163906|NCT03753763|450222839|FG000|Overall Study|Adverse Event|2|||
125163907|NCT03753763|450222840|FG001|Overall Study|Adverse Event|0|||
125163908|NCT03753763|450222839|FG000|Overall Study|Withdrawal by Subject|3|||
125163909|NCT03753763|450222840|FG001|Overall Study|Withdrawal by Subject|1|||
125163910|NCT03753763|450222839|FG000|Overall Study|clinical deterioration|1|||
125163911|NCT03753763|450222840|FG001|Overall Study|clinical deterioration|0|||
125163912|NCT00389831|450222841|FG000|Overall Study|Lack of Efficacy|0|||
125163913|NCT00389831|450222842|FG001|Overall Study|Lack of Efficacy|2|||
125163914|NCT00389831|450222841|FG000|Overall Study|Did not receive treatment.|0|||
125163915|NCT00389831|450222842|FG001|Overall Study|Did not receive treatment.|2|||
125163916|NCT00389831|450222841|FG000|Overall Study|Other reasons|0|||
125163917|NCT00389831|450222842|FG001|Overall Study|Other reasons|2|||
125163918|NCT00389831|450222841|FG000|Overall Study|Lost to Follow-up|0|||
125163919|NCT00389831|450222842|FG001|Overall Study|Lost to Follow-up|1|||
125163920|NCT03433755|450222843|FG000|Overall Study|Lost to Follow-up|1|||
125441212|NCT00794820|451244159|FG000|Overall Study|Resistant Disease|2|||
125163921|NCT03433755|450222844|FG001|Overall Study|Lost to Follow-up|0|||
125163922|NCT03433755|450222845|FG002|Overall Study|Lost to Follow-up|0|||
125163923|NCT03433755|450222846|FG003|Overall Study|Lost to Follow-up|0|||
125163924|NCT03433755|450222843|FG000|Overall Study|Decision by Sponsor|1|||
125163925|NCT03433755|450222844|FG001|Overall Study|Decision by Sponsor|0|||
125163926|NCT03433755|450222845|FG002|Overall Study|Decision by Sponsor|0|||
125225276|NCT00810199|450452116|FG000|Overall Study|Failure to return|1|||
125225277|NCT00810199|450452117|FG001|Overall Study|Failure to return|4|||
125441213|NCT00794820|451244159|FG000|Overall Study|Ineligible/Screen Failure|1|||
125441214|NCT04076020|451244160|FG000|Overall Study|Death|4|||
125441215|NCT04076020|451244161|FG001|Overall Study|Death|6|||
125441216|NCT04076020|451244160|FG000|Overall Study|Withdrawal by Subject|12|||
125441217|NCT04076020|451244161|FG001|Overall Study|Withdrawal by Subject|8|||
125441218|NCT02310126|451244163|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
125441219|NCT02310126|451244164|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
125441220|NCT02310126|451244163|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
125441221|NCT02310126|451244164|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
125441222|NCT03537261|451244170|FG000|Overall Study|Lost to Follow-up|4|||
125441223|NCT03537261|451244171|FG001|Overall Study|Lost to Follow-up|5|||
125441224|NCT03537261|451244170|FG000|Overall Study|Withdrawal by Subject|4|||
125441225|NCT03537261|451244171|FG001|Overall Study|Withdrawal by Subject|6|||
125441226|NCT03537261|451244170|FG000|Overall Study|Did not return study questionnaires|0|||
125441227|NCT03537261|451244171|FG001|Overall Study|Did not return study questionnaires|1|||
125441228|NCT03237013|451244172|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
125441229|NCT03237013|451244173|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
125441230|NCT03237013|451244174|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
125441231|NCT00502996|451244177|FG000|Overall Study|Lost to Follow-up|9|||
125441232|NCT00502996|451244177|FG000|Overall Study|Protocol Violation|2|||
125441233|NCT00502996|451244177|FG000|Overall Study|Treatment failure|25|||
125441234|NCT00502996|451244177|FG000|Overall Study|Withdrawal Informed Consent|6|||
125441235|NCT00502996|451244177|FG000|Overall Study|Adverse Event|2|||
125441236|NCT01729728|451244178|FG000|Overall Study|Adverse Event|0|||
125441237|NCT01729728|451244179|FG001|Overall Study|Adverse Event|6|||
125441238|NCT01729728|451244180|FG002|Overall Study|Adverse Event|0|||
125441239|NCT01729728|451244178|FG000|Overall Study|Protocol Violation|1|||
125441240|NCT01729728|451244179|FG001|Overall Study|Protocol Violation|0|||
125441241|NCT01729728|451244180|FG002|Overall Study|Protocol Violation|1|||
125441242|NCT02500979|451244181|FG000|Period 1|Hyperglycemia|1|||
125441243|NCT02500979|451244182|FG001|Period 1|Hyperglycemia|0|||
125441244|NCT02500979|451244181|FG000|Period 1|Severe non-compliance to protocol|0|||
125163927|NCT03433755|450222846|FG003|Overall Study|Decision by Sponsor|0|||
125163928|NCT04941729|450225021|FG000|Overall Study|Death|0|||
125163929|NCT04941729|450225022|FG001|Overall Study|Death|1|||
125163930|NCT04941729|450225021|FG000|Overall Study|Study terminated by sponsor|11|||
125225278|NCT00810199|450452116|FG000|Overall Study|Did not receive study drug|2|||
125163931|NCT04941729|450225022|FG001|Overall Study|Study terminated by sponsor|10|||
125163932|NCT03190330|450225023|FG000|Overall Study|Adverse Event|2|||
125163933|NCT03190330|450225023|FG000|Overall Study|Death|10|||
125163934|NCT03190330|450225023|FG000|Overall Study|Lost to Follow-up|1|||
125163935|NCT03190330|450225023|FG000|Overall Study|Withdrawal by Subject|6|||
125163936|NCT03190330|450225023|FG000|Overall Study|Progressive Disease|1|||
125163937|NCT00006721|450225024|FG000|Overall Study|Adverse Event|0|||
125163938|NCT00006721|450225025|FG001|Overall Study|Adverse Event|4|||
125163939|NCT00006721|450225026|FG002|Overall Study|Adverse Event|4|||
125163940|NCT00006721|450225024|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
125163941|NCT00006721|450225025|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
125163942|NCT00006721|450225026|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
125163943|NCT00006721|450225024|FG000|Overall Study|Progression/Relapse|0|||
125163944|NCT00006721|450225025|FG001|Overall Study|Progression/Relapse|1|||
125163945|NCT00006721|450225026|FG002|Overall Study|Progression/Relapse|2|||
125163946|NCT00006721|450225024|FG000|Overall Study|Death|0|||
125163947|NCT00006721|450225025|FG001|Overall Study|Death|1|||
125163948|NCT00006721|450225026|FG002|Overall Study|Death|2|||
125163949|NCT00006721|450225024|FG000|Overall Study|Other - Not Protocol Specified|0|||
125163950|NCT00006721|450225025|FG001|Overall Study|Other - Not Protocol Specified|7|||
125163951|NCT00006721|450225026|FG002|Overall Study|Other - Not Protocol Specified|7|||
125163952|NCT00006721|450225024|FG000|Overall Study|Ineligible|2|||
125163953|NCT00006721|450225025|FG001|Overall Study|Ineligible|12|||
125163954|NCT00006721|450225026|FG002|Overall Study|Ineligible|10|||
125163955|NCT00006721|450225024|FG000|Overall Study|Eligible but no Treatment Received|1|||
125163956|NCT00006721|450225025|FG001|Overall Study|Eligible but no Treatment Received|0|||
125225279|NCT00810199|450452117|FG001|Overall Study|Did not receive study drug|1|||
125441245|NCT02500979|451244182|FG001|Period 1|Severe non-compliance to protocol|1|||
125441246|NCT02500979|451244181|FG000|Period 1|Adverse Event|1|||
125441247|NCT02500979|451244182|FG001|Period 1|Adverse Event|0|||
125441248|NCT02500979|451244181|FG000|Period 1|Subject decision|2|||
125441249|NCT02500979|451244182|FG001|Period 1|Subject decision|0|||
125441250|NCT02500979|451244181|FG000|Period 2|Change in risk|1|||
125441251|NCT02500979|451244182|FG001|Period 2|Change in risk|0|||
125163957|NCT00006721|450225026|FG002|Overall Study|Eligible but no Treatment Received|0|||
125163958|NCT02081209|450225027|FG000|Overall Study|Withdrawal by Subject|1|||
125163959|NCT00191113|450225038|FG000|Core Study|Withdrawal by Subject|25|||
125163960|NCT00191113|450225039|FG001|Core Study|Withdrawal by Subject|9|||
125163961|NCT00191113|450225038|FG000|Core Study|Protocol Violation|6|||
125163962|NCT00191113|450225039|FG001|Core Study|Protocol Violation|2|||
125225280|NCT00715403|450452118|FG000|Overall Study|Progressive disease|0|||
125225281|NCT00715403|450452119|FG001|Overall Study|Progressive disease|1|||
125225282|NCT00715403|450452120|FG002|Overall Study|Progressive disease|3|||
125225283|NCT00715403|450452121|FG003|Overall Study|Progressive disease|9|||
125225284|NCT00715403|450452122|FG004|Overall Study|Progressive disease|5|||
125225285|NCT00715403|450452123|FG005|Overall Study|Progressive disease|14|||
125225286|NCT00715403|450452124|FG006|Overall Study|Progressive disease|1|||
125225287|NCT00715403|450452118|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
125225288|NCT00715403|450452119|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
125225289|NCT00715403|450452120|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
125225290|NCT00715403|450452121|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
125225291|NCT00715403|450452122|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
125225292|NCT00715403|450452123|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
125225293|NCT00715403|450452124|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
125225294|NCT00715403|450452118|FG000|Overall Study|Other Adverse Event than DLT|1|||
125225295|NCT00715403|450452119|FG001|Overall Study|Other Adverse Event than DLT|0|||
125225296|NCT00715403|450452120|FG002|Overall Study|Other Adverse Event than DLT|0|||
125225297|NCT00715403|450452121|FG003|Overall Study|Other Adverse Event than DLT|0|||
125225298|NCT00715403|450452122|FG004|Overall Study|Other Adverse Event than DLT|0|||
125225299|NCT00715403|450452123|FG005|Overall Study|Other Adverse Event than DLT|2|||
125225300|NCT00715403|450452124|FG006|Overall Study|Other Adverse Event than DLT|0|||
125225301|NCT00715403|450452118|FG000|Overall Study|Protocol Violation|0|||
125225302|NCT00715403|450452119|FG001|Overall Study|Protocol Violation|0|||
125225303|NCT00715403|450452120|FG002|Overall Study|Protocol Violation|0|||
125225304|NCT00715403|450452121|FG003|Overall Study|Protocol Violation|0|||
125225305|NCT00715403|450452122|FG004|Overall Study|Protocol Violation|0|||
125225306|NCT00715403|450452123|FG005|Overall Study|Protocol Violation|1|||
125225307|NCT00715403|450452124|FG006|Overall Study|Protocol Violation|0|||
125225308|NCT00715403|450452118|FG000|Overall Study|Other reason not defined above|0|||
125225309|NCT00715403|450452119|FG001|Overall Study|Other reason not defined above|0|||
125225310|NCT00715403|450452120|FG002|Overall Study|Other reason not defined above|1|||
125225311|NCT00715403|450452121|FG003|Overall Study|Other reason not defined above|0|||
125225312|NCT00715403|450452122|FG004|Overall Study|Other reason not defined above|1|||
125225313|NCT00715403|450452123|FG005|Overall Study|Other reason not defined above|1|||
125163963|NCT00191113|450225038|FG000|Core Study|Lost to Follow-up|3|||
125163964|NCT00191113|450225039|FG001|Core Study|Lost to Follow-up|0|||
125163965|NCT00191113|450225038|FG000|Core Study|Adverse Event|0|||
125163966|NCT00191113|450225039|FG001|Core Study|Adverse Event|2|||
125163967|NCT00191113|450225038|FG000|Core Study|Lack of Efficacy|0|||
125163968|NCT00191113|450225039|FG001|Core Study|Lack of Efficacy|2|||
125163969|NCT00191113|450225038|FG000|Core Study|Death|1|||
125163970|NCT00191113|450225039|FG001|Core Study|Death|0|||
125225314|NCT00715403|450452124|FG006|Overall Study|Other reason not defined above|0|||
125225315|NCT02175225|450452125|FG000|Overall Study|Withdrawal by Subject|1|||
125225316|NCT02175225|450452126|FG001|Overall Study|Withdrawal by Subject|2|||
125163971|NCT03786718|450225042|FG000|Overall Study|Lost to Follow-up|3|||
125163972|NCT03786718|450225042|FG000|Overall Study|Withdrawal by Subject|1|||
125163973|NCT03786718|450225042|FG000|Overall Study|Did not use the intervention|2|||
125163974|NCT03786718|450225042|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
125163975|NCT00368979|450225043|FG000|Overall Study|Adverse Event|9|||
125163976|NCT00368979|450225044|FG001|Overall Study|Adverse Event|16|||
125163977|NCT00368979|450225043|FG000|Overall Study|Lack of Efficacy|5|||
125163978|NCT00368979|450225044|FG001|Overall Study|Lack of Efficacy|3|||
125163979|NCT00368979|450225043|FG000|Overall Study|Other|3|||
125163980|NCT00368979|450225044|FG001|Overall Study|Other|1|||
125441252|NCT00672958|451244183|FG000|Overall Study|Adverse Event|11|||
125163981|NCT00368979|450225043|FG000|Overall Study|Lost to Follow-up|1|||
125225317|NCT02175225|450452125|FG000|Overall Study|Lost to Follow-up|6|||
125225318|NCT02175225|450452126|FG001|Overall Study|Lost to Follow-up|7|||
125225319|NCT02175225|450452125|FG000|Overall Study|Study drug not administered|1|||
125441253|NCT00672958|451244184|FG001|Overall Study|Adverse Event|9|||
125163982|NCT00368979|450225044|FG001|Overall Study|Lost to Follow-up|0|||
125163983|NCT00368979|450225043|FG000|Overall Study|Protocol Violation|2|||
125163984|NCT00368979|450225044|FG001|Overall Study|Protocol Violation|1|||
125163985|NCT00368979|450225043|FG000|Overall Study|Withdrawal by Subject|5|||
125225320|NCT02175225|450452126|FG001|Overall Study|Study drug not administered|2|||
125225321|NCT01883895|450452127|FG000|Overall Study|Lost to Follow-up|2|||
125225322|NCT00807365|450452128|FG000|Overall Study|Study Terminated|5|||
125225323|NCT03810456|450452129|FG000|Treatment|Urgent Family Matters|3|||
125225324|NCT03810456|450452130|FG001|Treatment|Urgent Family Matters|0|||
125225325|NCT03810456|450452131|FG002|Treatment|Urgent Family Matters|0|||
125225326|NCT03810456|450452129|FG000|Treatment|Scheduling Conflicts|0|||
125441254|NCT00672958|451244183|FG000|Overall Study|Lack of Efficacy|6|||
125441255|NCT00672958|451244184|FG001|Overall Study|Lack of Efficacy|11|||
125163986|NCT00368979|450225044|FG001|Overall Study|Withdrawal by Subject|9|||
125163987|NCT01570686|450225057|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125163988|NCT01570686|450225058|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125441256|NCT00672958|451244183|FG000|Overall Study|Non-compliance with study drug|2|||
125441257|NCT00672958|451244184|FG001|Overall Study|Non-compliance with study drug|3|||
125441258|NCT00672958|451244183|FG000|Overall Study|Protocol deviations|11|||
125441259|NCT00672958|451244184|FG001|Overall Study|Protocol deviations|5|||
125441260|NCT00672958|451244183|FG000|Overall Study|Voluntary withdrawal|12|||
125441261|NCT00672958|451244184|FG001|Overall Study|Voluntary withdrawal|8|||
125441262|NCT00672958|451244183|FG000|Overall Study|Lost to Follow-up|22|||
125441263|NCT00672958|451244184|FG001|Overall Study|Lost to Follow-up|17|||
125441264|NCT00672958|451244183|FG000|Overall Study|Reason not specified|0|||
125441265|NCT00672958|451244184|FG001|Overall Study|Reason not specified|3|||
125441266|NCT01380990|451244185|FG000|Overall Study|Treatment Failure|1|||
125441267|NCT01380990|451244186|FG001|Overall Study|Treatment Failure|0|||
125441268|NCT01380990|451244185|FG000|Overall Study|Death|0|||
125441269|NCT01380990|451244186|FG001|Overall Study|Death|1|||
125441270|NCT02374593|451244188|FG000|Overall Study|non-compliant|2|||
125441271|NCT02374593|451244189|FG001|Overall Study|non-compliant|0|||
125441272|NCT04267614|451244190|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
125441273|NCT04267614|451244190|FG000|Overall Study|Lost to Follow-up|115|||
125441274|NCT01830881|451244191|FG000|Overall Study|Changed decision to have an abortion|0|||
125441275|NCT01830881|451244192|FG001|Overall Study|Changed decision to have an abortion|1|||
125441276|NCT00988351|451244193|FG000|Overall Study|Withdrawal by Subject|8|||
125441277|NCT00988351|451244194|FG001|Overall Study|Withdrawal by Subject|0|||
125163989|NCT01570686|450225057|FG000|Overall Study|Administrative problems|0|||
125163990|NCT01570686|450225058|FG001|Overall Study|Administrative problems|1|||
125163991|NCT01570686|450225057|FG000|Overall Study|Adverse Event|8|||
125163992|NCT01570686|450225058|FG001|Overall Study|Adverse Event|6|||
125163993|NCT01570686|450225057|FG000|Overall Study|Lost to Follow-up|4|||
125163994|NCT01570686|450225058|FG001|Overall Study|Lost to Follow-up|3|||
125163995|NCT01570686|450225057|FG000|Overall Study|Protocol Deviation|3|||
125163996|NCT01570686|450225058|FG001|Overall Study|Protocol Deviation|0|||
125163997|NCT01570686|450225057|FG000|Overall Study|Withdrawal by Subject|4|||
125163998|NCT01570686|450225058|FG001|Overall Study|Withdrawal by Subject|4|||
125163999|NCT01570686|450225057|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125164000|NCT01570686|450225058|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125164001|NCT01136967|450225062|FG000|Overall Study|Adverse Event|9|||
125164002|NCT01136967|450225063|FG001|Overall Study|Adverse Event|12|||
125164003|NCT01136967|450225062|FG000|Overall Study|Participant Choice|8|||
125164004|NCT01136967|450225063|FG001|Overall Study|Participant Choice|3|||
125164005|NCT01136967|450225062|FG000|Overall Study|Lost to Follow-up|0|||
125164006|NCT01136967|450225063|FG001|Overall Study|Lost to Follow-up|1|||
125164007|NCT01136967|450225062|FG000|Overall Study|Withdrawal by Subject|1|||
125164008|NCT01136967|450225063|FG001|Overall Study|Withdrawal by Subject|2|||
125164009|NCT01136967|450225062|FG000|Overall Study|Clinical Progression|3|||
125164010|NCT01136967|450225063|FG001|Overall Study|Clinical Progression|5|||
125164011|NCT01136967|450225062|FG000|Overall Study|Radiation|1|||
125164012|NCT01136967|450225063|FG001|Overall Study|Radiation|0|||
125164013|NCT01136967|450225062|FG000|Overall Study|Non-compliance|1|||
125164014|NCT01136967|450225063|FG001|Overall Study|Non-compliance|0|||
125164015|NCT01136967|450225062|FG000|Overall Study|Investigator's Choice|1|||
125164016|NCT01136967|450225063|FG001|Overall Study|Investigator's Choice|1|||
125164017|NCT01136967|450225062|FG000|Overall Study|Increase in Lesion Size|0|||
125164018|NCT01136967|450225063|FG001|Overall Study|Increase in Lesion Size|2|||
125164019|NCT01136967|450225062|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
125164020|NCT01136967|450225063|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
125164021|NCT02885181|450225064|FG000|Overall Study|Investigator's Discretion|0|||
125164022|NCT02885181|450225065|FG001|Overall Study|Investigator's Discretion|1|||
125164023|NCT02885181|450225066|FG002|Overall Study|Investigator's Discretion|0|||
125164024|NCT02885181|450225067|FG003|Overall Study|Investigator's Discretion|1|||
125164025|NCT02885181|450225064|FG000|Overall Study|Adverse Event|0|||
125164026|NCT02885181|450225065|FG001|Overall Study|Adverse Event|0|||
125164027|NCT02885181|450225066|FG002|Overall Study|Adverse Event|0|||
125164028|NCT02885181|450225067|FG003|Overall Study|Adverse Event|1|||
125164029|NCT02885181|450225064|FG000|Overall Study|Withdrawal by Subject|0|||
125164030|NCT02885181|450225065|FG001|Overall Study|Withdrawal by Subject|0|||
125164031|NCT02885181|450225066|FG002|Overall Study|Withdrawal by Subject|0|||
125164032|NCT02885181|450225067|FG003|Overall Study|Withdrawal by Subject|1|||
125164033|NCT03327792|450225068|FG000|Overall Study|Adverse Event|4|||
125164034|NCT03327792|450225069|FG001|Overall Study|Adverse Event|0|||
125164035|NCT03327792|450225068|FG000|Overall Study|Family/Personal issues|3|||
125441278|NCT00988351|451244193|FG000|Overall Study|Lost to Follow-up|6|||
125441279|NCT00988351|451244194|FG001|Overall Study|Lost to Follow-up|9|||
125441280|NCT00988351|451244193|FG000|Overall Study|not using CPAP|5|||
125441281|NCT00988351|451244194|FG001|Overall Study|not using CPAP|3|||
125441282|NCT02038764|451244195|FG000|Overall Study|Adverse Event|0|||
125441283|NCT02038764|451244196|FG001|Overall Study|Adverse Event|0|||
125441284|NCT02038764|451244197|FG002|Overall Study|Adverse Event|1|||
125441285|NCT02038764|451244198|FG003|Overall Study|Adverse Event|0|||
125441286|NCT02038764|451244199|FG004|Overall Study|Adverse Event|0|||
125164036|NCT03327792|450225069|FG001|Overall Study|Family/Personal issues|2|||
125164037|NCT03327792|450225068|FG000|Overall Study|Lost to Follow-up|0|||
125164038|NCT03327792|450225069|FG001|Overall Study|Lost to Follow-up|1|||
125164039|NCT00123474|450225079|FG000|Randomized to Treatment|Randomized, never treated|1|||
125164040|NCT00123474|450225080|FG001|Randomized to Treatment|Randomized, never treated|4|||
125164041|NCT00123474|450225081|FG002|Randomized to Treatment|Randomized, never treated|2|||
125164042|NCT00123474|450225082|FG003|Randomized to Treatment|Randomized, never treated|1|||
125164043|NCT00123474|450225079|FG000|As Treated at Study Closure|not reported when site closed|1|||
125225327|NCT03810456|450452130|FG001|Treatment|Scheduling Conflicts|11|||
125225328|NCT03810456|450452131|FG002|Treatment|Scheduling Conflicts|0|||
125225329|NCT03810456|450452129|FG000|Treatment|No Longer Interested|0|||
125225330|NCT03810456|450452130|FG001|Treatment|No Longer Interested|12|||
125225331|NCT03810456|450452131|FG002|Treatment|No Longer Interested|0|||
125225332|NCT03810456|450452129|FG000|Treatment|Transportation Issues|0|||
125225333|NCT03810456|450452130|FG001|Treatment|Transportation Issues|1|||
125225334|NCT03810456|450452131|FG002|Treatment|Transportation Issues|0|||
125225335|NCT03810456|450452129|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
125225336|NCT03810456|450452130|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
125225337|NCT03810456|450452131|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
125225338|NCT03810456|450452129|FG000|1 Month Follow-Up|Relocated to Different State|1|||
125225339|NCT03810456|450452130|FG001|1 Month Follow-Up|Relocated to Different State|0|||
125225340|NCT03810456|450452131|FG002|1 Month Follow-Up|Relocated to Different State|1|||
125225341|NCT03810456|450452129|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
125164044|NCT00123474|450225080|FG001|As Treated at Study Closure|not reported when site closed|0|||
125164045|NCT00123474|450225081|FG002|As Treated at Study Closure|not reported when site closed|1|||
125164046|NCT00123474|450225082|FG003|As Treated at Study Closure|not reported when site closed|0|||
125164047|NCT00123474|450225079|FG000|As Treated at Study Closure|Adverse Event|10|||
125164048|NCT00123474|450225080|FG001|As Treated at Study Closure|Adverse Event|4|||
125164049|NCT00123474|450225081|FG002|As Treated at Study Closure|Adverse Event|10|||
125164050|NCT00123474|450225082|FG003|As Treated at Study Closure|Adverse Event|8|||
125164051|NCT00123474|450225079|FG000|As Treated at Study Closure|Disease Progression|35|||
125164052|NCT00123474|450225080|FG001|As Treated at Study Closure|Disease Progression|42|||
125164053|NCT00123474|450225081|FG002|As Treated at Study Closure|Disease Progression|29|||
125164054|NCT00123474|450225082|FG003|As Treated at Study Closure|Disease Progression|27|||
125164055|NCT00123474|450225079|FG000|As Treated at Study Closure|Investigator Request|12|||
125164056|NCT00123474|450225080|FG001|As Treated at Study Closure|Investigator Request|6|||
125164057|NCT00123474|450225081|FG002|As Treated at Study Closure|Investigator Request|7|||
125164058|NCT00123474|450225082|FG003|As Treated at Study Closure|Investigator Request|5|||
125164059|NCT00123474|450225079|FG000|As Treated at Study Closure|non-specified|54|||
125164060|NCT00123474|450225080|FG001|As Treated at Study Closure|non-specified|47|||
125164061|NCT00123474|450225081|FG002|As Treated at Study Closure|non-specified|57|||
125164062|NCT00123474|450225082|FG003|As Treated at Study Closure|non-specified|60|||
125164063|NCT00123474|450225079|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
125164064|NCT00123474|450225080|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
125164065|NCT00123474|450225081|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
125164066|NCT00123474|450225082|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
125164067|NCT00123474|450225079|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
125164068|NCT00123474|450225080|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
125164069|NCT00123474|450225081|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
125164070|NCT00123474|450225082|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
125164071|NCT01059344|450225083|FG000|Overall Study|Adverse Event|12|||
125164072|NCT01059344|450225084|FG001|Overall Study|Adverse Event|30|||
125164073|NCT01059344|450225083|FG000|Overall Study|Withdrawal by Subject|6|||
125164074|NCT01059344|450225084|FG001|Overall Study|Withdrawal by Subject|9|||
125164075|NCT01059344|450225083|FG000|Overall Study|Lost to Follow-up|1|||
125164076|NCT01059344|450225084|FG001|Overall Study|Lost to Follow-up|1|||
125164077|NCT01059344|450225083|FG000|Overall Study|Other|3|||
125164078|NCT01059344|450225084|FG001|Overall Study|Other|6|||
125164079|NCT00742924|450225085|FG000|Overall Study|Adverse Event|0|||
125164080|NCT00742924|450225086|FG001|Overall Study|Adverse Event|0|||
125164081|NCT00742924|450225087|FG002|Overall Study|Adverse Event|1|||
125164082|NCT00742924|450225088|FG003|Overall Study|Adverse Event|1|||
125164083|NCT00742924|450225085|FG000|Overall Study|Lack of Efficacy|5|||
125164084|NCT00742924|450225086|FG001|Overall Study|Lack of Efficacy|1|||
125164085|NCT00742924|450225087|FG002|Overall Study|Lack of Efficacy|2|||
125164086|NCT00742924|450225088|FG003|Overall Study|Lack of Efficacy|4|||
125164087|NCT00742924|450225085|FG000|Overall Study|Physician Decision|0|||
125164088|NCT00742924|450225086|FG001|Overall Study|Physician Decision|0|||
125441287|NCT02038764|451244195|FG000|Overall Study|Lost to Follow-up|0|||
125441288|NCT02038764|451244196|FG001|Overall Study|Lost to Follow-up|1|||
125164089|NCT00742924|450225087|FG002|Overall Study|Physician Decision|0|||
125164090|NCT00742924|450225088|FG003|Overall Study|Physician Decision|1|||
125164091|NCT00742924|450225085|FG000|Overall Study|Withdrawal by Subject|0|||
125164092|NCT00742924|450225086|FG001|Overall Study|Withdrawal by Subject|1|||
125164093|NCT00742924|450225087|FG002|Overall Study|Withdrawal by Subject|1|||
125441289|NCT02038764|451244197|FG002|Overall Study|Lost to Follow-up|0|||
125441290|NCT02038764|451244198|FG003|Overall Study|Lost to Follow-up|0|||
125441291|NCT02038764|451244199|FG004|Overall Study|Lost to Follow-up|0|||
125441292|NCT02038764|451244195|FG000|Overall Study|Withdrawal by Subject|0|||
125441293|NCT02038764|451244196|FG001|Overall Study|Withdrawal by Subject|0|||
125441294|NCT02038764|451244197|FG002|Overall Study|Withdrawal by Subject|0|||
125441295|NCT02038764|451244198|FG003|Overall Study|Withdrawal by Subject|0|||
125441296|NCT02038764|451244199|FG004|Overall Study|Withdrawal by Subject|1|||
125441297|NCT02038764|451244195|FG000|Overall Study|Other|1|||
125441298|NCT02038764|451244196|FG001|Overall Study|Other|0|||
125441299|NCT02038764|451244197|FG002|Overall Study|Other|1|||
125441300|NCT02038764|451244198|FG003|Overall Study|Other|0|||
125441301|NCT02038764|451244199|FG004|Overall Study|Other|0|||
125441302|NCT01927731|451244213|FG000|Overall Study|Graft Failure|1|||
125441303|NCT01927731|451244214|FG001|Overall Study|Graft Failure|2|||
125441304|NCT01927731|451244213|FG000|Overall Study|Physician Decision|2|||
125441305|NCT01927731|451244214|FG001|Overall Study|Physician Decision|3|||
125164094|NCT00742924|450225088|FG003|Overall Study|Withdrawal by Subject|0|||
125164095|NCT00660400|450225089|FG000|Overall Study|Lack of insurance approval|1|||
125164096|NCT00660400|450225089|FG000|Overall Study|Suboptimal organ function|1|||
125164097|NCT00660400|450225089|FG000|Overall Study|Intracranial hemorrhage|1|||
125164098|NCT00660400|450225089|FG000|Overall Study|Withdrawal by Subject|1|||
125164099|NCT00528411|450225091|FG000|Overall Study|Adverse Event|4|||
125164100|NCT00528411|450225092|FG001|Overall Study|Adverse Event|0|||
125164101|NCT00528411|450225093|FG002|Overall Study|Adverse Event|1|||
125164102|NCT00528411|450225091|FG000|Overall Study|Incorrect Enrolment|1|||
125164103|NCT00528411|450225092|FG001|Overall Study|Incorrect Enrolment|1|||
125164104|NCT00528411|450225093|FG002|Overall Study|Incorrect Enrolment|0|||
125164105|NCT00528411|450225091|FG000|Overall Study|Severe non-compliance to protocol|0|||
125164106|NCT00528411|450225092|FG001|Overall Study|Severe non-compliance to protocol|1|||
125164107|NCT00528411|450225093|FG002|Overall Study|Severe non-compliance to protocol|0|||
125164108|NCT00528411|450225091|FG000|Overall Study|Prior commitment medication|0|||
125164109|NCT00528411|450225092|FG001|Overall Study|Prior commitment medication|1|||
125164110|NCT00528411|450225093|FG002|Overall Study|Prior commitment medication|0|||
125164111|NCT02643355|450225094|FG000|Overall Study|Withdrawal by Subject|1|||
125164112|NCT02643355|450225095|FG001|Overall Study|Withdrawal by Subject|3|||
125164113|NCT02643355|450225094|FG000|Overall Study|Protocol Violation|0|||
125164114|NCT02643355|450225095|FG001|Overall Study|Protocol Violation|2|||
125164115|NCT01715571|450225096|FG000|Overall Study|Lost to Follow-up|8|||
125164116|NCT04524364|450225101|FG000|Overall Study|Physician Decision|3|||
125164117|NCT04524364|450225102|FG001|Overall Study|Physician Decision|6|||
125164118|NCT04524364|450225101|FG000|Overall Study|Adverse Event|0|||
125164119|NCT04524364|450225102|FG001|Overall Study|Adverse Event|1|||
125164120|NCT04524364|450225101|FG000|Overall Study|Investigational device deficiency|0|||
125164121|NCT04524364|450225102|FG001|Overall Study|Investigational device deficiency|1|||
125164122|NCT04524364|450225101|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
125164123|NCT04524364|450225102|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
125164124|NCT04524364|450225101|FG000|Overall Study|Device unavailability|0|||
125164125|NCT04524364|450225102|FG001|Overall Study|Device unavailability|2|||
125164126|NCT04524364|450225101|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
125164127|NCT04524364|450225102|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
125164128|NCT04524364|450225101|FG000|Overall Study|Low International normalized ratio (INR)|1|||
125164129|NCT04524364|450225102|FG001|Overall Study|Low International normalized ratio (INR)|0|||
125164130|NCT00826449|450225103|FG000|Overall Study|Disease Progression|4|||
125164131|NCT00826449|450225103|FG000|Overall Study|Withdrawal by Subject|1|||
125164132|NCT02994940|450225104|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
125164133|NCT02994940|450225105|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
125164134|NCT02994940|450225104|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
125164135|NCT02994940|450225105|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
125164136|NCT02994940|450225104|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
125164137|NCT02994940|450225105|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
125164138|NCT03233230|450225106|FG000|Overall Study|Adverse Event|6|||
125164139|NCT03233230|450225107|FG001|Overall Study|Adverse Event|3|||
125164140|NCT03233230|450225108|FG002|Overall Study|Adverse Event|6|||
125441306|NCT01927731|451244213|FG000|Overall Study|Withdrawal by Subject|0|||
125441307|NCT01927731|451244214|FG001|Overall Study|Withdrawal by Subject|2|||
125441308|NCT01927731|451244213|FG000|Overall Study|Death|0|||
125441309|NCT01927731|451244214|FG001|Overall Study|Death|3|||
125441310|NCT01388530|451244217|FG000|Overall Study|Lost to Follow-up|5|||
125441311|NCT00305864|451244218|FG000|Overall Study|Ineligible / No protocol treatment|0|||
125441312|NCT00305864|451244219|FG001|Overall Study|Ineligible / No protocol treatment|1|||
125164141|NCT03233230|450225109|FG003|Overall Study|Adverse Event|3|||
125164142|NCT03233230|450225106|FG000|Overall Study|Protocol Violation|1|||
125441313|NCT00305864|451244220|FG002|Overall Study|Ineligible / No protocol treatment|1|||
125164143|NCT03233230|450225107|FG001|Overall Study|Protocol Violation|2|||
125164144|NCT03233230|450225108|FG002|Overall Study|Protocol Violation|1|||
125164145|NCT03233230|450225109|FG003|Overall Study|Protocol Violation|1|||
125225342|NCT03810456|450452130|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
125225343|NCT03810456|450452131|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
125225344|NCT03810456|450452129|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
125164146|NCT03233230|450225106|FG000|Overall Study|Lack of Efficacy|1|||
125164147|NCT03233230|450225107|FG001|Overall Study|Lack of Efficacy|0|||
125164148|NCT03233230|450225108|FG002|Overall Study|Lack of Efficacy|0|||
125164149|NCT03233230|450225109|FG003|Overall Study|Lack of Efficacy|0|||
125164150|NCT03233230|450225106|FG000|Overall Study|Other|5|||
125164151|NCT03233230|450225107|FG001|Overall Study|Other|5|||
125164152|NCT03233230|450225108|FG002|Overall Study|Other|5|||
125164153|NCT03233230|450225109|FG003|Overall Study|Other|3|||
125164154|NCT03233230|450225106|FG000|Overall Study|Withdrawal by Subject|2|||
125164155|NCT03233230|450225107|FG001|Overall Study|Withdrawal by Subject|2|||
125164156|NCT03233230|450225108|FG002|Overall Study|Withdrawal by Subject|0|||
125164157|NCT03233230|450225109|FG003|Overall Study|Withdrawal by Subject|1|||
125225345|NCT03810456|450452130|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
125225346|NCT03810456|450452131|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
125225347|NCT03810456|450452129|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
125225348|NCT03810456|450452130|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
125225349|NCT03810456|450452131|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
125225350|NCT03810456|450452129|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
125225351|NCT03810456|450452130|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
125225352|NCT03810456|450452131|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
125225353|NCT03810456|450452129|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
125225354|NCT03810456|450452130|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
125225355|NCT03810456|450452131|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
125225356|NCT01094288|450454231|FG000|Overall Study|Adverse Event|0|||
125225357|NCT01094288|450454232|FG001|Overall Study|Adverse Event|3|||
125164158|NCT03233230|450225106|FG000|Overall Study|Lost to Follow-up|0|||
125164159|NCT03233230|450225107|FG001|Overall Study|Lost to Follow-up|3|||
125164160|NCT03233230|450225108|FG002|Overall Study|Lost to Follow-up|0|||
125164161|NCT03233230|450225109|FG003|Overall Study|Lost to Follow-up|0|||
125164162|NCT02987959|450225114|FG000|Overall Study|Grantor stopped supply of drugs|6|||
125164163|NCT04126213|450225117|FG000|Overall Study|Lost to Follow-up|9|||
125164164|NCT04126213|450225118|FG001|Overall Study|Lost to Follow-up|1|||
125164165|NCT04126213|450225119|FG002|Overall Study|Lost to Follow-up|5|||
125164166|NCT04126213|450225120|FG003|Overall Study|Lost to Follow-up|10|||
125164167|NCT04126213|450225121|FG004|Overall Study|Lost to Follow-up|4|||
125164168|NCT04126213|450225122|FG005|Overall Study|Lost to Follow-up|7|||
125164169|NCT04126213|450225117|FG000|Overall Study|Withdrawal by Subject|3|||
125164170|NCT04126213|450225118|FG001|Overall Study|Withdrawal by Subject|2|||
125164171|NCT04126213|450225119|FG002|Overall Study|Withdrawal by Subject|1|||
125164172|NCT04126213|450225120|FG003|Overall Study|Withdrawal by Subject|1|||
125164173|NCT04126213|450225121|FG004|Overall Study|Withdrawal by Subject|1|||
125164174|NCT04126213|450225122|FG005|Overall Study|Withdrawal by Subject|1|||
125164175|NCT04126213|450225117|FG000|Overall Study|Other|0|||
125164176|NCT04126213|450225118|FG001|Overall Study|Other|0|||
125164177|NCT04126213|450225119|FG002|Overall Study|Other|2|||
125164178|NCT04126213|450225120|FG003|Overall Study|Other|2|||
125164179|NCT04126213|450225121|FG004|Overall Study|Other|0|||
125164180|NCT04126213|450225122|FG005|Overall Study|Other|1|||
125164181|NCT04126213|450225117|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125164182|NCT04126213|450225118|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
125164183|NCT04126213|450225119|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125164184|NCT04126213|450225120|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125164185|NCT04126213|450225121|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125164186|NCT04126213|450225122|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
125164187|NCT02853370|450225123|FG000|Overall Study|Physician Decision|1|||
125164188|NCT02853370|450225123|FG000|Overall Study|Lack of Efficacy|2|||
125164189|NCT02853370|450225123|FG000|Overall Study|Death|1|||
125164190|NCT02853370|450225123|FG000|Overall Study|Adverse Event|4|||
125164191|NCT02853370|450225123|FG000|Overall Study|Withdrawal by Subject|3|||
125225358|NCT01094288|450454233|FG002|Overall Study|Adverse Event|1|||
125225359|NCT01094288|450454234|FG003|Overall Study|Adverse Event|1|||
125164192|NCT02196701|450225124|FG000|Overall Study|Adverse Event|1|||
125164193|NCT02196701|450225124|FG000|Overall Study|Lost to Follow-up|1|||
125164194|NCT02196701|450225124|FG000|Overall Study|Non-adherence to Protocol|1|||
125164195|NCT03275064|450225129|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
125164196|NCT03275064|450225130|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
125164197|NCT03275064|450225131|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
125164198|NCT03275064|450225132|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
125164199|NCT03275064|450225133|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
125441314|NCT00305864|451244221|FG003|Overall Study|Ineligible / No protocol treatment|13|||
125441315|NCT02836613|451244224|FG000|Overall Study|Accidental drowning|1|||
125441316|NCT02836613|451244225|FG001|Overall Study|Accidental drowning|0|||
125441317|NCT02836613|451244224|FG000|Overall Study|Lost to Follow-up|0|||
125441318|NCT02836613|451244225|FG001|Overall Study|Lost to Follow-up|1|||
125441319|NCT02836613|451244224|FG000|Overall Study|Withdrawal by Subject|0|||
125441320|NCT02836613|451244225|FG001|Overall Study|Withdrawal by Subject|2|||
125164200|NCT03275064|450225129|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
125225360|NCT01094288|450454235|FG004|Overall Study|Adverse Event|0|||
125441321|NCT03881059|451244226|FG000|Treatment Period - Part A|Adverse Event|1|||
125441322|NCT03881059|451244227|FG001|Treatment Period - Part A|Adverse Event|3|||
125441323|NCT03881059|451244228|FG002|Treatment Period - Part A|Adverse Event|4|||
125441324|NCT03881059|451244226|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
125441325|NCT03881059|451244227|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
125441326|NCT03881059|451244228|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
125441327|NCT03881059|451244226|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
125441328|NCT03881059|451244227|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
125441329|NCT03881059|451244228|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
125441330|NCT03881059|451244226|FG000|Treatment Period - Part A|Other reasons|2|||
125441331|NCT03881059|451244227|FG001|Treatment Period - Part A|Other reasons|1|||
125441332|NCT03881059|451244228|FG002|Treatment Period - Part A|Other reasons|0|||
125441333|NCT03881059|451244226|FG000|Treatment Period - Part B|Adverse Event|0|||
125441334|NCT03881059|451244227|FG001|Treatment Period - Part B|Adverse Event|0|||
125441335|NCT03881059|451244228|FG002|Treatment Period - Part B|Adverse Event|3|||
125441336|NCT03881059|451244226|FG000|Treatment Period - Part B|Death|0|||
125441337|NCT03881059|451244227|FG001|Treatment Period - Part B|Death|1|||
125441338|NCT03881059|451244228|FG002|Treatment Period - Part B|Death|1|||
125441339|NCT03881059|451244226|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
125441340|NCT03881059|451244227|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
125441341|NCT03881059|451244228|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
125441342|NCT03881059|451244226|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
125441343|NCT03881059|451244227|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
125441344|NCT03881059|451244228|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
125441345|NCT03881059|451244226|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
125441346|NCT03881059|451244227|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
125441347|NCT03881059|451244228|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
125441348|NCT03881059|451244226|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
125441349|NCT03881059|451244227|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
125441350|NCT03881059|451244228|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
125441351|NCT03881059|451244226|FG000|Treatment Period - Part B|Other reasons|4|||
125441352|NCT03881059|451244227|FG001|Treatment Period - Part B|Other reasons|3|||
125441353|NCT03881059|451244228|FG002|Treatment Period - Part B|Other reasons|3|||
125441354|NCT05284019|451244229|FG000|Overall Study|Study terminated|2|||
125164201|NCT03275064|450225130|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
125164202|NCT03275064|450225131|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
125164203|NCT03275064|450225132|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
125164204|NCT03275064|450225133|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
125164205|NCT03275064|450225129|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
125164206|NCT03275064|450225130|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
125164207|NCT03275064|450225131|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
125164208|NCT03275064|450225132|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
125164209|NCT03275064|450225133|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
125164210|NCT03275064|450225129|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
125164211|NCT03275064|450225130|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
125164212|NCT03275064|450225131|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
125164213|NCT03275064|450225132|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
125164214|NCT03275064|450225133|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
125164215|NCT03275064|450225129|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
125164216|NCT03275064|450225130|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
125164217|NCT03275064|450225131|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
125164218|NCT03275064|450225132|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
125225361|NCT01094288|450454236|FG005|Overall Study|Adverse Event|0|||
125225362|NCT01094288|450454237|FG006|Overall Study|Adverse Event|0|||
125441355|NCT05284019|451244230|FG001|Overall Study|Study terminated|2|||
125441356|NCT05284019|451244231|FG002|Overall Study|Study terminated|2|||
125441357|NCT05284019|451244232|FG003|Overall Study|Study terminated|5|||
125441358|NCT05284019|451244233|FG004|Overall Study|Study terminated|15|||
125441359|NCT05284019|451244229|FG000|Overall Study|Withdrawal by Subject|0|||
125441360|NCT05284019|451244230|FG001|Overall Study|Withdrawal by Subject|0|||
125164219|NCT03275064|450225133|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
125164220|NCT04159935|450225134|FG000|Overall Study|Study terminated due to COVID-19|1|||
125164221|NCT04159935|450225135|FG001|Overall Study|Study terminated due to COVID-19|3|||
125164222|NCT01341782|450225136|FG000|Overall Study|Adverse Event|1|||
125164223|NCT01341782|450225137|FG001|Overall Study|Adverse Event|1|||
125164224|NCT01341782|450225136|FG000|Overall Study|Withdrawal by Subject|6|||
125164225|NCT01341782|450225137|FG001|Overall Study|Withdrawal by Subject|5|||
125164226|NCT01341782|450225136|FG000|Overall Study|Missed 3 consecutive doses|0|||
125164227|NCT01341782|450225137|FG001|Overall Study|Missed 3 consecutive doses|4|||
125164228|NCT01341782|450225136|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
125164229|NCT01341782|450225137|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
125164230|NCT01341782|450225136|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
125164231|NCT01341782|450225137|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
125164232|NCT01341782|450225136|FG000|Overall Study|Other|5|||
125164233|NCT01341782|450225137|FG001|Overall Study|Other|0|||
125164234|NCT00620555|450225138|FG000|Overall Study|Adverse Event|4|||
125164235|NCT00620555|450225138|FG000|Overall Study|Protocol Violation|2|||
125164236|NCT00620555|450225138|FG000|Overall Study|Lack of Efficacy|12|||
125164237|NCT00620555|450225138|FG000|Overall Study|Withdrawal by Subject|1|||
125164238|NCT00620555|450225138|FG000|Overall Study|Choice of other treatment|1|||
125164239|NCT00620555|450225138|FG000|Overall Study|Visit failure against planned|1|||
125164240|NCT00724048|450225139|FG000|Overall Study|Adverse Event|1|||
125164241|NCT00724048|450225140|FG001|Overall Study|Adverse Event|1|||
125164242|NCT00724048|450225141|FG002|Overall Study|Adverse Event|1|||
125164243|NCT00724048|450225142|FG003|Overall Study|Adverse Event|0|||
125164244|NCT00724048|450225139|FG000|Overall Study|Lost to Follow-up|0|||
125164245|NCT00724048|450225140|FG001|Overall Study|Lost to Follow-up|1|||
125164246|NCT00724048|450225141|FG002|Overall Study|Lost to Follow-up|0|||
125164247|NCT00724048|450225142|FG003|Overall Study|Lost to Follow-up|0|||
125164248|NCT00724048|450225139|FG000|Overall Study|Withdrawal by Subject|1|||
125164249|NCT00724048|450225140|FG001|Overall Study|Withdrawal by Subject|2|||
125164250|NCT00724048|450225141|FG002|Overall Study|Withdrawal by Subject|1|||
125164251|NCT00724048|450225142|FG003|Overall Study|Withdrawal by Subject|2|||
125164252|NCT00724048|450225139|FG000|Overall Study|Investigator decision|0|||
125164253|NCT00724048|450225140|FG001|Overall Study|Investigator decision|0|||
125164254|NCT00724048|450225141|FG002|Overall Study|Investigator decision|1|||
125164255|NCT00724048|450225142|FG003|Overall Study|Investigator decision|0|||
125164256|NCT00724048|450225139|FG000|Overall Study|Did not tolerate study drug|0|||
125164257|NCT00724048|450225140|FG001|Overall Study|Did not tolerate study drug|0|||
125164258|NCT00724048|450225141|FG002|Overall Study|Did not tolerate study drug|0|||
125164259|NCT00724048|450225142|FG003|Overall Study|Did not tolerate study drug|1|||
125164260|NCT00724048|450225139|FG000|Overall Study|Other than specified|1|||
125164261|NCT00724048|450225140|FG001|Overall Study|Other than specified|1|||
125164262|NCT00724048|450225141|FG002|Overall Study|Other than specified|0|||
125164263|NCT00724048|450225142|FG003|Overall Study|Other than specified|0|||
125164264|NCT03923530|450225143|FG000|Overall Study|Withdrawal by Subject|1|||
125164265|NCT03923530|450225143|FG000|Overall Study|screen failure|3|||
125164266|NCT00911807|450225144|FG000|Overall Study|Adverse Event|2|||
125164267|NCT00911807|450225145|FG001|Overall Study|Adverse Event|1|||
125164268|NCT00911807|450225146|FG002|Overall Study|Adverse Event|5|||
125164269|NCT00911807|450225144|FG000|Overall Study|Death|0|||
125164270|NCT00911807|450225145|FG001|Overall Study|Death|0|||
125164271|NCT00911807|450225146|FG002|Overall Study|Death|1|||
125164272|NCT00911807|450225144|FG000|Overall Study|Protocol Violation|6|||
125164273|NCT00911807|450225145|FG001|Overall Study|Protocol Violation|4|||
125164274|NCT00911807|450225146|FG002|Overall Study|Protocol Violation|9|||
125164275|NCT00911807|450225144|FG000|Overall Study|Withdrawal by Subject|8|||
125164276|NCT00911807|450225145|FG001|Overall Study|Withdrawal by Subject|10|||
125164277|NCT00911807|450225146|FG002|Overall Study|Withdrawal by Subject|7|||
125164278|NCT00911807|450225144|FG000|Overall Study|Organizational reasons|1|||
125164279|NCT00911807|450225145|FG001|Overall Study|Organizational reasons|3|||
125164280|NCT00911807|450225146|FG002|Overall Study|Organizational reasons|1|||
125164281|NCT02991430|450225149|FG000|Treatment Period 1|Adverse Event|1|||
125164282|NCT02991430|450225150|FG001|Treatment Period 1|Adverse Event|0|||
125164283|NCT02991430|450225151|FG002|Treatment Period 1|Adverse Event|2|||
125164284|NCT02991430|450225149|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125164285|NCT02991430|450225150|FG001|Treatment Period 1|Withdrawal by Subject|4|||
125164286|NCT02991430|450225151|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125164287|NCT02991430|450225149|FG000|Treatment Period 2|Study Termination|6|||
125164288|NCT02991430|450225150|FG001|Treatment Period 2|Study Termination|3|||
125164289|NCT02991430|450225151|FG002|Treatment Period 2|Study Termination|3|||
125164290|NCT02991430|450225149|FG000|Treatment Period 2|Lost to Follow-up|0|||
125164291|NCT02991430|450225150|FG001|Treatment Period 2|Lost to Follow-up|0|||
125164292|NCT02991430|450225151|FG002|Treatment Period 2|Lost to Follow-up|1|||
125164293|NCT02991430|450225149|FG000|Post-treatment Observation Period|Study Termination|3|||
125164294|NCT02991430|450225150|FG001|Post-treatment Observation Period|Study Termination|6|||
125441361|NCT05284019|451244231|FG002|Overall Study|Withdrawal by Subject|0|||
125441362|NCT05284019|451244232|FG003|Overall Study|Withdrawal by Subject|1|||
125441363|NCT05284019|451244233|FG004|Overall Study|Withdrawal by Subject|1|||
125441364|NCT05284019|451244229|FG000|Overall Study|Lost to Follow-up|1|||
125441365|NCT05284019|451244230|FG001|Overall Study|Lost to Follow-up|0|||
125441366|NCT05284019|451244231|FG002|Overall Study|Lost to Follow-up|0|||
125441367|NCT05284019|451244232|FG003|Overall Study|Lost to Follow-up|2|||
125441368|NCT05284019|451244233|FG004|Overall Study|Lost to Follow-up|1|||
125441369|NCT02065570|451244234|FG000|Induction Study|Adverse Event|5|||
125441370|NCT02065570|451244235|FG001|Induction Study|Adverse Event|12|||
125441371|NCT02065570|451244236|FG002|Induction Study|Adverse Event|0|||
125441372|NCT02065570|451244237|FG003|Induction Study|Adverse Event|0|||
125441373|NCT02065570|451244234|FG000|Induction Study|Withdrawal by Subject|2|||
125441374|NCT02065570|451244235|FG001|Induction Study|Withdrawal by Subject|3|||
125441375|NCT02065570|451244236|FG002|Induction Study|Withdrawal by Subject|0|||
125441376|NCT02065570|451244237|FG003|Induction Study|Withdrawal by Subject|0|||
125441377|NCT02065570|451244234|FG000|Induction Study|Lost to Follow-up|1|||
125441378|NCT02065570|451244235|FG001|Induction Study|Lost to Follow-up|1|||
125441379|NCT02065570|451244236|FG002|Induction Study|Lost to Follow-up|0|||
125441380|NCT02065570|451244237|FG003|Induction Study|Lost to Follow-up|0|||
125441381|NCT02065570|451244234|FG000|Induction Study|Other, Not Specified|6|||
125441382|NCT02065570|451244235|FG001|Induction Study|Other, Not Specified|5|||
125441383|NCT02065570|451244236|FG002|Induction Study|Other, Not Specified|0|||
125441384|NCT02065570|451244237|FG003|Induction Study|Other, Not Specified|0|||
125441385|NCT02065570|451244234|FG000|Maintenance Study|Adverse Event|0|||
125441386|NCT02065570|451244235|FG001|Maintenance Study|Adverse Event|0|||
125441387|NCT02065570|451244236|FG002|Maintenance Study|Adverse Event|8|||
125441388|NCT02065570|451244237|FG003|Maintenance Study|Adverse Event|8|||
125441389|NCT02065570|451244234|FG000|Maintenance Study|Withdrawal by Subject|0|||
125441390|NCT02065570|451244235|FG001|Maintenance Study|Withdrawal by Subject|0|||
125441391|NCT02065570|451244236|FG002|Maintenance Study|Withdrawal by Subject|1|||
125441392|NCT02065570|451244237|FG003|Maintenance Study|Withdrawal by Subject|4|||
125441393|NCT02065570|451244234|FG000|Maintenance Study|Lost to Follow-up|0|||
125441394|NCT02065570|451244235|FG001|Maintenance Study|Lost to Follow-up|0|||
125441395|NCT02065570|451244236|FG002|Maintenance Study|Lost to Follow-up|2|||
125441396|NCT02065570|451244237|FG003|Maintenance Study|Lost to Follow-up|2|||
125441397|NCT02065570|451244234|FG000|Maintenance Study|Other, Not Specified|0|||
125441398|NCT02065570|451244235|FG001|Maintenance Study|Other, Not Specified|0|||
125441399|NCT02065570|451244236|FG002|Maintenance Study|Other, Not Specified|11|||
125441400|NCT02065570|451244237|FG003|Maintenance Study|Other, Not Specified|5|||
125441401|NCT00287469|451244238|FG000|Overall Study|serious adverse event|1|||
125441402|NCT00287469|451244239|FG001|Overall Study|serious adverse event|6|||
125441403|NCT00287469|451244238|FG000|Overall Study|Adverse Event|1|||
125441404|NCT00287469|451244239|FG001|Overall Study|Adverse Event|1|||
125441405|NCT00287469|451244238|FG000|Overall Study|moved from area|144|||
125441406|NCT00287469|451244239|FG001|Overall Study|moved from area|138|||
125441407|NCT00287469|451244238|FG000|Overall Study|Lost to Follow-up|74|||
125441408|NCT00287469|451244239|FG001|Overall Study|Lost to Follow-up|69|||
125441409|NCT01266993|451244240|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
125441410|NCT01266993|451244241|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
125441411|NCT01266993|451244240|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
125441412|NCT01266993|451244241|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
125441413|NCT00849680|451244246|FG000|Overall Study|Adverse Event|0|||
125441414|NCT00849680|451244247|FG001|Overall Study|Adverse Event|0|||
125441415|NCT00849680|451244248|FG002|Overall Study|Adverse Event|0|||
125441416|NCT00849680|451244249|FG003|Overall Study|Adverse Event|0|||
125441417|NCT00849680|451244250|FG004|Overall Study|Adverse Event|0|||
125441418|NCT00849680|451244251|FG005|Overall Study|Adverse Event|0|||
125441419|NCT00849680|451244252|FG006|Overall Study|Adverse Event|2|||
125441420|NCT00849680|451244253|FG007|Overall Study|Adverse Event|0|||
125441421|NCT00849680|451244246|FG000|Overall Study|Lost to Follow-up|7|||
125441422|NCT00849680|451244247|FG001|Overall Study|Lost to Follow-up|3|||
125441423|NCT00849680|451244248|FG002|Overall Study|Lost to Follow-up|12|||
125441424|NCT00849680|451244249|FG003|Overall Study|Lost to Follow-up|11|||
125441425|NCT00849680|451244250|FG004|Overall Study|Lost to Follow-up|8|||
125225363|NCT01094288|450454238|FG007|Overall Study|Adverse Event|0|||
125225364|NCT01094288|450454231|FG000|Overall Study|Withdrawal by Subject|0|||
125441426|NCT00849680|451244251|FG005|Overall Study|Lost to Follow-up|11|||
125441427|NCT00849680|451244252|FG006|Overall Study|Lost to Follow-up|12|||
125441428|NCT00849680|451244253|FG007|Overall Study|Lost to Follow-up|5|||
125441429|NCT00849680|451244246|FG000|Overall Study|Subject moved|1|||
125441430|NCT00849680|451244247|FG001|Overall Study|Subject moved|0|||
125441431|NCT00849680|451244248|FG002|Overall Study|Subject moved|3|||
125441432|NCT00849680|451244249|FG003|Overall Study|Subject moved|1|||
125441433|NCT00849680|451244250|FG004|Overall Study|Subject moved|0|||
125441434|NCT00849680|451244251|FG005|Overall Study|Subject moved|2|||
125441435|NCT00849680|451244252|FG006|Overall Study|Subject moved|2|||
125225365|NCT01094288|450454232|FG001|Overall Study|Withdrawal by Subject|1|||
125225366|NCT01094288|450454233|FG002|Overall Study|Withdrawal by Subject|2|||
125225367|NCT01094288|450454234|FG003|Overall Study|Withdrawal by Subject|0|||
125225368|NCT01094288|450454235|FG004|Overall Study|Withdrawal by Subject|0|||
125225369|NCT01094288|450454236|FG005|Overall Study|Withdrawal by Subject|0|||
125225370|NCT01094288|450454237|FG006|Overall Study|Withdrawal by Subject|0|||
125225371|NCT01094288|450454238|FG007|Overall Study|Withdrawal by Subject|2|||
125225372|NCT01094288|450454231|FG000|Overall Study|Initiation of Alternative Therapy|0|||
125225373|NCT01094288|450454232|FG001|Overall Study|Initiation of Alternative Therapy|0|||
125225374|NCT01094288|450454233|FG002|Overall Study|Initiation of Alternative Therapy|1|||
125225375|NCT01094288|450454234|FG003|Overall Study|Initiation of Alternative Therapy|0|||
125225376|NCT01094288|450454235|FG004|Overall Study|Initiation of Alternative Therapy|0|||
125225377|NCT01094288|450454236|FG005|Overall Study|Initiation of Alternative Therapy|0|||
125225378|NCT01094288|450454237|FG006|Overall Study|Initiation of Alternative Therapy|0|||
125225379|NCT01094288|450454238|FG007|Overall Study|Initiation of Alternative Therapy|0|||
125225380|NCT01094288|450454231|FG000|Overall Study|Reason not Specified|2|||
125225381|NCT01094288|450454232|FG001|Overall Study|Reason not Specified|3|||
125225382|NCT01094288|450454233|FG002|Overall Study|Reason not Specified|0|||
125225383|NCT01094288|450454234|FG003|Overall Study|Reason not Specified|1|||
125225384|NCT01094288|450454235|FG004|Overall Study|Reason not Specified|0|||
125225385|NCT01094288|450454236|FG005|Overall Study|Reason not Specified|0|||
125225386|NCT01094288|450454237|FG006|Overall Study|Reason not Specified|0|||
125225387|NCT01094288|450454238|FG007|Overall Study|Reason not Specified|0|||
125225388|NCT01094288|450454231|FG000|Overall Study|Ongoing Participants|0|||
125225389|NCT01094288|450454232|FG001|Overall Study|Ongoing Participants|3|||
125225390|NCT01094288|450454233|FG002|Overall Study|Ongoing Participants|0|||
125225391|NCT01094288|450454234|FG003|Overall Study|Ongoing Participants|0|||
125225392|NCT01094288|450454235|FG004|Overall Study|Ongoing Participants|0|||
125225393|NCT01094288|450454236|FG005|Overall Study|Ongoing Participants|0|||
125225394|NCT01094288|450454237|FG006|Overall Study|Ongoing Participants|0|||
125225395|NCT01094288|450454238|FG007|Overall Study|Ongoing Participants|0|||
125225396|NCT02611882|450454239|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
125225397|NCT02611882|450454240|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
125225398|NCT02611882|450454241|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
125225399|NCT01317940|450454242|FG000|Overall Study|Death|1|||
125225400|NCT01317940|450454243|FG001|Overall Study|Death|0|||
125225401|NCT01317940|450454244|FG002|Overall Study|Death|1|||
125225402|NCT01317940|450454245|FG003|Overall Study|Death|0|||
125225403|NCT01317940|450454246|FG004|Overall Study|Death|0|||
125225404|NCT01317940|450454247|FG005|Overall Study|Death|0|||
125225405|NCT01317940|450454242|FG000|Overall Study|Lost to Follow-up|0|||
125225406|NCT01317940|450454243|FG001|Overall Study|Lost to Follow-up|0|||
125225407|NCT01317940|450454244|FG002|Overall Study|Lost to Follow-up|1|||
125225408|NCT01317940|450454245|FG003|Overall Study|Lost to Follow-up|1|||
125225409|NCT01317940|450454246|FG004|Overall Study|Lost to Follow-up|1|||
125225410|NCT01317940|450454247|FG005|Overall Study|Lost to Follow-up|0|||
125225411|NCT01317940|450454242|FG000|Overall Study|Change in therapy plan|0|||
125225412|NCT01317940|450454243|FG001|Overall Study|Change in therapy plan|0|||
125225413|NCT01317940|450454244|FG002|Overall Study|Change in therapy plan|3|||
125225414|NCT01317940|450454245|FG003|Overall Study|Change in therapy plan|0|||
125225415|NCT01317940|450454246|FG004|Overall Study|Change in therapy plan|0|||
125225416|NCT01317940|450454247|FG005|Overall Study|Change in therapy plan|0|||
125225417|NCT04152200|450454248|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
125225418|NCT04152200|450454249|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
125225419|NCT04980014|450454250|FG000|Overall Study|Participants who are Duplicated|1|||
125225420|NCT04980014|450454250|FG000|Overall Study|Follow-up Failure|13|||
125225421|NCT04980014|450454250|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
125225422|NCT04980014|450454250|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
125225423|NCT04980014|450454250|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
125225424|NCT00593814|450454251|FG000|Overall Study|Death|7|||
125225425|NCT00593814|450454252|FG001|Overall Study|Death|0|||
125225426|NCT00593814|450454251|FG000|Overall Study|Withdrawal by Subject|7|||
125225427|NCT00593814|450454252|FG001|Overall Study|Withdrawal by Subject|0|||
125225428|NCT00593814|450454251|FG000|Overall Study|Lost to Follow-up|7|||
125225429|NCT00593814|450454252|FG001|Overall Study|Lost to Follow-up|0|||
125225430|NCT00593814|450454251|FG000|Overall Study|Physician Decision|3|||
125225431|NCT00593814|450454252|FG001|Overall Study|Physician Decision|0|||
125225432|NCT00715559|450454253|FG000|Overall Study|medication not tolerated - nausea|1|||
125225433|NCT02699996|450454254|FG000|Overall Study|Withdrawal by Subject|5|||
125225434|NCT02699996|450454255|FG001|Overall Study|Withdrawal by Subject|2|||
125225435|NCT01095835|450454258|FG000|Overall Study|Adverse Event|8|||
125225436|NCT01095835|450454259|FG001|Overall Study|Adverse Event|6|||
125225437|NCT01095835|450454260|FG002|Overall Study|Adverse Event|6|||
125225438|NCT01095835|450454258|FG000|Overall Study|Lack of Efficacy|0|||
125225439|NCT01095835|450454259|FG001|Overall Study|Lack of Efficacy|1|||
125225440|NCT01095835|450454260|FG002|Overall Study|Lack of Efficacy|0|||
125225441|NCT01095835|450454258|FG000|Overall Study|Physician Decision|0|||
125225442|NCT01095835|450454259|FG001|Overall Study|Physician Decision|0|||
125225443|NCT01095835|450454260|FG002|Overall Study|Physician Decision|1|||
125225444|NCT01095835|450454258|FG000|Overall Study|Withdrawal by Subject|1|||
125225445|NCT01095835|450454259|FG001|Overall Study|Withdrawal by Subject|3|||
125225446|NCT01095835|450454260|FG002|Overall Study|Withdrawal by Subject|0|||
125225447|NCT01095835|450454258|FG000|Overall Study|Non study compliance|0|||
125225448|NCT01095835|450454259|FG001|Overall Study|Non study compliance|0|||
125225449|NCT01095835|450454260|FG002|Overall Study|Non study compliance|1|||
125225450|NCT01095835|450454258|FG000|Overall Study|Protocol Violation|1|||
125225451|NCT01095835|450454259|FG001|Overall Study|Protocol Violation|2|||
125225452|NCT01095835|450454260|FG002|Overall Study|Protocol Violation|0|||
125225453|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
125225454|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
125225455|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
125225456|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
125225457|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
125225458|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
125225459|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
125225460|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
125225461|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
125225462|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
125225463|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
125225464|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
125225465|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
125225466|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
125225467|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
125225468|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
125225469|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
125225470|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
125225471|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
125225472|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
125225473|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
125225474|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
125225475|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
125225476|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
125225477|NCT01198002|450454261|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
125225478|NCT01198002|450454262|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
125225479|NCT01198002|450454263|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
125225480|NCT01198002|450454261|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
125225481|NCT01198002|450454262|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
125225482|NCT01198002|450454263|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
125225483|NCT01198002|450454261|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
125225484|NCT01198002|450454262|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
125225485|NCT01198002|450454263|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
125225486|NCT01198002|450454261|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
125225487|NCT01198002|450454262|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
125164295|NCT02991430|450225151|FG002|Post-treatment Observation Period|Study Termination|5|||
125164296|NCT01672970|450225152|FG000|Overall Study|Lack of Efficacy|12|||
125164297|NCT01672970|450225152|FG000|Overall Study|Adverse Event|18|||
125164298|NCT01672970|450225152|FG000|Overall Study|Withdrawal by Subject|2|||
125164299|NCT01672970|450225152|FG000|Overall Study|Lost to Follow-up|5|||
125164300|NCT01672970|450225152|FG000|Overall Study|Other|9|||
125164301|NCT01672970|450225152|FG000|Overall Study|Enrolled but not treated|1|||
125164302|NCT03835221|450225157|FG000|Methafilcon A|Withdrawal by Subject|1|||
125164303|NCT01770392|450225159|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
125164304|NCT04639713|450225162|FG000|Overall Study|Protocol Noncompliance|2|||
125164305|NCT04639713|450225162|FG000|Overall Study|Withdrawal by Subject|1|||
125164306|NCT02582866|450225165|FG000|Overall Study|Death|1|||
125164307|NCT02582866|450225165|FG000|Overall Study|Lack of Efficacy|2|||
125391607|NCT01545817|451068574|FG001|Pazopanib|Other reason|0|||
125164308|NCT02582866|450225165|FG000|Overall Study|Lost to Follow-up|2|||
125164309|NCT02582866|450225165|FG000|Overall Study|Withdrawal by Subject|7|||
125225488|NCT01198002|450454263|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
125225489|NCT01198002|450454261|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
125225490|NCT01198002|450454262|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
125164310|NCT02582866|450225165|FG000|Overall Study|Investigator decision|5|||
125164311|NCT02582866|450225165|FG000|Overall Study|Participant wants to get pregnant|1|||
125225491|NCT01198002|450454263|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
125225492|NCT01198002|450454261|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
125391608|NCT01545817|451068573|FG000|Everolimus|Other reason|0|||
125441436|NCT00849680|451244253|FG007|Overall Study|Subject moved|2|||
125441437|NCT00849680|451244246|FG000|Overall Study|Withdrawal by Subject|2|||
125441438|NCT00849680|451244247|FG001|Overall Study|Withdrawal by Subject|0|||
125441439|NCT00849680|451244248|FG002|Overall Study|Withdrawal by Subject|0|||
125441440|NCT00849680|451244249|FG003|Overall Study|Withdrawal by Subject|2|||
125441441|NCT00849680|451244250|FG004|Overall Study|Withdrawal by Subject|2|||
125441442|NCT00849680|451244251|FG005|Overall Study|Withdrawal by Subject|2|||
125441443|NCT00849680|451244252|FG006|Overall Study|Withdrawal by Subject|1|||
125441444|NCT00849680|451244253|FG007|Overall Study|Withdrawal by Subject|1|||
125441445|NCT00849680|451244246|FG000|Overall Study|Subject unable to comply with protocol|1|||
125441446|NCT00849680|451244247|FG001|Overall Study|Subject unable to comply with protocol|0|||
125441447|NCT00849680|451244248|FG002|Overall Study|Subject unable to comply with protocol|0|||
125441448|NCT00849680|451244249|FG003|Overall Study|Subject unable to comply with protocol|0|||
125441449|NCT00849680|451244250|FG004|Overall Study|Subject unable to comply with protocol|0|||
125441450|NCT00849680|451244251|FG005|Overall Study|Subject unable to comply with protocol|0|||
125441451|NCT00849680|451244252|FG006|Overall Study|Subject unable to comply with protocol|0|||
125441452|NCT00849680|451244253|FG007|Overall Study|Subject unable to comply with protocol|0|||
125441453|NCT02942004|451244256|FG000|Overall Study|Withdrawal by Subject|0|||
125441454|NCT02942004|451244257|FG001|Overall Study|Withdrawal by Subject|2|||
125441455|NCT02942004|451244258|FG002|Overall Study|Withdrawal by Subject|3|||
125441456|NCT02942004|451244256|FG000|Overall Study|Lost to Follow-up|1|||
125441457|NCT02942004|451244257|FG001|Overall Study|Lost to Follow-up|1|||
125441458|NCT02942004|451244258|FG002|Overall Study|Lost to Follow-up|2|||
125441459|NCT02942004|451244256|FG000|Overall Study|Randomized but not dosed|3|||
125441460|NCT02942004|451244257|FG001|Overall Study|Randomized but not dosed|9|||
125441461|NCT02942004|451244258|FG002|Overall Study|Randomized but not dosed|4|||
125441462|NCT03382600|451244259|FG000|Overall Study|Adverse Event|3|||
125441463|NCT03382600|451244260|FG001|Overall Study|Adverse Event|3|||
125441464|NCT03382600|451244259|FG000|Overall Study|Clinical Disease Progression|2|||
125441465|NCT03382600|451244260|FG001|Overall Study|Clinical Disease Progression|4|||
125164312|NCT02582866|450225165|FG000|Overall Study|Pregnancy|2|||
125164313|NCT02582866|450225165|FG000|Overall Study|Sponsor decision|1|||
125164314|NCT02582866|450225165|FG000|Overall Study|Withdrawal due to personal reasons|1|||
125164315|NCT01193127|450225172|FG000|Randomized|Surgery Cancelled|0|||
125164316|NCT01193127|450225173|FG001|Randomized|Surgery Cancelled|0|||
125164317|NCT01193127|450225174|FG002|Randomized|Surgery Cancelled|0|||
125164318|NCT01193127|450225175|FG003|Randomized|Surgery Cancelled|1|||
125164319|NCT01193127|450225172|FG000|Treated|Withdrawal by Subject|0|||
125164320|NCT01193127|450225173|FG001|Treated|Withdrawal by Subject|0|||
125164321|NCT01193127|450225174|FG002|Treated|Withdrawal by Subject|0|||
125164322|NCT01193127|450225175|FG003|Treated|Withdrawal by Subject|1|||
125164323|NCT03246646|450225178|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
125164324|NCT03246646|450225179|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
125164325|NCT03246646|450225178|FG000|Overall Study|Withdrawal by Subject|3|||
125164326|NCT03246646|450225179|FG001|Overall Study|Withdrawal by Subject|0|||
125164327|NCT03246646|450225178|FG000|Overall Study|Lost to Follow-up|7|||
125164328|NCT03246646|450225179|FG001|Overall Study|Lost to Follow-up|0|||
125164329|NCT02352779|450225182|FG000|Overall Study|Personal Issues|1|||
125164330|NCT02352779|450225183|FG001|Overall Study|Personal Issues|1|||
125164331|NCT02352779|450225184|FG002|Overall Study|Personal Issues|0|||
125164332|NCT02352779|450225182|FG000|Overall Study|Too Many Forms|2|||
125164333|NCT02352779|450225183|FG001|Overall Study|Too Many Forms|0|||
125164334|NCT02352779|450225184|FG002|Overall Study|Too Many Forms|0|||
125164335|NCT02352779|450225182|FG000|Overall Study|Feeling Overwhelmed|1|||
125164336|NCT02352779|450225183|FG001|Overall Study|Feeling Overwhelmed|0|||
125164337|NCT02352779|450225184|FG002|Overall Study|Feeling Overwhelmed|0|||
125164338|NCT02352779|450225182|FG000|Overall Study|Disliked Intervention|1|||
125164339|NCT02352779|450225183|FG001|Overall Study|Disliked Intervention|0|||
125164340|NCT02352779|450225184|FG002|Overall Study|Disliked Intervention|0|||
125164341|NCT02352779|450225182|FG000|Overall Study|Changed Mind|1|||
125164342|NCT02352779|450225183|FG001|Overall Study|Changed Mind|0|||
125164343|NCT02352779|450225184|FG002|Overall Study|Changed Mind|0|||
125164344|NCT02352779|450225182|FG000|Overall Study|Study Related Symptoms|1|||
125164345|NCT02352779|450225183|FG001|Overall Study|Study Related Symptoms|0|||
125164346|NCT02352779|450225184|FG002|Overall Study|Study Related Symptoms|0|||
125164347|NCT02352779|450225182|FG000|Overall Study|Absence of Symptoms|1|||
125164348|NCT02352779|450225183|FG001|Overall Study|Absence of Symptoms|0|||
125164349|NCT02352779|450225184|FG002|Overall Study|Absence of Symptoms|0|||
125441466|NCT03382600|451244259|FG000|Overall Study|Radiological Progression|40|||
125441467|NCT03382600|451244260|FG001|Overall Study|Radiological Progression|31|||
125441468|NCT03382600|451244259|FG000|Overall Study|Withdrawal by Subject|0|||
125441469|NCT03382600|451244260|FG001|Overall Study|Withdrawal by Subject|1|||
125164350|NCT02352779|450225182|FG000|Overall Study|Other Medical Reason|0|||
125164351|NCT02352779|450225183|FG001|Overall Study|Other Medical Reason|0|||
125164352|NCT02352779|450225184|FG002|Overall Study|Other Medical Reason|1|||
125441470|NCT03382600|451244259|FG000|Overall Study|Other|9|||
125164353|NCT02352779|450225182|FG000|Overall Study|No Reason|0|||
125164354|NCT02352779|450225183|FG001|Overall Study|No Reason|0|||
125164355|NCT02352779|450225184|FG002|Overall Study|No Reason|1|||
125164356|NCT00871741|450225189|FG000|Overall Study|Premature study termination|9|||
125164357|NCT00871741|450225190|FG001|Overall Study|Premature study termination|7|||
125164358|NCT01565850|450225191|FG000|Overall Study|Adverse Event|0|||
125164359|NCT01565850|450225192|FG001|Overall Study|Adverse Event|1|||
125164360|NCT01565850|450225191|FG000|Overall Study|Lost to Follow-up|12|||
125164361|NCT01565850|450225192|FG001|Overall Study|Lost to Follow-up|4|||
125164362|NCT01565850|450225191|FG000|Overall Study|Investigator's Discretion|2|||
125164363|NCT01565850|450225192|FG001|Overall Study|Investigator's Discretion|1|||
125164364|NCT01565850|450225191|FG000|Overall Study|Participant noncompliance|2|||
125164365|NCT01565850|450225192|FG001|Overall Study|Participant noncompliance|0|||
125164366|NCT01565850|450225191|FG000|Overall Study|Withdrew Consent|4|||
125164367|NCT01565850|450225192|FG001|Overall Study|Withdrew Consent|2|||
125164368|NCT03611543|450227738|FG000|Overall Study|Withdrawal by Subject|4|||
125164369|NCT03611543|450227739|FG001|Overall Study|Withdrawal by Subject|4|||
125164370|NCT03611543|450227738|FG000|Overall Study|Physician Decision|1|||
125164371|NCT03611543|450227739|FG001|Overall Study|Physician Decision|1|||
125164372|NCT03611543|450227738|FG000|Overall Study|Protocol Violation|2|||
125164373|NCT03611543|450227739|FG001|Overall Study|Protocol Violation|2|||
125164374|NCT03611543|450227738|FG000|Overall Study|Device failure|2|||
125164375|NCT03611543|450227739|FG001|Overall Study|Device failure|2|||
125164376|NCT03611543|450227738|FG000|Overall Study|Missing information|5|||
125164377|NCT03611543|450227739|FG001|Overall Study|Missing information|5|||
125164378|NCT04395001|450227740|FG000|Overall Study|Lost to Follow-up|8|||
125164379|NCT04395001|450227741|FG001|Overall Study|Lost to Follow-up|9|||
125164380|NCT04395001|450227742|FG002|Overall Study|Lost to Follow-up|5|||
125164381|NCT04395001|450227740|FG000|Overall Study|Withdrawal by Subject|3|||
125164382|NCT04395001|450227741|FG001|Overall Study|Withdrawal by Subject|1|||
125164383|NCT04395001|450227742|FG002|Overall Study|Withdrawal by Subject|3|||
125164384|NCT04395001|450227740|FG000|Overall Study|missed appointment|7|||
125164385|NCT04395001|450227741|FG001|Overall Study|missed appointment|4|||
125164386|NCT04395001|450227742|FG002|Overall Study|missed appointment|1|||
125164387|NCT02799095|450227743|FG000|Part A|Adverse Event|1|||
125164388|NCT02799095|450227744|FG001|Part A|Adverse Event|0|||
125164389|NCT02799095|450227745|FG002|Part A|Adverse Event|1|||
125164390|NCT02799095|450227746|FG003|Part A|Adverse Event|4|||
125164391|NCT02799095|450227747|FG004|Part A|Adverse Event|1|||
125164392|NCT02799095|450227748|FG005|Part A|Adverse Event|0|||
125164393|NCT02799095|450227749|FG006|Part A|Adverse Event|0|||
125164394|NCT02799095|450227750|FG007|Part A|Adverse Event|0|||
125164395|NCT02799095|450227751|FG008|Part A|Adverse Event|0|||
125164396|NCT02799095|450227752|FG009|Part A|Adverse Event|0|||
125164397|NCT02799095|450227753|FG010|Part A|Adverse Event|0|||
125164398|NCT02799095|450227754|FG011|Part A|Adverse Event|0|||
125164399|NCT02799095|450227755|FG012|Part A|Adverse Event|0|||
125164400|NCT02799095|450227756|FG013|Part A|Adverse Event|0|||
125164401|NCT02799095|450227757|FG014|Part A|Adverse Event|0|||
125164402|NCT02799095|450227758|FG015|Part A|Adverse Event|0|||
125164403|NCT02799095|450227759|FG016|Part A|Adverse Event|0|||
125164404|NCT02799095|450227743|FG000|Part A|Death|0|||
125164405|NCT02799095|450227744|FG001|Part A|Death|0|||
125164406|NCT02799095|450227745|FG002|Part A|Death|0|||
125164407|NCT02799095|450227746|FG003|Part A|Death|0|||
125164408|NCT02799095|450227747|FG004|Part A|Death|0|||
125164409|NCT02799095|450227748|FG005|Part A|Death|0|||
125164410|NCT02799095|450227749|FG006|Part A|Death|3|||
125164411|NCT02799095|450227750|FG007|Part A|Death|0|||
125164412|NCT02799095|450227751|FG008|Part A|Death|0|||
125164413|NCT02799095|450227752|FG009|Part A|Death|0|||
125164414|NCT02799095|450227753|FG010|Part A|Death|0|||
125164415|NCT02799095|450227754|FG011|Part A|Death|0|||
125164416|NCT02799095|450227755|FG012|Part A|Death|0|||
125164417|NCT02799095|450227756|FG013|Part A|Death|0|||
125164418|NCT02799095|450227757|FG014|Part A|Death|0|||
125164419|NCT02799095|450227758|FG015|Part A|Death|0|||
125164420|NCT02799095|450227759|FG016|Part A|Death|0|||
125164421|NCT02799095|450227743|FG000|Part A|Lost to Follow-up|0|||
125164422|NCT02799095|450227744|FG001|Part A|Lost to Follow-up|1|||
125164423|NCT02799095|450227745|FG002|Part A|Lost to Follow-up|0|||
125164424|NCT02799095|450227746|FG003|Part A|Lost to Follow-up|0|||
125164425|NCT02799095|450227747|FG004|Part A|Lost to Follow-up|0|||
125164426|NCT02799095|450227748|FG005|Part A|Lost to Follow-up|0|||
125164427|NCT02799095|450227749|FG006|Part A|Lost to Follow-up|1|||
125164428|NCT02799095|450227750|FG007|Part A|Lost to Follow-up|0|||
125164429|NCT02799095|450227751|FG008|Part A|Lost to Follow-up|0|||
125164430|NCT02799095|450227752|FG009|Part A|Lost to Follow-up|0|||
125164431|NCT02799095|450227753|FG010|Part A|Lost to Follow-up|0|||
125164432|NCT02799095|450227754|FG011|Part A|Lost to Follow-up|0|||
125164433|NCT02799095|450227755|FG012|Part A|Lost to Follow-up|0|||
125164434|NCT02799095|450227756|FG013|Part A|Lost to Follow-up|0|||
125164435|NCT02799095|450227757|FG014|Part A|Lost to Follow-up|0|||
125164436|NCT02799095|450227758|FG015|Part A|Lost to Follow-up|0|||
125164437|NCT02799095|450227759|FG016|Part A|Lost to Follow-up|0|||
125164438|NCT02799095|450227743|FG000|Part A|Progressive Disease|3|||
125164439|NCT02799095|450227744|FG001|Part A|Progressive Disease|3|||
125164440|NCT02799095|450227745|FG002|Part A|Progressive Disease|3|||
125164441|NCT02799095|450227746|FG003|Part A|Progressive Disease|2|||
125164442|NCT02799095|450227747|FG004|Part A|Progressive Disease|2|||
125164443|NCT02799095|450227748|FG005|Part A|Progressive Disease|0|||
125164444|NCT02799095|450227749|FG006|Part A|Progressive Disease|0|||
125164445|NCT02799095|450227750|FG007|Part A|Progressive Disease|0|||
125164446|NCT02799095|450227751|FG008|Part A|Progressive Disease|0|||
125164447|NCT02799095|450227752|FG009|Part A|Progressive Disease|0|||
125164448|NCT02799095|450227753|FG010|Part A|Progressive Disease|0|||
125164449|NCT02799095|450227754|FG011|Part A|Progressive Disease|0|||
125164450|NCT02799095|450227755|FG012|Part A|Progressive Disease|0|||
125164451|NCT02799095|450227756|FG013|Part A|Progressive Disease|0|||
125164452|NCT02799095|450227757|FG014|Part A|Progressive Disease|0|||
125164453|NCT02799095|450227758|FG015|Part A|Progressive Disease|0|||
125164454|NCT02799095|450227759|FG016|Part A|Progressive Disease|0|||
125164455|NCT02799095|450227743|FG000|Part A|Clinical Progression|1|||
125164456|NCT02799095|450227744|FG001|Part A|Clinical Progression|0|||
125164457|NCT02799095|450227745|FG002|Part A|Clinical Progression|2|||
125164458|NCT02799095|450227746|FG003|Part A|Clinical Progression|1|||
125164459|NCT02799095|450227747|FG004|Part A|Clinical Progression|5|||
125164460|NCT02799095|450227748|FG005|Part A|Clinical Progression|0|||
125164461|NCT02799095|450227749|FG006|Part A|Clinical Progression|0|||
125164462|NCT02799095|450227750|FG007|Part A|Clinical Progression|0|||
125164463|NCT02799095|450227751|FG008|Part A|Clinical Progression|0|||
125164464|NCT02799095|450227752|FG009|Part A|Clinical Progression|0|||
125164465|NCT02799095|450227753|FG010|Part A|Clinical Progression|0|||
125164466|NCT02799095|450227754|FG011|Part A|Clinical Progression|0|||
125164467|NCT02799095|450227755|FG012|Part A|Clinical Progression|0|||
125164468|NCT02799095|450227756|FG013|Part A|Clinical Progression|0|||
125164469|NCT02799095|450227757|FG014|Part A|Clinical Progression|0|||
125164470|NCT02799095|450227758|FG015|Part A|Clinical Progression|0|||
125164471|NCT02799095|450227759|FG016|Part A|Clinical Progression|0|||
125164472|NCT02799095|450227743|FG000|Part A|Protocol Deviation|0|||
125164473|NCT02799095|450227744|FG001|Part A|Protocol Deviation|0|||
125164474|NCT02799095|450227745|FG002|Part A|Protocol Deviation|1|||
125164475|NCT02799095|450227746|FG003|Part A|Protocol Deviation|0|||
125164476|NCT02799095|450227747|FG004|Part A|Protocol Deviation|0|||
125164477|NCT02799095|450227748|FG005|Part A|Protocol Deviation|0|||
125164478|NCT02799095|450227749|FG006|Part A|Protocol Deviation|0|||
125164479|NCT02799095|450227750|FG007|Part A|Protocol Deviation|0|||
125164480|NCT02799095|450227751|FG008|Part A|Protocol Deviation|0|||
125164481|NCT02799095|450227752|FG009|Part A|Protocol Deviation|0|||
125164482|NCT02799095|450227753|FG010|Part A|Protocol Deviation|0|||
125164483|NCT02799095|450227754|FG011|Part A|Protocol Deviation|0|||
125164484|NCT02799095|450227755|FG012|Part A|Protocol Deviation|0|||
125164485|NCT02799095|450227756|FG013|Part A|Protocol Deviation|0|||
125164486|NCT02799095|450227757|FG014|Part A|Protocol Deviation|0|||
125164487|NCT02799095|450227758|FG015|Part A|Protocol Deviation|0|||
125164488|NCT02799095|450227759|FG016|Part A|Protocol Deviation|0|||
125164489|NCT02799095|450227743|FG000|Part A|Withdrawal by Subject|0|||
125164490|NCT02799095|450227744|FG001|Part A|Withdrawal by Subject|0|||
125164491|NCT02799095|450227745|FG002|Part A|Withdrawal by Subject|0|||
125164492|NCT02799095|450227746|FG003|Part A|Withdrawal by Subject|1|||
125164493|NCT02799095|450227747|FG004|Part A|Withdrawal by Subject|3|||
125164494|NCT02799095|450227748|FG005|Part A|Withdrawal by Subject|1|||
125164495|NCT02799095|450227749|FG006|Part A|Withdrawal by Subject|1|||
125164496|NCT02799095|450227750|FG007|Part A|Withdrawal by Subject|0|||
125164497|NCT02799095|450227751|FG008|Part A|Withdrawal by Subject|0|||
125164498|NCT02799095|450227752|FG009|Part A|Withdrawal by Subject|0|||
125164499|NCT02799095|450227753|FG010|Part A|Withdrawal by Subject|0|||
125164500|NCT02799095|450227754|FG011|Part A|Withdrawal by Subject|0|||
125164501|NCT02799095|450227755|FG012|Part A|Withdrawal by Subject|0|||
125164502|NCT02799095|450227756|FG013|Part A|Withdrawal by Subject|0|||
125164503|NCT02799095|450227757|FG014|Part A|Withdrawal by Subject|0|||
125164504|NCT02799095|450227758|FG015|Part A|Withdrawal by Subject|0|||
125391609|NCT01545817|451068574|FG001|Everolimus|Other reason|7|||
125164505|NCT02799095|450227759|FG016|Part A|Withdrawal by Subject|0|||
125164506|NCT02799095|450227743|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
125164507|NCT02799095|450227744|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
125164508|NCT02799095|450227745|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
125164509|NCT02799095|450227746|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
125164510|NCT02799095|450227747|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
125164511|NCT02799095|450227748|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
125164512|NCT02799095|450227749|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
125164513|NCT02799095|450227750|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
125164514|NCT02799095|450227751|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
125164515|NCT02799095|450227752|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
125164516|NCT02799095|450227753|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
125164517|NCT02799095|450227754|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
125391610|NCT01545817|451068573|FG000|Everolimus|Disease progression|0|||
125391611|NCT01545817|451068574|FG001|Everolimus|Disease progression|25|||
125441471|NCT03382600|451244260|FG001|Overall Study|Other|7|||
125441472|NCT01448044|451244261|FG000|Treatment Period|Adverse Event|4|||
125441473|NCT01448044|451244262|FG001|Treatment Period|Adverse Event|3|||
125441474|NCT01448044|451244261|FG000|Treatment Period|Lack of Efficacy|5|||
125441475|NCT01448044|451244262|FG001|Treatment Period|Lack of Efficacy|12|||
125441476|NCT01448044|451244261|FG000|Treatment Period|Subject requested discontinue study drug|1|||
125441477|NCT01448044|451244262|FG001|Treatment Period|Subject requested discontinue study drug|0|||
125441478|NCT01448044|451244261|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
125441479|NCT01448044|451244262|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
125441480|NCT01448044|451244261|FG000|Treatment Period|Participant does not meet study criteria|1|||
125441481|NCT01448044|451244262|FG001|Treatment Period|Participant does not meet study criteria|0|||
125441482|NCT01448044|451244261|FG000|Treatment Period|Lost to Follow-up|2|||
125441483|NCT01448044|451244262|FG001|Treatment Period|Lost to Follow-up|1|||
125441484|NCT01448044|451244261|FG000|Treatment Period|Other reason|2|||
125441485|NCT01448044|451244262|FG001|Treatment Period|Other reason|0|||
125441486|NCT01448044|451244261|FG000|Follow Up Period|Withdrawal by Subject|1|||
125441487|NCT01448044|451244262|FG001|Follow Up Period|Withdrawal by Subject|1|||
125441488|NCT01448044|451244261|FG000|Follow Up Period|Lost to Follow-up|6|||
125164518|NCT02799095|450227755|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
125164519|NCT02799095|450227756|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
125164520|NCT02799095|450227757|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
125164521|NCT02799095|450227758|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
125164522|NCT02799095|450227759|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
125391612|NCT01545817|451068573|FG000|Everolimus|Adverse Event|0|||
125391613|NCT01545817|451068574|FG001|Everolimus|Adverse Event|6|||
125391614|NCT03026257|451068582|FG000|Overall Study|Adverse Event|3|||
125391615|NCT03026257|451068583|FG001|Overall Study|Adverse Event|0|||
125391616|NCT03026257|451068584|FG002|Overall Study|Adverse Event|0|||
125391617|NCT03026257|451068585|FG003|Overall Study|Adverse Event|0|||
125391618|NCT03026257|451068586|FG004|Overall Study|Adverse Event|0|||
125391619|NCT03026257|451068587|FG005|Overall Study|Adverse Event|0|||
125391620|NCT03026257|451068582|FG000|Overall Study|Lost to Follow-up|1|||
125391621|NCT03026257|451068583|FG001|Overall Study|Lost to Follow-up|0|||
125391622|NCT03026257|451068584|FG002|Overall Study|Lost to Follow-up|0|||
125391623|NCT03026257|451068585|FG003|Overall Study|Lost to Follow-up|0|||
125391624|NCT03026257|451068586|FG004|Overall Study|Lost to Follow-up|0|||
125391625|NCT03026257|451068587|FG005|Overall Study|Lost to Follow-up|0|||
125391626|NCT03026257|451068582|FG000|Overall Study|Protocol Violation|1|||
125391627|NCT03026257|451068583|FG001|Overall Study|Protocol Violation|0|||
125391628|NCT03026257|451068584|FG002|Overall Study|Protocol Violation|0|||
125391629|NCT03026257|451068585|FG003|Overall Study|Protocol Violation|1|||
125391630|NCT03026257|451068586|FG004|Overall Study|Protocol Violation|1|||
125391631|NCT03026257|451068587|FG005|Overall Study|Protocol Violation|0|||
125391632|NCT03026257|451068582|FG000|Overall Study|Withdrawal by Subject|1|||
125391633|NCT03026257|451068583|FG001|Overall Study|Withdrawal by Subject|1|||
125391634|NCT03026257|451068584|FG002|Overall Study|Withdrawal by Subject|0|||
125391635|NCT03026257|451068585|FG003|Overall Study|Withdrawal by Subject|0|||
125391636|NCT03026257|451068586|FG004|Overall Study|Withdrawal by Subject|0|||
125391637|NCT03026257|451068587|FG005|Overall Study|Withdrawal by Subject|0|||
125391638|NCT04380857|451068588|FG000|Overall Study|Lost to Follow-up|3|||
125391639|NCT04380857|451068589|FG001|Overall Study|Lost to Follow-up|3|||
125391640|NCT00838201|451068590|FG000|Overall Study|Investigator decision, or other reasons|2|||
125391641|NCT00838201|451068591|FG001|Overall Study|Investigator decision, or other reasons|3|||
125391642|NCT00838201|451068590|FG000|Overall Study|Noncompliance|0|||
125391643|NCT00838201|451068591|FG001|Overall Study|Noncompliance|1|||
125391644|NCT00838201|451068590|FG000|Overall Study|Administrative decision|1|||
125391645|NCT00838201|451068591|FG001|Overall Study|Administrative decision|2|||
125391646|NCT00838201|451068590|FG000|Overall Study|Disease progression|3|||
125391647|NCT00838201|451068591|FG001|Overall Study|Disease progression|3|||
125391648|NCT00838201|451068590|FG000|Overall Study|Consent withdrawn|16|||
125391649|NCT00838201|451068591|FG001|Overall Study|Consent withdrawn|19|||
125391650|NCT00838201|451068590|FG000|Overall Study|Lost to Follow-up|4|||
125391651|NCT00838201|451068591|FG001|Overall Study|Lost to Follow-up|3|||
125391652|NCT00838201|451068590|FG000|Overall Study|Adverse Event|5|||
125391653|NCT00838201|451068591|FG001|Overall Study|Adverse Event|9|||
125391654|NCT00838201|451068590|FG000|Overall Study|Death|11|||
125441489|NCT01448044|451244262|FG001|Follow Up Period|Lost to Follow-up|2|||
125441490|NCT01448044|451244261|FG000|Follow Up Period|Other|5|||
125164523|NCT02799095|450227743|FG000|Part B|Death|0|||
125164524|NCT02799095|450227744|FG001|Part B|Death|0|||
125391655|NCT00838201|451068591|FG001|Overall Study|Death|13|||
125391656|NCT03314584|451068603|FG000|Overall Study|Withdrawal by Subject|3|||
125391657|NCT03314584|451068604|FG001|Overall Study|Withdrawal by Subject|3|||
125391658|NCT03314584|451068603|FG000|Overall Study|Lost to Follow-up|4|||
125391659|NCT03314584|451068604|FG001|Overall Study|Lost to Follow-up|0|||
125391660|NCT06134817|451068605|FG000|Overall Study|Physician Departure - termination of study|1|||
125391661|NCT01990495|451068607|FG000|Overall Study|Physician Decision|5|||
125391662|NCT01990495|451068608|FG001|Overall Study|Physician Decision|4|||
125225493|NCT01198002|450454262|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
125225494|NCT01198002|450454263|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
125225495|NCT01198002|450454261|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
125225496|NCT01198002|450454262|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
125225497|NCT01198002|450454263|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
125225498|NCT00116688|450454267|FG000|Overall Study|Protocol deviation|1|||
125225499|NCT00116688|450454268|FG001|Overall Study|Protocol deviation|0|||
125225500|NCT00116688|450454267|FG000|Overall Study|Noncompliance|3|||
125225501|NCT00116688|450454268|FG001|Overall Study|Noncompliance|1|||
125225502|NCT00116688|450454267|FG000|Overall Study|Adverse Event|11|||
125225503|NCT00116688|450454268|FG001|Overall Study|Adverse Event|0|||
125225504|NCT00116688|450454267|FG000|Overall Study|Withdrawal by Subject|26|||
125225505|NCT00116688|450454268|FG001|Overall Study|Withdrawal by Subject|2|||
125225506|NCT00116688|450454267|FG000|Overall Study|Requirement for alternative therapy|11|||
125225507|NCT00116688|450454268|FG001|Overall Study|Requirement for alternative therapy|1|||
125225508|NCT00116688|450454267|FG000|Overall Study|Physician Decision|7|||
125225509|NCT00116688|450454268|FG001|Overall Study|Physician Decision|0|||
125225510|NCT00116688|450454267|FG000|Overall Study|Lost to Follow-up|3|||
125225511|NCT00116688|450454268|FG001|Overall Study|Lost to Follow-up|0|||
125225512|NCT00116688|450454267|FG000|Overall Study|Death|15|||
125225513|NCT00116688|450454268|FG001|Overall Study|Death|0|||
125225514|NCT00116688|450454267|FG000|Overall Study|Protocol-specified criteria|3|||
125225515|NCT00116688|450454268|FG001|Overall Study|Protocol-specified criteria|0|||
125225516|NCT00116688|450454267|FG000|Overall Study|Pregnancy|1|||
125225517|NCT00116688|450454268|FG001|Overall Study|Pregnancy|0|||
125225518|NCT00116688|450454267|FG000|Overall Study|Other|11|||
125225519|NCT00116688|450454268|FG001|Overall Study|Other|0|||
125164525|NCT02799095|450227745|FG002|Part B|Death|0|||
125164526|NCT02799095|450227746|FG003|Part B|Death|0|||
125164527|NCT02799095|450227747|FG004|Part B|Death|0|||
125164528|NCT02799095|450227748|FG005|Part B|Death|0|||
125164529|NCT02799095|450227749|FG006|Part B|Death|0|||
125164530|NCT02799095|450227750|FG007|Part B|Death|7|||
125164531|NCT02799095|450227751|FG008|Part B|Death|7|||
125164532|NCT02799095|450227752|FG009|Part B|Death|0|||
125164533|NCT02799095|450227753|FG010|Part B|Death|0|||
125164534|NCT02799095|450227754|FG011|Part B|Death|0|||
125164535|NCT02799095|450227755|FG012|Part B|Death|0|||
125164536|NCT02799095|450227756|FG013|Part B|Death|0|||
125164537|NCT02799095|450227757|FG014|Part B|Death|0|||
125164538|NCT02799095|450227758|FG015|Part B|Death|0|||
125164539|NCT02799095|450227759|FG016|Part B|Death|0|||
125164540|NCT02799095|450227743|FG000|Part B|Progressive Disease|0|||
125164541|NCT02799095|450227744|FG001|Part B|Progressive Disease|0|||
125164542|NCT02799095|450227745|FG002|Part B|Progressive Disease|0|||
125164543|NCT02799095|450227746|FG003|Part B|Progressive Disease|0|||
125164544|NCT02799095|450227747|FG004|Part B|Progressive Disease|0|||
125164545|NCT02799095|450227748|FG005|Part B|Progressive Disease|0|||
125164546|NCT02799095|450227749|FG006|Part B|Progressive Disease|0|||
125164547|NCT02799095|450227750|FG007|Part B|Progressive Disease|1|||
125164548|NCT02799095|450227751|FG008|Part B|Progressive Disease|0|||
125164549|NCT02799095|450227752|FG009|Part B|Progressive Disease|0|||
125164550|NCT02799095|450227753|FG010|Part B|Progressive Disease|0|||
125164551|NCT02799095|450227754|FG011|Part B|Progressive Disease|0|||
125164552|NCT02799095|450227755|FG012|Part B|Progressive Disease|0|||
125164553|NCT02799095|450227756|FG013|Part B|Progressive Disease|0|||
125164554|NCT02799095|450227757|FG014|Part B|Progressive Disease|0|||
125164555|NCT02799095|450227758|FG015|Part B|Progressive Disease|0|||
125164556|NCT02799095|450227759|FG016|Part B|Progressive Disease|0|||
125164557|NCT02799095|450227743|FG000|Part B|Withdrawal by Subject|0|||
125164558|NCT02799095|450227744|FG001|Part B|Withdrawal by Subject|0|||
125164559|NCT02799095|450227745|FG002|Part B|Withdrawal by Subject|0|||
125164560|NCT02799095|450227746|FG003|Part B|Withdrawal by Subject|0|||
125164561|NCT02799095|450227747|FG004|Part B|Withdrawal by Subject|0|||
125164562|NCT02799095|450227748|FG005|Part B|Withdrawal by Subject|0|||
125164563|NCT02799095|450227749|FG006|Part B|Withdrawal by Subject|0|||
125225520|NCT04006145|450454270|FG000|Overall Study|Lost to Follow-up|0|||
125225521|NCT04006145|450454271|FG001|Overall Study|Lost to Follow-up|1|||
125225522|NCT04006145|450454270|FG000|Overall Study|Other|1|||
125225523|NCT04006145|450454271|FG001|Overall Study|Other|2|||
125225524|NCT00010257|450454272|FG000|Overall Study|Withdrawal by Subject|1|||
125164564|NCT02799095|450227750|FG007|Part B|Withdrawal by Subject|10|||
125164565|NCT02799095|450227751|FG008|Part B|Withdrawal by Subject|7|||
125164566|NCT02799095|450227752|FG009|Part B|Withdrawal by Subject|0|||
125164567|NCT02799095|450227753|FG010|Part B|Withdrawal by Subject|0|||
125164568|NCT02799095|450227754|FG011|Part B|Withdrawal by Subject|0|||
125164569|NCT02799095|450227755|FG012|Part B|Withdrawal by Subject|0|||
125164570|NCT02799095|450227756|FG013|Part B|Withdrawal by Subject|0|||
125164571|NCT02799095|450227757|FG014|Part B|Withdrawal by Subject|0|||
125164572|NCT02799095|450227758|FG015|Part B|Withdrawal by Subject|0|||
125164573|NCT02799095|450227759|FG016|Part B|Withdrawal by Subject|0|||
125225525|NCT00010257|450454273|FG001|Overall Study|Withdrawal by Subject|0|||
125441491|NCT01448044|451244262|FG001|Follow Up Period|Other|11|||
125441492|NCT01000376|451244265|FG000|Cycle 1 Day 1|Adverse Event|1|||
125441493|NCT01000376|451244266|FG001|Cycle 1 Day 1|Adverse Event|0|||
125441494|NCT01000376|451244265|FG000|Cycle 1 Day 1|Progressive Disease|1|||
125441495|NCT01000376|451244266|FG001|Cycle 1 Day 1|Progressive Disease|0|||
125441496|NCT00507026|451244267|FG000|Overall Study|Lack of Efficacy|6|||
125441497|NCT00507026|451244268|FG001|Overall Study|Lack of Efficacy|4|||
125441498|NCT00507026|451244269|FG002|Overall Study|Lack of Efficacy|21|||
125441499|NCT00507026|451244267|FG000|Overall Study|Withdrawal by Subject|2|||
125441500|NCT00507026|451244268|FG001|Overall Study|Withdrawal by Subject|0|||
125441501|NCT00507026|451244269|FG002|Overall Study|Withdrawal by Subject|0|||
125441502|NCT00507026|451244267|FG000|Overall Study|Investigator Decision|1|||
125441503|NCT00507026|451244268|FG001|Overall Study|Investigator Decision|0|||
125441504|NCT00507026|451244269|FG002|Overall Study|Investigator Decision|0|||
125441505|NCT00507026|451244267|FG000|Overall Study|Adverse Event|2|||
125441506|NCT00507026|451244268|FG001|Overall Study|Adverse Event|0|||
125441507|NCT00507026|451244269|FG002|Overall Study|Adverse Event|0|||
125441508|NCT00507026|451244267|FG000|Overall Study|Protocol Violation|1|||
125441509|NCT00507026|451244268|FG001|Overall Study|Protocol Violation|0|||
125441510|NCT00507026|451244269|FG002|Overall Study|Protocol Violation|0|||
125441511|NCT00507026|451244267|FG000|Overall Study|Other|1|||
125441512|NCT00507026|451244268|FG001|Overall Study|Other|0|||
125441513|NCT00507026|451244269|FG002|Overall Study|Other|0|||
125441514|NCT00896454|451244270|FG000|Overall Study|Death|10|||
125441515|NCT00896454|451244270|FG000|Overall Study|Adverse Event|8|||
125441516|NCT00896454|451244270|FG000|Overall Study|Disease Progression|5|||
125441517|NCT00896454|451244270|FG000|Overall Study|Other|4|||
125441518|NCT00896454|451244270|FG000|Overall Study|Requirement for alternative therapy|3|||
125441519|NCT00896454|451244270|FG000|Overall Study|Ongoing in study|2|||
125441520|NCT00896454|451244270|FG000|Overall Study|Withdrawal by Subject|1|||
125441521|NCT03688711|451244273|FG000|Overall Study|Withdrawal by Subject|0|||
125441522|NCT03688711|451244274|FG001|Overall Study|Withdrawal by Subject|1|||
125441523|NCT01811563|451246775|FG000|Overall Study|Lost to Follow-up|5|||
125441524|NCT01811563|451246776|FG001|Overall Study|Lost to Follow-up|2|||
125441525|NCT01811563|451246775|FG000|Overall Study|Incorrect Randomization procedure|0|||
125441526|NCT01811563|451246776|FG001|Overall Study|Incorrect Randomization procedure|1|||
125441527|NCT01807221|451246779|FG000|Overall Study|Progressive disease|1|||
125441528|NCT01807221|451246780|FG001|Overall Study|Progressive disease|0|||
125441529|NCT01807221|451246781|FG002|Overall Study|Progressive disease|1|||
125441530|NCT01807221|451246782|FG003|Overall Study|Progressive disease|0|||
125441531|NCT01807221|451246783|FG004|Overall Study|Progressive disease|0|||
125441532|NCT01807221|451246784|FG005|Overall Study|Progressive disease|0|||
125441533|NCT01807221|451246779|FG000|Overall Study|Death|7|||
125441534|NCT01807221|451246780|FG001|Overall Study|Death|9|||
125441535|NCT01807221|451246781|FG002|Overall Study|Death|4|||
125441536|NCT01807221|451246782|FG003|Overall Study|Death|2|||
125441537|NCT01807221|451246783|FG004|Overall Study|Death|1|||
125441538|NCT01807221|451246784|FG005|Overall Study|Death|6|||
125441539|NCT01807221|451246779|FG000|Overall Study|Physician Decision|2|||
125441540|NCT01807221|451246780|FG001|Overall Study|Physician Decision|1|||
125441541|NCT01807221|451246781|FG002|Overall Study|Physician Decision|0|||
125441542|NCT01807221|451246782|FG003|Overall Study|Physician Decision|0|||
125441543|NCT01807221|451246783|FG004|Overall Study|Physician Decision|0|||
125441544|NCT01807221|451246784|FG005|Overall Study|Physician Decision|0|||
125441545|NCT01807221|451246779|FG000|Overall Study|Adverse Event|33|||
125441546|NCT01807221|451246780|FG001|Overall Study|Adverse Event|22|||
125441547|NCT01807221|451246781|FG002|Overall Study|Adverse Event|26|||
125441548|NCT01807221|451246782|FG003|Overall Study|Adverse Event|25|||
125441549|NCT01807221|451246783|FG004|Overall Study|Adverse Event|18|||
125441550|NCT01807221|451246784|FG005|Overall Study|Adverse Event|21|||
125441551|NCT01807221|451246779|FG000|Overall Study|Protocol Violation|0|||
125441552|NCT01807221|451246780|FG001|Overall Study|Protocol Violation|2|||
125441553|NCT01807221|451246781|FG002|Overall Study|Protocol Violation|1|||
125441554|NCT01807221|451246782|FG003|Overall Study|Protocol Violation|2|||
125441555|NCT01807221|451246783|FG004|Overall Study|Protocol Violation|0|||
125441556|NCT01807221|451246784|FG005|Overall Study|Protocol Violation|1|||
125441557|NCT01807221|451246779|FG000|Overall Study|Non-compliance|1|||
125441558|NCT01807221|451246780|FG001|Overall Study|Non-compliance|2|||
125441559|NCT01807221|451246781|FG002|Overall Study|Non-compliance|0|||
125441560|NCT01807221|451246782|FG003|Overall Study|Non-compliance|1|||
125441561|NCT01807221|451246783|FG004|Overall Study|Non-compliance|0|||
125441562|NCT01807221|451246784|FG005|Overall Study|Non-compliance|0|||
125441563|NCT01807221|451246779|FG000|Overall Study|Logistical difficulties|0|||
125441564|NCT01807221|451246780|FG001|Overall Study|Logistical difficulties|1|||
125441565|NCT01807221|451246781|FG002|Overall Study|Logistical difficulties|0|||
125441566|NCT01807221|451246782|FG003|Overall Study|Logistical difficulties|0|||
125441567|NCT01807221|451246783|FG004|Overall Study|Logistical difficulties|1|||
125441568|NCT01807221|451246784|FG005|Overall Study|Logistical difficulties|0|||
125441569|NCT01807221|451246779|FG000|Overall Study|Withdrawal by Subject|33|||
125441570|NCT01807221|451246780|FG001|Overall Study|Withdrawal by Subject|15|||
125164574|NCT02799095|450227743|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
125164575|NCT02799095|450227744|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
125164576|NCT02799095|450227745|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
125164577|NCT02799095|450227746|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
125164578|NCT02799095|450227747|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
125164579|NCT02799095|450227748|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
125164580|NCT02799095|450227749|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
125164581|NCT02799095|450227750|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
125164582|NCT02799095|450227751|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
125164583|NCT02799095|450227752|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
125164584|NCT02799095|450227753|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
125164585|NCT02799095|450227754|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
125164586|NCT02799095|450227755|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
125164587|NCT02799095|450227756|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
125164588|NCT02799095|450227757|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
125164589|NCT02799095|450227758|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
125164590|NCT02799095|450227759|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
125164591|NCT02799095|450227743|FG000|Part C|Adverse Event|0|||
125164592|NCT02799095|450227744|FG001|Part C|Adverse Event|0|||
125164593|NCT02799095|450227745|FG002|Part C|Adverse Event|0|||
125164594|NCT02799095|450227746|FG003|Part C|Adverse Event|0|||
125164595|NCT02799095|450227747|FG004|Part C|Adverse Event|0|||
125164596|NCT02799095|450227748|FG005|Part C|Adverse Event|0|||
125164597|NCT02799095|450227749|FG006|Part C|Adverse Event|0|||
125164598|NCT02799095|450227750|FG007|Part C|Adverse Event|0|||
125164599|NCT02799095|450227751|FG008|Part C|Adverse Event|0|||
125164600|NCT02799095|450227752|FG009|Part C|Adverse Event|0|||
125164601|NCT02799095|450227753|FG010|Part C|Adverse Event|3|||
125164602|NCT02799095|450227754|FG011|Part C|Adverse Event|1|||
125164603|NCT02799095|450227755|FG012|Part C|Adverse Event|0|||
125164604|NCT02799095|450227756|FG013|Part C|Adverse Event|1|||
125164605|NCT02799095|450227757|FG014|Part C|Adverse Event|0|||
125164606|NCT02799095|450227758|FG015|Part C|Adverse Event|0|||
125164607|NCT02799095|450227759|FG016|Part C|Adverse Event|0|||
125164608|NCT02799095|450227743|FG000|Part C|Death|0|||
125164609|NCT02799095|450227744|FG001|Part C|Death|0|||
125164610|NCT02799095|450227745|FG002|Part C|Death|0|||
125164611|NCT02799095|450227746|FG003|Part C|Death|0|||
125164612|NCT02799095|450227747|FG004|Part C|Death|0|||
125164613|NCT02799095|450227748|FG005|Part C|Death|0|||
125164614|NCT02799095|450227749|FG006|Part C|Death|0|||
125164615|NCT02799095|450227750|FG007|Part C|Death|0|||
125164616|NCT02799095|450227751|FG008|Part C|Death|0|||
125164617|NCT02799095|450227752|FG009|Part C|Death|0|||
125164618|NCT02799095|450227753|FG010|Part C|Death|7|||
125164619|NCT02799095|450227754|FG011|Part C|Death|5|||
125164620|NCT02799095|450227755|FG012|Part C|Death|6|||
125164621|NCT02799095|450227756|FG013|Part C|Death|8|||
125164622|NCT02799095|450227757|FG014|Part C|Death|1|||
125164623|NCT02799095|450227758|FG015|Part C|Death|8|||
125164624|NCT02799095|450227759|FG016|Part C|Death|1|||
125164625|NCT02799095|450227743|FG000|Part C|Lost to Follow-up|0|||
125164626|NCT02799095|450227744|FG001|Part C|Lost to Follow-up|0|||
125164627|NCT02799095|450227745|FG002|Part C|Lost to Follow-up|0|||
125391663|NCT01928862|451068609|FG000|Overall Study|Lost to Follow-up|1|||
125164628|NCT02799095|450227746|FG003|Part C|Lost to Follow-up|0|||
125164629|NCT02799095|450227747|FG004|Part C|Lost to Follow-up|0|||
125164630|NCT02799095|450227748|FG005|Part C|Lost to Follow-up|0|||
125164631|NCT02799095|450227749|FG006|Part C|Lost to Follow-up|0|||
125164632|NCT02799095|450227750|FG007|Part C|Lost to Follow-up|0|||
125164633|NCT02799095|450227751|FG008|Part C|Lost to Follow-up|0|||
125164634|NCT02799095|450227752|FG009|Part C|Lost to Follow-up|0|||
125164635|NCT02799095|450227753|FG010|Part C|Lost to Follow-up|1|||
125164636|NCT02799095|450227754|FG011|Part C|Lost to Follow-up|1|||
125164637|NCT02799095|450227755|FG012|Part C|Lost to Follow-up|1|||
125164638|NCT02799095|450227756|FG013|Part C|Lost to Follow-up|3|||
125164639|NCT02799095|450227757|FG014|Part C|Lost to Follow-up|0|||
125164640|NCT02799095|450227758|FG015|Part C|Lost to Follow-up|0|||
125164641|NCT02799095|450227759|FG016|Part C|Lost to Follow-up|0|||
125391664|NCT01928862|451068610|FG001|Overall Study|Lost to Follow-up|0|||
125391665|NCT01928862|451068611|FG002|Overall Study|Lost to Follow-up|0|||
125391666|NCT01928862|451068612|FG003|Overall Study|Lost to Follow-up|0|||
125391667|NCT01928862|451068613|FG004|Overall Study|Lost to Follow-up|1|||
125391668|NCT01478321|451068614|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
125391669|NCT01478321|451068614|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
125391670|NCT01478321|451068614|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
125391671|NCT01478321|451068614|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
125391672|NCT01478321|451068614|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
125391673|NCT01478321|451068614|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
125391674|NCT01478321|451068614|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
125391675|NCT01478321|451068614|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
125391676|NCT04649164|451068615|FG000|Overall Study|Withdrawal by Subject|1|||
125391677|NCT04649164|451068616|FG001|Overall Study|Withdrawal by Subject|1|||
125164642|NCT02799095|450227743|FG000|Part C|Progressive Disease|0|||
125164643|NCT02799095|450227744|FG001|Part C|Progressive Disease|0|||
125164644|NCT02799095|450227745|FG002|Part C|Progressive Disease|0|||
125164645|NCT02799095|450227746|FG003|Part C|Progressive Disease|0|||
125164646|NCT02799095|450227747|FG004|Part C|Progressive Disease|0|||
125164647|NCT02799095|450227748|FG005|Part C|Progressive Disease|0|||
125164648|NCT02799095|450227749|FG006|Part C|Progressive Disease|0|||
125164649|NCT02799095|450227750|FG007|Part C|Progressive Disease|0|||
125164650|NCT02799095|450227751|FG008|Part C|Progressive Disease|0|||
125164651|NCT02799095|450227752|FG009|Part C|Progressive Disease|2|||
125164652|NCT02799095|450227753|FG010|Part C|Progressive Disease|13|||
125164653|NCT02799095|450227754|FG011|Part C|Progressive Disease|2|||
125164654|NCT02799095|450227755|FG012|Part C|Progressive Disease|0|||
125164655|NCT02799095|450227756|FG013|Part C|Progressive Disease|1|||
125164656|NCT02799095|450227757|FG014|Part C|Progressive Disease|0|||
125164657|NCT02799095|450227758|FG015|Part C|Progressive Disease|0|||
125164658|NCT02799095|450227759|FG016|Part C|Progressive Disease|0|||
125164659|NCT02799095|450227743|FG000|Part C|Clinical Progression|0|||
125164660|NCT02799095|450227744|FG001|Part C|Clinical Progression|0|||
125164661|NCT02799095|450227745|FG002|Part C|Clinical Progression|0|||
125164662|NCT02799095|450227746|FG003|Part C|Clinical Progression|0|||
125391678|NCT04649164|451068617|FG002|Overall Study|Withdrawal by Subject|2|||
125391679|NCT04649164|451068615|FG000|Overall Study|Participant's care recipient expired|0|||
125391680|NCT04649164|451068616|FG001|Overall Study|Participant's care recipient expired|0|||
125391681|NCT04649164|451068617|FG002|Overall Study|Participant's care recipient expired|2|||
125391682|NCT03168464|451068618|FG000|Overall Study|Death|9|||
125391683|NCT03168464|451068618|FG000|Overall Study|Progression of disease|6|||
125164663|NCT02799095|450227747|FG004|Part C|Clinical Progression|0|||
125164664|NCT02799095|450227748|FG005|Part C|Clinical Progression|0|||
125164665|NCT02799095|450227749|FG006|Part C|Clinical Progression|0|||
125164666|NCT02799095|450227750|FG007|Part C|Clinical Progression|0|||
125164667|NCT02799095|450227751|FG008|Part C|Clinical Progression|0|||
125164668|NCT02799095|450227752|FG009|Part C|Clinical Progression|1|||
125164669|NCT02799095|450227753|FG010|Part C|Clinical Progression|3|||
125164670|NCT02799095|450227754|FG011|Part C|Clinical Progression|0|||
125164671|NCT02799095|450227755|FG012|Part C|Clinical Progression|0|||
125164672|NCT02799095|450227756|FG013|Part C|Clinical Progression|1|||
125164673|NCT02799095|450227757|FG014|Part C|Clinical Progression|0|||
125164674|NCT02799095|450227758|FG015|Part C|Clinical Progression|0|||
125164675|NCT02799095|450227759|FG016|Part C|Clinical Progression|0|||
125164676|NCT02799095|450227743|FG000|Part C|Withdrawal by Subject|0|||
125164677|NCT02799095|450227744|FG001|Part C|Withdrawal by Subject|0|||
125164678|NCT02799095|450227745|FG002|Part C|Withdrawal by Subject|0|||
125164679|NCT02799095|450227746|FG003|Part C|Withdrawal by Subject|0|||
125164680|NCT02799095|450227747|FG004|Part C|Withdrawal by Subject|0|||
125164681|NCT02799095|450227748|FG005|Part C|Withdrawal by Subject|0|||
125164682|NCT02799095|450227749|FG006|Part C|Withdrawal by Subject|0|||
125164683|NCT02799095|450227750|FG007|Part C|Withdrawal by Subject|0|||
125164684|NCT02799095|450227751|FG008|Part C|Withdrawal by Subject|0|||
125164685|NCT02799095|450227752|FG009|Part C|Withdrawal by Subject|0|||
125164686|NCT02799095|450227753|FG010|Part C|Withdrawal by Subject|13|||
125164687|NCT02799095|450227754|FG011|Part C|Withdrawal by Subject|15|||
125164688|NCT02799095|450227755|FG012|Part C|Withdrawal by Subject|13|||
125164689|NCT02799095|450227756|FG013|Part C|Withdrawal by Subject|21|||
125164690|NCT02799095|450227757|FG014|Part C|Withdrawal by Subject|0|||
125164691|NCT02799095|450227758|FG015|Part C|Withdrawal by Subject|12|||
125164692|NCT02799095|450227759|FG016|Part C|Withdrawal by Subject|1|||
125164693|NCT02799095|450227743|FG000|Part C|Physician Decision|0|||
125164694|NCT02799095|450227744|FG001|Part C|Physician Decision|0|||
125164695|NCT02799095|450227745|FG002|Part C|Physician Decision|0|||
125164696|NCT02799095|450227746|FG003|Part C|Physician Decision|0|||
125164697|NCT02799095|450227747|FG004|Part C|Physician Decision|0|||
125164698|NCT02799095|450227748|FG005|Part C|Physician Decision|0|||
125164699|NCT02799095|450227749|FG006|Part C|Physician Decision|0|||
125164700|NCT02799095|450227750|FG007|Part C|Physician Decision|0|||
125164701|NCT02799095|450227751|FG008|Part C|Physician Decision|0|||
125164702|NCT02799095|450227752|FG009|Part C|Physician Decision|0|||
125391684|NCT02053753|451068619|FG000|Overall Study|Withdrawal by Subject|2|||
125391685|NCT02053753|451068620|FG001|Overall Study|Withdrawal by Subject|4|||
125391686|NCT02053753|451068619|FG000|Overall Study|Decision by Sponsor|1|||
125391687|NCT02053753|451068620|FG001|Overall Study|Decision by Sponsor|1|||
125391688|NCT02053753|451068619|FG000|Overall Study|Lost to Follow-up|4|||
125391689|NCT02053753|451068620|FG001|Overall Study|Lost to Follow-up|3|||
125164703|NCT02799095|450227753|FG010|Part C|Physician Decision|1|||
125164704|NCT02799095|450227754|FG011|Part C|Physician Decision|0|||
125164705|NCT02799095|450227755|FG012|Part C|Physician Decision|0|||
125164706|NCT02799095|450227756|FG013|Part C|Physician Decision|0|||
125164707|NCT02799095|450227757|FG014|Part C|Physician Decision|0|||
125164708|NCT02799095|450227758|FG015|Part C|Physician Decision|0|||
125164709|NCT02799095|450227759|FG016|Part C|Physician Decision|0|||
125164710|NCT02799095|450227743|FG000|Part C|Other|0|||
125164711|NCT02799095|450227744|FG001|Part C|Other|0|||
125391690|NCT00634088|451068625|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
125391691|NCT00634088|451068626|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
125391692|NCT00634088|451068627|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
125391693|NCT00634088|451068628|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
125391694|NCT00634088|451068625|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
125391695|NCT00634088|451068626|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
125391696|NCT00634088|451068627|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
125391697|NCT00634088|451068628|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
125391698|NCT00634088|451068625|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
125391699|NCT00634088|451068626|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
125391700|NCT00634088|451068627|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
125391701|NCT00634088|451068628|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
125391702|NCT00634088|451068625|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
125391703|NCT00634088|451068626|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
125391704|NCT00634088|451068627|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
125391705|NCT00634088|451068628|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
125391706|NCT00634088|451068625|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
125441571|NCT01807221|451246781|FG002|Overall Study|Withdrawal by Subject|8|||
125441572|NCT01807221|451246782|FG003|Overall Study|Withdrawal by Subject|14|||
125441573|NCT01807221|451246783|FG004|Overall Study|Withdrawal by Subject|16|||
125441574|NCT01807221|451246784|FG005|Overall Study|Withdrawal by Subject|13|||
125441575|NCT01807221|451246779|FG000|Overall Study|Sponsor decision|2|||
125441576|NCT01807221|451246780|FG001|Overall Study|Sponsor decision|0|||
125441577|NCT01807221|451246781|FG002|Overall Study|Sponsor decision|1|||
125441578|NCT01807221|451246782|FG003|Overall Study|Sponsor decision|1|||
125441579|NCT01807221|451246783|FG004|Overall Study|Sponsor decision|0|||
125164712|NCT02799095|450227745|FG002|Part C|Other|0|||
125164713|NCT02799095|450227746|FG003|Part C|Other|0|||
125164714|NCT02799095|450227747|FG004|Part C|Other|0|||
125164715|NCT02799095|450227748|FG005|Part C|Other|0|||
125164716|NCT02799095|450227749|FG006|Part C|Other|0|||
125164717|NCT02799095|450227750|FG007|Part C|Other|0|||
125164718|NCT02799095|450227751|FG008|Part C|Other|0|||
125164719|NCT02799095|450227752|FG009|Part C|Other|0|||
125164720|NCT02799095|450227753|FG010|Part C|Other|0|||
125164721|NCT02799095|450227754|FG011|Part C|Other|2|||
125164722|NCT02799095|450227755|FG012|Part C|Other|2|||
125164723|NCT02799095|450227756|FG013|Part C|Other|0|||
125164724|NCT02799095|450227757|FG014|Part C|Other|0|||
125164725|NCT02799095|450227758|FG015|Part C|Other|0|||
125164726|NCT02799095|450227759|FG016|Part C|Other|0|||
125164727|NCT04347122|450227760|FG000|Overall Study|Physician Decision|0|||
125164728|NCT04347122|450227761|FG001|Overall Study|Physician Decision|3|||
125164729|NCT04347122|450227762|FG002|Overall Study|Physician Decision|3|||
125164730|NCT04347122|450227763|FG003|Overall Study|Physician Decision|6|||
125164731|NCT04994483|450227764|FG000|Overall Study|Adverse Event|26|||
125164732|NCT04994483|450227765|FG001|Overall Study|Adverse Event|17|||
125164733|NCT04994483|450227764|FG000|Overall Study|Lost to Follow-up|6|||
125164734|NCT04994483|450227765|FG001|Overall Study|Lost to Follow-up|10|||
125164735|NCT04994483|450227764|FG000|Overall Study|Noncompliance with study drug|8|||
125164736|NCT04994483|450227765|FG001|Overall Study|Noncompliance with study drug|5|||
125164737|NCT04994483|450227764|FG000|Overall Study|Physician Decision|5|||
125164738|NCT04994483|450227765|FG001|Overall Study|Physician Decision|0|||
125164739|NCT04994483|450227764|FG000|Overall Study|Withdrawal by Subject|41|||
125164740|NCT04994483|450227765|FG001|Overall Study|Withdrawal by Subject|38|||
125164741|NCT04994483|450227764|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
125164742|NCT04994483|450227765|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
125164743|NCT04994483|450227764|FG000|Overall Study|Met stopping criteria|1|||
125164744|NCT04994483|450227765|FG001|Overall Study|Met stopping criteria|0|||
125164745|NCT04994483|450227764|FG000|Overall Study|Randomized in error, not treated|4|||
125164746|NCT04994483|450227765|FG001|Overall Study|Randomized in error, not treated|3|||
125164747|NCT04994483|450227764|FG000|Overall Study|Lack of a reliable study partner|0|||
125164748|NCT04994483|450227765|FG001|Overall Study|Lack of a reliable study partner|1|||
125164749|NCT04994483|450227764|FG000|Overall Study|Met MRI exclusion criteria|0|||
125164750|NCT04994483|450227765|FG001|Overall Study|Met MRI exclusion criteria|1|||
125164751|NCT03589768|450227770|FG000|Overall Study|Death|1|||
125164752|NCT03589768|450227771|FG001|Overall Study|Death|0|||
125164753|NCT03589768|450227772|FG002|Overall Study|Death|8|||
125164754|NCT03589768|450227773|FG003|Overall Study|Death|3|||
125164755|NCT03589768|450227770|FG000|Overall Study|Withdrawal by Subject|2|||
125164756|NCT03589768|450227771|FG001|Overall Study|Withdrawal by Subject|0|||
125164757|NCT03589768|450227772|FG002|Overall Study|Withdrawal by Subject|0|||
125164758|NCT03589768|450227773|FG003|Overall Study|Withdrawal by Subject|0|||
125164759|NCT03589768|450227770|FG000|Overall Study|Protocol Violation|1|||
125164760|NCT03589768|450227771|FG001|Overall Study|Protocol Violation|0|||
125441580|NCT01807221|451246784|FG005|Overall Study|Sponsor decision|0|||
125164761|NCT03589768|450227772|FG002|Overall Study|Protocol Violation|0|||
125164762|NCT03589768|450227773|FG003|Overall Study|Protocol Violation|0|||
125441581|NCT01807221|451246779|FG000|Overall Study|Lost to Follow-up|1|||
125164763|NCT03283319|450227774|FG000|Overall Study|Lost to Follow-up|5|||
125164764|NCT03283319|450227775|FG001|Overall Study|Lost to Follow-up|4|||
125164765|NCT03283319|450227776|FG002|Overall Study|Lost to Follow-up|5|||
125164766|NCT03283319|450227777|FG003|Overall Study|Lost to Follow-up|5|||
125164767|NCT03283319|450227778|FG004|Overall Study|Lost to Follow-up|4|||
125164768|NCT03283319|450227779|FG005|Overall Study|Lost to Follow-up|3|||
125164769|NCT03283319|450227774|FG000|Overall Study|Withdrawal by Subject|2|||
125164770|NCT03283319|450227775|FG001|Overall Study|Withdrawal by Subject|2|||
125164771|NCT03283319|450227776|FG002|Overall Study|Withdrawal by Subject|2|||
125164772|NCT03283319|450227777|FG003|Overall Study|Withdrawal by Subject|1|||
125164773|NCT03283319|450227778|FG004|Overall Study|Withdrawal by Subject|0|||
125164774|NCT03283319|450227779|FG005|Overall Study|Withdrawal by Subject|1|||
125164775|NCT03283319|450227774|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
125164776|NCT03283319|450227775|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
125164777|NCT03283319|450227776|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
125164778|NCT03283319|450227777|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
125164779|NCT03283319|450227778|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
125164780|NCT03283319|450227779|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
125164781|NCT00721630|450227780|FG000|Overall Study|Participant found to be ineligible|1|||
125164782|NCT00792935|450227781|FG000|Overall Study|Adverse Event|2|||
125164783|NCT00792935|450227782|FG001|Overall Study|Adverse Event|1|||
125164784|NCT00792935|450227781|FG000|Overall Study|Lost to Follow-up|0|||
125164785|NCT00792935|450227782|FG001|Overall Study|Lost to Follow-up|1|||
125164786|NCT00792935|450227781|FG000|Overall Study|Protocol Violation|2|||
125164787|NCT00792935|450227782|FG001|Overall Study|Protocol Violation|0|||
125164788|NCT00792935|450227781|FG000|Overall Study|Withdrawal by Subject|0|||
125164789|NCT00792935|450227782|FG001|Overall Study|Withdrawal by Subject|1|||
125164790|NCT03186781|450227783|FG000|Overall Study|Lost to Follow-up|0|||
125164791|NCT03186781|450227784|FG001|Overall Study|Lost to Follow-up|0|||
125164792|NCT03186781|450227785|FG002|Overall Study|Lost to Follow-up|1|||
125164793|NCT03186781|450227786|FG003|Overall Study|Lost to Follow-up|0|||
125164794|NCT03186781|450227787|FG004|Overall Study|Lost to Follow-up|1|||
125164795|NCT03186781|450227788|FG005|Overall Study|Lost to Follow-up|0|||
125164796|NCT03186781|450227783|FG000|Overall Study|Moved from Area|0|||
125164797|NCT03186781|450227784|FG001|Overall Study|Moved from Area|0|||
125164798|NCT03186781|450227785|FG002|Overall Study|Moved from Area|0|||
125164799|NCT03186781|450227786|FG003|Overall Study|Moved from Area|0|||
125164800|NCT03186781|450227787|FG004|Overall Study|Moved from Area|1|||
125164801|NCT03186781|450227788|FG005|Overall Study|Moved from Area|0|||
125164802|NCT03186781|450227783|FG000|Overall Study|Withdrawal by Subject|0|||
125164803|NCT03186781|450227784|FG001|Overall Study|Withdrawal by Subject|0|||
125164804|NCT03186781|450227785|FG002|Overall Study|Withdrawal by Subject|0|||
125164805|NCT03186781|450227786|FG003|Overall Study|Withdrawal by Subject|0|||
125164806|NCT03186781|450227787|FG004|Overall Study|Withdrawal by Subject|1|||
125164807|NCT03186781|450227788|FG005|Overall Study|Withdrawal by Subject|0|||
125164808|NCT04663295|450227789|FG000|Run-in Period|Withdrawal by Subject|3|||
125164809|NCT04663295|450227789|FG000|Overall Study Period|Pregnancy|1|||
125164810|NCT04663295|450227789|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
125164811|NCT03954834|450227790|FG000|Overall Study|Adverse Event|1|||
125164812|NCT03954834|450227791|FG001|Overall Study|Adverse Event|3|||
125164813|NCT03954834|450227792|FG002|Overall Study|Adverse Event|1|||
125164814|NCT03954834|450227793|FG003|Overall Study|Adverse Event|1|||
125164815|NCT03954834|450227790|FG000|Overall Study|Death|0|||
125164816|NCT03954834|450227791|FG001|Overall Study|Death|0|||
125164817|NCT03954834|450227792|FG002|Overall Study|Death|0|||
125164818|NCT03954834|450227793|FG003|Overall Study|Death|1|||
125164819|NCT03954834|450227790|FG000|Overall Study|Physician Decision|0|||
125164820|NCT03954834|450227791|FG001|Overall Study|Physician Decision|1|||
125164821|NCT03954834|450227792|FG002|Overall Study|Physician Decision|0|||
125164822|NCT03954834|450227793|FG003|Overall Study|Physician Decision|2|||
125164823|NCT03954834|450227790|FG000|Overall Study|Protocol Violation|1|||
125164824|NCT03954834|450227791|FG001|Overall Study|Protocol Violation|0|||
125164825|NCT03954834|450227792|FG002|Overall Study|Protocol Violation|0|||
125164826|NCT03954834|450227793|FG003|Overall Study|Protocol Violation|1|||
125164827|NCT03954834|450227790|FG000|Overall Study|Withdrawal by Subject|2|||
125164828|NCT03954834|450227791|FG001|Overall Study|Withdrawal by Subject|3|||
125164829|NCT03954834|450227792|FG002|Overall Study|Withdrawal by Subject|13|||
125164830|NCT03954834|450227793|FG003|Overall Study|Withdrawal by Subject|6|||
125164831|NCT03954834|450227790|FG000|Overall Study|Participant left the country|0|||
125164832|NCT03954834|450227791|FG001|Overall Study|Participant left the country|0|||
125164833|NCT03954834|450227792|FG002|Overall Study|Participant left the country|1|||
125164834|NCT03954834|450227793|FG003|Overall Study|Participant left the country|0|||
125164835|NCT03954834|450227790|FG000|Overall Study|Lost to Follow-up|3|||
125164836|NCT03954834|450227791|FG001|Overall Study|Lost to Follow-up|2|||
125164837|NCT03954834|450227792|FG002|Overall Study|Lost to Follow-up|3|||
125164838|NCT03954834|450227793|FG003|Overall Study|Lost to Follow-up|5|||
125164839|NCT02903030|450227796|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
125225526|NCT01249417|450454279|FG000|Randomised Population|Study treatment not received|0|||
125225527|NCT01249417|450454280|FG001|Randomised Population|Study treatment not received|0|||
125225528|NCT01249417|450454281|FG002|Randomised Population|Study treatment not received|2|||
125225529|NCT01249417|450454279|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
125225530|NCT01249417|450454280|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
125225531|NCT01249417|450454281|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
125225532|NCT01249417|450454279|FG000|Treatment Phase - ITT Population|Other|0|||
125225533|NCT01249417|450454280|FG001|Treatment Phase - ITT Population|Other|0|||
125225534|NCT01249417|450454281|FG002|Treatment Phase - ITT Population|Other|1|||
125225535|NCT01249417|450454279|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
125225536|NCT01249417|450454280|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
125225537|NCT01249417|450454281|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
125225538|NCT01249417|450454279|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
125225539|NCT01249417|450454280|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
125225540|NCT01249417|450454281|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
125225541|NCT01249417|450454279|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
125225542|NCT01249417|450454280|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
125225543|NCT01249417|450454281|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
125225544|NCT00126594|450454283|FG000|Overall Study|Ineligible|2|||
125225545|NCT00126594|450454284|FG001|Overall Study|Ineligible|0|||
125225546|NCT00126594|450454283|FG000|Overall Study|Withdrawal by Subject|0|||
125225547|NCT00126594|450454284|FG001|Overall Study|Withdrawal by Subject|4|||
125225548|NCT00126594|450454283|FG000|Overall Study|Physician Decision|1|||
125225549|NCT00126594|450454284|FG001|Overall Study|Physician Decision|3|||
125225550|NCT00126594|450454283|FG000|Overall Study|Adverse Event|7|||
125225551|NCT00126594|450454284|FG001|Overall Study|Adverse Event|5|||
125225552|NCT00126594|450454283|FG000|Overall Study|Non-compliance|0|||
125225553|NCT00126594|450454284|FG001|Overall Study|Non-compliance|1|||
125225554|NCT00126594|450454283|FG000|Overall Study|Disease Progression|29|||
125225555|NCT00126594|450454284|FG001|Overall Study|Disease Progression|24|||
125225556|NCT03769649|450454285|FG000|Overall Study|Lost to Follow-up|4|||
125225557|NCT01290718|450454288|FG000|Overall Study|Early termination of the study|4|||
125225558|NCT00243919|450454289|FG000|Overall Study|Death|3|||
125225559|NCT00243919|450454290|FG001|Overall Study|Death|4|||
125225560|NCT00243919|450454291|FG002|Overall Study|Death|6|||
125225561|NCT00243919|450454289|FG000|Overall Study|Withdrawal by Subject|6|||
125225562|NCT00243919|450454290|FG001|Overall Study|Withdrawal by Subject|6|||
125225563|NCT00243919|450454291|FG002|Overall Study|Withdrawal by Subject|2|||
125225564|NCT00243919|450454289|FG000|Overall Study|Lost to Follow-up|6|||
125225565|NCT00243919|450454290|FG001|Overall Study|Lost to Follow-up|7|||
125225566|NCT00243919|450454291|FG002|Overall Study|Lost to Follow-up|3|||
125225567|NCT00243919|450454289|FG000|Overall Study|Administrative Error|1|||
125225568|NCT00243919|450454290|FG001|Overall Study|Administrative Error|0|||
125225569|NCT00243919|450454291|FG002|Overall Study|Administrative Error|0|||
125225570|NCT00243919|450454289|FG000|Overall Study|Physician Decision|1|||
125225571|NCT00243919|450454290|FG001|Overall Study|Physician Decision|1|||
125225572|NCT00243919|450454291|FG002|Overall Study|Physician Decision|0|||
125225573|NCT02059239|450454294|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
125225574|NCT02059239|450454295|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
125225575|NCT02059239|450454294|FG000|Overall Study|Physician Decision|1|||
125225576|NCT02059239|450454295|FG001|Overall Study|Physician Decision|0|||
125225577|NCT01268267|450454296|FG000|Overall Study|Protocol Violation|1|||
125225578|NCT04919317|450454301|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
125225579|NCT04919317|450454302|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
125225580|NCT04919317|450454301|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
125225581|NCT04919317|450454302|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
125225582|NCT00230048|450454303|FG000|Overall Study|Lost to Follow-up|13|||
125225583|NCT00230048|450454304|FG001|Overall Study|Lost to Follow-up|18|||
125441582|NCT01807221|451246780|FG001|Overall Study|Lost to Follow-up|0|||
125441583|NCT01807221|451246781|FG002|Overall Study|Lost to Follow-up|2|||
125441584|NCT01807221|451246782|FG003|Overall Study|Lost to Follow-up|1|||
125225584|NCT00731822|450454309|FG000|Overall Study|Adverse Event|2|||
125225585|NCT00731822|450454310|FG001|Overall Study|Adverse Event|1|||
125225586|NCT00731822|450454309|FG000|Overall Study|Protocol Violation|1|||
125225587|NCT00731822|450454310|FG001|Overall Study|Protocol Violation|0|||
125225588|NCT00731822|450454309|FG000|Overall Study|Lost to Follow-up|1|||
125225589|NCT00731822|450454310|FG001|Overall Study|Lost to Follow-up|0|||
125225590|NCT02127658|450454316|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
125225591|NCT02127658|450454317|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
125225592|NCT02127658|450454316|FG000|Overall Study|Withdrawal by Subject|0|||
125225593|NCT02127658|450454317|FG001|Overall Study|Withdrawal by Subject|2|||
125225594|NCT02127658|450454316|FG000|Overall Study|Physician Decision|0|||
125225595|NCT02127658|450454317|FG001|Overall Study|Physician Decision|1|||
125441585|NCT01807221|451246783|FG004|Overall Study|Lost to Follow-up|0|||
125441586|NCT01807221|451246784|FG005|Overall Study|Lost to Follow-up|0|||
125441587|NCT02609659|451246785|FG000|Overall Study|Adverse Event|1|||
125441588|NCT02609659|451246785|FG000|Overall Study|Lost to Follow-up|6|||
125441589|NCT02609659|451246785|FG000|Overall Study|Other|1|||
125441590|NCT01155388|451246786|FG000|Overall Study|Adverse Event|1|||
125441591|NCT01155388|451246787|FG001|Overall Study|Adverse Event|0|||
125441592|NCT01004250|451246788|FG000|Induction Therapy Period|Adverse Event|10|||
125441593|NCT01004250|451246788|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
125441594|NCT01004250|451246788|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
125441595|NCT01004250|451246788|FG000|Induction Therapy Period|Physician Decision|2|||
125441596|NCT01004250|451246788|FG000|Maintenance Therapy Period|Adverse Event|15|||
125441597|NCT01004250|451246788|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
125441598|NCT01004250|451246788|FG000|Maintenance Therapy Period|Protocol Violation|1|||
125441599|NCT01004250|451246788|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
125441600|NCT01004250|451246788|FG000|Maintenance Therapy Period|Physician Decision|4|||
125441601|NCT01004250|451246788|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
125441602|NCT03943589|451246789|FG000|Overall Study|Death|1|||
125441603|NCT03943589|451246789|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
125441604|NCT00900627|451246790|FG000|Overall Study|Condition under investigation worsened|4|||
125441605|NCT00900627|451246791|FG001|Overall Study|Condition under investigation worsened|0|||
125441606|NCT00900627|451246792|FG002|Overall Study|Condition under investigation worsened|5|||
125441607|NCT00900627|451246793|FG003|Overall Study|Condition under investigation worsened|3|||
125225596|NCT01443858|450454318|FG000|Overall Study|Withdrawal by Subject|9|||
125225597|NCT01443858|450454319|FG001|Overall Study|Withdrawal by Subject|8|||
125225598|NCT01443858|450454320|FG002|Overall Study|Withdrawal by Subject|5|||
125225599|NCT01443858|450454318|FG000|Overall Study|Lack of Efficacy|1|||
125225600|NCT01443858|450454319|FG001|Overall Study|Lack of Efficacy|0|||
125225601|NCT01443858|450454320|FG002|Overall Study|Lack of Efficacy|0|||
125225602|NCT01443858|450454318|FG000|Overall Study|Lost to Follow-up|5|||
125225603|NCT01443858|450454319|FG001|Overall Study|Lost to Follow-up|5|||
125225604|NCT01443858|450454320|FG002|Overall Study|Lost to Follow-up|2|||
125225605|NCT03589807|450454321|FG000|Overall Study|Lost to Follow-up|0|||
125225606|NCT03589807|450454322|FG001|Overall Study|Lost to Follow-up|2|||
125225607|NCT03589807|450454323|FG002|Overall Study|Lost to Follow-up|2|||
125225608|NCT03589807|450454324|FG003|Overall Study|Lost to Follow-up|3|||
125225609|NCT03589807|450454325|FG004|Overall Study|Lost to Follow-up|1|||
125225610|NCT03589807|450454326|FG005|Overall Study|Lost to Follow-up|1|||
125225611|NCT03589807|450454321|FG000|Overall Study|Withdrawal by Subject|0|||
125225612|NCT03589807|450454322|FG001|Overall Study|Withdrawal by Subject|5|||
125225613|NCT03589807|450454323|FG002|Overall Study|Withdrawal by Subject|0|||
125225614|NCT03589807|450454324|FG003|Overall Study|Withdrawal by Subject|0|||
125225615|NCT03589807|450454325|FG004|Overall Study|Withdrawal by Subject|0|||
125225616|NCT03589807|450454326|FG005|Overall Study|Withdrawal by Subject|0|||
125225617|NCT03589807|450454321|FG000|Overall Study|Protocol Violation|0|||
125225618|NCT03589807|450454322|FG001|Overall Study|Protocol Violation|0|||
125225619|NCT03589807|450454323|FG002|Overall Study|Protocol Violation|0|||
125225620|NCT03589807|450454324|FG003|Overall Study|Protocol Violation|1|||
125225621|NCT03589807|450454325|FG004|Overall Study|Protocol Violation|0|||
125225622|NCT03589807|450454326|FG005|Overall Study|Protocol Violation|0|||
125225623|NCT03589807|450454321|FG000|Overall Study|Enrolled but treatment not administered|0|||
125225624|NCT03589807|450454322|FG001|Overall Study|Enrolled but treatment not administered|0|||
125225625|NCT03589807|450454323|FG002|Overall Study|Enrolled but treatment not administered|0|||
125225626|NCT03589807|450454324|FG003|Overall Study|Enrolled but treatment not administered|0|||
125225627|NCT03589807|450454325|FG004|Overall Study|Enrolled but treatment not administered|1|||
125225628|NCT03589807|450454326|FG005|Overall Study|Enrolled but treatment not administered|0|||
125225629|NCT01534273|450454327|FG000|Period 1|Physician Decision|0|||
125225630|NCT01534273|450454328|FG001|Period 1|Physician Decision|0|||
125225631|NCT01534273|450454329|FG002|Period 1|Physician Decision|0|||
125441608|NCT00900627|451246794|FG004|Overall Study|Condition under investigation worsened|0|||
125441609|NCT00900627|451246795|FG005|Overall Study|Condition under investigation worsened|0|||
125441610|NCT00900627|451246790|FG000|Overall Study|Withdrawal by Subject|1|||
125441611|NCT00900627|451246791|FG001|Overall Study|Withdrawal by Subject|0|||
125441612|NCT00900627|451246792|FG002|Overall Study|Withdrawal by Subject|1|||
125225632|NCT01534273|450454330|FG003|Period 1|Physician Decision|1|||
125225633|NCT01534273|450454331|FG004|Period 1|Physician Decision|0|||
125225634|NCT01534273|450454332|FG005|Period 1|Physician Decision|0|||
125225635|NCT01534273|450454333|FG006|Period 1|Physician Decision|0|||
125225636|NCT03586050|450454334|FG000|Overall Study|Death|3|||
125225637|NCT03586050|450454334|FG000|Overall Study|Withdrawal by Subject|2|||
125225638|NCT01435759|450454336|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
125225639|NCT01435759|450454337|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
125225640|NCT01435759|450454338|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
125225641|NCT01435759|450454339|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
125225642|NCT01435759|450454340|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
125441613|NCT00900627|451246793|FG003|Overall Study|Withdrawal by Subject|0|||
125441614|NCT00900627|451246794|FG004|Overall Study|Withdrawal by Subject|1|||
125164840|NCT02903030|450227797|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
125164841|NCT01502410|450227798|FG000|Overall Study|Adverse Event|1|||
125164842|NCT01502410|450227799|FG001|Overall Study|Adverse Event|2|||
125164843|NCT01502410|450227800|FG002|Overall Study|Adverse Event|0|||
125164844|NCT01502410|450227801|FG003|Overall Study|Adverse Event|0|||
125164845|NCT01502410|450227798|FG000|Overall Study|Lack of Efficacy|7|||
125164846|NCT01502410|450227799|FG001|Overall Study|Lack of Efficacy|7|||
125164847|NCT01502410|450227800|FG002|Overall Study|Lack of Efficacy|0|||
125164848|NCT01502410|450227801|FG003|Overall Study|Lack of Efficacy|0|||
125164849|NCT01502410|450227798|FG000|Overall Study|Physician Decision|0|||
125164850|NCT01502410|450227799|FG001|Overall Study|Physician Decision|1|||
125164851|NCT01502410|450227800|FG002|Overall Study|Physician Decision|0|||
125164852|NCT01502410|450227801|FG003|Overall Study|Physician Decision|0|||
125164853|NCT01502410|450227798|FG000|Overall Study|Withdrawal by Subject|2|||
125164854|NCT01502410|450227799|FG001|Overall Study|Withdrawal by Subject|0|||
125164855|NCT01502410|450227800|FG002|Overall Study|Withdrawal by Subject|0|||
125164856|NCT01502410|450227801|FG003|Overall Study|Withdrawal by Subject|0|||
125164857|NCT01284361|450227805|FG000|Overall Study|Withdrawal by Subject|1|||
125164858|NCT01284361|450227805|FG000|Overall Study|Protocol Violation|5|||
125164859|NCT01284361|450227805|FG000|Overall Study|Adverse Event|1|||
125164860|NCT01284361|450227805|FG000|Overall Study|Lost to Follow-up|2|||
125164861|NCT00663026|450227806|FG000|Overall Study|Lost to Follow-up|1|||
125164862|NCT00663026|450227807|FG001|Overall Study|Lost to Follow-up|0|||
125164863|NCT00663026|450227808|FG002|Overall Study|Lost to Follow-up|0|||
125164864|NCT00663026|450227806|FG000|Overall Study|Other|1|||
125164865|NCT00663026|450227807|FG001|Overall Study|Other|2|||
125164866|NCT00663026|450227808|FG002|Overall Study|Other|0|||
125164867|NCT00663026|450227806|FG000|Overall Study|Adverse Event|0|||
125164868|NCT00663026|450227807|FG001|Overall Study|Adverse Event|2|||
125164869|NCT00663026|450227808|FG002|Overall Study|Adverse Event|3|||
125164870|NCT00663026|450227806|FG000|Overall Study|Caregiver Request|0|||
125164871|NCT00663026|450227807|FG001|Overall Study|Caregiver Request|2|||
125164872|NCT00663026|450227808|FG002|Overall Study|Caregiver Request|0|||
125164873|NCT00663026|450227806|FG000|Overall Study|Withdrawal by Subject|0|||
125164874|NCT00663026|450227807|FG001|Overall Study|Withdrawal by Subject|0|||
125164875|NCT00663026|450227808|FG002|Overall Study|Withdrawal by Subject|1|||
125164876|NCT00754650|450227809|FG000|Overall Study|Disease Progression|2|||
125164877|NCT00805675|450227810|FG000|Overall Study|Adverse Event|0|||
125164878|NCT00805675|450227811|FG001|Overall Study|Adverse Event|0|||
125164879|NCT00805675|450227812|FG002|Overall Study|Adverse Event|1|||
125164880|NCT00325195|450227814|FG000|Randomized|Not dosed|5|||
125164881|NCT00325195|450227815|FG001|Randomized|Not dosed|5|||
125164882|NCT00325195|450227816|FG002|Randomized|Not dosed|3|||
125164883|NCT00325195|450227814|FG000|Received Intervention: ITT Population|Adverse Event|15|||
125164884|NCT00325195|450227815|FG001|Received Intervention: ITT Population|Adverse Event|17|||
125164885|NCT00325195|450227816|FG002|Received Intervention: ITT Population|Adverse Event|1|||
125164886|NCT00325195|450227814|FG000|Received Intervention: ITT Population|Death|3|||
125164887|NCT00325195|450227815|FG001|Received Intervention: ITT Population|Death|1|||
125164888|NCT00325195|450227816|FG002|Received Intervention: ITT Population|Death|0|||
125164889|NCT00325195|450227814|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
125164890|NCT00325195|450227815|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
125164891|NCT00325195|450227816|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
125164892|NCT00325195|450227814|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
125164893|NCT00325195|450227815|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
125164894|NCT00325195|450227816|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
125164895|NCT00325195|450227814|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
125164896|NCT00325195|450227815|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
125164897|NCT00325195|450227816|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
125164898|NCT00686075|450227818|FG000|Overall Study|Withdrawal by Subject|4|||
125164899|NCT00686075|450227819|FG001|Overall Study|Withdrawal by Subject|3|||
125164900|NCT00686075|450227820|FG002|Overall Study|Withdrawal by Subject|3|||
125164901|NCT00686075|450227821|FG003|Overall Study|Withdrawal by Subject|7|||
125164902|NCT00686075|450227822|FG004|Overall Study|Withdrawal by Subject|1|||
125164903|NCT00686075|450227823|FG005|Overall Study|Withdrawal by Subject|0|||
125164904|NCT00686075|450227824|FG006|Overall Study|Withdrawal by Subject|0|||
125164905|NCT00686075|450227825|FG007|Overall Study|Withdrawal by Subject|2|||
125164906|NCT00686075|450227826|FG008|Overall Study|Withdrawal by Subject|4|||
125164907|NCT00686075|450227827|FG009|Overall Study|Withdrawal by Subject|6|||
125164908|NCT00686075|450227818|FG000|Overall Study|Lost to Follow-up|3|||
125164909|NCT00686075|450227819|FG001|Overall Study|Lost to Follow-up|6|||
125164910|NCT00686075|450227820|FG002|Overall Study|Lost to Follow-up|3|||
125164911|NCT00686075|450227821|FG003|Overall Study|Lost to Follow-up|2|||
125391707|NCT00634088|451068626|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
125164912|NCT00686075|450227822|FG004|Overall Study|Lost to Follow-up|3|||
125164913|NCT00686075|450227823|FG005|Overall Study|Lost to Follow-up|3|||
125164914|NCT00686075|450227824|FG006|Overall Study|Lost to Follow-up|0|||
125225643|NCT01435759|450454341|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
125225644|NCT01435759|450454336|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
125225645|NCT01435759|450454337|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
125391708|NCT00634088|451068627|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
125164915|NCT00686075|450227825|FG007|Overall Study|Lost to Follow-up|0|||
125164916|NCT00686075|450227826|FG008|Overall Study|Lost to Follow-up|2|||
125164917|NCT00686075|450227827|FG009|Overall Study|Lost to Follow-up|3|||
125164918|NCT00686075|450227818|FG000|Overall Study|Other|1|||
125164919|NCT00686075|450227819|FG001|Overall Study|Other|1|||
125164920|NCT00686075|450227820|FG002|Overall Study|Other|0|||
125164921|NCT00686075|450227821|FG003|Overall Study|Other|0|||
125164922|NCT00686075|450227822|FG004|Overall Study|Other|0|||
125164923|NCT00686075|450227823|FG005|Overall Study|Other|0|||
125164924|NCT00686075|450227824|FG006|Overall Study|Other|0|||
125164925|NCT00686075|450227825|FG007|Overall Study|Other|0|||
125164926|NCT00686075|450227826|FG008|Overall Study|Other|0|||
125164927|NCT00686075|450227827|FG009|Overall Study|Other|1|||
125164928|NCT04715932|450227828|FG000|Overall Study|Lost to Follow-up|1|||
125164929|NCT04715932|450227829|FG001|Overall Study|Lost to Follow-up|0|||
125164930|NCT02740699|450227840|FG000|Overall Study|Lost to Follow-up|5|||
125164931|NCT02740699|450227840|FG000|Overall Study|Withdrawal by Subject|14|||
125164932|NCT02740699|450227840|FG000|Overall Study|Physician Decision|5|||
125164933|NCT03783039|450227842|FG000|Overall Study|Death|2|||
125164934|NCT03783039|450227843|FG001|Overall Study|Death|1|||
125164935|NCT01682863|450227844|FG000|Overall Study|Subject/guardian decision|19|||
125164936|NCT01682863|450227845|FG001|Overall Study|Subject/guardian decision|12|||
125164937|NCT01682863|450227846|FG002|Overall Study|Subject/guardian decision|10|||
125164938|NCT01682863|450227844|FG000|Overall Study|Lost to Follow-up|5|||
125164939|NCT01682863|450227845|FG001|Overall Study|Lost to Follow-up|1|||
125164940|NCT01682863|450227846|FG002|Overall Study|Lost to Follow-up|6|||
125164941|NCT01682863|450227844|FG000|Overall Study|Death|1|||
125164942|NCT01682863|450227845|FG001|Overall Study|Death|3|||
125164943|NCT01682863|450227846|FG002|Overall Study|Death|4|||
125164944|NCT01682863|450227844|FG000|Overall Study|Protocol deviation|1|||
125164945|NCT01682863|450227845|FG001|Overall Study|Protocol deviation|0|||
125164946|NCT01682863|450227846|FG002|Overall Study|Protocol deviation|1|||
125164947|NCT01682863|450227844|FG000|Overall Study|Technical problems|1|||
125164948|NCT01682863|450227845|FG001|Overall Study|Technical problems|0|||
125164949|NCT01682863|450227846|FG002|Overall Study|Technical problems|0|||
125164950|NCT01682863|450227844|FG000|Overall Study|Adverse Event|0|||
125164951|NCT01682863|450227845|FG001|Overall Study|Adverse Event|1|||
125164952|NCT01682863|450227846|FG002|Overall Study|Adverse Event|2|||
125164953|NCT01682863|450227844|FG000|Overall Study|Physician Decision|0|||
125164954|NCT01682863|450227845|FG001|Overall Study|Physician Decision|0|||
125164955|NCT01682863|450227846|FG002|Overall Study|Physician Decision|1|||
125164956|NCT00918138|450227847|FG000|Overall Study|Subject withdrew consent|1|||
125164957|NCT00918138|450227848|FG001|Overall Study|Subject withdrew consent|1|||
125164958|NCT00918138|450227847|FG000|Overall Study|Death|1|||
125164959|NCT00918138|450227848|FG001|Overall Study|Death|0|||
125164960|NCT00552578|450227852|FG000|Overall Study|Lost to Follow-up|1|||
125164961|NCT00552578|450227853|FG001|Overall Study|Lost to Follow-up|1|||
125164962|NCT01716715|450227854|FG000|Overall Study|Never Treated|2|||
125164963|NCT01716715|450227855|FG001|Overall Study|Never Treated|4|||
125164964|NCT04228783|450227856|FG000|Overall Study|Adverse Event|1|||
125164965|NCT04228783|450227857|FG001|Overall Study|Adverse Event|0|||
125164966|NCT04228783|450227858|FG002|Overall Study|Adverse Event|2|||
125164967|NCT04228783|450227859|FG003|Overall Study|Adverse Event|0|||
125164968|NCT04228783|450227860|FG004|Overall Study|Adverse Event|0|||
125164969|NCT04228783|450227861|FG005|Overall Study|Adverse Event|1|||
125164970|NCT04228783|450227856|FG000|Overall Study|Death|0|||
125164971|NCT04228783|450227857|FG001|Overall Study|Death|0|||
125164972|NCT04228783|450227858|FG002|Overall Study|Death|0|||
125164973|NCT04228783|450227859|FG003|Overall Study|Death|0|||
125164974|NCT04228783|450227860|FG004|Overall Study|Death|1|||
125164975|NCT04228783|450227861|FG005|Overall Study|Death|0|||
125164976|NCT04228783|450227856|FG000|Overall Study|Lost to Follow-up|36|||
125164977|NCT04228783|450227857|FG001|Overall Study|Lost to Follow-up|36|||
125164978|NCT04228783|450227858|FG002|Overall Study|Lost to Follow-up|28|||
125164979|NCT04228783|450227859|FG003|Overall Study|Lost to Follow-up|6|||
125164980|NCT04228783|450227860|FG004|Overall Study|Lost to Follow-up|14|||
125164981|NCT04228783|450227861|FG005|Overall Study|Lost to Follow-up|3|||
125164982|NCT04228783|450227856|FG000|Overall Study|Physician Decision|1|||
125164983|NCT04228783|450227857|FG001|Overall Study|Physician Decision|2|||
125164984|NCT04228783|450227858|FG002|Overall Study|Physician Decision|0|||
125164985|NCT04228783|450227859|FG003|Overall Study|Physician Decision|0|||
125164986|NCT04228783|450227860|FG004|Overall Study|Physician Decision|0|||
125164987|NCT04228783|450227861|FG005|Overall Study|Physician Decision|0|||
125164988|NCT04228783|450227856|FG000|Overall Study|Protocol Violation|0|||
125164989|NCT04228783|450227857|FG001|Overall Study|Protocol Violation|0|||
125164990|NCT04228783|450227858|FG002|Overall Study|Protocol Violation|0|||
125164991|NCT04228783|450227859|FG003|Overall Study|Protocol Violation|1|||
125164992|NCT04228783|450227860|FG004|Overall Study|Protocol Violation|0|||
125164993|NCT04228783|450227861|FG005|Overall Study|Protocol Violation|0|||
125164994|NCT04228783|450227856|FG000|Overall Study|Withdrawal by Subject|6|||
125164995|NCT04228783|450227857|FG001|Overall Study|Withdrawal by Subject|10|||
125164996|NCT04228783|450227858|FG002|Overall Study|Withdrawal by Subject|19|||
125164997|NCT04228783|450227859|FG003|Overall Study|Withdrawal by Subject|1|||
125164998|NCT04228783|450227860|FG004|Overall Study|Withdrawal by Subject|2|||
125164999|NCT04228783|450227861|FG005|Overall Study|Withdrawal by Subject|0|||
125165000|NCT04228783|450227856|FG000|Overall Study|Other|4|||
125165001|NCT04228783|450227857|FG001|Overall Study|Other|3|||
125165002|NCT04228783|450227858|FG002|Overall Study|Other|2|||
125165003|NCT04228783|450227859|FG003|Overall Study|Other|1|||
125165004|NCT04228783|450227860|FG004|Overall Study|Other|0|||
125165005|NCT04228783|450227861|FG005|Overall Study|Other|0|||
125165006|NCT00626392|450227862|FG000|Run-in Period|Adverse Event|0|||
125165007|NCT00626392|450227863|FG001|Run-in Period|Adverse Event|0|||
125165008|NCT00626392|450227864|FG002|Run-in Period|Adverse Event|1|||
125165009|NCT00626392|450227865|FG003|Run-in Period|Adverse Event|0|||
125165010|NCT00626392|450227866|FG004|Run-in Period|Adverse Event|1|||
125165011|NCT00626392|450227867|FG005|Run-in Period|Adverse Event|0|||
125165012|NCT00626392|450227862|FG000|Run-in Period|Withdrawal by Subject|0|||
125165013|NCT00626392|450227863|FG001|Run-in Period|Withdrawal by Subject|1|||
125165014|NCT00626392|450227864|FG002|Run-in Period|Withdrawal by Subject|1|||
125165015|NCT00626392|450227865|FG003|Run-in Period|Withdrawal by Subject|1|||
125165016|NCT00626392|450227866|FG004|Run-in Period|Withdrawal by Subject|3|||
125165017|NCT00626392|450227867|FG005|Run-in Period|Withdrawal by Subject|1|||
125165018|NCT00626392|450227862|FG000|Run-in Period|Noncompliance|1|||
125165019|NCT00626392|450227863|FG001|Run-in Period|Noncompliance|0|||
125165020|NCT00626392|450227864|FG002|Run-in Period|Noncompliance|1|||
125165021|NCT00626392|450227865|FG003|Run-in Period|Noncompliance|0|||
125165022|NCT00626392|450227866|FG004|Run-in Period|Noncompliance|0|||
125165023|NCT00626392|450227867|FG005|Run-in Period|Noncompliance|0|||
125165024|NCT00626392|450227862|FG000|Coadministration Period|Adverse Event|3|||
125165025|NCT00626392|450227863|FG001|Coadministration Period|Adverse Event|1|||
125165026|NCT00626392|450227864|FG002|Coadministration Period|Adverse Event|7|||
125165027|NCT00626392|450227865|FG003|Coadministration Period|Adverse Event|4|||
125165028|NCT00626392|450227866|FG004|Coadministration Period|Adverse Event|3|||
125165029|NCT00626392|450227867|FG005|Coadministration Period|Adverse Event|4|||
125165030|NCT00626392|450227862|FG000|Coadministration Period|Withdrawal by Subject|1|||
125165031|NCT00626392|450227863|FG001|Coadministration Period|Withdrawal by Subject|1|||
125165032|NCT00626392|450227864|FG002|Coadministration Period|Withdrawal by Subject|0|||
125165033|NCT00626392|450227865|FG003|Coadministration Period|Withdrawal by Subject|1|||
125165034|NCT00626392|450227866|FG004|Coadministration Period|Withdrawal by Subject|0|||
125165035|NCT00626392|450227867|FG005|Coadministration Period|Withdrawal by Subject|1|||
125165036|NCT00626392|450227862|FG000|Coadministration Period|Protocol Violation|0|||
125165037|NCT00626392|450227863|FG001|Coadministration Period|Protocol Violation|1|||
125165038|NCT00626392|450227864|FG002|Coadministration Period|Protocol Violation|0|||
125165039|NCT00626392|450227865|FG003|Coadministration Period|Protocol Violation|1|||
125165040|NCT00626392|450227866|FG004|Coadministration Period|Protocol Violation|1|||
125165041|NCT00626392|450227867|FG005|Coadministration Period|Protocol Violation|0|||
125165042|NCT00626392|450227862|FG000|Coadministration Period|Other|0|||
125165043|NCT00626392|450227863|FG001|Coadministration Period|Other|2|||
125165044|NCT00626392|450227864|FG002|Coadministration Period|Other|3|||
125165045|NCT00626392|450227865|FG003|Coadministration Period|Other|1|||
125165046|NCT00626392|450227866|FG004|Coadministration Period|Other|1|||
125165047|NCT00626392|450227867|FG005|Coadministration Period|Other|1|||
125165048|NCT03151811|450227870|FG000|Overall Study|Randomized But Not Treated|18|||
125165049|NCT03151811|450227871|FG001|Overall Study|Randomized But Not Treated|3|||
125165050|NCT03151811|450227870|FG000|Overall Study|Progressive Disease|130|||
125165051|NCT03151811|450227871|FG001|Overall Study|Progressive Disease|170|||
125165052|NCT03151811|450227870|FG000|Overall Study|Adverse Event|49|||
125165053|NCT03151811|450227871|FG001|Overall Study|Adverse Event|40|||
125165054|NCT03151811|450227870|FG000|Overall Study|Lack of Efficacy|6|||
125165055|NCT03151811|450227871|FG001|Overall Study|Lack of Efficacy|8|||
125165056|NCT03151811|450227870|FG000|Overall Study|Physician Decision|21|||
125165057|NCT03151811|450227871|FG001|Overall Study|Physician Decision|9|||
125165058|NCT03151811|450227870|FG000|Overall Study|Withdrawal by Subject|17|||
125165059|NCT03151811|450227871|FG001|Overall Study|Withdrawal by Subject|7|||
125165060|NCT03151811|450227870|FG000|Overall Study|Lost to Follow-up|0|||
125441615|NCT00900627|451246795|FG005|Overall Study|Withdrawal by Subject|2|||
125165061|NCT03151811|450227871|FG001|Overall Study|Lost to Follow-up|1|||
125165062|NCT03151811|450227870|FG000|Overall Study|Study Terminated by Sponsor|5|||
125165063|NCT03151811|450227871|FG001|Overall Study|Study Terminated by Sponsor|11|||
125165064|NCT01085734|450227872|FG000|Overall Study|Adverse Event|0|||
125165065|NCT01085734|450227873|FG001|Overall Study|Adverse Event|2|||
125165066|NCT01085734|450227872|FG000|Overall Study|Death|1|||
125441616|NCT00900627|451246790|FG000|Overall Study|Adverse Event|1|||
125441617|NCT00900627|451246791|FG001|Overall Study|Adverse Event|2|||
125441618|NCT00900627|451246792|FG002|Overall Study|Adverse Event|0|||
125441619|NCT00900627|451246793|FG003|Overall Study|Adverse Event|3|||
125441620|NCT00900627|451246794|FG004|Overall Study|Adverse Event|0|||
125441621|NCT00900627|451246795|FG005|Overall Study|Adverse Event|0|||
125441622|NCT00900627|451246790|FG000|Overall Study|Death|0|||
125441623|NCT00900627|451246791|FG001|Overall Study|Death|0|||
125441624|NCT00900627|451246792|FG002|Overall Study|Death|0|||
125441625|NCT00900627|451246793|FG003|Overall Study|Death|0|||
125441626|NCT00900627|451246794|FG004|Overall Study|Death|28|||
125441627|NCT00900627|451246795|FG005|Overall Study|Death|24|||
125441628|NCT00373295|451246796|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
125441629|NCT00373295|451246797|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
125441630|NCT00373295|451246798|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
125441631|NCT00373295|451246799|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
125441632|NCT00373295|451246800|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
125441633|NCT00373295|451246801|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
125441634|NCT00830947|451246802|FG000|Overall Study|Lost to Follow-up|4|||
125441635|NCT00830947|451246803|FG001|Overall Study|Lost to Follow-up|4|||
125441636|NCT00962585|451246808|FG000|Overall Study|Adverse Event|0|||
125441637|NCT00962585|451246809|FG001|Overall Study|Adverse Event|2|||
125441638|NCT00962585|451246810|FG002|Overall Study|Adverse Event|1|||
125441639|NCT00962585|451246811|FG003|Overall Study|Adverse Event|0|||
125441640|NCT00962585|451246808|FG000|Overall Study|Lost to Follow-up|3|||
125441641|NCT00962585|451246809|FG001|Overall Study|Lost to Follow-up|0|||
125441642|NCT00962585|451246810|FG002|Overall Study|Lost to Follow-up|1|||
125441643|NCT00962585|451246811|FG003|Overall Study|Lost to Follow-up|0|||
125441644|NCT00962585|451246808|FG000|Overall Study|Protocol Violation|0|||
125441645|NCT00962585|451246809|FG001|Overall Study|Protocol Violation|0|||
125441646|NCT00962585|451246810|FG002|Overall Study|Protocol Violation|1|||
125441647|NCT00962585|451246811|FG003|Overall Study|Protocol Violation|0|||
125441648|NCT00962585|451246808|FG000|Overall Study|Withdrawal by Subject|1|||
125441649|NCT00962585|451246809|FG001|Overall Study|Withdrawal by Subject|0|||
125441650|NCT00962585|451246810|FG002|Overall Study|Withdrawal by Subject|0|||
125441651|NCT00962585|451246811|FG003|Overall Study|Withdrawal by Subject|0|||
125441652|NCT00962585|451246808|FG000|Overall Study|Withdrew Consent|2|||
125441653|NCT00962585|451246809|FG001|Overall Study|Withdrew Consent|0|||
125441654|NCT00962585|451246810|FG002|Overall Study|Withdrew Consent|0|||
125441655|NCT00962585|451246811|FG003|Overall Study|Withdrew Consent|0|||
125441656|NCT00594906|451246814|FG000|Overall Study|Physician Decision|1|||
125441657|NCT00594906|451246815|FG001|Overall Study|Physician Decision|0|||
125441658|NCT00594906|451246814|FG000|Overall Study|Physician Decision|0|||
125165067|NCT01085734|450227873|FG001|Overall Study|Death|0|||
125165068|NCT01085734|450227872|FG000|Overall Study|Lost to Follow-up|0|||
125165069|NCT01085734|450227873|FG001|Overall Study|Lost to Follow-up|1|||
125165070|NCT01085734|450227872|FG000|Overall Study|Withdrawal by Subject|0|||
125165071|NCT01085734|450227873|FG001|Overall Study|Withdrawal by Subject|1|||
125165072|NCT01739348|450227874|FG000|Part I (Base Study)|Adverse Event|41|||
125165073|NCT01739348|450227875|FG001|Part I (Base Study)|Adverse Event|52|||
125165074|NCT01739348|450227876|FG002|Part I (Base Study)|Adverse Event|8|||
125165075|NCT01739348|450227877|FG003|Part I (Base Study)|Adverse Event|33|||
125391709|NCT00634088|451068628|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
125391710|NCT00634088|451068625|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
125391711|NCT00634088|451068626|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
125391712|NCT00634088|451068627|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
125391713|NCT00634088|451068628|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
125391714|NCT01987427|451068638|FG000|Overall Study|Adverse Event|4|||
125391715|NCT01987427|451068639|FG001|Overall Study|Adverse Event|2|||
125391716|NCT01987427|451068640|FG002|Overall Study|Adverse Event|8|||
125391717|NCT01987427|451068638|FG000|Overall Study|Lost to Follow-up|6|||
125391718|NCT01987427|451068639|FG001|Overall Study|Lost to Follow-up|6|||
125391719|NCT01987427|451068640|FG002|Overall Study|Lost to Follow-up|9|||
125391720|NCT01987427|451068638|FG000|Overall Study|Withdrawal by Subject|2|||
125441659|NCT00594906|451246815|FG001|Overall Study|Physician Decision|1|||
125441660|NCT00594906|451246814|FG000|Overall Study|Death|0|||
125441661|NCT00594906|451246815|FG001|Overall Study|Death|1|||
125441662|NCT04430335|451246821|FG000|Overall Study|Withdrawal by Subject|1|||
125441663|NCT02564055|451246822|FG000|Overall Study|Adverse Event|1|||
125441664|NCT02564055|451246823|FG001|Overall Study|Adverse Event|0|||
125441665|NCT02564055|451246824|FG002|Overall Study|Adverse Event|4|||
125391721|NCT01987427|451068639|FG001|Overall Study|Withdrawal by Subject|1|||
125391722|NCT01987427|451068640|FG002|Overall Study|Withdrawal by Subject|3|||
125441666|NCT02564055|451246825|FG003|Overall Study|Adverse Event|1|||
125441667|NCT02564055|451246826|FG004|Overall Study|Adverse Event|4|||
125165076|NCT01739348|450227874|FG000|Part I (Base Study)|Death|10|||
125165077|NCT01739348|450227875|FG001|Part I (Base Study)|Death|7|||
125441668|NCT02564055|451246827|FG005|Overall Study|Adverse Event|1|||
125441669|NCT02564055|451246822|FG000|Overall Study|Protocol Violation|1|||
125441670|NCT02564055|451246823|FG001|Overall Study|Protocol Violation|0|||
125441671|NCT02564055|451246824|FG002|Overall Study|Protocol Violation|0|||
125441672|NCT02564055|451246825|FG003|Overall Study|Protocol Violation|0|||
125441673|NCT02564055|451246826|FG004|Overall Study|Protocol Violation|0|||
125441674|NCT02564055|451246827|FG005|Overall Study|Protocol Violation|0|||
125441675|NCT02564055|451246822|FG000|Overall Study|Reached stopping criteria|0|||
125441676|NCT02564055|451246823|FG001|Overall Study|Reached stopping criteria|0|||
125441677|NCT02564055|451246824|FG002|Overall Study|Reached stopping criteria|0|||
125441678|NCT02564055|451246825|FG003|Overall Study|Reached stopping criteria|0|||
125441679|NCT02564055|451246826|FG004|Overall Study|Reached stopping criteria|0|||
125441680|NCT02564055|451246827|FG005|Overall Study|Reached stopping criteria|1|||
125441681|NCT02564055|451246822|FG000|Overall Study|Lost to Follow-up|0|||
125441682|NCT02564055|451246823|FG001|Overall Study|Lost to Follow-up|1|||
125441683|NCT02564055|451246824|FG002|Overall Study|Lost to Follow-up|4|||
125441684|NCT02564055|451246825|FG003|Overall Study|Lost to Follow-up|2|||
125441685|NCT02564055|451246826|FG004|Overall Study|Lost to Follow-up|1|||
125441686|NCT02564055|451246827|FG005|Overall Study|Lost to Follow-up|0|||
125441687|NCT02564055|451246822|FG000|Overall Study|Physician Decision|0|||
125441688|NCT02564055|451246823|FG001|Overall Study|Physician Decision|0|||
125441689|NCT02564055|451246824|FG002|Overall Study|Physician Decision|1|||
125441690|NCT02564055|451246825|FG003|Overall Study|Physician Decision|0|||
125441691|NCT02564055|451246826|FG004|Overall Study|Physician Decision|0|||
125441692|NCT02564055|451246827|FG005|Overall Study|Physician Decision|0|||
125441693|NCT02564055|451246822|FG000|Overall Study|Withdrawal by Subject|4|||
125441694|NCT02564055|451246823|FG001|Overall Study|Withdrawal by Subject|4|||
125441695|NCT02564055|451246824|FG002|Overall Study|Withdrawal by Subject|3|||
125441696|NCT02564055|451246825|FG003|Overall Study|Withdrawal by Subject|3|||
125441697|NCT02564055|451246826|FG004|Overall Study|Withdrawal by Subject|10|||
125441698|NCT02564055|451246827|FG005|Overall Study|Withdrawal by Subject|10|||
125441699|NCT04747275|451246828|FG000|Overall Study|Study terminated|0|||
125441700|NCT04747275|451246829|FG001|Overall Study|Study terminated|1|||
125441701|NCT00531011|451246832|FG000|Overall Study|Withdrawal by Subject|2|||
125441702|NCT00531011|451246833|FG001|Overall Study|Withdrawal by Subject|4|||
125441703|NCT00531011|451246832|FG000|Overall Study|Death|1|||
125441704|NCT00531011|451246833|FG001|Overall Study|Death|0|||
125441705|NCT00531011|451246832|FG000|Overall Study|Lost to Follow-up|1|||
125441706|NCT00531011|451246833|FG001|Overall Study|Lost to Follow-up|0|||
125165078|NCT01739348|450227876|FG002|Part I (Base Study)|Death|2|||
125165079|NCT01739348|450227877|FG003|Part I (Base Study)|Death|8|||
125165080|NCT01739348|450227874|FG000|Part I (Base Study)|Lack of Efficacy|3|||
125165081|NCT01739348|450227875|FG001|Part I (Base Study)|Lack of Efficacy|8|||
125165082|NCT01739348|450227876|FG002|Part I (Base Study)|Lack of Efficacy|0|||
125165083|NCT01739348|450227877|FG003|Part I (Base Study)|Lack of Efficacy|7|||
125165084|NCT01739348|450227874|FG000|Part I (Base Study)|Lost to Follow-up|4|||
125165085|NCT01739348|450227875|FG001|Part I (Base Study)|Lost to Follow-up|2|||
125165086|NCT01739348|450227876|FG002|Part I (Base Study)|Lost to Follow-up|4|||
125165087|NCT01739348|450227877|FG003|Part I (Base Study)|Lost to Follow-up|4|||
125165088|NCT01739348|450227874|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
125165089|NCT01739348|450227875|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
125165090|NCT01739348|450227876|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
125165091|NCT01739348|450227877|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
125165092|NCT01739348|450227874|FG000|Part I (Base Study)|Physician Decision|10|||
125165093|NCT01739348|450227875|FG001|Part I (Base Study)|Physician Decision|7|||
125165094|NCT01739348|450227876|FG002|Part I (Base Study)|Physician Decision|1|||
125165095|NCT01739348|450227877|FG003|Part I (Base Study)|Physician Decision|4|||
125165096|NCT01739348|450227874|FG000|Part I (Base Study)|Protocol Violation|2|||
125165097|NCT01739348|450227875|FG001|Part I (Base Study)|Protocol Violation|0|||
125165098|NCT01739348|450227876|FG002|Part I (Base Study)|Protocol Violation|1|||
125165099|NCT01739348|450227877|FG003|Part I (Base Study)|Protocol Violation|2|||
125165100|NCT01739348|450227874|FG000|Part I (Base Study)|Screen Failure|2|||
125165101|NCT01739348|450227875|FG001|Part I (Base Study)|Screen Failure|0|||
125165102|NCT01739348|450227876|FG002|Part I (Base Study)|Screen Failure|0|||
125165103|NCT01739348|450227877|FG003|Part I (Base Study)|Screen Failure|0|||
125165104|NCT01739348|450227874|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
125165105|NCT01739348|450227875|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
125165106|NCT01739348|450227876|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
125165107|NCT01739348|450227877|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
125165108|NCT01739348|450227874|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
125165109|NCT01739348|450227875|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
125165110|NCT01739348|450227876|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
125165111|NCT01739348|450227877|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
125165112|NCT01739348|450227874|FG000|Part I (Base Study)|Participant Moved|4|||
125165113|NCT01739348|450227875|FG001|Part I (Base Study)|Participant Moved|3|||
125165114|NCT01739348|450227876|FG002|Part I (Base Study)|Participant Moved|1|||
125165115|NCT01739348|450227877|FG003|Part I (Base Study)|Participant Moved|7|||
125225646|NCT01435759|450454338|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
125225647|NCT01435759|450454339|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
125225648|NCT01435759|450454340|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
125225649|NCT01435759|450454341|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
125225650|NCT01435759|450454336|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
125225651|NCT01435759|450454337|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125225652|NCT01435759|450454338|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125225653|NCT01435759|450454339|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125225654|NCT01435759|450454340|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125225655|NCT01435759|450454341|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
125225656|NCT01435759|450454336|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
125225657|NCT01435759|450454337|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125225658|NCT01435759|450454338|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125225659|NCT01435759|450454339|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125225660|NCT01435759|450454340|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125225661|NCT01435759|450454341|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
125225662|NCT01435759|450454336|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
125225663|NCT01435759|450454337|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225664|NCT01435759|450454338|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225665|NCT01435759|450454339|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225666|NCT01435759|450454340|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225667|NCT01435759|450454341|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225668|NCT01435759|450454336|FG000|Antidepressant Lead-in Phase|Other|119|||
125225669|NCT01435759|450454337|FG001|Antidepressant Lead-in Phase|Other|0|||
125225670|NCT01435759|450454338|FG002|Antidepressant Lead-in Phase|Other|0|||
125225671|NCT01435759|450454339|FG003|Antidepressant Lead-in Phase|Other|0|||
125225672|NCT01435759|450454340|FG004|Antidepressant Lead-in Phase|Other|0|||
125225673|NCT01435759|450454341|FG005|Antidepressant Lead-in Phase|Other|0|||
125225674|NCT01435759|450454336|FG000|Double-blind Phase|Adverse Event|7|||
125225675|NCT01435759|450454337|FG001|Double-blind Phase|Adverse Event|0|||
125225676|NCT01435759|450454338|FG002|Double-blind Phase|Adverse Event|1|||
125225677|NCT01435759|450454339|FG003|Double-blind Phase|Adverse Event|1|||
125225678|NCT01435759|450454340|FG004|Double-blind Phase|Adverse Event|1|||
125225679|NCT01435759|450454341|FG005|Double-blind Phase|Adverse Event|3|||
125225680|NCT01435759|450454336|FG000|Double-blind Phase|Protocol Violation|2|||
125225681|NCT01435759|450454337|FG001|Double-blind Phase|Protocol Violation|0|||
125225682|NCT01435759|450454338|FG002|Double-blind Phase|Protocol Violation|1|||
125225683|NCT01435759|450454339|FG003|Double-blind Phase|Protocol Violation|2|||
125225684|NCT01435759|450454340|FG004|Double-blind Phase|Protocol Violation|0|||
125225685|NCT01435759|450454341|FG005|Double-blind Phase|Protocol Violation|1|||
125225686|NCT01435759|450454336|FG000|Double-blind Phase|Withdrawal by Subject|17|||
125225687|NCT01435759|450454337|FG001|Double-blind Phase|Withdrawal by Subject|4|||
125225688|NCT01435759|450454338|FG002|Double-blind Phase|Withdrawal by Subject|3|||
125225689|NCT01435759|450454339|FG003|Double-blind Phase|Withdrawal by Subject|4|||
125225690|NCT01435759|450454340|FG004|Double-blind Phase|Withdrawal by Subject|2|||
125225691|NCT01435759|450454341|FG005|Double-blind Phase|Withdrawal by Subject|2|||
125225692|NCT01435759|450454336|FG000|Double-blind Phase|Lost to Follow-up|31|||
125225693|NCT01435759|450454337|FG001|Double-blind Phase|Lost to Follow-up|1|||
125225694|NCT01435759|450454338|FG002|Double-blind Phase|Lost to Follow-up|2|||
125225695|NCT01435759|450454339|FG003|Double-blind Phase|Lost to Follow-up|0|||
125225696|NCT01435759|450454340|FG004|Double-blind Phase|Lost to Follow-up|3|||
125225697|NCT01435759|450454341|FG005|Double-blind Phase|Lost to Follow-up|3|||
125225698|NCT01435759|450454336|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
125225699|NCT01435759|450454337|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225700|NCT01435759|450454338|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225701|NCT01435759|450454339|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225702|NCT01435759|450454340|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
125225703|NCT01435759|450454341|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
125225704|NCT01435759|450454336|FG000|Double-blind Phase|Other|8|||
125225705|NCT01435759|450454337|FG001|Double-blind Phase|Other|2|||
125225706|NCT01435759|450454338|FG002|Double-blind Phase|Other|0|||
125225707|NCT01435759|450454339|FG003|Double-blind Phase|Other|2|||
125225708|NCT01435759|450454340|FG004|Double-blind Phase|Other|0|||
125225709|NCT01435759|450454341|FG005|Double-blind Phase|Other|0|||
125225710|NCT01211145|450454342|FG000|Overall Study|Reason not specified|3|||
125225711|NCT01211145|450454343|FG001|Overall Study|Reason not specified|2|||
125225712|NCT01211145|450454344|FG002|Overall Study|Reason not specified|2|||
125225713|NCT01211145|450454345|FG003|Overall Study|Reason not specified|1|||
125225714|NCT01211145|450454342|FG000|Overall Study|Lost to Follow-up|3|||
125225715|NCT01211145|450454343|FG001|Overall Study|Lost to Follow-up|2|||
125225716|NCT01211145|450454344|FG002|Overall Study|Lost to Follow-up|1|||
125225717|NCT01211145|450454345|FG003|Overall Study|Lost to Follow-up|2|||
125225718|NCT01211145|450454342|FG000|Overall Study|Study-specific withdrawal criteria|1|||
125441707|NCT00531011|451246832|FG000|Overall Study|Physician Decision|0|||
125165116|NCT01739348|450227874|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
125165117|NCT01739348|450227875|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
125165118|NCT01739348|450227876|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
125165119|NCT01739348|450227877|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
125165120|NCT01739348|450227874|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
125165121|NCT01739348|450227875|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
125165122|NCT01739348|450227876|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
125165123|NCT01739348|450227877|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
125165124|NCT01739348|450227874|FG000|Part II (Extension Study)|Adverse Event|10|||
125165125|NCT01739348|450227875|FG001|Part II (Extension Study)|Adverse Event|11|||
125165126|NCT01739348|450227876|FG002|Part II (Extension Study)|Adverse Event|7|||
125165127|NCT01739348|450227877|FG003|Part II (Extension Study)|Adverse Event|26|||
125165128|NCT01739348|450227874|FG000|Part II (Extension Study)|Death|3|||
125165129|NCT01739348|450227875|FG001|Part II (Extension Study)|Death|3|||
125165130|NCT01739348|450227876|FG002|Part II (Extension Study)|Death|2|||
125165131|NCT01739348|450227877|FG003|Part II (Extension Study)|Death|6|||
125165132|NCT01739348|450227874|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
125165133|NCT01739348|450227875|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
125165134|NCT01739348|450227876|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
125165135|NCT01739348|450227877|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
125165136|NCT01739348|450227874|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
125165137|NCT01739348|450227875|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
125165138|NCT01739348|450227876|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
125165139|NCT01739348|450227877|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
125165140|NCT01739348|450227874|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
125165141|NCT01739348|450227875|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
125165142|NCT01739348|450227876|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
125165143|NCT01739348|450227877|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
125165144|NCT01739348|450227874|FG000|Part II (Extension Study)|Physician Decision|7|||
125165145|NCT01739348|450227875|FG001|Part II (Extension Study)|Physician Decision|11|||
125165146|NCT01739348|450227876|FG002|Part II (Extension Study)|Physician Decision|6|||
125165147|NCT01739348|450227877|FG003|Part II (Extension Study)|Physician Decision|12|||
125165148|NCT01739348|450227874|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
125165149|NCT01739348|450227875|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
125165150|NCT01739348|450227876|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
125165151|NCT01739348|450227877|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
125165152|NCT01739348|450227874|FG000|Part II (Extension Study)|Participant Moved|3|||
125165153|NCT01739348|450227875|FG001|Part II (Extension Study)|Participant Moved|3|||
125165154|NCT01739348|450227876|FG002|Part II (Extension Study)|Participant Moved|0|||
125165155|NCT01739348|450227877|FG003|Part II (Extension Study)|Participant Moved|3|||
125165156|NCT01739348|450227874|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
125165157|NCT01739348|450227875|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
125165158|NCT01739348|450227876|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
125165159|NCT01739348|450227877|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
125165160|NCT01739348|450227874|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
125165161|NCT01739348|450227875|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
125165162|NCT01739348|450227876|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
125165163|NCT01739348|450227877|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
125165164|NCT01447420|450227881|FG000|Overall Study|Adverse Event|2|||
125165165|NCT01447420|450227882|FG001|Overall Study|Adverse Event|4|||
125165166|NCT01447420|450227883|FG002|Overall Study|Adverse Event|2|||
125165167|NCT01447420|450227881|FG000|Overall Study|Protocol Violation|3|||
125165168|NCT01447420|450227882|FG001|Overall Study|Protocol Violation|3|||
125165169|NCT01447420|450227883|FG002|Overall Study|Protocol Violation|0|||
125165170|NCT01447420|450227881|FG000|Overall Study|Withdrawal by Subject|4|||
125165171|NCT01447420|450227882|FG001|Overall Study|Withdrawal by Subject|1|||
125165172|NCT01447420|450227883|FG002|Overall Study|Withdrawal by Subject|0|||
125165173|NCT01447420|450227881|FG000|Overall Study|Lack of Efficacy|1|||
125165174|NCT01447420|450227882|FG001|Overall Study|Lack of Efficacy|19|||
125165175|NCT01447420|450227883|FG002|Overall Study|Lack of Efficacy|8|||
125165176|NCT04562155|450227884|FG000|Overall Study|COVID-19 pandemic|0|||
125165177|NCT04562155|450227885|FG001|Overall Study|COVID-19 pandemic|0|||
125165178|NCT04562155|450227886|FG002|Overall Study|COVID-19 pandemic|0|||
125165179|NCT04562155|450227887|FG003|Overall Study|COVID-19 pandemic|1|||
125165180|NCT04562155|450227884|FG000|Overall Study|Adverse Event|7|||
125165181|NCT04562155|450227885|FG001|Overall Study|Adverse Event|3|||
125165182|NCT04562155|450227886|FG002|Overall Study|Adverse Event|8|||
125165183|NCT04562155|450227887|FG003|Overall Study|Adverse Event|1|||
125165184|NCT04562155|450227884|FG000|Overall Study|Withdrawal by Subject|3|||
125165185|NCT04562155|450227885|FG001|Overall Study|Withdrawal by Subject|6|||
125165186|NCT04562155|450227886|FG002|Overall Study|Withdrawal by Subject|3|||
125441708|NCT00531011|451246833|FG001|Overall Study|Physician Decision|3|||
125441709|NCT02139982|451246834|FG000|Overall Study|Lack of Efficacy|0|||
125441710|NCT02139982|451246835|FG001|Overall Study|Lack of Efficacy|1|||
125441711|NCT02139982|451246836|FG002|Overall Study|Lack of Efficacy|0|||
125441712|NCT02139982|451246837|FG003|Overall Study|Lack of Efficacy|1|||
125441713|NCT02139982|451246838|FG004|Overall Study|Lack of Efficacy|0|||
125441714|NCT02139982|451246839|FG005|Overall Study|Lack of Efficacy|0|||
125441715|NCT02139982|451246840|FG006|Overall Study|Lack of Efficacy|0|||
125441716|NCT02139982|451246841|FG007|Overall Study|Lack of Efficacy|0|||
125441717|NCT02139982|451246842|FG008|Overall Study|Lack of Efficacy|0|||
125441718|NCT02139982|451246843|FG009|Overall Study|Lack of Efficacy|0|||
125441719|NCT04254679|451246874|FG000|Overall Study|Protocol Violation|1|||
125441720|NCT04254679|451246875|FG001|Overall Study|Protocol Violation|1|||
125441721|NCT04254679|451246874|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
125441722|NCT04254679|451246875|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
125441723|NCT02206152|451246880|FG000|Pre-Randomization|Withdrawal by Subject|2|||
125441724|NCT00478608|451246881|FG000|Overall Study|Adverse Event|1|||
125441725|NCT00478608|451246881|FG000|Overall Study|Serious Adverse Event|14|||
125441726|NCT00478608|451246881|FG000|Overall Study|Withdrawal by Subject|2|||
125441727|NCT00478608|451246881|FG000|Overall Study|Protocol Violation|3|||
125441728|NCT02080520|451246883|FG000|Overall Study|Self-reported symptoms|5|||
125441729|NCT02080520|451246884|FG001|Overall Study|Self-reported symptoms|6|||
125441730|NCT02080520|451246883|FG000|Overall Study|Unable to contact|2|||
125441731|NCT02080520|451246884|FG001|Overall Study|Unable to contact|1|||
125441732|NCT02080520|451246883|FG000|Overall Study|Initiated aspirin|2|||
125441733|NCT02080520|451246884|FG001|Overall Study|Initiated aspirin|0|||
125441734|NCT02080520|451246883|FG000|Overall Study|Atrial fibrillation|1|||
125441735|NCT02080520|451246884|FG001|Overall Study|Atrial fibrillation|1|||
125441736|NCT02080520|451246883|FG000|Overall Study|Cancer|1|||
125441737|NCT02080520|451246884|FG001|Overall Study|Cancer|2|||
125441738|NCT02080520|451246883|FG000|Overall Study|Not interested in study|1|||
125441739|NCT02080520|451246884|FG001|Overall Study|Not interested in study|3|||
125441740|NCT02080520|451246883|FG000|Overall Study|Too busy|1|||
125441741|NCT02080520|451246884|FG001|Overall Study|Too busy|1|||
125441742|NCT02080520|451246883|FG000|Overall Study|Work-related injury|1|||
125441743|NCT02080520|451246884|FG001|Overall Study|Work-related injury|0|||
125441744|NCT02080520|451246883|FG000|Overall Study|Personal reasons|0|||
125441745|NCT02080520|451246884|FG001|Overall Study|Personal reasons|3|||
125441746|NCT01394250|451246888|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
125441747|NCT01394250|451246889|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
125441748|NCT01394250|451246888|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
125441749|NCT01394250|451246889|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
125441750|NCT00432679|451246893|FG000|Overall Study|Adverse Event|2|||
125441751|NCT00432679|451246894|FG001|Overall Study|Adverse Event|1|||
125441752|NCT00432679|451246893|FG000|Overall Study|Withdrawal by Subject|3|||
125441753|NCT00432679|451246894|FG001|Overall Study|Withdrawal by Subject|2|||
125441754|NCT01177813|451246900|FG000|Overall Study|Adverse Event|8|||
125441755|NCT01177813|451246901|FG001|Overall Study|Adverse Event|2|||
125441756|NCT01177813|451246902|FG002|Overall Study|Adverse Event|4|||
125441757|NCT01177813|451246903|FG003|Overall Study|Adverse Event|6|||
125441758|NCT01177813|451246904|FG004|Overall Study|Adverse Event|3|||
125165187|NCT04562155|450227887|FG003|Overall Study|Withdrawal by Subject|3|||
125165188|NCT04562155|450227884|FG000|Overall Study|Participant personal reason|1|||
125165189|NCT04562155|450227885|FG001|Overall Study|Participant personal reason|0|||
125165190|NCT04562155|450227886|FG002|Overall Study|Participant personal reason|2|||
125165191|NCT04562155|450227887|FG003|Overall Study|Participant personal reason|1|||
125165192|NCT01268501|450227888|FG000|Overall Study|Lost to Follow-up|1|||
125165193|NCT01268501|450227888|FG000|Overall Study|Withdrawal by Subject|3|||
125165194|NCT01268501|450227888|FG000|Overall Study|Unacceptable Subjective Vision|3|||
125165195|NCT01268501|450227888|FG000|Overall Study|Handling Difficulties|2|||
125165196|NCT05293639|450227889|FG000|Overall Study|Withdrawal by Subject|1|||
125165197|NCT05293639|450227890|FG001|Overall Study|Withdrawal by Subject|1|||
125165198|NCT05293639|450227891|FG002|Overall Study|Withdrawal by Subject|2|||
125165199|NCT05293639|450227889|FG000|Overall Study|Death|0|||
125165200|NCT05293639|450227890|FG001|Overall Study|Death|1|||
125165201|NCT05293639|450227891|FG002|Overall Study|Death|0|||
125165202|NCT05293639|450227889|FG000|Overall Study|Lost to Follow-up|0|||
125165203|NCT05293639|450227890|FG001|Overall Study|Lost to Follow-up|0|||
125165204|NCT05293639|450227891|FG002|Overall Study|Lost to Follow-up|5|||
125165205|NCT05293639|450227889|FG000|Overall Study|Other|0|||
125165206|NCT05293639|450227890|FG001|Overall Study|Other|0|||
125225719|NCT01211145|450454343|FG001|Overall Study|Study-specific withdrawal criteria|0|||
125441759|NCT01177813|451246900|FG000|Overall Study|Lack of Efficacy|1|||
125441760|NCT01177813|451246901|FG001|Overall Study|Lack of Efficacy|0|||
125441761|NCT01177813|451246902|FG002|Overall Study|Lack of Efficacy|0|||
125441762|NCT01177813|451246903|FG003|Overall Study|Lack of Efficacy|0|||
125441763|NCT01177813|451246904|FG004|Overall Study|Lack of Efficacy|0|||
125441764|NCT01177813|451246900|FG000|Overall Study|Protocol Violation|3|||
125441765|NCT01177813|451246901|FG001|Overall Study|Protocol Violation|2|||
125441766|NCT01177813|451246902|FG002|Overall Study|Protocol Violation|2|||
125441767|NCT01177813|451246903|FG003|Overall Study|Protocol Violation|0|||
125441768|NCT01177813|451246904|FG004|Overall Study|Protocol Violation|1|||
125441769|NCT01177813|451246900|FG000|Overall Study|Lost to Follow-up|12|||
125441770|NCT01177813|451246901|FG001|Overall Study|Lost to Follow-up|5|||
125441771|NCT01177813|451246902|FG002|Overall Study|Lost to Follow-up|6|||
125441772|NCT01177813|451246903|FG003|Overall Study|Lost to Follow-up|3|||
125441773|NCT01177813|451246904|FG004|Overall Study|Lost to Follow-up|0|||
125441774|NCT01177813|451246900|FG000|Overall Study|Withdrawal by Subject|12|||
125441775|NCT01177813|451246901|FG001|Overall Study|Withdrawal by Subject|7|||
125441776|NCT01177813|451246902|FG002|Overall Study|Withdrawal by Subject|6|||
125441777|NCT01177813|451246903|FG003|Overall Study|Withdrawal by Subject|5|||
125441778|NCT01177813|451246904|FG004|Overall Study|Withdrawal by Subject|3|||
125441779|NCT01177813|451246900|FG000|Overall Study|Other reason not defined above|5|||
125441780|NCT01177813|451246901|FG001|Overall Study|Other reason not defined above|2|||
125441781|NCT01177813|451246902|FG002|Overall Study|Other reason not defined above|2|||
125441782|NCT01177813|451246903|FG003|Overall Study|Other reason not defined above|3|||
125441783|NCT01177813|451246904|FG004|Overall Study|Other reason not defined above|2|||
125441784|NCT00109928|451246907|FG000|Overall Study|Adverse Event|2|||
125441785|NCT00109928|451246907|FG000|Overall Study|Progression|6|||
125441786|NCT00109928|451246907|FG000|Overall Study|Death|2|||
125441787|NCT00109928|451246907|FG000|Overall Study|not protocol specified|2|||
125441788|NCT00109928|451246907|FG000|Overall Study|not eligible|1|||
125441789|NCT01196104|451246908|FG000|Overall Study|Lost to Follow-up|1|||
125441790|NCT01196104|451246909|FG001|Overall Study|Lost to Follow-up|0|||
125441791|NCT01196104|451246908|FG000|Overall Study|Physician Decision|0|||
125441792|NCT01196104|451246909|FG001|Overall Study|Physician Decision|1|||
125441793|NCT01196104|451246908|FG000|Overall Study|Withdrawal by Subject|3|||
125441794|NCT01196104|451246909|FG001|Overall Study|Withdrawal by Subject|3|||
125441795|NCT01196104|451246908|FG000|Overall Study|Various|0|||
125441796|NCT01196104|451246909|FG001|Overall Study|Various|1|||
125441797|NCT00610675|451246910|FG000|Overall Study|Untreated|4|||
125441798|NCT00610675|451246910|FG000|Overall Study|Adverse Event|67|||
125441799|NCT00610675|451246910|FG000|Overall Study|Insufficient Effect|31|||
125441800|NCT00610675|451246910|FG000|Overall Study|Withdrawal by Subject|28|||
125441801|NCT00610675|451246910|FG000|Overall Study|Reasons unrelated to trial|27|||
125441802|NCT00610675|451246910|FG000|Overall Study|Lack of Compliance|7|||
125441803|NCT00610675|451246910|FG000|Overall Study|Lost to Follow-up|31|||
125441804|NCT00610675|451246910|FG000|Overall Study|Other reason (not specified)|25|||
125441805|NCT01316692|451246913|FG000|Overall Study|Adverse Event|5|||
125441806|NCT01316692|451246913|FG000|Overall Study|Disease Progression|7|||
125441807|NCT00983619|451246914|FG000|Overall Study|Lost to Follow-up|0|||
125441808|NCT00983619|451246915|FG001|Overall Study|Lost to Follow-up|1|||
125441809|NCT00983619|451246916|FG002|Overall Study|Lost to Follow-up|0|||
125441810|NCT00983619|451246917|FG003|Overall Study|Lost to Follow-up|0|||
125441811|NCT00983619|451246918|FG004|Overall Study|Lost to Follow-up|0|||
125441812|NCT00983619|451246919|FG005|Overall Study|Lost to Follow-up|2|||
125441813|NCT00983619|451246920|FG006|Overall Study|Lost to Follow-up|0|||
125441814|NCT00983619|451246921|FG007|Overall Study|Lost to Follow-up|0|||
125441815|NCT00983619|451246922|FG008|Overall Study|Lost to Follow-up|0|||
125441816|NCT00983619|451246923|FG009|Overall Study|Lost to Follow-up|0|||
125441817|NCT00983619|451246924|FG010|Overall Study|Lost to Follow-up|0|||
125441818|NCT00983619|451246925|FG011|Overall Study|Lost to Follow-up|2|||
125441819|NCT00983619|451246914|FG000|Overall Study|Withdrawal by Subject|2|||
125441820|NCT00983619|451246915|FG001|Overall Study|Withdrawal by Subject|1|||
125441821|NCT00983619|451246916|FG002|Overall Study|Withdrawal by Subject|1|||
125441822|NCT00983619|451246917|FG003|Overall Study|Withdrawal by Subject|3|||
125441823|NCT00983619|451246918|FG004|Overall Study|Withdrawal by Subject|1|||
125441824|NCT00983619|451246919|FG005|Overall Study|Withdrawal by Subject|23|||
125441825|NCT00983619|451246920|FG006|Overall Study|Withdrawal by Subject|0|||
125441826|NCT00983619|451246921|FG007|Overall Study|Withdrawal by Subject|0|||
125441827|NCT00983619|451246922|FG008|Overall Study|Withdrawal by Subject|0|||
125441828|NCT00983619|451246923|FG009|Overall Study|Withdrawal by Subject|0|||
125441829|NCT00983619|451246924|FG010|Overall Study|Withdrawal by Subject|1|||
125441830|NCT00983619|451246925|FG011|Overall Study|Withdrawal by Subject|1|||
125225720|NCT01211145|450454344|FG002|Overall Study|Study-specific withdrawal criteria|0|||
125441831|NCT00983619|451246914|FG000|Overall Study|Death|0|||
125441832|NCT00983619|451246915|FG001|Overall Study|Death|2|||
125441833|NCT00983619|451246916|FG002|Overall Study|Death|2|||
125441834|NCT00983619|451246917|FG003|Overall Study|Death|1|||
125441835|NCT00983619|451246918|FG004|Overall Study|Death|2|||
125441836|NCT00983619|451246919|FG005|Overall Study|Death|30|||
125441837|NCT00983619|451246920|FG006|Overall Study|Death|1|||
125441838|NCT00983619|451246921|FG007|Overall Study|Death|0|||
125441839|NCT00983619|451246922|FG008|Overall Study|Death|1|||
125441840|NCT00983619|451246923|FG009|Overall Study|Death|2|||
125441841|NCT00983619|451246924|FG010|Overall Study|Death|9|||
125441842|NCT00983619|451246925|FG011|Overall Study|Death|8|||
125441843|NCT00983619|451246914|FG000|Overall Study|Other|1|||
125441844|NCT00983619|451246915|FG001|Overall Study|Other|0|||
125441845|NCT00983619|451246916|FG002|Overall Study|Other|0|||
125441846|NCT00983619|451246917|FG003|Overall Study|Other|1|||
125441847|NCT00983619|451246918|FG004|Overall Study|Other|0|||
125441848|NCT00983619|451246919|FG005|Overall Study|Other|12|||
125441849|NCT00983619|451246920|FG006|Overall Study|Other|2|||
125441850|NCT00983619|451246921|FG007|Overall Study|Other|2|||
125441851|NCT00983619|451246922|FG008|Overall Study|Other|0|||
125441852|NCT00983619|451246923|FG009|Overall Study|Other|1|||
125441853|NCT00983619|451246924|FG010|Overall Study|Other|1|||
125441854|NCT00983619|451246925|FG011|Overall Study|Other|0|||
125441855|NCT03772314|451246932|FG000|Overall Study|Adverse Event|7|||
125441856|NCT03772314|451246933|FG001|Overall Study|Adverse Event|2|||
125441857|NCT01536145|451246934|FG000|Overall Study|Progressive disease|3|||
125441858|NCT01536145|451246935|FG001|Overall Study|Progressive disease|4|||
125441859|NCT01536145|451246936|FG002|Overall Study|Progressive disease|1|||
125441860|NCT01536145|451246937|FG003|Overall Study|Progressive disease|2|||
125441861|NCT01536145|451246938|FG004|Overall Study|Progressive disease|1|||
125441862|NCT01536145|451246939|FG005|Overall Study|Progressive disease|2|||
125441863|NCT01536145|451246940|FG006|Overall Study|Progressive disease|1|||
125441864|NCT01536145|451246941|FG007|Overall Study|Progressive disease|2|||
125441865|NCT01536145|451246942|FG008|Overall Study|Progressive disease|1|||
125441866|NCT01536145|451246943|FG009|Overall Study|Progressive disease|3|||
125441867|NCT01536145|451246944|FG010|Overall Study|Progressive disease|3|||
125441868|NCT01536145|451246934|FG000|Overall Study|Withdrawal by Subject|0|||
125441869|NCT01536145|451246935|FG001|Overall Study|Withdrawal by Subject|0|||
125441870|NCT01536145|451246936|FG002|Overall Study|Withdrawal by Subject|1|||
125441871|NCT01536145|451246937|FG003|Overall Study|Withdrawal by Subject|0|||
125441872|NCT01536145|451246938|FG004|Overall Study|Withdrawal by Subject|0|||
125441873|NCT01536145|451246939|FG005|Overall Study|Withdrawal by Subject|1|||
125441874|NCT01536145|451246940|FG006|Overall Study|Withdrawal by Subject|0|||
125441875|NCT01536145|451246941|FG007|Overall Study|Withdrawal by Subject|0|||
125441876|NCT01536145|451246942|FG008|Overall Study|Withdrawal by Subject|2|||
125441877|NCT01536145|451246943|FG009|Overall Study|Withdrawal by Subject|0|||
125441878|NCT01536145|451246944|FG010|Overall Study|Withdrawal by Subject|2|||
125165207|NCT05293639|450227891|FG002|Overall Study|Other|1|||
125165208|NCT00827632|450227893|FG000|Overall Study|Lost to Follow-up|8|||
125165209|NCT00827632|450227894|FG001|Overall Study|Lost to Follow-up|12|||
125165210|NCT00827632|450227893|FG000|Overall Study|Early withdrawal|14|||
125165211|NCT00827632|450227894|FG001|Overall Study|Early withdrawal|11|||
125165212|NCT01910389|450227895|FG000|Overall Study|Withdrawal by Subject|2|||
125165213|NCT01910389|450227896|FG001|Overall Study|Withdrawal by Subject|0|||
125165214|NCT01910389|450227895|FG000|Overall Study|Study Closed|13|||
125165215|NCT01910389|450227896|FG001|Overall Study|Study Closed|8|||
125165216|NCT00407758|450227898|FG000|Overall Study|ineligible -improper prior treatment|1|||
125165217|NCT01458106|450227904|FG000|Overall Study|Withdrawal by Subject|2|||
125165218|NCT01458106|450227905|FG001|Overall Study|Withdrawal by Subject|0|||
125165219|NCT01458106|450227904|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
125165220|NCT01458106|450227905|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
125165221|NCT01458106|450227904|FG000|Overall Study|Withdrawn Per Protocol|0|||
125165222|NCT01458106|450227905|FG001|Overall Study|Withdrawn Per Protocol|1|||
125165223|NCT00073021|450227906|FG000|Overall Study|Protocol Violation|2|||
125165224|NCT00073021|450227907|FG001|Overall Study|Protocol Violation|1|||
125165225|NCT00073021|450227906|FG000|Overall Study|Adverse Event|4|||
125165226|NCT00073021|450227907|FG001|Overall Study|Adverse Event|4|||
125165227|NCT00073021|450227906|FG000|Overall Study|Withdrawal by Subject|6|||
125165228|NCT00073021|450227907|FG001|Overall Study|Withdrawal by Subject|5|||
125165229|NCT00073021|450227906|FG000|Overall Study|Physician Decision|3|||
125165230|NCT00073021|450227907|FG001|Overall Study|Physician Decision|1|||
125165231|NCT00073021|450227906|FG000|Overall Study|Lack of Efficacy|11|||
125165232|NCT00073021|450227907|FG001|Overall Study|Lack of Efficacy|5|||
125165233|NCT00855803|450227908|FG000|Overall Study|Death|2|||
125165234|NCT00855803|450227908|FG000|Overall Study|Lost to Follow-up|2|||
125165235|NCT00855803|450227908|FG000|Overall Study|Technical inability to undergo procedure|2|||
125165236|NCT00855803|450227908|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
125165237|NCT00855803|450227908|FG000|Overall Study|Withdrawal by Subject|3|||
125441879|NCT01536145|451246934|FG000|Overall Study|Other|0|||
125441880|NCT01536145|451246935|FG001|Overall Study|Other|0|||
125441881|NCT01536145|451246936|FG002|Overall Study|Other|0|||
125441882|NCT01536145|451246937|FG003|Overall Study|Other|0|||
125441883|NCT01536145|451246938|FG004|Overall Study|Other|1|||
125441884|NCT01536145|451246939|FG005|Overall Study|Other|0|||
125441885|NCT01536145|451246940|FG006|Overall Study|Other|0|||
125165238|NCT00855803|450227908|FG000|Overall Study|Physician Decision|3|||
125165239|NCT03276780|450227910|FG000|Overall Study|Withdrawal by Subject|5|||
125165240|NCT03276780|450227911|FG001|Overall Study|Withdrawal by Subject|3|||
125441886|NCT01536145|451246941|FG007|Overall Study|Other|0|||
125441887|NCT01536145|451246942|FG008|Overall Study|Other|0|||
125441888|NCT01536145|451246943|FG009|Overall Study|Other|3|||
125441889|NCT01536145|451246944|FG010|Overall Study|Other|2|||
125441890|NCT01536145|451246934|FG000|Overall Study|Death|0|||
125441891|NCT01536145|451246935|FG001|Overall Study|Death|0|||
125441892|NCT01536145|451246936|FG002|Overall Study|Death|0|||
125441893|NCT01536145|451246937|FG003|Overall Study|Death|0|||
125441894|NCT01536145|451246938|FG004|Overall Study|Death|0|||
125441895|NCT01536145|451246939|FG005|Overall Study|Death|0|||
125441896|NCT01536145|451246940|FG006|Overall Study|Death|1|||
125441897|NCT01536145|451246941|FG007|Overall Study|Death|0|||
125441898|NCT01536145|451246942|FG008|Overall Study|Death|0|||
125441899|NCT01536145|451246943|FG009|Overall Study|Death|0|||
125441900|NCT01536145|451246944|FG010|Overall Study|Death|0|||
125441901|NCT01536145|451246934|FG000|Overall Study|Adverse Event|0|||
125441902|NCT01536145|451246935|FG001|Overall Study|Adverse Event|0|||
125441903|NCT01536145|451246936|FG002|Overall Study|Adverse Event|0|||
125441904|NCT01536145|451246937|FG003|Overall Study|Adverse Event|0|||
125441905|NCT01536145|451246938|FG004|Overall Study|Adverse Event|0|||
125441906|NCT01536145|451246939|FG005|Overall Study|Adverse Event|0|||
125441907|NCT01536145|451246940|FG006|Overall Study|Adverse Event|0|||
125441908|NCT01536145|451246941|FG007|Overall Study|Adverse Event|2|||
125441909|NCT01536145|451246942|FG008|Overall Study|Adverse Event|0|||
125441910|NCT01536145|451246943|FG009|Overall Study|Adverse Event|0|||
125165241|NCT03276780|450227910|FG000|Overall Study|Lost to Follow-up|3|||
125441911|NCT01536145|451246944|FG010|Overall Study|Adverse Event|3|||
125441912|NCT01284140|451246949|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
125441913|NCT01284140|451246950|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
125441914|NCT01284140|451246949|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
125441915|NCT01284140|451246950|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
125441916|NCT00579982|451246951|FG000|Overall Study|Adverse Event|4|||
125441917|NCT00579982|451246951|FG000|Overall Study|Protocol Violation|4|||
125441918|NCT00088205|451246952|FG000|Overall Study|Adverse Event|4|||
125441919|NCT00088205|451246952|FG000|Overall Study|Progressive Disease|51|||
125441920|NCT00088205|451246952|FG000|Overall Study|Physician Decision|1|||
125441921|NCT00088205|451246952|FG000|Overall Study|Death Due to Study Disease|4|||
125441922|NCT03192215|451246953|FG000|Overall Study|Death|28|||
125441923|NCT03192215|451246954|FG001|Overall Study|Death|23|||
125441924|NCT03192215|451246953|FG000|Overall Study|Lost to Follow-up|10|||
125441925|NCT03192215|451246954|FG001|Overall Study|Lost to Follow-up|15|||
125441926|NCT03192215|451246953|FG000|Overall Study|Withdrawal by Subject|49|||
125441927|NCT03192215|451246954|FG001|Overall Study|Withdrawal by Subject|48|||
125441928|NCT03192215|451246953|FG000|Overall Study|Other as reported in analysis|4|||
125441929|NCT03192215|451246954|FG001|Overall Study|Other as reported in analysis|1|||
125441930|NCT05199233|451246957|FG000|Overall Study|Lack of Efficacy|1|||
125441931|NCT02443103|451246961|FG000|Overall Study|Adverse Event|2|||
125441932|NCT02443103|451246961|FG000|Overall Study|Noncompliance|1|||
125441933|NCT01630590|451246962|FG000|Overall Study|Adverse Event|9|||
125441934|NCT01630590|451246962|FG000|Overall Study|Lack of Efficacy|37|||
125441935|NCT01630590|451246962|FG000|Overall Study|Withdrawal by Subject|4|||
125441936|NCT01630590|451246962|FG000|Overall Study|2nd primary tumor|2|||
125441937|NCT01630590|451246962|FG000|Overall Study|Automobile accident|1|||
125441938|NCT01630590|451246962|FG000|Overall Study|Maximum benefit|4|||
125441939|NCT02366936|451246963|FG000|Overall Study|Withdrawal by Subject|2|||
125441940|NCT02366936|451246963|FG000|Overall Study|Lost to Follow-up|4|||
125441941|NCT02366936|451246963|FG000|Overall Study|Physician Decision|2|||
125441942|NCT03358329|451246966|FG000|Overall Study|Lost to Follow-up|2|||
125441943|NCT03358329|451246966|FG000|Overall Study|Withdrawal by Subject|2|||
125441944|NCT01313923|451246967|FG000|Overall Study|Physician Decision|3|||
125441945|NCT02471404|451246968|FG000|Overall Study|Adverse Event|7|||
125441946|NCT02471404|451246969|FG001|Overall Study|Adverse Event|1|||
125441947|NCT02471404|451246970|FG002|Overall Study|Adverse Event|2|||
125441948|NCT02471404|451246968|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
125441949|NCT02471404|451246969|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
125441950|NCT02471404|451246970|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
125441951|NCT02471404|451246968|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
125441952|NCT02471404|451246969|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
125441953|NCT02471404|451246970|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
125441954|NCT02471404|451246968|FG000|Overall Study|Lost to Follow-up|1|||
125441955|NCT02471404|451246969|FG001|Overall Study|Lost to Follow-up|1|||
125441956|NCT02471404|451246970|FG002|Overall Study|Lost to Follow-up|3|||
125441957|NCT02471404|451246968|FG000|Overall Study|Protocol Violation|1|||
125441958|NCT02471404|451246969|FG001|Overall Study|Protocol Violation|0|||
125441959|NCT02471404|451246970|FG002|Overall Study|Protocol Violation|0|||
125441960|NCT02471404|451246968|FG000|Overall Study|Withdrawal by Subject|8|||
125441961|NCT02471404|451246969|FG001|Overall Study|Withdrawal by Subject|4|||
125441962|NCT02471404|451246970|FG002|Overall Study|Withdrawal by Subject|5|||
125441963|NCT02471404|451246968|FG000|Overall Study|Other reasons not specified|10|||
125441964|NCT02471404|451246969|FG001|Overall Study|Other reasons not specified|7|||
125165242|NCT03276780|450227911|FG001|Overall Study|Lost to Follow-up|5|||
125441965|NCT02471404|451246970|FG002|Overall Study|Other reasons not specified|12|||
125165243|NCT03276780|450227910|FG000|Overall Study|Moved out of state|1|||
125441966|NCT02982720|451246971|FG000|Overall Study|Adverse Event|3|||
125441967|NCT02982720|451246971|FG000|Overall Study|Death|1|||
125441968|NCT02061761|451246974|FG000|Overall Study|Disease progression|2|||
125441969|NCT02061761|451246975|FG001|Overall Study|Disease progression|8|||
125441970|NCT02061761|451246976|FG002|Overall Study|Disease progression|4|||
125441971|NCT02061761|451246977|FG003|Overall Study|Disease progression|5|||
125441972|NCT02061761|451246978|FG004|Overall Study|Disease progression|9|||
125441973|NCT02061761|451246979|FG005|Overall Study|Disease progression|3|||
125441974|NCT02061761|451246980|FG006|Overall Study|Disease progression|1|||
125441975|NCT02061761|451246981|FG007|Overall Study|Disease progression|2|||
125441976|NCT02061761|451246982|FG008|Overall Study|Disease progression|28|||
125441977|NCT02061761|451246974|FG000|Overall Study|Study Drug toxicity|0|||
125441978|NCT02061761|451246975|FG001|Overall Study|Study Drug toxicity|0|||
125441979|NCT02061761|451246976|FG002|Overall Study|Study Drug toxicity|0|||
125441980|NCT02061761|451246977|FG003|Overall Study|Study Drug toxicity|0|||
125441981|NCT02061761|451246978|FG004|Overall Study|Study Drug toxicity|0|||
125441982|NCT02061761|451246979|FG005|Overall Study|Study Drug toxicity|1|||
125441983|NCT02061761|451246980|FG006|Overall Study|Study Drug toxicity|0|||
125441984|NCT02061761|451246981|FG007|Overall Study|Study Drug toxicity|2|||
125441985|NCT02061761|451246982|FG008|Overall Study|Study Drug toxicity|6|||
125441986|NCT02061761|451246974|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
125441987|NCT02061761|451246975|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
125441988|NCT02061761|451246976|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
125441989|NCT02061761|451246977|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
125441990|NCT02061761|451246978|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
125441991|NCT02061761|451246979|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
125441992|NCT02061761|451246980|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
125441993|NCT02061761|451246981|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
125441994|NCT02061761|451246982|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
125441995|NCT02061761|451246974|FG000|Overall Study|Participant request to discontinue study treatment|0|||
125441996|NCT02061761|451246975|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125441997|NCT02061761|451246976|FG002|Overall Study|Participant request to discontinue study treatment|2|||
125441998|NCT02061761|451246977|FG003|Overall Study|Participant request to discontinue study treatment|2|||
125441999|NCT02061761|451246978|FG004|Overall Study|Participant request to discontinue study treatment|0|||
125442000|NCT02061761|451246979|FG005|Overall Study|Participant request to discontinue study treatment|1|||
125442001|NCT02061761|451246980|FG006|Overall Study|Participant request to discontinue study treatment|0|||
125442002|NCT02061761|451246981|FG007|Overall Study|Participant request to discontinue study treatment|0|||
125442003|NCT02061761|451246982|FG008|Overall Study|Participant request to discontinue study treatment|2|||
125442004|NCT02061761|451246974|FG000|Overall Study|Withdrawal by Subject|0|||
125442005|NCT02061761|451246975|FG001|Overall Study|Withdrawal by Subject|0|||
125442006|NCT02061761|451246976|FG002|Overall Study|Withdrawal by Subject|0|||
125442007|NCT02061761|451246977|FG003|Overall Study|Withdrawal by Subject|0|||
125442008|NCT02061761|451246978|FG004|Overall Study|Withdrawal by Subject|0|||
125442009|NCT02061761|451246979|FG005|Overall Study|Withdrawal by Subject|0|||
125442010|NCT02061761|451246980|FG006|Overall Study|Withdrawal by Subject|0|||
125442011|NCT02061761|451246981|FG007|Overall Study|Withdrawal by Subject|0|||
125442012|NCT02061761|451246982|FG008|Overall Study|Withdrawal by Subject|2|||
125442013|NCT02061761|451246974|FG000|Overall Study|Maximum clinical benefit|0|||
125442014|NCT02061761|451246975|FG001|Overall Study|Maximum clinical benefit|0|||
125442015|NCT02061761|451246976|FG002|Overall Study|Maximum clinical benefit|0|||
125442016|NCT02061761|451246977|FG003|Overall Study|Maximum clinical benefit|1|||
125442017|NCT02061761|451246978|FG004|Overall Study|Maximum clinical benefit|0|||
125442018|NCT02061761|451246979|FG005|Overall Study|Maximum clinical benefit|0|||
125442019|NCT02061761|451246980|FG006|Overall Study|Maximum clinical benefit|0|||
125442020|NCT02061761|451246981|FG007|Overall Study|Maximum clinical benefit|0|||
125442021|NCT02061761|451246982|FG008|Overall Study|Maximum clinical benefit|6|||
125442022|NCT02061761|451246974|FG000|Overall Study|Participant no longer meets study criteria|0|||
125442023|NCT02061761|451246975|FG001|Overall Study|Participant no longer meets study criteria|0|||
125442024|NCT02061761|451246976|FG002|Overall Study|Participant no longer meets study criteria|0|||
125442025|NCT02061761|451246977|FG003|Overall Study|Participant no longer meets study criteria|0|||
125442026|NCT02061761|451246978|FG004|Overall Study|Participant no longer meets study criteria|0|||
125442027|NCT02061761|451246979|FG005|Overall Study|Participant no longer meets study criteria|0|||
125442028|NCT02061761|451246980|FG006|Overall Study|Participant no longer meets study criteria|0|||
125442029|NCT02061761|451246981|FG007|Overall Study|Participant no longer meets study criteria|0|||
125442030|NCT02061761|451246982|FG008|Overall Study|Participant no longer meets study criteria|1|||
125442031|NCT02061761|451246974|FG000|Overall Study|Other reasons|0|||
125442032|NCT02061761|451246975|FG001|Overall Study|Other reasons|0|||
125442033|NCT02061761|451246976|FG002|Overall Study|Other reasons|0|||
125442034|NCT02061761|451246977|FG003|Overall Study|Other reasons|0|||
125165244|NCT03276780|450227911|FG001|Overall Study|Moved out of state|1|||
125165245|NCT03276780|450227910|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
125225721|NCT01211145|450454345|FG003|Overall Study|Study-specific withdrawal criteria|0|||
125442035|NCT02061761|451246978|FG004|Overall Study|Other reasons|2|||
125442036|NCT02061761|451246979|FG005|Overall Study|Other reasons|0|||
125442037|NCT02061761|451246980|FG006|Overall Study|Other reasons|0|||
125442038|NCT02061761|451246981|FG007|Overall Study|Other reasons|0|||
125442039|NCT02061761|451246982|FG008|Overall Study|Other reasons|6|||
125442040|NCT02500316|451246988|FG000|Overall Study|Adverse Event|3|||
125442041|NCT02500316|451246988|FG000|Overall Study|Lost to Follow-up|2|||
125442042|NCT02500316|451246988|FG000|Overall Study|Protocol Violation|1|||
125442043|NCT02500316|451246988|FG000|Overall Study|Withdrawal by Subject|15|||
125442044|NCT02500316|451246988|FG000|Overall Study|Final height achieved|5|||
125442045|NCT02500316|451246988|FG000|Overall Study|Due to war activity|1|||
125442046|NCT01406717|451246989|FG000|Overall Study|Subject non-compliance|4|||
125442047|NCT01406717|451246990|FG001|Overall Study|Subject non-compliance|3|||
125442048|NCT01406717|451246989|FG000|Overall Study|Protocol Violation|5|||
125442049|NCT01406717|451246990|FG001|Overall Study|Protocol Violation|1|||
125442050|NCT01406717|451246989|FG000|Overall Study|Lost to Follow-up|14|||
125442051|NCT01406717|451246990|FG001|Overall Study|Lost to Follow-up|8|||
125442052|NCT01406717|451246989|FG000|Overall Study|Withdrawal by Subject|19|||
125442053|NCT01406717|451246990|FG001|Overall Study|Withdrawal by Subject|15|||
125442054|NCT01406717|451246989|FG000|Overall Study|Adverse Event|1|||
125442055|NCT01406717|451246990|FG001|Overall Study|Adverse Event|2|||
125442056|NCT01406717|451246989|FG000|Overall Study|Lack of Efficacy|0|||
125165246|NCT03276780|450227911|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
125165247|NCT03276780|450227910|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
125165248|NCT03276780|450227911|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
125165249|NCT03050060|450227912|FG000|Overall Study|Adverse Event|7|||
125165250|NCT03050060|450227912|FG000|Overall Study|Withdrawal by Subject|1|||
125165251|NCT03050060|450227912|FG000|Overall Study|Progression|7|||
125165252|NCT02304458|450227913|FG000|Overall Study|Adverse Event|0|||
125165253|NCT02304458|450227914|FG001|Overall Study|Adverse Event|0|||
125165254|NCT02304458|450227915|FG002|Overall Study|Adverse Event|7|||
125165255|NCT02304458|450227916|FG003|Overall Study|Adverse Event|0|||
125165256|NCT02304458|450227917|FG004|Overall Study|Adverse Event|0|||
125165257|NCT02304458|450227918|FG005|Overall Study|Adverse Event|0|||
125165258|NCT02304458|450227919|FG006|Overall Study|Adverse Event|3|||
125165259|NCT02304458|450227920|FG007|Overall Study|Adverse Event|4|||
125165260|NCT02304458|450227913|FG000|Overall Study|Death|0|||
125165261|NCT02304458|450227914|FG001|Overall Study|Death|0|||
125165262|NCT02304458|450227915|FG002|Overall Study|Death|2|||
125165263|NCT02304458|450227916|FG003|Overall Study|Death|0|||
125165264|NCT02304458|450227917|FG004|Overall Study|Death|0|||
125165265|NCT02304458|450227918|FG005|Overall Study|Death|0|||
125165266|NCT02304458|450227919|FG006|Overall Study|Death|1|||
125165267|NCT02304458|450227920|FG007|Overall Study|Death|0|||
125165268|NCT02304458|450227913|FG000|Overall Study|Lack of Efficacy|4|||
125165269|NCT02304458|450227914|FG001|Overall Study|Lack of Efficacy|6|||
125165270|NCT02304458|450227915|FG002|Overall Study|Lack of Efficacy|38|||
125165271|NCT02304458|450227916|FG003|Overall Study|Lack of Efficacy|5|||
125165272|NCT02304458|450227917|FG004|Overall Study|Lack of Efficacy|6|||
125165273|NCT02304458|450227918|FG005|Overall Study|Lack of Efficacy|6|||
125165274|NCT02304458|450227919|FG006|Overall Study|Lack of Efficacy|21|||
125165275|NCT02304458|450227920|FG007|Overall Study|Lack of Efficacy|4|||
125165276|NCT02304458|450227913|FG000|Overall Study|Physician Decision|2|||
125165277|NCT02304458|450227914|FG001|Overall Study|Physician Decision|0|||
125165278|NCT02304458|450227915|FG002|Overall Study|Physician Decision|16|||
125165279|NCT02304458|450227916|FG003|Overall Study|Physician Decision|1|||
125165280|NCT02304458|450227917|FG004|Overall Study|Physician Decision|0|||
125165281|NCT02304458|450227918|FG005|Overall Study|Physician Decision|0|||
125165282|NCT02304458|450227919|FG006|Overall Study|Physician Decision|3|||
125165283|NCT02304458|450227920|FG007|Overall Study|Physician Decision|0|||
125165284|NCT02304458|450227913|FG000|Overall Study|Protocol Violation|0|||
125165285|NCT02304458|450227914|FG001|Overall Study|Protocol Violation|0|||
125165286|NCT02304458|450227915|FG002|Overall Study|Protocol Violation|1|||
125165287|NCT02304458|450227916|FG003|Overall Study|Protocol Violation|0|||
125165288|NCT02304458|450227917|FG004|Overall Study|Protocol Violation|0|||
125165289|NCT02304458|450227918|FG005|Overall Study|Protocol Violation|0|||
125165290|NCT02304458|450227919|FG006|Overall Study|Protocol Violation|0|||
125165291|NCT02304458|450227920|FG007|Overall Study|Protocol Violation|0|||
125165292|NCT02304458|450227913|FG000|Overall Study|Withdrawal by Subject|1|||
125165293|NCT02304458|450227914|FG001|Overall Study|Withdrawal by Subject|0|||
125442057|NCT01406717|451246990|FG001|Overall Study|Lack of Efficacy|1|||
125442058|NCT01406717|451246989|FG000|Overall Study|Non-completion of visit activity|0|||
125165294|NCT02304458|450227915|FG002|Overall Study|Withdrawal by Subject|7|||
125165295|NCT02304458|450227916|FG003|Overall Study|Withdrawal by Subject|0|||
125165296|NCT02304458|450227917|FG004|Overall Study|Withdrawal by Subject|0|||
125165297|NCT02304458|450227918|FG005|Overall Study|Withdrawal by Subject|0|||
125165298|NCT02304458|450227919|FG006|Overall Study|Withdrawal by Subject|1|||
125165299|NCT02304458|450227920|FG007|Overall Study|Withdrawal by Subject|0|||
125165300|NCT03401450|450227921|FG000|Overall Study|Lost to Follow-up|4|||
125442059|NCT01406717|451246990|FG001|Overall Study|Non-completion of visit activity|1|||
125442060|NCT03257995|451246991|FG000|Overall Study|Adverse Event|0|||
125442061|NCT03257995|451246992|FG001|Overall Study|Adverse Event|1|||
125442062|NCT03257995|451246993|FG002|Overall Study|Adverse Event|0|||
125442063|NCT03257995|451246994|FG003|Overall Study|Adverse Event|0|||
125442064|NCT03257995|451246995|FG004|Overall Study|Adverse Event|0|||
125442065|NCT03257995|451246996|FG005|Overall Study|Adverse Event|0|||
125442066|NCT03257995|451246991|FG000|Overall Study|Protocol deviation|0|||
125442067|NCT03257995|451246992|FG001|Overall Study|Protocol deviation|0|||
125442068|NCT03257995|451246993|FG002|Overall Study|Protocol deviation|0|||
125442069|NCT03257995|451246994|FG003|Overall Study|Protocol deviation|0|||
125442070|NCT03257995|451246995|FG004|Overall Study|Protocol deviation|0|||
125442071|NCT03257995|451246996|FG005|Overall Study|Protocol deviation|2|||
125442072|NCT01556763|451247001|FG000|Overall Study|Withdrawal by Subject|0|||
125442073|NCT01556763|451247002|FG001|Overall Study|Withdrawal by Subject|1|||
125442074|NCT01556763|451247003|FG002|Overall Study|Withdrawal by Subject|0|||
125442075|NCT02337478|451247004|FG000|Overall Study|Lack of Efficacy|5|||
125442076|NCT02258464|451247005|FG000|Overall Study|Progressive disease (PD)|9|||
125165301|NCT03401450|450227922|FG001|Overall Study|Lost to Follow-up|6|||
125165302|NCT03401450|450227921|FG000|Overall Study|Anesthesia plan changed|2|||
125391723|NCT01987427|451068638|FG000|Overall Study|Lack of Efficacy|1|||
125391724|NCT01987427|451068639|FG001|Overall Study|Lack of Efficacy|0|||
125391725|NCT01987427|451068640|FG002|Overall Study|Lack of Efficacy|0|||
125391726|NCT01987427|451068638|FG000|Overall Study|Other|1|||
125391727|NCT01987427|451068639|FG001|Overall Study|Other|1|||
125391728|NCT01987427|451068640|FG002|Overall Study|Other|0|||
125391729|NCT01073865|451068641|FG000|Overall Study|Reasons other than below|19|||
125391730|NCT01073865|451068642|FG001|Overall Study|Reasons other than below|31|||
125391731|NCT01073865|451068641|FG000|Overall Study|Lost to Follow-up|1|||
125391732|NCT01073865|451068642|FG001|Overall Study|Lost to Follow-up|1|||
125391733|NCT01073865|451068641|FG000|Overall Study|Death|3|||
125165303|NCT03401450|450227922|FG001|Overall Study|Anesthesia plan changed|2|||
125165304|NCT03401450|450227921|FG000|Overall Study|Did not complete medication diary|4|||
125165305|NCT03401450|450227922|FG001|Overall Study|Did not complete medication diary|2|||
125165306|NCT03401450|450227921|FG000|Overall Study|post surgery medication change|2|||
125165307|NCT03401450|450227922|FG001|Overall Study|post surgery medication change|1|||
125165308|NCT03401450|450227921|FG000|Overall Study|Cancelled surgery|0|||
125165309|NCT03401450|450227922|FG001|Overall Study|Cancelled surgery|2|||
125391734|NCT01073865|451068642|FG001|Overall Study|Death|2|||
125391735|NCT01073865|451068641|FG000|Overall Study|Withdrawal by Subject|5|||
125391736|NCT01073865|451068642|FG001|Overall Study|Withdrawal by Subject|5|||
125391737|NCT00805766|451068643|FG000|Screening Period|Adverse Event|1|||
125391738|NCT00805766|451068643|FG000|Screening Period|Lack of Efficacy|2|||
125391739|NCT00805766|451068643|FG000|Screening Period|Pregnancy|1|||
125391740|NCT00805766|451068643|FG000|Screening Period|Responder|2|||
125391741|NCT00805766|451068643|FG000|Increased Dose Period|Adverse Event|4|||
125391742|NCT00805766|451068643|FG000|Increased Dose Period|Lack of Efficacy|7|||
125391743|NCT00805766|451068643|FG000|Increased Dose Period|Pregnancy|1|||
125391744|NCT00805766|451068643|FG000|Increased Dose Period|Withdrawal by Subject|1|||
125391745|NCT00600756|451068644|FG000|Analysis After 6 Months|Adverse Event|43|||
125391746|NCT00600756|451068645|FG001|Analysis After 6 Months|Adverse Event|33|||
125391747|NCT00600756|451068644|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
125391748|NCT00600756|451068645|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
125391749|NCT00600756|451068644|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
125165310|NCT02823652|450227923|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
125165311|NCT02823652|450227924|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
125165312|NCT02823652|450227925|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
125165313|NCT02823652|450227923|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
125165314|NCT02823652|450227924|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
125165315|NCT02823652|450227925|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
125165316|NCT02823652|450227923|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
125165317|NCT02823652|450227924|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
125165318|NCT02823652|450227925|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
125391750|NCT00600756|451068645|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
125391751|NCT00600756|451068644|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
125391752|NCT00600756|451068645|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
125391753|NCT00600756|451068644|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
125391754|NCT00600756|451068645|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
125391755|NCT00600756|451068644|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
125442077|NCT02258464|451247006|FG001|Overall Study|Progressive disease (PD)|17|||
125442078|NCT02258464|451247005|FG000|Overall Study|Study drug never administered|1|||
125442079|NCT02258464|451247006|FG001|Overall Study|Study drug never administered|1|||
125442080|NCT02258464|451247005|FG000|Overall Study|AE not related to clinical PD|1|||
125165319|NCT02823652|450227923|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
125442081|NCT02258464|451247006|FG001|Overall Study|AE not related to clinical PD|3|||
125442082|NCT02258464|451247005|FG000|Overall Study|Withdrawal by Subject|5|||
125442083|NCT02258464|451247006|FG001|Overall Study|Withdrawal by Subject|4|||
125442084|NCT02258464|451247005|FG000|Overall Study|AE related to clinical PD|1|||
125442085|NCT02258464|451247006|FG001|Overall Study|AE related to clinical PD|0|||
125442086|NCT04170296|451247007|FG000|Overall Study|Adverse Event|1|||
125442087|NCT04170296|451247008|FG001|Overall Study|Adverse Event|0|||
125442088|NCT04170296|451247007|FG000|Overall Study|Withdrawal by Subject|3|||
125442089|NCT04170296|451247008|FG001|Overall Study|Withdrawal by Subject|2|||
125442090|NCT04170296|451247007|FG000|Overall Study|Lost to Follow-up|4|||
125442091|NCT04170296|451247008|FG001|Overall Study|Lost to Follow-up|2|||
125225722|NCT01211145|450454342|FG000|Overall Study|Severe noncompliance to protocol|1|||
125225723|NCT01211145|450454343|FG001|Overall Study|Severe noncompliance to protocol|0|||
125225724|NCT01211145|450454344|FG002|Overall Study|Severe noncompliance to protocol|0|||
125225725|NCT01211145|450454345|FG003|Overall Study|Severe noncompliance to protocol|0|||
125442092|NCT00195715|451247009|FG000|Overall Study|Adverse Event|122|||
125442093|NCT00195715|451247009|FG000|Overall Study|Withdrawal by Subject|58|||
125442094|NCT00195715|451247009|FG000|Overall Study|Lost to Follow-up|27|||
125165320|NCT02823652|450227924|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
125165321|NCT02823652|450227925|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
125165322|NCT00633243|450230252|FG000|Overall Study|Withdrawal by Subject|0|||
125165323|NCT00633243|450230253|FG001|Overall Study|Withdrawal by Subject|1|||
125165324|NCT00633243|450230252|FG000|Overall Study|incarceration|0|||
125165325|NCT00633243|450230253|FG001|Overall Study|incarceration|2|||
125165326|NCT00633243|450230252|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
125165327|NCT00633243|450230253|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
125165328|NCT00633243|450230252|FG000|Overall Study|Not comfortable with self-injecting|0|||
125165329|NCT00633243|450230253|FG001|Overall Study|Not comfortable with self-injecting|1|||
125165330|NCT00633243|450230252|FG000|Overall Study|Mental Health--Depression|0|||
125165331|NCT00633243|450230253|FG001|Overall Study|Mental Health--Depression|1|||
125165332|NCT00633243|450230252|FG000|Overall Study|Couldn't tolerate side-effects|1|||
125165333|NCT00633243|450230253|FG001|Overall Study|Couldn't tolerate side-effects|1|||
125165334|NCT02022748|450230254|FG000|Overall Study|Adverse Event|1|||
125165335|NCT02022748|450230255|FG001|Overall Study|Adverse Event|1|||
125165336|NCT02022748|450230256|FG002|Overall Study|Adverse Event|0|||
125165337|NCT02022748|450230254|FG000|Overall Study|Withdrawal by Subject|0|||
125165338|NCT02022748|450230255|FG001|Overall Study|Withdrawal by Subject|1|||
125165339|NCT02022748|450230256|FG002|Overall Study|Withdrawal by Subject|0|||
125165340|NCT03665441|450230257|FG000|Overall Study|survival follow up ongoing|23|||
125165341|NCT03665441|450230258|FG001|Overall Study|survival follow up ongoing|0|||
125165342|NCT03665441|450230257|FG000|Overall Study|Patients ongoing on treatment|9|||
125165343|NCT03665441|450230258|FG001|Overall Study|Patients ongoing on treatment|6|||
125165344|NCT03665441|450230257|FG000|Overall Study|Randomized but not treated|7|||
125165345|NCT03665441|450230258|FG001|Overall Study|Randomized but not treated|11|||
125165346|NCT04345601|450230259|FG000|Overall Study|Death|0|||
125165347|NCT04345601|450230260|FG001|Overall Study|Death|3|||
125165348|NCT04345601|450230261|FG002|Overall Study|Death|2|||
125165349|NCT04345601|450230259|FG000|Overall Study|Lost to Follow-up|0|||
125165350|NCT04345601|450230260|FG001|Overall Study|Lost to Follow-up|0|||
125165351|NCT04345601|450230261|FG002|Overall Study|Lost to Follow-up|2|||
125165352|NCT03700385|450230262|FG000|Overall Study|Lost to Follow-up|1|||
125165353|NCT00372411|450230265|FG000|Overall Study|Withdrawal by Subject|3|||
125165354|NCT00372411|450230266|FG001|Overall Study|Withdrawal by Subject|4|||
125165355|NCT00372411|450230267|FG002|Overall Study|Withdrawal by Subject|1|||
125165356|NCT00372411|450230265|FG000|Overall Study|Death|0|||
125165357|NCT00372411|450230266|FG001|Overall Study|Death|2|||
125165358|NCT00372411|450230267|FG002|Overall Study|Death|1|||
125165359|NCT00372411|450230265|FG000|Overall Study|Lost to Follow-up|1|||
125165360|NCT00372411|450230266|FG001|Overall Study|Lost to Follow-up|1|||
125165361|NCT00372411|450230267|FG002|Overall Study|Lost to Follow-up|1|||
125165362|NCT00372411|450230265|FG000|Overall Study|Adverse Event|1|||
125165363|NCT00372411|450230266|FG001|Overall Study|Adverse Event|1|||
125165364|NCT00372411|450230267|FG002|Overall Study|Adverse Event|0|||
125165365|NCT00631657|450230268|FG000|6-Month Treatment Period|Adverse Event|47|||
125165366|NCT00631657|450230269|FG001|6-Month Treatment Period|Adverse Event|0|||
125165367|NCT00631657|450230270|FG002|6-Month Treatment Period|Adverse Event|7|||
125165368|NCT00631657|450230268|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
125165369|NCT00631657|450230269|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
125165370|NCT00631657|450230270|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
125165371|NCT00631657|450230268|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
125165372|NCT00631657|450230269|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
125165373|NCT00631657|450230270|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
125442095|NCT00195715|451247009|FG000|Overall Study|Protocol Violation|13|||
125165374|NCT00631657|450230268|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
125165375|NCT00631657|450230269|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
125165376|NCT00631657|450230270|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
125165377|NCT00631657|450230268|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
125442096|NCT00195715|451247009|FG000|Overall Study|Lack of Efficacy|93|||
125442097|NCT00195715|451247009|FG000|Overall Study|Pregnancy|14|||
125442098|NCT00195715|451247009|FG000|Overall Study|Investigative site closure|8|||
125442099|NCT00195715|451247009|FG000|Overall Study|Subject moved/relocated|7|||
125442100|NCT00195715|451247009|FG000|Overall Study|Subject non-compliance|6|||
125442101|NCT00195715|451247009|FG000|Overall Study|Subject started commercial Humira|5|||
125442102|NCT00195715|451247009|FG000|Overall Study|Subject choice|3|||
125442103|NCT00195715|451247009|FG000|Overall Study|Loss of response/no improvement|3|||
125442104|NCT00195715|451247009|FG000|Overall Study|Sponsor stopped study|1|||
125442105|NCT00195715|451247009|FG000|Overall Study|Administrative reasons|2|||
125442106|NCT00195715|451247009|FG000|Overall Study|Investigator's decision|2|||
125442107|NCT00195715|451247009|FG000|Overall Study|Subject wants to get pregnant|4|||
125442108|NCT00195715|451247009|FG000|Overall Study|Use of prohibited medication|2|||
125442109|NCT00195715|451247009|FG000|Overall Study|Planned surgery|2|||
125442110|NCT00195715|451247009|FG000|Overall Study|Increased infection rate|1|||
125442111|NCT00195715|451247009|FG000|Overall Study|Ineligible|1|||
125442112|NCT00195715|451247009|FG000|Overall Study|Colonic stricture|1|||
125442113|NCT00195715|451247009|FG000|Overall Study|Sponsor discontinued trial|1|||
125442114|NCT00195715|451247009|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
125442115|NCT00845871|451247010|FG000|Assessment Period|Adverse Event|2|||
125442116|NCT00845871|451247010|FG000|Assessment Period|Abnormal laboratory values|1|||
125442117|NCT00845871|451247010|FG000|Assessment Period|Abnormal test procedure results|1|||
125442118|NCT00845871|451247010|FG000|Assessment Period|Patient withdrew consent|3|||
125442119|NCT01370603|451247012|FG000|Period 1|Adverse Event|5|||
125442120|NCT01370603|451247013|FG001|Period 1|Adverse Event|3|||
125442121|NCT01370603|451247012|FG000|Period 1|Lost to Follow-up|2|||
125442122|NCT01370603|451247013|FG001|Period 1|Lost to Follow-up|0|||
125442123|NCT01370603|451247012|FG000|Period 1|Protocol Violation|2|||
125442124|NCT01370603|451247013|FG001|Period 1|Protocol Violation|2|||
125442125|NCT01370603|451247012|FG000|Period 1|Withdrawal by Subject|5|||
125442126|NCT01370603|451247013|FG001|Period 1|Withdrawal by Subject|5|||
125442127|NCT01370603|451247012|FG000|Crossover Washout|Adverse Event|2|||
125442128|NCT01370603|451247013|FG001|Crossover Washout|Adverse Event|1|||
125442129|NCT01370603|451247012|FG000|Crossover Washout|Lost to Follow-up|2|||
125442130|NCT01370603|451247013|FG001|Crossover Washout|Lost to Follow-up|0|||
125442131|NCT01370603|451247012|FG000|Crossover Washout|Protocol Violation|1|||
125442132|NCT01370603|451247013|FG001|Crossover Washout|Protocol Violation|0|||
125442133|NCT01370603|451247012|FG000|Crossover Washout|Withdrawal by Subject|4|||
125442134|NCT01370603|451247013|FG001|Crossover Washout|Withdrawal by Subject|1|||
125442135|NCT01370603|451247012|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
125442136|NCT01370603|451247013|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
125442137|NCT01370603|451247012|FG000|Period 2|Adverse Event|1|||
125442138|NCT01370603|451247013|FG001|Period 2|Adverse Event|4|||
125442139|NCT01370603|451247012|FG000|Period 2|Lost to Follow-up|1|||
125442140|NCT01370603|451247013|FG001|Period 2|Lost to Follow-up|0|||
125442141|NCT01370603|451247012|FG000|Period 2|Withdrawal by Subject|1|||
125442142|NCT01370603|451247013|FG001|Period 2|Withdrawal by Subject|0|||
125442143|NCT04039503|451247015|FG000|Overall Study|Adverse Event|3|||
125442144|NCT04039503|451247016|FG001|Overall Study|Adverse Event|0|||
125442145|NCT04039503|451247017|FG002|Overall Study|Adverse Event|2|||
125442146|NCT04039503|451247018|FG003|Overall Study|Adverse Event|0|||
125442147|NCT04039503|451247015|FG000|Overall Study|Lost to Follow-up|0|||
125442148|NCT04039503|451247016|FG001|Overall Study|Lost to Follow-up|0|||
125442149|NCT04039503|451247017|FG002|Overall Study|Lost to Follow-up|1|||
125442150|NCT04039503|451247018|FG003|Overall Study|Lost to Follow-up|0|||
125442151|NCT04039503|451247015|FG000|Overall Study|Protocol Violation|0|||
125442152|NCT04039503|451247016|FG001|Overall Study|Protocol Violation|1|||
125442153|NCT04039503|451247017|FG002|Overall Study|Protocol Violation|2|||
125442154|NCT04039503|451247018|FG003|Overall Study|Protocol Violation|1|||
125442155|NCT04039503|451247015|FG000|Overall Study|Withdrawal by Subject|4|||
125442156|NCT04039503|451247016|FG001|Overall Study|Withdrawal by Subject|3|||
125442157|NCT04039503|451247017|FG002|Overall Study|Withdrawal by Subject|5|||
125442158|NCT04039503|451247018|FG003|Overall Study|Withdrawal by Subject|2|||
125442159|NCT01163747|451247019|FG000|Overall Study|Adverse Event|0|||
125442160|NCT01163747|451247020|FG001|Overall Study|Adverse Event|5|||
125442161|NCT01163747|451247019|FG000|Overall Study|Insufficient Therapeutic Response|0|||
125442162|NCT01163747|451247020|FG001|Overall Study|Insufficient Therapeutic Response|1|||
125442163|NCT01163747|451247019|FG000|Overall Study|Protocol Violation|0|||
125442164|NCT01163747|451247020|FG001|Overall Study|Protocol Violation|1|||
125442165|NCT01163747|451247019|FG000|Overall Study|Refused Treatment|6|||
125442166|NCT01163747|451247020|FG001|Overall Study|Refused Treatment|4|||
125442167|NCT03681639|451248862|FG000|Overall Study|Death|4|||
125165378|NCT00631657|450230269|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
125165379|NCT00631657|450230270|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
125442168|NCT03681639|451248862|FG000|Overall Study|Lost to Follow-up|2|||
125442169|NCT03681639|451248862|FG000|Overall Study|Withdrawal by Subject|1|||
125442170|NCT03681639|451248862|FG000|Overall Study|Adverse Event|2|||
125442171|NCT00654940|451248863|FG000|Period 1|Adverse Event|0|||
125165380|NCT00631657|450230268|FG000|6-Month Treatment Period|Other|16|||
125391756|NCT00600756|451068645|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
125391757|NCT00600756|451068644|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
125391758|NCT00600756|451068645|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
125391759|NCT00600756|451068644|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
125391760|NCT00600756|451068645|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
125391761|NCT00600756|451068644|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
125391762|NCT00600756|451068645|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
125391763|NCT00600756|451068644|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
125391764|NCT00600756|451068645|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
125391765|NCT00600756|451068644|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
125391766|NCT00600756|451068645|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
125391767|NCT00600756|451068644|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
125391768|NCT00600756|451068645|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
125391769|NCT00600756|451068644|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
125391770|NCT00600756|451068645|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
125391771|NCT00600756|451068644|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
125391772|NCT00600756|451068645|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
125391773|NCT03373383|451068655|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
125391774|NCT03373383|451068656|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
125391775|NCT03373383|451068657|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
125391776|NCT03373383|451068658|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
125391777|NCT03373383|451068659|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
125391778|NCT03373383|451068655|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
125391779|NCT03373383|451068656|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
125391780|NCT03373383|451068657|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
125391781|NCT03373383|451068658|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
125391782|NCT03373383|451068659|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
125391783|NCT03373383|451068655|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
125391784|NCT03373383|451068656|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
125391785|NCT03373383|451068657|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
125391786|NCT03373383|451068658|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
125391787|NCT03373383|451068659|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
125391788|NCT03373383|451068655|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
125391789|NCT03373383|451068656|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
125391790|NCT03373383|451068657|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
125391791|NCT03373383|451068658|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
125391792|NCT03373383|451068659|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
125391793|NCT03373383|451068655|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
125391794|NCT03373383|451068656|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
125391795|NCT03373383|451068657|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
125391796|NCT03373383|451068658|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
125391797|NCT03373383|451068659|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
125391798|NCT03373383|451068655|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
125391799|NCT03373383|451068656|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
125391800|NCT03373383|451068657|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
125391801|NCT03373383|451068658|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
125391802|NCT03373383|451068659|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
125391803|NCT03373383|451068655|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
125391804|NCT03373383|451068656|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
125391805|NCT03373383|451068657|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
125391806|NCT03373383|451068658|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
125391807|NCT03373383|451068659|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
125391808|NCT03373383|451068655|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
125391809|NCT03373383|451068656|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
125391810|NCT03373383|451068657|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
125391811|NCT03373383|451068658|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
125391812|NCT03373383|451068659|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
125391813|NCT03373383|451068655|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
125391814|NCT03373383|451068656|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
125391815|NCT03373383|451068657|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
125391816|NCT03373383|451068658|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
125391817|NCT03373383|451068659|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
125391818|NCT02689258|451068660|FG000|Overall Study|Subject Non-Compliance|0|||
125391819|NCT02689258|451068661|FG001|Overall Study|Subject Non-Compliance|1|||
125391820|NCT02689258|451068662|FG002|Overall Study|Subject Non-Compliance|0|||
125391821|NCT02689258|451068663|FG003|Overall Study|Subject Non-Compliance|0|||
125225726|NCT01211145|450454342|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
125225727|NCT01211145|450454343|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
125225728|NCT01211145|450454344|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
125225729|NCT01211145|450454345|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
125225730|NCT01211145|450454342|FG000|Overall Study|Patient decision|2|||
125225731|NCT01211145|450454343|FG001|Overall Study|Patient decision|1|||
125225732|NCT01211145|450454344|FG002|Overall Study|Patient decision|0|||
125225733|NCT01211145|450454345|FG003|Overall Study|Patient decision|2|||
125225734|NCT00570401|450454348|FG000|Overall Study|Adverse Event|2|||
125225735|NCT02849587|450454349|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
125225736|NCT02849587|450454350|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
125225737|NCT02849587|450454351|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
125225738|NCT02849587|450454349|FG000|Overall Study|Withdrawal by Subject|0|||
125225739|NCT02849587|450454350|FG001|Overall Study|Withdrawal by Subject|1|||
125225740|NCT02849587|450454351|FG002|Overall Study|Withdrawal by Subject|0|||
125225741|NCT04202497|450454354|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
125225742|NCT04202497|450454355|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
125225743|NCT04202497|450454356|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
125225744|NCT04202497|450454357|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
125225745|NCT02115607|450454358|FG000|Overall Study|Withdrawal by Subject|1|||
125225746|NCT00102596|450454359|FG000|Part A|Screen failures|6|||
125165381|NCT00631657|450230269|FG001|6-Month Treatment Period|Other|0|||
125165382|NCT00631657|450230270|FG002|6-Month Treatment Period|Other|4|||
125165383|NCT00631657|450230268|FG000|6-Month Treatment Period|Not Treated|2|||
125165384|NCT00631657|450230269|FG001|6-Month Treatment Period|Not Treated|0|||
125165385|NCT00631657|450230270|FG002|6-Month Treatment Period|Not Treated|1|||
125165386|NCT00631657|450230268|FG000|7-Day Discontinuation Period|Not Treated|1|||
125165387|NCT00631657|450230269|FG001|7-Day Discontinuation Period|Not Treated|1|||
125165388|NCT00631657|450230270|FG002|7-Day Discontinuation Period|Not Treated|1|||
125165389|NCT00631657|450230268|FG000|7-Day Discontinuation Period|Other|1|||
125165390|NCT00631657|450230269|FG001|7-Day Discontinuation Period|Other|0|||
125165391|NCT00631657|450230270|FG002|7-Day Discontinuation Period|Other|0|||
125165392|NCT00699374|450230272|FG000|Overall Study|Death|93|||
125165393|NCT00699374|450230273|FG001|Overall Study|Death|83|||
125165394|NCT00699374|450230272|FG000|Overall Study|Adverse Event|70|||
125165395|NCT00699374|450230273|FG001|Overall Study|Adverse Event|67|||
125165396|NCT00699374|450230272|FG000|Overall Study|Global deterioration of health status|7|||
125165397|NCT00699374|450230273|FG001|Overall Study|Global deterioration of health status|8|||
125165398|NCT00699374|450230272|FG000|Overall Study|Lost to Follow-up|3|||
125165399|NCT00699374|450230273|FG001|Overall Study|Lost to Follow-up|5|||
125165400|NCT00699374|450230272|FG000|Overall Study|Withdrawal by Subject|34|||
125165401|NCT00699374|450230273|FG001|Overall Study|Withdrawal by Subject|44|||
125165402|NCT00699374|450230272|FG000|Overall Study|Objective progression or relapse|281|||
125165403|NCT00699374|450230273|FG001|Overall Study|Objective progression or relapse|277|||
125165404|NCT00699374|450230272|FG000|Overall Study|Other|18|||
125165405|NCT00699374|450230273|FG001|Overall Study|Other|15|||
125165406|NCT00699374|450230272|FG000|Overall Study|Protocol Violation|2|||
125165407|NCT00699374|450230273|FG001|Overall Study|Protocol Violation|6|||
125165408|NCT00699374|450230272|FG000|Overall Study|Study terminated by sponsor|13|||
125165409|NCT00699374|450230273|FG001|Overall Study|Study terminated by sponsor|28|||
125165410|NCT00699374|450230272|FG000|Overall Study|Randomized but not treated|4|||
125165411|NCT00699374|450230273|FG001|Overall Study|Randomized but not treated|2|||
125165412|NCT00699374|450230272|FG000|Overall Study|Died 28 days after last dose|5|||
125165413|NCT00699374|450230273|FG001|Overall Study|Died 28 days after last dose|9|||
125165414|NCT04091659|450230280|FG000|Overall Study|Protocol Violation|3|||
125165415|NCT04091659|450230281|FG001|Overall Study|Protocol Violation|0|||
125165416|NCT04091659|450230280|FG000|Overall Study|Lost to Follow-up|0|||
125165417|NCT04091659|450230281|FG001|Overall Study|Lost to Follow-up|1|||
125165418|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
125165419|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
125165420|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
125225747|NCT00102596|450454360|FG001|Part A|Screen failures|0|||
125225748|NCT00102596|450454359|FG000|Part A|Adverse Event|1|||
125225749|NCT00102596|450454360|FG001|Part A|Adverse Event|0|||
125225750|NCT00069264|450454361|FG000|Overall Study|Adverse Event|3|||
125165421|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
125165422|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
125165423|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
125165424|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
125165425|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
125165426|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
125165427|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
125165428|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Death|1|||
125165429|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Death|0|||
125225751|NCT00069264|450454361|FG000|Overall Study|Progressive Disease|23|||
125225752|NCT00069264|450454361|FG000|Overall Study|Withdrawal by Subject|3|||
125165430|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Death|0|||
125165431|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Death|0|||
125165432|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Death|0|||
125165433|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
125165434|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
125165435|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
125165436|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
125165437|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
125165438|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
125165439|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
125165440|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
125165441|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
125165442|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
125165443|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
125165444|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
125165445|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
125165446|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
125165447|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
125165448|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
125165449|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
125165450|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
125165451|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
125165452|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
125165453|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
125165454|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125165455|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125165456|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125165457|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
125165458|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Other|4|||
125165459|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Other|4|||
125165460|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Other|3|||
125165461|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Other|1|||
125165462|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Other|0|||
125165463|NCT01081834|450230285|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
125165464|NCT01081834|450230286|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
125165465|NCT01081834|450230287|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
125165466|NCT01081834|450230288|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
125165467|NCT01081834|450230289|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
125165468|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
125165469|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
125165470|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
125165471|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
125165472|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
125165473|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Death|1|||
125165474|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Death|0|||
125165475|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Death|0|||
125165476|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Death|0|||
125165477|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Death|0|||
125165478|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
125165479|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
125165480|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125165481|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125165482|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
125165483|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125165484|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
125165485|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125165486|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125165487|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
125165488|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
125165489|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
125225753|NCT00069264|450454361|FG000|Overall Study|Discon Therapy|3|||
125442172|NCT00654940|451248864|FG001|Period 1|Adverse Event|1|||
125442173|NCT00654940|451248863|FG000|Period 1|Intolerable Pain Level|1|||
125442174|NCT00654940|451248864|FG001|Period 1|Intolerable Pain Level|0|||
125391822|NCT02689258|451068664|FG004|Overall Study|Subject Non-Compliance|0|||
125391823|NCT02689258|451068665|FG005|Overall Study|Subject Non-Compliance|0|||
125391824|NCT02689258|451068666|FG006|Overall Study|Subject Non-Compliance|0|||
125391825|NCT02689258|451068667|FG007|Overall Study|Subject Non-Compliance|0|||
125391826|NCT02689258|451068668|FG008|Overall Study|Subject Non-Compliance|0|||
125391827|NCT02689258|451068669|FG009|Overall Study|Subject Non-Compliance|0|||
125391828|NCT02689258|451068670|FG010|Overall Study|Subject Non-Compliance|0|||
125391829|NCT02689258|451068671|FG011|Overall Study|Subject Non-Compliance|0|||
125391830|NCT02689258|451068660|FG000|Overall Study|Subject Refusal to Continue|0|||
125391831|NCT02689258|451068661|FG001|Overall Study|Subject Refusal to Continue|1|||
125391832|NCT02689258|451068662|FG002|Overall Study|Subject Refusal to Continue|0|||
125391833|NCT02689258|451068663|FG003|Overall Study|Subject Refusal to Continue|0|||
125391834|NCT02689258|451068664|FG004|Overall Study|Subject Refusal to Continue|0|||
125391835|NCT02689258|451068665|FG005|Overall Study|Subject Refusal to Continue|0|||
125391836|NCT02689258|451068666|FG006|Overall Study|Subject Refusal to Continue|0|||
125391837|NCT02689258|451068667|FG007|Overall Study|Subject Refusal to Continue|0|||
125391838|NCT02689258|451068668|FG008|Overall Study|Subject Refusal to Continue|1|||
125391839|NCT02689258|451068669|FG009|Overall Study|Subject Refusal to Continue|0|||
125391840|NCT02689258|451068670|FG010|Overall Study|Subject Refusal to Continue|0|||
125391841|NCT02689258|451068671|FG011|Overall Study|Subject Refusal to Continue|1|||
125391842|NCT02689258|451068660|FG000|Overall Study|Other|0|||
125391843|NCT02689258|451068661|FG001|Overall Study|Other|2|||
125391844|NCT02689258|451068662|FG002|Overall Study|Other|0|||
125391845|NCT02689258|451068663|FG003|Overall Study|Other|0|||
125391846|NCT02689258|451068664|FG004|Overall Study|Other|1|||
125391847|NCT02689258|451068665|FG005|Overall Study|Other|0|||
125391848|NCT02689258|451068666|FG006|Overall Study|Other|0|||
125391849|NCT02689258|451068667|FG007|Overall Study|Other|0|||
125391850|NCT02689258|451068668|FG008|Overall Study|Other|1|||
125391851|NCT02689258|451068669|FG009|Overall Study|Other|0|||
125391852|NCT02689258|451068670|FG010|Overall Study|Other|0|||
125391853|NCT02689258|451068671|FG011|Overall Study|Other|0|||
125391854|NCT04753164|451068675|FG000|Overall Study|Adverse Event|0|||
125391855|NCT04753164|451068676|FG001|Overall Study|Adverse Event|2|||
125391856|NCT04753164|451068675|FG000|Overall Study|Withdrawal by Subject|9|||
125391857|NCT04753164|451068676|FG001|Overall Study|Withdrawal by Subject|7|||
125391858|NCT04753164|451068675|FG000|Overall Study|Lost to Follow-up|6|||
125391859|NCT04753164|451068676|FG001|Overall Study|Lost to Follow-up|6|||
125391860|NCT04753164|451068675|FG000|Overall Study|Other|12|||
125391861|NCT04753164|451068676|FG001|Overall Study|Other|5|||
125391862|NCT00694369|451068677|FG000|Overall Study|Adverse Event|0|||
125391863|NCT00694369|451068678|FG001|Overall Study|Adverse Event|1|||
125391864|NCT00694369|451068679|FG002|Overall Study|Adverse Event|0|||
125391865|NCT00694369|451068680|FG003|Overall Study|Adverse Event|1|||
125391866|NCT00694369|451068681|FG004|Overall Study|Adverse Event|3|||
125391867|NCT00694369|451068677|FG000|Overall Study|Lost to Follow-up|0|||
125391868|NCT00694369|451068678|FG001|Overall Study|Lost to Follow-up|0|||
125391869|NCT00694369|451068679|FG002|Overall Study|Lost to Follow-up|1|||
125391870|NCT00694369|451068680|FG003|Overall Study|Lost to Follow-up|1|||
125391871|NCT00694369|451068681|FG004|Overall Study|Lost to Follow-up|0|||
125391872|NCT00694369|451068677|FG000|Overall Study|Physician Decision|0|||
125391873|NCT00694369|451068678|FG001|Overall Study|Physician Decision|0|||
125391874|NCT00694369|451068679|FG002|Overall Study|Physician Decision|0|||
125391875|NCT00694369|451068680|FG003|Overall Study|Physician Decision|0|||
125391876|NCT00694369|451068681|FG004|Overall Study|Physician Decision|1|||
125391877|NCT00694369|451068677|FG000|Overall Study|Protocol Violation|0|||
125391878|NCT00694369|451068678|FG001|Overall Study|Protocol Violation|1|||
125165490|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125165491|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125165492|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
125391879|NCT00694369|451068679|FG002|Overall Study|Protocol Violation|0|||
125391880|NCT00694369|451068680|FG003|Overall Study|Protocol Violation|0|||
125391881|NCT00694369|451068681|FG004|Overall Study|Protocol Violation|0|||
125391882|NCT00694369|451068677|FG000|Overall Study|Withdrawal by Subject|1|||
125391883|NCT00694369|451068678|FG001|Overall Study|Withdrawal by Subject|1|||
125391884|NCT00694369|451068679|FG002|Overall Study|Withdrawal by Subject|1|||
125391885|NCT00694369|451068680|FG003|Overall Study|Withdrawal by Subject|1|||
125391886|NCT00694369|451068681|FG004|Overall Study|Withdrawal by Subject|2|||
125391887|NCT00907374|451068684|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
125391888|NCT00907374|451068685|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
125391889|NCT02871739|451068690|FG000|Overall Study|Lost to Follow-up|3|||
125391890|NCT02871739|451068691|FG001|Overall Study|Lost to Follow-up|2|||
125391891|NCT02871739|451068692|FG002|Overall Study|Lost to Follow-up|0|||
125391892|NCT02871739|451068693|FG003|Overall Study|Lost to Follow-up|2|||
125391893|NCT00439556|451068694|FG000|Overall Study|Patient was taken off study for non-comp|0|||
125391894|NCT00439556|451068695|FG001|Overall Study|Patient was taken off study for non-comp|1|||
125391895|NCT00439556|451068696|FG002|Overall Study|Patient was taken off study for non-comp|0|||
125391896|NCT03818516|451068697|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
125391897|NCT04372602|451068700|FG000|Overall Study|Withdrawal by Subject|1|||
125391898|NCT04372602|451068701|FG001|Overall Study|Withdrawal by Subject|1|||
125391899|NCT04372602|451068700|FG000|Overall Study|Adverse Event|0|||
125391900|NCT04372602|451068701|FG001|Overall Study|Adverse Event|1|||
125391901|NCT04372602|451068700|FG000|Overall Study|Transitioned to comfort care|0|||
125165493|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
125165494|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125165495|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
125165496|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125165497|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
125165498|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
125165499|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
125165500|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
125165501|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
125165502|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
125165503|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Other|4|||
125165504|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Other|5|||
125165505|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Other|4|||
125165506|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Other|0|||
125165507|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Other|0|||
125165508|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
125165509|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
125165510|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
125165511|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
125165512|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
125165513|NCT01081834|450230285|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125165514|NCT01081834|450230286|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
125165515|NCT01081834|450230287|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125165516|NCT01081834|450230288|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125165517|NCT01081834|450230289|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
125165518|NCT01475097|450230294|FG000|Overall Study|Protocol Violation|1|||
125165519|NCT01475097|450230295|FG001|Overall Study|Protocol Violation|1|||
125165520|NCT01085201|450230306|FG000|Overall Study|Scheduling conflict|1|||
125165521|NCT01085201|450230307|FG001|Overall Study|Scheduling conflict|0|||
125165522|NCT01085201|450230308|FG002|Overall Study|Scheduling conflict|1|||
125165523|NCT01085201|450230309|FG003|Overall Study|Scheduling conflict|0|||
125165524|NCT01085201|450230310|FG004|Overall Study|Scheduling conflict|0|||
125165525|NCT01085201|450230306|FG000|Overall Study|Unknown- no study drug|2|||
125165526|NCT01085201|450230307|FG001|Overall Study|Unknown- no study drug|0|||
125165527|NCT01085201|450230308|FG002|Overall Study|Unknown- no study drug|0|||
125165528|NCT01085201|450230309|FG003|Overall Study|Unknown- no study drug|0|||
125165529|NCT01085201|450230310|FG004|Overall Study|Unknown- no study drug|0|||
125165530|NCT01085201|450230306|FG000|Overall Study|Fond ineligible after consent|0|||
125165531|NCT01085201|450230307|FG001|Overall Study|Fond ineligible after consent|1|||
125165532|NCT01085201|450230308|FG002|Overall Study|Fond ineligible after consent|1|||
125165533|NCT01085201|450230309|FG003|Overall Study|Fond ineligible after consent|0|||
125165534|NCT01085201|450230310|FG004|Overall Study|Fond ineligible after consent|0|||
125165535|NCT00867503|450230315|FG000|Overall Study|Withdrawal by Subject|1|||
125165536|NCT01001988|450230316|FG000|Overall Study|Protocol Violation|84|||
125165537|NCT01001988|450230316|FG000|Overall Study|Withdrawal by Subject|18|||
125165538|NCT01001988|450230316|FG000|Overall Study|Lost to Follow-up|15|||
125165539|NCT01442688|450230319|FG000|First Intervention|Withdrawal by Subject|1|||
125165540|NCT01442688|450230320|FG001|First Intervention|Withdrawal by Subject|0|||
125165541|NCT01442688|450230319|FG000|First Intervention|subject incarcerated|1|||
125165542|NCT01442688|450230320|FG001|First Intervention|subject incarcerated|0|||
125165543|NCT01442688|450230319|FG000|Second Intervention|Adverse Event|1|||
125165544|NCT01442688|450230320|FG001|Second Intervention|Adverse Event|0|||
125165545|NCT00927394|450230321|FG000|Overall Study|Adverse Event|14|||
125165546|NCT00927394|450230322|FG001|Overall Study|Adverse Event|9|||
125165547|NCT00927394|450230321|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
125165548|NCT00927394|450230322|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
125165549|NCT00927394|450230321|FG000|Overall Study|Withdrawal by Subject|20|||
125165550|NCT00927394|450230322|FG001|Overall Study|Withdrawal by Subject|24|||
125165551|NCT00927394|450230321|FG000|Overall Study|Lost to Follow-up|8|||
125165552|NCT00927394|450230322|FG001|Overall Study|Lost to Follow-up|14|||
125165553|NCT00927394|450230321|FG000|Overall Study|Administrative Problem|1|||
125165554|NCT00927394|450230322|FG001|Overall Study|Administrative Problem|0|||
125225754|NCT05067972|450454362|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
125391902|NCT04372602|451068701|FG001|Overall Study|Transitioned to comfort care|1|||
125391903|NCT01062555|451068705|FG000|Phase 1|Death|10|||
125391904|NCT01062555|451068706|FG001|Phase 1|Death|17|||
125391905|NCT01062555|451068707|FG002|Phase 1|Death|0|||
125391906|NCT01062555|451068708|FG003|Phase 1|Death|0|||
125391907|NCT01062555|451068705|FG000|Phase 1|Graft Failure|12|||
125391908|NCT01062555|451068706|FG001|Phase 1|Graft Failure|8|||
125391909|NCT01062555|451068707|FG002|Phase 1|Graft Failure|0|||
125391910|NCT01062555|451068708|FG003|Phase 1|Graft Failure|0|||
125391911|NCT01062555|451068705|FG000|Phase 1|Withdrawal by Subject|1|||
125391912|NCT01062555|451068706|FG001|Phase 1|Withdrawal by Subject|1|||
125391913|NCT01062555|451068707|FG002|Phase 1|Withdrawal by Subject|0|||
125391914|NCT01062555|451068708|FG003|Phase 1|Withdrawal by Subject|0|||
125391915|NCT01062555|451068705|FG000|Phase 2|Death|0|||
125391916|NCT01062555|451068706|FG001|Phase 2|Death|0|||
125391917|NCT01062555|451068707|FG002|Phase 2|Death|8|||
125391918|NCT01062555|451068708|FG003|Phase 2|Death|3|||
125391919|NCT01062555|451068705|FG000|Phase 2|Graft failure|0|||
125391920|NCT01062555|451068706|FG001|Phase 2|Graft failure|0|||
125391921|NCT01062555|451068707|FG002|Phase 2|Graft failure|7|||
125391922|NCT01062555|451068708|FG003|Phase 2|Graft failure|4|||
125391923|NCT01062555|451068705|FG000|Phase 2|Withdrawal by Subject|0|||
125391924|NCT01062555|451068706|FG001|Phase 2|Withdrawal by Subject|0|||
125391925|NCT01062555|451068707|FG002|Phase 2|Withdrawal by Subject|0|||
125391926|NCT01062555|451068708|FG003|Phase 2|Withdrawal by Subject|7|||
125391927|NCT01062555|451068705|FG000|Phase 2|Protocol Violation|0|||
125391928|NCT01062555|451068706|FG001|Phase 2|Protocol Violation|0|||
125391929|NCT01062555|451068707|FG002|Phase 2|Protocol Violation|0|||
125391930|NCT01062555|451068708|FG003|Phase 2|Protocol Violation|3|||
125391931|NCT01062555|451068705|FG000|Phase 2|Physician Decision|0|||
125391932|NCT01062555|451068706|FG001|Phase 2|Physician Decision|0|||
125165555|NCT00927394|450230321|FG000|Overall Study|Death|1|||
125391933|NCT01062555|451068707|FG002|Phase 2|Physician Decision|0|||
125165556|NCT00927394|450230322|FG001|Overall Study|Death|1|||
125165557|NCT00927394|450230321|FG000|Overall Study|Protocol deviation|16|||
125165558|NCT00927394|450230322|FG001|Overall Study|Protocol deviation|13|||
125165559|NCT00927394|450230321|FG000|Overall Study|Randomized in error|0|||
125165560|NCT00927394|450230322|FG001|Overall Study|Randomized in error|1|||
125165561|NCT01221363|450230323|FG000|Overall Study|Pregnancy|1|||
125165562|NCT01221363|450230324|FG001|Overall Study|Pregnancy|0|||
125165563|NCT01221363|450230323|FG000|Overall Study|Withdrawal by Subject|11|||
125165564|NCT01221363|450230324|FG001|Overall Study|Withdrawal by Subject|5|||
125165565|NCT02865460|450230325|FG000|Overall Study|Adverse Event|1|||
125165566|NCT02865460|450230326|FG001|Overall Study|Adverse Event|0|||
125165567|NCT02865460|450230325|FG000|Overall Study|Withdrawal by Subject|1|||
125165568|NCT02865460|450230326|FG001|Overall Study|Withdrawal by Subject|1|||
125165569|NCT02865460|450230325|FG000|Overall Study|Lost to Follow-up|7|||
125165570|NCT02865460|450230326|FG001|Overall Study|Lost to Follow-up|4|||
125165571|NCT02865460|450230325|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
125165572|NCT02865460|450230326|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
125165573|NCT02238795|450230327|FG000|Overall Study|Patient without purpura fulminans|1|||
125165574|NCT04480710|450230330|FG000|Overall Study|Adverse Event|0|||
125165575|NCT04480710|450230331|FG001|Overall Study|Adverse Event|2|||
125165576|NCT04480710|450230332|FG002|Overall Study|Adverse Event|0|||
125165577|NCT04480710|450230333|FG003|Overall Study|Adverse Event|0|||
125391934|NCT01062555|451068708|FG003|Phase 2|Physician Decision|17|||
125391935|NCT04964128|451068709|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
125391936|NCT04964128|451068709|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
125391937|NCT01471379|451068710|FG000|Overall Study|Adverse Event|1|||
125391938|NCT01471379|451068711|FG001|Overall Study|Adverse Event|0|||
125391939|NCT01471379|451068712|FG002|Overall Study|Adverse Event|0|||
125391940|NCT01471379|451068710|FG000|Overall Study|Study terminated|0|||
125391941|NCT01471379|451068711|FG001|Overall Study|Study terminated|1|||
125391942|NCT01471379|451068712|FG002|Overall Study|Study terminated|0|||
125391943|NCT02120794|451068713|FG000|Overall Study|Withdrawal by Subject|43|||
125391944|NCT02120794|451068713|FG000|Overall Study|Adverse Event|10|||
125391945|NCT02120794|451068713|FG000|Overall Study|Physician Decision|4|||
125391946|NCT02120794|451068713|FG000|Overall Study|Due to insurance coverage|1|||
125391947|NCT01070316|451068732|FG000|Extension Phase|Lack of Efficacy|3|||
125391948|NCT01070316|451068732|FG000|Extension Phase|Withdrawal by Subject|1|||
125391949|NCT00748215|451068733|FG000|Overall Study|Withdrawal by Subject|7|||
125391950|NCT00748215|451068734|FG001|Overall Study|Withdrawal by Subject|7|||
125391951|NCT00748215|451068733|FG000|Overall Study|Treatment change|2|||
125391952|NCT00748215|451068734|FG001|Overall Study|Treatment change|1|||
125391953|NCT00748215|451068733|FG000|Overall Study|Change in patient condition|0|||
125391954|NCT00748215|451068734|FG001|Overall Study|Change in patient condition|3|||
125391955|NCT00748215|451068733|FG000|Overall Study|Non-compliant|0|||
125391956|NCT00748215|451068734|FG001|Overall Study|Non-compliant|2|||
125165578|NCT04480710|450230330|FG000|Overall Study|Withdrawal by Subject|0|||
125165579|NCT04480710|450230331|FG001|Overall Study|Withdrawal by Subject|1|||
125391957|NCT00748215|451068733|FG000|Overall Study|Adverse Event|0|||
125391958|NCT00748215|451068734|FG001|Overall Study|Adverse Event|5|||
125442175|NCT04714216|451248865|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
125442176|NCT04714216|451248865|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
125442177|NCT00581113|451248866|FG000|Overall Study|Withdrawal by Subject|0|||
125442178|NCT00581113|451248867|FG001|Overall Study|Withdrawal by Subject|1|||
125442179|NCT01818141|451248868|FG000|Overall Study|Withdrawal by Subject|2|||
125442180|NCT01818141|451248869|FG001|Overall Study|Withdrawal by Subject|0|||
125442181|NCT01818141|451248868|FG000|Overall Study|No baseline C.diff colonies|1|||
125442182|NCT01818141|451248869|FG001|Overall Study|No baseline C.diff colonies|1|||
125442183|NCT01818141|451248868|FG000|Overall Study|Lost to Follow-up|0|||
125442184|NCT01818141|451248869|FG001|Overall Study|Lost to Follow-up|2|||
125442185|NCT00619476|451248870|FG000|Overall Study|Adverse Event|12|||
125442186|NCT00619476|451248871|FG001|Overall Study|Adverse Event|6|||
125442187|NCT00619476|451248872|FG002|Overall Study|Adverse Event|12|||
125442188|NCT00619476|451248873|FG003|Overall Study|Adverse Event|16|||
125442189|NCT00619476|451248870|FG000|Overall Study|Lack of Efficacy|6|||
125442190|NCT00619476|451248871|FG001|Overall Study|Lack of Efficacy|1|||
125442191|NCT00619476|451248872|FG002|Overall Study|Lack of Efficacy|1|||
125442192|NCT00619476|451248873|FG003|Overall Study|Lack of Efficacy|4|||
125442193|NCT00619476|451248870|FG000|Overall Study|Protocol Violation|5|||
125442194|NCT00619476|451248871|FG001|Overall Study|Protocol Violation|4|||
125442195|NCT00619476|451248872|FG002|Overall Study|Protocol Violation|4|||
125442196|NCT00619476|451248873|FG003|Overall Study|Protocol Violation|9|||
125442197|NCT00619476|451248870|FG000|Overall Study|Lost to Follow-up|1|||
125442198|NCT00619476|451248871|FG001|Overall Study|Lost to Follow-up|2|||
125442199|NCT00619476|451248872|FG002|Overall Study|Lost to Follow-up|0|||
125442200|NCT00619476|451248873|FG003|Overall Study|Lost to Follow-up|1|||
125442201|NCT00619476|451248870|FG000|Overall Study|Investigator Discretion|2|||
125442202|NCT00619476|451248871|FG001|Overall Study|Investigator Discretion|2|||
125442203|NCT00619476|451248872|FG002|Overall Study|Investigator Discretion|2|||
125442204|NCT00619476|451248873|FG003|Overall Study|Investigator Discretion|0|||
125442205|NCT00619476|451248870|FG000|Overall Study|Withdrawal by Subject|5|||
125442206|NCT00619476|451248871|FG001|Overall Study|Withdrawal by Subject|7|||
125442207|NCT00619476|451248872|FG002|Overall Study|Withdrawal by Subject|5|||
125442208|NCT00619476|451248873|FG003|Overall Study|Withdrawal by Subject|4|||
125442209|NCT03204695|451248875|FG000|Overall Study|Death|1|||
125442210|NCT03204695|451248875|FG000|Overall Study|Participant was treated with another device|1|||
125442211|NCT03204695|451248875|FG000|Overall Study|Physician Decision|2|||
125442212|NCT04834362|451248876|FG000|Overall Study|Death|1|||
125442213|NCT04834362|451248877|FG001|Overall Study|Death|2|||
125442214|NCT01349829|451248880|FG000|Overall Study|Lost to Follow-up|4|||
125442215|NCT01349829|451248881|FG001|Overall Study|Lost to Follow-up|8|||
125442216|NCT01349829|451248880|FG000|Overall Study|Consent withdrawal|3|||
125442217|NCT01349829|451248881|FG001|Overall Study|Consent withdrawal|8|||
125442218|NCT01349829|451248880|FG000|Overall Study|Migrated/moved|2|||
125442219|NCT01349829|451248881|FG001|Overall Study|Migrated/moved|7|||
125442220|NCT03095599|451248882|FG000|Overall Study|Withdrawal by Subject|1|||
125442221|NCT03095599|451248883|FG001|Overall Study|Withdrawal by Subject|0|||
125442222|NCT03095599|451248882|FG000|Overall Study|Lost to Follow-up|1|||
125442223|NCT03095599|451248883|FG001|Overall Study|Lost to Follow-up|0|||
125442224|NCT03095599|451248882|FG000|Overall Study|Withdrawal prior to vaccination|1|||
125442225|NCT03095599|451248883|FG001|Overall Study|Withdrawal prior to vaccination|0|||
125442226|NCT00742885|451248885|FG000|Overall Study|Lost to Follow-up|1|||
125442227|NCT00742885|451248886|FG001|Overall Study|Lost to Follow-up|0|||
125442228|NCT04781647|451248887|FG000|Overall Study|Study terminated by Sponsor|11|||
125442229|NCT04781647|451248888|FG001|Overall Study|Study terminated by Sponsor|9|||
125225755|NCT05067972|450454363|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
125225756|NCT05067972|450454364|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
125225757|NCT05067972|450454365|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
125225758|NCT05067972|450454366|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
125225759|NCT05067972|450454367|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
125225760|NCT05067972|450454368|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
125225761|NCT05067972|450454362|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
125225762|NCT05067972|450454363|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
125225763|NCT05067972|450454364|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
125442230|NCT04781647|451248889|FG002|Overall Study|Study terminated by Sponsor|9|||
125442231|NCT04781647|451248887|FG000|Overall Study|Withdrawal by Subject|1|||
125442232|NCT04781647|451248888|FG001|Overall Study|Withdrawal by Subject|2|||
125442233|NCT04781647|451248889|FG002|Overall Study|Withdrawal by Subject|0|||
125442234|NCT04781647|451248887|FG000|Overall Study|Adverse Event|0|||
125442235|NCT04781647|451248888|FG001|Overall Study|Adverse Event|1|||
125442236|NCT04781647|451248889|FG002|Overall Study|Adverse Event|1|||
125442237|NCT04781647|451248887|FG000|Overall Study|Protocol Violation|1|||
125442238|NCT04781647|451248888|FG001|Overall Study|Protocol Violation|0|||
125442239|NCT04781647|451248889|FG002|Overall Study|Protocol Violation|0|||
125442240|NCT04781647|451248887|FG000|Overall Study|Pregnancy|0|||
125442241|NCT04781647|451248888|FG001|Overall Study|Pregnancy|0|||
125442242|NCT04781647|451248889|FG002|Overall Study|Pregnancy|1|||
125225764|NCT05067972|450454365|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
125225765|NCT05067972|450454366|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
125225766|NCT05067972|450454367|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
125225767|NCT05067972|450454368|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
125225768|NCT05067972|450454362|FG000|Part 1: Treatment|Progressive Disease|3|||
125225769|NCT05067972|450454363|FG001|Part 1: Treatment|Progressive Disease|3|||
125225770|NCT05067972|450454364|FG002|Part 1: Treatment|Progressive Disease|4|||
125225771|NCT05067972|450454365|FG003|Part 1: Treatment|Progressive Disease|2|||
125225772|NCT05067972|450454366|FG004|Part 1: Treatment|Progressive Disease|3|||
125225773|NCT05067972|450454367|FG005|Part 1: Treatment|Progressive Disease|0|||
125225774|NCT05067972|450454368|FG006|Part 1: Treatment|Progressive Disease|2|||
125225775|NCT05067972|450454362|FG000|Part 1: Treatment|Physician Decision|0|||
125225776|NCT05067972|450454363|FG001|Part 1: Treatment|Physician Decision|0|||
125225777|NCT05067972|450454364|FG002|Part 1: Treatment|Physician Decision|0|||
125225778|NCT05067972|450454365|FG003|Part 1: Treatment|Physician Decision|1|||
125225779|NCT05067972|450454366|FG004|Part 1: Treatment|Physician Decision|0|||
125225780|NCT05067972|450454367|FG005|Part 1: Treatment|Physician Decision|0|||
125225781|NCT05067972|450454368|FG006|Part 1: Treatment|Physician Decision|0|||
125225782|NCT05067972|450454362|FG000|Part 1: Treatment|Death|0|||
125225783|NCT05067972|450454363|FG001|Part 1: Treatment|Death|0|||
125225784|NCT05067972|450454364|FG002|Part 1: Treatment|Death|0|||
125225785|NCT05067972|450454365|FG003|Part 1: Treatment|Death|2|||
125225786|NCT05067972|450454366|FG004|Part 1: Treatment|Death|0|||
125225787|NCT05067972|450454367|FG005|Part 1: Treatment|Death|0|||
125225788|NCT05067972|450454368|FG006|Part 1: Treatment|Death|0|||
125225789|NCT05067972|450454362|FG000|Part 1: Treatment|Adverse Event|0|||
125225790|NCT05067972|450454363|FG001|Part 1: Treatment|Adverse Event|0|||
125225791|NCT05067972|450454364|FG002|Part 1: Treatment|Adverse Event|0|||
125225792|NCT05067972|450454365|FG003|Part 1: Treatment|Adverse Event|0|||
125225793|NCT05067972|450454366|FG004|Part 1: Treatment|Adverse Event|0|||
125225794|NCT05067972|450454367|FG005|Part 1: Treatment|Adverse Event|2|||
125225795|NCT05067972|450454368|FG006|Part 1: Treatment|Adverse Event|1|||
125225796|NCT05067972|450454362|FG000|Part 1: Follow-up|Adverse Event|0|||
125225797|NCT05067972|450454363|FG001|Part 1: Follow-up|Adverse Event|0|||
125225798|NCT05067972|450454364|FG002|Part 1: Follow-up|Adverse Event|0|||
125225799|NCT05067972|450454365|FG003|Part 1: Follow-up|Adverse Event|0|||
125225800|NCT05067972|450454366|FG004|Part 1: Follow-up|Adverse Event|0|||
125225801|NCT05067972|450454367|FG005|Part 1: Follow-up|Adverse Event|1|||
125225802|NCT05067972|450454368|FG006|Part 1: Follow-up|Adverse Event|0|||
125225803|NCT05067972|450454362|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
125225804|NCT05067972|450454363|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
125225805|NCT05067972|450454364|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
125225806|NCT05067972|450454365|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
125225807|NCT05067972|450454366|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
125225808|NCT05067972|450454367|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
125225809|NCT05067972|450454368|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
125225810|NCT05067972|450454362|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
125225811|NCT05067972|450454363|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
125225812|NCT05067972|450454364|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
125225813|NCT05067972|450454365|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
125225814|NCT05067972|450454366|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
125225815|NCT05067972|450454367|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
125225816|NCT05067972|450454368|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
125225817|NCT05067972|450454362|FG000|Part 1: Follow-up|Physician Decision|0|||
125225818|NCT05067972|450454363|FG001|Part 1: Follow-up|Physician Decision|0|||
125225819|NCT05067972|450454364|FG002|Part 1: Follow-up|Physician Decision|0|||
125225820|NCT05067972|450454365|FG003|Part 1: Follow-up|Physician Decision|1|||
125225821|NCT05067972|450454366|FG004|Part 1: Follow-up|Physician Decision|0|||
125225822|NCT05067972|450454367|FG005|Part 1: Follow-up|Physician Decision|0|||
125225823|NCT05067972|450454368|FG006|Part 1: Follow-up|Physician Decision|0|||
125225824|NCT05067972|450454362|FG000|Part 1: Follow-up|Death|1|||
125225825|NCT05067972|450454363|FG001|Part 1: Follow-up|Death|2|||
125225826|NCT05067972|450454364|FG002|Part 1: Follow-up|Death|1|||
125225827|NCT05067972|450454365|FG003|Part 1: Follow-up|Death|0|||
125225828|NCT05067972|450454366|FG004|Part 1: Follow-up|Death|1|||
125225829|NCT05067972|450454367|FG005|Part 1: Follow-up|Death|0|||
125225830|NCT05067972|450454368|FG006|Part 1: Follow-up|Death|1|||
125225831|NCT01091246|450454369|FG000|Overall Study|Lost to Follow-up|23|||
125225832|NCT01091246|450454370|FG001|Overall Study|Lost to Follow-up|11|||
125225833|NCT01091246|450454371|FG002|Overall Study|Lost to Follow-up|7|||
125225834|NCT01091246|450454369|FG000|Overall Study|Adverse Event|1|||
125391959|NCT03200899|451068737|FG000|Overall Study|Lost to Follow-up|10|||
125225835|NCT01091246|450454370|FG001|Overall Study|Adverse Event|0|||
125225836|NCT01091246|450454371|FG002|Overall Study|Adverse Event|1|||
125225837|NCT01091246|450454369|FG000|Overall Study|Withdrawal by Subject|9|||
125391960|NCT03200899|451068738|FG001|Overall Study|Lost to Follow-up|23|||
125225838|NCT01091246|450454370|FG001|Overall Study|Withdrawal by Subject|5|||
125225839|NCT01091246|450454371|FG002|Overall Study|Withdrawal by Subject|4|||
125225840|NCT01091246|450454369|FG000|Overall Study|Subject not dosed|2|||
125225841|NCT01091246|450454370|FG001|Overall Study|Subject not dosed|0|||
125225842|NCT01091246|450454371|FG002|Overall Study|Subject not dosed|1|||
125225843|NCT02287038|450454372|FG000|Overall Study|Stopped attending appointments|3|||
125225844|NCT02287038|450454373|FG001|Overall Study|Stopped attending appointments|2|||
125225845|NCT02287038|450454372|FG000|Overall Study|Anxiety after starting medication|0|||
125225846|NCT02287038|450454373|FG001|Overall Study|Anxiety after starting medication|1|||
125225847|NCT02287038|450454372|FG000|Overall Study|Nausea after starting medication|1|||
125225848|NCT02287038|450454373|FG001|Overall Study|Nausea after starting medication|0|||
125225849|NCT02287038|450454372|FG000|Overall Study|Abnormal ECG after starting medication|1|||
125225850|NCT02287038|450454373|FG001|Overall Study|Abnormal ECG after starting medication|0|||
125225851|NCT01676012|450454381|FG000|Overall Study|Adverse Event|2|||
125225852|NCT01676012|450454381|FG000|Overall Study|incomplete set of videos|1|||
125225853|NCT02667301|450454394|FG000|Overall Study|Adverse Event|1|||
125225854|NCT02667301|450454394|FG000|Overall Study|Lack of Efficacy|1|||
125225855|NCT02283658|450454395|FG000|Overall Study|Withdrawal by Subject|1|||
125225856|NCT03528551|450454397|FG000|Overall Study|Lost to Follow-up|0|||
125225857|NCT03528551|450454398|FG001|Overall Study|Lost to Follow-up|1|||
125225858|NCT03528551|450454399|FG002|Overall Study|Lost to Follow-up|0|||
125225859|NCT03528551|450454397|FG000|Overall Study|Transferred to other arm/group|2|||
125225860|NCT03528551|450454398|FG001|Overall Study|Transferred to other arm/group|3|||
125225861|NCT03528551|450454399|FG002|Overall Study|Transferred to other arm/group|0|||
125225862|NCT03528551|450454397|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125225863|NCT03528551|450454398|FG001|Overall Study|Withdrawal by parent/guardian|5|||
125225864|NCT03528551|450454399|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125225865|NCT03528551|450454397|FG000|Overall Study|Protocol Violation|0|||
125225866|NCT03528551|450454398|FG001|Overall Study|Protocol Violation|3|||
125225867|NCT03528551|450454399|FG002|Overall Study|Protocol Violation|0|||
125225868|NCT03528551|450454397|FG000|Overall Study|Withdrawal by Subject|0|||
125225869|NCT03528551|450454398|FG001|Overall Study|Withdrawal by Subject|7|||
125225870|NCT03528551|450454399|FG002|Overall Study|Withdrawal by Subject|0|||
125225871|NCT00846586|450454400|FG000|Overall Study|Adverse Event|20|||
125225872|NCT00846586|450454401|FG001|Overall Study|Adverse Event|10|||
125225873|NCT00846586|450454400|FG000|Overall Study|Subject withdrew consent|8|||
125225874|NCT00846586|450454401|FG001|Overall Study|Subject withdrew consent|10|||
125225875|NCT00846586|450454400|FG000|Overall Study|Administrative problems|5|||
125225876|NCT00846586|450454401|FG001|Overall Study|Administrative problems|4|||
125225877|NCT00846586|450454400|FG000|Overall Study|Death|2|||
125225878|NCT00846586|450454401|FG001|Overall Study|Death|0|||
125225879|NCT00846586|450454400|FG000|Overall Study|Protocol deviation|2|||
125225880|NCT00846586|450454401|FG001|Overall Study|Protocol deviation|6|||
125225881|NCT00846586|450454400|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125225882|NCT00846586|450454401|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125225883|NCT00846586|450454400|FG000|Overall Study|Lost to Follow-up|1|||
125225884|NCT00846586|450454401|FG001|Overall Study|Lost to Follow-up|4|||
125225885|NCT00846586|450454400|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125225886|NCT00846586|450454401|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125225887|NCT00689338|450454402|FG000|Overall Study|Death|65|||
125225888|NCT00689338|450454402|FG000|Overall Study|Adverse Event|13|||
125225889|NCT00689338|450454402|FG000|Overall Study|Insufficient Clinical Response|1|||
125225890|NCT00689338|450454402|FG000|Overall Study|Lack of Efficacy|6|||
125225891|NCT00689338|450454402|FG000|Overall Study|Other|8|||
125225892|NCT00689338|450454402|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
125225893|NCT00689338|450454402|FG000|Overall Study|Lost to Follow-up|5|||
125225894|NCT00689338|450454402|FG000|Overall Study|Withdrawal by Subject|3|||
125225895|NCT00689338|450454402|FG000|Overall Study|Protocol Violation|15|||
125225896|NCT01061606|450454403|FG000|Overall Study|Adverse Event|1|||
125225897|NCT01061606|450454403|FG000|Overall Study|Death|1|||
125225898|NCT01061606|450454403|FG000|Overall Study|Disease Progression|4|||
125225899|NCT01061606|450454403|FG000|Overall Study|alternative therapy|2|||
125225900|NCT00735007|450454404|FG000|Overall Study|Adverse Event|4|||
125225901|NCT00735007|450454404|FG000|Overall Study|Protocol Violation|1|||
125225902|NCT01789047|450454405|FG000|Overall Study|Adverse Event|3|||
125225903|NCT01789047|450454406|FG001|Overall Study|Adverse Event|2|||
125225904|NCT01789047|450454405|FG000|Overall Study|Withdrawal by Subject|1|||
125225905|NCT01789047|450454406|FG001|Overall Study|Withdrawal by Subject|2|||
125225906|NCT03644017|450454407|FG000|Overall Study|Access Abandonment|5|||
125225907|NCT03644017|450454407|FG000|Overall Study|Kidney Transplant|2|||
125225908|NCT02700048|450454408|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
125225909|NCT02700048|450454409|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
125225910|NCT02340000|450454412|FG000|Time Period 1|Withdrawal by Subject|6|||
125225911|NCT02340000|450454413|FG001|Time Period 1|Withdrawal by Subject|8|||
125225912|NCT02340000|450454412|FG000|Time Period 1|Lost to Follow-up|6|||
125225913|NCT02340000|450454413|FG001|Time Period 1|Lost to Follow-up|7|||
125225914|NCT02340000|450454412|FG000|Time Period 2|Withdrawal by Subject|9|||
125225915|NCT02340000|450454413|FG001|Time Period 2|Withdrawal by Subject|7|||
125225916|NCT02340000|450454412|FG000|Time Period 2|Lost to Follow-up|10|||
125225917|NCT02340000|450454413|FG001|Time Period 2|Lost to Follow-up|8|||
125225918|NCT02668640|450454414|FG000|Overall Study|Lost to Follow-up|13|||
125225919|NCT02668640|450454414|FG000|Overall Study|Other, not specified|1|||
125225920|NCT03669588|450454415|FG000|Overall Study|Adverse Event|1|||
125225921|NCT03669588|450454416|FG001|Overall Study|Adverse Event|0|||
125225922|NCT03669588|450454415|FG000|Overall Study|Physician Decision|0|||
125225923|NCT03669588|450454416|FG001|Overall Study|Physician Decision|1|||
125225924|NCT03669588|450454415|FG000|Overall Study|Protocol Violation|1|||
125225925|NCT03669588|450454416|FG001|Overall Study|Protocol Violation|0|||
125225926|NCT03669588|450454415|FG000|Overall Study|Sponsor Decision|1|||
125225927|NCT03669588|450454416|FG001|Overall Study|Sponsor Decision|1|||
125225928|NCT03669588|450454415|FG000|Overall Study|Withdrawal by Subject|1|||
125225929|NCT03669588|450454416|FG001|Overall Study|Withdrawal by Subject|4|||
125225930|NCT03669588|450454415|FG000|Overall Study|Rescue Therapy Needed|0|||
125225931|NCT03669588|450454416|FG001|Overall Study|Rescue Therapy Needed|1|||
125225932|NCT00369343|450454417|FG000|Double-blind Phase|Adverse Event|19|||
125225933|NCT00369343|450454418|FG001|Double-blind Phase|Adverse Event|4|||
125225934|NCT00369343|450454417|FG000|Double-blind Phase|Failed to return|2|||
125225935|NCT00369343|450454418|FG001|Double-blind Phase|Failed to return|0|||
125225936|NCT00369343|450454417|FG000|Double-blind Phase|Lost to Follow-up|9|||
125225937|NCT00369343|450454418|FG001|Double-blind Phase|Lost to Follow-up|2|||
125225938|NCT00369343|450454417|FG000|Double-blind Phase|Protocol Violation|2|||
125225939|NCT00369343|450454418|FG001|Double-blind Phase|Protocol Violation|0|||
125225940|NCT00369343|450454417|FG000|Double-blind Phase|Withdrawal by Subject|8|||
125225941|NCT00369343|450454418|FG001|Double-blind Phase|Withdrawal by Subject|6|||
125225942|NCT00369343|450454417|FG000|Double-blind Phase|Lack of Efficacy|0|||
125225943|NCT00369343|450454418|FG001|Double-blind Phase|Lack of Efficacy|4|||
125225944|NCT00369343|450454417|FG000|Double-blind Phase|Protocol deviation|4|||
125225945|NCT00369343|450454418|FG001|Double-blind Phase|Protocol deviation|0|||
125225946|NCT00369343|450454417|FG000|Open-label Phase|Adverse Event|19|||
125225947|NCT00369343|450454418|FG001|Open-label Phase|Adverse Event|7|||
125225948|NCT00369343|450454417|FG000|Open-label Phase|Failed to return|4|||
125225949|NCT00369343|450454418|FG001|Open-label Phase|Failed to return|0|||
125225950|NCT00369343|450454417|FG000|Open-label Phase|Physician Decision|2|||
125225951|NCT00369343|450454418|FG001|Open-label Phase|Physician Decision|0|||
125225952|NCT00369343|450454417|FG000|Open-label Phase|Lost to Follow-up|5|||
125225953|NCT00369343|450454418|FG001|Open-label Phase|Lost to Follow-up|3|||
125225954|NCT00369343|450454417|FG000|Open-label Phase|inadvertently reported study completers|3|||
125225955|NCT00369343|450454418|FG001|Open-label Phase|inadvertently reported study completers|2|||
125225956|NCT00369343|450454417|FG000|Open-label Phase|Protocol Violation|1|||
125225957|NCT00369343|450454418|FG001|Open-label Phase|Protocol Violation|3|||
125225958|NCT00369343|450454417|FG000|Open-label Phase|Withdrawal by Subject|15|||
125225959|NCT00369343|450454418|FG001|Open-label Phase|Withdrawal by Subject|6|||
125225960|NCT00369343|450454417|FG000|Open-label Phase|Lack of Efficacy|4|||
125225961|NCT00369343|450454418|FG001|Open-label Phase|Lack of Efficacy|3|||
125225962|NCT00369343|450454417|FG000|Open-label Phase|Lack of continuance tolerability|3|||
125225963|NCT00369343|450454418|FG001|Open-label Phase|Lack of continuance tolerability|4|||
125225964|NCT00369343|450454417|FG000|Open-label Phase|did not take study drug|1|||
125225965|NCT00369343|450454418|FG001|Open-label Phase|did not take study drug|2|||
125225966|NCT01100502|450454419|FG000|Overall Study|Withdrawal by Subject|18|||
125225967|NCT01100502|450454420|FG001|Overall Study|Withdrawal by Subject|25|||
125225968|NCT01100502|450454419|FG000|Overall Study|Lost to Follow-up|13|||
125225969|NCT01100502|450454420|FG001|Overall Study|Lost to Follow-up|28|||
125225970|NCT01100502|450454419|FG000|Overall Study|Site request to end participation in study|0|||
125225971|NCT01100502|450454420|FG001|Overall Study|Site request to end participation in study|1|||
125225972|NCT01100502|450454419|FG000|Overall Study|Death|45|||
125225973|NCT01100502|450454420|FG001|Overall Study|Death|40|||
125225974|NCT01190813|450454423|FG000|Overall Study|Lost to Follow-up|1|||
125225975|NCT01190813|450454424|FG001|Overall Study|Lost to Follow-up|2|||
125225976|NCT01190813|450454423|FG000|Overall Study|Withdrawal by Subject|2|||
125225977|NCT01190813|450454424|FG001|Overall Study|Withdrawal by Subject|1|||
125225978|NCT01190813|450454423|FG000|Overall Study|Refused study treatment after randomized|1|||
125225979|NCT01190813|450454424|FG001|Overall Study|Refused study treatment after randomized|0|||
125225980|NCT01190813|450454423|FG000|Overall Study|Adverse Event|0|||
125225981|NCT01190813|450454424|FG001|Overall Study|Adverse Event|1|||
125225982|NCT02481050|450456014|FG000|Overall Study|Adverse Event|1|||
125391961|NCT00026793|451068740|FG000|Overall Study|Death on study due to underlying disease|4|||
125391962|NCT00026793|451068740|FG000|Overall Study|Physician Decision|2|||
125225983|NCT02481050|450456014|FG000|Overall Study|Disease Progression|47|||
125225984|NCT02481050|450456014|FG000|Overall Study|Withdrawal by Subject|7|||
125225985|NCT02481050|450456014|FG000|Overall Study|Other|3|||
125225986|NCT01386606|450456015|FG000|Overall Study|Adverse Event|0|||
125225987|NCT01386606|450456016|FG001|Overall Study|Adverse Event|1|||
125225988|NCT01386606|450456017|FG002|Overall Study|Adverse Event|0|||
125225989|NCT01386606|450456018|FG003|Overall Study|Adverse Event|0|||
125225990|NCT01386606|450456015|FG000|Overall Study|Withdrawal by Subject|0|||
125225991|NCT01386606|450456016|FG001|Overall Study|Withdrawal by Subject|1|||
125225992|NCT01386606|450456017|FG002|Overall Study|Withdrawal by Subject|1|||
125225993|NCT01386606|450456018|FG003|Overall Study|Withdrawal by Subject|0|||
125225994|NCT01386606|450456015|FG000|Overall Study|Protocol Violation|1|||
125225995|NCT01386606|450456016|FG001|Overall Study|Protocol Violation|0|||
125225996|NCT01386606|450456017|FG002|Overall Study|Protocol Violation|1|||
125225997|NCT01386606|450456018|FG003|Overall Study|Protocol Violation|1|||
125225998|NCT01386606|450456015|FG000|Overall Study|Lost to Follow-up|2|||
125225999|NCT01386606|450456016|FG001|Overall Study|Lost to Follow-up|0|||
125226000|NCT01386606|450456017|FG002|Overall Study|Lost to Follow-up|0|||
125226001|NCT01386606|450456018|FG003|Overall Study|Lost to Follow-up|0|||
125226002|NCT01386606|450456015|FG000|Overall Study|Subject incarcerated|0|||
125226003|NCT01386606|450456016|FG001|Overall Study|Subject incarcerated|1|||
125226004|NCT01386606|450456017|FG002|Overall Study|Subject incarcerated|0|||
125226005|NCT01386606|450456018|FG003|Overall Study|Subject incarcerated|0|||
125226006|NCT01386606|450456015|FG000|Overall Study|Unable to draw PK|1|||
125226007|NCT01386606|450456016|FG001|Overall Study|Unable to draw PK|0|||
125226008|NCT01386606|450456017|FG002|Overall Study|Unable to draw PK|0|||
125226009|NCT01386606|450456018|FG003|Overall Study|Unable to draw PK|0|||
125226010|NCT01386606|450456015|FG000|Overall Study|T levels too high|0|||
125226011|NCT01386606|450456016|FG001|Overall Study|T levels too high|1|||
125226012|NCT01386606|450456017|FG002|Overall Study|T levels too high|1|||
125226013|NCT01386606|450456018|FG003|Overall Study|T levels too high|0|||
125226014|NCT03246347|450456021|FG000|Overall Study|On Study|23|||
125226015|NCT01022203|450456022|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
125226016|NCT01022203|450456023|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
125226017|NCT01022203|450456022|FG000|Post Treatment Assessment|Physician Decision|2|||
125226018|NCT01022203|450456023|FG001|Post Treatment Assessment|Physician Decision|0|||
125226019|NCT01022203|450456022|FG000|Post Treatment Assessment|Adverse Event|0|||
125226020|NCT01022203|450456023|FG001|Post Treatment Assessment|Adverse Event|2|||
125226021|NCT01022203|450456022|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
125226022|NCT01022203|450456023|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
125226023|NCT00903201|450456024|FG000|Overall Study|Adverse Event|1|||
125226024|NCT00903201|450456025|FG001|Overall Study|Adverse Event|4|||
125226025|NCT00903201|450456026|FG002|Overall Study|Adverse Event|0|||
125226026|NCT00903201|450456024|FG000|Overall Study|Protocol Violation|2|||
125226027|NCT00903201|450456025|FG001|Overall Study|Protocol Violation|1|||
125226028|NCT00903201|450456026|FG002|Overall Study|Protocol Violation|0|||
125226029|NCT00903201|450456024|FG000|Overall Study|Lost to Follow-up|0|||
125226030|NCT00903201|450456025|FG001|Overall Study|Lost to Follow-up|1|||
125226031|NCT00903201|450456026|FG002|Overall Study|Lost to Follow-up|0|||
125226032|NCT00903201|450456024|FG000|Overall Study|Physician Decision|1|||
125226033|NCT00903201|450456025|FG001|Overall Study|Physician Decision|0|||
125226034|NCT00903201|450456026|FG002|Overall Study|Physician Decision|1|||
125226035|NCT00903201|450456024|FG000|Overall Study|Withdrawal by Subject|1|||
125226036|NCT00903201|450456025|FG001|Overall Study|Withdrawal by Subject|0|||
125226037|NCT00903201|450456026|FG002|Overall Study|Withdrawal by Subject|1|||
125226038|NCT04069715|450456028|FG000|Overall Study|Lost to Follow-up|1|||
125226039|NCT04069715|450456029|FG001|Overall Study|Lost to Follow-up|1|||
125226040|NCT04069715|450456028|FG000|Overall Study|Physician Decision|1|||
125226041|NCT04069715|450456029|FG001|Overall Study|Physician Decision|1|||
125226042|NCT04069715|450456028|FG000|Overall Study|Withdrawal by Subject|3|||
125226043|NCT04069715|450456029|FG001|Overall Study|Withdrawal by Subject|3|||
125226044|NCT03205150|450456030|FG000|Overall Study|Protocol deviation|1|||
125226045|NCT03205150|450456031|FG001|Overall Study|Protocol deviation|3|||
125226046|NCT03205150|450456032|FG002|Overall Study|Protocol deviation|0|||
125226047|NCT03205150|450456030|FG000|Overall Study|Patient/guardian decision|0|||
125226048|NCT03205150|450456031|FG001|Overall Study|Patient/guardian decision|3|||
125226049|NCT03205150|450456032|FG002|Overall Study|Patient/guardian decision|0|||
125226050|NCT03205150|450456030|FG000|Overall Study|Adverse Event|1|||
125226051|NCT03205150|450456031|FG001|Overall Study|Adverse Event|1|||
125391963|NCT00026793|451068740|FG000|Overall Study|Off study|2|||
125391964|NCT04151290|451068741|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
125391965|NCT01449526|451068742|FG000|Overall Study|Lost to Follow-up|1|||
125391966|NCT01449526|451068743|FG001|Overall Study|Lost to Follow-up|2|||
125391967|NCT01449526|451068742|FG000|Overall Study|Withdrawal by Subject|1|||
125391968|NCT01449526|451068743|FG001|Overall Study|Withdrawal by Subject|1|||
125391969|NCT01449526|451068742|FG000|Overall Study|Symptoms/complaints|0|||
125226052|NCT03205150|450456032|FG002|Overall Study|Adverse Event|1|||
125226053|NCT03205150|450456030|FG000|Overall Study|Lost to Follow-up|0|||
125391970|NCT01449526|451068743|FG001|Overall Study|Symptoms/complaints|1|||
125226054|NCT03205150|450456031|FG001|Overall Study|Lost to Follow-up|0|||
125226055|NCT03205150|450456032|FG002|Overall Study|Lost to Follow-up|1|||
125226056|NCT02723188|450456033|FG000|Overall Study|Withdrawal by Subject|1|||
125226057|NCT02723188|450456034|FG001|Overall Study|Withdrawal by Subject|0|||
125226058|NCT02723188|450456035|FG002|Overall Study|Withdrawal by Subject|0|||
125226059|NCT03652818|450456043|FG000|Overall Study|Adverse Event|1|||
125226060|NCT03652818|450456044|FG001|Overall Study|Adverse Event|0|||
125226061|NCT03652818|450456045|FG002|Overall Study|Adverse Event|0|||
125226062|NCT03652818|450456046|FG003|Overall Study|Adverse Event|0|||
125226063|NCT03652818|450456047|FG004|Overall Study|Adverse Event|0|||
125226064|NCT03652818|450456043|FG000|Overall Study|Physician Decision|1|||
125226065|NCT03652818|450456044|FG001|Overall Study|Physician Decision|0|||
125226066|NCT03652818|450456045|FG002|Overall Study|Physician Decision|0|||
125226067|NCT03652818|450456046|FG003|Overall Study|Physician Decision|0|||
125226068|NCT03652818|450456047|FG004|Overall Study|Physician Decision|0|||
125226069|NCT03652818|450456043|FG000|Overall Study|Lost to Follow-up|0|||
125226070|NCT03652818|450456044|FG001|Overall Study|Lost to Follow-up|1|||
125226071|NCT03652818|450456045|FG002|Overall Study|Lost to Follow-up|2|||
125226072|NCT03652818|450456046|FG003|Overall Study|Lost to Follow-up|1|||
125226073|NCT03652818|450456047|FG004|Overall Study|Lost to Follow-up|1|||
125226074|NCT01930539|450456049|FG000|Overall Study|Withdrawal by Subject|2|||
125226075|NCT01930539|450456050|FG001|Overall Study|Withdrawal by Subject|2|||
125226076|NCT01241279|450456051|FG000|Overall Study|Lost to Follow-up|0|||
125226077|NCT01241279|450456052|FG001|Overall Study|Lost to Follow-up|1|||
125226078|NCT00301834|450456055|FG000|Overall Study|Death|1|||
125226079|NCT01811732|450456056|FG000|Overall Study|Lost to Follow-up|24|||
125226080|NCT01811732|450456057|FG001|Overall Study|Lost to Follow-up|30|||
125226081|NCT01811732|450456056|FG000|Overall Study|Withdrawal by Subject|16|||
125226082|NCT01811732|450456057|FG001|Overall Study|Withdrawal by Subject|10|||
125226083|NCT01811732|450456056|FG000|Overall Study|Adverse Event|3|||
125226084|NCT01811732|450456057|FG001|Overall Study|Adverse Event|9|||
125226085|NCT01811732|450456056|FG000|Overall Study|Lack of Efficacy|3|||
125226086|NCT01811732|450456057|FG001|Overall Study|Lack of Efficacy|1|||
125226087|NCT01811732|450456056|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
125226088|NCT01811732|450456057|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
125226089|NCT01811732|450456056|FG000|Overall Study|Physician Decision|2|||
125226090|NCT01811732|450456057|FG001|Overall Study|Physician Decision|0|||
125226091|NCT01811732|450456056|FG000|Overall Study|Death|1|||
125226092|NCT01811732|450456057|FG001|Overall Study|Death|1|||
125226093|NCT01811732|450456056|FG000|Overall Study|Insufficient venous access|0|||
125226094|NCT01811732|450456057|FG001|Overall Study|Insufficient venous access|1|||
125226095|NCT01811732|450456056|FG000|Overall Study|Protocol Violation|0|||
125226096|NCT01811732|450456057|FG001|Overall Study|Protocol Violation|1|||
125226097|NCT01811732|450456056|FG000|Overall Study|Subject incarcerated|1|||
125226098|NCT01811732|450456057|FG001|Overall Study|Subject incarcerated|2|||
125226099|NCT01811732|450456056|FG000|Overall Study|Admitted to another facility|1|||
125226100|NCT01811732|450456057|FG001|Overall Study|Admitted to another facility|0|||
125226101|NCT01811732|450456056|FG000|Overall Study|Correct study drug not available on site|1|||
125226102|NCT01811732|450456057|FG001|Overall Study|Correct study drug not available on site|0|||
125226103|NCT01607593|450456058|FG000|Overall Study|Adverse Event|15|||
125226104|NCT01607593|450456058|FG000|Overall Study|Lack of Efficacy|16|||
125226105|NCT01607593|450456058|FG000|Overall Study|Lost to Follow-up|25|||
125226106|NCT01607593|450456058|FG000|Overall Study|Continuation|33|||
125226107|NCT01607593|450456058|FG000|Overall Study|Other|4|||
125226108|NCT03669549|450456061|FG000|Overall Study|Adverse Event|4|||
125226109|NCT03669549|450456061|FG000|Overall Study|Withdrawal by Subject|1|||
125226110|NCT03669549|450456061|FG000|Overall Study|Study terminated by the Sponsor|1|||
125226111|NCT02974868|450456062|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
125226112|NCT02974868|450456063|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
125226113|NCT02974868|450456064|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
125226114|NCT02974868|450456065|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
125226115|NCT02974868|450456062|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
125226116|NCT02974868|450456063|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
125226117|NCT02974868|450456064|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
125226118|NCT02974868|450456065|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
125442243|NCT04781647|451248887|FG000|Overall Study|Virology rebounded|1|||
125442244|NCT04781647|451248888|FG001|Overall Study|Virology rebounded|0|||
125442245|NCT04781647|451248889|FG002|Overall Study|Virology rebounded|0|||
125226119|NCT02974868|450456062|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
125226120|NCT02974868|450456063|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
125226121|NCT02974868|450456064|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
125226122|NCT02974868|450456065|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
125226123|NCT02974868|450456062|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
125226124|NCT02974868|450456063|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
125226125|NCT02974868|450456064|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
125226126|NCT02974868|450456065|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
125226127|NCT00297648|450456068|FG000|Overall Study|Adverse Event|13|||
125226128|NCT00297648|450456068|FG000|Overall Study|Lack of Efficacy|18|||
125226129|NCT00297648|450456068|FG000|Overall Study|Lost to Follow-up|1|||
125226130|NCT00297648|450456068|FG000|Overall Study|Withdrawal by Subject|3|||
125226131|NCT00297648|450456068|FG000|Overall Study|Other: Incompliance|1|||
125442246|NCT01755689|451248890|FG000|Overall Study|Withdrawal by Subject|1|||
125442247|NCT01755689|451248891|FG001|Overall Study|Withdrawal by Subject|3|||
125442248|NCT01755689|451248892|FG002|Overall Study|Withdrawal by Subject|2|||
125442249|NCT01755689|451248893|FG003|Overall Study|Withdrawal by Subject|1|||
125442250|NCT01755689|451248894|FG004|Overall Study|Withdrawal by Subject|1|||
125442251|NCT01755689|451248890|FG000|Overall Study|Migrated/moved from study area|0|||
125442252|NCT01755689|451248891|FG001|Overall Study|Migrated/moved from study area|1|||
125442253|NCT01755689|451248892|FG002|Overall Study|Migrated/moved from study area|1|||
125442254|NCT01755689|451248893|FG003|Overall Study|Migrated/moved from study area|1|||
125442255|NCT01755689|451248894|FG004|Overall Study|Migrated/moved from study area|1|||
125442256|NCT01755689|451248890|FG000|Overall Study|Lost to Follow-up|1|||
125442257|NCT01755689|451248891|FG001|Overall Study|Lost to Follow-up|0|||
125442258|NCT01755689|451248892|FG002|Overall Study|Lost to Follow-up|1|||
125442259|NCT01755689|451248893|FG003|Overall Study|Lost to Follow-up|0|||
125442260|NCT01755689|451248894|FG004|Overall Study|Lost to Follow-up|2|||
125442261|NCT01755689|451248890|FG000|Overall Study|Pregnancy|1|||
125442262|NCT01755689|451248891|FG001|Overall Study|Pregnancy|1|||
125442263|NCT01755689|451248892|FG002|Overall Study|Pregnancy|2|||
125442264|NCT01755689|451248893|FG003|Overall Study|Pregnancy|4|||
125442265|NCT01755689|451248894|FG004|Overall Study|Pregnancy|2|||
125442266|NCT01327547|451248895|FG000|Overall Study|Adverse Event|4|||
125442267|NCT01327547|451248896|FG001|Overall Study|Adverse Event|1|||
125442268|NCT01327547|451248895|FG000|Overall Study|Death|1|||
125442269|NCT01327547|451248896|FG001|Overall Study|Death|2|||
125442270|NCT01327547|451248895|FG000|Overall Study|Lost to Follow-up|6|||
125442271|NCT01327547|451248896|FG001|Overall Study|Lost to Follow-up|6|||
125442272|NCT01327547|451248895|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
125442273|NCT01327547|451248896|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
125442274|NCT01327547|451248895|FG000|Overall Study|Withdrawal by Subject|3|||
125442275|NCT01327547|451248896|FG001|Overall Study|Withdrawal by Subject|7|||
125442276|NCT01327547|451248895|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
125442277|NCT01327547|451248896|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
125442278|NCT01327547|451248895|FG000|Overall Study|Protocol Violation|1|||
125442279|NCT01327547|451248896|FG001|Overall Study|Protocol Violation|0|||
125442280|NCT01327547|451248895|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
125442281|NCT01327547|451248896|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
125442282|NCT01327547|451248895|FG000|Overall Study|Required prohibited medication|2|||
125442283|NCT01327547|451248896|FG001|Overall Study|Required prohibited medication|0|||
125442284|NCT01327547|451248895|FG000|Overall Study|Non-compliance with study procedures|1|||
125442285|NCT01327547|451248896|FG001|Overall Study|Non-compliance with study procedures|0|||
125442286|NCT01327547|451248895|FG000|Overall Study|By investigator in subject's interest|0|||
125442287|NCT01327547|451248896|FG001|Overall Study|By investigator in subject's interest|1|||
125442288|NCT00329719|451248897|FG000|Overall Study|Lost to Follow-up|0|||
125442289|NCT00329719|451248898|FG001|Overall Study|Lost to Follow-up|0|||
125442290|NCT00329719|451248899|FG002|Overall Study|Lost to Follow-up|0|||
125442291|NCT00329719|451248900|FG003|Overall Study|Lost to Follow-up|1|||
125442292|NCT01995357|451248903|FG000|Period 5|Lack of Efficacy|1|||
125442293|NCT01995357|451248904|FG001|Period 5|Lack of Efficacy|0|||
125442294|NCT01995357|451248905|FG002|Period 5|Lack of Efficacy|0|||
125442295|NCT01995357|451248906|FG003|Period 5|Lack of Efficacy|0|||
125442296|NCT01995357|451248907|FG004|Period 5|Lack of Efficacy|0|||
125442297|NCT01995357|451248908|FG005|Period 5|Lack of Efficacy|0|||
125442298|NCT01995357|451248903|FG000|Period 5|Adverse Event|1|||
125442299|NCT01995357|451248904|FG001|Period 5|Adverse Event|0|||
125442300|NCT01995357|451248905|FG002|Period 5|Adverse Event|1|||
125442301|NCT01995357|451248906|FG003|Period 5|Adverse Event|0|||
125442302|NCT01995357|451248907|FG004|Period 5|Adverse Event|0|||
125442303|NCT01995357|451248908|FG005|Period 5|Adverse Event|0|||
125442304|NCT02462083|451248909|FG000|Overall Study|Sponsor request|39|||
125442305|NCT02462083|451248909|FG000|Overall Study|Withdrawal by Subject|87|||
125442306|NCT02462083|451248909|FG000|Overall Study|Lost to Follow-up|41|||
125165580|NCT04480710|450230332|FG002|Overall Study|Withdrawal by Subject|0|||
125165581|NCT04480710|450230333|FG003|Overall Study|Withdrawal by Subject|0|||
125165582|NCT04480710|450230330|FG000|Overall Study|Physician Decision|0|||
125442307|NCT02462083|451248909|FG000|Overall Study|Lack of Efficacy|151|||
125442308|NCT02462083|451248909|FG000|Overall Study|Pregnancy|1|||
125442309|NCT02462083|451248909|FG000|Overall Study|Protocol Violation|6|||
125442310|NCT02462083|451248909|FG000|Overall Study|Adverse Event|33|||
125442311|NCT02462083|451248909|FG000|Overall Study|Worsening condition|16|||
125442312|NCT02462083|451248909|FG000|Overall Study|Other than specified|45|||
125442313|NCT02291289|451248910|FG000|Induction Treatment|Withdrawal by Subject|0|||
125442314|NCT02291289|451248911|FG001|Induction Treatment|Withdrawal by Subject|0|||
125165583|NCT04480710|450230331|FG001|Overall Study|Physician Decision|0|||
125442315|NCT02291289|451248912|FG002|Induction Treatment|Withdrawal by Subject|0|||
125442316|NCT02291289|451248913|FG003|Induction Treatment|Withdrawal by Subject|24|||
125442317|NCT02291289|451248914|FG004|Induction Treatment|Withdrawal by Subject|0|||
125442318|NCT02291289|451248915|FG005|Induction Treatment|Withdrawal by Subject|0|||
125442319|NCT02291289|451248916|FG006|Induction Treatment|Withdrawal by Subject|0|||
125442320|NCT02291289|451248917|FG007|Induction Treatment|Withdrawal by Subject|0|||
125226132|NCT03903172|450456069|FG000|Overall Study|screen fail|4|||
125226133|NCT03903172|450456070|FG001|Overall Study|screen fail|1|||
125226134|NCT01545388|450456071|FG000|Overall Study|Adverse Event|2|||
125226135|NCT01545388|450456072|FG001|Overall Study|Adverse Event|4|||
125226136|NCT01545388|450456073|FG002|Overall Study|Adverse Event|1|||
125226137|NCT01545388|450456071|FG000|Overall Study|Lack of Efficacy|3|||
125226138|NCT01545388|450456072|FG001|Overall Study|Lack of Efficacy|2|||
125226139|NCT01545388|450456073|FG002|Overall Study|Lack of Efficacy|5|||
125226140|NCT01545388|450456071|FG000|Overall Study|Participant moved or relocated|1|||
125226141|NCT01545388|450456072|FG001|Overall Study|Participant moved or relocated|0|||
125226142|NCT01545388|450456073|FG002|Overall Study|Participant moved or relocated|0|||
125226143|NCT01545388|450456071|FG000|Overall Study|Withdrawal by Subject|1|||
125226144|NCT01545388|450456072|FG001|Overall Study|Withdrawal by Subject|4|||
125226145|NCT01545388|450456073|FG002|Overall Study|Withdrawal by Subject|2|||
125226146|NCT01545388|450456071|FG000|Overall Study|Other|1|||
125226147|NCT01545388|450456072|FG001|Overall Study|Other|1|||
125226148|NCT01545388|450456073|FG002|Overall Study|Other|0|||
125226149|NCT01701245|450456074|FG000|Overall Study|Protocol Violation|1|||
125226150|NCT01701245|450456075|FG001|Overall Study|Protocol Violation|3|||
125226151|NCT01701245|450456074|FG000|Overall Study|Did not complete the open label period|11|||
125226152|NCT01701245|450456075|FG001|Overall Study|Did not complete the open label period|12|||
125226153|NCT01867008|450456080|FG000|Overall Study|Withdrawal by Subject|1|||
125226154|NCT04613518|450456081|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
125226155|NCT04613518|450456082|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
125226156|NCT04613518|450456083|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
125226157|NCT04613518|450456081|FG000|Double-Blind Treatment Period|Adverse Event|2|||
125226158|NCT04613518|450456082|FG001|Double-Blind Treatment Period|Adverse Event|0|||
125226159|NCT04613518|450456083|FG002|Double-Blind Treatment Period|Adverse Event|1|||
125226160|NCT04613518|450456081|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
125226161|NCT04613518|450456082|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
125226162|NCT04613518|450456083|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
125226163|NCT04613518|450456081|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
125226164|NCT04613518|450456082|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
125226165|NCT04613518|450456083|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
125226166|NCT04613518|450456081|FG000|Double-Blind Treatment Period|Other Reasons|2|||
125226167|NCT04613518|450456082|FG001|Double-Blind Treatment Period|Other Reasons|0|||
125226168|NCT04613518|450456083|FG002|Double-Blind Treatment Period|Other Reasons|0|||
125226169|NCT04613518|450456081|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
125226170|NCT04613518|450456082|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
125226171|NCT04613518|450456083|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
125226172|NCT04613518|450456081|FG000|Open-Label Treatment Period|Adverse Event|1|||
125226173|NCT04613518|450456082|FG001|Open-Label Treatment Period|Adverse Event|0|||
125226174|NCT04613518|450456083|FG002|Open-Label Treatment Period|Adverse Event|3|||
125226175|NCT04613518|450456081|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
125226176|NCT04613518|450456082|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
125226177|NCT04613518|450456083|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
125226178|NCT04613518|450456081|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
125226179|NCT04613518|450456082|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
125226180|NCT04613518|450456083|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
125226181|NCT04613518|450456081|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
125226182|NCT04613518|450456082|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
125226183|NCT04613518|450456083|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
125226184|NCT04613518|450456081|FG000|Open-Label Treatment Period|Other reasons|1|||
125226185|NCT04613518|450456082|FG001|Open-Label Treatment Period|Other reasons|0|||
125226186|NCT04613518|450456083|FG002|Open-Label Treatment Period|Other reasons|0|||
125226187|NCT05616013|450456084|FG000|Overall Study|Adverse Event|6|||
125226188|NCT05616013|450456085|FG001|Overall Study|Adverse Event|12|||
125226189|NCT05616013|450456086|FG002|Overall Study|Adverse Event|8|||
125226190|NCT05616013|450456087|FG003|Overall Study|Adverse Event|4|||
125226191|NCT05616013|450456088|FG004|Overall Study|Adverse Event|6|||
125226192|NCT05616013|450456089|FG005|Overall Study|Adverse Event|8|||
125226193|NCT05616013|450456090|FG006|Overall Study|Adverse Event|3|||
125226194|NCT05616013|450456091|FG007|Overall Study|Adverse Event|6|||
125226195|NCT05616013|450456092|FG008|Overall Study|Adverse Event|1|||
125226196|NCT05616013|450456084|FG000|Overall Study|Lost to Follow-up|5|||
125226197|NCT05616013|450456085|FG001|Overall Study|Lost to Follow-up|4|||
125226198|NCT05616013|450456086|FG002|Overall Study|Lost to Follow-up|3|||
125226199|NCT05616013|450456087|FG003|Overall Study|Lost to Follow-up|2|||
125226200|NCT05616013|450456088|FG004|Overall Study|Lost to Follow-up|0|||
125226201|NCT05616013|450456089|FG005|Overall Study|Lost to Follow-up|5|||
125226202|NCT05616013|450456090|FG006|Overall Study|Lost to Follow-up|2|||
125226203|NCT05616013|450456091|FG007|Overall Study|Lost to Follow-up|1|||
125226204|NCT05616013|450456092|FG008|Overall Study|Lost to Follow-up|2|||
125165584|NCT04480710|450230332|FG002|Overall Study|Physician Decision|1|||
125165585|NCT04480710|450230333|FG003|Overall Study|Physician Decision|0|||
125165586|NCT04480021|450230334|FG000|Overall Study|Lost to Follow-up|3|||
125165587|NCT04480021|450230335|FG001|Overall Study|Lost to Follow-up|4|||
125165588|NCT03384654|450230339|FG000|Overall Study|Withdrawal by Subject|0|||
125165589|NCT03384654|450230340|FG001|Overall Study|Withdrawal by Subject|0|||
125165590|NCT03384654|450230341|FG002|Overall Study|Withdrawal by Subject|1|||
125165591|NCT03384654|450230342|FG003|Overall Study|Withdrawal by Subject|0|||
125165592|NCT00423319|450230343|FG000|Overall Study|Death|2|||
125165593|NCT00423319|450230344|FG001|Overall Study|Death|0|||
125165594|NCT00423319|450230343|FG000|Overall Study|Adverse Event|93|||
125165595|NCT00423319|450230344|FG001|Overall Study|Adverse Event|112|||
125165596|NCT00423319|450230343|FG000|Overall Study|Withdrawal by Subject|86|||
125165597|NCT00423319|450230344|FG001|Overall Study|Withdrawal by Subject|99|||
125165598|NCT00423319|450230343|FG000|Overall Study|Lost to Follow-up|4|||
125165599|NCT00423319|450230344|FG001|Overall Study|Lost to Follow-up|3|||
125165600|NCT00423319|450230343|FG000|Overall Study|Poor compliance or noncompliance|1|||
125165601|NCT00423319|450230344|FG001|Overall Study|Poor compliance or noncompliance|1|||
125165602|NCT00423319|450230343|FG000|Overall Study|No longer meets study criteria|15|||
125165603|NCT00423319|450230344|FG001|Overall Study|No longer meets study criteria|15|||
125165604|NCT00423319|450230343|FG000|Overall Study|Other|23|||
125165605|NCT00423319|450230344|FG001|Overall Study|Other|22|||
125165606|NCT01584843|450230345|FG000|First Treatment Period|Adverse Event|0|||
125165607|NCT01584843|450230346|FG001|First Treatment Period|Adverse Event|0|||
125165608|NCT01584843|450230347|FG002|First Treatment Period|Adverse Event|1|||
125165609|NCT01584843|450230348|FG003|First Treatment Period|Adverse Event|0|||
125165610|NCT01584843|450230349|FG004|First Treatment Period|Adverse Event|0|||
125165611|NCT01584843|450230350|FG005|First Treatment Period|Adverse Event|0|||
125165612|NCT01584843|450230345|FG000|First Treatment Period|Protocol Violation|0|||
125165613|NCT01584843|450230346|FG001|First Treatment Period|Protocol Violation|0|||
125165614|NCT01584843|450230347|FG002|First Treatment Period|Protocol Violation|0|||
125165615|NCT01584843|450230348|FG003|First Treatment Period|Protocol Violation|0|||
125165616|NCT01584843|450230349|FG004|First Treatment Period|Protocol Violation|0|||
125165617|NCT01584843|450230350|FG005|First Treatment Period|Protocol Violation|1|||
125165618|NCT01584843|450230345|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
125165619|NCT01584843|450230346|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
125165620|NCT01584843|450230347|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
125165621|NCT01584843|450230348|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
125165622|NCT01584843|450230349|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
125165623|NCT01584843|450230350|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
125165624|NCT01584843|450230345|FG000|Second Treatment Period|Withdrawal by Subject|0|||
125165625|NCT01584843|450230346|FG001|Second Treatment Period|Withdrawal by Subject|0|||
125165626|NCT01584843|450230347|FG002|Second Treatment Period|Withdrawal by Subject|0|||
125165627|NCT01584843|450230348|FG003|Second Treatment Period|Withdrawal by Subject|0|||
125165628|NCT01584843|450230349|FG004|Second Treatment Period|Withdrawal by Subject|0|||
125165629|NCT01584843|450230350|FG005|Second Treatment Period|Withdrawal by Subject|1|||
125165630|NCT00311402|450230351|FG000|Overall Study|Adverse Event|118|||
125165631|NCT00311402|450230352|FG001|Overall Study|Adverse Event|105|||
125165632|NCT00311402|450230351|FG000|Overall Study|Lost to Follow-up|0|||
125165633|NCT00311402|450230352|FG001|Overall Study|Lost to Follow-up|3|||
125165634|NCT00311402|450230351|FG000|Overall Study|Withdrawal by Subject|17|||
125165635|NCT00311402|450230352|FG001|Overall Study|Withdrawal by Subject|18|||
125165636|NCT00311402|450230351|FG000|Overall Study|Lack of Efficacy|58|||
125165637|NCT00311402|450230352|FG001|Overall Study|Lack of Efficacy|42|||
125165638|NCT00311402|450230351|FG000|Overall Study|Protocol Violation|7|||
125165639|NCT00311402|450230352|FG001|Overall Study|Protocol Violation|6|||
125165640|NCT00311402|450230351|FG000|Overall Study|IRB's rejection etc.|10|||
125165641|NCT00311402|450230352|FG001|Overall Study|IRB's rejection etc.|3|||
125165642|NCT02640053|450230353|FG000|Overall Study|Withdrawal by Subject|2|||
125165643|NCT02640053|450230354|FG001|Overall Study|Withdrawal by Subject|1|||
125165644|NCT02640053|450230353|FG000|Overall Study|Adverse Event|1|||
125165645|NCT02640053|450230354|FG001|Overall Study|Adverse Event|1|||
125165646|NCT02640053|450230353|FG000|Overall Study|Alternative Therapy|1|||
125165647|NCT02640053|450230354|FG001|Overall Study|Alternative Therapy|1|||
125165648|NCT02640053|450230353|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
125165649|NCT02640053|450230354|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
125165650|NCT03283761|450230355|FG000|Study Treatment|Patient Non-Compliance|1|||
125165651|NCT03283761|450230355|FG000|Study Treatment|Alternative Cancer Therapy|7|||
125165652|NCT03283761|450230355|FG000|Study Treatment|Disease progression|21|||
125165653|NCT03283761|450230355|FG000|Study Treatment|Adverse Event|3|||
125165654|NCT03283761|450230355|FG000|Study Treatment|Withdrawal by Subject|4|||
125165655|NCT03283761|450230355|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
125165656|NCT03283761|450230355|FG000|Study Treatment|Symptomatic Deterioration|1|||
125165657|NCT03283761|450230355|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
125226205|NCT05616013|450456084|FG000|Overall Study|Non-compliance with study requirements|2|||
125226206|NCT05616013|450456085|FG001|Overall Study|Non-compliance with study requirements|2|||
125226207|NCT05616013|450456086|FG002|Overall Study|Non-compliance with study requirements|2|||
125226208|NCT05616013|450456087|FG003|Overall Study|Non-compliance with study requirements|3|||
125226209|NCT05616013|450456088|FG004|Overall Study|Non-compliance with study requirements|0|||
125226210|NCT05616013|450456089|FG005|Overall Study|Non-compliance with study requirements|2|||
125226211|NCT05616013|450456090|FG006|Overall Study|Non-compliance with study requirements|1|||
125226212|NCT05616013|450456091|FG007|Overall Study|Non-compliance with study requirements|1|||
125226213|NCT05616013|450456092|FG008|Overall Study|Non-compliance with study requirements|4|||
125226214|NCT05616013|450456084|FG000|Overall Study|Withdrawal by Subject|11|||
125226215|NCT05616013|450456085|FG001|Overall Study|Withdrawal by Subject|9|||
125226216|NCT05616013|450456086|FG002|Overall Study|Withdrawal by Subject|8|||
125226217|NCT05616013|450456087|FG003|Overall Study|Withdrawal by Subject|6|||
125226218|NCT05616013|450456088|FG004|Overall Study|Withdrawal by Subject|3|||
125226219|NCT05616013|450456089|FG005|Overall Study|Withdrawal by Subject|4|||
125226220|NCT05616013|450456090|FG006|Overall Study|Withdrawal by Subject|6|||
125226221|NCT05616013|450456091|FG007|Overall Study|Withdrawal by Subject|5|||
125226222|NCT05616013|450456092|FG008|Overall Study|Withdrawal by Subject|4|||
125226223|NCT05616013|450456084|FG000|Overall Study|Physician Decision|0|||
125226224|NCT05616013|450456085|FG001|Overall Study|Physician Decision|0|||
125226225|NCT05616013|450456086|FG002|Overall Study|Physician Decision|1|||
125226226|NCT05616013|450456087|FG003|Overall Study|Physician Decision|0|||
125226227|NCT05616013|450456088|FG004|Overall Study|Physician Decision|0|||
125226228|NCT05616013|450456089|FG005|Overall Study|Physician Decision|1|||
125226229|NCT05616013|450456090|FG006|Overall Study|Physician Decision|3|||
125226230|NCT05616013|450456091|FG007|Overall Study|Physician Decision|0|||
125226231|NCT05616013|450456092|FG008|Overall Study|Physician Decision|0|||
125226232|NCT05616013|450456084|FG000|Overall Study|Protocol Violation|0|||
125226233|NCT05616013|450456085|FG001|Overall Study|Protocol Violation|0|||
125226234|NCT05616013|450456086|FG002|Overall Study|Protocol Violation|0|||
125226235|NCT05616013|450456087|FG003|Overall Study|Protocol Violation|0|||
125226236|NCT05616013|450456088|FG004|Overall Study|Protocol Violation|0|||
125226237|NCT05616013|450456089|FG005|Overall Study|Protocol Violation|0|||
125226238|NCT05616013|450456090|FG006|Overall Study|Protocol Violation|1|||
125226239|NCT05616013|450456091|FG007|Overall Study|Protocol Violation|0|||
125226240|NCT05616013|450456092|FG008|Overall Study|Protocol Violation|2|||
125226241|NCT05616013|450456084|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
125226242|NCT05616013|450456085|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226243|NCT05616013|450456086|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226244|NCT05616013|450456087|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226245|NCT05616013|450456088|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226246|NCT05616013|450456089|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226247|NCT05616013|450456090|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226248|NCT05616013|450456091|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226249|NCT05616013|450456092|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
125226250|NCT05616013|450456084|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
125226251|NCT05616013|450456085|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226252|NCT05616013|450456086|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226253|NCT05616013|450456087|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226254|NCT05616013|450456088|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226255|NCT05616013|450456089|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226256|NCT05616013|450456090|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226257|NCT05616013|450456091|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226258|NCT05616013|450456092|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
125226259|NCT05616013|450456084|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
125226260|NCT05616013|450456085|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226261|NCT05616013|450456086|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226262|NCT05616013|450456087|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226263|NCT05616013|450456088|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226264|NCT05616013|450456089|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226265|NCT05616013|450456090|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125226266|NCT05616013|450456091|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125391971|NCT01449526|451068742|FG000|Overall Study|Lack of Motivation|0|||
125391972|NCT01449526|451068743|FG001|Overall Study|Lack of Motivation|1|||
125226267|NCT05616013|450456092|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
125391973|NCT01449526|451068742|FG000|Overall Study|Cannot maintain visits|0|||
125391974|NCT01449526|451068743|FG001|Overall Study|Cannot maintain visits|1|||
125391975|NCT01132495|451068744|FG000|Overall Study|Various reasons|40|||
125391976|NCT01132495|451068745|FG001|Overall Study|Various reasons|38|||
125226268|NCT05616013|450456084|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226269|NCT05616013|450456085|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
125226270|NCT05616013|450456086|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226271|NCT05616013|450456087|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226272|NCT05616013|450456088|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226273|NCT05616013|450456089|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226274|NCT05616013|450456090|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226275|NCT05616013|450456091|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226276|NCT05616013|450456092|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
125226277|NCT05616013|450456084|FG000|Overall Study|Participant Decision, Time Constraints|0|||
125226278|NCT05616013|450456085|FG001|Overall Study|Participant Decision, Time Constraints|1|||
125226279|NCT05616013|450456086|FG002|Overall Study|Participant Decision, Time Constraints|0|||
125226280|NCT05616013|450456087|FG003|Overall Study|Participant Decision, Time Constraints|0|||
125226281|NCT05616013|450456088|FG004|Overall Study|Participant Decision, Time Constraints|0|||
125226282|NCT05616013|450456089|FG005|Overall Study|Participant Decision, Time Constraints|0|||
125226283|NCT05616013|450456090|FG006|Overall Study|Participant Decision, Time Constraints|0|||
125226284|NCT05616013|450456091|FG007|Overall Study|Participant Decision, Time Constraints|0|||
125226285|NCT05616013|450456092|FG008|Overall Study|Participant Decision, Time Constraints|0|||
125226286|NCT05616013|450456084|FG000|Overall Study|Prohibited Concomitant Medication|0|||
125226287|NCT05616013|450456085|FG001|Overall Study|Prohibited Concomitant Medication|0|||
125226288|NCT05616013|450456086|FG002|Overall Study|Prohibited Concomitant Medication|1|||
125226289|NCT05616013|450456087|FG003|Overall Study|Prohibited Concomitant Medication|0|||
125226290|NCT05616013|450456088|FG004|Overall Study|Prohibited Concomitant Medication|0|||
125226291|NCT05616013|450456089|FG005|Overall Study|Prohibited Concomitant Medication|0|||
125226292|NCT05616013|450456090|FG006|Overall Study|Prohibited Concomitant Medication|0|||
125226293|NCT05616013|450456091|FG007|Overall Study|Prohibited Concomitant Medication|0|||
125226294|NCT05616013|450456092|FG008|Overall Study|Prohibited Concomitant Medication|0|||
125226295|NCT05616013|450456084|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226296|NCT05616013|450456085|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226297|NCT05616013|450456086|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
125226298|NCT05616013|450456087|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226299|NCT05616013|450456088|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226300|NCT05616013|450456089|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226301|NCT05616013|450456090|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226302|NCT05616013|450456091|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226303|NCT05616013|450456092|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
125226304|NCT05616013|450456084|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226305|NCT05616013|450456085|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226306|NCT05616013|450456086|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226307|NCT05616013|450456087|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
125226308|NCT05616013|450456088|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226309|NCT05616013|450456089|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226310|NCT05616013|450456090|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226311|NCT05616013|450456091|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226312|NCT05616013|450456092|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
125226313|NCT05616013|450456084|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226314|NCT05616013|450456085|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226315|NCT05616013|450456086|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226316|NCT05616013|450456087|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226317|NCT05616013|450456088|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226318|NCT05616013|450456089|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226319|NCT05616013|450456090|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
125226320|NCT05616013|450456091|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226321|NCT05616013|450456092|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
125226322|NCT05616013|450456084|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226323|NCT05616013|450456085|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125303179|NCT03100058|450736663|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303180|NCT03100058|450736664|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303181|NCT03100058|450736665|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303182|NCT03100058|450736666|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125226324|NCT05616013|450456086|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226325|NCT05616013|450456087|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226326|NCT05616013|450456088|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226327|NCT05616013|450456089|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226328|NCT05616013|450456090|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226329|NCT05616013|450456091|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
125226330|NCT05616013|450456092|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
125226331|NCT05616013|450456084|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226332|NCT05616013|450456085|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226333|NCT05616013|450456086|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226334|NCT05616013|450456087|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226335|NCT05616013|450456088|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226336|NCT05616013|450456089|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226337|NCT05616013|450456090|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226338|NCT05616013|450456091|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
125226339|NCT05616013|450456092|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
125226340|NCT05116202|450456093|FG000|Overall Study|Study Terminated by Sponsor|21|||
125226341|NCT05116202|450456094|FG001|Overall Study|Study Terminated by Sponsor|38|||
125226342|NCT05116202|450456095|FG002|Overall Study|Study Terminated by Sponsor|17|||
125226343|NCT05116202|450456096|FG003|Overall Study|Study Terminated by Sponsor|18|||
125226344|NCT05116202|450456097|FG004|Overall Study|Study Terminated by Sponsor|0|||
125226345|NCT05116202|450456093|FG000|Overall Study|Withdrawal by Subject|0|||
125226346|NCT05116202|450456094|FG001|Overall Study|Withdrawal by Subject|1|||
125226347|NCT05116202|450456095|FG002|Overall Study|Withdrawal by Subject|1|||
125226348|NCT05116202|450456096|FG003|Overall Study|Withdrawal by Subject|1|||
125226349|NCT05116202|450456097|FG004|Overall Study|Withdrawal by Subject|1|||
125226350|NCT05116202|450456093|FG000|Overall Study|Lost to Follow-up|0|||
125226351|NCT05116202|450456094|FG001|Overall Study|Lost to Follow-up|0|||
125226352|NCT05116202|450456095|FG002|Overall Study|Lost to Follow-up|0|||
125226353|NCT05116202|450456096|FG003|Overall Study|Lost to Follow-up|0|||
125226354|NCT05116202|450456097|FG004|Overall Study|Lost to Follow-up|2|||
125226355|NCT05116202|450456093|FG000|Overall Study|Death|1|||
125226356|NCT05116202|450456094|FG001|Overall Study|Death|1|||
125226357|NCT05116202|450456095|FG002|Overall Study|Death|2|||
125226358|NCT05116202|450456096|FG003|Overall Study|Death|1|||
125226359|NCT05116202|450456097|FG004|Overall Study|Death|5|||
125226360|NCT02322749|450456111|FG000|Period 2|Adverse Event|0|||
125226361|NCT02322749|450456112|FG001|Period 2|Adverse Event|0|||
125226362|NCT02322749|450456113|FG002|Period 2|Adverse Event|0|||
125226363|NCT02322749|450456114|FG003|Period 2|Adverse Event|1|||
125226364|NCT02322749|450456115|FG004|Period 2|Adverse Event|0|||
125226365|NCT02322749|450456116|FG005|Period 2|Adverse Event|0|||
125226366|NCT02322749|450456111|FG000|Period 2|Withdrawal by Subject|0|||
125226367|NCT02322749|450456112|FG001|Period 2|Withdrawal by Subject|0|||
125226368|NCT02322749|450456113|FG002|Period 2|Withdrawal by Subject|0|||
125226369|NCT02322749|450456114|FG003|Period 2|Withdrawal by Subject|1|||
125226370|NCT02322749|450456115|FG004|Period 2|Withdrawal by Subject|0|||
125226371|NCT02322749|450456116|FG005|Period 2|Withdrawal by Subject|0|||
125226372|NCT02322749|450456111|FG000|Period 3|Withdrawal by Subject|0|||
125226373|NCT02322749|450456112|FG001|Period 3|Withdrawal by Subject|0|||
125226374|NCT02322749|450456113|FG002|Period 3|Withdrawal by Subject|1|||
125226375|NCT02322749|450456114|FG003|Period 3|Withdrawal by Subject|0|||
125226376|NCT02322749|450456115|FG004|Period 3|Withdrawal by Subject|0|||
125226377|NCT02322749|450456116|FG005|Period 3|Withdrawal by Subject|0|||
125226378|NCT00073918|450456121|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
125226379|NCT00073918|450456121|FG000|Overall Study|Rapid disease progression|2|||
125226380|NCT00073918|450456121|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
125226381|NCT05158140|450456128|FG000|Overall Study|Death|0|||
125226382|NCT05158140|450456129|FG001|Overall Study|Death|0|||
125226383|NCT05158140|450456130|FG002|Overall Study|Death|0|||
125226384|NCT05158140|450456131|FG003|Overall Study|Death|1|||
125226385|NCT05158140|450456128|FG000|Overall Study|Lost to Follow-up|3|||
125226386|NCT05158140|450456129|FG001|Overall Study|Lost to Follow-up|6|||
125226387|NCT05158140|450456130|FG002|Overall Study|Lost to Follow-up|4|||
125226388|NCT05158140|450456131|FG003|Overall Study|Lost to Follow-up|3|||
125226389|NCT05158140|450456128|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125391977|NCT01132495|451068746|FG002|Overall Study|Various reasons|20|||
125226390|NCT05158140|450456129|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125226391|NCT05158140|450456130|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
125226392|NCT05158140|450456131|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125226393|NCT05158140|450456128|FG000|Overall Study|Withdrawal by Subject|3|||
125226394|NCT05158140|450456129|FG001|Overall Study|Withdrawal by Subject|7|||
125226395|NCT05158140|450456130|FG002|Overall Study|Withdrawal by Subject|3|||
125442321|NCT02291289|451248918|FG008|Induction Treatment|Withdrawal by Subject|0|||
125442322|NCT02291289|451248919|FG009|Induction Treatment|Withdrawal by Subject|18|||
125442323|NCT02291289|451248920|FG010|Induction Treatment|Withdrawal by Subject|0|||
125442324|NCT02291289|451248921|FG011|Induction Treatment|Withdrawal by Subject|0|||
125442325|NCT02291289|451248922|FG012|Induction Treatment|Withdrawal by Subject|0|||
125442326|NCT02291289|451248910|FG000|Induction Treatment|Adverse Event|0|||
125442327|NCT02291289|451248911|FG001|Induction Treatment|Adverse Event|0|||
125442328|NCT02291289|451248912|FG002|Induction Treatment|Adverse Event|0|||
125442329|NCT02291289|451248913|FG003|Induction Treatment|Adverse Event|3|||
125442330|NCT02291289|451248914|FG004|Induction Treatment|Adverse Event|0|||
125442331|NCT02291289|451248915|FG005|Induction Treatment|Adverse Event|0|||
125442332|NCT02291289|451248916|FG006|Induction Treatment|Adverse Event|0|||
125442333|NCT02291289|451248917|FG007|Induction Treatment|Adverse Event|0|||
125442334|NCT02291289|451248918|FG008|Induction Treatment|Adverse Event|0|||
125442335|NCT02291289|451248919|FG009|Induction Treatment|Adverse Event|1|||
125442336|NCT02291289|451248920|FG010|Induction Treatment|Adverse Event|0|||
125442337|NCT02291289|451248921|FG011|Induction Treatment|Adverse Event|0|||
125442338|NCT02291289|451248922|FG012|Induction Treatment|Adverse Event|0|||
125442339|NCT02291289|451248910|FG000|Induction Treatment|Death|25|||
125442340|NCT02291289|451248911|FG001|Induction Treatment|Death|0|||
125442341|NCT02291289|451248912|FG002|Induction Treatment|Death|0|||
125442342|NCT02291289|451248913|FG003|Induction Treatment|Death|111|||
125442343|NCT02291289|451248914|FG004|Induction Treatment|Death|0|||
125442344|NCT02291289|451248915|FG005|Induction Treatment|Death|0|||
125442345|NCT02291289|451248916|FG006|Induction Treatment|Death|1|||
125442346|NCT02291289|451248917|FG007|Induction Treatment|Death|0|||
125442347|NCT02291289|451248918|FG008|Induction Treatment|Death|0|||
125442348|NCT02291289|451248919|FG009|Induction Treatment|Death|82|||
125442349|NCT02291289|451248920|FG010|Induction Treatment|Death|0|||
125442350|NCT02291289|451248921|FG011|Induction Treatment|Death|0|||
125442351|NCT02291289|451248922|FG012|Induction Treatment|Death|0|||
125442352|NCT02291289|451248910|FG000|Induction Treatment|Lost to Follow-up|1|||
125442353|NCT02291289|451248911|FG001|Induction Treatment|Lost to Follow-up|0|||
125442354|NCT02291289|451248912|FG002|Induction Treatment|Lost to Follow-up|0|||
125442355|NCT02291289|451248913|FG003|Induction Treatment|Lost to Follow-up|12|||
125442356|NCT02291289|451248914|FG004|Induction Treatment|Lost to Follow-up|0|||
125442357|NCT02291289|451248915|FG005|Induction Treatment|Lost to Follow-up|0|||
125442358|NCT02291289|451248916|FG006|Induction Treatment|Lost to Follow-up|0|||
125442359|NCT02291289|451248917|FG007|Induction Treatment|Lost to Follow-up|0|||
125442360|NCT02291289|451248918|FG008|Induction Treatment|Lost to Follow-up|0|||
125442361|NCT02291289|451248919|FG009|Induction Treatment|Lost to Follow-up|9|||
125442362|NCT02291289|451248920|FG010|Induction Treatment|Lost to Follow-up|0|||
125442363|NCT02291289|451248921|FG011|Induction Treatment|Lost to Follow-up|0|||
125442364|NCT02291289|451248922|FG012|Induction Treatment|Lost to Follow-up|0|||
125442365|NCT02291289|451248910|FG000|Induction Treatment|Non-Compliance|0|||
125442366|NCT02291289|451248911|FG001|Induction Treatment|Non-Compliance|0|||
125442367|NCT02291289|451248912|FG002|Induction Treatment|Non-Compliance|0|||
125442368|NCT02291289|451248913|FG003|Induction Treatment|Non-Compliance|1|||
125442369|NCT02291289|451248914|FG004|Induction Treatment|Non-Compliance|0|||
125442370|NCT02291289|451248915|FG005|Induction Treatment|Non-Compliance|0|||
125442371|NCT02291289|451248916|FG006|Induction Treatment|Non-Compliance|0|||
125442372|NCT02291289|451248917|FG007|Induction Treatment|Non-Compliance|0|||
125442373|NCT02291289|451248918|FG008|Induction Treatment|Non-Compliance|0|||
125442374|NCT02291289|451248919|FG009|Induction Treatment|Non-Compliance|1|||
125442375|NCT02291289|451248920|FG010|Induction Treatment|Non-Compliance|0|||
125442376|NCT02291289|451248921|FG011|Induction Treatment|Non-Compliance|0|||
125442377|NCT02291289|451248922|FG012|Induction Treatment|Non-Compliance|0|||
125442378|NCT02291289|451248910|FG000|Induction Treatment|Reason Not Specified|0|||
125442379|NCT02291289|451248911|FG001|Induction Treatment|Reason Not Specified|0|||
125442380|NCT02291289|451248912|FG002|Induction Treatment|Reason Not Specified|0|||
125442381|NCT02291289|451248913|FG003|Induction Treatment|Reason Not Specified|4|||
125442382|NCT02291289|451248914|FG004|Induction Treatment|Reason Not Specified|0|||
125442383|NCT02291289|451248915|FG005|Induction Treatment|Reason Not Specified|0|||
125442384|NCT02291289|451248916|FG006|Induction Treatment|Reason Not Specified|0|||
125442385|NCT02291289|451248917|FG007|Induction Treatment|Reason Not Specified|0|||
125442386|NCT02291289|451248918|FG008|Induction Treatment|Reason Not Specified|0|||
125442387|NCT02291289|451248919|FG009|Induction Treatment|Reason Not Specified|7|||
125442388|NCT02291289|451248920|FG010|Induction Treatment|Reason Not Specified|0|||
125442389|NCT02291289|451248921|FG011|Induction Treatment|Reason Not Specified|0|||
125442390|NCT02291289|451248922|FG012|Induction Treatment|Reason Not Specified|0|||
125442391|NCT02291289|451248910|FG000|Induction Treatment|Physician Decision|0|||
125442392|NCT02291289|451248911|FG001|Induction Treatment|Physician Decision|0|||
125442393|NCT02291289|451248912|FG002|Induction Treatment|Physician Decision|0|||
125442394|NCT02291289|451248913|FG003|Induction Treatment|Physician Decision|3|||
125442395|NCT02291289|451248914|FG004|Induction Treatment|Physician Decision|0|||
125442396|NCT02291289|451248915|FG005|Induction Treatment|Physician Decision|0|||
125442397|NCT02291289|451248916|FG006|Induction Treatment|Physician Decision|0|||
125442398|NCT02291289|451248917|FG007|Induction Treatment|Physician Decision|0|||
125391978|NCT01132495|451068747|FG003|Overall Study|Various reasons|12|||
125165658|NCT03283761|450230355|FG000|Follow up|Lost to Follow-up|1|||
125165659|NCT03283761|450230355|FG000|Follow up|Symptomatic Deterioration|1|||
125165660|NCT03283761|450230355|FG000|Follow up|Death|29|||
125165661|NCT03283761|450230355|FG000|Follow up|study terminated|4|||
125165662|NCT03283761|450230355|FG000|Follow up|Primary Investigator Withdrawal|1|||
125165663|NCT03283761|450230355|FG000|Follow up|Switched to alternative therapy|1|||
125165664|NCT03283761|450230355|FG000|Follow up|Subject is now in Hospice|1|||
125165665|NCT02036775|450230356|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
125165666|NCT02036775|450230357|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
125165667|NCT02036775|450230358|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
125165668|NCT02036775|450230359|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
125165669|NCT02036775|450230360|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
125165670|NCT02036775|450230361|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
125165671|NCT00678886|450230362|FG000|Overall Study|Withdrawal by Subject|0|||
125165672|NCT00678886|450230363|FG001|Overall Study|Withdrawal by Subject|0|||
125165673|NCT00678886|450230364|FG002|Overall Study|Withdrawal by Subject|4|||
125165674|NCT00678886|450230365|FG003|Overall Study|Withdrawal by Subject|6|||
125165675|NCT00678886|450230362|FG000|Overall Study|Physician Decision|0|||
125165676|NCT00678886|450230363|FG001|Overall Study|Physician Decision|0|||
125165677|NCT00678886|450230364|FG002|Overall Study|Physician Decision|1|||
125165678|NCT00678886|450230365|FG003|Overall Study|Physician Decision|1|||
125165679|NCT00678886|450230362|FG000|Overall Study|Lost to Follow-up|0|||
125165680|NCT00678886|450230363|FG001|Overall Study|Lost to Follow-up|0|||
125165681|NCT00678886|450230364|FG002|Overall Study|Lost to Follow-up|3|||
125165682|NCT00678886|450230365|FG003|Overall Study|Lost to Follow-up|2|||
125165683|NCT00678886|450230362|FG000|Overall Study|Other|0|||
125165684|NCT00678886|450230363|FG001|Overall Study|Other|0|||
125165685|NCT00678886|450230364|FG002|Overall Study|Other|1|||
125165686|NCT00678886|450230365|FG003|Overall Study|Other|0|||
125165687|NCT00206323|450230366|FG000|Overall Study|Lack of Efficacy|4|||
125165688|NCT00206323|450230367|FG001|Overall Study|Lack of Efficacy|1|||
125165689|NCT00206323|450230366|FG000|Overall Study|Adverse Event|1|||
125165690|NCT00206323|450230367|FG001|Overall Study|Adverse Event|1|||
125165691|NCT00206323|450230366|FG000|Overall Study|Lost to Follow-up|1|||
125165692|NCT00206323|450230367|FG001|Overall Study|Lost to Follow-up|1|||
125165693|NCT02329847|450230368|FG000|Overall Study|Death|4|||
125165694|NCT02329847|450230369|FG001|Overall Study|Death|4|||
125165695|NCT02329847|450230370|FG002|Overall Study|Death|22|||
125165696|NCT02329847|450230371|FG003|Overall Study|Death|12|||
125165697|NCT02329847|450230372|FG004|Overall Study|Death|20|||
125165698|NCT02329847|450230373|FG005|Overall Study|Death|13|||
125165699|NCT02329847|450230368|FG000|Overall Study|Lost to Follow-up|0|||
125165700|NCT02329847|450230369|FG001|Overall Study|Lost to Follow-up|0|||
125165701|NCT02329847|450230370|FG002|Overall Study|Lost to Follow-up|2|||
125165702|NCT02329847|450230371|FG003|Overall Study|Lost to Follow-up|3|||
125165703|NCT02329847|450230372|FG004|Overall Study|Lost to Follow-up|0|||
125165704|NCT02329847|450230373|FG005|Overall Study|Lost to Follow-up|1|||
125165705|NCT02329847|450230368|FG000|Overall Study|Physician Decision|0|||
125165706|NCT02329847|450230369|FG001|Overall Study|Physician Decision|0|||
125165707|NCT02329847|450230370|FG002|Overall Study|Physician Decision|0|||
125165708|NCT02329847|450230371|FG003|Overall Study|Physician Decision|0|||
125165709|NCT02329847|450230372|FG004|Overall Study|Physician Decision|1|||
125165710|NCT02329847|450230373|FG005|Overall Study|Physician Decision|0|||
125165711|NCT02329847|450230368|FG000|Overall Study|Withdrawal by Subject|2|||
125165712|NCT02329847|450230369|FG001|Overall Study|Withdrawal by Subject|1|||
125165713|NCT02329847|450230370|FG002|Overall Study|Withdrawal by Subject|5|||
125165714|NCT02329847|450230371|FG003|Overall Study|Withdrawal by Subject|7|||
125165715|NCT02329847|450230372|FG004|Overall Study|Withdrawal by Subject|8|||
125165716|NCT02329847|450230373|FG005|Overall Study|Withdrawal by Subject|3|||
125165717|NCT02329847|450230368|FG000|Overall Study|Other|1|||
125165718|NCT02329847|450230369|FG001|Overall Study|Other|2|||
125165719|NCT02329847|450230370|FG002|Overall Study|Other|6|||
125165720|NCT02329847|450230371|FG003|Overall Study|Other|13|||
125165721|NCT02329847|450230372|FG004|Overall Study|Other|10|||
125165722|NCT02329847|450230373|FG005|Overall Study|Other|3|||
125165723|NCT04669691|450230380|FG000|Overall Study|Death|0|||
125165724|NCT04669691|450230381|FG001|Overall Study|Death|1|||
125165725|NCT04669691|450230382|FG002|Overall Study|Death|0|||
125165726|NCT04669691|450230383|FG003|Overall Study|Death|0|||
125165727|NCT04669691|450230384|FG004|Overall Study|Death|0|||
125165728|NCT04669691|450230385|FG005|Overall Study|Death|0|||
125165729|NCT01822275|450230387|FG000|Overall Study|Withdrawal by Subject|3|||
125165730|NCT01822275|450230387|FG000|Overall Study|Adverse Event|3|||
125165731|NCT01822275|450230387|FG000|Overall Study|Progression|14|||
125165732|NCT01822275|450230387|FG000|Overall Study|Physician Decision|2|||
125165733|NCT02132754|450230388|FG000|Overall Study|Adverse Event|0|||
125165734|NCT02132754|450230389|FG001|Overall Study|Adverse Event|0|||
125165735|NCT02132754|450230390|FG002|Overall Study|Adverse Event|0|||
125165736|NCT02132754|450230391|FG003|Overall Study|Adverse Event|0|||
125165737|NCT02132754|450230392|FG004|Overall Study|Adverse Event|0|||
125165738|NCT02132754|450230393|FG005|Overall Study|Adverse Event|0|||
125165739|NCT02132754|450230394|FG006|Overall Study|Adverse Event|0|||
125165740|NCT02132754|450230395|FG007|Overall Study|Adverse Event|0|||
125165741|NCT02132754|450230396|FG008|Overall Study|Adverse Event|0|||
125165742|NCT02132754|450230397|FG009|Overall Study|Adverse Event|0|||
125165743|NCT02132754|450230398|FG010|Overall Study|Adverse Event|0|||
125165744|NCT02132754|450230399|FG011|Overall Study|Adverse Event|0|||
125165745|NCT02132754|450230400|FG012|Overall Study|Adverse Event|0|||
125165746|NCT02132754|450230401|FG013|Overall Study|Adverse Event|0|||
125165747|NCT02132754|450230402|FG014|Overall Study|Adverse Event|0|||
125165748|NCT02132754|450230403|FG015|Overall Study|Adverse Event|0|||
125165749|NCT02132754|450230404|FG016|Overall Study|Adverse Event|0|||
125165750|NCT02132754|450230405|FG017|Overall Study|Adverse Event|1|||
125391979|NCT00082433|451068751|FG000|Overall Study|Adverse Event|12|||
125391980|NCT00082433|451068752|FG001|Overall Study|Adverse Event|17|||
125391981|NCT00082433|451068751|FG000|Overall Study|Death|8|||
125391982|NCT00082433|451068752|FG001|Overall Study|Death|18|||
125391983|NCT00082433|451068751|FG000|Overall Study|Disease Progression/Relapse|270|||
125391984|NCT00082433|451068752|FG001|Overall Study|Disease Progression/Relapse|388|||
125391985|NCT00082433|451068751|FG000|Overall Study|Physician Decision|50|||
125391986|NCT00082433|451068752|FG001|Overall Study|Physician Decision|61|||
125391987|NCT00082433|451068751|FG000|Overall Study|Lost to Follow-up|1|||
125391988|NCT00082433|451068752|FG001|Overall Study|Lost to Follow-up|2|||
125391989|NCT00082433|451068751|FG000|Overall Study|Study Drug Toxicity|179|||
125391990|NCT00082433|451068752|FG001|Overall Study|Study Drug Toxicity|66|||
125391991|NCT00082433|451068751|FG000|Overall Study|Withdrawal by Subject|55|||
125391992|NCT00082433|451068752|FG001|Overall Study|Withdrawal by Subject|30|||
125391993|NCT00082433|451068751|FG000|Overall Study|Still On Treatment|2|||
125391994|NCT00082433|451068752|FG001|Overall Study|Still On Treatment|1|||
125391995|NCT00082433|451068751|FG000|Overall Study|Not Treated|12|||
125391996|NCT00082433|451068752|FG001|Overall Study|Not Treated|11|||
125391997|NCT00082433|451068751|FG000|Overall Study|Ineligible|2|||
125391998|NCT00082433|451068752|FG001|Overall Study|Ineligible|1|||
125391999|NCT00082433|451068751|FG000|Overall Study|Noncompliance|2|||
125392000|NCT00082433|451068752|FG001|Overall Study|Noncompliance|1|||
125392001|NCT00082433|451068751|FG000|Overall Study|New primary cancer|1|||
125392002|NCT00082433|451068752|FG001|Overall Study|New primary cancer|0|||
125392003|NCT00082433|451068751|FG000|Overall Study|Impending surgery|0|||
125392004|NCT00082433|451068752|FG001|Overall Study|Impending surgery|1|||
125392005|NCT04097821|451068753|FG000|Overall Study|Subject Decision|0|||
125392006|NCT04097821|451068754|FG001|Overall Study|Subject Decision|0|||
125392007|NCT04097821|451068755|FG002|Overall Study|Subject Decision|0|||
125392008|NCT04097821|451068756|FG003|Overall Study|Subject Decision|1|||
125392009|NCT04097821|451068757|FG004|Overall Study|Subject Decision|2|||
125392010|NCT04097821|451068758|FG005|Overall Study|Subject Decision|2|||
125392011|NCT04097821|451068759|FG006|Overall Study|Subject Decision|0|||
125392012|NCT04097821|451068760|FG007|Overall Study|Subject Decision|1|||
125392013|NCT04097821|451068753|FG000|Overall Study|Death|0|||
125392014|NCT04097821|451068754|FG001|Overall Study|Death|0|||
125392015|NCT04097821|451068755|FG002|Overall Study|Death|3|||
125392016|NCT04097821|451068756|FG003|Overall Study|Death|1|||
125392017|NCT04097821|451068757|FG004|Overall Study|Death|0|||
125392018|NCT04097821|451068758|FG005|Overall Study|Death|0|||
125392019|NCT04097821|451068759|FG006|Overall Study|Death|0|||
125392020|NCT04097821|451068760|FG007|Overall Study|Death|0|||
125392021|NCT04097821|451068753|FG000|Overall Study|Physician Decision|1|||
125392022|NCT04097821|451068754|FG001|Overall Study|Physician Decision|2|||
125392023|NCT04097821|451068755|FG002|Overall Study|Physician Decision|0|||
125392024|NCT04097821|451068756|FG003|Overall Study|Physician Decision|0|||
125392025|NCT04097821|451068757|FG004|Overall Study|Physician Decision|0|||
125392026|NCT04097821|451068758|FG005|Overall Study|Physician Decision|0|||
125392027|NCT04097821|451068759|FG006|Overall Study|Physician Decision|0|||
125392028|NCT04097821|451068760|FG007|Overall Study|Physician Decision|0|||
125392029|NCT04097821|451068753|FG000|Overall Study|Adverse Event|0|||
125392030|NCT04097821|451068754|FG001|Overall Study|Adverse Event|0|||
125392031|NCT04097821|451068755|FG002|Overall Study|Adverse Event|1|||
125392032|NCT04097821|451068756|FG003|Overall Study|Adverse Event|1|||
125392033|NCT04097821|451068757|FG004|Overall Study|Adverse Event|0|||
125392034|NCT04097821|451068758|FG005|Overall Study|Adverse Event|0|||
125392035|NCT04097821|451068759|FG006|Overall Study|Adverse Event|0|||
125392036|NCT04097821|451068760|FG007|Overall Study|Adverse Event|0|||
125165751|NCT02132754|450230406|FG018|Overall Study|Adverse Event|0|||
125165752|NCT02132754|450230407|FG019|Overall Study|Adverse Event|0|||
125165753|NCT02132754|450230408|FG020|Overall Study|Adverse Event|0|||
125165754|NCT02132754|450230409|FG021|Overall Study|Adverse Event|0|||
125392037|NCT04097821|451068753|FG000|Overall Study|New Therapy For Study Indication|0|||
125392038|NCT04097821|451068754|FG001|Overall Study|New Therapy For Study Indication|0|||
125392039|NCT04097821|451068755|FG002|Overall Study|New Therapy For Study Indication|0|||
125392040|NCT04097821|451068756|FG003|Overall Study|New Therapy For Study Indication|0|||
125392041|NCT04097821|451068757|FG004|Overall Study|New Therapy For Study Indication|0|||
125392042|NCT04097821|451068758|FG005|Overall Study|New Therapy For Study Indication|0|||
125226396|NCT05158140|450456131|FG003|Overall Study|Withdrawal by Subject|7|||
125226397|NCT04414787|450456132|FG000|Overall Study|Patient Death|18|||
125226398|NCT04414787|450456133|FG001|Overall Study|Patient Death|18|||
125226399|NCT04414787|450456134|FG002|Overall Study|Patient Death|15|||
125226400|NCT04414787|450456135|FG003|Overall Study|Patient Death|15|||
125226401|NCT04414787|450456132|FG000|Overall Study|Patient Hospitalization|1|||
125226402|NCT04414787|450456133|FG001|Overall Study|Patient Hospitalization|1|||
125226403|NCT04414787|450456134|FG002|Overall Study|Patient Hospitalization|2|||
125226404|NCT04414787|450456135|FG003|Overall Study|Patient Hospitalization|2|||
125226405|NCT04414787|450456132|FG000|Overall Study|Lost to Follow-up|7|||
125226406|NCT04414787|450456133|FG001|Overall Study|Lost to Follow-up|7|||
125226407|NCT04414787|450456134|FG002|Overall Study|Lost to Follow-up|5|||
125226408|NCT04414787|450456135|FG003|Overall Study|Lost to Follow-up|5|||
125226409|NCT04414787|450456132|FG000|Overall Study|Residence in post-acute care facility|3|||
125226410|NCT04414787|450456133|FG001|Overall Study|Residence in post-acute care facility|3|||
125226411|NCT04414787|450456134|FG002|Overall Study|Residence in post-acute care facility|5|||
125226412|NCT04414787|450456135|FG003|Overall Study|Residence in post-acute care facility|5|||
125226413|NCT00919633|450456136|FG000|Overall Study|Adverse Event|1|||
125226414|NCT00919633|450456137|FG001|Overall Study|Adverse Event|9|||
125226415|NCT00919633|450456138|FG002|Overall Study|Adverse Event|12|||
125226416|NCT00919633|450456139|FG003|Overall Study|Adverse Event|10|||
125226417|NCT00919633|450456136|FG000|Overall Study|Death|0|||
125226418|NCT00919633|450456137|FG001|Overall Study|Death|0|||
125226419|NCT00919633|450456138|FG002|Overall Study|Death|2|||
125226420|NCT00919633|450456139|FG003|Overall Study|Death|0|||
125226421|NCT00919633|450456136|FG000|Overall Study|Lack of Efficacy|17|||
125226422|NCT00919633|450456137|FG001|Overall Study|Lack of Efficacy|3|||
125226423|NCT00919633|450456138|FG002|Overall Study|Lack of Efficacy|2|||
125226424|NCT00919633|450456139|FG003|Overall Study|Lack of Efficacy|3|||
125226425|NCT00919633|450456136|FG000|Overall Study|Withdrawal by Subject|1|||
125226426|NCT00919633|450456137|FG001|Overall Study|Withdrawal by Subject|2|||
125226427|NCT00919633|450456138|FG002|Overall Study|Withdrawal by Subject|4|||
125226428|NCT00919633|450456139|FG003|Overall Study|Withdrawal by Subject|3|||
125226429|NCT00919633|450456136|FG000|Overall Study|Lost to Follow-up|3|||
125226430|NCT00919633|450456137|FG001|Overall Study|Lost to Follow-up|1|||
125226431|NCT00919633|450456138|FG002|Overall Study|Lost to Follow-up|0|||
125226432|NCT00919633|450456139|FG003|Overall Study|Lost to Follow-up|2|||
125226433|NCT00919633|450456136|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
125226434|NCT00919633|450456137|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
125226435|NCT00919633|450456138|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
125226436|NCT00919633|450456139|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
125226437|NCT00919633|450456136|FG000|Overall Study|Protocol Violation|0|||
125226438|NCT00919633|450456137|FG001|Overall Study|Protocol Violation|0|||
125226439|NCT00919633|450456138|FG002|Overall Study|Protocol Violation|0|||
125226440|NCT00919633|450456139|FG003|Overall Study|Protocol Violation|1|||
125226441|NCT00919633|450456136|FG000|Overall Study|Physician Decision|0|||
125226442|NCT00919633|450456137|FG001|Overall Study|Physician Decision|0|||
125226443|NCT00919633|450456138|FG002|Overall Study|Physician Decision|0|||
125226444|NCT00919633|450456139|FG003|Overall Study|Physician Decision|1|||
125226445|NCT00919633|450456136|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
125226446|NCT00919633|450456137|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
125226447|NCT00919633|450456138|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
125226448|NCT00919633|450456139|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
125226449|NCT00919633|450456136|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
125226450|NCT00919633|450456137|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
125226451|NCT00919633|450456138|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
125226452|NCT00919633|450456139|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
125226453|NCT01526785|450456140|FG000|Overall Study|Study Terminated by Sponsor|8|||
125226454|NCT01526785|450456140|FG000|Overall Study|Death|2|||
125226455|NCT01526785|450456140|FG000|Overall Study|Physician Decision|1|||
125226456|NCT01526785|450456140|FG000|Overall Study|Withdrawal by Subject|2|||
125226457|NCT01121263|450456141|FG000|Overall Study|Death|3|||
125226458|NCT01121263|450456142|FG001|Overall Study|Death|2|||
125226459|NCT01121263|450456141|FG000|Overall Study|Lost to Follow-up|22|||
125226460|NCT01121263|450456142|FG001|Overall Study|Lost to Follow-up|12|||
125226461|NCT01121263|450456141|FG000|Overall Study|Withdrawal by Subject|0|||
125226462|NCT01121263|450456142|FG001|Overall Study|Withdrawal by Subject|1|||
125226463|NCT02007720|450456143|FG000|Overall Study|Withdrawal by Subject|9|||
125226464|NCT02007720|450456144|FG001|Overall Study|Withdrawal by Subject|11|||
125226465|NCT02007720|450456143|FG000|Overall Study|study terminated by sponsor|58|||
125226466|NCT02007720|450456144|FG001|Overall Study|study terminated by sponsor|54|||
125226467|NCT02007720|450456143|FG000|Overall Study|technical problem|4|||
125226468|NCT02007720|450456144|FG001|Overall Study|technical problem|2|||
125226469|NCT02007720|450456143|FG000|Overall Study|patient followd less than 165 days|11|||
125226470|NCT02007720|450456144|FG001|Overall Study|patient followd less than 165 days|5|||
125226471|NCT04194814|450456147|FG000|Overall Study|Physician Decision|3|||
125165755|NCT02132754|450230410|FG022|Overall Study|Adverse Event|0|||
125165756|NCT02132754|450230411|FG023|Overall Study|Adverse Event|0|||
125165757|NCT02132754|450230412|FG024|Overall Study|Adverse Event|0|||
125392043|NCT04097821|451068759|FG006|Overall Study|New Therapy For Study Indication|1|||
125392044|NCT04097821|451068760|FG007|Overall Study|New Therapy For Study Indication|0|||
125392045|NCT04477304|451068762|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
125165758|NCT02132754|450230413|FG025|Overall Study|Adverse Event|1|||
125165759|NCT02132754|450230414|FG026|Overall Study|Adverse Event|1|||
125165760|NCT02132754|450230415|FG027|Overall Study|Adverse Event|0|||
125165761|NCT02132754|450230416|FG028|Overall Study|Adverse Event|0|||
125165762|NCT02132754|450230417|FG029|Overall Study|Adverse Event|0|||
125165763|NCT02132754|450230418|FG030|Overall Study|Adverse Event|1|||
125165764|NCT02132754|450230419|FG031|Overall Study|Adverse Event|0|||
125165765|NCT02132754|450230420|FG032|Overall Study|Adverse Event|1|||
125165766|NCT02132754|450230421|FG033|Overall Study|Adverse Event|1|||
125165767|NCT02132754|450230388|FG000|Overall Study|Clinical Progression|0|||
125392046|NCT04477304|451068763|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
125392047|NCT00502697|451070560|FG000|Overall Study|Withdrawal by Subject|3|||
125392048|NCT00502697|451070561|FG001|Overall Study|Withdrawal by Subject|1|||
125392049|NCT00502697|451070560|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
125392050|NCT00502697|451070561|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
125392051|NCT00502697|451070560|FG000|Overall Study|found not to meet eligibility criteria|3|||
125392052|NCT00502697|451070561|FG001|Overall Study|found not to meet eligibility criteria|4|||
125392053|NCT00502697|451070560|FG000|Overall Study|did not meet assignment criteria|4|||
125392054|NCT00502697|451070561|FG001|Overall Study|did not meet assignment criteria|2|||
125392055|NCT00589108|451070564|FG000|Overall Study|Lost to Follow-up|1|||
125392056|NCT00589108|451070565|FG001|Overall Study|Lost to Follow-up|1|||
125392057|NCT00589108|451070566|FG002|Overall Study|Lost to Follow-up|1|||
125392058|NCT00589108|451070564|FG000|Overall Study|Death|3|||
125392059|NCT00589108|451070565|FG001|Overall Study|Death|3|||
125392060|NCT00589108|451070566|FG002|Overall Study|Death|4|||
125392061|NCT03256552|451070567|FG000|Overall Study|Protocol Violation|1|||
125392062|NCT03256552|451070567|FG000|Overall Study|Physician Decision|1|||
125392063|NCT03256552|451070567|FG000|Overall Study|Adverse Event|1|||
125392064|NCT03256552|451070567|FG000|Overall Study|Withdrawal by Subject|2|||
125392065|NCT05083442|451070573|FG000|Overall Study|Lost to Follow-up|1|||
125392066|NCT05083442|451070574|FG001|Overall Study|Lost to Follow-up|0|||
125392067|NCT05083442|451070573|FG000|Overall Study|Lack of Efficacy|0|||
125392068|NCT05083442|451070574|FG001|Overall Study|Lack of Efficacy|1|||
125392069|NCT05083442|451070573|FG000|Overall Study|Withdrawal by Subject|1|||
125392070|NCT05083442|451070574|FG001|Overall Study|Withdrawal by Subject|3|||
125392071|NCT05083442|451070573|FG000|Overall Study|scheduling difficulties|1|||
125392072|NCT05083442|451070574|FG001|Overall Study|scheduling difficulties|2|||
125392073|NCT03711162|451070577|FG000|Overall Study|Adverse Event|5|||
125392074|NCT03711162|451070578|FG001|Overall Study|Adverse Event|2|||
125392075|NCT03711162|451070579|FG002|Overall Study|Adverse Event|4|||
125392076|NCT03711162|451070577|FG000|Overall Study|Death|11|||
125392077|NCT03711162|451070578|FG001|Overall Study|Death|7|||
125392078|NCT03711162|451070579|FG002|Overall Study|Death|8|||
125392079|NCT03711162|451070577|FG000|Overall Study|Lost to Follow-up|1|||
125392080|NCT03711162|451070578|FG001|Overall Study|Lost to Follow-up|0|||
125392081|NCT03711162|451070579|FG002|Overall Study|Lost to Follow-up|1|||
125392082|NCT03711162|451070577|FG000|Overall Study|Study Terminated by Sponsor|139|||
125392083|NCT03711162|451070578|FG001|Overall Study|Study Terminated by Sponsor|152|||
125392084|NCT03711162|451070579|FG002|Overall Study|Study Terminated by Sponsor|146|||
125392085|NCT03711162|451070577|FG000|Overall Study|Withdrawal by Subject|17|||
125392086|NCT03711162|451070578|FG001|Overall Study|Withdrawal by Subject|10|||
125392087|NCT03711162|451070579|FG002|Overall Study|Withdrawal by Subject|10|||
125392088|NCT03711162|451070577|FG000|Overall Study|Miscellaneous|1|||
125392089|NCT03711162|451070578|FG001|Overall Study|Miscellaneous|2|||
125392090|NCT03711162|451070579|FG002|Overall Study|Miscellaneous|2|||
125392091|NCT03711162|451070577|FG000|Overall Study|Not Treated|1|||
125392092|NCT03711162|451070578|FG001|Overall Study|Not Treated|0|||
125392093|NCT03711162|451070579|FG002|Overall Study|Not Treated|1|||
125392094|NCT03711162|451070577|FG000|Overall Study|Physician Decision|0|||
125392095|NCT03711162|451070578|FG001|Overall Study|Physician Decision|2|||
125392096|NCT03711162|451070579|FG002|Overall Study|Physician Decision|0|||
125392097|NCT03711162|451070577|FG000|Overall Study|Lack of Efficacy|0|||
125392098|NCT03711162|451070578|FG001|Overall Study|Lack of Efficacy|0|||
125392099|NCT03711162|451070579|FG002|Overall Study|Lack of Efficacy|2|||
125392100|NCT03711162|451070577|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
125392101|NCT03711162|451070578|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
125392102|NCT03711162|451070579|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
125392103|NCT03034954|451070583|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
125165768|NCT02132754|450230389|FG001|Overall Study|Clinical Progression|0|||
125165769|NCT02132754|450230390|FG002|Overall Study|Clinical Progression|0|||
125165770|NCT02132754|450230391|FG003|Overall Study|Clinical Progression|0|||
125442399|NCT02291289|451248918|FG008|Induction Treatment|Physician Decision|0|||
125165771|NCT02132754|450230392|FG004|Overall Study|Clinical Progression|0|||
125165772|NCT02132754|450230393|FG005|Overall Study|Clinical Progression|0|||
125165773|NCT02132754|450230394|FG006|Overall Study|Clinical Progression|0|||
125165774|NCT02132754|450230395|FG007|Overall Study|Clinical Progression|0|||
125165775|NCT02132754|450230396|FG008|Overall Study|Clinical Progression|0|||
125165776|NCT02132754|450230397|FG009|Overall Study|Clinical Progression|1|||
125165777|NCT02132754|450230398|FG010|Overall Study|Clinical Progression|0|||
125165778|NCT02132754|450230399|FG011|Overall Study|Clinical Progression|0|||
125165779|NCT02132754|450230400|FG012|Overall Study|Clinical Progression|0|||
125165780|NCT02132754|450230401|FG013|Overall Study|Clinical Progression|0|||
125165781|NCT02132754|450230402|FG014|Overall Study|Clinical Progression|0|||
125165782|NCT02132754|450230403|FG015|Overall Study|Clinical Progression|0|||
125165783|NCT02132754|450230404|FG016|Overall Study|Clinical Progression|1|||
125165784|NCT02132754|450230405|FG017|Overall Study|Clinical Progression|1|||
125165785|NCT02132754|450230406|FG018|Overall Study|Clinical Progression|0|||
125165786|NCT02132754|450230407|FG019|Overall Study|Clinical Progression|1|||
125165787|NCT02132754|450230408|FG020|Overall Study|Clinical Progression|0|||
125165788|NCT02132754|450230409|FG021|Overall Study|Clinical Progression|0|||
125165789|NCT02132754|450230410|FG022|Overall Study|Clinical Progression|1|||
125165790|NCT02132754|450230411|FG023|Overall Study|Clinical Progression|0|||
125165791|NCT02132754|450230412|FG024|Overall Study|Clinical Progression|1|||
125165792|NCT02132754|450230413|FG025|Overall Study|Clinical Progression|1|||
125165793|NCT02132754|450230414|FG026|Overall Study|Clinical Progression|0|||
125165794|NCT02132754|450230415|FG027|Overall Study|Clinical Progression|1|||
125165795|NCT02132754|450230416|FG028|Overall Study|Clinical Progression|1|||
125165796|NCT02132754|450230417|FG029|Overall Study|Clinical Progression|0|||
125165797|NCT02132754|450230418|FG030|Overall Study|Clinical Progression|1|||
125165798|NCT02132754|450230419|FG031|Overall Study|Clinical Progression|0|||
125165799|NCT02132754|450230420|FG032|Overall Study|Clinical Progression|0|||
125165800|NCT02132754|450230421|FG033|Overall Study|Clinical Progression|2|||
125165801|NCT02132754|450230388|FG000|Overall Study|Death|0|||
125165802|NCT02132754|450230389|FG001|Overall Study|Death|0|||
125165803|NCT02132754|450230390|FG002|Overall Study|Death|0|||
125165804|NCT02132754|450230391|FG003|Overall Study|Death|0|||
125165805|NCT02132754|450230392|FG004|Overall Study|Death|0|||
125165806|NCT02132754|450230393|FG005|Overall Study|Death|0|||
125165807|NCT02132754|450230394|FG006|Overall Study|Death|0|||
125165808|NCT02132754|450230395|FG007|Overall Study|Death|0|||
125165809|NCT02132754|450230396|FG008|Overall Study|Death|0|||
125165810|NCT02132754|450230397|FG009|Overall Study|Death|0|||
125165811|NCT02132754|450230398|FG010|Overall Study|Death|0|||
125165812|NCT02132754|450230399|FG011|Overall Study|Death|0|||
125165813|NCT02132754|450230400|FG012|Overall Study|Death|0|||
125165814|NCT02132754|450230401|FG013|Overall Study|Death|0|||
125165815|NCT02132754|450230402|FG014|Overall Study|Death|0|||
125165816|NCT02132754|450230403|FG015|Overall Study|Death|1|||
125165817|NCT02132754|450230404|FG016|Overall Study|Death|0|||
125165818|NCT02132754|450230405|FG017|Overall Study|Death|0|||
125165819|NCT02132754|450230406|FG018|Overall Study|Death|0|||
125165820|NCT02132754|450230407|FG019|Overall Study|Death|1|||
125165821|NCT02132754|450230408|FG020|Overall Study|Death|0|||
125165822|NCT02132754|450230409|FG021|Overall Study|Death|1|||
125165823|NCT02132754|450230410|FG022|Overall Study|Death|0|||
125165824|NCT02132754|450230411|FG023|Overall Study|Death|0|||
125165825|NCT02132754|450230412|FG024|Overall Study|Death|0|||
125165826|NCT02132754|450230413|FG025|Overall Study|Death|0|||
125165827|NCT02132754|450230414|FG026|Overall Study|Death|1|||
125165828|NCT02132754|450230415|FG027|Overall Study|Death|0|||
125165829|NCT02132754|450230416|FG028|Overall Study|Death|0|||
125165830|NCT02132754|450230417|FG029|Overall Study|Death|0|||
125165831|NCT02132754|450230418|FG030|Overall Study|Death|0|||
125165832|NCT02132754|450230419|FG031|Overall Study|Death|0|||
125165833|NCT02132754|450230420|FG032|Overall Study|Death|0|||
125165834|NCT02132754|450230421|FG033|Overall Study|Death|2|||
125165835|NCT02132754|450230388|FG000|Overall Study|Excluded Medication|0|||
125165836|NCT02132754|450230389|FG001|Overall Study|Excluded Medication|0|||
125165837|NCT02132754|450230390|FG002|Overall Study|Excluded Medication|0|||
125165838|NCT02132754|450230391|FG003|Overall Study|Excluded Medication|0|||
125165839|NCT02132754|450230392|FG004|Overall Study|Excluded Medication|0|||
125165840|NCT02132754|450230393|FG005|Overall Study|Excluded Medication|0|||
125165841|NCT02132754|450230394|FG006|Overall Study|Excluded Medication|0|||
125165842|NCT02132754|450230395|FG007|Overall Study|Excluded Medication|0|||
125165843|NCT02132754|450230396|FG008|Overall Study|Excluded Medication|0|||
125165844|NCT02132754|450230397|FG009|Overall Study|Excluded Medication|0|||
125165845|NCT02132754|450230398|FG010|Overall Study|Excluded Medication|0|||
125165846|NCT02132754|450230399|FG011|Overall Study|Excluded Medication|0|||
125165847|NCT02132754|450230400|FG012|Overall Study|Excluded Medication|0|||
125165848|NCT02132754|450230401|FG013|Overall Study|Excluded Medication|0|||
125165849|NCT02132754|450230402|FG014|Overall Study|Excluded Medication|0|||
125165850|NCT02132754|450230403|FG015|Overall Study|Excluded Medication|0|||
125226472|NCT04194814|450456148|FG001|Overall Study|Physician Decision|0|||
125226473|NCT04194814|450456147|FG000|Overall Study|Withdrawal by Subject|0|||
125226474|NCT04194814|450456148|FG001|Overall Study|Withdrawal by Subject|2|||
125226475|NCT00329108|450457936|FG000|Overall Study|Adverse Event|2|||
125226476|NCT00329108|450457937|FG001|Overall Study|Adverse Event|2|||
125226477|NCT00329108|450457936|FG000|Overall Study|Lack of Efficacy|3|||
125226478|NCT00329108|450457937|FG001|Overall Study|Lack of Efficacy|3|||
125226479|NCT00329108|450457936|FG000|Overall Study|Withdrawal by Subject|0|||
125226480|NCT00329108|450457937|FG001|Overall Study|Withdrawal by Subject|2|||
125226481|NCT00329108|450457936|FG000|Overall Study|symptomatic deterioration|1|||
125226482|NCT00329108|450457937|FG001|Overall Study|symptomatic deterioration|1|||
125226483|NCT00329108|450457936|FG000|Overall Study|Subject no longer willing to participate|2|||
125226484|NCT00329108|450457937|FG001|Overall Study|Subject no longer willing to participate|2|||
125226485|NCT00329108|450457936|FG000|Overall Study|study terminated by sponsor|1|||
125226486|NCT00329108|450457937|FG001|Overall Study|study terminated by sponsor|0|||
125226487|NCT00329108|450457936|FG000|Overall Study|withdrew patient after SAE resolved|1|||
125226488|NCT00329108|450457937|FG001|Overall Study|withdrew patient after SAE resolved|0|||
125226489|NCT00329108|450457936|FG000|Overall Study|Protocol Violation|0|||
125226490|NCT00329108|450457937|FG001|Overall Study|Protocol Violation|2|||
125226491|NCT01389232|450457938|FG000|Overall Study|Had scaffold removed|15|||
125226492|NCT01389232|450457938|FG000|Overall Study|Personal reasons|2|||
125226493|NCT01389232|450457938|FG000|Overall Study|Adverse Event|1|||
125226494|NCT01389232|450457938|FG000|Overall Study|Death|1|||
125226495|NCT00789321|450457943|FG000|Overall Study|Adverse Event|0|||
125226496|NCT00789321|450457944|FG001|Overall Study|Adverse Event|1|||
125226497|NCT01162343|450457945|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
125226498|NCT01162343|450457945|FG000|Overall Study|Refused psychiatrist assessment|12|||
125226499|NCT03964207|450457946|FG000|First Treatment|Withdrawal by Subject|1|||
125226500|NCT03964207|450457947|FG001|First Treatment|Withdrawal by Subject|2|||
125226501|NCT03964207|450457946|FG000|First Treatment|Protocol Violation|1|||
125226502|NCT03964207|450457947|FG001|First Treatment|Protocol Violation|0|||
125226503|NCT03964207|450457946|FG000|First Treatment|Lost to Follow-up|1|||
125226504|NCT03964207|450457947|FG001|First Treatment|Lost to Follow-up|0|||
125226505|NCT03964207|450457946|FG000|Second Treatment|Lost to Follow-up|0|||
125226506|NCT03964207|450457947|FG001|Second Treatment|Lost to Follow-up|1|||
125226507|NCT03964207|450457946|FG000|Second Treatment|Adverse Event|1|||
125226508|NCT03964207|450457947|FG001|Second Treatment|Adverse Event|2|||
125226509|NCT01405560|450457950|FG000|Overall Study|Physician Decision|1|||
125226510|NCT01699750|450457954|FG000|Overall Study|Withdrew Consent|0|||
125226511|NCT01699750|450457955|FG001|Overall Study|Withdrew Consent|1|||
125226512|NCT01699750|450457954|FG000|Overall Study|Other|0|||
125226513|NCT01699750|450457955|FG001|Overall Study|Other|2|||
125226514|NCT02737358|450457956|FG000|Overall Study|Withdrawal by Subject|7|||
125226515|NCT02737358|450457957|FG001|Overall Study|Withdrawal by Subject|12|||
125226516|NCT02737358|450457956|FG000|Overall Study|Lost to Follow-up|2|||
125226517|NCT02737358|450457957|FG001|Overall Study|Lost to Follow-up|3|||
125226518|NCT02119299|450457958|FG000|Overall Study|Withdrawal by Subject|7|||
125226519|NCT02119299|450457958|FG000|Overall Study|Lack of Efficacy|1|||
125226520|NCT02119299|450457958|FG000|Overall Study|Pregnancy|1|||
125226521|NCT00744939|450457959|FG000|Overall Study|Withdrawal by Subject|9|||
125226522|NCT00744939|450457959|FG000|Overall Study|Protocol Violation|13|||
125226523|NCT00744939|450457959|FG000|Overall Study|Death|24|||
125392104|NCT03034954|451070584|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
125392105|NCT05228470|451070587|FG000|Overall Study|Death|6|||
125392106|NCT05228470|451070588|FG001|Overall Study|Death|11|||
125392107|NCT05228470|451070587|FG000|Overall Study|Withdrawal by Subject|1|||
125392108|NCT05228470|451070588|FG001|Overall Study|Withdrawal by Subject|8|||
125392109|NCT05228470|451070587|FG000|Overall Study|Ongoing|1|||
125392110|NCT05228470|451070588|FG001|Overall Study|Ongoing|11|||
125165851|NCT02132754|450230404|FG016|Overall Study|Excluded Medication|0|||
125165852|NCT02132754|450230405|FG017|Overall Study|Excluded Medication|0|||
125165853|NCT02132754|450230406|FG018|Overall Study|Excluded Medication|0|||
125165854|NCT02132754|450230407|FG019|Overall Study|Excluded Medication|0|||
125165855|NCT02132754|450230408|FG020|Overall Study|Excluded Medication|1|||
125165856|NCT02132754|450230409|FG021|Overall Study|Excluded Medication|0|||
125165857|NCT02132754|450230410|FG022|Overall Study|Excluded Medication|0|||
125165858|NCT02132754|450230411|FG023|Overall Study|Excluded Medication|0|||
125165859|NCT02132754|450230412|FG024|Overall Study|Excluded Medication|0|||
125165860|NCT02132754|450230413|FG025|Overall Study|Excluded Medication|0|||
125165861|NCT02132754|450230414|FG026|Overall Study|Excluded Medication|0|||
125165862|NCT02132754|450230415|FG027|Overall Study|Excluded Medication|0|||
125165863|NCT02132754|450230416|FG028|Overall Study|Excluded Medication|0|||
125165864|NCT02132754|450230417|FG029|Overall Study|Excluded Medication|0|||
125226524|NCT00744939|450457959|FG000|Overall Study|distance|4|||
125226525|NCT00744939|450457959|FG000|Overall Study|Lost to Follow-up|12|||
125226526|NCT00744939|450457959|FG000|Overall Study|Medical history exclusionary|1|||
125226527|NCT00744939|450457959|FG000|Overall Study|Did not receive Magnevist|7|||
125392111|NCT00136084|451070589|FG000|Overall Study|Death|12|||
125392112|NCT00136084|451070590|FG001|Overall Study|Death|5|||
125165865|NCT02132754|450230418|FG030|Overall Study|Excluded Medication|0|||
125165866|NCT02132754|450230419|FG031|Overall Study|Excluded Medication|0|||
125165867|NCT02132754|450230420|FG032|Overall Study|Excluded Medication|0|||
125165868|NCT02132754|450230421|FG033|Overall Study|Excluded Medication|1|||
125165869|NCT02132754|450230388|FG000|Overall Study|Physician Decision|0|||
125165870|NCT02132754|450230389|FG001|Overall Study|Physician Decision|0|||
125165871|NCT02132754|450230390|FG002|Overall Study|Physician Decision|0|||
125165872|NCT02132754|450230391|FG003|Overall Study|Physician Decision|0|||
125165873|NCT02132754|450230392|FG004|Overall Study|Physician Decision|0|||
125165874|NCT02132754|450230393|FG005|Overall Study|Physician Decision|0|||
125165875|NCT02132754|450230394|FG006|Overall Study|Physician Decision|0|||
125165876|NCT02132754|450230395|FG007|Overall Study|Physician Decision|0|||
125165877|NCT02132754|450230396|FG008|Overall Study|Physician Decision|0|||
125165878|NCT02132754|450230397|FG009|Overall Study|Physician Decision|1|||
125165879|NCT02132754|450230398|FG010|Overall Study|Physician Decision|0|||
125165880|NCT02132754|450230399|FG011|Overall Study|Physician Decision|1|||
125165881|NCT02132754|450230400|FG012|Overall Study|Physician Decision|1|||
125165882|NCT02132754|450230401|FG013|Overall Study|Physician Decision|0|||
125165883|NCT02132754|450230402|FG014|Overall Study|Physician Decision|0|||
125165884|NCT02132754|450230403|FG015|Overall Study|Physician Decision|1|||
125165885|NCT02132754|450230404|FG016|Overall Study|Physician Decision|0|||
125165886|NCT02132754|450230405|FG017|Overall Study|Physician Decision|0|||
125165887|NCT02132754|450230406|FG018|Overall Study|Physician Decision|0|||
125165888|NCT02132754|450230407|FG019|Overall Study|Physician Decision|0|||
125165889|NCT02132754|450230408|FG020|Overall Study|Physician Decision|0|||
125165890|NCT02132754|450230409|FG021|Overall Study|Physician Decision|0|||
125165891|NCT02132754|450230410|FG022|Overall Study|Physician Decision|0|||
125165892|NCT02132754|450230411|FG023|Overall Study|Physician Decision|0|||
125165893|NCT02132754|450230412|FG024|Overall Study|Physician Decision|1|||
125165894|NCT02132754|450230413|FG025|Overall Study|Physician Decision|0|||
125165895|NCT02132754|450230414|FG026|Overall Study|Physician Decision|0|||
125165896|NCT02132754|450230415|FG027|Overall Study|Physician Decision|0|||
125165897|NCT02132754|450230416|FG028|Overall Study|Physician Decision|0|||
125165898|NCT02132754|450230417|FG029|Overall Study|Physician Decision|0|||
125165899|NCT02132754|450230418|FG030|Overall Study|Physician Decision|0|||
125165900|NCT02132754|450230419|FG031|Overall Study|Physician Decision|1|||
125165901|NCT02132754|450230420|FG032|Overall Study|Physician Decision|0|||
125165902|NCT02132754|450230421|FG033|Overall Study|Physician Decision|3|||
125165903|NCT02132754|450230388|FG000|Overall Study|Progressive Disease|1|||
125165904|NCT02132754|450230389|FG001|Overall Study|Progressive Disease|1|||
125165905|NCT02132754|450230390|FG002|Overall Study|Progressive Disease|1|||
125165906|NCT02132754|450230391|FG003|Overall Study|Progressive Disease|1|||
125165907|NCT02132754|450230392|FG004|Overall Study|Progressive Disease|1|||
125165908|NCT02132754|450230393|FG005|Overall Study|Progressive Disease|1|||
125165909|NCT02132754|450230394|FG006|Overall Study|Progressive Disease|1|||
125165910|NCT02132754|450230395|FG007|Overall Study|Progressive Disease|1|||
125165911|NCT02132754|450230396|FG008|Overall Study|Progressive Disease|1|||
125165912|NCT02132754|450230397|FG009|Overall Study|Progressive Disease|3|||
125165913|NCT02132754|450230398|FG010|Overall Study|Progressive Disease|3|||
125165914|NCT02132754|450230399|FG011|Overall Study|Progressive Disease|2|||
125165915|NCT02132754|450230400|FG012|Overall Study|Progressive Disease|2|||
125165916|NCT02132754|450230401|FG013|Overall Study|Progressive Disease|3|||
125165917|NCT02132754|450230402|FG014|Overall Study|Progressive Disease|2|||
125165918|NCT02132754|450230403|FG015|Overall Study|Progressive Disease|1|||
125165919|NCT02132754|450230404|FG016|Overall Study|Progressive Disease|2|||
125165920|NCT02132754|450230405|FG017|Overall Study|Progressive Disease|1|||
125165921|NCT02132754|450230406|FG018|Overall Study|Progressive Disease|3|||
125165922|NCT02132754|450230407|FG019|Overall Study|Progressive Disease|1|||
125165923|NCT02132754|450230408|FG020|Overall Study|Progressive Disease|1|||
125165924|NCT02132754|450230409|FG021|Overall Study|Progressive Disease|3|||
125165925|NCT02132754|450230410|FG022|Overall Study|Progressive Disease|2|||
125165926|NCT02132754|450230411|FG023|Overall Study|Progressive Disease|3|||
125165927|NCT02132754|450230412|FG024|Overall Study|Progressive Disease|0|||
125165928|NCT02132754|450230413|FG025|Overall Study|Progressive Disease|1|||
125165929|NCT02132754|450230414|FG026|Overall Study|Progressive Disease|2|||
125165930|NCT02132754|450230415|FG027|Overall Study|Progressive Disease|1|||
125165931|NCT02132754|450230416|FG028|Overall Study|Progressive Disease|2|||
125165932|NCT02132754|450230417|FG029|Overall Study|Progressive Disease|3|||
125165933|NCT02132754|450230418|FG030|Overall Study|Progressive Disease|1|||
125165934|NCT02132754|450230419|FG031|Overall Study|Progressive Disease|1|||
125165935|NCT02132754|450230420|FG032|Overall Study|Progressive Disease|3|||
125165936|NCT02132754|450230421|FG033|Overall Study|Progressive Disease|6|||
125165937|NCT02132754|450230388|FG000|Overall Study|Screen Failure|0|||
125165938|NCT02132754|450230389|FG001|Overall Study|Screen Failure|0|||
125165939|NCT02132754|450230390|FG002|Overall Study|Screen Failure|0|||
125165940|NCT02132754|450230391|FG003|Overall Study|Screen Failure|0|||
125165941|NCT02132754|450230392|FG004|Overall Study|Screen Failure|0|||
125165942|NCT02132754|450230393|FG005|Overall Study|Screen Failure|0|||
125165943|NCT02132754|450230394|FG006|Overall Study|Screen Failure|0|||
125165944|NCT02132754|450230395|FG007|Overall Study|Screen Failure|0|||
125165945|NCT02132754|450230396|FG008|Overall Study|Screen Failure|0|||
125442400|NCT02291289|451248919|FG009|Induction Treatment|Physician Decision|1|||
125442401|NCT02291289|451248920|FG010|Induction Treatment|Physician Decision|0|||
125442402|NCT02291289|451248921|FG011|Induction Treatment|Physician Decision|0|||
125442403|NCT02291289|451248922|FG012|Induction Treatment|Physician Decision|0|||
125442404|NCT02291289|451248910|FG000|Induction Treatment|Protocol Violation|0|||
125442405|NCT02291289|451248911|FG001|Induction Treatment|Protocol Violation|0|||
125226528|NCT00744939|450457959|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
125226529|NCT00744939|450457959|FG000|Overall Study|coma|1|||
125226530|NCT00744939|450457959|FG000|Overall Study|incorrect race|1|||
125226531|NCT02452047|450457960|FG000|Overall Study|Adverse Event|0|||
125226532|NCT02452047|450457961|FG001|Overall Study|Adverse Event|1|||
125226533|NCT02452047|450457962|FG002|Overall Study|Adverse Event|1|||
125226534|NCT02452047|450457960|FG000|Overall Study|Death|1|||
125226535|NCT02452047|450457961|FG001|Overall Study|Death|3|||
125226536|NCT02452047|450457962|FG002|Overall Study|Death|1|||
125226537|NCT02452047|450457960|FG000|Overall Study|Physician Decision|1|||
125226538|NCT02452047|450457961|FG001|Overall Study|Physician Decision|0|||
125226539|NCT02452047|450457962|FG002|Overall Study|Physician Decision|0|||
125226540|NCT02452047|450457960|FG000|Overall Study|Lost to Follow-up|1|||
125226541|NCT02452047|450457961|FG001|Overall Study|Lost to Follow-up|1|||
125226542|NCT02452047|450457962|FG002|Overall Study|Lost to Follow-up|0|||
125226543|NCT02452047|450457960|FG000|Overall Study|Withdrawal by Subject|1|||
125226544|NCT02452047|450457961|FG001|Overall Study|Withdrawal by Subject|0|||
125226545|NCT02452047|450457962|FG002|Overall Study|Withdrawal by Subject|0|||
125226546|NCT00288912|450457963|FG000|Overall Study|Developed exclusion criterion|4|||
125226547|NCT00288912|450457964|FG001|Overall Study|Developed exclusion criterion|6|||
125226548|NCT00288912|450457965|FG002|Overall Study|Developed exclusion criterion|7|||
125226549|NCT00288912|450457963|FG000|Overall Study|Lost to Follow-up|9|||
125226550|NCT00288912|450457964|FG001|Overall Study|Lost to Follow-up|6|||
125226551|NCT00288912|450457965|FG002|Overall Study|Lost to Follow-up|9|||
125226552|NCT00288912|450457963|FG000|Overall Study|Withdrawal by Subject|4|||
125226553|NCT00288912|450457964|FG001|Overall Study|Withdrawal by Subject|5|||
125226554|NCT00288912|450457965|FG002|Overall Study|Withdrawal by Subject|12|||
125226555|NCT02026141|450457969|FG000|Overall Study|Protocol Violation|0|||
125226556|NCT02026141|450457970|FG001|Overall Study|Protocol Violation|1|||
125226557|NCT01783743|450457975|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
125226558|NCT01783743|450457976|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
125226559|NCT01783743|450457975|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
125226560|NCT01783743|450457976|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
125226561|NCT01783743|450457975|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
125226562|NCT01783743|450457976|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
125226563|NCT02771275|450457977|FG000|Overall Study|Reoperation|3|||
125226564|NCT02771275|450457977|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
125226565|NCT03191799|450457978|FG000|Overall Study|Withdrawal by Subject|4|||
125226566|NCT03191799|450457978|FG000|Overall Study|Physician Decision|2|||
125226567|NCT03191799|450457978|FG000|Overall Study|Lost to Follow-up|1|||
125226568|NCT03191799|450457978|FG000|Overall Study|Death|2|||
125226569|NCT00728494|450457991|FG000|Overall Study|Adverse Event|7|||
125226570|NCT00728494|450457992|FG001|Overall Study|Adverse Event|0|||
125226571|NCT00728494|450457991|FG000|Overall Study|Withdrawal by Subject|0|||
125226572|NCT00728494|450457992|FG001|Overall Study|Withdrawal by Subject|2|||
125226573|NCT00728494|450457991|FG000|Overall Study|Lack of Efficacy|2|||
125226574|NCT00728494|450457992|FG001|Overall Study|Lack of Efficacy|4|||
125226575|NCT00728494|450457991|FG000|Overall Study|No data available|0|||
125226576|NCT00728494|450457992|FG001|Overall Study|No data available|1|||
125226577|NCT03439137|450457993|FG000|Overall Study|Adverse Event|16|||
125226578|NCT03439137|450457994|FG001|Overall Study|Adverse Event|12|||
125226579|NCT03439137|450457993|FG000|Overall Study|Physician Decision|0|||
125226580|NCT03439137|450457994|FG001|Overall Study|Physician Decision|5|||
125226581|NCT03439137|450457993|FG000|Overall Study|Withdrawal by Subject|14|||
125442406|NCT02291289|451248912|FG002|Induction Treatment|Protocol Violation|0|||
125442407|NCT02291289|451248913|FG003|Induction Treatment|Protocol Violation|3|||
125442408|NCT02291289|451248914|FG004|Induction Treatment|Protocol Violation|0|||
125226582|NCT03439137|450457994|FG001|Overall Study|Withdrawal by Subject|4|||
125226583|NCT03439137|450457993|FG000|Overall Study|Conducting rescue therapy|2|||
125226584|NCT03439137|450457994|FG001|Overall Study|Conducting rescue therapy|1|||
125226585|NCT03439137|450457993|FG000|Overall Study|Difficult to control Hb|10|||
125226586|NCT03439137|450457994|FG001|Overall Study|Difficult to control Hb|2|||
125226587|NCT03439137|450457993|FG000|Overall Study|Initiation of a renal transplant|0|||
125226588|NCT03439137|450457994|FG001|Overall Study|Initiation of a renal transplant|2|||
125226589|NCT00748241|450457995|FG000|Overall Study|Implant failure|1|||
125226590|NCT00748241|450457995|FG000|Overall Study|Lost to Follow-up|5|||
125226591|NCT00748241|450457995|FG000|Overall Study|Death|2|||
125226592|NCT01240382|450457996|FG000|Overall Study|Adverse Event|2|||
125226593|NCT01240382|450457997|FG001|Overall Study|Adverse Event|1|||
125442409|NCT02291289|451248915|FG005|Induction Treatment|Protocol Violation|0|||
125442410|NCT02291289|451248916|FG006|Induction Treatment|Protocol Violation|0|||
125442411|NCT02291289|451248917|FG007|Induction Treatment|Protocol Violation|0|||
125442412|NCT02291289|451248918|FG008|Induction Treatment|Protocol Violation|0|||
125442413|NCT02291289|451248919|FG009|Induction Treatment|Protocol Violation|2|||
125442414|NCT02291289|451248920|FG010|Induction Treatment|Protocol Violation|0|||
125442415|NCT02291289|451248921|FG011|Induction Treatment|Protocol Violation|0|||
125442416|NCT02291289|451248922|FG012|Induction Treatment|Protocol Violation|0|||
125442417|NCT02291289|451248910|FG000|Induction Treatment|Missing|4|||
125442418|NCT02291289|451248911|FG001|Induction Treatment|Missing|0|||
125442419|NCT02291289|451248912|FG002|Induction Treatment|Missing|0|||
125442420|NCT02291289|451248913|FG003|Induction Treatment|Missing|14|||
125442421|NCT02291289|451248914|FG004|Induction Treatment|Missing|0|||
125442422|NCT02291289|451248915|FG005|Induction Treatment|Missing|0|||
125442423|NCT02291289|451248916|FG006|Induction Treatment|Missing|0|||
125442424|NCT02291289|451248917|FG007|Induction Treatment|Missing|0|||
125442425|NCT02291289|451248918|FG008|Induction Treatment|Missing|0|||
125442426|NCT02291289|451248919|FG009|Induction Treatment|Missing|54|||
125442427|NCT02291289|451248920|FG010|Induction Treatment|Missing|0|||
125442428|NCT02291289|451248921|FG011|Induction Treatment|Missing|0|||
125442429|NCT02291289|451248922|FG012|Induction Treatment|Missing|0|||
125442430|NCT02291289|451248910|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125442431|NCT02291289|451248911|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125442432|NCT02291289|451248912|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125442433|NCT02291289|451248913|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125442434|NCT02291289|451248914|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
125442435|NCT02291289|451248915|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
125442436|NCT02291289|451248916|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125442437|NCT02291289|451248917|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125442438|NCT02291289|451248918|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125442439|NCT02291289|451248919|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125442440|NCT02291289|451248920|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
125442441|NCT02291289|451248921|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
125442442|NCT02291289|451248922|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125442443|NCT02291289|451248910|FG000|Maintenance Treatment Phase|Death|0|||
125442444|NCT02291289|451248911|FG001|Maintenance Treatment Phase|Death|29|||
125442445|NCT02291289|451248912|FG002|Maintenance Treatment Phase|Death|16|||
125442446|NCT02291289|451248913|FG003|Maintenance Treatment Phase|Death|0|||
125442447|NCT02291289|451248914|FG004|Maintenance Treatment Phase|Death|188|||
125442448|NCT02291289|451248915|FG005|Maintenance Treatment Phase|Death|107|||
125442449|NCT02291289|451248916|FG006|Maintenance Treatment Phase|Death|0|||
125442450|NCT02291289|451248917|FG007|Maintenance Treatment Phase|Death|1|||
125165946|NCT02132754|450230397|FG009|Overall Study|Screen Failure|0|||
125165947|NCT02132754|450230398|FG010|Overall Study|Screen Failure|0|||
125165948|NCT02132754|450230399|FG011|Overall Study|Screen Failure|0|||
125165949|NCT02132754|450230400|FG012|Overall Study|Screen Failure|0|||
125165950|NCT02132754|450230401|FG013|Overall Study|Screen Failure|0|||
125165951|NCT02132754|450230402|FG014|Overall Study|Screen Failure|0|||
125165952|NCT02132754|450230403|FG015|Overall Study|Screen Failure|0|||
125165953|NCT02132754|450230404|FG016|Overall Study|Screen Failure|0|||
125165954|NCT02132754|450230405|FG017|Overall Study|Screen Failure|0|||
125165955|NCT02132754|450230406|FG018|Overall Study|Screen Failure|0|||
125165956|NCT02132754|450230407|FG019|Overall Study|Screen Failure|1|||
125165957|NCT02132754|450230408|FG020|Overall Study|Screen Failure|0|||
125165958|NCT02132754|450230409|FG021|Overall Study|Screen Failure|1|||
125165959|NCT02132754|450230410|FG022|Overall Study|Screen Failure|0|||
125165960|NCT02132754|450230411|FG023|Overall Study|Screen Failure|0|||
125165961|NCT02132754|450230412|FG024|Overall Study|Screen Failure|0|||
125165962|NCT02132754|450230413|FG025|Overall Study|Screen Failure|0|||
125165963|NCT02132754|450230414|FG026|Overall Study|Screen Failure|0|||
125165964|NCT02132754|450230415|FG027|Overall Study|Screen Failure|0|||
125165965|NCT02132754|450230416|FG028|Overall Study|Screen Failure|0|||
125165966|NCT02132754|450230417|FG029|Overall Study|Screen Failure|0|||
125165967|NCT02132754|450230418|FG030|Overall Study|Screen Failure|0|||
125165968|NCT02132754|450230419|FG031|Overall Study|Screen Failure|0|||
125165969|NCT02132754|450230420|FG032|Overall Study|Screen Failure|0|||
125165970|NCT02132754|450230421|FG033|Overall Study|Screen Failure|0|||
125442451|NCT02291289|451248918|FG008|Maintenance Treatment Phase|Death|1|||
125165971|NCT02132754|450230388|FG000|Overall Study|Transferred to Extension Study|0|||
125165972|NCT02132754|450230389|FG001|Overall Study|Transferred to Extension Study|0|||
125165973|NCT02132754|450230390|FG002|Overall Study|Transferred to Extension Study|0|||
125165974|NCT02132754|450230391|FG003|Overall Study|Transferred to Extension Study|0|||
125165975|NCT02132754|450230392|FG004|Overall Study|Transferred to Extension Study|0|||
125442452|NCT02291289|451248919|FG009|Maintenance Treatment Phase|Death|0|||
125442453|NCT02291289|451248920|FG010|Maintenance Treatment Phase|Death|46|||
125165976|NCT02132754|450230393|FG005|Overall Study|Transferred to Extension Study|0|||
125442454|NCT02291289|451248921|FG011|Maintenance Treatment Phase|Death|19|||
125442455|NCT02291289|451248922|FG012|Maintenance Treatment Phase|Death|0|||
125442456|NCT02291289|451248910|FG000|Maintenance Treatment Phase|Adverse Event|0|||
125226594|NCT01240382|450457996|FG000|Overall Study|Lack of Efficacy|0|||
125226595|NCT01240382|450457997|FG001|Overall Study|Lack of Efficacy|2|||
125226596|NCT01240382|450457996|FG000|Overall Study|Fear of adverse events|0|||
125226597|NCT01240382|450457997|FG001|Overall Study|Fear of adverse events|1|||
125226598|NCT02456727|450458005|FG000|Overall Study|Lost to Follow-up|63|||
125226599|NCT02456727|450458006|FG001|Overall Study|Lost to Follow-up|65|||
125226600|NCT02456727|450458005|FG000|Overall Study|Death|2|||
125226601|NCT02456727|450458006|FG001|Overall Study|Death|1|||
125226602|NCT02456727|450458005|FG000|Overall Study|Withdrawal by Subject|1|||
125226603|NCT02456727|450458006|FG001|Overall Study|Withdrawal by Subject|10|||
125226604|NCT02456727|450458005|FG000|Overall Study|Never Initiated Treatment|43|||
125226605|NCT02456727|450458006|FG001|Overall Study|Never Initiated Treatment|30|||
125226606|NCT02643693|450458010|FG000|Overall Study|Physician Decision|0|||
125226607|NCT02643693|450458011|FG001|Overall Study|Physician Decision|1|||
125226608|NCT02643693|450458012|FG002|Overall Study|Physician Decision|0|||
125226609|NCT02643693|450458013|FG003|Overall Study|Physician Decision|0|||
125226610|NCT02643693|450458014|FG004|Overall Study|Physician Decision|0|||
125226611|NCT02643693|450458015|FG005|Overall Study|Physician Decision|0|||
125226612|NCT02643693|450458010|FG000|Overall Study|Withdrawal by Subject|0|||
125226613|NCT02643693|450458011|FG001|Overall Study|Withdrawal by Subject|1|||
125226614|NCT02643693|450458012|FG002|Overall Study|Withdrawal by Subject|0|||
125226615|NCT02643693|450458013|FG003|Overall Study|Withdrawal by Subject|0|||
125226616|NCT02643693|450458014|FG004|Overall Study|Withdrawal by Subject|0|||
125392113|NCT00136084|451070589|FG000|Overall Study|Unacceptable toxicity|8|||
125392114|NCT00136084|451070590|FG001|Overall Study|Unacceptable toxicity|11|||
125392115|NCT00136084|451070589|FG000|Overall Study|Relapse|20|||
125392116|NCT00136084|451070590|FG001|Overall Study|Relapse|23|||
125392117|NCT00136084|451070589|FG000|Overall Study|Lost to Follow-up|2|||
125392118|NCT00136084|451070590|FG001|Overall Study|Lost to Follow-up|0|||
125392119|NCT00136084|451070589|FG000|Overall Study|No Response|1|||
125392120|NCT00136084|451070590|FG001|Overall Study|No Response|2|||
125392121|NCT00136084|451070589|FG000|Overall Study|Withdrawal by Subject|5|||
125392122|NCT00136084|451070590|FG001|Overall Study|Withdrawal by Subject|1|||
125392123|NCT02449239|451070591|FG000|Induction Phase|Lack of Efficacy|64|||
125392124|NCT02449239|451070591|FG000|Induction Phase|Adverse Event|1|||
125392125|NCT02449239|451070591|FG000|Induction Phase|Lost to Follow-up|1|||
125392126|NCT02449239|451070591|FG000|Induction Phase|Protocol Violation|1|||
125392127|NCT02449239|451070591|FG000|Induction Phase|Physician Decision|1|||
125392128|NCT02449239|451070591|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
125392129|NCT02449239|451070591|FG000|Induction Phase|Withdrawal by Subject|1|||
125392130|NCT02449239|451070591|FG000|Maintenance Month 3|Lack of Efficacy|14|||
125392131|NCT02449239|451070591|FG000|Maintenance Month 6|Lack of Efficacy|10|||
125392132|NCT02449239|451070591|FG000|Maintenance Month 6|Adverse Event|2|||
125392133|NCT02449239|451070591|FG000|Maintenance Month 6|Physician Decision|1|||
125392134|NCT02449239|451070591|FG000|Maintenance Month 9|Lack of Efficacy|2|||
125392135|NCT02449239|451070591|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
125392136|NCT02449239|451070591|FG000|Maintenance Month 12|Lack of Efficacy|5|||
125392137|NCT02449239|451070591|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
125392138|NCT02449239|451070591|FG000|Maintenance Month 12|Subject moved from area|1|||
125392139|NCT02449239|451070591|FG000|Maintenance Month 15|Lack of Efficacy|1|||
125392140|NCT02449239|451070591|FG000|Maintenance Month 21|Lack of Efficacy|1|||
125392141|NCT02449239|451070591|FG000|Maintenance Month 21|Sponsor decision|1|||
125392142|NCT00394212|451070593|FG000|Overall Study|Lost to Follow-up|3|||
125392143|NCT00394212|451070594|FG001|Overall Study|Lost to Follow-up|0|||
125392144|NCT00394212|451070593|FG000|Overall Study|Withdrawal by Subject|4|||
125392145|NCT00394212|451070594|FG001|Overall Study|Withdrawal by Subject|1|||
125392146|NCT00588445|451070595|FG000|Overall Study|Protocol Violation|1|||
125392147|NCT00588445|451070595|FG000|Overall Study|Withdrawal by Subject|3|||
125392148|NCT00588445|451070595|FG000|Overall Study|Disease Progression|1|||
125392149|NCT00588445|451070595|FG000|Overall Study|Not Treated|10|||
125392150|NCT03240133|451070596|FG000|Overall Study|Withdrawal by Subject|0|||
125392151|NCT03240133|451070597|FG001|Overall Study|Withdrawal by Subject|1|||
125392152|NCT03240133|451070598|FG002|Overall Study|Withdrawal by Subject|0|||
125392153|NCT03240133|451070596|FG000|Overall Study|Adverse Event|1|||
125392154|NCT03240133|451070597|FG001|Overall Study|Adverse Event|1|||
125392155|NCT03240133|451070598|FG002|Overall Study|Adverse Event|0|||
125392156|NCT03240133|451070596|FG000|Overall Study|Rash|1|||
125392157|NCT03240133|451070597|FG001|Overall Study|Rash|0|||
125392158|NCT03240133|451070598|FG002|Overall Study|Rash|0|||
125392159|NCT03240133|451070596|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
125392160|NCT03240133|451070597|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
125392161|NCT03240133|451070598|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
125392162|NCT03240133|451070596|FG000|Overall Study|Intercurrent illness.|0|||
125392163|NCT03240133|451070597|FG001|Overall Study|Intercurrent illness.|1|||
125392164|NCT03240133|451070598|FG002|Overall Study|Intercurrent illness.|0|||
125392165|NCT03240133|451070596|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
125392166|NCT03240133|451070597|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
125442457|NCT02291289|451248911|FG001|Maintenance Treatment Phase|Adverse Event|0|||
125442458|NCT02291289|451248912|FG002|Maintenance Treatment Phase|Adverse Event|0|||
125442459|NCT02291289|451248913|FG003|Maintenance Treatment Phase|Adverse Event|0|||
125442460|NCT02291289|451248914|FG004|Maintenance Treatment Phase|Adverse Event|1|||
125442461|NCT02291289|451248915|FG005|Maintenance Treatment Phase|Adverse Event|1|||
125442462|NCT02291289|451248916|FG006|Maintenance Treatment Phase|Adverse Event|0|||
125442463|NCT02291289|451248917|FG007|Maintenance Treatment Phase|Adverse Event|0|||
125442464|NCT02291289|451248918|FG008|Maintenance Treatment Phase|Adverse Event|0|||
125442465|NCT02291289|451248919|FG009|Maintenance Treatment Phase|Adverse Event|0|||
125442466|NCT02291289|451248920|FG010|Maintenance Treatment Phase|Adverse Event|0|||
125442467|NCT02291289|451248921|FG011|Maintenance Treatment Phase|Adverse Event|0|||
125442468|NCT02291289|451248922|FG012|Maintenance Treatment Phase|Adverse Event|0|||
125442469|NCT02291289|451248910|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
125442470|NCT02291289|451248911|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
125442471|NCT02291289|451248912|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
125442472|NCT02291289|451248913|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
125442473|NCT02291289|451248914|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
125442474|NCT02291289|451248915|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
125442475|NCT02291289|451248916|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
125442476|NCT02291289|451248917|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
125442477|NCT02291289|451248918|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
125442478|NCT02291289|451248919|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
125442479|NCT02291289|451248920|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
125442480|NCT02291289|451248921|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
125442481|NCT02291289|451248922|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
125442482|NCT02291289|451248910|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
125442483|NCT02291289|451248911|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
125442484|NCT02291289|451248912|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
125442485|NCT02291289|451248913|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
125442486|NCT02291289|451248914|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
125442487|NCT02291289|451248915|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
125442488|NCT02291289|451248916|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
125442489|NCT02291289|451248917|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
125442490|NCT02291289|451248918|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
125442491|NCT02291289|451248919|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
125442492|NCT02291289|451248920|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
125442493|NCT02291289|451248921|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
125442494|NCT02291289|451248922|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
125442495|NCT02291289|451248910|FG000|Maintenance Treatment Phase|Physician Decision|0|||
125165977|NCT02132754|450230394|FG006|Overall Study|Transferred to Extension Study|0|||
125165978|NCT02132754|450230395|FG007|Overall Study|Transferred to Extension Study|0|||
125165979|NCT02132754|450230396|FG008|Overall Study|Transferred to Extension Study|0|||
125165980|NCT02132754|450230397|FG009|Overall Study|Transferred to Extension Study|0|||
125165981|NCT02132754|450230398|FG010|Overall Study|Transferred to Extension Study|0|||
125165982|NCT02132754|450230399|FG011|Overall Study|Transferred to Extension Study|0|||
125165983|NCT02132754|450230400|FG012|Overall Study|Transferred to Extension Study|0|||
125165984|NCT02132754|450230401|FG013|Overall Study|Transferred to Extension Study|0|||
125165985|NCT02132754|450230402|FG014|Overall Study|Transferred to Extension Study|0|||
125165986|NCT02132754|450230403|FG015|Overall Study|Transferred to Extension Study|0|||
125165987|NCT02132754|450230404|FG016|Overall Study|Transferred to Extension Study|0|||
125165988|NCT02132754|450230405|FG017|Overall Study|Transferred to Extension Study|0|||
125165989|NCT02132754|450230406|FG018|Overall Study|Transferred to Extension Study|0|||
125165990|NCT02132754|450230407|FG019|Overall Study|Transferred to Extension Study|0|||
125165991|NCT02132754|450230408|FG020|Overall Study|Transferred to Extension Study|0|||
125165992|NCT02132754|450230409|FG021|Overall Study|Transferred to Extension Study|0|||
125226617|NCT02643693|450458015|FG005|Overall Study|Withdrawal by Subject|0|||
125226618|NCT02643693|450458010|FG000|Overall Study|Protocol Adherence Issues|2|||
125226619|NCT02643693|450458011|FG001|Overall Study|Protocol Adherence Issues|0|||
125226620|NCT02643693|450458012|FG002|Overall Study|Protocol Adherence Issues|1|||
125226621|NCT02643693|450458013|FG003|Overall Study|Protocol Adherence Issues|0|||
125165993|NCT02132754|450230410|FG022|Overall Study|Transferred to Extension Study|0|||
125165994|NCT02132754|450230411|FG023|Overall Study|Transferred to Extension Study|0|||
125226622|NCT02643693|450458014|FG004|Overall Study|Protocol Adherence Issues|0|||
125226623|NCT02643693|450458015|FG005|Overall Study|Protocol Adherence Issues|1|||
125442496|NCT02291289|451248911|FG001|Maintenance Treatment Phase|Physician Decision|2|||
125442497|NCT02291289|451248912|FG002|Maintenance Treatment Phase|Physician Decision|0|||
125442498|NCT02291289|451248913|FG003|Maintenance Treatment Phase|Physician Decision|0|||
125442499|NCT02291289|451248914|FG004|Maintenance Treatment Phase|Physician Decision|3|||
125442500|NCT02291289|451248915|FG005|Maintenance Treatment Phase|Physician Decision|0|||
125442501|NCT02291289|451248916|FG006|Maintenance Treatment Phase|Physician Decision|0|||
125442502|NCT02291289|451248917|FG007|Maintenance Treatment Phase|Physician Decision|0|||
125165995|NCT02132754|450230412|FG024|Overall Study|Transferred to Extension Study|0|||
125165996|NCT02132754|450230413|FG025|Overall Study|Transferred to Extension Study|0|||
125165997|NCT02132754|450230414|FG026|Overall Study|Transferred to Extension Study|0|||
125165998|NCT02132754|450230415|FG027|Overall Study|Transferred to Extension Study|0|||
125165999|NCT02132754|450230416|FG028|Overall Study|Transferred to Extension Study|0|||
125442503|NCT02291289|451248918|FG008|Maintenance Treatment Phase|Physician Decision|0|||
125442504|NCT02291289|451248919|FG009|Maintenance Treatment Phase|Physician Decision|0|||
125442505|NCT02291289|451248920|FG010|Maintenance Treatment Phase|Physician Decision|1|||
125442506|NCT02291289|451248921|FG011|Maintenance Treatment Phase|Physician Decision|3|||
125442507|NCT02291289|451248922|FG012|Maintenance Treatment Phase|Physician Decision|0|||
125442508|NCT02291289|451248910|FG000|Maintenance Treatment Phase|Not Treated|0|||
125226624|NCT00492297|450458016|FG000|Treatment|Death|2|||
125226625|NCT00492297|450458016|FG000|Treatment|Study terminated by sponsor|3|||
125226626|NCT00492297|450458016|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
125226627|NCT00492297|450458016|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
125226628|NCT00492297|450458016|FG000|Survival Only Follow-up|Death|46|||
125226629|NCT00492297|450458016|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
125226630|NCT00492297|450458016|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
125226631|NCT01408706|450458017|FG000|Overall Study|Physician Decision|1|||
125226632|NCT01408706|450458018|FG001|Overall Study|Physician Decision|0|||
125226633|NCT00888654|450458020|FG000|Overall Study|Problems swallowing oral meds.|1|||
125226634|NCT00888654|450458020|FG000|Overall Study|Not enough oral meds before surgery|3|||
125226635|NCT00888654|450458020|FG000|Overall Study|Surgery aborted|2|||
125226636|NCT00888654|450458020|FG000|Overall Study|Withdrawal by Subject|1|||
125226637|NCT00888654|450458020|FG000|Overall Study|Inelig. due to contraindication of med|1|||
125226638|NCT00888654|450458020|FG000|Overall Study|Change in surg date|1|||
125226639|NCT00888654|450458020|FG000|Overall Study|Stopped meds due to headaches|1|||
125226640|NCT00698815|450458021|FG000|Overall Study|Death|1|||
125226641|NCT00698815|450458022|FG001|Overall Study|Death|2|||
125226642|NCT00698815|450458023|FG002|Overall Study|Death|4|||
125226643|NCT00698815|450458021|FG000|Overall Study|Withdrawal by Subject|6|||
125226644|NCT00698815|450458022|FG001|Overall Study|Withdrawal by Subject|3|||
125226645|NCT00698815|450458023|FG002|Overall Study|Withdrawal by Subject|2|||
125226646|NCT00698815|450458021|FG000|Overall Study|MD discretion|2|||
125226647|NCT00698815|450458022|FG001|Overall Study|MD discretion|7|||
125226648|NCT00698815|450458023|FG002|Overall Study|MD discretion|2|||
125226649|NCT00698815|450458021|FG000|Overall Study|Did not receive protocol treatment|1|||
125226650|NCT00698815|450458022|FG001|Overall Study|Did not receive protocol treatment|2|||
125226651|NCT00698815|450458023|FG002|Overall Study|Did not receive protocol treatment|2|||
125226652|NCT01663402|450458026|FG000|Overall Study|Randomized but not treated|19|||
125226653|NCT01663402|450458027|FG001|Overall Study|Randomized but not treated|11|||
125226654|NCT01663402|450458026|FG000|Overall Study|Adverse Event|347|||
125226655|NCT01663402|450458027|FG001|Overall Study|Adverse Event|362|||
125226656|NCT01663402|450458026|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
125226657|NCT01663402|450458027|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
125226658|NCT01663402|450458026|FG000|Overall Study|Poor compliance to protocol|529|||
125226659|NCT01663402|450458027|FG001|Overall Study|Poor compliance to protocol|454|||
125226660|NCT01663402|450458026|FG000|Overall Study|Physician Decision|77|||
125226661|NCT01663402|450458027|FG001|Overall Study|Physician Decision|62|||
125226662|NCT01663402|450458026|FG000|Overall Study|Site terminated by sponsor|1|||
125226663|NCT01663402|450458027|FG001|Overall Study|Site terminated by sponsor|3|||
125226664|NCT01663402|450458026|FG000|Overall Study|Participant moved|139|||
125226665|NCT01663402|450458027|FG001|Overall Study|Participant moved|104|||
125226666|NCT01663402|450458026|FG000|Overall Study|Withdrawal by Subject|118|||
125226667|NCT01663402|450458027|FG001|Overall Study|Withdrawal by Subject|91|||
125226668|NCT01663402|450458026|FG000|Overall Study|Related to study drug administration|96|||
125226669|NCT01663402|450458027|FG001|Overall Study|Related to study drug administration|105|||
125226670|NCT01663402|450458026|FG000|Overall Study|Lost to Follow-up|17|||
125226671|NCT01663402|450458027|FG001|Overall Study|Lost to Follow-up|15|||
125226672|NCT01663402|450458026|FG000|Overall Study|Other than specified above|172|||
125226673|NCT01663402|450458027|FG001|Overall Study|Other than specified above|147|||
125442509|NCT02291289|451248911|FG001|Maintenance Treatment Phase|Not Treated|0|||
125166000|NCT02132754|450230417|FG029|Overall Study|Transferred to Extension Study|0|||
125166001|NCT02132754|450230418|FG030|Overall Study|Transferred to Extension Study|0|||
125226674|NCT03575702|450458030|FG000|Overall Study|Withdrawal by Subject|1|||
125226675|NCT03575702|450458031|FG001|Overall Study|Withdrawal by Subject|1|||
125226676|NCT03575702|450458030|FG000|Overall Study|Lost to Follow-up|1|||
125226677|NCT03575702|450458031|FG001|Overall Study|Lost to Follow-up|2|||
125226678|NCT03575702|450458030|FG000|Overall Study|Protocol Violation|0|||
125226679|NCT03575702|450458031|FG001|Overall Study|Protocol Violation|1|||
125226680|NCT03575702|450458030|FG000|Overall Study|Patient non compliance|4|||
125226681|NCT03575702|450458031|FG001|Overall Study|Patient non compliance|0|||
125442510|NCT02291289|451248912|FG002|Maintenance Treatment Phase|Not Treated|2|||
125442511|NCT02291289|451248913|FG003|Maintenance Treatment Phase|Not Treated|0|||
125442512|NCT02291289|451248914|FG004|Maintenance Treatment Phase|Not Treated|0|||
125166002|NCT02132754|450230419|FG031|Overall Study|Transferred to Extension Study|0|||
125166003|NCT02132754|450230420|FG032|Overall Study|Transferred to Extension Study|0|||
125166004|NCT02132754|450230421|FG033|Overall Study|Transferred to Extension Study|6|||
125166005|NCT02132754|450230388|FG000|Overall Study|Withdrawal by Subject|0|||
125166006|NCT02132754|450230389|FG001|Overall Study|Withdrawal by Subject|0|||
125166007|NCT02132754|450230390|FG002|Overall Study|Withdrawal by Subject|0|||
125166008|NCT02132754|450230391|FG003|Overall Study|Withdrawal by Subject|0|||
125166009|NCT02132754|450230392|FG004|Overall Study|Withdrawal by Subject|0|||
125166010|NCT02132754|450230393|FG005|Overall Study|Withdrawal by Subject|0|||
125166011|NCT02132754|450230394|FG006|Overall Study|Withdrawal by Subject|0|||
125166012|NCT02132754|450230395|FG007|Overall Study|Withdrawal by Subject|0|||
125166013|NCT02132754|450230396|FG008|Overall Study|Withdrawal by Subject|0|||
125166014|NCT02132754|450230397|FG009|Overall Study|Withdrawal by Subject|1|||
125166015|NCT02132754|450230398|FG010|Overall Study|Withdrawal by Subject|0|||
125166016|NCT02132754|450230399|FG011|Overall Study|Withdrawal by Subject|0|||
125166017|NCT02132754|450230400|FG012|Overall Study|Withdrawal by Subject|1|||
125166018|NCT02132754|450230401|FG013|Overall Study|Withdrawal by Subject|0|||
125166019|NCT02132754|450230402|FG014|Overall Study|Withdrawal by Subject|1|||
125166020|NCT02132754|450230403|FG015|Overall Study|Withdrawal by Subject|2|||
125166021|NCT02132754|450230404|FG016|Overall Study|Withdrawal by Subject|1|||
125166022|NCT02132754|450230405|FG017|Overall Study|Withdrawal by Subject|0|||
125166023|NCT02132754|450230406|FG018|Overall Study|Withdrawal by Subject|0|||
125166024|NCT02132754|450230407|FG019|Overall Study|Withdrawal by Subject|0|||
125166025|NCT02132754|450230408|FG020|Overall Study|Withdrawal by Subject|1|||
125166026|NCT02132754|450230409|FG021|Overall Study|Withdrawal by Subject|0|||
125166027|NCT02132754|450230410|FG022|Overall Study|Withdrawal by Subject|0|||
125166028|NCT02132754|450230411|FG023|Overall Study|Withdrawal by Subject|0|||
125166029|NCT02132754|450230412|FG024|Overall Study|Withdrawal by Subject|1|||
125166030|NCT02132754|450230413|FG025|Overall Study|Withdrawal by Subject|0|||
125166031|NCT02132754|450230414|FG026|Overall Study|Withdrawal by Subject|0|||
125166032|NCT02132754|450230415|FG027|Overall Study|Withdrawal by Subject|1|||
125166033|NCT02132754|450230416|FG028|Overall Study|Withdrawal by Subject|0|||
125166034|NCT02132754|450230417|FG029|Overall Study|Withdrawal by Subject|0|||
125166035|NCT02132754|450230418|FG030|Overall Study|Withdrawal by Subject|0|||
125166036|NCT02132754|450230419|FG031|Overall Study|Withdrawal by Subject|1|||
125166037|NCT02132754|450230420|FG032|Overall Study|Withdrawal by Subject|0|||
125166038|NCT02132754|450230421|FG033|Overall Study|Withdrawal by Subject|2|||
125166039|NCT02288182|450230424|FG000|Overall Study|Adverse Event|0|||
125166040|NCT02288182|450230425|FG001|Overall Study|Adverse Event|1|||
125166041|NCT02288182|450230424|FG000|Overall Study|Lost to Follow-up|0|||
125166042|NCT02288182|450230425|FG001|Overall Study|Lost to Follow-up|1|||
125166043|NCT03567382|450230427|FG000|Overall Study|Lost to Follow-up|1|||
125166044|NCT03567382|450230428|FG001|Overall Study|Lost to Follow-up|21|||
125166045|NCT03567382|450230429|FG002|Overall Study|Lost to Follow-up|1|||
125166046|NCT03567382|450230430|FG003|Overall Study|Lost to Follow-up|21|||
125166047|NCT03567382|450230427|FG000|Overall Study|Withdrawal by Subject|2|||
125166048|NCT03567382|450230428|FG001|Overall Study|Withdrawal by Subject|14|||
125166049|NCT03567382|450230429|FG002|Overall Study|Withdrawal by Subject|1|||
125166050|NCT03567382|450230430|FG003|Overall Study|Withdrawal by Subject|12|||
125166051|NCT00620659|450230433|FG000|Treatment Period 1|Adverse Event|1|||
125166052|NCT00620659|450230434|FG001|Treatment Period 1|Adverse Event|0|||
125166053|NCT00620659|450230435|FG002|Treatment Period 1|Adverse Event|0|||
125166054|NCT00620659|450230436|FG003|Treatment Period 1|Adverse Event|3|||
125166055|NCT00620659|450230437|FG004|Treatment Period 1|Adverse Event|0|||
125166056|NCT00620659|450230438|FG005|Treatment Period 1|Adverse Event|0|||
125166057|NCT00620659|450230433|FG000|Treatment Period 1|Protocol Violation|1|||
125166058|NCT00620659|450230434|FG001|Treatment Period 1|Protocol Violation|0|||
125166059|NCT00620659|450230435|FG002|Treatment Period 1|Protocol Violation|0|||
125166060|NCT00620659|450230436|FG003|Treatment Period 1|Protocol Violation|0|||
125166061|NCT00620659|450230437|FG004|Treatment Period 1|Protocol Violation|0|||
125166062|NCT00620659|450230438|FG005|Treatment Period 1|Protocol Violation|0|||
125166063|NCT00620659|450230433|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125166064|NCT00620659|450230434|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125166065|NCT00620659|450230435|FG002|Treatment Period 1|Withdrawal by Subject|1|||
125166066|NCT00620659|450230436|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125166067|NCT00620659|450230437|FG004|Treatment Period 1|Withdrawal by Subject|1|||
125166068|NCT00620659|450230438|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125166069|NCT00620659|450230433|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
125166070|NCT00620659|450230434|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
125166071|NCT00620659|450230435|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
125166072|NCT00620659|450230436|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
125166073|NCT00620659|450230437|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
125166074|NCT00620659|450230438|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
125166075|NCT00620659|450230433|FG000|Treatment Period 2|Adverse Event|0|||
125166076|NCT00620659|450230434|FG001|Treatment Period 2|Adverse Event|3|||
125166077|NCT00620659|450230435|FG002|Treatment Period 2|Adverse Event|0|||
125166078|NCT00620659|450230436|FG003|Treatment Period 2|Adverse Event|0|||
125166079|NCT00620659|450230437|FG004|Treatment Period 2|Adverse Event|2|||
125166080|NCT00620659|450230438|FG005|Treatment Period 2|Adverse Event|0|||
125166081|NCT00620659|450230433|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125166082|NCT00620659|450230434|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125166083|NCT00620659|450230435|FG002|Treatment Period 2|Withdrawal by Subject|1|||
125166084|NCT00620659|450230436|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125166085|NCT00620659|450230437|FG004|Treatment Period 2|Withdrawal by Subject|3|||
125166086|NCT00620659|450230438|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125166087|NCT00620659|450230433|FG000|Placebo Washout Period 2|Adverse Event|2|||
125166088|NCT00620659|450230434|FG001|Placebo Washout Period 2|Adverse Event|0|||
125166089|NCT00620659|450230435|FG002|Placebo Washout Period 2|Adverse Event|0|||
125226682|NCT01255163|450458032|FG000|Overall Study|Withdrawal by Subject|1|||
125226683|NCT01255163|450458033|FG001|Overall Study|Withdrawal by Subject|0|||
125226684|NCT01255163|450458032|FG000|Overall Study|Lost to Follow-up|2|||
125226685|NCT01255163|450458033|FG001|Overall Study|Lost to Follow-up|0|||
125226686|NCT01255163|450458032|FG000|Overall Study|Adverse Event|0|||
125226687|NCT01255163|450458033|FG001|Overall Study|Adverse Event|2|||
125226688|NCT01255163|450458032|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
125226689|NCT01255163|450458033|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
125226690|NCT02495389|450458034|FG000|Overall Study|Withdrawal by Subject|40|||
125226691|NCT01802385|450458036|FG000|Overall Study|Death|106|||
125226692|NCT01802385|450458037|FG001|Overall Study|Death|120|||
125226693|NCT03834493|450458038|FG000|Overall Study|Participants Ongoing|311|||
125226694|NCT03834493|450458039|FG001|Overall Study|Participants Ongoing|324|||
125226695|NCT03834493|450458038|FG000|Overall Study|Withdrawal by Subject|20|||
125226696|NCT03834493|450458039|FG001|Overall Study|Withdrawal by Subject|17|||
125226697|NCT03834493|450458038|FG000|Overall Study|Physician Decision|1|||
125226698|NCT03834493|450458039|FG001|Overall Study|Physician Decision|0|||
125226699|NCT03834493|450458038|FG000|Overall Study|Death|289|||
125226700|NCT03834493|450458039|FG001|Overall Study|Death|282|||
125226701|NCT05559905|450458040|FG000|Overall Study|Withdrawal by Subject|1|||
125226702|NCT05559905|450458041|FG001|Overall Study|Withdrawal by Subject|0|||
125226703|NCT05559905|450458042|FG002|Overall Study|Withdrawal by Subject|0|||
125226704|NCT05559905|450458040|FG000|Overall Study|Not Reported|1|||
125226705|NCT05559905|450458041|FG001|Overall Study|Not Reported|0|||
125226706|NCT05559905|450458042|FG002|Overall Study|Not Reported|0|||
125226707|NCT04003103|450458043|FG000|Overall Study|Death|1|||
125226708|NCT04003103|450458044|FG001|Overall Study|Death|0|||
125226709|NCT04003103|450458045|FG002|Overall Study|Death|0|||
125226710|NCT04003103|450458043|FG000|Overall Study|Lost to Follow-up|4|||
125226711|NCT04003103|450458044|FG001|Overall Study|Lost to Follow-up|3|||
125226712|NCT04003103|450458045|FG002|Overall Study|Lost to Follow-up|2|||
125226713|NCT04003103|450458043|FG000|Overall Study|Withdrawal by Subject|10|||
125226714|NCT04003103|450458044|FG001|Overall Study|Withdrawal by Subject|1|||
125226715|NCT04003103|450458045|FG002|Overall Study|Withdrawal by Subject|1|||
125226716|NCT04003103|450458043|FG000|Overall Study|Status not recorded|0|||
125226717|NCT04003103|450458044|FG001|Overall Study|Status not recorded|2|||
125226718|NCT04003103|450458045|FG002|Overall Study|Status not recorded|0|||
125226719|NCT03829462|450458048|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
125226720|NCT03829462|450458049|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
125226721|NCT03829462|450458048|FG000|Overall Study|No treatment due to progression disease|0|||
125226722|NCT03829462|450458049|FG001|Overall Study|No treatment due to progression disease|1|||
125226723|NCT05518539|450458053|FG000|Overall Study|Lost to Follow-up|6|||
125226724|NCT02053493|450458056|FG000|Overall Study|Withdrawal by Subject|1|||
125226725|NCT02053493|450458057|FG001|Overall Study|Withdrawal by Subject|1|||
125226726|NCT01619865|450458062|FG000|Overall Study|Adverse Event|1|||
125226727|NCT01619865|450458062|FG000|Overall Study|Death|2|||
125226728|NCT01619865|450458062|FG000|Overall Study|subject not able to comply|1|||
125226729|NCT01494818|450458063|FG000|Overall Study|Relocation|1|||
125226730|NCT01494818|450458064|FG001|Overall Study|Relocation|2|||
125226731|NCT01494818|450458063|FG000|Overall Study|Lost to Follow-up|1|||
125226732|NCT01494818|450458064|FG001|Overall Study|Lost to Follow-up|0|||
125226733|NCT00791999|450458065|FG000|Overall Study|Protocol planed withdrawal|14|||
125226734|NCT00791999|450458066|FG001|Overall Study|Protocol planed withdrawal|11|||
125226735|NCT00791999|450458067|FG002|Overall Study|Protocol planed withdrawal|11|||
125226736|NCT00791999|450458068|FG003|Overall Study|Protocol planed withdrawal|45|||
125226737|NCT00791999|450458065|FG000|Overall Study|Withdrawal by Subject|0|||
125226738|NCT00791999|450458066|FG001|Overall Study|Withdrawal by Subject|1|||
125226739|NCT00791999|450458067|FG002|Overall Study|Withdrawal by Subject|0|||
125226740|NCT00791999|450458068|FG003|Overall Study|Withdrawal by Subject|2|||
125226741|NCT00791999|450458065|FG000|Overall Study|Protocol Violation|3|||
125226742|NCT00791999|450458066|FG001|Overall Study|Protocol Violation|0|||
125166090|NCT00620659|450230436|FG003|Placebo Washout Period 2|Adverse Event|0|||
125226743|NCT00791999|450458067|FG002|Overall Study|Protocol Violation|1|||
125166091|NCT00620659|450230437|FG004|Placebo Washout Period 2|Adverse Event|0|||
125226744|NCT00791999|450458068|FG003|Overall Study|Protocol Violation|0|||
125226745|NCT00791999|450458065|FG000|Overall Study|Adverse Event|3|||
125226746|NCT00791999|450458066|FG001|Overall Study|Adverse Event|3|||
125226747|NCT00791999|450458067|FG002|Overall Study|Adverse Event|7|||
125226748|NCT00791999|450458068|FG003|Overall Study|Adverse Event|3|||
125226749|NCT00791999|450458065|FG000|Overall Study|Lack of Efficacy|0|||
125226750|NCT00791999|450458066|FG001|Overall Study|Lack of Efficacy|1|||
125226751|NCT00791999|450458067|FG002|Overall Study|Lack of Efficacy|0|||
125226752|NCT00791999|450458068|FG003|Overall Study|Lack of Efficacy|2|||
125226753|NCT00791999|450458065|FG000|Overall Study|Reason other than those above|1|||
125226754|NCT00791999|450458066|FG001|Overall Study|Reason other than those above|0|||
125226755|NCT00791999|450458067|FG002|Overall Study|Reason other than those above|1|||
125226756|NCT00791999|450458068|FG003|Overall Study|Reason other than those above|0|||
125226757|NCT01077323|450458069|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
125226758|NCT01077323|450458070|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
125226759|NCT01077323|450458071|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
125226760|NCT01077323|450458069|FG000|Overall Study|Dispensing of drug in baseline period|0|||
125226761|NCT01077323|450458070|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
125226762|NCT01077323|450458071|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
125226763|NCT01077323|450458069|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
125226764|NCT01077323|450458070|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
125226765|NCT01077323|450458071|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
125226766|NCT01710020|450458072|FG000|Period 1|Protocol Violation|1|||
125226767|NCT00427908|450458073|FG000|Primary Phase|Lost to Follow-up|4|||
125226768|NCT00427908|450458074|FG001|Primary Phase|Lost to Follow-up|0|||
125226769|NCT00427908|450458075|FG002|Primary Phase|Lost to Follow-up|2|||
125226770|NCT00427908|450458076|FG003|Primary Phase|Lost to Follow-up|0|||
125226771|NCT00427908|450458073|FG000|Primary Phase|Withdrawal by Subject|1|||
125226772|NCT00427908|450458074|FG001|Primary Phase|Withdrawal by Subject|2|||
125226773|NCT00427908|450458075|FG002|Primary Phase|Withdrawal by Subject|1|||
125226774|NCT00427908|450458076|FG003|Primary Phase|Withdrawal by Subject|0|||
125226775|NCT00427908|450458073|FG000|Primary Phase|Adverse Event|0|||
125226776|NCT00427908|450458074|FG001|Primary Phase|Adverse Event|1|||
125226777|NCT00427908|450458075|FG002|Primary Phase|Adverse Event|0|||
125226778|NCT00427908|450458076|FG003|Primary Phase|Adverse Event|0|||
125226779|NCT02984982|450458077|FG000|Overall Study|Adverse Event|2|||
125226780|NCT02984982|450458078|FG001|Overall Study|Adverse Event|5|||
125226781|NCT02984982|450458077|FG000|Overall Study|Poor Compliance to Protocol|4|||
125226782|NCT02984982|450458078|FG001|Overall Study|Poor Compliance to Protocol|4|||
125226783|NCT02984982|450458077|FG000|Overall Study|Withdrawal by Subject|2|||
125226784|NCT02984982|450458078|FG001|Overall Study|Withdrawal by Subject|0|||
125226785|NCT02984982|450458077|FG000|Overall Study|Randomized but not treated|0|||
125226786|NCT02984982|450458078|FG001|Overall Study|Randomized but not treated|1|||
125226787|NCT02153918|450458079|FG000|Overall Study|Refused further treatment|1|||
125226788|NCT02616783|450458080|FG000|Overall Study|Randomized but Not Treated|1|||
125226789|NCT02616783|450458081|FG001|Overall Study|Randomized but Not Treated|0|||
125226790|NCT02616783|450458080|FG000|Overall Study|Adverse Event|1|||
125226791|NCT02616783|450458081|FG001|Overall Study|Adverse Event|0|||
125226792|NCT02616783|450458080|FG000|Overall Study|Death|1|||
125226793|NCT02616783|450458081|FG001|Overall Study|Death|0|||
125226794|NCT02616783|450458080|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125226795|NCT02616783|450458081|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125226796|NCT02616783|450458080|FG000|Overall Study|Protocol Violation|1|||
125226797|NCT02616783|450458081|FG001|Overall Study|Protocol Violation|1|||
125226798|NCT02616783|450458080|FG000|Overall Study|Withdrew Consent|1|||
125226799|NCT02616783|450458081|FG001|Overall Study|Withdrew Consent|1|||
125226800|NCT04344301|450458082|FG000|Overall Study|Withdrawal by Subject|1|||
125226801|NCT04344301|450458083|FG001|Overall Study|Withdrawal by Subject|0|||
125226802|NCT04344301|450458082|FG000|Overall Study|Death|0|||
125226803|NCT04344301|450458083|FG001|Overall Study|Death|1|||
125226804|NCT01747499|450458084|FG000|Overall Study|Steroid refractory aGvHD|1|||
125226805|NCT01747499|450458085|FG001|Overall Study|Steroid refractory aGvHD|0|||
125226806|NCT01747499|450458086|FG002|Overall Study|Steroid refractory aGvHD|0|||
125226807|NCT01747499|450458087|FG003|Overall Study|Steroid refractory aGvHD|1|||
125226808|NCT01747499|450458088|FG004|Overall Study|Steroid refractory aGvHD|4|||
125226809|NCT01747499|450458084|FG000|Overall Study|Physician Decision|0|||
125226810|NCT01747499|450458085|FG001|Overall Study|Physician Decision|1|||
125226811|NCT01747499|450458086|FG002|Overall Study|Physician Decision|0|||
125226812|NCT01747499|450458087|FG003|Overall Study|Physician Decision|0|||
125226813|NCT01747499|450458088|FG004|Overall Study|Physician Decision|2|||
125226814|NCT01747499|450458084|FG000|Overall Study|Death|0|||
125226815|NCT01747499|450458085|FG001|Overall Study|Death|0|||
125392167|NCT03240133|451070598|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
125392168|NCT01176292|451070599|FG000|Overall Study|Lost to Follow-up|2|||
125392169|NCT01176292|451070600|FG001|Overall Study|Lost to Follow-up|4|||
125392170|NCT01176292|451070599|FG000|Overall Study|Adverse Event|1|||
125392171|NCT01176292|451070600|FG001|Overall Study|Adverse Event|1|||
125392172|NCT01176292|451070599|FG000|Overall Study|Physician Decision|0|||
125392173|NCT01176292|451070600|FG001|Overall Study|Physician Decision|2|||
125166092|NCT00620659|450230438|FG005|Placebo Washout Period 2|Adverse Event|0|||
125166093|NCT00620659|450230433|FG000|Treatment Period 3|Adverse Event|0|||
125166094|NCT00620659|450230434|FG001|Treatment Period 3|Adverse Event|2|||
125166095|NCT00620659|450230435|FG002|Treatment Period 3|Adverse Event|0|||
125166096|NCT00620659|450230436|FG003|Treatment Period 3|Adverse Event|0|||
125166097|NCT00620659|450230437|FG004|Treatment Period 3|Adverse Event|0|||
125166098|NCT00620659|450230438|FG005|Treatment Period 3|Adverse Event|0|||
125166099|NCT00620659|450230433|FG000|Treatment Period 3|Withdrawal by Subject|0|||
125166100|NCT00620659|450230434|FG001|Treatment Period 3|Withdrawal by Subject|0|||
125166101|NCT00620659|450230435|FG002|Treatment Period 3|Withdrawal by Subject|0|||
125166102|NCT00620659|450230436|FG003|Treatment Period 3|Withdrawal by Subject|1|||
125166103|NCT00620659|450230437|FG004|Treatment Period 3|Withdrawal by Subject|0|||
125166104|NCT00620659|450230438|FG005|Treatment Period 3|Withdrawal by Subject|0|||
125166105|NCT01214915|450230440|FG000|Overall Study|Adverse Event|8|||
125166106|NCT01214915|450230440|FG000|Overall Study|Lack of Efficacy|3|||
125166107|NCT02056392|450230441|FG000|Overall Study|Lost to Follow-up|0|||
125166108|NCT02056392|450230442|FG001|Overall Study|Lost to Follow-up|1|||
125166109|NCT02056392|450230443|FG002|Overall Study|Lost to Follow-up|2|||
125166110|NCT02056392|450230444|FG003|Overall Study|Lost to Follow-up|0|||
125166111|NCT02056392|450230445|FG004|Overall Study|Lost to Follow-up|0|||
125166112|NCT02056392|450230446|FG005|Overall Study|Lost to Follow-up|0|||
125166113|NCT02056392|450230441|FG000|Overall Study|Protocol Violation|1|||
125166114|NCT02056392|450230442|FG001|Overall Study|Protocol Violation|0|||
125166115|NCT02056392|450230443|FG002|Overall Study|Protocol Violation|1|||
125166116|NCT02056392|450230444|FG003|Overall Study|Protocol Violation|0|||
125166117|NCT02056392|450230445|FG004|Overall Study|Protocol Violation|0|||
125166118|NCT02056392|450230446|FG005|Overall Study|Protocol Violation|0|||
125166119|NCT02056392|450230441|FG000|Overall Study|Withdrawal by Subject|1|||
125166120|NCT02056392|450230442|FG001|Overall Study|Withdrawal by Subject|0|||
125166121|NCT02056392|450230443|FG002|Overall Study|Withdrawal by Subject|0|||
125166122|NCT02056392|450230444|FG003|Overall Study|Withdrawal by Subject|0|||
125166123|NCT02056392|450230445|FG004|Overall Study|Withdrawal by Subject|1|||
125166124|NCT02056392|450230446|FG005|Overall Study|Withdrawal by Subject|0|||
125166125|NCT04555720|450230449|FG000|Overall Study|Lost to Follow-up|2|||
125166126|NCT04555720|450230450|FG001|Overall Study|Lost to Follow-up|0|||
125166127|NCT04555720|450230451|FG002|Overall Study|Lost to Follow-up|0|||
125166128|NCT04555720|450230452|FG003|Overall Study|Lost to Follow-up|0|||
125166129|NCT04555720|450230449|FG000|Overall Study|Withdrawal by Subject|4|||
125166130|NCT04555720|450230450|FG001|Overall Study|Withdrawal by Subject|6|||
125166131|NCT04555720|450230451|FG002|Overall Study|Withdrawal by Subject|0|||
125166132|NCT04555720|450230452|FG003|Overall Study|Withdrawal by Subject|0|||
125166133|NCT00968799|450230453|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
125166134|NCT00719849|450230454|FG000|Overall Study|Death|0|||
125166135|NCT00719849|450230455|FG001|Overall Study|Death|1|||
125166136|NCT01372774|450230458|FG000|Overall Study|Withdrawal prior to treatment|4|||
125166137|NCT01372774|450230459|FG001|Overall Study|Withdrawal prior to treatment|5|||
125166138|NCT02201290|450230460|FG000|Overall Study|Withdrawal by Subject|2|||
125166139|NCT02201290|450230460|FG000|Overall Study|Lack of Efficacy|2|||
125166140|NCT02201290|450230460|FG000|Overall Study|Adverse Event|1|||
125166141|NCT01177059|450230461|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
125166142|NCT01177059|450230461|FG000|Overall Study|Withdrew consent|2|||
125166143|NCT01177059|450230461|FG000|Overall Study|Lost to Follow-up|18|||
125166144|NCT04003896|450232295|FG000|Overall Study|Withdrawal by Subject|3|||
125166145|NCT04003896|450232295|FG000|Overall Study|Physician Decision|1|||
125166146|NCT01957397|450232298|FG000|Test Period 1|sudden leakage/small bag|1|||
125166147|NCT01957397|450232299|FG001|Test Period 1|sudden leakage/small bag|1|||
125166148|NCT01957397|450232298|FG000|Test Period 1|Withdrawal by Subject|1|||
125166149|NCT01957397|450232299|FG001|Test Period 1|Withdrawal by Subject|0|||
125166150|NCT01957397|450232298|FG000|Test Period 2|Adverse Event|0|||
125166151|NCT01957397|450232299|FG001|Test Period 2|Adverse Event|1|||
125166152|NCT01957397|450232298|FG000|Test Period 3|Adverse Event|1|||
125166153|NCT01957397|450232299|FG001|Test Period 3|Adverse Event|2|||
125166154|NCT01957397|450232298|FG000|Test Period 3|the adhesive did not work|1|||
125166155|NCT01957397|450232299|FG001|Test Period 3|the adhesive did not work|0|||
125166156|NCT00324649|450232300|FG000|Overall Study|Adverse Event|1|||
125166157|NCT00324649|450232301|FG001|Overall Study|Adverse Event|4|||
125166158|NCT00324649|450232300|FG000|Overall Study|Withdrawal by Subject|0|||
125166159|NCT00324649|450232301|FG001|Overall Study|Withdrawal by Subject|1|||
125166160|NCT00324649|450232300|FG000|Overall Study|Noncompliance|1|||
125166161|NCT00324649|450232301|FG001|Overall Study|Noncompliance|0|||
125166162|NCT02315196|450232303|FG000|Overall Study|Withdrew consent|9|||
125166163|NCT00470067|450232304|FG000|Overall Study|Death|1|||
125166164|NCT00470067|450232304|FG000|Overall Study|Disease Progression|6|||
125166165|NCT03839823|450232305|FG000|Overall Study|Adverse Event|8|||
125166166|NCT03839823|450232306|FG001|Overall Study|Adverse Event|4|||
125166167|NCT03839823|450232305|FG000|Overall Study|Death|1|||
125392174|NCT01176292|451070599|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
125392175|NCT01176292|451070600|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
125226816|NCT01747499|450458086|FG002|Overall Study|Death|0|||
125226817|NCT01747499|450458087|FG003|Overall Study|Death|1|||
125226818|NCT01747499|450458088|FG004|Overall Study|Death|1|||
125226819|NCT01747499|450458084|FG000|Overall Study|Withdrawal by Subject|0|||
125226820|NCT01747499|450458085|FG001|Overall Study|Withdrawal by Subject|0|||
125226821|NCT01747499|450458086|FG002|Overall Study|Withdrawal by Subject|0|||
125226822|NCT01747499|450458087|FG003|Overall Study|Withdrawal by Subject|0|||
125226823|NCT01747499|450458088|FG004|Overall Study|Withdrawal by Subject|6|||
125226824|NCT01747499|450458084|FG000|Overall Study|Developed AML and death|0|||
125226825|NCT01747499|450458085|FG001|Overall Study|Developed AML and death|0|||
125226826|NCT01747499|450458086|FG002|Overall Study|Developed AML and death|0|||
125226827|NCT01747499|450458087|FG003|Overall Study|Developed AML and death|0|||
125226828|NCT01747499|450458088|FG004|Overall Study|Developed AML and death|1|||
125226829|NCT01747499|450458084|FG000|Overall Study|Determined not to be eligible|0|||
125226830|NCT01747499|450458085|FG001|Overall Study|Determined not to be eligible|0|||
125226831|NCT01747499|450458086|FG002|Overall Study|Determined not to be eligible|0|||
125226832|NCT01747499|450458087|FG003|Overall Study|Determined not to be eligible|0|||
125226833|NCT01747499|450458088|FG004|Overall Study|Determined not to be eligible|1|||
125226834|NCT05214118|450458091|FG000|Overall Study|Lost to Follow-up|0|||
125226835|NCT05214118|450458092|FG001|Overall Study|Lost to Follow-up|2|||
125226836|NCT05214118|450458091|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
125226837|NCT05214118|450458092|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
125226838|NCT05214118|450458091|FG000|Overall Study|moved|1|||
125226839|NCT05214118|450458092|FG001|Overall Study|moved|0|||
125226840|NCT04010461|450458093|FG000|Overall Study|COVID based withdrawal|5|||
125226841|NCT04010461|450458093|FG000|Overall Study|Withdrawal by Subject|5|||
125226842|NCT04010461|450458093|FG000|Overall Study|Adverse Event|1|||
125226843|NCT04010461|450458093|FG000|Overall Study|No Motor Threshold obtainable|1|||
125226844|NCT04010461|450458093|FG000|Overall Study|Physician Decision|1|||
125226845|NCT03797898|450458094|FG000|Overall Study|Lost to Follow-up|60|||
125226846|NCT03797898|450458095|FG001|Overall Study|Lost to Follow-up|69|||
125226847|NCT03797898|450458094|FG000|Overall Study|Withdrawal by Subject|9|||
125226848|NCT03797898|450458095|FG001|Overall Study|Withdrawal by Subject|7|||
125226849|NCT03797898|450458094|FG000|Overall Study|Became ineligible|5|||
125226850|NCT03797898|450458095|FG001|Overall Study|Became ineligible|2|||
125226851|NCT00086190|450458096|FG000|Overall Study|Adverse Event|6|||
125226852|NCT00086190|450458097|FG001|Overall Study|Adverse Event|2|||
125226853|NCT00086190|450458098|FG002|Overall Study|Adverse Event|2|||
125226854|NCT00086190|450458096|FG000|Overall Study|Withdrawal by Subject|0|||
125226855|NCT00086190|450458097|FG001|Overall Study|Withdrawal by Subject|2|||
125226856|NCT00086190|450458098|FG002|Overall Study|Withdrawal by Subject|2|||
125226857|NCT00086190|450458096|FG000|Overall Study|Protocol Violation|1|||
125226858|NCT00086190|450458097|FG001|Overall Study|Protocol Violation|0|||
125166168|NCT03839823|450232306|FG001|Overall Study|Death|0|||
125166169|NCT03839823|450232305|FG000|Overall Study|Physician Decision|1|||
125166170|NCT03839823|450232306|FG001|Overall Study|Physician Decision|5|||
125166171|NCT03839823|450232305|FG000|Overall Study|Progressive Disease (PD)|65|||
125166172|NCT03839823|450232306|FG001|Overall Study|Progressive Disease (PD)|65|||
125166173|NCT03839823|450232305|FG000|Overall Study|Subject Decision|2|||
125166174|NCT03839823|450232306|FG001|Overall Study|Subject Decision|9|||
125166175|NCT03839823|450232305|FG000|Overall Study|Not Treated|0|||
125166176|NCT03839823|450232306|FG001|Overall Study|Not Treated|10|||
125166177|NCT01517373|450232308|FG000|Run-in Period|Death|1|||
125166178|NCT01517373|450232309|FG001|Run-in Period|Death|0|||
125166179|NCT01517373|450232310|FG002|Run-in Period|Death|0|||
125166180|NCT01517373|450232311|FG003|Run-in Period|Death|0|||
125166181|NCT01517373|450232312|FG004|Run-in Period|Death|0|||
125166182|NCT01517373|450232313|FG005|Run-in Period|Death|0|||
125166183|NCT01517373|450232308|FG000|Run-in Period|Adverse Event|5|||
125166184|NCT01517373|450232309|FG001|Run-in Period|Adverse Event|0|||
125166185|NCT01517373|450232310|FG002|Run-in Period|Adverse Event|0|||
125166186|NCT01517373|450232311|FG003|Run-in Period|Adverse Event|0|||
125166187|NCT01517373|450232312|FG004|Run-in Period|Adverse Event|0|||
125166188|NCT01517373|450232313|FG005|Run-in Period|Adverse Event|0|||
125166189|NCT01517373|450232308|FG000|Run-in Period|Did not meet eligibility criteria|34|||
125166190|NCT01517373|450232309|FG001|Run-in Period|Did not meet eligibility criteria|0|||
125166191|NCT01517373|450232310|FG002|Run-in Period|Did not meet eligibility criteria|0|||
125166192|NCT01517373|450232311|FG003|Run-in Period|Did not meet eligibility criteria|0|||
125166193|NCT01517373|450232312|FG004|Run-in Period|Did not meet eligibility criteria|0|||
125166194|NCT01517373|450232313|FG005|Run-in Period|Did not meet eligibility criteria|0|||
125166195|NCT01517373|450232308|FG000|Run-in Period|Lost to Follow-up|1|||
125166196|NCT01517373|450232309|FG001|Run-in Period|Lost to Follow-up|0|||
125166197|NCT01517373|450232310|FG002|Run-in Period|Lost to Follow-up|0|||
125166198|NCT01517373|450232311|FG003|Run-in Period|Lost to Follow-up|0|||
125166199|NCT01517373|450232312|FG004|Run-in Period|Lost to Follow-up|0|||
125226859|NCT00086190|450458098|FG002|Overall Study|Protocol Violation|0|||
125226860|NCT00086190|450458096|FG000|Overall Study|Moved|1|||
125226861|NCT00086190|450458097|FG001|Overall Study|Moved|0|||
125226862|NCT00086190|450458098|FG002|Overall Study|Moved|0|||
125442513|NCT02291289|451248915|FG005|Maintenance Treatment Phase|Not Treated|0|||
125442514|NCT02291289|451248916|FG006|Maintenance Treatment Phase|Not Treated|0|||
125166200|NCT01517373|450232313|FG005|Run-in Period|Lost to Follow-up|0|||
125166201|NCT01517373|450232308|FG000|Run-in Period|Withdrawal by Subject|12|||
125166202|NCT01517373|450232309|FG001|Run-in Period|Withdrawal by Subject|0|||
125166203|NCT01517373|450232310|FG002|Run-in Period|Withdrawal by Subject|0|||
125166204|NCT01517373|450232311|FG003|Run-in Period|Withdrawal by Subject|0|||
125166205|NCT01517373|450232312|FG004|Run-in Period|Withdrawal by Subject|0|||
125166206|NCT01517373|450232313|FG005|Run-in Period|Withdrawal by Subject|0|||
125166207|NCT01517373|450232308|FG000|Run-in Period|Sponsor Decision|3|||
125166208|NCT01517373|450232309|FG001|Run-in Period|Sponsor Decision|0|||
125166209|NCT01517373|450232310|FG002|Run-in Period|Sponsor Decision|0|||
125166210|NCT01517373|450232311|FG003|Run-in Period|Sponsor Decision|0|||
125166211|NCT01517373|450232312|FG004|Run-in Period|Sponsor Decision|0|||
125166212|NCT01517373|450232313|FG005|Run-in Period|Sponsor Decision|0|||
125166213|NCT01517373|450232308|FG000|Run-in Period|Other|1|||
125166214|NCT01517373|450232309|FG001|Run-in Period|Other|0|||
125166215|NCT01517373|450232310|FG002|Run-in Period|Other|0|||
125166216|NCT01517373|450232311|FG003|Run-in Period|Other|0|||
125226863|NCT00086190|450458096|FG000|Overall Study|Worsening depression|0|||
125442515|NCT02291289|451248917|FG007|Maintenance Treatment Phase|Not Treated|0|||
125442516|NCT02291289|451248918|FG008|Maintenance Treatment Phase|Not Treated|0|||
125442517|NCT02291289|451248919|FG009|Maintenance Treatment Phase|Not Treated|0|||
125442518|NCT02291289|451248920|FG010|Maintenance Treatment Phase|Not Treated|0|||
125442519|NCT02291289|451248921|FG011|Maintenance Treatment Phase|Not Treated|0|||
125226864|NCT00086190|450458097|FG001|Overall Study|Worsening depression|0|||
125226865|NCT00086190|450458098|FG002|Overall Study|Worsening depression|2|||
125226866|NCT03902613|450458102|FG000|Overall Study|Physician Decision|1|||
125226867|NCT02027025|450458103|FG000|Overall Study|Adverse Event|0|||
125226868|NCT02027025|450458104|FG001|Overall Study|Adverse Event|1|||
125166217|NCT01517373|450232312|FG004|Run-in Period|Other|0|||
125166218|NCT01517373|450232313|FG005|Run-in Period|Other|0|||
125166219|NCT01517373|450232308|FG000|Treatment Period|Adverse Event|0|||
125166220|NCT01517373|450232309|FG001|Treatment Period|Adverse Event|0|||
125166221|NCT01517373|450232310|FG002|Treatment Period|Adverse Event|0|||
125166222|NCT01517373|450232311|FG003|Treatment Period|Adverse Event|0|||
125166223|NCT01517373|450232312|FG004|Treatment Period|Adverse Event|0|||
125166224|NCT01517373|450232313|FG005|Treatment Period|Adverse Event|2|||
125166225|NCT01517373|450232308|FG000|Treatment Period|Lost to Follow-up|0|||
125166226|NCT01517373|450232309|FG001|Treatment Period|Lost to Follow-up|0|||
125166227|NCT01517373|450232310|FG002|Treatment Period|Lost to Follow-up|1|||
125166228|NCT01517373|450232311|FG003|Treatment Period|Lost to Follow-up|1|||
125166229|NCT01517373|450232312|FG004|Treatment Period|Lost to Follow-up|0|||
125392176|NCT00997503|451070601|FG000|Overall Study|Death|53|||
125392177|NCT00997503|451070601|FG000|Overall Study|Withdrawal by Subject|76|||
125392178|NCT00997503|451070601|FG000|Overall Study|Lost to Follow-up|33|||
125392179|NCT00997503|451070601|FG000|Overall Study|Adverse Event|3|||
125392180|NCT00997503|451070601|FG000|Overall Study|Physician Decision|10|||
125392181|NCT00997503|451070601|FG000|Overall Study|Missed 12-month follow-up|85|||
125392182|NCT00997503|451070601|FG000|Overall Study|Other reason|13|||
125392183|NCT00116831|451070602|FG000|Overall Study|Adverse Event|14|||
125392184|NCT00116831|451070603|FG001|Overall Study|Adverse Event|16|||
125392185|NCT00116831|451070602|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
125392186|NCT00116831|451070603|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
125392187|NCT00116831|451070602|FG000|Overall Study|Lost to Follow-up|8|||
125392188|NCT00116831|451070603|FG001|Overall Study|Lost to Follow-up|6|||
125392189|NCT00116831|451070602|FG000|Overall Study|Protocol Violation|3|||
125392190|NCT00116831|451070603|FG001|Overall Study|Protocol Violation|6|||
125392191|NCT00116831|451070602|FG000|Overall Study|Hypoglycaemic events|1|||
125392192|NCT00116831|451070603|FG001|Overall Study|Hypoglycaemic events|0|||
125392193|NCT00116831|451070602|FG000|Overall Study|Low haemoglobin on screening|1|||
125392194|NCT00116831|451070603|FG001|Overall Study|Low haemoglobin on screening|0|||
125392195|NCT00116831|451070602|FG000|Overall Study|Withdrawn investigational product|1|||
125392196|NCT00116831|451070603|FG001|Overall Study|Withdrawn investigational product|0|||
125392197|NCT00116831|451070602|FG000|Overall Study|Withdrawal by Subject|32|||
125392198|NCT00116831|451070603|FG001|Overall Study|Withdrawal by Subject|32|||
125442520|NCT02291289|451248922|FG012|Maintenance Treatment Phase|Not Treated|0|||
125166230|NCT01517373|450232313|FG005|Treatment Period|Lost to Follow-up|0|||
125166231|NCT01517373|450232308|FG000|Treatment Period|Withdrawal by Subject|0|||
125166232|NCT01517373|450232309|FG001|Treatment Period|Withdrawal by Subject|3|||
125166233|NCT01517373|450232310|FG002|Treatment Period|Withdrawal by Subject|2|||
125392199|NCT00116831|451070602|FG000|Overall Study|Insufficient therapeutic effect|0|||
125166234|NCT01517373|450232311|FG003|Treatment Period|Withdrawal by Subject|2|||
125166235|NCT01517373|450232312|FG004|Treatment Period|Withdrawal by Subject|2|||
125166236|NCT01517373|450232313|FG005|Treatment Period|Withdrawal by Subject|3|||
125166237|NCT01517373|450232308|FG000|Treatment Period|Other|0|||
125226869|NCT02027025|450458105|FG002|Overall Study|Adverse Event|1|||
125442521|NCT02291289|451248910|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125166238|NCT01517373|450232309|FG001|Treatment Period|Other|0|||
125166239|NCT01517373|450232310|FG002|Treatment Period|Other|0|||
125166240|NCT01517373|450232311|FG003|Treatment Period|Other|0|||
125166241|NCT01517373|450232312|FG004|Treatment Period|Other|1|||
125166242|NCT01517373|450232313|FG005|Treatment Period|Other|0|||
125166243|NCT01517373|450232308|FG000|Treatment Period|Protocol Violation|0|||
125166244|NCT01517373|450232309|FG001|Treatment Period|Protocol Violation|0|||
125166245|NCT01517373|450232310|FG002|Treatment Period|Protocol Violation|0|||
125166246|NCT01517373|450232311|FG003|Treatment Period|Protocol Violation|0|||
125166247|NCT01517373|450232312|FG004|Treatment Period|Protocol Violation|1|||
125166248|NCT01517373|450232313|FG005|Treatment Period|Protocol Violation|0|||
125166249|NCT01517373|450232308|FG000|Treatment Period|Lack of Efficacy|0|||
125166250|NCT01517373|450232309|FG001|Treatment Period|Lack of Efficacy|1|||
125166251|NCT01517373|450232310|FG002|Treatment Period|Lack of Efficacy|1|||
125166252|NCT01517373|450232311|FG003|Treatment Period|Lack of Efficacy|3|||
125166253|NCT01517373|450232312|FG004|Treatment Period|Lack of Efficacy|2|||
125166254|NCT01517373|450232313|FG005|Treatment Period|Lack of Efficacy|0|||
125166255|NCT01517373|450232308|FG000|Treatment Period|Medication error without AEs|0|||
125166256|NCT01517373|450232309|FG001|Treatment Period|Medication error without AEs|0|||
125166257|NCT01517373|450232310|FG002|Treatment Period|Medication error without AEs|2|||
125166258|NCT01517373|450232311|FG003|Treatment Period|Medication error without AEs|1|||
125166259|NCT01517373|450232312|FG004|Treatment Period|Medication error without AEs|0|||
125166260|NCT01517373|450232313|FG005|Treatment Period|Medication error without AEs|2|||
125166261|NCT03678285|450232318|FG000|Overall Study|Adverse Event|2|||
125166262|NCT03678285|450232318|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
125166263|NCT03678285|450232318|FG000|Overall Study|Dehydrated prior to start of workout|1|||
125166264|NCT00616629|450232319|FG000|Overall Study|Protocol Violation|1|||
125166265|NCT00616629|450232320|FG001|Overall Study|Protocol Violation|2|||
125166266|NCT00616629|450232321|FG002|Overall Study|Protocol Violation|1|||
125166267|NCT00616629|450232322|FG003|Overall Study|Protocol Violation|0|||
125166268|NCT00616629|450232323|FG004|Overall Study|Protocol Violation|0|||
125166269|NCT00616629|450232319|FG000|Overall Study|AV-block|1|||
125166270|NCT00616629|450232320|FG001|Overall Study|AV-block|0|||
125166271|NCT00616629|450232321|FG002|Overall Study|AV-block|0|||
125166272|NCT00616629|450232322|FG003|Overall Study|AV-block|0|||
125166273|NCT00616629|450232323|FG004|Overall Study|AV-block|0|||
125166274|NCT01777620|450232324|FG000|Overall Study|Subject Withdrawal|1|||
125166275|NCT01777620|450232325|FG001|Overall Study|Subject Withdrawal|0|||
125166276|NCT04516759|450232331|FG000|Overall Study|Withdrawal by Subject|1|||
125166277|NCT04516759|450232332|FG001|Overall Study|Withdrawal by Subject|1|||
125166278|NCT04516759|450232331|FG000|Overall Study|Other|0|||
125166279|NCT04516759|450232332|FG001|Overall Study|Other|1|||
125166280|NCT04005352|450232333|FG000|Overall Study|Adverse Event|4|||
125166281|NCT04005352|450232334|FG001|Overall Study|Adverse Event|5|||
125166282|NCT04005352|450232333|FG000|Overall Study|Death|4|||
125166283|NCT04005352|450232334|FG001|Overall Study|Death|2|||
125166284|NCT04005352|450232333|FG000|Overall Study|Lost to Follow-up|6|||
125166285|NCT04005352|450232334|FG001|Overall Study|Lost to Follow-up|2|||
125166286|NCT04005352|450232333|FG000|Overall Study|Physician Decision|7|||
125166287|NCT04005352|450232334|FG001|Overall Study|Physician Decision|13|||
125166288|NCT04005352|450232333|FG000|Overall Study|Protocol Violation|0|||
125166289|NCT04005352|450232334|FG001|Overall Study|Protocol Violation|1|||
125166290|NCT04005352|450232333|FG000|Overall Study|Withdrawal by Subject|28|||
125166291|NCT04005352|450232334|FG001|Overall Study|Withdrawal by Subject|38|||
125166292|NCT04058067|450232337|FG000|Overall Study|Adverse Event|2|||
125166293|NCT04058067|450232338|FG001|Overall Study|Adverse Event|0|||
125166294|NCT04058067|450232337|FG000|Overall Study|Death|0|||
125166295|NCT04058067|450232338|FG001|Overall Study|Death|1|||
125166296|NCT04058067|450232337|FG000|Overall Study|Physician Decision|3|||
125166297|NCT04058067|450232338|FG001|Overall Study|Physician Decision|1|||
125166298|NCT04058067|450232337|FG000|Overall Study|Protocol Violation|0|||
125166299|NCT04058067|450232338|FG001|Overall Study|Protocol Violation|1|||
125166300|NCT04058067|450232337|FG000|Overall Study|Withdrawal by Subject|7|||
125166301|NCT04058067|450232338|FG001|Overall Study|Withdrawal by Subject|8|||
125166302|NCT00417170|450232339|FG000|Overall Study|Adverse Event|1|||
125166303|NCT00417170|450232340|FG001|Overall Study|Adverse Event|1|||
125166304|NCT00417170|450232339|FG000|Overall Study|Withdrawal by Subject|1|||
125166305|NCT00417170|450232340|FG001|Overall Study|Withdrawal by Subject|1|||
125166306|NCT00417170|450232339|FG000|Overall Study|Lost to Follow-up|0|||
125166307|NCT00417170|450232340|FG001|Overall Study|Lost to Follow-up|1|||
125166308|NCT05005312|450232342|FG000|Overall Study|Enrolled, but not treated|0|||
125166309|NCT05005312|450232343|FG001|Overall Study|Enrolled, but not treated|1|||
125166310|NCT01283035|450232344|FG000|Overall Study|Subject later found ineligible|1|||
125166311|NCT02704403|450232345|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
125166312|NCT02704403|450232346|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
125166313|NCT02704403|450232345|FG000|Overall Study|Administrative reasons by sponsor|1251|||
125166314|NCT02704403|450232346|FG001|Overall Study|Administrative reasons by sponsor|616|||
125442522|NCT02291289|451248911|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
125442523|NCT02291289|451248912|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125442524|NCT02291289|451248913|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125442525|NCT02291289|451248914|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125442526|NCT02291289|451248915|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125442527|NCT02291289|451248916|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125442528|NCT02291289|451248917|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125442529|NCT02291289|451248918|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125442530|NCT02291289|451248919|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125442531|NCT02291289|451248920|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125442532|NCT02291289|451248921|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125442533|NCT02291289|451248922|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
125442534|NCT02291289|451248910|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
125442535|NCT02291289|451248911|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
125442536|NCT02291289|451248912|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
125442537|NCT02291289|451248913|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
125442538|NCT02291289|451248914|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
125442539|NCT02291289|451248915|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
125442540|NCT02291289|451248916|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
125442541|NCT02291289|451248917|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
125442542|NCT02291289|451248918|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
125442543|NCT02291289|451248919|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
125442544|NCT02291289|451248920|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
125442545|NCT02291289|451248921|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
125442546|NCT02291289|451248922|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
125442547|NCT02291289|451248910|FG000|Early Disease Progression|Death|0|||
125442548|NCT02291289|451248911|FG001|Early Disease Progression|Death|0|||
125442549|NCT02291289|451248912|FG002|Early Disease Progression|Death|0|||
125442550|NCT02291289|451248913|FG003|Early Disease Progression|Death|0|||
125442551|NCT02291289|451248914|FG004|Early Disease Progression|Death|0|||
125442552|NCT02291289|451248915|FG005|Early Disease Progression|Death|0|||
125442553|NCT02291289|451248916|FG006|Early Disease Progression|Death|0|||
125442554|NCT02291289|451248917|FG007|Early Disease Progression|Death|0|||
125442555|NCT02291289|451248918|FG008|Early Disease Progression|Death|0|||
125442556|NCT02291289|451248919|FG009|Early Disease Progression|Death|0|||
125442557|NCT02291289|451248920|FG010|Early Disease Progression|Death|0|||
125442558|NCT02291289|451248921|FG011|Early Disease Progression|Death|0|||
125442559|NCT02291289|451248922|FG012|Early Disease Progression|Death|10|||
125442560|NCT02291289|451248910|FG000|Early Disease Progression|Lost to Follow-up|0|||
125442561|NCT02291289|451248911|FG001|Early Disease Progression|Lost to Follow-up|0|||
125442562|NCT02291289|451248912|FG002|Early Disease Progression|Lost to Follow-up|0|||
125442563|NCT02291289|451248913|FG003|Early Disease Progression|Lost to Follow-up|0|||
125442564|NCT02291289|451248914|FG004|Early Disease Progression|Lost to Follow-up|0|||
125442565|NCT02291289|451248915|FG005|Early Disease Progression|Lost to Follow-up|0|||
125442566|NCT02291289|451248916|FG006|Early Disease Progression|Lost to Follow-up|0|||
125442567|NCT02291289|451248917|FG007|Early Disease Progression|Lost to Follow-up|0|||
125442568|NCT02291289|451248918|FG008|Early Disease Progression|Lost to Follow-up|0|||
125442569|NCT02291289|451248919|FG009|Early Disease Progression|Lost to Follow-up|0|||
125442570|NCT02291289|451248920|FG010|Early Disease Progression|Lost to Follow-up|0|||
125442571|NCT02291289|451248921|FG011|Early Disease Progression|Lost to Follow-up|0|||
125442572|NCT02291289|451248922|FG012|Early Disease Progression|Lost to Follow-up|1|||
125442573|NCT01642186|451248925|FG000|Overall Study|Death|0|||
125226870|NCT02027025|450458103|FG000|Overall Study|Protocol Violation|1|||
125226871|NCT02027025|450458104|FG001|Overall Study|Protocol Violation|0|||
125226872|NCT02027025|450458105|FG002|Overall Study|Protocol Violation|0|||
125226873|NCT02027025|450458103|FG000|Overall Study|Lost to Follow-up|0|||
125226874|NCT02027025|450458104|FG001|Overall Study|Lost to Follow-up|2|||
125226875|NCT02027025|450458105|FG002|Overall Study|Lost to Follow-up|0|||
125226876|NCT02027025|450458103|FG000|Overall Study|Withdrawal by Subject|0|||
125226877|NCT02027025|450458104|FG001|Overall Study|Withdrawal by Subject|1|||
125226878|NCT02027025|450458105|FG002|Overall Study|Withdrawal by Subject|0|||
125226879|NCT02027025|450458103|FG000|Overall Study|Sponsor's decision|0|||
125226880|NCT02027025|450458104|FG001|Overall Study|Sponsor's decision|1|||
125442574|NCT01642186|451248926|FG001|Overall Study|Death|2|||
125442575|NCT01642186|451248927|FG002|Overall Study|Death|2|||
125442576|NCT01642186|451248925|FG000|Overall Study|Lost to Follow-up|0|||
125442577|NCT01642186|451248926|FG001|Overall Study|Lost to Follow-up|0|||
125442578|NCT01642186|451248927|FG002|Overall Study|Lost to Follow-up|1|||
125442579|NCT01668147|451248928|FG000|Overall Study|Withdrawal by Subject|6|||
125442580|NCT00590980|451248934|FG000|Overall Study|Did not meet all inclusion criteria|10|||
125442581|NCT00506285|451248936|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
125442582|NCT00506285|451248937|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
125442583|NCT00506285|451248936|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
125442584|NCT00506285|451248937|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
125442585|NCT00506285|451248936|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
125442586|NCT00506285|451248937|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
125442587|NCT00506285|451248936|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
125442588|NCT00506285|451248937|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
125442589|NCT00506285|451248936|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
125442590|NCT00506285|451248937|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
125442591|NCT01089556|451248938|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
125442592|NCT01089556|451248939|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
125442593|NCT01089556|451248940|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
125442594|NCT01089556|451248941|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
125442595|NCT01089556|451248942|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
125442596|NCT01089556|451248943|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
125442597|NCT01089556|451248938|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
125442598|NCT01089556|451248939|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
125442599|NCT01089556|451248940|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
125442600|NCT01089556|451248941|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
125442601|NCT01089556|451248942|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
125442602|NCT01089556|451248943|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
125442603|NCT01089556|451248938|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
125442604|NCT01089556|451248939|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
125442605|NCT01089556|451248940|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
125442606|NCT01089556|451248941|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
125442607|NCT01089556|451248942|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
125442608|NCT01089556|451248943|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
125442609|NCT01089556|451248938|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
125442610|NCT01089556|451248939|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
125442611|NCT01089556|451248940|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
125442612|NCT01089556|451248941|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
125442613|NCT01089556|451248942|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
125442614|NCT01089556|451248943|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
125442615|NCT01089556|451248938|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
125442616|NCT01089556|451248939|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
125442617|NCT01089556|451248940|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
125442618|NCT01089556|451248941|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
125442619|NCT01089556|451248942|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
125442620|NCT01089556|451248943|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
125442621|NCT01089556|451248938|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
125442622|NCT01089556|451248939|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
125442623|NCT01089556|451248940|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
125442624|NCT01089556|451248941|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
125442625|NCT01089556|451248942|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
125442626|NCT01089556|451248943|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
125442627|NCT01089556|451248938|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
125442628|NCT01089556|451248939|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
125442629|NCT01089556|451248940|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
125442630|NCT01089556|451248941|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
125442631|NCT01089556|451248942|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
125442632|NCT01089556|451248943|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
125226881|NCT02027025|450458105|FG002|Overall Study|Sponsor's decision|0|||
125226882|NCT01939314|450458106|FG000|Overall Study|Withdrawal by Subject|3|||
125226883|NCT01939314|450458107|FG001|Overall Study|Withdrawal by Subject|1|||
125226884|NCT01939314|450458106|FG000|Overall Study|Protocol Violation|1|||
125226885|NCT01939314|450458107|FG001|Overall Study|Protocol Violation|0|||
125226886|NCT01939314|450458106|FG000|Overall Study|Pregnancy|0|||
125226887|NCT01939314|450458107|FG001|Overall Study|Pregnancy|1|||
125226888|NCT01939314|450458106|FG000|Overall Study|Lost to Follow-up|5|||
125226889|NCT01939314|450458107|FG001|Overall Study|Lost to Follow-up|6|||
125226890|NCT04113694|450460071|FG000|Overall Study|Adverse Event|2|||
125226891|NCT04113694|450460071|FG000|Overall Study|Lost to Follow-up|2|||
125226892|NCT04113694|450460071|FG000|Overall Study|Withdrawal by Subject|6|||
125226893|NCT04113694|450460071|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
125226894|NCT03638128|450460076|FG000|Overall Study|Withdrawal by Subject|1|||
125442633|NCT01089556|451248938|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
125442634|NCT01089556|451248939|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
125442635|NCT01089556|451248940|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
125442636|NCT01089556|451248941|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
125442637|NCT01089556|451248942|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
125226895|NCT03638128|450460077|FG001|Overall Study|Withdrawal by Subject|7|||
125226896|NCT03638128|450460078|FG002|Overall Study|Withdrawal by Subject|6|||
125226897|NCT03638128|450460076|FG000|Overall Study|Sponsor Decision|15|||
125442638|NCT01089556|451248943|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
125442639|NCT01089556|451248938|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
125442640|NCT01089556|451248939|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
125442641|NCT01089556|451248940|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
125442642|NCT01089556|451248941|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
125442643|NCT01089556|451248942|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
125442644|NCT01089556|451248943|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
125442645|NCT01089556|451248938|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
125442646|NCT01089556|451248939|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
125442647|NCT01089556|451248940|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
125442648|NCT01089556|451248941|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
125442649|NCT01089556|451248942|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
125442650|NCT01089556|451248943|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
125442651|NCT01089556|451248938|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
125442652|NCT01089556|451248939|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
125442653|NCT01089556|451248940|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
125442654|NCT01089556|451248941|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
125442655|NCT01089556|451248942|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
125442656|NCT01089556|451248943|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
125442657|NCT01089556|451248938|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
125442658|NCT01089556|451248939|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
125442659|NCT01089556|451248940|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
125442660|NCT01089556|451248941|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
125442661|NCT01089556|451248942|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
125442662|NCT01089556|451248943|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
125442663|NCT01089556|451248938|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
125442664|NCT01089556|451248939|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
125442665|NCT01089556|451248940|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
125442666|NCT01089556|451248941|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
125442667|NCT01089556|451248942|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
125442668|NCT01089556|451248943|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
125442669|NCT01089556|451248938|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
125442670|NCT01089556|451248939|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
125442671|NCT01089556|451248940|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
125442672|NCT01089556|451248941|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
125442673|NCT01089556|451248942|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
125442674|NCT01089556|451248943|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
125442675|NCT01089556|451248938|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
125442676|NCT01089556|451248939|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
125442677|NCT01089556|451248940|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
125442678|NCT01089556|451248941|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
125442679|NCT01089556|451248942|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
125442680|NCT01089556|451248943|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
125442681|NCT01238575|451248944|FG000|Overall Study|Lack of Efficacy|2|||
125442682|NCT01238575|451248945|FG001|Overall Study|Lack of Efficacy|4|||
125166315|NCT02704403|450232345|FG000|Overall Study|Death|4|||
125166316|NCT02704403|450232346|FG001|Overall Study|Death|3|||
125166317|NCT02704403|450232345|FG000|Overall Study|Endpoint event|52|||
125166318|NCT02704403|450232346|FG001|Overall Study|Endpoint event|24|||
125166319|NCT02704403|450232345|FG000|Overall Study|Lost to Follow-up|22|||
125166320|NCT02704403|450232346|FG001|Overall Study|Lost to Follow-up|11|||
125166321|NCT02704403|450232345|FG000|Overall Study|Protocol Violation|15|||
125166322|NCT02704403|450232346|FG001|Overall Study|Protocol Violation|15|||
125166323|NCT02704403|450232345|FG000|Overall Study|Adverse Event|2|||
125166324|NCT02704403|450232346|FG001|Overall Study|Adverse Event|0|||
125166325|NCT02704403|450232345|FG000|Overall Study|Withdrawal by Subject|85|||
125166326|NCT02704403|450232346|FG001|Overall Study|Withdrawal by Subject|45|||
125166327|NCT02704403|450232345|FG000|Overall Study|Investigator decision|1|||
125166328|NCT02704403|450232346|FG001|Overall Study|Investigator decision|1|||
125166329|NCT02704403|450232345|FG000|Overall Study|Follow-up not possible|1|||
125166330|NCT02704403|450232346|FG001|Overall Study|Follow-up not possible|2|||
125166331|NCT00851318|450232347|FG000|Overall Study|Withdrawal by Subject|7|||
125166332|NCT00851318|450232348|FG001|Overall Study|Withdrawal by Subject|1|||
125166333|NCT00851318|450232349|FG002|Overall Study|Withdrawal by Subject|5|||
125166334|NCT00851318|450232350|FG003|Overall Study|Withdrawal by Subject|3|||
125166335|NCT00851318|450232347|FG000|Overall Study|Adverse Event|13|||
125166336|NCT00851318|450232348|FG001|Overall Study|Adverse Event|2|||
125166337|NCT00851318|450232349|FG002|Overall Study|Adverse Event|9|||
125166338|NCT00851318|450232350|FG003|Overall Study|Adverse Event|12|||
125166339|NCT00851318|450232347|FG000|Overall Study|Pregnancy|0|||
125166340|NCT00851318|450232348|FG001|Overall Study|Pregnancy|0|||
125166341|NCT00851318|450232349|FG002|Overall Study|Pregnancy|1|||
125166342|NCT00851318|450232350|FG003|Overall Study|Pregnancy|1|||
125166343|NCT00851318|450232347|FG000|Overall Study|Lack of Efficacy|8|||
125166344|NCT00851318|450232348|FG001|Overall Study|Lack of Efficacy|2|||
125166345|NCT00851318|450232349|FG002|Overall Study|Lack of Efficacy|4|||
125166346|NCT00851318|450232350|FG003|Overall Study|Lack of Efficacy|2|||
125166347|NCT00851318|450232347|FG000|Overall Study|Non-compliance with Study Procedures|2|||
125166348|NCT00851318|450232348|FG001|Overall Study|Non-compliance with Study Procedures|0|||
125166349|NCT00851318|450232349|FG002|Overall Study|Non-compliance with Study Procedures|1|||
125166350|NCT00851318|450232350|FG003|Overall Study|Non-compliance with Study Procedures|0|||
125166351|NCT00851318|450232347|FG000|Overall Study|Physician Decision|0|||
125166352|NCT00851318|450232348|FG001|Overall Study|Physician Decision|0|||
125166353|NCT00851318|450232349|FG002|Overall Study|Physician Decision|1|||
125166354|NCT00851318|450232350|FG003|Overall Study|Physician Decision|1|||
125166355|NCT01844856|450232357|FG000|Overall Study|Lost to Follow-up|15|||
125166356|NCT01844856|450232358|FG001|Overall Study|Lost to Follow-up|3|||
125166357|NCT01844856|450232357|FG000|Overall Study|Adverse Event|3|||
125166358|NCT01844856|450232358|FG001|Overall Study|Adverse Event|6|||
125166359|NCT01844856|450232357|FG000|Overall Study|Withdrawal by Subject|3|||
125166360|NCT01844856|450232358|FG001|Overall Study|Withdrawal by Subject|2|||
125166361|NCT01844856|450232357|FG000|Overall Study|Noncompliance|2|||
125166362|NCT01844856|450232358|FG001|Overall Study|Noncompliance|3|||
125166363|NCT01844856|450232357|FG000|Overall Study|Enterococcus Resistant|0|||
125166364|NCT01844856|450232358|FG001|Overall Study|Enterococcus Resistant|1|||
125166365|NCT01844856|450232357|FG000|Overall Study|Inadvertently Not Scheduled|1|||
125166366|NCT01844856|450232358|FG001|Overall Study|Inadvertently Not Scheduled|0|||
125166367|NCT01844856|450232357|FG000|Overall Study|Randomized but was a Screen Failure|0|||
125166368|NCT01844856|450232358|FG001|Overall Study|Randomized but was a Screen Failure|1|||
125166369|NCT01329549|450232365|FG000|Overall Study|Withdrawal by Subject|1|||
125166370|NCT01329549|450232365|FG000|Overall Study|Adverse Event|1|||
125166371|NCT02695537|450232375|FG000|Overall Study|Adverse Event|3|||
125166372|NCT02695537|450232375|FG000|Overall Study|Lack of Efficacy|28|||
125166373|NCT02695537|450232375|FG000|Overall Study|Withdrawal by Subject|4|||
125166374|NCT02695537|450232375|FG000|Overall Study|Protocol Violation|3|||
125166375|NCT03597529|450232376|FG000|Overall Study|Lost to Follow-up|10|||
125166376|NCT03597529|450232377|FG001|Overall Study|Lost to Follow-up|12|||
125166377|NCT03597529|450232376|FG000|Overall Study|Physician Decision|3|||
125392200|NCT00116831|451070603|FG001|Overall Study|Insufficient therapeutic effect|1|||
125166378|NCT03597529|450232377|FG001|Overall Study|Physician Decision|1|||
125166379|NCT03597529|450232376|FG000|Overall Study|Withdrawal by Subject|6|||
125166380|NCT03597529|450232377|FG001|Overall Study|Withdrawal by Subject|3|||
125166381|NCT03597529|450232376|FG000|Overall Study|Non-compliant with study activities|1|||
125166382|NCT03597529|450232377|FG001|Overall Study|Non-compliant with study activities|2|||
125166383|NCT01755767|450232380|FG000|Overall Study|Progressive Disease|8|||
125166384|NCT01755767|450232381|FG001|Overall Study|Progressive Disease|7|||
125166385|NCT01755767|450232382|FG002|Overall Study|Progressive Disease|91|||
125166386|NCT01755767|450232383|FG003|Overall Study|Progressive Disease|43|||
125166387|NCT01755767|450232380|FG000|Overall Study|Clinical Disease Progression|4|||
125166388|NCT01755767|450232381|FG001|Overall Study|Clinical Disease Progression|2|||
125166389|NCT01755767|450232382|FG002|Overall Study|Clinical Disease Progression|29|||
125166390|NCT01755767|450232383|FG003|Overall Study|Clinical Disease Progression|20|||
125392201|NCT00116831|451070602|FG000|Overall Study|Missing data for participant|1|||
125392202|NCT00116831|451070603|FG001|Overall Study|Missing data for participant|0|||
125392203|NCT00110812|451070604|FG000|Main Study|Death|0|||
125392204|NCT00110812|451070605|FG001|Main Study|Death|0|||
125392205|NCT00110812|451070606|FG002|Main Study|Death|2|||
125392206|NCT00110812|451070604|FG000|Main Study|Withdrawal by Subject|0|||
125392207|NCT00110812|451070605|FG001|Main Study|Withdrawal by Subject|0|||
125392208|NCT00110812|451070606|FG002|Main Study|Withdrawal by Subject|1|||
125392209|NCT00110812|451070604|FG000|Main Study|Lost to Follow-up|8|||
125392210|NCT00110812|451070605|FG001|Main Study|Lost to Follow-up|11|||
125392211|NCT00110812|451070606|FG002|Main Study|Lost to Follow-up|10|||
125392212|NCT00110812|451070604|FG000|Extended Follow-up|Death|1|||
125392213|NCT00110812|451070605|FG001|Extended Follow-up|Death|0|||
125392214|NCT00110812|451070606|FG002|Extended Follow-up|Death|3|||
125392215|NCT00110812|451070604|FG000|Extended Follow-up|Withdrawal by Subject|0|||
125392216|NCT00110812|451070605|FG001|Extended Follow-up|Withdrawal by Subject|1|||
125392217|NCT00110812|451070606|FG002|Extended Follow-up|Withdrawal by Subject|0|||
125166391|NCT01755767|450232380|FG000|Overall Study|Radiographic Disease Progression|9|||
125166392|NCT01755767|450232381|FG001|Overall Study|Radiographic Disease Progression|4|||
125166393|NCT01755767|450232382|FG002|Overall Study|Radiographic Disease Progression|44|||
125166394|NCT01755767|450232383|FG003|Overall Study|Radiographic Disease Progression|27|||
125392218|NCT00110812|451070604|FG000|Extended Follow-up|Lost to Follow-up|1|||
125392219|NCT00110812|451070605|FG001|Extended Follow-up|Lost to Follow-up|3|||
125392220|NCT00110812|451070606|FG002|Extended Follow-up|Lost to Follow-up|1|||
125166395|NCT01755767|450232380|FG000|Overall Study|Adverse Event|6|||
125392221|NCT01933048|451070607|FG000|Overall Study|Lost to Follow-up|15|||
125392222|NCT01933048|451070608|FG001|Overall Study|Lost to Follow-up|18|||
125166396|NCT01755767|450232381|FG001|Overall Study|Adverse Event|0|||
125166397|NCT01755767|450232382|FG002|Overall Study|Adverse Event|28|||
125166398|NCT01755767|450232383|FG003|Overall Study|Adverse Event|11|||
125166399|NCT01755767|450232380|FG000|Overall Study|Death|1|||
125166400|NCT01755767|450232381|FG001|Overall Study|Death|2|||
125166401|NCT01755767|450232382|FG002|Overall Study|Death|15|||
125166402|NCT01755767|450232383|FG003|Overall Study|Death|4|||
125166403|NCT01755767|450232380|FG000|Overall Study|Subject Decision|0|||
125166404|NCT01755767|450232381|FG001|Overall Study|Subject Decision|0|||
125166405|NCT01755767|450232382|FG002|Overall Study|Subject Decision|10|||
125166406|NCT01755767|450232383|FG003|Overall Study|Subject Decision|3|||
125166407|NCT01755767|450232380|FG000|Overall Study|Withdrawal by Subject|0|||
125166408|NCT01755767|450232381|FG001|Overall Study|Withdrawal by Subject|0|||
125166409|NCT01755767|450232382|FG002|Overall Study|Withdrawal by Subject|2|||
125166410|NCT01755767|450232383|FG003|Overall Study|Withdrawal by Subject|1|||
125166411|NCT01755767|450232380|FG000|Overall Study|Other|0|||
125166412|NCT01755767|450232381|FG001|Overall Study|Other|0|||
125166413|NCT01755767|450232382|FG002|Overall Study|Other|2|||
125166414|NCT01755767|450232383|FG003|Overall Study|Other|3|||
125166415|NCT01755767|450232380|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
125166416|NCT01755767|450232381|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
125166417|NCT01755767|450232382|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
125166418|NCT01755767|450232383|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
125166419|NCT03464630|450232384|FG000|Overall Study|Lost to Follow-up|62|||
125166420|NCT03464630|450232385|FG001|Overall Study|Lost to Follow-up|52|||
125166421|NCT03464630|450232384|FG000|Overall Study|Withdrawal by Subject|16|||
125166422|NCT03464630|450232385|FG001|Overall Study|Withdrawal by Subject|10|||
125166423|NCT03464630|450232384|FG000|Overall Study|Passive Disengagement|8|||
125166424|NCT03464630|450232385|FG001|Overall Study|Passive Disengagement|4|||
125166425|NCT00191165|450232386|FG000|Overall Study|Adverse Event|2|||
125166426|NCT00191165|450232387|FG001|Overall Study|Adverse Event|0|||
125166427|NCT00191165|450232386|FG000|Overall Study|Protocol Violation|0|||
125166428|NCT00191165|450232387|FG001|Overall Study|Protocol Violation|1|||
125166429|NCT00191165|450232386|FG000|Overall Study|Participant Moved Away|0|||
125166430|NCT00191165|450232387|FG001|Overall Study|Participant Moved Away|1|||
125166431|NCT03196635|450232389|FG000|Overall Study|Withdrawal by Subject|1|||
125166432|NCT00998309|450232395|FG000|Overall Study|Protocol Violation|4|||
125166433|NCT00380744|450232397|FG000|Overall Study|Death|0|||
125166434|NCT00380744|450232398|FG001|Overall Study|Death|0|||
125166435|NCT00380744|450232399|FG002|Overall Study|Death|0|||
125166436|NCT00380744|450232400|FG003|Overall Study|Death|0|||
125166437|NCT00380744|450232401|FG004|Overall Study|Death|0|||
125166438|NCT00380744|450232402|FG005|Overall Study|Death|0|||
125166439|NCT00380744|450232403|FG006|Overall Study|Death|1|||
125166440|NCT00380744|450232397|FG000|Overall Study|Withdrawal by Subject|1|||
125166441|NCT00380744|450232398|FG001|Overall Study|Withdrawal by Subject|0|||
125166442|NCT00380744|450232399|FG002|Overall Study|Withdrawal by Subject|0|||
125166443|NCT00380744|450232400|FG003|Overall Study|Withdrawal by Subject|0|||
125166444|NCT00380744|450232401|FG004|Overall Study|Withdrawal by Subject|0|||
125166445|NCT00380744|450232402|FG005|Overall Study|Withdrawal by Subject|0|||
125166446|NCT00380744|450232403|FG006|Overall Study|Withdrawal by Subject|0|||
125166447|NCT02348723|450232417|FG000|Overall Study|No ablation|21|||
125166448|NCT02348723|450232418|FG001|Overall Study|No ablation|20|||
125166449|NCT02348723|450232417|FG000|Overall Study|Non-compliant with Protocol|1|||
125166450|NCT02348723|450232418|FG001|Overall Study|Non-compliant with Protocol|0|||
125166451|NCT02348723|450232417|FG000|Overall Study|Lost to Follow-up|1|||
125166452|NCT02348723|450232418|FG001|Overall Study|Lost to Follow-up|1|||
125166453|NCT02348723|450232417|FG000|Overall Study|Consent withdrawn|1|||
125166454|NCT02348723|450232418|FG001|Overall Study|Consent withdrawn|3|||
125166455|NCT02348723|450232417|FG000|Overall Study|Reason other than specified|1|||
125166456|NCT02348723|450232418|FG001|Overall Study|Reason other than specified|1|||
125166457|NCT02348723|450232417|FG000|Overall Study|Adverse Event|3|||
125166458|NCT02348723|450232418|FG001|Overall Study|Adverse Event|1|||
125166459|NCT02365558|450232419|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
125166460|NCT02365558|450232420|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
125166461|NCT02365558|450232419|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
125166462|NCT02365558|450232420|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
125166463|NCT02828241|450232424|FG000|Overall Study|Adverse Event|7|||
125166464|NCT02828241|450232425|FG001|Overall Study|Adverse Event|2|||
125166465|NCT02828241|450232424|FG000|Overall Study|Protocol Violation|1|||
125166466|NCT02828241|450232425|FG001|Overall Study|Protocol Violation|0|||
125166467|NCT03918109|450232434|FG000|Overall Study|Withdrawal by Subject|0|||
125166468|NCT03918109|450232435|FG001|Overall Study|Withdrawal by Subject|0|||
125166469|NCT03918109|450232436|FG002|Overall Study|Withdrawal by Subject|2|||
125166470|NCT03918109|450232437|FG003|Overall Study|Withdrawal by Subject|1|||
125166471|NCT03918109|450232434|FG000|Overall Study|Lost to Follow-up|0|||
125166472|NCT03918109|450232435|FG001|Overall Study|Lost to Follow-up|0|||
125166473|NCT03918109|450232436|FG002|Overall Study|Lost to Follow-up|0|||
125166474|NCT03918109|450232437|FG003|Overall Study|Lost to Follow-up|1|||
125166475|NCT00861198|450232438|FG000|Overall Study|SpyGlass Failed|5|||
125166476|NCT01197755|450232439|FG000|Overall Study|Adverse Event|8|||
125166477|NCT01197755|450232440|FG001|Overall Study|Adverse Event|10|||
125166478|NCT01197755|450232441|FG002|Overall Study|Adverse Event|10|||
125166479|NCT01197755|450232439|FG000|Overall Study|Study-specific discontinuation criteria|2|||
125166480|NCT01197755|450232440|FG001|Overall Study|Study-specific discontinuation criteria|1|||
125166481|NCT01197755|450232441|FG002|Overall Study|Study-specific discontinuation criteria|0|||
125166482|NCT01197755|450232439|FG000|Overall Study|Entered the long-term extension study|18|||
125166483|NCT01197755|450232440|FG001|Overall Study|Entered the long-term extension study|21|||
125166484|NCT01197755|450232441|FG002|Overall Study|Entered the long-term extension study|35|||
125166485|NCT01197755|450232439|FG000|Overall Study|Lack of therapeutic response|0|||
125166486|NCT01197755|450232440|FG001|Overall Study|Lack of therapeutic response|7|||
125166487|NCT01197755|450232441|FG002|Overall Study|Lack of therapeutic response|4|||
125166488|NCT01197755|450232439|FG000|Overall Study|Severe non-compliance to the protocol|2|||
125166489|NCT01197755|450232440|FG001|Overall Study|Severe non-compliance to the protocol|1|||
125166490|NCT01197755|450232441|FG002|Overall Study|Severe non-compliance to the protocol|2|||
125166491|NCT01197755|450232439|FG000|Overall Study|Withdrawal by Subject|1|||
125166492|NCT01197755|450232440|FG001|Overall Study|Withdrawal by Subject|0|||
125166493|NCT01197755|450232441|FG002|Overall Study|Withdrawal by Subject|0|||
125166494|NCT01197755|450232439|FG000|Overall Study|Lost to Follow-up|0|||
125166495|NCT01197755|450232440|FG001|Overall Study|Lost to Follow-up|0|||
125166496|NCT01197755|450232441|FG002|Overall Study|Lost to Follow-up|1|||
125166497|NCT01197755|450232439|FG000|Overall Study|eg, change in circumstances|7|||
125166498|NCT01197755|450232440|FG001|Overall Study|eg, change in circumstances|3|||
125166499|NCT01197755|450232441|FG002|Overall Study|eg, change in circumstances|2|||
125166500|NCT00499174|450232444|FG000|Overall Study|Physician Decision|78|||
125166501|NCT00499174|450232445|FG001|Overall Study|Physician Decision|9|||
125166502|NCT02269163|450232446|FG000|Overall Study|Lost to Follow-up|1|||
125166503|NCT02269163|450232447|FG001|Overall Study|Lost to Follow-up|0|||
125166504|NCT02269163|450232446|FG000|Overall Study|Major protocol violation|0|||
125442683|NCT01238575|451248944|FG000|Overall Study|Adverse Event|2|||
125166505|NCT02269163|450232447|FG001|Overall Study|Major protocol violation|1|||
125166506|NCT02269163|450232446|FG000|Overall Study|Other|2|||
125166507|NCT02269163|450232447|FG001|Overall Study|Other|2|||
125166508|NCT02269163|450232446|FG000|Overall Study|Withdrawal by Subject|0|||
125166509|NCT02269163|450232447|FG001|Overall Study|Withdrawal by Subject|3|||
125166510|NCT02269163|450232446|FG000|Overall Study|Physician Decision|0|||
125166511|NCT02269163|450232447|FG001|Overall Study|Physician Decision|1|||
125166512|NCT00638027|450232453|FG000|Overall Study|Adverse Event|0|||
125166513|NCT00638027|450232454|FG001|Overall Study|Adverse Event|2|||
125166514|NCT00371397|450232455|FG000|Session 1|Withdrawal by Subject|1|||
125166515|NCT00371397|450232456|FG001|Session 1|Withdrawal by Subject|0|||
125166516|NCT00371397|450232457|FG002|Session 1|Withdrawal by Subject|0|||
125166517|NCT00371397|450232458|FG003|Session 1|Withdrawal by Subject|0|||
125166518|NCT00371397|450232459|FG004|Session 1|Withdrawal by Subject|0|||
125166519|NCT00371397|450232460|FG005|Session 1|Withdrawal by Subject|0|||
125166520|NCT00371397|450232461|FG006|Session 1|Withdrawal by Subject|0|||
125166521|NCT00371397|450232462|FG007|Session 1|Withdrawal by Subject|1|||
125166522|NCT00371397|450232463|FG008|Session 1|Withdrawal by Subject|0|||
125166523|NCT00371397|450232464|FG009|Session 1|Withdrawal by Subject|0|||
125166524|NCT00371397|450232465|FG010|Session 1|Withdrawal by Subject|0|||
125166525|NCT00371397|450232466|FG011|Session 1|Withdrawal by Subject|0|||
125166526|NCT01284621|450232467|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
125166527|NCT01284621|450232468|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
125166528|NCT01284621|450232469|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
125166529|NCT01284621|450232470|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
125166530|NCT01284621|450232471|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
125166531|NCT01284621|450232472|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
125166532|NCT02802631|450232473|FG000|Overall Study|Withdrawal by Subject|1|||
125166533|NCT02802631|450232474|FG001|Overall Study|Withdrawal by Subject|0|||
125166534|NCT02802631|450232475|FG002|Overall Study|Withdrawal by Subject|0|||
125166535|NCT02802631|450232476|FG003|Overall Study|Withdrawal by Subject|0|||
125166536|NCT02802631|450232477|FG004|Overall Study|Withdrawal by Subject|0|||
125166537|NCT02802631|450232478|FG005|Overall Study|Withdrawal by Subject|0|||
125166538|NCT02802631|450232479|FG006|Overall Study|Withdrawal by Subject|0|||
125166539|NCT02802631|450232480|FG007|Overall Study|Withdrawal by Subject|0|||
125166540|NCT02802631|450232473|FG000|Overall Study|Physician Decision|1|||
125166541|NCT02802631|450232474|FG001|Overall Study|Physician Decision|0|||
125166542|NCT02802631|450232475|FG002|Overall Study|Physician Decision|0|||
125166543|NCT02802631|450232476|FG003|Overall Study|Physician Decision|0|||
125226898|NCT03638128|450460077|FG001|Overall Study|Sponsor Decision|12|||
125442684|NCT01238575|451248945|FG001|Overall Study|Adverse Event|0|||
125166544|NCT02802631|450232477|FG004|Overall Study|Physician Decision|0|||
125166545|NCT02802631|450232478|FG005|Overall Study|Physician Decision|0|||
125166546|NCT02802631|450232479|FG006|Overall Study|Physician Decision|1|||
125226899|NCT03638128|450460078|FG002|Overall Study|Sponsor Decision|19|||
125226900|NCT03638128|450460076|FG000|Overall Study|Lost to Follow-up|0|||
125226901|NCT03638128|450460077|FG001|Overall Study|Lost to Follow-up|0|||
125226902|NCT03638128|450460078|FG002|Overall Study|Lost to Follow-up|1|||
125226903|NCT00945243|450460080|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
125226904|NCT02990000|450460081|FG000|Overall Study|Failed to provide data beyond baseline|36|||
125226905|NCT02990000|450460082|FG001|Overall Study|Failed to provide data beyond baseline|34|||
125226906|NCT04969289|450460083|FG000|Overall Study|Lost to Follow-up|13|||
125226907|NCT04969289|450460084|FG001|Overall Study|Lost to Follow-up|9|||
125226908|NCT00557466|450460085|FG000|Overall Study|Adverse Event|3|||
125226909|NCT00557466|450460086|FG001|Overall Study|Adverse Event|1|||
125226910|NCT00557466|450460087|FG002|Overall Study|Adverse Event|4|||
125226911|NCT00557466|450460088|FG003|Overall Study|Adverse Event|1|||
125226912|NCT00557466|450460089|FG004|Overall Study|Adverse Event|2|||
125226913|NCT00557466|450460090|FG005|Overall Study|Adverse Event|4|||
125226914|NCT00557466|450460085|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125226915|NCT00557466|450460086|FG001|Overall Study|Abnormal laboratory value(s)|2|||
125226916|NCT00557466|450460087|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125226917|NCT00557466|450460088|FG003|Overall Study|Abnormal laboratory value(s)|0|||
125226918|NCT00557466|450460089|FG004|Overall Study|Abnormal laboratory value(s)|0|||
125226919|NCT00557466|450460090|FG005|Overall Study|Abnormal laboratory value(s)|0|||
125226920|NCT00557466|450460085|FG000|Overall Study|Protocol deviation|0|||
125226921|NCT00557466|450460086|FG001|Overall Study|Protocol deviation|1|||
125226922|NCT00557466|450460087|FG002|Overall Study|Protocol deviation|0|||
125226923|NCT00557466|450460088|FG003|Overall Study|Protocol deviation|2|||
125226924|NCT00557466|450460089|FG004|Overall Study|Protocol deviation|0|||
125226925|NCT00557466|450460090|FG005|Overall Study|Protocol deviation|0|||
125226926|NCT00557466|450460085|FG000|Overall Study|Subject withdrew consent|0|||
125226927|NCT00557466|450460086|FG001|Overall Study|Subject withdrew consent|0|||
125226928|NCT00557466|450460087|FG002|Overall Study|Subject withdrew consent|0|||
125226929|NCT00557466|450460088|FG003|Overall Study|Subject withdrew consent|0|||
125226930|NCT00557466|450460089|FG004|Overall Study|Subject withdrew consent|1|||
125226931|NCT00557466|450460090|FG005|Overall Study|Subject withdrew consent|2|||
125226932|NCT00557466|450460085|FG000|Overall Study|Administrative problems|0|||
125226933|NCT00557466|450460086|FG001|Overall Study|Administrative problems|1|||
125226934|NCT00557466|450460087|FG002|Overall Study|Administrative problems|1|||
125226935|NCT00557466|450460088|FG003|Overall Study|Administrative problems|0|||
125226936|NCT00557466|450460089|FG004|Overall Study|Administrative problems|0|||
125226937|NCT00557466|450460090|FG005|Overall Study|Administrative problems|0|||
125226938|NCT00557466|450460085|FG000|Overall Study|Abnormal test procedure results|0|||
125226939|NCT00557466|450460086|FG001|Overall Study|Abnormal test procedure results|0|||
125226940|NCT00557466|450460087|FG002|Overall Study|Abnormal test procedure results|1|||
125226941|NCT00557466|450460088|FG003|Overall Study|Abnormal test procedure results|0|||
125226942|NCT00557466|450460089|FG004|Overall Study|Abnormal test procedure results|0|||
125226943|NCT00557466|450460090|FG005|Overall Study|Abnormal test procedure results|0|||
125226944|NCT00557466|450460085|FG000|Overall Study|Lost to Follow-up|0|||
125226945|NCT00557466|450460086|FG001|Overall Study|Lost to Follow-up|0|||
125226946|NCT00557466|450460087|FG002|Overall Study|Lost to Follow-up|0|||
125226947|NCT00557466|450460088|FG003|Overall Study|Lost to Follow-up|1|||
125226948|NCT00557466|450460089|FG004|Overall Study|Lost to Follow-up|0|||
125226949|NCT00557466|450460090|FG005|Overall Study|Lost to Follow-up|0|||
125226950|NCT00496769|450460093|FG000|Double Blind|>=1 reason assigned per patient|558|||
125226951|NCT00496769|450460094|FG001|Double Blind|>=1 reason assigned per patient|649|||
125226952|NCT00496769|450460095|FG002|Double Blind|>=1 reason assigned per patient|0|||
125226953|NCT00496769|450460093|FG000|Open Label|>=1 reason assigned per patient|0|||
125226954|NCT00496769|450460094|FG001|Open Label|>=1 reason assigned per patient|0|||
125226955|NCT00496769|450460095|FG002|Open Label|>=1 reason assigned per patient|1011|||
125226956|NCT02486692|450460096|FG000|Overall Study|did not login for randomization|4|||
125226957|NCT02486692|450460097|FG001|Overall Study|did not login for randomization|7|||
125226958|NCT02812186|450460100|FG000|Period 1|Post randomization screen failure|5|||
125226959|NCT02812186|450460101|FG001|Period 1|Post randomization screen failure|9|||
125226960|NCT02812186|450460100|FG000|Period 1|nonevaluable data sets|6|||
125226961|NCT02812186|450460101|FG001|Period 1|nonevaluable data sets|6|||
125226962|NCT01307787|450460102|FG000|Overall Study|Withdrawal by Subject|2|||
125226963|NCT01307787|450460103|FG001|Overall Study|Withdrawal by Subject|0|||
125226964|NCT01965327|450460110|FG000|Overall Study|Physician Decision|2|||
125226965|NCT03342001|450460111|FG000|Overall Study|Adverse Event|1|||
125226966|NCT03342001|450460111|FG000|Overall Study|Lost to Follow-up|1|||
125226967|NCT04161391|450460116|FG000|Overall Study|Adverse Event|0|||
125226968|NCT04161391|450460117|FG001|Overall Study|Adverse Event|1|||
125226969|NCT04161391|450460118|FG002|Overall Study|Adverse Event|0|||
125226970|NCT04161391|450460119|FG003|Overall Study|Adverse Event|1|||
125226971|NCT04161391|450460120|FG004|Overall Study|Adverse Event|0|||
125226972|NCT04161391|450460121|FG005|Overall Study|Adverse Event|0|||
125226973|NCT04161391|450460122|FG006|Overall Study|Adverse Event|0|||
125226974|NCT04161391|450460123|FG007|Overall Study|Adverse Event|3|||
125442685|NCT03230864|451248950|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
125166547|NCT02802631|450232480|FG007|Overall Study|Physician Decision|0|||
125166548|NCT02802631|450232473|FG000|Overall Study|Adverse Event|0|||
125166549|NCT02802631|450232474|FG001|Overall Study|Adverse Event|2|||
125166550|NCT02802631|450232475|FG002|Overall Study|Adverse Event|0|||
125166551|NCT02802631|450232476|FG003|Overall Study|Adverse Event|1|||
125166552|NCT02802631|450232477|FG004|Overall Study|Adverse Event|6|||
125166553|NCT02802631|450232478|FG005|Overall Study|Adverse Event|1|||
125166554|NCT02802631|450232479|FG006|Overall Study|Adverse Event|4|||
125166555|NCT02802631|450232480|FG007|Overall Study|Adverse Event|0|||
125166556|NCT02802631|450232473|FG000|Overall Study|Sponsor Decision|0|||
125166557|NCT02802631|450232474|FG001|Overall Study|Sponsor Decision|0|||
125166558|NCT02802631|450232475|FG002|Overall Study|Sponsor Decision|6|||
125166559|NCT02802631|450232476|FG003|Overall Study|Sponsor Decision|0|||
125166560|NCT02802631|450232477|FG004|Overall Study|Sponsor Decision|2|||
125442686|NCT03230864|451248951|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
125442687|NCT03230864|451248952|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
125442688|NCT03230864|451248953|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
125442689|NCT03230864|451248950|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
125442690|NCT03230864|451248951|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
125442691|NCT03230864|451248952|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
125442692|NCT03230864|451248953|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
125442693|NCT03230864|451248950|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
125442694|NCT03230864|451248951|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
125442695|NCT03230864|451248952|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
125442696|NCT03230864|451248953|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
125442697|NCT03230864|451248950|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
125442698|NCT03230864|451248951|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
125442699|NCT03230864|451248952|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
125442700|NCT03230864|451248953|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
125442701|NCT03230864|451248950|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
125442702|NCT03230864|451248951|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
125442703|NCT03230864|451248952|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
125442704|NCT03230864|451248953|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
125166561|NCT02802631|450232478|FG005|Overall Study|Sponsor Decision|0|||
125166562|NCT02802631|450232479|FG006|Overall Study|Sponsor Decision|0|||
125166563|NCT02802631|450232480|FG007|Overall Study|Sponsor Decision|4|||
125166564|NCT02968849|450232481|FG000|Overall Study|Death|8|||
125166565|NCT02968849|450232482|FG001|Overall Study|Death|10|||
125166566|NCT02968849|450232481|FG000|Overall Study|Lost to Follow-up|31|||
125166567|NCT02968849|450232482|FG001|Overall Study|Lost to Follow-up|29|||
125166568|NCT02968849|450232481|FG000|Overall Study|Withdrawal by Subject|73|||
125166569|NCT02968849|450232482|FG001|Overall Study|Withdrawal by Subject|64|||
125166570|NCT02968849|450232481|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
125166571|NCT02968849|450232482|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
125166572|NCT02968849|450232481|FG000|Overall Study|Physician Decision|6|||
125166573|NCT02968849|450232482|FG001|Overall Study|Physician Decision|9|||
125166574|NCT02968849|450232481|FG000|Overall Study|Other|16|||
125166575|NCT02968849|450232482|FG001|Overall Study|Other|10|||
125166576|NCT02551666|450232483|FG000|Overall Study|Withdrawal by Subject|1|||
125166577|NCT02551666|450232484|FG001|Overall Study|Withdrawal by Subject|3|||
125166578|NCT03395405|450234149|FG000|Overall Study|Death|0|||
125166579|NCT03395405|450234150|FG001|Overall Study|Death|2|||
125166580|NCT03395405|450234149|FG000|Overall Study|Lost to Follow-up|0|||
125166581|NCT03395405|450234150|FG001|Overall Study|Lost to Follow-up|1|||
125166582|NCT03395405|450234149|FG000|Overall Study|Protocol Violation|0|||
125166583|NCT03395405|450234150|FG001|Overall Study|Protocol Violation|1|||
125166584|NCT03395405|450234149|FG000|Overall Study|Withdrawal by Subject|3|||
125166585|NCT03395405|450234150|FG001|Overall Study|Withdrawal by Subject|1|||
125166586|NCT03395405|450234149|FG000|Overall Study|COVID-19 Pandemic|1|||
125166587|NCT03395405|450234150|FG001|Overall Study|COVID-19 Pandemic|0|||
125166588|NCT00461253|450234151|FG000|Overall Study|Death|985|||
125166589|NCT00461253|450234152|FG001|Overall Study|Death|0|||
125166590|NCT00461253|450234151|FG000|Overall Study|Protocol Violation|613|||
125166591|NCT00461253|450234152|FG001|Overall Study|Protocol Violation|236|||
125166592|NCT00461253|450234151|FG000|Overall Study|no response|2609|||
125166593|NCT00461253|450234152|FG001|Overall Study|no response|11789|||
125166594|NCT00461253|450234151|FG000|Overall Study|administrative|773|||
125166595|NCT00461253|450234152|FG001|Overall Study|administrative|7773|||
125166596|NCT03510598|450234153|FG000|Overall Study|Withdrawal by Subject|1|||
125166597|NCT04240392|450234155|FG000|Overall Study|Withdrawal by Subject|13|||
125166598|NCT04240392|450234156|FG001|Overall Study|Withdrawal by Subject|4|||
125166599|NCT04240392|450234155|FG000|Overall Study|Lost to Follow-up|11|||
125166600|NCT04240392|450234156|FG001|Overall Study|Lost to Follow-up|12|||
125166601|NCT05307510|450234157|FG000|Overall Study|Lost to Follow-up|3|||
125166602|NCT05307510|450234158|FG001|Overall Study|Lost to Follow-up|6|||
125166603|NCT05307510|450234157|FG000|Overall Study|Withdrawal by Subject|0|||
125166604|NCT05307510|450234158|FG001|Overall Study|Withdrawal by Subject|1|||
125166605|NCT01555671|450234161|FG000|Overall Study|Physician Decision|20|||
125166606|NCT01555671|450234162|FG001|Overall Study|Physician Decision|25|||
125166607|NCT03047330|450234163|FG000|Sleep Block 1|Withdrawal by Subject|3|||
125166608|NCT04590040|450234164|FG000|Treatment Period|Lost to Follow-up|2|||
125166609|NCT04590040|450234165|FG001|Treatment Period|Lost to Follow-up|5|||
125166610|NCT04590040|450234166|FG002|Treatment Period|Lost to Follow-up|0|||
125392223|NCT01933048|451070607|FG000|Overall Study|personal reasons|1|||
125392224|NCT01933048|451070608|FG001|Overall Study|personal reasons|1|||
125392225|NCT01933048|451070607|FG000|Overall Study|Protocol Violation|7|||
125392226|NCT01933048|451070608|FG001|Overall Study|Protocol Violation|8|||
125392227|NCT01933048|451070607|FG000|Overall Study|Physician Decision|1|||
125392228|NCT01933048|451070608|FG001|Overall Study|Physician Decision|0|||
125166611|NCT04590040|450234164|FG000|Treatment Period|Physician Decision|0|||
125166612|NCT04590040|450234165|FG001|Treatment Period|Physician Decision|0|||
125166613|NCT04590040|450234166|FG002|Treatment Period|Physician Decision|2|||
125166614|NCT00000378|450234170|FG000|Overall Study|Lack of Efficacy|16|||
125166615|NCT00000378|450234171|FG001|Overall Study|Lack of Efficacy|14|||
125166616|NCT00540293|450234174|FG000|Overall Study|Adverse event related to study drug|10|||
125166617|NCT00540293|450234174|FG000|Overall Study|Adverse event not related to study drug|7|||
125166618|NCT00540293|450234174|FG000|Overall Study|Withdrawal by Subject|6|||
125166619|NCT00540293|450234174|FG000|Overall Study|Protocol violation, & subject schedule|12|||
125166620|NCT02585934|450234179|FG000|Overall Study|Lost to Follow-up|2|||
125166621|NCT02585934|450234180|FG001|Overall Study|Lost to Follow-up|2|||
125166622|NCT02585934|450234179|FG000|Overall Study|Protocol Violation|14|||
125166623|NCT02585934|450234180|FG001|Overall Study|Protocol Violation|11|||
125166624|NCT02585934|450234179|FG000|Overall Study|Adverse Event|21|||
125166625|NCT02585934|450234180|FG001|Overall Study|Adverse Event|22|||
125166626|NCT02585934|450234179|FG000|Overall Study|Physician Decision|3|||
125166627|NCT02585934|450234180|FG001|Overall Study|Physician Decision|2|||
125166628|NCT02585934|450234179|FG000|Overall Study|Withdrawal by Subject|7|||
125166629|NCT02585934|450234180|FG001|Overall Study|Withdrawal by Subject|21|||
125166630|NCT02585934|450234179|FG000|Overall Study|Lack of Efficacy|2|||
125166631|NCT02585934|450234180|FG001|Overall Study|Lack of Efficacy|1|||
125166632|NCT02585934|450234179|FG000|Overall Study|Death|2|||
125166633|NCT02585934|450234180|FG001|Overall Study|Death|0|||
125166634|NCT02585934|450234179|FG000|Overall Study|Caregiver Withdrew Consent|7|||
125166635|NCT02585934|450234180|FG001|Overall Study|Caregiver Withdrew Consent|7|||
125166636|NCT02585934|450234179|FG000|Overall Study|Sponsor Termination|1|||
125166637|NCT02585934|450234180|FG001|Overall Study|Sponsor Termination|2|||
125166638|NCT02585934|450234179|FG000|Overall Study|Another Reason|10|||
125166639|NCT02585934|450234180|FG001|Overall Study|Another Reason|5|||
125166640|NCT04713553|450234181|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
125166641|NCT04713553|450234182|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
125166642|NCT04713553|450234183|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
125166643|NCT04713553|450234184|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
125166644|NCT04713553|450234185|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
125166645|NCT04713553|450234186|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
125166646|NCT04713553|450234187|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
125166647|NCT04713553|450234181|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
125166648|NCT04713553|450234182|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
125166649|NCT04713553|450234183|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
125166650|NCT04713553|450234184|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
125166651|NCT04713553|450234185|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
125166652|NCT04713553|450234186|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
125166653|NCT04713553|450234187|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
125166654|NCT04713553|450234181|FG000|Primary Study (2 Months)|Other|1|||
125166655|NCT04713553|450234182|FG001|Primary Study (2 Months)|Other|2|||
125166656|NCT04713553|450234183|FG002|Primary Study (2 Months)|Other|0|||
125166657|NCT04713553|450234184|FG003|Primary Study (2 Months)|Other|0|||
125166658|NCT04713553|450234185|FG004|Primary Study (2 Months)|Other|1|||
125166659|NCT04713553|450234186|FG005|Primary Study (2 Months)|Other|0|||
125166660|NCT04713553|450234187|FG006|Primary Study (2 Months)|Other|0|||
125166661|NCT04713553|450234181|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
125166662|NCT04713553|450234182|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
125166663|NCT04713553|450234183|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
125166664|NCT04713553|450234184|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
125166665|NCT04713553|450234185|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
125166666|NCT04713553|450234186|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
125166667|NCT04713553|450234187|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
125166668|NCT04713553|450234181|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
125226975|NCT04161391|450460124|FG008|Overall Study|Adverse Event|0|||
125442705|NCT03230864|451248950|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
125442706|NCT03230864|451248951|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
125442707|NCT03230864|451248952|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
125442708|NCT03230864|451248953|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
125442709|NCT03230864|451248950|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
125442710|NCT03230864|451248951|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
125442711|NCT03230864|451248952|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
125442712|NCT03230864|451248953|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
125442713|NCT03230864|451248950|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
125442714|NCT03230864|451248951|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
125442715|NCT03230864|451248952|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
125442716|NCT03230864|451248953|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
125442717|NCT03230864|451248950|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125442718|NCT03230864|451248951|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125442719|NCT03230864|451248952|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
125442720|NCT03230864|451248953|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
125442721|NCT03230864|451248950|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
125442722|NCT03230864|451248951|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
125442723|NCT03230864|451248952|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
125442724|NCT03230864|451248953|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
125442725|NCT00065468|451248960|FG000|Overall Study|Death|172|||
125442726|NCT00065468|451248961|FG001|Overall Study|Death|169|||
125442727|NCT00065468|451248962|FG002|Overall Study|Death|171|||
125442728|NCT00065468|451248960|FG000|Overall Study|Withdrawal by Subject|3|||
125442729|NCT00065468|451248961|FG001|Overall Study|Withdrawal by Subject|4|||
125442730|NCT00065468|451248962|FG002|Overall Study|Withdrawal by Subject|5|||
125442731|NCT00065468|451248960|FG000|Overall Study|Lost to Follow-up|5|||
125442732|NCT00065468|451248961|FG001|Overall Study|Lost to Follow-up|3|||
125442733|NCT00065468|451248962|FG002|Overall Study|Lost to Follow-up|2|||
125442734|NCT00065468|451248960|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
125442735|NCT00065468|451248961|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
125442736|NCT00065468|451248962|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
125442737|NCT00065468|451248960|FG000|Overall Study|Disease progression|0|||
125442738|NCT00065468|451248961|FG001|Overall Study|Disease progression|0|||
125442739|NCT00065468|451248962|FG002|Overall Study|Disease progression|1|||
125442740|NCT00065468|451248960|FG000|Overall Study|Other|14|||
125442741|NCT00065468|451248961|FG001|Overall Study|Other|24|||
125442742|NCT00065468|451248962|FG002|Overall Study|Other|18|||
125442743|NCT01225835|451248963|FG000|Overall Study|Completed protocol|2|||
125442744|NCT01225835|451248964|FG001|Overall Study|Completed protocol|1|||
125442745|NCT01225835|451248963|FG000|Overall Study|Did not meet hCG criterion|2|||
125442746|NCT01225835|451248964|FG001|Overall Study|Did not meet hCG criterion|0|||
125442747|NCT01225835|451248963|FG000|Overall Study|Adverse Event|2|||
125442748|NCT01225835|451248964|FG001|Overall Study|Adverse Event|1|||
125442749|NCT01225835|451248963|FG000|Overall Study|Other|1|||
125442750|NCT01225835|451248964|FG001|Overall Study|Other|1|||
125442751|NCT02589392|451248965|FG000|Overall Study|Adverse Event|1|||
125442752|NCT02589392|451248966|FG001|Overall Study|Adverse Event|1|||
125442753|NCT02589392|451248965|FG000|Overall Study|Withdrawal by Subject|1|||
125442754|NCT02589392|451248966|FG001|Overall Study|Withdrawal by Subject|2|||
125442755|NCT02589392|451248965|FG000|Overall Study|Protocol Violation|1|||
125442756|NCT02589392|451248966|FG001|Overall Study|Protocol Violation|1|||
125442757|NCT02589392|451248965|FG000|Overall Study|Lost to Follow-up|2|||
125442758|NCT02589392|451248966|FG001|Overall Study|Lost to Follow-up|2|||
125442759|NCT02589392|451248965|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
125442760|NCT02589392|451248966|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
125442761|NCT02207374|451248973|FG000|Overall Study|Withdrawal by Subject|5|||
125442762|NCT02207374|451248974|FG001|Overall Study|Withdrawal by Subject|9|||
125442763|NCT02207374|451248975|FG002|Overall Study|Withdrawal by Subject|4|||
125442764|NCT02207374|451248973|FG000|Overall Study|Death|1|||
125442765|NCT02207374|451248974|FG001|Overall Study|Death|0|||
125442766|NCT02207374|451248975|FG002|Overall Study|Death|1|||
125442767|NCT02207374|451248973|FG000|Overall Study|Missing follow-up information|0|||
125442768|NCT02207374|451248974|FG001|Overall Study|Missing follow-up information|1|||
125442769|NCT02207374|451248975|FG002|Overall Study|Missing follow-up information|1|||
125442770|NCT02087150|451248976|FG000|Overall Study|Death|0|||
125166669|NCT04713553|450234182|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
125166670|NCT04713553|450234183|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
125166671|NCT04713553|450234184|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
125166672|NCT04713553|450234185|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
125166673|NCT04713553|450234186|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
125442771|NCT02087150|451248977|FG001|Overall Study|Death|1|||
125442772|NCT02087150|451248978|FG002|Overall Study|Death|0|||
125226976|NCT04161391|450460116|FG000|Overall Study|Death|0|||
125166674|NCT04713553|450234187|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
125166675|NCT02448706|450234188|FG000|Overall Study|Withdrawal by Subject|4|||
125166676|NCT02448706|450234189|FG001|Overall Study|Withdrawal by Subject|3|||
125166677|NCT02448706|450234188|FG000|Overall Study|Protocol Violation|1|||
125166678|NCT02448706|450234189|FG001|Overall Study|Protocol Violation|1|||
125166679|NCT01359969|450234193|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
125166680|NCT03972163|450234197|FG000|Overall Study|Death|0|||
125166681|NCT03972163|450234198|FG001|Overall Study|Death|1|||
125166682|NCT01059539|450234200|FG000|Overall Study|Adverse Event|66|||
125166683|NCT01059539|450234200|FG000|Overall Study|Insufficient Therapeutic Response|26|||
125166684|NCT01059539|450234200|FG000|Overall Study|Protocol Violation|55|||
125166685|NCT01059539|450234200|FG000|Overall Study|Withdrawal of Consent|80|||
125166686|NCT01059539|450234200|FG000|Overall Study|Lost to Follow-up|42|||
125166687|NCT01059539|450234200|FG000|Overall Study|Reason Not Specified|2|||
125166688|NCT00537303|450234201|FG000|Overall Study|Adverse Event|1|||
125166689|NCT00537303|450234202|FG001|Overall Study|Adverse Event|4|||
125166690|NCT00537303|450234201|FG000|Overall Study|Lack of Efficacy|6|||
125166691|NCT00537303|450234202|FG001|Overall Study|Lack of Efficacy|7|||
125166692|NCT00537303|450234201|FG000|Overall Study|Protocol Violation|8|||
125166693|NCT00537303|450234202|FG001|Overall Study|Protocol Violation|4|||
125166694|NCT00537303|450234201|FG000|Overall Study|Withdrawal criteria|3|||
125166695|NCT00537303|450234202|FG001|Overall Study|Withdrawal criteria|3|||
125166696|NCT00537303|450234201|FG000|Overall Study|Unclassified|8|||
125166697|NCT00537303|450234202|FG001|Overall Study|Unclassified|7|||
125166698|NCT02085135|450234203|FG000|Overall Study|Adverse Event|4|||
125166699|NCT02085135|450234204|FG001|Overall Study|Adverse Event|7|||
125166700|NCT02085135|450234203|FG000|Overall Study|Lost to Follow-up|2|||
125166701|NCT02085135|450234204|FG001|Overall Study|Lost to Follow-up|2|||
125166702|NCT02085135|450234203|FG000|Overall Study|Withdrawal by Subject|3|||
125166703|NCT02085135|450234204|FG001|Overall Study|Withdrawal by Subject|0|||
125166704|NCT02085135|450234203|FG000|Overall Study|Lack of Efficacy|2|||
125166705|NCT02085135|450234204|FG001|Overall Study|Lack of Efficacy|0|||
125166706|NCT00554606|450234207|FG000|Overall Study|Adverse Event|3|||
125166707|NCT00554606|450234207|FG000|Overall Study|Abnormal laboratory values|1|||
125166708|NCT00554606|450234207|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
125166709|NCT00554606|450234207|FG000|Overall Study|Subject withdrew consent|2|||
125166710|NCT00554606|450234207|FG000|Overall Study|Lost to Follow-up|2|||
125166711|NCT00554606|450234207|FG000|Overall Study|Administrative problems|60|||
125166712|NCT00554606|450234207|FG000|Overall Study|Death|1|||
125166713|NCT00554606|450234207|FG000|Overall Study|Protocol deviation|2|||
125166714|NCT00849186|450234216|FG000|Overall Study|Adverse Event|2|||
125166715|NCT00849186|450234216|FG000|Overall Study|Withdrawal by Subject|1|||
125166716|NCT00849186|450234216|FG000|Overall Study|not treated|6|||
125166717|NCT00849186|450234216|FG000|Overall Study|Other|1|||
125166718|NCT00492024|450234217|FG000|Treatment|Adverse Event|3|||
125166719|NCT00492024|450234218|FG001|Treatment|Adverse Event|1|||
125166720|NCT00492024|450234217|FG000|Treatment|Lack of Efficacy|21|||
125166721|NCT00492024|450234218|FG001|Treatment|Lack of Efficacy|20|||
125166722|NCT00492024|450234217|FG000|Treatment|Lost to Follow-up|3|||
125166723|NCT00492024|450234218|FG001|Treatment|Lost to Follow-up|1|||
125166724|NCT00492024|450234217|FG000|Treatment|Withdrawal by Subject|2|||
125166725|NCT00492024|450234218|FG001|Treatment|Withdrawal by Subject|0|||
125166726|NCT00492024|450234217|FG000|Follow up|Lack of Efficacy|0|||
125166727|NCT00492024|450234218|FG001|Follow up|Lack of Efficacy|1|||
125166728|NCT00492024|450234217|FG000|Follow up|Lost to Follow-up|1|||
125166729|NCT00492024|450234218|FG001|Follow up|Lost to Follow-up|1|||
125166730|NCT03247816|450234219|FG000|Overall Study|Adverse Event|12|||
125166731|NCT03247816|450234219|FG000|Overall Study|Physician Decision|3|||
125166732|NCT03247816|450234219|FG000|Overall Study|Lack of Efficacy|1|||
125166733|NCT03247816|450234219|FG000|Overall Study|Lost to Follow-up|10|||
125166734|NCT03247816|450234219|FG000|Overall Study|Missing Feraccru stop date|3|||
125166735|NCT00936897|450234222|FG000|Overall Study|Withdrawal by Subject|9|||
125166736|NCT00936897|450234223|FG001|Overall Study|Withdrawal by Subject|19|||
125166737|NCT00936897|450234222|FG000|Overall Study|Adverse Event|4|||
125166738|NCT00936897|450234223|FG001|Overall Study|Adverse Event|13|||
125166739|NCT00936897|450234222|FG000|Overall Study|Other|3|||
125166740|NCT00936897|450234223|FG001|Overall Study|Other|9|||
125166741|NCT00936897|450234222|FG000|Overall Study|Lost to Follow-up|1|||
125166742|NCT00936897|450234223|FG001|Overall Study|Lost to Follow-up|10|||
125166743|NCT00936897|450234222|FG000|Overall Study|Administrative Decision|1|||
125166744|NCT00936897|450234223|FG001|Overall Study|Administrative Decision|2|||
125166745|NCT00936897|450234222|FG000|Overall Study|Protocol Violation|1|||
125166746|NCT00936897|450234223|FG001|Overall Study|Protocol Violation|1|||
125166747|NCT00936897|450234222|FG000|Overall Study|Ineligibility Determined|0|||
125166748|NCT00936897|450234223|FG001|Overall Study|Ineligibility Determined|3|||
125166749|NCT00936897|450234222|FG000|Overall Study|Noncompliance|0|||
125166750|NCT00936897|450234223|FG001|Overall Study|Noncompliance|2|||
125166751|NCT00936897|450234222|FG000|Overall Study|Death|0|||
125166752|NCT00936897|450234223|FG001|Overall Study|Death|1|||
125166753|NCT03257865|450234228|FG000|Overall Study|Adverse Event|4|||
125166754|NCT03257865|450234229|FG001|Overall Study|Adverse Event|8|||
125166755|NCT03257865|450234228|FG000|Overall Study|Lack of Efficacy|1|||
125166756|NCT03257865|450234229|FG001|Overall Study|Lack of Efficacy|2|||
125166757|NCT03257865|450234228|FG000|Overall Study|Non-compliance with Study Drug|0|||
125166758|NCT03257865|450234229|FG001|Overall Study|Non-compliance with Study Drug|2|||
125166759|NCT03257865|450234228|FG000|Overall Study|Withdrawal by Subject|23|||
125166760|NCT03257865|450234229|FG001|Overall Study|Withdrawal by Subject|17|||
125166761|NCT03257865|450234228|FG000|Overall Study|Physician Decision|3|||
125166762|NCT03257865|450234229|FG001|Overall Study|Physician Decision|1|||
125166763|NCT03257865|450234228|FG000|Overall Study|Other|0|||
125166764|NCT03257865|450234229|FG001|Overall Study|Other|1|||
125166765|NCT03257865|450234228|FG000|Overall Study|Lost to Follow-up|4|||
125166766|NCT03257865|450234229|FG001|Overall Study|Lost to Follow-up|4|||
125166767|NCT02677714|450234230|FG000|Overall Study|Withdrawal by Subject|2|||
125166768|NCT02677714|450234231|FG001|Overall Study|Withdrawal by Subject|0|||
125166769|NCT02792699|450234232|FG000|Overall Study|Adverse Event|1|||
125166770|NCT02792699|450234233|FG001|Overall Study|Adverse Event|2|||
125166771|NCT02792699|450234234|FG002|Overall Study|Adverse Event|4|||
125166772|NCT02792699|450234232|FG000|Overall Study|Withdrawal by Subject|4|||
125166773|NCT02792699|450234233|FG001|Overall Study|Withdrawal by Subject|4|||
125166774|NCT02792699|450234234|FG002|Overall Study|Withdrawal by Subject|3|||
125166775|NCT02792699|450234232|FG000|Overall Study|Lost to Follow-up|0|||
125166776|NCT02792699|450234233|FG001|Overall Study|Lost to Follow-up|1|||
125166777|NCT02792699|450234234|FG002|Overall Study|Lost to Follow-up|2|||
125166778|NCT02792699|450234232|FG000|Overall Study|Physician Decision|2|||
125166779|NCT02792699|450234233|FG001|Overall Study|Physician Decision|0|||
125166780|NCT02792699|450234234|FG002|Overall Study|Physician Decision|0|||
125166781|NCT02792699|450234232|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
125166782|NCT02792699|450234233|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
125166783|NCT02792699|450234234|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
125166784|NCT02792699|450234232|FG000|Overall Study|Other|1|||
125166785|NCT02792699|450234233|FG001|Overall Study|Other|0|||
125166786|NCT02792699|450234234|FG002|Overall Study|Other|0|||
125166787|NCT02538965|450234235|FG000|Treatment Period|Other = Death due to disease progression|1|||
125166788|NCT02538965|450234235|FG000|Treatment Period|Adverse Event|2|||
125166789|NCT02538965|450234235|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
125166790|NCT02538965|450234235|FG000|Treatment Period|Treatment Failure|9|||
125166791|NCT02538965|450234235|FG000|Treatment Period|Disease Progression|1|||
125166792|NCT02538965|450234235|FG000|Treatment Period|Physician Decision|2|||
125166793|NCT02538965|450234235|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
125166794|NCT02538965|450234235|FG000|Follow-Up Period|Withdrawal by Parent|4|||
125166795|NCT00875797|450234236|FG000|Overall Study|Protocol Violation|6|||
125166796|NCT00875797|450234237|FG001|Overall Study|Protocol Violation|3|||
125166797|NCT01338870|450234241|FG000|Overall Study|Lost to Follow-up|0|||
125166798|NCT01338870|450234242|FG001|Overall Study|Lost to Follow-up|0|||
125166799|NCT01338870|450234243|FG002|Overall Study|Lost to Follow-up|1|||
125166800|NCT01338870|450234244|FG003|Overall Study|Lost to Follow-up|0|||
125166801|NCT01338870|450234245|FG004|Overall Study|Lost to Follow-up|1|||
125166802|NCT01338870|450234246|FG005|Overall Study|Lost to Follow-up|0|||
125166803|NCT01338870|450234241|FG000|Overall Study|Withdrawal by Subject|2|||
125166804|NCT01338870|450234242|FG001|Overall Study|Withdrawal by Subject|3|||
125166805|NCT01338870|450234243|FG002|Overall Study|Withdrawal by Subject|4|||
125166806|NCT01338870|450234244|FG003|Overall Study|Withdrawal by Subject|0|||
125166807|NCT01338870|450234245|FG004|Overall Study|Withdrawal by Subject|0|||
125166808|NCT01338870|450234246|FG005|Overall Study|Withdrawal by Subject|2|||
125166809|NCT01338870|450234241|FG000|Overall Study|Other|3|||
125166810|NCT01338870|450234242|FG001|Overall Study|Other|3|||
125166811|NCT01338870|450234243|FG002|Overall Study|Other|3|||
125166812|NCT01338870|450234244|FG003|Overall Study|Other|2|||
125166813|NCT01338870|450234245|FG004|Overall Study|Other|0|||
125166814|NCT01338870|450234246|FG005|Overall Study|Other|2|||
125166815|NCT01338870|450234241|FG000|Overall Study|Protocol Violation|0|||
125166816|NCT01338870|450234242|FG001|Overall Study|Protocol Violation|2|||
125166817|NCT01338870|450234243|FG002|Overall Study|Protocol Violation|2|||
125166818|NCT01338870|450234244|FG003|Overall Study|Protocol Violation|2|||
125166819|NCT01338870|450234245|FG004|Overall Study|Protocol Violation|1|||
125166820|NCT01338870|450234246|FG005|Overall Study|Protocol Violation|1|||
125166821|NCT01338870|450234241|FG000|Overall Study|Adverse Event|4|||
125166822|NCT01338870|450234242|FG001|Overall Study|Adverse Event|4|||
125166823|NCT01338870|450234243|FG002|Overall Study|Adverse Event|1|||
125166824|NCT01338870|450234244|FG003|Overall Study|Adverse Event|5|||
125166825|NCT01338870|450234245|FG004|Overall Study|Adverse Event|4|||
125166826|NCT01338870|450234246|FG005|Overall Study|Adverse Event|1|||
125166827|NCT02871492|450234249|FG000|Overall Study|Lost to Follow-up|6|||
125166828|NCT02871492|450234250|FG001|Overall Study|Lost to Follow-up|3|||
125166829|NCT02871492|450234251|FG002|Overall Study|Lost to Follow-up|5|||
125166830|NCT02871492|450234249|FG000|Overall Study|Withdrawal by Subject|0|||
125166831|NCT02871492|450234250|FG001|Overall Study|Withdrawal by Subject|0|||
125226977|NCT04161391|450460117|FG001|Overall Study|Death|0|||
125226978|NCT04161391|450460118|FG002|Overall Study|Death|0|||
125226979|NCT04161391|450460119|FG003|Overall Study|Death|0|||
125226980|NCT04161391|450460120|FG004|Overall Study|Death|0|||
125226981|NCT04161391|450460121|FG005|Overall Study|Death|0|||
125226982|NCT04161391|450460122|FG006|Overall Study|Death|0|||
125226983|NCT04161391|450460123|FG007|Overall Study|Death|1|||
125226984|NCT04161391|450460124|FG008|Overall Study|Death|0|||
125226985|NCT04161391|450460116|FG000|Overall Study|Physician Decision|0|||
125226986|NCT04161391|450460117|FG001|Overall Study|Physician Decision|0|||
125226987|NCT04161391|450460118|FG002|Overall Study|Physician Decision|1|||
125226988|NCT04161391|450460119|FG003|Overall Study|Physician Decision|2|||
125226989|NCT04161391|450460120|FG004|Overall Study|Physician Decision|0|||
125226990|NCT04161391|450460121|FG005|Overall Study|Physician Decision|0|||
125226991|NCT04161391|450460122|FG006|Overall Study|Physician Decision|2|||
125226992|NCT04161391|450460123|FG007|Overall Study|Physician Decision|0|||
125226993|NCT04161391|450460124|FG008|Overall Study|Physician Decision|0|||
125166832|NCT02871492|450234251|FG002|Overall Study|Withdrawal by Subject|1|||
125166833|NCT04546724|450234252|FG000|Overall Study|Withdrawal by Subject|145|||
125166834|NCT04546724|450234253|FG001|Overall Study|Withdrawal by Subject|41|||
125166835|NCT04546724|450234252|FG000|Overall Study|Adverse Event|1|||
125166836|NCT04546724|450234253|FG001|Overall Study|Adverse Event|1|||
125166837|NCT04546724|450234252|FG000|Overall Study|Lost to Follow-up|186|||
125166838|NCT04546724|450234253|FG001|Overall Study|Lost to Follow-up|63|||
125166839|NCT04546724|450234252|FG000|Overall Study|Physician Decision|8|||
125166840|NCT04546724|450234253|FG001|Overall Study|Physician Decision|2|||
125166841|NCT04546724|450234252|FG000|Overall Study|Death|2|||
125166842|NCT04546724|450234253|FG001|Overall Study|Death|1|||
125166843|NCT04546724|450234252|FG000|Overall Study|subject has been out of town|1|||
125166844|NCT04546724|450234253|FG001|Overall Study|subject has been out of town|0|||
125166845|NCT04546724|450234252|FG000|Overall Study|subject is incarcerated|2|||
125166846|NCT04546724|450234253|FG001|Overall Study|subject is incarcerated|0|||
125166847|NCT04546724|450234252|FG000|Overall Study|subject is relocating|12|||
125166848|NCT04546724|450234253|FG001|Overall Study|subject is relocating|4|||
125166849|NCT04546724|450234252|FG000|Overall Study|Subject in another study|1|||
125166850|NCT04546724|450234253|FG001|Overall Study|Subject in another study|1|||
125166851|NCT02256436|450234254|FG000|Overall Study|Adverse Event|9|||
125166852|NCT02256436|450234255|FG001|Overall Study|Adverse Event|14|||
125166853|NCT02256436|450234254|FG000|Overall Study|Death|216|||
125166854|NCT02256436|450234255|FG001|Overall Study|Death|208|||
125166855|NCT02256436|450234254|FG000|Overall Study|Lost to Follow-up|1|||
125166856|NCT02256436|450234255|FG001|Overall Study|Lost to Follow-up|2|||
125166857|NCT02256436|450234254|FG000|Overall Study|Physician Decision|1|||
125166858|NCT02256436|450234255|FG001|Overall Study|Physician Decision|0|||
125166859|NCT02256436|450234254|FG000|Overall Study|Protocol Violation|0|||
125166860|NCT02256436|450234255|FG001|Overall Study|Protocol Violation|1|||
125166861|NCT02256436|450234254|FG000|Overall Study|Withdrawal by Subject|26|||
125166862|NCT02256436|450234255|FG001|Overall Study|Withdrawal by Subject|10|||
125166863|NCT02256436|450234254|FG000|Overall Study|Transferred to Extension Study|11|||
125166864|NCT02256436|450234255|FG001|Overall Study|Transferred to Extension Study|23|||
125166865|NCT02256436|450234254|FG000|Overall Study|Did Not Continue on Extension Study|8|||
125166866|NCT02256436|450234255|FG001|Overall Study|Did Not Continue on Extension Study|12|||
125166867|NCT01441947|450234257|FG000|Overall Study|Withdrawal by Subject|3|||
125166868|NCT01441947|450234258|FG001|Overall Study|Withdrawal by Subject|0|||
125166869|NCT00077857|450234260|FG000|Overall Study|Adverse Event|30|||
125166870|NCT00077857|450234261|FG001|Overall Study|Adverse Event|32|||
125166871|NCT00077857|450234260|FG000|Overall Study|Death|7|||
125166872|NCT00077857|450234261|FG001|Overall Study|Death|3|||
125166873|NCT00077857|450234260|FG000|Overall Study|Insufficient therapeutic response|112|||
125166874|NCT00077857|450234261|FG001|Overall Study|Insufficient therapeutic response|128|||
125166875|NCT00077857|450234260|FG000|Overall Study|Violation of selection criteria at entry|3|||
125166876|NCT00077857|450234261|FG001|Overall Study|Violation of selection criteria at entry|1|||
125166877|NCT00077857|450234260|FG000|Overall Study|Other protocol violation|0|||
125166878|NCT00077857|450234261|FG001|Overall Study|Other protocol violation|1|||
125166879|NCT00077857|450234260|FG000|Overall Study|Refused treatment|29|||
125166880|NCT00077857|450234261|FG001|Overall Study|Refused treatment|21|||
125166881|NCT00077857|450234260|FG000|Overall Study|Failure to return|5|||
125226994|NCT04161391|450460116|FG000|Overall Study|Progressive Disease|4|||
125226995|NCT04161391|450460117|FG001|Overall Study|Progressive Disease|3|||
125226996|NCT04161391|450460118|FG002|Overall Study|Progressive Disease|3|||
125226997|NCT04161391|450460119|FG003|Overall Study|Progressive Disease|5|||
125226998|NCT04161391|450460120|FG004|Overall Study|Progressive Disease|3|||
125166882|NCT00077857|450234261|FG001|Overall Study|Failure to return|5|||
125166883|NCT00077857|450234260|FG000|Overall Study|Other|15|||
125166884|NCT00077857|450234261|FG001|Overall Study|Other|13|||
125166885|NCT01292226|450234262|FG000|Overall Study|Adverse Event|5|||
125166886|NCT01292226|450234262|FG000|Overall Study|Death|1|||
125166887|NCT01292226|450234262|FG000|Overall Study|Graft loss|1|||
125226999|NCT04161391|450460121|FG005|Overall Study|Progressive Disease|3|||
125227000|NCT04161391|450460122|FG006|Overall Study|Progressive Disease|5|||
125166888|NCT01292226|450234262|FG000|Overall Study|Protocol Violation|3|||
125166889|NCT01292226|450234262|FG000|Overall Study|Withdrawal by Subject|1|||
125166890|NCT01292226|450234262|FG000|Overall Study|Other|2|||
125166891|NCT01844505|450234263|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
125166892|NCT01844505|450234264|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
125166893|NCT01844505|450234265|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
125166894|NCT01844505|450234263|FG000|Treatment Period|Other Reasons|120|||
125166895|NCT01844505|450234264|FG001|Treatment Period|Other Reasons|136|||
125166896|NCT01844505|450234265|FG002|Treatment Period|Other Reasons|58|||
125166897|NCT01844505|450234263|FG000|Treatment Period|Lost to Follow-up|9|||
125166898|NCT01844505|450234264|FG001|Treatment Period|Lost to Follow-up|11|||
125166899|NCT01844505|450234265|FG002|Treatment Period|Lost to Follow-up|6|||
125166900|NCT01844505|450234263|FG000|Treatment Period|Death|175|||
125166901|NCT01844505|450234264|FG001|Treatment Period|Death|154|||
125166902|NCT01844505|450234265|FG002|Treatment Period|Death|228|||
125166903|NCT00468650|450234266|FG000|Overall Study|Lost to Follow-up|4|||
125166904|NCT00468650|450234266|FG000|Overall Study|Withdrawal by Subject|2|||
125166905|NCT00468650|450234266|FG000|Overall Study|Protocol Violation|1|||
125166906|NCT04874155|450234267|FG000|Overall Study|Lost to Follow-up|1|||
125166907|NCT04874155|450234268|FG001|Overall Study|Lost to Follow-up|1|||
125166908|NCT04874155|450234267|FG000|Overall Study|Withdrawal by Subject|2|||
125166909|NCT04874155|450234268|FG001|Overall Study|Withdrawal by Subject|2|||
125166910|NCT03477903|450234273|FG000|Overall Study|Study Terminated by Sponsor|1|||
125166911|NCT03201965|450234274|FG000|Overall Study|Death|5|||
125166912|NCT03201965|450234275|FG001|Overall Study|Death|27|||
125166913|NCT03201965|450234276|FG002|Overall Study|Death|27|||
125166914|NCT03201965|450234274|FG000|Overall Study|Lost to Follow-up|0|||
125166915|NCT03201965|450234275|FG001|Overall Study|Lost to Follow-up|1|||
125166916|NCT03201965|450234276|FG002|Overall Study|Lost to Follow-up|0|||
125166917|NCT03201965|450234274|FG000|Overall Study|Withdrawal by Subject|3|||
125166918|NCT03201965|450234275|FG001|Overall Study|Withdrawal by Subject|13|||
125166919|NCT03201965|450234276|FG002|Overall Study|Withdrawal by Subject|4|||
125166920|NCT03201965|450234274|FG000|Overall Study|Ongoing|20|||
125166921|NCT03201965|450234275|FG001|Overall Study|Ongoing|152|||
125166922|NCT03201965|450234276|FG002|Overall Study|Ongoing|164|||
125166923|NCT00369317|450234277|FG000|Overall Study|Adverse Event|3|||
125166924|NCT00369317|450234277|FG000|Overall Study|Death|1|||
125166925|NCT00369317|450234277|FG000|Overall Study|Lack of Efficacy|5|||
125166926|NCT00369317|450234277|FG000|Overall Study|Physician Decision|2|||
125166927|NCT00369317|450234277|FG000|Overall Study|Withdrawal by Subject|8|||
125166928|NCT00369317|450234277|FG000|Overall Study|Ineligible|1|||
125166929|NCT00758680|450234286|FG000|Overall Study|Adverse Event|0|||
125166930|NCT00758680|450234287|FG001|Overall Study|Adverse Event|0|||
125166931|NCT00758680|450234288|FG002|Overall Study|Adverse Event|0|||
125166932|NCT00758680|450234289|FG003|Overall Study|Adverse Event|0|||
125166933|NCT00758680|450234290|FG004|Overall Study|Adverse Event|0|||
125166934|NCT00758680|450234291|FG005|Overall Study|Adverse Event|0|||
125166935|NCT00758680|450234292|FG006|Overall Study|Adverse Event|0|||
125166936|NCT00758680|450234293|FG007|Overall Study|Adverse Event|1|||
125166937|NCT00758680|450234294|FG008|Overall Study|Adverse Event|0|||
125166938|NCT00758680|450234295|FG009|Overall Study|Adverse Event|1|||
125166939|NCT00758680|450234286|FG000|Overall Study|Laboratory Adverse Event|0|||
125166940|NCT00758680|450234287|FG001|Overall Study|Laboratory Adverse Event|0|||
125166941|NCT00758680|450234288|FG002|Overall Study|Laboratory Adverse Event|0|||
125166942|NCT00758680|450234289|FG003|Overall Study|Laboratory Adverse Event|0|||
125166943|NCT00758680|450234290|FG004|Overall Study|Laboratory Adverse Event|0|||
125166944|NCT00758680|450234291|FG005|Overall Study|Laboratory Adverse Event|0|||
125166945|NCT00758680|450234292|FG006|Overall Study|Laboratory Adverse Event|0|||
125166946|NCT00758680|450234293|FG007|Overall Study|Laboratory Adverse Event|0|||
125166947|NCT00758680|450234294|FG008|Overall Study|Laboratory Adverse Event|1|||
125166948|NCT00758680|450234295|FG009|Overall Study|Laboratory Adverse Event|0|||
125166949|NCT00758680|450234286|FG000|Overall Study|Withdrawal by Subject|0|||
125166950|NCT00758680|450234287|FG001|Overall Study|Withdrawal by Subject|0|||
125166951|NCT00758680|450234288|FG002|Overall Study|Withdrawal by Subject|0|||
125166952|NCT00758680|450234289|FG003|Overall Study|Withdrawal by Subject|0|||
125166953|NCT00758680|450234290|FG004|Overall Study|Withdrawal by Subject|0|||
125166954|NCT00758680|450234291|FG005|Overall Study|Withdrawal by Subject|0|||
125166955|NCT00758680|450234292|FG006|Overall Study|Withdrawal by Subject|1|||
125166956|NCT00758680|450234293|FG007|Overall Study|Withdrawal by Subject|0|||
125166957|NCT00758680|450234294|FG008|Overall Study|Withdrawal by Subject|1|||
125166958|NCT00758680|450234295|FG009|Overall Study|Withdrawal by Subject|0|||
125166959|NCT00761865|450234296|FG000|Overall Study|Lost to Follow-up|8|||
125166960|NCT00761865|450234297|FG001|Overall Study|Lost to Follow-up|7|||
125166961|NCT00574912|450234298|FG000|Overall Study|Could not place IV lines.|3|||
125166962|NCT00574912|450234298|FG000|Overall Study|scheduling conflicts|3|||
125166963|NCT00574912|450234298|FG000|Overall Study|Physician Decision|2|||
125166964|NCT03866902|450234300|FG000|Overall Study|Lost to Follow-up|98|||
125166965|NCT03866902|450234301|FG001|Overall Study|Lost to Follow-up|82|||
125166966|NCT03866902|450234300|FG000|Overall Study|Pregnancy|18|||
125442773|NCT02087150|451248976|FG000|Overall Study|Lost to Follow-up|6|||
125442774|NCT02087150|451248977|FG001|Overall Study|Lost to Follow-up|13|||
125442775|NCT02087150|451248978|FG002|Overall Study|Lost to Follow-up|7|||
125442776|NCT02087150|451248976|FG000|Overall Study|Withdrawal by Subject|2|||
125442777|NCT02087150|451248977|FG001|Overall Study|Withdrawal by Subject|5|||
125442778|NCT02087150|451248978|FG002|Overall Study|Withdrawal by Subject|3|||
125442779|NCT02087150|451248976|FG000|Overall Study|Physician Decision|0|||
125442780|NCT02087150|451248977|FG001|Overall Study|Physician Decision|1|||
125442781|NCT02087150|451248978|FG002|Overall Study|Physician Decision|0|||
125442782|NCT02087150|451248976|FG000|Overall Study|Procedure not done|1|||
125442783|NCT02087150|451248977|FG001|Overall Study|Procedure not done|13|||
125442784|NCT02087150|451248978|FG002|Overall Study|Procedure not done|0|||
125442785|NCT02087150|451248976|FG000|Overall Study|F/U not completed w/in study window|0|||
125442786|NCT02087150|451248977|FG001|Overall Study|F/U not completed w/in study window|0|||
125442787|NCT02087150|451248978|FG002|Overall Study|F/U not completed w/in study window|1|||
125442788|NCT02087150|451248976|FG000|Overall Study|Other|1|||
125442789|NCT02087150|451248977|FG001|Overall Study|Other|0|||
125442790|NCT02087150|451248978|FG002|Overall Study|Other|0|||
125442791|NCT02087150|451248976|FG000|Overall Study|Pt moved out of town|0|||
125442792|NCT02087150|451248977|FG001|Overall Study|Pt moved out of town|1|||
125442793|NCT02087150|451248978|FG002|Overall Study|Pt moved out of town|0|||
125442794|NCT02372058|451248980|FG000|Overall Study|Withdrawal by Subject|3|||
125442795|NCT00972179|451248982|FG000|Overall Study|Noncompliance|1|||
125442796|NCT00972179|451248983|FG001|Overall Study|Noncompliance|0|||
125442797|NCT00972179|451248984|FG002|Overall Study|Noncompliance|0|||
125442798|NCT00972179|451248985|FG003|Overall Study|Noncompliance|0|||
125442799|NCT00972179|451248986|FG004|Overall Study|Noncompliance|1|||
125442800|NCT00972179|451248987|FG005|Overall Study|Noncompliance|0|||
125442801|NCT00972179|451248988|FG006|Overall Study|Noncompliance|1|||
125442802|NCT00972179|451248982|FG000|Overall Study|Withdrawal by Subject|0|||
125442803|NCT00972179|451248983|FG001|Overall Study|Withdrawal by Subject|3|||
125442804|NCT00972179|451248984|FG002|Overall Study|Withdrawal by Subject|0|||
125442805|NCT00972179|451248985|FG003|Overall Study|Withdrawal by Subject|1|||
125442806|NCT00972179|451248986|FG004|Overall Study|Withdrawal by Subject|0|||
125442807|NCT00972179|451248987|FG005|Overall Study|Withdrawal by Subject|0|||
125442808|NCT00972179|451248988|FG006|Overall Study|Withdrawal by Subject|2|||
125442809|NCT00972179|451248982|FG000|Overall Study|Administrative Decision|0|||
125442810|NCT00972179|451248983|FG001|Overall Study|Administrative Decision|0|||
125442811|NCT00972179|451248984|FG002|Overall Study|Administrative Decision|0|||
125442812|NCT00972179|451248985|FG003|Overall Study|Administrative Decision|0|||
125442813|NCT00972179|451248986|FG004|Overall Study|Administrative Decision|1|||
125442814|NCT00972179|451248987|FG005|Overall Study|Administrative Decision|0|||
125442815|NCT00972179|451248988|FG006|Overall Study|Administrative Decision|0|||
125442816|NCT00972179|451248982|FG000|Overall Study|Lost to Follow-up|0|||
125442817|NCT00972179|451248983|FG001|Overall Study|Lost to Follow-up|0|||
125442818|NCT00972179|451248984|FG002|Overall Study|Lost to Follow-up|1|||
125442819|NCT00972179|451248985|FG003|Overall Study|Lost to Follow-up|0|||
125442820|NCT00972179|451248986|FG004|Overall Study|Lost to Follow-up|0|||
125442821|NCT00972179|451248987|FG005|Overall Study|Lost to Follow-up|3|||
125442822|NCT00972179|451248988|FG006|Overall Study|Lost to Follow-up|1|||
125442823|NCT00932646|451248990|FG000|Overall Study|Adverse Event|2|||
125442824|NCT00932646|451248991|FG001|Overall Study|Adverse Event|1|||
125442825|NCT00932646|451248992|FG002|Overall Study|Adverse Event|1|||
125442826|NCT00932646|451248993|FG003|Overall Study|Adverse Event|1|||
125442827|NCT00932646|451248990|FG000|Overall Study|Lost to Follow-up|2|||
125442828|NCT00932646|451248991|FG001|Overall Study|Lost to Follow-up|1|||
125442829|NCT00932646|451248992|FG002|Overall Study|Lost to Follow-up|0|||
125442830|NCT00932646|451248993|FG003|Overall Study|Lost to Follow-up|0|||
125442831|NCT00932646|451248990|FG000|Overall Study|Withdrawal by Subject|1|||
125442832|NCT00932646|451248991|FG001|Overall Study|Withdrawal by Subject|1|||
125442833|NCT00932646|451248992|FG002|Overall Study|Withdrawal by Subject|3|||
125442834|NCT00932646|451248993|FG003|Overall Study|Withdrawal by Subject|0|||
125442835|NCT00653263|451248994|FG000|Overall Study|Withdrawal by Subject|1|||
125442836|NCT00653263|451248994|FG000|Overall Study|Physician Decision|1|||
125166967|NCT03866902|450234301|FG001|Overall Study|Pregnancy|24|||
125442837|NCT02285595|451248999|FG000|Overall Study|Lost to Follow-up|14|||
125442838|NCT02285595|451248999|FG000|Overall Study|Withdrawal by Subject|1|||
125442839|NCT00064025|451249010|FG000|Overall Study|Ineligible|4|||
125442840|NCT00064025|451249010|FG000|Overall Study|Inevaluable|3|||
125442841|NCT02468934|451249011|FG000|Overall Study|Withdrawal by Subject|4|||
125442842|NCT02468934|451249011|FG000|Overall Study|Screen Failure|3|||
125442843|NCT02218489|451249020|FG000|Overall Study|Withdrawal by Subject|4|||
125442844|NCT02218489|451249021|FG001|Overall Study|Withdrawal by Subject|3|||
125442845|NCT02218489|451249020|FG000|Overall Study|Lost to Follow-up|1|||
125442846|NCT02218489|451249021|FG001|Overall Study|Lost to Follow-up|0|||
125442847|NCT02404493|451249022|FG000|Overall Study|Adverse Event|1|||
125442848|NCT02404493|451249023|FG001|Overall Study|Adverse Event|1|||
125442849|NCT03699124|451250702|FG000|Overall Study|Adverse Event|6|||
125442850|NCT03699124|451250703|FG001|Overall Study|Adverse Event|5|||
125442851|NCT03699124|451250704|FG002|Overall Study|Adverse Event|2|||
125442852|NCT03699124|451250702|FG000|Overall Study|Death|0|||
125442853|NCT03699124|451250703|FG001|Overall Study|Death|2|||
125442854|NCT03699124|451250704|FG002|Overall Study|Death|0|||
125442855|NCT03699124|451250702|FG000|Overall Study|Lost to Follow-up|20|||
125442856|NCT03699124|451250703|FG001|Overall Study|Lost to Follow-up|16|||
125442857|NCT03699124|451250704|FG002|Overall Study|Lost to Follow-up|15|||
125442858|NCT03699124|451250702|FG000|Overall Study|Protocol Violation|1|||
125442859|NCT03699124|451250703|FG001|Overall Study|Protocol Violation|0|||
125442860|NCT03699124|451250704|FG002|Overall Study|Protocol Violation|0|||
125442861|NCT03699124|451250702|FG000|Overall Study|Withdrawal by Subject|13|||
125442862|NCT03699124|451250703|FG001|Overall Study|Withdrawal by Subject|14|||
125442863|NCT03699124|451250704|FG002|Overall Study|Withdrawal by Subject|13|||
125442864|NCT03699124|451250702|FG000|Overall Study|Other reasons|5|||
125227001|NCT04161391|450460123|FG007|Overall Study|Progressive Disease|2|||
125227002|NCT04161391|450460124|FG008|Overall Study|Progressive Disease|2|||
125227003|NCT02579629|450460140|FG000|Overall Study|Withdrawal by Subject|0|||
125227004|NCT02579629|450460141|FG001|Overall Study|Withdrawal by Subject|1|||
125227005|NCT02579629|450460142|FG002|Overall Study|Withdrawal by Subject|0|||
125227006|NCT02579629|450460140|FG000|Overall Study|Screen Failure|2|||
125227007|NCT02579629|450460141|FG001|Overall Study|Screen Failure|0|||
125227008|NCT02579629|450460142|FG002|Overall Study|Screen Failure|2|||
125227009|NCT00830219|450460143|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125227010|NCT00830219|450460144|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
125227011|NCT01294423|450460145|FG000|Overall Study|Adverse Event|1|||
125227012|NCT01294423|450460146|FG001|Overall Study|Adverse Event|2|||
125227013|NCT01294423|450460147|FG002|Overall Study|Adverse Event|3|||
125227014|NCT01294423|450460145|FG000|Overall Study|Withdrawal by Subject|1|||
125227015|NCT01294423|450460146|FG001|Overall Study|Withdrawal by Subject|2|||
125227016|NCT01294423|450460147|FG002|Overall Study|Withdrawal by Subject|2|||
125227017|NCT01294423|450460145|FG000|Overall Study|subject no longer meets study criteria|2|||
125227018|NCT01294423|450460146|FG001|Overall Study|subject no longer meets study criteria|5|||
125227019|NCT01294423|450460147|FG002|Overall Study|subject no longer meets study criteria|2|||
125227020|NCT01294423|450460145|FG000|Overall Study|poor/non-compliance|1|||
125227021|NCT01294423|450460146|FG001|Overall Study|poor/non-compliance|0|||
125227022|NCT01294423|450460147|FG002|Overall Study|poor/non-compliance|1|||
125227023|NCT01145482|450460148|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
125227024|NCT01145482|450460149|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
125227025|NCT04635839|450460150|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
125227026|NCT04635839|450460151|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
125227027|NCT00896493|450460152|FG000|Overall Study|Early disease relapse|3|||
125227028|NCT02870868|450460153|FG000|Overall Study|Withdrawal by Subject|2|||
125227029|NCT02870868|450460154|FG001|Overall Study|Withdrawal by Subject|1|||
125227030|NCT01739335|450460155|FG000|Overall Study|Lost to Follow-up|7|||
125166968|NCT03014180|450234302|FG000|Overall Study|Protocol Violation|2|||
125166969|NCT02377427|450234305|FG000|Part A (Up to Week 20)|Physician Decision|1|||
125166970|NCT02377427|450234306|FG001|Part A (Up to Week 20)|Physician Decision|0|||
125166971|NCT02377427|450234307|FG002|Part A (Up to Week 20)|Physician Decision|0|||
125166972|NCT02377427|450234308|FG003|Part A (Up to Week 20)|Physician Decision|0|||
125166973|NCT02377427|450234309|FG004|Part A (Up to Week 20)|Physician Decision|0|||
125166974|NCT02377427|450234305|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
125166975|NCT02377427|450234306|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
125166976|NCT02377427|450234307|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
125166977|NCT02377427|450234308|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
125166978|NCT02377427|450234309|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
125166979|NCT02377427|450234305|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
125166980|NCT02377427|450234306|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
125166981|NCT02377427|450234307|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
125166982|NCT02377427|450234308|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
125166983|NCT02377427|450234309|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
125166984|NCT02377427|450234305|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
125227031|NCT01739335|450460156|FG001|Overall Study|Lost to Follow-up|4|||
125227032|NCT01739335|450460155|FG000|Overall Study|Ineligible patient randomized|0|||
125442865|NCT03699124|451250703|FG001|Overall Study|Other reasons|3|||
125442866|NCT03699124|451250704|FG002|Overall Study|Other reasons|10|||
125442867|NCT00262743|451250705|FG000|Overall Study|Adverse Event|0|||
125442868|NCT00262743|451250706|FG001|Overall Study|Adverse Event|9|||
125227033|NCT01739335|450460156|FG001|Overall Study|Ineligible patient randomized|1|||
125227034|NCT01868646|450460159|FG000|Overall Study|Do not meet inclusion criteria|3|||
125227035|NCT01868646|450460160|FG001|Overall Study|Do not meet inclusion criteria|5|||
125227036|NCT00785356|450460167|FG000|Overall Study|Study prematurely terminated|8|||
125227037|NCT01232790|450460169|FG000|Randomization|Withdrawal by Subject|2|||
125442869|NCT00262743|451250705|FG000|Overall Study|Disease progression|0|||
125166985|NCT02377427|450234306|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
125442870|NCT00262743|451250706|FG001|Overall Study|Disease progression|3|||
125227038|NCT01232790|450460170|FG001|Randomization|Withdrawal by Subject|0|||
125227039|NCT01232790|450460169|FG000|Randomization|Protocol Violation|0|||
125227040|NCT01232790|450460170|FG001|Randomization|Protocol Violation|1|||
125227041|NCT01232790|450460169|FG000|Randomization|Physician Decision|0|||
125227042|NCT01232790|450460170|FG001|Randomization|Physician Decision|1|||
125227043|NCT01232790|450460169|FG000|Initial Assessment|Withdrawal by Subject|0|||
125227044|NCT01232790|450460170|FG001|Initial Assessment|Withdrawal by Subject|1|||
125227045|NCT01232790|450460169|FG000|First Crossover|Withdrawal by Subject|1|||
125227046|NCT01232790|450460170|FG001|First Crossover|Withdrawal by Subject|0|||
125227047|NCT01232790|450460169|FG000|Second Crossover|Withdrawal by Subject|1|||
125227048|NCT01232790|450460170|FG001|Second Crossover|Withdrawal by Subject|2|||
125227049|NCT03238417|450460171|FG000|Overall|non-response|955|||
125227050|NCT03238417|450460172|FG001|Overall|non-response|1920|||
125227051|NCT03238417|450460171|FG000|Overall|partial completion|48|||
125227052|NCT03238417|450460172|FG001|Overall|partial completion|68|||
125227053|NCT03238417|450460171|FG000|Baseline|Partial completion|17|||
125227054|NCT03238417|450460172|FG001|Baseline|Partial completion|48|||
125227055|NCT03238417|450460171|FG000|Baseline|non-response|372|||
125227056|NCT03238417|450460172|FG001|Baseline|non-response|669|||
125227057|NCT03238417|450460171|FG000|12-month|non-response|296|||
125227058|NCT03238417|450460172|FG001|12-month|non-response|669|||
125227059|NCT03238417|450460171|FG000|12-month|partial completion|23|||
125227060|NCT03238417|450460172|FG001|12-month|partial completion|37|||
125227061|NCT03238417|450460171|FG000|24-month|non-response|287|||
125227062|NCT03238417|450460172|FG001|24-month|non-response|594|||
125227063|NCT03238417|450460171|FG000|24-month|partial completion|8|||
125227064|NCT03238417|450460172|FG001|24-month|partial completion|31|||
125227065|NCT00083915|450460173|FG000|Overall Study|Death|6|||
125227066|NCT00083915|450460174|FG001|Overall Study|Death|3|||
125227067|NCT00083915|450460173|FG000|Overall Study|Physician Decision|11|||
125227068|NCT00083915|450460174|FG001|Overall Study|Physician Decision|6|||
125227069|NCT00083915|450460173|FG000|Overall Study|Withdrawal by Subject|8|||
125227070|NCT00083915|450460174|FG001|Overall Study|Withdrawal by Subject|3|||
125227071|NCT00083915|450460173|FG000|Overall Study|disease progression|18|||
125227072|NCT00083915|450460174|FG001|Overall Study|disease progression|23|||
125227073|NCT00083915|450460173|FG000|Overall Study|Failure to collect|3|||
125227074|NCT00083915|450460174|FG001|Overall Study|Failure to collect|0|||
125227075|NCT00083915|450460173|FG000|Overall Study|No response|3|||
125227076|NCT00083915|450460174|FG001|Overall Study|No response|1|||
125227077|NCT00083915|450460173|FG000|Overall Study|Insurance issues|1|||
125227078|NCT00083915|450460174|FG001|Overall Study|Insurance issues|1|||
125227079|NCT01239797|450460175|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
125227080|NCT01239797|450460176|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
125227081|NCT01239797|450460175|FG000|Randomized Participants|Participant withdrew consent|1|||
125227082|NCT01239797|450460176|FG001|Randomized Participants|Participant withdrew consent|7|||
125227083|NCT01239797|450460175|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
125227084|NCT01239797|450460176|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
125227085|NCT01239797|450460175|FG000|Treated Participants|Disease progression|185|||
125227086|NCT01239797|450460176|FG001|Treated Participants|Disease progression|185|||
125227087|NCT01239797|450460175|FG000|Treated Participants|Study drug toxicity|39|||
125227088|NCT01239797|450460176|FG001|Treated Participants|Study drug toxicity|45|||
125227089|NCT01239797|450460175|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
125227090|NCT01239797|450460176|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
125227091|NCT01239797|450460175|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
125227092|NCT01239797|450460176|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
125227093|NCT01239797|450460175|FG000|Treated Participants|Administrative reason by sponsor|13|||
125227094|NCT01239797|450460176|FG001|Treated Participants|Administrative reason by sponsor|4|||
125227095|NCT01239797|450460175|FG000|Treated Participants|Other reasons|14|||
125227096|NCT01239797|450460176|FG001|Treated Participants|Other reasons|14|||
125227097|NCT01239797|450460175|FG000|Treated Participants|Participant withdrew consent|6|||
125227098|NCT01239797|450460176|FG001|Treated Participants|Participant withdrew consent|11|||
125227099|NCT01239797|450460175|FG000|Treated Participants|Death|1|||
125227100|NCT01239797|450460176|FG001|Treated Participants|Death|1|||
125227101|NCT01239797|450460175|FG000|Treated Participants|Participant no longer meets study criteria|1|||
125227102|NCT01239797|450460176|FG001|Treated Participants|Participant no longer meets study criteria|1|||
125227103|NCT01239797|450460175|FG000|Treated Participants|Poor/non-compliance|0|||
125227104|NCT01239797|450460176|FG001|Treated Participants|Poor/non-compliance|1|||
125227105|NCT00853762|450460180|FG000|Overall Study|Premature Termination|16|||
125227106|NCT00853762|450460181|FG001|Overall Study|Premature Termination|15|||
125227107|NCT00853762|450460182|FG002|Overall Study|Premature Termination|14|||
125227108|NCT00853762|450460183|FG003|Overall Study|Premature Termination|21|||
125227109|NCT00853762|450460180|FG000|Overall Study|Protocol Violation|0|||
125227110|NCT00853762|450460181|FG001|Overall Study|Protocol Violation|0|||
125227111|NCT00853762|450460182|FG002|Overall Study|Protocol Violation|0|||
125227112|NCT00853762|450460183|FG003|Overall Study|Protocol Violation|1|||
125227113|NCT00853762|450460180|FG000|Overall Study|Withdrawal by Subject|0|||
125442871|NCT03249376|451250731|FG000|Overall Study|Adverse Event|11|||
125442872|NCT03249376|451250732|FG001|Overall Study|Adverse Event|5|||
125442873|NCT03249376|451250731|FG000|Overall Study|Lack of Efficacy|2|||
125442874|NCT03249376|451250732|FG001|Overall Study|Lack of Efficacy|4|||
125442875|NCT03249376|451250731|FG000|Overall Study|Protocol Violation|3|||
125442876|NCT03249376|451250732|FG001|Overall Study|Protocol Violation|2|||
125442877|NCT03249376|451250731|FG000|Overall Study|Physician Decision|0|||
125442878|NCT03249376|451250732|FG001|Overall Study|Physician Decision|2|||
125442879|NCT03249376|451250731|FG000|Overall Study|Withdrawal by Subject|3|||
125442880|NCT03249376|451250732|FG001|Overall Study|Withdrawal by Subject|9|||
125442881|NCT03249376|451250731|FG000|Overall Study|LTFU|2|||
125442882|NCT03249376|451250732|FG001|Overall Study|LTFU|1|||
125442883|NCT01154036|451250733|FG000|Phase I|Physician Decision|0|||
125442884|NCT01154036|451250734|FG001|Phase I|Physician Decision|1|||
125442885|NCT01154036|451250735|FG002|Phase I|Physician Decision|0|||
125442886|NCT01154036|451250736|FG003|Phase I|Physician Decision|0|||
125442887|NCT01154036|451250737|FG004|Phase I|Physician Decision|0|||
125442888|NCT01154036|451250738|FG005|Phase I|Physician Decision|0|||
125442889|NCT01154036|451250739|FG006|Phase I|Physician Decision|0|||
125442890|NCT01154036|451250740|FG007|Phase I|Physician Decision|0|||
125442891|NCT01154036|451250733|FG000|Phase I|Lost to Follow-up|0|||
125442892|NCT01154036|451250734|FG001|Phase I|Lost to Follow-up|3|||
125442893|NCT01154036|451250735|FG002|Phase I|Lost to Follow-up|6|||
125442894|NCT01154036|451250736|FG003|Phase I|Lost to Follow-up|0|||
125442895|NCT01154036|451250737|FG004|Phase I|Lost to Follow-up|0|||
125442896|NCT01154036|451250738|FG005|Phase I|Lost to Follow-up|0|||
125442897|NCT01154036|451250739|FG006|Phase I|Lost to Follow-up|0|||
125442898|NCT01154036|451250740|FG007|Phase I|Lost to Follow-up|0|||
125442899|NCT01154036|451250733|FG000|Phase I|Protocol Violation|0|||
125442900|NCT01154036|451250734|FG001|Phase I|Protocol Violation|3|||
125442901|NCT01154036|451250735|FG002|Phase I|Protocol Violation|9|||
125442902|NCT01154036|451250736|FG003|Phase I|Protocol Violation|0|||
125442903|NCT01154036|451250737|FG004|Phase I|Protocol Violation|0|||
125442904|NCT01154036|451250738|FG005|Phase I|Protocol Violation|0|||
125442905|NCT01154036|451250739|FG006|Phase I|Protocol Violation|0|||
125442906|NCT01154036|451250740|FG007|Phase I|Protocol Violation|0|||
125442907|NCT01154036|451250733|FG000|Phase I|Withdrawal by Subject|2|||
125442908|NCT01154036|451250734|FG001|Phase I|Withdrawal by Subject|10|||
125442909|NCT01154036|451250735|FG002|Phase I|Withdrawal by Subject|29|||
125442910|NCT01154036|451250736|FG003|Phase I|Withdrawal by Subject|0|||
125442911|NCT01154036|451250737|FG004|Phase I|Withdrawal by Subject|0|||
125442912|NCT01154036|451250738|FG005|Phase I|Withdrawal by Subject|0|||
125442913|NCT01154036|451250739|FG006|Phase I|Withdrawal by Subject|0|||
125442914|NCT01154036|451250740|FG007|Phase I|Withdrawal by Subject|0|||
125442915|NCT01154036|451250733|FG000|Phase I|Adverse Event|1|||
125442916|NCT01154036|451250734|FG001|Phase I|Adverse Event|11|||
125442917|NCT01154036|451250735|FG002|Phase I|Adverse Event|12|||
125442918|NCT01154036|451250736|FG003|Phase I|Adverse Event|0|||
125227114|NCT00853762|450460181|FG001|Overall Study|Withdrawal by Subject|0|||
125227115|NCT00853762|450460182|FG002|Overall Study|Withdrawal by Subject|1|||
125227116|NCT00853762|450460183|FG003|Overall Study|Withdrawal by Subject|0|||
125227117|NCT00853762|450460180|FG000|Overall Study|Other|0|||
125227118|NCT00853762|450460181|FG001|Overall Study|Other|2|||
125227119|NCT00853762|450460182|FG002|Overall Study|Other|0|||
125227120|NCT00853762|450460183|FG003|Overall Study|Other|0|||
125227121|NCT00853762|450460180|FG000|Overall Study|Randomised but not Treated|0|||
125227122|NCT00853762|450460181|FG001|Overall Study|Randomised but not Treated|2|||
125442919|NCT01154036|451250737|FG004|Phase I|Adverse Event|0|||
125442920|NCT01154036|451250738|FG005|Phase I|Adverse Event|0|||
125442921|NCT01154036|451250739|FG006|Phase I|Adverse Event|0|||
125442922|NCT01154036|451250740|FG007|Phase I|Adverse Event|0|||
125442923|NCT01154036|451250733|FG000|Phase II|Adverse Event|0|||
125442924|NCT01154036|451250734|FG001|Phase II|Adverse Event|0|||
125442925|NCT01154036|451250735|FG002|Phase II|Adverse Event|0|||
125442926|NCT01154036|451250736|FG003|Phase II|Adverse Event|0|||
125227123|NCT00853762|450460182|FG002|Overall Study|Randomised but not Treated|2|||
125442927|NCT01154036|451250737|FG004|Phase II|Adverse Event|1|||
125442928|NCT01154036|451250738|FG005|Phase II|Adverse Event|1|||
125442929|NCT01154036|451250739|FG006|Phase II|Adverse Event|1|||
125227124|NCT00853762|450460183|FG003|Overall Study|Randomised but not Treated|0|||
125227125|NCT02000921|450460189|FG000|Overall Study|Withdrawal by Subject|3|||
125227126|NCT02000921|450460190|FG001|Overall Study|Withdrawal by Subject|10|||
125442930|NCT01154036|451250740|FG007|Phase II|Adverse Event|1|||
125442931|NCT01154036|451250733|FG000|Phase II|Physician Decision|0|||
125442932|NCT01154036|451250734|FG001|Phase II|Physician Decision|0|||
125442933|NCT01154036|451250735|FG002|Phase II|Physician Decision|0|||
125442934|NCT01154036|451250736|FG003|Phase II|Physician Decision|0|||
125442935|NCT01154036|451250737|FG004|Phase II|Physician Decision|0|||
125442936|NCT01154036|451250738|FG005|Phase II|Physician Decision|0|||
125442937|NCT01154036|451250739|FG006|Phase II|Physician Decision|1|||
125442938|NCT01154036|451250740|FG007|Phase II|Physician Decision|0|||
125442939|NCT01154036|451250733|FG000|Phase II|Lost to Follow-up|0|||
125442940|NCT01154036|451250734|FG001|Phase II|Lost to Follow-up|0|||
125166986|NCT02377427|450234307|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
125166987|NCT02377427|450234308|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
125166988|NCT02377427|450234309|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
125166989|NCT00704730|450234311|FG000|Overall Study|Adverse Event|35|||
125166990|NCT00704730|450234312|FG001|Overall Study|Adverse Event|9|||
125166991|NCT00704730|450234311|FG000|Overall Study|Death|11|||
125166992|NCT00704730|450234312|FG001|Overall Study|Death|5|||
125166993|NCT00704730|450234311|FG000|Overall Study|Physician Decision|2|||
125166994|NCT00704730|450234312|FG001|Overall Study|Physician Decision|0|||
125166995|NCT00704730|450234311|FG000|Overall Study|Did not receive drug|5|||
125166996|NCT00704730|450234312|FG001|Overall Study|Did not receive drug|2|||
125166997|NCT00704730|450234311|FG000|Overall Study|Disease progression per PI|58|||
125166998|NCT00704730|450234312|FG001|Overall Study|Disease progression per PI|67|||
125166999|NCT00704730|450234311|FG000|Overall Study|data unavailable|1|||
125167000|NCT00704730|450234312|FG001|Overall Study|data unavailable|0|||
125167001|NCT00704730|450234311|FG000|Overall Study|Withdrawal by Subject|9|||
125167002|NCT00704730|450234312|FG001|Overall Study|Withdrawal by Subject|13|||
125167003|NCT01523457|450235936|FG000|Overall Study|Withdrawal by Subject|7|||
125167004|NCT01523457|450235937|FG001|Overall Study|Withdrawal by Subject|2|||
125167005|NCT02886624|450235941|FG000|12-week Post Treatment Follow-up|Death|1|||
125167006|NCT02886624|450235941|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
125167007|NCT03400943|450235945|FG000|Treatment Period 1|Adverse Event|0|||
125167008|NCT03400943|450235946|FG001|Treatment Period 1|Adverse Event|0|||
125167009|NCT03400943|450235947|FG002|Treatment Period 1|Adverse Event|0|||
125167010|NCT03400943|450235948|FG003|Treatment Period 1|Adverse Event|1|||
125167011|NCT03400943|450235945|FG000|Treatment Period 1|Lost to Follow-up|1|||
125167012|NCT03400943|450235946|FG001|Treatment Period 1|Lost to Follow-up|0|||
125167013|NCT03400943|450235947|FG002|Treatment Period 1|Lost to Follow-up|0|||
125167014|NCT03400943|450235948|FG003|Treatment Period 1|Lost to Follow-up|0|||
125167015|NCT03400943|450235945|FG000|Treatment Period 1|Protocol Violation|0|||
125167016|NCT03400943|450235946|FG001|Treatment Period 1|Protocol Violation|1|||
125167017|NCT03400943|450235947|FG002|Treatment Period 1|Protocol Violation|1|||
125167018|NCT03400943|450235948|FG003|Treatment Period 1|Protocol Violation|0|||
125167019|NCT03400943|450235945|FG000|Treatment Period 1|Study terminated by sponsor|2|||
125167020|NCT03400943|450235946|FG001|Treatment Period 1|Study terminated by sponsor|0|||
125167021|NCT03400943|450235947|FG002|Treatment Period 1|Study terminated by sponsor|0|||
125167022|NCT03400943|450235948|FG003|Treatment Period 1|Study terminated by sponsor|1|||
125167023|NCT03400943|450235945|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125167024|NCT03400943|450235946|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125167025|NCT03400943|450235947|FG002|Treatment Period 1|Withdrawal by Subject|3|||
125167026|NCT03400943|450235948|FG003|Treatment Period 1|Withdrawal by Subject|1|||
125167027|NCT03400943|450235945|FG000|Treatment Period 1|Other|2|||
125167028|NCT03400943|450235946|FG001|Treatment Period 1|Other|1|||
125167029|NCT03400943|450235947|FG002|Treatment Period 1|Other|2|||
125167030|NCT03400943|450235948|FG003|Treatment Period 1|Other|2|||
125167031|NCT03400943|450235945|FG000|Post-treatment Period 1|Adverse Event|2|||
125167032|NCT03400943|450235946|FG001|Post-treatment Period 1|Adverse Event|0|||
125167033|NCT03400943|450235947|FG002|Post-treatment Period 1|Adverse Event|0|||
125167034|NCT03400943|450235948|FG003|Post-treatment Period 1|Adverse Event|0|||
125167035|NCT03400943|450235945|FG000|Post-treatment Period 1|Protocol Violation|1|||
125167036|NCT03400943|450235946|FG001|Post-treatment Period 1|Protocol Violation|0|||
125167037|NCT03400943|450235947|FG002|Post-treatment Period 1|Protocol Violation|0|||
125167038|NCT03400943|450235948|FG003|Post-treatment Period 1|Protocol Violation|0|||
125167039|NCT03400943|450235945|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
125167040|NCT03400943|450235946|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
125167041|NCT03400943|450235947|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
125167042|NCT03400943|450235948|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
125167043|NCT03400943|450235945|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
125167044|NCT03400943|450235946|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
125167045|NCT03400943|450235947|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
125167046|NCT03400943|450235948|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
125167047|NCT03400943|450235945|FG000|Post-treatment Period 1|Other|2|||
125167048|NCT03400943|450235946|FG001|Post-treatment Period 1|Other|0|||
125167049|NCT03400943|450235947|FG002|Post-treatment Period 1|Other|4|||
125167050|NCT03400943|450235948|FG003|Post-treatment Period 1|Other|5|||
125167051|NCT03400943|450235945|FG000|Treatment Period 2|Study terminated by sponsor|0|||
125167052|NCT03400943|450235946|FG001|Treatment Period 2|Study terminated by sponsor|1|||
125167053|NCT03400943|450235947|FG002|Treatment Period 2|Study terminated by sponsor|0|||
125167054|NCT03400943|450235948|FG003|Treatment Period 2|Study terminated by sponsor|0|||
125167055|NCT03400943|450235945|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125167056|NCT03400943|450235946|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125167057|NCT03400943|450235947|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125167058|NCT03400943|450235948|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125167059|NCT03400943|450235945|FG000|Treatment Period 2|Other|1|||
125167060|NCT03400943|450235946|FG001|Treatment Period 2|Other|6|||
125167061|NCT03400943|450235947|FG002|Treatment Period 2|Other|0|||
125167062|NCT03400943|450235948|FG003|Treatment Period 2|Other|0|||
125167063|NCT03400943|450235945|FG000|Follow-up Period|Withdrawal by Subject|1|||
125167064|NCT03400943|450235946|FG001|Follow-up Period|Withdrawal by Subject|0|||
125167065|NCT03400943|450235947|FG002|Follow-up Period|Withdrawal by Subject|0|||
125167066|NCT03400943|450235948|FG003|Follow-up Period|Withdrawal by Subject|0|||
125167067|NCT02563106|450235949|FG000|Overall Study|Withdrawal by Subject|7|||
125167068|NCT02563106|450235950|FG001|Overall Study|Withdrawal by Subject|8|||
125167069|NCT02563106|450235949|FG000|Overall Study|Adverse Event|17|||
125167070|NCT02563106|450235950|FG001|Overall Study|Adverse Event|15|||
125167071|NCT02563106|450235949|FG000|Overall Study|Protocol Violation|1|||
125167072|NCT02563106|450235950|FG001|Overall Study|Protocol Violation|0|||
125167073|NCT02563106|450235949|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
125167074|NCT02563106|450235950|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
125167075|NCT02563106|450235949|FG000|Overall Study|Lost to Follow-up|3|||
125167076|NCT02563106|450235950|FG001|Overall Study|Lost to Follow-up|2|||
125167077|NCT02563106|450235949|FG000|Overall Study|Physician Decision|3|||
125167078|NCT02563106|450235950|FG001|Overall Study|Physician Decision|1|||
125167079|NCT02563106|450235949|FG000|Overall Study|Other reason - not specified|2|||
125167080|NCT02563106|450235950|FG001|Overall Study|Other reason - not specified|1|||
125167081|NCT04729309|450235951|FG000|Period 1|Subject unable to return for Period 2|3|||
125167082|NCT04729309|450235952|FG001|Period 1|Subject unable to return for Period 2|0|||
125167083|NCT04729309|450235951|FG000|Period 1|Lost to Follow-up|1|||
125167084|NCT04729309|450235952|FG001|Period 1|Lost to Follow-up|0|||
125167085|NCT01664130|450235959|FG000|Overall Study|competing secondary disease|2|||
125167086|NCT01161407|450235961|FG000|Overall Study|Protocol Violation|3|||
125167087|NCT01161407|450235962|FG001|Overall Study|Protocol Violation|1|||
125167088|NCT04746794|450235964|FG000|Overall Study|Did not complete any study assessment|50303|||
125167089|NCT04746794|450235965|FG001|Overall Study|Did not complete any study assessment|44997|||
125167090|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
125167091|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
125167092|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
125167093|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
125167094|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
125167095|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
125167096|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
125167097|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
125167098|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
125167099|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
125167100|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
125167101|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
125167102|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
125167103|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
125167104|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
125167105|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
125167106|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
125167107|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
125167108|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
125167109|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
125167110|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
125167111|NCT04040192|450235966|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
125167112|NCT04040192|450235967|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
125167113|NCT04040192|450235968|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
125167114|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
125167115|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
125167116|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
125392229|NCT01933048|451070607|FG000|Overall Study|unknown reasons|1|||
125392230|NCT01933048|451070608|FG001|Overall Study|unknown reasons|1|||
125392231|NCT00380393|451070609|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
125392232|NCT00380393|451070610|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
125167117|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
125167118|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
125167119|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
125167120|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
125167121|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
125167122|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
125392233|NCT00380393|451070609|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
125167123|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
125227127|NCT02000921|450460191|FG002|Overall Study|Withdrawal by Subject|5|||
125227128|NCT02000921|450460189|FG000|Overall Study|Lost to Follow-up|2|||
125227129|NCT02000921|450460190|FG001|Overall Study|Lost to Follow-up|4|||
125227130|NCT02000921|450460191|FG002|Overall Study|Lost to Follow-up|5|||
125227131|NCT02000921|450460189|FG000|Overall Study|Physician Decision|0|||
125227132|NCT02000921|450460190|FG001|Overall Study|Physician Decision|2|||
125227133|NCT02000921|450460191|FG002|Overall Study|Physician Decision|0|||
125227134|NCT02051296|450460196|FG000|Overall Study|Lost to Follow-up|1|||
125227135|NCT02051296|450460197|FG001|Overall Study|Lost to Follow-up|2|||
125227136|NCT02051296|450460196|FG000|Overall Study|withdraw prior to treatment|7|||
125227137|NCT02051296|450460197|FG001|Overall Study|withdraw prior to treatment|7|||
125227138|NCT02631941|450460200|FG000|Overall Study|Physician Decision|0|||
125227139|NCT02631941|450460201|FG001|Overall Study|Physician Decision|1|||
125227140|NCT02631941|450460202|FG002|Overall Study|Physician Decision|0|||
125227141|NCT02631941|450460203|FG003|Overall Study|Physician Decision|0|||
125227142|NCT02631941|450460204|FG004|Overall Study|Physician Decision|0|||
125227143|NCT02631941|450460205|FG005|Overall Study|Physician Decision|0|||
125227144|NCT02631941|450460206|FG006|Overall Study|Physician Decision|0|||
125227145|NCT02631941|450460207|FG007|Overall Study|Physician Decision|0|||
125227146|NCT02631941|450460208|FG008|Overall Study|Physician Decision|0|||
125227147|NCT02631941|450460209|FG009|Overall Study|Physician Decision|0|||
125227148|NCT02631941|450460200|FG000|Overall Study|Adverse Event|0|||
125227149|NCT02631941|450460201|FG001|Overall Study|Adverse Event|1|||
125227150|NCT02631941|450460202|FG002|Overall Study|Adverse Event|0|||
125227151|NCT02631941|450460203|FG003|Overall Study|Adverse Event|0|||
125227152|NCT02631941|450460204|FG004|Overall Study|Adverse Event|0|||
125227153|NCT02631941|450460205|FG005|Overall Study|Adverse Event|0|||
125227154|NCT02631941|450460206|FG006|Overall Study|Adverse Event|0|||
125227155|NCT02631941|450460207|FG007|Overall Study|Adverse Event|0|||
125227156|NCT02631941|450460208|FG008|Overall Study|Adverse Event|0|||
125227157|NCT02631941|450460209|FG009|Overall Study|Adverse Event|0|||
125227158|NCT02631941|450460200|FG000|Overall Study|Withdrawal by Subject|0|||
125227159|NCT02631941|450460201|FG001|Overall Study|Withdrawal by Subject|0|||
125227160|NCT02631941|450460202|FG002|Overall Study|Withdrawal by Subject|0|||
125227161|NCT02631941|450460203|FG003|Overall Study|Withdrawal by Subject|0|||
125227162|NCT02631941|450460204|FG004|Overall Study|Withdrawal by Subject|1|||
125227163|NCT02631941|450460205|FG005|Overall Study|Withdrawal by Subject|0|||
125227164|NCT02631941|450460206|FG006|Overall Study|Withdrawal by Subject|0|||
125227165|NCT02631941|450460207|FG007|Overall Study|Withdrawal by Subject|1|||
125227166|NCT02631941|450460208|FG008|Overall Study|Withdrawal by Subject|0|||
125227167|NCT02631941|450460209|FG009|Overall Study|Withdrawal by Subject|0|||
125227168|NCT02631941|450460200|FG000|Overall Study|Lost to Follow-up|0|||
125227169|NCT02631941|450460201|FG001|Overall Study|Lost to Follow-up|0|||
125227170|NCT02631941|450460202|FG002|Overall Study|Lost to Follow-up|0|||
125227171|NCT02631941|450460203|FG003|Overall Study|Lost to Follow-up|0|||
125227172|NCT02631941|450460204|FG004|Overall Study|Lost to Follow-up|0|||
125227173|NCT02631941|450460205|FG005|Overall Study|Lost to Follow-up|0|||
125227174|NCT02631941|450460206|FG006|Overall Study|Lost to Follow-up|0|||
125227175|NCT02631941|450460207|FG007|Overall Study|Lost to Follow-up|0|||
125227176|NCT02631941|450460208|FG008|Overall Study|Lost to Follow-up|1|||
125227177|NCT02631941|450460209|FG009|Overall Study|Lost to Follow-up|0|||
125227178|NCT02858401|450460211|FG000|Overall Study|Withdrew Consent|0|||
125167124|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
125167125|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
125167126|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
125167127|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
125167128|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
125167129|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
125167130|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
125167131|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
125167132|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
125167133|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
125167134|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
125227179|NCT02858401|450460212|FG001|Overall Study|Withdrew Consent|0|||
125227180|NCT02858401|450460213|FG002|Overall Study|Withdrew Consent|0|||
125227181|NCT02858401|450460214|FG003|Overall Study|Withdrew Consent|0|||
125227182|NCT02858401|450460215|FG004|Overall Study|Withdrew Consent|0|||
125227183|NCT02858401|450460216|FG005|Overall Study|Withdrew Consent|1|||
125227184|NCT02858401|450460217|FG006|Overall Study|Withdrew Consent|0|||
125227185|NCT02858401|450460211|FG000|Overall Study|Lost to Follow-up|0|||
125227186|NCT02858401|450460212|FG001|Overall Study|Lost to Follow-up|1|||
125227187|NCT02858401|450460213|FG002|Overall Study|Lost to Follow-up|0|||
125227188|NCT02858401|450460214|FG003|Overall Study|Lost to Follow-up|0|||
125227189|NCT02858401|450460215|FG004|Overall Study|Lost to Follow-up|0|||
125227190|NCT02858401|450460216|FG005|Overall Study|Lost to Follow-up|0|||
125227191|NCT02858401|450460217|FG006|Overall Study|Lost to Follow-up|0|||
125227192|NCT03722576|450460218|FG000|Overall Study|Withdrawal by Subject|3|||
125442941|NCT01154036|451250735|FG002|Phase II|Lost to Follow-up|0|||
125442942|NCT01154036|451250736|FG003|Phase II|Lost to Follow-up|1|||
125442943|NCT01154036|451250737|FG004|Phase II|Lost to Follow-up|2|||
125442944|NCT01154036|451250738|FG005|Phase II|Lost to Follow-up|0|||
125442945|NCT01154036|451250739|FG006|Phase II|Lost to Follow-up|2|||
125442946|NCT01154036|451250740|FG007|Phase II|Lost to Follow-up|1|||
125442947|NCT01154036|451250733|FG000|Phase II|Protocol Violation|0|||
125442948|NCT01154036|451250734|FG001|Phase II|Protocol Violation|0|||
125167135|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
125227193|NCT03722576|450460218|FG000|Overall Study|Adverse Event|2|||
125227194|NCT03722576|450460218|FG000|Overall Study|Physician Decision|1|||
125227195|NCT03722576|450460218|FG000|Overall Study|Lost to Follow-up|1|||
125227196|NCT02513550|450460221|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
125227197|NCT02513550|450460222|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
125227198|NCT02513550|450460223|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
125227199|NCT02513550|450460224|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
125227200|NCT02513550|450460225|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
125227201|NCT02513550|450460226|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
125227202|NCT02513550|450460221|FG000|Double Blind Treatment Period|Adverse Event|5|||
125227203|NCT02513550|450460222|FG001|Double Blind Treatment Period|Adverse Event|13|||
125227204|NCT02513550|450460223|FG002|Double Blind Treatment Period|Adverse Event|17|||
125227205|NCT02513550|450460224|FG003|Double Blind Treatment Period|Adverse Event|0|||
125227206|NCT02513550|450460225|FG004|Double Blind Treatment Period|Adverse Event|1|||
125227207|NCT02513550|450460226|FG005|Double Blind Treatment Period|Adverse Event|0|||
125227208|NCT02513550|450460221|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
125227209|NCT02513550|450460222|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
125227210|NCT02513550|450460223|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
125227211|NCT02513550|450460224|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
125227212|NCT02513550|450460225|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
125227213|NCT02513550|450460226|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
125227214|NCT02513550|450460221|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
125227215|NCT02513550|450460222|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
125227216|NCT02513550|450460223|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
125227217|NCT02513550|450460224|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
125227218|NCT02513550|450460225|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
125227219|NCT02513550|450460226|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
125442949|NCT01154036|451250735|FG002|Phase II|Protocol Violation|0|||
125442950|NCT01154036|451250736|FG003|Phase II|Protocol Violation|0|||
125167136|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
125167137|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
125167138|NCT04040192|450235966|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
125167139|NCT04040192|450235967|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
125167140|NCT04040192|450235968|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
125167141|NCT03200912|450235969|FG000|Overall Study|Adverse Event|3|||
125167142|NCT03200912|450235970|FG001|Overall Study|Adverse Event|0|||
125167143|NCT03200912|450235971|FG002|Overall Study|Adverse Event|0|||
125167144|NCT03200912|450235969|FG000|Overall Study|Withdrawal by Subject|1|||
125167145|NCT03200912|450235970|FG001|Overall Study|Withdrawal by Subject|2|||
125167146|NCT03200912|450235971|FG002|Overall Study|Withdrawal by Subject|4|||
125167147|NCT03200912|450235969|FG000|Overall Study|Non-compliance with study drug|0|||
125167148|NCT03200912|450235970|FG001|Overall Study|Non-compliance with study drug|1|||
125167149|NCT03200912|450235971|FG002|Overall Study|Non-compliance with study drug|0|||
125167150|NCT01955083|450235974|FG000|Overall Study|Lost to Follow-up|1|||
125167151|NCT01955083|450235975|FG001|Overall Study|Lost to Follow-up|1|||
125167152|NCT03583086|450235978|FG000|Overall Study|Death|2|||
125167153|NCT03583086|450235979|FG001|Overall Study|Death|6|||
125167154|NCT03583086|450235980|FG002|Overall Study|Death|12|||
125167155|NCT03583086|450235981|FG003|Overall Study|Death|10|||
125167156|NCT03583086|450235982|FG004|Overall Study|Death|14|||
125167157|NCT03583086|450235983|FG005|Overall Study|Death|14|||
125167158|NCT03583086|450235984|FG006|Overall Study|Death|4|||
125167159|NCT03583086|450235978|FG000|Overall Study|Withdrawal by Subject|0|||
125167160|NCT03583086|450235979|FG001|Overall Study|Withdrawal by Subject|0|||
125167161|NCT03583086|450235980|FG002|Overall Study|Withdrawal by Subject|1|||
125167162|NCT03583086|450235981|FG003|Overall Study|Withdrawal by Subject|0|||
125167163|NCT03583086|450235982|FG004|Overall Study|Withdrawal by Subject|0|||
125227220|NCT02513550|450460221|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125227221|NCT02513550|450460222|FG001|Double Blind Treatment Period|Protocol Violation|1|||
125227222|NCT02513550|450460223|FG002|Double Blind Treatment Period|Protocol Violation|4|||
125227223|NCT02513550|450460224|FG003|Double Blind Treatment Period|Protocol Violation|0|||
125227224|NCT02513550|450460225|FG004|Double Blind Treatment Period|Protocol Violation|0|||
125227225|NCT02513550|450460226|FG005|Double Blind Treatment Period|Protocol Violation|0|||
125442951|NCT01154036|451250737|FG004|Phase II|Protocol Violation|1|||
125442952|NCT01154036|451250738|FG005|Phase II|Protocol Violation|2|||
125442953|NCT01154036|451250739|FG006|Phase II|Protocol Violation|0|||
125442954|NCT01154036|451250740|FG007|Phase II|Protocol Violation|0|||
125442955|NCT01154036|451250733|FG000|Phase II|Withdrawal by Subject|0|||
125442956|NCT01154036|451250734|FG001|Phase II|Withdrawal by Subject|0|||
125442957|NCT01154036|451250735|FG002|Phase II|Withdrawal by Subject|0|||
125442958|NCT01154036|451250736|FG003|Phase II|Withdrawal by Subject|0|||
125442959|NCT01154036|451250737|FG004|Phase II|Withdrawal by Subject|4|||
125442960|NCT01154036|451250738|FG005|Phase II|Withdrawal by Subject|2|||
125442961|NCT01154036|451250739|FG006|Phase II|Withdrawal by Subject|5|||
125442962|NCT01154036|451250740|FG007|Phase II|Withdrawal by Subject|4|||
125442963|NCT01349907|451250741|FG000|Overall Study|Adverse Event|37|||
125442964|NCT01349907|451250742|FG001|Overall Study|Adverse Event|11|||
125442965|NCT01349907|451250741|FG000|Overall Study|Treatment failure|13|||
125442966|NCT01349907|451250742|FG001|Overall Study|Treatment failure|4|||
125442967|NCT01349907|451250741|FG000|Overall Study|Lost to Follow-up|25|||
125442968|NCT01349907|451250742|FG001|Overall Study|Lost to Follow-up|6|||
125442969|NCT01349907|451250741|FG000|Overall Study|Withdrawal by Subject|30|||
125442970|NCT01349907|451250742|FG001|Overall Study|Withdrawal by Subject|8|||
125442971|NCT01349907|451250741|FG000|Overall Study|Protocol Violation|33|||
125442972|NCT01349907|451250742|FG001|Overall Study|Protocol Violation|13|||
125442973|NCT01349907|451250741|FG000|Overall Study|Administrative|1|||
125442974|NCT01349907|451250742|FG001|Overall Study|Administrative|1|||
125442975|NCT01591460|451250745|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
125442976|NCT01591460|451250745|FG000|Overall Study|Futility Rule (Week 12)|7|||
125442977|NCT01591460|451250745|FG000|Overall Study|Futility Rule (Week 24)|3|||
125442978|NCT01591460|451250745|FG000|Overall Study|Rebound or Breakthrough|3|||
125442979|NCT01591460|451250745|FG000|Overall Study|Treatment Discontinued by Error|1|||
125442980|NCT01591460|451250745|FG000|Overall Study|Lost to Follow-up|1|||
125442981|NCT01591460|451250745|FG000|Overall Study|Noncompliance|1|||
125442982|NCT01591460|451250745|FG000|Overall Study|Participant Refusal|3|||
125442983|NCT01591460|451250745|FG000|Overall Study|Withdrawal by Subject|1|||
125442984|NCT01591460|451250745|FG000|Overall Study|Protocol Violation|1|||
125442985|NCT04102540|451250748|FG000|Overall Study|Withdrawn by PI|2|||
125442986|NCT04102540|451250748|FG000|Overall Study|Lost to Follow-up|6|||
125442987|NCT01744496|451250749|FG000|Titration Period|Adverse Event|2|||
125442988|NCT01744496|451250750|FG001|Titration Period|Adverse Event|1|||
125442989|NCT01744496|451250749|FG000|Titration Period|Personal reasons|0|||
125442990|NCT01744496|451250750|FG001|Titration Period|Personal reasons|1|||
125442991|NCT01744496|451250749|FG000|Maintenance Period|Adverse Event|1|||
125442992|NCT01744496|451250750|FG001|Maintenance Period|Adverse Event|3|||
125442993|NCT01744496|451250749|FG000|Maintenance Period|Protocol Violation|1|||
125442994|NCT01744496|451250750|FG001|Maintenance Period|Protocol Violation|0|||
125442995|NCT01744496|451250749|FG000|Maintenance Period|Withdrawal by Subject|1|||
125167164|NCT03583086|450235983|FG005|Overall Study|Withdrawal by Subject|0|||
125167165|NCT03583086|450235984|FG006|Overall Study|Withdrawal by Subject|1|||
125167166|NCT03583086|450235978|FG000|Overall Study|Refused follow-up|0|||
125167167|NCT03583086|450235979|FG001|Overall Study|Refused follow-up|0|||
125167168|NCT03583086|450235980|FG002|Overall Study|Refused follow-up|1|||
125167169|NCT03583086|450235981|FG003|Overall Study|Refused follow-up|0|||
125167170|NCT03583086|450235982|FG004|Overall Study|Refused follow-up|1|||
125167171|NCT03583086|450235983|FG005|Overall Study|Refused follow-up|0|||
125167172|NCT03583086|450235984|FG006|Overall Study|Refused follow-up|0|||
125167173|NCT03583086|450235978|FG000|Overall Study|Declining Performance Status|0|||
125167174|NCT03583086|450235979|FG001|Overall Study|Declining Performance Status|0|||
125167175|NCT03583086|450235980|FG002|Overall Study|Declining Performance Status|1|||
125167176|NCT03583086|450235981|FG003|Overall Study|Declining Performance Status|0|||
125167177|NCT03583086|450235982|FG004|Overall Study|Declining Performance Status|0|||
125167178|NCT03583086|450235983|FG005|Overall Study|Declining Performance Status|0|||
125167179|NCT03583086|450235984|FG006|Overall Study|Declining Performance Status|0|||
125167180|NCT03583086|450235978|FG000|Overall Study|Still on study|0|||
125167181|NCT03583086|450235979|FG001|Overall Study|Still on study|0|||
125167182|NCT03583086|450235980|FG002|Overall Study|Still on study|0|||
125167183|NCT03583086|450235981|FG003|Overall Study|Still on study|1|||
125167184|NCT03583086|450235982|FG004|Overall Study|Still on study|0|||
125167185|NCT03583086|450235983|FG005|Overall Study|Still on study|0|||
125167186|NCT03583086|450235984|FG006|Overall Study|Still on study|1|||
125167187|NCT03583086|450235978|FG000|Overall Study|Disease progression|0|||
125167188|NCT03583086|450235979|FG001|Overall Study|Disease progression|0|||
125167189|NCT03583086|450235980|FG002|Overall Study|Disease progression|0|||
125167190|NCT03583086|450235981|FG003|Overall Study|Disease progression|0|||
125167191|NCT03583086|450235982|FG004|Overall Study|Disease progression|0|||
125167192|NCT03583086|450235983|FG005|Overall Study|Disease progression|0|||
125442996|NCT01744496|451250750|FG001|Maintenance Period|Withdrawal by Subject|1|||
125442997|NCT01744496|451250749|FG000|Maintenance Period|Subject left town|1|||
125442998|NCT01744496|451250750|FG001|Maintenance Period|Subject left town|0|||
125442999|NCT01567163|451250752|FG000|Overall Study|Progressive Disease|2|||
125443000|NCT01567163|451250752|FG000|Overall Study|Lost to Follow-up|2|||
125167193|NCT03583086|450235984|FG006|Overall Study|Disease progression|1|||
125167194|NCT03583086|450235978|FG000|Overall Study|Undergoing radiation therapy|0|||
125167195|NCT03583086|450235979|FG001|Overall Study|Undergoing radiation therapy|0|||
125167196|NCT03583086|450235980|FG002|Overall Study|Undergoing radiation therapy|0|||
125167197|NCT03583086|450235981|FG003|Overall Study|Undergoing radiation therapy|0|||
125167198|NCT03583086|450235982|FG004|Overall Study|Undergoing radiation therapy|0|||
125167199|NCT03583086|450235983|FG005|Overall Study|Undergoing radiation therapy|0|||
125167200|NCT03583086|450235984|FG006|Overall Study|Undergoing radiation therapy|1|||
125167201|NCT03583086|450235978|FG000|Overall Study|Lost to Follow-up|0|||
125167202|NCT03583086|450235979|FG001|Overall Study|Lost to Follow-up|0|||
125227226|NCT02513550|450460221|FG000|Double Blind Treatment Period|Physician Decision|2|||
125227227|NCT02513550|450460222|FG001|Double Blind Treatment Period|Physician Decision|0|||
125227228|NCT02513550|450460223|FG002|Double Blind Treatment Period|Physician Decision|4|||
125227229|NCT02513550|450460224|FG003|Double Blind Treatment Period|Physician Decision|0|||
125227230|NCT02513550|450460225|FG004|Double Blind Treatment Period|Physician Decision|0|||
125227231|NCT02513550|450460226|FG005|Double Blind Treatment Period|Physician Decision|0|||
125227232|NCT02513550|450460221|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
125227233|NCT02513550|450460222|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
125227234|NCT02513550|450460223|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
125227235|NCT02513550|450460224|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
125227236|NCT02513550|450460225|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
125227237|NCT02513550|450460226|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
125227238|NCT02513550|450460221|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
125227239|NCT02513550|450460222|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
125227240|NCT02513550|450460223|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
125227241|NCT02513550|450460224|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
125227242|NCT02513550|450460225|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
125227243|NCT02513550|450460226|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
125227244|NCT02513550|450460221|FG000|Double Blind Treatment Period|Due to personal business|2|||
125227245|NCT02513550|450460222|FG001|Double Blind Treatment Period|Due to personal business|0|||
125227246|NCT02513550|450460223|FG002|Double Blind Treatment Period|Due to personal business|1|||
125227247|NCT02513550|450460224|FG003|Double Blind Treatment Period|Due to personal business|0|||
125167203|NCT03583086|450235980|FG002|Overall Study|Lost to Follow-up|0|||
125167204|NCT03583086|450235981|FG003|Overall Study|Lost to Follow-up|0|||
125167205|NCT03583086|450235982|FG004|Overall Study|Lost to Follow-up|0|||
125167206|NCT03583086|450235983|FG005|Overall Study|Lost to Follow-up|1|||
125167207|NCT03583086|450235984|FG006|Overall Study|Lost to Follow-up|0|||
125167208|NCT03583086|450235978|FG000|Overall Study|Adverse Event|0|||
125167209|NCT03583086|450235979|FG001|Overall Study|Adverse Event|0|||
125167210|NCT03583086|450235980|FG002|Overall Study|Adverse Event|0|||
125167211|NCT03583086|450235981|FG003|Overall Study|Adverse Event|0|||
125167212|NCT03583086|450235982|FG004|Overall Study|Adverse Event|0|||
125167213|NCT03583086|450235983|FG005|Overall Study|Adverse Event|1|||
125167214|NCT03583086|450235984|FG006|Overall Study|Adverse Event|0|||
125167215|NCT00128830|450235986|FG000|Overall Study|Adverse Event|10|||
125167216|NCT00128830|450235986|FG000|Overall Study|Withdrawal by Subject|14|||
125167217|NCT00128830|450235986|FG000|Overall Study|Lost to Follow-up|4|||
125167218|NCT00128830|450235986|FG000|Overall Study|Reached a virologic endpoint|29|||
125167219|NCT00128830|450235986|FG000|Overall Study|Non-compliant|4|||
125167220|NCT00128830|450235986|FG000|Overall Study|Discontinued or ineligible for study|2|||
125167221|NCT00128830|450235986|FG000|Overall Study|Other|9|||
125167222|NCT02927366|450235988|FG000|Overall Study|Adverse Event|1|||
125167223|NCT02927366|450235989|FG001|Overall Study|Adverse Event|0|||
125167224|NCT02927366|450235988|FG000|Overall Study|Patient schedule|1|||
125167225|NCT02927366|450235989|FG001|Overall Study|Patient schedule|0|||
125167226|NCT00426361|450235996|FG000|Overall Study|Lost to Follow-up|3|||
125227248|NCT02513550|450460225|FG004|Double Blind Treatment Period|Due to personal business|0|||
125167227|NCT00426361|450235997|FG001|Overall Study|Lost to Follow-up|2|||
125167228|NCT00426361|450235998|FG002|Overall Study|Lost to Follow-up|5|||
125167229|NCT00426361|450235996|FG000|Overall Study|Withdrawal by Subject|1|||
125167230|NCT00426361|450235997|FG001|Overall Study|Withdrawal by Subject|3|||
125167231|NCT00426361|450235998|FG002|Overall Study|Withdrawal by Subject|0|||
125167232|NCT04642365|450236001|FG000|Overall Study|Death|3|||
125167233|NCT04642365|450236002|FG001|Overall Study|Death|2|||
125167234|NCT04642365|450236003|FG002|Overall Study|Death|4|||
125167235|NCT04642365|450236004|FG003|Overall Study|Death|5|||
125167236|NCT04642365|450236005|FG004|Overall Study|Death|5|||
125227249|NCT02513550|450460226|FG005|Double Blind Treatment Period|Due to personal business|0|||
125167237|NCT04642365|450236006|FG005|Overall Study|Death|3|||
125167238|NCT04642365|450236007|FG006|Overall Study|Death|2|||
125167239|NCT04642365|450236008|FG007|Overall Study|Death|1|||
125167240|NCT04642365|450236001|FG000|Overall Study|Physician Decision|1|||
125167241|NCT04642365|450236002|FG001|Overall Study|Physician Decision|0|||
125167242|NCT04642365|450236003|FG002|Overall Study|Physician Decision|0|||
125167243|NCT04642365|450236004|FG003|Overall Study|Physician Decision|0|||
125167244|NCT04642365|450236005|FG004|Overall Study|Physician Decision|0|||
125167245|NCT04642365|450236006|FG005|Overall Study|Physician Decision|0|||
125227250|NCT02513550|450460221|FG000|Double Blind Treatment Period|Death|1|||
125227251|NCT02513550|450460222|FG001|Double Blind Treatment Period|Death|0|||
125227252|NCT02513550|450460223|FG002|Double Blind Treatment Period|Death|2|||
125167246|NCT04642365|450236007|FG006|Overall Study|Physician Decision|0|||
125167247|NCT04642365|450236008|FG007|Overall Study|Physician Decision|0|||
125167248|NCT04642365|450236001|FG000|Overall Study|Progressive Disease|1|||
125167249|NCT04642365|450236002|FG001|Overall Study|Progressive Disease|1|||
125167250|NCT04642365|450236003|FG002|Overall Study|Progressive Disease|1|||
125227253|NCT02513550|450460224|FG003|Double Blind Treatment Period|Death|0|||
125227254|NCT02513550|450460225|FG004|Double Blind Treatment Period|Death|0|||
125227255|NCT02513550|450460226|FG005|Double Blind Treatment Period|Death|0|||
125227256|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
125167251|NCT04642365|450236004|FG003|Overall Study|Progressive Disease|0|||
125167252|NCT04642365|450236005|FG004|Overall Study|Progressive Disease|0|||
125167253|NCT04642365|450236006|FG005|Overall Study|Progressive Disease|0|||
125167254|NCT04642365|450236007|FG006|Overall Study|Progressive Disease|1|||
125167255|NCT04642365|450236008|FG007|Overall Study|Progressive Disease|0|||
125167256|NCT04642365|450236001|FG000|Overall Study|Study Terminated By Sponsor|0|||
125167257|NCT04642365|450236002|FG001|Overall Study|Study Terminated By Sponsor|2|||
125227257|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
125227258|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
125227259|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125227260|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125227261|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
125227262|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
125227263|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
125227264|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
125227265|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
125227266|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
125227267|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
125227268|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
125227269|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
125227270|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
125227271|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125227272|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125227273|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
125227274|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
125392234|NCT00380393|451070610|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
125392235|NCT00380393|451070609|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
125392236|NCT00380393|451070610|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
125392237|NCT00380393|451070609|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
125392238|NCT00380393|451070610|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
125392239|NCT00380393|451070609|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
125392240|NCT00380393|451070610|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
125392241|NCT00380393|451070609|FG000|Month 14|Withdrawal by Subject|9|||
125392242|NCT00380393|451070610|FG001|Month 14|Withdrawal by Subject|7|||
125167258|NCT04642365|450236003|FG002|Overall Study|Study Terminated By Sponsor|1|||
125167259|NCT04642365|450236004|FG003|Overall Study|Study Terminated By Sponsor|1|||
125167260|NCT04642365|450236005|FG004|Overall Study|Study Terminated By Sponsor|1|||
125167261|NCT04642365|450236006|FG005|Overall Study|Study Terminated By Sponsor|2|||
125167262|NCT04642365|450236007|FG006|Overall Study|Study Terminated By Sponsor|2|||
125167263|NCT04642365|450236008|FG007|Overall Study|Study Terminated By Sponsor|1|||
125167264|NCT04642365|450236001|FG000|Overall Study|Symptomatic Deterioration|1|||
125167265|NCT04642365|450236002|FG001|Overall Study|Symptomatic Deterioration|1|||
125167266|NCT04642365|450236003|FG002|Overall Study|Symptomatic Deterioration|0|||
125167267|NCT04642365|450236004|FG003|Overall Study|Symptomatic Deterioration|0|||
125167268|NCT04642365|450236005|FG004|Overall Study|Symptomatic Deterioration|0|||
125227275|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
125392243|NCT00380393|451070609|FG000|Month 14|Death|1|||
125392244|NCT00380393|451070610|FG001|Month 14|Death|0|||
125392245|NCT00380393|451070609|FG000|Month 14|Lost to Follow-up|0|||
125227276|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
125227277|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
125227278|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
125227279|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
125392246|NCT00380393|451070610|FG001|Month 14|Lost to Follow-up|1|||
125392247|NCT00380393|451070609|FG000|Month 14|Migrated/moved from study area|39|||
125167269|NCT04642365|450236006|FG005|Overall Study|Symptomatic Deterioration|1|||
125167270|NCT04642365|450236007|FG006|Overall Study|Symptomatic Deterioration|0|||
125167271|NCT04642365|450236008|FG007|Overall Study|Symptomatic Deterioration|0|||
125167272|NCT04642365|450236001|FG000|Overall Study|Withdrawal by Subject|0|||
125167273|NCT04642365|450236002|FG001|Overall Study|Withdrawal by Subject|0|||
125167274|NCT04642365|450236003|FG002|Overall Study|Withdrawal by Subject|1|||
125167275|NCT04642365|450236004|FG003|Overall Study|Withdrawal by Subject|1|||
125167276|NCT04642365|450236005|FG004|Overall Study|Withdrawal by Subject|0|||
125167277|NCT04642365|450236006|FG005|Overall Study|Withdrawal by Subject|0|||
125167278|NCT04642365|450236007|FG006|Overall Study|Withdrawal by Subject|2|||
125167279|NCT04642365|450236008|FG007|Overall Study|Withdrawal by Subject|0|||
125167280|NCT04642365|450236001|FG000|Overall Study|Adverse Event|0|||
125167281|NCT04642365|450236002|FG001|Overall Study|Adverse Event|0|||
125167282|NCT04642365|450236003|FG002|Overall Study|Adverse Event|0|||
125167283|NCT04642365|450236004|FG003|Overall Study|Adverse Event|0|||
125167284|NCT04642365|450236005|FG004|Overall Study|Adverse Event|0|||
125167285|NCT04642365|450236006|FG005|Overall Study|Adverse Event|0|||
125167286|NCT04642365|450236007|FG006|Overall Study|Adverse Event|0|||
125167287|NCT04642365|450236008|FG007|Overall Study|Adverse Event|1|||
125167288|NCT02478320|450236009|FG000|Overall Study|Adverse Event|2|||
125167289|NCT02478320|450236010|FG001|Overall Study|Adverse Event|0|||
125167290|NCT02478320|450236009|FG000|Overall Study|Death|1|||
125167291|NCT02478320|450236010|FG001|Overall Study|Death|0|||
125167292|NCT02478320|450236009|FG000|Overall Study|Lack of Efficacy|4|||
125167293|NCT02478320|450236010|FG001|Overall Study|Lack of Efficacy|0|||
125167294|NCT02478320|450236009|FG000|Overall Study|Withdrawal by Subject|2|||
125167295|NCT02478320|450236010|FG001|Overall Study|Withdrawal by Subject|0|||
125167296|NCT02478320|450236009|FG000|Overall Study|Screen Failure|3|||
125167297|NCT02478320|450236010|FG001|Overall Study|Screen Failure|0|||
125167298|NCT03185013|450236011|FG000|Overall Study|Withdrawal by Subject|5|||
125167299|NCT03185013|450236012|FG001|Overall Study|Withdrawal by Subject|3|||
125167300|NCT03185013|450236011|FG000|Overall Study|Adverse Event|1|||
125167301|NCT03185013|450236012|FG001|Overall Study|Adverse Event|0|||
125167302|NCT03185013|450236011|FG000|Overall Study|Progressive Disease|1|||
125167303|NCT03185013|450236012|FG001|Overall Study|Progressive Disease|0|||
125167304|NCT03185013|450236011|FG000|Overall Study|Lost to Follow-up|8|||
125167305|NCT03185013|450236012|FG001|Overall Study|Lost to Follow-up|2|||
125167306|NCT03185013|450236011|FG000|Overall Study|Physician Decision|1|||
125167307|NCT03185013|450236012|FG001|Overall Study|Physician Decision|0|||
125167308|NCT03185013|450236011|FG000|Overall Study|Protocol Deviation|2|||
125167309|NCT03185013|450236012|FG001|Overall Study|Protocol Deviation|0|||
125167310|NCT03185013|450236011|FG000|Overall Study|Reason not Specified|3|||
125167311|NCT03185013|450236012|FG001|Overall Study|Reason not Specified|2|||
125167312|NCT03185013|450236011|FG000|Overall Study|Death|1|||
125167313|NCT03185013|450236012|FG001|Overall Study|Death|0|||
125167314|NCT00510289|450236016|FG000|Overall Study|Withdrawal by Subject|7|||
125167315|NCT00510289|450236016|FG000|Overall Study|Refused bone marrow biopsy|2|||
125167316|NCT00510289|450236016|FG000|Overall Study|Lost to Follow-up|1|||
125167317|NCT00510289|450236016|FG000|Overall Study|Progressed prior to starting drug|2|||
125167318|NCT00673387|450236019|FG000|Overall Study|Withdrawal by Subject|15|||
125167319|NCT00673387|450236020|FG001|Overall Study|Withdrawal by Subject|16|||
125167320|NCT00673387|450236021|FG002|Overall Study|Withdrawal by Subject|20|||
125167321|NCT00673387|450236022|FG003|Overall Study|Withdrawal by Subject|16|||
125167322|NCT00673387|450236023|FG004|Overall Study|Withdrawal by Subject|18|||
125167323|NCT00673387|450236024|FG005|Overall Study|Withdrawal by Subject|21|||
125167324|NCT00673387|450236025|FG006|Overall Study|Withdrawal by Subject|15|||
125167325|NCT00673387|450236026|FG007|Overall Study|Withdrawal by Subject|21|||
125167326|NCT00673387|450236019|FG000|Overall Study|Adverse Event|3|||
125167327|NCT00673387|450236020|FG001|Overall Study|Adverse Event|1|||
125167328|NCT00673387|450236021|FG002|Overall Study|Adverse Event|5|||
125167329|NCT00673387|450236022|FG003|Overall Study|Adverse Event|2|||
125167330|NCT00673387|450236023|FG004|Overall Study|Adverse Event|6|||
125167331|NCT00673387|450236024|FG005|Overall Study|Adverse Event|2|||
125167332|NCT00673387|450236025|FG006|Overall Study|Adverse Event|5|||
125167333|NCT00673387|450236026|FG007|Overall Study|Adverse Event|5|||
125167334|NCT00673387|450236019|FG000|Overall Study|Physician Decision|0|||
125167335|NCT00673387|450236020|FG001|Overall Study|Physician Decision|0|||
125167336|NCT00673387|450236021|FG002|Overall Study|Physician Decision|0|||
125167337|NCT00673387|450236022|FG003|Overall Study|Physician Decision|0|||
125167338|NCT00673387|450236023|FG004|Overall Study|Physician Decision|0|||
125167339|NCT00673387|450236024|FG005|Overall Study|Physician Decision|5|||
125167340|NCT00673387|450236025|FG006|Overall Study|Physician Decision|1|||
125167341|NCT00673387|450236026|FG007|Overall Study|Physician Decision|1|||
125167342|NCT00673387|450236019|FG000|Overall Study|Protocol Violation|3|||
125167343|NCT00673387|450236020|FG001|Overall Study|Protocol Violation|0|||
125167344|NCT00673387|450236021|FG002|Overall Study|Protocol Violation|1|||
125167345|NCT00673387|450236022|FG003|Overall Study|Protocol Violation|2|||
125167346|NCT00673387|450236023|FG004|Overall Study|Protocol Violation|0|||
125167347|NCT00673387|450236024|FG005|Overall Study|Protocol Violation|1|||
125167348|NCT00673387|450236025|FG006|Overall Study|Protocol Violation|1|||
125167349|NCT00673387|450236026|FG007|Overall Study|Protocol Violation|3|||
125167350|NCT00673387|450236019|FG000|Overall Study|Lost to Follow-up|8|||
125167351|NCT00673387|450236020|FG001|Overall Study|Lost to Follow-up|6|||
125167352|NCT00673387|450236021|FG002|Overall Study|Lost to Follow-up|5|||
125167353|NCT00673387|450236022|FG003|Overall Study|Lost to Follow-up|6|||
125167354|NCT00673387|450236023|FG004|Overall Study|Lost to Follow-up|6|||
125167355|NCT00673387|450236024|FG005|Overall Study|Lost to Follow-up|5|||
125167356|NCT00673387|450236025|FG006|Overall Study|Lost to Follow-up|8|||
125167357|NCT00673387|450236026|FG007|Overall Study|Lost to Follow-up|5|||
125167358|NCT00960115|450236029|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
125167359|NCT00960115|450236030|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
125167360|NCT04428333|450236031|FG000|Overall Study|Physician Decision|5|||
125167361|NCT04428333|450236032|FG001|Overall Study|Physician Decision|6|||
125167362|NCT04428333|450236031|FG000|Overall Study|Withdrawal by Subject|1|||
125167363|NCT04428333|450236032|FG001|Overall Study|Withdrawal by Subject|3|||
125167364|NCT04428333|450236031|FG000|Overall Study|Study Terminated By Sponsor|14|||
125167365|NCT04428333|450236032|FG001|Overall Study|Study Terminated By Sponsor|16|||
125167366|NCT02351960|450236033|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
125167367|NCT02351960|450236034|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
125167368|NCT02351960|450236033|FG000|Overall Study|Voluntary Withdrawal|5|||
125167369|NCT02351960|450236034|FG001|Overall Study|Voluntary Withdrawal|4|||
125167370|NCT02351960|450236033|FG000|Overall Study|Significant Protocol Deviation|0|||
125167371|NCT02351960|450236034|FG001|Overall Study|Significant Protocol Deviation|5|||
125167372|NCT00319982|450236035|FG000|Overall Study|Withdrawal by Subject|1|||
125167373|NCT00319982|450236036|FG001|Overall Study|Withdrawal by Subject|0|||
125167374|NCT01094886|450236037|FG000|Overall Study|Adverse Event|2|||
125167375|NCT01094886|450236037|FG000|Overall Study|Withdrawal by Subject|5|||
125167376|NCT03480386|450236038|FG000|Overall Study|Did not complete measures at 3-months|17|||
125167377|NCT03480386|450236039|FG001|Overall Study|Did not complete measures at 3-months|14|||
125167378|NCT03480386|450236038|FG000|Overall Study|No baseline measures|11|||
125167379|NCT03480386|450236039|FG001|Overall Study|No baseline measures|14|||
125167380|NCT03480386|450236038|FG000|Overall Study|Death|0|||
125167381|NCT03480386|450236039|FG001|Overall Study|Death|5|||
125167382|NCT03480386|450236038|FG000|Overall Study|Withdrawal by Subject|12|||
125167383|NCT03480386|450236039|FG001|Overall Study|Withdrawal by Subject|8|||
125167384|NCT03480386|450236038|FG000|Overall Study|Lost to Follow-up|2|||
125167385|NCT03480386|450236039|FG001|Overall Study|Lost to Follow-up|1|||
125167386|NCT03480386|450236038|FG000|Overall Study|Complicating disease|0|||
125167387|NCT03480386|450236039|FG001|Overall Study|Complicating disease|1|||
125167388|NCT03480386|450236038|FG000|Overall Study|Disease progression|3|||
125167389|NCT03480386|450236039|FG001|Overall Study|Disease progression|0|||
125167390|NCT03480386|450236038|FG000|Overall Study|Became ineligible|0|||
125167391|NCT03480386|450236039|FG001|Overall Study|Became ineligible|2|||
125167392|NCT04730349|450236041|FG000|Overall Study|Participant withdrew consent|1|||
125167393|NCT04730349|450236042|FG001|Overall Study|Participant withdrew consent|0|||
125167394|NCT04730349|450236041|FG000|Overall Study|Disease progression|6|||
125167395|NCT04730349|450236042|FG001|Overall Study|Disease progression|4|||
125167396|NCT04730349|450236041|FG000|Overall Study|Study drug toxicity|0|||
125167397|NCT04730349|450236042|FG001|Overall Study|Study drug toxicity|1|||
125167398|NCT02013674|450236048|FG000|Overall Study|Death|0|||
125167399|NCT02013674|450236049|FG001|Overall Study|Death|1|||
125167400|NCT02013674|450236048|FG000|Overall Study|Lost to Follow-up|1|||
125167401|NCT02013674|450236049|FG001|Overall Study|Lost to Follow-up|0|||
125167402|NCT00416884|450236051|FG000|Overall Study|Study terminated due to low accrual|1|||
125167403|NCT04051619|450236053|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
125167404|NCT04051619|450236054|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
125167405|NCT04051619|450236053|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
125167406|NCT04051619|450236054|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
125167407|NCT03610516|450237482|FG000|Treatment Epoch|Adverse Event|3|||
125167408|NCT03610516|450237483|FG001|Treatment Epoch|Adverse Event|1|||
125167409|NCT03610516|450237482|FG000|Treatment Epoch|Death|1|||
125167410|NCT03610516|450237483|FG001|Treatment Epoch|Death|0|||
125167411|NCT03610516|450237482|FG000|Treatment Epoch|Lack of Efficacy|0|||
125167412|NCT03610516|450237483|FG001|Treatment Epoch|Lack of Efficacy|1|||
125167413|NCT03610516|450237482|FG000|Treatment Epoch|No longer requires treatment|1|||
125167414|NCT03610516|450237483|FG001|Treatment Epoch|No longer requires treatment|0|||
125167415|NCT03610516|450237482|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
125167416|NCT03610516|450237483|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
125167417|NCT03610516|450237482|FG000|Treatment Epoch|Physician Decision|8|||
125167418|NCT03610516|450237483|FG001|Treatment Epoch|Physician Decision|5|||
125167419|NCT03610516|450237482|FG000|Treatment Epoch|Protocol Deviation|1|||
125167420|NCT03610516|450237483|FG001|Treatment Epoch|Protocol Deviation|0|||
125167421|NCT03610516|450237482|FG000|Treatment Epoch|Withdrawal by Subject|3|||
125167422|NCT03610516|450237483|FG001|Treatment Epoch|Withdrawal by Subject|1|||
125167423|NCT03610516|450237482|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
125167424|NCT03610516|450237483|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
125167425|NCT03610516|450237482|FG000|Post-Treatment Follow-up|Death|1|||
125167426|NCT03610516|450237483|FG001|Post-Treatment Follow-up|Death|0|||
125167427|NCT00660907|450237487|FG000|Overall Study|Incorrect Enrollment|1|||
125167428|NCT00660907|450237488|FG001|Overall Study|Incorrect Enrollment|1|||
125167429|NCT00660907|450237487|FG000|Overall Study|Adverse Event|33|||
125167430|NCT00660907|450237488|FG001|Overall Study|Adverse Event|19|||
125167431|NCT00660907|450237487|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
125167432|NCT00660907|450237488|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
125167433|NCT00660907|450237487|FG000|Overall Study|Withdrawal by Subject|23|||
125167434|NCT00660907|450237488|FG001|Overall Study|Withdrawal by Subject|32|||
125167435|NCT00660907|450237487|FG000|Overall Study|Lost to Follow-up|3|||
125167436|NCT00660907|450237488|FG001|Overall Study|Lost to Follow-up|3|||
125167437|NCT00660907|450237487|FG000|Overall Study|Poor/Non-Compliance|5|||
125167438|NCT00660907|450237488|FG001|Overall Study|Poor/Non-Compliance|1|||
125167439|NCT00660907|450237487|FG000|Overall Study|Safety|1|||
125167440|NCT00660907|450237488|FG001|Overall Study|Safety|0|||
125167441|NCT00660907|450237487|FG000|Overall Study|Death|1|||
125167442|NCT00660907|450237488|FG001|Overall Study|Death|3|||
125167443|NCT00660907|450237487|FG000|Overall Study|Various|11|||
125167444|NCT00660907|450237488|FG001|Overall Study|Various|8|||
125167445|NCT02932306|450237509|FG000|Overall Study|Withdrawal by Subject|16|||
125167446|NCT02932306|450237510|FG001|Overall Study|Withdrawal by Subject|25|||
125167447|NCT02932306|450237509|FG000|Overall Study|Adverse Event|3|||
125167448|NCT02932306|450237510|FG001|Overall Study|Adverse Event|0|||
125167449|NCT02932306|450237509|FG000|Overall Study|Pregnancy|2|||
125167450|NCT02932306|450237510|FG001|Overall Study|Pregnancy|0|||
125167451|NCT02932306|450237509|FG000|Overall Study|Protocol Violation|1|||
125167452|NCT02932306|450237510|FG001|Overall Study|Protocol Violation|1|||
125167453|NCT02932306|450237509|FG000|Overall Study|Noncompliance with Study Drug|1|||
125167454|NCT02932306|450237510|FG001|Overall Study|Noncompliance with Study Drug|1|||
125167455|NCT02932306|450237509|FG000|Overall Study|Lost to Follow-up|36|||
125167456|NCT02932306|450237510|FG001|Overall Study|Lost to Follow-up|40|||
125167457|NCT02932306|450237509|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
125167458|NCT02932306|450237510|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
125167459|NCT02932306|450237509|FG000|Overall Study|Lack of Efficacy|0|||
125167460|NCT02932306|450237510|FG001|Overall Study|Lack of Efficacy|2|||
125167461|NCT02932306|450237509|FG000|Overall Study|Worsening condition|2|||
125167462|NCT02932306|450237510|FG001|Overall Study|Worsening condition|0|||
125167463|NCT02932306|450237509|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
125167464|NCT02932306|450237510|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
125167465|NCT05776862|450237511|FG000|Overall Study|Adverse Event|0|||
125167466|NCT05776862|450237512|FG001|Overall Study|Adverse Event|1|||
125167467|NCT05776862|450237511|FG000|Overall Study|non-compliance|1|||
125167468|NCT05776862|450237512|FG001|Overall Study|non-compliance|0|||
125167469|NCT01199471|450237513|FG000|Overall Study|Protocol Violation|4|||
125167470|NCT01199471|450237513|FG000|Overall Study|Withdrawal by Subject|1|||
125167471|NCT01199471|450237513|FG000|Overall Study|Physician Decision|1|||
125167472|NCT02065700|450237514|FG000|Overall Study|Adverse Event|165|||
125167473|NCT02065700|450237515|FG001|Overall Study|Adverse Event|101|||
125167474|NCT02065700|450237514|FG000|Overall Study|Withdrawal by Subject|90|||
125167475|NCT02065700|450237515|FG001|Overall Study|Withdrawal by Subject|29|||
125167476|NCT02065700|450237514|FG000|Overall Study|Lost to Follow-up|12|||
125167477|NCT02065700|450237515|FG001|Overall Study|Lost to Follow-up|9|||
125167478|NCT02065700|450237514|FG000|Overall Study|Physician Decision|2|||
125167479|NCT02065700|450237515|FG001|Overall Study|Physician Decision|0|||
125167480|NCT02065700|450237514|FG000|Overall Study|Sponsor Request|38|||
125167481|NCT02065700|450237515|FG001|Overall Study|Sponsor Request|15|||
125167482|NCT02065700|450237514|FG000|Overall Study|Treatment Failure|3|||
125167483|NCT02065700|450237515|FG001|Overall Study|Treatment Failure|2|||
125167484|NCT02065700|450237514|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
125167485|NCT02065700|450237515|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
125167486|NCT02065700|450237514|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
125167487|NCT02065700|450237515|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
125167488|NCT02065700|450237514|FG000|Overall Study|Non-compliance with Study Procedures|2|||
125167489|NCT02065700|450237515|FG001|Overall Study|Non-compliance with Study Procedures|0|||
125167490|NCT02065700|450237514|FG000|Overall Study|Not Defined|21|||
125167491|NCT02065700|450237515|FG001|Overall Study|Not Defined|3|||
125167492|NCT01305044|450237520|FG000|Overall Study|Withdrawal by Subject|3|||
125167493|NCT01305044|450237521|FG001|Overall Study|Withdrawal by Subject|6|||
125167494|NCT02278055|450237525|FG000|Overall Study|Adverse Event|1|||
125167495|NCT02278055|450237525|FG000|Overall Study|Lost to Follow-up|1|||
125167496|NCT02278055|450237525|FG000|Overall Study|Withdrawal by Subject|2|||
125167497|NCT02278055|450237525|FG000|Overall Study|Progressive Disease|4|||
125167498|NCT03207243|450237526|FG000|Overall Study|Adverse Event|2|||
125167499|NCT03207243|450237527|FG001|Overall Study|Adverse Event|2|||
125167500|NCT03207243|450237526|FG000|Overall Study|Loss of Asthma Control|47|||
125167501|NCT03207243|450237527|FG001|Overall Study|Loss of Asthma Control|31|||
125167502|NCT03207243|450237526|FG000|Overall Study|Withdrawal by Subject|2|||
125167503|NCT03207243|450237527|FG001|Overall Study|Withdrawal by Subject|4|||
125167504|NCT03207243|450237526|FG000|Overall Study|Physician Decision|1|||
125167505|NCT03207243|450237527|FG001|Overall Study|Physician Decision|1|||
125167506|NCT03207243|450237526|FG000|Overall Study|Lost to Follow-up|0|||
125167507|NCT03207243|450237527|FG001|Overall Study|Lost to Follow-up|1|||
125167508|NCT03207243|450237526|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
125167509|NCT03207243|450237527|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
125167510|NCT03207243|450237526|FG000|Overall Study|Protocol Violation|0|||
125167511|NCT03207243|450237527|FG001|Overall Study|Protocol Violation|3|||
125167512|NCT04015908|450237528|FG000|Overall Study|Lost to Follow-up|0|||
125167513|NCT04015908|450237529|FG001|Overall Study|Lost to Follow-up|1|||
125167514|NCT04623086|450237530|FG000|Overall Study|Withdrawal by Subject|0|||
125167515|NCT04623086|450237531|FG001|Overall Study|Withdrawal by Subject|0|||
125167516|NCT04623086|450237532|FG002|Overall Study|Withdrawal by Subject|10|||
125167517|NCT00715624|450237533|FG000|Overall Study|Adverse Event|12|||
125167518|NCT00715624|450237534|FG001|Overall Study|Adverse Event|37|||
125167519|NCT00715624|450237533|FG000|Overall Study|Lack of Efficacy|11|||
125167520|NCT00715624|450237534|FG001|Overall Study|Lack of Efficacy|11|||
125167521|NCT00715624|450237533|FG000|Overall Study|Lost to Follow-up|1|||
125167522|NCT00715624|450237534|FG001|Overall Study|Lost to Follow-up|2|||
125167523|NCT00715624|450237533|FG000|Overall Study|Protocol Violation|1|||
125167524|NCT00715624|450237534|FG001|Overall Study|Protocol Violation|0|||
125167525|NCT00715624|450237533|FG000|Overall Study|Withdrawal by Subject|11|||
125167526|NCT00715624|450237534|FG001|Overall Study|Withdrawal by Subject|25|||
125167527|NCT00715624|450237533|FG000|Overall Study|Familial and personal reasons|10|||
125167528|NCT00715624|450237534|FG001|Overall Study|Familial and personal reasons|22|||
125167529|NCT00715624|450237533|FG000|Overall Study|Poor compliance|6|||
125167530|NCT00715624|450237534|FG001|Overall Study|Poor compliance|13|||
125167531|NCT00715624|450237533|FG000|Overall Study|Sponsor decision|0|||
125167532|NCT00715624|450237534|FG001|Overall Study|Sponsor decision|4|||
125167533|NCT00715624|450237533|FG000|Overall Study|Incorrect randomization (not treated)|0|||
125167534|NCT00715624|450237534|FG001|Overall Study|Incorrect randomization (not treated)|1|||
125167535|NCT00715624|450237533|FG000|Overall Study|Other|0|||
125167536|NCT00715624|450237534|FG001|Overall Study|Other|1|||
125167537|NCT00229723|450237535|FG000|Concomitant Phase|Adverse Event|4|||
125167538|NCT00229723|450237536|FG001|Concomitant Phase|Adverse Event|2|||
125167539|NCT00229723|450237537|FG002|Concomitant Phase|Adverse Event|5|||
125167540|NCT00229723|450237538|FG003|Concomitant Phase|Adverse Event|2|||
125167541|NCT00229723|450237539|FG004|Concomitant Phase|Adverse Event|0|||
125167542|NCT00229723|450237540|FG005|Concomitant Phase|Adverse Event|1|||
125167543|NCT00229723|450237541|FG006|Concomitant Phase|Adverse Event|2|||
125443001|NCT03405662|451250753|FG000|Overall Study|COVID-19 restriction|1|||
125167544|NCT00229723|450237535|FG000|Concomitant Phase|Objective disease progression|0|||
125167545|NCT00229723|450237536|FG001|Concomitant Phase|Objective disease progression|0|||
125167546|NCT00229723|450237537|FG002|Concomitant Phase|Objective disease progression|0|||
125167547|NCT00229723|450237538|FG003|Concomitant Phase|Objective disease progression|0|||
125167548|NCT00229723|450237539|FG004|Concomitant Phase|Objective disease progression|0|||
125167549|NCT00229723|450237540|FG005|Concomitant Phase|Objective disease progression|0|||
125167550|NCT00229723|450237541|FG006|Concomitant Phase|Objective disease progression|0|||
125167551|NCT00229723|450237535|FG000|Concomitant Phase|Clinical progression|0|||
125167552|NCT00229723|450237536|FG001|Concomitant Phase|Clinical progression|0|||
125167553|NCT00229723|450237537|FG002|Concomitant Phase|Clinical progression|0|||
125167554|NCT00229723|450237538|FG003|Concomitant Phase|Clinical progression|0|||
125167555|NCT00229723|450237539|FG004|Concomitant Phase|Clinical progression|0|||
125167556|NCT00229723|450237540|FG005|Concomitant Phase|Clinical progression|0|||
125167557|NCT00229723|450237541|FG006|Concomitant Phase|Clinical progression|1|||
125167558|NCT00229723|450237535|FG000|Concomitant Phase|Lost to Follow-up|0|||
125167559|NCT00229723|450237536|FG001|Concomitant Phase|Lost to Follow-up|0|||
125167560|NCT00229723|450237537|FG002|Concomitant Phase|Lost to Follow-up|0|||
125167561|NCT00229723|450237538|FG003|Concomitant Phase|Lost to Follow-up|0|||
125167562|NCT00229723|450237539|FG004|Concomitant Phase|Lost to Follow-up|1|||
125167563|NCT00229723|450237540|FG005|Concomitant Phase|Lost to Follow-up|0|||
125167564|NCT00229723|450237541|FG006|Concomitant Phase|Lost to Follow-up|0|||
125167565|NCT00229723|450237535|FG000|Concomitant Phase|Informed consent withdrawn|3|||
125167566|NCT00229723|450237536|FG001|Concomitant Phase|Informed consent withdrawn|2|||
125167567|NCT00229723|450237537|FG002|Concomitant Phase|Informed consent withdrawn|0|||
125167568|NCT00229723|450237538|FG003|Concomitant Phase|Informed consent withdrawn|2|||
125167569|NCT00229723|450237539|FG004|Concomitant Phase|Informed consent withdrawn|0|||
125167570|NCT00229723|450237540|FG005|Concomitant Phase|Informed consent withdrawn|0|||
125167571|NCT00229723|450237541|FG006|Concomitant Phase|Informed consent withdrawn|0|||
125167572|NCT00229723|450237535|FG000|Concomitant Phase|Severe non-compliance|0|||
125167573|NCT00229723|450237536|FG001|Concomitant Phase|Severe non-compliance|1|||
125443002|NCT03405662|451250754|FG001|Overall Study|COVID-19 restriction|0|||
125167574|NCT00229723|450237537|FG002|Concomitant Phase|Severe non-compliance|0|||
125167575|NCT00229723|450237538|FG003|Concomitant Phase|Severe non-compliance|0|||
125167576|NCT00229723|450237539|FG004|Concomitant Phase|Severe non-compliance|1|||
125443003|NCT03405662|451250753|FG000|Overall Study|unblinding|0|||
125443004|NCT03405662|451250754|FG001|Overall Study|unblinding|1|||
125443005|NCT03405662|451250753|FG000|Overall Study|placement in memory care facility|0|||
125443006|NCT03405662|451250754|FG001|Overall Study|placement in memory care facility|2|||
125443007|NCT01009047|451250764|FG000|Overall Study|Adverse Event|5|||
125443008|NCT01009047|451250765|FG001|Overall Study|Adverse Event|0|||
125443009|NCT01009047|451250764|FG000|Overall Study|Lost to Follow-up|0|||
125227280|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
125227281|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
125227282|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
125227283|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
125227284|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
125443010|NCT01009047|451250765|FG001|Overall Study|Lost to Follow-up|2|||
125443011|NCT01009047|451250764|FG000|Overall Study|Lack of Efficacy|4|||
125443012|NCT01009047|451250765|FG001|Overall Study|Lack of Efficacy|11|||
125443013|NCT01009047|451250764|FG000|Overall Study|Withdrawal by consent|16|||
125443014|NCT01009047|451250765|FG001|Overall Study|Withdrawal by consent|11|||
125443015|NCT01009047|451250764|FG000|Overall Study|Other|3|||
125443016|NCT01009047|451250765|FG001|Overall Study|Other|2|||
125443017|NCT04716881|451250766|FG000|Overall Study|Adverse Event|1|||
125443018|NCT04716881|451250766|FG000|Overall Study|Lost to Follow-up|1|||
125443019|NCT01558674|451250767|FG000|Part 1|Study Terminated by Sponsor|10|||
125443020|NCT01558674|451250768|FG001|Part 1|Study Terminated by Sponsor|0|||
125443021|NCT01558674|451250767|FG000|Part 1|Withdrawal by Subject|1|||
125443022|NCT01558674|451250768|FG001|Part 1|Withdrawal by Subject|0|||
125443023|NCT04147260|451250769|FG000|Overall Study|Adverse Event|1|||
125443024|NCT04147260|451250770|FG001|Overall Study|Adverse Event|0|||
125443025|NCT04147260|451250771|FG002|Overall Study|Adverse Event|1|||
125443026|NCT04147260|451250772|FG003|Overall Study|Adverse Event|2|||
125443027|NCT04147260|451250773|FG004|Overall Study|Adverse Event|0|||
125443028|NCT04147260|451250769|FG000|Overall Study|Withdrawal by Subject|0|||
125443029|NCT04147260|451250770|FG001|Overall Study|Withdrawal by Subject|0|||
125443030|NCT04147260|451250771|FG002|Overall Study|Withdrawal by Subject|1|||
125443031|NCT04147260|451250772|FG003|Overall Study|Withdrawal by Subject|1|||
125443032|NCT04147260|451250773|FG004|Overall Study|Withdrawal by Subject|0|||
125443033|NCT01555021|451250774|FG000|Overall Study|Lost to Follow-up|1|||
125443034|NCT01555021|451250775|FG001|Overall Study|Lost to Follow-up|2|||
125443035|NCT03875911|451250780|FG000|Overall Study|Lost to Follow-up|3|||
125443036|NCT03875911|451250781|FG001|Overall Study|Lost to Follow-up|6|||
125443037|NCT03875911|451250782|FG002|Overall Study|Lost to Follow-up|2|||
125443038|NCT03875911|451250780|FG000|Overall Study|Surgery cancelled|1|||
125443039|NCT03875911|451250781|FG001|Overall Study|Surgery cancelled|0|||
125443040|NCT03875911|451250782|FG002|Overall Study|Surgery cancelled|1|||
125443041|NCT03875911|451250780|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
125443042|NCT03875911|451250781|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
125443043|NCT03875911|451250782|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
125443044|NCT00750893|451250785|FG000|Overall Study|Adverse Event|5|||
125443045|NCT00750893|451250785|FG000|Overall Study|Withdrawal by Subject|10|||
125443046|NCT00750893|451250785|FG000|Overall Study|Lost to Follow-up|510|||
125443047|NCT00750893|451250785|FG000|Overall Study|Other|17|||
125443048|NCT01734850|451250786|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
125443049|NCT01734850|451250787|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
125443050|NCT01734850|451250788|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
125443051|NCT01734850|451250786|FG000|Overall Study|Not infused due to manufacturing failure|0|||
125443052|NCT01734850|451250787|FG001|Overall Study|Not infused due to manufacturing failure|0|||
125227285|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
125227286|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Death|0|||
125227287|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Death|0|||
125227288|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Death|1|||
125227289|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Death|0|||
125443053|NCT01734850|451250788|FG002|Overall Study|Not infused due to manufacturing failure|1|||
125443054|NCT03824938|451250789|FG000|Overall Study|Withdrawal by Subject|2|||
125443055|NCT03824938|451250790|FG001|Overall Study|Withdrawal by Subject|1|||
125443056|NCT03824938|451250791|FG002|Overall Study|Withdrawal by Subject|0|||
125443057|NCT03824938|451250792|FG003|Overall Study|Withdrawal by Subject|2|||
125443058|NCT03824938|451250793|FG004|Overall Study|Withdrawal by Subject|0|||
125443059|NCT03824938|451250794|FG005|Overall Study|Withdrawal by Subject|1|||
125443060|NCT03824938|451250789|FG000|Overall Study|Lost to Follow-up|0|||
125443061|NCT03824938|451250790|FG001|Overall Study|Lost to Follow-up|1|||
125443062|NCT03824938|451250791|FG002|Overall Study|Lost to Follow-up|0|||
125443063|NCT03824938|451250792|FG003|Overall Study|Lost to Follow-up|0|||
125443064|NCT03824938|451250793|FG004|Overall Study|Lost to Follow-up|1|||
125443065|NCT03824938|451250794|FG005|Overall Study|Lost to Follow-up|0|||
125443066|NCT02204293|451250798|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
125227290|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Death|0|||
125167577|NCT00229723|450237540|FG005|Concomitant Phase|Severe non-compliance|0|||
125167578|NCT00229723|450237541|FG006|Concomitant Phase|Severe non-compliance|0|||
125167579|NCT00229723|450237535|FG000|Concomitant Phase|Other|3|||
125167580|NCT00229723|450237536|FG001|Concomitant Phase|Other|0|||
125167581|NCT00229723|450237537|FG002|Concomitant Phase|Other|1|||
125167582|NCT00229723|450237538|FG003|Concomitant Phase|Other|1|||
125167583|NCT00229723|450237539|FG004|Concomitant Phase|Other|0|||
125167584|NCT00229723|450237540|FG005|Concomitant Phase|Other|2|||
125167585|NCT00229723|450237541|FG006|Concomitant Phase|Other|0|||
125167586|NCT00229723|450237535|FG000|Maintenance Phase|Adverse Event|7|||
125167587|NCT00229723|450237536|FG001|Maintenance Phase|Adverse Event|2|||
125167588|NCT00229723|450237537|FG002|Maintenance Phase|Adverse Event|1|||
125167589|NCT00229723|450237538|FG003|Maintenance Phase|Adverse Event|4|||
125167590|NCT00229723|450237539|FG004|Maintenance Phase|Adverse Event|7|||
125167591|NCT00229723|450237540|FG005|Maintenance Phase|Adverse Event|5|||
125167592|NCT00229723|450237541|FG006|Maintenance Phase|Adverse Event|2|||
125167593|NCT00229723|450237535|FG000|Maintenance Phase|Objective disease progression|5|||
125167594|NCT00229723|450237536|FG001|Maintenance Phase|Objective disease progression|5|||
125167595|NCT00229723|450237537|FG002|Maintenance Phase|Objective disease progression|3|||
125167596|NCT00229723|450237538|FG003|Maintenance Phase|Objective disease progression|6|||
125167597|NCT00229723|450237539|FG004|Maintenance Phase|Objective disease progression|2|||
125167598|NCT00229723|450237540|FG005|Maintenance Phase|Objective disease progression|9|||
125167599|NCT00229723|450237541|FG006|Maintenance Phase|Objective disease progression|5|||
125167600|NCT00229723|450237535|FG000|Maintenance Phase|Clinical progression|4|||
125167601|NCT00229723|450237536|FG001|Maintenance Phase|Clinical progression|1|||
125167602|NCT00229723|450237537|FG002|Maintenance Phase|Clinical progression|2|||
125167603|NCT00229723|450237538|FG003|Maintenance Phase|Clinical progression|2|||
125167604|NCT00229723|450237539|FG004|Maintenance Phase|Clinical progression|1|||
125167605|NCT00229723|450237540|FG005|Maintenance Phase|Clinical progression|1|||
125167606|NCT00229723|450237541|FG006|Maintenance Phase|Clinical progression|1|||
125167607|NCT00229723|450237535|FG000|Maintenance Phase|Lost to Follow-up|0|||
125167608|NCT00229723|450237536|FG001|Maintenance Phase|Lost to Follow-up|1|||
125167609|NCT00229723|450237537|FG002|Maintenance Phase|Lost to Follow-up|2|||
125167610|NCT00229723|450237538|FG003|Maintenance Phase|Lost to Follow-up|2|||
125167611|NCT00229723|450237539|FG004|Maintenance Phase|Lost to Follow-up|0|||
125167612|NCT00229723|450237540|FG005|Maintenance Phase|Lost to Follow-up|0|||
125167613|NCT00229723|450237541|FG006|Maintenance Phase|Lost to Follow-up|1|||
125167614|NCT00229723|450237535|FG000|Maintenance Phase|Informed consent withdrawn|1|||
125167615|NCT00229723|450237536|FG001|Maintenance Phase|Informed consent withdrawn|0|||
125167616|NCT00229723|450237537|FG002|Maintenance Phase|Informed consent withdrawn|0|||
125167617|NCT00229723|450237538|FG003|Maintenance Phase|Informed consent withdrawn|1|||
125167618|NCT00229723|450237539|FG004|Maintenance Phase|Informed consent withdrawn|1|||
125167619|NCT00229723|450237540|FG005|Maintenance Phase|Informed consent withdrawn|1|||
125167620|NCT00229723|450237541|FG006|Maintenance Phase|Informed consent withdrawn|0|||
125167621|NCT00229723|450237535|FG000|Maintenance Phase|Severe non-compliance|3|||
125167622|NCT00229723|450237536|FG001|Maintenance Phase|Severe non-compliance|1|||
125167623|NCT00229723|450237537|FG002|Maintenance Phase|Severe non-compliance|0|||
125167624|NCT00229723|450237538|FG003|Maintenance Phase|Severe non-compliance|0|||
125167625|NCT00229723|450237539|FG004|Maintenance Phase|Severe non-compliance|1|||
125167626|NCT00229723|450237540|FG005|Maintenance Phase|Severe non-compliance|0|||
125167627|NCT00229723|450237541|FG006|Maintenance Phase|Severe non-compliance|0|||
125167628|NCT00229723|450237535|FG000|Maintenance Phase|Other|5|||
125167629|NCT00229723|450237536|FG001|Maintenance Phase|Other|4|||
125167630|NCT00229723|450237537|FG002|Maintenance Phase|Other|1|||
125167631|NCT00229723|450237538|FG003|Maintenance Phase|Other|2|||
125167632|NCT00229723|450237539|FG004|Maintenance Phase|Other|3|||
125167633|NCT00229723|450237540|FG005|Maintenance Phase|Other|3|||
125167634|NCT00229723|450237541|FG006|Maintenance Phase|Other|1|||
125167635|NCT03421730|450237549|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167636|NCT03421730|450237550|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
125167637|NCT03421730|450237551|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167638|NCT03421730|450237552|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167639|NCT03421730|450237553|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167640|NCT03421730|450237554|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167641|NCT03421730|450237555|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167642|NCT03421730|450237556|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167643|NCT03421730|450237557|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167644|NCT03421730|450237558|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167645|NCT03421730|450237559|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167646|NCT03421730|450237560|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
125167647|NCT03421730|450237549|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167648|NCT03421730|450237550|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125227291|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Death|0|||
125227292|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
125227293|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
125227294|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
125227295|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
125227296|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
125227297|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
125227298|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
125227299|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
125227300|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
125227301|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
125227302|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
125227303|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
125227304|NCT02513550|450460221|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
125227305|NCT02513550|450460222|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
125227306|NCT02513550|450460223|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
125227307|NCT02513550|450460224|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
125227308|NCT02513550|450460225|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
125227309|NCT02513550|450460226|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
125227310|NCT02204917|450460228|FG000|Overall Study|Protocol Violation|1|||
125227311|NCT00749398|450460229|FG000|Overall Study|Lack of Efficacy|7|||
125227312|NCT00749398|450460229|FG000|Overall Study|Adverse Event|4|||
125227313|NCT00749398|450460229|FG000|Overall Study|Serious adverse event|11|||
125227314|NCT00749398|450460229|FG000|Overall Study|Withdrawal by Subject|17|||
125227315|NCT00749398|450460229|FG000|Overall Study|Lost to Follow-up|11|||
125227316|NCT00749398|450460229|FG000|Overall Study|Reason not specified|2|||
125227317|NCT00749398|450460229|FG000|Overall Study|Unknown reason|1|||
125227318|NCT02277028|450460233|FG000|Overall Study|Lost to Follow-up|1|||
125227319|NCT02277028|450460234|FG001|Overall Study|Lost to Follow-up|0|||
125227320|NCT02277028|450460233|FG000|Overall Study|Withdrawal by Subject|0|||
125227321|NCT02277028|450460234|FG001|Overall Study|Withdrawal by Subject|1|||
125227322|NCT05002972|450460235|FG000|Overall Study|Withdrawal by Subject|2|||
125227323|NCT02370511|450460239|FG000|Overall Study|Death|10|||
125227324|NCT02370511|450460240|FG001|Overall Study|Death|7|||
125227325|NCT02370511|450460241|FG002|Overall Study|Death|1|||
125227326|NCT02370511|450460239|FG000|Overall Study|Withdrawal by Subject|2|||
125227327|NCT02370511|450460240|FG001|Overall Study|Withdrawal by Subject|0|||
125227328|NCT02370511|450460241|FG002|Overall Study|Withdrawal by Subject|0|||
125227329|NCT02370511|450460239|FG000|Overall Study|Lost to Follow-up|0|||
125227330|NCT02370511|450460240|FG001|Overall Study|Lost to Follow-up|4|||
125227331|NCT02370511|450460241|FG002|Overall Study|Lost to Follow-up|0|||
125227332|NCT03882918|450460245|FG000|Overall Study|Study terminated by sponsor|98|||
125227333|NCT03882918|450460245|FG000|Overall Study|Protocol Violation|1|||
125227334|NCT03882918|450460245|FG000|Overall Study|Other|9|||
125227335|NCT03882918|450460245|FG000|Overall Study|Lack of Efficacy|14|||
125227336|NCT03882918|450460245|FG000|Overall Study|Adverse Event|13|||
125227337|NCT03882918|450460245|FG000|Overall Study|Withdrawal by Subject|5|||
125227338|NCT04350827|450460250|FG000|Overall Study|Lost to Follow-up|1|||
125227339|NCT04350827|450460251|FG001|Overall Study|Lost to Follow-up|2|||
125303063|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303064|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303065|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
125303066|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
125303067|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303068|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303069|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303070|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303071|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303072|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
125303073|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125303074|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
125303075|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
125303076|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125303077|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125443067|NCT02204293|451250799|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
125303078|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125443068|NCT02204293|451250800|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
125443069|NCT02204293|451250801|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
125443070|NCT02204293|451250802|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
125443071|NCT02204293|451250803|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
125227340|NCT02357459|450462054|FG000|Overall Study|Adverse Event|0|||
125227341|NCT02357459|450462055|FG001|Overall Study|Adverse Event|1|||
125227342|NCT02357459|450462056|FG002|Overall Study|Adverse Event|1|||
125227343|NCT02357459|450462054|FG000|Overall Study|Withdrawal by Subject|5|||
125227344|NCT02357459|450462055|FG001|Overall Study|Withdrawal by Subject|3|||
125227345|NCT02357459|450462056|FG002|Overall Study|Withdrawal by Subject|3|||
125227346|NCT02357459|450462054|FG000|Overall Study|Physician Decision|0|||
125227347|NCT02357459|450462055|FG001|Overall Study|Physician Decision|2|||
125227348|NCT02357459|450462056|FG002|Overall Study|Physician Decision|0|||
125227349|NCT02357459|450462054|FG000|Overall Study|Protocol Violation|1|||
125227350|NCT02357459|450462055|FG001|Overall Study|Protocol Violation|1|||
125227351|NCT02357459|450462056|FG002|Overall Study|Protocol Violation|0|||
125227352|NCT02357459|450462054|FG000|Overall Study|Lost to Follow-up|1|||
125227353|NCT02357459|450462055|FG001|Overall Study|Lost to Follow-up|3|||
125227354|NCT02357459|450462056|FG002|Overall Study|Lost to Follow-up|0|||
125227355|NCT02357459|450462054|FG000|Overall Study|Lack of Efficacy|7|||
125227356|NCT02357459|450462055|FG001|Overall Study|Lack of Efficacy|4|||
125227357|NCT02357459|450462056|FG002|Overall Study|Lack of Efficacy|4|||
125227358|NCT02357459|450462054|FG000|Overall Study|Patient Relocated|2|||
125227359|NCT02357459|450462055|FG001|Overall Study|Patient Relocated|0|||
125227360|NCT02357459|450462056|FG002|Overall Study|Patient Relocated|0|||
125227361|NCT02357459|450462054|FG000|Overall Study|Instruction from PCP|1|||
125227362|NCT02357459|450462055|FG001|Overall Study|Instruction from PCP|0|||
125227363|NCT02357459|450462056|FG002|Overall Study|Instruction from PCP|0|||
125227364|NCT02357459|450462054|FG000|Overall Study|Incarceration|0|||
125227365|NCT02357459|450462055|FG001|Overall Study|Incarceration|0|||
125227366|NCT02357459|450462056|FG002|Overall Study|Incarceration|1|||
125227367|NCT02357459|450462054|FG000|Overall Study|Pre-planned Knee surgery|0|||
125227368|NCT02357459|450462055|FG001|Overall Study|Pre-planned Knee surgery|0|||
125227369|NCT02357459|450462056|FG002|Overall Study|Pre-planned Knee surgery|2|||
125227370|NCT02357459|450462054|FG000|Overall Study|Job Commitments|0|||
125227371|NCT02357459|450462055|FG001|Overall Study|Job Commitments|0|||
125227372|NCT02357459|450462056|FG002|Overall Study|Job Commitments|1|||
125227373|NCT02188160|450462057|FG000|Overall Study|Adverse Event|1|||
125227374|NCT02188160|450462058|FG001|Overall Study|Adverse Event|0|||
125227375|NCT02188160|450462057|FG000|Overall Study|Use of an excluded medication|0|||
125227376|NCT02188160|450462058|FG001|Overall Study|Use of an excluded medication|1|||
125227377|NCT01655901|450462061|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
125227378|NCT01655901|450462062|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
125227379|NCT01655901|450462063|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
125227380|NCT01655901|450462064|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
125227381|NCT01655901|450462065|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
125227382|NCT01655901|450462066|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
125227383|NCT03256578|450462069|FG000|Overall Study|Excluded Post Randomization|66|||
125227384|NCT03256578|450462070|FG001|Overall Study|Excluded Post Randomization|56|||
125227385|NCT02371616|450462071|FG000|Overall Study|Protocol Violation|2|||
125227386|NCT02371616|450462072|FG001|Overall Study|Protocol Violation|1|||
125227387|NCT02371616|450462071|FG000|Overall Study|Adverse Event|0|||
125227388|NCT02371616|450462072|FG001|Overall Study|Adverse Event|1|||
125227389|NCT02371616|450462071|FG000|Overall Study|Withdrawal of Consent|1|||
125227390|NCT02371616|450462072|FG001|Overall Study|Withdrawal of Consent|0|||
125227391|NCT02371616|450462071|FG000|Overall Study|Other (Not specified)|1|||
125227392|NCT02371616|450462072|FG001|Overall Study|Other (Not specified)|5|||
125227393|NCT00754741|450462073|FG000|Overall Study|Died or disenrolled|57|||
125227394|NCT00754741|450462074|FG001|Overall Study|Died or disenrolled|69|||
125227395|NCT00754741|450462075|FG002|Overall Study|Died or disenrolled|54|||
125227396|NCT00922636|450462076|FG000|Overall Study|Adverse Event|3|||
125227397|NCT00922636|450462077|FG001|Overall Study|Adverse Event|3|||
125227398|NCT00922636|450462078|FG002|Overall Study|Adverse Event|2|||
125227399|NCT00922636|450462079|FG003|Overall Study|Adverse Event|3|||
125227400|NCT00922636|450462080|FG004|Overall Study|Adverse Event|2|||
125227401|NCT00922636|450462076|FG000|Overall Study|Lack of Efficacy|1|||
125227402|NCT00922636|450462077|FG001|Overall Study|Lack of Efficacy|7|||
125227403|NCT00922636|450462078|FG002|Overall Study|Lack of Efficacy|3|||
125227404|NCT00922636|450462079|FG003|Overall Study|Lack of Efficacy|2|||
125227405|NCT00922636|450462080|FG004|Overall Study|Lack of Efficacy|4|||
125227406|NCT00922636|450462076|FG000|Overall Study|Sponsor Decision|0|||
125227407|NCT00922636|450462077|FG001|Overall Study|Sponsor Decision|0|||
125227408|NCT00922636|450462078|FG002|Overall Study|Sponsor Decision|2|||
125227409|NCT00922636|450462079|FG003|Overall Study|Sponsor Decision|0|||
125227410|NCT00922636|450462080|FG004|Overall Study|Sponsor Decision|0|||
125227411|NCT00922636|450462076|FG000|Overall Study|Withdrawal by Subject|0|||
125227412|NCT00922636|450462077|FG001|Overall Study|Withdrawal by Subject|0|||
125227413|NCT00922636|450462078|FG002|Overall Study|Withdrawal by Subject|5|||
125227414|NCT00922636|450462079|FG003|Overall Study|Withdrawal by Subject|2|||
125227415|NCT00922636|450462080|FG004|Overall Study|Withdrawal by Subject|4|||
125227416|NCT00922636|450462076|FG000|Overall Study|Protocol Violation|0|||
125227417|NCT00922636|450462077|FG001|Overall Study|Protocol Violation|0|||
125167649|NCT03421730|450237551|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167650|NCT03421730|450237552|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167651|NCT03421730|450237553|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
125167652|NCT03421730|450237554|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167653|NCT03421730|450237555|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167654|NCT03421730|450237556|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167655|NCT03421730|450237557|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167656|NCT03421730|450237558|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167657|NCT03421730|450237559|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167658|NCT03421730|450237560|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
125167659|NCT03016975|450237567|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
125167660|NCT03016975|450237568|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
125167661|NCT03016975|450237569|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
125167662|NCT03016975|450237567|FG000|At 6 Months Follow-up|Death|2|||
125167663|NCT03016975|450237568|FG001|At 6 Months Follow-up|Death|0|||
125167664|NCT03016975|450237569|FG002|At 6 Months Follow-up|Death|0|||
125167665|NCT03016975|450237567|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
125167666|NCT03016975|450237568|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
125167667|NCT03016975|450237569|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
125167668|NCT03016975|450237567|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
125167669|NCT03016975|450237568|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
125167670|NCT03016975|450237569|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
125167671|NCT03016975|450237567|FG000|At 6 Months Follow-up|Aborted implant|1|||
125167672|NCT03016975|450237568|FG001|At 6 Months Follow-up|Aborted implant|0|||
125167673|NCT03016975|450237569|FG002|At 6 Months Follow-up|Aborted implant|0|||
125167674|NCT03016975|450237567|FG000|At 2 Year Follow-up|Death|1|||
125167675|NCT03016975|450237568|FG001|At 2 Year Follow-up|Death|0|||
125167676|NCT03016975|450237569|FG002|At 2 Year Follow-up|Death|0|||
125167677|NCT03016975|450237567|FG000|At 3 Year Follow-up|Death|1|||
125167678|NCT03016975|450237568|FG001|At 3 Year Follow-up|Death|0|||
125167679|NCT03016975|450237569|FG002|At 3 Year Follow-up|Death|0|||
125167680|NCT03016975|450237567|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
125167681|NCT03016975|450237568|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
125167682|NCT03016975|450237569|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
125167683|NCT03016975|450237567|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
125167684|NCT03016975|450237568|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
125167685|NCT03016975|450237569|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
125167686|NCT01590797|450237570|FG000|Overall Study|Adverse Event|4|||
125167687|NCT01590797|450237571|FG001|Overall Study|Adverse Event|3|||
125167688|NCT01590797|450237570|FG000|Overall Study|Lack of Efficacy|0|||
125167689|NCT01590797|450237571|FG001|Overall Study|Lack of Efficacy|2|||
125167690|NCT01590797|450237570|FG000|Overall Study|Lost to Follow-up|0|||
125167691|NCT01590797|450237571|FG001|Overall Study|Lost to Follow-up|1|||
125167692|NCT01590797|450237570|FG000|Overall Study|Protocol Violation|4|||
125167693|NCT01590797|450237571|FG001|Overall Study|Protocol Violation|1|||
125167694|NCT01590797|450237570|FG000|Overall Study|Withdrawal by Subject|7|||
125167695|NCT01590797|450237571|FG001|Overall Study|Withdrawal by Subject|5|||
125167696|NCT01590797|450237570|FG000|Overall Study|Other Protocol Specified Criteria|2|||
125167697|NCT01590797|450237571|FG001|Overall Study|Other Protocol Specified Criteria|4|||
125167698|NCT02901548|450237572|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
125167699|NCT01696279|450237578|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
125167700|NCT01696279|450237579|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
125167701|NCT01696279|450237580|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
125167702|NCT01696279|450237581|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
125167703|NCT01696279|450237578|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
125167704|NCT01696279|450237579|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
125167705|NCT01696279|450237580|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
125167706|NCT01696279|450237581|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
125167707|NCT01696279|450237578|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
125167708|NCT01696279|450237579|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
125167709|NCT01696279|450237580|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
125167710|NCT01696279|450237581|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
125167711|NCT01696279|450237578|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
125167712|NCT01696279|450237579|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
125167713|NCT01696279|450237580|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
125167714|NCT01696279|450237581|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
125167715|NCT01696279|450237578|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
125167716|NCT01696279|450237579|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
125167717|NCT01696279|450237580|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
125227418|NCT00922636|450462078|FG002|Overall Study|Protocol Violation|2|||
125227419|NCT00922636|450462079|FG003|Overall Study|Protocol Violation|2|||
125227420|NCT00922636|450462080|FG004|Overall Study|Protocol Violation|0|||
125227421|NCT00922636|450462076|FG000|Overall Study|Entry Criteria Not Met|0|||
125227422|NCT00922636|450462077|FG001|Overall Study|Entry Criteria Not Met|0|||
125227423|NCT00922636|450462078|FG002|Overall Study|Entry Criteria Not Met|1|||
125227424|NCT00922636|450462079|FG003|Overall Study|Entry Criteria Not Met|1|||
125227425|NCT00922636|450462080|FG004|Overall Study|Entry Criteria Not Met|0|||
125227426|NCT00922636|450462076|FG000|Overall Study|Parent/Caregiver Decision|2|||
125227427|NCT00922636|450462077|FG001|Overall Study|Parent/Caregiver Decision|4|||
125227428|NCT00922636|450462078|FG002|Overall Study|Parent/Caregiver Decision|3|||
125227429|NCT00922636|450462079|FG003|Overall Study|Parent/Caregiver Decision|5|||
125227430|NCT00922636|450462080|FG004|Overall Study|Parent/Caregiver Decision|2|||
125227431|NCT00922636|450462076|FG000|Overall Study|Lost to Follow-up|1|||
125227432|NCT00922636|450462077|FG001|Overall Study|Lost to Follow-up|2|||
125227433|NCT00922636|450462078|FG002|Overall Study|Lost to Follow-up|2|||
125227434|NCT00922636|450462079|FG003|Overall Study|Lost to Follow-up|2|||
125227435|NCT00922636|450462080|FG004|Overall Study|Lost to Follow-up|4|||
125227436|NCT01251952|450462081|FG000|Overall Study|Adverse Event|1|||
125227437|NCT03028142|450462082|FG000|Overall Study|Adverse Event|1|||
125227438|NCT03028142|450462083|FG001|Overall Study|Adverse Event|1|||
125227439|NCT03028142|450462084|FG002|Overall Study|Adverse Event|0|||
125227440|NCT03028142|450462085|FG003|Overall Study|Adverse Event|0|||
125227441|NCT03028142|450462086|FG004|Overall Study|Adverse Event|0|||
125227442|NCT03028142|450462087|FG005|Overall Study|Adverse Event|1|||
125227443|NCT03028142|450462082|FG000|Overall Study|Withdrawal by Subject|0|||
125227444|NCT03028142|450462083|FG001|Overall Study|Withdrawal by Subject|0|||
125227445|NCT03028142|450462084|FG002|Overall Study|Withdrawal by Subject|0|||
125227446|NCT03028142|450462085|FG003|Overall Study|Withdrawal by Subject|0|||
125227447|NCT03028142|450462086|FG004|Overall Study|Withdrawal by Subject|1|||
125227448|NCT03028142|450462087|FG005|Overall Study|Withdrawal by Subject|0|||
125227449|NCT02810418|450462088|FG000|Arm A Dose Escalation|Adverse Event|2|||
125227450|NCT02810418|450462089|FG001|Arm A Dose Escalation|Adverse Event|1|||
125227451|NCT02810418|450462090|FG002|Arm A Dose Escalation|Adverse Event|0|||
125227452|NCT02810418|450462091|FG003|Arm A Dose Escalation|Adverse Event|0|||
125227453|NCT02810418|450462092|FG004|Arm A Dose Escalation|Adverse Event|0|||
125227454|NCT02810418|450462093|FG005|Arm A Dose Escalation|Adverse Event|0|||
125227455|NCT02810418|450462094|FG006|Arm A Dose Escalation|Adverse Event|0|||
125227456|NCT02810418|450462088|FG000|Dose Expansion|Adverse Event|0|||
125227457|NCT02810418|450462089|FG001|Dose Expansion|Adverse Event|1|||
125227458|NCT02810418|450462090|FG002|Dose Expansion|Adverse Event|1|||
125227459|NCT02810418|450462091|FG003|Dose Expansion|Adverse Event|0|||
125227460|NCT02810418|450462092|FG004|Dose Expansion|Adverse Event|0|||
125227461|NCT02810418|450462093|FG005|Dose Expansion|Adverse Event|0|||
125227462|NCT02810418|450462094|FG006|Dose Expansion|Adverse Event|0|||
125227463|NCT02810418|450462088|FG000|Dose Expansion|Physician Decision|0|||
125227464|NCT02810418|450462089|FG001|Dose Expansion|Physician Decision|0|||
125227465|NCT02810418|450462090|FG002|Dose Expansion|Physician Decision|2|||
125227466|NCT02810418|450462091|FG003|Dose Expansion|Physician Decision|0|||
125227467|NCT02810418|450462092|FG004|Dose Expansion|Physician Decision|0|||
125227468|NCT02810418|450462093|FG005|Dose Expansion|Physician Decision|0|||
125227469|NCT02810418|450462094|FG006|Dose Expansion|Physician Decision|0|||
125227470|NCT02810418|450462088|FG000|Arm B Dose Escalation|Adverse Event|0|||
125227471|NCT02810418|450462089|FG001|Arm B Dose Escalation|Adverse Event|0|||
125227472|NCT02810418|450462090|FG002|Arm B Dose Escalation|Adverse Event|0|||
125227473|NCT02810418|450462091|FG003|Arm B Dose Escalation|Adverse Event|0|||
125227474|NCT02810418|450462092|FG004|Arm B Dose Escalation|Adverse Event|1|||
125227475|NCT02810418|450462093|FG005|Arm B Dose Escalation|Adverse Event|2|||
125227476|NCT02810418|450462094|FG006|Arm B Dose Escalation|Adverse Event|0|||
125167718|NCT01696279|450237581|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
125167719|NCT01696279|450237578|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
125167720|NCT01696279|450237579|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
125167721|NCT01696279|450237580|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
125167722|NCT01696279|450237581|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
125167723|NCT01696279|450237578|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
125167724|NCT01696279|450237579|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
125167725|NCT01696279|450237580|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
125227477|NCT02224625|450462095|FG000|Irritation|Adverse Event|6|||
125227478|NCT02224625|450462095|FG000|Sensitization|Adverse Event|55|||
125443072|NCT02204293|451250798|FG000|Core Study Part I|Adverse Event|1|||
125227479|NCT01573000|450462098|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
125227480|NCT01573000|450462099|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
125227481|NCT01573000|450462098|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
125227482|NCT01573000|450462099|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
125227483|NCT01573000|450462098|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
125227484|NCT01573000|450462099|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
125392248|NCT00380393|451070610|FG001|Month 14|Migrated/moved from study area|42|||
125167726|NCT01696279|450237581|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
125167727|NCT01696279|450237578|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
125167728|NCT01696279|450237579|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
125167729|NCT01696279|450237580|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
125167730|NCT01696279|450237581|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
125167731|NCT01696279|450237578|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
125167732|NCT01696279|450237579|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
125167733|NCT01696279|450237580|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
125167734|NCT01696279|450237581|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
125167735|NCT01696279|450237578|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
125167736|NCT01696279|450237579|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
125167737|NCT01696279|450237580|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
125167738|NCT01696279|450237581|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
125167739|NCT01696279|450237578|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
125167740|NCT01696279|450237579|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
125167741|NCT01696279|450237580|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
125167742|NCT01696279|450237581|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
125167743|NCT04106661|450237586|FG000|Overall Study|Protocol Violation|3|||
125167744|NCT04106661|450237587|FG001|Overall Study|Protocol Violation|0|||
125167745|NCT04106661|450237586|FG000|Overall Study|Scheduling difficulties|1|||
125167746|NCT04106661|450237587|FG001|Overall Study|Scheduling difficulties|1|||
125167747|NCT03503864|450237588|FG000|Overall Study|Protocol Violation|6|||
125167748|NCT03503864|450237588|FG000|Overall Study|Withdrawal by Subject|7|||
125167749|NCT02639052|450237590|FG000|Overall Study|Lost to Follow-up|1|||
125167750|NCT02730351|450237591|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
125167751|NCT02730351|450237592|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
125167752|NCT02730351|450237591|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
125167753|NCT02730351|450237592|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
125167754|NCT02730351|450237591|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
125167755|NCT02730351|450237592|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
125167756|NCT02730351|450237591|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
125167757|NCT02730351|450237592|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
125167758|NCT02730351|450237591|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
125167759|NCT02730351|450237592|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
125167760|NCT00838435|450237593|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
125167761|NCT00838435|450237593|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
125167762|NCT00838435|450237593|FG000|Part 2 (7 Years)|Adverse Event|2|||
125167763|NCT00838435|450237593|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
125167764|NCT00838435|450237593|FG000|Part 2 (7 Years)|Physician Decision|1|||
125167765|NCT00838435|450237593|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
125167766|NCT00838435|450237593|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
125167767|NCT03796039|450237595|FG000|Overall Study|Death|2|||
125167768|NCT03796039|450237596|FG001|Overall Study|Death|1|||
125167769|NCT03796039|450237595|FG000|Overall Study|Withdrawal by Subject|7|||
125167770|NCT03796039|450237596|FG001|Overall Study|Withdrawal by Subject|4|||
125167771|NCT00530218|450237597|FG000|Overall Study|CMV Not Detected|13|||
125167772|NCT00530218|450237597|FG000|Overall Study|Death|12|||
125167773|NCT02774642|450237600|FG000|Overall Study|Lost to Follow-up|9|||
125167774|NCT02774642|450237601|FG001|Overall Study|Lost to Follow-up|7|||
125167775|NCT01144715|450237602|FG000|Overall Study|Lost to Follow-up|2|||
125167776|NCT01144715|450237603|FG001|Overall Study|Lost to Follow-up|1|||
125167777|NCT01144715|450237602|FG000|Overall Study|Withdrawal by Subject|2|||
125167778|NCT01144715|450237603|FG001|Overall Study|Withdrawal by Subject|1|||
125167779|NCT01144715|450237602|FG000|Overall Study|Adverse Event|0|||
125167780|NCT01144715|450237603|FG001|Overall Study|Adverse Event|1|||
125167781|NCT02011386|450237604|FG000|Overall Study|Non-compliance|2|||
125167782|NCT02011386|450237604|FG000|Overall Study|Lack of Efficacy|3|||
125167783|NCT03255655|450237605|FG000|Overall Study|Lost to Follow-up|7|||
125167784|NCT03255655|450237606|FG001|Overall Study|Lost to Follow-up|4|||
125167785|NCT03365011|450237607|FG000|Overall Study|Withdrawal by Subject|1|||
125167786|NCT03365011|450237608|FG001|Overall Study|Withdrawal by Subject|2|||
125167787|NCT04853992|450237609|FG000|Treatment Period A|Adverse Event|0|||
125167788|NCT04853992|450237610|FG001|Treatment Period A|Adverse Event|1|||
125167789|NCT04853992|450237609|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
125167790|NCT04853992|450237610|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
125167791|NCT03582826|450237611|FG000|Overall Study|Lost to Follow-up|39|||
125167792|NCT03582826|450237612|FG001|Overall Study|Lost to Follow-up|0|||
125167793|NCT03582826|450237611|FG000|Overall Study|Withdrawal by Subject|2|||
125392249|NCT00380393|451070609|FG000|Month 14|Protocol Violation|2|||
125167794|NCT03582826|450237612|FG001|Overall Study|Withdrawal by Subject|0|||
125167795|NCT02099682|450237616|FG000|Overall Study|Data Not Available|51|||
125167796|NCT02099682|450237616|FG000|Overall Study|Lost to Follow-up|31|||
125443073|NCT02204293|451250799|FG001|Core Study Part I|Adverse Event|0|||
125443074|NCT02204293|451250800|FG002|Core Study Part I|Adverse Event|0|||
125443075|NCT02204293|451250801|FG003|Core Study Part I|Adverse Event|0|||
125443076|NCT02204293|451250802|FG004|Core Study Part I|Adverse Event|0|||
125443077|NCT02204293|451250803|FG005|Core Study Part I|Adverse Event|0|||
125443078|NCT02204293|451250798|FG000|Core Study Part I|Physician Decision|0|||
125443079|NCT02204293|451250799|FG001|Core Study Part I|Physician Decision|3|||
125443080|NCT02204293|451250800|FG002|Core Study Part I|Physician Decision|0|||
125443081|NCT02204293|451250801|FG003|Core Study Part I|Physician Decision|0|||
125443082|NCT02204293|451250802|FG004|Core Study Part I|Physician Decision|0|||
125443083|NCT02204293|451250803|FG005|Core Study Part I|Physician Decision|0|||
125443084|NCT02204293|451250798|FG000|LTE Phase|Study Suspended|0|||
125443085|NCT02204293|451250799|FG001|LTE Phase|Study Suspended|0|||
125443086|NCT02204293|451250800|FG002|LTE Phase|Study Suspended|0|||
125443087|NCT02204293|451250801|FG003|LTE Phase|Study Suspended|0|||
125443088|NCT02204293|451250802|FG004|LTE Phase|Study Suspended|0|||
125443089|NCT02204293|451250803|FG005|LTE Phase|Study Suspended|7|||
125443090|NCT02420327|451250804|FG000|Overall Study|Adverse Event|7|||
125443091|NCT02420327|451250804|FG000|Overall Study|Pregnancy|1|||
125443092|NCT02420327|451250804|FG000|Overall Study|Withdrawal by Subject|6|||
125443093|NCT02420327|451250804|FG000|Overall Study|Lost to Follow-up|1|||
125443094|NCT02420327|451250804|FG000|Overall Study|Protocol Violation|1|||
125443095|NCT02019602|451250806|FG000|Screening Period|Ineligibility|4|||
125443096|NCT02019602|451250807|FG001|Screening Period|Ineligibility|0|||
125443097|NCT02019602|451250806|FG000|Screening Period|Adverse Event|1|||
125443098|NCT02019602|451250807|FG001|Screening Period|Adverse Event|0|||
125443099|NCT00322374|451250808|FG000|Starting Dose|Physician Decision|2|||
125443100|NCT00322374|451250809|FG001|Starting Dose|Physician Decision|0|||
125443101|NCT00322374|451250810|FG002|Starting Dose|Physician Decision|0|||
125443102|NCT00322374|451250811|FG003|Starting Dose|Physician Decision|0|||
125443103|NCT00322374|451250808|FG000|Starting Dose|Study Drug Toxicity|4|||
125443104|NCT00322374|451250809|FG001|Starting Dose|Study Drug Toxicity|0|||
125443105|NCT00322374|451250810|FG002|Starting Dose|Study Drug Toxicity|0|||
125443106|NCT00322374|451250811|FG003|Starting Dose|Study Drug Toxicity|0|||
125443107|NCT00322374|451250808|FG000|First Escalation|Documented Disease Progression|0|||
125443108|NCT00322374|451250809|FG001|First Escalation|Documented Disease Progression|6|||
125443109|NCT00322374|451250810|FG002|First Escalation|Documented Disease Progression|0|||
125443110|NCT00322374|451250811|FG003|First Escalation|Documented Disease Progression|0|||
125443111|NCT00322374|451250808|FG000|First Escalation|Physician Decision|0|||
125443112|NCT00322374|451250809|FG001|First Escalation|Physician Decision|12|||
125443113|NCT00322374|451250810|FG002|First Escalation|Physician Decision|0|||
125443114|NCT00322374|451250811|FG003|First Escalation|Physician Decision|0|||
125443115|NCT00322374|451250808|FG000|First Escalation|Study Drug Toxicity|0|||
125443116|NCT00322374|451250809|FG001|First Escalation|Study Drug Toxicity|11|||
125443117|NCT00322374|451250810|FG002|First Escalation|Study Drug Toxicity|0|||
125443118|NCT00322374|451250811|FG003|First Escalation|Study Drug Toxicity|0|||
125443119|NCT00322374|451250808|FG000|First Escalation|Participant Request|0|||
125443120|NCT00322374|451250809|FG001|First Escalation|Participant Request|1|||
125443121|NCT00322374|451250810|FG002|First Escalation|Participant Request|0|||
125443122|NCT00322374|451250811|FG003|First Escalation|Participant Request|0|||
125443123|NCT00322374|451250808|FG000|Second Escalation|Physician Decision|0|||
125443124|NCT00322374|451250809|FG001|Second Escalation|Physician Decision|0|||
125443125|NCT00322374|451250810|FG002|Second Escalation|Physician Decision|5|||
125443126|NCT00322374|451250811|FG003|Second Escalation|Physician Decision|0|||
125443127|NCT00322374|451250808|FG000|Second Escalation|Study Drug Toxicity|0|||
125443128|NCT00322374|451250809|FG001|Second Escalation|Study Drug Toxicity|0|||
125443129|NCT00322374|451250810|FG002|Second Escalation|Study Drug Toxicity|1|||
125443130|NCT00322374|451250811|FG003|Second Escalation|Study Drug Toxicity|0|||
125443131|NCT02584855|451250816|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
125443132|NCT02584855|451250817|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
125443133|NCT02584855|451250818|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
125443134|NCT02584855|451250819|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
125443135|NCT02584855|451250820|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
125443136|NCT02584855|451250821|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
125443137|NCT02584855|451250816|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
125443138|NCT02584855|451250817|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
125443139|NCT02584855|451250818|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
125443140|NCT02584855|451250819|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
125443141|NCT02584855|451250820|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
125443142|NCT02584855|451250821|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
125443143|NCT02584855|451250816|FG000|Open-Label Treatment Period|Adverse Event|14|||
125443144|NCT02584855|451250817|FG001|Open-Label Treatment Period|Adverse Event|0|||
125443145|NCT02584855|451250818|FG002|Open-Label Treatment Period|Adverse Event|0|||
125443146|NCT02584855|451250819|FG003|Open-Label Treatment Period|Adverse Event|0|||
125443147|NCT02584855|451250820|FG004|Open-Label Treatment Period|Adverse Event|0|||
125443148|NCT02584855|451250821|FG005|Open-Label Treatment Period|Adverse Event|0|||
125443149|NCT02584855|451250816|FG000|Open-Label Treatment Period|Death|2|||
125227485|NCT01573000|450462098|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
125443150|NCT02584855|451250817|FG001|Open-Label Treatment Period|Death|0|||
125443151|NCT02584855|451250818|FG002|Open-Label Treatment Period|Death|0|||
125443152|NCT02584855|451250819|FG003|Open-Label Treatment Period|Death|0|||
125443153|NCT02584855|451250820|FG004|Open-Label Treatment Period|Death|0|||
125443154|NCT02584855|451250821|FG005|Open-Label Treatment Period|Death|0|||
125443155|NCT02584855|451250816|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
125443156|NCT02584855|451250817|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
125443157|NCT02584855|451250818|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
125443158|NCT02584855|451250819|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
125443159|NCT02584855|451250820|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
125443160|NCT02584855|451250821|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
125443161|NCT02584855|451250816|FG000|Open-Label Treatment Period|Protocol Violation|1|||
125443162|NCT02584855|451250817|FG001|Open-Label Treatment Period|Protocol Violation|0|||
125443163|NCT02584855|451250818|FG002|Open-Label Treatment Period|Protocol Violation|0|||
125443164|NCT02584855|451250819|FG003|Open-Label Treatment Period|Protocol Violation|0|||
125443165|NCT02584855|451250820|FG004|Open-Label Treatment Period|Protocol Violation|0|||
125443166|NCT02584855|451250821|FG005|Open-Label Treatment Period|Protocol Violation|0|||
125443167|NCT02584855|451250816|FG000|Open-Label Treatment Period|No PI Available|2|||
125443168|NCT02584855|451250817|FG001|Open-Label Treatment Period|No PI Available|0|||
125443169|NCT02584855|451250818|FG002|Open-Label Treatment Period|No PI Available|0|||
125443170|NCT02584855|451250819|FG003|Open-Label Treatment Period|No PI Available|0|||
125443171|NCT02584855|451250820|FG004|Open-Label Treatment Period|No PI Available|0|||
125443172|NCT02584855|451250821|FG005|Open-Label Treatment Period|No PI Available|0|||
125443173|NCT02584855|451250816|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
125443174|NCT02584855|451250817|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
125443175|NCT02584855|451250818|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
125443176|NCT02584855|451250819|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
125443177|NCT02584855|451250820|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
125443178|NCT02584855|451250821|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
125443179|NCT02584855|451250816|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
125167797|NCT02099682|450237616|FG000|Overall Study|Other|29|||
125167798|NCT02342639|450237617|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
125167799|NCT02342639|450237618|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
125167800|NCT02342639|450237617|FG000|Overall Study|Protocol Violation|0|||
125167801|NCT02342639|450237618|FG001|Overall Study|Protocol Violation|2|||
125167802|NCT02212379|450237619|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
125167803|NCT02212379|450237619|FG000|From Baseline to Week 48|Adverse Event|7|||
125167804|NCT02212379|450237619|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
125167805|NCT02212379|450237619|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
125167806|NCT02212379|450237619|FG000|From Week 48 to Week 96|Adverse Event|1|||
125167807|NCT02212379|450237619|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
125167808|NCT02105974|450237620|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
125167809|NCT02105974|450237621|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
125167810|NCT02105974|450237622|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
125167811|NCT02105974|450237620|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
125167812|NCT02105974|450237621|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
125167813|NCT02105974|450237622|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
125167814|NCT02105974|450237620|FG000|2 Week Run-in Period|Adverse Event|6|||
125167815|NCT02105974|450237621|FG001|2 Week Run-in Period|Adverse Event|0|||
125167816|NCT02105974|450237622|FG002|2 Week Run-in Period|Adverse Event|0|||
125167817|NCT02105974|450237620|FG000|2 Week Run-in Period|Study closed/terminated|1|||
125167818|NCT02105974|450237621|FG001|2 Week Run-in Period|Study closed/terminated|0|||
125167819|NCT02105974|450237622|FG002|2 Week Run-in Period|Study closed/terminated|0|||
125167820|NCT02105974|450237620|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
125167821|NCT02105974|450237621|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
125167822|NCT02105974|450237622|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
125167823|NCT02105974|450237620|FG000|2 Week Run-in Period|Withdrew consent|23|||
125167824|NCT02105974|450237621|FG001|2 Week Run-in Period|Withdrew consent|0|||
125167825|NCT02105974|450237622|FG002|2 Week Run-in Period|Withdrew consent|0|||
125167826|NCT02105974|450237620|FG000|2 Week Run-in Period|Investigator discretion|8|||
125227486|NCT01573000|450462099|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
125227487|NCT01573000|450462098|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
125443180|NCT02584855|451250817|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
125443181|NCT02584855|451250818|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
125443182|NCT02584855|451250819|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
125443183|NCT02584855|451250820|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
125167827|NCT02105974|450237621|FG001|2 Week Run-in Period|Investigator discretion|0|||
125167828|NCT02105974|450237622|FG002|2 Week Run-in Period|Investigator discretion|0|||
125167829|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
125167830|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
125167831|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
125167832|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
125167833|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
125167834|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
125167835|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
125167836|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
125167837|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
125167838|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
125167839|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
125167840|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
125167841|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
125167842|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
125167843|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
125167844|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
125167845|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
125167846|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
125167847|NCT02105974|450237620|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
125167848|NCT02105974|450237621|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
125167849|NCT02105974|450237622|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
125167850|NCT03155945|450237623|FG000|Overall Study|Lost to Follow-up|0|||
125167851|NCT03155945|450237624|FG001|Overall Study|Lost to Follow-up|1|||
125167852|NCT03155945|450237623|FG000|Overall Study|Withdrawal by Subject|0|||
125167853|NCT03155945|450237624|FG001|Overall Study|Withdrawal by Subject|1|||
125167854|NCT03155945|450237623|FG000|Overall Study|Other Reason|0|||
125167855|NCT03155945|450237624|FG001|Overall Study|Other Reason|1|||
125167856|NCT02203331|450237625|FG000|Overall Study|Pregnancy|1|||
125167857|NCT02203331|450237626|FG001|Overall Study|Pregnancy|0|||
125167858|NCT02203331|450237627|FG002|Overall Study|Pregnancy|0|||
125167859|NCT02203331|450237628|FG003|Overall Study|Pregnancy|0|||
125167860|NCT02203331|450237629|FG004|Overall Study|Pregnancy|2|||
125167861|NCT02203331|450237630|FG005|Overall Study|Pregnancy|0|||
125167862|NCT02203331|450237625|FG000|Overall Study|Withdrawal by Subject|1|||
125167863|NCT02203331|450237626|FG001|Overall Study|Withdrawal by Subject|0|||
125167864|NCT02203331|450237627|FG002|Overall Study|Withdrawal by Subject|1|||
125167865|NCT02203331|450237628|FG003|Overall Study|Withdrawal by Subject|0|||
125167866|NCT02203331|450237629|FG004|Overall Study|Withdrawal by Subject|0|||
125167867|NCT02203331|450237630|FG005|Overall Study|Withdrawal by Subject|3|||
125167868|NCT02203331|450237625|FG000|Overall Study|Adverse Event|4|||
125167869|NCT02203331|450237626|FG001|Overall Study|Adverse Event|8|||
125167870|NCT02203331|450237627|FG002|Overall Study|Adverse Event|3|||
125167871|NCT02203331|450237628|FG003|Overall Study|Adverse Event|4|||
125167872|NCT02203331|450237629|FG004|Overall Study|Adverse Event|3|||
125167873|NCT02203331|450237630|FG005|Overall Study|Adverse Event|3|||
125167874|NCT02203331|450237625|FG000|Overall Study|Other Reasons|1|||
125167875|NCT02203331|450237626|FG001|Overall Study|Other Reasons|2|||
125167876|NCT02203331|450237627|FG002|Overall Study|Other Reasons|0|||
125167877|NCT02203331|450237628|FG003|Overall Study|Other Reasons|2|||
125167878|NCT02203331|450237629|FG004|Overall Study|Other Reasons|0|||
125167879|NCT02203331|450237630|FG005|Overall Study|Other Reasons|0|||
125167880|NCT02203331|450237625|FG000|Overall Study|Lack of Efficacy|0|||
125167881|NCT02203331|450237626|FG001|Overall Study|Lack of Efficacy|2|||
125167882|NCT02203331|450237627|FG002|Overall Study|Lack of Efficacy|1|||
125167883|NCT02203331|450237628|FG003|Overall Study|Lack of Efficacy|0|||
125392250|NCT00380393|451070610|FG001|Month 14|Protocol Violation|0|||
125392251|NCT00380393|451070609|FG000|Month 14|Others|6|||
125392252|NCT00380393|451070610|FG001|Month 14|Others|6|||
125392253|NCT02780804|451070613|FG000|Overall Study|Death|1|||
125392254|NCT02780804|451070614|FG001|Overall Study|Death|0|||
125392255|NCT02780804|451070615|FG002|Overall Study|Death|0|||
125392256|NCT02780804|451070613|FG000|Overall Study|Lack of Efficacy|5|||
125392257|NCT02780804|451070614|FG001|Overall Study|Lack of Efficacy|8|||
125392258|NCT02780804|451070615|FG002|Overall Study|Lack of Efficacy|4|||
125392259|NCT02780804|451070613|FG000|Overall Study|Physician Decision|0|||
125392260|NCT02780804|451070614|FG001|Overall Study|Physician Decision|0|||
125392261|NCT02780804|451070615|FG002|Overall Study|Physician Decision|2|||
125392262|NCT02780804|451070613|FG000|Overall Study|Withdrawal by Subject|0|||
125392263|NCT02780804|451070614|FG001|Overall Study|Withdrawal by Subject|1|||
125392264|NCT02780804|451070615|FG002|Overall Study|Withdrawal by Subject|0|||
125392265|NCT02476968|451070616|FG000|Overall Study|Other|0|||
125167884|NCT02203331|450237629|FG004|Overall Study|Lack of Efficacy|0|||
125392266|NCT02476968|451070617|FG001|Overall Study|Other|2|||
125392267|NCT02476968|451070618|FG002|Overall Study|Other|0|||
125392268|NCT02476968|451070616|FG000|Overall Study|Lost to Follow-up|10|||
125392269|NCT02476968|451070617|FG001|Overall Study|Lost to Follow-up|0|||
125392270|NCT02476968|451070618|FG002|Overall Study|Lost to Follow-up|1|||
125392271|NCT02476968|451070616|FG000|Overall Study|Death|48|||
125227488|NCT01573000|450462099|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
125227489|NCT01573000|450462098|FG000|Crossover Phase|Lack of Efficacy|0|||
125227490|NCT01573000|450462099|FG001|Crossover Phase|Lack of Efficacy|13|||
125227491|NCT01573000|450462098|FG000|Crossover Phase|Lost to Follow-up|0|||
125227492|NCT01573000|450462099|FG001|Crossover Phase|Lost to Follow-up|2|||
125167885|NCT02203331|450237630|FG005|Overall Study|Lack of Efficacy|1|||
125227493|NCT01573000|450462098|FG000|Crossover Phase|Death|0|||
125167886|NCT02203331|450237625|FG000|Overall Study|Protocol Violation|0|||
125167887|NCT02203331|450237626|FG001|Overall Study|Protocol Violation|2|||
125167888|NCT02203331|450237627|FG002|Overall Study|Protocol Violation|0|||
125167889|NCT02203331|450237628|FG003|Overall Study|Protocol Violation|1|||
125167890|NCT02203331|450237629|FG004|Overall Study|Protocol Violation|1|||
125167891|NCT02203331|450237630|FG005|Overall Study|Protocol Violation|0|||
125167892|NCT02203331|450237625|FG000|Overall Study|Lost to Follow-up|0|||
125167893|NCT02203331|450237626|FG001|Overall Study|Lost to Follow-up|0|||
125167894|NCT02203331|450237627|FG002|Overall Study|Lost to Follow-up|0|||
125167895|NCT02203331|450237628|FG003|Overall Study|Lost to Follow-up|0|||
125167896|NCT02203331|450237629|FG004|Overall Study|Lost to Follow-up|1|||
125167897|NCT02203331|450237630|FG005|Overall Study|Lost to Follow-up|0|||
125167898|NCT05065567|450237636|FG000|Overall Study|Lost to Follow-up|10|||
125167899|NCT05065567|450237637|FG001|Overall Study|Lost to Follow-up|9|||
125167900|NCT05065567|450237638|FG002|Overall Study|Lost to Follow-up|6|||
125167901|NCT04975191|450238979|FG000|Overall Study|Protocol Violation|1|||
125167902|NCT04975191|450238980|FG001|Overall Study|Protocol Violation|2|||
125167903|NCT04975191|450238981|FG002|Overall Study|Protocol Violation|2|||
125167904|NCT04975191|450238982|FG003|Overall Study|Protocol Violation|2|||
125167905|NCT04975191|450238979|FG000|Overall Study|Lost to Follow-up|13|||
125167906|NCT04975191|450238980|FG001|Overall Study|Lost to Follow-up|3|||
125167907|NCT04975191|450238981|FG002|Overall Study|Lost to Follow-up|8|||
125167908|NCT04975191|450238982|FG003|Overall Study|Lost to Follow-up|8|||
125167909|NCT01056289|450238983|FG000|Open-label Phase|Adverse Event|29|||
125167910|NCT01056289|450238984|FG001|Open-label Phase|Adverse Event|0|||
125167911|NCT01056289|450238985|FG002|Open-label Phase|Adverse Event|0|||
125167912|NCT01056289|450238986|FG003|Open-label Phase|Adverse Event|0|||
125167913|NCT01056289|450238983|FG000|Open-label Phase|Lost to Follow-up|30|||
125167914|NCT01056289|450238984|FG001|Open-label Phase|Lost to Follow-up|0|||
125167915|NCT01056289|450238985|FG002|Open-label Phase|Lost to Follow-up|0|||
125167916|NCT01056289|450238986|FG003|Open-label Phase|Lost to Follow-up|0|||
125167917|NCT01056289|450238983|FG000|Open-label Phase|Other|9|||
125167918|NCT01056289|450238984|FG001|Open-label Phase|Other|0|||
125167919|NCT01056289|450238985|FG002|Open-label Phase|Other|0|||
125167920|NCT01056289|450238986|FG003|Open-label Phase|Other|0|||
125167921|NCT01056289|450238983|FG000|Open-label Phase|Protocol Violation|6|||
125167922|NCT01056289|450238984|FG001|Open-label Phase|Protocol Violation|0|||
125167923|NCT01056289|450238985|FG002|Open-label Phase|Protocol Violation|0|||
125167924|NCT01056289|450238986|FG003|Open-label Phase|Protocol Violation|0|||
125167925|NCT01056289|450238983|FG000|Open-label Phase|Withdrawal by Subject|26|||
125167926|NCT01056289|450238984|FG001|Open-label Phase|Withdrawal by Subject|0|||
125167927|NCT01056289|450238985|FG002|Open-label Phase|Withdrawal by Subject|0|||
125167928|NCT01056289|450238986|FG003|Open-label Phase|Withdrawal by Subject|0|||
125167929|NCT01056289|450238983|FG000|Open-label Phase|Lack of Efficacy|18|||
125167930|NCT01056289|450238984|FG001|Open-label Phase|Lack of Efficacy|0|||
125167931|NCT01056289|450238985|FG002|Open-label Phase|Lack of Efficacy|0|||
125167932|NCT01056289|450238986|FG003|Open-label Phase|Lack of Efficacy|0|||
125167933|NCT01056289|450238983|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
125167934|NCT01056289|450238984|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
125167935|NCT01056289|450238985|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
125167936|NCT01056289|450238986|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
125167937|NCT01056289|450238983|FG000|Double-blind Phase|Adverse Event|0|||
125167938|NCT01056289|450238984|FG001|Double-blind Phase|Adverse Event|1|||
125167939|NCT01056289|450238985|FG002|Double-blind Phase|Adverse Event|2|||
125167940|NCT01056289|450238986|FG003|Double-blind Phase|Adverse Event|1|||
125167941|NCT01056289|450238983|FG000|Double-blind Phase|Lost to Follow-up|0|||
125167942|NCT01056289|450238984|FG001|Double-blind Phase|Lost to Follow-up|2|||
125227494|NCT01573000|450462099|FG001|Crossover Phase|Death|3|||
125167943|NCT01056289|450238985|FG002|Double-blind Phase|Lost to Follow-up|2|||
125167944|NCT01056289|450238986|FG003|Double-blind Phase|Lost to Follow-up|2|||
125167945|NCT01056289|450238983|FG000|Double-blind Phase|Other|0|||
125167946|NCT01056289|450238984|FG001|Double-blind Phase|Other|0|||
125167947|NCT01056289|450238985|FG002|Double-blind Phase|Other|1|||
125167948|NCT01056289|450238986|FG003|Double-blind Phase|Other|2|||
125167949|NCT01056289|450238983|FG000|Double-blind Phase|Protocol Violation|0|||
125167950|NCT01056289|450238984|FG001|Double-blind Phase|Protocol Violation|0|||
125167951|NCT01056289|450238985|FG002|Double-blind Phase|Protocol Violation|1|||
125167952|NCT01056289|450238986|FG003|Double-blind Phase|Protocol Violation|1|||
125167953|NCT01056289|450238983|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125167954|NCT01056289|450238984|FG001|Double-blind Phase|Withdrawal by Subject|0|||
125167955|NCT01056289|450238985|FG002|Double-blind Phase|Withdrawal by Subject|4|||
125227495|NCT01573000|450462098|FG000|Long-Term Follow-Up|Death|3|||
125443184|NCT02584855|451250821|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
125443185|NCT02584855|451250816|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
125443186|NCT02584855|451250817|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
125443187|NCT02584855|451250818|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
125443188|NCT02584855|451250819|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
125443189|NCT02584855|451250820|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
125443190|NCT02584855|451250821|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
125443191|NCT02584855|451250816|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
125443192|NCT02584855|451250817|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
125443193|NCT02584855|451250818|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
125443194|NCT02584855|451250819|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
125443195|NCT02584855|451250820|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
125443196|NCT02584855|451250821|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
125443197|NCT02584855|451250816|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
125443198|NCT02584855|451250817|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
125443199|NCT02584855|451250818|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
125443200|NCT02584855|451250819|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
125443201|NCT02584855|451250820|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
125443202|NCT02584855|451250821|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
125443203|NCT02584855|451250816|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125443204|NCT02584855|451250817|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125443205|NCT02584855|451250818|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125443206|NCT02584855|451250819|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125443207|NCT02584855|451250820|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
125443208|NCT02584855|451250821|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
125443209|NCT02584855|451250816|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
125443210|NCT02584855|451250817|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
125443211|NCT02584855|451250818|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
125443212|NCT02584855|451250819|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
125443213|NCT02584855|451250820|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
125443214|NCT02584855|451250821|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
125443215|NCT02138747|451250822|FG000|Treatment Period 1|Adverse Event|10|||
125443216|NCT02138747|451250823|FG001|Treatment Period 1|Adverse Event|14|||
125227496|NCT01573000|450462099|FG001|Long-Term Follow-Up|Death|0|||
125443217|NCT02138747|451250824|FG002|Treatment Period 1|Adverse Event|2|||
125443218|NCT02138747|451250825|FG003|Treatment Period 1|Adverse Event|1|||
125443219|NCT02138747|451250822|FG000|Treatment Period 1|Lost to Follow-up|0|||
125167956|NCT01056289|450238986|FG003|Double-blind Phase|Withdrawal by Subject|2|||
125167957|NCT01056289|450238983|FG000|Double-blind Phase|Discontinuation symptom|0|||
125167958|NCT01056289|450238984|FG001|Double-blind Phase|Discontinuation symptom|1|||
125167959|NCT01056289|450238985|FG002|Double-blind Phase|Discontinuation symptom|2|||
125167960|NCT01056289|450238986|FG003|Double-blind Phase|Discontinuation symptom|2|||
125167961|NCT01056289|450238983|FG000|Double-blind Phase|Physician Decision|0|||
125167962|NCT01056289|450238984|FG001|Double-blind Phase|Physician Decision|0|||
125167963|NCT01056289|450238985|FG002|Double-blind Phase|Physician Decision|1|||
125167964|NCT01056289|450238986|FG003|Double-blind Phase|Physician Decision|0|||
125167965|NCT02618759|450238996|FG000|Overall Study|Lost to Follow-up|0|||
125167966|NCT02618759|450238997|FG001|Overall Study|Lost to Follow-up|1|||
125167967|NCT02618759|450238996|FG000|Overall Study|Withdrawal by Subject|1|||
125167968|NCT02618759|450238997|FG001|Overall Study|Withdrawal by Subject|0|||
125167969|NCT02618759|450238996|FG000|Overall Study|Other Reasons|1|||
125167970|NCT02618759|450238997|FG001|Overall Study|Other Reasons|4|||
125167971|NCT02856555|450239000|FG000|Overall Study|Adverse Event|1|||
125167972|NCT02856555|450239001|FG001|Overall Study|Adverse Event|0|||
125167973|NCT02856555|450239002|FG002|Overall Study|Adverse Event|0|||
125167974|NCT02856555|450239000|FG000|Overall Study|Lost to Follow-up|1|||
125167975|NCT02856555|450239001|FG001|Overall Study|Lost to Follow-up|3|||
125167976|NCT02856555|450239002|FG002|Overall Study|Lost to Follow-up|0|||
125167977|NCT02856555|450239000|FG000|Overall Study|Withdrawal by Subject|3|||
125167978|NCT02856555|450239001|FG001|Overall Study|Withdrawal by Subject|0|||
125167979|NCT02856555|450239002|FG002|Overall Study|Withdrawal by Subject|0|||
125167980|NCT02856555|450239000|FG000|Overall Study|Randomized but Never Treated|0|||
125167981|NCT02856555|450239001|FG001|Overall Study|Randomized but Never Treated|1|||
125167982|NCT02856555|450239002|FG002|Overall Study|Randomized but Never Treated|0|||
125167983|NCT03333941|450239003|FG000|Overall Study|Lost to Follow-up|10|||
125167984|NCT03333941|450239003|FG000|Overall Study|Death|2|||
125227497|NCT01573000|450462098|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
125167985|NCT03333941|450239003|FG000|Overall Study|Adverse Event|1|||
125167986|NCT03323437|450239008|FG000|Overall Study|Withdrawal by Subject|0|||
125167987|NCT03323437|450239009|FG001|Overall Study|Withdrawal by Subject|4|||
125167988|NCT00605540|450239010|FG000|Overall Study|Death|15|||
125167989|NCT00605540|450239010|FG000|Overall Study|Lost to Follow-up|23|||
125227498|NCT01573000|450462099|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
125227499|NCT03353792|450462100|FG000|Overall Study|Lost to Follow-up|1|||
125227500|NCT03353792|450462101|FG001|Overall Study|Lost to Follow-up|0|||
125227501|NCT03353792|450462100|FG000|Overall Study|Participant Unable to Manage Device|1|||
125227502|NCT03353792|450462101|FG001|Overall Study|Participant Unable to Manage Device|0|||
125227503|NCT02351934|450462103|FG000|Allocation|POD weight<pre-op weight|3|||
125227504|NCT02351934|450462104|FG001|Allocation|POD weight<pre-op weight|0|||
125227505|NCT02351934|450462103|FG000|Allocation|Hypotension preventing administration|2|||
125227506|NCT02351934|450462104|FG001|Allocation|Hypotension preventing administration|0|||
125227507|NCT02351934|450462103|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
125227508|NCT02351934|450462104|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
125227509|NCT02351934|450462103|FG000|Follow-Up|POD weight<pre-op weight|3|||
125227510|NCT02351934|450462104|FG001|Follow-Up|POD weight<pre-op weight|0|||
125227511|NCT02351934|450462103|FG000|Follow-Up|Acute Kidney Injury|1|||
125227512|NCT02351934|450462104|FG001|Follow-Up|Acute Kidney Injury|0|||
125227513|NCT02351934|450462103|FG000|Follow-Up|Early dismissal|3|||
125227514|NCT02351934|450462104|FG001|Follow-Up|Early dismissal|0|||
125227515|NCT02351934|450462103|FG000|Follow-Up|Hypotension|3|||
125227516|NCT02351934|450462104|FG001|Follow-Up|Hypotension|0|||
125227517|NCT02351934|450462103|FG000|Follow-Up|No documentation|2|||
125227518|NCT02351934|450462104|FG001|Follow-Up|No documentation|0|||
125227519|NCT02351934|450462103|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
125227520|NCT02351934|450462104|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
125227521|NCT02351934|450462103|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
125227522|NCT02351934|450462104|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
125227523|NCT01225549|450462109|FG000|Period 4 - Washout|Disallowed medication|0|||
125227524|NCT01225549|450462110|FG001|Period 4 - Washout|Disallowed medication|1|||
125227525|NCT01225549|450462111|FG002|Period 4 - Washout|Disallowed medication|0|||
125227526|NCT01225549|450462112|FG003|Period 4 - Washout|Disallowed medication|0|||
125227527|NCT01225549|450462113|FG004|Period 4 - Washout|Disallowed medication|0|||
125227528|NCT01225549|450462114|FG005|Period 4 - Washout|Disallowed medication|0|||
125227529|NCT01225549|450462115|FG006|Period 4 - Washout|Disallowed medication|0|||
125227530|NCT01225549|450462116|FG007|Period 4 - Washout|Disallowed medication|0|||
125227531|NCT01225549|450462117|FG008|Period 4 - Washout|Disallowed medication|0|||
125227532|NCT01225549|450462118|FG009|Period 4 - Washout|Disallowed medication|0|||
125227533|NCT01225549|450462109|FG000|Period 6 - Washout|Disallowed medication|0|||
125227534|NCT01225549|450462110|FG001|Period 6 - Washout|Disallowed medication|0|||
125227535|NCT01225549|450462111|FG002|Period 6 - Washout|Disallowed medication|0|||
125227536|NCT01225549|450462112|FG003|Period 6 - Washout|Disallowed medication|1|||
125227537|NCT01225549|450462113|FG004|Period 6 - Washout|Disallowed medication|0|||
125227538|NCT01225549|450462114|FG005|Period 6 - Washout|Disallowed medication|0|||
125227539|NCT01225549|450462115|FG006|Period 6 - Washout|Disallowed medication|0|||
125227540|NCT01225549|450462116|FG007|Period 6 - Washout|Disallowed medication|0|||
125227541|NCT01225549|450462117|FG008|Period 6 - Washout|Disallowed medication|0|||
125227542|NCT01225549|450462118|FG009|Period 6 - Washout|Disallowed medication|0|||
125227543|NCT00891813|450462120|FG000|Overall Study|Adverse Event|3|||
125227544|NCT00891813|450462120|FG000|Overall Study|Withdrawal by Subject|1|||
125227545|NCT00891813|450462120|FG000|Overall Study|Patient Noncompliance|6|||
125227546|NCT00891813|450462120|FG000|Overall Study|Protocol Violation|2|||
125227547|NCT00192114|450462121|FG000|Overall Study|Objective Tumor Progression|19|||
125227548|NCT00192114|450462121|FG000|Overall Study|Adverse Event|2|||
125227549|NCT00192114|450462121|FG000|Overall Study|Clinical Progression|2|||
125227550|NCT00192114|450462121|FG000|Overall Study|Death|1|||
125227551|NCT02718911|450462124|FG000|Overall Study|Adverse Event|0|||
125227552|NCT02718911|450462125|FG001|Overall Study|Adverse Event|0|||
125227553|NCT02718911|450462126|FG002|Overall Study|Adverse Event|0|||
125227554|NCT02718911|450462127|FG003|Overall Study|Adverse Event|0|||
125227555|NCT02718911|450462128|FG004|Overall Study|Adverse Event|0|||
125227556|NCT02718911|450462129|FG005|Overall Study|Adverse Event|0|||
125227557|NCT02718911|450462130|FG006|Overall Study|Adverse Event|0|||
125227558|NCT02718911|450462131|FG007|Overall Study|Adverse Event|0|||
125227559|NCT02718911|450462132|FG008|Overall Study|Adverse Event|0|||
125227560|NCT02718911|450462133|FG009|Overall Study|Adverse Event|2|||
125227561|NCT02718911|450462124|FG000|Overall Study|Death|2|||
125227562|NCT02718911|450462125|FG001|Overall Study|Death|3|||
125227563|NCT02718911|450462126|FG002|Overall Study|Death|1|||
125227564|NCT02718911|450462127|FG003|Overall Study|Death|0|||
125227565|NCT02718911|450462128|FG004|Overall Study|Death|1|||
125227566|NCT02718911|450462129|FG005|Overall Study|Death|3|||
125227567|NCT02718911|450462130|FG006|Overall Study|Death|1|||
125227568|NCT02718911|450462131|FG007|Overall Study|Death|1|||
125227569|NCT02718911|450462132|FG008|Overall Study|Death|4|||
125227570|NCT02718911|450462133|FG009|Overall Study|Death|3|||
125227571|NCT02718911|450462124|FG000|Overall Study|Lost to Follow-up|0|||
125227572|NCT02718911|450462125|FG001|Overall Study|Lost to Follow-up|0|||
125227573|NCT02718911|450462126|FG002|Overall Study|Lost to Follow-up|0|||
125227574|NCT02718911|450462127|FG003|Overall Study|Lost to Follow-up|0|||
125227575|NCT02718911|450462128|FG004|Overall Study|Lost to Follow-up|0|||
125227576|NCT02718911|450462129|FG005|Overall Study|Lost to Follow-up|0|||
125443220|NCT02138747|451250823|FG001|Treatment Period 1|Lost to Follow-up|1|||
125443221|NCT02138747|451250824|FG002|Treatment Period 1|Lost to Follow-up|1|||
125443222|NCT02138747|451250825|FG003|Treatment Period 1|Lost to Follow-up|0|||
125443223|NCT02138747|451250822|FG000|Treatment Period 1|Protocol Violation|0|||
125443224|NCT02138747|451250823|FG001|Treatment Period 1|Protocol Violation|2|||
125443225|NCT02138747|451250824|FG002|Treatment Period 1|Protocol Violation|0|||
125443226|NCT02138747|451250825|FG003|Treatment Period 1|Protocol Violation|0|||
125443227|NCT02138747|451250822|FG000|Treatment Period 1|Withdrawal by Subject|8|||
125443228|NCT02138747|451250823|FG001|Treatment Period 1|Withdrawal by Subject|4|||
125443229|NCT02138747|451250824|FG002|Treatment Period 1|Withdrawal by Subject|1|||
125443230|NCT02138747|451250825|FG003|Treatment Period 1|Withdrawal by Subject|3|||
125227577|NCT02718911|450462130|FG006|Overall Study|Lost to Follow-up|0|||
125227578|NCT02718911|450462131|FG007|Overall Study|Lost to Follow-up|0|||
125227579|NCT02718911|450462132|FG008|Overall Study|Lost to Follow-up|1|||
125227580|NCT02718911|450462133|FG009|Overall Study|Lost to Follow-up|0|||
125227581|NCT02718911|450462124|FG000|Overall Study|Physician Decision|2|||
125227582|NCT02718911|450462125|FG001|Overall Study|Physician Decision|0|||
125227583|NCT02718911|450462126|FG002|Overall Study|Physician Decision|1|||
125227584|NCT02718911|450462127|FG003|Overall Study|Physician Decision|1|||
125227585|NCT02718911|450462128|FG004|Overall Study|Physician Decision|0|||
125227586|NCT02718911|450462129|FG005|Overall Study|Physician Decision|0|||
125227587|NCT02718911|450462130|FG006|Overall Study|Physician Decision|0|||
125227588|NCT02718911|450462131|FG007|Overall Study|Physician Decision|1|||
125227589|NCT02718911|450462132|FG008|Overall Study|Physician Decision|2|||
125227590|NCT02718911|450462133|FG009|Overall Study|Physician Decision|1|||
125227591|NCT02718911|450462124|FG000|Overall Study|Withdrawal by Subject|0|||
125227592|NCT02718911|450462125|FG001|Overall Study|Withdrawal by Subject|0|||
125227593|NCT02718911|450462126|FG002|Overall Study|Withdrawal by Subject|0|||
125227594|NCT02718911|450462127|FG003|Overall Study|Withdrawal by Subject|0|||
125227595|NCT02718911|450462128|FG004|Overall Study|Withdrawal by Subject|1|||
125227596|NCT02718911|450462129|FG005|Overall Study|Withdrawal by Subject|0|||
125227597|NCT02718911|450462130|FG006|Overall Study|Withdrawal by Subject|0|||
125227598|NCT02718911|450462131|FG007|Overall Study|Withdrawal by Subject|0|||
125227599|NCT02718911|450462132|FG008|Overall Study|Withdrawal by Subject|1|||
125227600|NCT02718911|450462133|FG009|Overall Study|Withdrawal by Subject|4|||
125227601|NCT02718911|450462124|FG000|Overall Study|Reason Not Collected|0|||
125227602|NCT02718911|450462125|FG001|Overall Study|Reason Not Collected|0|||
125227603|NCT02718911|450462126|FG002|Overall Study|Reason Not Collected|1|||
125443231|NCT02138747|451250822|FG000|Treatment Period 1|Other - Miscellaneous|2|||
125443232|NCT02138747|451250823|FG001|Treatment Period 1|Other - Miscellaneous|4|||
125443233|NCT02138747|451250824|FG002|Treatment Period 1|Other - Miscellaneous|0|||
125167990|NCT00049530|450239012|FG000|Overall Study|Lack of Efficacy|25|||
125167991|NCT00049530|450239012|FG000|Overall Study|Adverse Event|2|||
125167992|NCT00049530|450239012|FG000|Overall Study|Death|1|||
125167993|NCT00049530|450239012|FG000|Overall Study|symptomatic deterioration|1|||
125167994|NCT00049530|450239012|FG000|Overall Study|ineligible|3|||
125167995|NCT02383810|450239013|FG000|Overall Study|Physician Decision|1|||
125167996|NCT02383810|450239014|FG001|Overall Study|Physician Decision|1|||
125167997|NCT02383810|450239015|FG002|Overall Study|Physician Decision|0|||
125167998|NCT02383810|450239016|FG003|Overall Study|Physician Decision|0|||
125167999|NCT02383810|450239017|FG004|Overall Study|Physician Decision|0|||
125168000|NCT02383810|450239018|FG005|Overall Study|Physician Decision|0|||
125168001|NCT02383810|450239019|FG006|Overall Study|Physician Decision|0|||
125168002|NCT02383810|450239020|FG007|Overall Study|Physician Decision|0|||
125168003|NCT02383810|450239013|FG000|Overall Study|Withdrawal by Subject|2|||
125168004|NCT02383810|450239014|FG001|Overall Study|Withdrawal by Subject|3|||
125168005|NCT02383810|450239015|FG002|Overall Study|Withdrawal by Subject|3|||
125168006|NCT02383810|450239016|FG003|Overall Study|Withdrawal by Subject|3|||
125168007|NCT02383810|450239017|FG004|Overall Study|Withdrawal by Subject|0|||
125168008|NCT02383810|450239018|FG005|Overall Study|Withdrawal by Subject|0|||
125168009|NCT02383810|450239019|FG006|Overall Study|Withdrawal by Subject|0|||
125168010|NCT02383810|450239020|FG007|Overall Study|Withdrawal by Subject|0|||
125168011|NCT02383810|450239013|FG000|Overall Study|Adverse Event|0|||
125168012|NCT02383810|450239014|FG001|Overall Study|Adverse Event|2|||
125168013|NCT02383810|450239015|FG002|Overall Study|Adverse Event|4|||
125227604|NCT02718911|450462127|FG003|Overall Study|Reason Not Collected|0|||
125227605|NCT02718911|450462128|FG004|Overall Study|Reason Not Collected|0|||
125227606|NCT02718911|450462129|FG005|Overall Study|Reason Not Collected|0|||
125227607|NCT02718911|450462130|FG006|Overall Study|Reason Not Collected|2|||
125227608|NCT02718911|450462131|FG007|Overall Study|Reason Not Collected|1|||
125443234|NCT02138747|451250825|FG003|Treatment Period 1|Other - Miscellaneous|0|||
125168014|NCT02383810|450239016|FG003|Overall Study|Adverse Event|5|||
125227609|NCT02718911|450462132|FG008|Overall Study|Reason Not Collected|4|||
125443235|NCT02138747|451250822|FG000|Treatment Period 2|Adverse Event|6|||
125443236|NCT02138747|451250823|FG001|Treatment Period 2|Adverse Event|3|||
125168015|NCT02383810|450239017|FG004|Overall Study|Adverse Event|0|||
125168016|NCT02383810|450239018|FG005|Overall Study|Adverse Event|1|||
125168017|NCT02383810|450239019|FG006|Overall Study|Adverse Event|1|||
125168018|NCT02383810|450239020|FG007|Overall Study|Adverse Event|0|||
125168019|NCT02383810|450239013|FG000|Overall Study|Lost to Follow-up|0|||
125168020|NCT02383810|450239014|FG001|Overall Study|Lost to Follow-up|1|||
125168021|NCT02383810|450239015|FG002|Overall Study|Lost to Follow-up|0|||
125168022|NCT02383810|450239016|FG003|Overall Study|Lost to Follow-up|1|||
125168023|NCT02383810|450239017|FG004|Overall Study|Lost to Follow-up|0|||
125168024|NCT02383810|450239018|FG005|Overall Study|Lost to Follow-up|0|||
125168025|NCT02383810|450239019|FG006|Overall Study|Lost to Follow-up|0|||
125168026|NCT02383810|450239020|FG007|Overall Study|Lost to Follow-up|0|||
125168027|NCT02383810|450239013|FG000|Overall Study|other|0|||
125168028|NCT02383810|450239014|FG001|Overall Study|other|0|||
125168029|NCT02383810|450239015|FG002|Overall Study|other|0|||
125168030|NCT02383810|450239016|FG003|Overall Study|other|2|||
125168031|NCT02383810|450239017|FG004|Overall Study|other|0|||
125168032|NCT02383810|450239018|FG005|Overall Study|other|0|||
125168033|NCT02383810|450239019|FG006|Overall Study|other|0|||
125168034|NCT02383810|450239020|FG007|Overall Study|other|0|||
125168035|NCT02383810|450239013|FG000|Overall Study|subject did not receive study treatment|0|||
125168036|NCT02383810|450239014|FG001|Overall Study|subject did not receive study treatment|1|||
125168037|NCT02383810|450239015|FG002|Overall Study|subject did not receive study treatment|0|||
125168038|NCT02383810|450239016|FG003|Overall Study|subject did not receive study treatment|0|||
125168039|NCT02383810|450239017|FG004|Overall Study|subject did not receive study treatment|0|||
125168040|NCT02383810|450239018|FG005|Overall Study|subject did not receive study treatment|0|||
125168041|NCT02383810|450239019|FG006|Overall Study|subject did not receive study treatment|0|||
125168042|NCT02383810|450239020|FG007|Overall Study|subject did not receive study treatment|0|||
125168043|NCT01635283|450239023|FG000|Overall Study|Tumor Progression|3|||
125168044|NCT01635283|450239023|FG000|Overall Study|Lost to Follow-up|1|||
125168045|NCT01433549|450239024|FG000|Phase 2: Second Study Product|Adverse Event|0|||
125168046|NCT01433549|450239025|FG001|Phase 2: Second Study Product|Adverse Event|1|||
125168047|NCT03511326|450239028|FG000|Overall Study|Withdrawal by Subject|1|||
125168048|NCT04628793|450239029|FG000|Overall Study|Study terminated by sponsor|0|||
125168049|NCT04628793|450239030|FG001|Overall Study|Study terminated by sponsor|0|||
125168050|NCT04628793|450239031|FG002|Overall Study|Study terminated by sponsor|8|||
125168051|NCT04628793|450239029|FG000|Overall Study|Withdrawal by Subject|2|||
125168052|NCT04628793|450239030|FG001|Overall Study|Withdrawal by Subject|3|||
125168053|NCT04628793|450239031|FG002|Overall Study|Withdrawal by Subject|0|||
125168054|NCT04628793|450239029|FG000|Overall Study|Lost to Follow-up|0|||
125168055|NCT04628793|450239030|FG001|Overall Study|Lost to Follow-up|1|||
125168056|NCT04628793|450239031|FG002|Overall Study|Lost to Follow-up|0|||
125168057|NCT01696058|450239032|FG000|Overall Study|Adverse Event|21|||
125168058|NCT01696058|450239033|FG001|Overall Study|Adverse Event|11|||
125168059|NCT01696058|450239032|FG000|Overall Study|Lack of Efficacy|2|||
125168060|NCT01696058|450239033|FG001|Overall Study|Lack of Efficacy|3|||
125168061|NCT01696058|450239032|FG000|Overall Study|Protocol Violation|9|||
125168062|NCT01696058|450239033|FG001|Overall Study|Protocol Violation|3|||
125168063|NCT01696058|450239032|FG000|Overall Study|Lost to Follow-up|2|||
125168064|NCT01696058|450239033|FG001|Overall Study|Lost to Follow-up|5|||
125227610|NCT02718911|450462133|FG009|Overall Study|Reason Not Collected|9|||
125168065|NCT01696058|450239032|FG000|Overall Study|Withdrawal by Subject|4|||
125168066|NCT01696058|450239033|FG001|Overall Study|Withdrawal by Subject|6|||
125168067|NCT01696058|450239032|FG000|Overall Study|Other reason prematurely discontinued|5|||
125168068|NCT01696058|450239033|FG001|Overall Study|Other reason prematurely discontinued|3|||
125168069|NCT01934335|450239034|FG000|Overall Study|Withdrawal by Subject|1|||
125168070|NCT01934335|450239035|FG001|Overall Study|Withdrawal by Subject|1|||
125168071|NCT05384171|450239036|FG000|Overall Study|Lost to Follow-up|9|||
125168072|NCT05384171|450239037|FG001|Overall Study|Lost to Follow-up|9|||
125168073|NCT05384171|450239036|FG000|Overall Study|Withdrawal by Subject|3|||
125168074|NCT05384171|450239037|FG001|Overall Study|Withdrawal by Subject|0|||
125168075|NCT00106964|450239038|FG000|Overall Study|Lost to Follow-up|8|||
125168076|NCT00106964|450239039|FG001|Overall Study|Lost to Follow-up|6|||
125168077|NCT00106964|450239040|FG002|Overall Study|Lost to Follow-up|2|||
125168078|NCT00106964|450239038|FG000|Overall Study|Pregnancy|2|||
125168079|NCT00106964|450239039|FG001|Overall Study|Pregnancy|3|||
125168080|NCT00106964|450239040|FG002|Overall Study|Pregnancy|2|||
125168081|NCT00106964|450239038|FG000|Overall Study|Death|1|||
125168082|NCT00106964|450239039|FG001|Overall Study|Death|1|||
125168083|NCT00106964|450239040|FG002|Overall Study|Death|0|||
125168084|NCT00106964|450239038|FG000|Overall Study|Incarceration|0|||
125168085|NCT00106964|450239039|FG001|Overall Study|Incarceration|1|||
125168086|NCT00106964|450239040|FG002|Overall Study|Incarceration|0|||
125168087|NCT00106964|450239038|FG000|Overall Study|Site Funding Terminated|0|||
125168088|NCT00106964|450239039|FG001|Overall Study|Site Funding Terminated|1|||
125168089|NCT00106964|450239040|FG002|Overall Study|Site Funding Terminated|1|||
125168090|NCT00106964|450239038|FG000|Overall Study|Failure to adhere|2|||
125168091|NCT00106964|450239039|FG001|Overall Study|Failure to adhere|0|||
125168092|NCT00106964|450239040|FG002|Overall Study|Failure to adhere|0|||
125168093|NCT00106964|450239038|FG000|Overall Study|Did not meet eligibility criteria|0|||
125168094|NCT00106964|450239039|FG001|Overall Study|Did not meet eligibility criteria|2|||
125168095|NCT00106964|450239040|FG002|Overall Study|Did not meet eligibility criteria|2|||
125168096|NCT00106964|450239038|FG000|Overall Study|Required disallowed medication|0|||
125168097|NCT00106964|450239039|FG001|Overall Study|Required disallowed medication|1|||
125168098|NCT00106964|450239040|FG002|Overall Study|Required disallowed medication|0|||
125168099|NCT01422187|450239045|FG000|Overall Study|Personal reason|1|||
125168100|NCT01422187|450239046|FG001|Overall Study|Personal reason|0|||
125168101|NCT01422187|450239047|FG002|Overall Study|Personal reason|0|||
125168102|NCT01422187|450239045|FG000|Overall Study|Lost to Follow-up|0|||
125168103|NCT01422187|450239046|FG001|Overall Study|Lost to Follow-up|1|||
125168104|NCT01422187|450239047|FG002|Overall Study|Lost to Follow-up|0|||
125168105|NCT00168818|450239048|FG000|Overall Study|Adverse Event|23|||
125168106|NCT00168818|450239049|FG001|Overall Study|Adverse Event|29|||
125168107|NCT00168818|450239050|FG002|Overall Study|Adverse Event|31|||
125168108|NCT00168818|450239048|FG000|Overall Study|Protocol Violation|16|||
125168109|NCT00168818|450239049|FG001|Overall Study|Protocol Violation|11|||
125168110|NCT00168818|450239050|FG002|Overall Study|Protocol Violation|11|||
125168111|NCT00168818|450239048|FG000|Overall Study|Lost to Follow-up|13|||
125168112|NCT00168818|450239049|FG001|Overall Study|Lost to Follow-up|4|||
125168113|NCT00168818|450239050|FG002|Overall Study|Lost to Follow-up|15|||
125168114|NCT00168818|450239048|FG000|Overall Study|Withdrawal by Subject|43|||
125168115|NCT00168818|450239049|FG001|Overall Study|Withdrawal by Subject|41|||
125168116|NCT00168818|450239050|FG002|Overall Study|Withdrawal by Subject|37|||
125168117|NCT00168818|450239048|FG000|Overall Study|Other|22|||
125168118|NCT00168818|450239049|FG001|Overall Study|Other|24|||
125168119|NCT00168818|450239050|FG002|Overall Study|Other|30|||
125168120|NCT00168818|450239048|FG000|Treatment|Adverse Event|77|||
125168121|NCT00168818|450239049|FG001|Treatment|Adverse Event|89|||
125168122|NCT00168818|450239050|FG002|Treatment|Adverse Event|68|||
125168123|NCT00168818|450239048|FG000|Treatment|Protocol Violation|8|||
125168124|NCT00168818|450239049|FG001|Treatment|Protocol Violation|11|||
125168125|NCT00168818|450239050|FG002|Treatment|Protocol Violation|11|||
125168126|NCT00168818|450239048|FG000|Treatment|Lost to Follow-up|0|||
125168127|NCT00168818|450239049|FG001|Treatment|Lost to Follow-up|2|||
125168128|NCT00168818|450239050|FG002|Treatment|Lost to Follow-up|1|||
125168129|NCT00168818|450239048|FG000|Treatment|Withdrawal by Subject|25|||
125168130|NCT00168818|450239049|FG001|Treatment|Withdrawal by Subject|20|||
125168131|NCT00168818|450239050|FG002|Treatment|Withdrawal by Subject|22|||
125168132|NCT00168818|450239048|FG000|Treatment|Other|23|||
125168133|NCT00168818|450239049|FG001|Treatment|Other|29|||
125168134|NCT00168818|450239050|FG002|Treatment|Other|31|||
125168135|NCT02227446|450239051|FG000|Overall Study|not eligible post randomization|18|||
125168136|NCT02227446|450239052|FG001|Overall Study|not eligible post randomization|29|||
125168137|NCT02227446|450239051|FG000|Overall Study|Withdrawal by Subject|4|||
125168138|NCT02227446|450239052|FG001|Overall Study|Withdrawal by Subject|5|||
125168139|NCT02309138|450239053|FG000|Overall Study|Withdrawal by Subject|44|||
125168140|NCT02309138|450239054|FG001|Overall Study|Withdrawal by Subject|15|||
125168141|NCT02309138|450239053|FG000|Overall Study|Protocol Violation|4|||
125168142|NCT02309138|450239054|FG001|Overall Study|Protocol Violation|2|||
125168143|NCT02309138|450239053|FG000|Overall Study|delivered before visit 2|0|||
125168144|NCT02309138|450239054|FG001|Overall Study|delivered before visit 2|1|||
125168145|NCT00735397|450239058|FG000|Overall Study|Adverse Event|194|||
125168146|NCT00735397|450239058|FG000|Overall Study|Lost to Follow-up|33|||
125168147|NCT00735397|450239058|FG000|Overall Study|Participant choice|252|||
125168148|NCT00735397|450239058|FG000|Overall Study|Inadequate therapeutic effect|202|||
125168149|NCT00735397|450239058|FG000|Overall Study|Administrative/Other|502|||
125168150|NCT00901576|450239067|FG000|Second Intervention|Withdrawal by Subject|0|||
125168151|NCT00901576|450239068|FG001|Second Intervention|Withdrawal by Subject|0|||
125168152|NCT00901576|450239069|FG002|Second Intervention|Withdrawal by Subject|0|||
125168153|NCT00901576|450239070|FG003|Second Intervention|Withdrawal by Subject|1|||
125168154|NCT00901576|450239071|FG004|Second Intervention|Withdrawal by Subject|0|||
125168155|NCT00901576|450239072|FG005|Second Intervention|Withdrawal by Subject|1|||
125168156|NCT00901576|450239067|FG000|Second Intervention|Physician Decision|1|||
125168157|NCT00901576|450239068|FG001|Second Intervention|Physician Decision|0|||
125168158|NCT00901576|450239069|FG002|Second Intervention|Physician Decision|0|||
125168159|NCT00901576|450239070|FG003|Second Intervention|Physician Decision|0|||
125168160|NCT00901576|450239071|FG004|Second Intervention|Physician Decision|0|||
125168161|NCT00901576|450239072|FG005|Second Intervention|Physician Decision|0|||
125168162|NCT01559389|450239073|FG000|Overall Study|Withdrawal by Subject|20|||
125168163|NCT01559389|450239074|FG001|Overall Study|Withdrawal by Subject|20|||
125168164|NCT01346293|450239075|FG000|Overall Study|Protocol Violation|30|||
125168165|NCT01346293|450239076|FG001|Overall Study|Protocol Violation|9|||
125168166|NCT01346293|450239075|FG000|Overall Study|Lost to Follow-up|21|||
125168167|NCT01346293|450239076|FG001|Overall Study|Lost to Follow-up|8|||
125168168|NCT01346293|450239075|FG000|Overall Study|Withdrawal by Subject|15|||
125168169|NCT01346293|450239076|FG001|Overall Study|Withdrawal by Subject|4|||
125168170|NCT01346293|450239075|FG000|Overall Study|Other|1|||
125168171|NCT01346293|450239076|FG001|Overall Study|Other|0|||
125168172|NCT00587990|450239080|FG000|Overall Study|Death|0|||
125168173|NCT00587990|450239081|FG001|Overall Study|Death|0|||
125443237|NCT02138747|451250824|FG002|Treatment Period 2|Adverse Event|1|||
125443238|NCT02138747|451250825|FG003|Treatment Period 2|Adverse Event|1|||
125443239|NCT02138747|451250822|FG000|Treatment Period 2|Lost to Follow-up|2|||
125443240|NCT02138747|451250823|FG001|Treatment Period 2|Lost to Follow-up|0|||
125443241|NCT02138747|451250824|FG002|Treatment Period 2|Lost to Follow-up|0|||
125443242|NCT02138747|451250825|FG003|Treatment Period 2|Lost to Follow-up|0|||
125443243|NCT02138747|451250822|FG000|Treatment Period 2|Protocol Violation|1|||
125443244|NCT02138747|451250823|FG001|Treatment Period 2|Protocol Violation|0|||
125443245|NCT02138747|451250824|FG002|Treatment Period 2|Protocol Violation|0|||
125443246|NCT02138747|451250825|FG003|Treatment Period 2|Protocol Violation|0|||
125443247|NCT02138747|451250822|FG000|Treatment Period 2|Withdrawal by Subject|5|||
125443248|NCT02138747|451250823|FG001|Treatment Period 2|Withdrawal by Subject|4|||
125443249|NCT02138747|451250824|FG002|Treatment Period 2|Withdrawal by Subject|1|||
125443250|NCT02138747|451250825|FG003|Treatment Period 2|Withdrawal by Subject|2|||
125443251|NCT02138747|451250822|FG000|Treatment Period 2|Other - Miscellaneous|3|||
125443252|NCT02138747|451250823|FG001|Treatment Period 2|Other - Miscellaneous|0|||
125443253|NCT02138747|451250824|FG002|Treatment Period 2|Other - Miscellaneous|0|||
125443254|NCT02138747|451250825|FG003|Treatment Period 2|Other - Miscellaneous|0|||
125443255|NCT00776100|451250833|FG000|Overall Study|Disease Progression|1|||
125443256|NCT00776100|451250834|FG001|Overall Study|Disease Progression|0|||
125443257|NCT03567993|451250835|FG000|Overall Study|Lost to Follow-up|4|||
125443258|NCT03567993|451250836|FG001|Overall Study|Lost to Follow-up|2|||
125443259|NCT03567993|451250835|FG000|Overall Study|Death|1|||
125443260|NCT03567993|451250836|FG001|Overall Study|Death|1|||
125443261|NCT03567993|451250835|FG000|Overall Study|Withdrawal by Subject|1|||
125443262|NCT03567993|451250836|FG001|Overall Study|Withdrawal by Subject|0|||
125443263|NCT04793464|451250837|FG000|Overall Study|Lost to Follow-up|458|||
125443264|NCT04793464|451250838|FG001|Overall Study|Lost to Follow-up|168|||
125443265|NCT04793464|451250839|FG002|Overall Study|Lost to Follow-up|5|||
125443266|NCT04793464|451250837|FG000|Overall Study|Withdrawal by Subject|43|||
125443267|NCT04793464|451250838|FG001|Overall Study|Withdrawal by Subject|15|||
125443268|NCT04793464|451250839|FG002|Overall Study|Withdrawal by Subject|0|||
125443269|NCT00641186|451250842|FG000|Overall Study|Adverse Event|3|||
125443270|NCT05221749|451250843|FG000|Overall Study|Lost to Follow-up|2|||
125443271|NCT05221749|451250844|FG001|Overall Study|Lost to Follow-up|3|||
125443272|NCT02388074|451250845|FG000|Overall Study|Lost in Transit|2|||
125443273|NCT02388074|451250845|FG000|Overall Study|Sample Not Returned|1|||
125443274|NCT00003458|451250848|FG000|Overall Study|Not evaluable|4|||
125443275|NCT02133924|451250849|FG000|Overall Study|Death|38|||
125443276|NCT02133924|451250849|FG000|Overall Study|Physician Decision|1|||
125443277|NCT02133924|451250849|FG000|Overall Study|Withdrawal by Subject|3|||
125443278|NCT01254890|451250850|FG000|Overall Study|Ineligible|0|||
125443279|NCT01254890|451250851|FG001|Overall Study|Ineligible|3|||
125168174|NCT00587990|450239082|FG002|Overall Study|Death|1|||
125168175|NCT02754856|450239083|FG000|Overall Study|Withdrawal by Subject|1|||
125168176|NCT01147107|450239087|FG000|Overall Study|Lack of Efficacy|5|||
125168177|NCT01147107|450239088|FG001|Overall Study|Lack of Efficacy|0|||
125168178|NCT01147107|450239087|FG000|Overall Study|Withdrawal by Subject|1|||
125168179|NCT01147107|450239088|FG001|Overall Study|Withdrawal by Subject|1|||
125168180|NCT04693416|450239089|FG000|Overall Study|Lost to Follow-up|13|||
125168181|NCT04693416|450239090|FG001|Overall Study|Lost to Follow-up|0|||
125168182|NCT00474266|450239091|FG000|Overall Study|Withdrawal by Subject|7|||
125168183|NCT00474266|450239092|FG001|Overall Study|Withdrawal by Subject|20|||
125168184|NCT00474266|450239093|FG002|Overall Study|Withdrawal by Subject|4|||
125227611|NCT01172873|450462136|FG000|Overall Study|Withdrawal by Subject|3|||
125227612|NCT01172873|450462137|FG001|Overall Study|Withdrawal by Subject|2|||
125443280|NCT01254890|451250850|FG000|Overall Study|Withdrawal by Subject|1|||
125443281|NCT01254890|451250851|FG001|Overall Study|Withdrawal by Subject|2|||
125443282|NCT01254890|451250850|FG000|Overall Study|Disease Progression|0|||
125227613|NCT00983372|450462138|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
125227614|NCT00983372|450462138|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
125227615|NCT00983372|450462138|FG000|Diltiazem ER Alone|Adverse Event|1|||
125443283|NCT01254890|451250851|FG001|Overall Study|Disease Progression|5|||
125443284|NCT04157686|451250856|FG000|Overall Study|Adverse Event|1|||
125443285|NCT04157686|451250857|FG001|Overall Study|Adverse Event|0|||
125443286|NCT04157686|451250858|FG002|Overall Study|Adverse Event|1|||
125443287|NCT04157686|451250859|FG003|Overall Study|Adverse Event|0|||
125443288|NCT04157686|451250860|FG004|Overall Study|Adverse Event|1|||
125168185|NCT00474266|450239094|FG003|Overall Study|Withdrawal by Subject|7|||
125227616|NCT00617357|450462145|FG000|Overall Study|Lost to Follow-up|7|||
125443289|NCT04157686|451250861|FG005|Overall Study|Adverse Event|0|||
125443290|NCT04157686|451250862|FG006|Overall Study|Adverse Event|0|||
125443291|NCT04157686|451250863|FG007|Overall Study|Adverse Event|0|||
125443292|NCT04157686|451250856|FG000|Overall Study|Pregnancy|0|||
125443293|NCT04157686|451250857|FG001|Overall Study|Pregnancy|1|||
125443294|NCT04157686|451250858|FG002|Overall Study|Pregnancy|3|||
125168186|NCT00813800|450239097|FG000|Overall Study|Screen Failure after Consent|2|||
125168187|NCT00813800|450239097|FG000|Overall Study|Adverse Event|1|||
125443295|NCT04157686|451250859|FG003|Overall Study|Pregnancy|0|||
125168188|NCT00813800|450239097|FG000|Overall Study|Worsening of depression|2|||
125168189|NCT00813800|450239097|FG000|Overall Study|Physician Decision|1|||
125168190|NCT03456453|450239098|FG000|Overall Study|Withdrawal by Subject|2|||
125168191|NCT03456453|450239099|FG001|Overall Study|Withdrawal by Subject|0|||
125168192|NCT03456453|450239098|FG000|Overall Study|Not released to community|1|||
125168193|NCT03456453|450239099|FG001|Overall Study|Not released to community|5|||
125168194|NCT03456453|450239098|FG000|Overall Study|Lost to Follow-up|0|||
125168195|NCT03456453|450239099|FG001|Overall Study|Lost to Follow-up|2|||
125168196|NCT02369458|450239115|FG000|Overall Study|Determined to be not eligible|1|||
125168197|NCT02369458|450239116|FG001|Overall Study|Determined to be not eligible|0|||
125168198|NCT00121134|450239117|FG000|Overall Study|Progression of Disease|5|||
125168199|NCT00121134|450239118|FG001|Overall Study|Progression of Disease|3|||
125168200|NCT00121134|450239119|FG002|Overall Study|Progression of Disease|4|||
125168201|NCT00121134|450239120|FG003|Overall Study|Progression of Disease|2|||
125168202|NCT00121134|450239117|FG000|Overall Study|Toxicity|4|||
125168203|NCT00121134|450239118|FG001|Overall Study|Toxicity|7|||
125168204|NCT00121134|450239119|FG002|Overall Study|Toxicity|13|||
125168205|NCT00121134|450239120|FG003|Overall Study|Toxicity|5|||
125168206|NCT00121134|450239117|FG000|Overall Study|Physician Decision|6|||
125168207|NCT00121134|450239118|FG001|Overall Study|Physician Decision|4|||
125168208|NCT00121134|450239119|FG002|Overall Study|Physician Decision|4|||
125168209|NCT00121134|450239120|FG003|Overall Study|Physician Decision|1|||
125168210|NCT00121134|450239117|FG000|Overall Study|Treatment Delay|1|||
125168211|NCT00121134|450239118|FG001|Overall Study|Treatment Delay|0|||
125168212|NCT00121134|450239119|FG002|Overall Study|Treatment Delay|0|||
125168213|NCT00121134|450239120|FG003|Overall Study|Treatment Delay|0|||
125168214|NCT00121134|450239117|FG000|Overall Study|Intercurrent Illness|0|||
125168215|NCT00121134|450239118|FG001|Overall Study|Intercurrent Illness|0|||
125168216|NCT00121134|450239119|FG002|Overall Study|Intercurrent Illness|0|||
125168217|NCT00121134|450239120|FG003|Overall Study|Intercurrent Illness|1|||
125168218|NCT00121134|450239117|FG000|Overall Study|Patient Personal Reasons|0|||
125168219|NCT00121134|450239118|FG001|Overall Study|Patient Personal Reasons|1|||
125168220|NCT00121134|450239119|FG002|Overall Study|Patient Personal Reasons|0|||
125168221|NCT00121134|450239120|FG003|Overall Study|Patient Personal Reasons|0|||
125168222|NCT00857584|450239132|FG000|Overall Study|Lack of Efficacy|1|||
125168223|NCT00857584|450239133|FG001|Overall Study|Lack of Efficacy|2|||
125168224|NCT00857584|450239132|FG000|Overall Study|Adverse Event|2|||
125168225|NCT00857584|450239133|FG001|Overall Study|Adverse Event|2|||
125168226|NCT00857584|450239132|FG000|Overall Study|Physician Decision|1|||
125168227|NCT00857584|450239133|FG001|Overall Study|Physician Decision|1|||
125168228|NCT00259272|450239134|FG000|Overall Study|Adverse Event|2|||
125168229|NCT00259272|450239135|FG001|Overall Study|Adverse Event|1|||
125168230|NCT00259272|450239136|FG002|Overall Study|Adverse Event|0|||
125168231|NCT00259272|450239137|FG003|Overall Study|Adverse Event|3|||
125168232|NCT00259272|450239134|FG000|Overall Study|Lack of Efficacy|5|||
125168233|NCT00259272|450239135|FG001|Overall Study|Lack of Efficacy|1|||
125168234|NCT00259272|450239136|FG002|Overall Study|Lack of Efficacy|2|||
125168235|NCT00259272|450239137|FG003|Overall Study|Lack of Efficacy|6|||
125168236|NCT00259272|450239134|FG000|Overall Study|Physician Decision|1|||
125168237|NCT00259272|450239135|FG001|Overall Study|Physician Decision|2|||
125168238|NCT00259272|450239136|FG002|Overall Study|Physician Decision|1|||
125168239|NCT00259272|450239137|FG003|Overall Study|Physician Decision|3|||
125168240|NCT00259272|450239134|FG000|Overall Study|Protocol Violation|2|||
125168241|NCT00259272|450239135|FG001|Overall Study|Protocol Violation|0|||
125168242|NCT00259272|450239136|FG002|Overall Study|Protocol Violation|0|||
125168243|NCT00259272|450239137|FG003|Overall Study|Protocol Violation|1|||
125168244|NCT00259272|450239134|FG000|Overall Study|Sponsor Decision|0|||
125168245|NCT00259272|450239135|FG001|Overall Study|Sponsor Decision|1|||
125168246|NCT00259272|450239136|FG002|Overall Study|Sponsor Decision|0|||
125392272|NCT02476968|451070617|FG001|Overall Study|Death|8|||
125392273|NCT02476968|451070618|FG002|Overall Study|Death|1|||
125392274|NCT02476968|451070616|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125392275|NCT02476968|451070617|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125392276|NCT02476968|451070618|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
125392277|NCT02476968|451070616|FG000|Overall Study|Patient decision|37|||
125168247|NCT00259272|450239137|FG003|Overall Study|Sponsor Decision|0|||
125168248|NCT00259272|450239134|FG000|Overall Study|Withdrawal by Subject|4|||
125168249|NCT00259272|450239135|FG001|Overall Study|Withdrawal by Subject|2|||
125168250|NCT00259272|450239136|FG002|Overall Study|Withdrawal by Subject|2|||
125168251|NCT00259272|450239137|FG003|Overall Study|Withdrawal by Subject|7|||
125168252|NCT00259272|450239134|FG000|Overall Study|Lost to Follow-up|1|||
125168253|NCT00259272|450239135|FG001|Overall Study|Lost to Follow-up|0|||
125168254|NCT00259272|450239136|FG002|Overall Study|Lost to Follow-up|0|||
125168255|NCT00259272|450239137|FG003|Overall Study|Lost to Follow-up|1|||
125168256|NCT00805467|450241068|FG000|Overall Study|Lack of Efficacy|0|||
125168257|NCT00805467|450241069|FG001|Overall Study|Lack of Efficacy|8|||
125168258|NCT00805467|450241070|FG002|Overall Study|Lack of Efficacy|13|||
125168259|NCT00805467|450241071|FG003|Overall Study|Lack of Efficacy|86|||
125168260|NCT00805467|450241068|FG000|Overall Study|Lost to Follow-up|0|||
125443296|NCT04157686|451250860|FG004|Overall Study|Pregnancy|0|||
125443297|NCT04157686|451250861|FG005|Overall Study|Pregnancy|0|||
125443298|NCT04157686|451250862|FG006|Overall Study|Pregnancy|3|||
125443299|NCT04157686|451250863|FG007|Overall Study|Pregnancy|0|||
125443300|NCT04157686|451250856|FG000|Overall Study|Lost to Follow-up|1|||
125443301|NCT04157686|451250857|FG001|Overall Study|Lost to Follow-up|2|||
125443302|NCT04157686|451250858|FG002|Overall Study|Lost to Follow-up|8|||
125443303|NCT04157686|451250859|FG003|Overall Study|Lost to Follow-up|6|||
125443304|NCT04157686|451250860|FG004|Overall Study|Lost to Follow-up|6|||
125443305|NCT04157686|451250861|FG005|Overall Study|Lost to Follow-up|3|||
125443306|NCT04157686|451250862|FG006|Overall Study|Lost to Follow-up|7|||
125443307|NCT04157686|451250863|FG007|Overall Study|Lost to Follow-up|9|||
125443308|NCT04157686|451250856|FG000|Overall Study|Lack of Efficacy|0|||
125443309|NCT04157686|451250857|FG001|Overall Study|Lack of Efficacy|0|||
125443310|NCT04157686|451250858|FG002|Overall Study|Lack of Efficacy|0|||
125443311|NCT04157686|451250859|FG003|Overall Study|Lack of Efficacy|0|||
125443312|NCT04157686|451250860|FG004|Overall Study|Lack of Efficacy|0|||
125443313|NCT04157686|451250861|FG005|Overall Study|Lack of Efficacy|2|||
125443314|NCT04157686|451250862|FG006|Overall Study|Lack of Efficacy|0|||
125443315|NCT04157686|451250863|FG007|Overall Study|Lack of Efficacy|1|||
125443316|NCT04157686|451250856|FG000|Overall Study|Withdrawal by Subject|10|||
125443317|NCT04157686|451250857|FG001|Overall Study|Withdrawal by Subject|10|||
125443318|NCT04157686|451250858|FG002|Overall Study|Withdrawal by Subject|12|||
125443319|NCT04157686|451250859|FG003|Overall Study|Withdrawal by Subject|20|||
125443320|NCT04157686|451250860|FG004|Overall Study|Withdrawal by Subject|12|||
125443321|NCT04157686|451250861|FG005|Overall Study|Withdrawal by Subject|11|||
125443322|NCT04157686|451250862|FG006|Overall Study|Withdrawal by Subject|18|||
125443323|NCT04157686|451250863|FG007|Overall Study|Withdrawal by Subject|24|||
125443324|NCT04157686|451250856|FG000|Overall Study|Physician Decision|0|||
125443325|NCT04157686|451250857|FG001|Overall Study|Physician Decision|0|||
125443326|NCT04157686|451250858|FG002|Overall Study|Physician Decision|1|||
125443327|NCT04157686|451250859|FG003|Overall Study|Physician Decision|0|||
125443328|NCT04157686|451250860|FG004|Overall Study|Physician Decision|1|||
125443329|NCT04157686|451250861|FG005|Overall Study|Physician Decision|0|||
125443330|NCT04157686|451250862|FG006|Overall Study|Physician Decision|3|||
125443331|NCT04157686|451250863|FG007|Overall Study|Physician Decision|0|||
125443332|NCT04157686|451250856|FG000|Overall Study|Death|0|||
125443333|NCT04157686|451250857|FG001|Overall Study|Death|0|||
125443334|NCT04157686|451250858|FG002|Overall Study|Death|0|||
125443335|NCT04157686|451250859|FG003|Overall Study|Death|2|||
125443336|NCT04157686|451250860|FG004|Overall Study|Death|0|||
125443337|NCT04157686|451250861|FG005|Overall Study|Death|0|||
125443338|NCT04157686|451250862|FG006|Overall Study|Death|0|||
125443339|NCT04157686|451250863|FG007|Overall Study|Death|0|||
125443340|NCT04157686|451250856|FG000|Overall Study|Protocol Violation|0|||
125443341|NCT04157686|451250857|FG001|Overall Study|Protocol Violation|0|||
125443342|NCT04157686|451250858|FG002|Overall Study|Protocol Violation|0|||
125443343|NCT04157686|451250859|FG003|Overall Study|Protocol Violation|0|||
125443344|NCT04157686|451250860|FG004|Overall Study|Protocol Violation|1|||
125443345|NCT04157686|451250861|FG005|Overall Study|Protocol Violation|0|||
125443346|NCT04157686|451250862|FG006|Overall Study|Protocol Violation|0|||
125443347|NCT04157686|451250863|FG007|Overall Study|Protocol Violation|0|||
125443348|NCT04157686|451250856|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
125443349|NCT04157686|451250857|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
125443350|NCT04157686|451250858|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
125443351|NCT04157686|451250859|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
125443352|NCT04157686|451250860|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
125168261|NCT00805467|450241069|FG001|Overall Study|Lost to Follow-up|1|||
125168262|NCT00805467|450241070|FG002|Overall Study|Lost to Follow-up|7|||
125168263|NCT00805467|450241071|FG003|Overall Study|Lost to Follow-up|21|||
125168264|NCT00805467|450241068|FG000|Overall Study|Withdrawal by Subject|0|||
125168265|NCT00805467|450241069|FG001|Overall Study|Withdrawal by Subject|6|||
125168266|NCT00805467|450241070|FG002|Overall Study|Withdrawal by Subject|45|||
125168267|NCT00805467|450241071|FG003|Overall Study|Withdrawal by Subject|50|||
125168268|NCT00805467|450241068|FG000|Overall Study|Protocol Violation|0|||
125168269|NCT00805467|450241069|FG001|Overall Study|Protocol Violation|3|||
125443353|NCT04157686|451250861|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
125443354|NCT04157686|451250862|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
125443355|NCT04157686|451250863|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
125443356|NCT01216293|451250864|FG000|Main Study|Adverse Event|1|||
125443357|NCT01216293|451250865|FG001|Main Study|Adverse Event|4|||
125443358|NCT01216293|451250866|FG002|Main Study|Adverse Event|2|||
125443359|NCT01216293|451250864|FG000|Main Study|Major Protocol Deviation|1|||
125443360|NCT01216293|451250865|FG001|Main Study|Major Protocol Deviation|0|||
125443361|NCT01216293|451250866|FG002|Main Study|Major Protocol Deviation|1|||
125443362|NCT01216293|451250864|FG000|Main Study|Lost to Follow-up|3|||
125443363|NCT01216293|451250865|FG001|Main Study|Lost to Follow-up|1|||
125168270|NCT00805467|450241070|FG002|Overall Study|Protocol Violation|0|||
125168271|NCT00805467|450241071|FG003|Overall Study|Protocol Violation|5|||
125168272|NCT00805467|450241068|FG000|Overall Study|Adverse Event|0|||
125227617|NCT00617357|450462145|FG000|Overall Study|Death|5|||
125227618|NCT00617357|450462145|FG000|Overall Study|insurance concerns|2|||
125443364|NCT01216293|451250866|FG002|Main Study|Lost to Follow-up|0|||
125168273|NCT00805467|450241069|FG001|Overall Study|Adverse Event|13|||
125168274|NCT00805467|450241070|FG002|Overall Study|Adverse Event|26|||
125168275|NCT00805467|450241071|FG003|Overall Study|Adverse Event|57|||
125168276|NCT00805467|450241068|FG000|Overall Study|Death|0|||
125168277|NCT00805467|450241069|FG001|Overall Study|Death|2|||
125168278|NCT00805467|450241070|FG002|Overall Study|Death|7|||
125168279|NCT00805467|450241071|FG003|Overall Study|Death|5|||
125168280|NCT00805467|450241068|FG000|Overall Study|Physician Decision|0|||
125168281|NCT00805467|450241069|FG001|Overall Study|Physician Decision|1|||
125168282|NCT00805467|450241070|FG002|Overall Study|Physician Decision|2|||
125168283|NCT00805467|450241071|FG003|Overall Study|Physician Decision|6|||
125168284|NCT00805467|450241068|FG000|Overall Study|Not reported|0|||
125168285|NCT00805467|450241069|FG001|Overall Study|Not reported|0|||
125168286|NCT00805467|450241070|FG002|Overall Study|Not reported|3|||
125168287|NCT00805467|450241071|FG003|Overall Study|Not reported|7|||
125168288|NCT01908907|450241072|FG000|Overall Study|Physician Decision|1|||
125168289|NCT01908907|450241073|FG001|Overall Study|Physician Decision|0|||
125168290|NCT01908907|450241072|FG000|Overall Study|Protocol Violation|1|||
125168291|NCT01908907|450241073|FG001|Overall Study|Protocol Violation|0|||
125168292|NCT00761657|450241074|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
125168293|NCT00761657|450241075|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
125168294|NCT00761657|450241076|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
125168295|NCT00761657|450241077|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
125168296|NCT00761657|450241078|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
125168297|NCT00761657|450241079|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
125168298|NCT00761657|450241080|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
125168299|NCT00761657|450241081|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
125168300|NCT00761657|450241082|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
125168301|NCT00761657|450241074|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168302|NCT00761657|450241075|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168303|NCT00761657|450241076|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
125168304|NCT00761657|450241077|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
125168305|NCT00761657|450241078|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168306|NCT00761657|450241079|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168307|NCT00761657|450241080|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168308|NCT00761657|450241081|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168309|NCT00761657|450241082|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
125168310|NCT00761657|450241074|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
125168311|NCT00761657|450241075|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
125168312|NCT00761657|450241076|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
125168313|NCT00761657|450241077|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
125168314|NCT00761657|450241078|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
125168315|NCT00761657|450241079|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
125168316|NCT00761657|450241080|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
125168317|NCT00761657|450241081|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
125168318|NCT00761657|450241082|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
125168319|NCT00761657|450241074|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
125168320|NCT00761657|450241075|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
125168321|NCT00761657|450241076|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
125168322|NCT00761657|450241077|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
125168323|NCT00761657|450241078|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
125168324|NCT00761657|450241079|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
125168325|NCT00761657|450241080|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
125168326|NCT00761657|450241081|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
125168327|NCT00761657|450241082|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
125168328|NCT00270855|450241090|FG000|Overall Study|Withdrawal by Subject|8|||
125227619|NCT00617357|450462145|FG000|Overall Study|Withdrawal by Subject|1|||
125227620|NCT00617357|450462145|FG000|Overall Study|Physician Decision|1|||
125168329|NCT00270855|450241091|FG001|Overall Study|Withdrawal by Subject|8|||
125168330|NCT02152605|450241094|FG000|Overall Study|Adverse Event|6|||
125168331|NCT02152605|450241095|FG001|Overall Study|Adverse Event|8|||
125168332|NCT02152605|450241094|FG000|Overall Study|Lack of Efficacy|7|||
125168333|NCT02152605|450241095|FG001|Overall Study|Lack of Efficacy|4|||
125168334|NCT02152605|450241094|FG000|Overall Study|Protocol deviation|1|||
125168335|NCT02152605|450241095|FG001|Overall Study|Protocol deviation|4|||
125168336|NCT02152605|450241094|FG000|Overall Study|Lost to Follow-up|1|||
125168337|NCT02152605|450241095|FG001|Overall Study|Lost to Follow-up|0|||
125168338|NCT02152605|450241094|FG000|Overall Study|Withdrew consent|4|||
125168339|NCT02152605|450241095|FG001|Overall Study|Withdrew consent|2|||
125168340|NCT03151408|450241096|FG000|Overall Study|Adverse Event|24|||
125168341|NCT03151408|450241097|FG001|Overall Study|Adverse Event|23|||
125168342|NCT03151408|450241096|FG000|Overall Study|Death|46|||
125168343|NCT03151408|450241097|FG001|Overall Study|Death|26|||
125168344|NCT03151408|450241096|FG000|Overall Study|Physician Decision|13|||
125168345|NCT03151408|450241097|FG001|Overall Study|Physician Decision|19|||
125443365|NCT01216293|451250864|FG000|Main Study|Voluntary Withdrawal|2|||
125443366|NCT01216293|451250865|FG001|Main Study|Voluntary Withdrawal|2|||
125443367|NCT01216293|451250866|FG002|Main Study|Voluntary Withdrawal|2|||
125443368|NCT01216293|451250864|FG000|Main Study|Other Reason Not Specified|0|||
125443369|NCT01216293|451250865|FG001|Main Study|Other Reason Not Specified|1|||
125443370|NCT01216293|451250866|FG002|Main Study|Other Reason Not Specified|1|||
125168346|NCT03151408|450241096|FG000|Overall Study|Withdrawal by Subject|16|||
125168347|NCT03151408|450241097|FG001|Overall Study|Withdrawal by Subject|20|||
125168348|NCT03151408|450241096|FG000|Overall Study|Progressive disease|45|||
125168349|NCT03151408|450241097|FG001|Overall Study|Progressive disease|61|||
125168350|NCT03151408|450241096|FG000|Overall Study|non-compliance by patient|1|||
125168351|NCT03151408|450241097|FG001|Overall Study|non-compliance by patient|0|||
125168352|NCT03151408|450241096|FG000|Overall Study|other reasons|56|||
125168353|NCT03151408|450241097|FG001|Overall Study|other reasons|52|||
125168354|NCT03151408|450241096|FG000|Overall Study|randomized and not treated|2|||
125168355|NCT03151408|450241097|FG001|Overall Study|randomized and not treated|2|||
125168356|NCT00837473|450241098|FG000|Overall Study|Lost to Follow-up|1|||
125168357|NCT00837473|450241098|FG000|Overall Study|Withdrawal by Subject|2|||
125168358|NCT01724489|450241099|FG000|Overall Study|Adverse Event|8|||
125168359|NCT01724489|450241100|FG001|Overall Study|Adverse Event|3|||
125168360|NCT01724489|450241099|FG000|Overall Study|Surgery, medication|1|||
125168361|NCT01724489|450241100|FG001|Overall Study|Surgery, medication|1|||
125168362|NCT01724489|450241099|FG000|Overall Study|Lost to Follow-up|1|||
125168363|NCT01724489|450241100|FG001|Overall Study|Lost to Follow-up|2|||
125168364|NCT01724489|450241099|FG000|Overall Study|Withdrawal by Subject|6|||
125168365|NCT01724489|450241100|FG001|Overall Study|Withdrawal by Subject|6|||
125168366|NCT04576923|450241101|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
125168367|NCT00923273|450241104|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
125168368|NCT00923273|450241105|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
125168369|NCT00923273|450241106|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
125168370|NCT00923273|450241107|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
125168371|NCT00923273|450241108|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
125168372|NCT00923273|450241104|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
125168373|NCT00923273|450241105|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
125168374|NCT00923273|450241106|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
125168375|NCT00923273|450241107|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
125168376|NCT00923273|450241108|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
125168377|NCT01473524|450241111|FG000|DB Phase|Adverse Event|4|||
125168378|NCT01473524|450241112|FG001|DB Phase|Adverse Event|8|||
125168379|NCT01473524|450241113|FG002|DB Phase|Adverse Event|2|||
125168380|NCT01473524|450241114|FG003|DB Phase|Adverse Event|0|||
125168381|NCT01473524|450241115|FG004|DB Phase|Adverse Event|0|||
125168382|NCT01473524|450241116|FG005|DB Phase|Adverse Event|0|||
125168383|NCT01473524|450241111|FG000|DB Phase|Death|1|||
125168384|NCT01473524|450241112|FG001|DB Phase|Death|0|||
125168385|NCT01473524|450241113|FG002|DB Phase|Death|0|||
125168386|NCT01473524|450241114|FG003|DB Phase|Death|0|||
125168387|NCT01473524|450241115|FG004|DB Phase|Death|0|||
125168388|NCT01473524|450241116|FG005|DB Phase|Death|0|||
125168389|NCT01473524|450241111|FG000|DB Phase|Withdrawal by Subject|2|||
125168390|NCT01473524|450241112|FG001|DB Phase|Withdrawal by Subject|1|||
125168391|NCT01473524|450241113|FG002|DB Phase|Withdrawal by Subject|1|||
125168392|NCT01473524|450241114|FG003|DB Phase|Withdrawal by Subject|0|||
125168393|NCT01473524|450241115|FG004|DB Phase|Withdrawal by Subject|0|||
125168394|NCT01473524|450241116|FG005|DB Phase|Withdrawal by Subject|0|||
125168395|NCT01473524|450241111|FG000|LTSE Phase|Withdrawal by Subject|0|||
125168396|NCT01473524|450241112|FG001|LTSE Phase|Withdrawal by Subject|0|||
125168397|NCT01473524|450241113|FG002|LTSE Phase|Withdrawal by Subject|0|||
125168398|NCT01473524|450241114|FG003|LTSE Phase|Withdrawal by Subject|3|||
125168399|NCT01473524|450241115|FG004|LTSE Phase|Withdrawal by Subject|3|||
125168400|NCT01473524|450241116|FG005|LTSE Phase|Withdrawal by Subject|6|||
125168401|NCT01473524|450241111|FG000|LTSE Phase|Death|0|||
125227621|NCT01764841|450462146|FG000|Overall Study|Logistical Difficulties|0|||
125443371|NCT01216293|451250864|FG000|Main Study|Randomized, Not Treated|1|||
125443372|NCT01216293|451250865|FG001|Main Study|Randomized, Not Treated|0|||
125168402|NCT01473524|450241112|FG001|LTSE Phase|Death|0|||
125168403|NCT01473524|450241113|FG002|LTSE Phase|Death|0|||
125168404|NCT01473524|450241114|FG003|LTSE Phase|Death|0|||
125168405|NCT01473524|450241115|FG004|LTSE Phase|Death|1|||
125168406|NCT01473524|450241116|FG005|LTSE Phase|Death|0|||
125168407|NCT01473524|450241111|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
125168408|NCT01473524|450241112|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
125168409|NCT01473524|450241113|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
125168410|NCT01473524|450241114|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
125168411|NCT01473524|450241115|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
125168412|NCT01473524|450241116|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
125168413|NCT01473524|450241111|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
125168414|NCT01473524|450241112|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
125168415|NCT01473524|450241113|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
125168416|NCT01473524|450241114|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
125168417|NCT01473524|450241115|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
125168418|NCT01473524|450241116|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
125168419|NCT01473524|450241111|FG000|LTSE Phase|Lost to Follow-up|0|||
125168420|NCT01473524|450241112|FG001|LTSE Phase|Lost to Follow-up|0|||
125168421|NCT01473524|450241113|FG002|LTSE Phase|Lost to Follow-up|0|||
125168422|NCT01473524|450241114|FG003|LTSE Phase|Lost to Follow-up|1|||
125168423|NCT01473524|450241115|FG004|LTSE Phase|Lost to Follow-up|3|||
125168424|NCT01473524|450241116|FG005|LTSE Phase|Lost to Follow-up|2|||
125168425|NCT01473524|450241111|FG000|LTSE Phase|Principal Investigator Decision|0|||
125168426|NCT01473524|450241112|FG001|LTSE Phase|Principal Investigator Decision|0|||
125168427|NCT01473524|450241113|FG002|LTSE Phase|Principal Investigator Decision|0|||
125168428|NCT01473524|450241114|FG003|LTSE Phase|Principal Investigator Decision|1|||
125168429|NCT01473524|450241115|FG004|LTSE Phase|Principal Investigator Decision|1|||
125168430|NCT01473524|450241116|FG005|LTSE Phase|Principal Investigator Decision|3|||
125168431|NCT01473524|450241111|FG000|LTSE Phase|Liver Transplantation|0|||
125168432|NCT01473524|450241112|FG001|LTSE Phase|Liver Transplantation|0|||
125168433|NCT01473524|450241113|FG002|LTSE Phase|Liver Transplantation|0|||
125168434|NCT01473524|450241114|FG003|LTSE Phase|Liver Transplantation|0|||
125168435|NCT01473524|450241115|FG004|LTSE Phase|Liver Transplantation|0|||
125168436|NCT01473524|450241116|FG005|LTSE Phase|Liver Transplantation|1|||
125168437|NCT01473524|450241111|FG000|LTSE Phase|Pregnancy|0|||
125168438|NCT01473524|450241112|FG001|LTSE Phase|Pregnancy|0|||
125168439|NCT01473524|450241113|FG002|LTSE Phase|Pregnancy|0|||
125168440|NCT01473524|450241114|FG003|LTSE Phase|Pregnancy|1|||
125168441|NCT01473524|450241115|FG004|LTSE Phase|Pregnancy|0|||
125168442|NCT01473524|450241116|FG005|LTSE Phase|Pregnancy|0|||
125168443|NCT01473524|450241111|FG000|LTSE Phase|Protocol Violation|0|||
125168444|NCT01473524|450241112|FG001|LTSE Phase|Protocol Violation|0|||
125168445|NCT01473524|450241113|FG002|LTSE Phase|Protocol Violation|0|||
125168446|NCT01473524|450241114|FG003|LTSE Phase|Protocol Violation|0|||
125168447|NCT01473524|450241115|FG004|LTSE Phase|Protocol Violation|0|||
125168448|NCT01473524|450241116|FG005|LTSE Phase|Protocol Violation|1|||
125168449|NCT01544179|450241117|FG000|Overall Study|Death|50|||
125168450|NCT01544179|450241118|FG001|Overall Study|Death|37|||
125168451|NCT01544179|450241117|FG000|Overall Study|Lost to Follow-up|0|||
125168452|NCT01544179|450241118|FG001|Overall Study|Lost to Follow-up|1|||
125168453|NCT01544179|450241117|FG000|Overall Study|Adverse Event|0|||
125168454|NCT01544179|450241118|FG001|Overall Study|Adverse Event|1|||
125168455|NCT01544179|450241117|FG000|Overall Study|Withdrawal by Subject|12|||
125168456|NCT01544179|450241118|FG001|Overall Study|Withdrawal by Subject|7|||
125168457|NCT01544179|450241117|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
125168458|NCT01544179|450241118|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125168459|NCT00282919|450241121|FG000|Overall Study|Lack of Efficacy|4|||
125168460|NCT00282919|450241121|FG000|Overall Study|Withdrawal by Subject|1|||
125168461|NCT00282919|450241121|FG000|Overall Study|Asymptomatic Parasitemia|2|||
125168462|NCT01438996|450241122|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
125168463|NCT01438996|450241123|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
125168464|NCT01438996|450241124|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
125168465|NCT02540850|450241125|FG000|Overall Study|Lost to Follow-up|69|||
125168466|NCT02540850|450241126|FG001|Overall Study|Lost to Follow-up|66|||
125168467|NCT02540850|450241127|FG002|Overall Study|Lost to Follow-up|34|||
125168468|NCT02861014|450241128|FG000|Primary Analysis|Adverse Event|7|||
125168469|NCT02861014|450241128|FG000|Primary Analysis|Death|1|||
125168470|NCT02861014|450241128|FG000|Primary Analysis|Lack of Efficacy|3|||
125168471|NCT02861014|450241128|FG000|Primary Analysis|Physician Decision|2|||
125168472|NCT02861014|450241128|FG000|Primary Analysis|Pregnancy|4|||
125168473|NCT02861014|450241128|FG000|Primary Analysis|Protocol Violation|2|||
125168474|NCT02861014|450241128|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
125227622|NCT01764841|450462147|FG001|Overall Study|Logistical Difficulties|1|||
125168475|NCT02861014|450241128|FG000|Primary Analysis|Withdrawal by Subject|14|||
125168476|NCT02861014|450241128|FG000|Primary Analysis|Commercial ocrelizumab|3|||
125168477|NCT02861014|450241128|FG000|Safety Follow-up|Adverse Event|1|||
125168478|NCT02861014|450241128|FG000|Safety Follow-up|Pregnancy|1|||
125227623|NCT01764841|450462148|FG002|Overall Study|Logistical Difficulties|0|||
125168479|NCT02861014|450241128|FG000|Safety Follow-up|Withdrawal by Subject|9|||
125168480|NCT02861014|450241128|FG000|Safety Follow-up|Study terminated by sponsor|1|||
125168481|NCT02861014|450241128|FG000|Safety Follow-up|Physician Decision|1|||
125168482|NCT02861014|450241128|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
125168483|NCT02861014|450241128|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
125168484|NCT01756079|450241134|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
125168485|NCT01756079|450241134|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
125168486|NCT01756079|450241134|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
125168487|NCT01756079|450241134|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
125227624|NCT01764841|450462149|FG003|Overall Study|Logistical Difficulties|0|||
125227625|NCT01764841|450462146|FG000|Overall Study|Death|3|||
125227626|NCT01764841|450462147|FG001|Overall Study|Death|0|||
125227627|NCT01764841|450462148|FG002|Overall Study|Death|1|||
125227628|NCT01764841|450462149|FG003|Overall Study|Death|4|||
125227629|NCT01764841|450462146|FG000|Overall Study|No Follow Up|1|||
125227630|NCT01764841|450462147|FG001|Overall Study|No Follow Up|0|||
125227631|NCT01764841|450462148|FG002|Overall Study|No Follow Up|1|||
125227632|NCT01764841|450462149|FG003|Overall Study|No Follow Up|0|||
125227633|NCT01764841|450462146|FG000|Overall Study|Protocol Violation|0|||
125227634|NCT01764841|450462147|FG001|Overall Study|Protocol Violation|1|||
125227635|NCT01764841|450462148|FG002|Overall Study|Protocol Violation|0|||
125227636|NCT01764841|450462149|FG003|Overall Study|Protocol Violation|0|||
125227637|NCT01764841|450462146|FG000|Overall Study|Withdrawal by Subject|16|||
125227638|NCT01764841|450462147|FG001|Overall Study|Withdrawal by Subject|24|||
125227639|NCT01764841|450462148|FG002|Overall Study|Withdrawal by Subject|11|||
125227640|NCT01764841|450462149|FG003|Overall Study|Withdrawal by Subject|15|||
125227641|NCT01764841|450462146|FG000|Overall Study|Lost to Follow-up|3|||
125227642|NCT01764841|450462147|FG001|Overall Study|Lost to Follow-up|0|||
125227643|NCT01764841|450462148|FG002|Overall Study|Lost to Follow-up|1|||
125168488|NCT01756079|450241134|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
125168489|NCT02794246|450241135|FG000|Overall Study|Withdrawal by Subject|2|||
125168490|NCT02794246|450241135|FG000|Overall Study|Physician Decision|4|||
125168491|NCT01994291|450241136|FG000|Overall Study|Adverse Event|4|||
125168492|NCT01994291|450241137|FG001|Overall Study|Adverse Event|1|||
125168493|NCT01994291|450241138|FG002|Overall Study|Adverse Event|3|||
125168494|NCT01994291|450241136|FG000|Overall Study|Lost to Follow-up|1|||
125168495|NCT01994291|450241137|FG001|Overall Study|Lost to Follow-up|1|||
125168496|NCT01994291|450241138|FG002|Overall Study|Lost to Follow-up|0|||
125168497|NCT01994291|450241136|FG000|Overall Study|Does not meet entrance criteria|1|||
125168498|NCT01994291|450241137|FG001|Overall Study|Does not meet entrance criteria|0|||
125168499|NCT01994291|450241138|FG002|Overall Study|Does not meet entrance criteria|0|||
125168500|NCT01994291|450241136|FG000|Overall Study|Medication error without associated AE|1|||
125168501|NCT01994291|450241137|FG001|Overall Study|Medication error without associated AE|0|||
125168502|NCT01994291|450241138|FG002|Overall Study|Medication error without associated AE|1|||
125168503|NCT01994291|450241136|FG000|Overall Study|Protocol Violation|1|||
125168504|NCT01994291|450241137|FG001|Overall Study|Protocol Violation|0|||
125168505|NCT01994291|450241138|FG002|Overall Study|Protocol Violation|0|||
125168506|NCT01994291|450241136|FG000|Overall Study|Withdrawal by Subject|6|||
125168507|NCT01994291|450241137|FG001|Overall Study|Withdrawal by Subject|3|||
125168508|NCT01994291|450241138|FG002|Overall Study|Withdrawal by Subject|5|||
125168509|NCT01994291|450241136|FG000|Overall Study|Other|1|||
125168510|NCT01994291|450241137|FG001|Overall Study|Other|2|||
125168511|NCT01994291|450241138|FG002|Overall Study|Other|0|||
125168512|NCT00856375|450241141|FG000|Overall Study|Other|0|||
125168513|NCT00856375|450241142|FG001|Overall Study|Other|1|||
125168514|NCT00856375|450241141|FG000|Overall Study|Death|32|||
125168515|NCT00856375|450241142|FG001|Overall Study|Death|30|||
125168516|NCT00856375|450241141|FG000|Overall Study|Sponsor Terminated Study|7|||
125168517|NCT00856375|450241142|FG001|Overall Study|Sponsor Terminated Study|7|||
125168518|NCT00856375|450241141|FG000|Overall Study|Withdrawal by Subject|2|||
125168519|NCT00856375|450241142|FG001|Overall Study|Withdrawal by Subject|1|||
125168520|NCT00856375|450241141|FG000|Overall Study|Lost to Follow-up|1|||
125168521|NCT00856375|450241142|FG001|Overall Study|Lost to Follow-up|2|||
125168522|NCT03201445|450241149|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
125168523|NCT03201445|450241150|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
125168524|NCT03201445|450241149|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
125168525|NCT03201445|450241150|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
125168526|NCT03201445|450241149|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
125168527|NCT03201445|450241150|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
125168528|NCT03201445|450241149|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
125168529|NCT03201445|450241150|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
125168530|NCT03201445|450241149|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
125168531|NCT03201445|450241150|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
125168532|NCT03201445|450241149|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
125168533|NCT03201445|450241150|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
125168534|NCT03201445|450241149|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
125168535|NCT03201445|450241150|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
125168536|NCT03201445|450241149|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
125168537|NCT03201445|450241150|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
125168538|NCT03201445|450241149|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
125168539|NCT03201445|450241150|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
125168540|NCT03201445|450241149|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
125168541|NCT03201445|450241150|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
125168542|NCT03201445|450241149|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
125227644|NCT01764841|450462149|FG003|Overall Study|Lost to Follow-up|0|||
125227645|NCT01791985|450462151|FG000|Overall Study|Adverse Event|7|||
125227646|NCT01791985|450462151|FG000|Overall Study|Withdrawal by Subject|1|||
125227647|NCT01103323|450462152|FG000|Without/Before Drug Switch|Adverse Event|50|||
125168543|NCT03201445|450241150|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
125168544|NCT03201445|450241149|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
125168545|NCT03201445|450241150|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
125168546|NCT03201445|450241149|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
125227648|NCT01103323|450462153|FG001|Without/Before Drug Switch|Adverse Event|7|||
125227649|NCT01103323|450462152|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
125227650|NCT01103323|450462153|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
125227651|NCT01103323|450462152|FG000|Without/Before Drug Switch|Protocol Violation|2|||
125227652|NCT01103323|450462153|FG001|Without/Before Drug Switch|Protocol Violation|0|||
125227653|NCT01103323|450462152|FG000|Without/Before Drug Switch|Physician Decision|2|||
125227654|NCT01103323|450462153|FG001|Without/Before Drug Switch|Physician Decision|0|||
125227655|NCT01103323|450462152|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
125227656|NCT01103323|450462153|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
125227657|NCT01103323|450462152|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
125227658|NCT01103323|450462153|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
125227659|NCT01103323|450462152|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
125227660|NCT01103323|450462153|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
125227661|NCT00372424|450462154|FG000|Overall Study|Adverse Event|2|||
125227662|NCT00372424|450462154|FG000|Overall Study|Withdrawal by Subject|1|||
125227663|NCT00372424|450462154|FG000|Overall Study|Death|1|||
125227664|NCT00372424|450462154|FG000|Overall Study|Objective Progression or Relapse|14|||
125227665|NCT00372424|450462154|FG000|Overall Study|Other|7|||
125227666|NCT00372424|450462154|FG000|Overall Study|Enrolled, Not Treated|1|||
125227667|NCT00072410|450462155|FG000|Overall Study|Progressive disease|0|||
125227668|NCT00072410|450462156|FG001|Overall Study|Progressive disease|3|||
125227669|NCT02314728|450462162|FG000|Overall Study|Protocol Violation|1|||
125227670|NCT02314728|450462163|FG001|Overall Study|Protocol Violation|0|||
125227671|NCT02314728|450462162|FG000|Overall Study|Lost to Follow-up|0|||
125227672|NCT02314728|450462163|FG001|Overall Study|Lost to Follow-up|1|||
125227673|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
125227674|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
125227675|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
125227676|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
125227677|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
125227678|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
125227679|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
125168547|NCT03201445|450241150|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
125168548|NCT03201445|450241149|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
125168549|NCT03201445|450241150|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
125168550|NCT03201445|450241149|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
125168551|NCT03201445|450241150|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
125168552|NCT03201445|450241149|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
125168553|NCT03201445|450241150|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
125168554|NCT03201445|450241149|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
125168555|NCT03201445|450241150|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
125168556|NCT03201445|450241149|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
125168557|NCT03201445|450241150|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
125168558|NCT03201445|450241149|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
125168559|NCT03201445|450241150|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
125168560|NCT03201445|450241149|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
125168561|NCT03201445|450241150|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
125168562|NCT03201445|450241149|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
125227680|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
125227681|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
125227682|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
125227683|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
125227684|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
125227685|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
125227686|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
125227687|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
125227688|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
125227689|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
125227690|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
125227691|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
125227692|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
125227693|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
125227694|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
125227695|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
125227696|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
125227697|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
125227698|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
125227699|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
125227700|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
125227701|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
125227702|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
125227703|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
125227704|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
125227705|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
125168563|NCT03201445|450241150|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
125168564|NCT01228019|450241151|FG000|Overall Study|Dose Violation|70|||
125168565|NCT01228019|450241151|FG000|Overall Study|Duplicate enrollment|1|||
125168566|NCT01228019|450241151|FG000|Overall Study|Missing pre-treatment data|72|||
125168567|NCT01228019|450241151|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
125168568|NCT01228019|450241151|FG000|Overall Study|Violation of Entry Criterion|9|||
125168569|NCT02087189|450241154|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
125168570|NCT01189487|450241159|FG000|Overall Study|Lack of Efficacy|2|||
125168571|NCT01189487|450241159|FG000|Overall Study|Adverse Event|1|||
125168572|NCT04630158|450241160|FG000|Overall Study|Adverse Event|1|||
125168573|NCT04630158|450241161|FG001|Overall Study|Adverse Event|1|||
125168574|NCT04630158|450241162|FG002|Overall Study|Adverse Event|1|||
125168575|NCT04630158|450241160|FG000|Overall Study|Physician Decision|0|||
125168576|NCT04630158|450241161|FG001|Overall Study|Physician Decision|2|||
125168577|NCT04630158|450241162|FG002|Overall Study|Physician Decision|0|||
125168578|NCT04630158|450241160|FG000|Overall Study|Protocol Violation|1|||
125168579|NCT04630158|450241161|FG001|Overall Study|Protocol Violation|0|||
125168580|NCT04630158|450241162|FG002|Overall Study|Protocol Violation|1|||
125168581|NCT04630158|450241160|FG000|Overall Study|Withdrawal by Subject|2|||
125168582|NCT04630158|450241161|FG001|Overall Study|Withdrawal by Subject|1|||
125168583|NCT04630158|450241162|FG002|Overall Study|Withdrawal by Subject|2|||
125168584|NCT03136965|450241167|FG000|Overall Study|Lost to Follow-up|0|||
125168585|NCT03136965|450241168|FG001|Overall Study|Lost to Follow-up|1|||
125168586|NCT03136965|450241169|FG002|Overall Study|Lost to Follow-up|0|||
125168587|NCT03485365|450241170|FG000|Overall Study|Protocol Violation|0|||
125168588|NCT03485365|450241171|FG001|Overall Study|Protocol Violation|0|||
125168589|NCT03485365|450241172|FG002|Overall Study|Protocol Violation|0|||
125168590|NCT03485365|450241173|FG003|Overall Study|Protocol Violation|1|||
125168591|NCT03485365|450241174|FG004|Overall Study|Protocol Violation|0|||
125168592|NCT03485365|450241175|FG005|Overall Study|Protocol Violation|0|||
125168593|NCT03485365|450241176|FG006|Overall Study|Protocol Violation|1|||
125168594|NCT03485365|450241177|FG007|Overall Study|Protocol Violation|0|||
125168595|NCT03485365|450241178|FG008|Overall Study|Protocol Violation|0|||
125168596|NCT04868968|450241179|FG000|Overall Study|Lost to Follow-up|1|||
125168597|NCT02910063|450241186|FG000|Phase 2|Withdrawal by Subject|3|||
125168598|NCT02910063|450241187|FG001|Phase 2|Withdrawal by Subject|0|||
125168599|NCT02910063|450241188|FG002|Phase 2|Withdrawal by Subject|0|||
125168600|NCT02910063|450241186|FG000|Phase 2|Lost to Follow-up|1|||
125168601|NCT02910063|450241187|FG001|Phase 2|Lost to Follow-up|0|||
125168602|NCT02910063|450241188|FG002|Phase 2|Lost to Follow-up|0|||
125168603|NCT02910063|450241186|FG000|Phase 2|Death|24|||
125168604|NCT02910063|450241187|FG001|Phase 2|Death|0|||
125168605|NCT02910063|450241188|FG002|Phase 2|Death|0|||
125168606|NCT02752087|450241189|FG000|Washout|Physician Decision|1|||
125168607|NCT02752087|450241190|FG001|Washout|Physician Decision|0|||
125168608|NCT00843635|450241191|FG000|Overall Study|Adverse Event|2|||
125168609|NCT00843635|450241192|FG001|Overall Study|Adverse Event|2|||
125168610|NCT00843635|450241193|FG002|Overall Study|Adverse Event|0|||
125227706|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
125168611|NCT01547130|450241194|FG000|Overall Study|Lost to Follow-up|9|||
125168612|NCT01547130|450241195|FG001|Overall Study|Lost to Follow-up|5|||
125168613|NCT03496610|450241196|FG000|Overall Study|Lost to Follow-up|3|||
125168614|NCT03496610|450241197|FG001|Overall Study|Lost to Follow-up|2|||
125168615|NCT03496610|450241196|FG000|Overall Study|Physician Decision|1|||
125168616|NCT03496610|450241197|FG001|Overall Study|Physician Decision|0|||
125168617|NCT03496610|450241196|FG000|Overall Study|Withdrawal by Subject|1|||
125168618|NCT03496610|450241197|FG001|Overall Study|Withdrawal by Subject|0|||
125168619|NCT04435184|450241198|FG000|Overall Study|follow-up blood draws missing|3|||
125168620|NCT04435184|450241199|FG001|Overall Study|follow-up blood draws missing|5|||
125168621|NCT02714426|450241200|FG000|Overall Study|Withdrawal by Subject|2|||
125168622|NCT02714426|450241201|FG001|Overall Study|Withdrawal by Subject|2|||
125168623|NCT04762277|450241205|FG000|Overall Study|Withdrawal by Subject|0|||
125168624|NCT04762277|450241206|FG001|Overall Study|Withdrawal by Subject|2|||
125168625|NCT04762277|450241205|FG000|Overall Study|Protocol Violation|0|||
125168626|NCT04762277|450241206|FG001|Overall Study|Protocol Violation|1|||
125168627|NCT04762277|450241205|FG000|Overall Study|Adverse Event|1|||
125168628|NCT04762277|450241206|FG001|Overall Study|Adverse Event|0|||
125168629|NCT01860677|450241207|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
125168630|NCT01860677|450241208|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
125168631|NCT00642278|450241209|FG000|Overall Study|Adverse Event|2|||
125168632|NCT00642278|450241210|FG001|Overall Study|Adverse Event|1|||
125168633|NCT00642278|450241211|FG002|Overall Study|Adverse Event|3|||
125168634|NCT00642278|450241212|FG003|Overall Study|Adverse Event|1|||
125168635|NCT00642278|450241213|FG004|Overall Study|Adverse Event|2|||
125168636|NCT00642278|450241214|FG005|Overall Study|Adverse Event|2|||
125168637|NCT00642278|450241215|FG006|Overall Study|Adverse Event|0|||
125168638|NCT00642278|450241209|FG000|Overall Study|Lack of Efficacy|0|||
125168639|NCT00642278|450241210|FG001|Overall Study|Lack of Efficacy|1|||
125168640|NCT00642278|450241211|FG002|Overall Study|Lack of Efficacy|0|||
125168641|NCT00642278|450241212|FG003|Overall Study|Lack of Efficacy|0|||
125168642|NCT00642278|450241213|FG004|Overall Study|Lack of Efficacy|0|||
125168643|NCT00642278|450241214|FG005|Overall Study|Lack of Efficacy|0|||
125168644|NCT00642278|450241215|FG006|Overall Study|Lack of Efficacy|0|||
125168645|NCT00642278|450241209|FG000|Overall Study|Lost to Follow-up|5|||
125168646|NCT00642278|450241210|FG001|Overall Study|Lost to Follow-up|1|||
125168647|NCT00642278|450241211|FG002|Overall Study|Lost to Follow-up|0|||
125168648|NCT00642278|450241212|FG003|Overall Study|Lost to Follow-up|1|||
125168649|NCT00642278|450241213|FG004|Overall Study|Lost to Follow-up|0|||
125168650|NCT00642278|450241214|FG005|Overall Study|Lost to Follow-up|1|||
125168651|NCT00642278|450241215|FG006|Overall Study|Lost to Follow-up|1|||
125168652|NCT00642278|450241209|FG000|Overall Study|Physician Decision|0|||
125168653|NCT00642278|450241210|FG001|Overall Study|Physician Decision|0|||
125168654|NCT00642278|450241211|FG002|Overall Study|Physician Decision|0|||
125168655|NCT00642278|450241212|FG003|Overall Study|Physician Decision|1|||
125168656|NCT00642278|450241213|FG004|Overall Study|Physician Decision|0|||
125168657|NCT00642278|450241214|FG005|Overall Study|Physician Decision|0|||
125168658|NCT00642278|450241215|FG006|Overall Study|Physician Decision|0|||
125168659|NCT00642278|450241209|FG000|Overall Study|Protocol Violation|0|||
125168660|NCT00642278|450241210|FG001|Overall Study|Protocol Violation|0|||
125168661|NCT00642278|450241211|FG002|Overall Study|Protocol Violation|1|||
125168662|NCT00642278|450241212|FG003|Overall Study|Protocol Violation|1|||
125168663|NCT00642278|450241213|FG004|Overall Study|Protocol Violation|0|||
125168664|NCT00642278|450241214|FG005|Overall Study|Protocol Violation|1|||
125168665|NCT00642278|450241215|FG006|Overall Study|Protocol Violation|2|||
125168666|NCT00642278|450241209|FG000|Overall Study|Withdrawal by Subject|1|||
125168667|NCT00642278|450241210|FG001|Overall Study|Withdrawal by Subject|1|||
125168668|NCT00642278|450241211|FG002|Overall Study|Withdrawal by Subject|1|||
125168669|NCT00642278|450241212|FG003|Overall Study|Withdrawal by Subject|3|||
125168670|NCT00642278|450241213|FG004|Overall Study|Withdrawal by Subject|6|||
125168671|NCT00642278|450241214|FG005|Overall Study|Withdrawal by Subject|2|||
125168672|NCT00642278|450241215|FG006|Overall Study|Withdrawal by Subject|2|||
125168673|NCT00642278|450241209|FG000|Overall Study|Noncompliance with study drug regimen|0|||
125168674|NCT00642278|450241210|FG001|Overall Study|Noncompliance with study drug regimen|0|||
125168675|NCT00642278|450241211|FG002|Overall Study|Noncompliance with study drug regimen|0|||
125168676|NCT00642278|450241212|FG003|Overall Study|Noncompliance with study drug regimen|1|||
125168677|NCT00642278|450241213|FG004|Overall Study|Noncompliance with study drug regimen|0|||
125168678|NCT00642278|450241214|FG005|Overall Study|Noncompliance with study drug regimen|0|||
125168679|NCT00642278|450241215|FG006|Overall Study|Noncompliance with study drug regimen|0|||
125168680|NCT00642278|450241209|FG000|Overall Study|Other|2|||
125168681|NCT00642278|450241210|FG001|Overall Study|Other|1|||
125168682|NCT00642278|450241211|FG002|Overall Study|Other|0|||
125168683|NCT00642278|450241212|FG003|Overall Study|Other|1|||
125168684|NCT00642278|450241213|FG004|Overall Study|Other|0|||
125168685|NCT00642278|450241214|FG005|Overall Study|Other|1|||
125168686|NCT00642278|450241215|FG006|Overall Study|Other|0|||
125168687|NCT00090363|450241216|FG000|Overall Study|Lost to Follow-up|1|||
125168688|NCT00090363|450241217|FG001|Overall Study|Lost to Follow-up|2|||
125168689|NCT00090363|450241218|FG002|Overall Study|Lost to Follow-up|1|||
125168690|NCT00090363|450241216|FG000|Overall Study|Withdrawal by Subject|7|||
125168691|NCT00090363|450241217|FG001|Overall Study|Withdrawal by Subject|7|||
125168692|NCT00090363|450241218|FG002|Overall Study|Withdrawal by Subject|6|||
125168693|NCT00090363|450241216|FG000|Overall Study|Study-specific discontinuation criteria|75|||
125168694|NCT00090363|450241217|FG001|Overall Study|Study-specific discontinuation criteria|74|||
125168695|NCT00090363|450241218|FG002|Overall Study|Study-specific discontinuation criteria|62|||
125168696|NCT00090363|450241216|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125168697|NCT00090363|450241217|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125168698|NCT00090363|450241218|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
125168699|NCT00090363|450241216|FG000|Overall Study|Consent expired|7|||
125168700|NCT00090363|450241217|FG001|Overall Study|Consent expired|10|||
125168701|NCT00090363|450241218|FG002|Overall Study|Consent expired|9|||
125168702|NCT00090363|450241216|FG000|Overall Study|Reasons not specified|2|||
125168703|NCT00090363|450241217|FG001|Overall Study|Reasons not specified|1|||
125168704|NCT00090363|450241218|FG002|Overall Study|Reasons not specified|1|||
125168705|NCT00090363|450241216|FG000|Overall Study|Continuing on study off treatment|14|||
125168706|NCT00090363|450241217|FG001|Overall Study|Continuing on study off treatment|13|||
125168707|NCT00090363|450241218|FG002|Overall Study|Continuing on study off treatment|16|||
125168708|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
125168709|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
125168710|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
125168711|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
125168712|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
125168713|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
125168714|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
125168715|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
125168716|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
125168717|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
125168718|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
125168719|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
125168720|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
125168721|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
125168722|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
125168723|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
125168724|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125168725|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125168726|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125168727|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125168728|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
125168729|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
125168730|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
125168731|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
125168732|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
125168733|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
125168734|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
125168735|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
125168736|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
125168737|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
125168738|NCT03713619|450241219|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
125168739|NCT03713619|450241220|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
125168740|NCT03713619|450241221|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
125168741|NCT03713619|450241222|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
125168742|NCT03713619|450241223|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
125168743|NCT03713619|450241219|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
125168744|NCT03713619|450241220|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
125168745|NCT03713619|450241221|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
125168746|NCT03713619|450241222|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
125168747|NCT03713619|450241223|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
125168748|NCT03713619|450241219|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
125168749|NCT03713619|450241220|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125168750|NCT03713619|450241221|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125168751|NCT03713619|450241222|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
125168752|NCT03713619|450241223|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125168753|NCT03713619|450241219|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
125168754|NCT03713619|450241220|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
125168755|NCT03713619|450241221|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
125168756|NCT03713619|450241222|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
125168757|NCT03713619|450241223|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
125168758|NCT03713619|450241219|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
125168759|NCT03713619|450241220|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
125168760|NCT03713619|450241221|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
125168761|NCT03713619|450241222|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
125168762|NCT03713619|450241223|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
125168763|NCT03713619|450241219|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
125168764|NCT03713619|450241220|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
125168765|NCT03713619|450241221|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
125168766|NCT03713619|450241222|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
125168767|NCT03713619|450241223|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
125168768|NCT03713619|450241219|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
125168769|NCT03713619|450241220|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
125168770|NCT03713619|450241221|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
125168771|NCT03713619|450241222|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
125168772|NCT03713619|450241223|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
125168773|NCT06281171|450241224|FG000|Timepoint 2|Lost to Follow-up|6|||
125168774|NCT06281171|450241225|FG001|Timepoint 2|Lost to Follow-up|4|||
125168775|NCT06281171|450241224|FG000|Timepoint 3|Lost to Follow-up|0|||
125168776|NCT06281171|450241225|FG001|Timepoint 3|Lost to Follow-up|5|||
125168777|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
125168778|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
125168779|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
125168780|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
125168781|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
125168782|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
125168783|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
125168784|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
125168785|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
125168786|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
125168787|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
125168788|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
125168789|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
125168790|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
125168791|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
125168792|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
125168793|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
125168794|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
125168795|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
125168796|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
125168797|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
125168798|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
125168799|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
125168800|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
125168801|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
125168802|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
125168803|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
125168804|NCT02552212|450241226|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
125168805|NCT02552212|450241227|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
125168806|NCT02552212|450241228|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
125168807|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
125168808|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
125168809|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
125168810|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
125168811|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
125168812|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
125168813|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
125168814|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
125168815|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
125168816|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
125168817|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
125168818|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
125168819|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
125168820|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
125168821|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
125168822|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
125168823|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
125168824|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
125168825|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
125168826|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
125168827|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
125168828|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
125168829|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
125168830|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
125168831|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
125168832|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
125168833|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
125168834|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
125168835|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
125168836|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
125168837|NCT02552212|450241226|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
125168838|NCT02552212|450241227|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
125168839|NCT02552212|450241228|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
125168840|NCT04572893|450241231|FG000|Part A|Adverse Event|1|||
125168841|NCT04572893|450241232|FG001|Part A|Adverse Event|0|||
125168842|NCT04572893|450241233|FG002|Part A|Adverse Event|0|||
125168843|NCT04572893|450241234|FG003|Part A|Adverse Event|0|||
125168844|NCT04572893|450241235|FG004|Part A|Adverse Event|0|||
125168845|NCT04572893|450241236|FG005|Part A|Adverse Event|0|||
125168846|NCT04572893|450241237|FG006|Part A|Adverse Event|0|||
125168847|NCT04572893|450241231|FG000|Part B|Withdrawal by Subject|0|||
125168848|NCT04572893|450241232|FG001|Part B|Withdrawal by Subject|0|||
125168849|NCT04572893|450241233|FG002|Part B|Withdrawal by Subject|0|||
125168850|NCT04572893|450241234|FG003|Part B|Withdrawal by Subject|0|||
125168851|NCT04572893|450241235|FG004|Part B|Withdrawal by Subject|0|||
125168852|NCT04572893|450241236|FG005|Part B|Withdrawal by Subject|1|||
125168853|NCT04572893|450241237|FG006|Part B|Withdrawal by Subject|0|||
125168854|NCT04572893|450241231|FG000|Part B|Study terminated by sponsor|0|||
125168855|NCT04572893|450241232|FG001|Part B|Study terminated by sponsor|0|||
125168856|NCT04572893|450241233|FG002|Part B|Study terminated by sponsor|0|||
125168857|NCT04572893|450241234|FG003|Part B|Study terminated by sponsor|0|||
125168858|NCT04572893|450241235|FG004|Part B|Study terminated by sponsor|7|||
125168859|NCT04572893|450241236|FG005|Part B|Study terminated by sponsor|5|||
125168860|NCT04572893|450241237|FG006|Part B|Study terminated by sponsor|3|||
125168861|NCT04572893|450241231|FG000|Part B|Lost to Follow-up|0|||
125168862|NCT04572893|450241232|FG001|Part B|Lost to Follow-up|0|||
125168863|NCT04572893|450241233|FG002|Part B|Lost to Follow-up|0|||
125168864|NCT04572893|450241234|FG003|Part B|Lost to Follow-up|0|||
125168865|NCT04572893|450241235|FG004|Part B|Lost to Follow-up|0|||
125168866|NCT04572893|450241236|FG005|Part B|Lost to Follow-up|0|||
125168867|NCT04572893|450241237|FG006|Part B|Lost to Follow-up|1|||
125168868|NCT04572893|450241231|FG000|Part B|Adverse Event|0|||
125168869|NCT04572893|450241232|FG001|Part B|Adverse Event|0|||
125168870|NCT04572893|450241233|FG002|Part B|Adverse Event|0|||
125168871|NCT04572893|450241234|FG003|Part B|Adverse Event|0|||
125168872|NCT04572893|450241235|FG004|Part B|Adverse Event|1|||
125168873|NCT04572893|450241236|FG005|Part B|Adverse Event|1|||
125168874|NCT04572893|450241237|FG006|Part B|Adverse Event|0|||
125168875|NCT00197496|450241238|FG000|Baseline to Discharge|not interested|1|||
125168876|NCT00197496|450241239|FG001|Baseline to Discharge|not interested|0|||
125168877|NCT00197496|450241238|FG000|Baseline to Discharge|MRSA|1|||
125168878|NCT00197496|450241239|FG001|Baseline to Discharge|MRSA|0|||
125168879|NCT00197496|450241238|FG000|Baseline to Discharge|Physician Decision|0|||
125168880|NCT00197496|450241239|FG001|Baseline to Discharge|Physician Decision|1|||
125168881|NCT00197496|450241238|FG000|Baseline to Discharge|Protocol Violation|0|||
125168882|NCT00197496|450241239|FG001|Baseline to Discharge|Protocol Violation|1|||
125168883|NCT00197496|450241238|FG000|Follow-up|Lost to Follow-up|2|||
125168884|NCT00197496|450241239|FG001|Follow-up|Lost to Follow-up|1|||
125168885|NCT00418821|450241240|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
125168886|NCT00103610|450241241|FG000|Overall Study|Entered Rescue Procedure|10|||
125168887|NCT00103610|450241242|FG001|Overall Study|Entered Rescue Procedure|52|||
125168888|NCT00103610|450241241|FG000|Overall Study|Death|16|||
125168889|NCT00103610|450241242|FG001|Overall Study|Death|12|||
125168890|NCT00103610|450241241|FG000|Overall Study|Elective Withdrawal|4|||
125168891|NCT00103610|450241242|FG001|Overall Study|Elective Withdrawal|0|||
125168892|NCT00103610|450241241|FG000|Overall Study|Lost to Follow-up|3|||
125168893|NCT00103610|450241242|FG001|Overall Study|Lost to Follow-up|1|||
125168894|NCT00103610|450241241|FG000|Overall Study|Adverse Event|2|||
125168895|NCT00103610|450241242|FG001|Overall Study|Adverse Event|2|||
125168896|NCT00103610|450241241|FG000|Overall Study|Other|2|||
125168897|NCT00103610|450241242|FG001|Overall Study|Other|7|||
125168898|NCT00103610|450241241|FG000|Overall Study|Failed mobilization|1|||
125168899|NCT00103610|450241242|FG001|Overall Study|Failed mobilization|5|||
125168900|NCT00103610|450241241|FG000|Overall Study|Noncompliance|0|||
125168901|NCT00103610|450241242|FG001|Overall Study|Noncompliance|1|||
125168902|NCT04042376|450241255|FG000|Overall Study|Withdrawal by Subject|1|||
125168903|NCT04042376|450241255|FG000|Overall Study|Death|3|||
125168904|NCT00213135|450242979|FG000|Overall Study|Adverse Event|9|||
125168905|NCT00213135|450242980|FG001|Overall Study|Adverse Event|5|||
125168906|NCT00213135|450242981|FG002|Overall Study|Adverse Event|5|||
125168907|NCT00213135|450242979|FG000|Overall Study|Lost to Follow-up|11|||
125168908|NCT00213135|450242980|FG001|Overall Study|Lost to Follow-up|8|||
125168909|NCT00213135|450242981|FG002|Overall Study|Lost to Follow-up|4|||
125168910|NCT00213135|450242979|FG000|Overall Study|Protocol Violation|4|||
125168911|NCT00213135|450242980|FG001|Overall Study|Protocol Violation|4|||
125168912|NCT00213135|450242981|FG002|Overall Study|Protocol Violation|10|||
125168913|NCT00213135|450242979|FG000|Overall Study|Death|1|||
125168914|NCT00213135|450242980|FG001|Overall Study|Death|1|||
125168915|NCT00213135|450242981|FG002|Overall Study|Death|2|||
125168916|NCT00213135|450242979|FG000|Overall Study|Disease progression|4|||
125168917|NCT00213135|450242980|FG001|Overall Study|Disease progression|5|||
125168918|NCT00213135|450242981|FG002|Overall Study|Disease progression|21|||
125168919|NCT00213135|450242979|FG000|Overall Study|Other|21|||
125168920|NCT00213135|450242980|FG001|Overall Study|Other|12|||
125168921|NCT00213135|450242981|FG002|Overall Study|Other|15|||
125168922|NCT00359801|450242982|FG000|Overall Study|Lost to Follow-up|72|||
125168923|NCT00359801|450242983|FG001|Overall Study|Lost to Follow-up|58|||
125168924|NCT00359801|450242982|FG000|Overall Study|Withdrawal by Subject|143|||
125168925|NCT00359801|450242983|FG001|Overall Study|Withdrawal by Subject|96|||
125168926|NCT00359801|450242982|FG000|Overall Study|Other|66|||
125168927|NCT00359801|450242983|FG001|Overall Study|Other|46|||
125168928|NCT00359801|450242982|FG000|Overall Study|Final Status Unknown: missing data|7|||
125168929|NCT00359801|450242983|FG001|Overall Study|Final Status Unknown: missing data|4|||
125168930|NCT00359801|450242982|FG000|Overall Study|Sponsor Decision|17|||
125168931|NCT00359801|450242983|FG001|Overall Study|Sponsor Decision|16|||
125168932|NCT01396512|450242985|FG000|Overall Study|Withdrawal by Subject|0|||
125168933|NCT01396512|450242986|FG001|Overall Study|Withdrawal by Subject|1|||
125168934|NCT02500043|450242989|FG000|Overall Study|Randomized, but not Treated|2|||
125168935|NCT02500043|450242990|FG001|Overall Study|Randomized, but not Treated|2|||
125168936|NCT02500043|450242989|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
125168937|NCT02500043|450242990|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
125168938|NCT02500043|450242989|FG000|Overall Study|Adverse Event|33|||
125168939|NCT02500043|450242990|FG001|Overall Study|Adverse Event|11|||
125168940|NCT02500043|450242989|FG000|Overall Study|Clinical Progression|54|||
125168941|NCT02500043|450242990|FG001|Overall Study|Clinical Progression|35|||
125168942|NCT02500043|450242989|FG000|Overall Study|Radiological Progression|192|||
125168943|NCT02500043|450242990|FG001|Overall Study|Radiological Progression|110|||
125168944|NCT02500043|450242989|FG000|Overall Study|Physician's Decision|11|||
125168945|NCT02500043|450242990|FG001|Overall Study|Physician's Decision|3|||
125168946|NCT02500043|450242989|FG000|Overall Study|Withdrawal by Subject|14|||
125168947|NCT02500043|450242990|FG001|Overall Study|Withdrawal by Subject|4|||
125168948|NCT02500043|450242989|FG000|Overall Study|Death|11|||
125168949|NCT02500043|450242990|FG001|Overall Study|Death|2|||
125168950|NCT02500043|450242989|FG000|Overall Study|Protocol Deviation|1|||
125168951|NCT02500043|450242990|FG001|Overall Study|Protocol Deviation|0|||
125168952|NCT02094417|450242991|FG000|Overall Study|Adverse Event|0|||
125168953|NCT02094417|450242992|FG001|Overall Study|Adverse Event|0|||
125168954|NCT02094417|450242993|FG002|Overall Study|Adverse Event|0|||
125168955|NCT02094417|450242994|FG003|Overall Study|Adverse Event|1|||
125168956|NCT02094417|450242991|FG000|Overall Study|Eligibility criteria|0|||
125168957|NCT02094417|450242992|FG001|Overall Study|Eligibility criteria|1|||
125168958|NCT02094417|450242993|FG002|Overall Study|Eligibility criteria|0|||
125168959|NCT02094417|450242994|FG003|Overall Study|Eligibility criteria|0|||
125168960|NCT02094417|450242991|FG000|Overall Study|No responder|4|||
125168961|NCT02094417|450242992|FG001|Overall Study|No responder|4|||
125168962|NCT02094417|450242993|FG002|Overall Study|No responder|4|||
125168963|NCT02094417|450242994|FG003|Overall Study|No responder|3|||
125168964|NCT02094417|450242991|FG000|Overall Study|Unable to conduct observations or assess|0|||
125168965|NCT02094417|450242992|FG001|Overall Study|Unable to conduct observations or assess|1|||
125168966|NCT02094417|450242993|FG002|Overall Study|Unable to conduct observations or assess|0|||
125168967|NCT02094417|450242994|FG003|Overall Study|Unable to conduct observations or assess|0|||
125168968|NCT02094417|450242991|FG000|Overall Study|Withdrawal by Subject|1|||
125168969|NCT02094417|450242992|FG001|Overall Study|Withdrawal by Subject|2|||
125168970|NCT02094417|450242993|FG002|Overall Study|Withdrawal by Subject|1|||
125168971|NCT02094417|450242994|FG003|Overall Study|Withdrawal by Subject|3|||
125168972|NCT03301649|450242997|FG000|Overall Study|Need alternate therapy due to live lice|17|||
125168973|NCT03301649|450242998|FG001|Overall Study|Need alternate therapy due to live lice|25|||
125168974|NCT03301649|450242999|FG002|Overall Study|Need alternate therapy due to live lice|81|||
125168975|NCT03301649|450242997|FG000|Overall Study|Lost to Follow-up|11|||
125168976|NCT03301649|450242998|FG001|Overall Study|Lost to Follow-up|11|||
125168977|NCT03301649|450242999|FG002|Overall Study|Lost to Follow-up|3|||
125168978|NCT03301649|450242997|FG000|Overall Study|Protocol Violation|0|||
125168979|NCT03301649|450242998|FG001|Overall Study|Protocol Violation|1|||
125168980|NCT03301649|450242999|FG002|Overall Study|Protocol Violation|1|||
125168981|NCT03301649|450242997|FG000|Overall Study|Withdrawal by Subject|10|||
125168982|NCT03301649|450242998|FG001|Overall Study|Withdrawal by Subject|4|||
125168983|NCT03301649|450242999|FG002|Overall Study|Withdrawal by Subject|0|||
125227707|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
125168984|NCT03301649|450242997|FG000|Overall Study|Other than specified|5|||
125168985|NCT03301649|450242998|FG001|Overall Study|Other than specified|3|||
125227708|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
125168986|NCT03301649|450242999|FG002|Overall Study|Other than specified|0|||
125168987|NCT01564537|450243000|FG000|Overall Study|Site Terminated by Sponsor|1|||
125168988|NCT01564537|450243001|FG001|Overall Study|Site Terminated by Sponsor|0|||
125168989|NCT01564537|450243000|FG000|Overall Study|Withdrawal by Subject|12|||
125168990|NCT01564537|450243001|FG001|Overall Study|Withdrawal by Subject|14|||
125168991|NCT01564537|450243000|FG000|Overall Study|Lost to Follow-up|7|||
125168992|NCT01564537|450243001|FG001|Overall Study|Lost to Follow-up|3|||
125168993|NCT01564537|450243000|FG000|Overall Study|Reason not specified|81|||
125168994|NCT01564537|450243001|FG001|Overall Study|Reason not specified|82|||
125168995|NCT01635218|450243002|FG000|Overall Study|Lost to Follow-up|3|||
125168996|NCT01635218|450243003|FG001|Overall Study|Lost to Follow-up|7|||
125168997|NCT01635218|450243004|FG002|Overall Study|Lost to Follow-up|6|||
125168998|NCT03559400|450243005|FG000|Overall Study|Lost to Follow-up|9|||
125168999|NCT03559400|450243006|FG001|Overall Study|Lost to Follow-up|7|||
125169000|NCT03559400|450243005|FG000|Overall Study|Death|0|||
125169001|NCT03559400|450243006|FG001|Overall Study|Death|2|||
125169002|NCT03262038|450243007|FG000|Overall Study|Withdrawal by Subject|0|||
125169003|NCT03262038|450243008|FG001|Overall Study|Withdrawal by Subject|1|||
125169004|NCT02679235|450243009|FG000|Overall Study|Withdrawal by Subject|3|||
125169005|NCT02679235|450243009|FG000|Overall Study|Adverse Event|1|||
125169006|NCT00094861|450243010|FG000|Overall Study|Adverse Event|5|||
125169007|NCT00094861|450243011|FG001|Overall Study|Adverse Event|2|||
125169008|NCT00094861|450243010|FG000|Overall Study|Withdrawal by Subject|5|||
125169009|NCT00094861|450243011|FG001|Overall Study|Withdrawal by Subject|3|||
125169010|NCT00094861|450243010|FG000|Overall Study|Physician Decision|1|||
125169011|NCT00094861|450243011|FG001|Overall Study|Physician Decision|1|||
125169012|NCT00094861|450243010|FG000|Overall Study|Lost to Follow-up|0|||
125169013|NCT00094861|450243011|FG001|Overall Study|Lost to Follow-up|1|||
125169014|NCT00094861|450243010|FG000|Overall Study|Death|4|||
125169015|NCT00094861|450243011|FG001|Overall Study|Death|2|||
125169016|NCT00094861|450243010|FG000|Overall Study|Other|3|||
125169017|NCT00094861|450243011|FG001|Overall Study|Other|0|||
125169018|NCT02549027|450243013|FG000|Washout After Period 4|Withdrawal by Subject|0|||
125169019|NCT02549027|450243014|FG001|Washout After Period 4|Withdrawal by Subject|1|||
125169020|NCT02549027|450243015|FG002|Washout After Period 4|Withdrawal by Subject|1|||
125169021|NCT02549027|450243016|FG003|Washout After Period 4|Withdrawal by Subject|1|||
125169022|NCT02549027|450243017|FG004|Washout After Period 4|Withdrawal by Subject|0|||
125169023|NCT02549027|450243018|FG005|Washout After Period 4|Withdrawal by Subject|0|||
125169024|NCT02549027|450243013|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
125169025|NCT02549027|450243014|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
125169026|NCT02549027|450243015|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
125169027|NCT02549027|450243016|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
125169028|NCT02549027|450243017|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
125169029|NCT02549027|450243018|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
125169030|NCT01421511|450243024|FG000|Overall Study|Lost to Follow-up|11|||
125169031|NCT01421511|450243025|FG001|Overall Study|Lost to Follow-up|14|||
125169032|NCT01421511|450243024|FG000|Overall Study|Randomized but didn't receive study drug|1|||
125169033|NCT01421511|450243025|FG001|Overall Study|Randomized but didn't receive study drug|7|||
125169034|NCT01421511|450243024|FG000|Overall Study|Physician Decision|0|||
125227709|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
125227710|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
125227711|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
125227712|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
125227713|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
125227714|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
125227715|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
125169035|NCT01421511|450243025|FG001|Overall Study|Physician Decision|1|||
125169036|NCT01421511|450243024|FG000|Overall Study|Withdrawal by Subject|6|||
125169037|NCT01421511|450243025|FG001|Overall Study|Withdrawal by Subject|5|||
125169038|NCT01421511|450243024|FG000|Overall Study|Death|1|||
125169039|NCT01421511|450243025|FG001|Overall Study|Death|1|||
125169040|NCT04581369|450243026|FG000|Overall Study|Death|7|||
125169041|NCT04581369|450243027|FG001|Overall Study|Death|6|||
125169042|NCT04581369|450243028|FG002|Overall Study|Death|0|||
125169043|NCT04581369|450243026|FG000|Overall Study|Lost to Follow-up|7|||
125169044|NCT04581369|450243027|FG001|Overall Study|Lost to Follow-up|3|||
125169045|NCT04581369|450243028|FG002|Overall Study|Lost to Follow-up|0|||
125169046|NCT04581369|450243026|FG000|Overall Study|liver transplant|2|||
125169047|NCT04581369|450243027|FG001|Overall Study|liver transplant|2|||
125169048|NCT04581369|450243028|FG002|Overall Study|liver transplant|0|||
125169049|NCT04581369|450243026|FG000|Overall Study|transitioned to hospice care|0|||
125169050|NCT04581369|450243027|FG001|Overall Study|transitioned to hospice care|5|||
125169051|NCT04581369|450243028|FG002|Overall Study|transitioned to hospice care|0|||
125169052|NCT00780910|450243029|FG000|Overall Study|Adverse Event|2|||
125169053|NCT01111825|450243030|FG000|Overall Study|Withdrawal by Subject|0|||
125169054|NCT01111825|450243031|FG001|Overall Study|Withdrawal by Subject|0|||
125169055|NCT01111825|450243032|FG002|Overall Study|Withdrawal by Subject|1|||
125227716|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
125169056|NCT01111825|450243033|FG003|Overall Study|Withdrawal by Subject|0|||
125227717|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
125227718|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
125227719|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
125227720|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
125227721|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
125227722|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
125227723|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
125227724|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
125227725|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
125227726|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
125227727|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
125227728|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
125227729|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
125227730|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
125227731|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
125227732|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
125227733|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
125227734|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
125227735|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
125227736|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
125227737|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
125227738|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
125227739|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
125227740|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
125227741|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
125227742|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
125227743|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
125227744|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
125227745|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
125227746|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
125227747|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
125227748|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
125227749|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
125227750|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
125227751|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
125227752|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
125227753|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
125443373|NCT01216293|451250866|FG002|Main Study|Randomized, Not Treated|0|||
125443374|NCT01216293|451250864|FG000|Calcium Absorption Substudy|Adverse Event|0|||
125443375|NCT01216293|451250865|FG001|Calcium Absorption Substudy|Adverse Event|2|||
125169057|NCT01111825|450243030|FG000|Overall Study|Lost to Follow-up|0|||
125169058|NCT01111825|450243031|FG001|Overall Study|Lost to Follow-up|0|||
125169059|NCT01111825|450243032|FG002|Overall Study|Lost to Follow-up|3|||
125169060|NCT01111825|450243033|FG003|Overall Study|Lost to Follow-up|1|||
125169061|NCT01111825|450243030|FG000|Overall Study|Adverse Event|2|||
125169062|NCT01111825|450243031|FG001|Overall Study|Adverse Event|1|||
125169063|NCT01111825|450243032|FG002|Overall Study|Adverse Event|4|||
125169064|NCT01111825|450243033|FG003|Overall Study|Adverse Event|0|||
125169065|NCT01111825|450243030|FG000|Overall Study|Disease Progression|1|||
125169066|NCT01111825|450243031|FG001|Overall Study|Disease Progression|0|||
125169067|NCT01111825|450243032|FG002|Overall Study|Disease Progression|0|||
125169068|NCT01111825|450243033|FG003|Overall Study|Disease Progression|0|||
125169069|NCT01111825|450243030|FG000|Overall Study|Discontinuation by Sponsor|0|||
125169070|NCT01111825|450243031|FG001|Overall Study|Discontinuation by Sponsor|0|||
125169071|NCT01111825|450243032|FG002|Overall Study|Discontinuation by Sponsor|0|||
125169072|NCT01111825|450243033|FG003|Overall Study|Discontinuation by Sponsor|20|||
125169073|NCT02552303|450243041|FG000|Allocation|Withdrawal by Subject|2|||
125169074|NCT02552303|450243042|FG001|Allocation|Withdrawal by Subject|1|||
125169075|NCT02552303|450243043|FG002|Allocation|Withdrawal by Subject|1|||
125169076|NCT02552303|450243044|FG003|Allocation|Withdrawal by Subject|1|||
125169077|NCT02552303|450243041|FG000|Allocation|ineligible|1|||
125169078|NCT02552303|450243042|FG001|Allocation|ineligible|1|||
125169079|NCT02552303|450243043|FG002|Allocation|ineligible|0|||
125169080|NCT02552303|450243044|FG003|Allocation|ineligible|0|||
125169081|NCT02552303|450243041|FG000|Follow-Up|Lost to Follow-up|0|||
125169082|NCT02552303|450243042|FG001|Follow-Up|Lost to Follow-up|0|||
125169083|NCT02552303|450243043|FG002|Follow-Up|Lost to Follow-up|1|||
125169084|NCT02552303|450243044|FG003|Follow-Up|Lost to Follow-up|0|||
125169085|NCT02552303|450243041|FG000|Follow-Up|ineligible|0|||
125169086|NCT02552303|450243042|FG001|Follow-Up|ineligible|2|||
125169087|NCT02552303|450243043|FG002|Follow-Up|ineligible|0|||
125169088|NCT02552303|450243044|FG003|Follow-Up|ineligible|0|||
125169089|NCT01377987|450243045|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
125169090|NCT01377987|450243046|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
125169091|NCT01775189|450243047|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125169092|NCT01775189|450243048|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
125169093|NCT01775189|450243049|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125169094|NCT01775189|450243050|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125169095|NCT01775189|450243051|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125169096|NCT01775189|450243052|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125169097|NCT01775189|450243053|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
125169098|NCT01775189|450243047|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125169099|NCT01775189|450243048|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
125169100|NCT01775189|450243049|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125169101|NCT01775189|450243050|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125169102|NCT01775189|450243051|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125169103|NCT01775189|450243052|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125169104|NCT01775189|450243053|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
125169105|NCT01775189|450243047|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
125169106|NCT01775189|450243048|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
125169107|NCT01775189|450243049|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
125169108|NCT01775189|450243050|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
125169109|NCT01775189|450243051|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
125169110|NCT01775189|450243052|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
125169111|NCT01775189|450243053|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
125169112|NCT01775189|450243047|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
125169113|NCT01775189|450243048|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
125169114|NCT01775189|450243049|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
125169115|NCT01775189|450243050|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
125169116|NCT01775189|450243051|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
125169117|NCT01775189|450243052|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
125169118|NCT01775189|450243053|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
125169119|NCT01775189|450243047|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
125169120|NCT01775189|450243048|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
125169121|NCT01775189|450243049|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
125169122|NCT01775189|450243050|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
125169123|NCT01775189|450243051|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
125169124|NCT01775189|450243052|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
125169125|NCT01775189|450243053|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
125169126|NCT01775189|450243047|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
125169127|NCT01775189|450243048|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
125169128|NCT01775189|450243049|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
125169129|NCT01775189|450243050|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
125169130|NCT01775189|450243051|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
125169131|NCT01775189|450243052|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
125169132|NCT01775189|450243053|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
125169133|NCT02121392|450243056|FG000|Prior to Intervention|Protocol Violation|40|||
125169134|NCT02121392|450243057|FG001|Prior to Intervention|Protocol Violation|35|||
125169135|NCT02121392|450243056|FG000|Prior to Intervention|Withdrawal by Subject|8|||
125169136|NCT02121392|450243057|FG001|Prior to Intervention|Withdrawal by Subject|6|||
125169137|NCT02121392|450243056|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
125169138|NCT02121392|450243057|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
125169139|NCT02121392|450243056|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
125169140|NCT02121392|450243057|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
125169141|NCT00741286|450243058|FG000|Overall Study|Lost to Follow-up|15|||
125169142|NCT00741286|450243059|FG001|Overall Study|Lost to Follow-up|10|||
125169143|NCT00741286|450243058|FG000|Overall Study|Adverse Event|1|||
125169144|NCT00741286|450243059|FG001|Overall Study|Adverse Event|6|||
125169145|NCT00741286|450243058|FG000|Overall Study|Protocol Violation|3|||
125169146|NCT00741286|450243059|FG001|Overall Study|Protocol Violation|2|||
125169147|NCT00741286|450243058|FG000|Overall Study|Primary Outcome|1|||
125169148|NCT00741286|450243059|FG001|Overall Study|Primary Outcome|1|||
125169149|NCT01352416|450243060|FG000|Overall Study|Physician Decision|1|||
125169150|NCT01352416|450243061|FG001|Overall Study|Physician Decision|2|||
125169151|NCT01352416|450243062|FG002|Overall Study|Physician Decision|2|||
125169152|NCT01352416|450243063|FG003|Overall Study|Physician Decision|1|||
125169153|NCT01831258|450243064|FG000|Overall Study|Withdrawal by Subject|2|||
125169154|NCT01831258|450243065|FG001|Overall Study|Withdrawal by Subject|1|||
125169155|NCT01831258|450243064|FG000|Overall Study|Lost to Follow-up|3|||
125169156|NCT01831258|450243065|FG001|Overall Study|Lost to Follow-up|2|||
125227754|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
125227755|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
125227756|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
125227757|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
125227758|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
125227759|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
125227760|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
125227761|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
125227762|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
125227763|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
125227764|NCT01791595|450462164|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
125227765|NCT01791595|450462165|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
125227766|NCT01791595|450462166|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
125227767|NCT01791595|450462167|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
125227768|NCT01791595|450462168|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
125227769|NCT01791595|450462169|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
125227770|NCT01791595|450462170|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
125227771|NCT01791595|450462164|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
125227772|NCT01791595|450462165|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
125227773|NCT01791595|450462166|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
125227774|NCT01791595|450462167|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
125227775|NCT01791595|450462168|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
125227776|NCT01791595|450462169|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
125227777|NCT01791595|450462170|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
125227778|NCT01791595|450462164|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
125227779|NCT01791595|450462165|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
125227780|NCT01791595|450462166|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
125227781|NCT01791595|450462167|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
125227782|NCT01791595|450462168|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
125227783|NCT01791595|450462169|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
125227784|NCT01791595|450462170|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
125227785|NCT01791595|450462164|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
125227786|NCT01791595|450462165|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
125227787|NCT01791595|450462166|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
125227788|NCT01791595|450462167|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
125227789|NCT01791595|450462168|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
125227790|NCT01791595|450462169|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
125227791|NCT01791595|450462170|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
125227792|NCT01791595|450462164|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
125227793|NCT01791595|450462165|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
125227794|NCT01791595|450462166|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
125227795|NCT01791595|450462167|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
125227796|NCT01791595|450462168|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
125227797|NCT01791595|450462169|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
125227798|NCT01791595|450462170|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
125227799|NCT03118934|450462171|FG000|Overall Study|Adverse Event|0|||
125227800|NCT03118934|450462172|FG001|Overall Study|Adverse Event|0|||
125227801|NCT03118934|450462173|FG002|Overall Study|Adverse Event|0|||
125227802|NCT03118934|450462174|FG003|Overall Study|Adverse Event|0|||
125227803|NCT03118934|450462175|FG004|Overall Study|Adverse Event|0|||
125227804|NCT03118934|450462176|FG005|Overall Study|Adverse Event|1|||
125227805|NCT03118934|450462171|FG000|Overall Study|Physician Decision|0|||
125227806|NCT03118934|450462172|FG001|Overall Study|Physician Decision|0|||
125227807|NCT03118934|450462173|FG002|Overall Study|Physician Decision|0|||
125227808|NCT03118934|450462174|FG003|Overall Study|Physician Decision|0|||
125227809|NCT03118934|450462175|FG004|Overall Study|Physician Decision|0|||
125227810|NCT03118934|450462176|FG005|Overall Study|Physician Decision|1|||
125227811|NCT03118934|450462171|FG000|Overall Study|Discontinued prior to exposure|0|||
125227812|NCT03118934|450462172|FG001|Overall Study|Discontinued prior to exposure|1|||
125227813|NCT03118934|450462173|FG002|Overall Study|Discontinued prior to exposure|1|||
125227814|NCT03118934|450462174|FG003|Overall Study|Discontinued prior to exposure|1|||
125227815|NCT03118934|450462175|FG004|Overall Study|Discontinued prior to exposure|2|||
125227816|NCT03118934|450462176|FG005|Overall Study|Discontinued prior to exposure|0|||
125227817|NCT02895347|450462177|FG000|Overall Study|Withdrawal by Subject|3|||
125227818|NCT02895347|450462178|FG001|Overall Study|Withdrawal by Subject|1|||
125227819|NCT03177148|450462182|FG000|Overall Study|Lost to Follow-up|50|||
125227820|NCT03177148|450462183|FG001|Overall Study|Lost to Follow-up|1|||
125227821|NCT03177148|450462182|FG000|Overall Study|Death|1|||
125169157|NCT00811928|450243074|FG000|Overall Study|AEs and SAEs Including Death|7|||
125169158|NCT00811928|450243075|FG001|Overall Study|AEs and SAEs Including Death|11|||
125169159|NCT00811928|450243074|FG000|Overall Study|Withdrawal by Subject|18|||
125169160|NCT00811928|450243075|FG001|Overall Study|Withdrawal by Subject|12|||
125169161|NCT00811928|450243074|FG000|Overall Study|Did Not Take Study Drug|3|||
125169162|NCT00811928|450243075|FG001|Overall Study|Did Not Take Study Drug|0|||
125169163|NCT00811928|450243074|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
125169164|NCT00811928|450243075|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
125169165|NCT00811928|450243074|FG000|Overall Study|Investigator Decision|2|||
125169166|NCT00811928|450243075|FG001|Overall Study|Investigator Decision|1|||
125169167|NCT00811928|450243074|FG000|Overall Study|Poor Compliance|2|||
125169168|NCT00811928|450243075|FG001|Overall Study|Poor Compliance|5|||
125169169|NCT00171951|450243076|FG000|Overall Study|Adverse Event|1|||
125169170|NCT00171951|450243076|FG000|Overall Study|Abnormal Laboratory Values|2|||
125169171|NCT00171951|450243076|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125169172|NCT00171951|450243076|FG000|Overall Study|Participants Withdrew Consent|3|||
125169173|NCT00171951|450243076|FG000|Overall Study|New Cancer Therapy|5|||
125169174|NCT00171951|450243076|FG000|Overall Study|Reason not Specified|2|||
125227822|NCT03177148|450462183|FG001|Overall Study|Death|0|||
125227823|NCT01419314|450462186|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
125227824|NCT01419314|450462187|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
125227825|NCT01419314|450462186|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
125227826|NCT01419314|450462187|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
125227827|NCT01419314|450462186|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
125227828|NCT01419314|450462187|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
125227829|NCT00732069|450462191|FG000|Washout After First Study Drug|Adverse Event|1|||
125227830|NCT00732069|450462192|FG001|Washout After First Study Drug|Adverse Event|0|||
125227831|NCT00732069|450462193|FG002|Washout After First Study Drug|Adverse Event|0|||
125227832|NCT00732069|450462194|FG003|Washout After First Study Drug|Adverse Event|0|||
125227833|NCT00732069|450462195|FG004|Washout After First Study Drug|Adverse Event|0|||
125227834|NCT00732069|450462196|FG005|Washout After First Study Drug|Adverse Event|0|||
125227835|NCT00577317|450462197|FG000|Overall Study|Study Terminated|0|||
125227836|NCT00577317|450462198|FG001|Overall Study|Study Terminated|2|||
125227837|NCT04460326|450462199|FG000|Completed at Least 4 Meals|Early discharge|5|||
125227838|NCT04460326|450462200|FG001|Completed at Least 4 Meals|Early discharge|5|||
125227839|NCT04460326|450462199|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
125227840|NCT04460326|450462200|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
125227841|NCT04460326|450462199|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
125227842|NCT04460326|450462200|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
125227843|NCT04460326|450462199|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
125227844|NCT04460326|450462200|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
125227845|NCT04460326|450462199|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
125227846|NCT04460326|450462200|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
125227847|NCT04460326|450462199|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
125227848|NCT04460326|450462200|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
125227849|NCT03160716|450462201|FG000|Overall Study|Lost to Follow-up|1|||
125227850|NCT04794751|450462203|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
125227851|NCT04794751|450462204|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
125227852|NCT04794751|450462203|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
125227853|NCT04794751|450462204|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
125227854|NCT04794751|450462203|FG000|Period 1|Protocol Violation|0|||
125227855|NCT04794751|450462204|FG001|Period 1|Protocol Violation|2|||
125227856|NCT04794751|450462203|FG000|Period 1|Withdrawal by Subject|0|||
125227857|NCT04794751|450462204|FG001|Period 1|Withdrawal by Subject|1|||
125227858|NCT04794751|450462203|FG000|Period 2|Withdrawal by Subject|0|||
125227859|NCT04794751|450462204|FG001|Period 2|Withdrawal by Subject|1|||
125227860|NCT04794751|450462203|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
125227861|NCT04794751|450462204|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
125227862|NCT04794751|450462203|FG000|Period 2|Protocol Violation|1|||
125227863|NCT04794751|450462204|FG001|Period 2|Protocol Violation|0|||
125227864|NCT00875810|450462208|FG000|Overall Study|Withdrawal by Subject|1|||
125227865|NCT00875810|450462208|FG000|Overall Study|Physician Decision|3|||
125169175|NCT00396812|450243077|FG000|Overall Study|Physician Decision|1|||
125227866|NCT00875810|450462208|FG000|Overall Study|Lost to Follow-up|39|||
125227867|NCT00875810|450462208|FG000|Overall Study|Patient enroled but not implanted|2|||
125227868|NCT00875810|450462208|FG000|Overall Study|Device explanted|1|||
125227869|NCT00780975|450462211|FG000|Overall Study|Progressive disease|3|||
125227870|NCT00780975|450462211|FG000|Overall Study|Toxicity|5|||
125227871|NCT03044314|450462213|FG000|Overall Study|Physician Decision|2|||
125227872|NCT03044314|450462213|FG000|Overall Study|Withdrawal by Subject|1|||
125169176|NCT02015065|450243078|FG000|Overall Study|Death on study|1|||
125169177|NCT02015065|450243079|FG001|Overall Study|Death on study|2|||
125227873|NCT03044314|450462213|FG000|Overall Study|Connector tubing not available|1|||
125169178|NCT02015065|450243080|FG002|Overall Study|Death on study|1|||
125169179|NCT00233402|450243113|FG000|Overall Study|No pathology data|12|||
125169180|NCT00233402|450243114|FG001|Overall Study|No pathology data|9|||
125169181|NCT00233402|450243113|FG000|Overall Study|No Ta/T1|89|||
125169182|NCT00233402|450243114|FG001|Overall Study|No Ta/T1|94|||
125169183|NCT00233402|450243113|FG000|Overall Study|Lost to follow up etc|3|||
125169184|NCT00233402|450243114|FG001|Overall Study|Lost to follow up etc|21|||
125169185|NCT00896480|450243120|FG000|Overall Study|Disease progression/recurrence|21|||
125169186|NCT03553576|450243124|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
125169187|NCT03553576|450243125|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
125169188|NCT03553576|450243124|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
125169189|NCT03553576|450243125|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
125169190|NCT03553576|450243124|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
125169191|NCT03553576|450243125|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
125169192|NCT03553576|450243124|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
125169193|NCT03553576|450243125|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
125169194|NCT03553576|450243124|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
125169195|NCT03553576|450243125|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
125169196|NCT03553576|450243124|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
125169197|NCT03553576|450243125|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
125169198|NCT03553576|450243124|FG000|Overall Study|Physician Decision|2|||
125169199|NCT03553576|450243125|FG001|Overall Study|Physician Decision|5|||
125169200|NCT00205803|450243126|FG000|Infant Series|Lost to Follow-up|10|||
125169201|NCT00205803|450243127|FG001|Infant Series|Lost to Follow-up|4|||
125169202|NCT00205803|450243126|FG000|Infant Series|Withdrawal by Subject|2|||
125169203|NCT00205803|450243127|FG001|Infant Series|Withdrawal by Subject|5|||
125169204|NCT00205803|450243126|FG000|Infant Series|Physician Decision|3|||
125169205|NCT00205803|450243127|FG001|Infant Series|Physician Decision|1|||
125169206|NCT00205803|450243126|FG000|Infant Series|Protocol Violation|1|||
125169207|NCT00205803|450243127|FG001|Infant Series|Protocol Violation|0|||
125169208|NCT00205803|450243126|FG000|Infant Series|Lost Kaiser coverage|0|||
125169209|NCT00205803|450243127|FG001|Infant Series|Lost Kaiser coverage|1|||
125169210|NCT00205803|450243126|FG000|Infant Series|Non-compliant|1|||
125169211|NCT00205803|450243127|FG001|Infant Series|Non-compliant|0|||
125169212|NCT00205803|450243126|FG000|Infant Series|Sponsor request|1|||
125169213|NCT00205803|450243127|FG001|Infant Series|Sponsor request|0|||
125169214|NCT00205803|450243126|FG000|After Infant Series|Adverse Event|1|||
125169215|NCT00205803|450243127|FG001|After Infant Series|Adverse Event|1|||
125169216|NCT00205803|450243126|FG000|After Infant Series|Protocol Violation|1|||
125169217|NCT00205803|450243127|FG001|After Infant Series|Protocol Violation|1|||
125169218|NCT00205803|450243126|FG000|After Infant Series|Lost to Follow-up|2|||
125169219|NCT00205803|450243127|FG001|After Infant Series|Lost to Follow-up|1|||
125169220|NCT00205803|450243126|FG000|After Infant Series|Physician Decision|3|||
125169221|NCT00205803|450243127|FG001|After Infant Series|Physician Decision|2|||
125169222|NCT00205803|450243126|FG000|After Infant Series|Withdrawal by Subject|1|||
125169223|NCT00205803|450243127|FG001|After Infant Series|Withdrawal by Subject|4|||
125169224|NCT00205803|450243126|FG000|After Infant Series|Other|10|||
125169225|NCT00205803|450243127|FG001|After Infant Series|Other|4|||
125169226|NCT00205803|450243126|FG000|Toddler Dose|Lost to Follow-up|2|||
125169227|NCT00205803|450243127|FG001|Toddler Dose|Lost to Follow-up|3|||
125169228|NCT05038800|450243129|FG000|Overall Study|Death|1|||
125169229|NCT05038800|450243130|FG001|Overall Study|Death|1|||
125169230|NCT05038800|450243131|FG002|Overall Study|Death|5|||
125169231|NCT05038800|450243132|FG003|Overall Study|Death|3|||
125169232|NCT05038800|450243133|FG004|Overall Study|Death|1|||
125169233|NCT05038800|450243129|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125169234|NCT05038800|450243130|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125169235|NCT05038800|450243131|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125169236|NCT05038800|450243132|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125169237|NCT05038800|450243133|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125169238|NCT05038800|450243129|FG000|Overall Study|Lack of Efficacy|0|||
125227874|NCT00969228|450462216|FG000|Overall Study|Adverse Event|1|||
125227875|NCT00969228|450462217|FG001|Overall Study|Adverse Event|0|||
125227876|NCT00969228|450462216|FG000|Overall Study|Withdrawal by Subject|4|||
125227877|NCT00969228|450462217|FG001|Overall Study|Withdrawal by Subject|0|||
125227878|NCT00969228|450462216|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
125169239|NCT05038800|450243130|FG001|Overall Study|Lack of Efficacy|0|||
125169240|NCT05038800|450243131|FG002|Overall Study|Lack of Efficacy|0|||
125169241|NCT05038800|450243132|FG003|Overall Study|Lack of Efficacy|0|||
125169242|NCT05038800|450243133|FG004|Overall Study|Lack of Efficacy|1|||
125169243|NCT01104792|450243136|FG000|Overall Study|Adverse Event|77|||
125169244|NCT01104792|450243136|FG000|Overall Study|Insufficient Therapeutic Response|22|||
125169245|NCT01104792|450243136|FG000|Overall Study|Protocol Violation|45|||
125169246|NCT01104792|450243136|FG000|Overall Study|Withdrawal of Consent|179|||
125169247|NCT01104792|450243136|FG000|Overall Study|Lost to Follow-up|43|||
125169248|NCT01104792|450243136|FG000|Overall Study|Reasons Not Specified|27|||
125169249|NCT01104792|450243136|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
125169250|NCT01102374|450243137|FG000|Overall Study|Death|9|||
125169251|NCT01102374|450243138|FG001|Overall Study|Death|13|||
125169252|NCT01102374|450243137|FG000|Overall Study|Lost to Follow-up|7|||
125169253|NCT01102374|450243138|FG001|Overall Study|Lost to Follow-up|6|||
125169254|NCT02071849|450243139|FG000|6-month Primary Endpoint|Did not receive device|4|||
125169255|NCT02071849|450243139|FG000|6-month Primary Endpoint|Adverse Event|1|||
125169256|NCT02071849|450243139|FG000|2-year Extended Follow-up|Adverse Event|1|||
125169257|NCT04619992|450243140|FG000|Overall Study|Withdrawal by Subject|1|||
125169258|NCT04619992|450243141|FG001|Overall Study|Withdrawal by Subject|0|||
125169259|NCT03301623|450243145|FG000|Overall Study|Death|3|||
125169260|NCT03301623|450243146|FG001|Overall Study|Death|1|||
125169261|NCT03301623|450243145|FG000|Overall Study|Withdrawal by Subject|11|||
125169262|NCT03301623|450243146|FG001|Overall Study|Withdrawal by Subject|13|||
125169263|NCT03301623|450243145|FG000|Overall Study|Lost to Follow-up|3|||
125169264|NCT03301623|450243146|FG001|Overall Study|Lost to Follow-up|1|||
125169265|NCT00658021|450243147|FG000|28-Week Treatment Period|Adverse Event|3|||
125169266|NCT00658021|450243148|FG001|28-Week Treatment Period|Adverse Event|1|||
125169267|NCT00658021|450243149|FG002|28-Week Treatment Period|Adverse Event|0|||
125169268|NCT00658021|450243147|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
125169269|NCT00658021|450243148|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
125169270|NCT00658021|450243149|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
125169271|NCT00658021|450243147|FG000|28-Week Treatment Period|Protocol Violation|0|||
125169272|NCT00658021|450243148|FG001|28-Week Treatment Period|Protocol Violation|2|||
125169273|NCT00658021|450243149|FG002|28-Week Treatment Period|Protocol Violation|1|||
125169274|NCT00658021|450243147|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
125169275|NCT00658021|450243148|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
125169276|NCT00658021|450243149|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
125169277|NCT00658021|450243147|FG000|28-Week Treatment Period|Physician Decision|1|||
125169278|NCT00658021|450243148|FG001|28-Week Treatment Period|Physician Decision|2|||
125169279|NCT00658021|450243149|FG002|28-Week Treatment Period|Physician Decision|1|||
125169280|NCT00658021|450243147|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
125169281|NCT00658021|450243148|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
125169282|NCT00658021|450243149|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
125169283|NCT00658021|450243147|FG000|28-Week Treatment Period|Loss of glucose control|1|||
125169284|NCT00658021|450243148|FG001|28-Week Treatment Period|Loss of glucose control|1|||
125169285|NCT00658021|450243149|FG002|28-Week Treatment Period|Loss of glucose control|10|||
125169286|NCT00658021|450243147|FG000|28-Week Treatment Period|Other|2|||
125169287|NCT00658021|450243148|FG001|28-Week Treatment Period|Other|3|||
125169288|NCT00658021|450243149|FG002|28-Week Treatment Period|Other|1|||
125169289|NCT00658021|450243147|FG000|28-Week Treatment Period|Did not receive treatment|2|||
125169290|NCT00658021|450243148|FG001|28-Week Treatment Period|Did not receive treatment|0|||
125169291|NCT00658021|450243149|FG002|28-Week Treatment Period|Did not receive treatment|0|||
125169292|NCT00658021|450243147|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
125169293|NCT00658021|450243148|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
125169294|NCT00658021|450243149|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
125169295|NCT00658021|450243147|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
125169296|NCT00658021|450243148|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
125169297|NCT00658021|450243149|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
125169298|NCT02092467|450243152|FG000|Overall Study|Death|49|||
125169299|NCT02092467|450243153|FG001|Overall Study|Death|66|||
125169300|NCT02092467|450243154|FG002|Overall Study|Death|38|||
125169301|NCT02092467|450243152|FG000|Overall Study|Lost to Follow-up|38|||
125169302|NCT02092467|450243153|FG001|Overall Study|Lost to Follow-up|35|||
125169303|NCT02092467|450243154|FG002|Overall Study|Lost to Follow-up|40|||
125169304|NCT02092467|450243152|FG000|Overall Study|Global Deterioration of Health Status|1|||
125169305|NCT02092467|450243153|FG001|Overall Study|Global Deterioration of Health Status|0|||
125169306|NCT02092467|450243154|FG002|Overall Study|Global Deterioration of Health Status|0|||
125169307|NCT02092467|450243152|FG000|Overall Study|Other|32|||
125169308|NCT02092467|450243153|FG001|Overall Study|Other|30|||
125169309|NCT02092467|450243154|FG002|Overall Study|Other|24|||
125169310|NCT02092467|450243152|FG000|Overall Study|Withdrawal by Subject|282|||
125169311|NCT02092467|450243153|FG001|Overall Study|Withdrawal by Subject|327|||
125169312|NCT02092467|450243154|FG002|Overall Study|Withdrawal by Subject|289|||
125169313|NCT02092467|450243152|FG000|Overall Study|Randomized but not treated|2|||
125169314|NCT02092467|450243153|FG001|Overall Study|Randomized but not treated|1|||
125169315|NCT02092467|450243154|FG002|Overall Study|Randomized but not treated|7|||
125169316|NCT02952898|450243160|FG000|Overall Study|Withdrawal by Subject|10|||
125227879|NCT00969228|450462217|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
125227880|NCT02563899|450462218|FG000|Overall Study|Protocol Violation|1|||
125227881|NCT02563899|450462219|FG001|Overall Study|Protocol Violation|0|||
125227882|NCT02563899|450462220|FG002|Overall Study|Protocol Violation|0|||
125227883|NCT02563899|450462221|FG003|Overall Study|Protocol Violation|0|||
125227884|NCT02563899|450462218|FG000|Overall Study|Withdrawal by Subject|0|||
125227885|NCT02563899|450462219|FG001|Overall Study|Withdrawal by Subject|0|||
125227886|NCT02563899|450462220|FG002|Overall Study|Withdrawal by Subject|1|||
125227887|NCT02563899|450462221|FG003|Overall Study|Withdrawal by Subject|0|||
125227888|NCT00794664|450462227|FG000|Treatment Period|Withdrawal by Subject|0|||
125227889|NCT00794664|450462228|FG001|Treatment Period|Withdrawal by Subject|2|||
125227890|NCT00794664|450462227|FG000|Treatment Period|Protocol non-compliance|0|||
125227891|NCT00794664|450462228|FG001|Treatment Period|Protocol non-compliance|1|||
125227892|NCT00794664|450462227|FG000|Treatment Period|Other|0|||
125227893|NCT00794664|450462228|FG001|Treatment Period|Other|1|||
125227894|NCT00794664|450462227|FG000|Treatment Period|Adverse Event|1|||
125227895|NCT00794664|450462228|FG001|Treatment Period|Adverse Event|8|||
125227896|NCT00794664|450462227|FG000|Follow-up Period|Other|1|||
125227897|NCT00794664|450462228|FG001|Follow-up Period|Other|2|||
125227898|NCT00794664|450462227|FG000|Follow-up Period|Withdrawal by Subject|0|||
125227899|NCT00794664|450462228|FG001|Follow-up Period|Withdrawal by Subject|2|||
125227900|NCT00794664|450462227|FG000|Follow-up Period|Protocol non-compliance|0|||
125227901|NCT00794664|450462228|FG001|Follow-up Period|Protocol non-compliance|1|||
125227902|NCT01305564|450462233|FG000|Overall Study|Death|21|||
125227903|NCT01305564|450462233|FG000|Overall Study|Lost to Follow-up|12|||
125227904|NCT01305564|450462233|FG000|Overall Study|Withdrawal by Subject|1|||
125227905|NCT01305564|450462233|FG000|Overall Study|Physician Decision|3|||
125227906|NCT01419535|450462235|FG000|Overall Study|could not maintain iv line|1|||
125227907|NCT01419535|450462236|FG001|Overall Study|could not maintain iv line|1|||
125227908|NCT01419535|450462235|FG000|Overall Study|Withdrawal by Subject|0|||
125227909|NCT01419535|450462236|FG001|Overall Study|Withdrawal by Subject|1|||
125227910|NCT01814007|450462244|FG000|Overall Study|Withdrawal by Subject|1|||
125227911|NCT02100124|450462245|FG000|Overall Study|Lost to Follow-up|5|||
125227912|NCT02100124|450462246|FG001|Overall Study|Lost to Follow-up|11|||
125227913|NCT02100124|450462247|FG002|Overall Study|Lost to Follow-up|3|||
125227914|NCT02100124|450462245|FG000|Overall Study|Withdrawal by Subject|1|||
125227915|NCT02100124|450462246|FG001|Overall Study|Withdrawal by Subject|0|||
125227916|NCT02100124|450462247|FG002|Overall Study|Withdrawal by Subject|0|||
125227917|NCT00916578|450464091|FG000|Overall Study|Physician Decision|2|||
125227918|NCT00916578|450464091|FG000|Overall Study|Withdrawal by Subject|3|||
125227919|NCT00916578|450464091|FG000|Overall Study|Insurance Denial|2|||
125227920|NCT01433159|450464096|FG000|Overall Study|Adverse Event|1|||
125227921|NCT01433159|450464097|FG001|Overall Study|Adverse Event|0|||
125227922|NCT01433159|450464096|FG000|Overall Study|Physician Decision|1|||
125227923|NCT01433159|450464097|FG001|Overall Study|Physician Decision|0|||
125227924|NCT01433159|450464096|FG000|Overall Study|Protocol Violation|0|||
125227925|NCT01433159|450464097|FG001|Overall Study|Protocol Violation|1|||
125227926|NCT01100853|450464098|FG000|Overall Study|Lost to Follow-up|11|||
125227927|NCT01100853|450464099|FG001|Overall Study|Lost to Follow-up|6|||
125227928|NCT01100853|450464098|FG000|Overall Study|Received <4 study injections|10|||
125227929|NCT01100853|450464099|FG001|Overall Study|Received <4 study injections|13|||
125227930|NCT01100853|450464098|FG000|Overall Study|Withdrawal by Subject|6|||
125227931|NCT01100853|450464099|FG001|Overall Study|Withdrawal by Subject|4|||
125227932|NCT01190891|450464100|FG000|Overall Study|Protocol Violation|1|||
125227933|NCT01190891|450464101|FG001|Overall Study|Protocol Violation|0|||
125227934|NCT01190891|450464100|FG000|Overall Study|Withdrawal by Subject|5|||
125227935|NCT01190891|450464101|FG001|Overall Study|Withdrawal by Subject|0|||
125227936|NCT00266708|450464102|FG000|Overall Study|No renal function|1|||
125227937|NCT00266708|450464103|FG001|Overall Study|No renal function|1|||
125227938|NCT00266708|450464102|FG000|Overall Study|Refused biopsy|3|||
125227939|NCT00266708|450464103|FG001|Overall Study|Refused biopsy|6|||
125227940|NCT00266708|450464102|FG000|Overall Study|Asthma|0|||
125227941|NCT00266708|450464103|FG001|Overall Study|Asthma|2|||
125227942|NCT01926028|450464104|FG000|Overall Study|Lost to Follow-up|7|||
125227943|NCT01926028|450464105|FG001|Overall Study|Lost to Follow-up|6|||
125227944|NCT01926028|450464106|FG002|Overall Study|Lost to Follow-up|0|||
125227945|NCT01926028|450464104|FG000|Overall Study|Physician Decision|1|||
125227946|NCT01926028|450464105|FG001|Overall Study|Physician Decision|5|||
125227947|NCT01926028|450464106|FG002|Overall Study|Physician Decision|0|||
125227948|NCT01926028|450464104|FG000|Overall Study|Withdrawal by Subject|9|||
125227949|NCT01926028|450464105|FG001|Overall Study|Withdrawal by Subject|9|||
125227950|NCT01926028|450464106|FG002|Overall Study|Withdrawal by Subject|2|||
125227951|NCT01926028|450464104|FG000|Overall Study|Non compliance or other reasons|4|||
125227952|NCT01926028|450464105|FG001|Overall Study|Non compliance or other reasons|2|||
125227953|NCT01926028|450464106|FG002|Overall Study|Non compliance or other reasons|0|||
125227954|NCT01130272|450464107|FG000|Overall Study|Adverse Event|2|||
125227955|NCT01130272|450464108|FG001|Overall Study|Adverse Event|5|||
125227956|NCT01130272|450464109|FG002|Overall Study|Adverse Event|6|||
125169317|NCT02952898|450243161|FG001|Overall Study|Withdrawal by Subject|8|||
125169318|NCT02952898|450243162|FG002|Overall Study|Withdrawal by Subject|8|||
125169319|NCT02952898|450243160|FG000|Overall Study|Adverse Event|8|||
125169320|NCT02952898|450243161|FG001|Overall Study|Adverse Event|8|||
125169321|NCT02952898|450243162|FG002|Overall Study|Adverse Event|3|||
125169322|NCT02952898|450243160|FG000|Overall Study|Lost to Follow-up|3|||
125169323|NCT02952898|450243161|FG001|Overall Study|Lost to Follow-up|2|||
125169324|NCT02952898|450243162|FG002|Overall Study|Lost to Follow-up|2|||
125169325|NCT02952898|450243160|FG000|Overall Study|Non-compliance with study drug|1|||
125169326|NCT02952898|450243161|FG001|Overall Study|Non-compliance with study drug|1|||
125169327|NCT02952898|450243162|FG002|Overall Study|Non-compliance with study drug|2|||
125169328|NCT04400682|450243167|FG000|Period 1|Withdrawal by Subject|1|||
125169329|NCT04400682|450243168|FG001|Period 1|Withdrawal by Subject|4|||
125169330|NCT02293863|450243169|FG000|Overall Study|Death|4|||
125169331|NCT02293863|450243170|FG001|Overall Study|Death|6|||
125169332|NCT02293863|450243171|FG002|Overall Study|Death|4|||
125169333|NCT02293863|450243169|FG000|Overall Study|Lost to Follow-up|2|||
125169334|NCT02293863|450243170|FG001|Overall Study|Lost to Follow-up|2|||
125169335|NCT02293863|450243171|FG002|Overall Study|Lost to Follow-up|2|||
125227957|NCT01130272|450464110|FG003|Overall Study|Adverse Event|22|||
125169336|NCT02293863|450243169|FG000|Overall Study|Withdrawal by Subject|3|||
125169337|NCT02293863|450243170|FG001|Overall Study|Withdrawal by Subject|3|||
125169338|NCT02293863|450243171|FG002|Overall Study|Withdrawal by Subject|1|||
125169339|NCT02293863|450243169|FG000|Overall Study|Reason Not Specified|0|||
125169340|NCT02293863|450243170|FG001|Overall Study|Reason Not Specified|2|||
125169341|NCT02293863|450243171|FG002|Overall Study|Reason Not Specified|2|||
125169342|NCT03462459|450243172|FG000|Overall Study|Death|1|||
125169343|NCT03462459|450243173|FG001|Overall Study|Death|0|||
125169344|NCT03462459|450243172|FG000|Overall Study|Lack of Efficacy|2|||
125169345|NCT03462459|450243173|FG001|Overall Study|Lack of Efficacy|4|||
125169346|NCT03462459|450243172|FG000|Overall Study|Lost to Follow-up|1|||
125169347|NCT03462459|450243173|FG001|Overall Study|Lost to Follow-up|3|||
125169348|NCT03462459|450243172|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
125169349|NCT03462459|450243173|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
125169350|NCT03462459|450243172|FG000|Overall Study|Withdrawal by Subject|3|||
125227958|NCT01130272|450464111|FG004|Overall Study|Adverse Event|7|||
125227959|NCT01130272|450464107|FG000|Overall Study|IVRS-confirmed constipation|0|||
125227960|NCT01130272|450464108|FG001|Overall Study|IVRS-confirmed constipation|1|||
125227961|NCT01130272|450464109|FG002|Overall Study|IVRS-confirmed constipation|1|||
125227962|NCT01130272|450464110|FG003|Overall Study|IVRS-confirmed constipation|2|||
125227963|NCT01130272|450464111|FG004|Overall Study|IVRS-confirmed constipation|0|||
125227964|NCT01130272|450464107|FG000|Overall Study|Rescue medications due to diarrhea|3|||
125227965|NCT01130272|450464108|FG001|Overall Study|Rescue medications due to diarrhea|5|||
125227966|NCT01130272|450464109|FG002|Overall Study|Rescue medications due to diarrhea|8|||
125169351|NCT03462459|450243173|FG001|Overall Study|Withdrawal by Subject|2|||
125169352|NCT03462459|450243172|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
125169353|NCT03462459|450243173|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
125169354|NCT02929056|450244739|FG000|Overall Study|Lost to Follow-up|0|||
125169355|NCT02929056|450244740|FG001|Overall Study|Lost to Follow-up|1|||
125169356|NCT03132155|450244741|FG000|Overall Study|Lack of Efficacy|6|||
125169357|NCT03132155|450244741|FG000|Overall Study|Lost to Follow-up|1|||
125169358|NCT03132155|450244741|FG000|Overall Study|Withdrawal by Subject|1|||
125169359|NCT02925403|450244745|FG000|Overall Study|Lost to Follow-up|0|||
125169360|NCT02925403|450244746|FG001|Overall Study|Lost to Follow-up|1|||
125169361|NCT00459043|450244747|FG000|Overall Study|Withdrawal by Subject|1|||
125169362|NCT00459043|450244748|FG001|Overall Study|Withdrawal by Subject|0|||
125169363|NCT02899195|450244751|FG000|Concurrent Durvalumab|Adverse Event|4|||
125169364|NCT02899195|450244751|FG000|Concurrent Durvalumab|Physician Decision|1|||
125169365|NCT02899195|450244751|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
125169366|NCT02899195|450244751|FG000|Concurrent Durvalumab|Progressive Disease|5|||
125169367|NCT02899195|450244751|FG000|Maintenance Durvalumab|Adverse Event|1|||
125169368|NCT02899195|450244751|FG000|Maintenance Durvalumab|Physician Decision|1|||
125169369|NCT02899195|450244751|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
125169370|NCT02899195|450244751|FG000|Maintenance Durvalumab|Progressive Disease|31|||
125169371|NCT03156504|450244752|FG000|Overall Study|Withdrawal by Subject|1|||
125227967|NCT01130272|450464110|FG003|Overall Study|Rescue medications due to diarrhea|8|||
125227968|NCT01130272|450464111|FG004|Overall Study|Rescue medications due to diarrhea|6|||
125227969|NCT01130272|450464107|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
125392278|NCT02476968|451070617|FG001|Overall Study|Patient decision|8|||
125169372|NCT00450801|450244753|FG000|Overall Study|Death|1|||
125169373|NCT03452137|450244754|FG000|Overall Study|Death|67|||
125169374|NCT03452137|450244755|FG001|Overall Study|Death|70|||
125169375|NCT03452137|450244754|FG000|Overall Study|Lost to Follow-up|4|||
125169376|NCT03452137|450244755|FG001|Overall Study|Lost to Follow-up|2|||
125169377|NCT03452137|450244754|FG000|Overall Study|Physician Decision|0|||
125169378|NCT03452137|450244755|FG001|Overall Study|Physician Decision|1|||
125169379|NCT03452137|450244754|FG000|Overall Study|Study Terminated by Sponsor|120|||
125169380|NCT03452137|450244755|FG001|Overall Study|Study Terminated by Sponsor|121|||
125169381|NCT03452137|450244754|FG000|Overall Study|Withdrawal by Subject|12|||
125169382|NCT03452137|450244755|FG001|Overall Study|Withdrawal by Subject|9|||
125169383|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
125169384|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
125169385|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
125169386|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
125169387|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
125169388|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
125169389|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
125169390|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
125169391|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
125169392|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
125169393|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
125169394|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
125169395|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
125169396|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
125169397|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
125169398|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
125169399|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
125169400|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
125169401|NCT00261443|450244756|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
125169402|NCT00261443|450244757|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
125169403|NCT00261443|450244758|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
125169404|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
125169405|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
125169406|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
125169407|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
125169408|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
125169409|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
125169410|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
125169411|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
125169412|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
125169413|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
125169414|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
125169415|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
125169416|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
125169417|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
125169418|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
125169419|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
125169420|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
125169421|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
125169422|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
125169423|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
125169424|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
125169425|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
125169426|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
125169427|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
125169428|NCT00261443|450244756|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
125169429|NCT00261443|450244757|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
125169430|NCT00261443|450244758|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
125169431|NCT00261443|450244756|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
125169432|NCT00261443|450244757|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
125169433|NCT00261443|450244758|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
125169434|NCT00261443|450244756|FG000|3: Assessment of Relapse|Adverse Event|0|||
125169435|NCT00261443|450244757|FG001|3: Assessment of Relapse|Adverse Event|15|||
125169436|NCT00261443|450244758|FG002|3: Assessment of Relapse|Adverse Event|19|||
125169437|NCT00261443|450244756|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
125169438|NCT00261443|450244757|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
125169439|NCT00261443|450244758|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
125169440|NCT00261443|450244756|FG000|3: Assessment of Relapse|Death|0|||
125169441|NCT00261443|450244757|FG001|3: Assessment of Relapse|Death|0|||
125169442|NCT00261443|450244758|FG002|3: Assessment of Relapse|Death|1|||
125169443|NCT00261443|450244756|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
125169444|NCT00261443|450244757|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
125169445|NCT00261443|450244758|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
125169446|NCT00261443|450244756|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
125169447|NCT00261443|450244757|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
125169448|NCT00261443|450244758|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
125169449|NCT00261443|450244756|FG000|3: Assessment of Relapse|Pregnancy|0|||
125169450|NCT00261443|450244757|FG001|3: Assessment of Relapse|Pregnancy|2|||
125169451|NCT00261443|450244758|FG002|3: Assessment of Relapse|Pregnancy|1|||
125169452|NCT00261443|450244756|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
125169453|NCT00261443|450244757|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
125169454|NCT00261443|450244758|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
125169455|NCT00261443|450244756|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
125169456|NCT00261443|450244757|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
125169457|NCT00261443|450244758|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
125169458|NCT00261443|450244756|FG000|3: Assessment of Relapse|Other Reasons|0|||
125169459|NCT00261443|450244757|FG001|3: Assessment of Relapse|Other Reasons|4|||
125169460|NCT00261443|450244758|FG002|3: Assessment of Relapse|Other Reasons|3|||
125169461|NCT00261443|450244756|FG000|4: Extension Phase|Adverse Event|0|||
125169462|NCT00261443|450244757|FG001|4: Extension Phase|Adverse Event|1|||
125169463|NCT00261443|450244758|FG002|4: Extension Phase|Adverse Event|0|||
125169464|NCT00261443|450244756|FG000|4: Extension Phase|Withdrawal by Subject|0|||
125169465|NCT00261443|450244757|FG001|4: Extension Phase|Withdrawal by Subject|1|||
125169466|NCT00261443|450244758|FG002|4: Extension Phase|Withdrawal by Subject|2|||
125169467|NCT00261443|450244756|FG000|4: Extension Phase|Lost to Follow-up|0|||
125169468|NCT00261443|450244757|FG001|4: Extension Phase|Lost to Follow-up|1|||
125169469|NCT00261443|450244758|FG002|4: Extension Phase|Lost to Follow-up|0|||
125169470|NCT02755649|450244759|FG000|Overall Study|Transitioned into OLE study|99|||
125169471|NCT02755649|450244760|FG001|Overall Study|Transitioned into OLE study|98|||
125169472|NCT02755649|450244761|FG002|Overall Study|Transitioned into OLE study|100|||
125169473|NCT02755649|450244759|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
125169474|NCT02755649|450244760|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
125169475|NCT02755649|450244761|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
125169476|NCT02755649|450244759|FG000|Overall Study|Physician Decision|0|||
125169477|NCT02755649|450244760|FG001|Overall Study|Physician Decision|0|||
125169478|NCT02755649|450244761|FG002|Overall Study|Physician Decision|2|||
125169479|NCT02755649|450244759|FG000|Overall Study|Withdrawal by Subject|0|||
125169480|NCT02755649|450244760|FG001|Overall Study|Withdrawal by Subject|1|||
125169481|NCT02755649|450244761|FG002|Overall Study|Withdrawal by Subject|0|||
125169482|NCT02755649|450244759|FG000|Overall Study|Undecided|1|||
125169483|NCT02755649|450244760|FG001|Overall Study|Undecided|0|||
125169484|NCT02755649|450244761|FG002|Overall Study|Undecided|0|||
125169485|NCT01286753|450244762|FG000|Overall Study|Adverse Event|7|||
125169486|NCT01286753|450244763|FG001|Overall Study|Adverse Event|6|||
125169487|NCT01286753|450244762|FG000|Overall Study|Progression|11|||
125169488|NCT01286753|450244763|FG001|Overall Study|Progression|13|||
125169489|NCT01286753|450244762|FG000|Overall Study|Refused Treatment|1|||
125169490|NCT01286753|450244763|FG001|Overall Study|Refused Treatment|0|||
125169491|NCT01286753|450244762|FG000|Overall Study|Withdrawal of Consent|0|||
125169492|NCT01286753|450244763|FG001|Overall Study|Withdrawal of Consent|2|||
125169493|NCT01286753|450244762|FG000|Overall Study|Discontinued to Join Extension Study|6|||
125169494|NCT01286753|450244763|FG001|Overall Study|Discontinued to Join Extension Study|4|||
125169495|NCT01286753|450244762|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
125169496|NCT01286753|450244763|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
125169497|NCT04933968|450244766|FG000|Overall Study|Adverse Event|0|||
125169498|NCT04933968|450244767|FG001|Overall Study|Adverse Event|0|||
125169499|NCT04933968|450244768|FG002|Overall Study|Adverse Event|1|||
125169500|NCT04933968|450244769|FG003|Overall Study|Adverse Event|1|||
125169501|NCT04933968|450244770|FG004|Overall Study|Adverse Event|0|||
125169502|NCT04933968|450244771|FG005|Overall Study|Adverse Event|0|||
125169503|NCT04933968|450244766|FG000|Overall Study|Lost to Follow-up|1|||
125169504|NCT04933968|450244767|FG001|Overall Study|Lost to Follow-up|0|||
125169505|NCT04933968|450244768|FG002|Overall Study|Lost to Follow-up|1|||
125169506|NCT04933968|450244769|FG003|Overall Study|Lost to Follow-up|0|||
125169507|NCT04933968|450244770|FG004|Overall Study|Lost to Follow-up|0|||
125169508|NCT04933968|450244771|FG005|Overall Study|Lost to Follow-up|0|||
125169509|NCT04933968|450244766|FG000|Overall Study|Randomized not treated|1|||
125169510|NCT04933968|450244767|FG001|Overall Study|Randomized not treated|0|||
125169511|NCT04933968|450244768|FG002|Overall Study|Randomized not treated|0|||
125169512|NCT04933968|450244769|FG003|Overall Study|Randomized not treated|0|||
125169513|NCT04933968|450244770|FG004|Overall Study|Randomized not treated|0|||
125169514|NCT04933968|450244771|FG005|Overall Study|Randomized not treated|0|||
125169515|NCT04933968|450244766|FG000|Overall Study|Sponsor terminated study|0|||
125169516|NCT04933968|450244767|FG001|Overall Study|Sponsor terminated study|0|||
125169517|NCT04933968|450244768|FG002|Overall Study|Sponsor terminated study|0|||
125169518|NCT04933968|450244769|FG003|Overall Study|Sponsor terminated study|1|||
125169519|NCT04933968|450244770|FG004|Overall Study|Sponsor terminated study|2|||
125169520|NCT04933968|450244771|FG005|Overall Study|Sponsor terminated study|0|||
125169521|NCT04933968|450244766|FG000|Overall Study|Other|0|||
125169522|NCT04933968|450244767|FG001|Overall Study|Other|0|||
125169523|NCT04933968|450244768|FG002|Overall Study|Other|0|||
125169524|NCT04933968|450244769|FG003|Overall Study|Other|1|||
125169525|NCT04933968|450244770|FG004|Overall Study|Other|0|||
125169526|NCT04933968|450244771|FG005|Overall Study|Other|0|||
125169527|NCT04933968|450244766|FG000|Overall Study|Missing|1|||
125169528|NCT04933968|450244767|FG001|Overall Study|Missing|3|||
125227970|NCT01130272|450464108|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
125227971|NCT01130272|450464109|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
125227972|NCT01130272|450464110|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
125227973|NCT01130272|450464111|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
125169529|NCT04933968|450244768|FG002|Overall Study|Missing|2|||
125169530|NCT04933968|450244769|FG003|Overall Study|Missing|1|||
125169531|NCT04933968|450244770|FG004|Overall Study|Missing|1|||
125169532|NCT04933968|450244771|FG005|Overall Study|Missing|0|||
125169533|NCT02119819|450244772|FG000|Overall Study|Adverse Event|3|||
125169534|NCT02119819|450244773|FG001|Overall Study|Adverse Event|1|||
125169535|NCT02119819|450244774|FG002|Overall Study|Adverse Event|2|||
125169536|NCT02119819|450244775|FG003|Overall Study|Adverse Event|3|||
125169537|NCT02119819|450244776|FG004|Overall Study|Adverse Event|0|||
125169538|NCT02119819|450244777|FG005|Overall Study|Adverse Event|1|||
125169539|NCT02119819|450244772|FG000|Overall Study|Lack of Efficacy|0|||
125169540|NCT02119819|450244773|FG001|Overall Study|Lack of Efficacy|0|||
125169541|NCT02119819|450244774|FG002|Overall Study|Lack of Efficacy|0|||
125169542|NCT02119819|450244775|FG003|Overall Study|Lack of Efficacy|0|||
125169543|NCT02119819|450244776|FG004|Overall Study|Lack of Efficacy|0|||
125169544|NCT02119819|450244777|FG005|Overall Study|Lack of Efficacy|1|||
125169545|NCT02119819|450244772|FG000|Overall Study|Lost to Follow-up|0|||
125169546|NCT02119819|450244773|FG001|Overall Study|Lost to Follow-up|0|||
125169547|NCT02119819|450244774|FG002|Overall Study|Lost to Follow-up|1|||
125169548|NCT02119819|450244775|FG003|Overall Study|Lost to Follow-up|2|||
125169549|NCT02119819|450244776|FG004|Overall Study|Lost to Follow-up|1|||
125169550|NCT02119819|450244777|FG005|Overall Study|Lost to Follow-up|2|||
125169551|NCT02119819|450244772|FG000|Overall Study|Physician Decision|1|||
125169552|NCT02119819|450244773|FG001|Overall Study|Physician Decision|1|||
125169553|NCT02119819|450244774|FG002|Overall Study|Physician Decision|0|||
125169554|NCT02119819|450244775|FG003|Overall Study|Physician Decision|0|||
125169555|NCT02119819|450244776|FG004|Overall Study|Physician Decision|0|||
125169556|NCT02119819|450244777|FG005|Overall Study|Physician Decision|1|||
125169557|NCT02119819|450244772|FG000|Overall Study|Withdrawal by Subject|5|||
125169558|NCT02119819|450244773|FG001|Overall Study|Withdrawal by Subject|3|||
125169559|NCT02119819|450244774|FG002|Overall Study|Withdrawal by Subject|0|||
125169560|NCT02119819|450244775|FG003|Overall Study|Withdrawal by Subject|0|||
125169561|NCT02119819|450244776|FG004|Overall Study|Withdrawal by Subject|6|||
125169562|NCT02119819|450244777|FG005|Overall Study|Withdrawal by Subject|10|||
125169563|NCT02119819|450244772|FG000|Overall Study|Jury Duty|0|||
125169564|NCT02119819|450244773|FG001|Overall Study|Jury Duty|0|||
125169565|NCT02119819|450244774|FG002|Overall Study|Jury Duty|1|||
125169566|NCT02119819|450244775|FG003|Overall Study|Jury Duty|0|||
125227974|NCT01130272|450464107|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
125227975|NCT01130272|450464108|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
125227976|NCT01130272|450464109|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
125227977|NCT01130272|450464110|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
125227978|NCT01130272|450464111|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
125227979|NCT01130272|450464107|FG000|Overall Study|Protocol Violation|0|||
125227980|NCT01130272|450464108|FG001|Overall Study|Protocol Violation|0|||
125227981|NCT01130272|450464109|FG002|Overall Study|Protocol Violation|3|||
125227982|NCT01130272|450464110|FG003|Overall Study|Protocol Violation|5|||
125227983|NCT01130272|450464111|FG004|Overall Study|Protocol Violation|5|||
125169567|NCT02119819|450244776|FG004|Overall Study|Jury Duty|0|||
125169568|NCT02119819|450244777|FG005|Overall Study|Jury Duty|0|||
125169569|NCT02119819|450244772|FG000|Overall Study|Protocol Violation|0|||
125169570|NCT02119819|450244773|FG001|Overall Study|Protocol Violation|0|||
125169571|NCT02119819|450244774|FG002|Overall Study|Protocol Violation|0|||
125227984|NCT01130272|450464107|FG000|Overall Study|Lost to Follow-up|4|||
125227985|NCT01130272|450464108|FG001|Overall Study|Lost to Follow-up|3|||
125227986|NCT01130272|450464109|FG002|Overall Study|Lost to Follow-up|4|||
125169572|NCT02119819|450244775|FG003|Overall Study|Protocol Violation|1|||
125169573|NCT02119819|450244776|FG004|Overall Study|Protocol Violation|0|||
125169574|NCT02119819|450244777|FG005|Overall Study|Protocol Violation|0|||
125169575|NCT02119819|450244772|FG000|Overall Study|Left the city to get a job|0|||
125169576|NCT02119819|450244773|FG001|Overall Study|Left the city to get a job|0|||
125169577|NCT02119819|450244774|FG002|Overall Study|Left the city to get a job|0|||
125169578|NCT02119819|450244775|FG003|Overall Study|Left the city to get a job|1|||
125169579|NCT02119819|450244776|FG004|Overall Study|Left the city to get a job|0|||
125169580|NCT02119819|450244777|FG005|Overall Study|Left the city to get a job|0|||
125169581|NCT02699684|450244778|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
125169582|NCT02699684|450244779|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
125169583|NCT04839692|450244780|FG000|Overall Study|Withdrawal by Subject|0|||
125169584|NCT04839692|450244781|FG001|Overall Study|Withdrawal by Subject|3|||
125169585|NCT04839692|450244780|FG000|Overall Study|Physician Decision|1|||
125169586|NCT04839692|450244781|FG001|Overall Study|Physician Decision|0|||
125169587|NCT03146962|450244782|FG000|Overall Study|Lost to Follow-up|1|||
125169588|NCT03146962|450244783|FG001|Overall Study|Lost to Follow-up|1|||
125169589|NCT03146962|450244784|FG002|Overall Study|Lost to Follow-up|0|||
125169590|NCT03146962|450244785|FG003|Overall Study|Lost to Follow-up|0|||
125169591|NCT03146962|450244786|FG004|Overall Study|Lost to Follow-up|0|||
125169592|NCT03146962|450244787|FG005|Overall Study|Lost to Follow-up|0|||
125169593|NCT03146962|450244788|FG006|Overall Study|Lost to Follow-up|0|||
125169594|NCT03146962|450244789|FG007|Overall Study|Lost to Follow-up|0|||
125169595|NCT03146962|450244790|FG008|Overall Study|Lost to Follow-up|0|||
125169596|NCT03146962|450244791|FG009|Overall Study|Lost to Follow-up|0|||
125169597|NCT03146962|450244782|FG000|Overall Study|Adverse Event|0|||
125169598|NCT03146962|450244783|FG001|Overall Study|Adverse Event|3|||
125169599|NCT03146962|450244784|FG002|Overall Study|Adverse Event|0|||
125169600|NCT03146962|450244785|FG003|Overall Study|Adverse Event|0|||
125169601|NCT03146962|450244786|FG004|Overall Study|Adverse Event|0|||
125169602|NCT03146962|450244787|FG005|Overall Study|Adverse Event|0|||
125169603|NCT03146962|450244788|FG006|Overall Study|Adverse Event|0|||
125169604|NCT03146962|450244789|FG007|Overall Study|Adverse Event|1|||
125169605|NCT03146962|450244790|FG008|Overall Study|Adverse Event|0|||
125169606|NCT03146962|450244791|FG009|Overall Study|Adverse Event|0|||
125169607|NCT03146962|450244782|FG000|Overall Study|Withdrawal by Subject|0|||
125169608|NCT03146962|450244783|FG001|Overall Study|Withdrawal by Subject|0|||
125169609|NCT03146962|450244784|FG002|Overall Study|Withdrawal by Subject|0|||
125169610|NCT03146962|450244785|FG003|Overall Study|Withdrawal by Subject|0|||
125169611|NCT03146962|450244786|FG004|Overall Study|Withdrawal by Subject|1|||
125169612|NCT03146962|450244787|FG005|Overall Study|Withdrawal by Subject|0|||
125169613|NCT03146962|450244788|FG006|Overall Study|Withdrawal by Subject|0|||
125169614|NCT03146962|450244789|FG007|Overall Study|Withdrawal by Subject|0|||
125169615|NCT03146962|450244790|FG008|Overall Study|Withdrawal by Subject|0|||
125169616|NCT03146962|450244791|FG009|Overall Study|Withdrawal by Subject|0|||
125169617|NCT03146962|450244782|FG000|Overall Study|Death|0|||
125169618|NCT03146962|450244783|FG001|Overall Study|Death|1|||
125169619|NCT03146962|450244784|FG002|Overall Study|Death|0|||
125169620|NCT03146962|450244785|FG003|Overall Study|Death|0|||
125169621|NCT03146962|450244786|FG004|Overall Study|Death|0|||
125169622|NCT03146962|450244787|FG005|Overall Study|Death|0|||
125169623|NCT03146962|450244788|FG006|Overall Study|Death|0|||
125169624|NCT03146962|450244789|FG007|Overall Study|Death|0|||
125169625|NCT03146962|450244790|FG008|Overall Study|Death|0|||
125169626|NCT03146962|450244791|FG009|Overall Study|Death|0|||
125169627|NCT03146962|450244782|FG000|Overall Study|COVID Precautions|1|||
125169628|NCT03146962|450244783|FG001|Overall Study|COVID Precautions|0|||
125169629|NCT03146962|450244784|FG002|Overall Study|COVID Precautions|0|||
125169630|NCT03146962|450244785|FG003|Overall Study|COVID Precautions|0|||
125169631|NCT03146962|450244786|FG004|Overall Study|COVID Precautions|0|||
125169632|NCT03146962|450244787|FG005|Overall Study|COVID Precautions|0|||
125169633|NCT03146962|450244788|FG006|Overall Study|COVID Precautions|0|||
125169634|NCT03146962|450244789|FG007|Overall Study|COVID Precautions|0|||
125169635|NCT03146962|450244790|FG008|Overall Study|COVID Precautions|0|||
125169636|NCT03146962|450244791|FG009|Overall Study|COVID Precautions|0|||
125169637|NCT03146962|450244782|FG000|Overall Study|Physician Decision|0|||
125169638|NCT03146962|450244783|FG001|Overall Study|Physician Decision|0|||
125169639|NCT03146962|450244784|FG002|Overall Study|Physician Decision|0|||
125169640|NCT03146962|450244785|FG003|Overall Study|Physician Decision|0|||
125169641|NCT03146962|450244786|FG004|Overall Study|Physician Decision|0|||
125169642|NCT03146962|450244787|FG005|Overall Study|Physician Decision|0|||
125169643|NCT03146962|450244788|FG006|Overall Study|Physician Decision|0|||
125169644|NCT03146962|450244789|FG007|Overall Study|Physician Decision|0|||
125169645|NCT03146962|450244790|FG008|Overall Study|Physician Decision|0|||
125169646|NCT03146962|450244791|FG009|Overall Study|Physician Decision|1|||
125169647|NCT03146962|450244782|FG000|Overall Study|Started New Treatment|0|||
125169648|NCT03146962|450244783|FG001|Overall Study|Started New Treatment|1|||
125169649|NCT03146962|450244784|FG002|Overall Study|Started New Treatment|0|||
125169650|NCT03146962|450244785|FG003|Overall Study|Started New Treatment|0|||
125169651|NCT03146962|450244786|FG004|Overall Study|Started New Treatment|0|||
125169652|NCT03146962|450244787|FG005|Overall Study|Started New Treatment|0|||
125169653|NCT03146962|450244788|FG006|Overall Study|Started New Treatment|0|||
125392279|NCT02476968|451070618|FG002|Overall Study|Patient decision|0|||
125169654|NCT03146962|450244789|FG007|Overall Study|Started New Treatment|0|||
125169655|NCT03146962|450244790|FG008|Overall Study|Started New Treatment|0|||
125169656|NCT03146962|450244791|FG009|Overall Study|Started New Treatment|0|||
125169657|NCT00926783|450244793|FG000|Overall Study|Incomplete CFAE Procedures|3|||
125169658|NCT00926783|450244794|FG001|Overall Study|Incomplete CFAE Procedures|3|||
125169659|NCT02186834|450244797|FG000|Dose Escalation|Death|0|||
125169660|NCT02186834|450244798|FG001|Dose Escalation|Death|0|||
125169661|NCT02186834|450244799|FG002|Dose Escalation|Death|0|||
125169662|NCT02186834|450244800|FG003|Dose Escalation|Death|1|||
125169663|NCT02186834|450244801|FG004|Dose Escalation|Death|0|||
125227987|NCT01130272|450464110|FG003|Overall Study|Lost to Follow-up|7|||
125227988|NCT01130272|450464111|FG004|Overall Study|Lost to Follow-up|6|||
125227989|NCT01130272|450464107|FG000|Overall Study|Withdrawal by Subject|4|||
125227990|NCT01130272|450464108|FG001|Overall Study|Withdrawal by Subject|11|||
125227991|NCT01130272|450464109|FG002|Overall Study|Withdrawal by Subject|10|||
125227992|NCT01130272|450464110|FG003|Overall Study|Withdrawal by Subject|9|||
125227993|NCT01130272|450464111|FG004|Overall Study|Withdrawal by Subject|8|||
125227994|NCT01130272|450464107|FG000|Overall Study|Physician Decision|1|||
125227995|NCT01130272|450464108|FG001|Overall Study|Physician Decision|1|||
125227996|NCT01130272|450464109|FG002|Overall Study|Physician Decision|0|||
125227997|NCT01130272|450464110|FG003|Overall Study|Physician Decision|1|||
125227998|NCT01130272|450464111|FG004|Overall Study|Physician Decision|2|||
125227999|NCT01130272|450464107|FG000|Overall Study|Sponsor decision|6|||
125228000|NCT01130272|450464108|FG001|Overall Study|Sponsor decision|15|||
125228001|NCT01130272|450464109|FG002|Overall Study|Sponsor decision|16|||
125228002|NCT01130272|450464110|FG003|Overall Study|Sponsor decision|13|||
125228003|NCT01130272|450464111|FG004|Overall Study|Sponsor decision|16|||
125228004|NCT01130272|450464107|FG000|Overall Study|Study arm discontinued|38|||
125228005|NCT01130272|450464108|FG001|Overall Study|Study arm discontinued|0|||
125228006|NCT01130272|450464109|FG002|Overall Study|Study arm discontinued|0|||
125228007|NCT01130272|450464110|FG003|Overall Study|Study arm discontinued|0|||
125228008|NCT01130272|450464111|FG004|Overall Study|Study arm discontinued|0|||
125228009|NCT01548404|450464112|FG000|Overall Study|Adverse Event|3|||
125228010|NCT01548404|450464113|FG001|Overall Study|Adverse Event|1|||
125228011|NCT01548404|450464112|FG000|Overall Study|Physician Decision|2|||
125228012|NCT01548404|450464113|FG001|Overall Study|Physician Decision|1|||
125228013|NCT01548404|450464112|FG000|Overall Study|Inadequate response to study treatment|23|||
125228014|NCT01548404|450464113|FG001|Overall Study|Inadequate response to study treatment|7|||
125228015|NCT01548404|450464112|FG000|Overall Study|Lost to Follow-up|2|||
125228016|NCT01548404|450464113|FG001|Overall Study|Lost to Follow-up|0|||
125228017|NCT01548404|450464112|FG000|Overall Study|Withdrawal by Subject|0|||
125228018|NCT01548404|450464113|FG001|Overall Study|Withdrawal by Subject|3|||
125228019|NCT01548404|450464112|FG000|Overall Study|Other than specified above|0|||
125228020|NCT01548404|450464113|FG001|Overall Study|Other than specified above|2|||
125228021|NCT00641056|450464114|FG000|Overall Study|Adverse Event|12|||
125228022|NCT00641056|450464115|FG001|Overall Study|Adverse Event|2|||
125228023|NCT00641056|450464114|FG000|Overall Study|Lost to Follow-up|2|||
125228024|NCT00641056|450464115|FG001|Overall Study|Lost to Follow-up|1|||
125228025|NCT00641056|450464114|FG000|Overall Study|Physician Decision|3|||
125228026|NCT00641056|450464115|FG001|Overall Study|Physician Decision|1|||
125228027|NCT00641056|450464114|FG000|Overall Study|Protocol Violation|2|||
125228028|NCT00641056|450464115|FG001|Overall Study|Protocol Violation|0|||
125228029|NCT00641056|450464114|FG000|Overall Study|Entry Criteria Not Met|3|||
125228030|NCT00641056|450464115|FG001|Overall Study|Entry Criteria Not Met|0|||
125228031|NCT00641056|450464114|FG000|Overall Study|Subject Decision|6|||
125228032|NCT00641056|450464115|FG001|Overall Study|Subject Decision|19|||
125228033|NCT00641056|450464114|FG000|Overall Study|Sponsor Decision|1|||
125228034|NCT00641056|450464115|FG001|Overall Study|Sponsor Decision|2|||
125228035|NCT00737048|450464116|FG000|Overall Study|Physician Decision|0|||
125228036|NCT00737048|450464117|FG001|Overall Study|Physician Decision|0|||
125228037|NCT00737048|450464118|FG002|Overall Study|Physician Decision|1|||
125228038|NCT00737048|450464116|FG000|Overall Study|Adverse Event|0|||
125228039|NCT00737048|450464117|FG001|Overall Study|Adverse Event|1|||
125228040|NCT00737048|450464118|FG002|Overall Study|Adverse Event|0|||
125228041|NCT00737048|450464116|FG000|Overall Study|Worsening of the symptoms|3|||
125228042|NCT00737048|450464117|FG001|Overall Study|Worsening of the symptoms|5|||
125228043|NCT00737048|450464118|FG002|Overall Study|Worsening of the symptoms|3|||
125228044|NCT04040439|450464120|FG000|Overall Study|Invalid registration|11|||
125228045|NCT04040439|450464120|FG000|Overall Study|No IC* on publication of study results|2|||
125228046|NCT01309386|450464121|FG000|Overall Study|Other|2|||
125228047|NCT01309386|450464122|FG001|Overall Study|Other|0|||
125228048|NCT01309386|450464121|FG000|Overall Study|Withdrawal by Subject|2|||
125228049|NCT01309386|450464122|FG001|Overall Study|Withdrawal by Subject|0|||
125228050|NCT01309386|450464121|FG000|Overall Study|Progressive disease|9|||
125228051|NCT01309386|450464122|FG001|Overall Study|Progressive disease|11|||
125228052|NCT01309386|450464121|FG000|Overall Study|Physician Decision|1|||
125228053|NCT01309386|450464122|FG001|Overall Study|Physician Decision|1|||
125228054|NCT01309386|450464121|FG000|Overall Study|Lack of Efficacy|3|||
125228055|NCT01309386|450464122|FG001|Overall Study|Lack of Efficacy|1|||
125228056|NCT01309386|450464121|FG000|Overall Study|Adverse Event|5|||
125228057|NCT01309386|450464122|FG001|Overall Study|Adverse Event|8|||
125228058|NCT02062437|450464123|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
125228059|NCT02062437|450464123|FG000|Overall Study|Patient not available for the 2y visit|18|||
125228060|NCT02062437|450464123|FG000|Overall Study|Death|2|||
125228061|NCT02062437|450464123|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
125228062|NCT01674725|450464124|FG000|Overall Study|Adverse Event|1|||
125228063|NCT01674725|450464125|FG001|Overall Study|Adverse Event|0|||
125228064|NCT01674725|450464124|FG000|Overall Study|Did not receive study drug|1|||
125228065|NCT01674725|450464125|FG001|Overall Study|Did not receive study drug|0|||
125228066|NCT01674725|450464124|FG000|Overall Study|Withdrawal by Subject|1|||
125228067|NCT01674725|450464125|FG001|Overall Study|Withdrawal by Subject|0|||
125228068|NCT01674725|450464124|FG000|Overall Study|Lost to Follow-up|0|||
125228069|NCT01674725|450464125|FG001|Overall Study|Lost to Follow-up|1|||
125228070|NCT02900352|450464126|FG000|Overall Study|Lost to Follow-up|28|||
125228071|NCT02900352|450464127|FG001|Overall Study|Lost to Follow-up|17|||
125228072|NCT03074695|450464128|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
125228073|NCT03074695|450464129|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
125228074|NCT03074695|450464128|FG000|Overall Study|Research staff not available|1|||
125228075|NCT03074695|450464129|FG001|Overall Study|Research staff not available|2|||
125228076|NCT03074695|450464128|FG000|Overall Study|Did not receive neuraxial block|2|||
125228077|NCT03074695|450464129|FG001|Overall Study|Did not receive neuraxial block|2|||
125228078|NCT01774981|450464130|FG000|Overall Study|Adverse Event|0|||
125228079|NCT01774981|450464131|FG001|Overall Study|Adverse Event|0|||
125228080|NCT01774981|450464132|FG002|Overall Study|Adverse Event|0|||
125228081|NCT01774981|450464133|FG003|Overall Study|Adverse Event|0|||
125228082|NCT01774981|450464134|FG004|Overall Study|Adverse Event|0|||
125228083|NCT01774981|450464135|FG005|Overall Study|Adverse Event|1|||
125228084|NCT01774981|450464136|FG006|Overall Study|Adverse Event|0|||
125228085|NCT01774981|450464137|FG007|Overall Study|Adverse Event|0|||
125228086|NCT01774981|450464130|FG000|Overall Study|Withdrawal by Subject|0|||
125228087|NCT01774981|450464131|FG001|Overall Study|Withdrawal by Subject|0|||
125228088|NCT01774981|450464132|FG002|Overall Study|Withdrawal by Subject|0|||
125228089|NCT01774981|450464133|FG003|Overall Study|Withdrawal by Subject|0|||
125228090|NCT01774981|450464134|FG004|Overall Study|Withdrawal by Subject|0|||
125228091|NCT01774981|450464135|FG005|Overall Study|Withdrawal by Subject|0|||
125228092|NCT01774981|450464136|FG006|Overall Study|Withdrawal by Subject|0|||
125228093|NCT01774981|450464137|FG007|Overall Study|Withdrawal by Subject|1|||
125228094|NCT01774981|450464130|FG000|Overall Study|Death|0|||
125228095|NCT01774981|450464131|FG001|Overall Study|Death|0|||
125228096|NCT01774981|450464132|FG002|Overall Study|Death|0|||
125228097|NCT01774981|450464133|FG003|Overall Study|Death|0|||
125228098|NCT01774981|450464134|FG004|Overall Study|Death|1|||
125228099|NCT01774981|450464135|FG005|Overall Study|Death|0|||
125228100|NCT01774981|450464136|FG006|Overall Study|Death|0|||
125228101|NCT01774981|450464137|FG007|Overall Study|Death|0|||
125228102|NCT00960193|450464138|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
125228103|NCT01324102|450464141|FG000|Overall Study|illness|1|||
125228104|NCT01324102|450464142|FG001|Overall Study|illness|6|||
125228105|NCT00386334|450464145|FG000|Double Blind Period|Adverse Event|9|||
125228106|NCT00386334|450464146|FG001|Double Blind Period|Adverse Event|14|||
125228107|NCT00386334|450464145|FG000|Double Blind Period|Protocol Violation|1|||
125228108|NCT00386334|450464146|FG001|Double Blind Period|Protocol Violation|1|||
125228109|NCT00386334|450464145|FG000|Double Blind Period|Withdrawal by Subject|9|||
125228110|NCT00386334|450464146|FG001|Double Blind Period|Withdrawal by Subject|13|||
125228111|NCT00386334|450464145|FG000|Double Blind Period|Lack of Efficacy|20|||
125228112|NCT00386334|450464146|FG001|Double Blind Period|Lack of Efficacy|11|||
125228113|NCT00386334|450464145|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
125228114|NCT00386334|450464146|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
125228115|NCT00386334|450464145|FG000|Double Blind Period|Other|3|||
125228116|NCT00386334|450464146|FG001|Double Blind Period|Other|3|||
125228117|NCT00386334|450464145|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
125228118|NCT00386334|450464146|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
125228119|NCT00902577|450464147|FG000|Overall Study|Withdrawal by Subject|6|||
125228120|NCT00902577|450464147|FG000|Overall Study|FMISO production failure|2|||
125228121|NCT00106002|450464148|FG000|Overall Study|Did not take any study drug|1|||
125228122|NCT00106002|450464148|FG000|Overall Study|Ineligible after Registration|1|||
125228123|NCT01249131|450464155|FG000|Washout Period of 10 Days|Adverse Event|0|||
125228124|NCT01249131|450464156|FG001|Washout Period of 10 Days|Adverse Event|0|||
125228125|NCT01249131|450464157|FG002|Washout Period of 10 Days|Adverse Event|0|||
125228126|NCT01249131|450464158|FG003|Washout Period of 10 Days|Adverse Event|0|||
125228127|NCT01249131|450464159|FG004|Washout Period of 10 Days|Adverse Event|1|||
125228128|NCT01249131|450464160|FG005|Washout Period of 10 Days|Adverse Event|0|||
125228129|NCT01245101|450464161|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
125228130|NCT01245101|450464162|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
125228131|NCT01245101|450464161|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
125228132|NCT01245101|450464162|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
125228133|NCT01245101|450464161|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
125228134|NCT01245101|450464162|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
125228135|NCT04456686|450464163|FG000|Overall Study|Adverse Event|2|||
125228136|NCT04456686|450464164|FG001|Overall Study|Adverse Event|1|||
125228137|NCT04456686|450464163|FG000|Overall Study|Lack of Efficacy|3|||
125228138|NCT04456686|450464164|FG001|Overall Study|Lack of Efficacy|1|||
125228139|NCT04456686|450464163|FG000|Overall Study|Withdrew consent|3|||
125228140|NCT04456686|450464164|FG001|Overall Study|Withdrew consent|1|||
125228141|NCT04456686|450464163|FG000|Overall Study|Physician Decision|2|||
125228142|NCT04456686|450464164|FG001|Overall Study|Physician Decision|2|||
125228143|NCT04456686|450464163|FG000|Overall Study|Withdrawal by Subject|5|||
125228144|NCT04456686|450464164|FG001|Overall Study|Withdrawal by Subject|1|||
125228145|NCT04456686|450464163|FG000|Overall Study|Protocol Violation|0|||
125228146|NCT04456686|450464164|FG001|Overall Study|Protocol Violation|1|||
125228147|NCT00473083|450464171|FG000|Overall Study|Adverse Event|1|||
125228148|NCT00473083|450464172|FG001|Overall Study|Adverse Event|0|||
125228149|NCT00473083|450464173|FG002|Overall Study|Adverse Event|0|||
125228150|NCT02915835|450464174|FG000|Overall Study|Physician Decision|1|||
125228151|NCT02915835|450464175|FG001|Overall Study|Physician Decision|0|||
125228152|NCT02915835|450464174|FG000|Overall Study|Withdrawal by Subject|0|||
125228153|NCT02915835|450464175|FG001|Overall Study|Withdrawal by Subject|1|||
125228154|NCT00113607|450464176|FG000|Overall Study|Adverse Event|40|||
125228155|NCT00113607|450464177|FG001|Overall Study|Adverse Event|71|||
125228156|NCT00113607|450464176|FG000|Overall Study|Death|8|||
125228157|NCT00113607|450464177|FG001|Overall Study|Death|8|||
125228158|NCT00113607|450464176|FG000|Overall Study|Withdrawal by Subject|50|||
125228159|NCT00113607|450464177|FG001|Overall Study|Withdrawal by Subject|58|||
125228160|NCT00113607|450464176|FG000|Overall Study|Lost to Follow-up|0|||
125228161|NCT00113607|450464177|FG001|Overall Study|Lost to Follow-up|2|||
125228162|NCT00113607|450464176|FG000|Overall Study|Disease Progression|180|||
125228163|NCT00113607|450464177|FG001|Overall Study|Disease Progression|142|||
125228164|NCT00113607|450464176|FG000|Overall Study|Complete Response (Confirmed)|14|||
125228165|NCT00113607|450464177|FG001|Overall Study|Complete Response (Confirmed)|24|||
125228166|NCT00113607|450464176|FG000|Overall Study|Other|43|||
125228167|NCT00113607|450464177|FG001|Overall Study|Other|32|||
125228168|NCT01222104|450464178|FG000|Overall Study|Lost to Follow-up|37|||
125228169|NCT01222104|450464178|FG000|Overall Study|Death|10|||
125228170|NCT01418339|450464179|FG000|Overall Study|Adverse Event|5|||
125228171|NCT01418339|450464180|FG001|Overall Study|Adverse Event|2|||
125228172|NCT01418339|450464179|FG000|Overall Study|Subject Withdrew Consent|1|||
125228173|NCT01418339|450464180|FG001|Overall Study|Subject Withdrew Consent|2|||
125228174|NCT01418339|450464179|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
125228175|NCT01418339|450464180|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
125228176|NCT03885908|450464181|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
125228177|NCT03885908|450464182|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
125228178|NCT03885908|450464181|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
125228179|NCT03885908|450464182|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
125228180|NCT03885908|450464181|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
125228181|NCT03885908|450464182|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
125228182|NCT03885908|450464181|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
125228183|NCT03885908|450464182|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
125228184|NCT00909844|450464183|FG000|Overall Study|Adverse Event|1|||
125228185|NCT00909844|450464183|FG000|Overall Study|Withdrawal by Subject|1|||
125228186|NCT00909844|450464183|FG000|Overall Study|Lost to Follow-up|2|||
125228187|NCT00706004|450464184|FG000|Overall Study|Did not meet eligibility criteria|2|||
125228188|NCT01064479|450464185|FG000|Overall Study|Death|10|||
125228189|NCT01064479|450464186|FG001|Overall Study|Death|11|||
125228190|NCT01064479|450464185|FG000|Overall Study|Withdrawal by Subject|2|||
125228191|NCT01064479|450464186|FG001|Overall Study|Withdrawal by Subject|2|||
125228192|NCT01064479|450464185|FG000|Overall Study|Disease progression|1|||
125228193|NCT01064479|450464186|FG001|Overall Study|Disease progression|1|||
125228194|NCT01064479|450464185|FG000|Overall Study|Toxicity|1|||
125228195|NCT01064479|450464186|FG001|Overall Study|Toxicity|1|||
125228196|NCT01064479|450464185|FG000|Overall Study|Other|1|||
125228197|NCT01064479|450464186|FG001|Overall Study|Other|2|||
125228198|NCT03093181|450464189|FG000|Overall Study|Withdrawal by Subject|2|||
125228199|NCT03093181|450464190|FG001|Overall Study|Withdrawal by Subject|1|||
125228200|NCT03093181|450464191|FG002|Overall Study|Withdrawal by Subject|2|||
125228201|NCT03093181|450464189|FG000|Overall Study|Other (Not specified)|1|||
125228202|NCT03093181|450464190|FG001|Overall Study|Other (Not specified)|0|||
125228203|NCT03093181|450464191|FG002|Overall Study|Other (Not specified)|0|||
125228204|NCT03093181|450464189|FG000|Overall Study|Adverse Event|0|||
125228205|NCT03093181|450464190|FG001|Overall Study|Adverse Event|1|||
125228206|NCT03093181|450464191|FG002|Overall Study|Adverse Event|0|||
125228207|NCT03093181|450464189|FG000|Overall Study|Other (Protocol violation)|0|||
125228208|NCT03093181|450464190|FG001|Overall Study|Other (Protocol violation)|0|||
125228209|NCT03093181|450464191|FG002|Overall Study|Other (Protocol violation)|1|||
125228210|NCT04210986|450464192|FG000|Overall Study|Lost to Follow-up|5|||
125228211|NCT04210986|450464193|FG001|Overall Study|Lost to Follow-up|2|||
125228212|NCT04210986|450464192|FG000|Overall Study|Withdrawal by Subject|3|||
125228213|NCT04210986|450464193|FG001|Overall Study|Withdrawal by Subject|1|||
125228214|NCT04210986|450464192|FG000|Overall Study|Protocol Violation|1|||
125228215|NCT04210986|450464193|FG001|Overall Study|Protocol Violation|1|||
125169664|NCT02186834|450244802|FG005|Dose Escalation|Death|0|||
125169665|NCT02186834|450244797|FG000|Treatment at RP2D|Died prior to treatment|0|||
125169666|NCT02186834|450244798|FG001|Treatment at RP2D|Died prior to treatment|0|||
125169667|NCT02186834|450244799|FG002|Treatment at RP2D|Died prior to treatment|0|||
125169668|NCT02186834|450244800|FG003|Treatment at RP2D|Died prior to treatment|0|||
125169669|NCT02186834|450244801|FG004|Treatment at RP2D|Died prior to treatment|0|||
125169670|NCT02186834|450244802|FG005|Treatment at RP2D|Died prior to treatment|1|||
125169671|NCT00749892|450244803|FG000|Overall Study|Withdrawal by Subject|3|||
125169672|NCT01191944|450244806|FG000|Overall Study|Adverse Event|11|||
125169673|NCT01191944|450244807|FG001|Overall Study|Adverse Event|12|||
125169674|NCT01191944|450244806|FG000|Overall Study|Protocol Violation|1|||
125169675|NCT01191944|450244807|FG001|Overall Study|Protocol Violation|2|||
125169676|NCT01191944|450244806|FG000|Overall Study|Withdrawal by Subject|4|||
125169677|NCT01191944|450244807|FG001|Overall Study|Withdrawal by Subject|2|||
125169678|NCT01191944|450244806|FG000|Overall Study|Other|1|||
125169679|NCT01191944|450244807|FG001|Overall Study|Other|3|||
125169680|NCT00469144|450244812|FG000|Overall Study|Death|0|||
125169681|NCT00469144|450244813|FG001|Overall Study|Death|1|||
125169682|NCT00469144|450244812|FG000|Overall Study|No Response|5|||
125169683|NCT00469144|450244813|FG001|Overall Study|No Response|5|||
125169684|NCT00469144|450244812|FG000|Overall Study|Progressive Disease|1|||
125169685|NCT00469144|450244813|FG001|Overall Study|Progressive Disease|0|||
125169686|NCT04602546|450244814|FG000|Overall Study|Training|2|||
125169687|NCT04602546|450244815|FG001|Overall Study|Training|2|||
125169688|NCT04602546|450244816|FG002|Overall Study|Training|1|||
125169689|NCT04602546|450244817|FG003|Overall Study|Training|2|||
125169690|NCT04602546|450244818|FG004|Overall Study|Training|0|||
125169691|NCT04602546|450244814|FG000|Overall Study|Randomized with disqualified data|2|||
125169692|NCT04602546|450244815|FG001|Overall Study|Randomized with disqualified data|0|||
125169693|NCT04602546|450244816|FG002|Overall Study|Randomized with disqualified data|2|||
125169694|NCT04602546|450244817|FG003|Overall Study|Randomized with disqualified data|5|||
125169695|NCT04602546|450244818|FG004|Overall Study|Randomized with disqualified data|3|||
125169696|NCT00253448|450244822|FG000|Overall Study|Withdrawal by Subject|1|||
125169697|NCT02564887|450244823|FG000|Overall Study|Lost to Follow-up|6|||
125169698|NCT02564887|450244824|FG001|Overall Study|Lost to Follow-up|0|||
125169699|NCT00000620|450244825|FG000|Overall Study|Death|86|||
125169700|NCT00000620|450244826|FG001|Overall Study|Death|67|||
125169701|NCT00000620|450244827|FG002|Overall Study|Death|112|||
125169702|NCT00000620|450244828|FG003|Overall Study|Death|126|||
125169703|NCT00000620|450244829|FG004|Overall Study|Death|64|||
125169704|NCT00000620|450244830|FG005|Overall Study|Death|77|||
125169705|NCT00000620|450244831|FG006|Overall Study|Death|91|||
125169706|NCT00000620|450244832|FG007|Overall Study|Death|95|||
125169707|NCT00000620|450244825|FG000|Overall Study|Lost to Follow-up|14|||
125169708|NCT00000620|450244826|FG001|Overall Study|Lost to Follow-up|14|||
125169709|NCT00000620|450244827|FG002|Overall Study|Lost to Follow-up|14|||
125169710|NCT00000620|450244828|FG003|Overall Study|Lost to Follow-up|14|||
125169711|NCT00000620|450244829|FG004|Overall Study|Lost to Follow-up|15|||
125169712|NCT00000620|450244830|FG005|Overall Study|Lost to Follow-up|15|||
125169713|NCT00000620|450244831|FG006|Overall Study|Lost to Follow-up|13|||
125169714|NCT00000620|450244832|FG007|Overall Study|Lost to Follow-up|14|||
125169715|NCT00000620|450244825|FG000|Overall Study|Withdrawal by Subject|40|||
125169716|NCT00000620|450244826|FG001|Overall Study|Withdrawal by Subject|27|||
125169717|NCT00000620|450244827|FG002|Overall Study|Withdrawal by Subject|28|||
125169718|NCT00000620|450244828|FG003|Overall Study|Withdrawal by Subject|27|||
125169719|NCT00000620|450244829|FG004|Overall Study|Withdrawal by Subject|30|||
125169720|NCT00000620|450244830|FG005|Overall Study|Withdrawal by Subject|32|||
125169721|NCT00000620|450244831|FG006|Overall Study|Withdrawal by Subject|32|||
125169722|NCT00000620|450244832|FG007|Overall Study|Withdrawal by Subject|21|||
125169723|NCT00000620|450244825|FG000|Overall Study|missed closeout visit|22|||
125169724|NCT00000620|450244826|FG001|Overall Study|missed closeout visit|28|||
125169725|NCT00000620|450244827|FG002|Overall Study|missed closeout visit|16|||
125169726|NCT00000620|450244828|FG003|Overall Study|missed closeout visit|11|||
125169727|NCT00000620|450244829|FG004|Overall Study|missed closeout visit|26|||
125169728|NCT00000620|450244830|FG005|Overall Study|missed closeout visit|28|||
125169729|NCT00000620|450244831|FG006|Overall Study|missed closeout visit|13|||
125169730|NCT00000620|450244832|FG007|Overall Study|missed closeout visit|16|||
125169731|NCT01199016|450244833|FG000|Overall Study|No longer meets eligibility criteria|4|||
125169732|NCT01199016|450244833|FG000|Overall Study|Entrance criteria|5|||
125169733|NCT01199016|450244833|FG000|Overall Study|Protocol Violation|9|||
125169734|NCT01199016|450244833|FG000|Overall Study|Other|13|||
125169735|NCT01199016|450244833|FG000|Overall Study|Withdrawal by Subject|21|||
125169736|NCT01199016|450244833|FG000|Overall Study|Lost to Follow-up|25|||
125169737|NCT00314951|450244842|FG000|Treatment|Didn't meet criteria for mITT population|16|||
125169738|NCT00314951|450244843|FG001|Treatment|Didn't meet criteria for mITT population|11|||
125169739|NCT00314951|450244842|FG000|Follow-up|mITT failure|44|||
125169740|NCT00314951|450244843|FG001|Follow-up|mITT failure|34|||
125169741|NCT05320887|450244846|FG000|Overall Study|Lost to Follow-up|0|||
125169742|NCT05320887|450244847|FG001|Overall Study|Lost to Follow-up|3|||
125228216|NCT04210986|450464192|FG000|Overall Study|Physician Decision|0|||
125228217|NCT04210986|450464193|FG001|Overall Study|Physician Decision|1|||
125228218|NCT02378662|450464194|FG000|Overall Study|Early Discontinuation|2|||
125228219|NCT02378662|450464195|FG001|Overall Study|Early Discontinuation|0|||
125228220|NCT01159574|450464196|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
125228221|NCT01159574|450464196|FG000|Treatment Phase|Adverse Event|3|||
125228222|NCT01159574|450464196|FG000|Treatment Phase|Death|6|||
125228223|NCT01159574|450464196|FG000|Treatment Phase|Physician Decision|2|||
125228224|NCT01159574|450464196|FG000|Treatment Phase|Withdrawal by Subject|7|||
125228225|NCT01159574|450464196|FG000|Treatment Phase|still on treatment|2|||
125228226|NCT01159574|450464196|FG000|Follow Up Phase|Lost to Follow-up|2|||
125228227|NCT01159574|450464196|FG000|Follow Up Phase|still being followed for overall surviva|18|||
125228228|NCT02666222|450464198|FG000|Overall Study|Death|2|||
125228229|NCT01474486|450464200|FG000|Overall Study|Death|2|||
125228230|NCT01474486|450464200|FG000|Overall Study|Withdrawal by Subject|4|||
125228231|NCT01474486|450464200|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
125228232|NCT03504917|450464201|FG000|Blinded Treatment Period|Protocol Violation|1|||
125228233|NCT03504917|450464202|FG001|Blinded Treatment Period|Protocol Violation|0|||
125228234|NCT03504917|450464201|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
125228235|NCT03504917|450464202|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
125228236|NCT03504917|450464201|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
125228237|NCT03504917|450464202|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
125228238|NCT03504917|450464201|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
125228239|NCT03504917|450464202|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
125228240|NCT03504917|450464201|FG000|Blinded Treatment Period|Adverse Event|4|||
125228241|NCT03504917|450464202|FG001|Blinded Treatment Period|Adverse Event|4|||
125228242|NCT03504917|450464201|FG000|Blinded Treatment Period|Physician Decision|1|||
125228243|NCT03504917|450464202|FG001|Blinded Treatment Period|Physician Decision|0|||
125228244|NCT03504917|450464201|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
125228245|NCT03504917|450464202|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
125228246|NCT03504917|450464201|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
125228247|NCT03504917|450464202|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
125228248|NCT03504917|450464201|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
125228249|NCT03504917|450464202|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
125228250|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
125228251|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
125228252|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
125228253|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
125228254|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
125228255|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
125228256|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
125228257|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
125228258|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
125228259|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
125228260|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
125228261|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
125228262|NCT03504917|450464201|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
125228263|NCT03504917|450464202|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
125228264|NCT04219189|450464203|FG000|Overall Study|Withdrawal by Subject|1|||
125228265|NCT04219189|450464204|FG001|Overall Study|Withdrawal by Subject|2|||
125228266|NCT04219189|450464203|FG000|Overall Study|Protocol Violation|0|||
125228267|NCT04219189|450464204|FG001|Overall Study|Protocol Violation|1|||
125228268|NCT04219189|450464203|FG000|Overall Study|Lost to Follow-up|0|||
125228269|NCT04219189|450464204|FG001|Overall Study|Lost to Follow-up|1|||
125228270|NCT04219189|450464203|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
125228271|NCT04219189|450464204|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
125228272|NCT03101020|450464205|FG000|Overall Study|Lack of time to participate|1|||
125228273|NCT03101020|450464206|FG001|Overall Study|Lack of time to participate|0|||
125228274|NCT03101020|450464205|FG000|Overall Study|Ran over by a car|0|||
125228275|NCT03101020|450464206|FG001|Overall Study|Ran over by a car|1|||
125228276|NCT03101020|450464205|FG000|Overall Study|Withdrawal by Subject|0|||
125228277|NCT03101020|450464206|FG001|Overall Study|Withdrawal by Subject|2|||
125228278|NCT04233879|450464207|FG000|Overall Study|Death|2|||
125228279|NCT04233879|450464208|FG001|Overall Study|Death|0|||
125228280|NCT04233879|450464207|FG000|Overall Study|Lost to Follow-up|3|||
125228281|NCT04233879|450464208|FG001|Overall Study|Lost to Follow-up|8|||
125228282|NCT04233879|450464207|FG000|Overall Study|Physician Decision|4|||
125228283|NCT04233879|450464208|FG001|Overall Study|Physician Decision|4|||
125228284|NCT04233879|450464207|FG000|Overall Study|Withdrawal by Subject|7|||
125228285|NCT04233879|450464208|FG001|Overall Study|Withdrawal by Subject|10|||
125228286|NCT04233879|450464207|FG000|Overall Study|Other|281|||
125228287|NCT04233879|450464208|FG001|Overall Study|Other|279|||
125228288|NCT03585270|450464211|FG000|Overall Study|Withdrawal by Subject|2|||
125228289|NCT03585270|450464212|FG001|Overall Study|Withdrawal by Subject|6|||
125228290|NCT03585270|450464211|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
125228291|NCT03585270|450464212|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
125228292|NCT03585270|450464211|FG000|Overall Study|Adverse Event|5|||
125228293|NCT03585270|450464212|FG001|Overall Study|Adverse Event|2|||
125228294|NCT03585270|450464211|FG000|Overall Study|Lost to Follow-up|1|||
125228295|NCT03585270|450464212|FG001|Overall Study|Lost to Follow-up|4|||
125228296|NCT03585270|450464211|FG000|Overall Study|Death|5|||
125228297|NCT03585270|450464212|FG001|Overall Study|Death|3|||
125228298|NCT03585270|450464211|FG000|Overall Study|Other reasons|2|||
125228299|NCT03585270|450464212|FG001|Overall Study|Other reasons|2|||
125228300|NCT03292016|450464213|FG000|Second Washout|Adverse Event|0|||
125228301|NCT03292016|450464214|FG001|Second Washout|Adverse Event|1|||
125228302|NCT03292016|450464215|FG002|Second Washout|Adverse Event|0|||
125228303|NCT03292016|450464216|FG003|Second Washout|Adverse Event|0|||
125228304|NCT03292016|450464217|FG004|Second Washout|Adverse Event|0|||
125228305|NCT03292016|450464218|FG005|Second Washout|Adverse Event|0|||
125228306|NCT01038687|450464223|FG000|Overall Study|Adverse Event|0|||
125228307|NCT01038687|450464224|FG001|Overall Study|Adverse Event|2|||
125228308|NCT01038687|450464225|FG002|Overall Study|Adverse Event|1|||
125228309|NCT01076543|450464227|FG000|Overall Study|Withdrawal by Subject|2|||
125228310|NCT01076543|450464228|FG001|Overall Study|Withdrawal by Subject|0|||
125228311|NCT01076543|450464229|FG002|Overall Study|Withdrawal by Subject|0|||
125169743|NCT05320887|450244848|FG002|Overall Study|Lost to Follow-up|0|||
125169744|NCT05320887|450244849|FG003|Overall Study|Lost to Follow-up|0|||
125169745|NCT01671332|450244854|FG000|Overall Study|Withdrawal by Subject|1|||
125169746|NCT01671332|450244855|FG001|Overall Study|Withdrawal by Subject|1|||
125169747|NCT02728843|450244856|FG000|Overall Study|Adverse Event|0|||
125169748|NCT02728843|450244857|FG001|Overall Study|Adverse Event|2|||
125169749|NCT02728843|450244858|FG002|Overall Study|Adverse Event|3|||
125169750|NCT02728843|450244859|FG003|Overall Study|Adverse Event|1|||
125169751|NCT02728843|450244860|FG004|Overall Study|Adverse Event|2|||
125169752|NCT02728843|450244856|FG000|Overall Study|Lack of Efficacy|0|||
125169753|NCT02728843|450244857|FG001|Overall Study|Lack of Efficacy|1|||
125169754|NCT02728843|450244858|FG002|Overall Study|Lack of Efficacy|1|||
125169755|NCT02728843|450244859|FG003|Overall Study|Lack of Efficacy|0|||
125169756|NCT02728843|450244860|FG004|Overall Study|Lack of Efficacy|0|||
125169757|NCT02728843|450244856|FG000|Overall Study|Protocol Violation|2|||
125169758|NCT02728843|450244857|FG001|Overall Study|Protocol Violation|0|||
125169759|NCT02728843|450244858|FG002|Overall Study|Protocol Violation|4|||
125169760|NCT02728843|450244859|FG003|Overall Study|Protocol Violation|2|||
125169761|NCT02728843|450244860|FG004|Overall Study|Protocol Violation|2|||
125169762|NCT02728843|450244856|FG000|Overall Study|Withdrawal by Subject|1|||
125169763|NCT02728843|450244857|FG001|Overall Study|Withdrawal by Subject|0|||
125169764|NCT02728843|450244858|FG002|Overall Study|Withdrawal by Subject|0|||
125169765|NCT02728843|450244859|FG003|Overall Study|Withdrawal by Subject|1|||
125169766|NCT02728843|450244860|FG004|Overall Study|Withdrawal by Subject|0|||
125169767|NCT02728843|450244856|FG000|Overall Study|Use of rescue medication|0|||
125169768|NCT02728843|450244857|FG001|Overall Study|Use of rescue medication|2|||
125169769|NCT02728843|450244858|FG002|Overall Study|Use of rescue medication|0|||
125169770|NCT02728843|450244859|FG003|Overall Study|Use of rescue medication|2|||
125169771|NCT02728843|450244860|FG004|Overall Study|Use of rescue medication|1|||
125169772|NCT01806506|450244862|FG000|Overall Study|Lost to Follow-up|2|||
125169773|NCT01806506|450244863|FG001|Overall Study|Lost to Follow-up|1|||
125169774|NCT04844762|450244868|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169775|NCT04844762|450244869|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169776|NCT04844762|450244870|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
125169777|NCT04844762|450244871|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169778|NCT04844762|450244872|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169779|NCT04844762|450244873|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125228312|NCT01076543|450464230|FG003|Overall Study|Withdrawal by Subject|0|||
125228313|NCT01076543|450464231|FG004|Overall Study|Withdrawal by Subject|0|||
125228314|NCT01076543|450464232|FG005|Overall Study|Withdrawal by Subject|0|||
125228315|NCT00338741|450464233|FG000|Overall Study|Lost to Follow-up|2|||
125228316|NCT00338741|450464234|FG001|Overall Study|Lost to Follow-up|0|||
125169780|NCT04844762|450244868|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
125169781|NCT04844762|450244869|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
125169782|NCT04844762|450244870|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
125169783|NCT04844762|450244871|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
125169784|NCT04844762|450244872|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
125169785|NCT04844762|450244873|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
125169786|NCT04844762|450244868|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169787|NCT04844762|450244869|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125228317|NCT05222880|450464235|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
125228318|NCT05222880|450464235|FG000|Overall Study|Withdrew Consent during Study|1|||
125228319|NCT05222880|450464235|FG000|Overall Study|COVID-19 Related|1|||
125228320|NCT01673178|450464249|FG000|Overall Study|Lost to Follow-up|0|||
125228321|NCT01673178|450464250|FG001|Overall Study|Lost to Follow-up|1|||
125228322|NCT01673178|450464251|FG002|Overall Study|Lost to Follow-up|0|||
125228323|NCT01673178|450464252|FG003|Overall Study|Lost to Follow-up|0|||
125228324|NCT01673178|450464253|FG004|Overall Study|Lost to Follow-up|0|||
125228325|NCT01673178|450464249|FG000|Overall Study|Withdrawal by Subject|0|||
125228326|NCT01673178|450464250|FG001|Overall Study|Withdrawal by Subject|0|||
125228327|NCT01673178|450464251|FG002|Overall Study|Withdrawal by Subject|1|||
125228328|NCT01673178|450464252|FG003|Overall Study|Withdrawal by Subject|4|||
125228329|NCT01673178|450464253|FG004|Overall Study|Withdrawal by Subject|2|||
125169788|NCT04844762|450244870|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
125169789|NCT04844762|450244871|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
125169790|NCT04844762|450244872|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169791|NCT04844762|450244873|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
125169792|NCT04844762|450244868|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169793|NCT04844762|450244869|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169794|NCT04844762|450244870|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
125169795|NCT04844762|450244871|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
125169796|NCT04844762|450244872|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
125169797|NCT04844762|450244873|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169798|NCT04844762|450244868|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
125169799|NCT04844762|450244869|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
125169800|NCT04844762|450244870|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169801|NCT04844762|450244871|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169802|NCT04844762|450244872|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169803|NCT04844762|450244873|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169804|NCT04844762|450244868|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
125169805|NCT04844762|450244869|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169806|NCT04844762|450244870|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169807|NCT04844762|450244871|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169808|NCT04844762|450244872|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169809|NCT04844762|450244873|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169810|NCT04844762|450244868|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169811|NCT04844762|450244869|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169812|NCT04844762|450244870|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169813|NCT04844762|450244871|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169814|NCT04844762|450244872|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
125169815|NCT04844762|450244873|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
125169816|NCT04844762|450244868|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
125169817|NCT04844762|450244869|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169818|NCT04844762|450244870|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169819|NCT04844762|450244871|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169820|NCT04844762|450244872|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169821|NCT04844762|450244873|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
125169822|NCT04844762|450244868|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
125169823|NCT04844762|450244869|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169824|NCT04844762|450244870|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169825|NCT04844762|450244871|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169826|NCT04844762|450244872|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
125169827|NCT04844762|450244873|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
125169828|NCT04844762|450244868|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
125169829|NCT04844762|450244869|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
125169830|NCT04844762|450244870|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
125169831|NCT04844762|450244871|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
125169832|NCT04844762|450244872|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
125169833|NCT04844762|450244873|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
125169834|NCT04844762|450244868|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
125169835|NCT04844762|450244869|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
125169836|NCT04844762|450244870|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
125169837|NCT04844762|450244871|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
125169838|NCT04844762|450244872|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
125169839|NCT04844762|450244873|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
125228330|NCT01673178|450464249|FG000|Overall Study|Protocol Violation|1|||
125228331|NCT01673178|450464250|FG001|Overall Study|Protocol Violation|1|||
125228332|NCT01673178|450464251|FG002|Overall Study|Protocol Violation|0|||
125228333|NCT01673178|450464252|FG003|Overall Study|Protocol Violation|1|||
125228334|NCT01673178|450464253|FG004|Overall Study|Protocol Violation|0|||
125228335|NCT01673178|450464249|FG000|Overall Study|Adverse Event|1|||
125228336|NCT01673178|450464250|FG001|Overall Study|Adverse Event|0|||
125228337|NCT01673178|450464251|FG002|Overall Study|Adverse Event|0|||
125228338|NCT01673178|450464252|FG003|Overall Study|Adverse Event|2|||
125228339|NCT01673178|450464253|FG004|Overall Study|Adverse Event|0|||
125228340|NCT01673178|450464249|FG000|Overall Study|Other|1|||
125228341|NCT01673178|450464250|FG001|Overall Study|Other|0|||
125228342|NCT01673178|450464251|FG002|Overall Study|Other|2|||
125228343|NCT01673178|450464252|FG003|Overall Study|Other|1|||
125228344|NCT01673178|450464253|FG004|Overall Study|Other|0|||
125228345|NCT00449163|450464258|FG000|Overall Study|Physician Decision|3|||
125228346|NCT00606307|450464259|FG000|Overall Study|Adverse Event|2|||
125228347|NCT00606307|450464259|FG000|Overall Study|Withdrawal by Subject|2|||
125228348|NCT00606307|450464259|FG000|Overall Study|Disease progression|6|||
125228349|NCT00606307|450464259|FG000|Overall Study|QTc prolongation|1|||
125228350|NCT04386902|450464267|FG000|Overall Study|Withdrawal by Subject|5|||
125228351|NCT04386902|450464267|FG000|Overall Study|Technical problems in the recording|5|||
125228352|NCT00828711|450464268|FG000|Overall Study|Lost to Follow-up|1|||
125228353|NCT00828711|450464269|FG001|Overall Study|Lost to Follow-up|0|||
125228354|NCT00828711|450464270|FG002|Overall Study|Lost to Follow-up|0|||
125228355|NCT02033759|450464272|FG000|Overall Study|Withdrawal by Subject|2|||
125228356|NCT02033759|450464273|FG001|Overall Study|Withdrawal by Subject|1|||
125228357|NCT02033759|450464272|FG000|Overall Study|Protocol Violation|1|||
125228358|NCT02033759|450464273|FG001|Overall Study|Protocol Violation|1|||
125228359|NCT01548599|450465662|FG000|Overall Study|Lost to Follow-up|0|||
125228360|NCT01548599|450465663|FG001|Overall Study|Lost to Follow-up|1|||
125228361|NCT01548599|450465662|FG000|Overall Study|Withdrawal by Subject|4|||
125228362|NCT01548599|450465663|FG001|Overall Study|Withdrawal by Subject|0|||
125228363|NCT01548599|450465662|FG000|Overall Study|Death|2|||
125228364|NCT01548599|450465663|FG001|Overall Study|Death|1|||
125228365|NCT05630196|450465664|FG000|Overall Study|Adverse Event|2|||
125228366|NCT05630196|450465665|FG001|Overall Study|Adverse Event|1|||
125228367|NCT05630196|450465664|FG000|Overall Study|Lost to Follow-up|1|||
125228368|NCT05630196|450465665|FG001|Overall Study|Lost to Follow-up|1|||
125228369|NCT05630196|450465664|FG000|Overall Study|Protocol Violation|2|||
125228370|NCT05630196|450465665|FG001|Overall Study|Protocol Violation|3|||
125228371|NCT05630196|450465664|FG000|Overall Study|Physician Decision|1|||
125228372|NCT05630196|450465665|FG001|Overall Study|Physician Decision|0|||
125228373|NCT05630196|450465664|FG000|Overall Study|Withdrawal by Subject|3|||
125228374|NCT05630196|450465665|FG001|Overall Study|Withdrawal by Subject|4|||
125228375|NCT00352118|450465667|FG000|Overall Study|Physician Decision|4|||
125228376|NCT02308046|450465668|FG000|Overall Study|Negative yeast culture at Baseline|32|||
125228377|NCT02308046|450465669|FG001|Overall Study|Negative yeast culture at Baseline|33|||
125228378|NCT02308046|450465668|FG000|Overall Study|Positive for STD at Baseline|1|||
125228379|NCT02308046|450465669|FG001|Overall Study|Positive for STD at Baseline|2|||
125228380|NCT02308046|450465668|FG000|Overall Study|Lost to Follow-up|1|||
125228381|NCT02308046|450465669|FG001|Overall Study|Lost to Follow-up|3|||
125228382|NCT01587885|450465672|FG000|Treatment Period 1|Failure to Return|0|||
125228383|NCT01587885|450465673|FG001|Treatment Period 1|Failure to Return|1|||
125228384|NCT01587885|450465672|FG000|Treatment Period 1|Protocol Violation|0|||
125228385|NCT01587885|450465673|FG001|Treatment Period 1|Protocol Violation|2|||
125228386|NCT00958074|450465674|FG000|Overall Study|Withdrawal by Subject|0|||
125228387|NCT00958074|450465675|FG001|Overall Study|Withdrawal by Subject|1|||
125228388|NCT03102762|450465676|FG000|Overall Study|Lost to Follow-up|1|||
125228389|NCT03102762|450465677|FG001|Overall Study|Lost to Follow-up|0|||
125228390|NCT00752089|450465682|FG000|Overall Study|Adverse Event|1|||
125228391|NCT00752089|450465682|FG000|Overall Study|Protocol Deviation|2|||
125228392|NCT00752089|450465682|FG000|Overall Study|Could not attend visit 9|1|||
125228393|NCT00752089|450465682|FG000|Overall Study|Not capable of wearing partial denture|1|||
125228394|NCT00752089|450465682|FG000|Overall Study|Cannot continue the study|1|||
125228395|NCT00001566|450465683|FG000|Overall Study|patients' choice to discontinue protocol|3|||
125228396|NCT00001566|450465683|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
125228397|NCT00001566|450465683|FG000|Overall Study|Death|13|||
125228398|NCT00001566|450465683|FG000|Overall Study|Lost to Follow-up|1|||
125228399|NCT00001566|450465683|FG000|Overall Study|unable to complete initial apheresis|1|||
125228400|NCT02914834|450465684|FG000|Overall Study|Study halted due to COVID|1|||
125228401|NCT02914834|450465685|FG001|Overall Study|Study halted due to COVID|1|||
125228402|NCT02914834|450465684|FG000|Overall Study|1 subject withdrew|0|||
125228403|NCT02914834|450465685|FG001|Overall Study|1 subject withdrew|1|||
125228404|NCT00975416|450465688|FG000|Overall Study|early discharge from tx|3|||
125228405|NCT00975416|450465689|FG001|Overall Study|early discharge from tx|5|||
125228406|NCT03555149|450465694|FG000|Overall Study|Death|18|||
125228407|NCT03555149|450465695|FG001|Overall Study|Death|15|||
125228408|NCT03555149|450465696|FG002|Overall Study|Death|15|||
125228409|NCT03555149|450465697|FG003|Overall Study|Death|4|||
125228410|NCT03555149|450465698|FG004|Overall Study|Death|4|||
125228411|NCT03555149|450465699|FG005|Overall Study|Death|11|||
125228412|NCT03555149|450465700|FG006|Overall Study|Death|12|||
125228413|NCT03555149|450465701|FG007|Overall Study|Death|1|||
125228414|NCT03555149|450465694|FG000|Overall Study|Lost to Follow-up|1|||
125169840|NCT00477633|450244874|FG000|Overall Study|Did not receive treatment|23|||
125169841|NCT00477633|450244874|FG000|Overall Study|Adverse Event|143|||
125169842|NCT00477633|450244874|FG000|Overall Study|Pregnancy|23|||
125169843|NCT00477633|450244874|FG000|Overall Study|Lost to Follow-up|271|||
125169844|NCT00477633|450244874|FG000|Overall Study|Withdrawal by Subject|149|||
125169845|NCT00477633|450244874|FG000|Overall Study|Protocol Violation|25|||
125169846|NCT00477633|450244874|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
125169847|NCT04123561|450244880|FG000|Overall Study|Lost to Follow-up|20|||
125169848|NCT04123561|450244881|FG001|Overall Study|Lost to Follow-up|12|||
125169849|NCT04123561|450244882|FG002|Overall Study|Lost to Follow-up|5|||
125169850|NCT04123561|450244880|FG000|Overall Study|Withdrawal by Subject|9|||
125169851|NCT04123561|450244881|FG001|Overall Study|Withdrawal by Subject|7|||
125169852|NCT04123561|450244882|FG002|Overall Study|Withdrawal by Subject|9|||
125169853|NCT04123561|450244880|FG000|Overall Study|Lack of Efficacy|7|||
125169854|NCT04123561|450244881|FG001|Overall Study|Lack of Efficacy|8|||
125169855|NCT04123561|450244882|FG002|Overall Study|Lack of Efficacy|6|||
125169856|NCT04123561|450244880|FG000|Overall Study|Adverse Event|5|||
125169857|NCT04123561|450244881|FG001|Overall Study|Adverse Event|2|||
125169858|NCT04123561|450244882|FG002|Overall Study|Adverse Event|3|||
125169859|NCT04123561|450244880|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
125169860|NCT04123561|450244881|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
125169861|NCT04123561|450244882|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
125169862|NCT04123561|450244880|FG000|Overall Study|Death|0|||
125169863|NCT04123561|450244881|FG001|Overall Study|Death|0|||
125169864|NCT04123561|450244882|FG002|Overall Study|Death|1|||
125169865|NCT04123561|450244880|FG000|Overall Study|Protocol Violation|0|||
125169866|NCT04123561|450244881|FG001|Overall Study|Protocol Violation|1|||
125169867|NCT04123561|450244882|FG002|Overall Study|Protocol Violation|0|||
125169868|NCT01374269|450244890|FG000|Overall Study|Withdrawal by Subject|4|||
125169869|NCT01374269|450244891|FG001|Overall Study|Withdrawal by Subject|0|||
125169870|NCT01374269|450244890|FG000|Overall Study|Lost to Follow-up|1|||
125169871|NCT01374269|450244891|FG001|Overall Study|Lost to Follow-up|3|||
125169872|NCT01374269|450244890|FG000|Overall Study|closed research|1|||
125169873|NCT01374269|450244891|FG001|Overall Study|closed research|2|||
125169874|NCT00278889|450244892|FG000|Overall Study|Withdrawal by Subject|0|||
125169875|NCT00278889|450244893|FG001|Overall Study|Withdrawal by Subject|5|||
125169876|NCT00278889|450244894|FG002|Overall Study|Withdrawal by Subject|3|||
125169877|NCT00278889|450244892|FG000|Overall Study|Lost to Follow-up|1|||
125169878|NCT00278889|450244893|FG001|Overall Study|Lost to Follow-up|1|||
125169879|NCT00278889|450244894|FG002|Overall Study|Lost to Follow-up|0|||
125169880|NCT00278889|450244892|FG000|Overall Study|Death|24|||
125169881|NCT00278889|450244893|FG001|Overall Study|Death|21|||
125169882|NCT00278889|450244894|FG002|Overall Study|Death|17|||
125169883|NCT01987479|450244895|FG000|Overall Study|Protocol Violation|1|||
125169884|NCT01987479|450244895|FG000|Overall Study|Physician Decision|2|||
125169885|NCT01987479|450244895|FG000|Overall Study|Participant/legal guardian decision|1|||
125169886|NCT01987479|450244895|FG000|Overall Study|Other|5|||
125169887|NCT01987479|450244895|FG000|Overall Study|Lost to Follow-up|1|||
125169888|NCT01987479|450244895|FG000|Overall Study|Adverse Event|7|||
125169889|NCT04998851|450247565|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
125169890|NCT04998851|450247566|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
125169891|NCT04998851|450247565|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
125169892|NCT04998851|450247566|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
125169893|NCT00478244|450247569|FG000|Overall Study|Did not receive transplant|1|||
125169894|NCT00509366|450247576|FG000|Overall Study|Not Treated (Screen Failure)|1|||
125169895|NCT00509366|450247577|FG001|Overall Study|Not Treated (Screen Failure)|1|||
125169896|NCT00509366|450247578|FG002|Overall Study|Not Treated (Screen Failure)|1|||
125169897|NCT00509366|450247579|FG003|Overall Study|Not Treated (Screen Failure)|0|||
125228415|NCT03555149|450465695|FG001|Overall Study|Lost to Follow-up|0|||
125228416|NCT03555149|450465696|FG002|Overall Study|Lost to Follow-up|0|||
125228417|NCT03555149|450465697|FG003|Overall Study|Lost to Follow-up|0|||
125228418|NCT03555149|450465698|FG004|Overall Study|Lost to Follow-up|0|||
125228419|NCT03555149|450465699|FG005|Overall Study|Lost to Follow-up|1|||
125169898|NCT00509366|450247580|FG004|Overall Study|Not Treated (Screen Failure)|0|||
125169899|NCT02906358|450247581|FG000|Overall Study|Withdrawal by Subject|10|||
125169900|NCT02906358|450247582|FG001|Overall Study|Withdrawal by Subject|7|||
125169901|NCT02906358|450247581|FG000|Overall Study|Lost to Follow-up|12|||
125169902|NCT02906358|450247582|FG001|Overall Study|Lost to Follow-up|15|||
125169903|NCT01145508|450247584|FG000|Overall Study|Adverse Event|1|||
125228420|NCT03555149|450465700|FG006|Overall Study|Lost to Follow-up|0|||
125228421|NCT03555149|450465701|FG007|Overall Study|Lost to Follow-up|0|||
125228422|NCT03555149|450465694|FG000|Overall Study|Physician Decision|1|||
125228423|NCT03555149|450465695|FG001|Overall Study|Physician Decision|0|||
125169904|NCT01145508|450247585|FG001|Overall Study|Adverse Event|0|||
125169905|NCT01145508|450247584|FG000|Overall Study|Death|1|||
125169906|NCT01145508|450247585|FG001|Overall Study|Death|0|||
125169907|NCT01145508|450247584|FG000|Overall Study|Physician Decision|2|||
125169908|NCT01145508|450247585|FG001|Overall Study|Physician Decision|1|||
125169909|NCT01145508|450247584|FG000|Overall Study|Never started treatment|1|||
125169910|NCT01145508|450247585|FG001|Overall Study|Never started treatment|1|||
125169911|NCT02045147|450247586|FG000|Overall Study|Withdrawal by Subject|2|||
125169912|NCT02045147|450247587|FG001|Overall Study|Withdrawal by Subject|0|||
125169913|NCT02045147|450247588|FG002|Overall Study|Withdrawal by Subject|0|||
125169914|NCT02045147|450247589|FG003|Overall Study|Withdrawal by Subject|0|||
125169915|NCT02045147|450247590|FG004|Overall Study|Withdrawal by Subject|0|||
125169916|NCT02045147|450247591|FG005|Overall Study|Withdrawal by Subject|0|||
125169917|NCT02045147|450247592|FG006|Overall Study|Withdrawal by Subject|0|||
125169918|NCT02045147|450247593|FG007|Overall Study|Withdrawal by Subject|1|||
125169919|NCT02045147|450247586|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
125169920|NCT02045147|450247587|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
125169921|NCT02045147|450247588|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
125169922|NCT02045147|450247589|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
125169923|NCT02045147|450247590|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
125169924|NCT02045147|450247591|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
125169925|NCT02045147|450247592|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
125169926|NCT02045147|450247593|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
125169927|NCT00264550|450247594|FG000|Overall Study|Death|0|||
125169928|NCT00264550|450247595|FG001|Overall Study|Death|3|||
125169929|NCT00264550|450247596|FG002|Overall Study|Death|0|||
125169930|NCT00264550|450247597|FG003|Overall Study|Death|0|||
125169931|NCT00264550|450247594|FG000|Overall Study|Lost to Follow-up|3|||
125169932|NCT00264550|450247595|FG001|Overall Study|Lost to Follow-up|1|||
125169933|NCT00264550|450247596|FG002|Overall Study|Lost to Follow-up|1|||
125169934|NCT00264550|450247597|FG003|Overall Study|Lost to Follow-up|1|||
125169935|NCT00264550|450247594|FG000|Overall Study|Adverse Event|23|||
125169936|NCT00264550|450247595|FG001|Overall Study|Adverse Event|18|||
125169937|NCT00264550|450247596|FG002|Overall Study|Adverse Event|9|||
125169938|NCT00264550|450247597|FG003|Overall Study|Adverse Event|14|||
125169939|NCT00264550|450247594|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125169940|NCT00264550|450247595|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
125169941|NCT00264550|450247596|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
125169942|NCT00264550|450247597|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
125169943|NCT00264550|450247594|FG000|Overall Study|Discontinued oral study agent|0|||
125169944|NCT00264550|450247595|FG001|Overall Study|Discontinued oral study agent|1|||
125169945|NCT00264550|450247596|FG002|Overall Study|Discontinued oral study agent|0|||
125169946|NCT00264550|450247597|FG003|Overall Study|Discontinued oral study agent|0|||
125169947|NCT00264550|450247594|FG000|Overall Study|Other|13|||
125169948|NCT00264550|450247595|FG001|Overall Study|Other|7|||
125169949|NCT00264550|450247596|FG002|Overall Study|Other|3|||
125169950|NCT00264550|450247597|FG003|Overall Study|Other|9|||
125169951|NCT02246114|450247598|FG000|Overall Study|miscarriage|1|||
125169952|NCT02246114|450247599|FG001|Overall Study|miscarriage|0|||
125169953|NCT01439009|450247605|FG000|Overall Study|Physician Decision|5|||
125169954|NCT01439009|450247606|FG001|Overall Study|Physician Decision|3|||
125169955|NCT01439009|450247605|FG000|Overall Study|Protocol Violation|2|||
125169956|NCT01439009|450247606|FG001|Overall Study|Protocol Violation|0|||
125169957|NCT01439009|450247605|FG000|Overall Study|Deviation of exclusion criteria|1|||
125169958|NCT01439009|450247606|FG001|Overall Study|Deviation of exclusion criteria|0|||
125169959|NCT00696787|450247608|FG000|Overall Study|Adverse Event|1|||
125169960|NCT00696787|450247609|FG001|Overall Study|Adverse Event|0|||
125169961|NCT00696787|450247610|FG002|Overall Study|Adverse Event|6|||
125169962|NCT00696787|450247608|FG000|Overall Study|Discontinuation by Sponsor|9|||
125169963|NCT00696787|450247609|FG001|Overall Study|Discontinuation by Sponsor|13|||
125169964|NCT00696787|450247610|FG002|Overall Study|Discontinuation by Sponsor|14|||
125228424|NCT03555149|450465696|FG002|Overall Study|Physician Decision|0|||
125228425|NCT03555149|450465697|FG003|Overall Study|Physician Decision|0|||
125169965|NCT00696787|450247608|FG000|Overall Study|Lack of Efficacy|0|||
125169966|NCT00696787|450247609|FG001|Overall Study|Lack of Efficacy|1|||
125169967|NCT00696787|450247610|FG002|Overall Study|Lack of Efficacy|0|||
125169968|NCT00696787|450247608|FG000|Overall Study|Lost to Follow-up|4|||
125169969|NCT00696787|450247609|FG001|Overall Study|Lost to Follow-up|0|||
125169970|NCT00696787|450247610|FG002|Overall Study|Lost to Follow-up|3|||
125169971|NCT00696787|450247608|FG000|Overall Study|Withdrawal by Subject|0|||
125169972|NCT00696787|450247609|FG001|Overall Study|Withdrawal by Subject|3|||
125169973|NCT00696787|450247610|FG002|Overall Study|Withdrawal by Subject|2|||
125169974|NCT00696787|450247608|FG000|Overall Study|Failed to return|1|||
125169975|NCT00696787|450247609|FG001|Overall Study|Failed to return|3|||
125169976|NCT00696787|450247610|FG002|Overall Study|Failed to return|1|||
125169977|NCT00129389|450247615|FG000|Overall Study|Adverse Event|19|||
125169978|NCT00129389|450247616|FG001|Overall Study|Adverse Event|87|||
125169979|NCT00129389|450247615|FG000|Overall Study|Death|0|||
125169980|NCT00129389|450247616|FG001|Overall Study|Death|1|||
125169981|NCT00129389|450247615|FG000|Overall Study|Lost to Follow-up|2|||
125169982|NCT00129389|450247616|FG001|Overall Study|Lost to Follow-up|1|||
125169983|NCT00129389|450247615|FG000|Overall Study|Physician Decision|0|||
125169984|NCT00129389|450247616|FG001|Overall Study|Physician Decision|4|||
125169985|NCT00129389|450247615|FG000|Overall Study|Protocol Violation|0|||
125169986|NCT00129389|450247616|FG001|Overall Study|Protocol Violation|6|||
125169987|NCT00129389|450247615|FG000|Overall Study|Withdrawal by Subject|9|||
125169988|NCT00129389|450247616|FG001|Overall Study|Withdrawal by Subject|23|||
125169989|NCT00129389|450247615|FG000|Overall Study|Relapse|1|||
125169990|NCT00129389|450247616|FG001|Overall Study|Relapse|0|||
125169991|NCT00129389|450247615|FG000|Overall Study|Not eligible|1|||
125169992|NCT00129389|450247616|FG001|Overall Study|Not eligible|2|||
125169993|NCT00129389|450247615|FG000|Overall Study|Crossed to the other arm|1|||
125169994|NCT00129389|450247616|FG001|Overall Study|Crossed to the other arm|16|||
125169995|NCT00603837|450247619|FG000|Overall Study|Physician Decision|3|||
125169996|NCT00603837|450247620|FG001|Overall Study|Physician Decision|0|||
125169997|NCT04611529|450247622|FG000|2-day Follow up|Lost to Follow-up|5|||
125169998|NCT04611529|450247623|FG001|2-day Follow up|Lost to Follow-up|6|||
125169999|NCT04611529|450247624|FG002|2-day Follow up|Lost to Follow-up|3|||
125170000|NCT00425373|450247688|FG000|Overall Study|Adverse Event|2|||
125170001|NCT00425373|450247689|FG001|Overall Study|Adverse Event|2|||
125170002|NCT00425373|450247690|FG002|Overall Study|Adverse Event|0|||
125170003|NCT00425373|450247691|FG003|Overall Study|Adverse Event|1|||
125170004|NCT00425373|450247692|FG004|Overall Study|Adverse Event|4|||
125170005|NCT00425373|450247693|FG005|Overall Study|Adverse Event|6|||
125170006|NCT00425373|450247694|FG006|Overall Study|Adverse Event|2|||
125170007|NCT00425373|450247695|FG007|Overall Study|Adverse Event|3|||
125170008|NCT00425373|450247696|FG008|Overall Study|Adverse Event|8|||
125170009|NCT00425373|450247688|FG000|Overall Study|Lost to Follow-up|0|||
125170010|NCT00425373|450247689|FG001|Overall Study|Lost to Follow-up|1|||
125170011|NCT00425373|450247690|FG002|Overall Study|Lost to Follow-up|0|||
125170012|NCT00425373|450247691|FG003|Overall Study|Lost to Follow-up|0|||
125170013|NCT00425373|450247692|FG004|Overall Study|Lost to Follow-up|1|||
125170014|NCT00425373|450247693|FG005|Overall Study|Lost to Follow-up|0|||
125170015|NCT00425373|450247694|FG006|Overall Study|Lost to Follow-up|0|||
125170016|NCT00425373|450247695|FG007|Overall Study|Lost to Follow-up|0|||
125170017|NCT00425373|450247696|FG008|Overall Study|Lost to Follow-up|0|||
125170018|NCT00425373|450247688|FG000|Overall Study|Protocol Violation|1|||
125170019|NCT00425373|450247689|FG001|Overall Study|Protocol Violation|0|||
125170020|NCT00425373|450247690|FG002|Overall Study|Protocol Violation|1|||
125170021|NCT00425373|450247691|FG003|Overall Study|Protocol Violation|0|||
125170022|NCT00425373|450247692|FG004|Overall Study|Protocol Violation|0|||
125170023|NCT00425373|450247693|FG005|Overall Study|Protocol Violation|0|||
125170024|NCT00425373|450247694|FG006|Overall Study|Protocol Violation|0|||
125170025|NCT00425373|450247695|FG007|Overall Study|Protocol Violation|5|||
125170026|NCT00425373|450247696|FG008|Overall Study|Protocol Violation|3|||
125170027|NCT00425373|450247688|FG000|Overall Study|Withdrawal by Subject|2|||
125170028|NCT00425373|450247689|FG001|Overall Study|Withdrawal by Subject|0|||
125170029|NCT00425373|450247690|FG002|Overall Study|Withdrawal by Subject|2|||
125170030|NCT00425373|450247691|FG003|Overall Study|Withdrawal by Subject|1|||
125170031|NCT00425373|450247692|FG004|Overall Study|Withdrawal by Subject|4|||
125170032|NCT00425373|450247693|FG005|Overall Study|Withdrawal by Subject|0|||
125170033|NCT00425373|450247694|FG006|Overall Study|Withdrawal by Subject|2|||
125170034|NCT00425373|450247695|FG007|Overall Study|Withdrawal by Subject|2|||
125170035|NCT00425373|450247696|FG008|Overall Study|Withdrawal by Subject|2|||
125170036|NCT00425373|450247688|FG000|Overall Study|Lack of Efficacy|0|||
125170037|NCT00425373|450247689|FG001|Overall Study|Lack of Efficacy|0|||
125170038|NCT00425373|450247690|FG002|Overall Study|Lack of Efficacy|0|||
125170039|NCT00425373|450247691|FG003|Overall Study|Lack of Efficacy|0|||
125170040|NCT00425373|450247692|FG004|Overall Study|Lack of Efficacy|1|||
125170041|NCT00425373|450247693|FG005|Overall Study|Lack of Efficacy|3|||
125170042|NCT00425373|450247694|FG006|Overall Study|Lack of Efficacy|3|||
125170043|NCT00425373|450247695|FG007|Overall Study|Lack of Efficacy|0|||
125170044|NCT00425373|450247696|FG008|Overall Study|Lack of Efficacy|5|||
125170045|NCT02052011|450247697|FG000|Overall Study|Lost to Follow-up|3|||
125170046|NCT02052011|450247698|FG001|Overall Study|Lost to Follow-up|0|||
125170047|NCT02052011|450247697|FG000|Overall Study|Withdrawal by Subject|1|||
125170048|NCT02052011|450247698|FG001|Overall Study|Withdrawal by Subject|2|||
125170049|NCT01851330|450247699|FG000|Overall Study|Lack of Efficacy|10|||
125170050|NCT01851330|450247700|FG001|Overall Study|Lack of Efficacy|9|||
125170051|NCT01851330|450247701|FG002|Overall Study|Lack of Efficacy|2|||
125170052|NCT01851330|450247699|FG000|Overall Study|Lost to Follow-up|1|||
125170053|NCT01851330|450247700|FG001|Overall Study|Lost to Follow-up|6|||
125170054|NCT01851330|450247701|FG002|Overall Study|Lost to Follow-up|9|||
125170055|NCT01851330|450247699|FG000|Overall Study|Withdrew Consent|2|||
125170056|NCT01851330|450247700|FG001|Overall Study|Withdrew Consent|1|||
125170057|NCT01851330|450247701|FG002|Overall Study|Withdrew Consent|0|||
125228426|NCT03555149|450465698|FG004|Overall Study|Physician Decision|0|||
125228427|NCT03555149|450465699|FG005|Overall Study|Physician Decision|0|||
125228428|NCT03555149|450465700|FG006|Overall Study|Physician Decision|0|||
125228429|NCT03555149|450465701|FG007|Overall Study|Physician Decision|0|||
125228430|NCT03555149|450465694|FG000|Overall Study|Study Terminated By Sponsor|1|||
125228431|NCT03555149|450465695|FG001|Overall Study|Study Terminated By Sponsor|0|||
125228432|NCT03555149|450465696|FG002|Overall Study|Study Terminated By Sponsor|0|||
125228433|NCT03555149|450465697|FG003|Overall Study|Study Terminated By Sponsor|0|||
125228434|NCT03555149|450465698|FG004|Overall Study|Study Terminated By Sponsor|0|||
125228435|NCT03555149|450465699|FG005|Overall Study|Study Terminated By Sponsor|2|||
125228436|NCT03555149|450465700|FG006|Overall Study|Study Terminated By Sponsor|3|||
125228437|NCT03555149|450465701|FG007|Overall Study|Study Terminated By Sponsor|1|||
125228438|NCT03555149|450465694|FG000|Overall Study|Withdrawal by Subject|3|||
125228439|NCT03555149|450465695|FG001|Overall Study|Withdrawal by Subject|0|||
125228440|NCT03555149|450465696|FG002|Overall Study|Withdrawal by Subject|0|||
125228441|NCT03555149|450465697|FG003|Overall Study|Withdrawal by Subject|2|||
125228442|NCT03555149|450465698|FG004|Overall Study|Withdrawal by Subject|0|||
125228443|NCT03555149|450465699|FG005|Overall Study|Withdrawal by Subject|1|||
125228444|NCT03555149|450465700|FG006|Overall Study|Withdrawal by Subject|0|||
125228445|NCT03555149|450465701|FG007|Overall Study|Withdrawal by Subject|0|||
125228446|NCT03863353|450465705|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
125228447|NCT03863353|450465706|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
125228448|NCT05817669|450465707|FG000|Overall Study|Prohibited medication used|1|||
125228449|NCT05817669|450465708|FG001|Overall Study|Prohibited medication used|2|||
125228450|NCT05817669|450465707|FG000|Overall Study|Adverse Event|1|||
125228451|NCT05817669|450465708|FG001|Overall Study|Adverse Event|0|||
125228452|NCT05817669|450465707|FG000|Overall Study|Withdrawal by Subject|1|||
125228453|NCT05817669|450465708|FG001|Overall Study|Withdrawal by Subject|2|||
125170058|NCT01851330|450247699|FG000|Overall Study|Investigator's Discretion|0|||
125170059|NCT01851330|450247700|FG001|Overall Study|Investigator's Discretion|0|||
125170060|NCT01851330|450247701|FG002|Overall Study|Investigator's Discretion|1|||
125170061|NCT02960490|450247703|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
125170062|NCT02960490|450247704|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
125170063|NCT02960490|450247705|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170064|NCT02960490|450247706|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170065|NCT02960490|450247707|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170066|NCT02960490|450247708|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170067|NCT02960490|450247709|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170068|NCT02960490|450247710|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170069|NCT02960490|450247711|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170070|NCT02960490|450247712|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
125170071|NCT02960490|450247703|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170072|NCT02960490|450247704|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
125170073|NCT02960490|450247705|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170074|NCT02960490|450247706|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170075|NCT02960490|450247707|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170076|NCT02960490|450247708|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170077|NCT02960490|450247709|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170078|NCT02960490|450247710|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170079|NCT02960490|450247711|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170080|NCT02960490|450247712|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
125170081|NCT02960490|450247703|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
125170082|NCT02960490|450247704|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
125170083|NCT02960490|450247705|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170084|NCT02960490|450247706|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170085|NCT02960490|450247707|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170086|NCT02960490|450247708|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170087|NCT02960490|450247709|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170088|NCT02960490|450247710|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170089|NCT02960490|450247711|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170090|NCT02960490|450247712|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
125170091|NCT02960490|450247703|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
125170092|NCT02960490|450247704|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
125170093|NCT02960490|450247705|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170094|NCT02960490|450247706|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125228454|NCT03810183|450465709|FG000|Overall Study|Study terminated by Sponsor|2|||
125228455|NCT03810183|450465710|FG001|Overall Study|Study terminated by Sponsor|1|||
125228456|NCT00323063|450465712|FG000|Overall Study|Adverse Event|1|||
125228457|NCT00323063|450465713|FG001|Overall Study|Adverse Event|0|||
125170095|NCT02960490|450247707|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170096|NCT02960490|450247708|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170097|NCT02960490|450247709|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170098|NCT02960490|450247710|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170099|NCT02960490|450247711|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170100|NCT02960490|450247712|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
125170101|NCT02960490|450247703|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170102|NCT02960490|450247704|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170103|NCT02960490|450247705|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
125170104|NCT02960490|450247706|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
125170105|NCT02960490|450247707|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170106|NCT02960490|450247708|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
125170107|NCT02960490|450247709|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170108|NCT02960490|450247710|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170109|NCT02960490|450247711|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170110|NCT02960490|450247712|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
125170111|NCT02960490|450247703|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170112|NCT02960490|450247704|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170113|NCT02960490|450247705|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
125170114|NCT02960490|450247706|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170115|NCT02960490|450247707|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
125170116|NCT02960490|450247708|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170117|NCT02960490|450247709|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170118|NCT02960490|450247710|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170119|NCT02960490|450247711|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170120|NCT02960490|450247712|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
125170121|NCT02960490|450247703|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
125170122|NCT02960490|450247704|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
125170123|NCT02960490|450247705|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
125170124|NCT02960490|450247706|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
125170125|NCT02960490|450247707|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
125170126|NCT02960490|450247708|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
125170127|NCT02960490|450247709|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
125170128|NCT02960490|450247710|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
125170129|NCT02960490|450247711|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
125170130|NCT02960490|450247712|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
125170131|NCT02960490|450247703|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170132|NCT02960490|450247704|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170133|NCT02960490|450247705|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170134|NCT02960490|450247706|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170135|NCT02960490|450247707|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170136|NCT02960490|450247708|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170137|NCT02960490|450247709|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
125170138|NCT02960490|450247710|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
125170139|NCT02960490|450247711|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
125170140|NCT02960490|450247712|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
125170141|NCT02960490|450247703|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170142|NCT02960490|450247704|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170143|NCT02960490|450247705|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170144|NCT02960490|450247706|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170145|NCT02960490|450247707|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170146|NCT02960490|450247708|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170147|NCT02960490|450247709|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170148|NCT02960490|450247710|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
125170149|NCT02960490|450247711|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170150|NCT02960490|450247712|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
125170151|NCT02960490|450247703|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
125170152|NCT02960490|450247704|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
125170153|NCT02960490|450247705|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
125170154|NCT02960490|450247706|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
125170155|NCT02960490|450247707|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
125170156|NCT02960490|450247708|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
125170157|NCT02960490|450247709|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
125170158|NCT02960490|450247710|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
125170159|NCT02960490|450247711|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
125170160|NCT02960490|450247712|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
125170161|NCT02960490|450247703|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170162|NCT02960490|450247704|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170163|NCT02960490|450247705|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170164|NCT02960490|450247706|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170165|NCT02960490|450247707|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170166|NCT02960490|450247708|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170167|NCT02960490|450247709|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
125170168|NCT02960490|450247710|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170169|NCT02960490|450247711|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170170|NCT02960490|450247712|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
125170171|NCT02960490|450247703|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170172|NCT02960490|450247704|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170173|NCT02960490|450247705|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170174|NCT02960490|450247706|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170175|NCT02960490|450247707|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170176|NCT02960490|450247708|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170177|NCT02960490|450247709|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170178|NCT02960490|450247710|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
125170179|NCT02960490|450247711|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170180|NCT02960490|450247712|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
125170181|NCT02368314|450247715|FG000|Overall Study|Withdrawal by Subject|2|||
125170182|NCT02368314|450247716|FG001|Overall Study|Withdrawal by Subject|1|||
125170183|NCT02368314|450247715|FG000|Overall Study|Adverse Event|1|||
125170184|NCT02368314|450247716|FG001|Overall Study|Adverse Event|2|||
125170185|NCT01333397|450247717|FG000|Overall Study|Lost to Follow-up|1|||
125170186|NCT01333397|450247718|FG001|Overall Study|Lost to Follow-up|0|||
125170187|NCT01333397|450247719|FG002|Overall Study|Lost to Follow-up|0|||
125170188|NCT01333397|450247720|FG003|Overall Study|Lost to Follow-up|1|||
125170189|NCT01333397|450247721|FG004|Overall Study|Lost to Follow-up|0|||
125170190|NCT01085357|450247722|FG000|Overall Study|Adverse Event|1|||
125170191|NCT01085357|450247723|FG001|Overall Study|Adverse Event|1|||
125170192|NCT01085357|450247722|FG000|Overall Study|Subject Decision|4|||
125170193|NCT01085357|450247723|FG001|Overall Study|Subject Decision|3|||
125170194|NCT01085357|450247722|FG000|Overall Study|Investigator Decision|1|||
125170195|NCT01085357|450247723|FG001|Overall Study|Investigator Decision|1|||
125170196|NCT01085357|450247722|FG000|Overall Study|Death|11|||
125170197|NCT01085357|450247723|FG001|Overall Study|Death|1|||
125170198|NCT01085357|450247722|FG000|Overall Study|Lost to Follow-up|2|||
125170199|NCT01085357|450247723|FG001|Overall Study|Lost to Follow-up|0|||
125170200|NCT02289456|450247733|FG000|Induction Period|Death|2|||
125170201|NCT02289456|450247733|FG000|Induction Period|Adverse Event|11|||
125170202|NCT02289456|450247733|FG000|Induction Period|Progressive Disease (PD)|4|||
125170203|NCT02289456|450247733|FG000|Induction Period|Symptomatic Deterioration|4|||
125170204|NCT02289456|450247733|FG000|Induction Period|Withdrawal by Subject|2|||
125170205|NCT02289456|450247733|FG000|Induction Period|Miscellaneous|1|||
125170206|NCT02289456|450247733|FG000|Monotherapy Period|Death|1|||
125170207|NCT02289456|450247733|FG000|Monotherapy Period|Adverse Event|1|||
125170208|NCT02289456|450247733|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
125170209|NCT02289456|450247733|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
125170210|NCT02289456|450247733|FG000|Monotherapy Period|Withdrawal by Subject|2|||
125170211|NCT02289456|450247733|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
125170212|NCT02289456|450247733|FG000|Monotherapy Period|Miscellaneous|1|||
125170213|NCT00920790|450247736|FG000|Overall Study|aggravation of general condition|14|||
125170214|NCT01661062|450247737|FG000|Overall Study|Completed Treatment Off Study|3|||
125170215|NCT01661062|450247737|FG000|Overall Study|Withdrawal by Subject|2|||
125170216|NCT04411914|450247738|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
125228458|NCT00323063|450465712|FG000|Overall Study|brain mets discovered prior to treatment|1|||
125228459|NCT00323063|450465713|FG001|Overall Study|brain mets discovered prior to treatment|0|||
125228460|NCT03786380|450465714|FG000|Overall Study|Adverse Event|1|||
125228461|NCT03786380|450465715|FG001|Overall Study|Adverse Event|0|||
125170217|NCT04411914|450247739|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
125170218|NCT00895414|450247745|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
125170219|NCT00895414|450247746|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
125170220|NCT00895414|450247745|FG000|First Intervention (14 Days)|Physician Decision|0|||
125170221|NCT00895414|450247746|FG001|First Intervention (14 Days)|Physician Decision|1|||
125170222|NCT00252239|450247747|FG000|Overall Study|Withdrawal by Subject|1|||
125170223|NCT00252239|450247748|FG001|Overall Study|Withdrawal by Subject|0|||
125170224|NCT00252239|450247749|FG002|Overall Study|Withdrawal by Subject|0|||
125170225|NCT00252239|450247750|FG003|Overall Study|Withdrawal by Subject|1|||
125170226|NCT00252239|450247747|FG000|Overall Study|Lost to Follow-up|0|||
125170227|NCT00252239|450247748|FG001|Overall Study|Lost to Follow-up|0|||
125170228|NCT00252239|450247749|FG002|Overall Study|Lost to Follow-up|2|||
125228462|NCT03786380|450465716|FG002|Overall Study|Adverse Event|0|||
125170229|NCT00252239|450247750|FG003|Overall Study|Lost to Follow-up|0|||
125170230|NCT00478426|450247751|FG000|Overall Study|Withdrawal by Subject|1|||
125170231|NCT03489109|450247758|FG000|Overall Study|Lost to Follow-up|1|||
125170232|NCT03489109|450247759|FG001|Overall Study|Lost to Follow-up|2|||
125170233|NCT02181790|450247760|FG000|Overall Study|study terminated|2|||
125170234|NCT02181790|450247761|FG001|Overall Study|study terminated|0|||
125170235|NCT00025259|450247763|FG000|Overall Study|Death|1|||
125170236|NCT00025259|450247764|FG001|Overall Study|Death|3|||
125170237|NCT00025259|450247765|FG002|Overall Study|Death|0|||
125170238|NCT00025259|450247766|FG003|Overall Study|Death|3|||
125170239|NCT00025259|450247767|FG004|Overall Study|Death|0|||
125170240|NCT00025259|450247768|FG005|Overall Study|Death|1|||
125170241|NCT00025259|450247769|FG006|Overall Study|Death|2|||
125170242|NCT00025259|450247763|FG000|Overall Study|Lack of Efficacy|2|||
125170243|NCT00025259|450247764|FG001|Overall Study|Lack of Efficacy|46|||
125170244|NCT00025259|450247765|FG002|Overall Study|Lack of Efficacy|60|||
125170245|NCT00025259|450247766|FG003|Overall Study|Lack of Efficacy|78|||
125170246|NCT00025259|450247767|FG004|Overall Study|Lack of Efficacy|11|||
125170247|NCT00025259|450247768|FG005|Overall Study|Lack of Efficacy|30|||
125170248|NCT00025259|450247769|FG006|Overall Study|Lack of Efficacy|38|||
125170249|NCT00025259|450247763|FG000|Overall Study|Lost to Follow-up|2|||
125170250|NCT00025259|450247764|FG001|Overall Study|Lost to Follow-up|9|||
125170251|NCT00025259|450247765|FG002|Overall Study|Lost to Follow-up|13|||
125170252|NCT00025259|450247766|FG003|Overall Study|Lost to Follow-up|13|||
125170253|NCT00025259|450247767|FG004|Overall Study|Lost to Follow-up|1|||
125170254|NCT00025259|450247768|FG005|Overall Study|Lost to Follow-up|3|||
125170255|NCT00025259|450247769|FG006|Overall Study|Lost to Follow-up|1|||
125170256|NCT00025259|450247763|FG000|Overall Study|Physician Decision|12|||
125170257|NCT00025259|450247764|FG001|Overall Study|Physician Decision|1|||
125170258|NCT00025259|450247765|FG002|Overall Study|Physician Decision|0|||
125170259|NCT00025259|450247766|FG003|Overall Study|Physician Decision|5|||
125170260|NCT00025259|450247767|FG004|Overall Study|Physician Decision|4|||
125170261|NCT00025259|450247768|FG005|Overall Study|Physician Decision|2|||
125170262|NCT00025259|450247769|FG006|Overall Study|Physician Decision|1|||
125170263|NCT00025259|450247763|FG000|Overall Study|Protocol Violation|3|||
125170264|NCT00025259|450247764|FG001|Overall Study|Protocol Violation|2|||
125228463|NCT03786380|450465717|FG003|Overall Study|Adverse Event|3|||
125228464|NCT03786380|450465718|FG004|Overall Study|Adverse Event|1|||
125170265|NCT00025259|450247765|FG002|Overall Study|Protocol Violation|2|||
125170266|NCT00025259|450247766|FG003|Overall Study|Protocol Violation|1|||
125170267|NCT00025259|450247767|FG004|Overall Study|Protocol Violation|2|||
125228465|NCT03786380|450465714|FG000|Overall Study|Lack of Efficacy|0|||
125228466|NCT03786380|450465715|FG001|Overall Study|Lack of Efficacy|0|||
125228467|NCT03786380|450465716|FG002|Overall Study|Lack of Efficacy|0|||
125228468|NCT03786380|450465717|FG003|Overall Study|Lack of Efficacy|0|||
125228469|NCT03786380|450465718|FG004|Overall Study|Lack of Efficacy|1|||
125228470|NCT03786380|450465714|FG000|Overall Study|Withdrawal by Subject|1|||
125228471|NCT03786380|450465715|FG001|Overall Study|Withdrawal by Subject|2|||
125228472|NCT03786380|450465716|FG002|Overall Study|Withdrawal by Subject|2|||
125228473|NCT03786380|450465717|FG003|Overall Study|Withdrawal by Subject|1|||
125228474|NCT03786380|450465718|FG004|Overall Study|Withdrawal by Subject|2|||
125170268|NCT00025259|450247768|FG005|Overall Study|Protocol Violation|1|||
125170269|NCT00025259|450247769|FG006|Overall Study|Protocol Violation|3|||
125170270|NCT00025259|450247763|FG000|Overall Study|Withdrawal by Subject|9|||
125170271|NCT00025259|450247764|FG001|Overall Study|Withdrawal by Subject|27|||
125170272|NCT00025259|450247765|FG002|Overall Study|Withdrawal by Subject|6|||
125170273|NCT00025259|450247766|FG003|Overall Study|Withdrawal by Subject|14|||
125170274|NCT00025259|450247767|FG004|Overall Study|Withdrawal by Subject|11|||
125170275|NCT00025259|450247768|FG005|Overall Study|Withdrawal by Subject|8|||
125170276|NCT00025259|450247769|FG006|Overall Study|Withdrawal by Subject|3|||
125170277|NCT00025259|450247763|FG000|Overall Study|Ineligible|14|||
125170278|NCT00025259|450247764|FG001|Overall Study|Ineligible|1|||
125170279|NCT00025259|450247765|FG002|Overall Study|Ineligible|0|||
125170280|NCT00025259|450247766|FG003|Overall Study|Ineligible|0|||
125228475|NCT03786380|450465714|FG000|Overall Study|Lost to Follow-up|3|||
125170281|NCT00025259|450247767|FG004|Overall Study|Ineligible|6|||
125170282|NCT00025259|450247768|FG005|Overall Study|Ineligible|0|||
125170283|NCT00025259|450247769|FG006|Overall Study|Ineligible|1|||
125170284|NCT00025259|450247763|FG000|Overall Study|Randomization error|1|||
125170285|NCT00025259|450247764|FG001|Overall Study|Randomization error|0|||
125170286|NCT00025259|450247765|FG002|Overall Study|Randomization error|0|||
125170287|NCT00025259|450247766|FG003|Overall Study|Randomization error|0|||
125170288|NCT00025259|450247767|FG004|Overall Study|Randomization error|1|||
125228476|NCT03786380|450465715|FG001|Overall Study|Lost to Follow-up|0|||
125228477|NCT03786380|450465716|FG002|Overall Study|Lost to Follow-up|1|||
125228478|NCT03786380|450465717|FG003|Overall Study|Lost to Follow-up|2|||
125170289|NCT00025259|450247768|FG005|Overall Study|Randomization error|7|||
125170290|NCT00025259|450247769|FG006|Overall Study|Randomization error|2|||
125170291|NCT00025259|450247763|FG000|Overall Study|Adverse Event|1|||
125170292|NCT00025259|450247764|FG001|Overall Study|Adverse Event|0|||
125170293|NCT00025259|450247765|FG002|Overall Study|Adverse Event|0|||
125228479|NCT03786380|450465718|FG004|Overall Study|Lost to Follow-up|0|||
125228480|NCT03786380|450465714|FG000|Overall Study|Physician Decision|0|||
125228481|NCT03786380|450465715|FG001|Overall Study|Physician Decision|0|||
125228482|NCT03786380|450465716|FG002|Overall Study|Physician Decision|1|||
125228483|NCT03786380|450465717|FG003|Overall Study|Physician Decision|0|||
125228484|NCT03786380|450465718|FG004|Overall Study|Physician Decision|0|||
125228485|NCT03786380|450465714|FG000|Overall Study|Study Terminated by the Sponsor|30|||
125228486|NCT03786380|450465715|FG001|Overall Study|Study Terminated by the Sponsor|20|||
125228487|NCT03786380|450465716|FG002|Overall Study|Study Terminated by the Sponsor|50|||
125228488|NCT03786380|450465717|FG003|Overall Study|Study Terminated by the Sponsor|57|||
125228489|NCT03786380|450465718|FG004|Overall Study|Study Terminated by the Sponsor|23|||
125228490|NCT03786380|450465714|FG000|Overall Study|Reason Not Specified|0|||
125228491|NCT03786380|450465715|FG001|Overall Study|Reason Not Specified|0|||
125228492|NCT03786380|450465716|FG002|Overall Study|Reason Not Specified|0|||
125228493|NCT03786380|450465717|FG003|Overall Study|Reason Not Specified|0|||
125228494|NCT03786380|450465718|FG004|Overall Study|Reason Not Specified|1|||
125228495|NCT01664091|450465719|FG000|Overall Study|Death|1|||
125228496|NCT01664091|450465719|FG000|Overall Study|Disease Progression|2|||
125228497|NCT01664091|450465719|FG000|Overall Study|Lost to Follow-up|2|||
125228498|NCT01664091|450465719|FG000|Overall Study|Withdrawal by Subject|1|||
125228499|NCT00726609|450465722|FG000|Overall Study|Adverse Event|10|||
125228500|NCT00726609|450465722|FG000|Overall Study|Withdrawal by Subject|2|||
125228501|NCT00726609|450465722|FG000|Overall Study|Lack of Efficacy|25|||
125228502|NCT00726609|450465722|FG000|Overall Study|Other|16|||
125228503|NCT00726609|450465722|FG000|Overall Study|Missing|42|||
125228504|NCT00726609|450465722|FG000|Overall Study|Other|3|||
125228505|NCT03327324|450465729|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228506|NCT03327324|450465730|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
125228507|NCT03327324|450465731|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228508|NCT03327324|450465732|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
125228509|NCT03327324|450465733|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228510|NCT03327324|450465734|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
125228511|NCT03327324|450465729|FG000|Baseline (Month 0-Month 3)|Refused|0|||
125228512|NCT03327324|450465730|FG001|Baseline (Month 0-Month 3)|Refused|0|||
125228513|NCT03327324|450465731|FG002|Baseline (Month 0-Month 3)|Refused|0|||
125228514|NCT03327324|450465732|FG003|Baseline (Month 0-Month 3)|Refused|0|||
125228515|NCT03327324|450465733|FG004|Baseline (Month 0-Month 3)|Refused|1|||
125228516|NCT03327324|450465734|FG005|Baseline (Month 0-Month 3)|Refused|0|||
125228517|NCT03327324|450465729|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
125228518|NCT03327324|450465730|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
125228519|NCT03327324|450465731|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
125228520|NCT03327324|450465732|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
125228521|NCT03327324|450465733|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
125228522|NCT03327324|450465734|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
125228523|NCT03327324|450465729|FG000|Baseline (Month 0-Month 3)|Death|0|||
125228524|NCT03327324|450465730|FG001|Baseline (Month 0-Month 3)|Death|0|||
125228525|NCT03327324|450465731|FG002|Baseline (Month 0-Month 3)|Death|0|||
125228526|NCT03327324|450465732|FG003|Baseline (Month 0-Month 3)|Death|0|||
125228527|NCT03327324|450465733|FG004|Baseline (Month 0-Month 3)|Death|1|||
125228528|NCT03327324|450465734|FG005|Baseline (Month 0-Month 3)|Death|0|||
125228529|NCT03327324|450465729|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125170294|NCT00025259|450247766|FG003|Overall Study|Adverse Event|0|||
125170295|NCT00025259|450247767|FG004|Overall Study|Adverse Event|0|||
125170296|NCT00025259|450247768|FG005|Overall Study|Adverse Event|0|||
125170297|NCT00025259|450247769|FG006|Overall Study|Adverse Event|0|||
125170298|NCT00863772|450247770|FG000|Overall Study|Adverse Event|1|||
125170299|NCT00863772|450247771|FG001|Overall Study|Adverse Event|4|||
125170300|NCT00863772|450247772|FG002|Overall Study|Adverse Event|0|||
125170301|NCT00863772|450247770|FG000|Overall Study|Lack of Efficacy|4|||
125170302|NCT00863772|450247771|FG001|Overall Study|Lack of Efficacy|2|||
125170303|NCT00863772|450247772|FG002|Overall Study|Lack of Efficacy|4|||
125170304|NCT00863772|450247770|FG000|Overall Study|Lost to Follow-up|5|||
125170305|NCT00863772|450247771|FG001|Overall Study|Lost to Follow-up|1|||
125170306|NCT00863772|450247772|FG002|Overall Study|Lost to Follow-up|1|||
125170307|NCT00863772|450247770|FG000|Overall Study|Protocol Violation|2|||
125228530|NCT03327324|450465730|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125170308|NCT00863772|450247771|FG001|Overall Study|Protocol Violation|0|||
125170309|NCT00863772|450247772|FG002|Overall Study|Protocol Violation|2|||
125170310|NCT00863772|450247770|FG000|Overall Study|Withdrawal by Subject|4|||
125228531|NCT03327324|450465731|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125170311|NCT00863772|450247771|FG001|Overall Study|Withdrawal by Subject|7|||
125170312|NCT00863772|450247772|FG002|Overall Study|Withdrawal by Subject|5|||
125228532|NCT03327324|450465732|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228533|NCT03327324|450465733|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228534|NCT03327324|450465734|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
125228535|NCT03327324|450465729|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228536|NCT03327324|450465730|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228537|NCT03327324|450465731|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
125228538|NCT03327324|450465732|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228539|NCT03327324|450465733|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228540|NCT03327324|450465734|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228541|NCT03327324|450465729|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
125228542|NCT03327324|450465730|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
125228543|NCT03327324|450465731|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
125228544|NCT03327324|450465732|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
125228545|NCT03327324|450465733|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
125228546|NCT03327324|450465734|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
125228547|NCT03327324|450465729|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
125228548|NCT03327324|450465730|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
125228549|NCT03327324|450465731|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
125228550|NCT03327324|450465732|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
125228551|NCT03327324|450465733|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
125443376|NCT01216293|451250866|FG002|Calcium Absorption Substudy|Adverse Event|0|||
125443377|NCT01216293|451250864|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
125443378|NCT01216293|451250865|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
125443379|NCT01216293|451250866|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
125443380|NCT01216293|451250864|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
125443381|NCT01216293|451250865|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
125170313|NCT00863772|450247770|FG000|Overall Study|Study terminated by sponsor|44|||
125228552|NCT03327324|450465734|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
125228553|NCT03327324|450465729|FG000|Intervention (Month 3-Month 6)|Death|1|||
125228554|NCT03327324|450465730|FG001|Intervention (Month 3-Month 6)|Death|0|||
125228555|NCT03327324|450465731|FG002|Intervention (Month 3-Month 6)|Death|1|||
125228556|NCT03327324|450465732|FG003|Intervention (Month 3-Month 6)|Death|1|||
125228557|NCT03327324|450465733|FG004|Intervention (Month 3-Month 6)|Death|1|||
125228558|NCT03327324|450465734|FG005|Intervention (Month 3-Month 6)|Death|0|||
125228559|NCT03327324|450465729|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228560|NCT03327324|450465730|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228561|NCT03327324|450465731|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125170314|NCT00863772|450247771|FG001|Overall Study|Study terminated by sponsor|45|||
125170315|NCT00863772|450247772|FG002|Overall Study|Study terminated by sponsor|36|||
125170316|NCT00863772|450247770|FG000|Overall Study|Entered extension study|6|||
125170317|NCT00863772|450247771|FG001|Overall Study|Entered extension study|4|||
125170318|NCT00863772|450247772|FG002|Overall Study|Entered extension study|9|||
125170319|NCT00863772|450247770|FG000|Overall Study|Other|1|||
125170320|NCT00863772|450247771|FG001|Overall Study|Other|2|||
125170321|NCT00863772|450247772|FG002|Overall Study|Other|4|||
125170322|NCT00863772|450247770|FG000|Overall Study|Randomized but not Treated|1|||
125170323|NCT00863772|450247771|FG001|Overall Study|Randomized but not Treated|0|||
125170324|NCT00863772|450247772|FG002|Overall Study|Randomized but not Treated|0|||
125170325|NCT01449370|450247773|FG000|Overall Study|Disease Progression|5|||
125170326|NCT01449370|450247774|FG001|Overall Study|Disease Progression|4|||
125170327|NCT01449370|450247775|FG002|Overall Study|Disease Progression|8|||
125170328|NCT01449370|450247776|FG003|Overall Study|Disease Progression|3|||
125170329|NCT01449370|450247777|FG004|Overall Study|Disease Progression|3|||
125170330|NCT01449370|450247778|FG005|Overall Study|Disease Progression|3|||
125170331|NCT01449370|450247779|FG006|Overall Study|Disease Progression|3|||
125170332|NCT01449370|450247780|FG007|Overall Study|Disease Progression|2|||
125170333|NCT01449370|450247781|FG008|Overall Study|Disease Progression|9|||
125170334|NCT01449370|450247782|FG009|Overall Study|Disease Progression|1|||
125170335|NCT01449370|450247783|FG010|Overall Study|Disease Progression|3|||
125170336|NCT01449370|450247784|FG011|Overall Study|Disease Progression|3|||
125170337|NCT01449370|450247785|FG012|Overall Study|Disease Progression|2|||
125170338|NCT01449370|450247786|FG013|Overall Study|Disease Progression|8|||
125170339|NCT01449370|450247787|FG014|Overall Study|Disease Progression|3|||
125170340|NCT01449370|450247788|FG015|Overall Study|Disease Progression|1|||
125170341|NCT01449370|450247789|FG016|Overall Study|Disease Progression|4|||
125170342|NCT01449370|450247790|FG017|Overall Study|Disease Progression|3|||
125170343|NCT01449370|450247791|FG018|Overall Study|Disease Progression|1|||
125170344|NCT01449370|450247792|FG019|Overall Study|Disease Progression|2|||
125170345|NCT01449370|450247793|FG020|Overall Study|Disease Progression|5|||
125170346|NCT01449370|450247794|FG021|Overall Study|Disease Progression|2|||
125170347|NCT01449370|450247795|FG022|Overall Study|Disease Progression|3|||
125170348|NCT01449370|450247796|FG023|Overall Study|Disease Progression|7|||
125170349|NCT01449370|450247797|FG024|Overall Study|Disease Progression|3|||
125170350|NCT01449370|450247773|FG000|Overall Study|Adverse Event|1|||
125170351|NCT01449370|450247774|FG001|Overall Study|Adverse Event|2|||
125170352|NCT01449370|450247775|FG002|Overall Study|Adverse Event|0|||
125170353|NCT01449370|450247776|FG003|Overall Study|Adverse Event|1|||
125170354|NCT01449370|450247777|FG004|Overall Study|Adverse Event|0|||
125170355|NCT01449370|450247778|FG005|Overall Study|Adverse Event|0|||
125170356|NCT01449370|450247779|FG006|Overall Study|Adverse Event|0|||
125170357|NCT01449370|450247780|FG007|Overall Study|Adverse Event|0|||
125170358|NCT01449370|450247781|FG008|Overall Study|Adverse Event|1|||
125170359|NCT01449370|450247782|FG009|Overall Study|Adverse Event|1|||
125170360|NCT01449370|450247783|FG010|Overall Study|Adverse Event|0|||
125170361|NCT01449370|450247784|FG011|Overall Study|Adverse Event|0|||
125170362|NCT01449370|450247785|FG012|Overall Study|Adverse Event|0|||
125170363|NCT01449370|450247786|FG013|Overall Study|Adverse Event|2|||
125170364|NCT01449370|450247787|FG014|Overall Study|Adverse Event|0|||
125170365|NCT01449370|450247788|FG015|Overall Study|Adverse Event|1|||
125170366|NCT01449370|450247789|FG016|Overall Study|Adverse Event|0|||
125170367|NCT01449370|450247790|FG017|Overall Study|Adverse Event|0|||
125170368|NCT01449370|450247791|FG018|Overall Study|Adverse Event|1|||
125170369|NCT01449370|450247792|FG019|Overall Study|Adverse Event|1|||
125170370|NCT01449370|450247793|FG020|Overall Study|Adverse Event|0|||
125170371|NCT01449370|450247794|FG021|Overall Study|Adverse Event|1|||
125170372|NCT01449370|450247795|FG022|Overall Study|Adverse Event|0|||
125170373|NCT01449370|450247796|FG023|Overall Study|Adverse Event|1|||
125170374|NCT01449370|450247797|FG024|Overall Study|Adverse Event|3|||
125170375|NCT01449370|450247773|FG000|Overall Study|Participant Decision|0|||
125170376|NCT01449370|450247774|FG001|Overall Study|Participant Decision|0|||
125170377|NCT01449370|450247775|FG002|Overall Study|Participant Decision|0|||
125170378|NCT01449370|450247776|FG003|Overall Study|Participant Decision|0|||
125170379|NCT01449370|450247777|FG004|Overall Study|Participant Decision|0|||
125170380|NCT01449370|450247778|FG005|Overall Study|Participant Decision|0|||
125170381|NCT01449370|450247779|FG006|Overall Study|Participant Decision|0|||
125170382|NCT01449370|450247780|FG007|Overall Study|Participant Decision|1|||
125170383|NCT01449370|450247781|FG008|Overall Study|Participant Decision|1|||
125170384|NCT01449370|450247782|FG009|Overall Study|Participant Decision|0|||
125170385|NCT01449370|450247783|FG010|Overall Study|Participant Decision|0|||
125170386|NCT01449370|450247784|FG011|Overall Study|Participant Decision|0|||
125170387|NCT01449370|450247785|FG012|Overall Study|Participant Decision|1|||
125170388|NCT01449370|450247786|FG013|Overall Study|Participant Decision|1|||
125170389|NCT01449370|450247787|FG014|Overall Study|Participant Decision|0|||
125170390|NCT01449370|450247788|FG015|Overall Study|Participant Decision|1|||
125170391|NCT01449370|450247789|FG016|Overall Study|Participant Decision|3|||
125170392|NCT01449370|450247790|FG017|Overall Study|Participant Decision|0|||
125170393|NCT01449370|450247791|FG018|Overall Study|Participant Decision|1|||
125170394|NCT01449370|450247792|FG019|Overall Study|Participant Decision|0|||
125170395|NCT01449370|450247793|FG020|Overall Study|Participant Decision|0|||
125170396|NCT01449370|450247794|FG021|Overall Study|Participant Decision|1|||
125170397|NCT01449370|450247795|FG022|Overall Study|Participant Decision|0|||
125170398|NCT01449370|450247796|FG023|Overall Study|Participant Decision|0|||
125170399|NCT01449370|450247797|FG024|Overall Study|Participant Decision|1|||
125170400|NCT01449370|450247773|FG000|Overall Study|Lost to Follow-up|0|||
125170401|NCT01449370|450247774|FG001|Overall Study|Lost to Follow-up|0|||
125170402|NCT01449370|450247775|FG002|Overall Study|Lost to Follow-up|0|||
125170403|NCT01449370|450247776|FG003|Overall Study|Lost to Follow-up|0|||
125170404|NCT01449370|450247777|FG004|Overall Study|Lost to Follow-up|0|||
125170405|NCT01449370|450247778|FG005|Overall Study|Lost to Follow-up|0|||
125170406|NCT01449370|450247779|FG006|Overall Study|Lost to Follow-up|0|||
125170407|NCT01449370|450247780|FG007|Overall Study|Lost to Follow-up|0|||
125170408|NCT01449370|450247781|FG008|Overall Study|Lost to Follow-up|0|||
125170409|NCT01449370|450247782|FG009|Overall Study|Lost to Follow-up|0|||
125170410|NCT01449370|450247783|FG010|Overall Study|Lost to Follow-up|0|||
125170411|NCT01449370|450247784|FG011|Overall Study|Lost to Follow-up|0|||
125170412|NCT01449370|450247785|FG012|Overall Study|Lost to Follow-up|0|||
125170413|NCT01449370|450247786|FG013|Overall Study|Lost to Follow-up|0|||
125170414|NCT01449370|450247787|FG014|Overall Study|Lost to Follow-up|0|||
125170415|NCT01449370|450247788|FG015|Overall Study|Lost to Follow-up|0|||
125170416|NCT01449370|450247789|FG016|Overall Study|Lost to Follow-up|0|||
125170417|NCT01449370|450247790|FG017|Overall Study|Lost to Follow-up|0|||
125170418|NCT01449370|450247791|FG018|Overall Study|Lost to Follow-up|0|||
125170419|NCT01449370|450247792|FG019|Overall Study|Lost to Follow-up|0|||
125170420|NCT01449370|450247793|FG020|Overall Study|Lost to Follow-up|1|||
125170421|NCT01449370|450247794|FG021|Overall Study|Lost to Follow-up|0|||
125170422|NCT01449370|450247795|FG022|Overall Study|Lost to Follow-up|0|||
125170423|NCT01449370|450247796|FG023|Overall Study|Lost to Follow-up|0|||
125170424|NCT01449370|450247797|FG024|Overall Study|Lost to Follow-up|0|||
125170425|NCT01449370|450247773|FG000|Overall Study|Other|0|||
125170426|NCT01449370|450247774|FG001|Overall Study|Other|0|||
125170427|NCT01449370|450247775|FG002|Overall Study|Other|0|||
125170428|NCT01449370|450247776|FG003|Overall Study|Other|0|||
125170429|NCT01449370|450247777|FG004|Overall Study|Other|0|||
125170430|NCT01449370|450247778|FG005|Overall Study|Other|0|||
125170431|NCT01449370|450247779|FG006|Overall Study|Other|0|||
125170432|NCT01449370|450247780|FG007|Overall Study|Other|0|||
125170433|NCT01449370|450247781|FG008|Overall Study|Other|1|||
125170434|NCT01449370|450247782|FG009|Overall Study|Other|1|||
125170435|NCT01449370|450247783|FG010|Overall Study|Other|0|||
125170436|NCT01449370|450247784|FG011|Overall Study|Other|0|||
125170437|NCT01449370|450247785|FG012|Overall Study|Other|0|||
125170438|NCT01449370|450247786|FG013|Overall Study|Other|0|||
125170439|NCT01449370|450247787|FG014|Overall Study|Other|0|||
125170440|NCT01449370|450247788|FG015|Overall Study|Other|0|||
125170441|NCT01449370|450247789|FG016|Overall Study|Other|0|||
125228562|NCT03327324|450465732|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125170442|NCT01449370|450247790|FG017|Overall Study|Other|0|||
125170443|NCT01449370|450247791|FG018|Overall Study|Other|0|||
125170444|NCT01449370|450247792|FG019|Overall Study|Other|0|||
125170445|NCT01449370|450247793|FG020|Overall Study|Other|0|||
125170446|NCT01449370|450247794|FG021|Overall Study|Other|0|||
125170447|NCT01449370|450247795|FG022|Overall Study|Other|1|||
125170448|NCT01449370|450247796|FG023|Overall Study|Other|1|||
125170449|NCT01449370|450247797|FG024|Overall Study|Other|0|||
125170450|NCT01449370|450247773|FG000|Overall Study|Medication Prohibited by Protocol|0|||
125170451|NCT01449370|450247774|FG001|Overall Study|Medication Prohibited by Protocol|0|||
125170452|NCT01449370|450247775|FG002|Overall Study|Medication Prohibited by Protocol|0|||
125170453|NCT01449370|450247776|FG003|Overall Study|Medication Prohibited by Protocol|0|||
125170454|NCT01449370|450247777|FG004|Overall Study|Medication Prohibited by Protocol|0|||
125170455|NCT01449370|450247778|FG005|Overall Study|Medication Prohibited by Protocol|0|||
125170456|NCT01449370|450247779|FG006|Overall Study|Medication Prohibited by Protocol|0|||
125170457|NCT01449370|450247780|FG007|Overall Study|Medication Prohibited by Protocol|0|||
125170458|NCT01449370|450247781|FG008|Overall Study|Medication Prohibited by Protocol|0|||
125170459|NCT01449370|450247782|FG009|Overall Study|Medication Prohibited by Protocol|0|||
125170460|NCT01449370|450247783|FG010|Overall Study|Medication Prohibited by Protocol|0|||
125170461|NCT01449370|450247784|FG011|Overall Study|Medication Prohibited by Protocol|0|||
125170462|NCT01449370|450247785|FG012|Overall Study|Medication Prohibited by Protocol|0|||
125228563|NCT03327324|450465733|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228564|NCT03327324|450465734|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
125228565|NCT03327324|450465729|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
125228566|NCT03327324|450465730|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228567|NCT03327324|450465731|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228568|NCT03327324|450465732|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228569|NCT03327324|450465733|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228570|NCT03327324|450465734|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
125228571|NCT03327324|450465729|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
125228572|NCT03327324|450465730|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
125228573|NCT03327324|450465731|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
125228574|NCT03327324|450465732|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
125170463|NCT01449370|450247786|FG013|Overall Study|Medication Prohibited by Protocol|0|||
125170464|NCT01449370|450247787|FG014|Overall Study|Medication Prohibited by Protocol|0|||
125170465|NCT01449370|450247788|FG015|Overall Study|Medication Prohibited by Protocol|0|||
125170466|NCT01449370|450247789|FG016|Overall Study|Medication Prohibited by Protocol|0|||
125170467|NCT01449370|450247790|FG017|Overall Study|Medication Prohibited by Protocol|0|||
125170468|NCT01449370|450247791|FG018|Overall Study|Medication Prohibited by Protocol|0|||
125170469|NCT01449370|450247792|FG019|Overall Study|Medication Prohibited by Protocol|0|||
125170470|NCT01449370|450247793|FG020|Overall Study|Medication Prohibited by Protocol|0|||
125170471|NCT01449370|450247794|FG021|Overall Study|Medication Prohibited by Protocol|0|||
125170472|NCT01449370|450247795|FG022|Overall Study|Medication Prohibited by Protocol|0|||
125170473|NCT01449370|450247796|FG023|Overall Study|Medication Prohibited by Protocol|1|||
125170474|NCT01449370|450247797|FG024|Overall Study|Medication Prohibited by Protocol|0|||
125170475|NCT01449370|450247773|FG000|Overall Study|Death|0|||
125228575|NCT03327324|450465733|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
125228576|NCT03327324|450465734|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
125228577|NCT03327324|450465729|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
125228578|NCT03327324|450465730|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
125228579|NCT03327324|450465731|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
125228580|NCT03327324|450465732|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
125170476|NCT01449370|450247774|FG001|Overall Study|Death|0|||
125170477|NCT01449370|450247775|FG002|Overall Study|Death|0|||
125170478|NCT01449370|450247776|FG003|Overall Study|Death|0|||
125170479|NCT01449370|450247777|FG004|Overall Study|Death|0|||
125170480|NCT01449370|450247778|FG005|Overall Study|Death|0|||
125170481|NCT01449370|450247779|FG006|Overall Study|Death|0|||
125170482|NCT01449370|450247780|FG007|Overall Study|Death|0|||
125170483|NCT01449370|450247781|FG008|Overall Study|Death|0|||
125170484|NCT01449370|450247782|FG009|Overall Study|Death|0|||
125170485|NCT01449370|450247783|FG010|Overall Study|Death|0|||
125170486|NCT01449370|450247784|FG011|Overall Study|Death|0|||
125170487|NCT01449370|450247785|FG012|Overall Study|Death|0|||
125170488|NCT01449370|450247786|FG013|Overall Study|Death|0|||
125170489|NCT01449370|450247787|FG014|Overall Study|Death|0|||
125170490|NCT01449370|450247788|FG015|Overall Study|Death|0|||
125170491|NCT01449370|450247789|FG016|Overall Study|Death|0|||
125170492|NCT01449370|450247790|FG017|Overall Study|Death|0|||
125170493|NCT01449370|450247791|FG018|Overall Study|Death|0|||
125170494|NCT01449370|450247792|FG019|Overall Study|Death|0|||
125170495|NCT01449370|450247793|FG020|Overall Study|Death|0|||
125170496|NCT01449370|450247794|FG021|Overall Study|Death|0|||
125170497|NCT01449370|450247795|FG022|Overall Study|Death|0|||
125170498|NCT01449370|450247796|FG023|Overall Study|Death|0|||
125170499|NCT01449370|450247797|FG024|Overall Study|Death|1|||
125170500|NCT00908310|450247798|FG000|Overall Study|Death|37|||
125170501|NCT00908310|450247798|FG000|Overall Study|Withdrawal by Subject|7|||
125170502|NCT00908310|450247798|FG000|Overall Study|Lost to Follow-up|7|||
125170503|NCT00908310|450247798|FG000|Overall Study|Screening failure|5|||
125170504|NCT00908310|450247798|FG000|Overall Study|Other reasons|4|||
125228581|NCT03327324|450465733|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
125228582|NCT03327324|450465734|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
125228583|NCT03327324|450465729|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228584|NCT03327324|450465730|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228585|NCT03327324|450465731|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228586|NCT03327324|450465732|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
125228587|NCT03327324|450465733|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
125228588|NCT03327324|450465734|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
125228589|NCT03327324|450465729|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
125228590|NCT03327324|450465730|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
125228591|NCT03327324|450465731|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
125228592|NCT03327324|450465732|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
125228593|NCT03327324|450465733|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
125228594|NCT03327324|450465734|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
125228595|NCT03327324|450465729|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
125228596|NCT03327324|450465730|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
125228597|NCT03327324|450465731|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
125228598|NCT03327324|450465732|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
125228599|NCT03327324|450465733|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
125228600|NCT03327324|450465734|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
125228601|NCT03080935|450465737|FG000|Overall Study|Death|34|||
125228602|NCT03080935|450465738|FG001|Overall Study|Death|50|||
125228603|NCT03080935|450465737|FG000|Overall Study|Lost to Follow-up|5|||
125228604|NCT03080935|450465738|FG001|Overall Study|Lost to Follow-up|4|||
125228605|NCT03080935|450465737|FG000|Overall Study|Withdrawal by Subject|11|||
125228606|NCT03080935|450465738|FG001|Overall Study|Withdrawal by Subject|15|||
125228607|NCT01614470|450465739|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
125170505|NCT00534404|450247801|FG000|Overall Study|Death|0|||
125170506|NCT00534404|450247802|FG001|Overall Study|Death|0|||
125170507|NCT00534404|450247803|FG002|Overall Study|Death|2|||
125170508|NCT00534404|450247801|FG000|Overall Study|Withdrawal by Subject|8|||
125170509|NCT00534404|450247802|FG001|Overall Study|Withdrawal by Subject|2|||
125170510|NCT00534404|450247803|FG002|Overall Study|Withdrawal by Subject|38|||
125170511|NCT00534404|450247801|FG000|Overall Study|Removed by study staff|2|||
125170512|NCT00534404|450247802|FG001|Overall Study|Removed by study staff|3|||
125170513|NCT00534404|450247803|FG002|Overall Study|Removed by study staff|1|||
125170514|NCT00534404|450247801|FG000|Overall Study|Lost to Follow-up|170|||
125170515|NCT00534404|450247802|FG001|Overall Study|Lost to Follow-up|138|||
125228608|NCT01614470|450465740|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
125228609|NCT01614470|450465741|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
125228610|NCT01614470|450465739|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
125228611|NCT01614470|450465740|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
125228612|NCT01614470|450465741|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
125170516|NCT00534404|450247803|FG002|Overall Study|Lost to Follow-up|201|||
125170517|NCT02785952|450247807|FG000|Overall Study|Adverse Event|31|||
125170518|NCT02785952|450247808|FG001|Overall Study|Adverse Event|19|||
125170519|NCT02785952|450247807|FG000|Overall Study|Refusal unrelated to adverse events|10|||
125170520|NCT02785952|450247808|FG001|Overall Study|Refusal unrelated to adverse events|5|||
125170521|NCT02785952|450247807|FG000|Overall Study|Disease progression/relapse|61|||
125170522|NCT02785952|450247808|FG001|Overall Study|Disease progression/relapse|89|||
125170523|NCT02785952|450247807|FG000|Overall Study|Death|11|||
125170524|NCT02785952|450247808|FG001|Overall Study|Death|7|||
125170525|NCT02785952|450247807|FG000|Overall Study|Other- not protocol specified|6|||
125170526|NCT02785952|450247808|FG001|Overall Study|Other- not protocol specified|4|||
125170527|NCT02785952|450247807|FG000|Overall Study|On protocol treatment|6|||
125170528|NCT02785952|450247808|FG001|Overall Study|On protocol treatment|3|||
125170529|NCT00351533|450247810|FG000|Overall Study|Extubated before first BAL|1|||
125170530|NCT00351533|450247811|FG001|Overall Study|Extubated before first BAL|0|||
125170531|NCT00351533|450247810|FG000|Overall Study|Lost to Follow-up|1|||
125170532|NCT00351533|450247811|FG001|Overall Study|Lost to Follow-up|3|||
125170533|NCT00351533|450247810|FG000|Overall Study|Physician Decision|0|||
125170534|NCT00351533|450247811|FG001|Overall Study|Physician Decision|1|||
125170535|NCT00351533|450247810|FG000|Overall Study|Withdrawal by Subject|0|||
125170536|NCT00351533|450247811|FG001|Overall Study|Withdrawal by Subject|1|||
125170537|NCT00315731|450247812|FG000|Overall Study|Lost to Follow-up|1|||
125170538|NCT00315731|450247812|FG000|Overall Study|Death|5|||
125170539|NCT04614246|450247813|FG000|Overall Study|Adverse Event|0|||
125170540|NCT04614246|450247814|FG001|Overall Study|Adverse Event|1|||
125170541|NCT04614246|450247815|FG002|Overall Study|Adverse Event|1|||
125170542|NCT04614246|450247816|FG003|Overall Study|Adverse Event|2|||
125170543|NCT04614246|450247817|FG004|Overall Study|Adverse Event|1|||
125228613|NCT02175121|450465742|FG000|Overall Study|Lack of Efficacy|1|||
125228614|NCT02175121|450465743|FG001|Overall Study|Lack of Efficacy|0|||
125228615|NCT02175121|450465744|FG002|Overall Study|Lack of Efficacy|0|||
125228616|NCT02175121|450465745|FG003|Overall Study|Lack of Efficacy|0|||
125228617|NCT02175121|450465746|FG004|Overall Study|Lack of Efficacy|0|||
125228618|NCT02175121|450465742|FG000|Overall Study|Lost to Follow-up|0|||
125228619|NCT02175121|450465743|FG001|Overall Study|Lost to Follow-up|1|||
125228620|NCT02175121|450465744|FG002|Overall Study|Lost to Follow-up|0|||
125228621|NCT02175121|450465745|FG003|Overall Study|Lost to Follow-up|1|||
125228622|NCT02175121|450465746|FG004|Overall Study|Lost to Follow-up|0|||
125228623|NCT02175121|450465742|FG000|Overall Study|Personal emergency|0|||
125228624|NCT02175121|450465743|FG001|Overall Study|Personal emergency|0|||
125228625|NCT02175121|450465744|FG002|Overall Study|Personal emergency|0|||
125228626|NCT02175121|450465745|FG003|Overall Study|Personal emergency|0|||
125228627|NCT02175121|450465746|FG004|Overall Study|Personal emergency|1|||
125228628|NCT02175121|450465742|FG000|Overall Study|Schedule conflict|0|||
125228629|NCT02175121|450465743|FG001|Overall Study|Schedule conflict|0|||
125228630|NCT02175121|450465744|FG002|Overall Study|Schedule conflict|1|||
125228631|NCT02175121|450465745|FG003|Overall Study|Schedule conflict|0|||
125228632|NCT02175121|450465746|FG004|Overall Study|Schedule conflict|0|||
125228633|NCT02175121|450465742|FG000|Overall Study|Time issues|0|||
125228634|NCT02175121|450465743|FG001|Overall Study|Time issues|0|||
125228635|NCT02175121|450465744|FG002|Overall Study|Time issues|1|||
125228636|NCT02175121|450465745|FG003|Overall Study|Time issues|0|||
125228637|NCT02175121|450465746|FG004|Overall Study|Time issues|0|||
125228638|NCT02557399|450465747|FG000|Overall Study|Adverse Event|6|||
125228639|NCT02557399|450465748|FG001|Overall Study|Adverse Event|5|||
125228640|NCT02557399|450465747|FG000|Overall Study|Protocol Violation|0|||
125228641|NCT02557399|450465748|FG001|Overall Study|Protocol Violation|1|||
125228642|NCT02557399|450465747|FG000|Overall Study|Protocol-defined stopping criteria|0|||
125228643|NCT02557399|450465748|FG001|Overall Study|Protocol-defined stopping criteria|1|||
125228644|NCT02557399|450465747|FG000|Overall Study|Withdrawal by Subject|1|||
125228645|NCT02557399|450465748|FG001|Overall Study|Withdrawal by Subject|1|||
125228646|NCT02848664|450465749|FG000|Overall Study|Withdrawal by Subject|2|||
125228647|NCT02848664|450465749|FG000|Overall Study|Adverse Event|1|||
125228648|NCT02848664|450465749|FG000|Overall Study|no assistance for device training|1|||
125228649|NCT00402727|450465750|FG000|Overall Study|Adverse Event|10|||
125170544|NCT04614246|450247813|FG000|Overall Study|Lost to Follow-up|0|||
125228650|NCT00402727|450465751|FG001|Overall Study|Adverse Event|6|||
125170545|NCT04614246|450247814|FG001|Overall Study|Lost to Follow-up|1|||
125170546|NCT04614246|450247815|FG002|Overall Study|Lost to Follow-up|0|||
125228651|NCT00402727|450465750|FG000|Overall Study|Death|1|||
125170547|NCT04614246|450247816|FG003|Overall Study|Lost to Follow-up|1|||
125170548|NCT04614246|450247817|FG004|Overall Study|Lost to Follow-up|3|||
125228652|NCT00402727|450465751|FG001|Overall Study|Death|0|||
125228653|NCT00402727|450465750|FG000|Overall Study|Lack of Efficacy|1|||
125228654|NCT00402727|450465751|FG001|Overall Study|Lack of Efficacy|3|||
125228655|NCT00402727|450465750|FG000|Overall Study|Lost to Follow-up|24|||
125228656|NCT00402727|450465751|FG001|Overall Study|Lost to Follow-up|11|||
125228657|NCT00402727|450465750|FG000|Overall Study|Physician Decision|1|||
125228658|NCT00402727|450465751|FG001|Overall Study|Physician Decision|1|||
125228659|NCT00402727|450465750|FG000|Overall Study|Protocol Violation|0|||
125228660|NCT00402727|450465751|FG001|Overall Study|Protocol Violation|4|||
125228661|NCT00402727|450465750|FG000|Overall Study|Withdrawal by Subject|3|||
125228662|NCT00402727|450465751|FG001|Overall Study|Withdrawal by Subject|7|||
125228663|NCT00402727|450465750|FG000|Overall Study|supply problems|2|||
125228664|NCT00402727|450465751|FG001|Overall Study|supply problems|1|||
125228665|NCT00402727|450465750|FG000|Overall Study|non-compliance|0|||
125228666|NCT00402727|450465751|FG001|Overall Study|non-compliance|1|||
125228667|NCT01405898|450465752|FG000|Overall Study|Withdrawal by Subject|2|||
125228668|NCT01405898|450465753|FG001|Overall Study|Withdrawal by Subject|2|||
125228669|NCT01687218|450465754|FG000|Overall Study|Withdrawal by Subject|2|||
125228670|NCT01687218|450465755|FG001|Overall Study|Withdrawal by Subject|3|||
125228671|NCT01687218|450465756|FG002|Overall Study|Withdrawal by Subject|0|||
125228672|NCT01687218|450465757|FG003|Overall Study|Withdrawal by Subject|1|||
125228673|NCT01687218|450465758|FG004|Overall Study|Withdrawal by Subject|1|||
125228674|NCT01687218|450465759|FG005|Overall Study|Withdrawal by Subject|0|||
125228675|NCT01687218|450465754|FG000|Overall Study|Relocated, no follow-up planned|1|||
125228676|NCT01687218|450465755|FG001|Overall Study|Relocated, no follow-up planned|0|||
125228677|NCT01687218|450465756|FG002|Overall Study|Relocated, no follow-up planned|1|||
125228678|NCT01687218|450465757|FG003|Overall Study|Relocated, no follow-up planned|1|||
125228679|NCT01687218|450465758|FG004|Overall Study|Relocated, no follow-up planned|0|||
125228680|NCT01687218|450465759|FG005|Overall Study|Relocated, no follow-up planned|0|||
125228681|NCT00887484|450465772|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
125228682|NCT00887484|450465772|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
125228683|NCT00887484|450465772|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
125228684|NCT01204671|450465773|FG000|Overall Study|Adverse Event|4|||
125228685|NCT01204671|450465774|FG001|Overall Study|Adverse Event|3|||
125228686|NCT01204671|450465775|FG002|Overall Study|Adverse Event|3|||
125228687|NCT01204671|450465776|FG003|Overall Study|Adverse Event|3|||
125228688|NCT01204671|450465777|FG004|Overall Study|Adverse Event|1|||
125228689|NCT01204671|450465773|FG000|Overall Study|Withdrawal by Subject|2|||
125228690|NCT01204671|450465774|FG001|Overall Study|Withdrawal by Subject|3|||
125228691|NCT01204671|450465775|FG002|Overall Study|Withdrawal by Subject|4|||
125228692|NCT01204671|450465776|FG003|Overall Study|Withdrawal by Subject|5|||
125228693|NCT01204671|450465777|FG004|Overall Study|Withdrawal by Subject|3|||
125228694|NCT01204671|450465773|FG000|Overall Study|Lost to Follow-up|7|||
125228695|NCT01204671|450465774|FG001|Overall Study|Lost to Follow-up|8|||
125228696|NCT01204671|450465775|FG002|Overall Study|Lost to Follow-up|6|||
125228697|NCT01204671|450465776|FG003|Overall Study|Lost to Follow-up|4|||
125228698|NCT01204671|450465777|FG004|Overall Study|Lost to Follow-up|0|||
125228699|NCT01204671|450465773|FG000|Overall Study|Unknown Completion Status|1|||
125228700|NCT01204671|450465774|FG001|Overall Study|Unknown Completion Status|1|||
125228701|NCT01204671|450465775|FG002|Overall Study|Unknown Completion Status|0|||
125228702|NCT01204671|450465776|FG003|Overall Study|Unknown Completion Status|0|||
125228703|NCT01204671|450465777|FG004|Overall Study|Unknown Completion Status|0|||
125228704|NCT01204671|450465773|FG000|Overall Study|Physician Decision|0|||
125228705|NCT01204671|450465774|FG001|Overall Study|Physician Decision|0|||
125228706|NCT01204671|450465775|FG002|Overall Study|Physician Decision|0|||
125228707|NCT01204671|450465776|FG003|Overall Study|Physician Decision|1|||
125228708|NCT01204671|450465777|FG004|Overall Study|Physician Decision|0|||
125228709|NCT01316224|450465778|FG000|Overall Study|Protocol Violation|3|||
125228710|NCT01316224|450465778|FG000|Overall Study|Adverse Event|3|||
125228711|NCT01316224|450465778|FG000|Overall Study|Lack of Efficacy|1|||
125228712|NCT01316224|450465778|FG000|Overall Study|Withdrawal by Subject|1|||
125228713|NCT01316224|450465778|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
125228714|NCT01316224|450465778|FG000|Overall Study|Other|1|||
125228715|NCT00264147|450465779|FG000|Treatment I Period|Adverse Event|3|||
125228716|NCT00264147|450465780|FG001|Treatment I Period|Adverse Event|6|||
125228717|NCT00264147|450465781|FG002|Treatment I Period|Adverse Event|3|||
125228718|NCT00264147|450465782|FG003|Treatment I Period|Adverse Event|5|||
125228719|NCT00264147|450465783|FG004|Treatment I Period|Adverse Event|7|||
125228720|NCT00264147|450465784|FG005|Treatment I Period|Adverse Event|0|||
125228721|NCT00264147|450465779|FG000|Treatment I Period|Laboratory Adverse Event|0|||
125228722|NCT00264147|450465780|FG001|Treatment I Period|Laboratory Adverse Event|0|||
125228723|NCT00264147|450465781|FG002|Treatment I Period|Laboratory Adverse Event|0|||
125228724|NCT00264147|450465782|FG003|Treatment I Period|Laboratory Adverse Event|1|||
125228725|NCT00264147|450465783|FG004|Treatment I Period|Laboratory Adverse Event|0|||
125228726|NCT00264147|450465784|FG005|Treatment I Period|Laboratory Adverse Event|0|||
125228727|NCT00264147|450465779|FG000|Treatment I Period|Lack of Efficacy|6|||
125228728|NCT00264147|450465780|FG001|Treatment I Period|Lack of Efficacy|2|||
125228729|NCT00264147|450465781|FG002|Treatment I Period|Lack of Efficacy|8|||
125170549|NCT04614246|450247813|FG000|Overall Study|Other reason|0|||
125170550|NCT04614246|450247814|FG001|Overall Study|Other reason|1|||
125170551|NCT04614246|450247815|FG002|Overall Study|Other reason|2|||
125170552|NCT04614246|450247816|FG003|Overall Study|Other reason|0|||
125170553|NCT04614246|450247817|FG004|Overall Study|Other reason|0|||
125170554|NCT04614246|450247813|FG000|Overall Study|Withdrawal by Subject|4|||
125170555|NCT04614246|450247814|FG001|Overall Study|Withdrawal by Subject|2|||
125170556|NCT04614246|450247815|FG002|Overall Study|Withdrawal by Subject|4|||
125170557|NCT04614246|450247816|FG003|Overall Study|Withdrawal by Subject|3|||
125170558|NCT04614246|450247817|FG004|Overall Study|Withdrawal by Subject|4|||
125170559|NCT04614246|450247813|FG000|Overall Study|Physician Decision|0|||
125170560|NCT04614246|450247814|FG001|Overall Study|Physician Decision|2|||
125170561|NCT04614246|450247815|FG002|Overall Study|Physician Decision|1|||
125170562|NCT04614246|450247816|FG003|Overall Study|Physician Decision|0|||
125170563|NCT04614246|450247817|FG004|Overall Study|Physician Decision|0|||
125170564|NCT04614246|450247813|FG000|Overall Study|Study terminated by sponsor|10|||
125170565|NCT04614246|450247814|FG001|Overall Study|Study terminated by sponsor|15|||
125170566|NCT04614246|450247815|FG002|Overall Study|Study terminated by sponsor|12|||
125170567|NCT04614246|450247816|FG003|Overall Study|Study terminated by sponsor|13|||
125170568|NCT04614246|450247817|FG004|Overall Study|Study terminated by sponsor|9|||
125170569|NCT04614246|450247813|FG000|Overall Study|Pregnancy|2|||
125170570|NCT04614246|450247814|FG001|Overall Study|Pregnancy|0|||
125170571|NCT04614246|450247815|FG002|Overall Study|Pregnancy|1|||
125170572|NCT04614246|450247816|FG003|Overall Study|Pregnancy|0|||
125170573|NCT04614246|450247817|FG004|Overall Study|Pregnancy|0|||
125170574|NCT01680497|450247818|FG000|Overall Study|Lost to Follow-up|2|||
125170575|NCT00725205|450247819|FG000|Overall Study|Adverse Event|22|||
125170576|NCT00725205|450247819|FG000|Overall Study|Investigator Discontinued|1|||
125170577|NCT00725205|450247819|FG000|Overall Study|Non-compliance With Protocol|14|||
125170578|NCT00725205|450247819|FG000|Overall Study|Other|8|||
125170579|NCT00725205|450247819|FG000|Overall Study|Protocol Defined Clinical Event|1|||
125170580|NCT00725205|450247819|FG000|Overall Study|Treatment Failure|41|||
125170581|NCT00996892|450247821|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
125170582|NCT00996892|450247822|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
125170583|NCT00996892|450247823|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
125170584|NCT00996892|450247824|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
125170585|NCT00996892|450247825|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
125170586|NCT00996892|450247826|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
125170587|NCT00996892|450247827|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
125170588|NCT00996892|450247828|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
125228730|NCT00264147|450465782|FG003|Treatment I Period|Lack of Efficacy|0|||
125228731|NCT00264147|450465783|FG004|Treatment I Period|Lack of Efficacy|1|||
125228732|NCT00264147|450465784|FG005|Treatment I Period|Lack of Efficacy|0|||
125228733|NCT00264147|450465779|FG000|Treatment I Period|Lost to Follow-up|1|||
125228734|NCT00264147|450465780|FG001|Treatment I Period|Lost to Follow-up|0|||
125228735|NCT00264147|450465781|FG002|Treatment I Period|Lost to Follow-up|0|||
125228736|NCT00264147|450465782|FG003|Treatment I Period|Lost to Follow-up|1|||
125228737|NCT00264147|450465783|FG004|Treatment I Period|Lost to Follow-up|1|||
125228738|NCT00264147|450465784|FG005|Treatment I Period|Lost to Follow-up|0|||
125228739|NCT00264147|450465779|FG000|Treatment I Period|Protocol Violation|2|||
125228740|NCT00264147|450465780|FG001|Treatment I Period|Protocol Violation|2|||
125228741|NCT00264147|450465781|FG002|Treatment I Period|Protocol Violation|0|||
125228742|NCT00264147|450465782|FG003|Treatment I Period|Protocol Violation|0|||
125228743|NCT00264147|450465783|FG004|Treatment I Period|Protocol Violation|0|||
125228744|NCT00264147|450465784|FG005|Treatment I Period|Protocol Violation|0|||
125228745|NCT00264147|450465779|FG000|Treatment I Period|Withdrawal by Subject|2|||
125228746|NCT00264147|450465780|FG001|Treatment I Period|Withdrawal by Subject|0|||
125228747|NCT00264147|450465781|FG002|Treatment I Period|Withdrawal by Subject|0|||
125228748|NCT00264147|450465782|FG003|Treatment I Period|Withdrawal by Subject|2|||
125228749|NCT00264147|450465783|FG004|Treatment I Period|Withdrawal by Subject|2|||
125228750|NCT00264147|450465784|FG005|Treatment I Period|Withdrawal by Subject|0|||
125228751|NCT00264147|450465779|FG000|Treatment I Period|Patient out of town for an extended time|0|||
125228752|NCT00264147|450465780|FG001|Treatment I Period|Patient out of town for an extended time|1|||
125228753|NCT00264147|450465781|FG002|Treatment I Period|Patient out of town for an extended time|0|||
125228754|NCT00264147|450465782|FG003|Treatment I Period|Patient out of town for an extended time|0|||
125228755|NCT00264147|450465783|FG004|Treatment I Period|Patient out of town for an extended time|0|||
125228756|NCT00264147|450465784|FG005|Treatment I Period|Patient out of town for an extended time|0|||
125170589|NCT00996892|450247829|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
125170590|NCT00996892|450247830|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
125170591|NCT00996892|450247831|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
125170592|NCT00996892|450247832|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
125170593|NCT00996892|450247833|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
125170594|NCT00996892|450247834|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
125170595|NCT00996892|450247835|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
125170596|NCT00996892|450247836|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
125228757|NCT00264147|450465779|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
125228758|NCT00264147|450465780|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
125228759|NCT00264147|450465781|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
125228760|NCT00264147|450465782|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
125228761|NCT00264147|450465783|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
125228762|NCT00264147|450465784|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
125228763|NCT00264147|450465779|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
125228764|NCT00264147|450465780|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
125228765|NCT00264147|450465781|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
125228766|NCT00264147|450465782|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
125228767|NCT00264147|450465783|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
125228768|NCT00264147|450465784|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
125228769|NCT00264147|450465779|FG000|Treatment II Period|Adverse Event|0|||
125228770|NCT00264147|450465780|FG001|Treatment II Period|Adverse Event|0|||
125228771|NCT00264147|450465781|FG002|Treatment II Period|Adverse Event|0|||
125228772|NCT00264147|450465782|FG003|Treatment II Period|Adverse Event|0|||
125228773|NCT00264147|450465783|FG004|Treatment II Period|Adverse Event|9|||
125228774|NCT00264147|450465784|FG005|Treatment II Period|Adverse Event|9|||
125228775|NCT00264147|450465779|FG000|Treatment II Period|Laboratory Adverse Event|0|||
125228776|NCT00264147|450465780|FG001|Treatment II Period|Laboratory Adverse Event|0|||
125228777|NCT00264147|450465781|FG002|Treatment II Period|Laboratory Adverse Event|0|||
125228778|NCT00264147|450465782|FG003|Treatment II Period|Laboratory Adverse Event|0|||
125228779|NCT00264147|450465783|FG004|Treatment II Period|Laboratory Adverse Event|0|||
125228780|NCT00264147|450465784|FG005|Treatment II Period|Laboratory Adverse Event|1|||
125228781|NCT00264147|450465779|FG000|Treatment II Period|Lack of Efficacy|0|||
125228782|NCT00264147|450465780|FG001|Treatment II Period|Lack of Efficacy|0|||
125228783|NCT00264147|450465781|FG002|Treatment II Period|Lack of Efficacy|0|||
125228784|NCT00264147|450465782|FG003|Treatment II Period|Lack of Efficacy|0|||
125228785|NCT00264147|450465783|FG004|Treatment II Period|Lack of Efficacy|20|||
125228786|NCT00264147|450465784|FG005|Treatment II Period|Lack of Efficacy|19|||
125228787|NCT00264147|450465779|FG000|Treatment II Period|Lost to Follow-up|0|||
125228788|NCT00264147|450465780|FG001|Treatment II Period|Lost to Follow-up|0|||
125228789|NCT00264147|450465781|FG002|Treatment II Period|Lost to Follow-up|0|||
125228790|NCT00264147|450465782|FG003|Treatment II Period|Lost to Follow-up|0|||
125228791|NCT00264147|450465783|FG004|Treatment II Period|Lost to Follow-up|1|||
125228792|NCT00264147|450465784|FG005|Treatment II Period|Lost to Follow-up|1|||
125228793|NCT00264147|450465779|FG000|Treatment II Period|Withdrawal by Subject|0|||
125228794|NCT00264147|450465780|FG001|Treatment II Period|Withdrawal by Subject|0|||
125228795|NCT00264147|450465781|FG002|Treatment II Period|Withdrawal by Subject|0|||
125228796|NCT00264147|450465782|FG003|Treatment II Period|Withdrawal by Subject|0|||
125228797|NCT00264147|450465783|FG004|Treatment II Period|Withdrawal by Subject|3|||
125228798|NCT00264147|450465784|FG005|Treatment II Period|Withdrawal by Subject|2|||
125228799|NCT00264147|450465779|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
125228800|NCT00264147|450465780|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
125228801|NCT00264147|450465781|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
125228802|NCT00264147|450465782|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
125228803|NCT00264147|450465783|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
125228804|NCT00264147|450465784|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
125228805|NCT03234465|450465785|FG000|Overall Study|Adverse Event|4|||
125228806|NCT03234465|450465786|FG001|Overall Study|Adverse Event|2|||
125228807|NCT03234465|450465785|FG000|Overall Study|Death|0|||
125228808|NCT03234465|450465786|FG001|Overall Study|Death|1|||
125228809|NCT03234465|450465785|FG000|Overall Study|Lost to Follow-up|1|||
125228810|NCT03234465|450465786|FG001|Overall Study|Lost to Follow-up|1|||
125228811|NCT03234465|450465785|FG000|Overall Study|Withdrawal by Subject|12|||
125228812|NCT03234465|450465786|FG001|Overall Study|Withdrawal by Subject|27|||
125228813|NCT03234465|450465785|FG000|Overall Study|Symptomatic deterioration|0|||
125228814|NCT03234465|450465786|FG001|Overall Study|Symptomatic deterioration|1|||
125228815|NCT03234465|450465785|FG000|Overall Study|Non-compliance|2|||
125228816|NCT03234465|450465786|FG001|Overall Study|Non-compliance|0|||
125228817|NCT03234465|450465785|FG000|Overall Study|Other|14|||
125228818|NCT03234465|450465786|FG001|Overall Study|Other|8|||
125228819|NCT03106077|450465787|FG000|Overall Study|Screen Failure|94|||
125228820|NCT03106077|450465788|FG001|Overall Study|Screen Failure|0|||
125228821|NCT01274533|450465791|FG000|Overall Study|Withdrawal by Subject|1|||
125228822|NCT01274533|450465791|FG000|Overall Study|Non-compliance|1|||
125228823|NCT01274533|450465791|FG000|Overall Study|Disease progression|2|||
125228824|NCT02008526|450465793|FG000|Overall Study|Death|0|||
125228825|NCT02008526|450465794|FG001|Overall Study|Death|2|||
125228826|NCT02008526|450465795|FG002|Overall Study|Death|1|||
125228827|NCT02008526|450465793|FG000|Overall Study|Withdrawal by Subject|3|||
125228828|NCT02008526|450465794|FG001|Overall Study|Withdrawal by Subject|3|||
125228829|NCT02008526|450465795|FG002|Overall Study|Withdrawal by Subject|2|||
125228830|NCT02008526|450465793|FG000|Overall Study|Lost to Follow-up|5|||
125170597|NCT00996892|450247837|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
125170598|NCT00996892|450247838|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
125170599|NCT00996892|450247839|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
125170600|NCT00996892|450247840|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
125170601|NCT00996892|450247821|FG000|Dose-Escalation Stage 1|Death|1|||
125170602|NCT00996892|450247822|FG001|Dose-Escalation Stage 1|Death|0|||
125170603|NCT00996892|450247823|FG002|Dose-Escalation Stage 1|Death|0|||
125170604|NCT00996892|450247824|FG003|Dose-Escalation Stage 1|Death|0|||
125170605|NCT00996892|450247825|FG004|Dose-Escalation Stage 1|Death|0|||
125170606|NCT00996892|450247826|FG005|Dose-Escalation Stage 1|Death|1|||
125170607|NCT00996892|450247827|FG006|Dose-Escalation Stage 1|Death|0|||
125170608|NCT00996892|450247828|FG007|Dose-Escalation Stage 1|Death|0|||
125170609|NCT00996892|450247829|FG008|Dose-Escalation Stage 1|Death|0|||
125170610|NCT00996892|450247830|FG009|Dose-Escalation Stage 1|Death|0|||
125170611|NCT00996892|450247831|FG010|Dose-Escalation Stage 1|Death|0|||
125170612|NCT00996892|450247832|FG011|Dose-Escalation Stage 1|Death|0|||
125170613|NCT00996892|450247833|FG012|Dose-Escalation Stage 1|Death|0|||
125170614|NCT00996892|450247834|FG013|Dose-Escalation Stage 1|Death|0|||
125170615|NCT00996892|450247835|FG014|Dose-Escalation Stage 1|Death|0|||
125170616|NCT00996892|450247836|FG015|Dose-Escalation Stage 1|Death|0|||
125170617|NCT00996892|450247837|FG016|Dose-Escalation Stage 1|Death|0|||
125170618|NCT00996892|450247838|FG017|Dose-Escalation Stage 1|Death|0|||
125170619|NCT00996892|450247839|FG018|Dose-Escalation Stage 1|Death|0|||
125170620|NCT00996892|450247840|FG019|Dose-Escalation Stage 1|Death|0|||
125170621|NCT00996892|450247821|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
125170622|NCT00996892|450247822|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
125170623|NCT00996892|450247823|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
125170624|NCT00996892|450247824|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
125170625|NCT00996892|450247825|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
125170626|NCT00996892|450247826|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
125170627|NCT00996892|450247827|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
125170628|NCT00996892|450247828|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
125170629|NCT00996892|450247829|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
125170630|NCT00996892|450247830|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
125170631|NCT00996892|450247831|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
125170632|NCT00996892|450247832|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
125170633|NCT00996892|450247833|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
125170634|NCT00996892|450247834|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
125170635|NCT00996892|450247835|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
125170636|NCT00996892|450247836|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
125170637|NCT00996892|450247837|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
125170638|NCT00996892|450247838|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
125170639|NCT00996892|450247839|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
125170640|NCT00996892|450247840|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
125170641|NCT00996892|450247821|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170642|NCT00996892|450247822|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
125170643|NCT00996892|450247823|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170644|NCT00996892|450247824|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
125170645|NCT00996892|450247825|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
125170646|NCT00996892|450247826|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
125170647|NCT00996892|450247827|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
125170648|NCT00996892|450247828|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170649|NCT00996892|450247829|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170650|NCT00996892|450247830|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170651|NCT00996892|450247831|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170652|NCT00996892|450247832|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170653|NCT00996892|450247833|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170654|NCT00996892|450247834|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170655|NCT00996892|450247835|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170656|NCT00996892|450247836|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170657|NCT00996892|450247837|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170658|NCT00996892|450247838|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170659|NCT00996892|450247839|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170660|NCT00996892|450247840|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
125170661|NCT00996892|450247821|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
125170662|NCT00996892|450247822|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
125170663|NCT00996892|450247823|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
125170664|NCT00996892|450247824|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
125170665|NCT00996892|450247825|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
125170666|NCT00996892|450247826|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
125170667|NCT00996892|450247827|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
125170668|NCT00996892|450247828|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
125170669|NCT00996892|450247829|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
125228831|NCT02008526|450465794|FG001|Overall Study|Lost to Follow-up|9|||
125170670|NCT00996892|450247830|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
125170671|NCT00996892|450247831|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
125170672|NCT00996892|450247832|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
125170673|NCT00996892|450247833|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
125170674|NCT00996892|450247834|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
125170675|NCT00996892|450247835|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
125170676|NCT00996892|450247836|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
125170677|NCT00996892|450247837|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
125170678|NCT00996892|450247838|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
125170679|NCT00996892|450247839|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
125170680|NCT00996892|450247840|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
125170681|NCT00996892|450247821|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
125170682|NCT00996892|450247822|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
125170683|NCT00996892|450247823|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
125170684|NCT00996892|450247824|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
125170685|NCT00996892|450247825|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
125170686|NCT00996892|450247826|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
125170687|NCT00996892|450247827|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
125170688|NCT00996892|450247828|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
125170689|NCT00996892|450247829|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
125170690|NCT00996892|450247830|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
125170691|NCT00996892|450247831|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
125170692|NCT00996892|450247832|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
125170693|NCT00996892|450247833|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
125170694|NCT00996892|450247834|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
125170695|NCT00996892|450247835|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
125170696|NCT00996892|450247836|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
125170697|NCT00996892|450247837|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
125170698|NCT00996892|450247838|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
125170699|NCT00996892|450247839|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
125170700|NCT00996892|450247840|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
125170701|NCT00996892|450247821|FG000|Dose-Escalation Stage 1A|Death|0|||
125170702|NCT00996892|450247822|FG001|Dose-Escalation Stage 1A|Death|0|||
125170703|NCT00996892|450247823|FG002|Dose-Escalation Stage 1A|Death|0|||
125170704|NCT00996892|450247824|FG003|Dose-Escalation Stage 1A|Death|0|||
125170705|NCT00996892|450247825|FG004|Dose-Escalation Stage 1A|Death|0|||
125170706|NCT00996892|450247826|FG005|Dose-Escalation Stage 1A|Death|0|||
125170707|NCT00996892|450247827|FG006|Dose-Escalation Stage 1A|Death|0|||
125170708|NCT00996892|450247828|FG007|Dose-Escalation Stage 1A|Death|0|||
125170709|NCT00996892|450247829|FG008|Dose-Escalation Stage 1A|Death|0|||
125170710|NCT00996892|450247830|FG009|Dose-Escalation Stage 1A|Death|2|||
125170711|NCT00996892|450247831|FG010|Dose-Escalation Stage 1A|Death|0|||
125170712|NCT00996892|450247832|FG011|Dose-Escalation Stage 1A|Death|1|||
125170713|NCT00996892|450247833|FG012|Dose-Escalation Stage 1A|Death|1|||
125170714|NCT00996892|450247834|FG013|Dose-Escalation Stage 1A|Death|0|||
125170715|NCT00996892|450247835|FG014|Dose-Escalation Stage 1A|Death|0|||
125170716|NCT00996892|450247836|FG015|Dose-Escalation Stage 1A|Death|0|||
125170717|NCT00996892|450247837|FG016|Dose-Escalation Stage 1A|Death|0|||
125170718|NCT00996892|450247838|FG017|Dose-Escalation Stage 1A|Death|0|||
125170719|NCT00996892|450247839|FG018|Dose-Escalation Stage 1A|Death|0|||
125170720|NCT00996892|450247840|FG019|Dose-Escalation Stage 1A|Death|0|||
125170721|NCT00996892|450247821|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
125170722|NCT00996892|450247822|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
125170723|NCT00996892|450247823|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
125170724|NCT00996892|450247824|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
125170725|NCT00996892|450247825|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
125170726|NCT00996892|450247826|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
125170727|NCT00996892|450247827|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
125170728|NCT00996892|450247828|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
125170729|NCT00996892|450247829|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
125170730|NCT00996892|450247830|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
125170731|NCT00996892|450247831|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
125170732|NCT00996892|450247832|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
125170733|NCT00996892|450247833|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
125170734|NCT00996892|450247834|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
125170735|NCT00996892|450247835|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
125170736|NCT00996892|450247836|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
125170737|NCT00996892|450247837|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
125170738|NCT00996892|450247838|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
125170739|NCT00996892|450247839|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
125170740|NCT00996892|450247840|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
125170741|NCT00996892|450247821|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170742|NCT00996892|450247822|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125228832|NCT02008526|450465795|FG002|Overall Study|Lost to Follow-up|6|||
125228833|NCT01118052|450465796|FG000|Overall Study|Never treated|2|||
125228834|NCT02949947|450465797|FG000|Overall Study|Non Compliance|0|||
125228835|NCT02949947|450465798|FG001|Overall Study|Non Compliance|1|||
125228836|NCT02949947|450465797|FG000|Overall Study|Insurance change|1|||
125228837|NCT02949947|450465798|FG001|Overall Study|Insurance change|0|||
125228838|NCT00492726|450465800|FG000|Overall Study|Adverse Event|10|||
125228839|NCT00492726|450465801|FG001|Overall Study|Adverse Event|6|||
125228840|NCT00492726|450465800|FG000|Overall Study|Death|7|||
125228841|NCT00492726|450465801|FG001|Overall Study|Death|2|||
125228842|NCT00492726|450465800|FG000|Overall Study|Lack of Efficacy|0|||
125228843|NCT00492726|450465801|FG001|Overall Study|Lack of Efficacy|2|||
125228844|NCT00492726|450465800|FG000|Overall Study|Lost to Follow-up|27|||
125228845|NCT00492726|450465801|FG001|Overall Study|Lost to Follow-up|19|||
125228846|NCT00492726|450465800|FG000|Overall Study|Physician Decision|0|||
125228847|NCT00492726|450465801|FG001|Overall Study|Physician Decision|1|||
125228848|NCT00492726|450465800|FG000|Overall Study|Withdrawal by Subject|6|||
125228849|NCT00492726|450465801|FG001|Overall Study|Withdrawal by Subject|3|||
125228850|NCT00492726|450465800|FG000|Overall Study|Non compliant with study medication|0|||
125228851|NCT00492726|450465801|FG001|Overall Study|Non compliant with study medication|3|||
125228852|NCT02230891|450465802|FG000|Baseline|Did not meet inclusion|0|||
125228853|NCT02230891|450465803|FG001|Baseline|Did not meet inclusion|1|||
125228854|NCT02230891|450465804|FG002|Baseline|Did not meet inclusion|1|||
125228855|NCT02230891|450465802|FG000|2 Week|Withdrawal by Subject|2|||
125228856|NCT02230891|450465803|FG001|2 Week|Withdrawal by Subject|2|||
125228857|NCT02230891|450465804|FG002|2 Week|Withdrawal by Subject|0|||
125228858|NCT02230891|450465802|FG000|2 Week|Consent withdrawn|1|||
125228859|NCT02230891|450465803|FG001|2 Week|Consent withdrawn|0|||
125228860|NCT02230891|450465804|FG002|2 Week|Consent withdrawn|0|||
125228861|NCT02230891|450465802|FG000|6 Month|Withdrawal by Subject|1|||
125228862|NCT02230891|450465803|FG001|6 Month|Withdrawal by Subject|1|||
125228863|NCT02230891|450465804|FG002|6 Month|Withdrawal by Subject|1|||
125228864|NCT02230891|450465802|FG000|6 Month|Physician Decision|0|||
125228865|NCT02230891|450465803|FG001|6 Month|Physician Decision|2|||
125228866|NCT02230891|450465804|FG002|6 Month|Physician Decision|0|||
125228867|NCT02230891|450465802|FG000|12 Month|Death|1|||
125228868|NCT02230891|450465803|FG001|12 Month|Death|0|||
125228869|NCT02230891|450465804|FG002|12 Month|Death|0|||
125228870|NCT02230891|450465802|FG000|12 Month|Lost to Follow-up|0|||
125228871|NCT02230891|450465803|FG001|12 Month|Lost to Follow-up|1|||
125228872|NCT02230891|450465804|FG002|12 Month|Lost to Follow-up|0|||
125228873|NCT02230891|450465802|FG000|12 Month|Withdrawal by Subject|0|||
125228874|NCT02230891|450465803|FG001|12 Month|Withdrawal by Subject|2|||
125228875|NCT02230891|450465804|FG002|12 Month|Withdrawal by Subject|0|||
125228876|NCT02230891|450465802|FG000|18 Month End of Study|Death|0|||
125228877|NCT02230891|450465803|FG001|18 Month End of Study|Death|0|||
125228878|NCT02230891|450465804|FG002|18 Month End of Study|Death|1|||
125228879|NCT02230891|450465802|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
125228880|NCT02230891|450465803|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
125228881|NCT02230891|450465804|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
125228882|NCT02404545|450465805|FG000|Overall Study|Sponsor Termination|6|||
125228883|NCT02404545|450465806|FG001|Overall Study|Sponsor Termination|6|||
125228884|NCT03141359|450465815|FG000|Overall Study|Death|32|||
125228885|NCT03141359|450465815|FG000|Overall Study|Still On Study (in follow up)|29|||
125228886|NCT01081626|450465816|FG000|Overall Study|Dosing error|1|||
125228887|NCT01081626|450465817|FG001|Overall Study|Dosing error|1|||
125228888|NCT01081626|450465816|FG000|Overall Study|Missing Estradiol|25|||
125228889|NCT01081626|450465817|FG001|Overall Study|Missing Estradiol|28|||
125228890|NCT01081626|450465816|FG000|Overall Study|Low antral follicle count|1|||
125228891|NCT01081626|450465817|FG001|Overall Study|Low antral follicle count|0|||
125228892|NCT01081626|450465816|FG000|Overall Study|Overstimulation|0|||
125228893|NCT01081626|450465817|FG001|Overall Study|Overstimulation|1|||
125228894|NCT01081626|450465816|FG000|Overall Study|Lost to Follow-up|0|||
125228895|NCT01081626|450465817|FG001|Overall Study|Lost to Follow-up|1|||
125228896|NCT01081626|450465816|FG000|Overall Study|Other|33|||
125228897|NCT01081626|450465817|FG001|Overall Study|Other|30|||
125228898|NCT00870727|450467870|FG000|Overall Study|Lost to Follow-up|0|||
125228899|NCT00870727|450467871|FG001|Overall Study|Lost to Follow-up|1|||
125228900|NCT00870727|450467870|FG000|Overall Study|Lack of Efficacy|1|||
125228901|NCT00870727|450467871|FG001|Overall Study|Lack of Efficacy|3|||
125228902|NCT00870727|450467870|FG000|Overall Study|Adverse Event|0|||
125228903|NCT00870727|450467871|FG001|Overall Study|Adverse Event|1|||
125228904|NCT00720278|450467872|FG000|Overall Study|Adverse Event|5|||
125228905|NCT00720278|450467873|FG001|Overall Study|Adverse Event|3|||
125228906|NCT00720278|450467874|FG002|Overall Study|Adverse Event|4|||
125228907|NCT00720278|450467872|FG000|Overall Study|Withdrawal by Subject|0|||
125228908|NCT00720278|450467873|FG001|Overall Study|Withdrawal by Subject|1|||
125228909|NCT00720278|450467874|FG002|Overall Study|Withdrawal by Subject|0|||
125228910|NCT00720278|450467872|FG000|Overall Study|Lost to Follow-up|0|||
125228911|NCT00720278|450467873|FG001|Overall Study|Lost to Follow-up|0|||
125228912|NCT00720278|450467874|FG002|Overall Study|Lost to Follow-up|1|||
125228913|NCT00720278|450467872|FG000|Overall Study|Non-compliance|1|||
125228914|NCT00720278|450467873|FG001|Overall Study|Non-compliance|0|||
125228915|NCT00720278|450467874|FG002|Overall Study|Non-compliance|0|||
125228916|NCT00720278|450467872|FG000|Overall Study|eligibility criteria violation|1|||
125228917|NCT00720278|450467873|FG001|Overall Study|eligibility criteria violation|0|||
125228918|NCT00720278|450467874|FG002|Overall Study|eligibility criteria violation|1|||
125228919|NCT01712516|450467875|FG000|Overall Study|Technical problems|0|||
125228920|NCT01712516|450467876|FG001|Overall Study|Technical problems|0|||
125228921|NCT01712516|450467877|FG002|Overall Study|Technical problems|0|||
125228922|NCT01712516|450467878|FG003|Overall Study|Technical problems|2|||
125228923|NCT01712516|450467875|FG000|Overall Study|Lost to Follow-up|0|||
125228924|NCT01712516|450467876|FG001|Overall Study|Lost to Follow-up|0|||
125228925|NCT01712516|450467877|FG002|Overall Study|Lost to Follow-up|2|||
125228926|NCT01712516|450467878|FG003|Overall Study|Lost to Follow-up|1|||
125228927|NCT01712516|450467875|FG000|Overall Study|Death|0|||
125228928|NCT01712516|450467876|FG001|Overall Study|Death|1|||
125228929|NCT01712516|450467877|FG002|Overall Study|Death|0|||
125228930|NCT01712516|450467878|FG003|Overall Study|Death|0|||
125228931|NCT01712516|450467875|FG000|Overall Study|Protocol deviation|1|||
125228932|NCT01712516|450467876|FG001|Overall Study|Protocol deviation|0|||
125228933|NCT01712516|450467877|FG002|Overall Study|Protocol deviation|1|||
125228934|NCT01712516|450467878|FG003|Overall Study|Protocol deviation|0|||
125228935|NCT01712516|450467875|FG000|Overall Study|Physician Decision|2|||
125228936|NCT01712516|450467876|FG001|Overall Study|Physician Decision|0|||
125228937|NCT01712516|450467877|FG002|Overall Study|Physician Decision|0|||
125228938|NCT01712516|450467878|FG003|Overall Study|Physician Decision|1|||
125228939|NCT01712516|450467875|FG000|Overall Study|Withdrawal by Subject|3|||
125228940|NCT01712516|450467876|FG001|Overall Study|Withdrawal by Subject|9|||
125228941|NCT01712516|450467877|FG002|Overall Study|Withdrawal by Subject|3|||
125228942|NCT01712516|450467878|FG003|Overall Study|Withdrawal by Subject|9|||
125228943|NCT01181167|450467882|FG000|Overall Study|Adverse Event|11|||
125170743|NCT00996892|450247823|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170744|NCT00996892|450247824|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170745|NCT00996892|450247825|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170746|NCT00996892|450247826|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170747|NCT00996892|450247827|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170748|NCT00996892|450247828|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170749|NCT00996892|450247829|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170750|NCT00996892|450247830|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
125170751|NCT00996892|450247831|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
125170752|NCT00996892|450247832|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
125170753|NCT00996892|450247833|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
125170754|NCT00996892|450247834|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125228944|NCT01181167|450467883|FG001|Overall Study|Adverse Event|21|||
125228945|NCT01181167|450467882|FG000|Overall Study|Lost to Follow-up|1|||
125228946|NCT01181167|450467883|FG001|Overall Study|Lost to Follow-up|0|||
125228947|NCT01181167|450467882|FG000|Overall Study|Physician Decision|2|||
125228948|NCT01181167|450467883|FG001|Overall Study|Physician Decision|3|||
125228949|NCT01181167|450467882|FG000|Overall Study|Protocol Violation|3|||
125228950|NCT01181167|450467883|FG001|Overall Study|Protocol Violation|0|||
125228951|NCT01181167|450467882|FG000|Overall Study|Withdrawal by Subject|6|||
125228952|NCT01181167|450467883|FG001|Overall Study|Withdrawal by Subject|8|||
125228953|NCT00161213|450467884|FG000|Overall Study|Withdrawal by Subject|1|||
125228954|NCT00161213|450467884|FG000|Overall Study|Evaluable for toxicity but not response|1|||
125228955|NCT03103503|450467885|FG000|Overall Study|Death|64|||
125228956|NCT03103503|450467885|FG000|Overall Study|Physician Decision|57|||
125228957|NCT03103503|450467885|FG000|Overall Study|Withdrawal by Subject|10|||
125228958|NCT03103503|450467885|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
125228959|NCT03103503|450467885|FG000|Overall Study|Lost to Follow-up|3|||
125228960|NCT03103503|450467885|FG000|Overall Study|Study Closure|757|||
125170755|NCT00996892|450247835|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125228961|NCT01384877|450467886|FG000|Treatment 2|Lost to Follow-up|2|||
125228962|NCT01384877|450467887|FG001|Treatment 2|Lost to Follow-up|2|||
125228963|NCT03630393|450467888|FG000|Overall Study|Death|1|||
125170756|NCT00996892|450247836|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125228964|NCT03630393|450467889|FG001|Overall Study|Death|0|||
125228965|NCT00408499|450467890|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
125228966|NCT00408499|450467891|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
125228967|NCT00408499|450467892|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
125228968|NCT00408499|450467893|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
125228969|NCT00408499|450467894|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
125228970|NCT00408499|450467890|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
125170757|NCT00996892|450247837|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170758|NCT00996892|450247838|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170759|NCT00996892|450247839|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125228971|NCT00408499|450467891|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
125228972|NCT00408499|450467892|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
125228973|NCT00408499|450467893|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
125228974|NCT00408499|450467894|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
125228975|NCT00408499|450467890|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
125228976|NCT00408499|450467891|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
125228977|NCT00408499|450467892|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
125228978|NCT00408499|450467893|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
125228979|NCT00408499|450467894|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
125228980|NCT00408499|450467890|FG000|Phase II- MTD Expansion|Adverse Event|0|||
125228981|NCT00408499|450467891|FG001|Phase II- MTD Expansion|Adverse Event|0|||
125228982|NCT00408499|450467892|FG002|Phase II- MTD Expansion|Adverse Event|0|||
125228983|NCT00408499|450467893|FG003|Phase II- MTD Expansion|Adverse Event|0|||
125228984|NCT00408499|450467894|FG004|Phase II- MTD Expansion|Adverse Event|9|||
125228985|NCT00408499|450467890|FG000|Phase II- MTD Expansion|Death|0|||
125228986|NCT00408499|450467891|FG001|Phase II- MTD Expansion|Death|0|||
125228987|NCT00408499|450467892|FG002|Phase II- MTD Expansion|Death|0|||
125228988|NCT00408499|450467893|FG003|Phase II- MTD Expansion|Death|0|||
125228989|NCT00408499|450467894|FG004|Phase II- MTD Expansion|Death|2|||
125228990|NCT00408499|450467890|FG000|Phase II- MTD Expansion|Physician Decision|0|||
125228991|NCT00408499|450467891|FG001|Phase II- MTD Expansion|Physician Decision|0|||
125228992|NCT00408499|450467892|FG002|Phase II- MTD Expansion|Physician Decision|0|||
125228993|NCT00408499|450467893|FG003|Phase II- MTD Expansion|Physician Decision|0|||
125228994|NCT00408499|450467894|FG004|Phase II- MTD Expansion|Physician Decision|1|||
125228995|NCT00408499|450467890|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
125228996|NCT00408499|450467891|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
125228997|NCT00408499|450467892|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
125228998|NCT00408499|450467893|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
125228999|NCT00408499|450467894|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
125229000|NCT00408499|450467890|FG000|Phase II- MTD Expansion|treatment delay|0|||
125229001|NCT00408499|450467891|FG001|Phase II- MTD Expansion|treatment delay|0|||
125229002|NCT00408499|450467892|FG002|Phase II- MTD Expansion|treatment delay|0|||
125229003|NCT00408499|450467893|FG003|Phase II- MTD Expansion|treatment delay|0|||
125229004|NCT00408499|450467894|FG004|Phase II- MTD Expansion|treatment delay|3|||
125229005|NCT01586195|450467898|FG000|Overall Study|Death|11|||
125229006|NCT01586195|450467898|FG000|Overall Study|Withdrawal of Consent|5|||
125229007|NCT01586195|450467898|FG000|Overall Study|Started new anti-melanoma therapy|1|||
125229008|NCT01586195|450467898|FG000|Overall Study|Reason not specified|9|||
125229009|NCT00997334|450467899|FG000|Overall Study|still on therapy|12|||
125229010|NCT00997334|450467899|FG000|Overall Study|Adverse Event|3|||
125229011|NCT00997334|450467899|FG000|Overall Study|Patient non-compliance|1|||
125229012|NCT00997334|450467899|FG000|Overall Study|Withdrawal by Subject|3|||
125229013|NCT00997334|450467899|FG000|Overall Study|Death|2|||
125229014|NCT00997334|450467899|FG000|Overall Study|Urgent Palliative Care|2|||
125229015|NCT00997334|450467899|FG000|Overall Study|No lesion amenable|1|||
125229016|NCT00997334|450467899|FG000|Overall Study|Ineligible|1|||
125229017|NCT02683109|450467901|FG000|Overall Study|Adverse Event|1|||
125229018|NCT02683109|450467902|FG001|Overall Study|Adverse Event|0|||
125170760|NCT00996892|450247840|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
125170761|NCT00996892|450247821|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
125170762|NCT00996892|450247822|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
125170763|NCT00996892|450247823|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
125170764|NCT00996892|450247824|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
125170765|NCT00996892|450247825|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
125170766|NCT00996892|450247826|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
125170767|NCT00996892|450247827|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
125170768|NCT00996892|450247828|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
125170769|NCT00996892|450247829|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
125170770|NCT00996892|450247830|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
125170771|NCT00996892|450247831|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
125170772|NCT00996892|450247832|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
125170773|NCT00996892|450247833|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
125170774|NCT00996892|450247834|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
125170775|NCT00996892|450247835|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
125170776|NCT00996892|450247836|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
125170777|NCT00996892|450247837|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
125170778|NCT00996892|450247838|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
125170779|NCT00996892|450247839|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
125170780|NCT00996892|450247840|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
125170781|NCT00996892|450247821|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
125170782|NCT00996892|450247822|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
125170783|NCT00996892|450247823|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
125170784|NCT00996892|450247824|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
125170785|NCT00996892|450247825|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
125170786|NCT00996892|450247826|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
125229019|NCT00183430|450467903|FG000|Overall Study|Adverse Event|1|||
125229020|NCT00183430|450467904|FG001|Overall Study|Adverse Event|0|||
125229021|NCT00183430|450467903|FG000|Overall Study|Lost to Follow-up|3|||
125229022|NCT00183430|450467904|FG001|Overall Study|Lost to Follow-up|0|||
125229023|NCT00183430|450467903|FG000|Overall Study|did not meet inclusion criteria|1|||
125229024|NCT00183430|450467904|FG001|Overall Study|did not meet inclusion criteria|0|||
125229025|NCT00183430|450467903|FG000|Overall Study|Withdrawal by Subject|1|||
125443382|NCT01216293|451250866|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
125443383|NCT01671748|451250867|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
125443384|NCT01671748|451250868|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
125443385|NCT01671748|451250867|FG000|4 Week run-in Phase|Adverse Event|1|||
125170787|NCT00996892|450247827|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
125170788|NCT00996892|450247828|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
125229026|NCT00183430|450467904|FG001|Overall Study|Withdrawal by Subject|0|||
125229027|NCT00883181|450467905|FG000|Overall Study|Hematological Adverse Event|26|||
125229028|NCT00883181|450467905|FG000|Overall Study|Non-hematological Adverse Event|55|||
125229029|NCT00883181|450467905|FG000|Overall Study|Disease Progression|94|||
125229030|NCT00883181|450467905|FG000|Overall Study|Administrative Reason|24|||
125229031|NCT00883181|450467905|FG000|Overall Study|Withdrawal by Subject|4|||
125229032|NCT00883181|450467905|FG000|Overall Study|Death|31|||
125229033|NCT00883181|450467905|FG000|Overall Study|Other|38|||
125229034|NCT00883181|450467905|FG000|Overall Study|Protocol Deviation|3|||
125229035|NCT00883181|450467905|FG000|Overall Study|Noncompliance|3|||
125229036|NCT00426270|450467910|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
125229037|NCT00426270|450467910|FG000|Overall Study|Adverse Event|5|||
125229038|NCT01450813|450467911|FG000|Overall Study|Physician Decision|1|||
125229039|NCT01450813|450467912|FG001|Overall Study|Physician Decision|1|||
125229040|NCT01450813|450467913|FG002|Overall Study|Physician Decision|0|||
125229041|NCT01450813|450467914|FG003|Overall Study|Physician Decision|3|||
125229042|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
125229043|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
125229044|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
125229045|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
125229046|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
125229047|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
125229048|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
125229049|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
125229050|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
125229051|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
125229052|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
125229053|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
125229054|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
125229055|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
125229056|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
125229057|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
125229058|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
125229059|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
125229060|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
125229061|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
125229062|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
125229063|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
125229064|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
125229065|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
125229066|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
125229067|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
125170789|NCT00996892|450247829|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
125170790|NCT00996892|450247830|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
125170791|NCT00996892|450247831|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
125170792|NCT00996892|450247832|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
125170793|NCT00996892|450247833|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
125170794|NCT00996892|450247834|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
125229068|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
125229069|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
125229070|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
125229071|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
125229072|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
125229073|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
125229074|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
125170795|NCT00996892|450247835|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
125170796|NCT00996892|450247836|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
125170797|NCT00996892|450247837|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
125170798|NCT00996892|450247838|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
125170799|NCT00996892|450247839|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
125170800|NCT00996892|450247840|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
125170801|NCT00996892|450247821|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
125170802|NCT00996892|450247822|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
125170803|NCT00996892|450247823|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
125170804|NCT00996892|450247824|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
125170805|NCT00996892|450247825|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
125170806|NCT00996892|450247826|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
125170807|NCT00996892|450247827|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
125170808|NCT00996892|450247828|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
125229075|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
125229076|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
125229077|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
125229078|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
125229079|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
125229080|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
125229081|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
125229082|NCT02709746|450467915|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
125229083|NCT02709746|450467916|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
125229084|NCT02709746|450467917|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
125229085|NCT02709746|450467918|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
125229086|NCT02709746|450467919|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
125229087|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
125229088|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
125229089|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
125229090|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
125229091|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
125229092|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
125229093|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
125229094|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
125229095|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
125229096|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
125229097|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
125229098|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
125229099|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
125229100|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
125229101|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
125229102|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
125229103|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
125229104|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
125229105|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
125229106|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
125229107|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
125229108|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
125229109|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
125229110|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
125229111|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
125229112|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
125229113|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
125229114|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
125229115|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
125229116|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
125229117|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
125229118|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
125229119|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
125229120|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
125229121|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
125229122|NCT02709746|450467915|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
125229123|NCT02709746|450467916|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
125229124|NCT02709746|450467917|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
125229125|NCT02709746|450467918|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
125170809|NCT00996892|450247829|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
125170810|NCT00996892|450247830|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
125170811|NCT00996892|450247831|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
125170812|NCT00996892|450247832|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
125170813|NCT00996892|450247833|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
125170814|NCT00996892|450247834|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
125170815|NCT00996892|450247835|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
125170816|NCT00996892|450247836|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
125170817|NCT00996892|450247837|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
125170818|NCT00996892|450247838|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
125170819|NCT00996892|450247839|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
125170820|NCT00996892|450247840|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
125170821|NCT00996892|450247821|FG000|Expansion Stage 2|Adverse Event|0|||
125170822|NCT00996892|450247822|FG001|Expansion Stage 2|Adverse Event|0|||
125170823|NCT00996892|450247823|FG002|Expansion Stage 2|Adverse Event|0|||
125170824|NCT00996892|450247824|FG003|Expansion Stage 2|Adverse Event|0|||
125170825|NCT00996892|450247825|FG004|Expansion Stage 2|Adverse Event|0|||
125170826|NCT00996892|450247826|FG005|Expansion Stage 2|Adverse Event|0|||
125170827|NCT00996892|450247827|FG006|Expansion Stage 2|Adverse Event|0|||
125170828|NCT00996892|450247828|FG007|Expansion Stage 2|Adverse Event|0|||
125170829|NCT00996892|450247829|FG008|Expansion Stage 2|Adverse Event|0|||
125170830|NCT00996892|450247830|FG009|Expansion Stage 2|Adverse Event|0|||
125170831|NCT00996892|450247831|FG010|Expansion Stage 2|Adverse Event|0|||
125170832|NCT00996892|450247832|FG011|Expansion Stage 2|Adverse Event|0|||
125170833|NCT00996892|450247833|FG012|Expansion Stage 2|Adverse Event|0|||
125170834|NCT00996892|450247834|FG013|Expansion Stage 2|Adverse Event|0|||
125170835|NCT00996892|450247835|FG014|Expansion Stage 2|Adverse Event|0|||
125170836|NCT00996892|450247836|FG015|Expansion Stage 2|Adverse Event|0|||
125170837|NCT00996892|450247837|FG016|Expansion Stage 2|Adverse Event|0|||
125170838|NCT00996892|450247838|FG017|Expansion Stage 2|Adverse Event|0|||
125170839|NCT00996892|450247839|FG018|Expansion Stage 2|Adverse Event|3|||
125170840|NCT00996892|450247840|FG019|Expansion Stage 2|Adverse Event|0|||
125170841|NCT00996892|450247821|FG000|Expansion Stage 2|Death|0|||
125170842|NCT00996892|450247822|FG001|Expansion Stage 2|Death|0|||
125170843|NCT00996892|450247823|FG002|Expansion Stage 2|Death|0|||
125170844|NCT00996892|450247824|FG003|Expansion Stage 2|Death|0|||
125170845|NCT00996892|450247825|FG004|Expansion Stage 2|Death|0|||
125170846|NCT00996892|450247826|FG005|Expansion Stage 2|Death|0|||
125170847|NCT00996892|450247827|FG006|Expansion Stage 2|Death|0|||
125170848|NCT00996892|450247828|FG007|Expansion Stage 2|Death|0|||
125170849|NCT00996892|450247829|FG008|Expansion Stage 2|Death|0|||
125170850|NCT00996892|450247830|FG009|Expansion Stage 2|Death|0|||
125170851|NCT00996892|450247831|FG010|Expansion Stage 2|Death|0|||
125170852|NCT00996892|450247832|FG011|Expansion Stage 2|Death|0|||
125170853|NCT00996892|450247833|FG012|Expansion Stage 2|Death|0|||
125170854|NCT00996892|450247834|FG013|Expansion Stage 2|Death|0|||
125170855|NCT00996892|450247835|FG014|Expansion Stage 2|Death|0|||
125170856|NCT00996892|450247836|FG015|Expansion Stage 2|Death|0|||
125170857|NCT00996892|450247837|FG016|Expansion Stage 2|Death|0|||
125170858|NCT00996892|450247838|FG017|Expansion Stage 2|Death|0|||
125170859|NCT00996892|450247839|FG018|Expansion Stage 2|Death|2|||
125170860|NCT00996892|450247840|FG019|Expansion Stage 2|Death|0|||
125170861|NCT00996892|450247821|FG000|Expansion Stage 2|Physician Decision|0|||
125170862|NCT00996892|450247822|FG001|Expansion Stage 2|Physician Decision|0|||
125170863|NCT00996892|450247823|FG002|Expansion Stage 2|Physician Decision|0|||
125170864|NCT00996892|450247824|FG003|Expansion Stage 2|Physician Decision|0|||
125170865|NCT00996892|450247825|FG004|Expansion Stage 2|Physician Decision|0|||
125170866|NCT00996892|450247826|FG005|Expansion Stage 2|Physician Decision|0|||
125170867|NCT00996892|450247827|FG006|Expansion Stage 2|Physician Decision|0|||
125170868|NCT00996892|450247828|FG007|Expansion Stage 2|Physician Decision|0|||
125170869|NCT00996892|450247829|FG008|Expansion Stage 2|Physician Decision|0|||
125170870|NCT00996892|450247830|FG009|Expansion Stage 2|Physician Decision|0|||
125170871|NCT00996892|450247831|FG010|Expansion Stage 2|Physician Decision|0|||
125443386|NCT01671748|451250868|FG001|4 Week run-in Phase|Adverse Event|0|||
125170872|NCT00996892|450247832|FG011|Expansion Stage 2|Physician Decision|0|||
125170873|NCT00996892|450247833|FG012|Expansion Stage 2|Physician Decision|0|||
125170874|NCT00996892|450247834|FG013|Expansion Stage 2|Physician Decision|0|||
125170875|NCT00996892|450247835|FG014|Expansion Stage 2|Physician Decision|0|||
125170876|NCT00996892|450247836|FG015|Expansion Stage 2|Physician Decision|0|||
125170877|NCT00996892|450247837|FG016|Expansion Stage 2|Physician Decision|0|||
125170878|NCT00996892|450247838|FG017|Expansion Stage 2|Physician Decision|0|||
125170879|NCT00996892|450247839|FG018|Expansion Stage 2|Physician Decision|1|||
125170880|NCT00996892|450247840|FG019|Expansion Stage 2|Physician Decision|0|||
125170881|NCT00996892|450247821|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
125170882|NCT00996892|450247822|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
125170883|NCT00996892|450247823|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
125170884|NCT00996892|450247824|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
125170885|NCT00996892|450247825|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
125170886|NCT00996892|450247826|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
125170887|NCT00996892|450247827|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
125170888|NCT00996892|450247828|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
125170889|NCT00996892|450247829|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
125170890|NCT00996892|450247830|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
125170891|NCT00996892|450247831|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
125170892|NCT00996892|450247832|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
125170893|NCT00996892|450247833|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
125170894|NCT00996892|450247834|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
125170895|NCT00996892|450247835|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
125170896|NCT00996892|450247836|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
125170897|NCT00996892|450247837|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
125170898|NCT00996892|450247838|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
125170899|NCT00996892|450247839|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
125170900|NCT00996892|450247840|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
125170901|NCT00996892|450247821|FG000|Expansion Stage 2|Disease Progression|0|||
125170902|NCT00996892|450247822|FG001|Expansion Stage 2|Disease Progression|0|||
125170903|NCT00996892|450247823|FG002|Expansion Stage 2|Disease Progression|0|||
125170904|NCT00996892|450247824|FG003|Expansion Stage 2|Disease Progression|0|||
125170905|NCT00996892|450247825|FG004|Expansion Stage 2|Disease Progression|0|||
125170906|NCT00996892|450247826|FG005|Expansion Stage 2|Disease Progression|0|||
125170907|NCT00996892|450247827|FG006|Expansion Stage 2|Disease Progression|0|||
125170908|NCT00996892|450247828|FG007|Expansion Stage 2|Disease Progression|0|||
125170909|NCT00996892|450247829|FG008|Expansion Stage 2|Disease Progression|0|||
125170910|NCT00996892|450247830|FG009|Expansion Stage 2|Disease Progression|0|||
125170911|NCT00996892|450247831|FG010|Expansion Stage 2|Disease Progression|0|||
125170912|NCT00996892|450247832|FG011|Expansion Stage 2|Disease Progression|0|||
125170913|NCT00996892|450247833|FG012|Expansion Stage 2|Disease Progression|0|||
125170914|NCT00996892|450247834|FG013|Expansion Stage 2|Disease Progression|0|||
125170915|NCT00996892|450247835|FG014|Expansion Stage 2|Disease Progression|0|||
125170916|NCT00996892|450247836|FG015|Expansion Stage 2|Disease Progression|0|||
125170917|NCT00996892|450247837|FG016|Expansion Stage 2|Disease Progression|0|||
125170918|NCT00996892|450247838|FG017|Expansion Stage 2|Disease Progression|0|||
125170919|NCT00996892|450247839|FG018|Expansion Stage 2|Disease Progression|28|||
125170920|NCT00996892|450247840|FG019|Expansion Stage 2|Disease Progression|0|||
125170921|NCT00996892|450247821|FG000|Expansion Stage 2A|Adverse Event|0|||
125170922|NCT00996892|450247822|FG001|Expansion Stage 2A|Adverse Event|0|||
125170923|NCT00996892|450247823|FG002|Expansion Stage 2A|Adverse Event|0|||
125170924|NCT00996892|450247824|FG003|Expansion Stage 2A|Adverse Event|0|||
125170925|NCT00996892|450247825|FG004|Expansion Stage 2A|Adverse Event|0|||
125170926|NCT00996892|450247826|FG005|Expansion Stage 2A|Adverse Event|0|||
125170927|NCT00996892|450247827|FG006|Expansion Stage 2A|Adverse Event|0|||
125170928|NCT00996892|450247828|FG007|Expansion Stage 2A|Adverse Event|0|||
125170929|NCT00996892|450247829|FG008|Expansion Stage 2A|Adverse Event|0|||
125170930|NCT00996892|450247830|FG009|Expansion Stage 2A|Adverse Event|0|||
125170931|NCT00996892|450247831|FG010|Expansion Stage 2A|Adverse Event|0|||
125170932|NCT00996892|450247832|FG011|Expansion Stage 2A|Adverse Event|0|||
125170933|NCT00996892|450247833|FG012|Expansion Stage 2A|Adverse Event|0|||
125170934|NCT00996892|450247834|FG013|Expansion Stage 2A|Adverse Event|0|||
125170935|NCT00996892|450247835|FG014|Expansion Stage 2A|Adverse Event|0|||
125170936|NCT00996892|450247836|FG015|Expansion Stage 2A|Adverse Event|0|||
125170937|NCT00996892|450247837|FG016|Expansion Stage 2A|Adverse Event|0|||
125170938|NCT00996892|450247838|FG017|Expansion Stage 2A|Adverse Event|0|||
125170939|NCT00996892|450247839|FG018|Expansion Stage 2A|Adverse Event|0|||
125170940|NCT00996892|450247840|FG019|Expansion Stage 2A|Adverse Event|8|||
125170941|NCT00996892|450247821|FG000|Expansion Stage 2A|Physician Decision|0|||
125170942|NCT00996892|450247822|FG001|Expansion Stage 2A|Physician Decision|0|||
125170943|NCT00996892|450247823|FG002|Expansion Stage 2A|Physician Decision|0|||
125170944|NCT00996892|450247824|FG003|Expansion Stage 2A|Physician Decision|0|||
125170945|NCT00996892|450247825|FG004|Expansion Stage 2A|Physician Decision|0|||
125170946|NCT00996892|450247826|FG005|Expansion Stage 2A|Physician Decision|0|||
125170947|NCT00996892|450247827|FG006|Expansion Stage 2A|Physician Decision|0|||
125170948|NCT00996892|450247828|FG007|Expansion Stage 2A|Physician Decision|0|||
125170949|NCT00996892|450247829|FG008|Expansion Stage 2A|Physician Decision|0|||
125170950|NCT00996892|450247830|FG009|Expansion Stage 2A|Physician Decision|0|||
125170951|NCT00996892|450247831|FG010|Expansion Stage 2A|Physician Decision|0|||
125443387|NCT01671748|451250867|FG000|4 Week run-in Phase|Not eligible|9|||
125170952|NCT00996892|450247832|FG011|Expansion Stage 2A|Physician Decision|0|||
125170953|NCT00996892|450247833|FG012|Expansion Stage 2A|Physician Decision|0|||
125170954|NCT00996892|450247834|FG013|Expansion Stage 2A|Physician Decision|0|||
125170955|NCT00996892|450247835|FG014|Expansion Stage 2A|Physician Decision|0|||
125170956|NCT00996892|450247836|FG015|Expansion Stage 2A|Physician Decision|0|||
125170957|NCT00996892|450247837|FG016|Expansion Stage 2A|Physician Decision|0|||
125170958|NCT00996892|450247838|FG017|Expansion Stage 2A|Physician Decision|0|||
125170959|NCT00996892|450247839|FG018|Expansion Stage 2A|Physician Decision|0|||
125170960|NCT00996892|450247840|FG019|Expansion Stage 2A|Physician Decision|2|||
125170961|NCT00996892|450247821|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
125170962|NCT00996892|450247822|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
125229126|NCT02709746|450467919|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
125229127|NCT01483118|450467922|FG000|Overall Study|Lost to Follow-up|12|||
125229128|NCT01483118|450467923|FG001|Overall Study|Lost to Follow-up|16|||
125229129|NCT02089347|450467929|FG000|Overall Study|Protocol Violation|1|||
125229130|NCT02089347|450467930|FG001|Overall Study|Protocol Violation|0|||
125170963|NCT00996892|450247823|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
125170964|NCT00996892|450247824|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
125170965|NCT00996892|450247825|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
125170966|NCT00996892|450247826|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
125170967|NCT00996892|450247827|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
125170968|NCT00996892|450247828|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
125170969|NCT00996892|450247829|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
125170970|NCT00996892|450247830|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
125170971|NCT00996892|450247831|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
125170972|NCT00996892|450247832|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
125170973|NCT00996892|450247833|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
125170974|NCT00996892|450247834|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
125170975|NCT00996892|450247835|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
125170976|NCT00996892|450247836|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
125170977|NCT00996892|450247837|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
125170978|NCT00996892|450247838|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
125170979|NCT00996892|450247839|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
125170980|NCT00996892|450247840|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
125170981|NCT00996892|450247821|FG000|Expansion Stage 2A|Disease Progression|0|||
125170982|NCT00996892|450247822|FG001|Expansion Stage 2A|Disease Progression|0|||
125170983|NCT00996892|450247823|FG002|Expansion Stage 2A|Disease Progression|0|||
125170984|NCT00996892|450247824|FG003|Expansion Stage 2A|Disease Progression|0|||
125170985|NCT00996892|450247825|FG004|Expansion Stage 2A|Disease Progression|0|||
125170986|NCT00996892|450247826|FG005|Expansion Stage 2A|Disease Progression|0|||
125170987|NCT00996892|450247827|FG006|Expansion Stage 2A|Disease Progression|0|||
125170988|NCT00996892|450247828|FG007|Expansion Stage 2A|Disease Progression|0|||
125170989|NCT00996892|450247829|FG008|Expansion Stage 2A|Disease Progression|0|||
125170990|NCT00996892|450247830|FG009|Expansion Stage 2A|Disease Progression|0|||
125170991|NCT00996892|450247831|FG010|Expansion Stage 2A|Disease Progression|0|||
125170992|NCT00996892|450247832|FG011|Expansion Stage 2A|Disease Progression|0|||
125170993|NCT00996892|450247833|FG012|Expansion Stage 2A|Disease Progression|0|||
125170994|NCT00996892|450247834|FG013|Expansion Stage 2A|Disease Progression|0|||
125170995|NCT00996892|450247835|FG014|Expansion Stage 2A|Disease Progression|0|||
125170996|NCT00996892|450247836|FG015|Expansion Stage 2A|Disease Progression|0|||
125170997|NCT00996892|450247837|FG016|Expansion Stage 2A|Disease Progression|0|||
125170998|NCT00996892|450247838|FG017|Expansion Stage 2A|Disease Progression|0|||
125170999|NCT00996892|450247839|FG018|Expansion Stage 2A|Disease Progression|0|||
125171000|NCT00996892|450247840|FG019|Expansion Stage 2A|Disease Progression|31|||
125171001|NCT01653912|450247841|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
125171002|NCT01653912|450247842|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
125171003|NCT01653912|450247843|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
125171004|NCT01653912|450247844|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
125171005|NCT01653912|450247845|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
125171006|NCT01653912|450247846|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
125171007|NCT01653912|450247841|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
125229131|NCT02783066|450467931|FG000|Overall Study|Withdrawal by Subject|13|||
125229132|NCT00551369|450467932|FG000|Overall Study|Protocol Violation|5|||
125229133|NCT00551369|450467932|FG000|Overall Study|Withdrawal by Subject|1|||
125229134|NCT00551369|450467932|FG000|Overall Study|Not treated per protocol and re|1|||
125229135|NCT00719901|450467933|FG000|Overall Study|Adverse Event|5|||
125229136|NCT00719901|450467933|FG000|Overall Study|Withdrawal by Subject|1|||
125229137|NCT00719901|450467933|FG000|Overall Study|Alternate Treatment|1|||
125229138|NCT00719901|450467933|FG000|Overall Study|Disease Progression|3|||
125229139|NCT00719901|450467933|FG000|Overall Study|Availability of Study Drug|1|||
125229140|NCT01122173|450467934|FG000|Overall Study|Lost to Follow-up|3|||
125229141|NCT01122173|450467934|FG000|Overall Study|Withdrawal by Subject|3|||
125229142|NCT01122173|450467934|FG000|Overall Study|Left study for other reasons|3|||
125229143|NCT01184872|450467935|FG000|Overall Study|Adverse Event|3|||
125229144|NCT01184872|450467936|FG001|Overall Study|Adverse Event|4|||
125229145|NCT01184872|450467935|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
125171008|NCT01653912|450247842|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
125171009|NCT01653912|450247843|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
125171010|NCT01653912|450247844|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
125171011|NCT01653912|450247845|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
125171012|NCT01653912|450247846|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
125171013|NCT01653912|450247841|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
125229146|NCT01184872|450467936|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125229147|NCT01184872|450467935|FG000|Overall Study|Withdrawal by Subject|2|||
125229148|NCT01184872|450467936|FG001|Overall Study|Withdrawal by Subject|0|||
125229149|NCT01184872|450467935|FG000|Overall Study|Lost to Follow-up|0|||
125229150|NCT01184872|450467936|FG001|Overall Study|Lost to Follow-up|1|||
125229151|NCT01184872|450467935|FG000|Overall Study|Administrative problems|1|||
125229152|NCT01184872|450467936|FG001|Overall Study|Administrative problems|1|||
125229153|NCT01184872|450467935|FG000|Overall Study|Protocol deviation|1|||
125229154|NCT01184872|450467936|FG001|Overall Study|Protocol deviation|0|||
125229155|NCT03426345|450467937|FG000|Overall Study|Adverse Event|4|||
125229156|NCT03426345|450467938|FG001|Overall Study|Adverse Event|4|||
125229157|NCT03426345|450467937|FG000|Overall Study|Lack of Efficacy|1|||
125229158|NCT03426345|450467938|FG001|Overall Study|Lack of Efficacy|0|||
125229159|NCT03426345|450467937|FG000|Overall Study|Withdrawal by Subject|5|||
125229160|NCT03426345|450467938|FG001|Overall Study|Withdrawal by Subject|6|||
125229161|NCT03426345|450467937|FG000|Overall Study|Lost to Follow-up|3|||
125229162|NCT03426345|450467938|FG001|Overall Study|Lost to Follow-up|1|||
125229163|NCT03426345|450467937|FG000|Overall Study|Protocol Deviation|3|||
125229164|NCT03426345|450467938|FG001|Overall Study|Protocol Deviation|4|||
125229165|NCT03426345|450467937|FG000|Overall Study|Reason Not Specified|1|||
125229166|NCT03426345|450467938|FG001|Overall Study|Reason Not Specified|2|||
125229167|NCT03426345|450467937|FG000|Overall Study|Missing Completion Status|1|||
125229168|NCT03426345|450467938|FG001|Overall Study|Missing Completion Status|0|||
125229169|NCT00116142|450467939|FG000|Overall Study|Adverse Event|8|||
125229170|NCT00116142|450467940|FG001|Overall Study|Adverse Event|7|||
125229171|NCT00116142|450467939|FG000|Overall Study|Protocol Violation|2|||
125229172|NCT00116142|450467940|FG001|Overall Study|Protocol Violation|1|||
125229173|NCT00116142|450467939|FG000|Overall Study|Withdrawal by Subject|5|||
125229174|NCT00116142|450467940|FG001|Overall Study|Withdrawal by Subject|5|||
125229175|NCT00116142|450467939|FG000|Overall Study|Physician Decision|3|||
125229176|NCT00116142|450467940|FG001|Overall Study|Physician Decision|1|||
125229177|NCT00116142|450467939|FG000|Overall Study|Delayed Radiation Therapy|1|||
125229178|NCT00116142|450467940|FG001|Overall Study|Delayed Radiation Therapy|0|||
125229179|NCT00116142|450467939|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
125229180|NCT00116142|450467940|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
125229181|NCT00116142|450467939|FG000|Overall Study|Patient stopped due to depression|0|||
125229182|NCT00116142|450467940|FG001|Overall Study|Patient stopped due to depression|1|||
125229183|NCT00116142|450467939|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
125229184|NCT00116142|450467940|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
125229185|NCT00116142|450467939|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
125171014|NCT01653912|450247842|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
125171015|NCT01653912|450247843|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
125171016|NCT01653912|450247844|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
125171017|NCT01653912|450247845|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
125171018|NCT01653912|450247846|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
125171019|NCT01653912|450247841|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171020|NCT01653912|450247842|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171021|NCT01653912|450247843|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171022|NCT01653912|450247844|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
125171023|NCT01653912|450247845|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171024|NCT01653912|450247846|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171025|NCT01653912|450247841|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
125171026|NCT01653912|450247842|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
125171027|NCT01653912|450247843|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
125171028|NCT01653912|450247844|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
125171029|NCT01653912|450247845|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
125171030|NCT01653912|450247846|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
125171031|NCT01653912|450247841|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
125171032|NCT01653912|450247842|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
125171033|NCT01653912|450247843|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
125171034|NCT01653912|450247844|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
125229186|NCT00116142|450467940|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
125229187|NCT00116142|450467939|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
125171035|NCT01653912|450247845|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
125171036|NCT01653912|450247846|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
125171037|NCT01653912|450247841|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
125229188|NCT00116142|450467940|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
125171038|NCT01653912|450247842|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
125229189|NCT00644059|450467941|FG000|Overall Study|Lost to Follow-up|37|||
125171039|NCT01653912|450247843|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171040|NCT01653912|450247844|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
125171041|NCT01653912|450247845|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
125229190|NCT00644059|450467942|FG001|Overall Study|Lost to Follow-up|34|||
125229191|NCT00644059|450467943|FG002|Overall Study|Lost to Follow-up|16|||
125229192|NCT00644059|450467941|FG000|Overall Study|Withdrawal by Subject|52|||
125171042|NCT01653912|450247846|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
125171043|NCT00602641|450249420|FG000|Overall Study|Never started protocol therapy|6|||
125171044|NCT00602641|450249421|FG001|Overall Study|Never started protocol therapy|2|||
125171045|NCT00602641|450249420|FG000|Overall Study|Still on treatment at time of analysis|8|||
125171046|NCT00602641|450249421|FG001|Overall Study|Still on treatment at time of analysis|15|||
125171047|NCT00602641|450249420|FG000|Overall Study|Adverse Event|62|||
125171048|NCT00602641|450249421|FG001|Overall Study|Adverse Event|53|||
125171049|NCT00602641|450249420|FG000|Overall Study|Disease progression|38|||
125171050|NCT00602641|450249421|FG001|Overall Study|Disease progression|55|||
125171051|NCT00602641|450249420|FG000|Overall Study|Death|6|||
125171052|NCT00602641|450249421|FG001|Overall Study|Death|5|||
125171053|NCT00602641|450249420|FG000|Overall Study|Withdrawal by Subject|15|||
125171054|NCT00602641|450249421|FG001|Overall Study|Withdrawal by Subject|12|||
125229193|NCT00644059|450467942|FG001|Overall Study|Withdrawal by Subject|60|||
125229194|NCT00644059|450467943|FG002|Overall Study|Withdrawal by Subject|30|||
125229195|NCT00644059|450467941|FG000|Overall Study|Adverse Event|8|||
125229196|NCT00644059|450467942|FG001|Overall Study|Adverse Event|5|||
125229197|NCT00644059|450467943|FG002|Overall Study|Adverse Event|1|||
125229198|NCT00644059|450467941|FG000|Overall Study|Inappropriate Enrollment|1|||
125229199|NCT00644059|450467942|FG001|Overall Study|Inappropriate Enrollment|3|||
125229200|NCT00644059|450467943|FG002|Overall Study|Inappropriate Enrollment|0|||
125229201|NCT00644059|450467941|FG000|Overall Study|Protocol Deviation/violation|20|||
125229202|NCT00644059|450467942|FG001|Overall Study|Protocol Deviation/violation|19|||
125229203|NCT00644059|450467943|FG002|Overall Study|Protocol Deviation/violation|15|||
125229204|NCT00644059|450467941|FG000|Overall Study|Unable to classify|6|||
125229205|NCT00644059|450467942|FG001|Overall Study|Unable to classify|2|||
125229206|NCT00644059|450467943|FG002|Overall Study|Unable to classify|3|||
125229207|NCT02133508|450467944|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
125229208|NCT02133508|450467944|FG000|Overall Study|Death|12|||
125229209|NCT02133508|450467944|FG000|Overall Study|Lost to Follow-up|2|||
125229210|NCT02497469|450467951|FG000|Overall Study|Randomized but not Treated|0|||
125229211|NCT02497469|450467952|FG001|Overall Study|Randomized but not Treated|2|||
125229212|NCT02497469|450467951|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
125229213|NCT02497469|450467952|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
125229214|NCT02497469|450467951|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
125229215|NCT02497469|450467952|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
125229216|NCT02497469|450467951|FG000|Overall Study|Significant Protocol Deviation|4|||
125229217|NCT02497469|450467952|FG001|Overall Study|Significant Protocol Deviation|5|||
125229218|NCT02497469|450467951|FG000|Overall Study|Lost to Follow-up|14|||
125229219|NCT02497469|450467952|FG001|Overall Study|Lost to Follow-up|4|||
125229220|NCT02497469|450467951|FG000|Overall Study|Voluntary Withdrawal|39|||
125229221|NCT02497469|450467952|FG001|Overall Study|Voluntary Withdrawal|41|||
125229222|NCT02497469|450467951|FG000|Overall Study|Pregnancy|1|||
125229223|NCT02497469|450467952|FG001|Overall Study|Pregnancy|1|||
125229224|NCT02497469|450467951|FG000|Overall Study|Lack of Efficacy|86|||
125229225|NCT02497469|450467952|FG001|Overall Study|Lack of Efficacy|40|||
125229226|NCT02497469|450467951|FG000|Overall Study|Reason not Specified|6|||
125229227|NCT02497469|450467952|FG001|Overall Study|Reason not Specified|6|||
125229228|NCT04076917|450467954|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
125229229|NCT04076917|450467954|FG000|Overall Study|Study closure|13|||
125229230|NCT04076917|450467954|FG000|Overall Study|Physician Decision|3|||
125229231|NCT04076917|450467954|FG000|Overall Study|Death|1|||
125229232|NCT04076917|450467954|FG000|Overall Study|Lost to Follow-up|1|||
125229233|NCT04076917|450467954|FG000|Overall Study|Withdrawal by Subject|1|||
125229234|NCT04076917|450467954|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
125229235|NCT01774591|450467957|FG000|Overall Study|Physician Decision|1|||
125229236|NCT01774591|450467958|FG001|Overall Study|Physician Decision|1|||
125229237|NCT01774591|450467957|FG000|Overall Study|Withdrawal by Subject|0|||
125229238|NCT01774591|450467958|FG001|Overall Study|Withdrawal by Subject|1|||
125229239|NCT01774591|450467957|FG000|Overall Study|Adverse Event|0|||
125229240|NCT01774591|450467958|FG001|Overall Study|Adverse Event|2|||
125229241|NCT01787552|450467959|FG000|Overall Study|Withdrawal by Subject|2|||
125229242|NCT01787552|450467960|FG001|Overall Study|Withdrawal by Subject|0|||
125229243|NCT01787552|450467961|FG002|Overall Study|Withdrawal by Subject|0|||
125229244|NCT01787552|450467962|FG003|Overall Study|Withdrawal by Subject|4|||
125229245|NCT01787552|450467959|FG000|Overall Study|Physician Decision|2|||
125229246|NCT01787552|450467960|FG001|Overall Study|Physician Decision|2|||
125229247|NCT01787552|450467961|FG002|Overall Study|Physician Decision|1|||
125229248|NCT01787552|450467962|FG003|Overall Study|Physician Decision|2|||
125229249|NCT01787552|450467959|FG000|Overall Study|Death|0|||
125229250|NCT01787552|450467960|FG001|Overall Study|Death|0|||
125171055|NCT00602641|450249420|FG000|Overall Study|Alternative therapy|5|||
125229251|NCT01787552|450467961|FG002|Overall Study|Death|0|||
125229252|NCT01787552|450467962|FG003|Overall Study|Death|1|||
125229253|NCT01787552|450467959|FG000|Overall Study|Adverse Event|2|||
125229254|NCT01787552|450467960|FG001|Overall Study|Adverse Event|5|||
125229255|NCT01787552|450467961|FG002|Overall Study|Adverse Event|2|||
125229256|NCT01787552|450467962|FG003|Overall Study|Adverse Event|16|||
125229257|NCT01787552|450467959|FG000|Overall Study|Study terminated by Sponsor|0|||
125229258|NCT01787552|450467960|FG001|Overall Study|Study terminated by Sponsor|0|||
125229259|NCT01787552|450467961|FG002|Overall Study|Study terminated by Sponsor|1|||
125229260|NCT01787552|450467962|FG003|Overall Study|Study terminated by Sponsor|3|||
125229261|NCT01787552|450467959|FG000|Overall Study|Progressive Disease|2|||
125229262|NCT01787552|450467960|FG001|Overall Study|Progressive Disease|2|||
125229263|NCT01787552|450467961|FG002|Overall Study|Progressive Disease|1|||
125229264|NCT01787552|450467962|FG003|Overall Study|Progressive Disease|1|||
125229265|NCT03055936|450467968|FG000|Overall Study|Adverse Event|0|||
125171056|NCT00602641|450249421|FG001|Overall Study|Alternative therapy|2|||
125171057|NCT00602641|450249420|FG000|Overall Study|Other Complicating Disease|5|||
125171058|NCT00602641|450249421|FG001|Overall Study|Other Complicating Disease|2|||
125171059|NCT00602641|450249420|FG000|Overall Study|Physician Decision|5|||
125171060|NCT00602641|450249421|FG001|Overall Study|Physician Decision|4|||
125171061|NCT00602641|450249420|FG000|Overall Study|Administrative Closure|1|||
125171062|NCT00602641|450249421|FG001|Overall Study|Administrative Closure|1|||
125171063|NCT00602641|450249420|FG000|Overall Study|Other|3|||
125171064|NCT00602641|450249421|FG001|Overall Study|Other|1|||
125171065|NCT03408639|450249427|FG000|Overall Study|Death|5|||
125171066|NCT03408639|450249428|FG001|Overall Study|Death|5|||
125171067|NCT03408639|450249427|FG000|Overall Study|Lost to Follow-up|1|||
125171068|NCT03408639|450249428|FG001|Overall Study|Lost to Follow-up|4|||
125171069|NCT03408639|450249427|FG000|Overall Study|Withdrawal by Subject|2|||
125171070|NCT03408639|450249428|FG001|Overall Study|Withdrawal by Subject|7|||
125171071|NCT03408639|450249427|FG000|Overall Study|Physician Decision|3|||
125171072|NCT03408639|450249428|FG001|Overall Study|Physician Decision|6|||
125171073|NCT00070499|450249429|FG000|Overall Study|Adverse Event|6|||
125171074|NCT00070499|450249430|FG001|Overall Study|Adverse Event|6|||
125171075|NCT00070499|450249431|FG002|Overall Study|Adverse Event|19|||
125171076|NCT00070499|450249432|FG003|Overall Study|Adverse Event|15|||
125171077|NCT00070499|450249429|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
125171078|NCT00070499|450249430|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
125171079|NCT00070499|450249431|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
125171080|NCT00070499|450249432|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
125171081|NCT00070499|450249429|FG000|Overall Study|Progression/relapse|4|||
125171082|NCT00070499|450249430|FG001|Overall Study|Progression/relapse|2|||
125171083|NCT00070499|450249431|FG002|Overall Study|Progression/relapse|1|||
125171084|NCT00070499|450249432|FG003|Overall Study|Progression/relapse|4|||
125171085|NCT00070499|450249429|FG000|Overall Study|Death|1|||
125171086|NCT00070499|450249430|FG001|Overall Study|Death|1|||
125171087|NCT00070499|450249431|FG002|Overall Study|Death|1|||
125171088|NCT00070499|450249432|FG003|Overall Study|Death|2|||
125171089|NCT00070499|450249429|FG000|Overall Study|Other - not protocol specified|7|||
125171090|NCT00070499|450249430|FG001|Overall Study|Other - not protocol specified|3|||
125171091|NCT00070499|450249431|FG002|Overall Study|Other - not protocol specified|12|||
125171092|NCT00070499|450249432|FG003|Overall Study|Other - not protocol specified|20|||
125171093|NCT00070499|450249429|FG000|Overall Study|Still on protocol treatment|10|||
125171094|NCT00070499|450249430|FG001|Overall Study|Still on protocol treatment|4|||
125171095|NCT00070499|450249431|FG002|Overall Study|Still on protocol treatment|79|||
125171096|NCT00070499|450249432|FG003|Overall Study|Still on protocol treatment|57|||
125171097|NCT00070499|450249429|FG000|Overall Study|Did not start treatment|1|||
125171098|NCT00070499|450249430|FG001|Overall Study|Did not start treatment|0|||
125171099|NCT00070499|450249431|FG002|Overall Study|Did not start treatment|0|||
125171100|NCT00070499|450249432|FG003|Overall Study|Did not start treatment|2|||
125171101|NCT00070499|450249429|FG000|Overall Study|Not eligible|2|||
125171102|NCT00070499|450249430|FG001|Overall Study|Not eligible|5|||
125171103|NCT00070499|450249431|FG002|Overall Study|Not eligible|3|||
125171104|NCT00070499|450249432|FG003|Overall Study|Not eligible|2|||
125171105|NCT00587860|450249440|FG000|Overall Study|Lost to Follow-up|2|||
125171106|NCT00587860|450249441|FG001|Overall Study|Lost to Follow-up|2|||
125171107|NCT00587860|450249440|FG000|Overall Study|Withdrawal by Subject|3|||
125171108|NCT00587860|450249441|FG001|Overall Study|Withdrawal by Subject|3|||
125171109|NCT01371747|450249444|FG000|Overall Study|Adverse Event|4|||
125171110|NCT01371747|450249445|FG001|Overall Study|Adverse Event|2|||
125171111|NCT01371747|450249446|FG002|Overall Study|Adverse Event|7|||
125171112|NCT01371747|450249447|FG003|Overall Study|Adverse Event|2|||
125229266|NCT03055936|450467969|FG001|Overall Study|Adverse Event|1|||
125171113|NCT01371747|450249448|FG004|Overall Study|Adverse Event|2|||
125171114|NCT01371747|450249449|FG005|Overall Study|Adverse Event|2|||
125171115|NCT01371747|450249444|FG000|Overall Study|Death|1|||
125171116|NCT01371747|450249445|FG001|Overall Study|Death|0|||
125171117|NCT01371747|450249446|FG002|Overall Study|Death|4|||
125171118|NCT01371747|450249447|FG003|Overall Study|Death|1|||
125171119|NCT01371747|450249448|FG004|Overall Study|Death|2|||
125171120|NCT01371747|450249449|FG005|Overall Study|Death|0|||
125171121|NCT01371747|450249444|FG000|Overall Study|Abnormal Renal Function|0|||
125171122|NCT01371747|450249445|FG001|Overall Study|Abnormal Renal Function|2|||
125229267|NCT03055936|450467970|FG002|Overall Study|Adverse Event|1|||
125229268|NCT03055936|450467971|FG003|Overall Study|Adverse Event|1|||
125229269|NCT03055936|450467968|FG000|Overall Study|Personal reason|2|||
125229270|NCT03055936|450467969|FG001|Overall Study|Personal reason|0|||
125229271|NCT03055936|450467970|FG002|Overall Study|Personal reason|1|||
125229272|NCT03055936|450467971|FG003|Overall Study|Personal reason|0|||
125229273|NCT03167242|450467972|FG000|Overall Study|Patient/Guardian Decision|0|||
125229274|NCT03167242|450467973|FG001|Overall Study|Patient/Guardian Decision|1|||
125229275|NCT03167242|450467974|FG002|Overall Study|Patient/Guardian Decision|2|||
125229276|NCT03167242|450467975|FG003|Overall Study|Patient/Guardian Decision|1|||
125229277|NCT03167242|450467976|FG004|Overall Study|Patient/Guardian Decision|1|||
125229278|NCT03167242|450467977|FG005|Overall Study|Patient/Guardian Decision|1|||
125229279|NCT03167242|450467978|FG006|Overall Study|Patient/Guardian Decision|0|||
125229280|NCT03167242|450467979|FG007|Overall Study|Patient/Guardian Decision|0|||
125229281|NCT03167242|450467980|FG008|Overall Study|Patient/Guardian Decision|0|||
125229282|NCT03167242|450467981|FG009|Overall Study|Patient/Guardian Decision|0|||
125229283|NCT03167242|450467982|FG010|Overall Study|Patient/Guardian Decision|1|||
125229284|NCT03167242|450467983|FG011|Overall Study|Patient/Guardian Decision|0|||
125229285|NCT03167242|450467972|FG000|Overall Study|Lost to Follow-up|0|||
125229286|NCT03167242|450467973|FG001|Overall Study|Lost to Follow-up|0|||
125229287|NCT03167242|450467974|FG002|Overall Study|Lost to Follow-up|1|||
125229288|NCT03167242|450467975|FG003|Overall Study|Lost to Follow-up|0|||
125229289|NCT03167242|450467976|FG004|Overall Study|Lost to Follow-up|0|||
125229290|NCT03167242|450467977|FG005|Overall Study|Lost to Follow-up|1|||
125229291|NCT03167242|450467978|FG006|Overall Study|Lost to Follow-up|2|||
125229292|NCT03167242|450467979|FG007|Overall Study|Lost to Follow-up|1|||
125229293|NCT03167242|450467980|FG008|Overall Study|Lost to Follow-up|0|||
125229294|NCT03167242|450467981|FG009|Overall Study|Lost to Follow-up|0|||
125229295|NCT03167242|450467982|FG010|Overall Study|Lost to Follow-up|1|||
125229296|NCT03167242|450467983|FG011|Overall Study|Lost to Follow-up|1|||
125229297|NCT03167242|450467972|FG000|Overall Study|Reason not provided|0|||
125229298|NCT03167242|450467973|FG001|Overall Study|Reason not provided|0|||
125229299|NCT03167242|450467974|FG002|Overall Study|Reason not provided|0|||
125229300|NCT03167242|450467975|FG003|Overall Study|Reason not provided|0|||
125229301|NCT03167242|450467976|FG004|Overall Study|Reason not provided|0|||
125229302|NCT03167242|450467977|FG005|Overall Study|Reason not provided|0|||
125229303|NCT03167242|450467978|FG006|Overall Study|Reason not provided|0|||
125229304|NCT03167242|450467979|FG007|Overall Study|Reason not provided|0|||
125229305|NCT03167242|450467980|FG008|Overall Study|Reason not provided|1|||
125229306|NCT03167242|450467981|FG009|Overall Study|Reason not provided|0|||
125229307|NCT03167242|450467982|FG010|Overall Study|Reason not provided|0|||
125229308|NCT03167242|450467983|FG011|Overall Study|Reason not provided|0|||
125229309|NCT01909804|450467984|FG000|Overall Study|Randomized but Never Treated|0|||
125229310|NCT01909804|450467985|FG001|Overall Study|Randomized but Never Treated|0|||
125229311|NCT01909804|450467986|FG002|Overall Study|Randomized but Never Treated|0|||
125229312|NCT01909804|450467987|FG003|Overall Study|Randomized but Never Treated|0|||
125229313|NCT01909804|450467988|FG004|Overall Study|Randomized but Never Treated|0|||
125229314|NCT01909804|450467989|FG005|Overall Study|Randomized but Never Treated|0|||
125229315|NCT01909804|450467990|FG006|Overall Study|Randomized but Never Treated|1|||
125229316|NCT01909804|450467991|FG007|Overall Study|Randomized but Never Treated|0|||
125229317|NCT01909804|450467992|FG008|Overall Study|Randomized but Never Treated|0|||
125229318|NCT01909804|450467993|FG009|Overall Study|Randomized but Never Treated|0|||
125229319|NCT01909804|450467994|FG010|Overall Study|Randomized but Never Treated|0|||
125229320|NCT01909804|450467995|FG011|Overall Study|Randomized but Never Treated|1|||
125229321|NCT01909804|450467984|FG000|Overall Study|Death|0|||
125171123|NCT01371747|450249446|FG002|Overall Study|Abnormal Renal Function|0|||
125171124|NCT01371747|450249447|FG003|Overall Study|Abnormal Renal Function|1|||
125171125|NCT01371747|450249448|FG004|Overall Study|Abnormal Renal Function|0|||
125171126|NCT01371747|450249449|FG005|Overall Study|Abnormal Renal Function|1|||
125171127|NCT01371747|450249444|FG000|Overall Study|High Serum Potassium Results|1|||
125171128|NCT01371747|450249445|FG001|Overall Study|High Serum Potassium Results|1|||
125171129|NCT01371747|450249446|FG002|Overall Study|High Serum Potassium Results|1|||
125171130|NCT01371747|450249447|FG003|Overall Study|High Serum Potassium Results|2|||
125171131|NCT01371747|450249448|FG004|Overall Study|High Serum Potassium Results|0|||
125171132|NCT01371747|450249449|FG005|Overall Study|High Serum Potassium Results|2|||
125171133|NCT01371747|450249444|FG000|Overall Study|Low Serum Potassium Results|1|||
125171134|NCT01371747|450249445|FG001|Overall Study|Low Serum Potassium Results|1|||
125171135|NCT01371747|450249446|FG002|Overall Study|Low Serum Potassium Results|1|||
125229322|NCT01909804|450467985|FG001|Overall Study|Death|0|||
125229323|NCT01909804|450467986|FG002|Overall Study|Death|0|||
125229324|NCT01909804|450467987|FG003|Overall Study|Death|0|||
125229325|NCT01909804|450467988|FG004|Overall Study|Death|0|||
125171136|NCT01371747|450249447|FG003|Overall Study|Low Serum Potassium Results|1|||
125229326|NCT01909804|450467989|FG005|Overall Study|Death|0|||
125229327|NCT01909804|450467990|FG006|Overall Study|Death|0|||
125229328|NCT01909804|450467991|FG007|Overall Study|Death|0|||
125229329|NCT01909804|450467992|FG008|Overall Study|Death|0|||
125171137|NCT01371747|450249448|FG004|Overall Study|Low Serum Potassium Results|0|||
125171138|NCT01371747|450249449|FG005|Overall Study|Low Serum Potassium Results|3|||
125171139|NCT01371747|450249444|FG000|Overall Study|Protocol Violation|0|||
125171140|NCT01371747|450249445|FG001|Overall Study|Protocol Violation|0|||
125171141|NCT01371747|450249446|FG002|Overall Study|Protocol Violation|1|||
125171142|NCT01371747|450249447|FG003|Overall Study|Protocol Violation|0|||
125171143|NCT01371747|450249448|FG004|Overall Study|Protocol Violation|0|||
125171144|NCT01371747|450249449|FG005|Overall Study|Protocol Violation|0|||
125171145|NCT01371747|450249444|FG000|Overall Study|Non-Compliance|3|||
125171146|NCT01371747|450249445|FG001|Overall Study|Non-Compliance|4|||
125171147|NCT01371747|450249446|FG002|Overall Study|Non-Compliance|3|||
125171148|NCT01371747|450249447|FG003|Overall Study|Non-Compliance|0|||
125171149|NCT01371747|450249448|FG004|Overall Study|Non-Compliance|0|||
125171150|NCT01371747|450249449|FG005|Overall Study|Non-Compliance|1|||
125171151|NCT01371747|450249444|FG000|Overall Study|Physician Decision|0|||
125171152|NCT01371747|450249445|FG001|Overall Study|Physician Decision|0|||
125171153|NCT01371747|450249446|FG002|Overall Study|Physician Decision|0|||
125171154|NCT01371747|450249447|FG003|Overall Study|Physician Decision|0|||
125171155|NCT01371747|450249448|FG004|Overall Study|Physician Decision|1|||
125171156|NCT01371747|450249449|FG005|Overall Study|Physician Decision|0|||
125171157|NCT01371747|450249444|FG000|Overall Study|Withdrawal by Subject|6|||
125171158|NCT01371747|450249445|FG001|Overall Study|Withdrawal by Subject|12|||
125171159|NCT01371747|450249446|FG002|Overall Study|Withdrawal by Subject|5|||
125171160|NCT01371747|450249447|FG003|Overall Study|Withdrawal by Subject|2|||
125171161|NCT01371747|450249448|FG004|Overall Study|Withdrawal by Subject|2|||
125171162|NCT01371747|450249449|FG005|Overall Study|Withdrawal by Subject|4|||
125171163|NCT01371747|450249444|FG000|Overall Study|Other Reasons|2|||
125171164|NCT01371747|450249445|FG001|Overall Study|Other Reasons|1|||
125171165|NCT01371747|450249446|FG002|Overall Study|Other Reasons|2|||
125171166|NCT01371747|450249447|FG003|Overall Study|Other Reasons|0|||
125171167|NCT01371747|450249448|FG004|Overall Study|Other Reasons|0|||
125171168|NCT01371747|450249449|FG005|Overall Study|Other Reasons|1|||
125171169|NCT03092219|450249450|FG000|Overall Study|Protocol Violation|7|||
125171170|NCT03092219|450249451|FG001|Overall Study|Protocol Violation|4|||
125171171|NCT01443728|450249452|FG000|Overall Study|Lost to Follow-up|2|||
125171172|NCT01443728|450249453|FG001|Overall Study|Lost to Follow-up|0|||
125171173|NCT01443728|450249452|FG000|Overall Study|Withdrawal by Subject|1|||
125171174|NCT01443728|450249453|FG001|Overall Study|Withdrawal by Subject|1|||
125171175|NCT01443728|450249452|FG000|Overall Study|Adverse Event|0|||
125171176|NCT01443728|450249453|FG001|Overall Study|Adverse Event|2|||
125171177|NCT01403051|450249454|FG000|Overall Study|Protocol Violation|2|||
125171178|NCT01403051|450249455|FG001|Overall Study|Protocol Violation|0|||
125171179|NCT01403051|450249454|FG000|Overall Study|Death|1|||
125171180|NCT01403051|450249455|FG001|Overall Study|Death|0|||
125171181|NCT01403051|450249454|FG000|Overall Study|Withdrawal by Subject|2|||
125171182|NCT01403051|450249455|FG001|Overall Study|Withdrawal by Subject|1|||
125171183|NCT01403051|450249454|FG000|Overall Study|Lost to Follow-up|5|||
125171184|NCT01403051|450249455|FG001|Overall Study|Lost to Follow-up|5|||
125171185|NCT04497948|450249463|FG000|Overall Study|Death|2|||
125171186|NCT02242045|450249464|FG000|Overall Study|Investigator's Discretion|1|||
125171187|NCT02242045|450249464|FG000|Overall Study|Progressive Disease|2|||
125171188|NCT02242045|450249464|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
125171189|NCT02242045|450249464|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
125171190|NCT03760185|450249465|FG000|Overall Study|Lost to Follow-up|1|||
125171191|NCT03760185|450249466|FG001|Overall Study|Lost to Follow-up|1|||
125171192|NCT02473523|450249467|FG000|Overall Study|Death|1|||
125171193|NCT02473523|450249467|FG000|Overall Study|Lost to Follow-up|1|||
125171194|NCT00976911|450249470|FG000|Overall Study|Withdrawal by Subject|4|||
125171195|NCT00976911|450249471|FG001|Overall Study|Withdrawal by Subject|6|||
125171196|NCT00976911|450249470|FG000|Overall Study|Death|138|||
125171197|NCT00976911|450249471|FG001|Overall Study|Death|126|||
125171198|NCT00976911|450249470|FG000|Overall Study|Adverse Event|0|||
125171199|NCT00976911|450249471|FG001|Overall Study|Adverse Event|1|||
125171200|NCT00976911|450249470|FG000|Overall Study|Protocol Violation|2|||
125171201|NCT00976911|450249471|FG001|Overall Study|Protocol Violation|0|||
125171202|NCT00976911|450249470|FG000|Overall Study|Other|8|||
125171203|NCT00976911|450249471|FG001|Overall Study|Other|9|||
125171204|NCT00976911|450249470|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
125171205|NCT00976911|450249471|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
125171206|NCT02954991|450249472|FG000|Overall Study|Death|92|||
125171207|NCT02954991|450249473|FG001|Overall Study|Death|11|||
125171208|NCT02954991|450249474|FG002|Overall Study|Death|2|||
125171209|NCT02954991|450249472|FG000|Overall Study|Lost to Follow-up|3|||
125171210|NCT02954991|450249473|FG001|Overall Study|Lost to Follow-up|2|||
125171211|NCT02954991|450249474|FG002|Overall Study|Lost to Follow-up|0|||
125171212|NCT02954991|450249472|FG000|Overall Study|Withdrawal by Subject|9|||
125171213|NCT02954991|450249473|FG001|Overall Study|Withdrawal by Subject|8|||
125171214|NCT02954991|450249474|FG002|Overall Study|Withdrawal by Subject|1|||
125171215|NCT02954991|450249472|FG000|Overall Study|Study Terminated by Sponsor|18|||
125171216|NCT02954991|450249473|FG001|Overall Study|Study Terminated by Sponsor|10|||
125229330|NCT01909804|450467993|FG009|Overall Study|Death|0|||
125171217|NCT02954991|450249474|FG002|Overall Study|Study Terminated by Sponsor|1|||
125171218|NCT02954991|450249472|FG000|Overall Study|Miscellaneous|2|||
125171219|NCT02954991|450249473|FG001|Overall Study|Miscellaneous|1|||
125171220|NCT02954991|450249474|FG002|Overall Study|Miscellaneous|1|||
125171221|NCT00576316|450249475|FG000|Overall Study|Adverse Event|9|||
125171222|NCT00576316|450249475|FG000|Overall Study|Withdrawal by Subject|2|||
125171223|NCT00576316|450249475|FG000|Overall Study|Protocol Violation|9|||
125171224|NCT02648932|450249477|FG000|Overall Study|No transplant|3|||
125171225|NCT02648932|450249478|FG001|Overall Study|No transplant|1|||
125171226|NCT01434810|450249479|FG000|Overall Study|Did not receive treatment|11|||
125171227|NCT01434810|450249480|FG001|Overall Study|Did not receive treatment|3|||
125171228|NCT01434810|450249479|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
125171229|NCT01434810|450249480|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
125171230|NCT04893018|450249483|FG000|Overall Study|Lost to Follow-up|1|||
125171231|NCT04893018|450249484|FG001|Overall Study|Lost to Follow-up|0|||
125171232|NCT04893018|450249483|FG000|Overall Study|Withdrawal by Subject|2|||
125171233|NCT04893018|450249484|FG001|Overall Study|Withdrawal by Subject|0|||
125171234|NCT04893018|450249483|FG000|Overall Study|Study Terminated|1|||
125171235|NCT04893018|450249484|FG001|Overall Study|Study Terminated|2|||
125171236|NCT01307111|450249487|FG000|IUD Insertion|Lost to Follow-up|2|||
125171237|NCT01307111|450249488|FG001|IUD Insertion|Lost to Follow-up|0|||
125171238|NCT01307111|450249487|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
125171239|NCT01307111|450249488|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
125171240|NCT02842073|450249497|FG000|Overall Study|Withdrawal by Subject|1|||
125171241|NCT00195338|450249498|FG000|Overall Study|Lost to Follow-up|2|||
125171242|NCT00195338|450249498|FG000|Overall Study|Adverse Event|5|||
125171243|NCT00195338|450249498|FG000|Overall Study|Lack of Efficacy|1|||
125171244|NCT00195338|450249498|FG000|Overall Study|Early closure of the site|4|||
125171245|NCT02252406|450249499|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
125171246|NCT02252406|450249500|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
125171247|NCT02252406|450249499|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
125171248|NCT02252406|450249500|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
125171249|NCT02252406|450249499|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
125171250|NCT02252406|450249500|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
125171251|NCT02252406|450249499|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
125171252|NCT02252406|450249500|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
125171253|NCT02252406|450249499|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
125171254|NCT02252406|450249500|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
125171255|NCT00447876|450249503|FG000|Overall Study|Withdrawal by Subject|1|||
125171256|NCT00447876|450249504|FG001|Overall Study|Withdrawal by Subject|4|||
125171257|NCT00447876|450249503|FG000|Overall Study|Lost to Follow-up|1|||
125171258|NCT00447876|450249504|FG001|Overall Study|Lost to Follow-up|0|||
125171259|NCT00447876|450249503|FG000|Overall Study|Deterioration of symptomology|1|||
125171260|NCT00447876|450249504|FG001|Overall Study|Deterioration of symptomology|0|||
125171261|NCT02533180|450249505|FG000|Overall Study|Death|0|||
125171262|NCT02533180|450249506|FG001|Overall Study|Death|2|||
125171263|NCT02533180|450249505|FG000|Overall Study|Lost to Follow-up|0|||
125171264|NCT02533180|450249506|FG001|Overall Study|Lost to Follow-up|1|||
125171265|NCT02533180|450249505|FG000|Overall Study|Physician Decision|0|||
125171266|NCT02533180|450249506|FG001|Overall Study|Physician Decision|1|||
125171267|NCT02533180|450249505|FG000|Overall Study|Withdrawal by Subject|2|||
125171268|NCT02533180|450249506|FG001|Overall Study|Withdrawal by Subject|5|||
125171269|NCT02533180|450249505|FG000|Overall Study|Screen Failure|37|||
125171270|NCT02533180|450249506|FG001|Overall Study|Screen Failure|0|||
125171271|NCT02533180|450249505|FG000|Overall Study|Protocol Deviation|0|||
125171272|NCT02533180|450249506|FG001|Overall Study|Protocol Deviation|1|||
125171273|NCT02533180|450249505|FG000|Overall Study|Non-compliance|0|||
125171274|NCT02533180|450249506|FG001|Overall Study|Non-compliance|1|||
125171275|NCT01609023|450249509|FG000|Overall Study|Lack of Efficacy|3|||
125171276|NCT01609023|450249509|FG000|Overall Study|Withdrawal by Subject|4|||
125171277|NCT01609023|450249509|FG000|Overall Study|Lost to Follow-up|8|||
125171278|NCT01609023|450249509|FG000|Overall Study|Toxicity|3|||
125171279|NCT01609023|450249509|FG000|Overall Study|Disease progression|10|||
125171280|NCT01609023|450249509|FG000|Overall Study|Physician Decision|2|||
125171281|NCT01609023|450249509|FG000|Overall Study|Death|2|||
125171282|NCT01609023|450249509|FG000|Overall Study|Personal reasons|1|||
125171283|NCT02047734|450249511|FG000|Overall Study|Adverse Event|18|||
125171284|NCT02047734|450249512|FG001|Overall Study|Adverse Event|13|||
125171285|NCT02047734|450249513|FG002|Overall Study|Adverse Event|13|||
125229331|NCT01909804|450467994|FG010|Overall Study|Death|1|||
125171286|NCT02047734|450249511|FG000|Overall Study|Lack of Efficacy|4|||
125171287|NCT02047734|450249512|FG001|Overall Study|Lack of Efficacy|5|||
125171288|NCT02047734|450249513|FG002|Overall Study|Lack of Efficacy|1|||
125171289|NCT02047734|450249511|FG000|Overall Study|Protocol Violation|3|||
125171290|NCT02047734|450249512|FG001|Overall Study|Protocol Violation|1|||
125171291|NCT02047734|450249513|FG002|Overall Study|Protocol Violation|1|||
125171292|NCT02047734|450249511|FG000|Overall Study|Lost to Follow-up|1|||
125171293|NCT02047734|450249512|FG001|Overall Study|Lost to Follow-up|4|||
125171294|NCT02047734|450249513|FG002|Overall Study|Lost to Follow-up|0|||
125171295|NCT02047734|450249511|FG000|Overall Study|Death|0|||
125171296|NCT02047734|450249512|FG001|Overall Study|Death|1|||
125171297|NCT02047734|450249513|FG002|Overall Study|Death|0|||
125171298|NCT02047734|450249511|FG000|Overall Study|Withdrawal by Subject|30|||
125171299|NCT02047734|450249512|FG001|Overall Study|Withdrawal by Subject|31|||
125171300|NCT02047734|450249513|FG002|Overall Study|Withdrawal by Subject|19|||
125171301|NCT02047734|450249511|FG000|Overall Study|Physician Decision|7|||
125171302|NCT02047734|450249512|FG001|Overall Study|Physician Decision|6|||
125171303|NCT02047734|450249513|FG002|Overall Study|Physician Decision|5|||
125171304|NCT02047734|450249511|FG000|Overall Study|Miscellaneous|2|||
125171305|NCT02047734|450249512|FG001|Overall Study|Miscellaneous|4|||
125171306|NCT02047734|450249513|FG002|Overall Study|Miscellaneous|6|||
125229332|NCT01909804|450467995|FG011|Overall Study|Death|0|||
125229333|NCT01909804|450467984|FG000|Overall Study|Lack of Efficacy|4|||
125229334|NCT01909804|450467985|FG001|Overall Study|Lack of Efficacy|1|||
125229335|NCT01909804|450467986|FG002|Overall Study|Lack of Efficacy|0|||
125229336|NCT01909804|450467987|FG003|Overall Study|Lack of Efficacy|0|||
125229337|NCT01909804|450467988|FG004|Overall Study|Lack of Efficacy|7|||
125229338|NCT01909804|450467989|FG005|Overall Study|Lack of Efficacy|3|||
125229339|NCT01909804|450467990|FG006|Overall Study|Lack of Efficacy|1|||
125229340|NCT01909804|450467991|FG007|Overall Study|Lack of Efficacy|1|||
125229341|NCT01909804|450467992|FG008|Overall Study|Lack of Efficacy|0|||
125229342|NCT01909804|450467993|FG009|Overall Study|Lack of Efficacy|1|||
125229343|NCT01909804|450467994|FG010|Overall Study|Lack of Efficacy|0|||
125229344|NCT01909804|450467995|FG011|Overall Study|Lack of Efficacy|1|||
125229345|NCT01909804|450467984|FG000|Overall Study|Withdrew Consent|0|||
125229346|NCT01909804|450467985|FG001|Overall Study|Withdrew Consent|0|||
125229347|NCT01909804|450467986|FG002|Overall Study|Withdrew Consent|0|||
125229348|NCT01909804|450467987|FG003|Overall Study|Withdrew Consent|0|||
125229349|NCT01909804|450467988|FG004|Overall Study|Withdrew Consent|1|||
125229350|NCT01909804|450467989|FG005|Overall Study|Withdrew Consent|1|||
125229351|NCT01909804|450467990|FG006|Overall Study|Withdrew Consent|0|||
125229352|NCT01909804|450467991|FG007|Overall Study|Withdrew Consent|0|||
125229353|NCT01909804|450467992|FG008|Overall Study|Withdrew Consent|0|||
125229354|NCT01909804|450467993|FG009|Overall Study|Withdrew Consent|0|||
125229355|NCT01909804|450467994|FG010|Overall Study|Withdrew Consent|0|||
125229356|NCT01909804|450467995|FG011|Overall Study|Withdrew Consent|0|||
125229357|NCT01909804|450467984|FG000|Overall Study|Protocol Violation|0|||
125229358|NCT01909804|450467985|FG001|Overall Study|Protocol Violation|0|||
125229359|NCT01909804|450467986|FG002|Overall Study|Protocol Violation|0|||
125229360|NCT01909804|450467987|FG003|Overall Study|Protocol Violation|0|||
125229361|NCT01909804|450467988|FG004|Overall Study|Protocol Violation|0|||
125229362|NCT01909804|450467989|FG005|Overall Study|Protocol Violation|0|||
125229363|NCT01909804|450467990|FG006|Overall Study|Protocol Violation|0|||
125229364|NCT01909804|450467991|FG007|Overall Study|Protocol Violation|0|||
125229365|NCT01909804|450467992|FG008|Overall Study|Protocol Violation|0|||
125229366|NCT01909804|450467993|FG009|Overall Study|Protocol Violation|0|||
125229367|NCT01909804|450467994|FG010|Overall Study|Protocol Violation|0|||
125229368|NCT01909804|450467995|FG011|Overall Study|Protocol Violation|1|||
125229369|NCT02144701|450467997|FG000|Overall Study|development of relapse, GVHD or death|9|||
125229370|NCT02144701|450467998|FG001|Overall Study|development of relapse, GVHD or death|3|||
125229371|NCT03217591|450467999|FG000|Overall Study|Adverse Event|1|||
125229372|NCT03217591|450468000|FG001|Overall Study|Adverse Event|2|||
125229373|NCT03217591|450468001|FG002|Overall Study|Adverse Event|6|||
125229374|NCT03217591|450467999|FG000|Overall Study|Withdrawal by Subject|0|||
125229375|NCT03217591|450468000|FG001|Overall Study|Withdrawal by Subject|1|||
125229376|NCT03217591|450468001|FG002|Overall Study|Withdrawal by Subject|3|||
125229377|NCT03217591|450467999|FG000|Overall Study|Lost to Follow-up|1|||
125229378|NCT03217591|450468000|FG001|Overall Study|Lost to Follow-up|0|||
125229379|NCT03217591|450468001|FG002|Overall Study|Lost to Follow-up|0|||
125229380|NCT03217591|450467999|FG000|Overall Study|Protocol Violation|1|||
125229381|NCT03217591|450468000|FG001|Overall Study|Protocol Violation|0|||
125229382|NCT03217591|450468001|FG002|Overall Study|Protocol Violation|1|||
125229383|NCT00249834|450468002|FG000|Overall Study|Ovarian stimulation failed|1|||
125229384|NCT00249834|450468003|FG001|Overall Study|Ovarian stimulation failed|0|||
125229385|NCT00249834|450468004|FG002|Overall Study|Ovarian stimulation failed|0|||
125229386|NCT00249834|450468005|FG003|Overall Study|Ovarian stimulation failed|0|||
125229387|NCT00249834|450468006|FG004|Overall Study|Ovarian stimulation failed|0|||
125229388|NCT00249834|450468007|FG005|Overall Study|Ovarian stimulation failed|0|||
125229389|NCT00249834|450468008|FG006|Overall Study|Ovarian stimulation failed|0|||
125229390|NCT00249834|450468009|FG007|Overall Study|Ovarian stimulation failed|0|||
125229391|NCT00249834|450468002|FG000|Overall Study|Failure of down-regulation|0|||
125229392|NCT00249834|450468003|FG001|Overall Study|Failure of down-regulation|0|||
125229393|NCT00249834|450468004|FG002|Overall Study|Failure of down-regulation|0|||
125171307|NCT02047734|450249511|FG000|Overall Study|Did Not Receive Study Drug|2|||
125171308|NCT02047734|450249512|FG001|Overall Study|Did Not Receive Study Drug|4|||
125171309|NCT02047734|450249513|FG002|Overall Study|Did Not Receive Study Drug|1|||
125171310|NCT02952586|450249519|FG000|Lead-In Phase (7 Days)|Death|0|||
125171311|NCT02952586|450249520|FG001|Lead-In Phase (7 Days)|Death|1|||
125171312|NCT02952586|450249519|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
125171313|NCT02952586|450249520|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
125171314|NCT02952586|450249519|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
125171315|NCT02952586|450249520|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
125171316|NCT02952586|450249519|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
125171317|NCT02952586|450249520|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
125171318|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
125171319|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
125171320|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
125171321|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
125171322|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
125171323|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
125171324|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
125171325|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
125171326|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
125171327|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
125171328|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
125171329|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
125171330|NCT02952586|450249519|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
125171331|NCT02952586|450249520|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
125171332|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Death|3|||
125171333|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Death|8|||
125171334|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
125171335|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
125171336|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
125171337|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
125171338|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
125171339|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
125171340|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
125171341|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
125171342|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
125171343|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
125171344|NCT02952586|450249519|FG000|CRT for Cisplatin (63 Days)|Other|1|||
125171345|NCT02952586|450249520|FG001|CRT for Cisplatin (63 Days)|Other|1|||
125171346|NCT02952586|450249519|FG000|CRT for IMRT (63 Days)|Death|5|||
125171347|NCT02952586|450249520|FG001|CRT for IMRT (63 Days)|Death|8|||
125171348|NCT02952586|450249519|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
125171349|NCT02952586|450249520|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
125171350|NCT02952586|450249519|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
125171351|NCT02952586|450249520|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
125171352|NCT02952586|450249519|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
125171353|NCT02952586|450249520|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
125171354|NCT02952586|450249519|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
125171355|NCT02952586|450249520|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
125229394|NCT00249834|450468005|FG003|Overall Study|Failure of down-regulation|0|||
125229395|NCT00249834|450468006|FG004|Overall Study|Failure of down-regulation|0|||
125229396|NCT00249834|450468007|FG005|Overall Study|Failure of down-regulation|0|||
125229397|NCT00249834|450468008|FG006|Overall Study|Failure of down-regulation|1|||
125229398|NCT00249834|450468009|FG007|Overall Study|Failure of down-regulation|0|||
125229399|NCT00249834|450468002|FG000|Overall Study|Protocol Violation|0|||
125229400|NCT00249834|450468003|FG001|Overall Study|Protocol Violation|19|||
125229401|NCT00249834|450468004|FG002|Overall Study|Protocol Violation|14|||
125229402|NCT00249834|450468005|FG003|Overall Study|Protocol Violation|8|||
125229403|NCT00249834|450468006|FG004|Overall Study|Protocol Violation|5|||
125229404|NCT00249834|450468007|FG005|Overall Study|Protocol Violation|2|||
125229405|NCT00249834|450468008|FG006|Overall Study|Protocol Violation|0|||
125229406|NCT00249834|450468009|FG007|Overall Study|Protocol Violation|0|||
125229407|NCT00269152|450468013|FG000|Overall Study|Adverse Event|9|||
125229408|NCT00269152|450468014|FG001|Overall Study|Adverse Event|3|||
125229409|NCT00269152|450468013|FG000|Overall Study|Withdrawal by Subject|7|||
125229410|NCT00269152|450468014|FG001|Overall Study|Withdrawal by Subject|3|||
125229411|NCT00269152|450468013|FG000|Overall Study|Physician Decision|2|||
125229412|NCT00269152|450468014|FG001|Overall Study|Physician Decision|3|||
125229413|NCT00269152|450468013|FG000|Overall Study|Protocol Violation|0|||
125229414|NCT00269152|450468014|FG001|Overall Study|Protocol Violation|1|||
125229415|NCT04249427|450468015|FG000|Overall Study|Adverse Event|3|||
125229416|NCT04249427|450468016|FG001|Overall Study|Adverse Event|1|||
125229417|NCT04249427|450468015|FG000|Overall Study|Lack of Efficacy|0|||
125171356|NCT02952586|450249519|FG000|CRT for IMRT (63 Days)|Other|1|||
125229418|NCT04249427|450468016|FG001|Overall Study|Lack of Efficacy|1|||
125229419|NCT04249427|450468015|FG000|Overall Study|Withdrawal by Subject|1|||
125171357|NCT02952586|450249520|FG001|CRT for IMRT (63 Days)|Other|0|||
125171358|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Death|17|||
125171359|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Death|11|||
125171360|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
125171361|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
125171362|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
125171363|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
125171364|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
125171365|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
125171366|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
125171367|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
125171368|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
125171369|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
125171370|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
125171371|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
125171372|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
125171373|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
125171374|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Other|2|||
125171375|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Other|1|||
125171376|NCT02952586|450249519|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
125171377|NCT02952586|450249520|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
125171378|NCT02952586|450249519|FG000|Follow-Up Phase (90 Days)|Death|12|||
125171379|NCT02952586|450249520|FG001|Follow-Up Phase (90 Days)|Death|10|||
125171380|NCT02952586|450249519|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
125171381|NCT02952586|450249520|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
125171382|NCT02952586|450249519|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
125171383|NCT02952586|450249520|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
125171384|NCT02952586|450249519|FG000|Follow-Up Phase (90 Days)|Other|7|||
125171385|NCT02952586|450249520|FG001|Follow-Up Phase (90 Days)|Other|5|||
125171386|NCT02952586|450249519|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
125171387|NCT02952586|450249520|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
125171388|NCT02952586|450249519|FG000|LT Follow-up (up to 45 Months)|Death|51|||
125171389|NCT02952586|450249520|FG001|LT Follow-up (up to 45 Months)|Death|31|||
125171390|NCT02952586|450249519|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
125171391|NCT02952586|450249520|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
125171392|NCT02952586|450249519|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
125171393|NCT02952586|450249520|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
125171394|NCT02952586|450249519|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
125171395|NCT02952586|450249520|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
125171396|NCT00492778|450249521|FG000|Overall Study|Ineligible by Pathology Review|8|||
125171397|NCT00492778|450249522|FG001|Overall Study|Ineligible by Pathology Review|1|||
125171398|NCT00789035|450249523|FG000|Overall Study|Adverse Event|0|||
125171399|NCT00789035|450249524|FG001|Overall Study|Adverse Event|2|||
125171400|NCT00789035|450249525|FG002|Overall Study|Adverse Event|0|||
125171401|NCT00789035|450249526|FG003|Overall Study|Adverse Event|1|||
125171402|NCT00789035|450249527|FG004|Overall Study|Adverse Event|3|||
125171403|NCT00789035|450249523|FG000|Overall Study|Lack of Efficacy|3|||
125171404|NCT00789035|450249524|FG001|Overall Study|Lack of Efficacy|0|||
125171405|NCT00789035|450249525|FG002|Overall Study|Lack of Efficacy|0|||
125171406|NCT00789035|450249526|FG003|Overall Study|Lack of Efficacy|0|||
125171407|NCT00789035|450249527|FG004|Overall Study|Lack of Efficacy|2|||
125171408|NCT00789035|450249523|FG000|Overall Study|Protocol Violation|1|||
125171409|NCT00789035|450249524|FG001|Overall Study|Protocol Violation|0|||
125171410|NCT00789035|450249525|FG002|Overall Study|Protocol Violation|0|||
125171411|NCT00789035|450249526|FG003|Overall Study|Protocol Violation|0|||
125171412|NCT00789035|450249527|FG004|Overall Study|Protocol Violation|0|||
125171413|NCT00789035|450249523|FG000|Overall Study|Withdrawal by Subject|0|||
125171414|NCT00789035|450249524|FG001|Overall Study|Withdrawal by Subject|2|||
125171415|NCT00789035|450249525|FG002|Overall Study|Withdrawal by Subject|0|||
125171416|NCT00789035|450249526|FG003|Overall Study|Withdrawal by Subject|0|||
125171417|NCT00789035|450249527|FG004|Overall Study|Withdrawal by Subject|0|||
125171418|NCT00789035|450249523|FG000|Overall Study|Other reason not defined above|2|||
125171419|NCT00789035|450249524|FG001|Overall Study|Other reason not defined above|3|||
125171420|NCT00789035|450249525|FG002|Overall Study|Other reason not defined above|1|||
125171421|NCT00789035|450249526|FG003|Overall Study|Other reason not defined above|0|||
125171422|NCT00789035|450249527|FG004|Overall Study|Other reason not defined above|1|||
125171423|NCT01118975|450249528|FG000|Overall Study|Adverse Event|0|||
125171424|NCT01118975|450249529|FG001|Overall Study|Adverse Event|1|||
125171425|NCT00789737|450249540|FG000|Overall Study|Withdrawal by Subject|13|||
125171426|NCT00789737|450249541|FG001|Overall Study|Withdrawal by Subject|22|||
125171427|NCT00789737|450249540|FG000|Overall Study|Lost to Follow-up|10|||
125171428|NCT00789737|450249541|FG001|Overall Study|Lost to Follow-up|14|||
125171429|NCT00789737|450249540|FG000|Overall Study|Adverse Event|8|||
125171430|NCT00789737|450249541|FG001|Overall Study|Adverse Event|8|||
125171431|NCT00789737|450249540|FG000|Overall Study|Protocol Violation|3|||
125171432|NCT00789737|450249541|FG001|Overall Study|Protocol Violation|0|||
125171433|NCT00789737|450249540|FG000|Overall Study|Lack of Efficacy|3|||
125171434|NCT00789737|450249541|FG001|Overall Study|Lack of Efficacy|0|||
125171435|NCT00789737|450249540|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
125171436|NCT00789737|450249541|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
125171437|NCT00789737|450249540|FG000|Overall Study|Other|11|||
125171438|NCT00789737|450249541|FG001|Overall Study|Other|7|||
125171439|NCT00384930|450249542|FG000|Overall Study|Adverse Event|5|||
125171440|NCT00384930|450249543|FG001|Overall Study|Adverse Event|4|||
125171441|NCT00384930|450249544|FG002|Overall Study|Adverse Event|12|||
125171442|NCT00384930|450249545|FG003|Overall Study|Adverse Event|11|||
125171443|NCT00384930|450249546|FG004|Overall Study|Adverse Event|14|||
125171444|NCT00384930|450249542|FG000|Overall Study|Entry Criteria Not Met|2|||
125171445|NCT00384930|450249543|FG001|Overall Study|Entry Criteria Not Met|6|||
125171446|NCT00384930|450249544|FG002|Overall Study|Entry Criteria Not Met|7|||
125171447|NCT00384930|450249545|FG003|Overall Study|Entry Criteria Not Met|8|||
125171448|NCT00384930|450249546|FG004|Overall Study|Entry Criteria Not Met|4|||
125229420|NCT04249427|450468016|FG001|Overall Study|Withdrawal by Subject|2|||
125171449|NCT00384930|450249542|FG000|Overall Study|Lack of Efficacy|1|||
125171450|NCT00384930|450249543|FG001|Overall Study|Lack of Efficacy|1|||
125171451|NCT00384930|450249544|FG002|Overall Study|Lack of Efficacy|2|||
125171452|NCT00384930|450249545|FG003|Overall Study|Lack of Efficacy|1|||
125171453|NCT00384930|450249546|FG004|Overall Study|Lack of Efficacy|2|||
125229421|NCT03886272|450468017|FG000|Period 1|Withdrawal by Subject|0|||
125229422|NCT03886272|450468018|FG001|Period 1|Withdrawal by Subject|0|||
125229423|NCT03886272|450468019|FG002|Period 1|Withdrawal by Subject|0|||
125229424|NCT03886272|450468020|FG003|Period 1|Withdrawal by Subject|0|||
125229425|NCT03886272|450468021|FG004|Period 1|Withdrawal by Subject|0|||
125229426|NCT03886272|450468022|FG005|Period 1|Withdrawal by Subject|1|||
125229427|NCT03886272|450468023|FG006|Period 1|Withdrawal by Subject|0|||
125171454|NCT00384930|450249542|FG000|Overall Study|Lost to Follow-up|5|||
125171455|NCT00384930|450249543|FG001|Overall Study|Lost to Follow-up|3|||
125171456|NCT00384930|450249544|FG002|Overall Study|Lost to Follow-up|0|||
125171457|NCT00384930|450249545|FG003|Overall Study|Lost to Follow-up|4|||
125171458|NCT00384930|450249546|FG004|Overall Study|Lost to Follow-up|6|||
125171459|NCT00384930|450249542|FG000|Overall Study|Physician Decision|0|||
125171460|NCT00384930|450249543|FG001|Overall Study|Physician Decision|1|||
125171461|NCT00384930|450249544|FG002|Overall Study|Physician Decision|1|||
125171462|NCT00384930|450249545|FG003|Overall Study|Physician Decision|0|||
125171463|NCT00384930|450249546|FG004|Overall Study|Physician Decision|1|||
125171464|NCT00384930|450249542|FG000|Overall Study|Protocol Violation|1|||
125171465|NCT00384930|450249543|FG001|Overall Study|Protocol Violation|0|||
125171466|NCT00384930|450249544|FG002|Overall Study|Protocol Violation|1|||
125171467|NCT00384930|450249545|FG003|Overall Study|Protocol Violation|6|||
125171468|NCT00384930|450249546|FG004|Overall Study|Protocol Violation|4|||
125171469|NCT00384930|450249542|FG000|Overall Study|Sponsor Decision|3|||
125171470|NCT00384930|450249543|FG001|Overall Study|Sponsor Decision|4|||
125171471|NCT00384930|450249544|FG002|Overall Study|Sponsor Decision|0|||
125171472|NCT00384930|450249545|FG003|Overall Study|Sponsor Decision|5|||
125171473|NCT00384930|450249546|FG004|Overall Study|Sponsor Decision|0|||
125171474|NCT00384930|450249542|FG000|Overall Study|Withdrawal by Subject|9|||
125171475|NCT00384930|450249543|FG001|Overall Study|Withdrawal by Subject|7|||
125171476|NCT00384930|450249544|FG002|Overall Study|Withdrawal by Subject|7|||
125171477|NCT00384930|450249545|FG003|Overall Study|Withdrawal by Subject|6|||
125171478|NCT00384930|450249546|FG004|Overall Study|Withdrawal by Subject|16|||
125171479|NCT00384930|450249542|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
125229428|NCT00931632|450468024|FG000|Overall Study|Withdrawal by Subject|2|||
125171480|NCT00384930|450249543|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
125171481|NCT00384930|450249544|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
125171482|NCT00384930|450249545|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
125229429|NCT00931632|450468025|FG001|Overall Study|Withdrawal by Subject|3|||
125229430|NCT00931632|450468024|FG000|Overall Study|Adverse Event|19|||
125171483|NCT00384930|450249546|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
125171484|NCT04988087|450249549|FG000|Overall Study|Adverse Event|4|||
125171485|NCT04988087|450249550|FG001|Overall Study|Adverse Event|0|||
125171486|NCT04988087|450249551|FG002|Overall Study|Adverse Event|0|||
125171487|NCT04988087|450249552|FG003|Overall Study|Adverse Event|0|||
125171488|NCT04988087|450249549|FG000|Overall Study|Withdrawal by Subject|1|||
125171489|NCT04988087|450249550|FG001|Overall Study|Withdrawal by Subject|1|||
125171490|NCT04988087|450249551|FG002|Overall Study|Withdrawal by Subject|0|||
125229431|NCT00931632|450468025|FG001|Overall Study|Adverse Event|15|||
125229432|NCT03372798|450468028|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
125229433|NCT03372798|450468029|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
125229434|NCT03372798|450468028|FG000|Overall Study|Failure of imaging probe|0|||
125171491|NCT04988087|450249552|FG003|Overall Study|Withdrawal by Subject|0|||
125171492|NCT04988087|450249549|FG000|Overall Study|Technical problems|7|||
125171493|NCT04988087|450249550|FG001|Overall Study|Technical problems|9|||
125171494|NCT04988087|450249551|FG002|Overall Study|Technical problems|1|||
125171495|NCT04988087|450249552|FG003|Overall Study|Technical problems|2|||
125171496|NCT02613182|450249553|FG000|Overall Study|Death|6|||
125171497|NCT02613182|450249553|FG000|Overall Study|Physician Decision|1|||
125171498|NCT02613182|450249553|FG000|Overall Study|Study Terminated by Sponsor|21|||
125171499|NCT02613182|450249553|FG000|Overall Study|Withdrawal by Subject|6|||
125171500|NCT03968978|450249554|FG000|Overall Study|Adverse Event|1|||
125171501|NCT03968978|450249555|FG001|Overall Study|Adverse Event|0|||
125229435|NCT03372798|450468029|FG001|Overall Study|Failure of imaging probe|1|||
125229436|NCT03188055|450468030|FG000|Overall Study|Unavailable for training|0|||
125229437|NCT03188055|450468031|FG001|Overall Study|Unavailable for training|0|||
125229438|NCT03188055|450468032|FG002|Overall Study|Unavailable for training|19|||
125229439|NCT03188055|450468033|FG003|Overall Study|Unavailable for training|0|||
125229440|NCT03188055|450468034|FG004|Overall Study|Unavailable for training|0|||
125229441|NCT03188055|450468035|FG005|Overall Study|Unavailable for training|0|||
125229442|NCT03188055|450468030|FG000|Overall Study|Lost to Follow-up|0|||
125229443|NCT03188055|450468031|FG001|Overall Study|Lost to Follow-up|18|||
125229444|NCT03188055|450468032|FG002|Overall Study|Lost to Follow-up|0|||
125229445|NCT03188055|450468033|FG003|Overall Study|Lost to Follow-up|11|||
125229446|NCT03188055|450468034|FG004|Overall Study|Lost to Follow-up|0|||
125229447|NCT03188055|450468035|FG005|Overall Study|Lost to Follow-up|0|||
125229448|NCT03188055|450468030|FG000|Overall Study|Withdrawal by Subject|0|||
125229449|NCT03188055|450468031|FG001|Overall Study|Withdrawal by Subject|1|||
125229450|NCT03188055|450468032|FG002|Overall Study|Withdrawal by Subject|0|||
125229451|NCT03188055|450468033|FG003|Overall Study|Withdrawal by Subject|1|||
125229452|NCT03188055|450468034|FG004|Overall Study|Withdrawal by Subject|0|||
125229453|NCT03188055|450468035|FG005|Overall Study|Withdrawal by Subject|0|||
125229454|NCT03139552|450468037|FG000|Overall Study|unable to attend tasting due to schedule|3|||
125229455|NCT02247466|450468046|FG000|Overall Study|Procedure changed to open surgery|0|||
125229456|NCT02247466|450468047|FG001|Overall Study|Procedure changed to open surgery|3|||
125229457|NCT01618968|450468048|FG000|Overall Study|Adverse Event|1|||
125229458|NCT01618968|450468049|FG001|Overall Study|Adverse Event|0|||
125229459|NCT01618968|450468050|FG002|Overall Study|Adverse Event|0|||
125229460|NCT01618968|450468051|FG003|Overall Study|Adverse Event|0|||
125229461|NCT01618968|450468048|FG000|Overall Study|Death|0|||
125229462|NCT01618968|450468049|FG001|Overall Study|Death|0|||
125229463|NCT01618968|450468050|FG002|Overall Study|Death|0|||
125229464|NCT01618968|450468051|FG003|Overall Study|Death|1|||
125229465|NCT00721799|450468052|FG000|Overall Study|Withdrawal by Subject|7|||
125229466|NCT00721799|450468052|FG000|Overall Study|withdraw by subject after scan 1|1|||
125229467|NCT04356937|450468055|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
125229468|NCT04356937|450468056|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
125229469|NCT03533751|450468057|FG000|Overall Study|Withdrawal by Subject|12|||
125229470|NCT03533751|450468058|FG001|Overall Study|Withdrawal by Subject|6|||
125229471|NCT03533751|450468059|FG002|Overall Study|Withdrawal by Subject|11|||
125229472|NCT03533751|450468060|FG003|Overall Study|Withdrawal by Subject|9|||
125229473|NCT03533751|450468061|FG004|Overall Study|Withdrawal by Subject|10|||
125229474|NCT03533751|450468057|FG000|Overall Study|Adverse Event|4|||
125229475|NCT03533751|450468058|FG001|Overall Study|Adverse Event|7|||
125229476|NCT03533751|450468059|FG002|Overall Study|Adverse Event|2|||
125229477|NCT03533751|450468060|FG003|Overall Study|Adverse Event|4|||
125229478|NCT03533751|450468061|FG004|Overall Study|Adverse Event|5|||
125229479|NCT03533751|450468057|FG000|Overall Study|Physician Decision|0|||
125229480|NCT03533751|450468058|FG001|Overall Study|Physician Decision|2|||
125229481|NCT03533751|450468059|FG002|Overall Study|Physician Decision|1|||
125229482|NCT03533751|450468060|FG003|Overall Study|Physician Decision|2|||
125229483|NCT03533751|450468061|FG004|Overall Study|Physician Decision|1|||
125229484|NCT03533751|450468057|FG000|Overall Study|Sponsor Decision|0|||
125229485|NCT03533751|450468058|FG001|Overall Study|Sponsor Decision|0|||
125229486|NCT03533751|450468059|FG002|Overall Study|Sponsor Decision|1|||
125229487|NCT03533751|450468060|FG003|Overall Study|Sponsor Decision|1|||
125229488|NCT03533751|450468061|FG004|Overall Study|Sponsor Decision|0|||
125229489|NCT03533751|450468057|FG000|Overall Study|Lost to Follow-up|3|||
125229490|NCT03533751|450468058|FG001|Overall Study|Lost to Follow-up|7|||
125229491|NCT03533751|450468059|FG002|Overall Study|Lost to Follow-up|6|||
125229492|NCT03533751|450468060|FG003|Overall Study|Lost to Follow-up|4|||
125229493|NCT03533751|450468061|FG004|Overall Study|Lost to Follow-up|3|||
125229494|NCT03533751|450468057|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
125229495|NCT03533751|450468058|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
125229496|NCT03533751|450468059|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
125229497|NCT03533751|450468060|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
125229498|NCT03533751|450468061|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
125229499|NCT03533751|450468057|FG000|Overall Study|Other|0|||
125229500|NCT03533751|450468058|FG001|Overall Study|Other|2|||
125229501|NCT03533751|450468059|FG002|Overall Study|Other|1|||
125229502|NCT03533751|450468060|FG003|Overall Study|Other|0|||
125229503|NCT03533751|450468061|FG004|Overall Study|Other|3|||
125171502|NCT01200069|450251357|FG000|Overall Study|Withdrawal by Subject|0|||
125171503|NCT01200069|450251358|FG001|Overall Study|Withdrawal by Subject|1|||
125171504|NCT02883049|450251359|FG000|Induction|Adverse Event|52|||
125171505|NCT02883049|450251360|FG001|Induction|Adverse Event|2|||
125171506|NCT02883049|450251361|FG002|Induction|Adverse Event|0|||
125171507|NCT02883049|450251362|FG003|Induction|Adverse Event|0|||
125171508|NCT02883049|450251363|FG004|Induction|Adverse Event|0|||
125171509|NCT02883049|450251364|FG005|Induction|Adverse Event|0|||
125171510|NCT02883049|450251365|FG006|Induction|Adverse Event|0|||
125171511|NCT02883049|450251366|FG007|Induction|Adverse Event|0|||
125171512|NCT02883049|450251367|FG008|Induction|Adverse Event|0|||
125171513|NCT02883049|450251368|FG009|Induction|Adverse Event|0|||
125171514|NCT02883049|450251369|FG010|Induction|Adverse Event|0|||
125171515|NCT02883049|450251370|FG011|Induction|Adverse Event|0|||
125171516|NCT02883049|450251371|FG012|Induction|Adverse Event|0|||
125171517|NCT02883049|450251372|FG013|Induction|Adverse Event|0|||
125171518|NCT02883049|450251373|FG014|Induction|Adverse Event|0|||
125171519|NCT02883049|450251374|FG015|Induction|Adverse Event|0|||
125171520|NCT02883049|450251359|FG000|Induction|Death|76|||
125171521|NCT02883049|450251360|FG001|Induction|Death|8|||
125171522|NCT02883049|450251361|FG002|Induction|Death|0|||
125171523|NCT02883049|450251362|FG003|Induction|Death|0|||
125171524|NCT02883049|450251363|FG004|Induction|Death|0|||
125171525|NCT02883049|450251364|FG005|Induction|Death|0|||
125171526|NCT02883049|450251365|FG006|Induction|Death|0|||
125171527|NCT02883049|450251366|FG007|Induction|Death|0|||
125171528|NCT02883049|450251367|FG008|Induction|Death|0|||
125171529|NCT02883049|450251368|FG009|Induction|Death|0|||
125171530|NCT02883049|450251369|FG010|Induction|Death|0|||
125171531|NCT02883049|450251370|FG011|Induction|Death|0|||
125171532|NCT02883049|450251371|FG012|Induction|Death|0|||
125171533|NCT02883049|450251372|FG013|Induction|Death|0|||
125171534|NCT02883049|450251373|FG014|Induction|Death|0|||
125171535|NCT02883049|450251374|FG015|Induction|Death|0|||
125171536|NCT02883049|450251359|FG000|Induction|Lost to Follow-up|2|||
125171537|NCT02883049|450251360|FG001|Induction|Lost to Follow-up|0|||
125171538|NCT02883049|450251361|FG002|Induction|Lost to Follow-up|0|||
125171539|NCT02883049|450251362|FG003|Induction|Lost to Follow-up|0|||
125171540|NCT02883049|450251363|FG004|Induction|Lost to Follow-up|0|||
125171541|NCT02883049|450251364|FG005|Induction|Lost to Follow-up|0|||
125171542|NCT02883049|450251365|FG006|Induction|Lost to Follow-up|0|||
125171543|NCT02883049|450251366|FG007|Induction|Lost to Follow-up|0|||
125171544|NCT02883049|450251367|FG008|Induction|Lost to Follow-up|0|||
125171545|NCT02883049|450251368|FG009|Induction|Lost to Follow-up|0|||
125171546|NCT02883049|450251369|FG010|Induction|Lost to Follow-up|0|||
125171547|NCT02883049|450251370|FG011|Induction|Lost to Follow-up|0|||
125171548|NCT02883049|450251371|FG012|Induction|Lost to Follow-up|0|||
125171549|NCT02883049|450251372|FG013|Induction|Lost to Follow-up|0|||
125171550|NCT02883049|450251373|FG014|Induction|Lost to Follow-up|0|||
125171551|NCT02883049|450251374|FG015|Induction|Lost to Follow-up|0|||
125171552|NCT02883049|450251359|FG000|Induction|Physician Decision|1407|||
125171553|NCT02883049|450251360|FG001|Induction|Physician Decision|8|||
125171554|NCT02883049|450251361|FG002|Induction|Physician Decision|0|||
125171555|NCT02883049|450251362|FG003|Induction|Physician Decision|0|||
125171556|NCT02883049|450251363|FG004|Induction|Physician Decision|0|||
125171557|NCT02883049|450251364|FG005|Induction|Physician Decision|0|||
125171558|NCT02883049|450251365|FG006|Induction|Physician Decision|0|||
125171559|NCT02883049|450251366|FG007|Induction|Physician Decision|0|||
125171560|NCT02883049|450251367|FG008|Induction|Physician Decision|0|||
125171561|NCT02883049|450251368|FG009|Induction|Physician Decision|0|||
125171562|NCT02883049|450251369|FG010|Induction|Physician Decision|0|||
125171563|NCT02883049|450251370|FG011|Induction|Physician Decision|0|||
125171564|NCT02883049|450251371|FG012|Induction|Physician Decision|0|||
125171565|NCT02883049|450251372|FG013|Induction|Physician Decision|0|||
125171566|NCT02883049|450251373|FG014|Induction|Physician Decision|0|||
125443388|NCT01671748|451250868|FG001|4 Week run-in Phase|Not eligible|0|||
125443389|NCT02555371|451252128|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
125443390|NCT02555371|451252129|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
125443391|NCT02555371|451252130|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
125171567|NCT02883049|450251374|FG015|Induction|Physician Decision|0|||
125171568|NCT02883049|450251359|FG000|Induction|Protocol Violation|6|||
125171569|NCT02883049|450251360|FG001|Induction|Protocol Violation|0|||
125171570|NCT02883049|450251361|FG002|Induction|Protocol Violation|0|||
125229504|NCT05117060|450468062|FG000|Overall Study|Adverse Event|3|||
125171571|NCT02883049|450251362|FG003|Induction|Protocol Violation|0|||
125171572|NCT02883049|450251363|FG004|Induction|Protocol Violation|0|||
125171573|NCT02883049|450251364|FG005|Induction|Protocol Violation|0|||
125171574|NCT02883049|450251365|FG006|Induction|Protocol Violation|0|||
125171575|NCT02883049|450251366|FG007|Induction|Protocol Violation|0|||
125171576|NCT02883049|450251367|FG008|Induction|Protocol Violation|0|||
125171577|NCT02883049|450251368|FG009|Induction|Protocol Violation|0|||
125171578|NCT02883049|450251369|FG010|Induction|Protocol Violation|0|||
125171579|NCT02883049|450251370|FG011|Induction|Protocol Violation|0|||
125171580|NCT02883049|450251371|FG012|Induction|Protocol Violation|0|||
125229505|NCT05117060|450468063|FG001|Overall Study|Adverse Event|5|||
125229506|NCT05117060|450468064|FG002|Overall Study|Adverse Event|6|||
125229507|NCT05117060|450468065|FG003|Overall Study|Adverse Event|1|||
125229508|NCT05117060|450468062|FG000|Overall Study|Lost to Follow-up|0|||
125229509|NCT05117060|450468063|FG001|Overall Study|Lost to Follow-up|0|||
125229510|NCT05117060|450468064|FG002|Overall Study|Lost to Follow-up|0|||
125229511|NCT05117060|450468065|FG003|Overall Study|Lost to Follow-up|1|||
125229512|NCT05117060|450468062|FG000|Overall Study|Lack of Efficacy|4|||
125229513|NCT05117060|450468063|FG001|Overall Study|Lack of Efficacy|5|||
125229514|NCT05117060|450468064|FG002|Overall Study|Lack of Efficacy|2|||
125229515|NCT05117060|450468065|FG003|Overall Study|Lack of Efficacy|6|||
125229516|NCT05117060|450468062|FG000|Overall Study|Withdrawal by Subject|8|||
125229517|NCT05117060|450468063|FG001|Overall Study|Withdrawal by Subject|5|||
125229518|NCT05117060|450468064|FG002|Overall Study|Withdrawal by Subject|5|||
125229519|NCT05117060|450468065|FG003|Overall Study|Withdrawal by Subject|6|||
125443392|NCT02555371|451252131|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
125229520|NCT05117060|450468062|FG000|Overall Study|Other|2|||
125229521|NCT05117060|450468063|FG001|Overall Study|Other|1|||
125229522|NCT05117060|450468064|FG002|Overall Study|Other|3|||
125229523|NCT05117060|450468065|FG003|Overall Study|Other|1|||
125229524|NCT04158219|450468066|FG000|Overall Study|Lost to Follow-up|1|||
125229525|NCT05965752|450468067|FG000|Overall Study|Adverse Event|0|||
125229526|NCT05965752|450468068|FG001|Overall Study|Adverse Event|1|||
125229527|NCT05965752|450468069|FG002|Overall Study|Adverse Event|0|||
125443393|NCT02555371|451252132|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
125171581|NCT02883049|450251372|FG013|Induction|Protocol Violation|0|||
125171582|NCT02883049|450251373|FG014|Induction|Protocol Violation|0|||
125229528|NCT05965752|450468070|FG003|Overall Study|Adverse Event|1|||
125229529|NCT05965752|450468071|FG004|Overall Study|Adverse Event|3|||
125229530|NCT05965752|450468067|FG000|Overall Study|Lost to Follow-up|2|||
125229531|NCT05965752|450468068|FG001|Overall Study|Lost to Follow-up|0|||
125229532|NCT05965752|450468069|FG002|Overall Study|Lost to Follow-up|1|||
125229533|NCT05965752|450468070|FG003|Overall Study|Lost to Follow-up|1|||
125229534|NCT05965752|450468071|FG004|Overall Study|Lost to Follow-up|1|||
125229535|NCT05965752|450468067|FG000|Overall Study|Withdrawal by Subject|2|||
125229536|NCT05965752|450468068|FG001|Overall Study|Withdrawal by Subject|2|||
125229537|NCT05965752|450468069|FG002|Overall Study|Withdrawal by Subject|1|||
125229538|NCT05965752|450468070|FG003|Overall Study|Withdrawal by Subject|5|||
125229539|NCT05965752|450468071|FG004|Overall Study|Withdrawal by Subject|0|||
125229540|NCT05965752|450468067|FG000|Overall Study|Disease Relapse|1|||
125229541|NCT05965752|450468068|FG001|Overall Study|Disease Relapse|0|||
125229542|NCT05965752|450468069|FG002|Overall Study|Disease Relapse|1|||
125229543|NCT05965752|450468070|FG003|Overall Study|Disease Relapse|0|||
125229544|NCT05965752|450468071|FG004|Overall Study|Disease Relapse|0|||
125229545|NCT05965752|450468067|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
125229546|NCT05965752|450468068|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
125171583|NCT02883049|450251374|FG015|Induction|Protocol Violation|0|||
125171584|NCT02883049|450251359|FG000|Induction|Withdrawal by Subject|6|||
125171585|NCT02883049|450251360|FG001|Induction|Withdrawal by Subject|0|||
125171586|NCT02883049|450251361|FG002|Induction|Withdrawal by Subject|0|||
125171587|NCT02883049|450251362|FG003|Induction|Withdrawal by Subject|0|||
125171588|NCT02883049|450251363|FG004|Induction|Withdrawal by Subject|0|||
125171589|NCT02883049|450251364|FG005|Induction|Withdrawal by Subject|0|||
125171590|NCT02883049|450251365|FG006|Induction|Withdrawal by Subject|0|||
125171591|NCT02883049|450251366|FG007|Induction|Withdrawal by Subject|0|||
125171592|NCT02883049|450251367|FG008|Induction|Withdrawal by Subject|0|||
125171593|NCT02883049|450251368|FG009|Induction|Withdrawal by Subject|0|||
125229547|NCT05965752|450468069|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
125229548|NCT05965752|450468070|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
125229549|NCT05965752|450468071|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
125229550|NCT05965752|450468067|FG000|Overall Study|Unable to Return for Study Visits|0|||
125229551|NCT05965752|450468068|FG001|Overall Study|Unable to Return for Study Visits|1|||
125229552|NCT05965752|450468069|FG002|Overall Study|Unable to Return for Study Visits|0|||
125229553|NCT05965752|450468070|FG003|Overall Study|Unable to Return for Study Visits|3|||
125229554|NCT05965752|450468071|FG004|Overall Study|Unable to Return for Study Visits|1|||
125229555|NCT05965752|450468067|FG000|Overall Study|Early Termination|0|||
125229556|NCT05965752|450468068|FG001|Overall Study|Early Termination|0|||
125229557|NCT05965752|450468069|FG002|Overall Study|Early Termination|1|||
125229558|NCT05965752|450468070|FG003|Overall Study|Early Termination|0|||
125229559|NCT05965752|450468071|FG004|Overall Study|Early Termination|0|||
125229560|NCT05965752|450468067|FG000|Overall Study|Reported Unwanted Symptoms|0|||
125443394|NCT02555371|451252128|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
125171594|NCT02883049|450251369|FG010|Induction|Withdrawal by Subject|0|||
125229561|NCT05965752|450468068|FG001|Overall Study|Reported Unwanted Symptoms|0|||
125229562|NCT05965752|450468069|FG002|Overall Study|Reported Unwanted Symptoms|0|||
125229563|NCT05965752|450468070|FG003|Overall Study|Reported Unwanted Symptoms|0|||
125171595|NCT02883049|450251370|FG011|Induction|Withdrawal by Subject|0|||
125171596|NCT02883049|450251371|FG012|Induction|Withdrawal by Subject|0|||
125171597|NCT02883049|450251372|FG013|Induction|Withdrawal by Subject|0|||
125171598|NCT02883049|450251373|FG014|Induction|Withdrawal by Subject|0|||
125171599|NCT02883049|450251374|FG015|Induction|Withdrawal by Subject|0|||
125171600|NCT02883049|450251359|FG000|Induction|Ineligible|35|||
125171601|NCT02883049|450251360|FG001|Induction|Ineligible|1|||
125171602|NCT02883049|450251361|FG002|Induction|Ineligible|0|||
125171603|NCT02883049|450251362|FG003|Induction|Ineligible|0|||
125171604|NCT02883049|450251363|FG004|Induction|Ineligible|0|||
125171605|NCT02883049|450251364|FG005|Induction|Ineligible|0|||
125171606|NCT02883049|450251365|FG006|Induction|Ineligible|0|||
125171607|NCT02883049|450251366|FG007|Induction|Ineligible|0|||
125171608|NCT02883049|450251367|FG008|Induction|Ineligible|0|||
125171609|NCT02883049|450251368|FG009|Induction|Ineligible|0|||
125171610|NCT02883049|450251369|FG010|Induction|Ineligible|0|||
125171611|NCT02883049|450251370|FG011|Induction|Ineligible|0|||
125171612|NCT02883049|450251371|FG012|Induction|Ineligible|0|||
125171613|NCT02883049|450251372|FG013|Induction|Ineligible|0|||
125171614|NCT02883049|450251373|FG014|Induction|Ineligible|0|||
125171615|NCT02883049|450251374|FG015|Induction|Ineligible|0|||
125171616|NCT02883049|450251359|FG000|Induction|Refusal of further protocol therapy|466|||
125171617|NCT02883049|450251360|FG001|Induction|Refusal of further protocol therapy|2|||
125171618|NCT02883049|450251361|FG002|Induction|Refusal of further protocol therapy|0|||
125171619|NCT02883049|450251362|FG003|Induction|Refusal of further protocol therapy|0|||
125171620|NCT02883049|450251363|FG004|Induction|Refusal of further protocol therapy|0|||
125171621|NCT02883049|450251364|FG005|Induction|Refusal of further protocol therapy|0|||
125171622|NCT02883049|450251365|FG006|Induction|Refusal of further protocol therapy|0|||
125171623|NCT02883049|450251366|FG007|Induction|Refusal of further protocol therapy|0|||
125171624|NCT02883049|450251367|FG008|Induction|Refusal of further protocol therapy|0|||
125171625|NCT02883049|450251368|FG009|Induction|Refusal of further protocol therapy|0|||
125171626|NCT02883049|450251369|FG010|Induction|Refusal of further protocol therapy|0|||
125171627|NCT02883049|450251370|FG011|Induction|Refusal of further protocol therapy|0|||
125171628|NCT02883049|450251371|FG012|Induction|Refusal of further protocol therapy|0|||
125171629|NCT02883049|450251372|FG013|Induction|Refusal of further protocol therapy|0|||
125171630|NCT02883049|450251373|FG014|Induction|Refusal of further protocol therapy|0|||
125171631|NCT02883049|450251374|FG015|Induction|Refusal of further protocol therapy|0|||
125171632|NCT02883049|450251359|FG000|Induction|Identified as Ph+ patients|279|||
125171633|NCT02883049|450251360|FG001|Induction|Identified as Ph+ patients|1|||
125171634|NCT02883049|450251361|FG002|Induction|Identified as Ph+ patients|0|||
125171635|NCT02883049|450251362|FG003|Induction|Identified as Ph+ patients|0|||
125171636|NCT02883049|450251363|FG004|Induction|Identified as Ph+ patients|0|||
125171637|NCT02883049|450251364|FG005|Induction|Identified as Ph+ patients|0|||
125171638|NCT02883049|450251365|FG006|Induction|Identified as Ph+ patients|0|||
125171639|NCT02883049|450251366|FG007|Induction|Identified as Ph+ patients|0|||
125171640|NCT02883049|450251367|FG008|Induction|Identified as Ph+ patients|0|||
125171641|NCT02883049|450251368|FG009|Induction|Identified as Ph+ patients|0|||
125171642|NCT02883049|450251369|FG010|Induction|Identified as Ph+ patients|0|||
125171643|NCT02883049|450251370|FG011|Induction|Identified as Ph+ patients|0|||
125171644|NCT02883049|450251371|FG012|Induction|Identified as Ph+ patients|0|||
125171645|NCT02883049|450251372|FG013|Induction|Identified as Ph+ patients|0|||
125171646|NCT02883049|450251373|FG014|Induction|Identified as Ph+ patients|0|||
125171647|NCT02883049|450251374|FG015|Induction|Identified as Ph+ patients|0|||
125171648|NCT02883049|450251359|FG000|Induction|M3 Marrow at Day29|8|||
125171649|NCT02883049|450251360|FG001|Induction|M3 Marrow at Day29|1|||
125171650|NCT02883049|450251361|FG002|Induction|M3 Marrow at Day29|0|||
125171651|NCT02883049|450251362|FG003|Induction|M3 Marrow at Day29|0|||
125171652|NCT02883049|450251363|FG004|Induction|M3 Marrow at Day29|0|||
125229564|NCT05965752|450468071|FG004|Overall Study|Reported Unwanted Symptoms|1|||
125229565|NCT05965752|450468067|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
125229566|NCT05965752|450468068|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
125229567|NCT05965752|450468069|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
125229568|NCT05965752|450468070|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
125229569|NCT05965752|450468071|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
125229570|NCT02074514|450468072|FG000|Overall Study|Lack of Efficacy|3|||
125229571|NCT02074514|450468073|FG001|Overall Study|Lack of Efficacy|2|||
125229572|NCT02074514|450468072|FG000|Overall Study|Lost to Follow-up|0|||
125229573|NCT02074514|450468073|FG001|Overall Study|Lost to Follow-up|1|||
125229574|NCT02074514|450468072|FG000|Overall Study|Withdrew Consent|0|||
125229575|NCT02074514|450468073|FG001|Overall Study|Withdrew Consent|1|||
125229576|NCT01274351|450468074|FG000|Overall Study|Lost to Follow-up|1|||
125229577|NCT01274351|450468074|FG000|Overall Study|patient not compliant with the protocol|1|||
125229578|NCT01274351|450468074|FG000|Overall Study|Pregnancy|1|||
125229579|NCT01274351|450468074|FG000|Overall Study|Death|2|||
125229580|NCT01274351|450468074|FG000|Overall Study|Withdrawal by Subject|3|||
125229581|NCT01274351|450468074|FG000|Overall Study|Adverse Event|8|||
125229582|NCT01274351|450468074|FG000|Overall Study|progression of disease|3|||
125171653|NCT02883049|450251364|FG005|Induction|M3 Marrow at Day29|0|||
125171654|NCT02883049|450251365|FG006|Induction|M3 Marrow at Day29|0|||
125171655|NCT02883049|450251366|FG007|Induction|M3 Marrow at Day29|0|||
125171656|NCT02883049|450251367|FG008|Induction|M3 Marrow at Day29|0|||
125171657|NCT02883049|450251368|FG009|Induction|M3 Marrow at Day29|0|||
125171658|NCT02883049|450251369|FG010|Induction|M3 Marrow at Day29|0|||
125171659|NCT02883049|450251370|FG011|Induction|M3 Marrow at Day29|0|||
125171660|NCT02883049|450251371|FG012|Induction|M3 Marrow at Day29|0|||
125171661|NCT02883049|450251372|FG013|Induction|M3 Marrow at Day29|0|||
125171662|NCT02883049|450251373|FG014|Induction|M3 Marrow at Day29|0|||
125171663|NCT02883049|450251374|FG015|Induction|M3 Marrow at Day29|0|||
125229583|NCT01274351|450468074|FG000|Overall Study|hospitalization|1|||
125229584|NCT03312738|450469947|FG000|Overall Study|Progressive disease|58|||
125229585|NCT03312738|450469948|FG001|Overall Study|Progressive disease|67|||
125229586|NCT03312738|450469947|FG000|Overall Study|Patient/guardian decision|13|||
125229587|NCT03312738|450469948|FG001|Overall Study|Patient/guardian decision|5|||
125229588|NCT03312738|450469947|FG000|Overall Study|Adverse Event|5|||
125229589|NCT03312738|450469948|FG001|Overall Study|Adverse Event|3|||
125229590|NCT03312738|450469947|FG000|Overall Study|Protocol deviation|2|||
125229591|NCT03312738|450469948|FG001|Overall Study|Protocol deviation|0|||
125229592|NCT03312738|450469947|FG000|Overall Study|Technical problems|0|||
125229593|NCT03312738|450469948|FG001|Overall Study|Technical problems|1|||
125229594|NCT03312738|450469947|FG000|Overall Study|Physician Decision|2|||
125229595|NCT03312738|450469948|FG001|Overall Study|Physician Decision|3|||
125229596|NCT02466399|450469955|FG000|Overall Study|Adverse Event|1|||
125229597|NCT02466399|450469956|FG001|Overall Study|Adverse Event|0|||
125229598|NCT02466399|450469955|FG000|Overall Study|Early exit due to family emergency|1|||
125229599|NCT02466399|450469956|FG001|Overall Study|Early exit due to family emergency|0|||
125229600|NCT03408899|450469957|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
125229601|NCT00606008|450469958|FG000|Overall Study|Adverse Event|1|||
125229602|NCT00606008|450469958|FG000|Overall Study|Withdrawal by Subject|4|||
125229603|NCT02014272|450469959|FG000|Intervention Period 1|Withdrawal by Subject|1|||
125229604|NCT02014272|450469960|FG001|Intervention Period 1|Withdrawal by Subject|0|||
125229605|NCT02014272|450469959|FG000|Intervention Period 1|Adverse Event|0|||
125229606|NCT02014272|450469960|FG001|Intervention Period 1|Adverse Event|1|||
125229607|NCT01863771|450469961|FG000|Induction Phase|Adverse Event|9|||
125229608|NCT01863771|450469962|FG001|Induction Phase|Adverse Event|0|||
125229609|NCT01863771|450469963|FG002|Induction Phase|Adverse Event|0|||
125229610|NCT01863771|450469964|FG003|Induction Phase|Adverse Event|0|||
125229611|NCT01863771|450469961|FG000|Induction Phase|Lack of Efficacy|10|||
125229612|NCT01863771|450469962|FG001|Induction Phase|Lack of Efficacy|0|||
125229613|NCT01863771|450469963|FG002|Induction Phase|Lack of Efficacy|0|||
125229614|NCT01863771|450469964|FG003|Induction Phase|Lack of Efficacy|0|||
125229615|NCT01863771|450469961|FG000|Induction Phase|Withdrawal by Subject|2|||
125229616|NCT01863771|450469962|FG001|Induction Phase|Withdrawal by Subject|0|||
125229617|NCT01863771|450469963|FG002|Induction Phase|Withdrawal by Subject|0|||
125229618|NCT01863771|450469964|FG003|Induction Phase|Withdrawal by Subject|0|||
125171664|NCT02883049|450251359|FG000|Induction|Inevaluable|33|||
125171665|NCT02883049|450251360|FG001|Induction|Inevaluable|1|||
125171666|NCT02883049|450251361|FG002|Induction|Inevaluable|0|||
125171667|NCT02883049|450251362|FG003|Induction|Inevaluable|0|||
125171668|NCT02883049|450251363|FG004|Induction|Inevaluable|0|||
125171669|NCT02883049|450251364|FG005|Induction|Inevaluable|0|||
125171670|NCT02883049|450251365|FG006|Induction|Inevaluable|0|||
125171671|NCT02883049|450251366|FG007|Induction|Inevaluable|0|||
125171672|NCT02883049|450251367|FG008|Induction|Inevaluable|0|||
125171673|NCT02883049|450251368|FG009|Induction|Inevaluable|0|||
125171674|NCT02883049|450251369|FG010|Induction|Inevaluable|0|||
125171675|NCT02883049|450251370|FG011|Induction|Inevaluable|0|||
125171676|NCT02883049|450251371|FG012|Induction|Inevaluable|0|||
125171677|NCT02883049|450251372|FG013|Induction|Inevaluable|0|||
125171678|NCT02883049|450251373|FG014|Induction|Inevaluable|0|||
125171679|NCT02883049|450251374|FG015|Induction|Inevaluable|0|||
125171680|NCT02883049|450251359|FG000|Induction|Identified as VHR at end of Induction|244|||
125171681|NCT02883049|450251360|FG001|Induction|Identified as VHR at end of Induction|0|||
125171682|NCT02883049|450251361|FG002|Induction|Identified as VHR at end of Induction|0|||
125171683|NCT02883049|450251362|FG003|Induction|Identified as VHR at end of Induction|0|||
125171684|NCT02883049|450251363|FG004|Induction|Identified as VHR at end of Induction|0|||
125171685|NCT02883049|450251364|FG005|Induction|Identified as VHR at end of Induction|0|||
125229619|NCT01863771|450469961|FG000|Maintenance Phase|Adverse Event|0|||
125229620|NCT01863771|450469962|FG001|Maintenance Phase|Adverse Event|0|||
125229621|NCT01863771|450469963|FG002|Maintenance Phase|Adverse Event|1|||
125229622|NCT01863771|450469964|FG003|Maintenance Phase|Adverse Event|1|||
125171686|NCT02883049|450251365|FG006|Induction|Identified as VHR at end of Induction|0|||
125171687|NCT02883049|450251366|FG007|Induction|Identified as VHR at end of Induction|0|||
125171688|NCT02883049|450251367|FG008|Induction|Identified as VHR at end of Induction|0|||
125171689|NCT02883049|450251368|FG009|Induction|Identified as VHR at end of Induction|0|||
125229623|NCT01863771|450469961|FG000|Maintenance Phase|Lack of Efficacy|0|||
125229624|NCT01863771|450469962|FG001|Maintenance Phase|Lack of Efficacy|3|||
125171690|NCT02883049|450251369|FG010|Induction|Identified as VHR at end of Induction|0|||
125171691|NCT02883049|450251370|FG011|Induction|Identified as VHR at end of Induction|0|||
125171692|NCT02883049|450251371|FG012|Induction|Identified as VHR at end of Induction|0|||
125171693|NCT02883049|450251372|FG013|Induction|Identified as VHR at end of Induction|0|||
125171694|NCT02883049|450251373|FG014|Induction|Identified as VHR at end of Induction|0|||
125171695|NCT02883049|450251374|FG015|Induction|Identified as VHR at end of Induction|0|||
125171696|NCT02883049|450251359|FG000|Induction|Moved to another non-COG institution|3|||
125171697|NCT02883049|450251360|FG001|Induction|Moved to another non-COG institution|0|||
125171698|NCT02883049|450251361|FG002|Induction|Moved to another non-COG institution|0|||
125171699|NCT02883049|450251362|FG003|Induction|Moved to another non-COG institution|0|||
125171700|NCT02883049|450251363|FG004|Induction|Moved to another non-COG institution|0|||
125171701|NCT02883049|450251364|FG005|Induction|Moved to another non-COG institution|0|||
125171702|NCT02883049|450251365|FG006|Induction|Moved to another non-COG institution|0|||
125171703|NCT02883049|450251366|FG007|Induction|Moved to another non-COG institution|0|||
125171704|NCT02883049|450251367|FG008|Induction|Moved to another non-COG institution|0|||
125171705|NCT02883049|450251368|FG009|Induction|Moved to another non-COG institution|0|||
125171706|NCT02883049|450251369|FG010|Induction|Moved to another non-COG institution|0|||
125171707|NCT02883049|450251370|FG011|Induction|Moved to another non-COG institution|0|||
125171708|NCT02883049|450251371|FG012|Induction|Moved to another non-COG institution|0|||
125171709|NCT02883049|450251372|FG013|Induction|Moved to another non-COG institution|0|||
125171710|NCT02883049|450251373|FG014|Induction|Moved to another non-COG institution|0|||
125171711|NCT02883049|450251374|FG015|Induction|Moved to another non-COG institution|0|||
125171712|NCT02883049|450251359|FG000|Induction|Randomization closed|41|||
125171713|NCT02883049|450251360|FG001|Induction|Randomization closed|0|||
125171714|NCT02883049|450251361|FG002|Induction|Randomization closed|0|||
125171715|NCT02883049|450251362|FG003|Induction|Randomization closed|0|||
125171716|NCT02883049|450251363|FG004|Induction|Randomization closed|0|||
125171717|NCT02883049|450251364|FG005|Induction|Randomization closed|0|||
125171718|NCT02883049|450251365|FG006|Induction|Randomization closed|0|||
125171719|NCT02883049|450251366|FG007|Induction|Randomization closed|0|||
125171720|NCT02883049|450251367|FG008|Induction|Randomization closed|0|||
125171721|NCT02883049|450251368|FG009|Induction|Randomization closed|0|||
125171722|NCT02883049|450251369|FG010|Induction|Randomization closed|0|||
125171723|NCT02883049|450251370|FG011|Induction|Randomization closed|0|||
125171724|NCT02883049|450251371|FG012|Induction|Randomization closed|0|||
125171725|NCT02883049|450251372|FG013|Induction|Randomization closed|0|||
125171726|NCT02883049|450251373|FG014|Induction|Randomization closed|0|||
125171727|NCT02883049|450251374|FG015|Induction|Randomization closed|0|||
125171728|NCT02883049|450251359|FG000|Induction|MRD negative|36|||
125171729|NCT02883049|450251360|FG001|Induction|MRD negative|0|||
125171730|NCT02883049|450251361|FG002|Induction|MRD negative|0|||
125171731|NCT02883049|450251362|FG003|Induction|MRD negative|0|||
125171732|NCT02883049|450251363|FG004|Induction|MRD negative|0|||
125171733|NCT02883049|450251364|FG005|Induction|MRD negative|0|||
125171734|NCT02883049|450251365|FG006|Induction|MRD negative|0|||
125171735|NCT02883049|450251366|FG007|Induction|MRD negative|0|||
125171736|NCT02883049|450251367|FG008|Induction|MRD negative|0|||
125171737|NCT02883049|450251368|FG009|Induction|MRD negative|0|||
125171738|NCT02883049|450251369|FG010|Induction|MRD negative|0|||
125171739|NCT02883049|450251370|FG011|Induction|MRD negative|0|||
125171740|NCT02883049|450251371|FG012|Induction|MRD negative|0|||
125171741|NCT02883049|450251372|FG013|Induction|MRD negative|0|||
125171742|NCT02883049|450251373|FG014|Induction|MRD negative|0|||
125171743|NCT02883049|450251374|FG015|Induction|MRD negative|0|||
125171744|NCT02883049|450251359|FG000|Induction|Identified as HR patients|165|||
125171745|NCT02883049|450251360|FG001|Induction|Identified as HR patients|0|||
125171746|NCT02883049|450251361|FG002|Induction|Identified as HR patients|0|||
125171747|NCT02883049|450251362|FG003|Induction|Identified as HR patients|0|||
125171748|NCT02883049|450251363|FG004|Induction|Identified as HR patients|0|||
125171749|NCT02883049|450251364|FG005|Induction|Identified as HR patients|0|||
125171750|NCT02883049|450251365|FG006|Induction|Identified as HR patients|0|||
125171751|NCT02883049|450251366|FG007|Induction|Identified as HR patients|0|||
125171752|NCT02883049|450251367|FG008|Induction|Identified as HR patients|0|||
125171753|NCT02883049|450251368|FG009|Induction|Identified as HR patients|0|||
125171754|NCT02883049|450251369|FG010|Induction|Identified as HR patients|0|||
125171755|NCT02883049|450251370|FG011|Induction|Identified as HR patients|0|||
125171756|NCT02883049|450251371|FG012|Induction|Identified as HR patients|0|||
125171757|NCT02883049|450251372|FG013|Induction|Identified as HR patients|0|||
125171758|NCT02883049|450251373|FG014|Induction|Identified as HR patients|0|||
125171759|NCT02883049|450251374|FG015|Induction|Identified as HR patients|0|||
125171760|NCT02883049|450251359|FG000|Induction|Developed SMN|0|||
125171761|NCT02883049|450251360|FG001|Induction|Developed SMN|1|||
125171762|NCT02883049|450251361|FG002|Induction|Developed SMN|0|||
125171763|NCT02883049|450251362|FG003|Induction|Developed SMN|0|||
125171764|NCT02883049|450251363|FG004|Induction|Developed SMN|0|||
125171765|NCT02883049|450251364|FG005|Induction|Developed SMN|0|||
125171766|NCT02883049|450251365|FG006|Induction|Developed SMN|0|||
125171767|NCT02883049|450251366|FG007|Induction|Developed SMN|0|||
125171768|NCT02883049|450251367|FG008|Induction|Developed SMN|0|||
125171769|NCT02883049|450251368|FG009|Induction|Developed SMN|0|||
125171770|NCT02883049|450251369|FG010|Induction|Developed SMN|0|||
125171771|NCT02883049|450251370|FG011|Induction|Developed SMN|0|||
125171772|NCT02883049|450251371|FG012|Induction|Developed SMN|0|||
125171773|NCT02883049|450251372|FG013|Induction|Developed SMN|0|||
125171774|NCT02883049|450251373|FG014|Induction|Developed SMN|0|||
125171775|NCT02883049|450251374|FG015|Induction|Developed SMN|0|||
125171776|NCT02883049|450251359|FG000|Induction|Enrolled onto another COG study|72|||
125171777|NCT02883049|450251360|FG001|Induction|Enrolled onto another COG study|0|||
125171778|NCT02883049|450251361|FG002|Induction|Enrolled onto another COG study|0|||
125171779|NCT02883049|450251362|FG003|Induction|Enrolled onto another COG study|0|||
125171780|NCT02883049|450251363|FG004|Induction|Enrolled onto another COG study|0|||
125171781|NCT02883049|450251364|FG005|Induction|Enrolled onto another COG study|0|||
125171782|NCT02883049|450251365|FG006|Induction|Enrolled onto another COG study|0|||
125171783|NCT02883049|450251366|FG007|Induction|Enrolled onto another COG study|0|||
125171784|NCT02883049|450251367|FG008|Induction|Enrolled onto another COG study|0|||
125171785|NCT02883049|450251368|FG009|Induction|Enrolled onto another COG study|0|||
125171786|NCT02883049|450251369|FG010|Induction|Enrolled onto another COG study|0|||
125171787|NCT02883049|450251370|FG011|Induction|Enrolled onto another COG study|0|||
125171788|NCT02883049|450251371|FG012|Induction|Enrolled onto another COG study|0|||
125171789|NCT02883049|450251372|FG013|Induction|Enrolled onto another COG study|0|||
125171790|NCT02883049|450251373|FG014|Induction|Enrolled onto another COG study|0|||
125171791|NCT02883049|450251374|FG015|Induction|Enrolled onto another COG study|0|||
125171792|NCT02883049|450251359|FG000|Induction|Incomplete induction data|17|||
125171793|NCT02883049|450251360|FG001|Induction|Incomplete induction data|0|||
125171794|NCT02883049|450251361|FG002|Induction|Incomplete induction data|0|||
125171795|NCT02883049|450251362|FG003|Induction|Incomplete induction data|0|||
125171796|NCT02883049|450251363|FG004|Induction|Incomplete induction data|0|||
125171797|NCT02883049|450251364|FG005|Induction|Incomplete induction data|0|||
125171798|NCT02883049|450251365|FG006|Induction|Incomplete induction data|0|||
125171799|NCT02883049|450251366|FG007|Induction|Incomplete induction data|0|||
125171800|NCT02883049|450251367|FG008|Induction|Incomplete induction data|0|||
125171801|NCT02883049|450251368|FG009|Induction|Incomplete induction data|0|||
125171802|NCT02883049|450251369|FG010|Induction|Incomplete induction data|0|||
125171803|NCT02883049|450251370|FG011|Induction|Incomplete induction data|0|||
125171804|NCT02883049|450251371|FG012|Induction|Incomplete induction data|0|||
125171805|NCT02883049|450251372|FG013|Induction|Incomplete induction data|0|||
125171806|NCT02883049|450251373|FG014|Induction|Incomplete induction data|0|||
125171807|NCT02883049|450251374|FG015|Induction|Incomplete induction data|0|||
125171808|NCT02883049|450251359|FG000|Post Induction|Adverse Event|0|||
125171809|NCT02883049|450251360|FG001|Post Induction|Adverse Event|0|||
125171810|NCT02883049|450251361|FG002|Post Induction|Adverse Event|0|||
125171811|NCT02883049|450251362|FG003|Post Induction|Adverse Event|7|||
125171812|NCT02883049|450251363|FG004|Post Induction|Adverse Event|8|||
125171813|NCT02883049|450251364|FG005|Post Induction|Adverse Event|3|||
125171814|NCT02883049|450251365|FG006|Post Induction|Adverse Event|4|||
125171815|NCT02883049|450251366|FG007|Post Induction|Adverse Event|5|||
125171816|NCT02883049|450251367|FG008|Post Induction|Adverse Event|6|||
125171817|NCT02883049|450251368|FG009|Post Induction|Adverse Event|7|||
125171818|NCT02883049|450251369|FG010|Post Induction|Adverse Event|2|||
125171819|NCT02883049|450251370|FG011|Post Induction|Adverse Event|2|||
125171820|NCT02883049|450251371|FG012|Post Induction|Adverse Event|0|||
125171821|NCT02883049|450251372|FG013|Post Induction|Adverse Event|0|||
125171822|NCT02883049|450251373|FG014|Post Induction|Adverse Event|5|||
125171823|NCT02883049|450251374|FG015|Post Induction|Adverse Event|2|||
125171824|NCT02883049|450251359|FG000|Post Induction|Death|0|||
125171825|NCT02883049|450251360|FG001|Post Induction|Death|0|||
125171826|NCT02883049|450251361|FG002|Post Induction|Death|0|||
125171827|NCT02883049|450251362|FG003|Post Induction|Death|9|||
125171828|NCT02883049|450251363|FG004|Post Induction|Death|9|||
125171829|NCT02883049|450251364|FG005|Post Induction|Death|0|||
125171830|NCT02883049|450251365|FG006|Post Induction|Death|1|||
125171831|NCT02883049|450251366|FG007|Post Induction|Death|6|||
125171832|NCT02883049|450251367|FG008|Post Induction|Death|5|||
125171833|NCT02883049|450251368|FG009|Post Induction|Death|3|||
125171834|NCT02883049|450251369|FG010|Post Induction|Death|1|||
125171835|NCT02883049|450251370|FG011|Post Induction|Death|0|||
125171836|NCT02883049|450251371|FG012|Post Induction|Death|1|||
125171837|NCT02883049|450251372|FG013|Post Induction|Death|1|||
125171838|NCT02883049|450251373|FG014|Post Induction|Death|10|||
125171839|NCT02883049|450251374|FG015|Post Induction|Death|2|||
125171840|NCT02883049|450251359|FG000|Post Induction|Lost to Follow-up|0|||
125171841|NCT02883049|450251360|FG001|Post Induction|Lost to Follow-up|0|||
125171842|NCT02883049|450251361|FG002|Post Induction|Lost to Follow-up|0|||
125171843|NCT02883049|450251362|FG003|Post Induction|Lost to Follow-up|0|||
125171844|NCT02883049|450251363|FG004|Post Induction|Lost to Follow-up|1|||
125171845|NCT02883049|450251364|FG005|Post Induction|Lost to Follow-up|1|||
125171846|NCT02883049|450251365|FG006|Post Induction|Lost to Follow-up|0|||
125171847|NCT02883049|450251366|FG007|Post Induction|Lost to Follow-up|0|||
125171848|NCT02883049|450251367|FG008|Post Induction|Lost to Follow-up|3|||
125171849|NCT02883049|450251368|FG009|Post Induction|Lost to Follow-up|0|||
125171850|NCT02883049|450251369|FG010|Post Induction|Lost to Follow-up|1|||
125171851|NCT02883049|450251370|FG011|Post Induction|Lost to Follow-up|0|||
125171852|NCT02883049|450251371|FG012|Post Induction|Lost to Follow-up|0|||
125171853|NCT02883049|450251372|FG013|Post Induction|Lost to Follow-up|0|||
125171854|NCT02883049|450251373|FG014|Post Induction|Lost to Follow-up|0|||
125171855|NCT02883049|450251374|FG015|Post Induction|Lost to Follow-up|0|||
125171856|NCT02883049|450251359|FG000|Post Induction|Physician Decision|0|||
125171857|NCT02883049|450251360|FG001|Post Induction|Physician Decision|0|||
125171858|NCT02883049|450251361|FG002|Post Induction|Physician Decision|0|||
125171859|NCT02883049|450251362|FG003|Post Induction|Physician Decision|27|||
125171860|NCT02883049|450251363|FG004|Post Induction|Physician Decision|27|||
125171861|NCT02883049|450251364|FG005|Post Induction|Physician Decision|23|||
125171862|NCT02883049|450251365|FG006|Post Induction|Physician Decision|30|||
125171863|NCT02883049|450251366|FG007|Post Induction|Physician Decision|56|||
125171864|NCT02883049|450251367|FG008|Post Induction|Physician Decision|85|||
125171865|NCT02883049|450251368|FG009|Post Induction|Physician Decision|12|||
125171866|NCT02883049|450251369|FG010|Post Induction|Physician Decision|5|||
125171867|NCT02883049|450251370|FG011|Post Induction|Physician Decision|14|||
125171868|NCT02883049|450251371|FG012|Post Induction|Physician Decision|1|||
125171869|NCT02883049|450251372|FG013|Post Induction|Physician Decision|11|||
125171870|NCT02883049|450251373|FG014|Post Induction|Physician Decision|19|||
125229625|NCT01863771|450469963|FG002|Maintenance Phase|Lack of Efficacy|7|||
125229626|NCT01863771|450469964|FG003|Maintenance Phase|Lack of Efficacy|38|||
125229627|NCT01863771|450469961|FG000|Maintenance Phase|Physician Decision|0|||
125229628|NCT01863771|450469962|FG001|Maintenance Phase|Physician Decision|0|||
125229629|NCT01863771|450469963|FG002|Maintenance Phase|Physician Decision|2|||
125229630|NCT01863771|450469964|FG003|Maintenance Phase|Physician Decision|1|||
125229631|NCT01863771|450469961|FG000|Maintenance Phase|Pregnancy|0|||
125229632|NCT01863771|450469962|FG001|Maintenance Phase|Pregnancy|1|||
125229633|NCT01863771|450469963|FG002|Maintenance Phase|Pregnancy|0|||
125229634|NCT01863771|450469964|FG003|Maintenance Phase|Pregnancy|0|||
125229635|NCT01863771|450469961|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125229636|NCT01863771|450469962|FG001|Maintenance Phase|Withdrawal by Subject|1|||
125229637|NCT01863771|450469963|FG002|Maintenance Phase|Withdrawal by Subject|2|||
125229638|NCT01863771|450469964|FG003|Maintenance Phase|Withdrawal by Subject|3|||
125229639|NCT01218308|450469965|FG000|Overall Study|Adverse Event|1|||
125229640|NCT01218308|450469966|FG001|Overall Study|Adverse Event|2|||
125229641|NCT01218308|450469965|FG000|Overall Study|Protocol Violation|0|||
125229642|NCT01218308|450469966|FG001|Overall Study|Protocol Violation|2|||
125229643|NCT01218308|450469965|FG000|Overall Study|Withdrawal by Subject|61|||
125229644|NCT01218308|450469966|FG001|Overall Study|Withdrawal by Subject|64|||
125229645|NCT01218308|450469965|FG000|Overall Study|Lost to Follow-up|27|||
125229646|NCT01218308|450469966|FG001|Overall Study|Lost to Follow-up|31|||
125229647|NCT01218308|450469965|FG000|Overall Study|Other|14|||
125229648|NCT01218308|450469966|FG001|Overall Study|Other|21|||
125229649|NCT00547339|450469967|FG000|Overall Study|Physician Decision|0|||
125229650|NCT00547339|450469968|FG001|Overall Study|Physician Decision|0|||
125229651|NCT00547339|450469969|FG002|Overall Study|Physician Decision|1|||
125229652|NCT00547339|450469970|FG003|Overall Study|Physician Decision|0|||
125229653|NCT01248455|450469971|FG000|Overall Study|switched to alternate treatment|1|||
125229654|NCT01117870|450469972|FG000|Overall Study|Inability to place needle|1|||
125229655|NCT01117870|450469973|FG001|Overall Study|Inability to place needle|0|||
125229656|NCT01065818|450469974|FG000|Overall Study|Withdrawal by Subject|1|||
125229657|NCT01065818|450469974|FG000|Overall Study|Not a candidate for surgery|1|||
125229658|NCT00095979|450469980|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
125229659|NCT01079780|450469982|FG000|Overall Study|Disease progression|43|||
125229660|NCT01079780|450469983|FG001|Overall Study|Disease progression|7|||
125229661|NCT01079780|450469984|FG002|Overall Study|Disease progression|31|||
125229662|NCT01079780|450469982|FG000|Overall Study|Adverse Event|13|||
125229663|NCT01079780|450469983|FG001|Overall Study|Adverse Event|5|||
125229664|NCT01079780|450469984|FG002|Overall Study|Adverse Event|7|||
125229665|NCT01079780|450469982|FG000|Overall Study|Death|2|||
125229666|NCT01079780|450469983|FG001|Overall Study|Death|0|||
125229667|NCT01079780|450469984|FG002|Overall Study|Death|2|||
125229668|NCT01079780|450469982|FG000|Overall Study|Withdrawal by Subject|6|||
125229669|NCT01079780|450469983|FG001|Overall Study|Withdrawal by Subject|4|||
125229670|NCT01079780|450469984|FG002|Overall Study|Withdrawal by Subject|4|||
125229671|NCT01079780|450469982|FG000|Overall Study|Alternative therapy|2|||
125229672|NCT01079780|450469983|FG001|Overall Study|Alternative therapy|0|||
125229673|NCT01079780|450469984|FG002|Overall Study|Alternative therapy|2|||
125229674|NCT01079780|450469982|FG000|Overall Study|Physician Decision|1|||
125229675|NCT01079780|450469983|FG001|Overall Study|Physician Decision|0|||
125171871|NCT02883049|450251374|FG015|Post Induction|Physician Decision|5|||
125171872|NCT02883049|450251359|FG000|Post Induction|Protocol Violation|0|||
125171873|NCT02883049|450251360|FG001|Post Induction|Protocol Violation|0|||
125171874|NCT02883049|450251361|FG002|Post Induction|Protocol Violation|0|||
125171875|NCT02883049|450251362|FG003|Post Induction|Protocol Violation|0|||
125171876|NCT02883049|450251363|FG004|Post Induction|Protocol Violation|0|||
125171877|NCT02883049|450251364|FG005|Post Induction|Protocol Violation|0|||
125171878|NCT02883049|450251365|FG006|Post Induction|Protocol Violation|0|||
125229676|NCT01079780|450469984|FG002|Overall Study|Physician Decision|1|||
125229677|NCT01079780|450469982|FG000|Overall Study|Error made in lesion measurement|1|||
125229678|NCT01079780|450469983|FG001|Overall Study|Error made in lesion measurement|0|||
125229679|NCT01079780|450469984|FG002|Overall Study|Error made in lesion measurement|0|||
125229680|NCT01079780|450469982|FG000|Overall Study|Patient had surgery|1|||
125171879|NCT02883049|450251366|FG007|Post Induction|Protocol Violation|1|||
125171880|NCT02883049|450251367|FG008|Post Induction|Protocol Violation|0|||
125171881|NCT02883049|450251368|FG009|Post Induction|Protocol Violation|0|||
125171882|NCT02883049|450251369|FG010|Post Induction|Protocol Violation|0|||
125171883|NCT02883049|450251370|FG011|Post Induction|Protocol Violation|0|||
125171884|NCT02883049|450251371|FG012|Post Induction|Protocol Violation|0|||
125171885|NCT02883049|450251372|FG013|Post Induction|Protocol Violation|0|||
125171886|NCT02883049|450251373|FG014|Post Induction|Protocol Violation|0|||
125171887|NCT02883049|450251374|FG015|Post Induction|Protocol Violation|0|||
125171888|NCT02883049|450251359|FG000|Post Induction|Withdrawal by Subject|0|||
125171889|NCT02883049|450251360|FG001|Post Induction|Withdrawal by Subject|0|||
125171890|NCT02883049|450251361|FG002|Post Induction|Withdrawal by Subject|0|||
125171891|NCT02883049|450251362|FG003|Post Induction|Withdrawal by Subject|5|||
125171892|NCT02883049|450251363|FG004|Post Induction|Withdrawal by Subject|2|||
125171893|NCT02883049|450251364|FG005|Post Induction|Withdrawal by Subject|1|||
125171894|NCT02883049|450251365|FG006|Post Induction|Withdrawal by Subject|0|||
125171895|NCT02883049|450251366|FG007|Post Induction|Withdrawal by Subject|0|||
125171896|NCT02883049|450251367|FG008|Post Induction|Withdrawal by Subject|2|||
125171897|NCT02883049|450251368|FG009|Post Induction|Withdrawal by Subject|0|||
125171898|NCT02883049|450251369|FG010|Post Induction|Withdrawal by Subject|1|||
125171899|NCT02883049|450251370|FG011|Post Induction|Withdrawal by Subject|1|||
125171900|NCT02883049|450251371|FG012|Post Induction|Withdrawal by Subject|0|||
125171901|NCT02883049|450251372|FG013|Post Induction|Withdrawal by Subject|0|||
125171902|NCT02883049|450251373|FG014|Post Induction|Withdrawal by Subject|1|||
125171903|NCT02883049|450251374|FG015|Post Induction|Withdrawal by Subject|0|||
125171904|NCT02883049|450251359|FG000|Post Induction|Ineligible|0|||
125171905|NCT02883049|450251360|FG001|Post Induction|Ineligible|0|||
125171906|NCT02883049|450251361|FG002|Post Induction|Ineligible|2|||
125171907|NCT02883049|450251362|FG003|Post Induction|Ineligible|0|||
125171908|NCT02883049|450251363|FG004|Post Induction|Ineligible|0|||
125171909|NCT02883049|450251364|FG005|Post Induction|Ineligible|0|||
125171910|NCT02883049|450251365|FG006|Post Induction|Ineligible|1|||
125171911|NCT02883049|450251366|FG007|Post Induction|Ineligible|0|||
125171912|NCT02883049|450251367|FG008|Post Induction|Ineligible|0|||
125171913|NCT02883049|450251368|FG009|Post Induction|Ineligible|0|||
125171914|NCT02883049|450251369|FG010|Post Induction|Ineligible|1|||
125171915|NCT02883049|450251370|FG011|Post Induction|Ineligible|0|||
125171916|NCT02883049|450251371|FG012|Post Induction|Ineligible|0|||
125171917|NCT02883049|450251372|FG013|Post Induction|Ineligible|0|||
125171918|NCT02883049|450251373|FG014|Post Induction|Ineligible|0|||
125171919|NCT02883049|450251374|FG015|Post Induction|Ineligible|1|||
125171920|NCT02883049|450251359|FG000|Post Induction|Refusal of further protocol therapy|0|||
125171921|NCT02883049|450251360|FG001|Post Induction|Refusal of further protocol therapy|0|||
125171922|NCT02883049|450251361|FG002|Post Induction|Refusal of further protocol therapy|0|||
125171923|NCT02883049|450251362|FG003|Post Induction|Refusal of further protocol therapy|11|||
125171924|NCT02883049|450251363|FG004|Post Induction|Refusal of further protocol therapy|15|||
125171925|NCT02883049|450251364|FG005|Post Induction|Refusal of further protocol therapy|9|||
125171926|NCT02883049|450251365|FG006|Post Induction|Refusal of further protocol therapy|13|||
125171927|NCT02883049|450251366|FG007|Post Induction|Refusal of further protocol therapy|5|||
125171928|NCT02883049|450251367|FG008|Post Induction|Refusal of further protocol therapy|21|||
125171929|NCT02883049|450251368|FG009|Post Induction|Refusal of further protocol therapy|7|||
125229681|NCT01079780|450469983|FG001|Overall Study|Patient had surgery|0|||
125229682|NCT01079780|450469984|FG002|Overall Study|Patient had surgery|0|||
125229683|NCT01079780|450469982|FG000|Overall Study|Treatment cycle delay|0|||
125229684|NCT01079780|450469983|FG001|Overall Study|Treatment cycle delay|0|||
125229685|NCT01079780|450469984|FG002|Overall Study|Treatment cycle delay|1|||
125229686|NCT01079780|450469982|FG000|Overall Study|Never started treatment|1|||
125229687|NCT01079780|450469983|FG001|Overall Study|Never started treatment|0|||
125229688|NCT01079780|450469984|FG002|Overall Study|Never started treatment|2|||
125229689|NCT03322293|450469985|FG000|Overall Study|Lost to Follow-up|0|||
125229690|NCT03322293|450469986|FG001|Overall Study|Lost to Follow-up|0|||
125229691|NCT03322293|450469987|FG002|Overall Study|Lost to Follow-up|1|||
125171930|NCT02883049|450251369|FG010|Post Induction|Refusal of further protocol therapy|0|||
125171931|NCT02883049|450251370|FG011|Post Induction|Refusal of further protocol therapy|7|||
125171932|NCT02883049|450251371|FG012|Post Induction|Refusal of further protocol therapy|3|||
125171933|NCT02883049|450251372|FG013|Post Induction|Refusal of further protocol therapy|0|||
125171934|NCT02883049|450251373|FG014|Post Induction|Refusal of further protocol therapy|4|||
125171935|NCT02883049|450251374|FG015|Post Induction|Refusal of further protocol therapy|1|||
125485305|NCT03523572|451412494|FG002|Dose Expansion|Clinical Progression|2|||
125229692|NCT03435055|450469988|FG000|Screening|Physician Decision|2|||
125229693|NCT03435055|450469988|FG000|Received Intervention|Did not complete nitrous administration|3|||
125171936|NCT02883049|450251359|FG000|Post Induction|Inevaluable|0|||
125171937|NCT02883049|450251360|FG001|Post Induction|Inevaluable|0|||
125171938|NCT02883049|450251361|FG002|Post Induction|Inevaluable|0|||
125171939|NCT02883049|450251362|FG003|Post Induction|Inevaluable|1|||
125171940|NCT02883049|450251363|FG004|Post Induction|Inevaluable|1|||
125171941|NCT02883049|450251364|FG005|Post Induction|Inevaluable|2|||
125171942|NCT02883049|450251365|FG006|Post Induction|Inevaluable|7|||
125171943|NCT02883049|450251366|FG007|Post Induction|Inevaluable|6|||
125171944|NCT02883049|450251367|FG008|Post Induction|Inevaluable|4|||
125171945|NCT02883049|450251368|FG009|Post Induction|Inevaluable|4|||
125171946|NCT02883049|450251369|FG010|Post Induction|Inevaluable|1|||
125171947|NCT02883049|450251370|FG011|Post Induction|Inevaluable|1|||
125171948|NCT02883049|450251371|FG012|Post Induction|Inevaluable|2|||
125171949|NCT02883049|450251372|FG013|Post Induction|Inevaluable|0|||
125171950|NCT02883049|450251373|FG014|Post Induction|Inevaluable|0|||
125171951|NCT02883049|450251374|FG015|Post Induction|Inevaluable|1|||
125171952|NCT02883049|450251359|FG000|Post Induction|Moved to another non-COG institution|0|||
125171953|NCT02883049|450251360|FG001|Post Induction|Moved to another non-COG institution|0|||
125171954|NCT02883049|450251361|FG002|Post Induction|Moved to another non-COG institution|0|||
125171955|NCT02883049|450251362|FG003|Post Induction|Moved to another non-COG institution|0|||
125171956|NCT02883049|450251363|FG004|Post Induction|Moved to another non-COG institution|0|||
125171957|NCT02883049|450251364|FG005|Post Induction|Moved to another non-COG institution|0|||
125171958|NCT02883049|450251365|FG006|Post Induction|Moved to another non-COG institution|0|||
125171959|NCT02883049|450251366|FG007|Post Induction|Moved to another non-COG institution|2|||
125171960|NCT02883049|450251367|FG008|Post Induction|Moved to another non-COG institution|2|||
125171961|NCT02883049|450251368|FG009|Post Induction|Moved to another non-COG institution|0|||
125171962|NCT02883049|450251369|FG010|Post Induction|Moved to another non-COG institution|0|||
125171963|NCT02883049|450251370|FG011|Post Induction|Moved to another non-COG institution|1|||
125171964|NCT02883049|450251371|FG012|Post Induction|Moved to another non-COG institution|0|||
125171965|NCT02883049|450251372|FG013|Post Induction|Moved to another non-COG institution|0|||
125171966|NCT02883049|450251373|FG014|Post Induction|Moved to another non-COG institution|0|||
125171967|NCT02883049|450251374|FG015|Post Induction|Moved to another non-COG institution|0|||
125171968|NCT02883049|450251359|FG000|Post Induction|Randomization closed|0|||
125171969|NCT02883049|450251360|FG001|Post Induction|Randomization closed|0|||
125171970|NCT02883049|450251361|FG002|Post Induction|Randomization closed|0|||
125171971|NCT02883049|450251362|FG003|Post Induction|Randomization closed|0|||
125171972|NCT02883049|450251363|FG004|Post Induction|Randomization closed|0|||
125171973|NCT02883049|450251364|FG005|Post Induction|Randomization closed|0|||
125171974|NCT02883049|450251365|FG006|Post Induction|Randomization closed|0|||
125171975|NCT02883049|450251366|FG007|Post Induction|Randomization closed|20|||
125171976|NCT02883049|450251367|FG008|Post Induction|Randomization closed|0|||
125171977|NCT02883049|450251368|FG009|Post Induction|Randomization closed|0|||
125171978|NCT02883049|450251369|FG010|Post Induction|Randomization closed|0|||
125171979|NCT02883049|450251370|FG011|Post Induction|Randomization closed|0|||
125171980|NCT02883049|450251371|FG012|Post Induction|Randomization closed|0|||
125171981|NCT02883049|450251372|FG013|Post Induction|Randomization closed|0|||
125171982|NCT02883049|450251373|FG014|Post Induction|Randomization closed|0|||
125171983|NCT02883049|450251374|FG015|Post Induction|Randomization closed|0|||
125171984|NCT02883049|450251359|FG000|Post Induction|MRD negative|0|||
125171985|NCT02883049|450251360|FG001|Post Induction|MRD negative|0|||
125171986|NCT02883049|450251361|FG002|Post Induction|MRD negative|0|||
125171987|NCT02883049|450251362|FG003|Post Induction|MRD negative|0|||
125171988|NCT02883049|450251363|FG004|Post Induction|MRD negative|0|||
125171989|NCT02883049|450251364|FG005|Post Induction|MRD negative|0|||
125171990|NCT02883049|450251365|FG006|Post Induction|MRD negative|0|||
125171991|NCT02883049|450251366|FG007|Post Induction|MRD negative|11|||
125171992|NCT02883049|450251367|FG008|Post Induction|MRD negative|0|||
125171993|NCT02883049|450251368|FG009|Post Induction|MRD negative|0|||
125171994|NCT02883049|450251369|FG010|Post Induction|MRD negative|0|||
125171995|NCT02883049|450251370|FG011|Post Induction|MRD negative|0|||
125171996|NCT02883049|450251371|FG012|Post Induction|MRD negative|0|||
125171997|NCT02883049|450251372|FG013|Post Induction|MRD negative|0|||
125171998|NCT02883049|450251373|FG014|Post Induction|MRD negative|0|||
125171999|NCT02883049|450251374|FG015|Post Induction|MRD negative|0|||
125172000|NCT02883049|450251359|FG000|Post Induction|Developed SMN|0|||
125172001|NCT02883049|450251360|FG001|Post Induction|Developed SMN|0|||
125172002|NCT02883049|450251361|FG002|Post Induction|Developed SMN|0|||
125172003|NCT02883049|450251362|FG003|Post Induction|Developed SMN|0|||
125172004|NCT02883049|450251363|FG004|Post Induction|Developed SMN|1|||
125172005|NCT02883049|450251364|FG005|Post Induction|Developed SMN|0|||
125172006|NCT02883049|450251365|FG006|Post Induction|Developed SMN|1|||
125172007|NCT02883049|450251366|FG007|Post Induction|Developed SMN|0|||
125172008|NCT02883049|450251367|FG008|Post Induction|Developed SMN|0|||
125172009|NCT02883049|450251368|FG009|Post Induction|Developed SMN|0|||
125172010|NCT02883049|450251369|FG010|Post Induction|Developed SMN|1|||
125172011|NCT02883049|450251370|FG011|Post Induction|Developed SMN|1|||
125172012|NCT02883049|450251371|FG012|Post Induction|Developed SMN|0|||
125172013|NCT02883049|450251372|FG013|Post Induction|Developed SMN|0|||
125172014|NCT02883049|450251373|FG014|Post Induction|Developed SMN|1|||
125172015|NCT02883049|450251374|FG015|Post Induction|Developed SMN|0|||
125172016|NCT02883049|450251359|FG000|Post Induction|Enrolled onto another COG study|0|||
125172017|NCT02883049|450251360|FG001|Post Induction|Enrolled onto another COG study|0|||
125172018|NCT02883049|450251361|FG002|Post Induction|Enrolled onto another COG study|0|||
125172019|NCT02883049|450251362|FG003|Post Induction|Enrolled onto another COG study|1|||
125172020|NCT02883049|450251363|FG004|Post Induction|Enrolled onto another COG study|1|||
125172021|NCT02883049|450251364|FG005|Post Induction|Enrolled onto another COG study|0|||
125172022|NCT02883049|450251365|FG006|Post Induction|Enrolled onto another COG study|0|||
125172023|NCT02883049|450251366|FG007|Post Induction|Enrolled onto another COG study|4|||
125172024|NCT02883049|450251367|FG008|Post Induction|Enrolled onto another COG study|0|||
125172025|NCT02883049|450251368|FG009|Post Induction|Enrolled onto another COG study|0|||
125172026|NCT02883049|450251369|FG010|Post Induction|Enrolled onto another COG study|0|||
125172027|NCT02883049|450251370|FG011|Post Induction|Enrolled onto another COG study|2|||
125172028|NCT02883049|450251371|FG012|Post Induction|Enrolled onto another COG study|0|||
125172029|NCT02883049|450251372|FG013|Post Induction|Enrolled onto another COG study|1|||
125172030|NCT02883049|450251373|FG014|Post Induction|Enrolled onto another COG study|0|||
125172031|NCT02883049|450251374|FG015|Post Induction|Enrolled onto another COG study|0|||
125172032|NCT02883049|450251359|FG000|Post Induction|Recurrent leukemia|0|||
125172033|NCT02883049|450251360|FG001|Post Induction|Recurrent leukemia|0|||
125172034|NCT02883049|450251361|FG002|Post Induction|Recurrent leukemia|0|||
125172035|NCT02883049|450251362|FG003|Post Induction|Recurrent leukemia|17|||
125172036|NCT02883049|450251363|FG004|Post Induction|Recurrent leukemia|12|||
125172037|NCT02883049|450251364|FG005|Post Induction|Recurrent leukemia|4|||
125172038|NCT02883049|450251365|FG006|Post Induction|Recurrent leukemia|1|||
125172039|NCT02883049|450251366|FG007|Post Induction|Recurrent leukemia|13|||
125172040|NCT02883049|450251367|FG008|Post Induction|Recurrent leukemia|27|||
125172041|NCT02883049|450251368|FG009|Post Induction|Recurrent leukemia|5|||
125172042|NCT02883049|450251369|FG010|Post Induction|Recurrent leukemia|3|||
125172043|NCT02883049|450251370|FG011|Post Induction|Recurrent leukemia|12|||
125172044|NCT02883049|450251371|FG012|Post Induction|Recurrent leukemia|1|||
125172045|NCT02883049|450251372|FG013|Post Induction|Recurrent leukemia|1|||
125172046|NCT02883049|450251373|FG014|Post Induction|Recurrent leukemia|9|||
125172047|NCT02883049|450251374|FG015|Post Induction|Recurrent leukemia|3|||
125172048|NCT02883049|450251359|FG000|Post Induction|Induction Failure|0|||
125172049|NCT02883049|450251360|FG001|Post Induction|Induction Failure|0|||
125172050|NCT02883049|450251361|FG002|Post Induction|Induction Failure|0|||
125172051|NCT02883049|450251362|FG003|Post Induction|Induction Failure|0|||
125172052|NCT02883049|450251363|FG004|Post Induction|Induction Failure|0|||
125172053|NCT02883049|450251364|FG005|Post Induction|Induction Failure|0|||
125172054|NCT02883049|450251365|FG006|Post Induction|Induction Failure|0|||
125172055|NCT02883049|450251366|FG007|Post Induction|Induction Failure|2|||
125172056|NCT02883049|450251367|FG008|Post Induction|Induction Failure|2|||
125172057|NCT02883049|450251368|FG009|Post Induction|Induction Failure|0|||
125172058|NCT02883049|450251369|FG010|Post Induction|Induction Failure|0|||
125172059|NCT02883049|450251370|FG011|Post Induction|Induction Failure|0|||
125172060|NCT02883049|450251371|FG012|Post Induction|Induction Failure|0|||
125172061|NCT02883049|450251372|FG013|Post Induction|Induction Failure|2|||
125172062|NCT02883049|450251373|FG014|Post Induction|Induction Failure|0|||
125172063|NCT02883049|450251374|FG015|Post Induction|Induction Failure|0|||
125172064|NCT01924754|450251378|FG000|Overall Study|Lost to Follow-up|1|||
125172065|NCT01924754|450251379|FG001|Overall Study|Lost to Follow-up|2|||
125172066|NCT01924754|450251380|FG002|Overall Study|Lost to Follow-up|1|||
125172067|NCT01924754|450251378|FG000|Overall Study|Pregnancy|0|||
125172068|NCT01924754|450251379|FG001|Overall Study|Pregnancy|1|||
125172069|NCT01924754|450251380|FG002|Overall Study|Pregnancy|2|||
125172070|NCT02245412|450251383|FG000|Treatment Period|Death|1|||
125172071|NCT02245412|450251384|FG001|Treatment Period|Death|1|||
125172072|NCT02245412|450251385|FG002|Treatment Period|Death|0|||
125172073|NCT02245412|450251383|FG000|Treatment Period|Physician Decision|1|||
125172074|NCT02245412|450251384|FG001|Treatment Period|Physician Decision|1|||
125172075|NCT02245412|450251385|FG002|Treatment Period|Physician Decision|0|||
125172076|NCT02245412|450251383|FG000|Treatment Period|Withdrawal by Subject|2|||
125172077|NCT02245412|450251384|FG001|Treatment Period|Withdrawal by Subject|1|||
125172078|NCT02245412|450251385|FG002|Treatment Period|Withdrawal by Subject|0|||
125172079|NCT02245412|450251383|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
125172080|NCT02245412|450251384|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
125229694|NCT01178294|450469989|FG000|Overall Study|Adverse Event|4|||
125229695|NCT01178294|450469989|FG000|Overall Study|Lost to Follow-up|2|||
125443395|NCT02555371|451252129|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
125172081|NCT02245412|450251385|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
125172082|NCT02245412|450251383|FG000|Follow-Up Period|Death|4|||
125172083|NCT02245412|450251384|FG001|Follow-Up Period|Death|2|||
125172084|NCT02245412|450251385|FG002|Follow-Up Period|Death|1|||
125172085|NCT02245412|450251383|FG000|Follow-Up Period|Physician Decision|1|||
125172086|NCT02245412|450251384|FG001|Follow-Up Period|Physician Decision|0|||
125172087|NCT02245412|450251385|FG002|Follow-Up Period|Physician Decision|0|||
125172088|NCT02245412|450251383|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
125172089|NCT02245412|450251384|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
125172090|NCT02245412|450251385|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
125172091|NCT01392963|450251386|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
125172092|NCT01392963|450251387|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
125172093|NCT01392963|450251386|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
125172094|NCT01392963|450251387|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
125172095|NCT01392963|450251386|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
125172096|NCT01392963|450251387|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
125172097|NCT00369486|450251388|FG000|4-Week Visit|Missed visit|2|||
125172098|NCT00369486|450251389|FG001|4-Week Visit|Missed visit|2|||
125172099|NCT00369486|450251390|FG002|4-Week Visit|Missed visit|0|||
125172100|NCT00369486|450251391|FG003|4-Week Visit|Missed visit|2|||
125172101|NCT00369486|450251392|FG004|4-Week Visit|Missed visit|1|||
125172102|NCT00369486|450251388|FG000|4-Week Visit|Dropped|0|||
125172103|NCT00369486|450251389|FG001|4-Week Visit|Dropped|0|||
125229696|NCT01178294|450469989|FG000|Overall Study|Lack of Efficacy|1|||
125229697|NCT01178294|450469989|FG000|Overall Study|Death|1|||
125229698|NCT01178294|450469989|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
125229699|NCT01178294|450469989|FG000|Overall Study|Subject status is terminal|1|||
125229700|NCT01178294|450469989|FG000|Overall Study|Completion status could not be verified|1|||
125229701|NCT03712280|450469991|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
125229702|NCT03712280|450469992|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
125229703|NCT03712280|450469993|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
125229704|NCT03712280|450469994|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
125229705|NCT03712280|450469991|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
125229706|NCT03712280|450469992|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
125229707|NCT03712280|450469993|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
125229708|NCT03712280|450469994|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
125229709|NCT03712280|450469991|FG000|Overall Study|Adverse Event|0|||
125229710|NCT03712280|450469992|FG001|Overall Study|Adverse Event|0|||
125229711|NCT03712280|450469993|FG002|Overall Study|Adverse Event|1|||
125229712|NCT03712280|450469994|FG003|Overall Study|Adverse Event|0|||
125229713|NCT05379920|450469998|FG000|Overall Study|Lost to Follow-up|0|||
125229714|NCT05379920|450469999|FG001|Overall Study|Lost to Follow-up|5|||
125229715|NCT05379920|450470000|FG002|Overall Study|Lost to Follow-up|0|||
125229716|NCT05379920|450470001|FG003|Overall Study|Lost to Follow-up|0|||
125229717|NCT03176771|450470004|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
125229718|NCT03176771|450470005|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
125229719|NCT03176771|450470006|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
125229720|NCT03176771|450470007|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
125229721|NCT03176771|450470008|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
125229722|NCT03176771|450470004|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
125229723|NCT03176771|450470005|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
125229724|NCT03176771|450470006|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
125229725|NCT03176771|450470007|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
125229726|NCT03176771|450470008|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
125229727|NCT03176771|450470004|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
125229728|NCT03176771|450470005|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
125229729|NCT03176771|450470006|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
125229730|NCT03176771|450470007|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
125229731|NCT03176771|450470008|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
125229732|NCT03176771|450470004|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
125229733|NCT03176771|450470005|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
125229734|NCT03176771|450470006|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
125229735|NCT03176771|450470007|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
125229736|NCT03176771|450470008|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
125229737|NCT03176771|450470004|FG000|Double-Blind Extension Period|Adverse Event|0|||
125229738|NCT03176771|450470005|FG001|Double-Blind Extension Period|Adverse Event|0|||
125229739|NCT03176771|450470006|FG002|Double-Blind Extension Period|Adverse Event|0|||
125229740|NCT03176771|450470007|FG003|Double-Blind Extension Period|Adverse Event|15|||
125229741|NCT03176771|450470008|FG004|Double-Blind Extension Period|Adverse Event|18|||
125229742|NCT03176771|450470004|FG000|Double-Blind Extension Period|Death|0|||
125172104|NCT00369486|450251390|FG002|4-Week Visit|Dropped|1|||
125172105|NCT00369486|450251391|FG003|4-Week Visit|Dropped|0|||
125172106|NCT00369486|450251392|FG004|4-Week Visit|Dropped|0|||
125172107|NCT00369486|450251388|FG000|8-Week Visit|Missed visit|0|||
125172108|NCT00369486|450251389|FG001|8-Week Visit|Missed visit|1|||
125172109|NCT00369486|450251390|FG002|8-Week Visit|Missed visit|0|||
125172110|NCT00369486|450251391|FG003|8-Week Visit|Missed visit|0|||
125172111|NCT00369486|450251392|FG004|8-Week Visit|Missed visit|1|||
125172112|NCT00369486|450251388|FG000|8-Week Visit|Dropped|0|||
125172113|NCT00369486|450251389|FG001|8-Week Visit|Dropped|0|||
125172114|NCT00369486|450251390|FG002|8-Week Visit|Dropped|0|||
125172115|NCT00369486|450251391|FG003|8-Week Visit|Dropped|1|||
125172116|NCT00369486|450251392|FG004|8-Week Visit|Dropped|0|||
125172117|NCT00369486|450251388|FG000|17-Week Visit|Missed visit|0|||
125172118|NCT00369486|450251389|FG001|17-Week Visit|Missed visit|0|||
125172119|NCT00369486|450251390|FG002|17-Week Visit|Missed visit|1|||
125172120|NCT00369486|450251391|FG003|17-Week Visit|Missed visit|1|||
125172121|NCT00369486|450251392|FG004|17-Week Visit|Missed visit|1|||
125172122|NCT00369486|450251388|FG000|34-Week Visit|Dropped|0|||
125172123|NCT00369486|450251389|FG001|34-Week Visit|Dropped|1|||
125172124|NCT00369486|450251390|FG002|34-Week Visit|Dropped|1|||
125172125|NCT00369486|450251391|FG003|34-Week Visit|Dropped|3|||
125172126|NCT00369486|450251392|FG004|34-Week Visit|Dropped|3|||
125172127|NCT00402116|450251393|FG000|Overall Study|Jaw infection after surgery-other|1|||
125172128|NCT00402116|450251394|FG001|Overall Study|Jaw infection after surgery-other|0|||
125172129|NCT00402116|450251395|FG002|Overall Study|Jaw infection after surgery-other|0|||
125172130|NCT00402116|450251393|FG000|Overall Study|Withdrawal by Subject|1|||
125172131|NCT00402116|450251394|FG001|Overall Study|Withdrawal by Subject|0|||
125172132|NCT00402116|450251395|FG002|Overall Study|Withdrawal by Subject|5|||
125172133|NCT00402116|450251393|FG000|Overall Study|Treatment completed per protocol|1|||
125172134|NCT00402116|450251394|FG001|Overall Study|Treatment completed per protocol|1|||
125172135|NCT00402116|450251395|FG002|Overall Study|Treatment completed per protocol|2|||
125172136|NCT00402116|450251393|FG000|Overall Study|other complicating disease|0|||
125172137|NCT00402116|450251394|FG001|Overall Study|other complicating disease|0|||
125172138|NCT00402116|450251395|FG002|Overall Study|other complicating disease|2|||
125172139|NCT00402116|450251393|FG000|Overall Study|Disease Progression|0|||
125172140|NCT00402116|450251394|FG001|Overall Study|Disease Progression|4|||
125172141|NCT00402116|450251395|FG002|Overall Study|Disease Progression|38|||
125172142|NCT00402116|450251393|FG000|Overall Study|mistaken thrombocytopenia|0|||
125172143|NCT00402116|450251394|FG001|Overall Study|mistaken thrombocytopenia|0|||
125172144|NCT00402116|450251395|FG002|Overall Study|mistaken thrombocytopenia|1|||
125172145|NCT00402116|450251393|FG000|Overall Study|decline related hyponatremia/tumor|0|||
125172146|NCT00402116|450251394|FG001|Overall Study|decline related hyponatremia/tumor|0|||
125172147|NCT00402116|450251395|FG002|Overall Study|decline related hyponatremia/tumor|1|||
125172148|NCT00402116|450251393|FG000|Overall Study|Adverse Event|0|||
125172149|NCT00402116|450251394|FG001|Overall Study|Adverse Event|1|||
125172150|NCT00402116|450251395|FG002|Overall Study|Adverse Event|6|||
125172151|NCT04778904|450251396|FG000|Overall Study|Protocol Violation|1|||
125172152|NCT04778904|450251397|FG001|Overall Study|Protocol Violation|0|||
125172153|NCT04778904|450251398|FG002|Overall Study|Protocol Violation|0|||
125172154|NCT04778904|450251399|FG003|Overall Study|Protocol Violation|0|||
125172155|NCT04778904|450251396|FG000|Overall Study|Withdrawal by Subject|0|||
125172156|NCT04778904|450251397|FG001|Overall Study|Withdrawal by Subject|0|||
125172157|NCT04778904|450251398|FG002|Overall Study|Withdrawal by Subject|1|||
125229743|NCT03176771|450470005|FG001|Double-Blind Extension Period|Death|0|||
125229744|NCT03176771|450470006|FG002|Double-Blind Extension Period|Death|0|||
125229745|NCT03176771|450470007|FG003|Double-Blind Extension Period|Death|3|||
125229746|NCT03176771|450470008|FG004|Double-Blind Extension Period|Death|4|||
125229747|NCT03176771|450470004|FG000|Double-Blind Extension Period|Physician Decision|0|||
125229748|NCT03176771|450470005|FG001|Double-Blind Extension Period|Physician Decision|0|||
125229749|NCT03176771|450470006|FG002|Double-Blind Extension Period|Physician Decision|0|||
125229750|NCT03176771|450470007|FG003|Double-Blind Extension Period|Physician Decision|3|||
125229751|NCT03176771|450470008|FG004|Double-Blind Extension Period|Physician Decision|1|||
125229752|NCT03176771|450470004|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
125229753|NCT03176771|450470005|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
125229754|NCT03176771|450470006|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
125229755|NCT03176771|450470007|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
125229756|NCT03176771|450470008|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
125229757|NCT02732639|450470010|FG000|Overall Study|Lost to Follow-up|1|||
125229758|NCT02662569|450470012|FG000|Overall Study|Withdrawal by Subject|6|||
125172158|NCT04778904|450251399|FG003|Overall Study|Withdrawal by Subject|0|||
125172159|NCT01810302|450251406|FG000|Overall Study|Death|1|||
125229759|NCT02662569|450470013|FG001|Overall Study|Withdrawal by Subject|1|||
125229760|NCT02662569|450470014|FG002|Overall Study|Withdrawal by Subject|6|||
125229761|NCT02662569|450470015|FG003|Overall Study|Withdrawal by Subject|4|||
125172160|NCT01810302|450251407|FG001|Overall Study|Death|0|||
125172161|NCT01810302|450251406|FG000|Overall Study|Physician Decision|0|||
125172162|NCT01810302|450251407|FG001|Overall Study|Physician Decision|1|||
125172163|NCT04138043|450251408|FG000|Overall Study|Withdrawal by Subject|0|||
125172164|NCT04138043|450251409|FG001|Overall Study|Withdrawal by Subject|1|||
125172165|NCT02856802|450251410|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
125229762|NCT02662569|450470012|FG000|Overall Study|Lost to Follow-up|1|||
125172166|NCT02856802|450251411|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
125172167|NCT02856802|450251410|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
125172168|NCT02856802|450251411|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
125172169|NCT02856802|450251410|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
125172170|NCT02856802|450251411|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
125172171|NCT02856802|450251410|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
125172172|NCT02856802|450251411|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
125172173|NCT02856802|450251410|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
125172174|NCT02856802|450251411|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
125172175|NCT02856802|450251410|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
125172176|NCT02856802|450251411|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
125172177|NCT03772717|450251412|FG000|Overall Study|Withdrawal by Subject|2|||
125172178|NCT03278626|450251418|FG000|Overall Study|Death|2|||
125172179|NCT03278626|450251418|FG000|Overall Study|Toxicity|1|||
125172180|NCT03278626|450251418|FG000|Overall Study|Disease Progression|2|||
125172181|NCT00580788|450251419|FG000|Overall Study|Adverse Event|0|||
125172182|NCT00580788|450251420|FG001|Overall Study|Adverse Event|0|||
125172183|NCT00580788|450251421|FG002|Overall Study|Adverse Event|0|||
125172184|NCT00580788|450251422|FG003|Overall Study|Adverse Event|1|||
125172185|NCT04971187|450251423|FG000|Overall Study|Screen failures|2|||
125172186|NCT03743415|450251429|FG000|Overall Study|Death|5|||
125172187|NCT03743415|450251430|FG001|Overall Study|Death|3|||
125172188|NCT03743415|450251431|FG002|Overall Study|Death|1|||
125172189|NCT03743415|450251432|FG003|Overall Study|Death|4|||
125172190|NCT03743415|450251433|FG004|Overall Study|Death|0|||
125172191|NCT03743415|450251434|FG005|Overall Study|Death|0|||
125172192|NCT03743415|450251435|FG006|Overall Study|Death|0|||
125172193|NCT03743415|450251436|FG007|Overall Study|Death|0|||
125172194|NCT03743415|450251437|FG008|Overall Study|Death|1|||
125172195|NCT03743415|450251438|FG009|Overall Study|Death|0|||
125172196|NCT03743415|450251429|FG000|Overall Study|Withdrawal by Subject|1|||
125172197|NCT03743415|450251430|FG001|Overall Study|Withdrawal by Subject|0|||
125172198|NCT03743415|450251431|FG002|Overall Study|Withdrawal by Subject|4|||
125172199|NCT03743415|450251432|FG003|Overall Study|Withdrawal by Subject|5|||
125172200|NCT03743415|450251433|FG004|Overall Study|Withdrawal by Subject|5|||
125172201|NCT03743415|450251434|FG005|Overall Study|Withdrawal by Subject|2|||
125172202|NCT03743415|450251435|FG006|Overall Study|Withdrawal by Subject|2|||
125172203|NCT03743415|450251436|FG007|Overall Study|Withdrawal by Subject|5|||
125172204|NCT03743415|450251437|FG008|Overall Study|Withdrawal by Subject|9|||
125172205|NCT03743415|450251438|FG009|Overall Study|Withdrawal by Subject|10|||
125172206|NCT03743415|450251429|FG000|Overall Study|Lost to Follow-up|2|||
125172207|NCT03743415|450251430|FG001|Overall Study|Lost to Follow-up|0|||
125172208|NCT03743415|450251431|FG002|Overall Study|Lost to Follow-up|2|||
125172209|NCT03743415|450251432|FG003|Overall Study|Lost to Follow-up|1|||
125172210|NCT03743415|450251433|FG004|Overall Study|Lost to Follow-up|1|||
125172211|NCT03743415|450251434|FG005|Overall Study|Lost to Follow-up|0|||
125172212|NCT03743415|450251435|FG006|Overall Study|Lost to Follow-up|1|||
125172213|NCT03743415|450251436|FG007|Overall Study|Lost to Follow-up|4|||
125172214|NCT03743415|450251437|FG008|Overall Study|Lost to Follow-up|13|||
125172215|NCT03743415|450251438|FG009|Overall Study|Lost to Follow-up|13|||
125172216|NCT01266031|450251442|FG000|Overall Study|Not treated|0|||
125172217|NCT01266031|450251443|FG001|Overall Study|Not treated|3|||
125172218|NCT01266031|450251444|FG002|Overall Study|Not treated|2|||
125172219|NCT00005957|450251449|FG000|Overall Study|No treated|3|||
125172220|NCT00005957|450251450|FG001|Overall Study|No treated|9|||
125172221|NCT00005957|450251449|FG000|Overall Study|Crossover to the other arm|5|||
125172222|NCT00005957|450251450|FG001|Overall Study|Crossover to the other arm|19|||
125172223|NCT00799825|450251451|FG000|Overall Study|Adverse Event|1|||
125172224|NCT00799825|450251451|FG000|Overall Study|Withdrawal by Subject|6|||
125172225|NCT00799825|450251451|FG000|Overall Study|Lost to Follow-up|38|||
125172226|NCT00799825|450251451|FG000|Overall Study|Pregnancy|3|||
125172227|NCT00582010|450251452|FG000|Overall Study|Death|0|||
125172228|NCT00582010|450251453|FG001|Overall Study|Death|1|||
125172229|NCT02439970|450251454|FG000|Overall Study|Study Terminated|2|||
125172230|NCT02439970|450251455|FG001|Overall Study|Study Terminated|3|||
125229763|NCT02662569|450470013|FG001|Overall Study|Lost to Follow-up|0|||
125172231|NCT03717012|450251456|FG000|Overall Study|Due to trial termination|1|||
125172232|NCT03717012|450251457|FG001|Overall Study|Due to trial termination|2|||
125172233|NCT03717012|450251456|FG000|Overall Study|Protocol Violation|0|||
125172234|NCT03717012|450251457|FG001|Overall Study|Protocol Violation|2|||
125172235|NCT03717012|450251456|FG000|Overall Study|Adverse Event|0|||
125172236|NCT03717012|450251457|FG001|Overall Study|Adverse Event|1|||
125172237|NCT03717012|450251456|FG000|Overall Study|Lung transplant|0|||
125172238|NCT03717012|450251457|FG001|Overall Study|Lung transplant|1|||
125172239|NCT02640690|450251458|FG000|Overall Study|Lost to Follow-up|7|||
125172240|NCT02640690|450251459|FG001|Overall Study|Lost to Follow-up|7|||
125172241|NCT02640690|450251458|FG000|Overall Study|Withdrawal by Subject|16|||
125172242|NCT02640690|450251459|FG001|Overall Study|Withdrawal by Subject|20|||
125172243|NCT02640690|450251458|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
125172244|NCT02640690|450251459|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
125172245|NCT01520870|450251460|FG000|Overall Study|Withdrawal by Subject|2|||
125172246|NCT02910011|450251463|FG000|Overall Study|Physician Decision|2|||
125172247|NCT02463357|450251464|FG000|Overall Study|Withdrawal by Subject|1|||
125172248|NCT02463357|450251465|FG001|Overall Study|Withdrawal by Subject|0|||
125172249|NCT02463357|450251466|FG002|Overall Study|Withdrawal by Subject|0|||
125172250|NCT02463357|450251467|FG003|Overall Study|Withdrawal by Subject|0|||
125172251|NCT02463357|450251468|FG004|Overall Study|Withdrawal by Subject|0|||
125172252|NCT02463357|450251464|FG000|Overall Study|Withdrawal by Subject|0|||
125172253|NCT02463357|450251465|FG001|Overall Study|Withdrawal by Subject|0|||
125172254|NCT02463357|450251466|FG002|Overall Study|Withdrawal by Subject|0|||
125172255|NCT02463357|450251467|FG003|Overall Study|Withdrawal by Subject|0|||
125172256|NCT02463357|450251468|FG004|Overall Study|Withdrawal by Subject|1|||
125172257|NCT01399658|450251471|FG000|Overall Study|Ineligible|1|||
125172258|NCT01399658|450251471|FG000|Overall Study|Machine Technical Issue|3|||
125172259|NCT01399658|450251471|FG000|Overall Study|Alternative therapy|1|||
125172260|NCT01399658|450251471|FG000|Overall Study|No reason given|1|||
125172261|NCT02460679|450251472|FG000|Overall Study|Investigator Decision|1|||
125172262|NCT02460679|450251472|FG000|Overall Study|Withdrawal by Subject|4|||
125443396|NCT02555371|451252130|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
125443397|NCT02555371|451252131|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
125443398|NCT02555371|451252132|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
125443399|NCT02555371|451252128|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
125443400|NCT02555371|451252129|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
125443401|NCT02555371|451252130|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
125443402|NCT02555371|451252131|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
125443403|NCT02555371|451252132|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
125172263|NCT02620579|450251473|FG000|Overall Study|Physician Decision|0|||
125172264|NCT02620579|450251474|FG001|Overall Study|Physician Decision|0|||
125172265|NCT02620579|450251475|FG002|Overall Study|Physician Decision|0|||
125172266|NCT02620579|450251476|FG003|Overall Study|Physician Decision|1|||
125172267|NCT02620579|450251473|FG000|Overall Study|Withdrawal by Subject|0|||
125172268|NCT02620579|450251474|FG001|Overall Study|Withdrawal by Subject|1|||
125172269|NCT02620579|450251475|FG002|Overall Study|Withdrawal by Subject|1|||
125172270|NCT02620579|450251476|FG003|Overall Study|Withdrawal by Subject|0|||
125172271|NCT00796107|450251482|FG000|Overall Study|Lack of Efficacy|1|||
125172272|NCT00796107|450251482|FG000|Overall Study|Progressive Disease|5|||
125172273|NCT01721317|450251484|FG000|Overall Study|Study Closed / Terminated|2|||
125172274|NCT01721317|450251485|FG001|Overall Study|Study Closed / Terminated|2|||
125172275|NCT01721317|450251484|FG000|Overall Study|Physician Decision|0|||
125172276|NCT01721317|450251485|FG001|Overall Study|Physician Decision|1|||
125172277|NCT01721317|450251484|FG000|Overall Study|Withdrawal by Subject|0|||
125172278|NCT01721317|450251485|FG001|Overall Study|Withdrawal by Subject|1|||
125172279|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
125172280|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
125172281|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
125172282|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
125172283|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
125172284|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
125172285|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
125172286|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
125172287|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
125172288|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
125172289|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
125172290|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
125172291|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
125172292|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
125172293|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
125172294|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
125229764|NCT02662569|450470014|FG002|Overall Study|Lost to Follow-up|0|||
125229765|NCT02662569|450470015|FG003|Overall Study|Lost to Follow-up|0|||
125229766|NCT00630916|450470019|FG000|Overall Study|Death|110|||
125172295|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
125172296|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
125172297|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
125229767|NCT00630916|450470019|FG000|Overall Study|Explant|8|||
125229768|NCT00630916|450470019|FG000|Overall Study|Lost to Follow-up|5|||
125172298|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
125229769|NCT00630916|450470019|FG000|Overall Study|Withdrawal by Subject|30|||
125229770|NCT00630916|450470019|FG000|Overall Study|Protocol Violation|7|||
125229771|NCT00630916|450470019|FG000|Overall Study|Physician Decision|47|||
125229772|NCT00630916|450470019|FG000|Overall Study|Lack of Efficacy|3|||
125229773|NCT01299584|450470026|FG000|Overall Study|Protocol Violation|9|||
125172299|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
125172300|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125172301|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
125172302|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125172303|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
125172304|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
125172305|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
125172306|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
125172307|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
125172308|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
125172309|NCT03713632|450251495|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
125172310|NCT03713632|450251496|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
125172311|NCT03713632|450251497|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
125172312|NCT03713632|450251498|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
125172313|NCT03713632|450251499|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
125172314|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
125172315|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
125172316|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
125172317|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
125172318|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
125172319|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
125172320|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
125172321|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
125172322|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
125172323|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
125172324|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
125172325|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
125172326|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
125172327|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
125172328|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
125172329|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
125172330|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
125172331|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
125172332|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
125172333|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
125172334|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
125172335|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
125172336|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
125172337|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
125172338|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
125172339|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
125172340|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
125172341|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
125172342|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
125172343|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
125172344|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Death|0|||
125172345|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Death|1|||
125172346|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Death|0|||
125172347|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Death|0|||
125172348|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Death|0|||
125172349|NCT03713632|450251495|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125172350|NCT03713632|450251496|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
125172351|NCT03713632|450251497|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125172352|NCT03713632|450251498|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125172353|NCT03713632|450251499|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
125172354|NCT02806024|450251500|FG000|Overall Study|Night Delivery|1|||
125172355|NCT02806024|450251501|FG001|Overall Study|Night Delivery|1|||
125172356|NCT02806024|450251500|FG000|Overall Study|DVT during antepartum admission|0|||
125172357|NCT02806024|450251501|FG001|Overall Study|DVT during antepartum admission|1|||
125172358|NCT02892149|450251502|FG000|Overall Study|Death|262|||
125172359|NCT02892149|450251503|FG001|Overall Study|Death|278|||
125172360|NCT02892149|450251502|FG000|Overall Study|Withdrawal by Subject|53|||
125172361|NCT02892149|450251503|FG001|Overall Study|Withdrawal by Subject|47|||
125172362|NCT02892149|450251502|FG000|Overall Study|Lost to Follow-up|37|||
125172363|NCT02892149|450251503|FG001|Overall Study|Lost to Follow-up|31|||
125172364|NCT01994850|450251504|FG000|Overall Study|Physician Decision|1|||
125172365|NCT01994850|450251504|FG000|Overall Study|Withdrawal by Subject|1|||
125172366|NCT00442962|450251505|FG000|Overall Study|Pregnancy|1|||
125172367|NCT00442962|450251505|FG000|Overall Study|Lost to Follow-up|7|||
125172368|NCT02756208|450251509|FG000|Overall Study|Withdrawal by Subject|1|||
125172369|NCT02756208|450251510|FG001|Overall Study|Withdrawal by Subject|0|||
125172370|NCT02756208|450251511|FG002|Overall Study|Withdrawal by Subject|1|||
125172371|NCT02756208|450251512|FG003|Overall Study|Withdrawal by Subject|3|||
125172372|NCT02756208|450251509|FG000|Overall Study|Lost to Follow-up|3|||
125172373|NCT02756208|450251510|FG001|Overall Study|Lost to Follow-up|1|||
125172374|NCT02756208|450251511|FG002|Overall Study|Lost to Follow-up|1|||
125172375|NCT02756208|450251512|FG003|Overall Study|Lost to Follow-up|1|||
125172376|NCT02756208|450251509|FG000|Overall Study|Physician Decision|1|||
125172377|NCT02756208|450251510|FG001|Overall Study|Physician Decision|0|||
125172378|NCT02756208|450251511|FG002|Overall Study|Physician Decision|0|||
125172379|NCT02756208|450251512|FG003|Overall Study|Physician Decision|0|||
125229774|NCT04079790|450470027|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
125229775|NCT04079790|450470028|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
125229776|NCT04079790|450470029|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
125229777|NCT04079790|450470030|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
125229778|NCT04079790|450470027|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
125172380|NCT02756208|450251509|FG000|Overall Study|Protocol Violation|0|||
125172381|NCT02756208|450251510|FG001|Overall Study|Protocol Violation|1|||
125172382|NCT02756208|450251511|FG002|Overall Study|Protocol Violation|0|||
125172383|NCT02756208|450251512|FG003|Overall Study|Protocol Violation|0|||
125172384|NCT04841577|450251514|FG000|Overall Study|Adverse Event|5|||
125172385|NCT04841577|450251515|FG001|Overall Study|Adverse Event|10|||
125172386|NCT04841577|450251514|FG000|Overall Study|Lost to Follow-up|8|||
125172387|NCT04841577|450251515|FG001|Overall Study|Lost to Follow-up|7|||
125172388|NCT04841577|450251514|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
125172389|NCT04841577|450251515|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
125172390|NCT04841577|450251514|FG000|Overall Study|Other|0|||
125172391|NCT04841577|450251515|FG001|Overall Study|Other|1|||
125172392|NCT01420965|450251520|FG000|Overall Study|Withdrawal by Subject|1|||
125172393|NCT01420965|450251521|FG001|Overall Study|Withdrawal by Subject|0|||
125172394|NCT01420965|450251522|FG002|Overall Study|Withdrawal by Subject|0|||
125172395|NCT01420965|450251520|FG000|Overall Study|Adverse Event|0|||
125172396|NCT01420965|450251521|FG001|Overall Study|Adverse Event|1|||
125172397|NCT01420965|450251522|FG002|Overall Study|Adverse Event|0|||
125172398|NCT00339144|450251527|FG000|Overall Study|Disease progression|5|||
125172399|NCT00339144|450251528|FG001|Overall Study|Disease progression|2|||
125172400|NCT00339144|450251529|FG002|Overall Study|Disease progression|2|||
125172401|NCT00339144|450251527|FG000|Overall Study|Study drug toxicity|3|||
125172402|NCT00339144|450251528|FG001|Overall Study|Study drug toxicity|1|||
125172403|NCT00339144|450251529|FG002|Overall Study|Study drug toxicity|1|||
125172404|NCT00339144|450251527|FG000|Overall Study|Participant's request to discontinuation|1|||
125172405|NCT00339144|450251528|FG001|Overall Study|Participant's request to discontinuation|0|||
125172406|NCT00339144|450251529|FG002|Overall Study|Participant's request to discontinuation|1|||
125172407|NCT03280381|450251530|FG000|Overall Study|Physician Decision|0|||
125172408|NCT03280381|450251531|FG001|Overall Study|Physician Decision|2|||
125172409|NCT02257385|450251532|FG000|Overall Study|Adverse Event|12|||
125172410|NCT02257385|450251533|FG001|Overall Study|Adverse Event|8|||
125172411|NCT02257385|450251532|FG000|Overall Study|Lack of Efficacy|1|||
125172412|NCT02257385|450251533|FG001|Overall Study|Lack of Efficacy|2|||
125172413|NCT02257385|450251532|FG000|Overall Study|Protocol Violation|5|||
125172414|NCT02257385|450251533|FG001|Overall Study|Protocol Violation|7|||
125172415|NCT02257385|450251532|FG000|Overall Study|Lost to Follow-up|0|||
125172416|NCT02257385|450251533|FG001|Overall Study|Lost to Follow-up|1|||
125172417|NCT02257385|450251532|FG000|Overall Study|Withdrawal by Subject|4|||
125172418|NCT02257385|450251533|FG001|Overall Study|Withdrawal by Subject|4|||
125172419|NCT03279692|450251534|FG000|Overall Study|Withdrawal by Subject|1|||
125172420|NCT02458287|450251536|FG000|Overall Study|Adverse Event|0|||
125172421|NCT02458287|450251537|FG001|Overall Study|Adverse Event|0|||
125172422|NCT02458287|450251538|FG002|Overall Study|Adverse Event|0|||
125172423|NCT02458287|450251539|FG003|Overall Study|Adverse Event|1|||
125229779|NCT04079790|450470028|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
125229780|NCT04079790|450470029|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
125229781|NCT04079790|450470030|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
125229782|NCT04079790|450470027|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
125229783|NCT04079790|450470028|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
125229784|NCT04079790|450470029|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
125229785|NCT04079790|450470030|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
125229786|NCT00390689|450470031|FG000|Overall Study|Adverse Event|2|||
125172424|NCT02458287|450251536|FG000|Overall Study|Lost to Follow-up|0|||
125229787|NCT00390689|450470032|FG001|Overall Study|Adverse Event|5|||
125229788|NCT00390689|450470033|FG002|Overall Study|Adverse Event|2|||
125172425|NCT02458287|450251537|FG001|Overall Study|Lost to Follow-up|1|||
125172426|NCT02458287|450251538|FG002|Overall Study|Lost to Follow-up|1|||
125172427|NCT02458287|450251539|FG003|Overall Study|Lost to Follow-up|0|||
125172428|NCT02458287|450251536|FG000|Overall Study|Protocol Violation|0|||
125172429|NCT02458287|450251537|FG001|Overall Study|Protocol Violation|1|||
125172430|NCT02458287|450251538|FG002|Overall Study|Protocol Violation|0|||
125172431|NCT02458287|450251539|FG003|Overall Study|Protocol Violation|0|||
125172432|NCT02458287|450251536|FG000|Overall Study|Withdrawal by Subject|0|||
125172433|NCT02458287|450251537|FG001|Overall Study|Withdrawal by Subject|2|||
125172434|NCT02458287|450251538|FG002|Overall Study|Withdrawal by Subject|2|||
125172435|NCT02458287|450251539|FG003|Overall Study|Withdrawal by Subject|1|||
125172436|NCT02458287|450251536|FG000|Overall Study|Relocated Out of State|0|||
125172437|NCT02458287|450251537|FG001|Overall Study|Relocated Out of State|0|||
125172438|NCT02458287|450251538|FG002|Overall Study|Relocated Out of State|0|||
125172439|NCT02458287|450251539|FG003|Overall Study|Relocated Out of State|1|||
125172440|NCT02800642|450251542|FG000|Overall Study|Death|3|||
125172441|NCT02800642|450251542|FG000|Overall Study|Other|10|||
125172442|NCT02800642|450251542|FG000|Overall Study|Physician Decision|2|||
125172443|NCT02800642|450251542|FG000|Overall Study|Adverse Event|6|||
125172444|NCT02800642|450251542|FG000|Overall Study|Withdrawal by Subject|3|||
125172445|NCT02800642|450251542|FG000|Overall Study|Lost to Follow-up|1|||
125172446|NCT02027428|450251543|FG000|Induction|Never treated|7|||
125172447|NCT02027428|450251544|FG001|Induction|Never treated|0|||
125172448|NCT02027428|450251545|FG002|Induction|Never treated|0|||
125172449|NCT02027428|450251543|FG000|Induction|Progressive disease|77|||
125172450|NCT02027428|450251544|FG001|Induction|Progressive disease|0|||
125172451|NCT02027428|450251545|FG002|Induction|Progressive disease|0|||
125172452|NCT02027428|450251543|FG000|Induction|Adverse Event|51|||
125172453|NCT02027428|450251544|FG001|Induction|Adverse Event|0|||
125172454|NCT02027428|450251545|FG002|Induction|Adverse Event|0|||
125172455|NCT02027428|450251543|FG000|Induction|Withdrawal by Subject|22|||
125172456|NCT02027428|450251544|FG001|Induction|Withdrawal by Subject|0|||
125172457|NCT02027428|450251545|FG002|Induction|Withdrawal by Subject|0|||
125172458|NCT02027428|450251543|FG000|Induction|Death|21|||
125172459|NCT02027428|450251544|FG001|Induction|Death|0|||
125172460|NCT02027428|450251545|FG002|Induction|Death|0|||
125172461|NCT02027428|450251543|FG000|Induction|Symptomatic deterioration|16|||
125172462|NCT02027428|450251544|FG001|Induction|Symptomatic deterioration|0|||
125172463|NCT02027428|450251545|FG002|Induction|Symptomatic deterioration|0|||
125172464|NCT02027428|450251543|FG000|Induction|Study terminated by sponsor|12|||
125172465|NCT02027428|450251544|FG001|Induction|Study terminated by sponsor|0|||
125172466|NCT02027428|450251545|FG002|Induction|Study terminated by sponsor|0|||
125172467|NCT02027428|450251543|FG000|Induction|Protocol Violation|1|||
125172468|NCT02027428|450251544|FG001|Induction|Protocol Violation|0|||
125172469|NCT02027428|450251545|FG002|Induction|Protocol Violation|0|||
125172470|NCT02027428|450251543|FG000|Induction|Miscellaneous|14|||
125172471|NCT02027428|450251544|FG001|Induction|Miscellaneous|0|||
125172472|NCT02027428|450251545|FG002|Induction|Miscellaneous|0|||
125172473|NCT02027428|450251543|FG000|Induction|Induction Treatment Ongoing|4|||
125172474|NCT02027428|450251544|FG001|Induction|Induction Treatment Ongoing|0|||
125172475|NCT02027428|450251545|FG002|Induction|Induction Treatment Ongoing|0|||
125172476|NCT02027428|450251543|FG000|Maintenance|Death|0|||
125172477|NCT02027428|450251544|FG001|Maintenance|Death|3|||
125172478|NCT02027428|450251545|FG002|Maintenance|Death|2|||
125172479|NCT02027428|450251543|FG000|Maintenance|Adverse Event|0|||
125172480|NCT02027428|450251544|FG001|Maintenance|Adverse Event|21|||
125172481|NCT02027428|450251545|FG002|Maintenance|Adverse Event|1|||
125172482|NCT02027428|450251543|FG000|Maintenance|Progressive disease|0|||
125172483|NCT02027428|450251544|FG001|Maintenance|Progressive disease|84|||
125172484|NCT02027428|450251545|FG002|Maintenance|Progressive disease|47|||
125172485|NCT02027428|450251543|FG000|Maintenance|Symptomatic deterioration|0|||
125172486|NCT02027428|450251544|FG001|Maintenance|Symptomatic deterioration|4|||
125172487|NCT02027428|450251545|FG002|Maintenance|Symptomatic deterioration|1|||
125172488|NCT02027428|450251543|FG000|Maintenance|Withdrawal by Subject|0|||
125172489|NCT02027428|450251544|FG001|Maintenance|Withdrawal by Subject|6|||
125172490|NCT02027428|450251545|FG002|Maintenance|Withdrawal by Subject|5|||
125172491|NCT02027428|450251543|FG000|Maintenance|Protocol Violation|0|||
125172492|NCT02027428|450251544|FG001|Maintenance|Protocol Violation|0|||
125172493|NCT02027428|450251545|FG002|Maintenance|Protocol Violation|1|||
125172494|NCT02027428|450251543|FG000|Maintenance|Other|0|||
125172495|NCT02027428|450251544|FG001|Maintenance|Other|6|||
125229789|NCT00390689|450470031|FG000|Overall Study|Lack of Efficacy|0|||
125172496|NCT02027428|450251545|FG002|Maintenance|Other|3|||
125172497|NCT02027428|450251543|FG000|Survival Follow-up|Death|0|||
125172498|NCT02027428|450251544|FG001|Survival Follow-up|Death|78|||
125172499|NCT02027428|450251545|FG002|Survival Follow-up|Death|45|||
125172500|NCT02027428|450251543|FG000|Survival Follow-up|Lost to Follow-up|0|||
125172501|NCT02027428|450251544|FG001|Survival Follow-up|Lost to Follow-up|1|||
125172502|NCT02027428|450251545|FG002|Survival Follow-up|Lost to Follow-up|1|||
125172503|NCT03371459|450251548|FG000|Washout|Lost to Follow-up|0|||
125172504|NCT03371459|450251549|FG001|Washout|Lost to Follow-up|1|||
125172505|NCT01589497|450251550|FG000|Overall Study|Withdrawal by Subject|0|||
125172506|NCT01589497|450251551|FG001|Overall Study|Withdrawal by Subject|1|||
125172507|NCT01589497|450251552|FG002|Overall Study|Withdrawal by Subject|0|||
125172508|NCT01589497|450251553|FG003|Overall Study|Withdrawal by Subject|1|||
125172509|NCT01589497|450251550|FG000|Overall Study|Death|1|||
125172510|NCT01589497|450251551|FG001|Overall Study|Death|0|||
125172511|NCT01589497|450251552|FG002|Overall Study|Death|0|||
125172512|NCT01589497|450251553|FG003|Overall Study|Death|0|||
125172513|NCT01589497|450251550|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
125172514|NCT01589497|450251551|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
125172515|NCT01589497|450251552|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
125172516|NCT01589497|450251553|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
125172517|NCT02542605|450251560|FG000|Part B: Challenge Phase|Sponsor decision|1|||
125172518|NCT02542605|450251561|FG001|Part B: Challenge Phase|Sponsor decision|0|||
125172519|NCT02542605|450251562|FG002|Part B: Challenge Phase|Sponsor decision|0|||
125172520|NCT02542605|450251560|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
125172521|NCT02542605|450251561|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
125172522|NCT02542605|450251562|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
125172523|NCT02682927|450251563|FG000|Overall Study|Adverse Event|0|||
125172524|NCT02682927|450251564|FG001|Overall Study|Adverse Event|0|||
125172525|NCT02682927|450251565|FG002|Overall Study|Adverse Event|5|||
125172526|NCT02682927|450251566|FG003|Overall Study|Adverse Event|1|||
125172527|NCT02682927|450251567|FG004|Overall Study|Adverse Event|0|||
125172528|NCT02682927|450251568|FG005|Overall Study|Adverse Event|2|||
125172529|NCT02682927|450251563|FG000|Overall Study|Death|0|||
125172530|NCT02682927|450251564|FG001|Overall Study|Death|0|||
125172531|NCT02682927|450251565|FG002|Overall Study|Death|0|||
125172532|NCT02682927|450251566|FG003|Overall Study|Death|1|||
125172533|NCT02682927|450251567|FG004|Overall Study|Death|0|||
125172534|NCT02682927|450251568|FG005|Overall Study|Death|0|||
125172535|NCT02682927|450251563|FG000|Overall Study|Lack of Efficacy|1|||
125172536|NCT02682927|450251564|FG001|Overall Study|Lack of Efficacy|0|||
125172537|NCT02682927|450251565|FG002|Overall Study|Lack of Efficacy|0|||
125172538|NCT02682927|450251566|FG003|Overall Study|Lack of Efficacy|1|||
125172539|NCT02682927|450251567|FG004|Overall Study|Lack of Efficacy|0|||
125172540|NCT02682927|450251568|FG005|Overall Study|Lack of Efficacy|0|||
125172541|NCT02682927|450251563|FG000|Overall Study|Other|0|||
125172542|NCT02682927|450251564|FG001|Overall Study|Other|0|||
125172543|NCT02682927|450251565|FG002|Overall Study|Other|0|||
125172544|NCT02682927|450251566|FG003|Overall Study|Other|2|||
125172545|NCT02682927|450251567|FG004|Overall Study|Other|0|||
125172546|NCT02682927|450251568|FG005|Overall Study|Other|0|||
125172547|NCT02682927|450251563|FG000|Overall Study|Withdrawal by Subject|2|||
125172548|NCT02682927|450251564|FG001|Overall Study|Withdrawal by Subject|0|||
125172549|NCT02682927|450251565|FG002|Overall Study|Withdrawal by Subject|1|||
125172550|NCT02682927|450251566|FG003|Overall Study|Withdrawal by Subject|0|||
125172551|NCT02682927|450251567|FG004|Overall Study|Withdrawal by Subject|1|||
125172552|NCT02682927|450251568|FG005|Overall Study|Withdrawal by Subject|1|||
125172553|NCT02766283|450251574|FG000|Overall Study|Lost to Follow-up|27|||
125172554|NCT04007991|450251575|FG000|Overall Study|Withdrawal by Subject|1|||
125172555|NCT04007991|450251576|FG001|Overall Study|Withdrawal by Subject|1|||
125172556|NCT04007991|450251575|FG000|Overall Study|Physician Decision|1|||
125172557|NCT04007991|450251576|FG001|Overall Study|Physician Decision|1|||
125172558|NCT04007991|450251575|FG000|Overall Study|Non-compliance with Study Drug|0|||
125172559|NCT04007991|450251576|FG001|Overall Study|Non-compliance with Study Drug|1|||
125172560|NCT04007991|450251575|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
125172561|NCT04007991|450251576|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
125172562|NCT04007991|450251575|FG000|Overall Study|Adverse event, non-fatal|5|||
125172563|NCT04007991|450251576|FG001|Overall Study|Adverse event, non-fatal|0|||
125172564|NCT04007991|450251575|FG000|Overall Study|Lost to Follow-up|2|||
125172565|NCT04007991|450251576|FG001|Overall Study|Lost to Follow-up|1|||
125172566|NCT05314816|450251577|FG000|Overall Study|Lost to Follow-up|5|||
125172567|NCT05314816|450251578|FG001|Overall Study|Lost to Follow-up|0|||
125172568|NCT05314816|450251579|FG002|Overall Study|Lost to Follow-up|1|||
125172569|NCT05314816|450251577|FG000|Overall Study|Protocol Violation|13|||
125172570|NCT05314816|450251578|FG001|Overall Study|Protocol Violation|8|||
125172571|NCT05314816|450251579|FG002|Overall Study|Protocol Violation|0|||
125172572|NCT05048329|450253334|FG000|Overall Study|Withdrawal by Subject|1|||
125172573|NCT05048329|450253334|FG000|Overall Study|Screenfail|1|||
125172574|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #1|24|||
125172575|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #1|0|||
125172576|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
125172577|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
125172578|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172579|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172580|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
125172581|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
125172582|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
125172583|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
125172584|NCT03888066|450253335|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172585|NCT03888066|450253336|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172586|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172587|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172588|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
125172589|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
125172590|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172591|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172592|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
125172593|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172594|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #2|5|||
125172595|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #2|0|||
125172596|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
125172597|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
125172598|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
125172599|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
125172600|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
125172601|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
125172602|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #3|11|||
125172603|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #3|0|||
125172604|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
125172605|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
125172606|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
125172607|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
125172608|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172609|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172610|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #4|3|||
125172611|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #4|0|||
125172612|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
125172613|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
125172614|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
125172615|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
125172616|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
125172617|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
125172618|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
125172619|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
125172620|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
125172621|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172622|NCT03888066|450253335|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
125172623|NCT03888066|450253336|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
125172624|NCT03888066|450253335|FG000|Run-in Phase|AE (Adverse Event)|17|||
125172625|NCT03888066|450253336|FG001|Run-in Phase|AE (Adverse Event)|0|||
125172626|NCT03888066|450253335|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
125172627|NCT03888066|450253336|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
125172628|NCT03888066|450253335|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172629|NCT03888066|450253336|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172630|NCT03888066|450253335|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
125172631|NCT03888066|450253336|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172632|NCT03888066|450253335|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
125172633|NCT03888066|450253336|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
125229790|NCT00390689|450470032|FG001|Overall Study|Lack of Efficacy|0|||
125229791|NCT00390689|450470033|FG002|Overall Study|Lack of Efficacy|1|||
125229792|NCT00390689|450470031|FG000|Overall Study|Protocol Violation|1|||
125229793|NCT00390689|450470032|FG001|Overall Study|Protocol Violation|0|||
125229794|NCT00390689|450470033|FG002|Overall Study|Protocol Violation|0|||
125229795|NCT00390689|450470031|FG000|Overall Study|Investigator's judgement|2|||
125229796|NCT00390689|450470032|FG001|Overall Study|Investigator's judgement|0|||
125172634|NCT03888066|450253335|FG000|Run-in Phase|Withdrawal by Subject|43|||
125172635|NCT03888066|450253336|FG001|Run-in Phase|Withdrawal by Subject|0|||
125172636|NCT03888066|450253335|FG000|Run-in Phase|AE; Physician Decision|1|||
125172637|NCT03888066|450253336|FG001|Run-in Phase|AE; Physician Decision|0|||
125172638|NCT03888066|450253335|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
125229797|NCT00390689|450470033|FG002|Overall Study|Investigator's judgement|0|||
125229798|NCT01253161|450470034|FG000|Overall Study|Adverse Event|1|||
125229799|NCT01924533|450470036|FG000|Overall Study|Death|181|||
125172639|NCT03888066|450253336|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
125172640|NCT03888066|450253335|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
125172641|NCT03888066|450253336|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
125172642|NCT03888066|450253335|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
125172643|NCT03888066|450253336|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
125172644|NCT03888066|450253335|FG000|Run-in Phase|Death|1|||
125172645|NCT03888066|450253336|FG001|Run-in Phase|Death|0|||
125172646|NCT03888066|450253335|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
125172647|NCT03888066|450253336|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
125172648|NCT03888066|450253335|FG000|Run-in Phase|Physician Decision|1|||
125172649|NCT03888066|450253336|FG001|Run-in Phase|Physician Decision|0|||
125172650|NCT03888066|450253335|FG000|Run-in Phase|Protocol Violation|13|||
125172651|NCT03888066|450253336|FG001|Run-in Phase|Protocol Violation|0|||
125172652|NCT03888066|450253335|FG000|Run-in Phase|Sponsor Request|34|||
125172653|NCT03888066|450253336|FG001|Run-in Phase|Sponsor Request|0|||
125172654|NCT03888066|450253335|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
125172655|NCT03888066|450253336|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
125172656|NCT03888066|450253335|FG000|Run-in Phase|Withdrawal Of Consent|1|||
125172657|NCT03888066|450253336|FG001|Run-in Phase|Withdrawal Of Consent|0|||
125172658|NCT03888066|450253335|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
125172659|NCT03888066|450253336|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
125172660|NCT03888066|450253335|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
125172661|NCT03888066|450253336|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
125172662|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
125172663|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
125172664|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
125172665|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
125172666|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
125172667|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
125172668|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
125172669|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
125172670|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
125172671|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
125172672|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
125172673|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
125172674|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
125172675|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
125172676|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
125172677|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
125172678|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
125172679|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
125172680|NCT03888066|450253335|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
125172681|NCT03888066|450253336|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
125172682|NCT05013008|450253338|FG000|Overall Study|Exclusion from mBFAS|5|||
125172683|NCT05013008|450253339|FG001|Overall Study|Exclusion from mBFAS|25|||
125172684|NCT04981717|450253340|FG000|Overall Study|Protocol Violation|0|||
125172685|NCT04981717|450253341|FG001|Overall Study|Protocol Violation|3|||
125172686|NCT04981717|450253340|FG000|Overall Study|Adverse Event|1|||
125172687|NCT04981717|450253341|FG001|Overall Study|Adverse Event|3|||
125172688|NCT04981717|450253340|FG000|Overall Study|Pregnancy|1|||
125172689|NCT04981717|450253341|FG001|Overall Study|Pregnancy|0|||
125172690|NCT04981717|450253340|FG000|Overall Study|Physician Decision|1|||
125172691|NCT04981717|450253341|FG001|Overall Study|Physician Decision|0|||
125172692|NCT04981717|450253340|FG000|Overall Study|Sponsor Request|157|||
125172693|NCT04981717|450253341|FG001|Overall Study|Sponsor Request|172|||
125172694|NCT04981717|450253340|FG000|Overall Study|Lost to Follow-up|4|||
125172695|NCT04981717|450253341|FG001|Overall Study|Lost to Follow-up|5|||
125172696|NCT04981717|450253340|FG000|Overall Study|Withdrawal by Subject|50|||
125172697|NCT04981717|450253341|FG001|Overall Study|Withdrawal by Subject|37|||
125172698|NCT02207634|450253345|FG000|Overall Study|Withdrawal by Subject|21|||
125172699|NCT02207634|450253346|FG001|Overall Study|Withdrawal by Subject|31|||
125172700|NCT02207634|450253345|FG000|Overall Study|Lost to Follow-up|1|||
125172701|NCT02207634|450253346|FG001|Overall Study|Lost to Follow-up|0|||
125172702|NCT00887289|450253347|FG000|Overall Study|Lack of Efficacy|14|||
125172703|NCT00887289|450253347|FG000|Overall Study|Adverse Event|27|||
125172704|NCT00887289|450253347|FG000|Overall Study|Withdrawal by Subject|26|||
125172705|NCT00887289|450253347|FG000|Overall Study|Lost to Follow-up|8|||
125172706|NCT00887289|450253347|FG000|Overall Study|Other|20|||
125172707|NCT00591773|450253350|FG000|Overall Study|Adverse Event|9|||
125172708|NCT00591773|450253351|FG001|Overall Study|Adverse Event|9|||
125172709|NCT00591773|450253352|FG002|Overall Study|Adverse Event|6|||
125172710|NCT00591773|450253350|FG000|Overall Study|Protocol Violation|2|||
125172711|NCT00591773|450253351|FG001|Overall Study|Protocol Violation|3|||
125172712|NCT00591773|450253352|FG002|Overall Study|Protocol Violation|0|||
125172713|NCT00591773|450253350|FG000|Overall Study|Lost to Follow-up|1|||
125172714|NCT00591773|450253351|FG001|Overall Study|Lost to Follow-up|4|||
125172715|NCT00591773|450253352|FG002|Overall Study|Lost to Follow-up|1|||
125172716|NCT00591773|450253350|FG000|Overall Study|Withdrawal by Subject|2|||
125172717|NCT00591773|450253351|FG001|Overall Study|Withdrawal by Subject|5|||
125172718|NCT00591773|450253352|FG002|Overall Study|Withdrawal by Subject|3|||
125172719|NCT00591773|450253350|FG000|Overall Study|Lack of Efficacy|1|||
125172720|NCT00591773|450253351|FG001|Overall Study|Lack of Efficacy|2|||
125172721|NCT00591773|450253352|FG002|Overall Study|Lack of Efficacy|2|||
125172722|NCT00591773|450253350|FG000|Overall Study|Other|1|||
125172723|NCT00591773|450253351|FG001|Overall Study|Other|1|||
125172724|NCT00591773|450253352|FG002|Overall Study|Other|4|||
125172725|NCT00459355|450253353|FG000|Overall Study|Subject no longer met inc criteria|20|||
125172726|NCT00459355|450253354|FG001|Overall Study|Subject no longer met inc criteria|18|||
125172727|NCT00287586|450253355|FG000|Overall Study|Withdrew Consent|19|||
125172728|NCT00287586|450253356|FG001|Overall Study|Withdrew Consent|30|||
125172729|NCT00287586|450253355|FG000|Overall Study|Lost to Follow-up|5|||
125172730|NCT00287586|450253356|FG001|Overall Study|Lost to Follow-up|4|||
125172731|NCT00287586|450253355|FG000|Overall Study|Death|2|||
125172732|NCT00287586|450253356|FG001|Overall Study|Death|3|||
125172733|NCT00287586|450253355|FG000|Overall Study|Elevated Hematocrit|3|||
125172734|NCT00287586|450253356|FG001|Overall Study|Elevated Hematocrit|0|||
125172735|NCT00287586|450253355|FG000|Overall Study|Rash|3|||
125172736|NCT00287586|450253356|FG001|Overall Study|Rash|0|||
125172737|NCT00287586|450253355|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
125172738|NCT00287586|450253356|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
125172739|NCT00287586|450253355|FG000|Overall Study|Stroke|2|||
125172740|NCT00287586|450253356|FG001|Overall Study|Stroke|0|||
125172741|NCT00287586|450253355|FG000|Overall Study|Myocardial Infarction|1|||
125172742|NCT00287586|450253356|FG001|Overall Study|Myocardial Infarction|0|||
125172743|NCT00287586|450253355|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
125172744|NCT00287586|450253356|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
125172745|NCT00287586|450253355|FG000|Overall Study|Cognitive Impairment|1|||
125172746|NCT00287586|450253356|FG001|Overall Study|Cognitive Impairment|0|||
125172747|NCT00287586|450253355|FG000|Overall Study|Pancreatic Cancer|1|||
125172748|NCT00287586|450253356|FG001|Overall Study|Pancreatic Cancer|3|||
125172749|NCT00287586|450253355|FG000|Overall Study|Sleep Apnea|1|||
125172750|NCT00287586|450253356|FG001|Overall Study|Sleep Apnea|0|||
125172751|NCT00287586|450253355|FG000|Overall Study|Shoulder Pain|1|||
125172752|NCT00287586|450253356|FG001|Overall Study|Shoulder Pain|0|||
125172753|NCT00287586|450253355|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
125172754|NCT00287586|450253356|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
125172755|NCT00287586|450253355|FG000|Overall Study|Nonadherence|1|||
125172756|NCT00287586|450253356|FG001|Overall Study|Nonadherence|1|||
125172757|NCT00287586|450253355|FG000|Overall Study|Enrolled in Another Study|1|||
125172758|NCT00287586|450253356|FG001|Overall Study|Enrolled in Another Study|0|||
125172759|NCT00287586|450253355|FG000|Overall Study|Major Depression|0|||
125172760|NCT00287586|450253356|FG001|Overall Study|Major Depression|2|||
125172761|NCT00287586|450253355|FG000|Overall Study|Lung Cancer|0|||
125172762|NCT00287586|450253356|FG001|Overall Study|Lung Cancer|2|||
125172763|NCT00287586|450253355|FG000|Overall Study|Elevated IPSS Score|0|||
125172764|NCT00287586|450253356|FG001|Overall Study|Elevated IPSS Score|1|||
125172765|NCT00287586|450253355|FG000|Overall Study|Retroperitoneal Cancer|0|||
125172766|NCT00287586|450253356|FG001|Overall Study|Retroperitoneal Cancer|1|||
125172767|NCT00287586|450253355|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
125172768|NCT00287586|450253356|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
125172769|NCT00287586|450253355|FG000|Overall Study|Mood Swings and Irritability|0|||
125172770|NCT00287586|450253356|FG001|Overall Study|Mood Swings and Irritability|1|||
125172771|NCT00287586|450253355|FG000|Overall Study|Bradycardia|0|||
125172772|NCT00287586|450253356|FG001|Overall Study|Bradycardia|1|||
125172773|NCT00287586|450253355|FG000|Overall Study|Itchy Swollen Eyes|0|||
125172774|NCT00287586|450253356|FG001|Overall Study|Itchy Swollen Eyes|1|||
125172775|NCT00287586|450253355|FG000|Overall Study|Recurrent Melanoma|0|||
125172776|NCT00287586|450253356|FG001|Overall Study|Recurrent Melanoma|1|||
125172777|NCT02135614|450253357|FG000|Overall Study|Randomized but Not Treated|2|||
125172778|NCT02135614|450253358|FG001|Overall Study|Randomized but Not Treated|1|||
125172779|NCT02135614|450253357|FG000|Overall Study|Adverse Event|0|||
125172780|NCT02135614|450253358|FG001|Overall Study|Adverse Event|1|||
125172781|NCT02135614|450253357|FG000|Overall Study|Death|1|||
125172782|NCT02135614|450253358|FG001|Overall Study|Death|0|||
125172783|NCT02135614|450253357|FG000|Overall Study|Investigator's Discretion|0|||
125172784|NCT02135614|450253358|FG001|Overall Study|Investigator's Discretion|1|||
125172785|NCT02135614|450253357|FG000|Overall Study|Withdrew Consent|2|||
125172786|NCT02135614|450253358|FG001|Overall Study|Withdrew Consent|2|||
125172787|NCT02135614|450253357|FG000|Overall Study|Lost to Follow-up|3|||
125172788|NCT02135614|450253358|FG001|Overall Study|Lost to Follow-up|0|||
125172789|NCT03106987|450253364|FG000|Overall Study|Death|37|||
125172790|NCT03106987|450253365|FG001|Overall Study|Death|22|||
125172791|NCT03106987|450253366|FG002|Overall Study|Death|12|||
125172792|NCT03106987|450253367|FG003|Overall Study|Death|8|||
125172793|NCT03106987|450253364|FG000|Overall Study|Lost to Follow-up|2|||
125172794|NCT03106987|450253365|FG001|Overall Study|Lost to Follow-up|0|||
125172795|NCT03106987|450253366|FG002|Overall Study|Lost to Follow-up|2|||
125172796|NCT03106987|450253367|FG003|Overall Study|Lost to Follow-up|2|||
125172797|NCT03106987|450253364|FG000|Overall Study|Withdrawal by Subject|5|||
125172798|NCT03106987|450253365|FG001|Overall Study|Withdrawal by Subject|1|||
125172799|NCT03106987|450253366|FG002|Overall Study|Withdrawal by Subject|4|||
125172800|NCT03106987|450253367|FG003|Overall Study|Withdrawal by Subject|1|||
125172801|NCT02114385|450253368|FG000|Overall Study|Withdrawal by Subject|3|||
125172802|NCT02114385|450253369|FG001|Overall Study|Withdrawal by Subject|2|||
125172803|NCT02114385|450253368|FG000|Overall Study|Lost to Follow-up|0|||
125172804|NCT02114385|450253369|FG001|Overall Study|Lost to Follow-up|6|||
125172805|NCT01275729|450253370|FG000|Overall Study|Death|3|||
125172806|NCT01275729|450253370|FG000|Overall Study|Withdrawal by Subject|1|||
125172807|NCT02681510|450253373|FG000|Overall Study|Withdrawal by Subject|1|||
125172808|NCT02681510|450253373|FG000|Overall Study|Lost to Follow-up|9|||
125172809|NCT04315506|450253374|FG000|Overall Study|Lost to Follow-up|74|||
125172810|NCT04315506|450253375|FG001|Overall Study|Lost to Follow-up|82|||
125172811|NCT04315506|450253374|FG000|Overall Study|Withdrawal by Subject|8|||
125172812|NCT04315506|450253375|FG001|Overall Study|Withdrawal by Subject|8|||
125172813|NCT04315506|450253374|FG000|Overall Study|Physician Decision|0|||
125172814|NCT04315506|450253375|FG001|Overall Study|Physician Decision|1|||
125172815|NCT00958893|450253376|FG000|Overall Study|Study prematurely terminated|4|||
125172816|NCT00741338|450253377|FG000|Overall Study|Adverse Event|0|||
125172817|NCT00741338|450253378|FG001|Overall Study|Adverse Event|1|||
125172818|NCT03593395|450253379|FG000|Overall Study|Lost to Follow-up|48|||
125172819|NCT03593395|450253380|FG001|Overall Study|Lost to Follow-up|3|||
125172820|NCT03593395|450253379|FG000|Overall Study|Withdrawal by Subject|5|||
125172821|NCT03593395|450253380|FG001|Overall Study|Withdrawal by Subject|24|||
125172822|NCT03593395|450253379|FG000|Overall Study|Death|2|||
125172823|NCT03593395|450253380|FG001|Overall Study|Death|3|||
125172824|NCT03593395|450253379|FG000|Overall Study|Physician Decision|0|||
125172825|NCT03593395|450253380|FG001|Overall Study|Physician Decision|6|||
125172826|NCT03593395|450253379|FG000|Overall Study|Participant Relocated|19|||
125172827|NCT03593395|450253380|FG001|Overall Study|Participant Relocated|3|||
125172828|NCT03593395|450253379|FG000|Overall Study|No Information|1|||
125172829|NCT03593395|450253380|FG001|Overall Study|No Information|7|||
125172830|NCT01098474|450253383|FG000|Active Phase|Other|0|||
125172831|NCT01098474|450253384|FG001|Active Phase|Other|0|||
125172832|NCT01098474|450253385|FG002|Active Phase|Other|3|||
125172833|NCT01098474|450253386|FG003|Active Phase|Other|0|||
125172834|NCT01098474|450253387|FG004|Active Phase|Other|0|||
125172835|NCT01098474|450253388|FG005|Active Phase|Other|0|||
125172836|NCT01098474|450253383|FG000|Active Phase|Withdrawal by Subject|1|||
125172837|NCT01098474|450253384|FG001|Active Phase|Withdrawal by Subject|1|||
125172838|NCT01098474|450253385|FG002|Active Phase|Withdrawal by Subject|2|||
125172839|NCT01098474|450253386|FG003|Active Phase|Withdrawal by Subject|0|||
125172840|NCT01098474|450253387|FG004|Active Phase|Withdrawal by Subject|0|||
125172841|NCT01098474|450253388|FG005|Active Phase|Withdrawal by Subject|0|||
125172842|NCT01098474|450253383|FG000|Active Phase|Lost to Follow-up|1|||
125172843|NCT01098474|450253384|FG001|Active Phase|Lost to Follow-up|0|||
125172844|NCT01098474|450253385|FG002|Active Phase|Lost to Follow-up|0|||
125172845|NCT01098474|450253386|FG003|Active Phase|Lost to Follow-up|0|||
125172846|NCT01098474|450253387|FG004|Active Phase|Lost to Follow-up|0|||
125172847|NCT01098474|450253388|FG005|Active Phase|Lost to Follow-up|0|||
125172848|NCT01098474|450253383|FG000|Follow Up Phase|Travelled out of study area|0|||
125172849|NCT01098474|450253384|FG001|Follow Up Phase|Travelled out of study area|0|||
125172850|NCT01098474|450253385|FG002|Follow Up Phase|Travelled out of study area|0|||
125172851|NCT01098474|450253386|FG003|Follow Up Phase|Travelled out of study area|0|||
125172852|NCT01098474|450253387|FG004|Follow Up Phase|Travelled out of study area|1|||
125172853|NCT01098474|450253388|FG005|Follow Up Phase|Travelled out of study area|0|||
125172854|NCT01098474|450253383|FG000|Follow Up Phase|Other|0|||
125172855|NCT01098474|450253384|FG001|Follow Up Phase|Other|0|||
125172856|NCT01098474|450253385|FG002|Follow Up Phase|Other|0|||
125172857|NCT01098474|450253386|FG003|Follow Up Phase|Other|0|||
125172858|NCT01098474|450253387|FG004|Follow Up Phase|Other|0|||
125172859|NCT01098474|450253388|FG005|Follow Up Phase|Other|4|||
125172860|NCT01098474|450253383|FG000|Follow Up Phase|Withdrawal by Subject|0|||
125172861|NCT01098474|450253384|FG001|Follow Up Phase|Withdrawal by Subject|0|||
125172862|NCT01098474|450253385|FG002|Follow Up Phase|Withdrawal by Subject|0|||
125172863|NCT01098474|450253386|FG003|Follow Up Phase|Withdrawal by Subject|2|||
125172864|NCT01098474|450253387|FG004|Follow Up Phase|Withdrawal by Subject|0|||
125172865|NCT01098474|450253388|FG005|Follow Up Phase|Withdrawal by Subject|1|||
125172866|NCT01098474|450253383|FG000|Follow Up Phase|Lost to Follow-up|0|||
125172867|NCT01098474|450253384|FG001|Follow Up Phase|Lost to Follow-up|0|||
125172868|NCT01098474|450253385|FG002|Follow Up Phase|Lost to Follow-up|0|||
125172869|NCT01098474|450253386|FG003|Follow Up Phase|Lost to Follow-up|0|||
125172870|NCT01098474|450253387|FG004|Follow Up Phase|Lost to Follow-up|1|||
125172871|NCT01098474|450253388|FG005|Follow Up Phase|Lost to Follow-up|0|||
125172872|NCT00704132|450253399|FG000|Overall Study|Clinical Adverse Experience|1|||
125172873|NCT00704132|450253400|FG001|Overall Study|Clinical Adverse Experience|0|||
125172874|NCT00704132|450253399|FG000|Overall Study|Lack of Efficacy|0|||
125172875|NCT00704132|450253400|FG001|Overall Study|Lack of Efficacy|1|||
125172876|NCT00704132|450253399|FG000|Overall Study|Withdrawal by Subject|0|||
125172877|NCT00704132|450253400|FG001|Overall Study|Withdrawal by Subject|1|||
125172878|NCT00182325|450253401|FG000|Overall Study|Lost to Follow-up|7|||
125172879|NCT00182325|450253402|FG001|Overall Study|Lost to Follow-up|7|||
125172880|NCT00182325|450253401|FG000|Overall Study|Miscarriage|5|||
125172881|NCT00182325|450253402|FG001|Overall Study|Miscarriage|3|||
125172882|NCT00182325|450253401|FG000|Overall Study|Did not complete survey|22|||
125172883|NCT00182325|450253402|FG001|Overall Study|Did not complete survey|43|||
125172884|NCT00652340|450253405|FG000|Overall Study|Had not progressed.|4|||
125172885|NCT00652340|450253406|FG001|Overall Study|Had not progressed.|3|||
125172886|NCT03682107|450253407|FG000|Overall Study|Withdrawal by Subject|0|||
125172887|NCT03682107|450253408|FG001|Overall Study|Withdrawal by Subject|1|||
125172888|NCT03682107|450253409|FG002|Overall Study|Withdrawal by Subject|0|||
125172889|NCT03682107|450253410|FG003|Overall Study|Withdrawal by Subject|0|||
125172890|NCT03682107|450253411|FG004|Overall Study|Withdrawal by Subject|0|||
125172891|NCT00214383|450253412|FG000|Overall Study|Lost to Follow-up|16|||
125172892|NCT00214383|450253413|FG001|Overall Study|Lost to Follow-up|26|||
125172893|NCT03607487|450253414|FG000|Overall Study|Withdrawal by Subject|2|||
125172894|NCT03607487|450253415|FG001|Overall Study|Withdrawal by Subject|0|||
125172895|NCT03607487|450253416|FG002|Overall Study|Withdrawal by Subject|0|||
125172896|NCT03607487|450253417|FG003|Overall Study|Withdrawal by Subject|1|||
125172897|NCT01890434|450253418|FG000|Overall Study|Adverse Event|8|||
125172898|NCT01890434|450253418|FG000|Overall Study|PCI at external hospital|1|||
125172899|NCT01890434|450253418|FG000|Overall Study|Assessment discrepancy|1|||
125172900|NCT01890434|450253418|FG000|Overall Study|CRC didn't contact participant for FU|1|||
125172901|NCT01890434|450253418|FG000|Overall Study|Could not get whole set of images|1|||
125172902|NCT01890434|450253418|FG000|Overall Study|Decline to return for GSPECT|1|||
125172903|NCT01890434|450253418|FG000|Overall Study|GSPECT at rest was not done|1|||
125172904|NCT01890434|450253418|FG000|Overall Study|Participant didn't complete MRI|1|||
125172905|NCT01890434|450253418|FG000|Overall Study|Uncontactable by phone|1|||
125172906|NCT01890434|450253418|FG000|Overall Study|Moved out of position|1|||
125172907|NCT01890434|450253418|FG000|Overall Study|Unable to contact|1|||
125172908|NCT01890434|450253418|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
125172909|NCT01141205|450253422|FG000|Overall Study|Physician Decision|1|||
125172910|NCT01141205|450253423|FG001|Overall Study|Physician Decision|1|||
125172911|NCT01141205|450253422|FG000|Overall Study|Lost to Follow-up|1|||
125172912|NCT01141205|450253423|FG001|Overall Study|Lost to Follow-up|0|||
125172913|NCT01141205|450253422|FG000|Overall Study|Withdrawal by Subject|1|||
125172914|NCT01141205|450253423|FG001|Overall Study|Withdrawal by Subject|1|||
125172915|NCT02655666|450253427|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
125172916|NCT01822366|450253428|FG000|Overall Study|Lost to Follow-up|5|||
125172917|NCT01822366|450253429|FG001|Overall Study|Lost to Follow-up|1|||
125172918|NCT01822366|450253430|FG002|Overall Study|Lost to Follow-up|5|||
125172919|NCT01822366|450253431|FG003|Overall Study|Lost to Follow-up|1|||
125172920|NCT01822366|450253428|FG000|Overall Study|Withdrawal by Subject|0|||
125172921|NCT01822366|450253429|FG001|Overall Study|Withdrawal by Subject|6|||
125172922|NCT01822366|450253430|FG002|Overall Study|Withdrawal by Subject|0|||
125172923|NCT01822366|450253431|FG003|Overall Study|Withdrawal by Subject|6|||
125172924|NCT01822366|450253428|FG000|Overall Study|Partial Intervention Completion|0|||
125172925|NCT01822366|450253429|FG001|Overall Study|Partial Intervention Completion|15|||
125172926|NCT01822366|450253430|FG002|Overall Study|Partial Intervention Completion|0|||
125172927|NCT01822366|450253431|FG003|Overall Study|Partial Intervention Completion|15|||
125172928|NCT05199090|450253432|FG000|Overall Study|Adverse Event|1|||
125172929|NCT05199090|450253433|FG001|Overall Study|Adverse Event|4|||
125172930|NCT05199090|450253434|FG002|Overall Study|Adverse Event|0|||
125172931|NCT05199090|450253435|FG003|Overall Study|Adverse Event|0|||
125172932|NCT05199090|450253436|FG004|Overall Study|Adverse Event|0|||
125172933|NCT05199090|450253437|FG005|Overall Study|Adverse Event|0|||
125172934|NCT05199090|450253432|FG000|Overall Study|Lost to Follow-up|1|||
125172935|NCT05199090|450253433|FG001|Overall Study|Lost to Follow-up|0|||
125172936|NCT05199090|450253434|FG002|Overall Study|Lost to Follow-up|1|||
125172937|NCT05199090|450253435|FG003|Overall Study|Lost to Follow-up|4|||
125172938|NCT05199090|450253436|FG004|Overall Study|Lost to Follow-up|0|||
125172939|NCT05199090|450253437|FG005|Overall Study|Lost to Follow-up|5|||
125172940|NCT05199090|450253432|FG000|Overall Study|Physician Decision|0|||
125172941|NCT05199090|450253433|FG001|Overall Study|Physician Decision|0|||
125172942|NCT05199090|450253434|FG002|Overall Study|Physician Decision|0|||
125172943|NCT05199090|450253435|FG003|Overall Study|Physician Decision|0|||
125172944|NCT05199090|450253436|FG004|Overall Study|Physician Decision|0|||
125229800|NCT01924533|450470037|FG001|Overall Study|Death|200|||
125229801|NCT01924533|450470036|FG000|Overall Study|Lost to Follow-up|0|||
125229802|NCT01924533|450470037|FG001|Overall Study|Lost to Follow-up|1|||
125172945|NCT05199090|450253437|FG005|Overall Study|Physician Decision|1|||
125172946|NCT05199090|450253432|FG000|Overall Study|Study terminated by sponsor|0|||
125172947|NCT05199090|450253433|FG001|Overall Study|Study terminated by sponsor|6|||
125172948|NCT05199090|450253434|FG002|Overall Study|Study terminated by sponsor|0|||
125172949|NCT05199090|450253435|FG003|Overall Study|Study terminated by sponsor|0|||
125172950|NCT05199090|450253436|FG004|Overall Study|Study terminated by sponsor|0|||
125172951|NCT05199090|450253437|FG005|Overall Study|Study terminated by sponsor|5|||
125172952|NCT05199090|450253432|FG000|Overall Study|Subject decision|0|||
125172953|NCT05199090|450253433|FG001|Overall Study|Subject decision|4|||
125172954|NCT05199090|450253434|FG002|Overall Study|Subject decision|0|||
125172955|NCT05199090|450253435|FG003|Overall Study|Subject decision|2|||
125172956|NCT05199090|450253436|FG004|Overall Study|Subject decision|5|||
125172957|NCT05199090|450253437|FG005|Overall Study|Subject decision|2|||
125172958|NCT03276078|450253438|FG000|Overall Study|Adverse Event|1|||
125172959|NCT02552732|450253439|FG000|Overall Study|Lost to Follow-up|2|||
125172960|NCT02552732|450253439|FG000|Overall Study|Physician Decision|1|||
125172961|NCT02552732|450253439|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
125172962|NCT02552732|450253439|FG000|Overall Study|Withdrawal by Subject|6|||
125172963|NCT02290223|450253440|FG000|6 Months|Lost to Follow-up|9|||
125172964|NCT02290223|450253441|FG001|6 Months|Lost to Follow-up|6|||
125172965|NCT02290223|450253440|FG000|6 Months|Withdrawal by Subject|5|||
125172966|NCT02290223|450253441|FG001|6 Months|Withdrawal by Subject|0|||
125172967|NCT02290223|450253440|FG000|6 Months|deceased (not related to study)|2|||
125172968|NCT02290223|450253441|FG001|6 Months|deceased (not related to study)|0|||
125172969|NCT02290223|450253440|FG000|12 Months|Lost to Follow-up|16|||
125172970|NCT02290223|450253441|FG001|12 Months|Lost to Follow-up|10|||
125172971|NCT02290223|450253440|FG000|12 Months|Refusal|0|||
125172972|NCT02290223|450253441|FG001|12 Months|Refusal|1|||
125172973|NCT01004003|450253447|FG000|Overall Study|Progressive disease|2|||
125172974|NCT01004003|450253448|FG001|Overall Study|Progressive disease|1|||
125172975|NCT01004003|450253449|FG002|Overall Study|Progressive disease|1|||
125172976|NCT01004003|450253450|FG003|Overall Study|Progressive disease|0|||
125172977|NCT01004003|450253451|FG004|Overall Study|Progressive disease|2|||
125172978|NCT01004003|450253452|FG005|Overall Study|Progressive disease|1|||
125172979|NCT01004003|450253453|FG006|Overall Study|Progressive disease|1|||
125172980|NCT01004003|450253454|FG007|Overall Study|Progressive disease|39|||
125172981|NCT01004003|450253455|FG008|Overall Study|Progressive disease|22|||
125172982|NCT01004003|450253447|FG000|Overall Study|Adverse Event|4|||
125172983|NCT01004003|450253448|FG001|Overall Study|Adverse Event|2|||
125172984|NCT01004003|450253449|FG002|Overall Study|Adverse Event|3|||
125172985|NCT01004003|450253450|FG003|Overall Study|Adverse Event|3|||
125172986|NCT01004003|450253451|FG004|Overall Study|Adverse Event|2|||
125172987|NCT01004003|450253452|FG005|Overall Study|Adverse Event|2|||
125172988|NCT01004003|450253453|FG006|Overall Study|Adverse Event|7|||
125172989|NCT01004003|450253454|FG007|Overall Study|Adverse Event|21|||
125172990|NCT01004003|450253455|FG008|Overall Study|Adverse Event|6|||
125172991|NCT01004003|450253447|FG000|Overall Study|Refused to continue taking trial med.|0|||
125172992|NCT01004003|450253448|FG001|Overall Study|Refused to continue taking trial med.|0|||
125172993|NCT01004003|450253449|FG002|Overall Study|Refused to continue taking trial med.|0|||
125172994|NCT01004003|450253450|FG003|Overall Study|Refused to continue taking trial med.|0|||
125172995|NCT01004003|450253451|FG004|Overall Study|Refused to continue taking trial med.|0|||
125172996|NCT01004003|450253452|FG005|Overall Study|Refused to continue taking trial med.|0|||
125172997|NCT01004003|450253453|FG006|Overall Study|Refused to continue taking trial med.|0|||
125172998|NCT01004003|450253454|FG007|Overall Study|Refused to continue taking trial med.|0|||
125172999|NCT01004003|450253455|FG008|Overall Study|Refused to continue taking trial med.|2|||
125173000|NCT01004003|450253447|FG000|Overall Study|Other|0|||
125173001|NCT01004003|450253448|FG001|Overall Study|Other|0|||
125173002|NCT01004003|450253449|FG002|Overall Study|Other|0|||
125173003|NCT01004003|450253450|FG003|Overall Study|Other|0|||
125173004|NCT01004003|450253451|FG004|Overall Study|Other|0|||
125173005|NCT01004003|450253452|FG005|Overall Study|Other|1|||
125173006|NCT01004003|450253453|FG006|Overall Study|Other|0|||
125173007|NCT01004003|450253454|FG007|Overall Study|Other|0|||
125173008|NCT01004003|450253455|FG008|Overall Study|Other|0|||
125173009|NCT05819203|450253458|FG000|Overall Study|Protocol Violation|1|||
125173010|NCT05819203|450253459|FG001|Overall Study|Protocol Violation|2|||
125173011|NCT05819203|450253458|FG000|Overall Study|Withdrawal by Subject|1|||
125173012|NCT05819203|450253459|FG001|Overall Study|Withdrawal by Subject|0|||
125229803|NCT01924533|450470036|FG000|Overall Study|Withdrawal by Subject|7|||
125173013|NCT02185053|450253460|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
125173014|NCT02185053|450253461|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
125173015|NCT02185053|450253462|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
125173016|NCT02185053|450253460|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
125173017|NCT02185053|450253461|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
125173018|NCT02185053|450253462|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
125173019|NCT02185053|450253460|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
125173020|NCT02185053|450253461|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
125173021|NCT02185053|450253462|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
125173022|NCT02185053|450253460|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
125173023|NCT02185053|450253461|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
125173024|NCT02185053|450253462|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
125173025|NCT02185053|450253460|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
125173026|NCT02185053|450253461|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
125173027|NCT02185053|450253462|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
125173028|NCT02185053|450253460|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
125173029|NCT02185053|450253461|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
125173030|NCT02185053|450253462|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
125173031|NCT02185053|450253460|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
125173032|NCT02185053|450253461|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
125173033|NCT02185053|450253462|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
125173034|NCT02185053|450253460|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
125173035|NCT02185053|450253461|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
125173036|NCT02185053|450253462|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
125173037|NCT02521376|450253465|FG000|Overall Study|Enrolled, But Not Treated|1|||
125173038|NCT02521376|450253466|FG001|Overall Study|Enrolled, But Not Treated|0|||
125173039|NCT02521376|450253467|FG002|Overall Study|Enrolled, But Not Treated|0|||
125173040|NCT02521376|450253468|FG003|Overall Study|Enrolled, But Not Treated|0|||
125173041|NCT03597464|450253474|FG000|Overall Study|Withdrawal by Subject|4|||
125173042|NCT03597464|450253475|FG001|Overall Study|Withdrawal by Subject|5|||
125173043|NCT03597464|450253474|FG000|Overall Study|Lost to Follow-up|3|||
125173044|NCT03597464|450253475|FG001|Overall Study|Lost to Follow-up|1|||
125173045|NCT03597464|450253474|FG000|Overall Study|Pregnancy|3|||
125173046|NCT03597464|450253475|FG001|Overall Study|Pregnancy|1|||
125173047|NCT03597464|450253474|FG000|Overall Study|Lack of Efficacy|2|||
125173048|NCT03597464|450253475|FG001|Overall Study|Lack of Efficacy|0|||
125173049|NCT03597464|450253474|FG000|Overall Study|Physician Decision|2|||
125173050|NCT03597464|450253475|FG001|Overall Study|Physician Decision|2|||
125173051|NCT03597464|450253474|FG000|Overall Study|Protocol Violation|1|||
125173052|NCT03597464|450253475|FG001|Overall Study|Protocol Violation|1|||
125173053|NCT03597464|450253474|FG000|Overall Study|Adverse Event|0|||
125173054|NCT03597464|450253475|FG001|Overall Study|Adverse Event|2|||
125173055|NCT03597464|450253474|FG000|Overall Study|Death|0|||
125173056|NCT03597464|450253475|FG001|Overall Study|Death|3|||
125173057|NCT00143247|450253480|FG000|Overall Study|Death|8|||
125173058|NCT00143247|450253480|FG000|Overall Study|Adverse Event|19|||
125173059|NCT00143247|450253480|FG000|Overall Study|Lack of Efficacy|3|||
125173060|NCT00143247|450253480|FG000|Overall Study|Withdrawal by Subject|55|||
125173061|NCT00143247|450253480|FG000|Overall Study|Study terminated by sponsor|31|||
125173062|NCT00143247|450253480|FG000|Overall Study|Protocol Violation|15|||
125173063|NCT00143247|450253480|FG000|Overall Study|Lost to Follow-up|12|||
125173064|NCT00143247|450253480|FG000|Overall Study|following inaccurate lab adverse event|1|||
125173065|NCT00143247|450253480|FG000|Overall Study|Other|12|||
125173066|NCT00340678|450253481|FG000|Overall Study|Lost to Follow-up|1|||
125173067|NCT00340678|450253482|FG001|Overall Study|Lost to Follow-up|0|||
125173068|NCT00340678|450253483|FG002|Overall Study|Lost to Follow-up|0|||
125173069|NCT00340678|450253484|FG003|Overall Study|Lost to Follow-up|0|||
125173070|NCT01762800|450254836|FG000|Overall Study|Adverse Event|8|||
125173071|NCT01762800|450254837|FG001|Overall Study|Adverse Event|13|||
125173072|NCT01762800|450254836|FG000|Overall Study|Lack of Efficacy|3|||
125173073|NCT01762800|450254837|FG001|Overall Study|Lack of Efficacy|2|||
125173074|NCT01762800|450254836|FG000|Overall Study|Study Closed/Terminated|0|||
125173075|NCT01762800|450254837|FG001|Overall Study|Study Closed/Terminated|1|||
125173076|NCT01762800|450254836|FG000|Overall Study|Physician Decision|1|||
125173077|NCT01762800|450254837|FG001|Overall Study|Physician Decision|1|||
125173078|NCT01762800|450254836|FG000|Overall Study|Withdrawal by Subject|7|||
125173079|NCT01762800|450254837|FG001|Overall Study|Withdrawal by Subject|4|||
125173080|NCT02111603|450254839|FG000|Overall Study|Withdrawal by Subject|1|||
125173081|NCT01753297|450254842|FG000|Overall Study|Lost to Follow-up|7|||
125173082|NCT01753297|450254843|FG001|Overall Study|Lost to Follow-up|2|||
125173083|NCT01753297|450254842|FG000|Overall Study|Withdrawal by Subject|26|||
125173084|NCT01753297|450254843|FG001|Overall Study|Withdrawal by Subject|23|||
125173085|NCT01753297|450254842|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
125173086|NCT01753297|450254843|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
125173087|NCT01753297|450254842|FG000|Overall Study|Death|0|||
125173088|NCT01753297|450254843|FG001|Overall Study|Death|2|||
125173089|NCT01753297|450254842|FG000|Overall Study|Did not attend end of study visit|7|||
125173090|NCT01753297|450254843|FG001|Overall Study|Did not attend end of study visit|8|||
125173091|NCT01174043|450254846|FG000|Overall Study|Disease progression|5|||
125173092|NCT01174043|450254846|FG000|Overall Study|Adverse Event|3|||
125173093|NCT01174043|450254846|FG000|Overall Study|Death|1|||
125173094|NCT01174043|450254846|FG000|Overall Study|Withdrawal by Subject|2|||
125173095|NCT01645787|450254852|FG000|Washout (2 Weeks)|Adverse Event|1|||
125173096|NCT01645787|450254853|FG001|Washout (2 Weeks)|Adverse Event|0|||
125173097|NCT01371539|450254854|FG000|Period One: One Week|Lost to Follow-up|0|||
125173098|NCT01371539|450254855|FG001|Period One: One Week|Lost to Follow-up|1|||
125173099|NCT01371539|450254854|FG000|Period Two: One Week|Lost to Follow-up|0|||
125173100|NCT01371539|450254855|FG001|Period Two: One Week|Lost to Follow-up|1|||
125173101|NCT01371539|450254854|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
125173102|NCT01371539|450254855|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
125173103|NCT01371539|450254854|FG000|Period Two: One Week|Time/job conflict|0|||
125173104|NCT01371539|450254855|FG001|Period Two: One Week|Time/job conflict|1|||
125173105|NCT01524978|450254872|FG000|Overall Study|Other|16|||
125173106|NCT01524978|450254873|FG001|Overall Study|Other|2|||
125173107|NCT01524978|450254874|FG002|Overall Study|Other|1|||
125173108|NCT01524978|450254875|FG003|Overall Study|Other|2|||
125173109|NCT01524978|450254876|FG004|Overall Study|Other|1|||
125173110|NCT01524978|450254877|FG005|Overall Study|Other|3|||
125173111|NCT01524978|450254878|FG006|Overall Study|Other|17|||
125173112|NCT01524978|450254879|FG007|Overall Study|Other|1|||
125173113|NCT01524978|450254880|FG008|Overall Study|Other|2|||
125173114|NCT01524978|450254881|FG009|Overall Study|Other|2|||
125173115|NCT01524978|450254882|FG010|Overall Study|Other|5|||
125173116|NCT01524978|450254872|FG000|Overall Study|Withdrawal by Subject|12|||
125173117|NCT01524978|450254873|FG001|Overall Study|Withdrawal by Subject|0|||
125173118|NCT01524978|450254874|FG002|Overall Study|Withdrawal by Subject|1|||
125173119|NCT01524978|450254875|FG003|Overall Study|Withdrawal by Subject|1|||
125173120|NCT01524978|450254876|FG004|Overall Study|Withdrawal by Subject|3|||
125173121|NCT01524978|450254877|FG005|Overall Study|Withdrawal by Subject|1|||
125173122|NCT01524978|450254878|FG006|Overall Study|Withdrawal by Subject|6|||
125173123|NCT01524978|450254879|FG007|Overall Study|Withdrawal by Subject|2|||
125173124|NCT01524978|450254880|FG008|Overall Study|Withdrawal by Subject|4|||
125173125|NCT01524978|450254881|FG009|Overall Study|Withdrawal by Subject|0|||
125173126|NCT01524978|450254882|FG010|Overall Study|Withdrawal by Subject|5|||
125173127|NCT01524978|450254872|FG000|Overall Study|Lost to Follow-up|0|||
125173128|NCT01524978|450254873|FG001|Overall Study|Lost to Follow-up|0|||
125173129|NCT01524978|450254874|FG002|Overall Study|Lost to Follow-up|3|||
125173130|NCT01524978|450254875|FG003|Overall Study|Lost to Follow-up|0|||
125173131|NCT01524978|450254876|FG004|Overall Study|Lost to Follow-up|1|||
125173132|NCT01524978|450254877|FG005|Overall Study|Lost to Follow-up|1|||
125173133|NCT01524978|450254878|FG006|Overall Study|Lost to Follow-up|2|||
125229804|NCT01924533|450470037|FG001|Overall Study|Withdrawal by Subject|3|||
125229805|NCT01924533|450470036|FG000|Overall Study|Other Eligibility criteria|1|||
125229806|NCT01924533|450470037|FG001|Overall Study|Other Eligibility criteria|1|||
125229807|NCT02747927|450470038|FG000|Overall Study|Adverse Event|5|||
125229808|NCT02747927|450470039|FG001|Overall Study|Adverse Event|14|||
125229809|NCT02747927|450470038|FG000|Overall Study|Lost to Follow-up|22|||
125229810|NCT02747927|450470039|FG001|Overall Study|Lost to Follow-up|43|||
125229811|NCT02747927|450470038|FG000|Overall Study|Pregnancy|34|||
125229812|NCT02747927|450470039|FG001|Overall Study|Pregnancy|66|||
125229813|NCT02747927|450470038|FG000|Overall Study|Protocol Violation|2|||
125229814|NCT02747927|450470039|FG001|Overall Study|Protocol Violation|4|||
125229815|NCT02747927|450470038|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
125173134|NCT01524978|450254879|FG007|Overall Study|Lost to Follow-up|0|||
125173135|NCT01524978|450254880|FG008|Overall Study|Lost to Follow-up|1|||
125173136|NCT01524978|450254881|FG009|Overall Study|Lost to Follow-up|1|||
125173137|NCT01524978|450254882|FG010|Overall Study|Lost to Follow-up|1|||
125173138|NCT01524978|450254872|FG000|Overall Study|Death|34|||
125173139|NCT01524978|450254873|FG001|Overall Study|Death|2|||
125173140|NCT01524978|450254874|FG002|Overall Study|Death|5|||
125173141|NCT01524978|450254875|FG003|Overall Study|Death|24|||
125173142|NCT01524978|450254876|FG004|Overall Study|Death|4|||
125173143|NCT01524978|450254877|FG005|Overall Study|Death|4|||
125173144|NCT01524978|450254878|FG006|Overall Study|Death|1|||
125173145|NCT01524978|450254879|FG007|Overall Study|Death|9|||
125173146|NCT01524978|450254880|FG008|Overall Study|Death|5|||
125173147|NCT01524978|450254881|FG009|Overall Study|Death|6|||
125173148|NCT01524978|450254882|FG010|Overall Study|Death|17|||
125229816|NCT02747927|450470039|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
125173149|NCT02165735|450254885|FG000|Overall Study|Lost to Follow-up|12|||
125173150|NCT02165735|450254886|FG001|Overall Study|Lost to Follow-up|10|||
125173151|NCT02165735|450254885|FG000|Overall Study|Withdrawal by Subject|3|||
125229817|NCT02747927|450470038|FG000|Overall Study|Reason not Specified|11|||
125229818|NCT02747927|450470039|FG001|Overall Study|Reason not Specified|27|||
125173152|NCT02165735|450254886|FG001|Overall Study|Withdrawal by Subject|0|||
125173153|NCT02165735|450254885|FG000|Overall Study|Participant indicated lack of time|1|||
125173154|NCT02165735|450254886|FG001|Overall Study|Participant indicated lack of time|3|||
125173155|NCT02165735|450254885|FG000|Overall Study|Protocol Violation|0|||
125173156|NCT02165735|450254886|FG001|Overall Study|Protocol Violation|1|||
125173157|NCT03066258|450254887|FG000|Overall Study|Death|1|||
125173158|NCT03066258|450254888|FG001|Overall Study|Death|0|||
125173159|NCT03066258|450254889|FG002|Overall Study|Death|0|||
125173160|NCT03066258|450254890|FG003|Overall Study|Death|0|||
125173161|NCT03066258|450254891|FG004|Overall Study|Death|1|||
125173162|NCT02784795|450254892|FG000|Overall Study|Progressive Disease|2|||
125173163|NCT02784795|450254893|FG001|Overall Study|Progressive Disease|1|||
125173164|NCT02784795|450254894|FG002|Overall Study|Progressive Disease|1|||
125173165|NCT02784795|450254895|FG003|Overall Study|Progressive Disease|0|||
125173166|NCT02784795|450254896|FG004|Overall Study|Progressive Disease|2|||
125173167|NCT02784795|450254897|FG005|Overall Study|Progressive Disease|0|||
125173168|NCT02784795|450254898|FG006|Overall Study|Progressive Disease|2|||
125173169|NCT02784795|450254899|FG007|Overall Study|Progressive Disease|0|||
125173170|NCT02784795|450254900|FG008|Overall Study|Progressive Disease|0|||
125173171|NCT02784795|450254901|FG009|Overall Study|Progressive Disease|0|||
125173172|NCT02784795|450254902|FG010|Overall Study|Progressive Disease|1|||
125173173|NCT02784795|450254903|FG011|Overall Study|Progressive Disease|0|||
125173174|NCT02784795|450254892|FG000|Overall Study|Adverse Event|1|||
125173175|NCT02784795|450254893|FG001|Overall Study|Adverse Event|0|||
125173176|NCT02784795|450254894|FG002|Overall Study|Adverse Event|0|||
125173177|NCT02784795|450254895|FG003|Overall Study|Adverse Event|1|||
125173178|NCT02784795|450254896|FG004|Overall Study|Adverse Event|0|||
125173179|NCT02784795|450254897|FG005|Overall Study|Adverse Event|0|||
125173180|NCT02784795|450254898|FG006|Overall Study|Adverse Event|1|||
125173181|NCT02784795|450254899|FG007|Overall Study|Adverse Event|0|||
125173182|NCT02784795|450254900|FG008|Overall Study|Adverse Event|0|||
125173183|NCT02784795|450254901|FG009|Overall Study|Adverse Event|0|||
125173184|NCT02784795|450254902|FG010|Overall Study|Adverse Event|0|||
125173185|NCT02784795|450254903|FG011|Overall Study|Adverse Event|2|||
125173186|NCT02784795|450254892|FG000|Overall Study|Withdrawal by Subject|1|||
125173187|NCT02784795|450254893|FG001|Overall Study|Withdrawal by Subject|0|||
125173188|NCT02784795|450254894|FG002|Overall Study|Withdrawal by Subject|2|||
125173189|NCT02784795|450254895|FG003|Overall Study|Withdrawal by Subject|1|||
125173190|NCT02784795|450254896|FG004|Overall Study|Withdrawal by Subject|3|||
125173191|NCT02784795|450254897|FG005|Overall Study|Withdrawal by Subject|0|||
125173192|NCT02784795|450254898|FG006|Overall Study|Withdrawal by Subject|0|||
125173193|NCT02784795|450254899|FG007|Overall Study|Withdrawal by Subject|1|||
125173194|NCT02784795|450254900|FG008|Overall Study|Withdrawal by Subject|0|||
125173195|NCT02784795|450254901|FG009|Overall Study|Withdrawal by Subject|0|||
125173196|NCT02784795|450254902|FG010|Overall Study|Withdrawal by Subject|0|||
125173197|NCT02784795|450254903|FG011|Overall Study|Withdrawal by Subject|2|||
125173198|NCT02784795|450254892|FG000|Overall Study|Death|0|||
125173199|NCT02784795|450254893|FG001|Overall Study|Death|0|||
125173200|NCT02784795|450254894|FG002|Overall Study|Death|0|||
125173201|NCT02784795|450254895|FG003|Overall Study|Death|0|||
125173202|NCT02784795|450254896|FG004|Overall Study|Death|1|||
125173203|NCT02784795|450254897|FG005|Overall Study|Death|0|||
125173204|NCT02784795|450254898|FG006|Overall Study|Death|0|||
125173205|NCT02784795|450254899|FG007|Overall Study|Death|0|||
125173206|NCT02784795|450254900|FG008|Overall Study|Death|0|||
125173207|NCT02784795|450254901|FG009|Overall Study|Death|0|||
125173208|NCT02784795|450254902|FG010|Overall Study|Death|0|||
125173209|NCT02784795|450254903|FG011|Overall Study|Death|0|||
125173210|NCT02784795|450254892|FG000|Overall Study|Physician Decision|0|||
125173211|NCT02784795|450254893|FG001|Overall Study|Physician Decision|0|||
125173212|NCT02784795|450254894|FG002|Overall Study|Physician Decision|0|||
125173213|NCT02784795|450254895|FG003|Overall Study|Physician Decision|0|||
125173214|NCT02784795|450254896|FG004|Overall Study|Physician Decision|0|||
125173215|NCT02784795|450254897|FG005|Overall Study|Physician Decision|0|||
125173216|NCT02784795|450254898|FG006|Overall Study|Physician Decision|1|||
125173217|NCT02784795|450254899|FG007|Overall Study|Physician Decision|0|||
125173218|NCT02784795|450254900|FG008|Overall Study|Physician Decision|0|||
125173219|NCT02784795|450254901|FG009|Overall Study|Physician Decision|0|||
125173220|NCT02784795|450254902|FG010|Overall Study|Physician Decision|0|||
125173221|NCT02784795|450254903|FG011|Overall Study|Physician Decision|0|||
125173222|NCT00595309|450254906|FG000|Overall Study|Lost to Follow-up|1|||
125173223|NCT00595309|450254906|FG000|Overall Study|planned vaccination against yellow fever|1|||
125229819|NCT05412134|450470040|FG000|Overall Study|Lost to Follow-up|2|||
125173224|NCT00595309|450254906|FG000|Overall Study|acute infection after V0|1|||
125173225|NCT00595309|450254906|FG000|Overall Study|personal reason|1|||
125173226|NCT00626561|450254907|FG000|Overall Study|Withdrawal by Subject|2|||
125173227|NCT00626561|450254907|FG000|Overall Study|Disease Progression|2|||
125173228|NCT00101283|450254908|FG000|Overall Study|Withdrawal by Subject|0|||
125173229|NCT00101283|450254909|FG001|Overall Study|Withdrawal by Subject|1|||
125173230|NCT00101283|450254908|FG000|Overall Study|Insurance Refusal|0|||
125173231|NCT00101283|450254909|FG001|Overall Study|Insurance Refusal|1|||
125173232|NCT00101283|450254908|FG000|Overall Study|Prostate Cancer Recurrence|0|||
125173233|NCT00101283|450254909|FG001|Overall Study|Prostate Cancer Recurrence|1|||
125173234|NCT00185588|450254910|FG000|Overall Study|Adverse Event|3|||
125173235|NCT00185588|450254911|FG001|Overall Study|Adverse Event|1|||
125229820|NCT05412134|450470041|FG001|Overall Study|Lost to Follow-up|0|||
125173236|NCT00185588|450254912|FG002|Overall Study|Adverse Event|4|||
125173237|NCT00185588|450254913|FG003|Overall Study|Adverse Event|2|||
125173238|NCT00185588|450254910|FG000|Overall Study|Lost to Follow-up|0|||
125173239|NCT00185588|450254911|FG001|Overall Study|Lost to Follow-up|0|||
125229821|NCT04275336|450470043|FG000|Overall Study|First venipuncture failed|4|||
125229822|NCT04275336|450470044|FG001|Overall Study|First venipuncture failed|6|||
125229823|NCT04275336|450470045|FG002|Overall Study|First venipuncture failed|5|||
125229824|NCT04275336|450470043|FG000|Overall Study|Unscheduled venipuncture|9|||
125229825|NCT04275336|450470044|FG001|Overall Study|Unscheduled venipuncture|13|||
125229826|NCT04275336|450470045|FG002|Overall Study|Unscheduled venipuncture|7|||
125229827|NCT04275336|450470043|FG000|Overall Study|Failed specimen of saliva|4|||
125229828|NCT04275336|450470044|FG001|Overall Study|Failed specimen of saliva|3|||
125229829|NCT04275336|450470045|FG002|Overall Study|Failed specimen of saliva|4|||
125229830|NCT00423046|450470052|FG000|Overall Study|Other|340|||
125229831|NCT00423046|450470053|FG001|Overall Study|Other|345|||
125229832|NCT00830128|450470054|FG000|Overall Study|Adverse Event|5|||
125229833|NCT00830128|450470054|FG000|Overall Study|Lack of Efficacy|7|||
125229834|NCT00830128|450470054|FG000|Overall Study|Protocol Violation|1|||
125229835|NCT00830128|450470054|FG000|Overall Study|Withdrawal by Subject|2|||
125229836|NCT00830128|450470054|FG000|Overall Study|Family obligation|1|||
125229837|NCT00830128|450470054|FG000|Overall Study|Relocation|1|||
125229838|NCT00830128|450470054|FG000|Overall Study|Work obligation|1|||
125229839|NCT00830128|450470054|FG000|Overall Study|Operating a vehicle|1|||
125229840|NCT05401565|450470055|FG000|Overall Study|Lost to Follow-up|1|||
125229841|NCT05401565|450470056|FG001|Overall Study|Lost to Follow-up|0|||
125229842|NCT05401565|450470055|FG000|Overall Study|Adverse Event|2|||
125229843|NCT05401565|450470056|FG001|Overall Study|Adverse Event|0|||
125229844|NCT01218802|450470065|FG000|Overall Study|Lost to Follow-up|5|||
125229845|NCT01218802|450470066|FG001|Overall Study|Lost to Follow-up|6|||
125229846|NCT01218802|450470065|FG000|Overall Study|Withdrawal by Subject|3|||
125229847|NCT01218802|450470066|FG001|Overall Study|Withdrawal by Subject|10|||
125229848|NCT01218802|450470065|FG000|Overall Study|Adverse Event|0|||
125229849|NCT01218802|450470066|FG001|Overall Study|Adverse Event|2|||
125229850|NCT01218802|450470065|FG000|Overall Study|Incarcerated|2|||
125229851|NCT01218802|450470066|FG001|Overall Study|Incarcerated|0|||
125229852|NCT03329885|450470067|FG000|Overall Study|Sponsor discontinued the study early|0|||
125229853|NCT03329885|450470068|FG001|Overall Study|Sponsor discontinued the study early|0|||
125229854|NCT03329885|450470069|FG002|Overall Study|Sponsor discontinued the study early|0|||
125229855|NCT03329885|450470070|FG003|Overall Study|Sponsor discontinued the study early|0|||
125229856|NCT03329885|450470071|FG004|Overall Study|Sponsor discontinued the study early|0|||
125229857|NCT03329885|450470072|FG005|Overall Study|Sponsor discontinued the study early|0|||
125229858|NCT03329885|450470073|FG006|Overall Study|Sponsor discontinued the study early|1|||
125229859|NCT03329885|450470074|FG007|Overall Study|Sponsor discontinued the study early|1|||
125229860|NCT03329885|450470075|FG008|Overall Study|Sponsor discontinued the study early|0|||
125229861|NCT03368807|450470080|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
125229862|NCT03368807|450470080|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
125229863|NCT03368807|450470080|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
125229864|NCT03368807|450470080|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
125229865|NCT00843492|450470081|FG000|Overall Study|Adverse Event|0|||
125229866|NCT00843492|450470082|FG001|Overall Study|Adverse Event|3|||
125229867|NCT00843492|450470081|FG000|Overall Study|Lost to Follow-up|4|||
125229868|NCT00843492|450470082|FG001|Overall Study|Lost to Follow-up|4|||
125229869|NCT00843492|450470081|FG000|Overall Study|Withdrawal by Subject|0|||
125229870|NCT00843492|450470082|FG001|Overall Study|Withdrawal by Subject|4|||
125229871|NCT00843492|450470081|FG000|Overall Study|Immobilization Stopped|1|||
125229872|NCT00843492|450470082|FG001|Overall Study|Immobilization Stopped|0|||
125229873|NCT00843492|450470081|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
125229874|NCT00843492|450470082|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
125229875|NCT00843492|450470081|FG000|Overall Study|Orthopedic Surgery|0|||
125229876|NCT00843492|450470082|FG001|Overall Study|Orthopedic Surgery|2|||
125229877|NCT00843492|450470081|FG000|Overall Study|Visit Not Performed|1|||
125229878|NCT00843492|450470082|FG001|Overall Study|Visit Not Performed|0|||
125229879|NCT00843492|450470081|FG000|Overall Study|Deep-vein Thrombosis|1|||
125229880|NCT00843492|450470082|FG001|Overall Study|Deep-vein Thrombosis|0|||
125229881|NCT01677741|450470084|FG000|Overall Study|Death|0|||
125229882|NCT01677741|450470085|FG001|Overall Study|Death|0|||
125229883|NCT01677741|450470086|FG002|Overall Study|Death|0|||
125229884|NCT01677741|450470087|FG003|Overall Study|Death|1|||
125229885|NCT01677741|450470088|FG004|Overall Study|Death|0|||
125229886|NCT01677741|450470089|FG005|Overall Study|Death|1|||
125229887|NCT01677741|450470090|FG006|Overall Study|Death|0|||
125229888|NCT01677741|450470091|FG007|Overall Study|Death|0|||
125229889|NCT01677741|450470084|FG000|Overall Study|Withdrawal by Subject|2|||
125229890|NCT01677741|450470085|FG001|Overall Study|Withdrawal by Subject|7|||
125229891|NCT01677741|450470086|FG002|Overall Study|Withdrawal by Subject|5|||
125229892|NCT01677741|450470087|FG003|Overall Study|Withdrawal by Subject|4|||
125229893|NCT01677741|450470088|FG004|Overall Study|Withdrawal by Subject|11|||
125229894|NCT01677741|450470089|FG005|Overall Study|Withdrawal by Subject|20|||
125229895|NCT01677741|450470090|FG006|Overall Study|Withdrawal by Subject|4|||
125229896|NCT01677741|450470091|FG007|Overall Study|Withdrawal by Subject|2|||
125229897|NCT01677741|450470084|FG000|Overall Study|Enrolled in a rollover study|0|||
125229898|NCT01677741|450470085|FG001|Overall Study|Enrolled in a rollover study|3|||
125229899|NCT01677741|450470086|FG002|Overall Study|Enrolled in a rollover study|2|||
125229900|NCT01677741|450470087|FG003|Overall Study|Enrolled in a rollover study|1|||
125229901|NCT01677741|450470088|FG004|Overall Study|Enrolled in a rollover study|6|||
125229902|NCT01677741|450470089|FG005|Overall Study|Enrolled in a rollover study|6|||
125229903|NCT01677741|450470090|FG006|Overall Study|Enrolled in a rollover study|7|||
125229904|NCT01677741|450470091|FG007|Overall Study|Enrolled in a rollover study|0|||
125229905|NCT01677741|450470084|FG000|Overall Study|Progressive disease|1|||
125229906|NCT01677741|450470085|FG001|Overall Study|Progressive disease|0|||
125229907|NCT01677741|450470086|FG002|Overall Study|Progressive disease|1|||
125229908|NCT01677741|450470087|FG003|Overall Study|Progressive disease|0|||
125229909|NCT01677741|450470088|FG004|Overall Study|Progressive disease|0|||
125229910|NCT01677741|450470089|FG005|Overall Study|Progressive disease|1|||
125229911|NCT01677741|450470090|FG006|Overall Study|Progressive disease|0|||
125229912|NCT01677741|450470091|FG007|Overall Study|Progressive disease|0|||
125229913|NCT01973218|450470092|FG000|Overall Study|Adverse Event|1|||
125229914|NCT01973218|450470093|FG001|Overall Study|Adverse Event|0|||
125229915|NCT01973218|450470092|FG000|Overall Study|Withdrawal by Subject|1|||
125229916|NCT01973218|450470093|FG001|Overall Study|Withdrawal by Subject|0|||
125229917|NCT01441973|450470098|FG000|Overall Study|Disease progression|8|||
125229918|NCT01441973|450470099|FG001|Overall Study|Disease progression|6|||
125229919|NCT01441973|450470098|FG000|Overall Study|Adverse event unrelated to study drug|3|||
125229920|NCT01441973|450470099|FG001|Overall Study|Adverse event unrelated to study drug|2|||
125229921|NCT01441973|450470098|FG000|Overall Study|Participant request to discontinue|1|||
125229922|NCT01441973|450470099|FG001|Overall Study|Participant request to discontinue|1|||
125229923|NCT01441973|450470098|FG000|Overall Study|Poor compliance/noncompliance|0|||
125229924|NCT01441973|450470099|FG001|Overall Study|Poor compliance/noncompliance|1|||
125229925|NCT01441973|450470098|FG000|Overall Study|Administrative reason by sponsor|3|||
125229926|NCT01441973|450470099|FG001|Overall Study|Administrative reason by sponsor|5|||
125229927|NCT01441973|450470098|FG000|Overall Study|Participant withdrew consent|0|||
125229928|NCT01441973|450470099|FG001|Overall Study|Participant withdrew consent|1|||
125229929|NCT01149655|450470100|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
125229930|NCT01149655|450470101|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
125229931|NCT01149655|450470102|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
125229932|NCT01149655|450470103|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
125173240|NCT00185588|450254912|FG002|Overall Study|Lost to Follow-up|1|||
125173241|NCT00185588|450254913|FG003|Overall Study|Lost to Follow-up|2|||
125173242|NCT00185588|450254910|FG000|Overall Study|Withdrawal by Subject|0|||
125173243|NCT00185588|450254911|FG001|Overall Study|Withdrawal by Subject|1|||
125173244|NCT00185588|450254912|FG002|Overall Study|Withdrawal by Subject|0|||
125173245|NCT00185588|450254913|FG003|Overall Study|Withdrawal by Subject|0|||
125173246|NCT00185588|450254910|FG000|Overall Study|Physician Decision|0|||
125173247|NCT00185588|450254911|FG001|Overall Study|Physician Decision|0|||
125173248|NCT00185588|450254912|FG002|Overall Study|Physician Decision|1|||
125173249|NCT00185588|450254913|FG003|Overall Study|Physician Decision|0|||
125173250|NCT02604407|450254914|FG000|Overall Study|Adverse Event|0|||
125173251|NCT02604407|450254915|FG001|Overall Study|Adverse Event|7|||
125173252|NCT02604407|450254916|FG002|Overall Study|Adverse Event|5|||
125173253|NCT02604407|450254914|FG000|Overall Study|Protocol Violation|2|||
125173254|NCT02604407|450254915|FG001|Overall Study|Protocol Violation|0|||
125173255|NCT02604407|450254916|FG002|Overall Study|Protocol Violation|0|||
125173256|NCT02604407|450254914|FG000|Overall Study|Withdrawal by Subject|3|||
125173257|NCT02604407|450254915|FG001|Overall Study|Withdrawal by Subject|3|||
125173258|NCT02604407|450254916|FG002|Overall Study|Withdrawal by Subject|5|||
125173259|NCT02604407|450254914|FG000|Overall Study|Lost to Follow-up|2|||
125173260|NCT02604407|450254915|FG001|Overall Study|Lost to Follow-up|1|||
125173261|NCT02604407|450254916|FG002|Overall Study|Lost to Follow-up|2|||
125173262|NCT02604407|450254914|FG000|Overall Study|Lack of Efficacy|1|||
125173263|NCT02604407|450254915|FG001|Overall Study|Lack of Efficacy|0|||
125173264|NCT02604407|450254916|FG002|Overall Study|Lack of Efficacy|0|||
125173265|NCT02604407|450254914|FG000|Overall Study|Other|3|||
125173266|NCT02604407|450254915|FG001|Overall Study|Other|1|||
125173267|NCT02604407|450254916|FG002|Overall Study|Other|4|||
125173268|NCT00398866|450254918|FG000|Overall Study|Adverse Event|1|||
125173269|NCT00398866|450254919|FG001|Overall Study|Adverse Event|0|||
125173270|NCT00398866|450254920|FG002|Overall Study|Adverse Event|0|||
125229933|NCT01149655|450470100|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
125229934|NCT01149655|450470101|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
125173271|NCT00398866|450254918|FG000|Overall Study|Lack of Efficacy|0|||
125173272|NCT00398866|450254919|FG001|Overall Study|Lack of Efficacy|0|||
125173273|NCT00398866|450254920|FG002|Overall Study|Lack of Efficacy|1|||
125173274|NCT00398866|450254918|FG000|Overall Study|Lost to Follow-up|7|||
125173275|NCT00398866|450254919|FG001|Overall Study|Lost to Follow-up|6|||
125173276|NCT00398866|450254920|FG002|Overall Study|Lost to Follow-up|4|||
125173277|NCT00398866|450254918|FG000|Overall Study|Withdrawal by Subject|5|||
125173278|NCT00398866|450254919|FG001|Overall Study|Withdrawal by Subject|1|||
125173279|NCT00398866|450254920|FG002|Overall Study|Withdrawal by Subject|2|||
125173280|NCT00398866|450254918|FG000|Overall Study|Unable to complete requirements of study|1|||
125173281|NCT00398866|450254919|FG001|Overall Study|Unable to complete requirements of study|1|||
125173282|NCT00398866|450254920|FG002|Overall Study|Unable to complete requirements of study|1|||
125173283|NCT00606632|450254921|FG000|Overall Study|Withdrawal by Subject|13|||
125173284|NCT00606632|450254921|FG000|Overall Study|Miscellaneous reasons|9|||
125173285|NCT00191191|450254924|FG000|Overall Study|Entry Criteria Exclusion|2|||
125173286|NCT00191191|450254925|FG001|Overall Study|Entry Criteria Exclusion|0|||
125173287|NCT00191191|450254924|FG000|Overall Study|Treated with Another Systemic Agent|1|||
125173288|NCT00191191|450254925|FG001|Overall Study|Treated with Another Systemic Agent|1|||
125173289|NCT00191191|450254924|FG000|Overall Study|Adverse Event|11|||
125173290|NCT00191191|450254925|FG001|Overall Study|Adverse Event|21|||
125173291|NCT00191191|450254924|FG000|Overall Study|Progressive Disease|84|||
125173292|NCT00191191|450254925|FG001|Overall Study|Progressive Disease|72|||
125173293|NCT00191191|450254924|FG000|Overall Study|Toxicity After Dose Reduction|7|||
125173294|NCT00191191|450254925|FG001|Overall Study|Toxicity After Dose Reduction|8|||
125173295|NCT00191191|450254924|FG000|Overall Study|Family/Caregiver Decision|5|||
125173296|NCT00191191|450254925|FG001|Overall Study|Family/Caregiver Decision|7|||
125173297|NCT00191191|450254924|FG000|Overall Study|Lost to Follow-up|1|||
125173298|NCT00191191|450254925|FG001|Overall Study|Lost to Follow-up|0|||
125173299|NCT00191191|450254924|FG000|Overall Study|Physician Decision|3|||
125173300|NCT00191191|450254925|FG001|Overall Study|Physician Decision|2|||
125173301|NCT00191191|450254924|FG000|Overall Study|Good Clinical Practice Violation|0|||
125173302|NCT00191191|450254925|FG001|Overall Study|Good Clinical Practice Violation|1|||
125173303|NCT05445492|450254926|FG000|Overall Study|Physician Decision|1|||
125173304|NCT03633825|450254927|FG000|Enrollment|Did not post on network|5066|||
125173305|NCT03633825|450254928|FG001|Enrollment|Did not post on network|5080|||
125173306|NCT03633825|450254927|FG000|Enrollment|Post not classified as crisis|13967|||
125173307|NCT03633825|450254928|FG001|Enrollment|Post not classified as crisis|13757|||
125173308|NCT03633825|450254927|FG000|Follow up|Lost to Follow-up|478|||
125173309|NCT03633825|450254928|FG001|Follow up|Lost to Follow-up|450|||
125173310|NCT03348163|450254929|FG000|Overall Study|Withdrawal by Subject|2|||
125173311|NCT03348163|450254930|FG001|Overall Study|Withdrawal by Subject|0|||
125173312|NCT01267994|450254931|FG000|Overall Study|Adverse Event|2|||
125173313|NCT03837743|450254932|FG000|Overall Study|Adverse Event|1|||
125173314|NCT03837743|450254932|FG000|Overall Study|Withdrawal by Subject|2|||
125173315|NCT01275430|450254934|FG000|Overall Study|Adverse Event|1|||
125173316|NCT01275430|450254934|FG000|Overall Study|No Contrast Injection|6|||
125173317|NCT01275430|450254934|FG000|Overall Study|Device Malfunction|1|||
125173318|NCT01275430|450254934|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
125173319|NCT04759768|450254935|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
125173320|NCT04759768|450254936|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
125173321|NCT04759768|450254935|FG000|Washout (7 Days)|Physician Decision|0|||
125173322|NCT04759768|450254936|FG001|Washout (7 Days)|Physician Decision|1|||
125173323|NCT02996487|450254937|FG000|Overall Study|Lost to Follow-up|1|||
125173324|NCT02996487|450254938|FG001|Overall Study|Lost to Follow-up|1|||
125173325|NCT02996487|450254939|FG002|Overall Study|Lost to Follow-up|0|||
125173326|NCT02996487|450254937|FG000|Overall Study|Death|0|||
125173327|NCT02996487|450254938|FG001|Overall Study|Death|1|||
125173328|NCT02996487|450254939|FG002|Overall Study|Death|0|||
125173329|NCT02996487|450254937|FG000|Overall Study|Withdrawal by Subject|2|||
125173330|NCT02996487|450254938|FG001|Overall Study|Withdrawal by Subject|3|||
125173331|NCT02996487|450254939|FG002|Overall Study|Withdrawal by Subject|0|||
125173332|NCT01130597|450254940|FG000|Overall Study|Protocol-specified (High K+)|1|||
125173333|NCT01130597|450254940|FG000|Overall Study|Adverse Event|4|||
125173334|NCT01130597|450254940|FG000|Overall Study|Death|1|||
125173335|NCT01130597|450254940|FG000|Overall Study|Protocol Violation|1|||
125173336|NCT01301729|450254941|FG000|Overall Study|Withdrawal by Subject|2|||
125173337|NCT01301729|450254941|FG000|Overall Study|Participant did not Return for Treatment|1|||
125173338|NCT01301729|450254941|FG000|Overall Study|Violated Selection Criteria|1|||
125173339|NCT04873934|450254942|FG000|Overall Study|Adverse Event|0|||
125173340|NCT04873934|450254943|FG001|Overall Study|Adverse Event|1|||
125173341|NCT04873934|450254942|FG000|Overall Study|Death|0|||
125173342|NCT04873934|450254943|FG001|Overall Study|Death|2|||
125173343|NCT04873934|450254942|FG000|Overall Study|Lost to Follow-up|13|||
125173344|NCT04873934|450254943|FG001|Overall Study|Lost to Follow-up|9|||
125173345|NCT04873934|450254942|FG000|Overall Study|Physician Decision|1|||
125173346|NCT04873934|450254943|FG001|Overall Study|Physician Decision|1|||
125173347|NCT04873934|450254942|FG000|Overall Study|Protocol deviation|2|||
125173348|NCT04873934|450254943|FG001|Overall Study|Protocol deviation|1|||
125173349|NCT04873934|450254942|FG000|Overall Study|Subject decision|1|||
125229935|NCT01149655|450470102|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
125173350|NCT04873934|450254943|FG001|Overall Study|Subject decision|8|||
125173351|NCT04873934|450254942|FG000|Overall Study|Withdrew consent|0|||
125173352|NCT04873934|450254943|FG001|Overall Study|Withdrew consent|4|||
125173353|NCT04873934|450254942|FG000|Overall Study|Missing|1|||
125173354|NCT04873934|450254943|FG001|Overall Study|Missing|0|||
125173355|NCT05794503|450254944|FG000|Overall Study|Operation Cancelled|2|||
125173356|NCT05794503|450254945|FG001|Overall Study|Operation Cancelled|0|||
125173357|NCT05794503|450254944|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
125173358|NCT05794503|450254945|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
125173359|NCT05794503|450254944|FG000|Overall Study|Protocol Violation|1|||
125173360|NCT05794503|450254945|FG001|Overall Study|Protocol Violation|0|||
125173361|NCT01464931|450254947|FG000|Overall Study|Withdrawal by Subject|1|||
125173362|NCT01464931|450254948|FG001|Overall Study|Withdrawal by Subject|0|||
125173363|NCT00338728|450254951|FG000|Overall Study|Screen Failure|14|||
125173364|NCT04102189|450254952|FG000|Overall Study|Withdrawal by Subject|1|||
125173365|NCT04102189|450254953|FG001|Overall Study|Withdrawal by Subject|2|||
125173366|NCT04102189|450254952|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125173367|NCT04102189|450254953|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125173368|NCT04102189|450254952|FG000|Overall Study|Lost to Follow-up|1|||
125173369|NCT04102189|450254953|FG001|Overall Study|Lost to Follow-up|0|||
125173370|NCT02933255|450254956|FG000|Overall Study|Discontinued due to study closure.|1|||
125173371|NCT02933255|450254957|FG001|Overall Study|Discontinued due to study closure.|0|||
125173372|NCT04803305|450254960|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
125173373|NCT04803305|450254961|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
125173374|NCT04803305|450254960|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
125173375|NCT04803305|450254961|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
125173376|NCT04803305|450254960|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
125173377|NCT04803305|450254961|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
125173378|NCT04803305|450254960|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
125173379|NCT04803305|450254961|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
125173380|NCT04803305|450254960|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
125173381|NCT04803305|450254961|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
125173382|NCT04803305|450254960|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
125173383|NCT04803305|450254961|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
125173384|NCT04803305|450254960|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
125173385|NCT04803305|450254961|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
125173386|NCT04803305|450254960|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
125173387|NCT04803305|450254961|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
125173388|NCT00708227|450254966|FG000|Overall Study|Physician Decision|0|||
125173389|NCT00708227|450254967|FG001|Overall Study|Physician Decision|3|||
125173390|NCT00708227|450254968|FG002|Overall Study|Physician Decision|1|||
125173391|NCT00708227|450254969|FG003|Overall Study|Physician Decision|2|||
125173392|NCT00708227|450254966|FG000|Overall Study|Withdrawal by Subject|1|||
125173393|NCT00708227|450254967|FG001|Overall Study|Withdrawal by Subject|2|||
125173394|NCT00708227|450254968|FG002|Overall Study|Withdrawal by Subject|0|||
125173395|NCT00708227|450254969|FG003|Overall Study|Withdrawal by Subject|1|||
125173396|NCT03654599|450254971|FG000|Overall Study|Lost to Follow-up|14|||
125173397|NCT03654599|450254972|FG001|Overall Study|Lost to Follow-up|12|||
125173398|NCT03654599|450254971|FG000|Overall Study|Death|8|||
125173399|NCT03654599|450254972|FG001|Overall Study|Death|6|||
125173400|NCT03654599|450254971|FG000|Overall Study|Withdrawal by Subject|6|||
125173401|NCT03654599|450254972|FG001|Overall Study|Withdrawal by Subject|4|||
125173402|NCT02017015|450257130|FG000|Overall Study|Adverse Event|9|||
125173403|NCT02017015|450257130|FG000|Overall Study|Withdrawal by Subject|21|||
125173404|NCT02017015|450257130|FG000|Overall Study|Death|4|||
125173405|NCT02017015|450257130|FG000|Overall Study|Progressive Disease|31|||
125173406|NCT02017015|450257130|FG000|Overall Study|Non-compliance with study drug|2|||
125173407|NCT02017015|450257130|FG000|Overall Study|Physician Decision|2|||
125173408|NCT02291510|450257138|FG000|Overall Study|Adverse Event|0|||
125173409|NCT02291510|450257139|FG001|Overall Study|Adverse Event|0|||
125173410|NCT02291510|450257140|FG002|Overall Study|Adverse Event|0|||
125173411|NCT02291510|450257141|FG003|Overall Study|Adverse Event|1|||
125173412|NCT03765788|450257142|FG000|Overall Study|Subject decision|2|||
125173413|NCT03765788|450257143|FG001|Overall Study|Subject decision|3|||
125173414|NCT03765788|450257142|FG000|Overall Study|Physician Decision|2|||
125173415|NCT03765788|450257143|FG001|Overall Study|Physician Decision|4|||
125173416|NCT03765788|450257142|FG000|Overall Study|Death|0|||
125173417|NCT03765788|450257143|FG001|Overall Study|Death|1|||
125173418|NCT03765788|450257142|FG000|Overall Study|Lost to Follow-up|1|||
125173419|NCT03765788|450257143|FG001|Overall Study|Lost to Follow-up|0|||
125173420|NCT03203850|450257144|FG000|Overall Study|Subject/guardian decision|4|||
125173421|NCT03203850|450257145|FG001|Overall Study|Subject/guardian decision|3|||
125173422|NCT03203850|450257144|FG000|Overall Study|Adverse Event|3|||
125173423|NCT03203850|450257145|FG001|Overall Study|Adverse Event|0|||
125173424|NCT03203850|450257144|FG000|Overall Study|Death|1|||
125173425|NCT03203850|450257145|FG001|Overall Study|Death|0|||
125173426|NCT01659125|450257146|FG000|Overall Study|Withdrawal by Subject|2|||
125173427|NCT01659125|450257146|FG000|Overall Study|Lost to Follow-up|7|||
125173428|NCT01659125|450257146|FG000|Overall Study|Technical Problem|1|||
125173429|NCT01659125|450257146|FG000|Overall Study|Time Constraints|2|||
125229936|NCT01149655|450470103|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
125173430|NCT01659125|450257146|FG000|Overall Study|Failed to Start Treatment|2|||
125173431|NCT02126826|450257147|FG000|Overall Study|Withdrawal by Subject|0|||
125173432|NCT02126826|450257148|FG001|Overall Study|Withdrawal by Subject|0|||
125173433|NCT02126826|450257149|FG002|Overall Study|Withdrawal by Subject|0|||
125173434|NCT02126826|450257150|FG003|Overall Study|Withdrawal by Subject|1|||
125173435|NCT02126826|450257151|FG004|Overall Study|Withdrawal by Subject|0|||
125173436|NCT02126826|450257152|FG005|Overall Study|Withdrawal by Subject|0|||
125173437|NCT02126826|450257153|FG006|Overall Study|Withdrawal by Subject|0|||
125173438|NCT02640482|450257154|FG000|Overall Study|Lost to Follow-up|3|||
125173439|NCT02640482|450257155|FG001|Overall Study|Lost to Follow-up|0|||
125173440|NCT01173120|450257156|FG000|Overall Study|Lack of Efficacy|2|||
125173441|NCT01173120|450257156|FG000|Overall Study|Lost to Follow-up|1|||
125173442|NCT01173120|450257156|FG000|Overall Study|Participant Decision|2|||
125173443|NCT01173120|450257156|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
125173444|NCT01173120|450257156|FG000|Overall Study|Switch-Participant Decision|12|||
125173445|NCT01173120|450257156|FG000|Overall Study|Switch-Difficulty With Device|12|||
125173446|NCT00517881|450257157|FG000|Overall Study|Protocol Violation|2|||
125173447|NCT00517881|450257157|FG000|Overall Study|Adverse Event|1|||
125173448|NCT00517881|450257157|FG000|Overall Study|Renal transplantation|2|||
125173449|NCT00113763|450257158|FG000|Overall Study|Adverse Event|5|||
125173450|NCT00113763|450257159|FG001|Overall Study|Adverse Event|2|||
125173451|NCT00113763|450257158|FG000|Overall Study|Disease Progression|28|||
125173452|NCT00113763|450257159|FG001|Overall Study|Disease Progression|14|||
125173453|NCT00113763|450257158|FG000|Overall Study|Lost to Follow-up|10|||
125173454|NCT00113763|450257159|FG001|Overall Study|Lost to Follow-up|0|||
125173455|NCT00113763|450257158|FG000|Overall Study|Withdrawal by Subject|1|||
125173456|NCT00113763|450257159|FG001|Overall Study|Withdrawal by Subject|4|||
125173457|NCT00113763|450257158|FG000|Overall Study|Other|27|||
125173458|NCT00113763|450257159|FG001|Overall Study|Other|6|||
125173459|NCT00113763|450257158|FG000|Overall Study|Non-compliance|1|||
125173460|NCT00113763|450257159|FG001|Overall Study|Non-compliance|0|||
125173461|NCT00113763|450257158|FG000|Overall Study|Ongoing|1|||
125173462|NCT00113763|450257159|FG001|Overall Study|Ongoing|0|||
125173463|NCT01383707|450257160|FG000|Overall Study|Consent withdrawal|6|||
125173464|NCT01383707|450257160|FG000|Overall Study|Death|19|||
125173465|NCT01383707|450257160|FG000|Overall Study|Other|8|||
125173466|NCT01383707|450257160|FG000|Overall Study|Sponsor's decision|2|||
125173467|NCT01383707|450257160|FG000|Overall Study|Adverse Event|14|||
125173468|NCT01383707|450257160|FG000|Overall Study|Progressive disease|23|||
125173469|NCT02013817|450257161|FG000|Overall Study|Adverse Event|12|||
125173470|NCT02013817|450257161|FG000|Overall Study|Withdrawal by Subject|4|||
125173471|NCT02013817|450257161|FG000|Overall Study|Death|2|||
125173472|NCT02013817|450257161|FG000|Overall Study|Other|9|||
125173473|NCT02129608|450257162|FG000|Overall Study|Lost to Follow-up|0|||
125173474|NCT02129608|450257163|FG001|Overall Study|Lost to Follow-up|1|||
125173475|NCT02129608|450257164|FG002|Overall Study|Lost to Follow-up|1|||
125173476|NCT02129608|450257162|FG000|Overall Study|Withdrawal by Subject|0|||
125173477|NCT02129608|450257163|FG001|Overall Study|Withdrawal by Subject|0|||
125173478|NCT02129608|450257164|FG002|Overall Study|Withdrawal by Subject|2|||
125173479|NCT00451204|450257171|FG000|Overall Study|Adverse Event|4|||
125173480|NCT00451204|450257172|FG001|Overall Study|Adverse Event|6|||
125173481|NCT00451204|450257171|FG000|Overall Study|Lack of Efficacy|4|||
125173482|NCT00451204|450257172|FG001|Overall Study|Lack of Efficacy|4|||
125173483|NCT00451204|450257171|FG000|Overall Study|Lost to Follow-up|4|||
125173484|NCT00451204|450257172|FG001|Overall Study|Lost to Follow-up|4|||
125173485|NCT00451204|450257171|FG000|Overall Study|Protocol Violation|1|||
125173486|NCT00451204|450257172|FG001|Overall Study|Protocol Violation|0|||
125173487|NCT00451204|450257171|FG000|Overall Study|Patient refusal|8|||
125173488|NCT00451204|450257172|FG001|Overall Study|Patient refusal|4|||
125173489|NCT00451204|450257171|FG000|Overall Study|Other|1|||
125229937|NCT01149655|450470100|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
125173490|NCT00451204|450257172|FG001|Overall Study|Other|2|||
125173491|NCT03055624|450257173|FG000|Overall Study|Study closed|9|||
125173492|NCT01582152|450257174|FG000|Overall Study|Disease Progression|4|||
125229938|NCT01149655|450470101|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
125229939|NCT01149655|450470102|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
125229940|NCT01149655|450470103|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
125229941|NCT01149655|450470100|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
125173493|NCT01582152|450257175|FG001|Overall Study|Disease Progression|5|||
125173494|NCT01582152|450257174|FG000|Overall Study|Adverse Event|2|||
125173495|NCT01582152|450257175|FG001|Overall Study|Adverse Event|1|||
125173496|NCT02794870|450257181|FG000|Overall Study|Withdrawal by Subject|2|||
125173497|NCT02794870|450257182|FG001|Overall Study|Withdrawal by Subject|0|||
125173498|NCT03336528|450257183|FG000|Overall Study|Protocol Violation|1|||
125173499|NCT03336528|450257184|FG001|Overall Study|Protocol Violation|1|||
125173500|NCT03336528|450257183|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
125173501|NCT03336528|450257184|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
125173502|NCT03336528|450257183|FG000|Overall Study|Did not receive study medication|1|||
125229942|NCT01149655|450470101|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
125229943|NCT01149655|450470102|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
125229944|NCT01149655|450470103|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
125229945|NCT01149655|450470100|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
125229946|NCT01149655|450470101|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
125229947|NCT01149655|450470102|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
125229948|NCT01149655|450470103|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
125229949|NCT01149655|450470100|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
125229950|NCT01149655|450470101|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
125229951|NCT01149655|450470102|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
125229952|NCT01149655|450470103|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
125229953|NCT01149655|450470100|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
125229954|NCT01149655|450470101|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
125229955|NCT01149655|450470102|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
125229956|NCT01149655|450470103|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
125229957|NCT01149655|450470100|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
125229958|NCT01149655|450470101|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
125229959|NCT01149655|450470102|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
125229960|NCT01149655|450470103|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
125229961|NCT01149655|450470100|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
125229962|NCT01149655|450470101|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
125229963|NCT01149655|450470102|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
125229964|NCT01149655|450470103|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
125229965|NCT01149655|450470100|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
125229966|NCT01149655|450470101|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
125229967|NCT01149655|450470102|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
125229968|NCT01149655|450470103|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
125229969|NCT01149655|450470100|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
125229970|NCT01149655|450470101|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
125229971|NCT01149655|450470102|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
125229972|NCT01149655|450470103|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
125229973|NCT01149655|450470100|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
125229974|NCT01149655|450470101|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
125229975|NCT01149655|450470102|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
125173503|NCT03336528|450257184|FG001|Overall Study|Did not receive study medication|2|||
125173504|NCT02437903|450257187|FG000|Overall Study|Adverse Event|1|||
125173505|NCT02437903|450257187|FG000|Overall Study|Withdrawal by Subject|1|||
125173506|NCT02437903|450257187|FG000|Overall Study|Lost to Follow-up|3|||
125173507|NCT00230178|450257190|FG000|Overall Study|Adverse Event|1|||
125173508|NCT00230178|450257191|FG001|Overall Study|Adverse Event|5|||
125173509|NCT00230178|450257192|FG002|Overall Study|Adverse Event|2|||
125173510|NCT00230178|450257190|FG000|Overall Study|Withdrawal by Subject|0|||
125173511|NCT00230178|450257191|FG001|Overall Study|Withdrawal by Subject|0|||
125173512|NCT00230178|450257192|FG002|Overall Study|Withdrawal by Subject|1|||
125173513|NCT00230178|450257190|FG000|Overall Study|Various other reasons|3|||
125173514|NCT00230178|450257191|FG001|Overall Study|Various other reasons|2|||
125173515|NCT00230178|450257192|FG002|Overall Study|Various other reasons|4|||
125173516|NCT04172597|450257200|FG000|Overall Study|Disease Progression|0|||
125173517|NCT04172597|450257201|FG001|Overall Study|Disease Progression|0|||
125173518|NCT04172597|450257202|FG002|Overall Study|Disease Progression|0|||
125173519|NCT04172597|450257203|FG003|Overall Study|Disease Progression|0|||
125173520|NCT04172597|450257204|FG004|Overall Study|Disease Progression|1|||
125173521|NCT00794339|450257205|FG000|Overall Study|Withdrawal by Subject|3|||
125173522|NCT00794339|450257205|FG000|Overall Study|Ineligible|4|||
125173523|NCT00794339|450257205|FG000|Overall Study|Tx prior to ATSM|3|||
125173524|NCT00794339|450257205|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
125173525|NCT00794339|450257205|FG000|Overall Study|Tx not per protocol|1|||
125173526|NCT01611857|450257206|FG000|Overall Study|Withdrawal by Subject|0|||
125173527|NCT01611857|450257207|FG001|Overall Study|Withdrawal by Subject|2|||
125173528|NCT00616421|450257220|FG000|Overall Study|Withdrawal by Subject|9|||
125173529|NCT00616421|450257221|FG001|Overall Study|Withdrawal by Subject|11|||
125173530|NCT00616421|450257222|FG002|Overall Study|Withdrawal by Subject|8|||
125173531|NCT00616421|450257220|FG000|Overall Study|Lost to Follow-up|12|||
125229976|NCT01149655|450470103|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
125229977|NCT01149655|450470100|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
125173532|NCT00616421|450257221|FG001|Overall Study|Lost to Follow-up|26|||
125173533|NCT00616421|450257222|FG002|Overall Study|Lost to Follow-up|30|||
125229978|NCT01149655|450470101|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
125173534|NCT00616421|450257220|FG000|Overall Study|Inappropriate enrollment|3|||
125173535|NCT00616421|450257221|FG001|Overall Study|Inappropriate enrollment|0|||
125229979|NCT01149655|450470102|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
125229980|NCT01149655|450470103|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
125229981|NCT01149655|450470100|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
125229982|NCT01149655|450470101|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
125229983|NCT01149655|450470102|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
125229984|NCT01149655|450470103|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
125229985|NCT01149655|450470100|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
125229986|NCT01149655|450470101|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
125229987|NCT01149655|450470102|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
125229988|NCT01149655|450470103|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
125229989|NCT01149655|450470100|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
125229990|NCT01149655|450470101|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
125229991|NCT01149655|450470102|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
125229992|NCT01149655|450470103|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
125229993|NCT04030598|450470104|FG000|Overall Study|Voluntary Withdrawal|0|||
125229994|NCT04030598|450470105|FG001|Overall Study|Voluntary Withdrawal|1|||
125229995|NCT04030598|450470106|FG002|Overall Study|Voluntary Withdrawal|0|||
125229996|NCT05079321|450470107|FG000|Overall Study|Withdrawal by Subject|2|||
125229997|NCT05079321|450470108|FG001|Overall Study|Withdrawal by Subject|2|||
125229998|NCT05079321|450470107|FG000|Overall Study|Lost to Follow-up|0|||
125229999|NCT05079321|450470108|FG001|Overall Study|Lost to Follow-up|1|||
125230000|NCT02003144|450470109|FG000|Open Label Maintenance Phase|Other than specified|2|||
125230001|NCT02003144|450470110|FG001|Open Label Maintenance Phase|Other than specified|4|||
125230002|NCT02003144|450470109|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
125230003|NCT02003144|450470110|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
125230004|NCT02003144|450470109|FG000|Open Label Maintenance Phase|Pregnancy|0|||
125230005|NCT02003144|450470110|FG001|Open Label Maintenance Phase|Pregnancy|2|||
125230006|NCT02003144|450470109|FG000|Open Label Maintenance Phase|Physician Decision|1|||
125230007|NCT02003144|450470110|FG001|Open Label Maintenance Phase|Physician Decision|1|||
125230008|NCT02003144|450470109|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
125230009|NCT02003144|450470110|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
125230010|NCT02003144|450470109|FG000|Open Label Maintenance Phase|Adverse Event|2|||
125230011|NCT02003144|450470110|FG001|Open Label Maintenance Phase|Adverse Event|1|||
125230012|NCT01324947|450470111|FG000|Overall Study|Adverse Event|7|||
125230013|NCT01324947|450470111|FG000|Overall Study|Death|10|||
125230014|NCT01324947|450470111|FG000|Overall Study|Other|3|||
125230015|NCT01324947|450470111|FG000|Overall Study|Progressive Disease|50|||
125230016|NCT01324947|450470111|FG000|Overall Study|Withdrawal by Subject|3|||
125230017|NCT01324947|450470111|FG000|Overall Study|1 discontinued before starting drug|1|||
125230018|NCT02873689|450471464|FG000|Overall Study|Lack of Efficacy|1|||
125230019|NCT02873689|450471465|FG001|Overall Study|Lack of Efficacy|0|||
125230020|NCT02873689|450471464|FG000|Overall Study|Withdrawal by Subject|2|||
125230021|NCT02873689|450471465|FG001|Overall Study|Withdrawal by Subject|2|||
125230022|NCT02873689|450471464|FG000|Overall Study|Protocol Violation|1|||
125230023|NCT02873689|450471465|FG001|Overall Study|Protocol Violation|0|||
125230024|NCT02873689|450471464|FG000|Overall Study|Adverse Event|2|||
125230025|NCT02873689|450471465|FG001|Overall Study|Adverse Event|2|||
125230026|NCT02873689|450471464|FG000|Overall Study|Randomized but not Treated|1|||
125230027|NCT02873689|450471465|FG001|Overall Study|Randomized but not Treated|1|||
125230028|NCT00350545|450471466|FG000|Overall Study|Withdrawal by Subject|2|||
125230029|NCT02997163|450471473|FG000|Overall Study|Adverse Event|1|||
125230030|NCT02997163|450471474|FG001|Overall Study|Adverse Event|0|||
125230031|NCT02997163|450471475|FG002|Overall Study|Adverse Event|0|||
125230032|NCT02997163|450471476|FG003|Overall Study|Adverse Event|1|||
125230033|NCT02337764|450471477|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
125230034|NCT02337764|450471477|FG000|Overall Study|Voluntary Withdrawal|12|||
125230035|NCT02337764|450471477|FG000|Overall Study|Lack of Efficacy|2|||
125230036|NCT01855958|450471489|FG000|Overall Study|Withdrawal by Subject|1|||
125230037|NCT01855958|450471490|FG001|Overall Study|Withdrawal by Subject|0|||
125230038|NCT00368251|450471491|FG000|Overall Study|SAE, non-fatal|1|||
125230039|NCT00368251|450471492|FG001|Overall Study|SAE, non-fatal|0|||
125230040|NCT00368251|450471493|FG002|Overall Study|SAE, non-fatal|0|||
125230041|NCT00368251|450471491|FG000|Overall Study|AE, non-serious non-fatal|0|||
125230042|NCT00368251|450471492|FG001|Overall Study|AE, non-serious non-fatal|0|||
125230043|NCT00368251|450471493|FG002|Overall Study|AE, non-serious non-fatal|1|||
125230044|NCT00607893|450471495|FG000|Overall Study|Lost to Follow-up|4|||
125230045|NCT00607893|450471496|FG001|Overall Study|Lost to Follow-up|0|||
125230046|NCT00607893|450471495|FG000|Overall Study|withdrew due to loss of interest|0|||
125230047|NCT00607893|450471496|FG001|Overall Study|withdrew due to loss of interest|1|||
125230048|NCT00607893|450471495|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
125230049|NCT00607893|450471496|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
125230050|NCT00607893|450471495|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
125230051|NCT00607893|450471496|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
125173536|NCT00616421|450257222|FG002|Overall Study|Inappropriate enrollment|1|||
125173537|NCT00616421|450257220|FG000|Overall Study|Administrative reason|1|||
125173538|NCT00616421|450257221|FG001|Overall Study|Administrative reason|0|||
125173539|NCT00616421|450257222|FG002|Overall Study|Administrative reason|0|||
125173540|NCT00616421|450257220|FG000|Overall Study|Protocol Violation|0|||
125173541|NCT00616421|450257221|FG001|Overall Study|Protocol Violation|1|||
125173542|NCT00616421|450257222|FG002|Overall Study|Protocol Violation|2|||
125173543|NCT00616421|450257220|FG000|Overall Study|Unable to classify|1|||
125173544|NCT00616421|450257221|FG001|Overall Study|Unable to classify|0|||
125173545|NCT00616421|450257222|FG002|Overall Study|Unable to classify|0|||
125173546|NCT02481869|450257223|FG000|Overall Study|Lost to Follow-up|3|||
125173547|NCT02481869|450257224|FG001|Overall Study|Lost to Follow-up|4|||
125173548|NCT02481869|450257223|FG000|Overall Study|Withdrawal by Subject|2|||
125173549|NCT02481869|450257224|FG001|Overall Study|Withdrawal by Subject|0|||
125173550|NCT00711880|450257225|FG000|Overall Study|Adverse Event|11|||
125173551|NCT00711880|450257226|FG001|Overall Study|Adverse Event|2|||
125173552|NCT00711880|450257225|FG000|Overall Study|Patient non-compliance|1|||
125173553|NCT00711880|450257226|FG001|Overall Study|Patient non-compliance|0|||
125173554|NCT00711880|450257225|FG000|Overall Study|Lack of Efficacy|1|||
125173555|NCT00711880|450257226|FG001|Overall Study|Lack of Efficacy|5|||
125173556|NCT03908437|450257229|FG000|Overall Study|Death|0|||
125173557|NCT03908437|450257230|FG001|Overall Study|Death|1|||
125173558|NCT03908437|450257229|FG000|Overall Study|Lost to Follow-up|31|||
125173559|NCT03908437|450257230|FG001|Overall Study|Lost to Follow-up|24|||
125173560|NCT02370238|450257231|FG000|Overall Study|Death|42|||
125173561|NCT02370238|450257232|FG001|Overall Study|Death|35|||
125173562|NCT02370238|450257231|FG000|Overall Study|Lost to Follow-up|1|||
125173563|NCT02370238|450257232|FG001|Overall Study|Lost to Follow-up|3|||
125173564|NCT02370238|450257231|FG000|Overall Study|Withdrawal by Subject|2|||
125173565|NCT02370238|450257232|FG001|Overall Study|Withdrawal by Subject|6|||
125173566|NCT02370238|450257231|FG000|Overall Study|Other|2|||
125173567|NCT02370238|450257232|FG001|Overall Study|Other|1|||
125173568|NCT04342819|450257235|FG000|Overall Study|Declined|4|||
125173569|NCT04342819|450257235|FG000|Overall Study|Not meeeting selection criteria|1|||
125173570|NCT01569295|450257236|FG000|Overall Study|Progressive Disease|75|||
125173571|NCT01569295|450257237|FG001|Overall Study|Progressive Disease|139|||
125173572|NCT01569295|450257236|FG000|Overall Study|Adverse Event|39|||
125173573|NCT01569295|450257237|FG001|Overall Study|Adverse Event|14|||
125173574|NCT01569295|450257236|FG000|Overall Study|Withdrawal by Subject|25|||
125173575|NCT01569295|450257237|FG001|Overall Study|Withdrawal by Subject|12|||
125173576|NCT01569295|450257236|FG000|Overall Study|Death|19|||
125173577|NCT01569295|450257237|FG001|Overall Study|Death|15|||
125173578|NCT01569295|450257236|FG000|Overall Study|Physician Decision|13|||
125173579|NCT01569295|450257237|FG001|Overall Study|Physician Decision|18|||
125173580|NCT01569295|450257236|FG000|Overall Study|Study Terminated by Sponsor|24|||
125173581|NCT01569295|450257237|FG001|Overall Study|Study Terminated by Sponsor|2|||
125173582|NCT01569295|450257236|FG000|Overall Study|Other Reason not Specified|3|||
125173583|NCT01569295|450257237|FG001|Overall Study|Other Reason not Specified|5|||
125173584|NCT01569295|450257236|FG000|Overall Study|Non-Compliance with Study Drug|6|||
125173585|NCT01569295|450257237|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125173586|NCT01569295|450257236|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
125173587|NCT01569295|450257237|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
125173588|NCT01569295|450257236|FG000|Overall Study|Lost to Follow-up|1|||
125173589|NCT01569295|450257237|FG001|Overall Study|Lost to Follow-up|1|||
125173590|NCT03597295|450257238|FG000|Overall Study|Death|70|||
125173591|NCT03597295|450257238|FG000|Overall Study|Lost to Follow-up|7|||
125173592|NCT00879411|450257239|FG000|Overall Study|lost to follow-up (non-AE)|162|||
125173593|NCT01884337|450257240|FG000|Treatment|Adverse Event|2|||
125173594|NCT01884337|450257241|FG001|Treatment|Adverse Event|2|||
125173595|NCT01884337|450257240|FG000|Treatment|Subj. request to discont. treatment|2|||
125173596|NCT01884337|450257241|FG001|Treatment|Subj. request to discont. treatment|0|||
125173597|NCT01884337|450257240|FG000|Follow-up Period|Lost to Follow-up|1|||
125173598|NCT01884337|450257241|FG001|Follow-up Period|Lost to Follow-up|1|||
125173599|NCT02455518|450257242|FG000|Overall Study|Protocol Violation|0|||
125173600|NCT02455518|450257243|FG001|Overall Study|Protocol Violation|1|||
125173601|NCT02455518|450257244|FG002|Overall Study|Protocol Violation|1|||
125173602|NCT02455518|450257245|FG003|Overall Study|Protocol Violation|3|||
125173603|NCT00428116|450257246|FG000|Overall Study|Death|1|||
125173604|NCT00428116|450257247|FG001|Overall Study|Death|0|||
125173605|NCT00428116|450257246|FG000|Overall Study|Withdrawal by Subject|1|||
125173606|NCT00428116|450257247|FG001|Overall Study|Withdrawal by Subject|0|||
125173607|NCT00428116|450257246|FG000|Overall Study|Lost to Follow-up|1|||
125173608|NCT00428116|450257247|FG001|Overall Study|Lost to Follow-up|0|||
125173609|NCT01038297|450257248|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
125173610|NCT01038297|450257249|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
125173611|NCT01038297|450257250|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
125173612|NCT02508935|450257251|FG000|Overall Study|Withdrawal by Subject|1|||
125173613|NCT02508935|450257251|FG000|Overall Study|Withdrawal by Caregiver|8|||
125173614|NCT02508935|450257251|FG000|Overall Study|Pain Score <4|1|||
125173615|NCT02508935|450257251|FG000|Overall Study|Emesis|3|||
125173616|NCT02508935|450257251|FG000|Overall Study|Adverse Event|3|||
125173617|NCT02508935|450257251|FG000|Overall Study|Protocol Violation|1|||
125173618|NCT02508935|450257251|FG000|Overall Study|Physician Decision|1|||
125173619|NCT02508935|450257251|FG000|Overall Study|Trial terminated by sponsor|5|||
125173620|NCT02125877|450257252|FG000|Overall Study|Physician Decision|1|||
125173621|NCT02125877|450257253|FG001|Overall Study|Physician Decision|0|||
125173622|NCT02125877|450257252|FG000|Overall Study|Death|0|||
125173623|NCT02125877|450257253|FG001|Overall Study|Death|1|||
125173624|NCT02125877|450257252|FG000|Overall Study|Administrative problems|0|||
125173625|NCT02125877|450257253|FG001|Overall Study|Administrative problems|1|||
125173626|NCT02125877|450257252|FG000|Overall Study|Participant/guardian decision|0|||
125173627|NCT02125877|450257253|FG001|Overall Study|Participant/guardian decision|2|||
125173628|NCT02125877|450257252|FG000|Overall Study|Withdrawal by Subject|2|||
125173629|NCT02125877|450257253|FG001|Overall Study|Withdrawal by Subject|1|||
125173630|NCT02125877|450257252|FG000|Overall Study|Protocol deviation|4|||
125173631|NCT02125877|450257253|FG001|Overall Study|Protocol deviation|1|||
125173632|NCT02125877|450257252|FG000|Overall Study|Adverse Event|6|||
125173633|NCT02125877|450257253|FG001|Overall Study|Adverse Event|4|||
125173634|NCT01973595|450257254|FG000|Washout|Withdrawal by Subject|1|||
125173635|NCT01973595|450257255|FG001|Washout|Withdrawal by Subject|0|||
125173636|NCT01973595|450257256|FG002|Washout|Withdrawal by Subject|1|||
125173637|NCT01973595|450257257|FG003|Washout|Withdrawal by Subject|0|||
125173638|NCT01210612|450257268|FG000|Overall Study|Withdrawal by Subject|0|||
125173639|NCT01210612|450257269|FG001|Overall Study|Withdrawal by Subject|2|||
125173640|NCT00710866|450257272|FG000|Overall Study|Protocol Violation|5|||
125173641|NCT00710866|450257273|FG001|Overall Study|Protocol Violation|4|||
125173642|NCT00710866|450257272|FG000|Overall Study|Withdrawal by Subject|2|||
125173643|NCT00710866|450257273|FG001|Overall Study|Withdrawal by Subject|1|||
125173644|NCT00710866|450257272|FG000|Overall Study|Lost to Follow-up|1|||
125173645|NCT00710866|450257273|FG001|Overall Study|Lost to Follow-up|0|||
125173646|NCT00710866|450257272|FG000|Overall Study|Failed to meet eligibility|1|||
125173647|NCT00710866|450257273|FG001|Overall Study|Failed to meet eligibility|1|||
125173648|NCT00086281|450257274|FG000|Phase 1|Adverse Event|0|||
125173649|NCT00086281|450257275|FG001|Phase 1|Adverse Event|0|||
125173650|NCT00086281|450257276|FG002|Phase 1|Adverse Event|0|||
125173651|NCT00086281|450257277|FG003|Phase 1|Adverse Event|0|||
125173652|NCT00086281|450257278|FG004|Phase 1|Adverse Event|0|||
125173653|NCT00086281|450257279|FG005|Phase 1|Adverse Event|0|||
125173654|NCT00086281|450257280|FG006|Phase 1|Adverse Event|0|||
125173655|NCT00086281|450257281|FG007|Phase 1|Adverse Event|0|||
125173656|NCT00086281|450257282|FG008|Phase 1|Adverse Event|0|||
125173657|NCT00086281|450257283|FG009|Phase 1|Adverse Event|1|||
125173658|NCT00086281|450257284|FG010|Phase 1|Adverse Event|2|||
125173659|NCT00086281|450257285|FG011|Phase 1|Adverse Event|1|||
125173660|NCT00086281|450257286|FG012|Phase 1|Adverse Event|1|||
125173661|NCT00086281|450257287|FG013|Phase 1|Adverse Event|1|||
125173662|NCT00086281|450257288|FG014|Phase 1|Adverse Event|2|||
125173663|NCT00086281|450257274|FG000|Phase 1|Protocol Violation|0|||
125173664|NCT00086281|450257275|FG001|Phase 1|Protocol Violation|0|||
125173665|NCT00086281|450257276|FG002|Phase 1|Protocol Violation|0|||
125173666|NCT00086281|450257277|FG003|Phase 1|Protocol Violation|0|||
125173667|NCT00086281|450257278|FG004|Phase 1|Protocol Violation|0|||
125173668|NCT00086281|450257279|FG005|Phase 1|Protocol Violation|0|||
125173669|NCT00086281|450257280|FG006|Phase 1|Protocol Violation|0|||
125173670|NCT00086281|450257281|FG007|Phase 1|Protocol Violation|0|||
125173671|NCT00086281|450257282|FG008|Phase 1|Protocol Violation|0|||
125173672|NCT00086281|450257283|FG009|Phase 1|Protocol Violation|0|||
125173673|NCT00086281|450257284|FG010|Phase 1|Protocol Violation|1|||
125173674|NCT00086281|450257285|FG011|Phase 1|Protocol Violation|0|||
125173675|NCT00086281|450257286|FG012|Phase 1|Protocol Violation|0|||
125173676|NCT00086281|450257287|FG013|Phase 1|Protocol Violation|0|||
125173677|NCT00086281|450257288|FG014|Phase 1|Protocol Violation|0|||
125173678|NCT00086281|450257274|FG000|Phase 1|Serious Adverse Event|0|||
125173679|NCT00086281|450257275|FG001|Phase 1|Serious Adverse Event|0|||
125173680|NCT00086281|450257276|FG002|Phase 1|Serious Adverse Event|0|||
125173681|NCT00086281|450257277|FG003|Phase 1|Serious Adverse Event|0|||
125173682|NCT00086281|450257278|FG004|Phase 1|Serious Adverse Event|0|||
125173683|NCT00086281|450257279|FG005|Phase 1|Serious Adverse Event|0|||
125173684|NCT00086281|450257280|FG006|Phase 1|Serious Adverse Event|0|||
125173685|NCT00086281|450257281|FG007|Phase 1|Serious Adverse Event|0|||
125173686|NCT00086281|450257282|FG008|Phase 1|Serious Adverse Event|0|||
125173687|NCT00086281|450257283|FG009|Phase 1|Serious Adverse Event|0|||
125173688|NCT00086281|450257284|FG010|Phase 1|Serious Adverse Event|0|||
125173689|NCT00086281|450257285|FG011|Phase 1|Serious Adverse Event|0|||
125173690|NCT00086281|450257286|FG012|Phase 1|Serious Adverse Event|0|||
125173691|NCT00086281|450257287|FG013|Phase 1|Serious Adverse Event|0|||
125173692|NCT00086281|450257288|FG014|Phase 1|Serious Adverse Event|1|||
125173693|NCT00086281|450257274|FG000|Phase 2|Adverse Event|0|||
125173694|NCT00086281|450257275|FG001|Phase 2|Adverse Event|0|||
125173695|NCT00086281|450257276|FG002|Phase 2|Adverse Event|0|||
125230052|NCT00607893|450471495|FG000|Overall Study|Declined to be treated|1|||
125230053|NCT00607893|450471496|FG001|Overall Study|Declined to be treated|0|||
125230054|NCT00607893|450471495|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
125230055|NCT00607893|450471496|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
125230056|NCT02669849|450471497|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
125230057|NCT02669849|450471498|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
125230058|NCT02669849|450471499|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
125230059|NCT02669849|450471497|FG000|Overall Study|Lost to Follow-up|1|||
125230060|NCT02669849|450471498|FG001|Overall Study|Lost to Follow-up|0|||
125230061|NCT02669849|450471499|FG002|Overall Study|Lost to Follow-up|3|||
125230062|NCT02669849|450471497|FG000|Overall Study|Death|1|||
125230063|NCT02669849|450471498|FG001|Overall Study|Death|1|||
125230064|NCT02669849|450471499|FG002|Overall Study|Death|2|||
125230065|NCT02669849|450471497|FG000|Overall Study|Study terminated by sponsor|16|||
125230066|NCT02669849|450471498|FG001|Overall Study|Study terminated by sponsor|1|||
125230067|NCT02669849|450471499|FG002|Overall Study|Study terminated by sponsor|14|||
125230068|NCT02669849|450471497|FG000|Overall Study|Other|0|||
125230069|NCT02669849|450471498|FG001|Overall Study|Other|0|||
125230070|NCT02669849|450471499|FG002|Overall Study|Other|2|||
125230071|NCT04745351|450471502|FG000|Overall Study|Death|51|||
125230072|NCT04745351|450471503|FG001|Overall Study|Death|25|||
125230073|NCT04745351|450471502|FG000|Overall Study|Lost to Follow-up|9|||
125230074|NCT04745351|450471503|FG001|Overall Study|Lost to Follow-up|3|||
125230075|NCT04745351|450471502|FG000|Overall Study|Randomized but Never Treated|3|||
125230076|NCT04745351|450471503|FG001|Overall Study|Randomized but Never Treated|3|||
125230077|NCT04745351|450471502|FG000|Overall Study|Adverse Event|4|||
125230078|NCT04745351|450471503|FG001|Overall Study|Adverse Event|0|||
125230079|NCT04745351|450471502|FG000|Overall Study|Withdrew Consent|1|||
125230080|NCT04745351|450471503|FG001|Overall Study|Withdrew Consent|2|||
125230081|NCT04745351|450471502|FG000|Overall Study|Investigator's Discretion|2|||
125230082|NCT04745351|450471503|FG001|Overall Study|Investigator's Discretion|0|||
125230083|NCT04745351|450471502|FG000|Overall Study|Protocol Violation|1|||
125230084|NCT04745351|450471503|FG001|Overall Study|Protocol Violation|0|||
125230085|NCT03499795|450471509|FG000|Overall Study|Adverse Event|1|||
125230086|NCT03499795|450471509|FG000|Overall Study|Lost to Follow-up|1|||
125230087|NCT03636256|450471512|FG000|Overall Study|Lost to Follow-up|3|||
125230088|NCT03636256|450471513|FG001|Overall Study|Lost to Follow-up|0|||
125230089|NCT03636256|450471514|FG002|Overall Study|Lost to Follow-up|2|||
125230090|NCT03636256|450471515|FG003|Overall Study|Lost to Follow-up|1|||
125230091|NCT03636256|450471516|FG004|Overall Study|Lost to Follow-up|0|||
125230092|NCT03636256|450471517|FG005|Overall Study|Lost to Follow-up|4|||
125230093|NCT03636256|450471518|FG006|Overall Study|Lost to Follow-up|2|||
125230094|NCT03636256|450471519|FG007|Overall Study|Lost to Follow-up|0|||
125230095|NCT03636256|450471520|FG008|Overall Study|Lost to Follow-up|4|||
125230096|NCT03636256|450471512|FG000|Overall Study|Withdrawal by Subject|0|||
125230097|NCT03636256|450471513|FG001|Overall Study|Withdrawal by Subject|0|||
125230098|NCT03636256|450471514|FG002|Overall Study|Withdrawal by Subject|0|||
125230099|NCT03636256|450471515|FG003|Overall Study|Withdrawal by Subject|0|||
125230100|NCT03636256|450471516|FG004|Overall Study|Withdrawal by Subject|0|||
125230101|NCT03636256|450471517|FG005|Overall Study|Withdrawal by Subject|0|||
125230102|NCT03636256|450471518|FG006|Overall Study|Withdrawal by Subject|0|||
125230103|NCT03636256|450471519|FG007|Overall Study|Withdrawal by Subject|0|||
125230104|NCT03636256|450471520|FG008|Overall Study|Withdrawal by Subject|1|||
125230105|NCT01516216|450471523|FG000|Overall Study|Adverse Event|2|||
125230106|NCT01516216|450471524|FG001|Overall Study|Adverse Event|4|||
125230107|NCT01516216|450471523|FG000|Overall Study|Disease Progression|38|||
125230108|NCT01516216|450471524|FG001|Overall Study|Disease Progression|34|||
125230109|NCT01516216|450471523|FG000|Overall Study|Withdrawal by Subject|9|||
125230110|NCT01516216|450471524|FG001|Overall Study|Withdrawal by Subject|11|||
125230111|NCT01516216|450471523|FG000|Overall Study|Potentially Curative Resection|6|||
125230112|NCT01516216|450471524|FG001|Overall Study|Potentially Curative Resection|12|||
125230113|NCT01516216|450471523|FG000|Overall Study|Nonadherence|2|||
125230114|NCT01516216|450471524|FG001|Overall Study|Nonadherence|3|||
125230115|NCT01516216|450471523|FG000|Overall Study|Physician Decision|6|||
125230116|NCT01516216|450471524|FG001|Overall Study|Physician Decision|3|||
125230117|NCT01516216|450471523|FG000|Overall Study|Prolonged Treatment Delay|5|||
125230118|NCT01516216|450471524|FG001|Overall Study|Prolonged Treatment Delay|1|||
125230119|NCT01516216|450471523|FG000|Overall Study|Intercurrent Illness|1|||
125230120|NCT01516216|450471524|FG001|Overall Study|Intercurrent Illness|0|||
125230121|NCT01516216|450471523|FG000|Overall Study|Death|1|||
125230122|NCT01516216|450471524|FG001|Overall Study|Death|1|||
125230123|NCT01603602|450471527|FG000|Overall Study|Adverse Event|1|||
125230124|NCT01603602|450471528|FG001|Overall Study|Adverse Event|0|||
125230125|NCT01603602|450471529|FG002|Overall Study|Adverse Event|0|||
125230126|NCT01603602|450471527|FG000|Overall Study|Personal Reasons|1|||
125230127|NCT01603602|450471528|FG001|Overall Study|Personal Reasons|0|||
125230128|NCT01603602|450471529|FG002|Overall Study|Personal Reasons|1|||
125230129|NCT04748718|450471533|FG000|Overall Study|Lost to Follow-up|50|||
125230130|NCT01935089|450471534|FG000|Overall Study|Adverse Event|2|||
125230131|NCT01935089|450471534|FG000|Overall Study|Withdrawal by Subject|1|||
125230132|NCT00723229|450471535|FG000|First Intervention|Lost to Follow-up|7|||
125230133|NCT00723229|450471536|FG001|First Intervention|Lost to Follow-up|3|||
125230134|NCT02337491|450471537|FG000|Overall Study|Death|1|||
125230135|NCT02337491|450471538|FG001|Overall Study|Death|1|||
125230136|NCT02337491|450471537|FG000|Overall Study|Adverse Event|0|||
125230137|NCT02337491|450471538|FG001|Overall Study|Adverse Event|1|||
125230138|NCT02337491|450471537|FG000|Overall Study|Withdrawal by Subject|3|||
125230139|NCT02337491|450471538|FG001|Overall Study|Withdrawal by Subject|0|||
125230140|NCT02337491|450471537|FG000|Overall Study|Progressive Disease|44|||
125230141|NCT02337491|450471538|FG001|Overall Study|Progressive Disease|28|||
125230142|NCT02337491|450471537|FG000|Overall Study|On Treatment|2|||
125230143|NCT02337491|450471538|FG001|Overall Study|On Treatment|0|||
125230144|NCT03530293|450471543|FG000|Pre-randomization|Adverse Event|12|||
125230145|NCT03530293|450471544|FG001|Pre-randomization|Adverse Event|0|||
125230146|NCT03530293|450471545|FG002|Pre-randomization|Adverse Event|0|||
125230147|NCT03530293|450471543|FG000|Pre-randomization|Protocol Violation|2|||
125230148|NCT03530293|450471544|FG001|Pre-randomization|Protocol Violation|0|||
125230149|NCT03530293|450471545|FG002|Pre-randomization|Protocol Violation|0|||
125230150|NCT03530293|450471543|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
125230151|NCT03530293|450471544|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
125230152|NCT03530293|450471545|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
125230153|NCT03530293|450471543|FG000|Pre-randomization|Withdrawal by Subject|5|||
125230154|NCT03530293|450471544|FG001|Pre-randomization|Withdrawal by Subject|0|||
125230155|NCT03530293|450471545|FG002|Pre-randomization|Withdrawal by Subject|0|||
125230156|NCT03530293|450471543|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
125230157|NCT03530293|450471544|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
125230158|NCT03530293|450471545|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
125230159|NCT03530293|450471543|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
125230160|NCT03530293|450471544|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
125230161|NCT03530293|450471545|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
125230162|NCT03530293|450471543|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
125230163|NCT03530293|450471544|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
125230164|NCT03530293|450471545|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
125230165|NCT03530293|450471543|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
125230166|NCT03530293|450471544|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
125230167|NCT03530293|450471545|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
125230168|NCT03530293|450471543|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
125230169|NCT03530293|450471544|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
125230170|NCT03530293|450471545|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
125230171|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
125230172|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
125230173|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
125230174|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
125230175|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
125230176|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
125230177|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
125230178|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
125230179|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
125230180|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
125230181|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
125230182|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
125230183|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
125230184|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
125230185|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
125230186|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
125230187|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
125173696|NCT00086281|450257277|FG003|Phase 2|Adverse Event|0|||
125173697|NCT00086281|450257278|FG004|Phase 2|Adverse Event|0|||
125173698|NCT00086281|450257279|FG005|Phase 2|Adverse Event|0|||
125173699|NCT00086281|450257280|FG006|Phase 2|Adverse Event|0|||
125173700|NCT00086281|450257281|FG007|Phase 2|Adverse Event|0|||
125173701|NCT00086281|450257282|FG008|Phase 2|Adverse Event|0|||
125173702|NCT00086281|450257283|FG009|Phase 2|Adverse Event|0|||
125173703|NCT00086281|450257284|FG010|Phase 2|Adverse Event|0|||
125173704|NCT00086281|450257285|FG011|Phase 2|Adverse Event|0|||
125173705|NCT00086281|450257286|FG012|Phase 2|Adverse Event|1|||
125173706|NCT00086281|450257287|FG013|Phase 2|Adverse Event|1|||
125173707|NCT00086281|450257288|FG014|Phase 2|Adverse Event|0|||
125173708|NCT03071276|450257290|FG000|Overall Study|Adverse Event|1|||
125173709|NCT03071276|450257290|FG000|Overall Study|Lack of Efficacy|14|||
125173710|NCT03390426|450257291|FG000|Overall Study|Protocol Violation|0|||
125173711|NCT03390426|450257292|FG001|Overall Study|Protocol Violation|1|||
125173712|NCT02516553|450257297|FG000|Overall Study|Progressive disease|2|||
125173713|NCT02516553|450257298|FG001|Overall Study|Progressive disease|2|||
125173714|NCT02516553|450257299|FG002|Overall Study|Progressive disease|3|||
125173715|NCT02516553|450257300|FG003|Overall Study|Progressive disease|5|||
125173716|NCT02516553|450257301|FG004|Overall Study|Progressive disease|3|||
125173717|NCT02516553|450257302|FG005|Overall Study|Progressive disease|0|||
125173718|NCT02516553|450257303|FG006|Overall Study|Progressive disease|5|||
125173719|NCT02516553|450257304|FG007|Overall Study|Progressive disease|5|||
125173720|NCT02516553|450257305|FG008|Overall Study|Progressive disease|11|||
125173721|NCT02516553|450257306|FG009|Overall Study|Progressive disease|3|||
125173722|NCT02516553|450257307|FG010|Overall Study|Progressive disease|10|||
125173723|NCT02516553|450257308|FG011|Overall Study|Progressive disease|8|||
125173724|NCT02516553|450257309|FG012|Overall Study|Progressive disease|8|||
125173725|NCT02516553|450257310|FG013|Overall Study|Progressive disease|2|||
125173726|NCT02516553|450257311|FG014|Overall Study|Progressive disease|2|||
125173727|NCT02516553|450257312|FG015|Overall Study|Progressive disease|2|||
125173728|NCT02516553|450257313|FG016|Overall Study|Progressive disease|1|||
125173729|NCT02516553|450257314|FG017|Overall Study|Progressive disease|9|||
125173730|NCT02516553|450257315|FG018|Overall Study|Progressive disease|12|||
125173731|NCT02516553|450257316|FG019|Overall Study|Progressive disease|7|||
125173732|NCT02516553|450257317|FG020|Overall Study|Progressive disease|16|||
125173733|NCT02516553|450257318|FG021|Overall Study|Progressive disease|18|||
125173734|NCT02516553|450257297|FG000|Overall Study|Dose limiting toxicity|0|||
125230188|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
125230189|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
125230190|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
125230191|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
125230192|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
125230193|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
125230194|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
125230195|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
125230196|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
125230197|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
125230198|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
125230199|NCT01668797|450471546|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
125230200|NCT01668797|450471547|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
125230201|NCT01668797|450471548|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
125173735|NCT02516553|450257298|FG001|Overall Study|Dose limiting toxicity|0|||
125173736|NCT02516553|450257299|FG002|Overall Study|Dose limiting toxicity|0|||
125173737|NCT02516553|450257300|FG003|Overall Study|Dose limiting toxicity|0|||
125173738|NCT02516553|450257301|FG004|Overall Study|Dose limiting toxicity|3|||
125173739|NCT02516553|450257302|FG005|Overall Study|Dose limiting toxicity|1|||
125173740|NCT02516553|450257303|FG006|Overall Study|Dose limiting toxicity|1|||
125173741|NCT02516553|450257304|FG007|Overall Study|Dose limiting toxicity|0|||
125173742|NCT02516553|450257305|FG008|Overall Study|Dose limiting toxicity|1|||
125230202|NCT01668797|450471549|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
125230203|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
125173743|NCT02516553|450257306|FG009|Overall Study|Dose limiting toxicity|0|||
125173744|NCT02516553|450257307|FG010|Overall Study|Dose limiting toxicity|0|||
125173745|NCT02516553|450257308|FG011|Overall Study|Dose limiting toxicity|1|||
125173746|NCT02516553|450257309|FG012|Overall Study|Dose limiting toxicity|0|||
125173747|NCT02516553|450257310|FG013|Overall Study|Dose limiting toxicity|1|||
125173748|NCT02516553|450257311|FG014|Overall Study|Dose limiting toxicity|0|||
125173749|NCT02516553|450257312|FG015|Overall Study|Dose limiting toxicity|0|||
125173750|NCT02516553|450257313|FG016|Overall Study|Dose limiting toxicity|1|||
125173751|NCT02516553|450257314|FG017|Overall Study|Dose limiting toxicity|1|||
125173752|NCT02516553|450257315|FG018|Overall Study|Dose limiting toxicity|0|||
125173753|NCT02516553|450257316|FG019|Overall Study|Dose limiting toxicity|2|||
125173754|NCT02516553|450257317|FG020|Overall Study|Dose limiting toxicity|0|||
125173755|NCT02516553|450257318|FG021|Overall Study|Dose limiting toxicity|0|||
125173756|NCT02516553|450257297|FG000|Overall Study|Other Adverse Events|0|||
125173757|NCT02516553|450257298|FG001|Overall Study|Other Adverse Events|0|||
125173758|NCT02516553|450257299|FG002|Overall Study|Other Adverse Events|0|||
125173759|NCT02516553|450257300|FG003|Overall Study|Other Adverse Events|1|||
125173760|NCT02516553|450257301|FG004|Overall Study|Other Adverse Events|0|||
125173761|NCT02516553|450257302|FG005|Overall Study|Other Adverse Events|1|||
125173762|NCT02516553|450257303|FG006|Overall Study|Other Adverse Events|0|||
125173763|NCT02516553|450257304|FG007|Overall Study|Other Adverse Events|0|||
125173764|NCT02516553|450257305|FG008|Overall Study|Other Adverse Events|0|||
125173765|NCT02516553|450257306|FG009|Overall Study|Other Adverse Events|1|||
125173766|NCT02516553|450257307|FG010|Overall Study|Other Adverse Events|3|||
125173767|NCT02516553|450257308|FG011|Overall Study|Other Adverse Events|2|||
125173768|NCT02516553|450257309|FG012|Overall Study|Other Adverse Events|0|||
125173769|NCT02516553|450257310|FG013|Overall Study|Other Adverse Events|1|||
125173770|NCT02516553|450257311|FG014|Overall Study|Other Adverse Events|0|||
125173771|NCT02516553|450257312|FG015|Overall Study|Other Adverse Events|0|||
125173772|NCT02516553|450257313|FG016|Overall Study|Other Adverse Events|0|||
125173773|NCT02516553|450257314|FG017|Overall Study|Other Adverse Events|2|||
125173774|NCT02516553|450257315|FG018|Overall Study|Other Adverse Events|1|||
125230204|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
125230205|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
125230206|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
125230207|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
125230208|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
125230209|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
125230210|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
125230211|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
125230212|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
125230213|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
125230214|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
125230215|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
125230216|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
125230217|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
125230218|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
125230219|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
125230220|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
125230221|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
125230222|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
125230223|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
125230224|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
125230225|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
125230226|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
125230227|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
125230228|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
125230229|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
125230230|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
125230231|NCT01668797|450471546|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
125230232|NCT01668797|450471547|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
125230233|NCT01668797|450471548|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
125230234|NCT01668797|450471549|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
125230235|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
125230236|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
125230237|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
125230238|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
125230239|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
125230240|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
125230241|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
125173775|NCT02516553|450257316|FG019|Overall Study|Other Adverse Events|2|||
125173776|NCT02516553|450257317|FG020|Overall Study|Other Adverse Events|2|||
125173777|NCT02516553|450257318|FG021|Overall Study|Other Adverse Events|1|||
125173778|NCT02516553|450257297|FG000|Overall Study|Refused to continue trial medication|0|||
125173779|NCT02516553|450257298|FG001|Overall Study|Refused to continue trial medication|0|||
125173780|NCT02516553|450257299|FG002|Overall Study|Refused to continue trial medication|0|||
125173781|NCT02516553|450257300|FG003|Overall Study|Refused to continue trial medication|0|||
125173782|NCT02516553|450257301|FG004|Overall Study|Refused to continue trial medication|0|||
125173783|NCT02516553|450257302|FG005|Overall Study|Refused to continue trial medication|0|||
125173784|NCT02516553|450257303|FG006|Overall Study|Refused to continue trial medication|0|||
125173785|NCT02516553|450257304|FG007|Overall Study|Refused to continue trial medication|0|||
125173786|NCT02516553|450257305|FG008|Overall Study|Refused to continue trial medication|0|||
125173787|NCT02516553|450257306|FG009|Overall Study|Refused to continue trial medication|0|||
125173788|NCT02516553|450257307|FG010|Overall Study|Refused to continue trial medication|1|||
125173789|NCT02516553|450257308|FG011|Overall Study|Refused to continue trial medication|0|||
125173790|NCT02516553|450257309|FG012|Overall Study|Refused to continue trial medication|0|||
125173791|NCT02516553|450257310|FG013|Overall Study|Refused to continue trial medication|0|||
125173792|NCT02516553|450257311|FG014|Overall Study|Refused to continue trial medication|0|||
125173793|NCT02516553|450257312|FG015|Overall Study|Refused to continue trial medication|0|||
125173794|NCT02516553|450257313|FG016|Overall Study|Refused to continue trial medication|0|||
125173795|NCT02516553|450257314|FG017|Overall Study|Refused to continue trial medication|0|||
125173796|NCT02516553|450257315|FG018|Overall Study|Refused to continue trial medication|1|||
125230242|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
125230243|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
125230244|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
125230245|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
125230246|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
125230247|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
125230248|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
125230249|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
125230250|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
125230251|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
125230252|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
125230253|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
125230254|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
125230255|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
125230256|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
125230257|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
125230258|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
125230259|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
125230260|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
125230261|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
125230262|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
125230263|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
125230264|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
125230265|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
125230266|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
125230267|NCT01668797|450471546|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
125230268|NCT01668797|450471547|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
125230269|NCT01668797|450471548|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
125230270|NCT01668797|450471549|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
125230271|NCT02530385|450471550|FG000|Overall Study|Withdrawal by Subject|0|||
125230272|NCT02530385|450471551|FG001|Overall Study|Withdrawal by Subject|1|||
125230273|NCT01569022|450471553|FG000|First Intervention|Lost to Follow-up|2|||
125230274|NCT01569022|450471554|FG001|First Intervention|Lost to Follow-up|1|||
125230275|NCT01569022|450471553|FG000|Second Intervention|Lost to Follow-up|2|||
125230276|NCT01569022|450471554|FG001|Second Intervention|Lost to Follow-up|2|||
125230277|NCT00433836|450471559|FG000|Overall Study|Adverse Event|7|||
125230278|NCT00433836|450471560|FG001|Overall Study|Adverse Event|0|||
125230279|NCT00433836|450471559|FG000|Overall Study|Lost to Follow-up|3|||
125230280|NCT00433836|450471560|FG001|Overall Study|Lost to Follow-up|0|||
125230281|NCT00433836|450471559|FG000|Overall Study|Withdrawal by Subject|2|||
125230282|NCT00433836|450471560|FG001|Overall Study|Withdrawal by Subject|1|||
125230283|NCT00433836|450471559|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125230284|NCT00433836|450471560|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125230285|NCT00433836|450471559|FG000|Overall Study|Protocol Violation|0|||
125230286|NCT00433836|450471560|FG001|Overall Study|Protocol Violation|2|||
125230287|NCT00433836|450471559|FG000|Overall Study|Condition no longer requires study drug|0|||
125230288|NCT00433836|450471560|FG001|Overall Study|Condition no longer requires study drug|1|||
125230289|NCT00433836|450471559|FG000|Overall Study|Abnormal laboratory values|0|||
125230290|NCT00433836|450471560|FG001|Overall Study|Abnormal laboratory values|1|||
125230291|NCT02446691|450471561|FG000|Overall Study|Withdrawal by Subject|2|||
125230292|NCT02446691|450471561|FG000|Overall Study|Lost to Follow-up|8|||
125230293|NCT02446691|450471561|FG000|Overall Study|Protocol Violation|1|||
125230294|NCT00472420|450471562|FG000|Induction Treatment Period|Physician Decision|9|||
125230295|NCT00472420|450471562|FG000|Induction Treatment Period|Adverse Event|3|||
125230296|NCT00472420|450471562|FG000|Induction Treatment Period|Non-compliance|1|||
125230297|NCT00472420|450471562|FG000|Induction Treatment Period|Death|3|||
125230298|NCT00472420|450471562|FG000|Follow-up Period|Death|5|||
125230299|NCT00472420|450471562|FG000|Follow-up Period|Physician Decision|9|||
125230300|NCT00472420|450471562|FG000|Follow-up Period|Lost to Follow-up|2|||
125230301|NCT00472420|450471562|FG000|Follow-up Period|Protocol Violation|1|||
125230302|NCT00686972|450471563|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
125230303|NCT01026493|450471566|FG000|Overall Study|Protocol Violation|0|||
125230304|NCT01026493|450471567|FG001|Overall Study|Protocol Violation|1|||
125230305|NCT01026493|450471568|FG002|Overall Study|Protocol Violation|0|||
125230306|NCT01026493|450471569|FG003|Overall Study|Protocol Violation|0|||
125230307|NCT01026493|450471570|FG004|Overall Study|Protocol Violation|2|||
125230308|NCT01026493|450471571|FG005|Overall Study|Protocol Violation|3|||
125230309|NCT01026493|450471572|FG006|Overall Study|Protocol Violation|4|||
125173797|NCT02516553|450257316|FG019|Overall Study|Refused to continue trial medication|0|||
125173798|NCT02516553|450257317|FG020|Overall Study|Refused to continue trial medication|0|||
125173799|NCT02516553|450257318|FG021|Overall Study|Refused to continue trial medication|1|||
125173800|NCT02516553|450257297|FG000|Overall Study|other reasons than listed|0|||
125230310|NCT01026493|450471573|FG007|Overall Study|Protocol Violation|1|||
125230311|NCT02674516|450471574|FG000|Overall Study|Lost to Follow-up|3|||
125230312|NCT02674516|450471575|FG001|Overall Study|Lost to Follow-up|0|||
125230313|NCT02674516|450471574|FG000|Overall Study|Protocol Violation|0|||
125230314|NCT02674516|450471575|FG001|Overall Study|Protocol Violation|4|||
125230315|NCT02674516|450471574|FG000|Overall Study|Knowledge of study hypothesis|1|||
125230316|NCT02674516|450471575|FG001|Overall Study|Knowledge of study hypothesis|0|||
125230317|NCT02295644|450471578|FG000|Overall Study|Did not meet inclusion criterion|0|||
125230318|NCT02295644|450471579|FG001|Overall Study|Did not meet inclusion criterion|0|||
125230319|NCT02295644|450471580|FG002|Overall Study|Did not meet inclusion criterion|1|||
125230320|NCT02295644|450471581|FG003|Overall Study|Did not meet inclusion criterion|2|||
125230321|NCT00324155|450471582|FG000|Enrolled and Randomized|No longer met study criteria|3|||
125230322|NCT00324155|450471583|FG001|Enrolled and Randomized|No longer met study criteria|0|||
125230323|NCT00324155|450471582|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
125230324|NCT00324155|450471583|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
125230325|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
125230326|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
125230327|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
125230328|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
125230329|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Death|8|||
125230330|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Death|15|||
125230331|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
125230332|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
125230333|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
125230334|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
125230335|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
125230336|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
125230337|NCT00324155|450471582|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
125230338|NCT00324155|450471583|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
125173801|NCT02516553|450257298|FG001|Overall Study|other reasons than listed|0|||
125173802|NCT02516553|450257299|FG002|Overall Study|other reasons than listed|0|||
125173803|NCT02516553|450257300|FG003|Overall Study|other reasons than listed|0|||
125173804|NCT02516553|450257301|FG004|Overall Study|other reasons than listed|0|||
125173805|NCT02516553|450257302|FG005|Overall Study|other reasons than listed|0|||
125173806|NCT02516553|450257303|FG006|Overall Study|other reasons than listed|0|||
125173807|NCT02516553|450257304|FG007|Overall Study|other reasons than listed|1|||
125173808|NCT02516553|450257305|FG008|Overall Study|other reasons than listed|1|||
125173809|NCT02516553|450257306|FG009|Overall Study|other reasons than listed|0|||
125173810|NCT02516553|450257307|FG010|Overall Study|other reasons than listed|1|||
125173811|NCT02516553|450257308|FG011|Overall Study|other reasons than listed|1|||
125173812|NCT02516553|450257309|FG012|Overall Study|other reasons than listed|0|||
125173813|NCT02516553|450257310|FG013|Overall Study|other reasons than listed|0|||
125173814|NCT02516553|450257311|FG014|Overall Study|other reasons than listed|0|||
125173815|NCT02516553|450257312|FG015|Overall Study|other reasons than listed|0|||
125173816|NCT02516553|450257313|FG016|Overall Study|other reasons than listed|0|||
125173817|NCT02516553|450257314|FG017|Overall Study|other reasons than listed|0|||
125173818|NCT02516553|450257315|FG018|Overall Study|other reasons than listed|0|||
125173819|NCT02516553|450257316|FG019|Overall Study|other reasons than listed|0|||
125173820|NCT02516553|450257317|FG020|Overall Study|other reasons than listed|2|||
125173821|NCT02516553|450257318|FG021|Overall Study|other reasons than listed|2|||
125173822|NCT02924727|450257323|FG000|Overall Study|Withdrawal by Subject|2|||
125173823|NCT02924727|450257324|FG001|Overall Study|Withdrawal by Subject|4|||
125173824|NCT02924727|450257323|FG000|Overall Study|Lost to Follow-up|2|||
125173825|NCT02924727|450257324|FG001|Overall Study|Lost to Follow-up|5|||
125173826|NCT02924727|450257323|FG000|Overall Study|Death|221|||
125173827|NCT02924727|450257324|FG001|Overall Study|Death|247|||
125173828|NCT02924727|450257323|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
125230339|NCT00324155|450471582|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
125230340|NCT00324155|450471583|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
125230341|NCT00324155|450471582|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
125230342|NCT00324155|450471583|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
125173829|NCT02924727|450257324|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
125173830|NCT03052127|450257325|FG000|Overall Study|Withdrawal by Subject|0|||
125173831|NCT03052127|450257326|FG001|Overall Study|Withdrawal by Subject|0|||
125173832|NCT03052127|450257327|FG002|Overall Study|Withdrawal by Subject|0|||
125173833|NCT03052127|450257328|FG003|Overall Study|Withdrawal by Subject|0|||
125173834|NCT03052127|450257329|FG004|Overall Study|Withdrawal by Subject|0|||
125173835|NCT03052127|450257330|FG005|Overall Study|Withdrawal by Subject|0|||
125173836|NCT03052127|450257331|FG006|Overall Study|Withdrawal by Subject|0|||
125173837|NCT03052127|450257332|FG007|Overall Study|Withdrawal by Subject|1|||
125173838|NCT03052127|450257333|FG008|Overall Study|Withdrawal by Subject|1|||
125173839|NCT03052127|450257334|FG009|Overall Study|Withdrawal by Subject|1|||
125173840|NCT03052127|450257335|FG010|Overall Study|Withdrawal by Subject|0|||
125173841|NCT03052127|450257336|FG011|Overall Study|Withdrawal by Subject|0|||
125173842|NCT03052127|450257325|FG000|Overall Study|Discontinuation by Sponsor|0|||
125173843|NCT03052127|450257326|FG001|Overall Study|Discontinuation by Sponsor|0|||
125173844|NCT03052127|450257327|FG002|Overall Study|Discontinuation by Sponsor|0|||
125173845|NCT03052127|450257328|FG003|Overall Study|Discontinuation by Sponsor|0|||
125173846|NCT03052127|450257329|FG004|Overall Study|Discontinuation by Sponsor|0|||
125173847|NCT03052127|450257330|FG005|Overall Study|Discontinuation by Sponsor|0|||
125173848|NCT03052127|450257331|FG006|Overall Study|Discontinuation by Sponsor|0|||
125173849|NCT03052127|450257332|FG007|Overall Study|Discontinuation by Sponsor|0|||
125173850|NCT03052127|450257333|FG008|Overall Study|Discontinuation by Sponsor|4|||
125173851|NCT03052127|450257334|FG009|Overall Study|Discontinuation by Sponsor|2|||
125173852|NCT03052127|450257335|FG010|Overall Study|Discontinuation by Sponsor|5|||
125173853|NCT03052127|450257336|FG011|Overall Study|Discontinuation by Sponsor|13|||
125173854|NCT03052127|450257325|FG000|Overall Study|Inability to comply with trial requirements|0|||
125173855|NCT03052127|450257326|FG001|Overall Study|Inability to comply with trial requirements|0|||
125173856|NCT03052127|450257327|FG002|Overall Study|Inability to comply with trial requirements|1|||
125173857|NCT03052127|450257328|FG003|Overall Study|Inability to comply with trial requirements|0|||
125173858|NCT03052127|450257329|FG004|Overall Study|Inability to comply with trial requirements|0|||
125173859|NCT03052127|450257330|FG005|Overall Study|Inability to comply with trial requirements|0|||
125173860|NCT03052127|450257331|FG006|Overall Study|Inability to comply with trial requirements|0|||
125173861|NCT03052127|450257332|FG007|Overall Study|Inability to comply with trial requirements|0|||
125173862|NCT03052127|450257333|FG008|Overall Study|Inability to comply with trial requirements|0|||
125173863|NCT03052127|450257334|FG009|Overall Study|Inability to comply with trial requirements|0|||
125173864|NCT03052127|450257335|FG010|Overall Study|Inability to comply with trial requirements|0|||
125173865|NCT03052127|450257336|FG011|Overall Study|Inability to comply with trial requirements|0|||
125173866|NCT03052127|450257325|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
125173867|NCT03052127|450257326|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173868|NCT03052127|450257327|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173869|NCT03052127|450257328|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173870|NCT03052127|450257329|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
125173871|NCT03052127|450257330|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
125173872|NCT03052127|450257331|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
125173873|NCT03052127|450257332|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125230343|NCT00324155|450471582|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
125230344|NCT00324155|450471583|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
125230345|NCT00324155|450471582|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
125230346|NCT00324155|450471583|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
125230347|NCT00324155|450471582|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
125230348|NCT00324155|450471583|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
125230349|NCT00324155|450471582|FG000|Follow-up Phase|On-going participants still on drug|11|||
125230350|NCT00324155|450471583|FG001|Follow-up Phase|On-going participants still on drug|6|||
125230351|NCT03307174|450471584|FG000|Overall Study|Unplanned ICU Administrion|5|||
125230352|NCT03307174|450471585|FG001|Overall Study|Unplanned ICU Administrion|3|||
125230353|NCT03307174|450471584|FG000|Overall Study|Aborted Surgery|1|||
125230354|NCT03307174|450471585|FG001|Overall Study|Aborted Surgery|2|||
125230355|NCT03307174|450471584|FG000|Overall Study|Hypotension|6|||
125230356|NCT03307174|450471585|FG001|Overall Study|Hypotension|0|||
125230357|NCT03307174|450471584|FG000|Overall Study|Nonfunctional epidural|1|||
125230358|NCT03307174|450471585|FG001|Overall Study|Nonfunctional epidural|1|||
125230359|NCT03307174|450471584|FG000|Overall Study|Planned epidural removal|1|||
125173874|NCT03052127|450257333|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173875|NCT03052127|450257334|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173876|NCT03052127|450257335|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173877|NCT03052127|450257336|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
125173878|NCT03694327|450257339|FG000|Overall Study|Lost to Follow-up|13|||
125173879|NCT03694327|450257340|FG001|Overall Study|Lost to Follow-up|23|||
125173880|NCT01982812|450257343|FG000|Overall Study|Death|1|||
125173881|NCT01982812|450257344|FG001|Overall Study|Death|5|||
125173882|NCT01982812|450257343|FG000|Overall Study|Adverse Event|0|||
125173883|NCT01982812|450257344|FG001|Overall Study|Adverse Event|5|||
125230360|NCT03307174|450471585|FG001|Overall Study|Planned epidural removal|0|||
125230361|NCT03307174|450471584|FG000|Overall Study|Intrathecal catheter placement|0|||
125230362|NCT03307174|450471585|FG001|Overall Study|Intrathecal catheter placement|1|||
125173884|NCT04784533|450257345|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
125173885|NCT04784533|450257346|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
125173886|NCT04784533|450257347|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173887|NCT04784533|450257348|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173888|NCT04784533|450257349|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173889|NCT04784533|450257350|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173890|NCT04784533|450257351|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173891|NCT04784533|450257352|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173892|NCT04784533|450257353|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173893|NCT04784533|450257354|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
125173894|NCT04784533|450257345|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
125173895|NCT04784533|450257346|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
125173896|NCT04784533|450257347|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173897|NCT04784533|450257348|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173898|NCT04784533|450257349|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173899|NCT04784533|450257350|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173900|NCT04784533|450257351|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173901|NCT04784533|450257352|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173902|NCT04784533|450257353|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173903|NCT04784533|450257354|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
125173904|NCT04784533|450257345|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173905|NCT04784533|450257346|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
125173906|NCT04784533|450257347|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173907|NCT04784533|450257348|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173908|NCT04784533|450257349|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173909|NCT04784533|450257350|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173910|NCT04784533|450257351|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173911|NCT04784533|450257352|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173912|NCT04784533|450257353|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173913|NCT04784533|450257354|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
125173914|NCT04784533|450257345|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
125173915|NCT04784533|450257346|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173916|NCT04784533|450257347|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173917|NCT04784533|450257348|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173918|NCT04784533|450257349|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173919|NCT04784533|450257350|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173920|NCT04784533|450257351|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173921|NCT04784533|450257352|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173922|NCT04784533|450257353|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173923|NCT04784533|450257354|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
125173924|NCT04784533|450257345|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
125173925|NCT04784533|450257346|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
125173926|NCT04784533|450257347|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173927|NCT04784533|450257348|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173928|NCT04784533|450257349|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173929|NCT04784533|450257350|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173930|NCT04784533|450257351|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173931|NCT04784533|450257352|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173932|NCT04784533|450257353|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173933|NCT04784533|450257354|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
125173934|NCT04784533|450257345|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
125173935|NCT04784533|450257346|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
125173936|NCT04784533|450257347|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173937|NCT04784533|450257348|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173938|NCT04784533|450257349|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173939|NCT04784533|450257350|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173940|NCT04784533|450257351|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173941|NCT04784533|450257352|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173942|NCT04784533|450257353|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173943|NCT04784533|450257354|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
125173944|NCT04784533|450257345|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173945|NCT04784533|450257346|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173946|NCT04784533|450257347|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
125173947|NCT04784533|450257348|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173948|NCT04784533|450257349|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173949|NCT04784533|450257350|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173950|NCT04784533|450257351|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173951|NCT04784533|450257352|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173952|NCT04784533|450257353|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173953|NCT04784533|450257354|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
125173954|NCT04784533|450257345|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173955|NCT04784533|450257346|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173956|NCT04784533|450257347|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173957|NCT04784533|450257348|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173958|NCT04784533|450257349|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173959|NCT04784533|450257350|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173960|NCT04784533|450257351|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173961|NCT04784533|450257352|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173962|NCT04784533|450257353|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
125173963|NCT04784533|450257354|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
125173964|NCT04784533|450257345|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173965|NCT04784533|450257346|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173966|NCT04784533|450257347|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173967|NCT04784533|450257348|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173968|NCT04784533|450257349|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173969|NCT04784533|450257350|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173970|NCT04784533|450257351|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173971|NCT04784533|450257352|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
125173972|NCT04784533|450257353|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
125173973|NCT04784533|450257354|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
125173974|NCT00307437|450257355|FG000|Controlled Period|Adverse Event|7|||
125173975|NCT00307437|450257356|FG001|Controlled Period|Adverse Event|2|||
125173976|NCT00307437|450257357|FG002|Controlled Period|Adverse Event|5|||
125173977|NCT00307437|450257358|FG003|Controlled Period|Adverse Event|0|||
125173978|NCT00307437|450257359|FG004|Controlled Period|Adverse Event|0|||
125173979|NCT00307437|450257360|FG005|Controlled Period|Adverse Event|0|||
125173980|NCT00307437|450257361|FG006|Controlled Period|Adverse Event|0|||
125173981|NCT00307437|450257355|FG000|Controlled Period|Death|0|||
125173982|NCT00307437|450257356|FG001|Controlled Period|Death|0|||
125173983|NCT00307437|450257357|FG002|Controlled Period|Death|1|||
125173984|NCT00307437|450257358|FG003|Controlled Period|Death|0|||
125173985|NCT00307437|450257359|FG004|Controlled Period|Death|0|||
125173986|NCT00307437|450257360|FG005|Controlled Period|Death|0|||
125173987|NCT00307437|450257361|FG006|Controlled Period|Death|0|||
125173988|NCT00307437|450257355|FG000|Controlled Period|Lack of Efficacy|2|||
125173989|NCT00307437|450257356|FG001|Controlled Period|Lack of Efficacy|0|||
125173990|NCT00307437|450257357|FG002|Controlled Period|Lack of Efficacy|0|||
125173991|NCT00307437|450257358|FG003|Controlled Period|Lack of Efficacy|0|||
125173992|NCT00307437|450257359|FG004|Controlled Period|Lack of Efficacy|0|||
125173993|NCT00307437|450257360|FG005|Controlled Period|Lack of Efficacy|0|||
125173994|NCT00307437|450257361|FG006|Controlled Period|Lack of Efficacy|0|||
125173995|NCT00307437|450257355|FG000|Controlled Period|Lost to Follow-up|2|||
125173996|NCT00307437|450257356|FG001|Controlled Period|Lost to Follow-up|3|||
125173997|NCT00307437|450257357|FG002|Controlled Period|Lost to Follow-up|0|||
125173998|NCT00307437|450257358|FG003|Controlled Period|Lost to Follow-up|0|||
125173999|NCT00307437|450257359|FG004|Controlled Period|Lost to Follow-up|0|||
125174000|NCT00307437|450257360|FG005|Controlled Period|Lost to Follow-up|0|||
125174001|NCT00307437|450257361|FG006|Controlled Period|Lost to Follow-up|0|||
125174002|NCT00307437|450257355|FG000|Controlled Period|Other|5|||
125174003|NCT00307437|450257356|FG001|Controlled Period|Other|1|||
125174004|NCT00307437|450257357|FG002|Controlled Period|Other|3|||
125174005|NCT00307437|450257358|FG003|Controlled Period|Other|0|||
125174006|NCT00307437|450257359|FG004|Controlled Period|Other|0|||
125174007|NCT00307437|450257360|FG005|Controlled Period|Other|0|||
125174008|NCT00307437|450257361|FG006|Controlled Period|Other|0|||
125174009|NCT00307437|450257355|FG000|After Controlled Period|Adverse Event|0|||
125174010|NCT00307437|450257356|FG001|After Controlled Period|Adverse Event|0|||
125174011|NCT00307437|450257357|FG002|After Controlled Period|Adverse Event|0|||
125174012|NCT00307437|450257358|FG003|After Controlled Period|Adverse Event|18|||
125174013|NCT00307437|450257359|FG004|After Controlled Period|Adverse Event|16|||
125174014|NCT00307437|450257360|FG005|After Controlled Period|Adverse Event|31|||
125174015|NCT00307437|450257361|FG006|After Controlled Period|Adverse Event|40|||
125174016|NCT00307437|450257355|FG000|After Controlled Period|Death|0|||
125174017|NCT00307437|450257356|FG001|After Controlled Period|Death|0|||
125174018|NCT00307437|450257357|FG002|After Controlled Period|Death|0|||
125174019|NCT00307437|450257358|FG003|After Controlled Period|Death|3|||
125174020|NCT00307437|450257359|FG004|After Controlled Period|Death|1|||
125174021|NCT00307437|450257360|FG005|After Controlled Period|Death|1|||
125174022|NCT00307437|450257361|FG006|After Controlled Period|Death|3|||
125174023|NCT00307437|450257355|FG000|After Controlled Period|Lack of Efficacy|0|||
125174024|NCT00307437|450257356|FG001|After Controlled Period|Lack of Efficacy|0|||
125174025|NCT00307437|450257357|FG002|After Controlled Period|Lack of Efficacy|0|||
125174026|NCT00307437|450257358|FG003|After Controlled Period|Lack of Efficacy|15|||
125174027|NCT00307437|450257359|FG004|After Controlled Period|Lack of Efficacy|17|||
125174028|NCT00307437|450257360|FG005|After Controlled Period|Lack of Efficacy|37|||
125174029|NCT00307437|450257361|FG006|After Controlled Period|Lack of Efficacy|24|||
125174030|NCT00307437|450257355|FG000|After Controlled Period|Lost to Follow-up|0|||
125174031|NCT00307437|450257356|FG001|After Controlled Period|Lost to Follow-up|0|||
125174032|NCT00307437|450257357|FG002|After Controlled Period|Lost to Follow-up|0|||
125174033|NCT00307437|450257358|FG003|After Controlled Period|Lost to Follow-up|7|||
125174034|NCT00307437|450257359|FG004|After Controlled Period|Lost to Follow-up|12|||
125174035|NCT00307437|450257360|FG005|After Controlled Period|Lost to Follow-up|13|||
125174036|NCT00307437|450257361|FG006|After Controlled Period|Lost to Follow-up|18|||
125174037|NCT00307437|450257355|FG000|After Controlled Period|Other|0|||
125174038|NCT00307437|450257356|FG001|After Controlled Period|Other|0|||
125174039|NCT00307437|450257357|FG002|After Controlled Period|Other|0|||
125174040|NCT00307437|450257358|FG003|After Controlled Period|Other|15|||
125174041|NCT00307437|450257359|FG004|After Controlled Period|Other|9|||
125174042|NCT00307437|450257360|FG005|After Controlled Period|Other|40|||
125174043|NCT00307437|450257361|FG006|After Controlled Period|Other|28|||
125174044|NCT03316547|450257370|FG000|Overall Study|Death|3|||
125174045|NCT03316547|450257371|FG001|Overall Study|Death|1|||
125174046|NCT03316547|450257370|FG000|Overall Study|Lost to Follow-up|6|||
125174047|NCT03316547|450257371|FG001|Overall Study|Lost to Follow-up|6|||
125174048|NCT03316547|450257370|FG000|Overall Study|Withdrawal by Subject|3|||
125174049|NCT03316547|450257371|FG001|Overall Study|Withdrawal by Subject|2|||
125174050|NCT03316547|450257370|FG000|Overall Study|Transfer to another hospital|6|||
125174051|NCT03316547|450257371|FG001|Overall Study|Transfer to another hospital|4|||
125174052|NCT00721227|450257372|FG000|Overall Study|Lost to Follow-up|3|||
125174053|NCT00721227|450257373|FG001|Overall Study|Lost to Follow-up|0|||
125174054|NCT00721227|450257372|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
125174055|NCT00721227|450257373|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
125174056|NCT02759692|450257374|FG000|Period 1|Test article no longer available|1|||
125174057|NCT02759692|450257375|FG001|Period 1|Test article no longer available|1|||
125174058|NCT02759692|450257374|FG000|Period 1|No longer meets eligibility criteria.|1|||
125174059|NCT02759692|450257375|FG001|Period 1|No longer meets eligibility criteria.|0|||
125174060|NCT02759692|450257374|FG000|Period 1|Miss-Randomized|1|||
125174061|NCT02759692|450257375|FG001|Period 1|Miss-Randomized|1|||
125174062|NCT02759692|450257374|FG000|Period 2|Lost to Follow-up|1|||
125174063|NCT02759692|450257375|FG001|Period 2|Lost to Follow-up|0|||
125174064|NCT02759692|450257374|FG000|Period 2|Test article no longer available|0|||
125174065|NCT02759692|450257375|FG001|Period 2|Test article no longer available|1|||
125174066|NCT00451178|450257376|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
125174067|NCT00451178|450257377|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
125174068|NCT00451178|450257376|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
125174069|NCT00451178|450257377|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
125174070|NCT00451178|450257376|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
125174071|NCT00451178|450257377|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
125174072|NCT00451178|450257376|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
125174073|NCT00451178|450257377|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
125174074|NCT00451178|450257376|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
125230363|NCT00846053|450471586|FG000|Overall Study|Physician Decision|3|||
125230364|NCT00846053|450471587|FG001|Overall Study|Physician Decision|0|||
125230365|NCT00111761|450471588|FG000|Part 1|Physician Decision|0|||
125230366|NCT00111761|450471589|FG001|Part 1|Physician Decision|1|||
125174075|NCT00451178|450257377|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
125174076|NCT00451178|450257376|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
125174077|NCT00451178|450257377|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
125174078|NCT00451178|450257376|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
125174079|NCT00451178|450257377|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
125174080|NCT00451178|450257376|FG000|Prior to Maintenance Therapy|PD|2|||
125174081|NCT00451178|450257377|FG001|Prior to Maintenance Therapy|PD|0|||
125174082|NCT00451178|450257376|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
125174083|NCT00451178|450257377|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
125174084|NCT00451178|450257376|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
125230367|NCT00111761|450471588|FG000|Part 1|Death|0|||
125174085|NCT00451178|450257377|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
125174086|NCT00451178|450257376|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
125174087|NCT00451178|450257377|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
125174088|NCT00451178|450257376|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
125174089|NCT00451178|450257377|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
125174090|NCT00451178|450257376|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
125174091|NCT00451178|450257377|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
125174092|NCT00451178|450257376|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
125174093|NCT00451178|450257377|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
125174094|NCT00451178|450257376|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
125174095|NCT00451178|450257377|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
125174096|NCT01243775|450257378|FG000|Overall Study|Withdrawal by Subject|2|||
125174097|NCT02447744|450257379|FG000|Overall Study|Withdrawal by Subject|3|||
125174098|NCT02447744|450257380|FG001|Overall Study|Withdrawal by Subject|1|||
125174099|NCT02447744|450257379|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
125174100|NCT02447744|450257380|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
125174101|NCT03207867|450257381|FG000|Overall Study|Adverse Event|1|||
125174102|NCT03207867|450257382|FG001|Overall Study|Adverse Event|0|||
125174103|NCT03207867|450257383|FG002|Overall Study|Adverse Event|1|||
125174104|NCT03207867|450257384|FG003|Overall Study|Adverse Event|0|||
125174105|NCT03207867|450257385|FG004|Overall Study|Adverse Event|0|||
125174106|NCT03207867|450257386|FG005|Overall Study|Adverse Event|2|||
125174107|NCT03207867|450257387|FG006|Overall Study|Adverse Event|1|||
125174108|NCT03207867|450257388|FG007|Overall Study|Adverse Event|1|||
125174109|NCT03207867|450257389|FG008|Overall Study|Adverse Event|2|||
125174110|NCT03207867|450257390|FG009|Overall Study|Adverse Event|2|||
125174111|NCT03207867|450257391|FG010|Overall Study|Adverse Event|0|||
125174112|NCT03207867|450257392|FG011|Overall Study|Adverse Event|0|||
125174113|NCT03207867|450257393|FG012|Overall Study|Adverse Event|0|||
125174114|NCT03207867|450257394|FG013|Overall Study|Adverse Event|0|||
125174115|NCT03207867|450257395|FG014|Overall Study|Adverse Event|0|||
125174116|NCT03207867|450257396|FG015|Overall Study|Adverse Event|0|||
125174117|NCT03207867|450257397|FG016|Overall Study|Adverse Event|3|||
125174118|NCT03207867|450257398|FG017|Overall Study|Adverse Event|1|||
125174119|NCT03207867|450257399|FG018|Overall Study|Adverse Event|2|||
125174120|NCT03207867|450257400|FG019|Overall Study|Adverse Event|1|||
125174121|NCT03207867|450257401|FG020|Overall Study|Adverse Event|0|||
125174122|NCT03207867|450257402|FG021|Overall Study|Adverse Event|0|||
125174123|NCT03207867|450257403|FG022|Overall Study|Adverse Event|0|||
125174124|NCT03207867|450257404|FG023|Overall Study|Adverse Event|0|||
125174125|NCT03207867|450257381|FG000|Overall Study|Death|0|||
125174126|NCT03207867|450257382|FG001|Overall Study|Death|0|||
125174127|NCT03207867|450257383|FG002|Overall Study|Death|0|||
125174128|NCT03207867|450257384|FG003|Overall Study|Death|0|||
125174129|NCT03207867|450257385|FG004|Overall Study|Death|0|||
125174130|NCT03207867|450257386|FG005|Overall Study|Death|1|||
125174131|NCT03207867|450257387|FG006|Overall Study|Death|0|||
125174132|NCT03207867|450257388|FG007|Overall Study|Death|3|||
125174133|NCT03207867|450257389|FG008|Overall Study|Death|1|||
125174134|NCT03207867|450257390|FG009|Overall Study|Death|2|||
125174135|NCT03207867|450257391|FG010|Overall Study|Death|0|||
125174136|NCT03207867|450257392|FG011|Overall Study|Death|1|||
125174137|NCT03207867|450257393|FG012|Overall Study|Death|0|||
125174138|NCT03207867|450257394|FG013|Overall Study|Death|1|||
125174139|NCT03207867|450257395|FG014|Overall Study|Death|0|||
125174140|NCT03207867|450257396|FG015|Overall Study|Death|0|||
125174141|NCT03207867|450257397|FG016|Overall Study|Death|0|||
125174142|NCT03207867|450257398|FG017|Overall Study|Death|2|||
125174143|NCT03207867|450257399|FG018|Overall Study|Death|0|||
125174144|NCT03207867|450257400|FG019|Overall Study|Death|1|||
125174145|NCT03207867|450257401|FG020|Overall Study|Death|0|||
125174146|NCT03207867|450257402|FG021|Overall Study|Death|0|||
125174147|NCT03207867|450257403|FG022|Overall Study|Death|0|||
125174148|NCT03207867|450257404|FG023|Overall Study|Death|0|||
125174149|NCT03207867|450257381|FG000|Overall Study|Physician Decision|3|||
125174150|NCT03207867|450257382|FG001|Overall Study|Physician Decision|5|||
125174151|NCT03207867|450257383|FG002|Overall Study|Physician Decision|0|||
125174152|NCT03207867|450257384|FG003|Overall Study|Physician Decision|3|||
125174153|NCT03207867|450257385|FG004|Overall Study|Physician Decision|2|||
125174154|NCT03207867|450257386|FG005|Overall Study|Physician Decision|0|||
125174155|NCT03207867|450257387|FG006|Overall Study|Physician Decision|0|||
125174156|NCT03207867|450257388|FG007|Overall Study|Physician Decision|0|||
125174157|NCT03207867|450257389|FG008|Overall Study|Physician Decision|4|||
125174158|NCT03207867|450257390|FG009|Overall Study|Physician Decision|2|||
125174159|NCT03207867|450257391|FG010|Overall Study|Physician Decision|0|||
125174160|NCT03207867|450257392|FG011|Overall Study|Physician Decision|4|||
125174161|NCT03207867|450257393|FG012|Overall Study|Physician Decision|0|||
125174162|NCT03207867|450257394|FG013|Overall Study|Physician Decision|0|||
125174163|NCT03207867|450257395|FG014|Overall Study|Physician Decision|2|||
125174164|NCT03207867|450257396|FG015|Overall Study|Physician Decision|1|||
125174165|NCT03207867|450257397|FG016|Overall Study|Physician Decision|1|||
125174166|NCT03207867|450257398|FG017|Overall Study|Physician Decision|2|||
125174167|NCT03207867|450257399|FG018|Overall Study|Physician Decision|1|||
125174168|NCT03207867|450257400|FG019|Overall Study|Physician Decision|3|||
125174169|NCT03207867|450257401|FG020|Overall Study|Physician Decision|0|||
125174170|NCT03207867|450257402|FG021|Overall Study|Physician Decision|0|||
125174171|NCT03207867|450257403|FG022|Overall Study|Physician Decision|0|||
125174172|NCT03207867|450257404|FG023|Overall Study|Physician Decision|0|||
125174173|NCT03207867|450257381|FG000|Overall Study|Progressive Disease|7|||
125174174|NCT03207867|450257382|FG001|Overall Study|Progressive Disease|7|||
125174175|NCT03207867|450257383|FG002|Overall Study|Progressive Disease|9|||
125174176|NCT03207867|450257384|FG003|Overall Study|Progressive Disease|10|||
125174177|NCT03207867|450257385|FG004|Overall Study|Progressive Disease|11|||
125174178|NCT03207867|450257386|FG005|Overall Study|Progressive Disease|10|||
125174179|NCT03207867|450257387|FG006|Overall Study|Progressive Disease|9|||
125174180|NCT03207867|450257388|FG007|Overall Study|Progressive Disease|8|||
125174181|NCT03207867|450257389|FG008|Overall Study|Progressive Disease|19|||
125174182|NCT03207867|450257390|FG009|Overall Study|Progressive Disease|23|||
125174183|NCT03207867|450257391|FG010|Overall Study|Progressive Disease|2|||
125174184|NCT03207867|450257392|FG011|Overall Study|Progressive Disease|24|||
125174185|NCT03207867|450257393|FG012|Overall Study|Progressive Disease|3|||
125174186|NCT03207867|450257394|FG013|Overall Study|Progressive Disease|11|||
125174187|NCT03207867|450257395|FG014|Overall Study|Progressive Disease|9|||
125174188|NCT03207867|450257396|FG015|Overall Study|Progressive Disease|5|||
125174189|NCT03207867|450257397|FG016|Overall Study|Progressive Disease|10|||
125174190|NCT03207867|450257398|FG017|Overall Study|Progressive Disease|14|||
125174191|NCT03207867|450257399|FG018|Overall Study|Progressive Disease|13|||
125174192|NCT03207867|450257400|FG019|Overall Study|Progressive Disease|14|||
125174193|NCT03207867|450257401|FG020|Overall Study|Progressive Disease|6|||
125174194|NCT03207867|450257402|FG021|Overall Study|Progressive Disease|3|||
125174195|NCT03207867|450257403|FG022|Overall Study|Progressive Disease|3|||
125174196|NCT03207867|450257404|FG023|Overall Study|Progressive Disease|3|||
125174197|NCT03207867|450257381|FG000|Overall Study|Patient/guardian Decision|0|||
125174198|NCT03207867|450257382|FG001|Overall Study|Patient/guardian Decision|0|||
125174199|NCT03207867|450257383|FG002|Overall Study|Patient/guardian Decision|1|||
125174200|NCT03207867|450257384|FG003|Overall Study|Patient/guardian Decision|1|||
125174201|NCT03207867|450257385|FG004|Overall Study|Patient/guardian Decision|1|||
125174202|NCT03207867|450257386|FG005|Overall Study|Patient/guardian Decision|2|||
125174203|NCT03207867|450257387|FG006|Overall Study|Patient/guardian Decision|1|||
125174204|NCT03207867|450257388|FG007|Overall Study|Patient/guardian Decision|0|||
125174205|NCT03207867|450257389|FG008|Overall Study|Patient/guardian Decision|1|||
125174206|NCT03207867|450257390|FG009|Overall Study|Patient/guardian Decision|0|||
125174207|NCT03207867|450257391|FG010|Overall Study|Patient/guardian Decision|0|||
125174208|NCT03207867|450257392|FG011|Overall Study|Patient/guardian Decision|1|||
125174209|NCT03207867|450257393|FG012|Overall Study|Patient/guardian Decision|0|||
125174210|NCT03207867|450257394|FG013|Overall Study|Patient/guardian Decision|1|||
125174211|NCT03207867|450257395|FG014|Overall Study|Patient/guardian Decision|2|||
125174212|NCT03207867|450257396|FG015|Overall Study|Patient/guardian Decision|0|||
125174213|NCT03207867|450257397|FG016|Overall Study|Patient/guardian Decision|1|||
125174214|NCT03207867|450257398|FG017|Overall Study|Patient/guardian Decision|3|||
125174215|NCT03207867|450257399|FG018|Overall Study|Patient/guardian Decision|4|||
125174216|NCT03207867|450257400|FG019|Overall Study|Patient/guardian Decision|1|||
125174217|NCT03207867|450257401|FG020|Overall Study|Patient/guardian Decision|0|||
125174218|NCT03207867|450257402|FG021|Overall Study|Patient/guardian Decision|0|||
125174219|NCT03207867|450257403|FG022|Overall Study|Patient/guardian Decision|0|||
125174220|NCT03207867|450257404|FG023|Overall Study|Patient/guardian Decision|0|||
125174221|NCT05422625|450257405|FG000|Overall Study|Withdrawal by Subject|1|||
125174222|NCT05422625|450257406|FG001|Overall Study|Withdrawal by Subject|0|||
125174223|NCT01277601|450259246|FG000|Overall Study|Adverse Event|5|||
125174224|NCT01277601|450259247|FG001|Overall Study|Adverse Event|3|||
125174225|NCT01277601|450259248|FG002|Overall Study|Adverse Event|0|||
125174226|NCT01277601|450259249|FG003|Overall Study|Adverse Event|7|||
125174227|NCT01277601|450259246|FG000|Overall Study|Withdrawal by Subject|18|||
125174228|NCT01277601|450259247|FG001|Overall Study|Withdrawal by Subject|21|||
125174229|NCT01277601|450259248|FG002|Overall Study|Withdrawal by Subject|8|||
125174230|NCT01277601|450259249|FG003|Overall Study|Withdrawal by Subject|17|||
125174231|NCT01277601|450259246|FG000|Overall Study|Lost to Follow-up|7|||
125174232|NCT01277601|450259247|FG001|Overall Study|Lost to Follow-up|9|||
125174233|NCT01277601|450259248|FG002|Overall Study|Lost to Follow-up|4|||
125174234|NCT01277601|450259249|FG003|Overall Study|Lost to Follow-up|2|||
125174235|NCT01277601|450259246|FG000|Overall Study|Physician Decision|3|||
125174236|NCT01277601|450259247|FG001|Overall Study|Physician Decision|5|||
125174237|NCT01277601|450259248|FG002|Overall Study|Physician Decision|1|||
125174238|NCT01277601|450259249|FG003|Overall Study|Physician Decision|6|||
125174239|NCT01277601|450259246|FG000|Overall Study|Pregnancy|2|||
125174240|NCT01277601|450259247|FG001|Overall Study|Pregnancy|2|||
125174241|NCT01277601|450259248|FG002|Overall Study|Pregnancy|4|||
125174242|NCT01277601|450259249|FG003|Overall Study|Pregnancy|1|||
125174243|NCT01277601|450259246|FG000|Overall Study|Noncompliance with Study Drug|1|||
125174244|NCT01277601|450259247|FG001|Overall Study|Noncompliance with Study Drug|3|||
125174245|NCT01277601|450259248|FG002|Overall Study|Noncompliance with Study Drug|2|||
125174246|NCT01277601|450259249|FG003|Overall Study|Noncompliance with Study Drug|0|||
125174247|NCT01277601|450259246|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
125174248|NCT01277601|450259247|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
125174249|NCT01277601|450259248|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
125174250|NCT01277601|450259249|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
125174251|NCT01277601|450259246|FG000|Overall Study|Protocol Violation|0|||
125174252|NCT01277601|450259247|FG001|Overall Study|Protocol Violation|2|||
125174253|NCT01277601|450259248|FG002|Overall Study|Protocol Violation|5|||
125174254|NCT01277601|450259249|FG003|Overall Study|Protocol Violation|0|||
125174255|NCT01277601|450259246|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
125174256|NCT01277601|450259247|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
125174257|NCT01277601|450259248|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
125174258|NCT01277601|450259249|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
125174259|NCT00678210|450259251|FG000|Overall Study|Adverse Event|1|||
125174260|NCT00678210|450259252|FG001|Overall Study|Adverse Event|2|||
125174261|NCT00678210|450259253|FG002|Overall Study|Adverse Event|3|||
125174262|NCT00678210|450259254|FG003|Overall Study|Adverse Event|3|||
125174263|NCT00678210|450259251|FG000|Overall Study|Lack of Efficacy|2|||
125174264|NCT00678210|450259252|FG001|Overall Study|Lack of Efficacy|3|||
125174265|NCT00678210|450259253|FG002|Overall Study|Lack of Efficacy|1|||
125174266|NCT00678210|450259254|FG003|Overall Study|Lack of Efficacy|9|||
125174267|NCT00678210|450259251|FG000|Overall Study|Lost to Follow-up|4|||
125174268|NCT00678210|450259252|FG001|Overall Study|Lost to Follow-up|2|||
125174269|NCT00678210|450259253|FG002|Overall Study|Lost to Follow-up|0|||
125174270|NCT00678210|450259254|FG003|Overall Study|Lost to Follow-up|1|||
125174271|NCT00678210|450259251|FG000|Overall Study|Withdrawal by Subject|3|||
125174272|NCT00678210|450259252|FG001|Overall Study|Withdrawal by Subject|4|||
125174273|NCT00678210|450259253|FG002|Overall Study|Withdrawal by Subject|1|||
125174274|NCT00678210|450259254|FG003|Overall Study|Withdrawal by Subject|7|||
125174275|NCT00678210|450259251|FG000|Overall Study|Other|1|||
125174276|NCT00678210|450259252|FG001|Overall Study|Other|0|||
125174277|NCT00678210|450259253|FG002|Overall Study|Other|1|||
125174278|NCT00678210|450259254|FG003|Overall Study|Other|0|||
125174279|NCT04825912|450259255|FG000|Overall Study|Death|3|||
125174280|NCT04825912|450259255|FG000|Overall Study|Withdrawal by Subject|1|||
125174281|NCT02077140|450259256|FG000|Overall Study|Lost to Follow-up|4|||
125174282|NCT02077140|450259257|FG001|Overall Study|Lost to Follow-up|1|||
125174283|NCT02077140|450259258|FG002|Overall Study|Lost to Follow-up|2|||
125174284|NCT02077140|450259259|FG003|Overall Study|Lost to Follow-up|2|||
125174285|NCT02077140|450259260|FG004|Overall Study|Lost to Follow-up|3|||
125174286|NCT02077140|450259256|FG000|Overall Study|Withdrawal by Subject|0|||
125174287|NCT02077140|450259257|FG001|Overall Study|Withdrawal by Subject|1|||
125174288|NCT02077140|450259258|FG002|Overall Study|Withdrawal by Subject|0|||
125174289|NCT02077140|450259259|FG003|Overall Study|Withdrawal by Subject|2|||
125174290|NCT02077140|450259260|FG004|Overall Study|Withdrawal by Subject|2|||
125174291|NCT00974922|450259261|FG000|Overall Study|study terminated|24|||
125174292|NCT01009814|450259264|FG000|Overall Study|No longer met study criteria|1|||
125174293|NCT01009814|450259265|FG001|Overall Study|No longer met study criteria|1|||
125174294|NCT01009814|450259266|FG002|Overall Study|No longer met study criteria|0|||
125174295|NCT01009814|450259267|FG003|Overall Study|No longer met study criteria|0|||
125174296|NCT01009814|450259268|FG004|Overall Study|No longer met study criteria|0|||
125174297|NCT00618371|450259269|FG000|Overall Study|Withdrawal by Subject|2|||
125174298|NCT03022084|450259272|FG000|Overall Study|Lost to Follow-up|2|||
125174299|NCT03022084|450259273|FG001|Overall Study|Lost to Follow-up|3|||
125174300|NCT01207583|450259276|FG000|Overall Study|Withdrawal by Subject|0|||
125174301|NCT01207583|450259277|FG001|Overall Study|Withdrawal by Subject|3|||
125174302|NCT01207583|450259278|FG002|Overall Study|Withdrawal by Subject|1|||
125174303|NCT01207583|450259276|FG000|Overall Study|Participant failed to return|1|||
125174304|NCT01207583|450259277|FG001|Overall Study|Participant failed to return|0|||
125174305|NCT01207583|450259278|FG002|Overall Study|Participant failed to return|0|||
125174306|NCT01207583|450259276|FG000|Overall Study|Lost to Follow-up|0|||
125174307|NCT01207583|450259277|FG001|Overall Study|Lost to Follow-up|2|||
125174308|NCT01207583|450259278|FG002|Overall Study|Lost to Follow-up|0|||
125174309|NCT04974749|450259287|FG000|Overall Study|Withdrawal by Subject|2|||
125174310|NCT04974749|450259287|FG000|Overall Study|Gestation|1|||
125174311|NCT04414618|450259288|FG000|Overall Study|Death|3|||
125174312|NCT04414618|450259289|FG001|Overall Study|Death|3|||
125174313|NCT04414618|450259288|FG000|Overall Study|Withdrawal by Subject|2|||
125174314|NCT04414618|450259289|FG001|Overall Study|Withdrawal by Subject|1|||
125174315|NCT04414618|450259288|FG000|Overall Study|Lost to Follow-up|2|||
125174316|NCT04414618|450259289|FG001|Overall Study|Lost to Follow-up|3|||
125174317|NCT04414618|450259288|FG000|Overall Study|Physician Decision|1|||
125174318|NCT04414618|450259289|FG001|Overall Study|Physician Decision|0|||
125174319|NCT00362336|450259290|FG000|Overall Study|Serious Adverse Event|1|||
125174320|NCT00362336|450259291|FG001|Overall Study|Serious Adverse Event|0|||
125174321|NCT00362336|450259292|FG002|Overall Study|Serious Adverse Event|1|||
125174322|NCT00362336|450259290|FG000|Overall Study|Protocol Violation|0|||
125174323|NCT00362336|450259291|FG001|Overall Study|Protocol Violation|0|||
125174324|NCT00362336|450259292|FG002|Overall Study|Protocol Violation|1|||
125174325|NCT00362336|450259290|FG000|Overall Study|Lost to Follow-up|6|||
125174326|NCT00362336|450259291|FG001|Overall Study|Lost to Follow-up|4|||
125174327|NCT00362336|450259292|FG002|Overall Study|Lost to Follow-up|0|||
125230368|NCT00111761|450471589|FG001|Part 1|Death|2|||
125230369|NCT00111761|450471588|FG000|Part 1|Other|0|||
125230370|NCT00111761|450471589|FG001|Part 1|Other|1|||
125230371|NCT00111761|450471588|FG000|Part 1|Withdrawal by Subject|0|||
125174328|NCT00362336|450259290|FG000|Overall Study|Withdrawal by Subject|3|||
125174329|NCT00362336|450259291|FG001|Overall Study|Withdrawal by Subject|3|||
125174330|NCT00362336|450259292|FG002|Overall Study|Withdrawal by Subject|1|||
125174331|NCT00658879|450259293|FG000|Overall Study|Protocol Violation|1|||
125174332|NCT02661217|450259296|FG000|Overall Study|Physician Decision|12|||
125174333|NCT02661217|450259297|FG001|Overall Study|Physician Decision|15|||
125174334|NCT02661217|450259296|FG000|Overall Study|Lost to Follow-up|1|||
125174335|NCT02661217|450259297|FG001|Overall Study|Lost to Follow-up|4|||
125174336|NCT02661217|450259296|FG000|Overall Study|Protocol Deviation|0|||
125174337|NCT02661217|450259297|FG001|Overall Study|Protocol Deviation|4|||
125174338|NCT02661217|450259296|FG000|Overall Study|Non-compliance with study treatment|5|||
125174339|NCT02661217|450259297|FG001|Overall Study|Non-compliance with study treatment|5|||
125174340|NCT02661217|450259296|FG000|Overall Study|Death|21|||
125174341|NCT02661217|450259297|FG001|Overall Study|Death|15|||
125174342|NCT02661217|450259296|FG000|Overall Study|Adverse Event|10|||
125174343|NCT02661217|450259297|FG001|Overall Study|Adverse Event|8|||
125174344|NCT02661217|450259296|FG000|Overall Study|Withdrawal by Subject|15|||
125174345|NCT02661217|450259297|FG001|Overall Study|Withdrawal by Subject|19|||
125174346|NCT02661217|450259296|FG000|Overall Study|Did not enter follow-up epoch|7|||
125174347|NCT02661217|450259297|FG001|Overall Study|Did not enter follow-up epoch|10|||
125174348|NCT02661217|450259296|FG000|Overall Study|Death - no study drug received|1|||
125174349|NCT02661217|450259297|FG001|Overall Study|Death - no study drug received|2|||
125174350|NCT02661217|450259296|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
125174351|NCT02661217|450259297|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
125174352|NCT02075515|450259298|FG000|Overall Study|Serious Adverse Event|1|||
125174353|NCT02075515|450259299|FG001|Overall Study|Serious Adverse Event|1|||
125174354|NCT02075515|450259300|FG002|Overall Study|Serious Adverse Event|1|||
125174355|NCT02075515|450259298|FG000|Overall Study|Non-Serious Adverse Event|0|||
125174356|NCT02075515|450259299|FG001|Overall Study|Non-Serious Adverse Event|1|||
125174357|NCT02075515|450259300|FG002|Overall Study|Non-Serious Adverse Event|0|||
125174358|NCT02075515|450259298|FG000|Overall Study|Withdrawal by Subject|2|||
125174359|NCT02075515|450259299|FG001|Overall Study|Withdrawal by Subject|0|||
125174360|NCT02075515|450259300|FG002|Overall Study|Withdrawal by Subject|1|||
125174361|NCT02075515|450259298|FG000|Overall Study|Lost to Follow-up|1|||
125174362|NCT02075515|450259299|FG001|Overall Study|Lost to Follow-up|3|||
125174363|NCT02075515|450259300|FG002|Overall Study|Lost to Follow-up|6|||
125174364|NCT00378573|450259301|FG000|Treatment Period|Adverse Event|9|||
125174365|NCT00378573|450259301|FG000|Treatment Period|Physician Decision|1|||
125174366|NCT00378573|450259301|FG000|Treatment Period|Withdrawal by Subject|2|||
125174367|NCT00378573|450259301|FG000|Treatment Period|Disease Progression|4|||
125174368|NCT00378573|450259301|FG000|Treatment Period|Sponsor decision to close study|1|||
125174369|NCT00378573|450259301|FG000|Follow-up|Death|12|||
125174370|NCT00378573|450259301|FG000|Follow-up|Lost to Follow-up|1|||
125174371|NCT00378573|450259301|FG000|Follow-up|Withdrawal by Subject|1|||
125174372|NCT00196326|450259306|FG000|Overall Study|Did not meet protocol requirements|64|||
125174373|NCT00196326|450259306|FG000|Overall Study|Non-compliance with the protocol|81|||
125174374|NCT00196326|450259306|FG000|Overall Study|Physician Decision|3|||
125174375|NCT00196326|450259306|FG000|Overall Study|Withdrawal by Subject|225|||
125174376|NCT00196326|450259306|FG000|Overall Study|Adverse Event|253|||
125230372|NCT00111761|450471589|FG001|Part 1|Withdrawal by Subject|1|||
125230373|NCT00111761|450471588|FG000|Part 2|Adverse Event|1|||
125174377|NCT00196326|450259306|FG000|Overall Study|Pregnancy|34|||
125174378|NCT00196326|450259306|FG000|Overall Study|Lost to Follow-up|304|||
125174379|NCT00196326|450259306|FG000|Overall Study|Other|22|||
125174380|NCT01372748|450259307|FG000|Overall Study|Lost to Follow-up|16|||
125174381|NCT01372748|450259308|FG001|Overall Study|Lost to Follow-up|34|||
125174382|NCT01372748|450259307|FG000|Overall Study|Withdrawal by Subject|7|||
125174383|NCT01372748|450259308|FG001|Overall Study|Withdrawal by Subject|5|||
125174384|NCT00134901|450259309|FG000|Overall Study|Lost to Follow-up|5|||
125174385|NCT00134901|450259310|FG001|Overall Study|Lost to Follow-up|5|||
125174386|NCT00134901|450259309|FG000|Overall Study|discontinued intervention|12|||
125174387|NCT00134901|450259310|FG001|Overall Study|discontinued intervention|10|||
125174388|NCT04238650|450259313|FG000|Overall Study|Withdrawal by Subject|0|||
125174389|NCT04238650|450259314|FG001|Overall Study|Withdrawal by Subject|1|||
125230374|NCT00111761|450471589|FG001|Part 2|Adverse Event|0|||
125174390|NCT01807065|450259315|FG000|Overall Study|Receive no sip-T due to IV access|1|||
125230375|NCT00111761|450471588|FG000|Part 2|Physician Decision|1|||
125174391|NCT01807065|450259316|FG001|Overall Study|Receive no sip-T due to IV access|1|||
125174392|NCT02789137|450259317|FG000|Overall Study|Dropped out/Died|58|||
125174393|NCT00356525|450259318|FG000|Overall Study|Progressive Disease|8|||
125174394|NCT00356525|450259319|FG001|Overall Study|Progressive Disease|5|||
125174395|NCT00356525|450259320|FG002|Overall Study|Progressive Disease|4|||
125174396|NCT00356525|450259321|FG003|Overall Study|Progressive Disease|2|||
125230376|NCT00111761|450471589|FG001|Part 2|Physician Decision|0|||
125230377|NCT00111761|450471588|FG000|Part 2|Death|1|||
125230378|NCT00111761|450471589|FG001|Part 2|Death|0|||
125230379|NCT00111761|450471588|FG000|Part 2|Disease progression|3|||
125230380|NCT00111761|450471589|FG001|Part 2|Disease progression|0|||
125230381|NCT00111761|450471588|FG000|Part 2|Protocol-specified criteria|1|||
125230382|NCT00111761|450471589|FG001|Part 2|Protocol-specified criteria|0|||
125230383|NCT00111761|450471588|FG000|Part 2|Other|1|||
125230384|NCT00111761|450471589|FG001|Part 2|Other|0|||
125230385|NCT00746551|450471590|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
125230386|NCT00746551|450471591|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
125230387|NCT00746551|450471590|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
125230388|NCT00746551|450471591|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
125230389|NCT00746551|450471590|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
125230390|NCT00746551|450471591|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
125230391|NCT00171249|450471592|FG000|Overall Study|Withdrawal by Subject|2|||
125230392|NCT00171249|450471593|FG001|Overall Study|Withdrawal by Subject|0|||
125230393|NCT00171249|450471594|FG002|Overall Study|Withdrawal by Subject|0|||
125230394|NCT00171249|450471595|FG003|Overall Study|Withdrawal by Subject|6|||
125230395|NCT00171249|450471596|FG004|Overall Study|Withdrawal by Subject|0|||
125230396|NCT00171249|450471597|FG005|Overall Study|Withdrawal by Subject|0|||
125230397|NCT00171249|450471598|FG006|Overall Study|Withdrawal by Subject|0|||
125230398|NCT00171249|450471592|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
125230399|NCT00171249|450471593|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125230400|NCT00171249|450471594|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
125230401|NCT00171249|450471595|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
125230402|NCT00171249|450471596|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125230403|NCT00171249|450471597|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
125230404|NCT00171249|450471598|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
125230405|NCT00171249|450471592|FG000|Overall Study|Death|7|||
125230406|NCT00171249|450471593|FG001|Overall Study|Death|1|||
125230407|NCT00171249|450471594|FG002|Overall Study|Death|0|||
125230408|NCT00171249|450471595|FG003|Overall Study|Death|4|||
125230409|NCT00171249|450471596|FG004|Overall Study|Death|0|||
125230410|NCT00171249|450471597|FG005|Overall Study|Death|3|||
125230411|NCT00171249|450471598|FG006|Overall Study|Death|1|||
125230412|NCT00171249|450471592|FG000|Overall Study|Other|10|||
125230413|NCT00171249|450471593|FG001|Overall Study|Other|0|||
125230414|NCT00171249|450471594|FG002|Overall Study|Other|0|||
125230415|NCT00171249|450471595|FG003|Overall Study|Other|43|||
125230416|NCT00171249|450471596|FG004|Overall Study|Other|0|||
125230417|NCT00171249|450471597|FG005|Overall Study|Other|2|||
125230418|NCT00171249|450471598|FG006|Overall Study|Other|0|||
125230419|NCT00171249|450471592|FG000|Overall Study|No Longer Requires Study Drug|4|||
125230420|NCT00171249|450471593|FG001|Overall Study|No Longer Requires Study Drug|0|||
125230421|NCT00171249|450471594|FG002|Overall Study|No Longer Requires Study Drug|0|||
125230422|NCT00171249|450471595|FG003|Overall Study|No Longer Requires Study Drug|3|||
125230423|NCT00171249|450471596|FG004|Overall Study|No Longer Requires Study Drug|0|||
125230424|NCT00171249|450471597|FG005|Overall Study|No Longer Requires Study Drug|5|||
125230425|NCT00171249|450471598|FG006|Overall Study|No Longer Requires Study Drug|0|||
125230426|NCT00171249|450471592|FG000|Overall Study|Administrative Problems|1|||
125230427|NCT00171249|450471593|FG001|Overall Study|Administrative Problems|0|||
125230428|NCT00171249|450471594|FG002|Overall Study|Administrative Problems|0|||
125230429|NCT00171249|450471595|FG003|Overall Study|Administrative Problems|2|||
125230430|NCT00171249|450471596|FG004|Overall Study|Administrative Problems|0|||
125230431|NCT00171249|450471597|FG005|Overall Study|Administrative Problems|0|||
125230432|NCT00171249|450471598|FG006|Overall Study|Administrative Problems|0|||
125230433|NCT00171249|450471592|FG000|Overall Study|Adverse Event|3|||
125230434|NCT00171249|450471593|FG001|Overall Study|Adverse Event|1|||
125230435|NCT00171249|450471594|FG002|Overall Study|Adverse Event|0|||
125230436|NCT00171249|450471595|FG003|Overall Study|Adverse Event|15|||
125230437|NCT00171249|450471596|FG004|Overall Study|Adverse Event|0|||
125230438|NCT00171249|450471597|FG005|Overall Study|Adverse Event|2|||
125230439|NCT00171249|450471598|FG006|Overall Study|Adverse Event|0|||
125230440|NCT00171249|450471592|FG000|Overall Study|Lost to Follow-up|5|||
125230441|NCT00171249|450471593|FG001|Overall Study|Lost to Follow-up|0|||
125230442|NCT00171249|450471594|FG002|Overall Study|Lost to Follow-up|0|||
125230443|NCT00171249|450471595|FG003|Overall Study|Lost to Follow-up|9|||
125230444|NCT00171249|450471596|FG004|Overall Study|Lost to Follow-up|0|||
125230445|NCT00171249|450471597|FG005|Overall Study|Lost to Follow-up|0|||
125230446|NCT00171249|450471598|FG006|Overall Study|Lost to Follow-up|0|||
125230447|NCT03608826|450471600|FG000|Overall Study|Death|3|||
125230448|NCT03608826|450471600|FG000|Overall Study|Heart Transplant|3|||
125230449|NCT03608826|450471600|FG000|Overall Study|Physician Decision|4|||
125230450|NCT03122171|450471613|FG000|Overall Study|Withdrawal by Subject|1|||
125230451|NCT00720499|450471620|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
125230452|NCT00720499|450471621|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
125230453|NCT00720499|450471620|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
125174397|NCT00356525|450259318|FG000|Overall Study|Adverse Event|1|||
125174398|NCT00356525|450259319|FG001|Overall Study|Adverse Event|3|||
125174399|NCT00356525|450259320|FG002|Overall Study|Adverse Event|1|||
125174400|NCT00356525|450259321|FG003|Overall Study|Adverse Event|1|||
125174401|NCT00356525|450259318|FG000|Overall Study|Lost to Follow-up|1|||
125174402|NCT00356525|450259319|FG001|Overall Study|Lost to Follow-up|0|||
125174403|NCT00356525|450259320|FG002|Overall Study|Lost to Follow-up|0|||
125174404|NCT00356525|450259321|FG003|Overall Study|Lost to Follow-up|0|||
125174405|NCT00356525|450259318|FG000|Overall Study|Physician Decision|2|||
125174406|NCT00356525|450259319|FG001|Overall Study|Physician Decision|2|||
125174407|NCT00356525|450259320|FG002|Overall Study|Physician Decision|2|||
125174408|NCT00356525|450259321|FG003|Overall Study|Physician Decision|1|||
125174409|NCT00356525|450259318|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
125174410|NCT00356525|450259319|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
125174411|NCT00356525|450259320|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
125174412|NCT00356525|450259321|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
125174413|NCT00356525|450259318|FG000|Overall Study|Withdrawal by Subject|1|||
125174414|NCT00356525|450259319|FG001|Overall Study|Withdrawal by Subject|1|||
125174415|NCT00356525|450259320|FG002|Overall Study|Withdrawal by Subject|0|||
125174416|NCT00356525|450259321|FG003|Overall Study|Withdrawal by Subject|3|||
125174417|NCT00356525|450259318|FG000|Overall Study|Death|0|||
125174418|NCT00356525|450259319|FG001|Overall Study|Death|0|||
125174419|NCT00356525|450259320|FG002|Overall Study|Death|0|||
125174420|NCT00356525|450259321|FG003|Overall Study|Death|1|||
125174421|NCT00356525|450259318|FG000|Overall Study|Sponsor Decision|0|||
125174422|NCT00356525|450259319|FG001|Overall Study|Sponsor Decision|0|||
125174423|NCT00356525|450259320|FG002|Overall Study|Sponsor Decision|0|||
125174424|NCT00356525|450259321|FG003|Overall Study|Sponsor Decision|1|||
125174425|NCT01295320|450259322|FG000|Overall Study|Adverse Event|2|||
125174426|NCT01295320|450259322|FG000|Overall Study|Lost to Follow-up|4|||
125174427|NCT01295320|450259322|FG000|Overall Study|Withdrawal by Subject|2|||
125174428|NCT01295320|450259322|FG000|Overall Study|Subject was bedridden|1|||
125174429|NCT01295320|450259322|FG000|Overall Study|Unable to travel|1|||
125174430|NCT00462904|450259323|FG000|Overall Study|Lost to Follow-up|1|||
125174431|NCT01685840|450259327|FG000|Overall Study|Death|77|||
125174432|NCT01685840|450259328|FG001|Overall Study|Death|66|||
125174433|NCT01685840|450259327|FG000|Overall Study|Lost to Follow-up|27|||
125174434|NCT01685840|450259328|FG001|Overall Study|Lost to Follow-up|25|||
125174435|NCT01685840|450259327|FG000|Overall Study|Physician Decision|3|||
125174436|NCT01685840|450259328|FG001|Overall Study|Physician Decision|7|||
125174437|NCT01685840|450259327|FG000|Overall Study|Withdrawal by Subject|14|||
125174438|NCT01685840|450259328|FG001|Overall Study|Withdrawal by Subject|17|||
125174439|NCT01685840|450259327|FG000|Overall Study|Futility|197|||
125174440|NCT01685840|450259328|FG001|Overall Study|Futility|200|||
125174441|NCT01685840|450259327|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
125174442|NCT01685840|450259328|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
125174443|NCT04036110|450259332|FG000|Overall Study|Lost to Follow-up|3|||
125174444|NCT04036110|450259333|FG001|Overall Study|Lost to Follow-up|2|||
125174445|NCT04036110|450259334|FG002|Overall Study|Lost to Follow-up|1|||
125174446|NCT04036110|450259332|FG000|Overall Study|Study Suspended|4|||
125174447|NCT04036110|450259333|FG001|Overall Study|Study Suspended|5|||
125174448|NCT04036110|450259334|FG002|Overall Study|Study Suspended|1|||
125174449|NCT00246324|450259339|FG000|Overall Study|Withdrawal by Subject|1|||
125174450|NCT02006732|450259340|FG000|Overall Study|Adverse Event|10|||
125174451|NCT02006732|450259341|FG001|Overall Study|Adverse Event|7|||
125174452|NCT02006732|450259342|FG002|Overall Study|Adverse Event|4|||
125174453|NCT02006732|450259343|FG003|Overall Study|Adverse Event|2|||
125174454|NCT02006732|450259340|FG000|Overall Study|Lack of Efficacy|6|||
125174455|NCT02006732|450259341|FG001|Overall Study|Lack of Efficacy|3|||
125174456|NCT02006732|450259342|FG002|Overall Study|Lack of Efficacy|1|||
125174457|NCT02006732|450259343|FG003|Overall Study|Lack of Efficacy|1|||
125174458|NCT02006732|450259340|FG000|Overall Study|Protocol Violation|1|||
125174459|NCT02006732|450259341|FG001|Overall Study|Protocol Violation|1|||
125174460|NCT02006732|450259342|FG002|Overall Study|Protocol Violation|0|||
125174461|NCT02006732|450259343|FG003|Overall Study|Protocol Violation|0|||
125174462|NCT02006732|450259340|FG000|Overall Study|Lost to Follow-up|0|||
125174463|NCT02006732|450259341|FG001|Overall Study|Lost to Follow-up|1|||
125174464|NCT02006732|450259342|FG002|Overall Study|Lost to Follow-up|0|||
125174465|NCT02006732|450259343|FG003|Overall Study|Lost to Follow-up|0|||
125174466|NCT02006732|450259340|FG000|Overall Study|Withdrawal by Subject|3|||
125174467|NCT02006732|450259341|FG001|Overall Study|Withdrawal by Subject|0|||
125174468|NCT02006732|450259342|FG002|Overall Study|Withdrawal by Subject|4|||
125174469|NCT02006732|450259343|FG003|Overall Study|Withdrawal by Subject|1|||
125174470|NCT03516513|450259344|FG000|Overall Study|Withdrawal by Subject|2|||
125174471|NCT03516513|450259345|FG001|Overall Study|Withdrawal by Subject|2|||
125174472|NCT03516513|450259346|FG002|Overall Study|Withdrawal by Subject|0|||
125174473|NCT03516513|450259347|FG003|Overall Study|Withdrawal by Subject|0|||
125174474|NCT01098487|450259348|FG000|Overall Study|Adverse Event|22|||
125174475|NCT01098487|450259348|FG000|Overall Study|Lack of Efficacy|11|||
125230454|NCT00720499|450471621|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
125230455|NCT00720499|450471620|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
125230456|NCT00720499|450471621|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
125230457|NCT01326871|450471624|FG000|Overall Study|Major surgery|0|||
125230458|NCT01326871|450471625|FG001|Overall Study|Major surgery|1|||
125230459|NCT01326871|450471626|FG002|Overall Study|Major surgery|0|||
125230460|NCT01326871|450471624|FG000|Overall Study|SAE and death|0|||
125230461|NCT01326871|450471625|FG001|Overall Study|SAE and death|2|||
125230462|NCT01326871|450471626|FG002|Overall Study|SAE and death|0|||
125230463|NCT01326871|450471624|FG000|Overall Study|Physician decision and decreased performance status|0|||
125230464|NCT01326871|450471625|FG001|Overall Study|Physician decision and decreased performance status|1|||
125230465|NCT01326871|450471626|FG002|Overall Study|Physician decision and decreased performance status|0|||
125230466|NCT01326871|450471624|FG000|Overall Study|Disease progression|0|||
125230467|NCT01326871|450471625|FG001|Overall Study|Disease progression|11|||
125230468|NCT01326871|450471626|FG002|Overall Study|Disease progression|5|||
125230469|NCT01326871|450471624|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
125230470|NCT01326871|450471625|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
125230471|NCT01326871|450471626|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
125230472|NCT01326871|450471624|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
125230473|NCT01326871|450471625|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
125230474|NCT01326871|450471626|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
125230475|NCT01326871|450471624|FG000|Overall Study|Withdrawal by Subject|0|||
125230476|NCT01326871|450471625|FG001|Overall Study|Withdrawal by Subject|1|||
125230477|NCT01326871|450471626|FG002|Overall Study|Withdrawal by Subject|0|||
125230478|NCT01326871|450471624|FG000|Overall Study|DLT|0|||
125230479|NCT01326871|450471625|FG001|Overall Study|DLT|2|||
125230480|NCT01326871|450471626|FG002|Overall Study|DLT|0|||
125230481|NCT01326871|450471624|FG000|Overall Study|SAE, disease progression and subject decision|0|||
125230482|NCT01326871|450471625|FG001|Overall Study|SAE, disease progression and subject decision|1|||
125230483|NCT01326871|450471626|FG002|Overall Study|SAE, disease progression and subject decision|0|||
125230484|NCT01326871|450471624|FG000|Overall Study|Death|0|||
125230485|NCT01326871|450471625|FG001|Overall Study|Death|1|||
125230486|NCT01326871|450471626|FG002|Overall Study|Death|0|||
125230487|NCT01326871|450471624|FG000|Overall Study|Other|0|||
125230488|NCT01326871|450471625|FG001|Overall Study|Other|3|||
125230489|NCT01326871|450471626|FG002|Overall Study|Other|0|||
125230490|NCT01326871|450471624|FG000|Overall Study|SAE and disease progression|0|||
125230491|NCT01326871|450471625|FG001|Overall Study|SAE and disease progression|0|||
125230492|NCT01326871|450471626|FG002|Overall Study|SAE and disease progression|1|||
125230493|NCT01326871|450471624|FG000|Overall Study|SAE and physician decision|0|||
125230494|NCT01326871|450471625|FG001|Overall Study|SAE and physician decision|0|||
125230495|NCT01326871|450471626|FG002|Overall Study|SAE and physician decision|1|||
125230496|NCT01326871|450471624|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
125230497|NCT01326871|450471625|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
125230498|NCT01326871|450471626|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
125230499|NCT01326871|450471624|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
125230500|NCT01326871|450471625|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
125230501|NCT01326871|450471626|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
125230502|NCT01326871|450471624|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
125230503|NCT01326871|450471625|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
125230504|NCT01326871|450471626|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
125230505|NCT01326871|450471624|FG000|Overall Study|Physician Decision|0|||
125230506|NCT01326871|450471625|FG001|Overall Study|Physician Decision|0|||
125230507|NCT01326871|450471626|FG002|Overall Study|Physician Decision|1|||
125230508|NCT01326871|450471624|FG000|Overall Study|SAE|0|||
125230509|NCT01326871|450471625|FG001|Overall Study|SAE|0|||
125230510|NCT01326871|450471626|FG002|Overall Study|SAE|1|||
125230511|NCT01326871|450471624|FG000|Overall Study|Disease progression and death|0|||
125230512|NCT01326871|450471625|FG001|Overall Study|Disease progression and death|0|||
125230513|NCT01326871|450471626|FG002|Overall Study|Disease progression and death|1|||
125230514|NCT01326871|450471624|FG000|Overall Study|Subject decision|0|||
125230515|NCT01326871|450471625|FG001|Overall Study|Subject decision|0|||
125230516|NCT01326871|450471626|FG002|Overall Study|Subject decision|1|||
125230517|NCT01296412|450471632|FG000|Overall Study|Adverse Event|8|||
125230518|NCT01296412|450471633|FG001|Overall Study|Adverse Event|29|||
125230519|NCT01296412|450471632|FG000|Overall Study|Lack of Efficacy|1|||
125230520|NCT01296412|450471633|FG001|Overall Study|Lack of Efficacy|0|||
125230521|NCT01296412|450471632|FG000|Overall Study|Lost to Follow-up|10|||
125230522|NCT01296412|450471633|FG001|Overall Study|Lost to Follow-up|7|||
125230523|NCT01296412|450471632|FG000|Overall Study|Non-compliance with study drug|1|||
125443404|NCT02555371|451252128|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
125230524|NCT01296412|450471633|FG001|Overall Study|Non-compliance with study drug|2|||
125230525|NCT01296412|450471632|FG000|Overall Study|Other reason not specified|20|||
125230526|NCT01296412|450471633|FG001|Overall Study|Other reason not specified|15|||
125230527|NCT01296412|450471632|FG000|Overall Study|Physician Decision|1|||
125230528|NCT01296412|450471633|FG001|Overall Study|Physician Decision|3|||
125230529|NCT01296412|450471632|FG000|Overall Study|Pregnancy|0|||
125230530|NCT01296412|450471633|FG001|Overall Study|Pregnancy|1|||
125230531|NCT01296412|450471632|FG000|Overall Study|Withdrawal by Subject|10|||
125230532|NCT01296412|450471633|FG001|Overall Study|Withdrawal by Subject|13|||
125230533|NCT02160626|450471635|FG000|Overall Study|Adverse Event|1|||
125230534|NCT02160626|450471636|FG001|Overall Study|Adverse Event|0|||
125230535|NCT02160626|450471637|FG002|Overall Study|Adverse Event|0|||
125174476|NCT01098487|450259348|FG000|Overall Study|Withdrawal by Subject|7|||
125174477|NCT01098487|450259348|FG000|Overall Study|Lost to Follow-up|3|||
125174478|NCT01098487|450259348|FG000|Overall Study|Physician Decision|1|||
125174479|NCT00345631|450259349|FG000|Overall Study|Withdrawal by Subject|1|||
125174480|NCT00345631|450259350|FG001|Overall Study|Withdrawal by Subject|0|||
125174481|NCT00345631|450259351|FG002|Overall Study|Withdrawal by Subject|1|||
125230536|NCT02160626|450471635|FG000|Overall Study|Schedule not conducive to study visits|0|||
125230537|NCT02160626|450471636|FG001|Overall Study|Schedule not conducive to study visits|0|||
125230538|NCT02160626|450471637|FG002|Overall Study|Schedule not conducive to study visits|1|||
125230539|NCT02160626|450471635|FG000|Overall Study|Withdrawal by Subject|0|||
125230540|NCT02160626|450471636|FG001|Overall Study|Withdrawal by Subject|1|||
125230541|NCT02160626|450471637|FG002|Overall Study|Withdrawal by Subject|0|||
125230542|NCT04239924|450471638|FG000|Overall Study|Lost to Follow-up|2|||
125230543|NCT00499122|450473743|FG000|Overall Study|Withdrawal by Subject|2|||
125230544|NCT00903968|450473744|FG000|Overall Study|Adverse Event|0|||
125230545|NCT00903968|450473745|FG001|Overall Study|Adverse Event|0|||
125230546|NCT00903968|450473746|FG002|Overall Study|Adverse Event|0|||
125230547|NCT00903968|450473747|FG003|Overall Study|Adverse Event|0|||
125230548|NCT00903968|450473748|FG004|Overall Study|Adverse Event|0|||
125230549|NCT00903968|450473749|FG005|Overall Study|Adverse Event|0|||
125230550|NCT00903968|450473750|FG006|Overall Study|Adverse Event|1|||
125230551|NCT00903968|450473751|FG007|Overall Study|Adverse Event|8|||
125230552|NCT00903968|450473744|FG000|Overall Study|DLT|0|||
125230553|NCT00903968|450473745|FG001|Overall Study|DLT|0|||
125230554|NCT00903968|450473746|FG002|Overall Study|DLT|0|||
125230555|NCT00903968|450473747|FG003|Overall Study|DLT|0|||
125174482|NCT00345631|450259349|FG000|Overall Study|Adverse Event|0|||
125174483|NCT00345631|450259350|FG001|Overall Study|Adverse Event|1|||
125174484|NCT00345631|450259351|FG002|Overall Study|Adverse Event|0|||
125174485|NCT00345631|450259349|FG000|Overall Study|Lost to Follow-up|3|||
125174486|NCT00345631|450259350|FG001|Overall Study|Lost to Follow-up|7|||
125174487|NCT00345631|450259351|FG002|Overall Study|Lost to Follow-up|4|||
125174488|NCT00345631|450259349|FG000|Overall Study|Other reasons|0|||
125174489|NCT00345631|450259350|FG001|Overall Study|Other reasons|0|||
125174490|NCT00345631|450259351|FG002|Overall Study|Other reasons|1|||
125174491|NCT00447993|450259352|FG000|Overall Study|Lost to Follow-up|0|||
125174492|NCT00447993|450259353|FG001|Overall Study|Lost to Follow-up|0|||
125174493|NCT00447993|450259354|FG002|Overall Study|Lost to Follow-up|2|||
125174494|NCT00447993|450259355|FG003|Overall Study|Lost to Follow-up|2|||
125174495|NCT00447993|450259352|FG000|Overall Study|Withdrawal by Subject|0|||
125174496|NCT00447993|450259353|FG001|Overall Study|Withdrawal by Subject|0|||
125174497|NCT00447993|450259354|FG002|Overall Study|Withdrawal by Subject|2|||
125174498|NCT00447993|450259355|FG003|Overall Study|Withdrawal by Subject|2|||
125174499|NCT01885195|450259356|FG000|Overall Study|Adverse Event|29|||
125174500|NCT01885195|450259356|FG000|Overall Study|Death|1|||
125174501|NCT01885195|450259356|FG000|Overall Study|Disease Progression|67|||
125174502|NCT01885195|450259356|FG000|Overall Study|Protocol Deviation|2|||
125174503|NCT01885195|450259356|FG000|Overall Study|Physician Decision|3|||
125230556|NCT00903968|450473748|FG004|Overall Study|DLT|0|||
125230557|NCT00903968|450473749|FG005|Overall Study|DLT|0|||
125230558|NCT00903968|450473750|FG006|Overall Study|DLT|2|||
125174504|NCT01885195|450259356|FG000|Overall Study|Patient/guardian decision|8|||
125230559|NCT00903968|450473751|FG007|Overall Study|DLT|0|||
125230560|NCT00903968|450473744|FG000|Overall Study|Withdrawal by Subject|1|||
125230561|NCT00903968|450473745|FG001|Overall Study|Withdrawal by Subject|0|||
125174505|NCT00548093|450259357|FG000|Overall Study|Death|33|||
125174506|NCT00548093|450259358|FG001|Overall Study|Death|13|||
125174507|NCT00548093|450259357|FG000|Overall Study|Lost to Follow-up|3|||
125174508|NCT00548093|450259358|FG001|Overall Study|Lost to Follow-up|1|||
125174509|NCT00548093|450259357|FG000|Overall Study|Objective progression or relapse|1|||
125174510|NCT00548093|450259358|FG001|Overall Study|Objective progression or relapse|1|||
125230562|NCT00903968|450473746|FG002|Overall Study|Withdrawal by Subject|1|||
125230563|NCT00903968|450473747|FG003|Overall Study|Withdrawal by Subject|0|||
125230564|NCT00903968|450473748|FG004|Overall Study|Withdrawal by Subject|1|||
125230565|NCT00903968|450473749|FG005|Overall Study|Withdrawal by Subject|1|||
125174511|NCT00548093|450259357|FG000|Overall Study|Other|11|||
125174512|NCT00548093|450259358|FG001|Overall Study|Other|1|||
125230566|NCT00903968|450473750|FG006|Overall Study|Withdrawal by Subject|0|||
125174513|NCT00548093|450259357|FG000|Overall Study|Withdrawal by Subject|1|||
125174514|NCT00548093|450259358|FG001|Overall Study|Withdrawal by Subject|0|||
125174515|NCT00548093|450259357|FG000|Overall Study|Completed post-treatment follow-up|1|||
125174516|NCT00548093|450259358|FG001|Overall Study|Completed post-treatment follow-up|0|||
125174517|NCT00509795|450259360|FG000|Overall Study|Adverse Event|4|||
125174518|NCT00509795|450259361|FG001|Overall Study|Adverse Event|3|||
125174519|NCT00509795|450259362|FG002|Overall Study|Adverse Event|5|||
125174520|NCT00509795|450259363|FG003|Overall Study|Adverse Event|4|||
125174521|NCT00509795|450259360|FG000|Overall Study|Death|3|||
125174522|NCT00509795|450259361|FG001|Overall Study|Death|1|||
125174523|NCT00509795|450259362|FG002|Overall Study|Death|2|||
125174524|NCT00509795|450259363|FG003|Overall Study|Death|7|||
125174525|NCT00509795|450259360|FG000|Overall Study|Lack of Efficacy|0|||
125174526|NCT00509795|450259361|FG001|Overall Study|Lack of Efficacy|0|||
125174527|NCT00509795|450259362|FG002|Overall Study|Lack of Efficacy|2|||
125174528|NCT00509795|450259363|FG003|Overall Study|Lack of Efficacy|2|||
125174529|NCT00509795|450259360|FG000|Overall Study|Lost to Follow-up|1|||
125174530|NCT00509795|450259361|FG001|Overall Study|Lost to Follow-up|2|||
125174531|NCT00509795|450259362|FG002|Overall Study|Lost to Follow-up|4|||
125174532|NCT00509795|450259363|FG003|Overall Study|Lost to Follow-up|4|||
125174533|NCT00509795|450259360|FG000|Overall Study|OTHER|1|||
125174534|NCT00509795|450259361|FG001|Overall Study|OTHER|0|||
125174535|NCT00509795|450259362|FG002|Overall Study|OTHER|4|||
125174536|NCT00509795|450259363|FG003|Overall Study|OTHER|1|||
125174537|NCT00509795|450259360|FG000|Overall Study|Protocol Violation|3|||
125174538|NCT00509795|450259361|FG001|Overall Study|Protocol Violation|0|||
125174539|NCT00509795|450259362|FG002|Overall Study|Protocol Violation|3|||
125174540|NCT00509795|450259363|FG003|Overall Study|Protocol Violation|1|||
125174541|NCT00509795|450259360|FG000|Overall Study|Withdrawal by Subject|10|||
125174542|NCT00509795|450259361|FG001|Overall Study|Withdrawal by Subject|5|||
125174543|NCT00509795|450259362|FG002|Overall Study|Withdrawal by Subject|7|||
125174544|NCT00509795|450259363|FG003|Overall Study|Withdrawal by Subject|8|||
125174545|NCT02296931|450259364|FG000|Overall Study|Protocol Violation|0|||
125174546|NCT02296931|450259365|FG001|Overall Study|Protocol Violation|2|||
125174547|NCT00912912|450259369|FG000|Overall Study|Withdrawal by Subject|1|||
125174548|NCT00912912|450259369|FG000|Overall Study|Disease Progression|3|||
125174549|NCT00306995|450259370|FG000|Study Part I|Withdrawal by Subject|0|||
125174550|NCT00306995|450259371|FG001|Study Part I|Withdrawal by Subject|0|||
125174551|NCT00306995|450259372|FG002|Study Part I|Withdrawal by Subject|0|||
125174552|NCT00306995|450259373|FG003|Study Part I|Withdrawal by Subject|0|||
125174553|NCT00306995|450259374|FG004|Study Part I|Withdrawal by Subject|0|||
125174554|NCT00306995|450259375|FG005|Study Part I|Withdrawal by Subject|0|||
125174555|NCT00306995|450259376|FG006|Study Part I|Withdrawal by Subject|1|||
125174556|NCT00306995|450259370|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
125174557|NCT00306995|450259371|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
125174558|NCT00306995|450259372|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
125174559|NCT00306995|450259373|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
125174560|NCT00306995|450259374|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
125174561|NCT00306995|450259375|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
125174562|NCT00306995|450259376|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
125174563|NCT04324073|450261614|FG000|Overall Study|withdrew consent|0|||
125174564|NCT04324073|450261615|FG001|Overall Study|withdrew consent|4|||
125174565|NCT04324073|450261616|FG002|Overall Study|withdrew consent|2|||
125174566|NCT04324073|450261617|FG003|Overall Study|withdrew consent|8|||
125174567|NCT05833139|450261618|FG000|Study Period 2|Adverse Event|1|||
125174568|NCT00371033|450261619|FG000|Overall Study|Lost to Follow-up|3|||
125174569|NCT00371033|450261620|FG001|Overall Study|Lost to Follow-up|2|||
125174570|NCT00371033|450261619|FG000|Overall Study|No longer interested|2|||
125174571|NCT00371033|450261620|FG001|Overall Study|No longer interested|0|||
125174572|NCT00371033|450261619|FG000|Overall Study|Uknown|3|||
125174573|NCT00371033|450261620|FG001|Overall Study|Uknown|1|||
125174574|NCT03922529|450261621|FG000|Overall Study|Withdrawal by Subject|13|||
125174575|NCT03922529|450261622|FG001|Overall Study|Withdrawal by Subject|12|||
125174576|NCT03922529|450261621|FG000|Overall Study|Death|7|||
125174577|NCT03922529|450261622|FG001|Overall Study|Death|12|||
125174578|NCT03922529|450261621|FG000|Overall Study|Lost to Follow-up|12|||
125174579|NCT03922529|450261622|FG001|Overall Study|Lost to Follow-up|19|||
125174580|NCT03922529|450261621|FG000|Overall Study|Adverse Event|1|||
125174581|NCT03922529|450261622|FG001|Overall Study|Adverse Event|0|||
125174582|NCT03922529|450261621|FG000|Overall Study|Death after withdrawal|1|||
125174583|NCT03922529|450261622|FG001|Overall Study|Death after withdrawal|0|||
125174584|NCT03922529|450261621|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
125174585|NCT03922529|450261622|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
125174586|NCT03922529|450261621|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
125174587|NCT03922529|450261622|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
125174588|NCT04158245|450261623|FG000|Overall Study|Lost to Follow-up|1|||
125174589|NCT03842228|450261626|FG000|Overall Study|Adverse Event|1|||
125230567|NCT00903968|450473751|FG007|Overall Study|Withdrawal by Subject|4|||
125230568|NCT00903968|450473744|FG000|Overall Study|Non-Compliance|0|||
125230569|NCT00903968|450473745|FG001|Overall Study|Non-Compliance|0|||
125230570|NCT00903968|450473746|FG002|Overall Study|Non-Compliance|0|||
125230571|NCT00903968|450473747|FG003|Overall Study|Non-Compliance|0|||
125230572|NCT00903968|450473748|FG004|Overall Study|Non-Compliance|0|||
125230573|NCT00903968|450473749|FG005|Overall Study|Non-Compliance|1|||
125230574|NCT00903968|450473750|FG006|Overall Study|Non-Compliance|0|||
125230575|NCT00903968|450473751|FG007|Overall Study|Non-Compliance|0|||
125230576|NCT00903968|450473744|FG000|Overall Study|Physician Decision|0|||
125230577|NCT00903968|450473745|FG001|Overall Study|Physician Decision|0|||
125230578|NCT00903968|450473746|FG002|Overall Study|Physician Decision|0|||
125230579|NCT00903968|450473747|FG003|Overall Study|Physician Decision|0|||
125230580|NCT00903968|450473748|FG004|Overall Study|Physician Decision|0|||
125230581|NCT00903968|450473749|FG005|Overall Study|Physician Decision|1|||
125230582|NCT00903968|450473750|FG006|Overall Study|Physician Decision|0|||
125230583|NCT00903968|450473751|FG007|Overall Study|Physician Decision|0|||
125230584|NCT00903968|450473744|FG000|Overall Study|Progressive Disease|2|||
125230585|NCT00903968|450473745|FG001|Overall Study|Progressive Disease|3|||
125230586|NCT00903968|450473746|FG002|Overall Study|Progressive Disease|2|||
125230587|NCT00903968|450473747|FG003|Overall Study|Progressive Disease|3|||
125230588|NCT00903968|450473748|FG004|Overall Study|Progressive Disease|3|||
125230589|NCT00903968|450473749|FG005|Overall Study|Progressive Disease|3|||
125230590|NCT00903968|450473750|FG006|Overall Study|Progressive Disease|0|||
125230591|NCT00903968|450473751|FG007|Overall Study|Progressive Disease|18|||
125230592|NCT00903968|450473744|FG000|Overall Study|Lack of Efficacy|0|||
125230593|NCT00903968|450473745|FG001|Overall Study|Lack of Efficacy|0|||
125230594|NCT00903968|450473746|FG002|Overall Study|Lack of Efficacy|0|||
125230595|NCT00903968|450473747|FG003|Overall Study|Lack of Efficacy|0|||
125230596|NCT00903968|450473748|FG004|Overall Study|Lack of Efficacy|0|||
125230597|NCT00903968|450473749|FG005|Overall Study|Lack of Efficacy|0|||
125230598|NCT00903968|450473750|FG006|Overall Study|Lack of Efficacy|0|||
125230599|NCT00903968|450473751|FG007|Overall Study|Lack of Efficacy|3|||
125230600|NCT01663623|450473752|FG000|Overall Study|Adverse Event|3|||
125230601|NCT01663623|450473753|FG001|Overall Study|Adverse Event|7|||
125230602|NCT01663623|450473752|FG000|Overall Study|Lack of Efficacy|5|||
125230603|NCT01663623|450473753|FG001|Overall Study|Lack of Efficacy|6|||
125230604|NCT01663623|450473752|FG000|Overall Study|Protocol Violation|0|||
125230605|NCT01663623|450473753|FG001|Overall Study|Protocol Violation|1|||
125230606|NCT01663623|450473752|FG000|Overall Study|Other-Study closed/terminated|1|||
125230607|NCT01663623|450473753|FG001|Overall Study|Other-Study closed/terminated|1|||
125230608|NCT01663623|450473752|FG000|Overall Study|Physician Decision|1|||
125230609|NCT01663623|450473753|FG001|Overall Study|Physician Decision|4|||
125230610|NCT01663623|450473752|FG000|Overall Study|Withdrawal by Subject|2|||
125230611|NCT01663623|450473753|FG001|Overall Study|Withdrawal by Subject|1|||
125230612|NCT02251275|450473754|FG000|Overall Study|Adverse Event|23|||
125230613|NCT02251275|450473755|FG001|Overall Study|Adverse Event|60|||
125230614|NCT02251275|450473756|FG002|Overall Study|Adverse Event|28|||
125230615|NCT02251275|450473757|FG003|Overall Study|Adverse Event|0|||
125230616|NCT02251275|450473758|FG004|Overall Study|Adverse Event|0|||
125230617|NCT02251275|450473754|FG000|Overall Study|Lost to Follow-up|5|||
125230618|NCT02251275|450473755|FG001|Overall Study|Lost to Follow-up|6|||
125230619|NCT02251275|450473756|FG002|Overall Study|Lost to Follow-up|4|||
125230620|NCT02251275|450473757|FG003|Overall Study|Lost to Follow-up|0|||
125230621|NCT02251275|450473758|FG004|Overall Study|Lost to Follow-up|0|||
125230622|NCT02251275|450473754|FG000|Overall Study|Physician Decision|19|||
125230623|NCT02251275|450473755|FG001|Overall Study|Physician Decision|30|||
125230624|NCT02251275|450473756|FG002|Overall Study|Physician Decision|26|||
125230625|NCT02251275|450473757|FG003|Overall Study|Physician Decision|0|||
125230626|NCT02251275|450473758|FG004|Overall Study|Physician Decision|1|||
125230627|NCT02251275|450473754|FG000|Overall Study|Protocol Deviation|0|||
125230628|NCT02251275|450473755|FG001|Overall Study|Protocol Deviation|0|||
125230629|NCT02251275|450473756|FG002|Overall Study|Protocol Deviation|1|||
125230630|NCT02251275|450473757|FG003|Overall Study|Protocol Deviation|0|||
125230631|NCT02251275|450473758|FG004|Overall Study|Protocol Deviation|0|||
125230632|NCT02251275|450473754|FG000|Overall Study|Withdrawal by Subject|25|||
125230633|NCT02251275|450473755|FG001|Overall Study|Withdrawal by Subject|51|||
125230634|NCT02251275|450473756|FG002|Overall Study|Withdrawal by Subject|35|||
125230635|NCT02251275|450473757|FG003|Overall Study|Withdrawal by Subject|1|||
125230636|NCT02251275|450473758|FG004|Overall Study|Withdrawal by Subject|0|||
125230637|NCT00856180|450473764|FG000|Overall Study|Adverse Event|4|||
125230638|NCT00856180|450473764|FG000|Overall Study|Progressive Disease|16|||
125230639|NCT02265510|450473765|FG000|Overall Study|Withdrawal by Subject|1|||
125230640|NCT02265510|450473766|FG001|Overall Study|Withdrawal by Subject|1|||
125230641|NCT02265510|450473767|FG002|Overall Study|Withdrawal by Subject|2|||
125230642|NCT02265510|450473768|FG003|Overall Study|Withdrawal by Subject|1|||
125230643|NCT02265510|450473769|FG004|Overall Study|Withdrawal by Subject|0|||
125230644|NCT02265510|450473770|FG005|Overall Study|Withdrawal by Subject|2|||
125230645|NCT02265510|450473771|FG006|Overall Study|Withdrawal by Subject|0|||
125230646|NCT02265510|450473772|FG007|Overall Study|Withdrawal by Subject|2|||
125174590|NCT03842228|450261627|FG001|Overall Study|Adverse Event|1|||
125174591|NCT03842228|450261628|FG002|Overall Study|Adverse Event|1|||
125174592|NCT03842228|450261629|FG003|Overall Study|Adverse Event|0|||
125174593|NCT03842228|450261630|FG004|Overall Study|Adverse Event|0|||
125174594|NCT03842228|450261631|FG005|Overall Study|Adverse Event|0|||
125174595|NCT03842228|450261632|FG006|Overall Study|Adverse Event|0|||
125174596|NCT03842228|450261626|FG000|Overall Study|Death|0|||
125174597|NCT03842228|450261627|FG001|Overall Study|Death|1|||
125174598|NCT03842228|450261628|FG002|Overall Study|Death|0|||
125174599|NCT03842228|450261629|FG003|Overall Study|Death|0|||
125174600|NCT03842228|450261630|FG004|Overall Study|Death|0|||
125174601|NCT03842228|450261631|FG005|Overall Study|Death|0|||
125174602|NCT03842228|450261632|FG006|Overall Study|Death|0|||
125174603|NCT03842228|450261626|FG000|Overall Study|Withdrawal by Subject|0|||
125174604|NCT03842228|450261627|FG001|Overall Study|Withdrawal by Subject|0|||
125174605|NCT03842228|450261628|FG002|Overall Study|Withdrawal by Subject|2|||
125174606|NCT03842228|450261629|FG003|Overall Study|Withdrawal by Subject|1|||
125174607|NCT03842228|450261630|FG004|Overall Study|Withdrawal by Subject|0|||
125174608|NCT03842228|450261631|FG005|Overall Study|Withdrawal by Subject|0|||
125174609|NCT03842228|450261632|FG006|Overall Study|Withdrawal by Subject|2|||
125174610|NCT03842228|450261626|FG000|Overall Study|Progression|8|||
125174611|NCT03842228|450261627|FG001|Overall Study|Progression|1|||
125174612|NCT03842228|450261628|FG002|Overall Study|Progression|7|||
125174613|NCT03842228|450261629|FG003|Overall Study|Progression|5|||
125174614|NCT03842228|450261630|FG004|Overall Study|Progression|4|||
125174615|NCT03842228|450261631|FG005|Overall Study|Progression|2|||
125174616|NCT03842228|450261632|FG006|Overall Study|Progression|3|||
125174617|NCT06390826|450261633|FG000|Overall Study|Never Start Protocol Therapy|1|||
125174618|NCT06390826|450261633|FG000|Overall Study|Adverse Event|1|||
125174619|NCT06390826|450261633|FG000|Overall Study|Disease Progression|8|||
125174620|NCT06390839|450261634|FG000|Overall Study|Ineligible|2|||
125174621|NCT06390839|450261634|FG000|Overall Study|Never start protocol therapy|3|||
125174622|NCT06390839|450261634|FG000|Overall Study|Adverse Event|1|||
125174623|NCT06390839|450261634|FG000|Overall Study|Alternative therapy|2|||
125174624|NCT06390839|450261634|FG000|Overall Study|Death|3|||
125174625|NCT06390839|450261634|FG000|Overall Study|Disease progression|28|||
125174626|NCT06390839|450261634|FG000|Overall Study|Withdrawal by Subject|2|||
125174627|NCT06390839|450261634|FG000|Overall Study|Complicating disease|1|||
125174628|NCT06390839|450261634|FG000|Overall Study|Noncompliance|1|||
125174629|NCT06351371|450261635|FG000|Overall Study|Mutation Status Not Confirmed|9|||
125174630|NCT06351371|450261635|FG000|Overall Study|Ineligible|1|||
125174631|NCT06351371|450261635|FG000|Overall Study|Adverse Event|4|||
125174632|NCT06351371|450261635|FG000|Overall Study|Death|1|||
125174633|NCT06351371|450261635|FG000|Overall Study|Disease progression|14|||
125174634|NCT06351371|450261635|FG000|Overall Study|Withdrawal by Subject|3|||
125174635|NCT06351371|450261635|FG000|Overall Study|Physician Decision|3|||
125174636|NCT01272037|450261637|FG000|Overall Study|Death|25|||
125174637|NCT01272037|450261638|FG001|Overall Study|Death|28|||
125174638|NCT01272037|450261637|FG000|Overall Study|Adverse Event|12|||
125174639|NCT01272037|450261638|FG001|Overall Study|Adverse Event|7|||
125174640|NCT01272037|450261637|FG000|Overall Study|Withdrawal by Subject|175|||
125174641|NCT01272037|450261638|FG001|Overall Study|Withdrawal by Subject|93|||
125174642|NCT01272037|450261637|FG000|Overall Study|Disease progression|70|||
125174643|NCT01272037|450261638|FG001|Overall Study|Disease progression|111|||
125174644|NCT01272037|450261637|FG000|Overall Study|Other reason|42|||
125174645|NCT01272037|450261638|FG001|Overall Study|Other reason|41|||
125174646|NCT01272037|450261637|FG000|Overall Study|Delinquent data|24|||
125174647|NCT01272037|450261638|FG001|Overall Study|Delinquent data|19|||
125174648|NCT01272037|450261637|FG000|Overall Study|Reason under review|33|||
125174649|NCT01272037|450261638|FG001|Overall Study|Reason under review|29|||
125174650|NCT01272037|450261637|FG000|Overall Study|On treatment|626|||
125174651|NCT01272037|450261638|FG001|Overall Study|On treatment|632|||
125174652|NCT01121562|450261639|FG000|Overall Study|Objective progression or relapse|8|||
125174653|NCT01121562|450261639|FG000|Overall Study|Withdrawal by Subject|1|||
125174654|NCT01121562|450261639|FG000|Overall Study|Adverse Event|1|||
125174655|NCT01121562|450261639|FG000|Overall Study|Sponsor Decision|1|||
125174656|NCT01121562|450261639|FG000|Overall Study|Met study discontinuation criteria|1|||
125174657|NCT04152863|450261640|FG000|Overall Study|Death|13|||
125174658|NCT04152863|450261641|FG001|Overall Study|Death|12|||
125174659|NCT04152863|450261642|FG002|Overall Study|Death|7|||
125174660|NCT04152863|450261640|FG000|Overall Study|Physician Decision|1|||
125174661|NCT04152863|450261641|FG001|Overall Study|Physician Decision|1|||
125174662|NCT04152863|450261642|FG002|Overall Study|Physician Decision|1|||
125174663|NCT04152863|450261640|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
125174664|NCT04152863|450261641|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
125174665|NCT04152863|450261642|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
125174666|NCT04152863|450261640|FG000|Overall Study|Withdrawal by Subject|2|||
125174667|NCT04152863|450261641|FG001|Overall Study|Withdrawal by Subject|1|||
125174668|NCT04152863|450261642|FG002|Overall Study|Withdrawal by Subject|3|||
125174669|NCT02540083|450261648|FG000|Overall Study|Withdrawal by Subject|16|||
125230647|NCT02265510|450473773|FG008|Overall Study|Withdrawal by Subject|0|||
125230648|NCT02265510|450473774|FG009|Overall Study|Withdrawal by Subject|0|||
125230649|NCT02265510|450473775|FG010|Overall Study|Withdrawal by Subject|0|||
125230650|NCT02265510|450473776|FG011|Overall Study|Withdrawal by Subject|0|||
125230651|NCT02265510|450473777|FG012|Overall Study|Withdrawal by Subject|1|||
125230652|NCT02265510|450473778|FG013|Overall Study|Withdrawal by Subject|0|||
125230653|NCT02265510|450473765|FG000|Overall Study|Disease Progression|0|||
125230654|NCT02265510|450473766|FG001|Overall Study|Disease Progression|1|||
125230655|NCT02265510|450473767|FG002|Overall Study|Disease Progression|2|||
125230656|NCT02265510|450473768|FG003|Overall Study|Disease Progression|1|||
125230657|NCT02265510|450473769|FG004|Overall Study|Disease Progression|1|||
125230658|NCT02265510|450473770|FG005|Overall Study|Disease Progression|0|||
125230659|NCT02265510|450473771|FG006|Overall Study|Disease Progression|0|||
125230660|NCT02265510|450473772|FG007|Overall Study|Disease Progression|0|||
125230661|NCT02265510|450473773|FG008|Overall Study|Disease Progression|0|||
125230662|NCT02265510|450473774|FG009|Overall Study|Disease Progression|0|||
125230663|NCT02265510|450473775|FG010|Overall Study|Disease Progression|0|||
125230664|NCT02265510|450473776|FG011|Overall Study|Disease Progression|0|||
125230665|NCT02265510|450473777|FG012|Overall Study|Disease Progression|0|||
125230666|NCT02265510|450473778|FG013|Overall Study|Disease Progression|0|||
125230667|NCT02265510|450473765|FG000|Overall Study|Death|2|||
125230668|NCT02265510|450473766|FG001|Overall Study|Death|0|||
125230669|NCT02265510|450473767|FG002|Overall Study|Death|2|||
125230670|NCT02265510|450473768|FG003|Overall Study|Death|2|||
125230671|NCT02265510|450473769|FG004|Overall Study|Death|1|||
125230672|NCT02265510|450473770|FG005|Overall Study|Death|3|||
125230673|NCT02265510|450473771|FG006|Overall Study|Death|2|||
125230674|NCT02265510|450473772|FG007|Overall Study|Death|1|||
125230675|NCT02265510|450473773|FG008|Overall Study|Death|3|||
125230676|NCT02265510|450473774|FG009|Overall Study|Death|3|||
125230677|NCT02265510|450473775|FG010|Overall Study|Death|4|||
125230678|NCT02265510|450473776|FG011|Overall Study|Death|12|||
125230679|NCT02265510|450473777|FG012|Overall Study|Death|7|||
125230680|NCT02265510|450473778|FG013|Overall Study|Death|6|||
125230681|NCT02265510|450473765|FG000|Overall Study|Lost to Follow-up|0|||
125230682|NCT02265510|450473766|FG001|Overall Study|Lost to Follow-up|0|||
125230683|NCT02265510|450473767|FG002|Overall Study|Lost to Follow-up|0|||
125230684|NCT02265510|450473768|FG003|Overall Study|Lost to Follow-up|0|||
125230685|NCT02265510|450473769|FG004|Overall Study|Lost to Follow-up|1|||
125230686|NCT02265510|450473770|FG005|Overall Study|Lost to Follow-up|0|||
125230687|NCT02265510|450473771|FG006|Overall Study|Lost to Follow-up|0|||
125230688|NCT02265510|450473772|FG007|Overall Study|Lost to Follow-up|0|||
125230689|NCT02265510|450473773|FG008|Overall Study|Lost to Follow-up|0|||
125230690|NCT02265510|450473774|FG009|Overall Study|Lost to Follow-up|2|||
125230691|NCT02265510|450473775|FG010|Overall Study|Lost to Follow-up|0|||
125230692|NCT02265510|450473776|FG011|Overall Study|Lost to Follow-up|0|||
125230693|NCT02265510|450473777|FG012|Overall Study|Lost to Follow-up|0|||
125230694|NCT02265510|450473778|FG013|Overall Study|Lost to Follow-up|2|||
125230695|NCT02265510|450473765|FG000|Overall Study|Other|0|||
125230696|NCT02265510|450473766|FG001|Overall Study|Other|1|||
125230697|NCT02265510|450473767|FG002|Overall Study|Other|0|||
125230698|NCT02265510|450473768|FG003|Overall Study|Other|0|||
125230699|NCT02265510|450473769|FG004|Overall Study|Other|0|||
125230700|NCT02265510|450473770|FG005|Overall Study|Other|0|||
125230701|NCT02265510|450473771|FG006|Overall Study|Other|0|||
125230702|NCT02265510|450473772|FG007|Overall Study|Other|0|||
125230703|NCT02265510|450473773|FG008|Overall Study|Other|0|||
125230704|NCT02265510|450473774|FG009|Overall Study|Other|0|||
125230705|NCT02265510|450473775|FG010|Overall Study|Other|0|||
125230706|NCT02265510|450473776|FG011|Overall Study|Other|0|||
125230707|NCT02265510|450473777|FG012|Overall Study|Other|0|||
125230708|NCT02265510|450473778|FG013|Overall Study|Other|0|||
125230709|NCT02265510|450473765|FG000|Overall Study|Study Terminated by Sponsor|0|||
125230710|NCT02265510|450473766|FG001|Overall Study|Study Terminated by Sponsor|0|||
125230711|NCT02265510|450473767|FG002|Overall Study|Study Terminated by Sponsor|0|||
125230712|NCT02265510|450473768|FG003|Overall Study|Study Terminated by Sponsor|0|||
125230713|NCT02265510|450473769|FG004|Overall Study|Study Terminated by Sponsor|0|||
125230714|NCT02265510|450473770|FG005|Overall Study|Study Terminated by Sponsor|1|||
125230715|NCT02265510|450473771|FG006|Overall Study|Study Terminated by Sponsor|1|||
125230716|NCT02265510|450473772|FG007|Overall Study|Study Terminated by Sponsor|1|||
125230717|NCT02265510|450473773|FG008|Overall Study|Study Terminated by Sponsor|1|||
125230718|NCT02265510|450473774|FG009|Overall Study|Study Terminated by Sponsor|2|||
125230719|NCT02265510|450473775|FG010|Overall Study|Study Terminated by Sponsor|1|||
125230720|NCT02265510|450473776|FG011|Overall Study|Study Terminated by Sponsor|4|||
125230721|NCT02265510|450473777|FG012|Overall Study|Study Terminated by Sponsor|1|||
125230722|NCT02265510|450473778|FG013|Overall Study|Study Terminated by Sponsor|2|||
125230723|NCT01004614|450473779|FG000|Washout|Withdrawal by Subject|0|||
125230724|NCT01004614|450473780|FG001|Washout|Withdrawal by Subject|1|||
125230725|NCT01004614|450473781|FG002|Washout|Withdrawal by Subject|0|||
125230726|NCT01004614|450473782|FG003|Washout|Withdrawal by Subject|0|||
125230727|NCT02111083|450473783|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
125230728|NCT02111083|450473784|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
125230729|NCT00368550|450473785|FG000|Overall Study|Adverse Event|7|||
125230730|NCT00368550|450473786|FG001|Overall Study|Adverse Event|4|||
125230731|NCT00368550|450473785|FG000|Overall Study|Lack of Efficacy|4|||
125230732|NCT00368550|450473786|FG001|Overall Study|Lack of Efficacy|9|||
125230733|NCT00368550|450473785|FG000|Overall Study|Withdrawal by Subject|17|||
125230734|NCT00368550|450473786|FG001|Overall Study|Withdrawal by Subject|10|||
125230735|NCT00486044|450473787|FG000|Overall Study|Withdrawal by Subject|2|||
125230736|NCT00486044|450473788|FG001|Overall Study|Withdrawal by Subject|1|||
125230737|NCT00486044|450473787|FG000|Overall Study|Adverse Event|0|||
125230738|NCT00486044|450473788|FG001|Overall Study|Adverse Event|1|||
125230739|NCT00486044|450473787|FG000|Overall Study|Lost to Follow-up|0|||
125230740|NCT00486044|450473788|FG001|Overall Study|Lost to Follow-up|1|||
125230741|NCT01670292|450473792|FG000|Overall Study|Lost to Follow-up|14|||
125230742|NCT03154086|450473797|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230743|NCT03154086|450473798|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230744|NCT03154086|450473799|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230745|NCT03154086|450473800|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
125230746|NCT03154086|450473801|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230747|NCT03154086|450473802|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230748|NCT03154086|450473803|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230749|NCT03154086|450473804|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230750|NCT03154086|450473805|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230751|NCT03154086|450473806|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230752|NCT03154086|450473807|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230753|NCT03154086|450473808|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230754|NCT03154086|450473809|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230755|NCT03154086|450473810|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230756|NCT03154086|450473811|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
125230757|NCT03154086|450473797|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230758|NCT03154086|450473798|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
125230759|NCT03154086|450473799|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230760|NCT03154086|450473800|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230761|NCT03154086|450473801|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230762|NCT03154086|450473802|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230763|NCT03154086|450473803|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230764|NCT03154086|450473804|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230765|NCT03154086|450473805|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230766|NCT03154086|450473806|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230767|NCT03154086|450473807|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230768|NCT03154086|450473808|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230769|NCT03154086|450473809|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230770|NCT03154086|450473810|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230771|NCT03154086|450473811|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
125230772|NCT03154086|450473797|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230773|NCT03154086|450473798|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230774|NCT03154086|450473799|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
125230775|NCT03154086|450473800|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230776|NCT03154086|450473801|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230777|NCT03154086|450473802|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230778|NCT03154086|450473803|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230779|NCT03154086|450473804|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230780|NCT03154086|450473805|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230781|NCT03154086|450473806|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230782|NCT03154086|450473807|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230783|NCT03154086|450473808|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230784|NCT03154086|450473809|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230785|NCT03154086|450473810|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230786|NCT03154086|450473811|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
125230787|NCT03154086|450473797|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
125230788|NCT03154086|450473798|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230789|NCT03154086|450473799|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230790|NCT03154086|450473800|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230791|NCT03154086|450473801|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230792|NCT03154086|450473802|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230793|NCT03154086|450473803|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230794|NCT03154086|450473804|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230795|NCT03154086|450473805|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230796|NCT03154086|450473806|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230797|NCT03154086|450473807|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230798|NCT03154086|450473808|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230799|NCT03154086|450473809|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230800|NCT03154086|450473810|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230801|NCT03154086|450473811|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
125230802|NCT03154086|450473797|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230803|NCT03154086|450473798|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230804|NCT03154086|450473799|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230805|NCT03154086|450473800|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230806|NCT03154086|450473801|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230807|NCT03154086|450473802|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230808|NCT03154086|450473803|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230809|NCT03154086|450473804|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230810|NCT03154086|450473805|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
125230811|NCT03154086|450473806|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230812|NCT03154086|450473807|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230813|NCT03154086|450473808|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230814|NCT03154086|450473809|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230815|NCT03154086|450473810|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230816|NCT03154086|450473811|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
125230817|NCT03154086|450473797|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230818|NCT03154086|450473798|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230819|NCT03154086|450473799|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230820|NCT03154086|450473800|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230821|NCT03154086|450473801|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230822|NCT03154086|450473802|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230823|NCT03154086|450473803|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230824|NCT03154086|450473804|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
125230825|NCT03154086|450473805|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230826|NCT03154086|450473806|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230827|NCT03154086|450473807|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230828|NCT03154086|450473808|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230829|NCT03154086|450473809|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230830|NCT03154086|450473810|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230831|NCT03154086|450473811|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
125230832|NCT03154086|450473797|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
125230833|NCT03154086|450473798|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
125230834|NCT03154086|450473799|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
125230835|NCT03154086|450473800|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
125230836|NCT03154086|450473801|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
125230837|NCT03154086|450473802|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
125230838|NCT03154086|450473803|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
125230839|NCT03154086|450473804|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
125230840|NCT03154086|450473805|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
125230841|NCT03154086|450473806|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
125230842|NCT03154086|450473807|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
125230843|NCT03154086|450473808|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
125230844|NCT03154086|450473809|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
125230845|NCT03154086|450473810|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
125230846|NCT03154086|450473811|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
125230847|NCT01603277|450473812|FG000|Overall Study|Adverse Event|1|||
125174670|NCT02797171|450261649|FG000|Overall Study|Lost to Follow-up|2|||
125174671|NCT02797171|450261650|FG001|Overall Study|Lost to Follow-up|0|||
125174672|NCT02797171|450261651|FG002|Overall Study|Lost to Follow-up|2|||
125174673|NCT02797171|450261652|FG003|Overall Study|Lost to Follow-up|1|||
125174674|NCT02797171|450261653|FG004|Overall Study|Lost to Follow-up|2|||
125174675|NCT02797171|450261654|FG005|Overall Study|Lost to Follow-up|0|||
125174676|NCT02797171|450261649|FG000|Overall Study|Withdrawal by Subject|1|||
125174677|NCT02797171|450261650|FG001|Overall Study|Withdrawal by Subject|1|||
125174678|NCT02797171|450261651|FG002|Overall Study|Withdrawal by Subject|0|||
125174679|NCT02797171|450261652|FG003|Overall Study|Withdrawal by Subject|0|||
125174680|NCT02797171|450261653|FG004|Overall Study|Withdrawal by Subject|0|||
125174681|NCT02797171|450261654|FG005|Overall Study|Withdrawal by Subject|0|||
125174682|NCT02797171|450261649|FG000|Overall Study|Protocol Violation|1|||
125174683|NCT02797171|450261650|FG001|Overall Study|Protocol Violation|0|||
125174684|NCT02797171|450261651|FG002|Overall Study|Protocol Violation|0|||
125174685|NCT02797171|450261652|FG003|Overall Study|Protocol Violation|0|||
125174686|NCT02797171|450261653|FG004|Overall Study|Protocol Violation|0|||
125230848|NCT01603277|450473813|FG001|Overall Study|Adverse Event|2|||
125230849|NCT01603277|450473812|FG000|Overall Study|Physician Decision|0|||
125230850|NCT01603277|450473813|FG001|Overall Study|Physician Decision|1|||
125230851|NCT01603277|450473812|FG000|Overall Study|Protocol Violation|6|||
125230852|NCT01603277|450473813|FG001|Overall Study|Protocol Violation|10|||
125174687|NCT02797171|450261654|FG005|Overall Study|Protocol Violation|0|||
125174688|NCT02797171|450261649|FG000|Overall Study|Participant unable to adhere|0|||
125174689|NCT02797171|450261650|FG001|Overall Study|Participant unable to adhere|1|||
125174690|NCT02797171|450261651|FG002|Overall Study|Participant unable to adhere|0|||
125174691|NCT02797171|450261652|FG003|Overall Study|Participant unable to adhere|0|||
125174692|NCT02797171|450261653|FG004|Overall Study|Participant unable to adhere|0|||
125174693|NCT02797171|450261654|FG005|Overall Study|Participant unable to adhere|0|||
125174694|NCT02797171|450261649|FG000|Overall Study|Not Randomized|0|||
125174695|NCT02797171|450261650|FG001|Overall Study|Not Randomized|0|||
125174696|NCT02797171|450261651|FG002|Overall Study|Not Randomized|0|||
125174697|NCT02797171|450261652|FG003|Overall Study|Not Randomized|0|||
125174698|NCT02797171|450261653|FG004|Overall Study|Not Randomized|0|||
125174699|NCT02797171|450261654|FG005|Overall Study|Not Randomized|1|||
125174700|NCT03993379|450261655|FG000|Overall Study|The study was terminated early due to business decision.|0|||
125174701|NCT03993379|450261656|FG001|Overall Study|The study was terminated early due to business decision.|2|||
125174702|NCT03993379|450261657|FG002|Overall Study|The study was terminated early due to business decision.|0|||
125174703|NCT03993379|450261658|FG003|Overall Study|The study was terminated early due to business decision.|0|||
125174704|NCT03993379|450261655|FG000|Overall Study|Withdrawal by Subject|0|||
125174705|NCT03993379|450261656|FG001|Overall Study|Withdrawal by Subject|1|||
125174706|NCT03993379|450261657|FG002|Overall Study|Withdrawal by Subject|0|||
125174707|NCT03993379|450261658|FG003|Overall Study|Withdrawal by Subject|0|||
125174708|NCT01427608|450261659|FG000|Overall Study|Death|1|||
125174709|NCT01427608|450261660|FG001|Overall Study|Death|0|||
125174710|NCT01427608|450261659|FG000|Overall Study|Withdrawal by Subject|7|||
125174711|NCT01427608|450261660|FG001|Overall Study|Withdrawal by Subject|3|||
125174712|NCT01427608|450261659|FG000|Overall Study|Relapsed-all cause|13|||
125174713|NCT01427608|450261660|FG001|Overall Study|Relapsed-all cause|34|||
125174714|NCT01427608|450261659|FG000|Overall Study|Events not attributed to study meds|0|||
125174715|NCT01427608|450261660|FG001|Overall Study|Events not attributed to study meds|1|||
125174716|NCT04289363|450261665|FG000|Overall Study|Lost to Follow-up|14|||
125174717|NCT04289363|450261666|FG001|Overall Study|Lost to Follow-up|0|||
125174718|NCT02585778|450261667|FG000|Overall Study|Adverse Event|17|||
125174719|NCT02585778|450261668|FG001|Overall Study|Adverse Event|4|||
125174720|NCT02585778|450261667|FG000|Overall Study|Participant did not wish to continue|9|||
125174721|NCT02585778|450261668|FG001|Overall Study|Participant did not wish to continue|4|||
125174722|NCT02585778|450261667|FG000|Overall Study|Poor compliance to study protocol|0|||
125174723|NCT02585778|450261668|FG001|Overall Study|Poor compliance to study protocol|2|||
125174724|NCT02585778|450261667|FG000|Overall Study|Death|0|||
125174725|NCT02585778|450261668|FG001|Overall Study|Death|1|||
125174726|NCT02585778|450261667|FG000|Overall Study|Randomized but not treated|1|||
125174727|NCT02585778|450261668|FG001|Overall Study|Randomized but not treated|2|||
125174728|NCT02585778|450261667|FG000|Overall Study|Other than specified above|6|||
125174729|NCT02585778|450261668|FG001|Overall Study|Other than specified above|2|||
125174730|NCT00445432|450261670|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
125174731|NCT00445432|450261671|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
125174732|NCT00445432|450261672|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
125174733|NCT00445432|450261673|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
125174734|NCT00445432|450261670|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
125174735|NCT00445432|450261671|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
125174736|NCT00445432|450261672|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
125174737|NCT00445432|450261673|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
125174738|NCT00445432|450261670|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
125174739|NCT00445432|450261671|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
125174740|NCT00445432|450261672|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
125174741|NCT00445432|450261673|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
125230853|NCT01603277|450473812|FG000|Overall Study|Withdrawal by Subject|5|||
125230854|NCT01603277|450473813|FG001|Overall Study|Withdrawal by Subject|4|||
125230855|NCT01603277|450473812|FG000|Overall Study|Non-Compliance|2|||
125174742|NCT00445432|450261670|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
125174743|NCT00445432|450261671|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
125174744|NCT00445432|450261672|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
125174745|NCT00445432|450261673|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
125174746|NCT00445432|450261670|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
125174747|NCT00445432|450261671|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
125174748|NCT00445432|450261672|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
125174749|NCT00445432|450261673|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
125230856|NCT01603277|450473813|FG001|Overall Study|Non-Compliance|1|||
125230857|NCT04494646|450473818|FG000|Overall Study|Adverse Event|0|||
125230858|NCT04494646|450473819|FG001|Overall Study|Adverse Event|1|||
125230859|NCT04494646|450473818|FG000|Overall Study|Withdrawal by Subject|0|||
125230860|NCT04494646|450473819|FG001|Overall Study|Withdrawal by Subject|1|||
125230861|NCT02785939|450473822|FG000|Overall Study|Progression|25|||
125230862|NCT02785939|450473823|FG001|Overall Study|Progression|8|||
125174750|NCT00445432|450261670|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
125174751|NCT00445432|450261671|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
125174752|NCT00445432|450261672|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
125174753|NCT00445432|450261673|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
125174754|NCT00445432|450261670|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
125174755|NCT00445432|450261671|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
125174756|NCT00445432|450261672|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
125174757|NCT00445432|450261673|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
125174758|NCT01482312|450261676|FG000|Period 1, 90 Minutes of Wear|Other|1|||
125174759|NCT01482312|450261677|FG001|Period 1, 90 Minutes of Wear|Other|0|||
125174760|NCT01482312|450261678|FG002|Period 1, 90 Minutes of Wear|Other|0|||
125174761|NCT01482312|450261676|FG000|Period 2, 90 Minutes of Wear|Other|1|||
125174762|NCT01482312|450261677|FG001|Period 2, 90 Minutes of Wear|Other|0|||
125174763|NCT01482312|450261678|FG002|Period 2, 90 Minutes of Wear|Other|0|||
125174764|NCT01699815|450261679|FG000|Overall Study|Protocol Violation|4|||
125174765|NCT01699815|450261680|FG001|Overall Study|Protocol Violation|7|||
125174766|NCT01699815|450261679|FG000|Overall Study|record could not be located|1|||
125174767|NCT01699815|450261680|FG001|Overall Study|record could not be located|0|||
125174768|NCT01699815|450261679|FG000|Overall Study|Adverse Event|0|||
125174769|NCT01699815|450261680|FG001|Overall Study|Adverse Event|1|||
125174770|NCT00799058|450261691|FG000|Overall Study|Withdrawal by Subject|2|||
125174771|NCT00799058|450261692|FG001|Overall Study|Withdrawal by Subject|2|||
125174772|NCT00799058|450261693|FG002|Overall Study|Withdrawal by Subject|2|||
125174773|NCT00799058|450261691|FG000|Overall Study|Lost to Follow-up|1|||
125174774|NCT00799058|450261692|FG001|Overall Study|Lost to Follow-up|2|||
125174775|NCT00799058|450261693|FG002|Overall Study|Lost to Follow-up|1|||
125174776|NCT00799058|450261691|FG000|Overall Study|Adverse Event|0|||
125174777|NCT00799058|450261692|FG001|Overall Study|Adverse Event|2|||
125174778|NCT00799058|450261693|FG002|Overall Study|Adverse Event|0|||
125174779|NCT00799058|450261691|FG000|Overall Study|Pregnancy|1|||
125174780|NCT00799058|450261692|FG001|Overall Study|Pregnancy|0|||
125174781|NCT00799058|450261693|FG002|Overall Study|Pregnancy|0|||
125174782|NCT00799058|450261691|FG000|Overall Study|Not adherent|3|||
125174783|NCT00799058|450261692|FG001|Overall Study|Not adherent|2|||
125174784|NCT00799058|450261693|FG002|Overall Study|Not adherent|1|||
125174785|NCT00799058|450261691|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
125174786|NCT00799058|450261692|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
125174787|NCT00799058|450261693|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
125174788|NCT00799058|450261691|FG000|Overall Study|IP dispensing error|1|||
125174789|NCT00799058|450261692|FG001|Overall Study|IP dispensing error|0|||
125174790|NCT00799058|450261693|FG002|Overall Study|IP dispensing error|0|||
125174791|NCT00799058|450261691|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
125174792|NCT00799058|450261692|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
125174793|NCT00799058|450261693|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
125174794|NCT00799058|450261691|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
125174795|NCT00799058|450261692|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
125174796|NCT00799058|450261693|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
125174797|NCT00799058|450261691|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
125174798|NCT00799058|450261692|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
125174799|NCT00799058|450261693|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
125174800|NCT00799058|450261691|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
125174801|NCT00799058|450261692|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
125174802|NCT00799058|450261693|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
125174803|NCT03639779|450261694|FG000|Overall Study|Lost to Follow-up|1|||
125174804|NCT02088697|450261695|FG000|Period I|Physician Decision|1|||
125230863|NCT02785939|450473822|FG000|Overall Study|Adverse Event|3|||
125230864|NCT02785939|450473823|FG001|Overall Study|Adverse Event|1|||
125230865|NCT02785939|450473822|FG000|Overall Study|Death|1|||
125174805|NCT02088697|450261696|FG001|Period I|Physician Decision|4|||
125174806|NCT02088697|450261695|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
125174807|NCT02088697|450261696|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
125174808|NCT00810511|450261697|FG000|Overall Study|Protocol Violation|0|||
125174809|NCT00810511|450261698|FG001|Overall Study|Protocol Violation|1|||
125230866|NCT02785939|450473823|FG001|Overall Study|Death|0|||
125230867|NCT02785939|450473822|FG000|Overall Study|Refusal|1|||
125174810|NCT00810511|450261697|FG000|Overall Study|Lack of Efficacy|9|||
125174811|NCT00810511|450261698|FG001|Overall Study|Lack of Efficacy|1|||
125230868|NCT02785939|450473823|FG001|Overall Study|Refusal|0|||
125230869|NCT02785939|450473822|FG000|Overall Study|Deteriorating health|1|||
125230870|NCT02785939|450473823|FG001|Overall Study|Deteriorating health|0|||
125230871|NCT02785939|450473822|FG000|Overall Study|Not protocol specified|0|||
125230872|NCT02785939|450473823|FG001|Overall Study|Not protocol specified|1|||
125230873|NCT04465422|450473824|FG000|Overall Study|Lost to Follow-up|0|||
125230874|NCT04465422|450473825|FG001|Overall Study|Lost to Follow-up|2|||
125230875|NCT00572832|450473829|FG000|Overall Study|Lost to Follow-up|0|||
125230876|NCT00572832|450473830|FG001|Overall Study|Lost to Follow-up|11|||
125230877|NCT00572832|450473829|FG000|Overall Study|Pregnancy|0|||
125230878|NCT00572832|450473830|FG001|Overall Study|Pregnancy|1|||
125230879|NCT03444584|450473836|FG000|Overall Study|Withdrawal by Subject|0|||
125230880|NCT03444584|450473837|FG001|Overall Study|Withdrawal by Subject|1|||
125230881|NCT03444584|450473836|FG000|Overall Study|Other|0|||
125230882|NCT03444584|450473837|FG001|Overall Study|Other|1|||
125230883|NCT01142336|450473838|FG000|Overall Study|Adverse Event|1|||
125230884|NCT01142336|450473839|FG001|Overall Study|Adverse Event|1|||
125230885|NCT01142336|450473838|FG000|Overall Study|Lost to Follow-up|0|||
125230886|NCT01142336|450473839|FG001|Overall Study|Lost to Follow-up|1|||
125230887|NCT01704261|450473840|FG000|Overall Study|Withdrawal by Subject|12|||
125230888|NCT01704261|450473841|FG001|Overall Study|Withdrawal by Subject|15|||
125230889|NCT01704261|450473840|FG000|Overall Study|Lost to Follow-up|1|||
125230890|NCT01704261|450473841|FG001|Overall Study|Lost to Follow-up|0|||
125230891|NCT02722967|450473842|FG000|Overall Study|Adverse Event|1|||
125230892|NCT02722967|450473843|FG001|Overall Study|Adverse Event|0|||
125230893|NCT02722967|450473844|FG002|Overall Study|Adverse Event|0|||
125230894|NCT02722967|450473842|FG000|Overall Study|Lost to Follow-up|0|||
125230895|NCT02722967|450473843|FG001|Overall Study|Lost to Follow-up|1|||
125230896|NCT02722967|450473844|FG002|Overall Study|Lost to Follow-up|0|||
125230897|NCT02722967|450473842|FG000|Overall Study|Non-compliance with patch wearing|2|||
125230898|NCT02722967|450473843|FG001|Overall Study|Non-compliance with patch wearing|1|||
125230899|NCT02722967|450473844|FG002|Overall Study|Non-compliance with patch wearing|1|||
125230900|NCT02722967|450473842|FG000|Overall Study|Withdrawal by Subject|1|||
125230901|NCT02722967|450473843|FG001|Overall Study|Withdrawal by Subject|0|||
125230902|NCT02722967|450473844|FG002|Overall Study|Withdrawal by Subject|1|||
125230903|NCT02722967|450473842|FG000|Overall Study|Physician Decision|1|||
125230904|NCT02722967|450473843|FG001|Overall Study|Physician Decision|0|||
125230905|NCT02722967|450473844|FG002|Overall Study|Physician Decision|0|||
125230906|NCT02722967|450473842|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
125230907|NCT02722967|450473843|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
125230908|NCT02722967|450473844|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
125230909|NCT02391337|450473845|FG000|6 Months Follow-up|Death|5|||
125230910|NCT02391337|450473846|FG001|6 Months Follow-up|Death|4|||
125230911|NCT02391337|450473845|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
125230912|NCT02391337|450473846|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
125230913|NCT02391337|450473845|FG000|12 Months Follow-up|Death|2|||
125230914|NCT02391337|450473846|FG001|12 Months Follow-up|Death|0|||
125230915|NCT02391337|450473845|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
125174812|NCT00810511|450261697|FG000|Overall Study|death in the family|0|||
125174813|NCT00810511|450261698|FG001|Overall Study|death in the family|1|||
125174814|NCT00810511|450261697|FG000|Overall Study|Lost to Follow-up|1|||
125174815|NCT00810511|450261698|FG001|Overall Study|Lost to Follow-up|0|||
125174816|NCT00810511|450261697|FG000|Overall Study|deposits on contact lens|0|||
125174817|NCT00810511|450261698|FG001|Overall Study|deposits on contact lens|1|||
125174818|NCT00911300|450261702|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
125174819|NCT00911300|450261703|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
125174820|NCT00911300|450261702|FG000|Overall Study|Death|1|||
125174821|NCT00911300|450261703|FG001|Overall Study|Death|0|||
125174822|NCT00911300|450261702|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
125174823|NCT00911300|450261703|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
125174824|NCT00911300|450261702|FG000|Overall Study|Adverse Event|14|||
125174825|NCT00911300|450261703|FG001|Overall Study|Adverse Event|6|||
125174826|NCT00911300|450261702|FG000|Overall Study|Protocol Violation|3|||
125174827|NCT00911300|450261703|FG001|Overall Study|Protocol Violation|2|||
125174828|NCT00911300|450261702|FG000|Overall Study|Consent Withdrawn|4|||
125174829|NCT00911300|450261703|FG001|Overall Study|Consent Withdrawn|12|||
125174830|NCT00911300|450261702|FG000|Overall Study|Coronary Angiography Performed|1|||
125174831|NCT00911300|450261703|FG001|Overall Study|Coronary Angiography Performed|0|||
125230916|NCT02391337|450473846|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
125230917|NCT02391337|450473845|FG000|12 Months Follow-up|Lost to Follow-up|0|||
125230918|NCT02391337|450473846|FG001|12 Months Follow-up|Lost to Follow-up|2|||
125174832|NCT00911300|450261702|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
125230919|NCT03704064|450473847|FG000|Overall Study|Lost to Follow-up|8|||
125230920|NCT03704064|450473848|FG001|Overall Study|Lost to Follow-up|4|||
125230921|NCT03704064|450473847|FG000|Overall Study|Withdrawal by Subject|1|||
125174833|NCT00911300|450261703|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
125174834|NCT00911300|450261702|FG000|Overall Study|Received Commercial Treatment|1|||
125230922|NCT03704064|450473848|FG001|Overall Study|Withdrawal by Subject|1|||
125392280|NCT01723163|451070619|FG000|Treatment Phase|Withdrawal by Subject|14|||
125174835|NCT00911300|450261703|FG001|Overall Study|Received Commercial Treatment|0|||
125174836|NCT00911300|450261702|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
125174837|NCT00911300|450261703|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
125174838|NCT00911300|450261702|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
125174839|NCT00911300|450261703|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
125174840|NCT00911300|450261702|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
125174841|NCT00911300|450261703|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
125174842|NCT00911300|450261702|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
125174843|NCT00911300|450261703|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
125174844|NCT00911300|450261702|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
125174845|NCT00911300|450261703|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
125174846|NCT00911300|450261702|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
125174847|NCT00911300|450261703|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
125174848|NCT00911300|450261702|FG000|Overall Study|International Normalized Ratio Too High|0|||
125174849|NCT00911300|450261703|FG001|Overall Study|International Normalized Ratio Too High|1|||
125174850|NCT00911300|450261702|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
125174851|NCT00911300|450261703|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
125174852|NCT00911300|450261702|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
125174853|NCT00911300|450261703|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
125174854|NCT00911300|450261702|FG000|Overall Study|Physician Decision|0|||
125174855|NCT00911300|450261703|FG001|Overall Study|Physician Decision|1|||
125174856|NCT00911300|450261702|FG000|Overall Study|Treatment Stopped by Mistake|0|||
125174857|NCT00911300|450261703|FG001|Overall Study|Treatment Stopped by Mistake|1|||
125174858|NCT00911300|450261702|FG000|Overall Study|Randomized; No Study Medication Received|0|||
125174859|NCT00911300|450261703|FG001|Overall Study|Randomized; No Study Medication Received|2|||
125174860|NCT01128543|450261705|FG000|Overall Study|Withdrawal by Subject|3|||
125174861|NCT01128543|450261705|FG000|Overall Study|Protocol Violation|1|||
125174862|NCT01941498|450261709|FG000|Overall Study|Relocated out of state|1|||
125174863|NCT00396565|450261710|FG000|Overall Study|Physician Decision|3|||
125174864|NCT00396565|450261711|FG001|Overall Study|Physician Decision|1|||
125174865|NCT00396565|450261712|FG002|Overall Study|Physician Decision|2|||
125174866|NCT00396565|450261710|FG000|Overall Study|Adverse Event|5|||
125174867|NCT00396565|450261711|FG001|Overall Study|Adverse Event|13|||
125174868|NCT00396565|450261712|FG002|Overall Study|Adverse Event|3|||
125174869|NCT00396565|450261710|FG000|Overall Study|Withdrawal by Subject|8|||
125174870|NCT00396565|450261711|FG001|Overall Study|Withdrawal by Subject|13|||
125174871|NCT00396565|450261712|FG002|Overall Study|Withdrawal by Subject|1|||
125174872|NCT00396565|450261710|FG000|Overall Study|Lack of Efficacy|32|||
125174873|NCT00396565|450261711|FG001|Overall Study|Lack of Efficacy|64|||
125174874|NCT00396565|450261712|FG002|Overall Study|Lack of Efficacy|11|||
125174875|NCT04324021|450261713|FG000|Overall Study|Adverse Event|1|||
125174876|NCT04324021|450261714|FG001|Overall Study|Adverse Event|0|||
125174877|NCT04324021|450261715|FG002|Overall Study|Adverse Event|0|||
125174878|NCT04324021|450261713|FG000|Overall Study|Lack of Efficacy|0|||
125174879|NCT04324021|450261714|FG001|Overall Study|Lack of Efficacy|0|||
125174880|NCT04324021|450261715|FG002|Overall Study|Lack of Efficacy|1|||
125174881|NCT04324021|450261713|FG000|Overall Study|Death|1|||
125174882|NCT04324021|450261714|FG001|Overall Study|Death|1|||
125174883|NCT04324021|450261715|FG002|Overall Study|Death|0|||
125174884|NCT03097991|450261716|FG000|Overall Study|Didn't meet study criteria|8|||
125174885|NCT03097991|450261717|FG001|Overall Study|Didn't meet study criteria|0|||
125174886|NCT03097991|450261716|FG000|Overall Study|Withdrawal by Subject|12|||
125174887|NCT03097991|450261717|FG001|Overall Study|Withdrawal by Subject|6|||
125174888|NCT03097991|450261716|FG000|Overall Study|Death of Baby|3|||
125174889|NCT03097991|450261717|FG001|Overall Study|Death of Baby|1|||
125174890|NCT03097991|450261716|FG000|Overall Study|Lost to Follow-up|24|||
125174891|NCT03097991|450261717|FG001|Overall Study|Lost to Follow-up|38|||
125174892|NCT03097991|450261716|FG000|Overall Study|Adverse Event|3|||
125174893|NCT03097991|450261717|FG001|Overall Study|Adverse Event|5|||
125174894|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
125174895|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
125174896|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
125174897|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Death|1|||
125174898|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Death|3|||
125174899|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Death|1|||
125174900|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
125174901|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
125174902|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
125174903|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
125174904|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
125174905|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
125174906|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
125174907|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
125174908|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
125174909|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
125174910|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
125174911|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
125174912|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
125174913|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
125174914|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
125174915|NCT00299130|450261718|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
125174916|NCT00299130|450261719|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
125174917|NCT00299130|450261720|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
125174918|NCT00299130|450261718|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
125174919|NCT00299130|450261719|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
125174920|NCT00299130|450261720|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
125174921|NCT00299130|450261718|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
125174922|NCT00299130|450261719|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
125174923|NCT00299130|450261720|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
125174924|NCT00299130|450261718|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
125174925|NCT00299130|450261719|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
125174926|NCT00299130|450261720|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
125174927|NCT00299130|450261718|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
125174928|NCT00299130|450261719|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
125174929|NCT00299130|450261720|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
125174930|NCT00299130|450261718|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
125174931|NCT00299130|450261719|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
125174932|NCT00299130|450261720|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
125174933|NCT00299130|450261718|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
125174934|NCT00299130|450261719|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
125174935|NCT00299130|450261720|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
125174936|NCT00299130|450261718|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
125174937|NCT00299130|450261719|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
125174938|NCT00299130|450261720|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
125174939|NCT00299130|450261718|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
125174940|NCT00299130|450261719|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
125174941|NCT00299130|450261720|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
125174942|NCT00299130|450261718|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
125174943|NCT00299130|450261719|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
125174944|NCT00299130|450261720|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
125174945|NCT02211417|450261721|FG000|Overall Study|Withdrawal by Subject|11|||
125174946|NCT02211417|450261722|FG001|Overall Study|Withdrawal by Subject|8|||
125174947|NCT02211417|450261721|FG000|Overall Study|Protocol Violation|1|||
125174948|NCT02211417|450261722|FG001|Overall Study|Protocol Violation|0|||
125174949|NCT02211417|450261721|FG000|Overall Study|Pregnancy|0|||
125174950|NCT02211417|450261722|FG001|Overall Study|Pregnancy|1|||
125174951|NCT02211417|450261721|FG000|Overall Study|Lost to Follow-up|2|||
125174952|NCT02211417|450261722|FG001|Overall Study|Lost to Follow-up|3|||
125174953|NCT02211417|450261721|FG000|Overall Study|Adverse Event|1|||
125174954|NCT02211417|450261722|FG001|Overall Study|Adverse Event|4|||
125174955|NCT01198132|450261723|FG000|Overall Study|Withdrawal by Subject|4|||
125174956|NCT01198132|450261724|FG001|Overall Study|Withdrawal by Subject|5|||
125174957|NCT01198132|450261723|FG000|Overall Study|Physician Decision|5|||
125174958|NCT01198132|450261724|FG001|Overall Study|Physician Decision|4|||
125174959|NCT01198132|450261723|FG000|Overall Study|Other Unspecified|3|||
125174960|NCT01198132|450261724|FG001|Overall Study|Other Unspecified|6|||
125174961|NCT01198132|450261723|FG000|Overall Study|Lack of Efficacy|2|||
125174962|NCT01198132|450261724|FG001|Overall Study|Lack of Efficacy|3|||
125174963|NCT01198132|450261723|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
125174964|NCT01198132|450261724|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
125174965|NCT01198132|450261723|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
125174966|NCT01198132|450261724|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
125174967|NCT01198132|450261723|FG000|Overall Study|Adverse Event|0|||
125174968|NCT01198132|450261724|FG001|Overall Study|Adverse Event|1|||
125174969|NCT01198132|450261723|FG000|Overall Study|Protocol Violation|1|||
125174970|NCT01198132|450261724|FG001|Overall Study|Protocol Violation|0|||
125174971|NCT01755091|450261725|FG000|Overall Study|Withdrawal by Subject|6|||
125174972|NCT01755091|450261726|FG001|Overall Study|Withdrawal by Subject|1|||
125174973|NCT01755091|450261727|FG002|Overall Study|Withdrawal by Subject|3|||
125174974|NCT01755091|450261725|FG000|Overall Study|Adverse Event|1|||
125174975|NCT01755091|450261726|FG001|Overall Study|Adverse Event|1|||
125174976|NCT01755091|450261727|FG002|Overall Study|Adverse Event|1|||
125174977|NCT01755091|450261725|FG000|Overall Study|Lost to Follow-up|1|||
125174978|NCT01755091|450261726|FG001|Overall Study|Lost to Follow-up|0|||
125174979|NCT01755091|450261727|FG002|Overall Study|Lost to Follow-up|1|||
125174980|NCT01755091|450261725|FG000|Overall Study|Physician Decision|1|||
125174981|NCT01755091|450261726|FG001|Overall Study|Physician Decision|1|||
125174982|NCT01755091|450261727|FG002|Overall Study|Physician Decision|2|||
125174983|NCT00490841|450261728|FG000|Overall Study|Death|5|||
125174984|NCT00490841|450261728|FG000|Overall Study|Withdrawal by Subject|4|||
125174985|NCT00490841|450261728|FG000|Overall Study|Lost to Follow-up|1|||
125174986|NCT00490841|450261728|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
125174987|NCT04700137|450261735|FG000|Overall Study|Lost to Follow-up|1|||
125174988|NCT04700137|450261736|FG001|Overall Study|Lost to Follow-up|6|||
125174989|NCT04700137|450261737|FG002|Overall Study|Lost to Follow-up|1|||
125174990|NCT04700137|450261738|FG003|Overall Study|Lost to Follow-up|1|||
125174991|NCT04700137|450261735|FG000|Overall Study|Withdrawal by Subject|0|||
125174992|NCT04700137|450261736|FG001|Overall Study|Withdrawal by Subject|0|||
125174993|NCT04700137|450261737|FG002|Overall Study|Withdrawal by Subject|1|||
125174994|NCT04700137|450261738|FG003|Overall Study|Withdrawal by Subject|0|||
125174995|NCT04700137|450261735|FG000|Overall Study|Death|0|||
125174996|NCT04700137|450261736|FG001|Overall Study|Death|0|||
125174997|NCT04700137|450261737|FG002|Overall Study|Death|1|||
125174998|NCT04700137|450261738|FG003|Overall Study|Death|0|||
125174999|NCT00174954|450261739|FG000|Overall Study|Adverse Event|2|||
125175000|NCT00174954|450261739|FG000|Overall Study|No tophi found in MRI|1|||
125175001|NCT00174954|450261739|FG000|Overall Study|Physician Decision|1|||
125175002|NCT00839254|450261740|FG000|Overall Study|Protocol Violation|0|||
125175003|NCT00839254|450261741|FG001|Overall Study|Protocol Violation|1|||
125175004|NCT00839254|450261742|FG002|Overall Study|Protocol Violation|1|||
125175005|NCT00839254|450261743|FG003|Overall Study|Protocol Violation|1|||
125175006|NCT00839254|450261744|FG004|Overall Study|Protocol Violation|0|||
125175007|NCT00839254|450261745|FG005|Overall Study|Protocol Violation|0|||
125175008|NCT00839254|450261746|FG006|Overall Study|Protocol Violation|1|||
125175009|NCT00839254|450261747|FG007|Overall Study|Protocol Violation|2|||
125175010|NCT00839254|450261740|FG000|Overall Study|Physician Decision|0|||
125175011|NCT00839254|450261741|FG001|Overall Study|Physician Decision|1|||
125175012|NCT00839254|450261742|FG002|Overall Study|Physician Decision|0|||
125175013|NCT00839254|450261743|FG003|Overall Study|Physician Decision|0|||
125175014|NCT00839254|450261744|FG004|Overall Study|Physician Decision|0|||
125175015|NCT00839254|450261745|FG005|Overall Study|Physician Decision|0|||
125175016|NCT00839254|450261746|FG006|Overall Study|Physician Decision|0|||
125175017|NCT00839254|450261747|FG007|Overall Study|Physician Decision|1|||
125175018|NCT00839254|450261740|FG000|Overall Study|Wrong treatment number allocation|0|||
125175019|NCT00839254|450261741|FG001|Overall Study|Wrong treatment number allocation|1|||
125175020|NCT00839254|450261742|FG002|Overall Study|Wrong treatment number allocation|0|||
125175021|NCT00839254|450261743|FG003|Overall Study|Wrong treatment number allocation|0|||
125175022|NCT00839254|450261744|FG004|Overall Study|Wrong treatment number allocation|0|||
125175023|NCT00839254|450261745|FG005|Overall Study|Wrong treatment number allocation|1|||
125175024|NCT00839254|450261746|FG006|Overall Study|Wrong treatment number allocation|0|||
125175025|NCT00839254|450261747|FG007|Overall Study|Wrong treatment number allocation|0|||
125175026|NCT00839254|450261740|FG000|Overall Study|Adverse Event|12|||
125175027|NCT00839254|450261741|FG001|Overall Study|Adverse Event|6|||
125175028|NCT00839254|450261742|FG002|Overall Study|Adverse Event|3|||
125175029|NCT00839254|450261743|FG003|Overall Study|Adverse Event|5|||
125175030|NCT00839254|450261744|FG004|Overall Study|Adverse Event|2|||
125175031|NCT00839254|450261745|FG005|Overall Study|Adverse Event|1|||
125175032|NCT00839254|450261746|FG006|Overall Study|Adverse Event|0|||
125175033|NCT00839254|450261747|FG007|Overall Study|Adverse Event|1|||
125175034|NCT00839254|450261740|FG000|Overall Study|Withdrawal by Subject|87|||
125175035|NCT00839254|450261741|FG001|Overall Study|Withdrawal by Subject|53|||
125175036|NCT00839254|450261742|FG002|Overall Study|Withdrawal by Subject|54|||
125175037|NCT00839254|450261743|FG003|Overall Study|Withdrawal by Subject|32|||
125175038|NCT00839254|450261744|FG004|Overall Study|Withdrawal by Subject|27|||
125175039|NCT00839254|450261745|FG005|Overall Study|Withdrawal by Subject|15|||
125175040|NCT00839254|450261746|FG006|Overall Study|Withdrawal by Subject|22|||
125175041|NCT00839254|450261747|FG007|Overall Study|Withdrawal by Subject|9|||
125175042|NCT00839254|450261740|FG000|Overall Study|Wrong group allocation|0|||
125175043|NCT00839254|450261741|FG001|Overall Study|Wrong group allocation|0|||
125175044|NCT00839254|450261742|FG002|Overall Study|Wrong group allocation|0|||
125175045|NCT00839254|450261743|FG003|Overall Study|Wrong group allocation|0|||
125175046|NCT00839254|450261744|FG004|Overall Study|Wrong group allocation|0|||
125175047|NCT00839254|450261745|FG005|Overall Study|Wrong group allocation|0|||
125175048|NCT00839254|450261746|FG006|Overall Study|Wrong group allocation|1|||
125175049|NCT00839254|450261747|FG007|Overall Study|Wrong group allocation|0|||
125175050|NCT00839254|450261740|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
125175051|NCT00839254|450261741|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
125175052|NCT00839254|450261742|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
125175053|NCT00839254|450261743|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
125175054|NCT00839254|450261744|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
125175055|NCT00839254|450261745|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
125175056|NCT00839254|450261746|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
125175057|NCT00839254|450261747|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
125175058|NCT00839254|450261740|FG000|Overall Study|Withdrawn due to non-compliance|2|||
125175059|NCT00839254|450261741|FG001|Overall Study|Withdrawn due to non-compliance|0|||
125175060|NCT00839254|450261742|FG002|Overall Study|Withdrawn due to non-compliance|0|||
125175061|NCT00839254|450261743|FG003|Overall Study|Withdrawn due to non-compliance|0|||
125175062|NCT00839254|450261744|FG004|Overall Study|Withdrawn due to non-compliance|0|||
125175063|NCT00839254|450261745|FG005|Overall Study|Withdrawn due to non-compliance|0|||
125175064|NCT00839254|450261746|FG006|Overall Study|Withdrawn due to non-compliance|0|||
125175065|NCT00839254|450261747|FG007|Overall Study|Withdrawn due to non-compliance|0|||
125175066|NCT00839254|450261740|FG000|Overall Study|Lost to Follow-up|51|||
125175067|NCT00839254|450261741|FG001|Overall Study|Lost to Follow-up|30|||
125175068|NCT00839254|450261742|FG002|Overall Study|Lost to Follow-up|32|||
125175069|NCT00839254|450261743|FG003|Overall Study|Lost to Follow-up|24|||
125175070|NCT00839254|450261744|FG004|Overall Study|Lost to Follow-up|8|||
125175071|NCT00839254|450261745|FG005|Overall Study|Lost to Follow-up|8|||
125175072|NCT00839254|450261746|FG006|Overall Study|Lost to Follow-up|4|||
125175073|NCT00839254|450261747|FG007|Overall Study|Lost to Follow-up|2|||
125175074|NCT01320150|450261749|FG000|Overall Study|Protocol Violation|15|||
125175075|NCT01320150|450261749|FG000|Overall Study|Withdrawal by Subject|5|||
125175076|NCT01320150|450261749|FG000|Overall Study|Death|2|||
125175077|NCT01320150|450261749|FG000|Overall Study|Lost to Follow-up|44|||
125175078|NCT00489827|450261761|FG000|Overall Study|Intraoperative exclusion criteria|1|||
125175079|NCT00489827|450261762|FG001|Overall Study|Intraoperative exclusion criteria|1|||
125175080|NCT00489827|450261761|FG000|Overall Study|Intraoperative exclusion criteria|1|||
125175081|NCT00489827|450261762|FG001|Overall Study|Intraoperative exclusion criteria|1|||
125175082|NCT01590277|450261763|FG000|Overall Study|Withdrawal by Subject|3|||
125175083|NCT01590277|450261763|FG000|Overall Study|Withdrawal by Subject|2|||
125175084|NCT01590277|450261763|FG000|Overall Study|Withdrawal by Subject|1|||
125175085|NCT01590277|450261763|FG000|Overall Study|Withdrawal by Subject|1|||
125175086|NCT04386616|450261764|FG000|Overall Study|Death|22|||
125175087|NCT04386616|450261765|FG001|Overall Study|Death|22|||
125175088|NCT04386616|450261766|FG002|Overall Study|Death|21|||
125175089|NCT04386616|450261764|FG000|Overall Study|Lost to Follow-up|5|||
125175090|NCT04386616|450261765|FG001|Overall Study|Lost to Follow-up|8|||
125175091|NCT04386616|450261766|FG002|Overall Study|Lost to Follow-up|6|||
125175092|NCT04386616|450261764|FG000|Overall Study|Withdrawal by Subject|2|||
125175093|NCT04386616|450261765|FG001|Overall Study|Withdrawal by Subject|4|||
125175094|NCT04386616|450261766|FG002|Overall Study|Withdrawal by Subject|1|||
125175095|NCT04386616|450261764|FG000|Overall Study|Adverse Event|1|||
125175096|NCT04386616|450261765|FG001|Overall Study|Adverse Event|1|||
125175097|NCT04386616|450261766|FG002|Overall Study|Adverse Event|0|||
125175098|NCT01377012|450261767|FG000|Core Study|Study terminated by Sponsor|47|||
125175099|NCT01377012|450261768|FG001|Core Study|Study terminated by Sponsor|54|||
125175100|NCT01377012|450261769|FG002|Core Study|Study terminated by Sponsor|46|||
125175101|NCT01377012|450261767|FG000|Core Study|Technical problems|1|||
125175102|NCT01377012|450261768|FG001|Core Study|Technical problems|0|||
125175103|NCT01377012|450261769|FG002|Core Study|Technical problems|0|||
125175104|NCT01377012|450261767|FG000|Core Study|Withdrawal by Subject|15|||
125175105|NCT01377012|450261768|FG001|Core Study|Withdrawal by Subject|23|||
125175106|NCT01377012|450261769|FG002|Core Study|Withdrawal by Subject|18|||
125175107|NCT01377012|450261767|FG000|Core Study|Protocol Violation|7|||
125175108|NCT01377012|450261768|FG001|Core Study|Protocol Violation|3|||
125175109|NCT01377012|450261769|FG002|Core Study|Protocol Violation|2|||
125175110|NCT01377012|450261767|FG000|Core Study|Pregnancy|0|||
125175111|NCT01377012|450261768|FG001|Core Study|Pregnancy|0|||
125175112|NCT01377012|450261769|FG002|Core Study|Pregnancy|1|||
125175113|NCT01377012|450261767|FG000|Core Study|Physician Decision|5|||
125175114|NCT01377012|450261768|FG001|Core Study|Physician Decision|4|||
125175115|NCT01377012|450261769|FG002|Core Study|Physician Decision|10|||
125175116|NCT01377012|450261767|FG000|Core Study|Non-Compliant with study treatment|0|||
125175117|NCT01377012|450261768|FG001|Core Study|Non-Compliant with study treatment|0|||
125175118|NCT01377012|450261769|FG002|Core Study|Non-Compliant with study treatment|1|||
125175119|NCT01377012|450261767|FG000|Core Study|No Longer require treatment|0|||
125175120|NCT01377012|450261768|FG001|Core Study|No Longer require treatment|0|||
125175121|NCT01377012|450261769|FG002|Core Study|No Longer require treatment|1|||
125175122|NCT01377012|450261767|FG000|Core Study|Lost to Follow-up|7|||
125175123|NCT01377012|450261768|FG001|Core Study|Lost to Follow-up|5|||
125175124|NCT01377012|450261769|FG002|Core Study|Lost to Follow-up|4|||
125175125|NCT01377012|450261767|FG000|Core Study|Lack of Efficacy|41|||
125175126|NCT01377012|450261768|FG001|Core Study|Lack of Efficacy|28|||
125175127|NCT01377012|450261769|FG002|Core Study|Lack of Efficacy|37|||
125175128|NCT01377012|450261767|FG000|Core Study|Death|1|||
125175129|NCT01377012|450261768|FG001|Core Study|Death|1|||
125175130|NCT01377012|450261769|FG002|Core Study|Death|1|||
125175131|NCT01377012|450261767|FG000|Core Study|Adverse Event|10|||
125175132|NCT01377012|450261768|FG001|Core Study|Adverse Event|14|||
125175133|NCT01377012|450261769|FG002|Core Study|Adverse Event|13|||
125175134|NCT01377012|450261767|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
125175135|NCT01377012|450261768|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
125175136|NCT01377012|450261769|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
125175137|NCT01377012|450261767|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
125175138|NCT01377012|450261768|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
125175139|NCT01377012|450261769|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
125175140|NCT01377012|450261767|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
125175141|NCT01377012|450261768|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
125175142|NCT01377012|450261769|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
125175143|NCT01377012|450261767|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
125175144|NCT01377012|450261768|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
125175145|NCT01377012|450261769|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
125175146|NCT01377012|450261767|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
125175147|NCT01377012|450261768|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
125175148|NCT01377012|450261769|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
125175149|NCT01377012|450261767|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
125175150|NCT01377012|450261768|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
125175151|NCT01377012|450261769|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
125175152|NCT00805961|450261772|FG000|Modality Therapy|Withdrawal by Subject|1|||
125175153|NCT00805961|450261772|FG000|Modality Therapy|Adverse Event|1|||
125175154|NCT00805961|450261772|FG000|Modality Therapy|Disease Progression|2|||
125175155|NCT00805961|450261772|FG000|Treatment-Free Interval|Adverse Event|3|||
125175156|NCT00805961|450261772|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
125175157|NCT00805961|450261772|FG000|Treatment-Free Interval|Physician Decision|1|||
125175158|NCT00805961|450261772|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
125175159|NCT00805961|450261772|FG000|Maintenance Treatment|Lack of Efficacy|13|||
125175160|NCT00805961|450261772|FG000|Maintenance Treatment|Intercurrent Illness|7|||
125175161|NCT00805961|450261772|FG000|Maintenance Treatment|Adverse Event|6|||
125175162|NCT00805961|450261772|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
125175163|NCT00805961|450261772|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
125175164|NCT00805961|450261772|FG000|Maintenance Treatment|Withdrawn Consent|1|||
125175165|NCT04380961|450261773|FG000|Overall Study|Lost to Follow-up|17|||
125175166|NCT04380961|450261774|FG001|Overall Study|Lost to Follow-up|11|||
125175167|NCT04380961|450261773|FG000|Overall Study|Withdrawal by Subject|3|||
125175168|NCT04380961|450261774|FG001|Overall Study|Withdrawal by Subject|0|||
125175169|NCT04380961|450261773|FG000|Overall Study|Death|22|||
125175170|NCT04380961|450261774|FG001|Overall Study|Death|16|||
125175171|NCT04380961|450261773|FG000|Overall Study|Other|1|||
125175172|NCT04380961|450261774|FG001|Overall Study|Other|0|||
125175173|NCT04380961|450261773|FG000|Overall Study|Randomized but Not Treated|1|||
125175174|NCT04380961|450261774|FG001|Overall Study|Randomized but Not Treated|2|||
125175175|NCT01862484|450261775|FG000|Overall Study|Lack of Efficacy|1|||
125175176|NCT01862484|450261776|FG001|Overall Study|Lack of Efficacy|1|||
125175177|NCT01862484|450261775|FG000|Overall Study|Lost to Follow-up|1|||
125175178|NCT01862484|450261776|FG001|Overall Study|Lost to Follow-up|2|||
125175179|NCT01862484|450261775|FG000|Overall Study|Protocol Violation|0|||
125175180|NCT01862484|450261776|FG001|Overall Study|Protocol Violation|2|||
125175181|NCT01862484|450261775|FG000|Overall Study|Withdrawal by Subject|0|||
125175182|NCT01862484|450261776|FG001|Overall Study|Withdrawal by Subject|3|||
125175183|NCT01632280|450261777|FG000|Overall Study|Withdrawal by Subject|1|||
125175184|NCT01632280|450261778|FG001|Overall Study|Withdrawal by Subject|0|||
125175185|NCT00993421|450261779|FG000|Overall Study|Adverse Event|2|||
125175186|NCT00993421|450261780|FG001|Overall Study|Adverse Event|7|||
125175187|NCT00993421|450261781|FG002|Overall Study|Adverse Event|6|||
125175188|NCT00993421|450261782|FG003|Overall Study|Adverse Event|9|||
125175189|NCT00993421|450261783|FG004|Overall Study|Adverse Event|5|||
125175190|NCT00993421|450261784|FG005|Overall Study|Adverse Event|7|||
125175191|NCT00993421|450261785|FG006|Overall Study|Adverse Event|1|||
125175192|NCT00993421|450261779|FG000|Overall Study|Sponsor Decision|36|||
125175193|NCT00993421|450261780|FG001|Overall Study|Sponsor Decision|31|||
125175194|NCT00993421|450261781|FG002|Overall Study|Sponsor Decision|28|||
125175195|NCT00993421|450261782|FG003|Overall Study|Sponsor Decision|30|||
125175196|NCT00993421|450261783|FG004|Overall Study|Sponsor Decision|38|||
125175197|NCT00993421|450261784|FG005|Overall Study|Sponsor Decision|30|||
125175198|NCT00993421|450261785|FG006|Overall Study|Sponsor Decision|29|||
125175199|NCT00993421|450261779|FG000|Overall Study|Lost to Follow-up|3|||
125175200|NCT00993421|450261780|FG001|Overall Study|Lost to Follow-up|5|||
125175201|NCT00993421|450261781|FG002|Overall Study|Lost to Follow-up|5|||
125175202|NCT00993421|450261782|FG003|Overall Study|Lost to Follow-up|0|||
125175203|NCT00993421|450261783|FG004|Overall Study|Lost to Follow-up|0|||
125175204|NCT00993421|450261784|FG005|Overall Study|Lost to Follow-up|0|||
125175205|NCT00993421|450261785|FG006|Overall Study|Lost to Follow-up|6|||
125175206|NCT00993421|450261779|FG000|Overall Study|Withdrawal by Subject|3|||
125175207|NCT00993421|450261780|FG001|Overall Study|Withdrawal by Subject|2|||
125175208|NCT00993421|450261781|FG002|Overall Study|Withdrawal by Subject|3|||
125175209|NCT00993421|450261782|FG003|Overall Study|Withdrawal by Subject|3|||
125175210|NCT00993421|450261783|FG004|Overall Study|Withdrawal by Subject|3|||
125175211|NCT00993421|450261784|FG005|Overall Study|Withdrawal by Subject|5|||
125175212|NCT00993421|450261785|FG006|Overall Study|Withdrawal by Subject|3|||
125175213|NCT00993421|450261779|FG000|Overall Study|Death|0|||
125175214|NCT00993421|450261780|FG001|Overall Study|Death|0|||
125175215|NCT00993421|450261781|FG002|Overall Study|Death|0|||
125175216|NCT00993421|450261782|FG003|Overall Study|Death|0|||
125175217|NCT00993421|450261783|FG004|Overall Study|Death|0|||
125175218|NCT00993421|450261784|FG005|Overall Study|Death|0|||
125175219|NCT00993421|450261785|FG006|Overall Study|Death|1|||
125175220|NCT00993421|450261779|FG000|Overall Study|Entry Criteria Exclusion|0|||
125175221|NCT00993421|450261780|FG001|Overall Study|Entry Criteria Exclusion|0|||
125175222|NCT00993421|450261781|FG002|Overall Study|Entry Criteria Exclusion|1|||
125175223|NCT00993421|450261782|FG003|Overall Study|Entry Criteria Exclusion|3|||
125175224|NCT00993421|450261783|FG004|Overall Study|Entry Criteria Exclusion|0|||
125175225|NCT00993421|450261784|FG005|Overall Study|Entry Criteria Exclusion|1|||
125175226|NCT00993421|450261785|FG006|Overall Study|Entry Criteria Exclusion|0|||
125175227|NCT00993421|450261779|FG000|Overall Study|Physician Decision|0|||
125175228|NCT00993421|450261780|FG001|Overall Study|Physician Decision|0|||
125175229|NCT00993421|450261781|FG002|Overall Study|Physician Decision|0|||
125175230|NCT00993421|450261782|FG003|Overall Study|Physician Decision|0|||
125175231|NCT00993421|450261783|FG004|Overall Study|Physician Decision|0|||
125175232|NCT00993421|450261784|FG005|Overall Study|Physician Decision|1|||
125175233|NCT00993421|450261785|FG006|Overall Study|Physician Decision|1|||
125175234|NCT00993421|450261779|FG000|Overall Study|Protocol Violation|0|||
125175235|NCT00993421|450261780|FG001|Overall Study|Protocol Violation|0|||
125175236|NCT00993421|450261781|FG002|Overall Study|Protocol Violation|0|||
125175237|NCT00993421|450261782|FG003|Overall Study|Protocol Violation|0|||
125175238|NCT00993421|450261783|FG004|Overall Study|Protocol Violation|0|||
125175239|NCT00993421|450261784|FG005|Overall Study|Protocol Violation|2|||
125175240|NCT00993421|450261785|FG006|Overall Study|Protocol Violation|1|||
125175241|NCT03736031|450261787|FG000|Overall Study|Death|2|||
125175242|NCT03736031|450261788|FG001|Overall Study|Death|4|||
125175243|NCT03736031|450261787|FG000|Overall Study|Lost to Follow-up|21|||
125175244|NCT03736031|450261788|FG001|Overall Study|Lost to Follow-up|2|||
125175245|NCT03736031|450261787|FG000|Overall Study|Withdrawal by Subject|9|||
125175246|NCT03736031|450261788|FG001|Overall Study|Withdrawal by Subject|0|||
125175247|NCT02215967|450261789|FG000|Overall Study|Patient became ineligible for treatment|0|||
125175248|NCT02215967|450261790|FG001|Overall Study|Patient became ineligible for treatment|0|||
125175249|NCT02215967|450261791|FG002|Overall Study|Patient became ineligible for treatment|0|||
125175250|NCT02215967|450261792|FG003|Overall Study|Patient became ineligible for treatment|3|||
125175251|NCT02215967|450261789|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
125175252|NCT02215967|450261790|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
125175253|NCT02215967|450261791|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
125175254|NCT02215967|450261792|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
125175255|NCT01954745|450261796|FG000|Overall Study|Radiological Progression|11|||
125175256|NCT01954745|450261796|FG000|Overall Study|Clinical Progression|5|||
125175257|NCT01954745|450261796|FG000|Overall Study|Adverse Event|2|||
125175258|NCT01954745|450261796|FG000|Overall Study|Death|1|||
125175259|NCT00352417|450261797|FG000|Overall Study|Adverse Event|1|||
125175260|NCT00352417|450261798|FG001|Overall Study|Adverse Event|0|||
125175261|NCT00352417|450261797|FG000|Overall Study|Protocol Violation|0|||
125175262|NCT00352417|450261798|FG001|Overall Study|Protocol Violation|2|||
125175263|NCT00352417|450261797|FG000|Overall Study|Withdrawal by Subject|1|||
125175264|NCT00352417|450261798|FG001|Overall Study|Withdrawal by Subject|2|||
125175265|NCT00352417|450261797|FG000|Overall Study|Lost to Follow-up|1|||
125175266|NCT00352417|450261798|FG001|Overall Study|Lost to Follow-up|0|||
125175267|NCT00352417|450261797|FG000|Overall Study|Schedule Change|2|||
125175268|NCT00352417|450261798|FG001|Overall Study|Schedule Change|1|||
125175269|NCT01496976|450263532|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
125175270|NCT05938621|450263533|FG000|Overall Study|Lost to Follow-up|1|||
125175271|NCT05938621|450263534|FG001|Overall Study|Lost to Follow-up|5|||
125175272|NCT05938621|450263535|FG002|Overall Study|Lost to Follow-up|2|||
125175273|NCT05938621|450263536|FG003|Overall Study|Lost to Follow-up|2|||
125175274|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
125175275|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
125175276|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
125175277|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
125230923|NCT03704064|450473847|FG000|Overall Study|No longer available for study visits|0|||
125175278|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
125175279|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
125175280|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
125175281|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
125175282|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
125175283|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
125175284|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
125175285|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
125175286|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
125175287|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
125175288|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
125175289|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
125175290|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
125175291|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
125175292|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
125175293|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
125175294|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
125175295|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
125175296|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
125175297|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
125175298|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
125175299|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
125175300|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
125175301|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
125175302|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
125175303|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
125175304|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
125175305|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
125175306|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
125175307|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
125175308|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
125175309|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
125175310|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
125175311|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
125175312|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
125175313|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
125175314|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
125175315|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
125175316|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
125175317|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
125175318|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
125175319|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
125175320|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175321|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175322|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175323|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175324|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175325|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175326|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175327|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
125175328|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175329|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
125175330|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175331|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175332|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175333|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175334|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175335|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175336|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175337|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175338|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175339|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
125175340|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175341|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175342|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175343|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175344|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175345|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
125175346|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
125175347|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125230924|NCT03704064|450473848|FG001|Overall Study|No longer available for study visits|1|||
125230925|NCT03704064|450473847|FG000|Overall Study|Censoring event|1|||
125230926|NCT03704064|450473848|FG001|Overall Study|Censoring event|0|||
125230927|NCT00062166|450473858|FG000|Overall Study|Withdrawal by Subject|6|||
125230928|NCT02475369|450473859|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
125230929|NCT02475369|450473860|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
125230930|NCT01200329|450473878|FG000|Overall Study|Lack of financial coverage|2|||
125230931|NCT01200329|450473878|FG000|Overall Study|Progressive disease|1|||
125230932|NCT03641508|450473883|FG000|First Injection|Lost to Follow-up|2|||
125230933|NCT03641508|450473884|FG001|First Injection|Lost to Follow-up|0|||
125230934|NCT03642990|450473885|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
125230935|NCT03642990|450473885|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
125230936|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
125230937|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
125230938|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
125230939|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
125230940|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
125230941|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
125230942|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
125230943|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
125230944|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
125230945|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
125230946|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
125230947|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
125230948|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
125230949|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
125230950|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
125230951|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
125230952|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
125230953|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
125230954|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
125230955|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
125230956|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
125230957|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
125230958|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
125230959|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
125230960|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
125230961|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
125230962|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
125230963|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
125230964|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
125230965|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
125230966|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
125230967|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
125230968|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
125230969|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
125230970|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
125230971|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
125230972|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
125230973|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
125230974|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
125230975|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
125230976|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
125230977|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
125230978|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
125230979|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
125230980|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
125230981|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
125230982|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
125230983|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
125230984|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
125230985|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
125230986|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
125230987|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
125230988|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
125230989|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
125175348|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175349|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175350|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175351|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175352|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175353|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175354|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
125175355|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
125175356|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175357|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175358|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175359|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175360|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175361|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175362|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175363|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
125175364|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
125175365|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175366|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175367|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175368|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175369|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175370|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175371|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175372|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
125175373|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175374|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
125175375|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
125175376|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175377|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175378|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175379|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175380|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175381|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
125175382|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
125175383|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
125175384|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175385|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175386|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175387|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175388|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175389|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175390|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
125175391|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175392|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
125175393|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175394|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175395|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175396|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175397|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175398|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175399|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
125175400|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175401|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
125175402|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175403|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175404|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175405|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175406|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175407|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175408|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
125175409|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175410|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175411|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
125175412|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175413|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175414|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175415|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175416|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175417|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
125175418|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175419|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175420|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
125175421|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175422|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175423|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175424|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175425|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175426|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
125175427|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175428|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175429|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
125175430|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175431|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175432|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175433|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175434|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175435|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
125175436|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175437|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175438|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175439|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175440|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175441|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175442|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
125175443|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175444|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
125175445|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
125175446|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
125175447|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175448|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175449|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175450|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175451|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175452|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175453|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
125175454|NCT03598790|450263537|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175455|NCT03598790|450263538|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175456|NCT03598790|450263539|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
125175457|NCT03598790|450263540|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175458|NCT03598790|450263541|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175459|NCT03598790|450263542|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175460|NCT03598790|450263543|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175461|NCT03598790|450263544|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175462|NCT03598790|450263545|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
125175463|NCT03598790|450263537|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125175464|NCT03598790|450263538|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125175465|NCT03598790|450263539|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125175466|NCT03598790|450263540|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
125175467|NCT03598790|450263541|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
125175468|NCT03598790|450263542|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
125175469|NCT03598790|450263543|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125175470|NCT03598790|450263544|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125175471|NCT03598790|450263545|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125175472|NCT03598790|450263537|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175473|NCT03598790|450263538|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175474|NCT03598790|450263539|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175475|NCT03598790|450263540|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
125175476|NCT03598790|450263541|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175477|NCT03598790|450263542|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175478|NCT03598790|450263543|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175479|NCT03598790|450263544|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175480|NCT03598790|450263545|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
125175481|NCT03598790|450263537|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175482|NCT03598790|450263538|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175483|NCT03598790|450263539|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175484|NCT03598790|450263540|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
125175485|NCT03598790|450263541|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175486|NCT03598790|450263542|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175487|NCT03598790|450263543|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175488|NCT03598790|450263544|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175489|NCT03598790|450263545|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125175490|NCT03598790|450263537|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175491|NCT03598790|450263538|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175492|NCT03598790|450263539|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175493|NCT03598790|450263540|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
125175494|NCT03598790|450263541|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
125175495|NCT03598790|450263542|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175496|NCT03598790|450263543|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175497|NCT03598790|450263544|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175498|NCT03598790|450263545|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
125175499|NCT03598790|450263537|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175500|NCT03598790|450263538|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175501|NCT03598790|450263539|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175502|NCT03598790|450263540|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
125175503|NCT03598790|450263541|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175504|NCT03598790|450263542|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175505|NCT03598790|450263543|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175506|NCT03598790|450263544|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175507|NCT03598790|450263545|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
125175508|NCT05292183|450263556|FG000|Overall Study|Adverse Event|1|||
125175509|NCT02506153|450263559|FG000|Overall Study|Adverse Event|359|||
125175510|NCT02506153|450263560|FG001|Overall Study|Adverse Event|114|||
125175511|NCT02506153|450263559|FG000|Overall Study|Refused unrelated to adverse event|127|||
125175512|NCT02506153|450263560|FG001|Overall Study|Refused unrelated to adverse event|18|||
125175513|NCT02506153|450263559|FG000|Overall Study|Progression/relapse|91|||
125175514|NCT02506153|450263560|FG001|Overall Study|Progression/relapse|136|||
125175515|NCT02506153|450263559|FG000|Overall Study|Death|2|||
125175516|NCT02506153|450263560|FG001|Overall Study|Death|1|||
125175517|NCT02506153|450263559|FG000|Overall Study|Other - not protocol specified|23|||
125175518|NCT02506153|450263560|FG001|Overall Study|Other - not protocol specified|12|||
125175519|NCT06400238|450263565|FG000|Overall Study|Started Protocol Therapy|2|||
125175520|NCT06400238|450263565|FG000|Overall Study|Adverse Event|1|||
125175521|NCT06400238|450263565|FG000|Overall Study|Death|1|||
125175522|NCT06400238|450263565|FG000|Overall Study|Disease Progression|27|||
125175523|NCT06400238|450263565|FG000|Overall Study|Withdrawal by Subject|2|||
125175524|NCT06400238|450263565|FG000|Overall Study|Physician Decision|2|||
125175525|NCT06419907|450263566|FG000|Overall Study|Protocol Violation|0|||
125175526|NCT06419907|450263567|FG001|Overall Study|Protocol Violation|3|||
125175527|NCT06419907|450263568|FG002|Overall Study|Protocol Violation|0|||
125175528|NCT06419907|450263569|FG003|Overall Study|Protocol Violation|1|||
125230990|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
125303079|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
125175529|NCT06419907|450263566|FG000|Overall Study|Lost to Follow-up|0|||
125175530|NCT06419907|450263567|FG001|Overall Study|Lost to Follow-up|0|||
125175531|NCT06419907|450263568|FG002|Overall Study|Lost to Follow-up|2|||
125175532|NCT06419907|450263569|FG003|Overall Study|Lost to Follow-up|1|||
125175533|NCT05929651|450263572|FG000|Overall Study|Protocol Deviation|1|||
125175534|NCT05929651|450263572|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
125175535|NCT02260570|450263573|FG000|Overall Study|Withdrawal by Subject|2|||
125175536|NCT02260570|450263574|FG001|Overall Study|Withdrawal by Subject|1|||
125175537|NCT02260570|450263573|FG000|Overall Study|Physician Decision|1|||
125175538|NCT02260570|450263574|FG001|Overall Study|Physician Decision|1|||
125175539|NCT05026177|450263575|FG000|Overall Study|Adverse Event|33|||
125175540|NCT05026177|450263576|FG001|Overall Study|Adverse Event|33|||
125175541|NCT05026177|450263577|FG002|Overall Study|Adverse Event|17|||
125175542|NCT05026177|450263575|FG000|Overall Study|Lost to Follow-up|7|||
125175543|NCT05026177|450263576|FG001|Overall Study|Lost to Follow-up|6|||
125175544|NCT05026177|450263577|FG002|Overall Study|Lost to Follow-up|8|||
125175545|NCT05026177|450263575|FG000|Overall Study|Noncompliance with study drug|6|||
125175546|NCT05026177|450263576|FG001|Overall Study|Noncompliance with study drug|2|||
125175547|NCT05026177|450263577|FG002|Overall Study|Noncompliance with study drug|1|||
125175548|NCT05026177|450263575|FG000|Overall Study|Physician Decision|4|||
125175549|NCT05026177|450263576|FG001|Overall Study|Physician Decision|1|||
125175550|NCT05026177|450263577|FG002|Overall Study|Physician Decision|0|||
125175551|NCT05026177|450263575|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
125175552|NCT05026177|450263576|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
125175553|NCT05026177|450263577|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
125175554|NCT05026177|450263575|FG000|Overall Study|Withdrawal by Subject|53|||
125175555|NCT05026177|450263576|FG001|Overall Study|Withdrawal by Subject|51|||
125175556|NCT05026177|450263577|FG002|Overall Study|Withdrawal by Subject|55|||
125175557|NCT05026177|450263575|FG000|Overall Study|Protocol Violation|0|||
125175558|NCT05026177|450263576|FG001|Overall Study|Protocol Violation|1|||
125175559|NCT05026177|450263577|FG002|Overall Study|Protocol Violation|0|||
125175560|NCT05026177|450263575|FG000|Overall Study|Study terminated by sponsor|70|||
125175561|NCT05026177|450263576|FG001|Overall Study|Study terminated by sponsor|74|||
125175562|NCT05026177|450263577|FG002|Overall Study|Study terminated by sponsor|67|||
125175563|NCT05026177|450263575|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
125175564|NCT05026177|450263576|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
125175565|NCT05026177|450263577|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
125175566|NCT05026177|450263575|FG000|Overall Study|Starting alternative treatment|0|||
125175567|NCT05026177|450263576|FG001|Overall Study|Starting alternative treatment|1|||
125175568|NCT05026177|450263577|FG002|Overall Study|Starting alternative treatment|1|||
125175569|NCT05026177|450263575|FG000|Overall Study|Noncompliance with study procedures|0|||
125175570|NCT05026177|450263576|FG001|Overall Study|Noncompliance with study procedures|1|||
125175571|NCT05026177|450263577|FG002|Overall Study|Noncompliance with study procedures|1|||
125175572|NCT05026177|450263575|FG000|Overall Study|Met stopping criteria|0|||
125175573|NCT05026177|450263576|FG001|Overall Study|Met stopping criteria|0|||
125175574|NCT05026177|450263577|FG002|Overall Study|Met stopping criteria|1|||
125175575|NCT05026177|450263575|FG000|Overall Study|Health issues preventing continuation|0|||
125175576|NCT05026177|450263576|FG001|Overall Study|Health issues preventing continuation|0|||
125175577|NCT05026177|450263577|FG002|Overall Study|Health issues preventing continuation|1|||
125175578|NCT05026177|450263575|FG000|Overall Study|Randomized in error, not treated|0|||
125175579|NCT05026177|450263576|FG001|Overall Study|Randomized in error, not treated|0|||
125175580|NCT05026177|450263577|FG002|Overall Study|Randomized in error, not treated|2|||
125175581|NCT04856917|450263578|FG000|Overall Study|Withdrawal by Subject|4|||
125175582|NCT04856917|450263579|FG001|Overall Study|Withdrawal by Subject|3|||
125175583|NCT04856917|450263580|FG002|Overall Study|Withdrawal by Subject|1|||
125175584|NCT04856917|450263578|FG000|Overall Study|Lost to Follow-up|3|||
125175585|NCT04856917|450263579|FG001|Overall Study|Lost to Follow-up|1|||
125175586|NCT04856917|450263580|FG002|Overall Study|Lost to Follow-up|1|||
125175587|NCT04856917|450263578|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
125175588|NCT04856917|450263579|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
125175589|NCT04856917|450263580|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
125175590|NCT04856917|450263578|FG000|Overall Study|Other|1|||
125175591|NCT04856917|450263579|FG001|Overall Study|Other|1|||
125175592|NCT04856917|450263580|FG002|Overall Study|Other|0|||
125175593|NCT01169337|450263581|FG000|Overall Study|Lack of Efficacy|5|||
125175594|NCT01169337|450263582|FG001|Overall Study|Lack of Efficacy|7|||
125175595|NCT01169337|450263583|FG002|Overall Study|Lack of Efficacy|0|||
125175596|NCT01169337|450263581|FG000|Overall Study|Adverse Event|12|||
125175597|NCT01169337|450263582|FG001|Overall Study|Adverse Event|18|||
125175598|NCT01169337|450263583|FG002|Overall Study|Adverse Event|0|||
125175599|NCT01169337|450263581|FG000|Overall Study|Death|2|||
125175600|NCT01169337|450263582|FG001|Overall Study|Death|0|||
125175601|NCT01169337|450263583|FG002|Overall Study|Death|0|||
125175602|NCT01169337|450263581|FG000|Overall Study|Withdrawal by Subject|11|||
125175603|NCT01169337|450263582|FG001|Overall Study|Withdrawal by Subject|11|||
125175604|NCT01169337|450263583|FG002|Overall Study|Withdrawal by Subject|6|||
125175605|NCT01169337|450263581|FG000|Overall Study|Noncompliance|2|||
125230991|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
125230992|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
125230993|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
125230994|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
125230995|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
125230996|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
125230997|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
125230998|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
125230999|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
125231000|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
125231001|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
125231002|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
125231003|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
125231004|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
125231005|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
125231006|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
125231007|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
125231008|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
125231009|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
125231010|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
125231011|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
125231012|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
125231013|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
125231014|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
125231015|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
125231016|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
125231017|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
125231018|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
125231019|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
125231020|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
125231021|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
125231022|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
125231023|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
125231024|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
125231025|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
125231026|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
125231027|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
125231028|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
125231029|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
125231030|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
125231031|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
125231032|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
125231033|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
125231034|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
125231035|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
125392281|NCT01723163|451070620|FG001|Treatment Phase|Withdrawal by Subject|6|||
125392282|NCT01723163|451070619|FG000|Treatment Phase|Withdrawal by PI|5|||
125392283|NCT01723163|451070620|FG001|Treatment Phase|Withdrawal by PI|1|||
125175606|NCT01169337|450263582|FG001|Overall Study|Noncompliance|0|||
125175607|NCT01169337|450263583|FG002|Overall Study|Noncompliance|0|||
125175608|NCT01169337|450263581|FG000|Overall Study|Other complicating disease|1|||
125175609|NCT01169337|450263582|FG001|Overall Study|Other complicating disease|1|||
125175610|NCT01169337|450263583|FG002|Overall Study|Other complicating disease|0|||
125175611|NCT01169337|450263581|FG000|Overall Study|Physician Decision|1|||
125175612|NCT01169337|450263582|FG001|Overall Study|Physician Decision|5|||
125392284|NCT01723163|451070619|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
125392285|NCT01723163|451070620|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
125392286|NCT01723163|451070619|FG000|3-Month Follow-up|Unable to Contact|12|||
125392287|NCT01723163|451070620|FG001|3-Month Follow-up|Unable to Contact|19|||
125175613|NCT01169337|450263583|FG002|Overall Study|Physician Decision|0|||
125175614|NCT01169337|450263581|FG000|Overall Study|Alternative therapy|0|||
125175615|NCT01169337|450263582|FG001|Overall Study|Alternative therapy|2|||
125175616|NCT01169337|450263583|FG002|Overall Study|Alternative therapy|0|||
125175617|NCT01169337|450263581|FG000|Overall Study|Changed hospital|0|||
125175618|NCT01169337|450263582|FG001|Overall Study|Changed hospital|1|||
125231036|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
125231037|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
125231038|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
125231039|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
125231040|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
125231041|NCT02717195|450473887|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
125231042|NCT02717195|450473888|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
125231043|NCT02717195|450473889|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
125231044|NCT02717195|450473890|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
125231045|NCT02717195|450473891|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
125231046|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
125231047|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
125231048|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
125231049|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
125231050|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
125231051|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
125231052|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
125231053|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
125231054|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
125231055|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
125231056|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
125231057|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
125231058|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
125231059|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
125231060|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
125231061|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
125231062|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
125231063|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
125231064|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
125231065|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
125231066|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125231067|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
125231068|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
125231069|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
125231070|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
125231071|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
125231072|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
125231073|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
125231074|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
125231075|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
125231076|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
125231077|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
125231078|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
125231079|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
125231080|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
125231081|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
125231082|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
125231083|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
125231084|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
125231085|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
125231086|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
125231087|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
125231088|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
125231089|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
125231090|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
125231091|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
125231092|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
125231093|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
125231094|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
125231095|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
125392288|NCT01723163|451070619|FG000|6-Month Follow-up|Death|1|||
125392289|NCT01723163|451070620|FG001|6-Month Follow-up|Death|0|||
125231096|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
125231097|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
125231098|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
125231099|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
125231100|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
125231101|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
125231102|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
125231103|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
125231104|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
125231105|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
125231106|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
125231107|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
125231108|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
125231109|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
125231110|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
125231111|NCT02717195|450473887|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
125231112|NCT02717195|450473888|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
125231113|NCT02717195|450473889|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
125231114|NCT02717195|450473890|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
125231115|NCT02717195|450473891|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
125231116|NCT00855218|450473892|FG000|Overall Study|Adverse Event|43|||
125231117|NCT00855218|450473893|FG001|Overall Study|Adverse Event|27|||
125231118|NCT00855218|450473892|FG000|Overall Study|Withdrawal by Subject|10|||
125231119|NCT00855218|450473893|FG001|Overall Study|Withdrawal by Subject|6|||
125231120|NCT00855218|450473892|FG000|Overall Study|Physician Decision|18|||
125231121|NCT00855218|450473893|FG001|Overall Study|Physician Decision|11|||
125231122|NCT00855218|450473892|FG000|Overall Study|Lost to Follow-up|0|||
125231123|NCT00855218|450473893|FG001|Overall Study|Lost to Follow-up|1|||
125231124|NCT00855218|450473892|FG000|Overall Study|Protocol Violation|5|||
125231125|NCT00855218|450473893|FG001|Overall Study|Protocol Violation|9|||
125231126|NCT00855218|450473892|FG000|Overall Study|non-compliant with study drug|3|||
125231127|NCT00855218|450473893|FG001|Overall Study|non-compliant with study drug|1|||
125231128|NCT00855218|450473892|FG000|Overall Study|patient convenience|2|||
125231129|NCT00855218|450473893|FG001|Overall Study|patient convenience|0|||
125231130|NCT00855218|450473892|FG000|Overall Study|technical problems|2|||
125231131|NCT00855218|450473893|FG001|Overall Study|technical problems|1|||
125231132|NCT00855218|450473892|FG000|Overall Study|Still treated with study medication|0|||
125231133|NCT00855218|450473893|FG001|Overall Study|Still treated with study medication|1|||
125231134|NCT00855218|450473892|FG000|Overall Study|Untreatable disease progression|54|||
125231135|NCT00855218|450473893|FG001|Overall Study|Untreatable disease progression|67|||
125231136|NCT00855218|450473892|FG000|Overall Study|Second malignancy|0|||
125231137|NCT00855218|450473893|FG001|Overall Study|Second malignancy|1|||
125231138|NCT00855218|450473892|FG000|Overall Study|Progression measurement proven|7|||
125231139|NCT00855218|450473893|FG001|Overall Study|Progression measurement proven|15|||
125231140|NCT00855218|450473892|FG000|Overall Study|Clinical endpoint reached|10|||
125231141|NCT00855218|450473893|FG001|Overall Study|Clinical endpoint reached|13|||
125231142|NCT00764790|450473894|FG000|Overall Study|Protocol Violation|0|||
125231143|NCT00764790|450473895|FG001|Overall Study|Protocol Violation|0|||
125231144|NCT00764790|450473896|FG002|Overall Study|Protocol Violation|1|||
125231145|NCT00764790|450473894|FG000|Overall Study|Withdrawal by Subject|10|||
125231146|NCT00764790|450473895|FG001|Overall Study|Withdrawal by Subject|12|||
125231147|NCT00764790|450473896|FG002|Overall Study|Withdrawal by Subject|6|||
125231148|NCT00764790|450473894|FG000|Overall Study|Lost to Follow-up|28|||
125231149|NCT00764790|450473895|FG001|Overall Study|Lost to Follow-up|29|||
125231150|NCT00764790|450473896|FG002|Overall Study|Lost to Follow-up|23|||
125231151|NCT03191552|450473897|FG000|Overall Study|Lost to Follow-up|1|||
125231152|NCT03191552|450473898|FG001|Overall Study|Lost to Follow-up|0|||
125231153|NCT03191552|450473899|FG002|Overall Study|Lost to Follow-up|0|||
125231154|NCT03191552|450473897|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
125231155|NCT03191552|450473898|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
125231156|NCT03191552|450473899|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
125231157|NCT01265498|450473900|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
125231158|NCT01265498|450473901|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
125231159|NCT00617279|450473904|FG000|Overall Study|Study terminated by Sponsor|10|||
125231160|NCT00617279|450473905|FG001|Overall Study|Study terminated by Sponsor|15|||
125231161|NCT00617279|450473904|FG000|Overall Study|Graft abandonment|2|||
125231162|NCT00617279|450473905|FG001|Overall Study|Graft abandonment|0|||
125231163|NCT00617279|450473904|FG000|Overall Study|Lost to Follow-up|1|||
125231164|NCT00617279|450473905|FG001|Overall Study|Lost to Follow-up|0|||
125231165|NCT00617279|450473904|FG000|Overall Study|Death|1|||
125231166|NCT00617279|450473905|FG001|Overall Study|Death|2|||
125231167|NCT00921024|450473908|FG000|Overall Study|Lost to Follow-up|2|||
125231168|NCT00921024|450473909|FG001|Overall Study|Lost to Follow-up|0|||
125231169|NCT00921024|450473908|FG000|Overall Study|Received concomittant therapy|2|||
125231170|NCT00921024|450473909|FG001|Overall Study|Received concomittant therapy|0|||
125231171|NCT00921024|450473908|FG000|Overall Study|Withdrawal by Subject|0|||
125231172|NCT00921024|450473909|FG001|Overall Study|Withdrawal by Subject|3|||
125231173|NCT03225287|450473910|FG000|Overall Study|Adverse Event|0|||
125231174|NCT03225287|450473911|FG001|Overall Study|Adverse Event|0|||
125231175|NCT03225287|450473912|FG002|Overall Study|Adverse Event|1|||
125231176|NCT03225287|450473910|FG000|Overall Study|Protocol non-compliance|0|||
125231177|NCT03225287|450473911|FG001|Overall Study|Protocol non-compliance|0|||
125231178|NCT03225287|450473912|FG002|Overall Study|Protocol non-compliance|1|||
125231179|NCT03225287|450473910|FG000|Overall Study|Subject withdraws consent|3|||
125231180|NCT03225287|450473911|FG001|Overall Study|Subject withdraws consent|0|||
125231181|NCT03225287|450473912|FG002|Overall Study|Subject withdraws consent|0|||
125231182|NCT03225287|450473910|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
125231183|NCT03225287|450473911|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
125231184|NCT03225287|450473912|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
125231185|NCT03225287|450473910|FG000|Overall Study|Trial drug not effective|0|||
125231186|NCT03225287|450473911|FG001|Overall Study|Trial drug not effective|1|||
125231187|NCT03225287|450473912|FG002|Overall Study|Trial drug not effective|0|||
125231188|NCT03225287|450473910|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
125231189|NCT03225287|450473911|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
125231190|NCT03225287|450473912|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
125231191|NCT03225287|450473910|FG000|Overall Study|Stem cell transplantation|0|||
125231192|NCT03225287|450473911|FG001|Overall Study|Stem cell transplantation|1|||
125231193|NCT03225287|450473912|FG002|Overall Study|Stem cell transplantation|0|||
125231194|NCT01093846|450473915|FG000|Overall Study|Adverse Event|0|||
125231195|NCT01093846|450473916|FG001|Overall Study|Adverse Event|0|||
125231196|NCT01093846|450473917|FG002|Overall Study|Adverse Event|1|||
125231197|NCT01093846|450473915|FG000|Overall Study|Lack of Efficacy|0|||
125231198|NCT01093846|450473916|FG001|Overall Study|Lack of Efficacy|0|||
125231199|NCT01093846|450473917|FG002|Overall Study|Lack of Efficacy|4|||
125231200|NCT01093846|450473915|FG000|Overall Study|Condition no longer required study drug|1|||
125231201|NCT01093846|450473916|FG001|Overall Study|Condition no longer required study drug|1|||
125231202|NCT01093846|450473917|FG002|Overall Study|Condition no longer required study drug|1|||
125231203|NCT01093846|450473915|FG000|Overall Study|Administrative Problems|18|||
125231204|NCT01093846|450473916|FG001|Overall Study|Administrative Problems|17|||
125231205|NCT01093846|450473917|FG002|Overall Study|Administrative Problems|15|||
125231206|NCT01416571|450473918|FG000|Overall Study|Lost to Follow-up|2|||
125231207|NCT00296244|450476310|FG000|Overall Study|Underwent retransplant|0|||
125231208|NCT00296244|450476311|FG001|Overall Study|Underwent retransplant|1|||
125231209|NCT00427934|450476312|FG000|Overall Study|Adverse Event|1|||
125231210|NCT00427934|450476313|FG001|Overall Study|Adverse Event|0|||
125231211|NCT00427934|450476314|FG002|Overall Study|Adverse Event|5|||
125231212|NCT00427934|450476315|FG003|Overall Study|Adverse Event|4|||
125231213|NCT00427934|450476312|FG000|Overall Study|Lack of Efficacy|0|||
125231214|NCT00427934|450476313|FG001|Overall Study|Lack of Efficacy|0|||
125231215|NCT00427934|450476314|FG002|Overall Study|Lack of Efficacy|5|||
125231216|NCT00427934|450476315|FG003|Overall Study|Lack of Efficacy|2|||
125231217|NCT00427934|450476312|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
125231218|NCT00427934|450476313|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
125231219|NCT00427934|450476314|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
125231220|NCT00427934|450476315|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
125231221|NCT00427934|450476312|FG000|Overall Study|Other|0|||
125231222|NCT00427934|450476313|FG001|Overall Study|Other|0|||
125231223|NCT00427934|450476314|FG002|Overall Study|Other|11|||
125231224|NCT00427934|450476315|FG003|Overall Study|Other|5|||
125231225|NCT00427934|450476312|FG000|Overall Study|Withdrawal by Subject|0|||
125175619|NCT01169337|450263583|FG002|Overall Study|Changed hospital|0|||
125175620|NCT01169337|450263581|FG000|Overall Study|Never started treatment|0|||
125175621|NCT01169337|450263582|FG001|Overall Study|Never started treatment|2|||
125175622|NCT01169337|450263583|FG002|Overall Study|Never started treatment|0|||
125175623|NCT01169337|450263581|FG000|Overall Study|Reason not reported|1|||
125175624|NCT01169337|450263582|FG001|Overall Study|Reason not reported|0|||
125175625|NCT01169337|450263583|FG002|Overall Study|Reason not reported|0|||
125231226|NCT00427934|450476313|FG001|Overall Study|Withdrawal by Subject|0|||
125231227|NCT00427934|450476314|FG002|Overall Study|Withdrawal by Subject|1|||
125231228|NCT00427934|450476315|FG003|Overall Study|Withdrawal by Subject|3|||
125231229|NCT04539275|450476318|FG000|Overall Study|Death|2|||
125231230|NCT04539275|450476319|FG001|Overall Study|Death|4|||
125231231|NCT04539275|450476318|FG000|Overall Study|Lost to Follow-up|1|||
125231232|NCT04539275|450476319|FG001|Overall Study|Lost to Follow-up|1|||
125231233|NCT04539275|450476318|FG000|Overall Study|Withdrawal by Subject|3|||
125231234|NCT04539275|450476319|FG001|Overall Study|Withdrawal by Subject|0|||
125231235|NCT01373164|450476320|FG000|Overall Study|Lost to Follow-up|0|||
125231236|NCT01373164|450476321|FG001|Overall Study|Lost to Follow-up|0|||
125231237|NCT01373164|450476322|FG002|Overall Study|Lost to Follow-up|1|||
125231238|NCT01373164|450476323|FG003|Overall Study|Lost to Follow-up|2|||
125175626|NCT01169337|450263581|FG000|Overall Study|Continuing lenalidomide|9|||
125175627|NCT01169337|450263582|FG001|Overall Study|Continuing lenalidomide|43|||
125175628|NCT01169337|450263583|FG002|Overall Study|Continuing lenalidomide|0|||
125175629|NCT04008030|450263584|FG000|Pre-Treatment|Withdrawal by Subject|0|||
125175630|NCT04008030|450263585|FG001|Pre-Treatment|Withdrawal by Subject|0|||
125231239|NCT01373164|450476324|FG004|Overall Study|Lost to Follow-up|0|||
125231240|NCT01373164|450476320|FG000|Overall Study|Withdrawal by Subject|0|||
125231241|NCT01373164|450476321|FG001|Overall Study|Withdrawal by Subject|1|||
125175631|NCT04008030|450263586|FG002|Pre-Treatment|Withdrawal by Subject|9|||
125175632|NCT04008030|450263584|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
125175633|NCT04008030|450263585|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
125175634|NCT04008030|450263586|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
125175635|NCT04008030|450263584|FG000|Pre-Treatment|Other reasons|0|||
125175636|NCT04008030|450263585|FG001|Pre-Treatment|Other reasons|1|||
125175637|NCT04008030|450263586|FG002|Pre-Treatment|Other reasons|6|||
125175638|NCT04008030|450263584|FG000|Treatment|Withdrawal by Subject|1|||
125175639|NCT04008030|450263585|FG001|Treatment|Withdrawal by Subject|1|||
125175640|NCT04008030|450263586|FG002|Treatment|Withdrawal by Subject|1|||
125175641|NCT04008030|450263584|FG000|Treatment|Death|2|||
125175642|NCT04008030|450263585|FG001|Treatment|Death|4|||
125175643|NCT04008030|450263586|FG002|Treatment|Death|0|||
125175644|NCT04008030|450263584|FG000|Treatment|Pregnancy|0|||
125175645|NCT04008030|450263585|FG001|Treatment|Pregnancy|1|||
125175646|NCT04008030|450263586|FG002|Treatment|Pregnancy|0|||
125175647|NCT04008030|450263584|FG000|Treatment|Participant no longer meets study criteria|0|||
125175648|NCT04008030|450263585|FG001|Treatment|Participant no longer meets study criteria|1|||
125175649|NCT04008030|450263586|FG002|Treatment|Participant no longer meets study criteria|0|||
125175650|NCT04008030|450263584|FG000|Treatment|Other reasons|5|||
125175651|NCT04008030|450263585|FG001|Treatment|Other reasons|13|||
125175652|NCT04008030|450263586|FG002|Treatment|Other reasons|6|||
125175653|NCT04008030|450263584|FG000|Treatment|Disease Progression|137|||
125175654|NCT04008030|450263585|FG001|Treatment|Disease Progression|82|||
125175655|NCT04008030|450263586|FG002|Treatment|Disease Progression|85|||
125175656|NCT04008030|450263584|FG000|Treatment|Study drug toxicity|28|||
125175657|NCT04008030|450263585|FG001|Treatment|Study drug toxicity|48|||
125175658|NCT04008030|450263586|FG002|Treatment|Study drug toxicity|8|||
125175659|NCT04008030|450263584|FG000|Treatment|Adverse Event unrelated to study drug|28|||
125175660|NCT04008030|450263585|FG001|Treatment|Adverse Event unrelated to study drug|22|||
125175661|NCT04008030|450263586|FG002|Treatment|Adverse Event unrelated to study drug|6|||
125175662|NCT04008030|450263584|FG000|Treatment|Maximum Clinical Benefit|0|||
125175663|NCT04008030|450263585|FG001|Treatment|Maximum Clinical Benefit|1|||
125175664|NCT04008030|450263586|FG002|Treatment|Maximum Clinical Benefit|9|||
125175665|NCT04008030|450263584|FG000|Treatment|On-going treatment|13|||
125175666|NCT04008030|450263585|FG001|Treatment|On-going treatment|20|||
125175667|NCT04008030|450263586|FG002|Treatment|On-going treatment|0|||
125175668|NCT03560037|450263587|FG000|Overall Study|Protocol Violation|1|||
125175669|NCT03560037|450263588|FG001|Overall Study|Protocol Violation|0|||
125175670|NCT03560037|450263587|FG000|Overall Study|Physician Decision|0|||
125175671|NCT03560037|450263588|FG001|Overall Study|Physician Decision|1|||
125175672|NCT04034927|450263589|FG000|Overall Study|Adverse Event|4|||
125175673|NCT04034927|450263590|FG001|Overall Study|Adverse Event|9|||
125175674|NCT04034927|450263589|FG000|Overall Study|Death|0|||
125175675|NCT04034927|450263590|FG001|Overall Study|Death|1|||
125175676|NCT04034927|450263589|FG000|Overall Study|Withdrawal by Subject|0|||
125175677|NCT04034927|450263590|FG001|Overall Study|Withdrawal by Subject|3|||
125175678|NCT04034927|450263589|FG000|Overall Study|Still on Treatment|2|||
125175679|NCT04034927|450263590|FG001|Overall Study|Still on Treatment|1|||
125175680|NCT04034927|450263589|FG000|Overall Study|Other|1|||
125175681|NCT04034927|450263590|FG001|Overall Study|Other|1|||
125175682|NCT03996447|450263593|FG000|First MRI Examination|Adverse Event|2|||
125175683|NCT03996447|450263594|FG001|First MRI Examination|Adverse Event|0|||
125175684|NCT03996447|450263593|FG000|First MRI Examination|Withdrawal by Subject|1|||
125175685|NCT03996447|450263594|FG001|First MRI Examination|Withdrawal by Subject|2|||
125175686|NCT03996447|450263593|FG000|First MRI Examination|Protocol Violation|0|||
125175687|NCT03996447|450263594|FG001|First MRI Examination|Protocol Violation|1|||
125175688|NCT03996447|450263593|FG000|Washout|Adverse Event|2|||
125175689|NCT03996447|450263594|FG001|Washout|Adverse Event|0|||
125175690|NCT03996447|450263593|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
125175691|NCT03996447|450263594|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
125231242|NCT01373164|450476322|FG002|Overall Study|Withdrawal by Subject|0|||
125175692|NCT03996447|450263593|FG000|Washout|Withdrawal by Subject|0|||
125175693|NCT03996447|450263594|FG001|Washout|Withdrawal by Subject|1|||
125175694|NCT03996447|450263593|FG000|Washout|Other reason|1|||
125231243|NCT01373164|450476323|FG003|Overall Study|Withdrawal by Subject|10|||
125175695|NCT03996447|450263594|FG001|Washout|Other reason|1|||
125175696|NCT03816878|450263595|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
125175697|NCT03816878|450263596|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
125231244|NCT01373164|450476324|FG004|Overall Study|Withdrawal by Subject|2|||
125231245|NCT01799941|450476329|FG000|Overall Study|Adverse Event|34|||
125175698|NCT03816878|450263595|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
125175699|NCT03816878|450263596|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
125175700|NCT03355469|450263597|FG000|Overall Study|COVID-19|3|||
125175701|NCT03355469|450263598|FG001|Overall Study|COVID-19|2|||
125175702|NCT03355469|450263599|FG002|Overall Study|COVID-19|3|||
125175703|NCT03355469|450263600|FG003|Overall Study|COVID-19|3|||
125175704|NCT03355469|450263597|FG000|Overall Study|Lost to Follow-up|1|||
125175705|NCT03355469|450263598|FG001|Overall Study|Lost to Follow-up|0|||
125175706|NCT03355469|450263599|FG002|Overall Study|Lost to Follow-up|1|||
125175707|NCT03355469|450263600|FG003|Overall Study|Lost to Follow-up|0|||
125175708|NCT03355469|450263597|FG000|Overall Study|Withdrawal by Subject|2|||
125175709|NCT03355469|450263598|FG001|Overall Study|Withdrawal by Subject|1|||
125175710|NCT03355469|450263599|FG002|Overall Study|Withdrawal by Subject|0|||
125175711|NCT03355469|450263600|FG003|Overall Study|Withdrawal by Subject|3|||
125175712|NCT01708941|450263601|FG000|Overall Study|Adverse Event|4|||
125175713|NCT01708941|450263602|FG001|Overall Study|Adverse Event|6|||
125175714|NCT01708941|450263603|FG002|Overall Study|Adverse Event|1|||
125175715|NCT01708941|450263604|FG003|Overall Study|Adverse Event|0|||
125175716|NCT01708941|450263601|FG000|Overall Study|Death|1|||
125175717|NCT01708941|450263602|FG001|Overall Study|Death|1|||
125175718|NCT01708941|450263603|FG002|Overall Study|Death|2|||
125175719|NCT01708941|450263604|FG003|Overall Study|Death|14|||
125175720|NCT01708941|450263601|FG000|Overall Study|Withdrawal by Subject|1|||
125175721|NCT01708941|450263602|FG001|Overall Study|Withdrawal by Subject|0|||
125175722|NCT01708941|450263603|FG002|Overall Study|Withdrawal by Subject|3|||
125175723|NCT01708941|450263604|FG003|Overall Study|Withdrawal by Subject|4|||
125175724|NCT01708941|450263601|FG000|Overall Study|Disease progression|9|||
125175725|NCT01708941|450263602|FG001|Overall Study|Disease progression|10|||
125175726|NCT01708941|450263603|FG002|Overall Study|Disease progression|8|||
125175727|NCT01708941|450263604|FG003|Overall Study|Disease progression|0|||
125175728|NCT01708941|450263601|FG000|Overall Study|Alternative therapy|0|||
125175729|NCT01708941|450263602|FG001|Overall Study|Alternative therapy|0|||
125175730|NCT01708941|450263603|FG002|Overall Study|Alternative therapy|2|||
125175731|NCT01708941|450263604|FG003|Overall Study|Alternative therapy|0|||
125175732|NCT01708941|450263601|FG000|Overall Study|Ineligible and never started treatment|1|||
125175733|NCT01708941|450263602|FG001|Overall Study|Ineligible and never started treatment|0|||
125175734|NCT01708941|450263603|FG002|Overall Study|Ineligible and never started treatment|1|||
125175735|NCT01708941|450263604|FG003|Overall Study|Ineligible and never started treatment|0|||
125175736|NCT01708941|450263601|FG000|Overall Study|Never started treatment|2|||
125175737|NCT01708941|450263602|FG001|Overall Study|Never started treatment|1|||
125175738|NCT01708941|450263603|FG002|Overall Study|Never started treatment|0|||
125175739|NCT01708941|450263604|FG003|Overall Study|Never started treatment|0|||
125175740|NCT01708941|450263601|FG000|Overall Study|Ineligible|0|||
125175741|NCT01708941|450263602|FG001|Overall Study|Ineligible|0|||
125175742|NCT01708941|450263603|FG002|Overall Study|Ineligible|2|||
125175743|NCT01708941|450263604|FG003|Overall Study|Ineligible|0|||
125175744|NCT01575548|450263605|FG000|Overall Study|Adverse Event|15|||
125175745|NCT01575548|450263606|FG001|Overall Study|Adverse Event|2|||
125175746|NCT01575548|450263605|FG000|Overall Study|Disease progression|12|||
125175747|NCT01575548|450263606|FG001|Overall Study|Disease progression|25|||
125175748|NCT01575548|450263605|FG000|Overall Study|Death|1|||
125175749|NCT01575548|450263606|FG001|Overall Study|Death|0|||
125175750|NCT01575548|450263605|FG000|Overall Study|Other complicating disease|1|||
125175751|NCT01575548|450263606|FG001|Overall Study|Other complicating disease|0|||
125175752|NCT01575548|450263605|FG000|Overall Study|Withdrawal by Subject|7|||
125175753|NCT01575548|450263606|FG001|Overall Study|Withdrawal by Subject|3|||
125175754|NCT01575548|450263605|FG000|Overall Study|Noncompliance|1|||
125175755|NCT01575548|450263606|FG001|Overall Study|Noncompliance|0|||
125175756|NCT01575548|450263605|FG000|Overall Study|Anticipated surgery|0|||
125231246|NCT01799941|450476329|FG000|Overall Study|Withdrawal by Subject|21|||
125231247|NCT01799941|450476329|FG000|Overall Study|Death|2|||
125231248|NCT01799941|450476329|FG000|Overall Study|Investigator Decision|4|||
125231249|NCT01799941|450476329|FG000|Overall Study|Lack of Efficacy|3|||
125231250|NCT01799941|450476329|FG000|Overall Study|Lost to Follow-up|17|||
125231251|NCT01799941|450476329|FG000|Overall Study|Other|15|||
125175757|NCT01575548|450263606|FG001|Overall Study|Anticipated surgery|1|||
125175758|NCT01575548|450263605|FG000|Overall Study|Never started protocol therapy|3|||
125175759|NCT01575548|450263606|FG001|Overall Study|Never started protocol therapy|2|||
125175760|NCT04175912|450263607|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
125231252|NCT00420745|450476336|FG000|Overall Study|Adverse Event|2|||
125231253|NCT00420745|450476337|FG001|Overall Study|Adverse Event|2|||
125175761|NCT04175912|450263608|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
125175762|NCT04175912|450263607|FG000|Overall Study|Adverse Event|0|||
125175763|NCT04175912|450263608|FG001|Overall Study|Adverse Event|3|||
125175764|NCT04175912|450263607|FG000|Overall Study|Never started treatment|3|||
125175765|NCT04175912|450263608|FG001|Overall Study|Never started treatment|3|||
125175766|NCT04175912|450263607|FG000|Overall Study|Death|0|||
125231254|NCT00420745|450476336|FG000|Overall Study|Lost to Follow-up|10|||
125231255|NCT00420745|450476337|FG001|Overall Study|Lost to Follow-up|2|||
125231256|NCT00420745|450476336|FG000|Overall Study|Protocol Violation|1|||
125231257|NCT00420745|450476337|FG001|Overall Study|Protocol Violation|0|||
125231258|NCT00420745|450476336|FG000|Overall Study|Physician Decision|1|||
125231259|NCT00420745|450476337|FG001|Overall Study|Physician Decision|1|||
125231260|NCT00420745|450476336|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
125175767|NCT04175912|450263608|FG001|Overall Study|Death|1|||
125175768|NCT02048813|450263612|FG000|Overall Study|Still on treatment|279|||
125175769|NCT02048813|450263613|FG001|Overall Study|Still on treatment|0|||
125175770|NCT02048813|450263612|FG000|Overall Study|Adverse Event|40|||
125175771|NCT02048813|450263613|FG001|Overall Study|Adverse Event|38|||
125175772|NCT02048813|450263612|FG000|Overall Study|Disease progression|13|||
125175773|NCT02048813|450263613|FG001|Overall Study|Disease progression|3|||
125175774|NCT02048813|450263612|FG000|Overall Study|Withdrawal by Subject|7|||
125175775|NCT02048813|450263613|FG001|Overall Study|Withdrawal by Subject|8|||
125175776|NCT02048813|450263612|FG000|Overall Study|Death|2|||
125175777|NCT02048813|450263613|FG001|Overall Study|Death|1|||
125175778|NCT02048813|450263612|FG000|Overall Study|Complication|2|||
125175779|NCT02048813|450263613|FG001|Overall Study|Complication|2|||
125175780|NCT02048813|450263612|FG000|Overall Study|Non-protocol therapy|0|||
125175781|NCT02048813|450263613|FG001|Overall Study|Non-protocol therapy|1|||
125175782|NCT02048813|450263612|FG000|Overall Study|Second primary cancer|2|||
125175783|NCT02048813|450263613|FG001|Overall Study|Second primary cancer|0|||
125175784|NCT02048813|450263612|FG000|Overall Study|Insurance|2|||
125175785|NCT02048813|450263613|FG001|Overall Study|Insurance|0|||
125175786|NCT02048813|450263612|FG000|Overall Study|Wound infection/healing|2|||
125175787|NCT02048813|450263613|FG001|Overall Study|Wound infection/healing|0|||
125175788|NCT02048813|450263612|FG000|Overall Study|Missed appointment|3|||
125175789|NCT02048813|450263613|FG001|Overall Study|Missed appointment|0|||
125175790|NCT02048813|450263612|FG000|Overall Study|Never started treatment|2|||
125175791|NCT02048813|450263613|FG001|Overall Study|Never started treatment|17|||
125175792|NCT01708954|450263614|FG000|Step 1|Disease progression|26|||
125175793|NCT01708954|450263615|FG001|Step 1|Disease progression|17|||
125175794|NCT01708954|450263616|FG002|Step 1|Disease progression|14|||
125175795|NCT01708954|450263614|FG000|Step 1|Adverse Event|3|||
125175796|NCT01708954|450263615|FG001|Step 1|Adverse Event|11|||
125175797|NCT01708954|450263616|FG002|Step 1|Adverse Event|13|||
125175798|NCT01708954|450263614|FG000|Step 1|Death|3|||
125175799|NCT01708954|450263615|FG001|Step 1|Death|2|||
125175800|NCT01708954|450263616|FG002|Step 1|Death|3|||
125175801|NCT01708954|450263614|FG000|Step 1|Withdrawal by Subject|2|||
125175802|NCT01708954|450263615|FG001|Step 1|Withdrawal by Subject|5|||
125175803|NCT01708954|450263616|FG002|Step 1|Withdrawal by Subject|3|||
125175804|NCT01708954|450263614|FG000|Step 1|Other complicating disease|0|||
125175805|NCT01708954|450263615|FG001|Step 1|Other complicating disease|2|||
125175806|NCT01708954|450263616|FG002|Step 1|Other complicating disease|0|||
125175807|NCT01708954|450263614|FG000|Step 1|Crossed over to Step 2|2|||
125175808|NCT01708954|450263615|FG001|Step 1|Crossed over to Step 2|0|||
125175809|NCT01708954|450263616|FG002|Step 1|Crossed over to Step 2|0|||
125175810|NCT01708954|450263614|FG000|Step 1|Symptomatic deterioration|1|||
125175811|NCT01708954|450263615|FG001|Step 1|Symptomatic deterioration|0|||
125175812|NCT01708954|450263616|FG002|Step 1|Symptomatic deterioration|1|||
125175813|NCT01708954|450263614|FG000|Step 1|Off-treatment reason not submitted|1|||
125175814|NCT01708954|450263615|FG001|Step 1|Off-treatment reason not submitted|1|||
125175815|NCT01708954|450263616|FG002|Step 1|Off-treatment reason not submitted|1|||
125175816|NCT01708954|450263614|FG000|Step 1|Ineligible or never received treatment|4|||
125175817|NCT01708954|450263615|FG001|Step 1|Ineligible or never received treatment|2|||
125175818|NCT01708954|450263616|FG002|Step 1|Ineligible or never received treatment|8|||
125175819|NCT01708954|450263614|FG000|Step 2|Disease progression|9|||
125175820|NCT01708954|450263615|FG001|Step 2|Disease progression|4|||
125175821|NCT01708954|450263616|FG002|Step 2|Disease progression|0|||
125175822|NCT01708954|450263614|FG000|Step 2|Adverse Event|3|||
125231261|NCT00420745|450476337|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
125392290|NCT01723163|451070619|FG000|6-Month Follow-up|Unable to Contact|17|||
125175823|NCT01708954|450263615|FG001|Step 2|Adverse Event|2|||
125175824|NCT01708954|450263616|FG002|Step 2|Adverse Event|0|||
125175825|NCT01708954|450263614|FG000|Step 2|Withdrawal by Subject|1|||
125175826|NCT01708954|450263615|FG001|Step 2|Withdrawal by Subject|1|||
125175827|NCT01708954|450263616|FG002|Step 2|Withdrawal by Subject|0|||
125175828|NCT06400251|450263617|FG000|Overall Study|Never Start Protocol Therapy|1|||
125175829|NCT06400251|450263617|FG000|Overall Study|Ineligible|2|||
125175830|NCT06400251|450263617|FG000|Overall Study|Mutation Status Not Confirmed|3|||
125175831|NCT06400251|450263617|FG000|Overall Study|Disease Progression|25|||
125175832|NCT06400251|450263617|FG000|Overall Study|Adverse Event|1|||
125175833|NCT06400251|450263617|FG000|Overall Study|Complicating Disease|1|||
125175834|NCT06400251|450263617|FG000|Overall Study|Physician Decision|2|||
125175835|NCT03631199|450263618|FG000|Overall Study|Progressive disease|9|||
125175836|NCT03631199|450263619|FG001|Overall Study|Progressive disease|5|||
125175837|NCT03631199|450263620|FG002|Overall Study|Progressive disease|5|||
125231262|NCT00420745|450476336|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
125231263|NCT00420745|450476337|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
125231264|NCT01125930|450476345|FG000|Overall Study|Adverse Event|0|||
125231265|NCT01125930|450476346|FG001|Overall Study|Adverse Event|1|||
125231266|NCT01125930|450476345|FG000|Overall Study|Withdrawal by Subject|1|||
125231267|NCT01125930|450476346|FG001|Overall Study|Withdrawal by Subject|6|||
125231268|NCT01125930|450476345|FG000|Overall Study|Protocol Violation|0|||
125231269|NCT01125930|450476346|FG001|Overall Study|Protocol Violation|1|||
125231270|NCT01125930|450476345|FG000|Overall Study|Lost to Follow-up|0|||
125231271|NCT01125930|450476346|FG001|Overall Study|Lost to Follow-up|2|||
125231272|NCT01715831|450476347|FG000|Overall Study|Adverse Event|1|||
125231273|NCT03098979|450476350|FG000|Overall Study|Adverse Event|1|||
125231274|NCT03098979|450476351|FG001|Overall Study|Adverse Event|0|||
125231275|NCT03098979|450476352|FG002|Overall Study|Adverse Event|1|||
125231276|NCT03098979|450476353|FG003|Overall Study|Adverse Event|4|||
125231277|NCT03098979|450476354|FG004|Overall Study|Adverse Event|6|||
125231278|NCT03098979|450476355|FG005|Overall Study|Adverse Event|1|||
125231279|NCT03098979|450476350|FG000|Overall Study|Withdrawal by Subject|2|||
125231280|NCT03098979|450476351|FG001|Overall Study|Withdrawal by Subject|1|||
125231281|NCT03098979|450476352|FG002|Overall Study|Withdrawal by Subject|1|||
125231282|NCT03098979|450476353|FG003|Overall Study|Withdrawal by Subject|1|||
125231283|NCT03098979|450476354|FG004|Overall Study|Withdrawal by Subject|2|||
125231284|NCT03098979|450476355|FG005|Overall Study|Withdrawal by Subject|1|||
125231285|NCT03098979|450476350|FG000|Overall Study|Death|1|||
125231286|NCT03098979|450476351|FG001|Overall Study|Death|0|||
125231287|NCT03098979|450476352|FG002|Overall Study|Death|2|||
125231288|NCT03098979|450476353|FG003|Overall Study|Death|0|||
125231289|NCT03098979|450476354|FG004|Overall Study|Death|1|||
125231290|NCT03098979|450476355|FG005|Overall Study|Death|0|||
125231291|NCT03098979|450476350|FG000|Overall Study|Physician Decision|2|||
125231292|NCT03098979|450476351|FG001|Overall Study|Physician Decision|1|||
125231293|NCT03098979|450476352|FG002|Overall Study|Physician Decision|0|||
125231294|NCT03098979|450476353|FG003|Overall Study|Physician Decision|0|||
125231295|NCT03098979|450476354|FG004|Overall Study|Physician Decision|0|||
125231296|NCT03098979|450476355|FG005|Overall Study|Physician Decision|0|||
125231297|NCT03098979|450476350|FG000|Overall Study|Non-compliance|0|||
125231298|NCT03098979|450476351|FG001|Overall Study|Non-compliance|0|||
125231299|NCT03098979|450476352|FG002|Overall Study|Non-compliance|0|||
125231300|NCT03098979|450476353|FG003|Overall Study|Non-compliance|0|||
125231301|NCT03098979|450476354|FG004|Overall Study|Non-compliance|0|||
125231302|NCT03098979|450476355|FG005|Overall Study|Non-compliance|1|||
125231303|NCT03098979|450476350|FG000|Overall Study|Protocol Violation|0|||
125231304|NCT03098979|450476351|FG001|Overall Study|Protocol Violation|0|||
125231305|NCT03098979|450476352|FG002|Overall Study|Protocol Violation|0|||
125231306|NCT03098979|450476353|FG003|Overall Study|Protocol Violation|0|||
125231307|NCT03098979|450476354|FG004|Overall Study|Protocol Violation|0|||
125231308|NCT03098979|450476355|FG005|Overall Study|Protocol Violation|1|||
125231309|NCT02426684|450476356|FG000|Overall Study|Physician Decision|1|||
125231310|NCT03736967|450476357|FG000|Overall Study|Withdrawal by Subject|26|||
125231311|NCT03736967|450476358|FG001|Overall Study|Withdrawal by Subject|25|||
125231312|NCT03736967|450476359|FG002|Overall Study|Withdrawal by Subject|23|||
125231313|NCT03736967|450476360|FG003|Overall Study|Withdrawal by Subject|26|||
125231314|NCT03736967|450476357|FG000|Overall Study|Lost to Follow-up|3|||
125231315|NCT03736967|450476358|FG001|Overall Study|Lost to Follow-up|2|||
125231316|NCT03736967|450476359|FG002|Overall Study|Lost to Follow-up|1|||
125231317|NCT03736967|450476360|FG003|Overall Study|Lost to Follow-up|1|||
125231318|NCT03736967|450476357|FG000|Overall Study|Physician Decision|1|||
125231319|NCT03736967|450476358|FG001|Overall Study|Physician Decision|0|||
125231320|NCT03736967|450476359|FG002|Overall Study|Physician Decision|0|||
125231321|NCT03736967|450476360|FG003|Overall Study|Physician Decision|1|||
125231322|NCT03736967|450476357|FG000|Overall Study|Adverse Event|0|||
125231323|NCT03736967|450476358|FG001|Overall Study|Adverse Event|1|||
125231324|NCT03736967|450476359|FG002|Overall Study|Adverse Event|0|||
125231325|NCT03736967|450476360|FG003|Overall Study|Adverse Event|1|||
125231326|NCT03736967|450476357|FG000|Overall Study|Death|0|||
125231327|NCT03736967|450476358|FG001|Overall Study|Death|0|||
125231328|NCT03736967|450476359|FG002|Overall Study|Death|0|||
125231329|NCT03736967|450476360|FG003|Overall Study|Death|1|||
125231330|NCT03736967|450476357|FG000|Overall Study|Randomized but never treated|1|||
125231331|NCT03736967|450476358|FG001|Overall Study|Randomized but never treated|0|||
125231332|NCT03736967|450476359|FG002|Overall Study|Randomized but never treated|0|||
125231333|NCT03736967|450476360|FG003|Overall Study|Randomized but never treated|0|||
125231334|NCT02369653|450476361|FG000|Overall Study|Lost to Follow-up|0|||
125231335|NCT02369653|450476362|FG001|Overall Study|Lost to Follow-up|1|||
125231336|NCT02369653|450476361|FG000|Overall Study|Administrative reason by sponsor|0|||
125231337|NCT02369653|450476362|FG001|Overall Study|Administrative reason by sponsor|1|||
125231338|NCT02369653|450476361|FG000|Overall Study|Death|1|||
125231339|NCT02369653|450476362|FG001|Overall Study|Death|2|||
125231340|NCT02369653|450476361|FG000|Overall Study|Participant withdrew consent|13|||
125231341|NCT02369653|450476362|FG001|Overall Study|Participant withdrew consent|3|||
125231342|NCT02419807|450476363|FG000|Overall Study|Withdrawal by Subject|4|||
125231343|NCT02419807|450476363|FG000|Overall Study|Physician Decision|1|||
125231344|NCT02419807|450476363|FG000|Overall Study|Protocol Violation|5|||
125231345|NCT01458587|450476364|FG000|Overall Study|Withdrawal by Subject|1|||
125231346|NCT01458587|450476365|FG001|Overall Study|Withdrawal by Subject|0|||
125231347|NCT01006629|450476366|FG000|Overall Study|Adverse Event|1|||
125231348|NCT01006629|450476366|FG000|Overall Study|Parent refused to continue participation|1|||
125231349|NCT01006629|450476366|FG000|Overall Study|Parent unable to perform site visit|4|||
125231350|NCT01118299|450476367|FG000|Overall Study|Death|7|||
125231351|NCT01118299|450476368|FG001|Overall Study|Death|5|||
125231352|NCT01118299|450476367|FG000|Overall Study|Withdrawal by Subject|8|||
125231353|NCT01118299|450476368|FG001|Overall Study|Withdrawal by Subject|8|||
125231354|NCT01118299|450476367|FG000|Overall Study|Lost to Follow-up|2|||
125231355|NCT01118299|450476368|FG001|Overall Study|Lost to Follow-up|1|||
125231356|NCT01118299|450476367|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
125231357|NCT01118299|450476368|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
125231358|NCT04459338|450476370|FG000|Overall Study|Loss of IV during study|1|||
125231359|NCT04459338|450476371|FG001|Overall Study|Loss of IV during study|0|||
125231360|NCT03157089|450476372|FG000|Overall Study|Treated only with pembrolizumab|1|||
125231361|NCT03157089|450476373|FG001|Overall Study|Treated only with pembrolizumab|0|||
125231362|NCT03157089|450476372|FG000|Overall Study|Adverse Event|5|||
125231363|NCT03157089|450476373|FG001|Overall Study|Adverse Event|4|||
125231364|NCT03157089|450476372|FG000|Overall Study|Progressive disease|6|||
125231365|NCT03157089|450476373|FG001|Overall Study|Progressive disease|8|||
125231366|NCT02932943|450476374|FG000|Overall Study|Lost to Follow-up|0|||
125231367|NCT02932943|450476375|FG001|Overall Study|Lost to Follow-up|2|||
125231368|NCT02932943|450476374|FG000|Overall Study|Adverse Event|2|||
125231369|NCT02932943|450476375|FG001|Overall Study|Adverse Event|2|||
125231370|NCT02932943|450476374|FG000|Overall Study|Withdrawal by Subject|3|||
125231371|NCT02932943|450476375|FG001|Overall Study|Withdrawal by Subject|3|||
125231372|NCT01454284|450476378|FG000|Overall Study|Adverse Event|20|||
125231373|NCT01454284|450476379|FG001|Overall Study|Adverse Event|7|||
125231374|NCT01454284|450476378|FG000|Overall Study|Death|0|||
125231375|NCT01454284|450476379|FG001|Overall Study|Death|3|||
125231376|NCT01454284|450476378|FG000|Overall Study|Lost to Follow-up|13|||
125231377|NCT01454284|450476379|FG001|Overall Study|Lost to Follow-up|8|||
125231378|NCT01454284|450476378|FG000|Overall Study|Protocol Violation|9|||
125231379|NCT01454284|450476379|FG001|Overall Study|Protocol Violation|6|||
125231380|NCT01454284|450476378|FG000|Overall Study|Withdrawal by Subject|58|||
125231381|NCT01454284|450476379|FG001|Overall Study|Withdrawal by Subject|36|||
125231382|NCT01454284|450476378|FG000|Overall Study|Physician Decision|16|||
125231383|NCT01454284|450476379|FG001|Overall Study|Physician Decision|11|||
125231384|NCT01454284|450476378|FG000|Overall Study|Sponsor Decision|0|||
125231385|NCT01454284|450476379|FG001|Overall Study|Sponsor Decision|2|||
125231386|NCT03248037|450476380|FG000|Overall Study|Withdrawal by Subject|6|||
125231387|NCT03248037|450476381|FG001|Overall Study|Withdrawal by Subject|9|||
125231388|NCT03248037|450476380|FG000|Overall Study|Adverse Event|15|||
125231389|NCT03248037|450476381|FG001|Overall Study|Adverse Event|0|||
125231390|NCT02300610|450476382|FG000|Overall Study|Withdrawal by Subject|1|||
125231391|NCT02300610|450476383|FG001|Overall Study|Withdrawal by Subject|0|||
125231392|NCT02300610|450476384|FG002|Overall Study|Withdrawal by Subject|1|||
125231393|NCT04018066|450476385|FG000|Overall Study|participants started taking medications during the study period|3|||
125231394|NCT04018066|450476385|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
125231395|NCT03817528|450476386|FG000|Overall Study|Withdrawal by Subject|1|||
125231396|NCT03817528|450476386|FG000|Overall Study|Adverse Event|2|||
125231397|NCT01259245|450476393|FG000|Overall Study|Withdrawal by Subject|27|||
125231398|NCT01259245|450476394|FG001|Overall Study|Withdrawal by Subject|24|||
125231399|NCT01259245|450476393|FG000|Overall Study|Death|1|||
125231400|NCT01259245|450476394|FG001|Overall Study|Death|2|||
125231401|NCT01462942|450476405|FG000|Overall Study|Adverse Event|7|||
125231402|NCT01462942|450476406|FG001|Overall Study|Adverse Event|12|||
125231403|NCT01462942|450476407|FG002|Overall Study|Adverse Event|10|||
125231404|NCT01462942|450476408|FG003|Overall Study|Adverse Event|11|||
125231405|NCT01462942|450476409|FG004|Overall Study|Adverse Event|11|||
125231406|NCT01462942|450476405|FG000|Overall Study|Other, including COPD exacerbation|3|||
125231407|NCT01462942|450476406|FG001|Overall Study|Other, including COPD exacerbation|5|||
125231408|NCT01462942|450476407|FG002|Overall Study|Other, including COPD exacerbation|2|||
125231409|NCT01462942|450476408|FG003|Overall Study|Other, including COPD exacerbation|8|||
125231410|NCT01462942|450476409|FG004|Overall Study|Other, including COPD exacerbation|5|||
125231411|NCT01462942|450476405|FG000|Overall Study|Withdrawal by Subject|14|||
125231412|NCT01462942|450476406|FG001|Overall Study|Withdrawal by Subject|10|||
125231413|NCT01462942|450476407|FG002|Overall Study|Withdrawal by Subject|14|||
125231414|NCT01462942|450476408|FG003|Overall Study|Withdrawal by Subject|16|||
125231415|NCT01462942|450476409|FG004|Overall Study|Withdrawal by Subject|19|||
125231416|NCT01462942|450476405|FG000|Overall Study|Lack of Efficacy|6|||
125231417|NCT01462942|450476406|FG001|Overall Study|Lack of Efficacy|0|||
125231418|NCT01462942|450476407|FG002|Overall Study|Lack of Efficacy|4|||
125175838|NCT03631199|450263621|FG003|Overall Study|Progressive disease|149|||
125175839|NCT03631199|450263622|FG004|Overall Study|Progressive disease|148|||
125175840|NCT03631199|450263618|FG000|Overall Study|Physician Decision|0|||
125175841|NCT03631199|450263619|FG001|Overall Study|Physician Decision|2|||
125175842|NCT03631199|450263620|FG002|Overall Study|Physician Decision|3|||
125175843|NCT03631199|450263621|FG003|Overall Study|Physician Decision|19|||
125175844|NCT03631199|450263622|FG004|Overall Study|Physician Decision|13|||
125175845|NCT03631199|450263618|FG000|Overall Study|Adverse Event|1|||
125175846|NCT03631199|450263619|FG001|Overall Study|Adverse Event|1|||
125175847|NCT03631199|450263620|FG002|Overall Study|Adverse Event|0|||
125175848|NCT03631199|450263621|FG003|Overall Study|Adverse Event|28|||
125175849|NCT03631199|450263622|FG004|Overall Study|Adverse Event|29|||
125175850|NCT03631199|450263618|FG000|Overall Study|Death|0|||
125175851|NCT03631199|450263619|FG001|Overall Study|Death|1|||
125175852|NCT03631199|450263620|FG002|Overall Study|Death|0|||
125175853|NCT03631199|450263621|FG003|Overall Study|Death|35|||
125175854|NCT03631199|450263622|FG004|Overall Study|Death|48|||
125175855|NCT03631199|450263618|FG000|Overall Study|Subject decision|0|||
125175856|NCT03631199|450263619|FG001|Overall Study|Subject decision|1|||
125175857|NCT03631199|450263620|FG002|Overall Study|Subject decision|0|||
125175858|NCT03631199|450263621|FG003|Overall Study|Subject decision|12|||
125175859|NCT03631199|450263622|FG004|Overall Study|Subject decision|12|||
125175860|NCT03631199|450263618|FG000|Overall Study|No treated|0|||
125175861|NCT03631199|450263619|FG001|Overall Study|No treated|0|||
125175862|NCT03631199|450263620|FG002|Overall Study|No treated|0|||
125175863|NCT03631199|450263621|FG003|Overall Study|No treated|0|||
125175864|NCT03631199|450263622|FG004|Overall Study|No treated|1|||
125175865|NCT03631199|450263618|FG000|Overall Study|Treatment ongoing|0|||
125175866|NCT03631199|450263619|FG001|Overall Study|Treatment ongoing|1|||
125175867|NCT03631199|450263620|FG002|Overall Study|Treatment ongoing|1|||
125175868|NCT03631199|450263621|FG003|Overall Study|Treatment ongoing|76|||
125175869|NCT03631199|450263622|FG004|Overall Study|Treatment ongoing|71|||
125175870|NCT03631199|450263618|FG000|Overall Study|Guardian decision|0|||
125175871|NCT03631199|450263619|FG001|Overall Study|Guardian decision|0|||
125175872|NCT03631199|450263620|FG002|Overall Study|Guardian decision|0|||
125175873|NCT03631199|450263621|FG003|Overall Study|Guardian decision|1|||
125175874|NCT03631199|450263622|FG004|Overall Study|Guardian decision|1|||
125175875|NCT02567435|450263623|FG000|Overall Study|Death|1|||
125175876|NCT02567435|450263624|FG001|Overall Study|Death|1|||
125175877|NCT02567435|450263625|FG002|Overall Study|Death|0|||
125175878|NCT02567435|450263626|FG003|Overall Study|Death|0|||
125175879|NCT02567435|450263623|FG000|Overall Study|Ineligible|1|||
125175880|NCT02567435|450263624|FG001|Overall Study|Ineligible|3|||
125175881|NCT02567435|450263625|FG002|Overall Study|Ineligible|0|||
125175882|NCT02567435|450263626|FG003|Overall Study|Ineligible|0|||
125175883|NCT02567435|450263623|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
125175884|NCT02567435|450263624|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
125175885|NCT02567435|450263625|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
125175886|NCT02567435|450263626|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
125175887|NCT04458922|450263628|FG000|Overall Study|Withdrawal by Subject|1|||
125175888|NCT04458922|450263629|FG001|Overall Study|Withdrawal by Subject|0|||
125175889|NCT04458922|450263630|FG002|Overall Study|Withdrawal by Subject|2|||
125175890|NCT04458922|450263628|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
125175891|NCT04458922|450263629|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
125175892|NCT04458922|450263630|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
125175893|NCT04458922|450263628|FG000|Overall Study|Adverse Event|1|||
125175894|NCT04458922|450263629|FG001|Overall Study|Adverse Event|0|||
125175895|NCT04458922|450263630|FG002|Overall Study|Adverse Event|0|||
125175896|NCT04458922|450263628|FG000|Overall Study|Started new study|0|||
125175897|NCT04458922|450263629|FG001|Overall Study|Started new study|0|||
125175898|NCT04458922|450263630|FG002|Overall Study|Started new study|1|||
125175899|NCT04458922|450263628|FG000|Overall Study|Progressive disease|6|||
125231419|NCT01462942|450476408|FG003|Overall Study|Lack of Efficacy|5|||
125175900|NCT04458922|450263629|FG001|Overall Study|Progressive disease|8|||
125175901|NCT04458922|450263630|FG002|Overall Study|Progressive disease|2|||
125175902|NCT04458922|450263628|FG000|Overall Study|Death|1|||
125175903|NCT04458922|450263629|FG001|Overall Study|Death|0|||
125175904|NCT04458922|450263630|FG002|Overall Study|Death|2|||
125175905|NCT04458922|450263628|FG000|Overall Study|Participant started chemotherapy|0|||
125231420|NCT01462942|450476409|FG004|Overall Study|Lack of Efficacy|3|||
125175906|NCT04458922|450263629|FG001|Overall Study|Participant started chemotherapy|1|||
125175907|NCT04458922|450263630|FG002|Overall Study|Participant started chemotherapy|0|||
125175908|NCT03651700|450263632|FG000|Overall Study|Withdrawal by Subject|1|||
125175909|NCT03651700|450263633|FG001|Overall Study|Withdrawal by Subject|0|||
125175910|NCT04856930|450263634|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
125175911|NCT04856930|450263635|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
125175912|NCT04856930|450263636|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
125175913|NCT04856930|450263634|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
125231421|NCT01462942|450476405|FG000|Overall Study|Lost to Follow-up|0|||
125231422|NCT01462942|450476406|FG001|Overall Study|Lost to Follow-up|1|||
125231423|NCT01462942|450476407|FG002|Overall Study|Lost to Follow-up|1|||
125231424|NCT01462942|450476408|FG003|Overall Study|Lost to Follow-up|1|||
125231425|NCT01462942|450476409|FG004|Overall Study|Lost to Follow-up|1|||
125231426|NCT01462942|450476405|FG000|Overall Study|Protocol Violation|4|||
125231427|NCT01462942|450476406|FG001|Overall Study|Protocol Violation|6|||
125231428|NCT01462942|450476407|FG002|Overall Study|Protocol Violation|9|||
125231429|NCT01462942|450476408|FG003|Overall Study|Protocol Violation|9|||
125231430|NCT01462942|450476409|FG004|Overall Study|Protocol Violation|6|||
125231431|NCT01027845|450476410|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
125231432|NCT01027845|450476411|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
125231433|NCT01027845|450476412|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
125231434|NCT01027845|450476413|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
125231435|NCT01027845|450476410|FG000|Primary Vaccination Phase|Adverse Event|1|||
125231436|NCT01027845|450476411|FG001|Primary Vaccination Phase|Adverse Event|0|||
125231437|NCT01027845|450476412|FG002|Primary Vaccination Phase|Adverse Event|0|||
125231438|NCT01027845|450476413|FG003|Primary Vaccination Phase|Adverse Event|0|||
125231439|NCT01027845|450476410|FG000|Primary Vaccination Phase|Protocol Violation|1|||
125231440|NCT01027845|450476411|FG001|Primary Vaccination Phase|Protocol Violation|0|||
125231441|NCT01027845|450476412|FG002|Primary Vaccination Phase|Protocol Violation|0|||
125231442|NCT01027845|450476413|FG003|Primary Vaccination Phase|Protocol Violation|0|||
125231443|NCT01027845|450476410|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
125231444|NCT01027845|450476411|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
125231445|NCT01027845|450476412|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
125231446|NCT01027845|450476413|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
125231447|NCT01027845|450476410|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
125231448|NCT01027845|450476411|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
125231449|NCT01027845|450476412|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
125231450|NCT01027845|450476413|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
125231451|NCT01027845|450476410|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
125231452|NCT01027845|450476411|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
125231453|NCT01027845|450476412|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
125231454|NCT01027845|450476413|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
125231455|NCT00087178|450476416|FG000|Overall Study|No follow up data|5|||
125231456|NCT00087178|450476417|FG001|Overall Study|No follow up data|15|||
125231457|NCT00087178|450476416|FG000|Overall Study|No clinical assessment|1|||
125231458|NCT00087178|450476417|FG001|Overall Study|No clinical assessment|2|||
125231459|NCT00087178|450476416|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
125231460|NCT00087178|450476417|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
125231461|NCT01692119|450476418|FG000|Overall Study|Protocol Violation|3|||
125231462|NCT01692119|450476419|FG001|Overall Study|Protocol Violation|1|||
125231463|NCT01692119|450476418|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
125231464|NCT01692119|450476419|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
125231465|NCT02147626|450476420|FG000|Overall Study|Lost to Follow-up|4|||
125231466|NCT02147626|450476421|FG001|Overall Study|Lost to Follow-up|4|||
125231467|NCT02147626|450476420|FG000|Overall Study|Pregnancy|1|||
125231468|NCT02147626|450476421|FG001|Overall Study|Pregnancy|2|||
125231469|NCT02147626|450476420|FG000|Overall Study|Withdrawal by Subject|0|||
125231470|NCT02147626|450476421|FG001|Overall Study|Withdrawal by Subject|1|||
125231471|NCT00997893|450476422|FG000|Overall Study|Adverse Event|1|||
125231472|NCT00997893|450476423|FG001|Overall Study|Adverse Event|0|||
125231473|NCT00997893|450476424|FG002|Overall Study|Adverse Event|0|||
125231474|NCT00997893|450476422|FG000|Overall Study|Unable to meet study timelines|1|||
125231475|NCT00997893|450476423|FG001|Overall Study|Unable to meet study timelines|0|||
125231476|NCT00997893|450476424|FG002|Overall Study|Unable to meet study timelines|0|||
125231477|NCT00997893|450476422|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
125231478|NCT00997893|450476423|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
125231479|NCT00997893|450476424|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
125231480|NCT00071981|450476425|FG000|Overall Study|Lack of Efficacy|37|||
125231481|NCT00071981|450476426|FG001|Overall Study|Lack of Efficacy|29|||
125231482|NCT00071981|450476427|FG002|Overall Study|Lack of Efficacy|30|||
125231483|NCT00071981|450476428|FG003|Overall Study|Lack of Efficacy|43|||
125231484|NCT00071981|450476425|FG000|Overall Study|Adverse Event|4|||
125231485|NCT00071981|450476426|FG001|Overall Study|Adverse Event|4|||
125231486|NCT00071981|450476427|FG002|Overall Study|Adverse Event|3|||
125231487|NCT00071981|450476428|FG003|Overall Study|Adverse Event|1|||
125231488|NCT00071981|450476425|FG000|Overall Study|Death|0|||
125231489|NCT00071981|450476426|FG001|Overall Study|Death|0|||
125231490|NCT00071981|450476427|FG002|Overall Study|Death|1|||
125231491|NCT00071981|450476428|FG003|Overall Study|Death|1|||
125231492|NCT00071981|450476425|FG000|Overall Study|Withdrawal by Subject|3|||
125231493|NCT00071981|450476426|FG001|Overall Study|Withdrawal by Subject|1|||
125231494|NCT00071981|450476427|FG002|Overall Study|Withdrawal by Subject|0|||
125231495|NCT00071981|450476428|FG003|Overall Study|Withdrawal by Subject|0|||
125231496|NCT00071981|450476425|FG000|Overall Study|No protocol therapy|2|||
125231497|NCT00071981|450476426|FG001|Overall Study|No protocol therapy|5|||
125231498|NCT00071981|450476427|FG002|Overall Study|No protocol therapy|1|||
125231499|NCT00071981|450476428|FG003|Overall Study|No protocol therapy|0|||
125231500|NCT00071981|450476425|FG000|Overall Study|others (not specified in the study)|0|||
125231501|NCT00071981|450476426|FG001|Overall Study|others (not specified in the study)|2|||
125231502|NCT00071981|450476427|FG002|Overall Study|others (not specified in the study)|2|||
125231503|NCT00071981|450476428|FG003|Overall Study|others (not specified in the study)|0|||
125231504|NCT00467519|450476429|FG000|Overall Study|Protocol Violation|8|||
125231505|NCT00467519|450476430|FG001|Overall Study|Protocol Violation|4|||
125231506|NCT00467519|450476429|FG000|Overall Study|Lost to Follow-up|2|||
125231507|NCT00467519|450476430|FG001|Overall Study|Lost to Follow-up|9|||
125231508|NCT00467519|450476429|FG000|Overall Study|Withdrawal by Subject|4|||
125231509|NCT00467519|450476430|FG001|Overall Study|Withdrawal by Subject|10|||
125231510|NCT01123655|450476431|FG000|Overall Study|Medication for RA had to be changed|1|||
125231511|NCT01123655|450476432|FG001|Overall Study|Medication for RA had to be changed|0|||
125231512|NCT01123655|450476433|FG002|Overall Study|Medication for RA had to be changed|0|||
125231513|NCT01123655|450476431|FG000|Overall Study|new illness|0|||
125231514|NCT01123655|450476432|FG001|Overall Study|new illness|1|||
125231515|NCT01123655|450476433|FG002|Overall Study|new illness|0|||
125231516|NCT01123655|450476431|FG000|Overall Study|began prohibitive drug|0|||
125231517|NCT01123655|450476432|FG001|Overall Study|began prohibitive drug|0|||
125231518|NCT01123655|450476433|FG002|Overall Study|began prohibitive drug|1|||
125231519|NCT00833755|450476434|FG000|Overall Study|Physician Decision|4|||
125231520|NCT00833755|450476435|FG001|Overall Study|Physician Decision|4|||
125231521|NCT00833755|450476436|FG002|Overall Study|Physician Decision|2|||
125231522|NCT00833755|450476437|FG003|Overall Study|Physician Decision|6|||
125231523|NCT00833755|450476434|FG000|Overall Study|Subject had scheduling issues|0|||
125231524|NCT00833755|450476435|FG001|Overall Study|Subject had scheduling issues|1|||
125231525|NCT00833755|450476436|FG002|Overall Study|Subject had scheduling issues|0|||
125231526|NCT00833755|450476437|FG003|Overall Study|Subject had scheduling issues|0|||
125231527|NCT01776554|450476441|FG000|Overall Study|Adverse Event|1|||
125231528|NCT01776554|450476442|FG001|Overall Study|Adverse Event|0|||
125231529|NCT01776554|450476441|FG000|Overall Study|Withdrawal by Subject|3|||
125231530|NCT01776554|450476442|FG001|Overall Study|Withdrawal by Subject|8|||
125231531|NCT01776554|450476441|FG000|Overall Study|Lost to Follow-up|6|||
125231532|NCT01776554|450476442|FG001|Overall Study|Lost to Follow-up|9|||
125231533|NCT01776554|450476441|FG000|Overall Study|Administrative Reason|2|||
125231534|NCT01776554|450476442|FG001|Overall Study|Administrative Reason|5|||
125231535|NCT01776554|450476441|FG000|Overall Study|Protocol Violation|1|||
125231536|NCT01776554|450476442|FG001|Overall Study|Protocol Violation|0|||
125231537|NCT01776554|450476441|FG000|Overall Study|Unclassified|4|||
125231538|NCT01776554|450476442|FG001|Overall Study|Unclassified|1|||
125231539|NCT02908347|450476446|FG000|Overall Study|Adverse Event|0|||
125231540|NCT02908347|450476447|FG001|Overall Study|Adverse Event|1|||
125231541|NCT02908347|450476446|FG000|Overall Study|Lost to Follow-up|1|||
125231542|NCT02908347|450476447|FG001|Overall Study|Lost to Follow-up|0|||
125231543|NCT03087058|450476453|FG000|Overall Study|Withdrawal by Subject|2|||
125231544|NCT03087058|450476454|FG001|Overall Study|Withdrawal by Subject|0|||
125231545|NCT03087058|450476455|FG002|Overall Study|Withdrawal by Subject|0|||
125231546|NCT02577029|450476456|FG000|Overall Study|Adverse Event|1|||
125231547|NCT02577029|450476457|FG001|Overall Study|Adverse Event|0|||
125231548|NCT02577029|450476458|FG002|Overall Study|Adverse Event|2|||
125231549|NCT02577029|450476459|FG003|Overall Study|Adverse Event|0|||
125231550|NCT02577029|450476460|FG004|Overall Study|Adverse Event|1|||
125231551|NCT02577029|450476461|FG005|Overall Study|Adverse Event|0|||
125231552|NCT02577029|450476462|FG006|Overall Study|Adverse Event|0|||
125231553|NCT02577029|450476463|FG007|Overall Study|Adverse Event|0|||
125231554|NCT02577029|450476456|FG000|Overall Study|Withdrawal by Subject|0|||
125231555|NCT02577029|450476457|FG001|Overall Study|Withdrawal by Subject|0|||
125231556|NCT02577029|450476458|FG002|Overall Study|Withdrawal by Subject|0|||
125231557|NCT02577029|450476459|FG003|Overall Study|Withdrawal by Subject|0|||
125231558|NCT02577029|450476460|FG004|Overall Study|Withdrawal by Subject|0|||
125231559|NCT02577029|450476461|FG005|Overall Study|Withdrawal by Subject|1|||
125231560|NCT02577029|450476462|FG006|Overall Study|Withdrawal by Subject|0|||
125231561|NCT02577029|450476463|FG007|Overall Study|Withdrawal by Subject|0|||
125231562|NCT02577029|450476456|FG000|Overall Study|Sponsor Termination of the Study|9|||
125231563|NCT02577029|450476457|FG001|Overall Study|Sponsor Termination of the Study|2|||
125231564|NCT02577029|450476458|FG002|Overall Study|Sponsor Termination of the Study|5|||
125231565|NCT02577029|450476459|FG003|Overall Study|Sponsor Termination of the Study|12|||
125231566|NCT02577029|450476460|FG004|Overall Study|Sponsor Termination of the Study|10|||
125231567|NCT02577029|450476461|FG005|Overall Study|Sponsor Termination of the Study|12|||
125231568|NCT02577029|450476462|FG006|Overall Study|Sponsor Termination of the Study|12|||
125231569|NCT02577029|450476463|FG007|Overall Study|Sponsor Termination of the Study|12|||
125231570|NCT02078817|450476464|FG000|Overall Study|Withdrawal by Subject|1|||
125231571|NCT01420536|450476465|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
125231572|NCT01420536|450476466|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
125231573|NCT03054428|450476467|FG000|Overall Study|Physician Decision|0|||
125231574|NCT03054428|450476468|FG001|Overall Study|Physician Decision|1|||
125231575|NCT03054428|450476469|FG002|Overall Study|Physician Decision|1|||
125231576|NCT03054428|450476467|FG000|Overall Study|Lack of Efficacy|3|||
125231577|NCT03054428|450476468|FG001|Overall Study|Lack of Efficacy|1|||
125231578|NCT03054428|450476469|FG002|Overall Study|Lack of Efficacy|0|||
125231579|NCT03054428|450476467|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
125231580|NCT03054428|450476468|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
125231581|NCT03054428|450476469|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
125231582|NCT03054428|450476467|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
125231583|NCT03054428|450476468|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
125231584|NCT03054428|450476469|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
125231585|NCT03054428|450476467|FG000|Overall Study|Transitioned to OLE study|76|||
125231586|NCT03054428|450476468|FG001|Overall Study|Transitioned to OLE study|76|||
125231587|NCT03054428|450476469|FG002|Overall Study|Transitioned to OLE study|73|||
125231588|NCT03054428|450476467|FG000|Overall Study|Withdrawal by Subject|3|||
125231589|NCT03054428|450476468|FG001|Overall Study|Withdrawal by Subject|2|||
125231590|NCT03054428|450476469|FG002|Overall Study|Withdrawal by Subject|3|||
125231591|NCT03054428|450476467|FG000|Overall Study|Lost to Follow-up|0|||
125231592|NCT03054428|450476468|FG001|Overall Study|Lost to Follow-up|0|||
125231593|NCT03054428|450476469|FG002|Overall Study|Lost to Follow-up|1|||
125231594|NCT01652690|450476471|FG000|Overall Study|Withdrawal by Subject|16|||
125231595|NCT01652690|450476472|FG001|Overall Study|Withdrawal by Subject|4|||
125231596|NCT01652690|450476471|FG000|Overall Study|Other|8|||
125231597|NCT01652690|450476472|FG001|Overall Study|Other|9|||
125231598|NCT01652690|450476471|FG000|Overall Study|Lost to Follow-up|6|||
125231599|NCT01652690|450476472|FG001|Overall Study|Lost to Follow-up|6|||
125231600|NCT01652690|450476471|FG000|Overall Study|Death|5|||
125231601|NCT01652690|450476472|FG001|Overall Study|Death|2|||
125231602|NCT03415178|450476473|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
125231603|NCT03415178|450476474|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
125231604|NCT03415178|450476473|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
125231605|NCT03415178|450476474|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
125231606|NCT01884597|450476475|FG000|Overall Study|Adverse Event|0|||
125231607|NCT01884597|450476476|FG001|Overall Study|Adverse Event|0|||
125231608|NCT01884597|450476477|FG002|Overall Study|Adverse Event|1|||
125231609|NCT01884597|450476475|FG000|Overall Study|Lack of Efficacy|1|||
125231610|NCT01884597|450476476|FG001|Overall Study|Lack of Efficacy|0|||
125231611|NCT01884597|450476477|FG002|Overall Study|Lack of Efficacy|0|||
125231612|NCT01884597|450476475|FG000|Overall Study|Death|0|||
125231613|NCT01884597|450476476|FG001|Overall Study|Death|1|||
125231614|NCT01884597|450476477|FG002|Overall Study|Death|0|||
125231615|NCT02097823|450476478|FG000|Overall Study|Withdrawal by Subject|1|||
125231616|NCT02097823|450476479|FG001|Overall Study|Withdrawal by Subject|1|||
125231617|NCT03082729|450476481|FG000|Overall Study|Lost to Follow-up|7|||
125231618|NCT03082729|450476481|FG000|Overall Study|Physician Decision|2|||
125231619|NCT03082729|450476481|FG000|Overall Study|Withdrawal by Subject|1|||
125231620|NCT03082729|450476481|FG000|Overall Study|Lack of Efficacy|9|||
125231621|NCT03082729|450476481|FG000|Overall Study|Adverse Event|4|||
125231622|NCT03082729|450476481|FG000|Overall Study|Protocol Violation|6|||
125231623|NCT03082729|450476481|FG000|Overall Study|Fear of study procedure|1|||
125231624|NCT03082729|450476481|FG000|Overall Study|Scheduling conflict|1|||
125231625|NCT00753519|450477987|FG000|Overall Study|Withdrawal by Subject|0|||
125231626|NCT00753519|450477988|FG001|Overall Study|Withdrawal by Subject|2|||
125231627|NCT00959751|450477989|FG000|Overall Study|Lost to Follow-up|2|||
125231628|NCT00959751|450477990|FG001|Overall Study|Lost to Follow-up|3|||
125231629|NCT00959751|450477989|FG000|Overall Study|Consent Withdrawn|0|||
125231630|NCT00959751|450477990|FG001|Overall Study|Consent Withdrawn|1|||
125231631|NCT00959751|450477989|FG000|Overall Study|Non-compliance to Study Procedures|0|||
125231632|NCT00959751|450477990|FG001|Overall Study|Non-compliance to Study Procedures|1|||
125231633|NCT00959751|450477989|FG000|Overall Study|No migraine headache without aura|7|||
125231634|NCT00959751|450477990|FG001|Overall Study|No migraine headache without aura|7|||
125231635|NCT00434252|450477991|FG000|Overall Study|Lack of Efficacy|50|||
125231636|NCT00434252|450477992|FG001|Overall Study|Lack of Efficacy|100|||
125231637|NCT00434252|450477991|FG000|Overall Study|Adverse Event|6|||
125231638|NCT00434252|450477992|FG001|Overall Study|Adverse Event|13|||
125231639|NCT00434252|450477991|FG000|Overall Study|Death|1|||
125231640|NCT00434252|450477992|FG001|Overall Study|Death|2|||
125231641|NCT00434252|450477991|FG000|Overall Study|Lost to Follow-up|0|||
125231642|NCT00434252|450477992|FG001|Overall Study|Lost to Follow-up|1|||
125231643|NCT00434252|450477991|FG000|Overall Study|Physician Decision|4|||
125231644|NCT00434252|450477992|FG001|Overall Study|Physician Decision|8|||
125231645|NCT00434252|450477991|FG000|Overall Study|Withdrawal by Subject|3|||
125231646|NCT00434252|450477992|FG001|Overall Study|Withdrawal by Subject|7|||
125231647|NCT02807259|450477993|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
125231648|NCT02807259|450477994|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
125231649|NCT02807259|450477993|FG000|Midline (3 Months)|migration, refusal, not available|30|||
125231650|NCT02807259|450477994|FG001|Midline (3 Months)|migration, refusal, not available|34|||
125231651|NCT02807259|450477993|FG000|Endline (3 Months)|migration, refusal, not available|35|||
125231652|NCT02807259|450477994|FG001|Endline (3 Months)|migration, refusal, not available|87|||
125231653|NCT03861039|450477995|FG000|Overall Study|Adverse Event|2|||
125231654|NCT03861039|450477996|FG001|Overall Study|Adverse Event|5|||
125231655|NCT03861039|450477997|FG002|Overall Study|Adverse Event|11|||
125231656|NCT03861039|450477995|FG000|Overall Study|Withdrawal by Subject|1|||
125231657|NCT03861039|450477996|FG001|Overall Study|Withdrawal by Subject|3|||
125231658|NCT03861039|450477997|FG002|Overall Study|Withdrawal by Subject|4|||
125231659|NCT01673386|450477998|FG000|Overall Study|Study terminated by sponsor|16|||
125231660|NCT01673386|450477999|FG001|Overall Study|Study terminated by sponsor|22|||
125231661|NCT01673386|450477998|FG000|Overall Study|Adverse Event|5|||
125231662|NCT01673386|450477999|FG001|Overall Study|Adverse Event|2|||
125231663|NCT01673386|450477998|FG000|Overall Study|Progressive disease|4|||
125231664|NCT01673386|450477999|FG001|Overall Study|Progressive disease|1|||
125231665|NCT01673386|450477998|FG000|Overall Study|Withdrawal by Subject|0|||
125231666|NCT01673386|450477999|FG001|Overall Study|Withdrawal by Subject|2|||
125231667|NCT02934178|450478000|FG000|Received Vaccination 2|Death|0|||
125231668|NCT02934178|450478001|FG001|Received Vaccination 2|Death|1|||
125231669|NCT02934178|450478000|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
125231670|NCT02934178|450478001|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
125231671|NCT01898078|450478005|FG000|Overall Study|Progressive Disease|1|||
125231672|NCT01898078|450478006|FG001|Overall Study|Progressive Disease|5|||
125231673|NCT01898078|450478005|FG000|Overall Study|Adverse Event|2|||
125231674|NCT01898078|450478006|FG001|Overall Study|Adverse Event|1|||
125231675|NCT01898078|450478005|FG000|Overall Study|Withdrawal by Subject|1|||
125231676|NCT01898078|450478006|FG001|Overall Study|Withdrawal by Subject|1|||
125231677|NCT01898078|450478005|FG000|Overall Study|Symptomatic Deterioration|2|||
125231678|NCT01898078|450478006|FG001|Overall Study|Symptomatic Deterioration|0|||
125231679|NCT01898078|450478005|FG000|Overall Study|Reason not Specified|0|||
125231680|NCT01898078|450478006|FG001|Overall Study|Reason not Specified|1|||
125231681|NCT01140906|450478007|FG000|Overall Study|Adverse Event|7|||
125231682|NCT01140906|450478008|FG001|Overall Study|Adverse Event|10|||
125231683|NCT01140906|450478009|FG002|Overall Study|Adverse Event|17|||
125231684|NCT01140906|450478010|FG003|Overall Study|Adverse Event|7|||
125231685|NCT01140906|450478007|FG000|Overall Study|Lack of Efficacy|6|||
125231686|NCT01140906|450478008|FG001|Overall Study|Lack of Efficacy|8|||
125231687|NCT01140906|450478009|FG002|Overall Study|Lack of Efficacy|2|||
125231688|NCT01140906|450478010|FG003|Overall Study|Lack of Efficacy|1|||
125231689|NCT01140906|450478007|FG000|Overall Study|Non-compliance|0|||
125231690|NCT01140906|450478008|FG001|Overall Study|Non-compliance|1|||
125231691|NCT01140906|450478009|FG002|Overall Study|Non-compliance|0|||
125231692|NCT01140906|450478010|FG003|Overall Study|Non-compliance|1|||
125231693|NCT01140906|450478007|FG000|Overall Study|Protocol Violation|5|||
125231694|NCT01140906|450478008|FG001|Overall Study|Protocol Violation|3|||
125231695|NCT01140906|450478009|FG002|Overall Study|Protocol Violation|2|||
125231696|NCT01140906|450478010|FG003|Overall Study|Protocol Violation|1|||
125231697|NCT01140906|450478007|FG000|Overall Study|Withdrawal of consent|6|||
125231698|NCT01140906|450478008|FG001|Overall Study|Withdrawal of consent|6|||
125231699|NCT01140906|450478009|FG002|Overall Study|Withdrawal of consent|2|||
125231700|NCT01140906|450478010|FG003|Overall Study|Withdrawal of consent|2|||
125231701|NCT01140906|450478007|FG000|Overall Study|Lost to Follow-up|1|||
125231702|NCT01140906|450478008|FG001|Overall Study|Lost to Follow-up|1|||
125231703|NCT01140906|450478009|FG002|Overall Study|Lost to Follow-up|0|||
125231704|NCT01140906|450478010|FG003|Overall Study|Lost to Follow-up|2|||
125231705|NCT01140906|450478007|FG000|Overall Study|Administrative or other reason|0|||
125231706|NCT01140906|450478008|FG001|Overall Study|Administrative or other reason|5|||
125231707|NCT01140906|450478009|FG002|Overall Study|Administrative or other reason|3|||
125231708|NCT01140906|450478010|FG003|Overall Study|Administrative or other reason|2|||
125231709|NCT00703534|450478011|FG000|Overall Study|Adverse Event|14|||
125231710|NCT00703534|450478012|FG001|Overall Study|Adverse Event|3|||
125231711|NCT00703534|450478011|FG000|Overall Study|Withdrawal by Subject|8|||
125231712|NCT00703534|450478012|FG001|Overall Study|Withdrawal by Subject|7|||
125231713|NCT00703534|450478011|FG000|Overall Study|Incorrect Enrollment|6|||
125231714|NCT00703534|450478012|FG001|Overall Study|Incorrect Enrollment|6|||
125231715|NCT00703534|450478011|FG000|Overall Study|Lost to Follow-up|1|||
125231716|NCT00703534|450478012|FG001|Overall Study|Lost to Follow-up|4|||
125231717|NCT00703534|450478011|FG000|Overall Study|Severe Non Compliance|1|||
125231718|NCT00703534|450478012|FG001|Overall Study|Severe Non Compliance|5|||
125231719|NCT00900562|450478013|FG000|Overall Study|Progressive disease|9|||
125231720|NCT00900562|450478014|FG001|Overall Study|Progressive disease|5|||
125231721|NCT00900562|450478013|FG000|Overall Study|Toxicity|1|||
125231722|NCT00900562|450478014|FG001|Overall Study|Toxicity|0|||
125231723|NCT00900562|450478013|FG000|Overall Study|Death|1|||
125231724|NCT00900562|450478014|FG001|Overall Study|Death|1|||
125231725|NCT00900562|450478013|FG000|Overall Study|Withdrawal by Subject|0|||
125231726|NCT00900562|450478014|FG001|Overall Study|Withdrawal by Subject|1|||
125175914|NCT04856930|450263635|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
125175915|NCT04856930|450263636|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
125175916|NCT04856930|450263634|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
125175917|NCT04856930|450263635|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
125175918|NCT04856930|450263636|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
125175919|NCT04856930|450263634|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
125175920|NCT04856930|450263635|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
125175921|NCT04856930|450263636|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
125175922|NCT04856930|450263634|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
125175923|NCT04856930|450263635|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
125175924|NCT04856930|450263636|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
125175925|NCT04856930|450263634|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
125175926|NCT04856930|450263635|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
125175927|NCT04856930|450263636|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
125175928|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
125175929|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
125175930|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
125175931|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
125175932|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
125175933|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
125175934|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
125175935|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
125175936|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
125175937|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
125175938|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
125175939|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
125175940|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
125175941|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
125175942|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
125175943|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
125175944|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
125175945|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
125175946|NCT04856930|450263634|FG000|Extension Period (16 Weeks)|Other than specified|0|||
125175947|NCT04856930|450263635|FG001|Extension Period (16 Weeks)|Other than specified|0|||
125175948|NCT04856930|450263636|FG002|Extension Period (16 Weeks)|Other than specified|1|||
125175949|NCT04856930|450263634|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
125175950|NCT04856930|450263635|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
125175951|NCT04856930|450263636|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
125175952|NCT04856930|450263634|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
125175953|NCT04856930|450263635|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
125175954|NCT04856930|450263636|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
125175955|NCT04856930|450263634|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
125175956|NCT04856930|450263635|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
125175957|NCT04856930|450263636|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
125175958|NCT04856930|450263634|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
125175959|NCT04856930|450263635|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
125175960|NCT04856930|450263636|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
125175961|NCT03965689|450263637|FG000|Overall Study|Too sick to get study intervention|2|||
125175962|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
125175963|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
125175964|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
125175965|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
125175966|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
125175967|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
125175968|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
125175969|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
125175970|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
125175971|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
125175972|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
125175973|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
125175974|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
125175975|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
125175976|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
125175977|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
125175978|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
125175979|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
125231727|NCT00900562|450478013|FG000|Overall Study|Unrelated adverse event|1|||
125231728|NCT00900562|450478014|FG001|Overall Study|Unrelated adverse event|0|||
125231729|NCT03587636|450478015|FG000|Overall Study|Lost to Follow-up|2|||
125231730|NCT03587636|450478016|FG001|Overall Study|Lost to Follow-up|5|||
125175980|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
125175981|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
125175982|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
125175983|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
125175984|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
125175985|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
125175986|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
125175987|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
125175988|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
125175989|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
125175990|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
125175991|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
125175992|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
125175993|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
125175994|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
125175995|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
125175996|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
125175997|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
125175998|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
125175999|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
125176000|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
125176001|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
125176002|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176003|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176004|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176005|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
125176006|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176007|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176008|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176009|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176010|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176011|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
125176012|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
125176013|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
125176014|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
125176015|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
125176016|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
125176017|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
125176018|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
125176019|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
125176020|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
125176021|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
125176022|NCT03104400|450263638|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176023|NCT03104400|450263639|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176024|NCT03104400|450263640|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176025|NCT03104400|450263641|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
125176026|NCT03104400|450263642|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176027|NCT03104400|450263643|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125231731|NCT02665117|450478017|FG000|Overall Study|Physician Decision|1|||
125231732|NCT02665117|450478018|FG001|Overall Study|Physician Decision|0|||
125231733|NCT03743194|450478020|FG000|Overall Study|Protocol Violation|7|||
125231734|NCT03743194|450478021|FG001|Overall Study|Protocol Violation|7|||
125231735|NCT03743194|450478020|FG000|Overall Study|Physician Decision|0|||
125231736|NCT03743194|450478021|FG001|Overall Study|Physician Decision|2|||
125231737|NCT01829347|450478024|FG000|VTI-210|Death|5|||
125231738|NCT01829347|450478025|FG001|VTI-210|Death|3|||
125231739|NCT01829347|450478024|FG000|VTI-210|Withdrawal by Subject|1|||
125176028|NCT03104400|450263644|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125231740|NCT01829347|450478025|FG001|VTI-210|Withdrawal by Subject|0|||
125231741|NCT01829347|450478024|FG000|VTI-210E|Death|2|||
125231742|NCT01829347|450478025|FG001|VTI-210E|Death|1|||
125231743|NCT01829347|450478024|FG000|VTI-210E|Study terminated prematurely|1|||
125176029|NCT03104400|450263645|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176030|NCT03104400|450263646|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176031|NCT03104400|450263647|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
125176032|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
125176033|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
125231744|NCT01829347|450478025|FG001|VTI-210E|Study terminated prematurely|5|||
125392291|NCT01723163|451070620|FG001|6-Month Follow-up|Unable to Contact|15|||
125231745|NCT02152007|450478037|FG000|Overall Study|Withdrawal by Subject|1|||
125231746|NCT01302899|450478040|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
125392292|NCT01723163|451070619|FG000|12-Month Follow-up|Death|1|||
125176034|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
125176035|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
125176036|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
125176037|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
125176038|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
125176039|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
125176040|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
125176041|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
125176042|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
125176043|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
125176044|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
125176045|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
125176046|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
125176047|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
125176048|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
125176049|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
125176050|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
125176051|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
125176052|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
125176053|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
125176054|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
125176055|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
125176056|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
125176057|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
125176058|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
125176059|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
125176060|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
125176061|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
125176062|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
125176063|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
125176064|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
125231747|NCT01302899|450478041|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
125231748|NCT01302899|450478040|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
125231749|NCT01302899|450478041|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
125231750|NCT02834975|450478042|FG000|Overall Study|Physician Decision|2|||
125231751|NCT02834975|450478042|FG000|Overall Study|Adverse Event|1|||
125231752|NCT02834975|450478042|FG000|Overall Study|Withdrawal by Subject|1|||
125231753|NCT02834975|450478042|FG000|Overall Study|Lack of Efficacy|1|||
125231754|NCT03558516|450478044|FG000|Overall Study|Protocol Violation|2|||
125231755|NCT03558516|450478045|FG001|Overall Study|Protocol Violation|2|||
125231756|NCT03363906|450478046|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
125231757|NCT03363906|450478047|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
125231758|NCT03363906|450478046|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
125231759|NCT03363906|450478047|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
125231760|NCT03363906|450478046|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
125231761|NCT03363906|450478047|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
125231762|NCT03363906|450478046|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
125231763|NCT03363906|450478047|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
125231764|NCT00676143|450478048|FG000|Overall Study|Adverse Event|34|||
125231765|NCT00676143|450478049|FG001|Overall Study|Adverse Event|60|||
125231766|NCT00676143|450478048|FG000|Overall Study|Death|4|||
125231767|NCT00676143|450478049|FG001|Overall Study|Death|4|||
125231768|NCT00676143|450478048|FG000|Overall Study|Lack of Efficacy|0|||
125231769|NCT00676143|450478049|FG001|Overall Study|Lack of Efficacy|6|||
125231770|NCT00676143|450478048|FG000|Overall Study|Lost to Follow-up|0|||
125231771|NCT00676143|450478049|FG001|Overall Study|Lost to Follow-up|13|||
125392293|NCT01723163|451070620|FG001|12-Month Follow-up|Death|0|||
125392294|NCT01723163|451070619|FG000|12-Month Follow-up|Unable to Contact|23|||
125176065|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
125176066|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
125392295|NCT01723163|451070620|FG001|12-Month Follow-up|Unable to Contact|28|||
125176067|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
125176068|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
125231772|NCT00676143|450478048|FG000|Overall Study|Physician Decision|5|||
125231773|NCT00676143|450478049|FG001|Overall Study|Physician Decision|8|||
125231774|NCT00676143|450478048|FG000|Overall Study|Protocol Violation|4|||
125176069|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
125176070|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
125392296|NCT01859507|451070623|FG000|Overall Study|left the country|4|||
125231775|NCT00676143|450478049|FG001|Overall Study|Protocol Violation|8|||
125231776|NCT00676143|450478048|FG000|Overall Study|Withdrawal by Subject|24|||
125231777|NCT00676143|450478049|FG001|Overall Study|Withdrawal by Subject|42|||
125231778|NCT00676143|450478048|FG000|Overall Study|Discontinuation of study by sponsor|65|||
125231779|NCT00676143|450478049|FG001|Overall Study|Discontinuation of study by sponsor|88|||
125392297|NCT01921829|451070624|FG000|Overall Study|Withdrawal by Subject|0|||
125231780|NCT00676143|450478048|FG000|Overall Study|Failed to return|2|||
125231781|NCT00676143|450478049|FG001|Overall Study|Failed to return|1|||
125231782|NCT00676143|450478048|FG000|Overall Study|Loss of caregiver|5|||
125231783|NCT00676143|450478049|FG001|Overall Study|Loss of caregiver|3|||
125231784|NCT00676143|450478048|FG000|Overall Study|Other|11|||
125231785|NCT00676143|450478049|FG001|Overall Study|Other|20|||
125231786|NCT00676143|450478048|FG000|Overall Study|Participant participation unknown|1|||
125231787|NCT00676143|450478049|FG001|Overall Study|Participant participation unknown|4|||
125231788|NCT00676143|450478048|FG000|Overall Study|Vasogenic edema recurrence|1|||
125231789|NCT00676143|450478049|FG001|Overall Study|Vasogenic edema recurrence|3|||
125231790|NCT00929669|450478050|FG000|Overall Study|elevated glucose levels|1|||
125231791|NCT02714153|450478052|FG000|Overall Study|Death|1|||
125231792|NCT02065557|450478056|FG000|Induction Period|Withdrawal by Subject|2|||
125231793|NCT02065557|450478057|FG001|Induction Period|Withdrawal by Subject|1|||
125231794|NCT02065557|450478058|FG002|Induction Period|Withdrawal by Subject|0|||
125231795|NCT02065557|450478059|FG003|Induction Period|Withdrawal by Subject|0|||
125231796|NCT02065557|450478060|FG004|Induction Period|Withdrawal by Subject|0|||
125231797|NCT02065557|450478061|FG005|Induction Period|Withdrawal by Subject|0|||
125231798|NCT02065557|450478056|FG000|Induction Period|Lack of Efficacy|2|||
125231799|NCT02065557|450478057|FG001|Induction Period|Lack of Efficacy|1|||
125231800|NCT02065557|450478058|FG002|Induction Period|Lack of Efficacy|1|||
125231801|NCT02065557|450478059|FG003|Induction Period|Lack of Efficacy|0|||
125231802|NCT02065557|450478060|FG004|Induction Period|Lack of Efficacy|0|||
125231803|NCT02065557|450478061|FG005|Induction Period|Lack of Efficacy|0|||
125231804|NCT02065557|450478056|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
125231805|NCT02065557|450478057|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
125231806|NCT02065557|450478058|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
125231807|NCT02065557|450478059|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
125231808|NCT02065557|450478060|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
125231809|NCT02065557|450478061|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
125231810|NCT02065557|450478056|FG000|Induction Period|Non-Responder at Week 8|4|||
125231811|NCT02065557|450478057|FG001|Induction Period|Non-Responder at Week 8|4|||
125231812|NCT02065557|450478058|FG002|Induction Period|Non-Responder at Week 8|0|||
125231813|NCT02065557|450478059|FG003|Induction Period|Non-Responder at Week 8|0|||
125231814|NCT02065557|450478060|FG004|Induction Period|Non-Responder at Week 8|0|||
125231815|NCT02065557|450478061|FG005|Induction Period|Non-Responder at Week 8|0|||
125231816|NCT02065557|450478056|FG000|Induction Period|Adverse Event|1|||
125231817|NCT02065557|450478057|FG001|Induction Period|Adverse Event|1|||
125231818|NCT02065557|450478058|FG002|Induction Period|Adverse Event|0|||
125231819|NCT02065557|450478059|FG003|Induction Period|Adverse Event|0|||
125231820|NCT02065557|450478060|FG004|Induction Period|Adverse Event|0|||
125231821|NCT02065557|450478061|FG005|Induction Period|Adverse Event|0|||
125231822|NCT02065557|450478056|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
125231823|NCT02065557|450478057|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
125231824|NCT02065557|450478058|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
125231825|NCT02065557|450478059|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
125231826|NCT02065557|450478060|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
125231827|NCT02065557|450478061|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
125231828|NCT02065557|450478056|FG000|Maintenance Period|Withdrawal by Subject|0|||
125231829|NCT02065557|450478057|FG001|Maintenance Period|Withdrawal by Subject|0|||
125231830|NCT02065557|450478058|FG002|Maintenance Period|Withdrawal by Subject|0|||
125231831|NCT02065557|450478059|FG003|Maintenance Period|Withdrawal by Subject|0|||
125231832|NCT02065557|450478060|FG004|Maintenance Period|Withdrawal by Subject|2|||
125231833|NCT02065557|450478061|FG005|Maintenance Period|Withdrawal by Subject|1|||
125231834|NCT02065557|450478056|FG000|Maintenance Period|Lack of Efficacy|0|||
125231835|NCT02065557|450478057|FG001|Maintenance Period|Lack of Efficacy|0|||
125231836|NCT02065557|450478058|FG002|Maintenance Period|Lack of Efficacy|0|||
125231837|NCT02065557|450478059|FG003|Maintenance Period|Lack of Efficacy|0|||
125231838|NCT02065557|450478060|FG004|Maintenance Period|Lack of Efficacy|5|||
125231839|NCT02065557|450478061|FG005|Maintenance Period|Lack of Efficacy|2|||
125231840|NCT02065557|450478056|FG000|Maintenance Period|Subject Non-Compliance|0|||
125231841|NCT02065557|450478057|FG001|Maintenance Period|Subject Non-Compliance|0|||
125231842|NCT02065557|450478058|FG002|Maintenance Period|Subject Non-Compliance|0|||
125231843|NCT02065557|450478059|FG003|Maintenance Period|Subject Non-Compliance|0|||
125231844|NCT02065557|450478060|FG004|Maintenance Period|Subject Non-Compliance|0|||
125231845|NCT02065557|450478061|FG005|Maintenance Period|Subject Non-Compliance|1|||
125231846|NCT00250588|450478062|FG000|Overall Study|Withdrawal by Subject|3|||
125231847|NCT00250588|450478063|FG001|Overall Study|Withdrawal by Subject|6|||
125231848|NCT00250588|450478064|FG002|Overall Study|Withdrawal by Subject|0|||
125231849|NCT00250588|450478062|FG000|Overall Study|Lost to Follow-up|6|||
125231850|NCT00250588|450478063|FG001|Overall Study|Lost to Follow-up|13|||
125231851|NCT00250588|450478064|FG002|Overall Study|Lost to Follow-up|13|||
125231852|NCT00706797|450478065|FG000|Overall Study|Lack of Efficacy|3|||
125231853|NCT00706797|450478066|FG001|Overall Study|Lack of Efficacy|0|||
125231854|NCT00706797|450478065|FG000|Overall Study|Adverse Event|0|||
125231855|NCT00706797|450478066|FG001|Overall Study|Adverse Event|3|||
125231856|NCT00706797|450478065|FG000|Overall Study|Withdrawal by Subject|8|||
125231857|NCT00706797|450478066|FG001|Overall Study|Withdrawal by Subject|1|||
125231858|NCT00706797|450478065|FG000|Overall Study|Death|1|||
125231859|NCT00706797|450478066|FG001|Overall Study|Death|0|||
125231860|NCT00706797|450478065|FG000|Overall Study|Discontinuation of study by sponsor|52|||
125231861|NCT00706797|450478066|FG001|Overall Study|Discontinuation of study by sponsor|63|||
125231862|NCT00706797|450478065|FG000|Overall Study|Protocol Violation|3|||
125231863|NCT00706797|450478066|FG001|Overall Study|Protocol Violation|2|||
125231864|NCT00706797|450478065|FG000|Overall Study|Lost to Follow-up|1|||
125231865|NCT00706797|450478066|FG001|Overall Study|Lost to Follow-up|2|||
125231866|NCT00706797|450478065|FG000|Overall Study|Other|1|||
125231867|NCT00706797|450478066|FG001|Overall Study|Other|0|||
125231868|NCT00485303|450478069|FG000|Overall Study|Adverse Event|5|||
125231869|NCT00485303|450478069|FG000|Overall Study|Progressive Disease|44|||
125231870|NCT00485303|450478069|FG000|Overall Study|Other|3|||
125231871|NCT00485303|450478069|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
125231872|NCT00485303|450478069|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
125231873|NCT00112957|450478078|FG000|Overall Study|Progressive disease|18|||
125231874|NCT00112957|450478078|FG000|Overall Study|Physician Decision|1|||
125231875|NCT02309359|450478081|FG000|Overall Study|Adverse Event|4|||
125231876|NCT02309359|450478082|FG001|Overall Study|Adverse Event|5|||
125231877|NCT02309359|450478083|FG002|Overall Study|Adverse Event|5|||
125231878|NCT02309359|450478084|FG003|Overall Study|Adverse Event|4|||
125231879|NCT02309359|450478085|FG004|Overall Study|Adverse Event|4|||
125231880|NCT02309359|450478081|FG000|Overall Study|Death|1|||
125231881|NCT02309359|450478082|FG001|Overall Study|Death|0|||
125231882|NCT02309359|450478083|FG002|Overall Study|Death|0|||
125231883|NCT02309359|450478084|FG003|Overall Study|Death|0|||
125231884|NCT02309359|450478085|FG004|Overall Study|Death|0|||
125231885|NCT02309359|450478081|FG000|Overall Study|Withdrawal by Subject|2|||
125231886|NCT02309359|450478082|FG001|Overall Study|Withdrawal by Subject|2|||
125231887|NCT02309359|450478083|FG002|Overall Study|Withdrawal by Subject|4|||
125231888|NCT02309359|450478084|FG003|Overall Study|Withdrawal by Subject|4|||
125231889|NCT02309359|450478085|FG004|Overall Study|Withdrawal by Subject|0|||
125231890|NCT02309359|450478081|FG000|Overall Study|Lack of Efficacy|3|||
125231891|NCT02309359|450478082|FG001|Overall Study|Lack of Efficacy|1|||
125231892|NCT02309359|450478083|FG002|Overall Study|Lack of Efficacy|0|||
125231893|NCT02309359|450478084|FG003|Overall Study|Lack of Efficacy|0|||
125231894|NCT02309359|450478085|FG004|Overall Study|Lack of Efficacy|3|||
125231895|NCT02309359|450478081|FG000|Overall Study|Lost to Follow-up|0|||
125231896|NCT02309359|450478082|FG001|Overall Study|Lost to Follow-up|0|||
125231897|NCT02309359|450478083|FG002|Overall Study|Lost to Follow-up|0|||
125231898|NCT02309359|450478084|FG003|Overall Study|Lost to Follow-up|1|||
125231899|NCT02309359|450478085|FG004|Overall Study|Lost to Follow-up|0|||
125231900|NCT02309359|450478081|FG000|Overall Study|Other|2|||
125231901|NCT02309359|450478082|FG001|Overall Study|Other|0|||
125231902|NCT02309359|450478083|FG002|Overall Study|Other|2|||
125231903|NCT02309359|450478084|FG003|Overall Study|Other|3|||
125231904|NCT02309359|450478085|FG004|Overall Study|Other|2|||
125231905|NCT00701363|450478086|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
125231906|NCT00701363|450478087|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
125231907|NCT00701363|450478088|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
125231908|NCT00701363|450478089|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
125231909|NCT00701363|450478086|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
125231910|NCT00701363|450478087|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
125231911|NCT00701363|450478088|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
125231912|NCT00701363|450478089|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
125231913|NCT00701363|450478086|FG000|Treatment Phase 1|Adverse Event|7|||
125231914|NCT00701363|450478087|FG001|Treatment Phase 1|Adverse Event|0|||
125231915|NCT00701363|450478088|FG002|Treatment Phase 1|Adverse Event|0|||
125231916|NCT00701363|450478089|FG003|Treatment Phase 1|Adverse Event|0|||
125231917|NCT00701363|450478086|FG000|Treatment Phase 1|Protocol Violation|1|||
125231918|NCT00701363|450478087|FG001|Treatment Phase 1|Protocol Violation|0|||
125231919|NCT00701363|450478088|FG002|Treatment Phase 1|Protocol Violation|0|||
125231920|NCT00701363|450478089|FG003|Treatment Phase 1|Protocol Violation|0|||
125231921|NCT00701363|450478086|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
125231922|NCT00701363|450478087|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
125231923|NCT00701363|450478088|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
125231924|NCT00701363|450478089|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
125231925|NCT00701363|450478086|FG000|Treatment Phase 1|Lack of Efficacy|1|||
125231926|NCT00701363|450478087|FG001|Treatment Phase 1|Lack of Efficacy|0|||
125231927|NCT00701363|450478088|FG002|Treatment Phase 1|Lack of Efficacy|0|||
125231928|NCT00701363|450478089|FG003|Treatment Phase 1|Lack of Efficacy|0|||
125231929|NCT00701363|450478086|FG000|Treatment Phase 2|Adverse Event|0|||
125231930|NCT00701363|450478087|FG001|Treatment Phase 2|Adverse Event|0|||
125231931|NCT00701363|450478088|FG002|Treatment Phase 2|Adverse Event|1|||
125231932|NCT00701363|450478089|FG003|Treatment Phase 2|Adverse Event|0|||
125231933|NCT00701363|450478086|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
125231934|NCT00701363|450478087|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
125231935|NCT00701363|450478088|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
125231936|NCT00701363|450478089|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
125231937|NCT00863707|450478092|FG000|Overall Study|Randomized, but drug not received|4|||
125231938|NCT00863707|450478093|FG001|Overall Study|Randomized, but drug not received|3|||
125231939|NCT00289276|450478094|FG000|Second Part of FAST Study (Expansion)|Death|0|||
125231940|NCT00289276|450478095|FG001|Second Part of FAST Study (Expansion)|Death|2|||
125231941|NCT00289276|450478094|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
125231942|NCT00289276|450478095|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
125231943|NCT00869960|450478096|FG000|Overall Study|Lost to Follow-up|2|||
125231944|NCT02029417|450478097|FG000|Overall Study|Death|1|||
125231945|NCT02029417|450478097|FG000|Overall Study|Adverse Event|1|||
125231946|NCT02783911|450478098|FG000|Overall Study|Lost to Follow-up|3|||
125231947|NCT02783911|450478099|FG001|Overall Study|Lost to Follow-up|32|||
125231948|NCT01041859|450478102|FG000|Open-Label Titration|Adverse Event|69|||
125231949|NCT01041859|450478103|FG001|Open-Label Titration|Adverse Event|0|||
125231950|NCT01041859|450478104|FG002|Open-Label Titration|Adverse Event|0|||
125231951|NCT01041859|450478102|FG000|Open-Label Titration|Lack of Efficacy|3|||
125231952|NCT01041859|450478103|FG001|Open-Label Titration|Lack of Efficacy|0|||
125231953|NCT01041859|450478104|FG002|Open-Label Titration|Lack of Efficacy|0|||
125231954|NCT01041859|450478102|FG000|Open-Label Titration|Lost to Follow-up|1|||
125231955|NCT01041859|450478103|FG001|Open-Label Titration|Lost to Follow-up|0|||
125231956|NCT01041859|450478104|FG002|Open-Label Titration|Lost to Follow-up|0|||
125231957|NCT01041859|450478102|FG000|Open-Label Titration|Physician Decision|1|||
125231958|NCT01041859|450478103|FG001|Open-Label Titration|Physician Decision|0|||
125231959|NCT01041859|450478104|FG002|Open-Label Titration|Physician Decision|0|||
125231960|NCT01041859|450478102|FG000|Open-Label Titration|Protocol Violation|1|||
125231961|NCT01041859|450478103|FG001|Open-Label Titration|Protocol Violation|0|||
125231962|NCT01041859|450478104|FG002|Open-Label Titration|Protocol Violation|0|||
125231963|NCT01041859|450478102|FG000|Open-Label Titration|Other|7|||
125231964|NCT01041859|450478103|FG001|Open-Label Titration|Other|0|||
125231965|NCT01041859|450478104|FG002|Open-Label Titration|Other|0|||
125231966|NCT01041859|450478102|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
125231967|NCT01041859|450478103|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
125231968|NCT01041859|450478104|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
125231969|NCT01041859|450478102|FG000|Open-Label Titration|Withdrawal by Subject|11|||
125231970|NCT01041859|450478103|FG001|Open-Label Titration|Withdrawal by Subject|0|||
125231971|NCT01041859|450478104|FG002|Open-Label Titration|Withdrawal by Subject|0|||
125231972|NCT01041859|450478102|FG000|Double-Blind Maintenance|Adverse Event|0|||
125231973|NCT01041859|450478103|FG001|Double-Blind Maintenance|Adverse Event|23|||
125231974|NCT01041859|450478104|FG002|Double-Blind Maintenance|Adverse Event|13|||
125231975|NCT01041859|450478102|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
125231976|NCT01041859|450478103|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
125231977|NCT01041859|450478104|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
125231978|NCT01041859|450478102|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
125231979|NCT01041859|450478103|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
125231980|NCT01041859|450478104|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
125231981|NCT01041859|450478102|FG000|Double-Blind Maintenance|Physician Decision|0|||
125231982|NCT01041859|450478103|FG001|Double-Blind Maintenance|Physician Decision|2|||
125231983|NCT01041859|450478104|FG002|Double-Blind Maintenance|Physician Decision|1|||
125231984|NCT01041859|450478102|FG000|Double-Blind Maintenance|Protocol Violation|0|||
125231985|NCT01041859|450478103|FG001|Double-Blind Maintenance|Protocol Violation|1|||
125231986|NCT01041859|450478104|FG002|Double-Blind Maintenance|Protocol Violation|3|||
125231987|NCT01041859|450478102|FG000|Double-Blind Maintenance|Other|0|||
125231988|NCT01041859|450478103|FG001|Double-Blind Maintenance|Other|6|||
125231989|NCT01041859|450478104|FG002|Double-Blind Maintenance|Other|2|||
125231990|NCT01041859|450478102|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
125231991|NCT01041859|450478103|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
125231992|NCT01041859|450478104|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
125231993|NCT01041859|450478102|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
125231994|NCT01041859|450478103|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
125231995|NCT01041859|450478104|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
125231996|NCT00885118|450478107|FG000|Overall Study|Adverse Event|1|||
125231997|NCT00885118|450478108|FG001|Overall Study|Adverse Event|0|||
125231998|NCT00885118|450478109|FG002|Overall Study|Adverse Event|0|||
125231999|NCT00885118|450478110|FG003|Overall Study|Adverse Event|0|||
125232000|NCT00885118|450478111|FG004|Overall Study|Adverse Event|0|||
125232001|NCT00885118|450478107|FG000|Overall Study|Withdrawal by Subject|0|||
125232002|NCT00885118|450478108|FG001|Overall Study|Withdrawal by Subject|0|||
125232003|NCT00885118|450478109|FG002|Overall Study|Withdrawal by Subject|0|||
125232004|NCT00885118|450478110|FG003|Overall Study|Withdrawal by Subject|0|||
125232005|NCT00885118|450478111|FG004|Overall Study|Withdrawal by Subject|1|||
125232006|NCT00885118|450478107|FG000|Overall Study|Other reason not defined above|0|||
125392298|NCT01921829|451070625|FG001|Overall Study|Withdrawal by Subject|1|||
125392299|NCT04476030|451070626|FG000|Overall Study|Withdrawal by Subject|20|||
125176071|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
125176072|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176073|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176074|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176075|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176076|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176077|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176078|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
125176079|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
125176080|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
125176081|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
125176082|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176083|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176084|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176085|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176086|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176087|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176088|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176089|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
125176090|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
125176091|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
125176092|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
125176093|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
125176094|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
125176095|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
125176096|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
125176097|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
125176098|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
125176099|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
125176100|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
125176101|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
125176102|NCT03104400|450263638|FG000|Period 2 Week 56 - 260)|Other|0|||
125176103|NCT03104400|450263639|FG001|Period 2 Week 56 - 260)|Other|0|||
125176104|NCT03104400|450263640|FG002|Period 2 Week 56 - 260)|Other|0|||
125176105|NCT03104400|450263641|FG003|Period 2 Week 56 - 260)|Other|0|||
125176106|NCT03104400|450263642|FG004|Period 2 Week 56 - 260)|Other|0|||
125176107|NCT03104400|450263643|FG005|Period 2 Week 56 - 260)|Other|0|||
125176108|NCT03104400|450263644|FG006|Period 2 Week 56 - 260)|Other|0|||
125176109|NCT03104400|450263645|FG007|Period 2 Week 56 - 260)|Other|0|||
125176110|NCT03104400|450263646|FG008|Period 2 Week 56 - 260)|Other|1|||
125176111|NCT03104400|450263647|FG009|Period 2 Week 56 - 260)|Other|1|||
125176112|NCT04948333|450263648|FG000|Overall Study|Adverse Event|6|||
125176113|NCT04948333|450263649|FG001|Overall Study|Adverse Event|4|||
125176114|NCT04948333|450263650|FG002|Overall Study|Adverse Event|0|||
125176115|NCT04948333|450263651|FG003|Overall Study|Adverse Event|2|||
125176116|NCT04948333|450263648|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
125176117|NCT04948333|450263649|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125176118|NCT04948333|450263650|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125176119|NCT04948333|450263651|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125176120|NCT04948333|450263648|FG000|Overall Study|Progressive Disease|1|||
125176121|NCT04948333|450263649|FG001|Overall Study|Progressive Disease|5|||
125176122|NCT04948333|450263650|FG002|Overall Study|Progressive Disease|0|||
125176123|NCT04948333|450263651|FG003|Overall Study|Progressive Disease|0|||
125176124|NCT04948333|450263648|FG000|Overall Study|Physician Decision|2|||
125176125|NCT04948333|450263649|FG001|Overall Study|Physician Decision|2|||
125176126|NCT04948333|450263650|FG002|Overall Study|Physician Decision|0|||
125176127|NCT04948333|450263651|FG003|Overall Study|Physician Decision|0|||
125176128|NCT04948333|450263648|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
125176129|NCT04948333|450263649|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
125176130|NCT04948333|450263650|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
125176131|NCT04948333|450263651|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
125176132|NCT04948333|450263648|FG000|Overall Study|Withdrawal by Subject|2|||
125176133|NCT04948333|450263649|FG001|Overall Study|Withdrawal by Subject|0|||
125176134|NCT04948333|450263650|FG002|Overall Study|Withdrawal by Subject|0|||
125176135|NCT04948333|450263651|FG003|Overall Study|Withdrawal by Subject|1|||
125176136|NCT04948333|450263648|FG000|Overall Study|Protocol Violation|0|||
125176137|NCT04948333|450263649|FG001|Overall Study|Protocol Violation|1|||
125176138|NCT04948333|450263650|FG002|Overall Study|Protocol Violation|0|||
125176139|NCT04948333|450263651|FG003|Overall Study|Protocol Violation|0|||
125176140|NCT04948333|450263648|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
125232007|NCT00885118|450478108|FG001|Overall Study|Other reason not defined above|0|||
125392300|NCT04476030|451070627|FG001|Overall Study|Withdrawal by Subject|16|||
125176141|NCT04948333|450263649|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
125176142|NCT04948333|450263650|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
125176143|NCT04948333|450263651|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
125176144|NCT01625988|450263652|FG000|Overall Study|Lost to Follow-up|5|||
125176145|NCT01625988|450263653|FG001|Overall Study|Lost to Follow-up|6|||
125176146|NCT01625988|450263652|FG000|Overall Study|Withdrawal by Subject|8|||
125176147|NCT01625988|450263653|FG001|Overall Study|Withdrawal by Subject|3|||
125176148|NCT01625988|450263652|FG000|Overall Study|Adverse Event|0|||
125176149|NCT01625988|450263653|FG001|Overall Study|Adverse Event|1|||
125176150|NCT01625988|450263652|FG000|Overall Study|Lack of Efficacy|0|||
125176151|NCT01625988|450263653|FG001|Overall Study|Lack of Efficacy|1|||
125176152|NCT01625988|450263652|FG000|Overall Study|Randomized Inappropriately|1|||
125176153|NCT01625988|450263653|FG001|Overall Study|Randomized Inappropriately|0|||
125176154|NCT01625988|450263652|FG000|Overall Study|Protocol Violation|0|||
125176155|NCT01625988|450263653|FG001|Overall Study|Protocol Violation|2|||
125176156|NCT01495702|450263654|FG000|Randomized Phase|Randomized But Not Treated|1|||
125176157|NCT01495702|450263655|FG001|Randomized Phase|Randomized But Not Treated|4|||
125176158|NCT01495702|450263654|FG000|Randomized Phase|Adverse Event|2|||
125176159|NCT01495702|450263655|FG001|Randomized Phase|Adverse Event|2|||
125176160|NCT01495702|450263654|FG000|Randomized Phase|Death|1|||
125176161|NCT01495702|450263655|FG001|Randomized Phase|Death|0|||
125176162|NCT01495702|450263654|FG000|Randomized Phase|Lack of Efficacy|2|||
125176163|NCT01495702|450263655|FG001|Randomized Phase|Lack of Efficacy|0|||
125176164|NCT01495702|450263654|FG000|Randomized Phase|Investigators Discretion|2|||
125176165|NCT01495702|450263655|FG001|Randomized Phase|Investigators Discretion|0|||
125176166|NCT01495702|450263654|FG000|Randomized Phase|Withdrew Consent|10|||
125176167|NCT01495702|450263655|FG001|Randomized Phase|Withdrew Consent|18|||
125176168|NCT01495702|450263654|FG000|Randomized Phase|Lost to Follow-up|4|||
125176169|NCT01495702|450263655|FG001|Randomized Phase|Lost to Follow-up|3|||
125176170|NCT01495702|450263654|FG000|Randomized Phase|Participant Noncompliance|1|||
125176171|NCT01495702|450263655|FG001|Randomized Phase|Participant Noncompliance|0|||
125176172|NCT01495702|450263654|FG000|Randomized Phase|Protocol Violation|3|||
125176173|NCT01495702|450263655|FG001|Randomized Phase|Protocol Violation|1|||
125176174|NCT01644617|450263656|FG000|Overall Study|Withdrawal by Subject|3|||
125176175|NCT01644617|450263657|FG001|Overall Study|Withdrawal by Subject|4|||
125176176|NCT01644617|450263658|FG002|Overall Study|Withdrawal by Subject|1|||
125176177|NCT01644617|450263656|FG000|Overall Study|Lost to Follow-up|0|||
125176178|NCT01644617|450263657|FG001|Overall Study|Lost to Follow-up|1|||
125176179|NCT01644617|450263658|FG002|Overall Study|Lost to Follow-up|0|||
125176180|NCT01644617|450263656|FG000|Overall Study|Adverse Event|3|||
125176181|NCT01644617|450263657|FG001|Overall Study|Adverse Event|0|||
125176182|NCT01644617|450263658|FG002|Overall Study|Adverse Event|6|||
125176183|NCT05246670|450263659|FG000|Overall Study|Withdrawal by Subject|2|||
125176184|NCT05246670|450263660|FG001|Overall Study|Withdrawal by Subject|3|||
125176185|NCT05246670|450263661|FG002|Overall Study|Withdrawal by Subject|0|||
125176186|NCT05246670|450263662|FG003|Overall Study|Withdrawal by Subject|1|||
125176187|NCT05246670|450263659|FG000|Overall Study|Adverse Event|0|||
125176188|NCT05246670|450263660|FG001|Overall Study|Adverse Event|0|||
125176189|NCT05246670|450263661|FG002|Overall Study|Adverse Event|1|||
125176190|NCT05246670|450263662|FG003|Overall Study|Adverse Event|0|||
125176191|NCT05246670|450263659|FG000|Overall Study|Physician Decision|1|||
125176192|NCT05246670|450263660|FG001|Overall Study|Physician Decision|0|||
125176193|NCT05246670|450263661|FG002|Overall Study|Physician Decision|0|||
125176194|NCT05246670|450263662|FG003|Overall Study|Physician Decision|0|||
125176195|NCT05246670|450263659|FG000|Overall Study|Protocol Violation|1|||
125176196|NCT05246670|450263660|FG001|Overall Study|Protocol Violation|0|||
125176197|NCT05246670|450263661|FG002|Overall Study|Protocol Violation|0|||
125176198|NCT05246670|450263662|FG003|Overall Study|Protocol Violation|0|||
125176199|NCT04152291|450263665|FG000|Overall Study|Covid-19 restrictions|27|||
125176200|NCT04152291|450263665|FG000|Overall Study|Withdrawal by Subject|3|||
125176201|NCT05124691|450263666|FG000|Phase II|Eligibility criteria|0|||
125176202|NCT05124691|450263667|FG001|Phase II|Eligibility criteria|1|||
125176203|NCT05124691|450263668|FG002|Phase II|Eligibility criteria|0|||
125392301|NCT04476030|451070626|FG000|Overall Study|Adverse Event|10|||
125392302|NCT04476030|451070627|FG001|Overall Study|Adverse Event|11|||
125176204|NCT05124691|450263666|FG000|Phase II|Withdrawal by Subject|6|||
125176205|NCT05124691|450263667|FG001|Phase II|Withdrawal by Subject|2|||
125176206|NCT05124691|450263668|FG002|Phase II|Withdrawal by Subject|3|||
125176207|NCT05124691|450263666|FG000|Phase III|Withdrawal by Subject|6|||
125176208|NCT05124691|450263667|FG001|Phase III|Withdrawal by Subject|4|||
125176209|NCT05124691|450263668|FG002|Phase III|Withdrawal by Subject|4|||
125176210|NCT05124691|450263666|FG000|Phase III|Lost to Follow-up|1|||
125176211|NCT05124691|450263667|FG001|Phase III|Lost to Follow-up|0|||
125176212|NCT05124691|450263668|FG002|Phase III|Lost to Follow-up|0|||
125176213|NCT03509467|450263669|FG000|Overall Study|Withdrawal by Subject|5|||
125176214|NCT03509467|450263670|FG001|Overall Study|Withdrawal by Subject|1|||
125392303|NCT04476030|451070626|FG000|Overall Study|Lost to Follow-up|7|||
125232008|NCT00885118|450478109|FG002|Overall Study|Other reason not defined above|1|||
125232009|NCT00885118|450478110|FG003|Overall Study|Other reason not defined above|0|||
125232010|NCT00885118|450478111|FG004|Overall Study|Other reason not defined above|0|||
125232011|NCT00666237|450478117|FG000|Overall Study|Death|5|||
125232012|NCT00666237|450478118|FG001|Overall Study|Death|5|||
125232013|NCT00666237|450478117|FG000|Overall Study|Lost to Follow-up|29|||
125232014|NCT00666237|450478118|FG001|Overall Study|Lost to Follow-up|25|||
125232015|NCT03321721|450478119|FG000|Overall Study|Lost to Follow-up|4|||
125232016|NCT03321721|450478120|FG001|Overall Study|Lost to Follow-up|8|||
125232017|NCT03321721|450478121|FG002|Overall Study|Lost to Follow-up|11|||
125232018|NCT01075048|450479678|FG000|Overall Study|Death|4|||
125232019|NCT01075048|450479679|FG001|Overall Study|Death|17|||
125232020|NCT01075048|450479680|FG002|Overall Study|Death|12|||
125232021|NCT01075048|450479678|FG000|Overall Study|Start of other or new therapy|4|||
125232022|NCT01075048|450479679|FG001|Overall Study|Start of other or new therapy|36|||
125232023|NCT01075048|450479680|FG002|Overall Study|Start of other or new therapy|46|||
125232024|NCT01075048|450479678|FG000|Overall Study|Withdrawal by Subject|1|||
125232025|NCT01075048|450479679|FG001|Overall Study|Withdrawal by Subject|6|||
125232026|NCT01075048|450479680|FG002|Overall Study|Withdrawal by Subject|3|||
125232027|NCT01075048|450479678|FG000|Overall Study|Lost to Follow-up|0|||
125232028|NCT01075048|450479679|FG001|Overall Study|Lost to Follow-up|1|||
125232029|NCT01075048|450479680|FG002|Overall Study|Lost to Follow-up|1|||
125232030|NCT01287936|450479684|FG000|Overall Study|Lost to Follow-up|0|||
125232031|NCT01287936|450479685|FG001|Overall Study|Lost to Follow-up|1|||
125232032|NCT01287936|450479686|FG002|Overall Study|Lost to Follow-up|1|||
125232033|NCT02791269|450479687|FG000|Overall Study|Lost to Follow-up|0|||
125232034|NCT02791269|450479688|FG001|Overall Study|Lost to Follow-up|1|||
125232035|NCT00336544|450479689|FG000|Overall Study|Lack of Efficacy|8|||
125232036|NCT00336544|450479690|FG001|Overall Study|Lack of Efficacy|5|||
125232037|NCT00336544|450479689|FG000|Overall Study|Adverse Event|4|||
125232038|NCT00336544|450479690|FG001|Overall Study|Adverse Event|9|||
125232039|NCT00336544|450479689|FG000|Overall Study|Withdrawal by Subject|4|||
125232040|NCT00336544|450479690|FG001|Overall Study|Withdrawal by Subject|3|||
125232041|NCT00336544|450479689|FG000|Overall Study|Other|3|||
125232042|NCT00336544|450479690|FG001|Overall Study|Other|5|||
125232043|NCT01649765|450479691|FG000|Overall Study|Adverse Event|5|||
125232044|NCT01649765|450479692|FG001|Overall Study|Adverse Event|3|||
125232045|NCT01649765|450479691|FG000|Overall Study|Lack of Efficacy|1|||
125232046|NCT01649765|450479692|FG001|Overall Study|Lack of Efficacy|1|||
125232047|NCT01649765|450479691|FG000|Overall Study|Physician Decision|0|||
125232048|NCT01649765|450479692|FG001|Overall Study|Physician Decision|3|||
125232049|NCT01649765|450479691|FG000|Overall Study|Protocol Violation|1|||
125232050|NCT01649765|450479692|FG001|Overall Study|Protocol Violation|0|||
125232051|NCT01649765|450479691|FG000|Overall Study|Withdrawal by Subject|2|||
125232052|NCT01649765|450479692|FG001|Overall Study|Withdrawal by Subject|1|||
125232053|NCT00715208|450479693|FG000|Overall Study|Withdrawal by Subject|1|||
125443405|NCT02555371|451252129|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
125443406|NCT02555371|451252130|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
125232054|NCT00715208|450479694|FG001|Overall Study|Withdrawal by Subject|1|||
125232055|NCT00715208|450479693|FG000|Overall Study|Adverse Event|0|||
125232056|NCT00715208|450479694|FG001|Overall Study|Adverse Event|6|||
125232057|NCT00715208|450479693|FG000|Overall Study|Lack of Efficacy|0|||
125232058|NCT00715208|450479694|FG001|Overall Study|Lack of Efficacy|2|||
125232059|NCT01648764|450479695|FG000|Overall Study|Progressive Disease|0|||
125232060|NCT01648764|450479696|FG001|Overall Study|Progressive Disease|1|||
125232061|NCT01648764|450479697|FG002|Overall Study|Progressive Disease|0|||
125232062|NCT01648764|450479698|FG003|Overall Study|Progressive Disease|0|||
125232063|NCT01648764|450479699|FG004|Overall Study|Progressive Disease|0|||
125232064|NCT01648764|450479700|FG005|Overall Study|Progressive Disease|1|||
125232065|NCT01648764|450479701|FG006|Overall Study|Progressive Disease|1|||
125232066|NCT01648764|450479702|FG007|Overall Study|Progressive Disease|0|||
125232067|NCT01648764|450479703|FG008|Overall Study|Progressive Disease|0|||
125232068|NCT01648764|450479704|FG009|Overall Study|Progressive Disease|2|||
125232069|NCT01648764|450479705|FG010|Overall Study|Progressive Disease|0|||
125232070|NCT01648764|450479706|FG011|Overall Study|Progressive Disease|1|||
125232071|NCT01648764|450479707|FG012|Overall Study|Progressive Disease|2|||
125232072|NCT01648764|450479708|FG013|Overall Study|Progressive Disease|1|||
125232073|NCT01648764|450479695|FG000|Overall Study|Adverse Event|0|||
125232074|NCT01648764|450479696|FG001|Overall Study|Adverse Event|0|||
125232075|NCT01648764|450479697|FG002|Overall Study|Adverse Event|0|||
125232076|NCT01648764|450479698|FG003|Overall Study|Adverse Event|0|||
125232077|NCT01648764|450479699|FG004|Overall Study|Adverse Event|0|||
125232078|NCT01648764|450479700|FG005|Overall Study|Adverse Event|1|||
125232079|NCT01648764|450479701|FG006|Overall Study|Adverse Event|0|||
125232080|NCT01648764|450479702|FG007|Overall Study|Adverse Event|0|||
125232081|NCT01648764|450479703|FG008|Overall Study|Adverse Event|0|||
125232082|NCT01648764|450479704|FG009|Overall Study|Adverse Event|1|||
125232083|NCT01648764|450479705|FG010|Overall Study|Adverse Event|0|||
125232084|NCT01648764|450479706|FG011|Overall Study|Adverse Event|3|||
125232085|NCT01648764|450479707|FG012|Overall Study|Adverse Event|1|||
125232086|NCT01648764|450479708|FG013|Overall Study|Adverse Event|1|||
125232087|NCT01648764|450479695|FG000|Overall Study|Death|0|||
125232088|NCT01648764|450479696|FG001|Overall Study|Death|0|||
125232089|NCT01648764|450479697|FG002|Overall Study|Death|0|||
125232090|NCT01648764|450479698|FG003|Overall Study|Death|0|||
125232091|NCT01648764|450479699|FG004|Overall Study|Death|0|||
125232092|NCT01648764|450479700|FG005|Overall Study|Death|0|||
125232093|NCT01648764|450479701|FG006|Overall Study|Death|1|||
125232094|NCT01648764|450479702|FG007|Overall Study|Death|0|||
125232095|NCT01648764|450479703|FG008|Overall Study|Death|0|||
125232096|NCT01648764|450479704|FG009|Overall Study|Death|0|||
125232097|NCT01648764|450479705|FG010|Overall Study|Death|0|||
125232098|NCT01648764|450479706|FG011|Overall Study|Death|0|||
125232099|NCT01648764|450479707|FG012|Overall Study|Death|0|||
125232100|NCT01648764|450479708|FG013|Overall Study|Death|1|||
125232101|NCT01648764|450479695|FG000|Overall Study|Withdrawal by Subject|0|||
125232102|NCT01648764|450479696|FG001|Overall Study|Withdrawal by Subject|0|||
125232103|NCT01648764|450479697|FG002|Overall Study|Withdrawal by Subject|0|||
125232104|NCT01648764|450479698|FG003|Overall Study|Withdrawal by Subject|0|||
125232105|NCT01648764|450479699|FG004|Overall Study|Withdrawal by Subject|0|||
125232106|NCT01648764|450479700|FG005|Overall Study|Withdrawal by Subject|0|||
125232107|NCT01648764|450479701|FG006|Overall Study|Withdrawal by Subject|2|||
125232108|NCT01648764|450479702|FG007|Overall Study|Withdrawal by Subject|0|||
125232109|NCT01648764|450479703|FG008|Overall Study|Withdrawal by Subject|0|||
125232110|NCT01648764|450479704|FG009|Overall Study|Withdrawal by Subject|0|||
125232111|NCT01648764|450479705|FG010|Overall Study|Withdrawal by Subject|0|||
125232112|NCT01648764|450479706|FG011|Overall Study|Withdrawal by Subject|0|||
125232113|NCT01648764|450479707|FG012|Overall Study|Withdrawal by Subject|1|||
125232114|NCT01648764|450479708|FG013|Overall Study|Withdrawal by Subject|0|||
125232115|NCT01648764|450479695|FG000|Overall Study|Investigator Decision|0|||
125232116|NCT01648764|450479696|FG001|Overall Study|Investigator Decision|0|||
125232117|NCT01648764|450479697|FG002|Overall Study|Investigator Decision|0|||
125232118|NCT01648764|450479698|FG003|Overall Study|Investigator Decision|0|||
125232119|NCT01648764|450479699|FG004|Overall Study|Investigator Decision|0|||
125232120|NCT01648764|450479700|FG005|Overall Study|Investigator Decision|0|||
125232121|NCT01648764|450479701|FG006|Overall Study|Investigator Decision|1|||
125232122|NCT01648764|450479702|FG007|Overall Study|Investigator Decision|0|||
125176215|NCT03509467|450263671|FG002|Overall Study|Withdrawal by Subject|6|||
125176216|NCT03509467|450263672|FG003|Overall Study|Withdrawal by Subject|7|||
125176217|NCT03509467|450263673|FG004|Overall Study|Withdrawal by Subject|10|||
125176218|NCT03509467|450263674|FG005|Overall Study|Withdrawal by Subject|10|||
125176219|NCT03509467|450263675|FG006|Overall Study|Withdrawal by Subject|10|||
125176220|NCT03509467|450263676|FG007|Overall Study|Withdrawal by Subject|10|||
125176221|NCT03509467|450263669|FG000|Overall Study|Death|0|||
125176222|NCT03509467|450263670|FG001|Overall Study|Death|0|||
125176223|NCT03509467|450263671|FG002|Overall Study|Death|2|||
125176224|NCT03509467|450263672|FG003|Overall Study|Death|2|||
125176225|NCT03509467|450263673|FG004|Overall Study|Death|1|||
125176226|NCT03509467|450263674|FG005|Overall Study|Death|0|||
125176227|NCT03509467|450263675|FG006|Overall Study|Death|1|||
125176228|NCT03509467|450263676|FG007|Overall Study|Death|0|||
125176229|NCT03509467|450263669|FG000|Overall Study|Proxy Withdrawal|0|||
125176230|NCT03509467|450263670|FG001|Overall Study|Proxy Withdrawal|0|||
125176231|NCT03509467|450263671|FG002|Overall Study|Proxy Withdrawal|0|||
125176232|NCT03509467|450263672|FG003|Overall Study|Proxy Withdrawal|0|||
125176233|NCT03509467|450263673|FG004|Overall Study|Proxy Withdrawal|0|||
125176234|NCT03509467|450263674|FG005|Overall Study|Proxy Withdrawal|0|||
125176235|NCT03509467|450263675|FG006|Overall Study|Proxy Withdrawal|0|||
125176236|NCT03509467|450263676|FG007|Overall Study|Proxy Withdrawal|1|||
125176237|NCT02829918|450263677|FG000|Overall Study|Death|2|||
125176238|NCT02829918|450263677|FG000|Overall Study|Withdrawal by Subject|4|||
125176239|NCT02829918|450263677|FG000|Overall Study|Adverse Event|1|||
125176240|NCT02829918|450263677|FG000|Overall Study|Progression|1|||
125176241|NCT04223752|450263683|FG000|Overall Study|Participant enrolled in error|0|||
125176242|NCT04223752|450263684|FG001|Overall Study|Participant enrolled in error|0|||
125176243|NCT04223752|450263685|FG002|Overall Study|Participant enrolled in error|0|||
125176244|NCT04223752|450263686|FG003|Overall Study|Participant enrolled in error|0|||
125176245|NCT04223752|450263687|FG004|Overall Study|Participant enrolled in error|1|||
125176246|NCT04223752|450263683|FG000|Overall Study|Death|0|||
125176247|NCT04223752|450263684|FG001|Overall Study|Death|0|||
125176248|NCT04223752|450263685|FG002|Overall Study|Death|0|||
125176249|NCT04223752|450263686|FG003|Overall Study|Death|2|||
125176250|NCT04223752|450263687|FG004|Overall Study|Death|1|||
125176251|NCT04759703|450263688|FG000|Overall Study|Withdrawal by Subject|4|||
125176252|NCT04759703|450263689|FG001|Overall Study|Withdrawal by Subject|9|||
125176253|NCT04759703|450263688|FG000|Overall Study|Adverse Event|1|||
125176254|NCT04759703|450263689|FG001|Overall Study|Adverse Event|0|||
125232123|NCT01648764|450479703|FG008|Overall Study|Investigator Decision|0|||
125232124|NCT01648764|450479704|FG009|Overall Study|Investigator Decision|0|||
125232125|NCT01648764|450479705|FG010|Overall Study|Investigator Decision|0|||
125232126|NCT01648764|450479706|FG011|Overall Study|Investigator Decision|1|||
125232127|NCT01648764|450479707|FG012|Overall Study|Investigator Decision|0|||
125232128|NCT01648764|450479708|FG013|Overall Study|Investigator Decision|0|||
125232129|NCT01316614|450479709|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
125232130|NCT01316614|450479709|FG000|Overall Study|Cytology slides not available for review|4|||
125232131|NCT01316614|450479709|FG000|Overall Study|Cystic lesion|5|||
125232132|NCT01316614|450479709|FG000|Overall Study|Inadequate number of passes|2|||
125232133|NCT01316614|450479709|FG000|Overall Study|Medically unstable|1|||
125232134|NCT03427411|450479710|FG000|Overall Study|Screen failure - platelets too low|0|||
125232135|NCT03427411|450479711|FG001|Overall Study|Screen failure - platelets too low|1|||
125232136|NCT00076570|450479712|FG000|Overall Study|Drug intolerance|8|||
125232137|NCT00076570|450479713|FG001|Overall Study|Drug intolerance|8|||
125232138|NCT04889040|450479714|FG000|Overall Study|Withdrawal by Subject|3|||
125232139|NCT04889040|450479715|FG001|Overall Study|Withdrawal by Subject|3|||
125232140|NCT04889040|450479714|FG000|Overall Study|Lost to Follow-up|0|||
125232141|NCT04889040|450479715|FG001|Overall Study|Lost to Follow-up|1|||
125232142|NCT04889040|450479714|FG000|Overall Study|Adverse Event|2|||
125232143|NCT04889040|450479715|FG001|Overall Study|Adverse Event|1|||
125232144|NCT02058095|450479716|FG000|Overall Study|Adverse Event|1|||
125232145|NCT02058095|450479717|FG001|Overall Study|Adverse Event|0|||
125232146|NCT00998946|450479718|FG000|Overall Study|Lost to Follow-up|1|||
125232147|NCT00998946|450479718|FG000|Overall Study|Withdrawal by Subject|1|||
125232148|NCT00998946|450479718|FG000|Overall Study|Death|2|||
125232149|NCT00998946|450479718|FG000|Overall Study|Reason Unspecified|3|||
125232150|NCT00998946|450479718|FG000|Overall Study|Enrolled but not Dosed|2|||
125232151|NCT00316004|450479721|FG000|Overall Study|Subject was not given study fluid.|14|||
125232152|NCT00316004|450479722|FG001|Overall Study|Subject was not given study fluid.|14|||
125232153|NCT00316004|450479723|FG002|Overall Study|Subject was not given study fluid.|21|||
125232154|NCT00977197|450479726|FG000|Overall Study|Withdrawal by Subject|3|||
125232155|NCT00977197|450479727|FG001|Overall Study|Withdrawal by Subject|4|||
125232156|NCT00977197|450479726|FG000|Overall Study|Adverse Event|3|||
125232157|NCT00977197|450479727|FG001|Overall Study|Adverse Event|1|||
125232158|NCT00977197|450479726|FG000|Overall Study|Lack of Efficacy|1|||
125232159|NCT00977197|450479727|FG001|Overall Study|Lack of Efficacy|0|||
125232160|NCT00977197|450479726|FG000|Overall Study|Lost to Follow-up|1|||
125232161|NCT00977197|450479727|FG001|Overall Study|Lost to Follow-up|3|||
125232162|NCT00977197|450479726|FG000|Overall Study|Nonadherence|1|||
125232163|NCT00977197|450479727|FG001|Overall Study|Nonadherence|1|||
125232164|NCT00784875|450479728|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
125232165|NCT00784875|450479729|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
125232166|NCT00784875|450479730|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
125232167|NCT00784875|450479731|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
125232168|NCT00784875|450479728|FG000|Period A - Baseline|Adverse Event|0|||
125232169|NCT00784875|450479729|FG001|Period A - Baseline|Adverse Event|0|||
125232170|NCT00784875|450479730|FG002|Period A - Baseline|Adverse Event|0|||
125232171|NCT00784875|450479731|FG003|Period A - Baseline|Adverse Event|8|||
125232172|NCT00784875|450479728|FG000|Period A - Baseline|Protocol Violation|0|||
125232173|NCT00784875|450479729|FG001|Period A - Baseline|Protocol Violation|0|||
125232174|NCT00784875|450479730|FG002|Period A - Baseline|Protocol Violation|0|||
125232175|NCT00784875|450479731|FG003|Period A - Baseline|Protocol Violation|25|||
125232176|NCT00784875|450479728|FG000|Period A - Baseline|Withdrawal by Subject|0|||
125232177|NCT00784875|450479729|FG001|Period A - Baseline|Withdrawal by Subject|0|||
125232178|NCT00784875|450479730|FG002|Period A - Baseline|Withdrawal by Subject|0|||
125232179|NCT00784875|450479731|FG003|Period A - Baseline|Withdrawal by Subject|27|||
125176255|NCT04759703|450263688|FG000|Overall Study|Lost to Follow-up|2|||
125176256|NCT04759703|450263689|FG001|Overall Study|Lost to Follow-up|0|||
125176257|NCT04487067|450263701|FG000|Overall Study|Adverse Event|3|||
125176258|NCT04487067|450263701|FG000|Overall Study|Death Other Than Progressive Disease|60|||
125176259|NCT04487067|450263701|FG000|Overall Study|Death Due To Progressive Disease|40|||
125176260|NCT04487067|450263701|FG000|Overall Study|Lost to Follow-up|3|||
125176261|NCT04487067|450263701|FG000|Overall Study|Progressive Disease|1|||
125176262|NCT04487067|450263701|FG000|Overall Study|Protocol Violation|3|||
125176263|NCT04487067|450263701|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
125176264|NCT04487067|450263701|FG000|Overall Study|Withdrawal by Subject|15|||
125176265|NCT04877457|450263702|FG000|Overall Study|Early termination of study due to low enrollment|2|||
125232180|NCT00784875|450479728|FG000|Period A - Baseline|Physician Decision|0|||
125232181|NCT00784875|450479729|FG001|Period A - Baseline|Physician Decision|0|||
125176266|NCT04877457|450263703|FG001|Overall Study|Early termination of study due to low enrollment|1|||
125232182|NCT00784875|450479730|FG002|Period A - Baseline|Physician Decision|0|||
125232183|NCT00784875|450479731|FG003|Period A - Baseline|Physician Decision|2|||
125232184|NCT00784875|450479728|FG000|Period A - Baseline|Sponsor Decision|0|||
125232185|NCT00784875|450479729|FG001|Period A - Baseline|Sponsor Decision|0|||
125232186|NCT00784875|450479730|FG002|Period A - Baseline|Sponsor Decision|0|||
125232187|NCT00784875|450479731|FG003|Period A - Baseline|Sponsor Decision|113|||
125232188|NCT00784875|450479728|FG000|Period A - Baseline|Lost to Follow-up|0|||
125232189|NCT00784875|450479729|FG001|Period A - Baseline|Lost to Follow-up|0|||
125176267|NCT06385483|450263704|FG000|Overall Study|Withdrawal by Subject|2|||
125176268|NCT06385483|450263704|FG000|Overall Study|Never start protocol therapy|2|||
125176269|NCT06385483|450263704|FG000|Overall Study|Disease progression|15|||
125176270|NCT02503787|450263705|FG000|Enrollment|Withdrawal by Subject|6|||
125176271|NCT02503787|450263705|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
125176272|NCT02503787|450263705|FG000|Enrollment|Physician Decision|2|||
125176273|NCT02503787|450263705|FG000|Enrollment|Insurance issue|2|||
125176274|NCT02503787|450263705|FG000|Enrollment|Lost to Follow-up|1|||
125176275|NCT02503787|450263705|FG000|Enrollment|Study closure|1|||
125176276|NCT02503787|450263705|FG000|Enrollment|Adverse Event|1|||
125176277|NCT02503787|450263705|FG000|Enrollment|Protocol Violation|1|||
125176278|NCT02503787|450263705|FG000|Enrollment|Inability to implant system|1|||
125176279|NCT02503787|450263705|FG000|Enrollment|Unable to be programmed|1|||
125176280|NCT02503787|450263705|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
125176281|NCT02503787|450263705|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
125176282|NCT02503787|450263705|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
125176283|NCT02503787|450263705|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
125176284|NCT02503787|450263705|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
125176285|NCT02503787|450263705|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
125176286|NCT04787627|450263706|FG000|Overall Study|Withdrawal by Subject|3|||
125176287|NCT04787627|450263707|FG001|Overall Study|Withdrawal by Subject|0|||
125176288|NCT04787627|450263706|FG000|Overall Study|Physician Decision|2|||
125176289|NCT04787627|450263707|FG001|Overall Study|Physician Decision|0|||
125176290|NCT04787627|450263706|FG000|Overall Study|Excluded|0|||
125176291|NCT04787627|450263707|FG001|Overall Study|Excluded|1|||
125176292|NCT00919854|450263709|FG000|Overall Study|Adverse Event|1|||
125176293|NCT00985491|450263710|FG000|Overall Study|Adverse Event|8|||
125176294|NCT00985491|450263710|FG000|Overall Study|device migration|7|||
125176295|NCT00985491|450263710|FG000|Overall Study|Withdrawal by Subject|1|||
125176296|NCT00985491|450263710|FG000|Overall Study|implant failure|3|||
125176297|NCT00588770|450264409|FG000|Overall Study|Disease progression|85|||
125176298|NCT00588770|450264410|FG001|Overall Study|Disease progression|68|||
125176299|NCT00588770|450264409|FG000|Overall Study|Adverse Event|29|||
125176300|NCT00588770|450264410|FG001|Overall Study|Adverse Event|58|||
125176301|NCT00588770|450264409|FG000|Overall Study|Death|13|||
125176302|NCT00588770|450264410|FG001|Overall Study|Death|22|||
125176303|NCT00588770|450264409|FG000|Overall Study|Withdrawal by Subject|15|||
125176304|NCT00588770|450264410|FG001|Overall Study|Withdrawal by Subject|25|||
125176305|NCT00588770|450264409|FG000|Overall Study|Alternative therapy|2|||
125176306|NCT00588770|450264410|FG001|Overall Study|Alternative therapy|4|||
125176307|NCT00588770|450264409|FG000|Overall Study|Other complicating disease|3|||
125176308|NCT00588770|450264410|FG001|Overall Study|Other complicating disease|2|||
125176309|NCT00588770|450264409|FG000|Overall Study|Not start protocol therapy|0|||
125176310|NCT00588770|450264410|FG001|Overall Study|Not start protocol therapy|9|||
125176311|NCT00588770|450264409|FG000|Overall Study|Lack of Efficacy|8|||
125176312|NCT00588770|450264410|FG001|Overall Study|Lack of Efficacy|10|||
125176313|NCT00588770|450264409|FG000|Overall Study|Physician discretion|2|||
125176314|NCT00588770|450264410|FG001|Overall Study|Physician discretion|0|||
125176315|NCT00588770|450264409|FG000|Overall Study|Patient non-compliance|2|||
125176316|NCT00588770|450264410|FG001|Overall Study|Patient non-compliance|2|||
125176317|NCT03698019|450264411|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
125176318|NCT03698019|450264412|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
125176319|NCT03698019|450264411|FG000|Step 1: Registration|Withdrawal by Subject|7|||
125176320|NCT03698019|450264412|FG001|Step 1: Registration|Withdrawal by Subject|2|||
125176321|NCT03698019|450264411|FG000|Step 1: Registration|Toxicity|0|||
125176322|NCT03698019|450264412|FG001|Step 1: Registration|Toxicity|1|||
125176323|NCT03698019|450264411|FG000|Step 1: Registration|Disease Progression|0|||
125176324|NCT03698019|450264412|FG001|Step 1: Registration|Disease Progression|12|||
125176325|NCT03698019|450264411|FG000|Step 1: Registration|Co-morbidities|0|||
125176326|NCT03698019|450264412|FG001|Step 1: Registration|Co-morbidities|1|||
125176327|NCT03698019|450264411|FG000|Step 1: Registration|Scheduling Issues|1|||
125176328|NCT03698019|450264412|FG001|Step 1: Registration|Scheduling Issues|0|||
125176329|NCT03698019|450264411|FG000|Step 1: Registration|Participant Refusal|0|||
125176330|NCT03698019|450264412|FG001|Step 1: Registration|Participant Refusal|1|||
125176331|NCT03698019|450264411|FG000|Step 2: Surgery|Participant Refusal|2|||
125176332|NCT03698019|450264412|FG001|Step 2: Surgery|Participant Refusal|1|||
125176333|NCT03698019|450264411|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
125176334|NCT03698019|450264412|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
125176335|NCT03698019|450264411|FG000|Step 2: Surgery|Metastatic Disease|16|||
125176336|NCT03698019|450264412|FG001|Step 2: Surgery|Metastatic Disease|9|||
125176337|NCT03698019|450264411|FG000|Step 2: Surgery|Residual Disease|2|||
125176338|NCT03698019|450264412|FG001|Step 2: Surgery|Residual Disease|1|||
125176339|NCT03698019|450264411|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
125176340|NCT03698019|450264412|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
125176341|NCT03698019|450264411|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
125176342|NCT03698019|450264412|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
125176343|NCT03698019|450264411|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
125176344|NCT03698019|450264412|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
125176345|NCT03698019|450264411|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
125176346|NCT03698019|450264412|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
125176347|NCT03698019|450264411|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
125176348|NCT03698019|450264412|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
125176349|NCT03698019|450264411|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
125176350|NCT03698019|450264412|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
125176351|NCT03698019|450264411|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
125176352|NCT03698019|450264412|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
125176353|NCT03698019|450264411|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
125176354|NCT03698019|450264412|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
125176355|NCT01856192|450264413|FG000|Overall Study|Adverse Event|12|||
125176356|NCT01856192|450264414|FG001|Overall Study|Adverse Event|4|||
125176357|NCT01856192|450264413|FG000|Overall Study|Alternative therapy|0|||
125176358|NCT01856192|450264414|FG001|Overall Study|Alternative therapy|3|||
125176359|NCT01856192|450264413|FG000|Overall Study|Death|3|||
125176360|NCT01856192|450264414|FG001|Overall Study|Death|5|||
125176361|NCT01856192|450264413|FG000|Overall Study|Lack of Efficacy|0|||
125176362|NCT01856192|450264414|FG001|Overall Study|Lack of Efficacy|5|||
125176363|NCT01856192|450264413|FG000|Overall Study|Withdrawal by Subject|1|||
125176364|NCT01856192|450264414|FG001|Overall Study|Withdrawal by Subject|1|||
125176365|NCT01856192|450264413|FG000|Overall Study|Other diseases|1|||
125176366|NCT01856192|450264414|FG001|Overall Study|Other diseases|0|||
125176367|NCT01856192|450264413|FG000|Overall Study|Never started treatment|7|||
125176368|NCT01856192|450264414|FG001|Overall Study|Never started treatment|5|||
125176369|NCT01856192|450264413|FG000|Overall Study|Path ineligible|20|||
125176370|NCT01856192|450264414|FG001|Overall Study|Path ineligible|34|||
125176371|NCT01856192|450264413|FG000|Overall Study|Non-path ineligible|2|||
125176372|NCT01856192|450264414|FG001|Overall Study|Non-path ineligible|2|||
125176373|NCT01856192|450264413|FG000|Overall Study|Physician Decision|1|||
125176374|NCT01856192|450264414|FG001|Overall Study|Physician Decision|1|||
125176375|NCT01856192|450264413|FG000|Overall Study|Suspicion of progressive disease|1|||
125176376|NCT01856192|450264414|FG001|Overall Study|Suspicion of progressive disease|0|||
125176377|NCT01856192|450264413|FG000|Overall Study|Non-compliance|1|||
125176378|NCT01856192|450264414|FG001|Overall Study|Non-compliance|0|||
125176379|NCT02642042|450264415|FG000|Overall Study|Adverse Event|22|||
125176380|NCT02642042|450264415|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
125176381|NCT02642042|450264415|FG000|Overall Study|Progression/Relapse|28|||
125176382|NCT02642042|450264415|FG000|Overall Study|Death|1|||
125176383|NCT02642042|450264415|FG000|Overall Study|Not Protocol Specified|2|||
125176384|NCT04976621|450264416|FG000|Overall Study|Lost to Follow-up|2|||
125176385|NCT04976621|450264417|FG001|Overall Study|Lost to Follow-up|1|||
125176386|NCT04976621|450264416|FG000|Overall Study|Withdrawal by Subject|1|||
125176387|NCT04976621|450264417|FG001|Overall Study|Withdrawal by Subject|0|||
125176388|NCT03348631|450264420|FG000|Overall Study|Not Eligible, No treatment|0|||
125176389|NCT03348631|450264421|FG001|Overall Study|Not Eligible, No treatment|1|||
125176390|NCT03348631|450264420|FG000|Overall Study|Not Eligible, Treated|2|||
125176391|NCT03348631|450264421|FG001|Overall Study|Not Eligible, Treated|0|||
125176392|NCT03348631|450264420|FG000|Overall Study|Eligible, No Treatment|1|||
125176393|NCT03348631|450264421|FG001|Overall Study|Eligible, No Treatment|0|||
125176394|NCT05223920|450264429|FG000|Overall Study|Adverse Event|6|||
125176395|NCT05223920|450264430|FG001|Overall Study|Adverse Event|3|||
125176396|NCT05223920|450264429|FG000|Overall Study|Death|2|||
125176397|NCT05223920|450264430|FG001|Overall Study|Death|0|||
125176398|NCT05223920|450264429|FG000|Overall Study|Disease Progression|1|||
125176399|NCT05223920|450264430|FG001|Overall Study|Disease Progression|2|||
125176400|NCT05223920|450264429|FG000|Overall Study|Physician Decision|1|||
125176401|NCT05223920|450264430|FG001|Overall Study|Physician Decision|2|||
125176402|NCT05223920|450264429|FG000|Overall Study|Sponsor decision|11|||
125176403|NCT05223920|450264430|FG001|Overall Study|Sponsor decision|9|||
125176404|NCT05223920|450264429|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
125176405|NCT05223920|450264430|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
125176406|NCT05223920|450264429|FG000|Overall Study|Subject decision|1|||
125176407|NCT05223920|450264430|FG001|Overall Study|Subject decision|0|||
125176408|NCT05223920|450264429|FG000|Overall Study|Withdrawal by Subject|1|||
125176409|NCT05223920|450264430|FG001|Overall Study|Withdrawal by Subject|6|||
125176410|NCT03790657|450264431|FG000|Overall Study|Adverse Event|1|||
125176411|NCT03790657|450264432|FG001|Overall Study|Adverse Event|1|||
125176412|NCT03790657|450264431|FG000|Overall Study|Withdrawal by Subject|1|||
125176413|NCT03790657|450264432|FG001|Overall Study|Withdrawal by Subject|1|||
125176414|NCT04186845|450264443|FG000|Overall Study|Death|2|||
125176415|NCT04186845|450264443|FG000|Overall Study|Lost to Follow-up|1|||
125176416|NCT04186845|450264443|FG000|Overall Study|Physician Decision|1|||
125176417|NCT04186845|450264443|FG000|Overall Study|Protocol Violation|1|||
125176418|NCT04186845|450264443|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
125176419|NCT04186845|450264443|FG000|Overall Study|Biopsy ordered but not done|1|||
125176420|NCT04186845|450264443|FG000|Overall Study|It was previously confirmed|1|||
125176421|NCT04186845|450264443|FG000|Overall Study|Patient cancelled scheduled scans|2|||
125176422|NCT04186845|450264443|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
125176423|NCT04186845|450264443|FG000|Overall Study|Subject refused confirmatory imaging|1|||
125176424|NCT04186845|450264443|FG000|Overall Study|Too small to biopsy|1|||
125176425|NCT05061420|450264446|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
125176426|NCT05061420|450264447|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
125176427|NCT05061420|450264448|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
125176428|NCT05061420|450264446|FG000|Overall Study|Progressive disease|11|||
125176429|NCT05061420|450264447|FG001|Overall Study|Progressive disease|15|||
125176430|NCT05061420|450264448|FG002|Overall Study|Progressive disease|14|||
125176431|NCT05061420|450264446|FG000|Overall Study|Withdrawal by Subject|2|||
125176432|NCT05061420|450264447|FG001|Overall Study|Withdrawal by Subject|0|||
125176433|NCT05061420|450264448|FG002|Overall Study|Withdrawal by Subject|1|||
125176434|NCT05061420|450264446|FG000|Overall Study|Not related to COVID-19|2|||
125176435|NCT05061420|450264447|FG001|Overall Study|Not related to COVID-19|0|||
125176436|NCT05061420|450264448|FG002|Overall Study|Not related to COVID-19|0|||
125176437|NCT02859142|450264449|FG000|Overall Study|Adverse Event|1|||
125176438|NCT02859142|450264450|FG001|Overall Study|Adverse Event|2|||
125176439|NCT02859142|450264449|FG000|Overall Study|Lost to Follow-up|1|||
125176440|NCT02859142|450264450|FG001|Overall Study|Lost to Follow-up|4|||
125176441|NCT02859142|450264449|FG000|Overall Study|Withdrawal by Subject|2|||
125176442|NCT02859142|450264450|FG001|Overall Study|Withdrawal by Subject|0|||
125176443|NCT02859142|450264449|FG000|Overall Study|Scheduling difficulties|0|||
125176444|NCT02859142|450264450|FG001|Overall Study|Scheduling difficulties|3|||
125176445|NCT03290079|450264451|FG000|Overall Study|Death|2|||
125176446|NCT02466685|450264452|FG000|Overall Study|Adverse Event|5|||
125176447|NCT02466685|450264453|FG001|Overall Study|Adverse Event|2|||
125176448|NCT02466685|450264452|FG000|Overall Study|Lost to Follow-up|1|||
125176449|NCT02466685|450264453|FG001|Overall Study|Lost to Follow-up|1|||
125176450|NCT02466685|450264452|FG000|Overall Study|Withdrawal by Subject|1|||
125176451|NCT02466685|450264453|FG001|Overall Study|Withdrawal by Subject|0|||
125176452|NCT02466685|450264452|FG000|Overall Study|Physician Decision|1|||
125176453|NCT02466685|450264453|FG001|Overall Study|Physician Decision|1|||
125176454|NCT04697069|450264454|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
125176455|NCT04697069|450264455|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
125176456|NCT04697069|450264454|FG000|Overall Study|Study termination|2|||
125176457|NCT04697069|450264455|FG001|Overall Study|Study termination|1|||
125176458|NCT05180227|450264456|FG000|Overall Study|Hypertension at screening|1|||
125176459|NCT05180227|450264456|FG000|Overall Study|Lost to Follow-up|1|||
125176460|NCT04739800|450264457|FG000|Overall Study|Adverse Event|2|||
125176461|NCT04739800|450264458|FG001|Overall Study|Adverse Event|1|||
125176462|NCT04739800|450264459|FG002|Overall Study|Adverse Event|4|||
125176463|NCT04739800|450264460|FG003|Overall Study|Adverse Event|5|||
125176464|NCT04739800|450264457|FG000|Overall Study|Never Treated|2|||
125176465|NCT04739800|450264458|FG001|Overall Study|Never Treated|0|||
125176466|NCT04739800|450264459|FG002|Overall Study|Never Treated|1|||
125176467|NCT04739800|450264460|FG003|Overall Study|Never Treated|1|||
125176468|NCT04739800|450264457|FG000|Overall Study|On Treatment|5|||
125176469|NCT04739800|450264458|FG001|Overall Study|On Treatment|9|||
125176470|NCT04739800|450264459|FG002|Overall Study|On Treatment|9|||
125176471|NCT04739800|450264460|FG003|Overall Study|On Treatment|9|||
125176472|NCT04739800|450264457|FG000|Overall Study|Symptomatic Deterioration|1|||
125176473|NCT04739800|450264458|FG001|Overall Study|Symptomatic Deterioration|1|||
125176474|NCT04739800|450264459|FG002|Overall Study|Symptomatic Deterioration|3|||
125176475|NCT04739800|450264460|FG003|Overall Study|Symptomatic Deterioration|0|||
125176476|NCT04739800|450264457|FG000|Overall Study|Withdrawal by Subject|1|||
125176477|NCT04739800|450264458|FG001|Overall Study|Withdrawal by Subject|2|||
125176478|NCT04739800|450264459|FG002|Overall Study|Withdrawal by Subject|1|||
125176479|NCT04739800|450264460|FG003|Overall Study|Withdrawal by Subject|3|||
125176480|NCT04739800|450264457|FG000|Overall Study|Other Reason|1|||
125176481|NCT04739800|450264458|FG001|Overall Study|Other Reason|3|||
125176482|NCT04739800|450264459|FG002|Overall Study|Other Reason|5|||
125176483|NCT04739800|450264460|FG003|Overall Study|Other Reason|4|||
125176484|NCT02779855|450264461|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
125176485|NCT02779855|450264462|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
125176486|NCT02779855|450264463|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
125176487|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
125176488|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Off-label use|283|||
125176489|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
125176490|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
125176491|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
125392304|NCT04476030|451070627|FG001|Overall Study|Lost to Follow-up|4|||
125232190|NCT00784875|450479730|FG002|Period A - Baseline|Lost to Follow-up|0|||
125232191|NCT00784875|450479731|FG003|Period A - Baseline|Lost to Follow-up|2|||
125232192|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
125232193|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
125232194|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
125232195|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
125232196|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
125232197|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
125232198|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
125232199|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
125232200|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
125232201|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
125232202|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
125232203|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
125232204|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
125232205|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
125232206|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
125232207|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
125232208|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
125176492|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
125176493|NCT01070953|450264467|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
125176494|NCT01070953|450264467|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
125176495|NCT01070953|450264467|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
125176496|NCT01070953|450264467|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
125176497|NCT03514017|450264468|FG000|Overall Study|Death|1|||
125176498|NCT03514017|450264468|FG000|Overall Study|Adverse Event|1|||
125176499|NCT05192889|450264471|FG000|Block 1: All Eligible Patients|Death|2|||
125176500|NCT05192889|450264472|FG001|Block 1: All Eligible Patients|Death|0|||
125176501|NCT05192889|450264473|FG002|Block 1: All Eligible Patients|Death|0|||
125176502|NCT05192889|450264471|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
125176503|NCT05192889|450264472|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
125176504|NCT05192889|450264473|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
125176505|NCT05192889|450264471|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
125176506|NCT05192889|450264472|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
125176507|NCT05192889|450264473|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
125176508|NCT01290302|450265968|FG000|Overall Study|Adverse Event|2|||
125176509|NCT01290302|450265969|FG001|Overall Study|Adverse Event|0|||
125176510|NCT01290302|450265968|FG000|Overall Study|Withdrawal by Subject|1|||
125176511|NCT01290302|450265969|FG001|Overall Study|Withdrawal by Subject|0|||
125176512|NCT01290302|450265968|FG000|Overall Study|Physician Decision|0|||
125176513|NCT01290302|450265969|FG001|Overall Study|Physician Decision|2|||
125176514|NCT01290302|450265968|FG000|Overall Study|Expiration of time for screening window|1|||
125176515|NCT01290302|450265969|FG001|Overall Study|Expiration of time for screening window|0|||
125176516|NCT01059786|450265970|FG000|Overall Study|Did not receive 6 cycles.|0|||
125176517|NCT01059786|450265971|FG001|Overall Study|Did not receive 6 cycles.|0|||
125176518|NCT01059786|450265972|FG002|Overall Study|Did not receive 6 cycles.|4|||
125176519|NCT01059786|450265973|FG003|Overall Study|Did not receive 6 cycles.|1|||
125176520|NCT01059786|450265974|FG004|Overall Study|Did not receive 6 cycles.|0|||
125176521|NCT02454608|450265977|FG000|Double-Blind Period|Lack of Efficacy|0|||
125176522|NCT02454608|450265978|FG001|Double-Blind Period|Lack of Efficacy|2|||
125176523|NCT02454608|450265979|FG002|Double-Blind Period|Lack of Efficacy|0|||
125176524|NCT02454608|450265977|FG000|Open Label Period|Lost to Follow-up|0|||
125176525|NCT02454608|450265978|FG001|Open Label Period|Lost to Follow-up|0|||
125176526|NCT02454608|450265979|FG002|Open Label Period|Lost to Follow-up|11|||
125176527|NCT02454608|450265977|FG000|Open Label Period|Withdrawal by Subject|0|||
125232209|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
125232210|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
125232211|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
125232212|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
125232213|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
125232214|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
125232215|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
125232216|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
125176528|NCT02454608|450265978|FG001|Open Label Period|Withdrawal by Subject|0|||
125176529|NCT02454608|450265979|FG002|Open Label Period|Withdrawal by Subject|8|||
125232217|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
125232218|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
125232219|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
125232220|NCT00784875|450479728|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
125232221|NCT00784875|450479729|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
125176530|NCT01769456|450265980|FG000|Overall Study|Lost to Follow-up|19|||
125176531|NCT01769456|450265980|FG000|Overall Study|Withdrawal by Subject|3|||
125176532|NCT01769456|450265980|FG000|Overall Study|Did not receive PCC intervention|6|||
125176533|NCT01769456|450265980|FG000|Overall Study|Moved out of the area|3|||
125176534|NCT01769456|450265980|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
125176535|NCT01769456|450265980|FG000|Overall Study|Parental request to youth to withdraw|1|||
125176536|NCT05490771|450265986|FG000|Overall Study|Disease progression|18|||
125176537|NCT05490771|450265986|FG000|Overall Study|Adverse Event|3|||
125176538|NCT05490771|450265986|FG000|Overall Study|Other complicating disease|1|||
125176539|NCT05490771|450265986|FG000|Overall Study|Withdrawal by Subject|3|||
125176540|NCT05490771|450265986|FG000|Overall Study|Physician Decision|1|||
125176541|NCT05490771|450265986|FG000|Overall Study|Still on treatment|2|||
125176542|NCT05490771|450265986|FG000|Overall Study|Never start protocol therapy|5|||
125176543|NCT05490771|450265986|FG000|Overall Study|Ineligible|2|||
125176544|NCT00661193|450265990|FG000|Overall Study|Adverse Event|2|||
125176545|NCT00661193|450265991|FG001|Overall Study|Adverse Event|1|||
125176546|NCT00661193|450265990|FG000|Overall Study|Withdrawal by Subject|3|||
125176547|NCT00661193|450265991|FG001|Overall Study|Withdrawal by Subject|1|||
125176548|NCT00661193|450265990|FG000|Overall Study|Progression|27|||
125176549|NCT00661193|450265991|FG001|Overall Study|Progression|24|||
125176550|NCT00661193|450265990|FG000|Overall Study|Not protocol specified|1|||
125176551|NCT00661193|450265991|FG001|Overall Study|Not protocol specified|0|||
125176552|NCT02862730|450265994|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
125176553|NCT02862730|450265995|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
125176554|NCT02862730|450265996|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
125176555|NCT02862730|450265997|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
125176556|NCT02862730|450265998|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
125176557|NCT02862730|450265999|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
125176558|NCT02862730|450266000|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
125176559|NCT02862730|450265994|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
125176560|NCT02862730|450265995|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
125176561|NCT02862730|450265996|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
125176562|NCT02862730|450265997|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
125176563|NCT02862730|450265998|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
125176564|NCT02862730|450265999|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
125176565|NCT02862730|450266000|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
125176566|NCT02862730|450265994|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
125176567|NCT02862730|450265995|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
125176568|NCT02862730|450265996|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
125176569|NCT02862730|450265997|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
125176570|NCT02862730|450265998|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
125176571|NCT02862730|450265999|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
125176572|NCT02862730|450266000|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
125176573|NCT02862730|450265994|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
125176574|NCT02862730|450265995|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
125176575|NCT02862730|450265996|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
125176576|NCT02862730|450265997|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
125176577|NCT02862730|450265998|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
125176578|NCT02862730|450265999|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
125176579|NCT02862730|450266000|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
125176580|NCT03685344|450266001|FG000|Overall Study|Withdrawal by Subject|1|||
125176581|NCT03685344|450266002|FG001|Overall Study|Withdrawal by Subject|1|||
125176582|NCT03685344|450266003|FG002|Overall Study|Withdrawal by Subject|2|||
125176583|NCT03685344|450266004|FG003|Overall Study|Withdrawal by Subject|0|||
125176584|NCT03685344|450266001|FG000|Overall Study|Physician Decision|1|||
125176585|NCT03685344|450266002|FG001|Overall Study|Physician Decision|1|||
125176586|NCT03685344|450266003|FG002|Overall Study|Physician Decision|5|||
125176587|NCT03685344|450266004|FG003|Overall Study|Physician Decision|0|||
125176588|NCT03685344|450266001|FG000|Overall Study|Death|1|||
125176589|NCT03685344|450266002|FG001|Overall Study|Death|1|||
125176590|NCT03685344|450266003|FG002|Overall Study|Death|0|||
125176591|NCT03685344|450266004|FG003|Overall Study|Death|0|||
125176592|NCT03126435|450266006|FG000|Overall Study|Death|90|||
125176593|NCT03126435|450266007|FG001|Overall Study|Death|84|||
125176594|NCT03126435|450266006|FG000|Overall Study|Lost to Follow-up|4|||
125176595|NCT03126435|450266007|FG001|Overall Study|Lost to Follow-up|3|||
125176596|NCT03126435|450266006|FG000|Overall Study|Physician Decision|0|||
125176597|NCT03126435|450266007|FG001|Overall Study|Physician Decision|1|||
125176598|NCT03126435|450266006|FG000|Overall Study|Withdrawal by Subject|6|||
125176599|NCT03126435|450266007|FG001|Overall Study|Withdrawal by Subject|12|||
125176600|NCT03126435|450266006|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
125176601|NCT03126435|450266007|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
125176602|NCT03971474|450266010|FG000|Overall Study|Adverse Event|11|||
125176603|NCT03971474|450266011|FG001|Overall Study|Adverse Event|7|||
125176604|NCT03971474|450266010|FG000|Overall Study|Refusal unrelated to adverse event|5|||
125176605|NCT03971474|450266011|FG001|Overall Study|Refusal unrelated to adverse event|1|||
125176606|NCT03971474|450266010|FG000|Overall Study|Progression/relapse|40|||
125176607|NCT03971474|450266011|FG001|Overall Study|Progression/relapse|47|||
125176608|NCT03971474|450266010|FG000|Overall Study|Death|6|||
125176609|NCT03971474|450266011|FG001|Overall Study|Death|3|||
125176610|NCT03971474|450266010|FG000|Overall Study|Other - not protocol specified|5|||
125176611|NCT03971474|450266011|FG001|Overall Study|Other - not protocol specified|4|||
125176612|NCT03971474|450266010|FG000|Overall Study|On treatment|0|||
125176613|NCT03971474|450266011|FG001|Overall Study|On treatment|7|||
125176614|NCT00261950|450266012|FG000|Overall Study|Lost to Follow-up|2|||
125176615|NCT00261950|450266012|FG000|Overall Study|Death|6|||
125176616|NCT00261950|450266012|FG000|Overall Study|Withdrawal by Subject|5|||
125176617|NCT00261950|450266012|FG000|Overall Study|Other|1|||
125176618|NCT00261950|450266012|FG000|Overall Study|Physician Decision|1|||
125176619|NCT00261950|450266012|FG000|Overall Study|Protocol specified Criteria|11|||
125176620|NCT01937871|450266019|FG000|Overall Study|Adverse Event|6|||
125176621|NCT01937871|450266020|FG001|Overall Study|Adverse Event|6|||
125176622|NCT01937871|450266021|FG002|Overall Study|Adverse Event|2|||
125176623|NCT01937871|450266019|FG000|Overall Study|Lost to Follow-up|8|||
125176624|NCT01937871|450266020|FG001|Overall Study|Lost to Follow-up|2|||
125176625|NCT01937871|450266021|FG002|Overall Study|Lost to Follow-up|4|||
125176626|NCT01937871|450266019|FG000|Overall Study|Withdrawal by Subject|9|||
125176627|NCT01937871|450266020|FG001|Overall Study|Withdrawal by Subject|6|||
125176628|NCT01937871|450266021|FG002|Overall Study|Withdrawal by Subject|4|||
125176629|NCT01937871|450266019|FG000|Overall Study|Physician Decision|0|||
125176630|NCT01937871|450266020|FG001|Overall Study|Physician Decision|1|||
125176631|NCT01937871|450266021|FG002|Overall Study|Physician Decision|0|||
125176632|NCT01937871|450266019|FG000|Overall Study|Entry Criteria Not Met|1|||
125176633|NCT01937871|450266020|FG001|Overall Study|Entry Criteria Not Met|2|||
125176634|NCT01937871|450266021|FG002|Overall Study|Entry Criteria Not Met|1|||
125176635|NCT00577863|450266028|FG000|Overall Study|Adverse Event|4|||
125176636|NCT00577863|450266029|FG001|Overall Study|Adverse Event|2|||
125176637|NCT00577863|450266028|FG000|Overall Study|Death|1|||
125176638|NCT00577863|450266029|FG001|Overall Study|Death|0|||
125176639|NCT00577863|450266028|FG000|Overall Study|Lost to Follow-up|2|||
125176640|NCT00577863|450266029|FG001|Overall Study|Lost to Follow-up|2|||
125176641|NCT00577863|450266028|FG000|Overall Study|Entry Criteria Exclusion|1|||
125176642|NCT00577863|450266029|FG001|Overall Study|Entry Criteria Exclusion|0|||
125176643|NCT00577863|450266028|FG000|Overall Study|Withdrawal by Subject|0|||
125176644|NCT00577863|450266029|FG001|Overall Study|Withdrawal by Subject|2|||
125176645|NCT00577863|450266028|FG000|Overall Study|Sponsor Decision|2|||
125176646|NCT00577863|450266029|FG001|Overall Study|Sponsor Decision|7|||
125176647|NCT00577863|450266028|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
125176648|NCT00577863|450266029|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
125176649|NCT03154125|450266030|FG000|Overall Study|Lost to Follow-up|11|||
125176650|NCT03154125|450266031|FG001|Overall Study|Lost to Follow-up|11|||
125176651|NCT03154125|450266032|FG002|Overall Study|Lost to Follow-up|0|||
125176652|NCT03154125|450266030|FG000|Overall Study|Withdrawal by Subject|49|||
125176653|NCT03154125|450266031|FG001|Overall Study|Withdrawal by Subject|55|||
125176654|NCT03154125|450266032|FG002|Overall Study|Withdrawal by Subject|8|||
125176655|NCT03154125|450266030|FG000|Overall Study|Physician Decision|13|||
125176656|NCT03154125|450266031|FG001|Overall Study|Physician Decision|6|||
125176657|NCT03154125|450266032|FG002|Overall Study|Physician Decision|0|||
125176658|NCT03154125|450266030|FG000|Overall Study|Protocol Violation|3|||
125176659|NCT03154125|450266031|FG001|Overall Study|Protocol Violation|5|||
125176660|NCT03154125|450266032|FG002|Overall Study|Protocol Violation|0|||
125232222|NCT00784875|450479730|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
125232223|NCT00784875|450479731|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
125232224|NCT00784875|450479728|FG000|Period C|Adverse Event|1|||
125232225|NCT00784875|450479729|FG001|Period C|Adverse Event|0|||
125232226|NCT00784875|450479730|FG002|Period C|Adverse Event|4|||
125232227|NCT00784875|450479731|FG003|Period C|Adverse Event|2|||
125176661|NCT05219448|450266033|FG000|Overall Study|Lost to Follow-up|9|||
125176662|NCT05219448|450266034|FG001|Overall Study|Lost to Follow-up|0|||
125176663|NCT02287922|450266035|FG000|Overall Study|Adverse Event|1|||
125176664|NCT02287922|450266036|FG001|Overall Study|Adverse Event|1|||
125176665|NCT02287922|450266037|FG002|Overall Study|Adverse Event|3|||
125176666|NCT02287922|450266038|FG003|Overall Study|Adverse Event|4|||
125176667|NCT02287922|450266035|FG000|Overall Study|Withdrawal by Subject|1|||
125176668|NCT02287922|450266036|FG001|Overall Study|Withdrawal by Subject|1|||
125176669|NCT02287922|450266037|FG002|Overall Study|Withdrawal by Subject|1|||
125176670|NCT02287922|450266038|FG003|Overall Study|Withdrawal by Subject|2|||
125176671|NCT02287922|450266035|FG000|Overall Study|Lost to Follow-up|0|||
125176672|NCT02287922|450266036|FG001|Overall Study|Lost to Follow-up|0|||
125176673|NCT02287922|450266037|FG002|Overall Study|Lost to Follow-up|1|||
125176674|NCT02287922|450266038|FG003|Overall Study|Lost to Follow-up|0|||
125176675|NCT02287922|450266035|FG000|Overall Study|Sponsor's decision|0|||
125176676|NCT02287922|450266036|FG001|Overall Study|Sponsor's decision|0|||
125232228|NCT00784875|450479728|FG000|Period C|Protocol Violation|0|||
125443407|NCT02555371|451252131|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
125176677|NCT02287922|450266037|FG002|Overall Study|Sponsor's decision|0|||
125176678|NCT02287922|450266038|FG003|Overall Study|Sponsor's decision|1|||
125176679|NCT02287922|450266035|FG000|Overall Study|Other|1|||
125176680|NCT02287922|450266036|FG001|Overall Study|Other|0|||
125176681|NCT02287922|450266037|FG002|Overall Study|Other|2|||
125176682|NCT02287922|450266038|FG003|Overall Study|Other|0|||
125176683|NCT00668317|450266039|FG000|Overall Study|Adverse Event|2|||
125176684|NCT01814553|450266048|FG000|Overall Study|PD per clinical progression|6|||
125176685|NCT01814553|450266049|FG001|Overall Study|PD per clinical progression|8|||
125176686|NCT01814553|450266048|FG000|Overall Study|Other Adverse Event|4|||
125176687|NCT01814553|450266049|FG001|Overall Study|Other Adverse Event|5|||
125176688|NCT01814553|450266048|FG000|Overall Study|Withdrawal by Subject|1|||
125176689|NCT01814553|450266049|FG001|Overall Study|Withdrawal by Subject|1|||
125176690|NCT01814553|450266048|FG000|Overall Study|Other than stated|7|||
125176691|NCT01814553|450266049|FG001|Overall Study|Other than stated|8|||
125176692|NCT04138823|450266050|FG000|Overall Study|Clinical disease progression|0|||
125176693|NCT04138823|450266051|FG001|Overall Study|Clinical disease progression|0|||
125176694|NCT04138823|450266052|FG002|Overall Study|Clinical disease progression|1|||
125176695|NCT04138823|450266050|FG000|Overall Study|Objective disease progression|3|||
125176696|NCT04138823|450266051|FG001|Overall Study|Objective disease progression|2|||
125176697|NCT04138823|450266052|FG002|Overall Study|Objective disease progression|5|||
125176698|NCT04868500|450266053|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
125176699|NCT04868500|450266054|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
125176700|NCT04868500|450266053|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
125176701|NCT04868500|450266054|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
125176702|NCT03340974|450266055|FG000|Completion of Study -Long Term Follow up|Death|8|||
125176703|NCT03340974|450266056|FG001|Completion of Study -Long Term Follow up|Death|5|||
125176704|NCT03340974|450266057|FG002|Completion of Study -Long Term Follow up|Death|5|||
125176705|NCT03340974|450266058|FG003|Completion of Study -Long Term Follow up|Death|7|||
125176706|NCT03340974|450266055|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
125176707|NCT03340974|450266056|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
125176708|NCT03340974|450266057|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
125176709|NCT03340974|450266058|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
125176710|NCT03340974|450266055|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
125176711|NCT03340974|450266056|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
125176712|NCT03340974|450266057|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
125176713|NCT03340974|450266058|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
125176714|NCT03340974|450266055|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
125176715|NCT03340974|450266056|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
125176716|NCT03340974|450266057|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
125176717|NCT03340974|450266058|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
125176718|NCT02676765|450266059|FG000|Overall Study|Lost to Follow-up|0|||
125176719|NCT02676765|450266060|FG001|Overall Study|Lost to Follow-up|1|||
125176720|NCT05299528|450266069|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
125176721|NCT05299528|450266070|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
125176722|NCT05299528|450266071|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
125176723|NCT05299528|450266072|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
125176724|NCT05299528|450266073|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
125176725|NCT05299528|450266074|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
125176726|NCT05299528|450266075|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
125176727|NCT05299528|450266069|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
125176728|NCT05299528|450266070|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
125176729|NCT05299528|450266071|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
125176730|NCT05299528|450266072|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
125176731|NCT05299528|450266073|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
125176732|NCT05299528|450266074|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
125176733|NCT05299528|450266075|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
125176734|NCT05299528|450266069|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
125176735|NCT05299528|450266070|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
125176736|NCT05299528|450266071|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
125176737|NCT05299528|450266072|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
125443408|NCT02555371|451252132|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
125443409|NCT02555371|451252128|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
125443410|NCT02555371|451252129|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
125443411|NCT02555371|451252130|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
125443412|NCT02555371|451252131|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
125176738|NCT05299528|450266073|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
125176739|NCT05299528|450266074|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
125176740|NCT05299528|450266075|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
125176741|NCT02445963|450266080|FG000|Overall Study|Lost to Follow-up|1|||
125176742|NCT02445963|450266081|FG001|Overall Study|Lost to Follow-up|0|||
125176743|NCT02445963|450266082|FG002|Overall Study|Lost to Follow-up|0|||
125176744|NCT02445963|450266083|FG003|Overall Study|Lost to Follow-up|0|||
125176745|NCT02445963|450266080|FG000|Overall Study|Change in employment|1|||
125176746|NCT02445963|450266081|FG001|Overall Study|Change in employment|0|||
125176747|NCT02445963|450266082|FG002|Overall Study|Change in employment|0|||
125176748|NCT02445963|450266083|FG003|Overall Study|Change in employment|0|||
125176749|NCT02445963|450266080|FG000|Overall Study|Symptoms post-vaccination|0|||
125176750|NCT02445963|450266081|FG001|Overall Study|Symptoms post-vaccination|0|||
125176751|NCT02445963|450266082|FG002|Overall Study|Symptoms post-vaccination|1|||
125176752|NCT02445963|450266083|FG003|Overall Study|Symptoms post-vaccination|0|||
125176753|NCT01957176|450266084|FG000|Overall Study|Adverse Event|2|||
125176754|NCT01957176|450266085|FG001|Overall Study|Adverse Event|0|||
125176755|NCT01957176|450266084|FG000|Overall Study|Physician Decision|2|||
125176756|NCT01957176|450266085|FG001|Overall Study|Physician Decision|1|||
125176757|NCT01957176|450266084|FG000|Overall Study|Withdrawal by Subject|1|||
125176758|NCT01957176|450266085|FG001|Overall Study|Withdrawal by Subject|0|||
125176759|NCT02359994|450266088|FG000|Overall Population Study|Adverse Event|1|||
125176760|NCT02359994|450266089|FG001|Overall Population Study|Adverse Event|1|||
125176761|NCT02359994|450266088|FG000|Overall Population Study|Death|1|||
125176762|NCT02359994|450266089|FG001|Overall Population Study|Death|5|||
125176763|NCT02359994|450266088|FG000|Overall Population Study|Lost to Follow-up|1|||
125176764|NCT02359994|450266089|FG001|Overall Population Study|Lost to Follow-up|1|||
125176765|NCT02359994|450266088|FG000|Overall Population Study|Withdrawal by Subject|1|||
125176766|NCT02359994|450266089|FG001|Overall Population Study|Withdrawal by Subject|0|||
125176767|NCT02359994|450266088|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
125176768|NCT02359994|450266089|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
125176769|NCT02359994|450266088|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
125176770|NCT02359994|450266089|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
125176771|NCT02359994|450266088|FG000|Extended Oncology 24-Month Survival|Death|19|||
125176772|NCT02359994|450266089|FG001|Extended Oncology 24-Month Survival|Death|21|||
125176773|NCT02359994|450266088|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
125176774|NCT02359994|450266089|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
125176775|NCT04597632|450266090|FG000|Overall Study|Withdrawal by Subject|10|||
125176776|NCT04597632|450266090|FG000|Overall Study|Lost to Follow-up|1|||
125176777|NCT04597632|450266090|FG000|Overall Study|Death|1|||
125176778|NCT04597632|450266090|FG000|Overall Study|Adverse Event|5|||
125176779|NCT01823835|450266091|FG000|Overall Study|Adverse Event|0|||
125176780|NCT01823835|450266092|FG001|Overall Study|Adverse Event|0|||
125176781|NCT01823835|450266093|FG002|Overall Study|Adverse Event|0|||
125176782|NCT01823835|450266094|FG003|Overall Study|Adverse Event|0|||
125176783|NCT01823835|450266095|FG004|Overall Study|Adverse Event|1|||
125176784|NCT01823835|450266096|FG005|Overall Study|Adverse Event|0|||
125176785|NCT01823835|450266097|FG006|Overall Study|Adverse Event|1|||
125176786|NCT01823835|450266098|FG007|Overall Study|Adverse Event|0|||
125176787|NCT01823835|450266099|FG008|Overall Study|Adverse Event|0|||
125176788|NCT01823835|450266100|FG009|Overall Study|Adverse Event|0|||
125176789|NCT01823835|450266101|FG010|Overall Study|Adverse Event|1|||
125176790|NCT01823835|450266102|FG011|Overall Study|Adverse Event|2|||
125176791|NCT01823835|450266103|FG012|Overall Study|Adverse Event|0|||
125176792|NCT01823835|450266104|FG013|Overall Study|Adverse Event|0|||
125176793|NCT01823835|450266105|FG014|Overall Study|Adverse Event|0|||
125176794|NCT01823835|450266091|FG000|Overall Study|Physician Decision|0|||
125176795|NCT01823835|450266092|FG001|Overall Study|Physician Decision|0|||
125176796|NCT01823835|450266093|FG002|Overall Study|Physician Decision|0|||
125176797|NCT01823835|450266094|FG003|Overall Study|Physician Decision|0|||
125176798|NCT01823835|450266095|FG004|Overall Study|Physician Decision|0|||
125176799|NCT01823835|450266096|FG005|Overall Study|Physician Decision|0|||
125176800|NCT01823835|450266097|FG006|Overall Study|Physician Decision|0|||
125176801|NCT01823835|450266098|FG007|Overall Study|Physician Decision|0|||
125176802|NCT01823835|450266099|FG008|Overall Study|Physician Decision|0|||
125176803|NCT01823835|450266100|FG009|Overall Study|Physician Decision|0|||
125176804|NCT01823835|450266101|FG010|Overall Study|Physician Decision|0|||
125176805|NCT01823835|450266102|FG011|Overall Study|Physician Decision|2|||
125176806|NCT01823835|450266103|FG012|Overall Study|Physician Decision|0|||
125176807|NCT01823835|450266104|FG013|Overall Study|Physician Decision|0|||
125232229|NCT00784875|450479729|FG001|Period C|Protocol Violation|0|||
125232230|NCT00784875|450479730|FG002|Period C|Protocol Violation|1|||
125232231|NCT00784875|450479731|FG003|Period C|Protocol Violation|2|||
125232232|NCT00784875|450479728|FG000|Period C|Lack of Efficacy|0|||
125232233|NCT00784875|450479729|FG001|Period C|Lack of Efficacy|0|||
125232234|NCT00784875|450479730|FG002|Period C|Lack of Efficacy|1|||
125232235|NCT00784875|450479731|FG003|Period C|Lack of Efficacy|0|||
125232236|NCT00784875|450479728|FG000|Period C|Withdrawal by Subject|1|||
125232237|NCT00784875|450479729|FG001|Period C|Withdrawal by Subject|1|||
125232238|NCT00784875|450479730|FG002|Period C|Withdrawal by Subject|2|||
125232239|NCT00784875|450479731|FG003|Period C|Withdrawal by Subject|0|||
125232240|NCT00784875|450479728|FG000|Period C|Physician Decision|0|||
125232241|NCT00784875|450479729|FG001|Period C|Physician Decision|0|||
125232242|NCT00784875|450479730|FG002|Period C|Physician Decision|1|||
125232243|NCT00784875|450479731|FG003|Period C|Physician Decision|1|||
125232244|NCT00784875|450479728|FG000|Period C|Sponsor Decision|5|||
125232245|NCT00784875|450479729|FG001|Period C|Sponsor Decision|5|||
125232246|NCT00784875|450479730|FG002|Period C|Sponsor Decision|4|||
125232247|NCT00784875|450479731|FG003|Period C|Sponsor Decision|2|||
125232248|NCT00784875|450479728|FG000|Period D|Adverse Event|0|||
125232249|NCT00784875|450479729|FG001|Period D|Adverse Event|2|||
125232250|NCT00784875|450479730|FG002|Period D|Adverse Event|2|||
125232251|NCT00784875|450479731|FG003|Period D|Adverse Event|0|||
125232252|NCT00784875|450479728|FG000|Period D|Protocol Violation|1|||
125232253|NCT00784875|450479729|FG001|Period D|Protocol Violation|0|||
125232254|NCT00784875|450479730|FG002|Period D|Protocol Violation|0|||
125232255|NCT00784875|450479731|FG003|Period D|Protocol Violation|0|||
125232256|NCT00784875|450479728|FG000|Period D|Withdrawal by Subject|2|||
125232257|NCT00784875|450479729|FG001|Period D|Withdrawal by Subject|0|||
125232258|NCT00784875|450479730|FG002|Period D|Withdrawal by Subject|2|||
125232259|NCT00784875|450479731|FG003|Period D|Withdrawal by Subject|0|||
125232260|NCT00784875|450479728|FG000|Period D|Physician Decision|0|||
125232261|NCT00784875|450479729|FG001|Period D|Physician Decision|1|||
125232262|NCT00784875|450479730|FG002|Period D|Physician Decision|0|||
125232263|NCT00784875|450479731|FG003|Period D|Physician Decision|0|||
125232264|NCT00784875|450479728|FG000|Period D|Sponsor Decision|1|||
125232265|NCT00784875|450479729|FG001|Period D|Sponsor Decision|1|||
125232266|NCT00784875|450479730|FG002|Period D|Sponsor Decision|1|||
125232267|NCT00784875|450479731|FG003|Period D|Sponsor Decision|0|||
125232268|NCT00784875|450479728|FG000|Period D|Lost to Follow-up|1|||
125232269|NCT00784875|450479729|FG001|Period D|Lost to Follow-up|0|||
125232270|NCT00784875|450479730|FG002|Period D|Lost to Follow-up|1|||
125232271|NCT00784875|450479731|FG003|Period D|Lost to Follow-up|1|||
125392305|NCT04476030|451070626|FG000|Overall Study|Physician Decision|1|||
125392306|NCT04476030|451070627|FG001|Overall Study|Physician Decision|1|||
125392307|NCT04476030|451070626|FG000|Overall Study|Protocol Deviation|2|||
125176808|NCT01823835|450266105|FG014|Overall Study|Physician Decision|0|||
125176809|NCT01823835|450266091|FG000|Overall Study|Progressive Disease|3|||
125176810|NCT01823835|450266092|FG001|Overall Study|Progressive Disease|4|||
125176811|NCT01823835|450266093|FG002|Overall Study|Progressive Disease|3|||
125176812|NCT01823835|450266094|FG003|Overall Study|Progressive Disease|6|||
125176813|NCT01823835|450266095|FG004|Overall Study|Progressive Disease|4|||
125176814|NCT01823835|450266096|FG005|Overall Study|Progressive Disease|6|||
125176815|NCT01823835|450266097|FG006|Overall Study|Progressive Disease|5|||
125176816|NCT01823835|450266098|FG007|Overall Study|Progressive Disease|3|||
125176817|NCT01823835|450266099|FG008|Overall Study|Progressive Disease|3|||
125176818|NCT01823835|450266100|FG009|Overall Study|Progressive Disease|18|||
125176819|NCT01823835|450266101|FG010|Overall Study|Progressive Disease|8|||
125176820|NCT01823835|450266102|FG011|Overall Study|Progressive Disease|46|||
125176821|NCT01823835|450266103|FG012|Overall Study|Progressive Disease|18|||
125176822|NCT01823835|450266104|FG013|Overall Study|Progressive Disease|4|||
125392308|NCT04476030|451070627|FG001|Overall Study|Protocol Deviation|0|||
125176823|NCT01823835|450266105|FG014|Overall Study|Progressive Disease|6|||
125176824|NCT01823835|450266091|FG000|Overall Study|Study Termination|0|||
125176825|NCT01823835|450266092|FG001|Overall Study|Study Termination|0|||
125176826|NCT01823835|450266093|FG002|Overall Study|Study Termination|0|||
125176827|NCT01823835|450266094|FG003|Overall Study|Study Termination|0|||
125176828|NCT01823835|450266095|FG004|Overall Study|Study Termination|1|||
125232272|NCT02842866|450479732|FG000|Overall Study|Serious Adverse Event|0|||
125232273|NCT02842866|450479733|FG001|Overall Study|Serious Adverse Event|1|||
125232274|NCT02842866|450479732|FG000|Overall Study|Protocol Violation|4|||
125232275|NCT02842866|450479733|FG001|Overall Study|Protocol Violation|2|||
125232276|NCT02842866|450479732|FG000|Overall Study|Lost to Follow-up|2|||
125232277|NCT02842866|450479733|FG001|Overall Study|Lost to Follow-up|0|||
125232278|NCT02842866|450479732|FG000|Overall Study|Withdrawal by Subject|1|||
125232279|NCT02842866|450479733|FG001|Overall Study|Withdrawal by Subject|0|||
125232280|NCT02897349|450479738|FG000|Overall Study|Lost to Follow-up|2|||
125232281|NCT02897349|450479739|FG001|Overall Study|Lost to Follow-up|2|||
125232282|NCT02897349|450479738|FG000|Overall Study|Adverse Event|3|||
125232283|NCT02897349|450479739|FG001|Overall Study|Adverse Event|3|||
125392309|NCT04476030|451070626|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
125392310|NCT04476030|451070627|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
125176829|NCT01823835|450266096|FG005|Overall Study|Study Termination|0|||
125176830|NCT01823835|450266097|FG006|Overall Study|Study Termination|0|||
125176831|NCT01823835|450266098|FG007|Overall Study|Study Termination|0|||
125176832|NCT01823835|450266099|FG008|Overall Study|Study Termination|0|||
125176833|NCT01823835|450266100|FG009|Overall Study|Study Termination|0|||
125176834|NCT01823835|450266101|FG010|Overall Study|Study Termination|0|||
125176835|NCT01823835|450266102|FG011|Overall Study|Study Termination|1|||
125176836|NCT01823835|450266103|FG012|Overall Study|Study Termination|0|||
125176837|NCT01823835|450266104|FG013|Overall Study|Study Termination|0|||
125176838|NCT01823835|450266105|FG014|Overall Study|Study Termination|0|||
125176839|NCT01823835|450266091|FG000|Overall Study|Withdrawal by Subject|0|||
125176840|NCT01823835|450266092|FG001|Overall Study|Withdrawal by Subject|0|||
125176841|NCT01823835|450266093|FG002|Overall Study|Withdrawal by Subject|1|||
125176842|NCT01823835|450266094|FG003|Overall Study|Withdrawal by Subject|0|||
125176843|NCT01823835|450266095|FG004|Overall Study|Withdrawal by Subject|0|||
125176844|NCT01823835|450266096|FG005|Overall Study|Withdrawal by Subject|0|||
125176845|NCT01823835|450266097|FG006|Overall Study|Withdrawal by Subject|0|||
125176846|NCT01823835|450266098|FG007|Overall Study|Withdrawal by Subject|0|||
125176847|NCT01823835|450266099|FG008|Overall Study|Withdrawal by Subject|0|||
125176848|NCT01823835|450266100|FG009|Overall Study|Withdrawal by Subject|1|||
125176849|NCT01823835|450266101|FG010|Overall Study|Withdrawal by Subject|1|||
125176850|NCT01823835|450266102|FG011|Overall Study|Withdrawal by Subject|2|||
125176851|NCT01823835|450266103|FG012|Overall Study|Withdrawal by Subject|1|||
125176852|NCT01823835|450266104|FG013|Overall Study|Withdrawal by Subject|0|||
125176853|NCT01823835|450266105|FG014|Overall Study|Withdrawal by Subject|0|||
125176854|NCT03017612|450266106|FG000|Overall Study|Adverse Event|2|||
125176855|NCT04895982|450266107|FG000|Overall Study|Withdrawal by Subject|0|||
125176856|NCT04895982|450266108|FG001|Overall Study|Withdrawal by Subject|0|||
125176857|NCT04895982|450266109|FG002|Overall Study|Withdrawal by Subject|0|||
125176858|NCT04895982|450266110|FG003|Overall Study|Withdrawal by Subject|0|||
125176859|NCT04895982|450266111|FG004|Overall Study|Withdrawal by Subject|0|||
125176860|NCT04895982|450266112|FG005|Overall Study|Withdrawal by Subject|1|||
125176861|NCT04895982|450266113|FG006|Overall Study|Withdrawal by Subject|1|||
125176862|NCT04895982|450266114|FG007|Overall Study|Withdrawal by Subject|0|||
125176863|NCT04895982|450266115|FG008|Overall Study|Withdrawal by Subject|0|||
125176864|NCT04895982|450266116|FG009|Overall Study|Withdrawal by Subject|1|||
125176865|NCT04895982|450266117|FG010|Overall Study|Withdrawal by Subject|0|||
125176866|NCT04895982|450266118|FG011|Overall Study|Withdrawal by Subject|1|||
125176867|NCT04895982|450266107|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125176868|NCT04895982|450266108|FG001|Overall Study|Withdrawal by parent/guardian|3|||
125176869|NCT04895982|450266109|FG002|Overall Study|Withdrawal by parent/guardian|3|||
125176870|NCT04895982|450266110|FG003|Overall Study|Withdrawal by parent/guardian|1|||
125176871|NCT04895982|450266111|FG004|Overall Study|Withdrawal by parent/guardian|3|||
125176872|NCT04895982|450266112|FG005|Overall Study|Withdrawal by parent/guardian|2|||
125176873|NCT04895982|450266113|FG006|Overall Study|Withdrawal by parent/guardian|1|||
125176874|NCT04895982|450266114|FG007|Overall Study|Withdrawal by parent/guardian|0|||
125176875|NCT04895982|450266115|FG008|Overall Study|Withdrawal by parent/guardian|3|||
125176876|NCT04895982|450266116|FG009|Overall Study|Withdrawal by parent/guardian|0|||
125176877|NCT04895982|450266117|FG010|Overall Study|Withdrawal by parent/guardian|0|||
125176878|NCT04895982|450266118|FG011|Overall Study|Withdrawal by parent/guardian|0|||
125176879|NCT04895982|450266107|FG000|Overall Study|Other|0|||
125176880|NCT04895982|450266108|FG001|Overall Study|Other|0|||
125176881|NCT04895982|450266109|FG002|Overall Study|Other|1|||
125176882|NCT04895982|450266110|FG003|Overall Study|Other|1|||
125176883|NCT04895982|450266111|FG004|Overall Study|Other|0|||
125176884|NCT04895982|450266112|FG005|Overall Study|Other|0|||
125176885|NCT04895982|450266113|FG006|Overall Study|Other|0|||
125176886|NCT04895982|450266114|FG007|Overall Study|Other|0|||
125176887|NCT04895982|450266115|FG008|Overall Study|Other|0|||
125176888|NCT04895982|450266116|FG009|Overall Study|Other|1|||
125176889|NCT04895982|450266117|FG010|Overall Study|Other|0|||
125176890|NCT04895982|450266118|FG011|Overall Study|Other|0|||
125176891|NCT04895982|450266107|FG000|Overall Study|Protocol Violation|0|||
125176892|NCT04895982|450266108|FG001|Overall Study|Protocol Violation|0|||
125176893|NCT04895982|450266109|FG002|Overall Study|Protocol Violation|1|||
125176894|NCT04895982|450266110|FG003|Overall Study|Protocol Violation|1|||
125176895|NCT04895982|450266111|FG004|Overall Study|Protocol Violation|1|||
125232284|NCT02897349|450479738|FG000|Overall Study|Other than listed above|0|||
125176896|NCT04895982|450266112|FG005|Overall Study|Protocol Violation|0|||
125176897|NCT04895982|450266113|FG006|Overall Study|Protocol Violation|0|||
125176898|NCT04895982|450266114|FG007|Overall Study|Protocol Violation|1|||
125176899|NCT04895982|450266115|FG008|Overall Study|Protocol Violation|0|||
125176900|NCT04895982|450266116|FG009|Overall Study|Protocol Violation|0|||
125176901|NCT04895982|450266117|FG010|Overall Study|Protocol Violation|0|||
125176902|NCT04895982|450266118|FG011|Overall Study|Protocol Violation|0|||
125176903|NCT04895982|450266107|FG000|Overall Study|Lost to Follow-up|0|||
125176904|NCT04895982|450266108|FG001|Overall Study|Lost to Follow-up|0|||
125176905|NCT04895982|450266109|FG002|Overall Study|Lost to Follow-up|1|||
125176906|NCT04895982|450266110|FG003|Overall Study|Lost to Follow-up|0|||
125176907|NCT04895982|450266111|FG004|Overall Study|Lost to Follow-up|0|||
125176908|NCT04895982|450266112|FG005|Overall Study|Lost to Follow-up|1|||
125176909|NCT04895982|450266113|FG006|Overall Study|Lost to Follow-up|0|||
125176910|NCT04895982|450266114|FG007|Overall Study|Lost to Follow-up|0|||
125176911|NCT04895982|450266115|FG008|Overall Study|Lost to Follow-up|1|||
125176912|NCT04895982|450266116|FG009|Overall Study|Lost to Follow-up|0|||
125176913|NCT04895982|450266117|FG010|Overall Study|Lost to Follow-up|0|||
125176914|NCT04895982|450266118|FG011|Overall Study|Lost to Follow-up|0|||
125176915|NCT04895982|450266107|FG000|Overall Study|Refused further study procedures|0|||
125176916|NCT04895982|450266108|FG001|Overall Study|Refused further study procedures|0|||
125176917|NCT04895982|450266109|FG002|Overall Study|Refused further study procedures|1|||
125176918|NCT04895982|450266110|FG003|Overall Study|Refused further study procedures|0|||
125176919|NCT04895982|450266111|FG004|Overall Study|Refused further study procedures|0|||
125176920|NCT04895982|450266112|FG005|Overall Study|Refused further study procedures|0|||
125176921|NCT04895982|450266113|FG006|Overall Study|Refused further study procedures|0|||
125176922|NCT04895982|450266114|FG007|Overall Study|Refused further study procedures|0|||
125176923|NCT04895982|450266115|FG008|Overall Study|Refused further study procedures|0|||
125176924|NCT04895982|450266116|FG009|Overall Study|Refused further study procedures|0|||
125176925|NCT04895982|450266117|FG010|Overall Study|Refused further study procedures|0|||
125176926|NCT04895982|450266118|FG011|Overall Study|Refused further study procedures|0|||
125176927|NCT01893346|450266119|FG000|Overall Study|Lost to Follow-up|0|||
125176928|NCT01893346|450266120|FG001|Overall Study|Lost to Follow-up|1|||
125176929|NCT01893346|450266121|FG002|Overall Study|Lost to Follow-up|0|||
125176930|NCT01893346|450266122|FG003|Overall Study|Lost to Follow-up|0|||
125176931|NCT01893346|450266119|FG000|Overall Study|Protocol Violation|1|||
125176932|NCT01893346|450266120|FG001|Overall Study|Protocol Violation|0|||
125176933|NCT01893346|450266121|FG002|Overall Study|Protocol Violation|0|||
125176934|NCT01893346|450266122|FG003|Overall Study|Protocol Violation|0|||
125176935|NCT01893346|450266119|FG000|Overall Study|Withdrawal by Subject|2|||
125176936|NCT01893346|450266120|FG001|Overall Study|Withdrawal by Subject|0|||
125176937|NCT01893346|450266121|FG002|Overall Study|Withdrawal by Subject|0|||
125176938|NCT01893346|450266122|FG003|Overall Study|Withdrawal by Subject|0|||
125176939|NCT01449812|450266125|FG000|Overall Study|Migrated/moved from study area|1|||
125176940|NCT01449812|450266126|FG001|Overall Study|Migrated/moved from study area|0|||
125176941|NCT01449812|450266127|FG002|Overall Study|Migrated/moved from study area|0|||
125176942|NCT01449812|450266125|FG000|Overall Study|Withdrawal by Subject|0|||
125176943|NCT01449812|450266126|FG001|Overall Study|Withdrawal by Subject|0|||
125176944|NCT01449812|450266127|FG002|Overall Study|Withdrawal by Subject|1|||
125176945|NCT01449812|450266125|FG000|Overall Study|Lost to Follow-up|1|||
125176946|NCT01449812|450266126|FG001|Overall Study|Lost to Follow-up|0|||
125176947|NCT01449812|450266127|FG002|Overall Study|Lost to Follow-up|0|||
125176948|NCT01866098|450266128|FG000|Overall Study|Lost to Follow-up|11|||
125176949|NCT01866098|450266129|FG001|Overall Study|Lost to Follow-up|18|||
125176950|NCT01866098|450266130|FG002|Overall Study|Lost to Follow-up|13|||
125176951|NCT01866098|450266128|FG000|Overall Study|Physician Decision|0|||
125176952|NCT01866098|450266129|FG001|Overall Study|Physician Decision|1|||
125176953|NCT01866098|450266130|FG002|Overall Study|Physician Decision|2|||
125176954|NCT01866098|450266128|FG000|Overall Study|Adverse Event|1|||
125176955|NCT01866098|450266129|FG001|Overall Study|Adverse Event|5|||
125176956|NCT01866098|450266130|FG002|Overall Study|Adverse Event|4|||
125176957|NCT01866098|450266128|FG000|Overall Study|Protocol Violation|1|||
125176958|NCT01866098|450266129|FG001|Overall Study|Protocol Violation|0|||
125176959|NCT01866098|450266130|FG002|Overall Study|Protocol Violation|0|||
125176960|NCT01866098|450266128|FG000|Overall Study|Withdrawal by Subject|1|||
125176961|NCT01866098|450266129|FG001|Overall Study|Withdrawal by Subject|2|||
125176962|NCT01866098|450266130|FG002|Overall Study|Withdrawal by Subject|0|||
125176963|NCT01866098|450266128|FG000|Overall Study|Unrelated Hospitalization|2|||
125176964|NCT01866098|450266129|FG001|Overall Study|Unrelated Hospitalization|0|||
125176965|NCT01866098|450266130|FG002|Overall Study|Unrelated Hospitalization|1|||
125176966|NCT01866098|450266128|FG000|Overall Study|Non-compliance|1|||
125176967|NCT01866098|450266129|FG001|Overall Study|Non-compliance|0|||
125176968|NCT01866098|450266130|FG002|Overall Study|Non-compliance|1|||
125176969|NCT01866098|450266128|FG000|Overall Study|Pregnancy|2|||
125176970|NCT01866098|450266129|FG001|Overall Study|Pregnancy|0|||
125176971|NCT01866098|450266130|FG002|Overall Study|Pregnancy|0|||
125176972|NCT01866098|450266128|FG000|Overall Study|Death|0|||
125176973|NCT01866098|450266129|FG001|Overall Study|Death|1|||
125176974|NCT01866098|450266130|FG002|Overall Study|Death|0|||
125176975|NCT04239027|450266131|FG000|Overall Study|Adverse Event|4|||
125176976|NCT04239027|450266131|FG000|Overall Study|Withdrawal by Subject|9|||
125176977|NCT04239027|450266131|FG000|Overall Study|Death|1|||
125176978|NCT04239027|450266131|FG000|Overall Study|Physician Decision|9|||
125176979|NCT04239027|450266131|FG000|Overall Study|Lost to Follow-up|2|||
125176980|NCT04239027|450266131|FG000|Overall Study|Lack of Efficacy|1|||
125176981|NCT03449446|450266132|FG000|Overall Study|Randomized but Never Treated|0|||
125176982|NCT03449446|450266133|FG001|Overall Study|Randomized but Never Treated|0|||
125176983|NCT03449446|450266134|FG002|Overall Study|Randomized but Never Treated|1|||
125232285|NCT02897349|450479739|FG001|Overall Study|Other than listed above|1|||
125232286|NCT01027949|450479745|FG000|Overall Study|Death|174|||
125232287|NCT01027949|450479745|FG000|Overall Study|Progressive Disease|163|||
125232288|NCT01027949|450479745|FG000|Overall Study|Adverse Event|172|||
125232289|NCT01027949|450479745|FG000|Overall Study|Withdrawal by Subject|113|||
125232290|NCT01027949|450479745|FG000|Overall Study|Lost to Follow-up|17|||
125232291|NCT01027949|450479745|FG000|Overall Study|Protocol Violation|13|||
125232292|NCT01027949|450479745|FG000|Overall Study|PI Decision|8|||
125232293|NCT01027949|450479745|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
125232294|NCT01027949|450479745|FG000|Overall Study|Non-compliance with Study Procedures|7|||
125232295|NCT01027949|450479745|FG000|Overall Study|Lung Transplant|5|||
125232296|NCT01027949|450479745|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
125232297|NCT01027949|450479745|FG000|Overall Study|Use of Excluded Medication|2|||
125232298|NCT01027949|450479745|FG000|Overall Study|Patient Self-discontinuation|1|||
125232299|NCT01027949|450479745|FG000|Overall Study|Pregnancy|1|||
125232300|NCT01027949|450479745|FG000|Overall Study|Surgery|1|||
125232301|NCT00671749|450479748|FG000|Overall Study|Adverse Event|2|||
125232302|NCT00671749|450479748|FG000|Overall Study|Withdrawal by Subject|4|||
125232303|NCT00671749|450479748|FG000|Overall Study|Protocol Violation|1|||
125232304|NCT00671749|450479748|FG000|Overall Study|Lost to Follow-up|1|||
125232305|NCT02515227|450479749|FG000|Overall Study|Adverse Event|0|||
125232306|NCT02515227|450479750|FG001|Overall Study|Adverse Event|2|||
125232307|NCT02515227|450479749|FG000|Overall Study|Progressive disease|2|||
125232308|NCT02515227|450479750|FG001|Overall Study|Progressive disease|9|||
125232309|NCT03451071|450479751|FG000|First Vaccine|Withdrawal by Subject|1|||
125232310|NCT03451071|450479751|FG000|Second Vaccine|Lost to Follow-up|19|||
125232311|NCT03451071|450479751|FG000|Third Vaccine|Lost to Follow-up|22|||
125232312|NCT03451071|450479751|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
125232313|NCT01901185|450479752|FG000|Overall Study|Withdrawal by Subject|2|||
125232314|NCT03502798|450479753|FG000|Overall Study|equipment failure|0|||
125232315|NCT03502798|450479754|FG001|Overall Study|equipment failure|7|||
125232316|NCT00296335|450479755|FG000|Overall Study|Recurrence|3|||
125232317|NCT00296335|450479756|FG001|Overall Study|Recurrence|51|||
125232318|NCT00296335|450479755|FG000|Overall Study|Adverse Event|17|||
125232319|NCT00296335|450479756|FG001|Overall Study|Adverse Event|27|||
125176984|NCT03449446|450266135|FG003|Overall Study|Randomized but Never Treated|1|||
125176985|NCT03449446|450266136|FG004|Overall Study|Randomized but Never Treated|1|||
125176986|NCT03449446|450266137|FG005|Overall Study|Randomized but Never Treated|0|||
125176987|NCT03449446|450266138|FG006|Overall Study|Randomized but Never Treated|0|||
125176988|NCT03449446|450266132|FG000|Overall Study|Unknown Reason|33|||
125176989|NCT03449446|450266133|FG001|Overall Study|Unknown Reason|1|||
125176990|NCT03449446|450266134|FG002|Overall Study|Unknown Reason|1|||
125176991|NCT03449446|450266135|FG003|Overall Study|Unknown Reason|1|||
125176992|NCT03449446|450266136|FG004|Overall Study|Unknown Reason|2|||
125176993|NCT03449446|450266137|FG005|Overall Study|Unknown Reason|2|||
125176994|NCT03449446|450266138|FG006|Overall Study|Unknown Reason|0|||
125176995|NCT03449446|450266132|FG000|Overall Study|Withdrew Consent|1|||
125176996|NCT03449446|450266133|FG001|Overall Study|Withdrew Consent|3|||
125176997|NCT03449446|450266134|FG002|Overall Study|Withdrew Consent|1|||
125176998|NCT03449446|450266135|FG003|Overall Study|Withdrew Consent|4|||
125176999|NCT03449446|450266136|FG004|Overall Study|Withdrew Consent|4|||
125177000|NCT03449446|450266137|FG005|Overall Study|Withdrew Consent|4|||
125177001|NCT03449446|450266138|FG006|Overall Study|Withdrew Consent|1|||
125177002|NCT03449446|450266132|FG000|Overall Study|Adverse Event|1|||
125177003|NCT03449446|450266133|FG001|Overall Study|Adverse Event|2|||
125177004|NCT03449446|450266134|FG002|Overall Study|Adverse Event|1|||
125177005|NCT03449446|450266135|FG003|Overall Study|Adverse Event|0|||
125177006|NCT03449446|450266136|FG004|Overall Study|Adverse Event|0|||
125177007|NCT03449446|450266137|FG005|Overall Study|Adverse Event|2|||
125177008|NCT03449446|450266138|FG006|Overall Study|Adverse Event|0|||
125177009|NCT03449446|450266132|FG000|Overall Study|Lost to Follow-up|0|||
125177010|NCT03449446|450266133|FG001|Overall Study|Lost to Follow-up|0|||
125177011|NCT03449446|450266134|FG002|Overall Study|Lost to Follow-up|2|||
125232320|NCT00296335|450479755|FG000|Overall Study|Lost to Follow-up|7|||
125232321|NCT00296335|450479756|FG001|Overall Study|Lost to Follow-up|33|||
125177012|NCT03449446|450266135|FG003|Overall Study|Lost to Follow-up|1|||
125177013|NCT03449446|450266136|FG004|Overall Study|Lost to Follow-up|3|||
125177014|NCT03449446|450266137|FG005|Overall Study|Lost to Follow-up|0|||
125232322|NCT00296335|450479755|FG000|Overall Study|Physician Decision|3|||
125177015|NCT03449446|450266138|FG006|Overall Study|Lost to Follow-up|0|||
125177016|NCT03449446|450266132|FG000|Overall Study|Investigator's Discretion|0|||
125177017|NCT03449446|450266133|FG001|Overall Study|Investigator's Discretion|1|||
125232323|NCT00296335|450479756|FG001|Overall Study|Physician Decision|11|||
125232324|NCT01401322|450479757|FG000|Overall Study|Withdrawal by Subject|1|||
125232325|NCT01401322|450479757|FG000|Overall Study|Physician Decision|1|||
125232326|NCT02737722|450479758|FG000|Overall Study|Physician Decision|0|||
125232327|NCT02737722|450479759|FG001|Overall Study|Physician Decision|0|||
125232328|NCT02737722|450479760|FG002|Overall Study|Physician Decision|1|||
125232329|NCT02737722|450479761|FG003|Overall Study|Physician Decision|0|||
125177018|NCT03449446|450266134|FG002|Overall Study|Investigator's Discretion|1|||
125177019|NCT03449446|450266135|FG003|Overall Study|Investigator's Discretion|2|||
125177020|NCT03449446|450266136|FG004|Overall Study|Investigator's Discretion|0|||
125177021|NCT03449446|450266137|FG005|Overall Study|Investigator's Discretion|0|||
125177022|NCT03449446|450266138|FG006|Overall Study|Investigator's Discretion|0|||
125177023|NCT03449446|450266132|FG000|Overall Study|Non Compliance with Study Drug|1|||
125177024|NCT03449446|450266133|FG001|Overall Study|Non Compliance with Study Drug|0|||
125177025|NCT03449446|450266134|FG002|Overall Study|Non Compliance with Study Drug|0|||
125177026|NCT03449446|450266135|FG003|Overall Study|Non Compliance with Study Drug|0|||
125177027|NCT03449446|450266136|FG004|Overall Study|Non Compliance with Study Drug|0|||
125177028|NCT03449446|450266137|FG005|Overall Study|Non Compliance with Study Drug|0|||
125177029|NCT03449446|450266138|FG006|Overall Study|Non Compliance with Study Drug|0|||
125177030|NCT03449446|450266132|FG000|Overall Study|Protocol Violation|0|||
125177031|NCT03449446|450266133|FG001|Overall Study|Protocol Violation|0|||
125177032|NCT03449446|450266134|FG002|Overall Study|Protocol Violation|0|||
125177033|NCT03449446|450266135|FG003|Overall Study|Protocol Violation|0|||
125177034|NCT03449446|450266136|FG004|Overall Study|Protocol Violation|1|||
125177035|NCT03449446|450266137|FG005|Overall Study|Protocol Violation|1|||
125177036|NCT03449446|450266138|FG006|Overall Study|Protocol Violation|0|||
125177037|NCT03449446|450266132|FG000|Overall Study|Death|0|||
125177038|NCT03449446|450266133|FG001|Overall Study|Death|0|||
125177039|NCT03449446|450266134|FG002|Overall Study|Death|0|||
125177040|NCT03449446|450266135|FG003|Overall Study|Death|0|||
125177041|NCT03449446|450266136|FG004|Overall Study|Death|1|||
125177042|NCT03449446|450266137|FG005|Overall Study|Death|0|||
125177043|NCT03449446|450266138|FG006|Overall Study|Death|0|||
125177044|NCT02839707|450266145|FG000|Phase I|Not eligible for analysis|9|||
125177045|NCT02839707|450266146|FG001|Phase I|Not eligible for analysis|0|||
125177046|NCT02839707|450266147|FG002|Phase I|Not eligible for analysis|0|||
125177047|NCT02839707|450266145|FG000|Phase II|Not treated according to protocol|4|||
125177048|NCT02839707|450266146|FG001|Phase II|Not treated according to protocol|0|||
125177049|NCT02839707|450266147|FG002|Phase II|Not treated according to protocol|2|||
125177050|NCT02839707|450266145|FG000|Phase III|Not treated according to protocol|0|||
125177051|NCT02839707|450266146|FG001|Phase III|Not treated according to protocol|0|||
125177052|NCT02839707|450266147|FG002|Phase III|Not treated according to protocol|4|||
125177053|NCT01950390|450266148|FG000|Overall Study|Never started treatment|3|||
125177054|NCT01950390|450266149|FG001|Overall Study|Never started treatment|2|||
125177055|NCT01950390|450266148|FG000|Overall Study|Disease progression|45|||
125177056|NCT01950390|450266149|FG001|Overall Study|Disease progression|52|||
125177057|NCT01950390|450266148|FG000|Overall Study|Adverse Event|22|||
125177058|NCT01950390|450266149|FG001|Overall Study|Adverse Event|16|||
125177059|NCT01950390|450266148|FG000|Overall Study|Death|5|||
125177060|NCT01950390|450266149|FG001|Overall Study|Death|3|||
125177061|NCT01950390|450266148|FG000|Overall Study|Withdrawal by Subject|5|||
125177062|NCT01950390|450266149|FG001|Overall Study|Withdrawal by Subject|1|||
125177063|NCT01950390|450266148|FG000|Overall Study|Alternative therapy|0|||
125177064|NCT01950390|450266149|FG001|Overall Study|Alternative therapy|3|||
125177065|NCT01950390|450266148|FG000|Overall Study|Complicating disease|1|||
125177066|NCT01950390|450266149|FG001|Overall Study|Complicating disease|0|||
125177067|NCT01950390|450266148|FG000|Overall Study|On treatment|1|||
125177068|NCT01950390|450266149|FG001|Overall Study|On treatment|0|||
125177069|NCT01950390|450266148|FG000|Overall Study|Symptomatic deterioration|2|||
125177070|NCT01950390|450266149|FG001|Overall Study|Symptomatic deterioration|1|||
125177071|NCT01950390|450266148|FG000|Overall Study|Physician Decision|0|||
125177072|NCT01950390|450266149|FG001|Overall Study|Physician Decision|4|||
125177073|NCT01950390|450266148|FG000|Overall Study|Lack of clinical benefit|0|||
125177074|NCT01950390|450266149|FG001|Overall Study|Lack of clinical benefit|1|||
125177075|NCT01950390|450266148|FG000|Overall Study|Maintained PR and moved to observation only|0|||
125177076|NCT01950390|450266149|FG001|Overall Study|Maintained PR and moved to observation only|1|||
125177077|NCT02586688|450267904|FG000|Overall Study|Lost to Follow-up|2|||
125177078|NCT02586688|450267905|FG001|Overall Study|Lost to Follow-up|1|||
125177079|NCT02586688|450267904|FG000|Overall Study|Withdrawal by Subject|1|||
125177080|NCT02586688|450267905|FG001|Overall Study|Withdrawal by Subject|1|||
125177081|NCT02586688|450267904|FG000|Overall Study|Adverse Event|3|||
125177082|NCT02586688|450267905|FG001|Overall Study|Adverse Event|1|||
125177083|NCT01433055|450267906|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
125177084|NCT01433055|450267907|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
125177085|NCT01433055|450267906|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
125177086|NCT01433055|450267907|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
125177087|NCT02717455|450267908|FG000|Overall Study|Adverse Event|1|||
125177088|NCT02717455|450267909|FG001|Overall Study|Adverse Event|0|||
125177089|NCT02717455|450267910|FG002|Overall Study|Adverse Event|0|||
125177090|NCT02717455|450267911|FG003|Overall Study|Adverse Event|2|||
125177091|NCT02717455|450267912|FG004|Overall Study|Adverse Event|2|||
125177092|NCT02717455|450267913|FG005|Overall Study|Adverse Event|2|||
125177093|NCT02717455|450267908|FG000|Overall Study|Withdrawal by Subject|1|||
125177094|NCT02717455|450267909|FG001|Overall Study|Withdrawal by Subject|1|||
125177095|NCT02717455|450267910|FG002|Overall Study|Withdrawal by Subject|0|||
125177096|NCT02717455|450267911|FG003|Overall Study|Withdrawal by Subject|2|||
125177097|NCT02717455|450267912|FG004|Overall Study|Withdrawal by Subject|2|||
125177098|NCT02717455|450267913|FG005|Overall Study|Withdrawal by Subject|1|||
125177099|NCT02717455|450267908|FG000|Overall Study|Death|1|||
125177100|NCT02717455|450267909|FG001|Overall Study|Death|0|||
125177101|NCT02717455|450267910|FG002|Overall Study|Death|0|||
125177102|NCT02717455|450267911|FG003|Overall Study|Death|0|||
125177103|NCT02717455|450267912|FG004|Overall Study|Death|1|||
125177104|NCT02717455|450267913|FG005|Overall Study|Death|0|||
125177105|NCT02717455|450267908|FG000|Overall Study|Did not receive study drug|0|||
125177106|NCT02717455|450267909|FG001|Overall Study|Did not receive study drug|0|||
125177107|NCT02717455|450267910|FG002|Overall Study|Did not receive study drug|0|||
125177108|NCT02717455|450267911|FG003|Overall Study|Did not receive study drug|1|||
125177109|NCT02717455|450267912|FG004|Overall Study|Did not receive study drug|0|||
125177110|NCT02717455|450267913|FG005|Overall Study|Did not receive study drug|1|||
125177111|NCT02717455|450267908|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
125177112|NCT02717455|450267909|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
125177113|NCT02717455|450267910|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
125177114|NCT02717455|450267911|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
125177115|NCT02717455|450267912|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
125177116|NCT02717455|450267913|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
125177117|NCT02717455|450267908|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
125177118|NCT02717455|450267909|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
125177119|NCT02717455|450267910|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
125177120|NCT02717455|450267911|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
125177121|NCT02717455|450267912|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
125177122|NCT02717455|450267913|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
125177123|NCT00233948|450267919|FG000|Overall Study|Adverse Event|1|||
125177124|NCT00233948|450267920|FG001|Overall Study|Adverse Event|0|||
125177125|NCT00233948|450267921|FG002|Overall Study|Adverse Event|0|||
125177126|NCT00233948|450267922|FG003|Overall Study|Adverse Event|0|||
125177127|NCT00233948|450267923|FG004|Overall Study|Adverse Event|0|||
125177128|NCT00233948|450267924|FG005|Overall Study|Adverse Event|0|||
125177129|NCT03573830|450267925|FG000|Overall Study|Dropped without completing treatment|0|||
125177130|NCT03573830|450267926|FG001|Overall Study|Dropped without completing treatment|7|||
125177131|NCT03573830|450267925|FG000|Overall Study|Lost to Follow-up|4|||
125177132|NCT03573830|450267926|FG001|Overall Study|Lost to Follow-up|0|||
125177133|NCT02465398|450267933|FG000|Overall Study|Death|7|||
125177134|NCT02465398|450267933|FG000|Overall Study|Revision|7|||
125177135|NCT02465398|450267933|FG000|Overall Study|did not receive study device|1|||
125177136|NCT02465398|450267933|FG000|Overall Study|Withdrawal by Subject|1|||
125177137|NCT02465398|450267933|FG000|Overall Study|Lost to Follow-up|14|||
125177138|NCT05244122|450267938|FG000|Overall Study|Withdrawal by Subject|318|||
125177139|NCT02969382|450267943|FG000|Overall Study|Adverse Event|8|||
125177140|NCT02969382|450267944|FG001|Overall Study|Adverse Event|10|||
125177141|NCT02969382|450267943|FG000|Overall Study|Lack of Efficacy|4|||
125177142|NCT02969382|450267944|FG001|Overall Study|Lack of Efficacy|5|||
125177143|NCT02969382|450267943|FG000|Overall Study|Death|0|||
125177144|NCT02969382|450267944|FG001|Overall Study|Death|1|||
125177145|NCT02969382|450267943|FG000|Overall Study|PROTOCOL DEVIATION|0|||
125177146|NCT02969382|450267944|FG001|Overall Study|PROTOCOL DEVIATION|1|||
125177147|NCT02969382|450267943|FG000|Overall Study|Withdrawal by Subject|14|||
125177148|NCT02969382|450267944|FG001|Overall Study|Withdrawal by Subject|9|||
125177149|NCT02847260|450267948|FG000|Overall Study|Adverse Event|3|||
125177150|NCT02847260|450267948|FG000|Overall Study|Withdrawal by Subject|2|||
125177151|NCT02847260|450267948|FG000|Overall Study|Clinical Deterioration|1|||
125177152|NCT02847260|450267948|FG000|Overall Study|Physician Decision|1|||
125177153|NCT00886015|450267951|FG000|Overall Study|Death|0|||
125177154|NCT00886015|450267952|FG001|Overall Study|Death|2|||
125177155|NCT01692626|450267953|FG000|Overall Study|Death|0|||
125177156|NCT01692626|450267954|FG001|Overall Study|Death|1|||
125177157|NCT01692626|450267953|FG000|Overall Study|Adverse Event|2|||
125177158|NCT01692626|450267954|FG001|Overall Study|Adverse Event|3|||
125177159|NCT01692626|450267953|FG000|Overall Study|Protocol Violation|1|||
125177160|NCT01692626|450267954|FG001|Overall Study|Protocol Violation|2|||
125177161|NCT01692626|450267953|FG000|Overall Study|Withdrawal by Subject|1|||
125177162|NCT01692626|450267954|FG001|Overall Study|Withdrawal by Subject|0|||
125177163|NCT00855894|450267955|FG000|Overall Study|Death|31|||
125177164|NCT00855894|450267955|FG000|Overall Study|Patient's decision|1|||
125177165|NCT00855894|450267955|FG000|Overall Study|Disease progression|1|||
125177166|NCT00444587|450267965|FG000|Overall Study|Death|2|||
125177167|NCT00444587|450267966|FG001|Overall Study|Death|1|||
125177168|NCT00444587|450267965|FG000|Overall Study|Progression of the disease|73|||
125177169|NCT00444587|450267966|FG001|Overall Study|Progression of the disease|8|||
125232330|NCT00284856|450479776|FG000|Overall Study|Adverse Event|3|||
125232331|NCT00284856|450479777|FG001|Overall Study|Adverse Event|3|||
125232332|NCT00284856|450479778|FG002|Overall Study|Adverse Event|3|||
125232333|NCT00284856|450479776|FG000|Overall Study|Lack of Efficacy|2|||
125232334|NCT00284856|450479777|FG001|Overall Study|Lack of Efficacy|1|||
125232335|NCT00284856|450479778|FG002|Overall Study|Lack of Efficacy|8|||
125232336|NCT00284856|450479776|FG000|Overall Study|Lost to Follow-up|25|||
125232337|NCT00284856|450479777|FG001|Overall Study|Lost to Follow-up|21|||
125232338|NCT00284856|450479778|FG002|Overall Study|Lost to Follow-up|22|||
125232339|NCT00284856|450479776|FG000|Overall Study|Protocol Violation|5|||
125232340|NCT00284856|450479777|FG001|Overall Study|Protocol Violation|4|||
125232341|NCT00284856|450479778|FG002|Overall Study|Protocol Violation|5|||
125232342|NCT00284856|450479776|FG000|Overall Study|Withdrawal by Subject|12|||
125232343|NCT00284856|450479777|FG001|Overall Study|Withdrawal by Subject|16|||
125232344|NCT00284856|450479778|FG002|Overall Study|Withdrawal by Subject|18|||
125232345|NCT00284856|450479776|FG000|Overall Study|Other|4|||
125232346|NCT00284856|450479777|FG001|Overall Study|Other|5|||
125232347|NCT00284856|450479778|FG002|Overall Study|Other|4|||
125232348|NCT01192815|450479780|FG000|Overall Study|Withdrawal by Subject|1|||
125232349|NCT01192815|450479780|FG000|Overall Study|Lack of Efficacy|1|||
125232350|NCT03451045|450479782|FG000|Overall Study|Lack of Efficacy|3|||
125232351|NCT03451045|450479783|FG001|Overall Study|Lack of Efficacy|2|||
125232352|NCT03451045|450479784|FG002|Overall Study|Lack of Efficacy|2|||
125232353|NCT03451045|450479782|FG000|Overall Study|Physician Decision|1|||
125232354|NCT03451045|450479783|FG001|Overall Study|Physician Decision|1|||
125232355|NCT03451045|450479784|FG002|Overall Study|Physician Decision|1|||
125232356|NCT03451045|450479782|FG000|Overall Study|Withdrawal by Subject|4|||
125232357|NCT03451045|450479783|FG001|Overall Study|Withdrawal by Subject|0|||
125232358|NCT03451045|450479784|FG002|Overall Study|Withdrawal by Subject|5|||
125232359|NCT03451045|450479782|FG000|Overall Study|Pregnancy|0|||
125232360|NCT03451045|450479783|FG001|Overall Study|Pregnancy|0|||
125232361|NCT03451045|450479784|FG002|Overall Study|Pregnancy|2|||
125232362|NCT03451045|450479782|FG000|Overall Study|Adverse Event|7|||
125232363|NCT03451045|450479783|FG001|Overall Study|Adverse Event|1|||
125232364|NCT03451045|450479784|FG002|Overall Study|Adverse Event|3|||
125232365|NCT03451045|450479782|FG000|Overall Study|Non-compliance with study|2|||
125232366|NCT03451045|450479783|FG001|Overall Study|Non-compliance with study|0|||
125232367|NCT03451045|450479784|FG002|Overall Study|Non-compliance with study|1|||
125232368|NCT03451045|450479782|FG000|Overall Study|any other reason|10|||
125232369|NCT03451045|450479783|FG001|Overall Study|any other reason|2|||
125232370|NCT03451045|450479784|FG002|Overall Study|any other reason|13|||
125232371|NCT04142242|450479787|FG000|Stage I|Non-compliance with the protocol|1|||
125232372|NCT04142242|450479788|FG001|Stage I|Non-compliance with the protocol|0|||
125232373|NCT04142242|450479789|FG002|Stage I|Non-compliance with the protocol|0|||
125232374|NCT04142242|450479790|FG003|Stage I|Non-compliance with the protocol|0|||
125232375|NCT04142242|450479791|FG004|Stage I|Non-compliance with the protocol|0|||
125232376|NCT04142242|450479792|FG005|Stage I|Non-compliance with the protocol|1|||
125232377|NCT04142242|450479787|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
125232378|NCT04142242|450479788|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
125232379|NCT04142242|450479789|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
125232380|NCT04142242|450479790|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
125232381|NCT04142242|450479791|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
125232382|NCT04142242|450479792|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
125232383|NCT04142242|450479787|FG000|Stage II|Non-compliance with the protocol|0|||
125232384|NCT04142242|450479788|FG001|Stage II|Non-compliance with the protocol|0|||
125232385|NCT04142242|450479789|FG002|Stage II|Non-compliance with the protocol|0|||
125232386|NCT04142242|450479790|FG003|Stage II|Non-compliance with the protocol|2|||
125232387|NCT04142242|450479791|FG004|Stage II|Non-compliance with the protocol|0|||
125232388|NCT04142242|450479792|FG005|Stage II|Non-compliance with the protocol|0|||
125232389|NCT04142242|450479787|FG000|Stage II|Lost to Follow-up|0|||
125232390|NCT04142242|450479788|FG001|Stage II|Lost to Follow-up|0|||
125232391|NCT04142242|450479789|FG002|Stage II|Lost to Follow-up|1|||
125232392|NCT04142242|450479790|FG003|Stage II|Lost to Follow-up|2|||
125232393|NCT04142242|450479791|FG004|Stage II|Lost to Follow-up|0|||
125232394|NCT04142242|450479792|FG005|Stage II|Lost to Follow-up|0|||
125232395|NCT04142242|450479787|FG000|Stage II|Withdrawal by Subject|0|||
125232396|NCT04142242|450479788|FG001|Stage II|Withdrawal by Subject|0|||
125232397|NCT04142242|450479789|FG002|Stage II|Withdrawal by Subject|5|||
125232398|NCT04142242|450479790|FG003|Stage II|Withdrawal by Subject|9|||
125232399|NCT04142242|450479791|FG004|Stage II|Withdrawal by Subject|0|||
125232400|NCT04142242|450479792|FG005|Stage II|Withdrawal by Subject|0|||
125232401|NCT03040726|450479793|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
125232402|NCT03040726|450479794|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
125232403|NCT03040726|450479793|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
125232404|NCT03040726|450479794|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
125232405|NCT03040726|450479793|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
125232406|NCT03040726|450479794|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
125232407|NCT03040726|450479793|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
125232408|NCT03040726|450479794|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
125232409|NCT03040726|450479793|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
125232410|NCT03040726|450479794|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
125232411|NCT00465179|450479796|FG000|Overall Study|Adverse Event|4|||
125232412|NCT00465179|450479796|FG000|Overall Study|Withdrawal by Subject|2|||
125232413|NCT00465179|450479796|FG000|Overall Study|Progression of Disease|47|||
125232414|NCT00262925|450479802|FG000|Overall Study|Lack of Efficacy|3|||
125232415|NCT00262925|450479802|FG000|Overall Study|Adverse Event|4|||
125232416|NCT00262925|450479802|FG000|Overall Study|Death|2|||
125232417|NCT00262925|450479802|FG000|Overall Study|alternative therapy|1|||
125232418|NCT00262925|450479802|FG000|Overall Study|Other|1|||
125232419|NCT04682301|450479804|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
125232420|NCT04682301|450479804|FG000|Overall Study|Death|2|||
125232421|NCT05219162|450479805|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
125232422|NCT05219162|450479805|FG000|Overall Study|Withdrawal by Subject|23|||
125232423|NCT01499810|450479821|FG000|Overall Study|Lost to Follow-up|10|||
125232424|NCT01499810|450479821|FG000|Overall Study|Protocol Violation|1|||
125232425|NCT01499810|450479821|FG000|Overall Study|Withdrawal by Subject|1|||
125232426|NCT02273167|450479827|FG000|Overall Study|Adverse Event|1|||
125232427|NCT02273167|450479828|FG001|Overall Study|Adverse Event|0|||
125232428|NCT02273167|450479829|FG002|Overall Study|Adverse Event|0|||
125232429|NCT02273167|450479827|FG000|Overall Study|Protocol Violation|3|||
125232430|NCT02273167|450479828|FG001|Overall Study|Protocol Violation|1|||
125232431|NCT02273167|450479829|FG002|Overall Study|Protocol Violation|1|||
125232432|NCT02273167|450479827|FG000|Overall Study|Lost to Follow-up|0|||
125232433|NCT02273167|450479828|FG001|Overall Study|Lost to Follow-up|1|||
125232434|NCT02273167|450479829|FG002|Overall Study|Lost to Follow-up|1|||
125232435|NCT02273167|450479827|FG000|Overall Study|Withdrawal by Subject|10|||
125232436|NCT02273167|450479828|FG001|Overall Study|Withdrawal by Subject|12|||
125232437|NCT02273167|450479829|FG002|Overall Study|Withdrawal by Subject|11|||
125232438|NCT02273167|450479827|FG000|Overall Study|Various|10|||
125232439|NCT02273167|450479828|FG001|Overall Study|Various|9|||
125232440|NCT02273167|450479829|FG002|Overall Study|Various|8|||
125232441|NCT02781324|450479834|FG000|Overall Study|Withdrawal by Subject|1|||
125232442|NCT02781324|450479835|FG001|Overall Study|Withdrawal by Subject|0|||
125232443|NCT02781324|450479834|FG000|Overall Study|Physician Decision|1|||
125232444|NCT02781324|450479835|FG001|Overall Study|Physician Decision|2|||
125232445|NCT00834041|450479836|FG000|Overall Study|Withdrawal by Subject|1|||
125232446|NCT00834041|450479837|FG001|Overall Study|Withdrawal by Subject|0|||
125232447|NCT00834041|450479836|FG000|Overall Study|Lost to Follow-up|0|||
125232448|NCT00834041|450479837|FG001|Overall Study|Lost to Follow-up|1|||
125232449|NCT03353220|450479838|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
125232450|NCT03353220|450479839|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
125232451|NCT02711137|450481674|FG000|Overall Study|Death|1|||
125232452|NCT02711137|450481675|FG001|Overall Study|Death|4|||
125232453|NCT02711137|450481676|FG002|Overall Study|Death|5|||
125232454|NCT02711137|450481677|FG003|Overall Study|Death|5|||
125232455|NCT02711137|450481678|FG004|Overall Study|Death|3|||
125232456|NCT02711137|450481679|FG005|Overall Study|Death|1|||
125232457|NCT02711137|450481680|FG006|Overall Study|Death|61|||
125232458|NCT02711137|450481681|FG007|Overall Study|Death|3|||
125232459|NCT02711137|450481682|FG008|Overall Study|Death|0|||
125232460|NCT02711137|450481683|FG009|Overall Study|Death|1|||
125232461|NCT02711137|450481684|FG010|Overall Study|Death|1|||
125232462|NCT02711137|450481685|FG011|Overall Study|Death|1|||
125232463|NCT02711137|450481686|FG012|Overall Study|Death|0|||
125232464|NCT02711137|450481687|FG013|Overall Study|Death|0|||
125232465|NCT02711137|450481688|FG014|Overall Study|Death|0|||
125232466|NCT02711137|450481674|FG000|Overall Study|Study Terminated by Sponsor|0|||
125232467|NCT02711137|450481675|FG001|Overall Study|Study Terminated by Sponsor|0|||
125232468|NCT02711137|450481676|FG002|Overall Study|Study Terminated by Sponsor|1|||
125232469|NCT02711137|450481677|FG003|Overall Study|Study Terminated by Sponsor|0|||
125232470|NCT02711137|450481678|FG004|Overall Study|Study Terminated by Sponsor|0|||
125232471|NCT02711137|450481679|FG005|Overall Study|Study Terminated by Sponsor|0|||
125232472|NCT02711137|450481680|FG006|Overall Study|Study Terminated by Sponsor|1|||
125232473|NCT02711137|450481681|FG007|Overall Study|Study Terminated by Sponsor|0|||
125232474|NCT02711137|450481682|FG008|Overall Study|Study Terminated by Sponsor|0|||
125232475|NCT02711137|450481683|FG009|Overall Study|Study Terminated by Sponsor|0|||
125232476|NCT02711137|450481684|FG010|Overall Study|Study Terminated by Sponsor|0|||
125232477|NCT02711137|450481685|FG011|Overall Study|Study Terminated by Sponsor|0|||
125232478|NCT02711137|450481686|FG012|Overall Study|Study Terminated by Sponsor|0|||
125232479|NCT02711137|450481687|FG013|Overall Study|Study Terminated by Sponsor|0|||
125232480|NCT02711137|450481688|FG014|Overall Study|Study Terminated by Sponsor|0|||
125232481|NCT02711137|450481674|FG000|Overall Study|Physician Decision|1|||
125232482|NCT02711137|450481675|FG001|Overall Study|Physician Decision|0|||
125232483|NCT02711137|450481676|FG002|Overall Study|Physician Decision|2|||
125232484|NCT02711137|450481677|FG003|Overall Study|Physician Decision|1|||
125232485|NCT02711137|450481678|FG004|Overall Study|Physician Decision|1|||
125232486|NCT02711137|450481679|FG005|Overall Study|Physician Decision|0|||
125232487|NCT02711137|450481680|FG006|Overall Study|Physician Decision|12|||
125232488|NCT02711137|450481681|FG007|Overall Study|Physician Decision|2|||
125232489|NCT02711137|450481682|FG008|Overall Study|Physician Decision|1|||
125232490|NCT02711137|450481683|FG009|Overall Study|Physician Decision|1|||
125232491|NCT02711137|450481684|FG010|Overall Study|Physician Decision|3|||
125232492|NCT02711137|450481685|FG011|Overall Study|Physician Decision|2|||
125232493|NCT02711137|450481686|FG012|Overall Study|Physician Decision|1|||
125232494|NCT02711137|450481687|FG013|Overall Study|Physician Decision|1|||
125232495|NCT02711137|450481688|FG014|Overall Study|Physician Decision|2|||
125232496|NCT02711137|450481674|FG000|Overall Study|Other|0|||
125232497|NCT02711137|450481675|FG001|Overall Study|Other|1|||
125232498|NCT02711137|450481676|FG002|Overall Study|Other|0|||
125232499|NCT02711137|450481677|FG003|Overall Study|Other|0|||
125232500|NCT02711137|450481678|FG004|Overall Study|Other|0|||
125232501|NCT02711137|450481679|FG005|Overall Study|Other|0|||
125232502|NCT02711137|450481680|FG006|Overall Study|Other|3|||
125232503|NCT02711137|450481681|FG007|Overall Study|Other|0|||
125232504|NCT02711137|450481682|FG008|Overall Study|Other|0|||
125232505|NCT02711137|450481683|FG009|Overall Study|Other|0|||
125232506|NCT02711137|450481684|FG010|Overall Study|Other|0|||
125232507|NCT02711137|450481685|FG011|Overall Study|Other|0|||
125232508|NCT02711137|450481686|FG012|Overall Study|Other|0|||
125232509|NCT02711137|450481687|FG013|Overall Study|Other|0|||
125232510|NCT02711137|450481688|FG014|Overall Study|Other|1|||
125232511|NCT02711137|450481674|FG000|Overall Study|Withdrawal by Subject|1|||
125232512|NCT02711137|450481675|FG001|Overall Study|Withdrawal by Subject|0|||
125232513|NCT02711137|450481676|FG002|Overall Study|Withdrawal by Subject|0|||
125232514|NCT02711137|450481677|FG003|Overall Study|Withdrawal by Subject|1|||
125232515|NCT02711137|450481678|FG004|Overall Study|Withdrawal by Subject|1|||
125232516|NCT02711137|450481679|FG005|Overall Study|Withdrawal by Subject|0|||
125232517|NCT02711137|450481680|FG006|Overall Study|Withdrawal by Subject|7|||
125232518|NCT02711137|450481681|FG007|Overall Study|Withdrawal by Subject|0|||
125232519|NCT02711137|450481682|FG008|Overall Study|Withdrawal by Subject|0|||
125232520|NCT02711137|450481683|FG009|Overall Study|Withdrawal by Subject|0|||
125232521|NCT02711137|450481684|FG010|Overall Study|Withdrawal by Subject|0|||
125177170|NCT00444587|450267965|FG000|Overall Study|Refused treatment/did not cooperate|4|||
125177171|NCT00444587|450267966|FG001|Overall Study|Refused treatment/did not cooperate|1|||
125177172|NCT00444587|450267965|FG000|Overall Study|Investigator decision|3|||
125177173|NCT00444587|450267966|FG001|Overall Study|Investigator decision|0|||
125177174|NCT00444587|450267965|FG000|Overall Study|Protocol Violation|1|||
125177175|NCT00444587|450267966|FG001|Overall Study|Protocol Violation|0|||
125177176|NCT00444587|450267965|FG000|Overall Study|Missing|0|||
125177177|NCT00444587|450267966|FG001|Overall Study|Missing|5|||
125177178|NCT01720225|450267975|FG000|Overall Study|Withdrawal by Subject|0|||
125177179|NCT01720225|450267976|FG001|Overall Study|Withdrawal by Subject|1|||
125177180|NCT01720225|450267975|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
125177181|NCT01720225|450267976|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
125177182|NCT01473407|450267977|FG000|Overall Study|Physician Decision|1|||
125177183|NCT01473407|450267978|FG001|Overall Study|Physician Decision|4|||
125177184|NCT01473407|450267977|FG000|Overall Study|Lost to Follow-up|10|||
125177185|NCT01473407|450267978|FG001|Overall Study|Lost to Follow-up|4|||
125177186|NCT01473407|450267977|FG000|Overall Study|Adverse Event|8|||
125177187|NCT01473407|450267978|FG001|Overall Study|Adverse Event|8|||
125177188|NCT01473407|450267977|FG000|Overall Study|Randomization Error|3|||
125177189|NCT01473407|450267978|FG001|Overall Study|Randomization Error|1|||
125177190|NCT01473407|450267977|FG000|Overall Study|Withdrawal by Subject|4|||
125177191|NCT01473407|450267978|FG001|Overall Study|Withdrawal by Subject|7|||
125177192|NCT01473407|450267977|FG000|Overall Study|Kidney Transplant|7|||
125177193|NCT01473407|450267978|FG001|Overall Study|Kidney Transplant|6|||
125177194|NCT01473407|450267977|FG000|Overall Study|Vacation/Travel|1|||
125177195|NCT01473407|450267978|FG001|Overall Study|Vacation/Travel|1|||
125177196|NCT01473407|450267977|FG000|Overall Study|Elevated Hemoglobin|1|||
125177197|NCT01473407|450267978|FG001|Overall Study|Elevated Hemoglobin|0|||
125177198|NCT01473407|450267977|FG000|Overall Study|Patient Received Aranesp|1|||
125177199|NCT01473407|450267978|FG001|Overall Study|Patient Received Aranesp|0|||
125177200|NCT01473407|450267977|FG000|Overall Study|Patient Lost Green Card Status|1|||
125177201|NCT01473407|450267978|FG001|Overall Study|Patient Lost Green Card Status|0|||
125177202|NCT01473407|450267977|FG000|Overall Study|Temperature Excursion|2|||
125177203|NCT01473407|450267978|FG001|Overall Study|Temperature Excursion|3|||
125232522|NCT02711137|450481685|FG011|Overall Study|Withdrawal by Subject|0|||
125232523|NCT02711137|450481686|FG012|Overall Study|Withdrawal by Subject|0|||
125232524|NCT02711137|450481687|FG013|Overall Study|Withdrawal by Subject|1|||
125232525|NCT02711137|450481688|FG014|Overall Study|Withdrawal by Subject|0|||
125232526|NCT02711137|450481674|FG000|Overall Study|Lost to Follow-up|1|||
125232527|NCT02711137|450481675|FG001|Overall Study|Lost to Follow-up|0|||
125232528|NCT02711137|450481676|FG002|Overall Study|Lost to Follow-up|0|||
125232529|NCT02711137|450481677|FG003|Overall Study|Lost to Follow-up|0|||
125232530|NCT02711137|450481678|FG004|Overall Study|Lost to Follow-up|0|||
125232531|NCT02711137|450481679|FG005|Overall Study|Lost to Follow-up|0|||
125232532|NCT02711137|450481680|FG006|Overall Study|Lost to Follow-up|2|||
125232533|NCT02711137|450481681|FG007|Overall Study|Lost to Follow-up|0|||
125232534|NCT02711137|450481682|FG008|Overall Study|Lost to Follow-up|0|||
125232535|NCT02711137|450481683|FG009|Overall Study|Lost to Follow-up|0|||
125232536|NCT02711137|450481684|FG010|Overall Study|Lost to Follow-up|0|||
125232537|NCT02711137|450481685|FG011|Overall Study|Lost to Follow-up|0|||
125232538|NCT02711137|450481686|FG012|Overall Study|Lost to Follow-up|0|||
125232539|NCT02711137|450481687|FG013|Overall Study|Lost to Follow-up|0|||
125232540|NCT02711137|450481688|FG014|Overall Study|Lost to Follow-up|0|||
125232541|NCT00750269|450481689|FG000|Overall Study|Protocol Violation|0|||
125232542|NCT00750269|450481690|FG001|Overall Study|Protocol Violation|1|||
125232543|NCT00750269|450481691|FG002|Overall Study|Protocol Violation|1|||
125232544|NCT00750269|450481692|FG003|Overall Study|Protocol Violation|2|||
125232545|NCT00750269|450481693|FG004|Overall Study|Protocol Violation|4|||
125232546|NCT00750269|450481689|FG000|Overall Study|Withdrawal by Subject|0|||
125232547|NCT00750269|450481690|FG001|Overall Study|Withdrawal by Subject|0|||
125232548|NCT00750269|450481691|FG002|Overall Study|Withdrawal by Subject|2|||
125232549|NCT00750269|450481692|FG003|Overall Study|Withdrawal by Subject|2|||
125232550|NCT00750269|450481693|FG004|Overall Study|Withdrawal by Subject|2|||
125232551|NCT00750269|450481689|FG000|Overall Study|Physician Decision|0|||
125232552|NCT00750269|450481690|FG001|Overall Study|Physician Decision|0|||
125232553|NCT00750269|450481691|FG002|Overall Study|Physician Decision|0|||
125232554|NCT00750269|450481692|FG003|Overall Study|Physician Decision|0|||
125232555|NCT00750269|450481693|FG004|Overall Study|Physician Decision|2|||
125232556|NCT00750269|450481689|FG000|Overall Study|Patient too large for positioning|0|||
125232557|NCT00750269|450481690|FG001|Overall Study|Patient too large for positioning|0|||
125232558|NCT00750269|450481691|FG002|Overall Study|Patient too large for positioning|1|||
125232559|NCT00750269|450481692|FG003|Overall Study|Patient too large for positioning|0|||
125232560|NCT00750269|450481693|FG004|Overall Study|Patient too large for positioning|0|||
125232561|NCT00750269|450481689|FG000|Overall Study|Site error|0|||
125232562|NCT00750269|450481690|FG001|Overall Study|Site error|0|||
125232563|NCT00750269|450481691|FG002|Overall Study|Site error|0|||
125232564|NCT00750269|450481692|FG003|Overall Study|Site error|1|||
125232565|NCT00750269|450481693|FG004|Overall Study|Site error|0|||
125232566|NCT00750269|450481689|FG000|Overall Study|SBRT plan could not be drawn|0|||
125232567|NCT00750269|450481690|FG001|Overall Study|SBRT plan could not be drawn|0|||
125232568|NCT00750269|450481691|FG002|Overall Study|SBRT plan could not be drawn|0|||
125232569|NCT00750269|450481692|FG003|Overall Study|SBRT plan could not be drawn|0|||
125232570|NCT00750269|450481693|FG004|Overall Study|SBRT plan could not be drawn|1|||
125232571|NCT00750269|450481689|FG000|Overall Study|Fiducials could not be placed|0|||
125232572|NCT00750269|450481690|FG001|Overall Study|Fiducials could not be placed|0|||
125232573|NCT00750269|450481691|FG002|Overall Study|Fiducials could not be placed|0|||
125232574|NCT00750269|450481692|FG003|Overall Study|Fiducials could not be placed|0|||
125232575|NCT00750269|450481693|FG004|Overall Study|Fiducials could not be placed|1|||
125232576|NCT01799889|450481694|FG000|Overall Study|Adverse Event|4|||
125232577|NCT01799889|450481695|FG001|Overall Study|Adverse Event|4|||
125232578|NCT01799889|450481696|FG002|Overall Study|Adverse Event|5|||
125232579|NCT01799889|450481697|FG003|Overall Study|Adverse Event|1|||
125232580|NCT01799889|450481698|FG004|Overall Study|Adverse Event|11|||
125232581|NCT01799889|450481699|FG005|Overall Study|Adverse Event|1|||
125232582|NCT01799889|450481700|FG006|Overall Study|Adverse Event|5|||
125232583|NCT01799889|450481701|FG007|Overall Study|Adverse Event|2|||
125232584|NCT01799889|450481702|FG008|Overall Study|Adverse Event|3|||
125232585|NCT01799889|450481703|FG009|Overall Study|Adverse Event|1|||
125232586|NCT01799889|450481704|FG010|Overall Study|Adverse Event|1|||
125232587|NCT01799889|450481705|FG011|Overall Study|Adverse Event|0|||
125232588|NCT01799889|450481694|FG000|Overall Study|Death|1|||
125232589|NCT01799889|450481695|FG001|Overall Study|Death|0|||
125232590|NCT01799889|450481696|FG002|Overall Study|Death|5|||
125232591|NCT01799889|450481697|FG003|Overall Study|Death|3|||
125232592|NCT01799889|450481698|FG004|Overall Study|Death|1|||
125232593|NCT01799889|450481699|FG005|Overall Study|Death|0|||
125232594|NCT01799889|450481700|FG006|Overall Study|Death|0|||
125232595|NCT01799889|450481701|FG007|Overall Study|Death|0|||
125232596|NCT01799889|450481702|FG008|Overall Study|Death|1|||
125232597|NCT01799889|450481703|FG009|Overall Study|Death|0|||
125232598|NCT01799889|450481704|FG010|Overall Study|Death|1|||
125232599|NCT01799889|450481705|FG011|Overall Study|Death|0|||
125232600|NCT01799889|450481694|FG000|Overall Study|Lack of Efficacy|1|||
125232601|NCT01799889|450481695|FG001|Overall Study|Lack of Efficacy|1|||
125232602|NCT01799889|450481696|FG002|Overall Study|Lack of Efficacy|0|||
125232603|NCT01799889|450481697|FG003|Overall Study|Lack of Efficacy|1|||
125232604|NCT01799889|450481698|FG004|Overall Study|Lack of Efficacy|2|||
125232605|NCT01799889|450481699|FG005|Overall Study|Lack of Efficacy|2|||
125232606|NCT01799889|450481700|FG006|Overall Study|Lack of Efficacy|0|||
125232607|NCT01799889|450481701|FG007|Overall Study|Lack of Efficacy|0|||
125232608|NCT01799889|450481702|FG008|Overall Study|Lack of Efficacy|2|||
125232609|NCT01799889|450481703|FG009|Overall Study|Lack of Efficacy|0|||
125232610|NCT01799889|450481704|FG010|Overall Study|Lack of Efficacy|1|||
125232611|NCT01799889|450481705|FG011|Overall Study|Lack of Efficacy|0|||
125232612|NCT01799889|450481694|FG000|Overall Study|Lost to Follow-up|0|||
125232613|NCT01799889|450481695|FG001|Overall Study|Lost to Follow-up|1|||
125232614|NCT01799889|450481696|FG002|Overall Study|Lost to Follow-up|0|||
125232615|NCT01799889|450481697|FG003|Overall Study|Lost to Follow-up|0|||
125232616|NCT01799889|450481698|FG004|Overall Study|Lost to Follow-up|0|||
125232617|NCT01799889|450481699|FG005|Overall Study|Lost to Follow-up|0|||
125232618|NCT01799889|450481700|FG006|Overall Study|Lost to Follow-up|0|||
125232619|NCT01799889|450481701|FG007|Overall Study|Lost to Follow-up|0|||
125232620|NCT01799889|450481702|FG008|Overall Study|Lost to Follow-up|0|||
125232621|NCT01799889|450481703|FG009|Overall Study|Lost to Follow-up|0|||
125232622|NCT01799889|450481704|FG010|Overall Study|Lost to Follow-up|0|||
125232623|NCT01799889|450481705|FG011|Overall Study|Lost to Follow-up|0|||
125232624|NCT01799889|450481694|FG000|Overall Study|Physician Decision|3|||
125232625|NCT01799889|450481695|FG001|Overall Study|Physician Decision|2|||
125232626|NCT01799889|450481696|FG002|Overall Study|Physician Decision|4|||
125232627|NCT01799889|450481697|FG003|Overall Study|Physician Decision|4|||
125232628|NCT01799889|450481698|FG004|Overall Study|Physician Decision|5|||
125232629|NCT01799889|450481699|FG005|Overall Study|Physician Decision|5|||
125232630|NCT01799889|450481700|FG006|Overall Study|Physician Decision|5|||
125232631|NCT01799889|450481701|FG007|Overall Study|Physician Decision|2|||
125232632|NCT01799889|450481702|FG008|Overall Study|Physician Decision|6|||
125232633|NCT01799889|450481703|FG009|Overall Study|Physician Decision|0|||
125232634|NCT01799889|450481704|FG010|Overall Study|Physician Decision|0|||
125232635|NCT01799889|450481705|FG011|Overall Study|Physician Decision|1|||
125232636|NCT01799889|450481694|FG000|Overall Study|Progressive Disease|30|||
125232637|NCT01799889|450481695|FG001|Overall Study|Progressive Disease|26|||
125232638|NCT01799889|450481696|FG002|Overall Study|Progressive Disease|25|||
125232639|NCT01799889|450481697|FG003|Overall Study|Progressive Disease|30|||
125232640|NCT01799889|450481698|FG004|Overall Study|Progressive Disease|23|||
125232641|NCT01799889|450481699|FG005|Overall Study|Progressive Disease|9|||
125232642|NCT01799889|450481700|FG006|Overall Study|Progressive Disease|8|||
125232643|NCT01799889|450481701|FG007|Overall Study|Progressive Disease|13|||
125232644|NCT01799889|450481702|FG008|Overall Study|Progressive Disease|18|||
125232645|NCT01799889|450481703|FG009|Overall Study|Progressive Disease|5|||
125232646|NCT01799889|450481704|FG010|Overall Study|Progressive Disease|3|||
125232647|NCT01799889|450481705|FG011|Overall Study|Progressive Disease|1|||
125232648|NCT01799889|450481694|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
125232649|NCT01799889|450481695|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
125232650|NCT01799889|450481696|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
125232651|NCT01799889|450481697|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
125232652|NCT01799889|450481698|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
125232653|NCT01799889|450481699|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
125232654|NCT01799889|450481700|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
125232655|NCT01799889|450481701|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
125232656|NCT01799889|450481702|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
125232657|NCT01799889|450481703|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
125232658|NCT01799889|450481704|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
125232659|NCT01799889|450481705|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
125177204|NCT01473407|450267977|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
125177205|NCT01473407|450267978|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
125177206|NCT01473407|450267977|FG000|Overall Study|Sponsor's Decision|10|||
125177207|NCT01473407|450267978|FG001|Overall Study|Sponsor's Decision|10|||
125177208|NCT01473407|450267977|FG000|Overall Study|Site Closure|1|||
125177209|NCT01473407|450267978|FG001|Overall Study|Site Closure|0|||
125177210|NCT04071405|450267979|FG000|Overall Study|Protocol Violation|3|||
125177211|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
125177212|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
125177213|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
125177214|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
125177215|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
125177216|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
125177217|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
125177218|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
125177219|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
125177220|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
125177221|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
125177222|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
125177223|NCT02422797|450267980|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
125232660|NCT01799889|450481694|FG000|Overall Study|Study Terminated By Sponsor|1|||
125232661|NCT01799889|450481695|FG001|Overall Study|Study Terminated By Sponsor|0|||
125232662|NCT01799889|450481696|FG002|Overall Study|Study Terminated By Sponsor|0|||
125232663|NCT01799889|450481697|FG003|Overall Study|Study Terminated By Sponsor|0|||
125177224|NCT02422797|450267981|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
125177225|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
125177226|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
125177227|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
125177228|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
125177229|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
125177230|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
125177231|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
125177232|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
125177233|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
125177234|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
125177235|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
125177236|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
125177237|NCT02422797|450267980|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
125177238|NCT02422797|450267981|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
125177239|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
125177240|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
125177241|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
125177242|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
125177243|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
125177244|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
125177245|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
125177246|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
125177247|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
125177248|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
125177249|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
125177250|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
125177251|NCT02422797|450267980|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
125177252|NCT02422797|450267981|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
125177253|NCT00369941|450267982|FG000|Overall Study|Never Treated|1|||
125177254|NCT00369941|450267983|FG001|Overall Study|Never Treated|2|||
125177255|NCT00369941|450267982|FG000|Overall Study|Adverse Event|14|||
125177256|NCT00369941|450267983|FG001|Overall Study|Adverse Event|28|||
125177257|NCT00369941|450267982|FG000|Overall Study|Lack of Efficacy|6|||
125177258|NCT00369941|450267983|FG001|Overall Study|Lack of Efficacy|10|||
125177259|NCT00369941|450267982|FG000|Overall Study|Lost to Follow-up|12|||
125177260|NCT00369941|450267983|FG001|Overall Study|Lost to Follow-up|22|||
125177261|NCT00369941|450267982|FG000|Overall Study|Protocol Violation|5|||
125177262|NCT00369941|450267983|FG001|Overall Study|Protocol Violation|3|||
125177263|NCT00369941|450267982|FG000|Overall Study|Withdrawal by Subject|5|||
125177264|NCT00369941|450267983|FG001|Overall Study|Withdrawal by Subject|18|||
125177265|NCT00369941|450267982|FG000|Overall Study|Pregnancy|4|||
125177266|NCT00369941|450267983|FG001|Overall Study|Pregnancy|2|||
125177267|NCT00369941|450267982|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
125177268|NCT00369941|450267983|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
125177269|NCT00369941|450267982|FG000|Overall Study|Moved|11|||
125177270|NCT00369941|450267983|FG001|Overall Study|Moved|5|||
125177271|NCT00369941|450267982|FG000|Overall Study|Treatment with Prohibited Medication|3|||
125177272|NCT00369941|450267983|FG001|Overall Study|Treatment with Prohibited Medication|1|||
125177273|NCT00369941|450267982|FG000|Overall Study|Employment Interfered with Study Visits|1|||
125177274|NCT00369941|450267983|FG001|Overall Study|Employment Interfered with Study Visits|0|||
125177275|NCT00369941|450267982|FG000|Overall Study|Study Site Terminated|2|||
125177276|NCT00369941|450267983|FG001|Overall Study|Study Site Terminated|0|||
125177277|NCT00369941|450267982|FG000|Overall Study|Miscellaneous|3|||
125177278|NCT00369941|450267983|FG001|Overall Study|Miscellaneous|3|||
125177279|NCT01027702|450267984|FG000|Overall Study|Received subsequent therapy|1|||
125177280|NCT01027702|450267985|FG001|Overall Study|Received subsequent therapy|2|||
125177281|NCT01027702|450267986|FG002|Overall Study|Received subsequent therapy|0|||
125177282|NCT01027702|450267987|FG003|Overall Study|Received subsequent therapy|4|||
125177283|NCT01027702|450267988|FG004|Overall Study|Received subsequent therapy|1|||
125177284|NCT01027702|450267989|FG005|Overall Study|Received subsequent therapy|0|||
125177285|NCT01027702|450267990|FG006|Overall Study|Received subsequent therapy|1|||
125177286|NCT01027702|450267984|FG000|Overall Study|Death|0|||
125177287|NCT01027702|450267985|FG001|Overall Study|Death|0|||
125177288|NCT01027702|450267986|FG002|Overall Study|Death|1|||
125177289|NCT01027702|450267987|FG003|Overall Study|Death|0|||
125177290|NCT01027702|450267988|FG004|Overall Study|Death|0|||
125177291|NCT01027702|450267989|FG005|Overall Study|Death|0|||
125177292|NCT01027702|450267990|FG006|Overall Study|Death|0|||
125177293|NCT00403585|450267991|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
125177294|NCT00403585|450267991|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
125232664|NCT01799889|450481698|FG004|Overall Study|Study Terminated By Sponsor|2|||
125232665|NCT01799889|450481699|FG005|Overall Study|Study Terminated By Sponsor|1|||
125232666|NCT01799889|450481700|FG006|Overall Study|Study Terminated By Sponsor|0|||
125232667|NCT01799889|450481701|FG007|Overall Study|Study Terminated By Sponsor|2|||
125232668|NCT01799889|450481702|FG008|Overall Study|Study Terminated By Sponsor|1|||
125232669|NCT01799889|450481703|FG009|Overall Study|Study Terminated By Sponsor|1|||
125232670|NCT01799889|450481704|FG010|Overall Study|Study Terminated By Sponsor|0|||
125232671|NCT01799889|450481705|FG011|Overall Study|Study Terminated By Sponsor|0|||
125232672|NCT01799889|450481694|FG000|Overall Study|Withdrawal by Subject|1|||
125232673|NCT01799889|450481695|FG001|Overall Study|Withdrawal by Subject|6|||
125232674|NCT01799889|450481696|FG002|Overall Study|Withdrawal by Subject|4|||
125232675|NCT01799889|450481697|FG003|Overall Study|Withdrawal by Subject|0|||
125232676|NCT01799889|450481698|FG004|Overall Study|Withdrawal by Subject|5|||
125232677|NCT01799889|450481699|FG005|Overall Study|Withdrawal by Subject|1|||
125232678|NCT01799889|450481700|FG006|Overall Study|Withdrawal by Subject|3|||
125232679|NCT01799889|450481701|FG007|Overall Study|Withdrawal by Subject|1|||
125232680|NCT01799889|450481702|FG008|Overall Study|Withdrawal by Subject|2|||
125232681|NCT01799889|450481703|FG009|Overall Study|Withdrawal by Subject|1|||
125232682|NCT01799889|450481704|FG010|Overall Study|Withdrawal by Subject|1|||
125232683|NCT01799889|450481705|FG011|Overall Study|Withdrawal by Subject|1|||
125232684|NCT01799889|450481694|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125232685|NCT01799889|450481695|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125232686|NCT01799889|450481696|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125232687|NCT01799889|450481697|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125232688|NCT01799889|450481698|FG004|Overall Study|Non-Compliance With Study Drug|0|||
125232689|NCT01799889|450481699|FG005|Overall Study|Non-Compliance With Study Drug|1|||
125232690|NCT01799889|450481700|FG006|Overall Study|Non-Compliance With Study Drug|0|||
125232691|NCT01799889|450481701|FG007|Overall Study|Non-Compliance With Study Drug|0|||
125232692|NCT01799889|450481702|FG008|Overall Study|Non-Compliance With Study Drug|0|||
125232693|NCT01799889|450481703|FG009|Overall Study|Non-Compliance With Study Drug|0|||
125232694|NCT01799889|450481704|FG010|Overall Study|Non-Compliance With Study Drug|0|||
125232695|NCT01799889|450481705|FG011|Overall Study|Non-Compliance With Study Drug|0|||
125232696|NCT03944616|450481706|FG000|Overall Study|Lost to Follow-up|0|||
125232697|NCT03944616|450481707|FG001|Overall Study|Lost to Follow-up|2|||
125232698|NCT01721798|450481708|FG000|Overall Study|Death|0|||
125232699|NCT01721798|450481709|FG001|Overall Study|Death|0|||
125232700|NCT01721798|450481710|FG002|Overall Study|Death|1|||
125232701|NCT01721798|450481711|FG003|Overall Study|Death|1|||
125232702|NCT01721798|450481708|FG000|Overall Study|Lost to Follow-up|2|||
125232703|NCT01721798|450481709|FG001|Overall Study|Lost to Follow-up|2|||
125232704|NCT01721798|450481710|FG002|Overall Study|Lost to Follow-up|9|||
125232705|NCT01721798|450481711|FG003|Overall Study|Lost to Follow-up|9|||
125232706|NCT01721798|450481708|FG000|Overall Study|Pregnancy|0|||
125232707|NCT01721798|450481709|FG001|Overall Study|Pregnancy|0|||
125232708|NCT01721798|450481710|FG002|Overall Study|Pregnancy|1|||
125232709|NCT01721798|450481711|FG003|Overall Study|Pregnancy|1|||
125232710|NCT01721798|450481708|FG000|Overall Study|Withdrawal by Subject|1|||
125177295|NCT00403585|450267991|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
125177296|NCT02964312|450268000|FG000|Overall Study|Lost to Follow-up|28|||
125177297|NCT02964312|450268000|FG000|Overall Study|Withdrawal by Subject|11|||
125177298|NCT02964312|450268000|FG000|Overall Study|Lack of Efficacy|10|||
125177299|NCT02964312|450268000|FG000|Overall Study|Did not consent to long-term FU|14|||
125177300|NCT02964312|450268000|FG000|Overall Study|Death|1|||
125177301|NCT02276807|450268001|FG000|Overall Study|Withdrawal by Subject|8|||
125177302|NCT02276807|450268002|FG001|Overall Study|Withdrawal by Subject|7|||
125177303|NCT02276807|450268001|FG000|Overall Study|Lost to Follow-up|10|||
125177304|NCT02276807|450268002|FG001|Overall Study|Lost to Follow-up|10|||
125177305|NCT01023035|450268004|FG000|Treatment Period|Adverse Event|27|||
125177306|NCT01023035|450268005|FG001|Treatment Period|Adverse Event|32|||
125177307|NCT01023035|450268006|FG002|Treatment Period|Adverse Event|50|||
125177308|NCT01023035|450268004|FG000|Treatment Period|Non-Medical Reasons|19|||
125177309|NCT01023035|450268005|FG001|Treatment Period|Non-Medical Reasons|22|||
125177310|NCT01023035|450268006|FG002|Treatment Period|Non-Medical Reasons|44|||
125177311|NCT01023035|450268004|FG000|Treatment Period|Treatment Failure|26|||
125177312|NCT01023035|450268005|FG001|Treatment Period|Treatment Failure|31|||
125177313|NCT01023035|450268006|FG002|Treatment Period|Treatment Failure|24|||
125232711|NCT01721798|450481709|FG001|Overall Study|Withdrawal by Subject|0|||
125232712|NCT01721798|450481710|FG002|Overall Study|Withdrawal by Subject|2|||
125232713|NCT01721798|450481711|FG003|Overall Study|Withdrawal by Subject|1|||
125177314|NCT01023035|450268004|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
125177315|NCT01023035|450268005|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
125177316|NCT01023035|450268006|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
125232714|NCT01721798|450481708|FG000|Overall Study|Not eligible for 24 month visit|1|||
125232715|NCT01721798|450481709|FG001|Overall Study|Not eligible for 24 month visit|0|||
125232716|NCT01721798|450481710|FG002|Overall Study|Not eligible for 24 month visit|8|||
125232717|NCT01721798|450481711|FG003|Overall Study|Not eligible for 24 month visit|7|||
125232718|NCT01294046|450481712|FG000|Overall Study|Infection and surgical explant|1|||
125232719|NCT01294046|450481712|FG000|Overall Study|Eligibility criteria expanded|1|||
125232720|NCT01294046|450481712|FG000|Overall Study|Stimulation response inadqequate|1|||
125232721|NCT01286129|450481715|FG000|Overall Study|Withdrawal by Subject|4|||
125232722|NCT01286129|450481716|FG001|Overall Study|Withdrawal by Subject|1|||
125232723|NCT01286129|450481715|FG000|Overall Study|Could not comply with study requirements|4|||
125232724|NCT01286129|450481716|FG001|Overall Study|Could not comply with study requirements|4|||
125232725|NCT01394276|450481717|FG000|Overall Study|Related Adverse event (AEs)|15|||
125232726|NCT01394276|450481717|FG000|Overall Study|Not related AEs|9|||
125232727|NCT01394276|450481717|FG000|Overall Study|Remission of disease|2|||
125232728|NCT01394276|450481717|FG000|Overall Study|Insufficient therapeutic effect|17|||
125232729|NCT01394276|450481717|FG000|Overall Study|Insufficient compliance|9|||
125232730|NCT01394276|450481717|FG000|Overall Study|Lost to Follow-up|5|||
125232731|NCT01394276|450481717|FG000|Overall Study|Participant moved to another site|1|||
125232732|NCT01394276|450481717|FG000|Overall Study|Pregnancy|1|||
125232733|NCT01394276|450481717|FG000|Overall Study|unavailability of drug at the Hospital|2|||
125232734|NCT01394276|450481717|FG000|Overall Study|Symptoms of concurrent diseases|1|||
125232735|NCT02187783|450481718|FG000|Overall Study|Adverse Event|8|||
125232736|NCT02187783|450481718|FG000|Overall Study|Death|3|||
125232737|NCT02187783|450481718|FG000|Overall Study|Progressive disease|80|||
125232738|NCT02187783|450481718|FG000|Overall Study|Protocol Violation|3|||
125232739|NCT02187783|450481718|FG000|Overall Study|Physician Decision|2|||
125232740|NCT02187783|450481718|FG000|Overall Study|Withdrawal by Subject|9|||
125232741|NCT02187783|450481718|FG000|Overall Study|Study terminated by sponsor|1|||
125232742|NCT00471497|450481719|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
125232743|NCT00471497|450481720|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
125232744|NCT00471497|450481721|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
125232745|NCT00471497|450481719|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
125232746|NCT00471497|450481720|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
125232747|NCT00471497|450481721|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
125232748|NCT00471497|450481719|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
125232749|NCT00471497|450481720|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
125232750|NCT00471497|450481721|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
125232751|NCT00471497|450481719|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
125232752|NCT00471497|450481720|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
125232753|NCT00471497|450481721|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
125232754|NCT00471497|450481719|FG000|Core Treatment Phase|Lost to Follow-up|6|||
125232755|NCT00471497|450481720|FG001|Core Treatment Phase|Lost to Follow-up|6|||
125232756|NCT00471497|450481721|FG002|Core Treatment Phase|Lost to Follow-up|3|||
125232757|NCT00471497|450481719|FG000|Core Treatment Phase|Death|3|||
125232758|NCT00471497|450481720|FG001|Core Treatment Phase|Death|9|||
125232759|NCT00471497|450481721|FG002|Core Treatment Phase|Death|3|||
125232760|NCT00471497|450481719|FG000|Core Treatment Phase|Disease Progression|10|||
125232761|NCT00471497|450481720|FG001|Core Treatment Phase|Disease Progression|2|||
125232762|NCT00471497|450481721|FG002|Core Treatment Phase|Disease Progression|4|||
125232763|NCT00471497|450481719|FG000|Core Treatment Phase|Protocol Violation|6|||
125232764|NCT00471497|450481720|FG001|Core Treatment Phase|Protocol Violation|15|||
125232765|NCT00471497|450481721|FG002|Core Treatment Phase|Protocol Violation|11|||
125232766|NCT00471497|450481719|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
125232767|NCT00471497|450481720|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
125232768|NCT00471497|450481721|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
125232769|NCT00471497|450481719|FG000|Core Treatment Phase|Administrative problems|14|||
125232770|NCT00471497|450481720|FG001|Core Treatment Phase|Administrative problems|14|||
125232771|NCT00471497|450481721|FG002|Core Treatment Phase|Administrative problems|12|||
125232772|NCT00471497|450481719|FG000|Core Treatment Phase|Adverse Event|43|||
125232773|NCT00471497|450481720|FG001|Core Treatment Phase|Adverse Event|53|||
125232774|NCT00471497|450481721|FG002|Core Treatment Phase|Adverse Event|89|||
125232775|NCT00471497|450481719|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
125232776|NCT00471497|450481720|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
125232777|NCT00471497|450481721|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
125232778|NCT00471497|450481719|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
125232779|NCT00471497|450481720|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
125232780|NCT00471497|450481721|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
125232781|NCT00471497|450481719|FG000|Extension Phase|Adverse Event|9|||
125232782|NCT00471497|450481720|FG001|Extension Phase|Adverse Event|5|||
125232783|NCT00471497|450481721|FG002|Extension Phase|Adverse Event|1|||
125232784|NCT00471497|450481719|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
125232785|NCT00471497|450481720|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
125232786|NCT00471497|450481721|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
125232787|NCT00471497|450481719|FG000|Extension Phase|Withdrawal by Subject|3|||
125232788|NCT00471497|450481720|FG001|Extension Phase|Withdrawal by Subject|1|||
125232789|NCT00471497|450481721|FG002|Extension Phase|Withdrawal by Subject|0|||
125443413|NCT02555371|451252132|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
125443414|NCT02555371|451252128|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
125443415|NCT02555371|451252129|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
125443416|NCT02555371|451252130|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
125443417|NCT02555371|451252131|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
125443418|NCT02555371|451252132|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
125443419|NCT02555371|451252128|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
125443420|NCT02555371|451252129|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
125443421|NCT02555371|451252130|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
125443422|NCT02555371|451252131|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
125443423|NCT02555371|451252132|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
125443424|NCT02555371|451252128|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
125177317|NCT01023035|450268004|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
125177318|NCT01023035|450268005|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
125177319|NCT01023035|450268006|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
125177320|NCT00524420|450268007|FG000|Overall Study|Lack of Efficacy|1|||
125177321|NCT00524420|450268008|FG001|Overall Study|Lack of Efficacy|0|||
125177322|NCT01090414|450268009|FG000|Study 101-99|Progressive Disease|28|||
125177323|NCT01090414|450268010|FG001|Study 101-99|Progressive Disease|48|||
125177324|NCT01090414|450268011|FG002|Study 101-99|Progressive Disease|10|||
125177325|NCT01090414|450268012|FG003|Study 101-99|Progressive Disease|4|||
125177326|NCT01090414|450268009|FG000|Study 101-99|Adverse Event|10|||
125177327|NCT01090414|450268010|FG001|Study 101-99|Adverse Event|28|||
125177328|NCT01090414|450268011|FG002|Study 101-99|Adverse Event|18|||
125177329|NCT01090414|450268012|FG003|Study 101-99|Adverse Event|0|||
125177330|NCT01090414|450268009|FG000|Study 101-99|Investigator Request|1|||
125177331|NCT01090414|450268010|FG001|Study 101-99|Investigator Request|11|||
125177332|NCT01090414|450268011|FG002|Study 101-99|Investigator Request|4|||
125177333|NCT01090414|450268012|FG003|Study 101-99|Investigator Request|0|||
125177334|NCT01090414|450268009|FG000|Study 101-99|Death|3|||
125177335|NCT01090414|450268010|FG001|Study 101-99|Death|8|||
125177336|NCT01090414|450268011|FG002|Study 101-99|Death|1|||
125177337|NCT01090414|450268012|FG003|Study 101-99|Death|0|||
125177338|NCT01090414|450268009|FG000|Study 101-99|Sponsor Discontinued Study|0|||
125177339|NCT01090414|450268010|FG001|Study 101-99|Sponsor Discontinued Study|7|||
125177340|NCT01090414|450268011|FG002|Study 101-99|Sponsor Discontinued Study|5|||
125177341|NCT01090414|450268012|FG003|Study 101-99|Sponsor Discontinued Study|0|||
125177342|NCT01090414|450268009|FG000|Study 101-99|Other (Unknown Reasons)|3|||
125177343|NCT01090414|450268010|FG001|Study 101-99|Other (Unknown Reasons)|3|||
125177344|NCT01090414|450268011|FG002|Study 101-99|Other (Unknown Reasons)|0|||
125177345|NCT01090414|450268012|FG003|Study 101-99|Other (Unknown Reasons)|0|||
125177346|NCT01090414|450268009|FG000|Study 101-99|Withdrew Consent|0|||
125177347|NCT01090414|450268010|FG001|Study 101-99|Withdrew Consent|2|||
125177348|NCT01090414|450268011|FG002|Study 101-99|Withdrew Consent|3|||
125177349|NCT01090414|450268012|FG003|Study 101-99|Withdrew Consent|1|||
125177350|NCT01090414|450268009|FG000|Study 101-99|Participant Request|3|||
125177351|NCT01090414|450268010|FG001|Study 101-99|Participant Request|1|||
125177352|NCT01090414|450268011|FG002|Study 101-99|Participant Request|0|||
125177353|NCT01090414|450268012|FG003|Study 101-99|Participant Request|0|||
125177354|NCT02413229|450268022|FG000|Overall Study|Adverse Event|0|||
125177355|NCT02413229|450268023|FG001|Overall Study|Adverse Event|0|||
125177356|NCT02413229|450268024|FG002|Overall Study|Adverse Event|0|||
125177357|NCT02413229|450268025|FG003|Overall Study|Adverse Event|1|||
125177358|NCT02413229|450268026|FG004|Overall Study|Adverse Event|0|||
125177359|NCT02413229|450268027|FG005|Overall Study|Adverse Event|0|||
125177360|NCT02413229|450268028|FG006|Overall Study|Adverse Event|0|||
125177361|NCT02413229|450268029|FG007|Overall Study|Adverse Event|1|||
125177362|NCT02413229|450268022|FG000|Overall Study|Lost to Follow-up|0|||
125177363|NCT02413229|450268023|FG001|Overall Study|Lost to Follow-up|0|||
125177364|NCT02413229|450268024|FG002|Overall Study|Lost to Follow-up|1|||
125177365|NCT02413229|450268025|FG003|Overall Study|Lost to Follow-up|0|||
125177366|NCT02413229|450268026|FG004|Overall Study|Lost to Follow-up|2|||
125177367|NCT02413229|450268027|FG005|Overall Study|Lost to Follow-up|0|||
125177368|NCT02413229|450268028|FG006|Overall Study|Lost to Follow-up|0|||
125177369|NCT02413229|450268029|FG007|Overall Study|Lost to Follow-up|0|||
125177370|NCT02413229|450268022|FG000|Overall Study|Withdrawal by Subject|1|||
125177371|NCT02413229|450268023|FG001|Overall Study|Withdrawal by Subject|1|||
125177372|NCT02413229|450268024|FG002|Overall Study|Withdrawal by Subject|0|||
125177373|NCT02413229|450268025|FG003|Overall Study|Withdrawal by Subject|0|||
125177374|NCT02413229|450268026|FG004|Overall Study|Withdrawal by Subject|1|||
125177375|NCT02413229|450268027|FG005|Overall Study|Withdrawal by Subject|0|||
125177376|NCT02413229|450268028|FG006|Overall Study|Withdrawal by Subject|0|||
125177377|NCT02413229|450268029|FG007|Overall Study|Withdrawal by Subject|2|||
125177378|NCT02413229|450268022|FG000|Overall Study|Progressive Disease|0|||
125177379|NCT02413229|450268023|FG001|Overall Study|Progressive Disease|0|||
125177380|NCT02413229|450268024|FG002|Overall Study|Progressive Disease|0|||
125232790|NCT00471497|450481719|FG000|Extension Phase|Lost to Follow-up|2|||
125232791|NCT00471497|450481720|FG001|Extension Phase|Lost to Follow-up|0|||
125232792|NCT00471497|450481721|FG002|Extension Phase|Lost to Follow-up|0|||
125232793|NCT00471497|450481719|FG000|Extension Phase|Death|1|||
125232794|NCT00471497|450481720|FG001|Extension Phase|Death|0|||
125232795|NCT00471497|450481721|FG002|Extension Phase|Death|0|||
125232796|NCT00471497|450481719|FG000|Extension Phase|Disease progression|2|||
125232797|NCT00471497|450481720|FG001|Extension Phase|Disease progression|0|||
125232798|NCT00471497|450481721|FG002|Extension Phase|Disease progression|0|||
125232799|NCT00471497|450481719|FG000|Extension Phase|Protocol Violation|2|||
125232800|NCT00471497|450481720|FG001|Extension Phase|Protocol Violation|2|||
125232801|NCT00471497|450481721|FG002|Extension Phase|Protocol Violation|0|||
125232802|NCT01654276|450481722|FG000|Overall Study|Lack of Efficacy|1|||
125232803|NCT01654276|450481722|FG000|Overall Study|Lost to Follow-up|4|||
125232804|NCT01654276|450481722|FG000|Overall Study|Withdrawal by Subject|1|||
125232805|NCT01991795|450481723|FG000|Overall Study|Lost to Follow-up|6|||
125232806|NCT01991795|450481724|FG001|Overall Study|Lost to Follow-up|4|||
125232807|NCT01991795|450481723|FG000|Overall Study|Withdrawal by Subject|117|||
125232808|NCT01991795|450481724|FG001|Overall Study|Withdrawal by Subject|94|||
125232809|NCT01991795|450481723|FG000|Overall Study|Site prematurely closed by sponsor|26|||
125232810|NCT01991795|450481724|FG001|Overall Study|Site prematurely closed by sponsor|25|||
125232811|NCT03344757|450481725|FG000|Overall Study|Withdrawal by Subject|18|||
125232812|NCT03344757|450481726|FG001|Overall Study|Withdrawal by Subject|16|||
125232813|NCT03344757|450481725|FG000|Overall Study|Lost to Follow-up|0|||
125232814|NCT03344757|450481726|FG001|Overall Study|Lost to Follow-up|2|||
125232815|NCT02121210|450481727|FG000|Overall Study|Adverse Event|5|||
125232816|NCT02121210|450481728|FG001|Overall Study|Adverse Event|7|||
125232817|NCT02121210|450481727|FG000|Overall Study|Lack of Efficacy|2|||
125232818|NCT02121210|450481728|FG001|Overall Study|Lack of Efficacy|0|||
125232819|NCT02121210|450481727|FG000|Overall Study|Other than specified above|0|||
125232820|NCT02121210|450481728|FG001|Overall Study|Other than specified above|2|||
125232821|NCT04609514|450481729|FG000|Overall Study|Lost to Follow-up|5|||
125232822|NCT04609514|450481730|FG001|Overall Study|Lost to Follow-up|4|||
125232823|NCT04609514|450481729|FG000|Overall Study|Withdrawal by PI|0|||
125232824|NCT04609514|450481730|FG001|Overall Study|Withdrawal by PI|2|||
125232825|NCT00909870|450481731|FG000|Overall Study|Adverse Event|13|||
125232826|NCT00909870|450481732|FG001|Overall Study|Adverse Event|7|||
125232827|NCT00909870|450481731|FG000|Overall Study|Protocol Violation|1|||
125232828|NCT00909870|450481732|FG001|Overall Study|Protocol Violation|2|||
125232829|NCT00909870|450481731|FG000|Overall Study|Withdrawal by Subject|5|||
125232830|NCT00909870|450481732|FG001|Overall Study|Withdrawal by Subject|8|||
125232831|NCT00909870|450481731|FG000|Overall Study|Lost to Follow-up|3|||
125232832|NCT00909870|450481732|FG001|Overall Study|Lost to Follow-up|3|||
125232833|NCT00909870|450481731|FG000|Overall Study|Physician Decision|0|||
125232834|NCT00909870|450481732|FG001|Overall Study|Physician Decision|2|||
125232835|NCT00909870|450481731|FG000|Overall Study|Other|1|||
125177381|NCT02413229|450268025|FG003|Overall Study|Progressive Disease|0|||
125177382|NCT02413229|450268026|FG004|Overall Study|Progressive Disease|0|||
125177383|NCT02413229|450268027|FG005|Overall Study|Progressive Disease|0|||
125177384|NCT02413229|450268028|FG006|Overall Study|Progressive Disease|0|||
125177385|NCT02413229|450268029|FG007|Overall Study|Progressive Disease|1|||
125177386|NCT02932462|450268030|FG000|Overall Study|Adverse Event|1|||
125177387|NCT02932462|450268031|FG001|Overall Study|Adverse Event|2|||
125177388|NCT02932462|450268030|FG000|Overall Study|Lost to Follow-up|4|||
125177389|NCT02932462|450268031|FG001|Overall Study|Lost to Follow-up|1|||
125177390|NCT02932462|450268030|FG000|Overall Study|Protocol Violation|0|||
125177391|NCT02932462|450268031|FG001|Overall Study|Protocol Violation|5|||
125177392|NCT02932462|450268030|FG000|Overall Study|Withdrawal by Subject|1|||
125177393|NCT02932462|450268031|FG001|Overall Study|Withdrawal by Subject|4|||
125177394|NCT02932462|450268030|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125177395|NCT02932462|450268031|FG001|Overall Study|Non-Compliance With Study Drug|1|||
125177396|NCT02932462|450268030|FG000|Overall Study|Progressive Disease|1|||
125177397|NCT02932462|450268031|FG001|Overall Study|Progressive Disease|0|||
125177398|NCT02652949|450268032|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
125177399|NCT02652949|450268032|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
125177400|NCT02652949|450268032|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
125177401|NCT02652949|450268032|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
125177402|NCT02652949|450268032|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
125177403|NCT02652949|450268032|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
125177404|NCT02652949|450268032|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
125177405|NCT02652949|450268032|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
125177406|NCT02652949|450268032|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
125232836|NCT00909870|450481732|FG001|Overall Study|Other|5|||
125232837|NCT01316575|450481733|FG000|Overall Study|Withdrawal by Subject|2|||
125232838|NCT01316575|450481734|FG001|Overall Study|Withdrawal by Subject|0|||
125232839|NCT01316575|450481733|FG000|Overall Study|Required alternate treatment|0|||
125232840|NCT01316575|450481734|FG001|Overall Study|Required alternate treatment|1|||
125232841|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
125232842|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
125232843|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232844|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232845|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232846|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232847|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232848|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232849|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232850|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
125232851|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
125232852|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
125232853|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232854|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232855|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232856|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232857|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232858|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232859|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232860|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
125232861|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
125232862|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232863|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232864|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232865|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232866|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232867|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232868|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232869|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232870|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
125232871|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
125232872|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
125232873|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232874|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232875|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232876|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232877|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232878|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232879|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232880|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
125232881|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
125232882|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
125232883|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232884|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232885|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232886|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232887|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232888|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232889|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232890|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
125232891|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
125232892|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
125232893|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232894|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232895|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232896|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232897|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232898|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232899|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232900|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
125232901|NCT01232283|450481737|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
125232902|NCT01232283|450481738|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
125232903|NCT01232283|450481739|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232904|NCT01232283|450481740|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232905|NCT01232283|450481741|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232906|NCT01232283|450481742|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232907|NCT01232283|450481743|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232908|NCT01232283|450481744|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232909|NCT01232283|450481745|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232910|NCT01232283|450481746|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
125232911|NCT01232283|450481737|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232912|NCT01232283|450481738|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232913|NCT01232283|450481739|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
125232914|NCT01232283|450481740|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
125232915|NCT01232283|450481741|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232916|NCT01232283|450481742|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232917|NCT01232283|450481743|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232918|NCT01232283|450481744|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232919|NCT01232283|450481745|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232920|NCT01232283|450481746|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
125232921|NCT01232283|450481737|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232922|NCT01232283|450481738|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232923|NCT01232283|450481739|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
125232924|NCT01232283|450481740|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
125232925|NCT01232283|450481741|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232926|NCT01232283|450481742|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232927|NCT01232283|450481743|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232928|NCT01232283|450481744|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232929|NCT01232283|450481745|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232930|NCT01232283|450481746|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
125232931|NCT01232283|450481737|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232932|NCT01232283|450481738|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232933|NCT01232283|450481739|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
125232934|NCT01232283|450481740|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232935|NCT01232283|450481741|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232936|NCT01232283|450481742|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232937|NCT01232283|450481743|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232938|NCT01232283|450481744|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232939|NCT01232283|450481745|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232940|NCT01232283|450481746|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
125232941|NCT01232283|450481737|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232942|NCT01232283|450481738|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232943|NCT01232283|450481739|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
125232944|NCT01232283|450481740|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
125232945|NCT01232283|450481741|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232946|NCT01232283|450481742|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232947|NCT01232283|450481743|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232948|NCT01232283|450481744|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232949|NCT01232283|450481745|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232950|NCT01232283|450481746|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
125232951|NCT01232283|450481737|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232952|NCT01232283|450481738|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232953|NCT01232283|450481739|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
125232954|NCT01232283|450481740|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
125232955|NCT01232283|450481741|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232956|NCT01232283|450481742|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232957|NCT01232283|450481743|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232958|NCT01232283|450481744|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232959|NCT01232283|450481745|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232960|NCT01232283|450481746|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
125232961|NCT01232283|450481737|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
125232962|NCT01232283|450481738|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
125232963|NCT01232283|450481739|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
125232964|NCT01232283|450481740|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
125232965|NCT01232283|450481741|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
125232966|NCT01232283|450481742|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
125232967|NCT01232283|450481743|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
125232968|NCT01232283|450481744|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
125232969|NCT01232283|450481745|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
125232970|NCT01232283|450481746|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
125232971|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232972|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232973|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232974|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232975|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
125232976|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
125232977|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232978|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
125232979|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232980|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
125232981|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232982|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232983|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232984|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232985|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
125232986|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232987|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
125232988|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
125232989|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232990|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
125232991|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
125232992|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
125232993|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
125232994|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
125232995|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
125232996|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
125232997|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
125232998|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
125232999|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
125233000|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
125233001|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233002|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233003|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233004|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233005|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
125233006|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233007|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233008|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233009|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233010|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
125233011|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233012|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233013|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233014|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233015|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
125233016|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233017|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
125233018|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
125233019|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233020|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
125233021|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233022|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233023|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233024|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233025|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233026|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233027|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233028|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
125233029|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233030|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
125233031|NCT01232283|450481737|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233032|NCT01232283|450481738|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233033|NCT01232283|450481739|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233034|NCT01232283|450481740|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233035|NCT01232283|450481741|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233036|NCT01232283|450481742|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
125233037|NCT01232283|450481743|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233038|NCT01232283|450481744|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233039|NCT01232283|450481745|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233040|NCT01232283|450481746|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
125233041|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233042|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233043|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233044|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233045|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233046|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233047|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233048|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
125233049|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
125233050|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
125233051|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233052|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233053|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233054|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233055|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233056|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233057|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125177407|NCT02652949|450268032|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
125177408|NCT02652949|450268032|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
125177409|NCT02652949|450268032|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
125177410|NCT02652949|450268032|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
125177411|NCT02652949|450268032|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
125177412|NCT02652949|450268032|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
125177413|NCT02652949|450268032|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
125177414|NCT02652949|450268032|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
125177415|NCT01487525|450268035|FG000|Overall Study|Withdrawal by Subject|0|||
125177416|NCT01487525|450268036|FG001|Overall Study|Withdrawal by Subject|1|||
125177417|NCT04650204|450268037|FG000|Overall Study|Study was Terminated|2|||
125177418|NCT04650204|450268038|FG001|Overall Study|Study was Terminated|1|||
125177419|NCT01330303|450268039|FG000|Period 1|Adverse Event|1|||
125177420|NCT01330303|450268040|FG001|Period 1|Adverse Event|0|||
125177421|NCT01330303|450268039|FG000|Period 1|Protocol Violation|0|||
125177422|NCT01330303|450268040|FG001|Period 1|Protocol Violation|1|||
125177423|NCT01330303|450268039|FG000|Period 1|Withdrawal by Subject|0|||
125177424|NCT01330303|450268040|FG001|Period 1|Withdrawal by Subject|1|||
125177425|NCT01107197|450268041|FG000|Overall Study|Death|12|||
125177426|NCT01107197|450268042|FG001|Overall Study|Death|10|||
125177427|NCT01107197|450268041|FG000|Overall Study|Lost to Follow-up|5|||
125177428|NCT01107197|450268042|FG001|Overall Study|Lost to Follow-up|8|||
125177429|NCT01107197|450268041|FG000|Overall Study|Withdrawal by Subject|3|||
125177430|NCT01107197|450268042|FG001|Overall Study|Withdrawal by Subject|5|||
125177431|NCT03548337|450268043|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
125177432|NCT03548337|450268044|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
125177433|NCT03548337|450268043|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
125177434|NCT03548337|450268044|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
125177435|NCT03548337|450268043|FG000|Infant Series|Lost to Follow-up|2|||
125177436|NCT03548337|450268044|FG001|Infant Series|Lost to Follow-up|1|||
125177437|NCT03548337|450268043|FG000|Infant Series|Adverse Event|0|||
125177438|NCT03548337|450268044|FG001|Infant Series|Adverse Event|2|||
125177439|NCT03548337|450268043|FG000|Infant Series|Randomized but Not Vaccinated|1|||
125177440|NCT03548337|450268044|FG001|Infant Series|Randomized but Not Vaccinated|0|||
125177441|NCT03548337|450268043|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
125177442|NCT03548337|450268044|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
125177443|NCT01911273|450268046|FG000|Overall Study|Progression of Disease|1|||
125177444|NCT01911273|450268047|FG001|Overall Study|Progression of Disease|0|||
125177445|NCT01911273|450268046|FG000|Overall Study|Withdrawal by Subject|0|||
125177446|NCT01911273|450268047|FG001|Overall Study|Withdrawal by Subject|2|||
125177447|NCT01855828|450268051|FG000|Overall Study|Adverse Event|1|||
125177448|NCT01855828|450268051|FG000|Overall Study|Withdrawal by Subject|1|||
125177449|NCT02517463|450268063|FG000|Overall Study|Lost to Follow-up|5|||
125233058|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
125233059|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
125177450|NCT02517463|450268064|FG001|Overall Study|Lost to Follow-up|2|||
125177451|NCT02890355|450268080|FG000|Overall Study|Adverse Event|5|||
125177452|NCT02890355|450268081|FG001|Overall Study|Adverse Event|5|||
125177453|NCT02890355|450268080|FG000|Overall Study|Refusal unrelated to adverse event|5|||
125177454|NCT02890355|450268081|FG001|Overall Study|Refusal unrelated to adverse event|10|||
125177455|NCT02890355|450268080|FG000|Overall Study|Progression/relapse|46|||
125177456|NCT02890355|450268081|FG001|Overall Study|Progression/relapse|39|||
125233060|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
125177457|NCT02890355|450268080|FG000|Overall Study|Not protocol specified|3|||
125177458|NCT02890355|450268081|FG001|Overall Study|Not protocol specified|4|||
125177459|NCT01128179|450268082|FG000|Overall Study|Death|1|||
125177460|NCT01128179|450268083|FG001|Overall Study|Death|0|||
125177461|NCT01128179|450268082|FG000|Overall Study|Protocol Violation|1|||
125177462|NCT01128179|450268083|FG001|Overall Study|Protocol Violation|0|||
125177463|NCT00720382|450268084|FG000|Overall Study|Adverse Event|54|||
125177464|NCT00720382|450268085|FG001|Overall Study|Adverse Event|17|||
125177465|NCT00720382|450268084|FG000|Overall Study|Lack of Efficacy|18|||
125233061|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233062|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233063|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233064|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233065|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233066|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233067|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233068|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
125233069|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
125233070|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
125233071|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233072|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233073|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233074|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233075|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233076|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233077|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233078|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
125233079|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
125233080|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
125233081|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233082|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233083|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233084|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233085|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233086|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233087|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233088|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
125233089|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
125233090|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
125233091|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233092|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233093|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233094|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233095|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233096|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233097|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233098|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233099|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
125233100|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
125233101|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233102|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233103|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233104|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233105|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233106|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233107|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233108|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125233109|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
125177466|NCT00720382|450268085|FG001|Overall Study|Lack of Efficacy|7|||
125177467|NCT00720382|450268084|FG000|Overall Study|Non-Compliance|15|||
125177468|NCT00720382|450268085|FG001|Overall Study|Non-Compliance|5|||
125233110|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
125177469|NCT00720382|450268084|FG000|Overall Study|Withdrawal by Subject|47|||
125177470|NCT00720382|450268085|FG001|Overall Study|Withdrawal by Subject|11|||
125177471|NCT00720382|450268084|FG000|Overall Study|Lost to Follow-up|28|||
125177472|NCT00720382|450268085|FG001|Overall Study|Lost to Follow-up|14|||
125177473|NCT00720382|450268084|FG000|Overall Study|administrative|14|||
125177474|NCT00720382|450268085|FG001|Overall Study|administrative|5|||
125177475|NCT04460885|450270470|FG000|Overall Study|Withdrawal by Subject|6|||
125177476|NCT04460885|450270471|FG001|Overall Study|Withdrawal by Subject|8|||
125177477|NCT04460885|450270470|FG000|Overall Study|Site closure|1|||
125177478|NCT04460885|450270471|FG001|Overall Study|Site closure|0|||
125177479|NCT04460885|450270470|FG000|Overall Study|Death|5|||
125177480|NCT04460885|450270471|FG001|Overall Study|Death|4|||
125177481|NCT04460885|450270470|FG000|Overall Study|Physician Decision|2|||
125177482|NCT04460885|450270471|FG001|Overall Study|Physician Decision|1|||
125177483|NCT04460885|450270470|FG000|Overall Study|Lost to Follow-up|4|||
125177484|NCT04460885|450270471|FG001|Overall Study|Lost to Follow-up|4|||
125177485|NCT04559347|450270472|FG000|Overall Study|Death|1|||
125177486|NCT04559347|450270473|FG001|Overall Study|Death|0|||
125177487|NCT04559347|450270472|FG000|Overall Study|Thoracotomy conversion|1|||
125177488|NCT04559347|450270473|FG001|Overall Study|Thoracotomy conversion|1|||
125177489|NCT04559347|450270472|FG000|Overall Study|Provider unavailable|2|||
125177490|NCT04559347|450270473|FG001|Overall Study|Provider unavailable|1|||
125177491|NCT04559347|450270472|FG000|Overall Study|Other|2|||
125177492|NCT04559347|450270473|FG001|Overall Study|Other|1|||
125177493|NCT03999996|450270478|FG000|Prior to Booster|Adverse Event|2|||
125177494|NCT03999996|450270479|FG001|Prior to Booster|Adverse Event|0|||
125177495|NCT03999996|450270480|FG002|Prior to Booster|Adverse Event|0|||
125177496|NCT03999996|450270481|FG003|Prior to Booster|Adverse Event|0|||
125177497|NCT03999996|450270478|FG000|Prior to Booster|Lost to Follow-up|17|||
125177498|NCT03999996|450270479|FG001|Prior to Booster|Lost to Follow-up|22|||
125177499|NCT03999996|450270480|FG002|Prior to Booster|Lost to Follow-up|0|||
125177500|NCT03999996|450270481|FG003|Prior to Booster|Lost to Follow-up|0|||
125177501|NCT03999996|450270478|FG000|Prior to Booster|Withdrawal of Consent|51|||
125177502|NCT03999996|450270479|FG001|Prior to Booster|Withdrawal of Consent|8|||
125177503|NCT03999996|450270480|FG002|Prior to Booster|Withdrawal of Consent|0|||
125177504|NCT03999996|450270481|FG003|Prior to Booster|Withdrawal of Consent|0|||
125177505|NCT03999996|450270478|FG000|Prior to Booster|Death|0|||
125177506|NCT03999996|450270479|FG001|Prior to Booster|Death|1|||
125177507|NCT03999996|450270480|FG002|Prior to Booster|Death|0|||
125177508|NCT03999996|450270481|FG003|Prior to Booster|Death|0|||
125177509|NCT03999996|450270478|FG000|Prior to Booster|Reason Not Specified|27|||
125177510|NCT03999996|450270479|FG001|Prior to Booster|Reason Not Specified|4|||
125177511|NCT03999996|450270480|FG002|Prior to Booster|Reason Not Specified|0|||
125177512|NCT03999996|450270481|FG003|Prior to Booster|Reason Not Specified|0|||
125177513|NCT03999996|450270478|FG000|Booster Phase|Lost to Follow-up|0|||
125177514|NCT03999996|450270479|FG001|Booster Phase|Lost to Follow-up|0|||
125177515|NCT03999996|450270480|FG002|Booster Phase|Lost to Follow-up|3|||
125177516|NCT03999996|450270481|FG003|Booster Phase|Lost to Follow-up|3|||
125177517|NCT03999996|450270478|FG000|Booster Phase|Withdrawal of Consent|0|||
125177518|NCT03999996|450270479|FG001|Booster Phase|Withdrawal of Consent|0|||
125177519|NCT03999996|450270480|FG002|Booster Phase|Withdrawal of Consent|0|||
125177520|NCT03999996|450270481|FG003|Booster Phase|Withdrawal of Consent|1|||
125177521|NCT03999996|450270478|FG000|Booster Phase|Reason Not Specified|0|||
125177522|NCT03999996|450270479|FG001|Booster Phase|Reason Not Specified|0|||
125177523|NCT03999996|450270480|FG002|Booster Phase|Reason Not Specified|0|||
125177524|NCT03999996|450270481|FG003|Booster Phase|Reason Not Specified|1|||
125177525|NCT00733005|450270482|FG000|Overall Study|Adverse Event|0|||
125177526|NCT00733005|450270483|FG001|Overall Study|Adverse Event|1|||
125177527|NCT00733005|450270482|FG000|Overall Study|Treatment Failure|0|||
125233111|NCT01232283|450481737|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125233112|NCT01232283|450481738|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125233113|NCT01232283|450481739|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125233114|NCT01232283|450481740|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125233115|NCT01232283|450481741|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125177528|NCT00733005|450270483|FG001|Overall Study|Treatment Failure|1|||
125233116|NCT01232283|450481742|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125233117|NCT01232283|450481743|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125233118|NCT01232283|450481744|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
125177529|NCT00733005|450270482|FG000|Overall Study|Withdrawal by Subject|0|||
125177530|NCT00733005|450270483|FG001|Overall Study|Withdrawal by Subject|1|||
125177531|NCT00733005|450270482|FG000|Overall Study|Protocol Violation|2|||
125177532|NCT00733005|450270483|FG001|Overall Study|Protocol Violation|0|||
125177533|NCT03410056|450270484|FG000|Overall Study|Decision by Sponsor|0|||
125177534|NCT03410056|450270485|FG001|Overall Study|Decision by Sponsor|0|||
125177535|NCT03410056|450270486|FG002|Overall Study|Decision by Sponsor|3|||
125177536|NCT03410056|450270487|FG003|Overall Study|Decision by Sponsor|0|||
125177537|NCT03410056|450270488|FG004|Overall Study|Decision by Sponsor|0|||
125177538|NCT03410056|450270489|FG005|Overall Study|Decision by Sponsor|0|||
125177539|NCT03410056|450270490|FG006|Overall Study|Decision by Sponsor|0|||
125177540|NCT03410056|450270484|FG000|Overall Study|Withdrawal by Subject|0|||
125177541|NCT03410056|450270485|FG001|Overall Study|Withdrawal by Subject|2|||
125233119|NCT01232283|450481745|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
125233120|NCT01232283|450481746|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
125233121|NCT00402831|450481747|FG000|Overall Study|Lost to Follow-up|1|||
125233122|NCT00402831|450481748|FG001|Overall Study|Lost to Follow-up|2|||
125233123|NCT00402831|450481747|FG000|Overall Study|Non-compliance with protocol|0|||
125233124|NCT00402831|450481748|FG001|Overall Study|Non-compliance with protocol|1|||
125233125|NCT02792504|450481753|FG000|Overall Study|Lost to Follow-up|24|||
125233126|NCT02792504|450481753|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
125233127|NCT00848497|450481760|FG000|Overall Study|Screen failure|2|||
125233128|NCT00848497|450481761|FG001|Overall Study|Screen failure|0|||
125233129|NCT00848497|450481760|FG000|Overall Study|Withdrawal by Subject|0|||
125233130|NCT00848497|450481761|FG001|Overall Study|Withdrawal by Subject|1|||
125233131|NCT01114724|450481762|FG000|Overall Study|Death|8|||
125233132|NCT01114724|450481762|FG000|Overall Study|Lost to Follow-up|1|||
125233133|NCT01114724|450481762|FG000|Overall Study|Withdrawal by Subject|1|||
125233134|NCT02966834|450481763|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
125233135|NCT02966834|450481764|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
125233136|NCT02966834|450481765|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
125233137|NCT02966834|450481766|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
125233138|NCT02966834|450481767|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
125233139|NCT02966834|450481768|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
125233140|NCT02966834|450481763|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
125233141|NCT02966834|450481764|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125233142|NCT02966834|450481765|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125233143|NCT02966834|450481766|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125233144|NCT02966834|450481767|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125233145|NCT02966834|450481768|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
125233146|NCT02966834|450481763|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
125233147|NCT02966834|450481764|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
125233148|NCT02966834|450481765|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
125233149|NCT02966834|450481766|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
125233150|NCT02966834|450481767|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
125233151|NCT02966834|450481768|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
125233152|NCT02966834|450481763|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
125233153|NCT02966834|450481764|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
125233154|NCT02966834|450481765|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
125233155|NCT02966834|450481766|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
125233156|NCT02966834|450481767|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
125233157|NCT02966834|450481768|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
125233158|NCT02966834|450481763|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125233159|NCT02966834|450481764|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125233160|NCT02966834|450481765|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125233161|NCT02966834|450481766|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
125233162|NCT02966834|450481767|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125233163|NCT02966834|450481768|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125233164|NCT02966834|450481763|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
125233165|NCT02966834|450481764|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
125233166|NCT02966834|450481765|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
125233167|NCT02966834|450481766|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
125233168|NCT02966834|450481767|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
125233169|NCT02966834|450481768|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
125233170|NCT03883386|450481769|FG000|First Assignment|Lost to Follow-up|1|||
125233171|NCT03883386|450481770|FG001|First Assignment|Lost to Follow-up|0|||
125233172|NCT03883386|450481769|FG000|First Assignment|Withdrawal by Subject|1|||
125233173|NCT03883386|450481770|FG001|First Assignment|Withdrawal by Subject|1|||
125233174|NCT02814526|450481771|FG000|Overall Study|Adverse Event|4|||
125233175|NCT02814526|450481772|FG001|Overall Study|Adverse Event|3|||
125233176|NCT02814526|450481771|FG000|Overall Study|Death|1|||
125233177|NCT02814526|450481772|FG001|Overall Study|Death|1|||
125233178|NCT02814526|450481771|FG000|Overall Study|Lost to Follow-up|3|||
125233179|NCT02814526|450481772|FG001|Overall Study|Lost to Follow-up|4|||
125233180|NCT02814526|450481771|FG000|Overall Study|non site physician decision|1|||
125233181|NCT02814526|450481772|FG001|Overall Study|non site physician decision|0|||
125233182|NCT02814526|450481771|FG000|Overall Study|participant noncompliance|1|||
125233183|NCT02814526|450481772|FG001|Overall Study|participant noncompliance|1|||
125233184|NCT02814526|450481771|FG000|Overall Study|Withdrawal by Subject|20|||
125233185|NCT02814526|450481772|FG001|Overall Study|Withdrawal by Subject|14|||
125233186|NCT02814526|450481771|FG000|Overall Study|safety risk|2|||
125233187|NCT02814526|450481772|FG001|Overall Study|safety risk|1|||
125233188|NCT02814526|450481771|FG000|Overall Study|early termination-study terminated|1|||
125233189|NCT02814526|450481772|FG001|Overall Study|early termination-study terminated|2|||
125233190|NCT02814526|450481771|FG000|Overall Study|Other|0|||
125233191|NCT02814526|450481772|FG001|Overall Study|Other|4|||
125233192|NCT00251758|450481773|FG000|Overall Study|Adverse Event|7|||
125233193|NCT00251758|450481774|FG001|Overall Study|Adverse Event|9|||
125233194|NCT00251758|450481775|FG002|Overall Study|Adverse Event|11|||
125233195|NCT00251758|450481773|FG000|Overall Study|Lost to Follow-up|4|||
125233196|NCT00251758|450481774|FG001|Overall Study|Lost to Follow-up|2|||
125233197|NCT00251758|450481775|FG002|Overall Study|Lost to Follow-up|5|||
125233198|NCT00251758|450481773|FG000|Overall Study|Withdrawal by Subject|13|||
125233199|NCT00251758|450481774|FG001|Overall Study|Withdrawal by Subject|7|||
125233200|NCT00251758|450481775|FG002|Overall Study|Withdrawal by Subject|3|||
125233201|NCT00251758|450481773|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
125233202|NCT00251758|450481774|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
125233203|NCT00251758|450481775|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
125233204|NCT00251758|450481773|FG000|Overall Study|Lack of Efficacy|3|||
125233205|NCT00251758|450481774|FG001|Overall Study|Lack of Efficacy|0|||
125233206|NCT00251758|450481775|FG002|Overall Study|Lack of Efficacy|0|||
125233207|NCT00251758|450481773|FG000|Overall Study|Noncompliant|0|||
125233208|NCT00251758|450481774|FG001|Overall Study|Noncompliant|2|||
125233209|NCT00251758|450481775|FG002|Overall Study|Noncompliant|2|||
125233210|NCT00251758|450481773|FG000|Overall Study|Pregnancy|0|||
125233211|NCT00251758|450481774|FG001|Overall Study|Pregnancy|1|||
125177542|NCT03410056|450270486|FG002|Overall Study|Withdrawal by Subject|5|||
125177543|NCT03410056|450270487|FG003|Overall Study|Withdrawal by Subject|5|||
125177544|NCT03410056|450270488|FG004|Overall Study|Withdrawal by Subject|0|||
125177545|NCT03410056|450270489|FG005|Overall Study|Withdrawal by Subject|0|||
125177546|NCT03410056|450270490|FG006|Overall Study|Withdrawal by Subject|0|||
125177547|NCT00266630|450270491|FG000|Overall Study|Adverse Event|8|||
125177548|NCT00266630|450270492|FG001|Overall Study|Adverse Event|6|||
125177549|NCT00266630|450270491|FG000|Overall Study|Lack of Efficacy|1|||
125177550|NCT00266630|450270492|FG001|Overall Study|Lack of Efficacy|4|||
125177551|NCT00266630|450270491|FG000|Overall Study|Entry Criteria not met|1|||
125177552|NCT00266630|450270492|FG001|Overall Study|Entry Criteria not met|0|||
125177553|NCT00266630|450270491|FG000|Overall Study|Protocol Violation|1|||
125177554|NCT00266630|450270492|FG001|Overall Study|Protocol Violation|3|||
125177555|NCT00266630|450270491|FG000|Overall Study|Physician Decision|1|||
125177556|NCT00266630|450270492|FG001|Overall Study|Physician Decision|2|||
125177557|NCT00266630|450270491|FG000|Overall Study|Withdrawal by Subject|10|||
125177558|NCT00266630|450270492|FG001|Overall Study|Withdrawal by Subject|2|||
125177559|NCT00266630|450270491|FG000|Overall Study|Lost to Follow-up|1|||
125177560|NCT00266630|450270492|FG001|Overall Study|Lost to Follow-up|0|||
125177561|NCT00266630|450270491|FG000|Overall Study|Other|19|||
125177562|NCT00266630|450270492|FG001|Overall Study|Other|11|||
125177563|NCT03284723|450270493|FG000|Overall Study|Death|0|||
125177564|NCT03284723|450270494|FG001|Overall Study|Death|0|||
125177565|NCT03284723|450270495|FG002|Overall Study|Death|0|||
125177566|NCT03284723|450270496|FG003|Overall Study|Death|1|||
125177567|NCT03284723|450270497|FG004|Overall Study|Death|0|||
125177568|NCT03284723|450270498|FG005|Overall Study|Death|0|||
125177569|NCT03284723|450270499|FG006|Overall Study|Death|1|||
125177570|NCT03284723|450270500|FG007|Overall Study|Death|0|||
125177571|NCT03284723|450270501|FG008|Overall Study|Death|0|||
125177572|NCT03284723|450270502|FG009|Overall Study|Death|2|||
125177573|NCT03284723|450270503|FG010|Overall Study|Death|1|||
125177574|NCT03284723|450270504|FG011|Overall Study|Death|0|||
125177575|NCT03284723|450270493|FG000|Overall Study|Lost to Follow-up|0|||
125177576|NCT03284723|450270494|FG001|Overall Study|Lost to Follow-up|0|||
125177577|NCT03284723|450270495|FG002|Overall Study|Lost to Follow-up|0|||
125177578|NCT03284723|450270496|FG003|Overall Study|Lost to Follow-up|0|||
125177579|NCT03284723|450270497|FG004|Overall Study|Lost to Follow-up|0|||
125177580|NCT03284723|450270498|FG005|Overall Study|Lost to Follow-up|2|||
125177581|NCT03284723|450270499|FG006|Overall Study|Lost to Follow-up|1|||
125177582|NCT03284723|450270500|FG007|Overall Study|Lost to Follow-up|0|||
125177583|NCT03284723|450270501|FG008|Overall Study|Lost to Follow-up|0|||
125177584|NCT03284723|450270502|FG009|Overall Study|Lost to Follow-up|2|||
125177585|NCT03284723|450270503|FG010|Overall Study|Lost to Follow-up|0|||
125177586|NCT03284723|450270504|FG011|Overall Study|Lost to Follow-up|0|||
125177587|NCT03284723|450270493|FG000|Overall Study|Study Terminated By Sponsor|0|||
125233212|NCT00251758|450481775|FG002|Overall Study|Pregnancy|0|||
125233213|NCT00251758|450481773|FG000|Overall Study|Per Subject Request|0|||
125177588|NCT03284723|450270494|FG001|Overall Study|Study Terminated By Sponsor|0|||
125177589|NCT03284723|450270495|FG002|Overall Study|Study Terminated By Sponsor|0|||
125177590|NCT03284723|450270496|FG003|Overall Study|Study Terminated By Sponsor|0|||
125177591|NCT03284723|450270497|FG004|Overall Study|Study Terminated By Sponsor|1|||
125177592|NCT03284723|450270498|FG005|Overall Study|Study Terminated By Sponsor|0|||
125177593|NCT03284723|450270499|FG006|Overall Study|Study Terminated By Sponsor|0|||
125177594|NCT03284723|450270500|FG007|Overall Study|Study Terminated By Sponsor|0|||
125233214|NCT00251758|450481774|FG001|Overall Study|Per Subject Request|0|||
125177595|NCT03284723|450270501|FG008|Overall Study|Study Terminated By Sponsor|1|||
125177596|NCT03284723|450270502|FG009|Overall Study|Study Terminated By Sponsor|1|||
125177597|NCT03284723|450270503|FG010|Overall Study|Study Terminated By Sponsor|1|||
125177598|NCT03284723|450270504|FG011|Overall Study|Study Terminated By Sponsor|1|||
125177599|NCT03284723|450270493|FG000|Overall Study|Withdrawal by Subject|0|||
125177600|NCT03284723|450270494|FG001|Overall Study|Withdrawal by Subject|0|||
125177601|NCT03284723|450270495|FG002|Overall Study|Withdrawal by Subject|0|||
125177602|NCT03284723|450270496|FG003|Overall Study|Withdrawal by Subject|0|||
125177603|NCT03284723|450270497|FG004|Overall Study|Withdrawal by Subject|5|||
125177604|NCT03284723|450270498|FG005|Overall Study|Withdrawal by Subject|3|||
125177605|NCT03284723|450270499|FG006|Overall Study|Withdrawal by Subject|1|||
125177606|NCT03284723|450270500|FG007|Overall Study|Withdrawal by Subject|0|||
125177607|NCT03284723|450270501|FG008|Overall Study|Withdrawal by Subject|6|||
125177608|NCT03284723|450270502|FG009|Overall Study|Withdrawal by Subject|0|||
125177609|NCT03284723|450270503|FG010|Overall Study|Withdrawal by Subject|3|||
125177610|NCT03284723|450270504|FG011|Overall Study|Withdrawal by Subject|1|||
125177611|NCT03284723|450270493|FG000|Overall Study|Other|1|||
125177612|NCT03284723|450270494|FG001|Overall Study|Other|0|||
125177613|NCT03284723|450270495|FG002|Overall Study|Other|1|||
125177614|NCT03284723|450270496|FG003|Overall Study|Other|0|||
125177615|NCT03284723|450270497|FG004|Overall Study|Other|1|||
125177616|NCT03284723|450270498|FG005|Overall Study|Other|0|||
125177617|NCT03284723|450270499|FG006|Overall Study|Other|0|||
125177618|NCT03284723|450270500|FG007|Overall Study|Other|0|||
125177619|NCT03284723|450270501|FG008|Overall Study|Other|0|||
125177620|NCT03284723|450270502|FG009|Overall Study|Other|0|||
125177621|NCT03284723|450270503|FG010|Overall Study|Other|1|||
125177622|NCT03284723|450270504|FG011|Overall Study|Other|0|||
125177623|NCT03284723|450270493|FG000|Overall Study|Adverse Event|0|||
125177624|NCT03284723|450270494|FG001|Overall Study|Adverse Event|0|||
125177625|NCT03284723|450270495|FG002|Overall Study|Adverse Event|0|||
125177626|NCT03284723|450270496|FG003|Overall Study|Adverse Event|0|||
125177627|NCT03284723|450270497|FG004|Overall Study|Adverse Event|0|||
125177628|NCT03284723|450270498|FG005|Overall Study|Adverse Event|0|||
125177629|NCT03284723|450270499|FG006|Overall Study|Adverse Event|0|||
125177630|NCT03284723|450270500|FG007|Overall Study|Adverse Event|0|||
125177631|NCT03284723|450270501|FG008|Overall Study|Adverse Event|1|||
125177632|NCT03284723|450270502|FG009|Overall Study|Adverse Event|0|||
125177633|NCT03284723|450270503|FG010|Overall Study|Adverse Event|0|||
125177634|NCT03284723|450270504|FG011|Overall Study|Adverse Event|0|||
125177635|NCT00615199|450270505|FG000|Overall Study|Adverse Event|3|||
125177636|NCT00615199|450270506|FG001|Overall Study|Adverse Event|1|||
125177637|NCT00615199|450270507|FG002|Overall Study|Adverse Event|1|||
125177638|NCT00615199|450270508|FG003|Overall Study|Adverse Event|0|||
125177639|NCT00615199|450270505|FG000|Overall Study|Lack of Efficacy|2|||
125177640|NCT00615199|450270506|FG001|Overall Study|Lack of Efficacy|0|||
125177641|NCT00615199|450270507|FG002|Overall Study|Lack of Efficacy|0|||
125177642|NCT00615199|450270508|FG003|Overall Study|Lack of Efficacy|1|||
125177643|NCT00615199|450270505|FG000|Overall Study|Lost to Follow-up|1|||
125177644|NCT00615199|450270506|FG001|Overall Study|Lost to Follow-up|0|||
125177645|NCT00615199|450270507|FG002|Overall Study|Lost to Follow-up|0|||
125177646|NCT00615199|450270508|FG003|Overall Study|Lost to Follow-up|0|||
125177647|NCT00615199|450270505|FG000|Overall Study|Other|0|||
125177648|NCT00615199|450270506|FG001|Overall Study|Other|0|||
125177649|NCT00615199|450270507|FG002|Overall Study|Other|0|||
125177650|NCT00615199|450270508|FG003|Overall Study|Other|1|||
125177651|NCT00615199|450270505|FG000|Overall Study|Withdrawal by Subject|2|||
125177652|NCT00615199|450270506|FG001|Overall Study|Withdrawal by Subject|1|||
125177653|NCT00615199|450270507|FG002|Overall Study|Withdrawal by Subject|0|||
125177654|NCT00615199|450270508|FG003|Overall Study|Withdrawal by Subject|0|||
125177655|NCT00064987|450270513|FG000|Overall Study|Physician Decision|3|||
125177656|NCT00064987|450270514|FG001|Overall Study|Physician Decision|0|||
125177657|NCT01214655|450270515|FG000|Part A|Progressive Disease|7|||
125177658|NCT01214655|450270516|FG001|Part A|Progressive Disease|0|||
125177659|NCT01214655|450270517|FG002|Part A|Progressive Disease|0|||
125177660|NCT01214655|450270515|FG000|Part A|Physician Decision|1|||
125177661|NCT01214655|450270516|FG001|Part A|Physician Decision|0|||
125177662|NCT01214655|450270517|FG002|Part A|Physician Decision|0|||
125177663|NCT01214655|450270515|FG000|Part B|Progressive disease|0|||
125177664|NCT01214655|450270516|FG001|Part B|Progressive disease|10|||
125177665|NCT01214655|450270517|FG002|Part B|Progressive disease|0|||
125177666|NCT01214655|450270515|FG000|Part B|Death|0|||
125177667|NCT01214655|450270516|FG001|Part B|Death|1|||
125177668|NCT01214655|450270517|FG002|Part B|Death|0|||
125177669|NCT01214655|450270515|FG000|Part B|Withdrawal by Subject|0|||
125177670|NCT01214655|450270516|FG001|Part B|Withdrawal by Subject|2|||
125177671|NCT01214655|450270517|FG002|Part B|Withdrawal by Subject|0|||
125177672|NCT01214655|450270515|FG000|Part C|Progressive Disease|0|||
125177673|NCT01214655|450270516|FG001|Part C|Progressive Disease|0|||
125177674|NCT01214655|450270517|FG002|Part C|Progressive Disease|5|||
125177675|NCT01214655|450270515|FG000|Part C|Death|0|||
125177676|NCT01214655|450270516|FG001|Part C|Death|0|||
125177677|NCT01214655|450270517|FG002|Part C|Death|1|||
125177678|NCT01214655|450270515|FG000|Part C|Physician Decision|0|||
125233215|NCT00251758|450481775|FG002|Overall Study|Per Subject Request|1|||
125233216|NCT00251758|450481773|FG000|Overall Study|Per Investigator Request|1|||
125233217|NCT00251758|450481774|FG001|Overall Study|Per Investigator Request|0|||
125233218|NCT00251758|450481775|FG002|Overall Study|Per Investigator Request|0|||
125233219|NCT01387269|450481777|FG000|Overall Study|Death|38|||
125233220|NCT01387269|450481778|FG001|Overall Study|Death|20|||
125233221|NCT01387269|450481777|FG000|Overall Study|Other|8|||
125233222|NCT01387269|450481778|FG001|Overall Study|Other|7|||
125233223|NCT01387269|450481777|FG000|Overall Study|Unrelated AE|12|||
125233224|NCT01387269|450481778|FG001|Overall Study|Unrelated AE|3|||
125233225|NCT01387269|450481777|FG000|Overall Study|Withdrawal by patient|32|||
125233226|NCT01387269|450481778|FG001|Overall Study|Withdrawal by patient|10|||
125233227|NCT01387269|450481777|FG000|Overall Study|Study drug-related AE|1|||
125233228|NCT01387269|450481778|FG001|Overall Study|Study drug-related AE|0|||
125233229|NCT01387269|450481777|FG000|Overall Study|Lost to Follow-up|1|||
125233230|NCT01387269|450481778|FG001|Overall Study|Lost to Follow-up|0|||
125233231|NCT01981616|450481783|FG000|Overall Study|Adverse Event|0|||
125233232|NCT01981616|450481784|FG001|Overall Study|Adverse Event|1|||
125233233|NCT01981616|450481783|FG000|Overall Study|Protocol Violation|1|||
125233234|NCT01981616|450481784|FG001|Overall Study|Protocol Violation|0|||
125233235|NCT01020123|450481786|FG000|Main Period|Withdrawal by Subject|6|||
125233236|NCT01020123|450481787|FG001|Main Period|Withdrawal by Subject|5|||
125233237|NCT01020123|450481788|FG002|Main Period|Withdrawal by Subject|3|||
125233238|NCT01020123|450481789|FG003|Main Period|Withdrawal by Subject|1|||
125233239|NCT01020123|450481790|FG004|Main Period|Withdrawal by Subject|6|||
125233240|NCT01020123|450481791|FG005|Main Period|Withdrawal by Subject|3|||
125233241|NCT01020123|450481792|FG006|Main Period|Withdrawal by Subject|2|||
125233242|NCT01020123|450481786|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
125233243|NCT01020123|450481787|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
125233244|NCT01020123|450481788|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
125233245|NCT01020123|450481789|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
125233246|NCT01020123|450481790|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
125233247|NCT01020123|450481791|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
125233248|NCT01020123|450481792|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
125233249|NCT01020123|450481786|FG000|Main Period|Adverse Event|5|||
125233250|NCT01020123|450481787|FG001|Main Period|Adverse Event|2|||
125233251|NCT01020123|450481788|FG002|Main Period|Adverse Event|2|||
125233252|NCT01020123|450481789|FG003|Main Period|Adverse Event|1|||
125233253|NCT01020123|450481790|FG004|Main Period|Adverse Event|1|||
125233254|NCT01020123|450481791|FG005|Main Period|Adverse Event|2|||
125233255|NCT01020123|450481792|FG006|Main Period|Adverse Event|1|||
125233256|NCT01020123|450481786|FG000|Main Period|Protocol Violation|4|||
125233257|NCT01020123|450481787|FG001|Main Period|Protocol Violation|4|||
125233258|NCT01020123|450481788|FG002|Main Period|Protocol Violation|2|||
125233259|NCT01020123|450481789|FG003|Main Period|Protocol Violation|5|||
125233260|NCT01020123|450481790|FG004|Main Period|Protocol Violation|2|||
125233261|NCT01020123|450481791|FG005|Main Period|Protocol Violation|3|||
125233262|NCT01020123|450481792|FG006|Main Period|Protocol Violation|2|||
125233263|NCT01020123|450481786|FG000|Main Period|Lost to Follow-up|0|||
125233264|NCT01020123|450481787|FG001|Main Period|Lost to Follow-up|2|||
125233265|NCT01020123|450481788|FG002|Main Period|Lost to Follow-up|0|||
125233266|NCT01020123|450481789|FG003|Main Period|Lost to Follow-up|0|||
125233267|NCT01020123|450481790|FG004|Main Period|Lost to Follow-up|0|||
125233268|NCT01020123|450481791|FG005|Main Period|Lost to Follow-up|0|||
125233269|NCT01020123|450481792|FG006|Main Period|Lost to Follow-up|0|||
125233270|NCT01020123|450481786|FG000|Main Period|Unclasified|2|||
125233271|NCT01020123|450481787|FG001|Main Period|Unclasified|0|||
125233272|NCT01020123|450481788|FG002|Main Period|Unclasified|1|||
125233273|NCT01020123|450481789|FG003|Main Period|Unclasified|0|||
125233274|NCT01020123|450481790|FG004|Main Period|Unclasified|1|||
125233275|NCT01020123|450481791|FG005|Main Period|Unclasified|3|||
125233276|NCT01020123|450481792|FG006|Main Period|Unclasified|6|||
125233277|NCT01020123|450481786|FG000|Extention Period|Withdrawal by Subject|2|||
125233278|NCT01020123|450481787|FG001|Extention Period|Withdrawal by Subject|1|||
125233279|NCT01020123|450481788|FG002|Extention Period|Withdrawal by Subject|1|||
125233280|NCT01020123|450481789|FG003|Extention Period|Withdrawal by Subject|0|||
125233281|NCT01020123|450481790|FG004|Extention Period|Withdrawal by Subject|0|||
125233282|NCT01020123|450481791|FG005|Extention Period|Withdrawal by Subject|0|||
125233283|NCT01020123|450481792|FG006|Extention Period|Withdrawal by Subject|0|||
125233284|NCT01020123|450481786|FG000|Extention Period|Adverse Event|0|||
125233285|NCT01020123|450481787|FG001|Extention Period|Adverse Event|0|||
125233286|NCT01020123|450481788|FG002|Extention Period|Adverse Event|0|||
125233287|NCT01020123|450481789|FG003|Extention Period|Adverse Event|1|||
125233288|NCT01020123|450481790|FG004|Extention Period|Adverse Event|0|||
125233289|NCT01020123|450481791|FG005|Extention Period|Adverse Event|0|||
125233290|NCT01020123|450481792|FG006|Extention Period|Adverse Event|0|||
125233291|NCT01020123|450481786|FG000|Extention Period|Protocol Violation|1|||
125233292|NCT01020123|450481787|FG001|Extention Period|Protocol Violation|1|||
125233293|NCT01020123|450481788|FG002|Extention Period|Protocol Violation|1|||
125233294|NCT01020123|450481789|FG003|Extention Period|Protocol Violation|0|||
125177679|NCT01214655|450270516|FG001|Part C|Physician Decision|0|||
125177680|NCT01214655|450270517|FG002|Part C|Physician Decision|1|||
125177681|NCT00764881|450270518|FG000|Overall Study|Adverse Event|5|||
125177682|NCT00764881|450270519|FG001|Overall Study|Adverse Event|1|||
125177683|NCT00764881|450270518|FG000|Overall Study|Withdrawal by Subject|1|||
125177684|NCT00764881|450270519|FG001|Overall Study|Withdrawal by Subject|3|||
125177685|NCT00764881|450270518|FG000|Overall Study|Protocol Violation|2|||
125177686|NCT00764881|450270519|FG001|Overall Study|Protocol Violation|2|||
125177687|NCT00764881|450270518|FG000|Overall Study|Lost to Follow-up|2|||
125177688|NCT00764881|450270519|FG001|Overall Study|Lost to Follow-up|0|||
125177689|NCT00764881|450270518|FG000|Overall Study|Noncompliant|1|||
125177690|NCT00764881|450270519|FG001|Overall Study|Noncompliant|0|||
125177691|NCT00764881|450270518|FG000|Overall Study|Accidentally discontinued study drug|1|||
125177692|NCT00764881|450270519|FG001|Overall Study|Accidentally discontinued study drug|0|||
125177693|NCT00764881|450270518|FG000|Overall Study|Wished to become pregnant|1|||
125177694|NCT00764881|450270519|FG001|Overall Study|Wished to become pregnant|0|||
125177695|NCT00764881|450270518|FG000|Overall Study|Carcinoma detected|1|||
125177696|NCT00764881|450270519|FG001|Overall Study|Carcinoma detected|0|||
125177697|NCT00764881|450270518|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
125177698|NCT00764881|450270519|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
125177699|NCT00764881|450270518|FG000|Overall Study|no treatment or no observation|2|||
125177700|NCT00764881|450270519|FG001|Overall Study|no treatment or no observation|2|||
125177701|NCT05256134|450270520|FG000|Overall Study|Study Terminated by Sponsor|11|||
125177702|NCT05256134|450270521|FG001|Overall Study|Study Terminated by Sponsor|10|||
125177703|NCT05256134|450270520|FG000|Overall Study|Withdrawal by Subject|1|||
125177704|NCT05256134|450270521|FG001|Overall Study|Withdrawal by Subject|3|||
125177705|NCT01567462|450270528|FG000|Overall Study|Withdrawal by Subject|4|||
125177706|NCT01567462|450270529|FG001|Overall Study|Withdrawal by Subject|7|||
125177707|NCT01977417|450270530|FG000|Overall Study|Adverse Event|1|||
125177708|NCT01977417|450270531|FG001|Overall Study|Adverse Event|0|||
125177709|NCT01977417|450270530|FG000|Overall Study|Withdrawal by Subject|2|||
125177710|NCT01977417|450270531|FG001|Overall Study|Withdrawal by Subject|4|||
125177711|NCT01977417|450270530|FG000|Overall Study|Female enrollment goal met|0|||
125177712|NCT01977417|450270531|FG001|Overall Study|Female enrollment goal met|2|||
125177713|NCT02548156|450270537|FG000|Washout Period 1|Lost to Follow-up|0|||
125177714|NCT02548156|450270538|FG001|Washout Period 1|Lost to Follow-up|0|||
125177715|NCT02548156|450270539|FG002|Washout Period 1|Lost to Follow-up|0|||
125177716|NCT02548156|450270540|FG003|Washout Period 1|Lost to Follow-up|0|||
125177717|NCT02548156|450270541|FG004|Washout Period 1|Lost to Follow-up|1|||
125177718|NCT02548156|450270542|FG005|Washout Period 1|Lost to Follow-up|0|||
125177719|NCT01068262|450270543|FG000|Overall Study|Adverse Event|2|||
125177720|NCT01068262|450270544|FG001|Overall Study|Adverse Event|0|||
125177721|NCT01068262|450270545|FG002|Overall Study|Adverse Event|1|||
125177722|NCT01068262|450270546|FG003|Overall Study|Adverse Event|0|||
125177723|NCT01068262|450270543|FG000|Overall Study|Protocol Violation|1|||
125177724|NCT01068262|450270544|FG001|Overall Study|Protocol Violation|0|||
125177725|NCT01068262|450270545|FG002|Overall Study|Protocol Violation|0|||
125177726|NCT01068262|450270546|FG003|Overall Study|Protocol Violation|0|||
125177727|NCT01068262|450270543|FG000|Overall Study|Withdrawal by Subject|0|||
125177728|NCT01068262|450270544|FG001|Overall Study|Withdrawal by Subject|1|||
125177729|NCT01068262|450270545|FG002|Overall Study|Withdrawal by Subject|0|||
125177730|NCT01068262|450270546|FG003|Overall Study|Withdrawal by Subject|0|||
125177731|NCT01153425|450270548|FG000|Overall Study|Withdrawal by Subject|3|||
125177732|NCT01153425|450270549|FG001|Overall Study|Withdrawal by Subject|3|||
125177733|NCT01232452|450270550|FG000|Overall Study|Adverse Event|17|||
125177734|NCT01232452|450270551|FG001|Overall Study|Adverse Event|15|||
125177735|NCT01232452|450270550|FG000|Overall Study|Withdrawal by Subject|11|||
125177736|NCT01232452|450270551|FG001|Overall Study|Withdrawal by Subject|8|||
125177737|NCT01232452|450270550|FG000|Overall Study|Physician Decision|8|||
125177738|NCT01232452|450270551|FG001|Overall Study|Physician Decision|12|||
125177739|NCT01232452|450270550|FG000|Overall Study|Protocol entry criterion not met|0|||
125177740|NCT01232452|450270551|FG001|Overall Study|Protocol entry criterion not met|2|||
125177741|NCT01232452|450270550|FG000|Overall Study|Sponsor Decision|3|||
125177742|NCT01232452|450270551|FG001|Overall Study|Sponsor Decision|1|||
125177743|NCT01232452|450270550|FG000|Overall Study|Protocol Violation|0|||
125177744|NCT01232452|450270551|FG001|Overall Study|Protocol Violation|1|||
125177745|NCT05024747|450270552|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
125177746|NCT05024747|450270553|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
125177747|NCT05024747|450270552|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
125177748|NCT05024747|450270553|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
125177749|NCT05024747|450270552|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
125177750|NCT05024747|450270553|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
125177751|NCT03022370|450270554|FG000|Overall Study|Death|6|||
125177752|NCT03022370|450270555|FG001|Overall Study|Death|12|||
125177753|NCT03022370|450270554|FG000|Overall Study|Lost to Follow-up|174|||
125177754|NCT03022370|450270555|FG001|Overall Study|Lost to Follow-up|109|||
125177755|NCT00699816|450270556|FG000|Overall Study|Protocol Violation|1|||
125177756|NCT00699816|450270557|FG001|Overall Study|Protocol Violation|3|||
125177757|NCT02454933|450270560|FG000|Overall Study|Progressive disease|10|||
125177758|NCT02454933|450270561|FG001|Overall Study|Progressive disease|7|||
125177759|NCT02454933|450270560|FG000|Overall Study|Adverse Event|1|||
125177760|NCT02454933|450270561|FG001|Overall Study|Adverse Event|1|||
125177761|NCT02454933|450270560|FG000|Overall Study|Withdrawal by Subject|0|||
125177762|NCT02454933|450270561|FG001|Overall Study|Withdrawal by Subject|3|||
125177763|NCT02454933|450270560|FG000|Overall Study|Lost to Follow-up|1|||
125177764|NCT02454933|450270561|FG001|Overall Study|Lost to Follow-up|0|||
125177765|NCT01526655|450270564|FG000|Overall Study|Withdrawal by Subject|0|||
125177766|NCT01526655|450270565|FG001|Overall Study|Withdrawal by Subject|1|||
125177767|NCT04753216|450270566|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
125177768|NCT04753216|450270566|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
125177769|NCT04753216|450270566|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
125177770|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
125177771|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Death|1|||
125177772|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
125177773|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
125177774|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
125177775|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
125177776|NCT02001987|450270568|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
125177777|NCT02001987|450270568|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
125177778|NCT02001987|450270568|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
125177779|NCT02001987|450270568|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
125177780|NCT02001987|450270568|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
125177781|NCT02001987|450270568|FG000|LTE Period (52 Weeks)|Other|3|||
125177782|NCT02288325|450270575|FG000|Run-in Period|Adverse Event|48|||
125177783|NCT02288325|450270576|FG001|Run-in Period|Adverse Event|0|||
125177784|NCT02288325|450270577|FG002|Run-in Period|Adverse Event|0|||
125177785|NCT02288325|450270575|FG000|Run-in Period|Lack of Efficacy|16|||
125177786|NCT02288325|450270576|FG001|Run-in Period|Lack of Efficacy|0|||
125177787|NCT02288325|450270577|FG002|Run-in Period|Lack of Efficacy|0|||
125177788|NCT02288325|450270575|FG000|Run-in Period|Withdrawal of Consent|28|||
125177789|NCT02288325|450270576|FG001|Run-in Period|Withdrawal of Consent|0|||
125177790|NCT02288325|450270577|FG002|Run-in Period|Withdrawal of Consent|0|||
125177791|NCT02288325|450270575|FG000|Run-in Period|Lost to Follow-up|25|||
125177792|NCT02288325|450270576|FG001|Run-in Period|Lost to Follow-up|0|||
125177793|NCT02288325|450270577|FG002|Run-in Period|Lost to Follow-up|0|||
125177794|NCT02288325|450270575|FG000|Run-in Period|Protocol Violation|17|||
125177795|NCT02288325|450270576|FG001|Run-in Period|Protocol Violation|0|||
125177796|NCT02288325|450270577|FG002|Run-in Period|Protocol Violation|0|||
125177797|NCT02288325|450270575|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
125177798|NCT02288325|450270576|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
125177799|NCT02288325|450270577|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
125177800|NCT02288325|450270575|FG000|Run-in Period|Reason not Specified|8|||
125177801|NCT02288325|450270576|FG001|Run-in Period|Reason not Specified|0|||
125177802|NCT02288325|450270577|FG002|Run-in Period|Reason not Specified|0|||
125177803|NCT02288325|450270575|FG000|Stabilization Period|Adverse Event|13|||
125177804|NCT02288325|450270576|FG001|Stabilization Period|Adverse Event|0|||
125177805|NCT02288325|450270577|FG002|Stabilization Period|Adverse Event|0|||
125177806|NCT02288325|450270575|FG000|Stabilization Period|Lack of Efficacy|22|||
125177807|NCT02288325|450270576|FG001|Stabilization Period|Lack of Efficacy|0|||
125177808|NCT02288325|450270577|FG002|Stabilization Period|Lack of Efficacy|0|||
125177809|NCT02288325|450270575|FG000|Stabilization Period|Withdrawal of Consent|23|||
125177810|NCT02288325|450270576|FG001|Stabilization Period|Withdrawal of Consent|0|||
125177811|NCT02288325|450270577|FG002|Stabilization Period|Withdrawal of Consent|0|||
125177812|NCT02288325|450270575|FG000|Stabilization Period|Lost to Follow-up|12|||
125177813|NCT02288325|450270576|FG001|Stabilization Period|Lost to Follow-up|0|||
125177814|NCT02288325|450270577|FG002|Stabilization Period|Lost to Follow-up|0|||
125177815|NCT02288325|450270575|FG000|Stabilization Period|Protocol Violation|8|||
125177816|NCT02288325|450270576|FG001|Stabilization Period|Protocol Violation|0|||
125177817|NCT02288325|450270577|FG002|Stabilization Period|Protocol Violation|0|||
125177818|NCT02288325|450270575|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
125177819|NCT02288325|450270576|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
125177820|NCT02288325|450270577|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
125177821|NCT02288325|450270575|FG000|Stabilization Period|Reason not Specified|15|||
125177822|NCT02288325|450270576|FG001|Stabilization Period|Reason not Specified|0|||
125177823|NCT02288325|450270577|FG002|Stabilization Period|Reason not Specified|0|||
125177824|NCT02288325|450270575|FG000|Double-blind Treatment Period|Adverse Event|0|||
125177825|NCT02288325|450270576|FG001|Double-blind Treatment Period|Adverse Event|2|||
125177826|NCT02288325|450270577|FG002|Double-blind Treatment Period|Adverse Event|5|||
125177827|NCT02288325|450270575|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
125177828|NCT02288325|450270576|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
125233295|NCT01020123|450481790|FG004|Extention Period|Protocol Violation|0|||
125233296|NCT01020123|450481791|FG005|Extention Period|Protocol Violation|0|||
125233297|NCT01020123|450481792|FG006|Extention Period|Protocol Violation|1|||
125233298|NCT01020123|450481786|FG000|Extention Period|Lost to Follow-up|0|||
125233299|NCT01020123|450481787|FG001|Extention Period|Lost to Follow-up|0|||
125233300|NCT01020123|450481788|FG002|Extention Period|Lost to Follow-up|0|||
125233301|NCT01020123|450481789|FG003|Extention Period|Lost to Follow-up|0|||
125233302|NCT01020123|450481790|FG004|Extention Period|Lost to Follow-up|0|||
125233303|NCT01020123|450481791|FG005|Extention Period|Lost to Follow-up|2|||
125233304|NCT01020123|450481792|FG006|Extention Period|Lost to Follow-up|0|||
125233305|NCT04711005|450481797|FG000|Overall Study|Withdrawal by Subject|0|||
125233306|NCT04711005|450481798|FG001|Overall Study|Withdrawal by Subject|0|||
125233307|NCT04711005|450481799|FG002|Overall Study|Withdrawal by Subject|0|||
125233308|NCT04711005|450481800|FG003|Overall Study|Withdrawal by Subject|0|||
125233309|NCT04711005|450481801|FG004|Overall Study|Withdrawal by Subject|0|||
125233310|NCT04711005|450481802|FG005|Overall Study|Withdrawal by Subject|0|||
125233311|NCT04711005|450481803|FG006|Overall Study|Withdrawal by Subject|0|||
125233312|NCT04711005|450481804|FG007|Overall Study|Withdrawal by Subject|1|||
125233313|NCT04711005|450481805|FG008|Overall Study|Withdrawal by Subject|0|||
125233314|NCT04711005|450481806|FG009|Overall Study|Withdrawal by Subject|0|||
125233315|NCT04711005|450481797|FG000|Overall Study|Physician Decision|0|||
125233316|NCT04711005|450481798|FG001|Overall Study|Physician Decision|0|||
125233317|NCT04711005|450481799|FG002|Overall Study|Physician Decision|0|||
125233318|NCT04711005|450481800|FG003|Overall Study|Physician Decision|0|||
125233319|NCT04711005|450481801|FG004|Overall Study|Physician Decision|0|||
125233320|NCT04711005|450481802|FG005|Overall Study|Physician Decision|0|||
125233321|NCT04711005|450481803|FG006|Overall Study|Physician Decision|0|||
125233322|NCT04711005|450481804|FG007|Overall Study|Physician Decision|2|||
125233323|NCT04711005|450481805|FG008|Overall Study|Physician Decision|1|||
125233324|NCT04711005|450481806|FG009|Overall Study|Physician Decision|0|||
125233325|NCT03824561|450481814|FG000|Overall Study|Protocol Violation|19|||
125233326|NCT01773928|450481815|FG000|Overall Study|Adverse Event|0|||
125233327|NCT01773928|450481816|FG001|Overall Study|Adverse Event|0|||
125233328|NCT01773928|450481817|FG002|Overall Study|Adverse Event|0|||
125233329|NCT01773928|450481818|FG003|Overall Study|Adverse Event|0|||
125233330|NCT01773928|450481819|FG004|Overall Study|Adverse Event|0|||
125233331|NCT01773928|450481820|FG005|Overall Study|Adverse Event|0|||
125233332|NCT01773928|450481821|FG006|Overall Study|Adverse Event|0|||
125233333|NCT01773928|450481822|FG007|Overall Study|Adverse Event|1|||
125233334|NCT01773928|450481823|FG008|Overall Study|Adverse Event|0|||
125233335|NCT01773928|450481815|FG000|Overall Study|Physician Decision|0|||
125233336|NCT01773928|450481816|FG001|Overall Study|Physician Decision|0|||
125233337|NCT01773928|450481817|FG002|Overall Study|Physician Decision|0|||
125233338|NCT01773928|450481818|FG003|Overall Study|Physician Decision|1|||
125233339|NCT01773928|450481819|FG004|Overall Study|Physician Decision|0|||
125233340|NCT01773928|450481820|FG005|Overall Study|Physician Decision|0|||
125233341|NCT01773928|450481821|FG006|Overall Study|Physician Decision|0|||
125233342|NCT01773928|450481822|FG007|Overall Study|Physician Decision|0|||
125233343|NCT01773928|450481823|FG008|Overall Study|Physician Decision|0|||
125233344|NCT01773928|450481815|FG000|Overall Study|Withdrawal by Subject|5|||
125233345|NCT01773928|450481816|FG001|Overall Study|Withdrawal by Subject|4|||
125233346|NCT01773928|450481817|FG002|Overall Study|Withdrawal by Subject|4|||
125233347|NCT01773928|450481818|FG003|Overall Study|Withdrawal by Subject|4|||
125233348|NCT01773928|450481819|FG004|Overall Study|Withdrawal by Subject|7|||
125233349|NCT01773928|450481820|FG005|Overall Study|Withdrawal by Subject|1|||
125233350|NCT01773928|450481821|FG006|Overall Study|Withdrawal by Subject|0|||
125233351|NCT01773928|450481822|FG007|Overall Study|Withdrawal by Subject|0|||
125233352|NCT01773928|450481823|FG008|Overall Study|Withdrawal by Subject|1|||
125233353|NCT01773928|450481815|FG000|Overall Study|Lost to Follow-up|0|||
125233354|NCT01773928|450481816|FG001|Overall Study|Lost to Follow-up|0|||
125233355|NCT01773928|450481817|FG002|Overall Study|Lost to Follow-up|0|||
125233356|NCT01773928|450481818|FG003|Overall Study|Lost to Follow-up|0|||
125233357|NCT01773928|450481819|FG004|Overall Study|Lost to Follow-up|0|||
125233358|NCT01773928|450481820|FG005|Overall Study|Lost to Follow-up|1|||
125233359|NCT01773928|450481821|FG006|Overall Study|Lost to Follow-up|0|||
125233360|NCT01773928|450481822|FG007|Overall Study|Lost to Follow-up|0|||
125233361|NCT01773928|450481823|FG008|Overall Study|Lost to Follow-up|0|||
125233362|NCT01773928|450481815|FG000|Overall Study|Subject misrepresented age|0|||
125233363|NCT01773928|450481816|FG001|Overall Study|Subject misrepresented age|1|||
125233364|NCT01773928|450481817|FG002|Overall Study|Subject misrepresented age|0|||
125233365|NCT01773928|450481818|FG003|Overall Study|Subject misrepresented age|0|||
125233366|NCT01773928|450481819|FG004|Overall Study|Subject misrepresented age|0|||
125233367|NCT01773928|450481820|FG005|Overall Study|Subject misrepresented age|0|||
125233368|NCT01773928|450481821|FG006|Overall Study|Subject misrepresented age|0|||
125233369|NCT01773928|450481822|FG007|Overall Study|Subject misrepresented age|0|||
125233370|NCT01773928|450481823|FG008|Overall Study|Subject misrepresented age|0|||
125233371|NCT01773928|450481815|FG000|Overall Study|Subject met exclusion criteria|0|||
125233372|NCT01773928|450481816|FG001|Overall Study|Subject met exclusion criteria|0|||
125233373|NCT01773928|450481817|FG002|Overall Study|Subject met exclusion criteria|0|||
125233374|NCT01773928|450481818|FG003|Overall Study|Subject met exclusion criteria|0|||
125233375|NCT01773928|450481819|FG004|Overall Study|Subject met exclusion criteria|0|||
125233376|NCT01773928|450481820|FG005|Overall Study|Subject met exclusion criteria|0|||
125233377|NCT01773928|450481821|FG006|Overall Study|Subject met exclusion criteria|0|||
125233378|NCT01773928|450481822|FG007|Overall Study|Subject met exclusion criteria|0|||
125233379|NCT01773928|450481823|FG008|Overall Study|Subject met exclusion criteria|1|||
125233380|NCT01773928|450481815|FG000|Overall Study|Randomized, had to leave, never returned|0|||
125233381|NCT01773928|450481816|FG001|Overall Study|Randomized, had to leave, never returned|0|||
125233382|NCT01773928|450481817|FG002|Overall Study|Randomized, had to leave, never returned|0|||
125233383|NCT01773928|450481818|FG003|Overall Study|Randomized, had to leave, never returned|1|||
125233384|NCT01773928|450481819|FG004|Overall Study|Randomized, had to leave, never returned|0|||
125233385|NCT01773928|450481820|FG005|Overall Study|Randomized, had to leave, never returned|0|||
125233386|NCT01773928|450481821|FG006|Overall Study|Randomized, had to leave, never returned|0|||
125233387|NCT01773928|450481822|FG007|Overall Study|Randomized, had to leave, never returned|0|||
125233388|NCT01773928|450481823|FG008|Overall Study|Randomized, had to leave, never returned|0|||
125233389|NCT01773928|450481815|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
125233390|NCT01773928|450481816|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
125233391|NCT01773928|450481817|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
125233392|NCT01773928|450481818|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
125233393|NCT01773928|450481819|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
125233394|NCT01773928|450481820|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
125233395|NCT01773928|450481821|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
125233396|NCT01773928|450481822|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
125233397|NCT01773928|450481823|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
125233398|NCT03092752|450481824|FG000|Overall Study|Aged <40 years|14209|||
125233399|NCT03092752|450481824|FG000|Overall Study|At least one claim with T2DM|61299|||
125233400|NCT03092752|450481824|FG000|Overall Study|Having no claim of study drugs|29282|||
125233401|NCT03092752|450481824|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
125233402|NCT03092752|450481824|FG000|Overall Study|<6 month history|245900|||
125233403|NCT03573297|450481827|FG000|Open Label Treatment Period|Adverse Event|67|||
125233404|NCT03573297|450481828|FG001|Open Label Treatment Period|Adverse Event|0|||
125177829|NCT02288325|450270577|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
125177830|NCT02288325|450270575|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
125177831|NCT02288325|450270576|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
125177832|NCT02288325|450270577|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
125177833|NCT02288325|450270575|FG000|Double-blind Treatment Period|Protocol Violation|0|||
125177834|NCT02288325|450270576|FG001|Double-blind Treatment Period|Protocol Violation|1|||
125177835|NCT02288325|450270577|FG002|Double-blind Treatment Period|Protocol Violation|2|||
125177836|NCT02288325|450270575|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
125177837|NCT02288325|450270576|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
125177838|NCT02288325|450270577|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
125177839|NCT02288325|450270575|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
125177840|NCT02288325|450270576|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
125177841|NCT02288325|450270577|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
125177842|NCT05211726|450270583|FG000|Overall Study|Withdrawal by Subject|2|||
125177843|NCT05211726|450270584|FG001|Overall Study|Withdrawal by Subject|3|||
125177844|NCT05211726|450270583|FG000|Overall Study|Protocol Violation|0|||
125177845|NCT05211726|450270584|FG001|Overall Study|Protocol Violation|1|||
125177846|NCT00344448|450270592|FG000|Screening|Withdrawal by Subject|0|||
125177847|NCT00344448|450270593|FG001|Screening|Withdrawal by Subject|1|||
125177848|NCT00344448|450270592|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
125177849|NCT00344448|450270593|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
125177850|NCT00344448|450270592|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
125177851|NCT00344448|450270593|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
125177852|NCT00344448|450270592|FG000|Open Label|Withdrawal by Subject|1|||
125177853|NCT00344448|450270593|FG001|Open Label|Withdrawal by Subject|1|||
125177854|NCT00344448|450270592|FG000|Open Label|Study terminated|1|||
125177855|NCT00344448|450270593|FG001|Open Label|Study terminated|0|||
125233405|NCT03573297|450481829|FG002|Open Label Treatment Period|Adverse Event|0|||
125233406|NCT03573297|450481830|FG003|Open Label Treatment Period|Adverse Event|0|||
125233407|NCT03573297|450481827|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
125233408|NCT03573297|450481828|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
125233409|NCT03573297|450481829|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
125233410|NCT03573297|450481830|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
125233411|NCT03573297|450481827|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
125233412|NCT03573297|450481828|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
125233413|NCT03573297|450481829|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
125233414|NCT03573297|450481830|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
125233415|NCT03573297|450481827|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
125233416|NCT03573297|450481828|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
125233417|NCT03573297|450481829|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
125233418|NCT03573297|450481830|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
125233419|NCT03573297|450481827|FG000|Open Label Treatment Period|Pregnancy|1|||
125233420|NCT03573297|450481828|FG001|Open Label Treatment Period|Pregnancy|0|||
125233421|NCT03573297|450481829|FG002|Open Label Treatment Period|Pregnancy|0|||
125233422|NCT03573297|450481830|FG003|Open Label Treatment Period|Pregnancy|0|||
125233423|NCT03573297|450481827|FG000|Open Label Treatment Period|Protocol Violation|17|||
125233424|NCT03573297|450481828|FG001|Open Label Treatment Period|Protocol Violation|0|||
125233425|NCT03573297|450481829|FG002|Open Label Treatment Period|Protocol Violation|0|||
125233426|NCT03573297|450481830|FG003|Open Label Treatment Period|Protocol Violation|0|||
125233427|NCT03573297|450481827|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
125233428|NCT03573297|450481828|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
125233429|NCT03573297|450481829|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
125233430|NCT03573297|450481830|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
125233431|NCT03573297|450481827|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
125233432|NCT03573297|450481828|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
125233433|NCT03573297|450481829|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
125233434|NCT03573297|450481830|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
125233435|NCT03573297|450481827|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
125233436|NCT03573297|450481828|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
125233437|NCT03573297|450481829|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
125233438|NCT03573297|450481830|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
125233439|NCT03573297|450481827|FG000|Open Label Treatment Period|Other, Not Specified|7|||
125233440|NCT03573297|450481828|FG001|Open Label Treatment Period|Other, Not Specified|0|||
125233441|NCT03573297|450481829|FG002|Open Label Treatment Period|Other, Not Specified|0|||
125233442|NCT03573297|450481830|FG003|Open Label Treatment Period|Other, Not Specified|0|||
125233443|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
125233444|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
125233445|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
125233446|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
125233447|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125233448|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125233449|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Adverse Event|5|||
125233450|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Adverse Event|1|||
125233451|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
125233452|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
125233453|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
125233454|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
125233455|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125233456|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
125233457|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
125233458|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
125233459|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125233460|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
125233461|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
125233462|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
125233463|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
125233464|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
125233465|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
125233466|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
125233467|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
125233468|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
125233469|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
125233470|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
125233471|NCT03573297|450481827|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
125233472|NCT03573297|450481828|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
125233473|NCT03573297|450481829|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
125233474|NCT03573297|450481830|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
125233475|NCT06996301|450481831|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
125233476|NCT06996301|450481832|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
125233477|NCT06996301|450481831|FG000|Overall Study|Patients with discordant diagnostic results|107|||
125233478|NCT06996301|450481832|FG001|Overall Study|Patients with discordant diagnostic results|90|||
125233479|NCT06996301|450481831|FG000|Overall Study|Lost to Follow-up|31|||
125233480|NCT06996301|450481832|FG001|Overall Study|Lost to Follow-up|56|||
125233481|NCT06996301|450481831|FG000|Overall Study|Withdrawal by Subject|12|||
125233482|NCT06996301|450481832|FG001|Overall Study|Withdrawal by Subject|7|||
125233483|NCT00661388|450481836|FG000|Overall Study|Adverse Event|14|||
125233484|NCT00661388|450481836|FG000|Overall Study|Protocol Violation|7|||
125233485|NCT00661388|450481836|FG000|Overall Study|Renal transplantation|1|||
125233486|NCT00661388|450481836|FG000|Overall Study|Dialysis initiation|1|||
125233487|NCT00661388|450481836|FG000|Overall Study|Administrative reasons|1|||
125233488|NCT03370172|450483187|FG000|Overall Study|Withdrawal by Subject|0|||
125233489|NCT03370172|450483188|FG001|Overall Study|Withdrawal by Subject|1|||
125233490|NCT01171534|450483192|FG000|Overall Study|Lost to Follow-up|0|||
125233491|NCT01171534|450483193|FG001|Overall Study|Lost to Follow-up|2|||
125233492|NCT01171534|450483192|FG000|Overall Study|screen failure|0|||
125233493|NCT01171534|450483193|FG001|Overall Study|screen failure|1|||
125233494|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
125233495|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
125233496|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
125233497|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
125233498|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
125233499|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
125233500|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
125233501|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
125233502|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
125233503|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
125233504|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
125233505|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
125233506|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
125233507|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
125233508|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
125233509|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
125233510|NCT00849056|450483194|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
125233511|NCT00849056|450483195|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
125233512|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
125233513|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
125233514|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
125233515|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
125233516|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
125233517|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
125233518|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
125233519|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
125233520|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
125233521|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
125233522|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
125233523|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
125233524|NCT00849056|450483194|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
125233525|NCT00849056|450483195|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
125233526|NCT03427892|450483196|FG000|Overall Study|Lost to Follow-up|2|||
125233527|NCT00548327|450483197|FG000|Overall Study|Adverse Event|0|||
125233528|NCT00548327|450483198|FG001|Overall Study|Adverse Event|1|||
125233529|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
125233530|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
125233531|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Death|1|||
125233532|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Death|3|||
125233533|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
125233534|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
125233535|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
125233536|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
125233537|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
125233538|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
125233539|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
125233540|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
125233541|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
125233542|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
125233543|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
125233544|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
125233545|NCT00362232|450483199|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
125233546|NCT00362232|450483200|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
125233547|NCT00362232|450483199|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
125233548|NCT00362232|450483200|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
125233549|NCT00362232|450483199|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
125233550|NCT00362232|450483200|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
125233551|NCT00362232|450483199|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
125233552|NCT00362232|450483200|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
125233553|NCT00362232|450483199|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
125233554|NCT00362232|450483200|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
125233555|NCT00274456|450483201|FG000|Overall Study|Still on treatment|2|||
125233556|NCT00274456|450483202|FG001|Overall Study|Still on treatment|3|||
125233557|NCT00274456|450483203|FG002|Overall Study|Still on treatment|5|||
125233558|NCT00274456|450483204|FG003|Overall Study|Still on treatment|1|||
125233559|NCT00274456|450483201|FG000|Overall Study|Unacceptable toxicity|10|||
125233560|NCT00274456|450483202|FG001|Overall Study|Unacceptable toxicity|5|||
125233561|NCT00274456|450483203|FG002|Overall Study|Unacceptable toxicity|12|||
125233562|NCT00274456|450483204|FG003|Overall Study|Unacceptable toxicity|16|||
125233563|NCT00274456|450483201|FG000|Overall Study|Adverse Event|0|||
125233564|NCT00274456|450483202|FG001|Overall Study|Adverse Event|1|||
125233565|NCT00274456|450483203|FG002|Overall Study|Adverse Event|2|||
125233566|NCT00274456|450483204|FG003|Overall Study|Adverse Event|2|||
125233567|NCT00274456|450483201|FG000|Overall Study|Physician Decision|7|||
125233568|NCT00274456|450483202|FG001|Overall Study|Physician Decision|5|||
125233569|NCT00274456|450483203|FG002|Overall Study|Physician Decision|6|||
125233570|NCT00274456|450483204|FG003|Overall Study|Physician Decision|13|||
125233571|NCT00274456|450483201|FG000|Overall Study|Lost to Follow-up|0|||
125233572|NCT00274456|450483202|FG001|Overall Study|Lost to Follow-up|0|||
125233573|NCT00274456|450483203|FG002|Overall Study|Lost to Follow-up|1|||
125233574|NCT00274456|450483204|FG003|Overall Study|Lost to Follow-up|0|||
125233575|NCT00274456|450483201|FG000|Overall Study|Withdrawal by Subject|18|||
125233576|NCT00274456|450483202|FG001|Overall Study|Withdrawal by Subject|13|||
125233577|NCT00274456|450483203|FG002|Overall Study|Withdrawal by Subject|9|||
125233578|NCT00274456|450483204|FG003|Overall Study|Withdrawal by Subject|13|||
125233579|NCT03255187|450483208|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
125233580|NCT03255187|450483209|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
125233581|NCT03255187|450483208|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
125233582|NCT03255187|450483209|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
125233583|NCT00375752|450483210|FG000|Overall Study|Lack of Efficacy|4|||
125233584|NCT00375752|450483211|FG001|Overall Study|Lack of Efficacy|4|||
125233585|NCT00375752|450483210|FG000|Overall Study|Adverse Event|1|||
125233586|NCT00375752|450483211|FG001|Overall Study|Adverse Event|6|||
125233587|NCT00375752|450483210|FG000|Overall Study|Withdrawal by Subject|6|||
125233588|NCT00375752|450483211|FG001|Overall Study|Withdrawal by Subject|1|||
125233589|NCT00375752|450483210|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
125233590|NCT00375752|450483211|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
125233591|NCT00375752|450483210|FG000|Overall Study|Protocol Violation|0|||
125233592|NCT00375752|450483211|FG001|Overall Study|Protocol Violation|2|||
125233593|NCT00375752|450483210|FG000|Overall Study|Administrative Problems|0|||
125233594|NCT00375752|450483211|FG001|Overall Study|Administrative Problems|1|||
125233595|NCT02034006|450483212|FG000|Overall Study|Withdrawal by Subject|7|||
125233596|NCT02034006|450483212|FG000|Overall Study|Lost to Follow-up|5|||
125233597|NCT02034006|450483212|FG000|Overall Study|Death|1|||
125233598|NCT02034006|450483212|FG000|Overall Study|Pregnancy|1|||
125233599|NCT00109343|450483216|FG000|Overall Study|Adverse Event|1|||
125233600|NCT00109343|450483217|FG001|Overall Study|Adverse Event|0|||
125233601|NCT00109343|450483218|FG002|Overall Study|Adverse Event|2|||
125233602|NCT00109343|450483216|FG000|Overall Study|Lack of Efficacy|1|||
125233603|NCT00109343|450483217|FG001|Overall Study|Lack of Efficacy|0|||
125233604|NCT00109343|450483218|FG002|Overall Study|Lack of Efficacy|0|||
125233605|NCT00109343|450483216|FG000|Overall Study|Lost to Follow-up|35|||
125233606|NCT00109343|450483217|FG001|Overall Study|Lost to Follow-up|20|||
125233607|NCT00109343|450483218|FG002|Overall Study|Lost to Follow-up|14|||
125233608|NCT00109343|450483216|FG000|Overall Study|Protocol Violation|1|||
125233609|NCT00109343|450483217|FG001|Overall Study|Protocol Violation|2|||
125233610|NCT00109343|450483218|FG002|Overall Study|Protocol Violation|2|||
125233611|NCT00109343|450483216|FG000|Overall Study|Withdrawal by Subject|15|||
125233612|NCT00109343|450483217|FG001|Overall Study|Withdrawal by Subject|11|||
125233613|NCT00109343|450483218|FG002|Overall Study|Withdrawal by Subject|10|||
125233614|NCT00109343|450483216|FG000|Overall Study|Subject Moved|6|||
125233615|NCT00109343|450483217|FG001|Overall Study|Subject Moved|2|||
125233616|NCT00109343|450483218|FG002|Overall Study|Subject Moved|1|||
125233617|NCT00109343|450483216|FG000|Overall Study|Other|5|||
125233618|NCT00109343|450483217|FG001|Overall Study|Other|2|||
125233619|NCT00109343|450483218|FG002|Overall Study|Other|1|||
125233620|NCT01499511|450483219|FG000|Overall Study|Death|1|||
125233621|NCT01499511|450483220|FG001|Overall Study|Death|0|||
125233622|NCT00577408|450483221|FG000|Overall Study|Stopped attending study visits|9|||
125233623|NCT00577408|450483222|FG001|Overall Study|Stopped attending study visits|11|||
125233624|NCT00577408|450483221|FG000|Overall Study|Continued opioid use|3|||
125233625|NCT00577408|450483222|FG001|Overall Study|Continued opioid use|2|||
125233626|NCT00577408|450483221|FG000|Overall Study|Non-compliance with study meds|0|||
125233627|NCT00577408|450483222|FG001|Overall Study|Non-compliance with study meds|3|||
125233628|NCT00577408|450483221|FG000|Overall Study|Refused Oral Naltrexone|0|||
125177856|NCT02374346|450270595|FG000|Overall Study|operated or discharged during weekend|48|||
125177857|NCT02565511|450270596|FG000|Overall Study|Study terminated by Sponsor|35|||
125177858|NCT02565511|450270597|FG001|Overall Study|Study terminated by Sponsor|22|||
125177859|NCT02565511|450270598|FG002|Overall Study|Study terminated by Sponsor|235|||
125177860|NCT02565511|450270599|FG003|Overall Study|Study terminated by Sponsor|156|||
125177861|NCT02565511|450270596|FG000|Overall Study|Withdrawal by Subject|3|||
125177862|NCT02565511|450270597|FG001|Overall Study|Withdrawal by Subject|0|||
125177863|NCT02565511|450270598|FG002|Overall Study|Withdrawal by Subject|12|||
125177864|NCT02565511|450270599|FG003|Overall Study|Withdrawal by Subject|5|||
125177865|NCT02565511|450270596|FG000|Overall Study|Adverse Event|0|||
125177866|NCT02565511|450270597|FG001|Overall Study|Adverse Event|0|||
125177867|NCT02565511|450270598|FG002|Overall Study|Adverse Event|1|||
125177868|NCT02565511|450270599|FG003|Overall Study|Adverse Event|1|||
125177869|NCT02565511|450270596|FG000|Overall Study|Lost to Follow-up|4|||
125177870|NCT02565511|450270597|FG001|Overall Study|Lost to Follow-up|1|||
125177871|NCT02565511|450270598|FG002|Overall Study|Lost to Follow-up|0|||
125177872|NCT02565511|450270599|FG003|Overall Study|Lost to Follow-up|1|||
125177873|NCT02565511|450270596|FG000|Overall Study|Physician Decision|0|||
125177874|NCT02565511|450270597|FG001|Overall Study|Physician Decision|0|||
125177875|NCT02565511|450270598|FG002|Overall Study|Physician Decision|0|||
125177876|NCT02565511|450270599|FG003|Overall Study|Physician Decision|1|||
125177877|NCT02565511|450270596|FG000|Overall Study|Protocol deviation|0|||
125177878|NCT02565511|450270597|FG001|Overall Study|Protocol deviation|0|||
125177879|NCT02565511|450270598|FG002|Overall Study|Protocol deviation|3|||
125177880|NCT02565511|450270599|FG003|Overall Study|Protocol deviation|0|||
125177881|NCT04807400|450270602|FG000|Overall Study|Adverse Event|2|||
125177882|NCT04807400|450270603|FG001|Overall Study|Adverse Event|3|||
125177883|NCT04807400|450270604|FG002|Overall Study|Adverse Event|3|||
125177884|NCT04807400|450270602|FG000|Overall Study|Death|2|||
125177885|NCT04807400|450270603|FG001|Overall Study|Death|0|||
125177886|NCT04807400|450270604|FG002|Overall Study|Death|0|||
125177887|NCT04807400|450270602|FG000|Overall Study|Lost to Follow-up|8|||
125177888|NCT04807400|450270603|FG001|Overall Study|Lost to Follow-up|6|||
125177889|NCT04807400|450270604|FG002|Overall Study|Lost to Follow-up|6|||
125177890|NCT04807400|450270602|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125177891|NCT04807400|450270603|FG001|Overall Study|Non-Compliance With Study Drug|4|||
125177892|NCT04807400|450270604|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125177893|NCT04807400|450270602|FG000|Overall Study|Participant Decision|20|||
125177894|NCT04807400|450270603|FG001|Overall Study|Participant Decision|19|||
125177895|NCT04807400|450270604|FG002|Overall Study|Participant Decision|26|||
125177896|NCT04807400|450270602|FG000|Overall Study|Physician Decision|0|||
125177897|NCT04807400|450270603|FG001|Overall Study|Physician Decision|1|||
125177898|NCT04807400|450270604|FG002|Overall Study|Physician Decision|0|||
125177899|NCT04807400|450270602|FG000|Overall Study|Protocol Violation|4|||
125177900|NCT04807400|450270603|FG001|Overall Study|Protocol Violation|3|||
125177901|NCT04807400|450270604|FG002|Overall Study|Protocol Violation|7|||
125177902|NCT04807400|450270602|FG000|Overall Study|Withdrawal by Subject|13|||
125177903|NCT04807400|450270603|FG001|Overall Study|Withdrawal by Subject|9|||
125177904|NCT04807400|450270604|FG002|Overall Study|Withdrawal by Subject|20|||
125177905|NCT04807400|450270602|FG000|Overall Study|Mis-randomized|1|||
125177906|NCT04807400|450270603|FG001|Overall Study|Mis-randomized|0|||
125177907|NCT04807400|450270604|FG002|Overall Study|Mis-randomized|0|||
125177908|NCT03656744|450270605|FG000|Overall Study|Adverse Event|1|||
125177909|NCT03656744|450270606|FG001|Overall Study|Adverse Event|4|||
125177910|NCT03656744|450270607|FG002|Overall Study|Adverse Event|1|||
125177911|NCT03656744|450270605|FG000|Overall Study|Protocol Violation|1|||
125177912|NCT03656744|450270606|FG001|Overall Study|Protocol Violation|0|||
125177913|NCT03656744|450270607|FG002|Overall Study|Protocol Violation|0|||
125177914|NCT03656744|450270605|FG000|Overall Study|Lost to Follow-up|2|||
125177915|NCT03656744|450270606|FG001|Overall Study|Lost to Follow-up|2|||
125177916|NCT03656744|450270607|FG002|Overall Study|Lost to Follow-up|0|||
125177917|NCT03656744|450270605|FG000|Overall Study|Withdrawal by Subject|0|||
125177918|NCT03656744|450270606|FG001|Overall Study|Withdrawal by Subject|1|||
125177919|NCT03656744|450270607|FG002|Overall Study|Withdrawal by Subject|0|||
125177920|NCT03656744|450270605|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
125177921|NCT03656744|450270606|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
125177922|NCT03656744|450270607|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
125177923|NCT03076775|450270610|FG000|Overall Study|Lost to Follow-up|1|||
125177924|NCT03076775|450270611|FG001|Overall Study|Lost to Follow-up|0|||
125233629|NCT00577408|450483222|FG001|Overall Study|Refused Oral Naltrexone|1|||
125177925|NCT01332292|450270614|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
125177926|NCT01332292|450270615|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
125177927|NCT01332292|450270614|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
125177928|NCT01332292|450270615|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
125177929|NCT01332292|450270614|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
125177930|NCT01332292|450270615|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
125233630|NCT00577408|450483221|FG000|Overall Study|Moved out of state|0|||
125233631|NCT00577408|450483222|FG001|Overall Study|Moved out of state|1|||
125233632|NCT00577408|450483221|FG000|Overall Study|Scheduling Issues|0|||
125233633|NCT00577408|450483222|FG001|Overall Study|Scheduling Issues|3|||
125233634|NCT00577408|450483221|FG000|Overall Study|Death|0|||
125233635|NCT00577408|450483222|FG001|Overall Study|Death|1|||
125233636|NCT00577408|450483221|FG000|Overall Study|Psychiatric hospitalization|0|||
125233637|NCT00577408|450483222|FG001|Overall Study|Psychiatric hospitalization|1|||
125233638|NCT00656617|450483223|FG000|Overall Study|Adverse Event|1|||
125233639|NCT00656617|450483223|FG000|Overall Study|Death|2|||
125233640|NCT00656617|450483223|FG000|Overall Study|Insurance Issues|2|||
125233641|NCT00656617|450483223|FG000|Overall Study|Move to different clinical trial|2|||
125233642|NCT02349386|450483233|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
125233643|NCT02349386|450483234|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
125233644|NCT02349386|450483235|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
125233645|NCT02349386|450483236|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
125233646|NCT02349386|450483233|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
125233647|NCT02349386|450483234|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
125233648|NCT02349386|450483235|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
125233649|NCT02349386|450483236|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
125233650|NCT02349386|450483233|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
125233651|NCT02349386|450483234|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
125233652|NCT02349386|450483235|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
125233653|NCT02349386|450483236|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
125233654|NCT02349386|450483233|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
125233655|NCT02349386|450483234|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
125233656|NCT02349386|450483235|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
125233657|NCT02349386|450483236|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
125233658|NCT02349386|450483233|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
125233659|NCT02349386|450483234|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
125233660|NCT02349386|450483235|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
125233661|NCT02349386|450483236|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
125233662|NCT02349386|450483233|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
125233663|NCT02349386|450483234|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
125233664|NCT02349386|450483235|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
125233665|NCT02349386|450483236|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
125233666|NCT01712178|450483237|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
125233667|NCT01712178|450483238|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
125233668|NCT01712178|450483237|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
125233669|NCT01712178|450483238|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
125233670|NCT01712178|450483237|FG000|Overall Study|Lost to Follow-up|0|||
125233671|NCT01712178|450483238|FG001|Overall Study|Lost to Follow-up|1|||
125233672|NCT00091819|450483239|FG000|Overall Study|Adverse Event|1|||
125233673|NCT00091819|450483240|FG001|Overall Study|Adverse Event|1|||
125233674|NCT00091819|450483239|FG000|Overall Study|Death|4|||
125233675|NCT00091819|450483240|FG001|Overall Study|Death|5|||
125233676|NCT00091819|450483239|FG000|Overall Study|Lost to Follow-up|26|||
125233677|NCT00091819|450483240|FG001|Overall Study|Lost to Follow-up|23|||
125233678|NCT00091819|450483239|FG000|Overall Study|Withdrawal by Subject|5|||
125233679|NCT00091819|450483240|FG001|Overall Study|Withdrawal by Subject|8|||
125233680|NCT00091819|450483239|FG000|Overall Study|Protocol Violation|1|||
125233681|NCT00091819|450483240|FG001|Overall Study|Protocol Violation|2|||
125233682|NCT00091819|450483239|FG000|Overall Study|Other|2|||
125233683|NCT00091819|450483240|FG001|Overall Study|Other|3|||
125233684|NCT00091819|450483239|FG000|Overall Study|Never received study treatment|3|||
125233685|NCT00091819|450483240|FG001|Overall Study|Never received study treatment|4|||
125233686|NCT00961415|450483241|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
125233687|NCT00961415|450483242|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
125233688|NCT00961415|450483243|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
125233689|NCT00961415|450483241|FG000|Induction Treatment Phase|Death|77|||
125233690|NCT00961415|450483242|FG001|Induction Treatment Phase|Death|0|||
125233691|NCT00961415|450483243|FG002|Induction Treatment Phase|Death|0|||
125233692|NCT00961415|450483241|FG000|Induction Treatment Phase|Protocol Violation|1|||
125233693|NCT00961415|450483242|FG001|Induction Treatment Phase|Protocol Violation|0|||
125233694|NCT00961415|450483243|FG002|Induction Treatment Phase|Protocol Violation|0|||
125233695|NCT00961415|450483241|FG000|Induction Treatment Phase|Physician Decision|2|||
125233696|NCT00961415|450483242|FG001|Induction Treatment Phase|Physician Decision|0|||
125233697|NCT00961415|450483243|FG002|Induction Treatment Phase|Physician Decision|0|||
125233698|NCT00961415|450483241|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
125233699|NCT00961415|450483242|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
125177931|NCT03910673|450270619|FG000|Overall Study|Adverse Event|0|||
125177932|NCT03910673|450270620|FG001|Overall Study|Adverse Event|0|||
125177933|NCT03910673|450270621|FG002|Overall Study|Adverse Event|0|||
125177934|NCT03910673|450270622|FG003|Overall Study|Adverse Event|2|||
125177935|NCT03910673|450270623|FG004|Overall Study|Adverse Event|0|||
125177936|NCT00098774|450270624|FG000|Overall Study|Adverse Event|2|||
125177937|NCT00098774|450270624|FG000|Overall Study|Disease Progression|9|||
125177938|NCT00098774|450270624|FG000|Overall Study|Withdrawal by Subject|1|||
125177939|NCT00098774|450270624|FG000|Overall Study|Failed (to respond) during induction|4|||
125177940|NCT00098774|450270624|FG000|Overall Study|Physician Decision|2|||
125177941|NCT02324582|450270625|FG000|Overall Study|Screen Failures|0|||
125177942|NCT02324582|450270626|FG001|Overall Study|Screen Failures|5|||
125177943|NCT03541317|450270627|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
125177944|NCT03541317|450270628|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
125177945|NCT03541317|450270629|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
125177946|NCT03541317|450270630|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
125177947|NCT03541317|450270631|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
125177948|NCT03541317|450270632|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
125177949|NCT02123446|450270633|FG000|Washout Period (1 Day)|Physician Decision|1|||
125177950|NCT02123446|450270634|FG001|Washout Period (1 Day)|Physician Decision|0|||
125177951|NCT04388553|450270635|FG000|Overall Study|Protocol Violation|1|||
125177952|NCT04388553|450270636|FG001|Overall Study|Protocol Violation|0|||
125177953|NCT04502212|450270639|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
125177954|NCT04502212|450270639|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
125177955|NCT04208750|450270655|FG000|Overall Study|Lost to Follow-up|16|||
125177956|NCT04208750|450270656|FG001|Overall Study|Lost to Follow-up|15|||
125177957|NCT05377749|450272635|FG000|3 Weeks|Lost to Follow-up|2|||
125177958|NCT05377749|450272636|FG001|3 Weeks|Lost to Follow-up|4|||
125177959|NCT05377749|450272635|FG000|3 Weeks|Withdrawal by Subject|1|||
125177960|NCT05377749|450272636|FG001|3 Weeks|Withdrawal by Subject|1|||
125177961|NCT02301390|450272639|FG000|Overall Study|Withdrawal by Subject|3|||
125177962|NCT02301390|450272640|FG001|Overall Study|Withdrawal by Subject|5|||
125177963|NCT02301390|450272639|FG000|Overall Study|Protocol Violation|1|||
125177964|NCT02301390|450272640|FG001|Overall Study|Protocol Violation|0|||
125177965|NCT02301390|450272639|FG000|Overall Study|Physician Decision|1|||
125177966|NCT02301390|450272640|FG001|Overall Study|Physician Decision|0|||
125177967|NCT02301390|450272639|FG000|Overall Study|Lost to Follow-up|0|||
125177968|NCT02301390|450272640|FG001|Overall Study|Lost to Follow-up|1|||
125177969|NCT02301390|450272639|FG000|Overall Study|Death|2|||
125177970|NCT02301390|450272640|FG001|Overall Study|Death|2|||
125177971|NCT02301390|450272639|FG000|Overall Study|Procedure not completed|0|||
125177972|NCT02301390|450272640|FG001|Overall Study|Procedure not completed|4|||
125177973|NCT02301390|450272639|FG000|Overall Study|Missed multiple visits|1|||
125177974|NCT02301390|450272640|FG001|Overall Study|Missed multiple visits|1|||
125177975|NCT02301390|450272639|FG000|Overall Study|study terminated|2|||
125177976|NCT02301390|450272640|FG001|Overall Study|study terminated|0|||
125177977|NCT02121652|450272641|FG000|Overall Study|Lost to Follow-up|2|||
125177978|NCT02121652|450272642|FG001|Overall Study|Lost to Follow-up|1|||
125177979|NCT02121652|450272641|FG000|Overall Study|Death|1|||
125177980|NCT02121652|450272642|FG001|Overall Study|Death|0|||
125177981|NCT02121652|450272641|FG000|Overall Study|Withdrawal by Subject|3|||
125177982|NCT02121652|450272642|FG001|Overall Study|Withdrawal by Subject|3|||
125177983|NCT04108299|450272649|FG000|Overall Study|Not interested in participating|2|||
125177984|NCT04108299|450272650|FG001|Overall Study|Not interested in participating|1|||
125177985|NCT04108299|450272651|FG002|Overall Study|Not interested in participating|2|||
125177986|NCT04108299|450272652|FG003|Overall Study|Not interested in participating|1|||
125177987|NCT00247676|450272653|FG000|Overall Study|Death|5|||
125177988|NCT00247676|450272653|FG000|Overall Study|Adverse Event|11|||
125177989|NCT00247676|450272653|FG000|Overall Study|Lack of Efficacy|15|||
125177990|NCT00247676|450272653|FG000|Overall Study|Other|3|||
125177991|NCT00247676|450272653|FG000|Overall Study|Withdrawal by Subject|2|||
125177992|NCT04123405|450272654|FG000|Overall Study|Adverse Event|1|||
125177993|NCT04123405|450272655|FG001|Overall Study|Adverse Event|2|||
125177994|NCT04123405|450272656|FG002|Overall Study|Adverse Event|3|||
125177995|NCT04123405|450272657|FG003|Overall Study|Adverse Event|3|||
125177996|NCT04123405|450272654|FG000|Overall Study|Exclusion criteria met|1|||
125177997|NCT04123405|450272655|FG001|Overall Study|Exclusion criteria met|2|||
125177998|NCT04123405|450272656|FG002|Overall Study|Exclusion criteria met|0|||
125177999|NCT04123405|450272657|FG003|Overall Study|Exclusion criteria met|2|||
125178000|NCT04123405|450272654|FG000|Overall Study|Withdrawal by Subject|1|||
125178001|NCT04123405|450272655|FG001|Overall Study|Withdrawal by Subject|3|||
125178002|NCT04123405|450272656|FG002|Overall Study|Withdrawal by Subject|0|||
125178003|NCT04123405|450272657|FG003|Overall Study|Withdrawal by Subject|2|||
125178004|NCT04123405|450272654|FG000|Overall Study|Contact to subject lost|0|||
125178005|NCT04123405|450272655|FG001|Overall Study|Contact to subject lost|0|||
125178006|NCT04123405|450272656|FG002|Overall Study|Contact to subject lost|0|||
125233700|NCT00961415|450483243|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
125233701|NCT00961415|450483241|FG000|Induction Treatment Phase|Other Reason|5|||
125233702|NCT00961415|450483242|FG001|Induction Treatment Phase|Other Reason|0|||
125233703|NCT00961415|450483243|FG002|Induction Treatment Phase|Other Reason|0|||
125233704|NCT00961415|450483241|FG000|Maintenance Treatment Phase|Death|0|||
125233705|NCT00961415|450483242|FG001|Maintenance Treatment Phase|Death|42|||
125233706|NCT00961415|450483243|FG002|Maintenance Treatment Phase|Death|34|||
125233707|NCT00961415|450483241|FG000|Maintenance Treatment Phase|Investigators decision|0|||
125233708|NCT00961415|450483242|FG001|Maintenance Treatment Phase|Investigators decision|2|||
125233709|NCT00961415|450483243|FG002|Maintenance Treatment Phase|Investigators decision|0|||
125233710|NCT00961415|450483241|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125233711|NCT00961415|450483242|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
125233712|NCT00961415|450483243|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
125233713|NCT00961415|450483241|FG000|Maintenance Treatment Phase|Other reason|0|||
125233714|NCT00961415|450483242|FG001|Maintenance Treatment Phase|Other reason|1|||
125233715|NCT00961415|450483243|FG002|Maintenance Treatment Phase|Other reason|3|||
125233716|NCT04759131|450483247|FG000|Overall Study|Investigator's discretion|1|||
125233717|NCT04759131|450483248|FG001|Overall Study|Investigator's discretion|0|||
125233718|NCT04759131|450483247|FG000|Overall Study|Subject withdrawal|1|||
125233719|NCT04759131|450483248|FG001|Overall Study|Subject withdrawal|0|||
125233720|NCT05144945|450483249|FG000|Overall Study|Withdrawal by Subject|1|||
125233721|NCT05144945|450483250|FG001|Overall Study|Withdrawal by Subject|0|||
125233722|NCT03692949|450483253|FG000|Overall Study|Lost to Follow-up|0|||
125233723|NCT03692949|450483254|FG001|Overall Study|Lost to Follow-up|0|||
125233724|NCT03692949|450483255|FG002|Overall Study|Lost to Follow-up|0|||
125233725|NCT03692949|450483256|FG003|Overall Study|Lost to Follow-up|0|||
125233726|NCT03692949|450483257|FG004|Overall Study|Lost to Follow-up|0|||
125233727|NCT03692949|450483258|FG005|Overall Study|Lost to Follow-up|0|||
125233728|NCT03692949|450483259|FG006|Overall Study|Lost to Follow-up|0|||
125233729|NCT03692949|450483260|FG007|Overall Study|Lost to Follow-up|1|||
125233730|NCT02592824|450483262|FG000|Overall Study|Protocol Violation|5|||
125233731|NCT02592824|450483263|FG001|Overall Study|Protocol Violation|3|||
125233732|NCT02592824|450483262|FG000|Overall Study|Lost to Follow-up|2|||
125233733|NCT02592824|450483263|FG001|Overall Study|Lost to Follow-up|1|||
125233734|NCT03426878|450483264|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
125233735|NCT03426878|450483264|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
125233736|NCT03426878|450483264|FG000|Overall Study|Declined to receive results|3|||
125233737|NCT03426878|450483264|FG000|Overall Study|Received negative results by mailed letter|65|||
125233738|NCT03426878|450483264|FG000|Overall Study|Lost to Follow-up|177|||
125233739|NCT00465517|450483265|FG000|Overall Study|Adverse Event|7|||
125233740|NCT00465517|450483266|FG001|Overall Study|Adverse Event|3|||
125233741|NCT00465517|450483265|FG000|Overall Study|Lost to Follow-up|1|||
125233742|NCT00465517|450483266|FG001|Overall Study|Lost to Follow-up|0|||
125233743|NCT00465517|450483265|FG000|Overall Study|Withdrawal by Subject|4|||
125233744|NCT00465517|450483266|FG001|Overall Study|Withdrawal by Subject|1|||
125233745|NCT05233761|450483273|FG000|Treatment Period A|Withdrawal by Subject|12|||
125233746|NCT05233761|450483274|FG001|Treatment Period A|Withdrawal by Subject|10|||
125233747|NCT05233761|450483273|FG000|Treatment Period A|Lost to Follow-up|6|||
125233748|NCT05233761|450483274|FG001|Treatment Period A|Lost to Follow-up|12|||
125233749|NCT05233761|450483273|FG000|Treatment Period A|Protocol Violation|8|||
125233750|NCT05233761|450483274|FG001|Treatment Period A|Protocol Violation|15|||
125233751|NCT01604785|450483275|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
125233752|NCT01604785|450483276|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
125233753|NCT05049122|450483279|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
125233754|NCT05049122|450483279|FG000|Overall Study|Participant moved|1|||
125233755|NCT05049122|450483279|FG000|Overall Study|At the direction of the doctor|1|||
125233756|NCT00560404|450483280|FG000|Overall Study|Adverse Event|2|||
125233757|NCT00560404|450483281|FG001|Overall Study|Adverse Event|3|||
125233758|NCT00560404|450483280|FG000|Overall Study|Death|3|||
125233759|NCT00560404|450483281|FG001|Overall Study|Death|3|||
125233760|NCT00560404|450483280|FG000|Overall Study|Protocol Violation|12|||
125233761|NCT00560404|450483281|FG001|Overall Study|Protocol Violation|7|||
125233762|NCT00560404|450483280|FG000|Overall Study|Administrative Reasons|1|||
125233763|NCT00560404|450483281|FG001|Overall Study|Administrative Reasons|1|||
125233764|NCT00560404|450483280|FG000|Overall Study|Withdrew Consent|4|||
125233765|NCT00560404|450483281|FG001|Overall Study|Withdrew Consent|0|||
125233766|NCT00560404|450483280|FG000|Overall Study|Failure to return|1|||
125233767|NCT00560404|450483281|FG001|Overall Study|Failure to return|2|||
125233768|NCT00560404|450483280|FG000|Overall Study|Other withdrawal reason|13|||
125443425|NCT02555371|451252129|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
125443426|NCT02555371|451252130|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
125233769|NCT00560404|450483281|FG001|Overall Study|Other withdrawal reason|5|||
125233770|NCT00392223|450483288|FG000|Overall Study|Adverse Event|5|||
125233771|NCT00392223|450483289|FG001|Overall Study|Adverse Event|4|||
125443427|NCT02555371|451252131|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
125443428|NCT02555371|451252132|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
125178007|NCT04123405|450272657|FG003|Overall Study|Contact to subject lost|1|||
125178008|NCT04123405|450272654|FG000|Overall Study|screening failure|1|||
125178009|NCT04123405|450272655|FG001|Overall Study|screening failure|0|||
125178010|NCT04123405|450272656|FG002|Overall Study|screening failure|0|||
125178011|NCT04123405|450272657|FG003|Overall Study|screening failure|0|||
125178012|NCT00662649|450272658|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
125178013|NCT00662649|450272659|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
125178014|NCT00662649|450272660|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
125178015|NCT00662649|450272661|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
125178016|NCT00662649|450272662|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
125178017|NCT00662649|450272658|FG000|Core Study (24 Months)|Adverse Event|22|||
125178018|NCT00662649|450272659|FG001|Core Study (24 Months)|Adverse Event|13|||
125178019|NCT00662649|450272660|FG002|Core Study (24 Months)|Adverse Event|18|||
125178020|NCT00662649|450272661|FG003|Core Study (24 Months)|Adverse Event|0|||
125178021|NCT00662649|450272662|FG004|Core Study (24 Months)|Adverse Event|0|||
125178022|NCT00662649|450272658|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
125178023|NCT00662649|450272659|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
125178024|NCT00662649|450272660|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
125178025|NCT00662649|450272661|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
125178026|NCT00662649|450272662|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
125178027|NCT00662649|450272658|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
125178028|NCT00662649|450272659|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
125178029|NCT00662649|450272660|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
125178030|NCT00662649|450272661|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
125178031|NCT00662649|450272662|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
125178032|NCT00662649|450272658|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
125178033|NCT00662649|450272659|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
125178034|NCT00662649|450272660|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
125178035|NCT00662649|450272661|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
125178036|NCT00662649|450272662|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
125178037|NCT00662649|450272658|FG000|Core Study (24 Months)|Protocol Violation|5|||
125178038|NCT00662649|450272659|FG001|Core Study (24 Months)|Protocol Violation|5|||
125178039|NCT00662649|450272660|FG002|Core Study (24 Months)|Protocol Violation|4|||
125178040|NCT00662649|450272661|FG003|Core Study (24 Months)|Protocol Violation|0|||
125178041|NCT00662649|450272662|FG004|Core Study (24 Months)|Protocol Violation|0|||
125178042|NCT00662649|450272658|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
125178043|NCT00662649|450272659|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
125178044|NCT00662649|450272660|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
125178045|NCT00662649|450272661|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
125178046|NCT00662649|450272662|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
125178047|NCT00662649|450272658|FG000|Core Study (24 Months)|Death|1|||
125178048|NCT00662649|450272659|FG001|Core Study (24 Months)|Death|0|||
125178049|NCT00662649|450272660|FG002|Core Study (24 Months)|Death|2|||
125178050|NCT00662649|450272661|FG003|Core Study (24 Months)|Death|0|||
125178051|NCT00662649|450272662|FG004|Core Study (24 Months)|Death|0|||
125178052|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
125178053|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
125178054|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
125178055|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
125178056|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
125178057|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
125178058|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
125178059|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
125178060|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
125178061|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
125178062|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
125178063|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
125178064|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
125178065|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
125178066|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
125178067|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
125178068|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
125178069|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
125178070|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
125178071|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
125178072|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
125178073|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
125233772|NCT00392223|450483288|FG000|Overall Study|Lost to Follow-up|1|||
125233773|NCT00392223|450483289|FG001|Overall Study|Lost to Follow-up|4|||
125233774|NCT00392223|450483288|FG000|Overall Study|Protocol Violation|0|||
125233775|NCT00392223|450483289|FG001|Overall Study|Protocol Violation|3|||
125233776|NCT00392223|450483288|FG000|Overall Study|Withdrawal by Subject|3|||
125233777|NCT00392223|450483289|FG001|Overall Study|Withdrawal by Subject|2|||
125233778|NCT03104374|450483293|FG000|Period 1|Adverse Event|7|||
125233779|NCT03104374|450483294|FG001|Period 1|Adverse Event|7|||
125233780|NCT03104374|450483295|FG002|Period 1|Adverse Event|12|||
125233781|NCT03104374|450483296|FG003|Period 1|Adverse Event|14|||
125233782|NCT03104374|450483293|FG000|Period 1|Withdrawal by Subject|18|||
125233783|NCT03104374|450483294|FG001|Period 1|Withdrawal by Subject|9|||
125233784|NCT03104374|450483295|FG002|Period 1|Withdrawal by Subject|10|||
125233785|NCT03104374|450483296|FG003|Period 1|Withdrawal by Subject|17|||
125233786|NCT03104374|450483293|FG000|Period 1|Lost to Follow-up|4|||
125233787|NCT03104374|450483294|FG001|Period 1|Lost to Follow-up|4|||
125233788|NCT03104374|450483295|FG002|Period 1|Lost to Follow-up|6|||
125233789|NCT03104374|450483296|FG003|Period 1|Lost to Follow-up|8|||
125233790|NCT03104374|450483293|FG000|Period 1|Lack of Efficacy|6|||
125233791|NCT03104374|450483294|FG001|Period 1|Lack of Efficacy|7|||
125233792|NCT03104374|450483295|FG002|Period 1|Lack of Efficacy|12|||
125233793|NCT03104374|450483296|FG003|Period 1|Lack of Efficacy|6|||
125233794|NCT03104374|450483293|FG000|Period 1|Other|2|||
125233795|NCT03104374|450483294|FG001|Period 1|Other|2|||
125233796|NCT03104374|450483295|FG002|Period 1|Other|4|||
125233797|NCT03104374|450483296|FG003|Period 1|Other|7|||
125233798|NCT03104374|450483293|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
125233799|NCT03104374|450483294|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
125233800|NCT03104374|450483295|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
125233801|NCT03104374|450483296|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
125233802|NCT03104374|450483293|FG000|Period 2|Adverse Event|4|||
125233803|NCT03104374|450483294|FG001|Period 2|Adverse Event|7|||
125233804|NCT03104374|450483295|FG002|Period 2|Adverse Event|10|||
125233805|NCT03104374|450483296|FG003|Period 2|Adverse Event|10|||
125233806|NCT03104374|450483293|FG000|Period 2|Withdrawal by Subject|3|||
125233807|NCT03104374|450483294|FG001|Period 2|Withdrawal by Subject|7|||
125178074|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
125178075|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
125178076|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
125178077|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
125178078|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
125178079|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
125178080|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
125178081|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
125178082|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
125178083|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
125178084|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
125178085|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
125178086|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
125178087|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
125178088|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
125178089|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
125178090|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
125178091|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
125178092|NCT00662649|450272658|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
125178093|NCT00662649|450272659|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
125178094|NCT00662649|450272660|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
125178095|NCT00662649|450272661|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
125178096|NCT00662649|450272662|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
125178097|NCT03594071|450272663|FG000|Overall Study|Re-operation|3|||
125178098|NCT03594071|450272663|FG000|Overall Study|Missed visit|2|||
125178099|NCT01026194|450272664|FG000|Period 1：Double Blind Period|Adverse Event|2|||
125178100|NCT01026194|450272665|FG001|Period 1：Double Blind Period|Adverse Event|1|||
125178101|NCT01026194|450272664|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
125178102|NCT01026194|450272665|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
125178103|NCT01026194|450272664|FG000|Period 1：Double Blind Period|Physician Decision|0|||
125178104|NCT01026194|450272665|FG001|Period 1：Double Blind Period|Physician Decision|4|||
125178105|NCT01026194|450272664|FG000|Period 2：Open-label Period|Adverse Event|4|||
125178106|NCT01026194|450272665|FG001|Period 2：Open-label Period|Adverse Event|5|||
125178107|NCT01026194|450272664|FG000|Period 2：Open-label Period|Physician Decision|3|||
125178108|NCT01026194|450272665|FG001|Period 2：Open-label Period|Physician Decision|1|||
125233808|NCT03104374|450483295|FG002|Period 2|Withdrawal by Subject|13|||
125233809|NCT03104374|450483296|FG003|Period 2|Withdrawal by Subject|16|||
125178109|NCT01026194|450272664|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
125178110|NCT01026194|450272665|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
125178111|NCT01750190|450272666|FG000|Overall Study|Adverse Event|47|||
125178112|NCT01750190|450272667|FG001|Overall Study|Adverse Event|19|||
125178113|NCT01750190|450272666|FG000|Overall Study|Death|38|||
125178114|NCT01750190|450272667|FG001|Overall Study|Death|11|||
125178115|NCT01750190|450272666|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
125178116|NCT01750190|450272667|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
125178117|NCT01750190|450272666|FG000|Overall Study|Lost to Follow-up|28|||
125178118|NCT01750190|450272667|FG001|Overall Study|Lost to Follow-up|7|||
125178119|NCT01750190|450272666|FG000|Overall Study|Physician Decision|16|||
125178120|NCT01750190|450272667|FG001|Overall Study|Physician Decision|17|||
125178121|NCT01750190|450272666|FG000|Overall Study|Protocol Violation|6|||
125178122|NCT01750190|450272667|FG001|Overall Study|Protocol Violation|5|||
125178123|NCT01750190|450272666|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
125178124|NCT01750190|450272667|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
125178125|NCT01750190|450272666|FG000|Overall Study|Withdrawal by Subject|83|||
125178126|NCT01750190|450272667|FG001|Overall Study|Withdrawal by Subject|89|||
125178127|NCT01750190|450272666|FG000|Overall Study|Kidney Transplant|8|||
125178128|NCT01750190|450272667|FG001|Overall Study|Kidney Transplant|4|||
125178129|NCT01750190|450272666|FG000|Overall Study|Dialysis|22|||
125178130|NCT01750190|450272667|FG001|Overall Study|Dialysis|8|||
125178131|NCT01750190|450272666|FG000|Overall Study|Other than Specified|13|||
125178132|NCT01750190|450272667|FG001|Overall Study|Other than Specified|4|||
125178133|NCT02009722|450272674|FG000|Overall Study|Protocol Violation|1|||
125178134|NCT02009722|450272675|FG001|Overall Study|Protocol Violation|2|||
125178135|NCT02009722|450272674|FG000|Overall Study|Did not receive intervention|0|||
125178136|NCT02009722|450272675|FG001|Overall Study|Did not receive intervention|1|||
125178137|NCT02955212|450272676|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
125178138|NCT02955212|450272677|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
125178139|NCT02955212|450272676|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
125178140|NCT02955212|450272677|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
125178141|NCT02955212|450272676|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
125178142|NCT02955212|450272677|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
125178143|NCT02955212|450272676|FG000|Period 1: Double-blind Treatment Period|Other|3|||
125178144|NCT02955212|450272677|FG001|Period 1: Double-blind Treatment Period|Other|2|||
125178145|NCT02955212|450272676|FG000|Period 2: Open-label Extension|Adverse Event|11|||
125178146|NCT02955212|450272677|FG001|Period 2: Open-label Extension|Adverse Event|7|||
125178147|NCT02955212|450272676|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
125178148|NCT02955212|450272677|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
125178149|NCT02955212|450272676|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
125178150|NCT02955212|450272677|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
125178151|NCT02955212|450272676|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
125178152|NCT02955212|450272677|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
125178153|NCT02955212|450272676|FG000|Period 2: Open-label Extension|Other|2|||
125178154|NCT02955212|450272677|FG001|Period 2: Open-label Extension|Other|4|||
125178155|NCT00545714|450272682|FG000|Induction Phase (6 Months)|Physician Decision|3|||
125178156|NCT00545714|450272682|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
125178157|NCT00545714|450272682|FG000|Induction Phase (6 Months)|Disease Progression|1|||
125178158|NCT00545714|450272682|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
125178159|NCT00545714|450272682|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
125178160|NCT00545714|450272682|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
125178161|NCT00545714|450272682|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
125178162|NCT00545714|450272682|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
125178163|NCT00545714|450272682|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
125178164|NCT00545714|450272682|FG000|Maintenance Phase (36 Months)|Death|2|||
125178165|NCT04428034|450272685|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
125178166|NCT00560391|450272686|FG000|Overall Study|Still on treatment|0|||
125178167|NCT00560391|450272687|FG001|Overall Study|Still on treatment|0|||
125178168|NCT00560391|450272688|FG002|Overall Study|Still on treatment|0|||
125178169|NCT00560391|450272689|FG003|Overall Study|Still on treatment|1|||
125178170|NCT00560391|450272690|FG004|Overall Study|Still on treatment|2|||
125178171|NCT02556801|450272691|FG000|Overall Study|Lost to Follow-up|1|||
125178172|NCT02556801|450272692|FG001|Overall Study|Lost to Follow-up|0|||
125178173|NCT02556801|450272693|FG002|Overall Study|Lost to Follow-up|2|||
125178174|NCT02556801|450272694|FG003|Overall Study|Lost to Follow-up|0|||
125178175|NCT02556801|450272691|FG000|Overall Study|Withdrawal by Subject|1|||
125178176|NCT02556801|450272692|FG001|Overall Study|Withdrawal by Subject|1|||
125178177|NCT02556801|450272693|FG002|Overall Study|Withdrawal by Subject|1|||
125178178|NCT02556801|450272694|FG003|Overall Study|Withdrawal by Subject|0|||
125178179|NCT02556801|450272691|FG000|Overall Study|Protocol Violation|0|||
125178180|NCT02556801|450272692|FG001|Overall Study|Protocol Violation|3|||
125178181|NCT02556801|450272693|FG002|Overall Study|Protocol Violation|1|||
125178182|NCT02556801|450272694|FG003|Overall Study|Protocol Violation|1|||
125178183|NCT02556801|450272691|FG000|Overall Study|Adverse Event|0|||
125178184|NCT02556801|450272692|FG001|Overall Study|Adverse Event|2|||
125178185|NCT02556801|450272693|FG002|Overall Study|Adverse Event|0|||
125178186|NCT02556801|450272694|FG003|Overall Study|Adverse Event|3|||
125178187|NCT02556801|450272691|FG000|Overall Study|Pregnancy|0|||
125178188|NCT02556801|450272692|FG001|Overall Study|Pregnancy|1|||
125178189|NCT02556801|450272693|FG002|Overall Study|Pregnancy|0|||
125178190|NCT02556801|450272694|FG003|Overall Study|Pregnancy|0|||
125178191|NCT02556801|450272691|FG000|Overall Study|Personal reasons patient|0|||
125178192|NCT02556801|450272692|FG001|Overall Study|Personal reasons patient|0|||
125178193|NCT02556801|450272693|FG002|Overall Study|Personal reasons patient|0|||
125178194|NCT02556801|450272694|FG003|Overall Study|Personal reasons patient|1|||
125178195|NCT03668808|450272695|FG000|First Intervention|Withdrawal by Subject|2|||
125178196|NCT03668808|450272696|FG001|First Intervention|Withdrawal by Subject|2|||
125178197|NCT01965860|450272706|FG000|Overall Study|Pregnancy|1|||
125178198|NCT01965860|450272707|FG001|Overall Study|Pregnancy|0|||
125178199|NCT01965860|450272708|FG002|Overall Study|Pregnancy|1|||
125178200|NCT01965860|450272706|FG000|Overall Study|Logistics|1|||
125178201|NCT01965860|450272707|FG001|Overall Study|Logistics|0|||
125178202|NCT01965860|450272708|FG002|Overall Study|Logistics|0|||
125178203|NCT03735121|450272712|FG000|Overall Study|Death|3|||
125178204|NCT03735121|450272713|FG001|Overall Study|Death|6|||
125178205|NCT03735121|450272714|FG002|Overall Study|Death|8|||
125178206|NCT03735121|450272715|FG003|Overall Study|Death|37|||
125178207|NCT03735121|450272716|FG004|Overall Study|Death|86|||
125178208|NCT03735121|450272712|FG000|Overall Study|Withdrawal by Subject|1|||
125178209|NCT03735121|450272713|FG001|Overall Study|Withdrawal by Subject|1|||
125178210|NCT03735121|450272714|FG002|Overall Study|Withdrawal by Subject|3|||
125178211|NCT03735121|450272715|FG003|Overall Study|Withdrawal by Subject|4|||
125178212|NCT03735121|450272716|FG004|Overall Study|Withdrawal by Subject|2|||
125178213|NCT03735121|450272712|FG000|Overall Study|Progressive Disease|0|||
125178214|NCT03735121|450272713|FG001|Overall Study|Progressive Disease|0|||
125178215|NCT03735121|450272714|FG002|Overall Study|Progressive Disease|1|||
125178216|NCT03735121|450272715|FG003|Overall Study|Progressive Disease|0|||
125178217|NCT03735121|450272716|FG004|Overall Study|Progressive Disease|0|||
125178218|NCT03735121|450272712|FG000|Overall Study|Lost to Follow-up|0|||
125178219|NCT03735121|450272713|FG001|Overall Study|Lost to Follow-up|0|||
125178220|NCT03735121|450272714|FG002|Overall Study|Lost to Follow-up|0|||
125178221|NCT03735121|450272715|FG003|Overall Study|Lost to Follow-up|0|||
125178222|NCT03735121|450272716|FG004|Overall Study|Lost to Follow-up|1|||
125178223|NCT03735121|450272712|FG000|Overall Study|Ongoing|3|||
125178224|NCT03735121|450272713|FG001|Overall Study|Ongoing|3|||
125178225|NCT03735121|450272714|FG002|Overall Study|Ongoing|26|||
125178226|NCT03735121|450272715|FG003|Overall Study|Ongoing|83|||
125178227|NCT03735121|450272716|FG004|Overall Study|Ongoing|158|||
125178228|NCT03138655|450272718|FG000|Overall Study|Adverse Event|2|||
125178229|NCT03138655|450272719|FG001|Overall Study|Adverse Event|1|||
125178230|NCT03138655|450272720|FG002|Overall Study|Adverse Event|2|||
125178231|NCT03138655|450272721|FG003|Overall Study|Adverse Event|1|||
125178232|NCT03138655|450272722|FG004|Overall Study|Adverse Event|1|||
125178233|NCT03138655|450272723|FG005|Overall Study|Adverse Event|4|||
125178234|NCT03138655|450272724|FG006|Overall Study|Adverse Event|2|||
125178235|NCT03138655|450272725|FG007|Overall Study|Adverse Event|2|||
125178236|NCT03138655|450272718|FG000|Overall Study|Withdrawal by Subject|0|||
125178237|NCT03138655|450272719|FG001|Overall Study|Withdrawal by Subject|1|||
125178238|NCT03138655|450272720|FG002|Overall Study|Withdrawal by Subject|0|||
125178239|NCT03138655|450272721|FG003|Overall Study|Withdrawal by Subject|0|||
125178240|NCT03138655|450272722|FG004|Overall Study|Withdrawal by Subject|0|||
125178241|NCT03138655|450272723|FG005|Overall Study|Withdrawal by Subject|0|||
125233810|NCT03104374|450483293|FG000|Period 2|Lost to Follow-up|2|||
125233811|NCT03104374|450483294|FG001|Period 2|Lost to Follow-up|2|||
125178242|NCT03138655|450272724|FG006|Overall Study|Withdrawal by Subject|1|||
125178243|NCT03138655|450272725|FG007|Overall Study|Withdrawal by Subject|0|||
125178244|NCT03138655|450272718|FG000|Overall Study|Reason not Specified|1|||
125178245|NCT03138655|450272719|FG001|Overall Study|Reason not Specified|0|||
125178246|NCT03138655|450272720|FG002|Overall Study|Reason not Specified|0|||
125178247|NCT03138655|450272721|FG003|Overall Study|Reason not Specified|2|||
125178248|NCT03138655|450272722|FG004|Overall Study|Reason not Specified|1|||
125178249|NCT03138655|450272723|FG005|Overall Study|Reason not Specified|1|||
125178250|NCT03138655|450272724|FG006|Overall Study|Reason not Specified|0|||
125178251|NCT03138655|450272725|FG007|Overall Study|Reason not Specified|0|||
125178252|NCT03151304|450272726|FG000|Overall Study|Termination of study by Sponsor|23|||
125233812|NCT03104374|450483295|FG002|Period 2|Lost to Follow-up|3|||
125178253|NCT03151304|450272726|FG000|Overall Study|missing|3|||
125178254|NCT03151304|450272726|FG000|Overall Study|Withdrawal by Subject|8|||
125178255|NCT03151304|450272726|FG000|Overall Study|multiple reasons|30|||
125178256|NCT03519087|450272727|FG000|Clinic Evaluation|Physician Decision|15|||
125178257|NCT03519087|450272728|FG001|Clinic Evaluation|Physician Decision|18|||
125233813|NCT03104374|450483296|FG003|Period 2|Lost to Follow-up|5|||
125233814|NCT03104374|450483293|FG000|Period 2|Lack of Efficacy|2|||
125233815|NCT03104374|450483294|FG001|Period 2|Lack of Efficacy|4|||
125233816|NCT03104374|450483295|FG002|Period 2|Lack of Efficacy|7|||
125233817|NCT03104374|450483296|FG003|Period 2|Lack of Efficacy|4|||
125233818|NCT03104374|450483293|FG000|Period 2|COVID-19 Infection|0|||
125233819|NCT03104374|450483294|FG001|Period 2|COVID-19 Infection|0|||
125233820|NCT03104374|450483295|FG002|Period 2|COVID-19 Infection|1|||
125233821|NCT03104374|450483296|FG003|Period 2|COVID-19 Infection|0|||
125233822|NCT03104374|450483293|FG000|Period 2|Other|3|||
125233823|NCT03104374|450483294|FG001|Period 2|Other|2|||
125233824|NCT03104374|450483295|FG002|Period 2|Other|2|||
125233825|NCT03104374|450483296|FG003|Period 2|Other|4|||
125233826|NCT00094445|450483299|FG000|Overall Study|Withdrawal by Subject|3|||
125233827|NCT00094445|450483299|FG000|Overall Study|Lost to Follow-up|1|||
125233828|NCT00094445|450483299|FG000|Overall Study|Progressive Disease|2|||
125233829|NCT00769561|450483300|FG000|Overall Study|Withdrawal by Subject|2|||
125233830|NCT00769561|450483301|FG001|Overall Study|Withdrawal by Subject|2|||
125233831|NCT00769561|450483300|FG000|Overall Study|Lost to Follow-up|1|||
125233832|NCT00769561|450483301|FG001|Overall Study|Lost to Follow-up|3|||
125233833|NCT04585893|450483302|FG000|Overall Study|Death|1|||
125233834|NCT04585893|450483303|FG001|Overall Study|Death|0|||
125233835|NCT03729362|450484986|FG000|Overall Study|Withdrawal by Subject|2|||
125233836|NCT03729362|450484987|FG001|Overall Study|Withdrawal by Subject|0|||
125233837|NCT03729362|450484986|FG000|Overall Study|Physician Decision|1|||
125233838|NCT03729362|450484987|FG001|Overall Study|Physician Decision|0|||
125233839|NCT03729362|450484986|FG000|Overall Study|COVID-19 Pandemic|1|||
125233840|NCT03729362|450484987|FG001|Overall Study|COVID-19 Pandemic|0|||
125233841|NCT03729362|450484986|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
125233842|NCT03729362|450484987|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
125233843|NCT03729362|450484986|FG000|Overall Study|Adverse Event|0|||
125233844|NCT03729362|450484987|FG001|Overall Study|Adverse Event|1|||
125233845|NCT03729362|450484986|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
125233846|NCT03729362|450484987|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
125233847|NCT01113749|450484988|FG000|Overall Study|Lost to Follow-up|1|||
125233848|NCT01113749|450484989|FG001|Overall Study|Lost to Follow-up|2|||
125233849|NCT00961064|450484992|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
125233850|NCT00961064|450484992|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
125233851|NCT00961064|450484992|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
125233852|NCT00961064|450484992|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
125233853|NCT00961064|450484992|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
125233854|NCT00961064|450484992|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
125233855|NCT00961064|450484992|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
125233856|NCT00961064|450484992|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
125233857|NCT00576758|450484993|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
125233858|NCT00576758|450484994|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
125233859|NCT00576758|450484993|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
125233860|NCT00576758|450484994|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
125233861|NCT00576758|450484993|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
125233862|NCT00576758|450484994|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
125233863|NCT00576758|450484993|FG000|Induction Treatment Period|Death|1|||
125233864|NCT00576758|450484994|FG001|Induction Treatment Period|Death|0|||
125233865|NCT00576758|450484993|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
125233866|NCT00576758|450484994|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
125233867|NCT00576758|450484993|FG000|Induction Treatment Period|Withdrew consent|1|||
125233868|NCT00576758|450484994|FG001|Induction Treatment Period|Withdrew consent|0|||
125233869|NCT00576758|450484993|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
125233870|NCT00576758|450484994|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
125233871|NCT00576758|450484993|FG000|Extension Treatment Period|Death|1|||
125233872|NCT00576758|450484994|FG001|Extension Treatment Period|Death|1|||
125233873|NCT00576758|450484993|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
125233874|NCT00576758|450484994|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
125233875|NCT00576758|450484993|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
125233876|NCT00576758|450484994|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
125233877|NCT00576758|450484993|FG000|Extension Treatment Period|Administrative/Other|3|||
125233878|NCT00576758|450484994|FG001|Extension Treatment Period|Administrative/Other|1|||
125233879|NCT00576758|450484993|FG000|Follow-up Period|Administrative/Other|6|||
125233880|NCT00576758|450484994|FG001|Follow-up Period|Administrative/Other|8|||
125233881|NCT00576758|450484993|FG000|Follow-up Period|Death|3|||
125233882|NCT00576758|450484994|FG001|Follow-up Period|Death|3|||
125233883|NCT00576758|450484993|FG000|Follow-up Period|Insufficient therapeutic response|16|||
125233884|NCT00576758|450484994|FG001|Follow-up Period|Insufficient therapeutic response|5|||
125233885|NCT00576758|450484993|FG000|Follow-up Period|Withdrew consent|2|||
125233886|NCT00576758|450484994|FG001|Follow-up Period|Withdrew consent|1|||
125178258|NCT03519087|450272729|FG002|Clinic Evaluation|Physician Decision|0|||
125178259|NCT03519087|450272730|FG003|Clinic Evaluation|Physician Decision|0|||
125178260|NCT03519087|450272731|FG004|Clinic Evaluation|Physician Decision|0|||
125178261|NCT03519087|450272727|FG000|Clinic Evaluation|Protocol Violation|1|||
125178262|NCT03519087|450272728|FG001|Clinic Evaluation|Protocol Violation|0|||
125178263|NCT03519087|450272729|FG002|Clinic Evaluation|Protocol Violation|0|||
125178264|NCT03519087|450272730|FG003|Clinic Evaluation|Protocol Violation|0|||
125178265|NCT03519087|450272731|FG004|Clinic Evaluation|Protocol Violation|0|||
125178266|NCT03519087|450272727|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
125178267|NCT03519087|450272728|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
125178268|NCT03519087|450272729|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
125178269|NCT03519087|450272730|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
125178270|NCT03519087|450272731|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
125178271|NCT03519087|450272727|FG000|Re-randomization for Treatment|Not appropriate|2|||
125178272|NCT03519087|450272728|FG001|Re-randomization for Treatment|Not appropriate|3|||
125178273|NCT03519087|450272729|FG002|Re-randomization for Treatment|Not appropriate|0|||
125178274|NCT03519087|450272730|FG003|Re-randomization for Treatment|Not appropriate|0|||
125178275|NCT03519087|450272731|FG004|Re-randomization for Treatment|Not appropriate|0|||
125178276|NCT03519087|450272727|FG000|Laboratory Testing|Lost to Follow-up|0|||
125178277|NCT03519087|450272728|FG001|Laboratory Testing|Lost to Follow-up|0|||
125178278|NCT03519087|450272729|FG002|Laboratory Testing|Lost to Follow-up|2|||
125178279|NCT03519087|450272730|FG003|Laboratory Testing|Lost to Follow-up|3|||
125178280|NCT03519087|450272731|FG004|Laboratory Testing|Lost to Follow-up|6|||
125178281|NCT03519087|450272727|FG000|Laboratory Testing|Protocol Violation|0|||
125178282|NCT03519087|450272728|FG001|Laboratory Testing|Protocol Violation|0|||
125178283|NCT03519087|450272729|FG002|Laboratory Testing|Protocol Violation|0|||
125178284|NCT03519087|450272730|FG003|Laboratory Testing|Protocol Violation|1|||
125178285|NCT03519087|450272731|FG004|Laboratory Testing|Protocol Violation|0|||
125178286|NCT01137071|450272732|FG000|Overall Study|Disease Progression|11|||
125178287|NCT01137071|450272732|FG000|Overall Study|Withdrawal by Subject|2|||
125178288|NCT01137071|450272732|FG000|Overall Study|Wrongly Included|1|||
125178289|NCT04194645|450272733|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178290|NCT04194645|450272734|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178291|NCT04194645|450272735|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178292|NCT04194645|450272736|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178293|NCT04194645|450272737|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178294|NCT04194645|450272738|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178295|NCT04194645|450272739|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178296|NCT04194645|450272740|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178297|NCT04194645|450272741|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178298|NCT04194645|450272742|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
125178299|NCT04194645|450272743|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178300|NCT04194645|450272744|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178301|NCT04194645|450272745|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178302|NCT04194645|450272746|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178303|NCT04194645|450272747|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
125178304|NCT01783886|450272748|FG000|Overall Study|Lost to Follow-up|0|||
125178305|NCT01783886|450272749|FG001|Overall Study|Lost to Follow-up|3|||
125178306|NCT01783886|450272750|FG002|Overall Study|Lost to Follow-up|0|||
125178307|NCT01783886|450272748|FG000|Overall Study|Protocol deviation|0|||
125178308|NCT01783886|450272749|FG001|Overall Study|Protocol deviation|0|||
125178309|NCT01783886|450272750|FG002|Overall Study|Protocol deviation|2|||
125178310|NCT01783886|450272748|FG000|Overall Study|Withdrawal of consent by participant|1|||
125178311|NCT01783886|450272749|FG001|Overall Study|Withdrawal of consent by participant|3|||
125178312|NCT01783886|450272750|FG002|Overall Study|Withdrawal of consent by participant|4|||
125178313|NCT01783886|450272748|FG000|Overall Study|Adverse Event|4|||
125178314|NCT01783886|450272749|FG001|Overall Study|Adverse Event|5|||
125178315|NCT01783886|450272750|FG002|Overall Study|Adverse Event|4|||
125178316|NCT04542057|450272751|FG000|Overall Study|Death|3|||
125178317|NCT04542057|450272752|FG001|Overall Study|Death|1|||
125178318|NCT04542057|450272751|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
125178319|NCT04542057|450272752|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
125178320|NCT04542057|450272751|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
125178321|NCT04542057|450272752|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
125178322|NCT04542057|450272751|FG000|Overall Study|Adverse Event|15|||
125178323|NCT04542057|450272752|FG001|Overall Study|Adverse Event|6|||
125178324|NCT04542057|450272751|FG000|Overall Study|COVID-19 adverse event|6|||
125178325|NCT04542057|450272752|FG001|Overall Study|COVID-19 adverse event|4|||
125178326|NCT04542057|450272751|FG000|Overall Study|Lack of Efficacy|2|||
125178327|NCT04542057|450272752|FG001|Overall Study|Lack of Efficacy|5|||
125178328|NCT04542057|450272751|FG000|Overall Study|Study terminated by sponsor|1|||
125178329|NCT04542057|450272752|FG001|Overall Study|Study terminated by sponsor|0|||
125178330|NCT04542057|450272751|FG000|Overall Study|Investigator discretion|2|||
125233887|NCT00761319|450484995|FG000|Overall Study|Protocol Violation|21|||
125178331|NCT04542057|450272752|FG001|Overall Study|Investigator discretion|1|||
125178332|NCT04542057|450272751|FG000|Overall Study|Withdrawal by Subject|52|||
125178333|NCT04542057|450272752|FG001|Overall Study|Withdrawal by Subject|30|||
125178334|NCT04542057|450272751|FG000|Overall Study|Lost to Follow-up|8|||
125178335|NCT04542057|450272752|FG001|Overall Study|Lost to Follow-up|11|||
125178336|NCT04542057|450272751|FG000|Overall Study|Other|2|||
125178337|NCT04542057|450272752|FG001|Overall Study|Other|2|||
125178338|NCT00104572|450272753|FG000|Overall Study|Withdrawal by Subject|3|||
125178339|NCT00104572|450272754|FG001|Overall Study|Withdrawal by Subject|3|||
125178340|NCT00104572|450272755|FG002|Overall Study|Withdrawal by Subject|0|||
125178341|NCT00940316|450272756|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
125178342|NCT00940316|450272757|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
125178343|NCT00940316|450272758|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
125178344|NCT00940316|450272756|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
125178345|NCT00940316|450272757|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
125178346|NCT00940316|450272758|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
125178347|NCT00940316|450272756|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
125178348|NCT00940316|450272757|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
125178349|NCT00940316|450272758|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
125178350|NCT00940316|450272756|FG000|Treated After Cycle 5|Adverse Event|0|||
125178351|NCT00940316|450272757|FG001|Treated After Cycle 5|Adverse Event|0|||
125178352|NCT00940316|450272758|FG002|Treated After Cycle 5|Adverse Event|1|||
125178353|NCT00940316|450272756|FG000|Treated After Cycle 5|Progressive disease|0|||
125178354|NCT00940316|450272757|FG001|Treated After Cycle 5|Progressive disease|1|||
125178355|NCT00940316|450272758|FG002|Treated After Cycle 5|Progressive disease|0|||
125178356|NCT00796757|450272760|FG000|Overall Study|Withdrawal by Subject|14|||
125178357|NCT00796757|450272760|FG000|Overall Study|Death|61|||
125178358|NCT00796757|450272760|FG000|Overall Study|Protocol Violation|1|||
125178359|NCT00796757|450272760|FG000|Overall Study|Participant noncompliance|1|||
125178360|NCT00796757|450272760|FG000|Overall Study|Investigator's decision|2|||
125178361|NCT00796757|450272760|FG000|Overall Study|Other|7|||
125178362|NCT02290405|450272763|FG000|Overall Study|Withdrawal by Subject|1|||
125178363|NCT02290405|450272764|FG001|Overall Study|Withdrawal by Subject|0|||
125178364|NCT02016183|450272765|FG000|Overall Study|Case Report Forms Uncollected|13|||
125178365|NCT02016183|450272765|FG000|Overall Study|Protocol Violation|52|||
125178366|NCT00996489|450272766|FG000|Overall Study|Device failure|45|||
125178367|NCT00996489|450272766|FG000|Overall Study|Discontinued|116|||
125178368|NCT03142191|450272767|FG000|Placebo Controlled Period|Death|0|||
125178369|NCT03142191|450272768|FG001|Placebo Controlled Period|Death|1|||
125178370|NCT03142191|450272769|FG002|Placebo Controlled Period|Death|1|||
125178371|NCT03142191|450272770|FG003|Placebo Controlled Period|Death|0|||
125178372|NCT03142191|450272771|FG004|Placebo Controlled Period|Death|0|||
125178373|NCT03142191|450272767|FG000|Placebo Controlled Period|Adverse Event|4|||
125178374|NCT03142191|450272768|FG001|Placebo Controlled Period|Adverse Event|5|||
125178375|NCT03142191|450272769|FG002|Placebo Controlled Period|Adverse Event|1|||
125178376|NCT03142191|450272770|FG003|Placebo Controlled Period|Adverse Event|0|||
125178377|NCT03142191|450272771|FG004|Placebo Controlled Period|Adverse Event|0|||
125178378|NCT03142191|450272767|FG000|Placebo Controlled Period|Progressive Disease|1|||
125178379|NCT03142191|450272768|FG001|Placebo Controlled Period|Progressive Disease|0|||
125178380|NCT03142191|450272769|FG002|Placebo Controlled Period|Progressive Disease|1|||
125178381|NCT03142191|450272770|FG003|Placebo Controlled Period|Progressive Disease|0|||
125178382|NCT03142191|450272771|FG004|Placebo Controlled Period|Progressive Disease|0|||
125178383|NCT03142191|450272767|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
125178384|NCT03142191|450272768|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
125178385|NCT03142191|450272769|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
125178386|NCT03142191|450272770|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
125178387|NCT03142191|450272771|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
125178388|NCT03142191|450272767|FG000|Placebo Controlled Period|Other Reasons|1|||
125178389|NCT03142191|450272768|FG001|Placebo Controlled Period|Other Reasons|0|||
125178390|NCT03142191|450272769|FG002|Placebo Controlled Period|Other Reasons|0|||
125178391|NCT03142191|450272770|FG003|Placebo Controlled Period|Other Reasons|0|||
125178392|NCT03142191|450272771|FG004|Placebo Controlled Period|Other Reasons|0|||
125178393|NCT03142191|450272767|FG000|Active Treatment Extension Period|Death|2|||
125178394|NCT03142191|450272768|FG001|Active Treatment Extension Period|Death|1|||
125178395|NCT03142191|450272769|FG002|Active Treatment Extension Period|Death|1|||
125178396|NCT03142191|450272770|FG003|Active Treatment Extension Period|Death|1|||
125178397|NCT03142191|450272771|FG004|Active Treatment Extension Period|Death|0|||
125178398|NCT03142191|450272767|FG000|Active Treatment Extension Period|Adverse Event|6|||
125178399|NCT03142191|450272768|FG001|Active Treatment Extension Period|Adverse Event|5|||
125178400|NCT03142191|450272769|FG002|Active Treatment Extension Period|Adverse Event|4|||
125178401|NCT03142191|450272770|FG003|Active Treatment Extension Period|Adverse Event|1|||
125178402|NCT03142191|450272771|FG004|Active Treatment Extension Period|Adverse Event|0|||
125178403|NCT03142191|450272767|FG000|Active Treatment Extension Period|Progressive Disease|10|||
125178404|NCT03142191|450272768|FG001|Active Treatment Extension Period|Progressive Disease|5|||
125233888|NCT00761319|450484996|FG001|Overall Study|Protocol Violation|14|||
125233889|NCT00761319|450484995|FG000|Overall Study|Adverse Event|11|||
125233890|NCT00761319|450484996|FG001|Overall Study|Adverse Event|7|||
125233891|NCT00761319|450484995|FG000|Overall Study|Withdrawal by Subject|8|||
125233892|NCT00761319|450484996|FG001|Overall Study|Withdrawal by Subject|7|||
125233893|NCT00761319|450484995|FG000|Overall Study|Noncompliance|4|||
125233894|NCT00761319|450484996|FG001|Overall Study|Noncompliance|3|||
125233895|NCT00761319|450484995|FG000|Overall Study|Lost to Follow-up|1|||
125233896|NCT00761319|450484996|FG001|Overall Study|Lost to Follow-up|1|||
125233897|NCT00761319|450484995|FG000|Overall Study|Nonspecified|2|||
125233898|NCT00761319|450484996|FG001|Overall Study|Nonspecified|2|||
125233899|NCT00761319|450484995|FG000|Overall Study|Missing|1|||
125233900|NCT00761319|450484996|FG001|Overall Study|Missing|0|||
125233901|NCT02472405|450484997|FG000|Overall Study|Lost to Follow-up|9|||
125233902|NCT02472405|450484997|FG000|Overall Study|Adverse Event|1|||
125233903|NCT01715298|450484998|FG000|Overall Study|Lost to Follow-up|0|||
125233904|NCT01715298|450484999|FG001|Overall Study|Lost to Follow-up|2|||
125233905|NCT01715298|450484998|FG000|Overall Study|Patient/guardian decision|7|||
125233906|NCT01715298|450484999|FG001|Overall Study|Patient/guardian decision|9|||
125233907|NCT00726453|450485001|FG000|Primary Enrollment Group|Death|18|||
125233908|NCT00726453|450485002|FG001|Primary Enrollment Group|Death|0|||
125233909|NCT00726453|450485001|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
125233910|NCT00726453|450485002|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
125233911|NCT00726453|450485001|FG000|38 mm Length Group|Death|0|||
125233912|NCT00726453|450485002|FG001|38 mm Length Group|Death|3|||
125233913|NCT01432951|450485005|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
125233914|NCT00853385|450485006|FG000|Overall Study|Death|0|||
125233915|NCT00853385|450485007|FG001|Overall Study|Death|0|||
125233916|NCT00853385|450485008|FG002|Overall Study|Death|0|||
125233917|NCT00853385|450485009|FG003|Overall Study|Death|0|||
125233918|NCT00853385|450485010|FG004|Overall Study|Death|1|||
125233919|NCT00853385|450485006|FG000|Overall Study|Adverse Event|24|||
125233920|NCT00853385|450485007|FG001|Overall Study|Adverse Event|24|||
125233921|NCT00853385|450485008|FG002|Overall Study|Adverse Event|2|||
125233922|NCT00853385|450485009|FG003|Overall Study|Adverse Event|5|||
125233923|NCT00853385|450485010|FG004|Overall Study|Adverse Event|22|||
125233924|NCT00853385|450485006|FG000|Overall Study|Lack of Efficacy|6|||
125233925|NCT00853385|450485007|FG001|Overall Study|Lack of Efficacy|7|||
125233926|NCT00853385|450485008|FG002|Overall Study|Lack of Efficacy|3|||
125233927|NCT00853385|450485009|FG003|Overall Study|Lack of Efficacy|3|||
125233928|NCT00853385|450485010|FG004|Overall Study|Lack of Efficacy|6|||
125233929|NCT00853385|450485006|FG000|Overall Study|Lost to Follow-up|2|||
125233930|NCT00853385|450485007|FG001|Overall Study|Lost to Follow-up|1|||
125233931|NCT00853385|450485008|FG002|Overall Study|Lost to Follow-up|0|||
125233932|NCT00853385|450485009|FG003|Overall Study|Lost to Follow-up|0|||
125233933|NCT00853385|450485010|FG004|Overall Study|Lost to Follow-up|0|||
125233934|NCT00853385|450485006|FG000|Overall Study|Withdrawal by Subject|4|||
125233935|NCT00853385|450485007|FG001|Overall Study|Withdrawal by Subject|2|||
125233936|NCT00853385|450485008|FG002|Overall Study|Withdrawal by Subject|0|||
125233937|NCT00853385|450485009|FG003|Overall Study|Withdrawal by Subject|1|||
125233938|NCT00853385|450485010|FG004|Overall Study|Withdrawal by Subject|1|||
125233939|NCT00853385|450485006|FG000|Overall Study|Other|18|||
125233940|NCT00853385|450485007|FG001|Overall Study|Other|9|||
125233941|NCT00853385|450485008|FG002|Overall Study|Other|4|||
125233942|NCT00853385|450485009|FG003|Overall Study|Other|4|||
125233943|NCT00853385|450485010|FG004|Overall Study|Other|12|||
125233944|NCT00915525|450485013|FG000|Overall Study|Protocol Violation|9|||
125233945|NCT00915525|450485014|FG001|Overall Study|Protocol Violation|4|||
125233946|NCT00915525|450485013|FG000|Overall Study|Withdrawal by Subject|59|||
125233947|NCT00915525|450485014|FG001|Overall Study|Withdrawal by Subject|21|||
125233948|NCT00915525|450485013|FG000|Overall Study|Lost to Follow-up|27|||
125233949|NCT00915525|450485014|FG001|Overall Study|Lost to Follow-up|16|||
125233950|NCT00915525|450485013|FG000|Overall Study|Pregnancy|2|||
125233951|NCT00915525|450485014|FG001|Overall Study|Pregnancy|0|||
125233952|NCT00915525|450485013|FG000|Overall Study|Lack of Efficacy|15|||
125233953|NCT00915525|450485014|FG001|Overall Study|Lack of Efficacy|32|||
125233954|NCT00915525|450485013|FG000|Overall Study|Adverse Event|29|||
125233955|NCT00915525|450485014|FG001|Overall Study|Adverse Event|13|||
125233956|NCT00915525|450485013|FG000|Overall Study|Missing|12|||
125233957|NCT00915525|450485014|FG001|Overall Study|Missing|1|||
125233958|NCT00915525|450485013|FG000|Overall Study|Other Reason|35|||
125233959|NCT00915525|450485014|FG001|Overall Study|Other Reason|12|||
125233960|NCT00915525|450485013|FG000|Overall Study|Site Closed|27|||
125233961|NCT00915525|450485014|FG001|Overall Study|Site Closed|9|||
125233962|NCT00915525|450485013|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
125233963|NCT00915525|450485014|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
125233964|NCT00915525|450485013|FG000|Overall Study|Study Burden|28|||
125233965|NCT00915525|450485014|FG001|Overall Study|Study Burden|12|||
125233966|NCT00915525|450485013|FG000|Overall Study|Non-Compliance|3|||
125233967|NCT00915525|450485014|FG001|Overall Study|Non-Compliance|1|||
125233968|NCT00915525|450485013|FG000|Overall Study|Patient Moved|15|||
125233969|NCT00915525|450485014|FG001|Overall Study|Patient Moved|9|||
125233970|NCT00941928|450485015|FG000|Overall Study|Withdrawal by Subject|1|||
125233971|NCT00941928|450485015|FG000|Overall Study|Disease Progression|1|||
125233972|NCT02765035|450485027|FG000|First Intervention (90 Days)|Adverse Event|1|||
125233973|NCT02765035|450485028|FG001|First Intervention (90 Days)|Adverse Event|1|||
125233974|NCT02765035|450485027|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
125233975|NCT02765035|450485028|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
125233976|NCT00984867|450485029|FG000|Overall Study|Adverse Event|3|||
125233977|NCT00984867|450485030|FG001|Overall Study|Adverse Event|7|||
125233978|NCT00984867|450485029|FG000|Overall Study|Death|1|||
125233979|NCT00984867|450485030|FG001|Overall Study|Death|0|||
125233980|NCT00984867|450485029|FG000|Overall Study|Withdrawal by Subject|13|||
125233981|NCT00984867|450485030|FG001|Overall Study|Withdrawal by Subject|4|||
125233982|NCT00984867|450485029|FG000|Overall Study|Lost to Follow-up|3|||
125233983|NCT00984867|450485030|FG001|Overall Study|Lost to Follow-up|4|||
125233984|NCT00984867|450485029|FG000|Overall Study|Poor/non-compliance|0|||
125233985|NCT00984867|450485030|FG001|Overall Study|Poor/non-compliance|1|||
125233986|NCT00984867|450485029|FG000|Overall Study|Subject no longer meets study criteria|1|||
125233987|NCT00984867|450485030|FG001|Overall Study|Subject no longer meets study criteria|1|||
125233988|NCT00984867|450485029|FG000|Overall Study|site closing|1|||
125233989|NCT00984867|450485030|FG001|Overall Study|site closing|0|||
125233990|NCT00984867|450485029|FG000|Overall Study|lack of efficacy and subject compliance|1|||
125233991|NCT00984867|450485030|FG001|Overall Study|lack of efficacy and subject compliance|0|||
125233992|NCT03482024|450485035|FG000|Overall Study|Physician Decision|1|||
125233993|NCT03482024|450485036|FG001|Overall Study|Physician Decision|0|||
125233994|NCT03482024|450485037|FG002|Overall Study|Physician Decision|0|||
125233995|NCT03482024|450485038|FG003|Overall Study|Physician Decision|0|||
125233996|NCT03482024|450485039|FG004|Overall Study|Physician Decision|0|||
125233997|NCT03937778|450485040|FG000|Overall Study|Withdrawal by Subject|1|||
125233998|NCT03937778|450485040|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
125233999|NCT00819039|450485041|FG000|Overall Study|Physician Decision|1|||
125234000|NCT00819039|450485042|FG001|Overall Study|Physician Decision|0|||
125234001|NCT00819039|450485043|FG002|Overall Study|Physician Decision|1|||
125234002|NCT00819039|450485041|FG000|Overall Study|Protocol Violation|1|||
125234003|NCT00819039|450485042|FG001|Overall Study|Protocol Violation|0|||
125234004|NCT00819039|450485043|FG002|Overall Study|Protocol Violation|0|||
125234005|NCT01240694|450485044|FG000|Overall Study|Adverse Event|9|||
125234006|NCT01240694|450485044|FG000|Overall Study|Lack of Efficacy|6|||
125234007|NCT01240694|450485044|FG000|Overall Study|Withdrawal by Subject|6|||
125234008|NCT01240694|450485044|FG000|Overall Study|Protocol Violation|2|||
125234009|NCT01240694|450485044|FG000|Overall Study|Lost to Follow-up|2|||
125234010|NCT01240694|450485044|FG000|Overall Study|Other than specified|3|||
125234011|NCT01240694|450485044|FG000|Overall Study|Withdrawn due to early study termination|107|||
125234012|NCT01881425|450485045|FG000|Overall Study|Death|5|||
125234013|NCT01881425|450485046|FG001|Overall Study|Death|1|||
125234014|NCT01881425|450485045|FG000|Overall Study|Withdrawal by Subject|8|||
125234015|NCT01881425|450485046|FG001|Overall Study|Withdrawal by Subject|3|||
125234016|NCT01881425|450485045|FG000|Overall Study|Physician Decision|2|||
125234017|NCT01881425|450485046|FG001|Overall Study|Physician Decision|1|||
125234018|NCT01881425|450485045|FG000|Overall Study|Adverse Event|3|||
125234019|NCT01881425|450485046|FG001|Overall Study|Adverse Event|0|||
125234020|NCT01881425|450485045|FG000|Overall Study|General Anesthesia panic attack|0|||
125234021|NCT01881425|450485046|FG001|Overall Study|General Anesthesia panic attack|1|||
125234022|NCT01881425|450485045|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
125234023|NCT01881425|450485046|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
125234024|NCT01881425|450485045|FG000|Overall Study|Lost to Follow-up|7|||
125234025|NCT01881425|450485046|FG001|Overall Study|Lost to Follow-up|2|||
125234026|NCT01200355|450485051|FG000|Overall Study|Death|7|||
125234027|NCT01200355|450485052|FG001|Overall Study|Death|2|||
125234028|NCT03185208|450485053|FG000|Overall Study|Did not start study medication|0|||
125234029|NCT03185208|450485054|FG001|Overall Study|Did not start study medication|3|||
125234030|NCT03834350|450485055|FG000|Overall Study|Withdrawal by Subject|1|||
125234031|NCT02410629|450485056|FG000|Overall Study|Family cannot commit to the study|2|||
125234032|NCT02410629|450485057|FG001|Overall Study|Family cannot commit to the study|1|||
125234033|NCT02410629|450485056|FG000|Overall Study|Subject returned to work|1|||
125234034|NCT02410629|450485057|FG001|Overall Study|Subject returned to work|0|||
125234035|NCT02410629|450485056|FG000|Overall Study|Subject moved back to home country|0|||
125234036|NCT02410629|450485057|FG001|Overall Study|Subject moved back to home country|1|||
125234037|NCT02410629|450485056|FG000|Overall Study|Subject underwent heart surgery|0|||
125234038|NCT02410629|450485057|FG001|Overall Study|Subject underwent heart surgery|1|||
125234039|NCT02765165|450485058|FG000|Treatment Period|Progressive disease|3|||
125234040|NCT02765165|450485059|FG001|Treatment Period|Progressive disease|2|||
125234041|NCT02765165|450485060|FG002|Treatment Period|Progressive disease|3|||
125234042|NCT02765165|450485061|FG003|Treatment Period|Progressive disease|3|||
125234043|NCT02765165|450485062|FG004|Treatment Period|Progressive disease|4|||
125234044|NCT02765165|450485063|FG005|Treatment Period|Progressive disease|2|||
125234045|NCT02765165|450485064|FG006|Treatment Period|Progressive disease|2|||
125234046|NCT02765165|450485058|FG000|Treatment Period|Physician Decision|0|||
125234047|NCT02765165|450485059|FG001|Treatment Period|Physician Decision|1|||
125234048|NCT02765165|450485060|FG002|Treatment Period|Physician Decision|0|||
125234049|NCT02765165|450485061|FG003|Treatment Period|Physician Decision|0|||
125234050|NCT02765165|450485062|FG004|Treatment Period|Physician Decision|0|||
125234051|NCT02765165|450485063|FG005|Treatment Period|Physician Decision|0|||
125234052|NCT02765165|450485064|FG006|Treatment Period|Physician Decision|0|||
125234053|NCT02765165|450485058|FG000|Treatment Period|Adverse Event|0|||
125234054|NCT02765165|450485059|FG001|Treatment Period|Adverse Event|1|||
125234055|NCT02765165|450485060|FG002|Treatment Period|Adverse Event|0|||
125234056|NCT02765165|450485061|FG003|Treatment Period|Adverse Event|0|||
125234057|NCT02765165|450485062|FG004|Treatment Period|Adverse Event|0|||
125234058|NCT02765165|450485063|FG005|Treatment Period|Adverse Event|0|||
125234059|NCT02765165|450485064|FG006|Treatment Period|Adverse Event|0|||
125234060|NCT02765165|450485058|FG000|Treatment Period|Withdrawal by Subject|0|||
125234061|NCT02765165|450485059|FG001|Treatment Period|Withdrawal by Subject|0|||
125234062|NCT02765165|450485060|FG002|Treatment Period|Withdrawal by Subject|0|||
125234063|NCT02765165|450485061|FG003|Treatment Period|Withdrawal by Subject|0|||
125234064|NCT02765165|450485062|FG004|Treatment Period|Withdrawal by Subject|2|||
125234065|NCT02765165|450485063|FG005|Treatment Period|Withdrawal by Subject|0|||
125234066|NCT02765165|450485064|FG006|Treatment Period|Withdrawal by Subject|0|||
125234067|NCT02765165|450485058|FG000|Treatment Period|Study terminated|0|||
125234068|NCT02765165|450485059|FG001|Treatment Period|Study terminated|0|||
125234069|NCT02765165|450485060|FG002|Treatment Period|Study terminated|0|||
125234070|NCT02765165|450485061|FG003|Treatment Period|Study terminated|0|||
125234071|NCT02765165|450485062|FG004|Treatment Period|Study terminated|0|||
125234072|NCT02765165|450485063|FG005|Treatment Period|Study terminated|1|||
125234073|NCT02765165|450485064|FG006|Treatment Period|Study terminated|2|||
125234074|NCT02765165|450485058|FG000|Post-treatment Follow-up|Death|1|||
125234075|NCT02765165|450485059|FG001|Post-treatment Follow-up|Death|2|||
125234076|NCT02765165|450485060|FG002|Post-treatment Follow-up|Death|1|||
125234077|NCT02765165|450485061|FG003|Post-treatment Follow-up|Death|1|||
125234078|NCT02765165|450485062|FG004|Post-treatment Follow-up|Death|1|||
125234079|NCT02765165|450485063|FG005|Post-treatment Follow-up|Death|1|||
125234080|NCT02765165|450485064|FG006|Post-treatment Follow-up|Death|0|||
125234081|NCT02765165|450485058|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
125234082|NCT02765165|450485059|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
125234083|NCT02765165|450485060|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
125234084|NCT02765165|450485061|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
125234085|NCT02765165|450485062|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
125234086|NCT02765165|450485063|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
125234087|NCT02765165|450485064|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
125234088|NCT02765165|450485058|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
125234089|NCT02765165|450485059|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
125234090|NCT02765165|450485060|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
125234091|NCT02765165|450485061|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
125234092|NCT02765165|450485062|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
125178405|NCT03142191|450272769|FG002|Active Treatment Extension Period|Progressive Disease|4|||
125178406|NCT03142191|450272770|FG003|Active Treatment Extension Period|Progressive Disease|1|||
125178407|NCT03142191|450272771|FG004|Active Treatment Extension Period|Progressive Disease|2|||
125178408|NCT03142191|450272767|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
125178409|NCT03142191|450272768|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
125178410|NCT03142191|450272769|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
125178411|NCT03142191|450272770|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
125178412|NCT03142191|450272771|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
125178413|NCT03142191|450272767|FG000|Active Treatment Extension Period|Physician Decision|2|||
125178414|NCT03142191|450272768|FG001|Active Treatment Extension Period|Physician Decision|0|||
125178415|NCT03142191|450272769|FG002|Active Treatment Extension Period|Physician Decision|0|||
125178416|NCT03142191|450272770|FG003|Active Treatment Extension Period|Physician Decision|0|||
125178417|NCT03142191|450272771|FG004|Active Treatment Extension Period|Physician Decision|0|||
125178418|NCT03142191|450272767|FG000|Active Treatment Extension Period|Other Reasons|3|||
125234093|NCT02765165|450485063|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
125234094|NCT02765165|450485064|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
125234095|NCT02765165|450485058|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
125234096|NCT02765165|450485059|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
125234097|NCT02765165|450485060|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
125234098|NCT02765165|450485061|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
125234099|NCT02765165|450485062|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
125392311|NCT04476030|451070626|FG000|Overall Study|Randomized but not Dosed|2|||
125392312|NCT04476030|451070627|FG001|Overall Study|Randomized but not Dosed|8|||
125178419|NCT03142191|450272768|FG001|Active Treatment Extension Period|Other Reasons|3|||
125178420|NCT03142191|450272769|FG002|Active Treatment Extension Period|Other Reasons|3|||
125178421|NCT03142191|450272770|FG003|Active Treatment Extension Period|Other Reasons|8|||
125178422|NCT03142191|450272771|FG004|Active Treatment Extension Period|Other Reasons|3|||
125178423|NCT03142191|450272767|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
125178424|NCT03142191|450272768|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
125178425|NCT03142191|450272769|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
125178426|NCT03142191|450272770|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
125178427|NCT03142191|450272771|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
125178428|NCT01277211|450272774|FG000|Overall Study|Adverse Event|60|||
125178429|NCT01277211|450272775|FG001|Overall Study|Adverse Event|22|||
125178430|NCT01277211|450272774|FG000|Overall Study|Pregnancy|9|||
125178431|NCT01277211|450272775|FG001|Overall Study|Pregnancy|4|||
125234100|NCT02765165|450485063|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
125234101|NCT02765165|450485064|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
125234102|NCT02765165|450485058|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
125234103|NCT02765165|450485059|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
125234104|NCT02765165|450485060|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
125234105|NCT02765165|450485061|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
125234106|NCT02765165|450485062|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
125234107|NCT02765165|450485063|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
125234108|NCT02765165|450485064|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
125234109|NCT02765165|450485058|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
125234110|NCT02765165|450485059|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
125234111|NCT02765165|450485060|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
125234112|NCT02765165|450485061|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
125234113|NCT02765165|450485062|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
125234114|NCT02765165|450485063|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
125234115|NCT02765165|450485064|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
125234116|NCT01206764|450485065|FG000|Overall Study|Adverse Event|20|||
125234117|NCT01206764|450485065|FG000|Overall Study|Abnormal laboratory value|2|||
125234118|NCT01206764|450485065|FG000|Overall Study|Abnormal test procedure result|1|||
125234119|NCT01206764|450485065|FG000|Overall Study|Patient withdrew consent|5|||
125234120|NCT01206764|450485065|FG000|Overall Study|Lost to Follow-up|6|||
125234121|NCT01206764|450485065|FG000|Overall Study|Death|11|||
125234122|NCT01206764|450485065|FG000|Overall Study|New cancer therapy|2|||
125234123|NCT01206764|450485065|FG000|Overall Study|Disease progression|88|||
125234124|NCT01206764|450485065|FG000|Overall Study|Protocol deviation|3|||
125234125|NCT01186770|450485066|FG000|Overall Study|Ineligibility|0|||
125234126|NCT01186770|450485067|FG001|Overall Study|Ineligibility|0|||
125234127|NCT01186770|450485068|FG002|Overall Study|Ineligibility|2|||
125234128|NCT01186770|450485069|FG003|Overall Study|Ineligibility|0|||
125234129|NCT01186770|450485066|FG000|Overall Study|Protocol Violation|7|||
125234130|NCT01186770|450485067|FG001|Overall Study|Protocol Violation|9|||
125234131|NCT01186770|450485068|FG002|Overall Study|Protocol Violation|12|||
125234132|NCT01186770|450485069|FG003|Overall Study|Protocol Violation|14|||
125234133|NCT01186770|450485066|FG000|Overall Study|Adverse Event|2|||
125234134|NCT01186770|450485067|FG001|Overall Study|Adverse Event|9|||
125234135|NCT01186770|450485068|FG002|Overall Study|Adverse Event|7|||
125234136|NCT01186770|450485069|FG003|Overall Study|Adverse Event|9|||
125234137|NCT01186770|450485066|FG000|Overall Study|Withdrawal by Subject|15|||
125234138|NCT01186770|450485067|FG001|Overall Study|Withdrawal by Subject|13|||
125234139|NCT01186770|450485068|FG002|Overall Study|Withdrawal by Subject|11|||
125234140|NCT01186770|450485069|FG003|Overall Study|Withdrawal by Subject|17|||
125234141|NCT01186770|450485066|FG000|Overall Study|Lost to Follow-up|10|||
125234142|NCT01186770|450485067|FG001|Overall Study|Lost to Follow-up|6|||
125234143|NCT01186770|450485068|FG002|Overall Study|Lost to Follow-up|14|||
125234144|NCT01186770|450485069|FG003|Overall Study|Lost to Follow-up|9|||
125234145|NCT01186770|450485066|FG000|Overall Study|Insufficient response to treatment|7|||
125234146|NCT01186770|450485067|FG001|Overall Study|Insufficient response to treatment|8|||
125234147|NCT01186770|450485068|FG002|Overall Study|Insufficient response to treatment|5|||
125234148|NCT01186770|450485069|FG003|Overall Study|Insufficient response to treatment|7|||
125234149|NCT01186770|450485066|FG000|Overall Study|Other than specified|0|||
125234150|NCT01186770|450485067|FG001|Overall Study|Other than specified|1|||
125178432|NCT01277211|450272774|FG000|Overall Study|Lost to Follow-up|14|||
125178433|NCT01277211|450272775|FG001|Overall Study|Lost to Follow-up|9|||
125178434|NCT01277211|450272774|FG000|Overall Study|Did not wish to continue|17|||
125178435|NCT01277211|450272775|FG001|Overall Study|Did not wish to continue|0|||
125178436|NCT01277211|450272774|FG000|Overall Study|Withdrew Consent|9|||
125234151|NCT01186770|450485068|FG002|Overall Study|Other than specified|1|||
125234152|NCT01186770|450485069|FG003|Overall Study|Other than specified|2|||
125234153|NCT02567188|450485070|FG000|Overall Study|Death|10|||
125234154|NCT02567188|450485070|FG000|Overall Study|Terminated Mircera Treatment|9|||
125234155|NCT02567188|450485070|FG000|Overall Study|Lost to Follow-up|5|||
125178437|NCT01277211|450272775|FG001|Overall Study|Withdrew Consent|9|||
125234156|NCT02567188|450485070|FG000|Overall Study|Adverse Event|1|||
125234157|NCT02567188|450485070|FG000|Overall Study|Withdrawal by Subject|1|||
125234158|NCT02567188|450485070|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
125234159|NCT02567188|450485070|FG000|Overall Study|Moved and Changed Clinic|1|||
125234160|NCT02567188|450485070|FG000|Overall Study|Started Hemodialysis|2|||
125234161|NCT02567188|450485070|FG000|Overall Study|Protocol Violation|5|||
125234162|NCT01033136|450485071|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
125234163|NCT01033136|450485072|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
125234164|NCT00321763|450485074|FG000|Overall Study|Adverse Event|1|||
125234165|NCT00321763|450485075|FG001|Overall Study|Adverse Event|1|||
125234166|NCT00321763|450485076|FG002|Overall Study|Adverse Event|0|||
125234167|NCT00321763|450485077|FG003|Overall Study|Adverse Event|1|||
125234168|NCT00321763|450485074|FG000|Overall Study|Withdrawal by Subject|2|||
125234169|NCT00321763|450485075|FG001|Overall Study|Withdrawal by Subject|0|||
125234170|NCT00321763|450485076|FG002|Overall Study|Withdrawal by Subject|1|||
125234171|NCT00321763|450485077|FG003|Overall Study|Withdrawal by Subject|0|||
125234172|NCT00321763|450485074|FG000|Overall Study|Lost to Follow-up|3|||
125234173|NCT00321763|450485075|FG001|Overall Study|Lost to Follow-up|1|||
125234174|NCT00321763|450485076|FG002|Overall Study|Lost to Follow-up|5|||
125234175|NCT00321763|450485077|FG003|Overall Study|Lost to Follow-up|4|||
125234176|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
125234177|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
125234178|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
125234179|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
125234180|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
125234181|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
125234182|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
125234183|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
125234184|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
125234185|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
125234186|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
125234187|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
125234188|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
125234189|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
125234190|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
125234191|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
125234192|NCT00410163|450485078|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
125234193|NCT00410163|450485079|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
125234194|NCT00410163|450485078|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
125234195|NCT00410163|450485079|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
125234196|NCT00410163|450485078|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
125234197|NCT00410163|450485079|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
125234198|NCT00410163|450485078|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
125234199|NCT00410163|450485079|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
125234200|NCT00410163|450485078|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
125234201|NCT00410163|450485079|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
125234202|NCT00410163|450485078|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
125234203|NCT00410163|450485079|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
125234204|NCT00797563|450485081|FG000|Overall Study|Adverse Event|1|||
125234205|NCT00688597|450485082|FG000|Overall Study|Adverse Event|2|||
125234206|NCT00688597|450485083|FG001|Overall Study|Adverse Event|0|||
125234207|NCT00688597|450485084|FG002|Overall Study|Adverse Event|0|||
125234208|NCT00688597|450485082|FG000|Overall Study|Physician Decision|1|||
125234209|NCT00688597|450485083|FG001|Overall Study|Physician Decision|0|||
125234210|NCT00688597|450485084|FG002|Overall Study|Physician Decision|0|||
125234211|NCT05853120|450485085|FG000|Overall Study|Lost to Follow-up|4|||
125234212|NCT05853120|450485086|FG001|Overall Study|Lost to Follow-up|4|||
125234213|NCT05853120|450485085|FG000|Overall Study|Physician Decision|3|||
125234214|NCT05853120|450485086|FG001|Overall Study|Physician Decision|0|||
125234215|NCT05853120|450485085|FG000|Overall Study|Withdrawal by Subject|5|||
125234216|NCT05853120|450485086|FG001|Overall Study|Withdrawal by Subject|2|||
125234217|NCT02763566|450485091|FG000|Overall Study|Lost to Follow-up|1|||
125234218|NCT02763566|450485092|FG001|Overall Study|Lost to Follow-up|4|||
125234219|NCT02763566|450485093|FG002|Overall Study|Lost to Follow-up|0|||
125234220|NCT02763566|450485094|FG003|Overall Study|Lost to Follow-up|1|||
125234221|NCT02763566|450485091|FG000|Overall Study|On study treatment at study conclusion|114|||
125234222|NCT02763566|450485092|FG001|Overall Study|On study treatment at study conclusion|34|||
125234223|NCT02763566|450485093|FG002|Overall Study|On study treatment at study conclusion|54|||
125234224|NCT02763566|450485094|FG003|Overall Study|On study treatment at study conclusion|13|||
125234225|NCT02763566|450485091|FG000|Overall Study|Withdrawal by Subject|3|||
125234226|NCT02763566|450485092|FG001|Overall Study|Withdrawal by Subject|1|||
125234227|NCT02763566|450485093|FG002|Overall Study|Withdrawal by Subject|0|||
125234228|NCT02763566|450485094|FG003|Overall Study|Withdrawal by Subject|0|||
125234229|NCT02855268|450485095|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
125234230|NCT02855268|450485096|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
125234231|NCT02855268|450485095|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
125234232|NCT02855268|450485096|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
125234233|NCT02855268|450485095|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
125234234|NCT02855268|450485096|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
125234235|NCT02855268|450485095|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
125234236|NCT02855268|450485096|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
125178438|NCT01277211|450272774|FG000|Overall Study|Non-compliance with protocol|13|||
125178439|NCT01277211|450272775|FG001|Overall Study|Non-compliance with protocol|4|||
125178440|NCT01277211|450272774|FG000|Overall Study|Did not meet protocol eligibility|1|||
125178441|NCT01277211|450272775|FG001|Overall Study|Did not meet protocol eligibility|0|||
125178442|NCT01277211|450272774|FG000|Overall Study|Administrative|3|||
125178443|NCT01277211|450272775|FG001|Overall Study|Administrative|0|||
125178444|NCT01277211|450272774|FG000|Overall Study|Pregnancy wish|0|||
125178445|NCT01277211|450272775|FG001|Overall Study|Pregnancy wish|2|||
125178446|NCT01277211|450272774|FG000|Overall Study|Discontinued prior to treatment|24|||
125178447|NCT01277211|450272775|FG001|Overall Study|Discontinued prior to treatment|13|||
125178448|NCT00770328|450272776|FG000|Overall Study|Adverse Event|11|||
125178449|NCT00770328|450272777|FG001|Overall Study|Adverse Event|2|||
125178450|NCT00770328|450272776|FG000|Overall Study|Lost to Follow-up|2|||
125178451|NCT00770328|450272777|FG001|Overall Study|Lost to Follow-up|2|||
125178452|NCT01130493|450272778|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
125178453|NCT01130493|450272779|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
125178454|NCT01130493|450272780|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
125178455|NCT01130493|450272778|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
125178456|NCT01130493|450272779|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
125178457|NCT01130493|450272780|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
125178458|NCT01130493|450272778|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
125178459|NCT01130493|450272779|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
125178460|NCT01130493|450272780|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
125178461|NCT01130493|450272778|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
125178462|NCT01130493|450272779|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
125178463|NCT01130493|450272780|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
125178464|NCT01130493|450272778|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
125178465|NCT01130493|450272779|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
125178466|NCT01130493|450272780|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
125178467|NCT01130493|450272778|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
125178468|NCT01130493|450272779|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
125178469|NCT01130493|450272780|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
125178470|NCT01130493|450272778|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
125178471|NCT01130493|450272779|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
125178472|NCT01130493|450272780|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
125178473|NCT01130493|450272778|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
125178474|NCT01130493|450272779|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
125178475|NCT01130493|450272780|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
125178476|NCT01130493|450272778|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
125178477|NCT01130493|450272779|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
125178478|NCT01130493|450272780|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
125178479|NCT01130493|450272778|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
125178480|NCT01130493|450272779|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
125178481|NCT01130493|450272780|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
125178482|NCT01130493|450272778|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
125178483|NCT01130493|450272779|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
125178484|NCT01130493|450272780|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
125178485|NCT01130493|450272778|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
125178486|NCT01130493|450272779|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
125178487|NCT01130493|450272780|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
125178488|NCT01130493|450272778|FG000|Part 2: OLE|Adverse Event|0|||
125234237|NCT02855268|450485095|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
125178489|NCT01130493|450272779|FG001|Part 2: OLE|Adverse Event|2|||
125178490|NCT01130493|450272780|FG002|Part 2: OLE|Adverse Event|1|||
125178491|NCT01130493|450272778|FG000|Part 2: OLE|Withdrawal by Subject|0|||
125178492|NCT01130493|450272779|FG001|Part 2: OLE|Withdrawal by Subject|1|||
125234238|NCT02855268|450485096|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
125234239|NCT02855268|450485095|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
125392313|NCT02404311|451070628|FG000|Part A: Month 0-18|Death|2|||
125234240|NCT02855268|450485096|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
125234241|NCT00639509|450485099|FG000|Overall Study|Death|1|||
125234242|NCT04513366|450485108|FG000|Treatment Phase|Withdrawal by Subject|6|||
125234243|NCT04513366|450485109|FG001|Treatment Phase|Withdrawal by Subject|8|||
125234244|NCT04513366|450485110|FG002|Treatment Phase|Withdrawal by Subject|3|||
125234245|NCT04513366|450485108|FG000|Treatment Phase|Lost to Follow-up|1|||
125234246|NCT04513366|450485109|FG001|Treatment Phase|Lost to Follow-up|2|||
125234247|NCT04513366|450485110|FG002|Treatment Phase|Lost to Follow-up|5|||
125234248|NCT04513366|450485108|FG000|Treatment Phase|Other than Specified|1|||
125234249|NCT04513366|450485109|FG001|Treatment Phase|Other than Specified|0|||
125234250|NCT04513366|450485110|FG002|Treatment Phase|Other than Specified|2|||
125234251|NCT04513366|450485108|FG000|Treatment Phase|Physician Decision|2|||
125234252|NCT04513366|450485109|FG001|Treatment Phase|Physician Decision|0|||
125234253|NCT04513366|450485110|FG002|Treatment Phase|Physician Decision|0|||
125234254|NCT04513366|450485108|FG000|Treatment Phase|Adverse Event|0|||
125234255|NCT04513366|450485109|FG001|Treatment Phase|Adverse Event|1|||
125234256|NCT04513366|450485110|FG002|Treatment Phase|Adverse Event|1|||
125234257|NCT04513366|450485108|FG000|Extension Phase|Withdrawal by Subject|3|||
125234258|NCT04513366|450485109|FG001|Extension Phase|Withdrawal by Subject|1|||
125234259|NCT04513366|450485110|FG002|Extension Phase|Withdrawal by Subject|1|||
125234260|NCT04513366|450485108|FG000|Extension Phase|Other than Specified|4|||
125234261|NCT04513366|450485109|FG001|Extension Phase|Other than Specified|0|||
125234262|NCT04513366|450485110|FG002|Extension Phase|Other than Specified|1|||
125234263|NCT04513366|450485108|FG000|Extension Phase|Lost to Follow-up|1|||
125234264|NCT04513366|450485109|FG001|Extension Phase|Lost to Follow-up|1|||
125234265|NCT04513366|450485110|FG002|Extension Phase|Lost to Follow-up|1|||
125234266|NCT04513366|450485108|FG000|Extension Phase|Sponsor Decision|0|||
125234267|NCT04513366|450485109|FG001|Extension Phase|Sponsor Decision|1|||
125234268|NCT04513366|450485110|FG002|Extension Phase|Sponsor Decision|0|||
125234269|NCT04513366|450485108|FG000|Extension Phase|Death|0|||
125234270|NCT04513366|450485109|FG001|Extension Phase|Death|1|||
125234271|NCT04513366|450485110|FG002|Extension Phase|Death|0|||
125234272|NCT04513366|450485108|FG000|Extension Phase|Adverse Event|0|||
125234273|NCT04513366|450485109|FG001|Extension Phase|Adverse Event|0|||
125234274|NCT04513366|450485110|FG002|Extension Phase|Adverse Event|1|||
125234275|NCT02657551|450485113|FG000|Overall Study|Adverse Event|2|||
125234276|NCT02657551|450485113|FG000|Overall Study|Withdrawal by Subject|1|||
125234277|NCT02657551|450485113|FG000|Overall Study|Non-Compliance|1|||
125234278|NCT02657551|450485113|FG000|Overall Study|Progression / Relapse|4|||
125234279|NCT04478266|450485115|FG000|Overall Study|Adverse Event|20|||
125234280|NCT04478266|450485116|FG001|Overall Study|Adverse Event|21|||
125234281|NCT04478266|450485115|FG000|Overall Study|Progressive disease|146|||
125234282|NCT04478266|450485116|FG001|Overall Study|Progressive disease|168|||
125234283|NCT04478266|450485115|FG000|Overall Study|Poor compliance to protocol|1|||
125234284|NCT04478266|450485116|FG001|Overall Study|Poor compliance to protocol|0|||
125234285|NCT04478266|450485115|FG000|Overall Study|Withdrawal by Subject|19|||
125234286|NCT04478266|450485116|FG001|Overall Study|Withdrawal by Subject|16|||
125234287|NCT04478266|450485115|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
125234288|NCT04478266|450485116|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
125234289|NCT04478266|450485115|FG000|Overall Study|Study terminated by sponsor|33|||
125234290|NCT04478266|450485116|FG001|Overall Study|Study terminated by sponsor|35|||
125234291|NCT04478266|450485115|FG000|Overall Study|Other: unspecified|5|||
125234292|NCT04478266|450485116|FG001|Overall Study|Other: unspecified|7|||
125234293|NCT04478266|450485115|FG000|Overall Study|Randomized but not treated|1|||
125234294|NCT04478266|450485116|FG001|Overall Study|Randomized but not treated|1|||
125234295|NCT04798027|450485119|FG000|Overall Study|Protocol Violation|0|||
125234296|NCT04798027|450485120|FG001|Overall Study|Protocol Violation|0|||
125234297|NCT04798027|450485121|FG002|Overall Study|Protocol Violation|0|||
125234298|NCT04798027|450485122|FG003|Overall Study|Protocol Violation|0|||
125234299|NCT04798027|450485123|FG004|Overall Study|Protocol Violation|1|||
125234300|NCT04798027|450485124|FG005|Overall Study|Protocol Violation|0|||
125234301|NCT04798027|450485125|FG006|Overall Study|Protocol Violation|0|||
125234302|NCT04798027|450485126|FG007|Overall Study|Protocol Violation|1|||
125234303|NCT04798027|450485127|FG008|Overall Study|Protocol Violation|0|||
125234304|NCT04798027|450485119|FG000|Overall Study|Withdrawal by Subject|1|||
125234305|NCT04798027|450485120|FG001|Overall Study|Withdrawal by Subject|0|||
125234306|NCT04798027|450485121|FG002|Overall Study|Withdrawal by Subject|1|||
125234307|NCT04798027|450485122|FG003|Overall Study|Withdrawal by Subject|1|||
125234308|NCT04798027|450485123|FG004|Overall Study|Withdrawal by Subject|1|||
125234309|NCT04798027|450485124|FG005|Overall Study|Withdrawal by Subject|1|||
125234310|NCT04798027|450485125|FG006|Overall Study|Withdrawal by Subject|3|||
125234311|NCT04798027|450485126|FG007|Overall Study|Withdrawal by Subject|2|||
125234312|NCT04798027|450485127|FG008|Overall Study|Withdrawal by Subject|2|||
125234313|NCT04798027|450485119|FG000|Overall Study|Lost to Follow-up|1|||
125234314|NCT04798027|450485120|FG001|Overall Study|Lost to Follow-up|3|||
125234315|NCT04798027|450485121|FG002|Overall Study|Lost to Follow-up|0|||
125234316|NCT04798027|450485122|FG003|Overall Study|Lost to Follow-up|0|||
125234317|NCT04798027|450485123|FG004|Overall Study|Lost to Follow-up|0|||
125234318|NCT04798027|450485124|FG005|Overall Study|Lost to Follow-up|1|||
125234319|NCT04798027|450485125|FG006|Overall Study|Lost to Follow-up|0|||
125234320|NCT04798027|450485126|FG007|Overall Study|Lost to Follow-up|0|||
125234321|NCT04798027|450485127|FG008|Overall Study|Lost to Follow-up|1|||
125234322|NCT04798027|450485119|FG000|Overall Study|Withdrawal by Sponsor|8|||
125234323|NCT04798027|450485120|FG001|Overall Study|Withdrawal by Sponsor|22|||
125234324|NCT04798027|450485121|FG002|Overall Study|Withdrawal by Sponsor|9|||
125234325|NCT04798027|450485122|FG003|Overall Study|Withdrawal by Sponsor|26|||
125234326|NCT04798027|450485123|FG004|Overall Study|Withdrawal by Sponsor|24|||
125234327|NCT04798027|450485124|FG005|Overall Study|Withdrawal by Sponsor|11|||
125234328|NCT04798027|450485125|FG006|Overall Study|Withdrawal by Sponsor|25|||
125234329|NCT04798027|450485126|FG007|Overall Study|Withdrawal by Sponsor|26|||
125234330|NCT04798027|450485127|FG008|Overall Study|Withdrawal by Sponsor|11|||
125234331|NCT02659865|450486306|FG000|Period 1|Withdrawal by Subject|1|||
125234332|NCT02659865|450486307|FG001|Period 1|Withdrawal by Subject|0|||
125234333|NCT02659865|450486308|FG002|Period 1|Withdrawal by Subject|0|||
125234334|NCT02659865|450486309|FG003|Period 1|Withdrawal by Subject|0|||
125234335|NCT02659865|450486310|FG004|Period 1|Withdrawal by Subject|0|||
125234336|NCT02659865|450486306|FG000|Period 1|Adverse Event|0|||
125234337|NCT02659865|450486307|FG001|Period 1|Adverse Event|0|||
125234338|NCT02659865|450486308|FG002|Period 1|Adverse Event|0|||
125234339|NCT02659865|450486309|FG003|Period 1|Adverse Event|0|||
125234340|NCT02659865|450486310|FG004|Period 1|Adverse Event|1|||
125234341|NCT02100631|450486311|FG000|Overall Study|Withdrawal by Subject|1|||
125234342|NCT02100631|450486312|FG001|Overall Study|Withdrawal by Subject|0|||
125234343|NCT02100631|450486313|FG002|Overall Study|Withdrawal by Subject|0|||
125234344|NCT02100631|450486311|FG000|Overall Study|Lost to Follow-up|3|||
125234345|NCT02100631|450486312|FG001|Overall Study|Lost to Follow-up|4|||
125234346|NCT02100631|450486313|FG002|Overall Study|Lost to Follow-up|0|||
125234347|NCT02100631|450486311|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
125234348|NCT02100631|450486312|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
125234349|NCT02100631|450486313|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
125234350|NCT00300053|450486314|FG000|Overall Study|Patient/Caregiver Preference|2|||
125234351|NCT00300053|450486315|FG001|Overall Study|Patient/Caregiver Preference|2|||
125234352|NCT00300053|450486316|FG002|Overall Study|Patient/Caregiver Preference|3|||
125234353|NCT00300053|450486314|FG000|Overall Study|Death|0|||
125234354|NCT00300053|450486315|FG001|Overall Study|Death|0|||
125234355|NCT00300053|450486316|FG002|Overall Study|Death|3|||
125234356|NCT00300053|450486314|FG000|Overall Study|Lost to Follow-up|0|||
125234357|NCT00300053|450486315|FG001|Overall Study|Lost to Follow-up|1|||
125234358|NCT00300053|450486316|FG002|Overall Study|Lost to Follow-up|0|||
125234359|NCT03261401|450486319|FG000|Overall Study|Withdrawal by Subject|0|||
125234360|NCT03261401|450486320|FG001|Overall Study|Withdrawal by Subject|0|||
125234361|NCT03261401|450486321|FG002|Overall Study|Withdrawal by Subject|0|||
125234362|NCT03261401|450486322|FG003|Overall Study|Withdrawal by Subject|0|||
125234363|NCT03261401|450486323|FG004|Overall Study|Withdrawal by Subject|0|||
125234364|NCT03261401|450486324|FG005|Overall Study|Withdrawal by Subject|1|||
125234365|NCT03261401|450486325|FG006|Overall Study|Withdrawal by Subject|0|||
125234366|NCT03261401|450486326|FG007|Overall Study|Withdrawal by Subject|0|||
125234367|NCT03261401|450486327|FG008|Overall Study|Withdrawal by Subject|0|||
125234368|NCT03261401|450486328|FG009|Overall Study|Withdrawal by Subject|0|||
125234369|NCT03261401|450486329|FG010|Overall Study|Withdrawal by Subject|0|||
125234370|NCT03261401|450486330|FG011|Overall Study|Withdrawal by Subject|0|||
125234371|NCT03261401|450486331|FG012|Overall Study|Withdrawal by Subject|0|||
125234372|NCT03261401|450486319|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
125234373|NCT03261401|450486320|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
125234374|NCT03261401|450486321|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
125234375|NCT03261401|450486322|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
125234376|NCT03261401|450486323|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
125234377|NCT03261401|450486324|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
125234378|NCT03261401|450486325|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
125234379|NCT03261401|450486326|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
125234380|NCT03261401|450486327|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
125234381|NCT03261401|450486328|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
125234382|NCT03261401|450486329|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
125234383|NCT03261401|450486330|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
125234384|NCT03261401|450486331|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
125234385|NCT01983930|450486337|FG000|Overall Study|Withdrawal by Subject|9|||
125234386|NCT01983930|450486338|FG001|Overall Study|Withdrawal by Subject|8|||
125234387|NCT01983930|450486337|FG000|Overall Study|Adverse Event|0|||
125234388|NCT01983930|450486338|FG001|Overall Study|Adverse Event|1|||
125234389|NCT00634504|450486341|FG000|Overall Study|Protocol Violation|1|||
125234390|NCT00634504|450486342|FG001|Overall Study|Protocol Violation|0|||
125234391|NCT05001620|450486345|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
125234392|NCT05001620|450486346|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
125234393|NCT00481676|450486349|FG000|Overall Study|Adverse Event|0|||
125234394|NCT00481676|450486350|FG001|Overall Study|Adverse Event|1|||
125234395|NCT00481676|450486349|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125234396|NCT00481676|450486350|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
125234397|NCT00481676|450486349|FG000|Overall Study|Administrative problem|1|||
125234398|NCT00481676|450486350|FG001|Overall Study|Administrative problem|0|||
125234399|NCT01513590|450486351|FG000|Overall Study|Adverse Event|2|||
125234400|NCT01513590|450486352|FG001|Overall Study|Adverse Event|3|||
125234401|NCT01513590|450486351|FG000|Overall Study|Withdrawal Criteria|3|||
125234402|NCT01513590|450486352|FG001|Overall Study|Withdrawal Criteria|0|||
125234403|NCT01513590|450486351|FG000|Overall Study|Unclassified|5|||
125234404|NCT01513590|450486352|FG001|Overall Study|Unclassified|10|||
125234405|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
125234406|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
125234407|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
125234408|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
125234409|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
125234410|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
125234411|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
125234412|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
125234413|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
125234414|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
125234415|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Death|3|||
125234416|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Death|1|||
125234417|NCT01056276|450486353|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
125234418|NCT01056276|450486354|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
125234419|NCT01056276|450486353|FG000|Maintenance Therapy|Toxicity|0|||
125234420|NCT01056276|450486354|FG001|Maintenance Therapy|Toxicity|2|||
125234421|NCT01056276|450486353|FG000|Maintenance Therapy|Progressive Disease|0|||
125234422|NCT01056276|450486354|FG001|Maintenance Therapy|Progressive Disease|9|||
125234423|NCT01056276|450486353|FG000|Maintenance Therapy|Physician Decision|0|||
125234424|NCT01056276|450486354|FG001|Maintenance Therapy|Physician Decision|1|||
125234425|NCT01056276|450486353|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
125234426|NCT01056276|450486354|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
125234427|NCT01056276|450486353|FG000|Maintenance Therapy|Intercurrent Illness|0|||
125234428|NCT01056276|450486354|FG001|Maintenance Therapy|Intercurrent Illness|1|||
125234429|NCT01056276|450486353|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
125234430|NCT01056276|450486354|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
125234431|NCT04424901|450486357|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
125234432|NCT04424901|450486358|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
125234433|NCT00147238|450486359|FG000|Overall Study|Inevaluable|8|||
125234434|NCT00297167|450486360|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
125234435|NCT00297167|450486361|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
125234436|NCT00297167|450486362|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
125234437|NCT00297167|450486360|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
125234438|NCT00297167|450486361|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
125234439|NCT00297167|450486362|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
125234440|NCT02701634|450486366|FG000|Overall Study|Adverse Event|2|||
125234441|NCT02701634|450486367|FG001|Overall Study|Adverse Event|3|||
125234442|NCT02701634|450486366|FG000|Overall Study|Death|1|||
125234443|NCT02701634|450486367|FG001|Overall Study|Death|0|||
125234444|NCT02701634|450486366|FG000|Overall Study|Investigator's Discretion|7|||
125234445|NCT02701634|450486367|FG001|Overall Study|Investigator's Discretion|4|||
125234446|NCT02701634|450486366|FG000|Overall Study|Study terminated by Sponsor|15|||
125234447|NCT02701634|450486367|FG001|Overall Study|Study terminated by Sponsor|17|||
125234448|NCT02701634|450486366|FG000|Overall Study|Withdrew Consent|6|||
125234449|NCT02701634|450486367|FG001|Overall Study|Withdrew Consent|7|||
125234450|NCT02701634|450486366|FG000|Overall Study|Randomized but not treated|1|||
125234451|NCT02701634|450486367|FG001|Overall Study|Randomized but not treated|0|||
125234452|NCT04009837|450486374|FG000|Overall Study|Withdrawal by Subject|5|||
125234453|NCT04009837|450486375|FG001|Overall Study|Withdrawal by Subject|4|||
125234454|NCT04009837|450486374|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
125234455|NCT04009837|450486375|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
125234456|NCT01572792|450486378|FG000|Lead-in Study|Lost to Follow-up|5|||
125234457|NCT01572792|450486379|FG001|Lead-in Study|Lost to Follow-up|9|||
125234458|NCT01572792|450486380|FG002|Lead-in Study|Lost to Follow-up|4|||
125234459|NCT01572792|450486381|FG003|Lead-in Study|Lost to Follow-up|2|||
125234460|NCT01572792|450486382|FG004|Lead-in Study|Lost to Follow-up|4|||
125234461|NCT01572792|450486378|FG000|Lead-in Study|Withdrawal by Subject|22|||
125234462|NCT01572792|450486379|FG001|Lead-in Study|Withdrawal by Subject|11|||
125234463|NCT01572792|450486380|FG002|Lead-in Study|Withdrawal by Subject|12|||
125178493|NCT01130493|450272780|FG002|Part 2: OLE|Withdrawal by Subject|4|||
125178494|NCT03452943|450272781|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
125178495|NCT03452943|450272782|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
125178496|NCT03452943|450272781|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
125178497|NCT03452943|450272782|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
125178498|NCT03452943|450272781|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
125178499|NCT03452943|450272782|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
125178500|NCT03452943|450272781|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
125178501|NCT03452943|450272782|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
125178502|NCT03452943|450272781|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
125178503|NCT03452943|450272782|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
125178504|NCT03452943|450272781|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
125178505|NCT03452943|450272782|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
125178506|NCT00879086|450272785|FG000|Overall Study|Adverse Event|3|||
125178507|NCT00879086|450272786|FG001|Overall Study|Adverse Event|15|||
125178508|NCT00879086|450272785|FG000|Overall Study|Participant choice|2|||
125178509|NCT00879086|450272786|FG001|Overall Study|Participant choice|2|||
125178510|NCT00879086|450272785|FG000|Overall Study|Progression of disease|40|||
125178511|NCT00879086|450272786|FG001|Overall Study|Progression of disease|26|||
125178512|NCT00879086|450272785|FG000|Overall Study|Withdrawal of consent|2|||
125178513|NCT00879086|450272786|FG001|Overall Study|Withdrawal of consent|1|||
125178514|NCT00879086|450272785|FG000|Overall Study|Other|4|||
125178515|NCT00879086|450272786|FG001|Overall Study|Other|6|||
125178516|NCT00879086|450272785|FG000|Overall Study|Death|1|||
125178517|NCT00879086|450272786|FG001|Overall Study|Death|2|||
125178518|NCT02536846|450272787|FG000|Overall Study|Withdrawal by Subject|1|||
125178519|NCT02593110|450272788|FG000|Overall Study|Withdrawal by Subject|0|||
125178520|NCT02593110|450272789|FG001|Overall Study|Withdrawal by Subject|3|||
125178521|NCT02593110|450272790|FG002|Overall Study|Withdrawal by Subject|3|||
125178522|NCT02593110|450272791|FG003|Overall Study|Withdrawal by Subject|2|||
125178523|NCT02593110|450272788|FG000|Overall Study|Death|0|||
125178524|NCT02593110|450272789|FG001|Overall Study|Death|0|||
125178525|NCT02593110|450272790|FG002|Overall Study|Death|1|||
125178526|NCT02593110|450272791|FG003|Overall Study|Death|0|||
125178527|NCT04604795|450272792|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
125178528|NCT04604795|450272793|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
125178529|NCT04604795|450272794|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178530|NCT04604795|450272795|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178531|NCT04604795|450272796|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178532|NCT04604795|450272797|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178533|NCT04604795|450272798|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178534|NCT04604795|450272799|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178535|NCT04604795|450272800|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178536|NCT04604795|450272801|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
125178537|NCT04604795|450272792|FG000|Part B: Up to Day 14|Adverse Event|0|||
125178538|NCT04604795|450272793|FG001|Part B: Up to Day 14|Adverse Event|0|||
125178539|NCT04604795|450272794|FG002|Part B: Up to Day 14|Adverse Event|0|||
125178540|NCT04604795|450272795|FG003|Part B: Up to Day 14|Adverse Event|0|||
125178541|NCT04604795|450272796|FG004|Part B: Up to Day 14|Adverse Event|2|||
125178542|NCT04604795|450272797|FG005|Part B: Up to Day 14|Adverse Event|1|||
125178543|NCT04604795|450272798|FG006|Part B: Up to Day 14|Adverse Event|0|||
125178544|NCT04604795|450272799|FG007|Part B: Up to Day 14|Adverse Event|0|||
125178545|NCT04604795|450272800|FG008|Part B: Up to Day 14|Adverse Event|0|||
125178546|NCT04604795|450272801|FG009|Part B: Up to Day 14|Adverse Event|0|||
125178547|NCT04604795|450272792|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178548|NCT04604795|450272793|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178549|NCT04604795|450272794|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178550|NCT04604795|450272795|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178551|NCT04604795|450272796|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178552|NCT04604795|450272797|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178553|NCT04604795|450272798|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178554|NCT04604795|450272799|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178555|NCT04604795|450272800|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
125178556|NCT04604795|450272801|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
125178557|NCT04604795|450272792|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178558|NCT04604795|450272793|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178559|NCT04604795|450272794|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178560|NCT04604795|450272795|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178561|NCT04604795|450272796|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178562|NCT04604795|450272797|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178563|NCT04604795|450272798|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125234464|NCT01572792|450486381|FG003|Lead-in Study|Withdrawal by Subject|24|||
125234465|NCT01572792|450486382|FG004|Lead-in Study|Withdrawal by Subject|11|||
125234466|NCT01572792|450486378|FG000|Lead-in Study|Protocol Violation|19|||
125234467|NCT01572792|450486379|FG001|Lead-in Study|Protocol Violation|10|||
125234468|NCT01572792|450486380|FG002|Lead-in Study|Protocol Violation|12|||
125234469|NCT01572792|450486381|FG003|Lead-in Study|Protocol Violation|13|||
125234470|NCT01572792|450486382|FG004|Lead-in Study|Protocol Violation|21|||
125234471|NCT01572792|450486378|FG000|Lead-in Study|Lack of Efficacy|20|||
125234472|NCT01572792|450486379|FG001|Lead-in Study|Lack of Efficacy|5|||
125234473|NCT01572792|450486380|FG002|Lead-in Study|Lack of Efficacy|4|||
125234474|NCT01572792|450486381|FG003|Lead-in Study|Lack of Efficacy|8|||
125234475|NCT01572792|450486382|FG004|Lead-in Study|Lack of Efficacy|10|||
125234476|NCT01572792|450486378|FG000|Lead-in Study|Adverse Event|21|||
125234477|NCT01572792|450486379|FG001|Lead-in Study|Adverse Event|21|||
125234478|NCT01572792|450486380|FG002|Lead-in Study|Adverse Event|22|||
125234479|NCT01572792|450486381|FG003|Lead-in Study|Adverse Event|16|||
125234480|NCT01572792|450486382|FG004|Lead-in Study|Adverse Event|14|||
125234481|NCT01572792|450486378|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
125234482|NCT01572792|450486379|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
125234483|NCT01572792|450486380|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
125234484|NCT01572792|450486381|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
125234485|NCT01572792|450486382|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
125234486|NCT01572792|450486378|FG000|Extension Study|Lost to Follow-up|6|||
125234487|NCT01572792|450486379|FG001|Extension Study|Lost to Follow-up|2|||
125234488|NCT01572792|450486380|FG002|Extension Study|Lost to Follow-up|0|||
125234489|NCT01572792|450486381|FG003|Extension Study|Lost to Follow-up|3|||
125234490|NCT01572792|450486382|FG004|Extension Study|Lost to Follow-up|3|||
125234491|NCT01572792|450486378|FG000|Extension Study|Withdrawal by Subject|7|||
125234492|NCT01572792|450486379|FG001|Extension Study|Withdrawal by Subject|6|||
125234493|NCT01572792|450486380|FG002|Extension Study|Withdrawal by Subject|11|||
125234494|NCT01572792|450486381|FG003|Extension Study|Withdrawal by Subject|8|||
125234495|NCT01572792|450486382|FG004|Extension Study|Withdrawal by Subject|14|||
125234496|NCT01572792|450486378|FG000|Extension Study|Protocol Violation|0|||
125234497|NCT01572792|450486379|FG001|Extension Study|Protocol Violation|4|||
125234498|NCT01572792|450486380|FG002|Extension Study|Protocol Violation|3|||
125234499|NCT01572792|450486381|FG003|Extension Study|Protocol Violation|4|||
125234500|NCT01572792|450486382|FG004|Extension Study|Protocol Violation|3|||
125234501|NCT01572792|450486378|FG000|Extension Study|Lack of Efficacy|2|||
125234502|NCT01572792|450486379|FG001|Extension Study|Lack of Efficacy|3|||
125234503|NCT01572792|450486380|FG002|Extension Study|Lack of Efficacy|3|||
125234504|NCT01572792|450486381|FG003|Extension Study|Lack of Efficacy|2|||
125234505|NCT01572792|450486382|FG004|Extension Study|Lack of Efficacy|2|||
125234506|NCT01572792|450486378|FG000|Extension Study|Adverse Event|7|||
125234507|NCT01572792|450486379|FG001|Extension Study|Adverse Event|6|||
125234508|NCT01572792|450486380|FG002|Extension Study|Adverse Event|5|||
125234509|NCT01572792|450486381|FG003|Extension Study|Adverse Event|6|||
125234510|NCT01572792|450486382|FG004|Extension Study|Adverse Event|4|||
125234511|NCT01572792|450486378|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
125234512|NCT01572792|450486379|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
125234513|NCT01572792|450486380|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
125234514|NCT01572792|450486381|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
125234515|NCT01572792|450486382|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
125234516|NCT03530696|450486383|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
125234517|NCT03530696|450486384|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
125234518|NCT02472353|450486385|FG000|Overall Study|Lost to Follow-up|1|||
125234519|NCT02472353|450486386|FG001|Overall Study|Lost to Follow-up|1|||
125234520|NCT02472353|450486385|FG000|Overall Study|Withdrawal by Subject|2|||
125234521|NCT02472353|450486386|FG001|Overall Study|Withdrawal by Subject|1|||
125234522|NCT02472353|450486385|FG000|Overall Study|Study Termination|1|||
125234523|NCT02472353|450486386|FG001|Overall Study|Study Termination|4|||
125234524|NCT01129128|450486387|FG000|Overall Study|Lost to Follow-up|2|||
125234525|NCT01129128|450486388|FG001|Overall Study|Lost to Follow-up|2|||
125234526|NCT01129128|450486389|FG002|Overall Study|Lost to Follow-up|1|||
125234527|NCT01129128|450486387|FG000|Overall Study|Protocol Violation|0|||
125234528|NCT01129128|450486388|FG001|Overall Study|Protocol Violation|1|||
125234529|NCT01129128|450486389|FG002|Overall Study|Protocol Violation|0|||
125234530|NCT01129128|450486387|FG000|Overall Study|Withdrawal by Subject|0|||
125234531|NCT01129128|450486388|FG001|Overall Study|Withdrawal by Subject|1|||
125234532|NCT01129128|450486389|FG002|Overall Study|Withdrawal by Subject|3|||
125234533|NCT01129128|450486387|FG000|Overall Study|Physician Decision|1|||
125234534|NCT01129128|450486388|FG001|Overall Study|Physician Decision|0|||
125234535|NCT01129128|450486389|FG002|Overall Study|Physician Decision|0|||
125234536|NCT05722015|450486398|FG000|Overall Study|Death|57|||
125234537|NCT05722015|450486399|FG001|Overall Study|Death|37|||
125234538|NCT05722015|450486398|FG000|Overall Study|Lost to Follow-up|1|||
125234539|NCT05722015|450486399|FG001|Overall Study|Lost to Follow-up|0|||
125234540|NCT05722015|450486398|FG000|Overall Study|Withdrawal by Subject|5|||
125178564|NCT04604795|450272799|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125392314|NCT02404311|451070629|FG001|Part A: Month 0-18|Death|0|||
125392315|NCT02404311|451070630|FG002|Part A: Month 0-18|Death|0|||
125392316|NCT02404311|451070631|FG003|Part A: Month 0-18|Death|0|||
125178565|NCT04604795|450272800|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
125178566|NCT04604795|450272801|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
125178567|NCT04604795|450272792|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178568|NCT04604795|450272793|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178569|NCT04604795|450272794|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178570|NCT04604795|450272795|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178571|NCT04604795|450272796|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178572|NCT04604795|450272797|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178573|NCT04604795|450272798|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178574|NCT04604795|450272799|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178575|NCT04604795|450272800|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
125178576|NCT04604795|450272801|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
125178577|NCT04604795|450272792|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178578|NCT04604795|450272793|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178579|NCT04604795|450272794|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178580|NCT04604795|450272795|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178581|NCT04604795|450272796|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178582|NCT04604795|450272797|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178583|NCT04604795|450272798|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178584|NCT04604795|450272799|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178585|NCT04604795|450272800|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
125178586|NCT04604795|450272801|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
125178587|NCT00111241|450272809|FG000|Overall Study|Lost to Follow-up|1|||
125178588|NCT00111241|450272810|FG001|Overall Study|Lost to Follow-up|0|||
125178589|NCT00111241|450272809|FG000|Overall Study|Withdrawal by Subject|4|||
125178590|NCT00111241|450272810|FG001|Overall Study|Withdrawal by Subject|0|||
125178591|NCT00111241|450272809|FG000|Overall Study|Protocol Violation|9|||
125178592|NCT00111241|450272810|FG001|Overall Study|Protocol Violation|8|||
125178593|NCT00111241|450272809|FG000|Overall Study|Adverse Event|1|||
125178594|NCT00111241|450272810|FG001|Overall Study|Adverse Event|0|||
125178595|NCT02096744|450272811|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
125178596|NCT02096744|450272812|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
125178597|NCT02096744|450272811|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
125178598|NCT02096744|450272812|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
125178599|NCT02096744|450272811|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
125178600|NCT02096744|450272812|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
125178601|NCT00952731|450272818|FG000|Overall Study|Drug supply expired|1|||
125178602|NCT00952731|450272819|FG001|Overall Study|Drug supply expired|0|||
125178603|NCT01450683|450272820|FG000|Overall Study|Adverse Event|2|||
125178604|NCT02108912|450272821|FG000|Overall Study|Lost to Follow-up|1|||
125178605|NCT02108912|450272822|FG001|Overall Study|Lost to Follow-up|1|||
125178606|NCT02108912|450272821|FG000|Overall Study|lack of transportation|1|||
125178607|NCT02108912|450272822|FG001|Overall Study|lack of transportation|0|||
125178608|NCT02108912|450272821|FG000|Overall Study|high blood pressure|1|||
125178609|NCT02108912|450272822|FG001|Overall Study|high blood pressure|0|||
125178610|NCT00625872|450272823|FG000|Overall Study|Withdrawal by Subject|1|||
125178611|NCT00625872|450272824|FG001|Overall Study|Withdrawal by Subject|0|||
125178612|NCT00625872|450272823|FG000|Overall Study|Does not meet inclusion criteria|1|||
125178613|NCT00625872|450272824|FG001|Overall Study|Does not meet inclusion criteria|0|||
125178614|NCT00625872|450272823|FG000|Overall Study|Terminated by sponsor|2|||
125178615|NCT00625872|450272824|FG001|Overall Study|Terminated by sponsor|5|||
125178616|NCT00625872|450272823|FG000|Overall Study|Randomized but not treated|0|||
125178617|NCT00625872|450272824|FG001|Overall Study|Randomized but not treated|1|||
125178618|NCT00852202|450272825|FG000|Overall Study|Adverse Event|2|||
125178619|NCT00852202|450272826|FG001|Overall Study|Adverse Event|3|||
125178620|NCT00852202|450272827|FG002|Overall Study|Adverse Event|7|||
125178621|NCT00852202|450272825|FG000|Overall Study|Lack of Efficacy|4|||
125178622|NCT00852202|450272826|FG001|Overall Study|Lack of Efficacy|1|||
125178623|NCT00852202|450272827|FG002|Overall Study|Lack of Efficacy|2|||
125178624|NCT00852202|450272825|FG000|Overall Study|Protocol Violation|2|||
125178625|NCT00852202|450272826|FG001|Overall Study|Protocol Violation|2|||
125178626|NCT00852202|450272827|FG002|Overall Study|Protocol Violation|7|||
125178627|NCT00852202|450272825|FG000|Overall Study|Withdrawal by Subject|3|||
125178628|NCT00852202|450272826|FG001|Overall Study|Withdrawal by Subject|1|||
125392317|NCT02404311|451070632|FG004|Part A: Month 0-18|Death|0|||
125392318|NCT02404311|451070628|FG000|Part A: Month 0-18|Physician Decision|1|||
125178629|NCT00852202|450272827|FG002|Overall Study|Withdrawal by Subject|2|||
125178630|NCT00852202|450272825|FG000|Overall Study|Lost to Follow-up|5|||
125178631|NCT00852202|450272826|FG001|Overall Study|Lost to Follow-up|5|||
125234541|NCT05722015|450486399|FG001|Overall Study|Withdrawal by Subject|1|||
125234542|NCT05722015|450486398|FG000|Overall Study|Participants Ongoing|188|||
125234543|NCT05722015|450486399|FG001|Overall Study|Participants Ongoing|88|||
125234544|NCT04058717|450486400|FG000|Randomization Period|Lost to Follow-up|2|||
125234545|NCT04058717|450486401|FG001|Randomization Period|Lost to Follow-up|3|||
125234546|NCT04058717|450486402|FG002|Randomization Period|Lost to Follow-up|4|||
125234547|NCT04058717|450486403|FG003|Randomization Period|Lost to Follow-up|4|||
125234548|NCT04058717|450486400|FG000|Randomization Period|Withdrawal by Subject|1|||
125234549|NCT04058717|450486401|FG001|Randomization Period|Withdrawal by Subject|3|||
125234550|NCT04058717|450486402|FG002|Randomization Period|Withdrawal by Subject|3|||
125234551|NCT04058717|450486403|FG003|Randomization Period|Withdrawal by Subject|3|||
125234552|NCT04058717|450486400|FG000|Randomization Period|PI decision|0|||
125234553|NCT04058717|450486401|FG001|Randomization Period|PI decision|1|||
125234554|NCT04058717|450486402|FG002|Randomization Period|PI decision|0|||
125234555|NCT04058717|450486403|FG003|Randomization Period|PI decision|0|||
125234556|NCT00671788|450486404|FG000|Overall Study|Adverse Event|8|||
125234557|NCT00671788|450486404|FG000|Overall Study|Refused further treatment|3|||
125234558|NCT00671788|450486404|FG000|Overall Study|Ineligible|1|||
125234559|NCT00671788|450486404|FG000|Overall Study|MD Decision|1|||
125234560|NCT00671788|450486404|FG000|Overall Study|Other|1|||
125234561|NCT01832766|450486405|FG000|Washout|Lost to Follow-up|0|||
125234562|NCT01832766|450486406|FG001|Washout|Lost to Follow-up|1|||
125234563|NCT01925417|450486409|FG000|Overall Study|Withdrawal by Subject|2|||
125234564|NCT01925417|450486409|FG000|Overall Study|Death|1|||
125234565|NCT03479905|450486410|FG000|Overall Study|Other airway method used|4|||
125234566|NCT03479905|450486411|FG001|Overall Study|Other airway method used|5|||
125234567|NCT03479905|450486412|FG002|Overall Study|Other airway method used|5|||
125234568|NCT00720759|450486413|FG000|Overall Study|Lost to Follow-up|0|||
125234569|NCT00720759|450486414|FG001|Overall Study|Lost to Follow-up|1|||
125234570|NCT00720759|450486415|FG002|Overall Study|Lost to Follow-up|1|||
125234571|NCT00720759|450486416|FG003|Overall Study|Lost to Follow-up|0|||
125234572|NCT01047319|450486417|FG000|Overall Study|Teva requested participant withdrawal|3|||
125234573|NCT01047319|450486418|FG001|Overall Study|Teva requested participant withdrawal|0|||
125234574|NCT01047319|450486419|FG002|Overall Study|Teva requested participant withdrawal|1|||
125234575|NCT01047319|450486417|FG000|Overall Study|Protocol Violation|3|||
125234576|NCT01047319|450486418|FG001|Overall Study|Protocol Violation|2|||
125234577|NCT01047319|450486419|FG002|Overall Study|Protocol Violation|4|||
125234578|NCT01047319|450486417|FG000|Overall Study|Lack of Efficacy|4|||
125234579|NCT01047319|450486418|FG001|Overall Study|Lack of Efficacy|3|||
125234580|NCT01047319|450486419|FG002|Overall Study|Lack of Efficacy|3|||
125234581|NCT01047319|450486417|FG000|Overall Study|Death|5|||
125234582|NCT01047319|450486418|FG001|Overall Study|Death|1|||
125234583|NCT01047319|450486419|FG002|Overall Study|Death|5|||
125234584|NCT01047319|450486417|FG000|Overall Study|Pregnancy|13|||
125234585|NCT01047319|450486418|FG001|Overall Study|Pregnancy|8|||
125234586|NCT01047319|450486419|FG002|Overall Study|Pregnancy|8|||
125234587|NCT01047319|450486417|FG000|Overall Study|Physician Decision|12|||
125234588|NCT01047319|450486418|FG001|Overall Study|Physician Decision|9|||
125234589|NCT01047319|450486419|FG002|Overall Study|Physician Decision|10|||
125234590|NCT01047319|450486417|FG000|Overall Study|Lost to Follow-up|14|||
125234591|NCT01047319|450486418|FG001|Overall Study|Lost to Follow-up|10|||
125234592|NCT01047319|450486419|FG002|Overall Study|Lost to Follow-up|10|||
125234593|NCT01047319|450486417|FG000|Overall Study|Adverse Event|16|||
125234594|NCT01047319|450486418|FG001|Overall Study|Adverse Event|27|||
125234595|NCT01047319|450486419|FG002|Overall Study|Adverse Event|21|||
125234596|NCT01047319|450486417|FG000|Overall Study|Withdrawal by Subject|77|||
125234597|NCT01047319|450486418|FG001|Overall Study|Withdrawal by Subject|75|||
125234598|NCT01047319|450486419|FG002|Overall Study|Withdrawal by Subject|87|||
125234599|NCT01047319|450486417|FG000|Overall Study|Study terminated by Sponsor|198|||
125234600|NCT01047319|450486418|FG001|Overall Study|Study terminated by Sponsor|215|||
125234601|NCT01047319|450486419|FG002|Overall Study|Study terminated by Sponsor|203|||
125234602|NCT02598661|450486422|FG000|Overall Study|Death|27|||
125234603|NCT02598661|450486423|FG001|Overall Study|Death|34|||
125234604|NCT02598661|450486424|FG002|Overall Study|Death|14|||
125234605|NCT02598661|450486425|FG003|Overall Study|Death|1|||
125234606|NCT02598661|450486426|FG004|Overall Study|Death|0|||
125234607|NCT02598661|450486422|FG000|Overall Study|Lost to Follow-up|2|||
125234608|NCT02598661|450486423|FG001|Overall Study|Lost to Follow-up|3|||
125234609|NCT02598661|450486424|FG002|Overall Study|Lost to Follow-up|2|||
125234610|NCT02598661|450486425|FG003|Overall Study|Lost to Follow-up|0|||
125234611|NCT02598661|450486426|FG004|Overall Study|Lost to Follow-up|0|||
125234612|NCT02598661|450486422|FG000|Overall Study|Withdrawal by Subject|13|||
125234613|NCT02598661|450486423|FG001|Overall Study|Withdrawal by Subject|24|||
125234614|NCT02598661|450486424|FG002|Overall Study|Withdrawal by Subject|14|||
125234615|NCT02598661|450486425|FG003|Overall Study|Withdrawal by Subject|1|||
125234616|NCT02598661|450486426|FG004|Overall Study|Withdrawal by Subject|1|||
125234617|NCT02598661|450486422|FG000|Overall Study|Adverse Event|0|||
125234618|NCT02598661|450486423|FG001|Overall Study|Adverse Event|0|||
125234619|NCT02598661|450486424|FG002|Overall Study|Adverse Event|1|||
125234620|NCT02598661|450486425|FG003|Overall Study|Adverse Event|0|||
125234621|NCT02598661|450486426|FG004|Overall Study|Adverse Event|0|||
125234622|NCT02598661|450486422|FG000|Overall Study|Randomized, Never Treated|0|||
125234623|NCT02598661|450486423|FG001|Overall Study|Randomized, Never Treated|0|||
125234624|NCT02598661|450486424|FG002|Overall Study|Randomized, Never Treated|0|||
125234625|NCT02598661|450486425|FG003|Overall Study|Randomized, Never Treated|0|||
125234626|NCT02598661|450486426|FG004|Overall Study|Randomized, Never Treated|1|||
125234627|NCT01366092|450486427|FG000|Overall Study|Progressive cGVHD|2|||
125234628|NCT01366092|450486427|FG000|Overall Study|Physician Decision|1|||
125234629|NCT01366092|450486427|FG000|Overall Study|Withdrawal by Subject|1|||
125234630|NCT03074500|450486428|FG000|Overall Study|Lost to Follow-up|1|||
125234631|NCT03074500|450486429|FG001|Overall Study|Lost to Follow-up|0|||
125234632|NCT03074500|450486430|FG002|Overall Study|Lost to Follow-up|0|||
125234633|NCT03074500|450486428|FG000|Overall Study|Lack of Efficacy|0|||
125234634|NCT03074500|450486429|FG001|Overall Study|Lack of Efficacy|1|||
125234635|NCT03074500|450486430|FG002|Overall Study|Lack of Efficacy|0|||
125234636|NCT03074500|450486428|FG000|Overall Study|Adverse Event|0|||
125234637|NCT03074500|450486429|FG001|Overall Study|Adverse Event|0|||
125234638|NCT03074500|450486430|FG002|Overall Study|Adverse Event|1|||
125234639|NCT03608163|450486431|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
125234640|NCT03608163|450486432|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
125234641|NCT03836053|450487701|FG000|Overall Study|Protocol-specified criteria|0|||
125234642|NCT03836053|450487702|FG001|Overall Study|Protocol-specified criteria|2|||
125234643|NCT03836053|450487703|FG002|Overall Study|Protocol-specified criteria|1|||
125234644|NCT03836053|450487701|FG000|Overall Study|Death|1|||
125234645|NCT03836053|450487702|FG001|Overall Study|Death|6|||
125234646|NCT03836053|450487703|FG002|Overall Study|Death|4|||
125234647|NCT03836053|450487701|FG000|Overall Study|Withdrawal of consent from study|0|||
125234648|NCT03836053|450487702|FG001|Overall Study|Withdrawal of consent from study|0|||
125234649|NCT03836053|450487703|FG002|Overall Study|Withdrawal of consent from study|1|||
125234650|NCT03836053|450487701|FG000|Overall Study|Decision by sponsor|0|||
125234651|NCT03836053|450487702|FG001|Overall Study|Decision by sponsor|2|||
125234652|NCT03836053|450487703|FG002|Overall Study|Decision by sponsor|4|||
125234653|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
125234654|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
125234655|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
125234656|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Death|1|||
125234657|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Death|1|||
125234658|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Death|0|||
125234659|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
125234660|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
125234661|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
125234662|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
125234663|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
125234664|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
125234665|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
125234666|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
125234667|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
125234668|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
125234669|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
125234670|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
125234671|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
125234672|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
125234673|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
125234674|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
125234675|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
125234676|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
125234677|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
125234678|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
125234679|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
125234680|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
125234681|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
125234682|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
125234683|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Other|10|||
125234684|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Other|4|||
125234685|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Other|0|||
125234686|NCT04006457|450487704|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
125234687|NCT04006457|450487705|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
125234688|NCT04006457|450487706|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
125234689|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
125234690|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
125234691|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
125234692|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
125234693|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
125178632|NCT00852202|450272827|FG002|Overall Study|Lost to Follow-up|6|||
125178633|NCT00852202|450272825|FG000|Overall Study|pregnancy,moving away and surgery|1|||
125234694|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
125234695|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
125234696|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
125234697|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
125234698|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
125234699|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
125234700|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
125234701|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
125234702|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
125234703|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
125234704|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Other|2|||
125234705|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Other|3|||
125234706|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Other|0|||
125234707|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
125234708|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
125234709|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
125234710|NCT04006457|450487704|FG000|Main Study: Treatment Period 2|Ongoing|86|||
125234711|NCT04006457|450487705|FG001|Main Study: Treatment Period 2|Ongoing|96|||
125234712|NCT04006457|450487706|FG002|Main Study: Treatment Period 2|Ongoing|0|||
125234713|NCT04006457|450487704|FG000|Main Study Observation Period|Adverse Event|1|||
125234714|NCT04006457|450487705|FG001|Main Study Observation Period|Adverse Event|1|||
125234715|NCT04006457|450487706|FG002|Main Study Observation Period|Adverse Event|0|||
125234716|NCT04006457|450487704|FG000|Main Study Observation Period|Lost to Follow-up|0|||
125234717|NCT04006457|450487705|FG001|Main Study Observation Period|Lost to Follow-up|1|||
125234718|NCT04006457|450487706|FG002|Main Study Observation Period|Lost to Follow-up|0|||
125234719|NCT04006457|450487704|FG000|Main Study Observation Period|Pregnancy|1|||
125234720|NCT04006457|450487705|FG001|Main Study Observation Period|Pregnancy|0|||
125234721|NCT04006457|450487706|FG002|Main Study Observation Period|Pregnancy|0|||
125234722|NCT04006457|450487704|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
125234723|NCT04006457|450487705|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
125234724|NCT04006457|450487706|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
125234725|NCT04006457|450487704|FG000|Main Study Observation Period|Other|8|||
125234726|NCT04006457|450487705|FG001|Main Study Observation Period|Other|16|||
125234727|NCT04006457|450487706|FG002|Main Study Observation Period|Other|0|||
125234728|NCT04006457|450487704|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
125234729|NCT04006457|450487705|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
125234730|NCT04006457|450487706|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
125234731|NCT04006457|450487704|FG000|Main Study Observation Period|Ongoing|2|||
125234732|NCT04006457|450487705|FG001|Main Study Observation Period|Ongoing|1|||
125234733|NCT04006457|450487706|FG002|Main Study Observation Period|Ongoing|0|||
125234734|NCT04006457|450487704|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
125178634|NCT00852202|450272826|FG001|Overall Study|pregnancy,moving away and surgery|0|||
125178635|NCT00852202|450272827|FG002|Overall Study|pregnancy,moving away and surgery|2|||
125178636|NCT05022212|450272830|FG000|Overall Study|Lost to Follow-up|0|||
125178637|NCT05022212|450272831|FG001|Overall Study|Lost to Follow-up|2|||
125178638|NCT01682811|450272832|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
125178639|NCT01682811|450272833|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
125178640|NCT01682811|450272834|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
125178641|NCT01682811|450272835|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
125178642|NCT01682811|450272836|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
125178643|NCT01682811|450272837|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
125178644|NCT01682811|450272838|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
125178645|NCT01682811|450272832|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
125178646|NCT01682811|450272833|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
125178647|NCT01682811|450272834|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
125178648|NCT01682811|450272835|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
125234735|NCT04006457|450487705|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
125234736|NCT04006457|450487706|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
125234737|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
125178649|NCT01682811|450272836|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
125178650|NCT01682811|450272837|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
125178651|NCT01682811|450272838|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
125178652|NCT01682811|450272832|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
125178653|NCT01682811|450272833|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
125234738|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
125178654|NCT01682811|450272834|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
125234739|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
125234740|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
125234741|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
125234742|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
125234743|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
125234744|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
125234745|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
125234746|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
125234747|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
125234748|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
125234749|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
125234750|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
125234751|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
125234752|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
125234753|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
125234754|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
125234755|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
125234756|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
125234757|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
125234758|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
125234759|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
125234760|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
125234761|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
125234762|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
125234763|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
125234764|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
125234765|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
125234766|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
125234767|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
125234768|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
125234769|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
125234770|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
125234771|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
125234772|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
125234773|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
125234774|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
125234775|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
125234776|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
125234777|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
125234778|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
125234779|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
125234780|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
125234781|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
125234782|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
125234783|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
125234784|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
125234785|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
125234786|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
125234787|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
125234788|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
125234789|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
125234790|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
125234791|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
125234792|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
125234793|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
125234794|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
125234795|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
125392319|NCT02404311|451070629|FG001|Part A: Month 0-18|Physician Decision|0|||
125392320|NCT02404311|451070630|FG002|Part A: Month 0-18|Physician Decision|0|||
125392321|NCT02404311|451070631|FG003|Part A: Month 0-18|Physician Decision|0|||
125392322|NCT02404311|451070632|FG004|Part A: Month 0-18|Physician Decision|0|||
125392323|NCT02404311|451070628|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
125234796|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
125234797|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
125234798|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
125234799|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
125234800|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
125234801|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
125234802|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
125234803|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
125234804|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
125234805|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
125234806|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
125234807|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
125234808|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
125234809|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
125234810|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
125234811|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
125234812|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
125234813|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
125234814|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
125234815|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
125234816|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
125234817|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
125234818|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
125234819|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
125234820|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
125234821|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
125234822|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
125234823|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
125234824|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
125234825|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
125234826|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
125234827|NCT00090103|450487713|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
125234828|NCT00090103|450487714|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
125234829|NCT00090103|450487715|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
125234830|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
125234831|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
125234832|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
125234833|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
125234834|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
125234835|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
125234836|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
125234837|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
125234838|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
125234839|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
125234840|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
125234841|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
125234842|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
125234843|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
125234844|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
125234845|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
125234846|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
125234847|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
125234848|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
125234849|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
125234850|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
125234851|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
125234852|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
125234853|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
125234854|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
125234855|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
125234856|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
125234857|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
125234858|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
125234859|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
125234860|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
125234861|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
125234862|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
125234863|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
125234864|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
125234865|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
125234866|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
125234867|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
125234868|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
125234869|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
125234870|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
125234871|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
125234872|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
125234873|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
125234874|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
125234875|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
125234876|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
125234877|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
125234878|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Death|1|||
125234879|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Death|0|||
125234880|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Death|1|||
125234881|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
125234882|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
125234883|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
125234884|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
125234885|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
125234886|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
125234887|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
125234888|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
125234889|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
125234890|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
125234891|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
125234892|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
125234893|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
125234894|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
125234895|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
125234896|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
125234897|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
125234898|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
125234899|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
125234900|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
125234901|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
125234902|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Depression|0|||
125234903|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Depression|1|||
125234904|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Depression|0|||
125234905|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
125234906|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
125234907|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
125234908|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Jailed|0|||
125234909|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Jailed|1|||
125234910|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Jailed|0|||
125234911|NCT00090103|450487713|FG000|16-Week Safety Follow-up Period|Other|0|||
125234912|NCT00090103|450487714|FG001|16-Week Safety Follow-up Period|Other|1|||
125234913|NCT00090103|450487715|FG002|16-Week Safety Follow-up Period|Other|0|||
125234914|NCT04476043|450487716|FG000|Overall Study|Withdrawal by Subject|1|||
125234915|NCT04476043|450487717|FG001|Overall Study|Withdrawal by Subject|3|||
125234916|NCT04476043|450487718|FG002|Overall Study|Withdrawal by Subject|4|||
125234917|NCT04476043|450487719|FG003|Overall Study|Withdrawal by Subject|1|||
125234918|NCT04476043|450487716|FG000|Overall Study|Lost to Follow-up|1|||
125234919|NCT04476043|450487717|FG001|Overall Study|Lost to Follow-up|1|||
125234920|NCT04476043|450487718|FG002|Overall Study|Lost to Follow-up|2|||
125234921|NCT04476043|450487719|FG003|Overall Study|Lost to Follow-up|1|||
125234922|NCT04476043|450487716|FG000|Overall Study|Adverse Event|2|||
125234923|NCT04476043|450487717|FG001|Overall Study|Adverse Event|0|||
125234924|NCT04476043|450487718|FG002|Overall Study|Adverse Event|1|||
125234925|NCT04476043|450487719|FG003|Overall Study|Adverse Event|0|||
125234926|NCT04476043|450487716|FG000|Overall Study|Protocol Violation|0|||
125234927|NCT04476043|450487717|FG001|Overall Study|Protocol Violation|1|||
125234928|NCT04476043|450487718|FG002|Overall Study|Protocol Violation|0|||
125234929|NCT04476043|450487719|FG003|Overall Study|Protocol Violation|0|||
125234930|NCT02194465|450487722|FG000|Overall Study|Adverse Event|6|||
125234931|NCT02194465|450487723|FG001|Overall Study|Adverse Event|1|||
125234932|NCT02194465|450487724|FG002|Overall Study|Adverse Event|4|||
125234933|NCT02194465|450487725|FG003|Overall Study|Adverse Event|4|||
125234934|NCT02194465|450487726|FG004|Overall Study|Adverse Event|4|||
125234935|NCT02194465|450487727|FG005|Overall Study|Adverse Event|2|||
125234936|NCT02194465|450487728|FG006|Overall Study|Adverse Event|0|||
125234937|NCT02194465|450487722|FG000|Overall Study|Lost to Follow-up|0|||
125234938|NCT02194465|450487723|FG001|Overall Study|Lost to Follow-up|0|||
125234939|NCT02194465|450487724|FG002|Overall Study|Lost to Follow-up|0|||
125234940|NCT02194465|450487725|FG003|Overall Study|Lost to Follow-up|1|||
125234941|NCT02194465|450487726|FG004|Overall Study|Lost to Follow-up|0|||
125234942|NCT02194465|450487727|FG005|Overall Study|Lost to Follow-up|1|||
125234943|NCT02194465|450487728|FG006|Overall Study|Lost to Follow-up|0|||
125234944|NCT02194465|450487722|FG000|Overall Study|Physician Decision|1|||
125234945|NCT02194465|450487723|FG001|Overall Study|Physician Decision|0|||
125234946|NCT02194465|450487724|FG002|Overall Study|Physician Decision|0|||
125234947|NCT02194465|450487725|FG003|Overall Study|Physician Decision|0|||
125234948|NCT02194465|450487726|FG004|Overall Study|Physician Decision|0|||
125234949|NCT02194465|450487727|FG005|Overall Study|Physician Decision|0|||
125234950|NCT02194465|450487728|FG006|Overall Study|Physician Decision|0|||
125234951|NCT02194465|450487722|FG000|Overall Study|Protocol Violation|1|||
125234952|NCT02194465|450487723|FG001|Overall Study|Protocol Violation|1|||
125234953|NCT02194465|450487724|FG002|Overall Study|Protocol Violation|2|||
125234954|NCT02194465|450487725|FG003|Overall Study|Protocol Violation|1|||
125234955|NCT02194465|450487726|FG004|Overall Study|Protocol Violation|1|||
125234956|NCT02194465|450487727|FG005|Overall Study|Protocol Violation|0|||
125234957|NCT02194465|450487728|FG006|Overall Study|Protocol Violation|0|||
125234958|NCT02194465|450487722|FG000|Overall Study|Withdrawal by Subject|1|||
125234959|NCT02194465|450487723|FG001|Overall Study|Withdrawal by Subject|3|||
125234960|NCT02194465|450487724|FG002|Overall Study|Withdrawal by Subject|1|||
125234961|NCT02194465|450487725|FG003|Overall Study|Withdrawal by Subject|2|||
125234962|NCT02194465|450487726|FG004|Overall Study|Withdrawal by Subject|2|||
125234963|NCT02194465|450487727|FG005|Overall Study|Withdrawal by Subject|1|||
125234964|NCT02194465|450487728|FG006|Overall Study|Withdrawal by Subject|2|||
125234965|NCT02194465|450487722|FG000|Overall Study|Discontinued follow-up period|0|||
125234966|NCT02194465|450487723|FG001|Overall Study|Discontinued follow-up period|2|||
125234967|NCT02194465|450487724|FG002|Overall Study|Discontinued follow-up period|1|||
125234968|NCT02194465|450487725|FG003|Overall Study|Discontinued follow-up period|0|||
125392324|NCT02404311|451070629|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
125392325|NCT02404311|451070630|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
125178655|NCT01682811|450272835|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
125178656|NCT01682811|450272836|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
125178657|NCT01682811|450272837|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
125178658|NCT01682811|450272838|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
125178659|NCT01682811|450272832|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
125178660|NCT01682811|450272833|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
125178661|NCT01682811|450272834|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
125178662|NCT01682811|450272835|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
125178663|NCT01682811|450272836|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
125178664|NCT01682811|450272837|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
125178665|NCT01682811|450272838|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
125178666|NCT02694328|450272839|FG000|Overall Study|Adverse Event|27|||
125178667|NCT02694328|450272840|FG001|Overall Study|Adverse Event|33|||
125178668|NCT02694328|450272839|FG000|Overall Study|Withdrawal by Subject|27|||
125178669|NCT02694328|450272840|FG001|Overall Study|Withdrawal by Subject|23|||
125178670|NCT02694328|450272839|FG000|Overall Study|Lost to Follow-up|26|||
125178671|NCT02694328|450272840|FG001|Overall Study|Lost to Follow-up|22|||
125178672|NCT02694328|450272839|FG000|Overall Study|Noncompliant with study drug|11|||
125178673|NCT02694328|450272840|FG001|Overall Study|Noncompliant with study drug|8|||
125178674|NCT02694328|450272839|FG000|Overall Study|Incarceration|1|||
125178675|NCT02694328|450272840|FG001|Overall Study|Incarceration|1|||
125178676|NCT02694328|450272839|FG000|Overall Study|Lack of Efficacy|1|||
125178677|NCT02694328|450272840|FG001|Overall Study|Lack of Efficacy|2|||
125178678|NCT02694328|450272839|FG000|Overall Study|Pregnancy|1|||
125178679|NCT02694328|450272840|FG001|Overall Study|Pregnancy|1|||
125178680|NCT02694328|450272839|FG000|Overall Study|Protocol Violation|6|||
125234969|NCT02194465|450487726|FG004|Overall Study|Discontinued follow-up period|2|||
125234970|NCT02194465|450487727|FG005|Overall Study|Discontinued follow-up period|0|||
125234971|NCT02194465|450487728|FG006|Overall Study|Discontinued follow-up period|0|||
125234972|NCT01408641|450487729|FG000|Overall Study|Physician Decision|1|||
125178681|NCT02694328|450272840|FG001|Overall Study|Protocol Violation|5|||
125178682|NCT02694328|450272839|FG000|Overall Study|Abnormal Laboratory Value|0|||
125234973|NCT01408641|450487730|FG001|Overall Study|Physician Decision|0|||
125234974|NCT03979313|450487731|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
125392326|NCT02404311|451070631|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
125178683|NCT02694328|450272840|FG001|Overall Study|Abnormal Laboratory Value|3|||
125178684|NCT02514447|450274778|FG000|Overall Study|Withdrawal by Subject|3|||
125178685|NCT02514447|450274779|FG001|Overall Study|Withdrawal by Subject|1|||
125178686|NCT02514447|450274780|FG002|Overall Study|Withdrawal by Subject|1|||
125178687|NCT02514447|450274781|FG003|Overall Study|Withdrawal by Subject|0|||
125178688|NCT02514447|450274782|FG004|Overall Study|Withdrawal by Subject|0|||
125178689|NCT02514447|450274783|FG005|Overall Study|Withdrawal by Subject|0|||
125178690|NCT02514447|450274784|FG006|Overall Study|Withdrawal by Subject|0|||
125178691|NCT02514447|450274785|FG007|Overall Study|Withdrawal by Subject|1|||
125178692|NCT02514447|450274786|FG008|Overall Study|Withdrawal by Subject|1|||
125178693|NCT02514447|450274778|FG000|Overall Study|Death|24|||
125178694|NCT02514447|450274779|FG001|Overall Study|Death|28|||
125178695|NCT02514447|450274780|FG002|Overall Study|Death|29|||
125178696|NCT02514447|450274781|FG003|Overall Study|Death|0|||
125178697|NCT02514447|450274782|FG004|Overall Study|Death|3|||
125178698|NCT02514447|450274783|FG005|Overall Study|Death|4|||
125178699|NCT02514447|450274784|FG006|Overall Study|Death|8|||
125178700|NCT02514447|450274785|FG007|Overall Study|Death|6|||
125178701|NCT02514447|450274786|FG008|Overall Study|Death|5|||
125178702|NCT02514447|450274778|FG000|Overall Study|Lost to Follow-up|1|||
125178703|NCT02514447|450274779|FG001|Overall Study|Lost to Follow-up|0|||
125178704|NCT02514447|450274780|FG002|Overall Study|Lost to Follow-up|0|||
125178705|NCT02514447|450274781|FG003|Overall Study|Lost to Follow-up|0|||
125178706|NCT02514447|450274782|FG004|Overall Study|Lost to Follow-up|0|||
125178707|NCT02514447|450274783|FG005|Overall Study|Lost to Follow-up|0|||
125178708|NCT02514447|450274784|FG006|Overall Study|Lost to Follow-up|0|||
125178709|NCT02514447|450274785|FG007|Overall Study|Lost to Follow-up|0|||
125178710|NCT02514447|450274786|FG008|Overall Study|Lost to Follow-up|1|||
125178711|NCT02514447|450274778|FG000|Overall Study|Sponsor Termination of Study|0|||
125178712|NCT02514447|450274779|FG001|Overall Study|Sponsor Termination of Study|1|||
125178713|NCT02514447|450274780|FG002|Overall Study|Sponsor Termination of Study|1|||
125178714|NCT02514447|450274781|FG003|Overall Study|Sponsor Termination of Study|0|||
125178715|NCT02514447|450274782|FG004|Overall Study|Sponsor Termination of Study|0|||
125178716|NCT02514447|450274783|FG005|Overall Study|Sponsor Termination of Study|0|||
125178717|NCT02514447|450274784|FG006|Overall Study|Sponsor Termination of Study|0|||
125178718|NCT02514447|450274785|FG007|Overall Study|Sponsor Termination of Study|0|||
125178719|NCT02514447|450274786|FG008|Overall Study|Sponsor Termination of Study|0|||
125178720|NCT02514447|450274778|FG000|Overall Study|Study completion per Investigator|1|||
125178721|NCT02514447|450274779|FG001|Overall Study|Study completion per Investigator|0|||
125178722|NCT02514447|450274780|FG002|Overall Study|Study completion per Investigator|1|||
125178723|NCT02514447|450274781|FG003|Overall Study|Study completion per Investigator|2|||
125178724|NCT02514447|450274782|FG004|Overall Study|Study completion per Investigator|0|||
125178725|NCT02514447|450274783|FG005|Overall Study|Study completion per Investigator|0|||
125178726|NCT02514447|450274784|FG006|Overall Study|Study completion per Investigator|0|||
125178727|NCT02514447|450274785|FG007|Overall Study|Study completion per Investigator|0|||
125178728|NCT02514447|450274786|FG008|Overall Study|Study completion per Investigator|1|||
125178729|NCT02731638|450274791|FG000|Overall Study|Lost to Follow-up|6|||
125178730|NCT02731638|450274792|FG001|Overall Study|Lost to Follow-up|9|||
125178731|NCT05626231|450274793|FG000|Provider Enrollment|Worked part-time|4|||
125178732|NCT05626231|450274793|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
125178733|NCT05626231|450274793|FG000|Provider Enrollment|Non-clinical employee|1|||
125178734|NCT05626231|450274793|FG000|Provider Enrollment|Provider does not see clients|3|||
125178735|NCT05626231|450274793|FG000|Provider Enrollment|Other|5|||
125178736|NCT05878093|450274794|FG000|Overall Study|Withdrawal by Subject|3|||
125178737|NCT05878093|450274795|FG001|Overall Study|Withdrawal by Subject|1|||
125178738|NCT04995029|450274796|FG000|Induction Phase|Did not meet eligibility criteria|5|||
125178739|NCT04995029|450274797|FG001|Induction Phase|Did not meet eligibility criteria|2|||
125178740|NCT04995029|450274798|FG002|Induction Phase|Did not meet eligibility criteria|0|||
125178741|NCT04995029|450274799|FG003|Induction Phase|Did not meet eligibility criteria|0|||
125178742|NCT04995029|450274796|FG000|Induction Phase|Withdrawal by Subject|85|||
125178743|NCT04995029|450274797|FG001|Induction Phase|Withdrawal by Subject|42|||
125178744|NCT04995029|450274798|FG002|Induction Phase|Withdrawal by Subject|0|||
125178745|NCT04995029|450274799|FG003|Induction Phase|Withdrawal by Subject|0|||
125178746|NCT04995029|450274796|FG000|Induction Phase|Lost to Follow-up|103|||
125178747|NCT04995029|450274797|FG001|Induction Phase|Lost to Follow-up|67|||
125178748|NCT04995029|450274798|FG002|Induction Phase|Lost to Follow-up|0|||
125178749|NCT04995029|450274799|FG003|Induction Phase|Lost to Follow-up|0|||
125178750|NCT04995029|450274796|FG000|Induction Phase|Adverse Event|5|||
125178751|NCT04995029|450274797|FG001|Induction Phase|Adverse Event|3|||
125178752|NCT04995029|450274798|FG002|Induction Phase|Adverse Event|0|||
125178753|NCT04995029|450274799|FG003|Induction Phase|Adverse Event|0|||
125178754|NCT04995029|450274796|FG000|Induction Phase|Physician Decision|11|||
125178755|NCT04995029|450274797|FG001|Induction Phase|Physician Decision|8|||
125178756|NCT04995029|450274798|FG002|Induction Phase|Physician Decision|0|||
125178757|NCT04995029|450274799|FG003|Induction Phase|Physician Decision|0|||
125178758|NCT04995029|450274796|FG000|Induction Phase|Incarceration|6|||
125234975|NCT03979313|450487732|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
125234976|NCT03979313|450487731|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
125234977|NCT03979313|450487732|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
125234978|NCT03979313|450487731|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
125234979|NCT03979313|450487732|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
125234980|NCT03979313|450487731|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
125234981|NCT03979313|450487732|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
125234982|NCT03979313|450487731|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
125234983|NCT03979313|450487732|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
125234984|NCT03979313|450487731|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
125234985|NCT03979313|450487732|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
125234986|NCT03979313|450487731|FG000|All Subjects|Any Other Reason|16|||
125234987|NCT03979313|450487732|FG001|All Subjects|Any Other Reason|23|||
125234988|NCT03979313|450487731|FG000|All Subjects|Covid-19|1|||
125234989|NCT03979313|450487732|FG001|All Subjects|Covid-19|3|||
125234990|NCT03979313|450487731|FG000|All Subjects|Withdrawal by Subject|35|||
125234991|NCT03979313|450487732|FG001|All Subjects|Withdrawal by Subject|44|||
125234992|NCT03979313|450487731|FG000|All Subjects|Death|0|||
125234993|NCT03979313|450487732|FG001|All Subjects|Death|5|||
125234994|NCT03979313|450487731|FG000|All Subjects|Lost to Follow-up|28|||
125234995|NCT03979313|450487732|FG001|All Subjects|Lost to Follow-up|61|||
125234996|NCT00089648|450487733|FG000|Overall Study|Adverse Event|7|||
125234997|NCT00089648|450487733|FG000|Overall Study|Withdrawal by Subject|1|||
125234998|NCT00089648|450487733|FG000|Overall Study|Lack of Efficacy|33|||
125234999|NCT00423605|450487734|FG000|Overall Study|Adverse Event|129|||
125235000|NCT00423605|450487734|FG000|Overall Study|Withdrawal by Subject|36|||
125235001|NCT00423605|450487734|FG000|Overall Study|Lost to Follow-up|15|||
125235002|NCT00423605|450487734|FG000|Overall Study|Lack of Efficacy|38|||
125235003|NCT00423605|450487734|FG000|Overall Study|Sponsor Decision|3|||
125235004|NCT00423605|450487734|FG000|Overall Study|Physician Decision|8|||
125235005|NCT00423605|450487734|FG000|Overall Study|Protocol Violation|7|||
125235006|NCT00423605|450487734|FG000|Overall Study|Not one of the pre-specified options|5|||
125235007|NCT03183908|450487737|FG000|Overall Study|Missing Symptom Diary Data|0|||
125235008|NCT03183908|450487738|FG001|Overall Study|Missing Symptom Diary Data|2|||
125235009|NCT01240746|450487742|FG000|Overall Study|Adverse Event|2|||
125235010|NCT01240746|450487743|FG001|Overall Study|Adverse Event|0|||
125235011|NCT01240746|450487744|FG002|Overall Study|Adverse Event|10|||
125235012|NCT01240746|450487742|FG000|Overall Study|Lost to Follow-up|23|||
125235013|NCT01240746|450487743|FG001|Overall Study|Lost to Follow-up|20|||
125235014|NCT01240746|450487744|FG002|Overall Study|Lost to Follow-up|102|||
125235015|NCT01240746|450487742|FG000|Overall Study|Protocol Violation|24|||
125235016|NCT01240746|450487743|FG001|Overall Study|Protocol Violation|15|||
125235017|NCT01240746|450487744|FG002|Overall Study|Protocol Violation|72|||
125235018|NCT01240746|450487742|FG000|Overall Study|Withdrawal by Subject|10|||
125392327|NCT02404311|451070632|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
125392328|NCT02404311|451070628|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
125392329|NCT02404311|451070629|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
125392330|NCT02404311|451070630|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
125178759|NCT04995029|450274797|FG001|Induction Phase|Incarceration|3|||
125178760|NCT04995029|450274798|FG002|Induction Phase|Incarceration|0|||
125178761|NCT04995029|450274799|FG003|Induction Phase|Incarceration|0|||
125178762|NCT04995029|450274796|FG000|Induction Phase|Not otherwise described|5|||
125178763|NCT04995029|450274797|FG001|Induction Phase|Not otherwise described|5|||
125178764|NCT04995029|450274798|FG002|Induction Phase|Not otherwise described|0|||
125178765|NCT04995029|450274799|FG003|Induction Phase|Not otherwise described|0|||
125178766|NCT04995029|450274796|FG000|Maintenance Phase|Lost to Follow-up|0|||
125178767|NCT04995029|450274797|FG001|Maintenance Phase|Lost to Follow-up|0|||
125178768|NCT04995029|450274798|FG002|Maintenance Phase|Lost to Follow-up|51|||
125178769|NCT04995029|450274799|FG003|Maintenance Phase|Lost to Follow-up|44|||
125178770|NCT04995029|450274796|FG000|Maintenance Phase|Did not meet eligibility criteria|0|||
125178771|NCT04995029|450274797|FG001|Maintenance Phase|Did not meet eligibility criteria|0|||
125178772|NCT04995029|450274798|FG002|Maintenance Phase|Did not meet eligibility criteria|0|||
125178773|NCT04995029|450274799|FG003|Maintenance Phase|Did not meet eligibility criteria|1|||
125178774|NCT04995029|450274796|FG000|Maintenance Phase|Adverse Event|0|||
125178775|NCT04995029|450274797|FG001|Maintenance Phase|Adverse Event|0|||
125178776|NCT04995029|450274798|FG002|Maintenance Phase|Adverse Event|0|||
125178777|NCT04995029|450274799|FG003|Maintenance Phase|Adverse Event|1|||
125178778|NCT04995029|450274796|FG000|Maintenance Phase|Physician Decision|0|||
125178779|NCT04995029|450274797|FG001|Maintenance Phase|Physician Decision|0|||
125178780|NCT04995029|450274798|FG002|Maintenance Phase|Physician Decision|8|||
125178781|NCT04995029|450274799|FG003|Maintenance Phase|Physician Decision|4|||
125178782|NCT04995029|450274796|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125235019|NCT01240746|450487743|FG001|Overall Study|Withdrawal by Subject|13|||
125235020|NCT01240746|450487744|FG002|Overall Study|Withdrawal by Subject|59|||
125235021|NCT03738696|450487745|FG000|Overall Study|Withdrawal by Subject|0|||
125235022|NCT03738696|450487746|FG001|Overall Study|Withdrawal by Subject|1|||
125178783|NCT04995029|450274797|FG001|Maintenance Phase|Withdrawal by Subject|0|||
125178784|NCT04995029|450274798|FG002|Maintenance Phase|Withdrawal by Subject|17|||
125178785|NCT04995029|450274799|FG003|Maintenance Phase|Withdrawal by Subject|31|||
125178786|NCT04995029|450274796|FG000|Maintenance Phase|Incarceration|0|||
125178787|NCT04995029|450274797|FG001|Maintenance Phase|Incarceration|0|||
125178788|NCT04995029|450274798|FG002|Maintenance Phase|Incarceration|4|||
125178789|NCT04995029|450274799|FG003|Maintenance Phase|Incarceration|3|||
125178790|NCT04995029|450274796|FG000|Maintenance Phase|Not otherwise described|0|||
125178791|NCT04995029|450274797|FG001|Maintenance Phase|Not otherwise described|0|||
125178792|NCT04995029|450274798|FG002|Maintenance Phase|Not otherwise described|2|||
125178793|NCT04995029|450274799|FG003|Maintenance Phase|Not otherwise described|3|||
125178794|NCT04995029|450274796|FG000|Maintenance Phase|Pregnancy|0|||
125178795|NCT04995029|450274797|FG001|Maintenance Phase|Pregnancy|0|||
125178796|NCT04995029|450274798|FG002|Maintenance Phase|Pregnancy|2|||
125178797|NCT04995029|450274799|FG003|Maintenance Phase|Pregnancy|2|||
125178798|NCT03690388|450274802|FG000|Overall Study|Adverse Event|8|||
125178799|NCT03690388|450274803|FG001|Overall Study|Adverse Event|1|||
125178800|NCT03690388|450274802|FG000|Overall Study|Radiographic Progression|14|||
125178801|NCT03690388|450274803|FG001|Overall Study|Radiographic Progression|29|||
125178802|NCT03690388|450274802|FG000|Overall Study|Clinical deterioration|10|||
125178803|NCT03690388|450274803|FG001|Overall Study|Clinical deterioration|6|||
125178804|NCT03690388|450274802|FG000|Overall Study|Withdrawal by Subject|2|||
125178805|NCT03690388|450274803|FG001|Overall Study|Withdrawal by Subject|0|||
125178806|NCT03690388|450274802|FG000|Overall Study|Lack of Efficacy|1|||
125178807|NCT03690388|450274803|FG001|Overall Study|Lack of Efficacy|0|||
125178808|NCT03690388|450274802|FG000|Overall Study|Lost to Follow-up|1|||
125178809|NCT03690388|450274803|FG001|Overall Study|Lost to Follow-up|0|||
125178810|NCT04100018|450274805|FG000|Pre-Treatment Period|Not Reported|0|||
125178811|NCT04100018|450274806|FG001|Pre-Treatment Period|Not Reported|4|||
125178812|NCT04100018|450274805|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
125178813|NCT04100018|450274806|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
125178814|NCT04100018|450274805|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
125178815|NCT04100018|450274806|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
125178816|NCT04100018|450274805|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
125178817|NCT04100018|450274806|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
125178818|NCT04100018|450274805|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
125178819|NCT04100018|450274806|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
125178820|NCT04100018|450274805|FG000|Treatment Period|Ongoing Treatment|1|||
125178821|NCT04100018|450274806|FG001|Treatment Period|Ongoing Treatment|0|||
125178822|NCT04100018|450274805|FG000|Treatment Period|Other Reason|26|||
125178823|NCT04100018|450274806|FG001|Treatment Period|Other Reason|37|||
125178824|NCT04100018|450274805|FG000|Treatment Period|Completed treatment as per protocol|1|||
125178825|NCT04100018|450274806|FG001|Treatment Period|Completed treatment as per protocol|2|||
125178826|NCT04100018|450274805|FG000|Treatment Period|Maximum clinical benefit|3|||
125178827|NCT04100018|450274806|FG001|Treatment Period|Maximum clinical benefit|0|||
125178828|NCT04100018|450274805|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
125178829|NCT04100018|450274806|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
125178830|NCT04100018|450274805|FG000|Treatment Period|Study drug toxicity|67|||
125178831|NCT04100018|450274806|FG001|Treatment Period|Study drug toxicity|28|||
125178832|NCT04100018|450274805|FG000|Treatment Period|Disease Progression|284|||
125178833|NCT04100018|450274806|FG001|Treatment Period|Disease Progression|327|||
125178834|NCT04100018|450274805|FG000|Treatment Period|Administrative reasons by sponsor|16|||
125178835|NCT04100018|450274806|FG001|Treatment Period|Administrative reasons by sponsor|30|||
125178836|NCT04100018|450274805|FG000|Treatment Period|Poor/Non-Compliance|1|||
125178837|NCT04100018|450274806|FG001|Treatment Period|Poor/Non-Compliance|0|||
125178838|NCT04100018|450274805|FG000|Treatment Period|Lost to Follow-up|2|||
125178839|NCT04100018|450274806|FG001|Treatment Period|Lost to Follow-up|2|||
125178840|NCT04100018|450274805|FG000|Treatment Period|Death|16|||
125178841|NCT04100018|450274806|FG001|Treatment Period|Death|11|||
125178842|NCT04100018|450274805|FG000|Treatment Period|Participant withdrew consent|10|||
125178843|NCT04100018|450274806|FG001|Treatment Period|Participant withdrew consent|10|||
125178844|NCT04100018|450274805|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
125178845|NCT04100018|450274806|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
125178846|NCT04100018|450274805|FG000|Treatment Period|Adverse Event|14|||
125178847|NCT04100018|450274806|FG001|Treatment Period|Adverse Event|6|||
125178848|NCT04100018|450274805|FG000|Treatment Period|Lack of Efficacy|4|||
125235023|NCT03738696|450487745|FG000|Overall Study|Lost to Follow-up|8|||
125178849|NCT04100018|450274806|FG001|Treatment Period|Lack of Efficacy|2|||
125178850|NCT02653625|450274813|FG000|Overall Study|Adverse Event|1|||
125178851|NCT02653625|450274813|FG000|Overall Study|Non-compliance with Study Drug|1|||
125178852|NCT02653625|450274813|FG000|Overall Study|Protocol Violation|1|||
125235024|NCT03738696|450487746|FG001|Overall Study|Lost to Follow-up|14|||
125178853|NCT02653625|450274813|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
125235025|NCT02566005|450487747|FG000|Overall Study|vaginal bleeding|0|||
125235026|NCT02566005|450487748|FG001|Overall Study|vaginal bleeding|1|||
125235027|NCT02566005|450487747|FG000|Overall Study|received foley|8|||
125235028|NCT02566005|450487748|FG001|Overall Study|received foley|0|||
125235029|NCT02566005|450487747|FG000|Overall Study|did not receive foley|0|||
125235030|NCT02566005|450487748|FG001|Overall Study|did not receive foley|1|||
125235031|NCT02566005|450487747|FG000|Overall Study|labor after randomization|0|||
125235032|NCT02566005|450487748|FG001|Overall Study|labor after randomization|4|||
125235033|NCT03617588|450487749|FG000|Overall Study|Withdrawal by Subject|1|||
125235034|NCT03617588|450487750|FG001|Overall Study|Withdrawal by Subject|0|||
125235035|NCT01294514|450487751|FG000|Overall Study|Excluded due to Arrhythmia|1|||
125235036|NCT02690727|450487752|FG000|Overall Study|Adverse Event|2|||
125235037|NCT02690727|450487753|FG001|Overall Study|Adverse Event|2|||
125235038|NCT00141921|450487759|FG000|Overall Study|Remain on Study|28|||
125235039|NCT00141921|450487759|FG000|Overall Study|Withdrawal by Subject|42|||
125235040|NCT00141921|450487759|FG000|Overall Study|Lost to Follow-up|19|||
125235041|NCT00141921|450487759|FG000|Overall Study|Noncompliance|17|||
125235042|NCT00141921|450487759|FG000|Overall Study|Disease Progression|7|||
125235043|NCT00141921|450487759|FG000|Overall Study|Protocol Deviation|7|||
125235044|NCT00141921|450487759|FG000|Overall Study|Adverse Event|5|||
125235045|NCT00141921|450487759|FG000|Overall Study|Administrative Decision|2|||
125235046|NCT00141921|450487759|FG000|Overall Study|Pregnancy|4|||
125235047|NCT00141921|450487759|FG000|Overall Study|Ineligibility Determined|2|||
125235048|NCT00141921|450487759|FG000|Overall Study|Other|8|||
125235049|NCT02471339|450487760|FG000|Overall Study|Did not provide follow-up data|2|||
125235050|NCT02471339|450487761|FG001|Overall Study|Did not provide follow-up data|0|||
125235051|NCT00626639|450487763|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
125235052|NCT00626639|450487764|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
125235053|NCT01461551|450487765|FG000|Overall Study|Physician Decision|2|||
125235054|NCT01461551|450487766|FG001|Overall Study|Physician Decision|1|||
125235055|NCT01461551|450487767|FG002|Overall Study|Physician Decision|2|||
125235056|NCT01155141|450487768|FG000|Overall Study|Withdrawal by Subject|1|||
125235057|NCT01155141|450487768|FG000|Overall Study|Screen Failure|1|||
125235058|NCT00303186|450487769|FG000|Overall Study|Other|52|||
125235059|NCT03473197|450487770|FG000|Overall Study|Adverse Event|4|||
125235060|NCT03473197|450487770|FG000|Overall Study|Lost to Follow-up|1|||
125235061|NCT03473197|450487770|FG000|Overall Study|Withdrawal by Subject|5|||
125235062|NCT00785629|450487773|FG000|Overall Study|Adverse Event|2|||
125235063|NCT00785629|450487774|FG001|Overall Study|Adverse Event|1|||
125235064|NCT00785629|450487775|FG002|Overall Study|Adverse Event|1|||
125235065|NCT00785629|450487776|FG003|Overall Study|Adverse Event|5|||
125235066|NCT00785629|450487773|FG000|Overall Study|Protocol Violation|1|||
125235067|NCT00785629|450487774|FG001|Overall Study|Protocol Violation|2|||
125235068|NCT00785629|450487775|FG002|Overall Study|Protocol Violation|4|||
125235069|NCT00785629|450487776|FG003|Overall Study|Protocol Violation|5|||
125235070|NCT00785629|450487773|FG000|Overall Study|administrative decision|5|||
125235071|NCT00785629|450487774|FG001|Overall Study|administrative decision|1|||
125235072|NCT00785629|450487775|FG002|Overall Study|administrative decision|3|||
125235073|NCT00785629|450487776|FG003|Overall Study|administrative decision|4|||
125235074|NCT00785629|450487773|FG000|Overall Study|Withdrawal by Subject|0|||
125235075|NCT00785629|450487774|FG001|Overall Study|Withdrawal by Subject|1|||
125235076|NCT00785629|450487775|FG002|Overall Study|Withdrawal by Subject|2|||
125235077|NCT00785629|450487776|FG003|Overall Study|Withdrawal by Subject|2|||
125235078|NCT00851591|450487778|FG000|Overall Study|Withdrawal by Subject|2|||
125235079|NCT00851591|450487779|FG001|Overall Study|Withdrawal by Subject|0|||
125235080|NCT01933594|450487787|FG000|Overall Study|Lost to Follow-up|1|||
125235081|NCT01933594|450487788|FG001|Overall Study|Lost to Follow-up|0|||
125235082|NCT01933594|450487789|FG002|Overall Study|Lost to Follow-up|0|||
125235083|NCT01933594|450487790|FG003|Overall Study|Lost to Follow-up|0|||
125235084|NCT01933594|450487791|FG004|Overall Study|Lost to Follow-up|1|||
125235085|NCT01933594|450487792|FG005|Overall Study|Lost to Follow-up|0|||
125235086|NCT01933594|450487787|FG000|Overall Study|Ineligible for subsequent study step|0|||
125235087|NCT01933594|450487788|FG001|Overall Study|Ineligible for subsequent study step|0|||
125235088|NCT01933594|450487789|FG002|Overall Study|Ineligible for subsequent study step|0|||
125235089|NCT01933594|450487790|FG003|Overall Study|Ineligible for subsequent study step|0|||
125235090|NCT01933594|450487791|FG004|Overall Study|Ineligible for subsequent study step|1|||
125235091|NCT01933594|450487792|FG005|Overall Study|Ineligible for subsequent study step|0|||
125235092|NCT00315445|450487793|FG000|Overall Study|Adverse Event|7|||
125235093|NCT00315445|450487794|FG001|Overall Study|Adverse Event|12|||
125235094|NCT00315445|450487795|FG002|Overall Study|Adverse Event|15|||
125235095|NCT00315445|450487793|FG000|Overall Study|Lack of Efficacy|16|||
125235096|NCT00315445|450487794|FG001|Overall Study|Lack of Efficacy|1|||
125235097|NCT00315445|450487795|FG002|Overall Study|Lack of Efficacy|7|||
125235098|NCT00315445|450487793|FG000|Overall Study|Lost to Follow-up|1|||
125235099|NCT00315445|450487794|FG001|Overall Study|Lost to Follow-up|0|||
125235100|NCT00315445|450487795|FG002|Overall Study|Lost to Follow-up|1|||
125235101|NCT00315445|450487793|FG000|Overall Study|Protocol Violation|2|||
125178854|NCT02090725|450274814|FG000|Overall Study|Withdrawal by Subject|1|||
125178855|NCT02090725|450274814|FG000|Overall Study|participants moved from area|3|||
125178856|NCT01499095|450274815|FG000|Overall Study|Randomized But Not Treated|1|||
125178857|NCT01499095|450274816|FG001|Overall Study|Randomized But Not Treated|1|||
125178858|NCT01499095|450274815|FG000|Overall Study|Adverse Event|12|||
125178859|NCT01499095|450274816|FG001|Overall Study|Adverse Event|7|||
125178860|NCT01499095|450274815|FG000|Overall Study|Lack of Efficacy|2|||
125178861|NCT01499095|450274816|FG001|Overall Study|Lack of Efficacy|1|||
125178862|NCT01499095|450274815|FG000|Overall Study|Protocol Violation|6|||
125178863|NCT01499095|450274816|FG001|Overall Study|Protocol Violation|7|||
125178864|NCT01499095|450274815|FG000|Overall Study|Received Rescue Therapy|32|||
125178865|NCT01499095|450274816|FG001|Overall Study|Received Rescue Therapy|40|||
125178866|NCT01499095|450274815|FG000|Overall Study|Diverse Reasons|22|||
125178867|NCT01499095|450274816|FG001|Overall Study|Diverse Reasons|25|||
125178868|NCT01499095|450274815|FG000|Overall Study|Lost to Follow-up|6|||
125178869|NCT01499095|450274816|FG001|Overall Study|Lost to Follow-up|4|||
125178870|NCT01499095|450274815|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
125178871|NCT01499095|450274816|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
125178872|NCT01499095|450274815|FG000|Overall Study|Hypoglycemia|3|||
125178873|NCT01499095|450274816|FG001|Overall Study|Hypoglycemia|1|||
125178874|NCT01499095|450274815|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
125178875|NCT01499095|450274816|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
125178876|NCT01499095|450274815|FG000|Overall Study|Change in Injection Schedule|2|||
125178877|NCT01499095|450274816|FG001|Overall Study|Change in Injection Schedule|0|||
125178878|NCT01499095|450274815|FG000|Overall Study|Perceived Lack of Efficacy|1|||
125178879|NCT01499095|450274816|FG001|Overall Study|Perceived Lack of Efficacy|1|||
125178880|NCT04358081|450274818|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
125178881|NCT04358081|450274819|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
125178882|NCT04358081|450274820|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
125178883|NCT04358081|450274818|FG000|Treatment Phase of Study|Adverse Event|1|||
125178884|NCT04358081|450274819|FG001|Treatment Phase of Study|Adverse Event|0|||
125178885|NCT04358081|450274820|FG002|Treatment Phase of Study|Adverse Event|1|||
125178886|NCT04358081|450274818|FG000|Treatment Phase of Study|Physician Decision|2|||
125178887|NCT04358081|450274819|FG001|Treatment Phase of Study|Physician Decision|0|||
125178888|NCT04358081|450274820|FG002|Treatment Phase of Study|Physician Decision|1|||
125178889|NCT04358081|450274818|FG000|Treatment Phase of Study|Protocol Violation|1|||
125178890|NCT04358081|450274819|FG001|Treatment Phase of Study|Protocol Violation|0|||
125178891|NCT04358081|450274820|FG002|Treatment Phase of Study|Protocol Violation|0|||
125178892|NCT04358081|450274818|FG000|Study Completion Phase|Death|0|||
125178893|NCT04358081|450274819|FG001|Study Completion Phase|Death|0|||
125178894|NCT04358081|450274820|FG002|Study Completion Phase|Death|1|||
125178895|NCT04358081|450274818|FG000|Study Completion Phase|Lost to Follow-up|1|||
125178896|NCT04358081|450274819|FG001|Study Completion Phase|Lost to Follow-up|0|||
125178897|NCT04358081|450274820|FG002|Study Completion Phase|Lost to Follow-up|1|||
125178898|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
125178899|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
125178900|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
125178901|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
125178902|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
125178903|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
125178904|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
125178905|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
125178906|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
125178907|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
125178908|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
125178909|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
125178910|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
125178911|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
125178912|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
125178913|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
125178914|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
125178915|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
125178916|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
125178917|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
125178918|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
125178919|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
125178920|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
125178921|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
125178922|NCT01130532|450274823|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
125178923|NCT01130532|450274824|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
125178924|NCT01130532|450274825|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
125178925|NCT01130532|450274826|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
125178926|NCT01130532|450274823|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
125178927|NCT01130532|450274824|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
125178928|NCT01130532|450274825|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
125178929|NCT01130532|450274826|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
125178930|NCT01130532|450274823|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
125178931|NCT01130532|450274824|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
125178932|NCT01130532|450274825|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
125178933|NCT01130532|450274826|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
125178934|NCT01130532|450274823|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
125178935|NCT01130532|450274824|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
125178936|NCT01130532|450274825|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
125178937|NCT01130532|450274826|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
125178938|NCT01130532|450274823|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
125178939|NCT01130532|450274824|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
125178940|NCT01130532|450274825|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
125178941|NCT01130532|450274826|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
125178942|NCT02762929|450274827|FG000|Overall Study|Adverse Event|0|||
125178943|NCT02762929|450274828|FG001|Overall Study|Adverse Event|0|||
125178944|NCT02762929|450274829|FG002|Overall Study|Adverse Event|0|||
125178945|NCT02762929|450274830|FG003|Overall Study|Adverse Event|1|||
125178946|NCT02762929|450274831|FG004|Overall Study|Adverse Event|0|||
125178947|NCT02762929|450274832|FG005|Overall Study|Adverse Event|0|||
125178948|NCT02762929|450274827|FG000|Overall Study|Lost to Follow-up|1|||
125178949|NCT02762929|450274828|FG001|Overall Study|Lost to Follow-up|2|||
125178950|NCT02762929|450274829|FG002|Overall Study|Lost to Follow-up|0|||
125178951|NCT02762929|450274830|FG003|Overall Study|Lost to Follow-up|1|||
125178952|NCT02762929|450274831|FG004|Overall Study|Lost to Follow-up|0|||
125178953|NCT02762929|450274832|FG005|Overall Study|Lost to Follow-up|0|||
125178954|NCT02762929|450274827|FG000|Overall Study|Withdrawal by Subject|0|||
125178955|NCT02762929|450274828|FG001|Overall Study|Withdrawal by Subject|1|||
125178956|NCT02762929|450274829|FG002|Overall Study|Withdrawal by Subject|0|||
125178957|NCT02762929|450274830|FG003|Overall Study|Withdrawal by Subject|0|||
125178958|NCT02762929|450274831|FG004|Overall Study|Withdrawal by Subject|0|||
125178959|NCT02762929|450274832|FG005|Overall Study|Withdrawal by Subject|0|||
125178960|NCT02762929|450274827|FG000|Overall Study|exclusionary medication disclosed late|0|||
125178961|NCT02762929|450274828|FG001|Overall Study|exclusionary medication disclosed late|0|||
125178962|NCT02762929|450274829|FG002|Overall Study|exclusionary medication disclosed late|0|||
125178963|NCT02762929|450274830|FG003|Overall Study|exclusionary medication disclosed late|1|||
125178964|NCT02762929|450274831|FG004|Overall Study|exclusionary medication disclosed late|0|||
125178965|NCT02762929|450274832|FG005|Overall Study|exclusionary medication disclosed late|0|||
125178966|NCT02656303|450274833|FG000|Overall Study|Adverse Event|3|||
125178967|NCT02656303|450274834|FG001|Overall Study|Adverse Event|2|||
125178968|NCT02656303|450274835|FG002|Overall Study|Adverse Event|0|||
125178969|NCT02656303|450274833|FG000|Overall Study|Death|12|||
125178970|NCT02656303|450274834|FG001|Overall Study|Death|4|||
125178971|NCT02656303|450274835|FG002|Overall Study|Death|1|||
125178972|NCT02656303|450274833|FG000|Overall Study|Lack of Efficacy|1|||
125178973|NCT02656303|450274834|FG001|Overall Study|Lack of Efficacy|0|||
125178974|NCT02656303|450274835|FG002|Overall Study|Lack of Efficacy|0|||
125178975|NCT02656303|450274833|FG000|Overall Study|Non-Compliance with Study|1|||
125178976|NCT02656303|450274834|FG001|Overall Study|Non-Compliance with Study|1|||
125178977|NCT02656303|450274835|FG002|Overall Study|Non-Compliance with Study|0|||
125178978|NCT02656303|450274833|FG000|Overall Study|Investigator Decision|2|||
125178979|NCT02656303|450274834|FG001|Overall Study|Investigator Decision|1|||
125178980|NCT02656303|450274835|FG002|Overall Study|Investigator Decision|0|||
125178981|NCT02656303|450274833|FG000|Overall Study|Progressive Disease|25|||
125178982|NCT02656303|450274834|FG001|Overall Study|Progressive Disease|14|||
125178983|NCT02656303|450274835|FG002|Overall Study|Progressive Disease|10|||
125178984|NCT02656303|450274833|FG000|Overall Study|Study Terminated by Sponsor|20|||
125178985|NCT02656303|450274834|FG001|Overall Study|Study Terminated by Sponsor|7|||
125178986|NCT02656303|450274835|FG002|Overall Study|Study Terminated by Sponsor|5|||
125178987|NCT02656303|450274833|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
125178988|NCT02656303|450274834|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
125178989|NCT02656303|450274835|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
125178990|NCT02656303|450274833|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
125178991|NCT02656303|450274834|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
125178992|NCT02656303|450274835|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
125178993|NCT02656303|450274833|FG000|Overall Study|Reason not Specified|1|||
125178994|NCT02656303|450274834|FG001|Overall Study|Reason not Specified|1|||
125178995|NCT02656303|450274835|FG002|Overall Study|Reason not Specified|2|||
125178996|NCT01842438|450274838|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
125178997|NCT01842438|450274839|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
125178998|NCT01842438|450274838|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
125178999|NCT01842438|450274839|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
125179000|NCT01842438|450274838|FG000|T2: 6month Follow-up|Death|0|||
125179001|NCT01842438|450274839|FG001|T2: 6month Follow-up|Death|1|||
125235102|NCT00315445|450487794|FG001|Overall Study|Protocol Violation|0|||
125235103|NCT00315445|450487795|FG002|Overall Study|Protocol Violation|1|||
125235104|NCT00315445|450487793|FG000|Overall Study|Other|1|||
125235105|NCT00315445|450487794|FG001|Overall Study|Other|3|||
125235106|NCT00315445|450487795|FG002|Overall Study|Other|0|||
125235107|NCT01811238|450487796|FG000|Overall Study|Withdrawal by Subject|42|||
125235108|NCT01811238|450487796|FG000|Overall Study|Adverse Event|25|||
125235109|NCT01811238|450487796|FG000|Overall Study|Protocol Violation|4|||
125235110|NCT01811238|450487796|FG000|Overall Study|Lack of Efficacy|4|||
125235111|NCT01811238|450487796|FG000|Overall Study|subject refused study medication|6|||
125235112|NCT01035138|450487797|FG000|Overall Study|Adverse Event|4|||
125235113|NCT01035138|450487798|FG001|Overall Study|Adverse Event|0|||
125235114|NCT01035138|450487799|FG002|Overall Study|Adverse Event|2|||
125235115|NCT01035138|450487797|FG000|Overall Study|Caregiver Decision|2|||
125235116|NCT01035138|450487798|FG001|Overall Study|Caregiver Decision|0|||
125235117|NCT01035138|450487799|FG002|Overall Study|Caregiver Decision|1|||
125235118|NCT01035138|450487797|FG000|Overall Study|Withdrawal by Subject|1|||
125235119|NCT01035138|450487798|FG001|Overall Study|Withdrawal by Subject|0|||
125235120|NCT01035138|450487799|FG002|Overall Study|Withdrawal by Subject|0|||
125235121|NCT01035138|450487797|FG000|Overall Study|Physician Decision|0|||
125235122|NCT01035138|450487798|FG001|Overall Study|Physician Decision|0|||
125235123|NCT01035138|450487799|FG002|Overall Study|Physician Decision|1|||
125235124|NCT01035138|450487797|FG000|Overall Study|Sponsor Decision|66|||
125235125|NCT01035138|450487798|FG001|Overall Study|Sponsor Decision|60|||
125235126|NCT01035138|450487799|FG002|Overall Study|Sponsor Decision|42|||
125235127|NCT01035138|450487797|FG000|Overall Study|Lost to Follow-up|0|||
125235128|NCT01035138|450487798|FG001|Overall Study|Lost to Follow-up|0|||
125235129|NCT01035138|450487799|FG002|Overall Study|Lost to Follow-up|1|||
125235130|NCT02164916|450487802|FG000|Overall Study|Adverse Event|3|||
125235131|NCT02164916|450487803|FG001|Overall Study|Adverse Event|8|||
125235132|NCT02164916|450487802|FG000|Overall Study|Death|1|||
125235133|NCT02164916|450487803|FG001|Overall Study|Death|1|||
125235134|NCT02164916|450487802|FG000|Overall Study|Refusal unrelated to adverse event|3|||
125235135|NCT02164916|450487803|FG001|Overall Study|Refusal unrelated to adverse event|7|||
125235136|NCT02164916|450487802|FG000|Overall Study|Progression|37|||
125235137|NCT02164916|450487803|FG001|Overall Study|Progression|26|||
125235138|NCT02164916|450487802|FG000|Overall Study|Not protocol specified|5|||
125235139|NCT02164916|450487803|FG001|Overall Study|Not protocol specified|1|||
125235140|NCT02164916|450487802|FG000|Overall Study|Reason under review|1|||
125235141|NCT02164916|450487803|FG001|Overall Study|Reason under review|6|||
125235142|NCT02164916|450487802|FG000|Overall Study|Not eligible|2|||
125235143|NCT02164916|450487803|FG001|Overall Study|Not eligible|5|||
125235144|NCT02916927|450487806|FG000|Overall Study|Discharged prior to study drug receipt|0|||
125235145|NCT02916927|450487807|FG001|Overall Study|Discharged prior to study drug receipt|2|||
125235146|NCT02916927|450487806|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
125235147|NCT02916927|450487807|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
125235148|NCT02916927|450487806|FG000|Overall Study|Withdrawal before first time point|1|||
125235149|NCT02916927|450487807|FG001|Overall Study|Withdrawal before first time point|0|||
125235150|NCT00655889|450487812|FG000|Overall Study|Inadequate cell growth|1|||
125235151|NCT00655889|450487812|FG000|Overall Study|Protocol Violation|1|||
125235152|NCT02318940|450487813|FG000|Overall Study|lost the record|1|||
125235153|NCT02318940|450487814|FG001|Overall Study|lost the record|0|||
125235154|NCT03454555|450489792|FG000|Overall Study|Death|6|||
125235155|NCT03454555|450489793|FG001|Overall Study|Death|6|||
125235156|NCT03454555|450489792|FG000|Overall Study|Lost to Follow-up|31|||
125235157|NCT03454555|450489793|FG001|Overall Study|Lost to Follow-up|12|||
125235158|NCT03454555|450489792|FG000|Overall Study|Physician Decision|2|||
125235159|NCT03454555|450489793|FG001|Overall Study|Physician Decision|6|||
125235160|NCT03454555|450489792|FG000|Overall Study|Withdrawal by Subject|34|||
125235161|NCT03454555|450489793|FG001|Overall Study|Withdrawal by Subject|5|||
125235162|NCT03454555|450489792|FG000|Overall Study|Ineligible|1|||
125235163|NCT03454555|450489793|FG001|Overall Study|Ineligible|5|||
125235164|NCT05399680|450489794|FG000|Overall Study|Lost to Follow-up|1|||
125235165|NCT05399680|450489795|FG001|Overall Study|Lost to Follow-up|0|||
125235166|NCT05399680|450489794|FG000|Overall Study|Death|0|||
125235167|NCT05399680|450489795|FG001|Overall Study|Death|1|||
125235168|NCT04530630|450489796|FG000|Overall Study|Physician Decision|1|||
125235169|NCT03675308|450489799|FG000|Overall Study|Adverse Event|3|||
125235170|NCT03675308|450489800|FG001|Overall Study|Adverse Event|2|||
125235171|NCT03675308|450489799|FG000|Overall Study|Withdrawal by Subject|6|||
125235172|NCT03675308|450489800|FG001|Overall Study|Withdrawal by Subject|4|||
125235173|NCT03675308|450489799|FG000|Overall Study|Lost to Follow-up|3|||
125235174|NCT03675308|450489800|FG001|Overall Study|Lost to Follow-up|0|||
125235175|NCT03675308|450489799|FG000|Overall Study|Lack of Efficacy|1|||
125235176|NCT03675308|450489800|FG001|Overall Study|Lack of Efficacy|1|||
125235177|NCT03675308|450489799|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
125235178|NCT03675308|450489800|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
125235179|NCT03675308|450489799|FG000|Overall Study|Other|0|||
125235180|NCT03675308|450489800|FG001|Overall Study|Other|1|||
125179002|NCT00782626|450274843|FG000|Overall Study|Adverse Event|1|||
125179003|NCT00782626|450274843|FG000|Overall Study|Progressive Disease|5|||
125179004|NCT00782626|450274843|FG000|Overall Study|Other Complicating Disease|1|||
125179005|NCT04909853|450274844|FG000|Part 1|Assigned but not treated|0|||
125179006|NCT04909853|450274845|FG001|Part 1|Assigned but not treated|0|||
125179007|NCT04909853|450274846|FG002|Part 1|Assigned but not treated|1|||
125179008|NCT04909853|450274847|FG003|Part 1|Assigned but not treated|0|||
125179009|NCT04909853|450274844|FG000|Part 2|Adverse Event|0|||
125179010|NCT04909853|450274845|FG001|Part 2|Adverse Event|0|||
125179011|NCT04909853|450274846|FG002|Part 2|Adverse Event|0|||
125179012|NCT04909853|450274847|FG003|Part 2|Adverse Event|1|||
125179013|NCT04054765|450274848|FG000|Baseline|Withdrawal by Subject|5|||
125179014|NCT04054765|450274849|FG001|Baseline|Withdrawal by Subject|3|||
125179015|NCT04054765|450274848|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
125179016|NCT04054765|450274849|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
125179017|NCT04054765|450274848|FG000|3-month Follow up|Withdrawal by Subject|0|||
125179018|NCT04054765|450274849|FG001|3-month Follow up|Withdrawal by Subject|3|||
125179019|NCT04054765|450274848|FG000|6-month Follow up|Lost to Follow-up|32|||
125179020|NCT04054765|450274849|FG001|6-month Follow up|Lost to Follow-up|32|||
125179021|NCT00077207|450274851|FG000|Overall Study|Adverse Event|5|||
125179022|NCT00077207|450274851|FG000|Overall Study|Lack of Efficacy|12|||
125179023|NCT00077207|450274851|FG000|Overall Study|Physician Decision|6|||
125179024|NCT00077207|450274851|FG000|Overall Study|Withdrawal by Subject|6|||
125179025|NCT00077207|450274851|FG000|Overall Study|Ineligible|1|||
125179026|NCT04182490|450274854|FG000|Overall Study|Withdrawal by Subject|3|||
125179027|NCT04182490|450274855|FG001|Overall Study|Withdrawal by Subject|3|||
125179028|NCT04182490|450274854|FG000|Overall Study|Lost to Follow-up|0|||
125179029|NCT04182490|450274855|FG001|Overall Study|Lost to Follow-up|1|||
125179030|NCT04182490|450274854|FG000|Overall Study|Physician Decision|0|||
125179031|NCT04182490|450274855|FG001|Overall Study|Physician Decision|1|||
125179032|NCT00853099|450274856|FG000|Double-blind Period|Adverse Event|7|||
125179033|NCT00853099|450274857|FG001|Double-blind Period|Adverse Event|9|||
125179034|NCT00853099|450274858|FG002|Double-blind Period|Adverse Event|13|||
125179035|NCT00853099|450274859|FG003|Double-blind Period|Adverse Event|0|||
125179036|NCT00853099|450274856|FG000|Double-blind Period|Withdrawal by Subject|2|||
125179037|NCT00853099|450274857|FG001|Double-blind Period|Withdrawal by Subject|3|||
125179038|NCT00853099|450274858|FG002|Double-blind Period|Withdrawal by Subject|0|||
125179039|NCT00853099|450274859|FG003|Double-blind Period|Withdrawal by Subject|0|||
125179040|NCT00853099|450274856|FG000|Double-blind Period|Lack of Efficacy|14|||
125179041|NCT00853099|450274857|FG001|Double-blind Period|Lack of Efficacy|17|||
125179042|NCT00853099|450274858|FG002|Double-blind Period|Lack of Efficacy|16|||
125179043|NCT00853099|450274859|FG003|Double-blind Period|Lack of Efficacy|0|||
125179044|NCT00853099|450274856|FG000|Double-blind Period|Other|0|||
125179045|NCT00853099|450274857|FG001|Double-blind Period|Other|0|||
125179046|NCT00853099|450274858|FG002|Double-blind Period|Other|1|||
125179047|NCT00853099|450274859|FG003|Double-blind Period|Other|0|||
125179048|NCT00853099|450274856|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
125179049|NCT00853099|450274857|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
125179050|NCT00853099|450274858|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
125179051|NCT00853099|450274859|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
125179052|NCT00853099|450274856|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
125179053|NCT00853099|450274857|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
125179054|NCT00853099|450274858|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
125179055|NCT00853099|450274859|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
125179056|NCT00853099|450274856|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
125179057|NCT00853099|450274857|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
125179058|NCT00853099|450274858|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
125179059|NCT00853099|450274859|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
125179060|NCT00853099|450274856|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
125235181|NCT01288430|450489803|FG000|Part 1|Progressive disease|2|||
125235182|NCT01288430|450489804|FG001|Part 1|Progressive disease|1|||
125179061|NCT00853099|450274857|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
125235183|NCT01288430|450489805|FG002|Part 1|Progressive disease|1|||
125179062|NCT00853099|450274858|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
125179063|NCT00853099|450274859|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
125179064|NCT00853099|450274856|FG000|Double-blind + Open-label Periods|Other|0|||
125179065|NCT00853099|450274857|FG001|Double-blind + Open-label Periods|Other|0|||
125179066|NCT00853099|450274858|FG002|Double-blind + Open-label Periods|Other|0|||
125179067|NCT00853099|450274859|FG003|Double-blind + Open-label Periods|Other|6|||
125179068|NCT01811472|450274860|FG000|Overall Study|Adverse Event|1|||
125179069|NCT01811472|450274861|FG001|Overall Study|Adverse Event|0|||
125179070|NCT01811472|450274862|FG002|Overall Study|Adverse Event|4|||
125179071|NCT01811472|450274860|FG000|Overall Study|Lost to Follow-up|0|||
125179072|NCT01811472|450274861|FG001|Overall Study|Lost to Follow-up|0|||
125235184|NCT01288430|450489806|FG003|Part 1|Progressive disease|6|||
125179073|NCT01811472|450274862|FG002|Overall Study|Lost to Follow-up|1|||
125179074|NCT01811472|450274860|FG000|Overall Study|Subject/guardian decision|1|||
125179075|NCT01811472|450274861|FG001|Overall Study|Subject/guardian decision|0|||
125179076|NCT01811472|450274862|FG002|Overall Study|Subject/guardian decision|0|||
125179077|NCT03280264|450274863|FG000|Overall Study|Adverse Event|1|||
125179078|NCT03280264|450274863|FG000|Overall Study|Physician Decision|1|||
125179079|NCT03280264|450274863|FG000|Overall Study|Withdrawal by Subject|1|||
125179080|NCT02738138|450274865|FG000|Overall Study|Adverse Event|0|||
125179081|NCT02738138|450274866|FG001|Overall Study|Adverse Event|1|||
125179082|NCT02738138|450274865|FG000|Overall Study|Lost to Follow-up|2|||
125179083|NCT02738138|450274866|FG001|Overall Study|Lost to Follow-up|0|||
125179084|NCT02738138|450274865|FG000|Overall Study|Other - not further specified|1|||
125179085|NCT02738138|450274866|FG001|Overall Study|Other - not further specified|0|||
125179086|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Other|34|||
125179087|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Other|0|||
125179088|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Other|0|||
125179089|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Other|0|||
125179090|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Death|14|||
125179091|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Death|0|||
125179092|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Death|0|||
125179093|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Death|0|||
125179094|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
125179095|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
125179096|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
125179097|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
125179098|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
125179099|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
125179100|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
125392331|NCT02404311|451070631|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
125392332|NCT02404311|451070632|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
125392333|NCT02404311|451070628|FG000|Part A: Month 0-18|HIV Infection|6|||
125392334|NCT02404311|451070629|FG001|Part A: Month 0-18|HIV Infection|2|||
125392335|NCT02404311|451070630|FG002|Part A: Month 0-18|HIV Infection|0|||
125179101|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
125179102|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
125179103|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
125179104|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
125179105|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
125179106|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
125179107|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
125179108|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
125179109|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
125179110|NCT01995513|450274869|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
125179111|NCT01995513|450274870|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
125179112|NCT01995513|450274871|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
125179113|NCT01995513|450274872|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
125179114|NCT01995513|450274869|FG000|Period 1: Second Open Label Treatment|Other|0|||
125179115|NCT01995513|450274870|FG001|Period 1: Second Open Label Treatment|Other|2|||
125179116|NCT01995513|450274871|FG002|Period 1: Second Open Label Treatment|Other|0|||
125392336|NCT02404311|451070631|FG003|Part A: Month 0-18|HIV Infection|0|||
125392337|NCT02404311|451070632|FG004|Part A: Month 0-18|HIV Infection|0|||
125392338|NCT02404311|451070628|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
125392339|NCT02404311|451070629|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
125392340|NCT02404311|451070630|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
125392341|NCT02404311|451070631|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
125392342|NCT02404311|451070632|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
125443429|NCT02555371|451252128|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
125179117|NCT01995513|450274872|FG003|Period 1: Second Open Label Treatment|Other|0|||
125179118|NCT01995513|450274869|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
125179119|NCT01995513|450274870|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
125392343|NCT02256891|451070637|FG000|Overall Study|Death|0|||
125392344|NCT02256891|451070638|FG001|Overall Study|Death|2|||
125392345|NCT02256891|451070637|FG000|Overall Study|Lost to Follow-up|0|||
125392346|NCT02256891|451070638|FG001|Overall Study|Lost to Follow-up|3|||
125235185|NCT01288430|450489807|FG004|Part 1|Progressive disease|2|||
125235186|NCT01288430|450489808|FG005|Part 1|Progressive disease|4|||
125235187|NCT01288430|450489809|FG006|Part 1|Progressive disease|2|||
125392347|NCT02256891|451070637|FG000|Overall Study|Physician Decision|7|||
125392348|NCT02256891|451070638|FG001|Overall Study|Physician Decision|3|||
125392349|NCT02256891|451070637|FG000|Overall Study|Screen Fail|5|||
125392350|NCT02256891|451070638|FG001|Overall Study|Screen Fail|4|||
125392351|NCT02256891|451070637|FG000|Overall Study|Equipment Malfunction|0|||
125235188|NCT01288430|450489810|FG007|Part 1|Progressive disease|0|||
125235189|NCT01288430|450489811|FG008|Part 1|Progressive disease|0|||
125235190|NCT01288430|450489812|FG009|Part 1|Progressive disease|0|||
125235191|NCT01288430|450489803|FG000|Part 1|Clinical disease progression|0|||
125235192|NCT01288430|450489804|FG001|Part 1|Clinical disease progression|0|||
125235193|NCT01288430|450489805|FG002|Part 1|Clinical disease progression|1|||
125235194|NCT01288430|450489806|FG003|Part 1|Clinical disease progression|0|||
125235195|NCT01288430|450489807|FG004|Part 1|Clinical disease progression|0|||
125235196|NCT01288430|450489808|FG005|Part 1|Clinical disease progression|2|||
125235197|NCT01288430|450489809|FG006|Part 1|Clinical disease progression|2|||
125235198|NCT01288430|450489810|FG007|Part 1|Clinical disease progression|0|||
125235199|NCT01288430|450489811|FG008|Part 1|Clinical disease progression|0|||
125235200|NCT01288430|450489812|FG009|Part 1|Clinical disease progression|0|||
125235201|NCT01288430|450489803|FG000|Part 1|Death due to disease progression|0|||
125235202|NCT01288430|450489804|FG001|Part 1|Death due to disease progression|0|||
125235203|NCT01288430|450489805|FG002|Part 1|Death due to disease progression|0|||
125235204|NCT01288430|450489806|FG003|Part 1|Death due to disease progression|0|||
125235205|NCT01288430|450489807|FG004|Part 1|Death due to disease progression|1|||
125235206|NCT01288430|450489808|FG005|Part 1|Death due to disease progression|0|||
125235207|NCT01288430|450489809|FG006|Part 1|Death due to disease progression|0|||
125235208|NCT01288430|450489810|FG007|Part 1|Death due to disease progression|0|||
125235209|NCT01288430|450489811|FG008|Part 1|Death due to disease progression|0|||
125235210|NCT01288430|450489812|FG009|Part 1|Death due to disease progression|0|||
125235211|NCT01288430|450489803|FG000|Part 1|Adverse Event|0|||
125235212|NCT01288430|450489804|FG001|Part 1|Adverse Event|0|||
125235213|NCT01288430|450489805|FG002|Part 1|Adverse Event|3|||
125235214|NCT01288430|450489806|FG003|Part 1|Adverse Event|1|||
125235215|NCT01288430|450489807|FG004|Part 1|Adverse Event|0|||
125235216|NCT01288430|450489808|FG005|Part 1|Adverse Event|0|||
125235217|NCT01288430|450489809|FG006|Part 1|Adverse Event|2|||
125235218|NCT01288430|450489810|FG007|Part 1|Adverse Event|0|||
125235219|NCT01288430|450489811|FG008|Part 1|Adverse Event|0|||
125235220|NCT01288430|450489812|FG009|Part 1|Adverse Event|0|||
125235221|NCT01288430|450489803|FG000|Part 1|Other|0|||
125235222|NCT01288430|450489804|FG001|Part 1|Other|2|||
125235223|NCT01288430|450489805|FG002|Part 1|Other|0|||
125235224|NCT01288430|450489806|FG003|Part 1|Other|0|||
125235225|NCT01288430|450489807|FG004|Part 1|Other|0|||
125235226|NCT01288430|450489808|FG005|Part 1|Other|0|||
125235227|NCT01288430|450489809|FG006|Part 1|Other|1|||
125235228|NCT01288430|450489810|FG007|Part 1|Other|0|||
125235229|NCT01288430|450489811|FG008|Part 1|Other|0|||
125235230|NCT01288430|450489812|FG009|Part 1|Other|0|||
125235231|NCT01288430|450489803|FG000|Part 2|Progressive disease|0|||
125235232|NCT01288430|450489804|FG001|Part 2|Progressive disease|0|||
125235233|NCT01288430|450489805|FG002|Part 2|Progressive disease|0|||
125235234|NCT01288430|450489806|FG003|Part 2|Progressive disease|0|||
125235235|NCT01288430|450489807|FG004|Part 2|Progressive disease|0|||
125235236|NCT01288430|450489808|FG005|Part 2|Progressive disease|0|||
125235237|NCT01288430|450489809|FG006|Part 2|Progressive disease|0|||
125235238|NCT01288430|450489810|FG007|Part 2|Progressive disease|8|||
125235239|NCT01288430|450489811|FG008|Part 2|Progressive disease|7|||
125235240|NCT01288430|450489812|FG009|Part 2|Progressive disease|2|||
125235241|NCT01288430|450489803|FG000|Part 2|Clinical disease progression|0|||
125235242|NCT01288430|450489804|FG001|Part 2|Clinical disease progression|0|||
125235243|NCT01288430|450489805|FG002|Part 2|Clinical disease progression|0|||
125235244|NCT01288430|450489806|FG003|Part 2|Clinical disease progression|0|||
125235245|NCT01288430|450489807|FG004|Part 2|Clinical disease progression|0|||
125235246|NCT01288430|450489808|FG005|Part 2|Clinical disease progression|0|||
125235247|NCT01288430|450489809|FG006|Part 2|Clinical disease progression|0|||
125235248|NCT01288430|450489810|FG007|Part 2|Clinical disease progression|2|||
125235249|NCT01288430|450489811|FG008|Part 2|Clinical disease progression|0|||
125235250|NCT01288430|450489812|FG009|Part 2|Clinical disease progression|0|||
125235251|NCT01288430|450489803|FG000|Part 2|Withdrawal by Subject|0|||
125235252|NCT01288430|450489804|FG001|Part 2|Withdrawal by Subject|0|||
125235253|NCT01288430|450489805|FG002|Part 2|Withdrawal by Subject|0|||
125392352|NCT02256891|451070638|FG001|Overall Study|Equipment Malfunction|1|||
125392353|NCT01344447|451070639|FG000|Overall Study|Adverse Event|1|||
125235254|NCT01288430|450489806|FG003|Part 2|Withdrawal by Subject|0|||
125235255|NCT01288430|450489807|FG004|Part 2|Withdrawal by Subject|0|||
125235256|NCT01288430|450489808|FG005|Part 2|Withdrawal by Subject|0|||
125235257|NCT01288430|450489809|FG006|Part 2|Withdrawal by Subject|0|||
125235258|NCT01288430|450489810|FG007|Part 2|Withdrawal by Subject|1|||
125235259|NCT01288430|450489811|FG008|Part 2|Withdrawal by Subject|4|||
125392354|NCT01344447|451070639|FG000|Overall Study|Protocol Violation|1|||
125392355|NCT01344447|451070639|FG000|Overall Study|Withdrawal by Subject|1|||
125235260|NCT01288430|450489812|FG009|Part 2|Withdrawal by Subject|0|||
125235261|NCT01288430|450489803|FG000|Part 2|Adverse Event|0|||
125235262|NCT01288430|450489804|FG001|Part 2|Adverse Event|0|||
125235263|NCT01288430|450489805|FG002|Part 2|Adverse Event|0|||
125235264|NCT01288430|450489806|FG003|Part 2|Adverse Event|0|||
125235265|NCT01288430|450489807|FG004|Part 2|Adverse Event|0|||
125235266|NCT01288430|450489808|FG005|Part 2|Adverse Event|0|||
125179120|NCT01995513|450274871|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
125179121|NCT01995513|450274872|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
125179122|NCT01995513|450274869|FG000|Period 2: Double Blind Treatment|Death|0|||
125179123|NCT01995513|450274870|FG001|Period 2: Double Blind Treatment|Death|0|||
125179124|NCT01995513|450274871|FG002|Period 2: Double Blind Treatment|Death|0|||
125179125|NCT01995513|450274872|FG003|Period 2: Double Blind Treatment|Death|1|||
125179126|NCT01995513|450274869|FG000|Period 2: Double Blind Treatment|Other|0|||
125179127|NCT01995513|450274870|FG001|Period 2: Double Blind Treatment|Other|0|||
125179128|NCT01995513|450274871|FG002|Period 2: Double Blind Treatment|Other|3|||
125179129|NCT01995513|450274872|FG003|Period 2: Double Blind Treatment|Other|3|||
125179130|NCT01995513|450274869|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
125179131|NCT01995513|450274870|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
125179132|NCT01995513|450274871|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
125179133|NCT01995513|450274872|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
125179134|NCT01995513|450274869|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
125179135|NCT01995513|450274870|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
125179136|NCT01995513|450274871|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
125179137|NCT01995513|450274872|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
125179138|NCT01995513|450274869|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
125179139|NCT01995513|450274870|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
125179140|NCT01995513|450274871|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
125179141|NCT01995513|450274872|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
125179142|NCT01995513|450274869|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
125179143|NCT01995513|450274870|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
125179144|NCT01995513|450274871|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
125179145|NCT01995513|450274872|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
125179146|NCT02071225|450274880|FG000|Overall Study|Withdrawal of Consent|2|||
125179147|NCT02071225|450274880|FG000|Overall Study|Protocol Deviation|1|||
125179148|NCT02071225|450274880|FG000|Overall Study|Lost to Follow-up|2|||
125179149|NCT02071225|450274880|FG000|Overall Study|Death|25|||
125179150|NCT00280735|450274885|FG000|Overall Study|Adverse Event|5|||
125179151|NCT00280735|450274885|FG000|Overall Study|Lack of Efficacy|3|||
125179152|NCT00280735|450274885|FG000|Overall Study|Withdrawal by Subject|8|||
125179153|NCT00280735|450274885|FG000|Overall Study|Intercurrent Illness|2|||
125179154|NCT01895777|450274886|FG000|Overall Study|Adverse Event|1|||
125179155|NCT01895777|450274887|FG001|Overall Study|Adverse Event|2|||
125179156|NCT01895777|450274886|FG000|Overall Study|Lost to Follow-up|2|||
125179157|NCT01895777|450274887|FG001|Overall Study|Lost to Follow-up|0|||
125179158|NCT01895777|450274886|FG000|Overall Study|Not treated|1|||
125179159|NCT01895777|450274887|FG001|Overall Study|Not treated|0|||
125179160|NCT01895777|450274886|FG000|Overall Study|Other reasons|3|||
125179161|NCT01895777|450274887|FG001|Overall Study|Other reasons|2|||
125179162|NCT01895777|450274886|FG000|Overall Study|Non-compliance with the CTP|2|||
125179163|NCT01895777|450274887|FG001|Overall Study|Non-compliance with the CTP|1|||
125179164|NCT02064296|450274888|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
125179165|NCT02064296|450274889|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
125179166|NCT02064296|450274890|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
125179167|NCT02064296|450274888|FG000|Intervention|Withdrawal by Subject|0|||
125179168|NCT02064296|450274889|FG001|Intervention|Withdrawal by Subject|1|||
125179169|NCT02064296|450274890|FG002|Intervention|Withdrawal by Subject|2|||
125179170|NCT03885661|450274902|FG000|Overall Study|Withdrawal by Subject|0|||
125179171|NCT03885661|450274903|FG001|Overall Study|Withdrawal by Subject|1|||
125179172|NCT03885661|450274902|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
125179173|NCT03885661|450274903|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
125179174|NCT02286843|450274908|FG000|Overall Study|Not Treated|4|||
125179175|NCT02286843|450274908|FG000|Overall Study|Protocol Violation|1|||
125179176|NCT02286843|450274908|FG000|Overall Study|Withdrawal by Subject|1|||
125179177|NCT03172494|450274909|FG000|Overall Study|Adverse Event|5|||
125179178|NCT03172494|450274910|FG001|Overall Study|Adverse Event|1|||
125179179|NCT03172494|450274911|FG002|Overall Study|Adverse Event|15|||
125443430|NCT02555371|451252129|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
125443431|NCT02555371|451252130|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
125443432|NCT02555371|451252131|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
125179180|NCT03172494|450274909|FG000|Overall Study|Protocol Violation|3|||
125179181|NCT03172494|450274910|FG001|Overall Study|Protocol Violation|2|||
125179182|NCT03172494|450274911|FG002|Overall Study|Protocol Violation|1|||
125179183|NCT03172494|450274909|FG000|Overall Study|Lack of Efficacy|0|||
125179184|NCT03172494|450274910|FG001|Overall Study|Lack of Efficacy|0|||
125179185|NCT03172494|450274911|FG002|Overall Study|Lack of Efficacy|4|||
125179186|NCT03172494|450274909|FG000|Overall Study|Pregnancy|0|||
125179187|NCT03172494|450274910|FG001|Overall Study|Pregnancy|1|||
125179188|NCT03172494|450274911|FG002|Overall Study|Pregnancy|0|||
125235267|NCT01288430|450489809|FG006|Part 2|Adverse Event|0|||
125235268|NCT01288430|450489810|FG007|Part 2|Adverse Event|1|||
125235269|NCT01288430|450489811|FG008|Part 2|Adverse Event|1|||
125235270|NCT01288430|450489812|FG009|Part 2|Adverse Event|0|||
125235271|NCT01288430|450489803|FG000|Part 2|Other|0|||
125235272|NCT01288430|450489804|FG001|Part 2|Other|0|||
125235273|NCT01288430|450489805|FG002|Part 2|Other|0|||
125235274|NCT01288430|450489806|FG003|Part 2|Other|0|||
125235275|NCT01288430|450489807|FG004|Part 2|Other|0|||
125235276|NCT01288430|450489808|FG005|Part 2|Other|0|||
125235277|NCT01288430|450489809|FG006|Part 2|Other|0|||
125235278|NCT01288430|450489810|FG007|Part 2|Other|0|||
125235279|NCT01288430|450489811|FG008|Part 2|Other|0|||
125235280|NCT01288430|450489812|FG009|Part 2|Other|1|||
125235281|NCT01386385|450489813|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
125235282|NCT01386385|450489814|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235283|NCT01386385|450489815|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235284|NCT01386385|450489816|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235285|NCT01386385|450489817|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235286|NCT01386385|450489818|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235287|NCT01386385|450489819|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235288|NCT01386385|450489820|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
125235289|NCT01386385|450489813|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
125235290|NCT01386385|450489814|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235291|NCT01386385|450489815|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235292|NCT01386385|450489816|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235293|NCT01386385|450489817|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235294|NCT01386385|450489818|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235295|NCT01386385|450489819|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235296|NCT01386385|450489820|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
125235297|NCT01386385|450489813|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235298|NCT01386385|450489814|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235299|NCT01386385|450489815|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
125235300|NCT01386385|450489816|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235301|NCT01386385|450489817|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235302|NCT01386385|450489818|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235303|NCT01386385|450489819|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235304|NCT01386385|450489820|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
125235305|NCT01386385|450489813|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235306|NCT01386385|450489814|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235307|NCT01386385|450489815|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235308|NCT01386385|450489816|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235309|NCT01386385|450489817|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
125235310|NCT01386385|450489818|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235311|NCT01386385|450489819|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235312|NCT01386385|450489820|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
125235313|NCT01386385|450489813|FG000|Phase II Concurrent CRT|Adverse Event|0|||
125235314|NCT01386385|450489814|FG001|Phase II Concurrent CRT|Adverse Event|0|||
125235315|NCT01386385|450489815|FG002|Phase II Concurrent CRT|Adverse Event|0|||
125235316|NCT01386385|450489816|FG003|Phase II Concurrent CRT|Adverse Event|0|||
125235317|NCT01386385|450489817|FG004|Phase II Concurrent CRT|Adverse Event|0|||
125235318|NCT01386385|450489818|FG005|Phase II Concurrent CRT|Adverse Event|0|||
125235319|NCT01386385|450489819|FG006|Phase II Concurrent CRT|Adverse Event|3|||
125235320|NCT01386385|450489820|FG007|Phase II Concurrent CRT|Adverse Event|3|||
125235321|NCT01386385|450489813|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235322|NCT01386385|450489814|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235323|NCT01386385|450489815|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235324|NCT01386385|450489816|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235325|NCT01386385|450489817|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235326|NCT01386385|450489818|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235327|NCT01386385|450489819|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
125235328|NCT01386385|450489820|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
125235329|NCT01386385|450489813|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
125235330|NCT01386385|450489814|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
125235331|NCT01386385|450489815|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
125235332|NCT01386385|450489816|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
125235333|NCT01386385|450489817|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
125235334|NCT01386385|450489818|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
125235335|NCT01386385|450489819|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
125235336|NCT01386385|450489820|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
125235337|NCT01386385|450489813|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125235338|NCT01386385|450489814|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125179189|NCT03172494|450274909|FG000|Overall Study|Withdrawal by Subject|10|||
125179190|NCT03172494|450274910|FG001|Overall Study|Withdrawal by Subject|8|||
125179191|NCT03172494|450274911|FG002|Overall Study|Withdrawal by Subject|8|||
125179192|NCT03172494|450274909|FG000|Overall Study|Severe hypoglycaemic episode|0|||
125179193|NCT03172494|450274910|FG001|Overall Study|Severe hypoglycaemic episode|0|||
125179194|NCT03172494|450274911|FG002|Overall Study|Severe hypoglycaemic episode|1|||
125179195|NCT03172494|450274909|FG000|Overall Study|Non-compliance towards treatment|2|||
125179196|NCT03172494|450274910|FG001|Overall Study|Non-compliance towards treatment|0|||
125179197|NCT03172494|450274911|FG002|Overall Study|Non-compliance towards treatment|0|||
125179198|NCT03086551|450274912|FG000|First Intervention|Failure to meet inclusion criterion|1|||
125179199|NCT03086551|450274913|FG001|First Intervention|Failure to meet inclusion criterion|0|||
125179200|NCT03086551|450274912|FG000|First Intervention|Lost to Follow-up|0|||
125179201|NCT03086551|450274913|FG001|First Intervention|Lost to Follow-up|1|||
125179202|NCT03086551|450274912|FG000|Washout|Lost to Follow-up|1|||
125179203|NCT03086551|450274913|FG001|Washout|Lost to Follow-up|2|||
125179204|NCT03086551|450274912|FG000|Washout|Withdrawal by Subject|2|||
125179205|NCT03086551|450274913|FG001|Washout|Withdrawal by Subject|1|||
125179206|NCT02764151|450274914|FG000|Overall Study|Subject refused further follow-up|0|||
125179207|NCT02764151|450274915|FG001|Overall Study|Subject refused further follow-up|0|||
125179208|NCT02764151|450274916|FG002|Overall Study|Subject refused further follow-up|0|||
125179209|NCT02764151|450274917|FG003|Overall Study|Subject refused further follow-up|1|||
125179210|NCT02764151|450274914|FG000|Overall Study|Other|0|||
125179211|NCT02764151|450274915|FG001|Overall Study|Other|0|||
125179212|NCT02764151|450274916|FG002|Overall Study|Other|0|||
125179213|NCT02764151|450274917|FG003|Overall Study|Other|2|||
125179214|NCT02201277|450274919|FG000|Overall Study|Death|3|||
125179215|NCT02201277|450274920|FG001|Overall Study|Death|4|||
125179216|NCT02201277|450274919|FG000|Overall Study|Lost to Follow-up|2|||
125179217|NCT02201277|450274920|FG001|Overall Study|Lost to Follow-up|1|||
125179218|NCT02201277|450274919|FG000|Overall Study|Failed retrieval|1|||
125179219|NCT02201277|450274920|FG001|Overall Study|Failed retrieval|0|||
125179220|NCT02201277|450274919|FG000|Overall Study|Physician Decision|1|||
125179221|NCT02201277|450274920|FG001|Overall Study|Physician Decision|0|||
125179222|NCT00489255|450274921|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
125179223|NCT00489255|450274922|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
125179224|NCT00489255|450274921|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
125179225|NCT00489255|450274922|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
125179226|NCT00489255|450274921|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
125179227|NCT00489255|450274922|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
125179228|NCT00489255|450274921|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
125179229|NCT00489255|450274922|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
125179230|NCT00489255|450274921|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
125179231|NCT00489255|450274922|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
125179232|NCT00489255|450274921|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
125179233|NCT00489255|450274922|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
125179234|NCT00489255|450274921|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
125179235|NCT00489255|450274922|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
125179236|NCT00489255|450274921|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
125179237|NCT00489255|450274922|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
125179238|NCT00489255|450274921|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
125179239|NCT00489255|450274922|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
125179240|NCT00489255|450274921|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
125179241|NCT00489255|450274922|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
125179242|NCT03485352|450274923|FG000|Overall Study|Lost to Follow-up|9|||
125179243|NCT01512160|450274924|FG000|Overall Study|Lost to Follow-up|1|||
125179244|NCT01512160|450274925|FG001|Overall Study|Lost to Follow-up|0|||
125179245|NCT01512160|450274926|FG002|Overall Study|Lost to Follow-up|0|||
125179246|NCT01512160|450274927|FG003|Overall Study|Lost to Follow-up|0|||
125179247|NCT01512160|450274924|FG000|Overall Study|Withdrawal by Subject|1|||
125179248|NCT01512160|450274925|FG001|Overall Study|Withdrawal by Subject|0|||
125179249|NCT01512160|450274926|FG002|Overall Study|Withdrawal by Subject|0|||
125179250|NCT01512160|450274927|FG003|Overall Study|Withdrawal by Subject|1|||
125179251|NCT01260701|450274929|FG000|Overall Study|Adverse Event|9|||
125179252|NCT01260701|450274929|FG000|Overall Study|Withdrawal by Subject|2|||
125179253|NCT01260701|450274929|FG000|Overall Study|Progression|53|||
125179254|NCT01260701|450274929|FG000|Overall Study|Death|2|||
125179255|NCT01260701|450274929|FG000|Overall Study|Not protocol specified|3|||
125179256|NCT01260701|450274929|FG000|Overall Study|Under review|1|||
125179257|NCT01260701|450274929|FG000|Overall Study|Ineligible|4|||
125179258|NCT01260701|450274929|FG000|Overall Study|Did not begin protocol therapy|1|||
125179259|NCT04205812|450276030|FG000|Randomized Treatment Period|Ongoing|28|||
125179260|NCT04205812|450276031|FG001|Randomized Treatment Period|Ongoing|138|||
125179261|NCT04205812|450276030|FG000|Randomized Treatment Period|Death|94|||
125179262|NCT04205812|450276031|FG001|Randomized Treatment Period|Death|226|||
125179263|NCT04205812|450276030|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
125179264|NCT04205812|450276031|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
125179265|NCT04205812|450276030|FG000|Randomized Treatment Period|Physician Decision|1|||
125179266|NCT04205812|450276031|FG001|Randomized Treatment Period|Physician Decision|4|||
125179267|NCT04205812|450276030|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
125179268|NCT04205812|450276031|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
125179269|NCT04205812|450276030|FG000|Randomized Treatment Period|Progressive Disease|0|||
125179270|NCT04205812|450276031|FG001|Randomized Treatment Period|Progressive Disease|1|||
125179271|NCT04205812|450276030|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
125179272|NCT04205812|450276031|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
125179273|NCT04205812|450276030|FG000|Monotherapy Treatment Period|Ongoing|17|||
125179274|NCT04205812|450276031|FG001|Monotherapy Treatment Period|Ongoing|0|||
125179275|NCT04205812|450276030|FG000|Monotherapy Treatment Period|Death|39|||
125179276|NCT04205812|450276031|FG001|Monotherapy Treatment Period|Death|0|||
125179277|NCT04205812|450276030|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
125179278|NCT04205812|450276031|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
125179279|NCT04205812|450276030|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
125179280|NCT04205812|450276031|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
125179281|NCT05221320|450276032|FG000|Overall Study|Lack of Efficacy|3|||
125179282|NCT05221320|450276033|FG001|Overall Study|Lack of Efficacy|7|||
125179283|NCT05221320|450276034|FG002|Overall Study|Lack of Efficacy|10|||
125179284|NCT05221320|450276035|FG003|Overall Study|Lack of Efficacy|1|||
125179285|NCT05221320|450276036|FG004|Overall Study|Lack of Efficacy|0|||
125179286|NCT05221320|450276037|FG005|Overall Study|Lack of Efficacy|0|||
125179287|NCT05221320|450276032|FG000|Overall Study|Physician Decision|1|||
125179288|NCT05221320|450276033|FG001|Overall Study|Physician Decision|0|||
125179289|NCT05221320|450276034|FG002|Overall Study|Physician Decision|3|||
125179290|NCT05221320|450276035|FG003|Overall Study|Physician Decision|1|||
125179291|NCT05221320|450276036|FG004|Overall Study|Physician Decision|0|||
125179292|NCT05221320|450276037|FG005|Overall Study|Physician Decision|0|||
125179293|NCT05221320|450276032|FG000|Overall Study|Withdrawal by Subject|0|||
125179294|NCT05221320|450276033|FG001|Overall Study|Withdrawal by Subject|3|||
125179295|NCT05221320|450276034|FG002|Overall Study|Withdrawal by Subject|1|||
125179296|NCT05221320|450276035|FG003|Overall Study|Withdrawal by Subject|0|||
125179297|NCT05221320|450276036|FG004|Overall Study|Withdrawal by Subject|0|||
125179298|NCT05221320|450276037|FG005|Overall Study|Withdrawal by Subject|0|||
125179299|NCT05221320|450276032|FG000|Overall Study|Death|0|||
125179300|NCT05221320|450276033|FG001|Overall Study|Death|5|||
125179301|NCT05221320|450276034|FG002|Overall Study|Death|6|||
125179302|NCT05221320|450276035|FG003|Overall Study|Death|0|||
125179303|NCT05221320|450276036|FG004|Overall Study|Death|1|||
125179304|NCT05221320|450276037|FG005|Overall Study|Death|0|||
125179305|NCT06473519|450276038|FG000|Overall Study|Lost to Follow-up|2|||
125179306|NCT06473519|450276039|FG001|Overall Study|Lost to Follow-up|5|||
125179307|NCT06473519|450276038|FG000|Overall Study|Withdrawal by Subject|1|||
125179308|NCT06473519|450276039|FG001|Overall Study|Withdrawal by Subject|4|||
125179309|NCT06473519|450276038|FG000|Overall Study|Randomized but not vaccinated|1|||
125179310|NCT06473519|450276039|FG001|Overall Study|Randomized but not vaccinated|2|||
125179311|NCT04903288|450276044|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
125179312|NCT04903288|450276044|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
125179313|NCT04903288|450276044|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
125179314|NCT04903288|450276044|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
125179315|NCT03713593|450276045|FG000|Overall Study|Sponsor Decision|73|||
125179316|NCT03713593|450276046|FG001|Overall Study|Sponsor Decision|41|||
125179317|NCT03713593|450276045|FG000|Overall Study|Lost to Follow-up|2|||
125179318|NCT03713593|450276046|FG001|Overall Study|Lost to Follow-up|1|||
125179319|NCT03713593|450276045|FG000|Overall Study|Death|314|||
125179320|NCT03713593|450276046|FG001|Overall Study|Death|349|||
125179321|NCT03713593|450276045|FG000|Overall Study|Withdrawal by Subject|6|||
125179322|NCT03713593|450276046|FG001|Overall Study|Withdrawal by Subject|8|||
125179323|NCT04776148|450276047|FG000|Overall Study|Death|249|||
125179324|NCT04776148|450276048|FG001|Overall Study|Death|260|||
125179325|NCT04776148|450276047|FG000|Overall Study|Lost to Follow-up|0|||
125179326|NCT04776148|450276048|FG001|Overall Study|Lost to Follow-up|1|||
125179327|NCT04776148|450276047|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125179328|NCT04776148|450276048|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125179329|NCT04776148|450276047|FG000|Overall Study|Withdrawal by Subject|3|||
125179330|NCT04776148|450276048|FG001|Overall Study|Withdrawal by Subject|4|||
125179331|NCT04776148|450276047|FG000|Overall Study|Sponsor Decision|30|||
125179332|NCT04776148|450276048|FG001|Overall Study|Sponsor Decision|15|||
125179333|NCT03130777|450276049|FG000|Overall Study|Death|0|||
125179334|NCT03130777|450276050|FG001|Overall Study|Death|1|||
125179335|NCT03130777|450276049|FG000|Overall Study|Did not meet eligibility criteria|1|||
125179336|NCT03130777|450276050|FG001|Overall Study|Did not meet eligibility criteria|0|||
125179337|NCT02498613|450276051|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
125179338|NCT02498613|450276052|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
125179339|NCT02498613|450276053|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
125179340|NCT02498613|450276054|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
125392356|NCT01344447|451070639|FG000|Overall Study|The contrast was not seen|1|||
125392357|NCT01344447|451070639|FG000|Overall Study|Physician Decision|1|||
125392358|NCT01344447|451070639|FG000|Overall Study|MRA unsuccessful|1|||
125392359|NCT01344447|451070639|FG000|Overall Study|Bolus tracking failed|1|||
125392360|NCT01344447|451070639|FG000|Overall Study|Error of power injector|1|||
125392361|NCT00218296|451070640|FG000|Overall Study|Lost to Follow-up|9|||
125392362|NCT00218296|451070641|FG001|Overall Study|Lost to Follow-up|7|||
125392363|NCT00218296|451070640|FG000|Overall Study|Withdrawal by Subject|36|||
125179341|NCT02498613|450276051|FG000|Overall Study|Withdrawal by Subject|3|||
125179342|NCT02498613|450276052|FG001|Overall Study|Withdrawal by Subject|1|||
125179343|NCT02498613|450276053|FG002|Overall Study|Withdrawal by Subject|0|||
125179344|NCT02498613|450276054|FG003|Overall Study|Withdrawal by Subject|0|||
125179345|NCT05168202|450276055|FG000|Overall Study|Progressive Disease|4|||
125179346|NCT05168202|450276056|FG001|Overall Study|Progressive Disease|4|||
125179347|NCT05168202|450276057|FG002|Overall Study|Progressive Disease|2|||
125179348|NCT05168202|450276058|FG003|Overall Study|Progressive Disease|3|||
125179349|NCT05168202|450276059|FG004|Overall Study|Progressive Disease|2|||
125179350|NCT05168202|450276060|FG005|Overall Study|Progressive Disease|3|||
125179351|NCT05168202|450276061|FG006|Overall Study|Progressive Disease|2|||
125179352|NCT05168202|450276055|FG000|Overall Study|Adverse Event|2|||
125179353|NCT05168202|450276056|FG001|Overall Study|Adverse Event|1|||
125179354|NCT05168202|450276057|FG002|Overall Study|Adverse Event|4|||
125179355|NCT05168202|450276058|FG003|Overall Study|Adverse Event|4|||
125179356|NCT05168202|450276059|FG004|Overall Study|Adverse Event|3|||
125179357|NCT05168202|450276060|FG005|Overall Study|Adverse Event|2|||
125179358|NCT05168202|450276061|FG006|Overall Study|Adverse Event|0|||
125179359|NCT05168202|450276055|FG000|Overall Study|Lack of Efficacy|0|||
125179360|NCT05168202|450276056|FG001|Overall Study|Lack of Efficacy|1|||
125179361|NCT05168202|450276057|FG002|Overall Study|Lack of Efficacy|1|||
125179362|NCT05168202|450276058|FG003|Overall Study|Lack of Efficacy|0|||
125179363|NCT05168202|450276059|FG004|Overall Study|Lack of Efficacy|1|||
125179364|NCT05168202|450276060|FG005|Overall Study|Lack of Efficacy|2|||
125179365|NCT05168202|450276061|FG006|Overall Study|Lack of Efficacy|2|||
125179366|NCT05168202|450276055|FG000|Overall Study|Withdrawal by Subject|0|||
125179367|NCT05168202|450276056|FG001|Overall Study|Withdrawal by Subject|0|||
125179368|NCT05168202|450276057|FG002|Overall Study|Withdrawal by Subject|1|||
125179369|NCT05168202|450276058|FG003|Overall Study|Withdrawal by Subject|1|||
125179370|NCT05168202|450276059|FG004|Overall Study|Withdrawal by Subject|1|||
125179371|NCT05168202|450276060|FG005|Overall Study|Withdrawal by Subject|1|||
125179372|NCT05168202|450276061|FG006|Overall Study|Withdrawal by Subject|0|||
125179373|NCT05168202|450276055|FG000|Overall Study|Disease Relapse|0|||
125179374|NCT05168202|450276056|FG001|Overall Study|Disease Relapse|1|||
125179375|NCT05168202|450276057|FG002|Overall Study|Disease Relapse|0|||
125179376|NCT05168202|450276058|FG003|Overall Study|Disease Relapse|1|||
125179377|NCT05168202|450276059|FG004|Overall Study|Disease Relapse|1|||
125179378|NCT05168202|450276060|FG005|Overall Study|Disease Relapse|0|||
125179379|NCT05168202|450276061|FG006|Overall Study|Disease Relapse|0|||
125179380|NCT05168202|450276055|FG000|Overall Study|Other Reasons|0|||
125179381|NCT05168202|450276056|FG001|Overall Study|Other Reasons|0|||
125179382|NCT05168202|450276057|FG002|Overall Study|Other Reasons|0|||
125179383|NCT05168202|450276058|FG003|Overall Study|Other Reasons|0|||
125179384|NCT05168202|450276059|FG004|Overall Study|Other Reasons|0|||
125179385|NCT05168202|450276060|FG005|Overall Study|Other Reasons|2|||
125179386|NCT05168202|450276061|FG006|Overall Study|Other Reasons|1|||
125179387|NCT05168202|450276055|FG000|Overall Study|Physician Decision|0|||
125179388|NCT05168202|450276056|FG001|Overall Study|Physician Decision|1|||
125179389|NCT05168202|450276057|FG002|Overall Study|Physician Decision|1|||
125179390|NCT05168202|450276058|FG003|Overall Study|Physician Decision|0|||
125179391|NCT05168202|450276059|FG004|Overall Study|Physician Decision|0|||
125179392|NCT05168202|450276060|FG005|Overall Study|Physician Decision|0|||
125179393|NCT05168202|450276061|FG006|Overall Study|Physician Decision|0|||
125179394|NCT05168202|450276055|FG000|Overall Study|Study Terminated by Sponsor|0|||
125179395|NCT05168202|450276056|FG001|Overall Study|Study Terminated by Sponsor|0|||
125179396|NCT05168202|450276057|FG002|Overall Study|Study Terminated by Sponsor|0|||
125179397|NCT05168202|450276058|FG003|Overall Study|Study Terminated by Sponsor|1|||
125179398|NCT05168202|450276059|FG004|Overall Study|Study Terminated by Sponsor|0|||
125179399|NCT05168202|450276060|FG005|Overall Study|Study Terminated by Sponsor|0|||
125179400|NCT05168202|450276061|FG006|Overall Study|Study Terminated by Sponsor|0|||
125179401|NCT05109611|450276062|FG000|Overall Study|Adverse Event|13|||
125179402|NCT05109611|450276063|FG001|Overall Study|Adverse Event|10|||
125179403|NCT05109611|450276062|FG000|Overall Study|Withdrawal by Subject|1|||
125179404|NCT05109611|450276063|FG001|Overall Study|Withdrawal by Subject|0|||
125179405|NCT05109611|450276062|FG000|Overall Study|Lost to Follow-up|1|||
125179406|NCT05109611|450276063|FG001|Overall Study|Lost to Follow-up|2|||
125179407|NCT05109611|450276062|FG000|Overall Study|Protocol Violation|0|||
125179408|NCT05109611|450276063|FG001|Overall Study|Protocol Violation|4|||
125179409|NCT05109611|450276062|FG000|Overall Study|Information unavailable|1|||
125179410|NCT05109611|450276063|FG001|Overall Study|Information unavailable|1|||
125179411|NCT06195930|450276064|FG000|Overall Study|Adverse Event|4|||
125235339|NCT01386385|450489815|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125235340|NCT01386385|450489816|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125235341|NCT01386385|450489817|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125235342|NCT01386385|450489818|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125235343|NCT01386385|450489819|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
125235344|NCT01386385|450489820|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
125235345|NCT01386385|450489813|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
125235346|NCT01386385|450489814|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
125235347|NCT01386385|450489815|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
125235348|NCT01386385|450489816|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
125235349|NCT01386385|450489817|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
125235350|NCT01386385|450489818|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
125235351|NCT01386385|450489819|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
125235352|NCT01386385|450489820|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
125235353|NCT04486716|450489822|FG000|Core Phase|Subject decision|6|||
125235354|NCT04486716|450489822|FG000|Core Phase|Adverse Event|5|||
125235355|NCT04486716|450489822|FG000|Core Phase|Lost to Follow-up|1|||
125235356|NCT04486716|450489822|FG000|Core Phase|Physician Decision|1|||
125235357|NCT04486716|450489822|FG000|Core Phase|Enrolled subjects not treated|9|||
125235358|NCT03737994|450489823|FG000|Overall Study|Withdrawal by Subject|0|||
125235359|NCT03737994|450489824|FG001|Overall Study|Withdrawal by Subject|0|||
125235360|NCT03737994|450489825|FG002|Overall Study|Withdrawal by Subject|0|||
125235361|NCT03737994|450489826|FG003|Overall Study|Withdrawal by Subject|0|||
125235362|NCT03737994|450489827|FG004|Overall Study|Withdrawal by Subject|0|||
125235363|NCT03737994|450489828|FG005|Overall Study|Withdrawal by Subject|0|||
125235364|NCT03737994|450489829|FG006|Overall Study|Withdrawal by Subject|1|||
125235365|NCT02332707|450489830|FG000|Overall Study|Adverse Event|0|||
125235366|NCT02332707|450489831|FG001|Overall Study|Adverse Event|0|||
125235367|NCT02332707|450489832|FG002|Overall Study|Adverse Event|0|||
125235368|NCT02332707|450489833|FG003|Overall Study|Adverse Event|0|||
125235369|NCT02332707|450489834|FG004|Overall Study|Adverse Event|0|||
125235370|NCT02332707|450489835|FG005|Overall Study|Adverse Event|0|||
125235371|NCT02332707|450489836|FG006|Overall Study|Adverse Event|0|||
125235372|NCT02332707|450489837|FG007|Overall Study|Adverse Event|0|||
125235373|NCT02332707|450489838|FG008|Overall Study|Adverse Event|0|||
125235374|NCT02332707|450489839|FG009|Overall Study|Adverse Event|0|||
125235375|NCT02332707|450489840|FG010|Overall Study|Adverse Event|0|||
125235376|NCT02332707|450489841|FG011|Overall Study|Adverse Event|0|||
125235377|NCT02332707|450489842|FG012|Overall Study|Adverse Event|1|||
125235378|NCT02332707|450489843|FG013|Overall Study|Adverse Event|0|||
125235379|NCT02332707|450489844|FG014|Overall Study|Adverse Event|0|||
125235380|NCT02332707|450489845|FG015|Overall Study|Adverse Event|0|||
125235381|NCT02332707|450489846|FG016|Overall Study|Adverse Event|0|||
125235382|NCT02332707|450489847|FG017|Overall Study|Adverse Event|0|||
125235383|NCT02332707|450489830|FG000|Overall Study|Lost to Follow-up|0|||
125235384|NCT02332707|450489831|FG001|Overall Study|Lost to Follow-up|0|||
125235385|NCT02332707|450489832|FG002|Overall Study|Lost to Follow-up|0|||
125235386|NCT02332707|450489833|FG003|Overall Study|Lost to Follow-up|0|||
125235387|NCT02332707|450489834|FG004|Overall Study|Lost to Follow-up|0|||
125235388|NCT02332707|450489835|FG005|Overall Study|Lost to Follow-up|1|||
125235389|NCT02332707|450489836|FG006|Overall Study|Lost to Follow-up|0|||
125235390|NCT02332707|450489837|FG007|Overall Study|Lost to Follow-up|0|||
125235391|NCT02332707|450489838|FG008|Overall Study|Lost to Follow-up|0|||
125392364|NCT00218296|451070641|FG001|Overall Study|Withdrawal by Subject|47|||
125392365|NCT00218296|451070640|FG000|Overall Study|Randomized but did not enter treatment|66|||
125392366|NCT00218296|451070641|FG001|Overall Study|Randomized but did not enter treatment|67|||
125392367|NCT03261947|451070649|FG000|Overall Study|Death|10|||
125392368|NCT03261947|451070650|FG001|Overall Study|Death|13|||
125392369|NCT03261947|451070651|FG002|Overall Study|Death|17|||
125392370|NCT03261947|451070652|FG003|Overall Study|Death|12|||
125392371|NCT03261947|451070653|FG004|Overall Study|Death|8|||
125392372|NCT03261947|451070649|FG000|Overall Study|Lost to Follow-up|0|||
125235392|NCT02332707|450489839|FG009|Overall Study|Lost to Follow-up|0|||
125235393|NCT02332707|450489840|FG010|Overall Study|Lost to Follow-up|2|||
125235394|NCT02332707|450489841|FG011|Overall Study|Lost to Follow-up|0|||
125235395|NCT02332707|450489842|FG012|Overall Study|Lost to Follow-up|3|||
125235396|NCT02332707|450489843|FG013|Overall Study|Lost to Follow-up|0|||
125235397|NCT02332707|450489844|FG014|Overall Study|Lost to Follow-up|0|||
125235398|NCT02332707|450489845|FG015|Overall Study|Lost to Follow-up|0|||
125235399|NCT02332707|450489846|FG016|Overall Study|Lost to Follow-up|0|||
125235400|NCT02332707|450489847|FG017|Overall Study|Lost to Follow-up|0|||
125235401|NCT02332707|450489830|FG000|Overall Study|Physician Decision|0|||
125392373|NCT03261947|451070650|FG001|Overall Study|Lost to Follow-up|0|||
125392374|NCT03261947|451070651|FG002|Overall Study|Lost to Follow-up|2|||
125235402|NCT02332707|450489831|FG001|Overall Study|Physician Decision|0|||
125235403|NCT02332707|450489832|FG002|Overall Study|Physician Decision|0|||
125392375|NCT03261947|451070652|FG003|Overall Study|Lost to Follow-up|1|||
125179412|NCT03041311|450276071|FG000|Overall Study|Death|39|||
125179413|NCT03041311|450276072|FG001|Overall Study|Death|42|||
125179414|NCT03041311|450276071|FG000|Overall Study|Lost to Follow-up|0|||
125179415|NCT03041311|450276072|FG001|Overall Study|Lost to Follow-up|1|||
125179416|NCT03041311|450276071|FG000|Overall Study|Withdrawal by Subject|8|||
125179417|NCT03041311|450276072|FG001|Overall Study|Withdrawal by Subject|5|||
125179418|NCT03041311|450276071|FG000|Overall Study|Sponsor Terminated Study|2|||
125179419|NCT03041311|450276072|FG001|Overall Study|Sponsor Terminated Study|4|||
125179420|NCT03041311|450276071|FG000|Overall Study|Disease Progression|3|||
125179421|NCT03041311|450276072|FG001|Overall Study|Disease Progression|1|||
125179422|NCT03041311|450276071|FG000|Overall Study|Randomized in error, did not receive drug|2|||
125179423|NCT03041311|450276072|FG001|Overall Study|Randomized in error, did not receive drug|0|||
125179424|NCT03934541|450276078|FG000|Overall Study|Study Terminated by Sponsor|0|||
125179425|NCT03934541|450276079|FG001|Overall Study|Study Terminated by Sponsor|1|||
125179426|NCT03934541|450276080|FG002|Overall Study|Study Terminated by Sponsor|0|||
125179427|NCT03934541|450276081|FG003|Overall Study|Study Terminated by Sponsor|0|||
125179428|NCT02673775|450276082|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
125179429|NCT02673775|450276083|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
125179430|NCT02673775|450276082|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
125179431|NCT02673775|450276083|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
125179432|NCT02673775|450276082|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
125179433|NCT02673775|450276083|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
125179434|NCT02673775|450276082|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
125179435|NCT02673775|450276083|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
125179436|NCT02441686|450276084|FG000|Induction|Adverse Event|4|||
125179437|NCT02441686|450276084|FG000|Induction|Complicating disease|1|||
125179438|NCT02441686|450276084|FG000|Induction|Physician Decision|1|||
125179439|NCT02441686|450276084|FG000|Induction|Withdrawal by Subject|1|||
125179440|NCT02441686|450276084|FG000|Induction|Did not receive treatment|1|||
125179441|NCT02441686|450276084|FG000|Maintenance|Remaining on Treatment|23|||
125179442|NCT02441686|450276084|FG000|Maintenance|Physician Decision|1|||
125179443|NCT02441686|450276084|FG000|Maintenance|Adverse Event|3|||
125179444|NCT02441686|450276084|FG000|Maintenance|Progressive Disease|10|||
125179445|NCT02441686|450276084|FG000|Maintenance|Withdrawal by Subject|1|||
125179446|NCT03164616|450276085|FG000|Overall Study|Death|250|||
125179447|NCT03164616|450276086|FG001|Overall Study|Death|264|||
125179448|NCT03164616|450276087|FG002|Overall Study|Death|279|||
125179449|NCT03164616|450276085|FG000|Overall Study|Lost to Follow-up|2|||
125179450|NCT03164616|450276086|FG001|Overall Study|Lost to Follow-up|2|||
125179451|NCT03164616|450276087|FG002|Overall Study|Lost to Follow-up|2|||
125179452|NCT03164616|450276085|FG000|Overall Study|Withdrawal by Subject|6|||
125179453|NCT03164616|450276086|FG001|Overall Study|Withdrawal by Subject|7|||
125179454|NCT03164616|450276087|FG002|Overall Study|Withdrawal by Subject|16|||
125179455|NCT06018129|450276099|FG000|Overall Study|Death|1|||
125179456|NCT06018129|450276100|FG001|Overall Study|Death|1|||
125179457|NCT06018129|450276101|FG002|Overall Study|Death|2|||
125179458|NCT06018129|450276099|FG000|Overall Study|Sponsor Decision|2|||
125179459|NCT06018129|450276100|FG001|Overall Study|Sponsor Decision|2|||
125179460|NCT06018129|450276101|FG002|Overall Study|Sponsor Decision|1|||
125179461|NCT04917861|450276102|FG000|Main Study (196 Days)|Adverse Event|0|||
125179462|NCT04917861|450276103|FG001|Main Study (196 Days)|Adverse Event|1|||
125179463|NCT04917861|450276104|FG002|Main Study (196 Days)|Adverse Event|0|||
125179464|NCT04917861|450276105|FG003|Main Study (196 Days)|Adverse Event|0|||
125179465|NCT04917861|450276102|FG000|Main Study (196 Days)|Death|0|||
125179466|NCT04917861|450276103|FG001|Main Study (196 Days)|Death|0|||
125179467|NCT04917861|450276104|FG002|Main Study (196 Days)|Death|0|||
125179468|NCT04917861|450276105|FG003|Main Study (196 Days)|Death|1|||
125179469|NCT04917861|450276102|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
125179470|NCT04917861|450276103|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
125179471|NCT04917861|450276104|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
125179472|NCT04917861|450276105|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
125179473|NCT04917861|450276102|FG000|Main Study (196 Days)|Physician Decision|0|||
125179474|NCT04917861|450276103|FG001|Main Study (196 Days)|Physician Decision|0|||
125179475|NCT04917861|450276104|FG002|Main Study (196 Days)|Physician Decision|0|||
125179476|NCT04917861|450276105|FG003|Main Study (196 Days)|Physician Decision|1|||
125179477|NCT04917861|450276102|FG000|Main Study (196 Days)|Pregnancy|1|||
125179478|NCT04917861|450276103|FG001|Main Study (196 Days)|Pregnancy|1|||
125179479|NCT04917861|450276104|FG002|Main Study (196 Days)|Pregnancy|0|||
125179480|NCT04917861|450276105|FG003|Main Study (196 Days)|Pregnancy|0|||
125179481|NCT04917861|450276102|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
125179482|NCT04917861|450276103|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
125179483|NCT04917861|450276104|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
125179484|NCT04917861|450276105|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
125179485|NCT04917861|450276102|FG000|Main Study (196 Days)|Other Than Specified|1|||
125179486|NCT04917861|450276103|FG001|Main Study (196 Days)|Other Than Specified|0|||
125179487|NCT04917861|450276104|FG002|Main Study (196 Days)|Other Than Specified|1|||
125235404|NCT02332707|450489833|FG003|Overall Study|Physician Decision|1|||
125235405|NCT02332707|450489834|FG004|Overall Study|Physician Decision|0|||
125235406|NCT02332707|450489835|FG005|Overall Study|Physician Decision|0|||
125235407|NCT02332707|450489836|FG006|Overall Study|Physician Decision|0|||
125235408|NCT02332707|450489837|FG007|Overall Study|Physician Decision|0|||
125235409|NCT02332707|450489838|FG008|Overall Study|Physician Decision|0|||
125235410|NCT02332707|450489839|FG009|Overall Study|Physician Decision|0|||
125235411|NCT02332707|450489840|FG010|Overall Study|Physician Decision|0|||
125235412|NCT02332707|450489841|FG011|Overall Study|Physician Decision|0|||
125235413|NCT02332707|450489842|FG012|Overall Study|Physician Decision|1|||
125235414|NCT02332707|450489843|FG013|Overall Study|Physician Decision|0|||
125235415|NCT02332707|450489844|FG014|Overall Study|Physician Decision|0|||
125235416|NCT02332707|450489845|FG015|Overall Study|Physician Decision|0|||
125235417|NCT02332707|450489846|FG016|Overall Study|Physician Decision|0|||
125235418|NCT02332707|450489847|FG017|Overall Study|Physician Decision|0|||
125235419|NCT02332707|450489830|FG000|Overall Study|Withdrawal by Subject|0|||
125235420|NCT02332707|450489831|FG001|Overall Study|Withdrawal by Subject|0|||
125235421|NCT02332707|450489832|FG002|Overall Study|Withdrawal by Subject|1|||
125235422|NCT02332707|450489833|FG003|Overall Study|Withdrawal by Subject|0|||
125235423|NCT02332707|450489834|FG004|Overall Study|Withdrawal by Subject|0|||
125235424|NCT02332707|450489835|FG005|Overall Study|Withdrawal by Subject|0|||
125235425|NCT02332707|450489836|FG006|Overall Study|Withdrawal by Subject|0|||
125235426|NCT02332707|450489837|FG007|Overall Study|Withdrawal by Subject|0|||
125235427|NCT02332707|450489838|FG008|Overall Study|Withdrawal by Subject|0|||
125235428|NCT02332707|450489839|FG009|Overall Study|Withdrawal by Subject|3|||
125235429|NCT02332707|450489840|FG010|Overall Study|Withdrawal by Subject|0|||
125235430|NCT02332707|450489841|FG011|Overall Study|Withdrawal by Subject|0|||
125235431|NCT02332707|450489842|FG012|Overall Study|Withdrawal by Subject|0|||
125235432|NCT02332707|450489843|FG013|Overall Study|Withdrawal by Subject|0|||
125235433|NCT02332707|450489844|FG014|Overall Study|Withdrawal by Subject|0|||
125235434|NCT02332707|450489845|FG015|Overall Study|Withdrawal by Subject|0|||
125392376|NCT03261947|451070653|FG004|Overall Study|Lost to Follow-up|0|||
125392377|NCT03261947|451070649|FG000|Overall Study|Withdrawal by Subject|0|||
125392378|NCT03261947|451070650|FG001|Overall Study|Withdrawal by Subject|0|||
125392379|NCT03261947|451070651|FG002|Overall Study|Withdrawal by Subject|3|||
125392380|NCT03261947|451070652|FG003|Overall Study|Withdrawal by Subject|0|||
125392381|NCT03261947|451070653|FG004|Overall Study|Withdrawal by Subject|1|||
125392382|NCT03261947|451070649|FG000|Overall Study|Site Terminated by Sponsor|0|||
125392383|NCT03261947|451070650|FG001|Overall Study|Site Terminated by Sponsor|0|||
125179488|NCT04917861|450276105|FG003|Main Study (196 Days)|Other Than Specified|2|||
125179489|NCT04917861|450276102|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
125179490|NCT04917861|450276103|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
125179491|NCT04917861|450276104|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
125179492|NCT04917861|450276105|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
125179493|NCT04917861|450276102|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
125179494|NCT04917861|450276103|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
125179495|NCT04917861|450276104|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
125179496|NCT04917861|450276105|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
125179497|NCT04917861|450276102|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
125179498|NCT04917861|450276103|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
125179499|NCT04917861|450276104|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
125179500|NCT04917861|450276105|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
125179501|NCT04917861|450276102|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
125179502|NCT04917861|450276103|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
125179503|NCT04917861|450276104|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
125179504|NCT04917861|450276105|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
125179505|NCT04917861|450276102|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
125179506|NCT04917861|450276103|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
125179507|NCT04917861|450276104|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
125235435|NCT02332707|450489846|FG016|Overall Study|Withdrawal by Subject|0|||
125235436|NCT02332707|450489847|FG017|Overall Study|Withdrawal by Subject|0|||
125235437|NCT01473134|450489848|FG000|Overall Study|Lost to Follow-up|21|||
125179508|NCT04917861|450276105|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
125179509|NCT04917861|450276102|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
125235438|NCT01473134|450489849|FG001|Overall Study|Lost to Follow-up|13|||
125235439|NCT01473134|450489848|FG000|Overall Study|Protocol Violation|32|||
125235440|NCT01473134|450489849|FG001|Overall Study|Protocol Violation|19|||
125235441|NCT01473134|450489848|FG000|Overall Study|Withdrawal by Subject|1|||
125235442|NCT01473134|450489849|FG001|Overall Study|Withdrawal by Subject|2|||
125235443|NCT01473134|450489848|FG000|Overall Study|Death|0|||
125235444|NCT01473134|450489849|FG001|Overall Study|Death|1|||
125392384|NCT03261947|451070651|FG002|Overall Study|Site Terminated by Sponsor|4|||
125392385|NCT03261947|451070652|FG003|Overall Study|Site Terminated by Sponsor|7|||
125392386|NCT03261947|451070653|FG004|Overall Study|Site Terminated by Sponsor|5|||
125235445|NCT01473134|450489848|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
125235446|NCT01473134|450489849|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
125235447|NCT04761822|450489850|FG000|Overall Study|Adverse Event|3|||
125235448|NCT04761822|450489851|FG001|Overall Study|Adverse Event|1|||
125235449|NCT04761822|450489852|FG002|Overall Study|Adverse Event|1|||
125235450|NCT04761822|450489853|FG003|Overall Study|Adverse Event|3|||
125235451|NCT04761822|450489850|FG000|Overall Study|Lost to Follow-up|1|||
125235452|NCT04761822|450489851|FG001|Overall Study|Lost to Follow-up|0|||
125235453|NCT04761822|450489852|FG002|Overall Study|Lost to Follow-up|2|||
125235454|NCT04761822|450489853|FG003|Overall Study|Lost to Follow-up|3|||
125235455|NCT04761822|450489850|FG000|Overall Study|Physician Decision|0|||
125235456|NCT04761822|450489851|FG001|Overall Study|Physician Decision|1|||
125235457|NCT04761822|450489852|FG002|Overall Study|Physician Decision|0|||
125235458|NCT04761822|450489853|FG003|Overall Study|Physician Decision|0|||
125235459|NCT04761822|450489850|FG000|Overall Study|Withdrawal by Subject|3|||
125235460|NCT04761822|450489851|FG001|Overall Study|Withdrawal by Subject|8|||
125235461|NCT04761822|450489852|FG002|Overall Study|Withdrawal by Subject|1|||
125179510|NCT04917861|450276103|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
125179511|NCT04917861|450276104|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
125179512|NCT04917861|450276105|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
125179513|NCT06389487|450276106|FG000|Overall Study|Lost to Follow-up|9|||
125179514|NCT06389487|450276107|FG001|Overall Study|Lost to Follow-up|5|||
125179515|NCT06389487|450276108|FG002|Overall Study|Lost to Follow-up|13|||
125179516|NCT06389487|450276106|FG000|Overall Study|Protocol Violation|0|||
125179517|NCT06389487|450276107|FG001|Overall Study|Protocol Violation|0|||
125179518|NCT06389487|450276108|FG002|Overall Study|Protocol Violation|2|||
125179519|NCT06389487|450276106|FG000|Overall Study|Withdrawal by Subject|2|||
125179520|NCT06389487|450276107|FG001|Overall Study|Withdrawal by Subject|2|||
125179521|NCT06389487|450276108|FG002|Overall Study|Withdrawal by Subject|1|||
125179522|NCT06389487|450276106|FG000|Overall Study|Other|1|||
125179523|NCT06389487|450276107|FG001|Overall Study|Other|0|||
125179524|NCT06389487|450276108|FG002|Overall Study|Other|1|||
125179525|NCT00001521|450277178|FG000|Overall Study|Withdrawal by Subject|3|||
125179526|NCT00001521|450277179|FG001|Overall Study|Withdrawal by Subject|3|||
125179527|NCT00001521|450277178|FG000|Overall Study|Physician Decision|1|||
125179528|NCT00001521|450277179|FG001|Overall Study|Physician Decision|1|||
125179529|NCT00001521|450277178|FG000|Overall Study|Noncompliant|6|||
125179530|NCT00001521|450277179|FG001|Overall Study|Noncompliant|3|||
125179531|NCT00970593|450277181|FG000|Overall Study|Adverse Event|1|||
125179532|NCT00970593|450277182|FG001|Overall Study|Adverse Event|1|||
125179533|NCT00970593|450277183|FG002|Overall Study|Adverse Event|0|||
125179534|NCT00970593|450277184|FG003|Overall Study|Adverse Event|0|||
125179535|NCT00970593|450277185|FG004|Overall Study|Adverse Event|0|||
125179536|NCT00970593|450277186|FG005|Overall Study|Adverse Event|0|||
125179537|NCT00970593|450277187|FG006|Overall Study|Adverse Event|0|||
125179538|NCT00970593|450277181|FG000|Overall Study|Discontinuation of study by sponsor|0|||
125179539|NCT00970593|450277182|FG001|Overall Study|Discontinuation of study by sponsor|0|||
125179540|NCT00970593|450277183|FG002|Overall Study|Discontinuation of study by sponsor|5|||
125179541|NCT00970593|450277184|FG003|Overall Study|Discontinuation of study by sponsor|0|||
125179542|NCT00970593|450277185|FG004|Overall Study|Discontinuation of study by sponsor|0|||
125179543|NCT00970593|450277186|FG005|Overall Study|Discontinuation of study by sponsor|0|||
125179544|NCT00970593|450277187|FG006|Overall Study|Discontinuation of study by sponsor|2|||
125179545|NCT00970593|450277181|FG000|Overall Study|Withdrawal by Subject|0|||
125179546|NCT00970593|450277182|FG001|Overall Study|Withdrawal by Subject|0|||
125179547|NCT00970593|450277183|FG002|Overall Study|Withdrawal by Subject|1|||
125179548|NCT00970593|450277184|FG003|Overall Study|Withdrawal by Subject|0|||
125179549|NCT00970593|450277185|FG004|Overall Study|Withdrawal by Subject|0|||
125179550|NCT00970593|450277186|FG005|Overall Study|Withdrawal by Subject|0|||
125179551|NCT00970593|450277187|FG006|Overall Study|Withdrawal by Subject|0|||
125179552|NCT04176250|450277188|FG000|Overall Study|Adverse Event|0|||
125179553|NCT04176250|450277189|FG001|Overall Study|Adverse Event|1|||
125179554|NCT04176250|450277190|FG002|Overall Study|Adverse Event|0|||
125179555|NCT04176250|450277191|FG003|Overall Study|Adverse Event|1|||
125179556|NCT04176250|450277192|FG004|Overall Study|Adverse Event|0|||
125179557|NCT04176250|450277193|FG005|Overall Study|Adverse Event|1|||
125179558|NCT04176250|450277188|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
125179559|NCT04176250|450277189|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
125179560|NCT04176250|450277190|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
125179561|NCT04176250|450277191|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
125179562|NCT04176250|450277192|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
125179563|NCT04176250|450277193|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
125179564|NCT04176250|450277188|FG000|Overall Study|Withdrawal by Subject|0|||
125179565|NCT04176250|450277189|FG001|Overall Study|Withdrawal by Subject|0|||
125179566|NCT04176250|450277190|FG002|Overall Study|Withdrawal by Subject|0|||
125179567|NCT04176250|450277191|FG003|Overall Study|Withdrawal by Subject|0|||
125179568|NCT04176250|450277192|FG004|Overall Study|Withdrawal by Subject|0|||
125179569|NCT04176250|450277193|FG005|Overall Study|Withdrawal by Subject|1|||
125179570|NCT04176250|450277188|FG000|Overall Study|Randomized in error|0|||
125179571|NCT04176250|450277189|FG001|Overall Study|Randomized in error|0|||
125179572|NCT04176250|450277190|FG002|Overall Study|Randomized in error|0|||
125179573|NCT04176250|450277191|FG003|Overall Study|Randomized in error|0|||
125179574|NCT04176250|450277192|FG004|Overall Study|Randomized in error|1|||
125179575|NCT04176250|450277193|FG005|Overall Study|Randomized in error|0|||
125179576|NCT01342081|450277196|FG000|Overall Study|Did not receive allocated intervention|0|||
125179577|NCT01342081|450277197|FG001|Overall Study|Did not receive allocated intervention|0|||
125179578|NCT01342081|450277198|FG002|Overall Study|Did not receive allocated intervention|1|||
125179579|NCT01342081|450277196|FG000|Overall Study|Adverse Event|1|||
125179580|NCT01342081|450277197|FG001|Overall Study|Adverse Event|0|||
125179581|NCT01342081|450277198|FG002|Overall Study|Adverse Event|0|||
125179582|NCT01342081|450277196|FG000|Overall Study|Physician Decision|0|||
125179583|NCT01342081|450277197|FG001|Overall Study|Physician Decision|1|||
125179584|NCT01342081|450277198|FG002|Overall Study|Physician Decision|0|||
125179585|NCT01342081|450277196|FG000|Overall Study|Withdrawal by Subject|1|||
125179586|NCT01342081|450277197|FG001|Overall Study|Withdrawal by Subject|1|||
125179587|NCT01342081|450277198|FG002|Overall Study|Withdrawal by Subject|0|||
125179588|NCT02790437|450277200|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
125179589|NCT02790437|450277201|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
125179590|NCT02790437|450277200|FG000|Overall Study|Adverse Event|1|||
125179591|NCT02790437|450277201|FG001|Overall Study|Adverse Event|0|||
125179592|NCT02790437|450277200|FG000|Overall Study|Withdrawal by Subject|1|||
125179593|NCT02790437|450277201|FG001|Overall Study|Withdrawal by Subject|0|||
125179594|NCT01202175|450277202|FG000|Overall Study|Lost to Follow-up|2|||
125179595|NCT01202175|450277202|FG000|Overall Study|Withdrawal by Subject|1|||
125179596|NCT01202175|450277202|FG000|Overall Study|Adverse Event|2|||
125179597|NCT04720053|450277206|FG000|Overall Study|Lost to Follow-up|12|||
125179598|NCT00666328|450277209|FG000|Overall Study|Death|2|||
125179599|NCT00666328|450277209|FG000|Overall Study|Lost to Follow-up|2|||
125179600|NCT00666328|450277209|FG000|Overall Study|No longer met eligibility criteria|1|||
125179601|NCT05064397|450277210|FG000|Overall Study|Adverse Event|4|||
125179602|NCT05064397|450277210|FG000|Overall Study|Lack of Efficacy|12|||
125179603|NCT05064397|450277210|FG000|Overall Study|Withdrawal by Subject|3|||
125179604|NCT05064397|450277210|FG000|Overall Study|Lost to Follow-up|1|||
125179605|NCT05064397|450277210|FG000|Overall Study|Other reasons|3|||
125179606|NCT02232984|450277211|FG000|Overall Study|Withdrawal by Subject|5|||
125179607|NCT02232984|450277211|FG000|Overall Study|Death|1|||
125179608|NCT02232984|450277211|FG000|Overall Study|Investigator withdrawal|10|||
125179609|NCT02232984|450277211|FG000|Overall Study|Device implant unsuccessful|53|||
125179610|NCT02232984|450277211|FG000|Overall Study|not disclosed by site|7|||
125179611|NCT02232984|450277211|FG000|Overall Study|Protocol Violation|1|||
125179612|NCT00535405|450277214|FG000|Overall Study|Adverse Event|6|||
125179613|NCT00535405|450277215|FG001|Overall Study|Adverse Event|8|||
125179614|NCT00535405|450277216|FG002|Overall Study|Adverse Event|3|||
125179615|NCT00535405|450277217|FG003|Overall Study|Adverse Event|8|||
125179616|NCT00535405|450277218|FG004|Overall Study|Adverse Event|6|||
125179617|NCT00535405|450277214|FG000|Overall Study|Lost to Follow-up|1|||
125179618|NCT00535405|450277215|FG001|Overall Study|Lost to Follow-up|3|||
125179619|NCT00535405|450277216|FG002|Overall Study|Lost to Follow-up|3|||
125179620|NCT00535405|450277217|FG003|Overall Study|Lost to Follow-up|2|||
125179621|NCT00535405|450277218|FG004|Overall Study|Lost to Follow-up|1|||
125179622|NCT00535405|450277214|FG000|Overall Study|Physician Decision|3|||
125179623|NCT00535405|450277215|FG001|Overall Study|Physician Decision|2|||
125179624|NCT00535405|450277216|FG002|Overall Study|Physician Decision|0|||
125179625|NCT00535405|450277217|FG003|Overall Study|Physician Decision|1|||
125179626|NCT00535405|450277218|FG004|Overall Study|Physician Decision|1|||
125179627|NCT00535405|450277214|FG000|Overall Study|Protocol Violation|2|||
125179628|NCT00535405|450277215|FG001|Overall Study|Protocol Violation|2|||
125179629|NCT00535405|450277216|FG002|Overall Study|Protocol Violation|2|||
125179630|NCT00535405|450277217|FG003|Overall Study|Protocol Violation|1|||
125179631|NCT00535405|450277218|FG004|Overall Study|Protocol Violation|0|||
125179632|NCT00535405|450277214|FG000|Overall Study|Withdrawal by Subject|5|||
125179633|NCT00535405|450277215|FG001|Overall Study|Withdrawal by Subject|11|||
125179634|NCT00535405|450277216|FG002|Overall Study|Withdrawal by Subject|10|||
125179635|NCT00535405|450277217|FG003|Overall Study|Withdrawal by Subject|10|||
125179636|NCT00535405|450277218|FG004|Overall Study|Withdrawal by Subject|8|||
125179637|NCT03404674|450277219|FG000|Overall Study|Inability to Attend Future Visits|0|||
125179638|NCT03404674|450277220|FG001|Overall Study|Inability to Attend Future Visits|1|||
125179639|NCT03404674|450277221|FG002|Overall Study|Inability to Attend Future Visits|1|||
125179640|NCT03404674|450277222|FG003|Overall Study|Inability to Attend Future Visits|0|||
125179641|NCT03404674|450277223|FG004|Overall Study|Inability to Attend Future Visits|0|||
125179642|NCT03404674|450277224|FG005|Overall Study|Inability to Attend Future Visits|0|||
125179643|NCT03404674|450277219|FG000|Overall Study|Behavioral Problems|0|||
125179644|NCT03404674|450277220|FG001|Overall Study|Behavioral Problems|0|||
125179645|NCT03404674|450277221|FG002|Overall Study|Behavioral Problems|1|||
125179646|NCT03404674|450277222|FG003|Overall Study|Behavioral Problems|0|||
125179647|NCT03404674|450277223|FG004|Overall Study|Behavioral Problems|0|||
125179648|NCT03404674|450277224|FG005|Overall Study|Behavioral Problems|0|||
125179649|NCT03404674|450277219|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
125179650|NCT03404674|450277220|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
125179651|NCT03404674|450277221|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
125179652|NCT03404674|450277222|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
125179653|NCT03404674|450277223|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
125179654|NCT03404674|450277224|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
125179655|NCT04728802|450277229|FG000|Overall Study|Withdrawal by Subject|4|||
125179656|NCT04728802|450277230|FG001|Overall Study|Withdrawal by Subject|20|||
125179657|NCT04728802|450277229|FG000|Overall Study|Physician Decision|7|||
125179658|NCT04728802|450277230|FG001|Overall Study|Physician Decision|7|||
125179659|NCT04728802|450277229|FG000|Overall Study|Protocol Violation|10|||
125179660|NCT04728802|450277230|FG001|Overall Study|Protocol Violation|4|||
125179661|NCT04728802|450277229|FG000|Overall Study|Transfer|1|||
125179662|NCT04728802|450277230|FG001|Overall Study|Transfer|0|||
125179663|NCT04728802|450277229|FG000|Overall Study|Death|4|||
125179664|NCT04728802|450277230|FG001|Overall Study|Death|5|||
125179665|NCT04728802|450277229|FG000|Overall Study|Other|3|||
125179666|NCT04728802|450277230|FG001|Overall Study|Other|0|||
125179667|NCT01176513|450277231|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
125179668|NCT01959295|450277236|FG000|Overall Study|Adverse Event|2|||
125179669|NCT01959295|450277237|FG001|Overall Study|Adverse Event|0|||
125179670|NCT01959295|450277236|FG000|Overall Study|Lost to Follow-up|0|||
125179671|NCT01959295|450277237|FG001|Overall Study|Lost to Follow-up|2|||
125179672|NCT01959295|450277236|FG000|Overall Study|Physician Decision|2|||
125179673|NCT01959295|450277237|FG001|Overall Study|Physician Decision|3|||
125179674|NCT01959295|450277236|FG000|Overall Study|Protocol Violation|16|||
125179675|NCT01959295|450277237|FG001|Overall Study|Protocol Violation|5|||
125179676|NCT01959295|450277236|FG000|Overall Study|Withdrawal by Subject|3|||
125179677|NCT01959295|450277237|FG001|Overall Study|Withdrawal by Subject|1|||
125179678|NCT01959295|450277236|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
125179679|NCT01959295|450277237|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
125179680|NCT04011722|450279095|FG000|30 Days|Death|5|||
125179681|NCT04011722|450279096|FG001|30 Days|Death|1|||
125179682|NCT04011722|450279095|FG000|1 Year|Death|13|||
125179683|NCT04011722|450279096|FG001|1 Year|Death|5|||
125179684|NCT04011722|450279095|FG000|1 Year|Withdrawal by Subject|8|||
125179685|NCT04011722|450279096|FG001|1 Year|Withdrawal by Subject|2|||
125179686|NCT04011722|450279095|FG000|1 Year|Missed Visit|6|||
125179687|NCT04011722|450279096|FG001|1 Year|Missed Visit|1|||
125179688|NCT04011722|450279095|FG000|1 Year|Pending Visit|0|||
125179689|NCT04011722|450279096|FG001|1 Year|Pending Visit|11|||
125179690|NCT04011722|450279095|FG000|1 Year|Not Yet Due|0|||
125179691|NCT04011722|450279096|FG001|1 Year|Not Yet Due|9|||
125179692|NCT04011722|450279095|FG000|2 Year|Death|16|||
125179693|NCT04011722|450279096|FG001|2 Year|Death|1|||
125179694|NCT04011722|450279095|FG000|2 Year|Withdrawal by Subject|10|||
125179695|NCT04011722|450279096|FG001|2 Year|Withdrawal by Subject|1|||
125179696|NCT04011722|450279095|FG000|2 Year|Missed Visit|9|||
125179697|NCT04011722|450279096|FG001|2 Year|Missed Visit|0|||
125179698|NCT04011722|450279095|FG000|2 Year|Visit Pending|1|||
125179699|NCT04011722|450279096|FG001|2 Year|Visit Pending|3|||
125179700|NCT04011722|450279095|FG000|2 Year|Not Yet Due|43|||
125179701|NCT04011722|450279096|FG001|2 Year|Not Yet Due|54|||
125179702|NCT04011722|450279095|FG000|3 Year|Death|10|||
125179703|NCT04011722|450279096|FG001|3 Year|Death|0|||
125179704|NCT04011722|450279095|FG000|3 Year|Withdrawal by Subject|2|||
125179705|NCT04011722|450279096|FG001|3 Year|Withdrawal by Subject|0|||
125179706|NCT04011722|450279095|FG000|3 Year|Missed Visit|2|||
125179707|NCT04011722|450279096|FG001|3 Year|Missed Visit|0|||
125179708|NCT04011722|450279095|FG000|3 Year|Pending Visit|34|||
125179709|NCT04011722|450279096|FG001|3 Year|Pending Visit|0|||
125179710|NCT04011722|450279095|FG000|3 Year|Not Yet Due|99|||
125179711|NCT04011722|450279096|FG001|3 Year|Not Yet Due|0|||
125179712|NCT05061134|450279097|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
125179713|NCT05061134|450279098|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
125179714|NCT05061134|450279099|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
125179715|NCT05061134|450279097|FG000|Overall Study|Subject not treated|0|||
125179716|NCT05061134|450279098|FG001|Overall Study|Subject not treated|0|||
125179717|NCT05061134|450279099|FG002|Overall Study|Subject not treated|2|||
125179718|NCT05061134|450279097|FG000|Overall Study|Other|0|||
125179719|NCT05061134|450279098|FG001|Overall Study|Other|0|||
125179720|NCT05061134|450279099|FG002|Overall Study|Other|9|||
125179721|NCT05061134|450279097|FG000|Overall Study|Withdrawal by Subject|9|||
125179722|NCT05061134|450279098|FG001|Overall Study|Withdrawal by Subject|8|||
125235462|NCT04761822|450489853|FG003|Overall Study|Withdrawal by Subject|11|||
125235463|NCT04761822|450489850|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
125235464|NCT04761822|450489851|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
125235465|NCT04761822|450489852|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
125235466|NCT04761822|450489853|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
125179723|NCT05061134|450279099|FG002|Overall Study|Withdrawal by Subject|5|||
125179724|NCT05061134|450279097|FG000|Overall Study|Study Terminated by Sponsor|22|||
125179725|NCT05061134|450279098|FG001|Overall Study|Study Terminated by Sponsor|14|||
125235467|NCT04761822|450489850|FG000|Overall Study|Participant requested unblinding|0|||
125235468|NCT04761822|450489851|FG001|Overall Study|Participant requested unblinding|0|||
125235469|NCT04761822|450489852|FG002|Overall Study|Participant requested unblinding|0|||
125235470|NCT04761822|450489853|FG003|Overall Study|Participant requested unblinding|1|||
125235471|NCT04734652|450489854|FG000|Overall Study|Withdrawal by Subject|2|||
125235472|NCT04734652|450489855|FG001|Overall Study|Withdrawal by Subject|0|||
125235473|NCT04734652|450489854|FG000|Overall Study|Death|0|||
125235474|NCT04734652|450489855|FG001|Overall Study|Death|1|||
125235475|NCT02233413|450489856|FG000|Overall Study|Lost to Follow-up|7|||
125235476|NCT02233413|450489857|FG001|Overall Study|Lost to Follow-up|9|||
125235477|NCT02233413|450489856|FG000|Overall Study|Withdrawal by Subject|4|||
125235478|NCT02233413|450489857|FG001|Overall Study|Withdrawal by Subject|5|||
125235479|NCT02471183|450489866|FG000|Main Treatment Period|Adverse Event|1|||
125235480|NCT02471183|450489866|FG000|Main Treatment Period|Withdrawal by Subject|1|||
125235481|NCT02471183|450489866|FG000|Extended Treatment Period|Lack of Efficacy|1|||
125235482|NCT00827567|450489868|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
125235483|NCT02326883|450489869|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
125235484|NCT02326883|450489870|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
125235485|NCT02326883|450489871|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
125235486|NCT02736617|450489872|FG000|Treatment|Adverse Event|1|||
125235487|NCT02736617|450489872|FG000|Treatment|Lack of Efficacy|1|||
125235488|NCT02736617|450489872|FG000|Treatment|Withdrawal by Subject|1|||
125235489|NCT02736617|450489872|FG000|Maintenance|Lack of Efficacy|4|||
125235490|NCT02736617|450489872|FG000|Maintenance|Physician Decision|1|||
125235491|NCT02911116|450489875|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125235492|NCT02911116|450489876|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125235493|NCT02911116|450489875|FG000|Overall Study|Lost to Follow-up|0|||
125235494|NCT02911116|450489876|FG001|Overall Study|Lost to Follow-up|1|||
125235495|NCT04796415|450489877|FG000|Overall Study|not interested|12|||
125235496|NCT04796415|450489877|FG000|Overall Study|health issue|8|||
125235497|NCT04796415|450489877|FG000|Overall Study|Other|4|||
125235498|NCT04796415|450489877|FG000|Overall Study|discharged from home health service|3|||
125235499|NCT04796415|450489877|FG000|Overall Study|re-hospitalization|2|||
125235500|NCT04796415|450489877|FG000|Overall Study|moving to nursing home|1|||
125235501|NCT04796415|450489877|FG000|Overall Study|lost contact|1|||
125235502|NCT02469857|450489878|FG000|Overall Study|Death|24|||
125235503|NCT02469857|450489879|FG001|Overall Study|Death|29|||
125235504|NCT02469857|450489878|FG000|Overall Study|Discontinuation|1|||
125235505|NCT02469857|450489879|FG001|Overall Study|Discontinuation|3|||
125235506|NCT02110693|450489880|FG000|Overall Study|Withdrawal by Subject|6|||
125235507|NCT02110693|450489881|FG001|Overall Study|Withdrawal by Subject|7|||
125235508|NCT02110693|450489880|FG000|Overall Study|skipped assessment|15|||
125235509|NCT02110693|450489881|FG001|Overall Study|skipped assessment|18|||
125235510|NCT02110693|450489880|FG000|Overall Study|technical difficulties|6|||
125235511|NCT02110693|450489881|FG001|Overall Study|technical difficulties|4|||
125235512|NCT02110693|450489880|FG000|Overall Study|Other|1|||
125179726|NCT05061134|450279099|FG002|Overall Study|Study Terminated by Sponsor|7|||
125179727|NCT05061134|450279097|FG000|Overall Study|Progressive Disease|1|||
125179728|NCT05061134|450279098|FG001|Overall Study|Progressive Disease|2|||
125179729|NCT05061134|450279099|FG002|Overall Study|Progressive Disease|0|||
125179730|NCT05061134|450279097|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
125179731|NCT05061134|450279098|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
125179732|NCT05061134|450279099|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
125179733|NCT05061134|450279097|FG000|Overall Study|Lost to Follow-up|1|||
125179734|NCT05061134|450279098|FG001|Overall Study|Lost to Follow-up|0|||
125179735|NCT05061134|450279099|FG002|Overall Study|Lost to Follow-up|0|||
125179736|NCT05061134|450279097|FG000|Overall Study|Physician Decision|1|||
125235513|NCT02110693|450489881|FG001|Overall Study|Other|0|||
125235514|NCT00937950|450489882|FG000|Overall Study|Withdrawal by Subject|23|||
125235515|NCT00937950|450489882|FG000|Overall Study|Migrated/moved from study area|27|||
125235516|NCT00937950|450489882|FG000|Overall Study|Lost to Follow-up|144|||
125235517|NCT00937950|450489882|FG000|Overall Study|Missing confirmed|4|||
125235518|NCT00937950|450489882|FG000|Overall Study|Other|18|||
125235519|NCT04810962|450489883|FG000|Overall Study|Adverse Event|0|||
125235520|NCT04810962|450489884|FG001|Overall Study|Adverse Event|1|||
125179737|NCT05061134|450279098|FG001|Overall Study|Physician Decision|1|||
125179738|NCT05061134|450279099|FG002|Overall Study|Physician Decision|0|||
125179739|NCT05061134|450279097|FG000|Overall Study|Disease progression|1|||
125179740|NCT05061134|450279098|FG001|Overall Study|Disease progression|0|||
125179741|NCT05061134|450279099|FG002|Overall Study|Disease progression|0|||
125179742|NCT05061134|450279097|FG000|Overall Study|Death|43|||
125179743|NCT05061134|450279098|FG001|Overall Study|Death|23|||
125179744|NCT05061134|450279099|FG002|Overall Study|Death|14|||
125179745|NCT05061134|450279097|FG000|Overall Study|Database lock|2|||
125179746|NCT05061134|450279098|FG001|Overall Study|Database lock|0|||
125179747|NCT05061134|450279099|FG002|Overall Study|Database lock|0|||
125179748|NCT04848480|450279103|FG000|Main Phase (26 Weeks)|Death|1|||
125179749|NCT04848480|450279104|FG001|Main Phase (26 Weeks)|Death|0|||
125179750|NCT04848480|450279103|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
125179751|NCT04848480|450279104|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
125179752|NCT04848480|450279103|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
125179753|NCT04848480|450279104|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
125179754|NCT04848480|450279103|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
125179755|NCT04848480|450279104|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
125179756|NCT04848480|450279103|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
125179757|NCT04848480|450279104|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
125179758|NCT04848480|450279103|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
125179759|NCT04848480|450279104|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
125179760|NCT01368497|450279105|FG000|Overall Study|Lost to Follow-up|2|||
125179761|NCT02366689|450279107|FG000|Overall Study|Withdrawal by Subject|1|||
125179762|NCT02366689|450279108|FG001|Overall Study|Withdrawal by Subject|0|||
125179763|NCT02366689|450279109|FG002|Overall Study|Withdrawal by Subject|1|||
125179764|NCT02366689|450279107|FG000|Overall Study|Lost to Follow-up|3|||
125179765|NCT02366689|450279108|FG001|Overall Study|Lost to Follow-up|2|||
125179766|NCT02366689|450279109|FG002|Overall Study|Lost to Follow-up|0|||
125179767|NCT02366689|450279107|FG000|Overall Study|Pregnancy|0|||
125179768|NCT02366689|450279108|FG001|Overall Study|Pregnancy|1|||
125179769|NCT02366689|450279109|FG002|Overall Study|Pregnancy|1|||
125179770|NCT03283566|450279110|FG000|Overall Study|Lost to Follow-up|1|||
125179771|NCT03283566|450279111|FG001|Overall Study|Lost to Follow-up|2|||
125179772|NCT03718832|450279112|FG000|Analysis Sample|Withdrawal by Subject|18|||
125179773|NCT03718832|450279113|FG001|Analysis Sample|Withdrawal by Subject|15|||
125179774|NCT03718832|450279112|FG000|Analysis Sample|Legal hold on data|1|||
125179775|NCT03718832|450279113|FG001|Analysis Sample|Legal hold on data|0|||
125179776|NCT03718832|450279112|FG000|Analysis Sample|Participant from treated household|0|||
125179777|NCT03718832|450279113|FG001|Analysis Sample|Participant from treated household|1|||
125179778|NCT03718832|450279112|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
125179779|NCT03718832|450279113|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
125179780|NCT03288714|450279118|FG000|Overall Study|Lost to Follow-up|2|||
125179781|NCT03288714|450279119|FG001|Overall Study|Lost to Follow-up|1|||
125179782|NCT03288714|450279118|FG000|Overall Study|Non-compliance with study schedule|2|||
125179783|NCT03288714|450279119|FG001|Overall Study|Non-compliance with study schedule|0|||
125179784|NCT03288714|450279118|FG000|Overall Study|Withdrawal by Subject|3|||
125179785|NCT03288714|450279119|FG001|Overall Study|Withdrawal by Subject|1|||
125179786|NCT03288714|450279118|FG000|Overall Study|Clinical Worsening|2|||
125179787|NCT03288714|450279119|FG001|Overall Study|Clinical Worsening|1|||
125179788|NCT03288714|450279118|FG000|Overall Study|Adverse Event|1|||
125179789|NCT03288714|450279119|FG001|Overall Study|Adverse Event|0|||
125179790|NCT04882241|450279120|FG000|Overall Study|Ongoing in study|46|||
125179791|NCT04882241|450279121|FG001|Overall Study|Ongoing in study|48|||
125179792|NCT04882241|450279122|FG002|Overall Study|Ongoing in study|0|||
125179793|NCT04882241|450279123|FG003|Overall Study|Ongoing in study|0|||
125179794|NCT04882241|450279120|FG000|Overall Study|Death|13|||
125179795|NCT04882241|450279121|FG001|Overall Study|Death|13|||
125179796|NCT04882241|450279122|FG002|Overall Study|Death|0|||
125179797|NCT04882241|450279123|FG003|Overall Study|Death|0|||
125179798|NCT02203357|450279133|FG000|Overall Study|Lost to Follow-up|58|||
125179799|NCT02203357|450279134|FG001|Overall Study|Lost to Follow-up|66|||
125179800|NCT02203357|450279135|FG002|Overall Study|Lost to Follow-up|70|||
125179801|NCT00470535|450279148|FG000|Overall Study|Disease Progression|13|||
125179802|NCT00470535|450279148|FG000|Overall Study|Withdrawal by Subject|1|||
125179803|NCT00470535|450279148|FG000|Overall Study|Adverse Event|1|||
125179804|NCT00470535|450279148|FG000|Overall Study|Death|1|||
125179805|NCT00470535|450279148|FG000|Overall Study|Other|2|||
125179806|NCT02070965|450279153|FG000|Overall Study|Lost to Follow-up|0|||
125179807|NCT02070965|450279154|FG001|Overall Study|Lost to Follow-up|1|||
125179808|NCT02070965|450279155|FG002|Overall Study|Lost to Follow-up|0|||
125179809|NCT02070965|450279153|FG000|Overall Study|Withdrawal by Subject|1|||
125179810|NCT02070965|450279154|FG001|Overall Study|Withdrawal by Subject|1|||
125179811|NCT02070965|450279155|FG002|Overall Study|Withdrawal by Subject|1|||
125179812|NCT02070965|450279153|FG000|Overall Study|Subject moved|1|||
125179813|NCT02070965|450279154|FG001|Overall Study|Subject moved|0|||
125179814|NCT02070965|450279155|FG002|Overall Study|Subject moved|0|||
125179815|NCT02515331|450279156|FG000|Overall Study|Withdrawal by Subject|0|||
125179816|NCT02515331|450279157|FG001|Overall Study|Withdrawal by Subject|0|||
125235521|NCT04810962|450489883|FG000|Overall Study|Lost to Follow-up|2|||
125179817|NCT02515331|450279158|FG002|Overall Study|Withdrawal by Subject|1|||
125179818|NCT02515331|450279156|FG000|Overall Study|Protocol deviation|0|||
125179819|NCT02515331|450279157|FG001|Overall Study|Protocol deviation|0|||
125179820|NCT02515331|450279158|FG002|Overall Study|Protocol deviation|3|||
125179821|NCT02515331|450279156|FG000|Overall Study|Adverse Event|2|||
125179822|NCT02515331|450279157|FG001|Overall Study|Adverse Event|0|||
125179823|NCT02515331|450279158|FG002|Overall Study|Adverse Event|0|||
125179824|NCT00124748|450279159|FG000|Overall Study|Adverse Event|8|||
125179825|NCT00124748|450279160|FG001|Overall Study|Adverse Event|39|||
125179826|NCT00124748|450279159|FG000|Overall Study|Abnormal laboratory Value|2|||
125179827|NCT00124748|450279160|FG001|Overall Study|Abnormal laboratory Value|2|||
125179828|NCT00124748|450279159|FG000|Overall Study|Abnormal Procedure|0|||
125179829|NCT00124748|450279160|FG001|Overall Study|Abnormal Procedure|1|||
125179830|NCT00124748|450279159|FG000|Overall Study|Lack of Efficacy|20|||
125179831|NCT00124748|450279160|FG001|Overall Study|Lack of Efficacy|41|||
125179832|NCT00124748|450279159|FG000|Overall Study|No longer requires study drug|1|||
125179833|NCT00124748|450279160|FG001|Overall Study|No longer requires study drug|1|||
125179834|NCT00124748|450279159|FG000|Overall Study|Protocol Violation|3|||
125179835|NCT00124748|450279160|FG001|Overall Study|Protocol Violation|1|||
125179836|NCT00124748|450279159|FG000|Overall Study|Withdrawal by Subject|5|||
125179837|NCT00124748|450279160|FG001|Overall Study|Withdrawal by Subject|15|||
125179838|NCT00124748|450279159|FG000|Overall Study|Lost to Follow-up|2|||
125179839|NCT00124748|450279160|FG001|Overall Study|Lost to Follow-up|7|||
125179840|NCT00124748|450279159|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
125179841|NCT00124748|450279160|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
125179842|NCT00124748|450279159|FG000|Overall Study|Death|1|||
125179843|NCT00124748|450279160|FG001|Overall Study|Death|3|||
125179844|NCT00322712|450279161|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
125179845|NCT03889886|450279163|FG000|Overall Study|Other|0|||
125179846|NCT03889886|450279164|FG001|Overall Study|Other|1|||
125179847|NCT03889886|450279165|FG002|Overall Study|Other|0|||
125179848|NCT03889886|450279166|FG003|Overall Study|Other|1|||
125179849|NCT03889886|450279163|FG000|Overall Study|Withdrawal by Subject|0|||
125179850|NCT03889886|450279164|FG001|Overall Study|Withdrawal by Subject|0|||
125179851|NCT03889886|450279165|FG002|Overall Study|Withdrawal by Subject|1|||
125179852|NCT03889886|450279166|FG003|Overall Study|Withdrawal by Subject|0|||
125179853|NCT03889886|450279163|FG000|Overall Study|Adverse Event|0|||
125179854|NCT03889886|450279164|FG001|Overall Study|Adverse Event|0|||
125179855|NCT03889886|450279165|FG002|Overall Study|Adverse Event|0|||
125179856|NCT03889886|450279166|FG003|Overall Study|Adverse Event|6|||
125179857|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
125179858|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
125179859|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
125179860|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179861|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
125179862|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
125179863|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179864|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179865|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179866|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179867|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179868|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179869|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179870|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179871|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179872|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179873|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
125179874|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
125179875|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179876|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
125179877|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
125179878|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
125179879|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
125179880|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179881|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179882|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179883|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179884|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179885|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179886|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179887|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179888|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179889|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125235522|NCT04810962|450489884|FG001|Overall Study|Lost to Follow-up|1|||
125235523|NCT04810962|450489883|FG000|Overall Study|Physician Decision|1|||
125235524|NCT04810962|450489884|FG001|Overall Study|Physician Decision|0|||
125235525|NCT04810962|450489883|FG000|Overall Study|Withdrawal by Subject|1|||
125235526|NCT04810962|450489884|FG001|Overall Study|Withdrawal by Subject|3|||
125235527|NCT04810962|450489883|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
125179890|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
125179891|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
125179892|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
125179893|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
125179894|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
125179895|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
125179896|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
125179897|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179898|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179899|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179900|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179901|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179902|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179903|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179904|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179905|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179906|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179907|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
125179908|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179909|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
125179910|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
125179911|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179912|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
125179913|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
125179914|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179915|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179916|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179917|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179918|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179919|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179920|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179921|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179922|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179923|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179924|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
125179925|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179926|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179927|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
125179928|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
125179929|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179930|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179931|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179932|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179933|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179934|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179935|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179936|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179937|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179938|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179939|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179940|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179941|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
125179942|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179943|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179944|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179945|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179946|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
125179947|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179948|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179949|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179950|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179951|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179952|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179953|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179954|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179955|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179956|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179957|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179958|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
125179959|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179960|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
125179961|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179962|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179963|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179964|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179965|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179966|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179967|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179968|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179969|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179970|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179971|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179972|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179973|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179974|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179975|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
125179976|NCT00758524|450279167|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179977|NCT00758524|450279168|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
125179978|NCT00758524|450279169|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179979|NCT00758524|450279170|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179980|NCT00758524|450279171|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179981|NCT00758524|450279172|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179982|NCT00758524|450279173|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179983|NCT00758524|450279174|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179984|NCT00758524|450279175|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179985|NCT00758524|450279176|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179986|NCT00758524|450279177|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179987|NCT00758524|450279178|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179988|NCT00758524|450279179|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179989|NCT00758524|450279180|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179990|NCT00758524|450279181|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179991|NCT00758524|450279182|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179992|NCT00758524|450279183|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
125179993|NCT00758524|450279167|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125179994|NCT00758524|450279168|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125179995|NCT00758524|450279169|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125179996|NCT00758524|450279170|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125179997|NCT00758524|450279171|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125179998|NCT00758524|450279172|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125179999|NCT00758524|450279173|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180000|NCT00758524|450279174|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180001|NCT00758524|450279175|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
125180002|NCT00758524|450279176|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180003|NCT00758524|450279177|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180004|NCT00758524|450279178|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180005|NCT00758524|450279179|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180006|NCT00758524|450279180|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180007|NCT00758524|450279181|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180008|NCT00758524|450279182|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180009|NCT00758524|450279183|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
125180010|NCT00758524|450279167|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180011|NCT00758524|450279168|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180012|NCT00758524|450279169|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180013|NCT00758524|450279170|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180014|NCT00758524|450279171|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180015|NCT00758524|450279172|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180016|NCT00758524|450279173|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
125180017|NCT00758524|450279174|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180018|NCT00758524|450279175|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180019|NCT00758524|450279176|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180020|NCT00758524|450279177|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180021|NCT00758524|450279178|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180022|NCT00758524|450279179|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180023|NCT00758524|450279180|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180024|NCT00758524|450279181|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180025|NCT00758524|450279182|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180026|NCT00758524|450279183|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
125180027|NCT04747470|450279198|FG000|Overall Study|Death|0|||
125180028|NCT04747470|450279199|FG001|Overall Study|Death|3|||
125180029|NCT04747470|450279200|FG002|Overall Study|Death|2|||
125180030|NCT04747470|450279201|FG003|Overall Study|Death|2|||
125180031|NCT04747470|450279202|FG004|Overall Study|Death|2|||
125180032|NCT04747470|450279203|FG005|Overall Study|Death|0|||
125180033|NCT04747470|450279204|FG006|Overall Study|Death|0|||
125180034|NCT04747470|450279205|FG007|Overall Study|Death|0|||
125180035|NCT04747470|450279206|FG008|Overall Study|Death|0|||
125180036|NCT04747470|450279207|FG009|Overall Study|Death|0|||
125180037|NCT04747470|450279208|FG010|Overall Study|Death|0|||
125180038|NCT04747470|450279198|FG000|Overall Study|Withdrew Consent|0|||
125180039|NCT04747470|450279199|FG001|Overall Study|Withdrew Consent|0|||
125180040|NCT04747470|450279200|FG002|Overall Study|Withdrew Consent|0|||
125180041|NCT04747470|450279201|FG003|Overall Study|Withdrew Consent|1|||
125180042|NCT04747470|450279202|FG004|Overall Study|Withdrew Consent|0|||
125180043|NCT04747470|450279203|FG005|Overall Study|Withdrew Consent|0|||
125180044|NCT04747470|450279204|FG006|Overall Study|Withdrew Consent|0|||
125180045|NCT04747470|450279205|FG007|Overall Study|Withdrew Consent|0|||
125180046|NCT04747470|450279206|FG008|Overall Study|Withdrew Consent|0|||
125180047|NCT04747470|450279207|FG009|Overall Study|Withdrew Consent|0|||
125180048|NCT04747470|450279208|FG010|Overall Study|Withdrew Consent|0|||
125180049|NCT04747470|450279198|FG000|Overall Study|Study Terminated by Sponsor|0|||
125180050|NCT04747470|450279199|FG001|Overall Study|Study Terminated by Sponsor|0|||
125180051|NCT04747470|450279200|FG002|Overall Study|Study Terminated by Sponsor|1|||
125180052|NCT04747470|450279201|FG003|Overall Study|Study Terminated by Sponsor|0|||
125180053|NCT04747470|450279202|FG004|Overall Study|Study Terminated by Sponsor|2|||
125180054|NCT04747470|450279203|FG005|Overall Study|Study Terminated by Sponsor|0|||
125180055|NCT04747470|450279204|FG006|Overall Study|Study Terminated by Sponsor|0|||
125180056|NCT04747470|450279205|FG007|Overall Study|Study Terminated by Sponsor|0|||
125180057|NCT04747470|450279206|FG008|Overall Study|Study Terminated by Sponsor|0|||
125180058|NCT04747470|450279207|FG009|Overall Study|Study Terminated by Sponsor|0|||
125180059|NCT04747470|450279208|FG010|Overall Study|Study Terminated by Sponsor|0|||
125180060|NCT01942993|450279209|FG000|Overall Study|Lost to Follow-up|1|||
125180061|NCT01942993|450279209|FG000|Overall Study|Physician Decision|1|||
125180062|NCT01350271|450279213|FG000|Overall Study|Lost to Follow-up|21|||
125180063|NCT01350271|450279214|FG001|Overall Study|Lost to Follow-up|17|||
125180064|NCT01350271|450279215|FG002|Overall Study|Lost to Follow-up|26|||
125180065|NCT02906670|450279216|FG000|Cohort 1, QW|Radiological Progression|1|||
125180066|NCT02906670|450279217|FG001|Cohort 1, QW|Radiological Progression|0|||
125180067|NCT02906670|450279218|FG002|Cohort 1, QW|Radiological Progression|0|||
125180068|NCT02906670|450279219|FG003|Cohort 1, QW|Radiological Progression|0|||
125180069|NCT02906670|450279220|FG004|Cohort 1, QW|Radiological Progression|0|||
125180070|NCT02906670|450279221|FG005|Cohort 1, QW|Radiological Progression|0|||
125180071|NCT02906670|450279222|FG006|Cohort 1, QW|Radiological Progression|0|||
125180072|NCT02906670|450279223|FG007|Cohort 1, QW|Radiological Progression|0|||
125180073|NCT02906670|450279224|FG008|Cohort 1, QW|Radiological Progression|0|||
125180074|NCT02906670|450279225|FG009|Cohort 1, QW|Radiological Progression|0|||
125180075|NCT02906670|450279216|FG000|Cohort 2, QW|Radiological Progression|0|||
125180076|NCT02906670|450279217|FG001|Cohort 2, QW|Radiological Progression|1|||
125180077|NCT02906670|450279218|FG002|Cohort 2, QW|Radiological Progression|0|||
125180078|NCT02906670|450279219|FG003|Cohort 2, QW|Radiological Progression|0|||
125180079|NCT02906670|450279220|FG004|Cohort 2, QW|Radiological Progression|0|||
125180080|NCT02906670|450279221|FG005|Cohort 2, QW|Radiological Progression|0|||
125180081|NCT02906670|450279222|FG006|Cohort 2, QW|Radiological Progression|0|||
125180082|NCT02906670|450279223|FG007|Cohort 2, QW|Radiological Progression|0|||
125180083|NCT02906670|450279224|FG008|Cohort 2, QW|Radiological Progression|0|||
125180084|NCT02906670|450279225|FG009|Cohort 2, QW|Radiological Progression|0|||
125303080|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125180085|NCT02906670|450279216|FG000|Cohort 3, QW|Radiological Progression|0|||
125180086|NCT02906670|450279217|FG001|Cohort 3, QW|Radiological Progression|0|||
125180087|NCT02906670|450279218|FG002|Cohort 3, QW|Radiological Progression|2|||
125180088|NCT02906670|450279219|FG003|Cohort 3, QW|Radiological Progression|0|||
125180089|NCT02906670|450279220|FG004|Cohort 3, QW|Radiological Progression|0|||
125235528|NCT04810962|450489884|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
125235529|NCT02412657|450489888|FG000|Overall Study|Lost to Follow-up|1|||
125235530|NCT02412657|450489889|FG001|Overall Study|Lost to Follow-up|0|||
125235531|NCT02412657|450489890|FG002|Overall Study|Lost to Follow-up|0|||
125235532|NCT02412657|450489888|FG000|Overall Study|Protocol Violation|0|||
125235533|NCT02412657|450489889|FG001|Overall Study|Protocol Violation|2|||
125235534|NCT02412657|450489890|FG002|Overall Study|Protocol Violation|3|||
125235535|NCT00460798|450489891|FG000|Overall Study|Death|59|||
125180090|NCT02906670|450279221|FG005|Cohort 3, QW|Radiological Progression|0|||
125180091|NCT02906670|450279222|FG006|Cohort 3, QW|Radiological Progression|0|||
125180092|NCT02906670|450279223|FG007|Cohort 3, QW|Radiological Progression|0|||
125180093|NCT02906670|450279224|FG008|Cohort 3, QW|Radiological Progression|0|||
125180094|NCT02906670|450279225|FG009|Cohort 3, QW|Radiological Progression|0|||
125180095|NCT02906670|450279216|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180096|NCT02906670|450279217|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180097|NCT02906670|450279218|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
125180098|NCT02906670|450279219|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180099|NCT02906670|450279220|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180100|NCT02906670|450279221|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180101|NCT02906670|450279222|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180102|NCT02906670|450279223|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180103|NCT02906670|450279224|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180104|NCT02906670|450279225|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
125180105|NCT02906670|450279216|FG000|Cohort 4, Q2W|Radiological Progression|0|||
125180106|NCT02906670|450279217|FG001|Cohort 4, Q2W|Radiological Progression|0|||
125180107|NCT02906670|450279218|FG002|Cohort 4, Q2W|Radiological Progression|0|||
125180108|NCT02906670|450279219|FG003|Cohort 4, Q2W|Radiological Progression|0|||
125180109|NCT02906670|450279220|FG004|Cohort 4, Q2W|Radiological Progression|0|||
125180110|NCT02906670|450279221|FG005|Cohort 4, Q2W|Radiological Progression|1|||
125180111|NCT02906670|450279222|FG006|Cohort 4, Q2W|Radiological Progression|0|||
125180112|NCT02906670|450279223|FG007|Cohort 4, Q2W|Radiological Progression|0|||
125180113|NCT02906670|450279224|FG008|Cohort 4, Q2W|Radiological Progression|0|||
125180114|NCT02906670|450279225|FG009|Cohort 4, Q2W|Radiological Progression|0|||
125180115|NCT02906670|450279216|FG000|Cohort 4, Q2W|Clinical Progression|0|||
125180116|NCT02906670|450279217|FG001|Cohort 4, Q2W|Clinical Progression|0|||
125180117|NCT02906670|450279218|FG002|Cohort 4, Q2W|Clinical Progression|0|||
125180118|NCT02906670|450279219|FG003|Cohort 4, Q2W|Clinical Progression|0|||
125180119|NCT02906670|450279220|FG004|Cohort 4, Q2W|Clinical Progression|0|||
125180120|NCT02906670|450279221|FG005|Cohort 4, Q2W|Clinical Progression|2|||
125180121|NCT02906670|450279222|FG006|Cohort 4, Q2W|Clinical Progression|0|||
125180122|NCT02906670|450279223|FG007|Cohort 4, Q2W|Clinical Progression|0|||
125180123|NCT02906670|450279224|FG008|Cohort 4, Q2W|Clinical Progression|0|||
125180124|NCT02906670|450279225|FG009|Cohort 4, Q2W|Clinical Progression|0|||
125180125|NCT02906670|450279216|FG000|Cohort 5, Q2W|Radiological Progression|0|||
125180126|NCT02906670|450279217|FG001|Cohort 5, Q2W|Radiological Progression|0|||
125180127|NCT02906670|450279218|FG002|Cohort 5, Q2W|Radiological Progression|0|||
125180128|NCT02906670|450279219|FG003|Cohort 5, Q2W|Radiological Progression|0|||
125180129|NCT02906670|450279220|FG004|Cohort 5, Q2W|Radiological Progression|0|||
125180130|NCT02906670|450279221|FG005|Cohort 5, Q2W|Radiological Progression|0|||
125180131|NCT02906670|450279222|FG006|Cohort 5, Q2W|Radiological Progression|4|||
125180132|NCT02906670|450279223|FG007|Cohort 5, Q2W|Radiological Progression|0|||
125180133|NCT02906670|450279224|FG008|Cohort 5, Q2W|Radiological Progression|0|||
125180134|NCT02906670|450279225|FG009|Cohort 5, Q2W|Radiological Progression|0|||
125180135|NCT02906670|450279216|FG000|Cohort 5, Q2W|Clinical Progression|0|||
125180136|NCT02906670|450279217|FG001|Cohort 5, Q2W|Clinical Progression|0|||
125180137|NCT02906670|450279218|FG002|Cohort 5, Q2W|Clinical Progression|0|||
125180138|NCT02906670|450279219|FG003|Cohort 5, Q2W|Clinical Progression|0|||
125180139|NCT02906670|450279220|FG004|Cohort 5, Q2W|Clinical Progression|0|||
125180140|NCT02906670|450279221|FG005|Cohort 5, Q2W|Clinical Progression|0|||
125180141|NCT02906670|450279222|FG006|Cohort 5, Q2W|Clinical Progression|1|||
125180142|NCT02906670|450279223|FG007|Cohort 5, Q2W|Clinical Progression|0|||
125180143|NCT02906670|450279224|FG008|Cohort 5, Q2W|Clinical Progression|0|||
125180144|NCT02906670|450279225|FG009|Cohort 5, Q2W|Clinical Progression|0|||
125180145|NCT02906670|450279216|FG000|Cohort 5, Q2W|Adverse Event|0|||
125180146|NCT02906670|450279217|FG001|Cohort 5, Q2W|Adverse Event|0|||
125180147|NCT02906670|450279218|FG002|Cohort 5, Q2W|Adverse Event|0|||
125180148|NCT02906670|450279219|FG003|Cohort 5, Q2W|Adverse Event|0|||
125180149|NCT02906670|450279220|FG004|Cohort 5, Q2W|Adverse Event|0|||
125180150|NCT02906670|450279221|FG005|Cohort 5, Q2W|Adverse Event|0|||
125235536|NCT00460798|450489891|FG000|Overall Study|Adverse Event|27|||
125392387|NCT03261947|451070649|FG000|Overall Study|Reason not Specified|2|||
125180151|NCT02906670|450279222|FG006|Cohort 5, Q2W|Adverse Event|1|||
125180152|NCT02906670|450279223|FG007|Cohort 5, Q2W|Adverse Event|0|||
125180153|NCT02906670|450279224|FG008|Cohort 5, Q2W|Adverse Event|0|||
125180154|NCT02906670|450279225|FG009|Cohort 5, Q2W|Adverse Event|0|||
125180155|NCT02906670|450279216|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180156|NCT02906670|450279217|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180157|NCT02906670|450279218|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180158|NCT02906670|450279219|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180159|NCT02906670|450279220|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180160|NCT02906670|450279221|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180161|NCT02906670|450279222|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
125180162|NCT02906670|450279223|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180163|NCT02906670|450279224|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180164|NCT02906670|450279225|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
125180165|NCT02906670|450279216|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
125180166|NCT02906670|450279217|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
125180167|NCT02906670|450279218|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
125180168|NCT02906670|450279219|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
125180169|NCT02906670|450279220|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
125180170|NCT02906670|450279221|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
125180171|NCT02906670|450279222|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
125180172|NCT02906670|450279223|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
125180173|NCT02906670|450279224|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
125180174|NCT02906670|450279225|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
125180175|NCT02906670|450279216|FG000|Cohort 5P, Q2W|Adverse Event|0|||
125180176|NCT02906670|450279217|FG001|Cohort 5P, Q2W|Adverse Event|0|||
125180177|NCT02906670|450279218|FG002|Cohort 5P, Q2W|Adverse Event|0|||
125180178|NCT02906670|450279219|FG003|Cohort 5P, Q2W|Adverse Event|0|||
125180179|NCT02906670|450279220|FG004|Cohort 5P, Q2W|Adverse Event|0|||
125180180|NCT02906670|450279221|FG005|Cohort 5P, Q2W|Adverse Event|0|||
125180181|NCT02906670|450279222|FG006|Cohort 5P, Q2W|Adverse Event|0|||
125180182|NCT02906670|450279223|FG007|Cohort 5P, Q2W|Adverse Event|1|||
125180183|NCT02906670|450279224|FG008|Cohort 5P, Q2W|Adverse Event|0|||
125180184|NCT02906670|450279225|FG009|Cohort 5P, Q2W|Adverse Event|0|||
125180185|NCT02906670|450279216|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
125180186|NCT02906670|450279217|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
125180187|NCT02906670|450279218|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
125180188|NCT02906670|450279219|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
125180189|NCT02906670|450279220|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
125180190|NCT02906670|450279221|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
125180191|NCT02906670|450279222|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
125180192|NCT02906670|450279223|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
125180193|NCT02906670|450279224|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
125180194|NCT02906670|450279225|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
125180195|NCT02906670|450279216|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
125180196|NCT02906670|450279217|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
125180197|NCT02906670|450279218|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
125180198|NCT02906670|450279219|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
125180199|NCT02906670|450279220|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
125180200|NCT02906670|450279221|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
125180201|NCT02906670|450279222|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
125180202|NCT02906670|450279223|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
125180203|NCT02906670|450279224|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
125180204|NCT02906670|450279225|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
125180205|NCT02906670|450279216|FG000|Cohort 4P, QW|Radiological Progression|0|||
125180206|NCT02906670|450279217|FG001|Cohort 4P, QW|Radiological Progression|0|||
125180207|NCT02906670|450279218|FG002|Cohort 4P, QW|Radiological Progression|0|||
125180208|NCT02906670|450279219|FG003|Cohort 4P, QW|Radiological Progression|3|||
125180209|NCT02906670|450279220|FG004|Cohort 4P, QW|Radiological Progression|0|||
125180210|NCT02906670|450279221|FG005|Cohort 4P, QW|Radiological Progression|0|||
125180211|NCT02906670|450279222|FG006|Cohort 4P, QW|Radiological Progression|0|||
125180212|NCT02906670|450279223|FG007|Cohort 4P, QW|Radiological Progression|0|||
125180213|NCT02906670|450279224|FG008|Cohort 4P, QW|Radiological Progression|0|||
125180214|NCT02906670|450279225|FG009|Cohort 4P, QW|Radiological Progression|0|||
125180215|NCT02906670|450279216|FG000|Cohort 7P, Q2W|Adverse Event|0|||
125180216|NCT02906670|450279217|FG001|Cohort 7P, Q2W|Adverse Event|0|||
125180217|NCT02906670|450279218|FG002|Cohort 7P, Q2W|Adverse Event|0|||
125180218|NCT02906670|450279219|FG003|Cohort 7P, Q2W|Adverse Event|0|||
125180219|NCT02906670|450279220|FG004|Cohort 7P, Q2W|Adverse Event|0|||
125180220|NCT02906670|450279221|FG005|Cohort 7P, Q2W|Adverse Event|0|||
125180221|NCT02906670|450279222|FG006|Cohort 7P, Q2W|Adverse Event|0|||
125180222|NCT02906670|450279223|FG007|Cohort 7P, Q2W|Adverse Event|0|||
125180223|NCT02906670|450279224|FG008|Cohort 7P, Q2W|Adverse Event|0|||
125180224|NCT02906670|450279225|FG009|Cohort 7P, Q2W|Adverse Event|1|||
125180225|NCT02906670|450279216|FG000|Cohort 7P, Q2W|Physician Decision|0|||
125180226|NCT02906670|450279217|FG001|Cohort 7P, Q2W|Physician Decision|0|||
125180227|NCT02906670|450279218|FG002|Cohort 7P, Q2W|Physician Decision|0|||
125180228|NCT02906670|450279219|FG003|Cohort 7P, Q2W|Physician Decision|0|||
125180229|NCT02906670|450279220|FG004|Cohort 7P, Q2W|Physician Decision|0|||
125180230|NCT02906670|450279221|FG005|Cohort 7P, Q2W|Physician Decision|0|||
125180231|NCT02906670|450279222|FG006|Cohort 7P, Q2W|Physician Decision|0|||
125180232|NCT02906670|450279223|FG007|Cohort 7P, Q2W|Physician Decision|0|||
125180233|NCT02906670|450279224|FG008|Cohort 7P, Q2W|Physician Decision|0|||
125180234|NCT02906670|450279225|FG009|Cohort 7P, Q2W|Physician Decision|1|||
125180235|NCT02906670|450279216|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180236|NCT02906670|450279217|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180237|NCT02906670|450279218|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180238|NCT02906670|450279219|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180239|NCT02906670|450279220|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180240|NCT02906670|450279221|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125392388|NCT03261947|451070650|FG001|Overall Study|Reason not Specified|0|||
125392389|NCT03261947|451070651|FG002|Overall Study|Reason not Specified|4|||
125180241|NCT02906670|450279222|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180242|NCT02906670|450279223|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180243|NCT02906670|450279224|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
125180244|NCT02906670|450279225|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
125180245|NCT02906670|450279216|FG000|Cohort 5P, QW|Radiological Progression|0|||
125180246|NCT02906670|450279217|FG001|Cohort 5P, QW|Radiological Progression|0|||
125180247|NCT02906670|450279218|FG002|Cohort 5P, QW|Radiological Progression|0|||
125180248|NCT02906670|450279219|FG003|Cohort 5P, QW|Radiological Progression|0|||
125180249|NCT02906670|450279220|FG004|Cohort 5P, QW|Radiological Progression|3|||
125180250|NCT02906670|450279221|FG005|Cohort 5P, QW|Radiological Progression|0|||
125180251|NCT02906670|450279222|FG006|Cohort 5P, QW|Radiological Progression|0|||
125180252|NCT02906670|450279223|FG007|Cohort 5P, QW|Radiological Progression|0|||
125180253|NCT02906670|450279224|FG008|Cohort 5P, QW|Radiological Progression|0|||
125180254|NCT02906670|450279225|FG009|Cohort 5P, QW|Radiological Progression|0|||
125180255|NCT01349192|450279226|FG000|Overall Study|Protocol Violation|0|||
125180256|NCT01349192|450279227|FG001|Overall Study|Protocol Violation|1|||
125180257|NCT01349192|450279226|FG000|Overall Study|Withdrawal by Subject|0|||
125180258|NCT01349192|450279227|FG001|Overall Study|Withdrawal by Subject|2|||
125180259|NCT01349192|450279226|FG000|Overall Study|Lost to Follow-up|1|||
125180260|NCT01349192|450279227|FG001|Overall Study|Lost to Follow-up|3|||
125180261|NCT01349192|450279226|FG000|Overall Study|Failure to adhere to Protocol|2|||
125180262|NCT01349192|450279227|FG001|Overall Study|Failure to adhere to Protocol|0|||
125180263|NCT03749330|450279228|FG000|Overall Study|Clinicians left work in the CICU|0|||
125180264|NCT03749330|450279229|FG001|Overall Study|Clinicians left work in the CICU|2|||
125180265|NCT03749330|450279230|FG002|Overall Study|Clinicians left work in the CICU|0|||
125180266|NCT03749330|450279231|FG003|Overall Study|Clinicians left work in the CICU|0|||
125180267|NCT03749330|450279232|FG004|Overall Study|Clinicians left work in the CICU|0|||
125180268|NCT03749330|450279233|FG005|Overall Study|Clinicians left work in the CICU|0|||
125180269|NCT01973439|450279234|FG000|Overall Study|Lost samples from one PK Day|2|||
125180270|NCT01973439|450279234|FG000|Overall Study|Vomiting after commencing once daily|1|||
125180271|NCT01973439|450279234|FG000|Overall Study|PK curve incomplete|2|||
125180272|NCT02038010|450279239|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
125180273|NCT02038010|450279240|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
125180274|NCT02038010|450279241|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
125180275|NCT02038010|450279242|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
125180276|NCT02038010|450279239|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
125180277|NCT02038010|450279240|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
125180278|NCT02038010|450279241|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
125180279|NCT02038010|450279242|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
125180280|NCT02038010|450279239|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
125180281|NCT02038010|450279240|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
125180282|NCT02038010|450279241|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
125180283|NCT02038010|450279242|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
125180284|NCT02038010|450279239|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
125180285|NCT02038010|450279240|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
125180286|NCT02038010|450279241|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
125180287|NCT02038010|450279242|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
125180288|NCT02038010|450279239|FG000|Follow Up|Death|4|||
125180289|NCT02038010|450279240|FG001|Follow Up|Death|3|||
125180290|NCT02038010|450279241|FG002|Follow Up|Death|0|||
125180291|NCT02038010|450279242|FG003|Follow Up|Death|0|||
125180292|NCT02038010|450279239|FG000|Follow Up|Other|3|||
125180293|NCT02038010|450279240|FG001|Follow Up|Other|0|||
125180294|NCT02038010|450279241|FG002|Follow Up|Other|0|||
125180295|NCT02038010|450279242|FG003|Follow Up|Other|0|||
125180296|NCT03908125|450279244|FG000|Overall Study|Withdrawal by Subject|92|||
125180297|NCT03908125|450279244|FG000|Overall Study|Lost to Follow-up|8|||
125180298|NCT02262325|450279245|FG000|Overall Study|Death|16|||
125180299|NCT02262325|450279245|FG000|Overall Study|Lost to Follow-up|1|||
125180300|NCT02815995|450279246|FG000|Overall Study|Disease Progression|3|||
125180301|NCT02815995|450279247|FG001|Overall Study|Disease Progression|7|||
125235537|NCT00460798|450489891|FG000|Overall Study|Lost to Follow-up|19|||
125235538|NCT00460798|450489891|FG000|Overall Study|Progressive Disease|99|||
125235539|NCT00460798|450489891|FG000|Overall Study|Other|27|||
125235540|NCT00460798|450489891|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
125235541|NCT00460798|450489891|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
125235542|NCT01898130|450489892|FG000|Treatment|Withdrawal by Subject|2|||
125235543|NCT01898130|450489892|FG000|Treatment|Progressive Disease|4|||
125235544|NCT01898130|450489892|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
125235545|NCT00630292|450489893|FG000|Overall Study|Withdrawal by Subject|1|||
125180302|NCT02815995|450279248|FG002|Overall Study|Disease Progression|2|||
125392390|NCT03261947|451070652|FG003|Overall Study|Reason not Specified|1|||
125180303|NCT02815995|450279249|FG003|Overall Study|Disease Progression|4|||
125180304|NCT02815995|450279250|FG004|Overall Study|Disease Progression|3|||
125180305|NCT02815995|450279251|FG005|Overall Study|Disease Progression|9|||
125180306|NCT02815995|450279252|FG006|Overall Study|Disease Progression|3|||
125180307|NCT02815995|450279253|FG007|Overall Study|Disease Progression|1|||
125180308|NCT02815995|450279246|FG000|Overall Study|Adverse Event|1|||
125180309|NCT02815995|450279247|FG001|Overall Study|Adverse Event|2|||
125180310|NCT02815995|450279248|FG002|Overall Study|Adverse Event|2|||
125180311|NCT02815995|450279249|FG003|Overall Study|Adverse Event|0|||
125180312|NCT02815995|450279250|FG004|Overall Study|Adverse Event|0|||
125180313|NCT02815995|450279251|FG005|Overall Study|Adverse Event|1|||
125180314|NCT02815995|450279252|FG006|Overall Study|Adverse Event|0|||
125180315|NCT02815995|450279253|FG007|Overall Study|Adverse Event|0|||
125180316|NCT02815995|450279246|FG000|Overall Study|Pregnancy|0|||
125180317|NCT02815995|450279247|FG001|Overall Study|Pregnancy|0|||
125180318|NCT02815995|450279248|FG002|Overall Study|Pregnancy|0|||
125180319|NCT02815995|450279249|FG003|Overall Study|Pregnancy|0|||
125180320|NCT02815995|450279250|FG004|Overall Study|Pregnancy|0|||
125180321|NCT02815995|450279251|FG005|Overall Study|Pregnancy|0|||
125180322|NCT02815995|450279252|FG006|Overall Study|Pregnancy|1|||
125180323|NCT02815995|450279253|FG007|Overall Study|Pregnancy|0|||
125180324|NCT01071915|450279254|FG000|Overall Study|Adverse Event|3|||
125180325|NCT01071915|450279254|FG000|Overall Study|Physician Decision|2|||
125180326|NCT01071915|450279254|FG000|Overall Study|Withdrawal by Subject|2|||
125180327|NCT01071915|450279254|FG000|Overall Study|Miscellaneous Reasons|2|||
125180328|NCT00114140|450279255|FG000|Overall Study|Protocol Violation|7|||
125180329|NCT00769379|450279258|FG000|Overall Study|No follow up data mapped to Other.|3|||
125180330|NCT00769379|450279259|FG001|Overall Study|No follow up data mapped to Other.|13|||
125180331|NCT01928472|450279260|FG000|Overall Study|Death|0|||
125180332|NCT01928472|450279261|FG001|Overall Study|Death|0|||
125180333|NCT01928472|450279262|FG002|Overall Study|Death|1|||
125180334|NCT01928472|450279263|FG003|Overall Study|Death|0|||
125180335|NCT01928472|450279260|FG000|Overall Study|Withdrawal by Subject|4|||
125180336|NCT01928472|450279261|FG001|Overall Study|Withdrawal by Subject|4|||
125180337|NCT01928472|450279262|FG002|Overall Study|Withdrawal by Subject|1|||
125180338|NCT01928472|450279263|FG003|Overall Study|Withdrawal by Subject|2|||
125180339|NCT01928472|450279260|FG000|Overall Study|Lost to Follow-up|2|||
125180340|NCT01928472|450279261|FG001|Overall Study|Lost to Follow-up|3|||
125180341|NCT01928472|450279262|FG002|Overall Study|Lost to Follow-up|4|||
125180342|NCT01928472|450279263|FG003|Overall Study|Lost to Follow-up|0|||
125180343|NCT01928472|450279260|FG000|Overall Study|Administrative Reason|2|||
125180344|NCT01928472|450279261|FG001|Overall Study|Administrative Reason|1|||
125180345|NCT01928472|450279262|FG002|Overall Study|Administrative Reason|0|||
125180346|NCT01928472|450279263|FG003|Overall Study|Administrative Reason|0|||
125180347|NCT01928472|450279260|FG000|Overall Study|Unclassified|0|||
125180348|NCT01928472|450279261|FG001|Overall Study|Unclassified|0|||
125180349|NCT01928472|450279262|FG002|Overall Study|Unclassified|1|||
125180350|NCT01928472|450279263|FG003|Overall Study|Unclassified|0|||
125180351|NCT01308424|450279264|FG000|Baseline Eligibility|Screen Failures|71|||
125180352|NCT01308424|450279265|FG001|Baseline Eligibility|Screen Failures|0|||
125180353|NCT01308424|450279266|FG002|Baseline Eligibility|Screen Failures|0|||
125180354|NCT01308424|450279264|FG000|Randomization|Adverse Event|0|||
125180355|NCT01308424|450279265|FG001|Randomization|Adverse Event|1|||
125180356|NCT01308424|450279266|FG002|Randomization|Adverse Event|1|||
125180357|NCT01308424|450279264|FG000|Randomization|Lost to Follow-up|0|||
125180358|NCT01308424|450279265|FG001|Randomization|Lost to Follow-up|1|||
125180359|NCT01308424|450279266|FG002|Randomization|Lost to Follow-up|0|||
125180360|NCT01308424|450279264|FG000|Randomization|Physician Decision|0|||
125235546|NCT00142415|450489894|FG000|Overall Study|Physician Decision|0|||
125180361|NCT01308424|450279265|FG001|Randomization|Physician Decision|1|||
125180362|NCT01308424|450279266|FG002|Randomization|Physician Decision|1|||
125180363|NCT00129545|450279270|FG000|Overall Study|Death|5|||
125180364|NCT00129545|450279271|FG001|Overall Study|Death|60|||
125180365|NCT00129545|450279272|FG002|Overall Study|Death|44|||
125180366|NCT00129545|450279270|FG000|Overall Study|Withdrawal by Subject|3|||
125180367|NCT00129545|450279271|FG001|Overall Study|Withdrawal by Subject|18|||
125180368|NCT00129545|450279272|FG002|Overall Study|Withdrawal by Subject|44|||
125180369|NCT00129545|450279270|FG000|Overall Study|Lost to Follow-up|2|||
125180370|NCT00129545|450279271|FG001|Overall Study|Lost to Follow-up|22|||
125235547|NCT00142415|450489895|FG001|Overall Study|Physician Decision|0|||
125235548|NCT00142415|450489896|FG002|Overall Study|Physician Decision|0|||
125235549|NCT00142415|450489897|FG003|Overall Study|Physician Decision|0|||
125235550|NCT00142415|450489898|FG004|Overall Study|Physician Decision|1|||
125235551|NCT00142415|450489899|FG005|Overall Study|Physician Decision|2|||
125235552|NCT01189266|450489900|FG000|Overall Study|Adverse Event|1|||
125235553|NCT01189266|450489901|FG001|Overall Study|Adverse Event|0|||
125235554|NCT01189266|450489902|FG002|Overall Study|Adverse Event|5|||
125235555|NCT01189266|450489900|FG000|Overall Study|Death|0|||
125235556|NCT01189266|450489901|FG001|Overall Study|Death|0|||
125235557|NCT01189266|450489902|FG002|Overall Study|Death|5|||
125235558|NCT01189266|450489900|FG000|Overall Study|Lack of Efficacy|4|||
125235559|NCT01189266|450489901|FG001|Overall Study|Lack of Efficacy|5|||
125235560|NCT01189266|450489902|FG002|Overall Study|Lack of Efficacy|44|||
125235561|NCT01189266|450489900|FG000|Overall Study|Physician Decision|0|||
125235562|NCT01189266|450489901|FG001|Overall Study|Physician Decision|0|||
125235563|NCT01189266|450489902|FG002|Overall Study|Physician Decision|1|||
125235564|NCT01189266|450489900|FG000|Overall Study|Protocol Violation|0|||
125235565|NCT01189266|450489901|FG001|Overall Study|Protocol Violation|1|||
125235566|NCT01189266|450489902|FG002|Overall Study|Protocol Violation|1|||
125235567|NCT01189266|450489900|FG000|Overall Study|Withdrawal by Subject|0|||
125235568|NCT01189266|450489901|FG001|Overall Study|Withdrawal by Subject|0|||
125235569|NCT01189266|450489902|FG002|Overall Study|Withdrawal by Subject|1|||
125235570|NCT01189266|450489900|FG000|Overall Study|Patient refuses further therapy|1|||
125235571|NCT01189266|450489901|FG001|Overall Study|Patient refuses further therapy|0|||
125235572|NCT01189266|450489902|FG002|Overall Study|Patient refuses further therapy|7|||
125235573|NCT01189266|450489900|FG000|Overall Study|No treatment|0|||
125235574|NCT01189266|450489901|FG001|Overall Study|No treatment|0|||
125235575|NCT01189266|450489902|FG002|Overall Study|No treatment|1|||
125235576|NCT00537277|450489903|FG000|Overall Study|Adverse Event|1|||
125235577|NCT00537277|450489903|FG000|Overall Study|Lack of Efficacy|2|||
125235578|NCT00537277|450489903|FG000|Overall Study|Lost to Follow-up|12|||
125235579|NCT00537277|450489903|FG000|Overall Study|Protocol Violation|11|||
125235580|NCT00537277|450489903|FG000|Overall Study|Unclassified|4|||
125235581|NCT00537277|450489903|FG000|Overall Study|Inability to tolerate trial medication|4|||
125235582|NCT00537277|450489903|FG000|Overall Study|Non-compliance with trial procedures|15|||
125235583|NCT03620162|450489904|FG000|Overall Study|Physician Decision|4|||
125235584|NCT03620162|450489905|FG001|Overall Study|Physician Decision|0|||
125235585|NCT03620162|450489906|FG002|Overall Study|Physician Decision|1|||
125235586|NCT03620162|450489907|FG003|Overall Study|Physician Decision|0|||
125235587|NCT03620162|450489908|FG004|Overall Study|Physician Decision|2|||
125235588|NCT03620162|450489904|FG000|Overall Study|Lost to Follow-up|2|||
125235589|NCT03620162|450489905|FG001|Overall Study|Lost to Follow-up|6|||
125235590|NCT03620162|450489906|FG002|Overall Study|Lost to Follow-up|7|||
125235591|NCT03620162|450489907|FG003|Overall Study|Lost to Follow-up|3|||
125235592|NCT03620162|450489908|FG004|Overall Study|Lost to Follow-up|2|||
125235593|NCT03620162|450489904|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
125235594|NCT03620162|450489905|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
125235595|NCT03620162|450489906|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
125235596|NCT03620162|450489907|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
125235597|NCT03620162|450489908|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
125235598|NCT01838876|450489911|FG000|Overall Study|Adverse Event|49|||
125235599|NCT01838876|450489911|FG000|Overall Study|Insufficient Therapeutic Response|10|||
125235600|NCT01838876|450489911|FG000|Overall Study|Protocol Violation|34|||
125235601|NCT01838876|450489911|FG000|Overall Study|Withdrawal of Consent|33|||
125235602|NCT01838876|450489911|FG000|Overall Study|Lost to Follow-up|21|||
125235603|NCT01838876|450489911|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
125235604|NCT01838876|450489911|FG000|Overall Study|Reason not Specified|7|||
125235605|NCT01838876|450489911|FG000|Overall Study|Did not meet eligibility criteria|78|||
125235606|NCT02101294|450489912|FG000|Overall Study|Withdrawal by Subject|5|||
125235607|NCT02101294|450489912|FG000|Overall Study|Lost to Follow-up|6|||
125235608|NCT03416179|450489913|FG000|Overall Study|Death|90|||
125235609|NCT03416179|450489914|FG001|Overall Study|Death|87|||
125235610|NCT03416179|450489915|FG002|Overall Study|Death|117|||
125235611|NCT03416179|450489916|FG003|Overall Study|Death|113|||
125235612|NCT03416179|450489913|FG000|Overall Study|Withdrawal by Subject|15|||
125235613|NCT03416179|450489914|FG001|Overall Study|Withdrawal by Subject|20|||
125235614|NCT03416179|450489915|FG002|Overall Study|Withdrawal by Subject|6|||
125235615|NCT03416179|450489916|FG003|Overall Study|Withdrawal by Subject|9|||
125235616|NCT03416179|450489913|FG000|Overall Study|Lost to Follow-up|1|||
125235617|NCT03416179|450489914|FG001|Overall Study|Lost to Follow-up|1|||
125235618|NCT03416179|450489915|FG002|Overall Study|Lost to Follow-up|0|||
125235619|NCT03416179|450489916|FG003|Overall Study|Lost to Follow-up|3|||
125235620|NCT03416179|450489913|FG000|Overall Study|Study participation terminated by Sponsor|93|||
125235621|NCT03416179|450489914|FG001|Overall Study|Study participation terminated by Sponsor|91|||
125235622|NCT03416179|450489915|FG002|Overall Study|Study participation terminated by Sponsor|26|||
125235623|NCT03416179|450489916|FG003|Overall Study|Study participation terminated by Sponsor|31|||
125235624|NCT03416179|450489913|FG000|Overall Study|Other|2|||
125235625|NCT03416179|450489914|FG001|Overall Study|Other|3|||
125235626|NCT03416179|450489915|FG002|Overall Study|Other|1|||
125235627|NCT03416179|450489916|FG003|Overall Study|Other|0|||
125235628|NCT01682031|450489919|FG000|Overall Study|Withdrawal by Subject|0|||
125235629|NCT01682031|450489920|FG001|Overall Study|Withdrawal by Subject|1|||
125235630|NCT01682031|450489919|FG000|Overall Study|Adverse Event|0|||
125235631|NCT01682031|450489920|FG001|Overall Study|Adverse Event|2|||
125235632|NCT01682031|450489919|FG000|Overall Study|MRI results indicate increased nodul|0|||
125235633|NCT01682031|450489920|FG001|Overall Study|MRI results indicate increased nodul|1|||
125235634|NCT01682031|450489919|FG000|Overall Study|Patient could not swallow tablets|1|||
125235635|NCT01682031|450489920|FG001|Overall Study|Patient could not swallow tablets|0|||
125235636|NCT01682031|450489919|FG000|Overall Study|Patient stopped selenium on his own|0|||
125235637|NCT01682031|450489920|FG001|Overall Study|Patient stopped selenium on his own|1|||
125235638|NCT01056536|450489926|FG000|Overall Study|Lost to Follow-up|202|||
125235639|NCT01056536|450489927|FG001|Overall Study|Lost to Follow-up|116|||
125235640|NCT01056536|450489928|FG002|Overall Study|Lost to Follow-up|248|||
125235641|NCT00924898|450489930|FG000|Overall Study|Withdrawal by Subject|2|||
125235642|NCT01285518|450489931|FG000|Overall Study|Lost to Follow-up|0|||
125235643|NCT01285518|450489932|FG001|Overall Study|Lost to Follow-up|0|||
125235644|NCT01285518|450489933|FG002|Overall Study|Lost to Follow-up|0|||
125235645|NCT01285518|450489934|FG003|Overall Study|Lost to Follow-up|0|||
125235646|NCT01285518|450489935|FG004|Overall Study|Lost to Follow-up|0|||
125235647|NCT01285518|450489936|FG005|Overall Study|Lost to Follow-up|1|||
125235648|NCT01285518|450489937|FG006|Overall Study|Lost to Follow-up|0|||
125235649|NCT01285518|450489938|FG007|Overall Study|Lost to Follow-up|0|||
125235650|NCT00294658|450489939|FG000|Overall Study|Death|0|||
125235651|NCT00294658|450489940|FG001|Overall Study|Death|1|||
125235652|NCT00294658|450489939|FG000|Overall Study|Lost to Follow-up|4|||
125235653|NCT00294658|450489940|FG001|Overall Study|Lost to Follow-up|0|||
125235654|NCT00294658|450489939|FG000|Overall Study|Physician Decision|1|||
125235655|NCT00294658|450489940|FG001|Overall Study|Physician Decision|2|||
125235656|NCT00294658|450489939|FG000|Overall Study|Pregnancy|0|||
125235657|NCT00294658|450489940|FG001|Overall Study|Pregnancy|1|||
125235658|NCT00294658|450489939|FG000|Overall Study|Withdrawal by Subject|0|||
125235659|NCT00294658|450489940|FG001|Overall Study|Withdrawal by Subject|4|||
125235660|NCT00294658|450489939|FG000|Overall Study|Found to have invasive thymoma|1|||
125235661|NCT00294658|450489940|FG001|Overall Study|Found to have invasive thymoma|0|||
125235662|NCT00294658|450489939|FG000|Overall Study|Patient and family were not satisfied|0|||
125235663|NCT00294658|450489940|FG001|Overall Study|Patient and family were not satisfied|1|||
125235664|NCT03805841|450489941|FG000|Overall Study|Clinical Progression|2|||
125235665|NCT03805841|450489942|FG001|Overall Study|Clinical Progression|0|||
125235666|NCT03805841|450489943|FG002|Overall Study|Clinical Progression|0|||
125235667|NCT03805841|450489941|FG000|Overall Study|Death|0|||
125235668|NCT03805841|450489942|FG001|Overall Study|Death|3|||
125235669|NCT03805841|450489943|FG002|Overall Study|Death|1|||
125235670|NCT03805841|450489941|FG000|Overall Study|Lost to Follow-up|0|||
125235671|NCT03805841|450489942|FG001|Overall Study|Lost to Follow-up|0|||
125235672|NCT03805841|450489943|FG002|Overall Study|Lost to Follow-up|1|||
125235673|NCT03805841|450489941|FG000|Overall Study|Withdrawal by Subject|2|||
125235674|NCT03805841|450489942|FG001|Overall Study|Withdrawal by Subject|3|||
125235675|NCT03805841|450489943|FG002|Overall Study|Withdrawal by Subject|0|||
125235676|NCT03805841|450489941|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
125235677|NCT03805841|450489942|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
125235678|NCT03805841|450489943|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
125235679|NCT00846365|450489946|FG000|Overall Study|Adverse Event|20|||
125235680|NCT00846365|450489947|FG001|Overall Study|Adverse Event|30|||
125235681|NCT00846365|450489948|FG002|Overall Study|Adverse Event|11|||
125235682|NCT00846365|450489946|FG000|Overall Study|Protocol Violation|5|||
125235683|NCT00846365|450489947|FG001|Overall Study|Protocol Violation|4|||
125235684|NCT00846365|450489948|FG002|Overall Study|Protocol Violation|0|||
125235685|NCT00846365|450489946|FG000|Overall Study|Lost to Follow-up|8|||
125235686|NCT00846365|450489947|FG001|Overall Study|Lost to Follow-up|2|||
125235687|NCT00846365|450489948|FG002|Overall Study|Lost to Follow-up|5|||
125235688|NCT00846365|450489946|FG000|Overall Study|Withdrawal by Subject|11|||
125235689|NCT00846365|450489947|FG001|Overall Study|Withdrawal by Subject|11|||
125235690|NCT00846365|450489948|FG002|Overall Study|Withdrawal by Subject|9|||
125235691|NCT00846365|450489946|FG000|Overall Study|Pregnancy|1|||
125235692|NCT00846365|450489947|FG001|Overall Study|Pregnancy|0|||
125235693|NCT00846365|450489948|FG002|Overall Study|Pregnancy|0|||
125235694|NCT00846365|450489946|FG000|Overall Study|Lack of Efficacy|1|||
125235695|NCT00846365|450489947|FG001|Overall Study|Lack of Efficacy|1|||
125235696|NCT00846365|450489948|FG002|Overall Study|Lack of Efficacy|2|||
125235697|NCT00846365|450489946|FG000|Overall Study|Other|9|||
125235698|NCT00846365|450489947|FG001|Overall Study|Other|1|||
125235699|NCT00846365|450489948|FG002|Overall Study|Other|6|||
125235700|NCT00862992|450489951|FG000|Overall Study|Adverse Event|2|||
125235701|NCT00862992|450489952|FG001|Overall Study|Adverse Event|1|||
125235702|NCT00862992|450489953|FG002|Overall Study|Adverse Event|1|||
125235703|NCT00862992|450489951|FG000|Overall Study|Physician Decision|1|||
125235704|NCT00862992|450489952|FG001|Overall Study|Physician Decision|0|||
125235705|NCT00862992|450489953|FG002|Overall Study|Physician Decision|0|||
125235706|NCT00862992|450489951|FG000|Overall Study|Withdrawal by Subject|0|||
125235707|NCT00862992|450489952|FG001|Overall Study|Withdrawal by Subject|0|||
125235708|NCT00862992|450489953|FG002|Overall Study|Withdrawal by Subject|2|||
125235709|NCT02696798|450489966|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
125235710|NCT02696798|450489967|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
125235711|NCT02696798|450489968|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
125235712|NCT02696798|450489966|FG000|Blinded Treatment Dosing Period|Death|0|||
125235713|NCT02696798|450489967|FG001|Blinded Treatment Dosing Period|Death|0|||
125235714|NCT02696798|450489968|FG002|Blinded Treatment Dosing Period|Death|1|||
125235715|NCT02696798|450489966|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
125235716|NCT02696798|450489967|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
125235717|NCT02696798|450489968|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
125235718|NCT02696798|450489966|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
125235719|NCT02696798|450489967|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
125235720|NCT02696798|450489968|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
125235721|NCT02696798|450489966|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
125235722|NCT02696798|450489967|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
125235723|NCT02696798|450489968|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
125235724|NCT02696798|450489966|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
125235725|NCT02696798|450489967|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
125235726|NCT02696798|450489968|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
125235727|NCT02696798|450489966|FG000|Extended Treatment Period|Adverse Event|1|||
125235728|NCT02696798|450489967|FG001|Extended Treatment Period|Adverse Event|4|||
125235729|NCT02696798|450489968|FG002|Extended Treatment Period|Adverse Event|5|||
125235730|NCT02696798|450489966|FG000|Extended Treatment Period|Lack of Efficacy|7|||
125235731|NCT02696798|450489967|FG001|Extended Treatment Period|Lack of Efficacy|2|||
125235732|NCT02696798|450489968|FG002|Extended Treatment Period|Lack of Efficacy|2|||
125235733|NCT02696798|450489966|FG000|Extended Treatment Period|Lost to Follow-up|1|||
125235734|NCT02696798|450489967|FG001|Extended Treatment Period|Lost to Follow-up|0|||
125235735|NCT02696798|450489968|FG002|Extended Treatment Period|Lost to Follow-up|0|||
125235736|NCT02696798|450489966|FG000|Extended Treatment Period|Physician Decision|0|||
125235737|NCT02696798|450489967|FG001|Extended Treatment Period|Physician Decision|1|||
125235738|NCT02696798|450489968|FG002|Extended Treatment Period|Physician Decision|0|||
125235739|NCT02696798|450489966|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
125235740|NCT02696798|450489967|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
125235741|NCT02696798|450489968|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
125235742|NCT02696798|450489966|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
125235743|NCT02696798|450489967|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
125235744|NCT02696798|450489968|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
125235745|NCT02696798|450489966|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
125235746|NCT02696798|450489967|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
125235747|NCT02696798|450489968|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
125235748|NCT02696798|450489966|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
125235749|NCT02696798|450489967|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
125235750|NCT02696798|450489968|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
125235751|NCT02696798|450489966|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
125235752|NCT02696798|450489967|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
125235753|NCT02696798|450489968|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
125235754|NCT02696798|450489966|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
125235755|NCT02696798|450489967|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
125235756|NCT02696798|450489968|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
125235757|NCT02696798|450489966|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
125235758|NCT02696798|450489967|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
125235759|NCT02696798|450489968|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
125235760|NCT01277861|450489969|FG000|Overall Study|Physician Decision|2|||
125235761|NCT01277861|450489970|FG001|Overall Study|Physician Decision|2|||
125235762|NCT00857389|450489971|FG000|Overall Study|Did not proceed to transplant|2|||
125235763|NCT01157845|450489972|FG000|Overall Study|Lost to Follow-up|5|||
125235764|NCT01157845|450489972|FG000|Overall Study|Withdrawal by Subject|12|||
125235765|NCT01157845|450489972|FG000|Overall Study|Physician Decision|3|||
125235766|NCT01157845|450489972|FG000|Overall Study|Protocol Violation|13|||
125235767|NCT01157845|450489972|FG000|Overall Study|Study was ended|1|||
125235768|NCT01157845|450489972|FG000|Overall Study|Device malfunction|1|||
125235769|NCT03311555|450489973|FG000|Overall Study|Adverse Event|1|||
125235770|NCT00788671|450491597|FG000|Overall Study|Death|2|||
125235771|NCT00788671|450491597|FG000|Overall Study|Unable to biopsy|1|||
125235772|NCT00788671|450491597|FG000|Overall Study|Withdrawal by Subject|4|||
125235773|NCT00788671|450491597|FG000|Overall Study|IUD expulsed|1|||
125180371|NCT00129545|450279272|FG002|Overall Study|Lost to Follow-up|13|||
125180372|NCT00129545|450279270|FG000|Overall Study|Physician Decision|0|||
125180373|NCT00129545|450279271|FG001|Overall Study|Physician Decision|3|||
125180374|NCT00129545|450279272|FG002|Overall Study|Physician Decision|10|||
125180375|NCT00129545|450279270|FG000|Overall Study|Device not implanted|16|||
125180376|NCT00129545|450279271|FG001|Overall Study|Device not implanted|61|||
125180377|NCT00129545|450279272|FG002|Overall Study|Device not implanted|0|||
125180378|NCT01841593|450279273|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
125180379|NCT01841593|450279274|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
125180380|NCT01841593|450279273|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
125180381|NCT01841593|450279274|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
125180382|NCT00307086|450279277|FG000|Overall Study|ineligible|5|||
125180383|NCT02969044|450279280|FG000|Overall Study|Withdrawal by Subject|2|||
125180384|NCT02969044|450279281|FG001|Overall Study|Withdrawal by Subject|6|||
125180385|NCT02969044|450279280|FG000|Overall Study|Adverse Event|3|||
125180386|NCT02969044|450279281|FG001|Overall Study|Adverse Event|0|||
125180387|NCT00312338|450279282|FG000|Overall Study|Adverse Event|7|||
125180388|NCT00312338|450279283|FG001|Overall Study|Adverse Event|2|||
125180389|NCT00312338|450279282|FG000|Overall Study|Lost to Follow-up|9|||
125180390|NCT00312338|450279283|FG001|Overall Study|Lost to Follow-up|1|||
125180391|NCT00312338|450279282|FG000|Overall Study|Withdrawal by Subject|4|||
125180392|NCT00312338|450279283|FG001|Overall Study|Withdrawal by Subject|0|||
125180393|NCT00312338|450279282|FG000|Overall Study|Subsequent infection|2|||
125180394|NCT00312338|450279283|FG001|Overall Study|Subsequent infection|0|||
125180395|NCT00262028|450279284|FG000|Overall Study|Withdrawal by Subject|6|||
125180396|NCT00262028|450279285|FG001|Overall Study|Withdrawal by Subject|3|||
125180397|NCT00262028|450279286|FG002|Overall Study|Withdrawal by Subject|6|||
125180398|NCT00262028|450279287|FG003|Overall Study|Withdrawal by Subject|5|||
125180399|NCT00262028|450279288|FG004|Overall Study|Withdrawal by Subject|2|||
125180400|NCT00262028|450279289|FG005|Overall Study|Withdrawal by Subject|3|||
125180401|NCT00262028|450279290|FG006|Overall Study|Withdrawal by Subject|5|||
125180402|NCT00262028|450279291|FG007|Overall Study|Withdrawal by Subject|7|||
125180403|NCT00262028|450279292|FG008|Overall Study|Withdrawal by Subject|2|||
125180404|NCT00262028|450279284|FG000|Overall Study|Lost to Follow-up|7|||
125180405|NCT00262028|450279285|FG001|Overall Study|Lost to Follow-up|7|||
125180406|NCT00262028|450279286|FG002|Overall Study|Lost to Follow-up|5|||
125180407|NCT00262028|450279287|FG003|Overall Study|Lost to Follow-up|5|||
125180408|NCT00262028|450279288|FG004|Overall Study|Lost to Follow-up|4|||
125180409|NCT00262028|450279289|FG005|Overall Study|Lost to Follow-up|3|||
125180410|NCT00262028|450279290|FG006|Overall Study|Lost to Follow-up|3|||
125180411|NCT00262028|450279291|FG007|Overall Study|Lost to Follow-up|5|||
125180412|NCT00262028|450279292|FG008|Overall Study|Lost to Follow-up|6|||
125180413|NCT00262028|450279284|FG000|Overall Study|Administrative Reason|11|||
125180414|NCT00262028|450279285|FG001|Overall Study|Administrative Reason|14|||
125180415|NCT00262028|450279286|FG002|Overall Study|Administrative Reason|9|||
125180416|NCT00262028|450279287|FG003|Overall Study|Administrative Reason|12|||
125180417|NCT00262028|450279288|FG004|Overall Study|Administrative Reason|6|||
125180418|NCT00262028|450279289|FG005|Overall Study|Administrative Reason|7|||
125180419|NCT00262028|450279290|FG006|Overall Study|Administrative Reason|4|||
125180420|NCT00262028|450279291|FG007|Overall Study|Administrative Reason|6|||
125180421|NCT00262028|450279292|FG008|Overall Study|Administrative Reason|10|||
125180422|NCT00262028|450279284|FG000|Overall Study|Protocol Violation|0|||
125180423|NCT00262028|450279285|FG001|Overall Study|Protocol Violation|0|||
125180424|NCT00262028|450279286|FG002|Overall Study|Protocol Violation|0|||
125180425|NCT00262028|450279287|FG003|Overall Study|Protocol Violation|1|||
125180426|NCT00262028|450279288|FG004|Overall Study|Protocol Violation|0|||
125180427|NCT00262028|450279289|FG005|Overall Study|Protocol Violation|0|||
125180428|NCT00262028|450279290|FG006|Overall Study|Protocol Violation|0|||
125180429|NCT00262028|450279291|FG007|Overall Study|Protocol Violation|0|||
125180430|NCT00262028|450279292|FG008|Overall Study|Protocol Violation|0|||
125180431|NCT00262028|450279284|FG000|Overall Study|Unable to classify|0|||
125180432|NCT00262028|450279285|FG001|Overall Study|Unable to classify|3|||
125180433|NCT00262028|450279286|FG002|Overall Study|Unable to classify|0|||
125180434|NCT00262028|450279287|FG003|Overall Study|Unable to classify|0|||
125180435|NCT00262028|450279288|FG004|Overall Study|Unable to classify|0|||
125180436|NCT00262028|450279289|FG005|Overall Study|Unable to classify|0|||
125180437|NCT00262028|450279290|FG006|Overall Study|Unable to classify|0|||
125180438|NCT00262028|450279291|FG007|Overall Study|Unable to classify|0|||
125180439|NCT00262028|450279292|FG008|Overall Study|Unable to classify|1|||
125180440|NCT02308124|450279293|FG000|Overall Study|Lost to Follow-up|6|||
125180441|NCT02308124|450279294|FG001|Overall Study|Lost to Follow-up|6|||
125180442|NCT02308124|450279295|FG002|Overall Study|Lost to Follow-up|6|||
125180443|NCT02308124|450279293|FG000|Overall Study|Adverse Event|0|||
125180444|NCT02308124|450279294|FG001|Overall Study|Adverse Event|2|||
125180445|NCT02308124|450279295|FG002|Overall Study|Adverse Event|2|||
125180446|NCT01329900|450279296|FG000|Overall Study|Elevated creatinine/renal function|1|||
125180447|NCT04233073|450279300|FG000|Overall Study|Death|5|||
125180448|NCT00143390|450279301|FG000|Overall Study|Death|2|||
125235774|NCT00788671|450491597|FG000|Overall Study|Lost to follow up|2|||
125235775|NCT03405870|450491598|FG000|Overall Study|Withdrawal|1|||
125235776|NCT03405870|450491599|FG001|Overall Study|Withdrawal|0|||
125235777|NCT03405870|450491600|FG002|Overall Study|Withdrawal|1|||
125235778|NCT03405870|450491601|FG003|Overall Study|Withdrawal|0|||
125235779|NCT03405870|450491602|FG004|Overall Study|Withdrawal|0|||
125235780|NCT03405870|450491603|FG005|Overall Study|Withdrawal|0|||
125235781|NCT03405870|450491604|FG006|Overall Study|Withdrawal|1|||
125235782|NCT03405870|450491605|FG007|Overall Study|Withdrawal|0|||
125235783|NCT05172609|450491606|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
125235784|NCT05172609|450491607|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
125235785|NCT05172609|450491606|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
125235786|NCT05172609|450491607|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
125235787|NCT05172609|450491606|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
125235788|NCT05172609|450491607|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
125235789|NCT00549055|450491608|FG000|Overall Study|Adverse Event|4|||
125235790|NCT00549055|450491608|FG000|Overall Study|Lack of Efficacy|18|||
125235791|NCT00549055|450491608|FG000|Overall Study|Stabilization|5|||
125235792|NCT00549055|450491608|FG000|Overall Study|Progression to fibrosis|2|||
125235793|NCT00549055|450491608|FG000|Overall Study|Decrease of size|1|||
125235794|NCT00549055|450491608|FG000|Overall Study|Active choroidal neovascula increased|1|||
125235795|NCT00549055|450491608|FG000|Overall Study|Vitreous hemorrhage|1|||
125235796|NCT00549055|450491608|FG000|Overall Study|Growth choroidal neovascularisation|1|||
125235797|NCT00549055|450491608|FG000|Overall Study|Choroidal neovascularization|1|||
125235798|NCT00549055|450491608|FG000|Overall Study|Very low visual acuity (VA)|1|||
125235799|NCT03846479|450491609|FG000|Overall Study|Death|8|||
125235800|NCT03846479|450491609|FG000|Overall Study|Lost to Follow-up|1|||
125235801|NCT05020015|450491610|FG000|Overall Study|Ongoing on study|1|||
125235802|NCT05020015|450491611|FG001|Overall Study|Ongoing on study|3|||
125235803|NCT05020015|450491612|FG002|Overall Study|Ongoing on study|4|||
125235804|NCT05020015|450491613|FG003|Overall Study|Ongoing on study|7|||
125235805|NCT05020015|450491610|FG000|Overall Study|Death|2|||
125235806|NCT05020015|450491611|FG001|Overall Study|Death|3|||
125235807|NCT05020015|450491612|FG002|Overall Study|Death|4|||
125235808|NCT05020015|450491613|FG003|Overall Study|Death|0|||
125235809|NCT05020015|450491610|FG000|Overall Study|Withdrawal by Subject|0|||
125235810|NCT05020015|450491611|FG001|Overall Study|Withdrawal by Subject|0|||
125235811|NCT05020015|450491612|FG002|Overall Study|Withdrawal by Subject|1|||
125235812|NCT05020015|450491613|FG003|Overall Study|Withdrawal by Subject|0|||
125235813|NCT05020015|450491610|FG000|Overall Study|Reason Not Specified|0|||
125235814|NCT05020015|450491611|FG001|Overall Study|Reason Not Specified|0|||
125235815|NCT05020015|450491612|FG002|Overall Study|Reason Not Specified|2|||
125235816|NCT05020015|450491613|FG003|Overall Study|Reason Not Specified|0|||
125235817|NCT06217380|450491616|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
125235818|NCT06217380|450491616|FG000|Overall Study|Physician Decision|1|||
125235819|NCT06217380|450491616|FG000|Overall Study|Withdrawal by Subject|2|||
125235820|NCT06633965|450491617|FG000|Overall Study|Withdrawal by Subject|0|||
125235821|NCT06633965|450491618|FG001|Overall Study|Withdrawal by Subject|1|||
125235822|NCT00947544|450491621|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
125235823|NCT00947544|450491622|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
125235824|NCT01963611|450491627|FG000|Overall Study|Adverse Event|1|||
125235825|NCT01963611|450491628|FG001|Overall Study|Adverse Event|1|||
125235826|NCT01963611|450491629|FG002|Overall Study|Adverse Event|3|||
125235827|NCT01963611|450491630|FG003|Overall Study|Adverse Event|4|||
125235828|NCT01963611|450491631|FG004|Overall Study|Adverse Event|3|||
125235829|NCT01963611|450491627|FG000|Overall Study|Protocol Violation|0|||
125235830|NCT01963611|450491628|FG001|Overall Study|Protocol Violation|0|||
125235831|NCT01963611|450491629|FG002|Overall Study|Protocol Violation|0|||
125235832|NCT01963611|450491630|FG003|Overall Study|Protocol Violation|1|||
125235833|NCT01963611|450491631|FG004|Overall Study|Protocol Violation|0|||
125235834|NCT01963611|450491627|FG000|Overall Study|Lack of Efficacy|0|||
125235835|NCT01963611|450491628|FG001|Overall Study|Lack of Efficacy|0|||
125235836|NCT01963611|450491629|FG002|Overall Study|Lack of Efficacy|0|||
125235837|NCT01963611|450491630|FG003|Overall Study|Lack of Efficacy|1|||
125235838|NCT01963611|450491631|FG004|Overall Study|Lack of Efficacy|0|||
125235839|NCT01963611|450491627|FG000|Overall Study|Withdrawal by Subject|3|||
125235840|NCT01963611|450491628|FG001|Overall Study|Withdrawal by Subject|2|||
125235841|NCT01963611|450491629|FG002|Overall Study|Withdrawal by Subject|1|||
125235842|NCT01963611|450491630|FG003|Overall Study|Withdrawal by Subject|1|||
125235843|NCT01963611|450491631|FG004|Overall Study|Withdrawal by Subject|3|||
125235844|NCT01963611|450491627|FG000|Overall Study|Other|47|||
125235845|NCT01963611|450491628|FG001|Overall Study|Other|46|||
125235846|NCT01963611|450491629|FG002|Overall Study|Other|48|||
125235847|NCT01963611|450491630|FG003|Overall Study|Other|45|||
125235848|NCT01963611|450491631|FG004|Overall Study|Other|45|||
125235849|NCT01126424|450491632|FG000|Overall Study|Adverse Event|0|||
125235850|NCT01126424|450491633|FG001|Overall Study|Adverse Event|0|||
125392391|NCT03261947|451070653|FG004|Overall Study|Reason not Specified|3|||
125392392|NCT03969992|451070654|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
125180449|NCT00143390|450279302|FG001|Overall Study|Death|0|||
125180450|NCT00143390|450279301|FG000|Overall Study|Not meeting entry criteria|2|||
125180451|NCT00143390|450279302|FG001|Overall Study|Not meeting entry criteria|5|||
125180452|NCT00143390|450279301|FG000|Overall Study|Withdrawal by Subject|4|||
125180453|NCT00143390|450279302|FG001|Overall Study|Withdrawal by Subject|4|||
125180454|NCT00143390|450279301|FG000|Overall Study|Progressive disease|119|||
125180455|NCT00143390|450279302|FG001|Overall Study|Progressive disease|115|||
125180456|NCT00143390|450279301|FG000|Overall Study|Protocol Violation|2|||
125180457|NCT00143390|450279302|FG001|Overall Study|Protocol Violation|0|||
125180458|NCT00143390|450279301|FG000|Overall Study|Study termination|10|||
125180459|NCT00143390|450279302|FG001|Overall Study|Study termination|15|||
125180460|NCT00143390|450279301|FG000|Overall Study|Adverse Event|9|||
125180461|NCT00143390|450279302|FG001|Overall Study|Adverse Event|8|||
125180462|NCT00143390|450279301|FG000|Overall Study|Other|1|||
125180463|NCT00143390|450279302|FG001|Overall Study|Other|2|||
125180464|NCT00041132|450279305|FG000|Overall Study|Adverse Event|19|||
125180465|NCT00041132|450279305|FG000|Overall Study|Death|1|||
125180466|NCT00041132|450279305|FG000|Overall Study|Not Eligible|7|||
125180467|NCT00041132|450279305|FG000|Overall Study|Withdrawal by Subject|1|||
125180468|NCT00041132|450279305|FG000|Overall Study|Physician Decision|2|||
125180469|NCT00995774|450279308|FG000|Training Period 2|Withdrawal by Subject|2|||
125180470|NCT00995774|450279309|FG001|Training Period 2|Withdrawal by Subject|0|||
125180471|NCT03953612|450279311|FG000|Overall Study|Randomized but did not start|1|||
125180472|NCT03953612|450279312|FG001|Overall Study|Randomized but did not start|1|||
125180473|NCT03953612|450279313|FG002|Overall Study|Randomized but did not start|1|||
125180474|NCT03953612|450279311|FG000|Overall Study|Withdrawal by Subject|2|||
125180475|NCT03953612|450279312|FG001|Overall Study|Withdrawal by Subject|1|||
125180476|NCT03953612|450279313|FG002|Overall Study|Withdrawal by Subject|0|||
125180477|NCT03200717|450279331|FG000|Overall Study|Progressive disease|24|||
125180478|NCT03200717|450279332|FG001|Overall Study|Progressive disease|5|||
125180479|NCT03200717|450279331|FG000|Overall Study|Adverse Event|11|||
125180480|NCT03200717|450279332|FG001|Overall Study|Adverse Event|8|||
125180481|NCT03200717|450279331|FG000|Overall Study|Physician Decision|3|||
125180482|NCT03200717|450279332|FG001|Overall Study|Physician Decision|2|||
125180483|NCT03200717|450279331|FG000|Overall Study|Death|2|||
125180484|NCT03200717|450279332|FG001|Overall Study|Death|0|||
125180485|NCT03200717|450279331|FG000|Overall Study|Subject/Guardian Decision|1|||
125180486|NCT03200717|450279332|FG001|Overall Study|Subject/Guardian Decision|0|||
125180487|NCT04211831|450279337|FG000|Overall Study|Withdrawal by Subject|4|||
125180488|NCT04211831|450279338|FG001|Overall Study|Withdrawal by Subject|1|||
125180489|NCT04211831|450279339|FG002|Overall Study|Withdrawal by Subject|1|||
125180490|NCT04211831|450279337|FG000|Overall Study|Protocol Violation|0|||
125180491|NCT04211831|450279338|FG001|Overall Study|Protocol Violation|0|||
125180492|NCT04211831|450279339|FG002|Overall Study|Protocol Violation|1|||
125180493|NCT04211831|450279337|FG000|Overall Study|Adverse Event|0|||
125180494|NCT04211831|450279338|FG001|Overall Study|Adverse Event|1|||
125180495|NCT04211831|450279339|FG002|Overall Study|Adverse Event|0|||
125180496|NCT04211831|450279337|FG000|Overall Study|Lack of Efficacy|0|||
125180497|NCT04211831|450279338|FG001|Overall Study|Lack of Efficacy|0|||
125180498|NCT04211831|450279339|FG002|Overall Study|Lack of Efficacy|1|||
125180499|NCT04211831|450279337|FG000|Overall Study|Lost to Follow-up|0|||
125180500|NCT04211831|450279338|FG001|Overall Study|Lost to Follow-up|0|||
125180501|NCT04211831|450279339|FG002|Overall Study|Lost to Follow-up|2|||
125180502|NCT04211831|450279337|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
125180503|NCT04211831|450279338|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
125180504|NCT04211831|450279339|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
125180505|NCT04211831|450279337|FG000|Overall Study|Other|0|||
125180506|NCT04211831|450279338|FG001|Overall Study|Other|1|||
125180507|NCT04211831|450279339|FG002|Overall Study|Other|0|||
125180508|NCT01256879|450279341|FG000|Overall Study|Withdrawal by Subject|1|||
125180509|NCT00397514|450279342|FG000|Overall Study|Withdrawal by Subject|1|||
125180510|NCT00397514|450279342|FG000|Overall Study|Pacing wire malfunction|1|||
125180511|NCT00397514|450279342|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
125180512|NCT00397514|450279342|FG000|Overall Study|early extubation|2|||
125180513|NCT00397514|450279342|FG000|Overall Study|poor echocardiographic windows|1|||
125180514|NCT03493685|450281365|FG000|Overall Study|Death|4|||
125180515|NCT03493685|450281366|FG001|Overall Study|Death|3|||
125180516|NCT03493685|450281365|FG000|Overall Study|Lost to Follow-up|3|||
125180517|NCT03493685|450281366|FG001|Overall Study|Lost to Follow-up|2|||
125180518|NCT03493685|450281365|FG000|Overall Study|Physician Decision|2|||
125180519|NCT03493685|450281366|FG001|Overall Study|Physician Decision|0|||
125180520|NCT03493685|450281365|FG000|Overall Study|Withdrawal by Subject|7|||
125180521|NCT03493685|450281366|FG001|Overall Study|Withdrawal by Subject|11|||
125180522|NCT03300817|450281367|FG000|Overall Study|Withdrawal by Subject|1|||
125180523|NCT03300817|450281367|FG000|Overall Study|Adverse Event|1|||
125180524|NCT03300817|450281367|FG000|Overall Study|Subject Found to be Ineligible|2|||
125235851|NCT01126424|450491634|FG002|Overall Study|Adverse Event|0|||
125235852|NCT01126424|450491635|FG003|Overall Study|Adverse Event|0|||
125235853|NCT01126424|450491636|FG004|Overall Study|Adverse Event|1|||
125235854|NCT01126424|450491637|FG005|Overall Study|Adverse Event|0|||
125235855|NCT01126424|450491632|FG000|Overall Study|Withdrawal by Subject|0|||
125235856|NCT01126424|450491633|FG001|Overall Study|Withdrawal by Subject|0|||
125235857|NCT01126424|450491634|FG002|Overall Study|Withdrawal by Subject|1|||
125235858|NCT01126424|450491635|FG003|Overall Study|Withdrawal by Subject|3|||
125235859|NCT01126424|450491636|FG004|Overall Study|Withdrawal by Subject|1|||
125235860|NCT01126424|450491637|FG005|Overall Study|Withdrawal by Subject|0|||
125235861|NCT03801252|450491638|FG000|Overall Study|Protocol Violation|1|||
125235862|NCT03801252|450491639|FG001|Overall Study|Protocol Violation|2|||
125235863|NCT01134042|450491640|FG000|Overall Study|Adverse Event|3|||
125235864|NCT01134042|450491641|FG001|Overall Study|Adverse Event|7|||
125235865|NCT01134042|450491642|FG002|Overall Study|Adverse Event|2|||
125235866|NCT01134042|450491640|FG000|Overall Study|Lack of Efficacy|21|||
125235867|NCT01134042|450491641|FG001|Overall Study|Lack of Efficacy|6|||
125235868|NCT01134042|450491642|FG002|Overall Study|Lack of Efficacy|18|||
125235869|NCT01134042|450491640|FG000|Overall Study|Protocol Violation|5|||
125235870|NCT01134042|450491641|FG001|Overall Study|Protocol Violation|3|||
125235871|NCT01134042|450491642|FG002|Overall Study|Protocol Violation|5|||
125235872|NCT01134042|450491640|FG000|Overall Study|Lost to Follow-up|2|||
125235873|NCT01134042|450491641|FG001|Overall Study|Lost to Follow-up|0|||
125235874|NCT01134042|450491642|FG002|Overall Study|Lost to Follow-up|1|||
125235875|NCT01134042|450491640|FG000|Overall Study|Physician Decision|4|||
125235876|NCT01134042|450491641|FG001|Overall Study|Physician Decision|8|||
125235877|NCT01134042|450491642|FG002|Overall Study|Physician Decision|1|||
125235878|NCT01134042|450491640|FG000|Overall Study|Withdrawal by Subject|13|||
125235879|NCT01134042|450491641|FG001|Overall Study|Withdrawal by Subject|4|||
125235880|NCT01134042|450491642|FG002|Overall Study|Withdrawal by Subject|7|||
125235881|NCT00393367|450491644|FG000|Overall Study|Protocol Violation|2|||
125235882|NCT00393367|450491645|FG001|Overall Study|Protocol Violation|5|||
125235883|NCT00393367|450491644|FG000|Overall Study|Withdrawal by Subject|0|||
125235884|NCT00393367|450491645|FG001|Overall Study|Withdrawal by Subject|2|||
125235885|NCT03286504|450491646|FG000|Overall Study|Lost to Follow-up|19|||
125235886|NCT03286504|450491647|FG001|Overall Study|Lost to Follow-up|16|||
125235887|NCT05350423|450491648|FG000|Overall Study|Lost to Follow-up|3|||
125235888|NCT05350423|450491649|FG001|Overall Study|Lost to Follow-up|3|||
125235889|NCT05350423|450491648|FG000|Overall Study|screen failure|5|||
125235890|NCT05350423|450491649|FG001|Overall Study|screen failure|6|||
125235891|NCT01432327|450491650|FG000|Posttest 3 Months|depression|3|||
125235892|NCT01432327|450491651|FG001|Posttest 3 Months|depression|0|||
125235893|NCT01432327|450491652|FG002|Posttest 3 Months|depression|0|||
125235894|NCT01432327|450491653|FG003|Posttest 3 Months|depression|0|||
125235895|NCT01432327|450491650|FG000|Posttest 3 Months|Lost to Follow-up|1|||
125235896|NCT01432327|450491651|FG001|Posttest 3 Months|Lost to Follow-up|0|||
125235897|NCT01432327|450491652|FG002|Posttest 3 Months|Lost to Follow-up|2|||
125235898|NCT01432327|450491653|FG003|Posttest 3 Months|Lost to Follow-up|1|||
125180525|NCT00265759|450281368|FG000|Overall Study|Withdrawal by Subject|0|||
125180526|NCT00265759|450281369|FG001|Overall Study|Withdrawal by Subject|1|||
125180527|NCT00265759|450281370|FG002|Overall Study|Withdrawal by Subject|2|||
125180528|NCT00265759|450281371|FG003|Overall Study|Withdrawal by Subject|2|||
125180529|NCT00265759|450281368|FG000|Overall Study|Cancel|0|||
125180530|NCT00265759|450281369|FG001|Overall Study|Cancel|0|||
125180531|NCT00265759|450281370|FG002|Overall Study|Cancel|0|||
125180532|NCT00265759|450281371|FG003|Overall Study|Cancel|3|||
125180533|NCT00265759|450281368|FG000|Overall Study|Ineligible|0|||
125180534|NCT00265759|450281369|FG001|Overall Study|Ineligible|0|||
125180535|NCT00265759|450281370|FG002|Overall Study|Ineligible|0|||
125180536|NCT00265759|450281371|FG003|Overall Study|Ineligible|1|||
125180537|NCT00265759|450281368|FG000|Overall Study|Bilateral disease|0|||
125180538|NCT00265759|450281369|FG001|Overall Study|Bilateral disease|0|||
125180539|NCT00265759|450281370|FG002|Overall Study|Bilateral disease|0|||
125180540|NCT00265759|450281371|FG003|Overall Study|Bilateral disease|2|||
125180541|NCT00265759|450281368|FG000|Overall Study|Discontinued due to intolerability|0|||
125180542|NCT00265759|450281369|FG001|Overall Study|Discontinued due to intolerability|0|||
125180543|NCT00265759|450281370|FG002|Overall Study|Discontinued due to intolerability|0|||
125180544|NCT00265759|450281371|FG003|Overall Study|Discontinued due to intolerability|1|||
125180545|NCT03729596|450281374|FG000|Overall Study|Death|3|||
125180546|NCT03729596|450281375|FG001|Overall Study|Death|5|||
125180547|NCT03729596|450281376|FG002|Overall Study|Death|4|||
125180548|NCT03729596|450281377|FG003|Overall Study|Death|1|||
125180549|NCT03729596|450281378|FG004|Overall Study|Death|0|||
125235899|NCT01432327|450491650|FG000|Posttest 3 Months|Allergic reaction|0|||
125180550|NCT03729596|450281379|FG005|Overall Study|Death|34|||
125180551|NCT03729596|450281380|FG006|Overall Study|Death|18|||
125180552|NCT03729596|450281381|FG007|Overall Study|Death|14|||
125180553|NCT03729596|450281382|FG008|Overall Study|Death|19|||
125180554|NCT03729596|450281383|FG009|Overall Study|Death|9|||
125235900|NCT01432327|450491651|FG001|Posttest 3 Months|Allergic reaction|2|||
125180555|NCT03729596|450281374|FG000|Overall Study|Lost to Follow-up|0|||
125180556|NCT03729596|450281375|FG001|Overall Study|Lost to Follow-up|0|||
125180557|NCT03729596|450281376|FG002|Overall Study|Lost to Follow-up|0|||
125180558|NCT03729596|450281377|FG003|Overall Study|Lost to Follow-up|0|||
125180559|NCT03729596|450281378|FG004|Overall Study|Lost to Follow-up|0|||
125180560|NCT03729596|450281379|FG005|Overall Study|Lost to Follow-up|0|||
125180561|NCT03729596|450281380|FG006|Overall Study|Lost to Follow-up|1|||
125180562|NCT03729596|450281381|FG007|Overall Study|Lost to Follow-up|0|||
125180563|NCT03729596|450281382|FG008|Overall Study|Lost to Follow-up|0|||
125180564|NCT03729596|450281383|FG009|Overall Study|Lost to Follow-up|1|||
125180565|NCT03729596|450281374|FG000|Overall Study|protocol amendment|0|||
125180566|NCT03729596|450281375|FG001|Overall Study|protocol amendment|1|||
125180567|NCT03729596|450281376|FG002|Overall Study|protocol amendment|3|||
125180568|NCT03729596|450281377|FG003|Overall Study|protocol amendment|6|||
125180569|NCT03729596|450281378|FG004|Overall Study|protocol amendment|5|||
125180570|NCT03729596|450281379|FG005|Overall Study|protocol amendment|0|||
125180571|NCT03729596|450281380|FG006|Overall Study|protocol amendment|0|||
125180572|NCT03729596|450281381|FG007|Overall Study|protocol amendment|0|||
125180573|NCT03729596|450281382|FG008|Overall Study|protocol amendment|0|||
125180574|NCT03729596|450281383|FG009|Overall Study|protocol amendment|0|||
125180575|NCT03729596|450281374|FG000|Overall Study|Withdrawal by Subject|0|||
125180576|NCT03729596|450281375|FG001|Overall Study|Withdrawal by Subject|0|||
125180577|NCT03729596|450281376|FG002|Overall Study|Withdrawal by Subject|0|||
125180578|NCT03729596|450281377|FG003|Overall Study|Withdrawal by Subject|0|||
125180579|NCT03729596|450281378|FG004|Overall Study|Withdrawal by Subject|0|||
125180580|NCT03729596|450281379|FG005|Overall Study|Withdrawal by Subject|4|||
125180581|NCT03729596|450281380|FG006|Overall Study|Withdrawal by Subject|2|||
125180582|NCT03729596|450281381|FG007|Overall Study|Withdrawal by Subject|3|||
125180583|NCT03729596|450281382|FG008|Overall Study|Withdrawal by Subject|2|||
125180584|NCT03729596|450281383|FG009|Overall Study|Withdrawal by Subject|3|||
125180585|NCT03729596|450281374|FG000|Overall Study|study terminated by sponsor|0|||
125180586|NCT03729596|450281375|FG001|Overall Study|study terminated by sponsor|0|||
125180587|NCT03729596|450281376|FG002|Overall Study|study terminated by sponsor|0|||
125180588|NCT03729596|450281377|FG003|Overall Study|study terminated by sponsor|0|||
125180589|NCT03729596|450281378|FG004|Overall Study|study terminated by sponsor|1|||
125180590|NCT03729596|450281379|FG005|Overall Study|study terminated by sponsor|3|||
125180591|NCT03729596|450281380|FG006|Overall Study|study terminated by sponsor|0|||
125180592|NCT03729596|450281381|FG007|Overall Study|study terminated by sponsor|1|||
125180593|NCT03729596|450281382|FG008|Overall Study|study terminated by sponsor|0|||
125180594|NCT03729596|450281383|FG009|Overall Study|study terminated by sponsor|0|||
125180595|NCT04467840|450281384|FG000|Overall Study|Death|35|||
125180596|NCT04467840|450281385|FG001|Overall Study|Death|39|||
125180597|NCT04467840|450281384|FG000|Overall Study|Withdrawal by Subject|8|||
125180598|NCT04467840|450281385|FG001|Overall Study|Withdrawal by Subject|4|||
125180599|NCT04467840|450281384|FG000|Overall Study|Adverse Event|2|||
125180600|NCT04467840|450281385|FG001|Overall Study|Adverse Event|0|||
125180601|NCT04467840|450281384|FG000|Overall Study|Lost to Follow-up|1|||
125180602|NCT04467840|450281385|FG001|Overall Study|Lost to Follow-up|3|||
125180603|NCT04467840|450281384|FG000|Overall Study|Physician Decision|1|||
125180604|NCT04467840|450281385|FG001|Overall Study|Physician Decision|0|||
125180605|NCT04467840|450281384|FG000|Overall Study|Other|1|||
125180606|NCT04467840|450281385|FG001|Overall Study|Other|5|||
125180607|NCT04467840|450281384|FG000|Overall Study|Missing study completion status|3|||
125180608|NCT04467840|450281385|FG001|Overall Study|Missing study completion status|1|||
125180609|NCT05126693|450281388|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
125180610|NCT05126693|450281389|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
125180611|NCT05126693|450281388|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
125180612|NCT05126693|450281389|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
125180613|NCT05126693|450281388|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
125180614|NCT05126693|450281389|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
125180615|NCT00443729|450281396|FG000|Overall Study|Never Treated|0|||
125180616|NCT00443729|450281397|FG001|Overall Study|Never Treated|1|||
125180617|NCT00443729|450281396|FG000|Overall Study|Lack of Efficacy|4|||
125180618|NCT00443729|450281397|FG001|Overall Study|Lack of Efficacy|2|||
125180619|NCT00443729|450281396|FG000|Overall Study|Lost to Follow-up|0|||
125180620|NCT00443729|450281397|FG001|Overall Study|Lost to Follow-up|1|||
125180621|NCT00443729|450281396|FG000|Overall Study|Physician Decision|2|||
125180622|NCT00443729|450281397|FG001|Overall Study|Physician Decision|1|||
125180623|NCT00443729|450281396|FG000|Overall Study|Protocol Violation|1|||
125180624|NCT00443729|450281397|FG001|Overall Study|Protocol Violation|1|||
125180625|NCT00443729|450281396|FG000|Overall Study|Withdrawal by Subject|3|||
125180626|NCT00443729|450281397|FG001|Overall Study|Withdrawal by Subject|1|||
125180627|NCT01269918|450281402|FG000|Overall Study|Did not receive study drug|0|||
125180628|NCT01269918|450281403|FG001|Overall Study|Did not receive study drug|3|||
125180629|NCT03571828|450281404|FG000|Overall Study|Withdrawal by Subject|1|||
125180630|NCT03571828|450281405|FG001|Overall Study|Withdrawal by Subject|0|||
125180631|NCT03571828|450281404|FG000|Overall Study|Decision by sponsor|5|||
125180632|NCT03571828|450281405|FG001|Overall Study|Decision by sponsor|1|||
125180633|NCT03571828|450281404|FG000|Overall Study|Death|2|||
125235901|NCT01432327|450491652|FG002|Posttest 3 Months|Allergic reaction|0|||
125235902|NCT01432327|450491653|FG003|Posttest 3 Months|Allergic reaction|0|||
125180634|NCT03571828|450281405|FG001|Overall Study|Death|0|||
125180635|NCT04471428|450281406|FG000|Overall Study|Withdrawal by Subject|29|||
125180636|NCT04471428|450281407|FG001|Overall Study|Withdrawal by Subject|1|||
125180637|NCT04471428|450281406|FG000|Overall Study|Physician Decision|0|||
125180638|NCT04471428|450281407|FG001|Overall Study|Physician Decision|1|||
125180639|NCT04471428|450281406|FG000|Overall Study|Reason Not Specified|0|||
125180640|NCT04471428|450281407|FG001|Overall Study|Reason Not Specified|2|||
125180641|NCT04471428|450281406|FG000|Overall Study|Death|106|||
125180642|NCT04471428|450281407|FG001|Overall Study|Death|114|||
125180643|NCT04471428|450281406|FG000|Overall Study|Ongoing in the study|45|||
125180644|NCT04471428|450281407|FG001|Overall Study|Ongoing in the study|68|||
125180645|NCT01870778|450281411|FG000|Overall Study|Withdrawal by Subject|8|||
125180646|NCT01870778|450281412|FG001|Overall Study|Withdrawal by Subject|7|||
125180647|NCT01870778|450281411|FG000|Overall Study|Lost to Follow-up|0|||
125180648|NCT01870778|450281412|FG001|Overall Study|Lost to Follow-up|2|||
125180649|NCT02553772|450281416|FG000|Overall Study|Adverse Event|2|||
125180650|NCT02553772|450281417|FG001|Overall Study|Adverse Event|3|||
125180651|NCT02553772|450281416|FG000|Overall Study|Lost to Follow-up|2|||
125180652|NCT02553772|450281417|FG001|Overall Study|Lost to Follow-up|1|||
125180653|NCT02553772|450281416|FG000|Overall Study|Withdrawal of Consent|1|||
125180654|NCT02553772|450281417|FG001|Overall Study|Withdrawal of Consent|1|||
125180655|NCT02553772|450281416|FG000|Overall Study|Lack of Efficacy|1|||
125180656|NCT02553772|450281417|FG001|Overall Study|Lack of Efficacy|0|||
125180657|NCT02553772|450281416|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125180658|NCT02553772|450281417|FG001|Overall Study|Other Miscellaneous Reasons|1|||
125180659|NCT00786409|450281418|FG000|Overall Study|Withdrawal by Subject|2|||
125180660|NCT00786409|450281418|FG000|Overall Study|Adverse Event|2|||
125180661|NCT00786409|450281418|FG000|Overall Study|Pregnancy|2|||
125180662|NCT00786409|450281418|FG000|Overall Study|Lost to Follow-up|1|||
125180663|NCT00610129|450281419|FG000|Overall Study|Not treated since patients ineligible|3|||
125180664|NCT01184079|450281425|FG000|Overall Study|Lost to Follow-up|14|||
125180665|NCT01184079|450281426|FG001|Overall Study|Lost to Follow-up|2|||
125180666|NCT02198963|450281431|FG000|Overall Study|Adverse Event|1|||
125180667|NCT02198963|450281431|FG000|Overall Study|Withdrawal by Subject|6|||
125180668|NCT00281957|450281435|FG000|Overall Study|Adverse Event|7|||
125180669|NCT00281957|450281436|FG001|Overall Study|Adverse Event|2|||
125180670|NCT00281957|450281435|FG000|Overall Study|Death|1|||
125180671|NCT00281957|450281436|FG001|Overall Study|Death|0|||
125180672|NCT00281957|450281435|FG000|Overall Study|Progression/relapse|47|||
125180673|NCT00281957|450281436|FG001|Overall Study|Progression/relapse|35|||
125180674|NCT00281957|450281435|FG000|Overall Study|Not protocol specified|8|||
125180675|NCT00281957|450281436|FG001|Overall Study|Not protocol specified|1|||
125180676|NCT00281957|450281435|FG000|Overall Study|Not eligible|1|||
125180677|NCT00281957|450281436|FG001|Overall Study|Not eligible|2|||
125180678|NCT00281957|450281435|FG000|Overall Study|Did not start treatment|3|||
125180679|NCT00281957|450281436|FG001|Overall Study|Did not start treatment|1|||
125180680|NCT00281957|450281435|FG000|Overall Study|Refusal unrelated to adverse events|0|||
125180681|NCT00281957|450281436|FG001|Overall Study|Refusal unrelated to adverse events|1|||
125180682|NCT01876446|450281437|FG000|Overall Study|Death|0|||
125180683|NCT01876446|450281438|FG001|Overall Study|Death|1|||
125180684|NCT01876446|450281437|FG000|Overall Study|Withdrawal by Subject|1|||
125180685|NCT01876446|450281438|FG001|Overall Study|Withdrawal by Subject|2|||
125180686|NCT01876446|450281437|FG000|Overall Study|Physician Decision|1|||
125180687|NCT01876446|450281438|FG001|Overall Study|Physician Decision|3|||
125180688|NCT03180645|450281440|FG000|Overall Study|Adverse Event|0|||
125180689|NCT03180645|450281441|FG001|Overall Study|Adverse Event|1|||
125180690|NCT03180645|450281442|FG002|Overall Study|Adverse Event|2|||
125180691|NCT01808573|450281443|FG000|Overall Study|Death|212|||
125180692|NCT01808573|450281444|FG001|Overall Study|Death|240|||
125180693|NCT01808573|450281443|FG000|Overall Study|Withdrawal by Subject|12|||
125180694|NCT01808573|450281444|FG001|Overall Study|Withdrawal by Subject|10|||
125180695|NCT01808573|450281443|FG000|Overall Study|Lost to Follow-up|3|||
125180696|NCT01808573|450281444|FG001|Overall Study|Lost to Follow-up|0|||
125235903|NCT01432327|450491650|FG000|Posttest 6 Months|Lost to Follow-up|0|||
125180697|NCT01808573|450281443|FG000|Overall Study|Discontinuation of study by sponsor|79|||
125180698|NCT01808573|450281444|FG001|Overall Study|Discontinuation of study by sponsor|64|||
125180699|NCT01808573|450281443|FG000|Overall Study|Randomized in Error|1|||
125180700|NCT01808573|450281444|FG001|Overall Study|Randomized in Error|0|||
125180701|NCT02208089|450281445|FG000|Overall Study|Withdrawal by Subject|1|||
125180702|NCT02208089|450281446|FG001|Overall Study|Withdrawal by Subject|0|||
125180703|NCT02208089|450281445|FG000|Overall Study|Lost to Follow-up|6|||
125180704|NCT02208089|450281446|FG001|Overall Study|Lost to Follow-up|0|||
125235904|NCT01432327|450491651|FG001|Posttest 6 Months|Lost to Follow-up|0|||
125180705|NCT03629184|450281448|FG000|Overall Study|Withdrawal by Subject|2|||
125180706|NCT03629184|450281449|FG001|Overall Study|Withdrawal by Subject|1|||
125180707|NCT03629184|450281448|FG000|Overall Study|Physician Decision|1|||
125180708|NCT03629184|450281449|FG001|Overall Study|Physician Decision|0|||
125443433|NCT02555371|451252132|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
125180709|NCT00972595|450281450|FG000|Period 1|Adverse Event|1|||
125180710|NCT00972595|450281451|FG001|Period 1|Adverse Event|0|||
125180711|NCT01461538|450281452|FG000|Overall Study|Death|15|||
125180712|NCT01461538|450281453|FG001|Overall Study|Death|6|||
125180713|NCT01461538|450281454|FG002|Overall Study|Death|2|||
125180714|NCT01461538|450281452|FG000|Overall Study|Study Stopped by Sponsor|2|||
125180715|NCT01461538|450281453|FG001|Overall Study|Study Stopped by Sponsor|1|||
125180716|NCT01461538|450281454|FG002|Overall Study|Study Stopped by Sponsor|0|||
125180717|NCT01461538|450281452|FG000|Overall Study|Withdrawal by Subject|1|||
125180718|NCT01461538|450281453|FG001|Overall Study|Withdrawal by Subject|1|||
125180719|NCT01461538|450281454|FG002|Overall Study|Withdrawal by Subject|0|||
125180720|NCT00141778|450281455|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
125180721|NCT00141778|450281456|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
125180722|NCT00141778|450281457|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
125180723|NCT00141778|450281455|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
125180724|NCT00141778|450281456|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
125180725|NCT00141778|450281457|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
125180726|NCT00141778|450281455|FG000|Started Study Medication|Withdrawal by Subject|0|||
125180727|NCT00141778|450281456|FG001|Started Study Medication|Withdrawal by Subject|2|||
125180728|NCT00141778|450281457|FG002|Started Study Medication|Withdrawal by Subject|0|||
125180729|NCT00141778|450281455|FG000|Started Study Medication|Difficulty Swallowing|0|||
125180730|NCT00141778|450281456|FG001|Started Study Medication|Difficulty Swallowing|1|||
125180731|NCT00141778|450281457|FG002|Started Study Medication|Difficulty Swallowing|0|||
125180732|NCT00141778|450281455|FG000|Started Study Medication|Chest Discomfort|0|||
125180733|NCT00141778|450281456|FG001|Started Study Medication|Chest Discomfort|0|||
125180734|NCT00141778|450281457|FG002|Started Study Medication|Chest Discomfort|1|||
125180735|NCT02729909|450281458|FG000|Overall Study|Lost to Follow-up|0|||
125180736|NCT02729909|450281459|FG001|Overall Study|Lost to Follow-up|1|||
125180737|NCT02729909|450281458|FG000|Overall Study|Lack of Efficacy|0|||
125180738|NCT02729909|450281459|FG001|Overall Study|Lack of Efficacy|2|||
125180739|NCT02729909|450281458|FG000|Overall Study|Significant Protocol Deviation|0|||
125180740|NCT02729909|450281459|FG001|Overall Study|Significant Protocol Deviation|2|||
125180741|NCT02729909|450281458|FG000|Overall Study|Voluntary Withdrawal|1|||
125180742|NCT02729909|450281459|FG001|Overall Study|Voluntary Withdrawal|0|||
125180743|NCT02046603|450281466|FG000|Overall Study|Other|11|||
125180744|NCT02046603|450281467|FG001|Overall Study|Other|66|||
125180745|NCT02046603|450281466|FG000|Overall Study|Protocol Violation|0|||
125180746|NCT02046603|450281467|FG001|Overall Study|Protocol Violation|1|||
125180747|NCT02046603|450281466|FG000|Overall Study|Participant/legal guardian decision|1|||
125180748|NCT02046603|450281467|FG001|Overall Study|Participant/legal guardian decision|3|||
125180749|NCT02046603|450281466|FG000|Overall Study|Physician Decision|2|||
125180750|NCT02046603|450281467|FG001|Overall Study|Physician Decision|1|||
125180751|NCT02046603|450281466|FG000|Overall Study|Lost to Follow-up|1|||
125180752|NCT02046603|450281467|FG001|Overall Study|Lost to Follow-up|2|||
125180753|NCT02046603|450281466|FG000|Overall Study|Death|0|||
125180754|NCT02046603|450281467|FG001|Overall Study|Death|1|||
125180755|NCT02046603|450281466|FG000|Overall Study|Adverse Event|0|||
125180756|NCT02046603|450281467|FG001|Overall Study|Adverse Event|1|||
125180757|NCT05101343|450281468|FG000|Overall Study|Withdrawal by Subject|2|||
125180758|NCT05101343|450281469|FG001|Overall Study|Withdrawal by Subject|1|||
125180759|NCT02461160|450281470|FG000|Overall Study|Lost to Follow-up|0|||
125180760|NCT02461160|450281471|FG001|Overall Study|Lost to Follow-up|0|||
125180761|NCT02461160|450281472|FG002|Overall Study|Lost to Follow-up|0|||
125180762|NCT02461160|450281473|FG003|Overall Study|Lost to Follow-up|0|||
125180763|NCT02461160|450281474|FG004|Overall Study|Lost to Follow-up|0|||
125180764|NCT02461160|450281475|FG005|Overall Study|Lost to Follow-up|0|||
125180765|NCT02461160|450281476|FG006|Overall Study|Lost to Follow-up|0|||
125180766|NCT02461160|450281477|FG007|Overall Study|Lost to Follow-up|1|||
125180767|NCT02461160|450281478|FG008|Overall Study|Lost to Follow-up|0|||
125180768|NCT02461160|450281479|FG009|Overall Study|Lost to Follow-up|0|||
125180769|NCT02461160|450281480|FG010|Overall Study|Lost to Follow-up|0|||
125180770|NCT02461160|450281481|FG011|Overall Study|Lost to Follow-up|0|||
125180771|NCT02461160|450281482|FG012|Overall Study|Lost to Follow-up|0|||
125180772|NCT00193050|450281483|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
125180773|NCT00193050|450281483|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
125180774|NCT00193050|450281483|FG000|Neoadjuvant Treatment|Physician Decision|2|||
125180775|NCT00193050|450281483|FG000|Neoadjuvant Treatment|Adverse Event|2|||
125180776|NCT00193050|450281483|FG000|Adjuvant|Physician Decision|5|||
125180777|NCT00193050|450281483|FG000|Adjuvant|Intercurrent Hospitalization|3|||
125180778|NCT00193050|450281483|FG000|Adjuvant|Lack of Efficacy|2|||
125180779|NCT00061932|450281484|FG000|Overall Study|Withdrawal by Subject|13|||
125180780|NCT00061932|450281485|FG001|Overall Study|Withdrawal by Subject|4|||
125180781|NCT02899962|450281486|FG000|Open-label Phase|Adverse Event|2|||
125180782|NCT02899962|450281487|FG001|Open-label Phase|Adverse Event|0|||
125180783|NCT02899962|450281488|FG002|Open-label Phase|Adverse Event|0|||
125443434|NCT02555371|451252128|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
125235905|NCT01432327|450491652|FG002|Posttest 6 Months|Lost to Follow-up|3|||
125235906|NCT01432327|450491653|FG003|Posttest 6 Months|Lost to Follow-up|2|||
125235907|NCT01432327|450491650|FG000|Posttest 6 Months|Allergic reaction|0|||
125235908|NCT01432327|450491651|FG001|Posttest 6 Months|Allergic reaction|0|||
125235909|NCT01432327|450491652|FG002|Posttest 6 Months|Allergic reaction|1|||
125235910|NCT01432327|450491653|FG003|Posttest 6 Months|Allergic reaction|0|||
125235911|NCT01432327|450491650|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
125235912|NCT01432327|450491651|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
125235913|NCT01432327|450491652|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
125235914|NCT01432327|450491653|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
125235915|NCT01432327|450491650|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
125235916|NCT01432327|450491651|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
125235917|NCT01432327|450491652|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
125235918|NCT01432327|450491653|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
125235919|NCT01432327|450491650|FG000|Posttest 1 Year|Lost to Follow-up|0|||
125235920|NCT01432327|450491651|FG001|Posttest 1 Year|Lost to Follow-up|0|||
125235921|NCT01432327|450491652|FG002|Posttest 1 Year|Lost to Follow-up|4|||
125235922|NCT01432327|450491653|FG003|Posttest 1 Year|Lost to Follow-up|2|||
125235923|NCT01432327|450491650|FG000|Posttest 1 Year|Allergic reaction|0|||
125235924|NCT01432327|450491651|FG001|Posttest 1 Year|Allergic reaction|0|||
125235925|NCT01432327|450491652|FG002|Posttest 1 Year|Allergic reaction|1|||
125235926|NCT01432327|450491653|FG003|Posttest 1 Year|Allergic reaction|1|||
125235927|NCT03320369|450491656|FG000|Overall Study|Adverse Event|1|||
125235928|NCT03320369|450491656|FG000|Overall Study|Withdrawal by Subject|2|||
125235929|NCT01732692|450491657|FG000|Overall Study|Adverse Event|0|||
125235930|NCT01732692|450491658|FG001|Overall Study|Adverse Event|1|||
125235931|NCT02030600|450491661|FG000|Treatment Period 1|Adverse Event|5|||
125235932|NCT02030600|450491662|FG001|Treatment Period 1|Adverse Event|7|||
125235933|NCT02030600|450491661|FG000|Treatment Period 1|Lack of Efficacy|0|||
125235934|NCT02030600|450491662|FG001|Treatment Period 1|Lack of Efficacy|1|||
125235935|NCT02030600|450491661|FG000|Treatment Period 1|Lost to Follow-up|11|||
125235936|NCT02030600|450491662|FG001|Treatment Period 1|Lost to Follow-up|3|||
125235937|NCT02030600|450491661|FG000|Treatment Period 1|Protocol Violation|22|||
125235938|NCT02030600|450491662|FG001|Treatment Period 1|Protocol Violation|17|||
125235939|NCT02030600|450491661|FG000|Treatment Period 1|Withdrawal by Subject|13|||
125235940|NCT02030600|450491662|FG001|Treatment Period 1|Withdrawal by Subject|17|||
125235941|NCT02030600|450491661|FG000|Treatment Period 1|Casebook Unsigned|1|||
125235942|NCT02030600|450491662|FG001|Treatment Period 1|Casebook Unsigned|0|||
125235943|NCT02030600|450491661|FG000|Treatment Period 1|Unclassified|1|||
125235944|NCT02030600|450491662|FG001|Treatment Period 1|Unclassified|0|||
125235945|NCT02030600|450491661|FG000|Treatment Period 2|Adverse Event|4|||
125235946|NCT02030600|450491662|FG001|Treatment Period 2|Adverse Event|4|||
125235947|NCT02030600|450491661|FG000|Treatment Period 2|Lack of Efficacy|2|||
125235948|NCT02030600|450491662|FG001|Treatment Period 2|Lack of Efficacy|1|||
125235949|NCT02030600|450491661|FG000|Treatment Period 2|Lost to Follow-up|4|||
125235950|NCT02030600|450491662|FG001|Treatment Period 2|Lost to Follow-up|2|||
125235951|NCT02030600|450491661|FG000|Treatment Period 2|Protocol Violation|1|||
125235952|NCT02030600|450491662|FG001|Treatment Period 2|Protocol Violation|2|||
125180784|NCT02899962|450281486|FG000|Open-label Phase|Lost to Follow-up|9|||
125180785|NCT02899962|450281487|FG001|Open-label Phase|Lost to Follow-up|0|||
125180786|NCT02899962|450281488|FG002|Open-label Phase|Lost to Follow-up|0|||
125180787|NCT02899962|450281486|FG000|Open-label Phase|Other reasons|9|||
125180788|NCT02899962|450281487|FG001|Open-label Phase|Other reasons|0|||
125180789|NCT02899962|450281488|FG002|Open-label Phase|Other reasons|0|||
125180790|NCT02899962|450281486|FG000|Open-label Phase|Withdrawal by Subject|7|||
125180791|NCT02899962|450281487|FG001|Open-label Phase|Withdrawal by Subject|0|||
125235953|NCT02030600|450491661|FG000|Treatment Period 2|Withdrawal by Subject|13|||
125235954|NCT02030600|450491662|FG001|Treatment Period 2|Withdrawal by Subject|9|||
125235955|NCT02030600|450491661|FG000|Treatment Period 2|Unclassified|1|||
125235956|NCT02030600|450491662|FG001|Treatment Period 2|Unclassified|0|||
125235957|NCT01155323|450491663|FG000|First Intervention|exclusion criteria|1|||
125235958|NCT01155323|450491664|FG001|First Intervention|exclusion criteria|1|||
125235959|NCT01155323|450491663|FG000|Second Intervention|Lost to Follow-up|1|||
125235960|NCT01155323|450491664|FG001|Second Intervention|Lost to Follow-up|1|||
125235961|NCT04154956|450491674|FG000|Overall Study|Death|109|||
125235962|NCT04154956|450491675|FG001|Overall Study|Death|110|||
125235963|NCT04154956|450491674|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
125235964|NCT04154956|450491675|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
125235965|NCT04154956|450491674|FG000|Overall Study|Withdrawal by Subject|1|||
125235966|NCT04154956|450491675|FG001|Overall Study|Withdrawal by Subject|7|||
125180792|NCT02899962|450281488|FG002|Open-label Phase|Withdrawal by Subject|0|||
125180793|NCT02899962|450281486|FG000|Maintenance Phase|Adverse Event|0|||
125180794|NCT02899962|450281487|FG001|Maintenance Phase|Adverse Event|2|||
125180795|NCT02899962|450281488|FG002|Maintenance Phase|Adverse Event|1|||
125235967|NCT04154956|450491674|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
125180796|NCT02899962|450281486|FG000|Maintenance Phase|Death|0|||
125235968|NCT04154956|450491675|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
125235969|NCT00805532|450491676|FG000|Overall Study|invalid data|0|||
125235970|NCT00805532|450491677|FG001|Overall Study|invalid data|1|||
125235971|NCT01859741|450491678|FG000|Overall Study|Death|3|||
125235972|NCT01859741|450491679|FG001|Overall Study|Death|2|||
125235973|NCT01859741|450491680|FG002|Overall Study|Death|4|||
125235974|NCT01859741|450491681|FG003|Overall Study|Death|3|||
125235975|NCT01859741|450491682|FG004|Overall Study|Death|5|||
125235976|NCT01859741|450491683|FG005|Overall Study|Death|4|||
125235977|NCT01859741|450491684|FG006|Overall Study|Death|51|||
125235978|NCT01859741|450491685|FG007|Overall Study|Death|51|||
125235979|NCT01859741|450491678|FG000|Overall Study|Lost to Follow-up|0|||
125235980|NCT01859741|450491679|FG001|Overall Study|Lost to Follow-up|0|||
125235981|NCT01859741|450491680|FG002|Overall Study|Lost to Follow-up|0|||
125235982|NCT01859741|450491681|FG003|Overall Study|Lost to Follow-up|0|||
125235983|NCT01859741|450491682|FG004|Overall Study|Lost to Follow-up|0|||
125235984|NCT01859741|450491683|FG005|Overall Study|Lost to Follow-up|1|||
125235985|NCT01859741|450491684|FG006|Overall Study|Lost to Follow-up|0|||
125235986|NCT01859741|450491685|FG007|Overall Study|Lost to Follow-up|4|||
125235987|NCT01859741|450491678|FG000|Overall Study|Withdrawal by Subject|0|||
125235988|NCT01859741|450491679|FG001|Overall Study|Withdrawal by Subject|1|||
125235989|NCT01859741|450491680|FG002|Overall Study|Withdrawal by Subject|2|||
125235990|NCT01859741|450491681|FG003|Overall Study|Withdrawal by Subject|0|||
125235991|NCT01859741|450491682|FG004|Overall Study|Withdrawal by Subject|0|||
125235992|NCT01859741|450491683|FG005|Overall Study|Withdrawal by Subject|1|||
125235993|NCT01859741|450491684|FG006|Overall Study|Withdrawal by Subject|1|||
125235994|NCT01859741|450491685|FG007|Overall Study|Withdrawal by Subject|1|||
125235995|NCT01859741|450491678|FG000|Overall Study|Study Terminated by Sponsor|0|||
125235996|NCT01859741|450491679|FG001|Overall Study|Study Terminated by Sponsor|0|||
125235997|NCT01859741|450491680|FG002|Overall Study|Study Terminated by Sponsor|0|||
125235998|NCT01859741|450491681|FG003|Overall Study|Study Terminated by Sponsor|0|||
125235999|NCT01859741|450491682|FG004|Overall Study|Study Terminated by Sponsor|1|||
125236000|NCT01859741|450491683|FG005|Overall Study|Study Terminated by Sponsor|0|||
125236001|NCT01859741|450491684|FG006|Overall Study|Study Terminated by Sponsor|16|||
125236002|NCT01859741|450491685|FG007|Overall Study|Study Terminated by Sponsor|14|||
125236003|NCT01859741|450491678|FG000|Overall Study|Other|0|||
125236004|NCT01859741|450491679|FG001|Overall Study|Other|0|||
125236005|NCT01859741|450491680|FG002|Overall Study|Other|0|||
125236006|NCT01859741|450491681|FG003|Overall Study|Other|0|||
125236007|NCT01859741|450491682|FG004|Overall Study|Other|0|||
125236008|NCT01859741|450491683|FG005|Overall Study|Other|0|||
125236009|NCT01859741|450491684|FG006|Overall Study|Other|2|||
125236010|NCT01859741|450491685|FG007|Overall Study|Other|0|||
125236011|NCT01281306|450491693|FG000|Overall Study|Lack of Efficacy|0|||
125236012|NCT01281306|450491694|FG001|Overall Study|Lack of Efficacy|1|||
125236013|NCT01281306|450491695|FG002|Overall Study|Lack of Efficacy|3|||
125236014|NCT01281306|450491696|FG003|Overall Study|Lack of Efficacy|0|||
125236015|NCT01281306|450491697|FG004|Overall Study|Lack of Efficacy|2|||
125236016|NCT01281306|450491698|FG005|Overall Study|Lack of Efficacy|0|||
125236017|NCT01281306|450491699|FG006|Overall Study|Lack of Efficacy|1|||
125236018|NCT01281306|450491693|FG000|Overall Study|Withdrawal by Subject|1|||
125236019|NCT01281306|450491694|FG001|Overall Study|Withdrawal by Subject|0|||
125236020|NCT01281306|450491695|FG002|Overall Study|Withdrawal by Subject|2|||
125236021|NCT01281306|450491696|FG003|Overall Study|Withdrawal by Subject|4|||
125236022|NCT01281306|450491697|FG004|Overall Study|Withdrawal by Subject|1|||
125236023|NCT01281306|450491698|FG005|Overall Study|Withdrawal by Subject|3|||
125236024|NCT01281306|450491699|FG006|Overall Study|Withdrawal by Subject|1|||
125236025|NCT01281306|450491693|FG000|Overall Study|Protocol deviation|0|||
125236026|NCT01281306|450491694|FG001|Overall Study|Protocol deviation|1|||
125236027|NCT01281306|450491695|FG002|Overall Study|Protocol deviation|1|||
125236028|NCT01281306|450491696|FG003|Overall Study|Protocol deviation|1|||
125236029|NCT01281306|450491697|FG004|Overall Study|Protocol deviation|1|||
125236030|NCT01281306|450491698|FG005|Overall Study|Protocol deviation|0|||
125236031|NCT01281306|450491699|FG006|Overall Study|Protocol deviation|0|||
125236032|NCT01281306|450491693|FG000|Overall Study|Condition no longer requires study drug|1|||
125236033|NCT01281306|450491694|FG001|Overall Study|Condition no longer requires study drug|0|||
125236034|NCT01281306|450491695|FG002|Overall Study|Condition no longer requires study drug|0|||
125236035|NCT01281306|450491696|FG003|Overall Study|Condition no longer requires study drug|0|||
125392393|NCT03969992|451070655|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
125236036|NCT01281306|450491697|FG004|Overall Study|Condition no longer requires study drug|0|||
125392394|NCT03969992|451070656|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
125236037|NCT01281306|450491698|FG005|Overall Study|Condition no longer requires study drug|1|||
125236038|NCT01281306|450491699|FG006|Overall Study|Condition no longer requires study drug|1|||
125236039|NCT01281306|450491693|FG000|Overall Study|Lost to Follow-up|1|||
125236040|NCT01281306|450491694|FG001|Overall Study|Lost to Follow-up|0|||
125236041|NCT01281306|450491695|FG002|Overall Study|Lost to Follow-up|0|||
125236042|NCT01281306|450491696|FG003|Overall Study|Lost to Follow-up|2|||
125236043|NCT01281306|450491697|FG004|Overall Study|Lost to Follow-up|0|||
125392395|NCT03969992|451070654|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
125180797|NCT02899962|450281487|FG001|Maintenance Phase|Death|0|||
125180798|NCT02899962|450281488|FG002|Maintenance Phase|Death|1|||
125180799|NCT02899962|450281486|FG000|Maintenance Phase|Lack of Efficacy|0|||
125180800|NCT02899962|450281487|FG001|Maintenance Phase|Lack of Efficacy|20|||
125180801|NCT02899962|450281488|FG002|Maintenance Phase|Lack of Efficacy|16|||
125180802|NCT02899962|450281486|FG000|Maintenance Phase|Lost to Follow-up|0|||
125180803|NCT02899962|450281487|FG001|Maintenance Phase|Lost to Follow-up|12|||
125180804|NCT02899962|450281488|FG002|Maintenance Phase|Lost to Follow-up|14|||
125180805|NCT02899962|450281486|FG000|Maintenance Phase|Other reasons|0|||
125180806|NCT02899962|450281487|FG001|Maintenance Phase|Other reasons|9|||
125180807|NCT02899962|450281488|FG002|Maintenance Phase|Other reasons|13|||
125180808|NCT02899962|450281486|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
125180809|NCT02899962|450281487|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
125180810|NCT02899962|450281488|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
125180811|NCT02899962|450281486|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
125180812|NCT02899962|450281487|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
125180813|NCT02899962|450281488|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
125180814|NCT02899962|450281486|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125180815|NCT02899962|450281487|FG001|Maintenance Phase|Withdrawal by Subject|30|||
125180816|NCT02899962|450281488|FG002|Maintenance Phase|Withdrawal by Subject|36|||
125180817|NCT01245283|450281489|FG000|Overall Study|Lost to Follow-up|14|||
125180818|NCT01245283|450281490|FG001|Overall Study|Lost to Follow-up|11|||
125180819|NCT01245283|450281491|FG002|Overall Study|Lost to Follow-up|11|||
125180820|NCT01610492|450281500|FG000|Overall Study|Adverse Event|1|||
125180821|NCT01610492|450281500|FG000|Overall Study|Lack of Efficacy|3|||
125180822|NCT01610492|450281500|FG000|Overall Study|Other: Reached stopping criteria|1|||
125180823|NCT01610492|450281500|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
125180824|NCT01982955|450281501|FG000|Overall Study|Randomized but not treated|0|||
125180825|NCT01982955|450281502|FG001|Overall Study|Randomized but not treated|0|||
125180826|NCT01982955|450281503|FG002|Overall Study|Randomized but not treated|0|||
125180827|NCT01982955|450281504|FG003|Overall Study|Randomized but not treated|1|||
125180828|NCT01982955|450281505|FG004|Overall Study|Randomized but not treated|0|||
125180829|NCT00866359|450281508|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
125180830|NCT00866359|450281509|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
125180831|NCT00866359|450281510|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
125180832|NCT00866359|450281511|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
125180833|NCT00866359|450281508|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
125180834|NCT00866359|450281509|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
125180835|NCT00866359|450281510|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
125180836|NCT00866359|450281511|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
125180837|NCT00866359|450281508|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
125180838|NCT00866359|450281509|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
125180839|NCT00866359|450281510|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
125180840|NCT00866359|450281511|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
125180841|NCT00866359|450281508|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
125180842|NCT00866359|450281509|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
125180843|NCT00866359|450281510|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
125180844|NCT00866359|450281511|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
125180845|NCT00866359|450281508|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
125180846|NCT00866359|450281509|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
125180847|NCT00866359|450281510|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
125180848|NCT00866359|450281511|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
125180849|NCT00866359|450281508|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
125180850|NCT00866359|450281509|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
125180851|NCT00866359|450281510|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
125180852|NCT00866359|450281511|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
125180853|NCT01625091|450281512|FG000|Intervention|Death|1|||
125180854|NCT01625091|450281513|FG001|Intervention|Death|1|||
125180855|NCT01625091|450281512|FG000|Intervention|Withdrawal by Subject|4|||
125180856|NCT01625091|450281513|FG001|Intervention|Withdrawal by Subject|1|||
125180857|NCT01625091|450281512|FG000|Intervention|Adverse Event|0|||
125180858|NCT01625091|450281513|FG001|Intervention|Adverse Event|2|||
125180859|NCT01625091|450281512|FG000|Intervention|Lost to Follow-up|4|||
125180860|NCT01625091|450281513|FG001|Intervention|Lost to Follow-up|4|||
125180861|NCT01625091|450281512|FG000|Intervention|Study termination|2|||
125180862|NCT01625091|450281513|FG001|Intervention|Study termination|3|||
125180863|NCT01625091|450281512|FG000|Post-intervention|Death|0|||
125180864|NCT01625091|450281513|FG001|Post-intervention|Death|1|||
125180865|NCT01625091|450281512|FG000|Post-intervention|Lost to Follow-up|2|||
125180866|NCT01625091|450281513|FG001|Post-intervention|Lost to Follow-up|0|||
125180867|NCT01625091|450281512|FG000|Post-intervention|Study termination|2|||
125180868|NCT01625091|450281513|FG001|Post-intervention|Study termination|1|||
125180869|NCT02163057|450281514|FG000|Overall Study|Participant Refusal to Continue|2|||
125236044|NCT01281306|450491698|FG005|Overall Study|Lost to Follow-up|0|||
125236045|NCT01281306|450491699|FG006|Overall Study|Lost to Follow-up|1|||
125236046|NCT01281306|450491693|FG000|Overall Study|Death|1|||
125236047|NCT01281306|450491694|FG001|Overall Study|Death|0|||
125236048|NCT01281306|450491695|FG002|Overall Study|Death|0|||
125236049|NCT01281306|450491696|FG003|Overall Study|Death|0|||
125236050|NCT01281306|450491697|FG004|Overall Study|Death|0|||
125236051|NCT01281306|450491698|FG005|Overall Study|Death|0|||
125236052|NCT01281306|450491699|FG006|Overall Study|Death|0|||
125236053|NCT01281306|450491693|FG000|Overall Study|Adverse Event|3|||
125236054|NCT01281306|450491694|FG001|Overall Study|Adverse Event|2|||
125236055|NCT01281306|450491695|FG002|Overall Study|Adverse Event|2|||
125236056|NCT01281306|450491696|FG003|Overall Study|Adverse Event|3|||
125236057|NCT01281306|450491697|FG004|Overall Study|Adverse Event|5|||
125236058|NCT01281306|450491698|FG005|Overall Study|Adverse Event|3|||
125236059|NCT01281306|450491699|FG006|Overall Study|Adverse Event|3|||
125236060|NCT01281306|450491693|FG000|Overall Study|Randomized in error|1|||
125236061|NCT01281306|450491694|FG001|Overall Study|Randomized in error|0|||
125236062|NCT01281306|450491695|FG002|Overall Study|Randomized in error|0|||
125236063|NCT01281306|450491696|FG003|Overall Study|Randomized in error|1|||
125236064|NCT01281306|450491697|FG004|Overall Study|Randomized in error|0|||
125236065|NCT01281306|450491698|FG005|Overall Study|Randomized in error|0|||
125236066|NCT01281306|450491699|FG006|Overall Study|Randomized in error|0|||
125236067|NCT04491994|450491700|FG000|Overall Study|Withdrawal by Subject|10|||
125236068|NCT04491994|450491701|FG001|Overall Study|Withdrawal by Subject|5|||
125236069|NCT04491994|450491700|FG000|Overall Study|developed fever > 3 days|4|||
125236070|NCT04491994|450491701|FG001|Overall Study|developed fever > 3 days|1|||
125236071|NCT04491994|450491700|FG000|Overall Study|Protocol Violation|11|||
125236072|NCT04491994|450491701|FG001|Overall Study|Protocol Violation|2|||
125236073|NCT04491994|450491700|FG000|Overall Study|Lost to Follow-up|4|||
125236074|NCT04491994|450491701|FG001|Overall Study|Lost to Follow-up|3|||
125236075|NCT02320396|450491707|FG000|Overall Study|Adverse Event|2|||
125236076|NCT02320396|450491708|FG001|Overall Study|Adverse Event|2|||
125236077|NCT02320396|450491707|FG000|Overall Study|Pregnancy|0|||
125236078|NCT02320396|450491708|FG001|Overall Study|Pregnancy|1|||
125236079|NCT02320396|450491707|FG000|Overall Study|Protocol Violation|0|||
125236080|NCT02320396|450491708|FG001|Overall Study|Protocol Violation|1|||
125236081|NCT02320396|450491707|FG000|Overall Study|Withdrawal by Subject|2|||
125236082|NCT02320396|450491708|FG001|Overall Study|Withdrawal by Subject|0|||
125236083|NCT03331562|450491709|FG000|Overall Study|Adverse Event|2|||
125236084|NCT03331562|450491710|FG001|Overall Study|Adverse Event|0|||
125236085|NCT03331562|450491709|FG000|Overall Study|Death|1|||
125236086|NCT03331562|450491710|FG001|Overall Study|Death|0|||
125236087|NCT03718000|450491711|FG000|Overall Study|Relocation|2|||
125236088|NCT03718000|450491712|FG001|Overall Study|Relocation|4|||
125236089|NCT03718000|450491711|FG000|Overall Study|Pregnancy|0|||
125236090|NCT03718000|450491712|FG001|Overall Study|Pregnancy|1|||
125236091|NCT02441283|450491713|FG000|Overall Study|Withdrew consent|15|||
125236092|NCT02441283|450491713|FG000|Overall Study|Lost to Follow-up|42|||
125236093|NCT02441283|450491713|FG000|Overall Study|Death|1|||
125236094|NCT02441283|450491713|FG000|Overall Study|Other, not specified|32|||
125392396|NCT03969992|451070655|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
125392397|NCT03969992|451070656|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
125392398|NCT03969992|451070654|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
125392399|NCT03969992|451070655|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
125392400|NCT03969992|451070656|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
125392401|NCT03969992|451070654|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
125392402|NCT03969992|451070655|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
125392403|NCT03969992|451070656|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
125180870|NCT02163057|450281515|FG001|Overall Study|Participant Refusal to Continue|2|||
125180871|NCT02163057|450281514|FG000|Overall Study|Participant Significant Noncompliance|0|||
125180872|NCT02163057|450281515|FG001|Overall Study|Participant Significant Noncompliance|1|||
125180873|NCT02163057|450281514|FG000|Overall Study|Progression of Disease|1|||
125180874|NCT02163057|450281515|FG001|Overall Study|Progression of Disease|2|||
125180875|NCT00768248|450281516|FG000|Overall Study|Research coordinator didn't collect data|1|||
125180876|NCT00768248|450281517|FG001|Overall Study|Research coordinator didn't collect data|1|||
125180877|NCT01547390|450281518|FG000|Overall Study|Withdrawal by Subject|10|||
125236095|NCT00226655|450491714|FG000|Overall Study|Death|13|||
125236096|NCT00226655|450491714|FG000|Overall Study|Withdrawal by Subject|15|||
125236097|NCT00226655|450491714|FG000|Overall Study|Adverse Event|35|||
125236098|NCT00226655|450491714|FG000|Overall Study|Physician Decision|6|||
125236099|NCT00226655|450491714|FG000|Overall Study|Clinical deterioration|10|||
125236100|NCT01910441|450491720|FG000|Overall Study|Sponsor decision|0|||
125236101|NCT01910441|450491721|FG001|Overall Study|Sponsor decision|2|||
125236102|NCT01910441|450491720|FG000|Overall Study|Lost to Follow-up|6|||
125236103|NCT01910441|450491721|FG001|Overall Study|Lost to Follow-up|5|||
125236104|NCT01910441|450491720|FG000|Overall Study|Withdrawal by Subject|0|||
125236105|NCT01910441|450491721|FG001|Overall Study|Withdrawal by Subject|1|||
125236106|NCT01910441|450491720|FG000|Overall Study|Non-compliance|0|||
125236107|NCT01910441|450491721|FG001|Overall Study|Non-compliance|1|||
125236108|NCT01910441|450491720|FG000|Overall Study|Adverse Event|1|||
125236109|NCT01910441|450491721|FG001|Overall Study|Adverse Event|0|||
125236110|NCT01910441|450491720|FG000|Overall Study|Physician Decision|0|||
125236111|NCT01910441|450491721|FG001|Overall Study|Physician Decision|1|||
125236112|NCT02340949|450491722|FG000|Overall Study|Adverse Event|4|||
125236113|NCT02340949|450491723|FG001|Overall Study|Adverse Event|2|||
125236114|NCT02340949|450491722|FG000|Overall Study|Withdrawal by Subject|2|||
125236115|NCT02340949|450491723|FG001|Overall Study|Withdrawal by Subject|0|||
125236116|NCT02340949|450491722|FG000|Overall Study|Progression disease|6|||
125236117|NCT02340949|450491723|FG001|Overall Study|Progression disease|2|||
125236118|NCT02340949|450491722|FG000|Overall Study|Death|3|||
125236119|NCT02340949|450491723|FG001|Overall Study|Death|0|||
125236120|NCT02340949|450491722|FG000|Overall Study|Physician Decision|1|||
125236121|NCT02340949|450491723|FG001|Overall Study|Physician Decision|0|||
125236122|NCT01192178|450491724|FG000|Overall Study|Withdrawal by Subject|6|||
125236123|NCT01192178|450491725|FG001|Overall Study|Withdrawal by Subject|10|||
125236124|NCT01192178|450491724|FG000|Overall Study|Protocol Violation|10|||
125236125|NCT01192178|450491725|FG001|Overall Study|Protocol Violation|3|||
125236126|NCT01192178|450491724|FG000|Overall Study|Physician Decision|2|||
125236127|NCT01192178|450491725|FG001|Overall Study|Physician Decision|4|||
125236128|NCT01192178|450491724|FG000|Overall Study|Lost to Follow-up|3|||
125236129|NCT01192178|450491725|FG001|Overall Study|Lost to Follow-up|3|||
125236130|NCT01192178|450491724|FG000|Overall Study|Adverse Event|2|||
125236131|NCT01192178|450491725|FG001|Overall Study|Adverse Event|1|||
125236132|NCT01192178|450491724|FG000|Overall Study|Lack of Efficacy|1|||
125236133|NCT01192178|450491725|FG001|Overall Study|Lack of Efficacy|2|||
125236134|NCT01977846|450491726|FG000|Total Study - Prospective|Death|0|||
125236135|NCT01977846|450491727|FG001|Total Study - Prospective|Death|1|||
125236136|NCT01977846|450491726|FG000|Total Study - Prospective|Lost to Follow-up|0|||
125236137|NCT01977846|450491727|FG001|Total Study - Prospective|Lost to Follow-up|8|||
125236138|NCT01977846|450491726|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
125236139|NCT01977846|450491727|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
125236140|NCT01977846|450491726|FG000|Total Study - Prospective|Not available at time of visit|0|||
125236141|NCT01977846|450491727|FG001|Total Study - Prospective|Not available at time of visit|5|||
125236142|NCT01977846|450491726|FG000|Total Study - Prospective|No show|0|||
125236143|NCT01977846|450491727|FG001|Total Study - Prospective|No show|1|||
125236144|NCT01977846|450491726|FG000|Total Study - Prospective|Protocol Violation|0|||
125236145|NCT01977846|450491727|FG001|Total Study - Prospective|Protocol Violation|1|||
125236146|NCT02460289|450491728|FG000|Overall Study|Adverse Event|1|||
125236147|NCT02460289|450491728|FG000|Overall Study|Withdrawal by Subject|8|||
125236148|NCT02460289|450491728|FG000|Overall Study|Lost to Follow-up|1|||
125236149|NCT01155570|450491729|FG000|Overall Study|Adverse Event|39|||
125236150|NCT01155570|450491729|FG000|Overall Study|Lack of Efficacy|46|||
125236151|NCT01155570|450491729|FG000|Overall Study|Participant's Economic Reasons|17|||
125236152|NCT01155570|450491729|FG000|Overall Study|No Hospital Visits|7|||
125236153|NCT01155570|450491729|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
125236154|NCT01155570|450491729|FG000|Overall Study|Adverse Event + Other Reasons|7|||
125236155|NCT01155570|450491729|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
125236156|NCT01155570|450491729|FG000|Overall Study|Other Reasons|23|||
125236157|NCT00296517|450491730|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
125236158|NCT00296517|450491731|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
125236159|NCT00296517|450491730|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
125236160|NCT00296517|450491731|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
125236161|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
125236162|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
125236163|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
125236164|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
125236165|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
125236166|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
125236167|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
125236168|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
125236169|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
125236170|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
125236171|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
125236172|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
125236173|NCT00296517|450491730|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
125236174|NCT00296517|450491731|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
125236175|NCT00964782|450491735|FG000|Overall Study|Lost to Follow-up|1|||
125236176|NCT00964782|450491736|FG001|Overall Study|Lost to Follow-up|0|||
125236177|NCT00596635|450491740|FG000|Overall Study|Lost to Follow-up|0|||
125236178|NCT00596635|450491741|FG001|Overall Study|Lost to Follow-up|2|||
125236179|NCT00596635|450491742|FG002|Overall Study|Lost to Follow-up|0|||
125236180|NCT00596635|450491740|FG000|Overall Study|Treatment for symptomatic UTI|4|||
125236181|NCT00596635|450491741|FG001|Overall Study|Treatment for symptomatic UTI|6|||
125236182|NCT00596635|450491742|FG002|Overall Study|Treatment for symptomatic UTI|3|||
125236183|NCT00596635|450491740|FG000|Overall Study|Hip fracture|2|||
125236184|NCT00596635|450491741|FG001|Overall Study|Hip fracture|3|||
125236185|NCT00596635|450491742|FG002|Overall Study|Hip fracture|3|||
125236186|NCT00596635|450491740|FG000|Overall Study|Could not provide urine specimen|1|||
125236187|NCT00596635|450491741|FG001|Overall Study|Could not provide urine specimen|2|||
125236188|NCT00596635|450491742|FG002|Overall Study|Could not provide urine specimen|2|||
125236189|NCT01143324|450491745|FG000|Overall Study|Lost to Follow-up|11|||
125236190|NCT01143324|450491745|FG000|Overall Study|Withdrawal by Subject|4|||
125236191|NCT01143324|450491745|FG000|Overall Study|Explant of the device|4|||
125236192|NCT01101178|450491749|FG000|Period 1|Withdrawal by Subject|1|||
125236193|NCT01101178|450491750|FG001|Period 1|Withdrawal by Subject|2|||
125236194|NCT01101178|450491749|FG000|Period 1|Positive drug screen|1|||
125236195|NCT01101178|450491750|FG001|Period 1|Positive drug screen|1|||
125236196|NCT01101178|450491749|FG000|Period 1|Adverse Event|2|||
125236197|NCT01101178|450491750|FG001|Period 1|Adverse Event|1|||
125236198|NCT01101178|450491749|FG000|Period 2|Withdrawal by Subject|0|||
125236199|NCT01101178|450491750|FG001|Period 2|Withdrawal by Subject|1|||
125236200|NCT01850641|450491751|FG000|Overall Study|Physician Decision|1|||
125236201|NCT01850641|450491751|FG000|Overall Study|Decrease in serum phosphorus|1|||
125180878|NCT01547390|450281519|FG001|Overall Study|Withdrawal by Subject|7|||
125236202|NCT01850641|450491751|FG000|Overall Study|Decrease in serum calcium|2|||
125236203|NCT01850641|450491751|FG000|Overall Study|Increase in serum ferritin|1|||
125236204|NCT00141817|450491752|FG000|Overall Study|Protocol Violation|0|||
125236205|NCT00141817|450491753|FG001|Overall Study|Protocol Violation|0|||
125236206|NCT00141817|450491754|FG002|Overall Study|Protocol Violation|1|||
125236207|NCT00141817|450491755|FG003|Overall Study|Protocol Violation|0|||
125236208|NCT00141817|450491752|FG000|Overall Study|Parent request|1|||
125236209|NCT00141817|450491753|FG001|Overall Study|Parent request|0|||
125236210|NCT00141817|450491754|FG002|Overall Study|Parent request|0|||
125236211|NCT00141817|450491755|FG003|Overall Study|Parent request|0|||
125236212|NCT00127803|450491756|FG000|Overall Study|Adverse Event|2|||
125180879|NCT01547390|450281518|FG000|Overall Study|termination of pregnancy|0|||
125180880|NCT01547390|450281519|FG001|Overall Study|termination of pregnancy|1|||
125180881|NCT01547390|450281518|FG000|Overall Study|Lost to Follow-up|0|||
125180882|NCT01547390|450281519|FG001|Overall Study|Lost to Follow-up|2|||
125180883|NCT01547390|450281518|FG000|Overall Study|Adverse Event|3|||
125180884|NCT01547390|450281519|FG001|Overall Study|Adverse Event|0|||
125180885|NCT01459783|450281520|FG000|Baseline to 6 Months|Death|1|||
125180886|NCT01459783|450281521|FG001|Baseline to 6 Months|Death|0|||
125180887|NCT01459783|450281520|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
125180888|NCT01459783|450281521|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
125180889|NCT01459783|450281520|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
125180890|NCT01459783|450281521|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
125180891|NCT01459783|450281520|FG000|6 Months to 12 Months|Death|0|||
125180892|NCT01459783|450281521|FG001|6 Months to 12 Months|Death|1|||
125180893|NCT01459783|450281520|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
125180894|NCT01459783|450281521|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
125180895|NCT01459783|450281520|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
125180896|NCT01459783|450281521|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
125180897|NCT01459783|450281520|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
125180898|NCT01459783|450281521|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
125180899|NCT00640315|450281522|FG000|Overall Study|Withdrawal by Subject|0|||
125180900|NCT00640315|450281523|FG001|Overall Study|Withdrawal by Subject|1|||
125180901|NCT04452669|450283456|FG000|Overall Study|Death|1|||
125180902|NCT04452669|450283457|FG001|Overall Study|Death|4|||
125180903|NCT05201794|450283458|FG000|Overall Study|Withdrawal by Subject|13|||
125180904|NCT05201794|450283459|FG001|Overall Study|Withdrawal by Subject|12|||
125180905|NCT05201794|450283460|FG002|Overall Study|Withdrawal by Subject|14|||
125180906|NCT05201794|450283461|FG003|Overall Study|Withdrawal by Subject|0|||
125180907|NCT05201794|450283458|FG000|Overall Study|Adverse Event|5|||
125236213|NCT00127803|450491757|FG001|Overall Study|Adverse Event|0|||
125236214|NCT00127803|450491758|FG002|Overall Study|Adverse Event|0|||
125236215|NCT00127803|450491759|FG003|Overall Study|Adverse Event|0|||
125236216|NCT00127803|450491756|FG000|Overall Study|Withdrawal by Subject|1|||
125236217|NCT00127803|450491757|FG001|Overall Study|Withdrawal by Subject|0|||
125236218|NCT00127803|450491758|FG002|Overall Study|Withdrawal by Subject|0|||
125180908|NCT05201794|450283459|FG001|Overall Study|Adverse Event|5|||
125180909|NCT05201794|450283460|FG002|Overall Study|Adverse Event|4|||
125180910|NCT05201794|450283461|FG003|Overall Study|Adverse Event|0|||
125180911|NCT05201794|450283458|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
125180912|NCT05201794|450283459|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
125236219|NCT00127803|450491759|FG003|Overall Study|Withdrawal by Subject|0|||
125236220|NCT00127803|450491756|FG000|Overall Study|Lost to Follow-up|0|||
125236221|NCT00127803|450491757|FG001|Overall Study|Lost to Follow-up|0|||
125236222|NCT00127803|450491758|FG002|Overall Study|Lost to Follow-up|0|||
125236223|NCT00127803|450491759|FG003|Overall Study|Lost to Follow-up|1|||
125180913|NCT05201794|450283460|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
125180914|NCT05201794|450283461|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125180915|NCT05201794|450283458|FG000|Overall Study|Non-Compliance With Study Drug|2|||
125180916|NCT05201794|450283459|FG001|Overall Study|Non-Compliance With Study Drug|3|||
125180917|NCT05201794|450283460|FG002|Overall Study|Non-Compliance With Study Drug|3|||
125180918|NCT05201794|450283461|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125180919|NCT05201794|450283458|FG000|Overall Study|Physician Decision|1|||
125180920|NCT05201794|450283459|FG001|Overall Study|Physician Decision|3|||
125180921|NCT05201794|450283460|FG002|Overall Study|Physician Decision|2|||
125180922|NCT05201794|450283461|FG003|Overall Study|Physician Decision|0|||
125180923|NCT05201794|450283458|FG000|Overall Study|Lost to Follow-up|2|||
125180924|NCT05201794|450283459|FG001|Overall Study|Lost to Follow-up|2|||
125180925|NCT05201794|450283460|FG002|Overall Study|Lost to Follow-up|0|||
125180926|NCT05201794|450283461|FG003|Overall Study|Lost to Follow-up|0|||
125180927|NCT05201794|450283458|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
125180928|NCT05201794|450283459|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
125180929|NCT05201794|450283460|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
125180930|NCT05201794|450283461|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
125180931|NCT05201794|450283458|FG000|Overall Study|Protocol Violation|2|||
125180932|NCT05201794|450283459|FG001|Overall Study|Protocol Violation|0|||
125180933|NCT05201794|450283460|FG002|Overall Study|Protocol Violation|1|||
125180934|NCT05201794|450283461|FG003|Overall Study|Protocol Violation|0|||
125180935|NCT05201794|450283458|FG000|Overall Study|Death|1|||
125180936|NCT05201794|450283459|FG001|Overall Study|Death|0|||
125180937|NCT05201794|450283460|FG002|Overall Study|Death|0|||
125180938|NCT05201794|450283461|FG003|Overall Study|Death|0|||
125180939|NCT05201794|450283458|FG000|Overall Study|Site Terminated By Sponsor|0|||
125180940|NCT05201794|450283459|FG001|Overall Study|Site Terminated By Sponsor|1|||
125180941|NCT05201794|450283460|FG002|Overall Study|Site Terminated By Sponsor|0|||
125180942|NCT05201794|450283461|FG003|Overall Study|Site Terminated By Sponsor|0|||
125180943|NCT05201794|450283458|FG000|Overall Study|Other|3|||
125180944|NCT05201794|450283459|FG001|Overall Study|Other|3|||
125180945|NCT05201794|450283460|FG002|Overall Study|Other|3|||
125180946|NCT05201794|450283461|FG003|Overall Study|Other|0|||
125180947|NCT05201794|450283458|FG000|Overall Study|Randomized But Not Treated|1|||
125180948|NCT05201794|450283459|FG001|Overall Study|Randomized But Not Treated|2|||
125180949|NCT05201794|450283460|FG002|Overall Study|Randomized But Not Treated|1|||
125180950|NCT05201794|450283461|FG003|Overall Study|Randomized But Not Treated|0|||
125180951|NCT04653454|450283466|FG000|Overall Study|Withdrawal by Subject|1|||
125180952|NCT04653454|450283466|FG000|Overall Study|Physician Decision|40|||
125180953|NCT03620708|450283467|FG000|Overall Study|Lost to Follow-up|1|||
125180954|NCT03620708|450283468|FG001|Overall Study|Lost to Follow-up|1|||
125180955|NCT03620708|450283469|FG002|Overall Study|Lost to Follow-up|2|||
125180956|NCT03620708|450283467|FG000|Overall Study|Withdrawal by Subject|0|||
125180957|NCT03620708|450283468|FG001|Overall Study|Withdrawal by Subject|0|||
125180958|NCT03620708|450283469|FG002|Overall Study|Withdrawal by Subject|1|||
125180959|NCT06082843|450283470|FG000|Overall Study|Withdrawal by Subject|0|||
125180960|NCT06082843|450283471|FG001|Overall Study|Withdrawal by Subject|2|||
125180961|NCT06082843|450283470|FG000|Overall Study|Study terminated by sponsor|12|||
125180962|NCT06082843|450283471|FG001|Overall Study|Study terminated by sponsor|8|||
125180963|NCT05525520|450283473|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
125180964|NCT05525520|450283474|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
125180965|NCT05525520|450283473|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
125180966|NCT05525520|450283474|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
125180967|NCT03176134|450283475|FG000|Overall Study|Lost to Follow-up|0|||
125180968|NCT03176134|450283476|FG001|Overall Study|Lost to Follow-up|2|||
125180969|NCT03176134|450283477|FG002|Overall Study|Lost to Follow-up|0|||
125180970|NCT03176134|450283478|FG003|Overall Study|Lost to Follow-up|0|||
125180971|NCT03176134|450283479|FG004|Overall Study|Lost to Follow-up|0|||
125180972|NCT03176134|450283480|FG005|Overall Study|Lost to Follow-up|0|||
125180973|NCT03176134|450283481|FG006|Overall Study|Lost to Follow-up|0|||
125180974|NCT03176134|450283482|FG007|Overall Study|Lost to Follow-up|0|||
125180975|NCT03176134|450283475|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
125180976|NCT03176134|450283476|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125180977|NCT03176134|450283477|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
125180978|NCT03176134|450283478|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125180979|NCT03176134|450283479|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125180980|NCT03176134|450283480|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
125180981|NCT03176134|450283481|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
125180982|NCT03176134|450283482|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
125180983|NCT03657797|450283483|FG000|Overall Study|Lost to Follow-up|0|||
125180984|NCT03657797|450283484|FG001|Overall Study|Lost to Follow-up|1|||
125180985|NCT03657797|450283485|FG002|Overall Study|Lost to Follow-up|1|||
125180986|NCT03657797|450283486|FG003|Overall Study|Lost to Follow-up|0|||
125180987|NCT03657797|450283483|FG000|Overall Study|Physician Decision|0|||
125180988|NCT03657797|450283484|FG001|Overall Study|Physician Decision|1|||
125180989|NCT03657797|450283485|FG002|Overall Study|Physician Decision|0|||
125236224|NCT02774889|450491769|FG000|Overall Study|Lost to Follow-up|2|||
125236225|NCT02774889|450491770|FG001|Overall Study|Lost to Follow-up|1|||
125236226|NCT00858988|450491771|FG000|Analysis|Lactulose unable to be detected in urine|2|||
125236227|NCT00858988|450491772|FG001|Analysis|Lactulose unable to be detected in urine|1|||
125236228|NCT00614393|450493814|FG000|Overall Study|Adverse Event|20|||
125236229|NCT00614393|450493815|FG001|Overall Study|Adverse Event|2|||
125236230|NCT00614393|450493816|FG002|Overall Study|Adverse Event|3|||
125236231|NCT00614393|450493817|FG003|Overall Study|Adverse Event|13|||
125236232|NCT00614393|450493818|FG004|Overall Study|Adverse Event|21|||
125236233|NCT00614393|450493814|FG000|Overall Study|Lost to Follow-up|0|||
125236234|NCT00614393|450493815|FG001|Overall Study|Lost to Follow-up|0|||
125236235|NCT00614393|450493816|FG002|Overall Study|Lost to Follow-up|0|||
125236236|NCT00614393|450493817|FG003|Overall Study|Lost to Follow-up|1|||
125236237|NCT00614393|450493818|FG004|Overall Study|Lost to Follow-up|2|||
125236238|NCT00614393|450493814|FG000|Overall Study|Physician Decision|17|||
125236239|NCT00614393|450493815|FG001|Overall Study|Physician Decision|0|||
125236240|NCT00614393|450493816|FG002|Overall Study|Physician Decision|1|||
125236241|NCT00614393|450493817|FG003|Overall Study|Physician Decision|8|||
125236242|NCT00614393|450493818|FG004|Overall Study|Physician Decision|9|||
125236243|NCT00614393|450493814|FG000|Overall Study|Progressive Disease|118|||
125236244|NCT00614393|450493815|FG001|Overall Study|Progressive Disease|5|||
125236245|NCT00614393|450493816|FG002|Overall Study|Progressive Disease|5|||
125236246|NCT00614393|450493817|FG003|Overall Study|Progressive Disease|138|||
125236247|NCT00614393|450493818|FG004|Overall Study|Progressive Disease|130|||
125236248|NCT00614393|450493814|FG000|Overall Study|Protocol Violation|1|||
125236249|NCT00614393|450493815|FG001|Overall Study|Protocol Violation|0|||
125236250|NCT00614393|450493816|FG002|Overall Study|Protocol Violation|0|||
125236251|NCT00614393|450493817|FG003|Overall Study|Protocol Violation|0|||
125236252|NCT00614393|450493818|FG004|Overall Study|Protocol Violation|0|||
125236253|NCT00614393|450493814|FG000|Overall Study|Terminated by Sponsor|0|||
125236254|NCT00614393|450493815|FG001|Overall Study|Terminated by Sponsor|0|||
125236255|NCT00614393|450493816|FG002|Overall Study|Terminated by Sponsor|0|||
125236256|NCT00614393|450493817|FG003|Overall Study|Terminated by Sponsor|0|||
125236257|NCT00614393|450493818|FG004|Overall Study|Terminated by Sponsor|1|||
125236258|NCT00614393|450493814|FG000|Overall Study|Withdrawal by Subject|20|||
125236259|NCT00614393|450493815|FG001|Overall Study|Withdrawal by Subject|1|||
125236260|NCT00614393|450493816|FG002|Overall Study|Withdrawal by Subject|1|||
125236261|NCT00614393|450493817|FG003|Overall Study|Withdrawal by Subject|16|||
125236262|NCT00614393|450493818|FG004|Overall Study|Withdrawal by Subject|13|||
125236263|NCT00614393|450493814|FG000|Overall Study|Other|4|||
125236264|NCT00614393|450493815|FG001|Overall Study|Other|0|||
125236265|NCT00614393|450493816|FG002|Overall Study|Other|0|||
125236266|NCT00614393|450493817|FG003|Overall Study|Other|4|||
125236267|NCT00614393|450493818|FG004|Overall Study|Other|2|||
125236268|NCT00614393|450493814|FG000|Overall Study|Not Treated|0|||
125236269|NCT00614393|450493815|FG001|Overall Study|Not Treated|0|||
125236270|NCT00614393|450493816|FG002|Overall Study|Not Treated|0|||
125236271|NCT00614393|450493817|FG003|Overall Study|Not Treated|0|||
125236272|NCT00614393|450493818|FG004|Overall Study|Not Treated|2|||
125236273|NCT02328105|450493819|FG000|Overall Study|Death|6|||
125236274|NCT02328105|450493819|FG000|Overall Study|Withdrawal by Subject|1|||
125236275|NCT02328105|450493819|FG000|Overall Study|Still On Study in Follow-Up|4|||
125236276|NCT00855582|450493820|FG000|Overall Study|Adverse Event|2|||
125236277|NCT00855582|450493821|FG001|Overall Study|Adverse Event|6|||
125236278|NCT00855582|450493822|FG002|Overall Study|Adverse Event|3|||
125236279|NCT00855582|450493820|FG000|Overall Study|Death|1|||
125236280|NCT00855582|450493821|FG001|Overall Study|Death|0|||
125236281|NCT00855582|450493822|FG002|Overall Study|Death|0|||
125236282|NCT00855582|450493820|FG000|Overall Study|Lack of Efficacy|1|||
125236283|NCT00855582|450493821|FG001|Overall Study|Lack of Efficacy|3|||
125236284|NCT00855582|450493822|FG002|Overall Study|Lack of Efficacy|8|||
125236285|NCT00855582|450493820|FG000|Overall Study|Lost to Follow-up|1|||
125236286|NCT00855582|450493821|FG001|Overall Study|Lost to Follow-up|3|||
125236287|NCT00855582|450493822|FG002|Overall Study|Lost to Follow-up|1|||
125236288|NCT00855582|450493820|FG000|Overall Study|Physician Decision|0|||
125236289|NCT00855582|450493821|FG001|Overall Study|Physician Decision|0|||
125236290|NCT00855582|450493822|FG002|Overall Study|Physician Decision|1|||
125236291|NCT00855582|450493820|FG000|Overall Study|Protocol Violation|6|||
125236292|NCT00855582|450493821|FG001|Overall Study|Protocol Violation|2|||
125236293|NCT00855582|450493822|FG002|Overall Study|Protocol Violation|6|||
125236294|NCT00855582|450493820|FG000|Overall Study|Entry Criteria Not Met|8|||
125236295|NCT00855582|450493821|FG001|Overall Study|Entry Criteria Not Met|6|||
125236296|NCT00855582|450493822|FG002|Overall Study|Entry Criteria Not Met|3|||
125236297|NCT00855582|450493820|FG000|Overall Study|Withdrawal by Subject|7|||
125236298|NCT00855582|450493821|FG001|Overall Study|Withdrawal by Subject|4|||
125236299|NCT00855582|450493822|FG002|Overall Study|Withdrawal by Subject|8|||
125236300|NCT01588509|450493826|FG000|Overall Study|Lost to Follow-up|1|||
125236301|NCT01588509|450493827|FG001|Overall Study|Lost to Follow-up|0|||
125236302|NCT03345004|450493828|FG000|Overall Study|Physician Decision|1|||
125236303|NCT03345004|450493829|FG001|Overall Study|Physician Decision|0|||
125236304|NCT03345004|450493828|FG000|Overall Study|Withdrawal by Subject|0|||
125236305|NCT03345004|450493829|FG001|Overall Study|Withdrawal by Subject|1|||
125236306|NCT01013753|450493830|FG000|Overall Study|Adverse Event|8|||
125236307|NCT01013753|450493830|FG000|Overall Study|Protocol Violation|3|||
125236308|NCT01013753|450493830|FG000|Overall Study|Lost to Follow-up|1|||
125236309|NCT01013753|450493830|FG000|Overall Study|Withdrawal by Subject|2|||
125236310|NCT01013753|450493830|FG000|Overall Study|Other|2|||
125236311|NCT04757636|450493831|FG000|Overall Study|Adverse Event|25|||
125236312|NCT04757636|450493832|FG001|Overall Study|Adverse Event|8|||
125236313|NCT04757636|450493833|FG002|Overall Study|Adverse Event|11|||
125236314|NCT04757636|450493831|FG000|Overall Study|Death|9|||
125236315|NCT04757636|450493832|FG001|Overall Study|Death|12|||
125236316|NCT04757636|450493833|FG002|Overall Study|Death|6|||
125236317|NCT04757636|450493831|FG000|Overall Study|Lack of Efficacy|2|||
125236318|NCT04757636|450493832|FG001|Overall Study|Lack of Efficacy|0|||
125236319|NCT04757636|450493833|FG002|Overall Study|Lack of Efficacy|0|||
125236320|NCT04757636|450493831|FG000|Overall Study|Lost to Follow-up|1|||
125236321|NCT04757636|450493832|FG001|Overall Study|Lost to Follow-up|6|||
125236322|NCT04757636|450493833|FG002|Overall Study|Lost to Follow-up|7|||
125236323|NCT04757636|450493831|FG000|Overall Study|Physician Decision|1|||
125236324|NCT04757636|450493832|FG001|Overall Study|Physician Decision|3|||
125236325|NCT04757636|450493833|FG002|Overall Study|Physician Decision|4|||
125236326|NCT04757636|450493831|FG000|Overall Study|Withdrawal by Subject|20|||
125236327|NCT04757636|450493832|FG001|Overall Study|Withdrawal by Subject|23|||
125236328|NCT04757636|450493833|FG002|Overall Study|Withdrawal by Subject|18|||
125236329|NCT04757636|450493831|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
125180990|NCT03657797|450283486|FG003|Overall Study|Physician Decision|0|||
125180991|NCT03657797|450283483|FG000|Overall Study|Withdrawal by Subject|0|||
125180992|NCT03657797|450283484|FG001|Overall Study|Withdrawal by Subject|1|||
125180993|NCT03657797|450283485|FG002|Overall Study|Withdrawal by Subject|2|||
125180994|NCT03657797|450283486|FG003|Overall Study|Withdrawal by Subject|0|||
125180995|NCT03657797|450283483|FG000|Overall Study|Adverse Event|0|||
125180996|NCT03657797|450283484|FG001|Overall Study|Adverse Event|0|||
125180997|NCT03657797|450283485|FG002|Overall Study|Adverse Event|2|||
125180998|NCT03657797|450283486|FG003|Overall Study|Adverse Event|0|||
125180999|NCT00118157|450283487|FG000|Overall Study|Adverse Event|2|||
125181000|NCT00118157|450283487|FG000|Overall Study|Death|8|||
125181001|NCT00118157|450283487|FG000|Overall Study|Withdrawal by Subject|2|||
125181002|NCT05989672|450283488|FG000|Overall Study|Adverse Event|3|||
125181003|NCT05989672|450283489|FG001|Overall Study|Adverse Event|0|||
125181004|NCT05989672|450283490|FG002|Overall Study|Adverse Event|0|||
125181005|NCT00696423|450283491|FG000|Overall Study|Lost to Follow-up|0|||
125181006|NCT00696423|450283492|FG001|Overall Study|Lost to Follow-up|5|||
125181007|NCT03989102|450283493|FG000|Year 1|Withdrawal by Subject|6|||
125181008|NCT03989102|450283494|FG001|Year 1|Withdrawal by Subject|2|||
125181009|NCT03989102|450283495|FG002|Year 1|Withdrawal by Subject|7|||
125181010|NCT03989102|450283493|FG000|Year 1|Lost to Follow-up|5|||
125181011|NCT03989102|450283494|FG001|Year 1|Lost to Follow-up|2|||
125181012|NCT03989102|450283495|FG002|Year 1|Lost to Follow-up|5|||
125181013|NCT03989102|450283493|FG000|Year 1|Subject met withdrawal criteria|1|||
125181014|NCT03989102|450283494|FG001|Year 1|Subject met withdrawal criteria|0|||
125181015|NCT03989102|450283495|FG002|Year 1|Subject met withdrawal criteria|1|||
125181016|NCT03989102|450283493|FG000|Year 2|Lost to Follow-up|7|||
125181017|NCT03989102|450283494|FG001|Year 2|Lost to Follow-up|3|||
125181018|NCT03989102|450283495|FG002|Year 2|Lost to Follow-up|4|||
125181019|NCT03989102|450283493|FG000|Year 2|Withdrawal by Subject|3|||
125236330|NCT04757636|450493832|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
125236331|NCT04757636|450493833|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
125236332|NCT04757636|450493831|FG000|Overall Study|Study Terminated by Sponsor|103|||
125236333|NCT04757636|450493832|FG001|Overall Study|Study Terminated by Sponsor|104|||
125236334|NCT04757636|450493833|FG002|Overall Study|Study Terminated by Sponsor|114|||
125236335|NCT04757636|450493831|FG000|Overall Study|Sponsor Decision|0|||
125236336|NCT04757636|450493832|FG001|Overall Study|Sponsor Decision|0|||
125236337|NCT04757636|450493833|FG002|Overall Study|Sponsor Decision|1|||
125236338|NCT04757636|450493831|FG000|Overall Study|Randomized in Error|0|||
125236339|NCT04757636|450493832|FG001|Overall Study|Randomized in Error|0|||
125236340|NCT04757636|450493833|FG002|Overall Study|Randomized in Error|2|||
125236341|NCT02097277|450493843|FG000|Overall Study|Subject no longer meets study criteria|0|||
125443435|NCT02555371|451252129|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
125181020|NCT03989102|450283494|FG001|Year 2|Withdrawal by Subject|1|||
125181021|NCT03989102|450283495|FG002|Year 2|Withdrawal by Subject|2|||
125181022|NCT03989102|450283493|FG000|Year 2|Subject non-compliant|3|||
125181023|NCT03989102|450283494|FG001|Year 2|Subject non-compliant|2|||
125181024|NCT03989102|450283495|FG002|Year 2|Subject non-compliant|0|||
125181025|NCT03989102|450283493|FG000|Year 2|Travel|1|||
125181026|NCT03989102|450283494|FG001|Year 2|Travel|0|||
125181027|NCT03989102|450283495|FG002|Year 2|Travel|1|||
125181028|NCT03989102|450283493|FG000|Year 2|P16 missing|4|||
125181029|NCT03989102|450283494|FG001|Year 2|P16 missing|2|||
125181030|NCT03989102|450283495|FG002|Year 2|P16 missing|1|||
125181031|NCT03989102|450283493|FG000|Year 2|P11 missing|1|||
125181032|NCT03989102|450283494|FG001|Year 2|P11 missing|3|||
125181033|NCT03989102|450283495|FG002|Year 2|P11 missing|7|||
125181034|NCT03989102|450283493|FG000|Year 2|Definitive displacement outside the study site|0|||
125181035|NCT03989102|450283494|FG001|Year 2|Definitive displacement outside the study site|1|||
125181036|NCT03989102|450283495|FG002|Year 2|Definitive displacement outside the study site|0|||
125181037|NCT03989102|450283493|FG000|Year 2|Subject missed last study visit|0|||
125181038|NCT03989102|450283494|FG001|Year 2|Subject missed last study visit|1|||
125181039|NCT03989102|450283495|FG002|Year 2|Subject missed last study visit|0|||
125181040|NCT03989102|450283493|FG000|Year 2|Death|0|||
125181041|NCT03989102|450283494|FG001|Year 2|Death|1|||
125181042|NCT03989102|450283495|FG002|Year 2|Death|0|||
125181043|NCT03989102|450283493|FG000|Year 2|Subject not reachable|0|||
125181044|NCT03989102|450283494|FG001|Year 2|Subject not reachable|0|||
125181045|NCT03989102|450283495|FG002|Year 2|Subject not reachable|1|||
125181046|NCT03989102|450283493|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
125181047|NCT03989102|450283494|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
125181048|NCT03989102|450283495|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
125181049|NCT03989102|450283493|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
125181050|NCT03989102|450283494|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
125181051|NCT03989102|450283495|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
125181052|NCT03989102|450283493|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
125181053|NCT03989102|450283494|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
125181054|NCT03989102|450283495|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
125181055|NCT03989102|450283493|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
125181056|NCT03989102|450283494|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
125181057|NCT03989102|450283495|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
125181058|NCT03989102|450283493|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
125181059|NCT03989102|450283494|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
125181060|NCT03989102|450283495|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
125181061|NCT03989102|450283493|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
125181062|NCT03989102|450283494|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
125181063|NCT03989102|450283495|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
125181064|NCT03642262|450283496|FG000|Period 1|Withdrawal by Subject|1|||
125181065|NCT03642262|450283497|FG001|Period 1|Withdrawal by Subject|1|||
125181066|NCT03642262|450283496|FG000|Period 1|Adverse Event|0|||
125181067|NCT03642262|450283497|FG001|Period 1|Adverse Event|1|||
125181068|NCT02760004|450283503|FG000|Overall Study|Lost to Follow-up|13|||
125181069|NCT02760004|450283504|FG001|Overall Study|Lost to Follow-up|22|||
125181070|NCT01050530|450283505|FG000|Overall Study|Adverse Event|6|||
125181071|NCT01050530|450283506|FG001|Overall Study|Adverse Event|3|||
125181072|NCT01050530|450283505|FG000|Overall Study|Lack of Efficacy|1|||
125181073|NCT01050530|450283506|FG001|Overall Study|Lack of Efficacy|4|||
125181074|NCT01050530|450283505|FG000|Overall Study|Withdrawal by Subject|0|||
125181075|NCT01050530|450283506|FG001|Overall Study|Withdrawal by Subject|3|||
125181076|NCT01050530|450283505|FG000|Overall Study|Protocol Violation|1|||
125181077|NCT01050530|450283506|FG001|Overall Study|Protocol Violation|0|||
125181078|NCT02288312|450283507|FG000|Overall Study|Pregnancy|1|||
125181079|NCT02288312|450283508|FG001|Overall Study|Pregnancy|0|||
125181080|NCT02288312|450283509|FG002|Overall Study|Pregnancy|0|||
125181081|NCT01276041|450283510|FG000|Overall Study|Adverse Event|2|||
125181082|NCT01276041|450283510|FG000|Overall Study|Protocol Violation|1|||
125181083|NCT00485264|450283511|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
125181084|NCT00485264|450283512|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
125181085|NCT00485264|450283513|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
125181086|NCT00485264|450283514|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
125181087|NCT00485264|450283515|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
125181088|NCT00485264|450283516|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
125181089|NCT00485264|450283511|FG000|Overall Study|Death|1|||
125181090|NCT00485264|450283512|FG001|Overall Study|Death|0|||
125181091|NCT00485264|450283513|FG002|Overall Study|Death|0|||
125181092|NCT00485264|450283514|FG003|Overall Study|Death|0|||
125181093|NCT00485264|450283515|FG004|Overall Study|Death|1|||
125181094|NCT00485264|450283516|FG005|Overall Study|Death|0|||
125181095|NCT00485264|450283511|FG000|Overall Study|Adverse Event|1|||
125181096|NCT00485264|450283512|FG001|Overall Study|Adverse Event|0|||
125181097|NCT00485264|450283513|FG002|Overall Study|Adverse Event|2|||
125181098|NCT00485264|450283514|FG003|Overall Study|Adverse Event|3|||
125181099|NCT00485264|450283515|FG004|Overall Study|Adverse Event|1|||
125181100|NCT00485264|450283516|FG005|Overall Study|Adverse Event|3|||
125181101|NCT00485264|450283511|FG000|Overall Study|Pregnancy|4|||
125181102|NCT00485264|450283512|FG001|Overall Study|Pregnancy|0|||
125181103|NCT00485264|450283513|FG002|Overall Study|Pregnancy|0|||
125181104|NCT00485264|450283514|FG003|Overall Study|Pregnancy|0|||
125181105|NCT00485264|450283515|FG004|Overall Study|Pregnancy|0|||
125181106|NCT00485264|450283516|FG005|Overall Study|Pregnancy|0|||
125181107|NCT00485264|450283511|FG000|Overall Study|Disallowed Medication|0|||
125181108|NCT00485264|450283512|FG001|Overall Study|Disallowed Medication|0|||
125181109|NCT00485264|450283513|FG002|Overall Study|Disallowed Medication|0|||
125181110|NCT00485264|450283514|FG003|Overall Study|Disallowed Medication|0|||
125181111|NCT00485264|450283515|FG004|Overall Study|Disallowed Medication|0|||
125181112|NCT00485264|450283516|FG005|Overall Study|Disallowed Medication|1|||
125181113|NCT00485264|450283511|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
125181114|NCT00485264|450283512|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
125181115|NCT00485264|450283513|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
125181116|NCT00485264|450283514|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
125181117|NCT00485264|450283515|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
125181118|NCT00485264|450283516|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
125181119|NCT00485264|450283511|FG000|Overall Study|Lack of Efficacy|0|||
125181120|NCT00485264|450283512|FG001|Overall Study|Lack of Efficacy|1|||
125181121|NCT00485264|450283513|FG002|Overall Study|Lack of Efficacy|0|||
125181122|NCT00485264|450283514|FG003|Overall Study|Lack of Efficacy|0|||
125181123|NCT00485264|450283515|FG004|Overall Study|Lack of Efficacy|0|||
125181124|NCT00485264|450283516|FG005|Overall Study|Lack of Efficacy|0|||
125181125|NCT00485264|450283511|FG000|Overall Study|Guardian Consent Withdrawn|1|||
125181126|NCT00485264|450283512|FG001|Overall Study|Guardian Consent Withdrawn|0|||
125181127|NCT00485264|450283513|FG002|Overall Study|Guardian Consent Withdrawn|0|||
125181128|NCT00485264|450283514|FG003|Overall Study|Guardian Consent Withdrawn|0|||
125181129|NCT00485264|450283515|FG004|Overall Study|Guardian Consent Withdrawn|1|||
125181130|NCT00485264|450283516|FG005|Overall Study|Guardian Consent Withdrawn|0|||
125181131|NCT00485264|450283511|FG000|Overall Study|Physician Decision|0|||
125181132|NCT00485264|450283512|FG001|Overall Study|Physician Decision|2|||
125181133|NCT00485264|450283513|FG002|Overall Study|Physician Decision|0|||
125181134|NCT00485264|450283514|FG003|Overall Study|Physician Decision|0|||
125181135|NCT00485264|450283515|FG004|Overall Study|Physician Decision|0|||
125181136|NCT00485264|450283516|FG005|Overall Study|Physician Decision|0|||
125181137|NCT00485264|450283511|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
125181138|NCT00485264|450283512|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
125181139|NCT00485264|450283513|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
125181140|NCT00485264|450283514|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
125181141|NCT00485264|450283515|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
125181142|NCT00485264|450283516|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
125181143|NCT00485264|450283511|FG000|Overall Study|Not Able to Attend Clinic|5|||
125181144|NCT00485264|450283512|FG001|Overall Study|Not Able to Attend Clinic|0|||
125181145|NCT00485264|450283513|FG002|Overall Study|Not Able to Attend Clinic|0|||
125181146|NCT00485264|450283514|FG003|Overall Study|Not Able to Attend Clinic|1|||
125181147|NCT00485264|450283515|FG004|Overall Study|Not Able to Attend Clinic|1|||
125181148|NCT00485264|450283516|FG005|Overall Study|Not Able to Attend Clinic|2|||
125181149|NCT00485264|450283511|FG000|Overall Study|Non-Compliant|17|||
125181150|NCT00485264|450283512|FG001|Overall Study|Non-Compliant|2|||
125181151|NCT00485264|450283513|FG002|Overall Study|Non-Compliant|1|||
125181152|NCT00485264|450283514|FG003|Overall Study|Non-Compliant|0|||
125181153|NCT00485264|450283515|FG004|Overall Study|Non-Compliant|1|||
125181154|NCT00485264|450283516|FG005|Overall Study|Non-Compliant|0|||
125181155|NCT00485264|450283511|FG000|Overall Study|Lost to Follow-up|2|||
125181156|NCT00485264|450283512|FG001|Overall Study|Lost to Follow-up|1|||
125181157|NCT00485264|450283513|FG002|Overall Study|Lost to Follow-up|1|||
125181158|NCT00485264|450283514|FG003|Overall Study|Lost to Follow-up|0|||
125181159|NCT00485264|450283515|FG004|Overall Study|Lost to Follow-up|0|||
125181160|NCT00485264|450283516|FG005|Overall Study|Lost to Follow-up|1|||
125181161|NCT00485264|450283511|FG000|Overall Study|Other Reason|3|||
125181162|NCT00485264|450283512|FG001|Overall Study|Other Reason|0|||
125181163|NCT00485264|450283513|FG002|Overall Study|Other Reason|0|||
125181164|NCT00485264|450283514|FG003|Overall Study|Other Reason|0|||
125181165|NCT00485264|450283515|FG004|Overall Study|Other Reason|0|||
125181166|NCT00485264|450283516|FG005|Overall Study|Other Reason|0|||
125181167|NCT00276484|450283517|FG000|Overall Study|Adverse Event|4|||
125181168|NCT00276484|450283518|FG001|Overall Study|Adverse Event|7|||
125181169|NCT00276484|450283517|FG000|Overall Study|Lost to Follow-up|1|||
125181170|NCT00276484|450283518|FG001|Overall Study|Lost to Follow-up|1|||
125181171|NCT00276484|450283517|FG000|Overall Study|Protocol Violation|0|||
125181172|NCT00276484|450283518|FG001|Overall Study|Protocol Violation|1|||
125181173|NCT00276484|450283517|FG000|Overall Study|Withdrawal by Subject|4|||
125181174|NCT00276484|450283518|FG001|Overall Study|Withdrawal by Subject|3|||
125181175|NCT00276484|450283517|FG000|Overall Study|Could not take time off work|0|||
125181176|NCT00276484|450283518|FG001|Overall Study|Could not take time off work|1|||
125181177|NCT02440464|450283519|FG000|Overall Study|Withdrawal by Subject|3|||
125181178|NCT02440464|450283520|FG001|Overall Study|Withdrawal by Subject|2|||
125181179|NCT04688671|450283521|FG000|Overall Study|Adverse Event|3|||
125181180|NCT04688671|450283522|FG001|Overall Study|Adverse Event|1|||
125181181|NCT04688671|450283521|FG000|Overall Study|Withdrawal by Subject|3|||
125181182|NCT04688671|450283522|FG001|Overall Study|Withdrawal by Subject|1|||
125181183|NCT04688671|450283521|FG000|Overall Study|Lack of Efficacy|1|||
125181184|NCT04688671|450283522|FG001|Overall Study|Lack of Efficacy|1|||
125236342|NCT02097277|450493844|FG001|Overall Study|Subject no longer meets study criteria|1|||
125236343|NCT02097277|450493845|FG002|Overall Study|Subject no longer meets study criteria|0|||
125236344|NCT02097277|450493846|FG003|Overall Study|Subject no longer meets study criteria|1|||
125236345|NCT02097277|450493847|FG004|Overall Study|Subject no longer meets study criteria|0|||
125236346|NCT02097277|450493843|FG000|Overall Study|Subject request to discontinue treatment|0|||
125236347|NCT02097277|450493844|FG001|Overall Study|Subject request to discontinue treatment|0|||
125236348|NCT02097277|450493845|FG002|Overall Study|Subject request to discontinue treatment|0|||
125236349|NCT02097277|450493846|FG003|Overall Study|Subject request to discontinue treatment|0|||
125181185|NCT04688671|450283521|FG000|Overall Study|Protocol Violation|1|||
125181186|NCT04688671|450283522|FG001|Overall Study|Protocol Violation|0|||
125181187|NCT04688671|450283521|FG000|Overall Study|Lost to Follow-up|0|||
125181188|NCT04688671|450283522|FG001|Overall Study|Lost to Follow-up|1|||
125181189|NCT01626690|450283523|FG000|Overall Study|Protocol Violation|1|||
125181190|NCT01626690|450283524|FG001|Overall Study|Protocol Violation|0|||
125181191|NCT01626690|450283523|FG000|Overall Study|Adverse Event|1|||
125181192|NCT01626690|450283524|FG001|Overall Study|Adverse Event|0|||
125181193|NCT02414958|450283528|FG000|Overall Study|Adverse Event|6|||
125181194|NCT02414958|450283529|FG001|Overall Study|Adverse Event|6|||
125181195|NCT02414958|450283530|FG002|Overall Study|Adverse Event|3|||
125181196|NCT02414958|450283528|FG000|Overall Study|Protocol Violation|10|||
125181197|NCT02414958|450283529|FG001|Overall Study|Protocol Violation|3|||
125181198|NCT02414958|450283530|FG002|Overall Study|Protocol Violation|1|||
125181199|NCT02414958|450283528|FG000|Overall Study|Lost to Follow-up|7|||
125181200|NCT02414958|450283529|FG001|Overall Study|Lost to Follow-up|4|||
125181201|NCT02414958|450283530|FG002|Overall Study|Lost to Follow-up|0|||
125181202|NCT02414958|450283528|FG000|Overall Study|Withdrawal by Subject|5|||
125181203|NCT02414958|450283529|FG001|Overall Study|Withdrawal by Subject|3|||
125181204|NCT02414958|450283530|FG002|Overall Study|Withdrawal by Subject|5|||
125181205|NCT02414958|450283528|FG000|Overall Study|Other than specified|4|||
125181206|NCT02414958|450283529|FG001|Overall Study|Other than specified|4|||
125181207|NCT02414958|450283530|FG002|Overall Study|Other than specified|5|||
125181208|NCT05767905|450283533|FG000|Overall Study|Adverse Event|0|||
125181209|NCT05767905|450283534|FG001|Overall Study|Adverse Event|0|||
125181210|NCT05767905|450283535|FG002|Overall Study|Adverse Event|1|||
125181211|NCT03762239|450283536|FG000|Overall Study|Appointment to the doctor|1|||
125181212|NCT03762239|450283537|FG001|Overall Study|Appointment to the doctor|1|||
125181213|NCT03645863|450283538|FG000|Overall Study|Withdrawal by Subject|1|||
125181214|NCT03645863|450283539|FG001|Overall Study|Withdrawal by Subject|0|||
125181215|NCT03645863|450283540|FG002|Overall Study|Withdrawal by Subject|0|||
125181216|NCT03624192|450283550|FG000|Overall Study|Lost to Follow-up|1|||
125181217|NCT03624192|450283551|FG001|Overall Study|Lost to Follow-up|1|||
125181218|NCT04660331|450283556|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
125181219|NCT04660331|450283557|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
125181220|NCT04660331|450283558|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
125181221|NCT02635984|450283559|FG000|Overall Study|Lost to Follow-up|2|||
125181222|NCT02635984|450283560|FG001|Overall Study|Lost to Follow-up|4|||
125181223|NCT02635984|450283559|FG000|Overall Study|Study Arm Closed|1|||
125181224|NCT02635984|450283560|FG001|Overall Study|Study Arm Closed|0|||
125181225|NCT01640249|450283562|FG000|Period 1|Withdrawal by Subject|1|||
125181226|NCT01640249|450283563|FG001|Period 1|Withdrawal by Subject|0|||
125181227|NCT01640249|450283564|FG002|Period 1|Withdrawal by Subject|0|||
125181228|NCT01640249|450283565|FG003|Period 1|Withdrawal by Subject|0|||
125181229|NCT01640249|450283566|FG004|Period 1|Withdrawal by Subject|0|||
125181230|NCT01640249|450283567|FG005|Period 1|Withdrawal by Subject|1|||
125181231|NCT01640249|450283568|FG006|Period 1|Withdrawal by Subject|0|||
125181232|NCT01215136|450283571|FG000|Overall Study|Adverse Event|2|||
125181233|NCT01215136|450283572|FG001|Overall Study|Adverse Event|9|||
125181234|NCT01215136|450283571|FG000|Overall Study|Disease Progression|3|||
125236350|NCT02097277|450493847|FG004|Overall Study|Subject request to discontinue treatment|1|||
125181235|NCT01215136|450283572|FG001|Overall Study|Disease Progression|14|||
125181236|NCT01215136|450283571|FG000|Overall Study|Symptomatic Deterioration|1|||
125181237|NCT01215136|450283572|FG001|Overall Study|Symptomatic Deterioration|1|||
125181238|NCT01215136|450283571|FG000|Overall Study|Death|0|||
125181239|NCT01215136|450283572|FG001|Overall Study|Death|2|||
125181240|NCT01215136|450283571|FG000|Overall Study|Withdrawal by Subject|0|||
125181241|NCT01215136|450283572|FG001|Overall Study|Withdrawal by Subject|1|||
125181242|NCT00613171|450283577|FG000|Overall Study|Adverse Event|7|||
125181243|NCT00613171|450283577|FG000|Overall Study|Withdrawal by Subject|3|||
125236351|NCT02097277|450493843|FG000|Overall Study|Lost to Follow-up|0|||
125236352|NCT02097277|450493844|FG001|Overall Study|Lost to Follow-up|1|||
125181244|NCT00613171|450283577|FG000|Overall Study|Reason not Specified|4|||
125181245|NCT00951496|450283578|FG000|Overall Study|Did not initiate study treatment|10|||
125181246|NCT00951496|450283579|FG001|Overall Study|Did not initiate study treatment|8|||
125181247|NCT00951496|450283580|FG002|Overall Study|Did not initiate study treatment|13|||
125181248|NCT01042093|450283592|FG000|Overall Study|Protocol Violation|2|||
125181249|NCT01042093|450283593|FG001|Overall Study|Protocol Violation|2|||
125181250|NCT01042093|450283594|FG002|Overall Study|Protocol Violation|2|||
125181251|NCT01042093|450283595|FG003|Overall Study|Protocol Violation|3|||
125181252|NCT01042093|450283592|FG000|Overall Study|Withdrawal by Subject|0|||
125181253|NCT01042093|450283593|FG001|Overall Study|Withdrawal by Subject|0|||
125181254|NCT01042093|450283594|FG002|Overall Study|Withdrawal by Subject|0|||
125181255|NCT01042093|450283595|FG003|Overall Study|Withdrawal by Subject|1|||
125181256|NCT02273388|450283596|FG000|Overall Study|Adverse Event|0|||
125181257|NCT02273388|450283597|FG001|Overall Study|Adverse Event|0|||
125181258|NCT02273388|450283598|FG002|Overall Study|Adverse Event|0|||
125181259|NCT02273388|450283599|FG003|Overall Study|Adverse Event|0|||
125181260|NCT02273388|450283600|FG004|Overall Study|Adverse Event|0|||
125181261|NCT02273388|450283601|FG005|Overall Study|Adverse Event|0|||
125181262|NCT02273388|450283602|FG006|Overall Study|Adverse Event|1|||
125181263|NCT02273388|450283603|FG007|Overall Study|Adverse Event|2|||
125181264|NCT02273388|450283604|FG008|Overall Study|Adverse Event|0|||
125181265|NCT02273388|450283605|FG009|Overall Study|Adverse Event|0|||
125181266|NCT02273388|450283606|FG010|Overall Study|Adverse Event|0|||
125181267|NCT02273388|450283607|FG011|Overall Study|Adverse Event|0|||
125181268|NCT02273388|450283596|FG000|Overall Study|Adverse Event study disease worse|4|||
125181269|NCT02273388|450283597|FG001|Overall Study|Adverse Event study disease worse|3|||
125181270|NCT02273388|450283598|FG002|Overall Study|Adverse Event study disease worse|3|||
125181271|NCT02273388|450283599|FG003|Overall Study|Adverse Event study disease worse|2|||
125181272|NCT02273388|450283600|FG004|Overall Study|Adverse Event study disease worse|4|||
125181273|NCT02273388|450283601|FG005|Overall Study|Adverse Event study disease worse|3|||
125181274|NCT02273388|450283602|FG006|Overall Study|Adverse Event study disease worse|14|||
125181275|NCT02273388|450283603|FG007|Overall Study|Adverse Event study disease worse|6|||
125181276|NCT02273388|450283604|FG008|Overall Study|Adverse Event study disease worse|6|||
125181277|NCT02273388|450283605|FG009|Overall Study|Adverse Event study disease worse|5|||
125181278|NCT02273388|450283606|FG010|Overall Study|Adverse Event study disease worse|10|||
125181279|NCT02273388|450283607|FG011|Overall Study|Adverse Event study disease worse|1|||
125181280|NCT02273388|450283596|FG000|Overall Study|Sponsor decision|0|||
125181281|NCT02273388|450283597|FG001|Overall Study|Sponsor decision|0|||
125181282|NCT02273388|450283598|FG002|Overall Study|Sponsor decision|0|||
125181283|NCT02273388|450283599|FG003|Overall Study|Sponsor decision|0|||
125181284|NCT02273388|450283600|FG004|Overall Study|Sponsor decision|0|||
125181285|NCT02273388|450283601|FG005|Overall Study|Sponsor decision|0|||
125181286|NCT02273388|450283602|FG006|Overall Study|Sponsor decision|0|||
125181287|NCT02273388|450283603|FG007|Overall Study|Sponsor decision|0|||
125181288|NCT02273388|450283604|FG008|Overall Study|Sponsor decision|0|||
125181289|NCT02273388|450283605|FG009|Overall Study|Sponsor decision|0|||
125181290|NCT02273388|450283606|FG010|Overall Study|Sponsor decision|0|||
125181291|NCT02273388|450283607|FG011|Overall Study|Sponsor decision|1|||
125181292|NCT01523002|450283615|FG000|Period 1|Withdrawal by Subject|1|||
125181293|NCT01523002|450283616|FG001|Period 1|Withdrawal by Subject|3|||
125181294|NCT01523002|450283615|FG000|Period 1|Lost to Follow-up|1|||
125181295|NCT01523002|450283616|FG001|Period 1|Lost to Follow-up|0|||
125181296|NCT01523002|450283615|FG000|Period 1|Adverse Event|0|||
125181297|NCT01523002|450283616|FG001|Period 1|Adverse Event|8|||
125181298|NCT01523002|450283615|FG000|Period 2|Withdrawal by Subject|4|||
125181299|NCT01523002|450283616|FG001|Period 2|Withdrawal by Subject|1|||
125181300|NCT01523002|450283615|FG000|Period 2|Adverse Event|2|||
125181301|NCT01523002|450283616|FG001|Period 2|Adverse Event|5|||
125181302|NCT01523002|450283615|FG000|Period 3|Withdrawal by Subject|1|||
125181303|NCT01523002|450283616|FG001|Period 3|Withdrawal by Subject|0|||
125181304|NCT01523002|450283615|FG000|Period 3|Adverse Event|3|||
125181305|NCT01523002|450283616|FG001|Period 3|Adverse Event|0|||
125181306|NCT01256502|450283617|FG000|Overall Study|Had scaffold removed|4|||
125181307|NCT01256502|450283617|FG000|Overall Study|Personal reasons|5|||
125181308|NCT01256502|450283617|FG000|Overall Study|Protocol deviation|1|||
125181309|NCT03281876|450283618|FG000|Overall Study|Adverse Event|4|||
125181310|NCT03281876|450283619|FG001|Overall Study|Adverse Event|15|||
125181311|NCT03281876|450283618|FG000|Overall Study|Lost to Follow-up|1|||
125181312|NCT03281876|450283619|FG001|Overall Study|Lost to Follow-up|4|||
125181313|NCT03281876|450283618|FG000|Overall Study|Withdrawal by Subject|11|||
125181314|NCT03281876|450283619|FG001|Overall Study|Withdrawal by Subject|15|||
125181315|NCT03281876|450283618|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
125181316|NCT03281876|450283619|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125181317|NCT03281876|450283618|FG000|Overall Study|OTHER|5|||
125181318|NCT03281876|450283619|FG001|Overall Study|OTHER|5|||
125181319|NCT01478373|450283620|FG000|Treatment Phase|Protocol Violation|1|||
125236353|NCT02097277|450493845|FG002|Overall Study|Lost to Follow-up|1|||
125181320|NCT01478373|450283620|FG000|Survival Phase|Adverse Event|8|||
125181321|NCT01478373|450283620|FG000|Survival Phase|Protocol Violation|1|||
125181322|NCT01478373|450283620|FG000|Survival Phase|crossover to another study|2|||
125181323|NCT01478373|450283620|FG000|Survival Phase|Progressive Disease|27|||
125181324|NCT01074944|450283622|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
125181325|NCT01074944|450283623|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
125181326|NCT01074944|450283624|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
125181327|NCT01074944|450283625|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
125236354|NCT02097277|450493846|FG003|Overall Study|Lost to Follow-up|0|||
125236355|NCT02097277|450493847|FG004|Overall Study|Lost to Follow-up|0|||
125236356|NCT02097277|450493843|FG000|Overall Study|Withdrawal by Subject|2|||
125236357|NCT02097277|450493844|FG001|Overall Study|Withdrawal by Subject|1|||
125236358|NCT02097277|450493845|FG002|Overall Study|Withdrawal by Subject|0|||
125236359|NCT02097277|450493846|FG003|Overall Study|Withdrawal by Subject|1|||
125236360|NCT02097277|450493847|FG004|Overall Study|Withdrawal by Subject|0|||
125236361|NCT02097277|450493843|FG000|Overall Study|Adverse Event|0|||
125236362|NCT02097277|450493844|FG001|Overall Study|Adverse Event|0|||
125236363|NCT02097277|450493845|FG002|Overall Study|Adverse Event|1|||
125236364|NCT02097277|450493846|FG003|Overall Study|Adverse Event|2|||
125236365|NCT02097277|450493847|FG004|Overall Study|Adverse Event|0|||
125236366|NCT01091259|450493848|FG000|Overall Study|Adverse Event|3|||
125236367|NCT01091259|450493848|FG000|Overall Study|Lack of Efficacy|2|||
125236368|NCT03813654|450493849|FG000|Overall Study|Protocol Violation|0|||
125236369|NCT03813654|450493850|FG001|Overall Study|Protocol Violation|1|||
125236370|NCT03813654|450493851|FG002|Overall Study|Protocol Violation|2|||
125236371|NCT03813654|450493849|FG000|Overall Study|Withdrawal by Subject|1|||
125236372|NCT03813654|450493850|FG001|Overall Study|Withdrawal by Subject|0|||
125236373|NCT03813654|450493851|FG002|Overall Study|Withdrawal by Subject|0|||
125236374|NCT01208051|450493852|FG000|Total Enrollment|Withdrawal by Subject|0|||
125236375|NCT01208051|450493853|FG001|Total Enrollment|Withdrawal by Subject|1|||
125236376|NCT01208051|450493854|FG002|Total Enrollment|Withdrawal by Subject|0|||
125236377|NCT01208051|450493855|FG003|Total Enrollment|Withdrawal by Subject|0|||
125236378|NCT01208051|450493856|FG004|Total Enrollment|Withdrawal by Subject|2|||
125236379|NCT01208051|450493852|FG000|Total Enrollment|Brain metastases|0|||
125236380|NCT01208051|450493853|FG001|Total Enrollment|Brain metastases|0|||
125236381|NCT01208051|450493854|FG002|Total Enrollment|Brain metastases|1|||
125236382|NCT01208051|450493855|FG003|Total Enrollment|Brain metastases|0|||
125236383|NCT01208051|450493856|FG004|Total Enrollment|Brain metastases|0|||
125236384|NCT00973973|450493861|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
125236385|NCT00973973|450493862|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
125236386|NCT00973973|450493861|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
125236387|NCT00973973|450493862|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
125236388|NCT00973973|450493861|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
125236389|NCT00973973|450493862|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
125236390|NCT00973973|450493861|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
125236391|NCT00973973|450493862|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
125236392|NCT00973973|450493861|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
125236393|NCT00973973|450493862|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
125236394|NCT00973973|450493861|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
125236395|NCT00973973|450493862|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
125236396|NCT00973973|450493861|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
125236397|NCT00973973|450493862|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
125236398|NCT00973973|450493861|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
125236399|NCT00973973|450493862|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
125236400|NCT00973973|450493861|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
125236401|NCT00973973|450493862|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
125236402|NCT00973973|450493861|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
125236403|NCT00973973|450493862|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
125236404|NCT00973973|450493861|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
125236405|NCT00973973|450493862|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
125236406|NCT00973973|450493861|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
125236407|NCT00973973|450493862|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
125236408|NCT01541748|450493863|FG000|Overall Study|Lost to Follow-up|17|||
125236409|NCT01541748|450493863|FG000|Overall Study|Moved out of state|1|||
125236410|NCT01541748|450493863|FG000|Overall Study|Withdrawal by Subject|7|||
125236411|NCT01541748|450493863|FG000|Overall Study|Screen failure|5|||
125236412|NCT01541748|450493863|FG000|Overall Study|Did not receive study device|1|||
125236413|NCT06057064|450493864|FG000|Overall Study|Death|2|||
125236414|NCT06057064|450493865|FG001|Overall Study|Death|0|||
125236415|NCT06057064|450493864|FG000|Overall Study|Physician Decision|1|||
125236416|NCT06057064|450493865|FG001|Overall Study|Physician Decision|0|||
125443436|NCT02555371|451252130|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
125236417|NCT06057064|450493864|FG000|Overall Study|Withdrawal by Subject|1|||
125236418|NCT06057064|450493865|FG001|Overall Study|Withdrawal by Subject|1|||
125236419|NCT02832037|450493866|FG000|Overall Study|Administrative reasons|0|||
125236420|NCT02832037|450493867|FG001|Overall Study|Administrative reasons|0|||
125236421|NCT02832037|450493868|FG002|Overall Study|Administrative reasons|1|||
125236422|NCT02832037|450493869|FG003|Overall Study|Administrative reasons|0|||
125236423|NCT02832037|450493870|FG004|Overall Study|Administrative reasons|0|||
125236424|NCT02832037|450493866|FG000|Overall Study|Protocol Violation|3|||
125236425|NCT02832037|450493867|FG001|Overall Study|Protocol Violation|0|||
125236426|NCT02832037|450493868|FG002|Overall Study|Protocol Violation|4|||
125181328|NCT01074944|450283626|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
125181329|NCT01074944|450283622|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
125236427|NCT02832037|450493869|FG003|Overall Study|Protocol Violation|1|||
125236428|NCT02832037|450493870|FG004|Overall Study|Protocol Violation|2|||
125236429|NCT02832037|450493866|FG000|Overall Study|Lost to Follow-up|2|||
125236430|NCT02832037|450493867|FG001|Overall Study|Lost to Follow-up|0|||
125236431|NCT02832037|450493868|FG002|Overall Study|Lost to Follow-up|3|||
125236432|NCT02832037|450493869|FG003|Overall Study|Lost to Follow-up|0|||
125236433|NCT02832037|450493870|FG004|Overall Study|Lost to Follow-up|5|||
125236434|NCT02832037|450493866|FG000|Overall Study|Withdrawal by Subject|9|||
125236435|NCT02832037|450493867|FG001|Overall Study|Withdrawal by Subject|8|||
125236436|NCT02832037|450493868|FG002|Overall Study|Withdrawal by Subject|0|||
125236437|NCT02832037|450493869|FG003|Overall Study|Withdrawal by Subject|4|||
125236438|NCT02832037|450493870|FG004|Overall Study|Withdrawal by Subject|8|||
125236439|NCT02832037|450493866|FG000|Overall Study|Adverse Event|5|||
125236440|NCT02832037|450493867|FG001|Overall Study|Adverse Event|4|||
125236441|NCT02832037|450493868|FG002|Overall Study|Adverse Event|0|||
125236442|NCT02832037|450493869|FG003|Overall Study|Adverse Event|2|||
125236443|NCT02832037|450493870|FG004|Overall Study|Adverse Event|4|||
125236444|NCT01137786|450493872|FG000|Overall Study|Lost to Follow-up|0|||
125236445|NCT01137786|450493873|FG001|Overall Study|Lost to Follow-up|2|||
125236446|NCT01137786|450493872|FG000|Overall Study|Withdrawal by Subject|1|||
125236447|NCT01137786|450493873|FG001|Overall Study|Withdrawal by Subject|1|||
125181330|NCT01074944|450283623|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
125181331|NCT01074944|450283624|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
125181332|NCT01074944|450283625|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
125181333|NCT01074944|450283626|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
125181334|NCT01074944|450283622|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
125181335|NCT01074944|450283623|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
125181336|NCT01074944|450283624|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
125181337|NCT01074944|450283625|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
125181338|NCT01074944|450283626|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
125181339|NCT01074944|450283622|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
125181340|NCT01074944|450283623|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
125181341|NCT01074944|450283624|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
125181342|NCT01074944|450283625|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
125181343|NCT01074944|450283626|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
125181344|NCT01074944|450283622|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
125181345|NCT01074944|450283623|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
125181346|NCT01074944|450283624|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
125181347|NCT01074944|450283625|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
125181348|NCT01074944|450283626|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
125181349|NCT01074944|450283622|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
125181350|NCT01074944|450283623|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
125181351|NCT01074944|450283624|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
125181352|NCT01074944|450283625|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
125181353|NCT01074944|450283626|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
125181354|NCT01074944|450283622|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
125181355|NCT01074944|450283623|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
125181356|NCT01074944|450283624|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
125181357|NCT01074944|450283625|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
125236448|NCT01531153|450493874|FG000|Overall Study|Withdrawal by Subject|10|||
125236449|NCT01531153|450493875|FG001|Overall Study|Withdrawal by Subject|9|||
125236450|NCT01531153|450493876|FG002|Overall Study|Withdrawal by Subject|15|||
125236451|NCT00770367|450493877|FG000|First Intervention|Withdrawal by Subject|0|||
125236452|NCT00770367|450493878|FG001|First Intervention|Withdrawal by Subject|2|||
125236453|NCT00770367|450493877|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
125392404|NCT03969992|451070654|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
125181358|NCT01074944|450283626|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
125181359|NCT01074944|450283622|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
125181360|NCT01074944|450283623|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
125181361|NCT01074944|450283624|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
125181362|NCT01074944|450283625|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
125181363|NCT01074944|450283626|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
125181364|NCT01074944|450283622|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
125181365|NCT01074944|450283623|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
125236454|NCT00770367|450493878|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
125236455|NCT00770367|450493877|FG000|Second Intervention|Lost to Follow-up|2|||
125236456|NCT00770367|450493878|FG001|Second Intervention|Lost to Follow-up|0|||
125236457|NCT00435942|450493879|FG000|Overall Study|Death|17|||
125236458|NCT00435942|450493880|FG001|Overall Study|Death|10|||
125236459|NCT00435942|450493879|FG000|Overall Study|Withdrawal by Subject|2|||
125236460|NCT00435942|450493880|FG001|Overall Study|Withdrawal by Subject|0|||
125236461|NCT00435942|450493879|FG000|Overall Study|Lost to Follow-up|0|||
125236462|NCT00435942|450493880|FG001|Overall Study|Lost to Follow-up|16|||
125236463|NCT00435942|450493879|FG000|Overall Study|Conversion to Open Repair|1|||
125236464|NCT00435942|450493880|FG001|Overall Study|Conversion to Open Repair|0|||
125236465|NCT00435942|450493879|FG000|Overall Study|Technical Failure|3|||
125236466|NCT00435942|450493880|FG001|Overall Study|Technical Failure|0|||
125236467|NCT00435942|450493879|FG000|Overall Study|Other|0|||
125236468|NCT00435942|450493880|FG001|Overall Study|Other|1|||
125181366|NCT01074944|450283624|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
125181367|NCT01074944|450283625|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
125181368|NCT01074944|450283626|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
125181369|NCT01074944|450283622|FG000|Long Term Treatment|Adverse Event|0|||
125181370|NCT01074944|450283623|FG001|Long Term Treatment|Adverse Event|0|||
125181371|NCT01074944|450283624|FG002|Long Term Treatment|Adverse Event|0|||
125181372|NCT01074944|450283625|FG003|Long Term Treatment|Adverse Event|3|||
125181373|NCT01074944|450283626|FG004|Long Term Treatment|Adverse Event|0|||
125181374|NCT01074944|450283622|FG000|Long Term Treatment|Lost to Follow-up|0|||
125181375|NCT01074944|450283623|FG001|Long Term Treatment|Lost to Follow-up|0|||
125181376|NCT01074944|450283624|FG002|Long Term Treatment|Lost to Follow-up|0|||
125181377|NCT01074944|450283625|FG003|Long Term Treatment|Lost to Follow-up|2|||
125181378|NCT01074944|450283626|FG004|Long Term Treatment|Lost to Follow-up|0|||
125181379|NCT01074944|450283622|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
125181380|NCT01074944|450283623|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
125181381|NCT01074944|450283624|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
125181382|NCT01074944|450283625|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
125181383|NCT01074944|450283626|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
125181384|NCT01074944|450283622|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
125181385|NCT01074944|450283623|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
125181386|NCT01074944|450283624|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
125181387|NCT01074944|450283625|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
125181388|NCT01074944|450283626|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
125181389|NCT01074944|450283622|FG000|Long Term Treatment|Withdrawal by Subject|0|||
125181390|NCT01074944|450283623|FG001|Long Term Treatment|Withdrawal by Subject|0|||
125181391|NCT01074944|450283624|FG002|Long Term Treatment|Withdrawal by Subject|0|||
125181392|NCT01074944|450283625|FG003|Long Term Treatment|Withdrawal by Subject|2|||
125181393|NCT01074944|450283626|FG004|Long Term Treatment|Withdrawal by Subject|0|||
125181394|NCT01074944|450283622|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
125181395|NCT01074944|450283623|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
125181396|NCT01074944|450283624|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
125181397|NCT01074944|450283625|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
125181398|NCT01074944|450283626|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
125181399|NCT01074944|450283622|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
125181400|NCT01074944|450283623|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
125181401|NCT01074944|450283624|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
125181402|NCT01074944|450283625|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
125181403|NCT01074944|450283626|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
125181404|NCT02905032|450283628|FG000|Overall Study|Withdrawal by Subject|2|||
125181405|NCT02905032|450283629|FG001|Overall Study|Withdrawal by Subject|0|||
125181406|NCT02905032|450283630|FG002|Overall Study|Withdrawal by Subject|0|||
125181407|NCT02905032|450283628|FG000|Overall Study|Protocol Violation|6|||
125236469|NCT00920816|450493881|FG000|Overall Study|Death|116|||
125236470|NCT00920816|450493882|FG001|Overall Study|Death|63|||
125236471|NCT00920816|450493883|FG002|Overall Study|Death|8|||
125236472|NCT00920816|450493884|FG003|Overall Study|Death|3|||
125181408|NCT02905032|450283629|FG001|Overall Study|Protocol Violation|12|||
125181409|NCT02905032|450283630|FG002|Overall Study|Protocol Violation|0|||
125181410|NCT00550459|450283631|FG000|Overall Study|Adverse Event|0|||
125181411|NCT00550459|450283632|FG001|Overall Study|Adverse Event|2|||
125181412|NCT00550459|450283631|FG000|Overall Study|Withdrawal by Subject|1|||
125181413|NCT00550459|450283632|FG001|Overall Study|Withdrawal by Subject|1|||
125181414|NCT00625820|450283633|FG000|Overall Study|Withdrawal by Subject|1|||
125181415|NCT00445146|450283634|FG000|Overall Study|Withdrew Consent|29|||
125181416|NCT00445146|450283634|FG000|Overall Study|Lack of Efficacy|28|||
125181417|NCT00445146|450283634|FG000|Overall Study|Investigator's Discretion|22|||
125181418|NCT00445146|450283634|FG000|Overall Study|Adverse Event|13|||
125181419|NCT00445146|450283634|FG000|Overall Study|Lost to Follow-up|13|||
125181420|NCT00445146|450283634|FG000|Overall Study|Death|9|||
125236473|NCT00920816|450493881|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
125236474|NCT00920816|450493882|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
125236475|NCT00920816|450493883|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
125236476|NCT00920816|450493884|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
125236477|NCT00920816|450493881|FG000|Overall Study|Global deterioration of health status|2|||
125236478|NCT00920816|450493882|FG001|Overall Study|Global deterioration of health status|0|||
125236479|NCT00920816|450493883|FG002|Overall Study|Global deterioration of health status|0|||
125236480|NCT00920816|450493884|FG003|Overall Study|Global deterioration of health status|0|||
125236481|NCT00920816|450493881|FG000|Overall Study|Objective progression or relapse|6|||
125236482|NCT00920816|450493882|FG001|Overall Study|Objective progression or relapse|2|||
125236483|NCT00920816|450493883|FG002|Overall Study|Objective progression or relapse|0|||
125236484|NCT00920816|450493884|FG003|Overall Study|Objective progression or relapse|0|||
125236485|NCT00920816|450493881|FG000|Overall Study|Other|26|||
125236486|NCT00920816|450493882|FG001|Overall Study|Other|15|||
125236487|NCT00920816|450493883|FG002|Overall Study|Other|1|||
125236488|NCT00920816|450493884|FG003|Overall Study|Other|2|||
125236489|NCT00920816|450493881|FG000|Overall Study|Lost to Follow-up|11|||
125236490|NCT00920816|450493882|FG001|Overall Study|Lost to Follow-up|2|||
125236491|NCT00920816|450493883|FG002|Overall Study|Lost to Follow-up|0|||
125236492|NCT00920816|450493884|FG003|Overall Study|Lost to Follow-up|0|||
125236493|NCT00920816|450493881|FG000|Overall Study|Adverse Event|1|||
125236494|NCT00920816|450493882|FG001|Overall Study|Adverse Event|1|||
125236495|NCT00920816|450493883|FG002|Overall Study|Adverse Event|1|||
125236496|NCT00920816|450493884|FG003|Overall Study|Adverse Event|0|||
125236497|NCT00920816|450493881|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
125236498|NCT00920816|450493882|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
125236499|NCT00920816|450493883|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
125236500|NCT00920816|450493884|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
125236501|NCT00920816|450493881|FG000|Overall Study|Randomized but not treated|3|||
125236502|NCT00920816|450493882|FG001|Overall Study|Randomized but not treated|0|||
125236503|NCT00920816|450493883|FG002|Overall Study|Randomized but not treated|0|||
125236504|NCT00920816|450493884|FG003|Overall Study|Randomized but not treated|0|||
125236505|NCT01180777|450493885|FG000|Overall Study|Protocol Violation|6|||
125236506|NCT01180777|450493885|FG000|Overall Study|Poor lens fit|4|||
125236507|NCT01180777|450493885|FG000|Overall Study|Lost to Follow-up|1|||
125236508|NCT01180777|450493885|FG000|Overall Study|Adverse Event|1|||
125236509|NCT04167462|450493890|FG000|Overall Study|Other reasons|3|||
125236510|NCT04167462|450493891|FG001|Overall Study|Other reasons|2|||
125236511|NCT04167462|450493890|FG000|Overall Study|Withdrawal by Subject|6|||
125236512|NCT04167462|450493891|FG001|Overall Study|Withdrawal by Subject|7|||
125236513|NCT04167462|450493890|FG000|Overall Study|Adverse Event|4|||
125236514|NCT04167462|450493891|FG001|Overall Study|Adverse Event|0|||
125236515|NCT04167462|450493890|FG000|Overall Study|Pregnancy|1|||
125236516|NCT04167462|450493891|FG001|Overall Study|Pregnancy|0|||
125236517|NCT04167462|450493890|FG000|Overall Study|Lack of Efficacy|0|||
125236518|NCT04167462|450493891|FG001|Overall Study|Lack of Efficacy|1|||
125236519|NCT02606253|450493892|FG000|Overall Study|Adverse Event|2|||
125236520|NCT02606253|450493893|FG001|Overall Study|Adverse Event|0|||
125236521|NCT02606253|450493894|FG002|Overall Study|Adverse Event|0|||
125236522|NCT02606253|450493892|FG000|Overall Study|Protocol Violation|2|||
125236523|NCT02606253|450493893|FG001|Overall Study|Protocol Violation|1|||
125236524|NCT02606253|450493894|FG002|Overall Study|Protocol Violation|0|||
125236525|NCT02606253|450493892|FG000|Overall Study|Physician Decision|1|||
125236526|NCT02606253|450493893|FG001|Overall Study|Physician Decision|1|||
125236527|NCT02606253|450493894|FG002|Overall Study|Physician Decision|0|||
125236528|NCT05522751|450493899|FG000|Overall Study|Adverse Event|1|||
125236529|NCT02475213|450493900|FG000|Overall Study|Adverse Event|2|||
125236530|NCT02475213|450493901|FG001|Overall Study|Adverse Event|0|||
125236531|NCT02475213|450493902|FG002|Overall Study|Adverse Event|0|||
125236532|NCT02475213|450493903|FG003|Overall Study|Adverse Event|1|||
125236533|NCT02475213|450493904|FG004|Overall Study|Adverse Event|1|||
125236534|NCT02475213|450493905|FG005|Overall Study|Adverse Event|4|||
125236535|NCT02475213|450493906|FG006|Overall Study|Adverse Event|6|||
125236536|NCT02475213|450493907|FG007|Overall Study|Adverse Event|2|||
125236537|NCT02475213|450493900|FG000|Overall Study|Physician Decision|1|||
125236538|NCT02475213|450493901|FG001|Overall Study|Physician Decision|1|||
125236539|NCT02475213|450493902|FG002|Overall Study|Physician Decision|1|||
125236540|NCT02475213|450493903|FG003|Overall Study|Physician Decision|0|||
125236541|NCT02475213|450493904|FG004|Overall Study|Physician Decision|0|||
125236542|NCT02475213|450493905|FG005|Overall Study|Physician Decision|1|||
125236543|NCT02475213|450493906|FG006|Overall Study|Physician Decision|4|||
125236544|NCT02475213|450493907|FG007|Overall Study|Physician Decision|0|||
125236545|NCT02475213|450493900|FG000|Overall Study|Progressive Disease|3|||
125236546|NCT02475213|450493901|FG001|Overall Study|Progressive Disease|2|||
125236547|NCT02475213|450493902|FG002|Overall Study|Progressive Disease|2|||
125236548|NCT02475213|450493903|FG003|Overall Study|Progressive Disease|13|||
125236549|NCT02475213|450493904|FG004|Overall Study|Progressive Disease|15|||
125236550|NCT02475213|450493905|FG005|Overall Study|Progressive Disease|25|||
125236551|NCT02475213|450493906|FG006|Overall Study|Progressive Disease|30|||
125236552|NCT02475213|450493907|FG007|Overall Study|Progressive Disease|10|||
125236553|NCT02475213|450493900|FG000|Overall Study|Death|0|||
125236554|NCT02475213|450493901|FG001|Overall Study|Death|0|||
125236555|NCT02475213|450493902|FG002|Overall Study|Death|0|||
125236556|NCT02475213|450493903|FG003|Overall Study|Death|0|||
125236557|NCT02475213|450493904|FG004|Overall Study|Death|0|||
125236558|NCT02475213|450493905|FG005|Overall Study|Death|4|||
125236559|NCT02475213|450493906|FG006|Overall Study|Death|1|||
125236560|NCT02475213|450493907|FG007|Overall Study|Death|0|||
125236561|NCT02475213|450493900|FG000|Overall Study|Protocol Violation|0|||
125236562|NCT02475213|450493901|FG001|Overall Study|Protocol Violation|0|||
125236563|NCT02475213|450493902|FG002|Overall Study|Protocol Violation|0|||
125236564|NCT02475213|450493903|FG003|Overall Study|Protocol Violation|0|||
125236565|NCT02475213|450493904|FG004|Overall Study|Protocol Violation|1|||
125236566|NCT02475213|450493905|FG005|Overall Study|Protocol Violation|0|||
125236567|NCT02475213|450493906|FG006|Overall Study|Protocol Violation|0|||
125236568|NCT02475213|450493907|FG007|Overall Study|Protocol Violation|0|||
125236569|NCT02475213|450493900|FG000|Overall Study|Withdrawal by Subject|0|||
125236570|NCT02475213|450493901|FG001|Overall Study|Withdrawal by Subject|0|||
125236571|NCT02475213|450493902|FG002|Overall Study|Withdrawal by Subject|0|||
125236572|NCT02475213|450493903|FG003|Overall Study|Withdrawal by Subject|1|||
125236573|NCT02475213|450493904|FG004|Overall Study|Withdrawal by Subject|0|||
125236574|NCT02475213|450493905|FG005|Overall Study|Withdrawal by Subject|2|||
125236575|NCT02475213|450493906|FG006|Overall Study|Withdrawal by Subject|2|||
125236576|NCT02475213|450493907|FG007|Overall Study|Withdrawal by Subject|0|||
125236577|NCT02475213|450493900|FG000|Overall Study|Other|0|||
125236578|NCT02475213|450493901|FG001|Overall Study|Other|0|||
125236579|NCT02475213|450493902|FG002|Overall Study|Other|0|||
125236580|NCT02475213|450493903|FG003|Overall Study|Other|1|||
125181421|NCT00445146|450283634|FG000|Overall Study|Protocol Violation|4|||
125181422|NCT00445146|450283634|FG000|Overall Study|Pregnancy|1|||
125181423|NCT00967330|450283635|FG000|Overall Study|Protocol Violation|3|||
125181424|NCT00967330|450283636|FG001|Overall Study|Protocol Violation|4|||
125181425|NCT00967330|450283635|FG000|Overall Study|Regular|10|||
125181426|NCT00967330|450283636|FG001|Overall Study|Regular|3|||
125181427|NCT00967330|450283635|FG000|Overall Study|Withdrawal by Subject|6|||
125181428|NCT00967330|450283636|FG001|Overall Study|Withdrawal by Subject|0|||
125181429|NCT00967330|450283635|FG000|Overall Study|Lost to Follow-up|1|||
125181430|NCT00967330|450283636|FG001|Overall Study|Lost to Follow-up|1|||
125181431|NCT00967330|450283635|FG000|Overall Study|Death|102|||
125181432|NCT00967330|450283636|FG001|Overall Study|Death|51|||
125181433|NCT00967330|450283635|FG000|Overall Study|Severe protocol deviation|0|||
125181434|NCT00967330|450283636|FG001|Overall Study|Severe protocol deviation|1|||
125181435|NCT02623725|450283638|FG000|Overall Study|Non compliance with protocol|9|||
125181436|NCT02623725|450283639|FG001|Overall Study|Non compliance with protocol|3|||
125181437|NCT02623725|450283638|FG000|Overall Study|Serious adverse event|0|||
125181438|NCT02623725|450283639|FG001|Overall Study|Serious adverse event|2|||
125181439|NCT02623725|450283638|FG000|Overall Study|Withdrawal by Subject|7|||
125181440|NCT02623725|450283639|FG001|Overall Study|Withdrawal by Subject|1|||
125181441|NCT03759392|450283640|FG000|Overall Study|Adverse Event|12|||
125181442|NCT03759392|450283641|FG001|Overall Study|Adverse Event|4|||
125181443|NCT03759392|450283640|FG000|Overall Study|Death|2|||
125181444|NCT03759392|450283641|FG001|Overall Study|Death|1|||
125181445|NCT03759392|450283640|FG000|Overall Study|Withdrawal by Subject|2|||
125181446|NCT03759392|450283641|FG001|Overall Study|Withdrawal by Subject|0|||
125181447|NCT03759392|450283640|FG000|Overall Study|Protocol Violation|2|||
125181448|NCT03759392|450283641|FG001|Overall Study|Protocol Violation|0|||
125181449|NCT03759392|450283640|FG000|Overall Study|Physician Decision|0|||
125181450|NCT03759392|450283641|FG001|Overall Study|Physician Decision|1|||
125181451|NCT03759392|450283640|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
125181452|NCT03759392|450283641|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
125236581|NCT02475213|450493904|FG004|Overall Study|Other|3|||
125236582|NCT02475213|450493905|FG005|Overall Study|Other|1|||
125236583|NCT02475213|450493906|FG006|Overall Study|Other|0|||
125181453|NCT03759392|450283640|FG000|Overall Study|No longer able to take medicines|1|||
125181454|NCT03759392|450283641|FG001|Overall Study|No longer able to take medicines|0|||
125181455|NCT03759392|450283640|FG000|Overall Study|Stopped taking study drug|1|||
125181456|NCT03759392|450283641|FG001|Overall Study|Stopped taking study drug|0|||
125181457|NCT02548143|450283642|FG000|Overall Study|Adverse Event|1|||
125181458|NCT02548143|450283643|FG001|Overall Study|Adverse Event|0|||
125181459|NCT02548143|450283642|FG000|Overall Study|Withdrawal by Subject|0|||
125181460|NCT02548143|450283643|FG001|Overall Study|Withdrawal by Subject|1|||
125236584|NCT02475213|450493907|FG007|Overall Study|Other|0|||
125236585|NCT00505921|450493908|FG000|Overall Study|Ineligible|1|||
125181461|NCT05620082|450283646|FG000|Overall Study|Discharged before study end|1|||
125181462|NCT05620082|450283647|FG001|Overall Study|Discharged before study end|4|||
125236586|NCT00505921|450493908|FG000|Overall Study|Failed to Mobilize|8|||
125236587|NCT02382939|450493914|FG000|Overall Study|Adverse Event|1|||
125181463|NCT05620082|450283648|FG002|Overall Study|Discharged before study end|0|||
125181464|NCT05620082|450283646|FG000|Overall Study|Moved to a different ward|1|||
125181465|NCT05620082|450283647|FG001|Overall Study|Moved to a different ward|0|||
125181466|NCT05620082|450283648|FG002|Overall Study|Moved to a different ward|0|||
125181467|NCT05620082|450283646|FG000|Overall Study|Feeling too unwell|1|||
125181468|NCT05620082|450283647|FG001|Overall Study|Feeling too unwell|0|||
125181469|NCT05620082|450283648|FG002|Overall Study|Feeling too unwell|0|||
125181470|NCT02603146|450285646|FG000|Overall Study|Lost to Follow-up|5|||
125181471|NCT02603146|450285647|FG001|Overall Study|Lost to Follow-up|6|||
125181472|NCT02603146|450285646|FG000|Overall Study|Withdrawal by Subject|8|||
125181473|NCT02603146|450285647|FG001|Overall Study|Withdrawal by Subject|10|||
125181474|NCT02603146|450285646|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
125181475|NCT02603146|450285647|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
125181476|NCT02603146|450285646|FG000|Overall Study|Participant moved|2|||
125181477|NCT02603146|450285647|FG001|Overall Study|Participant moved|0|||
125181478|NCT02603146|450285646|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
125181479|NCT02603146|450285647|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
125181480|NCT00654095|450285654|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
125181481|NCT00654095|450285654|FG000|Overall Study|Elevated triglyceride level (2)|1|||
125181482|NCT00654095|450285654|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
125181483|NCT00654095|450285654|FG000|Overall Study|Adverse Event|11|||
125181484|NCT00654095|450285654|FG000|Overall Study|Withdrawal by Subject|5|||
125181485|NCT00654095|450285654|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
125181486|NCT00654095|450285654|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
125181487|NCT00654095|450285654|FG000|Overall Study|Did not meet inclusion criteria|1|||
125181488|NCT01431079|450285655|FG000|Overall Study|Lost to Follow-up|35|||
125181489|NCT01431079|450285656|FG001|Overall Study|Lost to Follow-up|39|||
125181490|NCT03565900|450285659|FG000|Overall Study|Disposition Unknown|4|||
125181491|NCT03565900|450285660|FG001|Overall Study|Disposition Unknown|1|||
125181492|NCT03565900|450285659|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
125181493|NCT03565900|450285660|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
125181494|NCT03565900|450285659|FG000|Overall Study|Withdrawal by Subject|4|||
125181495|NCT03565900|450285660|FG001|Overall Study|Withdrawal by Subject|5|||
125181496|NCT03565900|450285659|FG000|Overall Study|Randomized By Mistake|0|||
125181497|NCT03565900|450285660|FG001|Overall Study|Randomized By Mistake|2|||
125181498|NCT03565900|450285659|FG000|Overall Study|Physician Decision|7|||
125181499|NCT03565900|450285660|FG001|Overall Study|Physician Decision|11|||
125181500|NCT03565900|450285659|FG000|Overall Study|Death|9|||
125181501|NCT03565900|450285660|FG001|Overall Study|Death|7|||
125181502|NCT00245466|450285668|FG000|Overall Study|Adverse Event|2|||
125181503|NCT00245466|450285669|FG001|Overall Study|Adverse Event|8|||
125181504|NCT00245466|450285670|FG002|Overall Study|Adverse Event|4|||
125181505|NCT00245466|450285668|FG000|Overall Study|Low prostate specific antigen suppr|16|||
125181506|NCT00245466|450285669|FG001|Overall Study|Low prostate specific antigen suppr|14|||
125181507|NCT00245466|450285670|FG002|Overall Study|Low prostate specific antigen suppr|5|||
125181508|NCT00245466|450285668|FG000|Overall Study|Insufficient testosterone suppr|12|||
125181509|NCT00245466|450285669|FG001|Overall Study|Insufficient testosterone suppr|12|||
125181510|NCT00245466|450285670|FG002|Overall Study|Insufficient testosterone suppr|21|||
125181511|NCT00245466|450285668|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
125181512|NCT00245466|450285669|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
125181513|NCT00245466|450285670|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
125181514|NCT00245466|450285668|FG000|Overall Study|Withdrawal by Subject|2|||
125181515|NCT00245466|450285669|FG001|Overall Study|Withdrawal by Subject|2|||
125181516|NCT00245466|450285670|FG002|Overall Study|Withdrawal by Subject|1|||
125181517|NCT00245466|450285668|FG000|Overall Study|Lost to Follow-up|3|||
125181518|NCT00245466|450285669|FG001|Overall Study|Lost to Follow-up|0|||
125181519|NCT00245466|450285670|FG002|Overall Study|Lost to Follow-up|0|||
125181520|NCT00245466|450285668|FG000|Overall Study|Disease progression|0|||
125181521|NCT00245466|450285669|FG001|Overall Study|Disease progression|3|||
125181522|NCT00245466|450285670|FG002|Overall Study|Disease progression|1|||
125181523|NCT00245466|450285668|FG000|Overall Study|Protocol Violation|1|||
125181524|NCT00245466|450285669|FG001|Overall Study|Protocol Violation|2|||
125181525|NCT00245466|450285670|FG002|Overall Study|Protocol Violation|2|||
125181526|NCT00245466|450285668|FG000|Overall Study|Death|0|||
125181527|NCT00245466|450285669|FG001|Overall Study|Death|2|||
125181528|NCT00245466|450285670|FG002|Overall Study|Death|0|||
125181529|NCT00245466|450285668|FG000|Overall Study|Administrative reasons|0|||
125181530|NCT00245466|450285669|FG001|Overall Study|Administrative reasons|1|||
125181531|NCT00245466|450285670|FG002|Overall Study|Administrative reasons|0|||
125181532|NCT01958437|450285671|FG000|Overall Study|Incidental MRI findings|0|||
125181533|NCT01958437|450285672|FG001|Overall Study|Incidental MRI findings|0|||
125181534|NCT01958437|450285673|FG002|Overall Study|Incidental MRI findings|1|||
125181535|NCT01958437|450285674|FG003|Overall Study|Incidental MRI findings|1|||
125236588|NCT02382939|450493915|FG001|Overall Study|Adverse Event|1|||
125236589|NCT02382939|450493914|FG000|Overall Study|Withdrawal by Subject|2|||
125236590|NCT02382939|450493915|FG001|Overall Study|Withdrawal by Subject|2|||
125236591|NCT05383209|450493918|FG000|Overall Study|Adverse Event: Non-ocular|0|||
125236592|NCT05383209|450493919|FG001|Overall Study|Adverse Event: Non-ocular|1|||
125236593|NCT05383209|450493920|FG002|Overall Study|Adverse Event: Non-ocular|0|||
125236594|NCT05383209|450493918|FG000|Overall Study|Lost to Follow-up|2|||
125236595|NCT05383209|450493919|FG001|Overall Study|Lost to Follow-up|1|||
125236596|NCT05383209|450493920|FG002|Overall Study|Lost to Follow-up|4|||
125236597|NCT05383209|450493918|FG000|Overall Study|Withdrawal by Subject|2|||
125236598|NCT05383209|450493919|FG001|Overall Study|Withdrawal by Subject|0|||
125236599|NCT05383209|450493920|FG002|Overall Study|Withdrawal by Subject|1|||
125236600|NCT05383209|450493918|FG000|Overall Study|Death|1|||
125236601|NCT05383209|450493919|FG001|Overall Study|Death|0|||
125236602|NCT05383209|450493920|FG002|Overall Study|Death|0|||
125236603|NCT05383209|450493918|FG000|Overall Study|Other|0|||
125236604|NCT05383209|450493919|FG001|Overall Study|Other|1|||
125236605|NCT05383209|450493920|FG002|Overall Study|Other|0|||
125236606|NCT01582451|450493921|FG000|Overall Study|Adverse Event|1|||
125236607|NCT01582451|450493922|FG001|Overall Study|Adverse Event|3|||
125236608|NCT01582451|450493921|FG000|Overall Study|Death|3|||
125236609|NCT01582451|450493922|FG001|Overall Study|Death|3|||
125236610|NCT01582451|450493921|FG000|Overall Study|Lost to Follow-up|0|||
125236611|NCT01582451|450493922|FG001|Overall Study|Lost to Follow-up|2|||
125236612|NCT01582451|450493921|FG000|Overall Study|Protocol Violation|11|||
125236613|NCT01582451|450493922|FG001|Overall Study|Protocol Violation|3|||
125236614|NCT01582451|450493921|FG000|Overall Study|Withdrawal by Subject|13|||
125236615|NCT01582451|450493922|FG001|Overall Study|Withdrawal by Subject|9|||
125236616|NCT01582451|450493921|FG000|Overall Study|Physician Decision|3|||
125236617|NCT01582451|450493922|FG001|Overall Study|Physician Decision|0|||
125236618|NCT01582451|450493921|FG000|Overall Study|Sponsor Decision|1|||
125236619|NCT01582451|450493922|FG001|Overall Study|Sponsor Decision|0|||
125236620|NCT00717886|450493923|FG000|Overall Study|Withdrawal by Subject|3|||
125236621|NCT00717886|450493923|FG000|Overall Study|Treatment Failure|1|||
125236622|NCT00716417|450493924|FG000|Overall Study|Adverse Event|0|||
125236623|NCT00716417|450493925|FG001|Overall Study|Adverse Event|0|||
125236624|NCT00716417|450493926|FG002|Overall Study|Adverse Event|2|||
125236625|NCT00716417|450493927|FG003|Overall Study|Adverse Event|1|||
125236626|NCT00716417|450493928|FG004|Overall Study|Adverse Event|0|||
125236627|NCT00716417|450493929|FG005|Overall Study|Adverse Event|0|||
125236628|NCT00716417|450493930|FG006|Overall Study|Adverse Event|3|||
125236629|NCT00716417|450493931|FG007|Overall Study|Adverse Event|1|||
125236630|NCT00716417|450493932|FG008|Overall Study|Adverse Event|0|||
125236631|NCT00716417|450493933|FG009|Overall Study|Adverse Event|3|||
125236632|NCT00716417|450493924|FG000|Overall Study|Withdrawal by Subject|0|||
125236633|NCT00716417|450493925|FG001|Overall Study|Withdrawal by Subject|1|||
125236634|NCT00716417|450493926|FG002|Overall Study|Withdrawal by Subject|0|||
125236635|NCT00716417|450493927|FG003|Overall Study|Withdrawal by Subject|2|||
125236636|NCT00716417|450493928|FG004|Overall Study|Withdrawal by Subject|0|||
125236637|NCT00716417|450493929|FG005|Overall Study|Withdrawal by Subject|0|||
125236638|NCT00716417|450493930|FG006|Overall Study|Withdrawal by Subject|1|||
125236639|NCT00716417|450493931|FG007|Overall Study|Withdrawal by Subject|0|||
125236640|NCT00716417|450493932|FG008|Overall Study|Withdrawal by Subject|0|||
125236641|NCT00716417|450493933|FG009|Overall Study|Withdrawal by Subject|0|||
125236642|NCT00716417|450493924|FG000|Overall Study|Progressive disease|3|||
125236643|NCT00716417|450493925|FG001|Overall Study|Progressive disease|5|||
125236644|NCT00716417|450493926|FG002|Overall Study|Progressive disease|3|||
125236645|NCT00716417|450493927|FG003|Overall Study|Progressive disease|8|||
125236646|NCT00716417|450493928|FG004|Overall Study|Progressive disease|0|||
125236647|NCT00716417|450493929|FG005|Overall Study|Progressive disease|3|||
125236648|NCT00716417|450493930|FG006|Overall Study|Progressive disease|3|||
125236649|NCT00716417|450493931|FG007|Overall Study|Progressive disease|1|||
125236650|NCT00716417|450493932|FG008|Overall Study|Progressive disease|5|||
125236651|NCT00716417|450493933|FG009|Overall Study|Progressive disease|0|||
125236652|NCT00716417|450493924|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
125236653|NCT00716417|450493925|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
125236654|NCT00716417|450493926|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
125236655|NCT00716417|450493927|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
125236656|NCT00716417|450493928|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
125236657|NCT00716417|450493929|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
125236658|NCT00716417|450493930|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
125236659|NCT00716417|450493931|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
125236660|NCT00716417|450493932|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
125236661|NCT00716417|450493933|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
125236662|NCT00716417|450493924|FG000|Overall Study|On patient request due to toxicities|0|||
125236663|NCT00716417|450493925|FG001|Overall Study|On patient request due to toxicities|0|||
125236664|NCT00716417|450493926|FG002|Overall Study|On patient request due to toxicities|0|||
125236665|NCT00716417|450493927|FG003|Overall Study|On patient request due to toxicities|0|||
125181536|NCT04886596|450285677|FG000|Overall Study|Adverse Event|442|||
125181537|NCT04886596|450285678|FG001|Overall Study|Adverse Event|441|||
125181538|NCT04886596|450285677|FG000|Overall Study|Lost to Follow-up|448|||
125181539|NCT04886596|450285678|FG001|Overall Study|Lost to Follow-up|465|||
125181540|NCT04886596|450285677|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
125181541|NCT04886596|450285678|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
125181542|NCT04886596|450285677|FG000|Overall Study|Migrated/moved from the study area|201|||
125181543|NCT04886596|450285678|FG001|Overall Study|Migrated/moved from the study area|184|||
125181544|NCT04886596|450285677|FG000|Overall Study|Other|298|||
125181545|NCT04886596|450285678|FG001|Overall Study|Other|326|||
125181546|NCT00948155|450285680|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
125181547|NCT00948155|450285681|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
125181548|NCT00948155|450285680|FG000|Washout 14 Days|Lost to Follow-up|1|||
125181549|NCT00948155|450285681|FG001|Washout 14 Days|Lost to Follow-up|2|||
125181550|NCT04620746|450285682|FG000|Overall Study|Adverse Event|2|||
125181551|NCT04620746|450285683|FG001|Overall Study|Adverse Event|0|||
125181552|NCT04620746|450285682|FG000|Overall Study|Uniterpretable skin test|1|||
125181553|NCT04620746|450285683|FG001|Overall Study|Uniterpretable skin test|0|||
125181554|NCT04620746|450285682|FG000|Overall Study|Withdrawal by Subject|0|||
125181555|NCT04620746|450285683|FG001|Overall Study|Withdrawal by Subject|1|||
125181556|NCT03473925|450285684|FG000|Overall Study|Death|48|||
125181557|NCT03473925|450285685|FG001|Overall Study|Death|44|||
125181558|NCT03473925|450285684|FG000|Overall Study|Sponsor Decision|2|||
125181559|NCT03473925|450285685|FG001|Overall Study|Sponsor Decision|7|||
125181560|NCT03473925|450285684|FG000|Overall Study|Withdrawal by Subject|1|||
125181561|NCT03473925|450285685|FG001|Overall Study|Withdrawal by Subject|3|||
125181562|NCT03473925|450285684|FG000|Overall Study|Not Treated|1|||
125181563|NCT03473925|450285685|FG001|Overall Study|Not Treated|1|||
125181564|NCT03411863|450285686|FG000|Overall Study|Withdrawal by Subject|3|||
125181565|NCT03411863|450285687|FG001|Overall Study|Withdrawal by Subject|1|||
125181566|NCT03411863|450285686|FG000|Overall Study|Physician Decision|0|||
125181567|NCT03411863|450285687|FG001|Overall Study|Physician Decision|1|||
125181568|NCT04661150|450285692|FG000|Overall Study|Ongoing in study|19|||
125181569|NCT04661150|450285693|FG001|Overall Study|Ongoing in study|20|||
125181570|NCT04661150|450285692|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
125181571|NCT04661150|450285693|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
125181572|NCT04661150|450285692|FG000|Overall Study|Death|2|||
125181573|NCT04661150|450285693|FG001|Overall Study|Death|0|||
125181574|NCT00100828|450285694|FG000|Overall Study|Physician Decision|6|||
125181575|NCT01197911|450285695|FG000|Overall Study|Adverse Event|0|||
125181576|NCT01197911|450285696|FG001|Overall Study|Adverse Event|0|||
125181577|NCT01197911|450285697|FG002|Overall Study|Adverse Event|1|||
125181578|NCT01526057|450285699|FG000|Overall Study|Withdrawal by Subject|3|||
125181579|NCT01526057|450285700|FG001|Overall Study|Withdrawal by Subject|2|||
125181580|NCT01526057|450285701|FG002|Overall Study|Withdrawal by Subject|2|||
125181581|NCT01526057|450285699|FG000|Overall Study|Adverse Event|3|||
125181582|NCT01526057|450285700|FG001|Overall Study|Adverse Event|1|||
125181583|NCT01526057|450285701|FG002|Overall Study|Adverse Event|1|||
125181584|NCT01526057|450285699|FG000|Overall Study|Death|1|||
125181585|NCT01526057|450285700|FG001|Overall Study|Death|0|||
125181586|NCT01526057|450285701|FG002|Overall Study|Death|0|||
125181587|NCT01526057|450285699|FG000|Overall Study|Lost to Follow-up|1|||
125181588|NCT01526057|450285700|FG001|Overall Study|Lost to Follow-up|0|||
125181589|NCT01526057|450285701|FG002|Overall Study|Lost to Follow-up|1|||
125181590|NCT01526057|450285699|FG000|Overall Study|Other|1|||
125181591|NCT01526057|450285700|FG001|Overall Study|Other|0|||
125181592|NCT01526057|450285701|FG002|Overall Study|Other|1|||
125181593|NCT01526057|450285699|FG000|Overall Study|Protocol Violation|0|||
125181594|NCT01526057|450285700|FG001|Overall Study|Protocol Violation|0|||
125181595|NCT01526057|450285701|FG002|Overall Study|Protocol Violation|1|||
125181596|NCT02289729|450285704|FG000|Overall Study|Lack of Efficacy|3|||
125181597|NCT02289729|450285704|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
125181598|NCT02289729|450285704|FG000|Overall Study|Withdrawal by Subject|1|||
125181599|NCT02289729|450285704|FG000|Overall Study|Death|1|||
125181600|NCT04870710|450285710|FG000|Overall Study|Lost to Follow-up|3|||
125181601|NCT00476190|450285711|FG000|Overall Study|Ineligible|1|||
125181602|NCT00476190|450285712|FG001|Overall Study|Ineligible|1|||
125181603|NCT00476190|450285711|FG000|Overall Study|Induction Death|2|||
125181604|NCT00476190|450285712|FG001|Overall Study|Induction Death|0|||
125181605|NCT00476190|450285711|FG000|Overall Study|Induction Failure|2|||
125181606|NCT00476190|450285712|FG001|Overall Study|Induction Failure|4|||
125181607|NCT00476190|450285711|FG000|Overall Study|Lost to Follow-up|1|||
125181608|NCT00476190|450285712|FG001|Overall Study|Lost to Follow-up|0|||
125181609|NCT00476190|450285711|FG000|Overall Study|Relapse/Progression|5|||
125181610|NCT00476190|450285712|FG001|Overall Study|Relapse/Progression|2|||
125181611|NCT00476190|450285711|FG000|Overall Study|Remission Death|0|||
125181612|NCT00476190|450285712|FG001|Overall Study|Remission Death|1|||
125181613|NCT00476190|450285711|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
125181614|NCT00476190|450285712|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
125181615|NCT00476190|450285711|FG000|Overall Study|Withdrawal by Subject|6|||
125181616|NCT00476190|450285712|FG001|Overall Study|Withdrawal by Subject|2|||
125181617|NCT00476190|450285711|FG000|Overall Study|Other|9|||
125181618|NCT00476190|450285712|FG001|Overall Study|Other|10|||
125181619|NCT05724589|450285713|FG000|Overall Study|Lost to Follow-up|1|||
125181620|NCT04331808|450285717|FG000|Overall Study|Withdrew consent|1|||
125181621|NCT04331808|450285718|FG001|Overall Study|Withdrew consent|0|||
125181622|NCT04331808|450285719|FG002|Overall Study|Withdrew consent|2|||
125181623|NCT04331808|450285720|FG003|Overall Study|Withdrew consent|3|||
125181624|NCT02189837|450285721|FG000|Overall Study|Withdrawal by Subject|2|||
125181625|NCT02189837|450285722|FG001|Overall Study|Withdrawal by Subject|1|||
125181626|NCT02189837|450285723|FG002|Overall Study|Withdrawal by Subject|3|||
125181627|NCT02189837|450285724|FG003|Overall Study|Withdrawal by Subject|1|||
125181628|NCT02189837|450285721|FG000|Overall Study|Sponsor Decision|0|||
125181629|NCT02189837|450285722|FG001|Overall Study|Sponsor Decision|0|||
125181630|NCT02189837|450285723|FG002|Overall Study|Sponsor Decision|0|||
125181631|NCT02189837|450285724|FG003|Overall Study|Sponsor Decision|1|||
125181632|NCT00822692|450285730|FG000|Overall Study|Lost to Follow-up|17|||
125181633|NCT00822692|450285731|FG001|Overall Study|Lost to Follow-up|25|||
125181634|NCT02443740|450285732|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181635|NCT02443740|450285733|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181636|NCT02443740|450285734|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181637|NCT02443740|450285735|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181638|NCT02443740|450285736|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181639|NCT02443740|450285737|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
125181640|NCT02443740|450285738|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181641|NCT02443740|450285739|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181642|NCT02443740|450285740|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181643|NCT02443740|450285741|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181644|NCT02443740|450285742|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
125181645|NCT02443740|450285732|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
125181646|NCT02443740|450285733|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181647|NCT02443740|450285734|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181648|NCT02443740|450285735|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181649|NCT02443740|450285736|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181650|NCT02443740|450285737|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181651|NCT02443740|450285738|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
125181652|NCT02443740|450285739|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181653|NCT02443740|450285740|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181654|NCT02443740|450285741|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181655|NCT02443740|450285742|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
125181656|NCT02443740|450285732|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181657|NCT02443740|450285733|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181658|NCT02443740|450285734|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181659|NCT02443740|450285735|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181660|NCT02443740|450285736|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181661|NCT02443740|450285737|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
125181662|NCT02443740|450285738|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181663|NCT02443740|450285739|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181664|NCT02443740|450285740|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181665|NCT02443740|450285741|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181666|NCT02443740|450285742|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
125181667|NCT00456300|450285743|FG000|Overall Study|Adverse Event|1|||
125181668|NCT00456300|450285744|FG001|Overall Study|Adverse Event|0|||
125181669|NCT02348112|450285748|FG000|Overall Study|Withdrawal by Subject|32|||
125181670|NCT02348112|450285749|FG001|Overall Study|Withdrawal by Subject|29|||
125181671|NCT02348112|450285748|FG000|Overall Study|Lost to Follow-up|24|||
125181672|NCT02348112|450285749|FG001|Overall Study|Lost to Follow-up|20|||
125181673|NCT02348112|450285748|FG000|Overall Study|Physician Decision|17|||
125181674|NCT02348112|450285749|FG001|Overall Study|Physician Decision|15|||
125181675|NCT02348112|450285748|FG000|Overall Study|Site closed due to PI leaving|0|||
125181676|NCT02348112|450285749|FG001|Overall Study|Site closed due to PI leaving|30|||
125181677|NCT02348112|450285748|FG000|Overall Study|Sponsor withdrawal|0|||
125181678|NCT02348112|450285749|FG001|Overall Study|Sponsor withdrawal|7|||
125181679|NCT02348112|450285748|FG000|Overall Study|Death|0|||
125181680|NCT02348112|450285749|FG001|Overall Study|Death|1|||
125181681|NCT01998841|450285757|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
125181682|NCT01998841|450285758|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
125181683|NCT01998841|450285759|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
125181684|NCT01998841|450285760|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
125181685|NCT01998841|450285761|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
125181686|NCT01998841|450285757|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
125236666|NCT00716417|450493928|FG004|Overall Study|On patient request due to toxicities|0|||
125236667|NCT00716417|450493929|FG005|Overall Study|On patient request due to toxicities|0|||
125236668|NCT00716417|450493930|FG006|Overall Study|On patient request due to toxicities|0|||
125236669|NCT00716417|450493931|FG007|Overall Study|On patient request due to toxicities|1|||
125236670|NCT00716417|450493932|FG008|Overall Study|On patient request due to toxicities|0|||
125236671|NCT00716417|450493933|FG009|Overall Study|On patient request due to toxicities|0|||
125236672|NCT01553851|450493934|FG000|Overall Study|Adverse Event|2|||
125236673|NCT01553851|450493934|FG000|Overall Study|constipation|1|||
125236674|NCT01369433|450493935|FG000|Overall Study|Adverse Event|31|||
125236675|NCT01369433|450493936|FG001|Overall Study|Adverse Event|1|||
125181687|NCT01998841|450285758|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
125181688|NCT01998841|450285759|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
125181689|NCT01998841|450285760|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
125392405|NCT03969992|451070655|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
125236676|NCT01369433|450493935|FG000|Overall Study|Required significant surgical procedure|1|||
125236677|NCT01369433|450493936|FG001|Overall Study|Required significant surgical procedure|0|||
125236678|NCT01369433|450493935|FG000|Overall Study|Non-compliance|1|||
125236679|NCT01369433|450493936|FG001|Overall Study|Non-compliance|0|||
125236680|NCT01369433|450493935|FG000|Overall Study|Withdrawal by Subject|5|||
125236681|NCT01369433|450493936|FG001|Overall Study|Withdrawal by Subject|2|||
125236682|NCT01369433|450493935|FG000|Overall Study|Study terminated by Sponsor|67|||
125236683|NCT01369433|450493936|FG001|Overall Study|Study terminated by Sponsor|0|||
125236684|NCT01369433|450493935|FG000|Overall Study|Lost to Follow-up|1|||
125236685|NCT01369433|450493936|FG001|Overall Study|Lost to Follow-up|0|||
125236686|NCT01369433|450493935|FG000|Overall Study|Death|5|||
125236687|NCT01369433|450493936|FG001|Overall Study|Death|0|||
125236688|NCT01369433|450493935|FG000|Overall Study|Investigator discretion|6|||
125236689|NCT01369433|450493936|FG001|Overall Study|Investigator discretion|1|||
125236690|NCT01369433|450493935|FG000|Overall Study|Progressive Disease|92|||
125236691|NCT01369433|450493936|FG001|Overall Study|Progressive Disease|12|||
125236692|NCT00487188|450493938|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
125236693|NCT00487188|450493939|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
125236694|NCT00487188|450493940|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
125236695|NCT00487188|450493938|FG000|Induction Phase|Adverse Event|5|||
125236696|NCT00487188|450493939|FG001|Induction Phase|Adverse Event|0|||
125236697|NCT00487188|450493940|FG002|Induction Phase|Adverse Event|0|||
125236698|NCT00487188|450493938|FG000|Induction Phase|Lack of Efficacy|0|||
125236699|NCT00487188|450493939|FG001|Induction Phase|Lack of Efficacy|1|||
125236700|NCT00487188|450493940|FG002|Induction Phase|Lack of Efficacy|0|||
125236701|NCT00487188|450493938|FG000|Induction Phase|Protocol Violation|1|||
125236702|NCT00487188|450493939|FG001|Induction Phase|Protocol Violation|0|||
125236703|NCT00487188|450493940|FG002|Induction Phase|Protocol Violation|0|||
125236704|NCT00487188|450493938|FG000|Induction Phase|Refused Treatment|1|||
125236705|NCT00487188|450493939|FG001|Induction Phase|Refused Treatment|2|||
125236706|NCT00487188|450493940|FG002|Induction Phase|Refused Treatment|0|||
125236707|NCT00487188|450493938|FG000|Induction Phase|Lost to Follow-up|2|||
125236708|NCT00487188|450493939|FG001|Induction Phase|Lost to Follow-up|2|||
125236709|NCT00487188|450493940|FG002|Induction Phase|Lost to Follow-up|0|||
125236710|NCT00487188|450493938|FG000|Induction Phase|Administrative|0|||
125236711|NCT00487188|450493939|FG001|Induction Phase|Administrative|1|||
125236712|NCT00487188|450493940|FG002|Induction Phase|Administrative|0|||
125236713|NCT00487188|450493938|FG000|Maintenance Phase|Adverse Event|1|||
125236714|NCT00487188|450493939|FG001|Maintenance Phase|Adverse Event|0|||
125236715|NCT00487188|450493940|FG002|Maintenance Phase|Adverse Event|0|||
125236716|NCT00487188|450493938|FG000|Maintenance Phase|Death|1|||
125236717|NCT00487188|450493939|FG001|Maintenance Phase|Death|0|||
125236718|NCT00487188|450493940|FG002|Maintenance Phase|Death|0|||
125236719|NCT00487188|450493938|FG000|Maintenance Phase|Lost to Follow-up|1|||
125236720|NCT00487188|450493939|FG001|Maintenance Phase|Lost to Follow-up|0|||
125236721|NCT00487188|450493940|FG002|Maintenance Phase|Lost to Follow-up|0|||
125236722|NCT00487188|450493938|FG000|Maintenance Phase|Administrative|0|||
125236723|NCT00487188|450493939|FG001|Maintenance Phase|Administrative|0|||
125392406|NCT03969992|451070656|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
125392407|NCT02063737|451070657|FG000|Overall Study|Lost to Follow-up|11|||
125392408|NCT02063737|451070658|FG001|Overall Study|Lost to Follow-up|4|||
125181690|NCT01998841|450285761|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
125181691|NCT02552121|450285762|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
125181692|NCT02552121|450285763|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125236724|NCT00487188|450493940|FG002|Maintenance Phase|Administrative|1|||
125236725|NCT03822416|450493951|FG000|Overall Study|Lost to Follow-up|1|||
125236726|NCT03822416|450493952|FG001|Overall Study|Lost to Follow-up|0|||
125236727|NCT03822416|450493951|FG000|Overall Study|Withdrawal by Subject|0|||
125236728|NCT03822416|450493952|FG001|Overall Study|Withdrawal by Subject|1|||
125236729|NCT04666298|450493955|FG000|Overall Study|Subject decision|1|||
125236730|NCT04666298|450493956|FG001|Overall Study|Subject decision|0|||
125236731|NCT04666298|450493957|FG002|Overall Study|Subject decision|0|||
125181693|NCT02552121|450285764|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125181694|NCT02552121|450285765|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125181695|NCT02552121|450285766|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125181696|NCT02552121|450285767|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125181697|NCT02552121|450285768|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125181698|NCT02552121|450285769|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
125181699|NCT02552121|450285762|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
125181700|NCT02552121|450285763|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181701|NCT02552121|450285764|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181702|NCT02552121|450285765|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181703|NCT02552121|450285766|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181704|NCT02552121|450285767|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181705|NCT02552121|450285768|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181706|NCT02552121|450285769|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
125181707|NCT02552121|450285762|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181708|NCT02552121|450285763|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
125181709|NCT02552121|450285764|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181710|NCT02552121|450285765|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181711|NCT02552121|450285766|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181712|NCT02552121|450285767|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181713|NCT02552121|450285768|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181714|NCT02552121|450285769|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
125181715|NCT02552121|450285762|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181716|NCT02552121|450285763|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
125181717|NCT02552121|450285764|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181718|NCT02552121|450285765|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181719|NCT02552121|450285766|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181720|NCT02552121|450285767|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181721|NCT02552121|450285768|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181722|NCT02552121|450285769|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
125181723|NCT02552121|450285762|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181724|NCT02552121|450285763|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
125181725|NCT02552121|450285764|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181726|NCT02552121|450285765|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181727|NCT02552121|450285766|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181728|NCT02552121|450285767|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181729|NCT02552121|450285768|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181730|NCT02552121|450285769|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
125181731|NCT02552121|450285762|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181732|NCT02552121|450285763|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
125181733|NCT02552121|450285764|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181734|NCT02552121|450285765|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181735|NCT02552121|450285766|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181736|NCT02552121|450285767|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181737|NCT02552121|450285768|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181738|NCT02552121|450285769|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
125181739|NCT02552121|450285762|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
125181740|NCT02552121|450285763|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
125181741|NCT02552121|450285764|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
125181742|NCT02552121|450285765|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
125181743|NCT02552121|450285766|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
125181744|NCT02552121|450285767|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
125181745|NCT02552121|450285768|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
125181746|NCT02552121|450285769|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
125181747|NCT02552121|450285762|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
125236732|NCT04666298|450493958|FG003|Overall Study|Subject decision|2|||
125236733|NCT04666298|450493955|FG000|Overall Study|Death|1|||
125236734|NCT04666298|450493956|FG001|Overall Study|Death|0|||
125236735|NCT04666298|450493957|FG002|Overall Study|Death|0|||
125236736|NCT04666298|450493958|FG003|Overall Study|Death|0|||
125181748|NCT02552121|450285763|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
125181749|NCT02552121|450285764|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
125236737|NCT04666298|450493955|FG000|Overall Study|Lost to Follow-up|0|||
125236738|NCT04666298|450493956|FG001|Overall Study|Lost to Follow-up|0|||
125181750|NCT02552121|450285765|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
125181751|NCT02552121|450285766|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
125181752|NCT02552121|450285767|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
125181753|NCT02552121|450285768|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
125181754|NCT02552121|450285769|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
125236739|NCT04666298|450493957|FG002|Overall Study|Lost to Follow-up|0|||
125236740|NCT04666298|450493958|FG003|Overall Study|Lost to Follow-up|1|||
125236741|NCT04666298|450493955|FG000|Overall Study|Physician Decision|0|||
125236742|NCT04666298|450493956|FG001|Overall Study|Physician Decision|0|||
125236743|NCT04666298|450493957|FG002|Overall Study|Physician Decision|0|||
125236744|NCT04666298|450493958|FG003|Overall Study|Physician Decision|1|||
125236745|NCT04666298|450493955|FG000|Overall Study|Protocol deviation|0|||
125236746|NCT04666298|450493956|FG001|Overall Study|Protocol deviation|0|||
125236747|NCT04666298|450493957|FG002|Overall Study|Protocol deviation|1|||
125236748|NCT04666298|450493958|FG003|Overall Study|Protocol deviation|0|||
125236749|NCT00844519|450493959|FG000|Overall Study|Withdrawal by Subject|1|||
125236750|NCT00844519|450493960|FG001|Overall Study|Withdrawal by Subject|1|||
125236751|NCT00844519|450493959|FG000|Overall Study|Adverse Event|1|||
125236752|NCT00844519|450493960|FG001|Overall Study|Adverse Event|0|||
125236753|NCT06438601|450493961|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
125236754|NCT06438601|450493962|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
125236755|NCT06438601|450493961|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
125236756|NCT06438601|450493962|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
125236757|NCT01311661|450493965|FG000|Overall Study|Adverse Event|2|||
125236758|NCT01311661|450493965|FG000|Overall Study|Protocol Violation|3|||
125236759|NCT01311661|450493965|FG000|Overall Study|Withdrawal by Subject|2|||
125236760|NCT00207740|450493966|FG000|Overall Study|Adverse Event|4|||
125236761|NCT00207740|450493967|FG001|Overall Study|Adverse Event|14|||
125236762|NCT00207740|450493968|FG002|Overall Study|Adverse Event|14|||
125236763|NCT00207740|450493969|FG003|Overall Study|Adverse Event|11|||
125236764|NCT00207740|450493966|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125236765|NCT00207740|450493967|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125236766|NCT00207740|450493968|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
125236767|NCT00207740|450493969|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
125236768|NCT00207740|450493966|FG000|Overall Study|Lost to Follow-up|0|||
125236769|NCT00207740|450493967|FG001|Overall Study|Lost to Follow-up|2|||
125236770|NCT00207740|450493968|FG002|Overall Study|Lost to Follow-up|1|||
125236771|NCT00207740|450493969|FG003|Overall Study|Lost to Follow-up|1|||
125236772|NCT00207740|450493966|FG000|Overall Study|Death|0|||
125236773|NCT00207740|450493967|FG001|Overall Study|Death|0|||
125236774|NCT00207740|450493968|FG002|Overall Study|Death|0|||
125236775|NCT00207740|450493969|FG003|Overall Study|Death|1|||
125236776|NCT00207740|450493966|FG000|Overall Study|Sponsor Directive|22|||
125236777|NCT00207740|450493967|FG001|Overall Study|Sponsor Directive|15|||
125236778|NCT00207740|450493968|FG002|Overall Study|Sponsor Directive|16|||
125236779|NCT00207740|450493969|FG003|Overall Study|Sponsor Directive|21|||
125236780|NCT00207740|450493966|FG000|Overall Study|Other|2|||
125236781|NCT00207740|450493967|FG001|Overall Study|Other|10|||
125236782|NCT00207740|450493968|FG002|Overall Study|Other|7|||
125236783|NCT00207740|450493969|FG003|Overall Study|Other|5|||
125236784|NCT00390013|450493970|FG000|Phase 1|tired|0|||
125236785|NCT00390013|450493971|FG001|Phase 1|tired|0|||
125236786|NCT00390013|450493972|FG002|Phase 1|tired|0|||
125236787|NCT00390013|450493973|FG003|Phase 1|tired|1|||
125236788|NCT00390013|450493970|FG000|Phase 2 First Treatment|tired|1|||
125236789|NCT00390013|450493971|FG001|Phase 2 First Treatment|tired|0|||
125236790|NCT00390013|450493972|FG002|Phase 2 First Treatment|tired|0|||
125236791|NCT00390013|450493973|FG003|Phase 2 First Treatment|tired|0|||
125236792|NCT00390013|450493970|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
125236793|NCT00390013|450493971|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
125236794|NCT00390013|450493972|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
125236795|NCT00390013|450493973|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
125236796|NCT03188822|450493976|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
125236797|NCT03188822|450493976|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
125236798|NCT01349595|450493981|FG000|Overall Study|Lack of funding|2|||
125236799|NCT01349595|450493982|FG001|Overall Study|Lack of funding|2|||
125236800|NCT04584788|450493983|FG000|Overall Study|Physician Decision|8|||
125236801|NCT04584788|450493983|FG000|Overall Study|Withdrawal by Subject|1|||
125236802|NCT04584788|450493983|FG000|Overall Study|Adverse Event|3|||
125236803|NCT00770809|450495968|FG000|Overall Study|Adverse Event|9|||
125236804|NCT00770809|450495969|FG001|Overall Study|Adverse Event|1|||
125236805|NCT00770809|450495970|FG002|Overall Study|Adverse Event|12|||
125236806|NCT00770809|450495968|FG000|Overall Study|Death|1|||
125236807|NCT00770809|450495969|FG001|Overall Study|Death|0|||
125236808|NCT00770809|450495970|FG002|Overall Study|Death|0|||
125236809|NCT00770809|450495968|FG000|Overall Study|Withdrawal by Subject|3|||
125236810|NCT00770809|450495969|FG001|Overall Study|Withdrawal by Subject|3|||
125236811|NCT00770809|450495970|FG002|Overall Study|Withdrawal by Subject|7|||
125236812|NCT00770809|450495968|FG000|Overall Study|Progression|2|||
125236813|NCT00770809|450495969|FG001|Overall Study|Progression|2|||
125236814|NCT00770809|450495970|FG002|Overall Study|Progression|0|||
125236815|NCT00770809|450495968|FG000|Overall Study|Complicating illness|0|||
125236816|NCT00770809|450495969|FG001|Overall Study|Complicating illness|0|||
125236817|NCT00770809|450495970|FG002|Overall Study|Complicating illness|1|||
125236818|NCT00770809|450495968|FG000|Overall Study|Other Medical Reasons|2|||
125236819|NCT00770809|450495969|FG001|Overall Study|Other Medical Reasons|4|||
125236820|NCT00770809|450495970|FG002|Overall Study|Other Medical Reasons|3|||
125236821|NCT03329001|450495982|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
125236822|NCT03329001|450495983|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
125236823|NCT03329001|450495984|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
125236824|NCT03329001|450495985|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
125236825|NCT03329001|450495986|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
125236826|NCT03329001|450495987|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
125236827|NCT03329001|450495988|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
125236828|NCT03329001|450495989|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
125236829|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236830|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236831|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236832|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
125236833|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236834|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236835|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236836|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
125236837|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236838|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236839|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236840|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
125236841|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236842|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236843|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236844|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
125236845|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236846|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236847|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236848|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
125236849|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236850|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236851|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236852|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
125236853|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236854|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236855|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
125236856|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236857|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236858|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236859|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236860|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
125236861|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236862|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236863|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
125236864|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236865|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236866|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236867|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236868|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
125236869|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236870|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236871|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
125443437|NCT02555371|451252131|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
125443438|NCT02555371|451252132|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
125181755|NCT02552121|450285762|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
125181756|NCT02552121|450285763|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
125181757|NCT02552121|450285764|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
125181758|NCT02552121|450285765|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
125181759|NCT02552121|450285766|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
125181760|NCT02552121|450285767|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
125181761|NCT02552121|450285768|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
125181762|NCT02552121|450285769|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
125181763|NCT02552121|450285762|FG000|Part 2: Cohort Expansion|Death|0|||
125181764|NCT02552121|450285763|FG001|Part 2: Cohort Expansion|Death|0|||
125181765|NCT02552121|450285764|FG002|Part 2: Cohort Expansion|Death|1|||
125181766|NCT02552121|450285765|FG003|Part 2: Cohort Expansion|Death|0|||
125181767|NCT02552121|450285766|FG004|Part 2: Cohort Expansion|Death|0|||
125181768|NCT02552121|450285767|FG005|Part 2: Cohort Expansion|Death|0|||
125181769|NCT02552121|450285768|FG006|Part 2: Cohort Expansion|Death|0|||
125181770|NCT02552121|450285769|FG007|Part 2: Cohort Expansion|Death|0|||
125181771|NCT03447743|450285770|FG000|Overall Study|Withdrawal by Subject|2|||
125181772|NCT03447743|450285770|FG000|Overall Study|Lost to Follow-up|3|||
125181773|NCT03447743|450285770|FG000|Overall Study|Adverse Event|1|||
125181774|NCT03447743|450285770|FG000|Overall Study|Did not meet criteria to continue|1|||
125181775|NCT02854527|450285771|FG000|Overall Study|Adverse Event|0|||
125181776|NCT02854527|450285772|FG001|Overall Study|Adverse Event|0|||
125181777|NCT02854527|450285773|FG002|Overall Study|Adverse Event|0|||
125181778|NCT02854527|450285774|FG003|Overall Study|Adverse Event|0|||
125181779|NCT02854527|450285775|FG004|Overall Study|Adverse Event|1|||
125181780|NCT02854527|450285776|FG005|Overall Study|Adverse Event|0|||
125181781|NCT02854527|450285777|FG006|Overall Study|Adverse Event|0|||
125181782|NCT02854527|450285778|FG007|Overall Study|Adverse Event|0|||
125181783|NCT02854527|450285779|FG008|Overall Study|Adverse Event|0|||
125181784|NCT02854527|450285780|FG009|Overall Study|Adverse Event|0|||
125181785|NCT02854527|450285771|FG000|Overall Study|Lost to Follow-up|0|||
125181786|NCT02854527|450285772|FG001|Overall Study|Lost to Follow-up|0|||
125181787|NCT02854527|450285773|FG002|Overall Study|Lost to Follow-up|0|||
125181788|NCT02854527|450285774|FG003|Overall Study|Lost to Follow-up|1|||
125181789|NCT02854527|450285775|FG004|Overall Study|Lost to Follow-up|0|||
125181790|NCT02854527|450285776|FG005|Overall Study|Lost to Follow-up|0|||
125181791|NCT02854527|450285777|FG006|Overall Study|Lost to Follow-up|0|||
125181792|NCT02854527|450285778|FG007|Overall Study|Lost to Follow-up|0|||
125181793|NCT02854527|450285779|FG008|Overall Study|Lost to Follow-up|0|||
125181794|NCT02854527|450285780|FG009|Overall Study|Lost to Follow-up|0|||
125181795|NCT03567980|450285781|FG000|Overall Study|Adverse Event|1|||
125181796|NCT02575833|450285783|FG000|Overall Study|Withdrawal by Subject|0|||
125181797|NCT02575833|450285784|FG001|Overall Study|Withdrawal by Subject|1|||
125181798|NCT02575833|450285783|FG000|Overall Study|Lost to Follow-up|1|||
125181799|NCT02575833|450285784|FG001|Overall Study|Lost to Follow-up|0|||
125181800|NCT03093259|450285785|FG000|Overall Study|Adverse Event|1|||
125181801|NCT03093259|450285786|FG001|Overall Study|Adverse Event|0|||
125181802|NCT03093259|450285785|FG000|Overall Study|Withdrawal by Subject|1|||
125181803|NCT03093259|450285786|FG001|Overall Study|Withdrawal by Subject|0|||
125181804|NCT01821807|450285787|FG000|Overall Study|Lost to Follow-up|3|||
125181805|NCT01821807|450285788|FG001|Overall Study|Lost to Follow-up|1|||
125181806|NCT02633787|450285790|FG000|Overall Study|Withdrawal by Subject|1|||
125181807|NCT01742897|450285791|FG000|Overall Study|Adverse Event|3|||
125181808|NCT01742897|450285791|FG000|Overall Study|Withdrawal by Subject|1|||
125181809|NCT01742897|450285791|FG000|Overall Study|Other|1|||
125181810|NCT02404805|450285792|FG000|Overall Study|Withdrawal by Subject|1|||
125181811|NCT02404805|450285793|FG001|Overall Study|Withdrawal by Subject|0|||
125181812|NCT02404805|450285794|FG002|Overall Study|Withdrawal by Subject|0|||
125181813|NCT02404805|450285795|FG003|Overall Study|Withdrawal by Subject|0|||
125181814|NCT02404805|450285796|FG004|Overall Study|Withdrawal by Subject|0|||
125181815|NCT02404805|450285797|FG005|Overall Study|Withdrawal by Subject|0|||
125181816|NCT02601014|450285799|FG000|Overall Study|Adverse Event|3|||
125181817|NCT02601014|450285800|FG001|Overall Study|Adverse Event|3|||
125181818|NCT02601014|450285799|FG000|Overall Study|Death|3|||
125181819|NCT02601014|450285800|FG001|Overall Study|Death|1|||
125181820|NCT02601014|450285799|FG000|Overall Study|Disease progression|4|||
125181821|NCT02601014|450285800|FG001|Overall Study|Disease progression|8|||
125181822|NCT01168427|450285801|FG000|Overall Study|Patient exited prior to implant|1|||
125181823|NCT02456740|450285802|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
125181824|NCT02456740|450285803|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
125181825|NCT02456740|450285804|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
125181826|NCT02456740|450285805|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
125181827|NCT02456740|450285806|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
125181828|NCT02456740|450285807|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
125181829|NCT02456740|450285808|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
125181830|NCT02456740|450285809|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
125181831|NCT02456740|450285810|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
125236872|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236873|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236874|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236875|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236876|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
125236877|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236878|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236879|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
125236880|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236881|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236882|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236883|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236884|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
125236885|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
125236886|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
125236887|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
125236888|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
125236889|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
125236890|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
125236891|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
125236892|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
125236893|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236894|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236895|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
125236896|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236897|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236898|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236899|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236900|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
125236901|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
125236902|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
125236903|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
125236904|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
125236905|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
125236906|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
125236907|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
125236908|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
125236909|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
125236910|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
125236911|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
125236912|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
125236913|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
125236914|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
125236915|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
125236916|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
125236917|NCT03329001|450495982|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
125236918|NCT03329001|450495983|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
125236919|NCT03329001|450495984|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
125236920|NCT03329001|450495985|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
125236921|NCT03329001|450495986|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
125236922|NCT03329001|450495987|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
125236923|NCT03329001|450495988|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
125236924|NCT03329001|450495989|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
125236925|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125236926|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125236927|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125236928|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
125236929|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125236930|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125236931|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125443439|NCT02555371|451252128|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
125181832|NCT02456740|450285802|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
125181833|NCT02456740|450285803|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
125181834|NCT02456740|450285804|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
125181835|NCT02456740|450285805|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
125181836|NCT02456740|450285806|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
125181837|NCT02456740|450285807|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
125181838|NCT02456740|450285808|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
125181839|NCT02456740|450285809|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
125181840|NCT02456740|450285810|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
125181841|NCT02456740|450285802|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
125181842|NCT02456740|450285803|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
125181843|NCT02456740|450285804|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
125181844|NCT02456740|450285805|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
125181845|NCT02456740|450285806|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
125181846|NCT02456740|450285807|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
125181847|NCT02456740|450285808|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
125181848|NCT02456740|450285809|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
125181849|NCT02456740|450285810|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
125181850|NCT02456740|450285802|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
125181851|NCT02456740|450285803|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
125181852|NCT02456740|450285804|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
125181853|NCT02456740|450285805|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
125181854|NCT02456740|450285806|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
125181855|NCT02456740|450285807|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
125181856|NCT02456740|450285808|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
125181857|NCT02456740|450285809|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
125181858|NCT02456740|450285810|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
125181859|NCT02456740|450285802|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
125181860|NCT02456740|450285803|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
125181861|NCT02456740|450285804|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
125181862|NCT02456740|450285805|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
125181863|NCT02456740|450285806|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
125181864|NCT02456740|450285807|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
125181865|NCT02456740|450285808|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
125181866|NCT02456740|450285809|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
125181867|NCT02456740|450285810|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
125181868|NCT02456740|450285802|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181869|NCT02456740|450285803|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181870|NCT02456740|450285804|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181871|NCT02456740|450285805|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181872|NCT02456740|450285806|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181873|NCT02456740|450285807|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181874|NCT02456740|450285808|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181875|NCT02456740|450285809|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
125181876|NCT02456740|450285810|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
125181877|NCT02456740|450285802|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125181878|NCT02456740|450285803|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125181879|NCT02456740|450285804|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125181880|NCT02456740|450285805|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
125181881|NCT02456740|450285806|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
125181882|NCT02456740|450285807|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
125181883|NCT02456740|450285808|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
125181884|NCT02456740|450285809|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
125181885|NCT02456740|450285810|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
125181886|NCT04871776|450285812|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
125443440|NCT02555371|451252129|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
125181887|NCT04871776|450285813|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
125181888|NCT04871776|450285814|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
125181889|NCT04871776|450285812|FG000|Overall Study|Did not meet eligibility criteria|1|||
125181890|NCT04871776|450285813|FG001|Overall Study|Did not meet eligibility criteria|1|||
125181891|NCT04871776|450285814|FG002|Overall Study|Did not meet eligibility criteria|1|||
125181892|NCT04075487|450287683|FG000|Overall Study|Withdrawal by Subject|1|||
125236932|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
125236933|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236934|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236935|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236936|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
125236937|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236938|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236939|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236940|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
125236941|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236942|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236943|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
125236944|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236945|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236946|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236947|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236948|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
125236949|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
125236950|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
125236951|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
125236952|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
125236953|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
125236954|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
125181893|NCT02848001|450287686|FG000|Overall Study|other reasons|0|||
125181894|NCT02848001|450287687|FG001|Overall Study|other reasons|0|||
125181895|NCT02848001|450287688|FG002|Overall Study|other reasons|1|||
125181896|NCT02848001|450287689|FG003|Overall Study|other reasons|0|||
125181897|NCT02848001|450287690|FG004|Overall Study|other reasons|4|||
125181898|NCT02848001|450287691|FG005|Overall Study|other reasons|1|||
125181899|NCT02848001|450287692|FG006|Overall Study|other reasons|0|||
125181900|NCT02848001|450287693|FG007|Overall Study|other reasons|2|||
125181901|NCT02848001|450287694|FG008|Overall Study|other reasons|2|||
125181902|NCT02848001|450287695|FG009|Overall Study|other reasons|3|||
125181903|NCT02848001|450287696|FG010|Overall Study|other reasons|0|||
125181904|NCT02848001|450287697|FG011|Overall Study|other reasons|1|||
125181905|NCT02848001|450287698|FG012|Overall Study|other reasons|1|||
125181906|NCT02848001|450287699|FG013|Overall Study|other reasons|0|||
125181907|NCT02848001|450287700|FG014|Overall Study|other reasons|0|||
125181908|NCT02848001|450287701|FG015|Overall Study|other reasons|2|||
125181909|NCT02848001|450287702|FG016|Overall Study|other reasons|1|||
125181910|NCT02848001|450287686|FG000|Overall Study|Lack of Efficacy|0|||
125181911|NCT02848001|450287687|FG001|Overall Study|Lack of Efficacy|1|||
125181912|NCT02848001|450287688|FG002|Overall Study|Lack of Efficacy|1|||
125181913|NCT02848001|450287689|FG003|Overall Study|Lack of Efficacy|2|||
125181914|NCT02848001|450287690|FG004|Overall Study|Lack of Efficacy|3|||
125181915|NCT02848001|450287691|FG005|Overall Study|Lack of Efficacy|0|||
125181916|NCT02848001|450287692|FG006|Overall Study|Lack of Efficacy|1|||
125181917|NCT02848001|450287693|FG007|Overall Study|Lack of Efficacy|0|||
125181918|NCT02848001|450287694|FG008|Overall Study|Lack of Efficacy|0|||
125181919|NCT02848001|450287695|FG009|Overall Study|Lack of Efficacy|1|||
125181920|NCT02848001|450287696|FG010|Overall Study|Lack of Efficacy|0|||
125181921|NCT02848001|450287697|FG011|Overall Study|Lack of Efficacy|2|||
125181922|NCT02848001|450287698|FG012|Overall Study|Lack of Efficacy|0|||
125181923|NCT02848001|450287699|FG013|Overall Study|Lack of Efficacy|2|||
125181924|NCT02848001|450287700|FG014|Overall Study|Lack of Efficacy|2|||
125181925|NCT02848001|450287701|FG015|Overall Study|Lack of Efficacy|0|||
125181926|NCT02848001|450287702|FG016|Overall Study|Lack of Efficacy|0|||
125181927|NCT02848001|450287686|FG000|Overall Study|Progressive Disease|2|||
125181928|NCT02848001|450287687|FG001|Overall Study|Progressive Disease|1|||
125181929|NCT02848001|450287688|FG002|Overall Study|Progressive Disease|0|||
125181930|NCT02848001|450287689|FG003|Overall Study|Progressive Disease|4|||
125181931|NCT02848001|450287690|FG004|Overall Study|Progressive Disease|3|||
125181932|NCT02848001|450287691|FG005|Overall Study|Progressive Disease|0|||
125181933|NCT02848001|450287692|FG006|Overall Study|Progressive Disease|4|||
125181934|NCT02848001|450287693|FG007|Overall Study|Progressive Disease|1|||
125181935|NCT02848001|450287694|FG008|Overall Study|Progressive Disease|0|||
125181936|NCT02848001|450287695|FG009|Overall Study|Progressive Disease|2|||
125181937|NCT02848001|450287696|FG010|Overall Study|Progressive Disease|3|||
125181938|NCT02848001|450287697|FG011|Overall Study|Progressive Disease|2|||
125181939|NCT02848001|450287698|FG012|Overall Study|Progressive Disease|1|||
125181940|NCT02848001|450287699|FG013|Overall Study|Progressive Disease|0|||
125181941|NCT02848001|450287700|FG014|Overall Study|Progressive Disease|2|||
125236955|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
125236956|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
125236957|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236958|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236959|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
125236960|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236961|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236962|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236963|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236964|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
125236965|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236966|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236967|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
125236968|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236969|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236970|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236971|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236972|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
125236973|NCT03329001|450495982|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236974|NCT03329001|450495983|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236975|NCT03329001|450495984|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236976|NCT03329001|450495985|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
125236977|NCT03329001|450495986|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236978|NCT03329001|450495987|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236979|NCT03329001|450495988|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236980|NCT03329001|450495989|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
125236981|NCT03329001|450495982|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236982|NCT03329001|450495983|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236983|NCT03329001|450495984|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236984|NCT03329001|450495985|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236985|NCT03329001|450495986|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236986|NCT03329001|450495987|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
125236987|NCT03329001|450495988|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236988|NCT03329001|450495989|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
125236989|NCT03329001|450495982|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236990|NCT03329001|450495983|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236991|NCT03329001|450495984|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236992|NCT03329001|450495985|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236993|NCT03329001|450495986|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
125236994|NCT03329001|450495987|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236995|NCT03329001|450495988|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236996|NCT03329001|450495989|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
125236997|NCT03329001|450495982|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
125236998|NCT03329001|450495983|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
125236999|NCT03329001|450495984|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
125237000|NCT03329001|450495985|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
125237001|NCT03329001|450495986|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
125237002|NCT03329001|450495987|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
125237003|NCT03329001|450495988|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
125237004|NCT03329001|450495989|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
125237005|NCT03329001|450495982|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237006|NCT03329001|450495983|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237007|NCT03329001|450495984|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237008|NCT03329001|450495985|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237009|NCT03329001|450495986|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
125237010|NCT03329001|450495987|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237011|NCT03329001|450495988|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237012|NCT03329001|450495989|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
125237013|NCT03329001|450495982|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
125237014|NCT03329001|450495983|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
125181942|NCT02848001|450287701|FG015|Overall Study|Progressive Disease|4|||
125181943|NCT02848001|450287702|FG016|Overall Study|Progressive Disease|0|||
125181944|NCT02848001|450287686|FG000|Overall Study|Adverse Event|0|||
125181945|NCT02848001|450287687|FG001|Overall Study|Adverse Event|0|||
125181946|NCT02848001|450287688|FG002|Overall Study|Adverse Event|0|||
125181947|NCT02848001|450287689|FG003|Overall Study|Adverse Event|0|||
125181948|NCT02848001|450287690|FG004|Overall Study|Adverse Event|2|||
125181949|NCT02848001|450287691|FG005|Overall Study|Adverse Event|0|||
125181950|NCT02848001|450287692|FG006|Overall Study|Adverse Event|0|||
125181951|NCT02848001|450287693|FG007|Overall Study|Adverse Event|0|||
125181952|NCT02848001|450287694|FG008|Overall Study|Adverse Event|0|||
125181953|NCT02848001|450287695|FG009|Overall Study|Adverse Event|1|||
125181954|NCT02848001|450287696|FG010|Overall Study|Adverse Event|0|||
125181955|NCT02848001|450287697|FG011|Overall Study|Adverse Event|1|||
125181956|NCT02848001|450287698|FG012|Overall Study|Adverse Event|1|||
125181957|NCT02848001|450287699|FG013|Overall Study|Adverse Event|0|||
125181958|NCT02848001|450287700|FG014|Overall Study|Adverse Event|2|||
125181959|NCT02848001|450287701|FG015|Overall Study|Adverse Event|0|||
125181960|NCT02848001|450287702|FG016|Overall Study|Adverse Event|0|||
125181961|NCT02848001|450287686|FG000|Overall Study|Death|0|||
125181962|NCT02848001|450287687|FG001|Overall Study|Death|0|||
125181963|NCT02848001|450287688|FG002|Overall Study|Death|0|||
125181964|NCT02848001|450287689|FG003|Overall Study|Death|1|||
125181965|NCT02848001|450287690|FG004|Overall Study|Death|3|||
125181966|NCT02848001|450287691|FG005|Overall Study|Death|1|||
125181967|NCT02848001|450287692|FG006|Overall Study|Death|2|||
125181968|NCT02848001|450287693|FG007|Overall Study|Death|3|||
125181969|NCT02848001|450287694|FG008|Overall Study|Death|4|||
125181970|NCT02848001|450287695|FG009|Overall Study|Death|1|||
125181971|NCT02848001|450287696|FG010|Overall Study|Death|0|||
125181972|NCT02848001|450287697|FG011|Overall Study|Death|1|||
125181973|NCT02848001|450287698|FG012|Overall Study|Death|3|||
125181974|NCT02848001|450287699|FG013|Overall Study|Death|0|||
125181975|NCT02848001|450287700|FG014|Overall Study|Death|2|||
125181976|NCT02848001|450287701|FG015|Overall Study|Death|3|||
125181977|NCT02848001|450287702|FG016|Overall Study|Death|0|||
125181978|NCT02848001|450287686|FG000|Overall Study|Physician Decision|0|||
125181979|NCT02848001|450287687|FG001|Overall Study|Physician Decision|0|||
125181980|NCT02848001|450287688|FG002|Overall Study|Physician Decision|0|||
125181981|NCT02848001|450287689|FG003|Overall Study|Physician Decision|0|||
125181982|NCT02848001|450287690|FG004|Overall Study|Physician Decision|0|||
125181983|NCT02848001|450287691|FG005|Overall Study|Physician Decision|0|||
125181984|NCT02848001|450287692|FG006|Overall Study|Physician Decision|0|||
125181985|NCT02848001|450287693|FG007|Overall Study|Physician Decision|0|||
125181986|NCT02848001|450287694|FG008|Overall Study|Physician Decision|1|||
125181987|NCT02848001|450287695|FG009|Overall Study|Physician Decision|1|||
125181988|NCT02848001|450287696|FG010|Overall Study|Physician Decision|0|||
125181989|NCT02848001|450287697|FG011|Overall Study|Physician Decision|0|||
125181990|NCT02848001|450287698|FG012|Overall Study|Physician Decision|2|||
125181991|NCT02848001|450287699|FG013|Overall Study|Physician Decision|0|||
125181992|NCT02848001|450287700|FG014|Overall Study|Physician Decision|0|||
125181993|NCT02848001|450287701|FG015|Overall Study|Physician Decision|0|||
125181994|NCT02848001|450287702|FG016|Overall Study|Physician Decision|0|||
125181995|NCT02848001|450287686|FG000|Overall Study|Withdrawal by Subject|0|||
125181996|NCT02848001|450287687|FG001|Overall Study|Withdrawal by Subject|0|||
125181997|NCT02848001|450287688|FG002|Overall Study|Withdrawal by Subject|0|||
125181998|NCT02848001|450287689|FG003|Overall Study|Withdrawal by Subject|0|||
125181999|NCT02848001|450287690|FG004|Overall Study|Withdrawal by Subject|0|||
125182000|NCT02848001|450287691|FG005|Overall Study|Withdrawal by Subject|1|||
125303081|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
125182001|NCT02848001|450287692|FG006|Overall Study|Withdrawal by Subject|1|||
125182002|NCT02848001|450287693|FG007|Overall Study|Withdrawal by Subject|1|||
125182003|NCT02848001|450287694|FG008|Overall Study|Withdrawal by Subject|0|||
125182004|NCT02848001|450287695|FG009|Overall Study|Withdrawal by Subject|0|||
125182005|NCT02848001|450287696|FG010|Overall Study|Withdrawal by Subject|0|||
125182006|NCT02848001|450287697|FG011|Overall Study|Withdrawal by Subject|0|||
125182007|NCT02848001|450287698|FG012|Overall Study|Withdrawal by Subject|0|||
125182008|NCT02848001|450287699|FG013|Overall Study|Withdrawal by Subject|0|||
125182009|NCT02848001|450287700|FG014|Overall Study|Withdrawal by Subject|0|||
125182010|NCT02848001|450287701|FG015|Overall Study|Withdrawal by Subject|0|||
125182011|NCT02848001|450287702|FG016|Overall Study|Withdrawal by Subject|0|||
125182012|NCT00725283|450287705|FG000|Overall Study|Missing Code|3|||
125182013|NCT00725283|450287705|FG000|Overall Study|Death|5|||
125182014|NCT00725283|450287705|FG000|Overall Study|Other|6|||
125182015|NCT00725283|450287705|FG000|Overall Study|Withdrawal by Subject|10|||
125182016|NCT02115269|450287706|FG000|Overall Study|Lost to Follow-up|43|||
125182017|NCT02115269|450287706|FG000|Overall Study|Did not complete patient diary|3|||
125182018|NCT02115269|450287706|FG000|Overall Study|Moved to another city|7|||
125182019|NCT02115269|450287706|FG000|Overall Study|Withdrawal by Subject|2|||
125182020|NCT02115269|450287706|FG000|Overall Study|Didn't take study drug|2|||
125182021|NCT01402570|450287707|FG000|Overall Study|Adverse Event|1|||
125237015|NCT03329001|450495984|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
125237016|NCT03329001|450495985|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
125237017|NCT03329001|450495986|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
125237018|NCT03329001|450495987|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
125237019|NCT03329001|450495988|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
125237020|NCT03329001|450495989|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
125237021|NCT03329001|450495982|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
125237022|NCT03329001|450495983|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
125237023|NCT03329001|450495984|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
125237024|NCT03329001|450495985|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
125237025|NCT03329001|450495986|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
125237026|NCT03329001|450495987|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
125237027|NCT03329001|450495988|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
125237028|NCT03329001|450495989|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
125237029|NCT03329001|450495982|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237030|NCT03329001|450495983|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237031|NCT03329001|450495984|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237032|NCT03329001|450495985|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237033|NCT03329001|450495986|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237034|NCT03329001|450495987|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237035|NCT03329001|450495988|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
125237036|NCT03329001|450495989|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
125237037|NCT03329001|450495982|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
125237038|NCT03329001|450495983|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
125237039|NCT03329001|450495984|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
125237040|NCT03329001|450495985|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
125237041|NCT03329001|450495986|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
125237042|NCT03329001|450495987|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
125237043|NCT03329001|450495988|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
125237044|NCT03329001|450495989|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
125237045|NCT03329001|450495982|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
125237046|NCT03329001|450495983|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
125237047|NCT03329001|450495984|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
125237048|NCT03329001|450495985|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
125237049|NCT03329001|450495986|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
125237050|NCT03329001|450495987|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
125237051|NCT03329001|450495988|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
125237052|NCT03329001|450495989|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
125237053|NCT02178956|450495990|FG000|Overall Study|Lost to Follow-up|4|||
125237054|NCT02178956|450495991|FG001|Overall Study|Lost to Follow-up|4|||
125237055|NCT02178956|450495990|FG000|Overall Study|Sponsor terminated study|49|||
125237056|NCT02178956|450495991|FG001|Overall Study|Sponsor terminated study|58|||
125237057|NCT02178956|450495990|FG000|Overall Study|Withdrawal by Subject|15|||
125237058|NCT02178956|450495991|FG001|Overall Study|Withdrawal by Subject|11|||
125237059|NCT02178956|450495990|FG000|Overall Study|Various Reasons|3|||
125237060|NCT02178956|450495991|FG001|Overall Study|Various Reasons|5|||
125237061|NCT01138046|450495992|FG000|Overall Study|Withdrawal due to death|6|||
125237062|NCT02709369|450495994|FG000|Overall Study|Lost to Follow-up|15|||
125237063|NCT02709369|450495994|FG000|Overall Study|Withdrawal by Subject|10|||
125237064|NCT02709369|450495994|FG000|Overall Study|Did not received intervention|2|||
125237065|NCT01900314|450495995|FG000|Overall Study|Lost to Follow-up|1|||
125237066|NCT01900314|450495996|FG001|Overall Study|Lost to Follow-up|0|||
125237067|NCT01900314|450495995|FG000|Overall Study|Protocol Violation|0|||
125237068|NCT01900314|450495996|FG001|Overall Study|Protocol Violation|1|||
125237069|NCT01900314|450495995|FG000|Overall Study|Withdrawal by Subject|3|||
125237070|NCT01900314|450495996|FG001|Overall Study|Withdrawal by Subject|3|||
125237071|NCT01104766|450495998|FG000|Overall Study|Did not meet inc/exc criteria|1|||
125237072|NCT01104766|450495999|FG001|Overall Study|Did not meet inc/exc criteria|0|||
125237073|NCT01104766|450496000|FG002|Overall Study|Did not meet inc/exc criteria|0|||
125237074|NCT01104766|450496001|FG003|Overall Study|Did not meet inc/exc criteria|0|||
125237075|NCT01104766|450495998|FG000|Overall Study|Adverse Event|17|||
125237076|NCT01104766|450495999|FG001|Overall Study|Adverse Event|15|||
125237077|NCT01104766|450496000|FG002|Overall Study|Adverse Event|20|||
125237078|NCT01104766|450496001|FG003|Overall Study|Adverse Event|14|||
125237079|NCT01104766|450495998|FG000|Overall Study|Lack of Efficacy|20|||
125237080|NCT01104766|450495999|FG001|Overall Study|Lack of Efficacy|15|||
125237081|NCT01104766|450496000|FG002|Overall Study|Lack of Efficacy|14|||
125237082|NCT01104766|450496001|FG003|Overall Study|Lack of Efficacy|8|||
125237083|NCT01104766|450495998|FG000|Overall Study|Protocol Violation|2|||
125237084|NCT01104766|450495999|FG001|Overall Study|Protocol Violation|0|||
125237085|NCT01104766|450496000|FG002|Overall Study|Protocol Violation|0|||
125237086|NCT01104766|450496001|FG003|Overall Study|Protocol Violation|0|||
125237087|NCT01104766|450495998|FG000|Overall Study|Withdrawal by Subject|17|||
125237088|NCT01104766|450495999|FG001|Overall Study|Withdrawal by Subject|19|||
125237089|NCT01104766|450496000|FG002|Overall Study|Withdrawal by Subject|25|||
125237090|NCT01104766|450496001|FG003|Overall Study|Withdrawal by Subject|15|||
125237091|NCT01104766|450495998|FG000|Overall Study|Lost to Follow-up|1|||
125237092|NCT01104766|450495999|FG001|Overall Study|Lost to Follow-up|2|||
125237093|NCT01104766|450496000|FG002|Overall Study|Lost to Follow-up|1|||
125237094|NCT01104766|450496001|FG003|Overall Study|Lost to Follow-up|1|||
125237095|NCT01341470|450496002|FG000|Overall Study|Sponsor decision|0|||
125237096|NCT01341470|450496003|FG001|Overall Study|Sponsor decision|0|||
125237097|NCT01341470|450496004|FG002|Overall Study|Sponsor decision|1|||
125237098|NCT01341470|450496005|FG003|Overall Study|Sponsor decision|1|||
125237099|NCT01341470|450496006|FG004|Overall Study|Sponsor decision|0|||
125237100|NCT01341470|450496007|FG005|Overall Study|Sponsor decision|1|||
125237101|NCT04225832|450496009|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
125237102|NCT04225832|450496010|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
125237103|NCT04225832|450496009|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
125237104|NCT04225832|450496010|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
125237105|NCT00311168|450496011|FG000|First Intervention|Withdrawal by Subject|2|||
125237106|NCT00311168|450496012|FG001|First Intervention|Withdrawal by Subject|2|||
125237107|NCT00311168|450496011|FG000|First Intervention|Lost to Follow-up|1|||
125237108|NCT00311168|450496012|FG001|First Intervention|Lost to Follow-up|1|||
125237109|NCT00311168|450496011|FG000|First Intervention|Protocol Violation|1|||
125237110|NCT00311168|450496012|FG001|First Intervention|Protocol Violation|1|||
125237111|NCT00311168|450496011|FG000|First Intervention|Adverse Event|1|||
125237112|NCT00311168|450496012|FG001|First Intervention|Adverse Event|0|||
125237113|NCT00311168|450496011|FG000|First Intervention|Other|2|||
125237114|NCT00311168|450496012|FG001|First Intervention|Other|2|||
125237115|NCT00311168|450496011|FG000|Second Intervention|Lost to Follow-up|9|||
125237116|NCT00311168|450496012|FG001|Second Intervention|Lost to Follow-up|2|||
125237117|NCT00311168|450496011|FG000|Second Intervention|Withdrawal by Subject|0|||
125237118|NCT00311168|450496012|FG001|Second Intervention|Withdrawal by Subject|1|||
125237119|NCT00311168|450496011|FG000|Second Intervention|Other|1|||
125237120|NCT00311168|450496012|FG001|Second Intervention|Other|1|||
125237121|NCT03965923|450496015|FG000|Overall Study|Withdrawal by Subject|1|||
125237122|NCT03965923|450496016|FG001|Overall Study|Withdrawal by Subject|2|||
125237123|NCT03965923|450496017|FG002|Overall Study|Withdrawal by Subject|3|||
125237124|NCT03965923|450496018|FG003|Overall Study|Withdrawal by Subject|1|||
125237125|NCT03965923|450496019|FG004|Overall Study|Withdrawal by Subject|2|||
125237126|NCT03965923|450496020|FG005|Overall Study|Withdrawal by Subject|0|||
125237127|NCT03965923|450496021|FG006|Overall Study|Withdrawal by Subject|4|||
125237128|NCT03965923|450496022|FG007|Overall Study|Withdrawal by Subject|3|||
125237129|NCT03965923|450496023|FG008|Overall Study|Withdrawal by Subject|4|||
125237130|NCT03965923|450496024|FG009|Overall Study|Withdrawal by Subject|0|||
125237131|NCT03965923|450496025|FG010|Overall Study|Withdrawal by Subject|2|||
125237132|NCT03965923|450496026|FG011|Overall Study|Withdrawal by Subject|0|||
125237133|NCT03965923|450496015|FG000|Overall Study|Lost to Follow-up|2|||
125237134|NCT03965923|450496016|FG001|Overall Study|Lost to Follow-up|1|||
125237135|NCT03965923|450496017|FG002|Overall Study|Lost to Follow-up|1|||
125237136|NCT03965923|450496018|FG003|Overall Study|Lost to Follow-up|0|||
125237137|NCT03965923|450496019|FG004|Overall Study|Lost to Follow-up|2|||
125237138|NCT03965923|450496020|FG005|Overall Study|Lost to Follow-up|1|||
125237139|NCT03965923|450496021|FG006|Overall Study|Lost to Follow-up|2|||
125237140|NCT03965923|450496022|FG007|Overall Study|Lost to Follow-up|1|||
125237141|NCT03965923|450496023|FG008|Overall Study|Lost to Follow-up|0|||
125237142|NCT03965923|450496024|FG009|Overall Study|Lost to Follow-up|2|||
125237143|NCT03965923|450496025|FG010|Overall Study|Lost to Follow-up|0|||
125237144|NCT03965923|450496026|FG011|Overall Study|Lost to Follow-up|0|||
125237145|NCT03965923|450496015|FG000|Overall Study|Death|0|||
125237146|NCT03965923|450496016|FG001|Overall Study|Death|0|||
125237147|NCT03965923|450496017|FG002|Overall Study|Death|0|||
125237148|NCT03965923|450496018|FG003|Overall Study|Death|0|||
125237149|NCT03965923|450496019|FG004|Overall Study|Death|0|||
125237150|NCT03965923|450496020|FG005|Overall Study|Death|0|||
125237151|NCT03965923|450496021|FG006|Overall Study|Death|0|||
125237152|NCT03965923|450496022|FG007|Overall Study|Death|1|||
125237153|NCT03965923|450496023|FG008|Overall Study|Death|4|||
125237154|NCT03965923|450496024|FG009|Overall Study|Death|0|||
125237155|NCT03965923|450496025|FG010|Overall Study|Death|4|||
125237156|NCT03965923|450496026|FG011|Overall Study|Death|0|||
125237157|NCT03965923|450496015|FG000|Overall Study|Other reason|0|||
125237158|NCT03965923|450496016|FG001|Overall Study|Other reason|0|||
125237159|NCT03965923|450496017|FG002|Overall Study|Other reason|0|||
125237160|NCT03965923|450496018|FG003|Overall Study|Other reason|1|||
125182022|NCT04179838|450287714|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
125182023|NCT04179838|450287715|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
125182024|NCT04179838|450287714|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
125182025|NCT04179838|450287715|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
125182026|NCT01290068|450287720|FG000|Overall Study|Adverse Event|1|||
125182027|NCT01290068|450287721|FG001|Overall Study|Adverse Event|3|||
125182028|NCT01290068|450287720|FG000|Overall Study|Lost to Follow-up|3|||
125182029|NCT01290068|450287721|FG001|Overall Study|Lost to Follow-up|0|||
125182030|NCT01290068|450287720|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
125182031|NCT01290068|450287721|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
125182032|NCT01290068|450287720|FG000|Overall Study|Other|3|||
125182033|NCT01290068|450287721|FG001|Overall Study|Other|1|||
125182034|NCT00513695|450287722|FG000|Overall Study|Discontinued therapy|2|||
125182035|NCT00513695|450287722|FG000|Overall Study|Progression prior to surgery|3|||
125182036|NCT01417156|450287728|FG000|Overall Study|Adverse Event|12|||
125182037|NCT01417156|450287728|FG000|Overall Study|Protocol Violation|2|||
125182038|NCT00818766|450287729|FG000|Overall Study|Could not be Contacted on Day 28|11|||
125182039|NCT00818766|450287730|FG001|Overall Study|Could not be Contacted on Day 28|10|||
125182040|NCT00818766|450287729|FG000|Overall Study|Death|1|||
125182041|NCT00818766|450287730|FG001|Overall Study|Death|0|||
125182042|NCT00818766|450287729|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
125182043|NCT00818766|450287730|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
125182044|NCT01996241|450287731|FG000|Overall Study|Lost to Follow-up|252|||
125182045|NCT01996241|450287732|FG001|Overall Study|Lost to Follow-up|235|||
125182046|NCT00086684|450287733|FG000|Overall Study|Adverse Event|12|||
125182047|NCT00086684|450287734|FG001|Overall Study|Adverse Event|17|||
125182048|NCT00086684|450287735|FG002|Overall Study|Adverse Event|14|||
125182049|NCT00086684|450287733|FG000|Overall Study|Lack of Efficacy|6|||
125182050|NCT00086684|450287734|FG001|Overall Study|Lack of Efficacy|6|||
125182051|NCT00086684|450287735|FG002|Overall Study|Lack of Efficacy|5|||
125182052|NCT00086684|450287733|FG000|Overall Study|Lost to Follow-up|15|||
125182053|NCT00086684|450287734|FG001|Overall Study|Lost to Follow-up|8|||
125182054|NCT00086684|450287735|FG002|Overall Study|Lost to Follow-up|10|||
125182055|NCT00086684|450287733|FG000|Overall Study|Protocol Violation|8|||
125182056|NCT00086684|450287734|FG001|Overall Study|Protocol Violation|3|||
125182057|NCT00086684|450287735|FG002|Overall Study|Protocol Violation|0|||
125182058|NCT00086684|450287733|FG000|Overall Study|Withdrawal by Subject|0|||
125182059|NCT00086684|450287734|FG001|Overall Study|Withdrawal by Subject|4|||
125182060|NCT00086684|450287735|FG002|Overall Study|Withdrawal by Subject|10|||
125182061|NCT00086684|450287733|FG000|Overall Study|NONCOMPLIANCE|5|||
125182062|NCT00086684|450287734|FG001|Overall Study|NONCOMPLIANCE|7|||
125182063|NCT00086684|450287735|FG002|Overall Study|NONCOMPLIANCE|6|||
125182064|NCT00086684|450287733|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125182065|NCT00086684|450287734|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
125182066|NCT00086684|450287735|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
125182067|NCT00086684|450287733|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
125182068|NCT00086684|450287734|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
125182069|NCT00086684|450287735|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
125182070|NCT00086684|450287733|FG000|Overall Study|Other|4|||
125182071|NCT00086684|450287734|FG001|Overall Study|Other|2|||
125182072|NCT00086684|450287735|FG002|Overall Study|Other|3|||
125182073|NCT04515147|450287737|FG000|Overall Study|Withdrawal by Subject|1|||
125182074|NCT04515147|450287738|FG001|Overall Study|Withdrawal by Subject|0|||
125182075|NCT04515147|450287739|FG002|Overall Study|Withdrawal by Subject|10|||
125182076|NCT04515147|450287740|FG003|Overall Study|Withdrawal by Subject|18|||
125182077|NCT04515147|450287741|FG004|Overall Study|Withdrawal by Subject|1|||
125182078|NCT04515147|450287742|FG005|Overall Study|Withdrawal by Subject|8|||
125182079|NCT04515147|450287737|FG000|Overall Study|Lost to Follow-up|0|||
125182080|NCT04515147|450287738|FG001|Overall Study|Lost to Follow-up|1|||
125182081|NCT04515147|450287739|FG002|Overall Study|Lost to Follow-up|5|||
125182082|NCT04515147|450287740|FG003|Overall Study|Lost to Follow-up|6|||
125182083|NCT04515147|450287741|FG004|Overall Study|Lost to Follow-up|2|||
125182084|NCT04515147|450287742|FG005|Overall Study|Lost to Follow-up|1|||
125182085|NCT04515147|450287737|FG000|Overall Study|Adverse Event|0|||
125182086|NCT04515147|450287738|FG001|Overall Study|Adverse Event|0|||
125182087|NCT04515147|450287739|FG002|Overall Study|Adverse Event|0|||
125237161|NCT03965923|450496019|FG004|Overall Study|Other reason|0|||
125182088|NCT04515147|450287740|FG003|Overall Study|Adverse Event|2|||
125182089|NCT04515147|450287741|FG004|Overall Study|Adverse Event|0|||
125182090|NCT04515147|450287742|FG005|Overall Study|Adverse Event|0|||
125182091|NCT04515147|450287737|FG000|Overall Study|Miscellaneous|0|||
125182092|NCT04515147|450287738|FG001|Overall Study|Miscellaneous|0|||
125182093|NCT04515147|450287739|FG002|Overall Study|Miscellaneous|0|||
125182094|NCT04515147|450287740|FG003|Overall Study|Miscellaneous|1|||
125182095|NCT04515147|450287741|FG004|Overall Study|Miscellaneous|0|||
125182096|NCT04515147|450287742|FG005|Overall Study|Miscellaneous|1|||
125182097|NCT02094300|450287743|FG000|Overall Study|Death|7|||
125182098|NCT02094300|450287743|FG000|Overall Study|Lost to Follow-up|10|||
125237162|NCT03965923|450496020|FG005|Overall Study|Other reason|0|||
125237163|NCT03965923|450496021|FG006|Overall Study|Other reason|0|||
125237164|NCT03965923|450496022|FG007|Overall Study|Other reason|0|||
125237165|NCT03965923|450496023|FG008|Overall Study|Other reason|0|||
125237166|NCT03965923|450496024|FG009|Overall Study|Other reason|0|||
125237167|NCT03965923|450496025|FG010|Overall Study|Other reason|2|||
125237168|NCT03965923|450496026|FG011|Overall Study|Other reason|0|||
125237169|NCT03282097|450496027|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
125237170|NCT03282097|450496028|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
125237171|NCT03282097|450496027|FG000|Intervention Visit Complete|Patient Death|13|||
125237172|NCT03282097|450496028|FG001|Intervention Visit Complete|Patient Death|15|||
125237173|NCT03282097|450496027|FG000|Intervention Visit Complete|Caregiver Death|0|||
125237174|NCT03282097|450496028|FG001|Intervention Visit Complete|Caregiver Death|3|||
125237175|NCT03282097|450496027|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
125237176|NCT03282097|450496028|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
125237177|NCT03282097|450496027|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
125237178|NCT03282097|450496028|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
125237179|NCT03282097|450496027|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
125237180|NCT03282097|450496028|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
125237181|NCT03282097|450496027|FG000|Primary Outcome Data Collection Complete|Missing|2|||
125237182|NCT03282097|450496028|FG001|Primary Outcome Data Collection Complete|Missing|3|||
125237183|NCT03282097|450496027|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
125237184|NCT03282097|450496028|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
125237185|NCT03282097|450496027|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
125237186|NCT03282097|450496028|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
125237187|NCT03282097|450496027|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
125237188|NCT03282097|450496028|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
125237189|NCT06001021|450496032|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
125237190|NCT06001021|450496033|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
125237191|NCT06001021|450496034|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
125237192|NCT06001021|450496035|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
125237193|NCT06001021|450496036|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
125237194|NCT06001021|450496037|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
125237195|NCT06001021|450496038|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
125237196|NCT06001021|450496032|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
125237197|NCT06001021|450496033|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
125237198|NCT06001021|450496034|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
125237199|NCT06001021|450496035|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
125237200|NCT06001021|450496036|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
125237201|NCT06001021|450496037|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
125237202|NCT06001021|450496038|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
125237203|NCT02755090|450496039|FG000|Overall Study|equipment malfunction|1|||
125237204|NCT02755090|450496040|FG001|Overall Study|equipment malfunction|0|||
125237205|NCT04797169|450496042|FG000|Overall Study|Lost to Follow-up|84|||
125237206|NCT04797169|450496043|FG001|Overall Study|Lost to Follow-up|67|||
125237207|NCT04797169|450496042|FG000|Overall Study|Pregnancy|1|||
125237208|NCT04797169|450496043|FG001|Overall Study|Pregnancy|3|||
125237209|NCT04797169|450496042|FG000|Overall Study|Withdrawal by Subject|27|||
125237210|NCT04797169|450496043|FG001|Overall Study|Withdrawal by Subject|35|||
125237211|NCT03839641|450496052|FG000|Overall Study|Withdrawal by Subject|1|||
125443441|NCT02555371|451252130|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
125182099|NCT02094300|450287743|FG000|Overall Study|Still be eligible for follow-up|3|||
125182100|NCT00942357|450287763|FG000|Overall Study|Ineligible|37|||
125182101|NCT00942357|450287764|FG001|Overall Study|Ineligible|40|||
125182102|NCT01960257|450287767|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
125182103|NCT01960257|450287768|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
125182104|NCT01960257|450287769|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
125182105|NCT01960257|450287767|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
125182106|NCT01960257|450287768|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
125182107|NCT01960257|450287769|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
125237212|NCT03839641|450496053|FG001|Overall Study|Withdrawal by Subject|1|||
125237213|NCT04221490|450496054|FG000|At 30 Days Follow-up|Death|7|||
125237214|NCT04221490|450496054|FG000|At 30 Days Follow-up|Missed Visit|4|||
125237215|NCT04221490|450496054|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
125237216|NCT04221490|450496054|FG000|At 6 Months Follow-up|Death|9|||
125237217|NCT04221490|450496054|FG000|At 6 Months Follow-up|Physician Decision|1|||
125237218|NCT04221490|450496054|FG000|At 6 Months Follow-up|Missed Visit|8|||
125182108|NCT01960257|450287767|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
125182109|NCT01960257|450287768|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
125182110|NCT01960257|450287769|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
125182111|NCT02002221|450287772|FG000|Overall Study|Adverse Event|2|||
125237219|NCT04221490|450496054|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
125237220|NCT03034967|450496055|FG000|Overall Study|Withdrawal by Subject|9|||
125237221|NCT03034967|450496056|FG001|Overall Study|Withdrawal by Subject|2|||
125237222|NCT03034967|450496057|FG002|Overall Study|Withdrawal by Subject|6|||
125237223|NCT03034967|450496058|FG003|Overall Study|Withdrawal by Subject|6|||
125237224|NCT03034967|450496059|FG004|Overall Study|Withdrawal by Subject|9|||
125237225|NCT03034967|450496060|FG005|Overall Study|Withdrawal by Subject|2|||
125237226|NCT03034967|450496055|FG000|Overall Study|Physician Decision|1|||
125237227|NCT03034967|450496056|FG001|Overall Study|Physician Decision|0|||
125237228|NCT03034967|450496057|FG002|Overall Study|Physician Decision|1|||
125237229|NCT03034967|450496058|FG003|Overall Study|Physician Decision|1|||
125237230|NCT03034967|450496059|FG004|Overall Study|Physician Decision|1|||
125237231|NCT03034967|450496060|FG005|Overall Study|Physician Decision|0|||
125237232|NCT03034967|450496055|FG000|Overall Study|Lost to Follow-up|0|||
125237233|NCT03034967|450496056|FG001|Overall Study|Lost to Follow-up|0|||
125237234|NCT03034967|450496057|FG002|Overall Study|Lost to Follow-up|0|||
125237235|NCT03034967|450496058|FG003|Overall Study|Lost to Follow-up|1|||
125237236|NCT03034967|450496059|FG004|Overall Study|Lost to Follow-up|0|||
125237237|NCT03034967|450496060|FG005|Overall Study|Lost to Follow-up|2|||
125237238|NCT03034967|450496055|FG000|Overall Study|Liver function test abnormality|0|||
125237239|NCT03034967|450496056|FG001|Overall Study|Liver function test abnormality|0|||
125237240|NCT03034967|450496057|FG002|Overall Study|Liver function test abnormality|1|||
125237241|NCT03034967|450496058|FG003|Overall Study|Liver function test abnormality|0|||
125237242|NCT03034967|450496059|FG004|Overall Study|Liver function test abnormality|0|||
125237243|NCT03034967|450496060|FG005|Overall Study|Liver function test abnormality|0|||
125237244|NCT03034967|450496055|FG000|Overall Study|Protocol Violation|1|||
125237245|NCT03034967|450496056|FG001|Overall Study|Protocol Violation|0|||
125237246|NCT03034967|450496057|FG002|Overall Study|Protocol Violation|0|||
125182112|NCT02002221|450287773|FG001|Overall Study|Adverse Event|1|||
125182113|NCT02002221|450287772|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125182114|NCT02002221|450287773|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125182115|NCT02002221|450287772|FG000|Overall Study|Patient withdrew consent|0|||
125182116|NCT02002221|450287773|FG001|Overall Study|Patient withdrew consent|1|||
125182117|NCT03347110|450287774|FG000|Overall Study|Other (Participant is incarcerated)|1|||
125182118|NCT03347110|450287774|FG000|Overall Study|Withdrawal by Subject|9|||
125182119|NCT03347110|450287774|FG000|Overall Study|Lost to Follow-up|1|||
125182120|NCT03347110|450287774|FG000|Overall Study|Lack of Efficacy|2|||
125182121|NCT03347110|450287774|FG000|Overall Study|Adverse Event, non-fatal|9|||
125182122|NCT01518322|450287775|FG000|Overall Study|FeNO measurement was missing|13|||
125182123|NCT00110396|450287780|FG000|Overall Study|Adverse Event|15|||
125182124|NCT00110396|450287780|FG000|Overall Study|Lost to Follow-up|1|||
125182125|NCT00110396|450287780|FG000|Overall Study|Administration of plasmapheresis|1|||
125182126|NCT00110396|450287780|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
125182127|NCT00110396|450287780|FG000|Overall Study|Lack of Efficacy|1|||
125182128|NCT00110396|450287780|FG000|Overall Study|Decided not to continue treatment|1|||
125182129|NCT00110396|450287780|FG000|Overall Study|Patient non-compliance|1|||
125182130|NCT00110396|450287780|FG000|Overall Study|Patient refused to continue|1|||
125182131|NCT00110396|450287780|FG000|Overall Study|Patient refused to participate|1|||
125182132|NCT00110396|450287780|FG000|Overall Study|Patient will|1|||
125182133|NCT00110396|450287780|FG000|Overall Study|Patient's decision|1|||
125182134|NCT00110396|450287780|FG000|Overall Study|Participation in MS vaccine study|1|||
125182135|NCT00110396|450287780|FG000|Overall Study|Pregnancy|1|||
125182136|NCT00110396|450287780|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
125182137|NCT00110396|450287780|FG000|Overall Study|Protocol Violation|2|||
125182138|NCT00110396|450287780|FG000|Overall Study|Patient refused to come back|1|||
125182139|NCT00110396|450287780|FG000|Overall Study|The patient has refused|2|||
125182140|NCT00110396|450287780|FG000|Overall Study|The patient has refused to visit site|1|||
125182141|NCT00110396|450287780|FG000|Overall Study|Patient is to be administered copaxone|1|||
125182142|NCT00882518|450287781|FG000|Overall Study|Adverse Event|9|||
125237247|NCT03034967|450496058|FG003|Overall Study|Protocol Violation|0|||
125237248|NCT03034967|450496059|FG004|Overall Study|Protocol Violation|0|||
125182143|NCT00882518|450287782|FG001|Overall Study|Adverse Event|18|||
125182144|NCT00882518|450287781|FG000|Overall Study|Withdrawal by Subject|9|||
125237249|NCT03034967|450496060|FG005|Overall Study|Protocol Violation|2|||
125237250|NCT03034967|450496055|FG000|Overall Study|Lack of Efficacy|0|||
125237251|NCT03034967|450496056|FG001|Overall Study|Lack of Efficacy|1|||
125237252|NCT03034967|450496057|FG002|Overall Study|Lack of Efficacy|2|||
125237253|NCT03034967|450496058|FG003|Overall Study|Lack of Efficacy|1|||
125237254|NCT03034967|450496059|FG004|Overall Study|Lack of Efficacy|1|||
125237255|NCT03034967|450496060|FG005|Overall Study|Lack of Efficacy|0|||
125182145|NCT00882518|450287782|FG001|Overall Study|Withdrawal by Subject|13|||
125182146|NCT00882518|450287781|FG000|Overall Study|Lack of Efficacy|12|||
125182147|NCT00882518|450287782|FG001|Overall Study|Lack of Efficacy|9|||
125182148|NCT00882518|450287781|FG000|Overall Study|Severe non-compliance to protocol|3|||
125182149|NCT00882518|450287782|FG001|Overall Study|Severe non-compliance to protocol|1|||
125237256|NCT03034967|450496055|FG000|Overall Study|Adverse Event, non-fatal|3|||
125237257|NCT03034967|450496056|FG001|Overall Study|Adverse Event, non-fatal|1|||
125237258|NCT03034967|450496057|FG002|Overall Study|Adverse Event, non-fatal|2|||
125237259|NCT03034967|450496058|FG003|Overall Study|Adverse Event, non-fatal|0|||
125237260|NCT03034967|450496059|FG004|Overall Study|Adverse Event, non-fatal|2|||
125237261|NCT03034967|450496060|FG005|Overall Study|Adverse Event, non-fatal|8|||
125237262|NCT03034967|450496055|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
125237263|NCT03034967|450496056|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
125237264|NCT03034967|450496057|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
125237265|NCT03034967|450496058|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
125237266|NCT03034967|450496059|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
125237267|NCT03034967|450496060|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
125237268|NCT02550795|450496070|FG000|Overall Study|Physician Decision|0|||
125237269|NCT02550795|450496071|FG001|Overall Study|Physician Decision|1|||
125182150|NCT00882518|450287781|FG000|Overall Study|Incorrect enrolment|4|||
125182151|NCT00882518|450287782|FG001|Overall Study|Incorrect enrolment|2|||
125182152|NCT00882518|450287781|FG000|Overall Study|Central lab closure for National day|1|||
125182153|NCT00882518|450287782|FG001|Overall Study|Central lab closure for National day|0|||
125182154|NCT00882518|450287781|FG000|Overall Study|Allocating random number by mistake|0|||
125182155|NCT00882518|450287782|FG001|Overall Study|Allocating random number by mistake|1|||
125182156|NCT02137252|450287783|FG000|Overall Study|trial terminated early|2|||
125182157|NCT02137252|450287784|FG001|Overall Study|trial terminated early|1|||
125182158|NCT03535740|450287785|FG000|Overall Study|Death|44|||
125182159|NCT03535740|450287785|FG000|Overall Study|Lost to Follow-up|1|||
125182160|NCT03535740|450287785|FG000|Overall Study|Withdrawal by Subject|13|||
125182161|NCT03535740|450287785|FG000|Overall Study|Site terminated by Sponsor|45|||
125182162|NCT05198518|450287790|FG000|Screening Visit|Deemed unable to participate|58|||
125182163|NCT05198518|450287791|FG001|Screening Visit|Deemed unable to participate|0|||
125182164|NCT05198518|450287792|FG002|Screening Visit|Deemed unable to participate|0|||
125182165|NCT02756611|450287795|FG000|Overall Study|Death|70|||
125182166|NCT02756611|450287795|FG000|Overall Study|Withdrawal by Subject|2|||
125182167|NCT02756611|450287795|FG000|Overall Study|Lost to Follow-up|3|||
125182168|NCT02756611|450287795|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
125182169|NCT02756611|450287795|FG000|Overall Study|Other|10|||
125182170|NCT03125798|450287797|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
125182171|NCT03125798|450287798|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
125182172|NCT03125798|450287797|FG000|Overall Study|Conversion to thoracotomy|7|||
125182173|NCT03125798|450287798|FG001|Overall Study|Conversion to thoracotomy|7|||
125182174|NCT00065156|450287802|FG000|Overall Study|Adverse Event|37|||
125182175|NCT00065156|450287802|FG000|Overall Study|Lack of Efficacy|52|||
125182176|NCT00065156|450287802|FG000|Overall Study|Withdrawal by Subject|8|||
125182177|NCT00065156|450287802|FG000|Overall Study|Lost to Follow-up|1|||
125182178|NCT00065156|450287802|FG000|Overall Study|Death|11|||
125182179|NCT00065156|450287802|FG000|Overall Study|Study Closed by Sponsor|2|||
125182180|NCT00065156|450287802|FG000|Overall Study|Disease Progression|7|||
125182181|NCT00065156|450287802|FG000|Overall Study|Investigator Decision|2|||
125182182|NCT00065156|450287802|FG000|Overall Study|Non-Compliance|2|||
125182183|NCT00065156|450287802|FG000|Overall Study|Loss of Response|1|||
125182184|NCT00065156|450287802|FG000|Overall Study|Secondary Malign Disease|1|||
125182185|NCT04583735|450287803|FG000|Double-masked Treatment Period|Adverse Event|0|||
125182186|NCT04583735|450287804|FG001|Double-masked Treatment Period|Adverse Event|1|||
125182187|NCT04583735|450287803|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
125182188|NCT04583735|450287804|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
125182189|NCT04583735|450287803|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
125182190|NCT04583735|450287804|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
125182191|NCT04583735|450287803|FG000|Open-label Treatment Period|Adverse Event|1|||
125237270|NCT02550795|450496072|FG002|Overall Study|Physician Decision|0|||
125237271|NCT00879658|450496073|FG000|Overall Study|Abnormal laboratory value(s)|3|||
125182192|NCT04583735|450287804|FG001|Open-label Treatment Period|Adverse Event|1|||
125182193|NCT04583735|450287803|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
125182194|NCT04583735|450287804|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
125182195|NCT04583735|450287803|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
125182196|NCT04583735|450287804|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
125237272|NCT00879658|450496074|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125237273|NCT00879658|450496075|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125182197|NCT00124917|450287805|FG000|Overall Study|Physician Decision|3|||
125182198|NCT03518008|450287806|FG000|Period 2, Second Week of Wear|Family emergency|0|||
125182199|NCT03518008|450287807|FG001|Period 2, Second Week of Wear|Family emergency|1|||
125182200|NCT01169350|450287808|FG000|Overall Study|Physician Decision|3|||
125182201|NCT01169350|450287808|FG000|Overall Study|Lost to Follow-up|2|||
125182202|NCT00931411|450287809|FG000|First Intervention - 42 Days|Adverse Event|2|||
125182203|NCT00931411|450287810|FG001|First Intervention - 42 Days|Adverse Event|3|||
125182204|NCT00931411|450287809|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
125182205|NCT00931411|450287810|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
125237274|NCT00879658|450496076|FG003|Overall Study|Abnormal laboratory value(s)|1|||
125237275|NCT00879658|450496077|FG004|Overall Study|Abnormal laboratory value(s)|0|||
125237276|NCT00879658|450496078|FG005|Overall Study|Abnormal laboratory value(s)|0|||
125237277|NCT00879658|450496079|FG006|Overall Study|Abnormal laboratory value(s)|0|||
125237278|NCT00879658|450496073|FG000|Overall Study|Administrative problems|2|||
125237279|NCT00879658|450496074|FG001|Overall Study|Administrative problems|1|||
125237280|NCT00879658|450496075|FG002|Overall Study|Administrative problems|0|||
125237281|NCT00879658|450496076|FG003|Overall Study|Administrative problems|1|||
125237282|NCT00879658|450496077|FG004|Overall Study|Administrative problems|0|||
125237283|NCT00879658|450496078|FG005|Overall Study|Administrative problems|0|||
125237284|NCT00879658|450496079|FG006|Overall Study|Administrative problems|0|||
125237285|NCT00879658|450496073|FG000|Overall Study|Adverse Event|6|||
125237286|NCT00879658|450496074|FG001|Overall Study|Adverse Event|4|||
125237287|NCT00879658|450496075|FG002|Overall Study|Adverse Event|3|||
125237288|NCT00879658|450496076|FG003|Overall Study|Adverse Event|1|||
125237289|NCT00879658|450496077|FG004|Overall Study|Adverse Event|2|||
125237290|NCT00879658|450496078|FG005|Overall Study|Adverse Event|0|||
125237291|NCT00879658|450496079|FG006|Overall Study|Adverse Event|0|||
125237292|NCT00879658|450496073|FG000|Overall Study|Protocol Violation|1|||
125237293|NCT00879658|450496074|FG001|Overall Study|Protocol Violation|0|||
125237294|NCT00879658|450496075|FG002|Overall Study|Protocol Violation|0|||
125237295|NCT00879658|450496076|FG003|Overall Study|Protocol Violation|0|||
125237296|NCT00879658|450496077|FG004|Overall Study|Protocol Violation|0|||
125237297|NCT00879658|450496078|FG005|Overall Study|Protocol Violation|0|||
125237298|NCT00879658|450496079|FG006|Overall Study|Protocol Violation|0|||
125237299|NCT00879658|450496073|FG000|Overall Study|Withdrawal by Subject|3|||
125237300|NCT00879658|450496074|FG001|Overall Study|Withdrawal by Subject|0|||
125237301|NCT00879658|450496075|FG002|Overall Study|Withdrawal by Subject|2|||
125237302|NCT00879658|450496076|FG003|Overall Study|Withdrawal by Subject|0|||
125237303|NCT00879658|450496077|FG004|Overall Study|Withdrawal by Subject|0|||
125237304|NCT00879658|450496078|FG005|Overall Study|Withdrawal by Subject|1|||
125237305|NCT00879658|450496079|FG006|Overall Study|Withdrawal by Subject|0|||
125237306|NCT00879658|450496073|FG000|Overall Study|Lack of Efficacy|0|||
125237307|NCT00879658|450496074|FG001|Overall Study|Lack of Efficacy|0|||
125237308|NCT00879658|450496075|FG002|Overall Study|Lack of Efficacy|2|||
125237309|NCT00879658|450496076|FG003|Overall Study|Lack of Efficacy|0|||
125237310|NCT00879658|450496077|FG004|Overall Study|Lack of Efficacy|0|||
125237311|NCT00879658|450496078|FG005|Overall Study|Lack of Efficacy|0|||
125237312|NCT00879658|450496079|FG006|Overall Study|Lack of Efficacy|0|||
125237313|NCT00879658|450496073|FG000|Overall Study|misrandomized (never received study med)|0|||
125237314|NCT00879658|450496074|FG001|Overall Study|misrandomized (never received study med)|0|||
125237315|NCT00879658|450496075|FG002|Overall Study|misrandomized (never received study med)|0|||
125237316|NCT00879658|450496076|FG003|Overall Study|misrandomized (never received study med)|1|||
125182206|NCT00931411|450287809|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
125182207|NCT00931411|450287810|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
125182208|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
125182209|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
125182210|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
125182211|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
125182212|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
125182213|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
125182214|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
125182215|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
125182216|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
125182217|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
125182218|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
125237317|NCT00879658|450496077|FG004|Overall Study|misrandomized (never received study med)|0|||
125237318|NCT00879658|450496078|FG005|Overall Study|misrandomized (never received study med)|0|||
125237319|NCT00879658|450496079|FG006|Overall Study|misrandomized (never received study med)|0|||
125237320|NCT00314145|450496082|FG000|Overall Study|Withdrawal by Subject|8|||
125237321|NCT00314145|450496083|FG001|Overall Study|Withdrawal by Subject|10|||
125237322|NCT00314145|450496082|FG000|Overall Study|Lost to Follow-up|5|||
125237323|NCT00314145|450496083|FG001|Overall Study|Lost to Follow-up|12|||
125237324|NCT00314145|450496082|FG000|Overall Study|Physician Decision|3|||
125237325|NCT00314145|450496083|FG001|Overall Study|Physician Decision|4|||
125237326|NCT00314145|450496082|FG000|Overall Study|Adverse Event|0|||
125237327|NCT00314145|450496083|FG001|Overall Study|Adverse Event|3|||
125237328|NCT00314145|450496082|FG000|Overall Study|Protocol Violation|3|||
125237329|NCT00314145|450496083|FG001|Overall Study|Protocol Violation|0|||
125237330|NCT00314145|450496082|FG000|Overall Study|Sponsor Decision|2|||
125237331|NCT00314145|450496083|FG001|Overall Study|Sponsor Decision|0|||
125443442|NCT02555371|451252131|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
125182219|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
125237332|NCT00580840|450496084|FG000|Run-in|Adverse Event|17|||
125182220|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
125182221|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
125182222|NCT04338022|450287813|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
125182223|NCT04338022|450287814|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
125182224|NCT04338022|450287813|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
125182225|NCT04338022|450287814|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
125182226|NCT04338022|450287813|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
125182227|NCT04338022|450287814|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
125182228|NCT04338022|450287813|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
125182229|NCT04338022|450287814|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
125182230|NCT04338022|450287813|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
125182231|NCT04338022|450287814|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
125182232|NCT04338022|450287813|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
125182233|NCT04338022|450287814|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
125182234|NCT04338022|450287813|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
125182235|NCT04338022|450287814|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
125182236|NCT02860546|450287819|FG000|Overall Study|Clinical Progression|6|||
125182237|NCT02860546|450287819|FG000|Overall Study|Radiological Progression|12|||
125182238|NCT02466321|450287820|FG000|Overall Study|Death|26|||
125182239|NCT02466321|450287820|FG000|Overall Study|Revision|6|||
125182240|NCT02466321|450287820|FG000|Overall Study|Lost to Follow-up|60|||
125182241|NCT02466321|450287820|FG000|Overall Study|Did not receive study device|1|||
125182242|NCT06071754|450287821|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
125182243|NCT00683657|450287827|FG000|Overall Study|Adverse Event|0|||
125182244|NCT00683657|450287828|FG001|Overall Study|Adverse Event|1|||
125182245|NCT00683657|450287827|FG000|Overall Study|Subject Withdrew Consent|1|||
125182246|NCT00683657|450287828|FG001|Overall Study|Subject Withdrew Consent|0|||
125182247|NCT01408043|450287830|FG000|Overall Study|unable to collect cells|1|||
125182248|NCT00739063|450287831|FG000|Overall Study|Screen failures|8|||
125182249|NCT00931528|450289323|FG000|Overall Study|Protocol Violation|9|||
125182250|NCT00931528|450289324|FG001|Overall Study|Protocol Violation|12|||
125182251|NCT00931528|450289323|FG000|Overall Study|Withdrawal by Subject|4|||
125182252|NCT00931528|450289324|FG001|Overall Study|Withdrawal by Subject|12|||
125182253|NCT00931528|450289323|FG000|Overall Study|Lost to Follow-up|6|||
125182254|NCT00931528|450289324|FG001|Overall Study|Lost to Follow-up|13|||
125182255|NCT00931528|450289323|FG000|Overall Study|Assessment outside of Time Frame|22|||
125182256|NCT00931528|450289324|FG001|Overall Study|Assessment outside of Time Frame|23|||
125182257|NCT00711243|450289328|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
125182258|NCT00711243|450289329|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
125182259|NCT00711243|450289330|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
125182260|NCT00711243|450289331|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
125182261|NCT00711243|450289332|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
125182262|NCT00711243|450289333|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
125182263|NCT00711243|450289328|FG000|Reached First Response/4 Cycles|Death|0|||
125182264|NCT00711243|450289329|FG001|Reached First Response/4 Cycles|Death|0|||
125182265|NCT00711243|450289330|FG002|Reached First Response/4 Cycles|Death|0|||
125182266|NCT00711243|450289331|FG003|Reached First Response/4 Cycles|Death|0|||
125182267|NCT00711243|450289332|FG004|Reached First Response/4 Cycles|Death|0|||
125182268|NCT00711243|450289333|FG005|Reached First Response/4 Cycles|Death|2|||
125182269|NCT00711243|450289328|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
125182270|NCT00711243|450289329|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
125182271|NCT00711243|450289330|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
125182272|NCT00711243|450289331|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
125182273|NCT00711243|450289332|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
125182274|NCT00711243|450289333|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
125182275|NCT00711243|450289328|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
125182276|NCT00711243|450289329|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
125182277|NCT00711243|450289330|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
125182278|NCT00711243|450289331|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
125182279|NCT00711243|450289332|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
125182280|NCT00711243|450289333|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
125182281|NCT00711243|450289328|FG000|Treated Cycle 5 After First Response|Death|0|||
125182282|NCT00711243|450289329|FG001|Treated Cycle 5 After First Response|Death|0|||
125182283|NCT00711243|450289330|FG002|Treated Cycle 5 After First Response|Death|0|||
125182284|NCT00711243|450289331|FG003|Treated Cycle 5 After First Response|Death|0|||
125182285|NCT00711243|450289332|FG004|Treated Cycle 5 After First Response|Death|0|||
125182286|NCT00711243|450289333|FG005|Treated Cycle 5 After First Response|Death|2|||
125237333|NCT00580840|450496085|FG001|Run-in|Adverse Event|0|||
125182287|NCT00711243|450289328|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
125237334|NCT00580840|450496086|FG002|Run-in|Adverse Event|0|||
125182288|NCT00711243|450289329|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
125182289|NCT00711243|450289330|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
125182290|NCT00711243|450289331|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
125182291|NCT00711243|450289332|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
125182292|NCT00711243|450289333|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
125182293|NCT00711243|450289328|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
125182294|NCT00711243|450289329|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
125182295|NCT00711243|450289330|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
125182296|NCT00711243|450289331|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
125182297|NCT00711243|450289332|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
125182298|NCT00711243|450289333|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
125182299|NCT01557504|450289336|FG000|Overall Study|Physician Decision|1|||
125182300|NCT01557504|450289337|FG001|Overall Study|Physician Decision|0|||
125182301|NCT01962103|450289338|FG000|Phase 1|Adverse Event|4|||
125182302|NCT01962103|450289339|FG001|Phase 1|Adverse Event|0|||
125182303|NCT01962103|450289340|FG002|Phase 1|Adverse Event|2|||
125182304|NCT01962103|450289341|FG003|Phase 1|Adverse Event|1|||
125182305|NCT01962103|450289342|FG004|Phase 1|Adverse Event|2|||
125182306|NCT01962103|450289343|FG005|Phase 1|Adverse Event|2|||
125182307|NCT01962103|450289344|FG006|Phase 1|Adverse Event|0|||
125182308|NCT01962103|450289345|FG007|Phase 1|Adverse Event|0|||
125182309|NCT01962103|450289346|FG008|Phase 1|Adverse Event|0|||
125182310|NCT01962103|450289338|FG000|Phase 1|Progressive Disease|8|||
125182311|NCT01962103|450289339|FG001|Phase 1|Progressive Disease|6|||
125182312|NCT01962103|450289340|FG002|Phase 1|Progressive Disease|8|||
125182313|NCT01962103|450289341|FG003|Phase 1|Progressive Disease|4|||
125182314|NCT01962103|450289342|FG004|Phase 1|Progressive Disease|5|||
125182315|NCT01962103|450289343|FG005|Phase 1|Progressive Disease|4|||
125182316|NCT01962103|450289344|FG006|Phase 1|Progressive Disease|0|||
125182317|NCT01962103|450289345|FG007|Phase 1|Progressive Disease|0|||
125182318|NCT01962103|450289346|FG008|Phase 1|Progressive Disease|0|||
125182319|NCT01962103|450289338|FG000|Phase 1|Withdrawal by Subject|0|||
125182320|NCT01962103|450289339|FG001|Phase 1|Withdrawal by Subject|0|||
125182321|NCT01962103|450289340|FG002|Phase 1|Withdrawal by Subject|0|||
125182322|NCT01962103|450289341|FG003|Phase 1|Withdrawal by Subject|2|||
125182323|NCT01962103|450289342|FG004|Phase 1|Withdrawal by Subject|0|||
125182324|NCT01962103|450289343|FG005|Phase 1|Withdrawal by Subject|0|||
125182325|NCT01962103|450289344|FG006|Phase 1|Withdrawal by Subject|0|||
125237335|NCT00580840|450496087|FG003|Run-in|Adverse Event|0|||
125237336|NCT00580840|450496084|FG000|Run-in|Lack of Efficacy|93|||
125237337|NCT00580840|450496085|FG001|Run-in|Lack of Efficacy|0|||
125237338|NCT00580840|450496086|FG002|Run-in|Lack of Efficacy|0|||
125237339|NCT00580840|450496087|FG003|Run-in|Lack of Efficacy|0|||
125237340|NCT00580840|450496084|FG000|Run-in|Loss of Efficacy|1|||
125237341|NCT00580840|450496085|FG001|Run-in|Loss of Efficacy|0|||
125237342|NCT00580840|450496086|FG002|Run-in|Loss of Efficacy|0|||
125237343|NCT00580840|450496087|FG003|Run-in|Loss of Efficacy|0|||
125237344|NCT00580840|450496084|FG000|Run-in|Lost to Follow-up|4|||
125237345|NCT00580840|450496085|FG001|Run-in|Lost to Follow-up|0|||
125237346|NCT00580840|450496086|FG002|Run-in|Lost to Follow-up|0|||
125237347|NCT00580840|450496087|FG003|Run-in|Lost to Follow-up|0|||
125237348|NCT00580840|450496084|FG000|Run-in|Withdrawal by Subject|5|||
125237349|NCT00580840|450496085|FG001|Run-in|Withdrawal by Subject|0|||
125237350|NCT00580840|450496086|FG002|Run-in|Withdrawal by Subject|0|||
125237351|NCT00580840|450496087|FG003|Run-in|Withdrawal by Subject|0|||
125237352|NCT00580840|450496084|FG000|Run-in|Other: Per Sponsor Request|2|||
125237353|NCT00580840|450496085|FG001|Run-in|Other: Per Sponsor Request|0|||
125237354|NCT00580840|450496086|FG002|Run-in|Other: Per Sponsor Request|0|||
125237355|NCT00580840|450496087|FG003|Run-in|Other: Per Sponsor Request|0|||
125237356|NCT00580840|450496084|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
125237357|NCT00580840|450496085|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
125237358|NCT00580840|450496086|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
125182326|NCT01962103|450289345|FG007|Phase 1|Withdrawal by Subject|0|||
125182327|NCT01962103|450289346|FG008|Phase 1|Withdrawal by Subject|0|||
125182328|NCT01962103|450289338|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
125182329|NCT01962103|450289339|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
125182330|NCT01962103|450289340|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
125182331|NCT01962103|450289341|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
125182332|NCT01962103|450289342|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
125182333|NCT01962103|450289343|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
125182334|NCT01962103|450289344|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
125182335|NCT01962103|450289345|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
125182336|NCT01962103|450289346|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
125237359|NCT00580840|450496087|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
125182337|NCT01962103|450289338|FG000|Phase 1|Physician Decision|0|||
125237360|NCT00580840|450496084|FG000|Run-in|Other: Exclusionary Lab Value|1|||
125237361|NCT00580840|450496085|FG001|Run-in|Other: Exclusionary Lab Value|0|||
125237362|NCT00580840|450496086|FG002|Run-in|Other: Exclusionary Lab Value|0|||
125237363|NCT00580840|450496087|FG003|Run-in|Other: Exclusionary Lab Value|0|||
125237364|NCT00580840|450496084|FG000|Double-Blind|Adverse Event|0|||
125237365|NCT00580840|450496085|FG001|Double-Blind|Adverse Event|3|||
125237366|NCT00580840|450496086|FG002|Double-Blind|Adverse Event|4|||
125237367|NCT00580840|450496087|FG003|Double-Blind|Adverse Event|1|||
125237368|NCT00580840|450496084|FG000|Double-Blind|Loss of Efficacy|0|||
125237369|NCT00580840|450496085|FG001|Double-Blind|Loss of Efficacy|1|||
125237370|NCT00580840|450496086|FG002|Double-Blind|Loss of Efficacy|2|||
125237371|NCT00580840|450496087|FG003|Double-Blind|Loss of Efficacy|10|||
125237372|NCT00580840|450496084|FG000|Double-Blind|Lost to Follow-up|0|||
125237373|NCT00580840|450496085|FG001|Double-Blind|Lost to Follow-up|1|||
125237374|NCT00580840|450496086|FG002|Double-Blind|Lost to Follow-up|0|||
125237375|NCT00580840|450496087|FG003|Double-Blind|Lost to Follow-up|2|||
125237376|NCT00580840|450496084|FG000|Double-Blind|Withdrawal by Subject|0|||
125237377|NCT00580840|450496085|FG001|Double-Blind|Withdrawal by Subject|1|||
125237378|NCT00580840|450496086|FG002|Double-Blind|Withdrawal by Subject|2|||
125237379|NCT00580840|450496087|FG003|Double-Blind|Withdrawal by Subject|2|||
125237380|NCT00580840|450496084|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
125237381|NCT00580840|450496085|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
125237382|NCT00580840|450496086|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
125237383|NCT00580840|450496087|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
125237384|NCT00580840|450496084|FG000|Double-Blind|Other: Forbidden Medication|0|||
125237385|NCT00580840|450496085|FG001|Double-Blind|Other: Forbidden Medication|0|||
125237386|NCT00580840|450496086|FG002|Double-Blind|Other: Forbidden Medication|1|||
125237387|NCT00580840|450496087|FG003|Double-Blind|Other: Forbidden Medication|0|||
125237388|NCT01551173|450496088|FG000|Overall Study|Withdrawal by Subject|11|||
125237389|NCT01551173|450496089|FG001|Overall Study|Withdrawal by Subject|16|||
125237390|NCT01551173|450496088|FG000|Overall Study|Adverse Event|7|||
125237391|NCT01551173|450496089|FG001|Overall Study|Adverse Event|6|||
125237392|NCT01551173|450496088|FG000|Overall Study|Lost to Follow-up|5|||
125237393|NCT01551173|450496089|FG001|Overall Study|Lost to Follow-up|7|||
125237394|NCT01551173|450496088|FG000|Overall Study|Other|5|||
125237395|NCT01551173|450496089|FG001|Overall Study|Other|3|||
125237396|NCT04530344|450496090|FG000|Overall Study|Lost to Follow-up|3|||
125237397|NCT04530344|450496091|FG001|Overall Study|Lost to Follow-up|3|||
125237398|NCT04530344|450496092|FG002|Overall Study|Lost to Follow-up|3|||
125237399|NCT04530344|450496093|FG003|Overall Study|Lost to Follow-up|10|||
125237400|NCT04530344|450496090|FG000|Overall Study|Withdrawal by Subject|14|||
125237401|NCT04530344|450496091|FG001|Overall Study|Withdrawal by Subject|5|||
125237402|NCT04530344|450496092|FG002|Overall Study|Withdrawal by Subject|18|||
125237403|NCT04530344|450496093|FG003|Overall Study|Withdrawal by Subject|33|||
125237404|NCT04530344|450496090|FG000|Overall Study|Adverse Event|0|||
125237405|NCT04530344|450496091|FG001|Overall Study|Adverse Event|0|||
125237406|NCT04530344|450496092|FG002|Overall Study|Adverse Event|0|||
125237407|NCT04530344|450496093|FG003|Overall Study|Adverse Event|1|||
125237408|NCT04530344|450496090|FG000|Overall Study|Lack of Efficacy|0|||
125237409|NCT04530344|450496091|FG001|Overall Study|Lack of Efficacy|0|||
125237410|NCT04530344|450496092|FG002|Overall Study|Lack of Efficacy|0|||
125237411|NCT04530344|450496093|FG003|Overall Study|Lack of Efficacy|1|||
125237412|NCT04530344|450496090|FG000|Overall Study|Physician Decision|0|||
125237413|NCT04530344|450496091|FG001|Overall Study|Physician Decision|0|||
125237414|NCT04530344|450496092|FG002|Overall Study|Physician Decision|1|||
125237415|NCT04530344|450496093|FG003|Overall Study|Physician Decision|1|||
125237416|NCT04530344|450496090|FG000|Overall Study|Pregnancy|0|||
125237417|NCT04530344|450496091|FG001|Overall Study|Pregnancy|0|||
125237418|NCT04530344|450496092|FG002|Overall Study|Pregnancy|2|||
125237419|NCT04530344|450496093|FG003|Overall Study|Pregnancy|1|||
125237420|NCT04530344|450496090|FG000|Overall Study|Protocol Violation|0|||
125237421|NCT04530344|450496091|FG001|Overall Study|Protocol Violation|0|||
125237422|NCT04530344|450496092|FG002|Overall Study|Protocol Violation|0|||
125237423|NCT04530344|450496093|FG003|Overall Study|Protocol Violation|1|||
125237424|NCT04530344|450496090|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
125237425|NCT04530344|450496091|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
125237426|NCT04530344|450496092|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
125237427|NCT04530344|450496093|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
125237428|NCT04530344|450496090|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
125237429|NCT04530344|450496091|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
125237430|NCT04530344|450496092|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
125237431|NCT04530344|450496093|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
125237432|NCT04530344|450496090|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
125237433|NCT04530344|450496091|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
125237434|NCT04530344|450496092|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
125237435|NCT04530344|450496093|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
125237436|NCT04530344|450496090|FG000|Overall Study|Personal Reasons|0|||
125237437|NCT04530344|450496091|FG001|Overall Study|Personal Reasons|0|||
125237438|NCT04530344|450496092|FG002|Overall Study|Personal Reasons|0|||
125237439|NCT04530344|450496093|FG003|Overall Study|Personal Reasons|1|||
125237440|NCT04530344|450496090|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
125237441|NCT04530344|450496091|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
125237442|NCT04530344|450496092|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
125237443|NCT04530344|450496093|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
125237444|NCT01402700|450496094|FG000|Overall Study|Death|3|||
125237445|NCT01402700|450496094|FG000|Overall Study|Withdrawal by Subject|3|||
125237446|NCT01402700|450496094|FG000|Overall Study|Missed Visit|1|||
125237447|NCT05523297|450496100|FG000|Overall Study|Death|7|||
125237448|NCT05523297|450496101|FG001|Overall Study|Death|8|||
125237449|NCT05523297|450496100|FG000|Overall Study|Lost to Follow-up|2|||
125237450|NCT05523297|450496101|FG001|Overall Study|Lost to Follow-up|1|||
125237451|NCT03462680|450496102|FG000|Overall Study|Withdrawal by Subject|3|||
125237452|NCT03462680|450496103|FG001|Overall Study|Withdrawal by Subject|5|||
125237453|NCT02246777|450496104|FG000|Overall Study|Adverse Event|2|||
125237454|NCT02246777|450496104|FG000|Overall Study|Change of residence|1|||
125237455|NCT02401230|450496105|FG000|Overall Study|Adverse Event|3|||
125237456|NCT02401230|450496106|FG001|Overall Study|Adverse Event|2|||
125237457|NCT02401230|450496107|FG002|Overall Study|Adverse Event|0|||
125237458|NCT02401230|450496105|FG000|Overall Study|Withdrawal by Subject|2|||
125237459|NCT02401230|450496106|FG001|Overall Study|Withdrawal by Subject|1|||
125237460|NCT02401230|450496107|FG002|Overall Study|Withdrawal by Subject|1|||
125237461|NCT02401230|450496105|FG000|Overall Study|Lost to Follow-up|1|||
125237462|NCT02401230|450496106|FG001|Overall Study|Lost to Follow-up|3|||
125237463|NCT02401230|450496107|FG002|Overall Study|Lost to Follow-up|3|||
125237464|NCT04133909|450496108|FG000|Overall Study|Death|11|||
125237465|NCT04133909|450496109|FG001|Overall Study|Death|11|||
125237466|NCT04133909|450496108|FG000|Overall Study|Adverse Event|4|||
125237467|NCT04133909|450496109|FG001|Overall Study|Adverse Event|5|||
125237468|NCT04133909|450496108|FG000|Overall Study|Lost to Follow-up|3|||
125182338|NCT01962103|450289339|FG001|Phase 1|Physician Decision|0|||
125182339|NCT01962103|450289340|FG002|Phase 1|Physician Decision|0|||
125182340|NCT01962103|450289341|FG003|Phase 1|Physician Decision|1|||
125182341|NCT01962103|450289342|FG004|Phase 1|Physician Decision|0|||
125182342|NCT01962103|450289343|FG005|Phase 1|Physician Decision|0|||
125182343|NCT01962103|450289344|FG006|Phase 1|Physician Decision|0|||
125182344|NCT01962103|450289345|FG007|Phase 1|Physician Decision|0|||
125182345|NCT01962103|450289346|FG008|Phase 1|Physician Decision|0|||
125182346|NCT01962103|450289338|FG000|Phase 1|Symptomatic Deterioration|3|||
125182347|NCT01962103|450289339|FG001|Phase 1|Symptomatic Deterioration|2|||
125182348|NCT01962103|450289340|FG002|Phase 1|Symptomatic Deterioration|2|||
125237469|NCT04133909|450496109|FG001|Overall Study|Lost to Follow-up|5|||
125237470|NCT04133909|450496108|FG000|Overall Study|Physician Decision|4|||
125237471|NCT04133909|450496109|FG001|Overall Study|Physician Decision|7|||
125237472|NCT04133909|450496108|FG000|Overall Study|Withdrawal by Subject|40|||
125237473|NCT04133909|450496109|FG001|Overall Study|Withdrawal by Subject|35|||
125237474|NCT04133909|450496108|FG000|Overall Study|Lack of Efficacy|2|||
125237475|NCT04133909|450496109|FG001|Overall Study|Lack of Efficacy|7|||
125237476|NCT04133909|450496108|FG000|Overall Study|Randomized in error|1|||
125237477|NCT04133909|450496109|FG001|Overall Study|Randomized in error|1|||
125237478|NCT00830765|450496110|FG000|Overall Study|Protocol Violation|3|||
125237479|NCT00830765|450496111|FG001|Overall Study|Protocol Violation|2|||
125237480|NCT01299909|450496112|FG000|Overall Study|Lost to Follow-up|22|||
125237481|NCT01299909|450496113|FG001|Overall Study|Lost to Follow-up|18|||
125237482|NCT01299909|450496114|FG002|Overall Study|Lost to Follow-up|17|||
125237483|NCT03069989|450496118|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
125237484|NCT03069989|450496119|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
125237485|NCT05399485|450497590|FG000|DBT Phase|Other|6|||
125237486|NCT05399485|450497591|FG001|DBT Phase|Other|5|||
125237487|NCT05399485|450497590|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
125182349|NCT01962103|450289341|FG003|Phase 1|Symptomatic Deterioration|2|||
125182350|NCT01962103|450289342|FG004|Phase 1|Symptomatic Deterioration|1|||
125182351|NCT01962103|450289343|FG005|Phase 1|Symptomatic Deterioration|1|||
125182352|NCT01962103|450289344|FG006|Phase 1|Symptomatic Deterioration|0|||
125237488|NCT05399485|450497591|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
125237489|NCT05399485|450497590|FG000|DBT Phase|Withdrawal by Subject|3|||
125237490|NCT05399485|450497591|FG001|DBT Phase|Withdrawal by Subject|2|||
125237491|NCT05399485|450497590|FG000|DBT Phase|Protocol Violation|2|||
125237492|NCT05399485|450497591|FG001|DBT Phase|Protocol Violation|1|||
125237493|NCT05399485|450497590|FG000|DBT Phase|Physician Decision|0|||
125237494|NCT05399485|450497591|FG001|DBT Phase|Physician Decision|1|||
125182353|NCT01962103|450289345|FG007|Phase 1|Symptomatic Deterioration|0|||
125182354|NCT01962103|450289346|FG008|Phase 1|Symptomatic Deterioration|0|||
125182355|NCT01962103|450289338|FG000|Phase 1|Miscellaneous|1|||
125182356|NCT01962103|450289339|FG001|Phase 1|Miscellaneous|0|||
125182357|NCT01962103|450289340|FG002|Phase 1|Miscellaneous|0|||
125182358|NCT01962103|450289341|FG003|Phase 1|Miscellaneous|0|||
125237495|NCT05399485|450497590|FG000|DBT Phase|Adverse Event|2|||
125237496|NCT05399485|450497591|FG001|DBT Phase|Adverse Event|1|||
125237497|NCT05399485|450497590|FG000|OLE Phase|Not reported|0|||
125237498|NCT05399485|450497591|FG001|OLE Phase|Not reported|1|||
125237499|NCT05399485|450497590|FG000|OLE Phase|Other|3|||
125237500|NCT05399485|450497591|FG001|OLE Phase|Other|3|||
125237501|NCT05399485|450497590|FG000|OLE Phase|Withdrawal by Subject|8|||
125237502|NCT05399485|450497591|FG001|OLE Phase|Withdrawal by Subject|5|||
125237503|NCT05399485|450497590|FG000|OLE Phase|Pregnancy|0|||
125237504|NCT05399485|450497591|FG001|OLE Phase|Pregnancy|1|||
125237505|NCT05399485|450497590|FG000|OLE Phase|Physician Decision|2|||
125237506|NCT05399485|450497591|FG001|OLE Phase|Physician Decision|0|||
125237507|NCT05399485|450497590|FG000|OLE Phase|Adverse Event|0|||
125237508|NCT05399485|450497591|FG001|OLE Phase|Adverse Event|1|||
125237509|NCT05399485|450497590|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
125237510|NCT05399485|450497591|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
125237511|NCT06125964|450497592|FG000|Overall Study|Lost to Follow-up|0|||
125237512|NCT06125964|450497593|FG001|Overall Study|Lost to Follow-up|1|||
125182359|NCT01962103|450289342|FG004|Phase 1|Miscellaneous|0|||
125182360|NCT01962103|450289343|FG005|Phase 1|Miscellaneous|0|||
125182361|NCT01962103|450289344|FG006|Phase 1|Miscellaneous|0|||
125182362|NCT01962103|450289345|FG007|Phase 1|Miscellaneous|0|||
125182363|NCT01962103|450289346|FG008|Phase 1|Miscellaneous|0|||
125182364|NCT01962103|450289338|FG000|Phase 2|Adverse Event|0|||
125182365|NCT01962103|450289339|FG001|Phase 2|Adverse Event|0|||
125182366|NCT01962103|450289340|FG002|Phase 2|Adverse Event|0|||
125182367|NCT01962103|450289341|FG003|Phase 2|Adverse Event|0|||
125182368|NCT01962103|450289342|FG004|Phase 2|Adverse Event|0|||
125182369|NCT01962103|450289343|FG005|Phase 2|Adverse Event|0|||
125182370|NCT01962103|450289344|FG006|Phase 2|Adverse Event|1|||
125182371|NCT01962103|450289345|FG007|Phase 2|Adverse Event|0|||
125182372|NCT01962103|450289346|FG008|Phase 2|Adverse Event|3|||
125182373|NCT01962103|450289338|FG000|Phase 2|Progressive Disease|0|||
125182374|NCT01962103|450289339|FG001|Phase 2|Progressive Disease|0|||
125182375|NCT01962103|450289340|FG002|Phase 2|Progressive Disease|0|||
125182376|NCT01962103|450289341|FG003|Phase 2|Progressive Disease|0|||
125182377|NCT01962103|450289342|FG004|Phase 2|Progressive Disease|0|||
125182378|NCT01962103|450289343|FG005|Phase 2|Progressive Disease|0|||
125182379|NCT01962103|450289344|FG006|Phase 2|Progressive Disease|11|||
125182380|NCT01962103|450289345|FG007|Phase 2|Progressive Disease|12|||
125182381|NCT01962103|450289346|FG008|Phase 2|Progressive Disease|11|||
125182382|NCT01962103|450289338|FG000|Phase 2|Symptomatic Deterioration|0|||
125182383|NCT01962103|450289339|FG001|Phase 2|Symptomatic Deterioration|0|||
125182384|NCT01962103|450289340|FG002|Phase 2|Symptomatic Deterioration|0|||
125182385|NCT01962103|450289341|FG003|Phase 2|Symptomatic Deterioration|0|||
125182386|NCT01962103|450289342|FG004|Phase 2|Symptomatic Deterioration|0|||
125182387|NCT01962103|450289343|FG005|Phase 2|Symptomatic Deterioration|0|||
125182388|NCT01962103|450289344|FG006|Phase 2|Symptomatic Deterioration|2|||
125182389|NCT01962103|450289345|FG007|Phase 2|Symptomatic Deterioration|2|||
125182390|NCT01962103|450289346|FG008|Phase 2|Symptomatic Deterioration|0|||
125182391|NCT01321749|450289347|FG000|Overall Study|Lost to Follow-up|4|||
125182392|NCT01321749|450289348|FG001|Overall Study|Lost to Follow-up|11|||
125182393|NCT01321749|450289347|FG000|Overall Study|Protocol Violation|4|||
125182394|NCT01321749|450289348|FG001|Overall Study|Protocol Violation|7|||
125182395|NCT01321749|450289347|FG000|Overall Study|Withdrawal by Subject|5|||
125182396|NCT01321749|450289348|FG001|Overall Study|Withdrawal by Subject|4|||
125182397|NCT02750618|450289349|FG000|Overall Study|Withdrawal by Subject|1|||
125182398|NCT01067105|450289352|FG000|Overall Study|Adverse Event|14|||
125182399|NCT01067105|450289352|FG000|Overall Study|Protocol Violation|48|||
125182400|NCT01067105|450289352|FG000|Overall Study|Withdrawal by Subject|36|||
125182401|NCT01067105|450289352|FG000|Overall Study|Lost to Follow-up|6|||
125182402|NCT01067105|450289352|FG000|Overall Study|Physician Decision|6|||
125182403|NCT01067105|450289352|FG000|Overall Study|Other|31|||
125182404|NCT02302833|450289355|FG000|Overall Study|Lost to Follow-up|3|||
125182405|NCT04878432|450289356|FG000|Overall Study|Adverse Event|1|||
125182406|NCT04878432|450289356|FG000|Overall Study|Death|2|||
125182407|NCT04878432|450289356|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
125182408|NCT04878432|450289356|FG000|Overall Study|Withdrawal by Subject|6|||
125182409|NCT04878432|450289356|FG000|Overall Study|Progressive Disease|7|||
125182410|NCT04878432|450289356|FG000|Overall Study|New Therapy for Study Indication|7|||
125182411|NCT04878432|450289356|FG000|Overall Study|Physician Decision|11|||
125182412|NCT00725491|450289359|FG000|Overall Study|Adverse Event|3|||
125182413|NCT00725491|450289360|FG001|Overall Study|Adverse Event|2|||
125182414|NCT00725491|450289359|FG000|Overall Study|Pregnancy|0|||
125182415|NCT00725491|450289360|FG001|Overall Study|Pregnancy|3|||
125182416|NCT00725491|450289359|FG000|Overall Study|Risk for hyperstimulation|2|||
125182417|NCT00725491|450289360|FG001|Overall Study|Risk for hyperstimulation|9|||
125182418|NCT00725491|450289359|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
125182419|NCT00725491|450289360|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
125182420|NCT00725491|450289359|FG000|Overall Study|Fertilization failure|0|||
125182421|NCT00725491|450289360|FG001|Overall Study|Fertilization failure|1|||
125237513|NCT06125964|450497594|FG002|Overall Study|Lost to Follow-up|0|||
125182422|NCT00725491|450289359|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
125237514|NCT06125964|450497595|FG003|Overall Study|Lost to Follow-up|0|||
125237515|NCT02469233|450497596|FG000|Overall Study|Death|1|||
125237516|NCT02469233|450497597|FG001|Overall Study|Death|1|||
125237517|NCT02469233|450497596|FG000|Overall Study|Lost to post or 6 month follow up|7|||
125237518|NCT02469233|450497597|FG001|Overall Study|Lost to post or 6 month follow up|2|||
125237519|NCT03474107|450497598|FG000|Overall Study|Adverse Event|42|||
125237520|NCT03474107|450497599|FG001|Overall Study|Adverse Event|46|||
125237521|NCT03474107|450497598|FG000|Overall Study|Death|2|||
125237522|NCT03474107|450497599|FG001|Overall Study|Death|2|||
125237523|NCT03474107|450497598|FG000|Overall Study|Lost to Follow-up|0|||
125237524|NCT03474107|450497599|FG001|Overall Study|Lost to Follow-up|1|||
125237525|NCT03474107|450497598|FG000|Overall Study|Progressive Disease|177|||
125237526|NCT03474107|450497599|FG001|Overall Study|Progressive Disease|180|||
125237527|NCT03474107|450497598|FG000|Overall Study|Protocol Violation|1|||
125237528|NCT03474107|450497599|FG001|Overall Study|Protocol Violation|1|||
125237529|NCT03474107|450497598|FG000|Overall Study|Withdrawal by Subject|15|||
125237530|NCT03474107|450497599|FG001|Overall Study|Withdrawal by Subject|27|||
125237531|NCT03474107|450497598|FG000|Overall Study|Physician Decision|7|||
125237532|NCT03474107|450497599|FG001|Overall Study|Physician Decision|22|||
125237533|NCT03474107|450497598|FG000|Overall Study|Miscellaneous|1|||
125237534|NCT03474107|450497599|FG001|Overall Study|Miscellaneous|6|||
125237535|NCT01787838|450497600|FG000|Overall Study|refused|1413|||
125237536|NCT03095287|450497601|FG000|Overall Study|Treatment Failure|1|||
125237537|NCT03095287|450497601|FG000|Overall Study|Adverse Event|1|||
125237538|NCT01431976|450497602|FG000|Overall Study|Adverse Event|6|||
125237539|NCT01431976|450497602|FG000|Overall Study|Lack of Efficacy|2|||
125237540|NCT01431976|450497602|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
125237541|NCT01431976|450497602|FG000|Overall Study|Physician Decision|1|||
125237542|NCT01431976|450497602|FG000|Overall Study|Withdrawal by Subject|1|||
125237543|NCT02127671|450497610|FG000|Overall Study|Death|2|||
125237544|NCT02127671|450497611|FG001|Overall Study|Death|2|||
125237545|NCT02127671|450497610|FG000|Overall Study|Lost to Follow-up|4|||
125237546|NCT02127671|450497611|FG001|Overall Study|Lost to Follow-up|2|||
125237547|NCT02127671|450497610|FG000|Overall Study|Physician Decision|1|||
125237548|NCT02127671|450497611|FG001|Overall Study|Physician Decision|0|||
125237549|NCT02127671|450497610|FG000|Overall Study|incarceration|0|||
125237550|NCT02127671|450497611|FG001|Overall Study|incarceration|1|||
125237551|NCT02127671|450497610|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
125237552|NCT02127671|450497611|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
125237553|NCT01136954|450497612|FG000|Overall Study|Adverse Event|3|||
125237554|NCT01136954|450497613|FG001|Overall Study|Adverse Event|2|||
125237555|NCT01136954|450497612|FG000|Overall Study|Withdrawal by Subject|6|||
125237556|NCT01136954|450497613|FG001|Overall Study|Withdrawal by Subject|2|||
125237557|NCT01136954|450497612|FG000|Overall Study|Lack of Efficacy|14|||
125237558|NCT01136954|450497613|FG001|Overall Study|Lack of Efficacy|13|||
125237559|NCT01136954|450497612|FG000|Overall Study|Physician Decision|0|||
125237560|NCT01136954|450497613|FG001|Overall Study|Physician Decision|1|||
125237561|NCT01136954|450497612|FG000|Overall Study|Other|1|||
125237562|NCT01136954|450497613|FG001|Overall Study|Other|3|||
125237563|NCT02394275|450497614|FG000|Overall Study|Adverse Event|22|||
125237564|NCT02394275|450497614|FG000|Overall Study|Lost to Follow-up|7|||
125237565|NCT00782067|450497617|FG000|Overall Study|Adverse Event|35|||
125237566|NCT00782067|450497617|FG000|Overall Study|Subject withdrew consent|11|||
125237567|NCT00782067|450497617|FG000|Overall Study|Lost to Follow-up|2|||
125237568|NCT00782067|450497617|FG000|Overall Study|Administrative problems|14|||
125237569|NCT00782067|450497617|FG000|Overall Study|Death|9|||
125237570|NCT00782067|450497617|FG000|Overall Study|Disease progression|43|||
125237571|NCT00782067|450497617|FG000|Overall Study|Protocol deviation|2|||
125237572|NCT00764517|450497621|FG000|Overall Study|Adverse Event|9|||
125237573|NCT00764517|450497622|FG001|Overall Study|Adverse Event|3|||
125237574|NCT00764517|450497621|FG000|Overall Study|Death|3|||
125237575|NCT00764517|450497622|FG001|Overall Study|Death|11|||
125237576|NCT00764517|450497621|FG000|Overall Study|Physician Decision|3|||
125237577|NCT00764517|450497622|FG001|Overall Study|Physician Decision|0|||
125237578|NCT00671060|450497630|FG000|Overall Study|Protocol Violation|1|||
125237579|NCT00671060|450497631|FG001|Overall Study|Protocol Violation|0|||
125237580|NCT00671060|450497630|FG000|Overall Study|Physician Decision|0|||
125237581|NCT00671060|450497631|FG001|Overall Study|Physician Decision|1|||
125237582|NCT02020941|450497632|FG000|Overall Study|Adverse Event|1|||
125237583|NCT02020941|450497632|FG000|Overall Study|Physician Decision|2|||
125237584|NCT02020941|450497632|FG000|Overall Study|Withdrawal by Subject|1|||
125237585|NCT02020941|450497632|FG000|Overall Study|Disease Progression|4|||
125237586|NCT02107898|450497635|FG000|Overall Study|Adverse Event|4|||
125237587|NCT02107898|450497636|FG001|Overall Study|Adverse Event|7|||
125237588|NCT02107898|450497635|FG000|Overall Study|Poor compliance to protocol|0|||
125237589|NCT02107898|450497636|FG001|Overall Study|Poor compliance to protocol|1|||
125237590|NCT02107898|450497635|FG000|Overall Study|Participant moved|0|||
125237591|NCT02107898|450497636|FG001|Overall Study|Participant moved|2|||
125237592|NCT02107898|450497635|FG000|Overall Study|Consent withdrawn by participant|2|||
125237593|NCT02107898|450497636|FG001|Overall Study|Consent withdrawn by participant|1|||
125237594|NCT02107898|450497635|FG000|Overall Study|Randomized but not treated|0|||
125237595|NCT02107898|450497636|FG001|Overall Study|Randomized but not treated|1|||
125237596|NCT03329989|450497637|FG000|Overall Study|Withdrawal by Subject|9|||
125237597|NCT03329989|450497637|FG000|Overall Study|Lost to Follow-up|8|||
125237598|NCT03329989|450497637|FG000|Overall Study|Adverse Event|5|||
125237599|NCT03329989|450497637|FG000|Overall Study|Protocol Violation|1|||
125237600|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
125237601|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
125237602|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
125237603|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
125237604|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
125237605|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
125237606|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
125237607|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
125237608|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
125237609|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
125237610|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
125237611|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
125237612|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
125237613|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
125237614|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
125237615|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
125237616|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
125237617|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
125237618|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
125237619|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
125237620|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
125237621|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
125237622|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
125237623|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
125237624|NCT00620542|450497638|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
125237625|NCT00620542|450497639|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
125237626|NCT00620542|450497640|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
125237627|NCT00620542|450497641|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
125237628|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
125237629|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
125237630|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
125182423|NCT00725491|450289360|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
125182424|NCT01495000|450289361|FG000|Overall Study|Lost to Follow-up|2|||
125182425|NCT01495000|450289362|FG001|Overall Study|Lost to Follow-up|2|||
125182426|NCT01495000|450289361|FG000|Overall Study|Protocol Violation|1|||
125182427|NCT01495000|450289362|FG001|Overall Study|Protocol Violation|0|||
125182428|NCT01495000|450289361|FG000|Overall Study|Withdrawal by Subject|10|||
125182429|NCT01495000|450289362|FG001|Overall Study|Withdrawal by Subject|10|||
125182430|NCT01514461|450289363|FG000|Overall Study|Adverse Event|2|||
125182431|NCT01514461|450289364|FG001|Overall Study|Adverse Event|1|||
125182432|NCT01514461|450289365|FG002|Overall Study|Adverse Event|3|||
125182433|NCT01514461|450289363|FG000|Overall Study|Physician Decision|1|||
125182434|NCT01514461|450289364|FG001|Overall Study|Physician Decision|1|||
125182435|NCT01514461|450289365|FG002|Overall Study|Physician Decision|0|||
125182436|NCT01514461|450289363|FG000|Overall Study|Patient/guardian decision|1|||
125182437|NCT01514461|450289364|FG001|Overall Study|Patient/guardian decision|1|||
125182438|NCT01514461|450289365|FG002|Overall Study|Patient/guardian decision|1|||
125182439|NCT01514461|450289363|FG000|Overall Study|Death|1|||
125182440|NCT01514461|450289364|FG001|Overall Study|Death|0|||
125182441|NCT01514461|450289365|FG002|Overall Study|Death|0|||
125182442|NCT03499067|450289366|FG000|First Intervention|Physician Decision|2|||
125182443|NCT03499067|450289367|FG001|First Intervention|Physician Decision|1|||
125182444|NCT03499067|450289366|FG000|First Intervention|Withdrawal by Subject|3|||
125182445|NCT03499067|450289367|FG001|First Intervention|Withdrawal by Subject|6|||
125182446|NCT02548832|450289368|FG000|Overall Study|Lost to Follow-up|2|||
125182447|NCT02548832|450289369|FG001|Overall Study|Lost to Follow-up|2|||
125182448|NCT02548832|450289370|FG002|Overall Study|Lost to Follow-up|2|||
125182450|NCT02058069|450289372|FG000|Overall Study|Exclusion due to implant size|5|||
125182451|NCT02058069|450289372|FG000|Overall Study|Withdrawal by Subject|6|||
125182452|NCT00711087|450289394|FG000|Overall Study|Lost to Follow-up|1|||
125182453|NCT00711087|450289395|FG001|Overall Study|Lost to Follow-up|0|||
125182454|NCT00856193|450289396|FG000|Period 2|Abnormal test procedure results|0|||
125182455|NCT00856193|450289397|FG001|Period 2|Abnormal test procedure results|1|||
125182456|NCT00856193|450289396|FG000|Period 2|Lost to Follow-up|0|||
125182457|NCT00856193|450289397|FG001|Period 2|Lost to Follow-up|1|||
125182458|NCT02569801|450289398|FG000|Overall Study|Withdrawal by Subject|9|||
125182459|NCT02569801|450289399|FG001|Overall Study|Withdrawal by Subject|9|||
125182460|NCT02569801|450289398|FG000|Overall Study|Sponsor Decision|13|||
125182461|NCT02569801|450289399|FG001|Overall Study|Sponsor Decision|14|||
125237631|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
125182462|NCT02569801|450289398|FG000|Overall Study|Progressive Disease|2|||
125182463|NCT02569801|450289399|FG001|Overall Study|Progressive Disease|7|||
125182464|NCT02569801|450289398|FG000|Overall Study|Lost to Follow-up|0|||
125182465|NCT02569801|450289399|FG001|Overall Study|Lost to Follow-up|1|||
125182466|NCT02569801|450289398|FG000|Overall Study|Death|12|||
125182467|NCT02569801|450289399|FG001|Overall Study|Death|4|||
125182468|NCT00428246|450289400|FG000|Overall Study|Withdrawal by Subject|0|||
125182469|NCT00428246|450289401|FG001|Overall Study|Withdrawal by Subject|0|||
125182470|NCT00428246|450289402|FG002|Overall Study|Withdrawal by Subject|1|||
125182471|NCT00428246|450289400|FG000|Overall Study|Adverse Event|1|||
125182472|NCT00428246|450289401|FG001|Overall Study|Adverse Event|0|||
125182473|NCT00428246|450289402|FG002|Overall Study|Adverse Event|0|||
125182474|NCT01125917|450289404|FG000|Overall Study|Adverse Event|43|||
125182475|NCT01125917|450289404|FG000|Overall Study|Lost to Follow-up|23|||
125182476|NCT01125917|450289404|FG000|Overall Study|Withdrawal by Subject|31|||
125182477|NCT01125917|450289404|FG000|Overall Study|Administrative|223|||
125182478|NCT01125917|450289404|FG000|Overall Study|Lack of Efficacy|19|||
125182479|NCT00838526|450289413|FG000|Overall Study|Adverse Event|3|||
125182480|NCT00838526|450289414|FG001|Overall Study|Adverse Event|12|||
125182481|NCT00838526|450289413|FG000|Overall Study|Lost to Follow-up|4|||
125182482|NCT00838526|450289414|FG001|Overall Study|Lost to Follow-up|12|||
125182483|NCT00838526|450289413|FG000|Overall Study|Withdrawal by Subject|4|||
125182484|NCT00838526|450289414|FG001|Overall Study|Withdrawal by Subject|5|||
125182485|NCT00838526|450289413|FG000|Overall Study|Lack of Efficacy|2|||
125182486|NCT00838526|450289414|FG001|Overall Study|Lack of Efficacy|3|||
125182487|NCT00838526|450289413|FG000|Overall Study|Other|11|||
125182488|NCT00838526|450289414|FG001|Overall Study|Other|7|||
125182489|NCT01320293|450289415|FG000|Overall Study|Lack of Efficacy|1|||
125182490|NCT01320293|450289415|FG000|Overall Study|Adverse Event|1|||
125182491|NCT00470470|450289416|FG000|Overall Study|Adverse Event|2|||
125182492|NCT00470470|450289416|FG000|Overall Study|Death|2|||
125182493|NCT00470470|450289416|FG000|Overall Study|Not treated|1|||
125182494|NCT03483012|450289417|FG000|Overall Study|Lack of Efficacy|6|||
125182495|NCT04782076|450289423|FG000|Overall Study|Family Emergency|1|||
125182496|NCT01949662|450289428|FG000|Overall Study|Death|9|||
125182497|NCT01949662|450289429|FG001|Overall Study|Death|7|||
125182498|NCT01949662|450289428|FG000|Overall Study|Discharged before an agitation event|8|||
125182499|NCT01949662|450289429|FG001|Overall Study|Discharged before an agitation event|3|||
125182500|NCT01949662|450289428|FG000|Overall Study|Dropped out|1|||
125182501|NCT01949662|450289429|FG001|Overall Study|Dropped out|3|||
125182502|NCT01949662|450289428|FG000|Overall Study|Ineligible|0|||
125182503|NCT01949662|450289429|FG001|Overall Study|Ineligible|1|||
125182504|NCT00729937|450289432|FG000|Overall Study|Lost to Follow-up|49|||
125182505|NCT00729937|450289433|FG001|Overall Study|Lost to Follow-up|58|||
125182506|NCT00729937|450289434|FG002|Overall Study|Lost to Follow-up|18|||
125182507|NCT00729937|450289435|FG003|Overall Study|Lost to Follow-up|33|||
125182508|NCT00729937|450289436|FG004|Overall Study|Lost to Follow-up|18|||
125182509|NCT00729937|450289437|FG005|Overall Study|Lost to Follow-up|23|||
125182510|NCT00729937|450289432|FG000|Overall Study|Physician Decision|7|||
125182511|NCT00729937|450289433|FG001|Overall Study|Physician Decision|16|||
125182512|NCT00729937|450289434|FG002|Overall Study|Physician Decision|2|||
125182513|NCT00729937|450289435|FG003|Overall Study|Physician Decision|0|||
125182514|NCT00729937|450289436|FG004|Overall Study|Physician Decision|5|||
125182515|NCT00729937|450289437|FG005|Overall Study|Physician Decision|8|||
125182516|NCT00729937|450289432|FG000|Overall Study|Death|1|||
125182517|NCT00729937|450289433|FG001|Overall Study|Death|0|||
125182518|NCT00729937|450289434|FG002|Overall Study|Death|1|||
125182519|NCT00729937|450289435|FG003|Overall Study|Death|0|||
125182520|NCT00729937|450289436|FG004|Overall Study|Death|0|||
125182521|NCT00729937|450289437|FG005|Overall Study|Death|1|||
125182522|NCT00729937|450289432|FG000|Overall Study|Withdrawal by Subject|3|||
125182523|NCT00729937|450289433|FG001|Overall Study|Withdrawal by Subject|5|||
125182524|NCT00729937|450289434|FG002|Overall Study|Withdrawal by Subject|6|||
125182525|NCT00729937|450289435|FG003|Overall Study|Withdrawal by Subject|0|||
125182526|NCT00729937|450289436|FG004|Overall Study|Withdrawal by Subject|4|||
125182527|NCT00729937|450289437|FG005|Overall Study|Withdrawal by Subject|2|||
125182528|NCT00729937|450289432|FG000|Overall Study|Randomized but not treated|12|||
125182529|NCT00729937|450289433|FG001|Overall Study|Randomized but not treated|6|||
125182530|NCT00729937|450289434|FG002|Overall Study|Randomized but not treated|1|||
125182531|NCT00729937|450289435|FG003|Overall Study|Randomized but not treated|0|||
125182532|NCT00729937|450289436|FG004|Overall Study|Randomized but not treated|1|||
125182533|NCT00729937|450289437|FG005|Overall Study|Randomized but not treated|3|||
125182534|NCT00729937|450289432|FG000|Overall Study|Did not meet eligibility criteria|2|||
125182535|NCT00729937|450289433|FG001|Overall Study|Did not meet eligibility criteria|1|||
125182536|NCT00729937|450289434|FG002|Overall Study|Did not meet eligibility criteria|0|||
125182537|NCT00729937|450289435|FG003|Overall Study|Did not meet eligibility criteria|0|||
125182538|NCT00729937|450289436|FG004|Overall Study|Did not meet eligibility criteria|0|||
125182539|NCT00729937|450289437|FG005|Overall Study|Did not meet eligibility criteria|0|||
125182540|NCT00729937|450289432|FG000|Overall Study|Incarcerated|0|||
125182541|NCT00729937|450289433|FG001|Overall Study|Incarcerated|2|||
125182542|NCT00729937|450289434|FG002|Overall Study|Incarcerated|1|||
125182543|NCT00729937|450289435|FG003|Overall Study|Incarcerated|1|||
125182544|NCT00729937|450289436|FG004|Overall Study|Incarcerated|0|||
125182545|NCT00729937|450289437|FG005|Overall Study|Incarcerated|0|||
125182546|NCT00243412|450289439|FG000|Overall Study|Death|0|||
125182547|NCT00243412|450289440|FG001|Overall Study|Death|1|||
125182548|NCT00243412|450289439|FG000|Overall Study|Adverse Event|4|||
125182549|NCT00243412|450289440|FG001|Overall Study|Adverse Event|2|||
125182550|NCT00243412|450289439|FG000|Overall Study|Lost to Follow-up|0|||
125182551|NCT00243412|450289440|FG001|Overall Study|Lost to Follow-up|1|||
125182552|NCT00243412|450289439|FG000|Overall Study|Physician Decision|1|||
125182553|NCT00243412|450289440|FG001|Overall Study|Physician Decision|1|||
125182554|NCT00243412|450289439|FG000|Overall Study|Withdrawal by Subject|4|||
125182555|NCT00243412|450289440|FG001|Overall Study|Withdrawal by Subject|5|||
125182556|NCT00243412|450289439|FG000|Overall Study|Other|1|||
125182557|NCT00243412|450289440|FG001|Overall Study|Other|1|||
125182558|NCT02586155|450289449|FG000|Overall Study|Adverse Event|2|||
125182559|NCT02586155|450289450|FG001|Overall Study|Adverse Event|3|||
125182560|NCT02586155|450289449|FG000|Overall Study|Withdrawal by Subject|31|||
125182561|NCT02586155|450289450|FG001|Overall Study|Withdrawal by Subject|24|||
125182562|NCT02586155|450289449|FG000|Overall Study|Lost to Follow-up|7|||
125182563|NCT02586155|450289450|FG001|Overall Study|Lost to Follow-up|13|||
125182564|NCT02586155|450289449|FG000|Overall Study|Death|61|||
125182565|NCT02586155|450289450|FG001|Overall Study|Death|72|||
125182566|NCT02586155|450289449|FG000|Overall Study|Other reasons|26|||
125182567|NCT02586155|450289450|FG001|Overall Study|Other reasons|15|||
125182568|NCT04779879|450289451|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
125182569|NCT04779879|450289452|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
125182570|NCT04779879|450289453|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
125182571|NCT04779879|450289454|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
125182572|NCT04779879|450289455|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
125182573|NCT04779879|450289456|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
125182574|NCT04779879|450289451|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
125182575|NCT04779879|450289452|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
125182576|NCT04779879|450289453|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
125182577|NCT04779879|450289454|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
125182578|NCT04779879|450289455|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
125182579|NCT04779879|450289456|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
125182580|NCT04779879|450289451|FG000|Part C: Up to Week 36|Death|0|||
125182581|NCT04779879|450289452|FG001|Part C: Up to Week 36|Death|0|||
125182582|NCT04779879|450289453|FG002|Part C: Up to Week 36|Death|0|||
125182583|NCT04779879|450289454|FG003|Part C: Up to Week 36|Death|0|||
125182584|NCT04779879|450289455|FG004|Part C: Up to Week 36|Death|0|||
125182585|NCT04779879|450289456|FG005|Part C: Up to Week 36|Death|1|||
125182586|NCT04779879|450289451|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
125182587|NCT04779879|450289452|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
125182588|NCT04779879|450289453|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
125182589|NCT04779879|450289454|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
125182590|NCT04779879|450289455|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
125182591|NCT04779879|450289456|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
125182592|NCT02072980|450289457|FG000|Period 2, Second Wear|Adverse Event|0|||
125182593|NCT02072980|450289458|FG001|Period 2, Second Wear|Adverse Event|1|||
125182594|NCT00955617|450289464|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
125182595|NCT00955617|450289465|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
125182596|NCT00955617|450289464|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
125182597|NCT00955617|450289465|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
125182598|NCT00955617|450289464|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
125182599|NCT00955617|450289465|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
125182600|NCT00955617|450289464|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
125182601|NCT00955617|450289465|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
125182602|NCT00070564|450290909|FG000|Overall Study|Progression|2|||
125182603|NCT00070564|450290910|FG001|Overall Study|Progression|4|||
125182604|NCT00070564|450290911|FG002|Overall Study|Progression|7|||
125182605|NCT00070564|450290912|FG003|Overall Study|Progression|7|||
125182606|NCT00070564|450290913|FG004|Overall Study|Progression|1|||
125182607|NCT00070564|450290914|FG005|Overall Study|Progression|0|||
125182608|NCT00070564|450290909|FG000|Overall Study|Delinquent|1|||
125182609|NCT00070564|450290910|FG001|Overall Study|Delinquent|4|||
125182610|NCT00070564|450290911|FG002|Overall Study|Delinquent|2|||
125182611|NCT00070564|450290912|FG003|Overall Study|Delinquent|0|||
125182612|NCT00070564|450290913|FG004|Overall Study|Delinquent|0|||
125182613|NCT00070564|450290914|FG005|Overall Study|Delinquent|0|||
125182614|NCT00070564|450290909|FG000|Overall Study|Adverse Event|150|||
125182615|NCT00070564|450290910|FG001|Overall Study|Adverse Event|142|||
125182616|NCT00070564|450290911|FG002|Overall Study|Adverse Event|120|||
125392409|NCT00594464|451070659|FG000|Overall Study|Withdrawal by Subject|1|||
125392410|NCT00594464|451070659|FG000|Overall Study|Delay in operation|2|||
125392411|NCT00775437|451070663|FG000|Overall Study|Loss of efficacy|2|||
125182617|NCT00070564|450290912|FG003|Overall Study|Adverse Event|108|||
125182618|NCT00070564|450290913|FG004|Overall Study|Adverse Event|63|||
125182619|NCT00070564|450290914|FG005|Overall Study|Adverse Event|36|||
125182620|NCT00070564|450290909|FG000|Overall Study|Death|4|||
125182621|NCT00070564|450290910|FG001|Overall Study|Death|1|||
125182622|NCT00070564|450290911|FG002|Overall Study|Death|5|||
125182623|NCT00070564|450290912|FG003|Overall Study|Death|3|||
125182624|NCT00070564|450290913|FG004|Overall Study|Death|0|||
125182625|NCT00070564|450290914|FG005|Overall Study|Death|1|||
125182626|NCT00070564|450290909|FG000|Overall Study|Other, not protocol specified|17|||
125182627|NCT00070564|450290910|FG001|Overall Study|Other, not protocol specified|15|||
125182628|NCT00070564|450290911|FG002|Overall Study|Other, not protocol specified|14|||
125182629|NCT00070564|450290912|FG003|Overall Study|Other, not protocol specified|19|||
125182630|NCT00070564|450290913|FG004|Overall Study|Other, not protocol specified|6|||
125182631|NCT00070564|450290914|FG005|Overall Study|Other, not protocol specified|7|||
125182632|NCT00070564|450290909|FG000|Overall Study|Withdrawal by Subject|26|||
125182633|NCT00070564|450290910|FG001|Overall Study|Withdrawal by Subject|37|||
125182634|NCT00070564|450290911|FG002|Overall Study|Withdrawal by Subject|23|||
125182635|NCT00070564|450290912|FG003|Overall Study|Withdrawal by Subject|30|||
125182636|NCT00070564|450290913|FG004|Overall Study|Withdrawal by Subject|8|||
125182637|NCT00070564|450290914|FG005|Overall Study|Withdrawal by Subject|8|||
125182638|NCT00070564|450290909|FG000|Overall Study|Not reported|0|||
125182639|NCT00070564|450290910|FG001|Overall Study|Not reported|0|||
125182640|NCT00070564|450290911|FG002|Overall Study|Not reported|0|||
125182641|NCT00070564|450290912|FG003|Overall Study|Not reported|0|||
125182642|NCT00070564|450290913|FG004|Overall Study|Not reported|1|||
125182643|NCT00070564|450290914|FG005|Overall Study|Not reported|0|||
125182644|NCT04576507|450290918|FG000|Overall Study|Adverse Event|4|||
125182645|NCT04576507|450290918|FG000|Overall Study|Withdrawal by Subject|1|||
125182646|NCT01749826|450290923|FG000|Overall Study|Study Terminated|20|||
125182647|NCT01749826|450290924|FG001|Overall Study|Study Terminated|0|||
125182648|NCT02721732|450290925|FG000|Overall Study|Adverse Event|2|||
125182649|NCT02721732|450290926|FG001|Overall Study|Adverse Event|0|||
125182650|NCT02721732|450290927|FG002|Overall Study|Adverse Event|2|||
125182651|NCT02721732|450290928|FG003|Overall Study|Adverse Event|0|||
125182652|NCT02721732|450290929|FG004|Overall Study|Adverse Event|1|||
125182653|NCT02721732|450290930|FG005|Overall Study|Adverse Event|0|||
125182654|NCT02721732|450290931|FG006|Overall Study|Adverse Event|1|||
125182655|NCT02721732|450290932|FG007|Overall Study|Adverse Event|0|||
125182656|NCT02721732|450290933|FG008|Overall Study|Adverse Event|1|||
125182657|NCT02721732|450290934|FG009|Overall Study|Adverse Event|1|||
125182658|NCT02721732|450290925|FG000|Overall Study|Death|0|||
125182659|NCT02721732|450290926|FG001|Overall Study|Death|0|||
125182660|NCT02721732|450290927|FG002|Overall Study|Death|0|||
125182661|NCT02721732|450290928|FG003|Overall Study|Death|0|||
125182662|NCT02721732|450290929|FG004|Overall Study|Death|1|||
125182663|NCT02721732|450290930|FG005|Overall Study|Death|0|||
125182664|NCT02721732|450290931|FG006|Overall Study|Death|1|||
125182665|NCT02721732|450290932|FG007|Overall Study|Death|0|||
125182666|NCT02721732|450290933|FG008|Overall Study|Death|0|||
125182667|NCT02721732|450290934|FG009|Overall Study|Death|1|||
125182668|NCT02721732|450290925|FG000|Overall Study|Lack of Efficacy|12|||
125182669|NCT02721732|450290926|FG001|Overall Study|Lack of Efficacy|11|||
125182670|NCT02721732|450290927|FG002|Overall Study|Lack of Efficacy|18|||
125182671|NCT02721732|450290928|FG003|Overall Study|Lack of Efficacy|5|||
125182672|NCT02721732|450290929|FG004|Overall Study|Lack of Efficacy|21|||
125182673|NCT02721732|450290930|FG005|Overall Study|Lack of Efficacy|2|||
125182674|NCT02721732|450290931|FG006|Overall Study|Lack of Efficacy|8|||
125182675|NCT02721732|450290932|FG007|Overall Study|Lack of Efficacy|11|||
125182676|NCT02721732|450290933|FG008|Overall Study|Lack of Efficacy|10|||
125182677|NCT02721732|450290934|FG009|Overall Study|Lack of Efficacy|20|||
125182678|NCT02721732|450290925|FG000|Overall Study|Physician Decision|0|||
125182679|NCT02721732|450290926|FG001|Overall Study|Physician Decision|0|||
125182680|NCT02721732|450290927|FG002|Overall Study|Physician Decision|1|||
125182681|NCT02721732|450290928|FG003|Overall Study|Physician Decision|0|||
125182682|NCT02721732|450290929|FG004|Overall Study|Physician Decision|0|||
125392412|NCT00775437|451070663|FG000|Overall Study|Withdrawal by Subject|3|||
125392413|NCT00775437|451070663|FG000|Overall Study|Lost to Follow-up|1|||
125182683|NCT02721732|450290930|FG005|Overall Study|Physician Decision|0|||
125182684|NCT02721732|450290931|FG006|Overall Study|Physician Decision|0|||
125182685|NCT02721732|450290932|FG007|Overall Study|Physician Decision|0|||
125182686|NCT02721732|450290933|FG008|Overall Study|Physician Decision|0|||
125182687|NCT02721732|450290934|FG009|Overall Study|Physician Decision|0|||
125182688|NCT02721732|450290925|FG000|Overall Study|Withdrawal by Subject|1|||
125182689|NCT02721732|450290926|FG001|Overall Study|Withdrawal by Subject|0|||
125182690|NCT02721732|450290927|FG002|Overall Study|Withdrawal by Subject|0|||
125182691|NCT02721732|450290928|FG003|Overall Study|Withdrawal by Subject|0|||
125182692|NCT02721732|450290929|FG004|Overall Study|Withdrawal by Subject|3|||
125182693|NCT02721732|450290930|FG005|Overall Study|Withdrawal by Subject|0|||
125182694|NCT02721732|450290931|FG006|Overall Study|Withdrawal by Subject|1|||
125182695|NCT02721732|450290932|FG007|Overall Study|Withdrawal by Subject|1|||
125182696|NCT02721732|450290933|FG008|Overall Study|Withdrawal by Subject|0|||
125182697|NCT02721732|450290934|FG009|Overall Study|Withdrawal by Subject|1|||
125182698|NCT02721732|450290925|FG000|Overall Study|Participant Choice|1|||
125182699|NCT02721732|450290926|FG001|Overall Study|Participant Choice|0|||
125182700|NCT02721732|450290927|FG002|Overall Study|Participant Choice|0|||
125182701|NCT02721732|450290928|FG003|Overall Study|Participant Choice|0|||
125182702|NCT02721732|450290929|FG004|Overall Study|Participant Choice|0|||
125182703|NCT02721732|450290930|FG005|Overall Study|Participant Choice|0|||
125182704|NCT02721732|450290931|FG006|Overall Study|Participant Choice|0|||
125182705|NCT02721732|450290932|FG007|Overall Study|Participant Choice|0|||
125182706|NCT02721732|450290933|FG008|Overall Study|Participant Choice|0|||
125182707|NCT02721732|450290934|FG009|Overall Study|Participant Choice|1|||
125182708|NCT02721732|450290925|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182709|NCT02721732|450290926|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182710|NCT02721732|450290927|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
125182711|NCT02721732|450290928|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182712|NCT02721732|450290929|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182713|NCT02721732|450290930|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182714|NCT02721732|450290931|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182715|NCT02721732|450290932|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182716|NCT02721732|450290933|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182717|NCT02721732|450290934|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
125182718|NCT02721732|450290925|FG000|Overall Study|Progression and withdrew consent|1|||
125182719|NCT02721732|450290926|FG001|Overall Study|Progression and withdrew consent|1|||
125182720|NCT02721732|450290927|FG002|Overall Study|Progression and withdrew consent|0|||
125182721|NCT02721732|450290928|FG003|Overall Study|Progression and withdrew consent|0|||
125182722|NCT02721732|450290929|FG004|Overall Study|Progression and withdrew consent|0|||
125182723|NCT02721732|450290930|FG005|Overall Study|Progression and withdrew consent|0|||
125182724|NCT02721732|450290931|FG006|Overall Study|Progression and withdrew consent|0|||
125182725|NCT02721732|450290932|FG007|Overall Study|Progression and withdrew consent|0|||
125182726|NCT02721732|450290933|FG008|Overall Study|Progression and withdrew consent|0|||
125182727|NCT02721732|450290934|FG009|Overall Study|Progression and withdrew consent|1|||
125182728|NCT02721732|450290925|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
125182729|NCT02721732|450290926|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
125182730|NCT02721732|450290927|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
125182731|NCT02721732|450290928|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
125182732|NCT02721732|450290929|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
125182733|NCT02721732|450290930|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
125182734|NCT02721732|450290931|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
125182735|NCT02721732|450290932|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
125182736|NCT02721732|450290933|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
125182737|NCT02721732|450290934|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
125182738|NCT02572570|450290941|FG000|Overall Study|Study Terminated|27|||
125182739|NCT02763046|450290942|FG000|Overall Study|Adverse Event|5|||
125182740|NCT02763046|450290943|FG001|Overall Study|Adverse Event|4|||
125182741|NCT02763046|450290944|FG002|Overall Study|Adverse Event|0|||
125182742|NCT02763046|450290942|FG000|Overall Study|Lack of Efficacy|1|||
125182743|NCT02763046|450290943|FG001|Overall Study|Lack of Efficacy|1|||
125182744|NCT02763046|450290944|FG002|Overall Study|Lack of Efficacy|3|||
125182745|NCT02763046|450290942|FG000|Overall Study|Physician Decision|1|||
125182746|NCT02763046|450290943|FG001|Overall Study|Physician Decision|0|||
125182747|NCT02763046|450290944|FG002|Overall Study|Physician Decision|1|||
125182748|NCT02763046|450290942|FG000|Overall Study|Subject/guardian decision|2|||
125182749|NCT02763046|450290943|FG001|Overall Study|Subject/guardian decision|0|||
125182750|NCT02763046|450290944|FG002|Overall Study|Subject/guardian decision|4|||
125182751|NCT03052751|450290948|FG000|Dosing Period 1|Adverse Event|0|||
125182752|NCT03052751|450290949|FG001|Dosing Period 1|Adverse Event|1|||
125182753|NCT03052751|450290950|FG002|Dosing Period 1|Adverse Event|0|||
125182754|NCT03052751|450290951|FG003|Dosing Period 1|Adverse Event|0|||
125182755|NCT03052751|450290952|FG004|Dosing Period 1|Adverse Event|0|||
125182756|NCT03052751|450290953|FG005|Dosing Period 1|Adverse Event|0|||
125182757|NCT03052751|450290948|FG000|Dosing Period 2|Adverse Event|0|||
125182758|NCT03052751|450290949|FG001|Dosing Period 2|Adverse Event|0|||
125182759|NCT03052751|450290950|FG002|Dosing Period 2|Adverse Event|3|||
125182760|NCT03052751|450290951|FG003|Dosing Period 2|Adverse Event|0|||
125182761|NCT03052751|450290952|FG004|Dosing Period 2|Adverse Event|0|||
125182762|NCT03052751|450290953|FG005|Dosing Period 2|Adverse Event|0|||
125182763|NCT03052751|450290948|FG000|Observation Period|Adverse Event|0|||
125182764|NCT03052751|450290949|FG001|Observation Period|Adverse Event|0|||
125392414|NCT01183975|451070664|FG000|Overall Study|Lost to Follow-up|73|||
125392415|NCT02907359|451070665|FG000|Overall Study|Death|234|||
125392416|NCT02907359|451070666|FG001|Overall Study|Death|117|||
125392417|NCT02907359|451070665|FG000|Overall Study|Withdrawal by Subject|6|||
125182765|NCT03052751|450290950|FG002|Observation Period|Adverse Event|0|||
125182766|NCT03052751|450290951|FG003|Observation Period|Adverse Event|0|||
125182767|NCT03052751|450290952|FG004|Observation Period|Adverse Event|1|||
125182768|NCT03052751|450290953|FG005|Observation Period|Adverse Event|0|||
125182769|NCT05017246|450290954|FG000|Overall Study|Withdrawal by Subject|5|||
125182770|NCT05017246|450290955|FG001|Overall Study|Withdrawal by Subject|3|||
125182771|NCT05017246|450290954|FG000|Overall Study|Determined to be ineligible|0|||
125182772|NCT05017246|450290955|FG001|Overall Study|Determined to be ineligible|1|||
125182773|NCT05017246|450290954|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
125182774|NCT05017246|450290955|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
125182775|NCT05017246|450290954|FG000|Overall Study|Technical failure|1|||
125182776|NCT05017246|450290955|FG001|Overall Study|Technical failure|3|||
125182777|NCT02719184|450290956|FG000|Overall Study|Other than listed|1|||
125182778|NCT02719184|450290957|FG001|Overall Study|Other than listed|12|||
125182779|NCT02719184|450290958|FG002|Overall Study|Other than listed|13|||
125182780|NCT02719184|450290959|FG003|Overall Study|Other than listed|22|||
125182781|NCT02719184|450290960|FG004|Overall Study|Other than listed|9|||
125182782|NCT02719184|450290956|FG000|Overall Study|Withdrawal by Subject|5|||
125182783|NCT02719184|450290957|FG001|Overall Study|Withdrawal by Subject|3|||
125182784|NCT02719184|450290958|FG002|Overall Study|Withdrawal by Subject|6|||
125182785|NCT02719184|450290959|FG003|Overall Study|Withdrawal by Subject|6|||
125182786|NCT02719184|450290960|FG004|Overall Study|Withdrawal by Subject|0|||
125182787|NCT02719184|450290956|FG000|Overall Study|Lost to Follow-up|0|||
125182788|NCT02719184|450290957|FG001|Overall Study|Lost to Follow-up|4|||
125182789|NCT02719184|450290958|FG002|Overall Study|Lost to Follow-up|1|||
125182790|NCT02719184|450290959|FG003|Overall Study|Lost to Follow-up|3|||
125182791|NCT02719184|450290960|FG004|Overall Study|Lost to Follow-up|0|||
125182792|NCT02719184|450290956|FG000|Overall Study|Protocol Violation|0|||
125182793|NCT02719184|450290957|FG001|Overall Study|Protocol Violation|3|||
125182794|NCT02719184|450290958|FG002|Overall Study|Protocol Violation|0|||
125182795|NCT02719184|450290959|FG003|Overall Study|Protocol Violation|2|||
125182796|NCT02719184|450290960|FG004|Overall Study|Protocol Violation|0|||
125182797|NCT02719184|450290956|FG000|Overall Study|Adverse Event|0|||
125182798|NCT02719184|450290957|FG001|Overall Study|Adverse Event|0|||
125182799|NCT02719184|450290958|FG002|Overall Study|Adverse Event|0|||
125182800|NCT02719184|450290959|FG003|Overall Study|Adverse Event|3|||
125182801|NCT02719184|450290960|FG004|Overall Study|Adverse Event|0|||
125182802|NCT02439216|450290961|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
125182803|NCT02439216|450290962|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182804|NCT02439216|450290963|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182805|NCT02439216|450290964|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182806|NCT02439216|450290965|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182807|NCT02439216|450290966|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182808|NCT02439216|450290967|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182809|NCT02439216|450290968|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182810|NCT02439216|450290969|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
125182811|NCT02439216|450290961|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182812|NCT02439216|450290962|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182813|NCT02439216|450290963|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182814|NCT02439216|450290964|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182815|NCT02439216|450290965|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182816|NCT02439216|450290966|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182817|NCT02439216|450290967|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182818|NCT02439216|450290968|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
125182819|NCT02439216|450290969|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
125182820|NCT02439216|450290961|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182821|NCT02439216|450290962|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182822|NCT02439216|450290963|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182823|NCT02439216|450290964|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182824|NCT02439216|450290965|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182825|NCT02439216|450290966|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182826|NCT02439216|450290967|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
125182827|NCT02439216|450290968|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
125182828|NCT02439216|450290969|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
125392418|NCT02907359|451070666|FG001|Overall Study|Withdrawal by Subject|11|||
125392419|NCT02907359|451070665|FG000|Overall Study|Lost to Follow-up|1|||
125392420|NCT02907359|451070666|FG001|Overall Study|Lost to Follow-up|0|||
125182829|NCT02439216|450290961|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182830|NCT02439216|450290962|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182831|NCT02439216|450290963|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182832|NCT02439216|450290964|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182833|NCT02439216|450290965|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182834|NCT02439216|450290966|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182835|NCT02439216|450290967|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182836|NCT02439216|450290968|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
125182837|NCT02439216|450290969|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
125182838|NCT02439216|450290961|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182839|NCT02439216|450290962|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182840|NCT02439216|450290963|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182841|NCT02439216|450290964|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182842|NCT02439216|450290965|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182843|NCT02439216|450290966|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182844|NCT02439216|450290967|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
125182845|NCT02439216|450290968|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
125182846|NCT02439216|450290969|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
125182847|NCT03359850|450290971|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
125182848|NCT03359850|450290972|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
125182849|NCT03359850|450290971|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
125182850|NCT03359850|450290972|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
125182851|NCT03359850|450290971|FG000|Extension Phase (Up to 28 Months)|Death|2|||
125182852|NCT03359850|450290972|FG001|Extension Phase (Up to 28 Months)|Death|4|||
125182853|NCT03359850|450290971|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
125182854|NCT03359850|450290972|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
125182855|NCT03359850|450290971|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
125182856|NCT03359850|450290972|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
125182857|NCT03472014|450290975|FG000|Overall Study|Lost to Follow-up|4|||
125182858|NCT02792517|450290976|FG000|Overall Study|Withdrawal by Subject|10|||
125182859|NCT02792517|450290976|FG000|Overall Study|Decision by Sponsor|7|||
125182860|NCT02792517|450290976|FG000|Overall Study|Lost to Follow-up|3|||
125182861|NCT03743051|450290981|FG000|Overall Study|Adverse Event|5|||
125182862|NCT03743051|450290982|FG001|Overall Study|Adverse Event|9|||
125182863|NCT03743051|450290981|FG000|Overall Study|Death|27|||
125182864|NCT03743051|450290982|FG001|Overall Study|Death|26|||
125182865|NCT03743051|450290981|FG000|Overall Study|Lost to Follow-up|4|||
125182866|NCT03743051|450290982|FG001|Overall Study|Lost to Follow-up|8|||
125182867|NCT03743051|450290981|FG000|Overall Study|Withdrawal by Subject|32|||
125182868|NCT03743051|450290982|FG001|Overall Study|Withdrawal by Subject|19|||
125182869|NCT03743051|450290981|FG000|Overall Study|Physician Decision|10|||
125182870|NCT03743051|450290982|FG001|Overall Study|Physician Decision|15|||
125182871|NCT03743051|450290981|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
125182872|NCT03743051|450290982|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
125182873|NCT00811733|450290983|FG000|Overall Study|Investigator Discretion|10|||
125182874|NCT00811733|450290984|FG001|Overall Study|Investigator Discretion|8|||
125182875|NCT00811733|450290983|FG000|Overall Study|Withdrawal by Subject|1|||
125182876|NCT00811733|450290984|FG001|Overall Study|Withdrawal by Subject|2|||
125182877|NCT00793871|450290985|FG000|Overall Study|Death|50|||
125182878|NCT00793871|450290985|FG000|Overall Study|Lost to Follow-up|3|||
125182879|NCT00793871|450290985|FG000|Overall Study|Study terminated by the Sponsor|7|||
125182880|NCT02500589|450290987|FG000|Overall Study|Withdrawal by Subject|11|||
125182881|NCT02500589|450290988|FG001|Overall Study|Withdrawal by Subject|14|||
125182882|NCT02500589|450290987|FG000|Overall Study|Lost to Follow-up|10|||
125182883|NCT02500589|450290988|FG001|Overall Study|Lost to Follow-up|12|||
125182884|NCT02500589|450290987|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
125182885|NCT02500589|450290988|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
125182886|NCT02500589|450290987|FG000|Overall Study|Death|7|||
125182887|NCT02500589|450290988|FG001|Overall Study|Death|5|||
125182888|NCT03652051|450290989|FG000|Stage 1|Adverse Event|0|||
125182889|NCT03652051|450290990|FG001|Stage 1|Adverse Event|5|||
125182890|NCT03652051|450290991|FG002|Stage 1|Adverse Event|7|||
125182891|NCT03652051|450290992|FG003|Stage 1|Adverse Event|1|||
125182892|NCT03652051|450290989|FG000|Stage 1|Withdrawal by Subject|0|||
125182893|NCT03652051|450290990|FG001|Stage 1|Withdrawal by Subject|0|||
125182894|NCT03652051|450290991|FG002|Stage 1|Withdrawal by Subject|1|||
125182895|NCT03652051|450290992|FG003|Stage 1|Withdrawal by Subject|0|||
125182896|NCT03652051|450290989|FG000|Stage 2|Adverse Event|0|||
125182897|NCT03652051|450290990|FG001|Stage 2|Adverse Event|2|||
125182898|NCT03652051|450290991|FG002|Stage 2|Adverse Event|1|||
125182899|NCT03652051|450290992|FG003|Stage 2|Adverse Event|0|||
125182900|NCT03652051|450290989|FG000|Stage 2|Protocol Violation|0|||
125182901|NCT03652051|450290990|FG001|Stage 2|Protocol Violation|1|||
125182902|NCT03652051|450290991|FG002|Stage 2|Protocol Violation|6|||
125182903|NCT03652051|450290992|FG003|Stage 2|Protocol Violation|0|||
125182904|NCT03652051|450290989|FG000|Stage 2|Lost to Follow-up|0|||
125182905|NCT03652051|450290990|FG001|Stage 2|Lost to Follow-up|2|||
125182906|NCT03652051|450290991|FG002|Stage 2|Lost to Follow-up|0|||
125182907|NCT03652051|450290992|FG003|Stage 2|Lost to Follow-up|3|||
125182908|NCT03652051|450290989|FG000|Stage 2|Withdrawal by Subject|0|||
125182909|NCT03652051|450290990|FG001|Stage 2|Withdrawal by Subject|11|||
125182910|NCT03652051|450290991|FG002|Stage 2|Withdrawal by Subject|9|||
125182911|NCT03652051|450290992|FG003|Stage 2|Withdrawal by Subject|3|||
125182912|NCT03442751|450290996|FG000|Overall Study|Withdrawal by Subject|3|||
125182913|NCT03442751|450290997|FG001|Overall Study|Withdrawal by Subject|1|||
125182914|NCT03442751|450290996|FG000|Overall Study|Lost to Follow-up|3|||
125182915|NCT03442751|450290997|FG001|Overall Study|Lost to Follow-up|0|||
125182916|NCT02766335|450290999|FG000|Initial Registration|Adverse Event|6|||
125182917|NCT02766335|450291000|FG001|Initial Registration|Adverse Event|3|||
125182918|NCT02766335|450291001|FG002|Initial Registration|Adverse Event|0|||
125182919|NCT02766335|450290999|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
125182920|NCT02766335|450291000|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
125182921|NCT02766335|450291001|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
125182922|NCT02766335|450290999|FG000|Initial Registration|Progression/relapse|49|||
125182923|NCT02766335|450291000|FG001|Initial Registration|Progression/relapse|15|||
125182924|NCT02766335|450291001|FG002|Initial Registration|Progression/relapse|0|||
125182925|NCT02766335|450290999|FG000|Initial Registration|Death|1|||
125182926|NCT02766335|450291000|FG001|Initial Registration|Death|3|||
125182927|NCT02766335|450291001|FG002|Initial Registration|Death|0|||
125182928|NCT02766335|450290999|FG000|Initial Registration|not protocol specified|1|||
125182929|NCT02766335|450291000|FG001|Initial Registration|not protocol specified|9|||
125182930|NCT02766335|450291001|FG002|Initial Registration|not protocol specified|0|||
125182931|NCT02766335|450290999|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
125182932|NCT02766335|450291000|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
125182933|NCT02766335|450291001|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
125182934|NCT02766335|450290999|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
125182935|NCT02766335|450291000|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
125182936|NCT02766335|450291001|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
125182937|NCT01515423|450291008|FG000|Open Label Phase|Adverse Event|57|||
125182938|NCT01515423|450291009|FG001|Open Label Phase|Adverse Event|0|||
125182939|NCT01515423|450291010|FG002|Open Label Phase|Adverse Event|0|||
125182940|NCT01515423|450291008|FG000|Open Label Phase|Death|2|||
125182941|NCT01515423|450291009|FG001|Open Label Phase|Death|0|||
125182942|NCT01515423|450291010|FG002|Open Label Phase|Death|0|||
125182943|NCT01515423|450291008|FG000|Open Label Phase|Lack of Efficacy|117|||
125182944|NCT01515423|450291009|FG001|Open Label Phase|Lack of Efficacy|0|||
125182945|NCT01515423|450291010|FG002|Open Label Phase|Lack of Efficacy|0|||
125182946|NCT01515423|450291008|FG000|Open Label Phase|Lost to Follow-up|21|||
125182947|NCT01515423|450291009|FG001|Open Label Phase|Lost to Follow-up|0|||
125182948|NCT01515423|450291010|FG002|Open Label Phase|Lost to Follow-up|0|||
125182949|NCT01515423|450291008|FG000|Open Label Phase|Withdrawal by Subject|118|||
125182950|NCT01515423|450291009|FG001|Open Label Phase|Withdrawal by Subject|0|||
125182951|NCT01515423|450291010|FG002|Open Label Phase|Withdrawal by Subject|0|||
125182952|NCT01515423|450291008|FG000|Open Label Phase|excluded from DB Phase|70|||
125182953|NCT01515423|450291009|FG001|Open Label Phase|excluded from DB Phase|0|||
125182954|NCT01515423|450291010|FG002|Open Label Phase|excluded from DB Phase|0|||
125182955|NCT01515423|450291008|FG000|Open Label Phase|Other|28|||
125182956|NCT01515423|450291009|FG001|Open Label Phase|Other|0|||
125182957|NCT01515423|450291010|FG002|Open Label Phase|Other|0|||
125182958|NCT01515423|450291008|FG000|DOUBLE BLIND|Adverse Event|0|||
125182959|NCT01515423|450291009|FG001|DOUBLE BLIND|Adverse Event|15|||
125182960|NCT01515423|450291010|FG002|DOUBLE BLIND|Adverse Event|13|||
125182961|NCT01515423|450291008|FG000|DOUBLE BLIND|Death|0|||
125182962|NCT01515423|450291009|FG001|DOUBLE BLIND|Death|1|||
125182963|NCT01515423|450291010|FG002|DOUBLE BLIND|Death|2|||
125182964|NCT01515423|450291008|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
125182965|NCT01515423|450291009|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
125182966|NCT01515423|450291010|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
125182967|NCT01515423|450291008|FG000|DOUBLE BLIND|Pregnancy|0|||
125182968|NCT01515423|450291009|FG001|DOUBLE BLIND|Pregnancy|2|||
125182969|NCT01515423|450291010|FG002|DOUBLE BLIND|Pregnancy|0|||
125182970|NCT01515423|450291008|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
125182971|NCT01515423|450291009|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
125182972|NCT01515423|450291010|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
125182973|NCT01515423|450291008|FG000|DOUBLE BLIND|Other|0|||
125182974|NCT01515423|450291009|FG001|DOUBLE BLIND|Other|6|||
125182975|NCT01515423|450291010|FG002|DOUBLE BLIND|Other|12|||
125182976|NCT01515423|450291008|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
125182977|NCT01515423|450291009|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
125182978|NCT01515423|450291010|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
125182979|NCT04421131|450291013|FG000|Overall Study|Lost to Follow-up|1|||
125182980|NCT04421131|450291013|FG000|Overall Study|Protocol Violation|2|||
125182981|NCT04421131|450291013|FG000|Overall Study|App crashed|5|||
125182982|NCT02501928|450291014|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
125182983|NCT02501928|450291015|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
125182984|NCT02501928|450291016|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
125182985|NCT02501928|450291017|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
125182986|NCT02501928|450291018|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
125182987|NCT02501928|450291019|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
125182988|NCT02452476|450291023|FG000|Overall Study|Death|4|||
125182989|NCT02452476|450291024|FG001|Overall Study|Death|7|||
125182990|NCT02452476|450291023|FG000|Overall Study|Lost to Follow-up|1|||
125182991|NCT02452476|450291024|FG001|Overall Study|Lost to Follow-up|1|||
125182992|NCT02452476|450291023|FG000|Overall Study|Physician Decision|1|||
125182993|NCT02452476|450291024|FG001|Overall Study|Physician Decision|1|||
125182994|NCT02452476|450291023|FG000|Overall Study|Not treated|5|||
125182995|NCT02452476|450291024|FG001|Overall Study|Not treated|1|||
125182996|NCT02201784|450291025|FG000|Overall Study|Failure to achieve adequate block|2|||
125182997|NCT02201784|450291026|FG001|Overall Study|Failure to achieve adequate block|0|||
125182998|NCT01757275|450291027|FG000|Overall Study|Lost to Follow-up|1|||
125182999|NCT01757275|450291028|FG001|Overall Study|Lost to Follow-up|2|||
125183000|NCT01757275|450291027|FG000|Overall Study|Adverse Event|3|||
125183001|NCT01757275|450291028|FG001|Overall Study|Adverse Event|3|||
125183002|NCT01757275|450291027|FG000|Overall Study|Withdrawal by Subject|2|||
125183003|NCT01757275|450291028|FG001|Overall Study|Withdrawal by Subject|4|||
125183004|NCT01757275|450291027|FG000|Overall Study|Not treated|3|||
125183005|NCT01757275|450291028|FG001|Overall Study|Not treated|4|||
125183006|NCT01401452|450291031|FG000|Overall Study|Adverse reaction|9|||
125183007|NCT01401452|450291031|FG000|Overall Study|Lost to Follow-up|12|||
125183008|NCT01401452|450291031|FG000|Overall Study|Lack of Efficacy|30|||
125183009|NCT01401452|450291031|FG000|Overall Study|Participant developed breast cancer|1|||
125183010|NCT01401452|450291031|FG000|Overall Study|Tx stopped due to financial reasons|1|||
125183011|NCT01401452|450291031|FG000|Overall Study|Tx stopped by psychiatrist|1|||
125183012|NCT01401452|450291031|FG000|Overall Study|No more visits within the 36 wk followup|4|||
125183013|NCT01401452|450291031|FG000|Overall Study|Subject did not come to follow up visits|2|||
125183014|NCT01401452|450291031|FG000|Overall Study|Subject didn't return for routine visits|1|||
125183015|NCT01401452|450291031|FG000|Overall Study|Subject moved to another city|1|||
125183016|NCT01401452|450291031|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
125183017|NCT01401452|450291031|FG000|Overall Study|Psoriatic arthritis|1|||
125183018|NCT01401452|450291031|FG000|Overall Study|Participant stopped Tx|2|||
125183019|NCT01401452|450291031|FG000|Overall Study|Discontinuation for personal reasons|1|||
125183020|NCT01401452|450291031|FG000|Overall Study|Treatment failure|1|||
125183021|NCT01401452|450291031|FG000|Overall Study|Unsatisfactory output|1|||
125183022|NCT01401452|450291031|FG000|Overall Study|Subject withdrew because of Tx success|1|||
125183023|NCT01401452|450291031|FG000|Overall Study|Subject chose to discontinue treatment|1|||
125183024|NCT01401452|450291031|FG000|Overall Study|Participant withdrew consent|1|||
125183025|NCT02654054|450291033|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
125183026|NCT02654054|450291034|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
125183027|NCT02654054|450291035|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
125183028|NCT02654054|450291033|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
125183029|NCT02654054|450291034|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
125183030|NCT02654054|450291035|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
125183031|NCT02654054|450291033|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
125183032|NCT02654054|450291034|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
125183033|NCT02654054|450291035|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
125183034|NCT02654054|450291033|FG000|Post-Treatment Follow-Up Period|Other|1|||
125183035|NCT02654054|450291034|FG001|Post-Treatment Follow-Up Period|Other|0|||
125183036|NCT02654054|450291035|FG002|Post-Treatment Follow-Up Period|Other|4|||
125183037|NCT02654054|450291033|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
125183038|NCT02654054|450291034|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
125183039|NCT02654054|450291035|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
125183040|NCT00420420|450291036|FG000|Overall Study|Adverse Event|5|||
125183041|NCT00420420|450291037|FG001|Overall Study|Adverse Event|3|||
125183042|NCT00420420|450291036|FG000|Overall Study|Protocol Violation|1|||
125183043|NCT00420420|450291037|FG001|Overall Study|Protocol Violation|1|||
125183044|NCT00420420|450291036|FG000|Overall Study|Withdrawal by Subject|1|||
125183045|NCT00420420|450291037|FG001|Overall Study|Withdrawal by Subject|0|||
125183046|NCT00420420|450291036|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
125183047|NCT00420420|450291037|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
125183048|NCT00273182|450291038|FG000|Overall Study|Death|450|||
125183049|NCT00273182|450291038|FG000|Overall Study|Lost to Follow-up|88|||
125183050|NCT00273182|450291038|FG000|Overall Study|Withdrawal by Subject|257|||
125183051|NCT00273182|450291038|FG000|Overall Study|Device/System Explant|154|||
125183052|NCT00273182|450291038|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
125183053|NCT00856492|450291039|FG000|Overall Study|Ineligible or withdrew consent|1|||
125183054|NCT00856492|450291040|FG001|Overall Study|Ineligible or withdrew consent|1|||
125183055|NCT00856492|450291041|FG002|Overall Study|Ineligible or withdrew consent|2|||
125183056|NCT05842967|450292973|FG000|Period 1: SSA|Adverse Event|1|||
125183057|NCT05842967|450292974|FG001|Period 1: SSA|Adverse Event|1|||
125183058|NCT05842967|450292975|FG002|Period 1: SSA|Adverse Event|0|||
125183059|NCT05842967|450292976|FG003|Period 1: SSA|Adverse Event|0|||
125183060|NCT05842967|450292973|FG000|Period 1: SSA|Death|1|||
125183061|NCT05842967|450292974|FG001|Period 1: SSA|Death|0|||
125183062|NCT05842967|450292975|FG002|Period 1: SSA|Death|0|||
125183063|NCT05842967|450292976|FG003|Period 1: SSA|Death|0|||
125183064|NCT05842967|450292973|FG000|Period 1: SSA|Lost to Follow-up|16|||
125183065|NCT05842967|450292974|FG001|Period 1: SSA|Lost to Follow-up|4|||
125183066|NCT05842967|450292975|FG002|Period 1: SSA|Lost to Follow-up|0|||
125183067|NCT05842967|450292976|FG003|Period 1: SSA|Lost to Follow-up|0|||
125183068|NCT05842967|450292973|FG000|Period 1: SSA|Physician Decision|1|||
125183069|NCT05842967|450292974|FG001|Period 1: SSA|Physician Decision|0|||
125183070|NCT05842967|450292975|FG002|Period 1: SSA|Physician Decision|0|||
125183071|NCT05842967|450292976|FG003|Period 1: SSA|Physician Decision|0|||
125183072|NCT05842967|450292973|FG000|Period 1: SSA|Withdrawal by Subject|2|||
125183073|NCT05842967|450292974|FG001|Period 1: SSA|Withdrawal by Subject|2|||
125183074|NCT05842967|450292975|FG002|Period 1: SSA|Withdrawal by Subject|0|||
125183075|NCT05842967|450292976|FG003|Period 1: SSA|Withdrawal by Subject|0|||
125183076|NCT05842967|450292973|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
125183077|NCT05842967|450292974|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
125183078|NCT05842967|450292975|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
125183079|NCT05842967|450292976|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
125183080|NCT05842967|450292973|FG000|Period 2: SSB|Adverse Event|0|||
125183081|NCT05842967|450292974|FG001|Period 2: SSB|Adverse Event|0|||
125183082|NCT05842967|450292975|FG002|Period 2: SSB|Adverse Event|2|||
125183083|NCT05842967|450292976|FG003|Period 2: SSB|Adverse Event|0|||
125183084|NCT05842967|450292973|FG000|Period 2: SSB|Lost to Follow-up|0|||
125183085|NCT05842967|450292974|FG001|Period 2: SSB|Lost to Follow-up|0|||
125183086|NCT05842967|450292975|FG002|Period 2: SSB|Lost to Follow-up|4|||
125183087|NCT05842967|450292976|FG003|Period 2: SSB|Lost to Follow-up|3|||
125183088|NCT05842967|450292973|FG000|Period 2: SSB|Withdrawal by Subject|0|||
125183089|NCT05842967|450292974|FG001|Period 2: SSB|Withdrawal by Subject|0|||
125183090|NCT05842967|450292975|FG002|Period 2: SSB|Withdrawal by Subject|1|||
125183091|NCT05842967|450292976|FG003|Period 2: SSB|Withdrawal by Subject|0|||
125183092|NCT05842967|450292973|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
125183093|NCT05842967|450292974|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
125183094|NCT05842967|450292975|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
125183095|NCT05842967|450292976|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
125183096|NCT05842967|450292973|FG000|Period 2: SSB|Protocol Violation|0|||
125183097|NCT05842967|450292974|FG001|Period 2: SSB|Protocol Violation|0|||
125183098|NCT05842967|450292975|FG002|Period 2: SSB|Protocol Violation|0|||
125183099|NCT05842967|450292976|FG003|Period 2: SSB|Protocol Violation|1|||
125183100|NCT01103180|450292977|FG000|Overall Study|Withdrawal by Subject|8|||
125183101|NCT01103180|450292978|FG001|Overall Study|Withdrawal by Subject|13|||
125183102|NCT01103180|450292977|FG000|Overall Study|Lost to Follow-up|13|||
125183103|NCT01103180|450292978|FG001|Overall Study|Lost to Follow-up|7|||
125183104|NCT01103180|450292977|FG000|Overall Study|Physician Decision|1|||
125183105|NCT01103180|450292978|FG001|Overall Study|Physician Decision|0|||
125183106|NCT01103180|450292977|FG000|Overall Study|Protocol Violation|0|||
125183107|NCT01103180|450292978|FG001|Overall Study|Protocol Violation|1|||
125183108|NCT01173523|450292979|FG000|Overall Study|Clinical Progression|1|||
125183109|NCT01173523|450292980|FG001|Overall Study|Clinical Progression|1|||
125183110|NCT01173523|450292979|FG000|Overall Study|Progressive Disease|10|||
125183111|NCT01173523|450292980|FG001|Overall Study|Progressive Disease|8|||
125183112|NCT01173523|450292979|FG000|Overall Study|Other|2|||
125183113|NCT01173523|450292980|FG001|Overall Study|Other|3|||
125183114|NCT01439802|450292985|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
125183115|NCT01439802|450292985|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
125183116|NCT01866826|450292986|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
125392421|NCT01405963|451070667|FG000|Overall Study|Moved Away|2|||
125183117|NCT01866826|450292987|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
125183118|NCT01866826|450292986|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
125183119|NCT01866826|450292987|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
125183120|NCT01866826|450292986|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
125183121|NCT01866826|450292987|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
125183122|NCT02493660|450292988|FG000|Overall Study|Physician Decision|0|||
125183123|NCT02493660|450292989|FG001|Overall Study|Physician Decision|1|||
125183124|NCT02493660|450292988|FG000|Overall Study|Adverse Event|4|||
125183125|NCT02493660|450292989|FG001|Overall Study|Adverse Event|2|||
125183126|NCT02493660|450292988|FG000|Overall Study|Withdrawal by Subject|2|||
125183127|NCT02493660|450292989|FG001|Overall Study|Withdrawal by Subject|3|||
125183128|NCT02493660|450292988|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
125183129|NCT02493660|450292989|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
125183130|NCT02493660|450292988|FG000|Overall Study|Protocol Violation|0|||
125183131|NCT02493660|450292989|FG001|Overall Study|Protocol Violation|1|||
125183132|NCT02493660|450292988|FG000|Overall Study|Death|0|||
125183133|NCT02493660|450292989|FG001|Overall Study|Death|1|||
125183134|NCT02493660|450292988|FG000|Overall Study|Lost to Follow-up|2|||
125183135|NCT02493660|450292989|FG001|Overall Study|Lost to Follow-up|4|||
125183136|NCT02502149|450292993|FG000|Intermediate|Discontinued prematurely|1|||
125183137|NCT02502149|450292994|FG001|Intermediate|Discontinued prematurely|0|||
125183138|NCT02502149|450292995|FG002|Intermediate|Discontinued prematurely|0|||
125183139|NCT02502149|450292996|FG003|Intermediate|Discontinued prematurely|0|||
125183140|NCT02502149|450292997|FG004|Intermediate|Discontinued prematurely|0|||
125183141|NCT02968576|450292998|FG000|Overall Study|Pregnancy|0|||
125183142|NCT02968576|450292999|FG001|Overall Study|Pregnancy|1|||
125183143|NCT02222922|450293000|FG000|Overall Study|Death|0|||
125183144|NCT02222922|450293001|FG001|Overall Study|Death|0|||
125183145|NCT02222922|450293002|FG002|Overall Study|Death|0|||
125183146|NCT02222922|450293003|FG003|Overall Study|Death|0|||
125183147|NCT02222922|450293004|FG004|Overall Study|Death|13|||
125183148|NCT02222922|450293005|FG005|Overall Study|Death|0|||
125183149|NCT02222922|450293006|FG006|Overall Study|Death|0|||
125183150|NCT02222922|450293007|FG007|Overall Study|Death|0|||
125183151|NCT02222922|450293008|FG008|Overall Study|Death|2|||
125183152|NCT02222922|450293000|FG000|Overall Study|Lost to Follow-up|0|||
125183153|NCT02222922|450293001|FG001|Overall Study|Lost to Follow-up|0|||
125183154|NCT02222922|450293002|FG002|Overall Study|Lost to Follow-up|1|||
125183155|NCT02222922|450293003|FG003|Overall Study|Lost to Follow-up|0|||
125183156|NCT02222922|450293004|FG004|Overall Study|Lost to Follow-up|9|||
125183157|NCT02222922|450293005|FG005|Overall Study|Lost to Follow-up|1|||
125183158|NCT02222922|450293006|FG006|Overall Study|Lost to Follow-up|0|||
125183159|NCT02222922|450293007|FG007|Overall Study|Lost to Follow-up|0|||
125183160|NCT02222922|450293008|FG008|Overall Study|Lost to Follow-up|0|||
125183161|NCT02222922|450293000|FG000|Overall Study|Other|0|||
125183162|NCT02222922|450293001|FG001|Overall Study|Other|0|||
125183163|NCT02222922|450293002|FG002|Overall Study|Other|0|||
125183164|NCT02222922|450293003|FG003|Overall Study|Other|2|||
125183165|NCT02222922|450293004|FG004|Overall Study|Other|10|||
125183166|NCT02222922|450293005|FG005|Overall Study|Other|2|||
125183167|NCT02222922|450293006|FG006|Overall Study|Other|2|||
125183168|NCT02222922|450293007|FG007|Overall Study|Other|4|||
125183169|NCT02222922|450293008|FG008|Overall Study|Other|1|||
125183170|NCT02222922|450293000|FG000|Overall Study|Participant refused further follow-up|1|||
125183171|NCT02222922|450293001|FG001|Overall Study|Participant refused further follow-up|0|||
125183172|NCT02222922|450293002|FG002|Overall Study|Participant refused further follow-up|0|||
125183173|NCT02222922|450293003|FG003|Overall Study|Participant refused further follow-up|1|||
125183174|NCT02222922|450293004|FG004|Overall Study|Participant refused further follow-up|6|||
125183175|NCT02222922|450293005|FG005|Overall Study|Participant refused further follow-up|0|||
125183176|NCT02222922|450293006|FG006|Overall Study|Participant refused further follow-up|0|||
125183177|NCT02222922|450293007|FG007|Overall Study|Participant refused further follow-up|0|||
125183178|NCT02222922|450293008|FG008|Overall Study|Participant refused further follow-up|3|||
125183179|NCT00116779|450293012|FG000|Overall Study|Adverse Event|4|||
125183180|NCT00116779|450293013|FG001|Overall Study|Adverse Event|2|||
125183181|NCT00116779|450293012|FG000|Overall Study|Protocol Violation|1|||
125183182|NCT00116779|450293013|FG001|Overall Study|Protocol Violation|4|||
125183183|NCT00116779|450293012|FG000|Overall Study|Withdrawal by Subject|4|||
125183184|NCT00116779|450293013|FG001|Overall Study|Withdrawal by Subject|1|||
125183185|NCT00116779|450293012|FG000|Overall Study|Inadequate testosterone suppression|7|||
125183186|NCT00116779|450293013|FG001|Overall Study|Inadequate testosterone suppression|9|||
125183187|NCT00116779|450293012|FG000|Overall Study|Physician Decision|3|||
125183188|NCT00116779|450293013|FG001|Overall Study|Physician Decision|1|||
125183189|NCT00116779|450293012|FG000|Overall Study|Elevated PSA levels|2|||
125183190|NCT00116779|450293013|FG001|Overall Study|Elevated PSA levels|2|||
125183191|NCT02105467|450293014|FG000|Period 1|Lost to Follow-up|1|||
125183192|NCT02105467|450293015|FG001|Period 1|Lost to Follow-up|0|||
125183193|NCT02105467|450293014|FG000|Period 1|Death|1|||
125183194|NCT02105467|450293015|FG001|Period 1|Death|0|||
125183195|NCT02105467|450293014|FG000|Period 2|Lost to Follow-up|1|||
125183196|NCT02105467|450293015|FG001|Period 2|Lost to Follow-up|0|||
125183197|NCT02105467|450293014|FG000|Period 2|Death|1|||
125183198|NCT02105467|450293015|FG001|Period 2|Death|0|||
125183199|NCT02105467|450293014|FG000|Period 2|Withdrawal by Subject|0|||
125237632|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
125183200|NCT02105467|450293015|FG001|Period 2|Withdrawal by Subject|2|||
125237633|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
125183201|NCT02105467|450293014|FG000|Period 3|Lost to Follow-up|0|||
125183202|NCT02105467|450293015|FG001|Period 3|Lost to Follow-up|1|||
125183203|NCT01037218|450293016|FG000|Overall Study|Adverse Event|4|||
125183204|NCT01037218|450293017|FG001|Overall Study|Adverse Event|2|||
125183205|NCT01037218|450293018|FG002|Overall Study|Adverse Event|2|||
125183206|NCT01037218|450293019|FG003|Overall Study|Adverse Event|1|||
125183207|NCT01037218|450293016|FG000|Overall Study|Lack of Efficacy|0|||
125183208|NCT01037218|450293017|FG001|Overall Study|Lack of Efficacy|2|||
125183209|NCT01037218|450293018|FG002|Overall Study|Lack of Efficacy|1|||
125183210|NCT01037218|450293019|FG003|Overall Study|Lack of Efficacy|5|||
125183211|NCT01037218|450293016|FG000|Overall Study|Lost to Follow-up|3|||
125183212|NCT01037218|450293017|FG001|Overall Study|Lost to Follow-up|5|||
125183213|NCT01037218|450293018|FG002|Overall Study|Lost to Follow-up|4|||
125183214|NCT01037218|450293019|FG003|Overall Study|Lost to Follow-up|2|||
125183215|NCT01037218|450293016|FG000|Overall Study|Withdrawal by Subject|6|||
125183216|NCT01037218|450293017|FG001|Overall Study|Withdrawal by Subject|7|||
125183217|NCT01037218|450293018|FG002|Overall Study|Withdrawal by Subject|7|||
125183218|NCT01037218|450293019|FG003|Overall Study|Withdrawal by Subject|4|||
125183219|NCT01037218|450293016|FG000|Overall Study|Partner Withdrew Consent|0|||
125183220|NCT01037218|450293017|FG001|Overall Study|Partner Withdrew Consent|3|||
125183221|NCT01037218|450293018|FG002|Overall Study|Partner Withdrew Consent|2|||
125183222|NCT01037218|450293019|FG003|Overall Study|Partner Withdrew Consent|1|||
125183223|NCT01037218|450293016|FG000|Overall Study|Protocol Violation|0|||
125183224|NCT01037218|450293017|FG001|Overall Study|Protocol Violation|0|||
125183225|NCT01037218|450293018|FG002|Overall Study|Protocol Violation|2|||
125183226|NCT01037218|450293019|FG003|Overall Study|Protocol Violation|2|||
125183227|NCT01037218|450293016|FG000|Overall Study|Various|3|||
125183228|NCT01037218|450293017|FG001|Overall Study|Various|2|||
125183229|NCT01037218|450293018|FG002|Overall Study|Various|3|||
125183230|NCT01037218|450293019|FG003|Overall Study|Various|1|||
125183231|NCT02676882|450293020|FG000|Overall Study|Adverse Event|1|||
125183232|NCT02676882|450293021|FG001|Overall Study|Adverse Event|0|||
125183233|NCT02676882|450293020|FG000|Overall Study|Lost to Follow-up|1|||
125183234|NCT02676882|450293021|FG001|Overall Study|Lost to Follow-up|0|||
125183235|NCT02676882|450293020|FG000|Overall Study|Withdrawal by Subject|1|||
125183236|NCT02676882|450293021|FG001|Overall Study|Withdrawal by Subject|2|||
125183237|NCT02568072|450293022|FG000|Overall Study|Unavailable for appointment|23|||
125183238|NCT02568072|450293022|FG000|Overall Study|Unable to contact|3|||
125183239|NCT02568072|450293022|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
125183240|NCT02568072|450293022|FG000|Overall Study|Withdrawal by Subject|1|||
125183241|NCT02568072|450293022|FG000|Overall Study|Sustained injury, marathon not run|24|||
125183242|NCT01321879|450293026|FG000|Overall Study|Lack of Efficacy|5|||
125183243|NCT01321879|450293026|FG000|Overall Study|Adverse Event|5|||
125183244|NCT01321879|450293026|FG000|Overall Study|Death|3|||
125183245|NCT01321879|450293026|FG000|Overall Study|Withdrawal by Subject|1|||
125183246|NCT00897715|450293027|FG000|Overall Study|Lost to Follow-up|0|||
125183247|NCT00897715|450293028|FG001|Overall Study|Lost to Follow-up|1|||
125183248|NCT00897715|450293027|FG000|Overall Study|Physician Decision|1|||
125183249|NCT00897715|450293028|FG001|Overall Study|Physician Decision|0|||
125183250|NCT00897715|450293027|FG000|Overall Study|increased risk of infection|1|||
125183251|NCT00897715|450293028|FG001|Overall Study|increased risk of infection|0|||
125183252|NCT00958828|450293029|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
125183253|NCT00958828|450293030|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
125183254|NCT00958828|450293029|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
125183255|NCT00958828|450293030|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
125183256|NCT02687451|450293032|FG000|Overall Study|Withdrawal by Subject|1|||
125183257|NCT02687451|450293033|FG001|Overall Study|Withdrawal by Subject|0|||
125183258|NCT02687451|450293034|FG002|Overall Study|Withdrawal by Subject|0|||
125183259|NCT02687451|450293035|FG003|Overall Study|Withdrawal by Subject|0|||
125183260|NCT02687451|450293036|FG004|Overall Study|Withdrawal by Subject|0|||
125183261|NCT02687451|450293037|FG005|Overall Study|Withdrawal by Subject|1|||
125183262|NCT01125189|450293044|FG000|Treatment Period|Lack of Efficacy|15|||
125183263|NCT01125189|450293045|FG001|Treatment Period|Lack of Efficacy|18|||
125183264|NCT01125189|450293046|FG002|Treatment Period|Lack of Efficacy|25|||
125183265|NCT01125189|450293044|FG000|Treatment Period|Adverse Event|7|||
125183266|NCT01125189|450293045|FG001|Treatment Period|Adverse Event|8|||
125183267|NCT01125189|450293046|FG002|Treatment Period|Adverse Event|8|||
125183268|NCT01125189|450293044|FG000|Treatment Period|Withdrawal by Subject|3|||
125183269|NCT01125189|450293045|FG001|Treatment Period|Withdrawal by Subject|1|||
125183270|NCT01125189|450293046|FG002|Treatment Period|Withdrawal by Subject|1|||
125183271|NCT01125189|450293044|FG000|Treatment Period|Death|1|||
125183272|NCT01125189|450293045|FG001|Treatment Period|Death|0|||
125183273|NCT01125189|450293046|FG002|Treatment Period|Death|0|||
125183274|NCT01125189|450293044|FG000|Treatment Period|Lost to Follow-up|1|||
125183275|NCT01125189|450293045|FG001|Treatment Period|Lost to Follow-up|2|||
125183276|NCT01125189|450293046|FG002|Treatment Period|Lost to Follow-up|1|||
125183277|NCT01125189|450293044|FG000|Treatment Period|Poor compliance/noncompliance|0|||
125183278|NCT01125189|450293045|FG001|Treatment Period|Poor compliance/noncompliance|1|||
125183279|NCT01125189|450293046|FG002|Treatment Period|Poor compliance/noncompliance|0|||
125183280|NCT01125189|450293044|FG000|Treatment Period|Participants requested to discontinue|1|||
125183281|NCT01125189|450293045|FG001|Treatment Period|Participants requested to discontinue|3|||
125183282|NCT01125189|450293046|FG002|Treatment Period|Participants requested to discontinue|4|||
125183283|NCT01125189|450293044|FG000|Treatment Period|Other reasons|1|||
125183284|NCT01125189|450293045|FG001|Treatment Period|Other reasons|1|||
125183285|NCT01125189|450293046|FG002|Treatment Period|Other reasons|0|||
125183286|NCT01125189|450293044|FG000|Treatment Period|Completed 24 week treatment period only|2|||
125183287|NCT01125189|450293045|FG001|Treatment Period|Completed 24 week treatment period only|1|||
125183288|NCT01125189|450293046|FG002|Treatment Period|Completed 24 week treatment period only|2|||
125183289|NCT01125189|450293044|FG000|Follow up Period|Withdrawal by Subject|3|||
125183290|NCT01125189|450293045|FG001|Follow up Period|Withdrawal by Subject|2|||
125183291|NCT01125189|450293046|FG002|Follow up Period|Withdrawal by Subject|5|||
125183292|NCT01125189|450293044|FG000|Follow up Period|Death|1|||
125183293|NCT01125189|450293045|FG001|Follow up Period|Death|0|||
125183294|NCT01125189|450293046|FG002|Follow up Period|Death|0|||
125183295|NCT01125189|450293044|FG000|Follow up Period|Lost to Follow-up|12|||
125183296|NCT01125189|450293045|FG001|Follow up Period|Lost to Follow-up|9|||
125183297|NCT01125189|450293046|FG002|Follow up Period|Lost to Follow-up|6|||
125183298|NCT01125189|450293044|FG000|Follow up Period|Other reasons|4|||
125183299|NCT01125189|450293045|FG001|Follow up Period|Other reasons|4|||
125183300|NCT01125189|450293046|FG002|Follow up Period|Other reasons|5|||
125183301|NCT00927589|450293047|FG000|Overall Study|Death|1|||
125183302|NCT00927589|450293047|FG000|Overall Study|Physician Decision|1|||
125183303|NCT00927589|450293047|FG000|Overall Study|Withdrawal by Subject|3|||
125183304|NCT00927589|450293047|FG000|Overall Study|Adverse Event|2|||
125183305|NCT00927589|450293047|FG000|Overall Study|Disease Progression|8|||
125183306|NCT00927589|450293047|FG000|Overall Study|Non-compliance|1|||
125183307|NCT00707239|450293048|FG000|Overall Study|Adverse Event|5|||
125183308|NCT00707239|450293049|FG001|Overall Study|Adverse Event|3|||
125183309|NCT00707239|450293050|FG002|Overall Study|Adverse Event|2|||
125183310|NCT00707239|450293048|FG000|Overall Study|Death|3|||
125183311|NCT00707239|450293049|FG001|Overall Study|Death|1|||
125183312|NCT00707239|450293050|FG002|Overall Study|Death|3|||
125183313|NCT00707239|450293048|FG000|Overall Study|Physician Decision|1|||
125183314|NCT00707239|450293049|FG001|Overall Study|Physician Decision|1|||
125183315|NCT00707239|450293050|FG002|Overall Study|Physician Decision|2|||
125183316|NCT00707239|450293048|FG000|Overall Study|Protocol Violation|0|||
125183317|NCT00707239|450293049|FG001|Overall Study|Protocol Violation|0|||
125183318|NCT00707239|450293050|FG002|Overall Study|Protocol Violation|1|||
125183319|NCT00707239|450293048|FG000|Overall Study|Lack of Efficacy|1|||
125183320|NCT00707239|450293049|FG001|Overall Study|Lack of Efficacy|2|||
125183321|NCT00707239|450293050|FG002|Overall Study|Lack of Efficacy|0|||
125183322|NCT00707239|450293048|FG000|Overall Study|Randomized, but not treated|1|||
125183323|NCT00707239|450293049|FG001|Overall Study|Randomized, but not treated|1|||
125183324|NCT00707239|450293050|FG002|Overall Study|Randomized, but not treated|1|||
125183325|NCT00707239|450293048|FG000|Overall Study|Other|8|||
125183326|NCT00707239|450293049|FG001|Overall Study|Other|3|||
125183327|NCT00707239|450293050|FG002|Overall Study|Other|5|||
125183328|NCT01651117|450293053|FG000|Overall Study|Death|2|||
125183329|NCT01651117|450293054|FG001|Overall Study|Death|3|||
125183330|NCT01651117|450293055|FG002|Overall Study|Death|2|||
125183331|NCT01651117|450293056|FG003|Overall Study|Death|2|||
125183332|NCT02714218|450293059|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125183333|NCT02714218|450293060|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
125183334|NCT02714218|450293061|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125183335|NCT02714218|450293059|FG000|Pre-Treatment Period|Other reasons|0|||
125183336|NCT02714218|450293060|FG001|Pre-Treatment Period|Other reasons|1|||
125183337|NCT02714218|450293061|FG002|Pre-Treatment Period|Other reasons|0|||
125183338|NCT02714218|450293059|FG000|Treatment Period|Disease Progression|55|||
125183339|NCT02714218|450293060|FG001|Treatment Period|Disease Progression|52|||
125183340|NCT02714218|450293061|FG002|Treatment Period|Disease Progression|14|||
125183341|NCT02714218|450293059|FG000|Treatment Period|Study drug toxicity|46|||
125183342|NCT02714218|450293060|FG001|Treatment Period|Study drug toxicity|70|||
125183343|NCT02714218|450293061|FG002|Treatment Period|Study drug toxicity|6|||
125183344|NCT02714218|450293059|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
125183345|NCT02714218|450293060|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
125183346|NCT02714218|450293061|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
125183347|NCT02714218|450293059|FG000|Treatment Period|Request to discontinue treatment|1|||
125183348|NCT02714218|450293060|FG001|Treatment Period|Request to discontinue treatment|4|||
125183349|NCT02714218|450293061|FG002|Treatment Period|Request to discontinue treatment|1|||
125392422|NCT01405963|451070668|FG001|Overall Study|Moved Away|0|||
125183350|NCT02714218|450293059|FG000|Treatment Period|Participant withdrew consent|2|||
125183351|NCT02714218|450293060|FG001|Treatment Period|Participant withdrew consent|2|||
125183352|NCT02714218|450293061|FG002|Treatment Period|Participant withdrew consent|0|||
125183353|NCT02714218|450293059|FG000|Treatment Period|Maximum clinical benefit|4|||
125183354|NCT02714218|450293060|FG001|Treatment Period|Maximum clinical benefit|2|||
125183355|NCT02714218|450293061|FG002|Treatment Period|Maximum clinical benefit|0|||
125183356|NCT02714218|450293059|FG000|Treatment Period|Administrative reason by sponsor|2|||
125183357|NCT02714218|450293060|FG001|Treatment Period|Administrative reason by sponsor|1|||
125183358|NCT02714218|450293061|FG002|Treatment Period|Administrative reason by sponsor|0|||
125183359|NCT02714218|450293059|FG000|Treatment Period|Other reasons|6|||
125183360|NCT02714218|450293060|FG001|Treatment Period|Other reasons|6|||
125183361|NCT02714218|450293061|FG002|Treatment Period|Other reasons|0|||
125183362|NCT02714218|450293059|FG000|Treatment Period|Completed treatment as per protocol|36|||
125183363|NCT02714218|450293060|FG001|Treatment Period|Completed treatment as per protocol|27|||
125183364|NCT02714218|450293061|FG002|Treatment Period|Completed treatment as per protocol|3|||
125183365|NCT02714218|450293059|FG000|Treatment Period|Not reported|9|||
125183366|NCT02714218|450293060|FG001|Treatment Period|Not reported|6|||
125183367|NCT02714218|450293061|FG002|Treatment Period|Not reported|0|||
125183368|NCT01113892|450293062|FG000|Overall Study|Lost to Follow-up|2|||
125183369|NCT01113892|450293063|FG001|Overall Study|Lost to Follow-up|2|||
125183370|NCT01113892|450293062|FG000|Overall Study|Withdrawal by Subject|1|||
125183371|NCT01113892|450293063|FG001|Overall Study|Withdrawal by Subject|1|||
125183372|NCT01113892|450293062|FG000|Overall Study|Death|2|||
125183373|NCT01113892|450293063|FG001|Overall Study|Death|4|||
125183374|NCT01113892|450293062|FG000|Overall Study|Graft no longer evaluable|9|||
125183375|NCT01113892|450293063|FG001|Overall Study|Graft no longer evaluable|9|||
125183376|NCT02603887|450293069|FG000|Stage 1|Adverse Event|4|||
125183377|NCT02603887|450293069|FG000|Stage 1|Disease progression|1|||
125183378|NCT02603887|450293069|FG000|Stage 2|FDA guidance|1|||
125183379|NCT00235755|450293078|FG000|4-Week Titration Phase|Adverse Event|6|||
125183380|NCT00235755|450293079|FG001|4-Week Titration Phase|Adverse Event|14|||
125183381|NCT00235755|450293080|FG002|4-Week Titration Phase|Adverse Event|20|||
125183382|NCT00235755|450293078|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
125183383|NCT00235755|450293079|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
125183384|NCT00235755|450293080|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
125183385|NCT00235755|450293078|FG000|4-Week Titration Phase|Protocol Violation|2|||
125183386|NCT00235755|450293079|FG001|4-Week Titration Phase|Protocol Violation|2|||
125183387|NCT00235755|450293080|FG002|4-Week Titration Phase|Protocol Violation|1|||
125183388|NCT00235755|450293078|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
125183389|NCT00235755|450293079|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
125183390|NCT00235755|450293080|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
125183391|NCT00235755|450293078|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
125183392|NCT00235755|450293079|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
125183393|NCT00235755|450293080|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
125183394|NCT00235755|450293078|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
125183395|NCT00235755|450293079|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
125183396|NCT00235755|450293080|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
125183397|NCT00235755|450293078|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
125183398|NCT00235755|450293079|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
125183399|NCT00235755|450293080|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
125183400|NCT00235755|450293078|FG000|12-Week Maintenance Phase|Adverse Event|8|||
125183401|NCT00235755|450293079|FG001|12-Week Maintenance Phase|Adverse Event|12|||
125183402|NCT00235755|450293080|FG002|12-Week Maintenance Phase|Adverse Event|26|||
125183403|NCT00235755|450293078|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
125183404|NCT00235755|450293079|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
125183405|NCT00235755|450293080|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
125183406|NCT00235755|450293078|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
125183407|NCT00235755|450293079|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
125183408|NCT00235755|450293080|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
125183409|NCT00235755|450293078|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
125183410|NCT00235755|450293079|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
125183411|NCT00235755|450293080|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
125183412|NCT00235755|450293078|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
125183413|NCT00235755|450293079|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
125183414|NCT00235755|450293080|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
125183415|NCT00235755|450293078|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
125183416|NCT00235755|450293079|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
125183417|NCT00235755|450293080|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
125183418|NCT03164551|450293081|FG000|Overall Study|Imaging discontinued prior completion|8|||
125183419|NCT03164551|450293082|FG001|Overall Study|Imaging discontinued prior completion|0|||
125183420|NCT03164551|450293081|FG000|Overall Study|Participant was non-compliant|1|||
125183421|NCT03164551|450293082|FG001|Overall Study|Participant was non-compliant|0|||
125183422|NCT03164551|450293081|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
125183423|NCT03164551|450293082|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
125183424|NCT03164551|450293081|FG000|Overall Study|Other|8|||
125183425|NCT03164551|450293082|FG001|Overall Study|Other|2|||
125183426|NCT02314026|450293085|FG000|Overall Study|Protocol Violation|28|||
125183427|NCT01406574|450293087|FG000|Overall Study|Adverse Event|0|||
125183428|NCT01406574|450293088|FG001|Overall Study|Adverse Event|0|||
125183429|NCT01406574|450293089|FG002|Overall Study|Adverse Event|1|||
125183430|NCT01406574|450293090|FG003|Overall Study|Adverse Event|3|||
125183431|NCT01406574|450293087|FG000|Overall Study|Physician Decision|0|||
125183432|NCT01406574|450293088|FG001|Overall Study|Physician Decision|0|||
125183433|NCT01406574|450293089|FG002|Overall Study|Physician Decision|0|||
125183434|NCT01406574|450293090|FG003|Overall Study|Physician Decision|1|||
125183435|NCT01406574|450293087|FG000|Overall Study|Withdrawal by Subject|0|||
125183436|NCT01406574|450293088|FG001|Overall Study|Withdrawal by Subject|1|||
125183437|NCT01406574|450293089|FG002|Overall Study|Withdrawal by Subject|0|||
125183438|NCT01406574|450293090|FG003|Overall Study|Withdrawal by Subject|0|||
125183439|NCT01406574|450293087|FG000|Overall Study|Definite progression of primary disease|1|||
125183440|NCT01406574|450293088|FG001|Overall Study|Definite progression of primary disease|0|||
125183441|NCT01406574|450293089|FG002|Overall Study|Definite progression of primary disease|0|||
125183442|NCT01406574|450293090|FG003|Overall Study|Definite progression of primary disease|0|||
125183443|NCT04052620|450293091|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
125183444|NCT04052620|450293092|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
125183445|NCT04052620|450293091|FG000|Overall Study|Withdrawal by Subject|1|||
125183446|NCT04052620|450293092|FG001|Overall Study|Withdrawal by Subject|0|||
125183447|NCT04052620|450293091|FG000|Overall Study|Lost to Follow-up|1|||
125183448|NCT04052620|450293092|FG001|Overall Study|Lost to Follow-up|1|||
125183449|NCT04052620|450293091|FG000|Overall Study|Adverse Event|1|||
125183450|NCT04052620|450293092|FG001|Overall Study|Adverse Event|0|||
125183451|NCT04052620|450293091|FG000|Overall Study|Subject did not meet study Criteria|0|||
125183452|NCT04052620|450293092|FG001|Overall Study|Subject did not meet study Criteria|1|||
125183453|NCT04052620|450293091|FG000|Overall Study|Screened failure, randomized by mistake|0|||
125183454|NCT04052620|450293092|FG001|Overall Study|Screened failure, randomized by mistake|1|||
125183455|NCT04052620|450293091|FG000|Overall Study|Personal reasons|2|||
125183456|NCT04052620|450293092|FG001|Overall Study|Personal reasons|4|||
125183457|NCT04052620|450293091|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
125183458|NCT04052620|450293092|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
125183459|NCT03552380|450293093|FG000|Study Treatment|Disease Progression|3|||
125183460|NCT03552380|450293094|FG001|Study Treatment|Disease Progression|4|||
125183461|NCT03552380|450293093|FG000|Study Treatment|Adverse Event|2|||
125183462|NCT03552380|450293094|FG001|Study Treatment|Adverse Event|2|||
125183463|NCT03552380|450293093|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
125183464|NCT03552380|450293094|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
125183465|NCT03552380|450293093|FG000|Follow up|Death|3|||
125183466|NCT03552380|450293094|FG001|Follow up|Death|4|||
125183467|NCT03552380|450293093|FG000|Follow up|Site IRB terminated|0|||
125183468|NCT03552380|450293094|FG001|Follow up|Site IRB terminated|1|||
125183469|NCT02431364|450293099|FG000|Overall Study|Adverse Event|0|||
125183470|NCT02431364|450293100|FG001|Overall Study|Adverse Event|1|||
125183471|NCT02431364|450293101|FG002|Overall Study|Adverse Event|0|||
125183472|NCT02431364|450293102|FG003|Overall Study|Adverse Event|0|||
125183473|NCT02431364|450293103|FG004|Overall Study|Adverse Event|0|||
125183474|NCT02431364|450293099|FG000|Overall Study|Randomized but never treated|0|||
125183475|NCT02431364|450293100|FG001|Overall Study|Randomized but never treated|0|||
125183476|NCT02431364|450293101|FG002|Overall Study|Randomized but never treated|0|||
125183477|NCT02431364|450293102|FG003|Overall Study|Randomized but never treated|1|||
125183478|NCT02431364|450293103|FG004|Overall Study|Randomized but never treated|0|||
125183479|NCT00916383|450293104|FG000|Overall Study|Adverse Event|1|||
125183480|NCT00916383|450293104|FG000|Overall Study|Death|1|||
125183481|NCT00916383|450293104|FG000|Overall Study|Protocol Violation|1|||
125183482|NCT00258960|450293105|FG000|Overall Study|Death|2|||
125183483|NCT00258960|450293105|FG000|Overall Study|Disease Progression|7|||
125183484|NCT00258960|450293105|FG000|Overall Study|Adverse Event|4|||
125183485|NCT00258960|450293105|FG000|Overall Study|Physician Decision|1|||
125183486|NCT00258960|450293105|FG000|Overall Study|Withdrawal by Subject|1|||
125183487|NCT00258960|450293105|FG000|Overall Study|Mistake|2|||
125183488|NCT00473590|450293106|FG000|Overall Study|Adverse Event|3|||
125183489|NCT00473590|450293107|FG001|Overall Study|Adverse Event|3|||
125183490|NCT00473590|450293106|FG000|Overall Study|Death|4|||
125183491|NCT00473590|450293107|FG001|Overall Study|Death|2|||
125183492|NCT00473590|450293106|FG000|Overall Study|Progression not resulting in death|24|||
125183493|NCT00473590|450293107|FG001|Overall Study|Progression not resulting in death|20|||
125183494|NCT00473590|450293106|FG000|Overall Study|Non-protocol-specified therapy|7|||
125183495|NCT00473590|450293107|FG001|Overall Study|Non-protocol-specified therapy|5|||
125183496|NCT00473590|450293106|FG000|Overall Study|Physician Decision|2|||
125183497|NCT00473590|450293107|FG001|Overall Study|Physician Decision|4|||
125183498|NCT00473590|450293106|FG000|Overall Study|Withdrawal by Subject|5|||
125183499|NCT00473590|450293107|FG001|Overall Study|Withdrawal by Subject|3|||
125183500|NCT00473590|450293106|FG000|Overall Study|Other|0|||
125183501|NCT00473590|450293107|FG001|Overall Study|Other|1|||
125183502|NCT01112059|450293108|FG000|Overall Study|Withdrawal by Subject|1|||
125183503|NCT01112059|450293109|FG001|Overall Study|Withdrawal by Subject|0|||
125183504|NCT03367819|450293114|FG000|Overall Study|Adverse Event|4|||
125237634|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
125183505|NCT03367819|450293115|FG001|Overall Study|Adverse Event|4|||
125183506|NCT03367819|450293114|FG000|Overall Study|Progressive Disease|15|||
125183507|NCT03367819|450293115|FG001|Overall Study|Progressive Disease|13|||
125183508|NCT03367819|450293114|FG000|Overall Study|Withdrawal by Subject|1|||
125392423|NCT01405963|451070667|FG000|Overall Study|Adverse Event|0|||
125392424|NCT01405963|451070668|FG001|Overall Study|Adverse Event|1|||
125392425|NCT01405963|451070667|FG000|Overall Study|Lost to Follow-up|0|||
125392426|NCT01405963|451070668|FG001|Overall Study|Lost to Follow-up|1|||
125392427|NCT04371380|451070677|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
125392428|NCT04371380|451070678|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
125183509|NCT03367819|450293115|FG001|Overall Study|Withdrawal by Subject|0|||
125183510|NCT03367819|450293114|FG000|Overall Study|Other|4|||
125183511|NCT03367819|450293115|FG001|Overall Study|Other|2|||
125183512|NCT00584454|450293116|FG000|Overall Study|Adverse Event|1|||
125183513|NCT00584454|450293116|FG000|Overall Study|Relocation|1|||
125183514|NCT00584454|450293116|FG000|Overall Study|Clinical Hold|2|||
125183515|NCT00725920|450293117|FG000|Overall Study|Lack of Efficacy|3|||
125183516|NCT00725920|450293118|FG001|Overall Study|Lack of Efficacy|6|||
125183517|NCT03918629|450293119|FG000|Overall Study|Adverse Event|19|||
125183518|NCT03918629|450293120|FG001|Overall Study|Adverse Event|20|||
125183519|NCT03918629|450293119|FG000|Overall Study|Death|14|||
125183520|NCT03918629|450293120|FG001|Overall Study|Death|7|||
125183521|NCT03918629|450293119|FG000|Overall Study|Lost to Follow-up|36|||
125183522|NCT03918629|450293120|FG001|Overall Study|Lost to Follow-up|28|||
125183523|NCT03918629|450293119|FG000|Overall Study|Physician Decision|1|||
125183524|NCT03918629|450293120|FG001|Overall Study|Physician Decision|0|||
125183525|NCT03918629|450293119|FG000|Overall Study|Protocol Violation|7|||
125183526|NCT03918629|450293120|FG001|Overall Study|Protocol Violation|4|||
125183527|NCT03918629|450293119|FG000|Overall Study|Withdrawal by Subject|47|||
125183528|NCT03918629|450293120|FG001|Overall Study|Withdrawal by Subject|47|||
125183529|NCT03918629|450293119|FG000|Overall Study|Other|7|||
125183530|NCT03918629|450293120|FG001|Overall Study|Other|11|||
125183531|NCT03918629|450293119|FG000|Overall Study|Randomized but not vaccinated|2|||
125183532|NCT03918629|450293120|FG001|Overall Study|Randomized but not vaccinated|1|||
125183533|NCT01891864|450293121|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
125183534|NCT01891864|450293122|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
125183535|NCT01891864|450293123|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
125183536|NCT01891864|450293124|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
125183537|NCT01891864|450293125|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
125183538|NCT01891864|450293126|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
125183539|NCT01891864|450293121|FG000|Treatment Period 1|Physician Decision|0|||
125183540|NCT01891864|450293122|FG001|Treatment Period 1|Physician Decision|1|||
125183541|NCT01891864|450293123|FG002|Treatment Period 1|Physician Decision|0|||
125183542|NCT01891864|450293124|FG003|Treatment Period 1|Physician Decision|0|||
125183543|NCT01891864|450293125|FG004|Treatment Period 1|Physician Decision|0|||
125183544|NCT01891864|450293126|FG005|Treatment Period 1|Physician Decision|0|||
125183545|NCT01891864|450293121|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
125183546|NCT01891864|450293122|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
125183547|NCT01891864|450293123|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
125183548|NCT01891864|450293124|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
125183549|NCT01891864|450293125|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
125183550|NCT01891864|450293126|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
125183551|NCT01891864|450293121|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
125183552|NCT01891864|450293122|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
125183553|NCT01891864|450293123|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
125183554|NCT01891864|450293124|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
125183555|NCT01891864|450293125|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
125392429|NCT04371380|451070679|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
125183556|NCT01891864|450293126|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
125183557|NCT01891864|450293121|FG000|Treatment Period 1|Withdrawal by Subject|2|||
125183558|NCT01891864|450293122|FG001|Treatment Period 1|Withdrawal by Subject|5|||
125392430|NCT00680901|451070686|FG000|Overall Study|Ongoing: On Study Treatment|1|||
125183559|NCT01891864|450293123|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125392431|NCT00680901|451070687|FG001|Overall Study|Ongoing: On Study Treatment|0|||
125183560|NCT01891864|450293124|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125183561|NCT01891864|450293125|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125183562|NCT01891864|450293126|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125183563|NCT01891864|450293121|FG000|Treatment Period 1|Lost to Follow-up|1|||
125183564|NCT01891864|450293122|FG001|Treatment Period 1|Lost to Follow-up|0|||
125183565|NCT01891864|450293123|FG002|Treatment Period 1|Lost to Follow-up|0|||
125183566|NCT01891864|450293124|FG003|Treatment Period 1|Lost to Follow-up|0|||
125183567|NCT01891864|450293125|FG004|Treatment Period 1|Lost to Follow-up|0|||
125183568|NCT01891864|450293126|FG005|Treatment Period 1|Lost to Follow-up|0|||
125183569|NCT01891864|450293121|FG000|Treatment Period 2|Protocol Violation|0|||
125183570|NCT01891864|450293122|FG001|Treatment Period 2|Protocol Violation|0|||
125392432|NCT00680901|451070686|FG000|Overall Study|Ongoing: In Follow Up|1|||
125392433|NCT00680901|451070687|FG001|Overall Study|Ongoing: In Follow Up|0|||
125183571|NCT01891864|450293123|FG002|Treatment Period 2|Protocol Violation|0|||
125183572|NCT01891864|450293124|FG003|Treatment Period 2|Protocol Violation|1|||
125183573|NCT01891864|450293125|FG004|Treatment Period 2|Protocol Violation|0|||
125183574|NCT01891864|450293126|FG005|Treatment Period 2|Protocol Violation|0|||
125183575|NCT01891864|450293121|FG000|Treatment Period 2|Physician Decision|0|||
125183576|NCT01891864|450293122|FG001|Treatment Period 2|Physician Decision|0|||
125183577|NCT01891864|450293123|FG002|Treatment Period 2|Physician Decision|1|||
125183578|NCT01891864|450293124|FG003|Treatment Period 2|Physician Decision|0|||
125183579|NCT01891864|450293125|FG004|Treatment Period 2|Physician Decision|0|||
125183580|NCT01891864|450293126|FG005|Treatment Period 2|Physician Decision|0|||
125183581|NCT01891864|450293121|FG000|Treatment Period 2|Site Termination|0|||
125183582|NCT01891864|450293122|FG001|Treatment Period 2|Site Termination|0|||
125183583|NCT01891864|450293123|FG002|Treatment Period 2|Site Termination|1|||
125183584|NCT01891864|450293124|FG003|Treatment Period 2|Site Termination|2|||
125183585|NCT01891864|450293125|FG004|Treatment Period 2|Site Termination|0|||
125183586|NCT01891864|450293126|FG005|Treatment Period 2|Site Termination|0|||
125183587|NCT01891864|450293121|FG000|Treatment Period 2|Lack of Efficacy|0|||
125183588|NCT01891864|450293122|FG001|Treatment Period 2|Lack of Efficacy|0|||
125183589|NCT01891864|450293123|FG002|Treatment Period 2|Lack of Efficacy|1|||
125183590|NCT01891864|450293124|FG003|Treatment Period 2|Lack of Efficacy|0|||
125183591|NCT01891864|450293125|FG004|Treatment Period 2|Lack of Efficacy|1|||
125183592|NCT01891864|450293126|FG005|Treatment Period 2|Lack of Efficacy|0|||
125183593|NCT01891864|450293121|FG000|Treatment Period 2|Adverse Event|0|||
125183594|NCT01891864|450293122|FG001|Treatment Period 2|Adverse Event|0|||
125183595|NCT01891864|450293123|FG002|Treatment Period 2|Adverse Event|1|||
125183596|NCT01891864|450293124|FG003|Treatment Period 2|Adverse Event|2|||
125183597|NCT01891864|450293125|FG004|Treatment Period 2|Adverse Event|0|||
125183598|NCT01891864|450293126|FG005|Treatment Period 2|Adverse Event|4|||
125183599|NCT01891864|450293121|FG000|Treatment Period 2|Termination of Site|0|||
125183600|NCT01891864|450293122|FG001|Treatment Period 2|Termination of Site|0|||
125183601|NCT01891864|450293123|FG002|Treatment Period 2|Termination of Site|0|||
125183602|NCT01891864|450293124|FG003|Treatment Period 2|Termination of Site|0|||
125183603|NCT01891864|450293125|FG004|Treatment Period 2|Termination of Site|2|||
125183604|NCT01891864|450293126|FG005|Treatment Period 2|Termination of Site|0|||
125183605|NCT01891864|450293121|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125183606|NCT01891864|450293122|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125183607|NCT01891864|450293123|FG002|Treatment Period 2|Withdrawal by Subject|3|||
125183608|NCT01891864|450293124|FG003|Treatment Period 2|Withdrawal by Subject|4|||
125183609|NCT01891864|450293125|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125183610|NCT01891864|450293126|FG005|Treatment Period 2|Withdrawal by Subject|1|||
125183611|NCT01891864|450293121|FG000|Extension Period|Lack of Efficacy|0|||
125183612|NCT01891864|450293122|FG001|Extension Period|Lack of Efficacy|0|||
125183613|NCT01891864|450293123|FG002|Extension Period|Lack of Efficacy|0|||
125183614|NCT01891864|450293124|FG003|Extension Period|Lack of Efficacy|1|||
125183615|NCT01891864|450293125|FG004|Extension Period|Lack of Efficacy|1|||
125183616|NCT01891864|450293126|FG005|Extension Period|Lack of Efficacy|0|||
125183617|NCT01891864|450293121|FG000|Extension Period|Pregnancy|0|||
125183618|NCT01891864|450293122|FG001|Extension Period|Pregnancy|0|||
125183619|NCT01891864|450293123|FG002|Extension Period|Pregnancy|1|||
125183620|NCT01891864|450293124|FG003|Extension Period|Pregnancy|0|||
125183621|NCT01891864|450293125|FG004|Extension Period|Pregnancy|0|||
125183622|NCT01891864|450293126|FG005|Extension Period|Pregnancy|0|||
125183623|NCT01891864|450293121|FG000|Extension Period|Adverse Event|0|||
125183624|NCT01891864|450293122|FG001|Extension Period|Adverse Event|0|||
125183625|NCT01891864|450293123|FG002|Extension Period|Adverse Event|4|||
125183626|NCT01891864|450293124|FG003|Extension Period|Adverse Event|2|||
125183627|NCT01891864|450293125|FG004|Extension Period|Adverse Event|2|||
125183628|NCT01891864|450293126|FG005|Extension Period|Adverse Event|0|||
125183629|NCT01891864|450293121|FG000|Extension Period|Withdrawal by Subject|0|||
125183630|NCT01891864|450293122|FG001|Extension Period|Withdrawal by Subject|0|||
125183631|NCT01891864|450293123|FG002|Extension Period|Withdrawal by Subject|1|||
125183632|NCT01891864|450293124|FG003|Extension Period|Withdrawal by Subject|2|||
125183633|NCT01891864|450293125|FG004|Extension Period|Withdrawal by Subject|4|||
125183634|NCT01891864|450293126|FG005|Extension Period|Withdrawal by Subject|0|||
125183635|NCT01891864|450293121|FG000|Extension Period|Lost to Follow-up|0|||
125183636|NCT01891864|450293122|FG001|Extension Period|Lost to Follow-up|0|||
125183637|NCT01891864|450293123|FG002|Extension Period|Lost to Follow-up|2|||
125183638|NCT01891864|450293124|FG003|Extension Period|Lost to Follow-up|0|||
125183639|NCT01891864|450293125|FG004|Extension Period|Lost to Follow-up|0|||
125183640|NCT01891864|450293126|FG005|Extension Period|Lost to Follow-up|0|||
125183641|NCT04720105|450293129|FG000|Overall Study|Lack of Efficacy|1|||
125183642|NCT04720105|450293129|FG000|Overall Study|Lost to Follow-up|1|||
125183643|NCT04720105|450293129|FG000|Overall Study|Withdrawal by Subject|3|||
125183644|NCT01133067|450293130|FG000|Overall Study|Death|136|||
125183645|NCT01133067|450293130|FG000|Overall Study|Lost to Follow-up|3|||
125183646|NCT04135937|450293134|FG000|Overall Study|Lost to Follow-up|2|||
125183647|NCT04135937|450293134|FG000|Overall Study|Withdrawal by Subject|1|||
125392434|NCT00680901|451070686|FG000|Overall Study|Adverse Event|1|||
125392435|NCT00680901|451070687|FG001|Overall Study|Adverse Event|1|||
125392436|NCT00680901|451070686|FG000|Overall Study|Lost to Follow-up|3|||
125392437|NCT00680901|451070687|FG001|Overall Study|Lost to Follow-up|5|||
125183648|NCT00868530|450293138|FG000|Overall Study|Adverse Event|3|||
125183649|NCT00868530|450293138|FG000|Overall Study|Lost to Follow-up|1|||
125183650|NCT00858273|450293139|FG000|Overall Study|Protocol Violation|3|||
125183651|NCT00858273|450293140|FG001|Overall Study|Protocol Violation|5|||
125183652|NCT04199104|450294707|FG000|Overall Study|Death|148|||
125183653|NCT04199104|450294708|FG001|Overall Study|Death|134|||
125183654|NCT04199104|450294707|FG000|Overall Study|Lost to Follow-up|1|||
125183655|NCT04199104|450294708|FG001|Overall Study|Lost to Follow-up|1|||
125183656|NCT04199104|450294707|FG000|Overall Study|Withdrawal by Subject|4|||
125183657|NCT04199104|450294708|FG001|Overall Study|Withdrawal by Subject|4|||
125183658|NCT04199104|450294707|FG000|Overall Study|Participants Ongoing|103|||
125183659|NCT04199104|450294708|FG001|Overall Study|Participants Ongoing|116|||
125183660|NCT02325973|450294713|FG000|Overall Study|Death|5|||
125183661|NCT02325973|450294713|FG000|Overall Study|Withdrawal by subject or investigator|16|||
125183662|NCT05655546|450294714|FG000|Overall Study|Withdrawal by Subject|2|||
125183663|NCT05655546|450294715|FG001|Overall Study|Withdrawal by Subject|4|||
125183664|NCT04510090|450294716|FG000|FE-HS|Withdrawal by Subject|0|||
125183665|NCT04510090|450294717|FG001|FE-HS|Withdrawal by Subject|0|||
125183666|NCT04510090|450294718|FG002|FE-HS|Withdrawal by Subject|0|||
125183667|NCT04510090|450294719|FG003|FE-HS|Withdrawal by Subject|0|||
125183668|NCT04510090|450294720|FG004|FE-HS|Withdrawal by Subject|1|||
125183669|NCT04510090|450294721|FG005|FE-HS|Withdrawal by Subject|0|||
125183670|NCT04510090|450294722|FG006|FE-HS|Withdrawal by Subject|0|||
125183671|NCT04510090|450294723|FG007|FE-HS|Withdrawal by Subject|0|||
125183672|NCT05825404|450294724|FG000|First Intervention (Weeks 2-5)|Death|0|||
125183673|NCT05825404|450294725|FG001|First Intervention (Weeks 2-5)|Death|1|||
125183674|NCT05825404|450294724|FG000|Second Intervention (Weeks 8-11)|Death|0|||
125183675|NCT05825404|450294725|FG001|Second Intervention (Weeks 8-11)|Death|1|||
125183676|NCT01415518|450294726|FG000|Overall Study|Withdrawal by Subject|2|||
125183677|NCT01415518|450294727|FG001|Overall Study|Withdrawal by Subject|12|||
125183678|NCT01415518|450294726|FG000|Overall Study|Protocol Violation|6|||
125183679|NCT01415518|450294727|FG001|Overall Study|Protocol Violation|8|||
125183680|NCT01415518|450294726|FG000|Overall Study|Lost to Follow-up|3|||
125183681|NCT01415518|450294727|FG001|Overall Study|Lost to Follow-up|5|||
125183682|NCT01415518|450294726|FG000|Overall Study|Adverse Event|3|||
125183683|NCT01415518|450294727|FG001|Overall Study|Adverse Event|4|||
125183684|NCT01415518|450294726|FG000|Overall Study|Death|1|||
125183685|NCT01415518|450294727|FG001|Overall Study|Death|1|||
125183686|NCT01415518|450294726|FG000|Overall Study|Condition under Investigation Worsened|1|||
125183687|NCT01415518|450294727|FG001|Overall Study|Condition under Investigation Worsened|1|||
125183688|NCT00679211|450294728|FG000|Overall Study|Progressive disease|82|||
125183689|NCT00679211|450294728|FG000|Overall Study|Adverse Event|7|||
125183690|NCT00679211|450294728|FG000|Overall Study|Withdrawal by Subject|2|||
125183691|NCT00679211|450294728|FG000|Overall Study|Physician Decision|5|||
125183692|NCT00679211|450294728|FG000|Overall Study|Refused to undergo protocol procedures|1|||
125183693|NCT00679211|450294728|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
125183694|NCT00679211|450294728|FG000|Overall Study|Other|1|||
125183695|NCT01730053|450294729|FG000|Overall Study|Participant moved|0|||
125183696|NCT01730053|450294730|FG001|Overall Study|Participant moved|0|||
125183697|NCT01730053|450294731|FG002|Overall Study|Participant moved|1|||
125183698|NCT01730053|450294732|FG003|Overall Study|Participant moved|0|||
125183699|NCT01730053|450294733|FG004|Overall Study|Participant moved|0|||
125183700|NCT01730053|450294734|FG005|Overall Study|Participant moved|0|||
125183701|NCT01730053|450294729|FG000|Overall Study|Physician Decision|0|||
125183702|NCT01730053|450294730|FG001|Overall Study|Physician Decision|0|||
125183703|NCT01730053|450294731|FG002|Overall Study|Physician Decision|0|||
125183704|NCT01730053|450294732|FG003|Overall Study|Physician Decision|1|||
125183705|NCT01730053|450294733|FG004|Overall Study|Physician Decision|0|||
125183706|NCT01730053|450294734|FG005|Overall Study|Physician Decision|0|||
125183707|NCT01730053|450294729|FG000|Overall Study|Adverse Event|2|||
125183708|NCT01730053|450294730|FG001|Overall Study|Adverse Event|6|||
125183709|NCT01730053|450294731|FG002|Overall Study|Adverse Event|3|||
125183710|NCT01730053|450294732|FG003|Overall Study|Adverse Event|3|||
125183711|NCT01730053|450294733|FG004|Overall Study|Adverse Event|2|||
125183712|NCT01730053|450294734|FG005|Overall Study|Adverse Event|2|||
125183713|NCT01730053|450294729|FG000|Overall Study|Poor compliance to protocol|1|||
125183714|NCT01730053|450294730|FG001|Overall Study|Poor compliance to protocol|2|||
125183715|NCT01730053|450294731|FG002|Overall Study|Poor compliance to protocol|2|||
125183716|NCT01730053|450294732|FG003|Overall Study|Poor compliance to protocol|0|||
125183717|NCT01730053|450294733|FG004|Overall Study|Poor compliance to protocol|0|||
125183718|NCT01730053|450294734|FG005|Overall Study|Poor compliance to protocol|2|||
125183719|NCT01730053|450294729|FG000|Overall Study|Other than specified|2|||
125183720|NCT01730053|450294730|FG001|Overall Study|Other than specified|6|||
125183721|NCT01730053|450294731|FG002|Overall Study|Other than specified|5|||
125183722|NCT01730053|450294732|FG003|Overall Study|Other than specified|4|||
125183723|NCT01730053|450294733|FG004|Overall Study|Other than specified|7|||
125183724|NCT01730053|450294734|FG005|Overall Study|Other than specified|9|||
125183725|NCT01470248|450294735|FG000|Overall Study|Withdrawal by Subject|1|||
125183726|NCT05085834|450294736|FG000|Overall Study|Lost to Follow-up|9|||
125183727|NCT05085834|450294737|FG001|Overall Study|Lost to Follow-up|2|||
125183728|NCT05085834|450294736|FG000|Overall Study|Adverse Event|6|||
125183729|NCT05085834|450294737|FG001|Overall Study|Adverse Event|0|||
125183730|NCT05085834|450294736|FG000|Overall Study|Death|1|||
125183731|NCT05085834|450294737|FG001|Overall Study|Death|0|||
125183732|NCT05085834|450294736|FG000|Overall Study|Inability to swallow the pill|0|||
125183733|NCT05085834|450294737|FG001|Overall Study|Inability to swallow the pill|1|||
125183734|NCT02243605|450294738|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
125183735|NCT02243605|450294739|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
125183736|NCT02243605|450294738|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
125183737|NCT02243605|450294739|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
125183738|NCT02243605|450294738|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
125183739|NCT02243605|450294739|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
125183740|NCT02243605|450294738|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
125183741|NCT02243605|450294739|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
125183742|NCT02243605|450294738|FG000|Stage 2 - Final Analysis Population|Progression|0|||
125183743|NCT02243605|450294739|FG001|Stage 2 - Final Analysis Population|Progression|1|||
125183744|NCT04173507|450294740|FG000|Overall Study|On Treatment|3|||
125183745|NCT04173507|450294740|FG000|Overall Study|Adverse Event|3|||
125183746|NCT04173507|450294740|FG000|Overall Study|Progression/Relapse|34|||
125183747|NCT04173507|450294740|FG000|Overall Study|Death|2|||
125183748|NCT01823328|450294741|FG000|Overall Study|Withdrawal by Subject|8|||
125183749|NCT01823328|450294742|FG001|Overall Study|Withdrawal by Subject|6|||
125183750|NCT02157935|450294743|FG000|Overall Study|Withdrawal by Subject|25|||
125183751|NCT02157935|450294744|FG001|Overall Study|Withdrawal by Subject|39|||
125183752|NCT02157935|450294743|FG000|Overall Study|Screen failure|1|||
125183753|NCT02157935|450294744|FG001|Overall Study|Screen failure|2|||
125183754|NCT02157935|450294743|FG000|Overall Study|Protocol Violation|1|||
125183755|NCT02157935|450294744|FG001|Overall Study|Protocol Violation|0|||
125183756|NCT02157935|450294743|FG000|Overall Study|Progressive disease|0|||
125183757|NCT02157935|450294744|FG001|Overall Study|Progressive disease|2|||
125183758|NCT02157935|450294743|FG000|Overall Study|Other|5|||
125183759|NCT02157935|450294744|FG001|Overall Study|Other|12|||
125183760|NCT02157935|450294743|FG000|Overall Study|Lack of Efficacy|0|||
125183761|NCT02157935|450294744|FG001|Overall Study|Lack of Efficacy|1|||
125183762|NCT02157935|450294743|FG000|Overall Study|Death|4|||
125183763|NCT02157935|450294744|FG001|Overall Study|Death|4|||
125183764|NCT02157935|450294743|FG000|Overall Study|Adverse Event|3|||
125183765|NCT02157935|450294744|FG001|Overall Study|Adverse Event|5|||
125183766|NCT02764762|450294745|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
125183767|NCT02764762|450294745|FG000|Overall Study|Lost to Follow-up|4|||
125183768|NCT02764762|450294745|FG000|Overall Study|Voluntary Withdrawal|8|||
125183769|NCT02764762|450294745|FG000|Overall Study|Site Termination|1|||
125183770|NCT02764762|450294745|FG000|Overall Study|Lack of Efficacy|16|||
125183771|NCT02764762|450294745|FG000|Overall Study|Reason not Specified|1|||
125183772|NCT02717507|450294748|FG000|Overall Study|Lost to Follow-up|5|||
125183773|NCT02717507|450294749|FG001|Overall Study|Lost to Follow-up|8|||
125183774|NCT02717507|450294748|FG000|Overall Study|Pregnancy|1|||
125183775|NCT02717507|450294749|FG001|Overall Study|Pregnancy|1|||
125183776|NCT02717507|450294748|FG000|Overall Study|Protocol Violation|2|||
125183777|NCT02717507|450294749|FG001|Overall Study|Protocol Violation|2|||
125183778|NCT02717507|450294748|FG000|Overall Study|Withdrawal by Subject|20|||
125183779|NCT02717507|450294749|FG001|Overall Study|Withdrawal by Subject|20|||
125183780|NCT02717507|450294748|FG000|Overall Study|Relapse|1|||
125183781|NCT02717507|450294749|FG001|Overall Study|Relapse|1|||
125183782|NCT02717507|450294748|FG000|Overall Study|Cardiac Event|2|||
125183783|NCT02717507|450294749|FG001|Overall Study|Cardiac Event|6|||
125183784|NCT00742209|450294754|FG000|Overall Study|Adverse Event|11|||
125183785|NCT00742209|450294755|FG001|Overall Study|Adverse Event|4|||
125183786|NCT00742209|450294756|FG002|Overall Study|Adverse Event|17|||
125183787|NCT00742209|450294757|FG003|Overall Study|Adverse Event|16|||
125183788|NCT00742209|450294758|FG004|Overall Study|Adverse Event|13|||
125183789|NCT00742209|450294754|FG000|Overall Study|Participant Withdrew Consent|8|||
125183790|NCT00742209|450294755|FG001|Overall Study|Participant Withdrew Consent|4|||
125183791|NCT00742209|450294756|FG002|Overall Study|Participant Withdrew Consent|14|||
125183792|NCT00742209|450294757|FG003|Overall Study|Participant Withdrew Consent|7|||
125183793|NCT00742209|450294758|FG004|Overall Study|Participant Withdrew Consent|4|||
125183794|NCT00742209|450294754|FG000|Overall Study|Protocol Violation|6|||
125183795|NCT00742209|450294755|FG001|Overall Study|Protocol Violation|5|||
125183796|NCT00742209|450294756|FG002|Overall Study|Protocol Violation|4|||
125183797|NCT00742209|450294757|FG003|Overall Study|Protocol Violation|5|||
125183798|NCT00742209|450294758|FG004|Overall Study|Protocol Violation|3|||
125183799|NCT00742209|450294754|FG000|Overall Study|Lost to Follow-up|3|||
125183800|NCT00742209|450294755|FG001|Overall Study|Lost to Follow-up|4|||
125183801|NCT00742209|450294756|FG002|Overall Study|Lost to Follow-up|5|||
125183802|NCT00742209|450294757|FG003|Overall Study|Lost to Follow-up|5|||
125183803|NCT00742209|450294758|FG004|Overall Study|Lost to Follow-up|3|||
125183804|NCT00742209|450294754|FG000|Overall Study|Lack of Efficacy|6|||
125183805|NCT00742209|450294755|FG001|Overall Study|Lack of Efficacy|1|||
125183806|NCT00742209|450294756|FG002|Overall Study|Lack of Efficacy|1|||
125183807|NCT00742209|450294757|FG003|Overall Study|Lack of Efficacy|3|||
125183808|NCT00742209|450294758|FG004|Overall Study|Lack of Efficacy|1|||
125183809|NCT00742209|450294754|FG000|Overall Study|Investigator Discretion|0|||
125183810|NCT00742209|450294755|FG001|Overall Study|Investigator Discretion|0|||
125183811|NCT00742209|450294756|FG002|Overall Study|Investigator Discretion|5|||
125183812|NCT00742209|450294757|FG003|Overall Study|Investigator Discretion|1|||
125183813|NCT00742209|450294758|FG004|Overall Study|Investigator Discretion|1|||
125183814|NCT02003209|450294762|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
125183815|NCT02003209|450294763|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
125183816|NCT00638508|450294764|FG000|Overall Study|Physician Decision|5|||
125183817|NCT00638508|450294765|FG001|Overall Study|Physician Decision|2|||
125183818|NCT03500198|450294766|FG000|Overall Study|Lost to Follow-up|0|||
125183819|NCT03500198|450294767|FG001|Overall Study|Lost to Follow-up|1|||
125183820|NCT00595621|450294768|FG000|Open Label Run in|Adverse Event|1|||
125183821|NCT00595621|450294769|FG001|Open Label Run in|Adverse Event|0|||
125183822|NCT00595621|450294768|FG000|Open Label Run in|Physician Decision|1|||
125183823|NCT00595621|450294769|FG001|Open Label Run in|Physician Decision|0|||
125183824|NCT00595621|450294768|FG000|Open Label Run in|Withdrawal by Subject|1|||
125183825|NCT00595621|450294769|FG001|Open Label Run in|Withdrawal by Subject|0|||
125183826|NCT00595621|450294768|FG000|Randomization and Study|Adverse Event|2|||
125183827|NCT00595621|450294769|FG001|Randomization and Study|Adverse Event|0|||
125183828|NCT00595621|450294768|FG000|Randomization and Study|Withdrawal by Subject|0|||
125183829|NCT00595621|450294769|FG001|Randomization and Study|Withdrawal by Subject|1|||
125183830|NCT00324987|450294770|FG000|Overall Study|Adverse Event|2|||
125183831|NCT00324987|450294771|FG001|Overall Study|Adverse Event|1|||
125183832|NCT00324987|450294770|FG000|Overall Study|Withdrawal by Subject|1|||
125183833|NCT00324987|450294771|FG001|Overall Study|Withdrawal by Subject|1|||
125183834|NCT00324987|450294770|FG000|Overall Study|Progression|1|||
125183835|NCT00324987|450294771|FG001|Overall Study|Progression|1|||
125183836|NCT00324987|450294770|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
125183837|NCT00324987|450294771|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
125183838|NCT02392481|450294772|FG000|Overall Study|Adverse Event|0|||
125183839|NCT02392481|450294773|FG001|Overall Study|Adverse Event|0|||
125183840|NCT02392481|450294774|FG002|Overall Study|Adverse Event|1|||
125183841|NCT02392481|450294775|FG003|Overall Study|Adverse Event|2|||
125183842|NCT02392481|450294772|FG000|Overall Study|Withdrawal by Subject|0|||
125183843|NCT02392481|450294773|FG001|Overall Study|Withdrawal by Subject|0|||
125183844|NCT02392481|450294774|FG002|Overall Study|Withdrawal by Subject|1|||
125183845|NCT02392481|450294775|FG003|Overall Study|Withdrawal by Subject|0|||
125183846|NCT01254643|450294777|FG000|Overall Study|Withdrawal by Subject|1|||
125183847|NCT03817125|450294778|FG000|Overall Study|Adverse Event|1|||
125183848|NCT03817125|450294779|FG001|Overall Study|Adverse Event|0|||
125183849|NCT03817125|450294778|FG000|Overall Study|Physician Decision|0|||
125183850|NCT03817125|450294779|FG001|Overall Study|Physician Decision|1|||
125183851|NCT03817125|450294778|FG000|Overall Study|Lack of Efficacy|1|||
125183852|NCT03817125|450294779|FG001|Overall Study|Lack of Efficacy|5|||
125183853|NCT01998919|450294780|FG000|Overall Study|Death|2|||
125183854|NCT01998919|450294781|FG001|Overall Study|Death|2|||
125183855|NCT01998919|450294780|FG000|Overall Study|Adverse Event|0|||
125183856|NCT01998919|450294781|FG001|Overall Study|Adverse Event|5|||
125183857|NCT01998919|450294780|FG000|Overall Study|Disease progression|31|||
125183858|NCT01998919|450294781|FG001|Overall Study|Disease progression|22|||
125183859|NCT01998919|450294780|FG000|Overall Study|Withdrawal by Subject|2|||
125183860|NCT01998919|450294781|FG001|Overall Study|Withdrawal by Subject|4|||
125183861|NCT01998919|450294780|FG000|Overall Study|Lost to Follow-up|2|||
125183862|NCT01998919|450294781|FG001|Overall Study|Lost to Follow-up|0|||
125183863|NCT01998919|450294780|FG000|Overall Study|Other|5|||
125183864|NCT01998919|450294781|FG001|Overall Study|Other|2|||
125183865|NCT02088177|450294784|FG000|Overall Study|Lost to Follow-up|3|||
125392438|NCT00680901|451070686|FG000|Overall Study|Subject decided to withdraw from the study|4|||
125183866|NCT01778530|450294786|FG000|Overall Study|Progression on study|1|||
125183867|NCT01778530|450294786|FG000|Overall Study|Adverse event/side effect|1|||
125183868|NCT01199939|450294787|FG000|Overall Study|Adverse Event|4|||
125183869|NCT01199939|450294787|FG000|Overall Study|Protocol Violation|3|||
125183870|NCT01199939|450294787|FG000|Overall Study|Lost to Follow-up|2|||
125183871|NCT01199939|450294787|FG000|Overall Study|Reached a virologic endpoint|4|||
125183872|NCT01894919|450294788|FG000|Overall Study|Withdrawal by Subject|1|||
125183873|NCT01894919|450294789|FG001|Overall Study|Withdrawal by Subject|0|||
125183874|NCT01894919|450294790|FG002|Overall Study|Withdrawal by Subject|0|||
125183875|NCT01894919|450294791|FG003|Overall Study|Withdrawal by Subject|0|||
125183876|NCT01894919|450294792|FG004|Overall Study|Withdrawal by Subject|1|||
125183877|NCT01894919|450294793|FG005|Overall Study|Withdrawal by Subject|0|||
125183878|NCT01894919|450294794|FG006|Overall Study|Withdrawal by Subject|0|||
125183879|NCT01894919|450294795|FG007|Overall Study|Withdrawal by Subject|0|||
125183880|NCT01894919|450294796|FG008|Overall Study|Withdrawal by Subject|0|||
125183881|NCT01894919|450294797|FG009|Overall Study|Withdrawal by Subject|1|||
125183882|NCT01894919|450294798|FG010|Overall Study|Withdrawal by Subject|1|||
125183883|NCT01894919|450294799|FG011|Overall Study|Withdrawal by Subject|0|||
125183884|NCT01894919|450294800|FG012|Overall Study|Withdrawal by Subject|0|||
125183885|NCT01894919|450294788|FG000|Overall Study|Adverse Event|0|||
125183886|NCT01894919|450294789|FG001|Overall Study|Adverse Event|0|||
125183887|NCT01894919|450294790|FG002|Overall Study|Adverse Event|0|||
125183888|NCT01894919|450294791|FG003|Overall Study|Adverse Event|0|||
125183889|NCT01894919|450294792|FG004|Overall Study|Adverse Event|0|||
125183890|NCT01894919|450294793|FG005|Overall Study|Adverse Event|0|||
125183891|NCT01894919|450294794|FG006|Overall Study|Adverse Event|0|||
125183892|NCT01894919|450294795|FG007|Overall Study|Adverse Event|0|||
125183893|NCT01894919|450294796|FG008|Overall Study|Adverse Event|0|||
125183894|NCT01894919|450294797|FG009|Overall Study|Adverse Event|0|||
125183895|NCT01894919|450294798|FG010|Overall Study|Adverse Event|1|||
125183896|NCT01894919|450294799|FG011|Overall Study|Adverse Event|0|||
125183897|NCT01894919|450294800|FG012|Overall Study|Adverse Event|0|||
125183898|NCT01894919|450294788|FG000|Overall Study|Other-Unspecified|1|||
125183899|NCT01894919|450294789|FG001|Overall Study|Other-Unspecified|0|||
125183900|NCT01894919|450294790|FG002|Overall Study|Other-Unspecified|0|||
125183901|NCT01894919|450294791|FG003|Overall Study|Other-Unspecified|0|||
125183902|NCT01894919|450294792|FG004|Overall Study|Other-Unspecified|0|||
125183903|NCT01894919|450294793|FG005|Overall Study|Other-Unspecified|0|||
125183904|NCT01894919|450294794|FG006|Overall Study|Other-Unspecified|0|||
125183905|NCT01894919|450294795|FG007|Overall Study|Other-Unspecified|0|||
125183906|NCT01894919|450294796|FG008|Overall Study|Other-Unspecified|0|||
125183907|NCT01894919|450294797|FG009|Overall Study|Other-Unspecified|0|||
125183908|NCT01894919|450294798|FG010|Overall Study|Other-Unspecified|0|||
125183909|NCT01894919|450294799|FG011|Overall Study|Other-Unspecified|0|||
125183910|NCT01894919|450294800|FG012|Overall Study|Other-Unspecified|0|||
125183911|NCT01894919|450294788|FG000|Overall Study|Lost to Follow-up|0|||
125183912|NCT01894919|450294789|FG001|Overall Study|Lost to Follow-up|0|||
125183913|NCT01894919|450294790|FG002|Overall Study|Lost to Follow-up|0|||
125183914|NCT01894919|450294791|FG003|Overall Study|Lost to Follow-up|0|||
125183915|NCT01894919|450294792|FG004|Overall Study|Lost to Follow-up|2|||
125183916|NCT01894919|450294793|FG005|Overall Study|Lost to Follow-up|0|||
125183917|NCT01894919|450294794|FG006|Overall Study|Lost to Follow-up|0|||
125183918|NCT01894919|450294795|FG007|Overall Study|Lost to Follow-up|0|||
125183919|NCT01894919|450294796|FG008|Overall Study|Lost to Follow-up|0|||
125183920|NCT01894919|450294797|FG009|Overall Study|Lost to Follow-up|0|||
125183921|NCT01894919|450294798|FG010|Overall Study|Lost to Follow-up|0|||
125183922|NCT01894919|450294799|FG011|Overall Study|Lost to Follow-up|0|||
125183923|NCT01894919|450294800|FG012|Overall Study|Lost to Follow-up|0|||
125183924|NCT01433471|450294801|FG000|Overall Study|Withdrawal by Subject|0|||
125183925|NCT01433471|450294802|FG001|Overall Study|Withdrawal by Subject|1|||
125183926|NCT03711188|450294805|FG000|Overall Study|Disease progression|11|||
125183927|NCT03711188|450294805|FG000|Overall Study|Adverse Event|1|||
125183928|NCT03238651|450294806|FG000|Overall Study|Other|0|||
125183929|NCT03238651|450294807|FG001|Overall Study|Other|0|||
125183930|NCT03238651|450294808|FG002|Overall Study|Other|0|||
125183931|NCT03238651|450294809|FG003|Overall Study|Other|0|||
125183932|NCT03238651|450294810|FG004|Overall Study|Other|1|||
125183933|NCT03238651|450294806|FG000|Overall Study|Progressive Disease|2|||
125183934|NCT03238651|450294807|FG001|Overall Study|Progressive Disease|2|||
125183935|NCT03238651|450294808|FG002|Overall Study|Progressive Disease|2|||
125183936|NCT03238651|450294809|FG003|Overall Study|Progressive Disease|2|||
125183937|NCT03238651|450294810|FG004|Overall Study|Progressive Disease|0|||
125183938|NCT03238651|450294806|FG000|Overall Study|Withdrawal by Subject|0|||
125183939|NCT03238651|450294807|FG001|Overall Study|Withdrawal by Subject|1|||
125183940|NCT03238651|450294808|FG002|Overall Study|Withdrawal by Subject|0|||
125183941|NCT03238651|450294809|FG003|Overall Study|Withdrawal by Subject|1|||
125183942|NCT03238651|450294810|FG004|Overall Study|Withdrawal by Subject|0|||
125183943|NCT03238651|450294806|FG000|Overall Study|Adverse Event|1|||
125183944|NCT03238651|450294807|FG001|Overall Study|Adverse Event|3|||
125183945|NCT03238651|450294808|FG002|Overall Study|Adverse Event|2|||
125183946|NCT03238651|450294809|FG003|Overall Study|Adverse Event|0|||
125183947|NCT03238651|450294810|FG004|Overall Study|Adverse Event|0|||
125183948|NCT03875508|450294811|FG000|Overall Study|Adverse Event|1|||
125183949|NCT03875508|450294811|FG000|Overall Study|Lost to Follow-up|8|||
125183950|NCT03875508|450294811|FG000|Overall Study|Lack of Efficacy|1|||
125183951|NCT03875508|450294811|FG000|Overall Study|Other, not specified|2|||
125183952|NCT01532934|450294821|FG000|Overall Study|Lost to Follow-up|11|||
125183953|NCT01532934|450294822|FG001|Overall Study|Lost to Follow-up|11|||
125183954|NCT01532934|450294821|FG000|Overall Study|In controlled environment|3|||
125183955|NCT01532934|450294822|FG001|Overall Study|In controlled environment|2|||
125183956|NCT01147068|450294823|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
125183957|NCT01147068|450294824|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
125183958|NCT01147068|450294825|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
125183959|NCT01147068|450294826|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
125183960|NCT01147068|450294827|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
125183961|NCT01147068|450294828|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
125183962|NCT01147068|450294829|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
125183963|NCT01147068|450294823|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
125183964|NCT01147068|450294824|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
125183965|NCT01147068|450294825|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
125183966|NCT01147068|450294826|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
125183967|NCT01147068|450294827|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
125183968|NCT01147068|450294828|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
125183969|NCT01147068|450294829|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
125183970|NCT01147068|450294823|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
125183971|NCT01147068|450294824|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
125183972|NCT01147068|450294825|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
125183973|NCT01147068|450294826|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
125183974|NCT01147068|450294827|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
125183975|NCT01147068|450294828|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
125183976|NCT01147068|450294829|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
125183977|NCT01147068|450294823|FG000|Subjects That Received 2nd Dose|Other|0|||
125183978|NCT01147068|450294824|FG001|Subjects That Received 2nd Dose|Other|3|||
125183979|NCT01147068|450294825|FG002|Subjects That Received 2nd Dose|Other|3|||
125183980|NCT01147068|450294826|FG003|Subjects That Received 2nd Dose|Other|0|||
125183981|NCT01147068|450294827|FG004|Subjects That Received 2nd Dose|Other|1|||
125183982|NCT01147068|450294828|FG005|Subjects That Received 2nd Dose|Other|0|||
125183983|NCT01147068|450294829|FG006|Subjects That Received 2nd Dose|Other|0|||
125183984|NCT01147068|450294823|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
125183985|NCT01147068|450294824|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
125183986|NCT01147068|450294825|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
125183987|NCT01147068|450294826|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
125183988|NCT01147068|450294827|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
125183989|NCT01147068|450294828|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
125183990|NCT01147068|450294829|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
125183991|NCT01147068|450294823|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
125183992|NCT01147068|450294824|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
125183993|NCT01147068|450294825|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
125183994|NCT01147068|450294826|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
125183995|NCT01147068|450294827|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
125183996|NCT01147068|450294828|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
125183997|NCT01147068|450294829|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
125183998|NCT01147068|450294823|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
125183999|NCT01147068|450294824|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
125184000|NCT01147068|450294825|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
125184001|NCT01147068|450294826|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
125184002|NCT01147068|450294827|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
125184003|NCT01147068|450294828|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
125184004|NCT01147068|450294829|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
125184005|NCT02291237|450294830|FG000|Overall Study|Study Terminated by Sponsor|72|||
125184006|NCT02291237|450294831|FG001|Overall Study|Study Terminated by Sponsor|67|||
125184007|NCT02291237|450294830|FG000|Overall Study|Adverse Event|1|||
125184008|NCT02291237|450294831|FG001|Overall Study|Adverse Event|3|||
125184009|NCT02291237|450294830|FG000|Overall Study|Investigator's Discretion|0|||
125184010|NCT02291237|450294831|FG001|Overall Study|Investigator's Discretion|3|||
125184011|NCT02291237|450294830|FG000|Overall Study|Withdrew Consent|11|||
125184012|NCT02291237|450294831|FG001|Overall Study|Withdrew Consent|11|||
125184013|NCT02291237|450294830|FG000|Overall Study|Lost to Follow-up|0|||
125184014|NCT02291237|450294831|FG001|Overall Study|Lost to Follow-up|2|||
125184015|NCT02291237|450294830|FG000|Overall Study|Subject Required Prohibited Medication|2|||
125184016|NCT02291237|450294831|FG001|Overall Study|Subject Required Prohibited Medication|0|||
125184017|NCT01149863|450294832|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
125184018|NCT01306305|450294833|FG000|Overall Study|Lost to Follow-up|1|||
125184019|NCT01306305|450294834|FG001|Overall Study|Lost to Follow-up|0|||
125184020|NCT01306305|450294833|FG000|Overall Study|Withdrew consent|1|||
125184021|NCT01306305|450294834|FG001|Overall Study|Withdrew consent|0|||
125184022|NCT03326193|450294835|FG000|Overall Study|Sponsor decision|35|||
125184023|NCT00699998|450294837|FG000|Overall Study|Withdrawal by Subject|194|||
125184024|NCT00699998|450294838|FG001|Overall Study|Withdrawal by Subject|83|||
125184025|NCT00699998|450294839|FG002|Overall Study|Withdrawal by Subject|202|||
125184026|NCT00699998|450294840|FG003|Overall Study|Withdrawal by Subject|80|||
125184027|NCT00699998|450294837|FG000|Overall Study|Physician Decision|3|||
125184028|NCT00699998|450294838|FG001|Overall Study|Physician Decision|2|||
125184029|NCT00699998|450294839|FG002|Overall Study|Physician Decision|1|||
125184030|NCT00699998|450294840|FG003|Overall Study|Physician Decision|1|||
125184031|NCT00699998|450294837|FG000|Overall Study|Lost to Follow-up|2|||
125184032|NCT00699998|450294838|FG001|Overall Study|Lost to Follow-up|1|||
125184033|NCT00699998|450294839|FG002|Overall Study|Lost to Follow-up|3|||
125184034|NCT00699998|450294840|FG003|Overall Study|Lost to Follow-up|1|||
125184035|NCT02698163|450294841|FG000|Overall Study|Lost to Follow-up|0|||
125184036|NCT02698163|450294842|FG001|Overall Study|Lost to Follow-up|1|||
125184037|NCT05373108|450294843|FG000|Overall Study|Withdrawal by Subject|2|||
125184038|NCT02892331|450294844|FG000|Overall Study|Withdrawal by Subject|0|||
125184039|NCT02892331|450294845|FG001|Overall Study|Withdrawal by Subject|1|||
125184040|NCT02892331|450294846|FG002|Overall Study|Withdrawal by Subject|1|||
125184041|NCT02892331|450294844|FG000|Overall Study|Sick family member|0|||
125184042|NCT02892331|450294845|FG001|Overall Study|Sick family member|0|||
125184043|NCT02892331|450294846|FG002|Overall Study|Sick family member|1|||
125184044|NCT02892331|450294844|FG000|Overall Study|Corona virus pandemic|1|||
125184045|NCT02892331|450294845|FG001|Overall Study|Corona virus pandemic|0|||
125184046|NCT02892331|450294846|FG002|Overall Study|Corona virus pandemic|1|||
125184047|NCT02892331|450294844|FG000|Overall Study|Lost to Follow-up|1|||
125184048|NCT02892331|450294845|FG001|Overall Study|Lost to Follow-up|0|||
125184049|NCT02892331|450294846|FG002|Overall Study|Lost to Follow-up|1|||
125184050|NCT02892331|450294844|FG000|Overall Study|Blood pressure was too elevated|0|||
125184051|NCT02892331|450294845|FG001|Overall Study|Blood pressure was too elevated|1|||
125184052|NCT02892331|450294846|FG002|Overall Study|Blood pressure was too elevated|0|||
125184053|NCT02892331|450294844|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
125184054|NCT02892331|450294845|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
125184055|NCT02892331|450294846|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
125184056|NCT00349973|450294850|FG000|Overall Study|Adverse Event|3|||
125184057|NCT00349973|450294851|FG001|Overall Study|Adverse Event|3|||
125184058|NCT00349973|450294850|FG000|Overall Study|Withdrawal by Subject|1|||
125184059|NCT00349973|450294851|FG001|Overall Study|Withdrawal by Subject|0|||
125184060|NCT04314037|450294852|FG000|Treatment Period 2|Adverse Event|1|||
125184061|NCT04314037|450294853|FG001|Treatment Period 2|Adverse Event|0|||
125184062|NCT04314037|450294852|FG000|Treatment Period 3|Protocol Violation|1|||
125184063|NCT04314037|450294853|FG001|Treatment Period 3|Protocol Violation|0|||
125184064|NCT04314037|450294852|FG000|Treatment Period 3|Adverse Event|0|||
125184065|NCT04314037|450294853|FG001|Treatment Period 3|Adverse Event|1|||
125184066|NCT02546986|450296441|FG000|Treatment Period|Progressive Disease|20|||
125184067|NCT02546986|450296442|FG001|Treatment Period|Progressive Disease|22|||
125184068|NCT02546986|450296441|FG000|Treatment Period|Adverse Event|14|||
125184069|NCT02546986|450296442|FG001|Treatment Period|Adverse Event|6|||
125184070|NCT02546986|450296441|FG000|Treatment Period|Symptomatic Deterioration|4|||
125184071|NCT02546986|450296442|FG001|Treatment Period|Symptomatic Deterioration|3|||
125184072|NCT02546986|450296441|FG000|Treatment Period|Death|3|||
125184073|NCT02546986|450296442|FG001|Treatment Period|Death|4|||
125184074|NCT02546986|450296441|FG000|Treatment Period|Physician Decision|1|||
125184075|NCT02546986|450296442|FG001|Treatment Period|Physician Decision|2|||
125184076|NCT02546986|450296441|FG000|Treatment Period|Protocol Violation|1|||
125184077|NCT02546986|450296442|FG001|Treatment Period|Protocol Violation|0|||
125184078|NCT02546986|450296441|FG000|Treatment Period|Withdrawal by Subject|1|||
125184079|NCT02546986|450296442|FG001|Treatment Period|Withdrawal by Subject|1|||
125184080|NCT02546986|450296441|FG000|Treatment Period|Non-compliance with Study Drug|0|||
125184081|NCT02546986|450296442|FG001|Treatment Period|Non-compliance with Study Drug|1|||
125184082|NCT02546986|450296441|FG000|Treatment Period|Study Terminated by Sponsor|0|||
125184083|NCT02546986|450296442|FG001|Treatment Period|Study Terminated by Sponsor|1|||
125184084|NCT02546986|450296441|FG000|Treatment Period|Miscellaneous|7|||
125184085|NCT02546986|450296442|FG001|Treatment Period|Miscellaneous|9|||
125184086|NCT02546986|450296441|FG000|Survival Follow-Up Phase|Missing Status|3|||
125184087|NCT02546986|450296442|FG001|Survival Follow-Up Phase|Missing Status|5|||
125184088|NCT02546986|450296441|FG000|Survival Follow-Up Phase|Death|18|||
125184089|NCT02546986|450296442|FG001|Survival Follow-Up Phase|Death|12|||
125184090|NCT02546986|450296441|FG000|Survival Follow-Up Phase|Alive|13|||
125184091|NCT02546986|450296442|FG001|Survival Follow-Up Phase|Alive|16|||
125184092|NCT02546986|450296441|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
125184093|NCT02546986|450296442|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
125184094|NCT01168232|450296443|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
125184095|NCT01168232|450296443|FG000|Overall Study|Ineligible- Wrong cell type|6|||
125184096|NCT01168232|450296443|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
125184097|NCT05012098|450296446|FG000|Overall Study|Disease progression|5|||
125184098|NCT05012098|450296447|FG001|Overall Study|Disease progression|2|||
125184099|NCT05012098|450296446|FG000|Overall Study|Adverse Event|1|||
125184100|NCT05012098|450296447|FG001|Overall Study|Adverse Event|0|||
125184101|NCT05012098|450296446|FG000|Overall Study|Withdrawal by Subject|1|||
125184102|NCT05012098|450296447|FG001|Overall Study|Withdrawal by Subject|0|||
125184103|NCT05012098|450296446|FG000|Overall Study|Discontinuation per protocol|1|||
125184104|NCT05012098|450296447|FG001|Overall Study|Discontinuation per protocol|0|||
125184105|NCT05258773|450296448|FG000|Overall Study|Screen Failure|1|||
125184106|NCT05258773|450296449|FG001|Overall Study|Screen Failure|1|||
125184107|NCT05258773|450296448|FG000|Overall Study|Adverse Event|1|||
125184108|NCT05258773|450296449|FG001|Overall Study|Adverse Event|0|||
125184109|NCT05258773|450296448|FG000|Overall Study|Withdrawal by Subject|0|||
125184110|NCT05258773|450296449|FG001|Overall Study|Withdrawal by Subject|1|||
125184111|NCT03018288|450296452|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
125184112|NCT03018288|450296453|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
125184113|NCT03018288|450296454|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
125184114|NCT03018288|450296455|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
125184115|NCT03018288|450296452|FG000|Overall Study|Participant withdrew consent.|0|||
125184116|NCT03018288|450296453|FG001|Overall Study|Participant withdrew consent.|0|||
125184117|NCT03018288|450296454|FG002|Overall Study|Participant withdrew consent.|1|||
125184118|NCT03018288|450296455|FG003|Overall Study|Participant withdrew consent.|0|||
125184119|NCT03018288|450296452|FG000|Overall Study|Switched to alternative treatment.|0|||
125184120|NCT03018288|450296453|FG001|Overall Study|Switched to alternative treatment.|0|||
125184121|NCT03018288|450296454|FG002|Overall Study|Switched to alternative treatment.|1|||
125184122|NCT03018288|450296455|FG003|Overall Study|Switched to alternative treatment.|0|||
125184123|NCT03018288|450296452|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
125184124|NCT03018288|450296453|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
125184125|NCT03018288|450296454|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
125184126|NCT03018288|450296455|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
125184127|NCT03018288|450296452|FG000|Overall Study|Screen failures|0|||
125184128|NCT03018288|450296453|FG001|Overall Study|Screen failures|0|||
125184129|NCT03018288|450296454|FG002|Overall Study|Screen failures|0|||
125184130|NCT03018288|450296455|FG003|Overall Study|Screen failures|51|||
125184131|NCT03018288|450296452|FG000|Overall Study|Chose treatment outside of UNC|0|||
125184132|NCT03018288|450296453|FG001|Overall Study|Chose treatment outside of UNC|0|||
125184133|NCT03018288|450296454|FG002|Overall Study|Chose treatment outside of UNC|0|||
125184134|NCT03018288|450296455|FG003|Overall Study|Chose treatment outside of UNC|1|||
125184135|NCT03018288|450296452|FG000|Overall Study|Unable to comply with protocol requirements|1|||
125184136|NCT03018288|450296453|FG001|Overall Study|Unable to comply with protocol requirements|1|||
125184137|NCT03018288|450296454|FG002|Overall Study|Unable to comply with protocol requirements|0|||
125184138|NCT03018288|450296455|FG003|Overall Study|Unable to comply with protocol requirements|1|||
125184139|NCT03018288|450296452|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
125184140|NCT03018288|450296453|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
125184141|NCT03018288|450296454|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
125184142|NCT03018288|450296455|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
125184143|NCT03018288|450296452|FG000|Overall Study|Physician Decision|0|||
125184144|NCT03018288|450296453|FG001|Overall Study|Physician Decision|0|||
125184145|NCT03018288|450296454|FG002|Overall Study|Physician Decision|0|||
125184146|NCT03018288|450296455|FG003|Overall Study|Physician Decision|1|||
125184147|NCT01490086|450296459|FG000|Overall Study|Consent withdrawn|4|||
125184148|NCT01490086|450296460|FG001|Overall Study|Consent withdrawn|4|||
125184149|NCT01490086|450296461|FG002|Overall Study|Consent withdrawn|3|||
125184150|NCT01490086|450296462|FG003|Overall Study|Consent withdrawn|0|||
125184151|NCT01490086|450296463|FG004|Overall Study|Consent withdrawn|1|||
125184152|NCT01490086|450296459|FG000|Overall Study|Non-compliance|0|||
125184153|NCT01490086|450296460|FG001|Overall Study|Non-compliance|1|||
125184154|NCT01490086|450296461|FG002|Overall Study|Non-compliance|0|||
125184155|NCT01490086|450296462|FG003|Overall Study|Non-compliance|0|||
125184156|NCT01490086|450296463|FG004|Overall Study|Non-compliance|0|||
125184157|NCT01490086|450296459|FG000|Overall Study|Abnormal laboratory findings|1|||
125184158|NCT01490086|450296460|FG001|Overall Study|Abnormal laboratory findings|0|||
125184159|NCT01490086|450296461|FG002|Overall Study|Abnormal laboratory findings|0|||
125184160|NCT01490086|450296462|FG003|Overall Study|Abnormal laboratory findings|0|||
125184161|NCT01490086|450296463|FG004|Overall Study|Abnormal laboratory findings|0|||
125184162|NCT01490086|450296459|FG000|Overall Study|Lost to Follow-up|0|||
125184163|NCT01490086|450296460|FG001|Overall Study|Lost to Follow-up|0|||
125184164|NCT01490086|450296461|FG002|Overall Study|Lost to Follow-up|0|||
125184165|NCT01490086|450296462|FG003|Overall Study|Lost to Follow-up|0|||
125184166|NCT01490086|450296463|FG004|Overall Study|Lost to Follow-up|1|||
125184167|NCT01490086|450296459|FG000|Overall Study|Physician Decision|3|||
125184168|NCT01490086|450296460|FG001|Overall Study|Physician Decision|4|||
125184169|NCT01490086|450296461|FG002|Overall Study|Physician Decision|2|||
125184170|NCT01490086|450296462|FG003|Overall Study|Physician Decision|3|||
125184171|NCT01490086|450296463|FG004|Overall Study|Physician Decision|1|||
125184172|NCT01490086|450296459|FG000|Overall Study|Adverse Event|0|||
125184173|NCT01490086|450296460|FG001|Overall Study|Adverse Event|0|||
125184174|NCT01490086|450296461|FG002|Overall Study|Adverse Event|1|||
125184175|NCT01490086|450296462|FG003|Overall Study|Adverse Event|2|||
125184176|NCT01490086|450296463|FG004|Overall Study|Adverse Event|0|||
125184177|NCT01490086|450296459|FG000|Overall Study|Lack of Efficacy|0|||
125184178|NCT01490086|450296460|FG001|Overall Study|Lack of Efficacy|3|||
125184179|NCT01490086|450296461|FG002|Overall Study|Lack of Efficacy|1|||
125184180|NCT01490086|450296462|FG003|Overall Study|Lack of Efficacy|0|||
125184181|NCT01490086|450296463|FG004|Overall Study|Lack of Efficacy|8|||
125184182|NCT01490086|450296459|FG000|Overall Study|Worsening of symptoms|0|||
125184183|NCT01490086|450296460|FG001|Overall Study|Worsening of symptoms|1|||
125184184|NCT01490086|450296461|FG002|Overall Study|Worsening of symptoms|0|||
125184185|NCT01490086|450296462|FG003|Overall Study|Worsening of symptoms|1|||
125184186|NCT01490086|450296463|FG004|Overall Study|Worsening of symptoms|0|||
125184187|NCT01490086|450296459|FG000|Overall Study|Subject uncontrollable and abusive|0|||
125184188|NCT01490086|450296460|FG001|Overall Study|Subject uncontrollable and abusive|1|||
125184189|NCT01490086|450296461|FG002|Overall Study|Subject uncontrollable and abusive|0|||
125184190|NCT01490086|450296462|FG003|Overall Study|Subject uncontrollable and abusive|0|||
125184191|NCT01490086|450296463|FG004|Overall Study|Subject uncontrollable and abusive|0|||
125184192|NCT01490086|450296459|FG000|Overall Study|Subject left hospital|0|||
125184193|NCT01490086|450296460|FG001|Overall Study|Subject left hospital|1|||
125184194|NCT01490086|450296461|FG002|Overall Study|Subject left hospital|0|||
125184195|NCT01490086|450296462|FG003|Overall Study|Subject left hospital|1|||
125184196|NCT01490086|450296463|FG004|Overall Study|Subject left hospital|0|||
125184197|NCT06025721|450296464|FG000|Overall Study|Physician Decision|1|||
125184198|NCT06025721|450296464|FG000|Overall Study|Protocol Violation|1|||
125184199|NCT06025721|450296464|FG000|Overall Study|Incarceration|1|||
125184200|NCT01127256|450296465|FG000|Overall Study|Adverse Event|13|||
125184201|NCT01127256|450296466|FG001|Overall Study|Adverse Event|13|||
125184202|NCT01127256|450296465|FG000|Overall Study|Lack of Efficacy|4|||
125184203|NCT01127256|450296466|FG001|Overall Study|Lack of Efficacy|0|||
125184204|NCT01127256|450296465|FG000|Overall Study|Lost to Follow-up|16|||
125184205|NCT01127256|450296466|FG001|Overall Study|Lost to Follow-up|17|||
125184206|NCT01127256|450296465|FG000|Overall Study|Withdrawal by Subject|5|||
125184207|NCT01127256|450296466|FG001|Overall Study|Withdrawal by Subject|9|||
125184208|NCT01127256|450296465|FG000|Overall Study|Protocol Violation|1|||
125184209|NCT01127256|450296466|FG001|Overall Study|Protocol Violation|0|||
125184210|NCT02068508|450296468|FG000|Overall Study|Case report forms uncollected|27|||
125184211|NCT02068508|450296468|FG000|Overall Study|Patient did not visit the study site|1|||
125184212|NCT02068508|450296468|FG000|Overall Study|Protocol Violation|4|||
125184213|NCT04429503|450296473|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
125184214|NCT04429503|450296474|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
125184215|NCT04429503|450296475|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
125184216|NCT04429503|450296476|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
125184217|NCT04429503|450296477|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
125184218|NCT04429503|450296478|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
125184219|NCT04429503|450296473|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
125184220|NCT04429503|450296474|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
125184221|NCT04429503|450296475|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
125184222|NCT04429503|450296476|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
125184223|NCT04429503|450296477|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
125184224|NCT04429503|450296478|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
125184225|NCT04429503|450296473|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
125184226|NCT04429503|450296474|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
125184227|NCT04429503|450296475|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
125184228|NCT04429503|450296476|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
125184229|NCT04429503|450296477|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
125184230|NCT04429503|450296478|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
125184231|NCT04429503|450296473|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
125184232|NCT04429503|450296474|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
125184233|NCT04429503|450296475|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
125184234|NCT04429503|450296476|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
125184235|NCT04429503|450296477|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
125184236|NCT04429503|450296478|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
125184237|NCT04429503|450296473|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
125184238|NCT04429503|450296474|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
125184239|NCT04429503|450296475|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
125184240|NCT04429503|450296476|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
125237635|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
125184241|NCT04429503|450296477|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
125237636|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
125237637|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
125184242|NCT04429503|450296478|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
125184243|NCT04429503|450296473|FG000|Main Study (Up to Wk 96)|Death|9|||
125184244|NCT04429503|450296474|FG001|Main Study (Up to Wk 96)|Death|18|||
125184245|NCT04429503|450296475|FG002|Main Study (Up to Wk 96)|Death|5|||
125184246|NCT04429503|450296476|FG003|Main Study (Up to Wk 96)|Death|0|||
125184247|NCT04429503|450296477|FG004|Main Study (Up to Wk 96)|Death|0|||
125184248|NCT04429503|450296478|FG005|Main Study (Up to Wk 96)|Death|0|||
125184249|NCT04429503|450296473|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
125184250|NCT04429503|450296474|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
125184251|NCT04429503|450296475|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
125184252|NCT04429503|450296476|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
125184253|NCT04429503|450296477|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
125184254|NCT04429503|450296478|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
125184255|NCT04429503|450296473|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
125184256|NCT04429503|450296474|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
125184257|NCT04429503|450296475|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
125184258|NCT04429503|450296476|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
125184259|NCT04429503|450296477|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
125184260|NCT04429503|450296478|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
125184261|NCT04429503|450296473|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
125184262|NCT04429503|450296474|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
125184263|NCT04429503|450296475|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
125184264|NCT04429503|450296476|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
125184265|NCT04429503|450296477|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
125184266|NCT04429503|450296478|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
125184267|NCT04429503|450296473|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
125184268|NCT04429503|450296474|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
125184269|NCT04429503|450296475|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
125184270|NCT04429503|450296476|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
125184271|NCT04429503|450296477|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
125184272|NCT04429503|450296478|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
125184273|NCT04429503|450296473|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
125184274|NCT04429503|450296474|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
125184275|NCT04429503|450296475|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
125184276|NCT04429503|450296476|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
125184277|NCT04429503|450296477|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
125184278|NCT04429503|450296478|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
125184279|NCT04429503|450296473|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
125184280|NCT04429503|450296474|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
125184281|NCT04429503|450296475|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
125184282|NCT04429503|450296476|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
125184283|NCT04429503|450296477|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
125184284|NCT04429503|450296478|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
125184285|NCT05516108|450296479|FG000|Overall Study|Time Commitment|3|||
125184286|NCT05516108|450296480|FG001|Overall Study|Time Commitment|1|||
125184287|NCT05516108|450296479|FG000|Overall Study|Reason Unknown|2|||
125184288|NCT05516108|450296480|FG001|Overall Study|Reason Unknown|4|||
125184289|NCT00709995|450296481|FG000|Overall Study|Adverse Event|4|||
125184290|NCT00709995|450296482|FG001|Overall Study|Adverse Event|2|||
125184291|NCT00709995|450296481|FG000|Overall Study|Withdrawal by Subject|1|||
125184292|NCT00709995|450296482|FG001|Overall Study|Withdrawal by Subject|3|||
125184293|NCT04341363|450296483|FG000|Overall Study|Adverse Event|1|||
125184294|NCT04341363|450296483|FG000|Overall Study|Withdrawal by Subject|1|||
125184295|NCT00063934|450296484|FG000|Overall Study|Ineligible|1|||
125184296|NCT00840749|450296488|FG000|Overall Study|Death|1|||
125184297|NCT00840749|450296489|FG001|Overall Study|Death|2|||
125184298|NCT00840749|450296488|FG000|Overall Study|not treated on study arm|11|||
125184299|NCT00840749|450296489|FG001|Overall Study|not treated on study arm|11|||
125184300|NCT00840749|450296488|FG000|Overall Study|study closed|19|||
125184301|NCT00840749|450296489|FG001|Overall Study|study closed|14|||
125184302|NCT02550561|450296490|FG000|Overall Study|Lost to Follow-up|5|||
125184303|NCT02550561|450296490|FG000|Overall Study|Withdrawal by Subject|1|||
125184304|NCT00395629|450296491|FG000|Core Study|Adverse Event|0|||
125184305|NCT00395629|450296492|FG001|Core Study|Adverse Event|3|||
125184306|NCT00395629|450296493|FG002|Core Study|Adverse Event|4|||
125184307|NCT00395629|450296491|FG000|Core Study|Abnormal laboratory value(s)|0|||
125184308|NCT00395629|450296492|FG001|Core Study|Abnormal laboratory value(s)|0|||
125184309|NCT00395629|450296493|FG002|Core Study|Abnormal laboratory value(s)|1|||
125184310|NCT00395629|450296491|FG000|Core Study|Protocol Violation|1|||
125184311|NCT00395629|450296492|FG001|Core Study|Protocol Violation|0|||
125184312|NCT00395629|450296493|FG002|Core Study|Protocol Violation|0|||
125184313|NCT00395629|450296491|FG000|Core Study|Withdrawal by Subject|0|||
125184314|NCT00395629|450296492|FG001|Core Study|Withdrawal by Subject|1|||
125184315|NCT00395629|450296493|FG002|Core Study|Withdrawal by Subject|1|||
125184316|NCT00395629|450296491|FG000|Core Study|Lost to Follow-up|0|||
125184317|NCT00395629|450296492|FG001|Core Study|Lost to Follow-up|0|||
125184318|NCT00395629|450296493|FG002|Core Study|Lost to Follow-up|1|||
125184319|NCT00395629|450296491|FG000|Extension Study|Adverse Event|0|||
125184320|NCT00395629|450296492|FG001|Extension Study|Adverse Event|0|||
125184321|NCT00395629|450296493|FG002|Extension Study|Adverse Event|2|||
125184322|NCT00395629|450296491|FG000|Extension Study|Administrative problems|0|||
125184323|NCT00395629|450296492|FG001|Extension Study|Administrative problems|0|||
125184324|NCT00395629|450296493|FG002|Extension Study|Administrative problems|1|||
125184325|NCT03534687|450296494|FG000|Overall Study|Lost to Follow-up|7|||
125184326|NCT03534687|450296495|FG001|Overall Study|Lost to Follow-up|2|||
125184327|NCT01051960|450296496|FG000|Overall Study|Adverse Event|1|||
125184328|NCT02394600|450296497|FG000|Overall Study|Adverse Event|3|||
125184329|NCT02394600|450296498|FG001|Overall Study|Adverse Event|0|||
125184330|NCT02394600|450296497|FG000|Overall Study|Lost to Follow-up|0|||
125184331|NCT02394600|450296498|FG001|Overall Study|Lost to Follow-up|1|||
125184332|NCT02394600|450296497|FG000|Overall Study|Withdrawal by Subject|0|||
125184333|NCT02394600|450296498|FG001|Overall Study|Withdrawal by Subject|1|||
125184334|NCT02394600|450296497|FG000|Overall Study|Protocol Violation|1|||
125184335|NCT02394600|450296498|FG001|Overall Study|Protocol Violation|0|||
125184336|NCT01686373|450296499|FG000|Overall Study|Lost to Follow-up|3|||
125184337|NCT01686373|450296500|FG001|Overall Study|Lost to Follow-up|0|||
125184338|NCT01686373|450296499|FG000|Overall Study|Withdrawal by Subject|0|||
125184339|NCT01686373|450296500|FG001|Overall Study|Withdrawal by Subject|1|||
125184340|NCT01686373|450296499|FG000|Overall Study|Adverse Event|0|||
125184341|NCT01686373|450296500|FG001|Overall Study|Adverse Event|1|||
125184342|NCT01960413|450296511|FG000|Overall Study|Withdrawal by Subject|1|||
125184343|NCT01960413|450296512|FG001|Overall Study|Withdrawal by Subject|1|||
125184344|NCT01960413|450296511|FG000|Overall Study|Physician Decision|1|||
125184345|NCT01960413|450296512|FG001|Overall Study|Physician Decision|0|||
125184346|NCT01960413|450296511|FG000|Overall Study|Lost to Follow-up|2|||
125184347|NCT01960413|450296512|FG001|Overall Study|Lost to Follow-up|0|||
125184348|NCT00791778|450296516|FG000|Double-blind Treatment|Adverse Event|49|||
125184349|NCT00791778|450296517|FG001|Double-blind Treatment|Adverse Event|9|||
125184350|NCT00791778|450296516|FG000|Double-blind Treatment|Physician Decision|6|||
125184351|NCT00791778|450296517|FG001|Double-blind Treatment|Physician Decision|26|||
125184352|NCT00791778|450296516|FG000|Double-blind Treatment|Protocol Violation|0|||
125184353|NCT00791778|450296517|FG001|Double-blind Treatment|Protocol Violation|4|||
125184354|NCT00791778|450296516|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
125184355|NCT00791778|450296517|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
125184356|NCT00791778|450296516|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
125184357|NCT00791778|450296517|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
125184358|NCT00791778|450296516|FG000|Follow-up|Withdrawal by Subject|3|||
125184359|NCT00791778|450296517|FG001|Follow-up|Withdrawal by Subject|0|||
125184360|NCT00791778|450296516|FG000|Follow-up|Lost to Follow-up|2|||
125184361|NCT00791778|450296517|FG001|Follow-up|Lost to Follow-up|1|||
125184362|NCT01082328|450296518|FG000|Overall Study|Adverse Event|1|||
125184363|NCT02285361|450296519|FG000|Overall Study|Protocol Violation|43|||
125184364|NCT02285361|450296519|FG000|Overall Study|Lost to Follow-up|5|||
125184365|NCT02285361|450296519|FG000|Overall Study|Not taken GIOTRIF|2|||
125184366|NCT02285361|450296519|FG000|Overall Study|Consented prior to the contract date|1|||
125392439|NCT00680901|451070687|FG001|Overall Study|Subject decided to withdraw from the study|15|||
125392440|NCT00680901|451070686|FG000|Overall Study|Sponsor decision|1|||
125392441|NCT00680901|451070687|FG001|Overall Study|Sponsor decision|0|||
125392442|NCT00680901|451070686|FG000|Overall Study|Physician Decision|0|||
125184367|NCT02059135|450296520|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
125184368|NCT02059135|450296521|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
125392443|NCT00680901|451070687|FG001|Overall Study|Physician Decision|2|||
125392444|NCT00680901|451070686|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
125184369|NCT02059135|450296520|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
125184370|NCT02059135|450296521|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
125184371|NCT02059135|450296520|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
125184372|NCT02059135|450296521|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
125184373|NCT02059135|450296520|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
125184374|NCT02059135|450296521|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
125184375|NCT02059135|450296520|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
125184376|NCT02059135|450296521|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
125184377|NCT02059135|450296520|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
125392445|NCT00680901|451070687|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
125184378|NCT02059135|450296521|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
125184379|NCT02059135|450296520|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
125184380|NCT02059135|450296521|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
125184381|NCT02059135|450296520|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
125184382|NCT02059135|450296521|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
125184383|NCT03335475|450296523|FG000|Overall Study|Did not wear accelerometer|4|||
125184384|NCT03335475|450296524|FG001|Overall Study|Did not wear accelerometer|0|||
125184385|NCT03335475|450296523|FG000|Overall Study|Withdrawal by Subject|0|||
125184386|NCT03335475|450296524|FG001|Overall Study|Withdrawal by Subject|1|||
125184387|NCT02755103|450296525|FG000|Overall Study|Lost to Follow-up|17|||
125184388|NCT02755103|450296526|FG001|Overall Study|Lost to Follow-up|15|||
125184389|NCT02755103|450296525|FG000|Overall Study|Death|0|||
125184390|NCT02755103|450296526|FG001|Overall Study|Death|1|||
125184391|NCT02755103|450296525|FG000|Overall Study|Physician Decision|0|||
125184392|NCT02755103|450296526|FG001|Overall Study|Physician Decision|1|||
125184393|NCT02755103|450296525|FG000|Overall Study|Pregnancy|0|||
125184394|NCT02755103|450296526|FG001|Overall Study|Pregnancy|1|||
125184395|NCT02755103|450296525|FG000|Overall Study|Withdrawal by Subject|3|||
125184396|NCT02755103|450296526|FG001|Overall Study|Withdrawal by Subject|0|||
125184397|NCT00658723|450296529|FG000|Overall Study|Lost to Follow-up|0|||
125184398|NCT00658723|450296530|FG001|Overall Study|Lost to Follow-up|2|||
125184399|NCT00658723|450296531|FG002|Overall Study|Lost to Follow-up|2|||
125184400|NCT00658723|450296529|FG000|Overall Study|Death|2|||
125184401|NCT00658723|450296530|FG001|Overall Study|Death|1|||
125184402|NCT00658723|450296531|FG002|Overall Study|Death|4|||
125184403|NCT00658723|450296529|FG000|Overall Study|Scheduling Issue|1|||
125184404|NCT00658723|450296530|FG001|Overall Study|Scheduling Issue|1|||
125184405|NCT00658723|450296531|FG002|Overall Study|Scheduling Issue|0|||
125184406|NCT00658723|450296529|FG000|Overall Study|Withdrawal by Subject|1|||
125184407|NCT00658723|450296530|FG001|Overall Study|Withdrawal by Subject|0|||
125184408|NCT00658723|450296531|FG002|Overall Study|Withdrawal by Subject|1|||
125184409|NCT02411656|450296532|FG000|Overall Study|Adverse Event|4|||
125184410|NCT02411656|450296532|FG000|Overall Study|Clinical Progression|33|||
125184411|NCT06481709|450296533|FG000|Overall Study|Withdrawal by Subject|0|||
125184412|NCT06481709|450296534|FG001|Overall Study|Withdrawal by Subject|0|||
125184413|NCT06481709|450296535|FG002|Overall Study|Withdrawal by Subject|2|||
125184414|NCT06481709|450296536|FG003|Overall Study|Withdrawal by Subject|0|||
125184415|NCT05366010|450296539|FG000|Overall Study|Withdrawal by Subject|1|||
125184416|NCT05366010|450296539|FG000|Overall Study|Protocol Violation|1|||
125184417|NCT05366010|450296539|FG000|Overall Study|Lost to Follow-up|2|||
125184418|NCT05366010|450296539|FG000|Overall Study|Screen Failure|2|||
125184419|NCT02224157|450296540|FG000|Overall Study|Severe non-compliance to protocol|2|||
125184420|NCT02224157|450296541|FG001|Overall Study|Severe non-compliance to protocol|2|||
125184421|NCT02224157|450296540|FG000|Overall Study|Other|13|||
125184422|NCT02224157|450296541|FG001|Overall Study|Other|10|||
125184423|NCT02224157|450296540|FG000|Overall Study|Subject decision|58|||
125184424|NCT02224157|450296541|FG001|Overall Study|Subject decision|50|||
125184425|NCT02224157|450296540|FG000|Overall Study|Prematurely closed site|4|||
125184426|NCT02224157|450296541|FG001|Overall Study|Prematurely closed site|2|||
125184427|NCT02224157|450296540|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
125184428|NCT02224157|450296541|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
125184429|NCT02224157|450296540|FG000|Overall Study|Lost to Follow-up|27|||
125184430|NCT02224157|450296541|FG001|Overall Study|Lost to Follow-up|35|||
125184431|NCT02224157|450296540|FG000|Overall Study|Death|1|||
125184432|NCT02224157|450296541|FG001|Overall Study|Death|1|||
125184433|NCT02224157|450296540|FG000|Overall Study|Adverse Event|1|||
125184434|NCT02224157|450296541|FG001|Overall Study|Adverse Event|3|||
125184435|NCT05906628|450296544|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
125184436|NCT05906628|450296545|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
125184437|NCT05906628|450296544|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
125184438|NCT05906628|450296545|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
125184439|NCT05906628|450296544|FG000|16-Week DBVC Period|Protocol Violation|4|||
125184440|NCT05906628|450296545|FG001|16-Week DBVC Period|Protocol Violation|2|||
125184441|NCT05906628|450296544|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
125184442|NCT05906628|450296545|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
125184443|NCT05906628|450296544|FG000|16-Week OLE Period|Death|1|||
125184444|NCT05906628|450296545|FG001|16-Week OLE Period|Death|0|||
125184445|NCT05906628|450296544|FG000|16-Week OLE Period|Lost to Follow-up|1|||
125184446|NCT05906628|450296545|FG001|16-Week OLE Period|Lost to Follow-up|1|||
125184447|NCT05906628|450296544|FG000|16-Week OLE Period|Protocol Violation|0|||
125184448|NCT05906628|450296545|FG001|16-Week OLE Period|Protocol Violation|1|||
125184449|NCT05906628|450296544|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
125184450|NCT05906628|450296545|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
125184451|NCT04578535|450296546|FG000|Overall Study|Lost to Follow-up|1|||
125184452|NCT04578535|450296547|FG001|Overall Study|Lost to Follow-up|0|||
125184453|NCT04578535|450296548|FG002|Overall Study|Lost to Follow-up|0|||
125184454|NCT04578535|450296549|FG003|Overall Study|Lost to Follow-up|1|||
125184455|NCT04578535|450296550|FG004|Overall Study|Lost to Follow-up|0|||
125184456|NCT04578535|450296551|FG005|Overall Study|Lost to Follow-up|2|||
125184457|NCT04578535|450296546|FG000|Overall Study|Pregnancy|1|||
125184458|NCT04578535|450296547|FG001|Overall Study|Pregnancy|0|||
125184459|NCT04578535|450296548|FG002|Overall Study|Pregnancy|0|||
125184460|NCT04578535|450296549|FG003|Overall Study|Pregnancy|0|||
125184461|NCT04578535|450296550|FG004|Overall Study|Pregnancy|0|||
125184462|NCT04578535|450296551|FG005|Overall Study|Pregnancy|0|||
125184463|NCT04578535|450296546|FG000|Overall Study|Withdrawal by Subject|0|||
125184464|NCT04578535|450296547|FG001|Overall Study|Withdrawal by Subject|0|||
125184465|NCT04578535|450296548|FG002|Overall Study|Withdrawal by Subject|0|||
125184466|NCT04578535|450296549|FG003|Overall Study|Withdrawal by Subject|1|||
125184467|NCT04578535|450296550|FG004|Overall Study|Withdrawal by Subject|1|||
125184468|NCT04578535|450296551|FG005|Overall Study|Withdrawal by Subject|5|||
125184469|NCT04578535|450296546|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
125184470|NCT04578535|450296547|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
125184471|NCT04578535|450296548|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
125184472|NCT04578535|450296549|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
125184473|NCT04578535|450296550|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
125184474|NCT04578535|450296551|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
125184475|NCT05317312|450296552|FG000|Overall Study|Withdrawal by Subject|0|||
125184476|NCT05317312|450296553|FG001|Overall Study|Withdrawal by Subject|1|||
125184477|NCT05317312|450296554|FG002|Overall Study|Withdrawal by Subject|0|||
125184478|NCT05317312|450296555|FG003|Overall Study|Withdrawal by Subject|0|||
125184479|NCT05317312|450296552|FG000|Overall Study|Lost to Follow-up|0|||
125184480|NCT05317312|450296553|FG001|Overall Study|Lost to Follow-up|0|||
125184481|NCT05317312|450296554|FG002|Overall Study|Lost to Follow-up|0|||
125184482|NCT05317312|450296555|FG003|Overall Study|Lost to Follow-up|1|||
125184483|NCT05317312|450296552|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
125184484|NCT05317312|450296553|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
125184485|NCT05317312|450296554|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
125184486|NCT05317312|450296555|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
125184487|NCT01060072|450296556|FG000|Overall Study|Adverse Event|1|||
125184488|NCT01060072|450296557|FG001|Overall Study|Adverse Event|1|||
125184489|NCT01060072|450296556|FG000|Overall Study|Physician Decision|0|||
125184490|NCT01060072|450296557|FG001|Overall Study|Physician Decision|2|||
125184491|NCT01060072|450296556|FG000|Overall Study|Protocol Violation|0|||
125184492|NCT01060072|450296557|FG001|Overall Study|Protocol Violation|1|||
125184493|NCT01060072|450296556|FG000|Overall Study|Acute cholecystitis|1|||
125184494|NCT01060072|450296557|FG001|Overall Study|Acute cholecystitis|0|||
125184495|NCT01060072|450296556|FG000|Overall Study|Excluded Medications|0|||
125184496|NCT01060072|450296557|FG001|Overall Study|Excluded Medications|1|||
125184497|NCT00837148|450296558|FG000|Overall Study|Adverse Event|1|||
125184498|NCT00837148|450296558|FG000|Overall Study|Death|1|||
125184499|NCT00380874|450296559|FG000|Overall Study|Adverse Event|7|||
125184500|NCT00380874|450296560|FG001|Overall Study|Adverse Event|7|||
125184501|NCT00380874|450296559|FG000|Overall Study|Death|1|||
125184502|NCT00380874|450296560|FG001|Overall Study|Death|0|||
125184503|NCT00380874|450296559|FG000|Overall Study|Withdrawal by Subject|2|||
125184504|NCT00380874|450296560|FG001|Overall Study|Withdrawal by Subject|1|||
125184505|NCT00380874|450296559|FG000|Overall Study|Not related to study drug|3|||
125184506|NCT00380874|450296560|FG001|Overall Study|Not related to study drug|2|||
125184507|NCT03839628|450296561|FG000|Overall Study|Withdrawal by Subject|1|||
125184508|NCT01707290|450296562|FG000|Overall Study|Adverse event (AE)|1|||
125184509|NCT01707290|450296563|FG001|Overall Study|Adverse event (AE)|0|||
125184510|NCT01707290|450296562|FG000|Overall Study|Physician Decision|1|||
125184511|NCT01707290|450296563|FG001|Overall Study|Physician Decision|0|||
125184512|NCT01707290|450296562|FG000|Overall Study|Lost to Follow-up|3|||
125184513|NCT01707290|450296563|FG001|Overall Study|Lost to Follow-up|0|||
125184514|NCT01707290|450296562|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
125184515|NCT01707290|450296563|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
125184516|NCT01707290|450296562|FG000|Overall Study|Commercial drug available|60|||
125184517|NCT01707290|450296563|FG001|Overall Study|Commercial drug available|1|||
125184518|NCT01707290|450296562|FG000|Overall Study|Other unspecified|17|||
125184519|NCT01707290|450296563|FG001|Overall Study|Other unspecified|0|||
125184520|NCT01964976|450296564|FG000|Overall Study|Protocol Violation|31|||
125184521|NCT01565889|450296568|FG000|Part A|Withdrawal by Subject|1|||
125184522|NCT01565889|450296569|FG001|Part A|Withdrawal by Subject|0|||
125184523|NCT01565889|450296570|FG002|Part A|Withdrawal by Subject|0|||
125184524|NCT01565889|450296571|FG003|Part A|Withdrawal by Subject|0|||
125184525|NCT01565889|450296572|FG004|Part A|Withdrawal by Subject|0|||
125184526|NCT01565889|450296573|FG005|Part A|Withdrawal by Subject|0|||
125184527|NCT01565889|450296568|FG000|Part B|Withdrawal by Subject|0|||
125184528|NCT01565889|450296569|FG001|Part B|Withdrawal by Subject|0|||
125184529|NCT01565889|450296570|FG002|Part B|Withdrawal by Subject|0|||
125184530|NCT01565889|450296571|FG003|Part B|Withdrawal by Subject|0|||
125184531|NCT01565889|450296572|FG004|Part B|Withdrawal by Subject|0|||
125184532|NCT01565889|450296573|FG005|Part B|Withdrawal by Subject|1|||
125237638|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
125184533|NCT01565889|450296568|FG000|Part B|Lack of Efficacy|0|||
125184534|NCT01565889|450296569|FG001|Part B|Lack of Efficacy|0|||
125184535|NCT01565889|450296570|FG002|Part B|Lack of Efficacy|0|||
125184536|NCT01565889|450296571|FG003|Part B|Lack of Efficacy|0|||
125184537|NCT01565889|450296572|FG004|Part B|Lack of Efficacy|0|||
125184538|NCT01565889|450296573|FG005|Part B|Lack of Efficacy|2|||
125184539|NCT01565889|450296568|FG000|Part B|Lost to Follow-up|0|||
125184540|NCT01565889|450296569|FG001|Part B|Lost to Follow-up|0|||
125184541|NCT01565889|450296570|FG002|Part B|Lost to Follow-up|0|||
125184542|NCT01565889|450296571|FG003|Part B|Lost to Follow-up|0|||
125184543|NCT01565889|450296572|FG004|Part B|Lost to Follow-up|0|||
125184544|NCT01565889|450296573|FG005|Part B|Lost to Follow-up|1|||
125184545|NCT01326845|450296576|FG000|Overall Study|Administrative Problems|5|||
125184546|NCT01326845|450296577|FG001|Overall Study|Administrative Problems|2|||
125184547|NCT01326845|450296576|FG000|Overall Study|Adverse Event|1|||
125184548|NCT01326845|450296577|FG001|Overall Study|Adverse Event|0|||
125184549|NCT01326845|450296576|FG000|Overall Study|Misisng|1|||
125184550|NCT01326845|450296577|FG001|Overall Study|Misisng|3|||
125184551|NCT00982657|450296578|FG000|Overall Study|Death|1|||
125184552|NCT00982657|450296579|FG001|Overall Study|Death|0|||
125184553|NCT00982657|450296580|FG002|Overall Study|Death|1|||
125184554|NCT00982657|450296581|FG003|Overall Study|Death|1|||
125184555|NCT00982657|450296578|FG000|Overall Study|Withdrawal by Subject|0|||
125184556|NCT00982657|450296579|FG001|Overall Study|Withdrawal by Subject|0|||
125184557|NCT00982657|450296580|FG002|Overall Study|Withdrawal by Subject|1|||
125184558|NCT00982657|450296581|FG003|Overall Study|Withdrawal by Subject|3|||
125184559|NCT00982657|450296578|FG000|Overall Study|Other|0|||
125184560|NCT00982657|450296579|FG001|Overall Study|Other|0|||
125184561|NCT00982657|450296580|FG002|Overall Study|Other|0|||
125184562|NCT00982657|450296581|FG003|Overall Study|Other|4|||
125184563|NCT00982657|450296578|FG000|Overall Study|On going at date of cut-off|0|||
125184564|NCT00982657|450296579|FG001|Overall Study|On going at date of cut-off|0|||
125184565|NCT00982657|450296580|FG002|Overall Study|On going at date of cut-off|0|||
125184566|NCT00982657|450296581|FG003|Overall Study|On going at date of cut-off|1|||
125184567|NCT00752128|450296584|FG000|Overall Study|Withdrawal by Subject|4|||
125184568|NCT02286713|450296585|FG000|One Week Follow-Up|Death|1|||
125184569|NCT02286713|450296586|FG001|One Week Follow-Up|Death|0|||
125184570|NCT02286713|450296585|FG000|One Week Follow-Up|Lost to Follow-up|17|||
125184571|NCT02286713|450296586|FG001|One Week Follow-Up|Lost to Follow-up|21|||
125184572|NCT02286713|450296585|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
125184573|NCT02286713|450296586|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
125184574|NCT02286713|450296585|FG000|Three Month Follow-Up|Death|1|||
125184575|NCT02286713|450296586|FG001|Three Month Follow-Up|Death|1|||
125184576|NCT02286713|450296585|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
125184577|NCT02286713|450296586|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
125184578|NCT02286713|450296585|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
125184579|NCT02286713|450296586|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
125184580|NCT02286713|450296585|FG000|Six Month Follow-Up|Death|2|||
125184581|NCT02286713|450296586|FG001|Six Month Follow-Up|Death|0|||
125184582|NCT02286713|450296585|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
125184583|NCT02286713|450296586|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
125184584|NCT03323398|450296587|FG000|Overall Study|Other than Specified|0|||
125184585|NCT03323398|450296588|FG001|Overall Study|Other than Specified|1|||
125184586|NCT03323398|450296589|FG002|Overall Study|Other than Specified|2|||
125184587|NCT03323398|450296590|FG003|Overall Study|Other than Specified|0|||
125392446|NCT00680901|451070686|FG000|Overall Study|Other protocol defined stopping criteria|17|||
125392447|NCT00680901|451070687|FG001|Overall Study|Other protocol defined stopping criteria|17|||
125392448|NCT04544293|451070688|FG000|Double-blind|Adverse Event|2|||
125184588|NCT03323398|450296591|FG004|Overall Study|Other than Specified|0|||
125184589|NCT03323398|450296592|FG005|Overall Study|Other than Specified|0|||
125184590|NCT03323398|450296593|FG006|Overall Study|Other than Specified|1|||
125184591|NCT03323398|450296594|FG007|Overall Study|Other than Specified|0|||
125184592|NCT03323398|450296595|FG008|Overall Study|Other than Specified|2|||
125184593|NCT03323398|450296587|FG000|Overall Study|Lost to Follow-up|1|||
125184594|NCT03323398|450296588|FG001|Overall Study|Lost to Follow-up|2|||
125184595|NCT03323398|450296589|FG002|Overall Study|Lost to Follow-up|1|||
125184596|NCT03323398|450296590|FG003|Overall Study|Lost to Follow-up|0|||
125392449|NCT04544293|451070689|FG001|Double-blind|Adverse Event|1|||
125392450|NCT04544293|451070688|FG000|Double-blind|Pregnancy|0|||
125184597|NCT03323398|450296591|FG004|Overall Study|Lost to Follow-up|0|||
125184598|NCT03323398|450296592|FG005|Overall Study|Lost to Follow-up|0|||
125184599|NCT03323398|450296593|FG006|Overall Study|Lost to Follow-up|0|||
125184600|NCT03323398|450296594|FG007|Overall Study|Lost to Follow-up|0|||
125184601|NCT03323398|450296595|FG008|Overall Study|Lost to Follow-up|0|||
125184602|NCT03323398|450296587|FG000|Overall Study|Death|4|||
125184603|NCT03323398|450296588|FG001|Overall Study|Death|6|||
125184604|NCT03323398|450296589|FG002|Overall Study|Death|2|||
125184605|NCT03323398|450296590|FG003|Overall Study|Death|2|||
125184606|NCT03323398|450296591|FG004|Overall Study|Death|1|||
125392451|NCT04544293|451070689|FG001|Double-blind|Pregnancy|1|||
125237639|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
125184607|NCT03323398|450296592|FG005|Overall Study|Death|2|||
125184608|NCT03323398|450296593|FG006|Overall Study|Death|0|||
125184609|NCT03323398|450296594|FG007|Overall Study|Death|0|||
125184610|NCT03323398|450296595|FG008|Overall Study|Death|6|||
125184611|NCT03323398|450296587|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
125184612|NCT03323398|450296588|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
125184613|NCT03323398|450296589|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
125184614|NCT03323398|450296590|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
125184615|NCT03323398|450296591|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
125184616|NCT03323398|450296592|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
125184617|NCT03323398|450296593|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
125184618|NCT03323398|450296594|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
125184619|NCT03323398|450296595|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
125184620|NCT03323398|450296587|FG000|Overall Study|Withdrawal by Subject|2|||
125184621|NCT03323398|450296588|FG001|Overall Study|Withdrawal by Subject|1|||
125184622|NCT03323398|450296589|FG002|Overall Study|Withdrawal by Subject|3|||
125184623|NCT03323398|450296590|FG003|Overall Study|Withdrawal by Subject|0|||
125184624|NCT03323398|450296591|FG004|Overall Study|Withdrawal by Subject|0|||
125184625|NCT03323398|450296592|FG005|Overall Study|Withdrawal by Subject|1|||
125184626|NCT03323398|450296593|FG006|Overall Study|Withdrawal by Subject|0|||
125184627|NCT03323398|450296594|FG007|Overall Study|Withdrawal by Subject|0|||
125184628|NCT03323398|450296595|FG008|Overall Study|Withdrawal by Subject|0|||
125184629|NCT03323398|450296587|FG000|Overall Study|Participant was Put on Hospice|0|||
125184630|NCT03323398|450296588|FG001|Overall Study|Participant was Put on Hospice|0|||
125184631|NCT03323398|450296589|FG002|Overall Study|Participant was Put on Hospice|0|||
125184632|NCT03323398|450296590|FG003|Overall Study|Participant was Put on Hospice|0|||
125184633|NCT03323398|450296591|FG004|Overall Study|Participant was Put on Hospice|0|||
125184634|NCT03323398|450296592|FG005|Overall Study|Participant was Put on Hospice|0|||
125184635|NCT03323398|450296593|FG006|Overall Study|Participant was Put on Hospice|1|||
125184636|NCT03323398|450296594|FG007|Overall Study|Participant was Put on Hospice|0|||
125184637|NCT03323398|450296595|FG008|Overall Study|Participant was Put on Hospice|0|||
125184638|NCT03323398|450296587|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
125184639|NCT03323398|450296588|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
125184640|NCT03323398|450296589|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
125184641|NCT03323398|450296590|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
125184642|NCT03323398|450296591|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
125184643|NCT03323398|450296592|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
125184644|NCT03323398|450296593|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
125184645|NCT03323398|450296594|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
125184646|NCT03323398|450296595|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
125184647|NCT02235454|450296596|FG000|Overall Study|Withdrawal by Subject|2|||
125184648|NCT03641469|450296597|FG000|Overall Study|Ineligible|2|||
125184649|NCT03641469|450296597|FG000|Overall Study|Withdrawal by Subject|5|||
125184650|NCT03641469|450296597|FG000|Overall Study|Physician Decision|1|||
125184651|NCT03641469|450296597|FG000|Overall Study|Protocol Violation|1|||
125184652|NCT03641469|450296597|FG000|Overall Study|Lost to Follow-up|2|||
125184653|NCT05479435|450296598|FG000|Overall Study|Withdrawal by Subject|1|||
125184654|NCT05479435|450296599|FG001|Overall Study|Withdrawal by Subject|0|||
125184655|NCT05479435|450296600|FG002|Overall Study|Withdrawal by Subject|0|||
125184656|NCT05479435|450296598|FG000|Overall Study|Covid 19|0|||
125184657|NCT05479435|450296599|FG001|Overall Study|Covid 19|0|||
125184658|NCT05479435|450296600|FG002|Overall Study|Covid 19|2|||
125184659|NCT02562235|450298765|FG000|Overall Study|Adverse Event|3|||
125184660|NCT05016960|450298766|FG000|Overall Study|Withdrawal by Subject|1|||
125184661|NCT05016960|450298767|FG001|Overall Study|Withdrawal by Subject|9|||
125184662|NCT04796961|450298768|FG000|Overall Study|Lost to Follow-up|10|||
125184663|NCT04796961|450298768|FG000|Overall Study|Withdrawal by Subject|3|||
125184664|NCT04796961|450298768|FG000|Overall Study|Left Organization|10|||
125184665|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
125184666|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
125184667|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
125184668|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
125184669|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
125184670|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
125184671|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
125392452|NCT04544293|451070688|FG000|Double-blind|Lost to Follow-up|0|||
125392453|NCT04544293|451070689|FG001|Double-blind|Lost to Follow-up|1|||
125184672|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
125184673|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
125184674|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
125184675|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
125184676|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
125392454|NCT04544293|451070688|FG000|Open-Label Extension|Study ongoing|79|||
125392455|NCT04544293|451070689|FG001|Open-Label Extension|Study ongoing|81|||
125184677|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
125184678|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
125184679|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
125184680|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
125184681|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
125184682|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
125184683|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
125184684|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
125184685|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
125184686|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
125184687|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
125184688|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
125184689|NCT02513160|450298772|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
125184690|NCT02513160|450298773|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
125184691|NCT02513160|450298774|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
125184692|NCT02513160|450298775|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
125184693|NCT02513160|450298772|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
125184694|NCT02513160|450298773|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
125184695|NCT02513160|450298774|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
125184696|NCT02513160|450298775|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
125184697|NCT02513160|450298772|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
125184698|NCT02513160|450298773|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
125184699|NCT02513160|450298774|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
125184700|NCT02513160|450298775|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
125184701|NCT02513160|450298772|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
125184702|NCT02513160|450298773|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
125184703|NCT02513160|450298774|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
125184704|NCT02513160|450298775|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
125184705|NCT02513160|450298772|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
125184706|NCT02513160|450298773|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
125184707|NCT02513160|450298774|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
125184708|NCT02513160|450298775|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
125184709|NCT02513160|450298772|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
125184710|NCT02513160|450298773|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
125184711|NCT02513160|450298774|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
125184712|NCT02513160|450298775|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
125184713|NCT02844543|450298776|FG000|Overall Study|Withdrawal by Subject|4|||
125184714|NCT02844543|450298776|FG000|Overall Study|Did not meet eligibility criteria|1|||
125184715|NCT04710576|450298782|FG000|Overall Study|Participants still in the study|73|||
125184716|NCT04710576|450298783|FG001|Overall Study|Participants still in the study|70|||
125184717|NCT04710576|450298784|FG002|Overall Study|Participants still in the study|60|||
125184718|NCT04710576|450298782|FG000|Overall Study|Death|2|||
125184719|NCT04710576|450298783|FG001|Overall Study|Death|7|||
125184720|NCT04710576|450298784|FG002|Overall Study|Death|12|||
125184721|NCT04710576|450298782|FG000|Overall Study|Withdrawal by Subject|4|||
125184722|NCT04710576|450298783|FG001|Overall Study|Withdrawal by Subject|3|||
125184723|NCT04710576|450298784|FG002|Overall Study|Withdrawal by Subject|7|||
125184724|NCT04710576|450298782|FG000|Overall Study|Sponsor decision|1|||
125184725|NCT04710576|450298783|FG001|Overall Study|Sponsor decision|0|||
125184726|NCT04710576|450298784|FG002|Overall Study|Sponsor decision|0|||
125184727|NCT03428958|450298785|FG000|Overall Study|Adverse Event|0|||
125184728|NCT03428958|450298786|FG001|Overall Study|Adverse Event|0|||
125184729|NCT03428958|450298787|FG002|Overall Study|Adverse Event|0|||
125184730|NCT03428958|450298788|FG003|Overall Study|Adverse Event|1|||
125184731|NCT03428958|450298789|FG004|Overall Study|Adverse Event|0|||
125184732|NCT03428958|450298790|FG005|Overall Study|Adverse Event|2|||
125184733|NCT03428958|450298791|FG006|Overall Study|Adverse Event|1|||
125184734|NCT03428958|450298792|FG007|Overall Study|Adverse Event|0|||
125184735|NCT03428958|450298793|FG008|Overall Study|Adverse Event|0|||
125184736|NCT03428958|450298794|FG009|Overall Study|Adverse Event|0|||
125184737|NCT03428958|450298795|FG010|Overall Study|Adverse Event|0|||
125184738|NCT03428958|450298796|FG011|Overall Study|Adverse Event|0|||
125184739|NCT03428958|450298797|FG012|Overall Study|Adverse Event|0|||
125184740|NCT03428958|450298798|FG013|Overall Study|Adverse Event|0|||
125392456|NCT01951157|451070690|FG000|Overall Study|Progressive Disease|12|||
125184741|NCT03428958|450298799|FG014|Overall Study|Adverse Event|0|||
125184742|NCT03428958|450298800|FG015|Overall Study|Adverse Event|0|||
125184743|NCT03428958|450298801|FG016|Overall Study|Adverse Event|0|||
125392457|NCT01951157|451070691|FG001|Overall Study|Progressive Disease|13|||
125392458|NCT01951157|451070692|FG002|Overall Study|Progressive Disease|10|||
125392459|NCT01951157|451070690|FG000|Overall Study|Treatment-unrelated AE|1|||
125184744|NCT03428958|450298785|FG000|Overall Study|Clinical Progression|2|||
125184745|NCT03428958|450298786|FG001|Overall Study|Clinical Progression|3|||
125184746|NCT03428958|450298787|FG002|Overall Study|Clinical Progression|2|||
125184747|NCT03428958|450298788|FG003|Overall Study|Clinical Progression|1|||
125184748|NCT03428958|450298789|FG004|Overall Study|Clinical Progression|0|||
125184749|NCT03428958|450298790|FG005|Overall Study|Clinical Progression|2|||
125184750|NCT03428958|450298791|FG006|Overall Study|Clinical Progression|0|||
125184751|NCT03428958|450298792|FG007|Overall Study|Clinical Progression|0|||
125184752|NCT03428958|450298793|FG008|Overall Study|Clinical Progression|0|||
125184753|NCT03428958|450298794|FG009|Overall Study|Clinical Progression|0|||
125184754|NCT03428958|450298795|FG010|Overall Study|Clinical Progression|0|||
125184755|NCT03428958|450298796|FG011|Overall Study|Clinical Progression|0|||
125184756|NCT03428958|450298797|FG012|Overall Study|Clinical Progression|0|||
125184757|NCT03428958|450298798|FG013|Overall Study|Clinical Progression|0|||
125184758|NCT03428958|450298799|FG014|Overall Study|Clinical Progression|0|||
125184759|NCT03428958|450298800|FG015|Overall Study|Clinical Progression|0|||
125184760|NCT03428958|450298801|FG016|Overall Study|Clinical Progression|0|||
125184761|NCT03428958|450298785|FG000|Overall Study|Progression per RECIST|6|||
125184762|NCT03428958|450298786|FG001|Overall Study|Progression per RECIST|6|||
125184763|NCT03428958|450298787|FG002|Overall Study|Progression per RECIST|7|||
125184764|NCT03428958|450298788|FG003|Overall Study|Progression per RECIST|4|||
125184765|NCT03428958|450298789|FG004|Overall Study|Progression per RECIST|0|||
125184766|NCT03428958|450298790|FG005|Overall Study|Progression per RECIST|7|||
125184767|NCT03428958|450298791|FG006|Overall Study|Progression per RECIST|8|||
125184768|NCT03428958|450298792|FG007|Overall Study|Progression per RECIST|0|||
125184769|NCT03428958|450298793|FG008|Overall Study|Progression per RECIST|0|||
125184770|NCT03428958|450298794|FG009|Overall Study|Progression per RECIST|0|||
125184771|NCT03428958|450298795|FG010|Overall Study|Progression per RECIST|0|||
125184772|NCT03428958|450298796|FG011|Overall Study|Progression per RECIST|0|||
125184773|NCT03428958|450298797|FG012|Overall Study|Progression per RECIST|1|||
125184774|NCT03428958|450298798|FG013|Overall Study|Progression per RECIST|0|||
125184775|NCT03428958|450298799|FG014|Overall Study|Progression per RECIST|0|||
125184776|NCT03428958|450298800|FG015|Overall Study|Progression per RECIST|0|||
125184777|NCT03428958|450298801|FG016|Overall Study|Progression per RECIST|0|||
125184778|NCT03428958|450298785|FG000|Overall Study|Death|2|||
125184779|NCT03428958|450298786|FG001|Overall Study|Death|2|||
125184780|NCT03428958|450298787|FG002|Overall Study|Death|0|||
125184781|NCT03428958|450298788|FG003|Overall Study|Death|0|||
125184782|NCT03428958|450298789|FG004|Overall Study|Death|0|||
125184783|NCT03428958|450298790|FG005|Overall Study|Death|7|||
125184784|NCT03428958|450298791|FG006|Overall Study|Death|9|||
125184785|NCT03428958|450298792|FG007|Overall Study|Death|6|||
125184786|NCT03428958|450298793|FG008|Overall Study|Death|0|||
125184787|NCT03428958|450298794|FG009|Overall Study|Death|0|||
125184788|NCT03428958|450298795|FG010|Overall Study|Death|3|||
125184789|NCT03428958|450298796|FG011|Overall Study|Death|0|||
125184790|NCT03428958|450298797|FG012|Overall Study|Death|4|||
125184791|NCT03428958|450298798|FG013|Overall Study|Death|0|||
125184792|NCT03428958|450298799|FG014|Overall Study|Death|0|||
125184793|NCT03428958|450298800|FG015|Overall Study|Death|0|||
125184794|NCT03428958|450298801|FG016|Overall Study|Death|0|||
125184795|NCT03428958|450298785|FG000|Overall Study|Lost to Follow-up|0|||
125184796|NCT03428958|450298786|FG001|Overall Study|Lost to Follow-up|0|||
125184797|NCT03428958|450298787|FG002|Overall Study|Lost to Follow-up|0|||
125184798|NCT03428958|450298788|FG003|Overall Study|Lost to Follow-up|0|||
125184799|NCT03428958|450298789|FG004|Overall Study|Lost to Follow-up|0|||
125184800|NCT03428958|450298790|FG005|Overall Study|Lost to Follow-up|1|||
125184801|NCT03428958|450298791|FG006|Overall Study|Lost to Follow-up|1|||
125184802|NCT03428958|450298792|FG007|Overall Study|Lost to Follow-up|0|||
125184803|NCT03428958|450298793|FG008|Overall Study|Lost to Follow-up|0|||
125184804|NCT03428958|450298794|FG009|Overall Study|Lost to Follow-up|0|||
125184805|NCT03428958|450298795|FG010|Overall Study|Lost to Follow-up|0|||
125184806|NCT03428958|450298796|FG011|Overall Study|Lost to Follow-up|0|||
125184807|NCT03428958|450298797|FG012|Overall Study|Lost to Follow-up|0|||
125184808|NCT03428958|450298798|FG013|Overall Study|Lost to Follow-up|0|||
125184809|NCT03428958|450298799|FG014|Overall Study|Lost to Follow-up|0|||
125184810|NCT03428958|450298800|FG015|Overall Study|Lost to Follow-up|0|||
125184811|NCT03428958|450298801|FG016|Overall Study|Lost to Follow-up|0|||
125184812|NCT03428958|450298785|FG000|Overall Study|Physician/Sponsor Decision|1|||
125237640|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
125184813|NCT03428958|450298786|FG001|Overall Study|Physician/Sponsor Decision|0|||
125184814|NCT03428958|450298787|FG002|Overall Study|Physician/Sponsor Decision|1|||
125184815|NCT03428958|450298788|FG003|Overall Study|Physician/Sponsor Decision|0|||
125184816|NCT03428958|450298789|FG004|Overall Study|Physician/Sponsor Decision|0|||
125184817|NCT03428958|450298790|FG005|Overall Study|Physician/Sponsor Decision|2|||
125184818|NCT03428958|450298791|FG006|Overall Study|Physician/Sponsor Decision|2|||
125184819|NCT03428958|450298792|FG007|Overall Study|Physician/Sponsor Decision|2|||
125184820|NCT03428958|450298793|FG008|Overall Study|Physician/Sponsor Decision|0|||
125184821|NCT03428958|450298794|FG009|Overall Study|Physician/Sponsor Decision|0|||
125184822|NCT03428958|450298795|FG010|Overall Study|Physician/Sponsor Decision|2|||
125184823|NCT03428958|450298796|FG011|Overall Study|Physician/Sponsor Decision|0|||
125184824|NCT03428958|450298797|FG012|Overall Study|Physician/Sponsor Decision|4|||
125184825|NCT03428958|450298798|FG013|Overall Study|Physician/Sponsor Decision|0|||
125184826|NCT03428958|450298799|FG014|Overall Study|Physician/Sponsor Decision|0|||
125184827|NCT03428958|450298800|FG015|Overall Study|Physician/Sponsor Decision|0|||
125184828|NCT03428958|450298801|FG016|Overall Study|Physician/Sponsor Decision|0|||
125184829|NCT03428958|450298785|FG000|Overall Study|Withdrawal by Subject|0|||
125184830|NCT03428958|450298786|FG001|Overall Study|Withdrawal by Subject|0|||
125184831|NCT03428958|450298787|FG002|Overall Study|Withdrawal by Subject|2|||
125184832|NCT03428958|450298788|FG003|Overall Study|Withdrawal by Subject|0|||
125184833|NCT03428958|450298789|FG004|Overall Study|Withdrawal by Subject|0|||
125184834|NCT03428958|450298790|FG005|Overall Study|Withdrawal by Subject|2|||
125184835|NCT03428958|450298791|FG006|Overall Study|Withdrawal by Subject|4|||
125184836|NCT03428958|450298792|FG007|Overall Study|Withdrawal by Subject|1|||
125184837|NCT03428958|450298793|FG008|Overall Study|Withdrawal by Subject|0|||
125184838|NCT03428958|450298794|FG009|Overall Study|Withdrawal by Subject|0|||
125184839|NCT03428958|450298795|FG010|Overall Study|Withdrawal by Subject|0|||
125184840|NCT03428958|450298796|FG011|Overall Study|Withdrawal by Subject|0|||
125184841|NCT03428958|450298797|FG012|Overall Study|Withdrawal by Subject|0|||
125184842|NCT03428958|450298798|FG013|Overall Study|Withdrawal by Subject|0|||
125184843|NCT03428958|450298799|FG014|Overall Study|Withdrawal by Subject|0|||
125184844|NCT03428958|450298800|FG015|Overall Study|Withdrawal by Subject|0|||
125184845|NCT03428958|450298801|FG016|Overall Study|Withdrawal by Subject|0|||
125184846|NCT01922037|450298802|FG000|Overall Study|Withdrawal by Subject|2|||
125184847|NCT01922037|450298803|FG001|Overall Study|Withdrawal by Subject|44|||
125184848|NCT01922037|450298802|FG000|Overall Study|Adverse Event|1|||
125184849|NCT01922037|450298803|FG001|Overall Study|Adverse Event|7|||
125184850|NCT01922037|450298802|FG000|Overall Study|Death|0|||
125184851|NCT01922037|450298803|FG001|Overall Study|Death|5|||
125184852|NCT01922037|450298802|FG000|Overall Study|Pregnancy|0|||
125184853|NCT01922037|450298803|FG001|Overall Study|Pregnancy|2|||
125184854|NCT01922037|450298802|FG000|Overall Study|Participant non-compliance|4|||
125184855|NCT01922037|450298803|FG001|Overall Study|Participant non-compliance|46|||
125184856|NCT01922037|450298802|FG000|Overall Study|Investigator/Sponsor decision|1|||
125184857|NCT01922037|450298803|FG001|Overall Study|Investigator/Sponsor decision|4|||
125184858|NCT01922037|450298802|FG000|Overall Study|Other unspecified|2|||
125184859|NCT01922037|450298803|FG001|Overall Study|Other unspecified|66|||
125184860|NCT00413699|450298807|FG000|Initial Period|Death|25|||
125184861|NCT00413699|450298808|FG001|Initial Period|Death|30|||
125184862|NCT00413699|450298809|FG002|Initial Period|Death|0|||
125184863|NCT00413699|450298807|FG000|Initial Period|Lack of Efficacy|59|||
125184864|NCT00413699|450298808|FG001|Initial Period|Lack of Efficacy|115|||
125184865|NCT00413699|450298809|FG002|Initial Period|Lack of Efficacy|0|||
125184866|NCT00413699|450298807|FG000|Initial Period|Lost to Follow-up|31|||
125184867|NCT00413699|450298808|FG001|Initial Period|Lost to Follow-up|101|||
125184868|NCT00413699|450298809|FG002|Initial Period|Lost to Follow-up|0|||
125184869|NCT00413699|450298807|FG000|Initial Period|Protocol Violation|38|||
125237641|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
125184870|NCT00413699|450298808|FG001|Initial Period|Protocol Violation|89|||
125184871|NCT00413699|450298809|FG002|Initial Period|Protocol Violation|0|||
125184872|NCT00413699|450298807|FG000|Initial Period|Pregnancy|10|||
125184873|NCT00413699|450298808|FG001|Initial Period|Pregnancy|8|||
125184874|NCT00413699|450298809|FG002|Initial Period|Pregnancy|0|||
125184875|NCT00413699|450298807|FG000|Initial Period|Did not meet entrance criteria|2|||
125237642|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
125237643|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
125237644|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
125237645|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
125237646|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
125237647|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
125392460|NCT01951157|451070691|FG001|Overall Study|Treatment-unrelated AE|0|||
125184876|NCT00413699|450298808|FG001|Initial Period|Did not meet entrance criteria|2|||
125184877|NCT00413699|450298809|FG002|Initial Period|Did not meet entrance criteria|0|||
125184878|NCT00413699|450298807|FG000|Initial Period|Medication error without adverse event|0|||
125184879|NCT00413699|450298808|FG001|Initial Period|Medication error without adverse event|1|||
125184880|NCT00413699|450298809|FG002|Initial Period|Medication error without adverse event|0|||
125184881|NCT00413699|450298807|FG000|Initial Period|Study terminated by Sponsor|0|||
125184882|NCT00413699|450298808|FG001|Initial Period|Study terminated by Sponsor|1|||
125184883|NCT00413699|450298809|FG002|Initial Period|Study terminated by Sponsor|0|||
125184884|NCT00413699|450298807|FG000|Initial Period|Other|67|||
125184885|NCT00413699|450298808|FG001|Initial Period|Other|211|||
125184886|NCT00413699|450298809|FG002|Initial Period|Other|0|||
125184887|NCT00413699|450298807|FG000|Initial Period|Adverse event related to study drug|178|||
125184888|NCT00413699|450298808|FG001|Initial Period|Adverse event related to study drug|527|||
125184889|NCT00413699|450298809|FG002|Initial Period|Adverse event related to study drug|0|||
125237648|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
125237649|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
125237650|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
125237651|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
125237652|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
125237653|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
125237654|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
125237655|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
125237656|NCT00620542|450497638|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
125237657|NCT00620542|450497639|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
125237658|NCT00620542|450497640|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
125237659|NCT00620542|450497641|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
125237660|NCT01283386|450497648|FG000|Overall Study|Death|2|||
125237661|NCT01283386|450497649|FG001|Overall Study|Death|0|||
125237662|NCT01283386|450497648|FG000|Overall Study|Withdrawal by Subject|2|||
125237663|NCT01283386|450497649|FG001|Overall Study|Withdrawal by Subject|1|||
125237664|NCT01283386|450497648|FG000|Overall Study|Relapse of underlying disease|1|||
125237665|NCT01283386|450497649|FG001|Overall Study|Relapse of underlying disease|3|||
125237666|NCT01283386|450497648|FG000|Overall Study|Progression of underlying disease|2|||
125237667|NCT01283386|450497649|FG001|Overall Study|Progression of underlying disease|7|||
125237668|NCT01283386|450497648|FG000|Overall Study|Reason not specified|1|||
125237669|NCT01283386|450497649|FG001|Overall Study|Reason not specified|0|||
125237670|NCT01283386|450497648|FG000|Overall Study|Protocol Violation|0|||
125237671|NCT01283386|450497649|FG001|Overall Study|Protocol Violation|1|||
125237672|NCT03483103|450497652|FG000|Pre-Treatment Phase|Other reasons|1|||
125237673|NCT03483103|450497652|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
125237674|NCT03483103|450497652|FG000|Pre-Treatment Phase|Disease-related complications|1|||
125237675|NCT03483103|450497652|FG000|Pre-Treatment Phase|Death|5|||
125237676|NCT03483103|450497652|FG000|Treatment Phase|Withdrawal by Subject|7|||
125237677|NCT03483103|450497652|FG000|Treatment Phase|Other reasons|1|||
125237678|NCT03483103|450497652|FG000|Treatment Phase|Death|23|||
125237679|NCT03483103|450497652|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
125237680|NCT03483103|450497652|FG000|Treatment Phase|Received nonconforming product|1|||
125237681|NCT02239328|450497653|FG000|Overall Study|Benign disease noted at time of surgery|6|||
125237682|NCT02239328|450497653|FG000|Overall Study|Equipment or website malfunction|2|||
125237683|NCT04115059|450497655|FG000|Overall Study|Withdrawal by Subject|1|||
125237684|NCT04115059|450497655|FG000|Overall Study|Lack of Efficacy|2|||
125237685|NCT06420232|450497656|FG000|Overall Study|Withdrawal by Subject|3|||
125237686|NCT03881371|450497657|FG000|Overall Study|Adverse Event|8|||
125237687|NCT03881371|450497658|FG001|Overall Study|Adverse Event|9|||
125237688|NCT03881371|450497657|FG000|Overall Study|Death|1|||
125237689|NCT03881371|450497658|FG001|Overall Study|Death|0|||
125237690|NCT03881371|450497657|FG000|Overall Study|Lost to Follow-up|1|||
125237691|NCT03881371|450497658|FG001|Overall Study|Lost to Follow-up|0|||
125237692|NCT03881371|450497657|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125237693|NCT03881371|450497658|FG001|Overall Study|Non-Compliance with Study Drug|2|||
125237694|NCT03881371|450497657|FG000|Overall Study|Physician Decision|3|||
125237695|NCT03881371|450497658|FG001|Overall Study|Physician Decision|3|||
125237696|NCT03881371|450497657|FG000|Overall Study|Withdrawal by Subject|2|||
125237697|NCT03881371|450497658|FG001|Overall Study|Withdrawal by Subject|10|||
125237698|NCT03881371|450497657|FG000|Overall Study|Discontinuation from Study|1|||
125237699|NCT03881371|450497658|FG001|Overall Study|Discontinuation from Study|0|||
125237700|NCT00933933|450497659|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
125237701|NCT00933933|450497660|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
125237702|NCT00933933|450497661|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
125237703|NCT00933933|450497659|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
125237704|NCT00933933|450497660|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
125237705|NCT00933933|450497661|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
125237706|NCT00963235|450497662|FG000|Overall Study|Withdrawal by Subject|22|||
125237707|NCT00963235|450497662|FG000|Overall Study|Lost to Follow-up|14|||
125237708|NCT00963235|450497662|FG000|Overall Study|Failed to return|9|||
125237709|NCT00963235|450497662|FG000|Overall Study|Protocol Violation|7|||
125237710|NCT00963235|450497662|FG000|Overall Study|Adverse Event|5|||
125237711|NCT00963235|450497662|FG000|Overall Study|Physician Decision|2|||
125237712|NCT00963235|450497662|FG000|Overall Study|Other|1|||
125237713|NCT01136915|450497663|FG000|Overall Study|Lost to Follow-up|2|||
125237714|NCT01136915|450497664|FG001|Overall Study|Lost to Follow-up|0|||
125237715|NCT01136915|450497663|FG000|Overall Study|Exclusion criterion met|0|||
125237716|NCT01136915|450497664|FG001|Overall Study|Exclusion criterion met|1|||
125237717|NCT01756235|450497665|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
125237718|NCT02337829|450497666|FG000|Overall Study|Death|0|||
125237719|NCT02337829|450497667|FG001|Overall Study|Death|1|||
125392461|NCT01951157|451070692|FG002|Overall Study|Treatment-unrelated AE|3|||
125237720|NCT02337829|450497668|FG002|Overall Study|Death|0|||
125237721|NCT02337829|450497669|FG003|Overall Study|Death|0|||
125237722|NCT02337829|450497666|FG000|Overall Study|Study terminated by sponsor|12|||
125237723|NCT02337829|450497667|FG001|Overall Study|Study terminated by sponsor|10|||
125237724|NCT02337829|450497668|FG002|Overall Study|Study terminated by sponsor|5|||
125237725|NCT02337829|450497669|FG003|Overall Study|Study terminated by sponsor|6|||
125237726|NCT02337829|450497666|FG000|Overall Study|discontinued for other reasons|6|||
125237727|NCT02337829|450497667|FG001|Overall Study|discontinued for other reasons|3|||
125237728|NCT02337829|450497668|FG002|Overall Study|discontinued for other reasons|1|||
125237729|NCT02337829|450497669|FG003|Overall Study|discontinued for other reasons|4|||
125237730|NCT02802228|450497682|FG000|Overall Study|Withdrawal by Subject|2|||
125237731|NCT02802228|450497683|FG001|Overall Study|Withdrawal by Subject|0|||
125237732|NCT02802228|450497682|FG000|Overall Study|Lost to Follow-up|1|||
125237733|NCT02802228|450497683|FG001|Overall Study|Lost to Follow-up|0|||
125237734|NCT02802228|450497682|FG000|Overall Study|Adverse Event|1|||
125237735|NCT02802228|450497683|FG001|Overall Study|Adverse Event|0|||
125237736|NCT02802228|450497682|FG000|Overall Study|Physician Decision|1|||
125237737|NCT02802228|450497683|FG001|Overall Study|Physician Decision|0|||
125237738|NCT00695019|450497684|FG000|Overall Study|Withdrawal by Subject|8|||
125237739|NCT00695019|450497685|FG001|Overall Study|Withdrawal by Subject|6|||
125237740|NCT00695019|450497686|FG002|Overall Study|Withdrawal by Subject|4|||
125237741|NCT00695019|450497684|FG000|Overall Study|Protocol Violation|1|||
125237742|NCT00695019|450497685|FG001|Overall Study|Protocol Violation|3|||
125237743|NCT00695019|450497686|FG002|Overall Study|Protocol Violation|1|||
125237744|NCT00695019|450497684|FG000|Overall Study|Lack of Efficacy|0|||
125237745|NCT00695019|450497685|FG001|Overall Study|Lack of Efficacy|0|||
125237746|NCT00695019|450497686|FG002|Overall Study|Lack of Efficacy|1|||
125237747|NCT00695019|450497684|FG000|Overall Study|Various|4|||
125237748|NCT00695019|450497685|FG001|Overall Study|Various|5|||
125237749|NCT00695019|450497686|FG002|Overall Study|Various|4|||
125237750|NCT03197129|450497693|FG000|Overall Study|did not answer the VPT: shyness|4|||
125237751|NCT03197129|450497694|FG001|Overall Study|did not answer the VPT: shyness|5|||
125237752|NCT02879695|450497697|FG000|Overall Study|Did not start study treatment|2|||
125237753|NCT02879695|450497698|FG001|Overall Study|Did not start study treatment|0|||
125237754|NCT02879695|450497699|FG002|Overall Study|Did not start study treatment|3|||
125237755|NCT02879695|450497700|FG003|Overall Study|Did not start study treatment|0|||
125237756|NCT02442349|450497701|FG000|Overall Study|Death|95|||
125237757|NCT02442349|450497701|FG000|Overall Study|Withdrawal by Subject|27|||
125237758|NCT02442349|450497701|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
125237759|NCT02442349|450497701|FG000|Overall Study|Lost to Follow-up|1|||
125237760|NCT03507790|450497702|FG000|Overall Study|Adverse Event|0|||
125237761|NCT03507790|450497703|FG001|Overall Study|Adverse Event|11|||
125237762|NCT03507790|450497704|FG002|Overall Study|Adverse Event|3|||
125237763|NCT03507790|450497702|FG000|Overall Study|Withdrawal by Subject|2|||
125237764|NCT03507790|450497703|FG001|Overall Study|Withdrawal by Subject|0|||
125237765|NCT03507790|450497704|FG002|Overall Study|Withdrawal by Subject|0|||
125237766|NCT03507790|450497702|FG000|Overall Study|Subject moved to another location|1|||
125237767|NCT03507790|450497703|FG001|Overall Study|Subject moved to another location|2|||
125237768|NCT03507790|450497704|FG002|Overall Study|Subject moved to another location|0|||
125237769|NCT03507790|450497702|FG000|Overall Study|Non-compliance with study drug|0|||
125237770|NCT03507790|450497703|FG001|Overall Study|Non-compliance with study drug|0|||
125237771|NCT03507790|450497704|FG002|Overall Study|Non-compliance with study drug|1|||
125237772|NCT03507790|450497702|FG000|Overall Study|COVID 19 Pandemic|0|||
125237773|NCT03507790|450497703|FG001|Overall Study|COVID 19 Pandemic|1|||
125237774|NCT03507790|450497704|FG002|Overall Study|COVID 19 Pandemic|0|||
125237775|NCT03507790|450497702|FG000|Overall Study|Lost to Follow-up|0|||
125237776|NCT03507790|450497703|FG001|Overall Study|Lost to Follow-up|1|||
125237777|NCT03507790|450497704|FG002|Overall Study|Lost to Follow-up|0|||
125237778|NCT03507790|450497702|FG000|Overall Study|Discontinuation of the trial at the site|1|||
125237779|NCT03507790|450497703|FG001|Overall Study|Discontinuation of the trial at the site|1|||
125237780|NCT03507790|450497704|FG002|Overall Study|Discontinuation of the trial at the site|0|||
125237781|NCT03507790|450497702|FG000|Overall Study|Randomized in error|0|||
125237782|NCT03507790|450497703|FG001|Overall Study|Randomized in error|0|||
125237783|NCT03507790|450497704|FG002|Overall Study|Randomized in error|1|||
125237784|NCT01160614|450497707|FG000|Overall Study|Withdrawal by Subject|0|||
125237785|NCT01160614|450497708|FG001|Overall Study|Withdrawal by Subject|2|||
125237786|NCT05845619|450497709|FG000|Overall Study|duplicate enrollment|2|||
125237787|NCT05845619|450497710|FG001|Overall Study|duplicate enrollment|2|||
125237788|NCT05845619|450497711|FG002|Overall Study|duplicate enrollment|1|||
125237789|NCT03636477|450497712|FG000|Overall Study|Adverse Event|0|||
125237790|NCT03636477|450497713|FG001|Overall Study|Adverse Event|0|||
125237791|NCT03636477|450497714|FG002|Overall Study|Adverse Event|1|||
125237792|NCT03621592|450497715|FG000|Overall Study|Lost to Follow-up|1|||
125237793|NCT03621592|450497716|FG001|Overall Study|Lost to Follow-up|0|||
125237794|NCT03621592|450497715|FG000|Overall Study|Lack of Improvement|1|||
125237795|NCT03621592|450497716|FG001|Overall Study|Lack of Improvement|0|||
125392462|NCT01951157|451070690|FG000|Overall Study|Study Termination|0|||
125237796|NCT03621592|450497715|FG000|Overall Study|Preference to receive wound care closer to home|1|||
125237797|NCT03621592|450497716|FG001|Overall Study|Preference to receive wound care closer to home|0|||
125237798|NCT03621592|450497715|FG000|Overall Study|Lack of healing|0|||
125237799|NCT03621592|450497716|FG001|Overall Study|Lack of healing|2|||
125237800|NCT02382380|450497717|FG000|Overall Study|Withdrawal by Subject|2|||
125237801|NCT02382380|450497718|FG001|Overall Study|Withdrawal by Subject|2|||
125237802|NCT02382380|450497717|FG000|Overall Study|Lost to Follow-up|0|||
125237803|NCT02382380|450497718|FG001|Overall Study|Lost to Follow-up|1|||
125237804|NCT04153864|450497726|FG000|Overall Study|Withdrawal by Subject|21|||
125237805|NCT04153864|450497727|FG001|Overall Study|Withdrawal by Subject|7|||
125237806|NCT04153864|450497728|FG002|Overall Study|Withdrawal by Subject|23|||
125237807|NCT04153864|450497729|FG003|Overall Study|Withdrawal by Subject|2|||
125237808|NCT04153864|450497726|FG000|Overall Study|Lost to Follow-up|4|||
125237809|NCT04153864|450497727|FG001|Overall Study|Lost to Follow-up|0|||
125237810|NCT04153864|450497728|FG002|Overall Study|Lost to Follow-up|3|||
125237811|NCT04153864|450497729|FG003|Overall Study|Lost to Follow-up|0|||
125237812|NCT04153864|450497726|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
125237813|NCT04153864|450497727|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
125237814|NCT04153864|450497728|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
125237815|NCT04153864|450497729|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
125237816|NCT00724945|450497730|FG000|Period 1|non-compliance|1|||
125237817|NCT00724945|450497731|FG001|Period 1|non-compliance|0|||
125237818|NCT00724945|450497730|FG000|Period 1|Adverse Event|1|||
125237819|NCT00724945|450497731|FG001|Period 1|Adverse Event|1|||
125237820|NCT00724945|450497730|FG000|Period 1|Lost to Follow-up|1|||
125237821|NCT00724945|450497731|FG001|Period 1|Lost to Follow-up|0|||
125237822|NCT00724945|450497730|FG000|Period 2|lens comfort issue|3|||
125237823|NCT00724945|450497731|FG001|Period 2|lens comfort issue|0|||
125237824|NCT00724945|450497730|FG000|Period 2|lens physiology issue|1|||
125237825|NCT00724945|450497731|FG001|Period 2|lens physiology issue|0|||
125237826|NCT04817410|450500298|FG000|Overall Study|Withdrawal by Subject|5|||
125237827|NCT04817410|450500298|FG000|Overall Study|Physician Decision|3|||
125237828|NCT03595748|450500300|FG000|Overall Study|Death|11|||
125237829|NCT03595748|450500301|FG001|Overall Study|Death|12|||
125237830|NCT03595748|450500300|FG000|Overall Study|Withdrawal by Subject|28|||
125237831|NCT03595748|450500301|FG001|Overall Study|Withdrawal by Subject|29|||
125237832|NCT03595748|450500300|FG000|Overall Study|Protocol Violation|0|||
125237833|NCT03595748|450500301|FG001|Overall Study|Protocol Violation|1|||
125237834|NCT04809974|450500303|FG000|Lead-in Phase|Withdrawal by Subject|3|||
125237835|NCT04809974|450500304|FG001|Lead-in Phase|Withdrawal by Subject|0|||
125237836|NCT04809974|450500305|FG002|Lead-in Phase|Withdrawal by Subject|0|||
125237837|NCT04809974|450500303|FG000|Lead-in Phase|No longer eligible|11|||
125237838|NCT04809974|450500304|FG001|Lead-in Phase|No longer eligible|0|||
125237839|NCT04809974|450500305|FG002|Lead-in Phase|No longer eligible|0|||
125237840|NCT04809974|450500303|FG000|Randomized Phase|Lost to Follow-up|0|||
125237841|NCT04809974|450500304|FG001|Randomized Phase|Lost to Follow-up|1|||
125237842|NCT04809974|450500305|FG002|Randomized Phase|Lost to Follow-up|5|||
125237843|NCT04809974|450500303|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
125237844|NCT04809974|450500304|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
125237845|NCT04809974|450500305|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
125237846|NCT04809974|450500303|FG000|Randomized Phase|Adverse Event|0|||
125237847|NCT04809974|450500304|FG001|Randomized Phase|Adverse Event|1|||
125237848|NCT04809974|450500305|FG002|Randomized Phase|Adverse Event|4|||
125237849|NCT04809974|450500303|FG000|Randomized Phase|Withdrawal by Subject|0|||
125237850|NCT04809974|450500304|FG001|Randomized Phase|Withdrawal by Subject|0|||
125237851|NCT04809974|450500305|FG002|Randomized Phase|Withdrawal by Subject|5|||
125237852|NCT05493111|450500306|FG000|Overall Study|Adverse Event|3|||
125237853|NCT05493111|450500307|FG001|Overall Study|Adverse Event|4|||
125392463|NCT01951157|451070691|FG001|Overall Study|Study Termination|0|||
125392464|NCT01951157|451070692|FG002|Overall Study|Study Termination|1|||
125392465|NCT01951157|451070690|FG000|Overall Study|Physician Decision|5|||
125237854|NCT05493111|450500306|FG000|Overall Study|Withdrawal of Consent|19|||
125237855|NCT05493111|450500307|FG001|Overall Study|Withdrawal of Consent|10|||
125237856|NCT05493111|450500306|FG000|Overall Study|Non-compliance|1|||
125237857|NCT05493111|450500307|FG001|Overall Study|Non-compliance|1|||
125237858|NCT05493111|450500306|FG000|Overall Study|Lost to Follow-up|8|||
125237859|NCT05493111|450500307|FG001|Overall Study|Lost to Follow-up|1|||
125237860|NCT05493111|450500306|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
125237861|NCT05493111|450500307|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
125237862|NCT05493111|450500306|FG000|Overall Study|Withdrawal by Subject|1|||
125237863|NCT05493111|450500307|FG001|Overall Study|Withdrawal by Subject|1|||
125237864|NCT01970371|450500308|FG000|Overall Study|Death|8|||
125392466|NCT01951157|451070691|FG001|Overall Study|Physician Decision|3|||
125392467|NCT01951157|451070692|FG002|Overall Study|Physician Decision|2|||
125237865|NCT01970371|450500309|FG001|Overall Study|Death|13|||
125237866|NCT01970371|450500310|FG002|Overall Study|Death|12|||
125237867|NCT01970371|450500308|FG000|Overall Study|Lost to Follow-up|0|||
125237868|NCT01970371|450500309|FG001|Overall Study|Lost to Follow-up|0|||
125237869|NCT01970371|450500310|FG002|Overall Study|Lost to Follow-up|1|||
125237870|NCT01348269|450500311|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
125237871|NCT01348269|450500312|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
125184890|NCT00413699|450298807|FG000|Initial Period|Adverse event not related to study drug|113|||
125184891|NCT00413699|450298808|FG001|Initial Period|Adverse event not related to study drug|248|||
125184892|NCT00413699|450298809|FG002|Initial Period|Adverse event not related to study drug|0|||
125184893|NCT00413699|450298807|FG000|Initial Period|Missing end of study page|0|||
125184894|NCT00413699|450298808|FG001|Initial Period|Missing end of study page|4|||
125184895|NCT00413699|450298809|FG002|Initial Period|Missing end of study page|0|||
125184896|NCT00413699|450298807|FG000|Initial Period|No longer willing to participate|116|||
125184897|NCT00413699|450298808|FG001|Initial Period|No longer willing to participate|368|||
125184898|NCT00413699|450298809|FG002|Initial Period|No longer willing to participate|0|||
125184899|NCT00413699|450298807|FG000|Extension Period|No Longer Willing to Participate|0|||
125184900|NCT00413699|450298808|FG001|Extension Period|No Longer Willing to Participate|0|||
125184901|NCT00413699|450298809|FG002|Extension Period|No Longer Willing to Participate|2|||
125184902|NCT00413699|450298807|FG000|Extension Period|Protocol Violation|0|||
125184903|NCT00413699|450298808|FG001|Extension Period|Protocol Violation|0|||
125184904|NCT00413699|450298809|FG002|Extension Period|Protocol Violation|1|||
125184905|NCT00413699|450298807|FG000|Extension Period|Adverse Event|0|||
125184906|NCT00413699|450298808|FG001|Extension Period|Adverse Event|0|||
125184907|NCT00413699|450298809|FG002|Extension Period|Adverse Event|2|||
125184908|NCT03511105|450298810|FG000|Overall Study|Adverse Event|1|||
125184909|NCT03511105|450298811|FG001|Overall Study|Adverse Event|0|||
125184910|NCT03511105|450298810|FG000|Overall Study|Withdrew consent|1|||
125184911|NCT03511105|450298811|FG001|Overall Study|Withdrew consent|0|||
125184912|NCT02810457|450298812|FG000|Overall Study|Randomised but no treatment received|2|||
125184913|NCT02810457|450298813|FG001|Overall Study|Randomised but no treatment received|1|||
125184914|NCT02810457|450298812|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
125184915|NCT02810457|450298813|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
125184916|NCT02810457|450298812|FG000|Overall Study|Adverse Event|37|||
125184917|NCT02810457|450298813|FG001|Overall Study|Adverse Event|43|||
125184918|NCT02810457|450298812|FG000|Overall Study|Patient decision|31|||
125184919|NCT02810457|450298813|FG001|Overall Study|Patient decision|35|||
125184920|NCT02810457|450298812|FG000|Overall Study|Patient lost to follow-up|2|||
125184921|NCT02810457|450298813|FG001|Overall Study|Patient lost to follow-up|2|||
125184922|NCT02810457|450298812|FG000|Overall Study|Death|39|||
125184923|NCT02810457|450298813|FG001|Overall Study|Death|28|||
125184924|NCT02810457|450298812|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
125184925|NCT02810457|450298813|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
125184926|NCT02810457|450298812|FG000|Overall Study|Clinical progression|15|||
125184927|NCT02810457|450298813|FG001|Overall Study|Clinical progression|16|||
125184928|NCT02810457|450298812|FG000|Overall Study|Investigator decision|3|||
125184929|NCT02810457|450298813|FG001|Overall Study|Investigator decision|2|||
125184930|NCT02810457|450298812|FG000|Overall Study|Patient ineligibility|3|||
125184931|NCT02810457|450298813|FG001|Overall Study|Patient ineligibility|0|||
125184932|NCT02810457|450298812|FG000|Overall Study|Miscalculated PD|1|||
125184933|NCT02810457|450298813|FG001|Overall Study|Miscalculated PD|0|||
125184934|NCT02810457|450298812|FG000|Overall Study|Physician Decision|0|||
125184935|NCT02810457|450298813|FG001|Overall Study|Physician Decision|1|||
125184936|NCT02832687|450298814|FG000|Overall Study|Adverse Event|0|||
125184937|NCT02832687|450298815|FG001|Overall Study|Adverse Event|2|||
125184938|NCT04231825|450298816|FG000|Overall Study|Protocol Violation|3|||
125184939|NCT04231825|450298817|FG001|Overall Study|Protocol Violation|3|||
125184940|NCT04231825|450298816|FG000|Overall Study|Lost to Follow-up|0|||
125184941|NCT04231825|450298817|FG001|Overall Study|Lost to Follow-up|1|||
125184942|NCT02019472|450298818|FG000|Overall Study|Adverse Event|14|||
125184943|NCT02019472|450298819|FG001|Overall Study|Adverse Event|23|||
125184944|NCT02019472|450298820|FG002|Overall Study|Adverse Event|17|||
125184945|NCT02019472|450298818|FG000|Overall Study|Death|0|||
125184946|NCT02019472|450298819|FG001|Overall Study|Death|1|||
125184947|NCT02019472|450298820|FG002|Overall Study|Death|1|||
125184948|NCT02019472|450298818|FG000|Overall Study|Lack of Efficacy|7|||
125184949|NCT02019472|450298819|FG001|Overall Study|Lack of Efficacy|4|||
125184950|NCT02019472|450298820|FG002|Overall Study|Lack of Efficacy|4|||
125184951|NCT02019472|450298818|FG000|Overall Study|Lost to Follow-up|0|||
125184952|NCT02019472|450298819|FG001|Overall Study|Lost to Follow-up|2|||
125184953|NCT02019472|450298820|FG002|Overall Study|Lost to Follow-up|1|||
125184954|NCT02019472|450298818|FG000|Overall Study|Physician Decision|1|||
125184955|NCT02019472|450298819|FG001|Overall Study|Physician Decision|2|||
125184956|NCT02019472|450298820|FG002|Overall Study|Physician Decision|0|||
125184957|NCT02019472|450298818|FG000|Overall Study|Pregnancy|1|||
125237872|NCT01348269|450500311|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
125184958|NCT02019472|450298819|FG001|Overall Study|Pregnancy|2|||
125184959|NCT02019472|450298820|FG002|Overall Study|Pregnancy|2|||
125184960|NCT02019472|450298818|FG000|Overall Study|Withdrawal by Subject|11|||
125184961|NCT02019472|450298819|FG001|Overall Study|Withdrawal by Subject|10|||
125184962|NCT02019472|450298820|FG002|Overall Study|Withdrawal by Subject|11|||
125184963|NCT02019472|450298818|FG000|Overall Study|Other|3|||
125184964|NCT02019472|450298819|FG001|Overall Study|Other|8|||
125184965|NCT02019472|450298820|FG002|Overall Study|Other|6|||
125184966|NCT01217112|450298823|FG000|Overall Study|Adverse Event|0|||
125184967|NCT01217112|450298824|FG001|Overall Study|Adverse Event|2|||
125184968|NCT01217112|450298825|FG002|Overall Study|Adverse Event|0|||
125184969|NCT01217112|450298826|FG003|Overall Study|Adverse Event|2|||
125184970|NCT01217112|450298827|FG004|Overall Study|Adverse Event|0|||
125184971|NCT01217112|450298823|FG000|Overall Study|Withdrawal by Subject|0|||
125184972|NCT01217112|450298824|FG001|Overall Study|Withdrawal by Subject|0|||
125184973|NCT01217112|450298825|FG002|Overall Study|Withdrawal by Subject|1|||
125184974|NCT01217112|450298826|FG003|Overall Study|Withdrawal by Subject|0|||
125184975|NCT01217112|450298827|FG004|Overall Study|Withdrawal by Subject|0|||
125184976|NCT01217112|450298823|FG000|Overall Study|Physician Decision|0|||
125184977|NCT01217112|450298824|FG001|Overall Study|Physician Decision|0|||
125184978|NCT01217112|450298825|FG002|Overall Study|Physician Decision|0|||
125184979|NCT01217112|450298826|FG003|Overall Study|Physician Decision|0|||
125184980|NCT01217112|450298827|FG004|Overall Study|Physician Decision|1|||
125184981|NCT03192488|450298828|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
125184982|NCT03192488|450298829|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
125184983|NCT03192488|450298830|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
125184984|NCT03192488|450298831|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
125184985|NCT03192488|450298832|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
125184986|NCT03192488|450298833|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
125184987|NCT03192488|450298828|FG000|Third Intervention (d1)|Adverse Event|0|||
125184988|NCT03192488|450298829|FG001|Third Intervention (d1)|Adverse Event|0|||
125184989|NCT03192488|450298830|FG002|Third Intervention (d1)|Adverse Event|0|||
125184990|NCT03192488|450298831|FG003|Third Intervention (d1)|Adverse Event|0|||
125184991|NCT03192488|450298832|FG004|Third Intervention (d1)|Adverse Event|1|||
125184992|NCT03192488|450298833|FG005|Third Intervention (d1)|Adverse Event|0|||
125184993|NCT01401361|450298834|FG000|Overall Study|Withdrawal by Subject|16|||
125184994|NCT01401361|450298834|FG000|Overall Study|Lack of Efficacy|6|||
125184995|NCT01401361|450298834|FG000|Overall Study|Physician Decision|1|||
125184996|NCT01401361|450298834|FG000|Overall Study|Lost to Follow-up|3|||
125184997|NCT01401361|450298834|FG000|Overall Study|Subject/family decision post procedure|2|||
125184998|NCT02512302|450298836|FG000|Period 1|Adverse Event|0|||
125184999|NCT02512302|450298837|FG001|Period 1|Adverse Event|1|||
125185000|NCT02512302|450298838|FG002|Period 1|Adverse Event|0|||
125185001|NCT02512302|450298839|FG003|Period 1|Adverse Event|0|||
125185002|NCT02512302|450298840|FG004|Period 1|Adverse Event|0|||
125185003|NCT02512302|450298841|FG005|Period 1|Adverse Event|0|||
125185004|NCT02512302|450298842|FG006|Period 1|Adverse Event|0|||
125185005|NCT02512302|450298843|FG007|Period 1|Adverse Event|0|||
125185006|NCT02512302|450298844|FG008|Period 1|Adverse Event|0|||
125185007|NCT02512302|450298845|FG009|Period 1|Adverse Event|0|||
125185008|NCT02512302|450298836|FG000|Period 2|Adverse Event|0|||
125185009|NCT02512302|450298837|FG001|Period 2|Adverse Event|0|||
125185010|NCT02512302|450298838|FG002|Period 2|Adverse Event|0|||
125185011|NCT02512302|450298839|FG003|Period 2|Adverse Event|0|||
125185012|NCT02512302|450298840|FG004|Period 2|Adverse Event|0|||
125185013|NCT02512302|450298841|FG005|Period 2|Adverse Event|0|||
125185014|NCT02512302|450298842|FG006|Period 2|Adverse Event|0|||
125185015|NCT02512302|450298843|FG007|Period 2|Adverse Event|0|||
125185016|NCT02512302|450298844|FG008|Period 2|Adverse Event|0|||
125185017|NCT02512302|450298845|FG009|Period 2|Adverse Event|1|||
125185018|NCT02512302|450298836|FG000|Period 3|Lost to Follow-up|0|||
125185019|NCT02512302|450298837|FG001|Period 3|Lost to Follow-up|0|||
125185020|NCT02512302|450298838|FG002|Period 3|Lost to Follow-up|1|||
125185021|NCT02512302|450298839|FG003|Period 3|Lost to Follow-up|0|||
125185022|NCT02512302|450298840|FG004|Period 3|Lost to Follow-up|0|||
125185023|NCT02512302|450298841|FG005|Period 3|Lost to Follow-up|0|||
125185024|NCT02512302|450298842|FG006|Period 3|Lost to Follow-up|0|||
125185025|NCT02512302|450298843|FG007|Period 3|Lost to Follow-up|0|||
125185026|NCT02512302|450298844|FG008|Period 3|Lost to Follow-up|0|||
125185027|NCT02512302|450298845|FG009|Period 3|Lost to Follow-up|0|||
125185028|NCT02512302|450298836|FG000|Period 4|Adverse Event|0|||
125185029|NCT02512302|450298837|FG001|Period 4|Adverse Event|0|||
125185030|NCT02512302|450298838|FG002|Period 4|Adverse Event|0|||
125185031|NCT02512302|450298839|FG003|Period 4|Adverse Event|0|||
125185032|NCT02512302|450298840|FG004|Period 4|Adverse Event|0|||
125185033|NCT02512302|450298841|FG005|Period 4|Adverse Event|0|||
125185034|NCT02512302|450298842|FG006|Period 4|Adverse Event|1|||
125185035|NCT02512302|450298843|FG007|Period 4|Adverse Event|0|||
125185036|NCT02512302|450298844|FG008|Period 4|Adverse Event|0|||
125185037|NCT02512302|450298845|FG009|Period 4|Adverse Event|0|||
125185038|NCT01002989|450298849|FG000|Overall Study|exclusion criteria, no consent|5|||
125185039|NCT02547428|450298856|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
125237873|NCT01348269|450500312|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
125237874|NCT01348269|450500311|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
125237875|NCT01348269|450500312|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
125237876|NCT04727749|450500313|FG000|Overall Study|Lost to Follow-up|10|||
125237877|NCT04727749|450500314|FG001|Overall Study|Lost to Follow-up|3|||
125237878|NCT01481779|450500315|FG000|Overall Study|Adverse Event|23|||
125185040|NCT02547428|450298857|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
125185041|NCT02547428|450298856|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
125185042|NCT02547428|450298857|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
125185043|NCT02547428|450298856|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
125185044|NCT02547428|450298857|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
125185045|NCT02547428|450298856|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
125185046|NCT02547428|450298857|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
125185047|NCT02547428|450298856|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
125185048|NCT02547428|450298857|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
125185049|NCT02547428|450298856|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
125185050|NCT02547428|450298857|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
125185051|NCT02547428|450298856|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
125185052|NCT02547428|450298857|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
125185053|NCT02547428|450298856|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
125185054|NCT02547428|450298857|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
125185055|NCT01479465|450298858|FG000|Overall Study|Disease Progression|9|||
125185056|NCT01479465|450298859|FG001|Overall Study|Disease Progression|61|||
125185057|NCT01479465|450298860|FG002|Overall Study|Disease Progression|65|||
125185058|NCT01479465|450298861|FG003|Overall Study|Disease Progression|70|||
125185059|NCT01479465|450298858|FG000|Overall Study|Study Discontinued by Sponsor|0|||
125185060|NCT01479465|450298859|FG001|Overall Study|Study Discontinued by Sponsor|7|||
125185061|NCT01479465|450298860|FG002|Overall Study|Study Discontinued by Sponsor|5|||
125185062|NCT01479465|450298861|FG003|Overall Study|Study Discontinued by Sponsor|3|||
125185063|NCT01479465|450298858|FG000|Overall Study|Adverse Event|0|||
125185064|NCT01479465|450298859|FG001|Overall Study|Adverse Event|3|||
125185065|NCT01479465|450298860|FG002|Overall Study|Adverse Event|6|||
125185066|NCT01479465|450298861|FG003|Overall Study|Adverse Event|4|||
125185067|NCT01479465|450298858|FG000|Overall Study|Investigator Discretion|1|||
125185068|NCT01479465|450298859|FG001|Overall Study|Investigator Discretion|4|||
125185069|NCT01479465|450298860|FG002|Overall Study|Investigator Discretion|2|||
125185070|NCT01479465|450298861|FG003|Overall Study|Investigator Discretion|4|||
125185071|NCT01479465|450298858|FG000|Overall Study|Subject Request|1|||
125185072|NCT01479465|450298859|FG001|Overall Study|Subject Request|3|||
125185073|NCT01479465|450298860|FG002|Overall Study|Subject Request|4|||
125185074|NCT01479465|450298861|FG003|Overall Study|Subject Request|2|||
125185075|NCT01479465|450298858|FG000|Overall Study|Subject Withdrew Consent|0|||
125185076|NCT01479465|450298859|FG001|Overall Study|Subject Withdrew Consent|5|||
125185077|NCT01479465|450298860|FG002|Overall Study|Subject Withdrew Consent|2|||
125185078|NCT01479465|450298861|FG003|Overall Study|Subject Withdrew Consent|1|||
125185079|NCT01479465|450298858|FG000|Overall Study|Protocol Violation|0|||
125185080|NCT01479465|450298859|FG001|Overall Study|Protocol Violation|1|||
125185081|NCT01479465|450298860|FG002|Overall Study|Protocol Violation|1|||
125185082|NCT01479465|450298861|FG003|Overall Study|Protocol Violation|0|||
125185083|NCT01479465|450298858|FG000|Overall Study|Death|0|||
125185084|NCT01479465|450298859|FG001|Overall Study|Death|0|||
125185085|NCT01479465|450298860|FG002|Overall Study|Death|0|||
125185086|NCT01479465|450298861|FG003|Overall Study|Death|1|||
125185087|NCT01479465|450298858|FG000|Overall Study|Lost to Follow-up|0|||
125185088|NCT01479465|450298859|FG001|Overall Study|Lost to Follow-up|0|||
125185089|NCT01479465|450298860|FG002|Overall Study|Lost to Follow-up|1|||
125185090|NCT01479465|450298861|FG003|Overall Study|Lost to Follow-up|0|||
125185091|NCT00370552|450298862|FG000|Overall Study|Adverse Event|2|||
125185092|NCT00370552|450298863|FG001|Overall Study|Adverse Event|2|||
125185093|NCT00370552|450298864|FG002|Overall Study|Adverse Event|2|||
125185094|NCT00370552|450298862|FG000|Overall Study|Disease progression|23|||
125185095|NCT00370552|450298863|FG001|Overall Study|Disease progression|23|||
125185096|NCT00370552|450298864|FG002|Overall Study|Disease progression|15|||
125185097|NCT00370552|450298862|FG000|Overall Study|Maximum clinical benefit|3|||
125185098|NCT00370552|450298863|FG001|Overall Study|Maximum clinical benefit|5|||
125185099|NCT00370552|450298864|FG002|Overall Study|Maximum clinical benefit|5|||
125185100|NCT00370552|450298862|FG000|Overall Study|Poor or noncompliance|0|||
125185101|NCT00370552|450298863|FG001|Overall Study|Poor or noncompliance|0|||
125185102|NCT00370552|450298864|FG002|Overall Study|Poor or noncompliance|1|||
125185103|NCT00370552|450298862|FG000|Overall Study|Study drug toxicity|11|||
125185104|NCT00370552|450298863|FG001|Overall Study|Study drug toxicity|8|||
125237879|NCT01481779|450500316|FG001|Overall Study|Adverse Event|5|||
125237880|NCT01481779|450500315|FG000|Overall Study|Lost to Follow-up|3|||
125237881|NCT01481779|450500316|FG001|Overall Study|Lost to Follow-up|2|||
125237882|NCT01481779|450500315|FG000|Overall Study|Protocol Violation|2|||
125185105|NCT00370552|450298864|FG002|Overall Study|Study drug toxicity|6|||
125185106|NCT00370552|450298862|FG000|Overall Study|Withdrawal by Subject|2|||
125185107|NCT00370552|450298863|FG001|Overall Study|Withdrawal by Subject|0|||
125185108|NCT00370552|450298864|FG002|Overall Study|Withdrawal by Subject|1|||
125392468|NCT01951157|451070690|FG000|Overall Study|Non-treatmentrelated death|2|||
125392469|NCT01951157|451070691|FG001|Overall Study|Non-treatmentrelated death|2|||
125392470|NCT01951157|451070692|FG002|Overall Study|Non-treatmentrelated death|2|||
125392471|NCT01951157|451070690|FG000|Overall Study|No treated|0|||
125185109|NCT00370552|450298862|FG000|Overall Study|Still on treatment|1|||
125185110|NCT00370552|450298863|FG001|Overall Study|Still on treatment|3|||
125185111|NCT00370552|450298864|FG002|Overall Study|Still on treatment|2|||
125185112|NCT00370552|450298862|FG000|Overall Study|Never treated|1|||
125185113|NCT00370552|450298863|FG001|Overall Study|Never treated|0|||
125185114|NCT00370552|450298864|FG002|Overall Study|Never treated|0|||
125185115|NCT00370552|450298862|FG000|Overall Study|Physician Decision|1|||
125185116|NCT00370552|450298863|FG001|Overall Study|Physician Decision|1|||
125185117|NCT00370552|450298864|FG002|Overall Study|Physician Decision|0|||
125185118|NCT00370552|450298862|FG000|Overall Study|Investigator decision|2|||
125185119|NCT00370552|450298863|FG001|Overall Study|Investigator decision|1|||
125185120|NCT00370552|450298864|FG002|Overall Study|Investigator decision|0|||
125185121|NCT00370552|450298862|FG000|Overall Study|High risk of allergic reaction|0|||
125185122|NCT00370552|450298863|FG001|Overall Study|High risk of allergic reaction|1|||
125185123|NCT00370552|450298864|FG002|Overall Study|High risk of allergic reaction|0|||
125185124|NCT00370552|450298862|FG000|Overall Study|Planned radiation for palliation|0|||
125185125|NCT00370552|450298863|FG001|Overall Study|Planned radiation for palliation|1|||
125185126|NCT00370552|450298864|FG002|Overall Study|Planned radiation for palliation|0|||
125185127|NCT00942084|450298876|FG000|Overall Study|Death|2|||
125185128|NCT01641640|450298878|FG000|Overall Study|Enrolled but not treated|1|||
125185129|NCT01641640|450298878|FG000|Overall Study|Efficacy failure|29|||
125185130|NCT01641640|450298878|FG000|Overall Study|Lost to Follow-up|3|||
125185131|NCT01641640|450298878|FG000|Overall Study|Withdrawal by Subject|2|||
125185132|NCT01641640|450298878|FG000|Overall Study|Adverse Event|1|||
125185133|NCT01234350|450298879|FG000|Overall Study|Adverse Event|277|||
125185134|NCT01234350|450298880|FG001|Overall Study|Adverse Event|92|||
125185135|NCT01234350|450298879|FG000|Overall Study|Withdrawal by Subject|61|||
125185136|NCT01234350|450298880|FG001|Overall Study|Withdrawal by Subject|36|||
125185137|NCT01234350|450298879|FG000|Overall Study|Lost to Follow-up|115|||
125185138|NCT01234350|450298880|FG001|Overall Study|Lost to Follow-up|47|||
125185139|NCT01234350|450298879|FG000|Overall Study|Covers a diverse set of reasons|234|||
125185140|NCT01234350|450298880|FG001|Overall Study|Covers a diverse set of reasons|92|||
125185141|NCT01836471|450298883|FG000|Overall Study|Pregnancy|1|||
125237883|NCT01481779|450500316|FG001|Overall Study|Protocol Violation|3|||
125237884|NCT01481779|450500315|FG000|Overall Study|Withdrawal by Subject|26|||
125237885|NCT01481779|450500316|FG001|Overall Study|Withdrawal by Subject|13|||
125237886|NCT01481779|450500315|FG000|Overall Study|Physician Decision|13|||
125237887|NCT01481779|450500316|FG001|Overall Study|Physician Decision|4|||
125237888|NCT01481779|450500315|FG000|Overall Study|Sponsor Decision|3|||
125237889|NCT01481779|450500316|FG001|Overall Study|Sponsor Decision|1|||
125237890|NCT02378181|450500317|FG000|Overall Study|Lost to Follow-up|2|||
125237891|NCT02378181|450500318|FG001|Overall Study|Lost to Follow-up|5|||
125237892|NCT02378181|450500317|FG000|Overall Study|Withdrawal by Subject|1|||
125237893|NCT02378181|450500318|FG001|Overall Study|Withdrawal by Subject|1|||
125237894|NCT02378181|450500317|FG000|Overall Study|Incarcerated|0|||
125237895|NCT02378181|450500318|FG001|Overall Study|Incarcerated|1|||
125237896|NCT03517137|450500329|FG000|Overall Study|Lack of Efficacy|1|||
125237897|NCT03517137|450500329|FG000|Overall Study|Adverse Event|2|||
125237898|NCT03517137|450500329|FG000|Overall Study|Withdrawal by Subject|2|||
125237899|NCT03517137|450500329|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
125237900|NCT02313155|450500331|FG000|Overall Study|Lost to Follow-up|0|||
125237901|NCT02313155|450500332|FG001|Overall Study|Lost to Follow-up|1|||
125237902|NCT00689936|450500333|FG000|Active Treatment Phase|Adverse Event|68|||
125237903|NCT00689936|450500334|FG001|Active Treatment Phase|Adverse Event|71|||
125392472|NCT01951157|451070691|FG001|Overall Study|No treated|1|||
125185142|NCT01836471|450298884|FG001|Overall Study|Pregnancy|0|||
125185143|NCT01836471|450298885|FG002|Overall Study|Pregnancy|0|||
125185144|NCT01836471|450298886|FG003|Overall Study|Pregnancy|0|||
125185145|NCT01836471|450298887|FG004|Overall Study|Pregnancy|0|||
125185146|NCT01836471|450298883|FG000|Overall Study|Withdrawal by Subject|3|||
125237904|NCT00689936|450500335|FG002|Active Treatment Phase|Adverse Event|76|||
125237905|NCT00689936|450500333|FG000|Active Treatment Phase|Disease Progression|273|||
125185147|NCT01836471|450298884|FG001|Overall Study|Withdrawal by Subject|4|||
125185148|NCT01836471|450298885|FG002|Overall Study|Withdrawal by Subject|1|||
125237906|NCT00689936|450500334|FG001|Active Treatment Phase|Disease Progression|362|||
125237907|NCT00689936|450500335|FG002|Active Treatment Phase|Disease Progression|339|||
125392473|NCT01951157|451070692|FG002|Overall Study|No treated|0|||
125392474|NCT01951157|451070690|FG000|Overall Study|Treatment-related AE|2|||
125392475|NCT01951157|451070691|FG001|Overall Study|Treatment-related AE|0|||
125237908|NCT00689936|450500333|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
125237909|NCT00689936|450500334|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
125237910|NCT00689936|450500335|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
125237911|NCT00689936|450500333|FG000|Active Treatment Phase|Death|60|||
125237912|NCT00689936|450500334|FG001|Active Treatment Phase|Death|28|||
125237913|NCT00689936|450500335|FG002|Active Treatment Phase|Death|37|||
125237914|NCT00689936|450500333|FG000|Active Treatment Phase|Lost to Follow-up|0|||
125237915|NCT00689936|450500334|FG001|Active Treatment Phase|Lost to Follow-up|2|||
125237916|NCT00689936|450500335|FG002|Active Treatment Phase|Lost to Follow-up|2|||
125237917|NCT00689936|450500333|FG000|Active Treatment Phase|Protocol Violation|2|||
125237918|NCT00689936|450500334|FG001|Active Treatment Phase|Protocol Violation|2|||
125237919|NCT00689936|450500335|FG002|Active Treatment Phase|Protocol Violation|4|||
125237920|NCT00689936|450500333|FG000|Active Treatment Phase|Study Close Out|64|||
125237921|NCT00689936|450500334|FG001|Active Treatment Phase|Study Close Out|26|||
125237922|NCT00689936|450500335|FG002|Active Treatment Phase|Study Close Out|21|||
125237923|NCT00689936|450500333|FG000|Active Treatment Phase|Miscellaneous|52|||
125237924|NCT00689936|450500334|FG001|Active Treatment Phase|Miscellaneous|34|||
125237925|NCT00689936|450500335|FG002|Active Treatment Phase|Miscellaneous|47|||
125237926|NCT00689936|450500333|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
125237927|NCT00689936|450500334|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
125237928|NCT00689936|450500335|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
125237929|NCT01303419|450500338|FG000|Overall Study|Discontinuation of study|60|||
125237930|NCT01303419|450500338|FG000|Overall Study|Did not complete both imaging methods|5|||
125237931|NCT01303419|450500338|FG000|Overall Study|Did not meet all I/E after screening|31|||
125237932|NCT01995201|450500339|FG000|From Baseline Until Week 24|Adverse Event|4|||
125237933|NCT01995201|450500340|FG001|From Baseline Until Week 24|Adverse Event|15|||
125237934|NCT01995201|450500341|FG002|From Baseline Until Week 24|Adverse Event|0|||
125237935|NCT01995201|450500342|FG003|From Baseline Until Week 24|Adverse Event|0|||
125237936|NCT01995201|450500343|FG004|From Baseline Until Week 24|Adverse Event|0|||
125237937|NCT01995201|450500344|FG005|From Baseline Until Week 24|Adverse Event|0|||
125237938|NCT01995201|450500345|FG006|From Baseline Until Week 24|Adverse Event|0|||
125237939|NCT01995201|450500339|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
125237940|NCT01995201|450500340|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
125237941|NCT01995201|450500341|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
125237942|NCT01995201|450500342|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
125237943|NCT01995201|450500343|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
125237944|NCT01995201|450500344|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
125237945|NCT01995201|450500345|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
125237946|NCT01995201|450500339|FG000|From Baseline Until Week 24|Death|0|||
125237947|NCT01995201|450500340|FG001|From Baseline Until Week 24|Death|1|||
125237948|NCT01995201|450500341|FG002|From Baseline Until Week 24|Death|0|||
125237949|NCT01995201|450500342|FG003|From Baseline Until Week 24|Death|0|||
125237950|NCT01995201|450500343|FG004|From Baseline Until Week 24|Death|0|||
125237951|NCT01995201|450500344|FG005|From Baseline Until Week 24|Death|0|||
125237952|NCT01995201|450500345|FG006|From Baseline Until Week 24|Death|0|||
125237953|NCT01995201|450500339|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
125237954|NCT01995201|450500340|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
125237955|NCT01995201|450500341|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
125237956|NCT01995201|450500342|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
125237957|NCT01995201|450500343|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
125237958|NCT01995201|450500344|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
125237959|NCT01995201|450500345|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
125237960|NCT01995201|450500339|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
125237961|NCT01995201|450500340|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
125237962|NCT01995201|450500341|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
125237963|NCT01995201|450500342|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
125237964|NCT01995201|450500343|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
125237965|NCT01995201|450500344|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
125237966|NCT01995201|450500345|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
125392476|NCT01951157|451070692|FG002|Overall Study|Treatment-related AE|4|||
125392477|NCT01951157|451070690|FG000|Overall Study|Consent withdrawn by subject|0|||
125392478|NCT01951157|451070691|FG001|Overall Study|Consent withdrawn by subject|1|||
125237967|NCT01995201|450500339|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
125237968|NCT01995201|450500340|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
125237969|NCT01995201|450500341|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
125237970|NCT01995201|450500342|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
125237971|NCT01995201|450500343|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
125237972|NCT01995201|450500344|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
125237973|NCT01995201|450500345|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
125237974|NCT01995201|450500339|FG000|From Baseline Until Week 24|Physician Decision|0|||
125392479|NCT01951157|451070692|FG002|Overall Study|Consent withdrawn by subject|3|||
125237975|NCT01995201|450500340|FG001|From Baseline Until Week 24|Physician Decision|2|||
125237976|NCT01995201|450500341|FG002|From Baseline Until Week 24|Physician Decision|0|||
125237977|NCT01995201|450500342|FG003|From Baseline Until Week 24|Physician Decision|0|||
125443443|NCT02555371|451252132|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
125185149|NCT01836471|450298886|FG003|Overall Study|Withdrawal by Subject|0|||
125185150|NCT01836471|450298887|FG004|Overall Study|Withdrawal by Subject|2|||
125185151|NCT01836471|450298883|FG000|Overall Study|Physician Decision|0|||
125185152|NCT01836471|450298884|FG001|Overall Study|Physician Decision|1|||
125185153|NCT01836471|450298885|FG002|Overall Study|Physician Decision|0|||
125185154|NCT01836471|450298886|FG003|Overall Study|Physician Decision|0|||
125185155|NCT01836471|450298887|FG004|Overall Study|Physician Decision|0|||
125185156|NCT01836471|450298883|FG000|Overall Study|Lost to Follow-up|0|||
125185157|NCT01836471|450298884|FG001|Overall Study|Lost to Follow-up|0|||
125185158|NCT01836471|450298885|FG002|Overall Study|Lost to Follow-up|0|||
125185159|NCT01836471|450298886|FG003|Overall Study|Lost to Follow-up|1|||
125185160|NCT01836471|450298887|FG004|Overall Study|Lost to Follow-up|1|||
125185161|NCT01836471|450298883|FG000|Overall Study|Adverse Event|6|||
125185162|NCT01836471|450298884|FG001|Overall Study|Adverse Event|3|||
125185163|NCT01836471|450298885|FG002|Overall Study|Adverse Event|1|||
125185164|NCT01836471|450298886|FG003|Overall Study|Adverse Event|1|||
125185165|NCT01836471|450298887|FG004|Overall Study|Adverse Event|2|||
125185166|NCT01836471|450298883|FG000|Overall Study|Non compliance with tx|1|||
125185167|NCT01836471|450298884|FG001|Overall Study|Non compliance with tx|1|||
125185168|NCT01836471|450298885|FG002|Overall Study|Non compliance with tx|0|||
125185169|NCT01836471|450298886|FG003|Overall Study|Non compliance with tx|0|||
125185170|NCT01836471|450298887|FG004|Overall Study|Non compliance with tx|0|||
125185171|NCT05506046|450298888|FG000|Overall Study|Lost to Follow-up|89|||
125185172|NCT05506046|450298889|FG001|Overall Study|Lost to Follow-up|101|||
125185173|NCT05506046|450298890|FG002|Overall Study|Lost to Follow-up|102|||
125185174|NCT05506046|450298891|FG003|Overall Study|Lost to Follow-up|99|||
125185175|NCT03051100|450298895|FG000|Overall Study|Withdrawal by Subject|1|||
125185176|NCT03051100|450298896|FG001|Overall Study|Withdrawal by Subject|0|||
125185177|NCT03776357|450298897|FG000|Overall Study|Lost to Follow-up|3|||
125185178|NCT05921903|450298898|FG000|Overall Study|Unsolicited non-SAE|0|||
125185179|NCT05921903|450298899|FG001|Overall Study|Unsolicited non-SAE|1|||
125185180|NCT05921903|450298900|FG002|Overall Study|Unsolicited non-SAE|0|||
125185181|NCT05921903|450298898|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
125185182|NCT05921903|450298899|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
125185183|NCT05921903|450298900|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
125185184|NCT05921903|450298898|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
125185185|NCT05921903|450298899|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
125185186|NCT05921903|450298900|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
125185187|NCT03305848|450298901|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
125185188|NCT03305848|450298901|FG000|Overall Study|Physician Decision|2|||
125185189|NCT00789854|450298904|FG000|Overall Study|Adverse Event|28|||
125185190|NCT00789854|450298905|FG001|Overall Study|Adverse Event|23|||
125185191|NCT00789854|450298906|FG002|Overall Study|Adverse Event|18|||
125185192|NCT00789854|450298904|FG000|Overall Study|Lost to Follow-up|1|||
125185193|NCT00789854|450298905|FG001|Overall Study|Lost to Follow-up|1|||
125185194|NCT00789854|450298906|FG002|Overall Study|Lost to Follow-up|4|||
125185195|NCT00789854|450298904|FG000|Overall Study|Withdrawal by Subject|9|||
125185196|NCT00789854|450298905|FG001|Overall Study|Withdrawal by Subject|6|||
125185197|NCT00789854|450298906|FG002|Overall Study|Withdrawal by Subject|17|||
125185198|NCT00789854|450298904|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125185199|NCT00789854|450298905|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
125185200|NCT00789854|450298906|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
125185201|NCT00789854|450298904|FG000|Overall Study|Severe non-compliance to the protocol|3|||
125185202|NCT00789854|450298905|FG001|Overall Study|Severe non-compliance to the protocol|0|||
125185203|NCT00789854|450298906|FG002|Overall Study|Severe non-compliance to the protocol|0|||
125185204|NCT00789854|450298904|FG000|Overall Study|Safety reasons|0|||
125185205|NCT00789854|450298905|FG001|Overall Study|Safety reasons|0|||
125185206|NCT00789854|450298906|FG002|Overall Study|Safety reasons|2|||
125185207|NCT00789854|450298904|FG000|Overall Study|Other|6|||
125185208|NCT00789854|450298905|FG001|Overall Study|Other|0|||
125185209|NCT00789854|450298906|FG002|Overall Study|Other|5|||
125185210|NCT03181633|450298907|FG000|Overall Study|Withdrawal by Subject|1|||
125185211|NCT03181633|450298907|FG000|Overall Study|Missing follow-up visit|1|||
125185212|NCT05303194|450298908|FG000|Overall Study|Lost to Follow-up|1|||
125185213|NCT05303194|450298909|FG001|Overall Study|Lost to Follow-up|1|||
125185214|NCT05303194|450298908|FG000|Overall Study|Withdrawal by Subject|0|||
125185215|NCT05303194|450298909|FG001|Overall Study|Withdrawal by Subject|1|||
125237978|NCT01995201|450500343|FG004|From Baseline Until Week 24|Physician Decision|0|||
125237979|NCT01995201|450500344|FG005|From Baseline Until Week 24|Physician Decision|0|||
125185216|NCT04837196|450298919|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
125185217|NCT04837196|450298920|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
125237980|NCT01995201|450500345|FG006|From Baseline Until Week 24|Physician Decision|0|||
125237981|NCT01995201|450500339|FG000|From Baseline Until Week 24|Protocol Violation|0|||
125237982|NCT01995201|450500340|FG001|From Baseline Until Week 24|Protocol Violation|9|||
125237983|NCT01995201|450500341|FG002|From Baseline Until Week 24|Protocol Violation|0|||
125237984|NCT01995201|450500342|FG003|From Baseline Until Week 24|Protocol Violation|0|||
125237985|NCT01995201|450500343|FG004|From Baseline Until Week 24|Protocol Violation|0|||
125237986|NCT01995201|450500344|FG005|From Baseline Until Week 24|Protocol Violation|0|||
125237987|NCT01995201|450500345|FG006|From Baseline Until Week 24|Protocol Violation|0|||
125237988|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Adverse Event|0|||
125237989|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Adverse Event|0|||
125237990|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Adverse Event|2|||
125237991|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Adverse Event|1|||
125237992|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Adverse Event|1|||
125237993|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Adverse Event|3|||
125237994|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Adverse Event|1|||
125237995|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Death|0|||
125237996|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Death|0|||
125237997|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Death|0|||
125237998|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Death|0|||
125237999|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Death|0|||
125238000|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Death|2|||
125238001|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Death|0|||
125238002|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
125238003|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
125238004|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
125238005|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
125238006|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
125238007|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
125238008|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
125238009|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
125238010|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
125238011|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
125238012|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
125238013|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
125238014|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
125238015|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
125238016|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
125238017|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
125238018|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
125238019|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
125238020|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
125238021|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
125238022|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
125238023|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Physician Decision|0|||
125238024|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Physician Decision|0|||
125238025|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Physician Decision|0|||
125238026|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Physician Decision|0|||
125238027|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Physician Decision|1|||
125238028|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Physician Decision|0|||
125238029|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Physician Decision|0|||
125238030|NCT01995201|450500339|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
125238031|NCT01995201|450500340|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
125238032|NCT01995201|450500341|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
125238033|NCT01995201|450500342|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
125238034|NCT01995201|450500343|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
125238035|NCT01995201|450500344|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
125238036|NCT01995201|450500345|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
125238037|NCT05376358|450500349|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
125238038|NCT05376358|450500350|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
125238039|NCT05376358|450500349|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
125238040|NCT05376358|450500350|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
125238041|NCT05376358|450500349|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
125238042|NCT05376358|450500350|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
125238043|NCT05376358|450500349|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
125238044|NCT05376358|450500350|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
125392480|NCT01951157|451070690|FG000|Overall Study|Treatment-related death|0|||
125392481|NCT01951157|451070691|FG001|Overall Study|Treatment-related death|2|||
125238045|NCT05376358|450500349|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
125238046|NCT05376358|450500350|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
125238047|NCT05376358|450500349|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
125238048|NCT05376358|450500350|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
125238049|NCT02213926|450500353|FG000|Overall Study|Death|59|||
125238050|NCT02213926|450500353|FG000|Overall Study|Withdrawal by Subject|10|||
125238051|NCT02213926|450500353|FG000|Overall Study|study terminated by sponsor|51|||
125238052|NCT02213926|450500353|FG000|Overall Study|Lost to Follow-up|3|||
125238053|NCT02213926|450500353|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
125238054|NCT01697579|450500356|FG000|Base Study-Cycle 1|Adverse Event|1|||
125238055|NCT01697579|450500357|FG001|Base Study-Cycle 1|Adverse Event|0|||
125238056|NCT01697579|450500358|FG002|Base Study-Cycle 1|Adverse Event|0|||
125238057|NCT01697579|450500359|FG003|Base Study-Cycle 1|Adverse Event|0|||
125238058|NCT01697579|450500360|FG004|Base Study-Cycle 1|Adverse Event|0|||
125238059|NCT01697579|450500361|FG005|Base Study-Cycle 1|Adverse Event|0|||
125238060|NCT01697579|450500362|FG006|Base Study-Cycle 1|Adverse Event|0|||
125238061|NCT01697579|450500356|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
125238062|NCT01697579|450500357|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
125238063|NCT01697579|450500358|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
125238064|NCT01697579|450500359|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
125238065|NCT01697579|450500360|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
125238066|NCT01697579|450500361|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
125238067|NCT01697579|450500362|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
125238068|NCT01697579|450500356|FG000|Base Study-Cycle 1|Protocol Violation|0|||
125238069|NCT01697579|450500357|FG001|Base Study-Cycle 1|Protocol Violation|0|||
125238070|NCT01697579|450500358|FG002|Base Study-Cycle 1|Protocol Violation|0|||
125238071|NCT01697579|450500359|FG003|Base Study-Cycle 1|Protocol Violation|0|||
125238072|NCT01697579|450500360|FG004|Base Study-Cycle 1|Protocol Violation|3|||
125238073|NCT01697579|450500361|FG005|Base Study-Cycle 1|Protocol Violation|0|||
125238074|NCT01697579|450500362|FG006|Base Study-Cycle 1|Protocol Violation|0|||
125238075|NCT01697579|450500356|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
125238076|NCT01697579|450500357|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
125238077|NCT01697579|450500358|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
125238078|NCT01697579|450500359|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
125238079|NCT01697579|450500360|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
125238080|NCT01697579|450500361|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
125238081|NCT01697579|450500362|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
125238082|NCT01697579|450500356|FG000|Base Study-Cycle 1|Technical Problems|0|||
125238083|NCT01697579|450500357|FG001|Base Study-Cycle 1|Technical Problems|0|||
125238084|NCT01697579|450500358|FG002|Base Study-Cycle 1|Technical Problems|1|||
125238085|NCT01697579|450500359|FG003|Base Study-Cycle 1|Technical Problems|1|||
125238086|NCT01697579|450500360|FG004|Base Study-Cycle 1|Technical Problems|0|||
125238087|NCT01697579|450500361|FG005|Base Study-Cycle 1|Technical Problems|0|||
125238088|NCT01697579|450500362|FG006|Base Study-Cycle 1|Technical Problems|0|||
125238089|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Death|0|||
125238090|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Death|0|||
125238091|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Death|0|||
125238092|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Death|0|||
125238093|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Death|0|||
125238094|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Death|0|||
125238095|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Death|2|||
125238096|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125238097|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125238098|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125238099|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125238100|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125238101|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
125238102|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
125238103|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
125238104|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
125238105|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
125238106|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
125238107|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
125238108|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
125238109|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
125238110|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
125238111|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
125238112|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
125238113|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
125238114|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
125185218|NCT04837196|450298921|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
125185219|NCT04837196|450298922|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
125185220|NCT04837196|450298923|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
125185221|NCT04837196|450298919|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
125185222|NCT04837196|450298920|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
125185223|NCT04837196|450298921|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
125185224|NCT04837196|450298922|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
125185225|NCT04837196|450298923|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
125185226|NCT04837196|450298919|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
125185227|NCT04837196|450298920|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
125185228|NCT04837196|450298921|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
125185229|NCT04837196|450298922|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
125185230|NCT04837196|450298923|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
125185231|NCT04837196|450298919|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
125185232|NCT04837196|450298920|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
125185233|NCT04837196|450298921|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
125185234|NCT04837196|450298922|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
125185235|NCT04837196|450298923|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
125185236|NCT04837196|450298919|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
125185237|NCT04837196|450298920|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
125185238|NCT04837196|450298921|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
125185239|NCT04837196|450298922|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
125185240|NCT04837196|450298923|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
125185241|NCT05271175|450298924|FG000|One Week Follow up|Lost to Follow-up|10|||
125185242|NCT05271175|450298925|FG001|One Week Follow up|Lost to Follow-up|7|||
125185243|NCT05271175|450298926|FG002|One Week Follow up|Lost to Follow-up|5|||
125185244|NCT05271175|450298924|FG000|One Month Follow up|Lost to Follow-up|12|||
125185245|NCT05271175|450298925|FG001|One Month Follow up|Lost to Follow-up|7|||
125185246|NCT05271175|450298926|FG002|One Month Follow up|Lost to Follow-up|9|||
125185247|NCT05271175|450298924|FG000|Six Months Follow up|Lost to Follow-up|8|||
125185248|NCT05271175|450298925|FG001|Six Months Follow up|Lost to Follow-up|2|||
125185249|NCT05271175|450298926|FG002|Six Months Follow up|Lost to Follow-up|2|||
125185250|NCT00991887|450298927|FG000|Overall Study|Lost to Follow-up|2|||
125185251|NCT00991887|450298928|FG001|Overall Study|Lost to Follow-up|1|||
125185252|NCT01522456|450298929|FG000|Overall Study|Adverse Event|2|||
125185253|NCT01522456|450298929|FG000|Overall Study|Lost to Follow-up|2|||
125185254|NCT01522456|450298929|FG000|Overall Study|Withdrawal by Subject|2|||
125185255|NCT01522456|450298929|FG000|Overall Study|Pregnancy|1|||
125185256|NCT01522456|450298929|FG000|Overall Study|Tolerability Assessment|1|||
125185257|NCT04581824|450300747|FG000|Overall Study|Lost to Follow-up|1|||
125185258|NCT04581824|450300748|FG001|Overall Study|Lost to Follow-up|0|||
125185259|NCT04581824|450300747|FG000|Overall Study|Withdrawal by Subject|2|||
125185260|NCT04581824|450300748|FG001|Overall Study|Withdrawal by Subject|7|||
125185261|NCT04581824|450300747|FG000|Overall Study|Study terminated by sponsor|37|||
125185262|NCT04581824|450300748|FG001|Overall Study|Study terminated by sponsor|23|||
125185263|NCT04796909|450300749|FG000|Overall Study|Withdrawal by Subject|1|||
125185264|NCT04796909|450300750|FG001|Overall Study|Withdrawal by Subject|1|||
125185265|NCT03879135|450300751|FG000|Overall Study|Physician Decision|0|||
125185266|NCT03879135|450300752|FG001|Overall Study|Physician Decision|0|||
125185267|NCT03879135|450300753|FG002|Overall Study|Physician Decision|0|||
125185268|NCT03879135|450300754|FG003|Overall Study|Physician Decision|1|||
125185269|NCT03879135|450300755|FG004|Overall Study|Physician Decision|0|||
125185270|NCT03879135|450300756|FG005|Overall Study|Physician Decision|0|||
125185271|NCT03879135|450300751|FG000|Overall Study|Withdrawal by Subject|0|||
125185272|NCT03879135|450300752|FG001|Overall Study|Withdrawal by Subject|0|||
125185273|NCT03879135|450300753|FG002|Overall Study|Withdrawal by Subject|0|||
125185274|NCT03879135|450300754|FG003|Overall Study|Withdrawal by Subject|0|||
125185275|NCT03879135|450300755|FG004|Overall Study|Withdrawal by Subject|0|||
125185276|NCT03879135|450300756|FG005|Overall Study|Withdrawal by Subject|1|||
125185277|NCT03879135|450300751|FG000|Overall Study|Site Closed by Sponsor|0|||
125185278|NCT03879135|450300752|FG001|Overall Study|Site Closed by Sponsor|0|||
125185279|NCT03879135|450300753|FG002|Overall Study|Site Closed by Sponsor|0|||
125185280|NCT03879135|450300754|FG003|Overall Study|Site Closed by Sponsor|1|||
125185281|NCT03879135|450300755|FG004|Overall Study|Site Closed by Sponsor|1|||
125185282|NCT03879135|450300756|FG005|Overall Study|Site Closed by Sponsor|0|||
125185283|NCT04162847|450300757|FG000|Overall Study|Withdrawal by Subject|7|||
125185284|NCT04162847|450300758|FG001|Overall Study|Withdrawal by Subject|1|||
125238115|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
125185285|NCT03874117|450300759|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
125185286|NCT03874117|450300760|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
125185287|NCT03874117|450300759|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
125238116|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
125238117|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
125238118|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
125238119|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
125238120|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
125238121|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
125238122|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
125238123|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
125238124|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
125238125|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
125238126|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
125238127|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
125238128|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
125238129|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
125238130|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
125238131|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
125238132|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
125238133|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
125238134|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
125238135|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
125238136|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
125238137|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
125238138|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
125238139|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
125238140|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
125238141|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
125238142|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
125238143|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
125238144|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
125238145|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
125238146|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
125238147|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
125238148|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
125238149|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
125238150|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
125238151|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
125238152|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
125238153|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
125238154|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
125238155|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
125238156|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
125238157|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
125238158|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
125238159|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
125238160|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
125238161|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
125238162|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
125238163|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
125238164|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
125238165|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
125238166|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
125238167|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
125238168|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
125238169|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
125238170|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
125238171|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
125238172|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
125238173|NCT01697579|450500356|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
125238174|NCT01697579|450500357|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
125238175|NCT01697579|450500358|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
125238176|NCT01697579|450500359|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
125238177|NCT01697579|450500360|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
125392482|NCT01951157|451070692|FG002|Overall Study|Treatment-related death|0|||
125392483|NCT04809220|451070693|FG000|Overall Study|Adverse Event|4|||
125238178|NCT01697579|450500361|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
125238179|NCT01697579|450500362|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
125238180|NCT01044498|450500365|FG000|Overall Study|Withdrew consent|1|||
125238181|NCT01044498|450500366|FG001|Overall Study|Withdrew consent|1|||
125238182|NCT01044498|450500365|FG000|Overall Study|Adverse Event|1|||
125238183|NCT01044498|450500366|FG001|Overall Study|Adverse Event|1|||
125238184|NCT01044498|450500365|FG000|Overall Study|Other|1|||
125238185|NCT01044498|450500366|FG001|Overall Study|Other|0|||
125238186|NCT02327078|450500371|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
125238187|NCT02327078|450500372|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
125238188|NCT02327078|450500373|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
125238189|NCT02327078|450500374|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
125238190|NCT02327078|450500375|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
125238191|NCT02327078|450500376|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
125238192|NCT02327078|450500377|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
125238193|NCT02327078|450500378|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
125238194|NCT02327078|450500379|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
125238195|NCT02327078|450500371|FG000|Overall Study|Death|2|||
125238196|NCT02327078|450500372|FG001|Overall Study|Death|4|||
125238197|NCT02327078|450500373|FG002|Overall Study|Death|10|||
125238198|NCT02327078|450500374|FG003|Overall Study|Death|6|||
125238199|NCT02327078|450500375|FG004|Overall Study|Death|4|||
125238200|NCT02327078|450500376|FG005|Overall Study|Death|3|||
125238201|NCT02327078|450500377|FG006|Overall Study|Death|2|||
125238202|NCT02327078|450500378|FG007|Overall Study|Death|51|||
125238203|NCT02327078|450500379|FG008|Overall Study|Death|97|||
125238204|NCT02327078|450500371|FG000|Overall Study|Lost to Follow-up|0|||
125238205|NCT02327078|450500372|FG001|Overall Study|Lost to Follow-up|1|||
125238206|NCT02327078|450500373|FG002|Overall Study|Lost to Follow-up|1|||
125238207|NCT02327078|450500374|FG003|Overall Study|Lost to Follow-up|0|||
125238208|NCT02327078|450500375|FG004|Overall Study|Lost to Follow-up|0|||
125238209|NCT02327078|450500376|FG005|Overall Study|Lost to Follow-up|0|||
125238210|NCT02327078|450500377|FG006|Overall Study|Lost to Follow-up|0|||
125238211|NCT02327078|450500378|FG007|Overall Study|Lost to Follow-up|2|||
125238212|NCT02327078|450500379|FG008|Overall Study|Lost to Follow-up|5|||
125238213|NCT02327078|450500371|FG000|Overall Study|Site Terminated by Sponsor|1|||
125238214|NCT02327078|450500372|FG001|Overall Study|Site Terminated by Sponsor|0|||
125238215|NCT02327078|450500373|FG002|Overall Study|Site Terminated by Sponsor|1|||
125238216|NCT02327078|450500374|FG003|Overall Study|Site Terminated by Sponsor|4|||
125238217|NCT02327078|450500375|FG004|Overall Study|Site Terminated by Sponsor|0|||
125238218|NCT02327078|450500376|FG005|Overall Study|Site Terminated by Sponsor|0|||
125238219|NCT02327078|450500377|FG006|Overall Study|Site Terminated by Sponsor|0|||
125238220|NCT02327078|450500378|FG007|Overall Study|Site Terminated by Sponsor|11|||
125238221|NCT02327078|450500379|FG008|Overall Study|Site Terminated by Sponsor|25|||
125238222|NCT02327078|450500371|FG000|Overall Study|Physician Decision|0|||
125238223|NCT02327078|450500372|FG001|Overall Study|Physician Decision|0|||
125238224|NCT02327078|450500373|FG002|Overall Study|Physician Decision|0|||
125238225|NCT02327078|450500374|FG003|Overall Study|Physician Decision|1|||
125238226|NCT02327078|450500375|FG004|Overall Study|Physician Decision|0|||
125238227|NCT02327078|450500376|FG005|Overall Study|Physician Decision|0|||
125238228|NCT02327078|450500377|FG006|Overall Study|Physician Decision|0|||
125238229|NCT02327078|450500378|FG007|Overall Study|Physician Decision|0|||
125238230|NCT02327078|450500379|FG008|Overall Study|Physician Decision|1|||
125238231|NCT02327078|450500371|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
125238232|NCT02327078|450500372|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
125238233|NCT02327078|450500373|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
125238234|NCT02327078|450500374|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
125238235|NCT02327078|450500375|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
125238236|NCT02327078|450500376|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
125238237|NCT02327078|450500377|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
125238238|NCT02327078|450500378|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
125238239|NCT02327078|450500379|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
125238240|NCT02327078|450500371|FG000|Overall Study|Reason not Specified|0|||
125238241|NCT02327078|450500372|FG001|Overall Study|Reason not Specified|0|||
125238242|NCT02327078|450500373|FG002|Overall Study|Reason not Specified|0|||
125238243|NCT02327078|450500374|FG003|Overall Study|Reason not Specified|0|||
125238244|NCT02327078|450500375|FG004|Overall Study|Reason not Specified|0|||
125238245|NCT02327078|450500376|FG005|Overall Study|Reason not Specified|0|||
125238246|NCT02327078|450500377|FG006|Overall Study|Reason not Specified|0|||
125238247|NCT02327078|450500378|FG007|Overall Study|Reason not Specified|5|||
125238248|NCT02327078|450500379|FG008|Overall Study|Reason not Specified|12|||
125238249|NCT05513950|450500380|FG000|Overall Study|Not treated due to technical reasons|0|||
125238250|NCT05513950|450500381|FG001|Overall Study|Not treated due to technical reasons|0|||
125238251|NCT05513950|450500382|FG002|Overall Study|Not treated due to technical reasons|1|||
125238252|NCT05513950|450500383|FG003|Overall Study|Not treated due to technical reasons|0|||
125185288|NCT03874117|450300760|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
125185289|NCT03874117|450300759|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
125185290|NCT03874117|450300760|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125185291|NCT03874117|450300759|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
125185292|NCT03874117|450300760|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
125238253|NCT06001866|450500384|FG000|Overall Study|Withdrawal by Subject|0|||
125238254|NCT06001866|450500385|FG001|Overall Study|Withdrawal by Subject|2|||
125185293|NCT03874117|450300759|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125185294|NCT03874117|450300760|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
125185295|NCT00813150|450300765|FG000|Treatment Period|Adverse Event|16|||
125185296|NCT00813150|450300766|FG001|Treatment Period|Adverse Event|15|||
125185297|NCT00813150|450300765|FG000|Treatment Period|Death|2|||
125185298|NCT00813150|450300766|FG001|Treatment Period|Death|0|||
125185299|NCT00813150|450300765|FG000|Treatment Period|Progressive disease|1|||
125185300|NCT00813150|450300766|FG001|Treatment Period|Progressive disease|0|||
125185301|NCT00813150|450300765|FG000|Treatment Period|Complete response|0|||
125185302|NCT00813150|450300766|FG001|Treatment Period|Complete response|1|||
125185303|NCT00813150|450300765|FG000|Treatment Period|Stable disease|1|||
125185304|NCT00813150|450300766|FG001|Treatment Period|Stable disease|2|||
125185305|NCT00813150|450300765|FG000|Treatment Period|Protocol Violation|3|||
125238255|NCT06001866|450500384|FG000|Overall Study|Protocol Violation|0|||
125238256|NCT06001866|450500385|FG001|Overall Study|Protocol Violation|2|||
125238257|NCT02903914|450500386|FG000|Overall Study|Adverse Event|0|||
125238258|NCT02903914|450500387|FG001|Overall Study|Adverse Event|0|||
125238259|NCT02903914|450500388|FG002|Overall Study|Adverse Event|1|||
125238260|NCT02903914|450500389|FG003|Overall Study|Adverse Event|0|||
125238261|NCT02903914|450500390|FG004|Overall Study|Adverse Event|0|||
125238262|NCT02903914|450500391|FG005|Overall Study|Adverse Event|0|||
125238263|NCT02903914|450500392|FG006|Overall Study|Adverse Event|2|||
125238264|NCT02903914|450500393|FG007|Overall Study|Adverse Event|0|||
125238265|NCT02903914|450500386|FG000|Overall Study|Withdrawal by Subject|3|||
125238266|NCT02903914|450500387|FG001|Overall Study|Withdrawal by Subject|1|||
125238267|NCT02903914|450500388|FG002|Overall Study|Withdrawal by Subject|28|||
125238268|NCT02903914|450500389|FG003|Overall Study|Withdrawal by Subject|0|||
125238269|NCT02903914|450500390|FG004|Overall Study|Withdrawal by Subject|1|||
125238270|NCT02903914|450500391|FG005|Overall Study|Withdrawal by Subject|2|||
125238271|NCT02903914|450500392|FG006|Overall Study|Withdrawal by Subject|12|||
125238272|NCT02903914|450500393|FG007|Overall Study|Withdrawal by Subject|0|||
125238273|NCT02903914|450500386|FG000|Overall Study|Progressive Disease|1|||
125238274|NCT02903914|450500387|FG001|Overall Study|Progressive Disease|0|||
125392484|NCT04809220|451070694|FG001|Overall Study|Adverse Event|0|||
125185306|NCT00813150|450300766|FG001|Treatment Period|Protocol Violation|4|||
125185307|NCT00813150|450300765|FG000|Treatment Period|Withdrawal by Subject|5|||
125185308|NCT00813150|450300766|FG001|Treatment Period|Withdrawal by Subject|3|||
125185309|NCT00813150|450300765|FG000|Treatment Period|Non compliance|0|||
125185310|NCT00813150|450300766|FG001|Treatment Period|Non compliance|1|||
125185311|NCT00813150|450300765|FG000|Treatment Period|Reason not specified|3|||
125185312|NCT00813150|450300766|FG001|Treatment Period|Reason not specified|4|||
125185313|NCT00813150|450300765|FG000|Treatment Period|Data not available|1|||
125185314|NCT00813150|450300766|FG001|Treatment Period|Data not available|2|||
125185315|NCT00813150|450300765|FG000|Long Term Follow-up|Death|0|||
125185316|NCT00813150|450300766|FG001|Long Term Follow-up|Death|4|||
125185317|NCT00813150|450300765|FG000|Long Term Follow-up|Other|0|||
125185318|NCT00813150|450300766|FG001|Long Term Follow-up|Other|3|||
125185319|NCT00813150|450300765|FG000|Long Term Follow-up|Lost to Follow-up|2|||
125238275|NCT02903914|450500388|FG002|Overall Study|Progressive Disease|4|||
125392485|NCT04809220|451070693|FG000|Overall Study|Death|1|||
125392486|NCT04809220|451070694|FG001|Overall Study|Death|0|||
125392487|NCT04809220|451070693|FG000|Overall Study|Lost to Follow-up|3|||
125392488|NCT04809220|451070694|FG001|Overall Study|Lost to Follow-up|0|||
125392489|NCT04809220|451070693|FG000|Overall Study|Physician Decision|0|||
125392490|NCT04809220|451070694|FG001|Overall Study|Physician Decision|1|||
125185320|NCT00813150|450300766|FG001|Long Term Follow-up|Lost to Follow-up|0|||
125238276|NCT02903914|450500389|FG003|Overall Study|Progressive Disease|0|||
125238277|NCT02903914|450500390|FG004|Overall Study|Progressive Disease|0|||
125238278|NCT02903914|450500391|FG005|Overall Study|Progressive Disease|0|||
125238279|NCT02903914|450500392|FG006|Overall Study|Progressive Disease|2|||
125392491|NCT04809220|451070693|FG000|Overall Study|Withdrawal by Subject|9|||
125185321|NCT00813150|450300765|FG000|Long Term Follow-up|Progression/Relapse|22|||
125185322|NCT00813150|450300766|FG001|Long Term Follow-up|Progression/Relapse|24|||
125185323|NCT03593525|450300780|FG000|Overall Study|Withdrawal by Subject|1|||
125185324|NCT03593525|450300781|FG001|Overall Study|Withdrawal by Subject|0|||
125185325|NCT03593525|450300780|FG000|Overall Study|Lost to Follow-up|7|||
125185326|NCT03593525|450300781|FG001|Overall Study|Lost to Follow-up|5|||
125185327|NCT03103087|450300782|FG000|Overall Study|Did not receive any study drug|1|||
125185328|NCT03103087|450300783|FG001|Overall Study|Did not receive any study drug|0|||
125185329|NCT03103087|450300784|FG002|Overall Study|Did not receive any study drug|0|||
125185330|NCT03103087|450300782|FG000|Overall Study|Protocol Violation|1|||
125185331|NCT03103087|450300783|FG001|Overall Study|Protocol Violation|2|||
125185332|NCT03103087|450300784|FG002|Overall Study|Protocol Violation|1|||
125185333|NCT03103087|450300782|FG000|Overall Study|Lack of Efficacy|2|||
125185334|NCT03103087|450300783|FG001|Overall Study|Lack of Efficacy|1|||
125185335|NCT03103087|450300784|FG002|Overall Study|Lack of Efficacy|1|||
125185336|NCT03103087|450300782|FG000|Overall Study|Pregnancy|0|||
125185337|NCT03103087|450300783|FG001|Overall Study|Pregnancy|0|||
125185338|NCT03103087|450300784|FG002|Overall Study|Pregnancy|1|||
125185339|NCT03103087|450300782|FG000|Overall Study|Adverse Event|2|||
125185340|NCT03103087|450300783|FG001|Overall Study|Adverse Event|15|||
125185341|NCT03103087|450300784|FG002|Overall Study|Adverse Event|6|||
125185342|NCT03103087|450300782|FG000|Overall Study|Withdrawal by Subject|13|||
125185343|NCT03103087|450300783|FG001|Overall Study|Withdrawal by Subject|6|||
125185344|NCT03103087|450300784|FG002|Overall Study|Withdrawal by Subject|6|||
125185345|NCT03103087|450300782|FG000|Overall Study|Lost to Follow-up|4|||
125185346|NCT03103087|450300783|FG001|Overall Study|Lost to Follow-up|2|||
125185347|NCT03103087|450300784|FG002|Overall Study|Lost to Follow-up|7|||
125185348|NCT03103087|450300782|FG000|Overall Study|Other reason not reported|1|||
125185349|NCT03103087|450300783|FG001|Overall Study|Other reason not reported|3|||
125185350|NCT03103087|450300784|FG002|Overall Study|Other reason not reported|5|||
125185351|NCT00075816|450300785|FG000|Overall Study|Did not undergo transplantation|14|||
125185352|NCT00075816|450300786|FG001|Overall Study|Did not undergo transplantation|11|||
125185353|NCT01892501|450300787|FG000|Overall Study|Protocol Violation|2|||
125185354|NCT01892501|450300787|FG000|Overall Study|Puncture not carried out|9|||
125185355|NCT01892501|450300787|FG000|Overall Study|Radiological monitoring not carried out|5|||
125185356|NCT01892501|450300787|FG000|Overall Study|Non-contributory histological result|12|||
125185357|NCT02549859|450300788|FG000|Long-term 60 Hz DBS|Study Closed|1|||
125185358|NCT03664232|450300790|FG000|Overall Study|Withdrawal by Subject|0|||
125185359|NCT03664232|450300791|FG001|Overall Study|Withdrawal by Subject|1|||
125185360|NCT03664232|450300792|FG002|Overall Study|Withdrawal by Subject|0|||
125185361|NCT03664232|450300793|FG003|Overall Study|Withdrawal by Subject|1|||
125185362|NCT03664232|450300790|FG000|Overall Study|Adverse Event|0|||
125185363|NCT03664232|450300791|FG001|Overall Study|Adverse Event|0|||
125185364|NCT03664232|450300792|FG002|Overall Study|Adverse Event|1|||
125185365|NCT03664232|450300793|FG003|Overall Study|Adverse Event|0|||
125185366|NCT03664232|450300790|FG000|Overall Study|Other-Non-compliance with study drug|0|||
125185367|NCT03664232|450300791|FG001|Overall Study|Other-Non-compliance with study drug|1|||
125185368|NCT03664232|450300792|FG002|Overall Study|Other-Non-compliance with study drug|0|||
125185369|NCT03664232|450300793|FG003|Overall Study|Other-Non-compliance with study drug|2|||
125185370|NCT03664232|450300790|FG000|Overall Study|Other-Unspecified|0|||
125185371|NCT03664232|450300791|FG001|Overall Study|Other-Unspecified|3|||
125185372|NCT03664232|450300792|FG002|Overall Study|Other-Unspecified|0|||
125185373|NCT03664232|450300793|FG003|Overall Study|Other-Unspecified|1|||
125185374|NCT03664232|450300790|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
125185375|NCT03664232|450300791|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
125185376|NCT03664232|450300792|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
125185377|NCT03664232|450300793|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
125185378|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
125185379|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
125185380|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
125185381|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
125185382|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
125185383|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185384|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185385|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185386|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185387|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185388|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185389|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125238280|NCT02903914|450500393|FG007|Overall Study|Progressive Disease|0|||
125238281|NCT02903914|450500386|FG000|Overall Study|Death|0|||
125392492|NCT04809220|451070694|FG001|Overall Study|Withdrawal by Subject|5|||
125238282|NCT02903914|450500387|FG001|Overall Study|Death|0|||
125238283|NCT02903914|450500388|FG002|Overall Study|Death|9|||
125238284|NCT02903914|450500389|FG003|Overall Study|Death|0|||
125238285|NCT02903914|450500390|FG004|Overall Study|Death|1|||
125238286|NCT02903914|450500391|FG005|Overall Study|Death|3|||
125238287|NCT02903914|450500392|FG006|Overall Study|Death|24|||
125238288|NCT02903914|450500393|FG007|Overall Study|Death|2|||
125238289|NCT02903914|450500386|FG000|Overall Study|Lost to Follow-up|0|||
125238290|NCT02903914|450500387|FG001|Overall Study|Lost to Follow-up|1|||
125238291|NCT02903914|450500388|FG002|Overall Study|Lost to Follow-up|0|||
125238292|NCT02903914|450500389|FG003|Overall Study|Lost to Follow-up|0|||
125238293|NCT02903914|450500390|FG004|Overall Study|Lost to Follow-up|2|||
125238294|NCT02903914|450500391|FG005|Overall Study|Lost to Follow-up|0|||
125238295|NCT02903914|450500392|FG006|Overall Study|Lost to Follow-up|1|||
125238296|NCT02903914|450500393|FG007|Overall Study|Lost to Follow-up|0|||
125238297|NCT02903914|450500386|FG000|Overall Study|Physician Decision|0|||
125238298|NCT02903914|450500387|FG001|Overall Study|Physician Decision|0|||
125238299|NCT02903914|450500388|FG002|Overall Study|Physician Decision|1|||
125238300|NCT02903914|450500389|FG003|Overall Study|Physician Decision|0|||
125238301|NCT02903914|450500390|FG004|Overall Study|Physician Decision|0|||
125238302|NCT02903914|450500391|FG005|Overall Study|Physician Decision|0|||
125238303|NCT02903914|450500392|FG006|Overall Study|Physician Decision|1|||
125238304|NCT02903914|450500393|FG007|Overall Study|Physician Decision|0|||
125238305|NCT02903914|450500386|FG000|Overall Study|Symptomatic Deterioration|0|||
125238306|NCT02903914|450500387|FG001|Overall Study|Symptomatic Deterioration|0|||
125238307|NCT02903914|450500388|FG002|Overall Study|Symptomatic Deterioration|1|||
125238308|NCT02903914|450500389|FG003|Overall Study|Symptomatic Deterioration|0|||
125238309|NCT02903914|450500390|FG004|Overall Study|Symptomatic Deterioration|0|||
125238310|NCT02903914|450500391|FG005|Overall Study|Symptomatic Deterioration|0|||
125238311|NCT02903914|450500392|FG006|Overall Study|Symptomatic Deterioration|0|||
125238312|NCT02903914|450500393|FG007|Overall Study|Symptomatic Deterioration|0|||
125238313|NCT02903914|450500386|FG000|Overall Study|New Cancer Therapy|2|||
125238314|NCT02903914|450500387|FG001|Overall Study|New Cancer Therapy|2|||
125238315|NCT02903914|450500388|FG002|Overall Study|New Cancer Therapy|21|||
125238316|NCT02903914|450500389|FG003|Overall Study|New Cancer Therapy|4|||
125238317|NCT02903914|450500390|FG004|Overall Study|New Cancer Therapy|3|||
125238318|NCT02903914|450500391|FG005|Overall Study|New Cancer Therapy|6|||
125238319|NCT02903914|450500392|FG006|Overall Study|New Cancer Therapy|56|||
125238320|NCT02903914|450500393|FG007|Overall Study|New Cancer Therapy|3|||
125238321|NCT02903914|450500386|FG000|Overall Study|Didn't Return to Site|1|||
125238322|NCT02903914|450500387|FG001|Overall Study|Didn't Return to Site|0|||
125238323|NCT02903914|450500388|FG002|Overall Study|Didn't Return to Site|1|||
125238324|NCT02903914|450500389|FG003|Overall Study|Didn't Return to Site|1|||
125238325|NCT02903914|450500390|FG004|Overall Study|Didn't Return to Site|0|||
125238326|NCT02903914|450500391|FG005|Overall Study|Didn't Return to Site|0|||
125238327|NCT02903914|450500392|FG006|Overall Study|Didn't Return to Site|2|||
125238328|NCT02903914|450500393|FG007|Overall Study|Didn't Return to Site|0|||
125238329|NCT02903914|450500386|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
125238330|NCT02903914|450500387|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
125238331|NCT02903914|450500388|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
125238332|NCT02903914|450500389|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
125238333|NCT02903914|450500390|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
125238334|NCT02903914|450500391|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
125238335|NCT02903914|450500392|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
125238336|NCT02903914|450500393|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
125238337|NCT02903914|450500386|FG000|Overall Study|Follow-up Did Not Occur|0|||
125238338|NCT02903914|450500387|FG001|Overall Study|Follow-up Did Not Occur|1|||
125238339|NCT02903914|450500388|FG002|Overall Study|Follow-up Did Not Occur|1|||
125238340|NCT02903914|450500389|FG003|Overall Study|Follow-up Did Not Occur|0|||
125238341|NCT02903914|450500390|FG004|Overall Study|Follow-up Did Not Occur|2|||
125238342|NCT02903914|450500391|FG005|Overall Study|Follow-up Did Not Occur|0|||
125238343|NCT02903914|450500392|FG006|Overall Study|Follow-up Did Not Occur|8|||
125238344|NCT02903914|450500393|FG007|Overall Study|Follow-up Did Not Occur|0|||
125238345|NCT02903914|450500386|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
125238346|NCT02903914|450500387|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
125238347|NCT02903914|450500388|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
125238348|NCT02903914|450500389|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
125238349|NCT02903914|450500390|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
125238350|NCT02903914|450500391|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
125238351|NCT02903914|450500392|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
125238352|NCT02903914|450500393|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
125238353|NCT02903914|450500386|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
125238354|NCT02903914|450500387|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
125238355|NCT02903914|450500388|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
125238356|NCT02903914|450500389|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
125238357|NCT02903914|450500390|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
125238358|NCT02903914|450500391|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
125238359|NCT02903914|450500392|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
125238360|NCT02903914|450500393|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
125238361|NCT02903914|450500386|FG000|Overall Study|Clinical Disease Progression|0|||
125238362|NCT02903914|450500387|FG001|Overall Study|Clinical Disease Progression|0|||
125238363|NCT02903914|450500388|FG002|Overall Study|Clinical Disease Progression|2|||
125238364|NCT02903914|450500389|FG003|Overall Study|Clinical Disease Progression|0|||
125238365|NCT02903914|450500390|FG004|Overall Study|Clinical Disease Progression|0|||
125238366|NCT02903914|450500391|FG005|Overall Study|Clinical Disease Progression|0|||
125238367|NCT02903914|450500392|FG006|Overall Study|Clinical Disease Progression|0|||
125238368|NCT02903914|450500393|FG007|Overall Study|Clinical Disease Progression|0|||
125238369|NCT02903914|450500386|FG000|Overall Study|Completed Follow-up Period|0|||
125238370|NCT02903914|450500387|FG001|Overall Study|Completed Follow-up Period|0|||
125238371|NCT02903914|450500388|FG002|Overall Study|Completed Follow-up Period|6|||
125238372|NCT02903914|450500389|FG003|Overall Study|Completed Follow-up Period|2|||
125238373|NCT02903914|450500390|FG004|Overall Study|Completed Follow-up Period|1|||
125238374|NCT02903914|450500391|FG005|Overall Study|Completed Follow-up Period|0|||
125238375|NCT02903914|450500392|FG006|Overall Study|Completed Follow-up Period|9|||
125238376|NCT02903914|450500393|FG007|Overall Study|Completed Follow-up Period|1|||
125238377|NCT02903914|450500386|FG000|Overall Study|Taken off Treatment per Protocol|0|||
125238378|NCT02903914|450500387|FG001|Overall Study|Taken off Treatment per Protocol|0|||
125238379|NCT02903914|450500388|FG002|Overall Study|Taken off Treatment per Protocol|0|||
125238380|NCT02903914|450500389|FG003|Overall Study|Taken off Treatment per Protocol|0|||
125238381|NCT02903914|450500390|FG004|Overall Study|Taken off Treatment per Protocol|0|||
125238382|NCT02903914|450500391|FG005|Overall Study|Taken off Treatment per Protocol|1|||
125238383|NCT02903914|450500392|FG006|Overall Study|Taken off Treatment per Protocol|0|||
125238384|NCT02903914|450500393|FG007|Overall Study|Taken off Treatment per Protocol|0|||
125238385|NCT02903914|450500386|FG000|Overall Study|Refused Further Treatment/Contact|0|||
125238386|NCT02903914|450500387|FG001|Overall Study|Refused Further Treatment/Contact|0|||
125238387|NCT02903914|450500388|FG002|Overall Study|Refused Further Treatment/Contact|0|||
125238388|NCT02903914|450500389|FG003|Overall Study|Refused Further Treatment/Contact|0|||
125238389|NCT02903914|450500390|FG004|Overall Study|Refused Further Treatment/Contact|0|||
125238390|NCT02903914|450500391|FG005|Overall Study|Refused Further Treatment/Contact|0|||
125238391|NCT02903914|450500392|FG006|Overall Study|Refused Further Treatment/Contact|1|||
125238392|NCT02903914|450500393|FG007|Overall Study|Refused Further Treatment/Contact|0|||
125238393|NCT02903914|450500386|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238394|NCT02903914|450500387|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238395|NCT02903914|450500388|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238396|NCT02903914|450500389|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238397|NCT02903914|450500390|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238398|NCT02903914|450500391|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238399|NCT02903914|450500392|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
125238400|NCT02903914|450500393|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
125238401|NCT04725188|450500396|FG000|Overall Study|Death|72|||
125238402|NCT04725188|450500397|FG001|Overall Study|Death|69|||
125238403|NCT04725188|450500398|FG002|Overall Study|Death|76|||
125238404|NCT04725188|450500396|FG000|Overall Study|Lost to Follow-up|1|||
125238405|NCT04725188|450500397|FG001|Overall Study|Lost to Follow-up|0|||
125238406|NCT04725188|450500398|FG002|Overall Study|Lost to Follow-up|1|||
125238407|NCT04725188|450500396|FG000|Overall Study|Withdrawal by Subject|2|||
125238408|NCT04725188|450500397|FG001|Overall Study|Withdrawal by Subject|2|||
125185390|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185391|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185392|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
125185393|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
125238409|NCT04725188|450500398|FG002|Overall Study|Withdrawal by Subject|1|||
125238410|NCT04725188|450500396|FG000|Overall Study|Sponsor Decision|12|||
125238411|NCT04725188|450500397|FG001|Overall Study|Sponsor Decision|12|||
125238412|NCT04725188|450500398|FG002|Overall Study|Sponsor Decision|7|||
125238413|NCT03765073|450500399|FG000|Stage 1|Lost to Follow-up|1|||
125238414|NCT03765073|450500400|FG001|Stage 1|Lost to Follow-up|0|||
125238415|NCT03765073|450500401|FG002|Stage 1|Lost to Follow-up|0|||
125238416|NCT03765073|450500402|FG003|Stage 1|Lost to Follow-up|0|||
125238417|NCT03765073|450500403|FG004|Stage 1|Lost to Follow-up|0|||
125238418|NCT03765073|450500404|FG005|Stage 1|Lost to Follow-up|0|||
125238419|NCT03765073|450500405|FG006|Stage 1|Lost to Follow-up|0|||
125238420|NCT03765073|450500406|FG007|Stage 1|Lost to Follow-up|0|||
125238421|NCT03765073|450500407|FG008|Stage 1|Lost to Follow-up|0|||
125238422|NCT03765073|450500408|FG009|Stage 1|Lost to Follow-up|0|||
125238423|NCT03765073|450500409|FG010|Stage 1|Lost to Follow-up|0|||
125238424|NCT03765073|450500410|FG011|Stage 1|Lost to Follow-up|0|||
125238425|NCT03765073|450500411|FG012|Stage 1|Lost to Follow-up|0|||
125185394|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
125185395|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
125185396|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
125185397|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
125185398|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185399|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185400|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185401|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185402|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185403|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185404|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185405|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185406|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185407|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
125185408|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
125185409|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
125185410|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
125185411|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
125185412|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
125185413|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185414|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185415|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185416|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185417|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185418|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185419|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185420|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185421|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185422|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
125185423|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
125185424|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
125185425|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
125185426|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
125185427|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
125185428|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185429|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185430|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185431|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185432|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185433|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185434|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185435|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185436|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185437|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
125185438|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
125185439|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185440|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
125185441|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
125185442|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
125185443|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185444|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185445|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185446|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185447|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185448|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185449|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125238426|NCT03765073|450500412|FG013|Stage 1|Lost to Follow-up|0|||
125238427|NCT03765073|450500413|FG014|Stage 1|Lost to Follow-up|0|||
125238428|NCT03765073|450500414|FG015|Stage 1|Lost to Follow-up|0|||
125238429|NCT03765073|450500415|FG016|Stage 1|Lost to Follow-up|0|||
125238430|NCT03765073|450500416|FG017|Stage 1|Lost to Follow-up|0|||
125238431|NCT03765073|450500417|FG018|Stage 1|Lost to Follow-up|0|||
125443444|NCT02555371|451252128|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
125443445|NCT02555371|451252129|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
125185450|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185451|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185452|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
125185453|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185454|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185455|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185456|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
125185457|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185458|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185459|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185460|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185461|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185462|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185463|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185464|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185465|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185466|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185467|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
125185468|NCT03334435|450300794|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185469|NCT03334435|450300795|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
125185470|NCT03334435|450300796|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
125185471|NCT03334435|450300797|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
125185472|NCT03334435|450300798|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
125185473|NCT03334435|450300799|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185474|NCT03334435|450300800|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185475|NCT03334435|450300801|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185476|NCT03334435|450300802|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185477|NCT03334435|450300803|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185478|NCT03334435|450300804|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185479|NCT03334435|450300805|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185480|NCT03334435|450300806|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185481|NCT03334435|450300807|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185482|NCT03334435|450300808|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
125185483|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
125185484|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
125185485|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
125185486|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
125185487|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
125185488|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
125185489|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
125185490|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
125185491|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
125185492|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
125185493|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
125185494|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
125185495|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
125185496|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
125185497|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
125185498|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
125185499|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
125185500|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
125185501|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
125185502|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
125185503|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
125185504|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
125185505|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
125185506|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
125185507|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
125185508|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
125185509|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
125185510|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
125185511|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
125185512|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
125185513|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
125185514|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
125238432|NCT03765073|450500418|FG019|Stage 1|Lost to Follow-up|0|||
125238433|NCT03765073|450500419|FG020|Stage 1|Lost to Follow-up|0|||
125238434|NCT03765073|450500399|FG000|Stage 1|Withdrawal by participant|0|||
125238435|NCT03765073|450500400|FG001|Stage 1|Withdrawal by participant|1|||
125238436|NCT03765073|450500401|FG002|Stage 1|Withdrawal by participant|0|||
125238437|NCT03765073|450500402|FG003|Stage 1|Withdrawal by participant|0|||
125238438|NCT03765073|450500403|FG004|Stage 1|Withdrawal by participant|0|||
125238439|NCT03765073|450500404|FG005|Stage 1|Withdrawal by participant|0|||
125238440|NCT03765073|450500405|FG006|Stage 1|Withdrawal by participant|0|||
125238441|NCT03765073|450500406|FG007|Stage 1|Withdrawal by participant|0|||
125238442|NCT03765073|450500407|FG008|Stage 1|Withdrawal by participant|0|||
125238443|NCT03765073|450500408|FG009|Stage 1|Withdrawal by participant|0|||
125238444|NCT03765073|450500409|FG010|Stage 1|Withdrawal by participant|0|||
125238445|NCT03765073|450500410|FG011|Stage 1|Withdrawal by participant|0|||
125238446|NCT03765073|450500411|FG012|Stage 1|Withdrawal by participant|0|||
125238447|NCT03765073|450500412|FG013|Stage 1|Withdrawal by participant|0|||
125238448|NCT03765073|450500413|FG014|Stage 1|Withdrawal by participant|0|||
125238449|NCT03765073|450500414|FG015|Stage 1|Withdrawal by participant|0|||
125238450|NCT03765073|450500415|FG016|Stage 1|Withdrawal by participant|0|||
125238451|NCT03765073|450500416|FG017|Stage 1|Withdrawal by participant|0|||
125238452|NCT03765073|450500417|FG018|Stage 1|Withdrawal by participant|0|||
125238453|NCT03765073|450500418|FG019|Stage 1|Withdrawal by participant|0|||
125238454|NCT03765073|450500419|FG020|Stage 1|Withdrawal by participant|0|||
125238455|NCT03765073|450500399|FG000|Stage 2|Death|0|||
125238456|NCT03765073|450500400|FG001|Stage 2|Death|0|||
125238457|NCT03765073|450500401|FG002|Stage 2|Death|0|||
125238458|NCT03765073|450500402|FG003|Stage 2|Death|0|||
125238459|NCT03765073|450500403|FG004|Stage 2|Death|0|||
125238460|NCT03765073|450500404|FG005|Stage 2|Death|0|||
125238461|NCT03765073|450500405|FG006|Stage 2|Death|0|||
125238462|NCT03765073|450500406|FG007|Stage 2|Death|0|||
125238463|NCT03765073|450500407|FG008|Stage 2|Death|0|||
125238464|NCT03765073|450500408|FG009|Stage 2|Death|1|||
125238465|NCT03765073|450500409|FG010|Stage 2|Death|0|||
125238466|NCT03765073|450500410|FG011|Stage 2|Death|1|||
125238467|NCT03765073|450500411|FG012|Stage 2|Death|0|||
125238468|NCT03765073|450500412|FG013|Stage 2|Death|0|||
125238469|NCT03765073|450500413|FG014|Stage 2|Death|0|||
125238470|NCT03765073|450500414|FG015|Stage 2|Death|0|||
125238471|NCT03765073|450500415|FG016|Stage 2|Death|2|||
125238472|NCT03765073|450500416|FG017|Stage 2|Death|0|||
125238473|NCT03765073|450500417|FG018|Stage 2|Death|0|||
125238474|NCT03765073|450500418|FG019|Stage 2|Death|0|||
125238475|NCT03765073|450500419|FG020|Stage 2|Death|0|||
125238476|NCT03765073|450500399|FG000|Stage 2|Lost to Follow-up|0|||
125238477|NCT03765073|450500400|FG001|Stage 2|Lost to Follow-up|0|||
125238478|NCT03765073|450500401|FG002|Stage 2|Lost to Follow-up|0|||
125238479|NCT03765073|450500402|FG003|Stage 2|Lost to Follow-up|5|||
125238480|NCT03765073|450500403|FG004|Stage 2|Lost to Follow-up|1|||
125238481|NCT03765073|450500404|FG005|Stage 2|Lost to Follow-up|0|||
125238482|NCT03765073|450500405|FG006|Stage 2|Lost to Follow-up|3|||
125238483|NCT03765073|450500406|FG007|Stage 2|Lost to Follow-up|3|||
125238484|NCT03765073|450500407|FG008|Stage 2|Lost to Follow-up|1|||
125238485|NCT03765073|450500408|FG009|Stage 2|Lost to Follow-up|6|||
125238486|NCT03765073|450500409|FG010|Stage 2|Lost to Follow-up|5|||
125238487|NCT03765073|450500410|FG011|Stage 2|Lost to Follow-up|1|||
125238488|NCT03765073|450500411|FG012|Stage 2|Lost to Follow-up|1|||
125238489|NCT03765073|450500412|FG013|Stage 2|Lost to Follow-up|3|||
125238490|NCT03765073|450500413|FG014|Stage 2|Lost to Follow-up|3|||
125238491|NCT03765073|450500414|FG015|Stage 2|Lost to Follow-up|1|||
125238492|NCT03765073|450500415|FG016|Stage 2|Lost to Follow-up|6|||
125238493|NCT03765073|450500416|FG017|Stage 2|Lost to Follow-up|0|||
125238494|NCT03765073|450500417|FG018|Stage 2|Lost to Follow-up|0|||
125238495|NCT03765073|450500418|FG019|Stage 2|Lost to Follow-up|0|||
125238496|NCT03765073|450500419|FG020|Stage 2|Lost to Follow-up|0|||
125238497|NCT03765073|450500399|FG000|Stage 2|Other|0|||
125238498|NCT03765073|450500400|FG001|Stage 2|Other|0|||
125238499|NCT03765073|450500401|FG002|Stage 2|Other|0|||
125238500|NCT03765073|450500402|FG003|Stage 2|Other|0|||
125238501|NCT03765073|450500403|FG004|Stage 2|Other|0|||
125238502|NCT03765073|450500404|FG005|Stage 2|Other|0|||
125238503|NCT03765073|450500405|FG006|Stage 2|Other|0|||
125238504|NCT03765073|450500406|FG007|Stage 2|Other|1|||
125238505|NCT03765073|450500407|FG008|Stage 2|Other|1|||
125238506|NCT03765073|450500408|FG009|Stage 2|Other|3|||
125238507|NCT03765073|450500409|FG010|Stage 2|Other|0|||
125238508|NCT03765073|450500410|FG011|Stage 2|Other|0|||
125238509|NCT03765073|450500411|FG012|Stage 2|Other|0|||
125238510|NCT03765073|450500412|FG013|Stage 2|Other|0|||
125238511|NCT03765073|450500413|FG014|Stage 2|Other|0|||
125238512|NCT03765073|450500414|FG015|Stage 2|Other|1|||
125238513|NCT03765073|450500415|FG016|Stage 2|Other|2|||
125238514|NCT03765073|450500416|FG017|Stage 2|Other|0|||
125238515|NCT03765073|450500417|FG018|Stage 2|Other|0|||
125238516|NCT03765073|450500418|FG019|Stage 2|Other|0|||
125238517|NCT03765073|450500419|FG020|Stage 2|Other|0|||
125238518|NCT03765073|450500399|FG000|Stage 2|Withdrawal by parent/guardian|0|||
125238519|NCT03765073|450500400|FG001|Stage 2|Withdrawal by parent/guardian|0|||
125238520|NCT03765073|450500401|FG002|Stage 2|Withdrawal by parent/guardian|0|||
125185515|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
125185516|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
125185517|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
125185518|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
125185519|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
125185520|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
125185521|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
125185522|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
125185523|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
125185524|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
125185525|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
125185526|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
125185527|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
125185528|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
125185529|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
125185530|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
125185531|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
125185532|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
125185533|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
125185534|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
125185535|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
125185536|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
125185537|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
125185538|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
125185539|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
125185540|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
125185541|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
125185542|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
125185543|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185544|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185545|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185546|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185547|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185548|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185549|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
125185550|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
125185551|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
125185552|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
125185553|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
125185554|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
125185555|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
125185556|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
125185557|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
125185558|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185559|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185560|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185561|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185562|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185563|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185564|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185565|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185566|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185567|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185568|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185569|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
125185570|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185571|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
125185572|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
125185573|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185574|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185575|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185576|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
125238521|NCT03765073|450500402|FG003|Stage 2|Withdrawal by parent/guardian|0|||
125238522|NCT03765073|450500403|FG004|Stage 2|Withdrawal by parent/guardian|0|||
125238523|NCT03765073|450500404|FG005|Stage 2|Withdrawal by parent/guardian|0|||
125238524|NCT03765073|450500405|FG006|Stage 2|Withdrawal by parent/guardian|0|||
125238525|NCT03765073|450500406|FG007|Stage 2|Withdrawal by parent/guardian|0|||
125238526|NCT03765073|450500407|FG008|Stage 2|Withdrawal by parent/guardian|0|||
125238527|NCT03765073|450500408|FG009|Stage 2|Withdrawal by parent/guardian|0|||
125238528|NCT03765073|450500409|FG010|Stage 2|Withdrawal by parent/guardian|3|||
125238529|NCT03765073|450500410|FG011|Stage 2|Withdrawal by parent/guardian|3|||
125238530|NCT03765073|450500411|FG012|Stage 2|Withdrawal by parent/guardian|3|||
125238531|NCT03765073|450500412|FG013|Stage 2|Withdrawal by parent/guardian|1|||
125238532|NCT03765073|450500413|FG014|Stage 2|Withdrawal by parent/guardian|1|||
125238533|NCT03765073|450500414|FG015|Stage 2|Withdrawal by parent/guardian|0|||
125238534|NCT03765073|450500415|FG016|Stage 2|Withdrawal by parent/guardian|3|||
125238535|NCT03765073|450500416|FG017|Stage 2|Withdrawal by parent/guardian|0|||
125238536|NCT03765073|450500417|FG018|Stage 2|Withdrawal by parent/guardian|0|||
125238537|NCT03765073|450500418|FG019|Stage 2|Withdrawal by parent/guardian|0|||
125238538|NCT03765073|450500419|FG020|Stage 2|Withdrawal by parent/guardian|0|||
125238539|NCT03765073|450500399|FG000|Stage 2|Withdrawal by Subject|0|||
125238540|NCT03765073|450500400|FG001|Stage 2|Withdrawal by Subject|0|||
125238541|NCT03765073|450500401|FG002|Stage 2|Withdrawal by Subject|0|||
125238542|NCT03765073|450500402|FG003|Stage 2|Withdrawal by Subject|3|||
125238543|NCT03765073|450500403|FG004|Stage 2|Withdrawal by Subject|3|||
125238544|NCT03765073|450500404|FG005|Stage 2|Withdrawal by Subject|3|||
125238545|NCT03765073|450500405|FG006|Stage 2|Withdrawal by Subject|0|||
125238546|NCT03765073|450500406|FG007|Stage 2|Withdrawal by Subject|1|||
125238547|NCT03765073|450500407|FG008|Stage 2|Withdrawal by Subject|0|||
125238548|NCT03765073|450500408|FG009|Stage 2|Withdrawal by Subject|5|||
125238549|NCT03765073|450500409|FG010|Stage 2|Withdrawal by Subject|0|||
125238550|NCT03765073|450500410|FG011|Stage 2|Withdrawal by Subject|0|||
125238551|NCT03765073|450500411|FG012|Stage 2|Withdrawal by Subject|0|||
125238552|NCT03765073|450500412|FG013|Stage 2|Withdrawal by Subject|0|||
125238553|NCT03765073|450500413|FG014|Stage 2|Withdrawal by Subject|0|||
125238554|NCT03765073|450500414|FG015|Stage 2|Withdrawal by Subject|0|||
125238555|NCT03765073|450500415|FG016|Stage 2|Withdrawal by Subject|0|||
125238556|NCT03765073|450500416|FG017|Stage 2|Withdrawal by Subject|0|||
125238557|NCT03765073|450500417|FG018|Stage 2|Withdrawal by Subject|0|||
125238558|NCT03765073|450500418|FG019|Stage 2|Withdrawal by Subject|0|||
125238559|NCT03765073|450500419|FG020|Stage 2|Withdrawal by Subject|0|||
125238560|NCT03765073|450500399|FG000|Stage 3|Adverse Event|0|||
125238561|NCT03765073|450500400|FG001|Stage 3|Adverse Event|0|||
125238562|NCT03765073|450500401|FG002|Stage 3|Adverse Event|0|||
125238563|NCT03765073|450500402|FG003|Stage 3|Adverse Event|0|||
125238564|NCT03765073|450500403|FG004|Stage 3|Adverse Event|0|||
125238565|NCT03765073|450500404|FG005|Stage 3|Adverse Event|0|||
125238566|NCT03765073|450500405|FG006|Stage 3|Adverse Event|0|||
125238567|NCT03765073|450500406|FG007|Stage 3|Adverse Event|0|||
125238568|NCT03765073|450500407|FG008|Stage 3|Adverse Event|0|||
125238569|NCT03765073|450500408|FG009|Stage 3|Adverse Event|0|||
125238570|NCT03765073|450500409|FG010|Stage 3|Adverse Event|0|||
125238571|NCT03765073|450500410|FG011|Stage 3|Adverse Event|0|||
125238572|NCT03765073|450500411|FG012|Stage 3|Adverse Event|0|||
125238573|NCT03765073|450500412|FG013|Stage 3|Adverse Event|0|||
125238574|NCT03765073|450500413|FG014|Stage 3|Adverse Event|0|||
125238575|NCT03765073|450500414|FG015|Stage 3|Adverse Event|0|||
125238576|NCT03765073|450500415|FG016|Stage 3|Adverse Event|0|||
125238577|NCT03765073|450500416|FG017|Stage 3|Adverse Event|0|||
125238578|NCT03765073|450500417|FG018|Stage 3|Adverse Event|1|||
125238579|NCT03765073|450500418|FG019|Stage 3|Adverse Event|0|||
125238580|NCT03765073|450500419|FG020|Stage 3|Adverse Event|0|||
125238581|NCT03765073|450500399|FG000|Stage 3|Death|0|||
125238582|NCT03765073|450500400|FG001|Stage 3|Death|0|||
125238583|NCT03765073|450500401|FG002|Stage 3|Death|0|||
125238584|NCT03765073|450500402|FG003|Stage 3|Death|0|||
125238585|NCT03765073|450500403|FG004|Stage 3|Death|0|||
125238586|NCT03765073|450500404|FG005|Stage 3|Death|0|||
125238587|NCT03765073|450500405|FG006|Stage 3|Death|0|||
125238588|NCT03765073|450500406|FG007|Stage 3|Death|0|||
125238589|NCT03765073|450500407|FG008|Stage 3|Death|0|||
125238590|NCT03765073|450500408|FG009|Stage 3|Death|0|||
125238591|NCT03765073|450500409|FG010|Stage 3|Death|0|||
125238592|NCT03765073|450500410|FG011|Stage 3|Death|0|||
125238593|NCT03765073|450500411|FG012|Stage 3|Death|0|||
125238594|NCT03765073|450500412|FG013|Stage 3|Death|0|||
125238595|NCT03765073|450500413|FG014|Stage 3|Death|0|||
125238596|NCT03765073|450500414|FG015|Stage 3|Death|0|||
125238597|NCT03765073|450500415|FG016|Stage 3|Death|0|||
125238598|NCT03765073|450500416|FG017|Stage 3|Death|0|||
125238599|NCT03765073|450500417|FG018|Stage 3|Death|0|||
125238600|NCT03765073|450500418|FG019|Stage 3|Death|3|||
125238601|NCT03765073|450500419|FG020|Stage 3|Death|2|||
125238602|NCT03765073|450500399|FG000|Stage 3|Lost to Follow-up|0|||
125238603|NCT03765073|450500400|FG001|Stage 3|Lost to Follow-up|0|||
125238604|NCT03765073|450500401|FG002|Stage 3|Lost to Follow-up|0|||
125238605|NCT03765073|450500402|FG003|Stage 3|Lost to Follow-up|0|||
125238606|NCT03765073|450500403|FG004|Stage 3|Lost to Follow-up|0|||
125238607|NCT03765073|450500404|FG005|Stage 3|Lost to Follow-up|0|||
125238608|NCT03765073|450500405|FG006|Stage 3|Lost to Follow-up|0|||
125238609|NCT03765073|450500406|FG007|Stage 3|Lost to Follow-up|0|||
125238610|NCT03765073|450500407|FG008|Stage 3|Lost to Follow-up|0|||
125238611|NCT03765073|450500408|FG009|Stage 3|Lost to Follow-up|0|||
125238612|NCT03765073|450500409|FG010|Stage 3|Lost to Follow-up|0|||
125238613|NCT03765073|450500410|FG011|Stage 3|Lost to Follow-up|0|||
125238614|NCT03765073|450500411|FG012|Stage 3|Lost to Follow-up|0|||
125238615|NCT03765073|450500412|FG013|Stage 3|Lost to Follow-up|0|||
125238616|NCT03765073|450500413|FG014|Stage 3|Lost to Follow-up|0|||
125238617|NCT03765073|450500414|FG015|Stage 3|Lost to Follow-up|0|||
125238618|NCT03765073|450500415|FG016|Stage 3|Lost to Follow-up|0|||
125238619|NCT03765073|450500416|FG017|Stage 3|Lost to Follow-up|8|||
125238620|NCT03765073|450500417|FG018|Stage 3|Lost to Follow-up|5|||
125238621|NCT03765073|450500418|FG019|Stage 3|Lost to Follow-up|7|||
125238622|NCT03765073|450500419|FG020|Stage 3|Lost to Follow-up|4|||
125238623|NCT03765073|450500399|FG000|Stage 3|No longer meets eligibility criteria|0|||
125238624|NCT03765073|450500400|FG001|Stage 3|No longer meets eligibility criteria|0|||
125238625|NCT03765073|450500401|FG002|Stage 3|No longer meets eligibility criteria|0|||
125238626|NCT03765073|450500402|FG003|Stage 3|No longer meets eligibility criteria|0|||
125238627|NCT03765073|450500403|FG004|Stage 3|No longer meets eligibility criteria|0|||
125238628|NCT03765073|450500404|FG005|Stage 3|No longer meets eligibility criteria|0|||
125238629|NCT03765073|450500405|FG006|Stage 3|No longer meets eligibility criteria|0|||
125238630|NCT03765073|450500406|FG007|Stage 3|No longer meets eligibility criteria|0|||
125238631|NCT03765073|450500407|FG008|Stage 3|No longer meets eligibility criteria|0|||
125238632|NCT03765073|450500408|FG009|Stage 3|No longer meets eligibility criteria|0|||
125238633|NCT03765073|450500409|FG010|Stage 3|No longer meets eligibility criteria|0|||
125238634|NCT03765073|450500410|FG011|Stage 3|No longer meets eligibility criteria|0|||
125238635|NCT03765073|450500411|FG012|Stage 3|No longer meets eligibility criteria|0|||
125238636|NCT03765073|450500412|FG013|Stage 3|No longer meets eligibility criteria|0|||
125238637|NCT03765073|450500413|FG014|Stage 3|No longer meets eligibility criteria|0|||
125238638|NCT03765073|450500414|FG015|Stage 3|No longer meets eligibility criteria|0|||
125238639|NCT03765073|450500415|FG016|Stage 3|No longer meets eligibility criteria|0|||
125238640|NCT03765073|450500416|FG017|Stage 3|No longer meets eligibility criteria|0|||
125238641|NCT03765073|450500417|FG018|Stage 3|No longer meets eligibility criteria|1|||
125238642|NCT03765073|450500418|FG019|Stage 3|No longer meets eligibility criteria|0|||
125238643|NCT03765073|450500419|FG020|Stage 3|No longer meets eligibility criteria|1|||
125238644|NCT03765073|450500399|FG000|Stage 3|Other|0|||
125238645|NCT03765073|450500400|FG001|Stage 3|Other|0|||
125238646|NCT03765073|450500401|FG002|Stage 3|Other|0|||
125238647|NCT03765073|450500402|FG003|Stage 3|Other|0|||
125238648|NCT03765073|450500403|FG004|Stage 3|Other|0|||
125238649|NCT03765073|450500404|FG005|Stage 3|Other|0|||
125238650|NCT03765073|450500405|FG006|Stage 3|Other|0|||
125238651|NCT03765073|450500406|FG007|Stage 3|Other|0|||
125238652|NCT03765073|450500407|FG008|Stage 3|Other|0|||
125238653|NCT03765073|450500408|FG009|Stage 3|Other|0|||
125238654|NCT03765073|450500409|FG010|Stage 3|Other|0|||
125238655|NCT03765073|450500410|FG011|Stage 3|Other|0|||
125238656|NCT03765073|450500411|FG012|Stage 3|Other|0|||
125238657|NCT03765073|450500412|FG013|Stage 3|Other|0|||
125238658|NCT03765073|450500413|FG014|Stage 3|Other|0|||
125238659|NCT03765073|450500414|FG015|Stage 3|Other|0|||
125238660|NCT03765073|450500415|FG016|Stage 3|Other|0|||
125238661|NCT03765073|450500416|FG017|Stage 3|Other|1|||
125238662|NCT03765073|450500417|FG018|Stage 3|Other|2|||
125238663|NCT03765073|450500418|FG019|Stage 3|Other|2|||
125238664|NCT03765073|450500419|FG020|Stage 3|Other|2|||
125238665|NCT03765073|450500399|FG000|Stage 3|Withdrawal by parent/guardian|0|||
125238666|NCT03765073|450500400|FG001|Stage 3|Withdrawal by parent/guardian|0|||
125238667|NCT03765073|450500401|FG002|Stage 3|Withdrawal by parent/guardian|0|||
125238668|NCT03765073|450500402|FG003|Stage 3|Withdrawal by parent/guardian|0|||
125443446|NCT02555371|451252130|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
125238669|NCT03765073|450500403|FG004|Stage 3|Withdrawal by parent/guardian|0|||
125238670|NCT03765073|450500404|FG005|Stage 3|Withdrawal by parent/guardian|0|||
125238671|NCT03765073|450500405|FG006|Stage 3|Withdrawal by parent/guardian|0|||
125238672|NCT03765073|450500406|FG007|Stage 3|Withdrawal by parent/guardian|0|||
125238673|NCT03765073|450500407|FG008|Stage 3|Withdrawal by parent/guardian|0|||
125238674|NCT03765073|450500408|FG009|Stage 3|Withdrawal by parent/guardian|0|||
125238675|NCT03765073|450500409|FG010|Stage 3|Withdrawal by parent/guardian|0|||
125238676|NCT03765073|450500410|FG011|Stage 3|Withdrawal by parent/guardian|0|||
125238677|NCT03765073|450500411|FG012|Stage 3|Withdrawal by parent/guardian|0|||
125238678|NCT03765073|450500412|FG013|Stage 3|Withdrawal by parent/guardian|0|||
125238679|NCT03765073|450500413|FG014|Stage 3|Withdrawal by parent/guardian|0|||
125238680|NCT03765073|450500414|FG015|Stage 3|Withdrawal by parent/guardian|0|||
125238681|NCT03765073|450500415|FG016|Stage 3|Withdrawal by parent/guardian|0|||
125238682|NCT03765073|450500416|FG017|Stage 3|Withdrawal by parent/guardian|0|||
125238683|NCT03765073|450500417|FG018|Stage 3|Withdrawal by parent/guardian|0|||
125238684|NCT03765073|450500418|FG019|Stage 3|Withdrawal by parent/guardian|6|||
125238685|NCT03765073|450500419|FG020|Stage 3|Withdrawal by parent/guardian|9|||
125238686|NCT03765073|450500399|FG000|Stage 3|Withdrawal by Subject|0|||
125238687|NCT03765073|450500400|FG001|Stage 3|Withdrawal by Subject|0|||
125238688|NCT03765073|450500401|FG002|Stage 3|Withdrawal by Subject|0|||
125238689|NCT03765073|450500402|FG003|Stage 3|Withdrawal by Subject|0|||
125238690|NCT03765073|450500403|FG004|Stage 3|Withdrawal by Subject|0|||
125238691|NCT03765073|450500404|FG005|Stage 3|Withdrawal by Subject|0|||
125238692|NCT03765073|450500405|FG006|Stage 3|Withdrawal by Subject|0|||
125238693|NCT03765073|450500406|FG007|Stage 3|Withdrawal by Subject|0|||
125238694|NCT03765073|450500407|FG008|Stage 3|Withdrawal by Subject|0|||
125238695|NCT03765073|450500408|FG009|Stage 3|Withdrawal by Subject|0|||
125238696|NCT03765073|450500409|FG010|Stage 3|Withdrawal by Subject|0|||
125238697|NCT03765073|450500410|FG011|Stage 3|Withdrawal by Subject|0|||
125238698|NCT03765073|450500411|FG012|Stage 3|Withdrawal by Subject|0|||
125238699|NCT03765073|450500412|FG013|Stage 3|Withdrawal by Subject|0|||
125238700|NCT03765073|450500413|FG014|Stage 3|Withdrawal by Subject|0|||
125238701|NCT03765073|450500414|FG015|Stage 3|Withdrawal by Subject|0|||
125238702|NCT03765073|450500415|FG016|Stage 3|Withdrawal by Subject|0|||
125238703|NCT03765073|450500416|FG017|Stage 3|Withdrawal by Subject|8|||
125238704|NCT03765073|450500417|FG018|Stage 3|Withdrawal by Subject|11|||
125238705|NCT03765073|450500418|FG019|Stage 3|Withdrawal by Subject|0|||
125238706|NCT03765073|450500419|FG020|Stage 3|Withdrawal by Subject|0|||
125238707|NCT04225039|450500422|FG000|Overall Study|Withdrawal by Subject|1|||
125238708|NCT04225039|450500423|FG001|Overall Study|Withdrawal by Subject|0|||
125238709|NCT04225039|450500424|FG002|Overall Study|Withdrawal by Subject|0|||
125238710|NCT04225039|450500425|FG003|Overall Study|Withdrawal by Subject|1|||
125238711|NCT04225039|450500422|FG000|Overall Study|Currently active on study treatment|0|||
125238712|NCT04225039|450500423|FG001|Overall Study|Currently active on study treatment|1|||
125238713|NCT04225039|450500424|FG002|Overall Study|Currently active on study treatment|0|||
125238714|NCT04225039|450500425|FG003|Overall Study|Currently active on study treatment|0|||
125238715|NCT04225039|450500422|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
125238716|NCT04225039|450500423|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
125238717|NCT04225039|450500424|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
125238718|NCT04225039|450500425|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
125238719|NCT04225039|450500422|FG000|Overall Study|Ineligible for treatment|0|||
125238720|NCT04225039|450500423|FG001|Overall Study|Ineligible for treatment|0|||
125238721|NCT04225039|450500424|FG002|Overall Study|Ineligible for treatment|0|||
125238722|NCT04225039|450500425|FG003|Overall Study|Ineligible for treatment|4|||
125238723|NCT02225587|450500434|FG000|Overall Study|Adverse Event|5|||
125238724|NCT02225587|450500435|FG001|Overall Study|Adverse Event|5|||
125238725|NCT02225587|450500434|FG000|Overall Study|Lost to Follow-up|5|||
125238726|NCT02225587|450500435|FG001|Overall Study|Lost to Follow-up|5|||
125238727|NCT02225587|450500434|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125238728|NCT02225587|450500435|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125238729|NCT02225587|450500434|FG000|Overall Study|Physician Decision|2|||
125238730|NCT02225587|450500435|FG001|Overall Study|Physician Decision|0|||
125238731|NCT02225587|450500434|FG000|Overall Study|Protocol Violation|1|||
125238732|NCT02225587|450500435|FG001|Overall Study|Protocol Violation|0|||
125238733|NCT02225587|450500434|FG000|Overall Study|Participant Moved|1|||
125238734|NCT02225587|450500435|FG001|Overall Study|Participant Moved|0|||
125238735|NCT02225587|450500434|FG000|Overall Study|Withdrawal by Subject|13|||
125238736|NCT02225587|450500435|FG001|Overall Study|Withdrawal by Subject|28|||
125185577|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185578|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
125185579|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185580|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185581|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185582|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
125238737|NCT01933932|450500438|FG000|Overall Study|Death|173|||
125238738|NCT01933932|450500439|FG001|Overall Study|Death|163|||
125238739|NCT01933932|450500438|FG000|Overall Study|Withdrawal by Subject|11|||
125238740|NCT01933932|450500439|FG001|Overall Study|Withdrawal by Subject|14|||
125238741|NCT01933932|450500438|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125238742|NCT01933932|450500439|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125238743|NCT01564407|450500442|FG000|Overall Study|Lost to Follow-up|0|||
125238744|NCT01564407|450500443|FG001|Overall Study|Lost to Follow-up|1|||
125238745|NCT01564407|450500444|FG002|Overall Study|Lost to Follow-up|0|||
125238746|NCT01564407|450500445|FG003|Overall Study|Lost to Follow-up|0|||
125238747|NCT01564407|450500446|FG004|Overall Study|Lost to Follow-up|0|||
125238748|NCT01564407|450500442|FG000|Overall Study|Withdrawal by Subject|0|||
125238749|NCT01564407|450500443|FG001|Overall Study|Withdrawal by Subject|1|||
125238750|NCT01564407|450500444|FG002|Overall Study|Withdrawal by Subject|0|||
125238751|NCT01564407|450500445|FG003|Overall Study|Withdrawal by Subject|0|||
125238752|NCT01564407|450500446|FG004|Overall Study|Withdrawal by Subject|0|||
125238753|NCT01564407|450500442|FG000|Overall Study|funding lost, study ended|0|||
125238754|NCT01564407|450500443|FG001|Overall Study|funding lost, study ended|0|||
125185583|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
125238755|NCT01564407|450500444|FG002|Overall Study|funding lost, study ended|0|||
125238756|NCT01564407|450500445|FG003|Overall Study|funding lost, study ended|1|||
125238757|NCT01564407|450500446|FG004|Overall Study|funding lost, study ended|0|||
125238758|NCT03126110|450500447|FG000|Phase 1|Death|2|||
125238759|NCT03126110|450500448|FG001|Phase 1|Death|2|||
125238760|NCT03126110|450500449|FG002|Phase 1|Death|4|||
125238761|NCT03126110|450500450|FG003|Phase 1|Death|3|||
125238762|NCT03126110|450500451|FG004|Phase 1|Death|4|||
125238763|NCT03126110|450500452|FG005|Phase 1|Death|4|||
125238764|NCT03126110|450500453|FG006|Phase 1|Death|3|||
125238765|NCT03126110|450500454|FG007|Phase 1|Death|4|||
125238766|NCT03126110|450500455|FG008|Phase 1|Death|5|||
125238767|NCT03126110|450500456|FG009|Phase 1|Death|2|||
125238768|NCT03126110|450500457|FG010|Phase 1|Death|6|||
125238769|NCT03126110|450500458|FG011|Phase 1|Death|0|||
125238770|NCT03126110|450500459|FG012|Phase 1|Death|0|||
125185584|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185585|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185586|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
125185587|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
125185588|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185589|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185590|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185591|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185592|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185593|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
125185594|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
125185595|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
125185596|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
125185597|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
125185598|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
125185599|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
125185600|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185601|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185602|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
125185603|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185604|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185605|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185606|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185607|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185608|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
125185609|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
125185610|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185611|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185612|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185613|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
125185614|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
125185615|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
125185616|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
125185617|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
125185618|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185619|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185620|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185621|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185622|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185623|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
125185624|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185625|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185626|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185627|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185628|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
125185629|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185630|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125185631|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
125238771|NCT03126110|450500460|FG013|Phase 1|Death|0|||
125238772|NCT03126110|450500461|FG014|Phase 1|Death|0|||
125238773|NCT03126110|450500462|FG015|Phase 1|Death|0|||
125238774|NCT03126110|450500463|FG016|Phase 1|Death|0|||
125238775|NCT03126110|450500447|FG000|Phase 1|Lost to Follow-up|0|||
125185632|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
125185633|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185634|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185635|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185636|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185637|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185638|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185639|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185640|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
125185641|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
125185642|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185643|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
125185644|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
125185645|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
125185646|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185647|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
125185648|NCT03334435|450300794|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185649|NCT03334435|450300795|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185650|NCT03334435|450300796|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185651|NCT03334435|450300797|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185652|NCT03334435|450300798|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185653|NCT03334435|450300799|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185654|NCT03334435|450300800|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185655|NCT03334435|450300801|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185656|NCT03334435|450300802|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185657|NCT03334435|450300803|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185658|NCT03334435|450300804|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185659|NCT03334435|450300805|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
125185660|NCT03334435|450300806|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
125185661|NCT03334435|450300807|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
125185662|NCT03334435|450300808|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
125185663|NCT03922321|450300809|FG000|Overall Study|Participant Moved|1|||
125185664|NCT03922321|450300809|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
125185665|NCT04067050|450300817|FG000|One Month|Lost to Follow-up|4|||
125185666|NCT04067050|450300818|FG001|One Month|Lost to Follow-up|0|||
125185667|NCT04067050|450300817|FG000|Two Month|Lost to Follow-up|1|||
125185668|NCT04067050|450300818|FG001|Two Month|Lost to Follow-up|0|||
125185669|NCT04067050|450300817|FG000|Two Month|Adverse Event|1|||
125185670|NCT04067050|450300818|FG001|Two Month|Adverse Event|0|||
125185671|NCT02342678|450300823|FG000|Overall Study|Lost to Follow-up|0|||
125185672|NCT02342678|450300824|FG001|Overall Study|Lost to Follow-up|1|||
125185673|NCT02342678|450300823|FG000|Overall Study|Too busy to complete study|0|||
125185674|NCT02342678|450300824|FG001|Overall Study|Too busy to complete study|2|||
125185675|NCT02342678|450300823|FG000|Overall Study|Family illness/emergency|0|||
125185676|NCT02342678|450300824|FG001|Overall Study|Family illness/emergency|1|||
125185677|NCT02342678|450300823|FG000|Overall Study|Illness/medical reason|1|||
125185678|NCT02342678|450300824|FG001|Overall Study|Illness/medical reason|1|||
125185679|NCT02383017|450300825|FG000|Overall Study|Injury Sustained Outside Study|1|||
125185680|NCT02383017|450300826|FG001|Overall Study|Injury Sustained Outside Study|0|||
125185681|NCT02383017|450300825|FG000|Overall Study|Compliance|3|||
125185682|NCT02383017|450300826|FG001|Overall Study|Compliance|2|||
125185683|NCT02383017|450300825|FG000|Overall Study|Found to be Hypogonadal|1|||
125185684|NCT02383017|450300826|FG001|Overall Study|Found to be Hypogonadal|0|||
125185685|NCT01068860|450300827|FG000|Overall Study|Withdrawal by Subject|0|||
125185686|NCT01068860|450300828|FG001|Overall Study|Withdrawal by Subject|0|||
125185687|NCT01068860|450300829|FG002|Overall Study|Withdrawal by Subject|0|||
125185688|NCT01068860|450300830|FG003|Overall Study|Withdrawal by Subject|0|||
125185689|NCT01068860|450300831|FG004|Overall Study|Withdrawal by Subject|0|||
125185690|NCT01068860|450300832|FG005|Overall Study|Withdrawal by Subject|2|||
125185691|NCT01068860|450300833|FG006|Overall Study|Withdrawal by Subject|0|||
125185692|NCT01068860|450300834|FG007|Overall Study|Withdrawal by Subject|0|||
125185693|NCT01068860|450300835|FG008|Overall Study|Withdrawal by Subject|0|||
125185694|NCT01068860|450300836|FG009|Overall Study|Withdrawal by Subject|3|||
125185695|NCT01068860|450300827|FG000|Overall Study|Administrative problems; misrandomized|0|||
125185696|NCT01068860|450300828|FG001|Overall Study|Administrative problems; misrandomized|0|||
125185697|NCT01068860|450300829|FG002|Overall Study|Administrative problems; misrandomized|0|||
125185698|NCT01068860|450300830|FG003|Overall Study|Administrative problems; misrandomized|1|||
125238776|NCT03126110|450500448|FG001|Phase 1|Lost to Follow-up|1|||
125185699|NCT01068860|450300831|FG004|Overall Study|Administrative problems; misrandomized|0|||
125185700|NCT01068860|450300832|FG005|Overall Study|Administrative problems; misrandomized|0|||
125185701|NCT01068860|450300833|FG006|Overall Study|Administrative problems; misrandomized|0|||
125238777|NCT03126110|450500449|FG002|Phase 1|Lost to Follow-up|0|||
125238778|NCT03126110|450500450|FG003|Phase 1|Lost to Follow-up|0|||
125238779|NCT03126110|450500451|FG004|Phase 1|Lost to Follow-up|0|||
125238780|NCT03126110|450500452|FG005|Phase 1|Lost to Follow-up|0|||
125238781|NCT03126110|450500453|FG006|Phase 1|Lost to Follow-up|0|||
125238782|NCT03126110|450500454|FG007|Phase 1|Lost to Follow-up|0|||
125238783|NCT03126110|450500455|FG008|Phase 1|Lost to Follow-up|1|||
125238784|NCT03126110|450500456|FG009|Phase 1|Lost to Follow-up|0|||
125238785|NCT03126110|450500457|FG010|Phase 1|Lost to Follow-up|0|||
125238786|NCT03126110|450500458|FG011|Phase 1|Lost to Follow-up|0|||
125238787|NCT03126110|450500459|FG012|Phase 1|Lost to Follow-up|0|||
125238788|NCT03126110|450500460|FG013|Phase 1|Lost to Follow-up|0|||
125238789|NCT03126110|450500461|FG014|Phase 1|Lost to Follow-up|0|||
125238790|NCT03126110|450500462|FG015|Phase 1|Lost to Follow-up|0|||
125238791|NCT03126110|450500463|FG016|Phase 1|Lost to Follow-up|0|||
125238792|NCT03126110|450500447|FG000|Phase 1|Withdrawal by Subject|1|||
125238793|NCT03126110|450500448|FG001|Phase 1|Withdrawal by Subject|0|||
125238794|NCT03126110|450500449|FG002|Phase 1|Withdrawal by Subject|0|||
125238795|NCT03126110|450500450|FG003|Phase 1|Withdrawal by Subject|1|||
125238796|NCT03126110|450500451|FG004|Phase 1|Withdrawal by Subject|1|||
125238797|NCT03126110|450500452|FG005|Phase 1|Withdrawal by Subject|0|||
125238798|NCT03126110|450500453|FG006|Phase 1|Withdrawal by Subject|0|||
125238799|NCT03126110|450500454|FG007|Phase 1|Withdrawal by Subject|0|||
125238800|NCT03126110|450500455|FG008|Phase 1|Withdrawal by Subject|2|||
125238801|NCT03126110|450500456|FG009|Phase 1|Withdrawal by Subject|1|||
125238802|NCT03126110|450500457|FG010|Phase 1|Withdrawal by Subject|0|||
125238803|NCT03126110|450500458|FG011|Phase 1|Withdrawal by Subject|0|||
125238804|NCT03126110|450500459|FG012|Phase 1|Withdrawal by Subject|0|||
125238805|NCT03126110|450500460|FG013|Phase 1|Withdrawal by Subject|0|||
125238806|NCT03126110|450500461|FG014|Phase 1|Withdrawal by Subject|0|||
125238807|NCT03126110|450500462|FG015|Phase 1|Withdrawal by Subject|0|||
125238808|NCT03126110|450500463|FG016|Phase 1|Withdrawal by Subject|0|||
125238809|NCT03126110|450500447|FG000|Phase 1|Safety follow-up no longer necessary|1|||
125238810|NCT03126110|450500448|FG001|Phase 1|Safety follow-up no longer necessary|0|||
125238811|NCT03126110|450500449|FG002|Phase 1|Safety follow-up no longer necessary|0|||
125238812|NCT03126110|450500450|FG003|Phase 1|Safety follow-up no longer necessary|0|||
125238813|NCT03126110|450500451|FG004|Phase 1|Safety follow-up no longer necessary|0|||
125238814|NCT03126110|450500452|FG005|Phase 1|Safety follow-up no longer necessary|0|||
125238815|NCT03126110|450500453|FG006|Phase 1|Safety follow-up no longer necessary|0|||
125238816|NCT03126110|450500454|FG007|Phase 1|Safety follow-up no longer necessary|0|||
125238817|NCT03126110|450500455|FG008|Phase 1|Safety follow-up no longer necessary|0|||
125238818|NCT03126110|450500456|FG009|Phase 1|Safety follow-up no longer necessary|0|||
125238819|NCT03126110|450500457|FG010|Phase 1|Safety follow-up no longer necessary|0|||
125238820|NCT03126110|450500458|FG011|Phase 1|Safety follow-up no longer necessary|0|||
125238821|NCT03126110|450500459|FG012|Phase 1|Safety follow-up no longer necessary|0|||
125238822|NCT03126110|450500460|FG013|Phase 1|Safety follow-up no longer necessary|0|||
125238823|NCT03126110|450500461|FG014|Phase 1|Safety follow-up no longer necessary|0|||
125238824|NCT03126110|450500462|FG015|Phase 1|Safety follow-up no longer necessary|0|||
125238825|NCT03126110|450500463|FG016|Phase 1|Safety follow-up no longer necessary|0|||
125238826|NCT03126110|450500447|FG000|Phase 1|Survival follow-up no longer necessary|0|||
125238827|NCT03126110|450500448|FG001|Phase 1|Survival follow-up no longer necessary|0|||
125238828|NCT03126110|450500449|FG002|Phase 1|Survival follow-up no longer necessary|1|||
125238829|NCT03126110|450500450|FG003|Phase 1|Survival follow-up no longer necessary|0|||
125238830|NCT03126110|450500451|FG004|Phase 1|Survival follow-up no longer necessary|0|||
125238831|NCT03126110|450500452|FG005|Phase 1|Survival follow-up no longer necessary|0|||
125238832|NCT03126110|450500453|FG006|Phase 1|Survival follow-up no longer necessary|0|||
125238833|NCT03126110|450500454|FG007|Phase 1|Survival follow-up no longer necessary|0|||
125238834|NCT03126110|450500455|FG008|Phase 1|Survival follow-up no longer necessary|0|||
125238835|NCT03126110|450500456|FG009|Phase 1|Survival follow-up no longer necessary|0|||
125238836|NCT03126110|450500457|FG010|Phase 1|Survival follow-up no longer necessary|0|||
125238837|NCT03126110|450500458|FG011|Phase 1|Survival follow-up no longer necessary|0|||
125238838|NCT03126110|450500459|FG012|Phase 1|Survival follow-up no longer necessary|0|||
125238839|NCT03126110|450500460|FG013|Phase 1|Survival follow-up no longer necessary|0|||
125238840|NCT03126110|450500461|FG014|Phase 1|Survival follow-up no longer necessary|0|||
125238841|NCT03126110|450500462|FG015|Phase 1|Survival follow-up no longer necessary|0|||
125238842|NCT03126110|450500463|FG016|Phase 1|Survival follow-up no longer necessary|0|||
125443447|NCT02555371|451252131|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
125238843|NCT03126110|450500447|FG000|Phase 2|Study terminated by the sponsor|0|||
125238844|NCT03126110|450500448|FG001|Phase 2|Study terminated by the sponsor|0|||
125238845|NCT03126110|450500449|FG002|Phase 2|Study terminated by the sponsor|0|||
125238846|NCT03126110|450500450|FG003|Phase 2|Study terminated by the sponsor|0|||
125238847|NCT03126110|450500451|FG004|Phase 2|Study terminated by the sponsor|0|||
125238848|NCT03126110|450500452|FG005|Phase 2|Study terminated by the sponsor|0|||
125238849|NCT03126110|450500453|FG006|Phase 2|Study terminated by the sponsor|0|||
125238850|NCT03126110|450500454|FG007|Phase 2|Study terminated by the sponsor|0|||
125238851|NCT03126110|450500455|FG008|Phase 2|Study terminated by the sponsor|0|||
125238852|NCT03126110|450500456|FG009|Phase 2|Study terminated by the sponsor|0|||
125238853|NCT03126110|450500457|FG010|Phase 2|Study terminated by the sponsor|0|||
125238854|NCT03126110|450500458|FG011|Phase 2|Study terminated by the sponsor|0|||
125238855|NCT03126110|450500459|FG012|Phase 2|Study terminated by the sponsor|0|||
125238856|NCT03126110|450500460|FG013|Phase 2|Study terminated by the sponsor|4|||
125238857|NCT03126110|450500461|FG014|Phase 2|Study terminated by the sponsor|0|||
125238858|NCT03126110|450500462|FG015|Phase 2|Study terminated by the sponsor|0|||
125238859|NCT03126110|450500463|FG016|Phase 2|Study terminated by the sponsor|0|||
125238860|NCT03126110|450500447|FG000|Phase 2|Withdrawal by Subject|0|||
125238861|NCT03126110|450500448|FG001|Phase 2|Withdrawal by Subject|0|||
125238862|NCT03126110|450500449|FG002|Phase 2|Withdrawal by Subject|0|||
125238863|NCT03126110|450500450|FG003|Phase 2|Withdrawal by Subject|0|||
125238864|NCT03126110|450500451|FG004|Phase 2|Withdrawal by Subject|0|||
125238865|NCT03126110|450500452|FG005|Phase 2|Withdrawal by Subject|0|||
125238866|NCT03126110|450500453|FG006|Phase 2|Withdrawal by Subject|0|||
125238867|NCT03126110|450500454|FG007|Phase 2|Withdrawal by Subject|0|||
125238868|NCT03126110|450500455|FG008|Phase 2|Withdrawal by Subject|0|||
125238869|NCT03126110|450500456|FG009|Phase 2|Withdrawal by Subject|0|||
125238870|NCT03126110|450500457|FG010|Phase 2|Withdrawal by Subject|0|||
125238871|NCT03126110|450500458|FG011|Phase 2|Withdrawal by Subject|1|||
125238872|NCT03126110|450500459|FG012|Phase 2|Withdrawal by Subject|3|||
125238873|NCT03126110|450500460|FG013|Phase 2|Withdrawal by Subject|3|||
125238874|NCT03126110|450500461|FG014|Phase 2|Withdrawal by Subject|2|||
125238875|NCT03126110|450500462|FG015|Phase 2|Withdrawal by Subject|1|||
125238876|NCT03126110|450500463|FG016|Phase 2|Withdrawal by Subject|0|||
125238877|NCT03126110|450500447|FG000|Phase 2|Lost to Follow-up|0|||
125238878|NCT03126110|450500448|FG001|Phase 2|Lost to Follow-up|0|||
125238879|NCT03126110|450500449|FG002|Phase 2|Lost to Follow-up|0|||
125238880|NCT03126110|450500450|FG003|Phase 2|Lost to Follow-up|0|||
125238881|NCT03126110|450500451|FG004|Phase 2|Lost to Follow-up|0|||
125238882|NCT03126110|450500452|FG005|Phase 2|Lost to Follow-up|0|||
125238883|NCT03126110|450500453|FG006|Phase 2|Lost to Follow-up|0|||
125238884|NCT03126110|450500454|FG007|Phase 2|Lost to Follow-up|0|||
125238885|NCT03126110|450500455|FG008|Phase 2|Lost to Follow-up|0|||
125185702|NCT01068860|450300834|FG007|Overall Study|Administrative problems; misrandomized|0|||
125185703|NCT01068860|450300835|FG008|Overall Study|Administrative problems; misrandomized|0|||
125185704|NCT01068860|450300836|FG009|Overall Study|Administrative problems; misrandomized|1|||
125185705|NCT01068860|450300827|FG000|Overall Study|Lost to Follow-up|0|||
125185706|NCT01068860|450300828|FG001|Overall Study|Lost to Follow-up|1|||
125185707|NCT01068860|450300829|FG002|Overall Study|Lost to Follow-up|0|||
125185708|NCT01068860|450300830|FG003|Overall Study|Lost to Follow-up|0|||
125185709|NCT01068860|450300831|FG004|Overall Study|Lost to Follow-up|0|||
125185710|NCT01068860|450300832|FG005|Overall Study|Lost to Follow-up|0|||
125185711|NCT01068860|450300833|FG006|Overall Study|Lost to Follow-up|0|||
125185712|NCT01068860|450300834|FG007|Overall Study|Lost to Follow-up|0|||
125185713|NCT01068860|450300835|FG008|Overall Study|Lost to Follow-up|0|||
125185714|NCT01068860|450300836|FG009|Overall Study|Lost to Follow-up|0|||
125185715|NCT00460603|450300837|FG000|Phase 1|Death|1|||
125185716|NCT00460603|450300838|FG001|Phase 1|Death|0|||
125185717|NCT00460603|450300839|FG002|Phase 1|Death|0|||
125185718|NCT00460603|450300840|FG003|Phase 1|Death|2|||
125185719|NCT00460603|450300841|FG004|Phase 1|Death|0|||
125185720|NCT00460603|450300842|FG005|Phase 1|Death|0|||
125185721|NCT00460603|450300843|FG006|Phase 1|Death|0|||
125185722|NCT00460603|450300844|FG007|Phase 1|Death|0|||
125185723|NCT00460603|450300845|FG008|Phase 1|Death|1|||
125185724|NCT00460603|450300846|FG009|Phase 1|Death|0|||
125185725|NCT00460603|450300847|FG010|Phase 1|Death|0|||
125185726|NCT00460603|450300848|FG011|Phase 1|Death|0|||
125185727|NCT00460603|450300837|FG000|Phase 1|Adverse Event|3|||
125185728|NCT00460603|450300838|FG001|Phase 1|Adverse Event|1|||
125185729|NCT00460603|450300839|FG002|Phase 1|Adverse Event|1|||
125185730|NCT00460603|450300840|FG003|Phase 1|Adverse Event|2|||
125185731|NCT00460603|450300841|FG004|Phase 1|Adverse Event|0|||
125185732|NCT00460603|450300842|FG005|Phase 1|Adverse Event|0|||
125185733|NCT00460603|450300843|FG006|Phase 1|Adverse Event|3|||
125185734|NCT00460603|450300844|FG007|Phase 1|Adverse Event|0|||
125185735|NCT00460603|450300845|FG008|Phase 1|Adverse Event|4|||
125185736|NCT00460603|450300846|FG009|Phase 1|Adverse Event|0|||
125238886|NCT03126110|450500456|FG009|Phase 2|Lost to Follow-up|0|||
125238887|NCT03126110|450500457|FG010|Phase 2|Lost to Follow-up|0|||
125238888|NCT03126110|450500458|FG011|Phase 2|Lost to Follow-up|1|||
125238889|NCT03126110|450500459|FG012|Phase 2|Lost to Follow-up|1|||
125443448|NCT02555371|451252132|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
125185737|NCT00460603|450300847|FG010|Phase 1|Adverse Event|0|||
125185738|NCT00460603|450300848|FG011|Phase 1|Adverse Event|0|||
125185739|NCT00460603|450300837|FG000|Phase 1|Lack of Efficacy|1|||
125185740|NCT00460603|450300838|FG001|Phase 1|Lack of Efficacy|0|||
125238890|NCT03126110|450500460|FG013|Phase 2|Lost to Follow-up|1|||
125238891|NCT03126110|450500461|FG014|Phase 2|Lost to Follow-up|2|||
125238892|NCT03126110|450500462|FG015|Phase 2|Lost to Follow-up|0|||
125238893|NCT03126110|450500463|FG016|Phase 2|Lost to Follow-up|0|||
125238894|NCT03126110|450500447|FG000|Phase 2|Death|0|||
125238895|NCT03126110|450500448|FG001|Phase 2|Death|0|||
125238896|NCT03126110|450500449|FG002|Phase 2|Death|0|||
125238897|NCT03126110|450500450|FG003|Phase 2|Death|0|||
125238898|NCT03126110|450500451|FG004|Phase 2|Death|0|||
125238899|NCT03126110|450500452|FG005|Phase 2|Death|0|||
125238900|NCT03126110|450500453|FG006|Phase 2|Death|0|||
125238901|NCT03126110|450500454|FG007|Phase 2|Death|0|||
125238902|NCT03126110|450500455|FG008|Phase 2|Death|0|||
125238903|NCT03126110|450500456|FG009|Phase 2|Death|0|||
125238904|NCT03126110|450500457|FG010|Phase 2|Death|0|||
125238905|NCT03126110|450500458|FG011|Phase 2|Death|6|||
125238906|NCT03126110|450500459|FG012|Phase 2|Death|12|||
125238907|NCT03126110|450500460|FG013|Phase 2|Death|25|||
125238908|NCT03126110|450500461|FG014|Phase 2|Death|11|||
125238909|NCT03126110|450500462|FG015|Phase 2|Death|3|||
125238910|NCT03126110|450500463|FG016|Phase 2|Death|2|||
125238911|NCT03126110|450500447|FG000|Phase 2|Progressive Disease|0|||
125238912|NCT03126110|450500448|FG001|Phase 2|Progressive Disease|0|||
125238913|NCT03126110|450500449|FG002|Phase 2|Progressive Disease|0|||
125238914|NCT03126110|450500450|FG003|Phase 2|Progressive Disease|0|||
125238915|NCT03126110|450500451|FG004|Phase 2|Progressive Disease|0|||
125238916|NCT03126110|450500452|FG005|Phase 2|Progressive Disease|0|||
125238917|NCT03126110|450500453|FG006|Phase 2|Progressive Disease|0|||
125238918|NCT03126110|450500454|FG007|Phase 2|Progressive Disease|0|||
125238919|NCT03126110|450500455|FG008|Phase 2|Progressive Disease|0|||
125238920|NCT03126110|450500456|FG009|Phase 2|Progressive Disease|0|||
125238921|NCT03126110|450500457|FG010|Phase 2|Progressive Disease|0|||
125238922|NCT03126110|450500458|FG011|Phase 2|Progressive Disease|0|||
125238923|NCT03126110|450500459|FG012|Phase 2|Progressive Disease|0|||
125238924|NCT03126110|450500460|FG013|Phase 2|Progressive Disease|1|||
125238925|NCT03126110|450500461|FG014|Phase 2|Progressive Disease|0|||
125238926|NCT03126110|450500462|FG015|Phase 2|Progressive Disease|0|||
125238927|NCT03126110|450500463|FG016|Phase 2|Progressive Disease|0|||
125238928|NCT03126110|450500447|FG000|Phase 2|Started new treatment|0|||
125238929|NCT03126110|450500448|FG001|Phase 2|Started new treatment|0|||
125238930|NCT03126110|450500449|FG002|Phase 2|Started new treatment|0|||
125238931|NCT03126110|450500450|FG003|Phase 2|Started new treatment|0|||
125238932|NCT03126110|450500451|FG004|Phase 2|Started new treatment|0|||
125238933|NCT03126110|450500452|FG005|Phase 2|Started new treatment|0|||
125238934|NCT03126110|450500453|FG006|Phase 2|Started new treatment|0|||
125238935|NCT03126110|450500454|FG007|Phase 2|Started new treatment|0|||
125238936|NCT03126110|450500455|FG008|Phase 2|Started new treatment|0|||
125238937|NCT03126110|450500456|FG009|Phase 2|Started new treatment|0|||
125238938|NCT03126110|450500457|FG010|Phase 2|Started new treatment|0|||
125238939|NCT03126110|450500458|FG011|Phase 2|Started new treatment|0|||
125238940|NCT03126110|450500459|FG012|Phase 2|Started new treatment|0|||
125238941|NCT03126110|450500460|FG013|Phase 2|Started new treatment|0|||
125238942|NCT03126110|450500461|FG014|Phase 2|Started new treatment|1|||
125238943|NCT03126110|450500462|FG015|Phase 2|Started new treatment|0|||
125238944|NCT03126110|450500463|FG016|Phase 2|Started new treatment|0|||
125238945|NCT04235374|450500464|FG000|Overall Study|Death|91|||
125238946|NCT04235374|450500465|FG001|Overall Study|Death|91|||
125238947|NCT04235374|450500464|FG000|Overall Study|Refused|2|||
125238948|NCT04235374|450500465|FG001|Overall Study|Refused|2|||
125238949|NCT04235374|450500464|FG000|Overall Study|Unavailable|12|||
125238950|NCT04235374|450500465|FG001|Overall Study|Unavailable|3|||
125238951|NCT04235374|450500464|FG000|Overall Study|Withdrawal by Subject|0|||
125238952|NCT04235374|450500465|FG001|Overall Study|Withdrawal by Subject|1|||
125238953|NCT04235374|450500464|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
125238954|NCT04235374|450500465|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
125238955|NCT00976027|450500468|FG000|Overall Study|Serious Adverse Event|36|||
125238956|NCT00976027|450500469|FG001|Overall Study|Serious Adverse Event|17|||
125238957|NCT00976027|450500468|FG000|Overall Study|Adverse Event|0|||
125443449|NCT02555371|451252128|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
125238958|NCT00976027|450500469|FG001|Overall Study|Adverse Event|2|||
125238959|NCT00976027|450500468|FG000|Overall Study|Protocol Violation|60|||
125238960|NCT00976027|450500469|FG001|Overall Study|Protocol Violation|27|||
125238961|NCT00976027|450500468|FG000|Overall Study|Lost to Follow-up|208|||
125238962|NCT00976027|450500469|FG001|Overall Study|Lost to Follow-up|103|||
125238963|NCT00976027|450500468|FG000|Overall Study|Withdrawal by Subject|107|||
125238964|NCT00976027|450500469|FG001|Overall Study|Withdrawal by Subject|66|||
125238965|NCT01771107|450500472|FG000|Overall Study|Adverse Event|1|||
125238966|NCT01771107|450500473|FG001|Overall Study|Adverse Event|3|||
125238967|NCT01771107|450500472|FG000|Overall Study|Withdrawal by Subject|0|||
125238968|NCT01771107|450500473|FG001|Overall Study|Withdrawal by Subject|2|||
125238969|NCT01771107|450500472|FG000|Overall Study|Lost to Follow-up|0|||
125238970|NCT01771107|450500473|FG001|Overall Study|Lost to Follow-up|1|||
125238971|NCT01771107|450500472|FG000|Overall Study|participant moved|0|||
125238972|NCT01771107|450500473|FG001|Overall Study|participant moved|1|||
125238973|NCT01771107|450500472|FG000|Overall Study|Other|0|||
125238974|NCT01771107|450500473|FG001|Overall Study|Other|1|||
125238975|NCT02296125|450500478|FG000|Overall Study|Withdrawal by Subject|18|||
125238976|NCT02296125|450500479|FG001|Overall Study|Withdrawal by Subject|8|||
125238977|NCT02296125|450500480|FG002|Overall Study|Withdrawal by Subject|6|||
125238978|NCT02296125|450500481|FG003|Overall Study|Withdrawal by Subject|2|||
125238979|NCT02296125|450500478|FG000|Overall Study|Adverse Event|41|||
125238980|NCT02296125|450500479|FG001|Overall Study|Adverse Event|52|||
125238981|NCT02296125|450500480|FG002|Overall Study|Adverse Event|9|||
125238982|NCT02296125|450500481|FG003|Overall Study|Adverse Event|4|||
125238983|NCT02296125|450500478|FG000|Overall Study|Severe non-compliance to protocol|0|||
125238984|NCT02296125|450500479|FG001|Overall Study|Severe non-compliance to protocol|1|||
125238985|NCT02296125|450500480|FG002|Overall Study|Severe non-compliance to protocol|0|||
125238986|NCT02296125|450500481|FG003|Overall Study|Severe non-compliance to protocol|0|||
125238987|NCT02296125|450500478|FG000|Overall Study|Condition under investigation worsened|153|||
125238988|NCT02296125|450500479|FG001|Overall Study|Condition under investigation worsened|199|||
125238989|NCT02296125|450500480|FG002|Overall Study|Condition under investigation worsened|39|||
125238990|NCT02296125|450500481|FG003|Overall Study|Condition under investigation worsened|56|||
125238991|NCT02296125|450500478|FG000|Overall Study|Any reason not specifically recorded|6|||
125238992|NCT02296125|450500479|FG001|Overall Study|Any reason not specifically recorded|4|||
125238993|NCT02296125|450500480|FG002|Overall Study|Any reason not specifically recorded|2|||
125238994|NCT02296125|450500481|FG003|Overall Study|Any reason not specifically recorded|0|||
125238995|NCT00157755|450500482|FG000|Overall Study|Death|2|||
125238996|NCT00157755|450500483|FG001|Overall Study|Death|3|||
125238997|NCT00157755|450500484|FG002|Overall Study|Death|3|||
125238998|NCT00157755|450500485|FG003|Overall Study|Death|2|||
125238999|NCT00157755|450500486|FG004|Overall Study|Death|0|||
125239000|NCT00157755|450500487|FG005|Overall Study|Death|0|||
125239001|NCT00157755|450500482|FG000|Overall Study|Lost to Follow-up|0|||
125239002|NCT00157755|450500483|FG001|Overall Study|Lost to Follow-up|0|||
125239003|NCT00157755|450500484|FG002|Overall Study|Lost to Follow-up|1|||
125239004|NCT00157755|450500485|FG003|Overall Study|Lost to Follow-up|0|||
125239005|NCT00157755|450500486|FG004|Overall Study|Lost to Follow-up|0|||
125239006|NCT00157755|450500487|FG005|Overall Study|Lost to Follow-up|0|||
125239007|NCT00157755|450500482|FG000|Overall Study|Withdrawal by Subject|0|||
125239008|NCT00157755|450500483|FG001|Overall Study|Withdrawal by Subject|0|||
125239009|NCT00157755|450500484|FG002|Overall Study|Withdrawal by Subject|1|||
125239010|NCT00157755|450500485|FG003|Overall Study|Withdrawal by Subject|1|||
125239011|NCT00157755|450500486|FG004|Overall Study|Withdrawal by Subject|1|||
125239012|NCT00157755|450500487|FG005|Overall Study|Withdrawal by Subject|2|||
125239013|NCT00157755|450500482|FG000|Overall Study|Explant due to infection|0|||
125239014|NCT00157755|450500483|FG001|Overall Study|Explant due to infection|0|||
125239015|NCT00157755|450500484|FG002|Overall Study|Explant due to infection|1|||
125239016|NCT00157755|450500485|FG003|Overall Study|Explant due to infection|0|||
125239017|NCT00157755|450500486|FG004|Overall Study|Explant due to infection|0|||
125239018|NCT00157755|450500487|FG005|Overall Study|Explant due to infection|0|||
125239019|NCT00157755|450500482|FG000|Overall Study|Medical reason|0|||
125239020|NCT00157755|450500483|FG001|Overall Study|Medical reason|0|||
125239021|NCT00157755|450500484|FG002|Overall Study|Medical reason|1|||
125239022|NCT00157755|450500485|FG003|Overall Study|Medical reason|1|||
125239023|NCT00157755|450500486|FG004|Overall Study|Medical reason|0|||
125239024|NCT00157755|450500487|FG005|Overall Study|Medical reason|0|||
125239025|NCT00157755|450500482|FG000|Overall Study|Study site closure|0|||
125239026|NCT00157755|450500483|FG001|Overall Study|Study site closure|1|||
125239027|NCT00157755|450500484|FG002|Overall Study|Study site closure|0|||
125239028|NCT00157755|450500485|FG003|Overall Study|Study site closure|0|||
125239029|NCT00157755|450500486|FG004|Overall Study|Study site closure|0|||
125239030|NCT00157755|450500487|FG005|Overall Study|Study site closure|0|||
125239031|NCT00157755|450500482|FG000|Overall Study|Subject non-compliance|0|||
125239032|NCT00157755|450500483|FG001|Overall Study|Subject non-compliance|0|||
125239033|NCT00157755|450500484|FG002|Overall Study|Subject non-compliance|0|||
125239034|NCT00157755|450500485|FG003|Overall Study|Subject non-compliance|0|||
125239035|NCT00157755|450500486|FG004|Overall Study|Subject non-compliance|0|||
125239036|NCT00157755|450500487|FG005|Overall Study|Subject non-compliance|1|||
125239037|NCT00157755|450500482|FG000|Overall Study|Study completion|0|||
125239038|NCT00157755|450500483|FG001|Overall Study|Study completion|0|||
125239039|NCT00157755|450500484|FG002|Overall Study|Study completion|0|||
125239040|NCT00157755|450500485|FG003|Overall Study|Study completion|0|||
125239041|NCT00157755|450500486|FG004|Overall Study|Study completion|1|||
125239042|NCT00157755|450500487|FG005|Overall Study|Study completion|2|||
125239043|NCT03314935|450500490|FG000|Phase 1|Death|4|||
125239044|NCT03314935|450500491|FG001|Phase 1|Death|2|||
125239045|NCT03314935|450500492|FG002|Phase 1|Death|5|||
125239046|NCT03314935|450500493|FG003|Phase 1|Death|4|||
125239047|NCT03314935|450500494|FG004|Phase 1|Death|3|||
125239048|NCT03314935|450500495|FG005|Phase 1|Death|4|||
125239049|NCT03314935|450500496|FG006|Phase 1|Death|5|||
125239050|NCT03314935|450500497|FG007|Phase 1|Death|4|||
125239051|NCT03314935|450500498|FG008|Phase 1|Death|3|||
125239052|NCT03314935|450500499|FG009|Phase 1|Death|0|||
125239053|NCT03314935|450500500|FG010|Phase 1|Death|0|||
125239054|NCT03314935|450500501|FG011|Phase 1|Death|0|||
125239055|NCT03314935|450500502|FG012|Phase 1|Death|0|||
125239056|NCT03314935|450500503|FG013|Phase 1|Death|0|||
125239057|NCT03314935|450500504|FG014|Phase 1|Death|0|||
125239058|NCT03314935|450500490|FG000|Phase 1|Withdrawal by Subject|2|||
125239059|NCT03314935|450500491|FG001|Phase 1|Withdrawal by Subject|1|||
125239060|NCT03314935|450500492|FG002|Phase 1|Withdrawal by Subject|1|||
125239061|NCT03314935|450500493|FG003|Phase 1|Withdrawal by Subject|2|||
125239062|NCT03314935|450500494|FG004|Phase 1|Withdrawal by Subject|1|||
125239063|NCT03314935|450500495|FG005|Phase 1|Withdrawal by Subject|0|||
125239064|NCT03314935|450500496|FG006|Phase 1|Withdrawal by Subject|1|||
125239065|NCT03314935|450500497|FG007|Phase 1|Withdrawal by Subject|0|||
125239066|NCT03314935|450500498|FG008|Phase 1|Withdrawal by Subject|1|||
125239067|NCT03314935|450500499|FG009|Phase 1|Withdrawal by Subject|0|||
125239068|NCT03314935|450500500|FG010|Phase 1|Withdrawal by Subject|0|||
125239069|NCT03314935|450500501|FG011|Phase 1|Withdrawal by Subject|0|||
125239070|NCT03314935|450500502|FG012|Phase 1|Withdrawal by Subject|0|||
125239071|NCT03314935|450500503|FG013|Phase 1|Withdrawal by Subject|0|||
125239072|NCT03314935|450500504|FG014|Phase 1|Withdrawal by Subject|0|||
125239073|NCT03314935|450500490|FG000|Phase 1|Progressive Disease|2|||
125239074|NCT03314935|450500491|FG001|Phase 1|Progressive Disease|0|||
125239075|NCT03314935|450500492|FG002|Phase 1|Progressive Disease|0|||
125239076|NCT03314935|450500493|FG003|Phase 1|Progressive Disease|1|||
125239077|NCT03314935|450500494|FG004|Phase 1|Progressive Disease|0|||
125239078|NCT03314935|450500495|FG005|Phase 1|Progressive Disease|0|||
125239079|NCT03314935|450500496|FG006|Phase 1|Progressive Disease|0|||
125239080|NCT03314935|450500497|FG007|Phase 1|Progressive Disease|0|||
125239081|NCT03314935|450500498|FG008|Phase 1|Progressive Disease|0|||
125239082|NCT03314935|450500499|FG009|Phase 1|Progressive Disease|0|||
125239083|NCT03314935|450500500|FG010|Phase 1|Progressive Disease|0|||
125239084|NCT03314935|450500501|FG011|Phase 1|Progressive Disease|0|||
125239085|NCT03314935|450500502|FG012|Phase 1|Progressive Disease|0|||
125239086|NCT03314935|450500503|FG013|Phase 1|Progressive Disease|0|||
125239087|NCT03314935|450500504|FG014|Phase 1|Progressive Disease|0|||
125239088|NCT03314935|450500490|FG000|Phase 1|Study Terminated by Sponsor|0|||
125239089|NCT03314935|450500491|FG001|Phase 1|Study Terminated by Sponsor|1|||
125239090|NCT03314935|450500492|FG002|Phase 1|Study Terminated by Sponsor|0|||
125239091|NCT03314935|450500493|FG003|Phase 1|Study Terminated by Sponsor|0|||
125239092|NCT03314935|450500494|FG004|Phase 1|Study Terminated by Sponsor|0|||
125239093|NCT03314935|450500495|FG005|Phase 1|Study Terminated by Sponsor|0|||
125239094|NCT03314935|450500496|FG006|Phase 1|Study Terminated by Sponsor|0|||
125239095|NCT03314935|450500497|FG007|Phase 1|Study Terminated by Sponsor|0|||
125239096|NCT03314935|450500498|FG008|Phase 1|Study Terminated by Sponsor|1|||
125239097|NCT03314935|450500499|FG009|Phase 1|Study Terminated by Sponsor|0|||
125239098|NCT03314935|450500500|FG010|Phase 1|Study Terminated by Sponsor|0|||
125239099|NCT03314935|450500501|FG011|Phase 1|Study Terminated by Sponsor|0|||
125239100|NCT03314935|450500502|FG012|Phase 1|Study Terminated by Sponsor|0|||
125239101|NCT03314935|450500503|FG013|Phase 1|Study Terminated by Sponsor|0|||
125239102|NCT03314935|450500504|FG014|Phase 1|Study Terminated by Sponsor|0|||
125239103|NCT03314935|450500490|FG000|Phase 1|"Captured as Other in Database"|0|||
125239104|NCT03314935|450500491|FG001|Phase 1|"Captured as Other in Database"|2|||
125239105|NCT03314935|450500492|FG002|Phase 1|"Captured as Other in Database"|0|||
125239106|NCT03314935|450500493|FG003|Phase 1|"Captured as Other in Database"|0|||
125185741|NCT00460603|450300839|FG002|Phase 1|Lack of Efficacy|1|||
125185742|NCT00460603|450300840|FG003|Phase 1|Lack of Efficacy|2|||
125185743|NCT00460603|450300841|FG004|Phase 1|Lack of Efficacy|2|||
125185744|NCT00460603|450300842|FG005|Phase 1|Lack of Efficacy|2|||
125185745|NCT00460603|450300843|FG006|Phase 1|Lack of Efficacy|2|||
125185746|NCT00460603|450300844|FG007|Phase 1|Lack of Efficacy|2|||
125185747|NCT00460603|450300845|FG008|Phase 1|Lack of Efficacy|11|||
125185748|NCT00460603|450300846|FG009|Phase 1|Lack of Efficacy|0|||
125185749|NCT00460603|450300847|FG010|Phase 1|Lack of Efficacy|0|||
125185750|NCT00460603|450300848|FG011|Phase 1|Lack of Efficacy|0|||
125185751|NCT00460603|450300837|FG000|Phase 1|Withdrawal by Subject|1|||
125185752|NCT00460603|450300838|FG001|Phase 1|Withdrawal by Subject|2|||
125185753|NCT00460603|450300839|FG002|Phase 1|Withdrawal by Subject|1|||
125185754|NCT00460603|450300840|FG003|Phase 1|Withdrawal by Subject|1|||
125185755|NCT00460603|450300841|FG004|Phase 1|Withdrawal by Subject|3|||
125185756|NCT00460603|450300842|FG005|Phase 1|Withdrawal by Subject|0|||
125185757|NCT00460603|450300843|FG006|Phase 1|Withdrawal by Subject|1|||
125239107|NCT03314935|450500494|FG004|Phase 1|"Captured as Other in Database"|0|||
125239108|NCT03314935|450500495|FG005|Phase 1|"Captured as Other in Database"|0|||
125239109|NCT03314935|450500496|FG006|Phase 1|"Captured as Other in Database"|1|||
125239110|NCT03314935|450500497|FG007|Phase 1|"Captured as Other in Database"|1|||
125239111|NCT03314935|450500498|FG008|Phase 1|"Captured as Other in Database"|1|||
125239112|NCT03314935|450500499|FG009|Phase 1|"Captured as Other in Database"|0|||
125239113|NCT03314935|450500500|FG010|Phase 1|"Captured as Other in Database"|0|||
125185758|NCT00460603|450300844|FG007|Phase 1|Withdrawal by Subject|0|||
125185759|NCT00460603|450300845|FG008|Phase 1|Withdrawal by Subject|2|||
125239114|NCT03314935|450500501|FG011|Phase 1|"Captured as Other in Database"|0|||
125239115|NCT03314935|450500502|FG012|Phase 1|"Captured as Other in Database"|0|||
125185760|NCT00460603|450300846|FG009|Phase 1|Withdrawal by Subject|0|||
125185761|NCT00460603|450300847|FG010|Phase 1|Withdrawal by Subject|0|||
125185762|NCT00460603|450300848|FG011|Phase 1|Withdrawal by Subject|0|||
125239116|NCT03314935|450500503|FG013|Phase 1|"Captured as Other in Database"|0|||
125239117|NCT03314935|450500504|FG014|Phase 1|"Captured as Other in Database"|0|||
125239118|NCT03314935|450500490|FG000|Phase 1|Lost to Follow-up|0|||
125239119|NCT03314935|450500491|FG001|Phase 1|Lost to Follow-up|0|||
125239120|NCT03314935|450500492|FG002|Phase 1|Lost to Follow-up|0|||
125239121|NCT03314935|450500493|FG003|Phase 1|Lost to Follow-up|0|||
125239122|NCT03314935|450500494|FG004|Phase 1|Lost to Follow-up|0|||
125239123|NCT03314935|450500495|FG005|Phase 1|Lost to Follow-up|0|||
125239124|NCT03314935|450500496|FG006|Phase 1|Lost to Follow-up|0|||
125239125|NCT03314935|450500497|FG007|Phase 1|Lost to Follow-up|0|||
125239126|NCT03314935|450500498|FG008|Phase 1|Lost to Follow-up|1|||
125239127|NCT03314935|450500499|FG009|Phase 1|Lost to Follow-up|0|||
125239128|NCT03314935|450500500|FG010|Phase 1|Lost to Follow-up|0|||
125239129|NCT03314935|450500501|FG011|Phase 1|Lost to Follow-up|0|||
125239130|NCT03314935|450500502|FG012|Phase 1|Lost to Follow-up|0|||
125239131|NCT03314935|450500503|FG013|Phase 1|Lost to Follow-up|0|||
125239132|NCT03314935|450500504|FG014|Phase 1|Lost to Follow-up|0|||
125239133|NCT03314935|450500490|FG000|Phase 2|Death|0|||
125239134|NCT03314935|450500491|FG001|Phase 2|Death|0|||
125239135|NCT03314935|450500492|FG002|Phase 2|Death|0|||
125239136|NCT03314935|450500493|FG003|Phase 2|Death|0|||
125239137|NCT03314935|450500494|FG004|Phase 2|Death|0|||
125239138|NCT03314935|450500495|FG005|Phase 2|Death|0|||
125239139|NCT03314935|450500496|FG006|Phase 2|Death|0|||
125239140|NCT03314935|450500497|FG007|Phase 2|Death|0|||
125239141|NCT03314935|450500498|FG008|Phase 2|Death|0|||
125239142|NCT03314935|450500499|FG009|Phase 2|Death|5|||
125239143|NCT03314935|450500500|FG010|Phase 2|Death|20|||
125239144|NCT03314935|450500501|FG011|Phase 2|Death|6|||
125239145|NCT03314935|450500502|FG012|Phase 2|Death|7|||
125239146|NCT03314935|450500503|FG013|Phase 2|Death|6|||
125239147|NCT03314935|450500504|FG014|Phase 2|Death|17|||
125239148|NCT03314935|450500490|FG000|Phase 2|Withdrawal by Subject|0|||
125239149|NCT03314935|450500491|FG001|Phase 2|Withdrawal by Subject|0|||
125239150|NCT03314935|450500492|FG002|Phase 2|Withdrawal by Subject|0|||
125392493|NCT04809220|451070693|FG000|Overall Study|Due to long-term overseas business trips|1|||
125392494|NCT04809220|451070694|FG001|Overall Study|Due to long-term overseas business trips|0|||
125392495|NCT00329407|451070701|FG000|Overall Study|Withdrawal by Subject|1|||
125392496|NCT00978068|451070702|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
125392497|NCT00978068|451070703|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
125392498|NCT00978068|451070702|FG000|Overall Study|Death|1|||
125185763|NCT00460603|450300837|FG000|Phase 1|Other|0|||
125185764|NCT00460603|450300838|FG001|Phase 1|Other|3|||
125185765|NCT00460603|450300839|FG002|Phase 1|Other|1|||
125185766|NCT00460603|450300840|FG003|Phase 1|Other|1|||
125185767|NCT00460603|450300841|FG004|Phase 1|Other|1|||
125185768|NCT00460603|450300842|FG005|Phase 1|Other|2|||
125185769|NCT00460603|450300843|FG006|Phase 1|Other|0|||
125185770|NCT00460603|450300844|FG007|Phase 1|Other|1|||
125185771|NCT00460603|450300845|FG008|Phase 1|Other|0|||
125185772|NCT00460603|450300846|FG009|Phase 1|Other|0|||
125185773|NCT00460603|450300847|FG010|Phase 1|Other|0|||
125185774|NCT00460603|450300848|FG011|Phase 1|Other|0|||
125185775|NCT00460603|450300837|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185776|NCT00460603|450300838|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185777|NCT00460603|450300839|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185778|NCT00460603|450300840|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185779|NCT00460603|450300841|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185780|NCT00460603|450300842|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185781|NCT00460603|450300843|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185782|NCT00460603|450300844|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185783|NCT00460603|450300845|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185784|NCT00460603|450300846|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
125185785|NCT00460603|450300847|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125185786|NCT00460603|450300848|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
125239151|NCT03314935|450500493|FG003|Phase 2|Withdrawal by Subject|0|||
125239152|NCT03314935|450500494|FG004|Phase 2|Withdrawal by Subject|0|||
125239153|NCT03314935|450500495|FG005|Phase 2|Withdrawal by Subject|0|||
125239154|NCT03314935|450500496|FG006|Phase 2|Withdrawal by Subject|0|||
125239155|NCT03314935|450500497|FG007|Phase 2|Withdrawal by Subject|0|||
125239156|NCT03314935|450500498|FG008|Phase 2|Withdrawal by Subject|0|||
125185787|NCT00460603|450300837|FG000|Phase 2|Adverse Event|0|||
125185788|NCT00460603|450300838|FG001|Phase 2|Adverse Event|0|||
125185789|NCT00460603|450300839|FG002|Phase 2|Adverse Event|0|||
125185790|NCT00460603|450300840|FG003|Phase 2|Adverse Event|0|||
125185791|NCT00460603|450300841|FG004|Phase 2|Adverse Event|0|||
125185792|NCT00460603|450300842|FG005|Phase 2|Adverse Event|0|||
125185793|NCT00460603|450300843|FG006|Phase 2|Adverse Event|0|||
125185794|NCT00460603|450300844|FG007|Phase 2|Adverse Event|0|||
125185795|NCT00460603|450300845|FG008|Phase 2|Adverse Event|0|||
125239157|NCT03314935|450500499|FG009|Phase 2|Withdrawal by Subject|1|||
125239158|NCT03314935|450500500|FG010|Phase 2|Withdrawal by Subject|4|||
125239159|NCT03314935|450500501|FG011|Phase 2|Withdrawal by Subject|0|||
125239160|NCT03314935|450500502|FG012|Phase 2|Withdrawal by Subject|1|||
125239161|NCT03314935|450500503|FG013|Phase 2|Withdrawal by Subject|0|||
125392499|NCT00978068|451070703|FG001|Overall Study|Death|2|||
125185796|NCT00460603|450300846|FG009|Phase 2|Adverse Event|12|||
125185797|NCT00460603|450300847|FG010|Phase 2|Adverse Event|9|||
125185798|NCT00460603|450300848|FG011|Phase 2|Adverse Event|10|||
125185799|NCT00460603|450300837|FG000|Phase 2|Death|0|||
125185800|NCT00460603|450300838|FG001|Phase 2|Death|0|||
125185801|NCT00460603|450300839|FG002|Phase 2|Death|0|||
125185802|NCT00460603|450300840|FG003|Phase 2|Death|0|||
125185803|NCT00460603|450300841|FG004|Phase 2|Death|0|||
125185804|NCT00460603|450300842|FG005|Phase 2|Death|0|||
125185805|NCT00460603|450300843|FG006|Phase 2|Death|0|||
125185806|NCT00460603|450300844|FG007|Phase 2|Death|0|||
125185807|NCT00460603|450300845|FG008|Phase 2|Death|0|||
125185808|NCT00460603|450300846|FG009|Phase 2|Death|4|||
125185809|NCT00460603|450300847|FG010|Phase 2|Death|2|||
125185810|NCT00460603|450300848|FG011|Phase 2|Death|2|||
125185811|NCT00460603|450300837|FG000|Phase 2|Protocol Violation|0|||
125185812|NCT00460603|450300838|FG001|Phase 2|Protocol Violation|0|||
125185813|NCT00460603|450300839|FG002|Phase 2|Protocol Violation|0|||
125185814|NCT00460603|450300840|FG003|Phase 2|Protocol Violation|0|||
125185815|NCT00460603|450300841|FG004|Phase 2|Protocol Violation|0|||
125185816|NCT00460603|450300842|FG005|Phase 2|Protocol Violation|0|||
125185817|NCT00460603|450300843|FG006|Phase 2|Protocol Violation|0|||
125185818|NCT00460603|450300844|FG007|Phase 2|Protocol Violation|0|||
125185819|NCT00460603|450300845|FG008|Phase 2|Protocol Violation|0|||
125185820|NCT00460603|450300846|FG009|Phase 2|Protocol Violation|1|||
125185821|NCT00460603|450300847|FG010|Phase 2|Protocol Violation|1|||
125185822|NCT00460603|450300848|FG011|Phase 2|Protocol Violation|0|||
125185823|NCT00460603|450300837|FG000|Phase 2|Lost to Follow-up|0|||
125185824|NCT00460603|450300838|FG001|Phase 2|Lost to Follow-up|0|||
125185825|NCT00460603|450300839|FG002|Phase 2|Lost to Follow-up|0|||
125185826|NCT00460603|450300840|FG003|Phase 2|Lost to Follow-up|0|||
125185827|NCT00460603|450300841|FG004|Phase 2|Lost to Follow-up|0|||
125185828|NCT00460603|450300842|FG005|Phase 2|Lost to Follow-up|0|||
125185829|NCT00460603|450300843|FG006|Phase 2|Lost to Follow-up|0|||
125185830|NCT00460603|450300844|FG007|Phase 2|Lost to Follow-up|0|||
125185831|NCT00460603|450300845|FG008|Phase 2|Lost to Follow-up|0|||
125185832|NCT00460603|450300846|FG009|Phase 2|Lost to Follow-up|1|||
125185833|NCT00460603|450300847|FG010|Phase 2|Lost to Follow-up|0|||
125185834|NCT00460603|450300848|FG011|Phase 2|Lost to Follow-up|0|||
125185835|NCT00460603|450300837|FG000|Phase 2|Other|0|||
125185836|NCT00460603|450300838|FG001|Phase 2|Other|0|||
125185837|NCT00460603|450300839|FG002|Phase 2|Other|0|||
125185838|NCT00460603|450300840|FG003|Phase 2|Other|0|||
125185839|NCT00460603|450300841|FG004|Phase 2|Other|0|||
125185840|NCT00460603|450300842|FG005|Phase 2|Other|0|||
125185841|NCT00460603|450300843|FG006|Phase 2|Other|0|||
125185842|NCT00460603|450300844|FG007|Phase 2|Other|0|||
125185843|NCT00460603|450300845|FG008|Phase 2|Other|0|||
125185844|NCT00460603|450300846|FG009|Phase 2|Other|6|||
125185845|NCT00460603|450300847|FG010|Phase 2|Other|16|||
125185846|NCT00460603|450300848|FG011|Phase 2|Other|7|||
125185847|NCT00460603|450300837|FG000|Phase 2|Objective Progression or Relapse|0|||
125185848|NCT00460603|450300838|FG001|Phase 2|Objective Progression or Relapse|0|||
125185849|NCT00460603|450300839|FG002|Phase 2|Objective Progression or Relapse|0|||
125185850|NCT00460603|450300840|FG003|Phase 2|Objective Progression or Relapse|0|||
125185851|NCT00460603|450300841|FG004|Phase 2|Objective Progression or Relapse|0|||
125185852|NCT00460603|450300842|FG005|Phase 2|Objective Progression or Relapse|0|||
125185853|NCT00460603|450300843|FG006|Phase 2|Objective Progression or Relapse|0|||
125185854|NCT00460603|450300844|FG007|Phase 2|Objective Progression or Relapse|0|||
125185855|NCT00460603|450300845|FG008|Phase 2|Objective Progression or Relapse|0|||
125185856|NCT00460603|450300846|FG009|Phase 2|Objective Progression or Relapse|9|||
125185857|NCT00460603|450300847|FG010|Phase 2|Objective Progression or Relapse|10|||
125185858|NCT00460603|450300848|FG011|Phase 2|Objective Progression or Relapse|17|||
125185859|NCT00460603|450300837|FG000|Phase 2|Global Deterioration of Health Status|0|||
125185860|NCT00460603|450300838|FG001|Phase 2|Global Deterioration of Health Status|0|||
125185861|NCT00460603|450300839|FG002|Phase 2|Global Deterioration of Health Status|0|||
125185862|NCT00460603|450300840|FG003|Phase 2|Global Deterioration of Health Status|0|||
125185863|NCT00460603|450300841|FG004|Phase 2|Global Deterioration of Health Status|0|||
125185864|NCT00460603|450300842|FG005|Phase 2|Global Deterioration of Health Status|0|||
125185865|NCT00460603|450300843|FG006|Phase 2|Global Deterioration of Health Status|0|||
125185866|NCT00460603|450300844|FG007|Phase 2|Global Deterioration of Health Status|0|||
125185867|NCT00460603|450300845|FG008|Phase 2|Global Deterioration of Health Status|0|||
125185868|NCT00460603|450300846|FG009|Phase 2|Global Deterioration of Health Status|0|||
125185869|NCT00460603|450300847|FG010|Phase 2|Global Deterioration of Health Status|1|||
125185870|NCT00460603|450300848|FG011|Phase 2|Global Deterioration of Health Status|0|||
125185871|NCT00460603|450300837|FG000|Phase 2|Withdrawal by Subject|0|||
125185872|NCT00460603|450300838|FG001|Phase 2|Withdrawal by Subject|0|||
125185873|NCT00460603|450300839|FG002|Phase 2|Withdrawal by Subject|0|||
125185874|NCT00460603|450300840|FG003|Phase 2|Withdrawal by Subject|0|||
125185875|NCT00460603|450300841|FG004|Phase 2|Withdrawal by Subject|0|||
125185876|NCT00460603|450300842|FG005|Phase 2|Withdrawal by Subject|0|||
125185877|NCT00460603|450300843|FG006|Phase 2|Withdrawal by Subject|0|||
125185878|NCT00460603|450300844|FG007|Phase 2|Withdrawal by Subject|0|||
125239162|NCT03314935|450500504|FG014|Phase 2|Withdrawal by Subject|1|||
125239163|NCT03314935|450500490|FG000|Phase 2|Progressive Disease|0|||
125239164|NCT03314935|450500491|FG001|Phase 2|Progressive Disease|0|||
125239165|NCT03314935|450500492|FG002|Phase 2|Progressive Disease|0|||
125239166|NCT03314935|450500493|FG003|Phase 2|Progressive Disease|0|||
125239167|NCT03314935|450500494|FG004|Phase 2|Progressive Disease|0|||
125239168|NCT03314935|450500495|FG005|Phase 2|Progressive Disease|0|||
125239169|NCT03314935|450500496|FG006|Phase 2|Progressive Disease|0|||
125239170|NCT03314935|450500497|FG007|Phase 2|Progressive Disease|0|||
125239171|NCT03314935|450500498|FG008|Phase 2|Progressive Disease|0|||
125239172|NCT03314935|450500499|FG009|Phase 2|Progressive Disease|1|||
125239173|NCT03314935|450500500|FG010|Phase 2|Progressive Disease|1|||
125239174|NCT03314935|450500501|FG011|Phase 2|Progressive Disease|1|||
125239175|NCT03314935|450500502|FG012|Phase 2|Progressive Disease|2|||
125239176|NCT03314935|450500503|FG013|Phase 2|Progressive Disease|0|||
125239177|NCT03314935|450500504|FG014|Phase 2|Progressive Disease|1|||
125239178|NCT03314935|450500490|FG000|Phase 2|Study Terminated by Sponsor|0|||
125239179|NCT03314935|450500491|FG001|Phase 2|Study Terminated by Sponsor|0|||
125239180|NCT03314935|450500492|FG002|Phase 2|Study Terminated by Sponsor|0|||
125239181|NCT03314935|450500493|FG003|Phase 2|Study Terminated by Sponsor|0|||
125239182|NCT03314935|450500494|FG004|Phase 2|Study Terminated by Sponsor|0|||
125239183|NCT03314935|450500495|FG005|Phase 2|Study Terminated by Sponsor|0|||
125239184|NCT03314935|450500496|FG006|Phase 2|Study Terminated by Sponsor|0|||
125239185|NCT03314935|450500497|FG007|Phase 2|Study Terminated by Sponsor|0|||
125239186|NCT03314935|450500498|FG008|Phase 2|Study Terminated by Sponsor|0|||
125239187|NCT03314935|450500499|FG009|Phase 2|Study Terminated by Sponsor|0|||
125239188|NCT03314935|450500500|FG010|Phase 2|Study Terminated by Sponsor|7|||
125239189|NCT03314935|450500501|FG011|Phase 2|Study Terminated by Sponsor|2|||
125239190|NCT03314935|450500502|FG012|Phase 2|Study Terminated by Sponsor|1|||
125239191|NCT03314935|450500503|FG013|Phase 2|Study Terminated by Sponsor|4|||
125239192|NCT03314935|450500504|FG014|Phase 2|Study Terminated by Sponsor|4|||
125239193|NCT03314935|450500490|FG000|Phase 2|Lost to Follow-up|0|||
125239194|NCT03314935|450500491|FG001|Phase 2|Lost to Follow-up|0|||
125239195|NCT03314935|450500492|FG002|Phase 2|Lost to Follow-up|0|||
125239196|NCT03314935|450500493|FG003|Phase 2|Lost to Follow-up|0|||
125239197|NCT03314935|450500494|FG004|Phase 2|Lost to Follow-up|0|||
125239198|NCT03314935|450500495|FG005|Phase 2|Lost to Follow-up|0|||
125239199|NCT03314935|450500496|FG006|Phase 2|Lost to Follow-up|0|||
125239200|NCT03314935|450500497|FG007|Phase 2|Lost to Follow-up|0|||
125239201|NCT03314935|450500498|FG008|Phase 2|Lost to Follow-up|0|||
125239202|NCT03314935|450500499|FG009|Phase 2|Lost to Follow-up|1|||
125239203|NCT03314935|450500500|FG010|Phase 2|Lost to Follow-up|0|||
125239204|NCT03314935|450500501|FG011|Phase 2|Lost to Follow-up|0|||
125239205|NCT03314935|450500502|FG012|Phase 2|Lost to Follow-up|0|||
125239206|NCT03314935|450500503|FG013|Phase 2|Lost to Follow-up|0|||
125239207|NCT03314935|450500504|FG014|Phase 2|Lost to Follow-up|1|||
125239208|NCT03314935|450500490|FG000|Phase 2|Physician Decision|0|||
125239209|NCT03314935|450500491|FG001|Phase 2|Physician Decision|0|||
125239210|NCT03314935|450500492|FG002|Phase 2|Physician Decision|0|||
125239211|NCT03314935|450500493|FG003|Phase 2|Physician Decision|0|||
125239212|NCT03314935|450500494|FG004|Phase 2|Physician Decision|0|||
125239213|NCT03314935|450500495|FG005|Phase 2|Physician Decision|0|||
125239214|NCT03314935|450500496|FG006|Phase 2|Physician Decision|0|||
125239215|NCT03314935|450500497|FG007|Phase 2|Physician Decision|0|||
125239216|NCT03314935|450500498|FG008|Phase 2|Physician Decision|0|||
125239217|NCT03314935|450500499|FG009|Phase 2|Physician Decision|0|||
125239218|NCT03314935|450500500|FG010|Phase 2|Physician Decision|1|||
125239219|NCT03314935|450500501|FG011|Phase 2|Physician Decision|0|||
125239220|NCT03314935|450500502|FG012|Phase 2|Physician Decision|0|||
125239221|NCT03314935|450500503|FG013|Phase 2|Physician Decision|0|||
125239222|NCT03314935|450500504|FG014|Phase 2|Physician Decision|0|||
125239223|NCT03785366|450500509|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
125239224|NCT03785366|450500510|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
125239225|NCT03785366|450500509|FG000|Overall Study|Lost to Follow-up|1|||
125239226|NCT03785366|450500510|FG001|Overall Study|Lost to Follow-up|0|||
125239227|NCT03785366|450500509|FG000|Overall Study|Partial IUD Expulsion|0|||
125239228|NCT03785366|450500510|FG001|Overall Study|Partial IUD Expulsion|2|||
125239229|NCT03785366|450500509|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
125239230|NCT03785366|450500510|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
125239231|NCT00569127|450500511|FG000|Overall Study|Adverse Event|57|||
125239232|NCT00569127|450500512|FG001|Overall Study|Adverse Event|47|||
125239233|NCT00569127|450500511|FG000|Overall Study|Withdrawal by Subject|13|||
125239234|NCT00569127|450500512|FG001|Overall Study|Withdrawal by Subject|27|||
125239235|NCT00569127|450500511|FG000|Overall Study|Progression|99|||
125239236|NCT00569127|450500512|FG001|Overall Study|Progression|100|||
125239237|NCT00569127|450500511|FG000|Overall Study|Death|4|||
125239238|NCT00569127|450500512|FG001|Overall Study|Death|3|||
125239239|NCT00569127|450500511|FG000|Overall Study|Other|20|||
125239240|NCT00569127|450500512|FG001|Overall Study|Other|19|||
125239241|NCT00569127|450500511|FG000|Overall Study|Lost to Follow-up|0|||
125239242|NCT00569127|450500512|FG001|Overall Study|Lost to Follow-up|3|||
125239243|NCT00569127|450500511|FG000|Overall Study|Not Eligible|14|||
125239244|NCT00569127|450500512|FG001|Overall Study|Not Eligible|11|||
125239245|NCT00569127|450500511|FG000|Overall Study|Still on Treatment|7|||
125239246|NCT00569127|450500512|FG001|Overall Study|Still on Treatment|3|||
125239247|NCT04279522|450500514|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
125239248|NCT04279522|450500515|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
125239249|NCT04279522|450500514|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
125239250|NCT04279522|450500515|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
125239251|NCT04279522|450500514|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
125239252|NCT04279522|450500515|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
125239253|NCT04279522|450500514|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
125239254|NCT04279522|450500515|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
125239255|NCT04279522|450500514|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
125239256|NCT04279522|450500515|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
125239257|NCT04279522|450500514|FG000|Period 2: Open Label Phase|Physician Decision|0|||
125239258|NCT04279522|450500515|FG001|Period 2: Open Label Phase|Physician Decision|3|||
125239259|NCT04279522|450500514|FG000|Period 2: Open Label Phase|Adverse Event|0|||
125239260|NCT04279522|450500515|FG001|Period 2: Open Label Phase|Adverse Event|1|||
125239261|NCT04279522|450500514|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
125239262|NCT04279522|450500515|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
125239263|NCT02452190|450501923|FG000|Overall Study|Withdrawal by Sponsor|1|||
125239264|NCT02452190|450501924|FG001|Overall Study|Withdrawal by Sponsor|3|||
125239265|NCT02452190|450501923|FG000|Overall Study|Pregnancy|1|||
125239266|NCT02452190|450501924|FG001|Overall Study|Pregnancy|0|||
125239267|NCT02452190|450501923|FG000|Overall Study|Investigator's Decision|2|||
125239268|NCT02452190|450501924|FG001|Overall Study|Investigator's Decision|0|||
125239269|NCT02452190|450501923|FG000|Overall Study|Lack of Efficacy|3|||
125239270|NCT02452190|450501924|FG001|Overall Study|Lack of Efficacy|1|||
125239271|NCT02452190|450501923|FG000|Overall Study|Lost to Follow-up|4|||
125239272|NCT02452190|450501924|FG001|Overall Study|Lost to Follow-up|3|||
125239273|NCT02452190|450501923|FG000|Overall Study|Adverse Event|2|||
125239274|NCT02452190|450501924|FG001|Overall Study|Adverse Event|5|||
125239275|NCT02452190|450501923|FG000|Overall Study|Withdrawal by Subject|20|||
125239276|NCT02452190|450501924|FG001|Overall Study|Withdrawal by Subject|11|||
125239277|NCT02452190|450501923|FG000|Overall Study|Noncompliance with study drug|1|||
125239278|NCT02452190|450501924|FG001|Overall Study|Noncompliance with study drug|0|||
125239279|NCT02452190|450501923|FG000|Overall Study|Participant traveled abroad|1|||
125239280|NCT02452190|450501924|FG001|Overall Study|Participant traveled abroad|0|||
125239281|NCT02452190|450501923|FG000|Overall Study|Death|0|||
125239282|NCT02452190|450501924|FG001|Overall Study|Death|1|||
125239283|NCT03112603|450501926|FG000|End of Randomization Period|Lost to Follow-up|3|||
125239284|NCT03112603|450501927|FG001|End of Randomization Period|Lost to Follow-up|0|||
125239285|NCT03112603|450501928|FG002|End of Randomization Period|Lost to Follow-up|0|||
125239286|NCT03112603|450501926|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
125239287|NCT03112603|450501927|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
125239288|NCT03112603|450501928|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
125239289|NCT03112603|450501926|FG000|End of Randomization Period|Physician Decision|43|||
125239290|NCT03112603|450501927|FG001|End of Randomization Period|Physician Decision|18|||
125239291|NCT03112603|450501928|FG002|End of Randomization Period|Physician Decision|0|||
125239292|NCT03112603|450501926|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
125239293|NCT03112603|450501927|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
125239294|NCT03112603|450501928|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
125239295|NCT03112603|450501926|FG000|End of Randomization Period|Death|10|||
125239296|NCT03112603|450501927|FG001|End of Randomization Period|Death|7|||
125239297|NCT03112603|450501928|FG002|End of Randomization Period|Death|0|||
125239298|NCT03112603|450501926|FG000|End of Randomization Period|Disease Relapse|12|||
125239299|NCT03112603|450501927|FG001|End of Randomization Period|Disease Relapse|7|||
125239300|NCT03112603|450501928|FG002|End of Randomization Period|Disease Relapse|0|||
125239301|NCT03112603|450501926|FG000|End of Randomization Period|Lack of Efficacy|25|||
125239302|NCT03112603|450501927|FG001|End of Randomization Period|Lack of Efficacy|77|||
125239303|NCT03112603|450501928|FG002|End of Randomization Period|Lack of Efficacy|0|||
125239304|NCT03112603|450501926|FG000|End of Randomization Period|Adverse Event|32|||
125239305|NCT03112603|450501927|FG001|End of Randomization Period|Adverse Event|12|||
125239306|NCT03112603|450501928|FG002|End of Randomization Period|Adverse Event|0|||
125239307|NCT03112603|450501926|FG000|End of Cross Over Period|Death|0|||
125239308|NCT03112603|450501927|FG001|End of Cross Over Period|Death|0|||
125239309|NCT03112603|450501928|FG002|End of Cross Over Period|Death|2|||
125239310|NCT03112603|450501926|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
125239311|NCT03112603|450501927|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
125239312|NCT03112603|450501928|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
125239313|NCT03112603|450501926|FG000|End of Cross Over Period|Physician Decision|0|||
125239314|NCT03112603|450501927|FG001|End of Cross Over Period|Physician Decision|0|||
125392500|NCT00978068|451070702|FG000|Overall Study|Lost to Follow-up|1|||
125185879|NCT00460603|450300845|FG008|Phase 2|Withdrawal by Subject|0|||
125185880|NCT00460603|450300846|FG009|Phase 2|Withdrawal by Subject|5|||
125185881|NCT00460603|450300847|FG010|Phase 2|Withdrawal by Subject|4|||
125185882|NCT00460603|450300848|FG011|Phase 2|Withdrawal by Subject|5|||
125185883|NCT00460603|450300837|FG000|Phase 2|Randomized, but not treated|0|||
125185884|NCT00460603|450300838|FG001|Phase 2|Randomized, but not treated|0|||
125185885|NCT00460603|450300839|FG002|Phase 2|Randomized, but not treated|0|||
125185886|NCT00460603|450300840|FG003|Phase 2|Randomized, but not treated|0|||
125185887|NCT00460603|450300841|FG004|Phase 2|Randomized, but not treated|0|||
125185888|NCT00460603|450300842|FG005|Phase 2|Randomized, but not treated|0|||
125185889|NCT00460603|450300843|FG006|Phase 2|Randomized, but not treated|0|||
125185890|NCT00460603|450300844|FG007|Phase 2|Randomized, but not treated|0|||
125185891|NCT00460603|450300845|FG008|Phase 2|Randomized, but not treated|0|||
125185892|NCT00460603|450300846|FG009|Phase 2|Randomized, but not treated|3|||
125185893|NCT00460603|450300847|FG010|Phase 2|Randomized, but not treated|0|||
125185894|NCT00460603|450300848|FG011|Phase 2|Randomized, but not treated|0|||
125185895|NCT00513240|450300849|FG000|Overall Study|Did not have intended surgery|3|||
125185896|NCT00513240|450300850|FG001|Overall Study|Did not have intended surgery|0|||
125185897|NCT00513240|450300849|FG000|Overall Study|Death|3|||
125185898|NCT00513240|450300850|FG001|Overall Study|Death|3|||
125185899|NCT00513240|450300849|FG000|Overall Study|Withdrawal by Subject|7|||
125185900|NCT00513240|450300850|FG001|Overall Study|Withdrawal by Subject|4|||
125185901|NCT05263908|450300851|FG000|Overall Study|No informed consent for publication of study results|397|||
125185902|NCT05263908|450300851|FG000|Overall Study|CRF not collected|1|||
125185903|NCT00289848|450300852|FG000|Overall Study|Adverse Event|6|||
125185904|NCT00289848|450300853|FG001|Overall Study|Adverse Event|4|||
125185905|NCT00289848|450300852|FG000|Overall Study|Death|1|||
125185906|NCT00289848|450300853|FG001|Overall Study|Death|0|||
125185907|NCT00289848|450300852|FG000|Overall Study|Lack of Efficacy|20|||
125185908|NCT00289848|450300853|FG001|Overall Study|Lack of Efficacy|24|||
125185909|NCT00289848|450300852|FG000|Overall Study|Lost to Follow-up|3|||
125185910|NCT00289848|450300853|FG001|Overall Study|Lost to Follow-up|1|||
125185911|NCT00289848|450300852|FG000|Overall Study|Protocol Violation|5|||
125185912|NCT00289848|450300853|FG001|Overall Study|Protocol Violation|2|||
125185913|NCT00289848|450300852|FG000|Overall Study|Withdrawal by Subject|5|||
125185914|NCT00289848|450300853|FG001|Overall Study|Withdrawal by Subject|11|||
125185915|NCT00289848|450300852|FG000|Overall Study|Patient Moved|6|||
125185916|NCT00289848|450300853|FG001|Overall Study|Patient Moved|2|||
125185917|NCT00289848|450300852|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
125185918|NCT00289848|450300853|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
125185919|NCT03871543|450300857|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
125185920|NCT03871543|450300857|FG000|Period 1|Investigator Error|1|||
125185921|NCT03871543|450300857|FG000|Period 1|Protocol Violation|2|||
125185922|NCT03871543|450300857|FG000|Period 1|COVID-19 Related|1|||
125185923|NCT03871543|450300857|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
125185924|NCT03871543|450300857|FG000|Period 1|Withdrawal by Subject|10|||
125185925|NCT03871543|450300857|FG000|Period 2|Adverse Event|1|||
125185926|NCT03871543|450300857|FG000|Period 2|Withdrawal by Subject|1|||
125185927|NCT01930162|450300859|FG000|Overall Study|Abnormal test procedure result(s)|4|||
125185928|NCT01930162|450300859|FG000|Overall Study|Death|1|||
125185929|NCT00031590|450300861|FG000|Overall Study|Adverse Event|1|||
125185930|NCT00031590|450300861|FG000|Overall Study|Withdrawal by parents|2|||
125185931|NCT00923013|450300867|FG000|Overall Study|Refused further treatment|0|||
125185932|NCT00923013|450300868|FG001|Overall Study|Refused further treatment|1|||
125185933|NCT00923013|450300869|FG002|Overall Study|Refused further treatment|2|||
125185934|NCT00923013|450300870|FG003|Overall Study|Refused further treatment|0|||
125185935|NCT00923013|450300871|FG004|Overall Study|Refused further treatment|0|||
125185936|NCT00923013|450300872|FG005|Overall Study|Refused further treatment|0|||
125185937|NCT00923013|450300867|FG000|Overall Study|Switched to alternative treatment|0|||
125185938|NCT00923013|450300868|FG001|Overall Study|Switched to alternative treatment|1|||
125185939|NCT00923013|450300869|FG002|Overall Study|Switched to alternative treatment|0|||
125185940|NCT00923013|450300870|FG003|Overall Study|Switched to alternative treatment|0|||
125185941|NCT00923013|450300871|FG004|Overall Study|Switched to alternative treatment|0|||
125185942|NCT00923013|450300872|FG005|Overall Study|Switched to alternative treatment|0|||
125185943|NCT00923013|450300867|FG000|Overall Study|Death on study|2|||
125185944|NCT00923013|450300868|FG001|Overall Study|Death on study|2|||
125185945|NCT00923013|450300869|FG002|Overall Study|Death on study|0|||
125185946|NCT00923013|450300870|FG003|Overall Study|Death on study|1|||
125185947|NCT00923013|450300871|FG004|Overall Study|Death on study|0|||
125185948|NCT00923013|450300872|FG005|Overall Study|Death on study|0|||
125185949|NCT02301169|450300875|FG000|Overall Study|Adverse Event|1|||
125185950|NCT02301169|450300876|FG001|Overall Study|Adverse Event|0|||
125185951|NCT01198470|450300881|FG000|Overall Study|Adverse Event|2|||
125185952|NCT02949973|450300882|FG000|Overall Study|Physician Decision|1|||
125185953|NCT01422213|450300883|FG000|Overall Study|Adverse Event|8|||
125185954|NCT01422213|450300884|FG001|Overall Study|Adverse Event|7|||
125185955|NCT01422213|450300885|FG002|Overall Study|Adverse Event|11|||
125185956|NCT01422213|450300883|FG000|Overall Study|Lack of Efficacy|10|||
125185957|NCT01422213|450300884|FG001|Overall Study|Lack of Efficacy|2|||
125392501|NCT00978068|451070703|FG001|Overall Study|Lost to Follow-up|2|||
125392502|NCT00978068|451070702|FG000|Overall Study|Physician Decision|0|||
125392503|NCT00978068|451070703|FG001|Overall Study|Physician Decision|1|||
125392504|NCT00978068|451070702|FG000|Overall Study|Unable to Comply with Study|0|||
125392505|NCT00978068|451070703|FG001|Overall Study|Unable to Comply with Study|2|||
125392506|NCT04258605|451070705|FG000|Overall Study|Death|1|||
125392507|NCT04258605|451070706|FG001|Overall Study|Death|0|||
125185958|NCT01422213|450300885|FG002|Overall Study|Lack of Efficacy|2|||
125185959|NCT01422213|450300883|FG000|Overall Study|Non-compliance with study drug|0|||
125185960|NCT01422213|450300884|FG001|Overall Study|Non-compliance with study drug|1|||
125185961|NCT01422213|450300885|FG002|Overall Study|Non-compliance with study drug|0|||
125185962|NCT01422213|450300883|FG000|Overall Study|Protocol Violation|0|||
125185963|NCT01422213|450300884|FG001|Overall Study|Protocol Violation|2|||
125185964|NCT01422213|450300885|FG002|Overall Study|Protocol Violation|4|||
125185965|NCT01422213|450300883|FG000|Overall Study|Withdrawal of Consent|7|||
125185966|NCT01422213|450300884|FG001|Overall Study|Withdrawal of Consent|3|||
125185967|NCT01422213|450300885|FG002|Overall Study|Withdrawal of Consent|5|||
125185968|NCT01422213|450300883|FG000|Overall Study|Lost to Follow-up|3|||
125185969|NCT01422213|450300884|FG001|Overall Study|Lost to Follow-up|3|||
125185970|NCT01422213|450300885|FG002|Overall Study|Lost to Follow-up|5|||
125185971|NCT01422213|450300883|FG000|Overall Study|Administrative or Other Reason(s)|5|||
125185972|NCT01422213|450300884|FG001|Overall Study|Administrative or Other Reason(s)|4|||
125185973|NCT01422213|450300885|FG002|Overall Study|Administrative or Other Reason(s)|2|||
125185974|NCT04129125|450300892|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
125185975|NCT04129125|450300892|FG000|Overall Study|Study device was not used|3|||
125185976|NCT04484142|450300893|FG000|Overall Study|Adverse Event|13|||
125185977|NCT04484142|450300893|FG000|Overall Study|Progressive Disease|87|||
125185978|NCT04484142|450300893|FG000|Overall Study|Clinical Progression|10|||
125185979|NCT04484142|450300893|FG000|Overall Study|Withdrawal by Subject|6|||
125185980|NCT04484142|450300893|FG000|Overall Study|Physician Decision|1|||
125185981|NCT02723344|450300894|FG000|Overall Study|Lost to Follow-up|0|||
125185982|NCT02723344|450300895|FG001|Overall Study|Lost to Follow-up|4|||
125185983|NCT02964247|450300898|FG000|Overall Study|Lost to Follow-up|2|||
125185984|NCT02964247|450300899|FG001|Overall Study|Lost to Follow-up|0|||
125185985|NCT02964247|450300898|FG000|Overall Study|Withdrawal by Subject|1|||
125185986|NCT02964247|450300899|FG001|Overall Study|Withdrawal by Subject|2|||
125185987|NCT00740636|450300902|FG000|Overall Study|Adverse Event|0|||
125185988|NCT00740636|450300903|FG001|Overall Study|Adverse Event|2|||
125185989|NCT00740636|450300902|FG000|Overall Study|Patient Ineligible|0|||
125185990|NCT00740636|450300903|FG001|Overall Study|Patient Ineligible|1|||
125185991|NCT00740636|450300902|FG000|Overall Study|Patient Not Treated|0|||
125185992|NCT00740636|450300903|FG001|Overall Study|Patient Not Treated|1|||
125185993|NCT00740636|450300902|FG000|Overall Study|Progressive Disease|1|||
125185994|NCT00740636|450300903|FG001|Overall Study|Progressive Disease|0|||
125185995|NCT00740636|450300902|FG000|Overall Study|Death|1|||
125185996|NCT00740636|450300903|FG001|Overall Study|Death|0|||
125185997|NCT03832686|450300904|FG000|Overall Study|Lost to Follow-up|6|||
125185998|NCT03832686|450300905|FG001|Overall Study|Lost to Follow-up|9|||
125185999|NCT03832686|450300904|FG000|Overall Study|Discontinued Intervention|5|||
125186000|NCT03832686|450300905|FG001|Overall Study|Discontinued Intervention|4|||
125186001|NCT01609790|450300906|FG000|Overall Study|Protocol Violation|1|||
125186002|NCT01609790|450300907|FG001|Overall Study|Protocol Violation|7|||
125186003|NCT01609790|450300908|FG002|Overall Study|Protocol Violation|8|||
125186004|NCT00739882|450302359|FG000|Double-blind Period|Adverse Event|1|||
125186005|NCT00739882|450302360|FG001|Double-blind Period|Adverse Event|2|||
125186006|NCT00739882|450302359|FG000|Double-blind Period|Protocol Violation|1|||
125186007|NCT00739882|450302360|FG001|Double-blind Period|Protocol Violation|0|||
125186008|NCT00739882|450302359|FG000|Double-blind Period|Lack of Efficacy|1|||
125186009|NCT00739882|450302360|FG001|Double-blind Period|Lack of Efficacy|1|||
125186010|NCT00739882|450302359|FG000|Double-blind Period|Other|16|||
125186011|NCT00739882|450302360|FG001|Double-blind Period|Other|8|||
125186012|NCT00739882|450302359|FG000|Open-label Period|Adverse Event|1|||
125186013|NCT00739882|450302360|FG001|Open-label Period|Adverse Event|0|||
125186014|NCT00739882|450302359|FG000|Open-label Period|Other|9|||
125186015|NCT00739882|450302360|FG001|Open-label Period|Other|5|||
125186016|NCT01662635|450302361|FG000|Overall Study|scarce samples for evaluation|30|||
125186017|NCT02445248|450302362|FG000|Overall Study|Death|45|||
125186018|NCT02445248|450302363|FG001|Overall Study|Death|12|||
125392508|NCT04258605|451070705|FG000|Overall Study|Early study termination|21|||
125186019|NCT02445248|450302362|FG000|Overall Study|Progressive disease|13|||
125186020|NCT02445248|450302363|FG001|Overall Study|Progressive disease|1|||
125186021|NCT02445248|450302362|FG000|Overall Study|Subject decision|8|||
125186022|NCT02445248|450302363|FG001|Overall Study|Subject decision|0|||
125186023|NCT02445248|450302362|FG000|Overall Study|Physician Decision|5|||
125186024|NCT02445248|450302363|FG001|Overall Study|Physician Decision|0|||
125392509|NCT04258605|451070706|FG001|Overall Study|Early study termination|2|||
125392510|NCT01712256|451070709|FG000|Overall Study|Lost to Follow-up|1|||
125239315|NCT03112603|450501928|FG002|End of Cross Over Period|Physician Decision|29|||
125239316|NCT03112603|450501926|FG000|End of Cross Over Period|Lack of Efficacy|0|||
125239317|NCT03112603|450501927|FG001|End of Cross Over Period|Lack of Efficacy|0|||
125239318|NCT03112603|450501928|FG002|End of Cross Over Period|Lack of Efficacy|8|||
125239319|NCT03112603|450501926|FG000|End of Cross Over Period|Adverse Event|0|||
125239320|NCT03112603|450501927|FG001|End of Cross Over Period|Adverse Event|0|||
125239321|NCT03112603|450501928|FG002|End of Cross Over Period|Adverse Event|6|||
125239322|NCT03112603|450501926|FG000|End of Cross Over Period|Disease Relapse|0|||
125239323|NCT03112603|450501927|FG001|End of Cross Over Period|Disease Relapse|0|||
125239324|NCT03112603|450501928|FG002|End of Cross Over Period|Disease Relapse|2|||
125239325|NCT03916926|450501932|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
125239326|NCT03916926|450501933|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
125239327|NCT03916926|450501932|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
125239328|NCT03916926|450501933|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
125239329|NCT03916926|450501932|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
125239330|NCT03916926|450501933|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
125239331|NCT03916926|450501932|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
125239332|NCT03916926|450501933|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
125239333|NCT03330197|450501934|FG000|Overall Study|Adverse Event|0|||
125239334|NCT03330197|450501935|FG001|Overall Study|Adverse Event|1|||
125239335|NCT03330197|450501934|FG000|Overall Study|Withdrawal by Subject|0|||
125239336|NCT03330197|450501935|FG001|Overall Study|Withdrawal by Subject|1|||
125239337|NCT04537299|450501936|FG000|Overall Study|Withdrawal by Subject|2|||
125239338|NCT04537299|450501937|FG001|Overall Study|Withdrawal by Subject|0|||
125239339|NCT04537299|450501936|FG000|Overall Study|Protocol Violation|1|||
125239340|NCT04537299|450501937|FG001|Overall Study|Protocol Violation|1|||
125239341|NCT03806296|450501938|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
125239342|NCT03806296|450501939|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
125239343|NCT03806296|450501940|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
125239344|NCT03806296|450501938|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
125239345|NCT03806296|450501939|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
125239346|NCT03806296|450501940|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
125239347|NCT03806296|450501938|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
125239348|NCT03806296|450501939|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
125239349|NCT03806296|450501940|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
125239350|NCT00876343|450501941|FG000|Overall Study|Adverse Event|7|||
125239351|NCT00876343|450501942|FG001|Overall Study|Adverse Event|8|||
125239352|NCT00876343|450501943|FG002|Overall Study|Adverse Event|2|||
125239353|NCT00876343|450501941|FG000|Overall Study|Withdrawal by Subject|4|||
125239354|NCT00876343|450501942|FG001|Overall Study|Withdrawal by Subject|4|||
125239355|NCT00876343|450501943|FG002|Overall Study|Withdrawal by Subject|3|||
125239356|NCT00876343|450501941|FG000|Overall Study|Lack of Efficacy|0|||
125239357|NCT00876343|450501942|FG001|Overall Study|Lack of Efficacy|0|||
125239358|NCT00876343|450501943|FG002|Overall Study|Lack of Efficacy|1|||
125239359|NCT00876343|450501941|FG000|Overall Study|Protocol Violation|4|||
125239360|NCT00876343|450501942|FG001|Overall Study|Protocol Violation|1|||
125239361|NCT00876343|450501943|FG002|Overall Study|Protocol Violation|1|||
125239362|NCT00876343|450501941|FG000|Overall Study|Physician Decision|0|||
125239363|NCT00876343|450501942|FG001|Overall Study|Physician Decision|1|||
125239364|NCT00876343|450501943|FG002|Overall Study|Physician Decision|1|||
125239365|NCT00876343|450501941|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
125239366|NCT00876343|450501942|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
125239367|NCT00876343|450501943|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
125239368|NCT00876343|450501941|FG000|Overall Study|Change of residence or other commitments|2|||
125239369|NCT00876343|450501942|FG001|Overall Study|Change of residence or other commitments|2|||
125239370|NCT00876343|450501943|FG002|Overall Study|Change of residence or other commitments|3|||
125239371|NCT04896385|450501944|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
125239372|NCT04896385|450501945|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
125239373|NCT04896385|450501946|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
125239374|NCT04896385|450501947|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
125239375|NCT04896385|450501944|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
125239376|NCT04896385|450501945|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
125239377|NCT04896385|450501946|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
125239378|NCT04896385|450501947|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
125239379|NCT04896385|450501944|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
125239380|NCT04896385|450501945|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
125239381|NCT04896385|450501946|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
125239382|NCT04896385|450501947|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
125239383|NCT04896385|450501944|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
125239384|NCT04896385|450501945|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
125239385|NCT04896385|450501946|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
125239386|NCT04896385|450501947|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
125239387|NCT04896385|450501944|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
125239388|NCT04896385|450501945|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
125239389|NCT04896385|450501946|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
125239390|NCT04896385|450501947|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
125239391|NCT04896385|450501944|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
125239392|NCT04896385|450501945|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
125239393|NCT04896385|450501946|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
125239394|NCT04896385|450501947|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
125239395|NCT01931098|450501951|FG000|Overall Study|Withdrawal by Subject|0|||
125239396|NCT01931098|450501952|FG001|Overall Study|Withdrawal by Subject|1|||
125239397|NCT01931098|450501951|FG000|Overall Study|Enrolled in different protocol|0|||
125239398|NCT01931098|450501952|FG001|Overall Study|Enrolled in different protocol|1|||
125239399|NCT01931098|450501951|FG000|Overall Study|Unable to begin trmt:active infection|0|||
125239400|NCT01931098|450501952|FG001|Overall Study|Unable to begin trmt:active infection|1|||
125239401|NCT01931098|450501951|FG000|Overall Study|Refused further treatment|0|||
125239402|NCT01931098|450501952|FG001|Overall Study|Refused further treatment|1|||
125239403|NCT01925794|450501959|FG000|180 Days|Death|2|||
125239404|NCT01925794|450501959|FG000|180 Days|Withdrawal by Subject|2|||
125239405|NCT01925794|450501959|FG000|270 Days|Death|2|||
125239406|NCT01925794|450501959|FG000|270 Days|Protocol Violation|3|||
125239407|NCT00790036|450501960|FG000|Overall Study|Abnormal lab values|3|||
125186025|NCT02445248|450302362|FG000|Overall Study|Adverse Event|1|||
125239408|NCT00790036|450501961|FG001|Overall Study|Abnormal lab values|2|||
125239409|NCT00790036|450501960|FG000|Overall Study|Administrative problems|5|||
125239410|NCT00790036|450501961|FG001|Overall Study|Administrative problems|9|||
125239411|NCT00790036|450501960|FG000|Overall Study|Adverse Event|113|||
125239412|NCT00790036|450501961|FG001|Overall Study|Adverse Event|44|||
125239413|NCT00790036|450501960|FG000|Overall Study|Death|1|||
125186026|NCT02445248|450302363|FG001|Overall Study|Adverse Event|0|||
125186027|NCT02445248|450302362|FG000|Overall Study|Lost to Follow-up|1|||
125186028|NCT02445248|450302363|FG001|Overall Study|Lost to Follow-up|0|||
125186029|NCT00351468|450302364|FG000|Overall Study|Adverse Event|42|||
125186030|NCT00351468|450302364|FG000|Overall Study|Withdrawal by Subject|39|||
125186031|NCT00351468|450302364|FG000|Overall Study|Various -follow up w clinical team|39|||
125186032|NCT00351468|450302364|FG000|Overall Study|Lack of Efficacy|32|||
125186033|NCT00351468|450302364|FG000|Overall Study|Non-compliance|8|||
125186034|NCT00351468|450302364|FG000|Overall Study|Lost to Follow-up|4|||
125186035|NCT00351468|450302364|FG000|Overall Study|Protocol Violation|3|||
125186036|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
125186037|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
125186038|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
125186039|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
125186040|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
125186041|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
125186042|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
125186043|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
125186044|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
125186045|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
125186046|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
125186047|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
125186048|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
125186049|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
125186050|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
125186051|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
125186052|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
125186053|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
125186054|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
125186055|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
125186056|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
125186057|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
125186058|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
125186059|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
125186060|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
125186061|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
125186062|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
125186063|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
125186064|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
125186065|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
125186066|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
125186067|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
125186068|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
125186069|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
125186070|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
125186071|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
125186072|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
125186073|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
125186074|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
125186075|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
125186076|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
125186077|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
125186078|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
125186079|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
125186080|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
125186081|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
125186082|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
125186083|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
125186084|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
125186085|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
125186086|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
125186087|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
125186088|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Site closed|0|||
125186089|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Site closed|0|||
125186090|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Site closed|1|||
125186091|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Site closed|0|||
125186092|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
125186093|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
125186094|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
125186095|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
125186096|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
125186097|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
125186098|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
125186099|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
125186100|NCT00838903|450302365|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
125186101|NCT00838903|450302366|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
125186102|NCT00838903|450302367|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
125186103|NCT00838903|450302368|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
125186104|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
125186105|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
125186106|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
125186107|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
125186108|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
125186109|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
125186110|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
125186111|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
125186112|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
125186113|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
125186114|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
125186115|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
125186116|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
125186117|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
125186118|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
125186119|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
125186120|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
125186121|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
125186122|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
125186123|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
125186124|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
125186125|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
125186126|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
125186127|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
125186128|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
125186129|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
125186130|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
125186131|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
125239414|NCT00790036|450501961|FG001|Overall Study|Death|0|||
125239415|NCT00790036|450501960|FG000|Overall Study|Disease progression|24|||
125186132|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
125186133|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
125186134|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
125186135|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
125186136|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
125186137|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
125186138|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
125186139|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
125186140|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
125186141|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
125186142|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
125186143|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
125186144|NCT00838903|450302365|FG000|Follow-up Period (8 Weeks)|Missing|1|||
125186145|NCT00838903|450302366|FG001|Follow-up Period (8 Weeks)|Missing|2|||
125186146|NCT00838903|450302367|FG002|Follow-up Period (8 Weeks)|Missing|1|||
125186147|NCT00838903|450302368|FG003|Follow-up Period (8 Weeks)|Missing|1|||
125186148|NCT04565145|450302369|FG000|Overall Study|Withdrawal by Subject|1|||
125186149|NCT04565145|450302370|FG001|Overall Study|Withdrawal by Subject|1|||
125186150|NCT03096314|450302371|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
125186151|NCT03096314|450302372|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
125186152|NCT00471822|450302373|FG000|Overall Study|Protocol Violation|2|||
125186153|NCT00683618|450302374|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
125186154|NCT00683618|450302375|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
125186155|NCT00683618|450302376|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
125186156|NCT00683618|450302374|FG000|Randomised Treatment Period|Protocol Violation|0|||
125186157|NCT00683618|450302375|FG001|Randomised Treatment Period|Protocol Violation|1|||
125186158|NCT00683618|450302376|FG002|Randomised Treatment Period|Protocol Violation|0|||
125186159|NCT00683618|450302374|FG000|Randomised Treatment Period|Adverse Event|2|||
125186160|NCT00683618|450302375|FG001|Randomised Treatment Period|Adverse Event|0|||
125186161|NCT00683618|450302376|FG002|Randomised Treatment Period|Adverse Event|2|||
125186162|NCT00683618|450302374|FG000|Randomised Treatment Period|Reason not provided|0|||
125186163|NCT00683618|450302375|FG001|Randomised Treatment Period|Reason not provided|0|||
125186164|NCT00683618|450302376|FG002|Randomised Treatment Period|Reason not provided|2|||
125186165|NCT00683618|450302374|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
125186166|NCT00683618|450302375|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
125186167|NCT00683618|450302376|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
125186168|NCT00683618|450302374|FG000|Extension Treatment Period|Adverse Event|1|||
125186169|NCT00683618|450302375|FG001|Extension Treatment Period|Adverse Event|0|||
125186170|NCT00683618|450302376|FG002|Extension Treatment Period|Adverse Event|0|||
125186171|NCT00683618|450302374|FG000|Extension Treatment Period|Protocol Violation|1|||
125186172|NCT00683618|450302375|FG001|Extension Treatment Period|Protocol Violation|0|||
125186173|NCT00683618|450302376|FG002|Extension Treatment Period|Protocol Violation|0|||
125186174|NCT04570670|450302377|FG000|Overall Study|Withdrawal by Subject|1|||
125186175|NCT04570670|450302378|FG001|Overall Study|Withdrawal by Subject|0|||
125186176|NCT01062425|450302379|FG000|Overall Study|Protocol Violation|3|||
125186177|NCT01062425|450302380|FG001|Overall Study|Protocol Violation|6|||
125186178|NCT03003962|450302381|FG000|Overall Study|Withdrawal by Subject|5|||
125186179|NCT03003962|450302382|FG001|Overall Study|Withdrawal by Subject|17|||
125186180|NCT03003962|450302381|FG000|Overall Study|Death|274|||
125186181|NCT03003962|450302382|FG001|Overall Study|Death|277|||
125186182|NCT03003962|450302381|FG000|Overall Study|Participants ongoing at DCO|55|||
125186183|NCT03003962|450302382|FG001|Overall Study|Participants ongoing at DCO|40|||
125186184|NCT02069015|450302384|FG000|Overall Study|Lost to Follow-up|39|||
125186185|NCT02069015|450302385|FG001|Overall Study|Lost to Follow-up|32|||
125186186|NCT02069015|450302384|FG000|Overall Study|Withdrawal by Subject|1|||
125186187|NCT02069015|450302385|FG001|Overall Study|Withdrawal by Subject|1|||
125186188|NCT01108718|450302388|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
125186189|NCT01108718|450302389|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
125186190|NCT00586703|450302392|FG000|Overall Study|Death|12|||
125186191|NCT03762265|450302397|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
125186192|NCT03762265|450302398|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
125186193|NCT03762265|450302397|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
125186194|NCT03762265|450302398|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
125186195|NCT03762265|450302397|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
125186196|NCT03762265|450302398|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
125186197|NCT03762265|450302397|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
125186198|NCT03762265|450302398|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
125186199|NCT03762265|450302397|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
125186200|NCT03762265|450302398|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
125186201|NCT03762265|450302397|FG000|BT Period: Weeks 1 to 37|Other|0|||
125186202|NCT03762265|450302398|FG001|BT Period: Weeks 1 to 37|Other|1|||
125186203|NCT03762265|450302397|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
125239416|NCT00790036|450501961|FG001|Overall Study|Disease progression|48|||
125239417|NCT00790036|450501960|FG000|Overall Study|Lost to Follow-up|1|||
125239418|NCT00790036|450501961|FG001|Overall Study|Lost to Follow-up|2|||
125239419|NCT00790036|450501960|FG000|Overall Study|Protocol Violation|10|||
125239420|NCT00790036|450501961|FG001|Overall Study|Protocol Violation|2|||
125239421|NCT00790036|450501960|FG000|Overall Study|Withdrawal by Subject|18|||
125239422|NCT00790036|450501961|FG001|Overall Study|Withdrawal by Subject|7|||
125239423|NCT00790036|450501960|FG000|Overall Study|Subject/guardian decision|20|||
125239424|NCT00790036|450501961|FG001|Overall Study|Subject/guardian decision|7|||
125239425|NCT02572167|450501962|FG000|Overall Study|Withdrawal by Subject|0|||
125239426|NCT02572167|450501963|FG001|Overall Study|Withdrawal by Subject|3|||
125239427|NCT02572167|450501964|FG002|Overall Study|Withdrawal by Subject|0|||
125239428|NCT02572167|450501962|FG000|Overall Study|Lost to Follow-up|2|||
125239429|NCT02572167|450501963|FG001|Overall Study|Lost to Follow-up|5|||
125239430|NCT02572167|450501964|FG002|Overall Study|Lost to Follow-up|3|||
125239431|NCT02572167|450501962|FG000|Overall Study|Death|0|||
125239432|NCT02572167|450501963|FG001|Overall Study|Death|8|||
125239433|NCT02572167|450501964|FG002|Overall Study|Death|3|||
125239434|NCT02572167|450501962|FG000|Overall Study|Did not meet inclusion criteria|0|||
125239435|NCT02572167|450501963|FG001|Overall Study|Did not meet inclusion criteria|0|||
125239436|NCT02572167|450501964|FG002|Overall Study|Did not meet inclusion criteria|1|||
125239437|NCT02572167|450501962|FG000|Overall Study|Study closure by Sponsor|4|||
125239438|NCT02572167|450501963|FG001|Overall Study|Study closure by Sponsor|40|||
125239439|NCT02572167|450501964|FG002|Overall Study|Study closure by Sponsor|24|||
125239440|NCT00005047|450501965|FG000|Overall Study|Withdrawal by Subject|12|||
125239441|NCT00005047|450501966|FG001|Overall Study|Withdrawal by Subject|0|||
125239442|NCT00005047|450501967|FG002|Overall Study|Withdrawal by Subject|0|||
125239443|NCT00005047|450501968|FG003|Overall Study|Withdrawal by Subject|0|||
125239444|NCT00005047|450501965|FG000|Overall Study|Adverse Event|5|||
125239445|NCT00005047|450501966|FG001|Overall Study|Adverse Event|0|||
125239446|NCT00005047|450501967|FG002|Overall Study|Adverse Event|0|||
125239447|NCT00005047|450501968|FG003|Overall Study|Adverse Event|0|||
125239448|NCT00005047|450501965|FG000|Overall Study|Lost to Follow-up|1|||
125239449|NCT00005047|450501966|FG001|Overall Study|Lost to Follow-up|0|||
125239450|NCT00005047|450501967|FG002|Overall Study|Lost to Follow-up|0|||
125239451|NCT00005047|450501968|FG003|Overall Study|Lost to Follow-up|0|||
125239452|NCT00005047|450501965|FG000|Overall Study|Lack of Efficacy|1|||
125239453|NCT00005047|450501966|FG001|Overall Study|Lack of Efficacy|0|||
125239454|NCT00005047|450501967|FG002|Overall Study|Lack of Efficacy|0|||
125239455|NCT00005047|450501968|FG003|Overall Study|Lack of Efficacy|0|||
125239456|NCT00088153|450501969|FG000|Overall Study|Physician Decision|3|||
125239457|NCT00088153|450501970|FG001|Overall Study|Physician Decision|3|||
125239458|NCT00088153|450501969|FG000|Overall Study|Withdrawal by Subject|10|||
125239459|NCT00088153|450501970|FG001|Overall Study|Withdrawal by Subject|10|||
125239460|NCT00088153|450501969|FG000|Overall Study|Lost to Follow-up|11|||
125239461|NCT00088153|450501970|FG001|Overall Study|Lost to Follow-up|12|||
125239462|NCT05248386|450501977|FG000|Overall Study|Technical problems|0|||
125239463|NCT05248386|450501978|FG001|Overall Study|Technical problems|1|||
125239464|NCT05248386|450501977|FG000|Overall Study|Withdrawal by Subject|15|||
125239465|NCT05248386|450501978|FG001|Overall Study|Withdrawal by Subject|10|||
125239466|NCT05248386|450501977|FG000|Overall Study|Physician Decision|0|||
125239467|NCT05248386|450501978|FG001|Overall Study|Physician Decision|1|||
125239468|NCT05248386|450501977|FG000|Overall Study|Adverse Event|2|||
125239469|NCT05248386|450501978|FG001|Overall Study|Adverse Event|4|||
125239470|NCT05248386|450501977|FG000|Overall Study|Other|1|||
125239471|NCT05248386|450501978|FG001|Overall Study|Other|0|||
125239472|NCT05248386|450501977|FG000|Overall Study|Lack of Efficacy|14|||
125239473|NCT05248386|450501978|FG001|Overall Study|Lack of Efficacy|12|||
125239474|NCT04967222|450501980|FG000|Randomized|Lost to Follow-up|0|||
125239475|NCT04967222|450501981|FG001|Randomized|Lost to Follow-up|1|||
125239476|NCT04967222|450501982|FG002|Randomized|Lost to Follow-up|1|||
125392511|NCT01714310|451072432|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
125239477|NCT04967222|450501980|FG000|Randomized|Physician Decision|0|||
125239478|NCT04967222|450501981|FG001|Randomized|Physician Decision|0|||
125239479|NCT04967222|450501982|FG002|Randomized|Physician Decision|1|||
125239480|NCT04967222|450501980|FG000|Randomized|Withdrawal by Subject|0|||
125239481|NCT04967222|450501981|FG001|Randomized|Withdrawal by Subject|0|||
125239482|NCT04967222|450501982|FG002|Randomized|Withdrawal by Subject|2|||
125239483|NCT04967222|450501980|FG000|Randomized|abnormal finding in MRI|0|||
125239484|NCT04967222|450501981|FG001|Randomized|abnormal finding in MRI|2|||
125239485|NCT04967222|450501982|FG002|Randomized|abnormal finding in MRI|0|||
125239486|NCT01295944|450501983|FG000|Overall Study|Switched to alternative treatment|1|||
125239487|NCT01295944|450501983|FG000|Overall Study|Ineligible|9|||
125239488|NCT01295944|450501983|FG000|Overall Study|Withdrawal by Subject|1|||
125239489|NCT01295944|450501983|FG000|Overall Study|Participant chose to be treated in Peru|1|||
125239490|NCT01295944|450501983|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
125239491|NCT01295944|450501983|FG000|Overall Study|Physician Decision|1|||
125239492|NCT01295944|450501983|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
125239493|NCT01295944|450501983|FG000|Overall Study|Disease progression|4|||
125239494|NCT01295944|450501983|FG000|Overall Study|Transferred care before starting new treatment|1|||
125239495|NCT05168800|450501984|FG000|Time 1 Survey|Did not start T1 survey|182|||
125239496|NCT05168800|450501985|FG001|Time 1 Survey|Did not start T1 survey|150|||
125239497|NCT05168800|450501986|FG002|Time 1 Survey|Did not start T1 survey|140|||
125239498|NCT05168800|450501984|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
125239499|NCT05168800|450501985|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
125239500|NCT05168800|450501986|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
125239501|NCT05168800|450501984|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
125239502|NCT05168800|450501985|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
125239503|NCT05168800|450501986|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
125239504|NCT05168800|450501984|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
125239505|NCT05168800|450501985|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
125239506|NCT05168800|450501986|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
125239507|NCT05168800|450501984|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
125239508|NCT05168800|450501985|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
125239509|NCT05168800|450501986|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
125239510|NCT05168800|450501984|FG000|Time 1 Survey|Withdrawal by Subject|6|||
125239511|NCT05168800|450501985|FG001|Time 1 Survey|Withdrawal by Subject|3|||
125239512|NCT05168800|450501986|FG002|Time 1 Survey|Withdrawal by Subject|2|||
125239513|NCT05168800|450501984|FG000|Time 2 Survey|Already excluded at Time 1|228|||
125239514|NCT05168800|450501985|FG001|Time 2 Survey|Already excluded at Time 1|202|||
125239515|NCT05168800|450501986|FG002|Time 2 Survey|Already excluded at Time 1|173|||
125239516|NCT05168800|450501984|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
125239517|NCT05168800|450501985|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
125239518|NCT05168800|450501986|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
125239519|NCT05168800|450501984|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
125239520|NCT05168800|450501985|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
125239521|NCT05168800|450501986|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
125239522|NCT05168800|450501984|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
125239523|NCT05168800|450501985|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
125239524|NCT05168800|450501986|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
125239525|NCT05168800|450501984|FG000|Time 2 Survey|Withdrawal by Subject|1|||
125239526|NCT05168800|450501985|FG001|Time 2 Survey|Withdrawal by Subject|0|||
125239527|NCT05168800|450501986|FG002|Time 2 Survey|Withdrawal by Subject|1|||
125239528|NCT05168800|450501984|FG000|Time 3 Survey|Already excluded at Time 1|228|||
125239529|NCT05168800|450501985|FG001|Time 3 Survey|Already excluded at Time 1|200|||
125239530|NCT05168800|450501986|FG002|Time 3 Survey|Already excluded at Time 1|173|||
125239531|NCT05168800|450501984|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
125239532|NCT05168800|450501985|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
125239533|NCT05168800|450501986|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
125239534|NCT05168800|450501984|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
125239535|NCT05168800|450501985|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
125239536|NCT05168800|450501986|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
125239537|NCT05168800|450501984|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
125239538|NCT05168800|450501985|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
125239539|NCT05168800|450501986|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
125239540|NCT03240874|450501987|FG000|Overall Study|Lost to Follow-up|0|||
125239541|NCT03240874|450501988|FG001|Overall Study|Lost to Follow-up|2|||
125239542|NCT03240874|450501989|FG002|Overall Study|Lost to Follow-up|4|||
125239543|NCT03240874|450501990|FG003|Overall Study|Lost to Follow-up|1|||
125239544|NCT04958707|450501991|FG000|Post Intervention|Withdrawal by Subject|1|||
125239545|NCT04958707|450501992|FG001|Post Intervention|Withdrawal by Subject|0|||
125239546|NCT04958707|450501993|FG002|Post Intervention|Withdrawal by Subject|0|||
125239547|NCT04958707|450501991|FG000|3 Months Follow- up|Lost to Follow-up|0|||
125239548|NCT04958707|450501992|FG001|3 Months Follow- up|Lost to Follow-up|3|||
125239549|NCT04958707|450501993|FG002|3 Months Follow- up|Lost to Follow-up|0|||
125239550|NCT04958707|450501991|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
125239551|NCT04958707|450501992|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
125239552|NCT04958707|450501993|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
125239553|NCT02629159|450501996|FG000|Overall Study|Adverse Event|17|||
125392512|NCT01714310|451072433|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
125392513|NCT01714310|451072434|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
125392514|NCT01714310|451072432|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
125239554|NCT02629159|450501997|FG001|Overall Study|Adverse Event|20|||
125239555|NCT02629159|450501998|FG002|Overall Study|Adverse Event|22|||
125239556|NCT02629159|450501996|FG000|Overall Study|Withdrawal by Subject|22|||
125239557|NCT02629159|450501997|FG001|Overall Study|Withdrawal by Subject|11|||
125239558|NCT02629159|450501998|FG002|Overall Study|Withdrawal by Subject|15|||
125239559|NCT02629159|450501996|FG000|Overall Study|Lost to Follow-up|7|||
125239560|NCT02629159|450501997|FG001|Overall Study|Lost to Follow-up|4|||
125239561|NCT02629159|450501998|FG002|Overall Study|Lost to Follow-up|5|||
125239562|NCT02629159|450501996|FG000|Overall Study|Lack of Efficacy|4|||
125239563|NCT02629159|450501997|FG001|Overall Study|Lack of Efficacy|0|||
125239564|NCT02629159|450501998|FG002|Overall Study|Lack of Efficacy|1|||
125239565|NCT02629159|450501996|FG000|Overall Study|Other|6|||
125239566|NCT02629159|450501997|FG001|Overall Study|Other|4|||
125239567|NCT02629159|450501998|FG002|Overall Study|Other|8|||
125239568|NCT03036254|450502003|FG000|Overall Study|Adverse Event|6|||
125239569|NCT03036254|450502004|FG001|Overall Study|Adverse Event|4|||
125239570|NCT03036254|450502003|FG000|Overall Study|Death|3|||
125239571|NCT03036254|450502004|FG001|Overall Study|Death|1|||
125239572|NCT03036254|450502003|FG000|Overall Study|Lack of Efficacy|5|||
125239573|NCT03036254|450502004|FG001|Overall Study|Lack of Efficacy|1|||
125239574|NCT03036254|450502003|FG000|Overall Study|Withdrawal by Subject|3|||
125239575|NCT03036254|450502004|FG001|Overall Study|Withdrawal by Subject|5|||
125239576|NCT04717557|450502013|FG000|Overall Study|Withdrawal by Subject|2|||
125239577|NCT04717557|450502014|FG001|Overall Study|Withdrawal by Subject|0|||
125239578|NCT04717557|450502013|FG000|Overall Study|Death|1|||
125239579|NCT04717557|450502014|FG001|Overall Study|Death|0|||
125239580|NCT05352399|450502016|FG000|Overall Study|Discontinued intervention|6|||
125239581|NCT01802281|450502019|FG000|Overall Study|Death|1|||
125239582|NCT01802281|450502020|FG001|Overall Study|Death|2|||
125239583|NCT01802281|450502019|FG000|Overall Study|Withdrawal by Subject|2|||
125239584|NCT01802281|450502020|FG001|Overall Study|Withdrawal by Subject|1|||
125239585|NCT01802281|450502019|FG000|Overall Study|Ineligible|5|||
125239586|NCT01802281|450502020|FG001|Overall Study|Ineligible|3|||
125239587|NCT02685735|450502021|FG000|Overall Study|Surgery Cancelled|4|||
125239588|NCT02685735|450502022|FG001|Overall Study|Surgery Cancelled|9|||
125239589|NCT02685735|450502021|FG000|Overall Study|Adverse Event|10|||
125239590|NCT02685735|450502022|FG001|Overall Study|Adverse Event|3|||
125239591|NCT02685735|450502021|FG000|Overall Study|Preop testing found to be incomplete|2|||
125239592|NCT02685735|450502022|FG001|Overall Study|Preop testing found to be incomplete|2|||
125239593|NCT02685735|450502021|FG000|Overall Study|Withdrawal by Subject|1|||
125239594|NCT02685735|450502022|FG001|Overall Study|Withdrawal by Subject|2|||
125239595|NCT02685735|450502021|FG000|Overall Study|Death|1|||
125239596|NCT02685735|450502022|FG001|Overall Study|Death|0|||
125239597|NCT00927472|450502032|FG000|Overall Study|Withdrawal by Subject|10|||
125239598|NCT00927472|450502033|FG001|Overall Study|Withdrawal by Subject|11|||
125239599|NCT00927472|450502032|FG000|Overall Study|Lost to Follow-up|1|||
125239600|NCT00927472|450502033|FG001|Overall Study|Lost to Follow-up|6|||
125239601|NCT00927472|450502032|FG000|Overall Study|Protocol Violation|0|||
125239602|NCT00927472|450502033|FG001|Overall Study|Protocol Violation|1|||
125239603|NCT00927472|450502032|FG000|Overall Study|Post treatment Assessment out of window|0|||
125239604|NCT00927472|450502033|FG001|Overall Study|Post treatment Assessment out of window|4|||
125239605|NCT04556097|450502034|FG000|Overall Study|Death|0|||
125239606|NCT04556097|450502035|FG001|Overall Study|Death|5|||
125239607|NCT04556097|450502036|FG002|Overall Study|Death|0|||
125239608|NCT04556097|450502037|FG003|Overall Study|Death|0|||
125239609|NCT04556097|450502034|FG000|Overall Study|No caregiver|43|||
125239610|NCT04556097|450502035|FG001|Overall Study|No caregiver|53|||
125239611|NCT04556097|450502036|FG002|Overall Study|No caregiver|0|||
125239612|NCT04556097|450502037|FG003|Overall Study|No caregiver|0|||
125239613|NCT04556097|450502034|FG000|Overall Study|Ineligible, SNF|2|||
125239614|NCT04556097|450502035|FG001|Overall Study|Ineligible, SNF|2|||
125239615|NCT04556097|450502036|FG002|Overall Study|Ineligible, SNF|0|||
125239616|NCT04556097|450502037|FG003|Overall Study|Ineligible, SNF|0|||
125239617|NCT04556097|450502034|FG000|Overall Study|Ineligible, health|3|||
125239618|NCT04556097|450502035|FG001|Overall Study|Ineligible, health|4|||
125239619|NCT04556097|450502036|FG002|Overall Study|Ineligible, health|0|||
125392515|NCT01714310|451072433|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
125392516|NCT01714310|451072434|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
125392517|NCT01714310|451072432|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
125392518|NCT01714310|451072433|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
125392519|NCT01714310|451072434|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
125392520|NCT01714310|451072432|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
125392521|NCT01714310|451072433|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
125239620|NCT04556097|450502037|FG003|Overall Study|Ineligible, health|0|||
125239621|NCT04556097|450502034|FG000|Overall Study|Ineligible, language|0|||
125239622|NCT04556097|450502035|FG001|Overall Study|Ineligible, language|1|||
125239623|NCT04556097|450502036|FG002|Overall Study|Ineligible, language|0|||
125239624|NCT04556097|450502037|FG003|Overall Study|Ineligible, language|0|||
125239625|NCT04556097|450502034|FG000|Overall Study|Ineligible, no longer in care management|0|||
125239626|NCT04556097|450502035|FG001|Overall Study|Ineligible, no longer in care management|2|||
125239627|NCT04556097|450502036|FG002|Overall Study|Ineligible, no longer in care management|1|||
125239628|NCT04556097|450502037|FG003|Overall Study|Ineligible, no longer in care management|0|||
125239629|NCT04556097|450502034|FG000|Overall Study|No dementia|13|||
125239630|NCT04556097|450502035|FG001|Overall Study|No dementia|3|||
125239631|NCT04556097|450502036|FG002|Overall Study|No dementia|0|||
125239632|NCT04556097|450502037|FG003|Overall Study|No dementia|0|||
125239633|NCT04556097|450502034|FG000|Overall Study|Missing identifier|2|||
125239634|NCT04556097|450502035|FG001|Overall Study|Missing identifier|4|||
125239635|NCT04556097|450502036|FG002|Overall Study|Missing identifier|0|||
125239636|NCT04556097|450502037|FG003|Overall Study|Missing identifier|0|||
125239637|NCT04556097|450502034|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
125239638|NCT04556097|450502035|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
125239639|NCT04556097|450502036|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
125239640|NCT04556097|450502037|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
125239641|NCT02516241|450502043|FG000|Overall Study|Death|255|||
125239642|NCT02516241|450502044|FG001|Overall Study|Death|262|||
125239643|NCT02516241|450502045|FG002|Overall Study|Death|270|||
125239644|NCT02516241|450502043|FG000|Overall Study|Lost to Follow-up|1|||
125239645|NCT02516241|450502044|FG001|Overall Study|Lost to Follow-up|1|||
125239646|NCT02516241|450502045|FG002|Overall Study|Lost to Follow-up|3|||
125239647|NCT02516241|450502043|FG000|Overall Study|Withdrawal by Subject|2|||
125239648|NCT02516241|450502044|FG001|Overall Study|Withdrawal by Subject|7|||
125239649|NCT02516241|450502045|FG002|Overall Study|Withdrawal by Subject|12|||
125239650|NCT02516241|450502043|FG000|Overall Study|participants ongoing at data cut-off|84|||
125239651|NCT02516241|450502044|FG001|Overall Study|participants ongoing at data cut-off|76|||
125239652|NCT02516241|450502045|FG002|Overall Study|participants ongoing at data cut-off|59|||
125239653|NCT03228537|450502046|FG000|Neoadjuvant|Adverse Event|2|||
125239654|NCT03228537|450502046|FG000|Neoadjuvant|Progression/Relapse|4|||
125239655|NCT03228537|450502046|FG000|Neoadjuvant|Death|1|||
125239656|NCT03228537|450502046|FG000|Surgery|Death|1|||
125239657|NCT03228537|450502046|FG000|Surgery|Other - Not Protocol Specified|2|||
125239658|NCT03228537|450502046|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
125239659|NCT03228537|450502046|FG000|Maintenance|Progression/Relapse|10|||
125239660|NCT05977868|450503216|FG000|Overall Study|Withdrawal by Subject|1|||
125239661|NCT05977868|450503217|FG001|Overall Study|Withdrawal by Subject|2|||
125239662|NCT05977868|450503216|FG000|Overall Study|Transitioned to comfort care|1|||
125239663|NCT05977868|450503217|FG001|Overall Study|Transitioned to comfort care|0|||
125239664|NCT03575364|450503224|FG000|Overall Study|Death|45|||
125239665|NCT03575364|450503224|FG000|Overall Study|Lost to Follow-up|114|||
125239666|NCT03575364|450503224|FG000|Overall Study|Withdrawal by Subject|21|||
125239667|NCT03575364|450503224|FG000|Overall Study|Physician Decision|11|||
125239668|NCT03575364|450503224|FG000|Overall Study|Subject Refused Follow-up|13|||
125239669|NCT03575364|450503224|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
125239670|NCT03575364|450503224|FG000|Overall Study|Patient moved out of the state|1|||
125239671|NCT03575364|450503224|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
125239672|NCT03575364|450503224|FG000|Overall Study|Patient is lost to follow up|1|||
125239673|NCT03575364|450503224|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
125239674|NCT04092777|450503228|FG000|Overall Study|Lost to Follow-up|28|||
125239675|NCT04092777|450503229|FG001|Overall Study|Lost to Follow-up|46|||
125239676|NCT04092777|450503228|FG000|Overall Study|Withdrawal by Subject|8|||
125239677|NCT04092777|450503229|FG001|Overall Study|Withdrawal by Subject|5|||
125392522|NCT01714310|451072434|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
125392523|NCT00654381|451072439|FG000|1st Stage|Adverse Event|3|||
125392524|NCT00654381|451072440|FG001|1st Stage|Adverse Event|3|||
125392525|NCT00654381|451072441|FG002|1st Stage|Adverse Event|3|||
125239678|NCT02306161|450503230|FG000|Overall Study|Death|1|||
125239679|NCT02306161|450503231|FG001|Overall Study|Death|3|||
125239680|NCT02306161|450503230|FG000|Overall Study|Lack of Efficacy|20|||
125239681|NCT02306161|450503231|FG001|Overall Study|Lack of Efficacy|43|||
125239682|NCT02306161|450503230|FG000|Overall Study|Physician Decision|30|||
125239683|NCT02306161|450503231|FG001|Overall Study|Physician Decision|18|||
125239684|NCT02306161|450503230|FG000|Overall Study|Withdrawal by Subject|4|||
125239685|NCT02306161|450503231|FG001|Overall Study|Withdrawal by Subject|0|||
125239686|NCT02306161|450503230|FG000|Overall Study|Ineligible|9|||
125239687|NCT02306161|450503231|FG001|Overall Study|Ineligible|5|||
125392526|NCT00654381|451072442|FG003|1st Stage|Adverse Event|3|||
125392527|NCT00654381|451072443|FG004|1st Stage|Adverse Event|2|||
125392528|NCT00654381|451072444|FG005|1st Stage|Adverse Event|1|||
125239688|NCT01081951|450503232|FG000|Overall Study|Death|54|||
125239689|NCT01081951|450503233|FG001|Overall Study|Death|47|||
125239690|NCT01081951|450503232|FG000|Overall Study|Withdrawal by Subject|2|||
125239691|NCT01081951|450503233|FG001|Overall Study|Withdrawal by Subject|6|||
125239692|NCT01081951|450503232|FG000|Overall Study|Allocated treatment but did not take it|0|||
125392529|NCT00654381|451072439|FG000|1st Stage|Withdrawal by Subject|0|||
125239693|NCT01081951|450503233|FG001|Overall Study|Allocated treatment but did not take it|1|||
125239694|NCT01081951|450503232|FG000|Overall Study|Lost to Follow-up|0|||
125239695|NCT01081951|450503233|FG001|Overall Study|Lost to Follow-up|1|||
125239696|NCT00975923|450503239|FG000|Overall Study|Withdrawal by Subject|0|||
125239697|NCT00975923|450503240|FG001|Overall Study|Withdrawal by Subject|1|||
125392530|NCT00654381|451072440|FG001|1st Stage|Withdrawal by Subject|0|||
125392531|NCT00654381|451072441|FG002|1st Stage|Withdrawal by Subject|0|||
125239698|NCT05291689|450503243|FG000|Overall Study|Adverse Event|3|||
125239699|NCT05291689|450503243|FG000|Overall Study|Lack of Efficacy|10|||
125239700|NCT05291689|450503243|FG000|Overall Study|Withdrawal by Subject|4|||
125239701|NCT01901562|450503244|FG000|Overall Study|Protocol Violation|5|||
125239702|NCT01901562|450503244|FG000|Overall Study|Excluded intraoperatively|4|||
125239703|NCT02612155|450503245|FG000|Overall Study|Death|1|||
125239704|NCT02612155|450503246|FG001|Overall Study|Death|1|||
125239705|NCT02612155|450503245|FG000|Overall Study|Lost to Follow-up|2|||
125239706|NCT02612155|450503246|FG001|Overall Study|Lost to Follow-up|2|||
125239707|NCT04435626|450503247|FG000|Overall Study|Lost to Follow-up|1|||
125239708|NCT04435626|450503248|FG001|Overall Study|Lost to Follow-up|5|||
125239709|NCT04435626|450503247|FG000|Overall Study|Withdrawal by Subject|6|||
125239710|NCT04435626|450503248|FG001|Overall Study|Withdrawal by Subject|7|||
125239711|NCT04435626|450503247|FG000|Overall Study|major GCP violations|8|||
125239712|NCT04435626|450503248|FG001|Overall Study|major GCP violations|7|||
125239713|NCT02864992|450503251|FG000|Overall Study|still on treatment|15|||
125239714|NCT02864992|450503252|FG001|Overall Study|still on treatment|1|||
125239715|NCT02864992|450503253|FG002|Overall Study|still on treatment|33|||
125239716|NCT05252702|450503254|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
125239717|NCT05252702|450503254|FG000|Overall Study|Death|16|||
125239718|NCT05252702|450503254|FG000|Overall Study|System explant|5|||
125239719|NCT05252702|450503254|FG000|Overall Study|Lost to Follow-up|1|||
125239720|NCT05252702|450503254|FG000|Overall Study|Withdrawn by investigator|1|||
125239721|NCT05252702|450503254|FG000|Overall Study|Visit not due|306|||
125239722|NCT05252702|450503254|FG000|Overall Study|Visit within window but not completed|92|||
125239723|NCT05252702|450503254|FG000|Overall Study|Unsuccessful implant|1|||
125239724|NCT02783274|450503256|FG000|Overall Study|Withdrawal by Subject|16|||
125239725|NCT02783274|450503256|FG000|Overall Study|Physician Decision|6|||
125239726|NCT02783274|450503256|FG000|Overall Study|Death|9|||
125239727|NCT02783274|450503256|FG000|Overall Study|Lost to Follow-up|22|||
125239728|NCT02783274|450503256|FG000|Overall Study|Other|22|||
125239729|NCT00098475|450503264|FG000|Step 1|Progressive disease|33|||
125239730|NCT00098475|450503265|FG001|Step 1|Progressive disease|35|||
125239731|NCT00098475|450503266|FG002|Step 1|Progressive disease|2|||
125239732|NCT00098475|450503267|FG003|Step 1|Progressive disease|1|||
125239733|NCT00098475|450503264|FG000|Step 1|Adverse Event|56|||
125239734|NCT00098475|450503265|FG001|Step 1|Adverse Event|37|||
125239735|NCT00098475|450503266|FG002|Step 1|Adverse Event|0|||
125239736|NCT00098475|450503267|FG003|Step 1|Adverse Event|1|||
125239737|NCT00098475|450503264|FG000|Step 1|Death|8|||
125239738|NCT00098475|450503265|FG001|Step 1|Death|5|||
125239739|NCT00098475|450503266|FG002|Step 1|Death|0|||
125239740|NCT00098475|450503267|FG003|Step 1|Death|1|||
125239741|NCT00098475|450503264|FG000|Step 1|Withdrawal by Subject|14|||
125239742|NCT00098475|450503265|FG001|Step 1|Withdrawal by Subject|11|||
125239743|NCT00098475|450503266|FG002|Step 1|Withdrawal by Subject|0|||
125239744|NCT00098475|450503267|FG003|Step 1|Withdrawal by Subject|0|||
125239745|NCT00098475|450503264|FG000|Step 1|Physician Decision|5|||
125239746|NCT00098475|450503265|FG001|Step 1|Physician Decision|2|||
125239747|NCT00098475|450503266|FG002|Step 1|Physician Decision|0|||
125239748|NCT00098475|450503267|FG003|Step 1|Physician Decision|0|||
125239749|NCT00098475|450503264|FG000|Step 1|Alternative therapy|31|||
125392532|NCT00654381|451072442|FG003|1st Stage|Withdrawal by Subject|1|||
125239750|NCT00098475|450503265|FG001|Step 1|Alternative therapy|43|||
125239751|NCT00098475|450503266|FG002|Step 1|Alternative therapy|1|||
125239752|NCT00098475|450503267|FG003|Step 1|Alternative therapy|0|||
125239753|NCT00098475|450503264|FG000|Step 1|Other disease|2|||
125239754|NCT00098475|450503265|FG001|Step 1|Other disease|1|||
125239755|NCT00098475|450503266|FG002|Step 1|Other disease|1|||
125239756|NCT00098475|450503267|FG003|Step 1|Other disease|0|||
125239757|NCT00098475|450503264|FG000|Step 1|Never started treatment|0|||
125239758|NCT00098475|450503265|FG001|Step 1|Never started treatment|2|||
125239759|NCT00098475|450503266|FG002|Step 1|Never started treatment|0|||
125239760|NCT00098475|450503267|FG003|Step 1|Never started treatment|0|||
125239761|NCT00098475|450503264|FG000|Step 1|Still on treatment as of this analysis|14|||
125239762|NCT00098475|450503265|FG001|Step 1|Still on treatment as of this analysis|27|||
125239763|NCT00098475|450503266|FG002|Step 1|Still on treatment as of this analysis|0|||
125239764|NCT00098475|450503267|FG003|Step 1|Still on treatment as of this analysis|0|||
125239765|NCT00098475|450503264|FG000|Step 1|Knee surgery|1|||
125239766|NCT00098475|450503265|FG001|Step 1|Knee surgery|0|||
125239767|NCT00098475|450503266|FG002|Step 1|Knee surgery|0|||
125239768|NCT00098475|450503267|FG003|Step 1|Knee surgery|0|||
125239769|NCT00098475|450503264|FG000|Step 1|Complications|1|||
125239770|NCT00098475|450503265|FG001|Step 1|Complications|0|||
125239771|NCT00098475|450503266|FG002|Step 1|Complications|0|||
125239772|NCT00098475|450503267|FG003|Step 1|Complications|0|||
125239773|NCT00098475|450503264|FG000|Step 1|Cannot comply due to other tx|0|||
125239774|NCT00098475|450503265|FG001|Step 1|Cannot comply due to other tx|1|||
125239775|NCT00098475|450503266|FG002|Step 1|Cannot comply due to other tx|0|||
125239776|NCT00098475|450503267|FG003|Step 1|Cannot comply due to other tx|0|||
125239777|NCT00098475|450503264|FG000|Step 1|Both patient and physician's decision|2|||
125392533|NCT00654381|451072443|FG004|1st Stage|Withdrawal by Subject|0|||
125392534|NCT00654381|451072444|FG005|1st Stage|Withdrawal by Subject|1|||
125392535|NCT00654381|451072439|FG000|1st Stage|Investigator's decision|0|||
125392536|NCT00654381|451072440|FG001|1st Stage|Investigator's decision|0|||
125186204|NCT03762265|450302398|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
125186205|NCT03762265|450302397|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
125186206|NCT03762265|450302398|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
125186207|NCT03762265|450302397|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
125186208|NCT03762265|450302398|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
125186209|NCT03762265|450302397|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
125186210|NCT03762265|450302398|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
125186211|NCT03762265|450302397|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
125186212|NCT03762265|450302398|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
125186213|NCT03762265|450302397|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
125186214|NCT03762265|450302398|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
125186215|NCT03762265|450302397|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
125186216|NCT03762265|450302398|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
125186217|NCT03762265|450302397|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
125186218|NCT03762265|450302398|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
125186219|NCT03762265|450302397|FG000|LTE Period: Weeks 61 to 109|Other|1|||
125186220|NCT03762265|450302398|FG001|LTE Period: Weeks 61 to 109|Other|0|||
125186221|NCT00806403|450302399|FG000|Overall Study|Death|4|||
125186222|NCT00806403|450302400|FG001|Overall Study|Death|3|||
125186223|NCT01882985|450302401|FG000|Overall Study|Lost to Follow-up|1|||
125186224|NCT01882985|450302401|FG000|Overall Study|Withdrawal by Subject|1|||
125186225|NCT00765102|450302402|FG000|Overall Study|Progressive disease|18|||
125186226|NCT00765102|450302402|FG000|Overall Study|Adverse Event|6|||
125186227|NCT00765102|450302402|FG000|Overall Study|Physician Decision|4|||
125186228|NCT00765102|450302402|FG000|Overall Study|Withdrawal by Subject|2|||
125186229|NCT00765102|450302402|FG000|Overall Study|Protocol Violation|1|||
125186230|NCT02857816|450302403|FG000|Overall Study|Screen Failure|33|||
125186231|NCT02857816|450302403|FG000|Overall Study|Withdrawal by Subject|4|||
125186232|NCT02857816|450302403|FG000|Overall Study|Lost to Follow-up|1|||
125186233|NCT01787292|450302406|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
125186234|NCT01787292|450302407|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
125186235|NCT01787292|450302406|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
125186236|NCT01787292|450302407|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
125186237|NCT01827111|450302408|FG000|Overall Study|Disease Progression|1|||
125186238|NCT02962648|450302410|FG000|Overall Study|Withdrawal by Subject|3|||
125186239|NCT02962648|450302410|FG000|Overall Study|Lost to Follow-up|3|||
125186240|NCT02962648|450302410|FG000|Overall Study|Physician Decision|1|||
125186241|NCT02962648|450302410|FG000|Overall Study|Subject had problems with transportation|2|||
125186242|NCT01597778|450302411|FG000|Overall Study|Death|7|||
125186243|NCT01597778|450302412|FG001|Overall Study|Death|10|||
125186244|NCT01597778|450302411|FG000|Overall Study|Withdrawal by Subject|3|||
125186245|NCT01597778|450302412|FG001|Overall Study|Withdrawal by Subject|4|||
125186246|NCT01597778|450302411|FG000|Overall Study|Adverse Event|1|||
125186247|NCT01597778|450302412|FG001|Overall Study|Adverse Event|1|||
125186248|NCT01597778|450302411|FG000|Overall Study|Protocol Violation|1|||
125186249|NCT01597778|450302412|FG001|Overall Study|Protocol Violation|11|||
125186250|NCT01597778|450302411|FG000|Overall Study|Transplanted off protocol|2|||
125186251|NCT01597778|450302412|FG001|Overall Study|Transplanted off protocol|3|||
125186252|NCT04383327|450302414|FG000|Overall Study|Lost to Follow-up|112|||
125186253|NCT04383327|450302415|FG001|Overall Study|Lost to Follow-up|14|||
125186254|NCT04383327|450302416|FG002|Overall Study|Lost to Follow-up|78|||
125186255|NCT04383327|450302417|FG003|Overall Study|Lost to Follow-up|13|||
125186256|NCT04383327|450302418|FG004|Overall Study|Lost to Follow-up|110|||
125186257|NCT04383327|450302419|FG005|Overall Study|Lost to Follow-up|13|||
125186258|NCT04383327|450302420|FG006|Overall Study|Lost to Follow-up|74|||
125186259|NCT04383327|450302421|FG007|Overall Study|Lost to Follow-up|13|||
125186260|NCT04383327|450302422|FG008|Overall Study|Lost to Follow-up|78|||
125186261|NCT04383327|450302423|FG009|Overall Study|Lost to Follow-up|10|||
125186262|NCT04383327|450302424|FG010|Overall Study|Lost to Follow-up|160|||
125186263|NCT04383327|450302425|FG011|Overall Study|Lost to Follow-up|13|||
125186264|NCT01289678|450302426|FG000|Overall Study|Physician Decision|6|||
125186265|NCT00468819|450302427|FG000|Overall Study|Withdrawal by Subject|4|||
125186266|NCT00468819|450302428|FG001|Overall Study|Withdrawal by Subject|0|||
125186267|NCT00468819|450302429|FG002|Overall Study|Withdrawal by Subject|1|||
125186268|NCT00468819|450302427|FG000|Overall Study|Lost to Follow-up|0|||
125186269|NCT00468819|450302428|FG001|Overall Study|Lost to Follow-up|0|||
125186270|NCT00468819|450302429|FG002|Overall Study|Lost to Follow-up|1|||
125186271|NCT00468819|450302427|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
125186272|NCT00468819|450302428|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
125186273|NCT00468819|450302429|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
125186274|NCT04030299|450302430|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
125186275|NCT04030299|450302430|FG000|Overall Study|Withdrawal by Subject|3|||
125392537|NCT00654381|451072441|FG002|1st Stage|Investigator's decision|0|||
125239778|NCT00098475|450503265|FG001|Step 1|Both patient and physician's decision|1|||
125239779|NCT00098475|450503266|FG002|Step 1|Both patient and physician's decision|0|||
125239780|NCT00098475|450503267|FG003|Step 1|Both patient and physician's decision|0|||
125239781|NCT00098475|450503264|FG000|Step 1|Incorrect disease assessment|2|||
125239782|NCT00098475|450503265|FG001|Step 1|Incorrect disease assessment|0|||
125239783|NCT00098475|450503266|FG002|Step 1|Incorrect disease assessment|0|||
125239784|NCT00098475|450503267|FG003|Step 1|Incorrect disease assessment|0|||
125239785|NCT00098475|450503264|FG000|Step 1|Off treatment for > specified timeframe|1|||
125239786|NCT00098475|450503265|FG001|Step 1|Off treatment for > specified timeframe|1|||
125239787|NCT00098475|450503266|FG002|Step 1|Off treatment for > specified timeframe|0|||
125239788|NCT00098475|450503267|FG003|Step 1|Off treatment for > specified timeframe|0|||
125239789|NCT00098475|450503264|FG000|Step 1|Declining performance status|0|||
125239790|NCT00098475|450503265|FG001|Step 1|Declining performance status|1|||
125239791|NCT00098475|450503266|FG002|Step 1|Declining performance status|0|||
125239792|NCT00098475|450503267|FG003|Step 1|Declining performance status|0|||
125239793|NCT00098475|450503264|FG000|Step 1|Insurance issue|0|||
125239794|NCT00098475|450503265|FG001|Step 1|Insurance issue|1|||
125239795|NCT00098475|450503266|FG002|Step 1|Insurance issue|0|||
125239796|NCT00098475|450503267|FG003|Step 1|Insurance issue|0|||
125239797|NCT00098475|450503264|FG000|Step 1|Rising paraprotein|0|||
125239798|NCT00098475|450503265|FG001|Step 1|Rising paraprotein|1|||
125239799|NCT00098475|450503266|FG002|Step 1|Rising paraprotein|0|||
125239800|NCT00098475|450503267|FG003|Step 1|Rising paraprotein|0|||
125239801|NCT00098475|450503264|FG000|Step 1|Referred to other physicians|0|||
125239802|NCT00098475|450503265|FG001|Step 1|Referred to other physicians|1|||
125239803|NCT00098475|450503266|FG002|Step 1|Referred to other physicians|0|||
125239804|NCT00098475|450503267|FG003|Step 1|Referred to other physicians|0|||
125239805|NCT00098475|450503264|FG000|Step 1|Criteria to continue treatment not met|0|||
125239806|NCT00098475|450503265|FG001|Step 1|Criteria to continue treatment not met|1|||
125239807|NCT00098475|450503266|FG002|Step 1|Criteria to continue treatment not met|0|||
125239808|NCT00098475|450503267|FG003|Step 1|Criteria to continue treatment not met|0|||
125239809|NCT00098475|450503264|FG000|Step 1|Misinterpretation of lab data|0|||
125239810|NCT00098475|450503265|FG001|Step 1|Misinterpretation of lab data|1|||
125239811|NCT00098475|450503266|FG002|Step 1|Misinterpretation of lab data|0|||
125239812|NCT00098475|450503267|FG003|Step 1|Misinterpretation of lab data|0|||
125239813|NCT00098475|450503264|FG000|Step 1|Patient fell with fracture|1|||
125239814|NCT00098475|450503265|FG001|Step 1|Patient fell with fracture|0|||
125239815|NCT00098475|450503266|FG002|Step 1|Patient fell with fracture|0|||
125239816|NCT00098475|450503267|FG003|Step 1|Patient fell with fracture|0|||
125392538|NCT00654381|451072442|FG003|1st Stage|Investigator's decision|1|||
125392539|NCT00654381|451072443|FG004|1st Stage|Investigator's decision|0|||
125392540|NCT00654381|451072444|FG005|1st Stage|Investigator's decision|0|||
125392541|NCT00654381|451072439|FG000|2nd Stage|Adverse Event|2|||
125392542|NCT00654381|451072440|FG001|2nd Stage|Adverse Event|0|||
125392543|NCT00654381|451072441|FG002|2nd Stage|Adverse Event|2|||
125186276|NCT04740918|450302431|FG000|Overall Study|Study Terminated by Sponsor|41|||
125186277|NCT04740918|450302432|FG001|Overall Study|Study Terminated by Sponsor|32|||
125186278|NCT04740918|450302431|FG000|Overall Study|Death|3|||
125186279|NCT04740918|450302432|FG001|Overall Study|Death|6|||
125186280|NCT04740918|450302431|FG000|Overall Study|Withdrawal by Subject|5|||
125186281|NCT04740918|450302432|FG001|Overall Study|Withdrawal by Subject|4|||
125186282|NCT04740918|450302431|FG000|Overall Study|Lost to Follow-up|1|||
125186283|NCT04740918|450302432|FG001|Overall Study|Lost to Follow-up|3|||
125186284|NCT04740918|450302431|FG000|Overall Study|Progressive disease|0|||
125186285|NCT04740918|450302432|FG001|Overall Study|Progressive disease|1|||
125186286|NCT02524847|450302433|FG000|Overall Study|Adverse Event|4|||
125186287|NCT02524847|450302433|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
125186288|NCT02524847|450302433|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
125186289|NCT02524847|450302433|FG000|Overall Study|Death|1|||
125186290|NCT02524847|450302433|FG000|Overall Study|Reason not Specified|1|||
125186291|NCT04352101|450302434|FG000|Overall Study|Physician Decision|2|||
125186292|NCT04352101|450302435|FG001|Overall Study|Physician Decision|1|||
125186293|NCT01709500|450302436|FG000|Overall Study|Randomized but not treated|0|||
125186294|NCT01709500|450302437|FG001|Overall Study|Randomized but not treated|1|||
125186295|NCT01709500|450302436|FG000|Overall Study|Adverse Event|5|||
125186296|NCT01709500|450302437|FG001|Overall Study|Adverse Event|1|||
125186297|NCT01709500|450302436|FG000|Overall Study|Poor compliance to protocol|2|||
125186298|NCT01709500|450302437|FG001|Overall Study|Poor compliance to protocol|1|||
125186299|NCT01709500|450302436|FG000|Overall Study|Other|3|||
125239817|NCT00098475|450503264|FG000|Step 1|Not documented|0|||
125239818|NCT00098475|450503265|FG001|Step 1|Not documented|1|||
125239819|NCT00098475|450503266|FG002|Step 1|Not documented|0|||
125186300|NCT01709500|450302437|FG001|Overall Study|Other|1|||
125186301|NCT01709500|450302436|FG000|Overall Study|Related to IMP administration|1|||
125239820|NCT00098475|450503267|FG003|Step 1|Not documented|0|||
125239821|NCT00098475|450503264|FG000|Step 2|Disease progression|1|||
125239822|NCT00098475|450503265|FG001|Step 2|Disease progression|4|||
125392544|NCT00654381|451072442|FG003|2nd Stage|Adverse Event|3|||
125392545|NCT00654381|451072443|FG004|2nd Stage|Adverse Event|7|||
125186302|NCT01709500|450302437|FG001|Overall Study|Related to IMP administration|0|||
125186303|NCT01709500|450302436|FG000|Overall Study|Treatment ongoing|156|||
125186304|NCT01709500|450302437|FG001|Overall Study|Treatment ongoing|78|||
125186305|NCT02387840|450302438|FG000|Overall Study|Death|0|||
125186306|NCT02387840|450302439|FG001|Overall Study|Death|0|||
125186307|NCT02387840|450302440|FG002|Overall Study|Death|0|||
125186308|NCT02387840|450302441|FG003|Overall Study|Death|0|||
125186309|NCT02387840|450302442|FG004|Overall Study|Death|0|||
125186310|NCT02387840|450302443|FG005|Overall Study|Death|1|||
125186311|NCT00908544|450302444|FG000|Overall Study|Withdrawal by Subject|2|||
125186312|NCT00908544|450302445|FG001|Overall Study|Withdrawal by Subject|4|||
125186313|NCT00908544|450302444|FG000|Overall Study|Lack of Efficacy|0|||
125186314|NCT00908544|450302445|FG001|Overall Study|Lack of Efficacy|1|||
125186315|NCT00908544|450302444|FG000|Overall Study|Pregnancy|1|||
125186316|NCT00908544|450302445|FG001|Overall Study|Pregnancy|0|||
125186317|NCT00908544|450302444|FG000|Overall Study|Relocation abroad|1|||
125186318|NCT00908544|450302445|FG001|Overall Study|Relocation abroad|1|||
125186319|NCT00908544|450302444|FG000|Overall Study|Unable to visit sutdy center|1|||
125186320|NCT00908544|450302445|FG001|Overall Study|Unable to visit sutdy center|0|||
125186321|NCT03170544|450302446|FG000|Part 1|Lost to Follow-up|1|||
125186322|NCT03170544|450302447|FG001|Part 1|Lost to Follow-up|0|||
125186323|NCT03170544|450302448|FG002|Part 1|Lost to Follow-up|0|||
125186324|NCT03170544|450302449|FG003|Part 1|Lost to Follow-up|0|||
125186325|NCT03170544|450302450|FG004|Part 1|Lost to Follow-up|0|||
125186326|NCT03170544|450302451|FG005|Part 1|Lost to Follow-up|0|||
125186327|NCT03170544|450302452|FG006|Part 1|Lost to Follow-up|0|||
125186328|NCT03170544|450302453|FG007|Part 1|Lost to Follow-up|0|||
125186329|NCT03170544|450302454|FG008|Part 1|Lost to Follow-up|0|||
125186330|NCT03170544|450302455|FG009|Part 1|Lost to Follow-up|0|||
125186331|NCT03170544|450302456|FG010|Part 1|Lost to Follow-up|0|||
125186332|NCT03170544|450302457|FG011|Part 1|Lost to Follow-up|0|||
125186333|NCT03170544|450302446|FG000|Part 1|Not treated|0|||
125186334|NCT03170544|450302447|FG001|Part 1|Not treated|0|||
125186335|NCT03170544|450302448|FG002|Part 1|Not treated|0|||
125186336|NCT03170544|450302449|FG003|Part 1|Not treated|1|||
125186337|NCT03170544|450302450|FG004|Part 1|Not treated|0|||
125186338|NCT03170544|450302451|FG005|Part 1|Not treated|0|||
125186339|NCT03170544|450302452|FG006|Part 1|Not treated|0|||
125186340|NCT03170544|450302453|FG007|Part 1|Not treated|0|||
125186341|NCT03170544|450302454|FG008|Part 1|Not treated|0|||
125186342|NCT03170544|450302455|FG009|Part 1|Not treated|0|||
125186343|NCT03170544|450302456|FG010|Part 1|Not treated|0|||
125186344|NCT03170544|450302457|FG011|Part 1|Not treated|0|||
125186345|NCT03539302|450302463|FG000|Overall Study|Spontaneous cardio version|0|||
125186346|NCT03539302|450302464|FG001|Overall Study|Spontaneous cardio version|0|||
125186347|NCT03539302|450302465|FG002|Overall Study|Spontaneous cardio version|0|||
125186348|NCT03539302|450302466|FG003|Overall Study|Spontaneous cardio version|0|||
125186349|NCT03539302|450302467|FG004|Overall Study|Spontaneous cardio version|0|||
125186350|NCT03539302|450302468|FG005|Overall Study|Spontaneous cardio version|1|||
125186351|NCT03539302|450302469|FG006|Overall Study|Spontaneous cardio version|1|||
125186352|NCT02174627|450302472|FG000|Overall Study|Missing|0|||
125186353|NCT02174627|450302473|FG001|Overall Study|Missing|1|||
125186354|NCT02174627|450302472|FG000|Overall Study|Incorrect enrolment before randomization|0|||
125186355|NCT02174627|450302473|FG001|Overall Study|Incorrect enrolment before randomization|1|||
125186356|NCT02174627|450302472|FG000|Overall Study|Participant decision|84|||
125186357|NCT02174627|450302473|FG001|Overall Study|Participant decision|128|||
125186358|NCT00071110|450302474|FG000|Overall Study|Protocol Violation|0|||
125186359|NCT00071110|450302475|FG001|Overall Study|Protocol Violation|4|||
125186360|NCT02389829|450302478|FG000|Overall Study|Lost to Follow-up|0|||
125186361|NCT02389829|450302479|FG001|Overall Study|Lost to Follow-up|1|||
125186362|NCT02362360|450302480|FG000|Period 1|Lack of Efficacy|1|||
125186363|NCT02362360|450302481|FG001|Period 1|Lack of Efficacy|0|||
125186364|NCT02362360|450302480|FG000|Period 1|Withdrawal by Subject|2|||
125186365|NCT02362360|450302481|FG001|Period 1|Withdrawal by Subject|1|||
125186366|NCT03578367|450302482|FG000|Overall Study|Adverse Event|0|||
125239823|NCT00098475|450503266|FG002|Step 2|Disease progression|0|||
125186367|NCT03578367|450302483|FG001|Overall Study|Adverse Event|3|||
125186368|NCT03578367|450302484|FG002|Overall Study|Adverse Event|0|||
125186369|NCT03578367|450302485|FG003|Overall Study|Adverse Event|5|||
125186370|NCT03578367|450302482|FG000|Overall Study|Withdrawal by Subject|2|||
125186371|NCT03578367|450302483|FG001|Overall Study|Withdrawal by Subject|2|||
125186372|NCT03578367|450302484|FG002|Overall Study|Withdrawal by Subject|1|||
125186373|NCT03578367|450302485|FG003|Overall Study|Withdrawal by Subject|3|||
125186374|NCT03578367|450302482|FG000|Overall Study|Physician Decision|0|||
125186375|NCT03578367|450302483|FG001|Overall Study|Physician Decision|0|||
125186376|NCT03578367|450302484|FG002|Overall Study|Physician Decision|14|||
125186377|NCT03578367|450302485|FG003|Overall Study|Physician Decision|0|||
125186378|NCT03578367|450302482|FG000|Overall Study|Death|1|||
125186379|NCT03578367|450302483|FG001|Overall Study|Death|0|||
125186380|NCT03578367|450302484|FG002|Overall Study|Death|0|||
125186381|NCT03578367|450302485|FG003|Overall Study|Death|0|||
125186382|NCT03578367|450302482|FG000|Overall Study|Not treated|0|||
125392546|NCT00654381|451072444|FG005|2nd Stage|Adverse Event|2|||
125392547|NCT00654381|451072439|FG000|2nd Stage|Withdrawal by Subject|0|||
125392548|NCT00654381|451072440|FG001|2nd Stage|Withdrawal by Subject|0|||
125392549|NCT00654381|451072441|FG002|2nd Stage|Withdrawal by Subject|0|||
125392550|NCT00654381|451072442|FG003|2nd Stage|Withdrawal by Subject|0|||
125392551|NCT00654381|451072443|FG004|2nd Stage|Withdrawal by Subject|1|||
125392552|NCT00654381|451072444|FG005|2nd Stage|Withdrawal by Subject|1|||
125392553|NCT00654381|451072439|FG000|2nd Stage|Investigator's decision|0|||
125186383|NCT03578367|450302483|FG001|Overall Study|Not treated|0|||
125239824|NCT00098475|450503267|FG003|Step 2|Disease progression|0|||
125239825|NCT00098475|450503264|FG000|Step 2|Adverse Event|2|||
125239826|NCT00098475|450503265|FG001|Step 2|Adverse Event|0|||
125239827|NCT00098475|450503266|FG002|Step 2|Adverse Event|0|||
125239828|NCT00098475|450503267|FG003|Step 2|Adverse Event|0|||
125239829|NCT00098475|450503264|FG000|Step 2|Withdrawal by Subject|0|||
125239830|NCT00098475|450503265|FG001|Step 2|Withdrawal by Subject|2|||
125239831|NCT00098475|450503266|FG002|Step 2|Withdrawal by Subject|0|||
125239832|NCT00098475|450503267|FG003|Step 2|Withdrawal by Subject|0|||
125239833|NCT00098475|450503264|FG000|Step 2|Physician Decision|0|||
125239834|NCT00098475|450503265|FG001|Step 2|Physician Decision|1|||
125239835|NCT00098475|450503266|FG002|Step 2|Physician Decision|0|||
125239836|NCT00098475|450503267|FG003|Step 2|Physician Decision|0|||
125239837|NCT00098475|450503264|FG000|Step 2|Alternative therapy|1|||
125239838|NCT00098475|450503265|FG001|Step 2|Alternative therapy|2|||
125239839|NCT00098475|450503266|FG002|Step 2|Alternative therapy|0|||
125239840|NCT00098475|450503267|FG003|Step 2|Alternative therapy|0|||
125239841|NCT00098475|450503264|FG000|Step 2|Never started treatment|1|||
125186384|NCT03578367|450302484|FG002|Overall Study|Not treated|1|||
125186385|NCT03578367|450302485|FG003|Overall Study|Not treated|0|||
125186386|NCT02729025|450302489|FG000|Overall Study|Sponsor Decision|0|||
125186387|NCT02729025|450302490|FG001|Overall Study|Sponsor Decision|1|||
125186388|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Adverse Event|7|||
125186389|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
125186390|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Non-compliance|3|||
125186391|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Other|17|||
125186392|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Physician Decision|2|||
125186393|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Pregnancy|1|||
125186394|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
125186395|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
125186396|NCT05207865|450303633|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
125186397|NCT05207865|450303633|FG000|Follow-up Phase|Lost to Follow-up|1|||
125186398|NCT05207865|450303633|FG000|Follow-up Phase|Non-compliance|1|||
125186399|NCT05207865|450303633|FG000|Follow-up Phase|Not reported|2|||
125186400|NCT05207865|450303633|FG000|Follow-up Phase|Not collected|11|||
125186401|NCT05423093|450303634|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
125186402|NCT05423093|450303634|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
125186403|NCT05423093|450303634|FG000|Attended Intervention Session|Lost to Follow-up|3|||
125186404|NCT05423093|450303634|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
125186405|NCT05423093|450303634|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
125186406|NCT05364931|450303635|FG000|Overall Study|Adverse Event|0|||
125186407|NCT05364931|450303636|FG001|Overall Study|Adverse Event|2|||
125186408|NCT05364931|450303637|FG002|Overall Study|Adverse Event|1|||
125186409|NCT05364931|450303638|FG003|Overall Study|Adverse Event|0|||
125186410|NCT05364931|450303635|FG000|Overall Study|Lost to Follow-up|1|||
125186411|NCT05364931|450303636|FG001|Overall Study|Lost to Follow-up|0|||
125186412|NCT05364931|450303637|FG002|Overall Study|Lost to Follow-up|0|||
125186413|NCT05364931|450303638|FG003|Overall Study|Lost to Follow-up|0|||
125186414|NCT05364931|450303635|FG000|Overall Study|Withdrawal by Subject|1|||
125186415|NCT05364931|450303636|FG001|Overall Study|Withdrawal by Subject|1|||
125186416|NCT05364931|450303637|FG002|Overall Study|Withdrawal by Subject|3|||
125239842|NCT00098475|450503265|FG001|Step 2|Never started treatment|1|||
125239843|NCT00098475|450503266|FG002|Step 2|Never started treatment|0|||
125186417|NCT05364931|450303638|FG003|Overall Study|Withdrawal by Subject|2|||
125186418|NCT05364931|450303635|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
125186419|NCT05364931|450303636|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
125186420|NCT05364931|450303637|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
125186421|NCT05364931|450303638|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
125186422|NCT05364931|450303635|FG000|Overall Study|Discontinued|1|||
125186423|NCT05364931|450303636|FG001|Overall Study|Discontinued|0|||
125186424|NCT05364931|450303637|FG002|Overall Study|Discontinued|0|||
125186425|NCT05364931|450303638|FG003|Overall Study|Discontinued|0|||
125239844|NCT00098475|450503267|FG003|Step 2|Never started treatment|0|||
125239845|NCT03370276|450503268|FG000|Overall Study|Death|0|||
125239846|NCT03370276|450503269|FG001|Overall Study|Death|2|||
125392554|NCT00654381|451072440|FG001|2nd Stage|Investigator's decision|0|||
125392555|NCT00654381|451072441|FG002|2nd Stage|Investigator's decision|1|||
125239847|NCT03370276|450503270|FG002|Overall Study|Death|5|||
125239848|NCT00831844|450503273|FG000|Overall Study|Adverse Event|2|||
125239849|NCT00831844|450503274|FG001|Overall Study|Adverse Event|0|||
125239850|NCT00831844|450503275|FG002|Overall Study|Adverse Event|0|||
125239851|NCT00831844|450503276|FG003|Overall Study|Adverse Event|0|||
125239852|NCT00831844|450503277|FG004|Overall Study|Adverse Event|1|||
125239853|NCT00831844|450503278|FG005|Overall Study|Adverse Event|1|||
125239854|NCT00831844|450503279|FG006|Overall Study|Adverse Event|2|||
125239855|NCT00831844|450503280|FG007|Overall Study|Adverse Event|0|||
125239856|NCT00831844|450503281|FG008|Overall Study|Adverse Event|0|||
125239857|NCT00831844|450503282|FG009|Overall Study|Adverse Event|0|||
125239858|NCT00831844|450503273|FG000|Overall Study|Death|0|||
125239859|NCT00831844|450503274|FG001|Overall Study|Death|0|||
125239860|NCT00831844|450503275|FG002|Overall Study|Death|0|||
125239861|NCT00831844|450503276|FG003|Overall Study|Death|1|||
125239862|NCT00831844|450503277|FG004|Overall Study|Death|0|||
125239863|NCT00831844|450503278|FG005|Overall Study|Death|0|||
125239864|NCT00831844|450503279|FG006|Overall Study|Death|0|||
125239865|NCT00831844|450503280|FG007|Overall Study|Death|0|||
125239866|NCT00831844|450503281|FG008|Overall Study|Death|0|||
125239867|NCT00831844|450503282|FG009|Overall Study|Death|0|||
125239868|NCT00831844|450503273|FG000|Overall Study|Lack of Efficacy|8|||
125239869|NCT00831844|450503274|FG001|Overall Study|Lack of Efficacy|10|||
125239870|NCT00831844|450503275|FG002|Overall Study|Lack of Efficacy|15|||
125239871|NCT00831844|450503276|FG003|Overall Study|Lack of Efficacy|8|||
125239872|NCT00831844|450503277|FG004|Overall Study|Lack of Efficacy|11|||
125239873|NCT00831844|450503278|FG005|Overall Study|Lack of Efficacy|17|||
125239874|NCT00831844|450503279|FG006|Overall Study|Lack of Efficacy|8|||
125239875|NCT00831844|450503280|FG007|Overall Study|Lack of Efficacy|9|||
125239876|NCT00831844|450503281|FG008|Overall Study|Lack of Efficacy|7|||
125239877|NCT00831844|450503282|FG009|Overall Study|Lack of Efficacy|0|||
125239878|NCT00831844|450503273|FG000|Overall Study|Physician Decision|0|||
125239879|NCT00831844|450503274|FG001|Overall Study|Physician Decision|1|||
125239880|NCT00831844|450503275|FG002|Overall Study|Physician Decision|3|||
125239881|NCT00831844|450503276|FG003|Overall Study|Physician Decision|1|||
125239882|NCT00831844|450503277|FG004|Overall Study|Physician Decision|1|||
125239883|NCT00831844|450503278|FG005|Overall Study|Physician Decision|1|||
125239884|NCT00831844|450503279|FG006|Overall Study|Physician Decision|0|||
125239885|NCT00831844|450503280|FG007|Overall Study|Physician Decision|0|||
125239886|NCT00831844|450503281|FG008|Overall Study|Physician Decision|1|||
125239887|NCT00831844|450503282|FG009|Overall Study|Physician Decision|0|||
125239888|NCT00831844|450503273|FG000|Overall Study|Withdrawal by Subject|0|||
125239889|NCT00831844|450503274|FG001|Overall Study|Withdrawal by Subject|0|||
125239890|NCT00831844|450503275|FG002|Overall Study|Withdrawal by Subject|1|||
125239891|NCT00831844|450503276|FG003|Overall Study|Withdrawal by Subject|0|||
125239892|NCT00831844|450503277|FG004|Overall Study|Withdrawal by Subject|0|||
125239893|NCT00831844|450503278|FG005|Overall Study|Withdrawal by Subject|0|||
125239894|NCT00831844|450503279|FG006|Overall Study|Withdrawal by Subject|0|||
125186426|NCT03504397|450303641|FG000|Overall Study|Progressive Disease|151|||
125186427|NCT03504397|450303642|FG001|Overall Study|Progressive Disease|199|||
125186428|NCT03504397|450303641|FG000|Overall Study|Withdrawal by Subject|29|||
125186429|NCT03504397|450303642|FG001|Overall Study|Withdrawal by Subject|17|||
125186430|NCT03504397|450303641|FG000|Overall Study|Lost to Follow-up|1|||
125186431|NCT03504397|450303642|FG001|Overall Study|Lost to Follow-up|0|||
125186432|NCT03504397|450303641|FG000|Overall Study|Death|14|||
125186433|NCT03504397|450303642|FG001|Overall Study|Death|16|||
125186434|NCT03504397|450303641|FG000|Overall Study|Adverse Event|40|||
125186435|NCT03504397|450303642|FG001|Overall Study|Adverse Event|14|||
125186436|NCT03504397|450303641|FG000|Overall Study|miscellaneous|17|||
125239895|NCT00831844|450503280|FG007|Overall Study|Withdrawal by Subject|1|||
125239896|NCT00831844|450503281|FG008|Overall Study|Withdrawal by Subject|1|||
125239897|NCT00831844|450503282|FG009|Overall Study|Withdrawal by Subject|0|||
125239898|NCT00831844|450503273|FG000|Overall Study|Ineligible|0|||
125239899|NCT00831844|450503274|FG001|Overall Study|Ineligible|1|||
125186437|NCT03504397|450303642|FG001|Overall Study|miscellaneous|15|||
125186438|NCT03504397|450303641|FG000|Overall Study|Protocol deviation|1|||
125239900|NCT00831844|450503275|FG002|Overall Study|Ineligible|1|||
125239901|NCT00831844|450503276|FG003|Overall Study|Ineligible|0|||
125239902|NCT00831844|450503277|FG004|Overall Study|Ineligible|1|||
125239903|NCT00831844|450503278|FG005|Overall Study|Ineligible|0|||
125239904|NCT00831844|450503279|FG006|Overall Study|Ineligible|0|||
125186439|NCT03504397|450303642|FG001|Overall Study|Protocol deviation|0|||
125186440|NCT03504397|450303641|FG000|Overall Study|Participants who did not take the study drug|4|||
125186441|NCT03504397|450303642|FG001|Overall Study|Participants who did not take the study drug|4|||
125239905|NCT00831844|450503280|FG007|Overall Study|Ineligible|0|||
125239906|NCT00831844|450503281|FG008|Overall Study|Ineligible|0|||
125239907|NCT00831844|450503282|FG009|Overall Study|Ineligible|0|||
125239908|NCT04057365|450503285|FG000|Overall Study|Withdrawal by Subject|2|||
125239909|NCT04057365|450503286|FG001|Overall Study|Withdrawal by Subject|0|||
125239910|NCT03976375|450503287|FG000|Overall Study|Death|158|||
125239911|NCT03976375|450503288|FG001|Overall Study|Death|160|||
125239912|NCT03976375|450503289|FG002|Overall Study|Death|42|||
125239913|NCT03976375|450503287|FG000|Overall Study|Lost to Follow-up|2|||
125239914|NCT03976375|450503288|FG001|Overall Study|Lost to Follow-up|1|||
125239915|NCT03976375|450503289|FG002|Overall Study|Lost to Follow-up|1|||
125239916|NCT03976375|450503287|FG000|Overall Study|Withdrawal by Subject|5|||
125239917|NCT03976375|450503288|FG001|Overall Study|Withdrawal by Subject|9|||
125239918|NCT03976375|450503289|FG002|Overall Study|Withdrawal by Subject|4|||
125239919|NCT03976375|450503287|FG000|Overall Study|Sponsor decision|20|||
125239920|NCT03976375|450503288|FG001|Overall Study|Sponsor decision|19|||
125239921|NCT03976375|450503289|FG002|Overall Study|Sponsor decision|1|||
125239922|NCT04635423|450503290|FG000|Overall Study|Ongoing|493|||
125239923|NCT04635423|450503291|FG001|Overall Study|Ongoing|501|||
125392556|NCT00654381|451072442|FG003|2nd Stage|Investigator's decision|1|||
125392557|NCT00654381|451072443|FG004|2nd Stage|Investigator's decision|0|||
125392558|NCT00654381|451072444|FG005|2nd Stage|Investigator's decision|0|||
125392559|NCT00654381|451072439|FG000|Extension Stage|Adverse Event|1|||
125392560|NCT00654381|451072440|FG001|Extension Stage|Adverse Event|2|||
125392561|NCT00654381|451072441|FG002|Extension Stage|Adverse Event|9|||
125392562|NCT00654381|451072442|FG003|Extension Stage|Adverse Event|7|||
125392563|NCT00654381|451072443|FG004|Extension Stage|Adverse Event|1|||
125392564|NCT00654381|451072444|FG005|Extension Stage|Adverse Event|1|||
125392565|NCT00654381|451072439|FG000|Extension Stage|Protocol Violation|0|||
125392566|NCT00654381|451072440|FG001|Extension Stage|Protocol Violation|0|||
125392567|NCT00654381|451072441|FG002|Extension Stage|Protocol Violation|0|||
125392568|NCT00654381|451072442|FG003|Extension Stage|Protocol Violation|1|||
125239924|NCT04635423|450503290|FG000|Overall Study|Withdrawal by Subject|36|||
125239925|NCT04635423|450503291|FG001|Overall Study|Withdrawal by Subject|29|||
125239926|NCT05119569|450503302|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
125239927|NCT05119569|450503303|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
125239928|NCT05119569|450503304|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
125239929|NCT05119569|450503305|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
125239930|NCT05119569|450503302|FG000|Double Blind Treatment Phase|Adverse Event|6|||
125239931|NCT05119569|450503303|FG001|Double Blind Treatment Phase|Adverse Event|0|||
125239932|NCT05119569|450503304|FG002|Double Blind Treatment Phase|Adverse Event|0|||
125239933|NCT05119569|450503305|FG003|Double Blind Treatment Phase|Adverse Event|0|||
125239934|NCT05119569|450503302|FG000|Open Label Extension Phase|Ongoing in the study|0|||
125239935|NCT05119569|450503303|FG001|Open Label Extension Phase|Ongoing in the study|0|||
125239936|NCT05119569|450503304|FG002|Open Label Extension Phase|Ongoing in the study|65|||
125239937|NCT05119569|450503305|FG003|Open Label Extension Phase|Ongoing in the study|34|||
125239938|NCT03683030|450503306|FG000|Overall Study|Enrolled but screen failures|12|||
125239939|NCT03683030|450503307|FG001|Overall Study|Enrolled but screen failures|7|||
125239940|NCT03683030|450503306|FG000|Overall Study|Enrolled but no catheter inserted|11|||
125239941|NCT03683030|450503307|FG001|Overall Study|Enrolled but no catheter inserted|13|||
125239942|NCT03683030|450503306|FG000|Overall Study|Withdrawal by Subject|0|||
125239943|NCT03683030|450503307|FG001|Overall Study|Withdrawal by Subject|2|||
125239944|NCT03683030|450503306|FG000|Overall Study|Early termination by subject|1|||
125239945|NCT03683030|450503307|FG001|Overall Study|Early termination by subject|0|||
125239946|NCT03683030|450503306|FG000|Overall Study|Lost to Follow-up|0|||
125239947|NCT03683030|450503307|FG001|Overall Study|Lost to Follow-up|6|||
125239948|NCT03683030|450503306|FG000|Overall Study|Death|0|||
125239949|NCT03683030|450503307|FG001|Overall Study|Death|2|||
125239950|NCT03683030|450503306|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
125239951|NCT03683030|450503307|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
125239952|NCT03980223|450503308|FG000|Overall Study|Lost to Follow-up|3|||
125239953|NCT03980223|450503309|FG001|Overall Study|Lost to Follow-up|7|||
125239954|NCT03980223|450503310|FG002|Overall Study|Lost to Follow-up|10|||
125239955|NCT03980223|450503311|FG003|Overall Study|Lost to Follow-up|8|||
125239956|NCT03980223|450503308|FG000|Overall Study|Withdrawal by Subject|0|||
125239957|NCT03980223|450503309|FG001|Overall Study|Withdrawal by Subject|0|||
125239958|NCT03980223|450503310|FG002|Overall Study|Withdrawal by Subject|1|||
125239959|NCT03980223|450503311|FG003|Overall Study|Withdrawal by Subject|2|||
125239960|NCT03980223|450503308|FG000|Overall Study|Physician Decision|0|||
125392569|NCT00654381|451072443|FG004|Extension Stage|Protocol Violation|0|||
125239961|NCT03980223|450503309|FG001|Overall Study|Physician Decision|0|||
125239962|NCT03980223|450503310|FG002|Overall Study|Physician Decision|1|||
125239963|NCT03980223|450503311|FG003|Overall Study|Physician Decision|0|||
125392570|NCT00654381|451072444|FG005|Extension Stage|Protocol Violation|0|||
125392571|NCT00654381|451072439|FG000|Extension Stage|Lack of Efficacy|0|||
125392572|NCT00654381|451072440|FG001|Extension Stage|Lack of Efficacy|0|||
125239964|NCT03980223|450503308|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
125239965|NCT03980223|450503309|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
125239966|NCT03980223|450503310|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
125239967|NCT03980223|450503311|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
125392573|NCT00654381|451072441|FG002|Extension Stage|Lack of Efficacy|1|||
125392574|NCT00654381|451072442|FG003|Extension Stage|Lack of Efficacy|0|||
125239968|NCT06239610|450503312|FG000|Overall Study|no usable migration data for minimum of one day|11|||
125239969|NCT01922934|450503316|FG000|Eligible Patients|Death|0|||
125239970|NCT01922934|450503317|FG001|Eligible Patients|Death|7|||
125239971|NCT01922934|450503316|FG000|Eligible Patients|Physician Decision|17|||
125239972|NCT01922934|450503317|FG001|Eligible Patients|Physician Decision|0|||
125239973|NCT01922934|450503316|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
125239974|NCT01922934|450503317|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
125239975|NCT01922934|450503316|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
125239976|NCT01922934|450503317|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
125239977|NCT01922934|450503316|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
125239978|NCT01922934|450503317|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
125239979|NCT01922934|450503316|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
125239980|NCT01922934|450503317|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
125239981|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
125239982|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
125239983|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
125239984|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
125239985|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
125239986|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
125239987|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
125239988|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
125239989|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
125239990|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
125239991|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
125239992|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
125239993|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
125239994|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
125239995|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
125239996|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
125239997|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
125239998|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
125239999|NCT01069939|450503322|FG000|Randomised and Included in the Analyses|Removal|1|||
125240000|NCT01069939|450503323|FG001|Randomised and Included in the Analyses|Removal|0|||
125240001|NCT05166876|450503324|FG000|Overall Study|Withdrawal by Subject|1|||
125240002|NCT05166876|450503325|FG001|Overall Study|Withdrawal by Subject|0|||
125240003|NCT05166876|450503326|FG002|Overall Study|Withdrawal by Subject|0|||
125240004|NCT00385840|450503328|FG000|Overall Study|Adverse Event|1|||
125240005|NCT00385840|450503329|FG001|Overall Study|Adverse Event|1|||
125240006|NCT00385840|450503328|FG000|Overall Study|Lost to Follow-up|3|||
125240007|NCT00385840|450503329|FG001|Overall Study|Lost to Follow-up|13|||
125240008|NCT00832975|450503331|FG000|Overall Study|Lost to Follow-up|7|||
125240009|NCT00832975|450503331|FG000|Overall Study|Protocol Violation|6|||
125240010|NCT00832975|450503331|FG000|Overall Study|Death|5|||
125240011|NCT00832975|450503331|FG000|Overall Study|Physician Decision|4|||
125240012|NCT00832975|450503331|FG000|Overall Study|Withdrawal by Subject|3|||
125240013|NCT00832975|450503331|FG000|Overall Study|Other reasons|14|||
125240014|NCT02101853|450503335|FG000|Block 1 Induction|Adverse Event|11|||
125240015|NCT02101853|450503336|FG001|Block 1 Induction|Adverse Event|0|||
125240016|NCT02101853|450503337|FG002|Block 1 Induction|Adverse Event|0|||
125240017|NCT02101853|450503338|FG003|Block 1 Induction|Adverse Event|0|||
125240018|NCT02101853|450503339|FG004|Block 1 Induction|Adverse Event|0|||
125240019|NCT02101853|450503340|FG005|Block 1 Induction|Adverse Event|0|||
125240020|NCT02101853|450503335|FG000|Block 1 Induction|Death|20|||
125240021|NCT02101853|450503336|FG001|Block 1 Induction|Death|0|||
125240022|NCT02101853|450503337|FG002|Block 1 Induction|Death|0|||
125240023|NCT02101853|450503338|FG003|Block 1 Induction|Death|0|||
125240024|NCT02101853|450503339|FG004|Block 1 Induction|Death|0|||
125240025|NCT02101853|450503340|FG005|Block 1 Induction|Death|0|||
125240026|NCT02101853|450503335|FG000|Block 1 Induction|Lack of Efficacy|6|||
125240027|NCT02101853|450503336|FG001|Block 1 Induction|Lack of Efficacy|0|||
125240028|NCT02101853|450503337|FG002|Block 1 Induction|Lack of Efficacy|0|||
125240029|NCT02101853|450503338|FG003|Block 1 Induction|Lack of Efficacy|0|||
125240030|NCT02101853|450503339|FG004|Block 1 Induction|Lack of Efficacy|0|||
125240031|NCT02101853|450503340|FG005|Block 1 Induction|Lack of Efficacy|0|||
125240032|NCT02101853|450503335|FG000|Block 1 Induction|Physician Decision|61|||
125240033|NCT02101853|450503336|FG001|Block 1 Induction|Physician Decision|0|||
125240034|NCT02101853|450503337|FG002|Block 1 Induction|Physician Decision|0|||
125240035|NCT02101853|450503338|FG003|Block 1 Induction|Physician Decision|0|||
125240036|NCT02101853|450503339|FG004|Block 1 Induction|Physician Decision|0|||
125240037|NCT02101853|450503340|FG005|Block 1 Induction|Physician Decision|0|||
125240038|NCT02101853|450503335|FG000|Block 1 Induction|Protocol Violation|2|||
125240039|NCT02101853|450503336|FG001|Block 1 Induction|Protocol Violation|0|||
125240040|NCT02101853|450503337|FG002|Block 1 Induction|Protocol Violation|0|||
125240041|NCT02101853|450503338|FG003|Block 1 Induction|Protocol Violation|0|||
125240042|NCT02101853|450503339|FG004|Block 1 Induction|Protocol Violation|0|||
125240043|NCT02101853|450503340|FG005|Block 1 Induction|Protocol Violation|0|||
125240044|NCT02101853|450503335|FG000|Block 1 Induction|Withdrawal by Subject|65|||
125240045|NCT02101853|450503336|FG001|Block 1 Induction|Withdrawal by Subject|0|||
125240046|NCT02101853|450503337|FG002|Block 1 Induction|Withdrawal by Subject|0|||
125240047|NCT02101853|450503338|FG003|Block 1 Induction|Withdrawal by Subject|0|||
125240048|NCT02101853|450503339|FG004|Block 1 Induction|Withdrawal by Subject|0|||
125240049|NCT02101853|450503340|FG005|Block 1 Induction|Withdrawal by Subject|0|||
125240050|NCT02101853|450503335|FG000|Block 1 Induction|Ineligible|8|||
125240051|NCT02101853|450503336|FG001|Block 1 Induction|Ineligible|0|||
125240052|NCT02101853|450503337|FG002|Block 1 Induction|Ineligible|0|||
125240053|NCT02101853|450503338|FG003|Block 1 Induction|Ineligible|0|||
125240054|NCT02101853|450503339|FG004|Block 1 Induction|Ineligible|0|||
125240055|NCT02101853|450503340|FG005|Block 1 Induction|Ineligible|0|||
125240056|NCT02101853|450503335|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
125240057|NCT02101853|450503336|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
125240058|NCT02101853|450503337|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
125240059|NCT02101853|450503338|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
125240060|NCT02101853|450503339|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
125240061|NCT02101853|450503340|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
125240062|NCT02101853|450503335|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
125240063|NCT02101853|450503336|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240064|NCT02101853|450503337|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240065|NCT02101853|450503338|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240066|NCT02101853|450503339|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240067|NCT02101853|450503340|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240068|NCT02101853|450503335|FG000|Post Induction Randomization|Adverse Event|0|||
125240069|NCT02101853|450503336|FG001|Post Induction Randomization|Adverse Event|3|||
125240070|NCT02101853|450503337|FG002|Post Induction Randomization|Adverse Event|8|||
125240071|NCT02101853|450503338|FG003|Post Induction Randomization|Adverse Event|4|||
125240072|NCT02101853|450503339|FG004|Post Induction Randomization|Adverse Event|4|||
125240073|NCT02101853|450503340|FG005|Post Induction Randomization|Adverse Event|0|||
125240074|NCT02101853|450503335|FG000|Post Induction Randomization|Death|0|||
125240075|NCT02101853|450503336|FG001|Post Induction Randomization|Death|9|||
125240076|NCT02101853|450503337|FG002|Post Induction Randomization|Death|2|||
125240077|NCT02101853|450503338|FG003|Post Induction Randomization|Death|2|||
125240078|NCT02101853|450503339|FG004|Post Induction Randomization|Death|0|||
125240079|NCT02101853|450503340|FG005|Post Induction Randomization|Death|0|||
125240080|NCT02101853|450503335|FG000|Post Induction Randomization|Lack of Efficacy|0|||
125240081|NCT02101853|450503336|FG001|Post Induction Randomization|Lack of Efficacy|14|||
125392575|NCT00654381|451072443|FG004|Extension Stage|Lack of Efficacy|0|||
125392576|NCT00654381|451072444|FG005|Extension Stage|Lack of Efficacy|0|||
125392577|NCT00654381|451072439|FG000|Extension Stage|Withdrawal by Subject|0|||
125392578|NCT00654381|451072440|FG001|Extension Stage|Withdrawal by Subject|0|||
125240082|NCT02101853|450503337|FG002|Post Induction Randomization|Lack of Efficacy|23|||
125240083|NCT02101853|450503338|FG003|Post Induction Randomization|Lack of Efficacy|18|||
125240084|NCT02101853|450503339|FG004|Post Induction Randomization|Lack of Efficacy|21|||
125240085|NCT02101853|450503340|FG005|Post Induction Randomization|Lack of Efficacy|0|||
125240086|NCT02101853|450503335|FG000|Post Induction Randomization|Physician Decision|0|||
125240087|NCT02101853|450503336|FG001|Post Induction Randomization|Physician Decision|43|||
125240088|NCT02101853|450503337|FG002|Post Induction Randomization|Physician Decision|23|||
125240089|NCT02101853|450503338|FG003|Post Induction Randomization|Physician Decision|14|||
125240090|NCT02101853|450503339|FG004|Post Induction Randomization|Physician Decision|14|||
125240091|NCT02101853|450503340|FG005|Post Induction Randomization|Physician Decision|0|||
125240092|NCT02101853|450503335|FG000|Post Induction Randomization|Protocol Violation|0|||
125240093|NCT02101853|450503336|FG001|Post Induction Randomization|Protocol Violation|3|||
125240094|NCT02101853|450503337|FG002|Post Induction Randomization|Protocol Violation|0|||
125240095|NCT02101853|450503338|FG003|Post Induction Randomization|Protocol Violation|0|||
125240096|NCT02101853|450503339|FG004|Post Induction Randomization|Protocol Violation|0|||
125240097|NCT02101853|450503340|FG005|Post Induction Randomization|Protocol Violation|0|||
125392579|NCT00654381|451072441|FG002|Extension Stage|Withdrawal by Subject|1|||
125392580|NCT00654381|451072442|FG003|Extension Stage|Withdrawal by Subject|1|||
125240098|NCT02101853|450503335|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
125392581|NCT00654381|451072443|FG004|Extension Stage|Withdrawal by Subject|1|||
125392582|NCT00654381|451072444|FG005|Extension Stage|Withdrawal by Subject|1|||
125240099|NCT02101853|450503336|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
125240100|NCT02101853|450503337|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
125240101|NCT02101853|450503338|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
125240102|NCT02101853|450503339|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
125240103|NCT02101853|450503340|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
125240104|NCT02101853|450503335|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240105|NCT02101853|450503336|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240106|NCT02101853|450503337|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240107|NCT02101853|450503338|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
125240108|NCT02101853|450503339|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240109|NCT02101853|450503340|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
125240110|NCT02101853|450503335|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
125240111|NCT02101853|450503336|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
125240112|NCT02101853|450503337|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
125240113|NCT02101853|450503338|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
125240114|NCT02101853|450503339|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
125240115|NCT02101853|450503340|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
125240116|NCT02101853|450503335|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
125240117|NCT02101853|450503336|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
125240118|NCT02101853|450503337|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
125240119|NCT02101853|450503338|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
125240120|NCT02101853|450503339|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
125240121|NCT02101853|450503340|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
125240122|NCT02101853|450503335|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
125240123|NCT02101853|450503336|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
125240124|NCT02101853|450503337|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
125240125|NCT02101853|450503338|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
125240126|NCT02101853|450503339|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
125240127|NCT02101853|450503340|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
125240128|NCT02101853|450503335|FG000|Blinatumomab Salvage Therapy|Death|0|||
125240129|NCT02101853|450503336|FG001|Blinatumomab Salvage Therapy|Death|0|||
125240130|NCT02101853|450503337|FG002|Blinatumomab Salvage Therapy|Death|0|||
125240131|NCT02101853|450503338|FG003|Blinatumomab Salvage Therapy|Death|0|||
125240132|NCT02101853|450503339|FG004|Blinatumomab Salvage Therapy|Death|0|||
125240133|NCT02101853|450503340|FG005|Blinatumomab Salvage Therapy|Death|2|||
125240134|NCT02101853|450503335|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
125240135|NCT02101853|450503336|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
125240136|NCT02101853|450503337|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
125240137|NCT02101853|450503338|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
125240138|NCT02101853|450503339|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
125240139|NCT02101853|450503340|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
125240140|NCT02101853|450503335|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
125240141|NCT02101853|450503336|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
125240142|NCT02101853|450503337|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
125240143|NCT02101853|450503338|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
125240144|NCT02101853|450503339|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
125240145|NCT02101853|450503340|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
125240146|NCT02101853|450503335|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
125240147|NCT02101853|450503336|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
125240148|NCT02101853|450503337|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
125240149|NCT02101853|450503338|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
125240150|NCT02101853|450503339|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
125240151|NCT02101853|450503340|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
125240152|NCT02112916|450503341|FG000|Overall Study|Adverse Event|6|||
125392583|NCT00654381|451072439|FG000|Extension Stage|Closure of the trial site|0|||
125392584|NCT00654381|451072440|FG001|Extension Stage|Closure of the trial site|0|||
125392585|NCT00654381|451072441|FG002|Extension Stage|Closure of the trial site|0|||
125392586|NCT00654381|451072442|FG003|Extension Stage|Closure of the trial site|0|||
125392587|NCT00654381|451072443|FG004|Extension Stage|Closure of the trial site|1|||
125392588|NCT00654381|451072444|FG005|Extension Stage|Closure of the trial site|1|||
125392589|NCT04164901|451072449|FG000|Overall Study|Withdrawal by Subject|4|||
125392590|NCT04164901|451072450|FG001|Overall Study|Withdrawal by Subject|4|||
125240153|NCT02112916|450503342|FG001|Overall Study|Adverse Event|9|||
125392591|NCT01293240|451072451|FG000|Overall Study|Noncompliance|2|||
125240154|NCT02112916|450503343|FG002|Overall Study|Adverse Event|3|||
125240155|NCT02112916|450503344|FG003|Overall Study|Adverse Event|2|||
125240156|NCT02112916|450503341|FG000|Overall Study|Death|9|||
125240157|NCT02112916|450503342|FG001|Overall Study|Death|9|||
125240158|NCT02112916|450503343|FG002|Overall Study|Death|3|||
125240159|NCT02112916|450503344|FG003|Overall Study|Death|4|||
125240160|NCT02112916|450503341|FG000|Overall Study|Lost to Follow-up|1|||
125240161|NCT02112916|450503342|FG001|Overall Study|Lost to Follow-up|0|||
125240162|NCT02112916|450503343|FG002|Overall Study|Lost to Follow-up|0|||
125240163|NCT02112916|450503344|FG003|Overall Study|Lost to Follow-up|0|||
125240164|NCT02112916|450503341|FG000|Overall Study|Physician Decision|94|||
125240165|NCT02112916|450503342|FG001|Overall Study|Physician Decision|72|||
125240166|NCT02112916|450503343|FG002|Overall Study|Physician Decision|24|||
125240167|NCT02112916|450503344|FG003|Overall Study|Physician Decision|15|||
125240168|NCT02112916|450503341|FG000|Overall Study|Withdrawal by Subject|5|||
125240169|NCT02112916|450503342|FG001|Overall Study|Withdrawal by Subject|3|||
125240170|NCT02112916|450503343|FG002|Overall Study|Withdrawal by Subject|1|||
125240171|NCT02112916|450503344|FG003|Overall Study|Withdrawal by Subject|1|||
125240172|NCT02112916|450503341|FG000|Overall Study|Ineligible|4|||
125240173|NCT02112916|450503342|FG001|Overall Study|Ineligible|8|||
125240174|NCT02112916|450503343|FG002|Overall Study|Ineligible|3|||
125240175|NCT02112916|450503344|FG003|Overall Study|Ineligible|8|||
125240176|NCT02112916|450503341|FG000|Overall Study|Inevaluable|6|||
125240177|NCT02112916|450503342|FG001|Overall Study|Inevaluable|4|||
125240178|NCT02112916|450503343|FG002|Overall Study|Inevaluable|5|||
125240179|NCT02112916|450503344|FG003|Overall Study|Inevaluable|5|||
125240180|NCT02112916|450503341|FG000|Overall Study|Refusal of further protocol therapy|19|||
125240181|NCT02112916|450503342|FG001|Overall Study|Refusal of further protocol therapy|16|||
125240182|NCT02112916|450503343|FG002|Overall Study|Refusal of further protocol therapy|1|||
125240183|NCT02112916|450503344|FG003|Overall Study|Refusal of further protocol therapy|7|||
125240184|NCT02112916|450503341|FG000|Overall Study|Development of SMN|1|||
125240185|NCT02112916|450503342|FG001|Overall Study|Development of SMN|0|||
125240186|NCT02112916|450503343|FG002|Overall Study|Development of SMN|0|||
125240187|NCT02112916|450503344|FG003|Overall Study|Development of SMN|1|||
125240188|NCT02112916|450503341|FG000|Overall Study|Relapse/Progression|10|||
125240189|NCT02112916|450503342|FG001|Overall Study|Relapse/Progression|18|||
125240190|NCT02112916|450503343|FG002|Overall Study|Relapse/Progression|15|||
125240191|NCT02112916|450503344|FG003|Overall Study|Relapse/Progression|2|||
125240192|NCT02112916|450503341|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
125240193|NCT02112916|450503342|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
125240194|NCT02112916|450503343|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
125240195|NCT02112916|450503344|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
125240196|NCT02112916|450503341|FG000|Overall Study|Still on Therapy|44|||
125240197|NCT02112916|450503342|FG001|Overall Study|Still on Therapy|47|||
125240198|NCT02112916|450503343|FG002|Overall Study|Still on Therapy|3|||
125240199|NCT02112916|450503344|FG003|Overall Study|Still on Therapy|2|||
125240200|NCT02112916|450503341|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
125240201|NCT02112916|450503342|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
125240202|NCT02112916|450503343|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
125240203|NCT02112916|450503344|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
125240204|NCT02112916|450503341|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
125443450|NCT02555371|451252129|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
125443451|NCT02555371|451252130|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
125240205|NCT02112916|450503342|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
125240206|NCT02112916|450503343|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
125240207|NCT02112916|450503344|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
125240208|NCT04409002|450503345|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
125240209|NCT04835441|450503346|FG000|Overall Study|Physician Decision|4|||
125240210|NCT04835441|450503347|FG001|Overall Study|Physician Decision|4|||
125240211|NCT04835441|450503346|FG000|Overall Study|Other|1|||
125240212|NCT04835441|450503347|FG001|Overall Study|Other|1|||
125240213|NCT04835441|450503346|FG000|Overall Study|Lost to Follow-up|0|||
125240214|NCT04835441|450503347|FG001|Overall Study|Lost to Follow-up|1|||
125240215|NCT05032196|450503348|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
125240216|NCT05032196|450503349|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
125240217|NCT05032196|450503350|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
125240218|NCT05032196|450503351|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
125240219|NCT05032196|450503352|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
125240220|NCT05032196|450503353|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
125240221|NCT05032196|450503348|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
125240222|NCT05032196|450503349|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
125240223|NCT05032196|450503350|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
125240224|NCT05032196|450503351|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
125240225|NCT05032196|450503352|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
125240226|NCT05032196|450503353|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
125240227|NCT05032196|450503348|FG000|Period 2 (Multidose)|Physician Decision|0|||
125240228|NCT05032196|450503349|FG001|Period 2 (Multidose)|Physician Decision|0|||
125240229|NCT05032196|450503350|FG002|Period 2 (Multidose)|Physician Decision|0|||
125240230|NCT05032196|450503351|FG003|Period 2 (Multidose)|Physician Decision|0|||
125240231|NCT05032196|450503352|FG004|Period 2 (Multidose)|Physician Decision|1|||
125240232|NCT05032196|450503353|FG005|Period 2 (Multidose)|Physician Decision|0|||
125240233|NCT05260008|450503354|FG000|Overall Study|Physician Decision|0|||
125240234|NCT05260008|450503355|FG001|Overall Study|Physician Decision|1|||
125240235|NCT05260008|450503356|FG002|Overall Study|Physician Decision|0|||
125240236|NCT05260008|450503357|FG003|Overall Study|Physician Decision|0|||
125240237|NCT05696847|450504376|FG000|Overall Study|Withdrawal by Subject|1|||
125240238|NCT05696847|450504377|FG001|Overall Study|Withdrawal by Subject|0|||
125240239|NCT05696847|450504378|FG002|Overall Study|Withdrawal by Subject|0|||
125240240|NCT05696847|450504379|FG003|Overall Study|Withdrawal by Subject|0|||
125240241|NCT05696847|450504380|FG004|Overall Study|Withdrawal by Subject|0|||
125240242|NCT05696847|450504381|FG005|Overall Study|Withdrawal by Subject|0|||
125240243|NCT05696847|450504376|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125240244|NCT05696847|450504377|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125240245|NCT05696847|450504378|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125240246|NCT05696847|450504379|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125240247|NCT05696847|450504380|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125240248|NCT05696847|450504381|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
125240249|NCT05696847|450504376|FG000|Overall Study|Adverse Event|0|||
125240250|NCT05696847|450504377|FG001|Overall Study|Adverse Event|0|||
125240251|NCT05696847|450504378|FG002|Overall Study|Adverse Event|0|||
125240252|NCT05696847|450504379|FG003|Overall Study|Adverse Event|0|||
125240253|NCT05696847|450504380|FG004|Overall Study|Adverse Event|0|||
125240254|NCT05696847|450504381|FG005|Overall Study|Adverse Event|1|||
125240255|NCT05696847|450504376|FG000|Overall Study|Sponsor Decision|0|||
125240256|NCT05696847|450504377|FG001|Overall Study|Sponsor Decision|0|||
125240257|NCT05696847|450504378|FG002|Overall Study|Sponsor Decision|0|||
125240258|NCT05696847|450504379|FG003|Overall Study|Sponsor Decision|1|||
125240259|NCT05696847|450504380|FG004|Overall Study|Sponsor Decision|0|||
125240260|NCT05696847|450504381|FG005|Overall Study|Sponsor Decision|0|||
125240261|NCT03323502|450504382|FG000|Overall Study|Resident could not be linked to CMS data|594|||
125240262|NCT03323502|450504383|FG001|Overall Study|Resident could not be linked to CMS data|435|||
125240263|NCT03323502|450504382|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
125240264|NCT03323502|450504383|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
125240265|NCT03323502|450504382|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
125240266|NCT03323502|450504383|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
125240267|NCT03323502|450504382|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
125240268|NCT03323502|450504383|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
125240269|NCT03323502|450504382|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
125240270|NCT03323502|450504383|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
125240271|NCT02278354|450504384|FG000|Overall Study|Lost to Follow-up|2|||
125240272|NCT02278354|450504385|FG001|Overall Study|Lost to Follow-up|2|||
125240273|NCT02278354|450504384|FG000|Overall Study|Withdrawal by Subject|0|||
125240274|NCT02278354|450504385|FG001|Overall Study|Withdrawal by Subject|1|||
125240275|NCT02278354|450504384|FG000|Overall Study|<10 professional fights|2|||
125240276|NCT02278354|450504385|FG001|Overall Study|<10 professional fights|0|||
125240277|NCT06354257|450504392|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125240278|NCT06354257|450504392|FG000|Treatment Period 2|Adverse Event|1|||
125240279|NCT03168672|450504393|FG000|Overall Study|Withdrawal by Subject|13|||
125240280|NCT03168672|450504393|FG000|Overall Study|Death|3|||
125240281|NCT03168672|450504393|FG000|Overall Study|Investigator's Decision|137|||
125240282|NCT03168672|450504393|FG000|Overall Study|Adverse Event|1|||
125240283|NCT03168672|450504393|FG000|Overall Study|Other|2|||
125240284|NCT03168672|450504393|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
125240285|NCT00433537|450504394|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
125240286|NCT00433537|450504395|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
125240287|NCT00433537|450504396|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
125240288|NCT00433537|450504394|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
125240289|NCT00433537|450504395|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
125240290|NCT00433537|450504396|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
125240291|NCT00433537|450504394|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
125240292|NCT00433537|450504395|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
125240293|NCT00433537|450504396|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
125240294|NCT00433537|450504394|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
125240295|NCT00433537|450504395|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
125240296|NCT00433537|450504396|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
125186442|NCT02596971|450303645|FG000|Overall Study|Death|5|||
125186443|NCT02596971|450303646|FG001|Overall Study|Death|1|||
125186444|NCT02596971|450303647|FG002|Overall Study|Death|5|||
125186445|NCT02596971|450303645|FG000|Overall Study|Withdrawal by Subject|5|||
125186446|NCT02596971|450303646|FG001|Overall Study|Withdrawal by Subject|1|||
125186447|NCT02596971|450303647|FG002|Overall Study|Withdrawal by Subject|4|||
125186448|NCT00595920|450303648|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
125186449|NCT03588910|450303649|FG000|Overall Study|Withdrawal by Subject|1|||
125186450|NCT03588910|450303650|FG001|Overall Study|Withdrawal by Subject|0|||
125186451|NCT03588910|450303649|FG000|Overall Study|Allergy|2|||
125186452|NCT03588910|450303650|FG001|Overall Study|Allergy|0|||
125186453|NCT03588910|450303649|FG000|Overall Study|Protocol Violation|0|||
125186454|NCT03588910|450303650|FG001|Overall Study|Protocol Violation|3|||
125186455|NCT03588910|450303649|FG000|Overall Study|Did not complete Day 1 Survey|5|||
125186456|NCT03588910|450303650|FG001|Overall Study|Did not complete Day 1 Survey|10|||
125186457|NCT03588910|450303649|FG000|Overall Study|Did not complete Day 7 Survey|5|||
125186458|NCT03588910|450303650|FG001|Overall Study|Did not complete Day 7 Survey|2|||
125186459|NCT00611923|450303651|FG000|Overall Study|Withdrawal by Subject|2|||
125186460|NCT00611923|450303652|FG001|Overall Study|Withdrawal by Subject|2|||
125186461|NCT03802825|450303660|FG000|Overall Study|Lost to follow-up for intervention|12|||
125186462|NCT03802825|450303661|FG001|Overall Study|Lost to follow-up for intervention|3|||
125186463|NCT03802825|450303660|FG000|Overall Study|Received only 1 component of intervention|0|||
125186464|NCT03802825|450303661|FG001|Overall Study|Received only 1 component of intervention|13|||
125186465|NCT03428152|450303663|FG000|Overall Study|Physician Decision|4|||
125186466|NCT03428152|450303664|FG001|Overall Study|Physician Decision|2|||
125186467|NCT03428152|450303663|FG000|Overall Study|Protocol Violation|3|||
125186468|NCT03428152|450303664|FG001|Overall Study|Protocol Violation|5|||
125186469|NCT03428152|450303663|FG000|Overall Study|Lack of Efficacy|0|||
125186470|NCT03428152|450303664|FG001|Overall Study|Lack of Efficacy|4|||
125186471|NCT04426006|450303665|FG000|Inclusion|Protocol Violation|1|||
125186472|NCT04426006|450303665|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
125186473|NCT04426006|450303665|FG000|Inclusion|Blood sample at inclusion not done|1|||
125186474|NCT04426006|450303665|FG000|3 Months|Lost to Follow-up|17|||
125186475|NCT04426006|450303665|FG000|12 Months|Lost to Follow-up|38|||
125186476|NCT03380429|450303668|FG000|Overall Study|Physician Decision|0|||
125186477|NCT03380429|450303669|FG001|Overall Study|Physician Decision|1|||
125186478|NCT03380429|450303670|FG002|Overall Study|Physician Decision|0|||
125186479|NCT03380429|450303671|FG003|Overall Study|Physician Decision|1|||
125186480|NCT03380429|450303672|FG004|Overall Study|Physician Decision|1|||
125186481|NCT03380429|450303668|FG000|Overall Study|Withdrawal by Subject|3|||
125186482|NCT03380429|450303669|FG001|Overall Study|Withdrawal by Subject|3|||
125186483|NCT03380429|450303670|FG002|Overall Study|Withdrawal by Subject|5|||
125186484|NCT03380429|450303671|FG003|Overall Study|Withdrawal by Subject|2|||
125186485|NCT03380429|450303672|FG004|Overall Study|Withdrawal by Subject|1|||
125186486|NCT03380429|450303668|FG000|Overall Study|Lost to Follow-up|0|||
125186487|NCT03380429|450303669|FG001|Overall Study|Lost to Follow-up|2|||
125186488|NCT03380429|450303670|FG002|Overall Study|Lost to Follow-up|4|||
125186489|NCT03380429|450303671|FG003|Overall Study|Lost to Follow-up|3|||
125186490|NCT03380429|450303672|FG004|Overall Study|Lost to Follow-up|1|||
125186491|NCT03380429|450303668|FG000|Overall Study|Protocol Violation|1|||
125186492|NCT03380429|450303669|FG001|Overall Study|Protocol Violation|0|||
125186493|NCT03380429|450303670|FG002|Overall Study|Protocol Violation|1|||
125186494|NCT03380429|450303671|FG003|Overall Study|Protocol Violation|0|||
125186495|NCT03380429|450303672|FG004|Overall Study|Protocol Violation|1|||
125186496|NCT03380429|450303668|FG000|Overall Study|Lack of Efficacy|0|||
125186497|NCT03380429|450303669|FG001|Overall Study|Lack of Efficacy|0|||
125186498|NCT03380429|450303670|FG002|Overall Study|Lack of Efficacy|0|||
125186499|NCT03380429|450303671|FG003|Overall Study|Lack of Efficacy|2|||
125186500|NCT03380429|450303672|FG004|Overall Study|Lack of Efficacy|1|||
125186501|NCT03380429|450303668|FG000|Overall Study|Adverse Event|1|||
125186502|NCT03380429|450303669|FG001|Overall Study|Adverse Event|1|||
125186503|NCT03380429|450303670|FG002|Overall Study|Adverse Event|1|||
125186504|NCT03380429|450303671|FG003|Overall Study|Adverse Event|2|||
125186505|NCT03380429|450303672|FG004|Overall Study|Adverse Event|0|||
125186506|NCT01924689|450303674|FG000|Overall Study|Death|0|||
125186507|NCT01924689|450303675|FG001|Overall Study|Death|1|||
125186508|NCT01924689|450303676|FG002|Overall Study|Death|0|||
125186509|NCT01924689|450303677|FG003|Overall Study|Death|1|||
125186510|NCT01924689|450303678|FG004|Overall Study|Death|0|||
125186511|NCT01924689|450303679|FG005|Overall Study|Death|0|||
125186512|NCT01924689|450303674|FG000|Overall Study|Disease progression|0|||
125186513|NCT01924689|450303675|FG001|Overall Study|Disease progression|0|||
125186514|NCT01924689|450303676|FG002|Overall Study|Disease progression|2|||
125186515|NCT01924689|450303677|FG003|Overall Study|Disease progression|0|||
125186516|NCT01924689|450303678|FG004|Overall Study|Disease progression|3|||
125186517|NCT01924689|450303679|FG005|Overall Study|Disease progression|2|||
125186518|NCT01924689|450303674|FG000|Overall Study|New therapy or study|3|||
125186519|NCT01924689|450303675|FG001|Overall Study|New therapy or study|2|||
125186520|NCT01924689|450303676|FG002|Overall Study|New therapy or study|1|||
125240297|NCT00433537|450504394|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
125240298|NCT00433537|450504395|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
125240299|NCT00433537|450504396|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
125240300|NCT00433537|450504394|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
125240301|NCT00433537|450504395|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
125240302|NCT00433537|450504396|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
125240303|NCT00433537|450504394|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
125240304|NCT00433537|450504395|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
125240305|NCT00433537|450504396|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
125392592|NCT01364428|451072459|FG000|Overall Study|Adverse Event|1|||
125392593|NCT01364428|451072460|FG001|Overall Study|Adverse Event|2|||
125392594|NCT01364428|451072459|FG000|Overall Study|Protocol Violation|2|||
125392595|NCT01364428|451072460|FG001|Overall Study|Protocol Violation|0|||
125392596|NCT01364428|451072459|FG000|Overall Study|Withdrawal Criteria|14|||
125392597|NCT01364428|451072460|FG001|Overall Study|Withdrawal Criteria|10|||
125392598|NCT01364428|451072459|FG000|Overall Study|Other|3|||
125392599|NCT01364428|451072460|FG001|Overall Study|Other|3|||
125240306|NCT00433537|450504394|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
125240307|NCT00433537|450504395|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
125240308|NCT00433537|450504396|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
125240309|NCT00433537|450504394|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
125240310|NCT00433537|450504395|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
125240311|NCT00433537|450504396|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
125240312|NCT01757847|450504397|FG000|Overall Study|Withdrawal by Subject|3|||
125240313|NCT01757847|450504398|FG001|Overall Study|Withdrawal by Subject|4|||
125240314|NCT05436613|450504399|FG000|Overall Study|Lost to Follow-up|9|||
125240315|NCT05436613|450504399|FG000|Overall Study|Withdrawal by Subject|3|||
125240316|NCT04738487|450504400|FG000|Overall Study|Participant Ongoing in Study|298|||
125240317|NCT04738487|450504401|FG001|Overall Study|Participant Ongoing in Study|297|||
125240318|NCT04738487|450504400|FG000|Overall Study|Withdrawal by Subject|7|||
125240319|NCT04738487|450504401|FG001|Overall Study|Withdrawal by Subject|9|||
125240320|NCT04738487|450504400|FG000|Overall Study|Lost to Follow-up|2|||
125240321|NCT04738487|450504401|FG001|Overall Study|Lost to Follow-up|0|||
125240322|NCT04738487|450504400|FG000|Overall Study|Death|287|||
125240323|NCT04738487|450504401|FG001|Overall Study|Death|306|||
125240324|NCT05350202|450504402|FG000|Visit 1 - Baseline|Not-treated|18|||
125240325|NCT05350202|450504403|FG001|Visit 1 - Baseline|Not-treated|0|||
125240326|NCT05350202|450504402|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
125240327|NCT05350202|450504403|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
125240328|NCT05350202|450504402|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
125240329|NCT05350202|450504403|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
125240330|NCT05350202|450504402|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
125240331|NCT05350202|450504403|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
125240332|NCT05350202|450504402|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
125240333|NCT05350202|450504403|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
125240334|NCT05350202|450504402|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
125240335|NCT05350202|450504403|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
125240336|NCT05350202|450504402|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
125240337|NCT05350202|450504403|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
125240338|NCT05556057|450504404|FG000|Overall Study|Lost to Follow-up|5|||
125240339|NCT05556057|450504405|FG001|Overall Study|Lost to Follow-up|4|||
125240340|NCT05556057|450504404|FG000|Overall Study|Withdrawal by Subject|0|||
125240341|NCT05556057|450504405|FG001|Overall Study|Withdrawal by Subject|2|||
125240342|NCT02390284|450504412|FG000|Overall Study|Physician Decision|0|||
125240343|NCT02390284|450504413|FG001|Overall Study|Physician Decision|0|||
125240344|NCT02390284|450504414|FG002|Overall Study|Physician Decision|9|||
125240345|NCT00658528|450504417|FG000|Overall Study|Adverse Event|5|||
125240346|NCT00658528|450504418|FG001|Overall Study|Adverse Event|7|||
125240347|NCT00658528|450504417|FG000|Overall Study|Lost to Follow-up|14|||
125240348|NCT00658528|450504418|FG001|Overall Study|Lost to Follow-up|22|||
125240349|NCT00658528|450504417|FG000|Overall Study|Withdrawal by Subject|8|||
125240350|NCT00658528|450504418|FG001|Overall Study|Withdrawal by Subject|6|||
125240351|NCT00658528|450504417|FG000|Overall Study|Withdrawal of consent|5|||
125240352|NCT00658528|450504418|FG001|Overall Study|Withdrawal of consent|6|||
125240353|NCT00658528|450504417|FG000|Overall Study|Other|8|||
125240354|NCT00658528|450504418|FG001|Overall Study|Other|4|||
125240355|NCT01937299|450504419|FG000|Overall Study|Adverse Event|13|||
125240356|NCT01937299|450504420|FG001|Overall Study|Adverse Event|0|||
125240357|NCT01937299|450504419|FG000|Overall Study|Lack of Efficacy|0|||
125240358|NCT01937299|450504420|FG001|Overall Study|Lack of Efficacy|4|||
125240359|NCT01937299|450504419|FG000|Overall Study|Withdrawal by Subject|1|||
125392600|NCT00743652|451072461|FG000|Overall Study|Parent/Legal Guardian Request|3|||
125392601|NCT00743652|451072462|FG001|Overall Study|Parent/Legal Guardian Request|2|||
125240360|NCT01937299|450504420|FG001|Overall Study|Withdrawal by Subject|0|||
125240361|NCT04017962|450504421|FG000|Overall Study|Death|2|||
125240362|NCT04017962|450504422|FG001|Overall Study|Death|0|||
125240363|NCT04017962|450504421|FG000|Overall Study|Lost to Follow-up|2|||
125240364|NCT04017962|450504422|FG001|Overall Study|Lost to Follow-up|0|||
125240365|NCT04017962|450504421|FG000|Overall Study|Physician Decision|1|||
125240366|NCT04017962|450504422|FG001|Overall Study|Physician Decision|0|||
125240367|NCT04017962|450504421|FG000|Overall Study|Discontinued LTV|5|||
125240368|NCT04017962|450504422|FG001|Overall Study|Discontinued LTV|0|||
125240369|NCT01260948|450504430|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
125240370|NCT01260948|450504431|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
125240371|NCT01260948|450504430|FG000|Second Intervention|Emesis|0|||
125240372|NCT01260948|450504431|FG001|Second Intervention|Emesis|1|||
125240373|NCT00462462|450504432|FG000|Overall Study|Physician Decision|0|||
125240374|NCT00462462|450504433|FG001|Overall Study|Physician Decision|1|||
125240375|NCT01163617|450504434|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240376|NCT01163617|450504435|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
125240377|NCT01163617|450504436|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240378|NCT01163617|450504437|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240379|NCT01163617|450504438|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240380|NCT01163617|450504439|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240381|NCT01163617|450504440|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240382|NCT01163617|450504441|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
125240383|NCT01163617|450504434|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240384|NCT01163617|450504435|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
125240385|NCT01163617|450504436|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240386|NCT01163617|450504437|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240387|NCT01163617|450504438|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240388|NCT01163617|450504439|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240389|NCT01163617|450504440|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240390|NCT01163617|450504441|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
125240391|NCT01163617|450504434|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240392|NCT01163617|450504435|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240393|NCT01163617|450504436|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
125240394|NCT01163617|450504437|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240395|NCT01163617|450504438|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240396|NCT01163617|450504439|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240397|NCT01163617|450504440|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240398|NCT01163617|450504441|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
125240399|NCT02394756|450504442|FG000|Period 1|Lens Discomfort|0|||
125240400|NCT02394756|450504443|FG001|Period 1|Lens Discomfort|0|||
125240401|NCT02394756|450504444|FG002|Period 1|Lens Discomfort|0|||
125240402|NCT02394756|450504445|FG003|Period 1|Lens Discomfort|0|||
125240403|NCT02394756|450504446|FG004|Period 1|Lens Discomfort|0|||
125240404|NCT02394756|450504447|FG005|Period 1|Lens Discomfort|1|||
125240405|NCT02394756|450504442|FG000|Period 1|Withdrawal by Subject|0|||
125240406|NCT02394756|450504443|FG001|Period 1|Withdrawal by Subject|1|||
125240407|NCT02394756|450504444|FG002|Period 1|Withdrawal by Subject|1|||
125240408|NCT02394756|450504445|FG003|Period 1|Withdrawal by Subject|1|||
125240409|NCT02394756|450504446|FG004|Period 1|Withdrawal by Subject|0|||
125240410|NCT02394756|450504447|FG005|Period 1|Withdrawal by Subject|0|||
125240411|NCT02394756|450504442|FG000|Period 2|Unsatisfactory Visual Response|0|||
125240412|NCT02394756|450504443|FG001|Period 2|Unsatisfactory Visual Response|0|||
125240413|NCT02394756|450504444|FG002|Period 2|Unsatisfactory Visual Response|0|||
125240414|NCT02394756|450504445|FG003|Period 2|Unsatisfactory Visual Response|0|||
125240415|NCT02394756|450504446|FG004|Period 2|Unsatisfactory Visual Response|1|||
125240416|NCT02394756|450504447|FG005|Period 2|Unsatisfactory Visual Response|0|||
125240417|NCT02335944|450504448|FG000|Treatment Phase|Progressive Disease|2|||
125240418|NCT02335944|450504449|FG001|Treatment Phase|Progressive Disease|5|||
125240419|NCT02335944|450504450|FG002|Treatment Phase|Progressive Disease|2|||
125240420|NCT02335944|450504451|FG003|Treatment Phase|Progressive Disease|11|||
125240421|NCT02335944|450504452|FG004|Treatment Phase|Progressive Disease|4|||
125240422|NCT02335944|450504453|FG005|Treatment Phase|Progressive Disease|25|||
125240423|NCT02335944|450504454|FG006|Treatment Phase|Progressive Disease|2|||
125240424|NCT02335944|450504455|FG007|Treatment Phase|Progressive Disease|30|||
125240425|NCT02335944|450504456|FG008|Treatment Phase|Progressive Disease|27|||
125240426|NCT02335944|450504457|FG009|Treatment Phase|Progressive Disease|0|||
125392602|NCT00743652|451072463|FG002|Overall Study|Parent/Legal Guardian Request|2|||
125240427|NCT02335944|450504448|FG000|Treatment Phase|Adverse Event|2|||
125240428|NCT02335944|450504449|FG001|Treatment Phase|Adverse Event|0|||
125392603|NCT00743652|451072464|FG003|Overall Study|Parent/Legal Guardian Request|2|||
125392604|NCT00743652|451072465|FG004|Overall Study|Parent/Legal Guardian Request|0|||
125392605|NCT00743652|451072461|FG000|Overall Study|Adverse Event|3|||
125392606|NCT00743652|451072462|FG001|Overall Study|Adverse Event|0|||
125392607|NCT00743652|451072463|FG002|Overall Study|Adverse Event|0|||
125392608|NCT00743652|451072464|FG003|Overall Study|Adverse Event|0|||
125392609|NCT00743652|451072465|FG004|Overall Study|Adverse Event|0|||
125392610|NCT00743652|451072461|FG000|Overall Study|Death|2|||
125392611|NCT00743652|451072462|FG001|Overall Study|Death|0|||
125392612|NCT00743652|451072463|FG002|Overall Study|Death|0|||
125392613|NCT00743652|451072464|FG003|Overall Study|Death|0|||
125392614|NCT00743652|451072465|FG004|Overall Study|Death|0|||
125186521|NCT01924689|450303677|FG003|Overall Study|New therapy or study|4|||
125186522|NCT01924689|450303678|FG004|Overall Study|New therapy or study|2|||
125186523|NCT01924689|450303679|FG005|Overall Study|New therapy or study|0|||
125186524|NCT01924689|450303674|FG000|Overall Study|Withdrawal of consent|0|||
125186525|NCT01924689|450303675|FG001|Overall Study|Withdrawal of consent|0|||
125186526|NCT01924689|450303676|FG002|Overall Study|Withdrawal of consent|1|||
125186527|NCT01924689|450303677|FG003|Overall Study|Withdrawal of consent|1|||
125186528|NCT01924689|450303678|FG004|Overall Study|Withdrawal of consent|0|||
125186529|NCT01924689|450303679|FG005|Overall Study|Withdrawal of consent|0|||
125186530|NCT01924689|450303674|FG000|Overall Study|Other|0|||
125186531|NCT01924689|450303675|FG001|Overall Study|Other|0|||
125186532|NCT01924689|450303676|FG002|Overall Study|Other|0|||
125186533|NCT01924689|450303677|FG003|Overall Study|Other|0|||
125186534|NCT01924689|450303678|FG004|Overall Study|Other|1|||
125186535|NCT01924689|450303679|FG005|Overall Study|Other|0|||
125186536|NCT03267212|450303680|FG000|First Intervention|Lost to Follow-up|0|||
125186537|NCT03267212|450303681|FG001|First Intervention|Lost to Follow-up|2|||
125186538|NCT03267212|450303680|FG000|First Intervention|Withdrawal by Subject|1|||
125186539|NCT03267212|450303681|FG001|First Intervention|Withdrawal by Subject|1|||
125186540|NCT03267212|450303680|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
125186541|NCT03267212|450303681|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
125186542|NCT05691712|450303684|FG000|Overall Study|Adverse Event|0|||
125186543|NCT05691712|450303685|FG001|Overall Study|Adverse Event|1|||
125186544|NCT05691712|450303686|FG002|Overall Study|Adverse Event|2|||
125186545|NCT05691712|450303687|FG003|Overall Study|Adverse Event|1|||
125186546|NCT05691712|450303684|FG000|Overall Study|Withdrawal by Subject|2|||
125186547|NCT05691712|450303685|FG001|Overall Study|Withdrawal by Subject|3|||
125186548|NCT05691712|450303686|FG002|Overall Study|Withdrawal by Subject|3|||
125186549|NCT05691712|450303687|FG003|Overall Study|Withdrawal by Subject|1|||
125186550|NCT05691712|450303684|FG000|Overall Study|Death|1|||
125186551|NCT05691712|450303685|FG001|Overall Study|Death|0|||
125186552|NCT05691712|450303686|FG002|Overall Study|Death|0|||
125186553|NCT05691712|450303687|FG003|Overall Study|Death|0|||
125186554|NCT05691712|450303684|FG000|Overall Study|Pregnancy|0|||
125186555|NCT05691712|450303685|FG001|Overall Study|Pregnancy|1|||
125186556|NCT05691712|450303686|FG002|Overall Study|Pregnancy|0|||
125186557|NCT05691712|450303687|FG003|Overall Study|Pregnancy|0|||
125186558|NCT05691712|450303684|FG000|Overall Study|Assigned Treatment by Mistake|1|||
125186559|NCT05691712|450303685|FG001|Overall Study|Assigned Treatment by Mistake|0|||
125186560|NCT05691712|450303686|FG002|Overall Study|Assigned Treatment by Mistake|0|||
125186561|NCT05691712|450303687|FG003|Overall Study|Assigned Treatment by Mistake|1|||
125186562|NCT00226499|450303688|FG000|Overall Study|Adverse Event|10|||
125186563|NCT00226499|450303689|FG001|Overall Study|Adverse Event|6|||
125186564|NCT00226499|450303690|FG002|Overall Study|Adverse Event|3|||
125186565|NCT00226499|450303688|FG000|Overall Study|Others|1064|||
125186566|NCT00226499|450303689|FG001|Overall Study|Others|1066|||
125186567|NCT00226499|450303690|FG002|Overall Study|Others|356|||
125186568|NCT00946920|450303691|FG000|Overall Study|Withdrawal by Subject|28|||
125186569|NCT00946920|450303692|FG001|Overall Study|Withdrawal by Subject|15|||
125186570|NCT00946920|450303691|FG000|Overall Study|Lost to Follow-up|2|||
125186571|NCT00946920|450303692|FG001|Overall Study|Lost to Follow-up|2|||
125186572|NCT00946920|450303691|FG000|Overall Study|Physician Decision|5|||
125186573|NCT00946920|450303692|FG001|Overall Study|Physician Decision|2|||
125186574|NCT00946920|450303691|FG000|Overall Study|Adverse Event|41|||
125186575|NCT00946920|450303692|FG001|Overall Study|Adverse Event|14|||
125186576|NCT00946920|450303691|FG000|Overall Study|Protocol Violation|16|||
125240429|NCT02335944|450504450|FG002|Treatment Phase|Adverse Event|0|||
125240430|NCT02335944|450504451|FG003|Treatment Phase|Adverse Event|2|||
125186577|NCT00946920|450303692|FG001|Overall Study|Protocol Violation|8|||
125186578|NCT00946920|450303691|FG000|Overall Study|Miscellaneous reasons|18|||
125186579|NCT00946920|450303692|FG001|Overall Study|Miscellaneous reasons|3|||
125186580|NCT01288079|450303702|FG000|Overall Study|Withdrawal by Subject|2|||
125186581|NCT01288079|450303703|FG001|Overall Study|Withdrawal by Subject|4|||
125392615|NCT00743652|451072461|FG000|Overall Study|Investigator Request|0|||
125392616|NCT00743652|451072462|FG001|Overall Study|Investigator Request|0|||
125392617|NCT00743652|451072463|FG002|Overall Study|Investigator Request|0|||
125392618|NCT00743652|451072464|FG003|Overall Study|Investigator Request|2|||
125240431|NCT02335944|450504452|FG004|Treatment Phase|Adverse Event|1|||
125240432|NCT02335944|450504453|FG005|Treatment Phase|Adverse Event|15|||
125240433|NCT02335944|450504454|FG006|Treatment Phase|Adverse Event|0|||
125240434|NCT02335944|450504455|FG007|Treatment Phase|Adverse Event|5|||
125240435|NCT02335944|450504456|FG008|Treatment Phase|Adverse Event|7|||
125240436|NCT02335944|450504457|FG009|Treatment Phase|Adverse Event|0|||
125240437|NCT02335944|450504448|FG000|Treatment Phase|Physician Decision|0|||
125240438|NCT02335944|450504449|FG001|Treatment Phase|Physician Decision|0|||
125240439|NCT02335944|450504450|FG002|Treatment Phase|Physician Decision|0|||
125240440|NCT02335944|450504451|FG003|Treatment Phase|Physician Decision|1|||
125240441|NCT02335944|450504452|FG004|Treatment Phase|Physician Decision|0|||
125240442|NCT02335944|450504453|FG005|Treatment Phase|Physician Decision|6|||
125240443|NCT02335944|450504454|FG006|Treatment Phase|Physician Decision|1|||
125240444|NCT02335944|450504455|FG007|Treatment Phase|Physician Decision|2|||
125240445|NCT02335944|450504456|FG008|Treatment Phase|Physician Decision|1|||
125240446|NCT02335944|450504457|FG009|Treatment Phase|Physician Decision|0|||
125240447|NCT02335944|450504448|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
125240448|NCT02335944|450504449|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
125240449|NCT02335944|450504450|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
125240450|NCT02335944|450504451|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
125240451|NCT02335944|450504452|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
125240452|NCT02335944|450504453|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
125240453|NCT02335944|450504454|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
125240454|NCT02335944|450504455|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
125240455|NCT02335944|450504456|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
125240456|NCT02335944|450504457|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
125240457|NCT02335944|450504448|FG000|Treatment Phase|Subject/Guardian Decision|0|||
125240458|NCT02335944|450504449|FG001|Treatment Phase|Subject/Guardian Decision|0|||
125240459|NCT02335944|450504450|FG002|Treatment Phase|Subject/Guardian Decision|1|||
125240460|NCT02335944|450504451|FG003|Treatment Phase|Subject/Guardian Decision|0|||
125240461|NCT02335944|450504452|FG004|Treatment Phase|Subject/Guardian Decision|0|||
125392619|NCT00743652|451072465|FG004|Overall Study|Investigator Request|0|||
125392620|NCT00743652|451072461|FG000|Overall Study|Other|1|||
125240462|NCT02335944|450504453|FG005|Treatment Phase|Subject/Guardian Decision|1|||
125240463|NCT02335944|450504454|FG006|Treatment Phase|Subject/Guardian Decision|0|||
125240464|NCT02335944|450504455|FG007|Treatment Phase|Subject/Guardian Decision|4|||
125240465|NCT02335944|450504456|FG008|Treatment Phase|Subject/Guardian Decision|0|||
125240466|NCT02335944|450504457|FG009|Treatment Phase|Subject/Guardian Decision|0|||
125240467|NCT02335944|450504448|FG000|Post-treatment Follow-up|Progressive Disease|0|||
125240468|NCT02335944|450504449|FG001|Post-treatment Follow-up|Progressive Disease|0|||
125240469|NCT02335944|450504450|FG002|Post-treatment Follow-up|Progressive Disease|0|||
125240470|NCT02335944|450504451|FG003|Post-treatment Follow-up|Progressive Disease|1|||
125240471|NCT02335944|450504452|FG004|Post-treatment Follow-up|Progressive Disease|0|||
125240472|NCT02335944|450504453|FG005|Post-treatment Follow-up|Progressive Disease|9|||
125240473|NCT02335944|450504454|FG006|Post-treatment Follow-up|Progressive Disease|0|||
125240474|NCT02335944|450504455|FG007|Post-treatment Follow-up|Progressive Disease|2|||
125240475|NCT02335944|450504456|FG008|Post-treatment Follow-up|Progressive Disease|3|||
125240476|NCT02335944|450504457|FG009|Post-treatment Follow-up|Progressive Disease|0|||
125240477|NCT02335944|450504448|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240478|NCT02335944|450504449|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240479|NCT02335944|450504450|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240480|NCT02335944|450504451|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240481|NCT02335944|450504452|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240482|NCT02335944|450504453|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
125240483|NCT02335944|450504454|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240484|NCT02335944|450504455|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240485|NCT02335944|450504456|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240486|NCT02335944|450504457|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
125240487|NCT02335944|450504448|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240488|NCT02335944|450504449|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240489|NCT02335944|450504450|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240490|NCT02335944|450504451|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240491|NCT02335944|450504452|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240492|NCT02335944|450504453|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240493|NCT02335944|450504454|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240494|NCT02335944|450504455|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
125240495|NCT02335944|450504456|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240496|NCT02335944|450504457|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
125240497|NCT02335944|450504448|FG000|Post-treatment Follow-up|Adverse Event|0|||
125240498|NCT02335944|450504449|FG001|Post-treatment Follow-up|Adverse Event|0|||
125240499|NCT02335944|450504450|FG002|Post-treatment Follow-up|Adverse Event|0|||
125392621|NCT00743652|451072462|FG001|Overall Study|Other|1|||
125240500|NCT02335944|450504451|FG003|Post-treatment Follow-up|Adverse Event|0|||
125240501|NCT02335944|450504452|FG004|Post-treatment Follow-up|Adverse Event|0|||
125240502|NCT02335944|450504453|FG005|Post-treatment Follow-up|Adverse Event|1|||
125240503|NCT02335944|450504454|FG006|Post-treatment Follow-up|Adverse Event|0|||
125240504|NCT02335944|450504455|FG007|Post-treatment Follow-up|Adverse Event|0|||
125240505|NCT02335944|450504456|FG008|Post-treatment Follow-up|Adverse Event|0|||
125240506|NCT02335944|450504457|FG009|Post-treatment Follow-up|Adverse Event|0|||
125240507|NCT02335944|450504448|FG000|Post-treatment Follow-up|Death|0|||
125240508|NCT02335944|450504449|FG001|Post-treatment Follow-up|Death|0|||
125240509|NCT02335944|450504450|FG002|Post-treatment Follow-up|Death|0|||
125240510|NCT02335944|450504451|FG003|Post-treatment Follow-up|Death|1|||
125240511|NCT02335944|450504452|FG004|Post-treatment Follow-up|Death|0|||
125240512|NCT02335944|450504453|FG005|Post-treatment Follow-up|Death|1|||
125240513|NCT02335944|450504454|FG006|Post-treatment Follow-up|Death|0|||
125240514|NCT02335944|450504455|FG007|Post-treatment Follow-up|Death|0|||
125240515|NCT02335944|450504456|FG008|Post-treatment Follow-up|Death|0|||
125240516|NCT02335944|450504457|FG009|Post-treatment Follow-up|Death|0|||
125240517|NCT02335944|450504448|FG000|Post-treatment Follow-up|Physician Decision|1|||
125240518|NCT02335944|450504449|FG001|Post-treatment Follow-up|Physician Decision|0|||
125240519|NCT02335944|450504450|FG002|Post-treatment Follow-up|Physician Decision|0|||
125240520|NCT02335944|450504451|FG003|Post-treatment Follow-up|Physician Decision|0|||
125240521|NCT02335944|450504452|FG004|Post-treatment Follow-up|Physician Decision|0|||
125240522|NCT02335944|450504453|FG005|Post-treatment Follow-up|Physician Decision|0|||
125240523|NCT02335944|450504454|FG006|Post-treatment Follow-up|Physician Decision|0|||
125240524|NCT02335944|450504455|FG007|Post-treatment Follow-up|Physician Decision|1|||
125240525|NCT02335944|450504456|FG008|Post-treatment Follow-up|Physician Decision|0|||
125240526|NCT02335944|450504457|FG009|Post-treatment Follow-up|Physician Decision|0|||
125240527|NCT01706328|450504463|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
125240528|NCT01706328|450504464|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125240529|NCT01706328|450504465|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
125240530|NCT01706328|450504463|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
125240531|NCT01706328|450504464|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
125240532|NCT01706328|450504465|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
125240533|NCT01706328|450504463|FG000|2-week Run-in Period|Physician Decision|4|||
125240534|NCT01706328|450504464|FG001|2-week Run-in Period|Physician Decision|0|||
125240535|NCT01706328|450504465|FG002|2-week Run-in Period|Physician Decision|0|||
125240536|NCT01706328|450504463|FG000|2-week Run-in Period|Adverse Event|4|||
125240537|NCT01706328|450504464|FG001|2-week Run-in Period|Adverse Event|0|||
125240538|NCT01706328|450504465|FG002|2-week Run-in Period|Adverse Event|0|||
125240539|NCT01706328|450504463|FG000|2-week Run-in Period|Lost to Follow-up|2|||
125240540|NCT01706328|450504464|FG001|2-week Run-in Period|Lost to Follow-up|0|||
125240541|NCT01706328|450504465|FG002|2-week Run-in Period|Lost to Follow-up|0|||
125240542|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
125240543|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
125240544|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
125240545|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
125240546|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
125240547|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
125240548|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
125240549|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
125240550|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
125240551|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
125240552|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
125240553|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
125240554|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
125240555|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
125240556|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
125240557|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
125240558|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
125240559|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
125240560|NCT01706328|450504463|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125240561|NCT01706328|450504464|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
125240562|NCT01706328|450504465|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
125240563|NCT03018938|450504468|FG000|Overall Study|Death|0|||
125240564|NCT03018938|450504469|FG001|Overall Study|Death|1|||
125240565|NCT03018938|450504468|FG000|Overall Study|Lost to Follow-up|21|||
125240566|NCT03018938|450504469|FG001|Overall Study|Lost to Follow-up|32|||
125240567|NCT03018938|450504468|FG000|Overall Study|Withdrawal by Subject|38|||
125240568|NCT03018938|450504469|FG001|Overall Study|Withdrawal by Subject|45|||
125240569|NCT03018938|450504468|FG000|Overall Study|Physician Decision|3|||
125240570|NCT03018938|450504469|FG001|Overall Study|Physician Decision|2|||
125240571|NCT03018938|450504468|FG000|Overall Study|Sponsor Decision|0|||
125240572|NCT03018938|450504469|FG001|Overall Study|Sponsor Decision|1|||
125240573|NCT03018938|450504468|FG000|Overall Study|Screen failure-After randomization|4|||
125240574|NCT03018938|450504469|FG001|Overall Study|Screen failure-After randomization|2|||
125240575|NCT03018938|450504468|FG000|Overall Study|Not recorded|0|||
125240576|NCT03018938|450504469|FG001|Overall Study|Not recorded|2|||
125240577|NCT00191100|450504470|FG000|Overall Study|Adverse Event|18|||
125240578|NCT00191100|450504471|FG001|Overall Study|Adverse Event|1|||
125240579|NCT00191100|450504470|FG000|Overall Study|Lost to Follow-up|2|||
125240580|NCT00191100|450504471|FG001|Overall Study|Lost to Follow-up|0|||
125240581|NCT00191100|450504470|FG000|Overall Study|Patient Moved|0|||
125240582|NCT00191100|450504471|FG001|Overall Study|Patient Moved|1|||
125240583|NCT00191100|450504470|FG000|Overall Study|Withdrawal by Subject|9|||
125240584|NCT00191100|450504471|FG001|Overall Study|Withdrawal by Subject|3|||
125240585|NCT00191100|450504470|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
125240586|NCT00191100|450504471|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
125240587|NCT00191100|450504470|FG000|Overall Study|Clinical Relapse|2|||
125240588|NCT00191100|450504471|FG001|Overall Study|Clinical Relapse|1|||
125240589|NCT00191100|450504470|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
125240590|NCT00191100|450504471|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
125240591|NCT00191100|450504470|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
125240592|NCT00191100|450504471|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
125240593|NCT00191100|450504470|FG000|Overall Study|Physician Decision|3|||
125240594|NCT00191100|450504471|FG001|Overall Study|Physician Decision|1|||
125240595|NCT00191100|450504470|FG000|Overall Study|Death from Study Drug Toxicity|2|||
125240596|NCT00191100|450504471|FG001|Overall Study|Death from Study Drug Toxicity|0|||
125240597|NCT00191100|450504470|FG000|Overall Study|Protocol Violation|1|||
125240598|NCT00191100|450504471|FG001|Overall Study|Protocol Violation|1|||
125240599|NCT00191100|450504470|FG000|Overall Study|Death from Other Cause|1|||
125240600|NCT00191100|450504471|FG001|Overall Study|Death from Other Cause|0|||
125240601|NCT00191100|450504470|FG000|Overall Study|Reason Not Specified|0|||
125240602|NCT00191100|450504471|FG001|Overall Study|Reason Not Specified|1|||
125240603|NCT02811159|450504474|FG000|Treatment Course 1|Lost to Follow-up|1|||
125240604|NCT02916771|450504475|FG000|Overall Study|Withdrawal by Subject|9|||
125240605|NCT02916771|450504475|FG000|Overall Study|Physician Decision|1|||
125240606|NCT02916771|450504475|FG000|Overall Study|Began treatment for another active malignancy|1|||
125240607|NCT01525589|450504476|FG000|Overall Study|Non-treatment-related AE|1|||
125240608|NCT01525589|450504477|FG001|Overall Study|Non-treatment-related AE|0|||
125240609|NCT01525589|450504478|FG002|Overall Study|Non-treatment-related AE|0|||
125240610|NCT01525589|450504476|FG000|Overall Study|Progressive disease|48|||
125240611|NCT01525589|450504477|FG001|Overall Study|Progressive disease|15|||
125240612|NCT01525589|450504478|FG002|Overall Study|Progressive disease|29|||
125240613|NCT01525589|450504476|FG000|Overall Study|Never treated|2|||
125240614|NCT01525589|450504477|FG001|Overall Study|Never treated|0|||
125240615|NCT01525589|450504478|FG002|Overall Study|Never treated|0|||
125240616|NCT01525589|450504476|FG000|Overall Study|Physician Decision|4|||
125240617|NCT01525589|450504477|FG001|Overall Study|Physician Decision|2|||
125240618|NCT01525589|450504478|FG002|Overall Study|Physician Decision|2|||
125240619|NCT01525589|450504476|FG000|Overall Study|Death|0|||
125240620|NCT01525589|450504477|FG001|Overall Study|Death|0|||
125240621|NCT01525589|450504478|FG002|Overall Study|Death|2|||
125240622|NCT01525589|450504476|FG000|Overall Study|Treatment-related AE|1|||
125240623|NCT01525589|450504477|FG001|Overall Study|Treatment-related AE|1|||
125240624|NCT01525589|450504478|FG002|Overall Study|Treatment-related AE|2|||
125240625|NCT01525589|450504476|FG000|Overall Study|Other reasons|0|||
125240626|NCT01525589|450504477|FG001|Overall Study|Other reasons|1|||
125240627|NCT01525589|450504478|FG002|Overall Study|Other reasons|0|||
125240628|NCT01525589|450504476|FG000|Overall Study|Withdrawal by Subject|0|||
125240629|NCT01525589|450504477|FG001|Overall Study|Withdrawal by Subject|1|||
125240630|NCT01525589|450504478|FG002|Overall Study|Withdrawal by Subject|0|||
125240631|NCT02924376|450504479|FG000|Overall Study|Progressive Disease|4|||
125240632|NCT02924376|450504480|FG001|Overall Study|Progressive Disease|0|||
125240633|NCT02924376|450504481|FG002|Overall Study|Progressive Disease|1|||
125240634|NCT02924376|450504482|FG003|Overall Study|Progressive Disease|0|||
125240635|NCT02924376|450504479|FG000|Overall Study|Death|73|||
125240636|NCT02924376|450504480|FG001|Overall Study|Death|18|||
125240637|NCT02924376|450504481|FG002|Overall Study|Death|15|||
125240638|NCT02924376|450504482|FG003|Overall Study|Death|2|||
125240639|NCT02924376|450504479|FG000|Overall Study|Lost to Follow-up|3|||
125240640|NCT02924376|450504480|FG001|Overall Study|Lost to Follow-up|0|||
125240641|NCT02924376|450504481|FG002|Overall Study|Lost to Follow-up|0|||
125240642|NCT02924376|450504482|FG003|Overall Study|Lost to Follow-up|0|||
125240643|NCT02924376|450504479|FG000|Overall Study|Study Terminated by Sponsor|19|||
125240644|NCT02924376|450504480|FG001|Overall Study|Study Terminated by Sponsor|0|||
125240645|NCT02924376|450504481|FG002|Overall Study|Study Terminated by Sponsor|0|||
125240646|NCT02924376|450504482|FG003|Overall Study|Study Terminated by Sponsor|0|||
125240647|NCT02924376|450504479|FG000|Overall Study|Physician Decision|1|||
125240648|NCT02924376|450504480|FG001|Overall Study|Physician Decision|0|||
125240649|NCT02924376|450504481|FG002|Overall Study|Physician Decision|0|||
125240650|NCT02924376|450504482|FG003|Overall Study|Physician Decision|0|||
125240651|NCT02924376|450504479|FG000|Overall Study|Withdrawal by Subject|7|||
125240652|NCT02924376|450504480|FG001|Overall Study|Withdrawal by Subject|2|||
125240653|NCT02924376|450504481|FG002|Overall Study|Withdrawal by Subject|1|||
125240654|NCT02924376|450504482|FG003|Overall Study|Withdrawal by Subject|0|||
125240655|NCT02924376|450504479|FG000|Overall Study|Rolled Over to Another Study|1|||
125240656|NCT02924376|450504480|FG001|Overall Study|Rolled Over to Another Study|0|||
125240657|NCT02924376|450504481|FG002|Overall Study|Rolled Over to Another Study|0|||
125240658|NCT02924376|450504482|FG003|Overall Study|Rolled Over to Another Study|0|||
125240659|NCT05763875|450504488|FG000|Overall Study|Subject decision|5|||
125240660|NCT05763875|450504489|FG001|Overall Study|Subject decision|2|||
125240661|NCT05763875|450504490|FG002|Overall Study|Subject decision|1|||
125240662|NCT05763875|450504488|FG000|Overall Study|Lost to Follow-up|4|||
125240663|NCT05763875|450504489|FG001|Overall Study|Lost to Follow-up|1|||
125240664|NCT05763875|450504490|FG002|Overall Study|Lost to Follow-up|2|||
125240665|NCT05763875|450504488|FG000|Overall Study|Adverse Event|1|||
125240666|NCT05763875|450504489|FG001|Overall Study|Adverse Event|0|||
125240667|NCT05763875|450504490|FG002|Overall Study|Adverse Event|0|||
125240668|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
125240669|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
125240670|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
125240671|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
125240672|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
125240673|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
125240674|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
125240675|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
125240676|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
125240677|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
125240678|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
125240679|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
125240680|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
125240681|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
125240682|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
125240683|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
125240684|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
125240685|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
125240686|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
125240687|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
125240688|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
125240689|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
125240690|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
125240691|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
125240692|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
125240693|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
125240694|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
125240695|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
125240696|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
125240697|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
125240698|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
125240699|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
125240700|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
125240701|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
125240702|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
125240703|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
125240704|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
125240705|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
125240706|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
125240707|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
125240708|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
125240709|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
125240710|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
125240711|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
125240712|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
125240713|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
125240714|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
125240715|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
125240716|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
125240717|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
125240718|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
125240719|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
125240720|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
125240721|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
125240722|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
125240723|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
125240724|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
125240725|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
125240726|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
125240727|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
125240728|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
125240729|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
125240730|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
125240731|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
125240732|NCT00217737|450504491|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
125240733|NCT00217737|450504492|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
125240734|NCT00217737|450504493|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
125240735|NCT00217737|450504494|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
125392622|NCT00743652|451072463|FG002|Overall Study|Other|0|||
125392623|NCT00743652|451072464|FG003|Overall Study|Other|0|||
125392624|NCT00743652|451072465|FG004|Overall Study|Other|0|||
125392625|NCT00743652|451072461|FG000|Overall Study|Lost to Follow-up|1|||
125392626|NCT00743652|451072462|FG001|Overall Study|Lost to Follow-up|0|||
125392627|NCT00743652|451072463|FG002|Overall Study|Lost to Follow-up|0|||
125392628|NCT00743652|451072464|FG003|Overall Study|Lost to Follow-up|0|||
125392629|NCT00743652|451072465|FG004|Overall Study|Lost to Follow-up|0|||
125392630|NCT02547129|451072466|FG000|Overall Study|Difficulty with ongoing infection|1|||
125392631|NCT02547129|451072467|FG001|Overall Study|Difficulty with ongoing infection|0|||
125240736|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
125240737|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
125240738|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
125240739|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
125240740|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
125240741|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
125240742|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
125240743|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
125240744|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Study suspension|0|||
125240745|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Study suspension|45|||
125240746|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Study suspension|0|||
125240747|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Study suspension|0|||
125240748|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
125240749|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
125240750|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
125240751|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
125240752|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Death|2|||
125240753|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Death|3|||
125240754|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Death|0|||
125240755|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Death|0|||
125240756|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
125240757|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
125240758|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
125240759|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
125240760|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
125240761|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
125240762|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
125240763|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
125240764|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
125240765|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
125392632|NCT03925324|451072468|FG000|Overall Study|Death|1|||
125240766|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
125240767|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
125240768|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
125240769|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
125392633|NCT03925324|451072469|FG001|Overall Study|Death|1|||
125392634|NCT00228917|451072472|FG000|Overall Study|Migrated/moved from study area|0|||
125392635|NCT00228917|451072473|FG001|Overall Study|Migrated/moved from study area|0|||
125392636|NCT00228917|451072474|FG002|Overall Study|Migrated/moved from study area|0|||
125392637|NCT00228917|451072475|FG003|Overall Study|Migrated/moved from study area|0|||
125392638|NCT00228917|451072476|FG004|Overall Study|Migrated/moved from study area|0|||
125392639|NCT00228917|451072477|FG005|Overall Study|Migrated/moved from study area|2|||
125392640|NCT00228917|451072478|FG006|Overall Study|Migrated/moved from study area|0|||
125392641|NCT00228917|451072479|FG007|Overall Study|Migrated/moved from study area|0|||
125240770|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
125240771|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
125240772|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
125240773|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
125240774|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
125240775|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
125240776|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
125240777|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
125240778|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
125240779|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
125240780|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
125240781|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
125240782|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
125240783|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
125240784|NCT00217737|450504491|FG000|Step 2 Randomization/Registration|Other|1|||
125240785|NCT00217737|450504492|FG001|Step 2 Randomization/Registration|Other|2|||
125240786|NCT00217737|450504493|FG002|Step 2 Randomization/Registration|Other|0|||
125240787|NCT00217737|450504494|FG003|Step 2 Randomization/Registration|Other|0|||
125240788|NCT04132050|450505066|FG000|Period I (Double-blind Period)|Adverse Event|3|||
125240789|NCT04132050|450505067|FG001|Period I (Double-blind Period)|Adverse Event|0|||
125240790|NCT04132050|450505066|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
125240791|NCT04132050|450505067|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
125240792|NCT04132050|450505066|FG000|R788 Treatment Period|Adverse Event|5|||
125240793|NCT04132050|450505067|FG001|R788 Treatment Period|Adverse Event|0|||
125240794|NCT04132050|450505066|FG000|R788 Treatment Period|Lack of Efficacy|5|||
125240795|NCT04132050|450505067|FG001|R788 Treatment Period|Lack of Efficacy|0|||
125240796|NCT04132050|450505066|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
125240797|NCT04132050|450505067|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
125240798|NCT03506477|450505068|FG000|Overall Study|Withdrawal by Subject|1|||
125240799|NCT03506477|450505069|FG001|Overall Study|Withdrawal by Subject|0|||
125240800|NCT00843882|450505070|FG000|Step 1|Lack of Efficacy|14|||
125240801|NCT00843882|450505071|FG001|Step 1|Lack of Efficacy|10|||
125240802|NCT00843882|450505072|FG002|Step 1|Lack of Efficacy|21|||
125240803|NCT00843882|450505070|FG000|Step 1|Adverse Event|8|||
125240804|NCT00843882|450505071|FG001|Step 1|Adverse Event|17|||
125240805|NCT00843882|450505072|FG002|Step 1|Adverse Event|20|||
125240806|NCT00843882|450505070|FG000|Step 1|Death|1|||
125240807|NCT00843882|450505071|FG001|Step 1|Death|2|||
125240808|NCT00843882|450505072|FG002|Step 1|Death|4|||
125240809|NCT00843882|450505070|FG000|Step 1|Withdrawal by Subject|6|||
125240810|NCT00843882|450505071|FG001|Step 1|Withdrawal by Subject|12|||
125240811|NCT00843882|450505072|FG002|Step 1|Withdrawal by Subject|9|||
125240812|NCT00843882|450505070|FG000|Step 1|Physician Decision|0|||
125240813|NCT00843882|450505071|FG001|Step 1|Physician Decision|5|||
125240814|NCT00843882|450505072|FG002|Step 1|Physician Decision|1|||
125240815|NCT00843882|450505070|FG000|Step 1|Patient and physician's decision|0|||
125240816|NCT00843882|450505071|FG001|Step 1|Patient and physician's decision|0|||
125240817|NCT00843882|450505072|FG002|Step 1|Patient and physician's decision|1|||
125240818|NCT00843882|450505070|FG000|Step 1|Other complicating disease|1|||
125392642|NCT00409617|451072480|FG000|Overall Study|Adverse Event|57|||
125240819|NCT00843882|450505071|FG001|Step 1|Other complicating disease|3|||
125240820|NCT00843882|450505072|FG002|Step 1|Other complicating disease|4|||
125240821|NCT00843882|450505070|FG000|Step 1|Alternative therapy|0|||
125240822|NCT00843882|450505071|FG001|Step 1|Alternative therapy|1|||
125240823|NCT00843882|450505072|FG002|Step 1|Alternative therapy|1|||
125240824|NCT00843882|450505070|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
125240825|NCT00843882|450505071|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
125240826|NCT00843882|450505072|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
125240827|NCT00843882|450505070|FG000|Step 1|Off treatment reason unknown|0|||
125240828|NCT00843882|450505071|FG001|Step 1|Off treatment reason unknown|1|||
125240829|NCT00843882|450505072|FG002|Step 1|Off treatment reason unknown|4|||
125240830|NCT00843882|450505070|FG000|Step 1|Never started treatment|2|||
125392643|NCT00409617|451072480|FG000|Overall Study|Lack of Efficacy|54|||
125392644|NCT00409617|451072480|FG000|Overall Study|Lost to Follow-up|2|||
125240831|NCT00843882|450505071|FG001|Step 1|Never started treatment|0|||
125240832|NCT00843882|450505072|FG002|Step 1|Never started treatment|0|||
125392645|NCT00409617|451072480|FG000|Overall Study|Protocol Violation|24|||
125392646|NCT00409617|451072480|FG000|Overall Study|Withdrawal by Subject|8|||
125392647|NCT00409617|451072480|FG000|Overall Study|Administrative reasons|1|||
125392648|NCT00409617|451072480|FG000|Overall Study|Not described|14|||
125392649|NCT02159521|451072481|FG000|Overall Study|Enrolled but not treated|3|||
125392650|NCT02159521|451072481|FG000|Overall Study|Withdrawal by Subject|7|||
125392651|NCT02159521|451072481|FG000|Overall Study|Lost to Follow-up|6|||
125392652|NCT02159521|451072481|FG000|Overall Study|Death|1|||
125392653|NCT02159521|451072481|FG000|Overall Study|Other than specified|1|||
125392654|NCT03131440|451072487|FG000|Overall Study|Withdrawal by Subject|1|||
125392655|NCT03131440|451072488|FG001|Overall Study|Withdrawal by Subject|3|||
125392656|NCT03131440|451072489|FG002|Overall Study|Withdrawal by Subject|0|||
125392657|NCT03131440|451072490|FG003|Overall Study|Withdrawal by Subject|0|||
125392658|NCT03131440|451072491|FG004|Overall Study|Withdrawal by Subject|1|||
125392659|NCT03131440|451072492|FG005|Overall Study|Withdrawal by Subject|0|||
125392660|NCT03131440|451072493|FG006|Overall Study|Withdrawal by Subject|0|||
125392661|NCT03131440|451072494|FG007|Overall Study|Withdrawal by Subject|1|||
125392662|NCT03131440|451072495|FG008|Overall Study|Withdrawal by Subject|1|||
125392663|NCT03131440|451072496|FG009|Overall Study|Withdrawal by Subject|1|||
125392664|NCT03131440|451072497|FG010|Overall Study|Withdrawal by Subject|0|||
125392665|NCT03131440|451072498|FG011|Overall Study|Withdrawal by Subject|1|||
125392666|NCT03131440|451072499|FG012|Overall Study|Withdrawal by Subject|1|||
125392667|NCT03131440|451072500|FG013|Overall Study|Withdrawal by Subject|0|||
125392668|NCT03131440|451072501|FG014|Overall Study|Withdrawal by Subject|1|||
125392669|NCT03131440|451072502|FG015|Overall Study|Withdrawal by Subject|0|||
125392670|NCT03131440|451072503|FG016|Overall Study|Withdrawal by Subject|0|||
125392671|NCT03131440|451072504|FG017|Overall Study|Withdrawal by Subject|0|||
125392672|NCT03131440|451072505|FG018|Overall Study|Withdrawal by Subject|1|||
125392673|NCT03131440|451072506|FG019|Overall Study|Withdrawal by Subject|0|||
125392674|NCT03131440|451072507|FG020|Overall Study|Withdrawal by Subject|1|||
125392675|NCT03131440|451072508|FG021|Overall Study|Withdrawal by Subject|1|||
125392676|NCT03131440|451072509|FG022|Overall Study|Withdrawal by Subject|1|||
125392677|NCT03131440|451072510|FG023|Overall Study|Withdrawal by Subject|0|||
125392678|NCT03131440|451072511|FG024|Overall Study|Withdrawal by Subject|0|||
125392679|NCT03131440|451072512|FG025|Overall Study|Withdrawal by Subject|0|||
125392680|NCT03131440|451072513|FG026|Overall Study|Withdrawal by Subject|0|||
125392681|NCT03131440|451072514|FG027|Overall Study|Withdrawal by Subject|0|||
125392682|NCT03131440|451072515|FG028|Overall Study|Withdrawal by Subject|0|||
125392683|NCT03131440|451072516|FG029|Overall Study|Withdrawal by Subject|0|||
125392684|NCT03131440|451072517|FG030|Overall Study|Withdrawal by Subject|1|||
125392685|NCT03131440|451072518|FG031|Overall Study|Withdrawal by Subject|0|||
125392686|NCT03131440|451072487|FG000|Overall Study|Lost to Follow-up|0|||
125240833|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
125240834|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
125240835|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
125240836|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
125240837|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
125240838|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
125240839|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
125240840|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
125240841|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
125240842|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
125240843|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
125392687|NCT03131440|451072488|FG001|Overall Study|Lost to Follow-up|0|||
125392688|NCT03131440|451072489|FG002|Overall Study|Lost to Follow-up|0|||
125392689|NCT03131440|451072490|FG003|Overall Study|Lost to Follow-up|0|||
125392690|NCT03131440|451072491|FG004|Overall Study|Lost to Follow-up|0|||
125392691|NCT03131440|451072492|FG005|Overall Study|Lost to Follow-up|1|||
125392692|NCT03131440|451072493|FG006|Overall Study|Lost to Follow-up|0|||
125392693|NCT03131440|451072494|FG007|Overall Study|Lost to Follow-up|0|||
125392694|NCT03131440|451072495|FG008|Overall Study|Lost to Follow-up|0|||
125392695|NCT03131440|451072496|FG009|Overall Study|Lost to Follow-up|0|||
125392696|NCT03131440|451072497|FG010|Overall Study|Lost to Follow-up|0|||
125392697|NCT03131440|451072498|FG011|Overall Study|Lost to Follow-up|0|||
125392698|NCT03131440|451072499|FG012|Overall Study|Lost to Follow-up|0|||
125392699|NCT03131440|451072500|FG013|Overall Study|Lost to Follow-up|0|||
125392700|NCT03131440|451072501|FG014|Overall Study|Lost to Follow-up|0|||
125392701|NCT03131440|451072502|FG015|Overall Study|Lost to Follow-up|0|||
125392702|NCT03131440|451072503|FG016|Overall Study|Lost to Follow-up|0|||
125392703|NCT03131440|451072504|FG017|Overall Study|Lost to Follow-up|0|||
125392704|NCT03131440|451072505|FG018|Overall Study|Lost to Follow-up|0|||
125392705|NCT03131440|451072506|FG019|Overall Study|Lost to Follow-up|2|||
125392706|NCT03131440|451072507|FG020|Overall Study|Lost to Follow-up|1|||
125392707|NCT03131440|451072508|FG021|Overall Study|Lost to Follow-up|0|||
125392708|NCT03131440|451072509|FG022|Overall Study|Lost to Follow-up|1|||
125392709|NCT03131440|451072510|FG023|Overall Study|Lost to Follow-up|0|||
125392710|NCT03131440|451072511|FG024|Overall Study|Lost to Follow-up|1|||
125392711|NCT03131440|451072512|FG025|Overall Study|Lost to Follow-up|0|||
125392712|NCT03131440|451072513|FG026|Overall Study|Lost to Follow-up|0|||
125240844|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
125240845|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
125240846|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
125240847|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
125240848|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
125240849|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
125240850|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
125240851|NCT00843882|450505070|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
125240852|NCT00843882|450505071|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
125240853|NCT00843882|450505072|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
125240854|NCT05317546|450505073|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
125240855|NCT05317546|450505074|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
125240856|NCT03331250|450505075|FG000|Overall Study|Withdrawal by Subject|1|||
125240857|NCT04590963|450505076|FG000|Overall Study|Death|118|||
125240858|NCT04590963|450505077|FG001|Overall Study|Death|59|||
125240859|NCT04590963|450505076|FG000|Overall Study|Lost to Follow-up|1|||
125240860|NCT04590963|450505077|FG001|Overall Study|Lost to Follow-up|1|||
125240861|NCT04590963|450505076|FG000|Overall Study|Progressive disease|0|||
125240862|NCT04590963|450505077|FG001|Overall Study|Progressive disease|1|||
125240863|NCT04590963|450505076|FG000|Overall Study|Study terminated by sponsor|103|||
125240864|NCT04590963|450505077|FG001|Overall Study|Study terminated by sponsor|50|||
125240865|NCT04590963|450505076|FG000|Overall Study|Withdrawal by Subject|15|||
125240866|NCT04590963|450505077|FG001|Overall Study|Withdrawal by Subject|8|||
125240867|NCT04590963|450505076|FG000|Overall Study|Ongoing at data cut-off|9|||
125240868|NCT04590963|450505077|FG001|Overall Study|Ongoing at data cut-off|4|||
125240869|NCT04590963|450505076|FG000|Overall Study|Screen failure|1|||
125240870|NCT04590963|450505077|FG001|Overall Study|Screen failure|0|||
125240871|NCT01063114|450505078|FG000|Overall Study|Lost to Follow-up|1|||
125240872|NCT02717611|450505091|FG000|Overall Study|Death|13|||
125240873|NCT02717611|450505091|FG000|Overall Study|Withdrawal by Subject|6|||
125240874|NCT02717611|450505091|FG000|Overall Study|Active, not recruiting|40|||
125240875|NCT02717611|450505091|FG000|Overall Study|Complicating disease|1|||
125240876|NCT02466971|450505095|FG000|Overall Study|eligible and never treated|14|||
125240877|NCT02466971|450505096|FG001|Overall Study|eligible and never treated|20|||
125240878|NCT02466971|450505095|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
125240879|NCT02466971|450505096|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
125240880|NCT02466971|450505095|FG000|Overall Study|ineligible and treated|1|||
125240881|NCT02466971|450505096|FG001|Overall Study|ineligible and treated|0|||
125240882|NCT02466971|450505095|FG000|Overall Study|ineligible and never treated|0|||
125240883|NCT02466971|450505096|FG001|Overall Study|ineligible and never treated|1|||
125240884|NCT04818112|450505101|FG000|Overall Study|Withdrawal by Subject|54|||
125240885|NCT04818112|450505102|FG001|Overall Study|Withdrawal by Subject|12|||
125240886|NCT04818112|450505101|FG000|Overall Study|Lost to Follow-up|38|||
125240887|NCT04818112|450505102|FG001|Overall Study|Lost to Follow-up|10|||
125240888|NCT02406612|450505103|FG000|Overall Study|Screening Failure|3|||
125240889|NCT02406612|450505104|FG001|Overall Study|Screening Failure|0|||
125240890|NCT02406612|450505103|FG000|Overall Study|Intra-procedural Exclusion|1|||
125240891|NCT02406612|450505104|FG001|Overall Study|Intra-procedural Exclusion|3|||
125240892|NCT02406612|450505103|FG000|Overall Study|Guidewire Failure|0|||
125240893|NCT02406612|450505104|FG001|Overall Study|Guidewire Failure|1|||
125240894|NCT05759338|450505109|FG000|Overall Study|Withdrawal by Subject|3|||
125240895|NCT06481579|450505110|FG000|Overall Study|Death|1|||
125240896|NCT06481579|450505111|FG001|Overall Study|Death|0|||
125240897|NCT06481579|450505110|FG000|Overall Study|Withdrawal by Subject|3|||
125392713|NCT03131440|451072514|FG027|Overall Study|Lost to Follow-up|2|||
125392714|NCT03131440|451072515|FG028|Overall Study|Lost to Follow-up|0|||
125392715|NCT03131440|451072516|FG029|Overall Study|Lost to Follow-up|2|||
125392716|NCT03131440|451072517|FG030|Overall Study|Lost to Follow-up|0|||
125392717|NCT03131440|451072518|FG031|Overall Study|Lost to Follow-up|0|||
125240898|NCT06481579|450505111|FG001|Overall Study|Withdrawal by Subject|0|||
125240899|NCT06481579|450505110|FG000|Overall Study|Other|1|||
125240900|NCT06481579|450505111|FG001|Overall Study|Other|1|||
125240901|NCT06170827|450505112|FG000|Overall Study|Withdrawal by Subject|1|||
125240902|NCT06170827|450505113|FG001|Overall Study|Withdrawal by Subject|1|||
125240903|NCT05253807|450505114|FG000|Overall Study|Death|1|||
125240904|NCT05253807|450505115|FG001|Overall Study|Death|4|||
125240905|NCT05253807|450505114|FG000|Overall Study|Withdrawal by Subject|1|||
125240906|NCT05253807|450505115|FG001|Overall Study|Withdrawal by Subject|0|||
125240907|NCT05253807|450505114|FG000|Overall Study|Study Terminated by Sponsor|1|||
125240908|NCT05253807|450505115|FG001|Overall Study|Study Terminated by Sponsor|1|||
125240909|NCT04611126|450505116|FG000|Overall Study|TIL expansion unsuccessful|1|||
125240910|NCT04611126|450505117|FG001|Overall Study|TIL expansion unsuccessful|0|||
125240911|NCT03459846|450505122|FG000|Overall Study|Death|52|||
125240912|NCT03459846|450505123|FG001|Overall Study|Death|46|||
125392718|NCT03131440|451072487|FG000|Overall Study|Death|0|||
125392719|NCT03131440|451072488|FG001|Overall Study|Death|0|||
125392720|NCT03131440|451072489|FG002|Overall Study|Death|0|||
125186582|NCT01288079|450303704|FG002|Overall Study|Withdrawal by Subject|1|||
125186583|NCT01288079|450303705|FG003|Overall Study|Withdrawal by Subject|0|||
125186584|NCT01288079|450303702|FG000|Overall Study|Adverse Event|2|||
125186585|NCT01288079|450303703|FG001|Overall Study|Adverse Event|1|||
125186586|NCT01288079|450303704|FG002|Overall Study|Adverse Event|2|||
125186587|NCT01288079|450303705|FG003|Overall Study|Adverse Event|3|||
125186588|NCT01288079|450303702|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
125186589|NCT01288079|450303703|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
125186590|NCT01288079|450303704|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
125186591|NCT01288079|450303705|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
125186592|NCT01288079|450303702|FG000|Overall Study|Condition under Investigation Worsened|0|||
125186593|NCT01288079|450303703|FG001|Overall Study|Condition under Investigation Worsened|0|||
125186594|NCT01288079|450303704|FG002|Overall Study|Condition under Investigation Worsened|0|||
125186595|NCT01288079|450303705|FG003|Overall Study|Condition under Investigation Worsened|1|||
125186596|NCT01288079|450303702|FG000|Overall Study|Lack of Efficacy|2|||
125186597|NCT01288079|450303703|FG001|Overall Study|Lack of Efficacy|2|||
125186598|NCT01288079|450303704|FG002|Overall Study|Lack of Efficacy|0|||
125186599|NCT01288079|450303705|FG003|Overall Study|Lack of Efficacy|2|||
125186600|NCT01288079|450303702|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
125186601|NCT01288079|450303703|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
125186602|NCT01288079|450303704|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
125186603|NCT01288079|450303705|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
125186604|NCT01288079|450303702|FG000|Overall Study|Lost to Follow-up|1|||
125186605|NCT01288079|450303703|FG001|Overall Study|Lost to Follow-up|1|||
125186606|NCT01288079|450303704|FG002|Overall Study|Lost to Follow-up|1|||
125186607|NCT01288079|450303705|FG003|Overall Study|Lost to Follow-up|0|||
125186608|NCT01288079|450303702|FG000|Overall Study|Other or Study Termination|11|||
125186609|NCT01288079|450303703|FG001|Overall Study|Other or Study Termination|15|||
125186610|NCT01288079|450303704|FG002|Overall Study|Other or Study Termination|14|||
125186611|NCT01288079|450303705|FG003|Overall Study|Other or Study Termination|8|||
125186612|NCT01530464|450303706|FG000|Washout (24h)|Withdrawal by Subject|1|||
125186613|NCT01530464|450303707|FG001|Washout (24h)|Withdrawal by Subject|0|||
125186614|NCT01530464|450303706|FG000|Washout (24h)|Withdrawal by Subject|0|||
125186615|NCT01530464|450303707|FG001|Washout (24h)|Withdrawal by Subject|1|||
125186616|NCT04564092|450303713|FG000|Overall Study|Withdrawal by Subject|1|||
125186617|NCT00503698|450303717|FG000|Overall Study|Protocol Violation|5|||
125186618|NCT00503698|450303718|FG001|Overall Study|Protocol Violation|6|||
125186619|NCT00503698|450303717|FG000|Overall Study|Adverse Event|52|||
125186620|NCT00503698|450303718|FG001|Overall Study|Adverse Event|41|||
125186621|NCT00503698|450303717|FG000|Overall Study|Death|1|||
125186622|NCT00503698|450303718|FG001|Overall Study|Death|0|||
125186623|NCT00503698|450303717|FG000|Overall Study|Lack of Efficacy|3|||
125186624|NCT00503698|450303718|FG001|Overall Study|Lack of Efficacy|4|||
125186625|NCT00503698|450303717|FG000|Overall Study|Trial terminated|216|||
125186626|NCT00503698|450303718|FG001|Overall Study|Trial terminated|253|||
125186627|NCT00503698|450303717|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
125186628|NCT00503698|450303718|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
125186629|NCT00503698|450303717|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
125186630|NCT00503698|450303718|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
125186631|NCT00503698|450303717|FG000|Overall Study|Any condition in exclusion criteria|4|||
125186632|NCT00503698|450303718|FG001|Overall Study|Any condition in exclusion criteria|6|||
125186633|NCT00503698|450303717|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
125186634|NCT00503698|450303718|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
125186635|NCT00503698|450303717|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
125186636|NCT00503698|450303718|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
125186637|NCT00503698|450303717|FG000|Overall Study|Critically ill|2|||
125186638|NCT00503698|450303718|FG001|Overall Study|Critically ill|0|||
125186639|NCT00503698|450303717|FG000|Overall Study|Unclassified|48|||
125186640|NCT00503698|450303718|FG001|Overall Study|Unclassified|32|||
125186641|NCT00503698|450303717|FG000|Overall Study|Not exposed to trial drug|11|||
125186642|NCT00503698|450303718|FG001|Overall Study|Not exposed to trial drug|6|||
125186643|NCT02107131|450303721|FG000|Overall Study|Lost to Follow-up|4|||
125186644|NCT02107131|450303722|FG001|Overall Study|Lost to Follow-up|4|||
125186645|NCT02107131|450303721|FG000|Overall Study|Physician Decision|1|||
125186646|NCT02107131|450303722|FG001|Overall Study|Physician Decision|0|||
125186647|NCT02107131|450303721|FG000|Overall Study|Withdrawal by Subject|2|||
125186648|NCT02107131|450303722|FG001|Overall Study|Withdrawal by Subject|0|||
125186649|NCT02107131|450303721|FG000|Overall Study|mental instability|1|||
125186650|NCT02107131|450303722|FG001|Overall Study|mental instability|0|||
125186651|NCT02107131|450303721|FG000|Overall Study|Death|0|||
125186652|NCT02107131|450303722|FG001|Overall Study|Death|1|||
125186653|NCT02107131|450303721|FG000|Overall Study|Protocol Violation|0|||
125186654|NCT02107131|450303722|FG001|Overall Study|Protocol Violation|4|||
125186655|NCT02259010|450303723|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
125186656|NCT03830333|450303724|FG000|Overall Study|Death|0|||
125186657|NCT03830333|450303725|FG001|Overall Study|Death|1|||
125240913|NCT03459846|450505122|FG000|Overall Study|Study terminated by sponsor|24|||
125240914|NCT03459846|450505123|FG001|Overall Study|Study terminated by sponsor|28|||
125240915|NCT03459846|450505122|FG000|Overall Study|Withdrawal by Subject|2|||
125240916|NCT03459846|450505123|FG001|Overall Study|Withdrawal by Subject|2|||
125240917|NCT06455111|450505129|FG000|Overall Study|Withdrawal by Subject|11|||
125240918|NCT06455111|450505130|FG001|Overall Study|Withdrawal by Subject|4|||
125240919|NCT05578872|450505138|FG000|Overall Study|Withdrawal by Subject|2|||
125240920|NCT05578872|450505139|FG001|Overall Study|Withdrawal by Subject|1|||
125240921|NCT05578872|450505138|FG000|Overall Study|Adverse Event|1|||
125240922|NCT05578872|450505139|FG001|Overall Study|Adverse Event|1|||
125240923|NCT05578872|450505138|FG000|Overall Study|Physician Decision|1|||
125240924|NCT05578872|450505139|FG001|Overall Study|Physician Decision|2|||
125240925|NCT05578872|450505138|FG000|Overall Study|Progressive disease|10|||
125240926|NCT05578872|450505139|FG001|Overall Study|Progressive disease|9|||
125240927|NCT05578872|450505138|FG000|Overall Study|Sponsor decision|0|||
125240928|NCT05578872|450505139|FG001|Overall Study|Sponsor decision|1|||
125240929|NCT05578872|450505138|FG000|Overall Study|Toxicity and Patient's decision|0|||
125240930|NCT05578872|450505139|FG001|Overall Study|Toxicity and Patient's decision|1|||
125240931|NCT04598828|450505862|FG000|Overall Study|Physician Decision|1|||
125240932|NCT04598828|450505863|FG001|Overall Study|Physician Decision|0|||
125240933|NCT04598828|450505862|FG000|Overall Study|Withdrawal by Subject|0|||
125240934|NCT04598828|450505863|FG001|Overall Study|Withdrawal by Subject|1|||
125240935|NCT04598828|450505862|FG000|Overall Study|Withdrawal by Subject|0|||
125240936|NCT04598828|450505863|FG001|Overall Study|Withdrawal by Subject|1|||
125240937|NCT06187909|450505864|FG000|Overall Study|Withdrawal by Subject|2|||
125240938|NCT06187909|450505865|FG001|Overall Study|Withdrawal by Subject|2|||
125240939|NCT02676973|450505866|FG000|Overall Study|Withdrawal by Subject|9|||
125240940|NCT02676973|450505867|FG001|Overall Study|Withdrawal by Subject|8|||
125240941|NCT02676973|450505868|FG002|Overall Study|Withdrawal by Subject|11|||
125240942|NCT02676973|450505866|FG000|Overall Study|Lost to Follow-up|8|||
125240943|NCT02676973|450505867|FG001|Overall Study|Lost to Follow-up|12|||
125240944|NCT02676973|450505868|FG002|Overall Study|Lost to Follow-up|8|||
125240945|NCT02676973|450505866|FG000|Overall Study|Death|2|||
125240946|NCT02676973|450505867|FG001|Overall Study|Death|1|||
125240947|NCT02676973|450505868|FG002|Overall Study|Death|5|||
125240948|NCT05020743|450505870|FG000|Overall Study|Enrollment in Interventional Study|2|||
125240949|NCT05020743|450505871|FG001|Overall Study|Enrollment in Interventional Study|9|||
125240950|NCT05020743|450505872|FG002|Overall Study|Enrollment in Interventional Study|0|||
125240951|NCT05020743|450505870|FG000|Overall Study|Withdrawal by Subject|0|||
125240952|NCT05020743|450505871|FG001|Overall Study|Withdrawal by Subject|3|||
125240953|NCT05020743|450505872|FG002|Overall Study|Withdrawal by Subject|1|||
125240954|NCT05020743|450505870|FG000|Overall Study|Lost to Follow-up|1|||
125240955|NCT05020743|450505871|FG001|Overall Study|Lost to Follow-up|0|||
125240956|NCT05020743|450505872|FG002|Overall Study|Lost to Follow-up|0|||
125240957|NCT05020743|450505870|FG000|Overall Study|Study Termination by Sponsor|10|||
125240958|NCT05020743|450505871|FG001|Overall Study|Study Termination by Sponsor|11|||
125240959|NCT05020743|450505872|FG002|Overall Study|Study Termination by Sponsor|10|||
125240960|NCT03488524|450505873|FG000|Overall Study|Withdrawal by Subject|51|||
125240961|NCT03488524|450505873|FG000|Overall Study|Death|19|||
125240962|NCT03488524|450505873|FG000|Overall Study|Study Sponsor|11|||
125240963|NCT03488524|450505873|FG000|Overall Study|Physician Decision|4|||
125240964|NCT03488524|450505873|FG000|Overall Study|Lost to Follow-up|3|||
125240965|NCT01078662|450505874|FG000|Overall Study|Death|41|||
125240966|NCT01078662|450505875|FG001|Overall Study|Death|103|||
125240967|NCT01078662|450505876|FG002|Overall Study|Death|18|||
125240968|NCT01078662|450505877|FG003|Overall Study|Death|5|||
125240969|NCT01078662|450505878|FG004|Overall Study|Death|8|||
125240970|NCT01078662|450505874|FG000|Overall Study|Patients reached data cut-off|12|||
125392721|NCT03131440|451072490|FG003|Overall Study|Death|0|||
125392722|NCT03131440|451072491|FG004|Overall Study|Death|0|||
125392723|NCT03131440|451072492|FG005|Overall Study|Death|0|||
125392724|NCT03131440|451072493|FG006|Overall Study|Death|0|||
125392725|NCT03131440|451072494|FG007|Overall Study|Death|0|||
125240971|NCT01078662|450505875|FG001|Overall Study|Patients reached data cut-off|53|||
125240972|NCT01078662|450505876|FG002|Overall Study|Patients reached data cut-off|2|||
125240973|NCT01078662|450505877|FG003|Overall Study|Patients reached data cut-off|2|||
125240974|NCT01078662|450505878|FG004|Overall Study|Patients reached data cut-off|3|||
125240975|NCT01078662|450505874|FG000|Overall Study|Withdrawal by Subject|4|||
125240976|NCT01078662|450505875|FG001|Overall Study|Withdrawal by Subject|11|||
125240977|NCT01078662|450505876|FG002|Overall Study|Withdrawal by Subject|1|||
125392726|NCT03131440|451072495|FG008|Overall Study|Death|0|||
125240978|NCT01078662|450505877|FG003|Overall Study|Withdrawal by Subject|0|||
125240979|NCT01078662|450505878|FG004|Overall Study|Withdrawal by Subject|0|||
125240980|NCT01078662|450505874|FG000|Overall Study|Protocol Violation|0|||
125392727|NCT03131440|451072496|FG009|Overall Study|Death|0|||
125240981|NCT01078662|450505875|FG001|Overall Study|Protocol Violation|1|||
125240982|NCT01078662|450505876|FG002|Overall Study|Protocol Violation|0|||
125392728|NCT03131440|451072497|FG010|Overall Study|Death|0|||
125240983|NCT01078662|450505877|FG003|Overall Study|Protocol Violation|0|||
125240984|NCT01078662|450505878|FG004|Overall Study|Protocol Violation|0|||
125240985|NCT01078662|450505874|FG000|Overall Study|Lost to Follow-up|1|||
125240986|NCT01078662|450505875|FG001|Overall Study|Lost to Follow-up|0|||
125240987|NCT01078662|450505876|FG002|Overall Study|Lost to Follow-up|0|||
125240988|NCT01078662|450505877|FG003|Overall Study|Lost to Follow-up|0|||
125240989|NCT01078662|450505878|FG004|Overall Study|Lost to Follow-up|0|||
125240990|NCT00325416|450505879|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
125240991|NCT00325416|450505880|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
125240992|NCT00325416|450505879|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
125240993|NCT00325416|450505880|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
125240994|NCT00325416|450505879|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
125240995|NCT00325416|450505880|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
125240996|NCT00325416|450505879|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
125240997|NCT00325416|450505880|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
125240998|NCT00325416|450505879|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
125240999|NCT00325416|450505880|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
125241000|NCT00325416|450505879|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
125241001|NCT00325416|450505880|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
125241002|NCT04589650|450505881|FG000|Overall Study|Subject decision|6|||
125241003|NCT04589650|450505882|FG001|Overall Study|Subject decision|2|||
125241004|NCT04589650|450505883|FG002|Overall Study|Subject decision|2|||
125241005|NCT04589650|450505884|FG003|Overall Study|Subject decision|0|||
125241006|NCT04589650|450505885|FG004|Overall Study|Subject decision|0|||
125241007|NCT04589650|450505886|FG005|Overall Study|Subject decision|0|||
125241008|NCT04589650|450505881|FG000|Overall Study|Adverse Event|3|||
125241009|NCT04589650|450505882|FG001|Overall Study|Adverse Event|1|||
125241010|NCT04589650|450505883|FG002|Overall Study|Adverse Event|1|||
125241011|NCT04589650|450505884|FG003|Overall Study|Adverse Event|1|||
125241012|NCT04589650|450505885|FG004|Overall Study|Adverse Event|0|||
125241013|NCT04589650|450505886|FG005|Overall Study|Adverse Event|1|||
125186658|NCT03830333|450303724|FG000|Overall Study|Withdrawal by Subject|5|||
125186659|NCT03830333|450303725|FG001|Overall Study|Withdrawal by Subject|1|||
125186660|NCT03830333|450303724|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
125186661|NCT03830333|450303725|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
125186662|NCT01546025|450303733|FG000|Overall Study|Lost to Follow-up|0|||
125186663|NCT01546025|450303734|FG001|Overall Study|Lost to Follow-up|1|||
125186664|NCT05966584|450303742|FG000|Overall Study|Lost to Follow-up|1|||
125186665|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
125186666|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
125186667|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
125186668|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125186669|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125186670|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125186671|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125186672|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125186673|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
125186674|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
125186675|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125186676|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125186677|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125186678|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125186679|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
125186680|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
125241014|NCT04589650|450505881|FG000|Overall Study|Physician Decision|1|||
125241015|NCT04589650|450505882|FG001|Overall Study|Physician Decision|1|||
125241016|NCT04589650|450505883|FG002|Overall Study|Physician Decision|0|||
125241017|NCT04589650|450505884|FG003|Overall Study|Physician Decision|0|||
125241018|NCT04589650|450505885|FG004|Overall Study|Physician Decision|0|||
125241019|NCT04589650|450505886|FG005|Overall Study|Physician Decision|0|||
125241020|NCT04589650|450505881|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125241021|NCT04589650|450505882|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125241022|NCT04589650|450505883|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125241023|NCT04589650|450505884|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
125241024|NCT04589650|450505885|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
125241025|NCT04589650|450505886|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
125186681|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
125186682|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125241026|NCT04589650|450505881|FG000|Overall Study|Death|0|||
125241027|NCT04589650|450505882|FG001|Overall Study|Death|0|||
125241028|NCT04589650|450505883|FG002|Overall Study|Death|0|||
125241029|NCT04589650|450505884|FG003|Overall Study|Death|1|||
125241030|NCT04589650|450505885|FG004|Overall Study|Death|0|||
125241031|NCT04589650|450505886|FG005|Overall Study|Death|0|||
125241032|NCT04589650|450505881|FG000|Overall Study|Guardian Decision|0|||
125241033|NCT04589650|450505882|FG001|Overall Study|Guardian Decision|0|||
125241034|NCT04589650|450505883|FG002|Overall Study|Guardian Decision|0|||
125241035|NCT04589650|450505884|FG003|Overall Study|Guardian Decision|1|||
125241036|NCT04589650|450505885|FG004|Overall Study|Guardian Decision|0|||
125241037|NCT04589650|450505886|FG005|Overall Study|Guardian Decision|0|||
125241038|NCT02324153|450505887|FG000|Overall Study|Withdrawal by Subject|4|||
125241039|NCT02324153|450505888|FG001|Overall Study|Withdrawal by Subject|1|||
125241040|NCT02324153|450505887|FG000|Overall Study|Surgery postponed after randomization|3|||
125241041|NCT02324153|450505888|FG001|Overall Study|Surgery postponed after randomization|0|||
125241042|NCT02324153|450505887|FG000|Overall Study|Developed delirium preoperatively|1|||
125241043|NCT02324153|450505888|FG001|Overall Study|Developed delirium preoperatively|0|||
125241044|NCT03122106|450505891|FG000|Overall Study|Not enough tissue|1|||
125241045|NCT03122106|450505891|FG000|Overall Study|Disease progression during screening|2|||
125241046|NCT03122106|450505891|FG000|Overall Study|Poor RNA quality for vaccine|1|||
125241047|NCT01913353|450505893|FG000|Overall Study|Adverse Event|2|||
125241048|NCT01913353|450505894|FG001|Overall Study|Adverse Event|0|||
125241049|NCT01913353|450505893|FG000|Overall Study|Physician Decision|0|||
125241050|NCT01913353|450505894|FG001|Overall Study|Physician Decision|2|||
125241051|NCT01913353|450505893|FG000|Overall Study|Withdrawal by Subject|20|||
125241052|NCT01913353|450505894|FG001|Overall Study|Withdrawal by Subject|6|||
125241053|NCT01913353|450505893|FG000|Overall Study|multiple reasons|10|||
125241054|NCT01913353|450505894|FG001|Overall Study|multiple reasons|7|||
125241055|NCT01147458|450505896|FG000|First Intervention|Study terminated by sponsor|8|||
125241056|NCT01147458|450505897|FG001|First Intervention|Study terminated by sponsor|8|||
125241057|NCT01147458|450505898|FG002|First Intervention|Study terminated by sponsor|7|||
125241058|NCT01147458|450505899|FG003|First Intervention|Study terminated by sponsor|8|||
125241059|NCT01147458|450505896|FG000|First Intervention|Protocol Violation|2|||
125241060|NCT01147458|450505897|FG001|First Intervention|Protocol Violation|3|||
125241061|NCT01147458|450505898|FG002|First Intervention|Protocol Violation|2|||
125241062|NCT01147458|450505899|FG003|First Intervention|Protocol Violation|3|||
125241063|NCT01147458|450505896|FG000|First Intervention|Withdrawal by Subject|3|||
125241064|NCT01147458|450505897|FG001|First Intervention|Withdrawal by Subject|0|||
125241065|NCT01147458|450505898|FG002|First Intervention|Withdrawal by Subject|1|||
125241066|NCT01147458|450505899|FG003|First Intervention|Withdrawal by Subject|0|||
125241067|NCT01147458|450505896|FG000|First Intervention|Adverse Event|0|||
125241068|NCT01147458|450505897|FG001|First Intervention|Adverse Event|3|||
125241069|NCT01147458|450505898|FG002|First Intervention|Adverse Event|2|||
125241070|NCT01147458|450505899|FG003|First Intervention|Adverse Event|3|||
125241071|NCT01147458|450505896|FG000|First Intervention|Other|1|||
125241072|NCT01147458|450505897|FG001|First Intervention|Other|2|||
125241073|NCT01147458|450505898|FG002|First Intervention|Other|0|||
125241074|NCT01147458|450505899|FG003|First Intervention|Other|0|||
125241075|NCT01147458|450505896|FG000|Second Intervention|Study terminated by sponsor|7|||
125241076|NCT01147458|450505897|FG001|Second Intervention|Study terminated by sponsor|5|||
125241077|NCT01147458|450505898|FG002|Second Intervention|Study terminated by sponsor|5|||
125241078|NCT01147458|450505899|FG003|Second Intervention|Study terminated by sponsor|3|||
125241079|NCT01147458|450505896|FG000|Second Intervention|Protocol Violation|0|||
125241080|NCT01147458|450505897|FG001|Second Intervention|Protocol Violation|1|||
125241081|NCT01147458|450505898|FG002|Second Intervention|Protocol Violation|1|||
125241082|NCT01147458|450505899|FG003|Second Intervention|Protocol Violation|0|||
125241083|NCT01147458|450505896|FG000|Second Intervention|Withdrawal by Subject|0|||
125241084|NCT01147458|450505897|FG001|Second Intervention|Withdrawal by Subject|1|||
125241085|NCT01147458|450505898|FG002|Second Intervention|Withdrawal by Subject|0|||
125241086|NCT01147458|450505899|FG003|Second Intervention|Withdrawal by Subject|0|||
125241087|NCT01147458|450505896|FG000|Second Intervention|Adverse Event|2|||
125241088|NCT01147458|450505897|FG001|Second Intervention|Adverse Event|0|||
125392729|NCT03131440|451072498|FG011|Overall Study|Death|0|||
125241089|NCT01147458|450505898|FG002|Second Intervention|Adverse Event|1|||
125241090|NCT01147458|450505899|FG003|Second Intervention|Adverse Event|1|||
125241091|NCT01147458|450505896|FG000|Second Intervention|Other|0|||
125241092|NCT01147458|450505897|FG001|Second Intervention|Other|0|||
125241093|NCT01147458|450505898|FG002|Second Intervention|Other|1|||
125241094|NCT01147458|450505899|FG003|Second Intervention|Other|0|||
125241095|NCT03550209|450505900|FG000|Overall Study|Lost to Follow-up|1|||
125241096|NCT03550209|450505901|FG001|Overall Study|Lost to Follow-up|0|||
125241097|NCT03550209|450505902|FG002|Overall Study|Lost to Follow-up|1|||
125241098|NCT03550209|450505903|FG003|Overall Study|Lost to Follow-up|0|||
125241099|NCT03550209|450505900|FG000|Overall Study|Withdrawal by Subject|0|||
125241100|NCT03550209|450505901|FG001|Overall Study|Withdrawal by Subject|3|||
125241101|NCT03550209|450505902|FG002|Overall Study|Withdrawal by Subject|1|||
125241102|NCT03550209|450505903|FG003|Overall Study|Withdrawal by Subject|2|||
125241103|NCT03550209|450505900|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
125241104|NCT03550209|450505901|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
125241105|NCT03550209|450505902|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
125241106|NCT03550209|450505903|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
125241107|NCT02555878|450505904|FG000|Overall Study|Lost to Follow-up|2|||
125241108|NCT02555878|450505905|FG001|Overall Study|Lost to Follow-up|3|||
125241109|NCT02555878|450505904|FG000|Overall Study|Withdrawal by Subject|48|||
125241110|NCT02555878|450505905|FG001|Overall Study|Withdrawal by Subject|48|||
125241111|NCT02555878|450505904|FG000|Overall Study|Adverse Event|12|||
125241112|NCT02555878|450505905|FG001|Overall Study|Adverse Event|8|||
125241113|NCT02555878|450505904|FG000|Overall Study|Death|74|||
125241114|NCT02555878|450505905|FG001|Overall Study|Death|59|||
125241115|NCT02555878|450505904|FG000|Overall Study|Protocol Violation|1|||
125241116|NCT02555878|450505905|FG001|Overall Study|Protocol Violation|2|||
125241117|NCT02555878|450505904|FG000|Overall Study|Physician Decision|12|||
125241118|NCT02555878|450505905|FG001|Overall Study|Physician Decision|13|||
125241119|NCT02555878|450505904|FG000|Overall Study|Other|17|||
125241120|NCT02555878|450505905|FG001|Overall Study|Other|17|||
125241121|NCT00765076|450505906|FG000|Overall Study|Adverse Event|1|||
125241122|NCT00765076|450505907|FG001|Overall Study|Adverse Event|0|||
125241123|NCT00765076|450505908|FG002|Overall Study|Adverse Event|0|||
125241124|NCT00765076|450505906|FG000|Overall Study|Withdrawal by Subject|0|||
125241125|NCT00765076|450505907|FG001|Overall Study|Withdrawal by Subject|0|||
125241126|NCT00765076|450505908|FG002|Overall Study|Withdrawal by Subject|1|||
125241127|NCT02875080|450505909|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
125241128|NCT02875080|450505910|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
125241129|NCT02875080|450505911|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
125241130|NCT00768053|450505912|FG000|Overall Study|Adverse Event|10|||
125241131|NCT00768053|450505912|FG000|Overall Study|Lost to Follow-up|1|||
125241132|NCT01164475|450505913|FG000|Overall Study|Lack of Efficacy|1|||
125241133|NCT01164475|450505914|FG001|Overall Study|Lack of Efficacy|0|||
125241134|NCT01164475|450505913|FG000|Overall Study|Other|0|||
125241135|NCT01164475|450505914|FG001|Overall Study|Other|1|||
125241136|NCT01164475|450505913|FG000|Overall Study|Progressive disease|0|||
125241137|NCT01164475|450505914|FG001|Overall Study|Progressive disease|1|||
125241138|NCT01164475|450505913|FG000|Overall Study|Protocol Violation|1|||
125241139|NCT01164475|450505914|FG001|Overall Study|Protocol Violation|0|||
125241140|NCT04603066|450505916|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
125241141|NCT04603066|450505917|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
125241142|NCT04937387|450505918|FG000|Overall Study|Adverse Event|1|||
125241143|NCT04937387|450505919|FG001|Overall Study|Adverse Event|0|||
125241144|NCT04937387|450505920|FG002|Overall Study|Adverse Event|2|||
125241145|NCT04937387|450505921|FG003|Overall Study|Adverse Event|0|||
125241146|NCT04937387|450505918|FG000|Overall Study|Lack of Efficacy|1|||
125241147|NCT04937387|450505919|FG001|Overall Study|Lack of Efficacy|0|||
125241148|NCT04937387|450505920|FG002|Overall Study|Lack of Efficacy|0|||
125241149|NCT04937387|450505921|FG003|Overall Study|Lack of Efficacy|1|||
125241150|NCT04937387|450505918|FG000|Overall Study|Withdrawal by Subject|1|||
125241151|NCT04937387|450505919|FG001|Overall Study|Withdrawal by Subject|0|||
125241152|NCT04937387|450505920|FG002|Overall Study|Withdrawal by Subject|1|||
125241153|NCT04937387|450505921|FG003|Overall Study|Withdrawal by Subject|1|||
125241154|NCT04937387|450505918|FG000|Overall Study|Randomized in error|0|||
125241155|NCT04937387|450505919|FG001|Overall Study|Randomized in error|0|||
125241156|NCT04937387|450505920|FG002|Overall Study|Randomized in error|0|||
125241157|NCT04937387|450505921|FG003|Overall Study|Randomized in error|1|||
125241158|NCT04134845|450505922|FG000|Overall Study|withdrawl by PI|12|||
125241159|NCT04134845|450505923|FG001|Overall Study|withdrawl by PI|5|||
125241160|NCT01371981|450505924|FG000|Overall Study|Adverse Event|12|||
125241161|NCT01371981|450505925|FG001|Overall Study|Adverse Event|17|||
125241162|NCT01371981|450505926|FG002|Overall Study|Adverse Event|0|||
125241163|NCT01371981|450505927|FG003|Overall Study|Adverse Event|4|||
125241164|NCT01371981|450505928|FG004|Overall Study|Adverse Event|1|||
125241165|NCT01371981|450505929|FG005|Overall Study|Adverse Event|0|||
125241166|NCT01371981|450505924|FG000|Overall Study|Death|22|||
125241167|NCT01371981|450505925|FG001|Overall Study|Death|16|||
125241168|NCT01371981|450505926|FG002|Overall Study|Death|0|||
125443452|NCT02555371|451252131|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
125241169|NCT01371981|450505927|FG003|Overall Study|Death|0|||
125241170|NCT01371981|450505928|FG004|Overall Study|Death|2|||
125241171|NCT01371981|450505929|FG005|Overall Study|Death|2|||
125241172|NCT01371981|450505924|FG000|Overall Study|Lack of Efficacy|69|||
125241173|NCT01371981|450505925|FG001|Overall Study|Lack of Efficacy|61|||
125241174|NCT01371981|450505926|FG002|Overall Study|Lack of Efficacy|4|||
125241175|NCT01371981|450505927|FG003|Overall Study|Lack of Efficacy|8|||
125241176|NCT01371981|450505928|FG004|Overall Study|Lack of Efficacy|5|||
125241177|NCT01371981|450505929|FG005|Overall Study|Lack of Efficacy|0|||
125241178|NCT01371981|450505924|FG000|Overall Study|Physician Decision|48|||
125241179|NCT01371981|450505925|FG001|Overall Study|Physician Decision|63|||
125241180|NCT01371981|450505926|FG002|Overall Study|Physician Decision|1|||
125241181|NCT01371981|450505927|FG003|Overall Study|Physician Decision|7|||
125241182|NCT01371981|450505928|FG004|Overall Study|Physician Decision|14|||
125241183|NCT01371981|450505929|FG005|Overall Study|Physician Decision|3|||
125392730|NCT03131440|451072499|FG012|Overall Study|Death|0|||
125392731|NCT03131440|451072500|FG013|Overall Study|Death|0|||
125392732|NCT03131440|451072501|FG014|Overall Study|Death|0|||
125392733|NCT03131440|451072502|FG015|Overall Study|Death|0|||
125392734|NCT03131440|451072503|FG016|Overall Study|Death|0|||
125392735|NCT03131440|451072504|FG017|Overall Study|Death|0|||
125392736|NCT03131440|451072505|FG018|Overall Study|Death|0|||
125392737|NCT03131440|451072506|FG019|Overall Study|Death|0|||
125392738|NCT03131440|451072507|FG020|Overall Study|Death|0|||
125392739|NCT03131440|451072508|FG021|Overall Study|Death|0|||
125392740|NCT03131440|451072509|FG022|Overall Study|Death|0|||
125392741|NCT03131440|451072510|FG023|Overall Study|Death|0|||
125392742|NCT03131440|451072511|FG024|Overall Study|Death|0|||
125392743|NCT03131440|451072512|FG025|Overall Study|Death|1|||
125392744|NCT03131440|451072513|FG026|Overall Study|Death|0|||
125392745|NCT03131440|451072514|FG027|Overall Study|Death|0|||
125392746|NCT03131440|451072515|FG028|Overall Study|Death|0|||
125392747|NCT03131440|451072516|FG029|Overall Study|Death|0|||
125392748|NCT03131440|451072517|FG030|Overall Study|Death|0|||
125392749|NCT03131440|451072518|FG031|Overall Study|Death|0|||
125392750|NCT00746941|451072521|FG000|Overall Study|Death|2|||
125392751|NCT00746941|451072522|FG001|Overall Study|Death|0|||
125392752|NCT00746941|451072523|FG002|Overall Study|Death|0|||
125392753|NCT00746941|451072524|FG003|Overall Study|Death|6|||
125392754|NCT00746941|451072521|FG000|Overall Study|Physician Decision|0|||
125392755|NCT00746941|451072522|FG001|Overall Study|Physician Decision|0|||
125392756|NCT00746941|451072523|FG002|Overall Study|Physician Decision|2|||
125392757|NCT00746941|451072524|FG003|Overall Study|Physician Decision|0|||
125392758|NCT00746941|451072521|FG000|Overall Study|Withdrawal by Subject|3|||
125392759|NCT00746941|451072522|FG001|Overall Study|Withdrawal by Subject|0|||
125392760|NCT00746941|451072523|FG002|Overall Study|Withdrawal by Subject|0|||
125392761|NCT00746941|451072524|FG003|Overall Study|Withdrawal by Subject|2|||
125392762|NCT00746941|451072521|FG000|Overall Study|Other, reason not provided|2|||
125392763|NCT00746941|451072522|FG001|Overall Study|Other, reason not provided|4|||
125392764|NCT00746941|451072523|FG002|Overall Study|Other, reason not provided|0|||
125392765|NCT00746941|451072524|FG003|Overall Study|Other, reason not provided|4|||
125392766|NCT00746941|451072521|FG000|Overall Study|Adverse Event|0|||
125392767|NCT00746941|451072522|FG001|Overall Study|Adverse Event|0|||
125392768|NCT00746941|451072523|FG002|Overall Study|Adverse Event|0|||
125392769|NCT00746941|451072524|FG003|Overall Study|Adverse Event|1|||
125392770|NCT03316885|451072525|FG000|Overall Study|Adverse Event|1|||
125392771|NCT03316885|451072525|FG000|Overall Study|Death|10|||
125392772|NCT03316885|451072525|FG000|Overall Study|Lost to Follow-up|4|||
125392773|NCT03316885|451072525|FG000|Overall Study|Withdrawal by Subject|9|||
125392774|NCT03316885|451072525|FG000|Overall Study|COVID related|8|||
125392775|NCT03216850|451072533|FG000|Overall Study|Pre-analytical error|6|||
125392776|NCT03190889|451072534|FG000|Overall Study|Lost to Follow-up|7|||
125392777|NCT03190889|451072535|FG001|Overall Study|Lost to Follow-up|7|||
125392778|NCT03190889|451072536|FG002|Overall Study|Lost to Follow-up|3|||
125392779|NCT03190889|451072534|FG000|Overall Study|Withdrawal by Subject|1|||
125186683|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125186684|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125186685|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125186686|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
125186687|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
125186688|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
125186689|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125186690|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125186691|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125186692|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125186693|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
125186694|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
125186695|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
125186696|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
125186697|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
125186698|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
125186699|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
125186700|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
125186701|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
125186702|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
125186703|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
125186704|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
125392780|NCT03190889|451072535|FG001|Overall Study|Withdrawal by Subject|1|||
125392781|NCT03190889|451072536|FG002|Overall Study|Withdrawal by Subject|2|||
125392782|NCT03190889|451072534|FG000|Overall Study|Did not complete protocol|4|||
125392783|NCT03190889|451072535|FG001|Overall Study|Did not complete protocol|9|||
125392784|NCT03190889|451072536|FG002|Overall Study|Did not complete protocol|0|||
125392785|NCT03190889|451072534|FG000|Overall Study|COVID-19|1|||
125392786|NCT03190889|451072535|FG001|Overall Study|COVID-19|0|||
125392787|NCT03190889|451072536|FG002|Overall Study|COVID-19|2|||
125392788|NCT00405548|451072537|FG000|Overall Study|Cognitive Memory problems on study day|1|||
125392789|NCT00405548|451072538|FG001|Overall Study|Cognitive Memory problems on study day|0|||
125392790|NCT00405548|451072537|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
125392791|NCT00405548|451072538|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
125392792|NCT00405548|451072537|FG000|Overall Study|Unable to self-administer shots|1|||
125392793|NCT00405548|451072538|FG001|Overall Study|Unable to self-administer shots|0|||
125392794|NCT00405548|451072537|FG000|Overall Study|Venous access failed during study day|1|||
125392795|NCT00405548|451072538|FG001|Overall Study|Venous access failed during study day|0|||
125392796|NCT00405548|451072537|FG000|Overall Study|Withdrawal by Subject|1|||
125392797|NCT00405548|451072538|FG001|Overall Study|Withdrawal by Subject|0|||
125392798|NCT02741700|451072539|FG000|Overall Study|Lost to Follow-up|17|||
125392799|NCT02741700|451072540|FG001|Overall Study|Lost to Follow-up|8|||
125392800|NCT02741700|451072539|FG000|Overall Study|Withdrawal by Subject|2|||
125392801|NCT02741700|451072540|FG001|Overall Study|Withdrawal by Subject|5|||
125392802|NCT02741700|451072539|FG000|Overall Study|Physician Decision|3|||
125392803|NCT02741700|451072540|FG001|Overall Study|Physician Decision|0|||
125392804|NCT02741700|451072539|FG000|Overall Study|Moved out of State|0|||
125392805|NCT02741700|451072540|FG001|Overall Study|Moved out of State|1|||
125392806|NCT02741700|451072539|FG000|Overall Study|Death|4|||
125392807|NCT02741700|451072540|FG001|Overall Study|Death|5|||
125392808|NCT00923559|451072541|FG000|Overall Study|Lost to Follow-up|2|||
125392809|NCT00923559|451072542|FG001|Overall Study|Lost to Follow-up|3|||
125392810|NCT00811577|451072543|FG000|Overall Study|Lost to Follow-up|7|||
125392811|NCT00811577|451072544|FG001|Overall Study|Lost to Follow-up|1|||
125392812|NCT00811577|451072543|FG000|Overall Study|Withdrawal by Subject|3|||
125392813|NCT00811577|451072544|FG001|Overall Study|Withdrawal by Subject|0|||
125392814|NCT01165138|451072547|FG000|Overall Study|Adverse Event|0|||
125392815|NCT01165138|451072548|FG001|Overall Study|Adverse Event|1|||
125392816|NCT01165138|451072549|FG002|Overall Study|Adverse Event|0|||
125392817|NCT01165138|451072550|FG003|Overall Study|Adverse Event|2|||
125392818|NCT01165138|451072547|FG000|Overall Study|Lack of Efficacy|0|||
125392819|NCT01165138|451072548|FG001|Overall Study|Lack of Efficacy|32|||
125392820|NCT01165138|451072549|FG002|Overall Study|Lack of Efficacy|6|||
125392821|NCT01165138|451072550|FG003|Overall Study|Lack of Efficacy|7|||
125392822|NCT01165138|451072547|FG000|Overall Study|Protocol Violation|0|||
125392823|NCT01165138|451072548|FG001|Overall Study|Protocol Violation|7|||
125392824|NCT01165138|451072549|FG002|Overall Study|Protocol Violation|0|||
125186705|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
125186706|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
125186707|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
125186708|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
125186709|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
125186710|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
125186711|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
125186712|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
125392825|NCT01165138|451072550|FG003|Overall Study|Protocol Violation|2|||
125392826|NCT01165138|451072547|FG000|Overall Study|Lost to Follow-up|0|||
125392827|NCT01165138|451072548|FG001|Overall Study|Lost to Follow-up|0|||
125392828|NCT01165138|451072549|FG002|Overall Study|Lost to Follow-up|1|||
125392829|NCT01165138|451072550|FG003|Overall Study|Lost to Follow-up|2|||
125392830|NCT01165138|451072547|FG000|Overall Study|Physician Decision|0|||
125392831|NCT01165138|451072548|FG001|Overall Study|Physician Decision|6|||
125392832|NCT01165138|451072549|FG002|Overall Study|Physician Decision|7|||
125392833|NCT01165138|451072550|FG003|Overall Study|Physician Decision|6|||
125186713|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
125241184|NCT01371981|450505924|FG000|Overall Study|Withdrawal by Subject|12|||
125392834|NCT01165138|451072547|FG000|Overall Study|Withdrawal by Subject|0|||
125392835|NCT01165138|451072548|FG001|Overall Study|Withdrawal by Subject|6|||
125443453|NCT02555371|451252132|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
125392836|NCT01165138|451072549|FG002|Overall Study|Withdrawal by Subject|6|||
125392837|NCT01165138|451072550|FG003|Overall Study|Withdrawal by Subject|3|||
125392838|NCT02641379|451072551|FG000|Overall Study|Exclusion criterion during screening|1|||
125392839|NCT02641379|451072552|FG001|Overall Study|Exclusion criterion during screening|0|||
125392840|NCT02641379|451072553|FG002|Overall Study|Exclusion criterion during screening|0|||
125392841|NCT02641379|451072554|FG003|Overall Study|Exclusion criterion during screening|1|||
125392842|NCT02641379|451072555|FG004|Overall Study|Exclusion criterion during screening|2|||
125392843|NCT02641379|451072556|FG005|Overall Study|Exclusion criterion during screening|0|||
125186714|NCT04242446|450305066|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125186715|NCT04242446|450305067|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
125186716|NCT04242446|450305068|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
125186717|NCT04242446|450305069|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125186718|NCT04242446|450305070|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125186719|NCT04242446|450305071|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125186720|NCT04242446|450305072|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125186721|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125186722|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125186723|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125186724|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
125186725|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
125186726|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
125186727|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
125186728|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125186729|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125186730|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125186731|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
125186732|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
125186733|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
125186734|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
125186735|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125186736|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125186737|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125186738|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
125186739|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
125186740|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
125186741|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
125186742|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
125186743|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
125186744|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
125186745|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
125186746|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
125186747|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
125186748|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
125186749|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
125186750|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
125186751|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
125186752|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
125186753|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
125186754|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
125186755|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
125186756|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
125186757|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
125186758|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
125186759|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
125186760|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
125186761|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
125186762|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
125186763|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
125186764|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
125186765|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
125186766|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
125186767|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
125186768|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
125186769|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
125186770|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
125186771|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
125186772|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
125186773|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
125186774|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
125186775|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
125186776|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
125186777|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
125186778|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
125186779|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
125186780|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
125186781|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
125186782|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
125186783|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
125186784|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
125186785|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
125186786|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
125186787|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
125186788|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
125186789|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
125186790|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
125186791|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
125186792|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
125186793|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
125186794|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
125186795|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
125186796|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
125186797|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
125186798|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
125186799|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
125186800|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
125186801|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
125186802|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
125186803|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
125186804|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
125186805|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
125186806|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
125186807|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
125186808|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
125186809|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
125186810|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
125186811|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
125186812|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
125186813|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
125186814|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
125186815|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
125186816|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
125186817|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
125186818|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
125186819|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
125186820|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
125186821|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
125186822|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
125186823|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
125186824|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
125186825|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
125186826|NCT04242446|450305066|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
125241185|NCT01371981|450505925|FG001|Overall Study|Withdrawal by Subject|19|||
125186827|NCT04242446|450305067|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
125186828|NCT04242446|450305068|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
125186829|NCT04242446|450305069|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
125186830|NCT04242446|450305070|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
125186831|NCT04242446|450305071|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
125186832|NCT04242446|450305072|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
125186833|NCT04563754|450305076|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
125186834|NCT04563754|450305077|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
125186835|NCT04563754|450305078|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
125186836|NCT04563754|450305076|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
125186837|NCT04563754|450305077|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
125186838|NCT04563754|450305078|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
125186839|NCT04563754|450305076|FG000|Follow up|Lost to Follow-up|61|||
125186840|NCT04563754|450305077|FG001|Follow up|Lost to Follow-up|23|||
125186841|NCT04563754|450305078|FG002|Follow up|Lost to Follow-up|5|||
125186842|NCT04563754|450305076|FG000|Follow up|Death|0|||
125186843|NCT04563754|450305077|FG001|Follow up|Death|2|||
125186844|NCT04563754|450305078|FG002|Follow up|Death|0|||
125186845|NCT04563754|450305076|FG000|Follow up|Ongoing|0|||
125186846|NCT04563754|450305077|FG001|Follow up|Ongoing|28|||
125186847|NCT04563754|450305078|FG002|Follow up|Ongoing|0|||
125186848|NCT04023396|450305079|FG000|Overall Study|Adverse Event|16|||
125186849|NCT04023396|450305079|FG000|Overall Study|Death|1|||
125186850|NCT04023396|450305079|FG000|Overall Study|Lost to Follow-up|1|||
125186851|NCT04023396|450305079|FG000|Overall Study|Withdrawal by Subject|14|||
125186852|NCT04023396|450305079|FG000|Overall Study|Pregnancy|4|||
125186853|NCT04023396|450305079|FG000|Overall Study|Lack of Efficacy|3|||
125186854|NCT04023396|450305079|FG000|Overall Study|Physician Decision|4|||
125186855|NCT04023396|450305079|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
125186856|NCT04075825|450305080|FG000|Overall Study|Withdrawal by Subject|6|||
125186857|NCT04075825|450305081|FG001|Overall Study|Withdrawal by Subject|8|||
125186858|NCT04075825|450305080|FG000|Overall Study|Physician Decision|3|||
125186859|NCT04075825|450305081|FG001|Overall Study|Physician Decision|1|||
125186860|NCT04075825|450305080|FG000|Overall Study|Lost to Follow-up|5|||
125186861|NCT04075825|450305081|FG001|Overall Study|Lost to Follow-up|1|||
125186862|NCT04075825|450305080|FG000|Overall Study|Participation in New Clinical Trial|1|||
125186863|NCT04075825|450305081|FG001|Overall Study|Participation in New Clinical Trial|1|||
125186864|NCT04075825|450305080|FG000|Overall Study|Reason Not Specified|2|||
125186865|NCT04075825|450305081|FG001|Overall Study|Reason Not Specified|2|||
125186866|NCT04021914|450305082|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
125186867|NCT03349060|450305083|FG000|Overall Study|Adverse Event|9|||
125186868|NCT03349060|450305084|FG001|Overall Study|Adverse Event|9|||
125186869|NCT03349060|450305085|FG002|Overall Study|Adverse Event|7|||
125186870|NCT03349060|450305083|FG000|Overall Study|Lack of Efficacy|1|||
125186871|NCT03349060|450305084|FG001|Overall Study|Lack of Efficacy|0|||
125186872|NCT03349060|450305085|FG002|Overall Study|Lack of Efficacy|2|||
125186873|NCT03349060|450305083|FG000|Overall Study|Lost to Follow-up|2|||
125186874|NCT03349060|450305084|FG001|Overall Study|Lost to Follow-up|1|||
125186875|NCT03349060|450305085|FG002|Overall Study|Lost to Follow-up|1|||
125186876|NCT03349060|450305083|FG000|Overall Study|Protocol Violation|2|||
125186877|NCT03349060|450305084|FG001|Overall Study|Protocol Violation|2|||
125186878|NCT03349060|450305085|FG002|Overall Study|Protocol Violation|1|||
125186879|NCT03349060|450305083|FG000|Overall Study|Withdrawal by Subject|5|||
125186880|NCT03349060|450305084|FG001|Overall Study|Withdrawal by Subject|3|||
125186881|NCT03349060|450305085|FG002|Overall Study|Withdrawal by Subject|4|||
125186882|NCT03349060|450305083|FG000|Overall Study|Medication error,no linked adverse event|0|||
125186883|NCT03349060|450305084|FG001|Overall Study|Medication error,no linked adverse event|0|||
125186884|NCT03349060|450305085|FG002|Overall Study|Medication error,no linked adverse event|1|||
125186885|NCT03349060|450305083|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
125186886|NCT03349060|450305084|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
125186887|NCT03349060|450305085|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
125186888|NCT03349060|450305083|FG000|Overall Study|Other|2|||
125186889|NCT03349060|450305084|FG001|Overall Study|Other|1|||
125186890|NCT03349060|450305085|FG002|Overall Study|Other|0|||
125186891|NCT02861586|450305086|FG000|Overall Study|Withdrawal by Subject|1|||
125186892|NCT02861586|450305087|FG001|Overall Study|Withdrawal by Subject|2|||
125186893|NCT02861586|450305088|FG002|Overall Study|Withdrawal by Subject|0|||
125186894|NCT02861586|450305089|FG003|Overall Study|Withdrawal by Subject|0|||
125186895|NCT02861586|450305090|FG004|Overall Study|Withdrawal by Subject|0|||
125186896|NCT02861586|450305091|FG005|Overall Study|Withdrawal by Subject|1|||
125186897|NCT02861586|450305092|FG006|Overall Study|Withdrawal by Subject|1|||
125186898|NCT02861586|450305093|FG007|Overall Study|Withdrawal by Subject|0|||
125186899|NCT02861586|450305086|FG000|Overall Study|Lost to Follow-up|3|||
125186900|NCT02861586|450305087|FG001|Overall Study|Lost to Follow-up|1|||
125186901|NCT02861586|450305088|FG002|Overall Study|Lost to Follow-up|1|||
125186902|NCT02861586|450305089|FG003|Overall Study|Lost to Follow-up|0|||
125186903|NCT02861586|450305090|FG004|Overall Study|Lost to Follow-up|0|||
125186904|NCT02861586|450305091|FG005|Overall Study|Lost to Follow-up|3|||
125186905|NCT02861586|450305092|FG006|Overall Study|Lost to Follow-up|0|||
125186906|NCT02861586|450305093|FG007|Overall Study|Lost to Follow-up|0|||
125186907|NCT02861586|450305086|FG000|Overall Study|Adverse Event|0|||
125186908|NCT02861586|450305087|FG001|Overall Study|Adverse Event|0|||
125186909|NCT02861586|450305088|FG002|Overall Study|Adverse Event|0|||
125186910|NCT02861586|450305089|FG003|Overall Study|Adverse Event|0|||
125186911|NCT02861586|450305090|FG004|Overall Study|Adverse Event|0|||
125186912|NCT02861586|450305091|FG005|Overall Study|Adverse Event|1|||
125186913|NCT02861586|450305092|FG006|Overall Study|Adverse Event|0|||
125186914|NCT02861586|450305093|FG007|Overall Study|Adverse Event|0|||
125186915|NCT00955409|450305094|FG000|Overall Study|Lack of Efficacy|1|||
125186916|NCT00955409|450305095|FG001|Overall Study|Lack of Efficacy|0|||
125186917|NCT00955409|450305096|FG002|Overall Study|Lack of Efficacy|0|||
125186918|NCT00955409|450305097|FG003|Overall Study|Lack of Efficacy|0|||
125186919|NCT00955409|450305098|FG004|Overall Study|Lack of Efficacy|0|||
125186920|NCT00955409|450305099|FG005|Overall Study|Lack of Efficacy|0|||
125186921|NCT00955409|450305100|FG006|Overall Study|Lack of Efficacy|0|||
125186922|NCT00955409|450305101|FG007|Overall Study|Lack of Efficacy|0|||
125186923|NCT00955409|450305102|FG008|Overall Study|Lack of Efficacy|0|||
125186924|NCT00955409|450305103|FG009|Overall Study|Lack of Efficacy|0|||
125186925|NCT00955409|450305094|FG000|Overall Study|Withdrawal by Subject|1|||
125186926|NCT00955409|450305095|FG001|Overall Study|Withdrawal by Subject|0|||
125186927|NCT00955409|450305096|FG002|Overall Study|Withdrawal by Subject|5|||
125186928|NCT00955409|450305097|FG003|Overall Study|Withdrawal by Subject|2|||
125186929|NCT00955409|450305098|FG004|Overall Study|Withdrawal by Subject|0|||
125186930|NCT00955409|450305099|FG005|Overall Study|Withdrawal by Subject|0|||
125186931|NCT00955409|450305100|FG006|Overall Study|Withdrawal by Subject|2|||
125186932|NCT00955409|450305101|FG007|Overall Study|Withdrawal by Subject|0|||
125186933|NCT00955409|450305102|FG008|Overall Study|Withdrawal by Subject|1|||
125186934|NCT00955409|450305103|FG009|Overall Study|Withdrawal by Subject|0|||
125186935|NCT00955409|450305094|FG000|Overall Study|Caregiver Request|2|||
125186936|NCT00955409|450305095|FG001|Overall Study|Caregiver Request|0|||
125186937|NCT00955409|450305096|FG002|Overall Study|Caregiver Request|6|||
125186938|NCT00955409|450305097|FG003|Overall Study|Caregiver Request|5|||
125186939|NCT00955409|450305098|FG004|Overall Study|Caregiver Request|0|||
125186940|NCT00955409|450305099|FG005|Overall Study|Caregiver Request|2|||
125186941|NCT00955409|450305100|FG006|Overall Study|Caregiver Request|3|||
125186942|NCT00955409|450305101|FG007|Overall Study|Caregiver Request|1|||
125186943|NCT00955409|450305102|FG008|Overall Study|Caregiver Request|3|||
125186944|NCT00955409|450305103|FG009|Overall Study|Caregiver Request|0|||
125186945|NCT00955409|450305094|FG000|Overall Study|Investigator Request|0|||
125186946|NCT00955409|450305095|FG001|Overall Study|Investigator Request|0|||
125186947|NCT00955409|450305096|FG002|Overall Study|Investigator Request|1|||
125186948|NCT00955409|450305097|FG003|Overall Study|Investigator Request|0|||
125186949|NCT00955409|450305098|FG004|Overall Study|Investigator Request|0|||
125186950|NCT00955409|450305099|FG005|Overall Study|Investigator Request|0|||
125186951|NCT00955409|450305100|FG006|Overall Study|Investigator Request|0|||
125186952|NCT00955409|450305101|FG007|Overall Study|Investigator Request|0|||
125186953|NCT00955409|450305102|FG008|Overall Study|Investigator Request|0|||
125186954|NCT00955409|450305103|FG009|Overall Study|Investigator Request|0|||
125186955|NCT00955409|450305094|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
125186956|NCT00955409|450305095|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
125186957|NCT00955409|450305096|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
125186958|NCT00955409|450305097|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
125186959|NCT00955409|450305098|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
125186960|NCT00955409|450305099|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
125186961|NCT00955409|450305100|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
125186962|NCT00955409|450305101|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
125186963|NCT00955409|450305102|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
125186964|NCT00955409|450305103|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
125186965|NCT00955409|450305094|FG000|Overall Study|Lost to Follow-up|0|||
125186966|NCT00955409|450305095|FG001|Overall Study|Lost to Follow-up|0|||
125186967|NCT00955409|450305096|FG002|Overall Study|Lost to Follow-up|1|||
125186968|NCT00955409|450305097|FG003|Overall Study|Lost to Follow-up|0|||
125186969|NCT00955409|450305098|FG004|Overall Study|Lost to Follow-up|0|||
125186970|NCT00955409|450305099|FG005|Overall Study|Lost to Follow-up|0|||
125186971|NCT00955409|450305100|FG006|Overall Study|Lost to Follow-up|1|||
125186972|NCT00955409|450305101|FG007|Overall Study|Lost to Follow-up|0|||
125186973|NCT00955409|450305102|FG008|Overall Study|Lost to Follow-up|0|||
125186974|NCT00955409|450305103|FG009|Overall Study|Lost to Follow-up|0|||
125186975|NCT00955409|450305094|FG000|Overall Study|Failed to Return|2|||
125186976|NCT00955409|450305095|FG001|Overall Study|Failed to Return|0|||
125186977|NCT00955409|450305096|FG002|Overall Study|Failed to Return|0|||
125186978|NCT00955409|450305097|FG003|Overall Study|Failed to Return|0|||
125186979|NCT00955409|450305098|FG004|Overall Study|Failed to Return|0|||
125186980|NCT00955409|450305099|FG005|Overall Study|Failed to Return|0|||
125186981|NCT00955409|450305100|FG006|Overall Study|Failed to Return|0|||
125186982|NCT00955409|450305101|FG007|Overall Study|Failed to Return|2|||
125186983|NCT00955409|450305102|FG008|Overall Study|Failed to Return|0|||
125186984|NCT00955409|450305103|FG009|Overall Study|Failed to Return|0|||
125186985|NCT00955409|450305094|FG000|Overall Study|Adverse Event (AE)|2|||
125186986|NCT00955409|450305095|FG001|Overall Study|Adverse Event (AE)|0|||
125186987|NCT00955409|450305096|FG002|Overall Study|Adverse Event (AE)|0|||
125186988|NCT00955409|450305097|FG003|Overall Study|Adverse Event (AE)|0|||
125186989|NCT00955409|450305098|FG004|Overall Study|Adverse Event (AE)|0|||
125186990|NCT00955409|450305099|FG005|Overall Study|Adverse Event (AE)|1|||
125186991|NCT00955409|450305100|FG006|Overall Study|Adverse Event (AE)|2|||
125186992|NCT00955409|450305101|FG007|Overall Study|Adverse Event (AE)|0|||
125186993|NCT00955409|450305102|FG008|Overall Study|Adverse Event (AE)|2|||
125186994|NCT00955409|450305103|FG009|Overall Study|Adverse Event (AE)|0|||
125186995|NCT00955409|450305094|FG000|Overall Study|Reason not Specified|2|||
125186996|NCT00955409|450305095|FG001|Overall Study|Reason not Specified|1|||
125186997|NCT00955409|450305096|FG002|Overall Study|Reason not Specified|13|||
125186998|NCT00955409|450305097|FG003|Overall Study|Reason not Specified|1|||
125186999|NCT00955409|450305098|FG004|Overall Study|Reason not Specified|2|||
125187000|NCT00955409|450305099|FG005|Overall Study|Reason not Specified|0|||
125187001|NCT00955409|450305100|FG006|Overall Study|Reason not Specified|16|||
125187002|NCT00955409|450305101|FG007|Overall Study|Reason not Specified|0|||
125187003|NCT00955409|450305102|FG008|Overall Study|Reason not Specified|8|||
125187004|NCT00955409|450305103|FG009|Overall Study|Reason not Specified|1|||
125187005|NCT00485732|450305104|FG000|Overall Study|Protocol Violation|1|||
125187006|NCT00485732|450305105|FG001|Overall Study|Protocol Violation|3|||
125187007|NCT00485732|450305104|FG000|Overall Study|Withdrawal by Subject|5|||
125187008|NCT00485732|450305105|FG001|Overall Study|Withdrawal by Subject|4|||
125187009|NCT00485732|450305104|FG000|Overall Study|Lost to Follow-up|2|||
125187010|NCT00485732|450305105|FG001|Overall Study|Lost to Follow-up|2|||
125187011|NCT00803790|450305106|FG000|Period 1|Adverse Event|0|||
125187012|NCT00803790|450305107|FG001|Period 1|Adverse Event|1|||
125187013|NCT00803790|450305108|FG002|Period 1|Adverse Event|0|||
125187014|NCT00803790|450305109|FG003|Period 1|Adverse Event|0|||
125187015|NCT00803790|450305106|FG000|Period 1|Lost to Follow-up|1|||
125187016|NCT00803790|450305107|FG001|Period 1|Lost to Follow-up|2|||
125187017|NCT00803790|450305108|FG002|Period 1|Lost to Follow-up|0|||
125187018|NCT00803790|450305109|FG003|Period 1|Lost to Follow-up|0|||
125187019|NCT00803790|450305106|FG000|Period 1|Withdrawal by Subject|8|||
125187020|NCT00803790|450305107|FG001|Period 1|Withdrawal by Subject|6|||
125187021|NCT00803790|450305108|FG002|Period 1|Withdrawal by Subject|0|||
125187022|NCT00803790|450305109|FG003|Period 1|Withdrawal by Subject|0|||
125187023|NCT00803790|450305106|FG000|Period 1|positive drug screen or personal reasons|0|||
125187024|NCT00803790|450305107|FG001|Period 1|positive drug screen or personal reasons|3|||
125187025|NCT00803790|450305108|FG002|Period 1|positive drug screen or personal reasons|0|||
125187026|NCT00803790|450305109|FG003|Period 1|positive drug screen or personal reasons|4|||
125241186|NCT01371981|450505926|FG002|Overall Study|Withdrawal by Subject|1|||
125241187|NCT01371981|450505927|FG003|Overall Study|Withdrawal by Subject|2|||
125241188|NCT01371981|450505928|FG004|Overall Study|Withdrawal by Subject|10|||
125241189|NCT01371981|450505929|FG005|Overall Study|Withdrawal by Subject|3|||
125241190|NCT01371981|450505924|FG000|Overall Study|Ineligible|19|||
125241191|NCT01371981|450505925|FG001|Overall Study|Ineligible|13|||
125241192|NCT01371981|450505926|FG002|Overall Study|Ineligible|0|||
125241193|NCT01371981|450505927|FG003|Overall Study|Ineligible|0|||
125392844|NCT02641379|451072557|FG006|Overall Study|Exclusion criterion during screening|0|||
125392845|NCT02641379|451072558|FG007|Overall Study|Exclusion criterion during screening|0|||
125241194|NCT01371981|450505928|FG004|Overall Study|Ineligible|0|||
125241195|NCT01371981|450505929|FG005|Overall Study|Ineligible|4|||
125392846|NCT02641379|451072559|FG008|Overall Study|Exclusion criterion during screening|0|||
125392847|NCT02641379|451072560|FG009|Overall Study|Exclusion criterion during screening|0|||
125392848|NCT02641379|451072561|FG010|Overall Study|Exclusion criterion during screening|0|||
125392849|NCT02641379|451072551|FG000|Overall Study|Withdrawal of informed consent|0|||
125392850|NCT02641379|451072552|FG001|Overall Study|Withdrawal of informed consent|1|||
125392851|NCT02641379|451072553|FG002|Overall Study|Withdrawal of informed consent|0|||
125392852|NCT02641379|451072554|FG003|Overall Study|Withdrawal of informed consent|0|||
125392853|NCT02641379|451072555|FG004|Overall Study|Withdrawal of informed consent|0|||
125392854|NCT02641379|451072556|FG005|Overall Study|Withdrawal of informed consent|0|||
125392855|NCT02641379|451072557|FG006|Overall Study|Withdrawal of informed consent|0|||
125187027|NCT00803790|450305106|FG000|Period 1|Protocol Violation|0|||
125187028|NCT00803790|450305107|FG001|Period 1|Protocol Violation|0|||
125241196|NCT01371981|450505924|FG000|Overall Study|Did not start treatment|2|||
125241197|NCT01371981|450505925|FG001|Overall Study|Did not start treatment|3|||
125187029|NCT00803790|450305108|FG002|Period 1|Protocol Violation|1|||
125187030|NCT00803790|450305109|FG003|Period 1|Protocol Violation|0|||
125187031|NCT00803790|450305106|FG000|Period 2|Adverse Event|0|||
125187032|NCT00803790|450305107|FG001|Period 2|Adverse Event|0|||
125187033|NCT00803790|450305108|FG002|Period 2|Adverse Event|1|||
125187034|NCT00803790|450305109|FG003|Period 2|Adverse Event|1|||
125187035|NCT00803790|450305106|FG000|Period 2|Withdrawal by Subject|1|||
125187036|NCT00803790|450305107|FG001|Period 2|Withdrawal by Subject|0|||
125187037|NCT00803790|450305108|FG002|Period 2|Withdrawal by Subject|0|||
125187038|NCT00803790|450305109|FG003|Period 2|Withdrawal by Subject|0|||
125187039|NCT00803790|450305106|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
125187040|NCT00803790|450305107|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
125187041|NCT00803790|450305108|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
125187042|NCT00803790|450305109|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
125187043|NCT01880554|450305110|FG000|Overall Study|Protocol Violation|14|||
125187044|NCT01880554|450305110|FG000|Overall Study|Simon's design requirements|2|||
125187045|NCT05161481|450305111|FG000|Overall Study|Withdrawal of consent|0|||
125187046|NCT05161481|450305112|FG001|Overall Study|Withdrawal of consent|1|||
125187047|NCT05161481|450305113|FG002|Overall Study|Withdrawal of consent|1|||
125187048|NCT05161481|450305111|FG000|Overall Study|Study terminated by sponsor|3|||
125187049|NCT05161481|450305112|FG001|Overall Study|Study terminated by sponsor|3|||
125187050|NCT05161481|450305113|FG002|Overall Study|Study terminated by sponsor|2|||
125187051|NCT05161481|450305111|FG000|Overall Study|Adverse Event|3|||
125187052|NCT05161481|450305112|FG001|Overall Study|Adverse Event|0|||
125187053|NCT05161481|450305113|FG002|Overall Study|Adverse Event|6|||
125187054|NCT05161481|450305111|FG000|Overall Study|Randomised in error and was not treated|1|||
125187055|NCT05161481|450305112|FG001|Overall Study|Randomised in error and was not treated|0|||
125187056|NCT05161481|450305113|FG002|Overall Study|Randomised in error and was not treated|0|||
125187057|NCT05161481|450305111|FG000|Overall Study|Subject decision|0|||
125187058|NCT05161481|450305112|FG001|Overall Study|Subject decision|0|||
125187059|NCT05161481|450305113|FG002|Overall Study|Subject decision|1|||
125187060|NCT03985800|450305114|FG000|Overall Study|Death|1|||
125187061|NCT03985800|450305115|FG001|Overall Study|Death|2|||
125187062|NCT03985800|450305114|FG000|Overall Study|Withdrawal by Subject|3|||
125187063|NCT03985800|450305115|FG001|Overall Study|Withdrawal by Subject|6|||
125187064|NCT03985800|450305114|FG000|Overall Study|Protocol Violation|2|||
125187065|NCT03985800|450305115|FG001|Overall Study|Protocol Violation|0|||
125187066|NCT04815083|450305116|FG000|Overall Study|Physician Decision|1|||
125187067|NCT04815083|450305116|FG000|Overall Study|Study pause|2|||
125187068|NCT04815083|450305116|FG000|Overall Study|Screening failure|4|||
125187069|NCT02570308|450305130|FG000|Overall Study|Death|1|||
125187070|NCT02570308|450305131|FG001|Overall Study|Death|5|||
125187071|NCT02570308|450305132|FG002|Overall Study|Death|4|||
125187072|NCT02570308|450305133|FG003|Overall Study|Death|4|||
125187073|NCT02570308|450305134|FG004|Overall Study|Death|69|||
125187074|NCT02570308|450305130|FG000|Overall Study|Lost to Follow-up|0|||
125187075|NCT02570308|450305131|FG001|Overall Study|Lost to Follow-up|0|||
125187076|NCT02570308|450305132|FG002|Overall Study|Lost to Follow-up|0|||
125187077|NCT02570308|450305133|FG003|Overall Study|Lost to Follow-up|0|||
125187078|NCT02570308|450305134|FG004|Overall Study|Lost to Follow-up|2|||
125187079|NCT02570308|450305130|FG000|Overall Study|Withdrawal by Subject|0|||
125187080|NCT02570308|450305131|FG001|Overall Study|Withdrawal by Subject|0|||
125187081|NCT02570308|450305132|FG002|Overall Study|Withdrawal by Subject|0|||
125187082|NCT02570308|450305133|FG003|Overall Study|Withdrawal by Subject|0|||
125187083|NCT02570308|450305134|FG004|Overall Study|Withdrawal by Subject|1|||
125187084|NCT02570308|450305130|FG000|Overall Study|Other|0|||
125187085|NCT02570308|450305131|FG001|Overall Study|Other|0|||
125187086|NCT02570308|450305132|FG002|Overall Study|Other|0|||
125187087|NCT02570308|450305133|FG003|Overall Study|Other|0|||
125187088|NCT02570308|450305134|FG004|Overall Study|Other|2|||
125187089|NCT00957801|450305135|FG000|Overall Study|Withdrawal by Subject|0|||
125187090|NCT00957801|450305136|FG001|Overall Study|Withdrawal by Subject|0|||
125187091|NCT00957801|450305137|FG002|Overall Study|Withdrawal by Subject|0|||
125187092|NCT00957801|450305138|FG003|Overall Study|Withdrawal by Subject|1|||
125187093|NCT01283464|450305139|FG000|Overall Study|Lost to Follow-up|0|||
125187094|NCT01283464|450305140|FG001|Overall Study|Lost to Follow-up|1|||
125187095|NCT01283464|450305139|FG000|Overall Study|Withdrawal by Subject|1|||
125187096|NCT01283464|450305140|FG001|Overall Study|Withdrawal by Subject|0|||
125187097|NCT01283464|450305139|FG000|Overall Study|Physician Decision|1|||
125187098|NCT01283464|450305140|FG001|Overall Study|Physician Decision|0|||
125187099|NCT01778855|450305141|FG000|Overall Study|Death|0|||
125187100|NCT01778855|450305142|FG001|Overall Study|Death|1|||
125187101|NCT01286467|450305145|FG000|Overall Study|Death|1|||
125187102|NCT01286467|450305146|FG001|Overall Study|Death|1|||
125187103|NCT01286467|450305147|FG002|Overall Study|Death|1|||
125187104|NCT01286467|450305148|FG003|Overall Study|Death|0|||
125187105|NCT01286467|450305145|FG000|Overall Study|Lost to Follow-up|0|||
125187106|NCT01286467|450305146|FG001|Overall Study|Lost to Follow-up|0|||
125187107|NCT01286467|450305147|FG002|Overall Study|Lost to Follow-up|0|||
125187108|NCT01286467|450305148|FG003|Overall Study|Lost to Follow-up|1|||
125187109|NCT01286467|450305145|FG000|Overall Study|Withdrawal by Subject|0|||
125187110|NCT01286467|450305146|FG001|Overall Study|Withdrawal by Subject|0|||
125241198|NCT01371981|450505926|FG002|Overall Study|Did not start treatment|0|||
125241199|NCT01371981|450505927|FG003|Overall Study|Did not start treatment|0|||
125241200|NCT01371981|450505928|FG004|Overall Study|Did not start treatment|0|||
125241201|NCT01371981|450505929|FG005|Overall Study|Did not start treatment|2|||
125187111|NCT01286467|450305147|FG002|Overall Study|Withdrawal by Subject|1|||
125187112|NCT01286467|450305148|FG003|Overall Study|Withdrawal by Subject|0|||
125187113|NCT01286467|450305145|FG000|Overall Study|Physician Decision|0|||
125187114|NCT01286467|450305146|FG001|Overall Study|Physician Decision|0|||
125187115|NCT01286467|450305147|FG002|Overall Study|Physician Decision|0|||
125187116|NCT01286467|450305148|FG003|Overall Study|Physician Decision|1|||
125187117|NCT01286467|450305145|FG000|Overall Study|Disease progression|3|||
125187118|NCT01286467|450305146|FG001|Overall Study|Disease progression|2|||
125187119|NCT01286467|450305147|FG002|Overall Study|Disease progression|2|||
125187120|NCT01286467|450305148|FG003|Overall Study|Disease progression|3|||
125187121|NCT01286467|450305145|FG000|Overall Study|Adverse Event|0|||
125187122|NCT01286467|450305146|FG001|Overall Study|Adverse Event|1|||
125187123|NCT01286467|450305147|FG002|Overall Study|Adverse Event|2|||
125187124|NCT01286467|450305148|FG003|Overall Study|Adverse Event|3|||
125187125|NCT01286467|450305145|FG000|Overall Study|Study drug stop longer than 14 days|0|||
125187126|NCT01286467|450305146|FG001|Overall Study|Study drug stop longer than 14 days|0|||
125187127|NCT01286467|450305147|FG002|Overall Study|Study drug stop longer than 14 days|1|||
125187128|NCT01286467|450305148|FG003|Overall Study|Study drug stop longer than 14 days|0|||
125187129|NCT01058642|450305149|FG000|Treatment Period 1|Adverse Event|0|||
125187130|NCT01058642|450305150|FG001|Treatment Period 1|Adverse Event|1|||
125187131|NCT01058642|450305151|FG002|Treatment Period 1|Adverse Event|1|||
125187132|NCT01058642|450305152|FG003|Treatment Period 1|Adverse Event|0|||
125187133|NCT01058642|450305149|FG000|Treatment Period 1|Physician Decision|0|||
125187134|NCT01058642|450305150|FG001|Treatment Period 1|Physician Decision|0|||
125187135|NCT01058642|450305151|FG002|Treatment Period 1|Physician Decision|1|||
125187136|NCT01058642|450305152|FG003|Treatment Period 1|Physician Decision|0|||
125187137|NCT01058642|450305149|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125187138|NCT01058642|450305150|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125187139|NCT01058642|450305151|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125187140|NCT01058642|450305152|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125187141|NCT01058642|450305149|FG000|Treatment Period 1|Lack of Efficacy|0|||
125187142|NCT01058642|450305150|FG001|Treatment Period 1|Lack of Efficacy|0|||
125187143|NCT01058642|450305151|FG002|Treatment Period 1|Lack of Efficacy|0|||
125187144|NCT01058642|450305152|FG003|Treatment Period 1|Lack of Efficacy|1|||
125187145|NCT01058642|450305149|FG000|Treatment Period 1|Protocol Violation|0|||
125187146|NCT01058642|450305150|FG001|Treatment Period 1|Protocol Violation|0|||
125187147|NCT01058642|450305151|FG002|Treatment Period 1|Protocol Violation|0|||
125187148|NCT01058642|450305152|FG003|Treatment Period 1|Protocol Violation|1|||
125187149|NCT01058642|450305149|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
125187150|NCT01058642|450305150|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
125187151|NCT01058642|450305151|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
125187152|NCT01058642|450305152|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
125187153|NCT01256450|450305153|FG000|Open-label Titration|Adverse Event|39|||
125187154|NCT01256450|450305154|FG001|Open-label Titration|Adverse Event|0|||
125187155|NCT01256450|450305155|FG002|Open-label Titration|Adverse Event|0|||
125187156|NCT01256450|450305153|FG000|Open-label Titration|Lost to Follow-up|7|||
125187157|NCT01256450|450305154|FG001|Open-label Titration|Lost to Follow-up|0|||
125187158|NCT01256450|450305155|FG002|Open-label Titration|Lost to Follow-up|0|||
125187159|NCT01256450|450305153|FG000|Open-label Titration|Lack of analgesic effect|30|||
125187160|NCT01256450|450305154|FG001|Open-label Titration|Lack of analgesic effect|0|||
125187161|NCT01256450|450305155|FG002|Open-label Titration|Lack of analgesic effect|0|||
125187162|NCT01256450|450305153|FG000|Open-label Titration|Non-compliance|9|||
125187163|NCT01256450|450305154|FG001|Open-label Titration|Non-compliance|0|||
125187164|NCT01256450|450305155|FG002|Open-label Titration|Non-compliance|0|||
125187165|NCT01256450|450305153|FG000|Open-label Titration|Screen failure|1|||
125187166|NCT01256450|450305154|FG001|Open-label Titration|Screen failure|0|||
125187167|NCT01256450|450305155|FG002|Open-label Titration|Screen failure|0|||
125187168|NCT01256450|450305153|FG000|Open-label Titration|Other|13|||
125187169|NCT01256450|450305154|FG001|Open-label Titration|Other|0|||
125187170|NCT01256450|450305155|FG002|Open-label Titration|Other|0|||
125187171|NCT01256450|450305153|FG000|Double-blind Treatment|Adverse Event|0|||
125187172|NCT01256450|450305154|FG001|Double-blind Treatment|Adverse Event|8|||
125187173|NCT01256450|450305155|FG002|Double-blind Treatment|Adverse Event|6|||
125187174|NCT01256450|450305153|FG000|Double-blind Treatment|Lost to Follow-up|0|||
125187175|NCT01256450|450305154|FG001|Double-blind Treatment|Lost to Follow-up|1|||
125187176|NCT01256450|450305155|FG002|Double-blind Treatment|Lost to Follow-up|7|||
125187177|NCT01256450|450305153|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
125187178|NCT01256450|450305154|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
125187179|NCT01256450|450305155|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
125241202|NCT03244189|450505930|FG000|Overall Study|Death|0|||
125241203|NCT03244189|450505931|FG001|Overall Study|Death|2|||
125241204|NCT03244189|450505930|FG000|Overall Study|Lost to Follow-up|92|||
125241205|NCT03244189|450505931|FG001|Overall Study|Lost to Follow-up|107|||
125241206|NCT03244189|450505930|FG000|Overall Study|Physician Decision|4|||
125241207|NCT03244189|450505931|FG001|Overall Study|Physician Decision|2|||
125241208|NCT03244189|450505930|FG000|Overall Study|Pregnancy|7|||
125241209|NCT03244189|450505931|FG001|Overall Study|Pregnancy|5|||
125241210|NCT03244189|450505930|FG000|Overall Study|Protocol Violation|0|||
125241211|NCT03244189|450505931|FG001|Overall Study|Protocol Violation|2|||
125241212|NCT03244189|450505930|FG000|Overall Study|Withdrawal by Subject|45|||
125241213|NCT03244189|450505931|FG001|Overall Study|Withdrawal by Subject|23|||
125241214|NCT03244189|450505930|FG000|Overall Study|Technical Problems|2|||
125241215|NCT03244189|450505931|FG001|Overall Study|Technical Problems|0|||
125241216|NCT02145390|450505934|FG000|Overall Study|Withdrawal by Subject|1|||
125241217|NCT01732783|450506747|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
125241218|NCT01732783|450506748|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
125241219|NCT01732783|450506749|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
125241220|NCT01732783|450506747|FG000|Overall Study|Death|13|||
125241221|NCT01732783|450506748|FG001|Overall Study|Death|4|||
125241222|NCT01732783|450506749|FG002|Overall Study|Death|1|||
125241223|NCT01732783|450506747|FG000|Overall Study|Lost to Follow-up|7|||
125241224|NCT01732783|450506748|FG001|Overall Study|Lost to Follow-up|1|||
125241225|NCT01732783|450506749|FG002|Overall Study|Lost to Follow-up|1|||
125241226|NCT01732783|450506747|FG000|Overall Study|Administrative Decision|8|||
125241227|NCT01732783|450506748|FG001|Overall Study|Administrative Decision|2|||
125241228|NCT01732783|450506749|FG002|Overall Study|Administrative Decision|1|||
125241229|NCT01732783|450506747|FG000|Overall Study|Withdrawal by Subject|1|||
125241230|NCT01732783|450506748|FG001|Overall Study|Withdrawal by Subject|0|||
125241231|NCT01732783|450506749|FG002|Overall Study|Withdrawal by Subject|0|||
125241232|NCT04615507|450506750|FG000|Period 1|Covid-19 exposure|2|||
125241233|NCT04615507|450506751|FG001|Period 1|Covid-19 exposure|1|||
125241234|NCT04615507|450506750|FG000|Period 2|Covid-19 exposure|0|||
125241235|NCT04615507|450506751|FG001|Period 2|Covid-19 exposure|1|||
125241236|NCT04615507|450506750|FG000|Period 2|Protocol Violation|1|||
125241237|NCT04615507|450506751|FG001|Period 2|Protocol Violation|0|||
125241238|NCT04615507|450506750|FG000|Period 2|Withdrawal by Subject|1|||
125241239|NCT04615507|450506751|FG001|Period 2|Withdrawal by Subject|0|||
125241240|NCT04615507|450506750|FG000|Period 2|Adverse Event|0|||
125241241|NCT04615507|450506751|FG001|Period 2|Adverse Event|1|||
125241242|NCT04615507|450506750|FG000|Period 3|Covid-19 exposure|0|||
125241243|NCT04615507|450506751|FG001|Period 3|Covid-19 exposure|1|||
125241244|NCT03421808|450506756|FG000|Overall Study|COVID related problems|2|||
125241245|NCT03421808|450506757|FG001|Overall Study|COVID related problems|0|||
125241246|NCT03421808|450506756|FG000|Overall Study|Withdrawal by Subject|1|||
125241247|NCT03421808|450506757|FG001|Overall Study|Withdrawal by Subject|0|||
125241248|NCT03421808|450506756|FG000|Overall Study|Protocol Violation|0|||
125241249|NCT03421808|450506757|FG001|Overall Study|Protocol Violation|1|||
125241250|NCT00632359|450506758|FG000|Overall Study|Withdrawal by Subject|2|||
125241251|NCT02872714|450506759|FG000|Overall Study|Progressive Disease|1|||
125241252|NCT02872714|450506760|FG001|Overall Study|Progressive Disease|2|||
125241253|NCT02872714|450506761|FG002|Overall Study|Progressive Disease|0|||
125241254|NCT02872714|450506762|FG003|Overall Study|Progressive Disease|0|||
125241255|NCT02872714|450506763|FG004|Overall Study|Progressive Disease|0|||
125241256|NCT02872714|450506759|FG000|Overall Study|Death|87|||
125241257|NCT02872714|450506760|FG001|Overall Study|Death|36|||
125241258|NCT02872714|450506761|FG002|Overall Study|Death|8|||
125241259|NCT02872714|450506762|FG003|Overall Study|Death|81|||
125241260|NCT02872714|450506763|FG004|Overall Study|Death|2|||
125241261|NCT02872714|450506759|FG000|Overall Study|Lost to Follow-up|2|||
125241262|NCT02872714|450506760|FG001|Overall Study|Lost to Follow-up|1|||
125241263|NCT02872714|450506761|FG002|Overall Study|Lost to Follow-up|0|||
125241264|NCT02872714|450506762|FG003|Overall Study|Lost to Follow-up|3|||
125241265|NCT02872714|450506763|FG004|Overall Study|Lost to Follow-up|0|||
125241266|NCT02872714|450506759|FG000|Overall Study|Physician Decision|0|||
125241267|NCT02872714|450506760|FG001|Overall Study|Physician Decision|0|||
125241268|NCT02872714|450506761|FG002|Overall Study|Physician Decision|0|||
125241269|NCT02872714|450506762|FG003|Overall Study|Physician Decision|1|||
125241270|NCT02872714|450506763|FG004|Overall Study|Physician Decision|0|||
125241271|NCT02872714|450506759|FG000|Overall Study|Withdrawal by Subject|1|||
125241272|NCT02872714|450506760|FG001|Overall Study|Withdrawal by Subject|3|||
125241273|NCT02872714|450506761|FG002|Overall Study|Withdrawal by Subject|0|||
125241274|NCT02872714|450506762|FG003|Overall Study|Withdrawal by Subject|2|||
125241275|NCT02872714|450506763|FG004|Overall Study|Withdrawal by Subject|0|||
125241276|NCT02872714|450506759|FG000|Overall Study|Captured as Other|2|||
125241277|NCT02872714|450506760|FG001|Overall Study|Captured as Other|0|||
125241278|NCT02872714|450506761|FG002|Overall Study|Captured as Other|0|||
125241279|NCT02872714|450506762|FG003|Overall Study|Captured as Other|1|||
125241280|NCT02872714|450506763|FG004|Overall Study|Captured as Other|0|||
125241281|NCT06717399|450506764|FG000|Overall Study|Death|1|||
125241282|NCT02180867|450506767|FG000|Overall Study|Adverse Event|3|||
125241283|NCT02180867|450506768|FG001|Overall Study|Adverse Event|4|||
125187180|NCT01256450|450305153|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
125187181|NCT01256450|450305154|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
125187182|NCT01256450|450305155|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
125392856|NCT02641379|451072558|FG007|Overall Study|Withdrawal of informed consent|1|||
125392857|NCT02641379|451072559|FG008|Overall Study|Withdrawal of informed consent|0|||
125392858|NCT02641379|451072560|FG009|Overall Study|Withdrawal of informed consent|0|||
125392859|NCT02641379|451072561|FG010|Overall Study|Withdrawal of informed consent|0|||
125392860|NCT02641379|451072551|FG000|Overall Study|Adverse Event|7|||
125392861|NCT02641379|451072552|FG001|Overall Study|Adverse Event|8|||
125392862|NCT02641379|451072553|FG002|Overall Study|Adverse Event|2|||
125392863|NCT02641379|451072554|FG003|Overall Study|Adverse Event|2|||
125392864|NCT02641379|451072555|FG004|Overall Study|Adverse Event|5|||
125392865|NCT02641379|451072556|FG005|Overall Study|Adverse Event|1|||
125392866|NCT02641379|451072557|FG006|Overall Study|Adverse Event|5|||
125392867|NCT02641379|451072558|FG007|Overall Study|Adverse Event|0|||
125392868|NCT02641379|451072559|FG008|Overall Study|Adverse Event|1|||
125392869|NCT02641379|451072560|FG009|Overall Study|Adverse Event|1|||
125392870|NCT02641379|451072561|FG010|Overall Study|Adverse Event|5|||
125392871|NCT02641379|451072551|FG000|Overall Study|Lack of Efficacy|0|||
125392872|NCT02641379|451072552|FG001|Overall Study|Lack of Efficacy|0|||
125392873|NCT02641379|451072553|FG002|Overall Study|Lack of Efficacy|2|||
125392874|NCT02641379|451072554|FG003|Overall Study|Lack of Efficacy|0|||
125392875|NCT02641379|451072555|FG004|Overall Study|Lack of Efficacy|0|||
125392876|NCT02641379|451072556|FG005|Overall Study|Lack of Efficacy|2|||
125392877|NCT02641379|451072557|FG006|Overall Study|Lack of Efficacy|0|||
125392878|NCT02641379|451072558|FG007|Overall Study|Lack of Efficacy|5|||
125392879|NCT02641379|451072559|FG008|Overall Study|Lack of Efficacy|0|||
125392880|NCT02641379|451072560|FG009|Overall Study|Lack of Efficacy|0|||
125392881|NCT02641379|451072561|FG010|Overall Study|Lack of Efficacy|0|||
125392882|NCT02641379|451072551|FG000|Overall Study|Participant unable to attend study visit|4|||
125392883|NCT02641379|451072552|FG001|Overall Study|Participant unable to attend study visit|10|||
125392884|NCT02641379|451072553|FG002|Overall Study|Participant unable to attend study visit|1|||
125392885|NCT02641379|451072554|FG003|Overall Study|Participant unable to attend study visit|2|||
125392886|NCT02641379|451072555|FG004|Overall Study|Participant unable to attend study visit|5|||
125392887|NCT02641379|451072556|FG005|Overall Study|Participant unable to attend study visit|1|||
125392888|NCT02641379|451072557|FG006|Overall Study|Participant unable to attend study visit|1|||
125392889|NCT02641379|451072558|FG007|Overall Study|Participant unable to attend study visit|1|||
125392890|NCT02641379|451072559|FG008|Overall Study|Participant unable to attend study visit|0|||
125392891|NCT02641379|451072560|FG009|Overall Study|Participant unable to attend study visit|2|||
125392892|NCT02641379|451072561|FG010|Overall Study|Participant unable to attend study visit|0|||
125392893|NCT02641379|451072551|FG000|Overall Study|Participant's compliance|0|||
125392894|NCT02641379|451072552|FG001|Overall Study|Participant's compliance|1|||
125392895|NCT02641379|451072553|FG002|Overall Study|Participant's compliance|0|||
125392896|NCT02641379|451072554|FG003|Overall Study|Participant's compliance|1|||
125392897|NCT02641379|451072555|FG004|Overall Study|Participant's compliance|0|||
125392898|NCT02641379|451072556|FG005|Overall Study|Participant's compliance|2|||
125392899|NCT02641379|451072557|FG006|Overall Study|Participant's compliance|0|||
125392900|NCT02641379|451072558|FG007|Overall Study|Participant's compliance|0|||
125392901|NCT02641379|451072559|FG008|Overall Study|Participant's compliance|1|||
125392902|NCT02641379|451072560|FG009|Overall Study|Participant's compliance|1|||
125392903|NCT02641379|451072561|FG010|Overall Study|Participant's compliance|1|||
125392904|NCT02641379|451072551|FG000|Overall Study|Participant cannot be reached|4|||
125392905|NCT02641379|451072552|FG001|Overall Study|Participant cannot be reached|4|||
125392906|NCT02641379|451072553|FG002|Overall Study|Participant cannot be reached|0|||
125392907|NCT02641379|451072554|FG003|Overall Study|Participant cannot be reached|8|||
125392908|NCT02641379|451072555|FG004|Overall Study|Participant cannot be reached|2|||
125392909|NCT02641379|451072556|FG005|Overall Study|Participant cannot be reached|1|||
125392910|NCT02641379|451072557|FG006|Overall Study|Participant cannot be reached|0|||
125392911|NCT02641379|451072558|FG007|Overall Study|Participant cannot be reached|1|||
125392912|NCT02641379|451072559|FG008|Overall Study|Participant cannot be reached|0|||
125392913|NCT02641379|451072560|FG009|Overall Study|Participant cannot be reached|2|||
125392914|NCT02641379|451072561|FG010|Overall Study|Participant cannot be reached|1|||
125392915|NCT02641379|451072551|FG000|Overall Study|PCR positive at Week 24|15|||
125392916|NCT02641379|451072552|FG001|Overall Study|PCR positive at Week 24|21|||
125392917|NCT02641379|451072553|FG002|Overall Study|PCR positive at Week 24|62|||
125392918|NCT02641379|451072554|FG003|Overall Study|PCR positive at Week 24|0|||
125187183|NCT01256450|450305153|FG000|Double-blind Treatment|Non-compliance|0|||
125392919|NCT02641379|451072555|FG004|Overall Study|PCR positive at Week 24|0|||
125392920|NCT02641379|451072556|FG005|Overall Study|PCR positive at Week 24|6|||
125392921|NCT02641379|451072557|FG006|Overall Study|PCR positive at Week 24|3|||
125392922|NCT02641379|451072558|FG007|Overall Study|PCR positive at Week 24|8|||
125392923|NCT02641379|451072559|FG008|Overall Study|PCR positive at Week 24|0|||
125392924|NCT02641379|451072560|FG009|Overall Study|PCR positive at Week 24|1|||
125392925|NCT02641379|451072561|FG010|Overall Study|PCR positive at Week 24|0|||
125241284|NCT02180867|450506769|FG002|Overall Study|Adverse Event|1|||
125241285|NCT02180867|450506770|FG003|Overall Study|Adverse Event|5|||
125241286|NCT02180867|450506771|FG004|Overall Study|Adverse Event|0|||
125241287|NCT02180867|450506772|FG005|Overall Study|Adverse Event|0|||
125241288|NCT02180867|450506773|FG006|Overall Study|Adverse Event|0|||
125241289|NCT02180867|450506767|FG000|Overall Study|Death|0|||
125241290|NCT02180867|450506768|FG001|Overall Study|Death|0|||
125241291|NCT02180867|450506769|FG002|Overall Study|Death|0|||
125241292|NCT02180867|450506770|FG003|Overall Study|Death|0|||
125241293|NCT02180867|450506771|FG004|Overall Study|Death|1|||
125241294|NCT02180867|450506772|FG005|Overall Study|Death|0|||
125241295|NCT02180867|450506773|FG006|Overall Study|Death|0|||
125241296|NCT02180867|450506767|FG000|Overall Study|Lack of Efficacy|0|||
125241297|NCT02180867|450506768|FG001|Overall Study|Lack of Efficacy|2|||
125241298|NCT02180867|450506769|FG002|Overall Study|Lack of Efficacy|0|||
125241299|NCT02180867|450506770|FG003|Overall Study|Lack of Efficacy|1|||
125241300|NCT02180867|450506771|FG004|Overall Study|Lack of Efficacy|6|||
125241301|NCT02180867|450506772|FG005|Overall Study|Lack of Efficacy|0|||
125241302|NCT02180867|450506773|FG006|Overall Study|Lack of Efficacy|1|||
125241303|NCT02180867|450506767|FG000|Overall Study|Physician Decision|1|||
125241304|NCT02180867|450506768|FG001|Overall Study|Physician Decision|3|||
125241305|NCT02180867|450506769|FG002|Overall Study|Physician Decision|1|||
125241306|NCT02180867|450506770|FG003|Overall Study|Physician Decision|10|||
125241307|NCT02180867|450506771|FG004|Overall Study|Physician Decision|9|||
125241308|NCT02180867|450506772|FG005|Overall Study|Physician Decision|3|||
125241309|NCT02180867|450506773|FG006|Overall Study|Physician Decision|4|||
125241310|NCT02180867|450506767|FG000|Overall Study|Withdrawal by Subject|0|||
125241311|NCT02180867|450506768|FG001|Overall Study|Withdrawal by Subject|0|||
125241312|NCT02180867|450506769|FG002|Overall Study|Withdrawal by Subject|0|||
125241313|NCT02180867|450506770|FG003|Overall Study|Withdrawal by Subject|1|||
125241314|NCT02180867|450506771|FG004|Overall Study|Withdrawal by Subject|1|||
125241315|NCT02180867|450506772|FG005|Overall Study|Withdrawal by Subject|0|||
125241316|NCT02180867|450506773|FG006|Overall Study|Withdrawal by Subject|0|||
125241317|NCT02180867|450506767|FG000|Overall Study|Ineligible|1|||
125241318|NCT02180867|450506768|FG001|Overall Study|Ineligible|2|||
125241319|NCT02180867|450506769|FG002|Overall Study|Ineligible|0|||
125241320|NCT02180867|450506770|FG003|Overall Study|Ineligible|3|||
125241321|NCT02180867|450506771|FG004|Overall Study|Ineligible|5|||
125241322|NCT02180867|450506772|FG005|Overall Study|Ineligible|0|||
125241323|NCT02180867|450506773|FG006|Overall Study|Ineligible|0|||
125241324|NCT02180867|450506767|FG000|Overall Study|Repeat Eligibility Studies|0|||
125241325|NCT02180867|450506768|FG001|Overall Study|Repeat Eligibility Studies|0|||
125241326|NCT02180867|450506769|FG002|Overall Study|Repeat Eligibility Studies|0|||
125241327|NCT02180867|450506770|FG003|Overall Study|Repeat Eligibility Studies|0|||
125241328|NCT02180867|450506771|FG004|Overall Study|Repeat Eligibility Studies|1|||
125241329|NCT02180867|450506772|FG005|Overall Study|Repeat Eligibility Studies|0|||
125241330|NCT02180867|450506773|FG006|Overall Study|Repeat Eligibility Studies|0|||
125241331|NCT02180867|450506767|FG000|Overall Study|Refusal of further protocol therapy|1|||
125241332|NCT02180867|450506768|FG001|Overall Study|Refusal of further protocol therapy|0|||
125241333|NCT02180867|450506769|FG002|Overall Study|Refusal of further protocol therapy|2|||
125241334|NCT02180867|450506770|FG003|Overall Study|Refusal of further protocol therapy|6|||
125241335|NCT02180867|450506771|FG004|Overall Study|Refusal of further protocol therapy|4|||
125241336|NCT02180867|450506772|FG005|Overall Study|Refusal of further protocol therapy|0|||
125241337|NCT02180867|450506773|FG006|Overall Study|Refusal of further protocol therapy|0|||
125241338|NCT02337686|450506774|FG000|Overall Study|Adverse Event|1|||
125241339|NCT00177671|450507584|FG000|Overall Study|Withdrawal by Subject|5|||
125241340|NCT00177671|450507585|FG001|Overall Study|Withdrawal by Subject|6|||
125241341|NCT00177671|450507584|FG000|Overall Study|medical complications|2|||
125241342|NCT00177671|450507585|FG001|Overall Study|medical complications|0|||
125241343|NCT00177671|450507584|FG000|Overall Study|Adverse Event|6|||
125241344|NCT00177671|450507585|FG001|Overall Study|Adverse Event|0|||
125241345|NCT00177671|450507584|FG000|Overall Study|Physician Decision|12|||
125241346|NCT00177671|450507585|FG001|Overall Study|Physician Decision|8|||
125241347|NCT02293499|450507586|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
125241348|NCT02293499|450507587|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
125241349|NCT02293499|450507588|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
125241350|NCT02293499|450507586|FG000|Intervention - Camp|Withdrawal by Subject|3|||
125241351|NCT02293499|450507587|FG001|Intervention - Camp|Withdrawal by Subject|6|||
125241352|NCT02293499|450507588|FG002|Intervention - Camp|Withdrawal by Subject|2|||
125241353|NCT02293499|450507586|FG000|Intervention - Camp|these are those not showing up at camp|24|||
125241354|NCT02293499|450507587|FG001|Intervention - Camp|these are those not showing up at camp|28|||
125241355|NCT02293499|450507588|FG002|Intervention - Camp|these are those not showing up at camp|4|||
125241356|NCT02293499|450507586|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
125241357|NCT02293499|450507587|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
125241358|NCT02293499|450507588|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
125241359|NCT02293499|450507586|FG000|3 Month Follow Up|Lost to Follow-up|14|||
125392926|NCT02641379|451072551|FG000|Overall Study|PCR positive at follow up 2|1|||
125392927|NCT02641379|451072552|FG001|Overall Study|PCR positive at follow up 2|0|||
125392928|NCT02641379|451072553|FG002|Overall Study|PCR positive at follow up 2|0|||
125392929|NCT02641379|451072554|FG003|Overall Study|PCR positive at follow up 2|0|||
125392930|NCT02641379|451072555|FG004|Overall Study|PCR positive at follow up 2|0|||
125392931|NCT02641379|451072556|FG005|Overall Study|PCR positive at follow up 2|0|||
125392932|NCT02641379|451072557|FG006|Overall Study|PCR positive at follow up 2|0|||
125392933|NCT02641379|451072558|FG007|Overall Study|PCR positive at follow up 2|0|||
125392934|NCT02641379|451072559|FG008|Overall Study|PCR positive at follow up 2|0|||
125392935|NCT02641379|451072560|FG009|Overall Study|PCR positive at follow up 2|0|||
125392936|NCT02641379|451072561|FG010|Overall Study|PCR positive at follow up 2|0|||
125392937|NCT02641379|451072551|FG000|Overall Study|Participant showed relapse|1|||
125187184|NCT01256450|450305154|FG001|Double-blind Treatment|Non-compliance|5|||
125187185|NCT01256450|450305155|FG002|Double-blind Treatment|Non-compliance|4|||
125187186|NCT01256450|450305153|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
125187187|NCT01256450|450305154|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
125187188|NCT01256450|450305155|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
125187189|NCT01256450|450305153|FG000|Double-blind Treatment|Other|0|||
125187190|NCT01256450|450305154|FG001|Double-blind Treatment|Other|9|||
125187191|NCT01256450|450305155|FG002|Double-blind Treatment|Other|12|||
125187192|NCT03866512|450305156|FG000|Overall Study|Lost to Follow-up|1|||
125187193|NCT03866512|450305157|FG001|Overall Study|Lost to Follow-up|2|||
125187194|NCT03866512|450305158|FG002|Overall Study|Lost to Follow-up|1|||
125187195|NCT03866512|450305156|FG000|Overall Study|Cannulation issues|0|||
125187196|NCT03866512|450305157|FG001|Overall Study|Cannulation issues|1|||
125187197|NCT03866512|450305158|FG002|Overall Study|Cannulation issues|2|||
125187198|NCT00777296|450305166|FG000|Overall Study|Adverse Event|0|||
125187199|NCT00777296|450305167|FG001|Overall Study|Adverse Event|1|||
125187200|NCT00777296|450305168|FG002|Overall Study|Adverse Event|0|||
125187201|NCT00777296|450305169|FG003|Overall Study|Adverse Event|1|||
125187202|NCT00777296|450305166|FG000|Overall Study|Withdrawal by Subject|1|||
125187203|NCT00777296|450305167|FG001|Overall Study|Withdrawal by Subject|0|||
125187204|NCT00777296|450305168|FG002|Overall Study|Withdrawal by Subject|0|||
125187205|NCT00777296|450305169|FG003|Overall Study|Withdrawal by Subject|0|||
125187206|NCT00777296|450305166|FG000|Overall Study|CRF form not completed|0|||
125187207|NCT00777296|450305167|FG001|Overall Study|CRF form not completed|0|||
125187208|NCT00777296|450305168|FG002|Overall Study|CRF form not completed|2|||
125187209|NCT00777296|450305169|FG003|Overall Study|CRF form not completed|0|||
125187210|NCT01139125|450305171|FG000|Overall Study|Withdrawal by Subject|1|||
125187211|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
125187212|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
125187213|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
125187214|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125187215|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125187216|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125187217|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
125187218|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
125187219|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
125187220|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
125187221|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
125187222|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
125187223|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
125187224|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
125187225|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
125187226|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125187227|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
125187228|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125187229|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125187230|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125187231|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
125187232|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
125187233|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125187234|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
125187235|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125187236|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125187237|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125187238|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
125187239|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
125392938|NCT02641379|451072552|FG001|Overall Study|Participant showed relapse|0|||
125187240|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
125187241|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
125241360|NCT02293499|450507587|FG001|3 Month Follow Up|Lost to Follow-up|15|||
125241361|NCT02293499|450507588|FG002|3 Month Follow Up|Lost to Follow-up|6|||
125241362|NCT02293499|450507586|FG000|6 Month Follow Up|Lost to Follow-up|17|||
125241363|NCT02293499|450507587|FG001|6 Month Follow Up|Lost to Follow-up|27|||
125241364|NCT02293499|450507588|FG002|6 Month Follow Up|Lost to Follow-up|6|||
125241365|NCT02293499|450507586|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
125241366|NCT02293499|450507587|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
125241367|NCT02293499|450507588|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
125241368|NCT02293499|450507586|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
125241369|NCT02293499|450507587|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
125241370|NCT02293499|450507588|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
125241371|NCT02293499|450507586|FG000|9 Month Follow Up|Lost to Follow-up|24|||
125241372|NCT02293499|450507587|FG001|9 Month Follow Up|Lost to Follow-up|28|||
125241373|NCT02293499|450507588|FG002|9 Month Follow Up|Lost to Follow-up|4|||
125241374|NCT02293499|450507586|FG000|12 Month Follow Up|Lost to Follow-up|26|||
125241375|NCT02293499|450507587|FG001|12 Month Follow Up|Lost to Follow-up|25|||
125241376|NCT02293499|450507588|FG002|12 Month Follow Up|Lost to Follow-up|6|||
125241377|NCT02293499|450507586|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
125241378|NCT02293499|450507587|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
125241379|NCT02293499|450507588|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
125241380|NCT02293499|450507586|FG000|15 Month Follow Up|Lost to Follow-up|22|||
125241381|NCT02293499|450507587|FG001|15 Month Follow Up|Lost to Follow-up|22|||
125241382|NCT02293499|450507588|FG002|15 Month Follow Up|Lost to Follow-up|7|||
125241383|NCT00690898|450507589|FG000|SCREENING|Screen failure|18|||
125241384|NCT00690898|450507589|FG000|TREATMENT|Adverse Event|3|||
125241385|NCT00690898|450507589|FG000|TREATMENT|Lack of Efficacy|18|||
125241386|NCT00690898|450507589|FG000|TREATMENT|Withdrawal by Subject|4|||
125241387|NCT00690898|450507589|FG000|TREATMENT|Other (not otherwise specified)|1|||
125241388|NCT01847209|450507592|FG000|Overall Study|Withdrawal by Subject|1|||
125241389|NCT01847209|450507592|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
125241390|NCT02008370|450507610|FG000|Overall Study|Lost to Follow-up|7|||
125241391|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
125241392|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
125241393|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
125241394|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
125241395|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
125241396|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
125241397|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
125241398|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
125241399|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
125241400|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
125241401|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Death|0|||
125241402|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Death|0|||
125241403|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Death|1|||
125241404|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Death|0|||
125241405|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Death|0|||
125241406|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
125241407|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
125241408|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
125241409|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
125241410|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
125241411|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Other|2|||
125241412|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Other|1|||
125241413|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Other|0|||
125241414|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Other|0|||
125241415|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Other|0|||
125241416|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
125241417|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
125241418|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
125241419|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
125241420|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
125241421|NCT03317496|450507614|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
125241422|NCT03317496|450507615|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
125241423|NCT03317496|450507616|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
125241424|NCT03317496|450507617|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
125241425|NCT03317496|450507618|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
125241426|NCT03317496|450507614|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
125241427|NCT03317496|450507615|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
125392939|NCT02641379|451072553|FG002|Overall Study|Participant showed relapse|0|||
125241428|NCT03317496|450507616|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
125241429|NCT03317496|450507617|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
125241430|NCT03317496|450507618|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
125241431|NCT03317496|450507614|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
125392940|NCT02641379|451072554|FG003|Overall Study|Participant showed relapse|0|||
125392941|NCT02641379|451072555|FG004|Overall Study|Participant showed relapse|0|||
125392942|NCT02641379|451072556|FG005|Overall Study|Participant showed relapse|0|||
125392943|NCT02641379|451072557|FG006|Overall Study|Participant showed relapse|1|||
125392944|NCT02641379|451072558|FG007|Overall Study|Participant showed relapse|0|||
125392945|NCT02641379|451072559|FG008|Overall Study|Participant showed relapse|0|||
125392946|NCT02641379|451072560|FG009|Overall Study|Participant showed relapse|0|||
125392947|NCT02641379|451072561|FG010|Overall Study|Participant showed relapse|0|||
125392948|NCT02641379|451072551|FG000|Overall Study|Participant stopped study/treatment|1|||
125392949|NCT02641379|451072552|FG001|Overall Study|Participant stopped study/treatment|3|||
125392950|NCT02641379|451072553|FG002|Overall Study|Participant stopped study/treatment|1|||
125392951|NCT02641379|451072554|FG003|Overall Study|Participant stopped study/treatment|0|||
125392952|NCT02641379|451072555|FG004|Overall Study|Participant stopped study/treatment|0|||
125392953|NCT02641379|451072556|FG005|Overall Study|Participant stopped study/treatment|1|||
125392954|NCT02641379|451072557|FG006|Overall Study|Participant stopped study/treatment|2|||
125392955|NCT02641379|451072558|FG007|Overall Study|Participant stopped study/treatment|0|||
125392956|NCT02641379|451072559|FG008|Overall Study|Participant stopped study/treatment|1|||
125392957|NCT02641379|451072560|FG009|Overall Study|Participant stopped study/treatment|0|||
125392958|NCT02641379|451072561|FG010|Overall Study|Participant stopped study/treatment|0|||
125392959|NCT02641379|451072551|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
125392960|NCT02641379|451072552|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
125392961|NCT02641379|451072553|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
125392962|NCT02641379|451072554|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
125392963|NCT02641379|451072555|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
125392964|NCT02641379|451072556|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
125392965|NCT02641379|451072557|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
125392966|NCT02641379|451072558|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
125392967|NCT02641379|451072559|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
125392968|NCT02641379|451072560|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
125392969|NCT02641379|451072561|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
125392970|NCT02641379|451072551|FG000|Overall Study|Financial problems|0|||
125392971|NCT02641379|451072552|FG001|Overall Study|Financial problems|1|||
125392972|NCT02641379|451072553|FG002|Overall Study|Financial problems|0|||
125392973|NCT02641379|451072554|FG003|Overall Study|Financial problems|0|||
125392974|NCT02641379|451072555|FG004|Overall Study|Financial problems|0|||
125392975|NCT02641379|451072556|FG005|Overall Study|Financial problems|0|||
125392976|NCT02641379|451072557|FG006|Overall Study|Financial problems|0|||
125392977|NCT02641379|451072558|FG007|Overall Study|Financial problems|0|||
125392978|NCT02641379|451072559|FG008|Overall Study|Financial problems|0|||
125392979|NCT02641379|451072560|FG009|Overall Study|Financial problems|0|||
125392980|NCT02641379|451072561|FG010|Overall Study|Financial problems|0|||
125392981|NCT02641379|451072551|FG000|Overall Study|PCR positive at Week 68|0|||
125392982|NCT02641379|451072552|FG001|Overall Study|PCR positive at Week 68|1|||
125392983|NCT02641379|451072553|FG002|Overall Study|PCR positive at Week 68|0|||
125392984|NCT02641379|451072554|FG003|Overall Study|PCR positive at Week 68|0|||
125392985|NCT02641379|451072555|FG004|Overall Study|PCR positive at Week 68|0|||
125392986|NCT02641379|451072556|FG005|Overall Study|PCR positive at Week 68|0|||
125392987|NCT02641379|451072557|FG006|Overall Study|PCR positive at Week 68|0|||
125392988|NCT02641379|451072558|FG007|Overall Study|PCR positive at Week 68|0|||
125392989|NCT02641379|451072559|FG008|Overall Study|PCR positive at Week 68|0|||
125392990|NCT02641379|451072560|FG009|Overall Study|PCR positive at Week 68|0|||
125392991|NCT02641379|451072561|FG010|Overall Study|PCR positive at Week 68|0|||
125392992|NCT02641379|451072551|FG000|Overall Study|PCR positive at Week 48|0|||
125392993|NCT02641379|451072552|FG001|Overall Study|PCR positive at Week 48|1|||
125392994|NCT02641379|451072553|FG002|Overall Study|PCR positive at Week 48|0|||
125392995|NCT02641379|451072554|FG003|Overall Study|PCR positive at Week 48|0|||
125392996|NCT02641379|451072555|FG004|Overall Study|PCR positive at Week 48|0|||
125392997|NCT02641379|451072556|FG005|Overall Study|PCR positive at Week 48|0|||
125392998|NCT02641379|451072557|FG006|Overall Study|PCR positive at Week 48|0|||
125392999|NCT02641379|451072558|FG007|Overall Study|PCR positive at Week 48|0|||
125393000|NCT02641379|451072559|FG008|Overall Study|PCR positive at Week 48|0|||
125393001|NCT02641379|451072560|FG009|Overall Study|PCR positive at Week 48|0|||
125393002|NCT02641379|451072561|FG010|Overall Study|PCR positive at Week 48|0|||
125393003|NCT02641379|451072551|FG000|Overall Study|PCR not performed at Week 12|0|||
125393004|NCT02641379|451072552|FG001|Overall Study|PCR not performed at Week 12|0|||
125393005|NCT02641379|451072553|FG002|Overall Study|PCR not performed at Week 12|1|||
125187242|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125187243|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125393006|NCT02641379|451072554|FG003|Overall Study|PCR not performed at Week 12|0|||
125393007|NCT02641379|451072555|FG004|Overall Study|PCR not performed at Week 12|0|||
125393008|NCT02641379|451072556|FG005|Overall Study|PCR not performed at Week 12|0|||
125393009|NCT02641379|451072557|FG006|Overall Study|PCR not performed at Week 12|0|||
125393010|NCT02641379|451072558|FG007|Overall Study|PCR not performed at Week 12|0|||
125241432|NCT03317496|450507615|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
125241433|NCT03317496|450507616|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
125241434|NCT03317496|450507617|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
125241435|NCT03317496|450507618|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
125241436|NCT03317496|450507614|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
125241437|NCT03317496|450507615|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
125241438|NCT03317496|450507616|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
125241439|NCT03317496|450507617|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
125241440|NCT03317496|450507618|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
125241441|NCT03317496|450507614|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
125241442|NCT03317496|450507615|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
125241443|NCT03317496|450507616|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
125241444|NCT03317496|450507617|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
125241445|NCT03317496|450507618|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
125241446|NCT03317496|450507614|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
125241447|NCT03317496|450507615|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
125241448|NCT03317496|450507616|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
125241449|NCT03317496|450507617|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
125241450|NCT03317496|450507618|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
125241451|NCT03317496|450507614|FG000|Phase 2: Treatment|Adverse Event|0|||
125241452|NCT03317496|450507615|FG001|Phase 2: Treatment|Adverse Event|0|||
125241453|NCT03317496|450507616|FG002|Phase 2: Treatment|Adverse Event|0|||
125241454|NCT03317496|450507617|FG003|Phase 2: Treatment|Adverse Event|0|||
125241455|NCT03317496|450507618|FG004|Phase 2: Treatment|Adverse Event|6|||
125241456|NCT03317496|450507614|FG000|Phase 2: Treatment|Progressive disease|0|||
125241457|NCT03317496|450507615|FG001|Phase 2: Treatment|Progressive disease|0|||
125241458|NCT03317496|450507616|FG002|Phase 2: Treatment|Progressive disease|0|||
125241459|NCT03317496|450507617|FG003|Phase 2: Treatment|Progressive disease|0|||
125241460|NCT03317496|450507618|FG004|Phase 2: Treatment|Progressive disease|22|||
125241461|NCT03317496|450507614|FG000|Phase 2: Treatment|Other|0|||
125241462|NCT03317496|450507615|FG001|Phase 2: Treatment|Other|0|||
125241463|NCT03317496|450507616|FG002|Phase 2: Treatment|Other|0|||
125241464|NCT03317496|450507617|FG003|Phase 2: Treatment|Other|0|||
125241465|NCT03317496|450507618|FG004|Phase 2: Treatment|Other|4|||
125241466|NCT03317496|450507614|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
125241467|NCT03317496|450507615|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
125241468|NCT03317496|450507616|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
125241469|NCT03317496|450507617|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
125241470|NCT03317496|450507618|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
125241471|NCT03317496|450507614|FG000|Phase 2: Treatment|Physician Decision|0|||
125241472|NCT03317496|450507615|FG001|Phase 2: Treatment|Physician Decision|0|||
125241473|NCT03317496|450507616|FG002|Phase 2: Treatment|Physician Decision|0|||
125241474|NCT03317496|450507617|FG003|Phase 2: Treatment|Physician Decision|0|||
125241475|NCT03317496|450507618|FG004|Phase 2: Treatment|Physician Decision|1|||
125241476|NCT03317496|450507614|FG000|Phase 2: Treatment|Death|0|||
125241477|NCT03317496|450507615|FG001|Phase 2: Treatment|Death|0|||
125241478|NCT03317496|450507616|FG002|Phase 2: Treatment|Death|0|||
125241479|NCT03317496|450507617|FG003|Phase 2: Treatment|Death|0|||
125241480|NCT03317496|450507618|FG004|Phase 2: Treatment|Death|1|||
125241481|NCT03317496|450507614|FG000|Phase 2: Follow-up|Death|0|||
125241482|NCT03317496|450507615|FG001|Phase 2: Follow-up|Death|0|||
125241483|NCT03317496|450507616|FG002|Phase 2: Follow-up|Death|0|||
125241484|NCT03317496|450507617|FG003|Phase 2: Follow-up|Death|0|||
125241485|NCT03317496|450507618|FG004|Phase 2: Follow-up|Death|24|||
125241486|NCT03317496|450507614|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
125241487|NCT03317496|450507615|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
125241488|NCT03317496|450507616|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
125241489|NCT03317496|450507617|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
125241490|NCT03317496|450507618|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
125241491|NCT03317496|450507614|FG000|Phase 2: Follow-up|Other|0|||
125241492|NCT03317496|450507615|FG001|Phase 2: Follow-up|Other|0|||
125241493|NCT03317496|450507616|FG002|Phase 2: Follow-up|Other|0|||
125241494|NCT03317496|450507617|FG003|Phase 2: Follow-up|Other|0|||
125241495|NCT03317496|450507618|FG004|Phase 2: Follow-up|Other|1|||
125241496|NCT03317496|450507614|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
125241497|NCT03317496|450507615|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
125241498|NCT03317496|450507616|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
125241499|NCT03317496|450507617|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
125241500|NCT03317496|450507618|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
125241501|NCT02737618|450507619|FG000|Overall Study|Withdrawal by Subject|9|||
125241502|NCT00817063|450507622|FG000|Overall Study|Adverse Event|32|||
125241503|NCT00817063|450507623|FG001|Overall Study|Adverse Event|13|||
125241504|NCT00817063|450507622|FG000|Overall Study|Death|1|||
125241505|NCT00817063|450507623|FG001|Overall Study|Death|1|||
125241506|NCT00817063|450507622|FG000|Overall Study|Lack of Efficacy|33|||
125241507|NCT00817063|450507623|FG001|Overall Study|Lack of Efficacy|86|||
125241508|NCT00817063|450507622|FG000|Overall Study|Failure to Return|13|||
125241509|NCT00817063|450507623|FG001|Overall Study|Failure to Return|12|||
125241510|NCT00817063|450507622|FG000|Overall Study|Violation of Selection at Entry|7|||
125241511|NCT00817063|450507623|FG001|Overall Study|Violation of Selection at Entry|4|||
125241512|NCT00817063|450507622|FG000|Overall Study|Protocol Violation|3|||
125241513|NCT00817063|450507623|FG001|Overall Study|Protocol Violation|8|||
125241514|NCT00817063|450507622|FG000|Overall Study|Withdrawal by Subject|17|||
125241515|NCT00817063|450507623|FG001|Overall Study|Withdrawal by Subject|37|||
125241516|NCT00817063|450507622|FG000|Overall Study|Early Improvement|19|||
125241517|NCT00817063|450507623|FG001|Overall Study|Early Improvement|4|||
125241518|NCT00817063|450507622|FG000|Overall Study|Administrative|10|||
125241519|NCT00817063|450507623|FG001|Overall Study|Administrative|4|||
125241520|NCT00817063|450507622|FG000|Overall Study|Abnormality of Laboratory Test|2|||
125241521|NCT00817063|450507623|FG001|Overall Study|Abnormality of Laboratory Test|1|||
125241522|NCT02362451|450507625|FG000|Overall Study|Withdrawal by Subject|0|||
125241523|NCT02362451|450507626|FG001|Overall Study|Withdrawal by Subject|1|||
125241524|NCT02362451|450507625|FG000|Overall Study|Lack of Efficacy|2|||
125241525|NCT02362451|450507626|FG001|Overall Study|Lack of Efficacy|0|||
125241526|NCT02362451|450507625|FG000|Overall Study|Progression|1|||
125241527|NCT02362451|450507626|FG001|Overall Study|Progression|0|||
125241528|NCT02362451|450507625|FG000|Overall Study|Participant chose other therapy.|1|||
125241529|NCT02362451|450507626|FG001|Overall Study|Participant chose other therapy.|0|||
125241530|NCT01879852|450507627|FG000|Overall Study|Withdrawal by Subject|2|||
125241531|NCT01879852|450507628|FG001|Overall Study|Withdrawal by Subject|0|||
125241532|NCT02696616|450507630|FG000|Overall Study|Adverse Event|0|||
125241533|NCT02696616|450507631|FG001|Overall Study|Adverse Event|1|||
125241534|NCT02696616|450507632|FG002|Overall Study|Adverse Event|0|||
125241535|NCT02696616|450507633|FG003|Overall Study|Adverse Event|0|||
125241536|NCT02696616|450507634|FG004|Overall Study|Adverse Event|0|||
125241537|NCT02696616|450507635|FG005|Overall Study|Adverse Event|0|||
125241538|NCT02696616|450507636|FG006|Overall Study|Adverse Event|0|||
125241539|NCT01500083|450507637|FG000|Overall Study|Adverse Event|4|||
125241540|NCT01500083|450507638|FG001|Overall Study|Adverse Event|17|||
125241541|NCT01500083|450507637|FG000|Overall Study|Death|0|||
125241542|NCT01500083|450507638|FG001|Overall Study|Death|2|||
125241543|NCT01500083|450507637|FG000|Overall Study|Lost to Follow-up|1|||
125241544|NCT01500083|450507638|FG001|Overall Study|Lost to Follow-up|0|||
125241545|NCT01500083|450507637|FG000|Overall Study|Withdrawal of Consent|0|||
125241546|NCT01500083|450507638|FG001|Overall Study|Withdrawal of Consent|1|||
125241547|NCT01500083|450507637|FG000|Overall Study|Disease Progression|2|||
125241548|NCT01500083|450507638|FG001|Overall Study|Disease Progression|10|||
125241549|NCT01500083|450507637|FG000|Overall Study|Investigator Discretion|3|||
125241550|NCT01500083|450507638|FG001|Overall Study|Investigator Discretion|8|||
125241551|NCT01500083|450507637|FG000|Overall Study|Other Reasons|2|||
125241552|NCT01500083|450507638|FG001|Overall Study|Other Reasons|5|||
125241553|NCT01555931|450507639|FG000|Overall Study|Lost to Follow-up|2|||
125241554|NCT01555931|450507640|FG001|Overall Study|Lost to Follow-up|5|||
125241555|NCT01922011|450507641|FG000|Overall Study|Protocol Violation|0|||
125241556|NCT01922011|450507642|FG001|Overall Study|Protocol Violation|1|||
125241557|NCT01922011|450507641|FG000|Overall Study|Physician Decision|0|||
125241558|NCT01922011|450507642|FG001|Overall Study|Physician Decision|1|||
125241559|NCT01922011|450507641|FG000|Overall Study|Parent/Guardian Decision|3|||
125241560|NCT01922011|450507642|FG001|Overall Study|Parent/Guardian Decision|0|||
125241561|NCT01922011|450507641|FG000|Overall Study|Lost to Follow-up|0|||
125241562|NCT01922011|450507642|FG001|Overall Study|Lost to Follow-up|1|||
125241563|NCT01922011|450507641|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
125241564|NCT01922011|450507642|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
125241565|NCT01922011|450507641|FG000|Overall Study|Not Treated|1|||
125241566|NCT01922011|450507642|FG001|Overall Study|Not Treated|0|||
125241567|NCT01922011|450507641|FG000|Overall Study|Lack of willing home health agency|1|||
125241568|NCT01922011|450507642|FG001|Overall Study|Lack of willing home health agency|0|||
125241569|NCT01922011|450507641|FG000|Overall Study|Randomized in error|1|||
125241570|NCT01922011|450507642|FG001|Overall Study|Randomized in error|0|||
125241571|NCT02299167|450507645|FG000|Overall Study|patients were excluded from the study|11|||
125241572|NCT00700635|450507646|FG000|Overall Study|Adverse Event|1|||
125241573|NCT00700635|450507647|FG001|Overall Study|Adverse Event|0|||
125241574|NCT00700635|450507648|FG002|Overall Study|Adverse Event|0|||
125241575|NCT00700635|450507646|FG000|Overall Study|Lost to Follow-up|1|||
125241576|NCT00700635|450507647|FG001|Overall Study|Lost to Follow-up|3|||
125241577|NCT00700635|450507648|FG002|Overall Study|Lost to Follow-up|0|||
125241578|NCT00700635|450507646|FG000|Overall Study|Protocol Violation|2|||
125241579|NCT00700635|450507647|FG001|Overall Study|Protocol Violation|2|||
125241580|NCT00700635|450507648|FG002|Overall Study|Protocol Violation|0|||
125241581|NCT00700635|450507646|FG000|Overall Study|Withdrawal by Subject|7|||
125241582|NCT00700635|450507647|FG001|Overall Study|Withdrawal by Subject|3|||
125241583|NCT00700635|450507648|FG002|Overall Study|Withdrawal by Subject|1|||
125241584|NCT05172570|450507649|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
125241585|NCT05172570|450507650|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
125241586|NCT05172570|450507651|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
125241587|NCT05172570|450507649|FG000|Overall Study|PI Decision due to equipment shortages|0|||
125241588|NCT05172570|450507650|FG001|Overall Study|PI Decision due to equipment shortages|0|||
125241589|NCT05172570|450507651|FG002|Overall Study|PI Decision due to equipment shortages|1|||
125241590|NCT02207608|450507657|FG000|Overall Study|Adverse Event|1|||
125241591|NCT02207608|450507658|FG001|Overall Study|Adverse Event|0|||
125241592|NCT00980460|450507659|FG000|Overall Study|Death|0|||
125241593|NCT00980460|450507660|FG001|Overall Study|Death|0|||
125241594|NCT00980460|450507661|FG002|Overall Study|Death|1|||
125241595|NCT00980460|450507662|FG003|Overall Study|Death|2|||
125241596|NCT00980460|450507663|FG004|Overall Study|Death|1|||
125241597|NCT00980460|450507659|FG000|Overall Study|Lack of Efficacy|0|||
125241598|NCT00980460|450507660|FG001|Overall Study|Lack of Efficacy|0|||
125241599|NCT00980460|450507661|FG002|Overall Study|Lack of Efficacy|10|||
125241600|NCT00980460|450507662|FG003|Overall Study|Lack of Efficacy|6|||
125241601|NCT00980460|450507663|FG004|Overall Study|Lack of Efficacy|8|||
125241602|NCT00980460|450507659|FG000|Overall Study|Lost to Follow-up|0|||
125241603|NCT00980460|450507660|FG001|Overall Study|Lost to Follow-up|0|||
125241604|NCT00980460|450507661|FG002|Overall Study|Lost to Follow-up|0|||
125241605|NCT00980460|450507662|FG003|Overall Study|Lost to Follow-up|1|||
125241606|NCT00980460|450507663|FG004|Overall Study|Lost to Follow-up|0|||
125241607|NCT00980460|450507659|FG000|Overall Study|Physician Decision|0|||
125241608|NCT00980460|450507660|FG001|Overall Study|Physician Decision|0|||
125241609|NCT00980460|450507661|FG002|Overall Study|Physician Decision|11|||
125241610|NCT00980460|450507662|FG003|Overall Study|Physician Decision|5|||
125241611|NCT00980460|450507663|FG004|Overall Study|Physician Decision|3|||
125241612|NCT00980460|450507659|FG000|Overall Study|Withdrawal by Subject|0|||
125241613|NCT00980460|450507660|FG001|Overall Study|Withdrawal by Subject|0|||
125241614|NCT00980460|450507661|FG002|Overall Study|Withdrawal by Subject|1|||
125241615|NCT00980460|450507662|FG003|Overall Study|Withdrawal by Subject|0|||
125241616|NCT00980460|450507663|FG004|Overall Study|Withdrawal by Subject|0|||
125241617|NCT00980460|450507659|FG000|Overall Study|Ineligible|0|||
125241618|NCT00980460|450507660|FG001|Overall Study|Ineligible|2|||
125241619|NCT00980460|450507661|FG002|Overall Study|Ineligible|3|||
125241620|NCT00980460|450507662|FG003|Overall Study|Ineligible|1|||
125241621|NCT00980460|450507663|FG004|Overall Study|Ineligible|4|||
125241622|NCT00980460|450507659|FG000|Overall Study|Refusal of further therapy|0|||
125241623|NCT00980460|450507660|FG001|Overall Study|Refusal of further therapy|2|||
125241624|NCT00980460|450507661|FG002|Overall Study|Refusal of further therapy|3|||
125241625|NCT00980460|450507662|FG003|Overall Study|Refusal of further therapy|2|||
125241626|NCT00980460|450507663|FG004|Overall Study|Refusal of further therapy|0|||
125241627|NCT00980460|450507659|FG000|Overall Study|No therapy within 42 days of resection|0|||
125241628|NCT00980460|450507660|FG001|Overall Study|No therapy within 42 days of resection|0|||
125241629|NCT00980460|450507661|FG002|Overall Study|No therapy within 42 days of resection|3|||
125241630|NCT00980460|450507662|FG003|Overall Study|No therapy within 42 days of resection|1|||
125187244|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125187245|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
125187246|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
125187247|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
125187248|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
125187249|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
125187250|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
125187251|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
125187252|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
125187253|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
125187254|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
125187255|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
125187256|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
125187257|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
125187258|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
125187259|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
125187260|NCT04242498|450305177|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125187261|NCT04242498|450305178|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
125241631|NCT00980460|450507663|FG004|Overall Study|No therapy within 42 days of resection|0|||
125241632|NCT00980460|450507659|FG000|Overall Study|No transplant by protocol timepoints|0|||
125241633|NCT00980460|450507660|FG001|Overall Study|No transplant by protocol timepoints|0|||
125241634|NCT00980460|450507661|FG002|Overall Study|No transplant by protocol timepoints|3|||
125241635|NCT00980460|450507662|FG003|Overall Study|No transplant by protocol timepoints|0|||
125241636|NCT00980460|450507663|FG004|Overall Study|No transplant by protocol timepoints|0|||
125241637|NCT01001104|450508350|FG000|Overall Study|Adverse Event|2|||
125241638|NCT01001104|450508351|FG001|Overall Study|Adverse Event|1|||
125187262|NCT04242498|450305179|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
125187263|NCT04242498|450305180|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125187264|NCT04242498|450305181|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125187265|NCT04242498|450305182|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125187266|NCT04242498|450305183|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
125187267|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125187268|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125187269|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125187270|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
125187271|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
125187272|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
125187273|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
125187274|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125187275|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125187276|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125187277|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
125187278|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
125187279|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
125187280|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
125187281|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125187282|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125187283|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125187284|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125187285|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
125187286|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
125187287|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
125187288|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
125187289|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
125187290|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
125187291|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
125187292|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
125187293|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
125187294|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
125187295|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
125187296|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
125187297|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
125187298|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
125187299|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
125187300|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
125187301|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
125187302|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
125187303|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
125187304|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
125187305|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
125187306|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
125187307|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
125187308|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
125187309|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
125187310|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
125187311|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
125187312|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
125187313|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
125187314|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
125187315|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
125187316|NCT04242498|450305177|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
125187317|NCT04242498|450305178|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
125187318|NCT04242498|450305179|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
125187319|NCT04242498|450305180|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
125241639|NCT01001104|450508352|FG002|Overall Study|Adverse Event|0|||
125241640|NCT01001104|450508353|FG003|Overall Study|Adverse Event|0|||
125241641|NCT01001104|450508350|FG000|Overall Study|Lost to Follow-up|0|||
125241642|NCT01001104|450508351|FG001|Overall Study|Lost to Follow-up|0|||
125241643|NCT01001104|450508352|FG002|Overall Study|Lost to Follow-up|1|||
125241644|NCT01001104|450508353|FG003|Overall Study|Lost to Follow-up|0|||
125241645|NCT01001104|450508350|FG000|Overall Study|Entry Criteria Not Met|0|||
125241646|NCT01001104|450508351|FG001|Overall Study|Entry Criteria Not Met|0|||
125241647|NCT01001104|450508352|FG002|Overall Study|Entry Criteria Not Met|0|||
125241648|NCT01001104|450508353|FG003|Overall Study|Entry Criteria Not Met|1|||
125241649|NCT01001104|450508350|FG000|Overall Study|Withdrawal by Subject|0|||
125241650|NCT01001104|450508351|FG001|Overall Study|Withdrawal by Subject|0|||
125241651|NCT01001104|450508352|FG002|Overall Study|Withdrawal by Subject|0|||
125241652|NCT01001104|450508353|FG003|Overall Study|Withdrawal by Subject|2|||
125241653|NCT02397837|450508355|FG000|Overall Study|Withdrawal by Subject|6|||
125241654|NCT02397837|450508356|FG001|Overall Study|Withdrawal by Subject|5|||
125241655|NCT02397837|450508355|FG000|Overall Study|Physician Decision|1|||
125241656|NCT02397837|450508356|FG001|Overall Study|Physician Decision|1|||
125241657|NCT00599313|450508357|FG000|Overall Study|Adverse Event|19|||
125241658|NCT00599313|450508357|FG000|Overall Study|Disease Progression|12|||
125241659|NCT00599313|450508357|FG000|Overall Study|Patient Request|4|||
125241660|NCT00599313|450508357|FG000|Overall Study|Ineligible|1|||
125241661|NCT02536794|450508358|FG000|Reached 1st Response Assessment|Adverse Event|2|||
125241662|NCT02536794|450508358|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
125241663|NCT02536794|450508358|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
125241664|NCT02536794|450508358|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
125241665|NCT02536794|450508358|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
125241666|NCT02536794|450508358|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
125241667|NCT01496456|450508365|FG000|Overall Study|Protocol Violation|1|||
125241668|NCT01496456|450508365|FG000|Overall Study|Lost to Follow-up|7|||
125241669|NCT01695746|450508368|FG000|Overall Study|Adverse Event|1|||
125241670|NCT01695746|450508368|FG000|Overall Study|Non-compliance by the participant|3|||
125241671|NCT01695746|450508368|FG000|Overall Study|Protocol Violation|5|||
125241672|NCT01695746|450508368|FG000|Overall Study|Participant not willing to participate|3|||
125241673|NCT03010501|450508370|FG000|Study Week 1|Withdrawal by Subject|2|||
125241674|NCT03010501|450508371|FG001|Study Week 1|Withdrawal by Subject|1|||
125241675|NCT03010501|450508372|FG002|Study Week 1|Withdrawal by Subject|0|||
125241676|NCT03010501|450508373|FG003|Study Week 1|Withdrawal by Subject|2|||
125241677|NCT03010501|450508374|FG004|Study Week 1|Withdrawal by Subject|0|||
125241678|NCT03010501|450508375|FG005|Study Week 1|Withdrawal by Subject|0|||
125241679|NCT03010501|450508370|FG000|Study Week 3|Withdrawal by Subject|0|||
125241680|NCT03010501|450508371|FG001|Study Week 3|Withdrawal by Subject|0|||
125241681|NCT03010501|450508372|FG002|Study Week 3|Withdrawal by Subject|0|||
125241682|NCT03010501|450508373|FG003|Study Week 3|Withdrawal by Subject|1|||
125241683|NCT03010501|450508374|FG004|Study Week 3|Withdrawal by Subject|0|||
125241684|NCT03010501|450508375|FG005|Study Week 3|Withdrawal by Subject|0|||
125241685|NCT00640289|450508376|FG000|Overall Study|Death|3|||
125241686|NCT00640289|450508376|FG000|Overall Study|Withdrawal by Subject|1|||
125241687|NCT00640289|450508376|FG000|Overall Study|Lost to Follow-up|1|||
125241688|NCT00640289|450508376|FG000|Overall Study|Data collected under different amendment|2|||
125241689|NCT00640289|450508376|FG000|Overall Study|Transferred to another center|1|||
125241690|NCT00640289|450508376|FG000|Overall Study|Missing status|5|||
125241691|NCT01202591|450508377|FG000|Overall Study|Adverse Event|2|||
125241692|NCT01202591|450508378|FG001|Overall Study|Adverse Event|1|||
125241693|NCT01202591|450508379|FG002|Overall Study|Adverse Event|4|||
125393011|NCT02641379|451072559|FG008|Overall Study|PCR not performed at Week 12|0|||
125393012|NCT02641379|451072560|FG009|Overall Study|PCR not performed at Week 12|0|||
125393013|NCT02641379|451072561|FG010|Overall Study|PCR not performed at Week 12|0|||
125393014|NCT02641379|451072551|FG000|Overall Study|No PCR at baseline|0|||
125393015|NCT02641379|451072552|FG001|Overall Study|No PCR at baseline|0|||
125393016|NCT02641379|451072553|FG002|Overall Study|No PCR at baseline|1|||
125393017|NCT02641379|451072554|FG003|Overall Study|No PCR at baseline|0|||
125393018|NCT02641379|451072555|FG004|Overall Study|No PCR at baseline|0|||
125393019|NCT02641379|451072556|FG005|Overall Study|No PCR at baseline|0|||
125393020|NCT02641379|451072557|FG006|Overall Study|No PCR at baseline|0|||
125393021|NCT02641379|451072558|FG007|Overall Study|No PCR at baseline|0|||
125393022|NCT02641379|451072559|FG008|Overall Study|No PCR at baseline|0|||
125393023|NCT02641379|451072560|FG009|Overall Study|No PCR at baseline|0|||
125393024|NCT02641379|451072561|FG010|Overall Study|No PCR at baseline|0|||
125241694|NCT01202591|450508380|FG003|Overall Study|Adverse Event|4|||
125241695|NCT01202591|450508381|FG004|Overall Study|Adverse Event|0|||
125241696|NCT01202591|450508382|FG005|Overall Study|Adverse Event|0|||
125393025|NCT02641379|451072551|FG000|Overall Study|PCR positive at Week 28|0|||
125393026|NCT02641379|451072552|FG001|Overall Study|PCR positive at Week 28|0|||
125393027|NCT02641379|451072553|FG002|Overall Study|PCR positive at Week 28|1|||
125393028|NCT02641379|451072554|FG003|Overall Study|PCR positive at Week 28|0|||
125187320|NCT04242498|450305181|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
125187321|NCT04242498|450305182|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
125187322|NCT04242498|450305183|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
125187323|NCT04760626|450305184|FG000|Overall Study|Withdrawal by Subject|24|||
125187324|NCT04760626|450305185|FG001|Overall Study|Withdrawal by Subject|20|||
125187325|NCT04760626|450305184|FG000|Overall Study|Lost to Follow-up|14|||
125187326|NCT04760626|450305185|FG001|Overall Study|Lost to Follow-up|19|||
125393029|NCT02641379|451072555|FG004|Overall Study|PCR positive at Week 28|0|||
125393030|NCT02641379|451072556|FG005|Overall Study|PCR positive at Week 28|0|||
125187327|NCT04760626|450305184|FG000|Overall Study|Physician Decision|3|||
125187328|NCT04760626|450305185|FG001|Overall Study|Physician Decision|5|||
125187329|NCT04760626|450305184|FG000|Overall Study|Death|3|||
125187330|NCT04760626|450305185|FG001|Overall Study|Death|6|||
125187331|NCT04760626|450305184|FG000|Overall Study|Site closure|1|||
125187332|NCT04760626|450305185|FG001|Overall Study|Site closure|0|||
125187333|NCT01753310|450305186|FG000|Overall Study|Entered into open label extension study|25|||
125187334|NCT01753310|450305187|FG001|Overall Study|Entered into open label extension study|22|||
125187335|NCT01753310|450305186|FG000|Overall Study|Adverse Event|1|||
125187336|NCT01753310|450305187|FG001|Overall Study|Adverse Event|0|||
125187337|NCT01753310|450305186|FG000|Overall Study|Lost to Follow-up|2|||
125187338|NCT01753310|450305187|FG001|Overall Study|Lost to Follow-up|0|||
125187339|NCT01753310|450305186|FG000|Overall Study|Subject decision|2|||
125187340|NCT01753310|450305187|FG001|Overall Study|Subject decision|2|||
125187341|NCT01753310|450305186|FG000|Overall Study|Sponsor decision|1|||
125187342|NCT01753310|450305187|FG001|Overall Study|Sponsor decision|0|||
125187343|NCT01753310|450305186|FG000|Overall Study|Withdrawal by Subject|1|||
125187344|NCT01753310|450305187|FG001|Overall Study|Withdrawal by Subject|0|||
125187345|NCT02946463|450305188|FG000|Primary Evaluation Period|Physician Decision|0|||
125187346|NCT02946463|450305189|FG001|Primary Evaluation Period|Physician Decision|1|||
125187347|NCT02946463|450305190|FG002|Primary Evaluation Period|Physician Decision|0|||
125187348|NCT02946463|450305191|FG003|Primary Evaluation Period|Physician Decision|0|||
125187349|NCT02946463|450305188|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
125187350|NCT02946463|450305189|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
125187351|NCT02946463|450305190|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
125187352|NCT02946463|450305191|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
125187353|NCT02946463|450305188|FG000|Extension Period|Death|4|||
125187354|NCT02946463|450305189|FG001|Extension Period|Death|4|||
125187355|NCT02946463|450305190|FG002|Extension Period|Death|0|||
125187356|NCT02946463|450305191|FG003|Extension Period|Death|0|||
125187357|NCT02946463|450305188|FG000|Extension Period|Withdrawal by Subject|4|||
125187358|NCT02946463|450305189|FG001|Extension Period|Withdrawal by Subject|3|||
125187359|NCT02946463|450305190|FG002|Extension Period|Withdrawal by Subject|0|||
125187360|NCT02946463|450305191|FG003|Extension Period|Withdrawal by Subject|0|||
125187361|NCT02946463|450305188|FG000|Extension Period|Other than specified|2|||
125187362|NCT02946463|450305189|FG001|Extension Period|Other than specified|3|||
125187363|NCT02946463|450305190|FG002|Extension Period|Other than specified|2|||
125187364|NCT02946463|450305191|FG003|Extension Period|Other than specified|0|||
125187365|NCT02946463|450305188|FG000|Extension Period|Physician Decision|1|||
125187366|NCT02946463|450305189|FG001|Extension Period|Physician Decision|4|||
125187367|NCT02946463|450305190|FG002|Extension Period|Physician Decision|0|||
125187368|NCT02946463|450305191|FG003|Extension Period|Physician Decision|0|||
125187369|NCT02946463|450305188|FG000|Extension Period|Pregnancy|3|||
125187370|NCT02946463|450305189|FG001|Extension Period|Pregnancy|1|||
125187371|NCT02946463|450305190|FG002|Extension Period|Pregnancy|0|||
125187372|NCT02946463|450305191|FG003|Extension Period|Pregnancy|0|||
125187373|NCT02946463|450305188|FG000|Extension Period|Adverse Event|1|||
125187374|NCT02946463|450305189|FG001|Extension Period|Adverse Event|2|||
125187375|NCT02946463|450305190|FG002|Extension Period|Adverse Event|0|||
125187376|NCT02946463|450305191|FG003|Extension Period|Adverse Event|0|||
125187377|NCT02946463|450305188|FG000|Extension Period|Lost to Follow-up|1|||
125187378|NCT02946463|450305189|FG001|Extension Period|Lost to Follow-up|0|||
125187379|NCT02946463|450305190|FG002|Extension Period|Lost to Follow-up|0|||
125187380|NCT02946463|450305191|FG003|Extension Period|Lost to Follow-up|0|||
125187381|NCT01383174|450305192|FG000|3 Month Assessment|Death|0|||
125187382|NCT01383174|450305193|FG001|3 Month Assessment|Death|1|||
125187383|NCT01383174|450305192|FG000|3 Month Assessment|Lost to Follow-up|2|||
125187384|NCT01383174|450305193|FG001|3 Month Assessment|Lost to Follow-up|0|||
125187385|NCT01383174|450305192|FG000|3 Month Assessment|Refused to complete|4|||
125187386|NCT01383174|450305193|FG001|3 Month Assessment|Refused to complete|0|||
125187387|NCT01383174|450305192|FG000|6 Month Assessment|Lost to Follow-up|1|||
125187388|NCT01383174|450305193|FG001|6 Month Assessment|Lost to Follow-up|1|||
125187389|NCT01383174|450305192|FG000|6 Month Assessment|Refused to complete|4|||
125187390|NCT01383174|450305193|FG001|6 Month Assessment|Refused to complete|0|||
125187391|NCT02169271|450305194|FG000|Overall Study|Protocol Violation|1|||
125187392|NCT02169271|450305195|FG001|Overall Study|Protocol Violation|2|||
125187393|NCT04616612|450305196|FG000|Overall Study|Lost to Follow-up|6|||
125393031|NCT02641379|451072557|FG006|Overall Study|PCR positive at Week 28|0|||
125393032|NCT02641379|451072558|FG007|Overall Study|PCR positive at Week 28|0|||
125393033|NCT02641379|451072559|FG008|Overall Study|PCR positive at Week 28|0|||
125393034|NCT02641379|451072560|FG009|Overall Study|PCR positive at Week 28|0|||
125393035|NCT02641379|451072561|FG010|Overall Study|PCR positive at Week 28|0|||
125393036|NCT02641379|451072551|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
125393037|NCT02641379|451072552|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
125393038|NCT02641379|451072553|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
125393039|NCT02641379|451072554|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
125393040|NCT02641379|451072555|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
125393041|NCT02641379|451072556|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
125393042|NCT02641379|451072557|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
125393043|NCT02641379|451072558|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
125393044|NCT02641379|451072559|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
125393045|NCT02641379|451072560|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
125393046|NCT02641379|451072561|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
125393047|NCT02641379|451072551|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
125393048|NCT02641379|451072552|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
125393049|NCT02641379|451072553|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
125393050|NCT02641379|451072554|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
125393051|NCT02641379|451072555|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
125393052|NCT02641379|451072556|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
125393053|NCT02641379|451072557|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
125393054|NCT02641379|451072558|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
125393055|NCT02641379|451072559|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
125393056|NCT02641379|451072560|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
125393057|NCT02641379|451072561|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
125241697|NCT01202591|450508377|FG000|Overall Study|Other reason as per investigator|3|||
125241698|NCT01202591|450508378|FG001|Overall Study|Other reason as per investigator|4|||
125241699|NCT01202591|450508379|FG002|Overall Study|Other reason as per investigator|7|||
125241700|NCT01202591|450508380|FG003|Overall Study|Other reason as per investigator|3|||
125241701|NCT01202591|450508381|FG004|Overall Study|Other reason as per investigator|1|||
125241702|NCT01202591|450508382|FG005|Overall Study|Other reason as per investigator|3|||
125241703|NCT01202591|450508377|FG000|Overall Study|Withdrawal by Subject|0|||
125241704|NCT01202591|450508378|FG001|Overall Study|Withdrawal by Subject|0|||
125241705|NCT01202591|450508379|FG002|Overall Study|Withdrawal by Subject|0|||
125241706|NCT01202591|450508380|FG003|Overall Study|Withdrawal by Subject|0|||
125241707|NCT01202591|450508381|FG004|Overall Study|Withdrawal by Subject|2|||
125241708|NCT01202591|450508382|FG005|Overall Study|Withdrawal by Subject|1|||
125241709|NCT01202591|450508377|FG000|Overall Study|Objective Disease Progression|0|||
125241710|NCT01202591|450508378|FG001|Overall Study|Objective Disease Progression|0|||
125241711|NCT01202591|450508379|FG002|Overall Study|Objective Disease Progression|0|||
125241712|NCT01202591|450508380|FG003|Overall Study|Objective Disease Progression|0|||
125241713|NCT01202591|450508381|FG004|Overall Study|Objective Disease Progression|2|||
125241714|NCT01202591|450508382|FG005|Overall Study|Objective Disease Progression|0|||
125241715|NCT02830087|450508387|FG000|Overall Study|No study staff to follow-up patients|4|||
125241716|NCT02830087|450508388|FG001|Overall Study|No study staff to follow-up patients|4|||
125241717|NCT02830087|450508389|FG002|Overall Study|No study staff to follow-up patients|4|||
125241718|NCT02830087|450508390|FG003|Overall Study|No study staff to follow-up patients|3|||
125241719|NCT02830087|450508391|FG004|Overall Study|No study staff to follow-up patients|3|||
125241720|NCT02830087|450508392|FG005|Overall Study|No study staff to follow-up patients|3|||
125241721|NCT02583269|450508393|FG000|Overall Study|Patient hospitalized prior to start|1|||
125241722|NCT02583269|450508394|FG001|Overall Study|Patient hospitalized prior to start|0|||
125241723|NCT02583269|450508395|FG002|Overall Study|Patient hospitalized prior to start|0|||
125241724|NCT02583269|450508396|FG003|Overall Study|Patient hospitalized prior to start|0|||
125393058|NCT02641379|451072551|FG000|Overall Study|Baseline viral load unavailable|0|||
125393059|NCT02641379|451072552|FG001|Overall Study|Baseline viral load unavailable|0|||
125393060|NCT02641379|451072553|FG002|Overall Study|Baseline viral load unavailable|0|||
125393061|NCT02641379|451072554|FG003|Overall Study|Baseline viral load unavailable|1|||
125393062|NCT02641379|451072555|FG004|Overall Study|Baseline viral load unavailable|0|||
125393063|NCT02641379|451072556|FG005|Overall Study|Baseline viral load unavailable|0|||
125241725|NCT02583269|450508397|FG004|Overall Study|Patient hospitalized prior to start|0|||
125241726|NCT03611946|450508401|FG000|Overall Study|Withdrawal by Subject|0|||
125241727|NCT03611946|450508402|FG001|Overall Study|Withdrawal by Subject|0|||
125241728|NCT03611946|450508403|FG002|Overall Study|Withdrawal by Subject|1|||
125241729|NCT03611946|450508404|FG003|Overall Study|Withdrawal by Subject|0|||
125241730|NCT03580928|450508410|FG000|Overall Study|Death|0|||
125241731|NCT03580928|450508411|FG001|Overall Study|Death|3|||
125241732|NCT03580928|450508410|FG000|Overall Study|Withdrawal by Subject|2|||
125393064|NCT02641379|451072557|FG006|Overall Study|Baseline viral load unavailable|0|||
125393065|NCT02641379|451072558|FG007|Overall Study|Baseline viral load unavailable|0|||
125241733|NCT03580928|450508411|FG001|Overall Study|Withdrawal by Subject|1|||
125393066|NCT02641379|451072559|FG008|Overall Study|Baseline viral load unavailable|0|||
125393067|NCT02641379|451072560|FG009|Overall Study|Baseline viral load unavailable|0|||
125393068|NCT02641379|451072561|FG010|Overall Study|Baseline viral load unavailable|0|||
125393069|NCT02641379|451072551|FG000|Overall Study|Blood could not be drawn|0|||
125393070|NCT02641379|451072552|FG001|Overall Study|Blood could not be drawn|0|||
125393071|NCT02641379|451072553|FG002|Overall Study|Blood could not be drawn|0|||
125393072|NCT02641379|451072554|FG003|Overall Study|Blood could not be drawn|0|||
125393073|NCT02641379|451072555|FG004|Overall Study|Blood could not be drawn|1|||
125393074|NCT02641379|451072556|FG005|Overall Study|Blood could not be drawn|0|||
125393075|NCT02641379|451072557|FG006|Overall Study|Blood could not be drawn|0|||
125393076|NCT02641379|451072558|FG007|Overall Study|Blood could not be drawn|0|||
125393077|NCT02641379|451072559|FG008|Overall Study|Blood could not be drawn|0|||
125393078|NCT02641379|451072560|FG009|Overall Study|Blood could not be drawn|0|||
125393079|NCT02641379|451072561|FG010|Overall Study|Blood could not be drawn|0|||
125393080|NCT02641379|451072551|FG000|Overall Study|Protocol Violation|0|||
125393081|NCT02641379|451072552|FG001|Overall Study|Protocol Violation|0|||
125393082|NCT02641379|451072553|FG002|Overall Study|Protocol Violation|0|||
125393083|NCT02641379|451072554|FG003|Overall Study|Protocol Violation|0|||
125393084|NCT02641379|451072555|FG004|Overall Study|Protocol Violation|2|||
125393085|NCT02641379|451072556|FG005|Overall Study|Protocol Violation|0|||
125393086|NCT02641379|451072557|FG006|Overall Study|Protocol Violation|0|||
125393087|NCT02641379|451072558|FG007|Overall Study|Protocol Violation|0|||
125393088|NCT02641379|451072559|FG008|Overall Study|Protocol Violation|1|||
125393089|NCT02641379|451072560|FG009|Overall Study|Protocol Violation|0|||
125393090|NCT02641379|451072561|FG010|Overall Study|Protocol Violation|0|||
125393091|NCT02641379|451072551|FG000|Overall Study|Participation in sili rescue study|0|||
125393092|NCT02641379|451072552|FG001|Overall Study|Participation in sili rescue study|0|||
125393093|NCT02641379|451072553|FG002|Overall Study|Participation in sili rescue study|0|||
125393094|NCT02641379|451072554|FG003|Overall Study|Participation in sili rescue study|0|||
125393095|NCT02641379|451072555|FG004|Overall Study|Participation in sili rescue study|0|||
125393096|NCT02641379|451072556|FG005|Overall Study|Participation in sili rescue study|1|||
125393097|NCT02641379|451072557|FG006|Overall Study|Participation in sili rescue study|0|||
125393098|NCT02641379|451072558|FG007|Overall Study|Participation in sili rescue study|0|||
125393099|NCT02641379|451072559|FG008|Overall Study|Participation in sili rescue study|0|||
125393100|NCT02641379|451072560|FG009|Overall Study|Participation in sili rescue study|0|||
125393101|NCT02641379|451072561|FG010|Overall Study|Participation in sili rescue study|0|||
125393102|NCT02641379|451072551|FG000|Overall Study|Lost to Follow-up|0|||
125393103|NCT02641379|451072552|FG001|Overall Study|Lost to Follow-up|0|||
125393104|NCT02641379|451072553|FG002|Overall Study|Lost to Follow-up|0|||
125393105|NCT02641379|451072554|FG003|Overall Study|Lost to Follow-up|0|||
125393106|NCT02641379|451072555|FG004|Overall Study|Lost to Follow-up|0|||
125393107|NCT02641379|451072556|FG005|Overall Study|Lost to Follow-up|0|||
125393108|NCT02641379|451072557|FG006|Overall Study|Lost to Follow-up|0|||
125393109|NCT02641379|451072558|FG007|Overall Study|Lost to Follow-up|0|||
125393110|NCT02641379|451072559|FG008|Overall Study|Lost to Follow-up|1|||
125393111|NCT02641379|451072560|FG009|Overall Study|Lost to Follow-up|0|||
125393112|NCT02641379|451072561|FG010|Overall Study|Lost to Follow-up|0|||
125393113|NCT02641379|451072551|FG000|Overall Study|Source data not found|0|||
125393114|NCT02641379|451072552|FG001|Overall Study|Source data not found|0|||
125393115|NCT02641379|451072553|FG002|Overall Study|Source data not found|0|||
125393116|NCT02641379|451072554|FG003|Overall Study|Source data not found|0|||
125393117|NCT02641379|451072555|FG004|Overall Study|Source data not found|0|||
125393118|NCT02641379|451072556|FG005|Overall Study|Source data not found|1|||
125393119|NCT02641379|451072557|FG006|Overall Study|Source data not found|0|||
125393120|NCT02641379|451072558|FG007|Overall Study|Source data not found|0|||
125393121|NCT02641379|451072559|FG008|Overall Study|Source data not found|0|||
125393122|NCT02641379|451072560|FG009|Overall Study|Source data not found|0|||
125393123|NCT02641379|451072561|FG010|Overall Study|Source data not found|0|||
125393124|NCT02641379|451072551|FG000|Overall Study|Participant showed weight reduction|0|||
125393125|NCT02641379|451072552|FG001|Overall Study|Participant showed weight reduction|0|||
125393126|NCT02641379|451072553|FG002|Overall Study|Participant showed weight reduction|0|||
125393127|NCT02641379|451072554|FG003|Overall Study|Participant showed weight reduction|0|||
125393128|NCT02641379|451072555|FG004|Overall Study|Participant showed weight reduction|0|||
125393129|NCT02641379|451072556|FG005|Overall Study|Participant showed weight reduction|0|||
125393130|NCT02641379|451072557|FG006|Overall Study|Participant showed weight reduction|0|||
125393131|NCT02641379|451072558|FG007|Overall Study|Participant showed weight reduction|1|||
125393132|NCT02641379|451072559|FG008|Overall Study|Participant showed weight reduction|0|||
125393133|NCT02641379|451072560|FG009|Overall Study|Participant showed weight reduction|0|||
125393134|NCT02641379|451072561|FG010|Overall Study|Participant showed weight reduction|0|||
125393135|NCT02641379|451072551|FG000|Overall Study|Non-response Week 12|0|||
125393136|NCT02641379|451072552|FG001|Overall Study|Non-response Week 12|0|||
125393137|NCT02641379|451072553|FG002|Overall Study|Non-response Week 12|0|||
125241734|NCT03580928|450508410|FG000|Overall Study|Lost to Follow-up|2|||
125393138|NCT02641379|451072554|FG003|Overall Study|Non-response Week 12|0|||
125393139|NCT02641379|451072555|FG004|Overall Study|Non-response Week 12|0|||
125393140|NCT02641379|451072556|FG005|Overall Study|Non-response Week 12|0|||
125393141|NCT02641379|451072557|FG006|Overall Study|Non-response Week 12|0|||
125393142|NCT02641379|451072558|FG007|Overall Study|Non-response Week 12|1|||
125393143|NCT02641379|451072559|FG008|Overall Study|Non-response Week 12|0|||
125393144|NCT02641379|451072560|FG009|Overall Study|Non-response Week 12|0|||
125393145|NCT02641379|451072561|FG010|Overall Study|Non-response Week 12|0|||
125393146|NCT02641379|451072551|FG000|Overall Study|No 2 Log drop at Week 12|0|||
125393147|NCT02641379|451072552|FG001|Overall Study|No 2 Log drop at Week 12|0|||
125393148|NCT02641379|451072553|FG002|Overall Study|No 2 Log drop at Week 12|0|||
125187394|NCT04616612|450305197|FG001|Overall Study|Lost to Follow-up|3|||
125187395|NCT01597973|450305198|FG000|Overall Study|Found ineligible before study medication started|4|||
125187396|NCT01597973|450305199|FG001|Overall Study|Found ineligible before study medication started|2|||
125187397|NCT01597973|450305198|FG000|Overall Study|Eligible pathogen not confirmed|14|||
125187398|NCT01597973|450305199|FG001|Overall Study|Eligible pathogen not confirmed|15|||
125187399|NCT01597973|450305198|FG000|Overall Study|LAR not authorized to consent|0|||
125187400|NCT01597973|450305199|FG001|Overall Study|LAR not authorized to consent|1|||
125187401|NCT01597973|450305198|FG000|Overall Study|Ineligible due to early seizures|1|||
125187402|NCT01597973|450305199|FG001|Overall Study|Ineligible due to early seizures|0|||
125187403|NCT01597973|450305198|FG000|Overall Study|Ineligible due to non-target infection|1|||
125187404|NCT01597973|450305199|FG001|Overall Study|Ineligible due to non-target infection|1|||
125187405|NCT02208362|450305200|FG000|Overall Study|Participant did not complete treatment|0|||
125187406|NCT02208362|450305201|FG001|Overall Study|Participant did not complete treatment|1|||
125187407|NCT02208362|450305202|FG002|Overall Study|Participant did not complete treatment|0|||
125187408|NCT02208362|450305203|FG003|Overall Study|Participant did not complete treatment|0|||
125187409|NCT02208362|450305204|FG004|Overall Study|Participant did not complete treatment|0|||
125187410|NCT02208362|450305205|FG005|Overall Study|Participant did not complete treatment|0|||
125187411|NCT02208362|450305206|FG006|Overall Study|Participant did not complete treatment|1|||
125187412|NCT02208362|450305207|FG007|Overall Study|Participant did not complete treatment|1|||
125187413|NCT02208362|450305208|FG008|Overall Study|Participant did not complete treatment|2|||
125187414|NCT02208362|450305209|FG009|Overall Study|Participant did not complete treatment|0|||
125187415|NCT02208362|450305210|FG010|Overall Study|Participant did not complete treatment|1|||
125187416|NCT02208362|450305211|FG011|Overall Study|Participant did not complete treatment|0|||
125187417|NCT02208362|450305200|FG000|Overall Study|Participant received disallowed treatment|0|||
125187418|NCT02208362|450305201|FG001|Overall Study|Participant received disallowed treatment|0|||
125187419|NCT02208362|450305202|FG002|Overall Study|Participant received disallowed treatment|0|||
125187420|NCT02208362|450305203|FG003|Overall Study|Participant received disallowed treatment|0|||
125187421|NCT02208362|450305204|FG004|Overall Study|Participant received disallowed treatment|0|||
125187422|NCT02208362|450305205|FG005|Overall Study|Participant received disallowed treatment|0|||
125187423|NCT02208362|450305206|FG006|Overall Study|Participant received disallowed treatment|0|||
125187424|NCT02208362|450305207|FG007|Overall Study|Participant received disallowed treatment|0|||
125187425|NCT02208362|450305208|FG008|Overall Study|Participant received disallowed treatment|1|||
125187426|NCT02208362|450305209|FG009|Overall Study|Participant received disallowed treatment|0|||
125187427|NCT02208362|450305210|FG010|Overall Study|Participant received disallowed treatment|0|||
125187428|NCT02208362|450305211|FG011|Overall Study|Participant received disallowed treatment|0|||
125187429|NCT04281485|450306558|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
125187430|NCT04281485|450306559|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
125187431|NCT04281485|450306558|FG000|Overall Study|Ongoing (Safety data collection)|10|||
125187432|NCT04281485|450306559|FG001|Overall Study|Ongoing (Safety data collection)|5|||
125187433|NCT02393950|450306563|FG000|Overall Study|Adverse Event|1|||
125187434|NCT02393950|450306564|FG001|Overall Study|Adverse Event|0|||
125187435|NCT02393950|450306563|FG000|Overall Study|Withdrawal by Subject|0|||
125187436|NCT02393950|450306564|FG001|Overall Study|Withdrawal by Subject|1|||
125187437|NCT04335123|450306565|FG000|Overall Study|Withdrawal by Subject|2|||
125187438|NCT04335123|450306566|FG001|Overall Study|Withdrawal by Subject|0|||
125187439|NCT04335123|450306565|FG000|Overall Study|Physician Decision|2|||
125187440|NCT04335123|450306566|FG001|Overall Study|Physician Decision|0|||
125187441|NCT01293695|450306569|FG000|Overall Study|Withdrawal by Subject|7|||
125187442|NCT01293695|450306570|FG001|Overall Study|Withdrawal by Subject|1|||
125187443|NCT01293695|450306569|FG000|Overall Study|Lost to Follow-up|8|||
125187444|NCT01293695|450306570|FG001|Overall Study|Lost to Follow-up|6|||
125187445|NCT02626026|450306571|FG000|Overall Study|Randomized but Never Treated|0|||
125187446|NCT02626026|450306572|FG001|Overall Study|Randomized but Never Treated|0|||
125187447|NCT02626026|450306573|FG002|Overall Study|Randomized but Never Treated|0|||
125187448|NCT02626026|450306574|FG003|Overall Study|Randomized but Never Treated|0|||
125187449|NCT02626026|450306575|FG004|Overall Study|Randomized but Never Treated|1|||
125187450|NCT02626026|450306576|FG005|Overall Study|Randomized but Never Treated|0|||
125187451|NCT00191477|450306578|FG000|Overall Study|Tumor Recurrence|49|||
125187452|NCT00191477|450306579|FG001|Overall Study|Tumor Recurrence|48|||
125187453|NCT00191477|450306578|FG000|Overall Study|Death, Study Disease|1|||
125241735|NCT03580928|450508411|FG001|Overall Study|Lost to Follow-up|0|||
125241736|NCT03580928|450508410|FG000|Overall Study|Progressive Disease|0|||
125241737|NCT03580928|450508411|FG001|Overall Study|Progressive Disease|1|||
125241738|NCT05800145|450508412|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
125241739|NCT05800145|450508413|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125241740|NCT05800145|450508414|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125241741|NCT05800145|450508415|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
125241742|NCT05800145|450508416|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125241743|NCT05800145|450508417|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125241744|NCT05800145|450508412|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
125241745|NCT05800145|450508413|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
125241746|NCT05800145|450508414|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
125241747|NCT05800145|450508415|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
125241748|NCT05800145|450508416|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
125241749|NCT05800145|450508417|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
125241750|NCT05800145|450508412|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
125241751|NCT05800145|450508413|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
125241752|NCT05800145|450508414|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
125241753|NCT05800145|450508415|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
125241754|NCT05800145|450508416|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
125241755|NCT05800145|450508417|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
125241756|NCT02850406|450508418|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241757|NCT02850406|450508419|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241758|NCT02850406|450508420|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241759|NCT02850406|450508421|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
125241760|NCT02850406|450508422|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241761|NCT02850406|450508423|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241762|NCT02850406|450508424|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241763|NCT02850406|450508425|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
125241764|NCT02850406|450508418|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
125241765|NCT02850406|450508419|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
125241766|NCT02850406|450508420|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
125241767|NCT02850406|450508421|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
125241768|NCT02850406|450508422|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
125241769|NCT02850406|450508423|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
125241770|NCT02850406|450508424|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
125241771|NCT02850406|450508425|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
125241772|NCT02850406|450508418|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241773|NCT02850406|450508419|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241774|NCT02850406|450508420|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
125241775|NCT02850406|450508421|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241776|NCT02850406|450508422|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241777|NCT02850406|450508423|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241778|NCT02850406|450508424|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241779|NCT02850406|450508425|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
125241780|NCT02850406|450508418|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
125241781|NCT02850406|450508419|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
125241782|NCT02850406|450508420|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
125241783|NCT02850406|450508421|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
125241784|NCT02850406|450508422|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
125241785|NCT02850406|450508423|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
125241786|NCT02850406|450508424|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
125241787|NCT02850406|450508425|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
125241788|NCT02850406|450508418|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
125241789|NCT02850406|450508419|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
125241790|NCT02850406|450508420|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
125241791|NCT02850406|450508421|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
125241792|NCT02850406|450508422|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
125241793|NCT02850406|450508423|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
125241794|NCT02850406|450508424|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
125241795|NCT02850406|450508425|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
125241796|NCT02850406|450508418|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241797|NCT02850406|450508419|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241798|NCT02850406|450508420|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241799|NCT02850406|450508421|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241800|NCT02850406|450508422|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
125241801|NCT02850406|450508423|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
125241802|NCT02850406|450508424|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241803|NCT02850406|450508425|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241804|NCT02850406|450508418|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241805|NCT02850406|450508419|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241806|NCT02850406|450508420|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241807|NCT02850406|450508421|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241808|NCT02850406|450508422|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
125241809|NCT02850406|450508423|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241810|NCT02850406|450508424|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241811|NCT02850406|450508425|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
125241812|NCT02850406|450508418|FG000|Part C (Up to 52 Weeks)|Other|0|||
125241813|NCT02850406|450508419|FG001|Part C (Up to 52 Weeks)|Other|0|||
125241814|NCT02850406|450508420|FG002|Part C (Up to 52 Weeks)|Other|0|||
125241815|NCT02850406|450508421|FG003|Part C (Up to 52 Weeks)|Other|0|||
125241816|NCT02850406|450508422|FG004|Part C (Up to 52 Weeks)|Other|1|||
125241817|NCT02850406|450508423|FG005|Part C (Up to 52 Weeks)|Other|3|||
125241818|NCT02850406|450508424|FG006|Part C (Up to 52 Weeks)|Other|0|||
125241819|NCT02850406|450508425|FG007|Part C (Up to 52 Weeks)|Other|0|||
125241820|NCT02850406|450508418|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241821|NCT02850406|450508419|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241822|NCT02850406|450508420|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241823|NCT02850406|450508421|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241824|NCT02850406|450508422|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241825|NCT02850406|450508423|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241826|NCT02850406|450508424|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
125241827|NCT02850406|450508425|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
125241828|NCT02850406|450508418|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241829|NCT02850406|450508419|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241830|NCT02850406|450508420|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241831|NCT02850406|450508421|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241832|NCT02850406|450508422|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241833|NCT02850406|450508423|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241834|NCT02850406|450508424|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
125241835|NCT02850406|450508425|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
125241836|NCT02850406|450508418|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
125241837|NCT02850406|450508419|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
125241838|NCT02850406|450508420|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
125241839|NCT02850406|450508421|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
125241840|NCT02850406|450508422|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
125241841|NCT02850406|450508423|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
125241842|NCT02850406|450508424|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
125241843|NCT02850406|450508425|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
125241844|NCT02850406|450508418|FG000|Part D (Up to 52 Weeks)|Other|0|||
125241845|NCT02850406|450508419|FG001|Part D (Up to 52 Weeks)|Other|0|||
125241846|NCT02850406|450508420|FG002|Part D (Up to 52 Weeks)|Other|0|||
125241847|NCT02850406|450508421|FG003|Part D (Up to 52 Weeks)|Other|0|||
125241848|NCT02850406|450508422|FG004|Part D (Up to 52 Weeks)|Other|0|||
125241849|NCT02850406|450508423|FG005|Part D (Up to 52 Weeks)|Other|0|||
125241850|NCT02850406|450508424|FG006|Part D (Up to 52 Weeks)|Other|0|||
125241851|NCT02850406|450508425|FG007|Part D (Up to 52 Weeks)|Other|1|||
125241852|NCT04167670|450509580|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
125241853|NCT04167670|450509581|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
125241854|NCT04167670|450509582|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
125241855|NCT04167670|450509580|FG000|Overall Study|Significant protocol deviation|3|||
125241856|NCT04167670|450509581|FG001|Overall Study|Significant protocol deviation|1|||
125241857|NCT04167670|450509582|FG002|Overall Study|Significant protocol deviation|0|||
125241858|NCT04167670|450509580|FG000|Overall Study|Lost to Follow-up|0|||
125241859|NCT04167670|450509581|FG001|Overall Study|Lost to Follow-up|3|||
125241860|NCT04167670|450509582|FG002|Overall Study|Lost to Follow-up|3|||
125241861|NCT04167670|450509580|FG000|Overall Study|Voluntary Withdrawal|0|||
125241862|NCT04167670|450509581|FG001|Overall Study|Voluntary Withdrawal|1|||
125241863|NCT04167670|450509582|FG002|Overall Study|Voluntary Withdrawal|1|||
125241864|NCT04167670|450509580|FG000|Overall Study|Withdrawal of Consent|4|||
125241865|NCT04167670|450509581|FG001|Overall Study|Withdrawal of Consent|1|||
125241866|NCT04167670|450509582|FG002|Overall Study|Withdrawal of Consent|3|||
125241867|NCT04167670|450509580|FG000|Overall Study|Miscellaneous|7|||
125241868|NCT04167670|450509581|FG001|Overall Study|Miscellaneous|5|||
125241869|NCT04167670|450509582|FG002|Overall Study|Miscellaneous|3|||
125241870|NCT00587457|450509587|FG000|Overall Study|Adverse Event|1|||
125241871|NCT00587457|450509588|FG001|Overall Study|Adverse Event|2|||
125241872|NCT00587457|450509589|FG002|Overall Study|Adverse Event|1|||
125241873|NCT00587457|450509587|FG000|Overall Study|Disease progression|2|||
125241874|NCT00587457|450509588|FG001|Overall Study|Disease progression|0|||
125241875|NCT00587457|450509589|FG002|Overall Study|Disease progression|2|||
125241876|NCT00587457|450509587|FG000|Overall Study|Initiation of alternative therapy|0|||
125241877|NCT00587457|450509588|FG001|Overall Study|Initiation of alternative therapy|1|||
125241878|NCT00587457|450509589|FG002|Overall Study|Initiation of alternative therapy|0|||
125241879|NCT00587457|450509587|FG000|Overall Study|Undefined|0|||
125241880|NCT00587457|450509588|FG001|Overall Study|Undefined|0|||
125241881|NCT00587457|450509589|FG002|Overall Study|Undefined|1|||
125393149|NCT02641379|451072554|FG003|Overall Study|No 2 Log drop at Week 12|0|||
125393150|NCT02641379|451072555|FG004|Overall Study|No 2 Log drop at Week 12|0|||
125393151|NCT02641379|451072556|FG005|Overall Study|No 2 Log drop at Week 12|0|||
125393152|NCT02641379|451072557|FG006|Overall Study|No 2 Log drop at Week 12|0|||
125393153|NCT02641379|451072558|FG007|Overall Study|No 2 Log drop at Week 12|0|||
125241882|NCT00587457|450509587|FG000|Overall Study|Development of neutralizing Abs|0|||
125241883|NCT00587457|450509588|FG001|Overall Study|Development of neutralizing Abs|0|||
125241884|NCT00587457|450509589|FG002|Overall Study|Development of neutralizing Abs|1|||
125241885|NCT00876395|450509590|FG000|Overall Study|Untreated|8|||
125241886|NCT00876395|450509591|FG001|Overall Study|Untreated|1|||
125241887|NCT00876395|450509590|FG000|Overall Study|Adverse Event|63|||
125241888|NCT00876395|450509591|FG001|Overall Study|Adverse Event|11|||
125241889|NCT00876395|450509590|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125241890|NCT00876395|450509591|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125241891|NCT00876395|450509590|FG000|Overall Study|Disease progression|259|||
125241892|NCT00876395|450509591|FG001|Overall Study|Disease progression|162|||
125241893|NCT00876395|450509590|FG000|Overall Study|New cancer therapy|25|||
125241894|NCT00876395|450509591|FG001|Overall Study|New cancer therapy|7|||
125241895|NCT00876395|450509590|FG000|Overall Study|Protocol Violation|5|||
125241896|NCT00876395|450509591|FG001|Overall Study|Protocol Violation|2|||
125241897|NCT00876395|450509590|FG000|Overall Study|Withdrawal by Subject|66|||
125241898|NCT00876395|450509591|FG001|Overall Study|Withdrawal by Subject|33|||
125241899|NCT00876395|450509590|FG000|Overall Study|Lost to Follow-up|2|||
125241900|NCT00876395|450509591|FG001|Overall Study|Lost to Follow-up|0|||
125241901|NCT00876395|450509590|FG000|Overall Study|Administrative problems|39|||
125241902|NCT00876395|450509591|FG001|Overall Study|Administrative problems|23|||
125241903|NCT00876395|450509590|FG000|Overall Study|Death|12|||
125241904|NCT00876395|450509591|FG001|Overall Study|Death|0|||
125241905|NCT03807843|450509592|FG000|Overall Study|Lost to Follow-up|1|||
125241906|NCT03807843|450509593|FG001|Overall Study|Lost to Follow-up|0|||
125241907|NCT01312129|450509594|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
125241908|NCT01312129|450509595|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
125241909|NCT00924651|450509598|FG000|Overall Study|Chemo started too soon|2|||
125241910|NCT00924651|450509599|FG001|Overall Study|Chemo started too soon|3|||
125241911|NCT00924651|450509598|FG000|Overall Study|No Reason|3|||
125241912|NCT00924651|450509599|FG001|Overall Study|No Reason|7|||
125241913|NCT00924651|450509598|FG000|Overall Study|Overwhelmed|6|||
125241914|NCT00924651|450509599|FG001|Overall Study|Overwhelmed|6|||
125241915|NCT00924651|450509598|FG000|Overall Study|Noncompliant|1|||
125241916|NCT00924651|450509599|FG001|Overall Study|Noncompliant|4|||
125241917|NCT00924651|450509598|FG000|Overall Study|Medical|1|||
125241918|NCT00924651|450509599|FG001|Overall Study|Medical|3|||
125241919|NCT00924651|450509598|FG000|Overall Study|Changed Mind|10|||
125241920|NCT00924651|450509599|FG001|Overall Study|Changed Mind|1|||
125241921|NCT00924651|450509598|FG000|Overall Study|Incomplete Form|2|||
125241922|NCT00924651|450509599|FG001|Overall Study|Incomplete Form|1|||
125241923|NCT00729586|450509600|FG000|Overall Study|Ineligible|0|||
125241924|NCT00729586|450509601|FG001|Overall Study|Ineligible|1|||
125241925|NCT00729586|450509600|FG000|Overall Study|never treated|1|||
125241926|NCT00729586|450509601|FG001|Overall Study|never treated|0|||
125241927|NCT00662259|450509602|FG000|Overall Study|Adverse Event|2|||
125241928|NCT00662259|450509603|FG001|Overall Study|Adverse Event|0|||
125241929|NCT01750346|450509604|FG000|Overall Study|Adverse Event|1|||
125241930|NCT01750346|450509605|FG001|Overall Study|Adverse Event|0|||
125241931|NCT01750346|450509606|FG002|Overall Study|Adverse Event|0|||
125241932|NCT02034591|450509607|FG000|Overall Study|Withdrawal by Subject|0|||
125241933|NCT02034591|450509608|FG001|Overall Study|Withdrawal by Subject|0|||
125241934|NCT02034591|450509609|FG002|Overall Study|Withdrawal by Subject|0|||
125241935|NCT02034591|450509610|FG003|Overall Study|Withdrawal by Subject|0|||
125393154|NCT02641379|451072559|FG008|Overall Study|No 2 Log drop at Week 12|0|||
125393155|NCT02641379|451072560|FG009|Overall Study|No 2 Log drop at Week 12|0|||
125393156|NCT02641379|451072561|FG010|Overall Study|No 2 Log drop at Week 12|1|||
125241936|NCT02034591|450509611|FG004|Overall Study|Withdrawal by Subject|1|||
125241937|NCT02034591|450509612|FG005|Overall Study|Withdrawal by Subject|0|||
125241938|NCT04307394|450509615|FG000|Overall Study|Lost to Follow-up|3|||
125241939|NCT04307394|450509615|FG000|Overall Study|Withdrawal by Subject|2|||
125241940|NCT01121926|450509616|FG000|First Intervention Period|Adverse Event|1|||
125241941|NCT01121926|450509617|FG001|First Intervention Period|Adverse Event|0|||
125393157|NCT02641379|451072551|FG000|Overall Study|Negative PCR result|0|||
125393158|NCT02641379|451072552|FG001|Overall Study|Negative PCR result|0|||
125241942|NCT01121926|450509616|FG000|Washout Period|Adverse Event|0|||
125241943|NCT01121926|450509617|FG001|Washout Period|Adverse Event|1|||
125241944|NCT01121926|450509616|FG000|Washout Period|Positive pregnancy test|0|||
125241945|NCT01121926|450509617|FG001|Washout Period|Positive pregnancy test|1|||
125241946|NCT00416949|450509618|FG000|Overall Study|Patients refused to participate|5|||
125241947|NCT02782468|450509619|FG000|Overall Study|Progressive Disease|2|||
125241948|NCT02782468|450509620|FG001|Overall Study|Progressive Disease|5|||
125241949|NCT02782468|450509621|FG002|Overall Study|Progressive Disease|0|||
125393159|NCT02641379|451072553|FG002|Overall Study|Negative PCR result|0|||
125241950|NCT02782468|450509622|FG003|Overall Study|Progressive Disease|4|||
125241951|NCT02782468|450509619|FG000|Overall Study|Adverse Event|0|||
125241952|NCT02782468|450509620|FG001|Overall Study|Adverse Event|2|||
125241953|NCT02782468|450509621|FG002|Overall Study|Adverse Event|2|||
125241954|NCT02782468|450509622|FG003|Overall Study|Adverse Event|3|||
125241955|NCT02782468|450509619|FG000|Overall Study|Other|0|||
125241956|NCT02782468|450509620|FG001|Overall Study|Other|0|||
125241957|NCT02782468|450509621|FG002|Overall Study|Other|1|||
125241958|NCT02782468|450509622|FG003|Overall Study|Other|1|||
125241959|NCT02782468|450509619|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
125241960|NCT02782468|450509620|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
125241961|NCT02782468|450509621|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
125241962|NCT02782468|450509622|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
125241963|NCT02782468|450509619|FG000|Overall Study|Symptomatic Deterioration|0|||
125241964|NCT02782468|450509620|FG001|Overall Study|Symptomatic Deterioration|0|||
125241965|NCT02782468|450509621|FG002|Overall Study|Symptomatic Deterioration|0|||
125241966|NCT02782468|450509622|FG003|Overall Study|Symptomatic Deterioration|1|||
125241967|NCT02782468|450509619|FG000|Overall Study|Withdrawal by Subject|1|||
125241968|NCT02782468|450509620|FG001|Overall Study|Withdrawal by Subject|0|||
125241969|NCT02782468|450509621|FG002|Overall Study|Withdrawal by Subject|0|||
125241970|NCT02782468|450509622|FG003|Overall Study|Withdrawal by Subject|0|||
125241971|NCT01410604|450509624|FG000|Overall Study|Adverse Event|2|||
125241972|NCT01410604|450509625|FG001|Overall Study|Adverse Event|1|||
125241973|NCT01410604|450509624|FG000|Overall Study|Lost to Follow-up|1|||
125241974|NCT01410604|450509625|FG001|Overall Study|Lost to Follow-up|0|||
125241975|NCT01410604|450509624|FG000|Overall Study|Physician Decision|0|||
125241976|NCT01410604|450509625|FG001|Overall Study|Physician Decision|1|||
125241977|NCT00356590|450509626|FG000|Overall Study|Adverse Event|54|||
125241978|NCT00356590|450509626|FG000|Overall Study|Death|10|||
125241979|NCT00356590|450509626|FG000|Overall Study|Lost to Follow-up|35|||
125241980|NCT00356590|450509626|FG000|Overall Study|Physician Decision|46|||
125241981|NCT00356590|450509626|FG000|Overall Study|Withdrawal by Subject|41|||
125241982|NCT00356590|450509626|FG000|Overall Study|Completed month 12 only|2|||
125241983|NCT00356590|450509626|FG000|Overall Study|Protocol issues|6|||
125241984|NCT00356590|450509626|FG000|Overall Study|Response status|28|||
125241985|NCT00356590|450509626|FG000|Overall Study|Other|52|||
125241986|NCT00898807|450509634|FG000|Overall Study|Withdrawal by Subject|5|||
125241987|NCT00898807|450509635|FG001|Overall Study|Withdrawal by Subject|3|||
125241988|NCT00898807|450509634|FG000|Overall Study|Family pressure to discontinue|2|||
125241989|NCT00898807|450509635|FG001|Overall Study|Family pressure to discontinue|2|||
125241990|NCT00898807|450509634|FG000|Overall Study|Lost to Follow-up|1|||
125241991|NCT00898807|450509635|FG001|Overall Study|Lost to Follow-up|3|||
125241992|NCT00898807|450509634|FG000|Overall Study|Death|0|||
125241993|NCT00898807|450509635|FG001|Overall Study|Death|1|||
125241994|NCT04919161|450509636|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
125241995|NCT04919161|450509637|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
125241996|NCT04919161|450509636|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
125241997|NCT04919161|450509637|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
125241998|NCT04919161|450509636|FG000|Overall Study|Acute ankle sprain after session 1|0|||
125241999|NCT04919161|450509637|FG001|Overall Study|Acute ankle sprain after session 1|1|||
125242000|NCT00712920|450509638|FG000|Overall Study|Adverse Event|3|||
125242001|NCT00712920|450509639|FG001|Overall Study|Adverse Event|4|||
125242002|NCT00712920|450509640|FG002|Overall Study|Adverse Event|7|||
125242003|NCT00712920|450509638|FG000|Overall Study|Withdrawal by Subject|4|||
125242004|NCT00712920|450509639|FG001|Overall Study|Withdrawal by Subject|2|||
125242005|NCT00712920|450509640|FG002|Overall Study|Withdrawal by Subject|1|||
125242006|NCT00712920|450509638|FG000|Overall Study|Lost to Follow-up|1|||
125242007|NCT00712920|450509639|FG001|Overall Study|Lost to Follow-up|4|||
125242008|NCT00712920|450509640|FG002|Overall Study|Lost to Follow-up|0|||
125242009|NCT00712920|450509638|FG000|Overall Study|Lack of Efficacy|1|||
125242010|NCT00712920|450509639|FG001|Overall Study|Lack of Efficacy|0|||
125242011|NCT00712920|450509640|FG002|Overall Study|Lack of Efficacy|1|||
125242012|NCT00712920|450509638|FG000|Overall Study|Other|5|||
125242013|NCT00712920|450509639|FG001|Overall Study|Other|7|||
125242014|NCT00712920|450509640|FG002|Overall Study|Other|3|||
125242015|NCT00712920|450509638|FG000|Overall Study|Non-compliance|3|||
125242016|NCT00712920|450509639|FG001|Overall Study|Non-compliance|0|||
125242017|NCT00712920|450509640|FG002|Overall Study|Non-compliance|0|||
125242018|NCT02489773|450509641|FG000|Overall Study|Lost to Follow-up|4|||
125242019|NCT02489773|450509642|FG001|Overall Study|Lost to Follow-up|1|||
125242020|NCT02489773|450509641|FG000|Overall Study|Physician Decision|1|||
125242021|NCT02489773|450509642|FG001|Overall Study|Physician Decision|0|||
125242022|NCT02489773|450509641|FG000|Overall Study|Withdrawal by Subject|1|||
125242023|NCT02489773|450509642|FG001|Overall Study|Withdrawal by Subject|0|||
125393160|NCT02641379|451072554|FG003|Overall Study|Negative PCR result|0|||
125242024|NCT02489773|450509641|FG000|Overall Study|Leave the country or the state|1|||
125393161|NCT02641379|451072555|FG004|Overall Study|Negative PCR result|0|||
125187454|NCT00191477|450306579|FG001|Overall Study|Death, Study Disease|1|||
125187455|NCT00191477|450306578|FG000|Overall Study|Death, Other Cause|3|||
125187456|NCT00191477|450306579|FG001|Overall Study|Death, Other Cause|6|||
125187457|NCT00191477|450306578|FG000|Overall Study|Lost to Follow-up|23|||
125187458|NCT00191477|450306579|FG001|Overall Study|Lost to Follow-up|21|||
125187459|NCT00191477|450306578|FG000|Overall Study|Protocol Violation|1|||
125187460|NCT00191477|450306579|FG001|Overall Study|Protocol Violation|1|||
125187461|NCT00191477|450306578|FG000|Overall Study|Treatment Change|2|||
125187462|NCT00191477|450306579|FG001|Overall Study|Treatment Change|0|||
125187463|NCT00191477|450306578|FG000|Overall Study|Withdrawal by Subject|2|||
125187464|NCT00191477|450306579|FG001|Overall Study|Withdrawal by Subject|0|||
125187465|NCT00191477|450306578|FG000|Overall Study|Other|2|||
125187466|NCT00191477|450306579|FG001|Overall Study|Other|0|||
125187467|NCT00191477|450306578|FG000|Overall Study|Not Eligible|41|||
125187468|NCT00191477|450306579|FG001|Overall Study|Not Eligible|38|||
125187469|NCT00191477|450306578|FG000|Overall Study|Pathological Specimen Lost|1|||
125187470|NCT00191477|450306579|FG001|Overall Study|Pathological Specimen Lost|0|||
125187471|NCT00191477|450306578|FG000|Overall Study|Discontinued Prior to Instillation|13|||
125187472|NCT00191477|450306579|FG001|Overall Study|Discontinued Prior to Instillation|14|||
125187473|NCT03922308|450306584|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
125187474|NCT03922308|450306585|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
125187475|NCT03922308|450306586|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
125187476|NCT03922308|450306584|FG000|Overall Study|Lost to Follow-up|1|||
125187477|NCT03922308|450306585|FG001|Overall Study|Lost to Follow-up|0|||
125187478|NCT03922308|450306586|FG002|Overall Study|Lost to Follow-up|0|||
125187479|NCT03922308|450306584|FG000|Overall Study|Reason not Specified|0|||
125187480|NCT03922308|450306585|FG001|Overall Study|Reason not Specified|2|||
125187481|NCT03922308|450306586|FG002|Overall Study|Reason not Specified|1|||
125187482|NCT01697748|450306587|FG000|Overall Study|ineligible skin incision|1|||
125187483|NCT01697748|450306588|FG001|Overall Study|ineligible skin incision|2|||
125187484|NCT01697748|450306587|FG000|Overall Study|ineligible uterine incision|4|||
125187485|NCT01697748|450306588|FG001|Overall Study|ineligible uterine incision|1|||
125187486|NCT01697748|450306587|FG000|Overall Study|Lost to Follow-up|53|||
125187487|NCT01697748|450306588|FG001|Overall Study|Lost to Follow-up|65|||
125187488|NCT03376789|450306591|FG000|Overall Study|Withdrawal by Subject|3|||
125187489|NCT03376789|450306592|FG001|Overall Study|Withdrawal by Subject|5|||
125187490|NCT03376789|450306591|FG000|Overall Study|Protocol Violation|0|||
125187491|NCT03376789|450306592|FG001|Overall Study|Protocol Violation|1|||
125187492|NCT03376789|450306591|FG000|Overall Study|Adverse Event|0|||
125187493|NCT03376789|450306592|FG001|Overall Study|Adverse Event|1|||
125187494|NCT03376789|450306591|FG000|Overall Study|Lost to Follow-up|1|||
125187495|NCT03376789|450306592|FG001|Overall Study|Lost to Follow-up|1|||
125187496|NCT03376789|450306591|FG000|Overall Study|Per sponsor due to noncompliance|1|||
125187497|NCT03376789|450306592|FG001|Overall Study|Per sponsor due to noncompliance|0|||
125187498|NCT03376789|450306591|FG000|Overall Study|Subject off study medication|0|||
125187499|NCT03376789|450306592|FG001|Overall Study|Subject off study medication|1|||
125187500|NCT04177095|450306593|FG000|Overall Study|Withdrawal by Subject|3|||
125187501|NCT04177095|450306593|FG000|Overall Study|Screen Failure|3|||
125187502|NCT04177095|450306593|FG000|Overall Study|Problems with the Trugraf assay|1|||
125187503|NCT03876743|450306596|FG000|Overall Study|Lost to Follow-up|6|||
125187504|NCT03876743|450306597|FG001|Overall Study|Lost to Follow-up|4|||
125187505|NCT03876743|450306598|FG002|Overall Study|Lost to Follow-up|4|||
125187506|NCT03876743|450306599|FG003|Overall Study|Lost to Follow-up|7|||
125187507|NCT03889418|450306600|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
125187508|NCT03889418|450306601|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187509|NCT03889418|450306602|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187510|NCT03889418|450306603|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187511|NCT03889418|450306604|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187512|NCT03889418|450306605|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187513|NCT03889418|450306606|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187514|NCT03889418|450306607|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187515|NCT03889418|450306608|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125187516|NCT03889418|450306609|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
125242025|NCT02489773|450509642|FG001|Overall Study|Leave the country or the state|1|||
125242026|NCT02115386|450509645|FG000|Overall Study|Protocol Violation|1|||
125187517|NCT03889418|450306600|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187518|NCT03889418|450306601|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
125187519|NCT03889418|450306602|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
125187520|NCT03889418|450306603|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187521|NCT03889418|450306604|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187522|NCT03889418|450306605|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187523|NCT03889418|450306606|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187524|NCT03889418|450306607|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187525|NCT03889418|450306608|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125242027|NCT02115386|450509645|FG000|Overall Study|Administrative - trial was terminated|6|||
125242028|NCT02493855|450509646|FG000|Overall Study|Non-compliance|1|||
125242029|NCT02493855|450509647|FG001|Overall Study|Non-compliance|0|||
125242030|NCT02493855|450509648|FG002|Overall Study|Non-compliance|0|||
125242031|NCT02493855|450509646|FG000|Overall Study|Adverse Event|0|||
125242032|NCT02493855|450509647|FG001|Overall Study|Adverse Event|1|||
125242033|NCT02493855|450509648|FG002|Overall Study|Adverse Event|0|||
125242034|NCT02493855|450509646|FG000|Overall Study|Withdrawal by Subject|1|||
125242035|NCT02493855|450509647|FG001|Overall Study|Withdrawal by Subject|0|||
125242036|NCT02493855|450509648|FG002|Overall Study|Withdrawal by Subject|0|||
125242037|NCT02453048|450509649|FG000|Overall Study|Only part of initial 6 mo. study|0|||
125242038|NCT02453048|450509650|FG001|Overall Study|Only part of initial 6 mo. study|0|||
125242039|NCT02453048|450509651|FG002|Overall Study|Only part of initial 6 mo. study|0|||
125242040|NCT02453048|450509652|FG003|Overall Study|Only part of initial 6 mo. study|0|||
125242041|NCT02453048|450509653|FG004|Overall Study|Only part of initial 6 mo. study|6|||
125242042|NCT02453048|450509649|FG000|Overall Study|Lost to Follow-up|0|||
125242043|NCT02453048|450509650|FG001|Overall Study|Lost to Follow-up|1|||
125242044|NCT02453048|450509651|FG002|Overall Study|Lost to Follow-up|2|||
125242045|NCT02453048|450509652|FG003|Overall Study|Lost to Follow-up|0|||
125242046|NCT02453048|450509653|FG004|Overall Study|Lost to Follow-up|0|||
125242047|NCT01482221|450509654|FG000|Overall Study|Lack of Efficacy|1|||
125242048|NCT01482221|450509655|FG001|Overall Study|Lack of Efficacy|0|||
125242049|NCT01482221|450509656|FG002|Overall Study|Lack of Efficacy|1|||
125242050|NCT01482221|450509654|FG000|Overall Study|Lost to Follow-up|3|||
125242051|NCT01482221|450509655|FG001|Overall Study|Lost to Follow-up|2|||
125242052|NCT01482221|450509656|FG002|Overall Study|Lost to Follow-up|1|||
125242053|NCT01482221|450509654|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
125242054|NCT01482221|450509655|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
125242055|NCT01482221|450509656|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
125242056|NCT01482221|450509654|FG000|Overall Study|Condition under Investigation Worsened|3|||
125242057|NCT01482221|450509655|FG001|Overall Study|Condition under Investigation Worsened|2|||
125242058|NCT01482221|450509656|FG002|Overall Study|Condition under Investigation Worsened|4|||
125242059|NCT01482221|450509654|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
125242060|NCT01482221|450509655|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
125242061|NCT01482221|450509656|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
125242062|NCT01482221|450509654|FG000|Overall Study|Adverse Event|1|||
125242063|NCT01482221|450509655|FG001|Overall Study|Adverse Event|7|||
125242064|NCT01482221|450509656|FG002|Overall Study|Adverse Event|3|||
125242065|NCT01482221|450509654|FG000|Overall Study|Withdrawal by Subject|10|||
125242066|NCT01482221|450509655|FG001|Overall Study|Withdrawal by Subject|7|||
125242067|NCT01482221|450509656|FG002|Overall Study|Withdrawal by Subject|12|||
125242068|NCT01482221|450509654|FG000|Overall Study|Incorrect randomization|0|||
125242069|NCT01482221|450509655|FG001|Overall Study|Incorrect randomization|1|||
125242070|NCT01482221|450509656|FG002|Overall Study|Incorrect randomization|0|||
125242071|NCT01482221|450509654|FG000|Overall Study|Physician Decision|0|||
125242072|NCT01482221|450509655|FG001|Overall Study|Physician Decision|1|||
125242073|NCT01482221|450509656|FG002|Overall Study|Physician Decision|0|||
125242074|NCT03086343|450509657|FG000|Period 1|Adverse Event|7|||
125242075|NCT03086343|450509658|FG001|Period 1|Adverse Event|7|||
125242076|NCT03086343|450509659|FG002|Period 1|Adverse Event|0|||
125242077|NCT03086343|450509660|FG003|Period 1|Adverse Event|1|||
125242078|NCT03086343|450509657|FG000|Period 1|Withdrawal by Subject|6|||
125242079|NCT03086343|450509658|FG001|Period 1|Withdrawal by Subject|10|||
125242080|NCT03086343|450509659|FG002|Period 1|Withdrawal by Subject|0|||
125242081|NCT03086343|450509660|FG003|Period 1|Withdrawal by Subject|0|||
125242082|NCT03086343|450509657|FG000|Period 1|Lost to Follow-up|1|||
125242083|NCT03086343|450509658|FG001|Period 1|Lost to Follow-up|3|||
125242084|NCT03086343|450509659|FG002|Period 1|Lost to Follow-up|1|||
125242085|NCT03086343|450509660|FG003|Period 1|Lost to Follow-up|0|||
125242086|NCT03086343|450509657|FG000|Period 1|Other, Not Specified|10|||
125242087|NCT03086343|450509658|FG001|Period 1|Other, Not Specified|12|||
125242088|NCT03086343|450509659|FG002|Period 1|Other, Not Specified|2|||
125242089|NCT03086343|450509660|FG003|Period 1|Other, Not Specified|1|||
125242090|NCT03086343|450509657|FG000|Period 1|Missing|1|||
125242091|NCT03086343|450509658|FG001|Period 1|Missing|0|||
125242092|NCT03086343|450509659|FG002|Period 1|Missing|0|||
125242093|NCT03086343|450509660|FG003|Period 1|Missing|0|||
125242094|NCT03086343|450509657|FG000|Period 2|Adverse Event|20|||
125242095|NCT03086343|450509658|FG001|Period 2|Adverse Event|11|||
125242096|NCT03086343|450509659|FG002|Period 2|Adverse Event|1|||
125242097|NCT03086343|450509660|FG003|Period 2|Adverse Event|2|||
125242098|NCT03086343|450509657|FG000|Period 2|Withdrawal by Subject|15|||
125242099|NCT03086343|450509658|FG001|Period 2|Withdrawal by Subject|25|||
125242100|NCT03086343|450509659|FG002|Period 2|Withdrawal by Subject|2|||
125242101|NCT03086343|450509660|FG003|Period 2|Withdrawal by Subject|2|||
125242102|NCT03086343|450509657|FG000|Period 2|Lost to Follow-up|6|||
125242103|NCT03086343|450509658|FG001|Period 2|Lost to Follow-up|11|||
125242104|NCT03086343|450509659|FG002|Period 2|Lost to Follow-up|1|||
125242105|NCT03086343|450509660|FG003|Period 2|Lost to Follow-up|0|||
125393162|NCT02641379|451072556|FG005|Overall Study|Negative PCR result|0|||
125393163|NCT02641379|451072557|FG006|Overall Study|Negative PCR result|0|||
125393164|NCT02641379|451072558|FG007|Overall Study|Negative PCR result|0|||
125393165|NCT02641379|451072559|FG008|Overall Study|Negative PCR result|0|||
125393166|NCT02641379|451072560|FG009|Overall Study|Negative PCR result|1|||
125393167|NCT02641379|451072561|FG010|Overall Study|Negative PCR result|0|||
125393168|NCT02641379|451072551|FG000|Overall Study|Participant's PCR high|0|||
125393169|NCT02641379|451072552|FG001|Overall Study|Participant's PCR high|0|||
125187526|NCT03889418|450306609|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
125187527|NCT03889418|450306600|FG000|October-December 2019 (Month 7-9)|Death|0|||
125187528|NCT03889418|450306601|FG001|October-December 2019 (Month 7-9)|Death|0|||
125187529|NCT03889418|450306602|FG002|October-December 2019 (Month 7-9)|Death|0|||
125187530|NCT03889418|450306603|FG003|October-December 2019 (Month 7-9)|Death|0|||
125187531|NCT03889418|450306604|FG004|October-December 2019 (Month 7-9)|Death|0|||
125187532|NCT03889418|450306605|FG005|October-December 2019 (Month 7-9)|Death|0|||
125187533|NCT03889418|450306606|FG006|October-December 2019 (Month 7-9)|Death|0|||
125187534|NCT03889418|450306607|FG007|October-December 2019 (Month 7-9)|Death|0|||
125187535|NCT03889418|450306608|FG008|October-December 2019 (Month 7-9)|Death|1|||
125187536|NCT03889418|450306609|FG009|October-December 2019 (Month 7-9)|Death|0|||
125187537|NCT03889418|450306600|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187538|NCT03889418|450306601|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187539|NCT03889418|450306602|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187540|NCT03889418|450306603|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
125187541|NCT03889418|450306604|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187542|NCT03889418|450306605|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187543|NCT03889418|450306606|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187544|NCT03889418|450306607|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
125187545|NCT03889418|450306608|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187546|NCT03889418|450306609|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
125187547|NCT03889418|450306600|FG000|April - June 2020 (Month 13-15)|Death|0|||
125187548|NCT03889418|450306601|FG001|April - June 2020 (Month 13-15)|Death|1|||
125187549|NCT03889418|450306602|FG002|April - June 2020 (Month 13-15)|Death|0|||
125187550|NCT03889418|450306603|FG003|April - June 2020 (Month 13-15)|Death|0|||
125187551|NCT03889418|450306604|FG004|April - June 2020 (Month 13-15)|Death|0|||
125187552|NCT03889418|450306605|FG005|April - June 2020 (Month 13-15)|Death|0|||
125187553|NCT03889418|450306606|FG006|April - June 2020 (Month 13-15)|Death|0|||
125187554|NCT03889418|450306607|FG007|April - June 2020 (Month 13-15)|Death|0|||
125187555|NCT03889418|450306608|FG008|April - June 2020 (Month 13-15)|Death|0|||
125187556|NCT03889418|450306609|FG009|April - June 2020 (Month 13-15)|Death|0|||
125187557|NCT03889418|450306600|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187558|NCT03889418|450306601|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187559|NCT03889418|450306602|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187560|NCT03889418|450306603|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
125187561|NCT03889418|450306604|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187562|NCT03889418|450306605|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187563|NCT03889418|450306606|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187564|NCT03889418|450306607|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187565|NCT03889418|450306608|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187566|NCT03889418|450306609|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
125187567|NCT03889418|450306600|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
125187568|NCT03889418|450306601|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
125187569|NCT03889418|450306602|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
125187570|NCT03889418|450306603|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
125187571|NCT03889418|450306604|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
125187572|NCT03889418|450306605|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
125187573|NCT03889418|450306606|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
125187574|NCT03889418|450306607|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
125187575|NCT03889418|450306608|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
125187576|NCT03889418|450306609|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
125393170|NCT02641379|451072553|FG002|Overall Study|Participant's PCR high|0|||
125187577|NCT03889418|450306600|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
125187578|NCT03889418|450306601|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
125187579|NCT03889418|450306602|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
125187580|NCT03889418|450306603|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
125187581|NCT03889418|450306604|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
125393171|NCT02641379|451072554|FG003|Overall Study|Participant's PCR high|0|||
125393172|NCT02641379|451072555|FG004|Overall Study|Participant's PCR high|0|||
125393173|NCT02641379|451072556|FG005|Overall Study|Participant's PCR high|0|||
125393174|NCT02641379|451072557|FG006|Overall Study|Participant's PCR high|0|||
125393175|NCT02641379|451072558|FG007|Overall Study|Participant's PCR high|1|||
125393176|NCT02641379|451072559|FG008|Overall Study|Participant's PCR high|0|||
125393177|NCT02641379|451072560|FG009|Overall Study|Participant's PCR high|0|||
125187582|NCT03889418|450306605|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
125187583|NCT03889418|450306606|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
125187584|NCT03889418|450306607|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
125187585|NCT03889418|450306608|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
125187586|NCT03889418|450306609|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
125187587|NCT00092118|450306610|FG000|Overall Study|Adverse Event|35|||
125187588|NCT00092118|450306611|FG001|Overall Study|Adverse Event|32|||
125187589|NCT00092118|450306610|FG000|Overall Study|Lack of Efficacy|12|||
125187590|NCT00092118|450306611|FG001|Overall Study|Lack of Efficacy|14|||
125187591|NCT00092118|450306610|FG000|Overall Study|Lost to Follow-up|4|||
125187592|NCT00092118|450306611|FG001|Overall Study|Lost to Follow-up|3|||
125187593|NCT00092118|450306610|FG000|Overall Study|Protocol Violation|23|||
125187594|NCT00092118|450306611|FG001|Overall Study|Protocol Violation|25|||
125187595|NCT00092118|450306610|FG000|Overall Study|Withdrawal by Subject|4|||
125187596|NCT00092118|450306611|FG001|Overall Study|Withdrawal by Subject|10|||
125187597|NCT00092118|450306610|FG000|Overall Study|Other|6|||
125187598|NCT00092118|450306611|FG001|Overall Study|Other|5|||
125187599|NCT03751098|450306612|FG000|Overall Study|Withdrawal by Subject|0|||
125187600|NCT03751098|450306613|FG001|Overall Study|Withdrawal by Subject|1|||
125187601|NCT02022202|450306615|FG000|Overall Study|Withdrawal by Subject|2|||
125187602|NCT02022202|450306615|FG000|Overall Study|Disease Progression|3|||
125187603|NCT02022202|450306615|FG000|Overall Study|Desire go to immediately to surgery|3|||
125187604|NCT05581641|450306616|FG000|Overall Study|Withdrawal by Subject|0|||
125187605|NCT05581641|450306617|FG001|Overall Study|Withdrawal by Subject|1|||
125187606|NCT05581641|450306618|FG002|Overall Study|Withdrawal by Subject|3|||
125187607|NCT05581641|450306619|FG003|Overall Study|Withdrawal by Subject|1|||
125187608|NCT05581641|450306616|FG000|Overall Study|Lost to Follow-up|0|||
125187609|NCT05581641|450306617|FG001|Overall Study|Lost to Follow-up|1|||
125187610|NCT05581641|450306618|FG002|Overall Study|Lost to Follow-up|0|||
125187611|NCT05581641|450306619|FG003|Overall Study|Lost to Follow-up|1|||
125187612|NCT05581641|450306616|FG000|Overall Study|Protocol Violation|1|||
125187613|NCT05581641|450306617|FG001|Overall Study|Protocol Violation|0|||
125187614|NCT05581641|450306618|FG002|Overall Study|Protocol Violation|0|||
125187615|NCT05581641|450306619|FG003|Overall Study|Protocol Violation|0|||
125187616|NCT05581641|450306616|FG000|Overall Study|Other|1|||
125187617|NCT05581641|450306617|FG001|Overall Study|Other|0|||
125187618|NCT05581641|450306618|FG002|Overall Study|Other|2|||
125187619|NCT05581641|450306619|FG003|Overall Study|Other|1|||
125187620|NCT02166333|450306622|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
125187621|NCT02166333|450306623|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
125187622|NCT02166333|450306624|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
125187623|NCT02166333|450306625|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
125187624|NCT02166333|450306626|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
125187625|NCT02166333|450306627|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
125187626|NCT02166333|450306622|FG000|Stage 1|Death|4|||
125187627|NCT02166333|450306623|FG001|Stage 1|Death|0|||
125187628|NCT02166333|450306624|FG002|Stage 1|Death|2|||
125187629|NCT02166333|450306625|FG003|Stage 1|Death|0|||
125187630|NCT02166333|450306626|FG004|Stage 1|Death|3|||
125187631|NCT02166333|450306627|FG005|Stage 1|Death|2|||
125187632|NCT02166333|450306622|FG000|Stage 1|Lost to Follow-up|12|||
125187633|NCT02166333|450306623|FG001|Stage 1|Lost to Follow-up|0|||
125187634|NCT02166333|450306624|FG002|Stage 1|Lost to Follow-up|6|||
125187635|NCT02166333|450306625|FG003|Stage 1|Lost to Follow-up|0|||
125187636|NCT02166333|450306626|FG004|Stage 1|Lost to Follow-up|3|||
125187637|NCT02166333|450306627|FG005|Stage 1|Lost to Follow-up|3|||
125187638|NCT02166333|450306622|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
125187639|NCT02166333|450306623|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
125187640|NCT02166333|450306624|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
125187641|NCT02166333|450306625|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
125187642|NCT02166333|450306626|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
125187643|NCT02166333|450306627|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
125187644|NCT02166333|450306622|FG000|Stage 2|Death|4|||
125187645|NCT02166333|450306623|FG001|Stage 2|Death|2|||
125187646|NCT02166333|450306624|FG002|Stage 2|Death|1|||
125187647|NCT02166333|450306625|FG003|Stage 2|Death|0|||
125187648|NCT02166333|450306626|FG004|Stage 2|Death|0|||
125187649|NCT02166333|450306627|FG005|Stage 2|Death|1|||
125393178|NCT02641379|451072561|FG010|Overall Study|Participant's PCR high|0|||
125187650|NCT02166333|450306622|FG000|Stage 2|Lost to Follow-up|23|||
125187651|NCT02166333|450306623|FG001|Stage 2|Lost to Follow-up|4|||
125187652|NCT02166333|450306624|FG002|Stage 2|Lost to Follow-up|11|||
125187653|NCT02166333|450306625|FG003|Stage 2|Lost to Follow-up|9|||
125187654|NCT02166333|450306626|FG004|Stage 2|Lost to Follow-up|3|||
125242106|NCT03086343|450509657|FG000|Period 2|COVID-19 Infection|5|||
125242107|NCT03086343|450509658|FG001|Period 2|COVID-19 Infection|0|||
125242108|NCT03086343|450509659|FG002|Period 2|COVID-19 Infection|0|||
125242109|NCT03086343|450509660|FG003|Period 2|COVID-19 Infection|0|||
125242110|NCT03086343|450509657|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
125242111|NCT03086343|450509658|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
125242112|NCT03086343|450509659|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
125242113|NCT03086343|450509660|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
125242114|NCT03086343|450509657|FG000|Period 2|Other, Not Specified|23|||
125242115|NCT03086343|450509658|FG001|Period 2|Other, Not Specified|22|||
125242116|NCT03086343|450509659|FG002|Period 2|Other, Not Specified|2|||
125242117|NCT03086343|450509660|FG003|Period 2|Other, Not Specified|4|||
125242118|NCT01047501|450509661|FG000|Overall Study|Adverse Event|7|||
125242119|NCT01047501|450509662|FG001|Overall Study|Adverse Event|8|||
125242120|NCT01047501|450509663|FG002|Overall Study|Adverse Event|5|||
125242121|NCT01047501|450509661|FG000|Overall Study|Withdrew Consent|6|||
125242122|NCT01047501|450509662|FG001|Overall Study|Withdrew Consent|2|||
125242123|NCT01047501|450509663|FG002|Overall Study|Withdrew Consent|4|||
125242124|NCT01047501|450509661|FG000|Overall Study|Lost to Follow-up|0|||
125242125|NCT01047501|450509662|FG001|Overall Study|Lost to Follow-up|1|||
125242126|NCT01047501|450509663|FG002|Overall Study|Lost to Follow-up|1|||
125242127|NCT01047501|450509661|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
125242128|NCT01047501|450509662|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
125242129|NCT01047501|450509663|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
125242130|NCT01047501|450509661|FG000|Overall Study|Death|1|||
125242131|NCT01047501|450509662|FG001|Overall Study|Death|0|||
125242132|NCT01047501|450509663|FG002|Overall Study|Death|0|||
125242133|NCT01047501|450509661|FG000|Overall Study|Other discontinuation|1|||
125242134|NCT01047501|450509662|FG001|Overall Study|Other discontinuation|0|||
125242135|NCT01047501|450509663|FG002|Overall Study|Other discontinuation|1|||
125242136|NCT01047501|450509661|FG000|Overall Study|Investigator judgement|0|||
125242137|NCT01047501|450509662|FG001|Overall Study|Investigator judgement|0|||
125242138|NCT01047501|450509663|FG002|Overall Study|Investigator judgement|1|||
125242139|NCT00741611|450509664|FG000|Overall Study|Death|0|||
125242140|NCT00741611|450509665|FG001|Overall Study|Death|0|||
125242141|NCT00741611|450509666|FG002|Overall Study|Death|1|||
125242142|NCT00741611|450509664|FG000|Overall Study|Withdrawal by Subject|0|||
125242143|NCT00741611|450509665|FG001|Overall Study|Withdrawal by Subject|2|||
125242144|NCT00741611|450509666|FG002|Overall Study|Withdrawal by Subject|2|||
125242145|NCT00429299|450509671|FG000|Overall Study|Disease Progression|1|||
125242146|NCT00429299|450509672|FG001|Overall Study|Disease Progression|1|||
125242147|NCT00429299|450509673|FG002|Overall Study|Disease Progression|0|||
125242148|NCT00429299|450509671|FG000|Overall Study|Adverse Event|2|||
125242149|NCT00429299|450509672|FG001|Overall Study|Adverse Event|5|||
125242150|NCT00429299|450509673|FG002|Overall Study|Adverse Event|1|||
125242151|NCT00429299|450509671|FG000|Overall Study|Protocol Violation|1|||
125242152|NCT00429299|450509672|FG001|Overall Study|Protocol Violation|0|||
125242153|NCT00429299|450509673|FG002|Overall Study|Protocol Violation|0|||
125242154|NCT00429299|450509671|FG000|Overall Study|Withdrawal by Subject|0|||
125242155|NCT00429299|450509672|FG001|Overall Study|Withdrawal by Subject|1|||
125242156|NCT00429299|450509673|FG002|Overall Study|Withdrawal by Subject|3|||
125242157|NCT01510756|450509674|FG000|Overall Study|Death|1|||
125242158|NCT01510756|450509674|FG000|Overall Study|Lack of Efficacy|2|||
125242159|NCT01510756|450509674|FG000|Overall Study|Physician Decision|1|||
125242160|NCT04871113|450509675|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242161|NCT04871113|450509676|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242162|NCT04871113|450509677|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242163|NCT04871113|450509678|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242164|NCT04871113|450509679|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242165|NCT04871113|450509680|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
125242166|NCT04871113|450509681|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242167|NCT04871113|450509682|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242168|NCT04871113|450509683|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242169|NCT04871113|450509684|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
125242170|NCT04871113|450509675|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242171|NCT04871113|450509676|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242172|NCT04871113|450509677|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242173|NCT04871113|450509678|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242174|NCT04871113|450509679|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242175|NCT04871113|450509680|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242176|NCT04871113|450509681|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
125242177|NCT04871113|450509682|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
125242178|NCT04871113|450509683|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242179|NCT04871113|450509684|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
125242180|NCT01257542|450509687|FG000|Overall Study|Protocol Violation|3|||
125187655|NCT02166333|450306627|FG005|Stage 2|Lost to Follow-up|6|||
125187656|NCT00682786|450306632|FG000|Overall Study|Withdrawal by Subject|2|||
125187657|NCT00682786|450306633|FG001|Overall Study|Withdrawal by Subject|2|||
125187658|NCT00682786|450306632|FG000|Overall Study|Did not receive irinotecan|0|||
125187659|NCT00682786|450306633|FG001|Overall Study|Did not receive irinotecan|1|||
125187660|NCT00359424|450306634|FG000|Overall Study|Death|99|||
125187661|NCT00359424|450306635|FG001|Overall Study|Death|58|||
125187662|NCT00359424|450306634|FG000|Overall Study|Lost to Follow-up|19|||
125187663|NCT00359424|450306635|FG001|Overall Study|Lost to Follow-up|7|||
125187664|NCT00359424|450306634|FG000|Overall Study|Withdrawal by Subject|10|||
125187665|NCT00359424|450306635|FG001|Overall Study|Withdrawal by Subject|2|||
125187666|NCT00359424|450306634|FG000|Overall Study|follow up not conducted|2|||
125187667|NCT00359424|450306635|FG001|Overall Study|follow up not conducted|0|||
125187668|NCT02462603|450306638|FG000|Overall Study|Investigator Decision|1|||
125187669|NCT02462603|450306638|FG000|Overall Study|Non-Compliance|1|||
125187670|NCT02462603|450306638|FG000|Overall Study|Withdrawal by Subject|2|||
125187671|NCT01591096|450306640|FG000|Overall Study|Adverse Event|1|||
125187672|NCT01831635|450306641|FG000|Overall Study|Withdrawal by Subject|0|||
125187673|NCT01831635|450306642|FG001|Overall Study|Withdrawal by Subject|2|||
125187674|NCT01831635|450306643|FG002|Overall Study|Withdrawal by Subject|0|||
125187675|NCT03655405|450306646|FG000|Overall Study|Death after initial data collection|4|||
125187676|NCT03655405|450306647|FG001|Overall Study|Death after initial data collection|2|||
125187677|NCT03655405|450306646|FG000|Overall Study|Died before initial data collection|1|||
125187678|NCT03655405|450306647|FG001|Overall Study|Died before initial data collection|2|||
125187679|NCT03655405|450306646|FG000|Overall Study|Protocol Violation|0|||
125187680|NCT03655405|450306647|FG001|Overall Study|Protocol Violation|1|||
125187681|NCT01991743|450306649|FG000|Overall Study|external cephalic version not performed|0|||
125187682|NCT01991743|450306650|FG001|Overall Study|external cephalic version not performed|0|||
125187683|NCT01991743|450306651|FG002|Overall Study|external cephalic version not performed|1|||
125187684|NCT01991743|450306652|FG003|Overall Study|external cephalic version not performed|0|||
125187685|NCT02859337|450306654|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
125187686|NCT02859337|450306655|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
125187687|NCT02859337|450306656|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
125187688|NCT02859337|450306654|FG000|Overall Study|Withdrawal by Subject|3|||
125187689|NCT02859337|450306655|FG001|Overall Study|Withdrawal by Subject|1|||
125187690|NCT02859337|450306656|FG002|Overall Study|Withdrawal by Subject|0|||
125187691|NCT02859337|450306654|FG000|Overall Study|Lost to Follow-up|1|||
125187692|NCT02859337|450306655|FG001|Overall Study|Lost to Follow-up|0|||
125187693|NCT02859337|450306656|FG002|Overall Study|Lost to Follow-up|0|||
125187694|NCT01445730|450306657|FG000|Overall Study|Adverse Event|1|||
125187695|NCT01445730|450306657|FG000|Overall Study|For the advice of a dentist|1|||
125187696|NCT01445730|450306657|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
125187697|NCT01167140|450306658|FG000|Overall Study|Withdrawal by Subject|1|||
125187698|NCT03805412|450306659|FG000|Overall Study|Lost to Follow-up|0|||
125187699|NCT03805412|450306660|FG001|Overall Study|Lost to Follow-up|1|||
125187700|NCT04390113|450306665|FG000|Overall Study|Not Treated|0|||
125187701|NCT04390113|450306666|FG001|Overall Study|Not Treated|1|||
125187702|NCT04390113|450306665|FG000|Overall Study|Adverse Event|1|||
125187703|NCT04390113|450306666|FG001|Overall Study|Adverse Event|0|||
125187704|NCT04390113|450306665|FG000|Overall Study|Death|2|||
125187705|NCT04390113|450306666|FG001|Overall Study|Death|1|||
125187706|NCT04390113|450306665|FG000|Overall Study|Physician Decision|1|||
125187707|NCT04390113|450306666|FG001|Overall Study|Physician Decision|3|||
125187708|NCT04390113|450306665|FG000|Overall Study|Study Terminated by Sponsor|5|||
125187709|NCT04390113|450306666|FG001|Overall Study|Study Terminated by Sponsor|3|||
125187710|NCT04390113|450306665|FG000|Overall Study|Withdrawal by Subject|10|||
125187711|NCT04390113|450306666|FG001|Overall Study|Withdrawal by Subject|5|||
125187712|NCT04390113|450306665|FG000|Overall Study|Other|1|||
125187713|NCT04390113|450306666|FG001|Overall Study|Other|0|||
125187714|NCT04390113|450306665|FG000|Overall Study|Missing|0|||
125187715|NCT04390113|450306666|FG001|Overall Study|Missing|1|||
125187716|NCT00030901|450306674|FG000|Initial Registration|Ineligible|167|||
125187717|NCT00030901|450306675|FG001|Initial Registration|Ineligible|0|||
125187718|NCT00030901|450306676|FG002|Initial Registration|Ineligible|0|||
125187719|NCT00030901|450306674|FG000|Randomization|Adverse Event|0|||
125187720|NCT00030901|450306675|FG001|Randomization|Adverse Event|11|||
125187721|NCT00030901|450306676|FG002|Randomization|Adverse Event|7|||
125187722|NCT00030901|450306674|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
125187723|NCT00030901|450306675|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
125187724|NCT00030901|450306676|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
125187725|NCT00030901|450306674|FG000|Randomization|Progression/Relapse|0|||
125187726|NCT00030901|450306675|FG001|Randomization|Progression/Relapse|22|||
125187727|NCT00030901|450306676|FG002|Randomization|Progression/Relapse|21|||
125187728|NCT00030901|450306674|FG000|Randomization|Death|0|||
125187729|NCT00030901|450306675|FG001|Randomization|Death|1|||
125187730|NCT00030901|450306676|FG002|Randomization|Death|3|||
125187731|NCT00030901|450306674|FG000|Randomization|Other|0|||
125242181|NCT01257542|450509688|FG001|Overall Study|Protocol Violation|5|||
125242182|NCT01257542|450509687|FG000|Overall Study|Withdrawal by Subject|0|||
125242183|NCT01257542|450509688|FG001|Overall Study|Withdrawal by Subject|2|||
125242184|NCT03600428|450509694|FG000|Overall Study|Not eligible|0|||
125242185|NCT03600428|450509695|FG001|Overall Study|Not eligible|1|||
125242186|NCT03600428|450509694|FG000|Overall Study|Lost to Follow-up|5|||
125242187|NCT03600428|450509695|FG001|Overall Study|Lost to Follow-up|4|||
125242188|NCT04398134|450509696|FG000|Overall Study|Adverse Event|0|||
125242189|NCT04398134|450509697|FG001|Overall Study|Adverse Event|0|||
125242190|NCT04398134|450509698|FG002|Overall Study|Adverse Event|1|||
125242191|NCT04398134|450509699|FG003|Overall Study|Adverse Event|0|||
125242192|NCT04398134|450509696|FG000|Overall Study|Withdrawal by Subject|2|||
125242193|NCT04398134|450509697|FG001|Overall Study|Withdrawal by Subject|0|||
125242194|NCT04398134|450509698|FG002|Overall Study|Withdrawal by Subject|0|||
125242195|NCT04398134|450509699|FG003|Overall Study|Withdrawal by Subject|1|||
125242196|NCT04398134|450509696|FG000|Overall Study|Study Terminated by Sponsor|30|||
125242197|NCT04398134|450509697|FG001|Overall Study|Study Terminated by Sponsor|11|||
125242198|NCT04398134|450509698|FG002|Overall Study|Study Terminated by Sponsor|32|||
125242199|NCT04398134|450509699|FG003|Overall Study|Study Terminated by Sponsor|11|||
125242200|NCT00153920|450509701|FG000|Overall Study|Adverse Event|9|||
125242201|NCT00153920|450509701|FG000|Overall Study|Progressive Disease|9|||
125242202|NCT00153920|450509701|FG000|Overall Study|Physician Decision|3|||
125242203|NCT00153920|450509701|FG000|Overall Study|Lack of Response|3|||
125242204|NCT00153920|450509701|FG000|Overall Study|Death|2|||
125242205|NCT00153920|450509701|FG000|Overall Study|Withdrawal by Subject|1|||
125242206|NCT00153920|450509701|FG000|Overall Study|Non-Protocol Therapy|1|||
125242207|NCT00153920|450509701|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
125242208|NCT00153920|450509701|FG000|Overall Study|Progressive Disease before Trt|1|||
125242209|NCT01666652|450509707|FG000|Overall Study|Serious Adverse Event|0|||
125242210|NCT01666652|450509708|FG001|Overall Study|Serious Adverse Event|0|||
125242211|NCT01666652|450509709|FG002|Overall Study|Serious Adverse Event|0|||
125242212|NCT01666652|450509710|FG003|Overall Study|Serious Adverse Event|1|||
125242213|NCT01666652|450509711|FG004|Overall Study|Serious Adverse Event|0|||
125242214|NCT01666652|450509707|FG000|Overall Study|Withdrawal by Subject|0|||
125242215|NCT01666652|450509708|FG001|Overall Study|Withdrawal by Subject|0|||
125242216|NCT01666652|450509709|FG002|Overall Study|Withdrawal by Subject|0|||
125242217|NCT01666652|450509710|FG003|Overall Study|Withdrawal by Subject|0|||
125242218|NCT01666652|450509711|FG004|Overall Study|Withdrawal by Subject|1|||
125242219|NCT01666652|450509707|FG000|Overall Study|Moved from study area|1|||
125242220|NCT01666652|450509708|FG001|Overall Study|Moved from study area|0|||
125242221|NCT01666652|450509709|FG002|Overall Study|Moved from study area|0|||
125242222|NCT01666652|450509710|FG003|Overall Study|Moved from study area|2|||
125242223|NCT01666652|450509711|FG004|Overall Study|Moved from study area|0|||
125242224|NCT01666652|450509707|FG000|Overall Study|Lost to Follow-up|1|||
125242225|NCT01666652|450509708|FG001|Overall Study|Lost to Follow-up|1|||
125242226|NCT01666652|450509709|FG002|Overall Study|Lost to Follow-up|1|||
125242227|NCT01666652|450509710|FG003|Overall Study|Lost to Follow-up|1|||
125242228|NCT01666652|450509711|FG004|Overall Study|Lost to Follow-up|0|||
125242229|NCT01018979|450509712|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
125242230|NCT01018979|450509713|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
125242231|NCT01018979|450509712|FG000|Overall Study|Not received at least one dose|0|||
125242232|NCT01018979|450509713|FG001|Overall Study|Not received at least one dose|1|||
125242233|NCT00544882|450509716|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
125242234|NCT00544882|450509717|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
125242235|NCT00544882|450509718|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
125242236|NCT00544882|450509716|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
125242237|NCT00544882|450509717|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
125242238|NCT00544882|450509718|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
125242239|NCT00544882|450509716|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
125242240|NCT00544882|450509717|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
125242241|NCT00544882|450509718|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
125242242|NCT00544882|450509716|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
125242243|NCT00544882|450509717|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
125242244|NCT00544882|450509718|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
125242245|NCT00544882|450509716|FG000|Cycle 3: Follow-up|Noncompliance|0|||
125242246|NCT00544882|450509717|FG001|Cycle 3: Follow-up|Noncompliance|1|||
125242247|NCT00544882|450509718|FG002|Cycle 3: Follow-up|Noncompliance|0|||
125242248|NCT00544882|450509716|FG000|Cycle 3: Follow-up|Pregnancy|0|||
125242249|NCT00544882|450509717|FG001|Cycle 3: Follow-up|Pregnancy|1|||
125242250|NCT00544882|450509718|FG002|Cycle 3: Follow-up|Pregnancy|0|||
125242251|NCT03043573|450509719|FG000|Overall Study|Lost to Follow-up|3|||
125242252|NCT03043573|450509720|FG001|Overall Study|Lost to Follow-up|3|||
125242253|NCT03043573|450509719|FG000|Overall Study|Physician Decision|0|||
125242254|NCT03043573|450509720|FG001|Overall Study|Physician Decision|5|||
125242255|NCT03043573|450509719|FG000|Overall Study|Withdrawal by Subject|0|||
125242256|NCT03043573|450509720|FG001|Overall Study|Withdrawal by Subject|4|||
125242257|NCT01251861|450509723|FG000|Overall Study|Disease progression|6|||
125242258|NCT01251861|450509724|FG001|Overall Study|Disease progression|6|||
125242259|NCT01251861|450509723|FG000|Overall Study|Adverse Event|2|||
125242260|NCT01251861|450509724|FG001|Overall Study|Adverse Event|17|||
125242261|NCT01251861|450509723|FG000|Overall Study|Withdrawal by Subject|2|||
125242262|NCT01251861|450509724|FG001|Overall Study|Withdrawal by Subject|2|||
125242263|NCT01251861|450509723|FG000|Overall Study|Alternative therapy|1|||
125242264|NCT01251861|450509724|FG001|Overall Study|Alternative therapy|0|||
125242265|NCT01251861|450509723|FG000|Overall Study|Other complicating disease|0|||
125242266|NCT01251861|450509724|FG001|Overall Study|Other complicating disease|1|||
125443454|NCT02555371|451252128|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
125443455|NCT02555371|451252129|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
125443456|NCT02555371|451252130|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
125443457|NCT02555371|451252131|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
125443458|NCT02555371|451252132|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
125187732|NCT00030901|450306675|FG001|Randomization|Other|36|||
125242267|NCT01251861|450509723|FG000|Overall Study|Physician Decision|1|||
125242268|NCT01251861|450509724|FG001|Overall Study|Physician Decision|0|||
125242269|NCT01251861|450509723|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
125242270|NCT01251861|450509724|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
125242271|NCT01251861|450509723|FG000|Overall Study|Other|1|||
125242272|NCT01251861|450509724|FG001|Overall Study|Other|0|||
125242273|NCT01251861|450509723|FG000|Overall Study|Never started therapy|4|||
125242274|NCT01251861|450509724|FG001|Overall Study|Never started therapy|1|||
125242275|NCT01251861|450509723|FG000|Overall Study|Potential interaction of drugs|0|||
125242276|NCT01251861|450509724|FG001|Overall Study|Potential interaction of drugs|1|||
125187733|NCT00030901|450306676|FG002|Randomization|Other|33|||
125187734|NCT00030901|450306674|FG000|Randomization|Ineligible|0|||
125187735|NCT00030901|450306675|FG001|Randomization|Ineligible|15|||
125187736|NCT00030901|450306676|FG002|Randomization|Ineligible|14|||
125187737|NCT01806051|450306677|FG000|Overall Study|Withdrawal by Subject|6|||
125187738|NCT02576847|450306678|FG000|Overall Study|Adverse Event|27|||
125187739|NCT02576847|450306678|FG000|Overall Study|Lost to Follow-up|22|||
125187740|NCT02576847|450306678|FG000|Overall Study|Physician Decision|1|||
125187741|NCT02576847|450306678|FG000|Overall Study|Pregnancy|1|||
125187742|NCT02576847|450306678|FG000|Overall Study|Protocol Violation|3|||
125187743|NCT02576847|450306678|FG000|Overall Study|Withdrawal by Subject|78|||
125187744|NCT02576847|450306678|FG000|Overall Study|Other|5|||
125187745|NCT03817190|450306679|FG000|Overall Study|Early Termination|13|||
125187746|NCT03817190|450306680|FG001|Overall Study|Early Termination|20|||
125187747|NCT03817190|450306679|FG000|Overall Study|Adverse Event|10|||
125187748|NCT03817190|450306680|FG001|Overall Study|Adverse Event|17|||
125187749|NCT03817190|450306679|FG000|Overall Study|Withdrawal by Subject|12|||
125187750|NCT03817190|450306680|FG001|Overall Study|Withdrawal by Subject|8|||
125187751|NCT03817190|450306679|FG000|Overall Study|Lost to Follow-up|11|||
125187752|NCT03817190|450306680|FG001|Overall Study|Lost to Follow-up|7|||
125187753|NCT03817190|450306679|FG000|Overall Study|Lack of Efficacy|7|||
125187754|NCT03817190|450306680|FG001|Overall Study|Lack of Efficacy|5|||
125187755|NCT03817190|450306679|FG000|Overall Study|Investigator Decision|5|||
125187756|NCT03817190|450306680|FG001|Overall Study|Investigator Decision|1|||
125187757|NCT03817190|450306679|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
125187758|NCT03817190|450306680|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
125187759|NCT03817190|450306679|FG000|Overall Study|Lack of Contact|1|||
125187760|NCT03817190|450306680|FG001|Overall Study|Lack of Contact|0|||
125187761|NCT03817190|450306679|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
125187762|NCT03817190|450306680|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
125187763|NCT03525678|450306681|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
125187764|NCT03525678|450306682|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
125187765|NCT03525678|450306683|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
125187766|NCT03525678|450306684|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
125187767|NCT03525678|450306685|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
125187768|NCT03525678|450306681|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
125242277|NCT00479232|450510923|FG000|Overall Study|Adverse Event|0|||
125242278|NCT00479232|450510924|FG001|Overall Study|Adverse Event|0|||
125242279|NCT00479232|450510925|FG002|Overall Study|Adverse Event|5|||
125242280|NCT00479232|450510926|FG003|Overall Study|Adverse Event|0|||
125242281|NCT00479232|450510927|FG004|Overall Study|Adverse Event|0|||
125242282|NCT00479232|450510928|FG005|Overall Study|Adverse Event|10|||
125242283|NCT00479232|450510923|FG000|Overall Study|Deviation from Protocol|0|||
125187769|NCT03525678|450306682|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
125187770|NCT03525678|450306683|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
125187771|NCT03525678|450306684|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
125242284|NCT00479232|450510924|FG001|Overall Study|Deviation from Protocol|0|||
125242285|NCT00479232|450510925|FG002|Overall Study|Deviation from Protocol|1|||
125242286|NCT00479232|450510926|FG003|Overall Study|Deviation from Protocol|0|||
125242287|NCT00479232|450510927|FG004|Overall Study|Deviation from Protocol|0|||
125242288|NCT00479232|450510928|FG005|Overall Study|Deviation from Protocol|0|||
125443459|NCT00513019|451252133|FG000|Overall Study|Adverse Event|1|||
125443460|NCT00513019|451252134|FG001|Overall Study|Adverse Event|0|||
125242289|NCT00479232|450510923|FG000|Overall Study|Lack of Efficacy|0|||
125242290|NCT00479232|450510924|FG001|Overall Study|Lack of Efficacy|0|||
125242291|NCT00479232|450510925|FG002|Overall Study|Lack of Efficacy|2|||
125242292|NCT00479232|450510926|FG003|Overall Study|Lack of Efficacy|0|||
125242293|NCT00479232|450510927|FG004|Overall Study|Lack of Efficacy|0|||
125242294|NCT00479232|450510928|FG005|Overall Study|Lack of Efficacy|4|||
125242295|NCT00479232|450510923|FG000|Overall Study|Physician Decision|0|||
125242296|NCT00479232|450510924|FG001|Overall Study|Physician Decision|0|||
125242297|NCT00479232|450510925|FG002|Overall Study|Physician Decision|2|||
125242298|NCT00479232|450510926|FG003|Overall Study|Physician Decision|0|||
125242299|NCT00479232|450510927|FG004|Overall Study|Physician Decision|0|||
125242300|NCT00479232|450510928|FG005|Overall Study|Physician Decision|1|||
125242301|NCT00479232|450510923|FG000|Overall Study|Progressive Disease|3|||
125242302|NCT00479232|450510924|FG001|Overall Study|Progressive Disease|1|||
125242303|NCT00479232|450510925|FG002|Overall Study|Progressive Disease|12|||
125242304|NCT00479232|450510926|FG003|Overall Study|Progressive Disease|3|||
125242305|NCT00479232|450510927|FG004|Overall Study|Progressive Disease|3|||
125242306|NCT00479232|450510928|FG005|Overall Study|Progressive Disease|12|||
125242307|NCT00479232|450510923|FG000|Overall Study|Withdrew Consent|0|||
125242308|NCT00479232|450510924|FG001|Overall Study|Withdrew Consent|2|||
125242309|NCT00479232|450510925|FG002|Overall Study|Withdrew Consent|6|||
125242310|NCT00479232|450510926|FG003|Overall Study|Withdrew Consent|0|||
125242311|NCT00479232|450510927|FG004|Overall Study|Withdrew Consent|1|||
125242312|NCT00479232|450510928|FG005|Overall Study|Withdrew Consent|3|||
125242313|NCT01373229|450510929|FG000|Overall Study|Death|3|||
125242314|NCT01373229|450510929|FG000|Overall Study|Physician Decision|3|||
125242315|NCT01991314|450510930|FG000|Overall Study|Adverse Event|5|||
125242316|NCT01991314|450510931|FG001|Overall Study|Adverse Event|1|||
125242317|NCT01991314|450510930|FG000|Overall Study|Lost to Follow-up|6|||
125242318|NCT01991314|450510931|FG001|Overall Study|Lost to Follow-up|10|||
125242319|NCT00970944|450510933|FG000|Overall Study|Death|1|||
125242320|NCT00970944|450510934|FG001|Overall Study|Death|0|||
125242321|NCT00970944|450510933|FG000|Overall Study|Physician Decision|0|||
125242322|NCT00970944|450510934|FG001|Overall Study|Physician Decision|2|||
125242323|NCT00972738|450510935|FG000|Overall Study|Adverse Event|7|||
125242324|NCT00972738|450510936|FG001|Overall Study|Adverse Event|1|||
125242325|NCT00972738|450510937|FG002|Overall Study|Adverse Event|8|||
125242326|NCT00972738|450510935|FG000|Overall Study|Protocol Violation|2|||
125242327|NCT00972738|450510936|FG001|Overall Study|Protocol Violation|1|||
125242328|NCT00972738|450510937|FG002|Overall Study|Protocol Violation|3|||
125242329|NCT00972738|450510935|FG000|Overall Study|Lost to Follow-up|1|||
125242330|NCT00972738|450510936|FG001|Overall Study|Lost to Follow-up|0|||
125242331|NCT00972738|450510937|FG002|Overall Study|Lost to Follow-up|1|||
125242332|NCT00972738|450510935|FG000|Overall Study|Lack of Efficacy|5|||
125242333|NCT00972738|450510936|FG001|Overall Study|Lack of Efficacy|1|||
125242334|NCT00972738|450510937|FG002|Overall Study|Lack of Efficacy|11|||
125242335|NCT00972738|450510935|FG000|Overall Study|Withdrawal by Subject|5|||
125242336|NCT00972738|450510936|FG001|Overall Study|Withdrawal by Subject|1|||
125242337|NCT00972738|450510937|FG002|Overall Study|Withdrawal by Subject|4|||
125242338|NCT00972738|450510935|FG000|Overall Study|Moved|0|||
125242339|NCT00972738|450510936|FG001|Overall Study|Moved|0|||
125242340|NCT00972738|450510937|FG002|Overall Study|Moved|1|||
125242341|NCT00972738|450510935|FG000|Overall Study|Other|1|||
125242342|NCT00972738|450510936|FG001|Overall Study|Other|2|||
125242343|NCT00972738|450510937|FG002|Overall Study|Other|1|||
125242344|NCT03915067|450510938|FG000|Overall Study|Adverse Event|0|||
125242345|NCT03915067|450510939|FG001|Overall Study|Adverse Event|0|||
125242346|NCT03915067|450510940|FG002|Overall Study|Adverse Event|1|||
125242347|NCT03915067|450510938|FG000|Overall Study|Withdrawal by Subject|4|||
125242348|NCT03915067|450510939|FG001|Overall Study|Withdrawal by Subject|3|||
125242349|NCT03915067|450510940|FG002|Overall Study|Withdrawal by Subject|0|||
125242350|NCT03915067|450510938|FG000|Overall Study|Lost to Follow-up|3|||
125242351|NCT03915067|450510939|FG001|Overall Study|Lost to Follow-up|2|||
125242352|NCT03915067|450510940|FG002|Overall Study|Lost to Follow-up|0|||
125242353|NCT03915067|450510938|FG000|Overall Study|Protocol Deviation|0|||
125242354|NCT03915067|450510939|FG001|Overall Study|Protocol Deviation|0|||
125242355|NCT03915067|450510940|FG002|Overall Study|Protocol Deviation|1|||
125242356|NCT03915067|450510938|FG000|Overall Study|Covid-19 Related Issues|2|||
125242357|NCT03915067|450510939|FG001|Overall Study|Covid-19 Related Issues|4|||
125242358|NCT03915067|450510940|FG002|Overall Study|Covid-19 Related Issues|4|||
125242359|NCT03915067|450510938|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
125242360|NCT03915067|450510939|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
125242361|NCT03915067|450510940|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
125242362|NCT01033942|450510941|FG000|Overall Study|Withdrawal by Subject|1|||
125242363|NCT01033942|450510942|FG001|Overall Study|Withdrawal by Subject|1|||
125187772|NCT03525678|450306685|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
125187773|NCT03525678|450306681|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
125187774|NCT03525678|450306682|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
125187775|NCT03525678|450306683|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
125187776|NCT03525678|450306684|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
125187777|NCT03525678|450306685|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
125187778|NCT03525678|450306681|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
125187779|NCT03525678|450306682|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
125187780|NCT03525678|450306683|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
125393179|NCT02641379|451072551|FG000|Overall Study|Participant treated after Week 24|0|||
125393180|NCT02641379|451072552|FG001|Overall Study|Participant treated after Week 24|0|||
125393181|NCT02641379|451072553|FG002|Overall Study|Participant treated after Week 24|0|||
125187781|NCT03525678|450306684|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
125187782|NCT03525678|450306685|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
125187783|NCT03525678|450306681|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
125187784|NCT03525678|450306682|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
125187785|NCT03525678|450306683|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
125187786|NCT03525678|450306684|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
125187787|NCT03525678|450306685|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
125187788|NCT03525678|450306681|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
125187789|NCT03525678|450306682|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
125187790|NCT03525678|450306683|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
125187791|NCT03525678|450306684|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
125187792|NCT03525678|450306685|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
125187793|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
125187794|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
125187795|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
125187796|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
125187797|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
125187798|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
125187799|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
125187800|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
125187801|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
125187802|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
125187803|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
125187804|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
125187805|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
125187806|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
125187807|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
125187808|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
125187809|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
125187810|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
125187811|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
125187812|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
125187813|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
125187814|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
125187815|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
125187816|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
125187817|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
125187818|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
125187819|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
125187820|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
125187821|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
125187822|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
125187823|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
125187824|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
125187825|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187826|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187827|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
125187828|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187829|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125393182|NCT02641379|451072554|FG003|Overall Study|Participant treated after Week 24|0|||
125393183|NCT02641379|451072555|FG004|Overall Study|Participant treated after Week 24|0|||
125393184|NCT02641379|451072556|FG005|Overall Study|Participant treated after Week 24|0|||
125393185|NCT02641379|451072557|FG006|Overall Study|Participant treated after Week 24|0|||
125393186|NCT02641379|451072558|FG007|Overall Study|Participant treated after Week 24|0|||
125393187|NCT02641379|451072559|FG008|Overall Study|Participant treated after Week 24|1|||
125187830|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187831|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
125242364|NCT01033942|450510943|FG002|Overall Study|Withdrawal by Subject|1|||
125242365|NCT01033942|450510941|FG000|Overall Study|Lost to Follow-up|1|||
125393188|NCT02641379|451072560|FG009|Overall Study|Participant treated after Week 24|0|||
125393189|NCT02641379|451072561|FG010|Overall Study|Participant treated after Week 24|0|||
125187832|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187833|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
125187834|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
125187835|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
125187836|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
125187837|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
125187838|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
125187839|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
125187840|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
125187841|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
125187842|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
125187843|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
125187844|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
125187845|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
125187846|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
125187847|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
125187848|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
125187849|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187850|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
125187851|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187852|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187853|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187854|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187855|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187856|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
125187857|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187858|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187859|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187860|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187861|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
125187862|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187863|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187864|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
125187865|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187866|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187867|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187868|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187869|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187870|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
125187871|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187872|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
125187873|NCT03896503|450308142|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
125187874|NCT03896503|450308143|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
125187875|NCT03896503|450308144|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
125187876|NCT03896503|450308145|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
125187877|NCT03896503|450308146|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
125242366|NCT01033942|450510942|FG001|Overall Study|Lost to Follow-up|0|||
125242367|NCT01033942|450510943|FG002|Overall Study|Lost to Follow-up|0|||
125393190|NCT02641379|451072551|FG000|Overall Study|Missing PCR result at Week 8|0|||
125393191|NCT02641379|451072552|FG001|Overall Study|Missing PCR result at Week 8|0|||
125242368|NCT01033942|450510941|FG000|Overall Study|Enrolled in Extension Study|0|||
125242369|NCT01033942|450510942|FG001|Overall Study|Enrolled in Extension Study|3|||
125242370|NCT01033942|450510943|FG002|Overall Study|Enrolled in Extension Study|0|||
125242371|NCT02693418|450510944|FG000|Overall Study|Lost to Follow-up|1|||
125242372|NCT02693418|450510945|FG001|Overall Study|Lost to Follow-up|2|||
125242373|NCT02693418|450510946|FG002|Overall Study|Lost to Follow-up|0|||
125242374|NCT02693418|450510947|FG003|Overall Study|Lost to Follow-up|0|||
125242375|NCT02693418|450510948|FG004|Overall Study|Lost to Follow-up|0|||
125242376|NCT02693418|450510944|FG000|Overall Study|Menses during study period|0|||
125242377|NCT02693418|450510945|FG001|Overall Study|Menses during study period|0|||
125242378|NCT02693418|450510946|FG002|Overall Study|Menses during study period|2|||
125242379|NCT02693418|450510947|FG003|Overall Study|Menses during study period|0|||
125242380|NCT02693418|450510948|FG004|Overall Study|Menses during study period|0|||
125242381|NCT02260986|450510954|FG000|Overall Study|Adverse Event|24|||
125242382|NCT02260986|450510955|FG001|Overall Study|Adverse Event|0|||
125242383|NCT02260986|450510956|FG002|Overall Study|Adverse Event|11|||
125242384|NCT02260986|450510954|FG000|Overall Study|Lack of Efficacy|27|||
125242385|NCT02260986|450510955|FG001|Overall Study|Lack of Efficacy|3|||
125242386|NCT02260986|450510956|FG002|Overall Study|Lack of Efficacy|0|||
125242387|NCT02260986|450510954|FG000|Overall Study|Protocol Violation|14|||
125242388|NCT02260986|450510955|FG001|Overall Study|Protocol Violation|5|||
125242389|NCT02260986|450510956|FG002|Overall Study|Protocol Violation|16|||
125242390|NCT02260986|450510954|FG000|Overall Study|Car accident|0|||
125242391|NCT02260986|450510955|FG001|Overall Study|Car accident|0|||
125242392|NCT02260986|450510956|FG002|Overall Study|Car accident|1|||
125242393|NCT02260986|450510954|FG000|Overall Study|Withdrawal by Subject|17|||
125242394|NCT02260986|450510955|FG001|Overall Study|Withdrawal by Subject|4|||
125242395|NCT02260986|450510956|FG002|Overall Study|Withdrawal by Subject|9|||
125242396|NCT02260986|450510954|FG000|Overall Study|Incorrect randomization|0|||
125242397|NCT02260986|450510955|FG001|Overall Study|Incorrect randomization|1|||
125242398|NCT02260986|450510956|FG002|Overall Study|Incorrect randomization|0|||
125242399|NCT02260986|450510954|FG000|Overall Study|Lack of investigation product supply|2|||
125242400|NCT02260986|450510955|FG001|Overall Study|Lack of investigation product supply|0|||
125242401|NCT02260986|450510956|FG002|Overall Study|Lack of investigation product supply|1|||
125242402|NCT02260986|450510954|FG000|Overall Study|Lost to Follow-up|4|||
125242403|NCT02260986|450510955|FG001|Overall Study|Lost to Follow-up|0|||
125242404|NCT02260986|450510956|FG002|Overall Study|Lost to Follow-up|3|||
125242405|NCT02260986|450510954|FG000|Overall Study|Pregnancy|2|||
125242406|NCT02260986|450510955|FG001|Overall Study|Pregnancy|0|||
125242407|NCT02260986|450510956|FG002|Overall Study|Pregnancy|0|||
125242408|NCT01793935|450510959|FG000|Overall Study|Pregnancy|1|||
125242409|NCT01793935|450510960|FG001|Overall Study|Pregnancy|0|||
125242410|NCT01793935|450510959|FG000|Overall Study|Protocol Violation|2|||
125242411|NCT01793935|450510960|FG001|Overall Study|Protocol Violation|1|||
125242412|NCT01793935|450510959|FG000|Overall Study|Adverse Event|2|||
125242413|NCT01793935|450510960|FG001|Overall Study|Adverse Event|0|||
125242414|NCT01793935|450510959|FG000|Overall Study|Patient did not take study medication|1|||
125242415|NCT01793935|450510960|FG001|Overall Study|Patient did not take study medication|1|||
125242416|NCT01793935|450510959|FG000|Overall Study|Lost to Follow-up|0|||
125242417|NCT01793935|450510960|FG001|Overall Study|Lost to Follow-up|1|||
125242418|NCT01771913|450510962|FG000|Overall Study|Withdrawal by Subject|1|||
125242419|NCT01771913|450510963|FG001|Overall Study|Withdrawal by Subject|0|||
125242420|NCT00313170|450510965|FG000|Overall Study|Death|2|||
125242421|NCT00313170|450510966|FG001|Overall Study|Death|4|||
125242422|NCT00313170|450510967|FG002|Overall Study|Death|2|||
125242423|NCT00313170|450510965|FG000|Overall Study|Adverse Event|1|||
125242424|NCT00313170|450510966|FG001|Overall Study|Adverse Event|2|||
125242425|NCT00313170|450510967|FG002|Overall Study|Adverse Event|0|||
125242426|NCT00313170|450510965|FG000|Overall Study|Disease progression|31|||
125242427|NCT00313170|450510966|FG001|Overall Study|Disease progression|26|||
125242428|NCT00313170|450510967|FG002|Overall Study|Disease progression|27|||
125242429|NCT00313170|450510965|FG000|Overall Study|Withdrawal by Subject|1|||
125242430|NCT00313170|450510966|FG001|Overall Study|Withdrawal by Subject|0|||
125242431|NCT00313170|450510967|FG002|Overall Study|Withdrawal by Subject|1|||
125242432|NCT00313170|450510965|FG000|Overall Study|Incorrect enrollment|0|||
125242433|NCT00313170|450510966|FG001|Overall Study|Incorrect enrollment|2|||
125242434|NCT00313170|450510967|FG002|Overall Study|Incorrect enrollment|1|||
125242435|NCT00313170|450510965|FG000|Overall Study|Lost to Follow-up|0|||
125242436|NCT00313170|450510966|FG001|Overall Study|Lost to Follow-up|0|||
125242437|NCT00313170|450510967|FG002|Overall Study|Lost to Follow-up|1|||
125242438|NCT00313170|450510965|FG000|Overall Study|Progression (investigators opinion)|1|||
125242439|NCT00313170|450510966|FG001|Overall Study|Progression (investigators opinion)|0|||
125242440|NCT00313170|450510967|FG002|Overall Study|Progression (investigators opinion)|0|||
125242441|NCT04900272|450510968|FG000|Overall Study|Lost to Follow-up|2|||
125242442|NCT04900272|450510968|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
125242443|NCT04900272|450510968|FG000|Overall Study|Withdrawal by Subject|1|||
125242444|NCT05059080|450510970|FG000|Overall Study|Withdrawal by Subject|3|||
125242445|NCT05059080|450510970|FG000|Overall Study|Study Terminated by Sponsor|64|||
125393192|NCT02641379|451072553|FG002|Overall Study|Missing PCR result at Week 8|0|||
125393193|NCT02641379|451072554|FG003|Overall Study|Missing PCR result at Week 8|0|||
125393194|NCT02641379|451072555|FG004|Overall Study|Missing PCR result at Week 8|0|||
125393195|NCT02641379|451072556|FG005|Overall Study|Missing PCR result at Week 8|0|||
125393196|NCT02641379|451072557|FG006|Overall Study|Missing PCR result at Week 8|0|||
125393197|NCT02641379|451072558|FG007|Overall Study|Missing PCR result at Week 8|0|||
125393198|NCT02641379|451072559|FG008|Overall Study|Missing PCR result at Week 8|0|||
125393199|NCT02641379|451072560|FG009|Overall Study|Missing PCR result at Week 8|1|||
125393200|NCT02641379|451072561|FG010|Overall Study|Missing PCR result at Week 8|0|||
125393201|NCT02641379|451072551|FG000|Overall Study|PCR positive|0|||
125393202|NCT02641379|451072552|FG001|Overall Study|PCR positive|0|||
125393203|NCT02641379|451072553|FG002|Overall Study|PCR positive|0|||
125393204|NCT02641379|451072554|FG003|Overall Study|PCR positive|0|||
125393205|NCT02641379|451072555|FG004|Overall Study|PCR positive|0|||
125393206|NCT02641379|451072556|FG005|Overall Study|PCR positive|0|||
125393207|NCT02641379|451072557|FG006|Overall Study|PCR positive|1|||
125393208|NCT02641379|451072558|FG007|Overall Study|PCR positive|0|||
125393209|NCT02641379|451072559|FG008|Overall Study|PCR positive|0|||
125393210|NCT02641379|451072560|FG009|Overall Study|PCR positive|0|||
125393211|NCT02641379|451072561|FG010|Overall Study|PCR positive|0|||
125393212|NCT04982250|451072562|FG000|Overall Study|Lost to Follow-up|0|||
125393213|NCT04982250|451072563|FG001|Overall Study|Lost to Follow-up|26|||
125393214|NCT04982250|451072564|FG002|Overall Study|Lost to Follow-up|0|||
125393215|NCT04982250|451072565|FG003|Overall Study|Lost to Follow-up|0|||
125393216|NCT04982250|451072566|FG004|Overall Study|Lost to Follow-up|72|||
125393217|NCT04982250|451072567|FG005|Overall Study|Lost to Follow-up|69|||
125393218|NCT04982250|451072562|FG000|Overall Study|Not Eligible to Enroll|0|||
125393219|NCT04982250|451072563|FG001|Overall Study|Not Eligible to Enroll|0|||
125393220|NCT04982250|451072564|FG002|Overall Study|Not Eligible to Enroll|0|||
125393221|NCT04982250|451072565|FG003|Overall Study|Not Eligible to Enroll|0|||
125393222|NCT04982250|451072566|FG004|Overall Study|Not Eligible to Enroll|10|||
125393223|NCT04982250|451072567|FG005|Overall Study|Not Eligible to Enroll|7|||
125393224|NCT01148511|451072568|FG000|Exposed to Study Drug|Protocol Violation|2|||
125393225|NCT01148511|451072569|FG001|Exposed to Study Drug|Protocol Violation|0|||
125393226|NCT01148511|451072570|FG002|Exposed to Study Drug|Protocol Violation|0|||
125393227|NCT01148511|451072568|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
125393228|NCT01148511|451072569|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
125393229|NCT01148511|451072570|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
125393230|NCT01148511|451072568|FG000|Randomized|Adverse Event|0|||
125393231|NCT01148511|451072569|FG001|Randomized|Adverse Event|1|||
125393232|NCT01148511|451072570|FG002|Randomized|Adverse Event|0|||
125393233|NCT01148511|451072568|FG000|Randomized|Protocol Violation|0|||
125393234|NCT01148511|451072569|FG001|Randomized|Protocol Violation|2|||
125393235|NCT01148511|451072570|FG002|Randomized|Protocol Violation|1|||
125393236|NCT01148511|451072568|FG000|Randomized|Lost to Follow-up|0|||
125393237|NCT01148511|451072569|FG001|Randomized|Lost to Follow-up|1|||
125393238|NCT01148511|451072570|FG002|Randomized|Lost to Follow-up|1|||
125393239|NCT01148511|451072568|FG000|Randomized|Consent withdrawal|0|||
125393240|NCT01148511|451072569|FG001|Randomized|Consent withdrawal|5|||
125393241|NCT01148511|451072570|FG002|Randomized|Consent withdrawal|3|||
125393242|NCT01148511|451072568|FG000|Randomized|Other|0|||
125393243|NCT01148511|451072569|FG001|Randomized|Other|1|||
125393244|NCT01148511|451072570|FG002|Randomized|Other|1|||
125393245|NCT01644175|451072573|FG000|Overall Study|Randomized But Not Treated|0|||
125393246|NCT01644175|451072574|FG001|Overall Study|Randomized But Not Treated|2|||
125393247|NCT01644175|451072573|FG000|Overall Study|Adverse Event|8|||
125393248|NCT01644175|451072574|FG001|Overall Study|Adverse Event|13|||
125393249|NCT01644175|451072573|FG000|Overall Study|Death|1|||
125393250|NCT01644175|451072574|FG001|Overall Study|Death|2|||
125393251|NCT01644175|451072573|FG000|Overall Study|Poor compliance to protocol|9|||
125393252|NCT01644175|451072574|FG001|Overall Study|Poor compliance to protocol|10|||
125393253|NCT01644175|451072573|FG000|Overall Study|Physician Decision|1|||
125393254|NCT01644175|451072574|FG001|Overall Study|Physician Decision|2|||
125187878|NCT03896503|450308147|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
125187879|NCT03896503|450308148|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
125187880|NCT03896503|450308149|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
125187881|NCT00210210|450308153|FG000|Overall Study|Withdrawal by Subject|3|||
125187882|NCT00210210|450308154|FG001|Overall Study|Withdrawal by Subject|2|||
125187883|NCT00210210|450308153|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
125187884|NCT00210210|450308154|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
125187885|NCT04225715|450308156|FG000|Overall Study|Reason not Specified|1|||
125187886|NCT04225715|450308157|FG001|Overall Study|Reason not Specified|0|||
125187887|NCT04225715|450308158|FG002|Overall Study|Reason not Specified|0|||
125187888|NCT04225715|450308159|FG003|Overall Study|Reason not Specified|0|||
125187889|NCT04225715|450308160|FG004|Overall Study|Reason not Specified|0|||
125393255|NCT01644175|451072573|FG000|Overall Study|Participant Moved|1|||
125242446|NCT05607043|450510971|FG000|Overall Study|Lost to Follow-up|2|||
125242447|NCT00800540|450510975|FG000|Period One: 6 Weeks|Noncompliance|1|||
125242448|NCT00800540|450510976|FG001|Period One: 6 Weeks|Noncompliance|0|||
125242449|NCT00800540|450510975|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
125242450|NCT00800540|450510976|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
125242451|NCT00800540|450510975|FG000|Period 2: 6 Weeks|Adverse Event|0|||
125242452|NCT00800540|450510976|FG001|Period 2: 6 Weeks|Adverse Event|1|||
125242453|NCT02447029|450510979|FG000|Overall Study|Withdrawal by Subject|3|||
125242454|NCT02447029|450510980|FG001|Overall Study|Withdrawal by Subject|2|||
125242455|NCT00549328|450510981|FG000|Overall Study|Adverse Event|2|||
125242456|NCT00549328|450510981|FG000|Overall Study|Disease Progression|10|||
125242457|NCT00549328|450510981|FG000|Overall Study|Death|1|||
125242458|NCT00549328|450510981|FG000|Overall Study|Use of Prohibited Medication|1|||
125242459|NCT00770484|450510982|FG000|Overall Study|Withdrawal by Subject|1|||
125242460|NCT00770484|450510983|FG001|Overall Study|Withdrawal by Subject|0|||
125242461|NCT03097315|450510988|FG000|Overall Study|Withdrawal by Subject|1|||
125242462|NCT01946802|450510989|FG000|Overall Study|Death|1|||
125242463|NCT01946802|450510989|FG000|Overall Study|Withdrawal by Subject|2|||
125242464|NCT01946802|450510989|FG000|Overall Study|Combined septic shock|1|||
125242465|NCT01946802|450510989|FG000|Overall Study|Protocol Violation|1|||
125242466|NCT04327271|450510990|FG000|Overall Study|Death|1|||
125242467|NCT04327271|450510991|FG001|Overall Study|Death|0|||
125242468|NCT04327271|450510990|FG000|Overall Study|Withdrawal by Subject|1|||
125242469|NCT04327271|450510991|FG001|Overall Study|Withdrawal by Subject|0|||
125242470|NCT04327271|450510990|FG000|Overall Study|randomization error (data capture)|4|||
125242471|NCT04327271|450510991|FG001|Overall Study|randomization error (data capture)|3|||
125242472|NCT03637374|450510992|FG000|Overall Study|Death|2|||
125242473|NCT03637374|450510993|FG001|Overall Study|Death|0|||
125242474|NCT01479530|450510995|FG000|Overall Study|Adverse Event|5|||
125242475|NCT01479530|450510996|FG001|Overall Study|Adverse Event|6|||
125242476|NCT01479530|450510995|FG000|Overall Study|Lack of Efficacy|0|||
125242477|NCT01479530|450510996|FG001|Overall Study|Lack of Efficacy|1|||
125242478|NCT01479530|450510995|FG000|Overall Study|Protocol Violation|2|||
125242479|NCT01479530|450510996|FG001|Overall Study|Protocol Violation|3|||
125242480|NCT01479530|450510995|FG000|Overall Study|Withdrawal of Consent|3|||
125242481|NCT01479530|450510996|FG001|Overall Study|Withdrawal of Consent|2|||
125242482|NCT00303628|450510997|FG000|Overall Study|Disease progression|0|||
125393256|NCT01644175|451072574|FG001|Overall Study|Participant Moved|2|||
125393257|NCT01644175|451072573|FG000|Overall Study|Consent withdrawn by participant|3|||
125393258|NCT01644175|451072574|FG001|Overall Study|Consent withdrawn by participant|4|||
125393259|NCT01644175|451072573|FG000|Overall Study|Related to Autoinjector Administration|2|||
125393260|NCT01644175|451072574|FG001|Overall Study|Related to Autoinjector Administration|1|||
125393261|NCT01644175|451072573|FG000|Overall Study|Last visit outside protocol visit window|4|||
125393262|NCT01644175|451072574|FG001|Overall Study|Last visit outside protocol visit window|11|||
125393263|NCT01644175|451072573|FG000|Overall Study|Selection criteria finally not met|0|||
125393264|NCT01644175|451072574|FG001|Overall Study|Selection criteria finally not met|1|||
125393265|NCT01644175|451072573|FG000|Overall Study|Site closure|2|||
125393266|NCT01644175|451072574|FG001|Overall Study|Site closure|2|||
125393267|NCT01644175|451072573|FG000|Overall Study|Lost to Follow-up|1|||
125393268|NCT01644175|451072574|FG001|Overall Study|Lost to Follow-up|0|||
125393269|NCT01644175|451072573|FG000|Overall Study|Other than specified above|0|||
125393270|NCT01644175|451072574|FG001|Overall Study|Other than specified above|3|||
125393271|NCT02818777|451072580|FG000|Overall Study|Adverse Event|3|||
125393272|NCT01418937|451072581|FG000|Overall Study|Lost to Follow-up|5|||
125242483|NCT00303628|450510998|FG001|Overall Study|Disease progression|1|||
125242484|NCT00303628|450510997|FG000|Overall Study|Adverse Event|26|||
125242485|NCT00303628|450510998|FG001|Overall Study|Adverse Event|36|||
125393273|NCT01418937|451072581|FG000|Overall Study|Protocol Violation|1|||
125393274|NCT01418937|451072581|FG000|Overall Study|Pregnancy|1|||
125393275|NCT01418937|451072581|FG000|Overall Study|Withdrawal by Subject|1|||
125242486|NCT00303628|450510997|FG000|Overall Study|Death|0|||
125242487|NCT00303628|450510998|FG001|Overall Study|Death|1|||
125242488|NCT00303628|450510997|FG000|Overall Study|Withdrawal by Subject|11|||
125242489|NCT00303628|450510998|FG001|Overall Study|Withdrawal by Subject|20|||
125242490|NCT00303628|450510997|FG000|Overall Study|Alternative therapy|2|||
125242491|NCT00303628|450510998|FG001|Overall Study|Alternative therapy|0|||
125242492|NCT00303628|450510997|FG000|Overall Study|Other complicating disease|0|||
125242493|NCT00303628|450510998|FG001|Overall Study|Other complicating disease|1|||
125242494|NCT00303628|450510997|FG000|Overall Study|Not start protocol therapy|3|||
125393276|NCT01324349|451072591|FG000|Overall Study|Death|1|||
125393277|NCT01324349|451072592|FG001|Overall Study|Death|1|||
125393278|NCT01324349|451072591|FG000|Overall Study|Withdrawal by Subject|0|||
125393279|NCT01324349|451072592|FG001|Overall Study|Withdrawal by Subject|1|||
125393280|NCT02013167|451072595|FG000|Overall Study|Withdrawal by Subject|15|||
125242495|NCT00303628|450510998|FG001|Overall Study|Not start protocol therapy|5|||
125242496|NCT00303628|450510997|FG000|Overall Study|Other|8|||
125242497|NCT00303628|450510998|FG001|Overall Study|Other|9|||
125242498|NCT00376506|450510999|FG000|Overall Study|Death|0|||
125242499|NCT00376506|450511000|FG001|Overall Study|Death|2|||
125242500|NCT00776997|450511002|FG000|Overall Study|Adverse Event|2|||
125242501|NCT02948400|450511003|FG000|Overall Study|Withdrawal by Subject|17|||
125242502|NCT02948400|450511004|FG001|Overall Study|Withdrawal by Subject|10|||
125242503|NCT02948400|450511003|FG000|Overall Study|failed to attend appointments|47|||
125242504|NCT02948400|450511004|FG001|Overall Study|failed to attend appointments|34|||
125242505|NCT02948400|450511003|FG000|Overall Study|COVID-related closure|6|||
125242506|NCT02948400|450511004|FG001|Overall Study|COVID-related closure|2|||
125242507|NCT02948400|450511003|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
125242508|NCT02948400|450511004|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
125242509|NCT02948400|450511003|FG000|Overall Study|motion sickness in virtual reality|2|||
125242510|NCT02948400|450511004|FG001|Overall Study|motion sickness in virtual reality|0|||
125242511|NCT02403271|450511005|FG000|Period 1|Other varied reasons|1|||
125242512|NCT02403271|450511006|FG001|Period 1|Other varied reasons|0|||
125242513|NCT02403271|450511005|FG000|Period 2|Withdrawal by Subject|0|||
125242514|NCT02403271|450511006|FG001|Period 2|Withdrawal by Subject|14|||
125242515|NCT02403271|450511005|FG000|Period 2|Death|0|||
125242516|NCT02403271|450511006|FG001|Period 2|Death|84|||
125242517|NCT02403271|450511005|FG000|Period 2|Lost to Follow-up|0|||
125242518|NCT02403271|450511006|FG001|Period 2|Lost to Follow-up|2|||
125242519|NCT02403271|450511005|FG000|Period 2|Study Terminated by Sponsor|0|||
125242520|NCT02403271|450511006|FG001|Period 2|Study Terminated by Sponsor|14|||
125242521|NCT02403271|450511005|FG000|Period 2|Other varied reasons|0|||
125242522|NCT02403271|450511006|FG001|Period 2|Other varied reasons|10|||
125242523|NCT03487445|450511007|FG000|Randomization|Not treated for administrative reasons|1|||
125242524|NCT03487445|450511008|FG001|Randomization|Not treated for administrative reasons|0|||
125242525|NCT00221104|450511009|FG000|Overall Study|Adverse Event|1|||
125242526|NCT00221104|450511010|FG001|Overall Study|Adverse Event|0|||
125242527|NCT00221104|450511009|FG000|Overall Study|Physician Decision|1|||
125242528|NCT00221104|450511010|FG001|Overall Study|Physician Decision|0|||
125242529|NCT00221104|450511009|FG000|Overall Study|Protocol Violation|2|||
125242530|NCT00221104|450511010|FG001|Overall Study|Protocol Violation|0|||
125242531|NCT00221104|450511009|FG000|Overall Study|Withdrawal by Subject|42|||
125242532|NCT00221104|450511010|FG001|Overall Study|Withdrawal by Subject|29|||
125242533|NCT00221104|450511009|FG000|Overall Study|Others|37|||
125242534|NCT00221104|450511010|FG001|Overall Study|Others|47|||
125242535|NCT03301714|450511011|FG000|Overall Study|Lost to Follow-up|10|||
125242536|NCT03301714|450511012|FG001|Overall Study|Lost to Follow-up|4|||
125242537|NCT03301714|450511013|FG002|Overall Study|Lost to Follow-up|4|||
125393281|NCT02013167|451072596|FG001|Overall Study|Withdrawal by Subject|14|||
125393282|NCT02013167|451072595|FG000|Overall Study|Sponsor Decision|1|||
125393283|NCT02013167|451072596|FG001|Overall Study|Sponsor Decision|3|||
125393284|NCT02013167|451072595|FG000|Overall Study|Lost to Follow-up|0|||
125393285|NCT02013167|451072596|FG001|Overall Study|Lost to Follow-up|1|||
125393286|NCT02013167|451072595|FG000|Overall Study|Death|85|||
125393287|NCT02013167|451072596|FG001|Overall Study|Death|160|||
125393288|NCT01113879|451072597|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
125393289|NCT01113879|451072598|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
125393290|NCT03913091|451072599|FG000|Overall Study|Lost to Follow-up|18|||
125393291|NCT03913091|451072600|FG001|Overall Study|Lost to Follow-up|11|||
125393292|NCT03913091|451072599|FG000|Overall Study|Required additional meds/surgery|1|||
125393293|NCT03913091|451072600|FG001|Overall Study|Required additional meds/surgery|2|||
125393294|NCT03913091|451072599|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
125393295|NCT03913091|451072600|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
125393296|NCT00969553|451072601|FG000|Overall Study|Progressive disease (PD)|2|||
125393297|NCT00969553|451072602|FG001|Overall Study|Progressive disease (PD)|2|||
125393298|NCT00969553|451072603|FG002|Overall Study|Progressive disease (PD)|6|||
125393299|NCT00969553|451072604|FG003|Overall Study|Progressive disease (PD)|9|||
125393300|NCT00969553|451072605|FG004|Overall Study|Progressive disease (PD)|2|||
125393301|NCT00969553|451072606|FG005|Overall Study|Progressive disease (PD)|4|||
125393302|NCT00969553|451072607|FG006|Overall Study|Progressive disease (PD)|2|||
125393303|NCT00969553|451072608|FG007|Overall Study|Progressive disease (PD)|12|||
125393304|NCT00969553|451072609|FG008|Overall Study|Progressive disease (PD)|3|||
125393305|NCT00969553|451072601|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
125393306|NCT00969553|451072602|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
125393307|NCT00969553|451072603|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
125242538|NCT03301714|450511011|FG000|Overall Study|Did not receive allocated intervention|0|||
125242539|NCT03301714|450511012|FG001|Overall Study|Did not receive allocated intervention|2|||
125242540|NCT03301714|450511013|FG002|Overall Study|Did not receive allocated intervention|3|||
125393308|NCT00969553|451072604|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
125393309|NCT00969553|451072605|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
125242541|NCT05324371|450511022|FG000|Overall Study|Withdrawal by Subject|1|||
125242542|NCT05324371|450511022|FG000|Overall Study|Death|1|||
125242543|NCT03599713|450511026|FG000|Overall Study|Death|38|||
125393310|NCT00969553|451072606|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
125242544|NCT03599713|450511027|FG001|Overall Study|Death|3|||
125242545|NCT03599713|450511026|FG000|Overall Study|Withdrawal by Subject|17|||
125242546|NCT03599713|450511027|FG001|Overall Study|Withdrawal by Subject|0|||
125242547|NCT03599713|450511026|FG000|Overall Study|Lost to Follow-up|4|||
125242548|NCT03599713|450511027|FG001|Overall Study|Lost to Follow-up|0|||
125242549|NCT03599713|450511026|FG000|Overall Study|Discontinued Due to End of Study|42|||
125242550|NCT03599713|450511027|FG001|Overall Study|Discontinued Due to End of Study|3|||
125242551|NCT01127061|450512200|FG000|Overall Study|Lost to Follow-up|7|||
125242552|NCT01127061|450512201|FG001|Overall Study|Lost to Follow-up|10|||
125242553|NCT01127061|450512200|FG000|Overall Study|Physician Decision|3|||
125242554|NCT01127061|450512201|FG001|Overall Study|Physician Decision|3|||
125242555|NCT04827446|450512202|FG000|Overall Study|Lost to Follow-up|1|||
125242556|NCT04827446|450512203|FG001|Overall Study|Lost to Follow-up|1|||
125242557|NCT04827446|450512202|FG000|Overall Study|Death|2|||
125242558|NCT04827446|450512203|FG001|Overall Study|Death|0|||
125242559|NCT04827446|450512202|FG000|Overall Study|Withdrawal by Subject|2|||
125242560|NCT04827446|450512203|FG001|Overall Study|Withdrawal by Subject|2|||
125242561|NCT00003456|450512206|FG000|Overall Study|Not evaluable|8|||
125242562|NCT05399771|450512207|FG000|Overall Study|Physician Decision|3|||
125242563|NCT05399771|450512207|FG000|Overall Study|Adverse Event|1|||
125242564|NCT00143507|450512210|FG000|Overall Study|Death|572|||
125242565|NCT00143507|450512211|FG001|Overall Study|Death|547|||
125242566|NCT00143507|450512210|FG000|Overall Study|Withdrawal by Subject|114|||
125242567|NCT00143507|450512211|FG001|Overall Study|Withdrawal by Subject|102|||
125242568|NCT00143507|450512210|FG000|Overall Study|Lost to Follow-up|1|||
125242569|NCT00143507|450512211|FG001|Overall Study|Lost to Follow-up|0|||
125242570|NCT00143507|450512210|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
125242571|NCT00143507|450512211|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
125242572|NCT00484159|450512212|FG000|Overall Study|Lost to Follow-up|1|||
125242573|NCT00484159|450512213|FG001|Overall Study|Lost to Follow-up|1|||
125242574|NCT00484159|450512214|FG002|Overall Study|Lost to Follow-up|0|||
125242575|NCT03234881|450512215|FG000|Overall Study|Lost to Follow-up|9|||
125242576|NCT03234881|450512216|FG001|Overall Study|Lost to Follow-up|3|||
125242577|NCT02513199|450512219|FG000|Treatment|Death|1|||
125242578|NCT02513199|450512219|FG000|Treatment|Lost to Follow-up|1|||
125242579|NCT02513199|450512219|FG000|Follow-Up|Death|11|||
125242580|NCT00407511|450512231|FG000|Overall Study|Adverse Event|9|||
125242581|NCT00407511|450512231|FG000|Overall Study|Lost to Follow-up|4|||
125242582|NCT00407511|450512231|FG000|Overall Study|Other|5|||
125242583|NCT00407511|450512231|FG000|Overall Study|Withdrawal by Subject|4|||
125242584|NCT00529035|450512232|FG000|Overall Study|Withdrawal by Subject|1|||
125242585|NCT03439514|450512233|FG000|Double-Blind Treatment Period|Other|4|||
125242586|NCT03439514|450512234|FG001|Double-Blind Treatment Period|Other|1|||
125242587|NCT03439514|450512233|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
125242588|NCT03439514|450512234|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
125242589|NCT03439514|450512233|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
125242590|NCT03439514|450512234|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
125242591|NCT03439514|450512233|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
125242592|NCT03439514|450512234|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
125242593|NCT03439514|450512233|FG000|Double-Blind Treatment Period|Death|1|||
125242594|NCT03439514|450512234|FG001|Double-Blind Treatment Period|Death|2|||
125242595|NCT01521364|450512235|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
125242596|NCT01521364|450512235|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
125242597|NCT02175758|450512236|FG000|Treatment Phase|Lost to Follow-up|0|||
125242598|NCT02175758|450512237|FG001|Treatment Phase|Lost to Follow-up|1|||
125242599|NCT02175758|450512238|FG002|Treatment Phase|Lost to Follow-up|0|||
125242600|NCT02175758|450512239|FG003|Treatment Phase|Lost to Follow-up|0|||
125242601|NCT02175758|450512240|FG004|Treatment Phase|Lost to Follow-up|0|||
125242602|NCT02175758|450512241|FG005|Treatment Phase|Lost to Follow-up|0|||
125242603|NCT02175758|450512236|FG000|Treatment Phase|Adverse Event|0|||
125242604|NCT02175758|450512237|FG001|Treatment Phase|Adverse Event|0|||
125242605|NCT02175758|450512238|FG002|Treatment Phase|Adverse Event|0|||
125242606|NCT02175758|450512239|FG003|Treatment Phase|Adverse Event|0|||
125242607|NCT02175758|450512240|FG004|Treatment Phase|Adverse Event|1|||
125242608|NCT02175758|450512241|FG005|Treatment Phase|Adverse Event|0|||
125242609|NCT02636283|450512242|FG000|Overall Study|Adverse Event|2|||
125242610|NCT02636283|450512243|FG001|Overall Study|Adverse Event|0|||
125242611|NCT02636283|450512242|FG000|Overall Study|Trial Terminated Prematurely|0|||
125242612|NCT02636283|450512243|FG001|Overall Study|Trial Terminated Prematurely|3|||
125242613|NCT03927157|450512246|FG000|Overall Study|Adverse Event|1|||
125242614|NCT03927157|450512247|FG001|Overall Study|Adverse Event|3|||
125242615|NCT03927157|450512246|FG000|Overall Study|Protocol Violation|1|||
125242616|NCT03927157|450512247|FG001|Overall Study|Protocol Violation|2|||
125242617|NCT03927157|450512246|FG000|Overall Study|Withdrawal by Subject|8|||
125242618|NCT03927157|450512247|FG001|Overall Study|Withdrawal by Subject|21|||
125242619|NCT03927157|450512246|FG000|Overall Study|Due to COVID-19 pandemic|5|||
125242620|NCT03927157|450512247|FG001|Overall Study|Due to COVID-19 pandemic|2|||
125242621|NCT03927157|450512246|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
125187890|NCT04225715|450308161|FG005|Overall Study|Reason not Specified|0|||
125187891|NCT04225715|450308162|FG006|Overall Study|Reason not Specified|0|||
125187892|NCT04225715|450308163|FG007|Overall Study|Reason not Specified|0|||
125187893|NCT04225715|450308164|FG008|Overall Study|Reason not Specified|0|||
125187894|NCT04225715|450308156|FG000|Overall Study|Protocol Violation|1|||
125187895|NCT04225715|450308157|FG001|Overall Study|Protocol Violation|0|||
125187896|NCT04225715|450308158|FG002|Overall Study|Protocol Violation|0|||
125187897|NCT04225715|450308159|FG003|Overall Study|Protocol Violation|0|||
125187898|NCT04225715|450308160|FG004|Overall Study|Protocol Violation|0|||
125187899|NCT04225715|450308161|FG005|Overall Study|Protocol Violation|9|||
125187900|NCT04225715|450308162|FG006|Overall Study|Protocol Violation|0|||
125187901|NCT04225715|450308163|FG007|Overall Study|Protocol Violation|0|||
125187902|NCT04225715|450308164|FG008|Overall Study|Protocol Violation|0|||
125187903|NCT04225715|450308156|FG000|Overall Study|Withdrawal by Subject|4|||
125187904|NCT04225715|450308157|FG001|Overall Study|Withdrawal by Subject|1|||
125187905|NCT04225715|450308158|FG002|Overall Study|Withdrawal by Subject|1|||
125187906|NCT04225715|450308159|FG003|Overall Study|Withdrawal by Subject|0|||
125187907|NCT04225715|450308160|FG004|Overall Study|Withdrawal by Subject|3|||
125187908|NCT04225715|450308161|FG005|Overall Study|Withdrawal by Subject|1|||
125187909|NCT04225715|450308162|FG006|Overall Study|Withdrawal by Subject|1|||
125187910|NCT04225715|450308163|FG007|Overall Study|Withdrawal by Subject|1|||
125187911|NCT04225715|450308164|FG008|Overall Study|Withdrawal by Subject|0|||
125187912|NCT04225715|450308156|FG000|Overall Study|Adverse Event|0|||
125187913|NCT04225715|450308157|FG001|Overall Study|Adverse Event|0|||
125187914|NCT04225715|450308158|FG002|Overall Study|Adverse Event|0|||
125187915|NCT04225715|450308159|FG003|Overall Study|Adverse Event|0|||
125187916|NCT04225715|450308160|FG004|Overall Study|Adverse Event|0|||
125187917|NCT04225715|450308161|FG005|Overall Study|Adverse Event|0|||
125187918|NCT04225715|450308162|FG006|Overall Study|Adverse Event|0|||
125187919|NCT04225715|450308163|FG007|Overall Study|Adverse Event|0|||
125187920|NCT04225715|450308164|FG008|Overall Study|Adverse Event|1|||
125187921|NCT04225715|450308156|FG000|Overall Study|Arm Terminated By Sponsor|0|||
125187922|NCT04225715|450308157|FG001|Overall Study|Arm Terminated By Sponsor|0|||
125187923|NCT04225715|450308158|FG002|Overall Study|Arm Terminated By Sponsor|0|||
125187924|NCT04225715|450308159|FG003|Overall Study|Arm Terminated By Sponsor|0|||
125187925|NCT04225715|450308160|FG004|Overall Study|Arm Terminated By Sponsor|0|||
125187926|NCT04225715|450308161|FG005|Overall Study|Arm Terminated By Sponsor|0|||
125187927|NCT04225715|450308162|FG006|Overall Study|Arm Terminated By Sponsor|0|||
125187928|NCT04225715|450308163|FG007|Overall Study|Arm Terminated By Sponsor|17|||
125187929|NCT04225715|450308164|FG008|Overall Study|Arm Terminated By Sponsor|18|||
125187930|NCT03318861|450308172|FG000|Overall Study|Death|2|||
125187931|NCT03318861|450308173|FG001|Overall Study|Death|3|||
125187932|NCT03318861|450308174|FG002|Overall Study|Death|3|||
125187933|NCT03318861|450308175|FG003|Overall Study|Death|2|||
125187934|NCT03318861|450308176|FG004|Overall Study|Death|2|||
125187935|NCT03318861|450308172|FG000|Overall Study|Enrolled But Never Treated|0|||
125187936|NCT03318861|450308173|FG001|Overall Study|Enrolled But Never Treated|1|||
125187937|NCT03318861|450308174|FG002|Overall Study|Enrolled But Never Treated|0|||
125187938|NCT03318861|450308175|FG003|Overall Study|Enrolled But Never Treated|1|||
125187939|NCT03318861|450308176|FG004|Overall Study|Enrolled But Never Treated|1|||
125187940|NCT03318861|450308172|FG000|Overall Study|Informed Consent Withdraw|0|||
125187941|NCT03318861|450308173|FG001|Overall Study|Informed Consent Withdraw|0|||
125187942|NCT03318861|450308174|FG002|Overall Study|Informed Consent Withdraw|0|||
125187943|NCT03318861|450308175|FG003|Overall Study|Informed Consent Withdraw|1|||
125187944|NCT03318861|450308176|FG004|Overall Study|Informed Consent Withdraw|0|||
125187945|NCT03318861|450308172|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
125187946|NCT03318861|450308173|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
125187947|NCT03318861|450308174|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
125187948|NCT03318861|450308175|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
125187949|NCT03318861|450308176|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
125187950|NCT00917852|450308177|FG000|Overall Study|Death|6|||
125187951|NCT00471081|450308178|FG000|Active Phase|Protocol Violation|1|||
125187952|NCT00471081|450308179|FG001|Active Phase|Protocol Violation|1|||
125187953|NCT00471081|450308178|FG000|Active Phase|Withdrawal by Subject|0|||
125187954|NCT00471081|450308179|FG001|Active Phase|Withdrawal by Subject|3|||
125187955|NCT00471081|450308178|FG000|Active Phase|Lost to Follow-up|0|||
125187956|NCT00471081|450308179|FG001|Active Phase|Lost to Follow-up|1|||
125187957|NCT00471081|450308178|FG000|Active Phase|Lost health plan/insurance|1|||
125187958|NCT00471081|450308179|FG001|Active Phase|Lost health plan/insurance|8|||
125187959|NCT00471081|450308178|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
125187960|NCT00471081|450308179|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
125187961|NCT00471081|450308178|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
125187962|NCT00471081|450308179|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
125187963|NCT00471081|450308178|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
125187964|NCT00471081|450308179|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
125187965|NCT02844933|450308180|FG000|Overall Study|Discontinued due to premature termination of study|3|||
125242622|NCT03927157|450512247|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
125242623|NCT03927157|450512246|FG000|Overall Study|Other than above|0|||
125242624|NCT03927157|450512247|FG001|Overall Study|Other than above|1|||
125242625|NCT00726557|450512248|FG000|Overall Study|Screening failure|4|||
125242626|NCT00726557|450512248|FG000|Overall Study|No end of treatment documentation|37|||
125242627|NCT00726557|450512248|FG000|Overall Study|No follow-up documentation available|55|||
125242628|NCT00726557|450512248|FG000|Overall Study|Treatment less than 3 months|17|||
125242629|NCT00726557|450512248|FG000|Overall Study|Inclusion criteria not met|15|||
125242630|NCT01239745|450512249|FG000|Overall Study|Study terminated by sponsor|45|||
125242631|NCT01239745|450512249|FG000|Overall Study|Adverse Event|1|||
125242632|NCT00081458|450512250|FG000|Overall Study|Adverse Event|1|||
125242633|NCT00081458|450512251|FG001|Overall Study|Adverse Event|5|||
125242634|NCT00081458|450512252|FG002|Overall Study|Adverse Event|2|||
125242635|NCT00081458|450512250|FG000|Overall Study|Withdrawal by Subject|0|||
125242636|NCT00081458|450512251|FG001|Overall Study|Withdrawal by Subject|3|||
125242637|NCT00081458|450512252|FG002|Overall Study|Withdrawal by Subject|1|||
125242638|NCT00081458|450512250|FG000|Overall Study|Randomized but not dosed|0|||
125242639|NCT00081458|450512251|FG001|Overall Study|Randomized but not dosed|0|||
125242640|NCT00081458|450512252|FG002|Overall Study|Randomized but not dosed|1|||
125242641|NCT03384966|450512253|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
125242642|NCT03384966|450512254|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
125242643|NCT03384966|450512255|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
125242644|NCT03384966|450512253|FG000|Follow-up Period|Adverse Event|1|||
125242645|NCT03384966|450512254|FG001|Follow-up Period|Adverse Event|0|||
125242646|NCT03384966|450512255|FG002|Follow-up Period|Adverse Event|0|||
125242647|NCT02202616|450512256|FG000|Overall Study|Screen failed|24|||
125242648|NCT02202616|450512256|FG000|Overall Study|Adverse Event|32|||
125242649|NCT02202616|450512256|FG000|Overall Study|Protocol deviation|18|||
125242650|NCT02202616|450512256|FG000|Overall Study|Patient withdrew consent|12|||
125242651|NCT02202616|450512256|FG000|Overall Study|Lost to Follow-up|6|||
125242652|NCT02202616|450512256|FG000|Overall Study|Administrative problems|6|||
125242653|NCT02202616|450512256|FG000|Overall Study|Abnormal test procedure result|1|||
125242654|NCT02202616|450512256|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125242655|NCT01334515|450512257|FG000|Overall Study|Adverse Event|1|||
125242656|NCT01334515|450512258|FG001|Overall Study|Adverse Event|6|||
125242657|NCT01334515|450512257|FG000|Overall Study|Death|1|||
125242658|NCT01334515|450512258|FG001|Overall Study|Death|0|||
125242659|NCT01334515|450512257|FG000|Overall Study|Lack of Efficacy|8|||
125242660|NCT01334515|450512258|FG001|Overall Study|Lack of Efficacy|21|||
125242661|NCT01334515|450512257|FG000|Overall Study|Physician Decision|1|||
125242662|NCT01334515|450512258|FG001|Overall Study|Physician Decision|1|||
125242663|NCT01334515|450512257|FG000|Overall Study|Withdrawal by Subject|1|||
125242664|NCT01334515|450512258|FG001|Overall Study|Withdrawal by Subject|1|||
125242665|NCT02836769|450512262|FG000|Overall Study|Lost to Follow-up|10|||
125242666|NCT02836769|450512262|FG000|Overall Study|Medical withdrawal|2|||
125242667|NCT02836769|450512262|FG000|Overall Study|Withdrawal by Subject|3|||
125393311|NCT00969553|451072607|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
125393312|NCT00969553|451072608|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
125393313|NCT00969553|451072609|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
125393314|NCT00969553|451072601|FG000|Overall Study|Other Adverse Event|0|||
125393315|NCT00969553|451072602|FG001|Overall Study|Other Adverse Event|0|||
125393316|NCT00969553|451072603|FG002|Overall Study|Other Adverse Event|0|||
125393317|NCT00969553|451072604|FG003|Overall Study|Other Adverse Event|1|||
125393318|NCT00969553|451072605|FG004|Overall Study|Other Adverse Event|0|||
125393319|NCT00969553|451072606|FG005|Overall Study|Other Adverse Event|0|||
125393320|NCT00969553|451072607|FG006|Overall Study|Other Adverse Event|1|||
125393321|NCT00969553|451072608|FG007|Overall Study|Other Adverse Event|0|||
125393322|NCT00969553|451072609|FG008|Overall Study|Other Adverse Event|0|||
125393323|NCT00969553|451072601|FG000|Overall Study|Refused cont. medication|1|||
125393324|NCT00969553|451072602|FG001|Overall Study|Refused cont. medication|1|||
125393325|NCT00969553|451072603|FG002|Overall Study|Refused cont. medication|0|||
125242668|NCT02989389|450512272|FG000|Period 1|Lost to Follow-up|0|||
125242669|NCT02989389|450512273|FG001|Period 1|Lost to Follow-up|1|||
125242670|NCT02989389|450512274|FG002|Period 1|Lost to Follow-up|0|||
125393326|NCT00969553|451072604|FG003|Overall Study|Refused cont. medication|2|||
125393327|NCT00969553|451072605|FG004|Overall Study|Refused cont. medication|0|||
125393328|NCT00969553|451072606|FG005|Overall Study|Refused cont. medication|0|||
125393329|NCT00969553|451072607|FG006|Overall Study|Refused cont. medication|0|||
125242671|NCT02989389|450512275|FG003|Period 1|Lost to Follow-up|0|||
125242672|NCT02989389|450512276|FG004|Period 1|Lost to Follow-up|0|||
125242673|NCT02989389|450512277|FG005|Period 1|Lost to Follow-up|0|||
125242674|NCT02989389|450512278|FG006|Period 1|Lost to Follow-up|0|||
125242675|NCT02989389|450512279|FG007|Period 1|Lost to Follow-up|0|||
125242676|NCT02989389|450512280|FG008|Period 1|Lost to Follow-up|0|||
125242677|NCT02989389|450512281|FG009|Period 1|Lost to Follow-up|0|||
125242678|NCT02989389|450512272|FG000|Period 1|Physician Decision|0|||
125242679|NCT02989389|450512273|FG001|Period 1|Physician Decision|0|||
125242680|NCT02989389|450512274|FG002|Period 1|Physician Decision|0|||
125242681|NCT02989389|450512275|FG003|Period 1|Physician Decision|0|||
125242682|NCT02989389|450512276|FG004|Period 1|Physician Decision|0|||
125242683|NCT02989389|450512277|FG005|Period 1|Physician Decision|0|||
125242684|NCT02989389|450512278|FG006|Period 1|Physician Decision|0|||
125242685|NCT02989389|450512279|FG007|Period 1|Physician Decision|0|||
125242686|NCT02989389|450512280|FG008|Period 1|Physician Decision|1|||
125242687|NCT02989389|450512281|FG009|Period 1|Physician Decision|0|||
125242688|NCT00374868|450512282|FG000|Overall Study|Adverse Event|12|||
125443461|NCT00513019|451252133|FG000|Overall Study|Withdrawal by Subject|4|||
125443462|NCT00513019|451252134|FG001|Overall Study|Withdrawal by Subject|5|||
125443463|NCT01500226|451252135|FG000|Overall Study|Adverse Event|31|||
125443464|NCT01500226|451252136|FG001|Overall Study|Adverse Event|38|||
125443465|NCT01500226|451252135|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
125443466|NCT01500226|451252136|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
125443467|NCT01500226|451252135|FG000|Overall Study|Withdrawal by Subject|93|||
125443468|NCT01500226|451252136|FG001|Overall Study|Withdrawal by Subject|96|||
125443469|NCT01500226|451252135|FG000|Overall Study|Death|12|||
125443470|NCT01500226|451252136|FG001|Overall Study|Death|4|||
125443471|NCT01500226|451252135|FG000|Overall Study|Disease Progression|16|||
125443472|NCT01500226|451252136|FG001|Overall Study|Disease Progression|14|||
125443473|NCT01500226|451252135|FG000|Overall Study|Protocol Violation|53|||
125443474|NCT01500226|451252136|FG001|Overall Study|Protocol Violation|39|||
125443475|NCT01500226|451252135|FG000|Overall Study|Physician Decision|17|||
125443476|NCT01500226|451252136|FG001|Overall Study|Physician Decision|15|||
125443477|NCT01500226|451252135|FG000|Overall Study|Lack of Efficacy|14|||
125443478|NCT01500226|451252136|FG001|Overall Study|Lack of Efficacy|30|||
125443479|NCT01500226|451252135|FG000|Overall Study|Lost to Follow-up|9|||
125443480|NCT01500226|451252136|FG001|Overall Study|Lost to Follow-up|5|||
125443481|NCT01500226|451252135|FG000|Overall Study|Other Reasons|19|||
125443482|NCT01500226|451252136|FG001|Overall Study|Other Reasons|16|||
125443483|NCT02955277|451252137|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
125443484|NCT02955277|451252138|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
125443485|NCT02955277|451252137|FG000|Post to Follow-up|Lost to Follow-up|8|||
125443486|NCT02955277|451252138|FG001|Post to Follow-up|Lost to Follow-up|11|||
125443487|NCT01809210|451252151|FG000|Overall Study|Withdrawal by Subject|0|||
125443488|NCT01809210|451252152|FG001|Overall Study|Withdrawal by Subject|0|||
125443489|NCT01809210|451252153|FG002|Overall Study|Withdrawal by Subject|1|||
125443490|NCT01809210|451252154|FG003|Overall Study|Withdrawal by Subject|1|||
125187966|NCT02844933|450308181|FG001|Overall Study|Discontinued due to premature termination of study|2|||
125187967|NCT04537078|450308182|FG000|Overall Study|Protocol Violation|3|||
125187968|NCT04537078|450308183|FG001|Overall Study|Protocol Violation|2|||
125187969|NCT04537078|450308182|FG000|Overall Study|Lost to Follow-up|1|||
125187970|NCT04537078|450308183|FG001|Overall Study|Lost to Follow-up|0|||
125187971|NCT04537078|450308182|FG000|Overall Study|Withdrawal by Subject|0|||
125187972|NCT04537078|450308183|FG001|Overall Study|Withdrawal by Subject|1|||
125187973|NCT01568892|450308184|FG000|Open-label Phase|Adverse Event|2|||
125187974|NCT01568892|450308185|FG001|Open-label Phase|Adverse Event|0|||
125187975|NCT01568892|450308184|FG000|Open-label Phase|Lack of Efficacy|4|||
125187976|NCT01568892|450308185|FG001|Open-label Phase|Lack of Efficacy|2|||
125187977|NCT01568892|450308184|FG000|Open-label Phase|Lost to Follow-up|0|||
125187978|NCT01568892|450308185|FG001|Open-label Phase|Lost to Follow-up|1|||
125187979|NCT01704495|450308193|FG000|Subjects Randomized|Other Reason|3|||
125187980|NCT01704495|450308194|FG001|Subjects Randomized|Other Reason|2|||
125187981|NCT01704495|450308195|FG002|Subjects Randomized|Other Reason|3|||
125187982|NCT01704495|450308196|FG003|Subjects Randomized|Other Reason|2|||
125187983|NCT01704495|450308193|FG000|Subjects Randomized|Discontinuation criteria met|4|||
125187984|NCT01704495|450308194|FG001|Subjects Randomized|Discontinuation criteria met|2|||
125187985|NCT01704495|450308195|FG002|Subjects Randomized|Discontinuation criteria met|2|||
125187986|NCT01704495|450308196|FG003|Subjects Randomized|Discontinuation criteria met|0|||
125187987|NCT01704495|450308193|FG000|Subjects Randomized|Adverse Event|8|||
125187988|NCT01704495|450308194|FG001|Subjects Randomized|Adverse Event|2|||
125187989|NCT01704495|450308195|FG002|Subjects Randomized|Adverse Event|0|||
125187990|NCT01704495|450308196|FG003|Subjects Randomized|Adverse Event|7|||
125443491|NCT01809210|451252155|FG004|Overall Study|Withdrawal by Subject|1|||
125443492|NCT01809210|451252156|FG005|Overall Study|Withdrawal by Subject|0|||
125443493|NCT01809210|451252157|FG006|Overall Study|Withdrawal by Subject|4|||
125443494|NCT01809210|451252151|FG000|Overall Study|Death|1|||
125443495|NCT01809210|451252152|FG001|Overall Study|Death|1|||
125187991|NCT01704495|450308193|FG000|Subjects Randomized|Withdrawal by Subject|5|||
125187992|NCT01704495|450308194|FG001|Subjects Randomized|Withdrawal by Subject|5|||
125187993|NCT01704495|450308195|FG002|Subjects Randomized|Withdrawal by Subject|5|||
125443496|NCT01809210|451252153|FG002|Overall Study|Death|2|||
125443497|NCT01809210|451252154|FG003|Overall Study|Death|0|||
125443498|NCT01809210|451252155|FG004|Overall Study|Death|1|||
125187994|NCT01704495|450308196|FG003|Subjects Randomized|Withdrawal by Subject|5|||
125187995|NCT01704495|450308193|FG000|Subjects Randomized|Protocol Violation|1|||
125242689|NCT00374868|450512282|FG000|Overall Study|Progressive Disease|7|||
125393330|NCT00969553|451072608|FG007|Overall Study|Refused cont. medication|1|||
125393331|NCT00969553|451072609|FG008|Overall Study|Refused cont. medication|0|||
125393332|NCT00969553|451072601|FG000|Overall Study|Not specified above|0|||
125393333|NCT00969553|451072602|FG001|Overall Study|Not specified above|0|||
125393334|NCT00969553|451072603|FG002|Overall Study|Not specified above|0|||
125393335|NCT00969553|451072604|FG003|Overall Study|Not specified above|4|||
125393336|NCT00969553|451072605|FG004|Overall Study|Not specified above|0|||
125393337|NCT00969553|451072606|FG005|Overall Study|Not specified above|0|||
125393338|NCT00969553|451072607|FG006|Overall Study|Not specified above|1|||
125393339|NCT00969553|451072608|FG007|Overall Study|Not specified above|1|||
125393340|NCT00969553|451072609|FG008|Overall Study|Not specified above|0|||
125393341|NCT02276612|451072611|FG000|Overall Study|Death|1|||
125393342|NCT02276612|451072612|FG001|Overall Study|Death|0|||
125393343|NCT02276612|451072611|FG000|Overall Study|Pregnancy|1|||
125393344|NCT02276612|451072612|FG001|Overall Study|Pregnancy|0|||
125393345|NCT02276612|451072611|FG000|Overall Study|Withdrew Consent|1|||
125393346|NCT02276612|451072612|FG001|Overall Study|Withdrew Consent|0|||
125393347|NCT02276612|451072611|FG000|Overall Study|Lost to Follow-up|1|||
125393348|NCT02276612|451072612|FG001|Overall Study|Lost to Follow-up|0|||
125393349|NCT02196324|451072613|FG000|Overall Study|Withdrawal by Subject|8|||
125393350|NCT02196324|451072614|FG001|Overall Study|Withdrawal by Subject|4|||
125393351|NCT02196324|451072613|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
125187996|NCT01704495|450308194|FG001|Subjects Randomized|Protocol Violation|1|||
125187997|NCT01704495|450308195|FG002|Subjects Randomized|Protocol Violation|2|||
125187998|NCT01704495|450308196|FG003|Subjects Randomized|Protocol Violation|0|||
125187999|NCT01704495|450308193|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
125188000|NCT01704495|450308194|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
125188001|NCT01704495|450308195|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
125188002|NCT01704495|450308196|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
125188003|NCT01704495|450308193|FG000|Optional Safety Extension|Adverse Event|0|||
125188004|NCT01704495|450308194|FG001|Optional Safety Extension|Adverse Event|4|||
125188005|NCT01704495|450308195|FG002|Optional Safety Extension|Adverse Event|0|||
125188006|NCT01704495|450308196|FG003|Optional Safety Extension|Adverse Event|1|||
125188007|NCT01704495|450308193|FG000|Optional Safety Extension|Other reason|27|||
125188008|NCT01704495|450308194|FG001|Optional Safety Extension|Other reason|29|||
125188009|NCT01704495|450308195|FG002|Optional Safety Extension|Other reason|30|||
125188010|NCT01704495|450308196|FG003|Optional Safety Extension|Other reason|28|||
125188011|NCT01704495|450308193|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
125188012|NCT01704495|450308194|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
125188013|NCT01704495|450308195|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
125188014|NCT01704495|450308196|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
125188015|NCT00997373|450308201|FG000|Overall Study|Withdrawal by Subject|5|||
125188016|NCT00997373|450308202|FG001|Overall Study|Withdrawal by Subject|0|||
125188017|NCT00997373|450308201|FG000|Overall Study|wrong tumor type|4|||
125188018|NCT00997373|450308202|FG001|Overall Study|wrong tumor type|0|||
125188019|NCT00997373|450308201|FG000|Overall Study|could not have hysterectomy|6|||
125188020|NCT00997373|450308202|FG001|Overall Study|could not have hysterectomy|0|||
125188021|NCT01592786|450308204|FG000|Overall Study|Adverse Event|60|||
125188022|NCT01592786|450308204|FG000|Overall Study|Lack of Efficacy|19|||
125188023|NCT01592786|450308204|FG000|Overall Study|Protocol Violation|14|||
125188024|NCT01592786|450308204|FG000|Overall Study|Withdrawal by Subject|23|||
125188025|NCT01592786|450308204|FG000|Overall Study|Lost to Follow-up|19|||
125188026|NCT01592786|450308204|FG000|Overall Study|Other|3|||
125188027|NCT02172664|450308207|FG000|Overall Study|Lost to Follow-up|4|||
125188028|NCT02172664|450308208|FG001|Overall Study|Lost to Follow-up|4|||
125188029|NCT02172664|450308207|FG000|Overall Study|Death|1|||
125188030|NCT02172664|450308208|FG001|Overall Study|Death|1|||
125188031|NCT02172664|450308207|FG000|Overall Study|Moved out of area|1|||
125188032|NCT02172664|450308208|FG001|Overall Study|Moved out of area|1|||
125188033|NCT03810092|450308209|FG000|Overall Study|no ground support|17|||
125188034|NCT03810092|450308209|FG000|Overall Study|ADL not done at J0|16|||
125188035|NCT03810092|450308209|FG000|Overall Study|No hemoglobin measure at J5|27|||
125188036|NCT02492867|450308214|FG000|Overall Study|Alternate therapy|1|||
125188037|NCT02492867|450308214|FG000|Overall Study|Withdrawal by Subject|2|||
125188038|NCT02492867|450308214|FG000|Overall Study|Disease progression after treatment started|1|||
125188039|NCT02492867|450308214|FG000|Overall Study|Death|1|||
125188040|NCT03296527|450308215|FG000|Overall Study|Adverse Event|15|||
125188041|NCT03296527|450308216|FG001|Overall Study|Adverse Event|33|||
125188042|NCT03296527|450308215|FG000|Overall Study|Protocol Deviation|4|||
125188043|NCT03296527|450308216|FG001|Overall Study|Protocol Deviation|0|||
125188044|NCT03296527|450308215|FG000|Overall Study|Participant withdrew consent|3|||
125188045|NCT03296527|450308216|FG001|Overall Study|Participant withdrew consent|1|||
125188046|NCT03296527|450308215|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
125188047|NCT03296527|450308216|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
125393352|NCT02196324|451072614|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
125393353|NCT02196324|451072613|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
125188048|NCT03296527|450308215|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
125188049|NCT03296527|450308216|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
125188050|NCT03296527|450308215|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
125188051|NCT03296527|450308216|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
125188052|NCT03296527|450308215|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
125188053|NCT03296527|450308216|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
125188054|NCT03296527|450308215|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
125188055|NCT03296527|450308216|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
125188056|NCT00122382|450308217|FG000|Double-Blind Study|Adverse Event|9|||
125188057|NCT00122382|450308218|FG001|Double-Blind Study|Adverse Event|11|||
125188058|NCT00122382|450308219|FG002|Double-Blind Study|Adverse Event|0|||
125188059|NCT00122382|450308217|FG000|Double-Blind Study|Death|2|||
125188060|NCT00122382|450308218|FG001|Double-Blind Study|Death|2|||
125188061|NCT00122382|450308219|FG002|Double-Blind Study|Death|0|||
125188062|NCT00122382|450308217|FG000|Double-Blind Study|Lack of Efficacy|0|||
125188063|NCT00122382|450308218|FG001|Double-Blind Study|Lack of Efficacy|8|||
125188064|NCT00122382|450308219|FG002|Double-Blind Study|Lack of Efficacy|0|||
125188065|NCT00122382|450308217|FG000|Double-Blind Study|Lost to Follow-up|2|||
125188066|NCT00122382|450308218|FG001|Double-Blind Study|Lost to Follow-up|1|||
125188067|NCT00122382|450308219|FG002|Double-Blind Study|Lost to Follow-up|0|||
125188068|NCT00122382|450308217|FG000|Double-Blind Study|Pregnancy|2|||
125188069|NCT00122382|450308218|FG001|Double-Blind Study|Pregnancy|0|||
125188070|NCT00122382|450308219|FG002|Double-Blind Study|Pregnancy|0|||
125188071|NCT00122382|450308217|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
125188072|NCT00122382|450308218|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
125188073|NCT00122382|450308219|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
125188074|NCT00122382|450308217|FG000|Double-Blind Study|Withdrawal of Consent|7|||
125188075|NCT00122382|450308218|FG001|Double-Blind Study|Withdrawal of Consent|3|||
125188076|NCT00122382|450308219|FG002|Double-Blind Study|Withdrawal of Consent|0|||
125188077|NCT00122382|450308217|FG000|Double-Blind Study|Protocol Violation|1|||
125188078|NCT00122382|450308218|FG001|Double-Blind Study|Protocol Violation|0|||
125188079|NCT00122382|450308219|FG002|Double-Blind Study|Protocol Violation|0|||
125188080|NCT00122382|450308217|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
125188081|NCT00122382|450308218|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
125188082|NCT00122382|450308219|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
125188083|NCT00122382|450308217|FG000|Double-Blind Study|Randomized but not treated|0|||
125188084|NCT00122382|450308218|FG001|Double-Blind Study|Randomized but not treated|2|||
125188085|NCT00122382|450308219|FG002|Double-Blind Study|Randomized but not treated|0|||
125188086|NCT00122382|450308217|FG000|Open-Label Study|Adverse Event|0|||
125188087|NCT00122382|450308218|FG001|Open-Label Study|Adverse Event|0|||
125188088|NCT00122382|450308219|FG002|Open-Label Study|Adverse Event|11|||
125188089|NCT00122382|450308217|FG000|Open-Label Study|Death|0|||
125188090|NCT00122382|450308218|FG001|Open-Label Study|Death|0|||
125188091|NCT00122382|450308219|FG002|Open-Label Study|Death|2|||
125188092|NCT00122382|450308217|FG000|Open-Label Study|Lack of Efficacy|0|||
125188093|NCT00122382|450308218|FG001|Open-Label Study|Lack of Efficacy|0|||
125188094|NCT00122382|450308219|FG002|Open-Label Study|Lack of Efficacy|3|||
125188095|NCT00122382|450308217|FG000|Open-Label Study|Lost to Follow-up|0|||
125188096|NCT00122382|450308218|FG001|Open-Label Study|Lost to Follow-up|0|||
125188097|NCT00122382|450308219|FG002|Open-Label Study|Lost to Follow-up|3|||
125188098|NCT00122382|450308217|FG000|Open-Label Study|Pregnancy|0|||
125188099|NCT00122382|450308218|FG001|Open-Label Study|Pregnancy|0|||
125188100|NCT00122382|450308219|FG002|Open-Label Study|Pregnancy|2|||
125188101|NCT00122382|450308217|FG000|Open-Label Study|Poor/Non-Compliance|0|||
125188102|NCT00122382|450308218|FG001|Open-Label Study|Poor/Non-Compliance|0|||
125188103|NCT00122382|450308219|FG002|Open-Label Study|Poor/Non-Compliance|1|||
125188104|NCT00122382|450308217|FG000|Open-Label Study|Withdrawal of Consent|0|||
125188105|NCT00122382|450308218|FG001|Open-Label Study|Withdrawal of Consent|0|||
125188106|NCT00122382|450308219|FG002|Open-Label Study|Withdrawal of Consent|4|||
125188107|NCT02040805|450308220|FG000|Overall Study|Lost to Follow-up|14|||
125188108|NCT02040805|450308221|FG001|Overall Study|Lost to Follow-up|9|||
125188109|NCT02040805|450308220|FG000|Overall Study|Withdrawal by Subject|28|||
125188110|NCT02040805|450308221|FG001|Overall Study|Withdrawal by Subject|41|||
125188111|NCT01213966|450308223|FG000|Overall Study|Protocol Violation|1|||
125188112|NCT01213966|450308224|FG001|Overall Study|Protocol Violation|0|||
125188113|NCT01213966|450308225|FG002|Overall Study|Protocol Violation|3|||
125188114|NCT01213966|450308226|FG003|Overall Study|Protocol Violation|1|||
125188115|NCT03591874|450308227|FG000|Overall Study|Adverse Event|4|||
125188116|NCT03591874|450308228|FG001|Overall Study|Adverse Event|0|||
125188117|NCT03591874|450308227|FG000|Overall Study|Withdrawal by Subject|2|||
125188118|NCT03591874|450308228|FG001|Overall Study|Withdrawal by Subject|1|||
125188119|NCT03591874|450308227|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
125188120|NCT03591874|450308228|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
125188121|NCT03591874|450308227|FG000|Overall Study|On Study at Time of Study Termination|12|||
125188122|NCT03591874|450308228|FG001|Overall Study|On Study at Time of Study Termination|6|||
125188123|NCT03644342|450308231|FG000|Overall Study|Adverse Event|2|||
125188124|NCT03644342|450308232|FG001|Overall Study|Adverse Event|0|||
125188125|NCT03644342|450308231|FG000|Overall Study|Protocol Violation|0|||
125188126|NCT03644342|450308232|FG001|Overall Study|Protocol Violation|1|||
125188127|NCT04762160|450308235|FG000|Overall Study|Study terminated early due to business reasons|5|||
125188128|NCT01205776|450308238|FG000|Overall Study|Lost to Follow-up|53|||
125188129|NCT01205776|450308239|FG001|Overall Study|Lost to Follow-up|61|||
125188130|NCT01205776|450308238|FG000|Overall Study|Withdrawal by Subject|11|||
125188131|NCT01205776|450308239|FG001|Overall Study|Withdrawal by Subject|34|||
125188132|NCT00734994|450308240|FG000|Overall Study|Withdrawal by Subject|1|||
125188133|NCT01622673|450308243|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125188134|NCT01622673|450308244|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125188135|NCT01622673|450308245|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125188136|NCT01622673|450308246|FG003|Treatment Period 1|Withdrawal by Subject|1|||
125188137|NCT01622673|450308247|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125188138|NCT01622673|450308248|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125188139|NCT01622673|450308243|FG000|Treatment Period 1|Protocol Violation|0|||
125188140|NCT01622673|450308244|FG001|Treatment Period 1|Protocol Violation|1|||
125188141|NCT01622673|450308245|FG002|Treatment Period 1|Protocol Violation|0|||
125188142|NCT01622673|450308246|FG003|Treatment Period 1|Protocol Violation|0|||
125188143|NCT01622673|450308247|FG004|Treatment Period 1|Protocol Violation|0|||
125188144|NCT01622673|450308248|FG005|Treatment Period 1|Protocol Violation|0|||
125188145|NCT01622673|450308243|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125188146|NCT01622673|450308244|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125188147|NCT01622673|450308245|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125188148|NCT01622673|450308246|FG003|Treatment Period 2|Withdrawal by Subject|1|||
125188149|NCT01622673|450308247|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125188150|NCT01622673|450308248|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125188151|NCT01622673|450308243|FG000|Treatment Period 3|Protocol Violation|0|||
125188152|NCT01622673|450308244|FG001|Treatment Period 3|Protocol Violation|1|||
125188153|NCT01622673|450308245|FG002|Treatment Period 3|Protocol Violation|0|||
125188154|NCT01622673|450308246|FG003|Treatment Period 3|Protocol Violation|0|||
125188155|NCT01622673|450308247|FG004|Treatment Period 3|Protocol Violation|0|||
125188156|NCT01622673|450308248|FG005|Treatment Period 3|Protocol Violation|0|||
125188157|NCT04146012|450308249|FG000|Overall Study|Study Terminated|30|||
125188158|NCT04146012|450308250|FG001|Overall Study|Study Terminated|15|||
125188159|NCT05514873|450308251|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
125188160|NCT05514873|450308251|FG000|Main Treatment Period|Adverse Event|2|||
125188161|NCT05514873|450308251|FG000|Extension Treatment Period|Lost to Follow-up|3|||
125188162|NCT02747108|450308254|FG000|Overall Study|Death|2|||
125188163|NCT02747108|450308255|FG001|Overall Study|Death|2|||
125188164|NCT02747108|450308254|FG000|Overall Study|Withdrawal by Subject|1|||
125188165|NCT02747108|450308255|FG001|Overall Study|Withdrawal by Subject|0|||
125188166|NCT02747108|450308254|FG000|Overall Study|Protocol Violation|2|||
125188167|NCT02747108|450308255|FG001|Overall Study|Protocol Violation|0|||
125188168|NCT00437021|450309110|FG000|Overall Study|Adverse Event|0|||
125188169|NCT00437021|450309111|FG001|Overall Study|Adverse Event|0|||
125188170|NCT00437021|450309112|FG002|Overall Study|Adverse Event|0|||
125188171|NCT00437021|450309113|FG003|Overall Study|Adverse Event|0|||
125188172|NCT00437021|450309114|FG004|Overall Study|Adverse Event|0|||
125188173|NCT00437021|450309115|FG005|Overall Study|Adverse Event|0|||
125188174|NCT00437021|450309116|FG006|Overall Study|Adverse Event|1|||
125188175|NCT00437021|450309117|FG007|Overall Study|Adverse Event|0|||
125188176|NCT00437021|450309118|FG008|Overall Study|Adverse Event|0|||
125188177|NCT00437021|450309119|FG009|Overall Study|Adverse Event|0|||
125188178|NCT00437021|450309120|FG010|Overall Study|Adverse Event|0|||
125188179|NCT00437021|450309121|FG011|Overall Study|Adverse Event|0|||
125188180|NCT00437021|450309110|FG000|Overall Study|Lost to Follow-up|0|||
125188181|NCT00437021|450309111|FG001|Overall Study|Lost to Follow-up|3|||
125188182|NCT00437021|450309112|FG002|Overall Study|Lost to Follow-up|0|||
125188183|NCT00437021|450309113|FG003|Overall Study|Lost to Follow-up|0|||
125188184|NCT00437021|450309114|FG004|Overall Study|Lost to Follow-up|0|||
125188185|NCT00437021|450309115|FG005|Overall Study|Lost to Follow-up|2|||
125188186|NCT00437021|450309116|FG006|Overall Study|Lost to Follow-up|0|||
125188187|NCT00437021|450309117|FG007|Overall Study|Lost to Follow-up|1|||
125188188|NCT00437021|450309118|FG008|Overall Study|Lost to Follow-up|0|||
125188189|NCT00437021|450309119|FG009|Overall Study|Lost to Follow-up|0|||
125188190|NCT00437021|450309120|FG010|Overall Study|Lost to Follow-up|0|||
125188191|NCT00437021|450309121|FG011|Overall Study|Lost to Follow-up|0|||
125188192|NCT00437021|450309110|FG000|Overall Study|Withdrawal by Subject|2|||
125188193|NCT00437021|450309111|FG001|Overall Study|Withdrawal by Subject|1|||
125188194|NCT00437021|450309112|FG002|Overall Study|Withdrawal by Subject|0|||
125188195|NCT00437021|450309113|FG003|Overall Study|Withdrawal by Subject|0|||
125188196|NCT00437021|450309114|FG004|Overall Study|Withdrawal by Subject|0|||
125188197|NCT00437021|450309115|FG005|Overall Study|Withdrawal by Subject|0|||
125188198|NCT00437021|450309116|FG006|Overall Study|Withdrawal by Subject|0|||
125188199|NCT00437021|450309117|FG007|Overall Study|Withdrawal by Subject|0|||
125188200|NCT00437021|450309118|FG008|Overall Study|Withdrawal by Subject|0|||
125188201|NCT00437021|450309119|FG009|Overall Study|Withdrawal by Subject|0|||
125188202|NCT00437021|450309120|FG010|Overall Study|Withdrawal by Subject|0|||
125188203|NCT00437021|450309121|FG011|Overall Study|Withdrawal by Subject|0|||
125188204|NCT05573464|450309122|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
125188205|NCT05573464|450309123|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
125188206|NCT05573464|450309122|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
125188207|NCT05573464|450309123|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
125188208|NCT05573464|450309122|FG000|12-week Treatment Period|Protocol Violation|3|||
125188209|NCT05573464|450309123|FG001|12-week Treatment Period|Protocol Violation|1|||
125188210|NCT05573464|450309122|FG000|12-week Treatment Period|Physician Decision|1|||
125188211|NCT05573464|450309123|FG001|12-week Treatment Period|Physician Decision|2|||
125188212|NCT05573464|450309122|FG000|12-week Treatment Period|Lost to Follow-up|2|||
125188213|NCT05573464|450309123|FG001|12-week Treatment Period|Lost to Follow-up|0|||
125188214|NCT05573464|450309122|FG000|12-week Treatment Period|Adverse Event|20|||
125188215|NCT05573464|450309123|FG001|12-week Treatment Period|Adverse Event|9|||
125188216|NCT05573464|450309122|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
125188217|NCT05573464|450309123|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
125188218|NCT05573464|450309122|FG000|12-week Treatment Period|Randomised, not treated|0|||
125188219|NCT05573464|450309123|FG001|12-week Treatment Period|Randomised, not treated|1|||
125188220|NCT05573464|450309122|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
125188221|NCT05573464|450309123|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
125188222|NCT05573464|450309122|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
125188223|NCT05573464|450309123|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
125188224|NCT05573464|450309122|FG000|52-week Treatment Period|Protocol Violation|1|||
125242690|NCT00374868|450512282|FG000|Overall Study|Physician Decision|13|||
125242691|NCT00374868|450512282|FG000|Overall Study|Lost to Follow-up|1|||
125242692|NCT00374868|450512282|FG000|Overall Study|Death|2|||
125393354|NCT02196324|451072614|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
125393355|NCT02196324|451072613|FG000|Overall Study|Other|1|||
125393356|NCT02196324|451072614|FG001|Overall Study|Other|0|||
125393357|NCT00692770|451072615|FG000|Overall Study|Protocol Violation|2|||
125393358|NCT00692770|451072616|FG001|Overall Study|Protocol Violation|7|||
125393359|NCT00692770|451072615|FG000|Overall Study|Withdrawal by Subject|97|||
125393360|NCT00692770|451072616|FG001|Overall Study|Withdrawal by Subject|36|||
125393361|NCT00692770|451072615|FG000|Overall Study|Adverse Event|136|||
125393362|NCT00692770|451072616|FG001|Overall Study|Adverse Event|41|||
125393363|NCT00692770|451072615|FG000|Overall Study|Death|10|||
125393364|NCT00692770|451072616|FG001|Overall Study|Death|5|||
125393365|NCT00692770|451072615|FG000|Overall Study|Lost to Follow-up|7|||
125393366|NCT00692770|451072616|FG001|Overall Study|Lost to Follow-up|3|||
125393367|NCT00692770|451072615|FG000|Overall Study|Non-compliant with study medication|11|||
125393368|NCT00692770|451072616|FG001|Overall Study|Non-compliant with study medication|5|||
125393369|NCT00692770|451072615|FG000|Overall Study|Progression by clinical judgment|2|||
125393370|NCT00692770|451072616|FG001|Overall Study|Progression by clinical judgment|3|||
125393371|NCT00692770|451072615|FG000|Overall Study|Physician decision not protocol driven|10|||
125393372|NCT00692770|451072616|FG001|Overall Study|Physician decision not protocol driven|14|||
125393373|NCT00692770|451072615|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
125393374|NCT00692770|451072616|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
125393375|NCT00692770|451072615|FG000|Overall Study|Protocol driven decision point|3|||
125393376|NCT00692770|451072616|FG001|Overall Study|Protocol driven decision point|7|||
125393377|NCT00692770|451072615|FG000|Overall Study|Completed all planned assessments|79|||
125393378|NCT00692770|451072616|FG001|Overall Study|Completed all planned assessments|101|||
125393379|NCT00692770|451072615|FG000|Overall Study|Radiological and clinical progression|8|||
125393380|NCT00692770|451072616|FG001|Overall Study|Radiological and clinical progression|8|||
125393381|NCT00692770|451072615|FG000|Overall Study|Clinical endpoint reached|16|||
125393382|NCT00692770|451072616|FG001|Overall Study|Clinical endpoint reached|43|||
125393383|NCT00692770|451072615|FG000|Overall Study|Study terminated by sponsor|2|||
125393384|NCT00692770|451072616|FG001|Overall Study|Study terminated by sponsor|2|||
125393385|NCT00692770|451072615|FG000|Overall Study|Randomized but not treated|3|||
125393386|NCT00692770|451072616|FG001|Overall Study|Randomized but not treated|4|||
125393387|NCT04327986|451072617|FG000|Overall Study|Physician Decision|2|||
125393388|NCT04327986|451072618|FG001|Overall Study|Physician Decision|0|||
125393389|NCT04327986|451072619|FG002|Overall Study|Physician Decision|0|||
125393390|NCT04327986|451072617|FG000|Overall Study|Death|1|||
125393391|NCT04327986|451072618|FG001|Overall Study|Death|0|||
125393392|NCT04327986|451072619|FG002|Overall Study|Death|0|||
125393393|NCT04248816|451072620|FG000|Overall Study|Ineligible post-randomization|7|||
125188225|NCT05573464|450309123|FG001|52-week Treatment Period|Protocol Violation|1|||
125188226|NCT05573464|450309122|FG000|52-week Treatment Period|Physician Decision|2|||
125188227|NCT05573464|450309123|FG001|52-week Treatment Period|Physician Decision|2|||
125242693|NCT00374868|450512282|FG000|Overall Study|Other - Not Specified|1|||
125242694|NCT04470427|450512283|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
125242695|NCT04470427|450512284|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
125242696|NCT04470427|450512285|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
125393394|NCT04248816|451072621|FG001|Overall Study|Ineligible post-randomization|21|||
125393395|NCT04248816|451072622|FG002|Overall Study|Ineligible post-randomization|25|||
125393396|NCT02046148|451074041|FG000|Overall Study|Lost to Follow-up|1|||
125393397|NCT02046148|451074042|FG001|Overall Study|Lost to Follow-up|1|||
125393398|NCT02046148|451074041|FG000|Overall Study|Withdrawal by Subject|0|||
125393399|NCT02046148|451074042|FG001|Overall Study|Withdrawal by Subject|2|||
125393400|NCT00097721|451074043|FG000|Overall Study|Adverse Event|8|||
125393401|NCT00097721|451074044|FG001|Overall Study|Adverse Event|1|||
125188228|NCT05573464|450309122|FG000|52-week Treatment Period|Lost to Follow-up|1|||
125188229|NCT05573464|450309123|FG001|52-week Treatment Period|Lost to Follow-up|1|||
125188230|NCT05573464|450309122|FG000|52-week Treatment Period|Adverse Event|11|||
125188231|NCT05573464|450309123|FG001|52-week Treatment Period|Adverse Event|8|||
125188232|NCT05573464|450309122|FG000|52-week Treatment Period|Death|1|||
125188233|NCT05573464|450309123|FG001|52-week Treatment Period|Death|1|||
125188234|NCT05734157|450309124|FG000|Overall Study|Death|3|||
125188235|NCT05734157|450309124|FG000|Overall Study|Withdrawal by Subject|2|||
125188236|NCT05734157|450309124|FG000|Overall Study|Lost to Follow-up|1|||
125188237|NCT05734157|450309124|FG000|Overall Study|Telephone call|3|||
125188238|NCT02275546|450309135|FG000|Treatment Period 2|Withdrawal by Subject|2|||
125188239|NCT02275546|450309136|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125188240|NCT02275546|450309135|FG000|Treatment Period 2|Protocol Violation|0|||
125188241|NCT02275546|450309136|FG001|Treatment Period 2|Protocol Violation|1|||
125188242|NCT02955355|450309137|FG000|Overall Study|Adverse Event|4|||
125188243|NCT02955355|450309137|FG000|Overall Study|Death|1|||
125188244|NCT02955355|450309137|FG000|Overall Study|Physician Decision|21|||
125188245|NCT02955355|450309137|FG000|Overall Study|Site Terminated by Sponsor|35|||
125188246|NCT02955355|450309137|FG000|Overall Study|Withdrawal by Subject|19|||
125188247|NCT02955355|450309137|FG000|Overall Study|Reason Not Specified|5|||
125188248|NCT02612623|450309138|FG000|Overall Study|Withdrawal by Subject|0|||
125188249|NCT02612623|450309139|FG001|Overall Study|Withdrawal by Subject|1|||
125188250|NCT02612623|450309140|FG002|Overall Study|Withdrawal by Subject|0|||
125188251|NCT02612623|450309141|FG003|Overall Study|Withdrawal by Subject|0|||
125188252|NCT02612623|450309138|FG000|Overall Study|Adverse Event|1|||
125188253|NCT02612623|450309139|FG001|Overall Study|Adverse Event|0|||
125188254|NCT02612623|450309140|FG002|Overall Study|Adverse Event|1|||
125188255|NCT02612623|450309141|FG003|Overall Study|Adverse Event|0|||
125188256|NCT05177484|450309142|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
125188257|NCT05177484|450309143|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
125188258|NCT05177484|450309142|FG000|Overall Study|Inadvertently withdrawn|3|||
125188259|NCT05177484|450309143|FG001|Overall Study|Inadvertently withdrawn|1|||
125188260|NCT05177484|450309142|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
125188261|NCT05177484|450309143|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
125188262|NCT05486091|450309148|FG000|Overall Study|Withdrawal by Subject|1|||
125188263|NCT05486091|450309148|FG000|Overall Study|Lost to Follow-up|2|||
125188264|NCT03971071|450309149|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
125188265|NCT03971071|450309150|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
125188266|NCT03971071|450309151|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
125188267|NCT03971071|450309152|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
125188268|NCT03971071|450309153|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
125188269|NCT03971071|450309149|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
125188270|NCT03971071|450309150|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
125188271|NCT03971071|450309151|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
125188272|NCT03971071|450309152|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125188273|NCT03971071|450309153|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
125188274|NCT03971071|450309149|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
125188275|NCT03971071|450309150|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
125188276|NCT03971071|450309151|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
125188277|NCT03971071|450309152|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
125188278|NCT03971071|450309153|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
125188279|NCT03971071|450309149|FG000|Open-label Treatment Period|Sponsor decision|0|||
125188280|NCT03971071|450309150|FG001|Open-label Treatment Period|Sponsor decision|0|||
125242697|NCT04470427|450512286|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
125242698|NCT04470427|450512287|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
125393402|NCT00097721|451074043|FG000|Overall Study|Withdrawal by Subject|6|||
125393403|NCT00097721|451074044|FG001|Overall Study|Withdrawal by Subject|1|||
125393404|NCT00097721|451074043|FG000|Overall Study|Progressive Disease|55|||
125393405|NCT00097721|451074044|FG001|Overall Study|Progressive Disease|27|||
125188281|NCT03971071|450309151|FG002|Open-label Treatment Period|Sponsor decision|0|||
125188282|NCT03971071|450309152|FG003|Open-label Treatment Period|Sponsor decision|0|||
125188283|NCT03971071|450309153|FG004|Open-label Treatment Period|Sponsor decision|1|||
125242699|NCT04470427|450512288|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
125242700|NCT04470427|450512283|FG000|Part B :Open-label|Other than specified|0|||
125242701|NCT04470427|450512284|FG001|Part B :Open-label|Other than specified|0|||
125242702|NCT04470427|450512285|FG002|Part B :Open-label|Other than specified|788|||
125242703|NCT04470427|450512286|FG003|Part B :Open-label|Other than specified|0|||
125242704|NCT04470427|450512287|FG004|Part B :Open-label|Other than specified|523|||
125242705|NCT04470427|450512288|FG005|Part B :Open-label|Other than specified|0|||
125242706|NCT04470427|450512283|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
125242707|NCT04470427|450512284|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
125242708|NCT04470427|450512285|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
125242709|NCT04470427|450512286|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
125242710|NCT04470427|450512287|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
125242711|NCT04470427|450512288|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
125242712|NCT04470427|450512283|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
125242713|NCT04470427|450512284|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
125242714|NCT04470427|450512285|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
125242715|NCT04470427|450512286|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
125242716|NCT04470427|450512287|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
125242717|NCT04470427|450512288|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
125242718|NCT01179516|450512289|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
125242719|NCT01179516|450512290|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
125242720|NCT01179516|450512291|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
125242721|NCT01179516|450512289|FG000|Overall Study|Lack of Efficacy|4|||
125242722|NCT01179516|450512290|FG001|Overall Study|Lack of Efficacy|2|||
125242723|NCT01179516|450512291|FG002|Overall Study|Lack of Efficacy|0|||
125242724|NCT01179516|450512289|FG000|Overall Study|Noncompliance with Study Drug|2|||
125242725|NCT01179516|450512290|FG001|Overall Study|Noncompliance with Study Drug|0|||
125242726|NCT01179516|450512291|FG002|Overall Study|Noncompliance with Study Drug|1|||
125242727|NCT01179516|450512289|FG000|Overall Study|Protocol Deviations|4|||
125242728|NCT01179516|450512290|FG001|Overall Study|Protocol Deviations|3|||
125242729|NCT01179516|450512291|FG002|Overall Study|Protocol Deviations|3|||
125242730|NCT01179516|450512289|FG000|Overall Study|Withdrawal of Consent|2|||
125242731|NCT01179516|450512290|FG001|Overall Study|Withdrawal of Consent|6|||
125242732|NCT01179516|450512291|FG002|Overall Study|Withdrawal of Consent|10|||
125242733|NCT01179516|450512289|FG000|Overall Study|Lost to Follow-up|7|||
125242734|NCT01179516|450512290|FG001|Overall Study|Lost to Follow-up|7|||
125242735|NCT01179516|450512291|FG002|Overall Study|Lost to Follow-up|3|||
125242736|NCT01179516|450512289|FG000|Overall Study|Other|2|||
125242737|NCT01179516|450512290|FG001|Overall Study|Other|0|||
125242738|NCT01179516|450512291|FG002|Overall Study|Other|2|||
125242739|NCT03349515|450512293|FG000|Overall Study|Lack of Efficacy|2|||
125242740|NCT03349515|450512294|FG001|Overall Study|Lack of Efficacy|0|||
125242741|NCT03349515|450512293|FG000|Overall Study|Physician Decision|3|||
125242742|NCT03349515|450512294|FG001|Overall Study|Physician Decision|1|||
125242743|NCT03412890|450512295|FG000|Overall Study|Adverse Event|5|||
125242744|NCT03412890|450512296|FG001|Overall Study|Adverse Event|5|||
125242745|NCT03412890|450512297|FG002|Overall Study|Adverse Event|9|||
125242746|NCT03412890|450512295|FG000|Overall Study|Protocol deviation|2|||
125242747|NCT03412890|450512296|FG001|Overall Study|Protocol deviation|1|||
125242748|NCT03412890|450512297|FG002|Overall Study|Protocol deviation|2|||
125242749|NCT03412890|450512295|FG000|Overall Study|Lost to Follow-up|7|||
125242750|NCT03412890|450512296|FG001|Overall Study|Lost to Follow-up|10|||
125242751|NCT03412890|450512297|FG002|Overall Study|Lost to Follow-up|10|||
125242752|NCT03412890|450512295|FG000|Overall Study|Withdrawal by Subject|9|||
125242753|NCT03412890|450512296|FG001|Overall Study|Withdrawal by Subject|12|||
125242754|NCT03412890|450512297|FG002|Overall Study|Withdrawal by Subject|11|||
125242755|NCT03412890|450512295|FG000|Overall Study|Lack of Efficacy|2|||
125242756|NCT03412890|450512296|FG001|Overall Study|Lack of Efficacy|7|||
125242757|NCT03412890|450512297|FG002|Overall Study|Lack of Efficacy|5|||
125242758|NCT03412890|450512295|FG000|Overall Study|Other|5|||
125242759|NCT03412890|450512296|FG001|Overall Study|Other|6|||
125242760|NCT03412890|450512297|FG002|Overall Study|Other|5|||
125242761|NCT03412890|450512295|FG000|Overall Study|Participants who did not receive any study drug|0|||
125242762|NCT03412890|450512296|FG001|Overall Study|Participants who did not receive any study drug|1|||
125242763|NCT03412890|450512297|FG002|Overall Study|Participants who did not receive any study drug|0|||
125242764|NCT02315625|450512298|FG000|First Intervention|Disease Progression|1|||
125242765|NCT02315625|450512299|FG001|First Intervention|Disease Progression|0|||
125242766|NCT02315625|450512298|FG000|Second Intervention|Physician Decision|2|||
125242767|NCT02315625|450512299|FG001|Second Intervention|Physician Decision|1|||
125242768|NCT02315625|450512298|FG000|Second Intervention|Study closure|1|||
125242769|NCT02315625|450512299|FG001|Second Intervention|Study closure|0|||
125242770|NCT02315625|450512298|FG000|Second Intervention|Disease Progression|1|||
125242771|NCT02315625|450512299|FG001|Second Intervention|Disease Progression|0|||
125242772|NCT00021255|450512300|FG000|Overall Study|Death|1|||
125242773|NCT00021255|450512301|FG001|Overall Study|Death|0|||
125242774|NCT00021255|450512302|FG002|Overall Study|Death|2|||
125393406|NCT00097721|451074043|FG000|Overall Study|Physician Decision|1|||
125188284|NCT03971071|450309149|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
125188285|NCT03971071|450309150|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
125188286|NCT03971071|450309151|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
125188287|NCT03971071|450309152|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
125188288|NCT03971071|450309153|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
125188289|NCT03971071|450309149|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
125188290|NCT03971071|450309150|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
125188291|NCT03971071|450309151|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
125188292|NCT03971071|450309152|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
125188293|NCT03971071|450309153|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
125188294|NCT03210714|450309156|FG000|Overall Study|Adverse Event|6|||
125188295|NCT03210714|450309156|FG000|Overall Study|Physician Decision|1|||
125188296|NCT03210714|450309156|FG000|Overall Study|Progressive disease|11|||
125188297|NCT03210714|450309156|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
125188298|NCT01909934|450309157|FG000|Overall Study|Withdrawal by Subject|3|||
125188299|NCT01909934|450309157|FG000|Overall Study|Lost to Follow-up|1|||
125188300|NCT01909934|450309157|FG000|Overall Study|Death|25|||
125188301|NCT01909934|450309157|FG000|Overall Study|Withdrawal of Informed Consent|1|||
125188302|NCT01909934|450309157|FG000|Overall Study|Reason Not Specified|1|||
125188303|NCT01139775|450309160|FG000|Overall Study|Adverse Event|0|||
125188304|NCT01139775|450309161|FG001|Overall Study|Adverse Event|6|||
125188305|NCT01139775|450309162|FG002|Overall Study|Adverse Event|2|||
125188306|NCT01139775|450309160|FG000|Overall Study|Protocol Violation|0|||
125188307|NCT01139775|450309161|FG001|Overall Study|Protocol Violation|5|||
125188308|NCT01139775|450309162|FG002|Overall Study|Protocol Violation|0|||
125188309|NCT01139775|450309160|FG000|Overall Study|Withdrawal by Subject|1|||
125188310|NCT01139775|450309161|FG001|Overall Study|Withdrawal by Subject|0|||
125188311|NCT01139775|450309162|FG002|Overall Study|Withdrawal by Subject|2|||
125188312|NCT01139775|450309160|FG000|Overall Study|Physician Decision|0|||
125188313|NCT01139775|450309161|FG001|Overall Study|Physician Decision|2|||
125188314|NCT01139775|450309162|FG002|Overall Study|Physician Decision|2|||
125188315|NCT03193853|450309165|FG000|Overall Study|Death|6|||
125188316|NCT01956773|450309173|FG000|Overall Study|Lost to Follow-up|628|||
125188317|NCT01956773|450309174|FG001|Overall Study|Lost to Follow-up|1|||
125188318|NCT00450437|450309175|FG000|Overall Study|Withdrawal by Subject|10|||
125188319|NCT00450437|450309176|FG001|Overall Study|Withdrawal by Subject|2|||
125188320|NCT00450437|450309177|FG002|Overall Study|Withdrawal by Subject|0|||
125188321|NCT00450437|450309178|FG003|Overall Study|Withdrawal by Subject|1|||
125188322|NCT00450437|450309175|FG000|Overall Study|Lost to Follow-up|31|||
125188323|NCT00450437|450309176|FG001|Overall Study|Lost to Follow-up|12|||
125188324|NCT00450437|450309177|FG002|Overall Study|Lost to Follow-up|19|||
125188325|NCT00450437|450309178|FG003|Overall Study|Lost to Follow-up|9|||
125188326|NCT00450437|450309175|FG000|Overall Study|Protocol Violation|0|||
125188327|NCT00450437|450309176|FG001|Overall Study|Protocol Violation|1|||
125188328|NCT00450437|450309177|FG002|Overall Study|Protocol Violation|0|||
125188329|NCT00450437|450309178|FG003|Overall Study|Protocol Violation|1|||
125188330|NCT00450437|450309175|FG000|Overall Study|Inappropriate enrollment|4|||
125188331|NCT00450437|450309176|FG001|Overall Study|Inappropriate enrollment|1|||
125188332|NCT00450437|450309177|FG002|Overall Study|Inappropriate enrollment|3|||
125188333|NCT00450437|450309178|FG003|Overall Study|Inappropriate enrollment|0|||
125188334|NCT00450437|450309175|FG000|Overall Study|Administrative reason|0|||
125188335|NCT00450437|450309176|FG001|Overall Study|Administrative reason|0|||
125188336|NCT00450437|450309177|FG002|Overall Study|Administrative reason|1|||
125188337|NCT00450437|450309178|FG003|Overall Study|Administrative reason|0|||
125188338|NCT00450437|450309175|FG000|Overall Study|Unable to Classify|1|||
125188339|NCT00450437|450309176|FG001|Overall Study|Unable to Classify|0|||
125188340|NCT00450437|450309177|FG002|Overall Study|Unable to Classify|1|||
125188341|NCT00450437|450309178|FG003|Overall Study|Unable to Classify|0|||
125188342|NCT03907488|450309179|FG000|Overall Study|Adverse Event|20|||
125188343|NCT03907488|450309180|FG001|Overall Study|Adverse Event|20|||
125188344|NCT03907488|450309179|FG000|Overall Study|Withdrawal by Subject|9|||
125188345|NCT03907488|450309180|FG001|Overall Study|Withdrawal by Subject|13|||
125188346|NCT03907488|450309179|FG000|Overall Study|Lack of Efficacy|0|||
125188347|NCT03907488|450309180|FG001|Overall Study|Lack of Efficacy|9|||
125188348|NCT03907488|450309179|FG000|Overall Study|Death|3|||
125188349|NCT03907488|450309180|FG001|Overall Study|Death|8|||
125188350|NCT03907488|450309179|FG000|Overall Study|not protocol specified|5|||
125188351|NCT03907488|450309180|FG001|Overall Study|not protocol specified|8|||
125188352|NCT03907488|450309179|FG000|Overall Study|Ineligible|9|||
125188353|NCT03907488|450309180|FG001|Overall Study|Ineligible|15|||
125188354|NCT02269098|450309181|FG000|Overall Study|Lost to Follow-up|14|||
125188355|NCT02269098|450309182|FG001|Overall Study|Lost to Follow-up|9|||
125188356|NCT03194542|450309185|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
125188357|NCT03194542|450309186|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
125188358|NCT03194542|450309187|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
125188359|NCT03194542|450309188|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
125242775|NCT00021255|450512300|FG000|Overall Study|Breast cancer relapse|5|||
125242776|NCT00021255|450512301|FG001|Overall Study|Breast cancer relapse|18|||
125242777|NCT00021255|450512302|FG002|Overall Study|Breast cancer relapse|11|||
125242778|NCT00021255|450512300|FG000|Overall Study|Second primary malignancy|0|||
125242779|NCT00021255|450512301|FG001|Overall Study|Second primary malignancy|4|||
125242780|NCT00021255|450512302|FG002|Overall Study|Second primary malignancy|1|||
125242781|NCT00021255|450512300|FG000|Overall Study|Withdrawal by Subject|41|||
125242782|NCT00021255|450512301|FG001|Overall Study|Withdrawal by Subject|64|||
125242783|NCT00021255|450512302|FG002|Overall Study|Withdrawal by Subject|26|||
125242784|NCT00021255|450512300|FG000|Overall Study|Lost to Follow-up|0|||
125242785|NCT00021255|450512301|FG001|Overall Study|Lost to Follow-up|2|||
125242786|NCT00021255|450512302|FG002|Overall Study|Lost to Follow-up|3|||
125242787|NCT00021255|450512300|FG000|Overall Study|Cardiac toxicity|0|||
125242788|NCT00021255|450512301|FG001|Overall Study|Cardiac toxicity|61|||
125242789|NCT00021255|450512302|FG002|Overall Study|Cardiac toxicity|32|||
125242790|NCT00021255|450512300|FG000|Overall Study|Herceptin toxicity|0|||
125242791|NCT00021255|450512301|FG001|Overall Study|Herceptin toxicity|22|||
125242792|NCT00021255|450512302|FG002|Overall Study|Herceptin toxicity|6|||
125242793|NCT00021255|450512300|FG000|Overall Study|Adverse Event|46|||
125242794|NCT00021255|450512301|FG001|Overall Study|Adverse Event|30|||
125242795|NCT00021255|450512302|FG002|Overall Study|Adverse Event|18|||
125242796|NCT00021255|450512300|FG000|Overall Study|Protocol Violation|0|||
125242797|NCT00021255|450512301|FG001|Overall Study|Protocol Violation|2|||
125242798|NCT00021255|450512302|FG002|Overall Study|Protocol Violation|0|||
125242799|NCT00021255|450512300|FG000|Overall Study|Other than specified above|0|||
125242800|NCT00021255|450512301|FG001|Overall Study|Other than specified above|38|||
125242801|NCT00021255|450512302|FG002|Overall Study|Other than specified above|19|||
125242802|NCT00021255|450512300|FG000|Overall Study|Missing|0|||
125242803|NCT00021255|450512301|FG001|Overall Study|Missing|27|||
125242804|NCT00021255|450512302|FG002|Overall Study|Missing|13|||
125242805|NCT00021255|450512300|FG000|Overall Study|Randomized but not treated|28|||
125242806|NCT00021255|450512301|FG001|Overall Study|Randomized but not treated|2|||
125242807|NCT00021255|450512302|FG002|Overall Study|Randomized but not treated|18|||
125242808|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
125242809|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
125242810|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
125242811|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
125242812|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
125242813|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
125242814|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
125242815|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
125242816|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
125242817|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
125242818|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
125242819|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
125242820|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
125242821|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
125242822|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
125242823|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
125242824|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
125242825|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
125242826|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
125242827|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
125242828|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
125242829|NCT02337946|450512305|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
125242830|NCT02337946|450512306|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
125242831|NCT02337946|450512307|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
125242832|NCT02337946|450512305|FG000|In-between Period|Without Informed Consent|1|||
125242833|NCT02337946|450512306|FG001|In-between Period|Without Informed Consent|0|||
125242834|NCT02337946|450512307|FG002|In-between Period|Without Informed Consent|0|||
125242835|NCT02337946|450512305|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
125242836|NCT02337946|450512306|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
125242837|NCT02337946|450512307|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
125242838|NCT02337946|450512305|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
125393407|NCT00097721|451074044|FG001|Overall Study|Physician Decision|3|||
125393408|NCT00097721|451074043|FG000|Overall Study|Reason not given|1|||
125242839|NCT02337946|450512306|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
125242840|NCT02337946|450512307|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
125242841|NCT02337946|450512305|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
125242842|NCT02337946|450512306|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
125242843|NCT02337946|450512307|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
125393409|NCT00097721|451074044|FG001|Overall Study|Reason not given|1|||
125393410|NCT01752855|451074048|FG000|Overall Study|Adverse Event|1|||
125393411|NCT01752855|451074049|FG001|Overall Study|Adverse Event|0|||
125393412|NCT01752855|451074048|FG000|Overall Study|Withdrew Consent|0|||
125393413|NCT01752855|451074049|FG001|Overall Study|Withdrew Consent|2|||
125393414|NCT01752855|451074048|FG000|Overall Study|Lack of Efficacy|0|||
125393415|NCT01752855|451074049|FG001|Overall Study|Lack of Efficacy|2|||
125393416|NCT00235872|451074058|FG000|Overall Study|Adverse Event|34|||
125393417|NCT00235872|451074058|FG000|Overall Study|Death|1|||
125393418|NCT00235872|451074058|FG000|Overall Study|Lost to Follow-up|1|||
125393419|NCT00235872|451074058|FG000|Overall Study|Withdrawal by Subject|50|||
125393420|NCT00235872|451074058|FG000|Overall Study|Administrative reason|61|||
125393421|NCT01446965|451074059|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
125393422|NCT01446965|451074060|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
125393423|NCT01446965|451074059|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
125188360|NCT03194542|450309185|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
125188361|NCT03194542|450309186|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
125188362|NCT03194542|450309187|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
125188363|NCT03194542|450309188|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
125188364|NCT03194542|450309185|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
125188365|NCT03194542|450309186|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
125188366|NCT03194542|450309187|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
125188367|NCT03194542|450309188|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
125188368|NCT03194542|450309185|FG000|Overall Study|Loss of Response|4|||
125188369|NCT03194542|450309186|FG001|Overall Study|Loss of Response|2|||
125188370|NCT03194542|450309187|FG002|Overall Study|Loss of Response|3|||
125188371|NCT03194542|450309188|FG003|Overall Study|Loss of Response|4|||
125188372|NCT03194542|450309185|FG000|Overall Study|Physician Decision|0|||
125188373|NCT03194542|450309186|FG001|Overall Study|Physician Decision|1|||
125188374|NCT03194542|450309187|FG002|Overall Study|Physician Decision|0|||
125188375|NCT03194542|450309188|FG003|Overall Study|Physician Decision|0|||
125188376|NCT03194542|450309185|FG000|Overall Study|Lack of Efficacy|2|||
125188377|NCT03194542|450309186|FG001|Overall Study|Lack of Efficacy|2|||
125188378|NCT03194542|450309187|FG002|Overall Study|Lack of Efficacy|2|||
125188379|NCT03194542|450309188|FG003|Overall Study|Lack of Efficacy|6|||
125188380|NCT03194542|450309185|FG000|Overall Study|Withdrawal by Subject|2|||
125188381|NCT03194542|450309186|FG001|Overall Study|Withdrawal by Subject|1|||
125188382|NCT03194542|450309187|FG002|Overall Study|Withdrawal by Subject|5|||
125188383|NCT03194542|450309188|FG003|Overall Study|Withdrawal by Subject|4|||
125188384|NCT03194542|450309185|FG000|Overall Study|Progressive Disease|1|||
125188385|NCT03194542|450309186|FG001|Overall Study|Progressive Disease|0|||
125188386|NCT03194542|450309187|FG002|Overall Study|Progressive Disease|1|||
125188387|NCT03194542|450309188|FG003|Overall Study|Progressive Disease|1|||
125188388|NCT03194542|450309185|FG000|Overall Study|Adverse Event|1|||
125188389|NCT03194542|450309186|FG001|Overall Study|Adverse Event|2|||
125188390|NCT03194542|450309187|FG002|Overall Study|Adverse Event|0|||
125188391|NCT03194542|450309188|FG003|Overall Study|Adverse Event|5|||
125188392|NCT03194542|450309185|FG000|Overall Study|Death|1|||
125188393|NCT03194542|450309186|FG001|Overall Study|Death|2|||
125188394|NCT03194542|450309187|FG002|Overall Study|Death|0|||
125188395|NCT03194542|450309188|FG003|Overall Study|Death|5|||
125188396|NCT03194542|450309185|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
125188397|NCT03194542|450309186|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
125188398|NCT03194542|450309187|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
125188399|NCT03194542|450309188|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
125188400|NCT01611883|450309191|FG000|Overall Study|Adverse Event|1|||
125188401|NCT01611883|450309192|FG001|Overall Study|Adverse Event|1|||
125188402|NCT05142722|450309793|FG000|Overall Study|Lost to Follow-up|16|||
125188403|NCT05142722|450309794|FG001|Overall Study|Lost to Follow-up|38|||
125188404|NCT05142722|450309793|FG000|Overall Study|Withdrawal by Subject|20|||
125188405|NCT05142722|450309794|FG001|Overall Study|Withdrawal by Subject|27|||
125188406|NCT05142722|450309793|FG000|Overall Study|Death|11|||
125188407|NCT05142722|450309794|FG001|Overall Study|Death|17|||
125188408|NCT05142722|450309793|FG000|Overall Study|Physician Decision|0|||
125188409|NCT05142722|450309794|FG001|Overall Study|Physician Decision|1|||
125188410|NCT05142722|450309793|FG000|Overall Study|Participant Moved Away|0|||
125188411|NCT05142722|450309794|FG001|Overall Study|Participant Moved Away|2|||
125188412|NCT05142722|450309793|FG000|Overall Study|Adverse Event|2|||
125188413|NCT05142722|450309794|FG001|Overall Study|Adverse Event|1|||
125393424|NCT01446965|451074060|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
125188414|NCT05731700|450309795|FG000|Overall Study|Death|1|||
125188415|NCT05468164|450309812|FG000|Treatment Period 4|Adverse Event|0|||
125188416|NCT05468164|450309813|FG001|Treatment Period 4|Adverse Event|0|||
125188417|NCT05468164|450309814|FG002|Treatment Period 4|Adverse Event|0|||
125188418|NCT05468164|450309815|FG003|Treatment Period 4|Adverse Event|1|||
125242844|NCT02337946|450512305|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
125393425|NCT02852265|451074061|FG000|3-month Follow-up|Lost to Follow-up|1|||
125242845|NCT02337946|450512306|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
125242846|NCT02337946|450512307|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
125242847|NCT02337946|450512305|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
125242848|NCT02337946|450512306|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
125242849|NCT02337946|450512307|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
125242850|NCT02337946|450512305|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
125242851|NCT02337946|450512306|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
125242852|NCT02337946|450512307|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
125242853|NCT02949934|450512312|FG000|Natural Drinking Period|Adverse Event|1|||
125242854|NCT02949934|450512313|FG001|Natural Drinking Period|Adverse Event|0|||
125242855|NCT02949934|450512314|FG002|Natural Drinking Period|Adverse Event|0|||
125242856|NCT02949934|450512315|FG003|Natural Drinking Period|Adverse Event|1|||
125242857|NCT02949934|450512316|FG004|Natural Drinking Period|Adverse Event|0|||
125242858|NCT02949934|450512317|FG005|Natural Drinking Period|Adverse Event|0|||
125242859|NCT02949934|450512312|FG000|Natural Drinking Period|Lost to Follow-up|0|||
125242860|NCT02949934|450512313|FG001|Natural Drinking Period|Lost to Follow-up|0|||
125242861|NCT02949934|450512314|FG002|Natural Drinking Period|Lost to Follow-up|0|||
125242862|NCT02949934|450512315|FG003|Natural Drinking Period|Lost to Follow-up|0|||
125242863|NCT02949934|450512316|FG004|Natural Drinking Period|Lost to Follow-up|1|||
125242864|NCT02949934|450512317|FG005|Natural Drinking Period|Lost to Follow-up|0|||
125242865|NCT02949934|450512312|FG000|Neuroimaging|Protocol Violation|2|||
125242866|NCT02949934|450512313|FG001|Neuroimaging|Protocol Violation|0|||
125242867|NCT02949934|450512314|FG002|Neuroimaging|Protocol Violation|0|||
125242868|NCT02949934|450512315|FG003|Neuroimaging|Protocol Violation|0|||
125242869|NCT02949934|450512316|FG004|Neuroimaging|Protocol Violation|1|||
125242870|NCT02949934|450512317|FG005|Neuroimaging|Protocol Violation|0|||
125242871|NCT02949934|450512312|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
125242872|NCT02949934|450512313|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
125242873|NCT02949934|450512314|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
125242874|NCT02949934|450512315|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
125242875|NCT02949934|450512316|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
125242876|NCT02949934|450512317|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
125242877|NCT02949934|450512312|FG000|Neuroimaging|Not scanned|0|||
125242878|NCT02949934|450512313|FG001|Neuroimaging|Not scanned|0|||
125242879|NCT02949934|450512314|FG002|Neuroimaging|Not scanned|1|||
125242880|NCT02949934|450512315|FG003|Neuroimaging|Not scanned|0|||
125242881|NCT02949934|450512316|FG004|Neuroimaging|Not scanned|0|||
125242882|NCT02949934|450512317|FG005|Neuroimaging|Not scanned|2|||
125242883|NCT02949934|450512312|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
125242884|NCT02949934|450512313|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
125242885|NCT02949934|450512314|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
125242886|NCT02949934|450512315|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
125242887|NCT02949934|450512316|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
125242888|NCT02949934|450512317|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
125242889|NCT02949934|450512312|FG000|Bar Laboratory|Adverse Event|1|||
125242890|NCT02949934|450512313|FG001|Bar Laboratory|Adverse Event|0|||
125242891|NCT02949934|450512314|FG002|Bar Laboratory|Adverse Event|2|||
125242892|NCT02949934|450512315|FG003|Bar Laboratory|Adverse Event|0|||
125242893|NCT02949934|450512316|FG004|Bar Laboratory|Adverse Event|1|||
125242894|NCT02949934|450512317|FG005|Bar Laboratory|Adverse Event|0|||
125242895|NCT02949934|450512312|FG000|Bar Laboratory|Protocol Violation|0|||
125242896|NCT02949934|450512313|FG001|Bar Laboratory|Protocol Violation|0|||
125242897|NCT02949934|450512314|FG002|Bar Laboratory|Protocol Violation|0|||
125242898|NCT02949934|450512315|FG003|Bar Laboratory|Protocol Violation|1|||
125242899|NCT02949934|450512316|FG004|Bar Laboratory|Protocol Violation|0|||
125242900|NCT02949934|450512317|FG005|Bar Laboratory|Protocol Violation|0|||
125242901|NCT00118287|450512320|FG000|Overall Study|Intracranial haemorrhage|1|||
125242902|NCT00118287|450512320|FG000|Overall Study|Muscle pain|1|||
125242903|NCT03442569|450512323|FG000|Overall Study|Subject was ineligible after enrollment|1|||
125242904|NCT01214720|450512326|FG000|Overall Study|Alive and still on treatment|34|||
125242905|NCT01214720|450512327|FG001|Overall Study|Alive and still on treatment|18|||
125242906|NCT01214720|450512326|FG000|Overall Study|Alive and in follow-up|45|||
125242907|NCT01214720|450512327|FG001|Overall Study|Alive and in follow-up|48|||
125242908|NCT01214720|450512326|FG000|Overall Study|Lost to Follow-up|6|||
125242909|NCT01214720|450512327|FG001|Overall Study|Lost to Follow-up|2|||
125242910|NCT02347787|450512328|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
125242911|NCT02347787|450512329|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
125242912|NCT02347787|450512328|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
125242913|NCT02347787|450512329|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
125242914|NCT02347787|450512328|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
125242915|NCT02347787|450512329|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
125242916|NCT02347787|450512328|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
125443499|NCT01809210|451252156|FG005|Overall Study|Death|3|||
125242917|NCT02347787|450512329|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
125443500|NCT01809210|451252157|FG006|Overall Study|Death|1|||
125188419|NCT04846569|450309816|FG000|Overall Study|Withdrawal by Subject|3|||
125188420|NCT04846569|450309817|FG001|Overall Study|Withdrawal by Subject|1|||
125188421|NCT01467713|450309818|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
125188422|NCT01467713|450309819|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
125188423|NCT01467713|450309820|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
125188424|NCT01467713|450309821|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
125188425|NCT01467713|450309818|FG000|Overall Study|Major Protocol Deviation|2|||
125188426|NCT01467713|450309819|FG001|Overall Study|Major Protocol Deviation|4|||
125188427|NCT01467713|450309820|FG002|Overall Study|Major Protocol Deviation|4|||
125188428|NCT01467713|450309821|FG003|Overall Study|Major Protocol Deviation|1|||
125188429|NCT01467713|450309818|FG000|Overall Study|Lost to Follow-up|9|||
125188430|NCT01467713|450309819|FG001|Overall Study|Lost to Follow-up|12|||
125188431|NCT01467713|450309820|FG002|Overall Study|Lost to Follow-up|6|||
125188432|NCT01467713|450309821|FG003|Overall Study|Lost to Follow-up|9|||
125188433|NCT01467713|450309818|FG000|Overall Study|Voluntary Withdrawal|18|||
125188434|NCT01467713|450309819|FG001|Overall Study|Voluntary Withdrawal|14|||
125188435|NCT01467713|450309820|FG002|Overall Study|Voluntary Withdrawal|21|||
125188436|NCT01467713|450309821|FG003|Overall Study|Voluntary Withdrawal|20|||
125188437|NCT01467713|450309818|FG000|Overall Study|Study Termination|23|||
125188438|NCT01467713|450309819|FG001|Overall Study|Study Termination|33|||
125188439|NCT01467713|450309820|FG002|Overall Study|Study Termination|28|||
125188440|NCT01467713|450309821|FG003|Overall Study|Study Termination|29|||
125188441|NCT01467713|450309818|FG000|Overall Study|Pregnancy|0|||
125188442|NCT01467713|450309819|FG001|Overall Study|Pregnancy|1|||
125188443|NCT01467713|450309820|FG002|Overall Study|Pregnancy|1|||
125188444|NCT01467713|450309821|FG003|Overall Study|Pregnancy|3|||
125188445|NCT01467713|450309818|FG000|Overall Study|Relapse|35|||
125188446|NCT01467713|450309819|FG001|Overall Study|Relapse|25|||
125188447|NCT01467713|450309820|FG002|Overall Study|Relapse|28|||
125188448|NCT01467713|450309821|FG003|Overall Study|Relapse|35|||
125188449|NCT01467713|450309818|FG000|Overall Study|Reason not Specified|6|||
125188450|NCT01467713|450309819|FG001|Overall Study|Reason not Specified|11|||
125188451|NCT01467713|450309820|FG002|Overall Study|Reason not Specified|8|||
125188452|NCT01467713|450309821|FG003|Overall Study|Reason not Specified|7|||
125188453|NCT00536939|450309822|FG000|Overall Study|Withdrawal by Subject|1|||
125188454|NCT00536939|450309823|FG001|Overall Study|Withdrawal by Subject|0|||
125188455|NCT00536939|450309822|FG000|Overall Study|Other Complicating Disease|1|||
125188456|NCT00536939|450309823|FG001|Overall Study|Other Complicating Disease|0|||
125188457|NCT01611935|450309826|FG000|Overall Study|Family Declined Participation|1|||
125188458|NCT01611935|450309827|FG001|Overall Study|Family Declined Participation|0|||
125188459|NCT03817853|450309831|FG000|Induction Phase|Adverse Event|5|||
125188460|NCT03817853|450309832|FG001|Induction Phase|Adverse Event|0|||
125188461|NCT03817853|450309833|FG002|Induction Phase|Adverse Event|0|||
125188462|NCT03817853|450309831|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
125188463|NCT03817853|450309832|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
125188464|NCT03817853|450309833|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
125188465|NCT03817853|450309831|FG000|Induction Phase|Physician Decision|2|||
125188466|NCT03817853|450309832|FG001|Induction Phase|Physician Decision|0|||
125188467|NCT03817853|450309833|FG002|Induction Phase|Physician Decision|0|||
125188468|NCT03817853|450309831|FG000|Induction Phase|Progressive Disease|6|||
125188469|NCT03817853|450309832|FG001|Induction Phase|Progressive Disease|0|||
125188470|NCT03817853|450309833|FG002|Induction Phase|Progressive Disease|0|||
125188471|NCT03817853|450309831|FG000|Induction Phase|Withdrawal by Subject|4|||
125188472|NCT03817853|450309832|FG001|Induction Phase|Withdrawal by Subject|0|||
125188473|NCT03817853|450309833|FG002|Induction Phase|Withdrawal by Subject|0|||
125188474|NCT03817853|450309831|FG000|Maintenance Phase|Adverse Event|0|||
125188475|NCT03817853|450309832|FG001|Maintenance Phase|Adverse Event|8|||
125188476|NCT03817853|450309833|FG002|Maintenance Phase|Adverse Event|0|||
125188477|NCT03817853|450309831|FG000|Maintenance Phase|Death|0|||
125188478|NCT03817853|450309832|FG001|Maintenance Phase|Death|5|||
125188479|NCT03817853|450309833|FG002|Maintenance Phase|Death|0|||
125188480|NCT03817853|450309831|FG000|Maintenance Phase|Progressive Disease|0|||
125188481|NCT03817853|450309832|FG001|Maintenance Phase|Progressive Disease|7|||
125188482|NCT03817853|450309833|FG002|Maintenance Phase|Progressive Disease|0|||
125188483|NCT03817853|450309831|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125188484|NCT03817853|450309832|FG001|Maintenance Phase|Withdrawal by Subject|2|||
125188485|NCT03817853|450309833|FG002|Maintenance Phase|Withdrawal by Subject|0|||
125188486|NCT03817853|450309831|FG000|Maintenance Phase|Physician Decision|0|||
125188487|NCT03817853|450309832|FG001|Maintenance Phase|Physician Decision|1|||
125188488|NCT03817853|450309833|FG002|Maintenance Phase|Physician Decision|0|||
125188489|NCT03817853|450309831|FG000|Maintenance Phase|Various reasons|0|||
125188490|NCT03817853|450309832|FG001|Maintenance Phase|Various reasons|4|||
125188491|NCT03817853|450309833|FG002|Maintenance Phase|Various reasons|0|||
125188492|NCT03817853|450309831|FG000|Maintenance Phase|Protocol Deviation|0|||
125188493|NCT03817853|450309832|FG001|Maintenance Phase|Protocol Deviation|1|||
125242918|NCT03720847|450513359|FG000|Washout|Physician Decision|1|||
125242919|NCT03720847|450513360|FG001|Washout|Physician Decision|2|||
125242920|NCT01239680|450513361|FG000|Overall Study|Withdrawal by Subject|2|||
125242921|NCT01239680|450513362|FG001|Overall Study|Withdrawal by Subject|0|||
125242922|NCT03033901|450513363|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
125242923|NCT03033901|450513363|FG000|Overall Study|Refused PSG|23|||
125242924|NCT03033901|450513363|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
125242925|NCT03033901|450513363|FG000|Overall Study|Missing Oximetry Data|3|||
125242926|NCT05177094|450513370|FG000|Overall Study|Adverse Event|5|||
125242927|NCT05177094|450513371|FG001|Overall Study|Adverse Event|5|||
125242928|NCT05177094|450513370|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
125242929|NCT05177094|450513371|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
125242930|NCT05177094|450513370|FG000|Overall Study|Protocol Deviation|3|||
125242931|NCT05177094|450513371|FG001|Overall Study|Protocol Deviation|0|||
125242932|NCT05177094|450513370|FG000|Overall Study|Withdrawal by Subject|6|||
125242933|NCT05177094|450513371|FG001|Overall Study|Withdrawal by Subject|3|||
125242934|NCT05177094|450513370|FG000|Overall Study|Participant could not tolerate long study visits|1|||
125242935|NCT05177094|450513371|FG001|Overall Study|Participant could not tolerate long study visits|0|||
125242936|NCT00875667|450513377|FG000|Overall Study|Adverse Event|29|||
125242937|NCT00875667|450513378|FG001|Overall Study|Adverse Event|10|||
125242938|NCT00875667|450513377|FG000|Overall Study|Withdrawal by Subject|17|||
125242939|NCT00875667|450513378|FG001|Overall Study|Withdrawal by Subject|5|||
125242940|NCT00875667|450513377|FG000|Overall Study|Death|7|||
125242941|NCT00875667|450513378|FG001|Overall Study|Death|2|||
125242942|NCT00875667|450513377|FG000|Overall Study|Protocol Violation|2|||
125242943|NCT00875667|450513378|FG001|Overall Study|Protocol Violation|0|||
125242944|NCT00875667|450513377|FG000|Overall Study|Disease Progression|100|||
125242945|NCT00875667|450513378|FG001|Overall Study|Disease Progression|49|||
125242946|NCT00875667|450513377|FG000|Overall Study|Miscellaneous|12|||
125242947|NCT00875667|450513378|FG001|Overall Study|Miscellaneous|6|||
125242948|NCT00875667|450513377|FG000|Overall Study|Randomized but no Study Drug Given|3|||
125242949|NCT00875667|450513378|FG001|Overall Study|Randomized but no Study Drug Given|1|||
125242950|NCT00894647|450513379|FG000|Overall Study|Adverse Event|5|||
125242951|NCT00894647|450513380|FG001|Overall Study|Adverse Event|4|||
125242952|NCT00894647|450513379|FG000|Overall Study|Withdrawal by Subject|4|||
125242953|NCT00894647|450513380|FG001|Overall Study|Withdrawal by Subject|4|||
125242954|NCT00894647|450513379|FG000|Overall Study|Lost to Follow-up|0|||
125242955|NCT00894647|450513380|FG001|Overall Study|Lost to Follow-up|2|||
125242956|NCT00894647|450513379|FG000|Overall Study|Non-compliance with study procedures|0|||
125242957|NCT00894647|450513380|FG001|Overall Study|Non-compliance with study procedures|2|||
125242958|NCT00894647|450513379|FG000|Overall Study|Other, not due to AE|1|||
125242959|NCT00894647|450513380|FG001|Overall Study|Other, not due to AE|2|||
125242960|NCT00195429|450513386|FG000|Overall Study|Adverse Event|2|||
125242961|NCT00195429|450513387|FG001|Overall Study|Adverse Event|4|||
125242962|NCT00195429|450513386|FG000|Overall Study|Lack of Efficacy|2|||
125242963|NCT00195429|450513387|FG001|Overall Study|Lack of Efficacy|1|||
125242964|NCT00195429|450513386|FG000|Overall Study|Lost to Follow-up|1|||
125242965|NCT00195429|450513387|FG001|Overall Study|Lost to Follow-up|0|||
125242966|NCT02541903|450513388|FG000|Overall Study|Death|1|||
125242967|NCT04795323|450513389|FG000|Overall Study|Did not interact with TARA|1|||
125242968|NCT04795323|450513390|FG001|Overall Study|Did not interact with TARA|0|||
125242969|NCT02691663|450513392|FG000|Overall Study|Screen failure after baseline|2|||
125242970|NCT02691663|450513393|FG001|Overall Study|Screen failure after baseline|2|||
125242971|NCT02691663|450513392|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
125242972|NCT02691663|450513393|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
125242973|NCT02691663|450513392|FG000|Overall Study|Withdrawn after Follow up 2|1|||
125242974|NCT02691663|450513393|FG001|Overall Study|Withdrawn after Follow up 2|1|||
125242975|NCT02691663|450513392|FG000|Overall Study|Lost to Follow-up|3|||
125393426|NCT02852265|451074062|FG001|3-month Follow-up|Lost to Follow-up|1|||
125393427|NCT01232296|451074063|FG000|Overall Study|Adverse Event|24|||
125393428|NCT01232296|451074064|FG001|Overall Study|Adverse Event|12|||
125393429|NCT01232296|451074063|FG000|Overall Study|Physician Decision|1|||
125242976|NCT02691663|450513393|FG001|Overall Study|Lost to Follow-up|2|||
125242977|NCT03142750|450513394|FG000|Overall Study|Lost to Follow-up|4|||
125242978|NCT03142750|450513395|FG001|Overall Study|Lost to Follow-up|1|||
125242979|NCT04925934|450513396|FG000|Overall Study|Adverse Event|1|||
125242980|NCT04925934|450513397|FG001|Overall Study|Adverse Event|0|||
125242981|NCT04925934|450513398|FG002|Overall Study|Adverse Event|0|||
125242982|NCT04925934|450513396|FG000|Overall Study|Lost to Follow-up|2|||
125242983|NCT04925934|450513397|FG001|Overall Study|Lost to Follow-up|0|||
125242984|NCT04925934|450513398|FG002|Overall Study|Lost to Follow-up|1|||
125242985|NCT04925934|450513396|FG000|Overall Study|Death|0|||
125242986|NCT04925934|450513397|FG001|Overall Study|Death|1|||
125242987|NCT04925934|450513398|FG002|Overall Study|Death|0|||
125393430|NCT01232296|451074064|FG001|Overall Study|Physician Decision|1|||
125242988|NCT04925934|450513396|FG000|Overall Study|Withdrawal by Subject|8|||
125242989|NCT04925934|450513397|FG001|Overall Study|Withdrawal by Subject|5|||
125188494|NCT03817853|450309833|FG002|Maintenance Phase|Protocol Deviation|0|||
125188495|NCT03817853|450309831|FG000|Follow-up Phase|Adverse Event|0|||
125188496|NCT03817853|450309832|FG001|Follow-up Phase|Adverse Event|0|||
125242990|NCT04925934|450513398|FG002|Overall Study|Withdrawal by Subject|9|||
125242991|NCT04925934|450513396|FG000|Overall Study|Other|2|||
125242992|NCT04925934|450513397|FG001|Overall Study|Other|2|||
125242993|NCT04925934|450513398|FG002|Overall Study|Other|2|||
125242994|NCT04925934|450513396|FG000|Overall Study|Eastern European Conflict|7|||
125242995|NCT04925934|450513397|FG001|Overall Study|Eastern European Conflict|3|||
125242996|NCT04925934|450513398|FG002|Overall Study|Eastern European Conflict|2|||
125242997|NCT03158688|450513399|FG000|Overall Study|Withdrawal by Subject|14|||
125242998|NCT03158688|450513400|FG001|Overall Study|Withdrawal by Subject|28|||
125242999|NCT03158688|450513399|FG000|Overall Study|Decision by sponsor|13|||
125243000|NCT03158688|450513400|FG001|Overall Study|Decision by sponsor|37|||
125243001|NCT03158688|450513399|FG000|Overall Study|Lost to Follow-up|4|||
125243002|NCT03158688|450513400|FG001|Overall Study|Lost to Follow-up|3|||
125243003|NCT03158688|450513399|FG000|Overall Study|Death|74|||
125243004|NCT03158688|450513400|FG001|Overall Study|Death|142|||
125243005|NCT01944774|450513408|FG000|Overall Study|Withdrawal by Subject|2|||
125243006|NCT01944774|450513409|FG001|Overall Study|Withdrawal by Subject|3|||
125243007|NCT01944774|450513410|FG002|Overall Study|Withdrawal by Subject|3|||
125243008|NCT01944774|450513408|FG000|Overall Study|Adverse Event|3|||
125243009|NCT01944774|450513409|FG001|Overall Study|Adverse Event|2|||
125243010|NCT01944774|450513410|FG002|Overall Study|Adverse Event|3|||
125243011|NCT01944774|450513408|FG000|Overall Study|Lack of Efficacy|1|||
125243012|NCT01944774|450513409|FG001|Overall Study|Lack of Efficacy|2|||
125243013|NCT01944774|450513410|FG002|Overall Study|Lack of Efficacy|2|||
125243014|NCT01944774|450513408|FG000|Overall Study|Lost to Follow-up|0|||
125243015|NCT01944774|450513409|FG001|Overall Study|Lost to Follow-up|1|||
125243016|NCT01944774|450513410|FG002|Overall Study|Lost to Follow-up|0|||
125243017|NCT03188185|450513411|FG000|Stage 1|Adverse Event|4|||
125243018|NCT03188185|450513412|FG001|Stage 1|Adverse Event|12|||
125243019|NCT03188185|450513413|FG002|Stage 1|Adverse Event|0|||
125243020|NCT03188185|450513414|FG003|Stage 1|Adverse Event|0|||
125243021|NCT03188185|450513411|FG000|Stage 1|Lack of Efficacy|0|||
125243022|NCT03188185|450513412|FG001|Stage 1|Lack of Efficacy|2|||
125243023|NCT03188185|450513413|FG002|Stage 1|Lack of Efficacy|0|||
125243024|NCT03188185|450513414|FG003|Stage 1|Lack of Efficacy|0|||
125243025|NCT03188185|450513411|FG000|Stage 1|Lost to Follow-up|6|||
125243026|NCT03188185|450513412|FG001|Stage 1|Lost to Follow-up|1|||
125243027|NCT03188185|450513413|FG002|Stage 1|Lost to Follow-up|0|||
125243028|NCT03188185|450513414|FG003|Stage 1|Lost to Follow-up|0|||
125243029|NCT03188185|450513411|FG000|Stage 1|Withdrawal by Subject|9|||
125243030|NCT03188185|450513412|FG001|Stage 1|Withdrawal by Subject|0|||
125243031|NCT03188185|450513413|FG002|Stage 1|Withdrawal by Subject|0|||
125243032|NCT03188185|450513414|FG003|Stage 1|Withdrawal by Subject|0|||
125243033|NCT03188185|450513411|FG000|Stage 1|Identified as a professional patient|0|||
125243034|NCT03188185|450513412|FG001|Stage 1|Identified as a professional patient|1|||
125243035|NCT03188185|450513413|FG002|Stage 1|Identified as a professional patient|0|||
125243036|NCT03188185|450513414|FG003|Stage 1|Identified as a professional patient|0|||
125243037|NCT03188185|450513411|FG000|Stage 2|Adverse Event|0|||
125243038|NCT03188185|450513412|FG001|Stage 2|Adverse Event|0|||
125243039|NCT03188185|450513413|FG002|Stage 2|Adverse Event|2|||
125243040|NCT03188185|450513414|FG003|Stage 2|Adverse Event|4|||
125243041|NCT03188185|450513411|FG000|Stage 2|Lack of Efficacy|0|||
125243042|NCT03188185|450513412|FG001|Stage 2|Lack of Efficacy|0|||
125243043|NCT03188185|450513413|FG002|Stage 2|Lack of Efficacy|3|||
125243044|NCT03188185|450513414|FG003|Stage 2|Lack of Efficacy|0|||
125243045|NCT03188185|450513411|FG000|Stage 2|Lost to Follow-up|0|||
125188497|NCT03817853|450309833|FG002|Follow-up Phase|Adverse Event|2|||
125188498|NCT03817853|450309831|FG000|Follow-up Phase|Death|0|||
125188499|NCT03817853|450309832|FG001|Follow-up Phase|Death|0|||
125188500|NCT03817853|450309833|FG002|Follow-up Phase|Death|1|||
125188501|NCT03817853|450309831|FG000|Follow-up Phase|Progressive Disease|0|||
125188502|NCT03817853|450309832|FG001|Follow-up Phase|Progressive Disease|0|||
125243046|NCT03188185|450513412|FG001|Stage 2|Lost to Follow-up|0|||
125188503|NCT03817853|450309833|FG002|Follow-up Phase|Progressive Disease|3|||
125188504|NCT03817853|450309831|FG000|Follow-up Phase|Withdrawal by Subject|0|||
125243047|NCT03188185|450513413|FG002|Stage 2|Lost to Follow-up|1|||
125243048|NCT03188185|450513414|FG003|Stage 2|Lost to Follow-up|0|||
125243049|NCT03188185|450513411|FG000|Stage 2|Physician Decision|0|||
125243050|NCT03188185|450513412|FG001|Stage 2|Physician Decision|0|||
125243051|NCT03188185|450513413|FG002|Stage 2|Physician Decision|0|||
125243052|NCT03188185|450513414|FG003|Stage 2|Physician Decision|1|||
125243053|NCT03188185|450513411|FG000|Stage 2|Withdrawal by Subject|0|||
125243054|NCT03188185|450513412|FG001|Stage 2|Withdrawal by Subject|0|||
125243055|NCT03188185|450513413|FG002|Stage 2|Withdrawal by Subject|3|||
125243056|NCT03188185|450513414|FG003|Stage 2|Withdrawal by Subject|1|||
125243057|NCT03325439|450513415|FG000|Overall Study|Ineligibility|3|||
125243058|NCT00774748|450513420|FG000|Overall Study|Lost to Follow-up|3|||
125243059|NCT02503865|450513421|FG000|Overall Study|Moved out of area|1|||
125243060|NCT02503865|450513422|FG001|Overall Study|Moved out of area|8|||
125188505|NCT03817853|450309832|FG001|Follow-up Phase|Withdrawal by Subject|0|||
125188506|NCT03817853|450309833|FG002|Follow-up Phase|Withdrawal by Subject|1|||
125188507|NCT00314340|450309834|FG000|Overall Study|lost interest|1|||
125188508|NCT01620138|450309837|FG000|Overall Study|Withdrawal by Subject|3|||
125188509|NCT01620138|450309838|FG001|Overall Study|Withdrawal by Subject|0|||
125188510|NCT01620138|450309837|FG000|Overall Study|Lack of Efficacy|1|||
125188511|NCT01620138|450309838|FG001|Overall Study|Lack of Efficacy|0|||
125188512|NCT01620138|450309837|FG000|Overall Study|Adverse Event|2|||
125188513|NCT01620138|450309838|FG001|Overall Study|Adverse Event|0|||
125188514|NCT03252535|450309839|FG000|Overall Study|Withdrawal by Subject|1|||
125188515|NCT03252535|450309840|FG001|Overall Study|Withdrawal by Subject|0|||
125188516|NCT03252535|450309841|FG002|Overall Study|Withdrawal by Subject|0|||
125188517|NCT03252535|450309839|FG000|Overall Study|Physician Decision|0|||
125188518|NCT03252535|450309840|FG001|Overall Study|Physician Decision|1|||
125188519|NCT03252535|450309841|FG002|Overall Study|Physician Decision|0|||
125188520|NCT03252535|450309839|FG000|Overall Study|Met discontinuation criteria|0|||
125188521|NCT03252535|450309840|FG001|Overall Study|Met discontinuation criteria|1|||
125188522|NCT03252535|450309841|FG002|Overall Study|Met discontinuation criteria|0|||
125188523|NCT05600283|450309842|FG000|Overall Study|Withdrawal by Subject|3|||
125188524|NCT05600283|450309843|FG001|Overall Study|Withdrawal by Subject|8|||
125188525|NCT05600283|450309842|FG000|Overall Study|invalid individual swab|1|||
125188526|NCT05600283|450309843|FG001|Overall Study|invalid individual swab|0|||
125188527|NCT05600283|450309842|FG000|Overall Study|missing clinician collection|3|||
125188528|NCT05600283|450309843|FG001|Overall Study|missing clinician collection|0|||
125188529|NCT05600283|450309842|FG000|Overall Study|screening failure|0|||
125188530|NCT05600283|450309843|FG001|Overall Study|screening failure|2|||
125188531|NCT01662492|450309852|FG000|Overall Study|Other miscellaneous reasons.|1|||
125188532|NCT01662492|450309853|FG001|Overall Study|Other miscellaneous reasons.|0|||
125188533|NCT01662492|450309854|FG002|Overall Study|Other miscellaneous reasons.|1|||
125188534|NCT01662492|450309852|FG000|Overall Study|Withdrawal by Subject|0|||
125188535|NCT01662492|450309853|FG001|Overall Study|Withdrawal by Subject|0|||
125188536|NCT01662492|450309854|FG002|Overall Study|Withdrawal by Subject|1|||
125188537|NCT01662492|450309852|FG000|Overall Study|Protocol Violation|1|||
125188538|NCT01662492|450309853|FG001|Overall Study|Protocol Violation|0|||
125188539|NCT01662492|450309854|FG002|Overall Study|Protocol Violation|0|||
125188540|NCT01662492|450309852|FG000|Overall Study|Lost to Follow-up|0|||
125188541|NCT01662492|450309853|FG001|Overall Study|Lost to Follow-up|0|||
125188542|NCT01662492|450309854|FG002|Overall Study|Lost to Follow-up|2|||
125188543|NCT01662492|450309852|FG000|Overall Study|Lack of Efficacy|1|||
125188544|NCT01662492|450309853|FG001|Overall Study|Lack of Efficacy|1|||
125188545|NCT01662492|450309854|FG002|Overall Study|Lack of Efficacy|2|||
125188546|NCT01100086|450310963|FG000|Period 1|Withdrawal by Subject|1|||
125188547|NCT01100086|450310964|FG001|Period 1|Withdrawal by Subject|0|||
125188548|NCT02954601|450310969|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
125188549|NCT02954601|450310970|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
125188550|NCT02954601|450310971|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
125188551|NCT02954601|450310972|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
125188552|NCT00333983|450310973|FG000|Overall Study|Lost to Follow-up|2|||
125188553|NCT00333983|450310974|FG001|Overall Study|Lost to Follow-up|1|||
125188554|NCT00333983|450310975|FG002|Overall Study|Lost to Follow-up|0|||
125188555|NCT00333983|450310973|FG000|Overall Study|Adverse Event|1|||
125188556|NCT00333983|450310974|FG001|Overall Study|Adverse Event|1|||
125188557|NCT00333983|450310975|FG002|Overall Study|Adverse Event|1|||
125188558|NCT00333983|450310973|FG000|Overall Study|Withdrawal by Subject|0|||
125188559|NCT00333983|450310974|FG001|Overall Study|Withdrawal by Subject|3|||
125188560|NCT00333983|450310975|FG002|Overall Study|Withdrawal by Subject|1|||
125188561|NCT00833105|450310976|FG000|Overall Study|Withdrawal by Subject|1|||
125188562|NCT00833105|450310976|FG000|Overall Study|Adverse Event|2|||
125188563|NCT02075203|450310984|FG000|Overall Study|Withdrawal by Subject|1|||
125188564|NCT02075203|450310985|FG001|Overall Study|Withdrawal by Subject|0|||
125188565|NCT02075203|450310986|FG002|Overall Study|Withdrawal by Subject|1|||
125188566|NCT02075203|450310984|FG000|Overall Study|Adverse Event|1|||
125188567|NCT02075203|450310985|FG001|Overall Study|Adverse Event|0|||
125188568|NCT02075203|450310986|FG002|Overall Study|Adverse Event|0|||
125188569|NCT02075203|450310984|FG000|Overall Study|participant refused to use contraception|1|||
125188570|NCT02075203|450310985|FG001|Overall Study|participant refused to use contraception|0|||
125188571|NCT02075203|450310986|FG002|Overall Study|participant refused to use contraception|0|||
125188572|NCT03214224|450310987|FG000|Overall Study|Protocol Violation|1|||
125188573|NCT03214224|450310987|FG000|Overall Study|Withdrawal by Subject|2|||
125188574|NCT03214224|450310987|FG000|Overall Study|Practice controls or therapists|6|||
125188575|NCT02712320|450310988|FG000|Overall Study|Lost to Follow-up|1|||
125188576|NCT02712320|450310988|FG000|Overall Study|Withdrawal by Subject|1|||
125188577|NCT02712320|450310988|FG000|Overall Study|Transferred to another facility|1|||
125188578|NCT02712320|450310988|FG000|Overall Study|Treating with the prohibited medications|2|||
125243061|NCT02503865|450513423|FG002|Overall Study|Moved out of area|0|||
125188579|NCT00568451|450310991|FG000|Overall Study|Disease Progression|0|||
125188580|NCT00568451|450310992|FG001|Overall Study|Disease Progression|0|||
125188581|NCT00568451|450310993|FG002|Overall Study|Disease Progression|2|||
125188582|NCT00568451|450310994|FG003|Overall Study|Disease Progression|7|||
125188583|NCT05266053|450310995|FG000|Overall Study|Withdrawal by Subject|8|||
125188584|NCT05266053|450310996|FG001|Overall Study|Withdrawal by Subject|4|||
125188585|NCT05344560|450310997|FG000|Period 1|Subject out of visit window|1|||
125188586|NCT05344560|450310998|FG001|Period 1|Subject out of visit window|1|||
125188587|NCT05344560|450310997|FG000|Period 2|Covid-19 Related|1|||
125188588|NCT05344560|450310998|FG001|Period 2|Covid-19 Related|0|||
125188589|NCT05344560|450310997|FG000|Period 2|Adverse Event|1|||
125188590|NCT05344560|450310998|FG001|Period 2|Adverse Event|0|||
125188591|NCT05344560|450310997|FG000|Period 2|Subject out of visit window|1|||
125188592|NCT05344560|450310998|FG001|Period 2|Subject out of visit window|1|||
125188593|NCT05344560|450310997|FG000|Period 3|Subject out of visit window|1|||
125188594|NCT05344560|450310998|FG001|Period 3|Subject out of visit window|0|||
125243062|NCT02503865|450513421|FG000|Overall Study|Refused treatment|4|||
125243063|NCT02503865|450513422|FG001|Overall Study|Refused treatment|39|||
125243064|NCT02503865|450513423|FG002|Overall Study|Refused treatment|2|||
125243065|NCT00303953|450513424|FG000|Overall Study|Ineligible|1|||
125243066|NCT00303953|450513424|FG000|Overall Study|Death|1|||
125243067|NCT00303953|450513424|FG000|Overall Study|Adverse Event|4|||
125243068|NCT00303953|450513424|FG000|Overall Study|Lack of Efficacy|12|||
125243069|NCT00303953|450513424|FG000|Overall Study|Physician Decision|1|||
125243070|NCT01132755|450513427|FG000|Overall Study|Procedure not done due to medical reason|23|||
125243071|NCT01132755|450513427|FG000|Overall Study|Protocol Violation|15|||
125188595|NCT01343043|450311001|FG000|Overall Study|Disease progression before treatment|1|||
125188596|NCT01343043|450311002|FG001|Overall Study|Disease progression before treatment|0|||
125188597|NCT01343043|450311003|FG002|Overall Study|Disease progression before treatment|0|||
125188598|NCT01343043|450311004|FG003|Overall Study|Disease progression before treatment|0|||
125188599|NCT01343043|450311001|FG000|Overall Study|Withdrawal by Subject|1|||
125188600|NCT01343043|450311002|FG001|Overall Study|Withdrawal by Subject|0|||
125188601|NCT01343043|450311003|FG002|Overall Study|Withdrawal by Subject|0|||
125188602|NCT01343043|450311004|FG003|Overall Study|Withdrawal by Subject|0|||
125188603|NCT01343043|450311001|FG000|Overall Study|Death|1|||
125188604|NCT01343043|450311002|FG001|Overall Study|Death|1|||
125188605|NCT01343043|450311003|FG002|Overall Study|Death|0|||
125188606|NCT01343043|450311004|FG003|Overall Study|Death|1|||
125188607|NCT00360282|450311005|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
125188608|NCT00360282|450311006|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
125188609|NCT00360282|450311007|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
125188610|NCT00360282|450311008|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
125188611|NCT00360282|450311005|FG000|Second Intervention|Adverse Event|0|||
125188612|NCT00360282|450311006|FG001|Second Intervention|Adverse Event|1|||
125188613|NCT00360282|450311007|FG002|Second Intervention|Adverse Event|0|||
125188614|NCT00360282|450311008|FG003|Second Intervention|Adverse Event|0|||
125188615|NCT00925704|450311009|FG000|First Intervention|Withdrew consent|0|||
125188616|NCT00925704|450311010|FG001|First Intervention|Withdrew consent|0|||
125188617|NCT00925704|450311011|FG002|First Intervention|Withdrew consent|0|||
125188618|NCT00925704|450311012|FG003|First Intervention|Withdrew consent|1|||
125188619|NCT00925704|450311013|FG004|First Intervention|Withdrew consent|1|||
125188620|NCT00925704|450311014|FG005|First Intervention|Withdrew consent|0|||
125188621|NCT00925704|450311009|FG000|Second Intervention|Withdrawal by Subject|1|||
125188622|NCT00925704|450311010|FG001|Second Intervention|Withdrawal by Subject|0|||
125188623|NCT00925704|450311011|FG002|Second Intervention|Withdrawal by Subject|0|||
125188624|NCT00925704|450311012|FG003|Second Intervention|Withdrawal by Subject|0|||
125188625|NCT00925704|450311013|FG004|Second Intervention|Withdrawal by Subject|1|||
125188626|NCT00925704|450311014|FG005|Second Intervention|Withdrawal by Subject|0|||
125188627|NCT00925704|450311009|FG000|Third Intervention|Withdrew consent|0|||
125188628|NCT00925704|450311010|FG001|Third Intervention|Withdrew consent|0|||
125188629|NCT00925704|450311011|FG002|Third Intervention|Withdrew consent|0|||
125188630|NCT00925704|450311012|FG003|Third Intervention|Withdrew consent|0|||
125188631|NCT00925704|450311013|FG004|Third Intervention|Withdrew consent|0|||
125188632|NCT00925704|450311014|FG005|Third Intervention|Withdrew consent|1|||
125243072|NCT01132755|450513427|FG000|Overall Study|Withdrawal by Subject|4|||
125243073|NCT02232698|450513428|FG000|Overall Study|Pregnancy|1|||
125243074|NCT02232698|450513429|FG001|Overall Study|Pregnancy|1|||
125188633|NCT02996968|450311015|FG000|Overall Study|Withdrawal by Subject|1|||
125188634|NCT02996968|450311016|FG001|Overall Study|Withdrawal by Subject|0|||
125188635|NCT02044302|450311020|FG000|Overall Study|study terminated|2|||
125243075|NCT02232698|450513428|FG000|Overall Study|Met exclusion criteria|1|||
125243076|NCT02232698|450513429|FG001|Overall Study|Met exclusion criteria|1|||
125243077|NCT02232698|450513428|FG000|Overall Study|Had device-associated symptoms|7|||
125188636|NCT02044302|450311021|FG001|Overall Study|study terminated|0|||
125188637|NCT00449865|450311026|FG000|Overall Study|Withdrawal by Subject|110|||
125188638|NCT00449865|450311027|FG001|Overall Study|Withdrawal by Subject|110|||
125243078|NCT02232698|450513429|FG001|Overall Study|Had device-associated symptoms|0|||
125243079|NCT02232698|450513428|FG000|Overall Study|Non-compliance with study device|1|||
125188639|NCT00449865|450311026|FG000|Overall Study|Lost to Follow-up|36|||
125188640|NCT00449865|450311027|FG001|Overall Study|Lost to Follow-up|37|||
125188641|NCT00449865|450311026|FG000|Overall Study|Physician Decision|13|||
125188642|NCT00449865|450311027|FG001|Overall Study|Physician Decision|12|||
125188643|NCT00449865|450311026|FG000|Overall Study|Death|31|||
125188644|NCT00449865|450311027|FG001|Overall Study|Death|40|||
125188645|NCT00449865|450311026|FG000|Overall Study|Protocol Violation|8|||
125188646|NCT00449865|450311027|FG001|Overall Study|Protocol Violation|7|||
125188647|NCT00449865|450311026|FG000|Overall Study|Study was stopped|324|||
125188648|NCT00449865|450311027|FG001|Overall Study|Study was stopped|328|||
125188649|NCT00444535|450311028|FG000|Overall Study|Withdrawal by Subject|5|||
125188650|NCT00444535|450311028|FG000|Overall Study|Physician Decision|5|||
125188651|NCT00444535|450311028|FG000|Overall Study|progressive disease|1|||
125188652|NCT00444535|450311028|FG000|Overall Study|Adverse Event|2|||
125188653|NCT02556775|450311029|FG000|Overall Study|Withdrawal by Subject|1|||
125188654|NCT02556775|450311030|FG001|Overall Study|Withdrawal by Subject|0|||
125188655|NCT02556775|450311031|FG002|Overall Study|Withdrawal by Subject|1|||
125188656|NCT02556775|450311032|FG003|Overall Study|Withdrawal by Subject|0|||
125188657|NCT02556775|450311029|FG000|Overall Study|Lost to Follow-up|1|||
125188658|NCT02556775|450311030|FG001|Overall Study|Lost to Follow-up|0|||
125188659|NCT02556775|450311031|FG002|Overall Study|Lost to Follow-up|0|||
125188660|NCT02556775|450311032|FG003|Overall Study|Lost to Follow-up|0|||
125188661|NCT00558467|450311038|FG000|Overall Study|Adverse Event|1|||
125188662|NCT00558467|450311039|FG001|Overall Study|Adverse Event|2|||
125188663|NCT00558467|450311038|FG000|Overall Study|Lack of Efficacy|0|||
125188664|NCT00558467|450311039|FG001|Overall Study|Lack of Efficacy|1|||
125188665|NCT00558467|450311038|FG000|Overall Study|Patient moving out of state|0|||
125188666|NCT00558467|450311039|FG001|Overall Study|Patient moving out of state|1|||
125188667|NCT02025725|450311048|FG000|Overall Study|Adverse Event|5|||
125188668|NCT02025725|450311049|FG001|Overall Study|Adverse Event|0|||
125188669|NCT02025725|450311048|FG000|Overall Study|Lost to Follow-up|2|||
125188670|NCT02025725|450311049|FG001|Overall Study|Lost to Follow-up|0|||
125188671|NCT02025725|450311048|FG000|Overall Study|Protocol Violation|1|||
125188672|NCT02025725|450311049|FG001|Overall Study|Protocol Violation|1|||
125188673|NCT02025725|450311048|FG000|Overall Study|Withdrawal by Subject|3|||
125188674|NCT02025725|450311049|FG001|Overall Study|Withdrawal by Subject|2|||
125188675|NCT02025725|450311048|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
125188676|NCT02025725|450311049|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
125188677|NCT06509438|450311050|FG000|Overall Study|Adverse Event|1|||
125188678|NCT06509438|450311050|FG000|Overall Study|Lost to Follow-up|3|||
125188679|NCT03331796|450311051|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
125188680|NCT03331796|450311052|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
125188681|NCT03331796|450311053|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
125188682|NCT03331796|450311051|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
125188683|NCT03331796|450311052|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
125188684|NCT03331796|450311053|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
125188685|NCT03331796|450311051|FG000|Extended Follow-up|Adverse Event|1|||
125188686|NCT03331796|450311052|FG001|Extended Follow-up|Adverse Event|0|||
125188687|NCT03331796|450311053|FG002|Extended Follow-up|Adverse Event|1|||
125188688|NCT03331796|450311051|FG000|Extended Follow-up|Lost to Follow-up|0|||
125188689|NCT03331796|450311052|FG001|Extended Follow-up|Lost to Follow-up|0|||
125188690|NCT03331796|450311053|FG002|Extended Follow-up|Lost to Follow-up|1|||
125188691|NCT03331796|450311051|FG000|Extended Follow-up|Withdrawal by Subject|1|||
125188692|NCT03331796|450311052|FG001|Extended Follow-up|Withdrawal by Subject|0|||
125188693|NCT03331796|450311053|FG002|Extended Follow-up|Withdrawal by Subject|0|||
125188694|NCT03331796|450311051|FG000|Extended Follow-up|Termination of Funding|0|||
125188695|NCT03331796|450311052|FG001|Extended Follow-up|Termination of Funding|1|||
125188696|NCT03331796|450311053|FG002|Extended Follow-up|Termination of Funding|0|||
125188697|NCT02867592|450311054|FG000|Overall Study|Adverse Event|3|||
125188698|NCT02867592|450311055|FG001|Overall Study|Adverse Event|0|||
125188699|NCT02867592|450311056|FG002|Overall Study|Adverse Event|2|||
125188700|NCT02867592|450311057|FG003|Overall Study|Adverse Event|1|||
125188701|NCT02867592|450311058|FG004|Overall Study|Adverse Event|1|||
125188702|NCT02867592|450311059|FG005|Overall Study|Adverse Event|5|||
125188703|NCT02867592|450311054|FG000|Overall Study|Death|0|||
125188704|NCT02867592|450311055|FG001|Overall Study|Death|0|||
125188705|NCT02867592|450311056|FG002|Overall Study|Death|0|||
125188706|NCT02867592|450311057|FG003|Overall Study|Death|1|||
125188707|NCT02867592|450311058|FG004|Overall Study|Death|0|||
125188708|NCT02867592|450311059|FG005|Overall Study|Death|1|||
125188709|NCT02867592|450311054|FG000|Overall Study|Lack of Efficacy|8|||
125188710|NCT02867592|450311055|FG001|Overall Study|Lack of Efficacy|10|||
125188711|NCT02867592|450311056|FG002|Overall Study|Lack of Efficacy|8|||
125188712|NCT02867592|450311057|FG003|Overall Study|Lack of Efficacy|8|||
125188713|NCT02867592|450311058|FG004|Overall Study|Lack of Efficacy|12|||
125188714|NCT02867592|450311059|FG005|Overall Study|Lack of Efficacy|17|||
125188715|NCT02867592|450311054|FG000|Overall Study|Physician Decision|1|||
125188716|NCT02867592|450311055|FG001|Overall Study|Physician Decision|2|||
125188717|NCT02867592|450311056|FG002|Overall Study|Physician Decision|2|||
125243080|NCT02232698|450513429|FG001|Overall Study|Non-compliance with study device|4|||
125243081|NCT02232698|450513428|FG000|Overall Study|Allocated to control group|0|||
125243082|NCT02232698|450513429|FG001|Overall Study|Allocated to control group|3|||
125243083|NCT02232698|450513428|FG000|Overall Study|Withdrawal by Subject|0|||
125243084|NCT02232698|450513429|FG001|Overall Study|Withdrawal by Subject|11|||
125243085|NCT00387127|450513430|FG000|Overall Study|Lost to Follow-up|0|||
125243086|NCT00387127|450513431|FG001|Overall Study|Lost to Follow-up|4|||
125243087|NCT00387127|450513430|FG000|Overall Study|Death|16|||
125243088|NCT00387127|450513431|FG001|Overall Study|Death|16|||
125243089|NCT00387127|450513430|FG000|Overall Study|Physician Decision|0|||
125243090|NCT00387127|450513431|FG001|Overall Study|Physician Decision|1|||
125243091|NCT00387127|450513430|FG000|Overall Study|Withdrawal by Subject|3|||
125243092|NCT00387127|450513431|FG001|Overall Study|Withdrawal by Subject|2|||
125243093|NCT00387127|450513430|FG000|Overall Study|Required by Protocol Amendment #4|12|||
125243094|NCT00387127|450513431|FG001|Overall Study|Required by Protocol Amendment #4|10|||
125243095|NCT00387127|450513430|FG000|Overall Study|Serious Adverse Event|1|||
125243096|NCT00387127|450513431|FG001|Overall Study|Serious Adverse Event|1|||
125243097|NCT00387127|450513430|FG000|Overall Study|Sponsor Unblinded|1|||
125243098|NCT00387127|450513431|FG001|Overall Study|Sponsor Unblinded|0|||
125243099|NCT02393755|450513432|FG000|Overall Study|Withdrawal by Subject|0|||
125243100|NCT02393755|450513433|FG001|Overall Study|Withdrawal by Subject|3|||
125243101|NCT02393755|450513432|FG000|Overall Study|Adverse Event|0|||
125243102|NCT02393755|450513433|FG001|Overall Study|Adverse Event|2|||
125243103|NCT02393755|450513432|FG000|Overall Study|Physician Decision|0|||
125243104|NCT02393755|450513433|FG001|Overall Study|Physician Decision|2|||
125243105|NCT01786109|450513434|FG000|Overall Study|fail manometry barostat tube placement|1|||
125243106|NCT01786109|450513435|FG001|Overall Study|fail manometry barostat tube placement|0|||
125243107|NCT01786109|450513436|FG002|Overall Study|fail manometry barostat tube placement|0|||
125243108|NCT01786109|450513434|FG000|Overall Study|unrelated illness|0|||
125243109|NCT01786109|450513435|FG001|Overall Study|unrelated illness|0|||
125243110|NCT01786109|450513436|FG002|Overall Study|unrelated illness|1|||
125243111|NCT01786109|450513434|FG000|Overall Study|adverse effects colon preparation|0|||
125243112|NCT01786109|450513435|FG001|Overall Study|adverse effects colon preparation|0|||
125243113|NCT01786109|450513436|FG002|Overall Study|adverse effects colon preparation|1|||
125243114|NCT04069520|450513442|FG000|Overall Study|Lost to Follow-up|0|||
125243115|NCT04069520|450513443|FG001|Overall Study|Lost to Follow-up|2|||
125243116|NCT04069520|450513442|FG000|Overall Study|Withdrawal by Subject|0|||
125243117|NCT04069520|450513443|FG001|Overall Study|Withdrawal by Subject|1|||
125243118|NCT04069520|450513442|FG000|Overall Study|Prior Injury|1|||
125243119|NCT04069520|450513443|FG001|Overall Study|Prior Injury|0|||
125243120|NCT04069520|450513442|FG000|Overall Study|Orthodontia|1|||
125243121|NCT04069520|450513443|FG001|Overall Study|Orthodontia|0|||
125243122|NCT04069520|450513442|FG000|Overall Study|Cut from team|0|||
125243123|NCT04069520|450513443|FG001|Overall Study|Cut from team|2|||
125243124|NCT01068912|450513444|FG000|Overall Study|Adverse Event|2|||
125243125|NCT01068912|450513445|FG001|Overall Study|Adverse Event|3|||
125243126|NCT01068912|450513446|FG002|Overall Study|Adverse Event|2|||
125243127|NCT01068912|450513444|FG000|Overall Study|Withdrawal by Subject|5|||
125243128|NCT01068912|450513445|FG001|Overall Study|Withdrawal by Subject|6|||
125243129|NCT01068912|450513446|FG002|Overall Study|Withdrawal by Subject|6|||
125243130|NCT01068912|450513444|FG000|Overall Study|Lost to Follow-up|3|||
125243131|NCT01068912|450513445|FG001|Overall Study|Lost to Follow-up|7|||
125243132|NCT01068912|450513446|FG002|Overall Study|Lost to Follow-up|3|||
125243133|NCT01068912|450513444|FG000|Overall Study|Protocol Violation|0|||
125243134|NCT01068912|450513445|FG001|Overall Study|Protocol Violation|2|||
125243135|NCT01068912|450513446|FG002|Overall Study|Protocol Violation|0|||
125243136|NCT01068912|450513444|FG000|Overall Study|aggravation influenza|1|||
125243137|NCT01068912|450513445|FG001|Overall Study|aggravation influenza|1|||
125243138|NCT01068912|450513446|FG002|Overall Study|aggravation influenza|1|||
125243139|NCT01068912|450513444|FG000|Overall Study|other underlying illness|0|||
125243140|NCT01068912|450513445|FG001|Overall Study|other underlying illness|3|||
125243141|NCT01068912|450513446|FG002|Overall Study|other underlying illness|3|||
125188718|NCT02867592|450311057|FG003|Overall Study|Physician Decision|0|||
125188719|NCT02867592|450311058|FG004|Overall Study|Physician Decision|5|||
125188720|NCT02867592|450311059|FG005|Overall Study|Physician Decision|1|||
125188721|NCT02867592|450311054|FG000|Overall Study|Protocol Violation|0|||
125188722|NCT02867592|450311055|FG001|Overall Study|Protocol Violation|0|||
125188723|NCT02867592|450311056|FG002|Overall Study|Protocol Violation|0|||
125188724|NCT02867592|450311057|FG003|Overall Study|Protocol Violation|0|||
125243142|NCT04822194|450513447|FG000|Overall Study|Withdrawal by Subject|5|||
125188725|NCT02867592|450311058|FG004|Overall Study|Protocol Violation|1|||
125188726|NCT02867592|450311059|FG005|Overall Study|Protocol Violation|1|||
125243143|NCT04822194|450513448|FG001|Overall Study|Withdrawal by Subject|4|||
125243144|NCT04822194|450513447|FG000|Overall Study|Technical issues with MR scanner|1|||
125243145|NCT04822194|450513448|FG001|Overall Study|Technical issues with MR scanner|0|||
125243146|NCT04822194|450513447|FG000|Overall Study|Lost to Follow-up|5|||
125243147|NCT04822194|450513448|FG001|Overall Study|Lost to Follow-up|7|||
125243148|NCT01947933|450513450|FG000|Overall Study|Withdrawal by Subject|0|||
125243149|NCT01947933|450513451|FG001|Overall Study|Withdrawal by Subject|0|||
125243150|NCT01947933|450513452|FG002|Overall Study|Withdrawal by Subject|1|||
125243151|NCT01947933|450513453|FG003|Overall Study|Withdrawal by Subject|0|||
125243152|NCT01947933|450513454|FG004|Overall Study|Withdrawal by Subject|0|||
125243153|NCT01947933|450513455|FG005|Overall Study|Withdrawal by Subject|0|||
125243154|NCT01947933|450513456|FG006|Overall Study|Withdrawal by Subject|0|||
125243155|NCT01947933|450513457|FG007|Overall Study|Withdrawal by Subject|0|||
125243156|NCT01947933|450513458|FG008|Overall Study|Withdrawal by Subject|0|||
125243157|NCT01947933|450513450|FG000|Overall Study|Lost to Follow-up|0|||
125243158|NCT01947933|450513451|FG001|Overall Study|Lost to Follow-up|0|||
125243159|NCT01947933|450513452|FG002|Overall Study|Lost to Follow-up|0|||
125243160|NCT01947933|450513453|FG003|Overall Study|Lost to Follow-up|0|||
125243161|NCT01947933|450513454|FG004|Overall Study|Lost to Follow-up|0|||
125243162|NCT01947933|450513455|FG005|Overall Study|Lost to Follow-up|0|||
125243163|NCT01947933|450513456|FG006|Overall Study|Lost to Follow-up|0|||
125243164|NCT01947933|450513457|FG007|Overall Study|Lost to Follow-up|0|||
125243165|NCT01947933|450513458|FG008|Overall Study|Lost to Follow-up|1|||
125243166|NCT00294398|450513461|FG000|Overall Study|Lost to Follow-up|21|||
125243167|NCT00294398|450513462|FG001|Overall Study|Lost to Follow-up|26|||
125243168|NCT02965833|450513463|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
125243169|NCT02965833|450513464|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
125243170|NCT02965833|450513463|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
125243171|NCT02965833|450513464|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
125243172|NCT02965833|450513463|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
125243173|NCT02965833|450513464|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
125243174|NCT02965833|450513463|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
125243175|NCT02965833|450513464|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
125243176|NCT02965833|450513463|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
125243177|NCT02965833|450513464|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
125243178|NCT03407482|450513468|FG000|Overall Study|Adverse Event|12|||
125243179|NCT03407482|450513468|FG000|Overall Study|Disease Relapse|1|||
125243180|NCT03407482|450513468|FG000|Overall Study|Lost to Follow-up|1|||
125243181|NCT03407482|450513468|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125243182|NCT03407482|450513468|FG000|Overall Study|Pregnancy|2|||
125243183|NCT03407482|450513468|FG000|Overall Study|Protocol Violation|1|||
125243184|NCT03407482|450513468|FG000|Overall Study|Study Terminated By Sponsor|106|||
125243185|NCT03407482|450513468|FG000|Overall Study|Withdrawal by Subject|6|||
125243186|NCT03407482|450513468|FG000|Overall Study|Data Entry Error|1|||
125243187|NCT05643794|450514626|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
125243188|NCT05643794|450514627|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
125243189|NCT05643794|450514628|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
125243190|NCT05643794|450514626|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
125243191|NCT05643794|450514627|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125243192|NCT05643794|450514628|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125243193|NCT05643794|450514626|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
125243194|NCT05643794|450514627|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
125243195|NCT05643794|450514628|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
125243196|NCT05643794|450514626|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
125243197|NCT05643794|450514627|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
125243198|NCT05643794|450514628|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
125243199|NCT05643794|450514626|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
125243200|NCT05643794|450514627|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
125243201|NCT05643794|450514628|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
125243202|NCT05643794|450514626|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
125243203|NCT05643794|450514627|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
125243204|NCT05643794|450514628|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
125393431|NCT01232296|451074063|FG000|Overall Study|Progressive disease|43|||
125393432|NCT01232296|451074064|FG001|Overall Study|Progressive disease|61|||
125393433|NCT01232296|451074063|FG000|Overall Study|Study terminated by sponsor|0|||
125393434|NCT01232296|451074064|FG001|Overall Study|Study terminated by sponsor|1|||
125243205|NCT01363076|450514633|FG000|Overall Study|Withdrawal by Subject|0|||
125243206|NCT01363076|450514634|FG001|Overall Study|Withdrawal by Subject|1|||
125243207|NCT04706403|450514635|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
125243208|NCT04706403|450514636|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
125393435|NCT01232296|451074063|FG000|Overall Study|Technical problems|3|||
125243209|NCT04706403|450514637|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
125243210|NCT04706403|450514638|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
125393436|NCT01232296|451074064|FG001|Overall Study|Technical problems|0|||
125393437|NCT01232296|451074063|FG000|Overall Study|Subject/guardian decision|10|||
125393438|NCT01232296|451074064|FG001|Overall Study|Subject/guardian decision|2|||
125188727|NCT02867592|450311054|FG000|Overall Study|Withdrawal by Subject|0|||
125188728|NCT02867592|450311055|FG001|Overall Study|Withdrawal by Subject|1|||
125188729|NCT02867592|450311056|FG002|Overall Study|Withdrawal by Subject|0|||
125188730|NCT02867592|450311057|FG003|Overall Study|Withdrawal by Subject|1|||
125188731|NCT02867592|450311058|FG004|Overall Study|Withdrawal by Subject|3|||
125188732|NCT02867592|450311059|FG005|Overall Study|Withdrawal by Subject|3|||
125188733|NCT02867592|450311054|FG000|Overall Study|Ineligible|1|||
125188734|NCT02867592|450311055|FG001|Overall Study|Ineligible|1|||
125188735|NCT02867592|450311056|FG002|Overall Study|Ineligible|0|||
125188736|NCT02867592|450311057|FG003|Overall Study|Ineligible|0|||
125188737|NCT02867592|450311058|FG004|Overall Study|Ineligible|2|||
125188738|NCT02867592|450311059|FG005|Overall Study|Ineligible|0|||
125188739|NCT02867592|450311054|FG000|Overall Study|No Treatment|1|||
125188740|NCT02867592|450311055|FG001|Overall Study|No Treatment|0|||
125188741|NCT02867592|450311056|FG002|Overall Study|No Treatment|0|||
125188742|NCT02867592|450311057|FG003|Overall Study|No Treatment|0|||
125188743|NCT02867592|450311058|FG004|Overall Study|No Treatment|0|||
125188744|NCT02867592|450311059|FG005|Overall Study|No Treatment|0|||
125188745|NCT02867592|450311054|FG000|Overall Study|Still on Therapy|0|||
125188746|NCT02867592|450311055|FG001|Overall Study|Still on Therapy|0|||
125188747|NCT02867592|450311056|FG002|Overall Study|Still on Therapy|0|||
125188748|NCT02867592|450311057|FG003|Overall Study|Still on Therapy|0|||
125188749|NCT02867592|450311058|FG004|Overall Study|Still on Therapy|1|||
125188750|NCT02867592|450311059|FG005|Overall Study|Still on Therapy|0|||
125188751|NCT02867592|450311054|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
125188752|NCT02867592|450311055|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
125188753|NCT02867592|450311056|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
125188754|NCT02867592|450311057|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
125188755|NCT02867592|450311058|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
125188756|NCT02867592|450311059|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
125188757|NCT02867592|450311054|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
125188758|NCT02867592|450311055|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
125188759|NCT02867592|450311056|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
125188760|NCT02867592|450311057|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
125188761|NCT02867592|450311058|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
125188762|NCT02867592|450311059|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
125188763|NCT00594165|450311060|FG000|Overall Study|Major protocol violation|1|||
125188764|NCT00594165|450311060|FG000|Overall Study|Lack of Efficacy|12|||
125188765|NCT00594165|450311060|FG000|Overall Study|Adverse Event|52|||
125188766|NCT00594165|450311060|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
125188767|NCT00594165|450311060|FG000|Overall Study|Subject withdrew consent|27|||
125188768|NCT00594165|450311060|FG000|Overall Study|Study ended per sponsor|102|||
125188769|NCT00594165|450311060|FG000|Overall Study|Lost to Follow-up|4|||
125188770|NCT00594165|450311060|FG000|Overall Study|Other: PI discretion|5|||
125188771|NCT00594165|450311060|FG000|Overall Study|Other: Subject moving|3|||
125188772|NCT00594165|450311060|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
125188773|NCT00594165|450311060|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
125188774|NCT00594165|450311060|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
125188775|NCT00594165|450311060|FG000|Overall Study|Other: Site terminated participation|2|||
125188776|NCT00571727|450311063|FG000|Overall Study|Did not enter in this study|1|||
125188777|NCT00571727|450311063|FG000|Overall Study|Non-compliance|4|||
125188778|NCT00571727|450311063|FG000|Overall Study|Lost to Follow-up|30|||
125188779|NCT00571727|450311063|FG000|Overall Study|Poor growth|1|||
125188780|NCT00571727|450311063|FG000|Overall Study|Parent/patient decision|2|||
125188781|NCT00571727|450311063|FG000|Overall Study|Participant transferred to commercial drug|14|||
125188782|NCT00571727|450311063|FG000|Overall Study|Unable to provide study drug|6|||
125188783|NCT00571727|450311063|FG000|Overall Study|On-treatment at end of study|8|||
125188784|NCT03581292|450311064|FG000|Overall Study|Physician Decision|9|||
125188785|NCT03581292|450311065|FG001|Overall Study|Physician Decision|5|||
125188786|NCT03581292|450311064|FG000|Overall Study|Withdrawal by Subject|3|||
125188787|NCT03581292|450311065|FG001|Overall Study|Withdrawal by Subject|0|||
125188788|NCT03581292|450311064|FG000|Overall Study|Withdrawal before Therapy Start|1|||
125188789|NCT03581292|450311065|FG001|Overall Study|Withdrawal before Therapy Start|0|||
125188790|NCT01735916|450312935|FG000|Overall Study|Subject not eligible to be randomized|11|||
125188791|NCT01735916|450312936|FG001|Overall Study|Subject not eligible to be randomized|0|||
125188792|NCT01735916|450312937|FG002|Overall Study|Subject not eligible to be randomized|0|||
125188793|NCT01735916|450312935|FG000|Overall Study|Early termination of study by sponsor|4|||
125188794|NCT01735916|450312936|FG001|Overall Study|Early termination of study by sponsor|19|||
125393439|NCT01232296|451074063|FG000|Overall Study|Death|1|||
125188795|NCT01735916|450312937|FG002|Overall Study|Early termination of study by sponsor|7|||
125188796|NCT01735916|450312935|FG000|Overall Study|Withdrawal by Subject|3|||
125188797|NCT01735916|450312936|FG001|Overall Study|Withdrawal by Subject|0|||
125188798|NCT01735916|450312937|FG002|Overall Study|Withdrawal by Subject|0|||
125188799|NCT04227197|450312941|FG000|Randomization|Protocol Violation|1|||
125188800|NCT04227197|450312942|FG001|Randomization|Protocol Violation|0|||
125188801|NCT04227197|450312941|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
125188802|NCT04227197|450312942|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
125188803|NCT04227197|450312941|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
125188804|NCT04227197|450312942|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
125188805|NCT04227197|450312941|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
125188806|NCT04227197|450312942|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
125188807|NCT04227197|450312941|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
125188808|NCT04227197|450312942|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
125188809|NCT04227197|450312941|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
125188810|NCT04227197|450312942|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
125188811|NCT04227197|450312941|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
125188812|NCT04227197|450312942|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
125188813|NCT00570141|450312943|FG000|Overall Study|Adverse Event|1|||
125188814|NCT00570141|450312943|FG000|Overall Study|Missed visits|1|||
125188815|NCT00570141|450312943|FG000|Overall Study|Lost to Follow-up|1|||
125188816|NCT01209949|450312955|FG000|Overall Study|Lost to Follow-up|3|||
125188817|NCT00729612|450312960|FG000|Overall Study|Non evaluable for response|10|||
125188818|NCT03207815|450312966|FG000|Overall Study|Protocol Violation|3|||
125188819|NCT03207815|450312967|FG001|Overall Study|Protocol Violation|1|||
125188820|NCT03207815|450312966|FG000|Overall Study|Adverse Event|1|||
125188821|NCT03207815|450312967|FG001|Overall Study|Adverse Event|2|||
125188822|NCT03207815|450312966|FG000|Overall Study|Lost to Follow-up|1|||
125188823|NCT03207815|450312967|FG001|Overall Study|Lost to Follow-up|2|||
125188824|NCT03207815|450312966|FG000|Overall Study|Investigator's Discretion|1|||
125188825|NCT03207815|450312967|FG001|Overall Study|Investigator's Discretion|1|||
125188826|NCT03207815|450312966|FG000|Overall Study|Lack of Efficacy|0|||
125188827|NCT03207815|450312967|FG001|Overall Study|Lack of Efficacy|1|||
125188828|NCT03207815|450312966|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
125188829|NCT03207815|450312967|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
125188830|NCT03207815|450312966|FG000|Overall Study|Withdrew Consent|1|||
125188831|NCT03207815|450312967|FG001|Overall Study|Withdrew Consent|0|||
125188832|NCT01671007|450312968|FG000|Overall Study|Other reasons than listed|166|||
125188833|NCT01671007|450312969|FG001|Overall Study|Other reasons than listed|373|||
125188834|NCT01671007|450312970|FG002|Overall Study|Other reasons than listed|197|||
125188835|NCT01671007|450312971|FG003|Overall Study|Other reasons than listed|228|||
125188836|NCT01671007|450312972|FG004|Overall Study|Other reasons than listed|14|||
125188837|NCT01671007|450312973|FG005|Overall Study|Other reasons than listed|71|||
125188838|NCT01671007|450312974|FG006|Overall Study|Other reasons than listed|17|||
125188839|NCT01671007|450312975|FG007|Overall Study|Other reasons than listed|66|||
125188840|NCT01671007|450312976|FG008|Overall Study|Other reasons than listed|0|||
125188841|NCT01671007|450312968|FG000|Overall Study|Withdrawal by Subject|36|||
125188842|NCT01671007|450312969|FG001|Overall Study|Withdrawal by Subject|59|||
125188843|NCT01671007|450312970|FG002|Overall Study|Withdrawal by Subject|53|||
125188844|NCT01671007|450312971|FG003|Overall Study|Withdrawal by Subject|58|||
125188845|NCT01671007|450312972|FG004|Overall Study|Withdrawal by Subject|4|||
125188846|NCT01671007|450312973|FG005|Overall Study|Withdrawal by Subject|15|||
125188847|NCT01671007|450312974|FG006|Overall Study|Withdrawal by Subject|1|||
125188848|NCT01671007|450312975|FG007|Overall Study|Withdrawal by Subject|19|||
125188849|NCT01671007|450312976|FG008|Overall Study|Withdrawal by Subject|0|||
125188850|NCT01671007|450312968|FG000|Overall Study|Lost to Follow-up|93|||
125188851|NCT01671007|450312969|FG001|Overall Study|Lost to Follow-up|142|||
125188852|NCT01671007|450312970|FG002|Overall Study|Lost to Follow-up|91|||
125188853|NCT01671007|450312971|FG003|Overall Study|Lost to Follow-up|63|||
125188854|NCT01671007|450312972|FG004|Overall Study|Lost to Follow-up|7|||
125188855|NCT01671007|450312973|FG005|Overall Study|Lost to Follow-up|20|||
125188856|NCT01671007|450312974|FG006|Overall Study|Lost to Follow-up|2|||
125188857|NCT01671007|450312975|FG007|Overall Study|Lost to Follow-up|28|||
125188858|NCT01671007|450312976|FG008|Overall Study|Lost to Follow-up|0|||
125188859|NCT01671007|450312968|FG000|Overall Study|No end of study case report form|3|||
125393440|NCT01232296|451074064|FG001|Overall Study|Death|6|||
125393441|NCT02871375|451074065|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
125188860|NCT01671007|450312969|FG001|Overall Study|No end of study case report form|1|||
125188861|NCT01671007|450312970|FG002|Overall Study|No end of study case report form|0|||
125188862|NCT01671007|450312971|FG003|Overall Study|No end of study case report form|2|||
125188863|NCT01671007|450312972|FG004|Overall Study|No end of study case report form|0|||
125188864|NCT01671007|450312973|FG005|Overall Study|No end of study case report form|0|||
125188865|NCT01671007|450312974|FG006|Overall Study|No end of study case report form|0|||
125188866|NCT01671007|450312975|FG007|Overall Study|No end of study case report form|0|||
125188867|NCT01671007|450312976|FG008|Overall Study|No end of study case report form|0|||
125188868|NCT01671007|450312968|FG000|Overall Study|Not eligible|23|||
125188869|NCT01671007|450312969|FG001|Overall Study|Not eligible|76|||
125188870|NCT01671007|450312970|FG002|Overall Study|Not eligible|25|||
125188871|NCT01671007|450312971|FG003|Overall Study|Not eligible|17|||
125188872|NCT01671007|450312972|FG004|Overall Study|Not eligible|0|||
125188873|NCT01671007|450312973|FG005|Overall Study|Not eligible|6|||
125188874|NCT01671007|450312974|FG006|Overall Study|Not eligible|1|||
125188875|NCT01671007|450312975|FG007|Overall Study|Not eligible|19|||
125188876|NCT01671007|450312976|FG008|Overall Study|Not eligible|0|||
125188877|NCT00391768|450312977|FG000|Overall Study|Withdrawal by Subject|0|||
125188878|NCT00391768|450312978|FG001|Overall Study|Withdrawal by Subject|0|||
125188879|NCT00391768|450312979|FG002|Overall Study|Withdrawal by Subject|1|||
125188880|NCT00391768|450312980|FG003|Overall Study|Withdrawal by Subject|0|||
125188881|NCT00391768|450312981|FG004|Overall Study|Withdrawal by Subject|0|||
125188882|NCT00391768|450312982|FG005|Overall Study|Withdrawal by Subject|1|||
125188883|NCT00391768|450312983|FG006|Overall Study|Withdrawal by Subject|1|||
125188884|NCT00391768|450312977|FG000|Overall Study|Lost to Follow-up|0|||
125188885|NCT00391768|450312978|FG001|Overall Study|Lost to Follow-up|0|||
125188886|NCT00391768|450312979|FG002|Overall Study|Lost to Follow-up|0|||
125188887|NCT00391768|450312980|FG003|Overall Study|Lost to Follow-up|1|||
125188888|NCT00391768|450312981|FG004|Overall Study|Lost to Follow-up|2|||
125188889|NCT00391768|450312982|FG005|Overall Study|Lost to Follow-up|2|||
125188890|NCT00391768|450312983|FG006|Overall Study|Lost to Follow-up|3|||
125188891|NCT00406367|450312984|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
125188892|NCT00406367|450312985|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
125188893|NCT00406367|450312984|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
125188894|NCT00406367|450312985|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
125188895|NCT00406367|450312984|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
125188896|NCT00406367|450312985|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
125188897|NCT00406367|450312984|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
125188898|NCT00406367|450312985|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
125188899|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
125188900|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
125188901|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
125188902|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
125188903|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
125188904|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
125188905|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
125188906|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
125188907|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
125188908|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
125188909|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
125188910|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
125188911|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
125188912|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
125188913|NCT00406367|450312984|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
125188914|NCT00406367|450312985|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
125188915|NCT00171210|450312986|FG000|Overall Study|Adverse Event|16|||
125188916|NCT00171210|450312987|FG001|Overall Study|Adverse Event|27|||
125188917|NCT00171210|450312986|FG000|Overall Study|Abnormal laboratory value(s)|6|||
125188918|NCT00171210|450312987|FG001|Overall Study|Abnormal laboratory value(s)|3|||
125188919|NCT00171210|450312986|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125188920|NCT00171210|450312987|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125188921|NCT00171210|450312986|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
125188922|NCT00171210|450312987|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
125188923|NCT00171210|450312986|FG000|Overall Study|Protocol Violation|0|||
125188924|NCT00171210|450312987|FG001|Overall Study|Protocol Violation|2|||
125188925|NCT00171210|450312986|FG000|Overall Study|Withdrawal by Subject|32|||
125188926|NCT00171210|450312987|FG001|Overall Study|Withdrawal by Subject|30|||
125188927|NCT00171210|450312986|FG000|Overall Study|Lost to Follow-up|1|||
125188928|NCT00171210|450312987|FG001|Overall Study|Lost to Follow-up|0|||
125188929|NCT00171210|450312986|FG000|Overall Study|Administrative problems|1|||
125188930|NCT00171210|450312987|FG001|Overall Study|Administrative problems|1|||
125188931|NCT00171210|450312986|FG000|Overall Study|Death|2|||
125188932|NCT00171210|450312987|FG001|Overall Study|Death|3|||
125188933|NCT00171210|450312986|FG000|Overall Study|Stopped at end of core|0|||
125188934|NCT00171210|450312987|FG001|Overall Study|Stopped at end of core|32|||
125188935|NCT00171210|450312986|FG000|Overall Study|Stopped at end of extension 1|0|||
125188936|NCT00171210|450312987|FG001|Overall Study|Stopped at end of extension 1|1|||
125188937|NCT03187301|450312990|FG000|Titration Period|Adverse Event|0|||
125188938|NCT03187301|450312991|FG001|Titration Period|Adverse Event|0|||
125393442|NCT02871375|451074066|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
125188939|NCT03187301|450312992|FG002|Titration Period|Adverse Event|0|||
125188940|NCT03187301|450312993|FG003|Titration Period|Adverse Event|0|||
125188941|NCT03187301|450312994|FG004|Titration Period|Adverse Event|0|||
125188942|NCT03187301|450312995|FG005|Titration Period|Adverse Event|0|||
125188943|NCT03187301|450312996|FG006|Titration Period|Adverse Event|5|||
125188944|NCT03187301|450312990|FG000|Titration Period|Withdrawal by Subject|0|||
125188945|NCT03187301|450312991|FG001|Titration Period|Withdrawal by Subject|0|||
125188946|NCT03187301|450312992|FG002|Titration Period|Withdrawal by Subject|0|||
125188947|NCT03187301|450312993|FG003|Titration Period|Withdrawal by Subject|0|||
125188948|NCT03187301|450312994|FG004|Titration Period|Withdrawal by Subject|0|||
125188949|NCT03187301|450312995|FG005|Titration Period|Withdrawal by Subject|0|||
125188950|NCT03187301|450312996|FG006|Titration Period|Withdrawal by Subject|1|||
125188951|NCT03187301|450312990|FG000|Titration Period|Exclusion Criteria Met|0|||
125188952|NCT03187301|450312991|FG001|Titration Period|Exclusion Criteria Met|0|||
125188953|NCT03187301|450312992|FG002|Titration Period|Exclusion Criteria Met|0|||
125188954|NCT03187301|450312993|FG003|Titration Period|Exclusion Criteria Met|0|||
125188955|NCT03187301|450312994|FG004|Titration Period|Exclusion Criteria Met|0|||
125188956|NCT03187301|450312995|FG005|Titration Period|Exclusion Criteria Met|0|||
125188957|NCT03187301|450312996|FG006|Titration Period|Exclusion Criteria Met|1|||
125188958|NCT03187301|450312990|FG000|Pre-Intervention|Withdrawal by Subject|1|||
125188959|NCT03187301|450312991|FG001|Pre-Intervention|Withdrawal by Subject|0|||
125188960|NCT03187301|450312992|FG002|Pre-Intervention|Withdrawal by Subject|0|||
125188961|NCT03187301|450312993|FG003|Pre-Intervention|Withdrawal by Subject|0|||
125188962|NCT03187301|450312994|FG004|Pre-Intervention|Withdrawal by Subject|0|||
125188963|NCT03187301|450312995|FG005|Pre-Intervention|Withdrawal by Subject|0|||
125188964|NCT03187301|450312996|FG006|Pre-Intervention|Withdrawal by Subject|0|||
125188965|NCT05005507|450313002|FG000|Overall Study|Premature termination of study|1|||
125188966|NCT04630002|450313007|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
125188967|NCT04630002|450313008|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
125188968|NCT04630002|450313009|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
125188969|NCT04630002|450313007|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
125188970|NCT04630002|450313008|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
125188971|NCT04630002|450313009|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
125188972|NCT04630002|450313007|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
125188973|NCT04630002|450313008|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
125188974|NCT04630002|450313009|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
125188975|NCT04630002|450313007|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
125188976|NCT04630002|450313008|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
125188977|NCT04630002|450313009|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
125188978|NCT04630002|450313007|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
125188979|NCT04630002|450313008|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
125188980|NCT04630002|450313009|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
125188981|NCT04630002|450313007|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
125188982|NCT04630002|450313008|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
125188983|NCT04630002|450313009|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
125188984|NCT04630002|450313007|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
125188985|NCT04630002|450313008|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
125188986|NCT04630002|450313009|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
125188987|NCT04630002|450313007|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
125188988|NCT04630002|450313008|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
125188989|NCT04630002|450313009|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
125188990|NCT00442897|450313011|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
125188991|NCT00442897|450313012|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
125188992|NCT00442897|450313011|FG000|Base Study (12 Week Follow-up)|Death|0|||
125188993|NCT00442897|450313012|FG001|Base Study (12 Week Follow-up)|Death|1|||
125188994|NCT00442897|450313011|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
125188995|NCT00442897|450313012|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
125188996|NCT00442897|450313011|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
125188997|NCT00442897|450313012|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
125188998|NCT00442897|450313011|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
125188999|NCT00442897|450313012|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
125189000|NCT00442897|450313011|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
125189001|NCT00442897|450313012|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
125189002|NCT00442897|450313011|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
125189003|NCT00442897|450313012|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
125189004|NCT00442897|450313011|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
125189005|NCT00442897|450313012|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
125189006|NCT04498182|450313013|FG000|Overall Study|Adverse Event|2|||
125243211|NCT04706403|450514639|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
125243212|NCT00182637|450514640|FG000|Overall Study|Adverse Event|2|||
125243213|NCT00182637|450514640|FG000|Overall Study|Disease Progression|1|||
125243214|NCT04766333|450514642|FG000|Overall Study|Lost to Follow-up|40|||
125243215|NCT04766333|450514643|FG001|Overall Study|Lost to Follow-up|826|||
125243216|NCT00639379|450514647|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
125243217|NCT00639379|450514648|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
125243218|NCT00639379|450514647|FG000|Period 1 - 2 Weeks|lens issue|3|||
125243219|NCT00639379|450514648|FG001|Period 1 - 2 Weeks|lens issue|0|||
125243220|NCT00723944|450514649|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
125243221|NCT00723944|450514650|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
125243222|NCT00723944|450514649|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
125243223|NCT00723944|450514650|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
125243224|NCT00723944|450514649|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
125243225|NCT00723944|450514650|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
125243226|NCT02400736|450514651|FG000|Overall Study|Lost to Follow-up|6|||
125243227|NCT02400736|450514652|FG001|Overall Study|Lost to Follow-up|6|||
125243228|NCT02400736|450514651|FG000|Overall Study|Withdrawal by Subject|2|||
125243229|NCT02400736|450514652|FG001|Overall Study|Withdrawal by Subject|1|||
125243230|NCT02400736|450514651|FG000|Overall Study|Moved from the area|3|||
125243231|NCT02400736|450514652|FG001|Overall Study|Moved from the area|1|||
125243232|NCT02383173|450514655|FG000|Overall Study|Palliative Care Team withdrew|0|||
125243233|NCT02383173|450514656|FG001|Overall Study|Palliative Care Team withdrew|2|||
125243234|NCT01297244|450514657|FG000|Overall Study|Progressive disease|22|||
125243235|NCT01297244|450514658|FG001|Overall Study|Progressive disease|3|||
125243236|NCT01297244|450514657|FG000|Overall Study|Adverse Event|9|||
125243237|NCT01297244|450514658|FG001|Overall Study|Adverse Event|1|||
125243238|NCT01297244|450514657|FG000|Overall Study|Death|1|||
125243239|NCT01297244|450514658|FG001|Overall Study|Death|1|||
125243240|NCT01297244|450514657|FG000|Overall Study|Clinical progression|1|||
125243241|NCT01297244|450514658|FG001|Overall Study|Clinical progression|1|||
125243242|NCT01297244|450514657|FG000|Overall Study|Withdrawal by Subject|2|||
125243243|NCT01297244|450514658|FG001|Overall Study|Withdrawal by Subject|0|||
125243244|NCT03677401|450514659|FG000|Overall Study|Adverse Event|4|||
125243245|NCT03677401|450514660|FG001|Overall Study|Adverse Event|14|||
125243246|NCT03677401|450514659|FG000|Overall Study|Lack of Efficacy|3|||
125243247|NCT03677401|450514660|FG001|Overall Study|Lack of Efficacy|1|||
125243248|NCT03677401|450514659|FG000|Overall Study|Withdrawal by Subject|2|||
125243249|NCT03677401|450514660|FG001|Overall Study|Withdrawal by Subject|2|||
125243250|NCT03677401|450514659|FG000|Overall Study|Sponsor decision|0|||
125243251|NCT03677401|450514660|FG001|Overall Study|Sponsor decision|1|||
125243252|NCT03677401|450514659|FG000|Overall Study|Reason Unspecified|1|||
125243253|NCT03677401|450514660|FG001|Overall Study|Reason Unspecified|0|||
125243254|NCT01177410|450514663|FG000|Overall Study|Adverse Event|0|||
125243255|NCT01177410|450514664|FG001|Overall Study|Adverse Event|2|||
125243256|NCT01177410|450514665|FG002|Overall Study|Adverse Event|2|||
125243257|NCT01177410|450514663|FG000|Overall Study|Withdrawal by Subject|1|||
125243258|NCT01177410|450514664|FG001|Overall Study|Withdrawal by Subject|4|||
125243259|NCT01177410|450514665|FG002|Overall Study|Withdrawal by Subject|3|||
125243260|NCT01177410|450514663|FG000|Overall Study|Lost to Follow-up|0|||
125243261|NCT01177410|450514664|FG001|Overall Study|Lost to Follow-up|1|||
125243262|NCT01177410|450514665|FG002|Overall Study|Lost to Follow-up|0|||
125243263|NCT02143778|450514667|FG000|Overall Study|Withdrawal by Subject|2|||
125243264|NCT02143778|450514667|FG000|Overall Study|Device malfunction|1|||
125243265|NCT00625378|450514669|FG000|Overall Study|Adverse Event|22|||
125243266|NCT00625378|450514670|FG001|Overall Study|Adverse Event|0|||
125243267|NCT00625378|450514669|FG000|Overall Study|Withdrawal by Subject|16|||
125243268|NCT00625378|450514670|FG001|Overall Study|Withdrawal by Subject|0|||
125243269|NCT00625378|450514669|FG000|Overall Study|Death|38|||
125243270|NCT00625378|450514670|FG001|Overall Study|Death|0|||
125243271|NCT00625378|450514669|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
125243272|NCT00625378|450514670|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
125243273|NCT00625378|450514669|FG000|Overall Study|Lost to Follow-up|17|||
125243274|NCT00625378|450514670|FG001|Overall Study|Lost to Follow-up|0|||
125243275|NCT00625378|450514669|FG000|Overall Study|Non-compliant with study medication|3|||
125243276|NCT00625378|450514670|FG001|Overall Study|Non-compliant with study medication|0|||
125243277|NCT00625378|450514669|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
125243278|NCT00625378|450514670|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
125243279|NCT00625378|450514669|FG000|Overall Study|Medical decision|1|||
125243280|NCT00625378|450514670|FG001|Overall Study|Medical decision|0|||
125243281|NCT00625378|450514669|FG000|Overall Study|Multiple toxicities|1|||
125243282|NCT00625378|450514670|FG001|Overall Study|Multiple toxicities|0|||
125243283|NCT00625378|450514669|FG000|Overall Study|New cancer|1|||
125243284|NCT00625378|450514670|FG001|Overall Study|New cancer|0|||
125243285|NCT00625378|450514669|FG000|Overall Study|PTA program|2|||
125243286|NCT00625378|450514670|FG001|Overall Study|PTA program|0|||
125443501|NCT00504348|451252158|FG000|Overall Study|Adverse Event|3|||
125243287|NCT00625378|450514669|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
125243288|NCT00625378|450514670|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
125243289|NCT00625378|450514669|FG000|Overall Study|Sponsor decision|1|||
125243290|NCT00625378|450514670|FG001|Overall Study|Sponsor decision|0|||
125243291|NCT00625378|450514669|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
125243292|NCT00625378|450514670|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
125243293|NCT00625378|450514669|FG000|Overall Study|Switch to commercial drug|6|||
125243294|NCT00625378|450514670|FG001|Overall Study|Switch to commercial drug|1|||
125243295|NCT00625378|450514669|FG000|Overall Study|Missing|2|||
125243296|NCT00625378|450514670|FG001|Overall Study|Missing|0|||
125243297|NCT00625378|450514669|FG000|Overall Study|End of treatment not available|2|||
125243298|NCT00625378|450514670|FG001|Overall Study|End of treatment not available|0|||
125243299|NCT00625378|450514669|FG000|Overall Study|Never treated|2|||
125243300|NCT00625378|450514670|FG001|Overall Study|Never treated|0|||
125243301|NCT02639559|450514672|FG000|Overall Study|Mobilization failure|0|||
125243302|NCT02639559|450514673|FG001|Overall Study|Mobilization failure|3|||
125393443|NCT03144180|451074072|FG000|Overall Study|STAT Delivery|1|||
125393444|NCT03144180|451074073|FG001|Overall Study|STAT Delivery|1|||
125393445|NCT03144180|451074072|FG000|Overall Study|Provider forgot to fill out forms|1|||
125393446|NCT03144180|451074073|FG001|Overall Study|Provider forgot to fill out forms|3|||
125393447|NCT03144180|451074072|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
125393448|NCT03144180|451074073|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
125393449|NCT03144180|451074072|FG000|Overall Study|Scrub tech removed tube cap|0|||
125393450|NCT03144180|451074073|FG001|Overall Study|Scrub tech removed tube cap|1|||
125393451|NCT00606892|451074078|FG000|First Intervention|Protocol Violation|1|||
125393452|NCT00606892|451074079|FG001|First Intervention|Protocol Violation|4|||
125393453|NCT03554291|451074085|FG000|Overall Study|Death|2|||
125393454|NCT03554291|451074086|FG001|Overall Study|Death|1|||
125393455|NCT03554291|451074085|FG000|Overall Study|Lost to Follow-up|1|||
125393456|NCT03554291|451074086|FG001|Overall Study|Lost to Follow-up|0|||
125393457|NCT03554291|451074085|FG000|Overall Study|Withdrawal by Subject|1|||
125393458|NCT03554291|451074086|FG001|Overall Study|Withdrawal by Subject|0|||
125393459|NCT03554291|451074085|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
125393460|NCT03554291|451074086|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
125393461|NCT00500292|451074090|FG000|Overall Study|Adverse Event|3|||
125393462|NCT00500292|451074091|FG001|Overall Study|Adverse Event|6|||
125189007|NCT04498182|450313014|FG001|Overall Study|Adverse Event|3|||
125189008|NCT04498182|450313015|FG002|Overall Study|Adverse Event|2|||
125189009|NCT04498182|450313013|FG000|Overall Study|Withdrawal of Consent|3|||
125189010|NCT04498182|450313014|FG001|Overall Study|Withdrawal of Consent|4|||
125189011|NCT04498182|450313015|FG002|Overall Study|Withdrawal of Consent|3|||
125189012|NCT04498182|450313013|FG000|Overall Study|Non-Compliant|1|||
125189013|NCT04498182|450313014|FG001|Overall Study|Non-Compliant|0|||
125189014|NCT04498182|450313015|FG002|Overall Study|Non-Compliant|1|||
125189015|NCT04498182|450313013|FG000|Overall Study|Lost to Follow-up|0|||
125189016|NCT04498182|450313014|FG001|Overall Study|Lost to Follow-up|0|||
125189017|NCT04498182|450313015|FG002|Overall Study|Lost to Follow-up|1|||
125189018|NCT04498182|450313013|FG000|Overall Study|Investigator Decision|0|||
125189019|NCT04498182|450313014|FG001|Overall Study|Investigator Decision|0|||
125189020|NCT04498182|450313015|FG002|Overall Study|Investigator Decision|1|||
125189021|NCT04498182|450313013|FG000|Overall Study|Protocol Violation|1|||
125189022|NCT04498182|450313014|FG001|Overall Study|Protocol Violation|0|||
125189023|NCT04498182|450313015|FG002|Overall Study|Protocol Violation|2|||
125189024|NCT02182843|450313017|FG000|Overall Study|Withdrawal by Subject|7|||
125189025|NCT02182843|450313017|FG000|Overall Study|Lost to Follow-up|2|||
125189026|NCT02182843|450313017|FG000|Overall Study|Adverse Event|1|||
125189027|NCT02375971|450313018|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
125189028|NCT02375971|450313019|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
125189029|NCT02375971|450313020|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
125243303|NCT02639559|450514672|FG000|Overall Study|Issues with vascular acess|1|||
125243304|NCT02639559|450514673|FG001|Overall Study|Issues with vascular acess|0|||
125243305|NCT03880565|450514674|FG000|Overall Study|Withdrawal by Subject|1|||
125243306|NCT03880565|450514675|FG001|Overall Study|Withdrawal by Subject|0|||
125243307|NCT02969018|450514680|FG000|Overall Study|Adverse Event|2|||
125243308|NCT02969018|450514681|FG001|Overall Study|Adverse Event|4|||
125243309|NCT02969018|450514682|FG002|Overall Study|Adverse Event|1|||
125243310|NCT02969018|450514683|FG003|Overall Study|Adverse Event|2|||
125243311|NCT02969018|450514684|FG004|Overall Study|Adverse Event|0|||
125393463|NCT00500292|451074092|FG002|Overall Study|Adverse Event|4|||
125393464|NCT00500292|451074090|FG000|Overall Study|Condition under investigation worsened|21|||
125393465|NCT00500292|451074091|FG001|Overall Study|Condition under investigation worsened|23|||
125189030|NCT02375971|450313018|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
125189031|NCT02375971|450313019|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
125189032|NCT02375971|450313020|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
125189033|NCT02375971|450313018|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
125243312|NCT02969018|450514685|FG005|Overall Study|Adverse Event|1|||
125243313|NCT02969018|450514686|FG006|Overall Study|Adverse Event|2|||
125243314|NCT02969018|450514687|FG007|Overall Study|Adverse Event|0|||
125243315|NCT02969018|450514680|FG000|Overall Study|Lack of Efficacy|0|||
125243316|NCT02969018|450514681|FG001|Overall Study|Lack of Efficacy|1|||
125243317|NCT02969018|450514682|FG002|Overall Study|Lack of Efficacy|0|||
125243318|NCT02969018|450514683|FG003|Overall Study|Lack of Efficacy|0|||
125243319|NCT02969018|450514684|FG004|Overall Study|Lack of Efficacy|1|||
125243320|NCT02969018|450514685|FG005|Overall Study|Lack of Efficacy|1|||
125243321|NCT02969018|450514686|FG006|Overall Study|Lack of Efficacy|1|||
125243322|NCT02969018|450514687|FG007|Overall Study|Lack of Efficacy|1|||
125393466|NCT00500292|451074092|FG002|Overall Study|Condition under investigation worsened|19|||
125189034|NCT02375971|450313019|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
125189035|NCT02375971|450313020|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
125189036|NCT02375971|450313018|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
125189037|NCT02375971|450313019|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
125189038|NCT02375971|450313020|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
125189039|NCT02375971|450313018|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
125189040|NCT02375971|450313019|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
125189041|NCT02375971|450313020|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
125189042|NCT02375971|450313018|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
125189043|NCT02375971|450313019|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
125189044|NCT02375971|450313020|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
125189045|NCT02375971|450313018|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
125189046|NCT02375971|450313019|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
125189047|NCT02375971|450313020|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
125189048|NCT02375971|450313018|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
125189049|NCT02375971|450313019|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
125189050|NCT02375971|450313020|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
125189051|NCT00832455|450313022|FG000|Overall Study|Adverse Event|13|||
125189052|NCT00832455|450313022|FG000|Overall Study|Lost to Follow-up|26|||
125189053|NCT00832455|450313022|FG000|Overall Study|Protocol Violation|4|||
125189054|NCT00832455|450313022|FG000|Overall Study|Withdrawal by Subject|17|||
125189055|NCT00832455|450313022|FG000|Overall Study|Screening Failure|2|||
125189056|NCT00832455|450313022|FG000|Overall Study|Stopped Medication|4|||
125189057|NCT00832455|450313022|FG000|Overall Study|Parent misunderstood study|1|||
125189058|NCT00832455|450313022|FG000|Overall Study|Parent dissatisfied|1|||
125189059|NCT00832455|450313022|FG000|Overall Study|No improvement|3|||
125189060|NCT00832455|450313022|FG000|Overall Study|Patient moved|1|||
125189061|NCT02275819|450313023|FG000|Overall Study|Adverse Event|0|||
125189062|NCT02275819|450313024|FG001|Overall Study|Adverse Event|1|||
125189063|NCT01346059|450313025|FG000|Overall Study|Withdrawal by Subject|1|||
125189064|NCT01346059|450313026|FG001|Overall Study|Withdrawal by Subject|0|||
125189065|NCT05047211|450313028|FG000|Overall Study|Lost to Follow-up|8|||
125189066|NCT05047211|450313029|FG001|Overall Study|Lost to Follow-up|5|||
125189067|NCT00561392|450313030|FG000|Overall Study|Adverse Event|38|||
125189068|NCT00561392|450313030|FG000|Overall Study|Lack of Efficacy|2|||
125189069|NCT00561392|450313030|FG000|Overall Study|Protocol Violation|1|||
125189070|NCT00561392|450313030|FG000|Overall Study|Withdrawal by Subject|8|||
125189071|NCT00561392|450313030|FG000|Overall Study|Administrative problems|4|||
125189072|NCT01575834|450313031|FG000|Overall Study|Withdrawal by Subject|352|||
125189073|NCT01575834|450313032|FG001|Overall Study|Withdrawal by Subject|390|||
125189074|NCT01575834|450313031|FG000|Overall Study|Death|81|||
125189075|NCT01575834|450313032|FG001|Overall Study|Death|74|||
125189076|NCT01575834|450313031|FG000|Overall Study|Other|70|||
125189077|NCT01575834|450313032|FG001|Overall Study|Other|70|||
125189078|NCT01575834|450313031|FG000|Overall Study|Adverse Event|63|||
125189079|NCT01575834|450313032|FG001|Overall Study|Adverse Event|61|||
125189080|NCT01575834|450313031|FG000|Overall Study|Lost to Follow-up|55|||
125189081|NCT01575834|450313032|FG001|Overall Study|Lost to Follow-up|68|||
125189082|NCT01575834|450313031|FG000|Overall Study|Noncompliance|52|||
125189083|NCT01575834|450313032|FG001|Overall Study|Noncompliance|27|||
125189084|NCT01575834|450313031|FG000|Overall Study|Administrative decision|15|||
125189085|NCT01575834|450313032|FG001|Overall Study|Administrative decision|33|||
125189086|NCT01575834|450313031|FG000|Overall Study|Ineligibility Determined|5|||
125189087|NCT01575834|450313032|FG001|Overall Study|Ineligibility Determined|8|||
125189088|NCT01575834|450313031|FG000|Overall Study|Protocol Deviation|4|||
125189089|NCT01575834|450313032|FG001|Overall Study|Protocol Deviation|3|||
125189090|NCT01575834|450313031|FG000|Overall Study|Requirement for Alternative Therapy|2|||
125189091|NCT01575834|450313032|FG001|Overall Study|Requirement for Alternative Therapy|4|||
125189092|NCT01000155|450313039|FG000|Overall Study|Withdrawal by Subject|1|||
125189093|NCT01000155|450313039|FG000|Overall Study|Adverse Event|1|||
125189094|NCT00720213|450313042|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
125189095|NCT00720213|450313043|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
125189096|NCT00720213|450313044|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
125189097|NCT01808066|450313049|FG000|Overall Study|Withdrawal by Subject|15|||
125243323|NCT02969018|450514680|FG000|Overall Study|Lost to Follow-up|1|||
125243324|NCT02969018|450514681|FG001|Overall Study|Lost to Follow-up|2|||
125243325|NCT02969018|450514682|FG002|Overall Study|Lost to Follow-up|2|||
125243326|NCT02969018|450514683|FG003|Overall Study|Lost to Follow-up|0|||
125243327|NCT02969018|450514684|FG004|Overall Study|Lost to Follow-up|1|||
125243328|NCT02969018|450514685|FG005|Overall Study|Lost to Follow-up|1|||
125243329|NCT02969018|450514686|FG006|Overall Study|Lost to Follow-up|0|||
125243330|NCT02969018|450514687|FG007|Overall Study|Lost to Follow-up|1|||
125243331|NCT02969018|450514680|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243332|NCT02969018|450514681|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243333|NCT02969018|450514682|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243334|NCT02969018|450514683|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243335|NCT02969018|450514684|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243336|NCT02969018|450514685|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243337|NCT02969018|450514686|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
125243338|NCT02969018|450514687|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
125243339|NCT02969018|450514680|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125243340|NCT02969018|450514681|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125243341|NCT02969018|450514682|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125243342|NCT02969018|450514683|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125243343|NCT02969018|450514684|FG004|Overall Study|Non-Compliance With Study Drug|0|||
125243344|NCT02969018|450514685|FG005|Overall Study|Non-Compliance With Study Drug|0|||
125243345|NCT02969018|450514686|FG006|Overall Study|Non-Compliance With Study Drug|0|||
125243346|NCT02969018|450514687|FG007|Overall Study|Non-Compliance With Study Drug|0|||
125243347|NCT02969018|450514680|FG000|Overall Study|Other|0|||
125243348|NCT02969018|450514681|FG001|Overall Study|Other|0|||
125243349|NCT02969018|450514682|FG002|Overall Study|Other|0|||
125243350|NCT02969018|450514683|FG003|Overall Study|Other|1|||
125243351|NCT02969018|450514684|FG004|Overall Study|Other|0|||
125243352|NCT02969018|450514685|FG005|Overall Study|Other|0|||
125243353|NCT02969018|450514686|FG006|Overall Study|Other|0|||
125243354|NCT02969018|450514687|FG007|Overall Study|Other|2|||
125243355|NCT02969018|450514680|FG000|Overall Study|Pregnancy|0|||
125243356|NCT02969018|450514681|FG001|Overall Study|Pregnancy|0|||
125243357|NCT02969018|450514682|FG002|Overall Study|Pregnancy|0|||
125243358|NCT02969018|450514683|FG003|Overall Study|Pregnancy|0|||
125243359|NCT02969018|450514684|FG004|Overall Study|Pregnancy|0|||
125243360|NCT02969018|450514685|FG005|Overall Study|Pregnancy|1|||
125243361|NCT02969018|450514686|FG006|Overall Study|Pregnancy|0|||
125243362|NCT02969018|450514687|FG007|Overall Study|Pregnancy|0|||
125243363|NCT02969018|450514680|FG000|Overall Study|Protocol Violation|0|||
125243364|NCT02969018|450514681|FG001|Overall Study|Protocol Violation|0|||
125243365|NCT02969018|450514682|FG002|Overall Study|Protocol Violation|1|||
125243366|NCT02969018|450514683|FG003|Overall Study|Protocol Violation|1|||
125243367|NCT02969018|450514684|FG004|Overall Study|Protocol Violation|0|||
125243368|NCT02969018|450514685|FG005|Overall Study|Protocol Violation|0|||
125243369|NCT02969018|450514686|FG006|Overall Study|Protocol Violation|0|||
125443502|NCT00504348|451252158|FG000|Overall Study|Lack of Efficacy|4|||
125443503|NCT00504348|451252158|FG000|Overall Study|Physician Decision|1|||
125443504|NCT01118962|451252159|FG000|Overall Study|Adverse Event|2|||
125443505|NCT01118962|451252159|FG000|Overall Study|Lack of Efficacy|1|||
125443506|NCT01118962|451252159|FG000|Overall Study|Protocol Violation|1|||
125443507|NCT01118962|451252159|FG000|Overall Study|Withdrawal by Subject|4|||
125443508|NCT01118962|451252159|FG000|Overall Study|Pregnancy|1|||
125443509|NCT01118962|451252159|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
125443510|NCT01023308|451252162|FG000|Overall Study|Abnormal test proceedure results|3|||
125443511|NCT01023308|451252163|FG001|Overall Study|Abnormal test proceedure results|8|||
125443512|NCT01023308|451252162|FG000|Overall Study|Administrative problems|2|||
125443513|NCT01023308|451252163|FG001|Overall Study|Administrative problems|1|||
125443514|NCT01023308|451252162|FG000|Overall Study|Adverse Event|130|||
125443515|NCT01023308|451252163|FG001|Overall Study|Adverse Event|66|||
125443516|NCT01023308|451252162|FG000|Overall Study|Death|21|||
125443517|NCT01023308|451252163|FG001|Overall Study|Death|17|||
125443518|NCT01023308|451252162|FG000|Overall Study|Disease progression|82|||
125443519|NCT01023308|451252163|FG001|Overall Study|Disease progression|153|||
125443520|NCT01023308|451252162|FG000|Overall Study|New Cancer therapy|4|||
125243370|NCT02969018|450514687|FG007|Overall Study|Protocol Violation|0|||
125243371|NCT02969018|450514680|FG000|Overall Study|Withdrawal by Subject|0|||
125243372|NCT02969018|450514681|FG001|Overall Study|Withdrawal by Subject|1|||
125243373|NCT02969018|450514682|FG002|Overall Study|Withdrawal by Subject|2|||
125243374|NCT02969018|450514683|FG003|Overall Study|Withdrawal by Subject|1|||
125243375|NCT02969018|450514684|FG004|Overall Study|Withdrawal by Subject|0|||
125443521|NCT01023308|451252163|FG001|Overall Study|New Cancer therapy|7|||
125443522|NCT01023308|451252162|FG000|Overall Study|Protocol Violation|3|||
125443523|NCT01023308|451252163|FG001|Overall Study|Protocol Violation|4|||
125443524|NCT01023308|451252162|FG000|Overall Study|Untreated|5|||
125243376|NCT02969018|450514685|FG005|Overall Study|Withdrawal by Subject|4|||
125443525|NCT01023308|451252163|FG001|Overall Study|Untreated|5|||
125243377|NCT02969018|450514686|FG006|Overall Study|Withdrawal by Subject|4|||
125243378|NCT02969018|450514687|FG007|Overall Study|Withdrawal by Subject|3|||
125243379|NCT00367458|450514688|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
125243380|NCT00367458|450514689|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
125243381|NCT05762679|450514695|FG000|Overall Study|Withdrawal by Subject|1|||
125243382|NCT05762679|450514695|FG000|Overall Study|No analyzable imaging data|1|||
125243383|NCT03670628|450514696|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
125243384|NCT03670628|450514697|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
125243385|NCT03670628|450514696|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
125243386|NCT03670628|450514697|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
125243387|NCT02942407|450514698|FG000|Overall Study|Lost to Follow-up|3|||
125243388|NCT02942407|450514699|FG001|Overall Study|Lost to Follow-up|2|||
125243389|NCT02942407|450514698|FG000|Overall Study|Withdrawal by Subject|7|||
125243390|NCT02942407|450514699|FG001|Overall Study|Withdrawal by Subject|9|||
125243391|NCT02942407|450514698|FG000|Overall Study|Death|16|||
125243392|NCT02942407|450514699|FG001|Overall Study|Death|13|||
125243393|NCT01716156|450514701|FG000|Overall Study|Protocol Violation|1|||
125243394|NCT01716156|450514702|FG001|Overall Study|Protocol Violation|0|||
125243395|NCT01716156|450514703|FG002|Overall Study|Protocol Violation|0|||
125243396|NCT01716156|450514701|FG000|Overall Study|Withdrawal by Subject|0|||
125243397|NCT01716156|450514702|FG001|Overall Study|Withdrawal by Subject|1|||
125243398|NCT01716156|450514703|FG002|Overall Study|Withdrawal by Subject|2|||
125243399|NCT01716156|450514701|FG000|Overall Study|Lost to Follow-up|1|||
125243400|NCT01716156|450514702|FG001|Overall Study|Lost to Follow-up|0|||
125243401|NCT01716156|450514703|FG002|Overall Study|Lost to Follow-up|0|||
125243402|NCT03925220|450514704|FG000|Overall Study|Withdrawal by Subject|4|||
125243403|NCT03925220|450514705|FG001|Overall Study|Withdrawal by Subject|4|||
125243404|NCT03925220|450514706|FG002|Overall Study|Withdrawal by Subject|4|||
125243405|NCT03925220|450514707|FG003|Overall Study|Withdrawal by Subject|4|||
125243406|NCT03925220|450514704|FG000|Overall Study|Lost to Follow-up|40|||
125243407|NCT03925220|450514705|FG001|Overall Study|Lost to Follow-up|46|||
125243408|NCT03925220|450514706|FG002|Overall Study|Lost to Follow-up|37|||
125243409|NCT03925220|450514707|FG003|Overall Study|Lost to Follow-up|38|||
125243410|NCT05221866|450514708|FG000|Overall Study|Withdrawal by Subject|5|||
125243411|NCT05221866|450514709|FG001|Overall Study|Withdrawal by Subject|7|||
125243412|NCT05221866|450514710|FG002|Overall Study|Withdrawal by Subject|6|||
125243413|NCT05221866|450514711|FG003|Overall Study|Withdrawal by Subject|4|||
125243414|NCT05221866|450514708|FG000|Overall Study|Physician Decision|3|||
125243415|NCT05221866|450514709|FG001|Overall Study|Physician Decision|2|||
125243416|NCT05221866|450514710|FG002|Overall Study|Physician Decision|1|||
125243417|NCT05221866|450514711|FG003|Overall Study|Physician Decision|4|||
125243418|NCT05221866|450514708|FG000|Overall Study|Lost to Follow-up|12|||
125243419|NCT05221866|450514709|FG001|Overall Study|Lost to Follow-up|17|||
125243420|NCT05221866|450514710|FG002|Overall Study|Lost to Follow-up|14|||
125243421|NCT05221866|450514711|FG003|Overall Study|Lost to Follow-up|14|||
125303082|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125189098|NCT01252095|450313050|FG000|Overall Study|Disease progression|1|||
125189099|NCT01252095|450313051|FG001|Overall Study|Disease progression|0|||
125189100|NCT00365794|450313052|FG000|Overall Study|Withdrawal by Subject|2|||
125189101|NCT00745901|450313053|FG000|Overall Study|Adverse Event|3|||
125189102|NCT00745901|450313054|FG001|Overall Study|Adverse Event|4|||
125189103|NCT00745901|450313053|FG000|Overall Study|Protocol Violation|0|||
125189104|NCT00745901|450313054|FG001|Overall Study|Protocol Violation|1|||
125189105|NCT00745901|450313053|FG000|Overall Study|Withdrawal by Subject|1|||
125189106|NCT00745901|450313054|FG001|Overall Study|Withdrawal by Subject|0|||
125189107|NCT00745901|450313053|FG000|Overall Study|Lost to Follow-up|7|||
125189108|NCT00745901|450313054|FG001|Overall Study|Lost to Follow-up|4|||
125189109|NCT00745901|450313053|FG000|Overall Study|Pregnancy|2|||
125189110|NCT00745901|450313054|FG001|Overall Study|Pregnancy|4|||
125189111|NCT00745901|450313053|FG000|Overall Study|Lack of compliance|2|||
125189112|NCT00745901|450313054|FG001|Overall Study|Lack of compliance|2|||
125189113|NCT00745901|450313053|FG000|Overall Study|Patient's next menses did not start with|1|||
125189114|NCT00745901|450313054|FG001|Overall Study|Patient's next menses did not start with|0|||
125189115|NCT00745901|450313053|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
125189116|NCT00745901|450313054|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
125189117|NCT00745901|450313053|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
125189118|NCT00745901|450313054|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
125189119|NCT00745901|450313053|FG000|Overall Study|Patient didn't take any study medication|7|||
125189120|NCT00745901|450313054|FG001|Overall Study|Patient didn't take any study medication|3|||
125189121|NCT00884117|450313055|FG000|Overall Study|Adverse Event|2|||
125189122|NCT00884117|450313055|FG000|Overall Study|Withdrawal by Subject|89|||
125189123|NCT00884117|450313055|FG000|Overall Study|Death|3|||
125189124|NCT00884117|450313055|FG000|Overall Study|Lost to Follow-up|143|||
125189125|NCT00884117|450313055|FG000|Overall Study|Other|12|||
125243422|NCT05221866|450514708|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
125243423|NCT05221866|450514709|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
125243424|NCT05221866|450514710|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
125243425|NCT05221866|450514711|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
125243426|NCT05561140|450514712|FG000|Randomized Treatment Period|Adverse Event|1|||
125243427|NCT05561140|450514713|FG001|Randomized Treatment Period|Adverse Event|0|||
125243428|NCT05561140|450514712|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
125243429|NCT05561140|450514713|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
125243430|NCT05561140|450514712|FG000|Open Label Treatment Period|Adverse Event|6|||
125243431|NCT05561140|450514713|FG001|Open Label Treatment Period|Adverse Event|4|||
125243432|NCT05561140|450514712|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
125243433|NCT05561140|450514713|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
125243434|NCT05561140|450514712|FG000|Open Label Treatment Period|Physician Decision|0|||
125243435|NCT05561140|450514713|FG001|Open Label Treatment Period|Physician Decision|1|||
125243436|NCT05561140|450514712|FG000|Open Label Treatment Period|Pregnancy|1|||
125243437|NCT05561140|450514713|FG001|Open Label Treatment Period|Pregnancy|0|||
125243438|NCT05561140|450514712|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
125243439|NCT05561140|450514713|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
125243440|NCT05561140|450514712|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
125243441|NCT05561140|450514713|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
125243442|NCT05561140|450514712|FG000|Open Label Treatment Period|Other|1|||
125243443|NCT05561140|450514713|FG001|Open Label Treatment Period|Other|0|||
125243444|NCT06377488|450514714|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
125243445|NCT06377488|450514714|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
125243446|NCT06377488|450514714|FG000|Overall Study|Protocol Violation|1|||
125243447|NCT06377488|450514714|FG000|Overall Study|Lost to Follow-up|1|||
125243448|NCT06377488|450514714|FG000|Overall Study|Incorrect Lens Dispensed|2|||
125243449|NCT00866320|450514715|FG000|Overall Study|Withdrawal by Subject|4|||
125243450|NCT00866320|450514715|FG000|Overall Study|Death|2|||
125243451|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
125243452|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
125243453|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
125243454|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Death|1|||
125243455|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Death|0|||
125243456|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Death|0|||
125243457|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
125243458|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
125243459|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
125243460|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
125243461|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
125243462|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
125243463|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
125243464|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
125243465|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
125243466|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
125243467|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
125243468|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
125243469|NCT05073315|450514716|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
125243470|NCT05073315|450514717|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
125243471|NCT05073315|450514718|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
125243472|NCT05073315|450514716|FG000|Period 2|Adverse Event|0|||
125243473|NCT05073315|450514717|FG001|Period 2|Adverse Event|3|||
125243474|NCT05073315|450514718|FG002|Period 2|Adverse Event|6|||
125243475|NCT05073315|450514716|FG000|Period 2|Lost to Follow-up|0|||
125243476|NCT05073315|450514717|FG001|Period 2|Lost to Follow-up|5|||
125243477|NCT05073315|450514718|FG002|Period 2|Lost to Follow-up|5|||
125243478|NCT05073315|450514716|FG000|Period 2|Withdrawal by Subject|0|||
125243479|NCT05073315|450514717|FG001|Period 2|Withdrawal by Subject|4|||
125243480|NCT05073315|450514718|FG002|Period 2|Withdrawal by Subject|9|||
125243481|NCT05073315|450514716|FG000|Period 2|Protocol Violation|0|||
125243482|NCT05073315|450514717|FG001|Period 2|Protocol Violation|0|||
125243483|NCT05073315|450514718|FG002|Period 2|Protocol Violation|1|||
125243484|NCT05089357|450514721|FG000|Overall Study|Withdrawal by Subject|23|||
125243485|NCT05089357|450514721|FG000|Overall Study|Lost to Follow-up|6|||
125243486|NCT05089357|450514721|FG000|Overall Study|Medical reason|1|||
125393467|NCT00500292|451074090|FG000|Overall Study|Withdrawal by Subject|0|||
125393468|NCT00500292|451074091|FG001|Overall Study|Withdrawal by Subject|1|||
125243487|NCT05089357|450514721|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
125243488|NCT05089357|450514721|FG000|Overall Study|Pregnancy|2|||
125243489|NCT05537571|450514722|FG000|Overall Study|Withdrawal by Subject|1|||
125243490|NCT05537571|450514723|FG001|Overall Study|Withdrawal by Subject|1|||
125243491|NCT05537571|450514724|FG002|Overall Study|Withdrawal by Subject|0|||
125243492|NCT05537571|450514725|FG003|Overall Study|Withdrawal by Subject|0|||
125243493|NCT05537571|450514726|FG004|Overall Study|Withdrawal by Subject|0|||
125243494|NCT05537571|450514722|FG000|Overall Study|Adverse Event|2|||
125393469|NCT00500292|451074092|FG002|Overall Study|Withdrawal by Subject|0|||
125189126|NCT00153179|450313056|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
125189127|NCT00153179|450313057|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
125189128|NCT00153179|450313058|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
125189129|NCT00153179|450313059|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
125189130|NCT04495829|450313060|FG000|Overall Study|Lost to Follow-up|2|||
125189131|NCT04495829|450313060|FG000|Overall Study|Inclusion criterion not met|3|||
125189132|NCT02712554|450313061|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
125189133|NCT02712554|450313062|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
125189134|NCT02712554|450313061|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
125189135|NCT02712554|450313062|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
125189136|NCT02712554|450313061|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
125189137|NCT02712554|450313062|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
125189138|NCT02712554|450313061|FG000|Part B: Qualification Phase|Adverse Event|0|||
125189139|NCT02712554|450313062|FG001|Part B: Qualification Phase|Adverse Event|1|||
125189140|NCT02712554|450313061|FG000|Part B: Treatment Phase|Adverse Event|0|||
125189141|NCT02712554|450313062|FG001|Part B: Treatment Phase|Adverse Event|1|||
125189142|NCT02712554|450313061|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
125189143|NCT02712554|450313062|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
125189144|NCT02712554|450313061|FG000|Part B: Treatment Phase|Other|0|||
125189145|NCT02712554|450313062|FG001|Part B: Treatment Phase|Other|1|||
125189146|NCT03859427|450313063|FG000|Overall Study|Withdrawal by Subject|4|||
125189147|NCT03859427|450313064|FG001|Overall Study|Withdrawal by Subject|7|||
125189148|NCT03859427|450313063|FG000|Overall Study|Decision by sponsor|0|||
125189149|NCT03859427|450313064|FG001|Overall Study|Decision by sponsor|3|||
125189150|NCT03859427|450313063|FG000|Overall Study|Lost to Follow-up|3|||
125189151|NCT03859427|450313064|FG001|Overall Study|Lost to Follow-up|2|||
125189152|NCT03859427|450313063|FG000|Overall Study|Death|22|||
125189153|NCT03859427|450313064|FG001|Overall Study|Death|25|||
125189154|NCT02503540|450313065|FG000|Overall Study|Death|2|||
125189155|NCT02503540|450313065|FG000|Overall Study|Withdrawal by Subject|1|||
125189156|NCT01804946|450313066|FG000|Overall Study|Protocol Violation|1|||
125189157|NCT01804946|450313067|FG001|Overall Study|Protocol Violation|0|||
125189158|NCT01804946|450313066|FG000|Overall Study|Adverse Event|0|||
125189159|NCT01804946|450313067|FG001|Overall Study|Adverse Event|1|||
125189160|NCT01804946|450313066|FG000|Overall Study|Insufficient data available|0|||
125189161|NCT01804946|450313067|FG001|Overall Study|Insufficient data available|1|||
125189162|NCT01804946|450313066|FG000|Overall Study|Do not meet inclusion criteria|1|||
125189163|NCT01804946|450313067|FG001|Overall Study|Do not meet inclusion criteria|2|||
125189164|NCT00722137|450313068|FG000|Overall Study|Overt Disease Progression|5|||
125189165|NCT00722137|450313069|FG001|Overall Study|Overt Disease Progression|4|||
125189166|NCT00722137|450313068|FG000|Overall Study|Adverse Event|17|||
125189167|NCT00722137|450313069|FG001|Overall Study|Adverse Event|21|||
125189168|NCT00722137|450313068|FG000|Overall Study|Death|12|||
125189169|NCT00722137|450313069|FG001|Overall Study|Death|7|||
125189170|NCT00722137|450313068|FG000|Overall Study|Withdrawal by Subject|6|||
125189171|NCT00722137|450313069|FG001|Overall Study|Withdrawal by Subject|9|||
125189172|NCT00722137|450313068|FG000|Overall Study|Other Reason Unknown|3|||
125189173|NCT00722137|450313069|FG001|Overall Study|Other Reason Unknown|4|||
125189174|NCT00722137|450313068|FG000|Overall Study|Randomized But Not Treated|2|||
125189175|NCT00722137|450313069|FG001|Overall Study|Randomized But Not Treated|3|||
125189176|NCT01129557|450313070|FG000|Overall Study|Adverse Event|1|||
125189177|NCT01129557|450313071|FG001|Overall Study|Adverse Event|2|||
125189178|NCT01129557|450313072|FG002|Overall Study|Adverse Event|2|||
125189179|NCT01129557|450313070|FG000|Overall Study|Novartis terminated study early|3|||
125189180|NCT01129557|450313071|FG001|Overall Study|Novartis terminated study early|3|||
125189181|NCT01129557|450313072|FG002|Overall Study|Novartis terminated study early|2|||
125189182|NCT00669669|450313073|FG000|Overall Study|To late to start treatment|1|||
125189183|NCT00848718|450313074|FG000|Overall Study|Adverse Event|2|||
125189184|NCT00848718|450313075|FG001|Overall Study|Adverse Event|2|||
125189185|NCT00848718|450313076|FG002|Overall Study|Adverse Event|1|||
125189186|NCT00848718|450313077|FG003|Overall Study|Adverse Event|1|||
125189187|NCT00848718|450313078|FG004|Overall Study|Adverse Event|1|||
125189188|NCT00848718|450313079|FG005|Overall Study|Adverse Event|0|||
125189189|NCT00848718|450313080|FG006|Overall Study|Adverse Event|0|||
125189190|NCT00848718|450313081|FG007|Overall Study|Adverse Event|1|||
125189191|NCT00848718|450313082|FG008|Overall Study|Adverse Event|1|||
125189192|NCT00848718|450313083|FG009|Overall Study|Adverse Event|0|||
125189193|NCT00848718|450313084|FG010|Overall Study|Adverse Event|0|||
125189194|NCT00848718|450313085|FG011|Overall Study|Adverse Event|0|||
125189195|NCT00848718|450313086|FG012|Overall Study|Adverse Event|2|||
125189196|NCT00848718|450313074|FG000|Overall Study|Lack of Efficacy|0|||
125189197|NCT00848718|450313075|FG001|Overall Study|Lack of Efficacy|0|||
125243495|NCT05537571|450514723|FG001|Overall Study|Adverse Event|0|||
125243496|NCT05537571|450514724|FG002|Overall Study|Adverse Event|0|||
125243497|NCT05537571|450514725|FG003|Overall Study|Adverse Event|0|||
125243498|NCT05537571|450514726|FG004|Overall Study|Adverse Event|0|||
125243499|NCT05537571|450514722|FG000|Overall Study|Hepatitis A screening result|2|||
125243500|NCT05537571|450514723|FG001|Overall Study|Hepatitis A screening result|0|||
125243501|NCT05537571|450514724|FG002|Overall Study|Hepatitis A screening result|0|||
125243502|NCT05537571|450514725|FG003|Overall Study|Hepatitis A screening result|0|||
125243503|NCT05537571|450514726|FG004|Overall Study|Hepatitis A screening result|0|||
125243504|NCT05537571|450514722|FG000|Overall Study|Lost to Follow-up|0|||
125243505|NCT05537571|450514723|FG001|Overall Study|Lost to Follow-up|0|||
125243506|NCT05537571|450514724|FG002|Overall Study|Lost to Follow-up|1|||
125243507|NCT05537571|450514725|FG003|Overall Study|Lost to Follow-up|0|||
125243508|NCT05537571|450514726|FG004|Overall Study|Lost to Follow-up|1|||
125243509|NCT05752487|450514731|FG000|Overall Study|Enrolled, not treated|9|||
125243510|NCT05752487|450514731|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
125243511|NCT05752487|450514731|FG000|Overall Study|Withdrawal by Subject|2|||
125243512|NCT03091439|450514732|FG000|Overall Study|Study Terminated by the Sponsor|1|||
125243513|NCT03091439|450514733|FG001|Overall Study|Study Terminated by the Sponsor|0|||
125243514|NCT01860989|450514734|FG000|Overall Study|Unsatisfactory therapeutic|5|||
125243515|NCT01685437|450514737|FG000|Overall Study|Withdrawal by Subject|22|||
125243516|NCT01685437|450514737|FG000|Overall Study|Lost to Follow-up|3|||
125243517|NCT01685437|450514737|FG000|Overall Study|Adverse Event|1|||
125243518|NCT01685437|450514737|FG000|Overall Study|Protocol Violation|4|||
125243519|NCT01685437|450514737|FG000|Overall Study|Unable to make visits due to work|1|||
125243520|NCT03770455|450514744|FG000|Overall Study|Screen failures|3|||
125243521|NCT01039675|450514747|FG000|Overall Study|Adverse Event|0|||
125243522|NCT01039675|450514748|FG001|Overall Study|Adverse Event|2|||
125243523|NCT01039675|450514747|FG000|Overall Study|Lack of Efficacy|0|||
125243524|NCT01039675|450514748|FG001|Overall Study|Lack of Efficacy|2|||
125243525|NCT01039675|450514747|FG000|Overall Study|Withdrawal by Subject|0|||
125243526|NCT01039675|450514748|FG001|Overall Study|Withdrawal by Subject|1|||
125243527|NCT01039675|450514747|FG000|Overall Study|Lost to Follow-up|0|||
125243528|NCT01039675|450514748|FG001|Overall Study|Lost to Follow-up|1|||
125243529|NCT01039675|450514747|FG000|Overall Study|Physician Decision|0|||
125243530|NCT01039675|450514748|FG001|Overall Study|Physician Decision|1|||
125243531|NCT00134719|450516531|FG000|Primary Vaccination Phase|Adverse Event|4|||
125243532|NCT00134719|450516532|FG001|Primary Vaccination Phase|Adverse Event|0|||
125243533|NCT00134719|450516533|FG002|Primary Vaccination Phase|Adverse Event|0|||
125243534|NCT00134719|450516531|FG000|Primary Vaccination Phase|Protocol Violation|1|||
125243535|NCT00134719|450516532|FG001|Primary Vaccination Phase|Protocol Violation|0|||
125243536|NCT00134719|450516533|FG002|Primary Vaccination Phase|Protocol Violation|0|||
125243537|NCT00134719|450516531|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
125243538|NCT00134719|450516532|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
125243539|NCT00134719|450516533|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
125243540|NCT00134719|450516531|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
125243541|NCT00134719|450516532|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
125243542|NCT00134719|450516533|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
125243543|NCT00134719|450516531|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
125243544|NCT00134719|450516532|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
125243545|NCT00134719|450516533|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
125243546|NCT00134719|450516531|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
125243547|NCT00134719|450516532|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
125243548|NCT00134719|450516533|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
125243549|NCT03439839|450516534|FG000|Overall Study|Death|3|||
125243550|NCT03439839|450516535|FG001|Overall Study|Death|0|||
125243551|NCT02582632|450516543|FG000|Overall Study|Other|1|||
125243552|NCT03298061|450516544|FG000|Overall Study|Adverse Event|3|||
125243553|NCT03298061|450516544|FG000|Overall Study|Lack of Efficacy|6|||
125243554|NCT03298061|450516544|FG000|Overall Study|Protocol Violation|1|||
125243555|NCT03298061|450516544|FG000|Overall Study|Physician Decision|7|||
125243556|NCT03298061|450516544|FG000|Overall Study|Withdrawal by Subject|10|||
125243557|NCT00992836|450516547|FG000|Overall Study|Lost to Follow-up|1|||
125243558|NCT00992836|450516547|FG000|Overall Study|Withdrawal by Subject|2|||
125243559|NCT00992836|450516547|FG000|Overall Study|Protocol Violation|2|||
125243560|NCT01617967|450516551|FG000|Overall Study|Protocol Violation|0|||
125243561|NCT01617967|450516552|FG001|Overall Study|Protocol Violation|0|||
125243562|NCT01617967|450516553|FG002|Overall Study|Protocol Violation|0|||
125243563|NCT01617967|450516554|FG003|Overall Study|Protocol Violation|1|||
125243564|NCT01617967|450516555|FG004|Overall Study|Protocol Violation|0|||
125243565|NCT01617967|450516556|FG005|Overall Study|Protocol Violation|0|||
125243566|NCT01617967|450516551|FG000|Overall Study|Withdrawal by Subject|0|||
125243567|NCT01617967|450516552|FG001|Overall Study|Withdrawal by Subject|0|||
125243568|NCT01617967|450516553|FG002|Overall Study|Withdrawal by Subject|0|||
125243569|NCT01617967|450516554|FG003|Overall Study|Withdrawal by Subject|0|||
125243570|NCT01617967|450516555|FG004|Overall Study|Withdrawal by Subject|0|||
125189198|NCT00848718|450313076|FG002|Overall Study|Lack of Efficacy|1|||
125189199|NCT00848718|450313077|FG003|Overall Study|Lack of Efficacy|0|||
125189200|NCT00848718|450313078|FG004|Overall Study|Lack of Efficacy|0|||
125189201|NCT00848718|450313079|FG005|Overall Study|Lack of Efficacy|0|||
125189202|NCT00848718|450313080|FG006|Overall Study|Lack of Efficacy|1|||
125189203|NCT00848718|450313081|FG007|Overall Study|Lack of Efficacy|0|||
125189204|NCT00848718|450313082|FG008|Overall Study|Lack of Efficacy|0|||
125189205|NCT00848718|450313083|FG009|Overall Study|Lack of Efficacy|0|||
125189206|NCT00848718|450313084|FG010|Overall Study|Lack of Efficacy|0|||
125189207|NCT00848718|450313085|FG011|Overall Study|Lack of Efficacy|0|||
125189208|NCT00848718|450313086|FG012|Overall Study|Lack of Efficacy|0|||
125189209|NCT00848718|450313074|FG000|Overall Study|Physician Decision|0|||
125189210|NCT00848718|450313075|FG001|Overall Study|Physician Decision|1|||
125189211|NCT00848718|450313076|FG002|Overall Study|Physician Decision|0|||
125189212|NCT00848718|450313077|FG003|Overall Study|Physician Decision|0|||
125189213|NCT00848718|450313078|FG004|Overall Study|Physician Decision|1|||
125189214|NCT00848718|450313079|FG005|Overall Study|Physician Decision|1|||
125189215|NCT00848718|450313080|FG006|Overall Study|Physician Decision|0|||
125189216|NCT00848718|450313081|FG007|Overall Study|Physician Decision|0|||
125189217|NCT00848718|450313082|FG008|Overall Study|Physician Decision|1|||
125189218|NCT00848718|450313083|FG009|Overall Study|Physician Decision|2|||
125189219|NCT00848718|450313084|FG010|Overall Study|Physician Decision|0|||
125189220|NCT00848718|450313085|FG011|Overall Study|Physician Decision|0|||
125189221|NCT00848718|450313086|FG012|Overall Study|Physician Decision|1|||
125189222|NCT00848718|450313074|FG000|Overall Study|Progressive disease before treatment|1|||
125189223|NCT00848718|450313075|FG001|Overall Study|Progressive disease before treatment|5|||
125189224|NCT00848718|450313076|FG002|Overall Study|Progressive disease before treatment|1|||
125189225|NCT00848718|450313077|FG003|Overall Study|Progressive disease before treatment|3|||
125189226|NCT00848718|450313078|FG004|Overall Study|Progressive disease before treatment|4|||
125189227|NCT00848718|450313079|FG005|Overall Study|Progressive disease before treatment|4|||
125189228|NCT00848718|450313080|FG006|Overall Study|Progressive disease before treatment|2|||
125189229|NCT00848718|450313081|FG007|Overall Study|Progressive disease before treatment|1|||
125189230|NCT00848718|450313082|FG008|Overall Study|Progressive disease before treatment|2|||
125189231|NCT00848718|450313083|FG009|Overall Study|Progressive disease before treatment|7|||
125189232|NCT00848718|450313084|FG010|Overall Study|Progressive disease before treatment|3|||
125189233|NCT00848718|450313085|FG011|Overall Study|Progressive disease before treatment|6|||
125189234|NCT00848718|450313086|FG012|Overall Study|Progressive disease before treatment|2|||
125189235|NCT00848718|450313074|FG000|Overall Study|Protocol Violation|0|||
125189236|NCT00848718|450313075|FG001|Overall Study|Protocol Violation|1|||
125189237|NCT00848718|450313076|FG002|Overall Study|Protocol Violation|0|||
125189238|NCT00848718|450313077|FG003|Overall Study|Protocol Violation|0|||
125189239|NCT00848718|450313078|FG004|Overall Study|Protocol Violation|0|||
125189240|NCT00848718|450313079|FG005|Overall Study|Protocol Violation|0|||
125189241|NCT00848718|450313080|FG006|Overall Study|Protocol Violation|0|||
125189242|NCT00848718|450313081|FG007|Overall Study|Protocol Violation|1|||
125189243|NCT00848718|450313082|FG008|Overall Study|Protocol Violation|0|||
125189244|NCT00848718|450313083|FG009|Overall Study|Protocol Violation|0|||
125189245|NCT00848718|450313084|FG010|Overall Study|Protocol Violation|0|||
125189246|NCT00848718|450313085|FG011|Overall Study|Protocol Violation|0|||
125189247|NCT00848718|450313086|FG012|Overall Study|Protocol Violation|1|||
125189248|NCT00848718|450313074|FG000|Overall Study|Withdrawal by Subject|1|||
125189249|NCT00848718|450313075|FG001|Overall Study|Withdrawal by Subject|0|||
125189250|NCT00848718|450313076|FG002|Overall Study|Withdrawal by Subject|0|||
125189251|NCT00848718|450313077|FG003|Overall Study|Withdrawal by Subject|1|||
125189252|NCT00848718|450313078|FG004|Overall Study|Withdrawal by Subject|0|||
125189253|NCT00848718|450313079|FG005|Overall Study|Withdrawal by Subject|0|||
125189254|NCT00848718|450313080|FG006|Overall Study|Withdrawal by Subject|0|||
125189255|NCT00848718|450313081|FG007|Overall Study|Withdrawal by Subject|0|||
125189256|NCT00848718|450313082|FG008|Overall Study|Withdrawal by Subject|0|||
125189257|NCT00848718|450313083|FG009|Overall Study|Withdrawal by Subject|0|||
125189258|NCT00848718|450313084|FG010|Overall Study|Withdrawal by Subject|1|||
125189259|NCT00848718|450313085|FG011|Overall Study|Withdrawal by Subject|0|||
125189260|NCT00848718|450313086|FG012|Overall Study|Withdrawal by Subject|0|||
125189261|NCT00848718|450313074|FG000|Overall Study|Progressive disease during treatment|3|||
125189262|NCT00848718|450313075|FG001|Overall Study|Progressive disease during treatment|0|||
125189263|NCT00848718|450313076|FG002|Overall Study|Progressive disease during treatment|3|||
125189264|NCT00848718|450313077|FG003|Overall Study|Progressive disease during treatment|0|||
125189265|NCT00848718|450313078|FG004|Overall Study|Progressive disease during treatment|0|||
125189266|NCT00848718|450313079|FG005|Overall Study|Progressive disease during treatment|0|||
125189267|NCT00848718|450313080|FG006|Overall Study|Progressive disease during treatment|0|||
125189268|NCT00848718|450313081|FG007|Overall Study|Progressive disease during treatment|2|||
125189269|NCT00848718|450313082|FG008|Overall Study|Progressive disease during treatment|0|||
125189270|NCT00848718|450313083|FG009|Overall Study|Progressive disease during treatment|0|||
125189271|NCT00848718|450313084|FG010|Overall Study|Progressive disease during treatment|0|||
125243571|NCT01617967|450516556|FG005|Overall Study|Withdrawal by Subject|1|||
125189272|NCT00848718|450313085|FG011|Overall Study|Progressive disease during treatment|0|||
125189273|NCT00848718|450313086|FG012|Overall Study|Progressive disease during treatment|2|||
125189274|NCT02418182|450313088|FG000|Overall Study|Unable to re-consent|18|||
125189275|NCT02418182|450313089|FG001|Overall Study|Unable to re-consent|15|||
125189276|NCT02418182|450313088|FG000|Overall Study|Lost to Follow-up|0|||
125189277|NCT02418182|450313089|FG001|Overall Study|Lost to Follow-up|2|||
125189278|NCT02431676|450313092|FG000|Overall Study|no lab obtained|0|||
125243572|NCT01617967|450516551|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
125243573|NCT01617967|450516552|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
125243574|NCT01617967|450516553|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
125243575|NCT01617967|450516554|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
125189279|NCT02431676|450313093|FG001|Overall Study|no lab obtained|1|||
125189280|NCT02431676|450313094|FG002|Overall Study|no lab obtained|2|||
125189281|NCT01120184|450315023|FG000|Overall Study|Adverse Event|0|||
125189282|NCT01120184|450315024|FG001|Overall Study|Adverse Event|1|||
125189283|NCT01120184|450315025|FG002|Overall Study|Adverse Event|0|||
125189284|NCT01120184|450315023|FG000|Overall Study|Lost to Follow-up|13|||
125189285|NCT01120184|450315024|FG001|Overall Study|Lost to Follow-up|13|||
125189286|NCT01120184|450315025|FG002|Overall Study|Lost to Follow-up|11|||
125189287|NCT01120184|450315023|FG000|Overall Study|Physician Decision|9|||
125189288|NCT01120184|450315024|FG001|Overall Study|Physician Decision|1|||
125189289|NCT01120184|450315025|FG002|Overall Study|Physician Decision|3|||
125189290|NCT01120184|450315023|FG000|Overall Study|Reason not Specified|8|||
125189291|NCT01120184|450315024|FG001|Overall Study|Reason not Specified|3|||
125189292|NCT01120184|450315025|FG002|Overall Study|Reason not Specified|12|||
125189293|NCT01120184|450315023|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
125189294|NCT01120184|450315024|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
125189295|NCT01120184|450315025|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
125189296|NCT01120184|450315023|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
125189297|NCT01120184|450315024|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
125189298|NCT01120184|450315025|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
125189299|NCT01120184|450315023|FG000|Overall Study|Death|170|||
125189300|NCT01120184|450315024|FG001|Overall Study|Death|176|||
125189301|NCT01120184|450315025|FG002|Overall Study|Death|169|||
125189302|NCT04003636|450315026|FG000|Overall Study|Death|409|||
125189303|NCT04003636|450315027|FG001|Overall Study|Death|443|||
125189304|NCT04003636|450315026|FG000|Overall Study|Lost to Follow-up|0|||
125189305|NCT04003636|450315027|FG001|Overall Study|Lost to Follow-up|1|||
125189306|NCT04003636|450315026|FG000|Overall Study|Withdrawal by Subject|5|||
125189307|NCT04003636|450315027|FG001|Overall Study|Withdrawal by Subject|2|||
125189308|NCT04003636|450315026|FG000|Overall Study|Participant On-going|119|||
125189309|NCT04003636|450315027|FG001|Overall Study|Participant On-going|90|||
125189310|NCT03656068|450315028|FG000|Overall Study|Withdrawal by Subject|4|||
125189311|NCT03656068|450315028|FG000|Overall Study|Adverse Event|1|||
125189312|NCT03270657|450315030|FG000|Overall Study|Withdrawal by Subject|1|||
125189313|NCT00162981|450315031|FG000|Overall Study|Adverse Event|2|||
125189314|NCT00162981|450315032|FG001|Overall Study|Adverse Event|5|||
125189315|NCT00162981|450315031|FG000|Overall Study|Withdrawal by Subject|1|||
125189316|NCT00162981|450315032|FG001|Overall Study|Withdrawal by Subject|1|||
125189317|NCT00162981|450315031|FG000|Overall Study|Physician Decision|1|||
125189318|NCT00162981|450315032|FG001|Overall Study|Physician Decision|0|||
125189319|NCT00455403|450315039|FG000|Overall Study|Lost to Follow-up|2|||
125189320|NCT00455403|450315040|FG001|Overall Study|Lost to Follow-up|1|||
125189321|NCT00455403|450315039|FG000|Overall Study|Withdrawal by Subject|1|||
125189322|NCT00455403|450315040|FG001|Overall Study|Withdrawal by Subject|3|||
125189323|NCT00455403|450315039|FG000|Overall Study|Protocol Violation|0|||
125243576|NCT01617967|450516555|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
125243577|NCT01617967|450516556|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
125243578|NCT05276804|450516561|FG000|Overall Study|screen failure|23|||
125243579|NCT05276804|450516562|FG001|Overall Study|screen failure|0|||
125243580|NCT02827708|450516563|FG000|Overall Study|Lost to Follow-up|3|||
125243581|NCT02827708|450516564|FG001|Overall Study|Lost to Follow-up|1|||
125243582|NCT02827708|450516563|FG000|Overall Study|Withdrawal by Subject|1|||
125243583|NCT02827708|450516564|FG001|Overall Study|Withdrawal by Subject|2|||
125243584|NCT02827708|450516563|FG000|Overall Study|Death|1|||
125189324|NCT00455403|450315040|FG001|Overall Study|Protocol Violation|2|||
125189325|NCT00350207|450315041|FG000|Overall Study|Adverse Event|5|||
125189326|NCT00350207|450315042|FG001|Overall Study|Adverse Event|2|||
125189327|NCT00350207|450315043|FG002|Overall Study|Adverse Event|2|||
125189328|NCT00350207|450315041|FG000|Overall Study|Lack of Efficacy|1|||
125189329|NCT00350207|450315042|FG001|Overall Study|Lack of Efficacy|0|||
125189330|NCT00350207|450315043|FG002|Overall Study|Lack of Efficacy|2|||
125189331|NCT00350207|450315041|FG000|Overall Study|Lost to Follow-up|1|||
125189332|NCT00350207|450315042|FG001|Overall Study|Lost to Follow-up|0|||
125189333|NCT00350207|450315043|FG002|Overall Study|Lost to Follow-up|1|||
125189334|NCT00350207|450315041|FG000|Overall Study|Withdrawal by Subject|0|||
125243585|NCT02827708|450516564|FG001|Overall Study|Death|2|||
125393470|NCT00500292|451074090|FG000|Overall Study|Other|1|||
125393471|NCT00500292|451074091|FG001|Overall Study|Other|1|||
125393472|NCT00500292|451074092|FG002|Overall Study|Other|4|||
125189335|NCT00350207|450315042|FG001|Overall Study|Withdrawal by Subject|1|||
125393473|NCT01068509|451074093|FG000|Overall Study|Death|0|||
125393474|NCT01068509|451074094|FG001|Overall Study|Death|0|||
125393475|NCT01068509|451074095|FG002|Overall Study|Death|1|||
125393476|NCT01068509|451074093|FG000|Overall Study|Disease Progression|5|||
125393477|NCT01068509|451074094|FG001|Overall Study|Disease Progression|20|||
125393478|NCT01068509|451074095|FG002|Overall Study|Disease Progression|18|||
125393479|NCT01068509|451074093|FG000|Overall Study|Lost to Follow-up|1|||
125393480|NCT01068509|451074094|FG001|Overall Study|Lost to Follow-up|0|||
125393481|NCT01068509|451074095|FG002|Overall Study|Lost to Follow-up|0|||
125393482|NCT01068509|451074093|FG000|Overall Study|Withdrew Consent|0|||
125393483|NCT01068509|451074094|FG001|Overall Study|Withdrew Consent|1|||
125393484|NCT01068509|451074095|FG002|Overall Study|Withdrew Consent|2|||
125393485|NCT01068509|451074093|FG000|Overall Study|Reason Not Specified|0|||
125393486|NCT01068509|451074094|FG001|Overall Study|Reason Not Specified|1|||
125393487|NCT01068509|451074095|FG002|Overall Study|Reason Not Specified|0|||
125393488|NCT00856908|451074104|FG000|Overall Study|Lost to Follow-up|1|||
125393489|NCT00856908|451074105|FG001|Overall Study|Lost to Follow-up|0|||
125393490|NCT00962104|451074106|FG000|Overall Study|Adverse Event|10|||
125393491|NCT00962104|451074107|FG001|Overall Study|Adverse Event|3|||
125393492|NCT00962104|451074106|FG000|Overall Study|Entry Criteria Not Met|1|||
125393493|NCT00962104|451074107|FG001|Overall Study|Entry Criteria Not Met|2|||
125393494|NCT00962104|451074106|FG000|Overall Study|Lack of Efficacy|0|||
125393495|NCT00962104|451074107|FG001|Overall Study|Lack of Efficacy|1|||
125393496|NCT00962104|451074106|FG000|Overall Study|Lost to Follow-up|10|||
125393497|NCT00962104|451074107|FG001|Overall Study|Lost to Follow-up|4|||
125393498|NCT00962104|451074106|FG000|Overall Study|Physician Decision|1|||
125393499|NCT00962104|451074107|FG001|Overall Study|Physician Decision|0|||
125393500|NCT00962104|451074106|FG000|Overall Study|Protocol Violation|6|||
125393501|NCT00962104|451074107|FG001|Overall Study|Protocol Violation|8|||
125393502|NCT00962104|451074106|FG000|Overall Study|Sponsor Decision|0|||
125393503|NCT00962104|451074107|FG001|Overall Study|Sponsor Decision|1|||
125393504|NCT00962104|451074106|FG000|Overall Study|Withdrawal by Subject|10|||
125393505|NCT00962104|451074107|FG001|Overall Study|Withdrawal by Subject|6|||
125393506|NCT00962104|451074106|FG000|Overall Study|Other|2|||
125393507|NCT00962104|451074107|FG001|Overall Study|Other|0|||
125393508|NCT00842348|451074108|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
125393509|NCT00842348|451074109|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
125393510|NCT00842348|451074108|FG000|Study 729|Disease progression/death|19|||
125393511|NCT00842348|451074109|FG001|Study 729|Disease progression/death|30|||
125443526|NCT01023308|451252162|FG000|Overall Study|Lost to Follow-up|1|||
125443527|NCT01023308|451252163|FG001|Overall Study|Lost to Follow-up|0|||
125189336|NCT00350207|450315043|FG002|Overall Study|Withdrawal by Subject|1|||
125189337|NCT00350207|450315041|FG000|Overall Study|Other|1|||
125189338|NCT00350207|450315042|FG001|Overall Study|Other|3|||
125189339|NCT00350207|450315043|FG002|Overall Study|Other|1|||
125189340|NCT00495391|450315044|FG000|Overall Study|Lack of Efficacy|34|||
125189341|NCT00495391|450315045|FG001|Overall Study|Lack of Efficacy|18|||
125189342|NCT00495391|450315044|FG000|Overall Study|Withdrawal by Subject|2|||
125189343|NCT00495391|450315045|FG001|Overall Study|Withdrawal by Subject|3|||
125189344|NCT04509076|450315054|FG000|Overall Study|Withdrawal by Subject|1|||
125189345|NCT04509076|450315055|FG001|Overall Study|Withdrawal by Subject|2|||
125189346|NCT04509076|450315054|FG000|Overall Study|Lost to Follow-up|1|||
125189347|NCT04509076|450315055|FG001|Overall Study|Lost to Follow-up|2|||
125189348|NCT00502242|450315060|FG000|Overall Study|Lack of Efficacy|1|||
125189349|NCT00502242|450315061|FG001|Overall Study|Lack of Efficacy|11|||
125189350|NCT00502242|450315060|FG000|Overall Study|Adverse Event|31|||
125189351|NCT00502242|450315061|FG001|Overall Study|Adverse Event|20|||
125189352|NCT00502242|450315060|FG000|Overall Study|Physician Decision|2|||
125189353|NCT00502242|450315061|FG001|Overall Study|Physician Decision|3|||
125189354|NCT00502242|450315060|FG000|Overall Study|Other - Unspecified|8|||
125189355|NCT00502242|450315061|FG001|Overall Study|Other - Unspecified|14|||
125393512|NCT00842348|451074108|FG000|Study 729|Adverse Event|1|||
125443528|NCT01023308|451252162|FG000|Overall Study|Withdrawal by Subject|34|||
125443529|NCT01023308|451252163|FG001|Overall Study|Withdrawal by Subject|18|||
125189356|NCT00502242|450315060|FG000|Overall Study|Protocol Violation|3|||
125393513|NCT00842348|451074109|FG001|Study 729|Adverse Event|1|||
125393514|NCT00842348|451074108|FG000|Study 729|Protocol Violation|1|||
125393515|NCT00842348|451074109|FG001|Study 729|Protocol Violation|1|||
125393516|NCT00842348|451074108|FG000|Study 729|Withdrawal by Subject|2|||
125393517|NCT00842348|451074109|FG001|Study 729|Withdrawal by Subject|4|||
125393518|NCT00842348|451074108|FG000|Study 729|Due to Sponsor stopping the study|1|||
125443530|NCT00551213|451252164|FG000|Overall Study|Adverse Event|6|||
125189357|NCT00502242|450315061|FG001|Overall Study|Protocol Violation|1|||
125243586|NCT01137812|450516565|FG000|Overall Study|Adverse Event|21|||
125393519|NCT00842348|451074109|FG001|Study 729|Due to Sponsor stopping the study|1|||
125393520|NCT00842348|451074108|FG000|Study 729|Due to non-availability of IP|0|||
125243587|NCT01137812|450516566|FG001|Overall Study|Adverse Event|14|||
125243588|NCT01137812|450516565|FG000|Overall Study|Lost to Follow-up|6|||
125243589|NCT01137812|450516566|FG001|Overall Study|Lost to Follow-up|8|||
125243590|NCT01137812|450516565|FG000|Overall Study|Physician Decision|25|||
125189358|NCT00502242|450315060|FG000|Overall Study|Withdrawal by Subject|6|||
125189359|NCT00502242|450315061|FG001|Overall Study|Withdrawal by Subject|7|||
125243591|NCT01137812|450516566|FG001|Overall Study|Physician Decision|17|||
125243592|NCT01137812|450516565|FG000|Overall Study|Protocol Violation|5|||
125243593|NCT01137812|450516566|FG001|Overall Study|Protocol Violation|4|||
125243594|NCT01137812|450516565|FG000|Overall Study|Withdrawal by Subject|5|||
125243595|NCT01137812|450516566|FG001|Overall Study|Withdrawal by Subject|13|||
125243596|NCT01137812|450516565|FG000|Overall Study|Death|2|||
125243597|NCT01137812|450516566|FG001|Overall Study|Death|0|||
125243598|NCT01137812|450516565|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
125243599|NCT01137812|450516566|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
125243600|NCT01137812|450516565|FG000|Overall Study|Other|19|||
125243601|NCT01137812|450516566|FG001|Overall Study|Other|27|||
125243602|NCT04621760|450516570|FG000|Overall Study|Lost to Follow-up|2|||
125243603|NCT04621760|450516571|FG001|Overall Study|Lost to Follow-up|4|||
125243604|NCT04621760|450516570|FG000|Overall Study|Withdrawal by Subject|1|||
125243605|NCT04621760|450516571|FG001|Overall Study|Withdrawal by Subject|0|||
125243606|NCT04602000|450516572|FG000|Overall Study|Withdrawal by Subject|3|||
125243607|NCT04602000|450516573|FG001|Overall Study|Withdrawal by Subject|6|||
125243608|NCT04602000|450516574|FG002|Overall Study|Withdrawal by Subject|3|||
125243609|NCT04602000|450516575|FG003|Overall Study|Withdrawal by Subject|27|||
125243610|NCT04602000|450516576|FG004|Overall Study|Withdrawal by Subject|39|||
125243611|NCT04602000|450516572|FG000|Overall Study|Physician Decision|1|||
125243612|NCT04602000|450516573|FG001|Overall Study|Physician Decision|0|||
125189360|NCT01812109|450315062|FG000|Overall Study|research personnel delay|16|||
125189361|NCT01812109|450315062|FG000|Overall Study|NIRS Unattainable|17|||
125189362|NCT03313180|450315063|FG000|Overall Study|Adverse Event|120|||
125189363|NCT03313180|450315063|FG000|Overall Study|Lost to Follow-up|3|||
125189364|NCT03313180|450315063|FG000|Overall Study|Withdrawal by Subject|39|||
125189365|NCT03313180|450315063|FG000|Overall Study|Other than listed above|15|||
125189366|NCT03313180|450315063|FG000|Overall Study|Covid-19 related|2|||
125189367|NCT00461630|450315064|FG000|Overall Study|Death|798|||
125189368|NCT00461630|450315065|FG001|Overall Study|Death|732|||
125189369|NCT00461630|450315064|FG000|Overall Study|Lost to Follow-up|108|||
125189370|NCT00461630|450315065|FG001|Overall Study|Lost to Follow-up|95|||
125189371|NCT00891020|450315068|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
125189372|NCT00891020|450315069|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
125189373|NCT00891020|450315070|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
125189374|NCT00891020|450315068|FG000|24 Week Treatment Period|Death|0|||
125189375|NCT00891020|450315069|FG001|24 Week Treatment Period|Death|2|||
125189376|NCT00891020|450315070|FG002|24 Week Treatment Period|Death|0|||
125189377|NCT00891020|450315068|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
125189378|NCT00891020|450315069|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
125189379|NCT00891020|450315070|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
125189380|NCT00891020|450315068|FG000|24 Week Treatment Period|Failure to return|4|||
125189381|NCT00891020|450315069|FG001|24 Week Treatment Period|Failure to return|5|||
125189382|NCT00891020|450315070|FG002|24 Week Treatment Period|Failure to return|5|||
125189383|NCT00891020|450315068|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
125189384|NCT00891020|450315069|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
125189385|NCT00891020|450315070|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
125189386|NCT00891020|450315068|FG000|24 Week Treatment Period|Other protocol violation|1|||
125189387|NCT00891020|450315069|FG001|24 Week Treatment Period|Other protocol violation|1|||
125189388|NCT00891020|450315070|FG002|24 Week Treatment Period|Other protocol violation|2|||
125189389|NCT00891020|450315068|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
125189390|NCT00891020|450315069|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
125189391|NCT00891020|450315070|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
125189392|NCT00891020|450315068|FG000|24 Week Treatment Period|Withdrew consent|6|||
125189393|NCT00891020|450315069|FG001|24 Week Treatment Period|Withdrew consent|3|||
125189394|NCT00891020|450315070|FG002|24 Week Treatment Period|Withdrew consent|15|||
125243613|NCT04602000|450516574|FG002|Overall Study|Physician Decision|0|||
125243614|NCT04602000|450516575|FG003|Overall Study|Physician Decision|2|||
125243615|NCT04602000|450516576|FG004|Overall Study|Physician Decision|2|||
125243616|NCT04602000|450516572|FG000|Overall Study|Death|0|||
125189395|NCT00891020|450315068|FG000|24 Week Treatment Period|Administrative/Other|5|||
125189396|NCT00891020|450315069|FG001|24 Week Treatment Period|Administrative/Other|6|||
125189397|NCT00891020|450315070|FG002|24 Week Treatment Period|Administrative/Other|1|||
125189398|NCT00891020|450315068|FG000|Long-term Extension Period|Adverse Event|1|||
125189399|NCT00891020|450315069|FG001|Long-term Extension Period|Adverse Event|11|||
125243617|NCT04602000|450516573|FG001|Overall Study|Death|1|||
125243618|NCT04602000|450516574|FG002|Overall Study|Death|0|||
125243619|NCT04602000|450516575|FG003|Overall Study|Death|1|||
125189400|NCT00891020|450315070|FG002|Long-term Extension Period|Adverse Event|10|||
125189401|NCT00891020|450315068|FG000|Long-term Extension Period|Death|0|||
125189402|NCT00891020|450315069|FG001|Long-term Extension Period|Death|0|||
125189403|NCT00891020|450315070|FG002|Long-term Extension Period|Death|1|||
125189404|NCT00891020|450315068|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
125189405|NCT00891020|450315069|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
125189406|NCT00891020|450315070|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
125189407|NCT00891020|450315068|FG000|Long-term Extension Period|Protocol Violation|0|||
125189408|NCT00891020|450315069|FG001|Long-term Extension Period|Protocol Violation|1|||
125189409|NCT00891020|450315070|FG002|Long-term Extension Period|Protocol Violation|1|||
125189410|NCT00891020|450315068|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
125189411|NCT00891020|450315069|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
125189412|NCT00891020|450315070|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
125189413|NCT00891020|450315068|FG000|Long-term Extension Period|Failure to return|0|||
125189414|NCT00891020|450315069|FG001|Long-term Extension Period|Failure to return|2|||
125189415|NCT00891020|450315070|FG002|Long-term Extension Period|Failure to return|3|||
125189416|NCT00891020|450315068|FG000|Long-term Extension Period|Administrative|1|||
125189417|NCT00891020|450315069|FG001|Long-term Extension Period|Administrative|2|||
125189418|NCT00891020|450315070|FG002|Long-term Extension Period|Administrative|2|||
125189419|NCT00320710|450315078|FG000|Overall Study|Disease progression|24|||
125189420|NCT00320710|450315079|FG001|Overall Study|Disease progression|19|||
125189421|NCT00320710|450315080|FG002|Overall Study|Disease progression|2|||
125189422|NCT00320710|450315078|FG000|Overall Study|Death|10|||
125189423|NCT00320710|450315079|FG001|Overall Study|Death|7|||
125189424|NCT00320710|450315080|FG002|Overall Study|Death|1|||
125189425|NCT00320710|450315078|FG000|Overall Study|Administrative problems|1|||
125189426|NCT00320710|450315079|FG001|Overall Study|Administrative problems|2|||
125189427|NCT00320710|450315080|FG002|Overall Study|Administrative problems|0|||
125189428|NCT00320710|450315078|FG000|Overall Study|Withdrawal by Subject|20|||
125189429|NCT00320710|450315079|FG001|Overall Study|Withdrawal by Subject|26|||
125189430|NCT00320710|450315080|FG002|Overall Study|Withdrawal by Subject|1|||
125189431|NCT00320710|450315078|FG000|Overall Study|Protocol Violation|6|||
125189432|NCT00320710|450315079|FG001|Overall Study|Protocol Violation|5|||
125189433|NCT00320710|450315080|FG002|Overall Study|Protocol Violation|0|||
125189434|NCT00320710|450315078|FG000|Overall Study|Abnormal test procedure result(s)|2|||
125189435|NCT00320710|450315079|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125189436|NCT00320710|450315080|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125189437|NCT00320710|450315078|FG000|Overall Study|Abnormal laboratory value(s)|12|||
125189438|NCT00320710|450315079|FG001|Overall Study|Abnormal laboratory value(s)|3|||
125189439|NCT00320710|450315080|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125189440|NCT00320710|450315078|FG000|Overall Study|Adverse Event|18|||
125189441|NCT00320710|450315079|FG001|Overall Study|Adverse Event|14|||
125189442|NCT00320710|450315080|FG002|Overall Study|Adverse Event|1|||
125189443|NCT00320710|450315078|FG000|Overall Study|Lost to Follow-up|1|||
125189444|NCT00320710|450315079|FG001|Overall Study|Lost to Follow-up|0|||
125189445|NCT00320710|450315080|FG002|Overall Study|Lost to Follow-up|0|||
125189446|NCT03448419|450315081|FG000|Overall Study|Adverse Event|10|||
125189447|NCT03448419|450315082|FG001|Overall Study|Adverse Event|9|||
125189448|NCT03448419|450315081|FG000|Overall Study|Lost to Follow-up|0|||
125189449|NCT03448419|450315082|FG001|Overall Study|Lost to Follow-up|2|||
125189450|NCT03448419|450315081|FG000|Overall Study|Withdrawal by Subject|3|||
125189451|NCT03448419|450315082|FG001|Overall Study|Withdrawal by Subject|1|||
125189452|NCT03448419|450315081|FG000|Overall Study|Not treated|0|||
125189453|NCT03448419|450315082|FG001|Overall Study|Not treated|1|||
125189454|NCT03448419|450315081|FG000|Overall Study|Patient did not attend all visits|0|||
125189455|NCT03448419|450315082|FG001|Overall Study|Patient did not attend all visits|2|||
125189456|NCT03448419|450315081|FG000|Overall Study|Withdrawn by Sponsor|0|||
125189457|NCT03448419|450315082|FG001|Overall Study|Withdrawn by Sponsor|1|||
125189458|NCT04548193|450315086|FG000|Overall Study|Lost to Follow-up|0|||
125189459|NCT04548193|450315087|FG001|Overall Study|Lost to Follow-up|1|||
125189460|NCT04548193|450315086|FG000|Overall Study|Death|0|||
125189461|NCT04548193|450315087|FG001|Overall Study|Death|1|||
125189462|NCT04548193|450315086|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
125189463|NCT04548193|450315087|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
125189464|NCT04548193|450315086|FG000|Overall Study|Withdrawal by Subject|2|||
125189465|NCT04548193|450315087|FG001|Overall Study|Withdrawal by Subject|2|||
125189466|NCT00630825|450315088|FG000|Overall Study|Adverse Event|4|||
125189467|NCT00630825|450315089|FG001|Overall Study|Adverse Event|4|||
125243620|NCT04602000|450516576|FG004|Overall Study|Death|2|||
125243621|NCT04602000|450516572|FG000|Overall Study|Lost to Follow-up|0|||
125189468|NCT00630825|450315090|FG002|Overall Study|Adverse Event|3|||
125189469|NCT00630825|450315091|FG003|Overall Study|Adverse Event|1|||
125189470|NCT00630825|450315088|FG000|Overall Study|Entry Criteria Not Met|1|||
125189471|NCT00630825|450315089|FG001|Overall Study|Entry Criteria Not Met|0|||
125189472|NCT00630825|450315090|FG002|Overall Study|Entry Criteria Not Met|2|||
125189473|NCT00630825|450315091|FG003|Overall Study|Entry Criteria Not Met|1|||
125189474|NCT00630825|450315088|FG000|Overall Study|Lost to Follow-up|1|||
125189475|NCT00630825|450315089|FG001|Overall Study|Lost to Follow-up|1|||
125189476|NCT00630825|450315090|FG002|Overall Study|Lost to Follow-up|1|||
125189477|NCT00630825|450315091|FG003|Overall Study|Lost to Follow-up|1|||
125189478|NCT00630825|450315088|FG000|Overall Study|Physician Decision|1|||
125189479|NCT00630825|450315089|FG001|Overall Study|Physician Decision|0|||
125189480|NCT00630825|450315090|FG002|Overall Study|Physician Decision|0|||
125189481|NCT00630825|450315091|FG003|Overall Study|Physician Decision|0|||
125189482|NCT00630825|450315088|FG000|Overall Study|Withdrawal by Subject|2|||
125189483|NCT00630825|450315089|FG001|Overall Study|Withdrawal by Subject|2|||
125189484|NCT00630825|450315090|FG002|Overall Study|Withdrawal by Subject|2|||
125189485|NCT00630825|450315091|FG003|Overall Study|Withdrawal by Subject|3|||
125189486|NCT02211209|450315093|FG000|Overall Study|Investigator judgment|0|||
125189487|NCT02211209|450315094|FG001|Overall Study|Investigator judgment|1|||
125189488|NCT02211209|450315093|FG000|Overall Study|Voluntary withdrawal|1|||
125189489|NCT02211209|450315094|FG001|Overall Study|Voluntary withdrawal|4|||
125189490|NCT02211209|450315093|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
125189491|NCT02211209|450315094|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
125189492|NCT02211209|450315093|FG000|Overall Study|Reason Not Specified|1|||
125189493|NCT02211209|450315094|FG001|Overall Study|Reason Not Specified|0|||
125189494|NCT02792062|450315095|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
125189495|NCT02792062|450315096|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
125189496|NCT02792062|450315097|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
125189497|NCT02792062|450315098|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
125189498|NCT02792062|450315099|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
125189499|NCT02792062|450315100|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
125189500|NCT00931255|450315101|FG000|Overall Study|Follow up biopsy not done|2|||
125189501|NCT00931255|450315102|FG001|Overall Study|Follow up biopsy not done|3|||
125189502|NCT01372995|450315103|FG000|Overall Study|Spouse withdrew participant from study|0|||
125189503|NCT01372995|450315104|FG001|Overall Study|Spouse withdrew participant from study|1|||
125189504|NCT01372995|450315105|FG002|Overall Study|Spouse withdrew participant from study|0|||
125189505|NCT01372995|450315103|FG000|Overall Study|Physician Decision|0|||
125189506|NCT01372995|450315104|FG001|Overall Study|Physician Decision|0|||
125189507|NCT01372995|450315105|FG002|Overall Study|Physician Decision|1|||
125189508|NCT01297517|450315111|FG000|Overall Study|Adverse Event|21|||
125189509|NCT01297517|450315112|FG001|Overall Study|Adverse Event|7|||
125189510|NCT01297517|450315113|FG002|Overall Study|Adverse Event|16|||
125189511|NCT01297517|450315111|FG000|Overall Study|Lost to Follow-up|1|||
125189512|NCT01297517|450315112|FG001|Overall Study|Lost to Follow-up|0|||
125189513|NCT01297517|450315113|FG002|Overall Study|Lost to Follow-up|1|||
125189514|NCT01297517|450315111|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
125189515|NCT01297517|450315112|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
125189516|NCT01297517|450315113|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
125189517|NCT01297517|450315111|FG000|Overall Study|Noncompliance|1|||
125189518|NCT01297517|450315112|FG001|Overall Study|Noncompliance|0|||
125189519|NCT01297517|450315113|FG002|Overall Study|Noncompliance|0|||
125189520|NCT01297517|450315111|FG000|Overall Study|Protocol Violation|1|||
125189521|NCT01297517|450315112|FG001|Overall Study|Protocol Violation|1|||
125189522|NCT01297517|450315113|FG002|Overall Study|Protocol Violation|1|||
125189523|NCT01297517|450315111|FG000|Overall Study|Inadequate Control of IOP|1|||
125189524|NCT01297517|450315112|FG001|Overall Study|Inadequate Control of IOP|1|||
125189525|NCT01297517|450315113|FG002|Overall Study|Inadequate Control of IOP|2|||
125189526|NCT01741688|450315115|FG000|Overall Study|Lack of insurance coverage|2|||
125189527|NCT01741688|450315115|FG000|Overall Study|Withdrawal by Subject|1|||
125189528|NCT02282813|450315116|FG000|Overall Study|Withdrawal by Subject|4|||
125189529|NCT02282813|450315117|FG001|Overall Study|Withdrawal by Subject|5|||
125189530|NCT02282813|450315118|FG002|Overall Study|Withdrawal by Subject|0|||
125189531|NCT02282813|450315116|FG000|Overall Study|Adverse Event|3|||
125189532|NCT02282813|450315117|FG001|Overall Study|Adverse Event|10|||
125189533|NCT02282813|450315118|FG002|Overall Study|Adverse Event|1|||
125189534|NCT02282813|450315116|FG000|Overall Study|Subject non-compliance|1|||
125189535|NCT02282813|450315117|FG001|Overall Study|Subject non-compliance|4|||
125189536|NCT02282813|450315118|FG002|Overall Study|Subject non-compliance|0|||
125189537|NCT02282813|450315116|FG000|Overall Study|Physician Decision|0|||
125189538|NCT02282813|450315117|FG001|Overall Study|Physician Decision|3|||
125189539|NCT02282813|450315118|FG002|Overall Study|Physician Decision|1|||
125189540|NCT02282813|450315116|FG000|Overall Study|Lost to Follow-up|2|||
125189541|NCT02282813|450315117|FG001|Overall Study|Lost to Follow-up|0|||
125189542|NCT02282813|450315118|FG002|Overall Study|Lost to Follow-up|1|||
125189543|NCT02282813|450315116|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
125189544|NCT02282813|450315117|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
125189545|NCT02282813|450315118|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
125189546|NCT02282813|450315116|FG000|Overall Study|Lack of Efficacy|1|||
125189547|NCT02282813|450315117|FG001|Overall Study|Lack of Efficacy|0|||
125189548|NCT02282813|450315118|FG002|Overall Study|Lack of Efficacy|0|||
125393521|NCT00842348|451074109|FG001|Study 729|Due to non-availability of IP|1|||
125393522|NCT00842348|451074108|FG000|Study 729|Sponsor's decision|1|||
125393523|NCT00842348|451074109|FG001|Study 729|Sponsor's decision|0|||
125393524|NCT00842348|451074108|FG000|Study 729|Surgical resection|1|||
125189549|NCT02282813|450315116|FG000|Overall Study|Administrative reasons|0|||
125189550|NCT02282813|450315117|FG001|Overall Study|Administrative reasons|1|||
125189551|NCT02282813|450315118|FG002|Overall Study|Administrative reasons|0|||
125189552|NCT02220764|450315120|FG000|Overall Study|Lost to Follow-up|3|||
125189553|NCT02220764|450315121|FG001|Overall Study|Lost to Follow-up|1|||
125189554|NCT02220764|450315120|FG000|Overall Study|Death|1|||
125189555|NCT02220764|450315121|FG001|Overall Study|Death|0|||
125189556|NCT05000164|450315122|FG000|Overall Study|Adverse Event|1|||
125189557|NCT05000164|450315122|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
125189558|NCT05000164|450315122|FG000|Overall Study|Lens Discomfort|3|||
125189559|NCT05000164|450315122|FG000|Overall Study|Withdrew Consent during Study|2|||
125189560|NCT05000164|450315122|FG000|Overall Study|Subject Withdrawn by PI|2|||
125189561|NCT05000164|450315122|FG000|Overall Study|Other Fractured Test Article|1|||
125189562|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
125189563|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
125189564|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
125189565|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
125189566|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
125189567|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
125189568|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
125189569|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
125189570|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
125189571|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
125189572|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
125189573|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
125189574|NCT03493854|450315123|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
125189575|NCT03493854|450315124|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
125189576|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
125189577|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
125189578|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
125189579|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
125189580|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
125189581|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
125189582|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
125189583|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
125189584|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
125189585|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
125189586|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
125189587|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
125189588|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
125189589|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
125189590|NCT03493854|450315123|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
125189591|NCT03493854|450315124|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
125189592|NCT03493854|450315123|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
125189593|NCT03493854|450315124|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
125189594|NCT03493854|450315123|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
125189595|NCT03493854|450315124|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
125189596|NCT03493854|450315123|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
125189597|NCT03493854|450315124|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
125189598|NCT00739661|450315127|FG000|Overall Study|Adverse Event|2|||
125189599|NCT00739661|450315128|FG001|Overall Study|Adverse Event|0|||
125189600|NCT00739661|450315127|FG000|Overall Study|Physician decision to withdraw patient|1|||
125189601|NCT00739661|450315128|FG001|Overall Study|Physician decision to withdraw patient|0|||
125189602|NCT00739661|450315127|FG000|Overall Study|Patient decision to withdraw|9|||
125189603|NCT00739661|450315128|FG001|Overall Study|Patient decision to withdraw|4|||
125189604|NCT00739661|450315127|FG000|Overall Study|Disease progression, radiographic|33|||
125189605|NCT00739661|450315128|FG001|Overall Study|Disease progression, radiographic|37|||
125189606|NCT00739661|450315127|FG000|Overall Study|Reason for discontinuation not available|1|||
125189607|NCT00739661|450315128|FG001|Overall Study|Reason for discontinuation not available|1|||
125189608|NCT02198664|450315129|FG000|Overall Study|Adverse Event|2|||
125189609|NCT02198664|450315130|FG001|Overall Study|Adverse Event|0|||
125189610|NCT02198664|450315129|FG000|Overall Study|Withdrawal by Subject|11|||
125189611|NCT02198664|450315130|FG001|Overall Study|Withdrawal by Subject|8|||
125189612|NCT02198664|450315129|FG000|Overall Study|Failure to tolerate|2|||
125393525|NCT00842348|451074109|FG001|Study 729|Surgical resection|0|||
125393526|NCT03274986|451074110|FG000|Overall Study|Withdrawal by Subject|0|||
125243622|NCT04602000|450516573|FG001|Overall Study|Lost to Follow-up|0|||
125243623|NCT04602000|450516574|FG002|Overall Study|Lost to Follow-up|0|||
125243624|NCT04602000|450516575|FG003|Overall Study|Lost to Follow-up|3|||
125243625|NCT04602000|450516576|FG004|Overall Study|Lost to Follow-up|4|||
125243626|NCT04602000|450516572|FG000|Overall Study|Other|4|||
125243627|NCT04602000|450516573|FG001|Overall Study|Other|1|||
125243628|NCT04602000|450516574|FG002|Overall Study|Other|2|||
125243629|NCT04602000|450516575|FG003|Overall Study|Other|5|||
125393527|NCT03274986|451074111|FG001|Overall Study|Withdrawal by Subject|1|||
125393528|NCT03274986|451074110|FG000|Overall Study|Lost to Follow-up|0|||
125393529|NCT03274986|451074111|FG001|Overall Study|Lost to Follow-up|1|||
125393530|NCT00603746|451074114|FG000|Overall Study|Adverse Event|2|||
125393531|NCT00603746|451074115|FG001|Overall Study|Adverse Event|3|||
125393532|NCT00603746|451074116|FG002|Overall Study|Adverse Event|0|||
125393533|NCT00603746|451074117|FG003|Overall Study|Adverse Event|1|||
125393534|NCT00603746|451074118|FG004|Overall Study|Adverse Event|0|||
125189613|NCT02198664|450315130|FG001|Overall Study|Failure to tolerate|0|||
125189614|NCT02198664|450315129|FG000|Overall Study|Not stated|1|||
125189615|NCT02198664|450315130|FG001|Overall Study|Not stated|0|||
125189616|NCT05343364|450315134|FG000|Overall Study|Miscellaneous|0|||
125189617|NCT05343364|450315135|FG001|Overall Study|Miscellaneous|1|||
125189618|NCT02105987|450315137|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
125189619|NCT02105987|450315138|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
125189620|NCT02105987|450315139|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
125189621|NCT02105987|450315140|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
125189622|NCT02105987|450315141|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
125189623|NCT02105987|450315142|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
125189624|NCT02105987|450315137|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
125189625|NCT02105987|450315138|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
125189626|NCT02105987|450315139|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
125189627|NCT02105987|450315140|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
125189628|NCT02105987|450315141|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
125189629|NCT02105987|450315142|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
125189630|NCT02105987|450315137|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
125189631|NCT02105987|450315138|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
125189632|NCT02105987|450315139|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189633|NCT02105987|450315140|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189634|NCT02105987|450315141|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189635|NCT02105987|450315142|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189636|NCT02105987|450315137|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
125189637|NCT02105987|450315138|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
125189638|NCT02105987|450315139|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189639|NCT02105987|450315140|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189640|NCT02105987|450315141|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189641|NCT02105987|450315142|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189642|NCT02105987|450315137|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
125189643|NCT02105987|450315138|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
125189644|NCT02105987|450315139|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
125189645|NCT02105987|450315140|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
125189646|NCT02105987|450315141|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
125189647|NCT02105987|450315142|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
125189648|NCT02105987|450315137|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
125189649|NCT02105987|450315138|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
125189650|NCT02105987|450315139|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
125189651|NCT02105987|450315140|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
125189652|NCT02105987|450315141|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
125189653|NCT02105987|450315142|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
125243630|NCT04602000|450516576|FG004|Overall Study|Other|4|||
125189654|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
125189655|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
125189656|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
125189657|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
125189658|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
125243631|NCT04602000|450516572|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
125243632|NCT04602000|450516573|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
125243633|NCT04602000|450516574|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
125243634|NCT04602000|450516575|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
125189659|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
125393535|NCT00603746|451074119|FG005|Overall Study|Adverse Event|4|||
125393536|NCT00603746|451074114|FG000|Overall Study|Lack of Efficacy|34|||
125393537|NCT00603746|451074115|FG001|Overall Study|Lack of Efficacy|11|||
125393538|NCT00603746|451074116|FG002|Overall Study|Lack of Efficacy|6|||
125243635|NCT04602000|450516576|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
125189660|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
125189661|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
125189662|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
125189663|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
125189664|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
125189665|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
125189666|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189667|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189668|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
125189669|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
125189670|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189671|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
125189672|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189673|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189674|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
125189675|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
125189676|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189677|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
125189678|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
125189679|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
125189680|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
125189681|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
125189682|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
125189683|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
125189684|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
125189685|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
125189686|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
125189687|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
125189688|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
125189689|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
125189690|NCT02105987|450315137|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
125189691|NCT02105987|450315138|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
125189692|NCT02105987|450315139|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
125189693|NCT02105987|450315140|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
125189694|NCT02105987|450315141|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
125189695|NCT02105987|450315142|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
125189696|NCT02105987|450315137|FG000|Continuation Phase|Protocol Violation|0|||
125189697|NCT02105987|450315138|FG001|Continuation Phase|Protocol Violation|0|||
125189698|NCT02105987|450315139|FG002|Continuation Phase|Protocol Violation|0|||
125189699|NCT02105987|450315140|FG003|Continuation Phase|Protocol Violation|0|||
125189700|NCT02105987|450315141|FG004|Continuation Phase|Protocol Violation|1|||
125189701|NCT02105987|450315142|FG005|Continuation Phase|Protocol Violation|0|||
125189702|NCT01262872|450315143|FG000|Step 2|Death|0|||
125189703|NCT01262872|450315144|FG001|Step 2|Death|0|||
125189704|NCT01262872|450315145|FG002|Step 2|Death|0|||
125189705|NCT01262872|450315146|FG003|Step 2|Death|1|||
125189706|NCT01262872|450315147|FG004|Step 2|Death|0|||
125189707|NCT01262872|450315148|FG005|Step 2|Death|2|||
125189708|NCT01262872|450315149|FG006|Step 2|Death|2|||
125189709|NCT01262872|450315150|FG007|Step 2|Death|1|||
125189710|NCT01262872|450315143|FG000|Step 2|Protocol Violation|0|||
125189711|NCT01262872|450315144|FG001|Step 2|Protocol Violation|0|||
125189712|NCT01262872|450315145|FG002|Step 2|Protocol Violation|1|||
125189713|NCT01262872|450315146|FG003|Step 2|Protocol Violation|0|||
125189714|NCT01262872|450315147|FG004|Step 2|Protocol Violation|0|||
125189715|NCT01262872|450315148|FG005|Step 2|Protocol Violation|0|||
125189716|NCT01262872|450315149|FG006|Step 2|Protocol Violation|3|||
125189717|NCT01262872|450315150|FG007|Step 2|Protocol Violation|1|||
125189718|NCT01262872|450315143|FG000|Step 2|Withdrawal by Subject|0|||
125243636|NCT00471354|450516578|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
125243637|NCT00471354|450516578|FG000|Overall Study|Adverse Event|13|||
125393539|NCT00603746|451074117|FG003|Overall Study|Lack of Efficacy|11|||
125393540|NCT00603746|451074118|FG004|Overall Study|Lack of Efficacy|12|||
125393541|NCT00603746|451074119|FG005|Overall Study|Lack of Efficacy|8|||
125189719|NCT01262872|450315144|FG001|Step 2|Withdrawal by Subject|0|||
125189720|NCT01262872|450315145|FG002|Step 2|Withdrawal by Subject|4|||
125189721|NCT01262872|450315146|FG003|Step 2|Withdrawal by Subject|6|||
125189722|NCT01262872|450315147|FG004|Step 2|Withdrawal by Subject|3|||
125189723|NCT01262872|450315148|FG005|Step 2|Withdrawal by Subject|1|||
125189724|NCT01262872|450315149|FG006|Step 2|Withdrawal by Subject|2|||
125189725|NCT01262872|450315150|FG007|Step 2|Withdrawal by Subject|1|||
125189726|NCT01262872|450315143|FG000|Step 2|Migrated/moved from study area|0|||
125393542|NCT00603746|451074114|FG000|Overall Study|Protocol Violation|0|||
125189727|NCT01262872|450315144|FG001|Step 2|Migrated/moved from study area|0|||
125189728|NCT01262872|450315145|FG002|Step 2|Migrated/moved from study area|4|||
125189729|NCT01262872|450315146|FG003|Step 2|Migrated/moved from study area|3|||
125189730|NCT01262872|450315147|FG004|Step 2|Migrated/moved from study area|2|||
125189731|NCT01262872|450315148|FG005|Step 2|Migrated/moved from study area|6|||
125189732|NCT01262872|450315149|FG006|Step 2|Migrated/moved from study area|2|||
125189733|NCT01262872|450315150|FG007|Step 2|Migrated/moved from study area|3|||
125189734|NCT01753570|450315151|FG000|Overall Study|Adverse Event|1|||
125189735|NCT01753570|450315152|FG001|Overall Study|Adverse Event|0|||
125189736|NCT01753570|450315153|FG002|Overall Study|Adverse Event|1|||
125189737|NCT01753570|450315151|FG000|Overall Study|Physician Decision|0|||
125189738|NCT01753570|450315152|FG001|Overall Study|Physician Decision|1|||
125189739|NCT01753570|450315153|FG002|Overall Study|Physician Decision|0|||
125189740|NCT01753570|450315151|FG000|Overall Study|Withdrawal by Subject|1|||
125189741|NCT01753570|450315152|FG001|Overall Study|Withdrawal by Subject|4|||
125189742|NCT01753570|450315153|FG002|Overall Study|Withdrawal by Subject|0|||
125189743|NCT01420068|450315157|FG000|Overall Study|Administrative problems|1|||
125189744|NCT01420068|450315158|FG001|Overall Study|Administrative problems|3|||
125189745|NCT01420068|450315157|FG000|Overall Study|Withdrawal by Subject|1|||
125189746|NCT01420068|450315158|FG001|Overall Study|Withdrawal by Subject|2|||
125189747|NCT01153815|450315165|FG000|Overall Study|Adverse Event|3|||
125189748|NCT01153815|450315166|FG001|Overall Study|Adverse Event|1|||
125189749|NCT01153815|450315165|FG000|Overall Study|Withdrawal by Subject|6|||
125189750|NCT01153815|450315166|FG001|Overall Study|Withdrawal by Subject|4|||
125189751|NCT01786993|450315167|FG000|Overall Study|Death|6|||
125189752|NCT01786993|450315168|FG001|Overall Study|Death|7|||
125189753|NCT01786993|450315167|FG000|Overall Study|Withdrawal by Subject|3|||
125189754|NCT01786993|450315168|FG001|Overall Study|Withdrawal by Subject|2|||
125189755|NCT01786993|450315167|FG000|Overall Study|Lost to Follow-up|0|||
125189756|NCT01786993|450315168|FG001|Overall Study|Lost to Follow-up|1|||
125189757|NCT01786993|450315167|FG000|Overall Study|Subject Non-Compliance|1|||
125189758|NCT01786993|450315168|FG001|Overall Study|Subject Non-Compliance|0|||
125189759|NCT01786993|450315167|FG000|Overall Study|System Explant|1|||
125189760|NCT01786993|450315168|FG001|Overall Study|System Explant|0|||
125189761|NCT01786993|450315167|FG000|Overall Study|Hospice Admission|1|||
125189762|NCT01786993|450315168|FG001|Overall Study|Hospice Admission|0|||
125189763|NCT01890122|450315169|FG000|Overall Study|Adverse Event|1|||
125189764|NCT01890122|450315170|FG001|Overall Study|Adverse Event|1|||
125189765|NCT01890122|450315171|FG002|Overall Study|Adverse Event|1|||
125189766|NCT01890122|450315172|FG003|Overall Study|Adverse Event|2|||
125189767|NCT01890122|450315169|FG000|Overall Study|Major Protocol Deviation|3|||
125189768|NCT01890122|450315170|FG001|Overall Study|Major Protocol Deviation|1|||
125243638|NCT00471354|450516578|FG000|Overall Study|Protocol Violation|12|||
125243639|NCT00471354|450516578|FG000|Overall Study|Withdrawal by Subject|1|||
125243640|NCT00471354|450516578|FG000|Overall Study|Physician Decision|4|||
125243641|NCT00471354|450516578|FG000|Overall Study|Sponsor Decision|1|||
125243642|NCT00471354|450516578|FG000|Overall Study|Lost to Follow-up|3|||
125243643|NCT00471354|450516578|FG000|Overall Study|Lack of Efficacy|5|||
125243644|NCT00471354|450516578|FG000|Overall Study|Patient/Caregiver Decision|12|||
125243645|NCT01875237|450516579|FG000|Overall Study|GVDH before DLI|1|||
125243646|NCT01875237|450516580|FG001|Overall Study|GVDH before DLI|0|||
125243647|NCT01875237|450516579|FG000|Overall Study|DLI cells could not be produced|1|||
125243648|NCT01875237|450516580|FG001|Overall Study|DLI cells could not be produced|0|||
125243649|NCT01913470|450516584|FG000|Overall Study|Lost to Follow-up|0|||
125243650|NCT01913470|450516585|FG001|Overall Study|Lost to Follow-up|1|||
125243651|NCT01913470|450516584|FG000|Overall Study|Physician Decision|0|||
125243652|NCT01913470|450516585|FG001|Overall Study|Physician Decision|1|||
125243653|NCT01913470|450516584|FG000|Overall Study|Withdrawal by Subject|0|||
125243654|NCT01913470|450516585|FG001|Overall Study|Withdrawal by Subject|1|||
125243655|NCT02573467|450516586|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
125393543|NCT00603746|451074115|FG001|Overall Study|Protocol Violation|3|||
125189769|NCT01890122|450315171|FG002|Overall Study|Major Protocol Deviation|0|||
125189770|NCT01890122|450315172|FG003|Overall Study|Major Protocol Deviation|1|||
125189771|NCT01890122|450315169|FG000|Overall Study|Lost to Follow-up|0|||
125189772|NCT01890122|450315170|FG001|Overall Study|Lost to Follow-up|1|||
125189773|NCT01890122|450315171|FG002|Overall Study|Lost to Follow-up|2|||
125189774|NCT01890122|450315172|FG003|Overall Study|Lost to Follow-up|2|||
125189775|NCT01890122|450315169|FG000|Overall Study|Voluntary Withdrawal|8|||
125189776|NCT01890122|450315170|FG001|Overall Study|Voluntary Withdrawal|8|||
125189777|NCT01890122|450315171|FG002|Overall Study|Voluntary Withdrawal|2|||
125189778|NCT01890122|450315172|FG003|Overall Study|Voluntary Withdrawal|11|||
125189779|NCT01890122|450315169|FG000|Overall Study|Lack of Efficacy|14|||
125189780|NCT01890122|450315170|FG001|Overall Study|Lack of Efficacy|24|||
125189781|NCT01890122|450315171|FG002|Overall Study|Lack of Efficacy|7|||
125189782|NCT01890122|450315172|FG003|Overall Study|Lack of Efficacy|41|||
125189783|NCT01890122|450315169|FG000|Overall Study|Reason not Specified|0|||
125189784|NCT01890122|450315170|FG001|Overall Study|Reason not Specified|1|||
125189785|NCT01890122|450315171|FG002|Overall Study|Reason not Specified|1|||
125243656|NCT02573467|450516587|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
125243657|NCT02573467|450516588|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
125243658|NCT02573467|450516589|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
125243659|NCT02573467|450516586|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
125243660|NCT02573467|450516587|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
125243661|NCT02573467|450516588|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
125243662|NCT02573467|450516589|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
125243663|NCT02573467|450516586|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
125243664|NCT02573467|450516587|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
125243665|NCT02573467|450516588|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
125243666|NCT02573467|450516589|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
125243667|NCT02573467|450516586|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
125243668|NCT02573467|450516587|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
125243669|NCT02573467|450516588|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
125243670|NCT02573467|450516589|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
125243671|NCT02573467|450516586|FG000|Post-treatment Follow up Epoch|Death|1|||
125243672|NCT02573467|450516587|FG001|Post-treatment Follow up Epoch|Death|1|||
125243673|NCT02573467|450516588|FG002|Post-treatment Follow up Epoch|Death|0|||
125243674|NCT02573467|450516589|FG003|Post-treatment Follow up Epoch|Death|1|||
125243675|NCT02573467|450516586|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
125243676|NCT02573467|450516587|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
125243677|NCT02573467|450516588|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
125243678|NCT02573467|450516589|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
125243679|NCT02573467|450516586|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
125243680|NCT02573467|450516587|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
125243681|NCT02573467|450516588|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
125243682|NCT02573467|450516589|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
125243683|NCT00923702|450516590|FG000|Overall Study|Ongoing enrollment|0|||
125243684|NCT00923702|450516591|FG001|Overall Study|Ongoing enrollment|0|||
125243685|NCT00923702|450516592|FG002|Overall Study|Ongoing enrollment|0|||
125243686|NCT00923702|450516593|FG003|Overall Study|Ongoing enrollment|0|||
125243687|NCT00923702|450516594|FG004|Overall Study|Ongoing enrollment|354|||
125243688|NCT02153827|450516595|FG000|Overall Study|Lost to Follow-up|3|||
125243689|NCT02153827|450516596|FG001|Overall Study|Lost to Follow-up|9|||
125243690|NCT04790201|450516597|FG000|Overall Study|Lost to Follow-up|0|||
125243691|NCT04790201|450516598|FG001|Overall Study|Lost to Follow-up|0|||
125243692|NCT04790201|450516599|FG002|Overall Study|Lost to Follow-up|2|||
125243693|NCT04790201|450516597|FG000|Overall Study|Death|0|||
125243694|NCT04790201|450516598|FG001|Overall Study|Death|1|||
125243695|NCT04790201|450516599|FG002|Overall Study|Death|0|||
125243696|NCT04790201|450516597|FG000|Overall Study|Protocol Violation|1|||
125243697|NCT04790201|450516598|FG001|Overall Study|Protocol Violation|0|||
125243698|NCT04790201|450516599|FG002|Overall Study|Protocol Violation|1|||
125243699|NCT04339972|450516603|FG000|Overall Study|Scheduling Issues|3|||
125243700|NCT04339972|450516604|FG001|Overall Study|Scheduling Issues|3|||
125243701|NCT04339972|450516603|FG000|Overall Study|dropout|1|||
125243702|NCT04339972|450516604|FG001|Overall Study|dropout|1|||
125243703|NCT04339972|450516603|FG000|Overall Study|Technical issues|1|||
125243704|NCT04339972|450516604|FG001|Overall Study|Technical issues|0|||
125243705|NCT04339972|450516603|FG000|Overall Study|Claustraphobia|0|||
125243706|NCT04339972|450516604|FG001|Overall Study|Claustraphobia|1|||
125243707|NCT01529268|450516607|FG000|Overall Study|Lost to Follow-up|9|||
125243708|NCT01529268|450516608|FG001|Overall Study|Lost to Follow-up|3|||
125243709|NCT01529268|450516607|FG000|Overall Study|Moved|3|||
125243710|NCT01529268|450516608|FG001|Overall Study|Moved|0|||
125243711|NCT02691572|450516613|FG000|Overall Study|Withdrawal by Subject|1|||
125243712|NCT02691572|450516614|FG001|Overall Study|Withdrawal by Subject|0|||
125243713|NCT02691572|450516613|FG000|Overall Study|Protocol Violation|0|||
125393544|NCT00603746|451074116|FG002|Overall Study|Protocol Violation|1|||
125393545|NCT00603746|451074117|FG003|Overall Study|Protocol Violation|0|||
125393546|NCT00603746|451074118|FG004|Overall Study|Protocol Violation|1|||
125243714|NCT02691572|450516614|FG001|Overall Study|Protocol Violation|1|||
125243715|NCT00699751|450516615|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
125243716|NCT00699751|450516616|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
125243717|NCT00699751|450516615|FG000|Period 1: Without/Before Drug Switch|Death|28|||
125393547|NCT00603746|451074119|FG005|Overall Study|Protocol Violation|0|||
125393548|NCT00603746|451074114|FG000|Overall Study|Lost to Follow-up|0|||
125393549|NCT00603746|451074115|FG001|Overall Study|Lost to Follow-up|1|||
125243718|NCT00699751|450516616|FG001|Period 1: Without/Before Drug Switch|Death|29|||
125243719|NCT00699751|450516615|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
125243720|NCT00699751|450516616|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
125243721|NCT00699751|450516615|FG000|Period 1: Without/Before Drug Switch|Other|30|||
125393550|NCT00603746|451074116|FG002|Overall Study|Lost to Follow-up|1|||
125393551|NCT00603746|451074117|FG003|Overall Study|Lost to Follow-up|0|||
125393552|NCT00603746|451074118|FG004|Overall Study|Lost to Follow-up|0|||
125243722|NCT00699751|450516616|FG001|Period 1: Without/Before Drug Switch|Other|20|||
125243723|NCT00699751|450516615|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
125243724|NCT00699751|450516616|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
125243725|NCT00699751|450516615|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
125243726|NCT00699751|450516616|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
125243727|NCT00699751|450516615|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
125243728|NCT00699751|450516616|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
125243729|NCT00699751|450516615|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
125243730|NCT00699751|450516616|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
125243731|NCT03370302|450516620|FG000|Dose Escalation Phase|Other|0|||
125243732|NCT03370302|450516621|FG001|Dose Escalation Phase|Other|1|||
125243733|NCT03370302|450516622|FG002|Dose Escalation Phase|Other|1|||
125243734|NCT03370302|450516623|FG003|Dose Escalation Phase|Other|0|||
125243735|NCT03370302|450516624|FG004|Dose Escalation Phase|Other|0|||
125243736|NCT03370302|450516625|FG005|Dose Escalation Phase|Other|0|||
125243737|NCT03370302|450516620|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
125243738|NCT03370302|450516621|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
125243739|NCT03370302|450516622|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
125243740|NCT03370302|450516623|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
125243741|NCT03370302|450516624|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
125243742|NCT03370302|450516625|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
125243743|NCT03370302|450516620|FG000|Dose Escalation Phase|Adverse Event|1|||
125243744|NCT03370302|450516621|FG001|Dose Escalation Phase|Adverse Event|0|||
125243745|NCT03370302|450516622|FG002|Dose Escalation Phase|Adverse Event|2|||
125243746|NCT03370302|450516623|FG003|Dose Escalation Phase|Adverse Event|0|||
125243747|NCT03370302|450516624|FG004|Dose Escalation Phase|Adverse Event|0|||
125243748|NCT03370302|450516625|FG005|Dose Escalation Phase|Adverse Event|0|||
125243749|NCT03370302|450516620|FG000|Dose Escalation Phase|Progressive Disease|2|||
125243750|NCT03370302|450516621|FG001|Dose Escalation Phase|Progressive Disease|4|||
125243751|NCT03370302|450516622|FG002|Dose Escalation Phase|Progressive Disease|2|||
125243752|NCT03370302|450516623|FG003|Dose Escalation Phase|Progressive Disease|0|||
125243753|NCT03370302|450516624|FG004|Dose Escalation Phase|Progressive Disease|3|||
125243754|NCT03370302|450516625|FG005|Dose Escalation Phase|Progressive Disease|1|||
125243755|NCT03370302|450516620|FG000|Dose Expansion Phase|Progressive Disease|0|||
125243756|NCT03370302|450516621|FG001|Dose Expansion Phase|Progressive Disease|0|||
125243757|NCT03370302|450516622|FG002|Dose Expansion Phase|Progressive Disease|0|||
125243758|NCT03370302|450516623|FG003|Dose Expansion Phase|Progressive Disease|6|||
125243759|NCT03370302|450516624|FG004|Dose Expansion Phase|Progressive Disease|0|||
125243760|NCT03370302|450516625|FG005|Dose Expansion Phase|Progressive Disease|0|||
125243761|NCT00985790|450516626|FG000|Overall Study|Withdrawal by Subject|1|||
125243762|NCT00985790|450516627|FG001|Overall Study|Withdrawal by Subject|1|||
125243763|NCT00985790|450516626|FG000|Overall Study|Lost to Follow-up|6|||
125243764|NCT00985790|450516627|FG001|Overall Study|Lost to Follow-up|7|||
125243765|NCT04180696|450516629|FG000|Overall Study|Death|5|||
125243766|NCT04180696|450516630|FG001|Overall Study|Death|6|||
125243767|NCT04180696|450516629|FG000|Overall Study|Lost to Follow-up|1|||
125243768|NCT04180696|450516630|FG001|Overall Study|Lost to Follow-up|0|||
125243769|NCT04180696|450516629|FG000|Overall Study|Withdrawal by Subject|0|||
125243770|NCT04180696|450516630|FG001|Overall Study|Withdrawal by Subject|1|||
125243771|NCT02593864|450516633|FG000|Overall Study|Withdrawal by Subject|3|||
125243772|NCT02593864|450516633|FG000|Overall Study|Lost to Follow-up|3|||
125243773|NCT04739709|450516634|FG000|Overall Study|Physician Decision|1|||
125243774|NCT04739709|450516635|FG001|Overall Study|Physician Decision|0|||
125243775|NCT04124965|450516636|FG000|Overall Study|Adverse event, non-fatal|3|||
125243776|NCT04124965|450516637|FG001|Overall Study|Adverse event, non-fatal|1|||
125243777|NCT04124965|450516636|FG000|Overall Study|Withdrawal by Subject|1|||
125243778|NCT04124965|450516637|FG001|Overall Study|Withdrawal by Subject|1|||
125243779|NCT04124965|450516636|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
125243780|NCT04124965|450516637|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
125243781|NCT04124965|450516636|FG000|Overall Study|Pregnancy|1|||
125243782|NCT04124965|450516637|FG001|Overall Study|Pregnancy|0|||
125243783|NCT04124965|450516636|FG000|Overall Study|Sponsor and participant decision|0|||
125393553|NCT00603746|451074119|FG005|Overall Study|Lost to Follow-up|0|||
125393554|NCT00603746|451074114|FG000|Overall Study|Physician Decision|1|||
125243784|NCT04124965|450516637|FG001|Overall Study|Sponsor and participant decision|1|||
125243785|NCT04124965|450516636|FG000|Overall Study|Personal surgery|0|||
125243786|NCT04124965|450516637|FG001|Overall Study|Personal surgery|1|||
125243787|NCT04124965|450516636|FG000|Overall Study|Physician Decision|0|||
125243788|NCT04124965|450516637|FG001|Overall Study|Physician Decision|1|||
125243789|NCT02184156|450516638|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
125243790|NCT02184156|450516639|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
125243791|NCT02184156|450516638|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
125243792|NCT02184156|450516639|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
125243793|NCT00002874|450516640|FG000|Overall Study|Withdrawal by Subject|1|||
125393555|NCT00603746|451074115|FG001|Overall Study|Physician Decision|0|||
125189786|NCT01890122|450315172|FG003|Overall Study|Reason not Specified|2|||
125189787|NCT01890122|450315169|FG000|Overall Study|Randomized but not Treated|1|||
125189788|NCT01890122|450315170|FG001|Overall Study|Randomized but not Treated|1|||
125189789|NCT01890122|450315171|FG002|Overall Study|Randomized but not Treated|0|||
125189790|NCT01890122|450315172|FG003|Overall Study|Randomized but not Treated|0|||
125189791|NCT02062450|450315173|FG000|Overall Study|No follow-up visit|124|||
125189792|NCT02907177|450315176|FG000|Overall Study|Death|0|||
125189793|NCT02907177|450315177|FG001|Overall Study|Death|1|||
125189794|NCT02907177|450315176|FG000|Overall Study|Physician Decision|3|||
125189795|NCT02907177|450315177|FG001|Overall Study|Physician Decision|3|||
125189796|NCT02907177|450315176|FG000|Overall Study|Withdrawal by Subject|15|||
125189797|NCT02907177|450315177|FG001|Overall Study|Withdrawal by Subject|7|||
125189798|NCT02907177|450315176|FG000|Overall Study|Sponsor's Decision|50|||
125189799|NCT02907177|450315177|FG001|Overall Study|Sponsor's Decision|57|||
125189800|NCT02505217|450315178|FG000|Overall Study|Withdrawal by Subject|1|||
125189801|NCT02505217|450315179|FG001|Overall Study|Withdrawal by Subject|2|||
125189802|NCT00570687|450316755|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189803|NCT00570687|450316756|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189804|NCT00570687|450316757|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189805|NCT00570687|450316758|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189806|NCT00570687|450316759|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
125189807|NCT00570687|450316760|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
125189808|NCT00570687|450316761|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
125189809|NCT00570687|450316762|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
125189810|NCT00570687|450316763|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
125189811|NCT00570687|450316764|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
125189812|NCT00570687|450316755|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189813|NCT00570687|450316756|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189814|NCT00570687|450316757|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189815|NCT00570687|450316758|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189816|NCT00570687|450316759|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189817|NCT00570687|450316760|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189818|NCT00570687|450316761|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189819|NCT00570687|450316762|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189820|NCT00570687|450316763|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
125189821|NCT00570687|450316764|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189822|NCT00570687|450316755|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189823|NCT00570687|450316756|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189824|NCT00570687|450316757|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189825|NCT00570687|450316758|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189826|NCT00570687|450316759|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189827|NCT00570687|450316760|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189828|NCT00570687|450316761|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
125189829|NCT00570687|450316762|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189830|NCT00570687|450316763|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189831|NCT00570687|450316764|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
125189832|NCT01102257|450316770|FG000|Overall Study|Adverse Event|1|||
125189833|NCT01102257|450316771|FG001|Overall Study|Adverse Event|0|||
125189834|NCT01102257|450316770|FG000|Overall Study|Adverse Event|1|||
125189835|NCT01102257|450316771|FG001|Overall Study|Adverse Event|0|||
125189836|NCT03048747|450316772|FG000|Overall Study|Adverse Event|2|||
125189837|NCT03048747|450316772|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
125189838|NCT03048747|450316772|FG000|Overall Study|Physician Decision|1|||
125189839|NCT00824772|450316773|FG000|Overall Study|Withdrawal by Subject|8|||
125189840|NCT00866281|450316774|FG000|Overall Study|Adverse Event|1|||
125189841|NCT00866281|450316775|FG001|Overall Study|Adverse Event|0|||
125189842|NCT00866281|450316774|FG000|Overall Study|Withdrawal by participants|3|||
125189843|NCT00866281|450316775|FG001|Overall Study|Withdrawal by participants|0|||
125189844|NCT00866281|450316774|FG000|Overall Study|Disease progression|3|||
125189845|NCT00866281|450316775|FG001|Overall Study|Disease progression|11|||
125189846|NCT00866281|450316774|FG000|Overall Study|New cancer therapy|0|||
125189847|NCT00866281|450316775|FG001|Overall Study|New cancer therapy|4|||
125189848|NCT00529087|450316777|FG000|Overall Study|Adverse Event|10|||
125189849|NCT00529087|450316778|FG001|Overall Study|Adverse Event|13|||
125189850|NCT00529087|450316779|FG002|Overall Study|Adverse Event|4|||
125189851|NCT00529087|450316777|FG000|Overall Study|Lost to Follow-up|6|||
125189852|NCT00529087|450316778|FG001|Overall Study|Lost to Follow-up|4|||
125189853|NCT00529087|450316779|FG002|Overall Study|Lost to Follow-up|1|||
125189854|NCT00529087|450316777|FG000|Overall Study|Protocol Violation|8|||
125189855|NCT00529087|450316778|FG001|Overall Study|Protocol Violation|7|||
125189856|NCT00529087|450316779|FG002|Overall Study|Protocol Violation|6|||
125189857|NCT00529087|450316777|FG000|Overall Study|Withdrawal by Subject|3|||
125189858|NCT00529087|450316778|FG001|Overall Study|Withdrawal by Subject|3|||
125189859|NCT00529087|450316779|FG002|Overall Study|Withdrawal by Subject|3|||
125189860|NCT00529087|450316777|FG000|Overall Study|Protocol deviation|1|||
125189861|NCT00529087|450316778|FG001|Overall Study|Protocol deviation|1|||
125189862|NCT00529087|450316779|FG002|Overall Study|Protocol deviation|2|||
125189863|NCT00318474|450316780|FG000|Overall Study|Adverse Event|1|||
125189864|NCT00318474|450316781|FG001|Overall Study|Adverse Event|1|||
125189865|NCT00318474|450316780|FG000|Overall Study|Lost to Follow-up|0|||
125189866|NCT00318474|450316781|FG001|Overall Study|Lost to Follow-up|1|||
125189867|NCT00318474|450316780|FG000|Overall Study|Pregnancy|0|||
125189868|NCT00318474|450316781|FG001|Overall Study|Pregnancy|2|||
125189869|NCT00318474|450316780|FG000|Overall Study|Protocol Violation|1|||
125189870|NCT00318474|450316781|FG001|Overall Study|Protocol Violation|0|||
125189871|NCT00318474|450316780|FG000|Overall Study|Withdrawal by Subject|3|||
125189872|NCT00318474|450316781|FG001|Overall Study|Withdrawal by Subject|2|||
125189873|NCT00318474|450316780|FG000|Overall Study|Fall in GFR|3|||
125189874|NCT00318474|450316781|FG001|Overall Study|Fall in GFR|3|||
125189875|NCT00318474|450316780|FG000|Overall Study|Post-therapy hyperflycemia|0|||
125189876|NCT00318474|450316781|FG001|Overall Study|Post-therapy hyperflycemia|1|||
125189877|NCT00318474|450316780|FG000|Overall Study|Trial terminated|10|||
125189878|NCT00318474|450316781|FG001|Overall Study|Trial terminated|7|||
125189879|NCT00457002|450316786|FG000|Overall Study|Death|40|||
125189880|NCT00457002|450316787|FG001|Overall Study|Death|47|||
125189881|NCT00457002|450316786|FG000|Overall Study|Adverse Event|284|||
125189882|NCT00457002|450316787|FG001|Overall Study|Adverse Event|260|||
125189883|NCT00457002|450316786|FG000|Overall Study|Withdrawal by Subject|299|||
125189884|NCT00457002|450316787|FG001|Overall Study|Withdrawal by Subject|271|||
125189885|NCT00457002|450316786|FG000|Overall Study|Lost to Follow-up|72|||
125189886|NCT00457002|450316787|FG001|Overall Study|Lost to Follow-up|71|||
125189887|NCT00457002|450316786|FG000|Overall Study|Poor/Non-compliance|46|||
125189888|NCT00457002|450316787|FG001|Overall Study|Poor/Non-compliance|33|||
125189889|NCT00457002|450316786|FG000|Overall Study|No longer met criteria|41|||
125189890|NCT00457002|450316787|FG001|Overall Study|No longer met criteria|37|||
125189891|NCT00457002|450316786|FG000|Overall Study|Administrative reason by Sponsor|1|||
125189892|NCT00457002|450316787|FG001|Overall Study|Administrative reason by Sponsor|0|||
125189893|NCT00457002|450316786|FG000|Overall Study|non-specified|29|||
125189894|NCT00457002|450316787|FG001|Overall Study|non-specified|38|||
125189895|NCT00457002|450316786|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
125189896|NCT00457002|450316787|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
125189897|NCT02283268|450316793|FG000|Overall Study|Withdrawal by Subject|1|||
125189898|NCT01017874|450316794|FG000|Overall Study|Withdrawal by Subject|23|||
125189899|NCT01017874|450316795|FG001|Overall Study|Withdrawal by Subject|20|||
125189900|NCT01017874|450316794|FG000|Overall Study|Sponsor decision|3|||
125189901|NCT01017874|450316795|FG001|Overall Study|Sponsor decision|1|||
125189902|NCT01017874|450316794|FG000|Overall Study|Lost to Follow-up|3|||
125189903|NCT01017874|450316795|FG001|Overall Study|Lost to Follow-up|2|||
125189904|NCT01017874|450316794|FG000|Overall Study|Physician Decision|1|||
125189905|NCT01017874|450316795|FG001|Overall Study|Physician Decision|3|||
125189906|NCT01966120|450316796|FG000|Overall Study|Withdrawal by Subject|0|||
125189907|NCT01966120|450316797|FG001|Overall Study|Withdrawal by Subject|5|||
125189908|NCT01966120|450316796|FG000|Overall Study|Lost to Follow-up|1|||
125189909|NCT01966120|450316797|FG001|Overall Study|Lost to Follow-up|1|||
125189910|NCT02588612|450316800|FG000|Overall Study|Physician Decision|1|||
125189911|NCT02588612|450316800|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
125189912|NCT02588612|450316800|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
125189913|NCT02588612|450316800|FG000|Overall Study|Death prior to T-cell infusion|1|||
125189914|NCT02841995|450316801|FG000|Overall Study|Disease progression|5|||
125189915|NCT02841995|450316802|FG001|Overall Study|Disease progression|11|||
125189916|NCT02841995|450316803|FG002|Overall Study|Disease progression|8|||
125189917|NCT02841995|450316801|FG000|Overall Study|Withdrawal by Subject|2|||
125189918|NCT02841995|450316802|FG001|Overall Study|Withdrawal by Subject|4|||
125189919|NCT02841995|450316803|FG002|Overall Study|Withdrawal by Subject|4|||
125189920|NCT02841995|450316801|FG000|Overall Study|Adverse Event|2|||
125189921|NCT02841995|450316802|FG001|Overall Study|Adverse Event|0|||
125189922|NCT02841995|450316803|FG002|Overall Study|Adverse Event|1|||
125189923|NCT02841995|450316801|FG000|Overall Study|Investigator decision|2|||
125189924|NCT02841995|450316802|FG001|Overall Study|Investigator decision|0|||
125189925|NCT02841995|450316803|FG002|Overall Study|Investigator decision|1|||
125189926|NCT02841995|450316801|FG000|Overall Study|Death|0|||
125189927|NCT02841995|450316802|FG001|Overall Study|Death|0|||
125189928|NCT02841995|450316803|FG002|Overall Study|Death|2|||
125189929|NCT02841995|450316801|FG000|Overall Study|Noncompliance to protocol|1|||
125189930|NCT02841995|450316802|FG001|Overall Study|Noncompliance to protocol|0|||
125189931|NCT02841995|450316803|FG002|Overall Study|Noncompliance to protocol|0|||
125189932|NCT02841995|450316801|FG000|Overall Study|Sponsor decision|1|||
125189933|NCT02841995|450316802|FG001|Overall Study|Sponsor decision|0|||
125189934|NCT02841995|450316803|FG002|Overall Study|Sponsor decision|0|||
125189935|NCT02841995|450316801|FG000|Overall Study|Other|4|||
125189936|NCT02841995|450316802|FG001|Overall Study|Other|1|||
125189937|NCT02841995|450316803|FG002|Overall Study|Other|5|||
125189938|NCT03809663|450316810|FG000|Overall Study|Decision by sponsor|24|||
125189939|NCT03809663|450316811|FG001|Overall Study|Decision by sponsor|18|||
125189940|NCT03809663|450316812|FG002|Overall Study|Decision by sponsor|20|||
125189941|NCT03809663|450316813|FG003|Overall Study|Decision by sponsor|20|||
125189942|NCT03809663|450316814|FG004|Overall Study|Decision by sponsor|0|||
125189943|NCT03809663|450316815|FG005|Overall Study|Decision by sponsor|0|||
125189944|NCT03809663|450316810|FG000|Overall Study|Withdrawal by Subject|26|||
125189945|NCT03809663|450316811|FG001|Overall Study|Withdrawal by Subject|22|||
125189946|NCT03809663|450316812|FG002|Overall Study|Withdrawal by Subject|27|||
125189947|NCT03809663|450316813|FG003|Overall Study|Withdrawal by Subject|26|||
125189948|NCT03809663|450316814|FG004|Overall Study|Withdrawal by Subject|0|||
125189949|NCT03809663|450316815|FG005|Overall Study|Withdrawal by Subject|0|||
125189950|NCT03809663|450316810|FG000|Overall Study|Lost to Follow-up|1|||
125189951|NCT03809663|450316811|FG001|Overall Study|Lost to Follow-up|4|||
125189952|NCT03809663|450316812|FG002|Overall Study|Lost to Follow-up|1|||
125189953|NCT03809663|450316813|FG003|Overall Study|Lost to Follow-up|1|||
125189954|NCT03809663|450316814|FG004|Overall Study|Lost to Follow-up|0|||
125189955|NCT03809663|450316815|FG005|Overall Study|Lost to Follow-up|0|||
125189956|NCT01703260|450316817|FG000|Overall Study|Adverse Event|1|||
125189957|NCT01703260|450316818|FG001|Overall Study|Adverse Event|2|||
125189958|NCT01703260|450316819|FG002|Overall Study|Adverse Event|2|||
125189959|NCT01703260|450316817|FG000|Overall Study|Lost to Follow-up|1|||
125189960|NCT01703260|450316818|FG001|Overall Study|Lost to Follow-up|0|||
125189961|NCT01703260|450316819|FG002|Overall Study|Lost to Follow-up|0|||
125189962|NCT01703260|450316817|FG000|Overall Study|Withdrawal by Subject|0|||
125189963|NCT01703260|450316818|FG001|Overall Study|Withdrawal by Subject|0|||
125189964|NCT01703260|450316819|FG002|Overall Study|Withdrawal by Subject|1|||
125189965|NCT01703260|450316817|FG000|Overall Study|Study Termination|1|||
125189966|NCT01703260|450316818|FG001|Overall Study|Study Termination|2|||
125189967|NCT01703260|450316819|FG002|Overall Study|Study Termination|0|||
125189968|NCT02042014|450316821|FG000|Overall Study|Adverse Event|1|||
125189969|NCT02042014|450316821|FG000|Overall Study|Physician Decision|7|||
125189970|NCT03309943|450316826|FG000|Overall Study|Withdrawal by Subject|0|||
125189971|NCT03309943|450316827|FG001|Overall Study|Withdrawal by Subject|1|||
125189972|NCT03309943|450316826|FG000|Overall Study|Inappropriate behavior towards staff|0|||
125189973|NCT03309943|450316827|FG001|Overall Study|Inappropriate behavior towards staff|1|||
125189974|NCT03123393|450316828|FG000|Overall Study|Study Terminated by Sponsor|6|||
125189975|NCT03123393|450316829|FG001|Overall Study|Study Terminated by Sponsor|9|||
125189976|NCT03123393|450316828|FG000|Overall Study|Withdrawal by Subject|2|||
125189977|NCT03123393|450316829|FG001|Overall Study|Withdrawal by Subject|1|||
125189978|NCT03123393|450316828|FG000|Overall Study|Reason not Specified|13|||
125189979|NCT03123393|450316829|FG001|Overall Study|Reason not Specified|13|||
125189980|NCT00558701|450316834|FG000|Overall Study|Protocol Deviations|1|||
125189981|NCT00558701|450316835|FG001|Overall Study|Protocol Deviations|4|||
125189982|NCT00427648|450316836|FG000|Overall Study|Protocol Violation|1|||
125189983|NCT00427648|450316837|FG001|Overall Study|Protocol Violation|2|||
125189984|NCT00427648|450316836|FG000|Overall Study|Adverse Event|0|||
125189985|NCT00427648|450316837|FG001|Overall Study|Adverse Event|1|||
125189986|NCT00628212|450316842|FG000|Overall Study|Adverse Event|2|||
125189987|NCT00628212|450316843|FG001|Overall Study|Adverse Event|0|||
125189988|NCT00628212|450316844|FG002|Overall Study|Adverse Event|1|||
125189989|NCT00628212|450316845|FG003|Overall Study|Adverse Event|2|||
125189990|NCT00628212|450316842|FG000|Overall Study|Physician Decision|1|||
125189991|NCT00628212|450316843|FG001|Overall Study|Physician Decision|1|||
125189992|NCT00628212|450316844|FG002|Overall Study|Physician Decision|2|||
125189993|NCT00628212|450316845|FG003|Overall Study|Physician Decision|3|||
125189994|NCT01681212|450316846|FG000|Overall Study|No longer met study criteria|5|||
125189995|NCT01681212|450316846|FG000|Overall Study|Administrative reason by sponsor|1|||
125189996|NCT01464424|450316849|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
125189997|NCT01464424|450316850|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
125189998|NCT01464333|450316852|FG000|Overall Study|Adverse Event|34|||
125189999|NCT01464333|450316852|FG000|Overall Study|Lack of Efficacy|72|||
125190000|NCT01464333|450316852|FG000|Overall Study|Withdrawal by Subject|11|||
125190001|NCT01464333|450316852|FG000|Overall Study|Other|4|||
125190002|NCT01464333|450316852|FG000|Overall Study|No Hospital Visit|42|||
125190003|NCT00789373|450316853|FG000|Induction|Adverse Event|64|||
125190004|NCT00789373|450316854|FG001|Induction|Adverse Event|0|||
125190005|NCT00789373|450316855|FG002|Induction|Adverse Event|0|||
125190006|NCT00789373|450316853|FG000|Induction|Death Due to study disease|24|||
125190007|NCT00789373|450316854|FG001|Induction|Death Due to study disease|0|||
125190008|NCT00789373|450316855|FG002|Induction|Death Due to study disease|0|||
125190009|NCT00789373|450316853|FG000|Induction|Death due to adverse event|19|||
125190010|NCT00789373|450316854|FG001|Induction|Death due to adverse event|0|||
125190011|NCT00789373|450316855|FG002|Induction|Death due to adverse event|0|||
125190012|NCT00789373|450316853|FG000|Induction|Death due to toxicity|11|||
125190013|NCT00789373|450316854|FG001|Induction|Death due to toxicity|0|||
125190014|NCT00789373|450316855|FG002|Induction|Death due to toxicity|0|||
125190015|NCT00789373|450316853|FG000|Induction|Death due to procedure|1|||
125190016|NCT00789373|450316854|FG001|Induction|Death due to procedure|0|||
125190017|NCT00789373|450316855|FG002|Induction|Death due to procedure|0|||
125190018|NCT00789373|450316853|FG000|Induction|Investigator decision|7|||
125190019|NCT00789373|450316854|FG001|Induction|Investigator decision|0|||
125190020|NCT00789373|450316855|FG002|Induction|Investigator decision|0|||
125190021|NCT00789373|450316853|FG000|Induction|Protocol entry criteria not met|9|||
125190022|NCT00789373|450316854|FG001|Induction|Protocol entry criteria not met|0|||
125190023|NCT00789373|450316855|FG002|Induction|Protocol entry criteria not met|0|||
125190024|NCT00789373|450316853|FG000|Induction|Lost to Follow-up|6|||
125190025|NCT00789373|450316854|FG001|Induction|Lost to Follow-up|0|||
125190026|NCT00789373|450316855|FG002|Induction|Lost to Follow-up|0|||
125190027|NCT00789373|450316853|FG000|Induction|Protocol Violation|1|||
125190028|NCT00789373|450316854|FG001|Induction|Protocol Violation|0|||
125190029|NCT00789373|450316855|FG002|Induction|Protocol Violation|0|||
125190030|NCT00789373|450316853|FG000|Induction|Progressive Disease|220|||
125190031|NCT00789373|450316854|FG001|Induction|Progressive Disease|0|||
125190032|NCT00789373|450316855|FG002|Induction|Progressive Disease|0|||
125190033|NCT00789373|450316853|FG000|Induction|Withdrawal by Subject|37|||
125190034|NCT00789373|450316854|FG001|Induction|Withdrawal by Subject|0|||
125190035|NCT00789373|450316855|FG002|Induction|Withdrawal by Subject|0|||
125190036|NCT00789373|450316853|FG000|Maintenance|Adverse Event|0|||
125190037|NCT00789373|450316854|FG001|Maintenance|Adverse Event|65|||
125190038|NCT00789373|450316855|FG002|Maintenance|Adverse Event|12|||
125190039|NCT00789373|450316853|FG000|Maintenance|Death due to study disease|0|||
125190040|NCT00789373|450316854|FG001|Maintenance|Death due to study disease|3|||
125190041|NCT00789373|450316855|FG002|Maintenance|Death due to study disease|1|||
125190042|NCT00789373|450316853|FG000|Maintenance|Death due to adverse event|0|||
125190043|NCT00789373|450316854|FG001|Maintenance|Death due to adverse event|4|||
125190044|NCT00789373|450316855|FG002|Maintenance|Death due to adverse event|1|||
125190045|NCT00789373|450316853|FG000|Maintenance|Death due to toxicity|0|||
125190046|NCT00789373|450316854|FG001|Maintenance|Death due to toxicity|1|||
125190047|NCT00789373|450316855|FG002|Maintenance|Death due to toxicity|2|||
125190048|NCT00789373|450316853|FG000|Maintenance|Investigator Decision|0|||
125190049|NCT00789373|450316854|FG001|Maintenance|Investigator Decision|4|||
125190050|NCT00789373|450316855|FG002|Maintenance|Investigator Decision|2|||
125190051|NCT00789373|450316853|FG000|Maintenance|Protocol entry criteria not met|0|||
125190052|NCT00789373|450316854|FG001|Maintenance|Protocol entry criteria not met|2|||
125190053|NCT00789373|450316855|FG002|Maintenance|Protocol entry criteria not met|0|||
125190054|NCT00789373|450316853|FG000|Maintenance|Lost to Follow-up|0|||
125190055|NCT00789373|450316854|FG001|Maintenance|Lost to Follow-up|2|||
125190056|NCT00789373|450316855|FG002|Maintenance|Lost to Follow-up|0|||
125190057|NCT00789373|450316853|FG000|Maintenance|Progressive Disease|0|||
125190058|NCT00789373|450316854|FG001|Maintenance|Progressive Disease|253|||
125190059|NCT00789373|450316855|FG002|Maintenance|Progressive Disease|152|||
125190060|NCT00789373|450316853|FG000|Maintenance|Withdrawal by Subject|0|||
125190061|NCT00789373|450316854|FG001|Maintenance|Withdrawal by Subject|21|||
125190062|NCT00789373|450316855|FG002|Maintenance|Withdrawal by Subject|8|||
125190063|NCT00789373|450316853|FG000|Maintenance|Sponsor Decision|0|||
125190064|NCT00789373|450316854|FG001|Maintenance|Sponsor Decision|0|||
125190065|NCT00789373|450316855|FG002|Maintenance|Sponsor Decision|2|||
125190066|NCT00789373|450316853|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
125190067|NCT00789373|450316854|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
125190068|NCT00789373|450316855|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
125190069|NCT03321968|450316856|FG000|Overall Study|Withdrawal by Subject|1|||
125190070|NCT03321968|450316857|FG001|Overall Study|Withdrawal by Subject|2|||
125190071|NCT03321968|450316858|FG002|Overall Study|Withdrawal by Subject|1|||
125190072|NCT03321968|450316856|FG000|Overall Study|Lost to Follow-up|2|||
125190073|NCT03321968|450316857|FG001|Overall Study|Lost to Follow-up|0|||
125190074|NCT03321968|450316858|FG002|Overall Study|Lost to Follow-up|1|||
125190075|NCT03321968|450316856|FG000|Overall Study|Other than specified|0|||
125190076|NCT03321968|450316857|FG001|Overall Study|Other than specified|0|||
125190077|NCT03321968|450316858|FG002|Overall Study|Other than specified|1|||
125190078|NCT04830969|450316859|FG000|Overall Study|Withdrawal by Subject|6|||
125190079|NCT04830969|450316860|FG001|Overall Study|Withdrawal by Subject|2|||
125190080|NCT04830969|450316859|FG000|Overall Study|Protocol Violation|3|||
125190081|NCT04830969|450316860|FG001|Overall Study|Protocol Violation|9|||
125190082|NCT04830969|450316859|FG000|Overall Study|Lost to Follow-up|4|||
125190083|NCT04830969|450316860|FG001|Overall Study|Lost to Follow-up|4|||
125190084|NCT01537042|450316874|FG000|Overall Study|Adverse Event|0|||
125190085|NCT01537042|450316875|FG001|Overall Study|Adverse Event|2|||
125190086|NCT01537042|450316874|FG000|Overall Study|Lack of Efficacy|0|||
125190087|NCT01537042|450316875|FG001|Overall Study|Lack of Efficacy|1|||
125190088|NCT01537042|450316874|FG000|Overall Study|Protocol Violation|0|||
125190089|NCT01537042|450316875|FG001|Overall Study|Protocol Violation|1|||
125190090|NCT01537042|450316874|FG000|Overall Study|Other|0|||
125190091|NCT01537042|450316875|FG001|Overall Study|Other|1|||
125190092|NCT00979654|450316876|FG000|Overall Study|Lost to Follow-up|1|||
125190093|NCT00979654|450316876|FG000|Overall Study|Withdrawal by Subject|22|||
125190094|NCT00979654|450316876|FG000|Overall Study|Death|1|||
125190095|NCT00979654|450316876|FG000|Overall Study|Lack of Efficacy|6|||
125190096|NCT00979654|450316876|FG000|Overall Study|Adverse Event|1|||
125190097|NCT00979654|450316876|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
125190098|NCT00979654|450316876|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
125190099|NCT00979654|450316876|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
125190100|NCT00979654|450316876|FG000|Overall Study|Serious Adverse Event|1|||
125190101|NCT00979654|450316876|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
125190102|NCT01779440|450316877|FG000|Overall Study|Withdrawal by Subject|3|||
125190103|NCT01779440|450316878|FG001|Overall Study|Withdrawal by Subject|5|||
125190104|NCT01205269|450316879|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
125190105|NCT01205269|450316880|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
125190106|NCT01205269|450316881|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
125190107|NCT01205269|450316882|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
125190108|NCT01205269|450316883|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
125190109|NCT01205269|450316884|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
125243794|NCT00002874|450516641|FG001|Overall Study|Withdrawal by Subject|1|||
125243795|NCT00002874|450516640|FG000|Overall Study|Protocol Violation|44|||
125243796|NCT00002874|450516641|FG001|Overall Study|Protocol Violation|34|||
125243797|NCT01397747|450516646|FG000|Overall Study|Multitarget DNA test excluded|689|||
125243798|NCT01397747|450516646|FG000|Overall Study|Colonoscopy excluded|304|||
125243799|NCT01397747|450516646|FG000|Overall Study|FIT excluded|34|||
125243800|NCT03828383|450516647|FG000|Overall Study|Lost to Follow-up|3|||
125243801|NCT03828383|450516648|FG001|Overall Study|Lost to Follow-up|2|||
125243802|NCT03828383|450516647|FG000|Overall Study|Withdrawal by Subject|4|||
125243803|NCT03828383|450516648|FG001|Overall Study|Withdrawal by Subject|5|||
125243804|NCT00504309|450516649|FG000|Overall Study|Death|0|||
125243805|NCT00504309|450516650|FG001|Overall Study|Death|0|||
125243806|NCT00504309|450516651|FG002|Overall Study|Death|0|||
125243807|NCT00504309|450516652|FG003|Overall Study|Death|0|||
125243808|NCT00504309|450516653|FG004|Overall Study|Death|1|||
125243809|NCT00504309|450516654|FG005|Overall Study|Death|0|||
125243810|NCT00504309|450516649|FG000|Overall Study|Withdrawal by Subject|0|||
125243811|NCT00504309|450516650|FG001|Overall Study|Withdrawal by Subject|0|||
125243812|NCT00504309|450516651|FG002|Overall Study|Withdrawal by Subject|1|||
125243813|NCT00504309|450516652|FG003|Overall Study|Withdrawal by Subject|0|||
125243814|NCT00504309|450516653|FG004|Overall Study|Withdrawal by Subject|0|||
125243815|NCT00504309|450516654|FG005|Overall Study|Withdrawal by Subject|0|||
125243816|NCT03158311|450516657|FG000|Overall Study|Subject/Guardian Decision|10|||
125243817|NCT03158311|450516658|FG001|Overall Study|Subject/Guardian Decision|6|||
125243818|NCT03158311|450516659|FG002|Overall Study|Subject/Guardian Decision|11|||
125243819|NCT03158311|450516657|FG000|Overall Study|Adverse Event|5|||
125243820|NCT03158311|450516658|FG001|Overall Study|Adverse Event|3|||
125243821|NCT03158311|450516659|FG002|Overall Study|Adverse Event|3|||
125243822|NCT03158311|450516657|FG000|Overall Study|Techinical Problems|3|||
125243823|NCT03158311|450516658|FG001|Overall Study|Techinical Problems|1|||
125243824|NCT03158311|450516659|FG002|Overall Study|Techinical Problems|5|||
125243825|NCT03158311|450516657|FG000|Overall Study|Physician Decision|2|||
125243826|NCT03158311|450516658|FG001|Overall Study|Physician Decision|3|||
125243827|NCT03158311|450516659|FG002|Overall Study|Physician Decision|7|||
125243828|NCT03158311|450516657|FG000|Overall Study|Lost to Follow-up|1|||
125243829|NCT03158311|450516658|FG001|Overall Study|Lost to Follow-up|1|||
125190110|NCT01408303|450316885|FG000|Overall Study|Adverse Event|3|||
125190111|NCT01408303|450316886|FG001|Overall Study|Adverse Event|7|||
125190112|NCT01408303|450316887|FG002|Overall Study|Adverse Event|2|||
125190113|NCT01408303|450316885|FG000|Overall Study|Lost to Follow-up|0|||
125190114|NCT01408303|450316886|FG001|Overall Study|Lost to Follow-up|1|||
125190115|NCT01408303|450316887|FG002|Overall Study|Lost to Follow-up|2|||
125243830|NCT03158311|450516659|FG002|Overall Study|Lost to Follow-up|1|||
125243831|NCT03158311|450516657|FG000|Overall Study|Sponsor decision|1|||
125243832|NCT03158311|450516658|FG001|Overall Study|Sponsor decision|0|||
125243833|NCT03158311|450516659|FG002|Overall Study|Sponsor decision|0|||
125243834|NCT03158311|450516657|FG000|Overall Study|Pregnancy|0|||
125243835|NCT03158311|450516658|FG001|Overall Study|Pregnancy|2|||
125243836|NCT03158311|450516659|FG002|Overall Study|Pregnancy|0|||
125243837|NCT03158311|450516657|FG000|Overall Study|Randomized in error|0|||
125243838|NCT03158311|450516658|FG001|Overall Study|Randomized in error|0|||
125243839|NCT03158311|450516659|FG002|Overall Study|Randomized in error|1|||
125243840|NCT01018953|450516660|FG000|Overall Study|Adverse Event|2|||
125243841|NCT01018953|450516660|FG000|Overall Study|Withdrawal by Subject|1|||
125243842|NCT01018953|450516660|FG000|Overall Study|Study termination by sponsor|5|||
125243843|NCT01928771|450516667|FG000|Overall Study|Adverse Event|6|||
125243844|NCT01928771|450516668|FG001|Overall Study|Adverse Event|5|||
125190116|NCT01408303|450316885|FG000|Overall Study|Withdrawal by Subject|2|||
125243845|NCT01928771|450516669|FG002|Overall Study|Adverse Event|1|||
125243846|NCT01928771|450516667|FG000|Overall Study|Death|2|||
125243847|NCT01928771|450516668|FG001|Overall Study|Death|2|||
125243848|NCT01928771|450516669|FG002|Overall Study|Death|2|||
125243849|NCT01928771|450516667|FG000|Overall Study|Lost to Follow-up|5|||
125243850|NCT01928771|450516668|FG001|Overall Study|Lost to Follow-up|6|||
125243851|NCT01928771|450516669|FG002|Overall Study|Lost to Follow-up|3|||
125243852|NCT01928771|450516667|FG000|Overall Study|Withdrawal by Subject|20|||
125243853|NCT01928771|450516668|FG001|Overall Study|Withdrawal by Subject|15|||
125243854|NCT01928771|450516669|FG002|Overall Study|Withdrawal by Subject|17|||
125243855|NCT01928771|450516667|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
125243856|NCT01928771|450516668|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
125243857|NCT01928771|450516669|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
125243858|NCT01928771|450516667|FG000|Overall Study|Other Reasons|9|||
125243859|NCT01928771|450516668|FG001|Overall Study|Other Reasons|9|||
125243860|NCT01928771|450516669|FG002|Overall Study|Other Reasons|14|||
125243861|NCT01928771|450516667|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
125243862|NCT01928771|450516668|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
125243863|NCT01928771|450516669|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
125243864|NCT03932331|450516670|FG000|Overall Study|Death|0|||
125243865|NCT03932331|450516671|FG001|Overall Study|Death|7|||
125243866|NCT03932331|450516672|FG002|Overall Study|Death|2|||
125243867|NCT03932331|450516670|FG000|Overall Study|Withdrawal by Subject|0|||
125243868|NCT03932331|450516671|FG001|Overall Study|Withdrawal by Subject|3|||
125243869|NCT03932331|450516672|FG002|Overall Study|Withdrawal by Subject|0|||
125243870|NCT03932331|450516670|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
125243871|NCT03932331|450516671|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
125243872|NCT03932331|450516672|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
125243873|NCT03932331|450516670|FG000|Overall Study|Progressive disease|3|||
125243874|NCT03932331|450516671|FG001|Overall Study|Progressive disease|0|||
125243875|NCT03932331|450516672|FG002|Overall Study|Progressive disease|0|||
125243876|NCT03932331|450516670|FG000|Overall Study|Lung infection|1|||
125243877|NCT03932331|450516671|FG001|Overall Study|Lung infection|0|||
125243878|NCT03932331|450516672|FG002|Overall Study|Lung infection|0|||
125243879|NCT03932331|450516670|FG000|Overall Study|Other|0|||
125243880|NCT03932331|450516671|FG001|Overall Study|Other|0|||
125243881|NCT03932331|450516672|FG002|Overall Study|Other|58|||
125243882|NCT01407367|450516675|FG000|Overall Study|Death|24|||
125243883|NCT01407367|450516676|FG001|Overall Study|Death|32|||
125243884|NCT01407367|450516675|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
125243885|NCT01407367|450516676|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
125243886|NCT01407367|450516675|FG000|Overall Study|Withdrawal by Subject|4|||
125243887|NCT01407367|450516676|FG001|Overall Study|Withdrawal by Subject|15|||
125243888|NCT01407367|450516675|FG000|Overall Study|Lost to Follow-up|0|||
125243889|NCT01407367|450516676|FG001|Overall Study|Lost to Follow-up|2|||
125243890|NCT01452347|450516679|FG000|Overall Study|Adverse Event|2|||
125243891|NCT01452347|450516680|FG001|Overall Study|Adverse Event|1|||
125243892|NCT01452347|450516679|FG000|Overall Study|Non compliance protocol|2|||
125243893|NCT01452347|450516680|FG001|Overall Study|Non compliance protocol|0|||
125243894|NCT01452347|450516679|FG000|Overall Study|Lost to Follow-up|2|||
125243895|NCT01452347|450516680|FG001|Overall Study|Lost to Follow-up|0|||
125243896|NCT01452347|450516679|FG000|Overall Study|Withdrawal by Subject|3|||
125243897|NCT01452347|450516680|FG001|Overall Study|Withdrawal by Subject|3|||
125243898|NCT01452347|450516679|FG000|Overall Study|Not treated|6|||
125243899|NCT01452347|450516680|FG001|Overall Study|Not treated|3|||
125243900|NCT01452347|450516679|FG000|Overall Study|Other reason not defined above|2|||
125243901|NCT01452347|450516680|FG001|Overall Study|Other reason not defined above|0|||
125243902|NCT02642679|450518399|FG000|Overall Study|Withdrawal by Subject|1|||
125243903|NCT02642679|450518399|FG000|Overall Study|Physician Decision|1|||
125243904|NCT02642679|450518399|FG000|Overall Study|Physician Decision|1|||
125243905|NCT01112267|450518401|FG000|Overall Study|Adverse Event|24|||
125243906|NCT01112267|450518402|FG001|Overall Study|Adverse Event|6|||
125243907|NCT01112267|450518401|FG000|Overall Study|Withdrawal by Subject|3|||
125243908|NCT01112267|450518402|FG001|Overall Study|Withdrawal by Subject|5|||
125243909|NCT01112267|450518401|FG000|Overall Study|Protocol Violation|5|||
125243910|NCT01112267|450518402|FG001|Overall Study|Protocol Violation|3|||
125243911|NCT01112267|450518401|FG000|Overall Study|Participants not compliant|1|||
125243912|NCT01112267|450518402|FG001|Overall Study|Participants not compliant|2|||
125243913|NCT01112267|450518401|FG000|Overall Study|Participants not receive any study drug|1|||
125243914|NCT01112267|450518402|FG001|Overall Study|Participants not receive any study drug|2|||
125243915|NCT05638737|450518405|FG000|Overall Study|Withdrawal by Subject|4|||
125243916|NCT05638737|450518406|FG001|Overall Study|Withdrawal by Subject|7|||
125243917|NCT04633447|450518409|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
125243918|NCT04633447|450518410|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
125243919|NCT04633447|450518409|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
125243920|NCT04633447|450518410|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
125243921|NCT04633447|450518409|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
125243922|NCT04633447|450518410|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
125393556|NCT00603746|451074116|FG002|Overall Study|Physician Decision|0|||
125190117|NCT01408303|450316886|FG001|Overall Study|Withdrawal by Subject|3|||
125190118|NCT01408303|450316887|FG002|Overall Study|Withdrawal by Subject|1|||
125190119|NCT01408303|450316885|FG000|Overall Study|Protocol Violation|0|||
125190120|NCT01408303|450316886|FG001|Overall Study|Protocol Violation|1|||
125190121|NCT01408303|450316887|FG002|Overall Study|Protocol Violation|0|||
125190122|NCT01408303|450316885|FG000|Overall Study|Noncompliance|1|||
125190123|NCT01408303|450316886|FG001|Overall Study|Noncompliance|0|||
125190124|NCT01408303|450316887|FG002|Overall Study|Noncompliance|1|||
125190125|NCT01207687|450316888|FG000|Overall Study|Adverse Event|1|||
125190126|NCT01207687|450316888|FG000|Overall Study|Withdrawal by Subject|1|||
125190127|NCT01486446|450316889|FG000|Overall Study|Adverse Event|1|||
125190128|NCT01486446|450316890|FG001|Overall Study|Adverse Event|0|||
125190129|NCT01801865|450316891|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
125190130|NCT01801865|450316891|FG000|Overall Study|Physician Decision|7|||
125190131|NCT00523848|450316892|FG000|Overall Study|Adverse Event|11|||
125190132|NCT00523848|450316892|FG000|Overall Study|Withdrawal by Subject|2|||
125190133|NCT00523848|450316892|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
125190134|NCT00523848|450316892|FG000|Overall Study|Disease Progression|5|||
125190135|NCT00523848|450316892|FG000|Overall Study|Other, unspecified|4|||
125190136|NCT01367886|450316893|FG000|Overall Study|Lost to Follow-up|4|||
125190137|NCT01367886|450316893|FG000|Overall Study|Lack of Efficacy|2|||
125190138|NCT01367886|450316893|FG000|Overall Study|Death|1|||
125190139|NCT00985504|450316896|FG000|Acute Treatment Period|Adverse Event|3|||
125190140|NCT00985504|450316897|FG001|Acute Treatment Period|Adverse Event|4|||
125190141|NCT00985504|450316896|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
125190142|NCT00985504|450316897|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
125190143|NCT00985504|450316896|FG000|Acute Treatment Period|Protocol Violation|2|||
125190144|NCT00985504|450316897|FG001|Acute Treatment Period|Protocol Violation|0|||
125190145|NCT00985504|450316896|FG000|Acute Treatment Period|Sponsor Decision|0|||
125190146|NCT00985504|450316897|FG001|Acute Treatment Period|Sponsor Decision|1|||
125190147|NCT00985504|450316896|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
125190148|NCT00985504|450316897|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
125190149|NCT00985504|450316896|FG000|Optimization Period|Adverse Event|7|||
125190150|NCT00985504|450316897|FG001|Optimization Period|Adverse Event|9|||
125190151|NCT00985504|450316896|FG000|Optimization Period|Death|0|||
125190152|NCT00985504|450316897|FG001|Optimization Period|Death|1|||
125190153|NCT00985504|450316896|FG000|Optimization Period|Lack of Efficacy|5|||
125190154|NCT00985504|450316897|FG001|Optimization Period|Lack of Efficacy|3|||
125190155|NCT00985504|450316896|FG000|Optimization Period|Lost to Follow-up|0|||
125190156|NCT00985504|450316897|FG001|Optimization Period|Lost to Follow-up|1|||
125190157|NCT00985504|450316896|FG000|Optimization Period|Physician Decision|1|||
125190158|NCT00985504|450316897|FG001|Optimization Period|Physician Decision|0|||
125190159|NCT00985504|450316896|FG000|Optimization Period|Protocol Violation|3|||
125190160|NCT00985504|450316897|FG001|Optimization Period|Protocol Violation|1|||
125190161|NCT00985504|450316896|FG000|Optimization Period|Withdrawal by Subject|10|||
125190162|NCT00985504|450316897|FG001|Optimization Period|Withdrawal by Subject|8|||
125190163|NCT03711786|450316902|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
125190164|NCT03711786|450316903|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
125190165|NCT03711786|450316902|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
125190166|NCT03711786|450316903|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
125190167|NCT03711786|450316902|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
125190168|NCT03711786|450316903|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
125190169|NCT03711786|450316902|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
125190170|NCT03711786|450316903|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
125190171|NCT03711786|450316902|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
125190172|NCT03711786|450316903|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
125190173|NCT03711786|450316902|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
125190174|NCT03711786|450316903|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
125190175|NCT03379727|450316907|FG000|Overall Study|Lack of Efficacy|73|||
125190176|NCT03379727|450316907|FG000|Overall Study|Adverse Event|32|||
125190177|NCT03379727|450316907|FG000|Overall Study|Death|18|||
125190178|NCT03379727|450316907|FG000|Overall Study|Patient/guardian decision|17|||
125190179|NCT03379727|450316907|FG000|Overall Study|Physician Decision|104|||
125190180|NCT03379727|450316907|FG000|Overall Study|Protocol Violation|4|||
125190181|NCT03379727|450316907|FG000|Overall Study|Lost to Follow-up|1|||
125190182|NCT04031846|450316908|FG000|Overall Study|Lost to Follow-up|4|||
125190183|NCT04031846|450316909|FG001|Overall Study|Lost to Follow-up|4|||
125190184|NCT04031846|450316908|FG000|Overall Study|Physician Decision|0|||
125190185|NCT04031846|450316909|FG001|Overall Study|Physician Decision|1|||
125190186|NCT04031846|450316908|FG000|Overall Study|Protocol Violation|1|||
125190187|NCT04031846|450316909|FG001|Overall Study|Protocol Violation|1|||
125190188|NCT04031846|450316908|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
125190189|NCT04031846|450316909|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
125190190|NCT06868654|450316910|FG000|Overall Study|Death|4|||
125190191|NCT06868654|450316911|FG001|Overall Study|Death|14|||
125190192|NCT06868654|450316910|FG000|Overall Study|Lost to Follow-up|0|||
125190193|NCT06868654|450316911|FG001|Overall Study|Lost to Follow-up|1|||
125190194|NCT06868654|450316910|FG000|Overall Study|Withdrawal by Subject|5|||
125190195|NCT06868654|450316911|FG001|Overall Study|Withdrawal by Subject|3|||
125190196|NCT06868654|450316910|FG000|Overall Study|Physician Decision|0|||
125190197|NCT06868654|450316911|FG001|Overall Study|Physician Decision|1|||
125190198|NCT06868654|450316910|FG000|Overall Study|Ongoing|23|||
125190199|NCT06868654|450316911|FG001|Overall Study|Ongoing|21|||
125190200|NCT00764660|450316916|FG000|Overall Study|Adverse Event|6|||
125190201|NCT00764660|450316917|FG001|Overall Study|Adverse Event|3|||
125190202|NCT00764660|450316916|FG000|Overall Study|Lost to Follow-up|3|||
125190203|NCT00764660|450316917|FG001|Overall Study|Lost to Follow-up|4|||
125190204|NCT00764660|450316916|FG000|Overall Study|Withdrawal by Subject|7|||
125190205|NCT00764660|450316917|FG001|Overall Study|Withdrawal by Subject|3|||
125190206|NCT00764660|450316916|FG000|Overall Study|Noncompliance With Protocol|5|||
125190207|NCT00764660|450316917|FG001|Overall Study|Noncompliance With Protocol|1|||
125190208|NCT00764660|450316916|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
125190209|NCT00764660|450316917|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
125190210|NCT01131455|450316918|FG000|Overall Study|Death of PI|6|||
125190211|NCT01131455|450316919|FG001|Overall Study|Death of PI|4|||
125190212|NCT01131455|450316920|FG002|Overall Study|Death of PI|0|||
125190213|NCT03103152|450316921|FG000|Overall Study|Physician Decision|5|||
125190214|NCT03103152|450316922|FG001|Overall Study|Physician Decision|2|||
125190215|NCT03103152|450316923|FG002|Overall Study|Physician Decision|6|||
125190216|NCT03103152|450316924|FG003|Overall Study|Physician Decision|3|||
125190217|NCT03103152|450316925|FG004|Overall Study|Physician Decision|3|||
125190218|NCT03103152|450316926|FG005|Overall Study|Physician Decision|1|||
125190219|NCT03103152|450316921|FG000|Overall Study|Protocol Violation|2|||
125190220|NCT03103152|450316922|FG001|Overall Study|Protocol Violation|2|||
125190221|NCT03103152|450316923|FG002|Overall Study|Protocol Violation|1|||
125190222|NCT03103152|450316924|FG003|Overall Study|Protocol Violation|2|||
125190223|NCT03103152|450316925|FG004|Overall Study|Protocol Violation|1|||
125190224|NCT03103152|450316926|FG005|Overall Study|Protocol Violation|1|||
125190225|NCT03103152|450316921|FG000|Overall Study|Inter-current illness|0|||
125190226|NCT03103152|450316922|FG001|Overall Study|Inter-current illness|0|||
125190227|NCT03103152|450316923|FG002|Overall Study|Inter-current illness|1|||
125190228|NCT03103152|450316924|FG003|Overall Study|Inter-current illness|0|||
125190229|NCT03103152|450316925|FG004|Overall Study|Inter-current illness|0|||
125190230|NCT03103152|450316926|FG005|Overall Study|Inter-current illness|0|||
125190231|NCT03103152|450316921|FG000|Overall Study|Death|0|||
125190232|NCT03103152|450316922|FG001|Overall Study|Death|1|||
125190233|NCT03103152|450316923|FG002|Overall Study|Death|0|||
125190234|NCT03103152|450316924|FG003|Overall Study|Death|0|||
125190235|NCT03103152|450316925|FG004|Overall Study|Death|0|||
125190236|NCT03103152|450316926|FG005|Overall Study|Death|0|||
125190237|NCT03103152|450316921|FG000|Overall Study|Adverse Event|0|||
125190238|NCT03103152|450316922|FG001|Overall Study|Adverse Event|0|||
125190239|NCT03103152|450316923|FG002|Overall Study|Adverse Event|1|||
125190240|NCT03103152|450316924|FG003|Overall Study|Adverse Event|0|||
125190241|NCT03103152|450316925|FG004|Overall Study|Adverse Event|0|||
125190242|NCT03103152|450316926|FG005|Overall Study|Adverse Event|1|||
125190243|NCT03103152|450316921|FG000|Overall Study|Withdrawal by Subject|1|||
125190244|NCT03103152|450316922|FG001|Overall Study|Withdrawal by Subject|0|||
125190245|NCT03103152|450316923|FG002|Overall Study|Withdrawal by Subject|1|||
125190246|NCT03103152|450316924|FG003|Overall Study|Withdrawal by Subject|1|||
125190247|NCT03103152|450316925|FG004|Overall Study|Withdrawal by Subject|1|||
125190248|NCT03103152|450316926|FG005|Overall Study|Withdrawal by Subject|1|||
125190249|NCT03103152|450316921|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
125190250|NCT03103152|450316922|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
125190251|NCT03103152|450316923|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
125190252|NCT03103152|450316924|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
125190253|NCT03103152|450316925|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
125190254|NCT03103152|450316926|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
125190255|NCT03103152|450316921|FG000|Overall Study|Unacceptable side effects|0|||
125190256|NCT03103152|450316922|FG001|Overall Study|Unacceptable side effects|0|||
125190257|NCT03103152|450316923|FG002|Overall Study|Unacceptable side effects|0|||
125190258|NCT03103152|450316924|FG003|Overall Study|Unacceptable side effects|0|||
125190259|NCT03103152|450316925|FG004|Overall Study|Unacceptable side effects|0|||
125190260|NCT03103152|450316926|FG005|Overall Study|Unacceptable side effects|1|||
125190261|NCT03103152|450316921|FG000|Overall Study|Lost to Follow-up|0|||
125190262|NCT03103152|450316922|FG001|Overall Study|Lost to Follow-up|1|||
125190263|NCT03103152|450316923|FG002|Overall Study|Lost to Follow-up|0|||
125190264|NCT03103152|450316924|FG003|Overall Study|Lost to Follow-up|1|||
125190265|NCT03103152|450316925|FG004|Overall Study|Lost to Follow-up|0|||
125190266|NCT03103152|450316926|FG005|Overall Study|Lost to Follow-up|1|||
125190267|NCT03103152|450316921|FG000|Overall Study|Testicular pain|0|||
125190268|NCT03103152|450316922|FG001|Overall Study|Testicular pain|0|||
125190269|NCT03103152|450316923|FG002|Overall Study|Testicular pain|0|||
125190270|NCT03103152|450316924|FG003|Overall Study|Testicular pain|1|||
125190271|NCT03103152|450316925|FG004|Overall Study|Testicular pain|0|||
125190272|NCT03103152|450316926|FG005|Overall Study|Testicular pain|0|||
125190273|NCT01540487|450318680|FG000|Overall Study|Protocol Violation|1|||
125190274|NCT01540487|450318681|FG001|Overall Study|Protocol Violation|0|||
125190275|NCT02525783|450318684|FG000|Overall Study|Lost to Follow-up|10|||
125190276|NCT01894841|450318685|FG000|Overall Study|Withdrawal by Subject|9|||
125190277|NCT01894841|450318686|FG001|Overall Study|Withdrawal by Subject|4|||
125190278|NCT01894841|450318685|FG000|Overall Study|Withdrawn by investigator|2|||
125190279|NCT01894841|450318686|FG001|Overall Study|Withdrawn by investigator|2|||
125190280|NCT01894841|450318685|FG000|Overall Study|Lost to Follow-up|7|||
125190281|NCT01894841|450318686|FG001|Overall Study|Lost to Follow-up|3|||
125190282|NCT00454246|450318689|FG000|Overall Study|Adverse Event|2|||
125190283|NCT00454246|450318690|FG001|Overall Study|Adverse Event|2|||
125190284|NCT00454246|450318691|FG002|Overall Study|Adverse Event|0|||
125190285|NCT00454246|450318689|FG000|Overall Study|Violation of selection criteria at entry|6|||
125190286|NCT00454246|450318690|FG001|Overall Study|Violation of selection criteria at entry|0|||
125190287|NCT00454246|450318691|FG002|Overall Study|Violation of selection criteria at entry|0|||
125190288|NCT00454246|450318689|FG000|Overall Study|Protocol Violation|1|||
125190289|NCT00454246|450318690|FG001|Overall Study|Protocol Violation|0|||
125190290|NCT00454246|450318691|FG002|Overall Study|Protocol Violation|0|||
125190291|NCT00454246|450318689|FG000|Overall Study|Refused Treatment|1|||
125190292|NCT00454246|450318690|FG001|Overall Study|Refused Treatment|1|||
125190293|NCT00454246|450318691|FG002|Overall Study|Refused Treatment|0|||
125190294|NCT00454246|450318689|FG000|Overall Study|Failure to return|1|||
125190295|NCT00454246|450318690|FG001|Overall Study|Failure to return|0|||
125190296|NCT00454246|450318691|FG002|Overall Study|Failure to return|0|||
125190297|NCT00454246|450318689|FG000|Overall Study|Early termination of study|62|||
125190298|NCT00454246|450318690|FG001|Overall Study|Early termination of study|26|||
125190299|NCT00454246|450318691|FG002|Overall Study|Early termination of study|9|||
125190300|NCT05326529|450318692|FG000|Overall Study|Lack of Efficacy|0|||
125190301|NCT05326529|450318693|FG001|Overall Study|Lack of Efficacy|1|||
125190302|NCT05326529|450318694|FG002|Overall Study|Lack of Efficacy|0|||
125190303|NCT05326529|450318692|FG000|Overall Study|Physician Decision|0|||
125190304|NCT05326529|450318693|FG001|Overall Study|Physician Decision|0|||
125190305|NCT05326529|450318694|FG002|Overall Study|Physician Decision|2|||
125190306|NCT01379768|450318695|FG000|Overall Study|Adverse Event|1|||
125190307|NCT01379768|450318696|FG001|Overall Study|Adverse Event|1|||
125190308|NCT01379768|450318697|FG002|Overall Study|Adverse Event|0|||
125190309|NCT01379768|450318695|FG000|Overall Study|Lost to Follow-up|2|||
125190310|NCT01379768|450318696|FG001|Overall Study|Lost to Follow-up|0|||
125190311|NCT01379768|450318697|FG002|Overall Study|Lost to Follow-up|0|||
125190312|NCT01295671|450318701|FG000|Overall Study|Lost to Follow-up|4|||
125190313|NCT01295671|450318702|FG001|Overall Study|Lost to Follow-up|6|||
125190314|NCT01295671|450318703|FG002|Overall Study|Lost to Follow-up|3|||
125190315|NCT01295671|450318701|FG000|Overall Study|Withdrawal by Subject|3|||
125190316|NCT01295671|450318702|FG001|Overall Study|Withdrawal by Subject|1|||
125190317|NCT01295671|450318703|FG002|Overall Study|Withdrawal by Subject|0|||
125190318|NCT00708552|450318706|FG000|Overall Study|Adverse Event|10|||
125190319|NCT00708552|450318707|FG001|Overall Study|Adverse Event|3|||
125190320|NCT00708552|450318708|FG002|Overall Study|Adverse Event|4|||
125190321|NCT00708552|450318709|FG003|Overall Study|Adverse Event|6|||
125190322|NCT00708552|450318706|FG000|Overall Study|Lack of Efficacy|0|||
125190323|NCT00708552|450318707|FG001|Overall Study|Lack of Efficacy|4|||
125190324|NCT00708552|450318708|FG002|Overall Study|Lack of Efficacy|1|||
125190325|NCT00708552|450318709|FG003|Overall Study|Lack of Efficacy|0|||
125190326|NCT00708552|450318706|FG000|Overall Study|Protocol Violation|0|||
125190327|NCT00708552|450318707|FG001|Overall Study|Protocol Violation|0|||
125190328|NCT00708552|450318708|FG002|Overall Study|Protocol Violation|2|||
125190329|NCT00708552|450318709|FG003|Overall Study|Protocol Violation|4|||
125190330|NCT00708552|450318706|FG000|Overall Study|Lost to Follow-up|4|||
125190331|NCT00708552|450318707|FG001|Overall Study|Lost to Follow-up|2|||
125190332|NCT00708552|450318708|FG002|Overall Study|Lost to Follow-up|0|||
125190333|NCT00708552|450318709|FG003|Overall Study|Lost to Follow-up|1|||
125190334|NCT00708552|450318706|FG000|Overall Study|Physician Decision|1|||
125190335|NCT00708552|450318707|FG001|Overall Study|Physician Decision|2|||
125190336|NCT00708552|450318708|FG002|Overall Study|Physician Decision|0|||
125190337|NCT00708552|450318709|FG003|Overall Study|Physician Decision|0|||
125190338|NCT00708552|450318706|FG000|Overall Study|Withdrawal by Subject|12|||
125190339|NCT00708552|450318707|FG001|Overall Study|Withdrawal by Subject|7|||
125190340|NCT00708552|450318708|FG002|Overall Study|Withdrawal by Subject|8|||
125190341|NCT00708552|450318709|FG003|Overall Study|Withdrawal by Subject|10|||
125190342|NCT03168711|450318713|FG000|Overall Study|Adverse Event|2|||
125190343|NCT03168711|450318714|FG001|Overall Study|Adverse Event|0|||
125190344|NCT03168711|450318713|FG000|Overall Study|Withdrawal by Subject|0|||
125190345|NCT03168711|450318714|FG001|Overall Study|Withdrawal by Subject|1|||
125190346|NCT03168711|450318713|FG000|Overall Study|Death|0|||
125190347|NCT03168711|450318714|FG001|Overall Study|Death|1|||
125190348|NCT01609010|450318715|FG000|Overall Study|Stable disease (SD)|22|||
125190349|NCT01609010|450318716|FG001|Overall Study|Stable disease (SD)|16|||
125243923|NCT04633447|450518409|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
125243924|NCT04633447|450518410|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
125243925|NCT04633447|450518409|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
125243926|NCT04633447|450518410|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
125243927|NCT04633447|450518409|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
125243928|NCT04633447|450518410|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
125243929|NCT03641924|450518411|FG000|Overall Study|Withdrawal by Subject|26|||
125243930|NCT03641924|450518411|FG000|Overall Study|Lost to Follow-up|16|||
125243931|NCT03641924|450518411|FG000|Overall Study|Protocol Violation|10|||
125243932|NCT04333498|450518412|FG000|Overall Study|Lost to Follow-up|1|||
125243933|NCT04333498|450518413|FG001|Overall Study|Lost to Follow-up|0|||
125243934|NCT04333498|450518412|FG000|Overall Study|Lost to Follow-up|0|||
125243935|NCT04333498|450518413|FG001|Overall Study|Lost to Follow-up|1|||
125243936|NCT01565694|450518414|FG000|Dose-Titration Period|Adverse Event|4|||
125243937|NCT01565694|450518414|FG000|Dose-Titration Period|Protocol Violation|10|||
125243938|NCT01565694|450518414|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
125243939|NCT05417113|450518418|FG000|Overall Study|Lost to Follow-up|2|||
125243940|NCT05417113|450518419|FG001|Overall Study|Lost to Follow-up|2|||
125243941|NCT01022580|450518420|FG000|Overall Study|Death|18|||
125243942|NCT01022580|450518421|FG001|Overall Study|Death|22|||
125243943|NCT00541229|450518422|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
125243944|NCT00541229|450518423|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
125243945|NCT00541229|450518424|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
125243946|NCT00541229|450518425|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
125243947|NCT00541229|450518426|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
125243948|NCT00541229|450518427|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
125243949|NCT00541229|450518422|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
125243950|NCT00541229|450518423|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
125243951|NCT00541229|450518424|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
125243952|NCT00541229|450518425|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
125243953|NCT00541229|450518426|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
125243954|NCT00541229|450518427|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
125243955|NCT00541229|450518422|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
125243956|NCT00541229|450518423|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
125243957|NCT00541229|450518424|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
125243958|NCT00541229|450518425|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
125243959|NCT00541229|450518426|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
125243960|NCT00541229|450518427|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
125243961|NCT00541229|450518422|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
125243962|NCT00541229|450518423|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
125243963|NCT00541229|450518424|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
125243964|NCT00541229|450518425|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
125243965|NCT00541229|450518426|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
125243966|NCT00541229|450518427|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
125243967|NCT00541229|450518422|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
125243968|NCT00541229|450518423|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
125243969|NCT00541229|450518424|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
125243970|NCT00541229|450518425|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
125243971|NCT00541229|450518426|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
125243972|NCT00541229|450518427|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
125243973|NCT00541229|450518422|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
125243974|NCT00541229|450518423|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
125243975|NCT00541229|450518424|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
125243976|NCT00541229|450518425|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
125243977|NCT00541229|450518426|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
125243978|NCT00541229|450518427|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
125243979|NCT00541229|450518422|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
125243980|NCT00541229|450518423|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
125243981|NCT00541229|450518424|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
125243982|NCT00541229|450518425|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
125243983|NCT00541229|450518426|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
125243984|NCT00541229|450518427|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
125243985|NCT00541229|450518422|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
125243986|NCT00541229|450518423|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
125243987|NCT00541229|450518424|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
125243988|NCT00541229|450518425|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
125243989|NCT00541229|450518426|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
125243990|NCT00541229|450518427|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
125243991|NCT00541229|450518422|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
125243992|NCT00541229|450518423|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
125243993|NCT00541229|450518424|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
125243994|NCT00541229|450518425|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
125243995|NCT00541229|450518426|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
125243996|NCT00541229|450518427|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
125243997|NCT00541229|450518422|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
125243998|NCT00541229|450518423|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
125243999|NCT00541229|450518424|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
125244000|NCT00541229|450518425|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
125244001|NCT00541229|450518426|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
125244002|NCT00541229|450518427|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
125244003|NCT00541229|450518422|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
125244004|NCT00541229|450518423|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
125244005|NCT00541229|450518424|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
125244006|NCT00541229|450518425|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
125244007|NCT00541229|450518426|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
125244008|NCT00541229|450518427|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
125244009|NCT00541229|450518422|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
125244010|NCT00541229|450518423|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
125244011|NCT00541229|450518424|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
125393557|NCT00603746|451074117|FG003|Overall Study|Physician Decision|0|||
125393558|NCT00603746|451074118|FG004|Overall Study|Physician Decision|1|||
125393559|NCT00603746|451074119|FG005|Overall Study|Physician Decision|0|||
125393560|NCT00603746|451074114|FG000|Overall Study|Withdrawal by Subject|1|||
125393561|NCT00603746|451074115|FG001|Overall Study|Withdrawal by Subject|0|||
125393562|NCT00603746|451074116|FG002|Overall Study|Withdrawal by Subject|0|||
125393563|NCT00603746|451074117|FG003|Overall Study|Withdrawal by Subject|1|||
125393564|NCT00603746|451074118|FG004|Overall Study|Withdrawal by Subject|3|||
125393565|NCT00603746|451074119|FG005|Overall Study|Withdrawal by Subject|1|||
125393566|NCT01524627|451074124|FG000|Overall Study|Physician Decision|0|||
125393567|NCT01524627|451074125|FG001|Overall Study|Physician Decision|1|||
125393568|NCT01524627|451074124|FG000|Overall Study|Lost to Follow-up|1|||
125393569|NCT01524627|451074125|FG001|Overall Study|Lost to Follow-up|1|||
125393570|NCT03323658|451074126|FG000|Overall Study|Adverse Event|0|||
125393571|NCT03323658|451074127|FG001|Overall Study|Adverse Event|1|||
125393572|NCT03323658|451074128|FG002|Overall Study|Adverse Event|0|||
125393573|NCT00615056|451074129|FG000|Overall Study|Death|31|||
125393574|NCT00615056|451074130|FG001|Overall Study|Death|31|||
125393575|NCT00615056|451074131|FG002|Overall Study|Death|21|||
125393576|NCT00615056|451074132|FG003|Overall Study|Death|23|||
125393577|NCT00615056|451074129|FG000|Overall Study|Lost to Follow-up|1|||
125393578|NCT00615056|451074130|FG001|Overall Study|Lost to Follow-up|2|||
125393579|NCT00615056|451074131|FG002|Overall Study|Lost to Follow-up|4|||
125393580|NCT00615056|451074132|FG003|Overall Study|Lost to Follow-up|5|||
125393581|NCT00615056|451074129|FG000|Overall Study|Other|13|||
125393582|NCT00615056|451074130|FG001|Overall Study|Other|15|||
125393583|NCT00615056|451074131|FG002|Overall Study|Other|10|||
125393584|NCT00615056|451074132|FG003|Overall Study|Other|7|||
125393585|NCT00615056|451074129|FG000|Overall Study|Objective progression or relapse|0|||
125393586|NCT00615056|451074130|FG001|Overall Study|Objective progression or relapse|2|||
125393587|NCT00615056|451074131|FG002|Overall Study|Objective progression or relapse|0|||
125393588|NCT00615056|451074132|FG003|Overall Study|Objective progression or relapse|0|||
125393589|NCT00615056|451074129|FG000|Overall Study|Withdrawal by Subject|0|||
125393590|NCT00615056|451074130|FG001|Overall Study|Withdrawal by Subject|1|||
125393591|NCT00615056|451074131|FG002|Overall Study|Withdrawal by Subject|1|||
125393592|NCT00615056|451074132|FG003|Overall Study|Withdrawal by Subject|0|||
125393593|NCT00615056|451074129|FG000|Overall Study|Discontinued by Sponsor|1|||
125393594|NCT00615056|451074130|FG001|Overall Study|Discontinued by Sponsor|0|||
125393595|NCT00615056|451074131|FG002|Overall Study|Discontinued by Sponsor|0|||
125393596|NCT00615056|451074132|FG003|Overall Study|Discontinued by Sponsor|0|||
125393597|NCT00615056|451074129|FG000|Overall Study|Randomized but not treated|3|||
125393598|NCT00615056|451074130|FG001|Overall Study|Randomized but not treated|0|||
125393599|NCT00615056|451074131|FG002|Overall Study|Randomized but not treated|0|||
125393600|NCT00615056|451074132|FG003|Overall Study|Randomized but not treated|0|||
125393601|NCT00262067|451074133|FG000|Overall Study|Death|190|||
125393602|NCT00262067|451074134|FG001|Overall Study|Death|89|||
125393603|NCT00262067|451074135|FG002|Overall Study|Death|186|||
125393604|NCT00262067|451074136|FG003|Overall Study|Death|99|||
125393605|NCT00262067|451074133|FG000|Overall Study|Lost to Follow-up|5|||
125393606|NCT00262067|451074134|FG001|Overall Study|Lost to Follow-up|4|||
125393607|NCT00262067|451074135|FG002|Overall Study|Lost to Follow-up|7|||
125393608|NCT00262067|451074136|FG003|Overall Study|Lost to Follow-up|5|||
125393609|NCT00262067|451074133|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
125244012|NCT00541229|450518425|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
125244013|NCT00541229|450518426|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
125393610|NCT00262067|451074134|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
125443531|NCT00551213|451252165|FG001|Overall Study|Adverse Event|3|||
125190350|NCT01609010|450318715|FG000|Overall Study|Progressive disease (PD)|8|||
125190351|NCT01609010|450318716|FG001|Overall Study|Progressive disease (PD)|10|||
125190352|NCT01609010|450318715|FG000|Overall Study|Adverse Event|3|||
125190353|NCT01609010|450318716|FG001|Overall Study|Adverse Event|6|||
125190354|NCT01609010|450318715|FG000|Overall Study|Withdrawal by Subject|2|||
125190355|NCT01609010|450318716|FG001|Overall Study|Withdrawal by Subject|2|||
125190356|NCT01609010|450318715|FG000|Overall Study|Other|2|||
125190357|NCT01609010|450318716|FG001|Overall Study|Other|0|||
125190358|NCT01609010|450318715|FG000|Overall Study|Other malignancy|1|||
125190359|NCT01609010|450318716|FG001|Overall Study|Other malignancy|0|||
125190360|NCT01609010|450318715|FG000|Overall Study|Pathology review|2|||
125190361|NCT01609010|450318716|FG001|Overall Study|Pathology review|1|||
125190362|NCT01609010|450318715|FG000|Overall Study|Protocol Violation|1|||
125190363|NCT01609010|450318716|FG001|Overall Study|Protocol Violation|1|||
125190364|NCT01609010|450318715|FG000|Overall Study|New cancer|1|||
125190365|NCT01609010|450318716|FG001|Overall Study|New cancer|0|||
125190366|NCT01609010|450318715|FG000|Overall Study|Lost to Follow-up|1|||
125190367|NCT01609010|450318716|FG001|Overall Study|Lost to Follow-up|1|||
125190368|NCT00808210|450318721|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
125190369|NCT00808210|450318722|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
125190370|NCT00808210|450318721|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
125190371|NCT00808210|450318722|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
125190372|NCT00808210|450318721|FG000|Double-Blind TX Period|Adverse Event|0|||
125190373|NCT00808210|450318722|FG001|Double-Blind TX Period|Adverse Event|1|||
125190374|NCT00808210|450318721|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
125190375|NCT00808210|450318722|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
125190376|NCT00808210|450318721|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
125190377|NCT00808210|450318722|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
125190378|NCT00808210|450318721|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
125190379|NCT00808210|450318722|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
125190380|NCT02356588|450318723|FG000|Overall Study|Lack of Efficacy|4|||
125190381|NCT02356588|450318724|FG001|Overall Study|Lack of Efficacy|10|||
125190382|NCT02356588|450318723|FG000|Overall Study|Adverse Event|0|||
125190383|NCT02356588|450318724|FG001|Overall Study|Adverse Event|2|||
125190384|NCT02356588|450318723|FG000|Overall Study|Withdrawal by Subject|1|||
125190385|NCT02356588|450318724|FG001|Overall Study|Withdrawal by Subject|0|||
125190386|NCT02356588|450318723|FG000|Overall Study|Protocol Violation|0|||
125190387|NCT02356588|450318724|FG001|Overall Study|Protocol Violation|1|||
125190388|NCT03150719|450318727|FG000|Overall Study|Adverse Event|0|||
125190389|NCT03150719|450318728|FG001|Overall Study|Adverse Event|1|||
125190390|NCT03150719|450318727|FG000|Overall Study|Death|0|||
125190391|NCT03150719|450318728|FG001|Overall Study|Death|1|||
125190392|NCT03150719|450318727|FG000|Overall Study|Other|1|||
125190393|NCT03150719|450318728|FG001|Overall Study|Other|0|||
125190394|NCT01790984|450318729|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
125190395|NCT01790984|450318730|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
125190396|NCT01790984|450318731|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
125190397|NCT01790984|450318732|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
125190398|NCT01346696|450318734|FG000|Overall Study|Death|1|||
125190399|NCT00105079|450318736|FG000|Overall Study|Adverse Event|5|||
125190400|NCT00105079|450318737|FG001|Overall Study|Adverse Event|12|||
125190401|NCT00105079|450318736|FG000|Overall Study|Death|3|||
125190402|NCT00105079|450318737|FG001|Overall Study|Death|1|||
125190403|NCT00105079|450318736|FG000|Overall Study|Lost to Follow-up|12|||
125190404|NCT00105079|450318737|FG001|Overall Study|Lost to Follow-up|12|||
125190405|NCT00105079|450318736|FG000|Overall Study|Lack of Efficacy|9|||
125190406|NCT00105079|450318737|FG001|Overall Study|Lack of Efficacy|3|||
125190407|NCT00105079|450318736|FG000|Overall Study|Refused treatment|6|||
125190408|NCT00105079|450318737|FG001|Overall Study|Refused treatment|4|||
125190409|NCT00105079|450318736|FG000|Overall Study|Violation of selection criteria at entry|0|||
125190410|NCT00105079|450318737|FG001|Overall Study|Violation of selection criteria at entry|2|||
125190411|NCT00105079|450318736|FG000|Overall Study|Protocol Violation|1|||
125190412|NCT00105079|450318737|FG001|Overall Study|Protocol Violation|0|||
125190413|NCT00105079|450318736|FG000|Overall Study|Other|3|||
125190414|NCT00105079|450318737|FG001|Overall Study|Other|1|||
125190415|NCT01609296|450318743|FG000|Overall Study|Death|253|||
125190416|NCT01609296|450318743|FG000|Overall Study|Withdrawal by Subject|151|||
125190417|NCT01609296|450318743|FG000|Overall Study|Lost to Follow-up|21|||
125190418|NCT01609296|450318743|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
125190419|NCT01609296|450318743|FG000|Overall Study|missed visit but known to be alive|28|||
125190420|NCT00386360|450318744|FG000|Overall Study|Adverse Event|4|||
125190421|NCT00386360|450318745|FG001|Overall Study|Adverse Event|2|||
125190422|NCT00386360|450318744|FG000|Overall Study|Physician Decision|2|||
125190423|NCT00386360|450318745|FG001|Overall Study|Physician Decision|2|||
125244014|NCT00541229|450518427|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
125244015|NCT00541229|450518422|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
125244016|NCT00541229|450518423|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
125244017|NCT00541229|450518424|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
125244018|NCT00541229|450518425|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
125244019|NCT00541229|450518426|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
125244020|NCT00541229|450518427|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
125244021|NCT00541229|450518422|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
125244022|NCT00541229|450518423|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
125244023|NCT00541229|450518424|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
125244024|NCT00541229|450518425|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
125244025|NCT00541229|450518426|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
125244026|NCT00541229|450518427|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
125244027|NCT00541229|450518422|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
125244028|NCT00541229|450518423|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
125244029|NCT00541229|450518424|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
125244030|NCT00541229|450518425|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
125244031|NCT00541229|450518426|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
125244032|NCT00541229|450518427|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
125244033|NCT00541229|450518422|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
125244034|NCT00541229|450518423|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
125244035|NCT00541229|450518424|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
125244036|NCT00541229|450518425|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
125244037|NCT00541229|450518426|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
125244038|NCT00541229|450518427|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
125244039|NCT01807520|450518428|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
125244040|NCT01807520|450518429|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
125244041|NCT01807520|450518430|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
125244042|NCT01807520|450518431|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
125244043|NCT01807520|450518432|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
125244044|NCT01807520|450518433|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
125244045|NCT01807520|450518434|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
125244046|NCT01807520|450518428|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
125244047|NCT01807520|450518429|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
125244048|NCT01807520|450518430|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
125244049|NCT01807520|450518431|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
125244050|NCT01807520|450518432|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
125244051|NCT01807520|450518433|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
125244052|NCT01807520|450518434|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
125244053|NCT01807520|450518428|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
125244054|NCT01807520|450518429|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
125244055|NCT01807520|450518430|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
125244056|NCT01807520|450518431|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
125244057|NCT01807520|450518432|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
125244058|NCT01807520|450518433|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
125244059|NCT01807520|450518434|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
125244060|NCT01807520|450518428|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
125244061|NCT01807520|450518429|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
125244062|NCT01807520|450518430|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
125244063|NCT01807520|450518431|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
125244064|NCT01807520|450518432|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
125244065|NCT01807520|450518433|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
125244066|NCT01807520|450518434|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
125244067|NCT01807520|450518428|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
125244068|NCT01807520|450518429|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
125244069|NCT01807520|450518430|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
125244070|NCT01807520|450518431|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
125244071|NCT01807520|450518432|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
125244072|NCT01807520|450518433|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
125244073|NCT01807520|450518434|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
125244074|NCT01807520|450518428|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
125244075|NCT01807520|450518429|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
125244076|NCT01807520|450518430|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
125244077|NCT01807520|450518431|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
125244078|NCT01807520|450518432|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
125244079|NCT01807520|450518433|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
125190424|NCT00386360|450318744|FG000|Overall Study|Lost to Follow-up|0|||
125190425|NCT00386360|450318745|FG001|Overall Study|Lost to Follow-up|2|||
125190426|NCT00386360|450318744|FG000|Overall Study|Protocol Violation|0|||
125190427|NCT00386360|450318745|FG001|Overall Study|Protocol Violation|3|||
125190428|NCT00386360|450318744|FG000|Overall Study|Withdrawal by Subject|3|||
125190429|NCT00386360|450318745|FG001|Overall Study|Withdrawal by Subject|6|||
125190430|NCT00386360|450318744|FG000|Overall Study|Did not take any study medication|0|||
125190431|NCT00386360|450318745|FG001|Overall Study|Did not take any study medication|2|||
125190432|NCT02230904|450318746|FG000|Overall Study|Safety follow up could not take place|0|||
125190433|NCT02230904|450318747|FG001|Overall Study|Safety follow up could not take place|1|||
125190434|NCT01532518|450318748|FG000|Overall Study|Withdrawal by Subject|0|||
125190435|NCT01532518|450318749|FG001|Overall Study|Withdrawal by Subject|0|||
125190436|NCT01532518|450318750|FG002|Overall Study|Withdrawal by Subject|1|||
125190437|NCT02155283|450318754|FG000|Overall Study|Lost to Follow-up|3|||
125190438|NCT02155283|450318754|FG000|Overall Study|Withdrawal by Subject|1|||
125190439|NCT02155283|450318754|FG000|Overall Study|Protocol Violation|3|||
125190440|NCT00463047|450318758|FG000|Titration Period 1|Adverse Event|10|||
125190441|NCT00463047|450318759|FG001|Titration Period 1|Adverse Event|8|||
125190442|NCT00463047|450318758|FG000|Titration Period 1|Lack of Efficacy|10|||
125190443|NCT00463047|450318759|FG001|Titration Period 1|Lack of Efficacy|4|||
125190444|NCT00463047|450318758|FG000|Titration Period 1|Lost to Follow-up|2|||
125190445|NCT00463047|450318759|FG001|Titration Period 1|Lost to Follow-up|0|||
125190446|NCT00463047|450318758|FG000|Titration Period 1|Non-compliance with study medication|3|||
125190447|NCT00463047|450318759|FG001|Titration Period 1|Non-compliance with study medication|5|||
125190448|NCT00463047|450318758|FG000|Titration Period 1|Protocol Violation|5|||
125190449|NCT00463047|450318759|FG001|Titration Period 1|Protocol Violation|5|||
125190450|NCT00463047|450318758|FG000|Titration Period 1|Withdrawal by Subject|3|||
125190451|NCT00463047|450318759|FG001|Titration Period 1|Withdrawal by Subject|5|||
125190452|NCT00463047|450318758|FG000|Titration Period 1|Non-compliance procedures|4|||
125190453|NCT00463047|450318759|FG001|Titration Period 1|Non-compliance procedures|10|||
125190454|NCT00463047|450318758|FG000|Titration Period 1|Other|0|||
125190455|NCT00463047|450318759|FG001|Titration Period 1|Other|2|||
125190456|NCT00463047|450318758|FG000|Titration Period 2|Adverse Event|9|||
125190457|NCT00463047|450318759|FG001|Titration Period 2|Adverse Event|9|||
125190458|NCT00463047|450318758|FG000|Titration Period 2|Lack of Efficacy|6|||
125190459|NCT00463047|450318759|FG001|Titration Period 2|Lack of Efficacy|4|||
125190460|NCT00463047|450318758|FG000|Titration Period 2|Withdrawal by Subject|1|||
125190461|NCT00463047|450318759|FG001|Titration Period 2|Withdrawal by Subject|0|||
125190462|NCT00463047|450318758|FG000|Titration Period 2|Protocol Violation|2|||
125190463|NCT00463047|450318759|FG001|Titration Period 2|Protocol Violation|3|||
125190464|NCT00463047|450318758|FG000|Titration Period 2|Lost to Follow-up|1|||
125190465|NCT00463047|450318759|FG001|Titration Period 2|Lost to Follow-up|2|||
125190466|NCT00463047|450318758|FG000|Titration Period 2|Non-compliance study medication|4|||
125190467|NCT00463047|450318759|FG001|Titration Period 2|Non-compliance study medication|2|||
125190468|NCT00463047|450318758|FG000|Titration Period 2|Non-compliance procedures|4|||
125190469|NCT00463047|450318759|FG001|Titration Period 2|Non-compliance procedures|1|||
125190470|NCT00463047|450318758|FG000|Titration Period 2|Other|3|||
125190471|NCT00463047|450318759|FG001|Titration Period 2|Other|2|||
125190472|NCT00463047|450318758|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
125190473|NCT00463047|450318759|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
125190474|NCT00463047|450318758|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
125190475|NCT00463047|450318759|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
125190476|NCT00463047|450318758|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
125190477|NCT00463047|450318759|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
125190478|NCT00463047|450318758|FG000|Double-Blind Treatment Period 1|Other|1|||
125190479|NCT00463047|450318759|FG001|Double-Blind Treatment Period 1|Other|0|||
125190480|NCT00463047|450318758|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
125190481|NCT00463047|450318759|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
125190482|NCT00463047|450318758|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
125190483|NCT00463047|450318759|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
125190484|NCT00463047|450318758|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
125190485|NCT00463047|450318759|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
125190486|NCT03020992|450318765|FG000|Overall Study|Adverse Event|5|||
125190487|NCT03020992|450318765|FG000|Overall Study|Withdrawal by Subject|1|||
125190488|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
125190489|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
125190490|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
125190491|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
125190492|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Pregnancy|0|||
125190493|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Pregnancy|1|||
125190494|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
125190495|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
125244080|NCT01807520|450518434|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
125244081|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
125244082|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
125244083|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
125244084|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
125244085|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
125244086|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
125244087|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
125244088|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
125244089|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
125244090|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
125244091|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
125244092|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
125244093|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
125244094|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
125244095|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
125244096|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
125244097|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
125244098|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
125244099|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
125244100|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
125244101|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
125244102|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
125190496|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
125190497|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
125190498|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
125190499|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
125190500|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Other|3|||
125190501|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Other|0|||
125190502|NCT01006122|450318766|FG000|First Double-blind Intervention Period|Adverse Event|0|||
125190503|NCT01006122|450318767|FG001|First Double-blind Intervention Period|Adverse Event|4|||
125190504|NCT01006122|450318766|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
125190505|NCT01006122|450318767|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
125190506|NCT01006122|450318766|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
125190507|NCT01006122|450318767|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
125190508|NCT01006122|450318766|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
125190509|NCT01006122|450318767|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
125190510|NCT01006122|450318766|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
125190511|NCT01006122|450318767|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
125190512|NCT01006122|450318766|FG000|Second Double-blind Intervention Period|Death|0|||
125190513|NCT01006122|450318767|FG001|Second Double-blind Intervention Period|Death|1|||
125190514|NCT00529308|450318772|FG000|Overall Study|Withdrawal by Subject|1|||
125190515|NCT00529308|450318773|FG001|Overall Study|Withdrawal by Subject|1|||
125190516|NCT03926117|450318784|FG000|Overall Study|Unclassified|1|||
125190517|NCT03926117|450318785|FG001|Overall Study|Unclassified|4|||
125190518|NCT03926117|450318786|FG002|Overall Study|Unclassified|1|||
125190519|NCT03926117|450318787|FG003|Overall Study|Unclassified|4|||
125190520|NCT03926117|450318784|FG000|Overall Study|Withdrawal by Subject|3|||
125190521|NCT03926117|450318785|FG001|Overall Study|Withdrawal by Subject|0|||
125190522|NCT03926117|450318786|FG002|Overall Study|Withdrawal by Subject|1|||
125190523|NCT03926117|450318787|FG003|Overall Study|Withdrawal by Subject|1|||
125190524|NCT03926117|450318784|FG000|Overall Study|Lost to Follow-up|0|||
125190525|NCT03926117|450318785|FG001|Overall Study|Lost to Follow-up|2|||
125190526|NCT03926117|450318786|FG002|Overall Study|Lost to Follow-up|1|||
125190527|NCT03926117|450318787|FG003|Overall Study|Lost to Follow-up|0|||
125190528|NCT03926117|450318784|FG000|Overall Study|Adverse Event|1|||
125190529|NCT03926117|450318785|FG001|Overall Study|Adverse Event|2|||
125190530|NCT03926117|450318786|FG002|Overall Study|Adverse Event|3|||
125190531|NCT03926117|450318787|FG003|Overall Study|Adverse Event|1|||
125190532|NCT03926117|450318784|FG000|Overall Study|Randomized but not treated|1|||
125190533|NCT03926117|450318785|FG001|Overall Study|Randomized but not treated|1|||
125244103|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
125244104|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
125244105|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
125190534|NCT03926117|450318786|FG002|Overall Study|Randomized but not treated|0|||
125190535|NCT03926117|450318787|FG003|Overall Study|Randomized but not treated|1|||
125190536|NCT02554682|450318788|FG000|Overall Study|Lost to Follow-up|11|||
125244106|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
125244107|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
125190537|NCT02554682|450318789|FG001|Overall Study|Lost to Follow-up|9|||
125190538|NCT02554682|450318790|FG002|Overall Study|Lost to Follow-up|4|||
125190539|NCT02554682|450318791|FG003|Overall Study|Lost to Follow-up|3|||
125190540|NCT02554682|450318792|FG004|Overall Study|Lost to Follow-up|2|||
125190541|NCT02554682|450318793|FG005|Overall Study|Lost to Follow-up|1|||
125190542|NCT02554682|450318794|FG006|Overall Study|Lost to Follow-up|6|||
125190543|NCT02554682|450318795|FG007|Overall Study|Lost to Follow-up|6|||
125190544|NCT02554682|450318796|FG008|Overall Study|Lost to Follow-up|2|||
125190545|NCT02554682|450318797|FG009|Overall Study|Lost to Follow-up|2|||
125190546|NCT02554682|450318788|FG000|Overall Study|Withdrawal by Subject|2|||
125190547|NCT02554682|450318789|FG001|Overall Study|Withdrawal by Subject|1|||
125190548|NCT02554682|450318790|FG002|Overall Study|Withdrawal by Subject|0|||
125190549|NCT02554682|450318791|FG003|Overall Study|Withdrawal by Subject|0|||
125190550|NCT02554682|450318792|FG004|Overall Study|Withdrawal by Subject|0|||
125190551|NCT02554682|450318793|FG005|Overall Study|Withdrawal by Subject|0|||
125190552|NCT02554682|450318794|FG006|Overall Study|Withdrawal by Subject|0|||
125190553|NCT02554682|450318795|FG007|Overall Study|Withdrawal by Subject|0|||
125190554|NCT02554682|450318796|FG008|Overall Study|Withdrawal by Subject|0|||
125190555|NCT02554682|450318797|FG009|Overall Study|Withdrawal by Subject|0|||
125190556|NCT02554682|450318788|FG000|Overall Study|Physician Decision|2|||
125190557|NCT02554682|450318789|FG001|Overall Study|Physician Decision|2|||
125190558|NCT02554682|450318790|FG002|Overall Study|Physician Decision|0|||
125190559|NCT02554682|450318791|FG003|Overall Study|Physician Decision|0|||
125190560|NCT02554682|450318792|FG004|Overall Study|Physician Decision|0|||
125190561|NCT02554682|450318793|FG005|Overall Study|Physician Decision|0|||
125190562|NCT02554682|450318794|FG006|Overall Study|Physician Decision|0|||
125190563|NCT02554682|450318795|FG007|Overall Study|Physician Decision|0|||
125190564|NCT02554682|450318796|FG008|Overall Study|Physician Decision|0|||
125190565|NCT02554682|450318797|FG009|Overall Study|Physician Decision|0|||
125190566|NCT04526288|450318800|FG000|Overall Study|Disease Progression|1|||
125190567|NCT04526288|450318801|FG001|Overall Study|Disease Progression|0|||
125190568|NCT00996125|450318804|FG000|Overall Study|Adverse Event|0|||
125190569|NCT00996125|450318805|FG001|Overall Study|Adverse Event|2|||
125190570|NCT00996125|450318804|FG000|Overall Study|Lost to Follow-up|1|||
125190571|NCT00996125|450318805|FG001|Overall Study|Lost to Follow-up|6|||
125190572|NCT00996125|450318804|FG000|Overall Study|Withdrawal by Subject|4|||
125190573|NCT00996125|450318805|FG001|Overall Study|Withdrawal by Subject|3|||
125190574|NCT00952068|450318806|FG000|Overall Study|Adverse Event|3|||
125190575|NCT00952068|450318806|FG000|Overall Study|Withdrawal by Subject|4|||
125190576|NCT00708461|450318813|FG000|Overall Study|Lost to Follow-up|18|||
125190577|NCT00708461|450318814|FG001|Overall Study|Lost to Follow-up|11|||
125190578|NCT00708461|450318813|FG000|Overall Study|Withdrawal by Subject|8|||
125190579|NCT00708461|450318814|FG001|Overall Study|Withdrawal by Subject|9|||
125190580|NCT00708461|450318813|FG000|Overall Study|left workforce|115|||
125190581|NCT00708461|450318814|FG001|Overall Study|left workforce|180|||
125190582|NCT02630251|450318817|FG000|Overall Study|Physician Decision|0|||
125190583|NCT02630251|450318818|FG001|Overall Study|Physician Decision|0|||
125190584|NCT02630251|450318819|FG002|Overall Study|Physician Decision|1|||
125190585|NCT02630251|450318820|FG003|Overall Study|Physician Decision|0|||
125190586|NCT01796392|450318823|FG000|Overall Study|Withdrawal by Subject|2|||
125190587|NCT01796392|450318824|FG001|Overall Study|Withdrawal by Subject|0|||
125190588|NCT01796392|450318823|FG000|Overall Study|Death|5|||
125190589|NCT01796392|450318824|FG001|Overall Study|Death|1|||
125190590|NCT01796392|450318823|FG000|Overall Study|Excluded for medical reasons|1|||
125190591|NCT01796392|450318824|FG001|Overall Study|Excluded for medical reasons|2|||
125190592|NCT01796392|450318823|FG000|Overall Study|Lost to Follow-up|1|||
125190593|NCT01796392|450318824|FG001|Overall Study|Lost to Follow-up|0|||
125190594|NCT03517540|450318831|FG000|Overall Study|Protocol Violation|2|||
125190595|NCT03517540|450318832|FG001|Overall Study|Protocol Violation|0|||
125190596|NCT03517540|450318833|FG002|Overall Study|Protocol Violation|0|||
125190597|NCT03517540|450318834|FG003|Overall Study|Protocol Violation|1|||
125190598|NCT03517540|450318831|FG000|Overall Study|Adverse Event|9|||
125190599|NCT03517540|450318832|FG001|Overall Study|Adverse Event|3|||
125190600|NCT03517540|450318833|FG002|Overall Study|Adverse Event|8|||
125190601|NCT03517540|450318834|FG003|Overall Study|Adverse Event|1|||
125190602|NCT03517540|450318831|FG000|Overall Study|Withdrawal by Subject|3|||
125190603|NCT03517540|450318832|FG001|Overall Study|Withdrawal by Subject|4|||
125190604|NCT03517540|450318833|FG002|Overall Study|Withdrawal by Subject|1|||
125190605|NCT03517540|450318834|FG003|Overall Study|Withdrawal by Subject|3|||
125190606|NCT03668119|450320607|FG000|Pre-treatment|Disease Progression|1|||
125190607|NCT03668119|450320608|FG001|Pre-treatment|Disease Progression|0|||
125190608|NCT03668119|450320607|FG000|Treatment|Disease Progression|76|||
125190609|NCT03668119|450320608|FG001|Treatment|Disease Progression|57|||
125190610|NCT03668119|450320607|FG000|Treatment|Study drug toxicity|19|||
125190611|NCT03668119|450320608|FG001|Treatment|Study drug toxicity|1|||
125190612|NCT03668119|450320607|FG000|Treatment|Death|3|||
125190613|NCT03668119|450320608|FG001|Treatment|Death|0|||
125190614|NCT03668119|450320607|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
125190615|NCT03668119|450320608|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
125393611|NCT00262067|451074135|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
125393612|NCT00262067|451074136|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
125393613|NCT00262067|451074133|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
125393614|NCT00262067|451074134|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
125393615|NCT00262067|451074135|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
125393616|NCT00262067|451074136|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
125393617|NCT00655564|451074137|FG000|Overall Study|Adverse Event|1|||
125393618|NCT00655564|451074137|FG000|Overall Study|Lost to Follow-up|1|||
125393619|NCT00655564|451074137|FG000|Overall Study|Desired Alternate Therapy|1|||
125393620|NCT04536727|451074138|FG000|Overall Study|Lost to Follow-up|1|||
125393621|NCT04536727|451074139|FG001|Overall Study|Lost to Follow-up|1|||
125393622|NCT04536727|451074138|FG000|Overall Study|Death|0|||
125393623|NCT04536727|451074139|FG001|Overall Study|Death|1|||
125393624|NCT01077804|451074140|FG000|Overall Study|Unreachable|102|||
125393625|NCT01077804|451074140|FG000|Overall Study|Refused to continue|79|||
125393626|NCT01077804|451074140|FG000|Overall Study|Other|18|||
125393627|NCT00256698|451074141|FG000|Overall Study|Withdrawal by Subject|7|||
125393628|NCT00256698|451074142|FG001|Overall Study|Withdrawal by Subject|7|||
125393629|NCT00256698|451074141|FG000|Overall Study|Adverse Event|13|||
125393630|NCT00256698|451074142|FG001|Overall Study|Adverse Event|6|||
125393631|NCT00256698|451074141|FG000|Overall Study|Protocol Violation|6|||
125393632|NCT00256698|451074142|FG001|Overall Study|Protocol Violation|5|||
125393633|NCT00256698|451074141|FG000|Overall Study|Lost to Follow-up|1|||
125393634|NCT00256698|451074142|FG001|Overall Study|Lost to Follow-up|3|||
125393635|NCT00256698|451074141|FG000|Overall Study|disease progression|97|||
125244108|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
125244109|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
125244110|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
125244111|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
125244112|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
125244113|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
125244114|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
125244115|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
125244116|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
125244117|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
125244118|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
125244119|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
125244120|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
125244121|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
125244122|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
125244123|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
125244124|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
125244125|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
125244126|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
125244127|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
125244128|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
125244129|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
125244130|NCT01807520|450518428|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
125244131|NCT01807520|450518429|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
125244132|NCT01807520|450518430|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
125244133|NCT01807520|450518431|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
125393636|NCT00256698|451074142|FG001|Overall Study|disease progression|105|||
125393637|NCT00256698|451074141|FG000|Overall Study|still ongoing at data cut-off|41|||
125393638|NCT00256698|451074142|FG001|Overall Study|still ongoing at data cut-off|46|||
125393639|NCT00256698|451074141|FG000|Overall Study|withdrawn due to osteoporosis|1|||
125393640|NCT00256698|451074142|FG001|Overall Study|withdrawn due to osteoporosis|0|||
125393641|NCT00256698|451074141|FG000|Overall Study|Prematurely Discontinued|1|||
125393642|NCT00256698|451074142|FG001|Overall Study|Prematurely Discontinued|0|||
125393643|NCT02620046|451074144|FG000|Overall Study|Adverse Event|22|||
125393644|NCT02620046|451074145|FG001|Overall Study|Adverse Event|42|||
125244134|NCT01807520|450518432|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
125244135|NCT01807520|450518433|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
125393645|NCT02620046|451074144|FG000|Overall Study|Lost to Follow-up|4|||
125393646|NCT02620046|451074145|FG001|Overall Study|Lost to Follow-up|10|||
125393647|NCT02620046|451074144|FG000|Overall Study|Withdrawal by Subject|36|||
125393648|NCT02620046|451074145|FG001|Overall Study|Withdrawal by Subject|66|||
125393649|NCT02620046|451074144|FG000|Overall Study|Site Termination|3|||
125393650|NCT02620046|451074145|FG001|Overall Study|Site Termination|3|||
125393651|NCT02620046|451074144|FG000|Overall Study|Pregnancy|3|||
125393652|NCT02620046|451074145|FG001|Overall Study|Pregnancy|7|||
125393653|NCT02620046|451074144|FG000|Overall Study|Lack of Efficacy|81|||
125244136|NCT01807520|450518434|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
125190616|NCT03668119|450320607|FG000|Treatment|Withdrawal by Subject|1|||
125190617|NCT03668119|450320608|FG001|Treatment|Withdrawal by Subject|1|||
125190618|NCT03668119|450320607|FG000|Treatment|Participant request to discontinue study treatment|3|||
125190619|NCT03668119|450320608|FG001|Treatment|Participant request to discontinue study treatment|1|||
125190620|NCT03668119|450320607|FG000|Treatment|Maximum Clinical Benefit|0|||
125190621|NCT03668119|450320608|FG001|Treatment|Maximum Clinical Benefit|1|||
125190622|NCT03668119|450320607|FG000|Treatment|Participants completed treatment|27|||
125190623|NCT03668119|450320608|FG001|Treatment|Participants completed treatment|11|||
125190624|NCT03668119|450320607|FG000|Treatment|Other reasons|2|||
125190625|NCT03668119|450320608|FG001|Treatment|Other reasons|1|||
125190626|NCT05336227|450320609|FG000|Overall Study|Adverse Event|1|||
125190627|NCT05336227|450320610|FG001|Overall Study|Adverse Event|0|||
125190628|NCT05336227|450320609|FG000|Overall Study|Lost to Follow-up|2|||
125190629|NCT05336227|450320610|FG001|Overall Study|Lost to Follow-up|0|||
125190630|NCT05336227|450320609|FG000|Overall Study|Withdrawal by Subject|1|||
125190631|NCT05336227|450320610|FG001|Overall Study|Withdrawal by Subject|0|||
125244137|NCT01807520|450518428|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
125244138|NCT01807520|450518429|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
125244139|NCT01807520|450518430|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
125244140|NCT01807520|450518431|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
125244141|NCT01807520|450518432|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
125244142|NCT01807520|450518433|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
125244143|NCT01807520|450518434|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
125244144|NCT01807520|450518428|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
125244145|NCT01807520|450518429|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
125244146|NCT01807520|450518430|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
125244147|NCT01807520|450518431|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
125244148|NCT01807520|450518432|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
125244149|NCT01807520|450518433|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
125244150|NCT01807520|450518434|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
125244151|NCT01807520|450518428|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
125244152|NCT01807520|450518429|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
125244153|NCT01807520|450518430|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
125244154|NCT01807520|450518431|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
125244155|NCT01807520|450518432|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
125244156|NCT01807520|450518433|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
125244157|NCT01807520|450518434|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
125393654|NCT02620046|451074145|FG001|Overall Study|Lack of Efficacy|146|||
125393655|NCT02620046|451074144|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
125393656|NCT02620046|451074145|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
125393657|NCT02620046|451074144|FG000|Overall Study|Reason Not Specified|13|||
125393658|NCT02620046|451074145|FG001|Overall Study|Reason Not Specified|21|||
125393659|NCT02620046|451074144|FG000|Overall Study|Significant Protocol Deviation|0|||
125393660|NCT02620046|451074145|FG001|Overall Study|Significant Protocol Deviation|1|||
125393661|NCT03962543|451074147|FG000|Treatment Phase|Death|0|||
125393662|NCT03962543|451074148|FG001|Treatment Phase|Death|1|||
125393663|NCT03962543|451074147|FG000|Treatment Phase|Withdrawal by Subject|3|||
125393664|NCT03962543|451074148|FG001|Treatment Phase|Withdrawal by Subject|0|||
125393665|NCT03962543|451074147|FG000|Treatment Phase|Adverse Event|3|||
125393666|NCT03962543|451074148|FG001|Treatment Phase|Adverse Event|12|||
125393667|NCT03962543|451074147|FG000|Treatment Phase|Lost to Follow-up|1|||
125393668|NCT03962543|451074148|FG001|Treatment Phase|Lost to Follow-up|2|||
125190632|NCT01068678|450320613|FG000|Overall Study|Lack of Efficacy|3|||
125190633|NCT01068678|450320614|FG001|Overall Study|Lack of Efficacy|2|||
125190634|NCT01068678|450320613|FG000|Overall Study|Protocol Violation|5|||
125190635|NCT01068678|450320614|FG001|Overall Study|Protocol Violation|1|||
125190636|NCT01068678|450320613|FG000|Overall Study|Withdrawal criteria|12|||
125190637|NCT01068678|450320614|FG001|Overall Study|Withdrawal criteria|6|||
125244158|NCT01500096|450518435|FG000|Overall Study|Lost to Follow-up|1|||
125244159|NCT01500096|450518436|FG001|Overall Study|Lost to Follow-up|0|||
125244160|NCT01500096|450518437|FG002|Overall Study|Lost to Follow-up|0|||
125244161|NCT01500096|450518438|FG003|Overall Study|Lost to Follow-up|2|||
125244162|NCT01797185|450518439|FG000|Overall Study|Adverse Event|5|||
125393669|NCT03962543|451074147|FG000|Treatment Phase|Radiographic PD|9|||
125393670|NCT03962543|451074148|FG001|Treatment Phase|Radiographic PD|3|||
125190638|NCT01068678|450320613|FG000|Overall Study|Unclassified|18|||
125190639|NCT01068678|450320614|FG001|Overall Study|Unclassified|15|||
125190640|NCT00347958|450320615|FG000|Overall Study|Adverse Event|1|||
125393671|NCT03962543|451074147|FG000|Treatment Phase|Participant Decision|3|||
125393672|NCT03962543|451074148|FG001|Treatment Phase|Participant Decision|8|||
125393673|NCT03962543|451074147|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
125244163|NCT01797185|450518440|FG001|Overall Study|Adverse Event|15|||
125244164|NCT01797185|450518441|FG002|Overall Study|Adverse Event|6|||
125244165|NCT01797185|450518439|FG000|Overall Study|Withdrawal by Subject|6|||
125244166|NCT01797185|450518440|FG001|Overall Study|Withdrawal by Subject|9|||
125190641|NCT00347958|450320615|FG000|Overall Study|Protocol Violation|2|||
125190642|NCT00347958|450320615|FG000|Overall Study|Withdrawal by Subject|1|||
125190643|NCT00754234|450320616|FG000|Overall Study|Withdrawal by Subject|3|||
125190644|NCT03055338|450320617|FG000|Overall Study|Lost to Follow-up|9|||
125190645|NCT03055338|450320618|FG001|Overall Study|Lost to Follow-up|2|||
125190646|NCT03055338|450320619|FG002|Overall Study|Lost to Follow-up|3|||
125190647|NCT03055338|450320617|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
125190648|NCT03055338|450320618|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
125190649|NCT03055338|450320619|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
125190650|NCT03055338|450320617|FG000|Overall Study|Physician Decision|0|||
125190651|NCT03055338|450320618|FG001|Overall Study|Physician Decision|0|||
125190652|NCT03055338|450320619|FG002|Overall Study|Physician Decision|2|||
125190653|NCT03055338|450320617|FG000|Overall Study|Withdrawal by Subject|9|||
125190654|NCT03055338|450320618|FG001|Overall Study|Withdrawal by Subject|8|||
125190655|NCT03055338|450320619|FG002|Overall Study|Withdrawal by Subject|7|||
125190656|NCT00975611|450320620|FG000|Overall Study|Screen Fail|16|||
125190657|NCT00975611|450320620|FG000|Overall Study|Physician Decision|1|||
125190658|NCT03058705|450320621|FG000|Overall Study|Withdrawal by Subject|2|||
125190659|NCT03058705|450320621|FG000|Overall Study|Physician Decision|2|||
125190660|NCT01682226|450320622|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
125190661|NCT01682226|450320622|FG000|Overall Study|Participants did not receive treatment|2|||
125190662|NCT01682226|450320622|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
125190663|NCT02151851|450320623|FG000|Overall Study|Lack of Efficacy|67|||
125393674|NCT03962543|451074148|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
125393675|NCT03962543|451074147|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
125393676|NCT03962543|451074148|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
125393677|NCT03962543|451074147|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
125393678|NCT03962543|451074148|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
125393679|NCT03962543|451074147|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
125393680|NCT03962543|451074148|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
125393681|NCT03962543|451074147|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
125393682|NCT03962543|451074148|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
125393683|NCT03962543|451074147|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
125393684|NCT03962543|451074148|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
125393685|NCT03962543|451074147|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
125393686|NCT03962543|451074148|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
125393687|NCT03962543|451074147|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
125393688|NCT03962543|451074148|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
125393689|NCT03962543|451074147|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
125393690|NCT03962543|451074148|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
125393691|NCT03962543|451074147|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
125393692|NCT03962543|451074148|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
125393693|NCT00560950|451074149|FG000|Overall Study|Lost to Follow-up|1|||
125393694|NCT00560950|451074150|FG001|Overall Study|Lost to Follow-up|0|||
125190664|NCT02151851|450320624|FG001|Overall Study|Lack of Efficacy|94|||
125190665|NCT02151851|450320623|FG000|Overall Study|Protocol Violation|0|||
125190666|NCT02151851|450320624|FG001|Overall Study|Protocol Violation|1|||
125190667|NCT02151851|450320623|FG000|Overall Study|Withdrawal by Subject|2|||
125190668|NCT02151851|450320624|FG001|Overall Study|Withdrawal by Subject|5|||
125190669|NCT02151851|450320623|FG000|Overall Study|Medical impairment|1|||
125190670|NCT02151851|450320624|FG001|Overall Study|Medical impairment|0|||
125190671|NCT02151851|450320623|FG000|Overall Study|Low compliance to study visits|0|||
125190672|NCT02151851|450320624|FG001|Overall Study|Low compliance to study visits|1|||
125190673|NCT02151851|450320623|FG000|Overall Study|Subject entered into study in error|0|||
125393695|NCT03264404|451075754|FG000|Overall Study|Death|2|||
125190674|NCT02151851|450320624|FG001|Overall Study|Subject entered into study in error|1|||
125190675|NCT02151851|450320623|FG000|Overall Study|Adverse Event|6|||
125190676|NCT02151851|450320624|FG001|Overall Study|Adverse Event|28|||
125190677|NCT02159053|450320625|FG000|Overall Study|Death|2|||
125190678|NCT02159053|450320626|FG001|Overall Study|Death|0|||
125190679|NCT02159053|450320627|FG002|Overall Study|Death|1|||
125190680|NCT02159053|450320625|FG000|Overall Study|Physician Decision|0|||
125190681|NCT02159053|450320626|FG001|Overall Study|Physician Decision|1|||
125190682|NCT02159053|450320627|FG002|Overall Study|Physician Decision|1|||
125190683|NCT02159053|450320625|FG000|Overall Study|Lack of Efficacy|3|||
125190684|NCT02159053|450320626|FG001|Overall Study|Lack of Efficacy|4|||
125190685|NCT02159053|450320627|FG002|Overall Study|Lack of Efficacy|7|||
125190686|NCT02159053|450320625|FG000|Overall Study|Adverse Event|7|||
125190687|NCT02159053|450320626|FG001|Overall Study|Adverse Event|6|||
125393696|NCT03264404|451075754|FG000|Overall Study|Physician Decision|1|||
125393697|NCT03264404|451075754|FG000|Overall Study|Disease Progression|28|||
125393698|NCT03264404|451075754|FG000|Overall Study|Adverse Event|1|||
125393699|NCT03264404|451075754|FG000|Overall Study|Off study prior to treatment|2|||
125190688|NCT02159053|450320627|FG002|Overall Study|Adverse Event|5|||
125190689|NCT02159053|450320625|FG000|Overall Study|Participants/guardian decision|8|||
125393700|NCT03036566|451075755|FG000|Overall Study|Lost to Follow-up|3|||
125393701|NCT01914666|451075759|FG000|Treatment Period|Lack of Efficacy|0|||
125190690|NCT02159053|450320626|FG001|Overall Study|Participants/guardian decision|10|||
125190691|NCT02159053|450320627|FG002|Overall Study|Participants/guardian decision|6|||
125190692|NCT03503370|450320634|FG000|Overall Study|Death|3|||
125190693|NCT03503370|450320635|FG001|Overall Study|Death|1|||
125190694|NCT00298272|450320640|FG000|Double-blind Phase|Adverse Event|2|||
125190695|NCT00298272|450320641|FG001|Double-blind Phase|Adverse Event|0|||
125190696|NCT00298272|450320640|FG000|Double-blind Phase|Failure to Return|2|||
125190697|NCT00298272|450320641|FG001|Double-blind Phase|Failure to Return|0|||
125190698|NCT00298272|450320640|FG000|Double-blind Phase|Protocol Violation|2|||
125190699|NCT00298272|450320641|FG001|Double-blind Phase|Protocol Violation|0|||
125190700|NCT00298272|450320640|FG000|Double-blind Phase|Withdrawal by Subject|2|||
125190701|NCT00298272|450320641|FG001|Double-blind Phase|Withdrawal by Subject|0|||
125190702|NCT00298272|450320640|FG000|Open Label Retreatment Phase|Adverse Event|1|||
125190703|NCT00298272|450320641|FG001|Open Label Retreatment Phase|Adverse Event|2|||
125190704|NCT00298272|450320640|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
125190705|NCT00298272|450320641|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
125190706|NCT00298272|450320640|FG000|Open Label Retreatment Phase|Failure to Return|1|||
125190707|NCT00298272|450320641|FG001|Open Label Retreatment Phase|Failure to Return|0|||
125190708|NCT00298272|450320640|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
125190709|NCT00298272|450320641|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
125190710|NCT00298272|450320640|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
125190711|NCT00298272|450320641|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
125190712|NCT00298272|450320640|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
125190713|NCT00298272|450320641|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
125190714|NCT00298272|450320640|FG000|Safety Follow-up Phase|Failure to Return|1|||
125190715|NCT00298272|450320641|FG001|Safety Follow-up Phase|Failure to Return|1|||
125190716|NCT00298272|450320640|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
125190717|NCT00298272|450320641|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
125190718|NCT00298272|450320640|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
125190719|NCT00298272|450320641|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
125190720|NCT04168112|450320642|FG000|Overall Study|Lost to Follow-up|1|||
125190721|NCT04168112|450320643|FG001|Overall Study|Lost to Follow-up|0|||
125190722|NCT04168112|450320642|FG000|Overall Study|Withdrawal by Subject|1|||
125190723|NCT04168112|450320643|FG001|Overall Study|Withdrawal by Subject|0|||
125190724|NCT01344824|450320646|FG000|Overall Study|Adverse Event|15|||
125190725|NCT01344824|450320646|FG000|Overall Study|Withdrawal by Subject|6|||
125190726|NCT01344824|450320646|FG000|Overall Study|Other complicating disease|1|||
125190727|NCT01344824|450320646|FG000|Overall Study|Progression|15|||
125190728|NCT01436370|450320655|FG000|Overall Study|Lost to Follow-up|0|||
125190729|NCT01436370|450320656|FG001|Overall Study|Lost to Follow-up|0|||
125190730|NCT01436370|450320657|FG002|Overall Study|Lost to Follow-up|0|||
125190731|NCT01436370|450320658|FG003|Overall Study|Lost to Follow-up|0|||
125190732|NCT01436370|450320659|FG004|Overall Study|Lost to Follow-up|1|||
125190733|NCT01436370|450320660|FG005|Overall Study|Lost to Follow-up|0|||
125190734|NCT01436370|450320661|FG006|Overall Study|Lost to Follow-up|0|||
125190735|NCT01436370|450320662|FG007|Overall Study|Lost to Follow-up|0|||
125190736|NCT02395848|450320663|FG000|Overall Study|Lost to Follow-up|2|||
125190737|NCT01754129|450320664|FG000|Overall Study|Death|13|||
125190738|NCT01754129|450320664|FG000|Overall Study|Duodopa discontinuation|9|||
125190739|NCT01754129|450320664|FG000|Overall Study|Lost to Follow-up|7|||
125190740|NCT01754129|450320664|FG000|Overall Study|Withdrew consent|1|||
125190741|NCT01754129|450320664|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
125190742|NCT02058537|450320665|FG000|Overall Study|Withdrawal by Subject|1|||
125190743|NCT02126579|450320666|FG000|Overall Study|disease progression|0|||
125190744|NCT02126579|450320667|FG001|Overall Study|disease progression|0|||
125190745|NCT02126579|450320668|FG002|Overall Study|disease progression|0|||
125190746|NCT02126579|450320669|FG003|Overall Study|disease progression|1|||
125190747|NCT02126579|450320670|FG004|Overall Study|disease progression|0|||
125190748|NCT02126579|450320671|FG005|Overall Study|disease progression|0|||
125190749|NCT02126579|450320672|FG006|Overall Study|disease progression|1|||
125190750|NCT05483686|450320676|FG000|Overall Study|Lost to Follow-up|5|||
125190751|NCT05483686|450320677|FG001|Overall Study|Lost to Follow-up|7|||
125190752|NCT03351608|450320686|FG000|Overall Study|Lost to Follow-up|0|||
125393702|NCT01914666|451075760|FG001|Treatment Period|Lack of Efficacy|0|||
125190753|NCT03351608|450320687|FG001|Overall Study|Lost to Follow-up|1|||
125190754|NCT03351608|450320688|FG002|Overall Study|Lost to Follow-up|1|||
125190755|NCT03351608|450320689|FG003|Overall Study|Lost to Follow-up|1|||
125190756|NCT03351608|450320690|FG004|Overall Study|Lost to Follow-up|1|||
125190757|NCT03351608|450320686|FG000|Overall Study|Physician Decision|1|||
125190758|NCT03351608|450320687|FG001|Overall Study|Physician Decision|0|||
125190759|NCT03351608|450320688|FG002|Overall Study|Physician Decision|0|||
125190760|NCT03351608|450320689|FG003|Overall Study|Physician Decision|2|||
125190761|NCT03351608|450320690|FG004|Overall Study|Physician Decision|1|||
125393703|NCT01914666|451075761|FG002|Treatment Period|Lack of Efficacy|2|||
125190762|NCT03351608|450320686|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
125244167|NCT01797185|450518441|FG002|Overall Study|Withdrawal by Subject|5|||
125244168|NCT01797185|450518439|FG000|Overall Study|Site terminated|8|||
125244169|NCT01797185|450518440|FG001|Overall Study|Site terminated|4|||
125244170|NCT01797185|450518441|FG002|Overall Study|Site terminated|0|||
125244171|NCT01797185|450518439|FG000|Overall Study|Lost to Follow-up|2|||
125244172|NCT01797185|450518440|FG001|Overall Study|Lost to Follow-up|6|||
125244173|NCT01797185|450518441|FG002|Overall Study|Lost to Follow-up|1|||
125244174|NCT01797185|450518439|FG000|Overall Study|Withdrawn per sponsor|5|||
125244175|NCT01797185|450518440|FG001|Overall Study|Withdrawn per sponsor|0|||
125244176|NCT01797185|450518441|FG002|Overall Study|Withdrawn per sponsor|0|||
125244177|NCT01797185|450518439|FG000|Overall Study|Physician Decision|1|||
125244178|NCT01797185|450518440|FG001|Overall Study|Physician Decision|3|||
125244179|NCT01797185|450518441|FG002|Overall Study|Physician Decision|0|||
125244180|NCT01797185|450518439|FG000|Overall Study|Protocol Violation|1|||
125244181|NCT01797185|450518440|FG001|Overall Study|Protocol Violation|1|||
125244182|NCT01797185|450518441|FG002|Overall Study|Protocol Violation|0|||
125244183|NCT03520569|450518442|FG000|Overall Study|Withdrawal by Subject|1|||
125393704|NCT01914666|451075759|FG000|Treatment Period|Adverse Event|10|||
125190763|NCT03351608|450320687|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
125190764|NCT03351608|450320688|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
125190765|NCT03351608|450320689|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
125190766|NCT03351608|450320690|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
125190767|NCT03351608|450320686|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125190768|NCT03351608|450320687|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125190769|NCT03351608|450320688|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125190770|NCT03351608|450320689|FG003|Overall Study|Withdrawal by parent/guardian|1|||
125190771|NCT03351608|450320690|FG004|Overall Study|Withdrawal by parent/guardian|0|||
125190772|NCT03351608|450320686|FG000|Overall Study|Other|0|||
125190773|NCT03351608|450320687|FG001|Overall Study|Other|1|||
125190774|NCT03351608|450320688|FG002|Overall Study|Other|1|||
125190775|NCT03351608|450320689|FG003|Overall Study|Other|3|||
125190776|NCT03351608|450320690|FG004|Overall Study|Other|0|||
125190777|NCT02877004|450320691|FG000|Overall Study|Pregnancy|0|||
125190778|NCT02877004|450320692|FG001|Overall Study|Pregnancy|0|||
125190779|NCT02877004|450320693|FG002|Overall Study|Pregnancy|1|||
125190780|NCT02727478|450320694|FG000|Overall Study|Withdrawal by Subject|8|||
125190781|NCT02727478|450320695|FG001|Overall Study|Withdrawal by Subject|10|||
125190782|NCT02633293|450320696|FG000|Overall Study|Death|56|||
125190783|NCT02633293|450320696|FG000|Overall Study|Progressive Disease|12|||
125190784|NCT02633293|450320696|FG000|Overall Study|Adverse Event|29|||
125190785|NCT02633293|450320696|FG000|Overall Study|Withdrawal by Subject|41|||
125190786|NCT02633293|450320696|FG000|Overall Study|Protocol Violation|1|||
125190787|NCT02633293|450320696|FG000|Overall Study|Lost to Follow-up|1|||
125190788|NCT02633293|450320696|FG000|Overall Study|Study Terminated by Sponsor|24|||
125190789|NCT02633293|450320696|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
125190790|NCT02633293|450320696|FG000|Overall Study|Lung Transplant|5|||
125190791|NCT02633293|450320696|FG000|Overall Study|Lack of Efficacy|2|||
125190792|NCT02633293|450320696|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
125190793|NCT03877068|450320697|FG000|Overall Study|Physician Decision|9|||
125190794|NCT03877068|450320698|FG001|Overall Study|Physician Decision|3|||
125190795|NCT00778817|450320699|FG000|Overall Study|Adverse Event|2|||
125190796|NCT00778817|450320699|FG000|Overall Study|Withdrawal by Subject|2|||
125190797|NCT01418378|450320700|FG000|Overall Study|Death|1|||
125190798|NCT01418378|450320701|FG001|Overall Study|Death|2|||
125190799|NCT01418378|450320700|FG000|Overall Study|Physician Decision|0|||
125190800|NCT01418378|450320701|FG001|Overall Study|Physician Decision|1|||
125190801|NCT01418378|450320700|FG000|Overall Study|ligament imbalance|0|||
125190802|NCT01418378|450320701|FG001|Overall Study|ligament imbalance|1|||
125190803|NCT01418378|450320700|FG000|Overall Study|developed chronic myopathy|0|||
125190804|NCT01418378|450320701|FG001|Overall Study|developed chronic myopathy|1|||
125190805|NCT01051791|450320707|FG000|Overall Study|Failed screening|3|||
125244184|NCT03418675|450518445|FG000|Overall Study|Lost to Follow-up|13|||
125244185|NCT03418675|450518446|FG001|Overall Study|Lost to Follow-up|10|||
125190806|NCT01051791|450320707|FG000|Overall Study|Withdrawal by Subject|1|||
125244186|NCT03418675|450518445|FG000|Overall Study|Adverse Event|2|||
125244187|NCT03418675|450518446|FG001|Overall Study|Adverse Event|0|||
125190807|NCT00288626|450320712|FG000|Overall Study|Death|3|||
125190808|NCT00288626|450320712|FG000|Overall Study|Withdrawal by Subject|4|||
125190809|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
125190810|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
125190811|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
125190812|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
125244188|NCT03422718|450518447|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
125244189|NCT03422718|450518448|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
125244190|NCT03422718|450518449|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
125393705|NCT01914666|451075760|FG001|Treatment Period|Adverse Event|4|||
125244191|NCT03422718|450518450|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
125244192|NCT03422718|450518451|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
125244193|NCT03422718|450518452|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
125244194|NCT03422718|450518453|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
125244195|NCT03422718|450518454|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
125244196|NCT03422718|450518447|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
125244197|NCT03422718|450518448|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
125244198|NCT03422718|450518449|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
125244199|NCT03422718|450518450|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
125244200|NCT03422718|450518451|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
125244201|NCT03422718|450518452|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
125244202|NCT03422718|450518453|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
125244203|NCT03422718|450518454|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
125244204|NCT03422718|450518447|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
125244205|NCT03422718|450518448|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
125244206|NCT03422718|450518449|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
125244207|NCT03422718|450518450|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
125244208|NCT03422718|450518451|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
125244209|NCT03422718|450518452|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
125244210|NCT03422718|450518453|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
125244211|NCT03422718|450518454|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
125244212|NCT03422718|450518447|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
125244213|NCT03422718|450518448|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
125244214|NCT03422718|450518449|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
125244215|NCT03422718|450518450|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
125244216|NCT03422718|450518451|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
125244217|NCT03422718|450518452|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
125244218|NCT03422718|450518453|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
125244219|NCT03422718|450518454|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
125244220|NCT03422718|450518447|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
125244221|NCT03422718|450518448|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
125244222|NCT03422718|450518449|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
125244223|NCT03422718|450518450|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
125244224|NCT03422718|450518451|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
125244225|NCT03422718|450518452|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
125244226|NCT03422718|450518453|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
125244227|NCT03422718|450518454|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
125244228|NCT03422718|450518447|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
125244229|NCT03422718|450518448|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
125244230|NCT03422718|450518449|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
125244231|NCT03422718|450518450|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
125244232|NCT03422718|450518451|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
125244233|NCT03422718|450518452|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
125244234|NCT03422718|450518453|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
125244235|NCT03422718|450518454|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
125244236|NCT01178411|450518455|FG000|Overall Study|Adverse Event|5|||
125244237|NCT01178411|450518455|FG000|Overall Study|Withdrawal by Subject|4|||
125244238|NCT01178411|450518455|FG000|Overall Study|Protocol Violation|1|||
125244239|NCT01178411|450518455|FG000|Overall Study|Progressive disease per RECIST|32|||
125244240|NCT01178411|450518455|FG000|Overall Study|Progressive disease per clinician|9|||
125244241|NCT01178411|450518455|FG000|Overall Study|Physician Decision|6|||
125244242|NCT01178411|450518455|FG000|Overall Study|Death|1|||
125244243|NCT01178411|450518455|FG000|Overall Study|No reason provided|1|||
125244244|NCT01178411|450518455|FG000|Overall Study|Drug manufacturing ended|1|||
125244245|NCT00421733|450518463|FG000|Overall Study|Adverse Event|4|||
125244246|NCT00421733|450518464|FG001|Overall Study|Adverse Event|9|||
125244247|NCT00421733|450518465|FG002|Overall Study|Adverse Event|2|||
125244248|NCT00421733|450518463|FG000|Overall Study|Lost to Follow-up|1|||
125244249|NCT00421733|450518464|FG001|Overall Study|Lost to Follow-up|2|||
125393706|NCT01914666|451075761|FG002|Treatment Period|Adverse Event|2|||
125393707|NCT01914666|451075759|FG000|Treatment Period|Withdrawal by Subject|3|||
125393708|NCT01914666|451075760|FG001|Treatment Period|Withdrawal by Subject|2|||
125393709|NCT01914666|451075761|FG002|Treatment Period|Withdrawal by Subject|2|||
125244250|NCT00421733|450518465|FG002|Overall Study|Lost to Follow-up|4|||
125244251|NCT00421733|450518463|FG000|Overall Study|Withdrawal by Subject|1|||
125244252|NCT00421733|450518464|FG001|Overall Study|Withdrawal by Subject|2|||
125244253|NCT00421733|450518465|FG002|Overall Study|Withdrawal by Subject|7|||
125244254|NCT00421733|450518463|FG000|Overall Study|Death|0|||
125190813|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
125190814|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
125190815|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
125190816|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
125190817|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
125190818|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
125190819|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
125190820|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
125190821|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
125190822|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
125190823|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
125190824|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
125190825|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
125190826|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
125190827|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
125190828|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
125190829|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
125190830|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
125190831|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
125190832|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
125190833|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
125190834|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
125190835|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
125190836|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
125190837|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
125190838|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
125190839|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
125190840|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
125190841|NCT00506415|450320722|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
125190842|NCT00506415|450320723|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
125190843|NCT00506415|450320724|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
125190844|NCT00506415|450320725|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
125190845|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
125190846|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
125190847|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
125190848|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
125190849|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
125190850|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
125190851|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
125190852|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
125190853|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
125190854|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
125190855|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
125190856|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
125190857|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
125190858|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
125190859|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
125190860|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
125190861|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
125190862|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
125190863|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
125190864|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
125190865|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
125190866|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
125190867|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
125190868|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
125190869|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
125190870|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
125190871|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
125190872|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
125190873|NCT00506415|450320722|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
125190874|NCT00506415|450320723|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
125190875|NCT00506415|450320724|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
125190876|NCT00506415|450320725|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
125190877|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
125190878|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
125190879|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
125190880|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
125190881|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
125190882|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
125190883|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
125190884|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
125190885|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
125190886|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
125190887|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
125190888|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
125190889|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
125190890|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
125190891|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
125190892|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
125190893|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
125190894|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
125190895|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
125190896|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
125190897|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
125190898|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
125190899|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
125190900|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
125190901|NCT00506415|450320722|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
125190902|NCT00506415|450320723|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
125190903|NCT00506415|450320724|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
125190904|NCT00506415|450320725|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
125190905|NCT04578457|450320726|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
125190906|NCT04578457|450320726|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
125190907|NCT04578457|450320726|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
125190908|NCT04578457|450320726|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
125190909|NCT02019264|450320729|FG000|Overall Study|Not treated|6|||
125190910|NCT02019264|450320730|FG001|Overall Study|Not treated|4|||
125190911|NCT02019264|450320729|FG000|Overall Study|Lost to Follow-up|50|||
125190912|NCT02019264|450320730|FG001|Overall Study|Lost to Follow-up|47|||
125190913|NCT02019264|450320729|FG000|Overall Study|Withdrawal by Subject|142|||
125190914|NCT02019264|450320730|FG001|Overall Study|Withdrawal by Subject|117|||
125190915|NCT02019264|450320729|FG000|Overall Study|Administrative reason|36|||
125190916|NCT02019264|450320730|FG001|Overall Study|Administrative reason|28|||
125190917|NCT02019264|450320729|FG000|Overall Study|Missing|14|||
125190918|NCT02019264|450320730|FG001|Overall Study|Missing|11|||
125190919|NCT02187198|450320733|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
125190920|NCT02187198|450320734|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
125190921|NCT02187198|450320733|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
125190922|NCT02187198|450320734|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
125190923|NCT00546377|450320735|FG000|Overall Study|Deemed ineligible|1|||
125190924|NCT00546377|450320735|FG000|Overall Study|Adverse Event|6|||
125190925|NCT01964222|450320736|FG000|Overall Study|Lost to Follow-up|7|||
125190926|NCT01964222|450320737|FG001|Overall Study|Lost to Follow-up|5|||
125190927|NCT01964222|450320736|FG000|Overall Study|Withdrawal by Subject|6|||
125190928|NCT01964222|450320737|FG001|Overall Study|Withdrawal by Subject|6|||
125190929|NCT01964222|450320736|FG000|Overall Study|Screening Failure|2|||
125190930|NCT01964222|450320737|FG001|Overall Study|Screening Failure|0|||
125190931|NCT01737710|450320740|FG000|Overall Study|Lost to Follow-up|0|||
125190932|NCT01737710|450320741|FG001|Overall Study|Lost to Follow-up|2|||
125190933|NCT01737710|450320742|FG002|Overall Study|Lost to Follow-up|2|||
125190934|NCT01737710|450320743|FG003|Overall Study|Lost to Follow-up|0|||
125190935|NCT01737710|450320744|FG004|Overall Study|Lost to Follow-up|0|||
125190936|NCT01737710|450320740|FG000|Overall Study|Withdrawal by Subject|1|||
125190937|NCT01737710|450320741|FG001|Overall Study|Withdrawal by Subject|1|||
125190938|NCT01737710|450320742|FG002|Overall Study|Withdrawal by Subject|1|||
125244255|NCT00421733|450518464|FG001|Overall Study|Death|3|||
125190939|NCT01737710|450320743|FG003|Overall Study|Withdrawal by Subject|0|||
125190940|NCT01737710|450320744|FG004|Overall Study|Withdrawal by Subject|0|||
125190941|NCT01737710|450320740|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
125190942|NCT01737710|450320741|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
125190943|NCT01737710|450320742|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
125190944|NCT01737710|450320743|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
125244256|NCT00421733|450518465|FG002|Overall Study|Death|0|||
125393710|NCT01914666|451075759|FG000|Treatment Period|Physician Decision|0|||
125393711|NCT01914666|451075760|FG001|Treatment Period|Physician Decision|0|||
125393712|NCT01914666|451075761|FG002|Treatment Period|Physician Decision|2|||
125393713|NCT03252522|451075762|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
125393714|NCT03252522|451075763|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
125393715|NCT03252522|451075764|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
125393716|NCT03252522|451075762|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
125393717|NCT03252522|451075763|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
125393718|NCT03252522|451075764|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
125393719|NCT03252522|451075762|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
125393720|NCT03252522|451075763|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
125393721|NCT03252522|451075764|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
125393722|NCT03252522|451075762|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
125393723|NCT03252522|451075763|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
125393724|NCT03252522|451075764|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
125393725|NCT03252522|451075762|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
125393726|NCT03252522|451075763|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
125393727|NCT03252522|451075764|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
125393728|NCT03252522|451075762|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
125393729|NCT03252522|451075763|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
125393730|NCT03252522|451075764|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
125393731|NCT03252522|451075762|FG000|Phase 2: Open Label|Adverse Event|0|||
125393732|NCT03252522|451075763|FG001|Phase 2: Open Label|Adverse Event|0|||
125393733|NCT03252522|451075764|FG002|Phase 2: Open Label|Adverse Event|2|||
125393734|NCT03252522|451075762|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
125393735|NCT03252522|451075763|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
125393736|NCT03252522|451075764|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
125393737|NCT02181556|451075765|FG000|Overall Study|Withdrawal by Subject|1|||
125393738|NCT01940120|451075766|FG000|Overall Study|Death|40|||
125190945|NCT01737710|450320744|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
125190946|NCT02677922|450320751|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
125190947|NCT02677922|450320752|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
125190948|NCT02677922|450320753|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
125190949|NCT02677922|450320754|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
125190950|NCT02677922|450320755|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
125190951|NCT02677922|450320756|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
125190952|NCT02677922|450320751|FG000|Treatment Period|Adverse Event|0|||
125190953|NCT02677922|450320752|FG001|Treatment Period|Adverse Event|0|||
125190954|NCT02677922|450320753|FG002|Treatment Period|Adverse Event|1|||
125190955|NCT02677922|450320754|FG003|Treatment Period|Adverse Event|3|||
125190956|NCT02677922|450320755|FG004|Treatment Period|Adverse Event|5|||
125190957|NCT02677922|450320756|FG005|Treatment Period|Adverse Event|2|||
125190958|NCT02677922|450320751|FG000|Treatment Period|Progressive Disease|1|||
125190959|NCT02677922|450320752|FG001|Treatment Period|Progressive Disease|1|||
125190960|NCT02677922|450320753|FG002|Treatment Period|Progressive Disease|0|||
125190961|NCT02677922|450320754|FG003|Treatment Period|Progressive Disease|0|||
125190962|NCT02677922|450320755|FG004|Treatment Period|Progressive Disease|8|||
125190963|NCT02677922|450320756|FG005|Treatment Period|Progressive Disease|7|||
125190964|NCT02677922|450320751|FG000|Treatment Period|Lack of Efficacy|0|||
125190965|NCT02677922|450320752|FG001|Treatment Period|Lack of Efficacy|0|||
125190966|NCT02677922|450320753|FG002|Treatment Period|Lack of Efficacy|0|||
125190967|NCT02677922|450320754|FG003|Treatment Period|Lack of Efficacy|1|||
125190968|NCT02677922|450320755|FG004|Treatment Period|Lack of Efficacy|1|||
125190969|NCT02677922|450320756|FG005|Treatment Period|Lack of Efficacy|6|||
125190970|NCT02677922|450320751|FG000|Treatment Period|Withdrawal by Subject|0|||
125190971|NCT02677922|450320752|FG001|Treatment Period|Withdrawal by Subject|0|||
125190972|NCT02677922|450320753|FG002|Treatment Period|Withdrawal by Subject|1|||
125190973|NCT02677922|450320754|FG003|Treatment Period|Withdrawal by Subject|3|||
125190974|NCT02677922|450320755|FG004|Treatment Period|Withdrawal by Subject|5|||
125190975|NCT02677922|450320756|FG005|Treatment Period|Withdrawal by Subject|5|||
125190976|NCT02677922|450320751|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
125190977|NCT02677922|450320752|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
125190978|NCT02677922|450320753|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
125190979|NCT02677922|450320754|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
125393739|NCT01940120|451075766|FG000|Overall Study|Withdrawal by Subject|8|||
125393740|NCT00427635|451075767|FG000|Treatment Phase|Withdrawal by Subject|1|||
125393741|NCT00427635|451075768|FG001|Treatment Phase|Withdrawal by Subject|0|||
125393742|NCT00427635|451075767|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
125393743|NCT00427635|451075768|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
125393744|NCT03277846|451075769|FG000|Overall Study|Inpatient stay too brief|12|||
125190980|NCT02677922|450320755|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
125190981|NCT02677922|450320756|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
125244257|NCT00421733|450518463|FG000|Overall Study|Required dialysis|1|||
125244258|NCT00421733|450518464|FG001|Overall Study|Required dialysis|0|||
125244259|NCT00421733|450518465|FG002|Overall Study|Required dialysis|0|||
125244260|NCT00421733|450518463|FG000|Overall Study|Administrative|2|||
125244261|NCT00421733|450518464|FG001|Overall Study|Administrative|0|||
125244262|NCT00421733|450518465|FG002|Overall Study|Administrative|0|||
125244263|NCT00421733|450518463|FG000|Overall Study|Did not satisfy entry criteria|1|||
125244264|NCT00421733|450518464|FG001|Overall Study|Did not satisfy entry criteria|3|||
125244265|NCT00421733|450518465|FG002|Overall Study|Did not satisfy entry criteria|2|||
125244266|NCT00421733|450518463|FG000|Overall Study|Sponsor request|1|||
125244267|NCT00421733|450518464|FG001|Overall Study|Sponsor request|0|||
125244268|NCT00421733|450518465|FG002|Overall Study|Sponsor request|3|||
125244269|NCT00421733|450518463|FG000|Overall Study|Protocol deviation|4|||
125244270|NCT00421733|450518464|FG001|Overall Study|Protocol deviation|7|||
125244271|NCT00421733|450518465|FG002|Overall Study|Protocol deviation|2|||
125244272|NCT02265744|450518466|FG000|Overall Study|Poor/Non-compliance|1|||
125244273|NCT02265744|450518467|FG001|Overall Study|Poor/Non-compliance|1|||
125244274|NCT02265744|450518468|FG002|Overall Study|Poor/Non-compliance|0|||
125244275|NCT02265744|450518469|FG003|Overall Study|Poor/Non-compliance|0|||
125244276|NCT02265744|450518470|FG004|Overall Study|Poor/Non-compliance|2|||
125244277|NCT02265744|450518466|FG000|Overall Study|Lost to Follow-up|0|||
125244278|NCT02265744|450518467|FG001|Overall Study|Lost to Follow-up|0|||
125244279|NCT02265744|450518468|FG002|Overall Study|Lost to Follow-up|0|||
125244280|NCT02265744|450518469|FG003|Overall Study|Lost to Follow-up|1|||
125244281|NCT02265744|450518470|FG004|Overall Study|Lost to Follow-up|0|||
125244282|NCT02265744|450518466|FG000|Overall Study|Death|0|||
125244283|NCT02265744|450518467|FG001|Overall Study|Death|0|||
125244284|NCT02265744|450518468|FG002|Overall Study|Death|0|||
125244285|NCT02265744|450518469|FG003|Overall Study|Death|2|||
125244286|NCT02265744|450518470|FG004|Overall Study|Death|0|||
125244287|NCT02265744|450518466|FG000|Overall Study|Withdrawal by Subject|2|||
125244288|NCT02265744|450518467|FG001|Overall Study|Withdrawal by Subject|0|||
125244289|NCT02265744|450518468|FG002|Overall Study|Withdrawal by Subject|0|||
125244290|NCT02265744|450518469|FG003|Overall Study|Withdrawal by Subject|2|||
125244291|NCT02265744|450518470|FG004|Overall Study|Withdrawal by Subject|0|||
125244292|NCT02265744|450518466|FG000|Overall Study|Participant request to discontinue|2|||
125244293|NCT02265744|450518467|FG001|Overall Study|Participant request to discontinue|2|||
125244294|NCT02265744|450518468|FG002|Overall Study|Participant request to discontinue|2|||
125244295|NCT02265744|450518469|FG003|Overall Study|Participant request to discontinue|0|||
125244296|NCT02265744|450518470|FG004|Overall Study|Participant request to discontinue|0|||
125244297|NCT02265744|450518466|FG000|Overall Study|Adverse Event|8|||
125244298|NCT02265744|450518467|FG001|Overall Study|Adverse Event|4|||
125244299|NCT02265744|450518468|FG002|Overall Study|Adverse Event|9|||
125244300|NCT02265744|450518469|FG003|Overall Study|Adverse Event|8|||
125244301|NCT02265744|450518470|FG004|Overall Study|Adverse Event|2|||
125244302|NCT02265744|450518466|FG000|Overall Study|Lack of Efficacy|2|||
125244303|NCT02265744|450518467|FG001|Overall Study|Lack of Efficacy|4|||
125244304|NCT02265744|450518468|FG002|Overall Study|Lack of Efficacy|3|||
125244305|NCT02265744|450518469|FG003|Overall Study|Lack of Efficacy|4|||
125244306|NCT02265744|450518470|FG004|Overall Study|Lack of Efficacy|5|||
125244307|NCT02265744|450518466|FG000|Overall Study|Reason not provided by Investigator|1|||
125244308|NCT02265744|450518467|FG001|Overall Study|Reason not provided by Investigator|0|||
125244309|NCT02265744|450518468|FG002|Overall Study|Reason not provided by Investigator|0|||
125244310|NCT02265744|450518469|FG003|Overall Study|Reason not provided by Investigator|2|||
125244311|NCT02265744|450518470|FG004|Overall Study|Reason not provided by Investigator|0|||
125244312|NCT02265744|450518466|FG000|Overall Study|Administrative reason by sponsor|3|||
125244313|NCT02265744|450518467|FG001|Overall Study|Administrative reason by sponsor|2|||
125244314|NCT02265744|450518468|FG002|Overall Study|Administrative reason by sponsor|2|||
125244315|NCT02265744|450518469|FG003|Overall Study|Administrative reason by sponsor|3|||
125244316|NCT02265744|450518470|FG004|Overall Study|Administrative reason by sponsor|3|||
125244317|NCT02265744|450518466|FG000|Overall Study|Subject no longer meets study criteria|0|||
125244318|NCT02265744|450518467|FG001|Overall Study|Subject no longer meets study criteria|0|||
125244319|NCT02265744|450518468|FG002|Overall Study|Subject no longer meets study criteria|0|||
125244320|NCT02265744|450518469|FG003|Overall Study|Subject no longer meets study criteria|0|||
125244321|NCT02265744|450518470|FG004|Overall Study|Subject no longer meets study criteria|1|||
125244322|NCT02265744|450518466|FG000|Overall Study|Pregnancy|1|||
125244323|NCT02265744|450518467|FG001|Overall Study|Pregnancy|2|||
125244324|NCT02265744|450518468|FG002|Overall Study|Pregnancy|1|||
125244325|NCT02265744|450518469|FG003|Overall Study|Pregnancy|1|||
125244326|NCT02265744|450518470|FG004|Overall Study|Pregnancy|0|||
125244327|NCT05161936|450518473|FG000|Overall Study|Study terminated by Sponsor|1|||
125244328|NCT05161936|450518474|FG001|Overall Study|Study terminated by Sponsor|0|||
125244329|NCT05161936|450518475|FG002|Overall Study|Study terminated by Sponsor|0|||
125244330|NCT05161936|450518473|FG000|Overall Study|Withdrawal by Subject|0|||
125244331|NCT05161936|450518474|FG001|Overall Study|Withdrawal by Subject|0|||
125244332|NCT05161936|450518475|FG002|Overall Study|Withdrawal by Subject|1|||
125244333|NCT04999020|450518483|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
125393745|NCT03277846|451075770|FG001|Overall Study|Inpatient stay too brief|11|||
125190982|NCT02677922|450320751|FG000|Treatment Period|Disease Relapse|0|||
125190983|NCT02677922|450320752|FG001|Treatment Period|Disease Relapse|0|||
125190984|NCT02677922|450320753|FG002|Treatment Period|Disease Relapse|0|||
125190985|NCT02677922|450320754|FG003|Treatment Period|Disease Relapse|3|||
125190986|NCT02677922|450320755|FG004|Treatment Period|Disease Relapse|6|||
125190987|NCT02677922|450320756|FG005|Treatment Period|Disease Relapse|1|||
125190988|NCT02677922|450320751|FG000|Treatment Period|Allogeneic HSCT|1|||
125190989|NCT02677922|450320752|FG001|Treatment Period|Allogeneic HSCT|0|||
125190990|NCT02677922|450320753|FG002|Treatment Period|Allogeneic HSCT|0|||
125190991|NCT02677922|450320754|FG003|Treatment Period|Allogeneic HSCT|1|||
125190992|NCT02677922|450320755|FG004|Treatment Period|Allogeneic HSCT|4|||
125190993|NCT02677922|450320756|FG005|Treatment Period|Allogeneic HSCT|1|||
125190994|NCT02677922|450320751|FG000|Treatment Period|Other Reasons|0|||
125190995|NCT02677922|450320752|FG001|Treatment Period|Other Reasons|0|||
125190996|NCT02677922|450320753|FG002|Treatment Period|Other Reasons|0|||
125190997|NCT02677922|450320754|FG003|Treatment Period|Other Reasons|1|||
125190998|NCT02677922|450320755|FG004|Treatment Period|Other Reasons|3|||
125190999|NCT02677922|450320756|FG005|Treatment Period|Other Reasons|5|||
125191000|NCT02677922|450320751|FG000|Treatment Period|Death|0|||
125191001|NCT02677922|450320752|FG001|Treatment Period|Death|0|||
125191002|NCT02677922|450320753|FG002|Treatment Period|Death|0|||
125191003|NCT02677922|450320754|FG003|Treatment Period|Death|0|||
125191004|NCT02677922|450320755|FG004|Treatment Period|Death|12|||
125191005|NCT02677922|450320756|FG005|Treatment Period|Death|1|||
125191006|NCT02677922|450320751|FG000|Treatment Period|Non-compliance with Study Drug|0|||
125191007|NCT02677922|450320752|FG001|Treatment Period|Non-compliance with Study Drug|0|||
125191008|NCT02677922|450320753|FG002|Treatment Period|Non-compliance with Study Drug|0|||
125191009|NCT02677922|450320754|FG003|Treatment Period|Non-compliance with Study Drug|0|||
125191010|NCT02677922|450320755|FG004|Treatment Period|Non-compliance with Study Drug|1|||
125191011|NCT02677922|450320756|FG005|Treatment Period|Non-compliance with Study Drug|0|||
125191012|NCT02677922|450320751|FG000|Treatment Period|Physician Decision|0|||
125191013|NCT02677922|450320752|FG001|Treatment Period|Physician Decision|0|||
125191014|NCT02677922|450320753|FG002|Treatment Period|Physician Decision|0|||
125191015|NCT02677922|450320754|FG003|Treatment Period|Physician Decision|0|||
125191016|NCT02677922|450320755|FG004|Treatment Period|Physician Decision|0|||
125191017|NCT02677922|450320756|FG005|Treatment Period|Physician Decision|1|||
125191018|NCT02677922|450320751|FG000|Treatment Period|Symptomatic Deterioration|0|||
125191019|NCT02677922|450320752|FG001|Treatment Period|Symptomatic Deterioration|0|||
125191020|NCT02677922|450320753|FG002|Treatment Period|Symptomatic Deterioration|0|||
125191021|NCT02677922|450320754|FG003|Treatment Period|Symptomatic Deterioration|0|||
125191022|NCT02677922|450320755|FG004|Treatment Period|Symptomatic Deterioration|1|||
125191023|NCT02677922|450320756|FG005|Treatment Period|Symptomatic Deterioration|0|||
125191024|NCT01791894|450320759|FG000|Overall Study|Adverse Event|1|||
125191025|NCT02268916|450320766|FG000|Overall Study|Lost to Follow-up|1|||
125191026|NCT02268916|450320767|FG001|Overall Study|Lost to Follow-up|1|||
125191027|NCT02268916|450320766|FG000|Overall Study|Withdrawal by Subject|6|||
125191028|NCT02268916|450320767|FG001|Overall Study|Withdrawal by Subject|5|||
125191029|NCT02268916|450320766|FG000|Overall Study|Participant did not have diabetes|1|||
125191030|NCT02268916|450320767|FG001|Overall Study|Participant did not have diabetes|0|||
125191031|NCT02268916|450320766|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
125191032|NCT02268916|450320767|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
125191033|NCT02418949|450320768|FG000|Overall Study|Withdrawal by Subject|1|||
125191034|NCT02418949|450320769|FG001|Overall Study|Withdrawal by Subject|0|||
125191035|NCT02418949|450320770|FG002|Overall Study|Withdrawal by Subject|1|||
125191036|NCT02418949|450320771|FG003|Overall Study|Withdrawal by Subject|1|||
125191037|NCT02418949|450320768|FG000|Overall Study|Lost to Follow-up|1|||
125191038|NCT02418949|450320769|FG001|Overall Study|Lost to Follow-up|0|||
125191039|NCT02418949|450320770|FG002|Overall Study|Lost to Follow-up|1|||
125191040|NCT02418949|450320771|FG003|Overall Study|Lost to Follow-up|0|||
125191041|NCT02418949|450320768|FG000|Overall Study|Physician Decision|1|||
125191042|NCT02418949|450320769|FG001|Overall Study|Physician Decision|1|||
125191043|NCT02418949|450320770|FG002|Overall Study|Physician Decision|1|||
125191044|NCT02418949|450320771|FG003|Overall Study|Physician Decision|0|||
125191045|NCT02684097|450320773|FG000|Overall Study|Lack of Efficacy|13|||
125393746|NCT01572038|451075772|FG000|Overall Study|Death|648|||
125393747|NCT01572038|451075772|FG000|Overall Study|Withdrawal by Subject|204|||
125191046|NCT02684097|450320774|FG001|Overall Study|Lack of Efficacy|6|||
125191047|NCT00460811|450320775|FG000|Overall Study|Adverse Event|4|||
125191048|NCT00460811|450320776|FG001|Overall Study|Adverse Event|6|||
125191049|NCT00460811|450320777|FG002|Overall Study|Adverse Event|3|||
125191050|NCT00460811|450320778|FG003|Overall Study|Adverse Event|10|||
125191051|NCT00460811|450320779|FG004|Overall Study|Adverse Event|2|||
125191052|NCT00460811|450320775|FG000|Overall Study|Noncompliance|1|||
125191053|NCT00460811|450320776|FG001|Overall Study|Noncompliance|0|||
125191054|NCT00460811|450320777|FG002|Overall Study|Noncompliance|0|||
125191055|NCT00460811|450320778|FG003|Overall Study|Noncompliance|2|||
125191056|NCT00460811|450320779|FG004|Overall Study|Noncompliance|1|||
125191057|NCT00460811|450320775|FG000|Overall Study|Withdrawal by Subject|7|||
125191058|NCT00460811|450320776|FG001|Overall Study|Withdrawal by Subject|7|||
125191059|NCT00460811|450320777|FG002|Overall Study|Withdrawal by Subject|6|||
125191060|NCT00460811|450320778|FG003|Overall Study|Withdrawal by Subject|3|||
125191061|NCT00460811|450320779|FG004|Overall Study|Withdrawal by Subject|11|||
125191062|NCT00460811|450320775|FG000|Overall Study|Physician Decision|1|||
125191063|NCT00460811|450320776|FG001|Overall Study|Physician Decision|0|||
125191064|NCT00460811|450320777|FG002|Overall Study|Physician Decision|0|||
125191065|NCT00460811|450320778|FG003|Overall Study|Physician Decision|0|||
125191066|NCT00460811|450320779|FG004|Overall Study|Physician Decision|0|||
125191067|NCT00460811|450320775|FG000|Overall Study|Lost to Follow-up|3|||
125191068|NCT00460811|450320776|FG001|Overall Study|Lost to Follow-up|2|||
125191069|NCT00460811|450320777|FG002|Overall Study|Lost to Follow-up|5|||
125191070|NCT00460811|450320778|FG003|Overall Study|Lost to Follow-up|3|||
125191071|NCT00460811|450320779|FG004|Overall Study|Lost to Follow-up|6|||
125191072|NCT02748356|450320780|FG000|Overall Study|Withdrawal by Subject|1|||
125191073|NCT03515811|450320782|FG000|Overall Study|Lost to Follow-up|2|||
125191074|NCT03515811|450320783|FG001|Overall Study|Lost to Follow-up|1|||
125191075|NCT03515811|450320782|FG000|Overall Study|Protocol Violation|1|||
125191076|NCT03515811|450320783|FG001|Overall Study|Protocol Violation|1|||
125191077|NCT03515811|450320782|FG000|Overall Study|Death|1|||
125191078|NCT03515811|450320783|FG001|Overall Study|Death|1|||
125191079|NCT03515811|450320782|FG000|Overall Study|Withdrawal by Subject|0|||
125191080|NCT03515811|450320783|FG001|Overall Study|Withdrawal by Subject|2|||
125191081|NCT03515811|450320782|FG000|Overall Study|Technical Problems|1|||
125191082|NCT03515811|450320783|FG001|Overall Study|Technical Problems|0|||
125191083|NCT03515811|450320782|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
125191084|NCT03515811|450320783|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
125191085|NCT03515811|450320782|FG000|Overall Study|COVID-19|0|||
125191086|NCT03515811|450320783|FG001|Overall Study|COVID-19|1|||
125191087|NCT00237458|450320784|FG000|Overall Study|Lack of Efficacy|1|||
125191088|NCT00237458|450320784|FG000|Overall Study|Adverse Event|1|||
125191089|NCT00237458|450320784|FG000|Overall Study|Withdrawal by Subject|1|||
125191090|NCT04331067|450320785|FG000|Overall Study|Adverse Event|1|||
125191091|NCT04331067|450320786|FG001|Overall Study|Adverse Event|3|||
125191092|NCT04331067|450320787|FG002|Overall Study|Adverse Event|1|||
125191093|NCT04331067|450320785|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
125191094|NCT04331067|450320786|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
125191095|NCT04331067|450320787|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
125191096|NCT04339062|450320788|FG000|Overall Study|Death|0|||
125191097|NCT04339062|450320789|FG001|Overall Study|Death|1|||
125191098|NCT05870371|450320790|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
125191099|NCT05870371|450320791|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
125191100|NCT01777282|450320792|FG000|Overall Study|Persistent Hyperglycemia|0|||
125191101|NCT01777282|450320793|FG001|Overall Study|Persistent Hyperglycemia|0|||
125191102|NCT01777282|450320794|FG002|Overall Study|Persistent Hyperglycemia|1|||
125191103|NCT01777282|450320795|FG003|Overall Study|Persistent Hyperglycemia|0|||
125191104|NCT01777282|450320796|FG004|Overall Study|Persistent Hyperglycemia|0|||
125244334|NCT04999020|450518484|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
125244335|NCT04999020|450518485|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
125244336|NCT04999020|450518486|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
125244337|NCT04999020|450518483|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
125244338|NCT04999020|450518484|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
125244339|NCT04999020|450518485|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
125244340|NCT04999020|450518486|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
125244341|NCT04999020|450518483|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
125244342|NCT04999020|450518484|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
125191105|NCT01777282|450320792|FG000|Overall Study|New Antidiabetic Medication|0|||
125191106|NCT01777282|450320793|FG001|Overall Study|New Antidiabetic Medication|0|||
125191107|NCT01777282|450320794|FG002|Overall Study|New Antidiabetic Medication|1|||
125191108|NCT01777282|450320795|FG003|Overall Study|New Antidiabetic Medication|0|||
125191109|NCT01777282|450320796|FG004|Overall Study|New Antidiabetic Medication|0|||
125191110|NCT01777282|450320792|FG000|Overall Study|Adverse Event|4|||
125191111|NCT01777282|450320793|FG001|Overall Study|Adverse Event|4|||
125191112|NCT01777282|450320794|FG002|Overall Study|Adverse Event|2|||
125191113|NCT01777282|450320795|FG003|Overall Study|Adverse Event|1|||
125191114|NCT01777282|450320796|FG004|Overall Study|Adverse Event|3|||
125244343|NCT04999020|450518485|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
125244344|NCT04999020|450518486|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
125191115|NCT01777282|450320792|FG000|Overall Study|Withdrawal by Subject|4|||
125191116|NCT01777282|450320793|FG001|Overall Study|Withdrawal by Subject|0|||
125191117|NCT01777282|450320794|FG002|Overall Study|Withdrawal by Subject|0|||
125191118|NCT01777282|450320795|FG003|Overall Study|Withdrawal by Subject|1|||
125244345|NCT04999020|450518483|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125393748|NCT01572038|451075772|FG000|Overall Study|Lost to Follow-up|81|||
125393749|NCT01572038|451075772|FG000|Overall Study|Physician Decision|20|||
125393750|NCT01572038|451075772|FG000|Overall Study|Patient Decision|14|||
125393751|NCT01572038|451075772|FG000|Overall Study|Progressive Disease|8|||
125393752|NCT01572038|451075772|FG000|Overall Study|Site Closed Before Completing Form|6|||
125393753|NCT01572038|451075772|FG000|Overall Study|Enrolled into Another Trial|3|||
125393754|NCT01572038|451075772|FG000|Overall Study|Participated in Another Trial|3|||
125393755|NCT01572038|451075772|FG000|Overall Study|Termination by Sponsor|2|||
125393756|NCT01572038|451075772|FG000|Overall Study|Patient Deterioration|1|||
125393757|NCT01572038|451075772|FG000|Overall Study|Sponsor Decision|1|||
125393758|NCT01888497|451075773|FG000|Washout Period 1|Withdrawal by Subject|0|||
125393759|NCT01888497|451075774|FG001|Washout Period 1|Withdrawal by Subject|0|||
125393760|NCT01888497|451075775|FG002|Washout Period 1|Withdrawal by Subject|1|||
125393761|NCT01888497|451075776|FG003|Washout Period 1|Withdrawal by Subject|1|||
125393762|NCT01888497|451075773|FG000|Washout Period 2|Adverse Event|0|||
125393763|NCT01888497|451075774|FG001|Washout Period 2|Adverse Event|0|||
125393764|NCT01888497|451075775|FG002|Washout Period 2|Adverse Event|0|||
125393765|NCT01888497|451075776|FG003|Washout Period 2|Adverse Event|1|||
125393766|NCT01888497|451075773|FG000|Washout Period 2|Withdrawal by Subject|0|||
125393767|NCT01888497|451075774|FG001|Washout Period 2|Withdrawal by Subject|0|||
125393768|NCT01888497|451075775|FG002|Washout Period 2|Withdrawal by Subject|0|||
125393769|NCT01888497|451075776|FG003|Washout Period 2|Withdrawal by Subject|1|||
125393770|NCT04152447|451075777|FG000|Overall Study|Lost to Follow-up|1|||
125393771|NCT04152447|451075778|FG001|Overall Study|Lost to Follow-up|0|||
125393772|NCT04152447|451075777|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
125393773|NCT04152447|451075778|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
125393774|NCT04152447|451075777|FG000|Overall Study|Withdrawal by Subject|0|||
125393775|NCT04152447|451075778|FG001|Overall Study|Withdrawal by Subject|1|||
125393776|NCT04152447|451075777|FG000|Overall Study|Found ineligible after enrolling|1|||
125393777|NCT04152447|451075778|FG001|Overall Study|Found ineligible after enrolling|1|||
125393778|NCT04152447|451075777|FG000|Overall Study|Did not receive VR headset in time.|0|||
125393779|NCT04152447|451075778|FG001|Overall Study|Did not receive VR headset in time.|2|||
125393780|NCT04013191|451075779|FG000|Overall Study|Adverse Event|1|||
125393781|NCT04013191|451075780|FG001|Overall Study|Adverse Event|0|||
125393782|NCT01275066|451075791|FG000|Overall Study|Withdrawal by Subject|0|||
125393783|NCT01275066|451075792|FG001|Overall Study|Withdrawal by Subject|0|||
125393784|NCT01275066|451075793|FG002|Overall Study|Withdrawal by Subject|1|||
125393785|NCT01275066|451075791|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
125393786|NCT01275066|451075792|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
125393787|NCT01275066|451075793|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
125393788|NCT00913744|451075796|FG000|Overall Study|Adverse Event|2|||
125393789|NCT00913744|451075797|FG001|Overall Study|Adverse Event|0|||
125393790|NCT00913744|451075796|FG000|Overall Study|Withdrawal by Subject|2|||
125393791|NCT00913744|451075797|FG001|Overall Study|Withdrawal by Subject|1|||
125393792|NCT00913744|451075796|FG000|Overall Study|Death|1|||
125393793|NCT00913744|451075797|FG001|Overall Study|Death|0|||
125393794|NCT00805935|451075798|FG000|Overall Study|Stimulation Failure|1|||
125393795|NCT00805935|451075799|FG001|Overall Study|Stimulation Failure|5|||
125191119|NCT01777282|450320796|FG004|Overall Study|Withdrawal by Subject|2|||
125191120|NCT01777282|450320792|FG000|Overall Study|Protocol Violation|2|||
125191121|NCT01777282|450320793|FG001|Overall Study|Protocol Violation|0|||
125191122|NCT01777282|450320794|FG002|Overall Study|Protocol Violation|1|||
125191123|NCT01777282|450320795|FG003|Overall Study|Protocol Violation|0|||
125191124|NCT01777282|450320796|FG004|Overall Study|Protocol Violation|2|||
125191125|NCT01777282|450320792|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
125191126|NCT01777282|450320793|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
125191127|NCT01777282|450320794|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
125191128|NCT01777282|450320795|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
125191129|NCT01777282|450320796|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
125191130|NCT01780038|450322389|FG000|Overall Study|Lost to Follow-up|4|||
125191131|NCT01780038|450322390|FG001|Overall Study|Lost to Follow-up|1|||
125191132|NCT01085630|450322391|FG000|Overall Study|Insufficient data|1|||
125393796|NCT00805935|451075800|FG002|Overall Study|Stimulation Failure|2|||
125393797|NCT00805935|451075801|FG003|Overall Study|Stimulation Failure|2|||
125393798|NCT00805935|451075798|FG000|Overall Study|Cycle cancelled|0|||
125393799|NCT00805935|451075799|FG001|Overall Study|Cycle cancelled|0|||
125393800|NCT00805935|451075800|FG002|Overall Study|Cycle cancelled|2|||
125393801|NCT00805935|451075801|FG003|Overall Study|Cycle cancelled|0|||
125393802|NCT00805935|451075798|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
125393803|NCT00805935|451075799|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
125393804|NCT00805935|451075800|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
125393805|NCT00805935|451075801|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
125191133|NCT01085630|450322392|FG001|Overall Study|Insufficient data|0|||
125191134|NCT01085630|450322391|FG000|Overall Study|Ineligible|3|||
125191135|NCT01085630|450322392|FG001|Overall Study|Ineligible|0|||
125191136|NCT02609607|450322398|FG000|Overall Study|Lost to Follow-up|0|||
125191137|NCT02609607|450322399|FG001|Overall Study|Lost to Follow-up|1|||
125244346|NCT04999020|450518484|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125244347|NCT04999020|450518485|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
125244348|NCT04999020|450518486|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
125244349|NCT04999020|450518483|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
125244350|NCT04999020|450518484|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
125244351|NCT04999020|450518485|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
125244352|NCT04999020|450518486|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
125244353|NCT04999020|450518483|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
125244354|NCT04999020|450518484|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
125244355|NCT04999020|450518485|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
125244356|NCT04999020|450518486|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
125244357|NCT04999020|450518483|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
125244358|NCT04999020|450518484|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
125244359|NCT04999020|450518485|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
125244360|NCT04999020|450518486|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
125244361|NCT04999020|450518483|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
125244362|NCT04999020|450518484|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
125244363|NCT04999020|450518485|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
125244364|NCT04999020|450518486|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
125244365|NCT02448043|450518487|FG000|Overall Study|Withdrawal by Subject|2|||
125244366|NCT02448043|450518488|FG001|Overall Study|Withdrawal by Subject|2|||
125244367|NCT02448043|450518487|FG000|Overall Study|Protocol Violation|1|||
125244368|NCT02448043|450518488|FG001|Overall Study|Protocol Violation|2|||
125244369|NCT00933166|450518493|FG000|Overall Study|Lost to Follow-up|4|||
125244370|NCT00933166|450518493|FG000|Overall Study|Lack of Efficacy|9|||
125244371|NCT00933166|450518493|FG000|Overall Study|Unavailable|4|||
125244372|NCT00933166|450518493|FG000|Overall Study|Withdrawal by Subject|1|||
125244373|NCT02112552|450518502|FG000|Overall Study|Withdrawal by Subject|1|||
125244374|NCT02112552|450518502|FG000|Overall Study|Adverse Event|1|||
125244375|NCT04465955|450518504|FG000|Overall Study|Withdrew consent|6|||
125244376|NCT04465955|450518505|FG001|Overall Study|Withdrew consent|10|||
125244377|NCT04465955|450518506|FG002|Overall Study|Withdrew consent|7|||
125244378|NCT04465955|450518504|FG000|Overall Study|Adverse Event|6|||
125244379|NCT04465955|450518505|FG001|Overall Study|Adverse Event|5|||
125244380|NCT04465955|450518506|FG002|Overall Study|Adverse Event|1|||
125244381|NCT04465955|450518504|FG000|Overall Study|Lost to Follow-up|2|||
125244382|NCT04465955|450518505|FG001|Overall Study|Lost to Follow-up|0|||
125244383|NCT04465955|450518506|FG002|Overall Study|Lost to Follow-up|3|||
125244384|NCT04465955|450518504|FG000|Overall Study|Other|1|||
125244385|NCT04465955|450518505|FG001|Overall Study|Other|1|||
125244386|NCT04465955|450518506|FG002|Overall Study|Other|3|||
125393806|NCT00805935|451075798|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
125191138|NCT00651261|450322400|FG000|Overall Study|Adverse Event|32|||
125191139|NCT00651261|450322401|FG001|Overall Study|Adverse Event|22|||
125191140|NCT00651261|450322400|FG000|Overall Study|Death|18|||
125191141|NCT00651261|450322401|FG001|Overall Study|Death|18|||
125191142|NCT00651261|450322400|FG000|Overall Study|Withdrawal by Subject|22|||
125191143|NCT00651261|450322401|FG001|Overall Study|Withdrawal by Subject|40|||
125191144|NCT00651261|450322400|FG000|Overall Study|Induction failure|24|||
125191145|NCT00651261|450322401|FG001|Overall Study|Induction failure|35|||
125191146|NCT00651261|450322400|FG000|Overall Study|Disease progression|58|||
125191147|NCT00651261|450322401|FG001|Overall Study|Disease progression|58|||
125191148|NCT00651261|450322400|FG000|Overall Study|Alternative therapy|109|||
125191149|NCT00651261|450322401|FG001|Overall Study|Alternative therapy|107|||
125191150|NCT00651261|450322400|FG000|Overall Study|Other disease or participant decisions|23|||
125191151|NCT00651261|450322401|FG001|Overall Study|Other disease or participant decisions|23|||
125191152|NCT00651261|450322400|FG000|Overall Study|Never treated|5|||
125191153|NCT00651261|450322401|FG001|Overall Study|Never treated|3|||
125191154|NCT01134107|450322402|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
125191155|NCT01134107|450322403|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
125191156|NCT01134107|450322402|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
125191157|NCT01134107|450322403|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
125393807|NCT00805935|451075799|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
125393808|NCT00805935|451075800|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
125191158|NCT01134107|450322402|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
125191159|NCT01134107|450322403|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
125191160|NCT01134107|450322402|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
125191161|NCT01134107|450322403|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
125244387|NCT03501277|450518509|FG000|Intervention Period 1 (4 Days)|Other|0|||
125244388|NCT03501277|450518510|FG001|Intervention Period 1 (4 Days)|Other|0|||
125244389|NCT03501277|450518511|FG002|Intervention Period 1 (4 Days)|Other|1|||
125244390|NCT03501277|450518512|FG003|Intervention Period 1 (4 Days)|Other|0|||
125191162|NCT01134107|450322402|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
125191163|NCT01134107|450322403|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
125191164|NCT01134107|450322402|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
125191165|NCT01134107|450322403|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
125191166|NCT01134107|450322402|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
125191167|NCT01134107|450322403|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
125191168|NCT00687271|450322404|FG000|Overall Study|Adverse Event|1|||
125191169|NCT00687271|450322405|FG001|Overall Study|Adverse Event|3|||
125191170|NCT00687271|450322406|FG002|Overall Study|Adverse Event|1|||
125191171|NCT00687271|450322407|FG003|Overall Study|Adverse Event|0|||
125191172|NCT00687271|450322404|FG000|Overall Study|Lost to Follow-up|0|||
125191173|NCT00687271|450322405|FG001|Overall Study|Lost to Follow-up|1|||
125191174|NCT00687271|450322406|FG002|Overall Study|Lost to Follow-up|0|||
125191175|NCT00687271|450322407|FG003|Overall Study|Lost to Follow-up|0|||
125191176|NCT00687271|450322404|FG000|Overall Study|Protocol Violation|2|||
125191177|NCT00687271|450322405|FG001|Overall Study|Protocol Violation|1|||
125191178|NCT00687271|450322406|FG002|Overall Study|Protocol Violation|1|||
125191179|NCT00687271|450322407|FG003|Overall Study|Protocol Violation|0|||
125191180|NCT00687271|450322404|FG000|Overall Study|Withdrawal by Subject|0|||
125191181|NCT00687271|450322405|FG001|Overall Study|Withdrawal by Subject|1|||
125191182|NCT00687271|450322406|FG002|Overall Study|Withdrawal by Subject|3|||
125191183|NCT00687271|450322407|FG003|Overall Study|Withdrawal by Subject|0|||
125191184|NCT03656692|450322408|FG000|Overall Study|Worsening of disease activity|2|||
125191185|NCT03656692|450322408|FG000|Overall Study|Physician Decision|1|||
125191186|NCT02801617|450322416|FG000|Overall Study|Protocol Violation|2|||
125191187|NCT02801617|450322417|FG001|Overall Study|Protocol Violation|6|||
125191188|NCT01372618|450322418|FG000|Overall Study|PI Died. Study Terminated|9|||
125191189|NCT01954056|450322419|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
125191190|NCT01954056|450322420|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
125191191|NCT01081769|450322421|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
125191192|NCT01081769|450322422|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
125191193|NCT01081769|450322421|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
125191194|NCT01081769|450322422|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
125191195|NCT01081769|450322421|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
125191196|NCT01081769|450322422|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
125191197|NCT01081769|450322421|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
125191198|NCT01081769|450322422|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
125191199|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Adverse Event|14|||
125191200|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Adverse Event|11|||
125191201|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Death|1|||
125191202|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Death|1|||
125191203|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
125191204|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
125191205|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
125191206|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
125191207|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Pregnancy|1|||
125191208|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Pregnancy|0|||
125191209|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
125191210|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
125191211|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
125191212|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
125191213|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Other|0|||
125191214|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Other|1|||
125191215|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Ineligibility|3|||
125191216|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Ineligibility|4|||
125191217|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
125191218|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
125191219|NCT01081769|450322421|FG000|CORE Intent-To-Treat|Patient Moved|2|||
125191220|NCT01081769|450322422|FG001|CORE Intent-To-Treat|Patient Moved|2|||
125191221|NCT00507455|450322423|FG000|Overall Study|Adverse Event|3|||
125191222|NCT00507455|450322424|FG001|Overall Study|Adverse Event|3|||
125191223|NCT00507455|450322425|FG002|Overall Study|Adverse Event|6|||
125191224|NCT00507455|450322423|FG000|Overall Study|Withdrawal by Subject|2|||
125191225|NCT00507455|450322424|FG001|Overall Study|Withdrawal by Subject|1|||
125191226|NCT00507455|450322425|FG002|Overall Study|Withdrawal by Subject|2|||
125191227|NCT00507455|450322423|FG000|Overall Study|Protocol Violation|4|||
125191228|NCT00507455|450322424|FG001|Overall Study|Protocol Violation|1|||
125191229|NCT00507455|450322425|FG002|Overall Study|Protocol Violation|1|||
125191230|NCT00507455|450322423|FG000|Overall Study|Lost to Follow-up|2|||
125191231|NCT00507455|450322424|FG001|Overall Study|Lost to Follow-up|0|||
125191232|NCT00507455|450322425|FG002|Overall Study|Lost to Follow-up|2|||
125191233|NCT00507455|450322423|FG000|Overall Study|Lack of Efficacy|0|||
125191234|NCT00507455|450322424|FG001|Overall Study|Lack of Efficacy|1|||
125191235|NCT00507455|450322425|FG002|Overall Study|Lack of Efficacy|0|||
125244391|NCT03501277|450518509|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
125244392|NCT03501277|450518510|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
125244393|NCT03501277|450518511|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
125244394|NCT03501277|450518512|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
125244395|NCT03501277|450518509|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
125244396|NCT03501277|450518510|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
125244397|NCT03501277|450518511|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
125244398|NCT03501277|450518512|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
125244399|NCT03501277|450518509|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
125244400|NCT03501277|450518510|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
125244401|NCT03501277|450518511|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
125244402|NCT03501277|450518512|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
125244403|NCT01327703|450518513|FG000|Second Treatment Period|Adverse Event|1|||
125244404|NCT01327703|450518514|FG001|Second Treatment Period|Adverse Event|1|||
125244405|NCT01327703|450518513|FG000|Second Treatment Period|Protocol Violation|0|||
125244406|NCT01327703|450518514|FG001|Second Treatment Period|Protocol Violation|1|||
125244407|NCT01131585|450518515|FG000|Overall Study|Adverse Event|0|||
125244408|NCT01131585|450518516|FG001|Overall Study|Adverse Event|2|||
125244409|NCT01131585|450518515|FG000|Overall Study|Abnormal laboratory value|1|||
125244410|NCT01131585|450518516|FG001|Overall Study|Abnormal laboratory value|0|||
125244411|NCT01131585|450518515|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125244412|NCT01131585|450518516|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125244413|NCT01131585|450518515|FG000|Overall Study|Protocol Violation|2|||
125244414|NCT01131585|450518516|FG001|Overall Study|Protocol Violation|1|||
125244415|NCT01131585|450518515|FG000|Overall Study|Withdrawal by Subject|3|||
125244416|NCT01131585|450518516|FG001|Overall Study|Withdrawal by Subject|3|||
125244417|NCT01131585|450518515|FG000|Overall Study|Lost to Follow-up|0|||
125244418|NCT01131585|450518516|FG001|Overall Study|Lost to Follow-up|1|||
125244419|NCT01131585|450518515|FG000|Overall Study|Administrative problems|1|||
125244420|NCT01131585|450518516|FG001|Overall Study|Administrative problems|1|||
125244421|NCT01131585|450518515|FG000|Overall Study|Study termination|78|||
125244422|NCT01131585|450518516|FG001|Overall Study|Study termination|32|||
125244423|NCT00812097|450518517|FG000|Overall Study|Death|3|||
125244424|NCT00812097|450518518|FG001|Overall Study|Death|10|||
125393809|NCT00805935|451075801|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
125191236|NCT00507455|450322423|FG000|Overall Study|Other - miscellaneous reason|1|||
125191237|NCT00507455|450322424|FG001|Overall Study|Other - miscellaneous reason|0|||
125191238|NCT00507455|450322425|FG002|Overall Study|Other - miscellaneous reason|1|||
125191239|NCT03363776|450322431|FG000|Overall Study|Progressive disease|2|||
125191240|NCT03363776|450322432|FG001|Overall Study|Progressive disease|3|||
125191241|NCT03363776|450322433|FG002|Overall Study|Progressive disease|1|||
125191242|NCT03363776|450322431|FG000|Overall Study|Study drug toxicity|0|||
125191243|NCT03363776|450322432|FG001|Overall Study|Study drug toxicity|0|||
125191244|NCT03363776|450322433|FG002|Overall Study|Study drug toxicity|1|||
125191245|NCT03363776|450322431|FG000|Overall Study|Death|1|||
125191246|NCT03363776|450322432|FG001|Overall Study|Death|0|||
125191247|NCT03363776|450322433|FG002|Overall Study|Death|0|||
125191248|NCT02097238|450322438|FG000|Overall Study|Death|1|||
125191249|NCT02097238|450322438|FG000|Overall Study|Physician Decision|1|||
125191250|NCT02097238|450322438|FG000|Overall Study|Progressive Disease|17|||
125191251|NCT01106911|450322439|FG000|Overall Study|Physician Decision|2|||
125191252|NCT01106911|450322439|FG000|Overall Study|deemed ineligible after screening|3|||
125191253|NCT01814696|450322441|FG000|Overall Study|Withdrawal by Subject|1|||
125191254|NCT01814696|450322442|FG001|Overall Study|Withdrawal by Subject|0|||
125191255|NCT01814696|450322441|FG000|Overall Study|Randomized to wrong group|1|||
125191256|NCT01814696|450322442|FG001|Overall Study|Randomized to wrong group|0|||
125191257|NCT02861807|450322443|FG000|Overall Study|Lost to Follow-up|7|||
125191258|NCT02861807|450322444|FG001|Overall Study|Lost to Follow-up|6|||
125191259|NCT02861807|450322443|FG000|Overall Study|Withdrawal by Subject|5|||
125191260|NCT02861807|450322444|FG001|Overall Study|Withdrawal by Subject|8|||
125191261|NCT00410813|450322445|FG000|Overall Study|Adverse Event|6|||
125191262|NCT00410813|450322446|FG001|Overall Study|Adverse Event|11|||
125191263|NCT00410813|450322445|FG000|Overall Study|Progression|32|||
125191264|NCT00410813|450322446|FG001|Overall Study|Progression|21|||
125191265|NCT00410813|450322445|FG000|Overall Study|Not protocol specified|3|||
125191266|NCT00410813|450322446|FG001|Overall Study|Not protocol specified|4|||
125191267|NCT00410813|450322445|FG000|Overall Study|Ineligible|2|||
125191268|NCT00410813|450322446|FG001|Overall Study|Ineligible|4|||
125191269|NCT00410813|450322445|FG000|Overall Study|Death|0|||
125191270|NCT00410813|450322446|FG001|Overall Study|Death|2|||
125191271|NCT00954941|450322447|FG000|Overall Study|Received treatment at home|1|||
125244425|NCT00812097|450518519|FG002|Overall Study|Death|3|||
125244426|NCT00812097|450518520|FG003|Overall Study|Death|3|||
125244427|NCT00812097|450518517|FG000|Overall Study|Withdrawal by Subject|14|||
125244428|NCT00812097|450518518|FG001|Overall Study|Withdrawal by Subject|12|||
125244429|NCT00812097|450518519|FG002|Overall Study|Withdrawal by Subject|8|||
125244430|NCT00812097|450518520|FG003|Overall Study|Withdrawal by Subject|2|||
125244431|NCT00812097|450518517|FG000|Overall Study|Lost to Follow-up|90|||
125244432|NCT00812097|450518518|FG001|Overall Study|Lost to Follow-up|14|||
125244433|NCT00812097|450518519|FG002|Overall Study|Lost to Follow-up|17|||
125244434|NCT00812097|450518520|FG003|Overall Study|Lost to Follow-up|5|||
125244435|NCT00812097|450518517|FG000|Overall Study|Explantation of study device(s)|27|||
125244436|NCT00812097|450518518|FG001|Overall Study|Explantation of study device(s)|29|||
125244437|NCT00812097|450518519|FG002|Overall Study|Explantation of study device(s)|14|||
125244438|NCT00812097|450518520|FG003|Overall Study|Explantation of study device(s)|20|||
125244439|NCT00812097|450518517|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
125244440|NCT00812097|450518518|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
125244441|NCT00812097|450518519|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
125244442|NCT00812097|450518520|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
125244443|NCT00927082|450518521|FG000|Overall Study|Lost to Follow-up|9|||
125244444|NCT00927082|450518522|FG001|Overall Study|Lost to Follow-up|8|||
125244445|NCT00927082|450518523|FG002|Overall Study|Lost to Follow-up|12|||
125244446|NCT00927082|450518524|FG003|Overall Study|Lost to Follow-up|16|||
125244447|NCT00927082|450518521|FG000|Overall Study|Withdrawal by Subject|3|||
125244448|NCT00927082|450518522|FG001|Overall Study|Withdrawal by Subject|2|||
125244449|NCT00927082|450518523|FG002|Overall Study|Withdrawal by Subject|7|||
125244450|NCT00927082|450518524|FG003|Overall Study|Withdrawal by Subject|2|||
125244451|NCT00927082|450518521|FG000|Overall Study|Death|0|||
125244452|NCT00927082|450518522|FG001|Overall Study|Death|0|||
125244453|NCT00927082|450518523|FG002|Overall Study|Death|1|||
125244454|NCT00927082|450518524|FG003|Overall Study|Death|0|||
125244455|NCT00927082|450518521|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
125244456|NCT00927082|450518522|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
125244457|NCT00927082|450518523|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
125244458|NCT00927082|450518524|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
125244459|NCT00317369|450518525|FG000|Overall Study|Adverse Event|2|||
125244460|NCT00317369|450518526|FG001|Overall Study|Adverse Event|1|||
125244461|NCT00317369|450518527|FG002|Overall Study|Adverse Event|0|||
125244462|NCT00317369|450518525|FG000|Overall Study|Lack of Efficacy|0|||
125244463|NCT00317369|450518526|FG001|Overall Study|Lack of Efficacy|1|||
125244464|NCT00317369|450518527|FG002|Overall Study|Lack of Efficacy|1|||
125244465|NCT00317369|450518525|FG000|Overall Study|Withdrawal by Subject|0|||
125244466|NCT00317369|450518526|FG001|Overall Study|Withdrawal by Subject|0|||
125244467|NCT00317369|450518527|FG002|Overall Study|Withdrawal by Subject|1|||
125244468|NCT00849472|450518528|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
125244469|NCT00849472|450518528|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
125244470|NCT00849472|450518528|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
125244471|NCT00849472|450518528|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
125244472|NCT00849472|450518528|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
125244473|NCT00849472|450518528|FG000|Weekly Paclitaxel|Disease Progression|1|||
125244474|NCT00849472|450518528|FG000|Weekly Paclitaxel|Adverse Event|11|||
125244475|NCT00849472|450518528|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
125393810|NCT00805935|451075798|FG000|Overall Study|Lost to Follow-up|1|||
125393811|NCT00805935|451075799|FG001|Overall Study|Lost to Follow-up|0|||
125393812|NCT00805935|451075800|FG002|Overall Study|Lost to Follow-up|0|||
125191272|NCT00954941|450322448|FG001|Overall Study|Received treatment at home|0|||
125191273|NCT00954941|450322447|FG000|Overall Study|Withdrawal by Subject|1|||
125191274|NCT00954941|450322448|FG001|Overall Study|Withdrawal by Subject|0|||
125191275|NCT00954941|450322447|FG000|Overall Study|Insurance Denial|2|||
125191276|NCT00954941|450322448|FG001|Overall Study|Insurance Denial|2|||
125191277|NCT00954941|450322447|FG000|Overall Study|Physician Decision|2|||
125191278|NCT00954941|450322448|FG001|Overall Study|Physician Decision|2|||
125191279|NCT00954941|450322447|FG000|Overall Study|Ineligible|2|||
125191280|NCT00954941|450322448|FG001|Overall Study|Ineligible|2|||
125191281|NCT00954941|450322447|FG000|Overall Study|Adverse Event|0|||
125191282|NCT00954941|450322448|FG001|Overall Study|Adverse Event|1|||
125191283|NCT05027451|450322449|FG000|Overall Study|Lost to Follow-up|1|||
125191284|NCT05027451|450322450|FG001|Overall Study|Lost to Follow-up|1|||
125191285|NCT00812981|450322451|FG000|Overall Study|Other|0|||
125191286|NCT00812981|450322452|FG001|Overall Study|Other|1|||
125191287|NCT02199795|450322453|FG000|Overall Study|no longer met inclusion criteria|1|||
125191288|NCT02199795|450322454|FG001|Overall Study|no longer met inclusion criteria|0|||
125191289|NCT02199795|450322453|FG000|Overall Study|withdrew due to shoulder pain|1|||
125191290|NCT02199795|450322454|FG001|Overall Study|withdrew due to shoulder pain|0|||
125191291|NCT05310071|450322455|FG000|Overall Study|Death|0|||
125244476|NCT00849472|450518528|FG000|Weekly Paclitaxel|Physician Decision|3|||
125244477|NCT00849472|450518528|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
125244478|NCT00849472|450518528|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
125244479|NCT00849472|450518528|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
125244480|NCT00849472|450518528|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
125244481|NCT00849472|450518528|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
125393813|NCT00805935|451075801|FG003|Overall Study|Lost to Follow-up|0|||
125191292|NCT05310071|450322456|FG001|Overall Study|Death|3|||
125191293|NCT05310071|450322455|FG000|Overall Study|Adverse Event|4|||
125191294|NCT05310071|450322456|FG001|Overall Study|Adverse Event|31|||
125191295|NCT05310071|450322455|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
125191296|NCT05310071|450322456|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
125191297|NCT05310071|450322455|FG000|Overall Study|Protocol Deviation|2|||
125191298|NCT05310071|450322456|FG001|Overall Study|Protocol Deviation|0|||
125191299|NCT05310071|450322455|FG000|Overall Study|Randomized by Mistake|0|||
125191300|NCT05310071|450322456|FG001|Overall Study|Randomized by Mistake|1|||
125191301|NCT05310071|450322455|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
125191302|NCT05310071|450322456|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
125191303|NCT05310071|450322455|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
125191304|NCT05310071|450322456|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
125191305|NCT05310071|450322455|FG000|Overall Study|Site Terminated by Sponsor|0|||
125191306|NCT05310071|450322456|FG001|Overall Study|Site Terminated by Sponsor|2|||
125191307|NCT05310071|450322455|FG000|Overall Study|Study Terminated by Sponsor|282|||
125191308|NCT05310071|450322456|FG001|Overall Study|Study Terminated by Sponsor|559|||
125191309|NCT05310071|450322455|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
125191310|NCT05310071|450322456|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
125191311|NCT05310071|450322455|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
125191312|NCT05310071|450322456|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
125191313|NCT05310071|450322455|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
125191314|NCT05310071|450322456|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
125191315|NCT05310071|450322455|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
125191316|NCT05310071|450322456|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
125191317|NCT05310071|450322455|FG000|Overall Study|Withdrawal by Participant - Other|25|||
125191318|NCT05310071|450322456|FG001|Overall Study|Withdrawal by Participant - Other|30|||
125191319|NCT05310071|450322455|FG000|Overall Study|Lost to Follow-up|2|||
125191320|NCT05310071|450322456|FG001|Overall Study|Lost to Follow-up|4|||
125191321|NCT05310071|450322455|FG000|Overall Study|Reason Not Specified|1|||
125191322|NCT05310071|450322456|FG001|Overall Study|Reason Not Specified|3|||
125191323|NCT02097745|450322463|FG000|Overall Study|Adverse Event|25|||
125191324|NCT02097745|450322463|FG000|Overall Study|Death|16|||
125191325|NCT02097745|450322463|FG000|Overall Study|Failure to Return|14|||
125191326|NCT02097745|450322463|FG000|Overall Study|Administrative/Other|27|||
125191327|NCT02097745|450322463|FG000|Overall Study|Reason Not Specified|96|||
125191328|NCT00425750|450322464|FG000|Overall Study|Death|1|||
125191329|NCT00425750|450322464|FG000|Overall Study|Withdrawal by Subject|3|||
125191330|NCT00425750|450322464|FG000|Overall Study|Adverse Event|3|||
125191331|NCT00425750|450322464|FG000|Overall Study|Progression of disease|18|||
125191332|NCT01757184|450322465|FG000|Double-blind Period|Adverse Event|1|||
125191333|NCT01757184|450322466|FG001|Double-blind Period|Adverse Event|0|||
125191334|NCT01757184|450322467|FG002|Double-blind Period|Adverse Event|0|||
125191335|NCT01757184|450322468|FG003|Double-blind Period|Adverse Event|0|||
125191336|NCT01757184|450322465|FG000|Open-label Period|Lost to Follow-up|0|||
125191337|NCT01757184|450322466|FG001|Open-label Period|Lost to Follow-up|0|||
125191338|NCT01757184|450322467|FG002|Open-label Period|Lost to Follow-up|2|||
125191339|NCT01757184|450322468|FG003|Open-label Period|Lost to Follow-up|0|||
125191340|NCT01757184|450322465|FG000|Open-label Period|Withdrawal by Subject|0|||
125191341|NCT01757184|450322466|FG001|Open-label Period|Withdrawal by Subject|0|||
125191342|NCT01757184|450322467|FG002|Open-label Period|Withdrawal by Subject|1|||
125191343|NCT01757184|450322468|FG003|Open-label Period|Withdrawal by Subject|1|||
125191344|NCT01757184|450322465|FG000|Open-label Period|Discontinued by Sponsor|0|||
125191345|NCT01757184|450322466|FG001|Open-label Period|Discontinued by Sponsor|0|||
125191346|NCT01757184|450322467|FG002|Open-label Period|Discontinued by Sponsor|1|||
125191347|NCT01757184|450322468|FG003|Open-label Period|Discontinued by Sponsor|2|||
125191348|NCT01276756|450322478|FG000|Overall Study|Lost to Follow-up|2|||
125191349|NCT01276756|450322479|FG001|Overall Study|Lost to Follow-up|0|||
125191350|NCT01276756|450322478|FG000|Overall Study|Adverse Event|3|||
125191351|NCT01276756|450322479|FG001|Overall Study|Adverse Event|2|||
125191352|NCT02589639|450322480|FG000|Overall Study|Lost to Follow-up|1|||
125191353|NCT02589639|450322481|FG001|Overall Study|Lost to Follow-up|0|||
125191354|NCT02589639|450322482|FG002|Overall Study|Lost to Follow-up|0|||
125191355|NCT02589639|450322480|FG000|Overall Study|Protocol Violation|1|||
125191356|NCT02589639|450322481|FG001|Overall Study|Protocol Violation|0|||
125191357|NCT02589639|450322482|FG002|Overall Study|Protocol Violation|0|||
125191358|NCT02589639|450322480|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
125191359|NCT02589639|450322481|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
125191360|NCT02589639|450322482|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
125191361|NCT02589639|450322480|FG000|Overall Study|Adverse Event|4|||
125191362|NCT02589639|450322481|FG001|Overall Study|Adverse Event|5|||
125191363|NCT02589639|450322482|FG002|Overall Study|Adverse Event|3|||
125191364|NCT02589639|450322480|FG000|Overall Study|Other reason than specified above|1|||
125244482|NCT00849472|450518528|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
125244483|NCT00849472|450518528|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
125244484|NCT00849472|450518528|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
125244485|NCT00825175|450518529|FG000|Overall Study|Withdrawal by Subject|0|||
125244486|NCT00825175|450518530|FG001|Overall Study|Withdrawal by Subject|5|||
125244487|NCT01428128|450518532|FG000|Overall Study|Withdrawal by Subject|4|||
125244488|NCT01428128|450518532|FG000|Overall Study|Screen failure by p53|10|||
125244489|NCT01428128|450518532|FG000|Overall Study|Received Neulasta in one cycle|2|||
125244490|NCT01428128|450518532|FG000|Overall Study|Adverse Event|1|||
125244491|NCT00424008|450518533|FG000|Overall Study|Adverse Event|8|||
125244492|NCT00424008|450518534|FG001|Overall Study|Adverse Event|6|||
125244493|NCT00424008|450518533|FG000|Overall Study|Lack of Efficacy|40|||
125244494|NCT00424008|450518534|FG001|Overall Study|Lack of Efficacy|34|||
125244495|NCT00424008|450518533|FG000|Overall Study|Lost to Follow-up|1|||
125244496|NCT00424008|450518534|FG001|Overall Study|Lost to Follow-up|2|||
125244497|NCT00424008|450518533|FG000|Overall Study|Withdrawal by Subject|5|||
125244498|NCT00424008|450518534|FG001|Overall Study|Withdrawal by Subject|8|||
125244499|NCT00424008|450518533|FG000|Overall Study|Noncompliance with protocol|13|||
125244500|NCT00424008|450518534|FG001|Overall Study|Noncompliance with protocol|7|||
125244501|NCT00424008|450518533|FG000|Overall Study|Did not meet protocol eligibility|16|||
125244502|NCT00424008|450518534|FG001|Overall Study|Did not meet protocol eligibility|21|||
125244503|NCT00424008|450518533|FG000|Overall Study|Administrative|266|||
125244504|NCT00424008|450518534|FG001|Overall Study|Administrative|257|||
125244505|NCT02530242|450518551|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
125244506|NCT02530242|450518552|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
125244507|NCT00283959|450518553|FG000|Extension Period|Low Compliance|1|||
125244508|NCT05591755|450518554|FG000|Overall Study|Screen Failure|1|||
125244509|NCT05591755|450518555|FG001|Overall Study|Screen Failure|0|||
125244510|NCT05591755|450518556|FG002|Overall Study|Screen Failure|0|||
125244511|NCT05591755|450518557|FG003|Overall Study|Screen Failure|0|||
125244512|NCT05591755|450518554|FG000|Overall Study|Protocol Violation|0|||
125244513|NCT05591755|450518555|FG001|Overall Study|Protocol Violation|0|||
125244514|NCT05591755|450518556|FG002|Overall Study|Protocol Violation|2|||
125244515|NCT05591755|450518557|FG003|Overall Study|Protocol Violation|0|||
125244516|NCT05591755|450518554|FG000|Overall Study|Withdrawal by Subject|0|||
125244517|NCT05591755|450518555|FG001|Overall Study|Withdrawal by Subject|1|||
125244518|NCT05591755|450518556|FG002|Overall Study|Withdrawal by Subject|0|||
125244519|NCT05591755|450518557|FG003|Overall Study|Withdrawal by Subject|0|||
125244520|NCT00433290|450518558|FG000|Overall Study|Adverse Event|24|||
125244521|NCT00433290|450518559|FG001|Overall Study|Adverse Event|7|||
125244522|NCT00433290|450518558|FG000|Overall Study|Lack of Efficacy|1|||
125244523|NCT00433290|450518559|FG001|Overall Study|Lack of Efficacy|5|||
125244524|NCT00433290|450518558|FG000|Overall Study|Withdrawal by Subject|4|||
125244525|NCT00433290|450518559|FG001|Overall Study|Withdrawal by Subject|2|||
125244526|NCT00433290|450518558|FG000|Overall Study|Protocol Violation|3|||
125393814|NCT00805935|451075798|FG000|Overall Study|No positive serum pregnancy|8|||
125244527|NCT00433290|450518559|FG001|Overall Study|Protocol Violation|2|||
125244528|NCT00433290|450518558|FG000|Overall Study|Physician Decision|2|||
125244529|NCT00433290|450518559|FG001|Overall Study|Physician Decision|0|||
125244530|NCT00433290|450518558|FG000|Overall Study|Entry Criteria Not Met|0|||
125244531|NCT00433290|450518559|FG001|Overall Study|Entry Criteria Not Met|1|||
125244532|NCT00433290|450518558|FG000|Overall Study|Lost to Follow-up|1|||
125244533|NCT00433290|450518559|FG001|Overall Study|Lost to Follow-up|0|||
125244534|NCT01483651|450518560|FG000|Overall Study|Withdrawal by Subject|0|||
125393815|NCT00805935|451075799|FG001|Overall Study|No positive serum pregnancy|7|||
125393816|NCT00805935|451075800|FG002|Overall Study|No positive serum pregnancy|6|||
125393817|NCT00805935|451075801|FG003|Overall Study|No positive serum pregnancy|5|||
125393818|NCT00805935|451075798|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
125393819|NCT00805935|451075799|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
125393820|NCT00805935|451075800|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
125393821|NCT00805935|451075801|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
125393822|NCT00805935|451075798|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
125393823|NCT00805935|451075799|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
125244535|NCT01483651|450518561|FG001|Overall Study|Withdrawal by Subject|1|||
125244536|NCT01483651|450518562|FG002|Overall Study|Withdrawal by Subject|1|||
125244537|NCT01483651|450518563|FG003|Overall Study|Withdrawal by Subject|0|||
125244538|NCT01483651|450518564|FG004|Overall Study|Withdrawal by Subject|0|||
125244539|NCT01483651|450518565|FG005|Overall Study|Withdrawal by Subject|1|||
125244540|NCT00308685|450518572|FG000|Overall Study|Lost to Follow-up|1|||
125244541|NCT00308685|450518573|FG001|Overall Study|Lost to Follow-up|0|||
125244542|NCT00308685|450518572|FG000|Overall Study|Need to administer prohibited medication|1|||
125244543|NCT00308685|450518573|FG001|Overall Study|Need to administer prohibited medication|2|||
125244544|NCT00308685|450518572|FG000|Overall Study|Other than specified|1|||
125244545|NCT00308685|450518573|FG001|Overall Study|Other than specified|3|||
125244546|NCT03345095|450518574|FG000|Overall Study|Lack of Efficacy|184|||
125244547|NCT03345095|450518575|FG001|Overall Study|Lack of Efficacy|156|||
125191365|NCT02589639|450322481|FG001|Overall Study|Other reason than specified above|2|||
125191366|NCT02589639|450322482|FG002|Overall Study|Other reason than specified above|1|||
125191367|NCT02589639|450322480|FG000|Overall Study|Not Treated|0|||
125191368|NCT02589639|450322481|FG001|Overall Study|Not Treated|3|||
125191369|NCT02589639|450322482|FG002|Overall Study|Not Treated|0|||
125191370|NCT02203721|450322483|FG000|Overall Study|Lost to Follow-up|1|||
125191371|NCT02203721|450322484|FG001|Overall Study|Lost to Follow-up|0|||
125191372|NCT02203721|450322483|FG000|Overall Study|Death|0|||
125191373|NCT02203721|450322484|FG001|Overall Study|Death|2|||
125191374|NCT02203721|450322483|FG000|Overall Study|Illness|0|||
125191375|NCT02203721|450322484|FG001|Overall Study|Illness|1|||
125191376|NCT02593097|450322492|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
125191377|NCT02593097|450322493|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
125191378|NCT02593097|450322492|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
125191379|NCT02593097|450322493|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
125191380|NCT02593097|450322492|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
125191381|NCT02593097|450322493|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
125191382|NCT02593097|450322492|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
125191383|NCT02593097|450322493|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
125191384|NCT02593097|450322492|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
125191385|NCT02593097|450322493|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
125191386|NCT00703157|450322494|FG000|Overall Study|Lost to Follow-up|0|||
125191387|NCT00703157|450322495|FG001|Overall Study|Lost to Follow-up|1|||
125191388|NCT00703157|450322494|FG000|Overall Study|source data permanently lost/ other|4|||
125191389|NCT00703157|450322495|FG001|Overall Study|source data permanently lost/ other|1|||
125191390|NCT02968173|450322496|FG000|Overall Study|Withdrawal by Subject|1|||
125191391|NCT02670525|450322497|FG000|Overall Study|Death|94|||
125191392|NCT02670525|450322498|FG001|Overall Study|Death|14|||
125191393|NCT02670525|450322497|FG000|Overall Study|Lost to Follow-up|4|||
125191394|NCT02670525|450322498|FG001|Overall Study|Lost to Follow-up|1|||
125191395|NCT02670525|450322497|FG000|Overall Study|Subject withdrew consent|1|||
125191396|NCT02670525|450322498|FG001|Overall Study|Subject withdrew consent|0|||
125191397|NCT02670525|450322497|FG000|Overall Study|Unknown, data entry delayed|123|||
125191398|NCT02670525|450322498|FG001|Overall Study|Unknown, data entry delayed|78|||
125191399|NCT01554527|450322499|FG000|Overall Study|Withdrawal by Subject|1|||
125191400|NCT01554527|450322500|FG001|Overall Study|Withdrawal by Subject|0|||
125191401|NCT01554527|450322501|FG002|Overall Study|Withdrawal by Subject|3|||
125191402|NCT01554527|450322499|FG000|Overall Study|Lost to Follow-up|0|||
125191403|NCT01554527|450322500|FG001|Overall Study|Lost to Follow-up|0|||
125191404|NCT01554527|450322501|FG002|Overall Study|Lost to Follow-up|4|||
125191405|NCT01554527|450322499|FG000|Overall Study|Physician Decision|0|||
125191406|NCT01554527|450322500|FG001|Overall Study|Physician Decision|0|||
125191407|NCT01554527|450322501|FG002|Overall Study|Physician Decision|1|||
125191408|NCT01052480|450322502|FG000|Overall Study|Lost to Follow-up|3|||
125191409|NCT01052480|450322503|FG001|Overall Study|Lost to Follow-up|3|||
125191410|NCT01052480|450322502|FG000|Overall Study|Protocol Violation|1|||
125191411|NCT01052480|450322503|FG001|Overall Study|Protocol Violation|0|||
125191412|NCT01052480|450322502|FG000|Overall Study|Withdrawal by Subject|3|||
125191413|NCT01052480|450322503|FG001|Overall Study|Withdrawal by Subject|7|||
125191414|NCT01052480|450322502|FG000|Overall Study|Physician Decision|0|||
125191415|NCT01052480|450322503|FG001|Overall Study|Physician Decision|2|||
125191416|NCT01052480|450322502|FG000|Overall Study|Death|1|||
125191417|NCT01052480|450322503|FG001|Overall Study|Death|5|||
125191418|NCT00529373|450322504|FG000|Base Study|Adverse Event|525|||
125191419|NCT00529373|450322505|FG001|Base Study|Adverse Event|470|||
125191420|NCT00529373|450322504|FG000|Base Study|Lack of Efficacy|16|||
125191421|NCT00529373|450322505|FG001|Base Study|Lack of Efficacy|75|||
125191422|NCT00529373|450322504|FG000|Base Study|Lost to Follow-up|221|||
125191423|NCT00529373|450322505|FG001|Base Study|Lost to Follow-up|208|||
125191424|NCT00529373|450322504|FG000|Base Study|Other Protocol Specified Criteria|19|||
125191425|NCT00529373|450322505|FG001|Base Study|Other Protocol Specified Criteria|20|||
125191426|NCT00529373|450322504|FG000|Base Study|Physician Decision|60|||
125191427|NCT00529373|450322505|FG001|Base Study|Physician Decision|52|||
125191428|NCT00529373|450322504|FG000|Base Study|Protocol Violation|48|||
125191429|NCT00529373|450322505|FG001|Base Study|Protocol Violation|38|||
125191430|NCT00529373|450322504|FG000|Base Study|Withdrawal by Subject|1062|||
125191431|NCT00529373|450322505|FG001|Base Study|Withdrawal by Subject|967|||
125191432|NCT00529373|450322504|FG000|Base Study|Did not continue into Extension|1795|||
125191433|NCT00529373|450322505|FG001|Base Study|Did not continue into Extension|2238|||
125191434|NCT00529373|450322504|FG000|First Extension Study|Adverse Event|162|||
125191435|NCT00529373|450322505|FG001|First Extension Study|Adverse Event|142|||
125191436|NCT00529373|450322504|FG000|First Extension Study|Lack of Efficacy|65|||
125191437|NCT00529373|450322505|FG001|First Extension Study|Lack of Efficacy|427|||
125191438|NCT00529373|450322504|FG000|First Extension Study|Lost to Follow-up|41|||
125191439|NCT00529373|450322505|FG001|First Extension Study|Lost to Follow-up|37|||
125191440|NCT00529373|450322504|FG000|First Extension Study|Other|27|||
125191441|NCT00529373|450322505|FG001|First Extension Study|Other|47|||
125191442|NCT00529373|450322504|FG000|First Extension Study|Physician Decision|50|||
125244548|NCT03345095|450518574|FG000|Overall Study|Adverse Event|36|||
125244549|NCT03345095|450518575|FG001|Overall Study|Adverse Event|118|||
125244550|NCT03345095|450518574|FG000|Overall Study|Withdrawal by Subject|22|||
125244551|NCT03345095|450518575|FG001|Overall Study|Withdrawal by Subject|59|||
125244552|NCT03345095|450518574|FG000|Overall Study|Physician Decision|3|||
125244553|NCT03345095|450518575|FG001|Overall Study|Physician Decision|18|||
125244554|NCT03345095|450518574|FG000|Overall Study|Death|2|||
125244555|NCT03345095|450518575|FG001|Overall Study|Death|4|||
125244556|NCT03345095|450518574|FG000|Overall Study|Other reasons|2|||
125244557|NCT03345095|450518575|FG001|Overall Study|Other reasons|11|||
125244558|NCT03345095|450518574|FG000|Overall Study|Protocol Violation|0|||
125244559|NCT03345095|450518575|FG001|Overall Study|Protocol Violation|1|||
125244560|NCT01121575|450518576|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
125244561|NCT01121575|450518577|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
125244562|NCT01121575|450518578|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
125244563|NCT01121575|450518579|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
125244564|NCT01121575|450518580|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
125244565|NCT01121575|450518581|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
125244566|NCT01121575|450518576|FG000|Overall Study|Unspecified Reasons|8|||
125244567|NCT01121575|450518577|FG001|Overall Study|Unspecified Reasons|6|||
125393824|NCT00805935|451075800|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
125393825|NCT00805935|451075801|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
125393826|NCT00805935|451075798|FG000|Overall Study|Biochemical pregnancy|0|||
125393827|NCT00805935|451075799|FG001|Overall Study|Biochemical pregnancy|1|||
125393828|NCT00805935|451075800|FG002|Overall Study|Biochemical pregnancy|0|||
125393829|NCT00805935|451075801|FG003|Overall Study|Biochemical pregnancy|0|||
125393830|NCT00805935|451075798|FG000|Overall Study|Chemical pregnancy|0|||
125244568|NCT01121575|450518578|FG002|Overall Study|Unspecified Reasons|7|||
125244569|NCT01121575|450518579|FG003|Overall Study|Unspecified Reasons|5|||
125244570|NCT01121575|450518580|FG004|Overall Study|Unspecified Reasons|13|||
125244571|NCT01121575|450518581|FG005|Overall Study|Unspecified Reasons|10|||
125244572|NCT01121575|450518576|FG000|Overall Study|Death|6|||
125244573|NCT01121575|450518577|FG001|Overall Study|Death|0|||
125244574|NCT01121575|450518578|FG002|Overall Study|Death|0|||
125244575|NCT01121575|450518579|FG003|Overall Study|Death|1|||
125244576|NCT01121575|450518580|FG004|Overall Study|Death|7|||
125244577|NCT01121575|450518581|FG005|Overall Study|Death|1|||
125244578|NCT02665455|450518583|FG000|Overall Study|Withdrawal by Subject|6|||
125244579|NCT02665455|450518583|FG000|Overall Study|Lost to Follow-up|1|||
125244580|NCT02665455|450518583|FG000|Overall Study|Adverse Event|1|||
125244581|NCT02665455|450518583|FG000|Overall Study|Protocol Violation|1|||
125244582|NCT00724503|450518584|FG000|Overall Study|Lost to Follow-up|4|||
125393831|NCT00805935|451075799|FG001|Overall Study|Chemical pregnancy|5|||
125393832|NCT00805935|451075800|FG002|Overall Study|Chemical pregnancy|3|||
125393833|NCT00805935|451075801|FG003|Overall Study|Chemical pregnancy|2|||
125393834|NCT00805935|451075798|FG000|Overall Study|Ectopic pregnancy|0|||
125393835|NCT00805935|451075799|FG001|Overall Study|Ectopic pregnancy|0|||
125393836|NCT00805935|451075800|FG002|Overall Study|Ectopic pregnancy|1|||
125393837|NCT00805935|451075801|FG003|Overall Study|Ectopic pregnancy|0|||
125393838|NCT00805935|451075798|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
125393839|NCT00805935|451075799|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
125393840|NCT00805935|451075800|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
125393841|NCT00805935|451075801|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
125393842|NCT02945410|451075802|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
125393843|NCT02945410|451075803|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
125393844|NCT02945410|451075804|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
125393845|NCT02945410|451075805|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
125393846|NCT02945410|451075806|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
125393847|NCT02945410|451075807|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
125393848|NCT02945410|451075802|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
125393849|NCT02945410|451075803|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
125393850|NCT02945410|451075804|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
125393851|NCT02945410|451075805|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
125393852|NCT02945410|451075806|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
125393853|NCT02945410|451075807|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
125393854|NCT02945410|451075802|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
125393855|NCT02945410|451075803|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
125244583|NCT00724503|450518585|FG001|Overall Study|Lost to Follow-up|8|||
125244584|NCT00724503|450518584|FG000|Overall Study|Withdrawal by Subject|11|||
125244585|NCT00724503|450518585|FG001|Overall Study|Withdrawal by Subject|23|||
125244586|NCT00724503|450518584|FG000|Overall Study|Death|190|||
125244587|NCT00724503|450518585|FG001|Overall Study|Death|182|||
125244588|NCT00724503|450518584|FG000|Overall Study|Adverse Event|1|||
125244589|NCT00724503|450518585|FG001|Overall Study|Adverse Event|0|||
125244590|NCT00724503|450518584|FG000|Overall Study|Not otherwise specified|4|||
125244591|NCT00724503|450518585|FG001|Overall Study|Not otherwise specified|7|||
125244592|NCT01186419|450518586|FG000|Overall Study|Withdrawal by Subject|5|||
125393856|NCT02945410|451075804|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
125393857|NCT02945410|451075805|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
125393858|NCT02945410|451075806|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
125393859|NCT02945410|451075807|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
125393860|NCT01344369|451075808|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
125393861|NCT01344369|451075809|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
125393862|NCT01344369|451075808|FG000|Washout of 28 Days|Physician Decision|0|||
125393863|NCT01344369|451075809|FG001|Washout of 28 Days|Physician Decision|1|||
125393864|NCT01344369|451075808|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
125393865|NCT01344369|451075809|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
125393866|NCT01454726|451075810|FG000|Overall Study|Withdrawal by Subject|0|||
125393867|NCT01454726|451075811|FG001|Overall Study|Withdrawal by Subject|1|||
125393868|NCT04200248|451075812|FG000|Overall Study|Personal reasons|0|||
125393869|NCT04200248|451075813|FG001|Overall Study|Personal reasons|0|||
125393870|NCT04200248|451075814|FG002|Overall Study|Personal reasons|1|||
125393871|NCT04200248|451075812|FG000|Overall Study|Discontinued prior to treatment|3|||
125393872|NCT04200248|451075813|FG001|Overall Study|Discontinued prior to treatment|3|||
125393873|NCT04200248|451075814|FG002|Overall Study|Discontinued prior to treatment|2|||
125393874|NCT03848845|451075815|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
125393875|NCT03848845|451075816|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
125393876|NCT03848845|451075817|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
125393877|NCT03848845|451075818|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
125393878|NCT03848845|451075815|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
125393879|NCT03848845|451075816|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
125393880|NCT03848845|451075817|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
125393881|NCT03848845|451075818|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
125393882|NCT03848845|451075815|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
125393883|NCT03848845|451075816|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
125191443|NCT00529373|450322505|FG001|First Extension Study|Physician Decision|45|||
125191444|NCT00529373|450322504|FG000|First Extension Study|Protocol Violation|16|||
125191445|NCT00529373|450322505|FG001|First Extension Study|Protocol Violation|13|||
125191446|NCT00529373|450322504|FG000|First Extension Study|Withdrawal by Subject|296|||
125191447|NCT00529373|450322505|FG001|First Extension Study|Withdrawal by Subject|287|||
125191448|NCT00529373|450322504|FG000|First Extension Study|Disposition record non-existing|0|||
125191449|NCT00529373|450322505|FG001|First Extension Study|Disposition record non-existing|1|||
125191450|NCT00529373|450322504|FG000|First Extension Study|Discontinued after 5 years completion|208|||
125191451|NCT00529373|450322505|FG001|First Extension Study|Discontinued after 5 years completion|346|||
125191452|NCT00529373|450322504|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
125191453|NCT00529373|450322505|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
125191454|NCT00529373|450322504|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
125191455|NCT00529373|450322505|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
125191456|NCT00529373|450322504|FG000|Second Extension Study|Adverse Event|101|||
125191457|NCT00529373|450322505|FG001|Second Extension Study|Adverse Event|51|||
125191458|NCT00529373|450322504|FG000|Second Extension Study|Lack of Efficacy|7|||
125191459|NCT00529373|450322505|FG001|Second Extension Study|Lack of Efficacy|15|||
125191460|NCT00529373|450322504|FG000|Second Extension Study|Lost to Follow-up|18|||
125191461|NCT00529373|450322505|FG001|Second Extension Study|Lost to Follow-up|12|||
125191462|NCT00529373|450322504|FG000|Second Extension Study|Other|7|||
125191463|NCT00529373|450322505|FG001|Second Extension Study|Other|12|||
125191464|NCT00529373|450322504|FG000|Second Extension Study|Physician Decision|63|||
125191465|NCT00529373|450322505|FG001|Second Extension Study|Physician Decision|26|||
125191466|NCT00529373|450322504|FG000|Second Extension Study|Protocol Violation|2|||
125191467|NCT00529373|450322505|FG001|Second Extension Study|Protocol Violation|1|||
125191468|NCT00529373|450322504|FG000|Second Extension Study|Withdrawal by Subject|97|||
125191469|NCT00529373|450322505|FG001|Second Extension Study|Withdrawal by Subject|75|||
125191470|NCT00529373|450322504|FG000|Second Extension Study|Status Missing|5|||
125191471|NCT00529373|450322505|FG001|Second Extension Study|Status Missing|5|||
125191472|NCT01863667|450322512|FG000|Overall Study|Adverse Event|1|||
125191473|NCT01863667|450322513|FG001|Overall Study|Adverse Event|0|||
125191474|NCT01863667|450322512|FG000|Overall Study|Study terminated by Sponsor|30|||
125191475|NCT01863667|450322513|FG001|Overall Study|Study terminated by Sponsor|30|||
125191476|NCT01863667|450322512|FG000|Overall Study|Withdrawal by Subject|2|||
125191477|NCT01863667|450322513|FG001|Overall Study|Withdrawal by Subject|2|||
125191478|NCT03627546|450322514|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
125393884|NCT03848845|451075817|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
125393885|NCT03848845|451075818|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
125191479|NCT03627546|450322515|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
125191480|NCT03627546|450322516|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
125191481|NCT03627546|450322514|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
125191482|NCT03627546|450322515|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
125443532|NCT00551213|451252164|FG000|Overall Study|Progressive Disease|41|||
125191483|NCT03627546|450322516|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
125393886|NCT03848845|451075815|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
125393887|NCT03848845|451075816|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
125393888|NCT03848845|451075817|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
125393889|NCT03848845|451075818|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
125393890|NCT00934544|451075824|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
125393891|NCT00934544|451075825|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
125393892|NCT00934544|451075826|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
125393893|NCT00934544|451075824|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
125393894|NCT00934544|451075825|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
125393895|NCT00934544|451075826|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
125393896|NCT00934544|451075824|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
125393897|NCT00934544|451075825|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
125393898|NCT00934544|451075826|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
125393899|NCT00934544|451075824|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
125393900|NCT00934544|451075825|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
125393901|NCT00934544|451075826|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
125393902|NCT00934544|451075824|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
125191484|NCT02965573|450322519|FG000|Overall Study|Lack of Efficacy|1|||
125191485|NCT02965573|450322520|FG001|Overall Study|Lack of Efficacy|0|||
125191486|NCT00315458|450322521|FG000|Overall Study|Administrative|0|||
125191487|NCT00315458|450322522|FG001|Overall Study|Administrative|3|||
125191488|NCT00315458|450322523|FG002|Overall Study|Administrative|8|||
125191489|NCT00315458|450322524|FG003|Overall Study|Administrative|21|||
125191490|NCT00315458|450322521|FG000|Overall Study|Adverse Event|2|||
125191491|NCT00315458|450322522|FG001|Overall Study|Adverse Event|4|||
125191492|NCT00315458|450322523|FG002|Overall Study|Adverse Event|23|||
125191493|NCT00315458|450322524|FG003|Overall Study|Adverse Event|3|||
125191494|NCT00315458|450322521|FG000|Overall Study|Lost to Follow-up|1|||
125191495|NCT00315458|450322522|FG001|Overall Study|Lost to Follow-up|2|||
125191496|NCT00315458|450322523|FG002|Overall Study|Lost to Follow-up|0|||
125191497|NCT00315458|450322524|FG003|Overall Study|Lost to Follow-up|2|||
125191498|NCT00315458|450322521|FG000|Overall Study|Withdrawal by Subject|0|||
125191499|NCT00315458|450322522|FG001|Overall Study|Withdrawal by Subject|3|||
125191500|NCT00315458|450322523|FG002|Overall Study|Withdrawal by Subject|0|||
125191501|NCT00315458|450322524|FG003|Overall Study|Withdrawal by Subject|2|||
125191502|NCT00315458|450322521|FG000|Overall Study|Lack of Efficacy|0|||
125191503|NCT00315458|450322522|FG001|Overall Study|Lack of Efficacy|0|||
125191504|NCT00315458|450322523|FG002|Overall Study|Lack of Efficacy|20|||
125191505|NCT00315458|450322524|FG003|Overall Study|Lack of Efficacy|1|||
125191506|NCT00315458|450322521|FG000|Overall Study|Did not qualify|0|||
125191507|NCT00315458|450322522|FG001|Overall Study|Did not qualify|0|||
125191508|NCT00315458|450322523|FG002|Overall Study|Did not qualify|1|||
125191509|NCT00315458|450322524|FG003|Overall Study|Did not qualify|0|||
125191510|NCT00987337|450322525|FG000|Overall Study|Adverse Event|10|||
125191511|NCT00987337|450322526|FG001|Overall Study|Adverse Event|9|||
125191512|NCT00987337|450322527|FG002|Overall Study|Adverse Event|8|||
125191513|NCT00987337|450322525|FG000|Overall Study|Insufficient Virologic Response|10|||
125191514|NCT00987337|450322526|FG001|Overall Study|Insufficient Virologic Response|7|||
125191515|NCT00987337|450322527|FG002|Overall Study|Insufficient Virologic Response|12|||
125191516|NCT00987337|450322525|FG000|Overall Study|Virologic Breakthrough|2|||
125191517|NCT00987337|450322526|FG001|Overall Study|Virologic Breakthrough|2|||
125191518|NCT00987337|450322527|FG002|Overall Study|Virologic Breakthrough|8|||
125191519|NCT00987337|450322525|FG000|Overall Study|Lost to Follow-up|10|||
125191520|NCT00987337|450322526|FG001|Overall Study|Lost to Follow-up|6|||
125191521|NCT00987337|450322527|FG002|Overall Study|Lost to Follow-up|2|||
125191522|NCT00987337|450322525|FG000|Overall Study|Withdrawal by Subject|6|||
125191523|NCT00987337|450322526|FG001|Overall Study|Withdrawal by Subject|9|||
125191524|NCT00987337|450322527|FG002|Overall Study|Withdrawal by Subject|9|||
125191525|NCT00987337|450322525|FG000|Overall Study|Other|0|||
125191526|NCT00987337|450322526|FG001|Overall Study|Other|2|||
125191527|NCT00987337|450322527|FG002|Overall Study|Other|5|||
125191528|NCT00987337|450322525|FG000|Overall Study|Protocol Violation|1|||
125191529|NCT00987337|450322526|FG001|Overall Study|Protocol Violation|0|||
125191530|NCT00987337|450322527|FG002|Overall Study|Protocol Violation|2|||
125191531|NCT00987337|450322525|FG000|Overall Study|Participant Relapsed|18|||
125191532|NCT00987337|450322526|FG001|Overall Study|Participant Relapsed|20|||
125191533|NCT00987337|450322527|FG002|Overall Study|Participant Relapsed|5|||
125191534|NCT00086619|450322529|FG000|Overall Study|Withdrawal by Subject|6|||
125191535|NCT00086619|450322530|FG001|Overall Study|Withdrawal by Subject|6|||
125191536|NCT00086619|450322529|FG000|Overall Study|Adverse Event|8|||
125191537|NCT00086619|450322530|FG001|Overall Study|Adverse Event|10|||
125191538|NCT00086619|450322529|FG000|Overall Study|Protocol Violation|1|||
125244593|NCT01186419|450518587|FG001|Overall Study|Withdrawal by Subject|3|||
125191539|NCT00086619|450322530|FG001|Overall Study|Protocol Violation|1|||
125244594|NCT01186419|450518586|FG000|Overall Study|Adverse Event|1|||
125244595|NCT01186419|450518587|FG001|Overall Study|Adverse Event|2|||
125244596|NCT01186419|450518586|FG000|Overall Study|Physician Decision|0|||
125244597|NCT01186419|450518587|FG001|Overall Study|Physician Decision|3|||
125244598|NCT01186419|450518586|FG000|Overall Study|Other|1|||
125244599|NCT01186419|450518587|FG001|Overall Study|Other|1|||
125244600|NCT01937117|450518588|FG000|Overall Study|Disease Progression|7|||
125244601|NCT01937117|450518588|FG000|Overall Study|Physician Decision|4|||
125244602|NCT01937117|450518588|FG000|Overall Study|Adverse Event|2|||
125244603|NCT01179399|450518589|FG000|Overall Study|Adverse Event|1|||
125244604|NCT01179399|450518589|FG000|Overall Study|Lack of Efficacy|30|||
125244605|NCT01179399|450518589|FG000|Overall Study|Withdrawal by Subject|1|||
125244606|NCT03921541|450520075|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
125244607|NCT03921541|450520076|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
125244608|NCT01653262|450520077|FG000|Overall Study|Lack of Efficacy|1|||
125244609|NCT01653262|450520077|FG000|Overall Study|SAE, non-fatal|1|||
125244610|NCT01653262|450520077|FG000|Overall Study|AE, non-serious non-fatal|1|||
125244611|NCT00420407|450520079|FG000|Overall Study|Lost to Follow-up|0|||
125244612|NCT00420407|450520080|FG001|Overall Study|Lost to Follow-up|3|||
125244613|NCT00420407|450520079|FG000|Overall Study|Physician Decision|2|||
125244614|NCT00420407|450520080|FG001|Overall Study|Physician Decision|1|||
125244615|NCT00420407|450520079|FG000|Overall Study|subject identified as detainee|1|||
125244616|NCT00420407|450520080|FG001|Overall Study|subject identified as detainee|0|||
125244617|NCT00420407|450520079|FG000|Overall Study|subject identified as Jehovah's witness|1|||
125244618|NCT00420407|450520080|FG001|Overall Study|subject identified as Jehovah's witness|0|||
125244619|NCT00420407|450520079|FG000|Overall Study|Withdrawal by Subject|0|||
125244620|NCT00420407|450520080|FG001|Overall Study|Withdrawal by Subject|2|||
125244621|NCT02724644|450520082|FG000|Overall Study|Adverse Event|7|||
125244622|NCT02724644|450520083|FG001|Overall Study|Adverse Event|1|||
125244623|NCT02724644|450520082|FG000|Overall Study|Lost to Follow-up|6|||
125244624|NCT02724644|450520083|FG001|Overall Study|Lost to Follow-up|2|||
125244625|NCT02724644|450520082|FG000|Overall Study|Withdrawal by Subject|7|||
125244626|NCT02724644|450520083|FG001|Overall Study|Withdrawal by Subject|1|||
125244627|NCT02724644|450520082|FG000|Overall Study|Administrative|1|||
125244628|NCT02724644|450520083|FG001|Overall Study|Administrative|0|||
125244629|NCT01734928|450520084|FG000|Randomization|Physician Decision|0|||
125244630|NCT01734928|450520085|FG001|Randomization|Physician Decision|1|||
125244631|NCT01734928|450520084|FG000|Randomization|clinical progression|0|||
125244632|NCT01734928|450520085|FG001|Randomization|clinical progression|1|||
125244633|NCT01734928|450520084|FG000|Randomization|progressive disease|0|||
125244634|NCT01734928|450520085|FG001|Randomization|progressive disease|2|||
125244635|NCT01734928|450520084|FG000|Randomization|Withdrew informed consent|0|||
125244636|NCT01734928|450520085|FG001|Randomization|Withdrew informed consent|4|||
125244637|NCT01734928|450520084|FG000|Randomization|Death|1|||
125244638|NCT01734928|450520085|FG001|Randomization|Death|0|||
125244639|NCT01734928|450520084|FG000|Randomization|Randomization error|1|||
125244640|NCT01734928|450520085|FG001|Randomization|Randomization error|0|||
125244641|NCT01734928|450520084|FG000|Randomization|Lost to Follow-up|1|||
125244642|NCT01734928|450520085|FG001|Randomization|Lost to Follow-up|0|||
125244643|NCT01734928|450520084|FG000|Treatment Period|Lost to Follow-up|0|||
125244644|NCT01734928|450520085|FG001|Treatment Period|Lost to Follow-up|2|||
125244645|NCT01734928|450520084|FG000|Treatment Period|Progressive Disease|167|||
125244646|NCT01734928|450520085|FG001|Treatment Period|Progressive Disease|165|||
125393903|NCT00934544|451075825|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
125393904|NCT00934544|451075826|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
125393905|NCT00934544|451075824|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
125393906|NCT00934544|451075825|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
125393907|NCT00934544|451075826|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
125393908|NCT00934544|451075824|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
125393909|NCT00934544|451075825|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
125393910|NCT00934544|451075826|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
125393911|NCT00934544|451075824|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
125393912|NCT00934544|451075825|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
125393913|NCT00934544|451075826|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
125393914|NCT00934544|451075824|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
125244647|NCT01734928|450520084|FG000|Treatment Period|Adverse Event|39|||
125244648|NCT01734928|450520085|FG001|Treatment Period|Adverse Event|52|||
125244649|NCT01734928|450520084|FG000|Treatment Period|Withdrawal of Consent|25|||
125244650|NCT01734928|450520085|FG001|Treatment Period|Withdrawal of Consent|22|||
125244651|NCT01734928|450520084|FG000|Treatment Period|Death|20|||
125244652|NCT01734928|450520085|FG001|Treatment Period|Death|9|||
125244653|NCT01734928|450520084|FG000|Treatment Period|Other Reasons|27|||
125244654|NCT01734928|450520085|FG001|Treatment Period|Other Reasons|19|||
125244655|NCT01734928|450520084|FG000|Treatment Period|Pregnancy|0|||
125244656|NCT01734928|450520085|FG001|Treatment Period|Pregnancy|1|||
125191540|NCT00489918|450322531|FG000|Overall Study|Withdrawal by Subject|2|||
125191541|NCT00489918|450322532|FG001|Overall Study|Withdrawal by Subject|1|||
125191542|NCT00489918|450322533|FG002|Overall Study|Withdrawal by Subject|1|||
125191543|NCT00489918|450322534|FG003|Overall Study|Withdrawal by Subject|0|||
125191544|NCT00489918|450322535|FG004|Overall Study|Withdrawal by Subject|1|||
125191545|NCT00489918|450322531|FG000|Overall Study|Adverse Event|0|||
125191546|NCT00489918|450322532|FG001|Overall Study|Adverse Event|1|||
125191547|NCT00489918|450322533|FG002|Overall Study|Adverse Event|1|||
125191548|NCT00489918|450322534|FG003|Overall Study|Adverse Event|0|||
125191549|NCT00489918|450322535|FG004|Overall Study|Adverse Event|0|||
125191550|NCT00489918|450322531|FG000|Overall Study|Lost to Follow-up|0|||
125191551|NCT00489918|450322532|FG001|Overall Study|Lost to Follow-up|0|||
125191552|NCT00489918|450322533|FG002|Overall Study|Lost to Follow-up|1|||
125191553|NCT00489918|450322534|FG003|Overall Study|Lost to Follow-up|1|||
125393915|NCT00934544|451075825|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
125393916|NCT00934544|451075826|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
125393917|NCT00934544|451075824|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
125393918|NCT00934544|451075825|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
125393919|NCT00934544|451075826|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
125393920|NCT00934544|451075824|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
125393921|NCT00934544|451075825|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
125393922|NCT00934544|451075826|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
125393923|NCT00934544|451075824|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
125393924|NCT00934544|451075825|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
125393925|NCT00934544|451075826|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
125393926|NCT00934544|451075824|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
125393927|NCT00934544|451075825|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
125393928|NCT00934544|451075826|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
125393929|NCT00934544|451075824|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
125393930|NCT00934544|451075825|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
125393931|NCT00934544|451075826|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
125393932|NCT00934544|451075824|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
125393933|NCT00934544|451075825|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
125393934|NCT00934544|451075826|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
125393935|NCT00934544|451075824|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
125393936|NCT00934544|451075825|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
125393937|NCT00934544|451075826|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
125393938|NCT00302003|451075827|FG000|Overall Study|Lack of Efficacy|62|||
125393939|NCT00302003|451075827|FG000|Overall Study|Lost to Follow-up|1|||
125393940|NCT00302003|451075827|FG000|Overall Study|Physician Decision|2|||
125393941|NCT00302003|451075827|FG000|Overall Study|Withdrawal by Subject|5|||
125393942|NCT00302003|451075827|FG000|Overall Study|Ineligible|9|||
125393943|NCT00302003|451075827|FG000|Overall Study|Protocol Violation|1|||
125393944|NCT01218516|451075828|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
125393945|NCT01218516|451075829|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
125393946|NCT01218516|451075830|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
125393947|NCT01218516|451075831|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
125393948|NCT01218516|451075828|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
125393949|NCT01218516|451075829|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
125393950|NCT01218516|451075830|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
125393951|NCT01218516|451075831|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
125393952|NCT01218516|451075828|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
125393953|NCT01218516|451075829|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
125191554|NCT00489918|450322535|FG004|Overall Study|Lost to Follow-up|0|||
125191555|NCT00489918|450322531|FG000|Overall Study|Physician Decision|0|||
125191556|NCT00489918|450322532|FG001|Overall Study|Physician Decision|0|||
125191557|NCT00489918|450322533|FG002|Overall Study|Physician Decision|1|||
125191558|NCT00489918|450322534|FG003|Overall Study|Physician Decision|0|||
125191559|NCT00489918|450322535|FG004|Overall Study|Physician Decision|0|||
125191560|NCT01209520|450322536|FG000|Overall Study|Withdrawal by Subject|3|||
125191561|NCT00961350|450322537|FG000|Overall Study|Adverse Event|18|||
125191562|NCT00961350|450322538|FG001|Overall Study|Adverse Event|33|||
125191563|NCT00961350|450322537|FG000|Overall Study|Withdrawal by Subject|10|||
125191564|NCT00961350|450322538|FG001|Overall Study|Withdrawal by Subject|10|||
125191565|NCT00961350|450322537|FG000|Overall Study|Lost to Follow-up|3|||
125191566|NCT00961350|450322538|FG001|Overall Study|Lost to Follow-up|3|||
125191567|NCT00961350|450322537|FG000|Overall Study|Misc|16|||
125191568|NCT00961350|450322538|FG001|Overall Study|Misc|21|||
125191569|NCT02134015|450322539|FG000|Overall Study|Protocol Violation|0|||
125393954|NCT01218516|451075830|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
125393955|NCT01218516|451075831|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
125191570|NCT02134015|450322540|FG001|Overall Study|Protocol Violation|1|||
125191571|NCT02134015|450322539|FG000|Overall Study|Death|2|||
125191572|NCT02134015|450322540|FG001|Overall Study|Death|1|||
125191573|NCT02134015|450322539|FG000|Overall Study|Reason not provided|1|||
125191574|NCT02134015|450322540|FG001|Overall Study|Reason not provided|2|||
125191575|NCT02134015|450322539|FG000|Overall Study|Clinical progression|14|||
125191576|NCT02134015|450322540|FG001|Overall Study|Clinical progression|7|||
125191577|NCT02134015|450322539|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
125191578|NCT02134015|450322540|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
125191579|NCT02134015|450322539|FG000|Overall Study|Study terminated by sponsor|2|||
125191580|NCT02134015|450322540|FG001|Overall Study|Study terminated by sponsor|3|||
125191581|NCT02134015|450322539|FG000|Overall Study|Adverse Event|9|||
125191582|NCT02134015|450322540|FG001|Overall Study|Adverse Event|10|||
125191583|NCT02134015|450322539|FG000|Overall Study|Withdrawal by Subject|3|||
125191584|NCT02134015|450322540|FG001|Overall Study|Withdrawal by Subject|7|||
125191585|NCT00326716|450324232|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
125191586|NCT00326716|450324233|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
125191587|NCT00326716|450324234|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
125191588|NCT00326716|450324235|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
125191589|NCT00684411|450324236|FG000|Overall Study|New Primary Cancer|1|||
125191590|NCT00684411|450324236|FG000|Overall Study|Disease Progression|10|||
125191591|NCT00684411|450324236|FG000|Overall Study|Adverse Event|1|||
125191592|NCT05253573|450324237|FG000|Overall Study|Death|1|||
125191593|NCT05253573|450324238|FG001|Overall Study|Death|0|||
125191594|NCT06098339|450324239|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
125191595|NCT06098339|450324240|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
125191596|NCT06098339|450324239|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
125191597|NCT06098339|450324240|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
125191598|NCT04134767|450324241|FG000|Overall Study|Death|0|||
125191599|NCT04134767|450324242|FG001|Overall Study|Death|1|||
125191600|NCT04134767|450324241|FG000|Overall Study|Removed for harassing staff|0|||
125191601|NCT04134767|450324242|FG001|Overall Study|Removed for harassing staff|1|||
125191602|NCT04134767|450324241|FG000|Overall Study|Lost to Follow-up|44|||
125191603|NCT04134767|450324242|FG001|Overall Study|Lost to Follow-up|40|||
125191604|NCT02276560|450324243|FG000|Overall Study|Adverse Event|1|||
125191605|NCT02276560|450324244|FG001|Overall Study|Adverse Event|0|||
125191606|NCT02276560|450324245|FG002|Overall Study|Adverse Event|0|||
125191607|NCT00300885|450324246|FG000|Treatment|Adverse Event|134|||
125191608|NCT00300885|450324247|FG001|Treatment|Adverse Event|82|||
125191609|NCT00300885|450324246|FG000|Treatment|Death|20|||
125191610|NCT00300885|450324247|FG001|Treatment|Death|7|||
125191611|NCT00300885|450324246|FG000|Treatment|Lack of Efficacy|1|||
125191612|NCT00300885|450324247|FG001|Treatment|Lack of Efficacy|1|||
125191613|NCT00300885|450324246|FG000|Treatment|Lost to Follow-up|3|||
125191614|NCT00300885|450324247|FG001|Treatment|Lost to Follow-up|2|||
125191615|NCT00300885|450324246|FG000|Treatment|Physician Decision|4|||
125191616|NCT00300885|450324247|FG001|Treatment|Physician Decision|5|||
125191617|NCT00300885|450324246|FG000|Treatment|Protocol Violation|11|||
125191618|NCT00300885|450324247|FG001|Treatment|Protocol Violation|11|||
125191619|NCT00300885|450324246|FG000|Treatment|Withdrawal by Subject|26|||
125191620|NCT00300885|450324247|FG001|Treatment|Withdrawal by Subject|23|||
125191621|NCT00300885|450324246|FG000|Treatment|Disease progression|171|||
125191622|NCT00300885|450324247|FG001|Treatment|Disease progression|238|||
125191623|NCT00300885|450324246|FG000|Treatment|Random code broken (subject died)|0|||
125191624|NCT00300885|450324247|FG001|Treatment|Random code broken (subject died)|1|||
125191625|NCT00300885|450324246|FG000|Treatment|Non-compliant with study medication|3|||
125191626|NCT00300885|450324247|FG001|Treatment|Non-compliant with study medication|4|||
125191627|NCT00300885|450324246|FG000|Follow-up|Death|141|||
125191628|NCT00300885|450324247|FG001|Follow-up|Death|163|||
125191629|NCT00300885|450324246|FG000|Follow-up|Lost to Follow-up|11|||
125191630|NCT00300885|450324247|FG001|Follow-up|Lost to Follow-up|7|||
125191631|NCT00300885|450324246|FG000|Follow-up|Withdrawal by Subject|26|||
125191632|NCT00300885|450324247|FG001|Follow-up|Withdrawal by Subject|25|||
125191633|NCT02582242|450324248|FG000|Overall Study|Adverse Event|4|||
125191634|NCT02582242|450324249|FG001|Overall Study|Adverse Event|3|||
125191635|NCT02582242|450324248|FG000|Overall Study|Protocol Violation|3|||
125191636|NCT02582242|450324249|FG001|Overall Study|Protocol Violation|1|||
125191637|NCT02582242|450324248|FG000|Overall Study|Lost to Follow-up|0|||
125191638|NCT02582242|450324249|FG001|Overall Study|Lost to Follow-up|1|||
125191639|NCT02582242|450324248|FG000|Overall Study|Withdrawal by Subject|11|||
125191640|NCT02582242|450324249|FG001|Overall Study|Withdrawal by Subject|11|||
125191641|NCT02582242|450324248|FG000|Overall Study|Unclassified|2|||
125191642|NCT02582242|450324249|FG001|Overall Study|Unclassified|1|||
125191643|NCT00459290|450324253|FG000|Overall Study|Adverse Event|3|||
125191644|NCT00459290|450324253|FG000|Overall Study|Ineligible|2|||
125244657|NCT01778985|450520086|FG000|Overall Study|Lost to Follow-up|1|||
125244658|NCT01778985|450520087|FG001|Overall Study|Lost to Follow-up|0|||
125244659|NCT01778985|450520086|FG000|Overall Study|Physician Decision|2|||
125244660|NCT01778985|450520087|FG001|Overall Study|Physician Decision|2|||
125244661|NCT01778985|450520086|FG000|Overall Study|Protocol Violation|4|||
125244662|NCT01778985|450520087|FG001|Overall Study|Protocol Violation|1|||
125244663|NCT01631188|450520093|FG000|Overall Study|Physician Decision|75|||
125244664|NCT03600350|450520094|FG000|Overall Study|Death|1|||
125244665|NCT03600350|450520094|FG000|Overall Study|On Follow Up|18|||
125244666|NCT03684057|450520095|FG000|Overall Study|Withdrawal by Subject|4|||
125244667|NCT03684057|450520096|FG001|Overall Study|Withdrawal by Subject|5|||
125244668|NCT01105130|450520097|FG000|Overall Study|Withdrawal by Subject|4|||
125244669|NCT01105130|450520098|FG001|Overall Study|Withdrawal by Subject|6|||
125244670|NCT01105130|450520099|FG002|Overall Study|Withdrawal by Subject|2|||
125244671|NCT01105130|450520097|FG000|Overall Study|Never Started|2|||
125244672|NCT01105130|450520098|FG001|Overall Study|Never Started|2|||
125244673|NCT01105130|450520099|FG002|Overall Study|Never Started|4|||
125244674|NCT01105130|450520097|FG000|Overall Study|Toxicity|1|||
125244675|NCT01105130|450520098|FG001|Overall Study|Toxicity|3|||
125244676|NCT01105130|450520099|FG002|Overall Study|Toxicity|2|||
125244677|NCT01105130|450520097|FG000|Overall Study|Multiple Reasons|3|||
125244678|NCT01105130|450520098|FG001|Overall Study|Multiple Reasons|0|||
125244679|NCT01105130|450520099|FG002|Overall Study|Multiple Reasons|2|||
125244680|NCT01363440|450520102|FG000|Overall Study|Adverse Event|5|||
125244681|NCT01363440|450520103|FG001|Overall Study|Adverse Event|4|||
125244682|NCT01363440|450520104|FG002|Overall Study|Adverse Event|4|||
125244683|NCT01363440|450520102|FG000|Overall Study|Death|3|||
125244684|NCT01363440|450520103|FG001|Overall Study|Death|7|||
125244685|NCT01363440|450520104|FG002|Overall Study|Death|5|||
125244686|NCT01363440|450520102|FG000|Overall Study|Withdrawal by Subject|9|||
125244687|NCT01363440|450520103|FG001|Overall Study|Withdrawal by Subject|11|||
125244688|NCT01363440|450520104|FG002|Overall Study|Withdrawal by Subject|11|||
125244689|NCT01363440|450520102|FG000|Overall Study|Lost to Follow-up|2|||
125244690|NCT01363440|450520103|FG001|Overall Study|Lost to Follow-up|4|||
125244691|NCT01363440|450520104|FG002|Overall Study|Lost to Follow-up|5|||
125244692|NCT01363440|450520102|FG000|Overall Study|Other|4|||
125244693|NCT01363440|450520103|FG001|Overall Study|Other|5|||
125244694|NCT01363440|450520104|FG002|Overall Study|Other|2|||
125244695|NCT02323334|450520105|FG000|Period 3|Lost to Follow-up|0|||
125244696|NCT02323334|450520106|FG001|Period 3|Lost to Follow-up|0|||
125244697|NCT02323334|450520107|FG002|Period 3|Lost to Follow-up|1|||
125244698|NCT02323334|450520108|FG003|Period 3|Lost to Follow-up|0|||
125244699|NCT02323334|450520109|FG004|Period 3|Lost to Follow-up|0|||
125244700|NCT02323334|450520110|FG005|Period 3|Lost to Follow-up|0|||
125244701|NCT02323334|450520111|FG006|Period 3|Lost to Follow-up|0|||
125244702|NCT02323334|450520112|FG007|Period 3|Lost to Follow-up|0|||
125244703|NCT02323334|450520113|FG008|Period 3|Lost to Follow-up|0|||
125244704|NCT02323334|450520114|FG009|Period 3|Lost to Follow-up|0|||
125244705|NCT02323334|450520115|FG010|Period 3|Lost to Follow-up|0|||
125244706|NCT02323334|450520116|FG011|Period 3|Lost to Follow-up|0|||
125244707|NCT02323334|450520117|FG012|Period 3|Lost to Follow-up|0|||
125244708|NCT02323334|450520118|FG013|Period 3|Lost to Follow-up|0|||
125244709|NCT02323334|450520119|FG014|Period 3|Lost to Follow-up|0|||
125244710|NCT02323334|450520120|FG015|Period 3|Lost to Follow-up|0|||
125244711|NCT02323334|450520121|FG016|Period 3|Lost to Follow-up|0|||
125244712|NCT02323334|450520105|FG000|Period 3|Withdrawal by Subject|1|||
125244713|NCT02323334|450520106|FG001|Period 3|Withdrawal by Subject|0|||
125244714|NCT02323334|450520107|FG002|Period 3|Withdrawal by Subject|0|||
125244715|NCT02323334|450520108|FG003|Period 3|Withdrawal by Subject|0|||
125244716|NCT02323334|450520109|FG004|Period 3|Withdrawal by Subject|0|||
125244717|NCT02323334|450520110|FG005|Period 3|Withdrawal by Subject|0|||
125244718|NCT02323334|450520111|FG006|Period 3|Withdrawal by Subject|0|||
125244719|NCT02323334|450520112|FG007|Period 3|Withdrawal by Subject|0|||
125244720|NCT02323334|450520113|FG008|Period 3|Withdrawal by Subject|0|||
125244721|NCT02323334|450520114|FG009|Period 3|Withdrawal by Subject|0|||
125244722|NCT02323334|450520115|FG010|Period 3|Withdrawal by Subject|0|||
125244723|NCT02323334|450520116|FG011|Period 3|Withdrawal by Subject|0|||
125244724|NCT02323334|450520117|FG012|Period 3|Withdrawal by Subject|0|||
125244725|NCT02323334|450520118|FG013|Period 3|Withdrawal by Subject|0|||
125244726|NCT02323334|450520119|FG014|Period 3|Withdrawal by Subject|0|||
125244727|NCT02323334|450520120|FG015|Period 3|Withdrawal by Subject|0|||
125244728|NCT02323334|450520121|FG016|Period 3|Withdrawal by Subject|0|||
125244729|NCT01129284|450520123|FG000|Overall Study|Adverse Event|2|||
125244730|NCT01129284|450520124|FG001|Overall Study|Adverse Event|0|||
125244731|NCT01129284|450520125|FG002|Overall Study|Adverse Event|1|||
125244732|NCT01625182|450520126|FG000|Overall Study|Administrative problems|1|||
125244733|NCT01625182|450520127|FG001|Overall Study|Administrative problems|0|||
125244734|NCT01625182|450520126|FG000|Overall Study|Protocol deviation|0|||
125244735|NCT01625182|450520127|FG001|Overall Study|Protocol deviation|2|||
125244736|NCT01625182|450520126|FG000|Overall Study|Adverse Event|2|||
125244737|NCT01625182|450520127|FG001|Overall Study|Adverse Event|0|||
125244738|NCT01625182|450520126|FG000|Overall Study|Withdrawal by Subject|5|||
125244739|NCT01625182|450520127|FG001|Overall Study|Withdrawal by Subject|1|||
125244740|NCT01625182|450520126|FG000|Overall Study|Lack of Efficacy|12|||
125244741|NCT01625182|450520127|FG001|Overall Study|Lack of Efficacy|8|||
125244742|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
125244743|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
125244744|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
125244745|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
125244746|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
125244747|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
125244748|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
125244749|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
125244750|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
125244751|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
125244752|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
125244753|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
125244754|NCT00447278|450520130|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
125244755|NCT00447278|450520131|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
125244756|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
125393956|NCT01218516|451075828|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
125393957|NCT01218516|451075829|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
125393958|NCT01218516|451075830|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
125191645|NCT02366637|450324254|FG000|First Intervention Period|Adverse Event|0|||
125191646|NCT02366637|450324255|FG001|First Intervention Period|Adverse Event|1|||
125191647|NCT02366637|450324254|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
125191648|NCT02366637|450324255|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
125191649|NCT02366637|450324254|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
125191650|NCT02366637|450324255|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
125191651|NCT02309411|450324256|FG000|Overall Study|Physician Decision|1|||
125191652|NCT02309411|450324257|FG001|Overall Study|Physician Decision|0|||
125191653|NCT02309411|450324258|FG002|Overall Study|Physician Decision|0|||
125191654|NCT02309411|450324256|FG000|Overall Study|Withdrawal by Subject|1|||
125191655|NCT02309411|450324257|FG001|Overall Study|Withdrawal by Subject|1|||
125191656|NCT02309411|450324258|FG002|Overall Study|Withdrawal by Subject|0|||
125191657|NCT00839800|450324261|FG000|Overall Study|Adverse Event|8|||
125191658|NCT00839800|450324262|FG001|Overall Study|Adverse Event|12|||
125191659|NCT00839800|450324261|FG000|Overall Study|Lost to Follow-up|31|||
125191660|NCT00839800|450324262|FG001|Overall Study|Lost to Follow-up|26|||
125191661|NCT00839800|450324261|FG000|Overall Study|Withdrawal by Subject|28|||
125191662|NCT00839800|450324262|FG001|Overall Study|Withdrawal by Subject|34|||
125191663|NCT00839800|450324261|FG000|Overall Study|Incorrect Enrolment|3|||
125191664|NCT00839800|450324262|FG001|Overall Study|Incorrect Enrolment|3|||
125191665|NCT00839800|450324261|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
125191666|NCT00839800|450324262|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
125191667|NCT00839800|450324261|FG000|Overall Study|Safety Reasons|2|||
125191668|NCT00839800|450324262|FG001|Overall Study|Safety Reasons|1|||
125191669|NCT00839800|450324261|FG000|Overall Study|Other|8|||
125191670|NCT00839800|450324262|FG001|Overall Study|Other|14|||
125191671|NCT00839800|450324261|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
125191672|NCT00839800|450324262|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
125191673|NCT02510664|450324265|FG000|Overall Study|Transferred Care|9|||
125191674|NCT02510664|450324266|FG001|Overall Study|Transferred Care|9|||
125191675|NCT02510664|450324267|FG002|Overall Study|Transferred Care|0|||
125191676|NCT02510664|450324265|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
125191677|NCT02510664|450324266|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
125191678|NCT02510664|450324267|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
125191679|NCT02510664|450324265|FG000|Overall Study|Time Constraints|1|||
125191680|NCT02510664|450324266|FG001|Overall Study|Time Constraints|1|||
125191681|NCT02510664|450324267|FG002|Overall Study|Time Constraints|0|||
125191682|NCT06110494|450324270|FG000|Overall Study|Protocol Violation|2|||
125191683|NCT06110494|450324271|FG001|Overall Study|Protocol Violation|0|||
125191684|NCT06110494|450324272|FG002|Overall Study|Protocol Violation|1|||
125191685|NCT06110494|450324270|FG000|Overall Study|Dixon's test for outlier analysis|1|||
125191686|NCT06110494|450324271|FG001|Overall Study|Dixon's test for outlier analysis|1|||
125191687|NCT06110494|450324272|FG002|Overall Study|Dixon's test for outlier analysis|0|||
125191688|NCT02914613|450324277|FG000|Overall Study|Withdrawal by Subject|1|||
125191689|NCT02914613|450324278|FG001|Overall Study|Withdrawal by Subject|2|||
125191690|NCT02914613|450324277|FG000|Overall Study|Adverse Event|1|||
125244757|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
125244758|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
125244759|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
125191691|NCT02914613|450324278|FG001|Overall Study|Adverse Event|0|||
125191692|NCT03850496|450324289|FG000|Overall Study|Withdrawal by Subject|1|||
125244760|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
125244761|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
125244762|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
125244763|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
125244764|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
125244765|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
125244766|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
125244767|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
125244768|NCT00447278|450520130|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
125244769|NCT00447278|450520131|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
125244770|NCT05427916|450520135|FG000|Overall Study|Adverse Event|3|||
125244771|NCT05427916|450520136|FG001|Overall Study|Adverse Event|0|||
125244772|NCT05427916|450520135|FG000|Overall Study|Lack of Efficacy|6|||
125244773|NCT05427916|450520136|FG001|Overall Study|Lack of Efficacy|0|||
125244774|NCT05427916|450520135|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
125244775|NCT05427916|450520136|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
125244776|NCT03558672|450520137|FG000|Overall Study|Study Early Termination|10|||
125244777|NCT01158404|450520145|FG000|Overall Study|Withdrawal by Subject|0|||
125244778|NCT01158404|450520146|FG001|Overall Study|Withdrawal by Subject|1|||
125244779|NCT01158404|450520147|FG002|Overall Study|Withdrawal by Subject|0|||
125244780|NCT01158404|450520148|FG003|Overall Study|Withdrawal by Subject|0|||
125244781|NCT01158404|450520149|FG004|Overall Study|Withdrawal by Subject|3|||
125244782|NCT01158404|450520150|FG005|Overall Study|Withdrawal by Subject|1|||
125244783|NCT01158404|450520151|FG006|Overall Study|Withdrawal by Subject|0|||
125244784|NCT01158404|450520152|FG007|Overall Study|Withdrawal by Subject|1|||
125244785|NCT01158404|450520145|FG000|Overall Study|Physician Decision|0|||
125244786|NCT01158404|450520146|FG001|Overall Study|Physician Decision|0|||
125244787|NCT01158404|450520147|FG002|Overall Study|Physician Decision|0|||
125244788|NCT01158404|450520148|FG003|Overall Study|Physician Decision|0|||
125244789|NCT01158404|450520149|FG004|Overall Study|Physician Decision|0|||
125244790|NCT01158404|450520150|FG005|Overall Study|Physician Decision|0|||
125244791|NCT01158404|450520151|FG006|Overall Study|Physician Decision|0|||
125244792|NCT01158404|450520152|FG007|Overall Study|Physician Decision|1|||
125244793|NCT01158404|450520145|FG000|Overall Study|Progressive Disease|0|||
125244794|NCT01158404|450520146|FG001|Overall Study|Progressive Disease|0|||
125244795|NCT01158404|450520147|FG002|Overall Study|Progressive Disease|0|||
125244796|NCT01158404|450520148|FG003|Overall Study|Progressive Disease|0|||
125244797|NCT01158404|450520149|FG004|Overall Study|Progressive Disease|0|||
125244798|NCT01158404|450520150|FG005|Overall Study|Progressive Disease|0|||
125244799|NCT01158404|450520151|FG006|Overall Study|Progressive Disease|1|||
125244800|NCT01158404|450520152|FG007|Overall Study|Progressive Disease|0|||
125244801|NCT02384460|450520154|FG000|Overall Study|Protocol Violation|0|||
125244802|NCT02384460|450520155|FG001|Overall Study|Protocol Violation|1|||
125244803|NCT02384460|450520154|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
125244804|NCT02384460|450520155|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
125244805|NCT02384460|450520154|FG000|Overall Study|Adverse Event|5|||
125244806|NCT02384460|450520155|FG001|Overall Study|Adverse Event|2|||
125244807|NCT02384460|450520154|FG000|Overall Study|Withdrawal by Subject|0|||
125244808|NCT02384460|450520155|FG001|Overall Study|Withdrawal by Subject|3|||
125244809|NCT02384460|450520154|FG000|Overall Study|Elective medical treatment|1|||
125244810|NCT02384460|450520155|FG001|Overall Study|Elective medical treatment|0|||
125244811|NCT02384460|450520154|FG000|Overall Study|Non-compliance|1|||
125191693|NCT03850496|450324290|FG001|Overall Study|Withdrawal by Subject|0|||
125191694|NCT03850496|450324291|FG002|Overall Study|Withdrawal by Subject|0|||
125191695|NCT03850496|450324289|FG000|Overall Study|Lost to Follow-up|0|||
125191696|NCT03850496|450324290|FG001|Overall Study|Lost to Follow-up|1|||
125191697|NCT03850496|450324291|FG002|Overall Study|Lost to Follow-up|4|||
125191698|NCT03777436|450324292|FG000|Placebo-controlled Phase|Adverse Event|8|||
125191699|NCT03777436|450324293|FG001|Placebo-controlled Phase|Adverse Event|10|||
125191700|NCT03777436|450324294|FG002|Placebo-controlled Phase|Adverse Event|0|||
125191701|NCT03777436|450324292|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
125244812|NCT02384460|450520155|FG001|Overall Study|Non-compliance|0|||
125244813|NCT01060111|450520156|FG000|Overall Study|Adverse Event|9|||
125244814|NCT01060111|450520157|FG001|Overall Study|Adverse Event|5|||
125244815|NCT01060111|450520158|FG002|Overall Study|Adverse Event|18|||
125244816|NCT01060111|450520156|FG000|Overall Study|Lack of Efficacy|2|||
125244817|NCT01060111|450520157|FG001|Overall Study|Lack of Efficacy|1|||
125244818|NCT01060111|450520158|FG002|Overall Study|Lack of Efficacy|0|||
125244819|NCT01060111|450520156|FG000|Overall Study|Inappropriate participant|5|||
125244820|NCT01060111|450520157|FG001|Overall Study|Inappropriate participant|4|||
125244821|NCT01060111|450520158|FG002|Overall Study|Inappropriate participant|5|||
125244822|NCT01060111|450520156|FG000|Overall Study|Participants' evasion for hospital visit|0|||
125244823|NCT01060111|450520157|FG001|Overall Study|Participants' evasion for hospital visit|3|||
125244824|NCT01060111|450520158|FG002|Overall Study|Participants' evasion for hospital visit|2|||
125244825|NCT01060111|450520156|FG000|Overall Study|Participants' non-cooperation|8|||
125244826|NCT01060111|450520157|FG001|Overall Study|Participants' non-cooperation|6|||
125244827|NCT01060111|450520158|FG002|Overall Study|Participants' non-cooperation|6|||
125244828|NCT01060111|450520156|FG000|Overall Study|Adverse event and insufficient effect|0|||
125244829|NCT01060111|450520157|FG001|Overall Study|Adverse event and insufficient effect|1|||
125244830|NCT01060111|450520158|FG002|Overall Study|Adverse event and insufficient effect|0|||
125244831|NCT01060111|450520156|FG000|Overall Study|Participants' non-cooperation|1|||
125244832|NCT01060111|450520157|FG001|Overall Study|Participants' non-cooperation|0|||
125244833|NCT01060111|450520158|FG002|Overall Study|Participants' non-cooperation|0|||
125244834|NCT01060111|450520156|FG000|Overall Study|Other|2|||
125244835|NCT01060111|450520157|FG001|Overall Study|Other|3|||
125244836|NCT01060111|450520158|FG002|Overall Study|Other|4|||
125244837|NCT00997126|450520161|FG000|Overall Study|Physician Decision|7|||
125244838|NCT00997126|450520162|FG001|Overall Study|Physician Decision|11|||
125244839|NCT00896233|450520169|FG000|Overall Study|Claustrophobia during MRI|1|||
125244840|NCT04280562|450520170|FG000|Study|Adverse Event|2|||
125244841|NCT04280562|450520171|FG001|Study|Adverse Event|0|||
125244842|NCT04280562|450520170|FG000|Study|Lost to Follow-up|3|||
125244843|NCT04280562|450520171|FG001|Study|Lost to Follow-up|3|||
125244844|NCT02965456|450520172|FG000|Overall Study|Lost to Follow-up|40|||
125244845|NCT02965456|450520173|FG001|Overall Study|Lost to Follow-up|18|||
125244846|NCT02965456|450520172|FG000|Overall Study|Subject Request|22|||
125244847|NCT02965456|450520173|FG001|Overall Study|Subject Request|13|||
125244848|NCT02965456|450520172|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
125244849|NCT02965456|450520173|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
125244850|NCT02965456|450520172|FG000|Overall Study|Adverse Event|3|||
125244851|NCT02965456|450520173|FG001|Overall Study|Adverse Event|0|||
125244852|NCT02965456|450520172|FG000|Overall Study|Noncompliance with Study Drug|1|||
125244853|NCT02965456|450520173|FG001|Overall Study|Noncompliance with Study Drug|1|||
125244854|NCT02965456|450520172|FG000|Overall Study|Worsening Condition|0|||
125244855|NCT02965456|450520173|FG001|Overall Study|Worsening Condition|2|||
125244856|NCT02965456|450520172|FG000|Overall Study|Lack of Efficacy|1|||
125244857|NCT02965456|450520173|FG001|Overall Study|Lack of Efficacy|0|||
125244858|NCT02965456|450520172|FG000|Overall Study|Physician Decision|0|||
125244859|NCT02965456|450520173|FG001|Overall Study|Physician Decision|1|||
125244860|NCT02965456|450520172|FG000|Overall Study|Pregnancy|1|||
125244861|NCT02965456|450520173|FG001|Overall Study|Pregnancy|0|||
125244862|NCT02965456|450520172|FG000|Overall Study|Protocol Violation|0|||
125244863|NCT02965456|450520173|FG001|Overall Study|Protocol Violation|1|||
125244864|NCT02965456|450520172|FG000|Overall Study|Participant ran out of study drug|0|||
125244865|NCT02965456|450520173|FG001|Overall Study|Participant ran out of study drug|1|||
125244866|NCT02583477|450520174|FG000|Overall Study|Adverse Event|0|||
125244867|NCT02583477|450520175|FG001|Overall Study|Adverse Event|2|||
125244868|NCT02583477|450520174|FG000|Overall Study|Death|1|||
125244869|NCT02583477|450520175|FG001|Overall Study|Death|16|||
125244870|NCT02583477|450520174|FG000|Overall Study|Study terminated|2|||
125244871|NCT02583477|450520175|FG001|Overall Study|Study terminated|2|||
125244872|NCT01860404|450520180|FG000|Overall Study|Lost to Follow-up|3|||
125244873|NCT01860404|450520181|FG001|Overall Study|Lost to Follow-up|4|||
125244874|NCT01860404|450520182|FG002|Overall Study|Lost to Follow-up|1|||
125244875|NCT01860404|450520183|FG003|Overall Study|Lost to Follow-up|6|||
125244876|NCT01860404|450520184|FG004|Overall Study|Lost to Follow-up|4|||
125244877|NCT01860404|450520180|FG000|Overall Study|Withdrawal by Subject|0|||
125244878|NCT01860404|450520181|FG001|Overall Study|Withdrawal by Subject|0|||
125244879|NCT01860404|450520182|FG002|Overall Study|Withdrawal by Subject|4|||
125244880|NCT01860404|450520183|FG003|Overall Study|Withdrawal by Subject|0|||
125244881|NCT01860404|450520184|FG004|Overall Study|Withdrawal by Subject|0|||
125244882|NCT02762604|450520185|FG000|Overall Study|Lost to Follow-up|2|||
125244883|NCT02762604|450520186|FG001|Overall Study|Lost to Follow-up|7|||
125244884|NCT02762604|450520185|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
125244885|NCT02762604|450520186|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
125244886|NCT06038643|450520187|FG000|Overall Study|Withdrawal by Subject|9|||
125393959|NCT01218516|451075831|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
125393960|NCT01218516|451075828|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
125244887|NCT06038643|450520188|FG001|Overall Study|Withdrawal by Subject|4|||
125244888|NCT06038643|450520187|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
125244889|NCT06038643|450520188|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
125244890|NCT05259033|450520198|FG000|Overall Study|Withdrawal by Subject|10|||
125244891|NCT05259033|450520199|FG001|Overall Study|Withdrawal by Subject|5|||
125244892|NCT05259033|450520198|FG000|Overall Study|Lost to Follow-up|1|||
125244893|NCT05259033|450520199|FG001|Overall Study|Lost to Follow-up|0|||
125244894|NCT05259033|450520198|FG000|Overall Study|Death|2|||
125244895|NCT05259033|450520199|FG001|Overall Study|Death|0|||
125244896|NCT04210375|450520200|FG000|Overall Study|Death|0|||
125244897|NCT04210375|450520201|FG001|Overall Study|Death|1|||
125244898|NCT04210375|450520202|FG002|Overall Study|Death|0|||
125244899|NCT04210375|450520203|FG003|Overall Study|Death|0|||
125244900|NCT01405911|450520204|FG000|Overall Study|Pre-treatment lab AE|0|||
125393961|NCT01218516|451075829|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
125393962|NCT01218516|451075830|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
125393963|NCT01218516|451075831|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
125393964|NCT01218516|451075828|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
125393965|NCT01218516|451075829|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
125393966|NCT01218516|451075830|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
125393967|NCT01218516|451075831|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
125393968|NCT01218516|451075828|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
125393969|NCT01218516|451075829|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
125393970|NCT01218516|451075830|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
125393971|NCT01218516|451075831|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
125191702|NCT03777436|450324293|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
125191703|NCT03777436|450324294|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
125191704|NCT03777436|450324292|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
125191705|NCT03777436|450324293|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
125191706|NCT03777436|450324294|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
125191707|NCT03777436|450324292|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
125191708|NCT03777436|450324293|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
125191709|NCT03777436|450324294|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
125191710|NCT03777436|450324292|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
125191711|NCT03777436|450324293|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
125191712|NCT03777436|450324294|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
125191713|NCT03777436|450324292|FG000|Placebo-controlled Phase|Physician Decision|0|||
125191714|NCT03777436|450324293|FG001|Placebo-controlled Phase|Physician Decision|1|||
125191715|NCT03777436|450324294|FG002|Placebo-controlled Phase|Physician Decision|0|||
125191716|NCT03777436|450324292|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
125191717|NCT03777436|450324293|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
125191718|NCT03777436|450324294|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
125191719|NCT03777436|450324292|FG000|Apremilast Extension Phase|Adverse Event|0|||
125191720|NCT03777436|450324293|FG001|Apremilast Extension Phase|Adverse Event|0|||
125191721|NCT03777436|450324294|FG002|Apremilast Extension Phase|Adverse Event|6|||
125191722|NCT03777436|450324292|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
125191723|NCT03777436|450324293|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
125191724|NCT03777436|450324294|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
125191725|NCT03777436|450324292|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
125191726|NCT03777436|450324293|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
125191727|NCT03777436|450324294|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
125191728|NCT03777436|450324292|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
125191729|NCT03777436|450324293|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
125191730|NCT03777436|450324294|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
125191731|NCT03777436|450324292|FG000|Apremilast Extension Phase|Miscellaneous|0|||
125191732|NCT03777436|450324293|FG001|Apremilast Extension Phase|Miscellaneous|0|||
125191733|NCT03777436|450324294|FG002|Apremilast Extension Phase|Miscellaneous|1|||
125191734|NCT00869999|450324297|FG000|Overall Study|Withdrawal by Subject|1|||
125191735|NCT00869999|450324297|FG000|Overall Study|removed prior to starting therapy|1|||
125191736|NCT04478695|450324298|FG000|Overall Study|Death|1|||
125191737|NCT04478695|450324299|FG001|Overall Study|Death|0|||
125191738|NCT00644917|450324300|FG000|Overall Study|Withdrawal by Subject|2|||
125191739|NCT00758485|450324301|FG000|Overall Study|Lost to Follow-up|0|||
125191740|NCT00758485|450324302|FG001|Overall Study|Lost to Follow-up|1|||
125191741|NCT00758485|450324301|FG000|Overall Study|Not Treated|1|||
125191742|NCT00758485|450324302|FG001|Overall Study|Not Treated|2|||
125191743|NCT02347774|450324303|FG000|Study Participation|Lost to Follow-up|3|||
125191744|NCT02347774|450324304|FG001|Study Participation|Lost to Follow-up|6|||
125191745|NCT02347774|450324305|FG002|Study Participation|Lost to Follow-up|2|||
125191746|NCT02347774|450324303|FG000|Study Participation|Withdrawal by Subject|8|||
125191747|NCT02347774|450324304|FG001|Study Participation|Withdrawal by Subject|9|||
125191748|NCT02347774|450324305|FG002|Study Participation|Withdrawal by Subject|15|||
125191749|NCT02347774|450324303|FG000|Study Participation|Adverse Event|1|||
125191750|NCT02347774|450324304|FG001|Study Participation|Adverse Event|4|||
125191751|NCT02347774|450324305|FG002|Study Participation|Adverse Event|6|||
125191752|NCT02347774|450324303|FG000|Study Participation|withdrew consent|1|||
125191753|NCT02347774|450324304|FG001|Study Participation|withdrew consent|1|||
125191754|NCT02347774|450324305|FG002|Study Participation|withdrew consent|1|||
125191755|NCT02347774|450324303|FG000|Study Participation|Met Prolonged QT criteria|1|||
125191756|NCT02347774|450324304|FG001|Study Participation|Met Prolonged QT criteria|0|||
125191757|NCT02347774|450324305|FG002|Study Participation|Met Prolonged QT criteria|0|||
125191758|NCT02347774|450324303|FG000|Study Participation|non-compliance with study drug|0|||
125191759|NCT02347774|450324304|FG001|Study Participation|non-compliance with study drug|1|||
125191760|NCT02347774|450324305|FG002|Study Participation|non-compliance with study drug|0|||
125191761|NCT02347774|450324303|FG000|Study Participation|incarceration|1|||
125244901|NCT01405911|450520205|FG001|Overall Study|Pre-treatment lab AE|1|||
125244902|NCT01405911|450520206|FG002|Overall Study|Pre-treatment lab AE|0|||
125244903|NCT01405911|450520204|FG000|Overall Study|Lost to Follow-up|0|||
125244904|NCT01405911|450520205|FG001|Overall Study|Lost to Follow-up|1|||
125244905|NCT01405911|450520206|FG002|Overall Study|Lost to Follow-up|0|||
125244906|NCT01405911|450520204|FG000|Overall Study|Protocol Violation|1|||
125244907|NCT01405911|450520205|FG001|Overall Study|Protocol Violation|0|||
125244908|NCT01405911|450520206|FG002|Overall Study|Protocol Violation|0|||
125244909|NCT01405911|450520204|FG000|Overall Study|Withdrawal by Subject|3|||
125244910|NCT01405911|450520205|FG001|Overall Study|Withdrawal by Subject|1|||
125244911|NCT01405911|450520206|FG002|Overall Study|Withdrawal by Subject|1|||
125244912|NCT01980888|450520209|FG000|Overall Study|Study Terminated by Sponsor|116|||
125244913|NCT01980888|450520210|FG001|Overall Study|Study Terminated by Sponsor|122|||
125244914|NCT01980888|450520209|FG000|Overall Study|Withdrew Consent|17|||
125244915|NCT01980888|450520210|FG001|Overall Study|Withdrew Consent|6|||
125244916|NCT01980888|450520209|FG000|Overall Study|Investigator's Discretion|8|||
125244917|NCT01980888|450520210|FG001|Overall Study|Investigator's Discretion|3|||
125244918|NCT01980888|450520209|FG000|Overall Study|Non-Compliance with Study Drug|3|||
125244919|NCT01980888|450520210|FG001|Overall Study|Non-Compliance with Study Drug|2|||
125244920|NCT05762744|450520212|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
125244921|NCT05762744|450520213|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
125244922|NCT05762744|450520212|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
125244923|NCT05762744|450520213|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
125244924|NCT01671059|450520214|FG000|Overall Study|Adverse Event|4|||
125244925|NCT01671059|450520214|FG000|Overall Study|Lack of Efficacy|1|||
125244926|NCT01560416|450520215|FG000|Randomized Phase|Crossover Participants|7|||
125244927|NCT01560416|450520216|FG001|Randomized Phase|Crossover Participants|0|||
125244928|NCT03334175|450520217|FG000|Overall Study|Lost to Follow-up|0|||
125244929|NCT03334175|450520218|FG001|Overall Study|Lost to Follow-up|1|||
125244930|NCT03738215|450520219|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
125244931|NCT03738215|450520220|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
125244932|NCT03738215|450520221|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
125244933|NCT03738215|450520219|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
125244934|NCT03738215|450520220|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
125244935|NCT03738215|450520221|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
125244936|NCT03738215|450520219|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
125244937|NCT03738215|450520220|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
125244938|NCT03738215|450520221|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
125244939|NCT03738215|450520219|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
125244940|NCT03738215|450520220|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
125244941|NCT03738215|450520221|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
125244942|NCT03738215|450520219|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
125244943|NCT03738215|450520220|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
125244944|NCT03738215|450520221|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
125244945|NCT03738215|450520219|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
125244946|NCT03738215|450520220|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
125244947|NCT03738215|450520221|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
125244948|NCT03738215|450520219|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
125244949|NCT03738215|450520220|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
125244950|NCT03738215|450520221|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
125244951|NCT03738215|450520219|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
125244952|NCT03738215|450520220|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
125244953|NCT03738215|450520221|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
125244954|NCT03738215|450520219|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
125244955|NCT03738215|450520220|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
125244956|NCT03738215|450520221|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
125244957|NCT03738215|450520219|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
125244958|NCT03738215|450520220|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
125443533|NCT00551213|451252165|FG001|Overall Study|Progressive Disease|12|||
125244959|NCT03738215|450520221|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
125244960|NCT01695772|450520222|FG000|Overall Study|Withdrawal by Subject|18|||
125244961|NCT01695772|450520222|FG000|Overall Study|Progressive Disease|8|||
125244962|NCT01695772|450520222|FG000|Overall Study|Investigator Decision|5|||
125244963|NCT01695772|450520222|FG000|Overall Study|Lost to Follow-up|4|||
125244964|NCT01695772|450520222|FG000|Overall Study|Protocol Violation|2|||
125244965|NCT01695772|450520222|FG000|Overall Study|Unspecified Reason|1|||
125244966|NCT04073407|450520226|FG000|Part 1|Withdrawal by Subject|1|||
125244967|NCT04073407|450520227|FG001|Part 1|Withdrawal by Subject|0|||
125303083|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125443534|NCT00551213|451252164|FG000|Overall Study|Withdrawal by Subject|2|||
125191762|NCT02347774|450324304|FG001|Study Participation|incarceration|0|||
125191763|NCT02347774|450324305|FG002|Study Participation|incarceration|0|||
125191764|NCT02347774|450324303|FG000|Study Participation|randomized in error|0|||
125191765|NCT02347774|450324304|FG001|Study Participation|randomized in error|0|||
125191766|NCT02347774|450324305|FG002|Study Participation|randomized in error|1|||
125191767|NCT02347774|450324303|FG000|On Study Treatment|Adverse Event|9|||
125191768|NCT02347774|450324304|FG001|On Study Treatment|Adverse Event|15|||
125191769|NCT02347774|450324305|FG002|On Study Treatment|Adverse Event|19|||
125191770|NCT02347774|450324303|FG000|On Study Treatment|Lack of Efficacy|3|||
125191771|NCT02347774|450324304|FG001|On Study Treatment|Lack of Efficacy|0|||
125191772|NCT02347774|450324305|FG002|On Study Treatment|Lack of Efficacy|2|||
125191773|NCT02347774|450324303|FG000|On Study Treatment|non-complicance with study medication|0|||
125191774|NCT02347774|450324304|FG001|On Study Treatment|non-complicance with study medication|2|||
125191775|NCT02347774|450324305|FG002|On Study Treatment|non-complicance with study medication|0|||
125191776|NCT02347774|450324303|FG000|On Study Treatment|Protocol Violation|0|||
125191777|NCT02347774|450324304|FG001|On Study Treatment|Protocol Violation|0|||
125191778|NCT02347774|450324305|FG002|On Study Treatment|Protocol Violation|1|||
125191779|NCT02347774|450324303|FG000|On Study Treatment|withdrew consent|9|||
125191780|NCT02347774|450324304|FG001|On Study Treatment|withdrew consent|8|||
125191781|NCT02347774|450324305|FG002|On Study Treatment|withdrew consent|12|||
125191782|NCT02347774|450324303|FG000|On Study Treatment|Lost to Follow-up|2|||
125191783|NCT02347774|450324304|FG001|On Study Treatment|Lost to Follow-up|6|||
125191784|NCT02347774|450324305|FG002|On Study Treatment|Lost to Follow-up|1|||
125191785|NCT02347774|450324303|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
125191786|NCT02347774|450324304|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
125191787|NCT02347774|450324305|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
125191788|NCT02347774|450324303|FG000|On Study Treatment|ranomized in error|0|||
125191789|NCT02347774|450324304|FG001|On Study Treatment|ranomized in error|0|||
125191790|NCT02347774|450324305|FG002|On Study Treatment|ranomized in error|1|||
125191791|NCT00656292|450324306|FG000|Overall Study|Withdrawal by Subject|2|||
125191792|NCT00656292|450324307|FG001|Overall Study|Withdrawal by Subject|3|||
125191793|NCT00656292|450324306|FG000|Overall Study|Screen failure|1|||
125191794|NCT00656292|450324307|FG001|Overall Study|Screen failure|2|||
125191795|NCT00921557|450324308|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
125191796|NCT00921557|450324309|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
125191797|NCT00921557|450324310|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
125191798|NCT00921557|450324308|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
125191799|NCT00921557|450324309|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
125191800|NCT00921557|450324310|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
125191801|NCT00921557|450324308|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
125191802|NCT00921557|450324309|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
125191803|NCT00921557|450324310|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
125191804|NCT00921557|450324308|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
125191805|NCT00921557|450324309|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
125191806|NCT00921557|450324310|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
125191807|NCT00921557|450324308|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
125191808|NCT00921557|450324309|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
125191809|NCT00921557|450324310|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
125191810|NCT01431716|450324318|FG000|Overall Study|Withdrawal of consent|1|||
125191811|NCT01303172|450324329|FG000|Overall Study|Physician Decision|9|||
125191812|NCT01303172|450324330|FG001|Overall Study|Physician Decision|6|||
125191813|NCT01303172|450324329|FG000|Overall Study|Adverse Event|5|||
125191814|NCT01303172|450324330|FG001|Overall Study|Adverse Event|2|||
125191815|NCT01303172|450324329|FG000|Overall Study|Withdrawal by Subject|4|||
125191816|NCT01303172|450324330|FG001|Overall Study|Withdrawal by Subject|2|||
125191817|NCT01303172|450324329|FG000|Overall Study|Death|20|||
125191818|NCT01303172|450324330|FG001|Overall Study|Death|7|||
125191819|NCT01303172|450324329|FG000|Overall Study|Lack of Efficacy|25|||
125191820|NCT01303172|450324330|FG001|Overall Study|Lack of Efficacy|17|||
125191821|NCT00462709|450324335|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
125191822|NCT00462709|450324335|FG000|Overall Study|Lost to Follow-up|10|||
125191823|NCT00462709|450324335|FG000|Overall Study|Withdrawal by Subject|8|||
125191824|NCT00462709|450324335|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
125191825|NCT00462709|450324335|FG000|Overall Study|Death|2|||
125191826|NCT00462709|450324335|FG000|Overall Study|Logistical reasons|2|||
125244968|NCT04073407|450520226|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
125191827|NCT00462709|450324335|FG000|Overall Study|Physician Decision|1|||
125191828|NCT00462709|450324335|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
125191829|NCT04468347|450324340|FG000|Overall Study|Withdrawal by Subject|0|||
125191830|NCT04468347|450324341|FG001|Overall Study|Withdrawal by Subject|1|||
125191831|NCT04468347|450324342|FG002|Overall Study|Withdrawal by Subject|3|||
125191832|NCT04468347|450324343|FG003|Overall Study|Withdrawal by Subject|3|||
125191833|NCT04468347|450324340|FG000|Overall Study|Lost to Follow-up|0|||
125191834|NCT04468347|450324341|FG001|Overall Study|Lost to Follow-up|0|||
125191835|NCT04468347|450324342|FG002|Overall Study|Lost to Follow-up|1|||
125191836|NCT04468347|450324343|FG003|Overall Study|Lost to Follow-up|1|||
125191837|NCT04468347|450324340|FG000|Overall Study|Physician Decision|1|||
125191838|NCT04468347|450324341|FG001|Overall Study|Physician Decision|0|||
125191839|NCT04468347|450324342|FG002|Overall Study|Physician Decision|2|||
125191840|NCT04468347|450324343|FG003|Overall Study|Physician Decision|0|||
125191841|NCT04468347|450324340|FG000|Overall Study|Protocol Violation|1|||
125191842|NCT04468347|450324341|FG001|Overall Study|Protocol Violation|0|||
125191843|NCT04468347|450324342|FG002|Overall Study|Protocol Violation|0|||
125191844|NCT04468347|450324343|FG003|Overall Study|Protocol Violation|0|||
125191845|NCT00554515|450324344|FG000|Overall Study|Withdrawal by Subject|3|||
125191846|NCT00554515|450324344|FG000|Overall Study|Disease progression|52|||
125191847|NCT00554515|450324344|FG000|Overall Study|Physician Decision|18|||
125191848|NCT00554515|450324344|FG000|Overall Study|Withdrawal by Subject|11|||
125191849|NCT00554515|450324344|FG000|Overall Study|Adverse Event|9|||
125191850|NCT00554515|450324344|FG000|Overall Study|Death|2|||
125191851|NCT00554515|450324344|FG000|Overall Study|Achieved Stable Disease|7|||
125191852|NCT00554515|450324344|FG000|Overall Study|Other|1|||
125191853|NCT00554515|450324344|FG000|Overall Study|Misc|15|||
125191854|NCT00488644|450324345|FG000|Overall Study|Not Eligible|1|||
125191855|NCT00488644|450324345|FG000|Overall Study|Not Evaluable|1|||
125191856|NCT02977572|450324346|FG000|Overall Study|Exclusion criterion|2|||
125191857|NCT02977572|450324347|FG001|Overall Study|Exclusion criterion|2|||
125191858|NCT05107492|450324348|FG000|Overall Study|Lost to Follow-up|1|||
125191859|NCT05107492|450324349|FG001|Overall Study|Lost to Follow-up|0|||
125191860|NCT01197534|450324351|FG000|Overall Study|Not reported|16|||
125191861|NCT01197534|450324352|FG001|Overall Study|Not reported|10|||
125191862|NCT01197534|450324353|FG002|Overall Study|Not reported|16|||
125191863|NCT01197534|450324351|FG000|Overall Study|Enrolment in long term extension|57|||
125191864|NCT01197534|450324352|FG001|Overall Study|Enrolment in long term extension|66|||
125191865|NCT01197534|450324353|FG002|Overall Study|Enrolment in long term extension|119|||
125191866|NCT01197534|450324351|FG000|Overall Study|Severe non-compliance to protocol|3|||
125191867|NCT01197534|450324352|FG001|Overall Study|Severe non-compliance to protocol|4|||
125191868|NCT01197534|450324353|FG002|Overall Study|Severe non-compliance to protocol|1|||
125191869|NCT01197534|450324351|FG000|Overall Study|Lack of therapeutic response|9|||
125191870|NCT01197534|450324352|FG001|Overall Study|Lack of therapeutic response|4|||
125191871|NCT01197534|450324353|FG002|Overall Study|Lack of therapeutic response|9|||
125191872|NCT01197534|450324351|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
125191873|NCT01197534|450324352|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
125191874|NCT01197534|450324353|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
125191875|NCT01197534|450324351|FG000|Overall Study|Lost to Follow-up|1|||
125191876|NCT01197534|450324352|FG001|Overall Study|Lost to Follow-up|4|||
125191877|NCT01197534|450324353|FG002|Overall Study|Lost to Follow-up|2|||
125191878|NCT01197534|450324351|FG000|Overall Study|Adverse Event|35|||
125191879|NCT01197534|450324352|FG001|Overall Study|Adverse Event|36|||
125191880|NCT01197534|450324353|FG002|Overall Study|Adverse Event|24|||
125191881|NCT02522884|450324357|FG000|Overall Study|Withdrawal by Subject|6|||
125191882|NCT02522884|450324357|FG000|Overall Study|Death|3|||
125191883|NCT02522884|450324357|FG000|Overall Study|Missed 12-month Follow-up|9|||
125191884|NCT00591565|450324358|FG000|Overall Study|lost follow up, withdrawn|5|||
125191885|NCT03564119|450324362|FG000|Overall Study|Adverse Event|4|||
125191886|NCT03564119|450324363|FG001|Overall Study|Adverse Event|0|||
125191887|NCT03564119|450324362|FG000|Overall Study|Lost to Follow-up|1|||
125191888|NCT03564119|450324363|FG001|Overall Study|Lost to Follow-up|4|||
125191889|NCT03564119|450324362|FG000|Overall Study|Protocol Violation|1|||
125191890|NCT03564119|450324363|FG001|Overall Study|Protocol Violation|0|||
125191891|NCT03564119|450324362|FG000|Overall Study|Withdrawal by Subject|9|||
125191892|NCT03564119|450324363|FG001|Overall Study|Withdrawal by Subject|4|||
125191893|NCT03564119|450324362|FG000|Overall Study|Other Than Specified|0|||
125191894|NCT03564119|450324363|FG001|Overall Study|Other Than Specified|1|||
125191895|NCT00634036|450324364|FG000|Overall Study|Lost to Follow-up|1|||
125191896|NCT00634036|450324365|FG001|Overall Study|Lost to Follow-up|1|||
125191897|NCT00634036|450324364|FG000|Overall Study|Withdrawal by Subject|1|||
125191898|NCT00634036|450324365|FG001|Overall Study|Withdrawal by Subject|1|||
125191899|NCT03896022|450324371|FG000|Overall Study|Withdrawal by Subject|1|||
125191900|NCT03896022|450324372|FG001|Overall Study|Withdrawal by Subject|0|||
125191901|NCT03896022|450324373|FG002|Overall Study|Withdrawal by Subject|0|||
125191902|NCT03896022|450324371|FG000|Overall Study|Did not have procedure|3|||
125191903|NCT03896022|450324372|FG001|Overall Study|Did not have procedure|0|||
125191904|NCT03896022|450324373|FG002|Overall Study|Did not have procedure|0|||
125191905|NCT00615550|450324378|FG000|Overall Study|Lost to Follow-up|6|||
125191906|NCT00615550|450324379|FG001|Overall Study|Lost to Follow-up|1|||
125191907|NCT00564850|450324380|FG000|Overall Study|Protocol Violation|2|||
125191908|NCT02640664|450324381|FG000|Epoch 1|Withdrawal of informed consent|1|||
125191909|NCT02640664|450324382|FG001|Epoch 1|Withdrawal of informed consent|0|||
125191910|NCT02640664|450324383|FG002|Epoch 1|Withdrawal of informed consent|0|||
125244969|NCT04073407|450520227|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
125244970|NCT04073407|450520226|FG000|Part 2|Withdrawal by Subject|0|||
125244971|NCT04073407|450520227|FG001|Part 2|Withdrawal by Subject|1|||
125244972|NCT03022630|450521971|FG000|Overall Study|Death|9|||
125244973|NCT03022630|450521972|FG001|Overall Study|Death|7|||
125244974|NCT03022630|450521971|FG000|Overall Study|Withdrawal by Subject|0|||
125244975|NCT03022630|450521972|FG001|Overall Study|Withdrawal by Subject|5|||
125244976|NCT00088881|450521973|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
125244977|NCT00088881|450521973|FG000|Step 1 - R-CHOP|Adverse Event|1|||
125244978|NCT00088881|450521973|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
125244979|NCT00088881|450521973|FG000|Step 1 - R-CHOP|Physician Decision|1|||
125244980|NCT00088881|450521973|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
125244981|NCT00088881|450521973|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
125244982|NCT00088881|450521973|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
125244983|NCT00835978|450521974|FG000|Overall Study|Death|33|||
125244984|NCT00835978|450521975|FG001|Overall Study|Death|40|||
125244985|NCT00835978|450521976|FG002|Overall Study|Death|49|||
125244986|NCT00835978|450521977|FG003|Overall Study|Death|4|||
125244987|NCT00835978|450521974|FG000|Overall Study|Lost to Follow-up|3|||
125244988|NCT00835978|450521975|FG001|Overall Study|Lost to Follow-up|4|||
125244989|NCT00835978|450521976|FG002|Overall Study|Lost to Follow-up|2|||
125244990|NCT00835978|450521977|FG003|Overall Study|Lost to Follow-up|1|||
125244991|NCT00835978|450521974|FG000|Overall Study|Other|5|||
125244992|NCT00835978|450521975|FG001|Overall Study|Other|1|||
125244993|NCT00835978|450521976|FG002|Overall Study|Other|8|||
125244994|NCT00835978|450521977|FG003|Overall Study|Other|0|||
125244995|NCT00835978|450521974|FG000|Overall Study|Objective progression or relapse|2|||
125244996|NCT00835978|450521975|FG001|Overall Study|Objective progression or relapse|0|||
125244997|NCT00835978|450521976|FG002|Overall Study|Objective progression or relapse|1|||
125244998|NCT00835978|450521977|FG003|Overall Study|Objective progression or relapse|0|||
125244999|NCT00835978|450521974|FG000|Overall Study|Adverse Event|1|||
125245000|NCT00835978|450521975|FG001|Overall Study|Adverse Event|0|||
125245001|NCT00835978|450521976|FG002|Overall Study|Adverse Event|1|||
125245002|NCT00835978|450521977|FG003|Overall Study|Adverse Event|0|||
125245003|NCT00835978|450521974|FG000|Overall Study|Withdrawal by Subject|0|||
125245004|NCT00835978|450521975|FG001|Overall Study|Withdrawal by Subject|3|||
125245005|NCT00835978|450521976|FG002|Overall Study|Withdrawal by Subject|0|||
125245006|NCT00835978|450521977|FG003|Overall Study|Withdrawal by Subject|5|||
125245007|NCT00835978|450521974|FG000|Overall Study|Study terminated by sponsor|12|||
125245008|NCT00835978|450521975|FG001|Overall Study|Study terminated by sponsor|8|||
125245009|NCT00835978|450521976|FG002|Overall Study|Study terminated by sponsor|30|||
125245010|NCT00835978|450521977|FG003|Overall Study|Study terminated by sponsor|0|||
125245011|NCT02927145|450521978|FG000|Initial Recruitment|Withdrawal by Subject|0|||
125245012|NCT02927145|450521979|FG001|Initial Recruitment|Withdrawal by Subject|1|||
125245013|NCT02927145|450521980|FG002|Initial Recruitment|Withdrawal by Subject|1|||
125245014|NCT02927145|450521981|FG003|Initial Recruitment|Withdrawal by Subject|4|||
125245015|NCT02927145|450521982|FG004|Initial Recruitment|Withdrawal by Subject|1|||
125245016|NCT02927145|450521983|FG005|Initial Recruitment|Withdrawal by Subject|1|||
125245017|NCT02927145|450521984|FG006|Initial Recruitment|Withdrawal by Subject|0|||
125245018|NCT02927145|450521985|FG007|Initial Recruitment|Withdrawal by Subject|0|||
125245019|NCT02927145|450521986|FG008|Initial Recruitment|Withdrawal by Subject|2|||
125245020|NCT02927145|450521978|FG000|Initial Recruitment|Adverse Event|0|||
125245021|NCT02927145|450521979|FG001|Initial Recruitment|Adverse Event|0|||
125245022|NCT02927145|450521980|FG002|Initial Recruitment|Adverse Event|0|||
125245023|NCT02927145|450521981|FG003|Initial Recruitment|Adverse Event|0|||
125245024|NCT02927145|450521982|FG004|Initial Recruitment|Adverse Event|2|||
125245025|NCT02927145|450521983|FG005|Initial Recruitment|Adverse Event|0|||
125245026|NCT02927145|450521984|FG006|Initial Recruitment|Adverse Event|0|||
125245027|NCT02927145|450521985|FG007|Initial Recruitment|Adverse Event|0|||
125245028|NCT02927145|450521986|FG008|Initial Recruitment|Adverse Event|0|||
125245029|NCT02927145|450521978|FG000|Invitation for Additional Challenge|Pregnancy|0|||
125245030|NCT02927145|450521979|FG001|Invitation for Additional Challenge|Pregnancy|0|||
125245031|NCT02927145|450521980|FG002|Invitation for Additional Challenge|Pregnancy|0|||
125245032|NCT02927145|450521981|FG003|Invitation for Additional Challenge|Pregnancy|0|||
125245033|NCT02927145|450521982|FG004|Invitation for Additional Challenge|Pregnancy|0|||
125245034|NCT02927145|450521983|FG005|Invitation for Additional Challenge|Pregnancy|0|||
125245035|NCT02927145|450521984|FG006|Invitation for Additional Challenge|Pregnancy|1|||
125245036|NCT02927145|450521985|FG007|Invitation for Additional Challenge|Pregnancy|0|||
125245037|NCT02927145|450521986|FG008|Invitation for Additional Challenge|Pregnancy|0|||
125245038|NCT00327171|450521987|FG000|Overall Study|Did not receive study medication|3|||
125245039|NCT00327171|450521988|FG001|Overall Study|Did not receive study medication|0|||
125245040|NCT00327171|450521987|FG000|Overall Study|Adverse Event|23|||
125245041|NCT00327171|450521988|FG001|Overall Study|Adverse Event|23|||
125420829|NCT01260350|451166146|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125245042|NCT00327171|450521987|FG000|Overall Study|Disease progression/lack of efficacy|68|||
125245043|NCT00327171|450521988|FG001|Overall Study|Disease progression/lack of efficacy|69|||
125191911|NCT02640664|450324381|FG000|Epoch 1|Death|0|||
125191912|NCT02640664|450324382|FG001|Epoch 1|Death|0|||
125191913|NCT02640664|450324383|FG002|Epoch 1|Death|1|||
125191914|NCT02640664|450324381|FG000|Epoch 2|Withdrawal of informed consent|3|||
125191915|NCT02640664|450324382|FG001|Epoch 2|Withdrawal of informed consent|4|||
125191916|NCT02640664|450324383|FG002|Epoch 2|Withdrawal of informed consent|2|||
125191917|NCT02640664|450324381|FG000|Epoch 2|Subject/guardian decision|0|||
125191918|NCT02640664|450324382|FG001|Epoch 2|Subject/guardian decision|2|||
125191919|NCT02640664|450324383|FG002|Epoch 2|Subject/guardian decision|2|||
125191920|NCT02640664|450324381|FG000|Epoch 2|Lost to Follow-up|3|||
125191921|NCT02640664|450324382|FG001|Epoch 2|Lost to Follow-up|4|||
125191922|NCT02640664|450324383|FG002|Epoch 2|Lost to Follow-up|1|||
125191923|NCT02640664|450324381|FG000|Epoch 2|Death|0|||
125191924|NCT02640664|450324382|FG001|Epoch 2|Death|0|||
125191925|NCT02640664|450324383|FG002|Epoch 2|Death|1|||
125191926|NCT00314327|450324384|FG000|Overall Study|Withdrawal by Subject|1|||
125191927|NCT02741076|450324387|FG000|Overall Study|Adverse Event|0|||
125191928|NCT02741076|450324388|FG001|Overall Study|Adverse Event|1|||
125191929|NCT02741076|450324389|FG002|Overall Study|Adverse Event|1|||
125191930|NCT02741076|450324390|FG003|Overall Study|Adverse Event|0|||
125191931|NCT02741076|450324387|FG000|Overall Study|Lack of Efficacy|1|||
125191932|NCT02741076|450324388|FG001|Overall Study|Lack of Efficacy|0|||
125191933|NCT02741076|450324389|FG002|Overall Study|Lack of Efficacy|0|||
125191934|NCT02741076|450324390|FG003|Overall Study|Lack of Efficacy|0|||
125191935|NCT02741076|450324387|FG000|Overall Study|Withdrawal by Subject|0|||
125191936|NCT02741076|450324388|FG001|Overall Study|Withdrawal by Subject|1|||
125191937|NCT02741076|450324389|FG002|Overall Study|Withdrawal by Subject|0|||
125191938|NCT02741076|450324390|FG003|Overall Study|Withdrawal by Subject|0|||
125191939|NCT02741076|450324387|FG000|Overall Study|Sponsor Request|2|||
125191940|NCT02741076|450324388|FG001|Overall Study|Sponsor Request|3|||
125191941|NCT02741076|450324389|FG002|Overall Study|Sponsor Request|0|||
125191942|NCT02741076|450324390|FG003|Overall Study|Sponsor Request|1|||
125191943|NCT02741076|450324387|FG000|Overall Study|No additional information available|0|||
125191944|NCT02741076|450324388|FG001|Overall Study|No additional information available|0|||
125191945|NCT02741076|450324389|FG002|Overall Study|No additional information available|1|||
125191946|NCT02741076|450324390|FG003|Overall Study|No additional information available|1|||
125191947|NCT02748213|450324393|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
125191948|NCT02748213|450324394|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
125191949|NCT02748213|450324393|FG000|Overall Study|Abnormal Laboratory Test|1|||
125191950|NCT02748213|450324394|FG001|Overall Study|Abnormal Laboratory Test|0|||
125191951|NCT02748213|450324393|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
125191952|NCT02748213|450324394|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
125191953|NCT02748213|450324393|FG000|Overall Study|Death|5|||
125191954|NCT02748213|450324394|FG001|Overall Study|Death|3|||
125191955|NCT02748213|450324393|FG000|Overall Study|Insufficient Therapeutic Response|56|||
125191956|NCT02748213|450324394|FG001|Overall Study|Insufficient Therapeutic Response|57|||
125191957|NCT02748213|450324393|FG000|Overall Study|Violation of Selection Criteria|2|||
125191958|NCT02748213|450324394|FG001|Overall Study|Violation of Selection Criteria|0|||
125191959|NCT02748213|450324393|FG000|Overall Study|Protocol Violation|6|||
125191960|NCT02748213|450324394|FG001|Overall Study|Protocol Violation|4|||
125191961|NCT02748213|450324393|FG000|Overall Study|Refused Treatment*|6|||
125191962|NCT02748213|450324394|FG001|Overall Study|Refused Treatment*|6|||
125191963|NCT02748213|450324393|FG000|Overall Study|Failure to Return|1|||
125191964|NCT02748213|450324394|FG001|Overall Study|Failure to Return|0|||
125191965|NCT02748213|450324393|FG000|Overall Study|Other|30|||
125191966|NCT02748213|450324394|FG001|Overall Study|Other|29|||
125191967|NCT04200651|450324395|FG000|Overall Study|Moved to another country during follow-up|2|||
125191968|NCT04200651|450324396|FG001|Overall Study|Moved to another country during follow-up|2|||
125191969|NCT04200651|450324395|FG000|Overall Study|Lost to Follow-up|1|||
125191970|NCT04200651|450324396|FG001|Overall Study|Lost to Follow-up|3|||
125191971|NCT03225105|450324398|FG000|Overall Study|Withdrawal by Subject|1|||
125191972|NCT03225105|450324399|FG001|Overall Study|Withdrawal by Subject|0|||
125191973|NCT03225105|450324400|FG002|Overall Study|Withdrawal by Subject|0|||
125191974|NCT03225105|450324401|FG003|Overall Study|Withdrawal by Subject|0|||
125191975|NCT03225105|450324398|FG000|Overall Study|Death|0|||
125191976|NCT03225105|450324399|FG001|Overall Study|Death|4|||
125191977|NCT03225105|450324400|FG002|Overall Study|Death|2|||
125191978|NCT03225105|450324401|FG003|Overall Study|Death|0|||
125191979|NCT03225105|450324398|FG000|Overall Study|Study termination per Sponsor Decision|2|||
125191980|NCT03225105|450324399|FG001|Overall Study|Study termination per Sponsor Decision|0|||
125191981|NCT03225105|450324400|FG002|Overall Study|Study termination per Sponsor Decision|3|||
125191982|NCT03225105|450324401|FG003|Overall Study|Study termination per Sponsor Decision|3|||
125191983|NCT01500382|450324402|FG000|Washout Period|Study site went out of business|0|||
125191984|NCT01500382|450324403|FG001|Washout Period|Study site went out of business|0|||
125191985|NCT01500382|450324404|FG002|Washout Period|Study site went out of business|1|||
125191986|NCT01500382|450324405|FG003|Washout Period|Study site went out of business|0|||
125191987|NCT00617890|450326043|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
125245044|NCT00327171|450521987|FG000|Overall Study|Investigator/participant request|1|||
125245045|NCT00327171|450521988|FG001|Overall Study|Investigator/participant request|8|||
125245046|NCT00327171|450521987|FG000|Overall Study|Clinical progression|12|||
125245047|NCT00327171|450521988|FG001|Overall Study|Clinical progression|8|||
125245048|NCT00327171|450521987|FG000|Overall Study|Undisclosed history of ischemia|0|||
125245049|NCT00327171|450521988|FG001|Overall Study|Undisclosed history of ischemia|1|||
125245050|NCT00327171|450521987|FG000|Overall Study|Other|1|||
125245051|NCT00327171|450521988|FG001|Overall Study|Other|0|||
125245052|NCT02506036|450521991|FG000|First Intervention (4-6 Weeks)|Death|1|||
125245053|NCT02506036|450521992|FG001|First Intervention (4-6 Weeks)|Death|0|||
125245054|NCT02506036|450521991|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
125245055|NCT02506036|450521992|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
125245056|NCT02506036|450521991|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
125245057|NCT02506036|450521992|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
125245058|NCT00530075|450521993|FG000|Overall Study|Adverse Event|1|||
125245059|NCT00530075|450521993|FG000|Overall Study|Death|1|||
125245060|NCT00530075|450521993|FG000|Overall Study|Lack of Efficacy|3|||
125191988|NCT00617890|450326044|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
125191989|NCT00617890|450326045|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
125191990|NCT00617890|450326046|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
125191991|NCT00617890|450326043|FG000|Overall Study|Lack of Efficacy|23|||
125191992|NCT00617890|450326044|FG001|Overall Study|Lack of Efficacy|26|||
125191993|NCT00617890|450326045|FG002|Overall Study|Lack of Efficacy|30|||
125191994|NCT00617890|450326046|FG003|Overall Study|Lack of Efficacy|97|||
125191995|NCT00617890|450326043|FG000|Overall Study|Lost to Follow-up|0|||
125191996|NCT00617890|450326044|FG001|Overall Study|Lost to Follow-up|0|||
125191997|NCT00617890|450326045|FG002|Overall Study|Lost to Follow-up|1|||
125191998|NCT00617890|450326046|FG003|Overall Study|Lost to Follow-up|2|||
125191999|NCT00617890|450326043|FG000|Overall Study|Withdrawal by Subject|4|||
125192000|NCT00617890|450326044|FG001|Overall Study|Withdrawal by Subject|1|||
125192001|NCT00617890|450326045|FG002|Overall Study|Withdrawal by Subject|0|||
125192002|NCT00617890|450326046|FG003|Overall Study|Withdrawal by Subject|2|||
125192003|NCT00617890|450326043|FG000|Overall Study|Protocol Violation|2|||
125192004|NCT00617890|450326044|FG001|Overall Study|Protocol Violation|1|||
125192005|NCT00617890|450326045|FG002|Overall Study|Protocol Violation|0|||
125192006|NCT00617890|450326046|FG003|Overall Study|Protocol Violation|0|||
125192007|NCT00617890|450326043|FG000|Overall Study|Adverse Event|1|||
125192008|NCT00617890|450326044|FG001|Overall Study|Adverse Event|0|||
125192009|NCT00617890|450326045|FG002|Overall Study|Adverse Event|3|||
125192010|NCT00617890|450326046|FG003|Overall Study|Adverse Event|8|||
125192011|NCT00617890|450326043|FG000|Overall Study|Not treated|1|||
125192012|NCT00617890|450326044|FG001|Overall Study|Not treated|0|||
125192013|NCT00617890|450326045|FG002|Overall Study|Not treated|1|||
125192014|NCT00617890|450326046|FG003|Overall Study|Not treated|1|||
125192015|NCT02640950|450326048|FG000|Overall Study|Adverse Event|1|||
125192016|NCT02640950|450326048|FG000|Overall Study|Withdrawal by Subject|1|||
125192017|NCT00915018|450326049|FG000|Overall Study|Death|75|||
125192018|NCT00915018|450326050|FG001|Overall Study|Death|70|||
125192019|NCT00915018|450326049|FG000|Overall Study|Lost to Follow-up|10|||
125192020|NCT00915018|450326050|FG001|Overall Study|Lost to Follow-up|5|||
125192021|NCT00915018|450326049|FG000|Overall Study|Withdrawal by Subject|38|||
125192022|NCT00915018|450326050|FG001|Overall Study|Withdrawal by Subject|27|||
125192023|NCT00915018|450326049|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
125192024|NCT00915018|450326050|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
125192025|NCT00154284|450326051|FG000|Overall Study|Adverse Event|6|||
125192026|NCT00154284|450326052|FG001|Overall Study|Adverse Event|9|||
125245061|NCT00530075|450521993|FG000|Overall Study|Protocol Violation|1|||
125245062|NCT00530075|450521993|FG000|Overall Study|Withdrawal by Subject|1|||
125245063|NCT00758043|450521994|FG000|Overall Study|Adverse Event|1|||
125245064|NCT00758043|450521995|FG001|Overall Study|Adverse Event|20|||
125245065|NCT00758043|450521996|FG002|Overall Study|Adverse Event|12|||
125192027|NCT00154284|450326051|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125192028|NCT00154284|450326052|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125192029|NCT00154284|450326051|FG000|Overall Study|Lack of Efficacy|1|||
125192030|NCT00154284|450326052|FG001|Overall Study|Lack of Efficacy|2|||
125192031|NCT00154284|450326051|FG000|Overall Study|Protocol Violation|0|||
125192032|NCT00154284|450326052|FG001|Overall Study|Protocol Violation|1|||
125192033|NCT00566020|450326053|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
125192034|NCT00566020|450326054|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
125192035|NCT00566020|450326053|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
125192036|NCT00566020|450326054|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
125192037|NCT00566020|450326053|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
125192038|NCT00566020|450326054|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
125192039|NCT00566020|450326053|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
125192040|NCT00566020|450326054|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
125245066|NCT00758043|450521997|FG003|Overall Study|Adverse Event|62|||
125245067|NCT00758043|450521994|FG000|Overall Study|Lack of Efficacy|0|||
125192041|NCT00566020|450326053|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
125192042|NCT00566020|450326054|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
125192043|NCT00566020|450326053|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
125192044|NCT00566020|450326054|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
125192045|NCT02101736|450326055|FG000|Overall Study|Protocol Violation|3|||
125192046|NCT02101736|450326056|FG001|Overall Study|Protocol Violation|0|||
125245068|NCT00758043|450521995|FG001|Overall Study|Lack of Efficacy|6|||
125245069|NCT00758043|450521996|FG002|Overall Study|Lack of Efficacy|18|||
125245070|NCT00758043|450521997|FG003|Overall Study|Lack of Efficacy|12|||
125245071|NCT00758043|450521994|FG000|Overall Study|Refused Further Treatment|0|||
125245072|NCT00758043|450521995|FG001|Overall Study|Refused Further Treatment|11|||
125245073|NCT00758043|450521996|FG002|Overall Study|Refused Further Treatment|5|||
125245074|NCT00758043|450521997|FG003|Overall Study|Refused Further Treatment|8|||
125245075|NCT00758043|450521994|FG000|Overall Study|Lost to Follow-up|0|||
125245076|NCT00758043|450521995|FG001|Overall Study|Lost to Follow-up|2|||
125245077|NCT00758043|450521996|FG002|Overall Study|Lost to Follow-up|2|||
125245078|NCT00758043|450521997|FG003|Overall Study|Lost to Follow-up|5|||
125245079|NCT00758043|450521994|FG000|Overall Study|Withdrawal by Subject|0|||
125245080|NCT00758043|450521995|FG001|Overall Study|Withdrawal by Subject|1|||
125245081|NCT00758043|450521996|FG002|Overall Study|Withdrawal by Subject|1|||
125245082|NCT00758043|450521997|FG003|Overall Study|Withdrawal by Subject|4|||
125245083|NCT00758043|450521994|FG000|Overall Study|Required Prohibited Medication|0|||
125245084|NCT00758043|450521995|FG001|Overall Study|Required Prohibited Medication|0|||
125245085|NCT00758043|450521996|FG002|Overall Study|Required Prohibited Medication|1|||
125245086|NCT00758043|450521997|FG003|Overall Study|Required Prohibited Medication|3|||
125245087|NCT00758043|450521994|FG000|Overall Study|Non-Compliant With study Drug|0|||
125245088|NCT00758043|450521995|FG001|Overall Study|Non-Compliant With study Drug|0|||
125245089|NCT00758043|450521996|FG002|Overall Study|Non-Compliant With study Drug|0|||
125245090|NCT00758043|450521997|FG003|Overall Study|Non-Compliant With study Drug|1|||
125245091|NCT00758043|450521994|FG000|Overall Study|Other Reasons|0|||
125245092|NCT00758043|450521995|FG001|Overall Study|Other Reasons|1|||
125245093|NCT00758043|450521996|FG002|Overall Study|Other Reasons|0|||
125245094|NCT00758043|450521997|FG003|Overall Study|Other Reasons|5|||
125192047|NCT02101736|450326055|FG000|Overall Study|Withdrawal by Subject|1|||
125245095|NCT00552058|450522003|FG000|Overall Study|Adverse Event|8|||
125245096|NCT00552058|450522004|FG001|Overall Study|Adverse Event|7|||
125245097|NCT00552058|450522003|FG000|Overall Study|Lack of Efficacy|1|||
125245098|NCT00552058|450522004|FG001|Overall Study|Lack of Efficacy|5|||
125245099|NCT00552058|450522003|FG000|Overall Study|Lost to Follow-up|1|||
125245100|NCT00552058|450522004|FG001|Overall Study|Lost to Follow-up|0|||
125245101|NCT00552058|450522003|FG000|Overall Study|Withdrawal by Subject|4|||
125245102|NCT00552058|450522004|FG001|Overall Study|Withdrawal by Subject|4|||
125245103|NCT00552058|450522003|FG000|Overall Study|Other: Protocol Violation|0|||
125245104|NCT00552058|450522004|FG001|Overall Study|Other: Protocol Violation|1|||
125245105|NCT00552058|450522003|FG000|Overall Study|Other: Non Compliance|1|||
125245106|NCT00552058|450522004|FG001|Overall Study|Other: Non Compliance|2|||
125245107|NCT00552058|450522003|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
125245108|NCT00552058|450522004|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
125245109|NCT00552058|450522003|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
125245110|NCT00552058|450522004|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
125245111|NCT00552058|450522003|FG000|Overall Study|Other: Positive Stool Result|0|||
125245112|NCT00552058|450522004|FG001|Overall Study|Other: Positive Stool Result|1|||
125245113|NCT00552058|450522003|FG000|Overall Study|Other: Randomized in error|0|||
125245114|NCT00552058|450522004|FG001|Overall Study|Other: Randomized in error|1|||
125245115|NCT00552058|450522003|FG000|Overall Study|Other: Sponsors Decision|0|||
125393972|NCT01218516|451075828|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
125393973|NCT01218516|451075829|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
125393974|NCT01218516|451075830|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
125393975|NCT01218516|451075831|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
125393976|NCT01218516|451075828|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
125192048|NCT02101736|450326056|FG001|Overall Study|Withdrawal by Subject|1|||
125393977|NCT01218516|451075829|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
125443535|NCT00551213|451252165|FG001|Overall Study|Withdrawal by Subject|0|||
125443536|NCT00551213|451252164|FG000|Overall Study|Not Treated|1|||
125245116|NCT00552058|450522004|FG001|Overall Study|Other: Sponsors Decision|1|||
125245117|NCT00552058|450522003|FG000|Overall Study|Other: Early Roll Over|1|||
125245118|NCT00552058|450522004|FG001|Overall Study|Other: Early Roll Over|0|||
125245119|NCT00845182|450522005|FG000|Overall Study|Lost to Follow-up|3|||
125245120|NCT00845182|450522006|FG001|Overall Study|Lost to Follow-up|3|||
125245121|NCT00845182|450522007|FG002|Overall Study|Lost to Follow-up|4|||
125245122|NCT00845182|450522005|FG000|Overall Study|Adverse Event|0|||
125245123|NCT00845182|450522006|FG001|Overall Study|Adverse Event|1|||
125245124|NCT00845182|450522007|FG002|Overall Study|Adverse Event|1|||
125245125|NCT00845182|450522005|FG000|Overall Study|Physician Decision|0|||
125245126|NCT00845182|450522006|FG001|Overall Study|Physician Decision|0|||
125245127|NCT00845182|450522007|FG002|Overall Study|Physician Decision|1|||
125245128|NCT01348698|450522008|FG000|Overall Study|Does not meet lesion size criteria|1|||
125245129|NCT01348698|450522008|FG000|Overall Study|Death|3|||
125245130|NCT01348698|450522008|FG000|Overall Study|PI decision to close study|68|||
125245131|NCT02595749|450522009|FG000|Overall Study|Withdrawal by Subject|12|||
125245132|NCT02595749|450522010|FG001|Overall Study|Withdrawal by Subject|7|||
125245133|NCT00263562|450522011|FG000|Overall Study|Protocol Violation|3|||
125245134|NCT00263562|450522012|FG001|Overall Study|Protocol Violation|0|||
125245135|NCT00986232|450522015|FG000|Overall Study|Adverse Event|1|||
125245136|NCT00986232|450522016|FG001|Overall Study|Adverse Event|2|||
125245137|NCT00986232|450522017|FG002|Overall Study|Adverse Event|3|||
125245138|NCT00986232|450522018|FG003|Overall Study|Adverse Event|0|||
125245139|NCT00986232|450522015|FG000|Overall Study|Lost to Follow-up|19|||
125245140|NCT00986232|450522016|FG001|Overall Study|Lost to Follow-up|12|||
125245141|NCT00986232|450522017|FG002|Overall Study|Lost to Follow-up|12|||
125245142|NCT00986232|450522018|FG003|Overall Study|Lost to Follow-up|7|||
125245143|NCT00986232|450522015|FG000|Overall Study|Protocol Violation|2|||
125245144|NCT00986232|450522016|FG001|Overall Study|Protocol Violation|3|||
125245145|NCT00986232|450522017|FG002|Overall Study|Protocol Violation|0|||
125245146|NCT00986232|450522018|FG003|Overall Study|Protocol Violation|1|||
125245147|NCT00986232|450522015|FG000|Overall Study|Withdrawal by Subject|13|||
125245148|NCT00986232|450522016|FG001|Overall Study|Withdrawal by Subject|16|||
125245149|NCT00986232|450522017|FG002|Overall Study|Withdrawal by Subject|12|||
125245150|NCT00986232|450522018|FG003|Overall Study|Withdrawal by Subject|3|||
125245151|NCT00986232|450522015|FG000|Overall Study|Missed one or more bleeds|13|||
125245152|NCT00986232|450522016|FG001|Overall Study|Missed one or more bleeds|10|||
125245153|NCT00986232|450522017|FG002|Overall Study|Missed one or more bleeds|6|||
125245154|NCT00986232|450522018|FG003|Overall Study|Missed one or more bleeds|7|||
125245155|NCT00986232|450522015|FG000|Overall Study|Incomplete safety follow-up|3|||
125245156|NCT00986232|450522016|FG001|Overall Study|Incomplete safety follow-up|7|||
125245157|NCT00986232|450522017|FG002|Overall Study|Incomplete safety follow-up|2|||
125245158|NCT00986232|450522018|FG003|Overall Study|Incomplete safety follow-up|2|||
125245159|NCT05558410|450522019|FG000|Overall Study|Adverse Event|1|||
125245160|NCT05558410|450522020|FG001|Overall Study|Adverse Event|2|||
125245161|NCT05558410|450522021|FG002|Overall Study|Adverse Event|0|||
125245162|NCT05558410|450522019|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
125245163|NCT05558410|450522020|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
125245164|NCT05558410|450522021|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
125245165|NCT05558410|450522019|FG000|Overall Study|Lost to Follow-up|10|||
125245166|NCT05558410|450522020|FG001|Overall Study|Lost to Follow-up|17|||
125245167|NCT05558410|450522021|FG002|Overall Study|Lost to Follow-up|19|||
125245168|NCT05558410|450522019|FG000|Overall Study|Death|1|||
125245169|NCT05558410|450522020|FG001|Overall Study|Death|0|||
125245170|NCT05558410|450522021|FG002|Overall Study|Death|0|||
125245171|NCT05558410|450522019|FG000|Overall Study|Other non-compliance|0|||
125245172|NCT05558410|450522020|FG001|Overall Study|Other non-compliance|1|||
125245173|NCT05558410|450522021|FG002|Overall Study|Other non-compliance|2|||
125245174|NCT05558410|450522019|FG000|Overall Study|Sponsor Decision|1|||
125245175|NCT05558410|450522020|FG001|Overall Study|Sponsor Decision|0|||
125245176|NCT05558410|450522021|FG002|Overall Study|Sponsor Decision|0|||
125245177|NCT05558410|450522019|FG000|Overall Study|Other|1|||
125245178|NCT05558410|450522020|FG001|Overall Study|Other|0|||
125245179|NCT05558410|450522021|FG002|Overall Study|Other|1|||
125245180|NCT02400580|450522022|FG000|Overall Study|Withdrawal by Subject|1|||
125245181|NCT02400580|450522023|FG001|Overall Study|Withdrawal by Subject|1|||
125245182|NCT02400580|450522022|FG000|Overall Study|Adverse Event|1|||
125245183|NCT02400580|450522023|FG001|Overall Study|Adverse Event|0|||
125393978|NCT01218516|451075830|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
125393979|NCT01218516|451075831|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
125393980|NCT01218516|451075828|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
125393981|NCT01218516|451075829|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
125245184|NCT00965094|450522024|FG000|Overall Study|Adverse Event|5|||
125245185|NCT00965094|450522025|FG001|Overall Study|Adverse Event|0|||
125245186|NCT00965094|450522024|FG000|Overall Study|Lost to Follow-up|0|||
125245187|NCT00965094|450522025|FG001|Overall Study|Lost to Follow-up|1|||
125245188|NCT01336972|450522026|FG000|Overall Study|Adverse Event|1|||
125393982|NCT01218516|451075830|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
125245189|NCT01336972|450522027|FG001|Overall Study|Adverse Event|1|||
125245190|NCT01336972|450522028|FG002|Overall Study|Adverse Event|0|||
125245191|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
125245192|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
125245193|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
125245194|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
125245195|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
125393983|NCT01218516|451075831|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
125245196|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
125245197|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
125245198|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
125245199|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
125245200|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
125245201|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
125245202|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
125245203|NCT03446573|450522032|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
125245204|NCT03446573|450522033|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
125245205|NCT03446573|450522032|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
125245206|NCT03446573|450522033|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
125245207|NCT03446573|450522032|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
125245208|NCT03446573|450522033|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
125245209|NCT03446573|450522032|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
125245210|NCT03446573|450522033|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
125245211|NCT03446573|450522032|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
125245212|NCT03446573|450522033|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
125245213|NCT03446573|450522032|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
125245214|NCT03446573|450522033|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
125245215|NCT03446573|450522032|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
125245216|NCT03446573|450522033|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
125245217|NCT05987540|450522036|FG000|Overall Study|Withdrawal by Subject|2|||
125245218|NCT05987540|450522036|FG000|Overall Study|Death|1|||
125245219|NCT05987540|450522036|FG000|Overall Study|Study Termination|1|||
125245220|NCT05987540|450522036|FG000|Overall Study|Adverse Event|2|||
125245221|NCT00471107|450522037|FG000|Overall Study|Technical problems/data loss|3|||
125245222|NCT00471107|450522038|FG001|Overall Study|Technical problems/data loss|1|||
125245223|NCT00471107|450522039|FG002|Overall Study|Technical problems/data loss|3|||
125245224|NCT04996264|450522040|FG000|Overall Study|Lost to Follow-up|0|||
125245225|NCT04996264|450522041|FG001|Overall Study|Lost to Follow-up|1|||
125245226|NCT04996264|450522040|FG000|Overall Study|Withdrawal by Subject|4|||
125245227|NCT04996264|450522041|FG001|Overall Study|Withdrawal by Subject|3|||
125245228|NCT04996264|450522040|FG000|Overall Study|1 left AMA|0|||
125245229|NCT04996264|450522041|FG001|Overall Study|1 left AMA|1|||
125245230|NCT04996264|450522040|FG000|Overall Study|Subject changed hospitals|0|||
125245231|NCT04996264|450522041|FG001|Overall Study|Subject changed hospitals|1|||
125245232|NCT04996264|450522040|FG000|Overall Study|unable to complete due to work|0|||
125245233|NCT04996264|450522041|FG001|Overall Study|unable to complete due to work|1|||
125245234|NCT04433975|450522042|FG000|1-month Follow Up|Withdrawal by Subject|1|||
125245235|NCT04433975|450522043|FG001|1-month Follow Up|Withdrawal by Subject|1|||
125245236|NCT04433975|450522042|FG000|1-month Follow Up|Lost to Follow-up|21|||
125245237|NCT04433975|450522043|FG001|1-month Follow Up|Lost to Follow-up|25|||
125245238|NCT04433975|450522042|FG000|3-month Follow Up|Lost to Follow-up|20|||
125245239|NCT04433975|450522043|FG001|3-month Follow Up|Lost to Follow-up|24|||
125245240|NCT04433975|450522042|FG000|3-month Follow Up|Death|1|||
125245241|NCT04433975|450522043|FG001|3-month Follow Up|Death|0|||
125245242|NCT04433975|450522042|FG000|3-month Follow Up|Withdrawal by Subject|2|||
125245243|NCT04433975|450522043|FG001|3-month Follow Up|Withdrawal by Subject|0|||
125245244|NCT04433975|450522042|FG000|6-month Follow Up|Lost to Follow-up|23|||
125245245|NCT04433975|450522043|FG001|6-month Follow Up|Lost to Follow-up|28|||
125245246|NCT04433975|450522042|FG000|6-month Follow Up|Withdrawal by Subject|1|||
125245247|NCT04433975|450522043|FG001|6-month Follow Up|Withdrawal by Subject|1|||
125245248|NCT04433975|450522042|FG000|9-month Follow Up|Lost to Follow-up|27|||
125245249|NCT04433975|450522043|FG001|9-month Follow Up|Lost to Follow-up|36|||
125245250|NCT04433975|450522042|FG000|9-month Follow Up|Death|0|||
125393984|NCT01218516|451075828|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
125393985|NCT01218516|451075829|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
125393986|NCT01218516|451075830|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
125393987|NCT01218516|451075831|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
125393988|NCT01218516|451075828|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
125393989|NCT01218516|451075829|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
125420830|NCT01260350|451166147|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125245251|NCT04433975|450522043|FG001|9-month Follow Up|Death|1|||
125245252|NCT04433975|450522042|FG000|12-month Follow Up|Lost to Follow-up|27|||
125245253|NCT04433975|450522043|FG001|12-month Follow Up|Lost to Follow-up|31|||
125245254|NCT04606771|450522044|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
125245255|NCT04606771|450522045|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
125245256|NCT04606771|450522044|FG000|Overall Study|Death|5|||
125420831|NCT01260350|451166148|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125245257|NCT04606771|450522045|FG001|Overall Study|Death|6|||
125192049|NCT02498444|450326062|FG000|Overall Study|Withdrawal by Subject|3|||
125192050|NCT02498444|450326063|FG001|Overall Study|Withdrawal by Subject|0|||
125192051|NCT02498444|450326062|FG000|Overall Study|Physician Decision|1|||
125192052|NCT02498444|450326063|FG001|Overall Study|Physician Decision|0|||
125192053|NCT02027545|450326064|FG000|Overall Study|Failed to sign HIPAA|0|||
125192054|NCT02027545|450326065|FG001|Overall Study|Failed to sign HIPAA|2|||
125192055|NCT02027545|450326064|FG000|Overall Study|Failed to attend study visit|2|||
125192056|NCT02027545|450326065|FG001|Overall Study|Failed to attend study visit|0|||
125192057|NCT02027545|450326064|FG000|Overall Study|Protocol Violation|1|||
125192058|NCT02027545|450326065|FG001|Overall Study|Protocol Violation|0|||
125192059|NCT02453334|450326066|FG000|Overall Study|Death|15|||
125192060|NCT02453334|450326067|FG001|Overall Study|Death|13|||
125192061|NCT02453334|450326066|FG000|Overall Study|Adverse Event|2|||
125192062|NCT02453334|450326067|FG001|Overall Study|Adverse Event|1|||
125192063|NCT02453334|450326066|FG000|Overall Study|Lost to Follow-up|5|||
125192064|NCT02453334|450326067|FG001|Overall Study|Lost to Follow-up|9|||
125192065|NCT02453334|450326066|FG000|Overall Study|Physician Decision|1|||
125192066|NCT02453334|450326067|FG001|Overall Study|Physician Decision|0|||
125192067|NCT02453334|450326066|FG000|Overall Study|Withdrawal by Subject|17|||
125192068|NCT02453334|450326067|FG001|Overall Study|Withdrawal by Subject|13|||
125192069|NCT02453334|450326066|FG000|Overall Study|Other reason|1|||
125192070|NCT02453334|450326067|FG001|Overall Study|Other reason|4|||
125192071|NCT02693106|450326070|FG000|Overall Study|No time|3|||
125192072|NCT02509507|450326071|FG000|Overall Study|Death|21|||
125192073|NCT02509507|450326072|FG001|Overall Study|Death|3|||
125192074|NCT02509507|450326073|FG002|Overall Study|Death|22|||
125192075|NCT02509507|450326074|FG003|Overall Study|Death|14|||
125192076|NCT02509507|450326075|FG004|Overall Study|Death|8|||
125192077|NCT02509507|450326076|FG005|Overall Study|Death|12|||
125192078|NCT02509507|450326077|FG006|Overall Study|Death|5|||
125192079|NCT02509507|450326078|FG007|Overall Study|Death|4|||
125192080|NCT02509507|450326079|FG008|Overall Study|Death|8|||
125192081|NCT02509507|450326071|FG000|Overall Study|Lost to Follow-up|0|||
125192082|NCT02509507|450326072|FG001|Overall Study|Lost to Follow-up|1|||
125192083|NCT02509507|450326073|FG002|Overall Study|Lost to Follow-up|0|||
125192084|NCT02509507|450326074|FG003|Overall Study|Lost to Follow-up|0|||
125192085|NCT02509507|450326075|FG004|Overall Study|Lost to Follow-up|0|||
125192086|NCT02509507|450326076|FG005|Overall Study|Lost to Follow-up|2|||
125192087|NCT02509507|450326077|FG006|Overall Study|Lost to Follow-up|0|||
125192088|NCT02509507|450326078|FG007|Overall Study|Lost to Follow-up|0|||
125192089|NCT02509507|450326079|FG008|Overall Study|Lost to Follow-up|0|||
125192090|NCT02509507|450326071|FG000|Overall Study|Withdrawal by Subject|2|||
125192091|NCT02509507|450326072|FG001|Overall Study|Withdrawal by Subject|0|||
125192092|NCT02509507|450326073|FG002|Overall Study|Withdrawal by Subject|1|||
125192093|NCT02509507|450326074|FG003|Overall Study|Withdrawal by Subject|4|||
125192094|NCT02509507|450326075|FG004|Overall Study|Withdrawal by Subject|1|||
125192095|NCT02509507|450326076|FG005|Overall Study|Withdrawal by Subject|3|||
125192096|NCT02509507|450326077|FG006|Overall Study|Withdrawal by Subject|4|||
125192097|NCT02509507|450326078|FG007|Overall Study|Withdrawal by Subject|0|||
125192098|NCT02509507|450326079|FG008|Overall Study|Withdrawal by Subject|1|||
125192099|NCT03337113|450326085|FG000|Overall Study|Adverse Event|1|||
125192100|NCT03337113|450326086|FG001|Overall Study|Adverse Event|1|||
125192101|NCT03337113|450326087|FG002|Overall Study|Adverse Event|0|||
125192102|NCT03337113|450326088|FG003|Overall Study|Adverse Event|1|||
125192103|NCT03337113|450326085|FG000|Overall Study|Physician Decision|0|||
125192104|NCT03337113|450326086|FG001|Overall Study|Physician Decision|2|||
125192105|NCT03337113|450326087|FG002|Overall Study|Physician Decision|0|||
125192106|NCT03337113|450326088|FG003|Overall Study|Physician Decision|1|||
125192107|NCT03337113|450326085|FG000|Overall Study|Withdrawal by Subject|0|||
125192108|NCT03337113|450326086|FG001|Overall Study|Withdrawal by Subject|0|||
125192109|NCT03337113|450326087|FG002|Overall Study|Withdrawal by Subject|1|||
125192110|NCT03337113|450326088|FG003|Overall Study|Withdrawal by Subject|0|||
125192111|NCT02176655|450326092|FG000|Overall Study|Subjects did not treat|6|||
125192112|NCT04938180|450326097|FG000|Overall Study|Adverse Event|1|||
125192113|NCT04747886|450326098|FG000|Overall Study|Withdrawal by Subject|1|||
125192114|NCT04747886|450326099|FG001|Overall Study|Withdrawal by Subject|4|||
125192115|NCT00402688|450326105|FG000|Overall Study|Adverse Event|12|||
125192116|NCT00402688|450326106|FG001|Overall Study|Adverse Event|9|||
125192117|NCT00402688|450326107|FG002|Overall Study|Adverse Event|3|||
125192118|NCT00402688|450326105|FG000|Overall Study|Withdrawal by Subject|3|||
125192119|NCT00402688|450326106|FG001|Overall Study|Withdrawal by Subject|1|||
125192120|NCT00402688|450326107|FG002|Overall Study|Withdrawal by Subject|1|||
125245258|NCT04606771|450522044|FG000|Overall Study|Wrong randomisation|0|||
125192121|NCT00402688|450326105|FG000|Overall Study|Physician Decision|0|||
125192122|NCT00402688|450326106|FG001|Overall Study|Physician Decision|0|||
125192123|NCT00402688|450326107|FG002|Overall Study|Physician Decision|1|||
125192124|NCT00402688|450326105|FG000|Overall Study|Lack of Efficacy|4|||
125192125|NCT00402688|450326106|FG001|Overall Study|Lack of Efficacy|4|||
125192126|NCT00402688|450326107|FG002|Overall Study|Lack of Efficacy|5|||
125192127|NCT00402688|450326105|FG000|Overall Study|Protocol Violation|1|||
125245259|NCT04606771|450522045|FG001|Overall Study|Wrong randomisation|1|||
125245260|NCT04392635|450522048|FG000|Overall Study|Lost to Follow-up|0|||
125245261|NCT04392635|450522049|FG001|Overall Study|Lost to Follow-up|1|||
125245262|NCT02030418|450522050|FG000|Overall Study|Death|78|||
125245263|NCT02030418|450522050|FG000|Overall Study|Missed 12-Month Visit|9|||
125245264|NCT02030418|450522050|FG000|Overall Study|Withdrawn|57|||
125245265|NCT00888849|450522051|FG000|Overall Study|Death|4|||
125245266|NCT00888849|450522052|FG001|Overall Study|Death|7|||
125245267|NCT00888849|450522051|FG000|Overall Study|Lost to Follow-up|1|||
125245268|NCT00888849|450522052|FG001|Overall Study|Lost to Follow-up|2|||
125245269|NCT04149353|450522058|FG000|Overall Study|Study terminated|1|||
125245270|NCT00356421|450522060|FG000|Overall Study|Lack of Efficacy|3|||
125245271|NCT00356421|450522061|FG001|Overall Study|Lack of Efficacy|0|||
125245272|NCT00356421|450522060|FG000|Overall Study|Withdrawal by Subject|9|||
125245273|NCT00356421|450522061|FG001|Overall Study|Withdrawal by Subject|2|||
125245274|NCT00356421|450522060|FG000|Overall Study|Related to study drug|15|||
125245275|NCT00356421|450522061|FG001|Overall Study|Related to study drug|12|||
125245276|NCT00356421|450522060|FG000|Overall Study|Not related to study drug|5|||
125245277|NCT00356421|450522061|FG001|Overall Study|Not related to study drug|3|||
125245278|NCT00887588|450522062|FG000|Core Period|Death|1|||
125245279|NCT00887588|450522063|FG001|Core Period|Death|1|||
125245280|NCT00887588|450522062|FG000|Core Period|Lost to Follow-up|3|||
125245281|NCT00887588|450522063|FG001|Core Period|Lost to Follow-up|1|||
125245282|NCT00887588|450522062|FG000|Core Period|Withdrawal by Subject|6|||
125245283|NCT00887588|450522063|FG001|Core Period|Withdrawal by Subject|8|||
125245284|NCT00887588|450522062|FG000|Core Period|Adverse Event|9|||
125245285|NCT00887588|450522063|FG001|Core Period|Adverse Event|11|||
125245286|NCT00887588|450522062|FG000|Extension Period|Adverse Event|4|||
125245287|NCT00887588|450522063|FG001|Extension Period|Adverse Event|4|||
125245288|NCT00887588|450522062|FG000|Extension Period|Death|0|||
125245289|NCT00887588|450522063|FG001|Extension Period|Death|1|||
125245290|NCT00887588|450522062|FG000|Extension Period|Protocol deviation|1|||
125245291|NCT00887588|450522063|FG001|Extension Period|Protocol deviation|0|||
125245292|NCT00887588|450522062|FG000|Extension Period|Lost to Follow-up|1|||
125245293|NCT00887588|450522063|FG001|Extension Period|Lost to Follow-up|0|||
125245294|NCT03753542|450522066|FG000|Overall Study|Lost to Follow-up|9|||
125245295|NCT03753542|450522067|FG001|Overall Study|Lost to Follow-up|14|||
125245296|NCT06100250|450522068|FG000|Overall Study|Lost to Follow-up|5|||
125245297|NCT02021318|450522069|FG000|Overall Study|Adverse Event|2|||
125245298|NCT02021318|450522070|FG001|Overall Study|Adverse Event|1|||
125245299|NCT02021318|450522069|FG000|Overall Study|Death|33|||
125245300|NCT02021318|450522070|FG001|Overall Study|Death|34|||
125245301|NCT02021318|450522069|FG000|Overall Study|Lost to Follow-up|3|||
125245302|NCT02021318|450522070|FG001|Overall Study|Lost to Follow-up|3|||
125245303|NCT02021318|450522069|FG000|Overall Study|Progressive Disease|0|||
125245304|NCT02021318|450522070|FG001|Overall Study|Progressive Disease|1|||
125245305|NCT02021318|450522069|FG000|Overall Study|Withdrawal by Subject|30|||
125245306|NCT02021318|450522070|FG001|Overall Study|Withdrawal by Subject|18|||
125245307|NCT02021318|450522069|FG000|Overall Study|Physician Decision|3|||
125245308|NCT02021318|450522070|FG001|Overall Study|Physician Decision|3|||
125245309|NCT02021318|450522069|FG000|Overall Study|Miscellaneous|2|||
125245310|NCT02021318|450522070|FG001|Overall Study|Miscellaneous|3|||
125245311|NCT00421993|450522072|FG000|Overall Study|Withdrawal by Subject|22|||
125245312|NCT00421993|450522073|FG001|Overall Study|Withdrawal by Subject|23|||
125393990|NCT01218516|451075830|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
125393991|NCT01218516|451075831|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
125245313|NCT00421993|450522074|FG002|Overall Study|Withdrawal by Subject|23|||
125245314|NCT00421993|450522075|FG003|Overall Study|Withdrawal by Subject|24|||
125245315|NCT00421993|450522072|FG000|Overall Study|Lost to Follow-up|18|||
125245316|NCT00421993|450522073|FG001|Overall Study|Lost to Follow-up|19|||
125245317|NCT00421993|450522074|FG002|Overall Study|Lost to Follow-up|22|||
125245318|NCT00421993|450522075|FG003|Overall Study|Lost to Follow-up|20|||
125245319|NCT00421993|450522072|FG000|Overall Study|Adverse Event|11|||
125245320|NCT00421993|450522073|FG001|Overall Study|Adverse Event|1|||
125245321|NCT00421993|450522074|FG002|Overall Study|Adverse Event|6|||
125245322|NCT00421993|450522075|FG003|Overall Study|Adverse Event|4|||
125393992|NCT02042924|451075832|FG000|Overall Study|Early Death|1|||
125393993|NCT00283439|451075833|FG000|Overall Study|Adverse Event|0|||
125245323|NCT00421993|450522072|FG000|Overall Study|Protocol Violation|2|||
125245324|NCT00421993|450522073|FG001|Overall Study|Protocol Violation|2|||
125245325|NCT00421993|450522074|FG002|Overall Study|Protocol Violation|0|||
125245326|NCT00421993|450522075|FG003|Overall Study|Protocol Violation|1|||
125245327|NCT00421993|450522072|FG000|Overall Study|Lack of Efficacy|0|||
125245328|NCT00421993|450522073|FG001|Overall Study|Lack of Efficacy|3|||
125245329|NCT00421993|450522074|FG002|Overall Study|Lack of Efficacy|0|||
125245330|NCT00421993|450522075|FG003|Overall Study|Lack of Efficacy|5|||
125245331|NCT00421993|450522072|FG000|Overall Study|Pregnancy|0|||
125245332|NCT00421993|450522073|FG001|Overall Study|Pregnancy|1|||
125245333|NCT00421993|450522074|FG002|Overall Study|Pregnancy|1|||
125245334|NCT00421993|450522075|FG003|Overall Study|Pregnancy|2|||
125245335|NCT00421993|450522072|FG000|Overall Study|Subject transportation issues|0|||
125245336|NCT00421993|450522073|FG001|Overall Study|Subject transportation issues|0|||
125245337|NCT00421993|450522074|FG002|Overall Study|Subject transportation issues|0|||
125245338|NCT00421993|450522075|FG003|Overall Study|Subject transportation issues|1|||
125245339|NCT02015104|450522080|FG000|Overall Study|Withdrew consent after first dose drug|1|||
125245340|NCT02015104|450522081|FG001|Overall Study|Withdrew consent after first dose drug|0|||
125245341|NCT02015104|450522080|FG000|Overall Study|Withdrew consent prior to treatment|0|||
125245342|NCT02015104|450522081|FG001|Overall Study|Withdrew consent prior to treatment|1|||
125245343|NCT01030900|450522088|FG000|Overall Study|Not treated due to congestive heart failure|1|||
125245344|NCT01030900|450522088|FG000|Overall Study|Not treated due to rapid disease|1|||
125245345|NCT00441896|450522089|FG000|Overall Study|Withdrawal by Subject|0|||
125245346|NCT00441896|450522090|FG001|Overall Study|Withdrawal by Subject|0|||
125245347|NCT00441896|450522091|FG002|Overall Study|Withdrawal by Subject|0|||
125245348|NCT00441896|450522092|FG003|Overall Study|Withdrawal by Subject|1|||
125245349|NCT00441896|450522093|FG004|Overall Study|Withdrawal by Subject|0|||
125245350|NCT00441896|450522094|FG005|Overall Study|Withdrawal by Subject|0|||
125245351|NCT00441896|450522095|FG006|Overall Study|Withdrawal by Subject|0|||
125245352|NCT00441896|450522096|FG007|Overall Study|Withdrawal by Subject|0|||
125245353|NCT00441896|450522097|FG008|Overall Study|Withdrawal by Subject|0|||
125245354|NCT00441896|450522098|FG009|Overall Study|Withdrawal by Subject|0|||
125245355|NCT00441896|450522089|FG000|Overall Study|Other|0|||
125245356|NCT00441896|450522090|FG001|Overall Study|Other|0|||
125245357|NCT00441896|450522091|FG002|Overall Study|Other|0|||
125245358|NCT00441896|450522092|FG003|Overall Study|Other|0|||
125245359|NCT00441896|450522093|FG004|Overall Study|Other|1|||
125245360|NCT00441896|450522094|FG005|Overall Study|Other|0|||
125245361|NCT00441896|450522095|FG006|Overall Study|Other|0|||
125245362|NCT00441896|450522096|FG007|Overall Study|Other|0|||
125245363|NCT00441896|450522097|FG008|Overall Study|Other|0|||
125245364|NCT00441896|450522098|FG009|Overall Study|Other|0|||
125245365|NCT01301092|450522099|FG000|Overall Study|Lost to Follow-up|0|||
125245366|NCT01301092|450522100|FG001|Overall Study|Lost to Follow-up|0|||
125245367|NCT01301092|450522101|FG002|Overall Study|Lost to Follow-up|1|||
125245368|NCT01350973|450522105|FG000|Overall Study|Adverse Event|4|||
125245369|NCT01350973|450522106|FG001|Overall Study|Adverse Event|7|||
125245370|NCT01350973|450522107|FG002|Overall Study|Adverse Event|7|||
125245371|NCT01350973|450522105|FG000|Overall Study|Voluntary Withdrawal|2|||
125245372|NCT01350973|450522106|FG001|Overall Study|Voluntary Withdrawal|1|||
125245373|NCT01350973|450522107|FG002|Overall Study|Voluntary Withdrawal|1|||
125245374|NCT02638493|450522108|FG000|Overall Study|Inability to provide semen samples|2|||
125245375|NCT02638493|450522109|FG001|Overall Study|Inability to provide semen samples|0|||
125245376|NCT02638493|450522110|FG002|Overall Study|Inability to provide semen samples|0|||
125245377|NCT01033071|450522111|FG000|Overall Study|Adverse Event|28|||
125245378|NCT01033071|450522112|FG001|Overall Study|Adverse Event|51|||
125245379|NCT01033071|450522113|FG002|Overall Study|Adverse Event|26|||
125245380|NCT01033071|450522111|FG000|Overall Study|Protocol Violation|0|||
125245381|NCT01033071|450522112|FG001|Overall Study|Protocol Violation|2|||
125245382|NCT01033071|450522113|FG002|Overall Study|Protocol Violation|1|||
125245383|NCT01033071|450522111|FG000|Overall Study|Lost to Follow-up|4|||
125245384|NCT01033071|450522112|FG001|Overall Study|Lost to Follow-up|5|||
125245385|NCT01033071|450522113|FG002|Overall Study|Lost to Follow-up|5|||
125245386|NCT01033071|450522111|FG000|Overall Study|Withdrawal by Subject|17|||
125245387|NCT01033071|450522112|FG001|Overall Study|Withdrawal by Subject|14|||
125245388|NCT01033071|450522113|FG002|Overall Study|Withdrawal by Subject|11|||
125245389|NCT01033071|450522111|FG000|Overall Study|Lack of Efficacy|0|||
125245390|NCT01033071|450522112|FG001|Overall Study|Lack of Efficacy|1|||
125245391|NCT01033071|450522113|FG002|Overall Study|Lack of Efficacy|1|||
125245392|NCT01033071|450522111|FG000|Overall Study|Other|6|||
125245393|NCT01033071|450522112|FG001|Overall Study|Other|4|||
125245394|NCT01033071|450522113|FG002|Overall Study|Other|3|||
125245395|NCT00004859|450522116|FG000|Overall Study|Lack of Efficacy|43|||
125245396|NCT00004859|450522117|FG001|Overall Study|Lack of Efficacy|113|||
125245397|NCT00004859|450522116|FG000|Overall Study|Adverse Event|31|||
125245398|NCT00004859|450522117|FG001|Overall Study|Adverse Event|93|||
125245399|NCT00004859|450522116|FG000|Overall Study|Death|5|||
125245400|NCT00004859|450522117|FG001|Overall Study|Death|5|||
125245401|NCT00004859|450522116|FG000|Overall Study|Withdrawal by Subject|7|||
125245402|NCT00004859|450522117|FG001|Overall Study|Withdrawal by Subject|33|||
125245403|NCT00004859|450522116|FG000|Overall Study|Protocol Violation|2|||
125245404|NCT00004859|450522117|FG001|Overall Study|Protocol Violation|2|||
125245405|NCT00004859|450522116|FG000|Overall Study|other disease|0|||
125245406|NCT00004859|450522117|FG001|Overall Study|other disease|3|||
125245407|NCT00004859|450522116|FG000|Overall Study|error|3|||
125245408|NCT00004859|450522117|FG001|Overall Study|error|1|||
125245409|NCT00004859|450522116|FG000|Overall Study|missing data|14|||
125245410|NCT00004859|450522117|FG001|Overall Study|missing data|11|||
125245411|NCT00004859|450522116|FG000|Overall Study|Other|13|||
125245412|NCT00004859|450522117|FG001|Overall Study|Other|21|||
125245413|NCT04941898|450524478|FG000|Overall Study|Protocol Violation|1|||
125245414|NCT00884949|450524479|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
125245415|NCT00884949|450524479|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
125245416|NCT01567085|450524482|FG000|Overall Study|Death|6|||
125245417|NCT01567085|450524482|FG000|Overall Study|Adverse Event|6|||
125245418|NCT01567085|450524482|FG000|Overall Study|Lost to Follow-up|3|||
125245419|NCT01567085|450524482|FG000|Overall Study|Graft loss|2|||
125245420|NCT01567085|450524482|FG000|Overall Study|Renal transplantectomy|1|||
125245421|NCT01567085|450524482|FG000|Overall Study|Returned to chronic dialysis|1|||
125245422|NCT01567085|450524482|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
125245423|NCT00504231|450524486|FG000|Overall Study|Discrepant chart documentation re route|0|||
125245424|NCT00504231|450524487|FG001|Overall Study|Discrepant chart documentation re route|0|||
125245425|NCT00504231|450524488|FG002|Overall Study|Discrepant chart documentation re route|1|||
125245426|NCT00504231|450524489|FG003|Overall Study|Discrepant chart documentation re route|0|||
125245427|NCT03928704|450524491|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
125245428|NCT03928704|450524492|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
125245429|NCT03928704|450524493|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
125245430|NCT03928704|450524494|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
125245431|NCT03928704|450524495|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
125245432|NCT03928704|450524496|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
125245433|NCT03928704|450524491|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
125245434|NCT03928704|450524492|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
125245435|NCT03928704|450524493|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
125245436|NCT03928704|450524494|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
125245437|NCT03928704|450524495|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
125245438|NCT03928704|450524496|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
125245439|NCT03928704|450524491|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
125245440|NCT03928704|450524492|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
125245441|NCT03928704|450524493|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
125245442|NCT03928704|450524494|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
125245443|NCT03928704|450524495|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
125245444|NCT03928704|450524496|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
125245445|NCT03928704|450524491|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
125245446|NCT03928704|450524492|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
125245447|NCT03928704|450524493|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
125245448|NCT03928704|450524494|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
125245449|NCT03928704|450524495|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
125245450|NCT03928704|450524496|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
125245451|NCT03928704|450524491|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
125245452|NCT03928704|450524492|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
125245453|NCT03928704|450524493|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
125245454|NCT03928704|450524494|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
125245455|NCT03928704|450524495|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
125245456|NCT03928704|450524496|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
125245457|NCT03928704|450524491|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
125245458|NCT03928704|450524492|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
125245459|NCT03928704|450524493|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
125245460|NCT03928704|450524494|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
125245461|NCT03928704|450524495|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
125245462|NCT03928704|450524496|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
125245463|NCT03928704|450524491|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
125245464|NCT03928704|450524492|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
125245465|NCT03928704|450524493|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
125245466|NCT03928704|450524494|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
125245467|NCT03928704|450524495|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
125245468|NCT03928704|450524496|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
125245469|NCT03928704|450524491|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
125245470|NCT03928704|450524492|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
125245471|NCT03928704|450524493|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
125245472|NCT03928704|450524494|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
125245473|NCT03928704|450524495|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
125245474|NCT03928704|450524496|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
125245475|NCT03928704|450524491|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
125245476|NCT03928704|450524492|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
125245477|NCT03928704|450524493|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
125245478|NCT03928704|450524494|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
125303084|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125245479|NCT03928704|450524495|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
125245480|NCT03928704|450524496|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
125245481|NCT03928704|450524491|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
125245482|NCT03928704|450524492|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
125245483|NCT03928704|450524493|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
125245484|NCT03928704|450524494|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
125245485|NCT03928704|450524495|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
125245486|NCT03928704|450524496|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
125245487|NCT04575324|450524499|FG000|Overall Study|Lost to Follow-up|29|||
125245488|NCT04575324|450524500|FG001|Overall Study|Lost to Follow-up|25|||
125245489|NCT04575324|450524499|FG000|Overall Study|Death|1|||
125245490|NCT04575324|450524500|FG001|Overall Study|Death|2|||
125245491|NCT04575324|450524499|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
125245492|NCT04575324|450524500|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
125245493|NCT01002105|450524503|FG000|Overall Study|Lost to Follow-up|10|||
125245494|NCT01002105|450524504|FG001|Overall Study|Lost to Follow-up|16|||
125245495|NCT01002105|450524503|FG000|Overall Study|non compliance|5|||
125245496|NCT01002105|450524504|FG001|Overall Study|non compliance|3|||
125245497|NCT01002105|450524503|FG000|Overall Study|condition worsened|4|||
125245498|NCT01002105|450524504|FG001|Overall Study|condition worsened|2|||
125245499|NCT00456612|450524508|FG000|Overall Study|Withdrawal by Subject|3|||
125245500|NCT00266812|450524509|FG000|Overall Study|Disease Progression|9|||
125245501|NCT00266812|450524510|FG001|Overall Study|Disease Progression|3|||
125245502|NCT00266812|450524509|FG000|Overall Study|Death|5|||
125245503|NCT00266812|450524510|FG001|Overall Study|Death|4|||
125245504|NCT00266812|450524509|FG000|Overall Study|Adverse Event|3|||
125245505|NCT00266812|450524510|FG001|Overall Study|Adverse Event|1|||
125245506|NCT00266812|450524509|FG000|Overall Study|Protocol Violation|0|||
125245507|NCT00266812|450524510|FG001|Overall Study|Protocol Violation|1|||
125245508|NCT00266812|450524509|FG000|Overall Study|Withdrawal by Subject|0|||
125245509|NCT00266812|450524510|FG001|Overall Study|Withdrawal by Subject|2|||
125245510|NCT00266812|450524509|FG000|Overall Study|Discontinued before starting study drug|4|||
125245511|NCT00266812|450524510|FG001|Overall Study|Discontinued before starting study drug|0|||
125245512|NCT03695094|450524511|FG000|Overall Study|Adverse Event|1|||
125245513|NCT03695094|450524512|FG001|Overall Study|Adverse Event|1|||
125245514|NCT03695094|450524511|FG000|Overall Study|Withdrawal by Subject|1|||
125245515|NCT03695094|450524512|FG001|Overall Study|Withdrawal by Subject|0|||
125245516|NCT02316613|450524515|FG000|Overall Study|Death|63|||
125245517|NCT02316613|450524515|FG000|Overall Study|Lost to Follow-up|9|||
125245518|NCT02316613|450524515|FG000|Overall Study|Lymphoma transformation|2|||
125192128|NCT00402688|450326106|FG001|Overall Study|Protocol Violation|1|||
125192129|NCT00402688|450326107|FG002|Overall Study|Protocol Violation|1|||
125192130|NCT00402688|450326105|FG000|Overall Study|Lost to Follow-up|1|||
125192131|NCT00402688|450326106|FG001|Overall Study|Lost to Follow-up|0|||
125192132|NCT00402688|450326107|FG002|Overall Study|Lost to Follow-up|2|||
125192133|NCT00402688|450326105|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
125192134|NCT00402688|450326106|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
125192135|NCT00402688|450326107|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
125192136|NCT00402688|450326105|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
125192137|NCT00402688|450326106|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
125192138|NCT00402688|450326107|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
125192139|NCT00402688|450326105|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
125192140|NCT00402688|450326106|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
125192141|NCT00402688|450326107|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
125192142|NCT03259425|450326109|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
125192143|NCT04157296|450326110|FG000|Overall Study|Withdrawal by Subject|0|||
125192144|NCT04157296|450326111|FG001|Overall Study|Withdrawal by Subject|1|||
125245519|NCT02316613|450524515|FG000|Overall Study|Participant moved/changed medical team|11|||
125245520|NCT02316613|450524515|FG000|Overall Study|No data and duplicate cases|5|||
125245521|NCT02316613|450524515|FG000|Overall Study|Did not met selection criteria|14|||
125245522|NCT01166945|450524516|FG000|Randomized|diagnosed with Group A strep|4|||
125245523|NCT01166945|450524517|FG001|Randomized|diagnosed with Group A strep|4|||
125192145|NCT04157296|450326110|FG000|Overall Study|Did not obtain second fMRI.|0|||
125245524|NCT01166945|450524516|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
125245525|NCT01166945|450524517|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
125245526|NCT01166945|450524516|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
125245527|NCT01166945|450524517|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
125245528|NCT01166945|450524516|FG000|Day 30|Lost to Follow-up|4|||
125245529|NCT01166945|450524517|FG001|Day 30|Lost to Follow-up|3|||
125192146|NCT04157296|450326111|FG001|Overall Study|Did not obtain second fMRI.|1|||
125192147|NCT04157296|450326110|FG000|Overall Study|MRI failed/no second fMRI|0|||
125192148|NCT04157296|450326111|FG001|Overall Study|MRI failed/no second fMRI|1|||
125245530|NCT03309605|450524520|FG000|Overall Study|Adverse Event|0|||
125443537|NCT00551213|451252165|FG001|Overall Study|Not Treated|2|||
125192149|NCT02237196|450326112|FG000|Overall Study|Adverse Event|0|||
125192150|NCT02237196|450326113|FG001|Overall Study|Adverse Event|1|||
125192151|NCT02237196|450326114|FG002|Overall Study|Adverse Event|1|||
125192152|NCT02237196|450326115|FG003|Overall Study|Adverse Event|0|||
125192153|NCT02237196|450326112|FG000|Overall Study|Lost to Follow-up|4|||
125192154|NCT02237196|450326113|FG001|Overall Study|Lost to Follow-up|2|||
125192155|NCT02237196|450326114|FG002|Overall Study|Lost to Follow-up|4|||
125192156|NCT02237196|450326115|FG003|Overall Study|Lost to Follow-up|6|||
125192157|NCT02237196|450326112|FG000|Overall Study|Physician Decision|2|||
125192158|NCT02237196|450326113|FG001|Overall Study|Physician Decision|0|||
125192159|NCT02237196|450326114|FG002|Overall Study|Physician Decision|0|||
125192160|NCT02237196|450326115|FG003|Overall Study|Physician Decision|1|||
125192161|NCT02237196|450326112|FG000|Overall Study|Pregnancy|0|||
125192162|NCT02237196|450326113|FG001|Overall Study|Pregnancy|0|||
125192163|NCT02237196|450326114|FG002|Overall Study|Pregnancy|1|||
125192164|NCT02237196|450326115|FG003|Overall Study|Pregnancy|1|||
125192165|NCT02237196|450326112|FG000|Overall Study|Withdrawal by Subject|1|||
125192166|NCT02237196|450326113|FG001|Overall Study|Withdrawal by Subject|1|||
125192167|NCT02237196|450326114|FG002|Overall Study|Withdrawal by Subject|4|||
125192168|NCT02237196|450326115|FG003|Overall Study|Withdrawal by Subject|1|||
125192169|NCT02237196|450326112|FG000|Overall Study|Site Error|1|||
125192170|NCT02237196|450326113|FG001|Overall Study|Site Error|2|||
125192171|NCT02237196|450326114|FG002|Overall Study|Site Error|0|||
125192172|NCT02237196|450326115|FG003|Overall Study|Site Error|2|||
125192173|NCT01421225|450326128|FG000|Overall Study|Withdrawal by Subject|0|||
125192174|NCT01421225|450326129|FG001|Overall Study|Withdrawal by Subject|1|||
125192175|NCT01322490|450326130|FG000|Treatment Period|Adverse Event|12|||
125192176|NCT01322490|450326131|FG001|Treatment Period|Adverse Event|18|||
125192177|NCT01322490|450326132|FG002|Treatment Period|Adverse Event|15|||
125192178|NCT01322490|450326130|FG000|Treatment Period|Death|5|||
125192179|NCT01322490|450326131|FG001|Treatment Period|Death|7|||
125192180|NCT01322490|450326132|FG002|Treatment Period|Death|3|||
125192181|NCT01322490|450326130|FG000|Treatment Period|Lack of Efficacy|89|||
125192182|NCT01322490|450326131|FG001|Treatment Period|Lack of Efficacy|100|||
125192183|NCT01322490|450326132|FG002|Treatment Period|Lack of Efficacy|112|||
125393994|NCT00283439|451075834|FG001|Overall Study|Adverse Event|0|||
125393995|NCT00283439|451075835|FG002|Overall Study|Adverse Event|0|||
125393996|NCT00283439|451075836|FG003|Overall Study|Adverse Event|1|||
125393997|NCT00283439|451075833|FG000|Overall Study|Death|0|||
125192184|NCT01322490|450326130|FG000|Treatment Period|Physician Decision|0|||
125192185|NCT01322490|450326131|FG001|Treatment Period|Physician Decision|2|||
125192186|NCT01322490|450326132|FG002|Treatment Period|Physician Decision|1|||
125192187|NCT01322490|450326130|FG000|Treatment Period|Protocol Violation|7|||
125192188|NCT01322490|450326131|FG001|Treatment Period|Protocol Violation|5|||
125192189|NCT01322490|450326132|FG002|Treatment Period|Protocol Violation|4|||
125192190|NCT01322490|450326130|FG000|Treatment Period|Withdrawal by Subject|14|||
125192191|NCT01322490|450326131|FG001|Treatment Period|Withdrawal by Subject|16|||
125192192|NCT01322490|450326132|FG002|Treatment Period|Withdrawal by Subject|11|||
125192193|NCT01322490|450326130|FG000|Treatment Period|Non-compliance with study drug|0|||
125192194|NCT01322490|450326131|FG001|Treatment Period|Non-compliance with study drug|0|||
125192195|NCT01322490|450326132|FG002|Treatment Period|Non-compliance with study drug|1|||
125192196|NCT01322490|450326130|FG000|Treatment Period|Other per report|2|||
125192197|NCT01322490|450326131|FG001|Treatment Period|Other per report|2|||
125192198|NCT01322490|450326132|FG002|Treatment Period|Other per report|1|||
125192199|NCT01322490|450326130|FG000|Treatment Period|Randomized but Not Treated|3|||
125192200|NCT01322490|450326131|FG001|Treatment Period|Randomized but Not Treated|3|||
125192201|NCT01322490|450326132|FG002|Treatment Period|Randomized but Not Treated|5|||
125192202|NCT01322490|450326130|FG000|Long Term Follow-up Period|Death|235|||
125192203|NCT01322490|450326131|FG001|Long Term Follow-up Period|Death|239|||
125192204|NCT01322490|450326132|FG002|Long Term Follow-up Period|Death|236|||
125192205|NCT01322490|450326130|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
125192206|NCT01322490|450326131|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
125192207|NCT01322490|450326132|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
125192208|NCT01322490|450326130|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
125192209|NCT01322490|450326131|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
125192210|NCT01322490|450326132|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
125192211|NCT01322490|450326130|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
125192212|NCT01322490|450326131|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
125192213|NCT01322490|450326132|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
125192214|NCT01322490|450326130|FG000|Long Term Follow-up Period|Other per report|3|||
125192215|NCT01322490|450326131|FG001|Long Term Follow-up Period|Other per report|2|||
125192216|NCT01322490|450326132|FG002|Long Term Follow-up Period|Other per report|2|||
125192217|NCT01322490|450326130|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
125192218|NCT01322490|450326131|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
125192219|NCT01322490|450326132|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
125192220|NCT00356148|450326133|FG000|Overall Study|Reoperation within 30 days|2|||
125393998|NCT00283439|451075834|FG001|Overall Study|Death|0|||
125192221|NCT00356148|450326134|FG001|Overall Study|Reoperation within 30 days|1|||
125192222|NCT02693002|450326135|FG000|Overall Study|Withdrawal by Subject|1|||
125192223|NCT02693002|450326136|FG001|Overall Study|Withdrawal by Subject|0|||
125192224|NCT00014495|450326137|FG000|Overall Study|Death|0|||
125192225|NCT00014495|450326138|FG001|Overall Study|Death|0|||
125192226|NCT00014495|450326139|FG002|Overall Study|Death|1|||
125192227|NCT00014495|450326140|FG003|Overall Study|Death|0|||
125192228|NCT00014495|450326137|FG000|Overall Study|Clinical deterioration|0|||
125192229|NCT00014495|450326138|FG001|Overall Study|Clinical deterioration|0|||
125192230|NCT00014495|450326139|FG002|Overall Study|Clinical deterioration|0|||
125192231|NCT00014495|450326140|FG003|Overall Study|Clinical deterioration|1|||
125192232|NCT00984542|450326141|FG000|Overall Study|disease progression|19|||
125192233|NCT00984542|450326141|FG000|Overall Study|toxicity|7|||
125192234|NCT00984542|450326141|FG000|Overall Study|Death|7|||
125192235|NCT00984542|450326141|FG000|Overall Study|complicating disease|3|||
125192236|NCT00984542|450326141|FG000|Overall Study|Withdrawal by Subject|3|||
125192237|NCT00984542|450326141|FG000|Overall Study|clinical deterioration|2|||
125192238|NCT02929589|450326176|FG000|Overall Study|Withdrawal by Subject|1|||
125192239|NCT02929589|450326177|FG001|Overall Study|Withdrawal by Subject|0|||
125192240|NCT02929589|450326178|FG002|Overall Study|Withdrawal by Subject|0|||
125192241|NCT02929589|450326179|FG003|Overall Study|Withdrawal by Subject|0|||
125192242|NCT02929589|450326176|FG000|Overall Study|Physician Decision|2|||
125192243|NCT02929589|450326177|FG001|Overall Study|Physician Decision|0|||
125192244|NCT02929589|450326178|FG002|Overall Study|Physician Decision|0|||
125192245|NCT02929589|450326179|FG003|Overall Study|Physician Decision|0|||
125192246|NCT01422889|450326180|FG000|Overall Study|No Data Entered for Study Stent|9|||
125192247|NCT02091089|450326181|FG000|Overall Study|Lost to Follow-up|2|||
125192248|NCT02343939|450326182|FG000|Overall Study|Death|0|||
125192249|NCT02343939|450326183|FG001|Overall Study|Death|15|||
125192250|NCT02343939|450326184|FG002|Overall Study|Death|4|||
125192251|NCT02343939|450326185|FG003|Overall Study|Death|2|||
125192252|NCT02343939|450326186|FG004|Overall Study|Death|5|||
125192253|NCT02343939|450326187|FG005|Overall Study|Death|11|||
125192254|NCT02343939|450326188|FG006|Overall Study|Death|8|||
125192255|NCT02343939|450326189|FG007|Overall Study|Death|22|||
125192256|NCT02343939|450326190|FG008|Overall Study|Death|1|||
125192257|NCT02343939|450326182|FG000|Overall Study|Study terminated by sponsor|0|||
125192258|NCT02343939|450326183|FG001|Overall Study|Study terminated by sponsor|27|||
125192259|NCT02343939|450326184|FG002|Overall Study|Study terminated by sponsor|0|||
125192260|NCT02343939|450326185|FG003|Overall Study|Study terminated by sponsor|1|||
125192261|NCT02343939|450326186|FG004|Overall Study|Study terminated by sponsor|1|||
125192262|NCT02343939|450326187|FG005|Overall Study|Study terminated by sponsor|5|||
125192263|NCT02343939|450326188|FG006|Overall Study|Study terminated by sponsor|3|||
125192264|NCT02343939|450326189|FG007|Overall Study|Study terminated by sponsor|4|||
125192265|NCT02343939|450326190|FG008|Overall Study|Study terminated by sponsor|0|||
125192266|NCT02343939|450326182|FG000|Overall Study|Withdrew consent|3|||
125192267|NCT02343939|450326183|FG001|Overall Study|Withdrew consent|6|||
125192268|NCT02343939|450326184|FG002|Overall Study|Withdrew consent|1|||
125192269|NCT02343939|450326185|FG003|Overall Study|Withdrew consent|2|||
125192270|NCT02343939|450326186|FG004|Overall Study|Withdrew consent|2|||
125192271|NCT02343939|450326187|FG005|Overall Study|Withdrew consent|0|||
125192272|NCT02343939|450326188|FG006|Overall Study|Withdrew consent|0|||
125192273|NCT02343939|450326189|FG007|Overall Study|Withdrew consent|8|||
125245531|NCT03309605|450524521|FG001|Overall Study|Adverse Event|0|||
125192274|NCT02343939|450326190|FG008|Overall Study|Withdrew consent|6|||
125192275|NCT02343939|450326182|FG000|Overall Study|Treatment failure|0|||
125192276|NCT02343939|450326183|FG001|Overall Study|Treatment failure|0|||
125192277|NCT02343939|450326184|FG002|Overall Study|Treatment failure|0|||
125192278|NCT02343939|450326185|FG003|Overall Study|Treatment failure|0|||
125192279|NCT02343939|450326186|FG004|Overall Study|Treatment failure|0|||
125192280|NCT02343939|450326187|FG005|Overall Study|Treatment failure|0|||
125192281|NCT02343939|450326188|FG006|Overall Study|Treatment failure|2|||
125192282|NCT02343939|450326189|FG007|Overall Study|Treatment failure|1|||
125192283|NCT02343939|450326190|FG008|Overall Study|Treatment failure|0|||
125192284|NCT02343939|450326182|FG000|Overall Study|Investigator's discretion|0|||
125192285|NCT02343939|450326183|FG001|Overall Study|Investigator's discretion|0|||
125192286|NCT02343939|450326184|FG002|Overall Study|Investigator's discretion|0|||
125192287|NCT02343939|450326185|FG003|Overall Study|Investigator's discretion|1|||
125192288|NCT02343939|450326186|FG004|Overall Study|Investigator's discretion|0|||
125192289|NCT02343939|450326187|FG005|Overall Study|Investigator's discretion|0|||
125192290|NCT02343939|450326188|FG006|Overall Study|Investigator's discretion|1|||
125192291|NCT02343939|450326189|FG007|Overall Study|Investigator's discretion|0|||
125192292|NCT02343939|450326190|FG008|Overall Study|Investigator's discretion|0|||
125192293|NCT02343939|450326182|FG000|Overall Study|Adverse Event|0|||
125192294|NCT02343939|450326183|FG001|Overall Study|Adverse Event|0|||
125192295|NCT02343939|450326184|FG002|Overall Study|Adverse Event|0|||
125192296|NCT02343939|450326185|FG003|Overall Study|Adverse Event|0|||
125192297|NCT02343939|450326186|FG004|Overall Study|Adverse Event|0|||
125192298|NCT02343939|450326187|FG005|Overall Study|Adverse Event|1|||
125192299|NCT02343939|450326188|FG006|Overall Study|Adverse Event|0|||
125192300|NCT02343939|450326189|FG007|Overall Study|Adverse Event|0|||
125192301|NCT02343939|450326190|FG008|Overall Study|Adverse Event|0|||
125192302|NCT02343939|450326182|FG000|Overall Study|Never Treated With ENTO|0|||
125192303|NCT02343939|450326183|FG001|Overall Study|Never Treated With ENTO|0|||
125192304|NCT02343939|450326184|FG002|Overall Study|Never Treated With ENTO|0|||
125192305|NCT02343939|450326185|FG003|Overall Study|Never Treated With ENTO|0|||
125192306|NCT02343939|450326186|FG004|Overall Study|Never Treated With ENTO|0|||
125192307|NCT02343939|450326187|FG005|Overall Study|Never Treated With ENTO|0|||
125192308|NCT02343939|450326188|FG006|Overall Study|Never Treated With ENTO|1|||
125192309|NCT02343939|450326189|FG007|Overall Study|Never Treated With ENTO|2|||
125192310|NCT02343939|450326190|FG008|Overall Study|Never Treated With ENTO|0|||
125192311|NCT01580670|450326195|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
125192312|NCT01580670|450326195|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
125192313|NCT00665431|450326198|FG000|Overall Study|Adverse Event|16|||
125192314|NCT00665431|450326199|FG001|Overall Study|Adverse Event|22|||
125192315|NCT00665431|450326200|FG002|Overall Study|Adverse Event|6|||
125192316|NCT00665431|450326198|FG000|Overall Study|Withdrawal by Subject|17|||
125192317|NCT00665431|450326199|FG001|Overall Study|Withdrawal by Subject|25|||
125192318|NCT00665431|450326200|FG002|Overall Study|Withdrawal by Subject|15|||
125192319|NCT00665431|450326198|FG000|Overall Study|Lost to Follow-up|3|||
125192320|NCT00665431|450326199|FG001|Overall Study|Lost to Follow-up|3|||
125192321|NCT00665431|450326200|FG002|Overall Study|Lost to Follow-up|1|||
125192322|NCT00665431|450326198|FG000|Overall Study|Other|4|||
125192323|NCT00665431|450326199|FG001|Overall Study|Other|7|||
125192324|NCT00665431|450326200|FG002|Overall Study|Other|2|||
125192325|NCT00757042|450326208|FG000|Overall Study|Lost to Follow-up|0|||
125192326|NCT00757042|450326209|FG001|Overall Study|Lost to Follow-up|0|||
125192327|NCT00757042|450326210|FG002|Overall Study|Lost to Follow-up|0|||
125192328|NCT00757042|450326211|FG003|Overall Study|Lost to Follow-up|0|||
125192329|NCT00757042|450326212|FG004|Overall Study|Lost to Follow-up|0|||
125192330|NCT00757042|450326213|FG005|Overall Study|Lost to Follow-up|0|||
125192331|NCT00757042|450326214|FG006|Overall Study|Lost to Follow-up|0|||
125192332|NCT00757042|450326215|FG007|Overall Study|Lost to Follow-up|0|||
125192333|NCT00757042|450326216|FG008|Overall Study|Lost to Follow-up|1|||
125192334|NCT00757042|450326217|FG009|Overall Study|Lost to Follow-up|0|||
125192335|NCT00757042|450326218|FG010|Overall Study|Lost to Follow-up|0|||
125192336|NCT00757042|450326208|FG000|Overall Study|Ineligibility Determined|0|||
125192337|NCT00757042|450326209|FG001|Overall Study|Ineligibility Determined|0|||
125192338|NCT00757042|450326210|FG002|Overall Study|Ineligibility Determined|0|||
125192339|NCT00757042|450326211|FG003|Overall Study|Ineligibility Determined|0|||
125192340|NCT00757042|450326212|FG004|Overall Study|Ineligibility Determined|0|||
125192341|NCT00757042|450326213|FG005|Overall Study|Ineligibility Determined|0|||
125192342|NCT00757042|450326214|FG006|Overall Study|Ineligibility Determined|0|||
125192343|NCT00757042|450326215|FG007|Overall Study|Ineligibility Determined|0|||
125192344|NCT00757042|450326216|FG008|Overall Study|Ineligibility Determined|0|||
125192345|NCT00757042|450326217|FG009|Overall Study|Ineligibility Determined|0|||
125192346|NCT00757042|450326218|FG010|Overall Study|Ineligibility Determined|1|||
125192347|NCT00757042|450326208|FG000|Overall Study|Withdrawal by Subject|0|||
125192348|NCT00757042|450326209|FG001|Overall Study|Withdrawal by Subject|0|||
125192349|NCT00757042|450326210|FG002|Overall Study|Withdrawal by Subject|0|||
125192350|NCT00757042|450326211|FG003|Overall Study|Withdrawal by Subject|0|||
125192351|NCT00757042|450326212|FG004|Overall Study|Withdrawal by Subject|0|||
125192352|NCT00757042|450326213|FG005|Overall Study|Withdrawal by Subject|0|||
125192353|NCT00757042|450326214|FG006|Overall Study|Withdrawal by Subject|0|||
125192354|NCT00757042|450326215|FG007|Overall Study|Withdrawal by Subject|0|||
125192355|NCT00757042|450326216|FG008|Overall Study|Withdrawal by Subject|0|||
125192356|NCT00757042|450326217|FG009|Overall Study|Withdrawal by Subject|1|||
125192357|NCT00757042|450326218|FG010|Overall Study|Withdrawal by Subject|0|||
125192358|NCT01870973|450326222|FG000|Overall Study|Lost to Follow-up|10|||
125192359|NCT01870973|450326223|FG001|Overall Study|Lost to Follow-up|3|||
125192360|NCT01266291|450326225|FG000|Overall Study|Adverse Event|1|||
125192361|NCT03291431|450326226|FG000|Overall Study|Protocol Violation|2|||
125192362|NCT03291431|450326227|FG001|Overall Study|Protocol Violation|1|||
125192363|NCT03291431|450326226|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
125192364|NCT03291431|450326227|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
125192365|NCT03291431|450326226|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
125192366|NCT03291431|450326227|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
125192367|NCT00550745|450326230|FG000|Overall Study|Death|20|||
125192368|NCT00550745|450326231|FG001|Overall Study|Death|16|||
125192369|NCT00550745|450326230|FG000|Overall Study|Lost to Follow-up|45|||
125192370|NCT00550745|450326231|FG001|Overall Study|Lost to Follow-up|30|||
125192371|NCT00550745|450326230|FG000|Overall Study|Physician Decision|0|||
125192372|NCT00550745|450326231|FG001|Overall Study|Physician Decision|2|||
125192373|NCT00550745|450326230|FG000|Overall Study|Protocol Violation|4|||
125192374|NCT00550745|450326231|FG001|Overall Study|Protocol Violation|2|||
125192375|NCT00550745|450326230|FG000|Overall Study|Withdrawal by Subject|17|||
125192376|NCT00550745|450326231|FG001|Overall Study|Withdrawal by Subject|10|||
125192377|NCT00550745|450326230|FG000|Overall Study|Screen failure|1|||
125192378|NCT00550745|450326231|FG001|Overall Study|Screen failure|0|||
125192379|NCT03850483|450326234|FG000|Treatment for Stage 1|Adverse Event|1|||
125192380|NCT03850483|450326235|FG001|Treatment for Stage 1|Adverse Event|1|||
125192381|NCT03850483|450326236|FG002|Treatment for Stage 1|Adverse Event|3|||
125192382|NCT03850483|450326237|FG003|Treatment for Stage 1|Adverse Event|0|||
125192383|NCT03850483|450326238|FG004|Treatment for Stage 1|Adverse Event|2|||
125192384|NCT03850483|450326239|FG005|Treatment for Stage 1|Adverse Event|0|||
125192385|NCT03850483|450326240|FG006|Treatment for Stage 1|Adverse Event|2|||
125192386|NCT03850483|450326241|FG007|Treatment for Stage 1|Adverse Event|2|||
125192387|NCT03850483|450326242|FG008|Treatment for Stage 1|Adverse Event|0|||
125192388|NCT03850483|450326243|FG009|Treatment for Stage 1|Adverse Event|0|||
125192389|NCT03850483|450326234|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
125192390|NCT03850483|450326235|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
125192391|NCT03850483|450326236|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
125192392|NCT03850483|450326237|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
125192393|NCT03850483|450326238|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
125192394|NCT03850483|450326239|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
125192395|NCT03850483|450326240|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
125192396|NCT03850483|450326241|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
125192397|NCT03850483|450326242|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
125192398|NCT03850483|450326243|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
125192399|NCT03850483|450326234|FG000|Treatment for Stage 1|Protocol Violation|1|||
125192400|NCT03850483|450326235|FG001|Treatment for Stage 1|Protocol Violation|0|||
125192401|NCT03850483|450326236|FG002|Treatment for Stage 1|Protocol Violation|0|||
125192402|NCT03850483|450326237|FG003|Treatment for Stage 1|Protocol Violation|0|||
125192403|NCT03850483|450326238|FG004|Treatment for Stage 1|Protocol Violation|0|||
125192404|NCT03850483|450326239|FG005|Treatment for Stage 1|Protocol Violation|0|||
125192405|NCT03850483|450326240|FG006|Treatment for Stage 1|Protocol Violation|1|||
125192406|NCT03850483|450326241|FG007|Treatment for Stage 1|Protocol Violation|0|||
125192407|NCT03850483|450326242|FG008|Treatment for Stage 1|Protocol Violation|0|||
125192408|NCT03850483|450326243|FG009|Treatment for Stage 1|Protocol Violation|0|||
125192409|NCT03850483|450326234|FG000|Treatment for Stage 1|Physician Decision|0|||
125192410|NCT03850483|450326235|FG001|Treatment for Stage 1|Physician Decision|0|||
125192411|NCT03850483|450326236|FG002|Treatment for Stage 1|Physician Decision|0|||
125192412|NCT03850483|450326237|FG003|Treatment for Stage 1|Physician Decision|0|||
125192413|NCT03850483|450326238|FG004|Treatment for Stage 1|Physician Decision|0|||
125192414|NCT03850483|450326239|FG005|Treatment for Stage 1|Physician Decision|1|||
125192415|NCT03850483|450326240|FG006|Treatment for Stage 1|Physician Decision|0|||
125192416|NCT03850483|450326241|FG007|Treatment for Stage 1|Physician Decision|0|||
125192417|NCT03850483|450326242|FG008|Treatment for Stage 1|Physician Decision|0|||
125192418|NCT03850483|450326243|FG009|Treatment for Stage 1|Physician Decision|0|||
125192419|NCT03850483|450326234|FG000|Treatment for Stage 1|Other|0|||
125192420|NCT03850483|450326235|FG001|Treatment for Stage 1|Other|0|||
125192421|NCT03850483|450326236|FG002|Treatment for Stage 1|Other|0|||
125192422|NCT03850483|450326237|FG003|Treatment for Stage 1|Other|0|||
125192423|NCT03850483|450326238|FG004|Treatment for Stage 1|Other|2|||
125192424|NCT03850483|450326239|FG005|Treatment for Stage 1|Other|1|||
125192425|NCT03850483|450326240|FG006|Treatment for Stage 1|Other|0|||
125192426|NCT03850483|450326241|FG007|Treatment for Stage 1|Other|0|||
125192427|NCT03850483|450326242|FG008|Treatment for Stage 1|Other|0|||
125192428|NCT03850483|450326243|FG009|Treatment for Stage 1|Other|0|||
125192429|NCT03850483|450326234|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192430|NCT03850483|450326235|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192431|NCT03850483|450326236|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
125192432|NCT03850483|450326237|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192433|NCT03850483|450326238|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192434|NCT03850483|450326239|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192435|NCT03850483|450326240|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192436|NCT03850483|450326241|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192437|NCT03850483|450326242|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192438|NCT03850483|450326243|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
125192439|NCT03850483|450326234|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192440|NCT03850483|450326235|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192441|NCT03850483|450326236|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192442|NCT03850483|450326237|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192443|NCT03850483|450326238|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192444|NCT03850483|450326239|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
125192445|NCT03850483|450326240|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192446|NCT03850483|450326241|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125245532|NCT03309605|450524522|FG002|Overall Study|Adverse Event|0|||
125393999|NCT00283439|451075835|FG002|Overall Study|Death|1|||
125394000|NCT00283439|451075836|FG003|Overall Study|Death|0|||
125394001|NCT00283439|451075833|FG000|Overall Study|Disease progression|0|||
125394002|NCT00283439|451075834|FG001|Overall Study|Disease progression|1|||
125394003|NCT00283439|451075835|FG002|Overall Study|Disease progression|0|||
125394004|NCT00283439|451075836|FG003|Overall Study|Disease progression|0|||
125394005|NCT00283439|451075833|FG000|Overall Study|Requirement for alternative therapy|1|||
125394006|NCT00283439|451075834|FG001|Overall Study|Requirement for alternative therapy|2|||
125394007|NCT00283439|451075835|FG002|Overall Study|Requirement for alternative therapy|5|||
125394008|NCT00283439|451075836|FG003|Overall Study|Requirement for alternative therapy|2|||
125394009|NCT00283439|451075833|FG000|Overall Study|Stem cell transplant|6|||
125192447|NCT03850483|450326242|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192448|NCT03850483|450326243|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
125192449|NCT03850483|450326234|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
125192450|NCT03850483|450326235|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
125192451|NCT03850483|450326236|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
125192452|NCT03850483|450326237|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
125192453|NCT03850483|450326238|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
125192454|NCT03850483|450326239|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
125192455|NCT03850483|450326240|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
125192456|NCT03850483|450326241|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
125192457|NCT03850483|450326242|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
125192458|NCT03850483|450326243|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
125192459|NCT03850483|450326234|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
125192460|NCT03850483|450326235|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
125192461|NCT03850483|450326236|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
125192462|NCT03850483|450326237|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
125192463|NCT03850483|450326238|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
125192464|NCT03850483|450326239|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
125192465|NCT03850483|450326240|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
125192466|NCT03850483|450326241|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
125192467|NCT03850483|450326242|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
125192468|NCT03850483|450326243|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
125192469|NCT03850483|450326234|FG000|Treatment for Stage 1|Death|0|||
125192470|NCT03850483|450326235|FG001|Treatment for Stage 1|Death|0|||
125192471|NCT03850483|450326236|FG002|Treatment for Stage 1|Death|0|||
125192472|NCT03850483|450326237|FG003|Treatment for Stage 1|Death|0|||
125192473|NCT03850483|450326238|FG004|Treatment for Stage 1|Death|0|||
125192474|NCT03850483|450326239|FG005|Treatment for Stage 1|Death|1|||
125192475|NCT03850483|450326240|FG006|Treatment for Stage 1|Death|0|||
125192476|NCT03850483|450326241|FG007|Treatment for Stage 1|Death|0|||
125192477|NCT03850483|450326242|FG008|Treatment for Stage 1|Death|0|||
125192478|NCT03850483|450326243|FG009|Treatment for Stage 1|Death|0|||
125192479|NCT03850483|450326234|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
125192480|NCT03850483|450326235|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
125192481|NCT03850483|450326236|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
125192482|NCT03850483|450326237|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
125192483|NCT03850483|450326238|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
125192484|NCT03850483|450326239|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
125192485|NCT03850483|450326240|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
125192486|NCT03850483|450326241|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
125192487|NCT03850483|450326242|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
125192488|NCT03850483|450326243|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
125192489|NCT03850483|450326234|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
125192490|NCT03850483|450326235|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
125192491|NCT03850483|450326236|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
125192492|NCT03850483|450326237|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
125192493|NCT03850483|450326238|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
125192494|NCT03850483|450326239|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
125192495|NCT03850483|450326240|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
125192496|NCT03850483|450326241|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
125192497|NCT03850483|450326242|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
125192498|NCT03850483|450326243|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
125192499|NCT03850483|450326234|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192500|NCT03850483|450326235|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192501|NCT03850483|450326236|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192502|NCT03850483|450326237|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192503|NCT03850483|450326238|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192504|NCT03850483|450326239|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192505|NCT03850483|450326240|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
125192506|NCT03850483|450326241|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
125394010|NCT00283439|451075834|FG001|Overall Study|Stem cell transplant|6|||
125394011|NCT00283439|451075835|FG002|Overall Study|Stem cell transplant|4|||
125394012|NCT00283439|451075836|FG003|Overall Study|Stem cell transplant|3|||
125245533|NCT03309605|450524523|FG003|Overall Study|Adverse Event|1|||
125245534|NCT03309605|450524524|FG004|Overall Study|Adverse Event|0|||
125245535|NCT03309605|450524525|FG005|Overall Study|Adverse Event|0|||
125245536|NCT03309605|450524526|FG006|Overall Study|Adverse Event|2|||
125245537|NCT03309605|450524527|FG007|Overall Study|Adverse Event|1|||
125245538|NCT03309605|450524520|FG000|Overall Study|Withdrawal by Subject|0|||
125245539|NCT03309605|450524521|FG001|Overall Study|Withdrawal by Subject|0|||
125245540|NCT03309605|450524522|FG002|Overall Study|Withdrawal by Subject|0|||
125245541|NCT03309605|450524523|FG003|Overall Study|Withdrawal by Subject|0|||
125245542|NCT03309605|450524524|FG004|Overall Study|Withdrawal by Subject|1|||
125245543|NCT03309605|450524525|FG005|Overall Study|Withdrawal by Subject|0|||
125245544|NCT03309605|450524526|FG006|Overall Study|Withdrawal by Subject|1|||
125245545|NCT03309605|450524527|FG007|Overall Study|Withdrawal by Subject|1|||
125245546|NCT00784927|450524528|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
125245547|NCT00784927|450524528|FG000|Overall Study|Protocol Violation|1|||
125245548|NCT00784927|450524528|FG000|Overall Study|Ineligible|1|||
125245549|NCT01795937|450524535|FG000|Overall Study|Withdrawal by Subject|1|||
125245550|NCT01795937|450524536|FG001|Overall Study|Withdrawal by Subject|0|||
125245551|NCT01795937|450524537|FG002|Overall Study|Withdrawal by Subject|0|||
125245552|NCT01795937|450524535|FG000|Overall Study|Physician Decision|0|||
125245553|NCT01795937|450524536|FG001|Overall Study|Physician Decision|1|||
125245554|NCT01795937|450524537|FG002|Overall Study|Physician Decision|0|||
125245555|NCT01028053|450524538|FG000|Overall Study|Screen Failure|113|||
125245556|NCT01028053|450524538|FG000|Overall Study|Patient Request|11|||
125245557|NCT01028053|450524538|FG000|Overall Study|Protocol Violation|1|||
125192507|NCT03850483|450326242|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192508|NCT03850483|450326243|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
125192509|NCT03850483|450326234|FG000|Follow-up for Stage 1|Physician Decision|0|||
125192510|NCT03850483|450326235|FG001|Follow-up for Stage 1|Physician Decision|0|||
125192511|NCT03850483|450326236|FG002|Follow-up for Stage 1|Physician Decision|0|||
125192512|NCT03850483|450326237|FG003|Follow-up for Stage 1|Physician Decision|0|||
125192513|NCT03850483|450326238|FG004|Follow-up for Stage 1|Physician Decision|1|||
125192514|NCT03850483|450326239|FG005|Follow-up for Stage 1|Physician Decision|0|||
125192515|NCT03850483|450326240|FG006|Follow-up for Stage 1|Physician Decision|1|||
125192516|NCT03850483|450326241|FG007|Follow-up for Stage 1|Physician Decision|0|||
125192517|NCT03850483|450326242|FG008|Follow-up for Stage 1|Physician Decision|0|||
125192518|NCT03850483|450326243|FG009|Follow-up for Stage 1|Physician Decision|0|||
125192519|NCT03850483|450326234|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
125192520|NCT03850483|450326235|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
125192521|NCT03850483|450326236|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
125192522|NCT03850483|450326237|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
125192523|NCT03850483|450326238|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
125192524|NCT03850483|450326239|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
125192525|NCT03850483|450326240|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
125192526|NCT03850483|450326241|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
125192527|NCT03850483|450326242|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
125192528|NCT03850483|450326243|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
125192529|NCT03850483|450326234|FG000|Follow-up for Stage 1|Adverse Event|0|||
125192530|NCT03850483|450326235|FG001|Follow-up for Stage 1|Adverse Event|0|||
125192531|NCT03850483|450326236|FG002|Follow-up for Stage 1|Adverse Event|1|||
125192532|NCT03850483|450326237|FG003|Follow-up for Stage 1|Adverse Event|0|||
125192533|NCT03850483|450326238|FG004|Follow-up for Stage 1|Adverse Event|0|||
125192534|NCT03850483|450326239|FG005|Follow-up for Stage 1|Adverse Event|1|||
125192535|NCT03850483|450326240|FG006|Follow-up for Stage 1|Adverse Event|0|||
125192536|NCT03850483|450326241|FG007|Follow-up for Stage 1|Adverse Event|0|||
125192537|NCT03850483|450326242|FG008|Follow-up for Stage 1|Adverse Event|0|||
125192538|NCT03850483|450326243|FG009|Follow-up for Stage 1|Adverse Event|0|||
125192539|NCT03850483|450326234|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125192540|NCT03850483|450326235|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
125192541|NCT03850483|450326236|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125245558|NCT01028053|450524538|FG000|Overall Study|Physician Decision|2|||
125192542|NCT03850483|450326237|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125192543|NCT03850483|450326238|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
125192544|NCT03850483|450326239|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
125192545|NCT03850483|450326240|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125192546|NCT03850483|450326241|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125192547|NCT03850483|450326242|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125245559|NCT01028053|450524538|FG000|Overall Study|Technical Problem|1|||
125245560|NCT01028053|450524538|FG000|Overall Study|Terminated by Sponsor|1|||
125245561|NCT01028053|450524538|FG000|Overall Study|Various reasons|4|||
125245562|NCT04027946|450524539|FG000|Overall Study|Screen failures|3|||
125245563|NCT00983957|450524540|FG000|Overall Study|Adverse Event|1|||
125192548|NCT03850483|450326243|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
125192549|NCT03850483|450326234|FG000|Follow-up for Stage 1|Other|0|||
125192550|NCT03850483|450326235|FG001|Follow-up for Stage 1|Other|2|||
125394013|NCT00283439|451075833|FG000|Overall Study|Treatment discontinued|0|||
125394014|NCT00283439|451075834|FG001|Overall Study|Treatment discontinued|2|||
125394015|NCT00283439|451075835|FG002|Overall Study|Treatment discontinued|1|||
125394016|NCT00283439|451075836|FG003|Overall Study|Treatment discontinued|3|||
125394017|NCT00283439|451075833|FG000|Overall Study|Other|1|||
125394018|NCT00283439|451075834|FG001|Overall Study|Other|0|||
125394019|NCT00283439|451075835|FG002|Overall Study|Other|0|||
125394020|NCT00283439|451075836|FG003|Overall Study|Other|0|||
125394021|NCT04033003|451075838|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
125394022|NCT04033003|451075839|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
125394023|NCT04033003|451075838|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
125394024|NCT04033003|451075839|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
125394025|NCT04033003|451075838|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
125394026|NCT04033003|451075839|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
125394027|NCT04033003|451075838|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
125443538|NCT01383993|451252166|FG000|Overall Study|Adverse Event|1|||
125192551|NCT03850483|450326236|FG002|Follow-up for Stage 1|Other|0|||
125192552|NCT03850483|450326237|FG003|Follow-up for Stage 1|Other|2|||
125192553|NCT03850483|450326238|FG004|Follow-up for Stage 1|Other|0|||
125192554|NCT03850483|450326239|FG005|Follow-up for Stage 1|Other|1|||
125192555|NCT03850483|450326240|FG006|Follow-up for Stage 1|Other|0|||
125192556|NCT03850483|450326241|FG007|Follow-up for Stage 1|Other|0|||
125192557|NCT03850483|450326242|FG008|Follow-up for Stage 1|Other|0|||
125192558|NCT03850483|450326243|FG009|Follow-up for Stage 1|Other|0|||
125192559|NCT03850483|450326234|FG000|Treatment for Stage 2|Adverse Event|0|||
125192560|NCT03850483|450326235|FG001|Treatment for Stage 2|Adverse Event|0|||
125192561|NCT03850483|450326236|FG002|Treatment for Stage 2|Adverse Event|0|||
125192562|NCT03850483|450326237|FG003|Treatment for Stage 2|Adverse Event|0|||
125192563|NCT03850483|450326238|FG004|Treatment for Stage 2|Adverse Event|0|||
125192564|NCT03850483|450326239|FG005|Treatment for Stage 2|Adverse Event|0|||
125192565|NCT03850483|450326240|FG006|Treatment for Stage 2|Adverse Event|0|||
125192566|NCT03850483|450326241|FG007|Treatment for Stage 2|Adverse Event|0|||
125192567|NCT03850483|450326242|FG008|Treatment for Stage 2|Adverse Event|0|||
125192568|NCT03850483|450326243|FG009|Treatment for Stage 2|Adverse Event|1|||
125192569|NCT03850483|450326234|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
125192570|NCT03850483|450326235|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
125192571|NCT03850483|450326236|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
125192572|NCT03850483|450326237|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
125192573|NCT03850483|450326238|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
125192574|NCT03850483|450326239|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
125192575|NCT03850483|450326240|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
125192576|NCT03850483|450326241|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
125192577|NCT03850483|450326242|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
125192578|NCT03850483|450326243|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
125192579|NCT03850483|450326234|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
125192580|NCT03850483|450326235|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
125192581|NCT03850483|450326236|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
125192582|NCT03850483|450326237|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
125192583|NCT03850483|450326238|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
125192584|NCT03850483|450326239|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
125192585|NCT03850483|450326240|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
125192586|NCT03850483|450326241|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
125192587|NCT03850483|450326242|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
125192588|NCT03850483|450326243|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
125192589|NCT03850483|450326234|FG000|Treatment for Stage 2|Physician Decision|0|||
125192590|NCT03850483|450326235|FG001|Treatment for Stage 2|Physician Decision|0|||
125192591|NCT03850483|450326236|FG002|Treatment for Stage 2|Physician Decision|0|||
125192592|NCT03850483|450326237|FG003|Treatment for Stage 2|Physician Decision|0|||
125192593|NCT03850483|450326238|FG004|Treatment for Stage 2|Physician Decision|0|||
125192594|NCT03850483|450326239|FG005|Treatment for Stage 2|Physician Decision|0|||
125192595|NCT03850483|450326240|FG006|Treatment for Stage 2|Physician Decision|0|||
125192596|NCT03850483|450326241|FG007|Treatment for Stage 2|Physician Decision|0|||
125192597|NCT03850483|450326242|FG008|Treatment for Stage 2|Physician Decision|0|||
125192598|NCT03850483|450326243|FG009|Treatment for Stage 2|Physician Decision|1|||
125192599|NCT03850483|450326234|FG000|Treatment for Stage 2|Protocol Violation|0|||
125192600|NCT03850483|450326235|FG001|Treatment for Stage 2|Protocol Violation|0|||
125192601|NCT03850483|450326236|FG002|Treatment for Stage 2|Protocol Violation|0|||
125192602|NCT03850483|450326237|FG003|Treatment for Stage 2|Protocol Violation|0|||
125192603|NCT03850483|450326238|FG004|Treatment for Stage 2|Protocol Violation|0|||
125192604|NCT03850483|450326239|FG005|Treatment for Stage 2|Protocol Violation|0|||
125192605|NCT03850483|450326240|FG006|Treatment for Stage 2|Protocol Violation|0|||
125192606|NCT03850483|450326241|FG007|Treatment for Stage 2|Protocol Violation|0|||
125192607|NCT03850483|450326242|FG008|Treatment for Stage 2|Protocol Violation|1|||
125192608|NCT03850483|450326243|FG009|Treatment for Stage 2|Protocol Violation|0|||
125192609|NCT03850483|450326234|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
125192610|NCT03850483|450326235|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
125192611|NCT03850483|450326236|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
125192612|NCT03850483|450326237|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
125192613|NCT03850483|450326238|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
125192614|NCT03850483|450326239|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
125192615|NCT03850483|450326240|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
125192616|NCT03850483|450326241|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
125192617|NCT03850483|450326242|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
125192618|NCT03850483|450326243|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
125192619|NCT03850483|450326234|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192620|NCT03850483|450326235|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192621|NCT03850483|450326236|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125394028|NCT04033003|451075839|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
125394029|NCT04033003|451075838|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
125394030|NCT04033003|451075839|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
125394031|NCT04033003|451075838|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
125394032|NCT04033003|451075839|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
125394033|NCT04033003|451075838|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
125394034|NCT04033003|451075839|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
125394035|NCT04033003|451075838|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
125394036|NCT04033003|451075839|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
125394037|NCT04033003|451075838|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
125394038|NCT04033003|451075839|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
125394039|NCT04033003|451075838|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
125394040|NCT04033003|451075839|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
125394041|NCT04033003|451075838|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
125394042|NCT04033003|451075839|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
125394043|NCT04033003|451075838|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
125394044|NCT04033003|451075839|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
125394045|NCT04033003|451075838|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
125394046|NCT04033003|451075839|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
125394047|NCT00430092|451075840|FG000|Overall Study|Adverse Event|0|||
125394048|NCT00430092|451075841|FG001|Overall Study|Adverse Event|0|||
125394049|NCT00430092|451075842|FG002|Overall Study|Adverse Event|1|||
125394050|NCT00430092|451075840|FG000|Overall Study|Lack of Efficacy|5|||
125394051|NCT00430092|451075841|FG001|Overall Study|Lack of Efficacy|2|||
125394052|NCT00430092|451075842|FG002|Overall Study|Lack of Efficacy|54|||
125394053|NCT00430092|451075840|FG000|Overall Study|Lost to Follow-up|1|||
125394054|NCT00430092|451075841|FG001|Overall Study|Lost to Follow-up|0|||
125394055|NCT00430092|451075842|FG002|Overall Study|Lost to Follow-up|0|||
125394056|NCT00430092|451075840|FG000|Overall Study|Protocol Violation|0|||
125192622|NCT03850483|450326237|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192623|NCT03850483|450326238|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192624|NCT03850483|450326239|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192625|NCT03850483|450326240|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192626|NCT03850483|450326241|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192627|NCT03850483|450326242|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
125192628|NCT03850483|450326243|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
125192629|NCT03850483|450326234|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
125192630|NCT03850483|450326235|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
125192631|NCT03850483|450326236|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
125192632|NCT03850483|450326237|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
125192633|NCT03850483|450326238|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
125192634|NCT03850483|450326239|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
125192635|NCT03850483|450326240|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
125192636|NCT03850483|450326241|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
125192637|NCT03850483|450326242|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
125192638|NCT03850483|450326243|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
125192639|NCT03850483|450326234|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
125192640|NCT03850483|450326235|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
125192641|NCT03850483|450326236|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
125394057|NCT00430092|451075841|FG001|Overall Study|Protocol Violation|1|||
125394058|NCT00430092|451075842|FG002|Overall Study|Protocol Violation|1|||
125394059|NCT00430092|451075840|FG000|Overall Study|Withdrawal by Subject|0|||
125394060|NCT00430092|451075841|FG001|Overall Study|Withdrawal by Subject|1|||
125192642|NCT03850483|450326237|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
125192643|NCT03850483|450326238|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
125192644|NCT03850483|450326239|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
125394061|NCT00430092|451075842|FG002|Overall Study|Withdrawal by Subject|1|||
125394062|NCT00706966|451075843|FG000|Overall Study|Adverse Event|1|||
125394063|NCT00850200|451075850|FG000|Overall Study|Physician Decision|2|||
125394064|NCT00850200|451075850|FG000|Overall Study|Did not recieve treatment|2|||
125394065|NCT00850200|451075850|FG000|Overall Study|Withdrawal by Subject|1|||
125394066|NCT00794196|451075858|FG000|Overall Study|Lost to Follow-up|5|||
125394067|NCT00794196|451075859|FG001|Overall Study|Lost to Follow-up|23|||
125394068|NCT02129803|451075860|FG000|Overall Study|Protocol Violation|4|||
125394069|NCT02129803|451075861|FG001|Overall Study|Protocol Violation|0|||
125394070|NCT02129803|451075860|FG000|Overall Study|Physician Decision|0|||
125394071|NCT02129803|451075861|FG001|Overall Study|Physician Decision|1|||
125394072|NCT02129803|451075860|FG000|Overall Study|Difficulty sleeping|1|||
125394073|NCT02129803|451075861|FG001|Overall Study|Difficulty sleeping|0|||
125394074|NCT02129803|451075860|FG000|Overall Study|Morning headache|0|||
125394075|NCT02129803|451075861|FG001|Overall Study|Morning headache|1|||
125394076|NCT02129803|451075860|FG000|Overall Study|Withdrawal by Subject|1|||
125394077|NCT02129803|451075861|FG001|Overall Study|Withdrawal by Subject|1|||
125394078|NCT00149747|451075863|FG000|Overall Study|Death|1|||
125394079|NCT00149747|451075864|FG001|Overall Study|Death|0|||
125394080|NCT00149747|451075863|FG000|Overall Study|Withdrawal by Subject|3|||
125394081|NCT00149747|451075864|FG001|Overall Study|Withdrawal by Subject|3|||
125394082|NCT00850395|451075870|FG000|Overall Study|Death|1|||
125394083|NCT00850395|451075870|FG000|Overall Study|Adverse Event|1|||
125394084|NCT00850395|451075870|FG000|Overall Study|Insufficient clinical response|3|||
125394085|NCT00850395|451075870|FG000|Overall Study|Other|5|||
125394086|NCT06049043|451075871|FG000|Overall Study|Lost to Follow-up|11|||
125394087|NCT06049043|451075872|FG001|Overall Study|Lost to Follow-up|9|||
125394088|NCT02739269|451075876|FG000|Overall Study|Protocol Violation|5|||
125394089|NCT02739269|451075877|FG001|Overall Study|Protocol Violation|0|||
125394090|NCT02739269|451075876|FG000|Overall Study|Cycle cancellation|2|||
125443539|NCT01383993|451252167|FG001|Overall Study|Adverse Event|1|||
125443540|NCT01383993|451252168|FG002|Overall Study|Adverse Event|0|||
125443541|NCT01383993|451252166|FG000|Overall Study|Withdrawal by Subject|0|||
125443542|NCT01383993|451252167|FG001|Overall Study|Withdrawal by Subject|0|||
125192645|NCT03850483|450326240|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
125192646|NCT03850483|450326241|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
125192647|NCT03850483|450326242|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
125245564|NCT00983957|450524540|FG000|Overall Study|Personal Reasons|1|||
125245565|NCT00790933|450524541|FG000|Overall Study|Adverse Event|94|||
125245566|NCT00790933|450524542|FG001|Overall Study|Adverse Event|119|||
125245567|NCT00790933|450524543|FG002|Overall Study|Adverse Event|65|||
125245568|NCT00790933|450524544|FG003|Overall Study|Adverse Event|5|||
125245569|NCT00790933|450524545|FG004|Overall Study|Adverse Event|69|||
125245570|NCT00790933|450524541|FG000|Overall Study|Protocol Violation(s)|8|||
125245571|NCT00790933|450524542|FG001|Overall Study|Protocol Violation(s)|18|||
125245572|NCT00790933|450524543|FG002|Overall Study|Protocol Violation(s)|7|||
125245573|NCT00790933|450524544|FG003|Overall Study|Protocol Violation(s)|0|||
125245574|NCT00790933|450524545|FG004|Overall Study|Protocol Violation(s)|12|||
125192648|NCT03850483|450326243|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
125192649|NCT03850483|450326234|FG000|Follow-up For Stage 2|Other|0|||
125192650|NCT03850483|450326235|FG001|Follow-up For Stage 2|Other|0|||
125192651|NCT03850483|450326236|FG002|Follow-up For Stage 2|Other|0|||
125192652|NCT03850483|450326237|FG003|Follow-up For Stage 2|Other|0|||
125192653|NCT03850483|450326238|FG004|Follow-up For Stage 2|Other|0|||
125192654|NCT03850483|450326239|FG005|Follow-up For Stage 2|Other|0|||
125192655|NCT03850483|450326240|FG006|Follow-up For Stage 2|Other|0|||
125192656|NCT03850483|450326241|FG007|Follow-up For Stage 2|Other|0|||
125192657|NCT03850483|450326242|FG008|Follow-up For Stage 2|Other|0|||
125192658|NCT03850483|450326243|FG009|Follow-up For Stage 2|Other|1|||
125192659|NCT01464593|450328049|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
125192660|NCT00302328|450328050|FG000|Overall Study|Physician Decision|0|||
125192661|NCT00302328|450328051|FG001|Overall Study|Physician Decision|1|||
125192662|NCT00302328|450328052|FG002|Overall Study|Physician Decision|0|||
125245575|NCT00790933|450524541|FG000|Overall Study|Lack of Efficacy|192|||
125245576|NCT00790933|450524542|FG001|Overall Study|Lack of Efficacy|176|||
125245577|NCT00790933|450524543|FG002|Overall Study|Lack of Efficacy|130|||
125443543|NCT01383993|451252168|FG002|Overall Study|Withdrawal by Subject|1|||
125192663|NCT01288937|450328055|FG000|Overall Study|Adverse Event|1|||
125394091|NCT02739269|451075877|FG001|Overall Study|Cycle cancellation|2|||
125394092|NCT02739269|451075876|FG000|Overall Study|Withdrawal by Subject|0|||
125192664|NCT01288937|450328056|FG001|Overall Study|Adverse Event|0|||
125192665|NCT02490371|450328057|FG000|Overall Study|Lost to Follow-up|1|||
125192666|NCT02490371|450328058|FG001|Overall Study|Lost to Follow-up|1|||
125245578|NCT00790933|450524544|FG003|Overall Study|Lack of Efficacy|1|||
125394093|NCT02739269|451075877|FG001|Overall Study|Withdrawal by Subject|2|||
125394094|NCT01354496|451075878|FG000|Period 1|Adverse Event|0|||
125245579|NCT00790933|450524545|FG004|Overall Study|Lack of Efficacy|121|||
125245580|NCT00790933|450524541|FG000|Overall Study|Study Terminated by Sponsor|0|||
125394095|NCT01354496|451075879|FG001|Period 1|Adverse Event|0|||
125443544|NCT01383993|451252166|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
125394096|NCT01354496|451075880|FG002|Period 1|Adverse Event|1|||
125394097|NCT01354496|451075881|FG003|Period 1|Adverse Event|0|||
125394098|NCT01354496|451075882|FG004|Period 1|Adverse Event|0|||
125394099|NCT01354496|451075883|FG005|Period 1|Adverse Event|0|||
125394100|NCT01354496|451075878|FG000|Period 1|Physician Decision|0|||
125394101|NCT01354496|451075879|FG001|Period 1|Physician Decision|0|||
125394102|NCT01354496|451075880|FG002|Period 1|Physician Decision|1|||
125394103|NCT01354496|451075881|FG003|Period 1|Physician Decision|0|||
125394104|NCT01354496|451075882|FG004|Period 1|Physician Decision|0|||
125394105|NCT01354496|451075883|FG005|Period 1|Physician Decision|0|||
125394106|NCT01354496|451075878|FG000|Period 2|Adverse Event|0|||
125394107|NCT01354496|451075879|FG001|Period 2|Adverse Event|0|||
125394108|NCT01354496|451075880|FG002|Period 2|Adverse Event|0|||
125394109|NCT01354496|451075881|FG003|Period 2|Adverse Event|1|||
125394110|NCT01354496|451075882|FG004|Period 2|Adverse Event|0|||
125394111|NCT01354496|451075883|FG005|Period 2|Adverse Event|0|||
125394112|NCT01354496|451075878|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
125394113|NCT01354496|451075879|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
125394114|NCT01354496|451075880|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
125394115|NCT01354496|451075881|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
125394116|NCT01354496|451075882|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
125394117|NCT01354496|451075883|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
125394118|NCT01228747|451075884|FG000|Overall Study|Adverse Event|8|||
125394119|NCT01228747|451075885|FG001|Overall Study|Adverse Event|4|||
125394120|NCT01228747|451075884|FG000|Overall Study|Lack of Efficacy|40|||
125394121|NCT01228747|451075885|FG001|Overall Study|Lack of Efficacy|27|||
125394122|NCT01228747|451075884|FG000|Overall Study|Protocol Violation|6|||
125394123|NCT01228747|451075885|FG001|Overall Study|Protocol Violation|5|||
125394124|NCT01228747|451075884|FG000|Overall Study|Lost to Follow-up|4|||
125394125|NCT01228747|451075885|FG001|Overall Study|Lost to Follow-up|3|||
125394126|NCT01228747|451075884|FG000|Overall Study|Withdrawal by Subject|5|||
125394127|NCT01228747|451075885|FG001|Overall Study|Withdrawal by Subject|1|||
125394128|NCT01228747|451075884|FG000|Overall Study|Other Reason|2|||
125394129|NCT01228747|451075885|FG001|Overall Study|Other Reason|5|||
125394130|NCT02036502|451075886|FG000|Part 1:Dose Determination/Escalation|Death|3|||
125394131|NCT02036502|451075887|FG001|Part 1:Dose Determination/Escalation|Death|2|||
125394132|NCT02036502|451075888|FG002|Part 1:Dose Determination/Escalation|Death|0|||
125394133|NCT02036502|451075889|FG003|Part 1:Dose Determination/Escalation|Death|0|||
125394134|NCT02036502|451075890|FG004|Part 1:Dose Determination/Escalation|Death|0|||
125394135|NCT02036502|451075891|FG005|Part 1:Dose Determination/Escalation|Death|0|||
125394136|NCT02036502|451075892|FG006|Part 1:Dose Determination/Escalation|Death|0|||
125394137|NCT02036502|451075893|FG007|Part 1:Dose Determination/Escalation|Death|0|||
125394138|NCT02036502|451075886|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
125394139|NCT02036502|451075887|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125394140|NCT02036502|451075888|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125394141|NCT02036502|451075889|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125394142|NCT02036502|451075890|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125394143|NCT02036502|451075891|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125192667|NCT02476578|450328061|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
125192668|NCT02476578|450328062|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
125192669|NCT02476578|450328061|FG000|Overall Study|Lost to Follow-up|6|||
125192670|NCT02476578|450328062|FG001|Overall Study|Lost to Follow-up|13|||
125192671|NCT03018080|450328063|FG000|Overall Study|Death|12|||
125192672|NCT03018080|450328064|FG001|Overall Study|Death|19|||
125192673|NCT01019694|450328067|FG000|Overall Study|Adverse Event|12|||
125192674|NCT01019694|450328068|FG001|Overall Study|Adverse Event|16|||
125192675|NCT01019694|450328069|FG002|Overall Study|Adverse Event|19|||
125192676|NCT01019694|450328067|FG000|Overall Study|Protocol Violation|2|||
125192677|NCT01019694|450328068|FG001|Overall Study|Protocol Violation|6|||
125192678|NCT01019694|450328069|FG002|Overall Study|Protocol Violation|4|||
125394144|NCT02036502|451075892|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125394145|NCT02036502|451075893|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
125394146|NCT02036502|451075886|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125394147|NCT02036502|451075887|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
125394148|NCT02036502|451075888|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125394149|NCT02036502|451075889|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125394150|NCT02036502|451075890|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125394151|NCT02036502|451075891|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125394152|NCT02036502|451075892|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125192679|NCT01019694|450328067|FG000|Overall Study|Lost to Follow-up|5|||
125192680|NCT01019694|450328068|FG001|Overall Study|Lost to Follow-up|3|||
125192681|NCT01019694|450328069|FG002|Overall Study|Lost to Follow-up|3|||
125192682|NCT01019694|450328067|FG000|Overall Study|Withdrawal by Subject|4|||
125192683|NCT01019694|450328068|FG001|Overall Study|Withdrawal by Subject|6|||
125394153|NCT02036502|451075893|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
125245581|NCT00790933|450524542|FG001|Overall Study|Study Terminated by Sponsor|0|||
125245582|NCT00790933|450524543|FG002|Overall Study|Study Terminated by Sponsor|1|||
125245583|NCT00790933|450524544|FG003|Overall Study|Study Terminated by Sponsor|0|||
125245584|NCT00790933|450524545|FG004|Overall Study|Study Terminated by Sponsor|0|||
125192684|NCT01019694|450328069|FG002|Overall Study|Withdrawal by Subject|12|||
125192685|NCT01019694|450328067|FG000|Overall Study|Not treated|0|||
125192686|NCT01019694|450328068|FG001|Overall Study|Not treated|2|||
125192687|NCT01019694|450328069|FG002|Overall Study|Not treated|3|||
125192688|NCT01019694|450328067|FG000|Overall Study|Other reason (not specified)|1|||
125192689|NCT01019694|450328068|FG001|Overall Study|Other reason (not specified)|5|||
125192690|NCT01019694|450328069|FG002|Overall Study|Other reason (not specified)|6|||
125192691|NCT00026494|450328072|FG000|Overall Study|Withdrawal by Subject|1|||
125192692|NCT00026494|450328073|FG001|Overall Study|Withdrawal by Subject|0|||
125192693|NCT00026494|450328074|FG002|Overall Study|Withdrawal by Subject|1|||
125192694|NCT00026494|450328075|FG003|Overall Study|Withdrawal by Subject|0|||
125192695|NCT00026494|450328072|FG000|Overall Study|Patient non-compliance|1|||
125192696|NCT00026494|450328073|FG001|Overall Study|Patient non-compliance|0|||
125192697|NCT00026494|450328074|FG002|Overall Study|Patient non-compliance|0|||
125192698|NCT00026494|450328075|FG003|Overall Study|Patient non-compliance|0|||
125192699|NCT00026494|450328072|FG000|Overall Study|Patient not treated|0|||
125192700|NCT00026494|450328073|FG001|Overall Study|Patient not treated|0|||
125192701|NCT00026494|450328074|FG002|Overall Study|Patient not treated|2|||
125192702|NCT00026494|450328075|FG003|Overall Study|Patient not treated|0|||
125192703|NCT00026494|450328072|FG000|Overall Study|Clinical progression|0|||
125192704|NCT00026494|450328073|FG001|Overall Study|Clinical progression|0|||
125192705|NCT00026494|450328074|FG002|Overall Study|Clinical progression|3|||
125245585|NCT00790933|450524541|FG000|Overall Study|Withdrawal by Subject|123|||
125245586|NCT00790933|450524542|FG001|Overall Study|Withdrawal by Subject|120|||
125245587|NCT00790933|450524543|FG002|Overall Study|Withdrawal by Subject|52|||
125245588|NCT00790933|450524544|FG003|Overall Study|Withdrawal by Subject|6|||
125245589|NCT00790933|450524545|FG004|Overall Study|Withdrawal by Subject|50|||
125245590|NCT00790933|450524541|FG000|Overall Study|Lost to Follow-up|13|||
125245591|NCT00790933|450524542|FG001|Overall Study|Lost to Follow-up|31|||
125245592|NCT00790933|450524543|FG002|Overall Study|Lost to Follow-up|10|||
125245593|NCT00790933|450524544|FG003|Overall Study|Lost to Follow-up|1|||
125245594|NCT00790933|450524545|FG004|Overall Study|Lost to Follow-up|15|||
125245595|NCT00790933|450524541|FG000|Overall Study|Reason Not Specified|8|||
125245596|NCT00790933|450524542|FG001|Overall Study|Reason Not Specified|16|||
125245597|NCT00790933|450524543|FG002|Overall Study|Reason Not Specified|4|||
125245598|NCT00790933|450524544|FG003|Overall Study|Reason Not Specified|1|||
125245599|NCT00790933|450524545|FG004|Overall Study|Reason Not Specified|9|||
125245600|NCT00245570|450524548|FG000|Washout Between Periods III and IV|Adverse Event|0|||
125245601|NCT00245570|450524549|FG001|Washout Between Periods III and IV|Adverse Event|1|||
125245602|NCT00245570|450524550|FG002|Washout Between Periods III and IV|Adverse Event|0|||
125245603|NCT00245570|450524551|FG003|Washout Between Periods III and IV|Adverse Event|0|||
125245604|NCT00245570|450524552|FG004|Washout Between Periods III and IV|Adverse Event|0|||
125245605|NCT00245570|450524553|FG005|Washout Between Periods III and IV|Adverse Event|0|||
125245606|NCT01829165|450524554|FG000|Overall Study|Did not complete intervention|2|||
125245607|NCT01829165|450524555|FG001|Overall Study|Did not complete intervention|0|||
125245608|NCT04233580|450524576|FG000|Overall Study|Adverse Event|3|||
125245609|NCT04233580|450524577|FG001|Overall Study|Adverse Event|3|||
125245610|NCT04233580|450524576|FG000|Overall Study|Withdrawal by Subject|2|||
125245611|NCT04233580|450524577|FG001|Overall Study|Withdrawal by Subject|1|||
125245612|NCT02441114|450524578|FG000|Washout2|Withdrawal by Subject|4|||
125245613|NCT01371565|450524580|FG000|Overall Study|Withdrawal by Subject|1|||
125245614|NCT01371565|450524580|FG000|Overall Study|Death|1|||
125245615|NCT01371565|450524580|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
125245616|NCT02070991|450524581|FG000|Overall Study|Death|2|||
125245617|NCT02070991|450524582|FG001|Overall Study|Death|0|||
125245618|NCT02070991|450524581|FG000|Overall Study|Withdrawal by Subject|1|||
125245619|NCT02070991|450524582|FG001|Overall Study|Withdrawal by Subject|0|||
125245620|NCT00827242|450524583|FG000|Overall Study|Withdrawal by Subject|2|||
125192706|NCT00026494|450328075|FG003|Overall Study|Clinical progression|0|||
125192707|NCT01684423|450328076|FG000|Overall Study|Withdrawal by Subject|0|||
125192708|NCT01684423|450328077|FG001|Overall Study|Withdrawal by Subject|0|||
125192709|NCT01684423|450328078|FG002|Overall Study|Withdrawal by Subject|1|||
125192710|NCT01684423|450328079|FG003|Overall Study|Withdrawal by Subject|0|||
125245621|NCT00827242|450524584|FG001|Overall Study|Withdrawal by Subject|4|||
125245622|NCT00827242|450524583|FG000|Overall Study|Protocol Violation|1|||
125245623|NCT00827242|450524584|FG001|Overall Study|Protocol Violation|3|||
125245624|NCT00827242|450524583|FG000|Overall Study|Lost to Follow-up|0|||
125443545|NCT01383993|451252167|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
125192711|NCT01684423|450328080|FG004|Overall Study|Withdrawal by Subject|0|||
125245625|NCT00827242|450524584|FG001|Overall Study|Lost to Follow-up|3|||
125245626|NCT00827242|450524583|FG000|Overall Study|Adverse Event Excluding Death|2|||
125245627|NCT00827242|450524584|FG001|Overall Study|Adverse Event Excluding Death|1|||
125394154|NCT02036502|451075886|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
125394155|NCT02036502|451075887|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
125394156|NCT02036502|451075888|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
125394157|NCT02036502|451075889|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
125394158|NCT02036502|451075890|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
125394159|NCT02036502|451075891|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
125394160|NCT02036502|451075892|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
125394161|NCT02036502|451075893|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
125192712|NCT00441129|450328081|FG000|Overall Study|Withdrawal by Subject|6|||
125192713|NCT00441129|450328082|FG001|Overall Study|Withdrawal by Subject|14|||
125192714|NCT01455597|450328083|FG000|Overall Study|Adverse Event|7|||
125192715|NCT01455597|450328084|FG001|Overall Study|Adverse Event|0|||
125192716|NCT01455597|450328085|FG002|Overall Study|Adverse Event|5|||
125192717|NCT01455597|450328086|FG003|Overall Study|Adverse Event|1|||
125192718|NCT01455597|450328083|FG000|Overall Study|Lack of Efficacy|0|||
125192719|NCT01455597|450328084|FG001|Overall Study|Lack of Efficacy|1|||
125192720|NCT01455597|450328085|FG002|Overall Study|Lack of Efficacy|2|||
125192721|NCT01455597|450328086|FG003|Overall Study|Lack of Efficacy|0|||
125192722|NCT01455597|450328083|FG000|Overall Study|Lost to Follow-up|3|||
125192723|NCT01455597|450328084|FG001|Overall Study|Lost to Follow-up|0|||
125192724|NCT01455597|450328085|FG002|Overall Study|Lost to Follow-up|2|||
125192725|NCT01455597|450328086|FG003|Overall Study|Lost to Follow-up|1|||
125192726|NCT01455597|450328083|FG000|Overall Study|Withdrew Consent|6|||
125192727|NCT01455597|450328084|FG001|Overall Study|Withdrew Consent|5|||
125192728|NCT01455597|450328085|FG002|Overall Study|Withdrew Consent|8|||
125192729|NCT01455597|450328086|FG003|Overall Study|Withdrew Consent|5|||
125192730|NCT01455597|450328083|FG000|Overall Study|Reason not Specified|1|||
125192731|NCT01455597|450328084|FG001|Overall Study|Reason not Specified|2|||
125192732|NCT01455597|450328085|FG002|Overall Study|Reason not Specified|3|||
125192733|NCT01455597|450328086|FG003|Overall Study|Reason not Specified|3|||
125192734|NCT03412734|450328089|FG000|Overall Study|Incorrect labeling of samples|2|||
125192735|NCT03412734|450328090|FG001|Overall Study|Incorrect labeling of samples|0|||
125192736|NCT03412734|450328089|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
125192737|NCT03412734|450328090|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
125192738|NCT00423332|450328091|FG000|Overall Study|Adverse Event|6|||
125192739|NCT00423332|450328092|FG001|Overall Study|Adverse Event|2|||
125192740|NCT00423332|450328091|FG000|Overall Study|Withdrawal by Subject|1|||
125192741|NCT00423332|450328092|FG001|Overall Study|Withdrawal by Subject|0|||
125192742|NCT00423332|450328091|FG000|Overall Study|Condition under investigation worsened|1|||
125192743|NCT00423332|450328092|FG001|Overall Study|Condition under investigation worsened|1|||
125192744|NCT00423332|450328091|FG000|Overall Study|Progressive at Week 6|0|||
125192745|NCT00423332|450328092|FG001|Overall Study|Progressive at Week 6|1|||
125192746|NCT00423332|450328091|FG000|Overall Study|Unblinded before 12 weeks|1|||
125192747|NCT00423332|450328092|FG001|Overall Study|Unblinded before 12 weeks|3|||
125192748|NCT01136356|450328093|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
125192749|NCT01136356|450328094|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
125192750|NCT01136356|450328093|FG000|First 18-day Withdrawal|Physician Decision|1|||
125192751|NCT01136356|450328094|FG001|First 18-day Withdrawal|Physician Decision|0|||
125192752|NCT01136356|450328093|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
125192753|NCT01136356|450328094|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
125192754|NCT00927862|450328095|FG000|Overall Study|Missing data needed for endpt analyses|27|||
125192755|NCT00927862|450328096|FG001|Overall Study|Missing data needed for endpt analyses|45|||
125192756|NCT00820248|450328097|FG000|Overall Study|No treated|4|||
125192757|NCT00820248|450328098|FG001|Overall Study|No treated|1|||
125192758|NCT04112043|450328099|FG000|Overall Study|Withdrawal by Subject|1|||
125192759|NCT04112043|450328100|FG001|Overall Study|Withdrawal by Subject|1|||
125192760|NCT04112043|450328101|FG002|Overall Study|Withdrawal by Subject|1|||
125192761|NCT04112043|450328099|FG000|Overall Study|Taking NR supplement|1|||
125192762|NCT04112043|450328100|FG001|Overall Study|Taking NR supplement|0|||
125192763|NCT04112043|450328101|FG002|Overall Study|Taking NR supplement|0|||
125192764|NCT04112043|450328099|FG000|Overall Study|Adverse Event|0|||
125192765|NCT04112043|450328100|FG001|Overall Study|Adverse Event|1|||
125192766|NCT04112043|450328101|FG002|Overall Study|Adverse Event|0|||
125192767|NCT01750697|450328102|FG000|Overall Study|Transferred Back to Local Hospital|1|||
125192768|NCT01750697|450328102|FG000|Overall Study|Physician and Family Decision|1|||
125192769|NCT01750697|450328102|FG000|Overall Study|Transferred to Adult Services|5|||
125192770|NCT01750697|450328102|FG000|Overall Study|Physician Decision|1|||
125192771|NCT01750697|450328102|FG000|Overall Study|Withdrawal by Subject|1|||
125192772|NCT03674112|450328106|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
125192773|NCT03674112|450328107|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
125192774|NCT03674112|450328106|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
125192775|NCT03674112|450328107|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
125394162|NCT02036502|451075886|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
125394163|NCT02036502|451075887|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
125394164|NCT02036502|451075888|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
125394165|NCT02036502|451075889|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
125394166|NCT02036502|451075890|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
125394167|NCT02036502|451075891|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
125394168|NCT02036502|451075892|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
125394169|NCT02036502|451075893|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
125394170|NCT02036502|451075886|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
125394171|NCT02036502|451075887|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
125394172|NCT02036502|451075888|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
125394173|NCT02036502|451075889|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
125394174|NCT02036502|451075890|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
125394175|NCT02036502|451075891|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
125443546|NCT01383993|451252168|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
125192776|NCT03674112|450328106|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
125192777|NCT03674112|450328107|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
125192778|NCT03674112|450328106|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
125192779|NCT03674112|450328107|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
125192780|NCT03674112|450328106|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
125192781|NCT03674112|450328107|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
125192782|NCT03674112|450328106|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
125192783|NCT03674112|450328107|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
125192784|NCT03674112|450328106|FG000|Follow-Up Period (≥3 Years)|Death|2|||
125192785|NCT03674112|450328107|FG001|Follow-Up Period (≥3 Years)|Death|0|||
125192786|NCT03674112|450328106|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
125192787|NCT03674112|450328107|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
125192788|NCT00862823|450328110|FG000|First Intervention|Withdrawal by Subject|1|||
125192789|NCT00862823|450328111|FG001|First Intervention|Withdrawal by Subject|1|||
125192790|NCT02049814|450328112|FG000|Overall Study|Reason not Specified|4|||
125192791|NCT02049814|450328113|FG001|Overall Study|Reason not Specified|3|||
125192792|NCT02049814|450328112|FG000|Overall Study|Pregnancy|1|||
125192793|NCT02049814|450328113|FG001|Overall Study|Pregnancy|0|||
125192794|NCT02049814|450328112|FG000|Overall Study|Lost to Follow-up|2|||
125192795|NCT02049814|450328113|FG001|Overall Study|Lost to Follow-up|3|||
125192796|NCT02049814|450328112|FG000|Overall Study|Serious Protocol Violation|5|||
125192797|NCT02049814|450328113|FG001|Overall Study|Serious Protocol Violation|7|||
125192798|NCT02049814|450328112|FG000|Overall Study|Study Termination|0|||
125192799|NCT02049814|450328113|FG001|Overall Study|Study Termination|1|||
125192800|NCT02049814|450328112|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
125192801|NCT02049814|450328113|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
125192802|NCT02049814|450328112|FG000|Overall Study|Voluntary withdrawal|9|||
125192803|NCT02049814|450328113|FG001|Overall Study|Voluntary withdrawal|8|||
125192804|NCT01282372|450328115|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
125192805|NCT01282372|450328115|FG000|Overall Study|Lost to Follow-up|23|||
125192806|NCT01282372|450328115|FG000|Overall Study|Withdrawal by Subject|11|||
125192807|NCT01282372|450328115|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
125192808|NCT01282372|450328115|FG000|Overall Study|Death|1|||
125192809|NCT01282372|450328115|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
125192810|NCT01282372|450328115|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
125192811|NCT01282372|450328115|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
125192812|NCT01282372|450328115|FG000|Overall Study|Adverse Event|12|||
125192813|NCT02993250|450328117|FG000|Overall Study|Lost to Follow-up|0|||
125192814|NCT02993250|450328118|FG001|Overall Study|Lost to Follow-up|1|||
125192815|NCT02527434|450328119|FG000|Overall Study|Lost to Follow-up|2|||
125192816|NCT02527434|450328120|FG001|Overall Study|Lost to Follow-up|2|||
125192817|NCT02527434|450328121|FG002|Overall Study|Lost to Follow-up|0|||
125192818|NCT02527434|450328119|FG000|Overall Study|Death|19|||
125192819|NCT02527434|450328120|FG001|Overall Study|Death|6|||
125192820|NCT02527434|450328121|FG002|Overall Study|Death|17|||
125192821|NCT02527434|450328119|FG000|Overall Study|Withdrawal by Subject|5|||
125192822|NCT02527434|450328120|FG001|Overall Study|Withdrawal by Subject|3|||
125192823|NCT02527434|450328121|FG002|Overall Study|Withdrawal by Subject|3|||
125192824|NCT02527434|450328119|FG000|Overall Study|Reason Not Specified|1|||
125192825|NCT02527434|450328120|FG001|Overall Study|Reason Not Specified|0|||
125192826|NCT02527434|450328121|FG002|Overall Study|Reason Not Specified|0|||
125192827|NCT02527434|450328119|FG000|Overall Study|Site closure|1|||
125192828|NCT02527434|450328120|FG001|Overall Study|Site closure|0|||
125192829|NCT02527434|450328121|FG002|Overall Study|Site closure|0|||
125192830|NCT00568061|450328122|FG000|Overall Study|Inclusion / exclusion criteria|5|||
125192831|NCT00568061|450328123|FG001|Overall Study|Inclusion / exclusion criteria|1|||
125192832|NCT00568061|450328122|FG000|Overall Study|Adverse Event|0|||
125192833|NCT00568061|450328123|FG001|Overall Study|Adverse Event|1|||
125394176|NCT02036502|451075892|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
125394177|NCT02036502|451075893|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
125394178|NCT02036502|451075886|FG000|Part 2:Dose Confirmation|Death|0|||
125394179|NCT02036502|451075887|FG001|Part 2:Dose Confirmation|Death|0|||
125394180|NCT02036502|451075888|FG002|Part 2:Dose Confirmation|Death|1|||
125192834|NCT01896128|450328124|FG000|Overall Study|Withdrawal by Subject|3|||
125192835|NCT01896128|450328125|FG001|Overall Study|Withdrawal by Subject|3|||
125192836|NCT02484456|450328128|FG000|Washout Period|Withdrawal by Subject|0|||
125192837|NCT02484456|450328129|FG001|Washout Period|Withdrawal by Subject|1|||
125192838|NCT02484456|450328128|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
125192839|NCT02484456|450328129|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
125192840|NCT02484456|450328128|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
125192841|NCT02484456|450328129|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
125192842|NCT02484456|450328128|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
125192843|NCT02484456|450328129|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
125192844|NCT01996254|450328132|FG000|Overall Study|Change in Eligibility|0|||
125192845|NCT01996254|450328133|FG001|Overall Study|Change in Eligibility|2|||
125192846|NCT01996254|450328134|FG002|Overall Study|Change in Eligibility|0|||
125192847|NCT01996254|450328132|FG000|Overall Study|Withdrawal by Subject|0|||
125192848|NCT01996254|450328133|FG001|Overall Study|Withdrawal by Subject|3|||
125192849|NCT01996254|450328134|FG002|Overall Study|Withdrawal by Subject|4|||
125192850|NCT01996254|450328132|FG000|Overall Study|Lost to Follow-up|1|||
125192851|NCT01996254|450328133|FG001|Overall Study|Lost to Follow-up|0|||
125192852|NCT01996254|450328134|FG002|Overall Study|Lost to Follow-up|4|||
125192853|NCT03348930|450328135|FG000|Washout (1 Week)|Lost to Follow-up|1|||
125192854|NCT03348930|450328136|FG001|Washout (1 Week)|Lost to Follow-up|1|||
125192855|NCT00708214|450328139|FG000|Overall Study|Other Adverse Event|3|||
125192856|NCT00708214|450328140|FG001|Overall Study|Other Adverse Event|6|||
125192857|NCT00708214|450328141|FG002|Overall Study|Other Adverse Event|2|||
125192858|NCT00708214|450328139|FG000|Overall Study|Other|0|||
125192859|NCT00708214|450328140|FG001|Overall Study|Other|1|||
125192860|NCT00708214|450328141|FG002|Overall Study|Other|1|||
125192861|NCT00708214|450328139|FG000|Overall Study|Progressive Disease|4|||
125192862|NCT00708214|450328140|FG001|Overall Study|Progressive Disease|6|||
125192863|NCT00708214|450328141|FG002|Overall Study|Progressive Disease|5|||
125192864|NCT02411396|450328142|FG000|Overall Study|Lost to Follow-up|31|||
125192865|NCT02411396|450328142|FG000|Overall Study|Death|10|||
125192866|NCT02865499|450328143|FG000|Baseline|Adverse Event|1|||
125192867|NCT02865499|450328143|FG000|Baseline|Withdrawal by Subject|1|||
125192868|NCT01931995|450328144|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
125192869|NCT01931995|450328145|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
125192870|NCT01931995|450328144|FG000|First Intervention (1 Day)|Physician Decision|1|||
125192871|NCT01931995|450328145|FG001|First Intervention (1 Day)|Physician Decision|1|||
125192872|NCT01931995|450328144|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
125192873|NCT01931995|450328145|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
125192874|NCT02064816|450328148|FG000|Overall Study|Adverse Event|3|||
125192875|NCT02064816|450328149|FG001|Overall Study|Adverse Event|2|||
125192876|NCT02064816|450328148|FG000|Overall Study|Withdrawal by Subject|2|||
125192877|NCT02064816|450328149|FG001|Overall Study|Withdrawal by Subject|1|||
125192878|NCT02064816|450328148|FG000|Overall Study|Lost to Follow-up|2|||
125192879|NCT02064816|450328149|FG001|Overall Study|Lost to Follow-up|1|||
125192880|NCT02064816|450328148|FG000|Overall Study|Therapeutic failure|0|||
125192881|NCT02064816|450328149|FG001|Overall Study|Therapeutic failure|1|||
125192882|NCT02064816|450328148|FG000|Overall Study|Other|1|||
125192883|NCT02064816|450328149|FG001|Overall Study|Other|3|||
125192884|NCT01732458|450328150|FG000|Overall Study|Lost to Follow-up|0|||
125192885|NCT01732458|450328151|FG001|Overall Study|Lost to Follow-up|2|||
125192886|NCT01732458|450328152|FG002|Overall Study|Lost to Follow-up|0|||
125192887|NCT01732458|450328153|FG003|Overall Study|Lost to Follow-up|0|||
125192888|NCT01732458|450328150|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125192889|NCT01732458|450328151|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125192890|NCT01732458|450328152|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125192891|NCT01732458|450328153|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125192892|NCT01732458|450328150|FG000|Overall Study|Physician Decision|1|||
125192893|NCT01732458|450328151|FG001|Overall Study|Physician Decision|2|||
125192894|NCT01732458|450328152|FG002|Overall Study|Physician Decision|2|||
125192895|NCT01732458|450328153|FG003|Overall Study|Physician Decision|0|||
125192896|NCT01732458|450328150|FG000|Overall Study|Protocol Violation|2|||
125192897|NCT01732458|450328151|FG001|Overall Study|Protocol Violation|0|||
125394181|NCT02036502|451075889|FG003|Part 2:Dose Confirmation|Death|0|||
125192898|NCT01732458|450328152|FG002|Overall Study|Protocol Violation|0|||
125192899|NCT01732458|450328153|FG003|Overall Study|Protocol Violation|2|||
125192900|NCT01732458|450328150|FG000|Overall Study|Screen Failure|0|||
125192901|NCT01732458|450328151|FG001|Overall Study|Screen Failure|1|||
125192902|NCT01732458|450328152|FG002|Overall Study|Screen Failure|0|||
125394182|NCT02036502|451075890|FG004|Part 2:Dose Confirmation|Death|0|||
125192903|NCT01732458|450328153|FG003|Overall Study|Screen Failure|0|||
125394183|NCT02036502|451075891|FG005|Part 2:Dose Confirmation|Death|0|||
125394184|NCT02036502|451075892|FG006|Part 2:Dose Confirmation|Death|0|||
125394185|NCT02036502|451075893|FG007|Part 2:Dose Confirmation|Death|0|||
125394186|NCT02036502|451075886|FG000|Part 2:Dose Confirmation|Not treated|0|||
125394187|NCT02036502|451075887|FG001|Part 2:Dose Confirmation|Not treated|0|||
125394188|NCT02036502|451075888|FG002|Part 2:Dose Confirmation|Not treated|0|||
125394189|NCT02036502|451075889|FG003|Part 2:Dose Confirmation|Not treated|1|||
125394190|NCT02036502|451075890|FG004|Part 2:Dose Confirmation|Not treated|0|||
125394191|NCT02036502|451075891|FG005|Part 2:Dose Confirmation|Not treated|0|||
125394192|NCT02036502|451075892|FG006|Part 2:Dose Confirmation|Not treated|0|||
125394193|NCT02036502|451075893|FG007|Part 2:Dose Confirmation|Not treated|0|||
125394194|NCT02036502|451075886|FG000|Part 3:Dose Expansion|Adverse Event|0|||
125394195|NCT02036502|451075887|FG001|Part 3:Dose Expansion|Adverse Event|0|||
125394196|NCT02036502|451075888|FG002|Part 3:Dose Expansion|Adverse Event|0|||
125394197|NCT02036502|451075889|FG003|Part 3:Dose Expansion|Adverse Event|0|||
125394198|NCT02036502|451075890|FG004|Part 3:Dose Expansion|Adverse Event|0|||
125394199|NCT02036502|451075891|FG005|Part 3:Dose Expansion|Adverse Event|4|||
125394200|NCT02036502|451075892|FG006|Part 3:Dose Expansion|Adverse Event|0|||
125394201|NCT02036502|451075893|FG007|Part 3:Dose Expansion|Adverse Event|2|||
125394202|NCT02036502|451075886|FG000|Part 3:Dose Expansion|Death|0|||
125394203|NCT02036502|451075887|FG001|Part 3:Dose Expansion|Death|0|||
125394204|NCT02036502|451075888|FG002|Part 3:Dose Expansion|Death|0|||
125394205|NCT02036502|451075889|FG003|Part 3:Dose Expansion|Death|0|||
125394206|NCT02036502|451075890|FG004|Part 3:Dose Expansion|Death|0|||
125394207|NCT02036502|451075891|FG005|Part 3:Dose Expansion|Death|24|||
125394208|NCT02036502|451075892|FG006|Part 3:Dose Expansion|Death|0|||
125394209|NCT02036502|451075893|FG007|Part 3:Dose Expansion|Death|3|||
125394210|NCT02036502|451075886|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
125394211|NCT02036502|451075887|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
125394212|NCT02036502|451075888|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
125394213|NCT02036502|451075889|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
125394214|NCT02036502|451075890|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
125394215|NCT02036502|451075891|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
125394216|NCT02036502|451075892|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
125394217|NCT02036502|451075893|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
125394218|NCT02036502|451075886|FG000|Part 3:Dose Expansion|Physician Decision|0|||
125394219|NCT02036502|451075887|FG001|Part 3:Dose Expansion|Physician Decision|0|||
125394220|NCT02036502|451075888|FG002|Part 3:Dose Expansion|Physician Decision|0|||
125394221|NCT02036502|451075889|FG003|Part 3:Dose Expansion|Physician Decision|0|||
125192904|NCT03759587|450328154|FG000|Overall Study|Adverse Event|5|||
125192905|NCT03759587|450328154|FG000|Overall Study|Progressive Disease|10|||
125192906|NCT03759587|450328154|FG000|Overall Study|Site Terminated by Sponsor|3|||
125192907|NCT03759587|450328154|FG000|Overall Study|Withdrawal by Subject|1|||
125192908|NCT04615403|450328155|FG000|Overall Study|Death|1|||
125192909|NCT03340454|450328158|FG000|Overall Study|Lost to Follow-up|0|||
125192910|NCT03340454|450328159|FG001|Overall Study|Lost to Follow-up|4|||
125192911|NCT01464164|450328160|FG000|Overall Study|Screen failure|0|||
125192912|NCT01464164|450328161|FG001|Overall Study|Screen failure|1|||
125192913|NCT01464164|450328162|FG002|Overall Study|Screen failure|2|||
125192914|NCT01464164|450328163|FG003|Overall Study|Screen failure|0|||
125192915|NCT01464164|450328164|FG004|Overall Study|Screen failure|0|||
125192916|NCT01464164|450328165|FG005|Overall Study|Screen failure|0|||
125192917|NCT01464164|450328166|FG006|Overall Study|Screen failure|0|||
125192918|NCT01464164|450328160|FG000|Overall Study|Physician Decision|0|||
125192919|NCT01464164|450328161|FG001|Overall Study|Physician Decision|1|||
125192920|NCT01464164|450328162|FG002|Overall Study|Physician Decision|0|||
125192921|NCT01464164|450328163|FG003|Overall Study|Physician Decision|0|||
125192922|NCT01464164|450328164|FG004|Overall Study|Physician Decision|0|||
125192923|NCT01464164|450328165|FG005|Overall Study|Physician Decision|0|||
125192924|NCT01464164|450328166|FG006|Overall Study|Physician Decision|2|||
125192925|NCT00570063|450328167|FG000|Overall Study|Adverse Event|4|||
125192926|NCT00570063|450328168|FG001|Overall Study|Adverse Event|1|||
125192927|NCT00570063|450328167|FG000|Overall Study|Lack of Efficacy|0|||
125192928|NCT00570063|450328168|FG001|Overall Study|Lack of Efficacy|1|||
125192929|NCT00570063|450328167|FG000|Overall Study|Withdrawal by Subject|4|||
125192930|NCT00570063|450328168|FG001|Overall Study|Withdrawal by Subject|3|||
125192931|NCT00570063|450328167|FG000|Overall Study|Sponsor's Decision|7|||
125192932|NCT00570063|450328168|FG001|Overall Study|Sponsor's Decision|3|||
125192933|NCT00697463|450328169|FG000|Overall Study|Withdrawal by Subject|1|||
125192934|NCT03307252|450328170|FG000|Part 2, Period 1|Treatment not received|0|||
125192935|NCT03307252|450328171|FG001|Part 2, Period 1|Treatment not received|0|||
125192936|NCT03307252|450328172|FG002|Part 2, Period 1|Treatment not received|0|||
125394222|NCT02036502|451075890|FG004|Part 3:Dose Expansion|Physician Decision|0|||
125394223|NCT02036502|451075891|FG005|Part 3:Dose Expansion|Physician Decision|1|||
125394224|NCT02036502|451075892|FG006|Part 3:Dose Expansion|Physician Decision|0|||
125394225|NCT02036502|451075893|FG007|Part 3:Dose Expansion|Physician Decision|0|||
125192937|NCT03307252|450328173|FG003|Part 2, Period 1|Treatment not received|0|||
125192938|NCT03307252|450328174|FG004|Part 2, Period 1|Treatment not received|0|||
125192939|NCT03307252|450328175|FG005|Part 2, Period 1|Treatment not received|1|||
125192940|NCT03307252|450328176|FG006|Part 2, Period 1|Treatment not received|0|||
125192941|NCT03307252|450328177|FG007|Part 2, Period 1|Treatment not received|0|||
125192942|NCT03307252|450328178|FG008|Part 2, Period 1|Treatment not received|0|||
125192943|NCT03307252|450328179|FG009|Part 2, Period 1|Treatment not received|0|||
125192944|NCT03307252|450328180|FG010|Part 2, Period 1|Treatment not received|0|||
125192945|NCT03307252|450328170|FG000|Part 2, Period 3|Other than listed|0|||
125192946|NCT03307252|450328171|FG001|Part 2, Period 3|Other than listed|0|||
125192947|NCT03307252|450328172|FG002|Part 2, Period 3|Other than listed|0|||
125192948|NCT03307252|450328173|FG003|Part 2, Period 3|Other than listed|0|||
125192949|NCT03307252|450328174|FG004|Part 2, Period 3|Other than listed|1|||
125192950|NCT03307252|450328175|FG005|Part 2, Period 3|Other than listed|0|||
125192951|NCT03307252|450328176|FG006|Part 2, Period 3|Other than listed|0|||
125192952|NCT03307252|450328177|FG007|Part 2, Period 3|Other than listed|0|||
125192953|NCT03307252|450328178|FG008|Part 2, Period 3|Other than listed|0|||
125192954|NCT03307252|450328179|FG009|Part 2, Period 3|Other than listed|0|||
125192955|NCT03307252|450328180|FG010|Part 2, Period 3|Other than listed|0|||
125192956|NCT03307252|450328170|FG000|Part 2, Period 4|Other than listed|0|||
125192957|NCT03307252|450328171|FG001|Part 2, Period 4|Other than listed|0|||
125192958|NCT03307252|450328172|FG002|Part 2, Period 4|Other than listed|0|||
125192959|NCT03307252|450328173|FG003|Part 2, Period 4|Other than listed|0|||
125192960|NCT03307252|450328174|FG004|Part 2, Period 4|Other than listed|0|||
125192961|NCT03307252|450328175|FG005|Part 2, Period 4|Other than listed|0|||
125192962|NCT03307252|450328176|FG006|Part 2, Period 4|Other than listed|1|||
125192963|NCT03307252|450328177|FG007|Part 2, Period 4|Other than listed|0|||
125192964|NCT03307252|450328178|FG008|Part 2, Period 4|Other than listed|0|||
125192965|NCT03307252|450328179|FG009|Part 2, Period 4|Other than listed|0|||
125192966|NCT03307252|450328180|FG010|Part 2, Period 4|Other than listed|0|||
125192967|NCT03307252|450328170|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192968|NCT03307252|450328171|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192969|NCT03307252|450328172|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192970|NCT03307252|450328173|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192971|NCT03307252|450328174|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192972|NCT03307252|450328175|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192973|NCT03307252|450328176|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192974|NCT03307252|450328177|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192975|NCT03307252|450328178|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192976|NCT03307252|450328179|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
125192977|NCT03307252|450328180|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
125192978|NCT02568189|450328181|FG000|Overall Study|Protocol Violation|0|||
125192979|NCT02568189|450328182|FG001|Overall Study|Protocol Violation|0|||
125192980|NCT02568189|450328183|FG002|Overall Study|Protocol Violation|19|||
125192981|NCT02568189|450328184|FG003|Overall Study|Protocol Violation|18|||
125192982|NCT02157376|450328185|FG000|Overall Study|Death|10|||
125192983|NCT02157376|450328186|FG001|Overall Study|Death|4|||
125192984|NCT02157376|450328185|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125192985|NCT02157376|450328186|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125192986|NCT02157376|450328185|FG000|Overall Study|Withdrawal by Subject|3|||
125192987|NCT02157376|450328186|FG001|Overall Study|Withdrawal by Subject|8|||
125192988|NCT02157376|450328185|FG000|Overall Study|Not treated|8|||
125192989|NCT02157376|450328186|FG001|Overall Study|Not treated|3|||
125192990|NCT02157376|450328185|FG000|Overall Study|Investigator's misjudgement|1|||
125192991|NCT02157376|450328186|FG001|Overall Study|Investigator's misjudgement|2|||
125192992|NCT01074268|450328187|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
125192993|NCT01074268|450328188|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
125192994|NCT01074268|450328187|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
125192995|NCT01074268|450328188|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
125192996|NCT01074268|450328187|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
125192997|NCT01074268|450328188|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
125192998|NCT01074268|450328187|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
125192999|NCT01074268|450328188|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
125193000|NCT01074268|450328187|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
125193001|NCT01074268|450328188|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
125193002|NCT01074268|450328187|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
125193003|NCT01074268|450328188|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
125193004|NCT01074268|450328187|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
125193005|NCT01074268|450328188|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
125193006|NCT01074268|450328187|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
125193007|NCT01074268|450328188|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
125193008|NCT01074268|450328187|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
125193009|NCT01074268|450328188|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
125193010|NCT01578239|450328191|FG000|Treatment Period|Progressive Disease|19|||
125193011|NCT01578239|450328192|FG001|Treatment Period|Progressive Disease|64|||
125193012|NCT01578239|450328191|FG000|Treatment Period|Physician Decision|17|||
125193013|NCT01578239|450328192|FG001|Treatment Period|Physician Decision|17|||
125193014|NCT01578239|450328191|FG000|Treatment Period|Adverse Event|13|||
125193015|NCT01578239|450328192|FG001|Treatment Period|Adverse Event|10|||
125193016|NCT01578239|450328191|FG000|Treatment Period|Non-compliance|2|||
125193017|NCT01578239|450328192|FG001|Treatment Period|Non-compliance|0|||
125193018|NCT01578239|450328191|FG000|Treatment Period|Withdrawal by Subject|10|||
125193019|NCT01578239|450328192|FG001|Treatment Period|Withdrawal by Subject|9|||
125193020|NCT01578239|450328191|FG000|Treatment Period|Other|6|||
125193021|NCT01578239|450328192|FG001|Treatment Period|Other|1|||
125193022|NCT01578239|450328191|FG000|Long-term Follow-Up Period|Death|69|||
125193023|NCT01578239|450328192|FG001|Long-term Follow-Up Period|Death|64|||
125193024|NCT01578239|450328191|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
125193025|NCT01578239|450328192|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
125193026|NCT01578239|450328191|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
125193027|NCT01578239|450328192|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
125193028|NCT01578239|450328191|FG000|Long-term Follow-Up Period|Other|2|||
125193029|NCT01578239|450328192|FG001|Long-term Follow-Up Period|Other|2|||
125193030|NCT01031680|450328198|FG000|Overall Study|Adverse Event|8|||
125193031|NCT01031680|450328199|FG001|Overall Study|Adverse Event|3|||
125193032|NCT01031680|450328198|FG000|Overall Study|Lost to Follow-up|2|||
125193033|NCT01031680|450328199|FG001|Overall Study|Lost to Follow-up|10|||
125193034|NCT01031680|450328198|FG000|Overall Study|Withdrawal by Subject|12|||
125193035|NCT01031680|450328199|FG001|Overall Study|Withdrawal by Subject|16|||
125193036|NCT01031680|450328198|FG000|Overall Study|Death|2|||
125193037|NCT01031680|450328199|FG001|Overall Study|Death|1|||
125193038|NCT01031680|450328198|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
125193039|NCT01031680|450328199|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
125193040|NCT01031680|450328198|FG000|Overall Study|Poor/Non-compliance|5|||
125193041|NCT01031680|450328199|FG001|Overall Study|Poor/Non-compliance|6|||
125193042|NCT01031680|450328198|FG000|Overall Study|Safety|1|||
125193043|NCT01031680|450328199|FG001|Overall Study|Safety|0|||
125193044|NCT01031680|450328198|FG000|Overall Study|Incorrect Enrolment|1|||
125193045|NCT01031680|450328199|FG001|Overall Study|Incorrect Enrolment|2|||
125193046|NCT01031680|450328198|FG000|Overall Study|Administrative Reason by Sponsor|0|||
125193047|NCT01031680|450328199|FG001|Overall Study|Administrative Reason by Sponsor|1|||
125193048|NCT01031680|450328198|FG000|Overall Study|Various|0|||
125193049|NCT01031680|450328199|FG001|Overall Study|Various|2|||
125193050|NCT02654977|450328204|FG000|Overall Study|Death|1|||
125193051|NCT02654977|450328204|FG000|Overall Study|Lost to Follow-up|1|||
125193052|NCT02654977|450328204|FG000|Overall Study|Adverse Event|1|||
125193053|NCT02654977|450328204|FG000|Overall Study|Withdrawal by Subject|1|||
125193054|NCT02654977|450328204|FG000|Overall Study|Lack of Efficacy|3|||
125193055|NCT01921101|450328205|FG000|Overall Study|Death|16|||
125193056|NCT01921101|450328206|FG001|Overall Study|Death|6|||
125193057|NCT01483027|450328207|FG000|Overall Study|Administrative Reasons|2|||
125193058|NCT01483027|450328208|FG001|Overall Study|Administrative Reasons|1|||
125193059|NCT01483027|450328207|FG000|Overall Study|Withdrawal by Subject|21|||
125193060|NCT01483027|450328208|FG001|Overall Study|Withdrawal by Subject|32|||
125193061|NCT01483027|450328207|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
125193062|NCT01483027|450328208|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
125193063|NCT01483027|450328207|FG000|Overall Study|Lost to Follow-up|1|||
125193064|NCT01483027|450328208|FG001|Overall Study|Lost to Follow-up|1|||
125193065|NCT01483027|450328207|FG000|Overall Study|Adverse Event|0|||
125193066|NCT01483027|450328208|FG001|Overall Study|Adverse Event|1|||
125193067|NCT01483027|450328207|FG000|Overall Study|Withdrawal by Subject|0|||
125193068|NCT01483027|450328208|FG001|Overall Study|Withdrawal by Subject|1|||
125193069|NCT04432831|450330141|FG000|Overall Study|Withdrawal by Subject|24|||
125193070|NCT04432831|450330142|FG001|Overall Study|Withdrawal by Subject|28|||
125193071|NCT04432831|450330143|FG002|Overall Study|Withdrawal by Subject|21|||
125193072|NCT04432831|450330141|FG000|Overall Study|Death|23|||
125193073|NCT04432831|450330142|FG001|Overall Study|Death|23|||
125245628|NCT00827242|450524583|FG000|Overall Study|Entry Criteria Not Met|4|||
125245629|NCT00827242|450524584|FG001|Overall Study|Entry Criteria Not Met|1|||
125245630|NCT00827242|450524583|FG000|Overall Study|Physician Decision|2|||
125193074|NCT04432831|450330143|FG002|Overall Study|Death|17|||
125193075|NCT04432831|450330141|FG000|Overall Study|Lost to Follow-up|15|||
125193076|NCT04432831|450330142|FG001|Overall Study|Lost to Follow-up|15|||
125193077|NCT04432831|450330143|FG002|Overall Study|Lost to Follow-up|12|||
125193078|NCT04432831|450330141|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
125193079|NCT04432831|450330142|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
125193080|NCT04432831|450330143|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
125245631|NCT00827242|450524584|FG001|Overall Study|Physician Decision|0|||
125193081|NCT04432831|450330141|FG000|Overall Study|Reason Not Specified|7|||
125193082|NCT04432831|450330142|FG001|Overall Study|Reason Not Specified|11|||
125193083|NCT04432831|450330143|FG002|Overall Study|Reason Not Specified|9|||
125193084|NCT04432831|450330141|FG000|Overall Study|Adverse Event|7|||
125245632|NCT00827242|450524583|FG000|Overall Study|Death|1|||
125245633|NCT00827242|450524584|FG001|Overall Study|Death|0|||
125245634|NCT00827242|450524583|FG000|Overall Study|Lack of Efficacy|1|||
125245635|NCT00827242|450524584|FG001|Overall Study|Lack of Efficacy|0|||
125245636|NCT00899847|450524585|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
125245637|NCT01769443|450524586|FG000|Overall Study|Study closure|1|||
125245638|NCT01769443|450524587|FG001|Overall Study|Study closure|0|||
125245639|NCT01279200|450524588|FG000|Overall Study|Withdrawal by Subject|1|||
125245640|NCT01279200|450524589|FG001|Overall Study|Withdrawal by Subject|3|||
125245641|NCT01279200|450524588|FG000|Overall Study|Patient withdrawal due to high cost|0|||
125245642|NCT01279200|450524589|FG001|Overall Study|Patient withdrawal due to high cost|1|||
125245643|NCT01279200|450524588|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
125245644|NCT01279200|450524589|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
125245645|NCT01279200|450524588|FG000|Overall Study|ultrasound screening failure|0|||
125245646|NCT01279200|450524589|FG001|Overall Study|ultrasound screening failure|1|||
125245647|NCT01279200|450524588|FG000|Overall Study|Lost to Follow-up|0|||
125245648|NCT01279200|450524589|FG001|Overall Study|Lost to Follow-up|1|||
125245649|NCT01279200|450524588|FG000|Overall Study|Adverse Event|1|||
125245650|NCT01279200|450524589|FG001|Overall Study|Adverse Event|0|||
125245651|NCT01149538|450524592|FG000|Overall Study|Lost to Follow-up|0|||
125245652|NCT01149538|450524593|FG001|Overall Study|Lost to Follow-up|1|||
125245653|NCT01149538|450524592|FG000|Overall Study|Withdrawal by Subject|5|||
125245654|NCT01149538|450524593|FG001|Overall Study|Withdrawal by Subject|3|||
125245655|NCT05507450|450524599|FG000|Overall Study|Death|0|||
125245656|NCT05507450|450524600|FG001|Overall Study|Death|0|||
125245657|NCT05507450|450524601|FG002|Overall Study|Death|1|||
125245658|NCT05507450|450524602|FG003|Overall Study|Death|0|||
125245659|NCT05507450|450524599|FG000|Overall Study|Lost to Follow-up|22|||
125245660|NCT05507450|450524600|FG001|Overall Study|Lost to Follow-up|20|||
125245661|NCT05507450|450524601|FG002|Overall Study|Lost to Follow-up|20|||
125245662|NCT05507450|450524602|FG003|Overall Study|Lost to Follow-up|7|||
125245663|NCT05507450|450524599|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125245664|NCT05507450|450524600|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
125245665|NCT05507450|450524601|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125245666|NCT05507450|450524602|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125245667|NCT05507450|450524599|FG000|Overall Study|Withdrawal by Subject|4|||
125245668|NCT05507450|450524600|FG001|Overall Study|Withdrawal by Subject|11|||
125245669|NCT05507450|450524601|FG002|Overall Study|Withdrawal by Subject|7|||
125245670|NCT05507450|450524602|FG003|Overall Study|Withdrawal by Subject|3|||
125245671|NCT05507450|450524599|FG000|Overall Study|Participant left the country|0|||
125245672|NCT05507450|450524600|FG001|Overall Study|Participant left the country|0|||
125245673|NCT05507450|450524601|FG002|Overall Study|Participant left the country|1|||
125245674|NCT05507450|450524602|FG003|Overall Study|Participant left the country|0|||
125245675|NCT00514917|450524606|FG000|Overall Study|Death|4|||
125245676|NCT00514917|450524607|FG001|Overall Study|Death|10|||
125245677|NCT00514917|450524606|FG000|Overall Study|Protocol Violation|1|||
125245678|NCT00514917|450524607|FG001|Overall Study|Protocol Violation|0|||
125245679|NCT00514917|450524606|FG000|Overall Study|Lost to Follow-up|4|||
125245680|NCT00514917|450524607|FG001|Overall Study|Lost to Follow-up|3|||
125245681|NCT00514917|450524606|FG000|Overall Study|Withdrawal by Subject|18|||
125245682|NCT00514917|450524607|FG001|Overall Study|Withdrawal by Subject|16|||
125245683|NCT00514917|450524606|FG000|Overall Study|Discontinued due to study closure|88|||
125245684|NCT00514917|450524607|FG001|Overall Study|Discontinued due to study closure|81|||
125245685|NCT00514917|450524606|FG000|Overall Study|Undefined|11|||
125245686|NCT00514917|450524607|FG001|Overall Study|Undefined|5|||
125245687|NCT02697422|450524608|FG000|Overall Study|Declined exit survey|9|||
125245688|NCT02697422|450524609|FG001|Overall Study|Declined exit survey|2|||
125245689|NCT02697422|450524608|FG000|Overall Study|Lost to Follow-up|13|||
125245690|NCT02697422|450524609|FG001|Overall Study|Lost to Follow-up|8|||
125245691|NCT02697422|450524608|FG000|Overall Study|Death|2|||
125245692|NCT02697422|450524609|FG001|Overall Study|Death|1|||
125245693|NCT02697422|450524608|FG000|Overall Study|Withdrawal by Subject|0|||
125245694|NCT02697422|450524609|FG001|Overall Study|Withdrawal by Subject|1|||
125245695|NCT02697422|450524608|FG000|Overall Study|Physician Decision|1|||
125245696|NCT02697422|450524609|FG001|Overall Study|Physician Decision|1|||
125245697|NCT02697422|450524608|FG000|Overall Study|Exit survey data lost|1|||
125245698|NCT02697422|450524609|FG001|Overall Study|Exit survey data lost|0|||
125245699|NCT01873833|450524613|FG000|Overall Study|Withdrawal by Subject|1|||
125245700|NCT03983109|450524616|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
125245701|NCT03983109|450524617|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
125245702|NCT02068599|450524618|FG000|Overall Study|Adverse Event|4|||
125245703|NCT02068599|450524619|FG001|Overall Study|Adverse Event|1|||
125245704|NCT02068599|450524620|FG002|Overall Study|Adverse Event|1|||
125245705|NCT02068599|450524618|FG000|Overall Study|Withdrawal by Subject|2|||
125245706|NCT02068599|450524619|FG001|Overall Study|Withdrawal by Subject|7|||
125245707|NCT02068599|450524620|FG002|Overall Study|Withdrawal by Subject|5|||
125245708|NCT02068599|450524618|FG000|Overall Study|Protocol Violation|4|||
125245709|NCT02068599|450524619|FG001|Overall Study|Protocol Violation|2|||
125245710|NCT02068599|450524620|FG002|Overall Study|Protocol Violation|3|||
125245711|NCT02068599|450524618|FG000|Overall Study|Lost to Follow-up|1|||
125245712|NCT02068599|450524619|FG001|Overall Study|Lost to Follow-up|0|||
125245713|NCT02068599|450524620|FG002|Overall Study|Lost to Follow-up|0|||
125245714|NCT02068599|450524618|FG000|Overall Study|Lack of Efficacy|0|||
125245715|NCT02068599|450524619|FG001|Overall Study|Lack of Efficacy|0|||
125245716|NCT02068599|450524620|FG002|Overall Study|Lack of Efficacy|3|||
125245717|NCT02068599|450524618|FG000|Overall Study|Noncompliance|0|||
125245718|NCT02068599|450524619|FG001|Overall Study|Noncompliance|0|||
125245719|NCT02068599|450524620|FG002|Overall Study|Noncompliance|1|||
125245720|NCT01871727|450524623|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
125245721|NCT01871727|450524624|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
125245722|NCT01871727|450524625|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
125245723|NCT01871727|450524626|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
125245724|NCT01871727|450524627|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
125245725|NCT01871727|450524623|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
125245726|NCT01871727|450524624|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
125245727|NCT01871727|450524625|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
125245728|NCT01871727|450524626|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
125245729|NCT01871727|450524627|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
125245730|NCT01871727|450524623|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
125245731|NCT01871727|450524624|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
125245732|NCT01871727|450524625|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
125245733|NCT01871727|450524626|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
125245734|NCT01871727|450524627|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
125245735|NCT01871727|450524623|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
125245736|NCT01871727|450524624|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
125245737|NCT01871727|450524625|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
125245738|NCT01871727|450524626|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
125245739|NCT01871727|450524627|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
125245740|NCT01871727|450524623|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
125245741|NCT01871727|450524624|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
125245742|NCT01871727|450524625|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
125245743|NCT01871727|450524626|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
125245744|NCT01871727|450524627|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
125245745|NCT01871727|450524623|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
125245746|NCT01871727|450524624|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
125245747|NCT01871727|450524625|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
125245748|NCT01871727|450524626|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
125245749|NCT01871727|450524627|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
125245750|NCT01871727|450524623|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
125245751|NCT01871727|450524624|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
125245752|NCT01871727|450524625|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
125245753|NCT01871727|450524626|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
125245754|NCT01871727|450524627|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
125245755|NCT01263028|450524628|FG000|Overall Study|Withdrawal by Subject|1|||
125245756|NCT01263028|450524628|FG000|Overall Study|Adverse Event|1|||
125245757|NCT01263028|450524628|FG000|Overall Study|Study terminated due to low enrollment.|4|||
125245758|NCT00309244|450524629|FG000|Overall Study|Adverse Event|29|||
125245759|NCT00309244|450524630|FG001|Overall Study|Adverse Event|12|||
125245760|NCT00309244|450524629|FG000|Overall Study|Lost to Follow-up|6|||
125245761|NCT00309244|450524630|FG001|Overall Study|Lost to Follow-up|22|||
125245762|NCT00309244|450524629|FG000|Overall Study|Physician Decision|5|||
125245763|NCT00309244|450524630|FG001|Overall Study|Physician Decision|8|||
125245764|NCT00309244|450524629|FG000|Overall Study|Protocol Violation|6|||
125245765|NCT00309244|450524630|FG001|Overall Study|Protocol Violation|3|||
125245766|NCT00309244|450524629|FG000|Overall Study|Withdrawal by Subject|50|||
125245767|NCT00309244|450524630|FG001|Overall Study|Withdrawal by Subject|32|||
125245768|NCT00309244|450524629|FG000|Overall Study|Various|7|||
125245769|NCT00309244|450524630|FG001|Overall Study|Various|7|||
125245770|NCT00309244|450524629|FG000|Overall Study|Randomized but not dosed|11|||
125245771|NCT00309244|450524630|FG001|Overall Study|Randomized but not dosed|12|||
125245772|NCT00309244|450524629|FG000|Overall Study|Death|4|||
125245773|NCT00309244|450524630|FG001|Overall Study|Death|1|||
125245774|NCT03019588|450524631|FG000|Overall Study|Death|44|||
125245775|NCT03019588|450524632|FG001|Overall Study|Death|46|||
125245776|NCT03019588|450524631|FG000|Overall Study|Study terminated by Sponsor|3|||
125245777|NCT03019588|450524632|FG001|Overall Study|Study terminated by Sponsor|1|||
125245778|NCT00501085|450524633|FG000|Overall Study|Lost to Follow-up|195|||
125245779|NCT00501085|450524633|FG000|Overall Study|Withdrawal by Subject|34|||
125245780|NCT00501085|450524633|FG000|Overall Study|Subject Decision|1|||
125245781|NCT00501085|450524633|FG000|Overall Study|Revision Surgery|7|||
125193085|NCT04432831|450330142|FG001|Overall Study|Adverse Event|7|||
125193086|NCT04432831|450330143|FG002|Overall Study|Adverse Event|7|||
125193087|NCT04432831|450330141|FG000|Overall Study|Physician Decision|1|||
125193088|NCT04432831|450330142|FG001|Overall Study|Physician Decision|3|||
125193089|NCT04432831|450330143|FG002|Overall Study|Physician Decision|6|||
125193090|NCT04432831|450330141|FG000|Overall Study|Protocol Violation|1|||
125193091|NCT04432831|450330142|FG001|Overall Study|Protocol Violation|0|||
125193092|NCT04432831|450330143|FG002|Overall Study|Protocol Violation|2|||
125193093|NCT04432831|450330141|FG000|Overall Study|Pregnancy|0|||
125193094|NCT04432831|450330142|FG001|Overall Study|Pregnancy|1|||
125193095|NCT04432831|450330143|FG002|Overall Study|Pregnancy|0|||
125193096|NCT04432831|450330141|FG000|Overall Study|Lack of Efficacy|0|||
125245782|NCT00501085|450524633|FG000|Overall Study|Explantation Surgery|26|||
125245783|NCT00501085|450524633|FG000|Overall Study|Adverse Event|4|||
125245784|NCT00501085|450524633|FG000|Overall Study|Non-Compliance|24|||
125245785|NCT00501085|450524633|FG000|Overall Study|Study closed by sponsor|109|||
125245786|NCT00501085|450524633|FG000|Overall Study|Other loss to follow-up|32|||
125245787|NCT00366535|450524634|FG000|First Phase: 12 Weeks|Adverse Event|1|||
125245788|NCT00366535|450524635|FG001|First Phase: 12 Weeks|Adverse Event|3|||
125245789|NCT00366535|450524634|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
125245790|NCT00366535|450524635|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
125245791|NCT00366535|450524634|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
125245792|NCT00366535|450524635|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
125245793|NCT00366535|450524634|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
125193097|NCT04432831|450330142|FG001|Overall Study|Lack of Efficacy|0|||
125193098|NCT04432831|450330143|FG002|Overall Study|Lack of Efficacy|2|||
125193099|NCT00652626|450330146|FG000|Initial Treatment Phase|Adverse Event|0|||
125193100|NCT00652626|450330147|FG001|Initial Treatment Phase|Adverse Event|0|||
125193101|NCT00652626|450330148|FG002|Initial Treatment Phase|Adverse Event|0|||
125193102|NCT00652626|450330149|FG003|Initial Treatment Phase|Adverse Event|0|||
125193103|NCT00652626|450330150|FG004|Initial Treatment Phase|Adverse Event|1|||
125193104|NCT00652626|450330151|FG005|Initial Treatment Phase|Adverse Event|0|||
125193105|NCT00652626|450330152|FG006|Initial Treatment Phase|Adverse Event|0|||
125193106|NCT00652626|450330146|FG000|Initial Treatment Phase|Protocol Violation|0|||
125193107|NCT00652626|450330147|FG001|Initial Treatment Phase|Protocol Violation|0|||
125193108|NCT00652626|450330148|FG002|Initial Treatment Phase|Protocol Violation|0|||
125193109|NCT00652626|450330149|FG003|Initial Treatment Phase|Protocol Violation|1|||
125193110|NCT00652626|450330150|FG004|Initial Treatment Phase|Protocol Violation|0|||
125245794|NCT00366535|450524635|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
125245795|NCT02958527|450524640|FG000|Overall Study|Not collected CRFs|12|||
125245796|NCT00250718|450524643|FG000|Overall Study|Death|1|||
125245797|NCT00250718|450524643|FG000|Overall Study|Adverse Event|1|||
125245798|NCT00250718|450524643|FG000|Overall Study|Withdrawal by Subject|1|||
125245799|NCT01666314|450524644|FG000|Overall Study|Adverse Event|3|||
125245800|NCT01666314|450524645|FG001|Overall Study|Adverse Event|13|||
125245801|NCT01666314|450524646|FG002|Overall Study|Adverse Event|7|||
125245802|NCT01666314|450524647|FG003|Overall Study|Adverse Event|7|||
125245803|NCT01666314|450524644|FG000|Overall Study|Progressive Disease|11|||
125245804|NCT01666314|450524645|FG001|Overall Study|Progressive Disease|9|||
125245805|NCT01666314|450524646|FG002|Overall Study|Progressive Disease|19|||
125245806|NCT01666314|450524647|FG003|Overall Study|Progressive Disease|20|||
125245807|NCT01666314|450524644|FG000|Overall Study|Symptomatic Deterioration|1|||
125245808|NCT01666314|450524645|FG001|Overall Study|Symptomatic Deterioration|0|||
125245809|NCT01666314|450524646|FG002|Overall Study|Symptomatic Deterioration|2|||
125245810|NCT01666314|450524647|FG003|Overall Study|Symptomatic Deterioration|0|||
125245811|NCT01666314|450524644|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
125245812|NCT01666314|450524645|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
125245813|NCT01666314|450524646|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
125245814|NCT01666314|450524647|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
125245815|NCT01666314|450524644|FG000|Overall Study|Withdrawal by Subject|1|||
125245816|NCT01666314|450524645|FG001|Overall Study|Withdrawal by Subject|1|||
125193111|NCT00652626|450330151|FG005|Initial Treatment Phase|Protocol Violation|0|||
125193112|NCT00652626|450330152|FG006|Initial Treatment Phase|Protocol Violation|0|||
125193113|NCT00652626|450330146|FG000|Initial Treatment Phase|Physician Decision|0|||
125245817|NCT01666314|450524646|FG002|Overall Study|Withdrawal by Subject|2|||
125245818|NCT01666314|450524647|FG003|Overall Study|Withdrawal by Subject|3|||
125245819|NCT01666314|450524644|FG000|Overall Study|Reason not Specified|10|||
125245820|NCT01666314|450524645|FG001|Overall Study|Reason not Specified|7|||
125394226|NCT02036502|451075886|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
125394227|NCT02036502|451075887|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
125193114|NCT00652626|450330147|FG001|Initial Treatment Phase|Physician Decision|0|||
125193115|NCT00652626|450330148|FG002|Initial Treatment Phase|Physician Decision|0|||
125193116|NCT00652626|450330149|FG003|Initial Treatment Phase|Physician Decision|0|||
125394228|NCT02036502|451075888|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
125394229|NCT02036502|451075889|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
125394230|NCT02036502|451075890|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
125245821|NCT01666314|450524646|FG002|Overall Study|Reason not Specified|5|||
125245822|NCT01666314|450524647|FG003|Overall Study|Reason not Specified|5|||
125245823|NCT00422461|450526613|FG000|Overall Study|Adverse Event|1|||
125245824|NCT00422461|450526614|FG001|Overall Study|Adverse Event|2|||
125245825|NCT00422461|450526615|FG002|Overall Study|Adverse Event|1|||
125245826|NCT00422461|450526616|FG003|Overall Study|Adverse Event|1|||
125245827|NCT00422461|450526613|FG000|Overall Study|Other|0|||
125245828|NCT00422461|450526614|FG001|Overall Study|Other|0|||
125245829|NCT00422461|450526615|FG002|Overall Study|Other|0|||
125245830|NCT00422461|450526616|FG003|Overall Study|Other|2|||
125245831|NCT00422461|450526613|FG000|Overall Study|Participants no longer willing to participate in study|1|||
125245832|NCT00422461|450526614|FG001|Overall Study|Participants no longer willing to participate in study|0|||
125245833|NCT00422461|450526615|FG002|Overall Study|Participants no longer willing to participate in study|0|||
125245834|NCT00422461|450526616|FG003|Overall Study|Participants no longer willing to participate in study|0|||
125245835|NCT00422461|450526613|FG000|Overall Study|Randomized but not treated|1|||
125245836|NCT00422461|450526614|FG001|Overall Study|Randomized but not treated|1|||
125245837|NCT00422461|450526615|FG002|Overall Study|Randomized but not treated|0|||
125245838|NCT00422461|450526616|FG003|Overall Study|Randomized but not treated|0|||
125245839|NCT01471574|450526617|FG000|Treatment Period|Lack of Efficacy|12|||
125245840|NCT01471574|450526618|FG001|Treatment Period|Lack of Efficacy|4|||
125245841|NCT01471574|450526619|FG002|Treatment Period|Lack of Efficacy|14|||
125245842|NCT01471574|450526620|FG003|Treatment Period|Lack of Efficacy|1|||
125245843|NCT01471574|450526617|FG000|Treatment Period|Adverse Event|7|||
125245844|NCT01471574|450526618|FG001|Treatment Period|Adverse Event|3|||
125245845|NCT01471574|450526619|FG002|Treatment Period|Adverse Event|6|||
125245846|NCT01471574|450526620|FG003|Treatment Period|Adverse Event|1|||
125245847|NCT01471574|450526617|FG000|Treatment Period|Withdrawal by Subject|5|||
125245848|NCT01471574|450526618|FG001|Treatment Period|Withdrawal by Subject|1|||
125245849|NCT01471574|450526619|FG002|Treatment Period|Withdrawal by Subject|1|||
125245850|NCT01471574|450526620|FG003|Treatment Period|Withdrawal by Subject|0|||
125245851|NCT01471574|450526617|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
125245852|NCT01471574|450526618|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
125245853|NCT01471574|450526619|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
125245854|NCT01471574|450526620|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
125245855|NCT01471574|450526617|FG000|Treatment Period|Lost to Follow-up|1|||
125245856|NCT01471574|450526618|FG001|Treatment Period|Lost to Follow-up|2|||
125245857|NCT01471574|450526619|FG002|Treatment Period|Lost to Follow-up|2|||
125245858|NCT01471574|450526620|FG003|Treatment Period|Lost to Follow-up|0|||
125245859|NCT01471574|450526617|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
125245860|NCT01471574|450526618|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
125245861|NCT01471574|450526619|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
125245862|NCT01471574|450526620|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
125245863|NCT01471574|450526617|FG000|Treatment Period|Other|1|||
125245864|NCT01471574|450526618|FG001|Treatment Period|Other|0|||
125245865|NCT01471574|450526619|FG002|Treatment Period|Other|0|||
125245866|NCT01471574|450526620|FG003|Treatment Period|Other|0|||
125245867|NCT01471574|450526617|FG000|Follow-up Period|Withdrawal by Subject|3|||
125245868|NCT01471574|450526618|FG001|Follow-up Period|Withdrawal by Subject|0|||
125245869|NCT01471574|450526619|FG002|Follow-up Period|Withdrawal by Subject|3|||
125245870|NCT01471574|450526620|FG003|Follow-up Period|Withdrawal by Subject|1|||
125245871|NCT01471574|450526617|FG000|Follow-up Period|Lost to Follow-up|4|||
125245872|NCT01471574|450526618|FG001|Follow-up Period|Lost to Follow-up|1|||
125245873|NCT01471574|450526619|FG002|Follow-up Period|Lost to Follow-up|3|||
125245874|NCT01471574|450526620|FG003|Follow-up Period|Lost to Follow-up|2|||
125245875|NCT01471574|450526617|FG000|Follow-up Period|Death|0|||
125245876|NCT01471574|450526618|FG001|Follow-up Period|Death|0|||
125245877|NCT01471574|450526619|FG002|Follow-up Period|Death|1|||
125245878|NCT01471574|450526620|FG003|Follow-up Period|Death|0|||
125245879|NCT01471574|450526617|FG000|Follow-up Period|Follow-up no longer required|0|||
125245880|NCT01471574|450526618|FG001|Follow-up Period|Follow-up no longer required|1|||
125245881|NCT01471574|450526619|FG002|Follow-up Period|Follow-up no longer required|0|||
125245882|NCT01471574|450526620|FG003|Follow-up Period|Follow-up no longer required|0|||
125245883|NCT00864513|450526626|FG000|Overall Study|Withdrawal by Subject|3|||
125245884|NCT00574951|450526627|FG000|Overall Study|Ineligible - improper prior treatment|1|||
125245885|NCT01160744|450526640|FG000|Overall Study|Withdrawal by Subject|11|||
125245886|NCT01160744|450526641|FG001|Overall Study|Withdrawal by Subject|5|||
125245887|NCT01160744|450526642|FG002|Overall Study|Withdrawal by Subject|6|||
125245888|NCT01160744|450526643|FG003|Overall Study|Withdrawal by Subject|4|||
125245889|NCT01160744|450526640|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
125245890|NCT01160744|450526641|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
125245891|NCT01160744|450526642|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
125245892|NCT01160744|450526643|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
125245893|NCT02056288|450526644|FG000|In-Hospital Data|Surgery cancelled|1|||
125245894|NCT02056288|450526645|FG001|In-Hospital Data|Surgery cancelled|0|||
125245895|NCT02056288|450526644|FG000|In-Hospital Data|Protocol Violation|3|||
125245896|NCT02056288|450526645|FG001|In-Hospital Data|Protocol Violation|0|||
125245897|NCT02056288|450526644|FG000|In-Hospital Data|Physician Decision|1|||
125245898|NCT02056288|450526645|FG001|In-Hospital Data|Physician Decision|0|||
125245899|NCT02056288|450526644|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
125245900|NCT02056288|450526645|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
125245901|NCT02301429|450526646|FG000|Overall Study|not acceptable vascular anatomy|3|||
125245902|NCT00500110|450526647|FG000|Overall Study|Withdrawal by Subject|3|||
125245903|NCT01502072|450526648|FG000|Overall Study|Withdrawal by Subject|1|||
125245904|NCT01502072|450526649|FG001|Overall Study|Withdrawal by Subject|0|||
125245905|NCT01502072|450526650|FG002|Overall Study|Withdrawal by Subject|0|||
125245906|NCT01502072|450526648|FG000|Overall Study|Death|0|||
125245907|NCT01502072|450526649|FG001|Overall Study|Death|1|||
125245908|NCT01502072|450526650|FG002|Overall Study|Death|0|||
125245909|NCT03954938|450526651|FG000|Overall Study|Withdrawal by Subject|2|||
125245910|NCT03954938|450526651|FG000|Overall Study|Adverse Event|1|||
125245911|NCT04676646|450526652|FG000|Open-label Run-in Phase|Adverse Event|3|||
125245912|NCT04676646|450526653|FG001|Open-label Run-in Phase|Adverse Event|0|||
125245913|NCT04676646|450526654|FG002|Open-label Run-in Phase|Adverse Event|0|||
125245914|NCT04676646|450526652|FG000|Open-label Run-in Phase|Death|3|||
125245915|NCT04676646|450526653|FG001|Open-label Run-in Phase|Death|0|||
125245916|NCT04676646|450526654|FG002|Open-label Run-in Phase|Death|0|||
125245917|NCT04676646|450526652|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
125245918|NCT04676646|450526653|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
125245919|NCT04676646|450526654|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
125245920|NCT04676646|450526652|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
125245921|NCT04676646|450526653|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
125245922|NCT04676646|450526654|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
125245923|NCT04676646|450526652|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
125245924|NCT04676646|450526653|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
125245925|NCT04676646|450526654|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
125245926|NCT04676646|450526652|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
125245927|NCT04676646|450526653|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
125245928|NCT04676646|450526654|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
125245929|NCT04676646|450526652|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
125245930|NCT04676646|450526653|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
125245931|NCT04676646|450526654|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
125245932|NCT04676646|450526652|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
125245933|NCT04676646|450526653|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
125245934|NCT04676646|450526654|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
125245935|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
125245936|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
125245937|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
125193117|NCT00652626|450330150|FG004|Initial Treatment Phase|Physician Decision|1|||
125193118|NCT00652626|450330151|FG005|Initial Treatment Phase|Physician Decision|0|||
125193119|NCT00652626|450330152|FG006|Initial Treatment Phase|Physician Decision|0|||
125193120|NCT00652626|450330146|FG000|Initial Treatment Phase|Sponsor Request|0|||
125193121|NCT00652626|450330147|FG001|Initial Treatment Phase|Sponsor Request|0|||
125193122|NCT00652626|450330148|FG002|Initial Treatment Phase|Sponsor Request|1|||
125193123|NCT00652626|450330149|FG003|Initial Treatment Phase|Sponsor Request|0|||
125193124|NCT00652626|450330150|FG004|Initial Treatment Phase|Sponsor Request|0|||
125193125|NCT00652626|450330151|FG005|Initial Treatment Phase|Sponsor Request|0|||
125193126|NCT00652626|450330152|FG006|Initial Treatment Phase|Sponsor Request|0|||
125193127|NCT00652626|450330146|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
125193128|NCT00652626|450330147|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
125193129|NCT00652626|450330148|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
125193130|NCT00652626|450330149|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
125193131|NCT00652626|450330150|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
125193132|NCT00652626|450330151|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
125193133|NCT00652626|450330152|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
125193134|NCT00652626|450330146|FG000|Extension Phase|Withdrawal by Subject|0|||
125245938|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Death|0|||
125245939|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Death|1|||
125245940|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Death|2|||
125245941|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
125245942|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
125245943|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
125193135|NCT00652626|450330147|FG001|Extension Phase|Withdrawal by Subject|0|||
125193136|NCT00652626|450330148|FG002|Extension Phase|Withdrawal by Subject|0|||
125193137|NCT00652626|450330149|FG003|Extension Phase|Withdrawal by Subject|0|||
125193138|NCT00652626|450330150|FG004|Extension Phase|Withdrawal by Subject|0|||
125245944|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
125245945|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
125245946|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
125245947|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
125245948|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
125245949|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
125245950|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
125245951|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
125245952|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
125245953|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
125245954|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
125245955|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
125245956|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
125245957|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
125245958|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
125245959|NCT04676646|450526652|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
125245960|NCT04676646|450526653|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
125245961|NCT04676646|450526654|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
125245962|NCT02217982|450526655|FG000|Overall Study|Trial discontinued|1|||
125245963|NCT02217982|450526656|FG001|Overall Study|Trial discontinued|0|||
125245964|NCT02217982|450526655|FG000|Overall Study|Adverse Event|0|||
125245965|NCT02217982|450526656|FG001|Overall Study|Adverse Event|1|||
125245966|NCT04270760|450526657|FG000|Overall Study|Withdrawal by Subject|0|||
125245967|NCT04270760|450526658|FG001|Overall Study|Withdrawal by Subject|1|||
125245968|NCT04270760|450526659|FG002|Overall Study|Withdrawal by Subject|3|||
125245969|NCT04270760|450526660|FG003|Overall Study|Withdrawal by Subject|0|||
125245970|NCT04270760|450526661|FG004|Overall Study|Withdrawal by Subject|0|||
125245971|NCT04270760|450526657|FG000|Overall Study|Lost to Follow-up|1|||
125245972|NCT04270760|450526658|FG001|Overall Study|Lost to Follow-up|2|||
125245973|NCT04270760|450526659|FG002|Overall Study|Lost to Follow-up|1|||
125245974|NCT04270760|450526660|FG003|Overall Study|Lost to Follow-up|0|||
125245975|NCT04270760|450526661|FG004|Overall Study|Lost to Follow-up|0|||
125245976|NCT04270760|450526657|FG000|Overall Study|Death|0|||
125245977|NCT04270760|450526658|FG001|Overall Study|Death|0|||
125245978|NCT04270760|450526659|FG002|Overall Study|Death|0|||
125245979|NCT04270760|450526660|FG003|Overall Study|Death|0|||
125245980|NCT04270760|450526661|FG004|Overall Study|Death|1|||
125245981|NCT02421510|450526662|FG000|Overall Study|Other|4|||
125245982|NCT02421510|450526663|FG001|Overall Study|Other|2|||
125245983|NCT02421510|450526664|FG002|Overall Study|Other|3|||
125245984|NCT02421510|450526662|FG000|Overall Study|Protocol Violation|1|||
125245985|NCT02421510|450526663|FG001|Overall Study|Protocol Violation|2|||
125245986|NCT02421510|450526664|FG002|Overall Study|Protocol Violation|0|||
125245987|NCT02421510|450526662|FG000|Overall Study|Death|1|||
125245988|NCT02421510|450526663|FG001|Overall Study|Death|0|||
125245989|NCT02421510|450526664|FG002|Overall Study|Death|0|||
125245990|NCT02421510|450526662|FG000|Overall Study|Noncompliance with study drug|1|||
125245991|NCT02421510|450526663|FG001|Overall Study|Noncompliance with study drug|0|||
125245992|NCT02421510|450526664|FG002|Overall Study|Noncompliance with study drug|0|||
125245993|NCT02421510|450526662|FG000|Overall Study|Physician Decision|1|||
125245994|NCT02421510|450526663|FG001|Overall Study|Physician Decision|1|||
125245995|NCT02421510|450526664|FG002|Overall Study|Physician Decision|3|||
125245996|NCT02421510|450526662|FG000|Overall Study|Adverse Event|9|||
125245997|NCT02421510|450526663|FG001|Overall Study|Adverse Event|10|||
125245998|NCT02421510|450526664|FG002|Overall Study|Adverse Event|18|||
125245999|NCT02421510|450526662|FG000|Overall Study|Pregnancy|1|||
125246000|NCT02421510|450526663|FG001|Overall Study|Pregnancy|1|||
125246001|NCT02421510|450526664|FG002|Overall Study|Pregnancy|0|||
125246002|NCT02421510|450526662|FG000|Overall Study|Withdrawal by Subject|14|||
125246003|NCT02421510|450526663|FG001|Overall Study|Withdrawal by Subject|18|||
125246004|NCT02421510|450526664|FG002|Overall Study|Withdrawal by Subject|12|||
125246005|NCT02421510|450526662|FG000|Overall Study|Lost to Follow-up|1|||
125246006|NCT02421510|450526663|FG001|Overall Study|Lost to Follow-up|1|||
125246007|NCT02421510|450526664|FG002|Overall Study|Lost to Follow-up|0|||
125246008|NCT02609633|450526669|FG000|Overall Study|Consent Withdrawn|0|||
125246009|NCT02609633|450526670|FG001|Overall Study|Consent Withdrawn|1|||
125246010|NCT02609633|450526669|FG000|Overall Study|Protocol Deviation|1|||
125246011|NCT02609633|450526670|FG001|Overall Study|Protocol Deviation|0|||
125246012|NCT02609633|450526669|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
125394231|NCT02036502|451075891|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
125193139|NCT00652626|450330151|FG005|Extension Phase|Withdrawal by Subject|2|||
125193140|NCT00652626|450330152|FG006|Extension Phase|Withdrawal by Subject|0|||
125193141|NCT00652626|450330146|FG000|Extension Phase|Adverse Event|0|||
125193142|NCT00652626|450330147|FG001|Extension Phase|Adverse Event|0|||
125193143|NCT00652626|450330148|FG002|Extension Phase|Adverse Event|0|||
125193144|NCT00652626|450330149|FG003|Extension Phase|Adverse Event|0|||
125193145|NCT00652626|450330150|FG004|Extension Phase|Adverse Event|0|||
125193146|NCT00652626|450330151|FG005|Extension Phase|Adverse Event|2|||
125193147|NCT00652626|450330152|FG006|Extension Phase|Adverse Event|1|||
125193148|NCT00652626|450330146|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
125394232|NCT02036502|451075892|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
125193149|NCT00652626|450330147|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
125193150|NCT00652626|450330148|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
125193151|NCT00652626|450330149|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
125193152|NCT00652626|450330150|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
125193153|NCT00652626|450330151|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
125193154|NCT00652626|450330152|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
125193155|NCT00652626|450330146|FG000|Extension Phase|Physician Decision|0|||
125193156|NCT00652626|450330147|FG001|Extension Phase|Physician Decision|0|||
125193157|NCT00652626|450330148|FG002|Extension Phase|Physician Decision|0|||
125193158|NCT00652626|450330149|FG003|Extension Phase|Physician Decision|0|||
125193159|NCT00652626|450330150|FG004|Extension Phase|Physician Decision|0|||
125193160|NCT00652626|450330151|FG005|Extension Phase|Physician Decision|1|||
125193161|NCT00652626|450330152|FG006|Extension Phase|Physician Decision|1|||
125193162|NCT00652626|450330146|FG000|Extension Phase|Death|0|||
125193163|NCT00652626|450330147|FG001|Extension Phase|Death|0|||
125193164|NCT00652626|450330148|FG002|Extension Phase|Death|0|||
125193165|NCT00652626|450330149|FG003|Extension Phase|Death|0|||
125193166|NCT00652626|450330150|FG004|Extension Phase|Death|0|||
125193167|NCT00652626|450330151|FG005|Extension Phase|Death|1|||
125193168|NCT00652626|450330152|FG006|Extension Phase|Death|1|||
125193169|NCT01623310|450330153|FG000|Overall Study|Adverse Event|21|||
125193170|NCT01623310|450330153|FG000|Overall Study|Lost to Follow-up|18|||
125193171|NCT01623310|450330153|FG000|Overall Study|Lack of Efficacy|6|||
125193172|NCT01623310|450330153|FG000|Overall Study|Protocol Violation|6|||
125193173|NCT01623310|450330153|FG000|Overall Study|Withdrawal by Subject|25|||
125193174|NCT01623310|450330153|FG000|Overall Study|Became potentially child-bearing|1|||
125193175|NCT01623310|450330153|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
125193176|NCT01623310|450330153|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
125193177|NCT02898597|450330154|FG000|Overall Study|Protocol Violation|4|||
125193178|NCT02898597|450330155|FG001|Overall Study|Protocol Violation|2|||
125193179|NCT02898597|450330154|FG000|Overall Study|Lost to Follow-up|0|||
125193180|NCT02898597|450330155|FG001|Overall Study|Lost to Follow-up|9|||
125193181|NCT02898597|450330154|FG000|Overall Study|Death|0|||
125193182|NCT02898597|450330155|FG001|Overall Study|Death|1|||
125193183|NCT02530125|450330156|FG000|Completed Treatment|Early termination of study|1|||
125193184|NCT02530125|450330156|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
125193185|NCT00356603|450330157|FG000|Overall Study|Other|6|||
125193186|NCT00356603|450330158|FG001|Overall Study|Other|3|||
125193187|NCT00728468|450330160|FG000|Overall Study|Enrolled but not treated|1|||
125193188|NCT00728468|450330160|FG000|Overall Study|Death|1|||
125193189|NCT00728468|450330160|FG000|Overall Study|Protocol Violation|4|||
125193190|NCT00728468|450330160|FG000|Overall Study|Objective progression or relapse|9|||
125193191|NCT00728468|450330160|FG000|Overall Study|Study terminated by sponsor|1|||
125193192|NCT01568034|450330161|FG000|Overall Study|Withdrawal by Subject|1|||
125193193|NCT01568034|450330162|FG001|Overall Study|Withdrawal by Subject|0|||
125193194|NCT01568034|450330163|FG002|Overall Study|Withdrawal by Subject|0|||
125193195|NCT01568034|450330164|FG003|Overall Study|Withdrawal by Subject|0|||
125193196|NCT01262287|450330165|FG000|Overall Study|Lost to Follow-up|2|||
125193197|NCT01262287|450330166|FG001|Overall Study|Lost to Follow-up|1|||
125193198|NCT00932373|450330167|FG000|Overall Study|Progressive disease|3|||
125193199|NCT00932373|450330168|FG001|Overall Study|Progressive disease|1|||
125193200|NCT00932373|450330169|FG002|Overall Study|Progressive disease|0|||
125193201|NCT00932373|450330170|FG003|Overall Study|Progressive disease|0|||
125193202|NCT00932373|450330171|FG004|Overall Study|Progressive disease|10|||
125193203|NCT00932373|450330172|FG005|Overall Study|Progressive disease|1|||
125193204|NCT00932373|450330173|FG006|Overall Study|Progressive disease|0|||
125193205|NCT00932373|450330174|FG007|Overall Study|Progressive disease|2|||
125193206|NCT00932373|450330175|FG008|Overall Study|Progressive disease|1|||
125193207|NCT00932373|450330176|FG009|Overall Study|Progressive disease|9|||
125193208|NCT00932373|450330177|FG010|Overall Study|Progressive disease|2|||
125193209|NCT00932373|450330167|FG000|Overall Study|Adverse Event|0|||
125193210|NCT00932373|450330168|FG001|Overall Study|Adverse Event|0|||
125193211|NCT00932373|450330169|FG002|Overall Study|Adverse Event|0|||
125193212|NCT00932373|450330170|FG003|Overall Study|Adverse Event|0|||
125193213|NCT00932373|450330171|FG004|Overall Study|Adverse Event|2|||
125193214|NCT00932373|450330172|FG005|Overall Study|Adverse Event|1|||
125193215|NCT00932373|450330173|FG006|Overall Study|Adverse Event|0|||
125193216|NCT00932373|450330174|FG007|Overall Study|Adverse Event|1|||
125193217|NCT00932373|450330175|FG008|Overall Study|Adverse Event|0|||
125193218|NCT00932373|450330176|FG009|Overall Study|Adverse Event|2|||
125193219|NCT00932373|450330177|FG010|Overall Study|Adverse Event|1|||
125193220|NCT00932373|450330167|FG000|Overall Study|Physician Decision|0|||
125193221|NCT00932373|450330168|FG001|Overall Study|Physician Decision|0|||
125193222|NCT00932373|450330169|FG002|Overall Study|Physician Decision|1|||
125193223|NCT00932373|450330170|FG003|Overall Study|Physician Decision|0|||
125193224|NCT00932373|450330171|FG004|Overall Study|Physician Decision|2|||
125193225|NCT00932373|450330172|FG005|Overall Study|Physician Decision|0|||
125193226|NCT00932373|450330173|FG006|Overall Study|Physician Decision|0|||
125193227|NCT00932373|450330174|FG007|Overall Study|Physician Decision|0|||
125193228|NCT00932373|450330175|FG008|Overall Study|Physician Decision|0|||
125193229|NCT00932373|450330176|FG009|Overall Study|Physician Decision|1|||
125193230|NCT00932373|450330177|FG010|Overall Study|Physician Decision|0|||
125193231|NCT00932373|450330167|FG000|Overall Study|Dose limiting toxicity|0|||
125193232|NCT00932373|450330168|FG001|Overall Study|Dose limiting toxicity|0|||
125193233|NCT00932373|450330169|FG002|Overall Study|Dose limiting toxicity|0|||
125193234|NCT00932373|450330170|FG003|Overall Study|Dose limiting toxicity|0|||
125193235|NCT00932373|450330171|FG004|Overall Study|Dose limiting toxicity|0|||
125193236|NCT00932373|450330172|FG005|Overall Study|Dose limiting toxicity|1|||
125193237|NCT00932373|450330173|FG006|Overall Study|Dose limiting toxicity|0|||
125193238|NCT00932373|450330174|FG007|Overall Study|Dose limiting toxicity|0|||
125193239|NCT00932373|450330175|FG008|Overall Study|Dose limiting toxicity|0|||
125193240|NCT00932373|450330176|FG009|Overall Study|Dose limiting toxicity|0|||
125193241|NCT00932373|450330177|FG010|Overall Study|Dose limiting toxicity|0|||
125193242|NCT00932373|450330167|FG000|Overall Study|Withdrawal by Subject|0|||
125193243|NCT00932373|450330168|FG001|Overall Study|Withdrawal by Subject|0|||
125193244|NCT00932373|450330169|FG002|Overall Study|Withdrawal by Subject|0|||
125193245|NCT00932373|450330170|FG003|Overall Study|Withdrawal by Subject|0|||
125193246|NCT00932373|450330171|FG004|Overall Study|Withdrawal by Subject|0|||
125193247|NCT00932373|450330172|FG005|Overall Study|Withdrawal by Subject|0|||
125193248|NCT00932373|450330173|FG006|Overall Study|Withdrawal by Subject|0|||
125193249|NCT00932373|450330174|FG007|Overall Study|Withdrawal by Subject|0|||
125193250|NCT00932373|450330175|FG008|Overall Study|Withdrawal by Subject|1|||
125193251|NCT00932373|450330176|FG009|Overall Study|Withdrawal by Subject|0|||
125193252|NCT00932373|450330177|FG010|Overall Study|Withdrawal by Subject|0|||
125193253|NCT00932373|450330167|FG000|Overall Study|Clinical progression|0|||
125193254|NCT00932373|450330168|FG001|Overall Study|Clinical progression|0|||
125193255|NCT00932373|450330169|FG002|Overall Study|Clinical progression|0|||
125193256|NCT00932373|450330170|FG003|Overall Study|Clinical progression|0|||
125193257|NCT00932373|450330171|FG004|Overall Study|Clinical progression|0|||
125193258|NCT00932373|450330172|FG005|Overall Study|Clinical progression|0|||
125193259|NCT00932373|450330173|FG006|Overall Study|Clinical progression|1|||
125193260|NCT00932373|450330174|FG007|Overall Study|Clinical progression|0|||
125193261|NCT00932373|450330175|FG008|Overall Study|Clinical progression|0|||
125193262|NCT00932373|450330176|FG009|Overall Study|Clinical progression|0|||
125193263|NCT00932373|450330177|FG010|Overall Study|Clinical progression|0|||
125193264|NCT00932373|450330167|FG000|Overall Study|Lack of Efficacy|0|||
125193265|NCT00932373|450330168|FG001|Overall Study|Lack of Efficacy|0|||
125193266|NCT00932373|450330169|FG002|Overall Study|Lack of Efficacy|0|||
125193267|NCT00932373|450330170|FG003|Overall Study|Lack of Efficacy|0|||
125193268|NCT00932373|450330171|FG004|Overall Study|Lack of Efficacy|0|||
125193269|NCT00932373|450330172|FG005|Overall Study|Lack of Efficacy|0|||
125193270|NCT00932373|450330173|FG006|Overall Study|Lack of Efficacy|0|||
125193271|NCT00932373|450330174|FG007|Overall Study|Lack of Efficacy|0|||
125193272|NCT00932373|450330175|FG008|Overall Study|Lack of Efficacy|0|||
125193273|NCT00932373|450330176|FG009|Overall Study|Lack of Efficacy|1|||
125193274|NCT00932373|450330177|FG010|Overall Study|Lack of Efficacy|0|||
125193275|NCT01637922|450330178|FG000|Overall Study|Adverse Event|0|||
125193276|NCT01637922|450330179|FG001|Overall Study|Adverse Event|1|||
125193277|NCT01637922|450330178|FG000|Overall Study|Protocol Violation|0|||
125193278|NCT01637922|450330179|FG001|Overall Study|Protocol Violation|1|||
125193279|NCT01637922|450330178|FG000|Overall Study|Withdrawal by Subject|0|||
125394233|NCT02036502|451075893|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
125394234|NCT02036502|451075886|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
125394235|NCT02036502|451075887|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
125193280|NCT01637922|450330179|FG001|Overall Study|Withdrawal by Subject|3|||
125193281|NCT01637922|450330178|FG000|Overall Study|Lost to Follow-up|2|||
125193282|NCT01637922|450330179|FG001|Overall Study|Lost to Follow-up|0|||
125193283|NCT00638404|450330180|FG000|Overall Study|Physician Decision|8|||
125193284|NCT00638404|450330181|FG001|Overall Study|Physician Decision|0|||
125193285|NCT02492984|450330182|FG000|Overall Study|Adverse Event|1|||
125193286|NCT02492984|450330183|FG001|Overall Study|Adverse Event|0|||
125193287|NCT02492984|450330182|FG000|Overall Study|Protocol Violation|1|||
125193288|NCT02492984|450330183|FG001|Overall Study|Protocol Violation|0|||
125193289|NCT02492984|450330182|FG000|Overall Study|Withdrawal by Subject|1|||
125193290|NCT02492984|450330183|FG001|Overall Study|Withdrawal by Subject|0|||
125394236|NCT02036502|451075888|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
125394237|NCT02036502|451075889|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
125394238|NCT02036502|451075890|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
125394239|NCT02036502|451075891|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
125394240|NCT02036502|451075892|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
125394241|NCT02036502|451075893|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
125394242|NCT02036502|451075886|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
125394243|NCT02036502|451075887|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
125394244|NCT02036502|451075888|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
125394245|NCT02036502|451075889|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
125394246|NCT02036502|451075890|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
125394247|NCT02036502|451075891|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
125394248|NCT02036502|451075892|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
125394249|NCT02036502|451075893|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
125394250|NCT02036502|451075886|FG000|Part 3:Dose Expansion|Not Treated|0|||
125394251|NCT02036502|451075887|FG001|Part 3:Dose Expansion|Not Treated|0|||
125394252|NCT02036502|451075888|FG002|Part 3:Dose Expansion|Not Treated|0|||
125394253|NCT02036502|451075889|FG003|Part 3:Dose Expansion|Not Treated|0|||
125394254|NCT02036502|451075890|FG004|Part 3:Dose Expansion|Not Treated|0|||
125394255|NCT02036502|451075891|FG005|Part 3:Dose Expansion|Not Treated|2|||
125394256|NCT02036502|451075892|FG006|Part 3:Dose Expansion|Not Treated|0|||
125394257|NCT02036502|451075893|FG007|Part 3:Dose Expansion|Not Treated|0|||
125394258|NCT02442778|451075894|FG000|Overall Study|Adverse Event|2|||
125394259|NCT02442778|451075895|FG001|Overall Study|Adverse Event|6|||
125394260|NCT02442778|451075896|FG002|Overall Study|Adverse Event|6|||
125394261|NCT02442778|451075894|FG000|Overall Study|Death|0|||
125394262|NCT02442778|451075895|FG001|Overall Study|Death|2|||
125394263|NCT02442778|451075896|FG002|Overall Study|Death|0|||
125394264|NCT02442778|451075894|FG000|Overall Study|Lack of Efficacy|1|||
125394265|NCT02442778|451075895|FG001|Overall Study|Lack of Efficacy|0|||
125394266|NCT02442778|451075896|FG002|Overall Study|Lack of Efficacy|0|||
125394267|NCT02442778|451075894|FG000|Overall Study|Lost to Follow-up|1|||
125394268|NCT02442778|451075895|FG001|Overall Study|Lost to Follow-up|1|||
125394269|NCT02442778|451075896|FG002|Overall Study|Lost to Follow-up|1|||
125394270|NCT02442778|451075894|FG000|Overall Study|Non-compliance with study drug|2|||
125394271|NCT02442778|451075895|FG001|Overall Study|Non-compliance with study drug|0|||
125394272|NCT02442778|451075896|FG002|Overall Study|Non-compliance with study drug|1|||
125394273|NCT02442778|451075894|FG000|Overall Study|Physician Decision|1|||
125394274|NCT02442778|451075895|FG001|Overall Study|Physician Decision|1|||
125394275|NCT02442778|451075896|FG002|Overall Study|Physician Decision|1|||
125394276|NCT02442778|451075894|FG000|Overall Study|Protocol Deviation|3|||
125394277|NCT02442778|451075895|FG001|Overall Study|Protocol Deviation|0|||
125394278|NCT02442778|451075896|FG002|Overall Study|Protocol Deviation|1|||
125394279|NCT02442778|451075894|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
125394280|NCT02442778|451075895|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
125394281|NCT02442778|451075896|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
125394282|NCT02442778|451075894|FG000|Overall Study|Withdrawal by Subject|4|||
125394283|NCT02442778|451075895|FG001|Overall Study|Withdrawal by Subject|4|||
125394284|NCT02442778|451075896|FG002|Overall Study|Withdrawal by Subject|3|||
125394285|NCT02442778|451075894|FG000|Overall Study|Reason not specified|1|||
125394286|NCT02442778|451075895|FG001|Overall Study|Reason not specified|4|||
125394287|NCT02442778|451075896|FG002|Overall Study|Reason not specified|0|||
125394288|NCT02849548|451075903|FG000|Overall Study|Lost to Follow-up|1|||
125394289|NCT02849548|451075904|FG001|Overall Study|Lost to Follow-up|2|||
125394290|NCT02849548|451075903|FG000|Overall Study|Protocol Violation|1|||
125394291|NCT02849548|451075904|FG001|Overall Study|Protocol Violation|0|||
125394292|NCT02357147|451075906|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
125394293|NCT02357147|451075907|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
125443547|NCT02561455|451252171|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
125443548|NCT02561455|451252172|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
125394294|NCT02357147|451075906|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
125394295|NCT02357147|451075907|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
125394296|NCT02357147|451075906|FG000|Combination Treatment Phase|Investigator Discretion|1|||
125394297|NCT02357147|451075907|FG001|Combination Treatment Phase|Investigator Discretion|1|||
125394298|NCT02357147|451075906|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
125443549|NCT02561455|451252173|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
125443550|NCT02561455|451252174|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
125443551|NCT02561455|451252171|FG000|Overall Study|Withdrawal by Subject|1|||
125394299|NCT02357147|451075907|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
125394300|NCT02357147|451075906|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
125394301|NCT02357147|451075907|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
125443552|NCT02561455|451252172|FG001|Overall Study|Withdrawal by Subject|0|||
125443553|NCT02561455|451252173|FG002|Overall Study|Withdrawal by Subject|1|||
125394302|NCT02357147|451075906|FG000|Combination Treatment Phase|Adverse Event|12|||
125394303|NCT02357147|451075907|FG001|Combination Treatment Phase|Adverse Event|4|||
125394304|NCT02357147|451075906|FG000|Combination Treatment Phase|Death|1|||
125394305|NCT02357147|451075907|FG001|Combination Treatment Phase|Death|1|||
125394306|NCT02357147|451075906|FG000|Combination Treatment Phase|Sponsor Decision|0|||
125394307|NCT02357147|451075907|FG001|Combination Treatment Phase|Sponsor Decision|12|||
125394308|NCT02357147|451075906|FG000|Combination Treatment Phase|Other|1|||
125394309|NCT02357147|451075907|FG001|Combination Treatment Phase|Other|0|||
125394310|NCT02357147|451075906|FG000|Combination Treatment Phase|Not treated|0|||
125394311|NCT02357147|451075907|FG001|Combination Treatment Phase|Not treated|2|||
125394312|NCT02357147|451075906|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
125394313|NCT02357147|451075907|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
125394314|NCT02357147|451075906|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
125394315|NCT02357147|451075907|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
125394316|NCT02357147|451075906|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
125394317|NCT02357147|451075907|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
125394318|NCT02357147|451075906|FG000|Maintenance Treatment Phase|Adverse Event|0|||
125193291|NCT04090060|450330189|FG000|Overall Study|Lost to Follow-up|76|||
125193292|NCT04090060|450330190|FG001|Overall Study|Lost to Follow-up|77|||
125193293|NCT01164579|450330197|FG000|Overall Study|Lack of Efficacy|0|||
125193294|NCT01164579|450330198|FG001|Overall Study|Lack of Efficacy|0|||
125193295|NCT01164579|450330199|FG002|Overall Study|Lack of Efficacy|6|||
125193296|NCT01164579|450330197|FG000|Overall Study|Lost to Follow-up|1|||
125193297|NCT01164579|450330198|FG001|Overall Study|Lost to Follow-up|1|||
125193298|NCT01164579|450330199|FG002|Overall Study|Lost to Follow-up|0|||
125193299|NCT01164579|450330197|FG000|Overall Study|Withdrawal by Subject|2|||
125394319|NCT02357147|451075907|FG001|Maintenance Treatment Phase|Adverse Event|3|||
125394320|NCT02357147|451075906|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
125394321|NCT02357147|451075907|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
125394322|NCT02357147|451075906|FG000|Maintenance Treatment Phase|Not Treated|1|||
125394323|NCT02357147|451075907|FG001|Maintenance Treatment Phase|Not Treated|0|||
125420832|NCT01260350|451166149|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420833|NCT01260350|451166150|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125193300|NCT01164579|450330198|FG001|Overall Study|Withdrawal by Subject|5|||
125193301|NCT01164579|450330199|FG002|Overall Study|Withdrawal by Subject|3|||
125193302|NCT01164579|450330197|FG000|Overall Study|Protocol Violation|0|||
125193303|NCT01164579|450330198|FG001|Overall Study|Protocol Violation|1|||
125193304|NCT01164579|450330199|FG002|Overall Study|Protocol Violation|2|||
125193305|NCT01164579|450330197|FG000|Overall Study|Adverse Event|4|||
125193306|NCT01164579|450330198|FG001|Overall Study|Adverse Event|2|||
125193307|NCT01164579|450330199|FG002|Overall Study|Adverse Event|5|||
125193308|NCT01164579|450330197|FG000|Overall Study|Reason not specified|1|||
125193309|NCT01164579|450330198|FG001|Overall Study|Reason not specified|0|||
125193310|NCT01164579|450330199|FG002|Overall Study|Reason not specified|0|||
125193311|NCT03491462|450330202|FG000|Overall Study|Lost to Follow-up|2|||
125193312|NCT03491462|450330203|FG001|Overall Study|Lost to Follow-up|0|||
125193313|NCT03491462|450330202|FG000|Overall Study|Adverse Event|11|||
125193314|NCT03491462|450330203|FG001|Overall Study|Adverse Event|1|||
125193315|NCT03491462|450330202|FG000|Overall Study|Physician Decision|3|||
125193316|NCT03491462|450330203|FG001|Overall Study|Physician Decision|0|||
125193317|NCT03491462|450330202|FG000|Overall Study|Withdrawal by Subject|22|||
125193318|NCT03491462|450330203|FG001|Overall Study|Withdrawal by Subject|15|||
125193319|NCT00740792|450330204|FG000|Overall Study|Adverse Event|3|||
125193320|NCT00740792|450330205|FG001|Overall Study|Adverse Event|1|||
125193321|NCT00740792|450330206|FG002|Overall Study|Adverse Event|1|||
125193322|NCT00740792|450330207|FG003|Overall Study|Adverse Event|3|||
125193323|NCT00740792|450330204|FG000|Overall Study|Lack of Efficacy|1|||
125193324|NCT00740792|450330205|FG001|Overall Study|Lack of Efficacy|1|||
125193325|NCT00740792|450330206|FG002|Overall Study|Lack of Efficacy|0|||
125193326|NCT00740792|450330207|FG003|Overall Study|Lack of Efficacy|3|||
125193327|NCT00740792|450330204|FG000|Overall Study|Lost to Follow-up|2|||
125193328|NCT00740792|450330205|FG001|Overall Study|Lost to Follow-up|1|||
125193329|NCT00740792|450330206|FG002|Overall Study|Lost to Follow-up|0|||
125193330|NCT00740792|450330207|FG003|Overall Study|Lost to Follow-up|0|||
125193331|NCT00740792|450330204|FG000|Overall Study|Protocol Violation|0|||
125193332|NCT00740792|450330205|FG001|Overall Study|Protocol Violation|1|||
125193333|NCT00740792|450330206|FG002|Overall Study|Protocol Violation|0|||
125193334|NCT00740792|450330207|FG003|Overall Study|Protocol Violation|2|||
125193335|NCT00740792|450330204|FG000|Overall Study|Withdrawal by Subject|1|||
125193336|NCT00740792|450330205|FG001|Overall Study|Withdrawal by Subject|1|||
125420834|NCT01260350|451166151|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420835|NCT01260350|451166152|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
125193337|NCT00740792|450330206|FG002|Overall Study|Withdrawal by Subject|0|||
125193338|NCT00740792|450330207|FG003|Overall Study|Withdrawal by Subject|0|||
125193339|NCT00740792|450330204|FG000|Overall Study|administrative|3|||
125193340|NCT00740792|450330205|FG001|Overall Study|administrative|3|||
125246013|NCT02609633|450526670|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
125246014|NCT02609633|450526669|FG000|Overall Study|Reason not Specified|2|||
125246015|NCT02609633|450526670|FG001|Overall Study|Reason not Specified|1|||
125246016|NCT02287025|450526673|FG000|Overall Study|Not treated|2|||
125246017|NCT02287025|450526674|FG001|Overall Study|Not treated|0|||
125246018|NCT02287025|450526673|FG000|Overall Study|Progression of disease|3|||
125246019|NCT02287025|450526674|FG001|Overall Study|Progression of disease|2|||
125246020|NCT02287025|450526673|FG000|Overall Study|Adverse Event|2|||
125246021|NCT02287025|450526674|FG001|Overall Study|Adverse Event|4|||
125246022|NCT02287025|450526673|FG000|Overall Study|Withdrawal by Subject|2|||
125246023|NCT02287025|450526674|FG001|Overall Study|Withdrawal by Subject|2|||
125246024|NCT02287025|450526673|FG000|Overall Study|Screening failed|1|||
125246025|NCT02287025|450526674|FG001|Overall Study|Screening failed|1|||
125246026|NCT01096186|450526675|FG000|Overall Study|Adverse Event|16|||
125246027|NCT01096186|450526675|FG000|Overall Study|Death|4|||
125246028|NCT01096186|450526675|FG000|Overall Study|Lack of Efficacy|4|||
125246029|NCT01096186|450526675|FG000|Overall Study|Lost to Follow-up|2|||
125246030|NCT01096186|450526675|FG000|Overall Study|Withdrawal by Subject|22|||
125246031|NCT01096186|450526675|FG000|Overall Study|Physician Decision|1|||
125246032|NCT01096186|450526675|FG000|Overall Study|Noncompliance with study drug|1|||
125246033|NCT04053452|450526676|FG000|Overall Study|Withdrawal by Subject|1|||
125246034|NCT04053452|450526677|FG001|Overall Study|Withdrawal by Subject|0|||
125246035|NCT04053452|450526676|FG000|Overall Study|Time restraint due to inpatient needs|1|||
125246036|NCT04053452|450526677|FG001|Overall Study|Time restraint due to inpatient needs|2|||
125193341|NCT00740792|450330206|FG002|Overall Study|administrative|8|||
125193342|NCT00740792|450330207|FG003|Overall Study|administrative|2|||
125193343|NCT00912743|450330212|FG000|Overall Study|Adverse Event|3|||
125193344|NCT00912743|450330213|FG001|Overall Study|Adverse Event|1|||
125193345|NCT00912743|450330212|FG000|Overall Study|Lack of Efficacy|9|||
125193346|NCT00912743|450330213|FG001|Overall Study|Lack of Efficacy|18|||
125193347|NCT00912743|450330212|FG000|Overall Study|Toxicity|0|||
125193348|NCT00912743|450330213|FG001|Overall Study|Toxicity|1|||
125193349|NCT00912743|450330212|FG000|Overall Study|End of treatment form was not collected|1|||
125193350|NCT00912743|450330213|FG001|Overall Study|End of treatment form was not collected|0|||
125193351|NCT00179660|450330223|FG000|Overall Study|Adverse Event|7|||
125193352|NCT00179660|450330223|FG000|Overall Study|Lack of therapeutic effect|28|||
125193353|NCT00179660|450330223|FG000|Overall Study|Withdrawal by Subject|2|||
125193354|NCT00179660|450330223|FG000|Overall Study|Lost to Follow-up|1|||
125193355|NCT00179660|450330223|FG000|Overall Study|Death|3|||
125193356|NCT00179660|450330223|FG000|Overall Study|Other - Unspecified|9|||
125193357|NCT00685399|450330228|FG000|Treatment Period 1|Withdrawal by Subject|2|||
125193358|NCT00685399|450330229|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125193359|NCT00685399|450330230|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125193360|NCT00685399|450330231|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125193361|NCT00685399|450330232|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125193362|NCT00685399|450330233|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125193363|NCT00685399|450330234|FG006|Treatment Period 1|Withdrawal by Subject|0|||
125193364|NCT00685399|450330235|FG007|Treatment Period 1|Withdrawal by Subject|0|||
125193365|NCT00685399|450330228|FG000|Treatment Period 1|Protocol Violation|1|||
125193366|NCT00685399|450330229|FG001|Treatment Period 1|Protocol Violation|0|||
125193367|NCT00685399|450330230|FG002|Treatment Period 1|Protocol Violation|0|||
125193368|NCT00685399|450330231|FG003|Treatment Period 1|Protocol Violation|0|||
125193369|NCT00685399|450330232|FG004|Treatment Period 1|Protocol Violation|0|||
125193370|NCT00685399|450330233|FG005|Treatment Period 1|Protocol Violation|0|||
125193371|NCT00685399|450330234|FG006|Treatment Period 1|Protocol Violation|0|||
125193372|NCT00685399|450330235|FG007|Treatment Period 1|Protocol Violation|0|||
125193373|NCT00685399|450330228|FG000|Treatment Period 1|Administrative|2|||
125193374|NCT00685399|450330229|FG001|Treatment Period 1|Administrative|0|||
125193375|NCT00685399|450330230|FG002|Treatment Period 1|Administrative|0|||
125193376|NCT00685399|450330231|FG003|Treatment Period 1|Administrative|0|||
125193377|NCT00685399|450330232|FG004|Treatment Period 1|Administrative|0|||
125193378|NCT00685399|450330233|FG005|Treatment Period 1|Administrative|0|||
125193379|NCT00685399|450330234|FG006|Treatment Period 1|Administrative|0|||
125193380|NCT00685399|450330235|FG007|Treatment Period 1|Administrative|0|||
125246037|NCT00122187|450526682|FG000|Overall Study|Withdrew because of resource limitations|2|||
125246038|NCT00122187|450526683|FG001|Overall Study|Withdrew because of resource limitations|2|||
125246039|NCT02061592|450526684|FG000|Period 1|Withdrawal by Subject|1|||
125246040|NCT02061592|450526685|FG001|Period 1|Withdrawal by Subject|0|||
125246041|NCT02061592|450526684|FG000|Period 1|Protocol Violation|1|||
125394324|NCT00403273|451077686|FG000|Overall Study|Lost to Follow-up|3|||
125394325|NCT00403273|451077687|FG001|Overall Study|Lost to Follow-up|2|||
125394326|NCT00403273|451077686|FG000|Overall Study|Physician Decision|0|||
125394327|NCT00403273|451077687|FG001|Overall Study|Physician Decision|1|||
125394328|NCT00403273|451077686|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
125394329|NCT00403273|451077687|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
125394330|NCT02586012|451077691|FG000|Overall Study|Withdrawal by Subject|1|||
125394331|NCT02586012|451077692|FG001|Overall Study|Withdrawal by Subject|1|||
125246042|NCT02061592|450526685|FG001|Period 1|Protocol Violation|0|||
125246043|NCT02061592|450526684|FG000|Period 2|Lost to Follow-up|0|||
125246044|NCT02061592|450526685|FG001|Period 2|Lost to Follow-up|1|||
125246045|NCT03338023|450526686|FG000|Overall Study|Withdrawal by Subject|3|||
125246046|NCT03338023|450526687|FG001|Overall Study|Withdrawal by Subject|4|||
125246047|NCT03338023|450526686|FG000|Overall Study|Protocol Violation|3|||
125246048|NCT03338023|450526687|FG001|Overall Study|Protocol Violation|3|||
125246049|NCT03338023|450526686|FG000|Overall Study|Lost to Follow-up|2|||
125246050|NCT03338023|450526687|FG001|Overall Study|Lost to Follow-up|1|||
125246051|NCT03338023|450526686|FG000|Overall Study|Physician Decision|1|||
125246052|NCT03338023|450526687|FG001|Overall Study|Physician Decision|2|||
125246053|NCT00799864|450526688|FG000|Overall Study|Participant reached a virologic endpoint|9|||
125246054|NCT00799864|450526689|FG001|Overall Study|Participant reached a virologic endpoint|2|||
125246055|NCT00799864|450526690|FG002|Overall Study|Participant reached a virologic endpoint|2|||
125246056|NCT00799864|450526691|FG003|Overall Study|Participant reached a virologic endpoint|0|||
125246057|NCT00799864|450526692|FG004|Overall Study|Participant reached a virologic endpoint|0|||
125246058|NCT00799864|450526688|FG000|Overall Study|Other|2|||
125246059|NCT00799864|450526689|FG001|Overall Study|Other|1|||
125246060|NCT00799864|450526690|FG002|Overall Study|Other|0|||
125246061|NCT00799864|450526691|FG003|Overall Study|Other|0|||
125246062|NCT00799864|450526692|FG004|Overall Study|Other|0|||
125246063|NCT00685698|450526695|FG000|Overall Study|Withdrawal by Subject|1|||
125246064|NCT00685698|450526695|FG000|Overall Study|Protocol Violation|6|||
125246065|NCT00685698|450526695|FG000|Overall Study|Adverse Event|3|||
125246066|NCT00685698|450526695|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
125246067|NCT00685698|450526695|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
125246068|NCT00685698|450526695|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
125246069|NCT05061706|450526697|FG000|Overall Study|Adverse Event|29|||
125246070|NCT05061706|450526698|FG001|Overall Study|Adverse Event|1|||
125246071|NCT05061706|450526697|FG000|Overall Study|Lack of Efficacy|0|||
125246072|NCT05061706|450526698|FG001|Overall Study|Lack of Efficacy|1|||
125246073|NCT05061706|450526697|FG000|Overall Study|Lost to Follow-up|2|||
125246074|NCT05061706|450526698|FG001|Overall Study|Lost to Follow-up|2|||
125246075|NCT05061706|450526697|FG000|Overall Study|Protocol Violation|3|||
125246076|NCT05061706|450526698|FG001|Overall Study|Protocol Violation|1|||
125246077|NCT05061706|450526697|FG000|Overall Study|Withdrawal by Subject|3|||
125246078|NCT05061706|450526698|FG001|Overall Study|Withdrawal by Subject|9|||
125246079|NCT00724893|450526699|FG000|Overall Study|Adverse Event|76|||
125246080|NCT00724893|450526700|FG001|Overall Study|Adverse Event|142|||
125246081|NCT00724893|450526699|FG000|Overall Study|Withdrawal by Subject|0|||
125246082|NCT00724893|450526700|FG001|Overall Study|Withdrawal by Subject|1|||
125246083|NCT00724893|450526699|FG000|Overall Study|Lack of virologic response|94|||
125246084|NCT00724893|450526700|FG001|Overall Study|Lack of virologic response|202|||
125246085|NCT00724893|450526699|FG000|Overall Study|Reason not specified|193|||
125246086|NCT00724893|450526700|FG001|Overall Study|Reason not specified|7|||
125246087|NCT00724893|450526699|FG000|Overall Study|Patient choice|0|||
125246088|NCT00724893|450526700|FG001|Overall Study|Patient choice|26|||
125246089|NCT00724893|450526699|FG000|Overall Study|Geographic reasons|0|||
125246090|NCT00724893|450526700|FG001|Overall Study|Geographic reasons|11|||
125246091|NCT00724893|450526699|FG000|Overall Study|Incarceration|0|||
125246092|NCT00724893|450526700|FG001|Overall Study|Incarceration|9|||
125246093|NCT00724893|450526699|FG000|Overall Study|Substance abuse|0|||
125246094|NCT00724893|450526700|FG001|Overall Study|Substance abuse|3|||
125246095|NCT00724893|450526699|FG000|Overall Study|Financial reasons|0|||
125246096|NCT00724893|450526700|FG001|Overall Study|Financial reasons|2|||
125246097|NCT00724893|450526699|FG000|Overall Study|Assigned shorter treatment|0|||
125246098|NCT00724893|450526700|FG001|Overall Study|Assigned shorter treatment|2|||
125246099|NCT00724893|450526699|FG000|Overall Study|Lost to Follow-up|0|||
125246100|NCT00724893|450526700|FG001|Overall Study|Lost to Follow-up|52|||
125246101|NCT00724893|450526699|FG000|Overall Study|Unknown, missing data|1|||
125246102|NCT00724893|450526700|FG001|Overall Study|Unknown, missing data|1|||
125246103|NCT01078545|450526703|FG000|Overall Study|Lost to Follow-up|13|||
125246104|NCT01078545|450526703|FG000|Overall Study|Physician Decision|6|||
125246105|NCT01078545|450526703|FG000|Overall Study|Withdrawal by Subject|3|||
125246106|NCT01078545|450526703|FG000|Overall Study|Death|3|||
125246107|NCT01078545|450526703|FG000|Overall Study|Participant moved to another physician|1|||
125246108|NCT01774370|450526706|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
125246109|NCT01774370|450526706|FG000|Overall Study|Administered prior to the contract date|4|||
125246110|NCT01774370|450526706|FG000|Overall Study|Subjects of contraindications|34|||
125246111|NCT01774370|450526706|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
125246112|NCT01774370|450526706|FG000|Overall Study|Follow-up failure|34|||
125246113|NCT05436288|450526707|FG000|Overall Study|Lost to Follow-up|1|||
125246114|NCT05436288|450526707|FG000|Overall Study|Adverse Event|1|||
125246115|NCT01436500|450526711|FG000|Overall Study|Death|1|||
125394332|NCT02586012|451077693|FG002|Overall Study|Withdrawal by Subject|0|||
125246116|NCT01436500|450526712|FG001|Overall Study|Death|0|||
125246117|NCT01436500|450526713|FG002|Overall Study|Death|0|||
125246118|NCT01436500|450526714|FG003|Overall Study|Death|0|||
125193381|NCT00685399|450330228|FG000|Treatment Period 1|Lack of Efficacy|1|||
125246119|NCT01436500|450526715|FG004|Overall Study|Death|0|||
125246120|NCT01436500|450526711|FG000|Overall Study|Adverse Event|0|||
125246121|NCT01436500|450526712|FG001|Overall Study|Adverse Event|2|||
125193382|NCT00685399|450330229|FG001|Treatment Period 1|Lack of Efficacy|0|||
125193383|NCT00685399|450330230|FG002|Treatment Period 1|Lack of Efficacy|0|||
125193384|NCT00685399|450330231|FG003|Treatment Period 1|Lack of Efficacy|0|||
125193385|NCT00685399|450330232|FG004|Treatment Period 1|Lack of Efficacy|0|||
125193386|NCT00685399|450330233|FG005|Treatment Period 1|Lack of Efficacy|0|||
125193387|NCT00685399|450330234|FG006|Treatment Period 1|Lack of Efficacy|0|||
125193388|NCT00685399|450330235|FG007|Treatment Period 1|Lack of Efficacy|0|||
125193389|NCT00685399|450330228|FG000|Treatment Period 2|Administrative Problems|0|||
125193390|NCT00685399|450330229|FG001|Treatment Period 2|Administrative Problems|2|||
125246122|NCT01436500|450526713|FG002|Overall Study|Adverse Event|2|||
125246123|NCT01436500|450526714|FG003|Overall Study|Adverse Event|0|||
125246124|NCT01436500|450526715|FG004|Overall Study|Adverse Event|1|||
125246125|NCT01436500|450526711|FG000|Overall Study|Withdrawal by Subject|0|||
125246126|NCT01436500|450526712|FG001|Overall Study|Withdrawal by Subject|0|||
125246127|NCT01436500|450526713|FG002|Overall Study|Withdrawal by Subject|2|||
125246128|NCT01436500|450526714|FG003|Overall Study|Withdrawal by Subject|0|||
125246129|NCT01436500|450526715|FG004|Overall Study|Withdrawal by Subject|2|||
125246130|NCT01436500|450526711|FG000|Overall Study|Physician Decision|0|||
125246131|NCT01436500|450526712|FG001|Overall Study|Physician Decision|0|||
125246132|NCT01436500|450526713|FG002|Overall Study|Physician Decision|1|||
125246133|NCT01436500|450526714|FG003|Overall Study|Physician Decision|0|||
125246134|NCT01436500|450526715|FG004|Overall Study|Physician Decision|0|||
125246135|NCT01436500|450526711|FG000|Overall Study|liver transplant|1|||
125246136|NCT01436500|450526712|FG001|Overall Study|liver transplant|0|||
125246137|NCT01436500|450526713|FG002|Overall Study|liver transplant|0|||
125246138|NCT01436500|450526714|FG003|Overall Study|liver transplant|0|||
125246139|NCT01436500|450526715|FG004|Overall Study|liver transplant|0|||
125246140|NCT01436500|450526711|FG000|Overall Study|initiation of dialysis|0|||
125246141|NCT01436500|450526712|FG001|Overall Study|initiation of dialysis|0|||
125246142|NCT01436500|450526713|FG002|Overall Study|initiation of dialysis|0|||
125246143|NCT01436500|450526714|FG003|Overall Study|initiation of dialysis|0|||
125246144|NCT01436500|450526715|FG004|Overall Study|initiation of dialysis|1|||
125246145|NCT01436500|450526711|FG000|Overall Study|discontinued study drug|1|||
125246146|NCT01436500|450526712|FG001|Overall Study|discontinued study drug|0|||
125246147|NCT01436500|450526713|FG002|Overall Study|discontinued study drug|0|||
125246148|NCT01436500|450526714|FG003|Overall Study|discontinued study drug|0|||
125246149|NCT01436500|450526715|FG004|Overall Study|discontinued study drug|0|||
125246150|NCT01436500|450526711|FG000|Overall Study|Other|0|||
125246151|NCT01436500|450526712|FG001|Overall Study|Other|1|||
125246152|NCT01436500|450526713|FG002|Overall Study|Other|0|||
125246153|NCT01436500|450526714|FG003|Overall Study|Other|1|||
125246154|NCT01436500|450526715|FG004|Overall Study|Other|0|||
125246155|NCT01487161|450526719|FG000|Overall Study|Adverse Event|1|||
125246156|NCT01487161|450526720|FG001|Overall Study|Adverse Event|0|||
125246157|NCT01487161|450526721|FG002|Overall Study|Adverse Event|0|||
125246158|NCT01487161|450526722|FG003|Overall Study|Adverse Event|0|||
125246159|NCT01487161|450526719|FG000|Overall Study|Withdrawal by Subject|1|||
125246160|NCT01487161|450526720|FG001|Overall Study|Withdrawal by Subject|1|||
125246161|NCT01487161|450526721|FG002|Overall Study|Withdrawal by Subject|1|||
125246162|NCT01487161|450526722|FG003|Overall Study|Withdrawal by Subject|2|||
125246163|NCT01487161|450526719|FG000|Overall Study|missing data|0|||
125394333|NCT02586012|451077694|FG003|Overall Study|Withdrawal by Subject|1|||
125394334|NCT02586012|451077695|FG004|Overall Study|Withdrawal by Subject|0|||
125193391|NCT00685399|450330230|FG002|Treatment Period 2|Administrative Problems|1|||
125193392|NCT00685399|450330231|FG003|Treatment Period 2|Administrative Problems|0|||
125193393|NCT00685399|450330232|FG004|Treatment Period 2|Administrative Problems|0|||
125193394|NCT00685399|450330233|FG005|Treatment Period 2|Administrative Problems|0|||
125193395|NCT00685399|450330234|FG006|Treatment Period 2|Administrative Problems|0|||
125193396|NCT00685399|450330235|FG007|Treatment Period 2|Administrative Problems|0|||
125193397|NCT00685399|450330228|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125193398|NCT00685399|450330229|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125246164|NCT01487161|450526720|FG001|Overall Study|missing data|1|||
125246165|NCT01487161|450526721|FG002|Overall Study|missing data|0|||
125246166|NCT01487161|450526722|FG003|Overall Study|missing data|0|||
125246167|NCT02945046|450526723|FG000|Overall Study|Adverse Event|1|||
125246168|NCT02945046|450526724|FG001|Overall Study|Adverse Event|0|||
125246169|NCT02945046|450526725|FG002|Overall Study|Adverse Event|2|||
125246170|NCT02945046|450526723|FG000|Overall Study|Withdrawal by Subject|3|||
125246171|NCT02945046|450526724|FG001|Overall Study|Withdrawal by Subject|3|||
125246172|NCT02945046|450526725|FG002|Overall Study|Withdrawal by Subject|3|||
125246173|NCT02945046|450526723|FG000|Overall Study|Protocol Violation|2|||
125246174|NCT02945046|450526724|FG001|Overall Study|Protocol Violation|3|||
125246175|NCT02945046|450526725|FG002|Overall Study|Protocol Violation|2|||
125246176|NCT02945046|450526723|FG000|Overall Study|Lost to Follow-up|1|||
125246177|NCT02945046|450526724|FG001|Overall Study|Lost to Follow-up|1|||
125246178|NCT02945046|450526725|FG002|Overall Study|Lost to Follow-up|0|||
125246179|NCT02945046|450526723|FG000|Overall Study|Lack of Efficacy|1|||
125246180|NCT02945046|450526724|FG001|Overall Study|Lack of Efficacy|2|||
125246181|NCT02945046|450526725|FG002|Overall Study|Lack of Efficacy|1|||
125246182|NCT02945046|450526723|FG000|Overall Study|Other than specified|5|||
125246183|NCT02945046|450526724|FG001|Overall Study|Other than specified|4|||
125246184|NCT02945046|450526725|FG002|Overall Study|Other than specified|7|||
125246185|NCT03113136|450526726|FG000|Overall Study|Lost to Follow-up|22|||
125246186|NCT03113136|450526727|FG001|Overall Study|Lost to Follow-up|47|||
125246187|NCT03113136|450526728|FG002|Overall Study|Lost to Follow-up|54|||
125246188|NCT03113136|450526726|FG000|Overall Study|Withdrawal by Subject|4|||
125246189|NCT03113136|450526727|FG001|Overall Study|Withdrawal by Subject|13|||
125246190|NCT03113136|450526728|FG002|Overall Study|Withdrawal by Subject|14|||
125246191|NCT03113136|450526726|FG000|Overall Study|Ineligible|0|||
125246192|NCT03113136|450526727|FG001|Overall Study|Ineligible|2|||
125246193|NCT03113136|450526728|FG002|Overall Study|Ineligible|1|||
125246194|NCT03113136|450526726|FG000|Overall Study|Study Team Decision|1|||
125246195|NCT03113136|450526727|FG001|Overall Study|Study Team Decision|4|||
125246196|NCT03113136|450526728|FG002|Overall Study|Study Team Decision|0|||
125246197|NCT02675452|450526729|FG000|Overall Study|Sponsor decision|0|||
125246198|NCT02675452|450526730|FG001|Overall Study|Sponsor decision|0|||
125246199|NCT02675452|450526731|FG002|Overall Study|Sponsor decision|0|||
125246200|NCT02675452|450526732|FG003|Overall Study|Sponsor decision|0|||
125246201|NCT02675452|450526733|FG004|Overall Study|Sponsor decision|0|||
125246202|NCT02675452|450526734|FG005|Overall Study|Sponsor decision|0|||
125246203|NCT02675452|450526735|FG006|Overall Study|Sponsor decision|0|||
125246204|NCT02675452|450526736|FG007|Overall Study|Sponsor decision|0|||
125246205|NCT02675452|450526737|FG008|Overall Study|Sponsor decision|0|||
125246206|NCT02675452|450526738|FG009|Overall Study|Sponsor decision|1|||
125246207|NCT02675452|450526739|FG010|Overall Study|Sponsor decision|0|||
125246208|NCT02675452|450526740|FG011|Overall Study|Sponsor decision|0|||
125246209|NCT02675452|450526741|FG012|Overall Study|Sponsor decision|0|||
125246210|NCT02675452|450526742|FG013|Overall Study|Sponsor decision|2|||
125246211|NCT02675452|450526743|FG014|Overall Study|Sponsor decision|1|||
125246212|NCT02675452|450526744|FG015|Overall Study|Sponsor decision|0|||
125246213|NCT02675452|450526745|FG016|Overall Study|Sponsor decision|1|||
125246214|NCT02675452|450526746|FG017|Overall Study|Sponsor decision|0|||
125246215|NCT02675452|450526747|FG018|Overall Study|Sponsor decision|0|||
125246216|NCT02675452|450526748|FG019|Overall Study|Sponsor decision|0|||
125246217|NCT02675452|450526749|FG020|Overall Study|Sponsor decision|0|||
125246218|NCT02675452|450526750|FG021|Overall Study|Sponsor decision|0|||
125246219|NCT02675452|450526751|FG022|Overall Study|Sponsor decision|0|||
125246220|NCT02675452|450526752|FG023|Overall Study|Sponsor decision|0|||
125246221|NCT02675452|450526753|FG024|Overall Study|Sponsor decision|0|||
125246222|NCT02675452|450526754|FG025|Overall Study|Sponsor decision|0|||
125246223|NCT02675452|450526755|FG026|Overall Study|Sponsor decision|2|||
125246224|NCT02675452|450526756|FG027|Overall Study|Sponsor decision|0|||
125246225|NCT02675452|450526757|FG028|Overall Study|Sponsor decision|0|||
125246226|NCT02675452|450526729|FG000|Overall Study|Withdrawal by Subject|0|||
125246227|NCT02675452|450526730|FG001|Overall Study|Withdrawal by Subject|0|||
125246228|NCT02675452|450526731|FG002|Overall Study|Withdrawal by Subject|0|||
125246229|NCT02675452|450526732|FG003|Overall Study|Withdrawal by Subject|0|||
125246230|NCT02675452|450526733|FG004|Overall Study|Withdrawal by Subject|0|||
125246231|NCT02675452|450526734|FG005|Overall Study|Withdrawal by Subject|0|||
125246232|NCT02675452|450526735|FG006|Overall Study|Withdrawal by Subject|0|||
125246233|NCT02675452|450526736|FG007|Overall Study|Withdrawal by Subject|0|||
125246234|NCT02675452|450526737|FG008|Overall Study|Withdrawal by Subject|0|||
125246235|NCT02675452|450526738|FG009|Overall Study|Withdrawal by Subject|1|||
125246236|NCT02675452|450526739|FG010|Overall Study|Withdrawal by Subject|0|||
125246237|NCT02675452|450526740|FG011|Overall Study|Withdrawal by Subject|1|||
125246238|NCT02675452|450526741|FG012|Overall Study|Withdrawal by Subject|0|||
125246239|NCT02675452|450526742|FG013|Overall Study|Withdrawal by Subject|1|||
125246240|NCT02675452|450526743|FG014|Overall Study|Withdrawal by Subject|1|||
125246241|NCT02675452|450526744|FG015|Overall Study|Withdrawal by Subject|0|||
125246242|NCT02675452|450526745|FG016|Overall Study|Withdrawal by Subject|2|||
125246243|NCT02675452|450526746|FG017|Overall Study|Withdrawal by Subject|0|||
125246244|NCT02675452|450526747|FG018|Overall Study|Withdrawal by Subject|0|||
125246245|NCT02675452|450526748|FG019|Overall Study|Withdrawal by Subject|0|||
125246246|NCT02675452|450526749|FG020|Overall Study|Withdrawal by Subject|0|||
125246247|NCT02675452|450526750|FG021|Overall Study|Withdrawal by Subject|0|||
125246248|NCT02675452|450526751|FG022|Overall Study|Withdrawal by Subject|3|||
125246249|NCT02675452|450526752|FG023|Overall Study|Withdrawal by Subject|0|||
125246250|NCT02675452|450526753|FG024|Overall Study|Withdrawal by Subject|1|||
125246251|NCT02675452|450526754|FG025|Overall Study|Withdrawal by Subject|0|||
125246252|NCT02675452|450526755|FG026|Overall Study|Withdrawal by Subject|1|||
125246253|NCT02675452|450526756|FG027|Overall Study|Withdrawal by Subject|3|||
125246254|NCT02675452|450526757|FG028|Overall Study|Withdrawal by Subject|4|||
125246255|NCT02675452|450526729|FG000|Overall Study|Death|0|||
125394335|NCT02586012|451077696|FG005|Overall Study|Withdrawal by Subject|2|||
125394336|NCT02586012|451077691|FG000|Overall Study|Protocol Violation|0|||
125394337|NCT02586012|451077692|FG001|Overall Study|Protocol Violation|0|||
125394338|NCT02586012|451077693|FG002|Overall Study|Protocol Violation|0|||
125394339|NCT02586012|451077694|FG003|Overall Study|Protocol Violation|0|||
125394340|NCT02586012|451077695|FG004|Overall Study|Protocol Violation|0|||
125394341|NCT02586012|451077696|FG005|Overall Study|Protocol Violation|1|||
125394342|NCT02586012|451077691|FG000|Overall Study|study terminated|0|||
125394343|NCT02586012|451077692|FG001|Overall Study|study terminated|2|||
125394344|NCT02586012|451077693|FG002|Overall Study|study terminated|1|||
125394345|NCT02586012|451077694|FG003|Overall Study|study terminated|1|||
125394346|NCT02586012|451077695|FG004|Overall Study|study terminated|1|||
125394347|NCT02586012|451077696|FG005|Overall Study|study terminated|0|||
125394348|NCT03240575|451077699|FG000|Overall Study|Adverse Event|0|||
125394349|NCT03240575|451077700|FG001|Overall Study|Adverse Event|2|||
125394350|NCT03240575|451077701|FG002|Overall Study|Adverse Event|0|||
125394351|NCT03240575|451077702|FG003|Overall Study|Adverse Event|1|||
125394352|NCT03240575|451077699|FG000|Overall Study|Withdrawal by Subject|2|||
125394353|NCT03240575|451077700|FG001|Overall Study|Withdrawal by Subject|11|||
125394354|NCT03240575|451077701|FG002|Overall Study|Withdrawal by Subject|0|||
125394355|NCT03240575|451077702|FG003|Overall Study|Withdrawal by Subject|1|||
125394356|NCT03240575|451077699|FG000|Overall Study|Other|0|||
125394357|NCT03240575|451077700|FG001|Overall Study|Other|1|||
125394358|NCT03240575|451077701|FG002|Overall Study|Other|0|||
125193399|NCT00685399|450330230|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125394359|NCT03240575|451077702|FG003|Overall Study|Other|0|||
125394360|NCT02342704|451077712|FG000|Overall Study|Physician Decision|0|||
125193400|NCT00685399|450330231|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125193401|NCT00685399|450330232|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125193402|NCT00685399|450330233|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125193403|NCT00685399|450330234|FG006|Treatment Period 2|Withdrawal by Subject|0|||
125193404|NCT00685399|450330235|FG007|Treatment Period 2|Withdrawal by Subject|2|||
125193405|NCT00685399|450330228|FG000|Treatment Period 2|Adverse Event|0|||
125193406|NCT00685399|450330229|FG001|Treatment Period 2|Adverse Event|0|||
125193407|NCT00685399|450330230|FG002|Treatment Period 2|Adverse Event|0|||
125193408|NCT00685399|450330231|FG003|Treatment Period 2|Adverse Event|0|||
125193409|NCT00685399|450330232|FG004|Treatment Period 2|Adverse Event|0|||
125193410|NCT00685399|450330233|FG005|Treatment Period 2|Adverse Event|1|||
125193411|NCT00685399|450330234|FG006|Treatment Period 2|Adverse Event|0|||
125193412|NCT00685399|450330235|FG007|Treatment Period 2|Adverse Event|0|||
125193413|NCT00685399|450330228|FG000|Treatment Period 2|Lack of Efficacy|0|||
125193414|NCT00685399|450330229|FG001|Treatment Period 2|Lack of Efficacy|10|||
125193415|NCT00685399|450330230|FG002|Treatment Period 2|Lack of Efficacy|2|||
125193416|NCT00685399|450330231|FG003|Treatment Period 2|Lack of Efficacy|0|||
125193417|NCT00685399|450330232|FG004|Treatment Period 2|Lack of Efficacy|0|||
125193418|NCT00685399|450330233|FG005|Treatment Period 2|Lack of Efficacy|1|||
125193419|NCT00685399|450330234|FG006|Treatment Period 2|Lack of Efficacy|0|||
125193420|NCT00685399|450330235|FG007|Treatment Period 2|Lack of Efficacy|0|||
125193421|NCT00685399|450330228|FG000|Extension|Administrative Issues|0|||
125193422|NCT00685399|450330229|FG001|Extension|Administrative Issues|0|||
125193423|NCT00685399|450330230|FG002|Extension|Administrative Issues|0|||
125193424|NCT00685399|450330231|FG003|Extension|Administrative Issues|1|||
125193425|NCT00685399|450330232|FG004|Extension|Administrative Issues|0|||
125193426|NCT00685399|450330233|FG005|Extension|Administrative Issues|0|||
125193427|NCT00685399|450330234|FG006|Extension|Administrative Issues|0|||
125193428|NCT00685399|450330235|FG007|Extension|Administrative Issues|0|||
125193429|NCT00685399|450330228|FG000|Extension|Withdrawal by Subject|0|||
125193430|NCT00685399|450330229|FG001|Extension|Withdrawal by Subject|0|||
125193431|NCT00685399|450330230|FG002|Extension|Withdrawal by Subject|0|||
125193432|NCT00685399|450330231|FG003|Extension|Withdrawal by Subject|1|||
125193433|NCT00685399|450330232|FG004|Extension|Withdrawal by Subject|0|||
125193434|NCT00685399|450330233|FG005|Extension|Withdrawal by Subject|0|||
125193435|NCT00685399|450330234|FG006|Extension|Withdrawal by Subject|0|||
125193436|NCT00685399|450330235|FG007|Extension|Withdrawal by Subject|0|||
125193437|NCT00685399|450330228|FG000|Extension|Protocol Violation|0|||
125193438|NCT00685399|450330229|FG001|Extension|Protocol Violation|0|||
125193439|NCT00685399|450330230|FG002|Extension|Protocol Violation|0|||
125193440|NCT00685399|450330231|FG003|Extension|Protocol Violation|1|||
125193441|NCT00685399|450330232|FG004|Extension|Protocol Violation|0|||
125193442|NCT00685399|450330233|FG005|Extension|Protocol Violation|0|||
125193443|NCT00685399|450330234|FG006|Extension|Protocol Violation|0|||
125193444|NCT00685399|450330235|FG007|Extension|Protocol Violation|0|||
125193445|NCT00685399|450330228|FG000|Extension|Lack of Efficacy|0|||
125193446|NCT00685399|450330229|FG001|Extension|Lack of Efficacy|0|||
125394361|NCT02342704|451077713|FG001|Overall Study|Physician Decision|3|||
125394362|NCT02342704|451077712|FG000|Overall Study|Sponsor Termination|49|||
125394363|NCT02342704|451077713|FG001|Overall Study|Sponsor Termination|43|||
125394364|NCT02342704|451077712|FG000|Overall Study|Other|0|||
125394365|NCT02342704|451077713|FG001|Overall Study|Other|1|||
125394366|NCT02342704|451077712|FG000|Overall Study|Withdrawal by Subject|1|||
125394367|NCT02342704|451077713|FG001|Overall Study|Withdrawal by Subject|0|||
125394368|NCT02342704|451077712|FG000|Overall Study|Lost to Follow-up|2|||
125394369|NCT02342704|451077713|FG001|Overall Study|Lost to Follow-up|1|||
125193447|NCT00685399|450330230|FG002|Extension|Lack of Efficacy|0|||
125193448|NCT00685399|450330231|FG003|Extension|Lack of Efficacy|2|||
125193449|NCT00685399|450330232|FG004|Extension|Lack of Efficacy|0|||
125193450|NCT00685399|450330233|FG005|Extension|Lack of Efficacy|0|||
125193451|NCT00685399|450330234|FG006|Extension|Lack of Efficacy|0|||
125193452|NCT00685399|450330235|FG007|Extension|Lack of Efficacy|0|||
125193453|NCT00685399|450330228|FG000|Extension|Adverse Event|0|||
125193454|NCT00685399|450330229|FG001|Extension|Adverse Event|0|||
125193455|NCT00685399|450330230|FG002|Extension|Adverse Event|0|||
125193456|NCT00685399|450330231|FG003|Extension|Adverse Event|2|||
125193457|NCT00685399|450330232|FG004|Extension|Adverse Event|0|||
125193458|NCT00685399|450330233|FG005|Extension|Adverse Event|0|||
125193459|NCT00685399|450330234|FG006|Extension|Adverse Event|0|||
125193460|NCT00685399|450330235|FG007|Extension|Adverse Event|0|||
125193461|NCT00178685|450330237|FG000|Overall Study|Death|3|||
125193462|NCT00178685|450330238|FG001|Overall Study|Death|3|||
125193463|NCT00178685|450330239|FG002|Overall Study|Death|6|||
125193464|NCT00178685|450330237|FG000|Overall Study|Lost to Follow-up|100|||
125193465|NCT00178685|450330238|FG001|Overall Study|Lost to Follow-up|187|||
125193466|NCT00178685|450330239|FG002|Overall Study|Lost to Follow-up|183|||
125193467|NCT00178685|450330237|FG000|Overall Study|Withdrawal by Subject|8|||
125193468|NCT00178685|450330238|FG001|Overall Study|Withdrawal by Subject|14|||
125193469|NCT00178685|450330239|FG002|Overall Study|Withdrawal by Subject|7|||
125193470|NCT01562782|450330242|FG000|Overall Study|Withdrawal by Subject|3|||
125193471|NCT01562782|450330243|FG001|Overall Study|Withdrawal by Subject|3|||
125193472|NCT01562782|450330242|FG000|Overall Study|screen failure|1|||
125193473|NCT01562782|450330243|FG001|Overall Study|screen failure|2|||
125193474|NCT00090493|450330250|FG000|Overall Study|Physician Decision|2|||
125193475|NCT02071706|450330251|FG000|Overall Study|Adverse Event|1|||
125193476|NCT02071706|450330251|FG000|Overall Study|Withdrawal by Subject|2|||
125193477|NCT01908829|450330257|FG000|Overall Study|Adverse Event|13|||
125193478|NCT01908829|450330258|FG001|Overall Study|Adverse Event|11|||
125193479|NCT01908829|450330259|FG002|Overall Study|Adverse Event|13|||
125193480|NCT01908829|450330257|FG000|Overall Study|Lost to Follow-up|4|||
125193481|NCT01908829|450330258|FG001|Overall Study|Lost to Follow-up|2|||
125193482|NCT01908829|450330259|FG002|Overall Study|Lost to Follow-up|1|||
125193483|NCT01908829|450330257|FG000|Overall Study|Randomized no double-blind drug received|1|||
125193484|NCT01908829|450330258|FG001|Overall Study|Randomized no double-blind drug received|0|||
125193485|NCT01908829|450330259|FG002|Overall Study|Randomized no double-blind drug received|1|||
125193486|NCT01908829|450330257|FG000|Overall Study|Discontinued (no EoT page)|2|||
125193487|NCT01908829|450330258|FG001|Overall Study|Discontinued (no EoT page)|0|||
125193488|NCT01908829|450330259|FG002|Overall Study|Discontinued (no EoT page)|0|||
125193489|NCT01908829|450330257|FG000|Overall Study|Miscellaneous|0|||
125193490|NCT01908829|450330258|FG001|Overall Study|Miscellaneous|2|||
125193491|NCT01908829|450330259|FG002|Overall Study|Miscellaneous|0|||
125193492|NCT01908829|450330257|FG000|Overall Study|Protocol Violation|2|||
125193493|NCT01908829|450330258|FG001|Overall Study|Protocol Violation|2|||
125193494|NCT01908829|450330259|FG002|Overall Study|Protocol Violation|0|||
125193495|NCT01908829|450330257|FG000|Overall Study|Lack of Efficacy|1|||
125193496|NCT01908829|450330258|FG001|Overall Study|Lack of Efficacy|3|||
125193497|NCT01908829|450330259|FG002|Overall Study|Lack of Efficacy|2|||
125193498|NCT01908829|450330257|FG000|Overall Study|Withdrawal by Subject|26|||
125193499|NCT01908829|450330258|FG001|Overall Study|Withdrawal by Subject|29|||
125193500|NCT01908829|450330259|FG002|Overall Study|Withdrawal by Subject|22|||
125193501|NCT02792192|450330260|FG000|Overall Study|Death|1|||
125193502|NCT02792192|450330261|FG001|Overall Study|Death|0|||
125193503|NCT02792192|450330262|FG002|Overall Study|Death|0|||
125193504|NCT02792192|450330263|FG003|Overall Study|Death|0|||
125193505|NCT02792192|450330260|FG000|Overall Study|Informed Consent Withdrawn|4|||
125193506|NCT02792192|450330261|FG001|Overall Study|Informed Consent Withdrawn|0|||
125193507|NCT02792192|450330262|FG002|Overall Study|Informed Consent Withdrawn|0|||
125193508|NCT02792192|450330263|FG003|Overall Study|Informed Consent Withdrawn|0|||
125193509|NCT02792192|450330260|FG000|Overall Study|Physician Decision|1|||
125193510|NCT02792192|450330261|FG001|Overall Study|Physician Decision|0|||
125193511|NCT02792192|450330262|FG002|Overall Study|Physician Decision|0|||
125193512|NCT02792192|450330263|FG003|Overall Study|Physician Decision|0|||
125193513|NCT02792192|450330260|FG000|Overall Study|Progressive Disease|0|||
125193514|NCT02792192|450330261|FG001|Overall Study|Progressive Disease|1|||
125193515|NCT02792192|450330262|FG002|Overall Study|Progressive Disease|0|||
125394370|NCT02342704|451077712|FG000|Overall Study|Adverse Event|1|||
125193516|NCT02792192|450330263|FG003|Overall Study|Progressive Disease|0|||
125193517|NCT02792192|450330260|FG000|Overall Study|Study Terminated By Sponsor|6|||
125193518|NCT02792192|450330261|FG001|Overall Study|Study Terminated By Sponsor|10|||
125193519|NCT02792192|450330262|FG002|Overall Study|Study Terminated By Sponsor|0|||
125193520|NCT02792192|450330263|FG003|Overall Study|Study Terminated By Sponsor|0|||
125193521|NCT02320058|450330264|FG000|Overall Study|Death|25|||
125193522|NCT02320058|450330265|FG001|Overall Study|Death|10|||
125193523|NCT02320058|450330264|FG000|Overall Study|Lost to Follow-up|4|||
125193524|NCT02320058|450330265|FG001|Overall Study|Lost to Follow-up|0|||
125193525|NCT02320058|450330264|FG000|Overall Study|Other reasons|4|||
125193526|NCT02320058|450330265|FG001|Overall Study|Other reasons|1|||
125193527|NCT02320058|450330264|FG000|Overall Study|Withdrawal by Subject|8|||
125193528|NCT02320058|450330265|FG001|Overall Study|Withdrawal by Subject|2|||
125193529|NCT02320058|450330264|FG000|Overall Study|Not reported|1|||
125246256|NCT02675452|450526730|FG001|Overall Study|Death|0|||
125246257|NCT02675452|450526731|FG002|Overall Study|Death|1|||
125246258|NCT02675452|450526732|FG003|Overall Study|Death|0|||
125246259|NCT02675452|450526733|FG004|Overall Study|Death|0|||
125246260|NCT02675452|450526734|FG005|Overall Study|Death|1|||
125246261|NCT02675452|450526735|FG006|Overall Study|Death|0|||
125246262|NCT02675452|450526736|FG007|Overall Study|Death|0|||
125246263|NCT02675452|450526737|FG008|Overall Study|Death|1|||
125246264|NCT02675452|450526738|FG009|Overall Study|Death|0|||
125246265|NCT02675452|450526739|FG010|Overall Study|Death|0|||
125246266|NCT02675452|450526740|FG011|Overall Study|Death|0|||
125246267|NCT02675452|450526741|FG012|Overall Study|Death|1|||
125246268|NCT02675452|450526742|FG013|Overall Study|Death|0|||
125246269|NCT02675452|450526743|FG014|Overall Study|Death|0|||
125246270|NCT02675452|450526744|FG015|Overall Study|Death|2|||
125246271|NCT02675452|450526745|FG016|Overall Study|Death|0|||
125246272|NCT02675452|450526746|FG017|Overall Study|Death|0|||
125246273|NCT02675452|450526747|FG018|Overall Study|Death|4|||
125246274|NCT02675452|450526748|FG019|Overall Study|Death|3|||
125246275|NCT02675452|450526749|FG020|Overall Study|Death|3|||
125246276|NCT02675452|450526750|FG021|Overall Study|Death|3|||
125246277|NCT02675452|450526751|FG022|Overall Study|Death|7|||
125246278|NCT02675452|450526752|FG023|Overall Study|Death|5|||
125246279|NCT02675452|450526753|FG024|Overall Study|Death|3|||
125246280|NCT02675452|450526754|FG025|Overall Study|Death|4|||
125246281|NCT02675452|450526755|FG026|Overall Study|Death|7|||
125246282|NCT02675452|450526756|FG027|Overall Study|Death|6|||
125246283|NCT02675452|450526757|FG028|Overall Study|Death|9|||
125246284|NCT02675452|450526729|FG000|Overall Study|Lost to Follow-up|0|||
125246285|NCT02675452|450526730|FG001|Overall Study|Lost to Follow-up|1|||
125246286|NCT02675452|450526731|FG002|Overall Study|Lost to Follow-up|0|||
125246287|NCT02675452|450526732|FG003|Overall Study|Lost to Follow-up|0|||
125246288|NCT02675452|450526733|FG004|Overall Study|Lost to Follow-up|0|||
125246289|NCT02675452|450526734|FG005|Overall Study|Lost to Follow-up|0|||
125246290|NCT02675452|450526735|FG006|Overall Study|Lost to Follow-up|0|||
125246291|NCT02675452|450526736|FG007|Overall Study|Lost to Follow-up|0|||
125246292|NCT02675452|450526737|FG008|Overall Study|Lost to Follow-up|0|||
125246293|NCT02675452|450526738|FG009|Overall Study|Lost to Follow-up|0|||
125246294|NCT02675452|450526739|FG010|Overall Study|Lost to Follow-up|0|||
125246295|NCT02675452|450526740|FG011|Overall Study|Lost to Follow-up|0|||
125193530|NCT02320058|450330265|FG001|Overall Study|Not reported|0|||
125193531|NCT01339923|450330266|FG000|Overall Study|Adverse Event|1|||
125193532|NCT01339923|450330267|FG001|Overall Study|Adverse Event|1|||
125193533|NCT01339923|450330268|FG002|Overall Study|Adverse Event|1|||
125193534|NCT01339923|450330269|FG003|Overall Study|Adverse Event|0|||
125193535|NCT01339923|450330270|FG004|Overall Study|Adverse Event|0|||
125193536|NCT01339923|450330271|FG005|Overall Study|Adverse Event|0|||
125193537|NCT01339923|450330272|FG006|Overall Study|Adverse Event|1|||
125193538|NCT01339923|450330266|FG000|Overall Study|Inappropriate Enrollment|1|||
125193539|NCT01339923|450330267|FG001|Overall Study|Inappropriate Enrollment|0|||
125193540|NCT01339923|450330268|FG002|Overall Study|Inappropriate Enrollment|0|||
125193541|NCT01339923|450330269|FG003|Overall Study|Inappropriate Enrollment|0|||
125193542|NCT01339923|450330270|FG004|Overall Study|Inappropriate Enrollment|0|||
125193543|NCT01339923|450330271|FG005|Overall Study|Inappropriate Enrollment|1|||
125193544|NCT01339923|450330272|FG006|Overall Study|Inappropriate Enrollment|0|||
125193545|NCT01339923|450330266|FG000|Overall Study|Lost to Follow-up|4|||
125193546|NCT01339923|450330267|FG001|Overall Study|Lost to Follow-up|4|||
125193547|NCT01339923|450330268|FG002|Overall Study|Lost to Follow-up|0|||
125193548|NCT01339923|450330269|FG003|Overall Study|Lost to Follow-up|3|||
125193549|NCT01339923|450330270|FG004|Overall Study|Lost to Follow-up|1|||
125193550|NCT01339923|450330271|FG005|Overall Study|Lost to Follow-up|1|||
125193551|NCT01339923|450330272|FG006|Overall Study|Lost to Follow-up|5|||
125193552|NCT01339923|450330266|FG000|Overall Study|Protocol Violation|0|||
125193553|NCT01339923|450330267|FG001|Overall Study|Protocol Violation|0|||
125193554|NCT01339923|450330268|FG002|Overall Study|Protocol Violation|0|||
125193555|NCT01339923|450330269|FG003|Overall Study|Protocol Violation|0|||
125193556|NCT01339923|450330270|FG004|Overall Study|Protocol Violation|0|||
125193557|NCT01339923|450330271|FG005|Overall Study|Protocol Violation|3|||
125193558|NCT01339923|450330272|FG006|Overall Study|Protocol Violation|1|||
125193559|NCT01339923|450330266|FG000|Overall Study|Unable to Classify|1|||
125193560|NCT01339923|450330267|FG001|Overall Study|Unable to Classify|0|||
125193561|NCT01339923|450330268|FG002|Overall Study|Unable to Classify|1|||
125193562|NCT01339923|450330269|FG003|Overall Study|Unable to Classify|0|||
125193563|NCT01339923|450330270|FG004|Overall Study|Unable to Classify|0|||
125193564|NCT01339923|450330271|FG005|Overall Study|Unable to Classify|1|||
125394371|NCT02342704|451077713|FG001|Overall Study|Adverse Event|3|||
125394372|NCT02347527|451077715|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
125394373|NCT02347527|451077716|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
125394374|NCT02347527|451077717|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
125394375|NCT02347527|451077718|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
125394376|NCT02347527|451077715|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
125394377|NCT02347527|451077716|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
125394378|NCT02347527|451077717|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
125394379|NCT02347527|451077718|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
125394380|NCT02347527|451077715|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
125394381|NCT02347527|451077716|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
125394382|NCT02347527|451077717|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
125394383|NCT02347527|451077718|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
125394384|NCT02347527|451077715|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
125394385|NCT02347527|451077716|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
125394386|NCT02347527|451077717|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
125394387|NCT02347527|451077718|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
125394388|NCT02347527|451077715|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
125394389|NCT02347527|451077716|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
125394390|NCT02347527|451077717|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
125394391|NCT02347527|451077718|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
125394392|NCT01632891|451077719|FG000|Overall Study|Lost to Follow-up|0|||
125394393|NCT01632891|451077720|FG001|Overall Study|Lost to Follow-up|1|||
125394394|NCT01632891|451077719|FG000|Overall Study|Withdrawal by Subject|1|||
125394395|NCT01632891|451077720|FG001|Overall Study|Withdrawal by Subject|0|||
125394396|NCT01466270|451077721|FG000|Overall Study|Withdrawal by Subject|4|||
125394397|NCT01466270|451077722|FG001|Overall Study|Withdrawal by Subject|1|||
125394398|NCT01466270|451077721|FG000|Overall Study|Physician Decision|1|||
125394399|NCT01466270|451077722|FG001|Overall Study|Physician Decision|0|||
125394400|NCT01466270|451077721|FG000|Overall Study|Lost to Follow-up|1|||
125394401|NCT01466270|451077722|FG001|Overall Study|Lost to Follow-up|3|||
125394402|NCT01466270|451077721|FG000|Overall Study|Progression|1|||
125394403|NCT01466270|451077722|FG001|Overall Study|Progression|0|||
125394404|NCT01466270|451077721|FG000|Overall Study|Toxicity|4|||
125394405|NCT01466270|451077722|FG001|Overall Study|Toxicity|1|||
125394406|NCT01466270|451077721|FG000|Overall Study|Multiple|1|||
125394407|NCT01466270|451077722|FG001|Overall Study|Multiple|1|||
125394408|NCT02118428|451077727|FG000|Overall Study|Physician Decision|0|||
125394409|NCT02118428|451077728|FG001|Overall Study|Physician Decision|1|||
125394410|NCT02118428|451077729|FG002|Overall Study|Physician Decision|0|||
125394411|NCT02118428|451077727|FG000|Overall Study|Withdrawal by Subject|2|||
125394412|NCT02118428|451077728|FG001|Overall Study|Withdrawal by Subject|2|||
125394413|NCT02118428|451077729|FG002|Overall Study|Withdrawal by Subject|0|||
125394414|NCT02118428|451077727|FG000|Overall Study|Death|7|||
125394415|NCT02118428|451077728|FG001|Overall Study|Death|5|||
125394416|NCT02118428|451077729|FG002|Overall Study|Death|0|||
125394417|NCT02118428|451077727|FG000|Overall Study|Lost to Follow-up|3|||
125394418|NCT02118428|451077728|FG001|Overall Study|Lost to Follow-up|1|||
125394419|NCT02118428|451077729|FG002|Overall Study|Lost to Follow-up|0|||
125394420|NCT02118428|451077727|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
125394421|NCT02118428|451077728|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
125394422|NCT02118428|451077729|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
125394423|NCT04171414|451077730|FG000|Overall Study|Death|1|||
125394424|NCT04171414|451077730|FG000|Overall Study|Withdrawal by Subject|1|||
125394425|NCT02884089|451077737|FG000|Period 1|Dosing error|2|||
125394426|NCT02884089|451077738|FG001|Period 1|Dosing error|2|||
125394427|NCT02884089|451077739|FG002|Period 1|Dosing error|0|||
125394428|NCT02884089|451077740|FG003|Period 1|Dosing error|0|||
125394429|NCT02884089|451077737|FG000|Washout Period 1|Lost to Follow-up|0|||
125394430|NCT02884089|451077738|FG001|Washout Period 1|Lost to Follow-up|1|||
125394431|NCT02884089|451077739|FG002|Washout Period 1|Lost to Follow-up|0|||
125193565|NCT01339923|450330272|FG006|Overall Study|Unable to Classify|5|||
125193566|NCT01339923|450330266|FG000|Overall Study|Withdrawal by Subject|7|||
125394432|NCT02884089|451077740|FG003|Washout Period 1|Lost to Follow-up|1|||
125394433|NCT02884089|451077737|FG000|Washout Period 1|Withdrawal by Subject|0|||
125394434|NCT02884089|451077738|FG001|Washout Period 1|Withdrawal by Subject|1|||
125394435|NCT02884089|451077739|FG002|Washout Period 1|Withdrawal by Subject|0|||
125394436|NCT02884089|451077740|FG003|Washout Period 1|Withdrawal by Subject|0|||
125394437|NCT02884089|451077737|FG000|Period 2|Adverse Event|1|||
125394438|NCT02884089|451077738|FG001|Period 2|Adverse Event|0|||
125394439|NCT02884089|451077739|FG002|Period 2|Adverse Event|0|||
125193567|NCT01339923|450330267|FG001|Overall Study|Withdrawal by Subject|11|||
125246296|NCT02675452|450526741|FG012|Overall Study|Lost to Follow-up|1|||
125246297|NCT02675452|450526742|FG013|Overall Study|Lost to Follow-up|0|||
125246298|NCT02675452|450526743|FG014|Overall Study|Lost to Follow-up|0|||
125246299|NCT02675452|450526744|FG015|Overall Study|Lost to Follow-up|0|||
125246300|NCT02675452|450526745|FG016|Overall Study|Lost to Follow-up|0|||
125246301|NCT02675452|450526746|FG017|Overall Study|Lost to Follow-up|0|||
125246302|NCT02675452|450526747|FG018|Overall Study|Lost to Follow-up|0|||
125246303|NCT02675452|450526748|FG019|Overall Study|Lost to Follow-up|0|||
125246304|NCT02675452|450526749|FG020|Overall Study|Lost to Follow-up|0|||
125246305|NCT02675452|450526750|FG021|Overall Study|Lost to Follow-up|0|||
125246306|NCT02675452|450526751|FG022|Overall Study|Lost to Follow-up|0|||
125246307|NCT02675452|450526752|FG023|Overall Study|Lost to Follow-up|0|||
125246308|NCT02675452|450526753|FG024|Overall Study|Lost to Follow-up|0|||
125246309|NCT02675452|450526754|FG025|Overall Study|Lost to Follow-up|0|||
125246310|NCT02675452|450526755|FG026|Overall Study|Lost to Follow-up|1|||
125246311|NCT02675452|450526756|FG027|Overall Study|Lost to Follow-up|0|||
125246312|NCT02675452|450526757|FG028|Overall Study|Lost to Follow-up|0|||
125246313|NCT02675452|450526729|FG000|Overall Study|Other|0|||
125246314|NCT02675452|450526730|FG001|Overall Study|Other|0|||
125246315|NCT02675452|450526731|FG002|Overall Study|Other|0|||
125246316|NCT02675452|450526732|FG003|Overall Study|Other|0|||
125246317|NCT02675452|450526733|FG004|Overall Study|Other|0|||
125246318|NCT02675452|450526734|FG005|Overall Study|Other|0|||
125246319|NCT02675452|450526735|FG006|Overall Study|Other|0|||
125246320|NCT02675452|450526736|FG007|Overall Study|Other|0|||
125246321|NCT02675452|450526737|FG008|Overall Study|Other|0|||
125246322|NCT02675452|450526738|FG009|Overall Study|Other|0|||
125246323|NCT02675452|450526739|FG010|Overall Study|Other|0|||
125246324|NCT02675452|450526740|FG011|Overall Study|Other|0|||
125246325|NCT02675452|450526741|FG012|Overall Study|Other|0|||
125246326|NCT02675452|450526742|FG013|Overall Study|Other|0|||
125246327|NCT02675452|450526743|FG014|Overall Study|Other|0|||
125246328|NCT02675452|450526744|FG015|Overall Study|Other|0|||
125246329|NCT02675452|450526745|FG016|Overall Study|Other|0|||
125246330|NCT02675452|450526746|FG017|Overall Study|Other|0|||
125246331|NCT02675452|450526747|FG018|Overall Study|Other|0|||
125246332|NCT02675452|450526748|FG019|Overall Study|Other|0|||
125246333|NCT02675452|450526749|FG020|Overall Study|Other|0|||
125246334|NCT02675452|450526750|FG021|Overall Study|Other|0|||
125246335|NCT02675452|450526751|FG022|Overall Study|Other|0|||
125246336|NCT02675452|450526752|FG023|Overall Study|Other|0|||
125246337|NCT02675452|450526753|FG024|Overall Study|Other|0|||
125246338|NCT02675452|450526754|FG025|Overall Study|Other|0|||
125246339|NCT02675452|450526755|FG026|Overall Study|Other|1|||
125246340|NCT02675452|450526756|FG027|Overall Study|Other|0|||
125246341|NCT02675452|450526757|FG028|Overall Study|Other|0|||
125246342|NCT02939781|450526758|FG000|Overall Study|Protocol Violation|8|||
125246343|NCT02939781|450526758|FG000|Overall Study|Withdrawal by Subject|1|||
125246344|NCT02569242|450526760|FG000|Overall Study|Death|1|||
125246345|NCT02569242|450526761|FG001|Overall Study|Death|0|||
125246346|NCT02569242|450526760|FG000|Overall Study|Withdrawal by Subject|0|||
125246347|NCT02569242|450526761|FG001|Overall Study|Withdrawal by Subject|1|||
125246348|NCT00689052|450526762|FG000|Overall Study|Adverse Event|4|||
125246349|NCT00689052|450526763|FG001|Overall Study|Adverse Event|6|||
125246350|NCT00689052|450526762|FG000|Overall Study|Protocol Violation|1|||
125246351|NCT00689052|450526763|FG001|Overall Study|Protocol Violation|0|||
125246352|NCT00689052|450526762|FG000|Overall Study|Lost to Follow-up|2|||
125246353|NCT00689052|450526763|FG001|Overall Study|Lost to Follow-up|0|||
125246354|NCT00689052|450526762|FG000|Overall Study|Withdrawal by Subject|2|||
125246355|NCT00689052|450526763|FG001|Overall Study|Withdrawal by Subject|0|||
125246356|NCT00689052|450526762|FG000|Overall Study|Early termination of the trial|22|||
125246357|NCT00689052|450526763|FG001|Overall Study|Early termination of the trial|24|||
125246358|NCT03003468|450526764|FG000|Overall Study|Withdrawal by Subject|0|||
125246359|NCT03003468|450526765|FG001|Overall Study|Withdrawal by Subject|0|||
125246360|NCT03003468|450526766|FG002|Overall Study|Withdrawal by Subject|1|||
125246361|NCT03003468|450526764|FG000|Overall Study|No measurable lesions|0|||
125246362|NCT03003468|450526765|FG001|Overall Study|No measurable lesions|0|||
125246363|NCT03003468|450526766|FG002|Overall Study|No measurable lesions|1|||
125246364|NCT02114684|450526767|FG000|Overall Study|Death|6|||
125246365|NCT02114684|450526768|FG001|Overall Study|Death|4|||
125246366|NCT02114684|450526767|FG000|Overall Study|Lost to Follow-up|1|||
125246367|NCT02114684|450526768|FG001|Overall Study|Lost to Follow-up|2|||
125246368|NCT02114684|450526767|FG000|Overall Study|Withdrawal by Subject|1|||
125246369|NCT02114684|450526768|FG001|Overall Study|Withdrawal by Subject|2|||
125246370|NCT02114684|450526767|FG000|Overall Study|Relocation|3|||
125246371|NCT02114684|450526768|FG001|Overall Study|Relocation|1|||
125246372|NCT02114684|450526767|FG000|Overall Study|Rifampicin resistant on culture|0|||
125246373|NCT02114684|450526768|FG001|Overall Study|Rifampicin resistant on culture|1|||
125246374|NCT02114684|450526767|FG000|Overall Study|Patient Incarcerated|1|||
125246375|NCT02114684|450526768|FG001|Overall Study|Patient Incarcerated|0|||
125246376|NCT04625972|450526771|FG000|Overall Study|Death|3|||
125246377|NCT04625972|450526772|FG001|Overall Study|Death|2|||
125394440|NCT02884089|451077740|FG003|Period 2|Adverse Event|0|||
125394441|NCT02884089|451077737|FG000|Period 3|Withdrawal by Subject|0|||
125394442|NCT02884089|451077738|FG001|Period 3|Withdrawal by Subject|0|||
125394443|NCT02884089|451077739|FG002|Period 3|Withdrawal by Subject|1|||
125394444|NCT02884089|451077740|FG003|Period 3|Withdrawal by Subject|0|||
125394445|NCT02884089|451077737|FG000|Washout Period 3|Withdrawal by Subject|0|||
125394446|NCT02884089|451077738|FG001|Washout Period 3|Withdrawal by Subject|0|||
125246378|NCT04625972|450526771|FG000|Overall Study|Lost to Follow-up|82|||
125246379|NCT04625972|450526772|FG001|Overall Study|Lost to Follow-up|38|||
125246380|NCT04625972|450526771|FG000|Overall Study|Physician Decision|2|||
125246381|NCT04625972|450526772|FG001|Overall Study|Physician Decision|0|||
125246382|NCT04625972|450526771|FG000|Overall Study|Protocol Violation|0|||
125246383|NCT04625972|450526772|FG001|Overall Study|Protocol Violation|1|||
125246384|NCT04625972|450526771|FG000|Overall Study|Withdrawal by Subject|37|||
125246385|NCT04625972|450526772|FG001|Overall Study|Withdrawal by Subject|24|||
125246386|NCT04625972|450526771|FG000|Overall Study|Not specified elsewhere|8|||
125246387|NCT04625972|450526772|FG001|Overall Study|Not specified elsewhere|6|||
125246388|NCT03259308|450526780|FG000|Overall Study|Adverse Event|5|||
125394447|NCT02884089|451077739|FG002|Washout Period 3|Withdrawal by Subject|1|||
125394448|NCT02884089|451077740|FG003|Washout Period 3|Withdrawal by Subject|0|||
125193568|NCT01339923|450330268|FG002|Overall Study|Withdrawal by Subject|6|||
125193569|NCT01339923|450330269|FG003|Overall Study|Withdrawal by Subject|1|||
125193570|NCT01339923|450330270|FG004|Overall Study|Withdrawal by Subject|4|||
125193571|NCT01339923|450330271|FG005|Overall Study|Withdrawal by Subject|3|||
125193572|NCT01339923|450330272|FG006|Overall Study|Withdrawal by Subject|2|||
125193573|NCT01430403|450330273|FG000|Overall Study|Lost to Follow-up|5|||
125193574|NCT01430403|450330274|FG001|Overall Study|Lost to Follow-up|5|||
125193575|NCT01430403|450330275|FG002|Overall Study|Lost to Follow-up|3|||
125193576|NCT01430403|450330273|FG000|Overall Study|Physician Decision|1|||
125193577|NCT01430403|450330274|FG001|Overall Study|Physician Decision|0|||
125193578|NCT01430403|450330275|FG002|Overall Study|Physician Decision|0|||
125193579|NCT01430403|450330273|FG000|Overall Study|Protocol Violation|2|||
125193580|NCT01430403|450330274|FG001|Overall Study|Protocol Violation|3|||
125193581|NCT01430403|450330275|FG002|Overall Study|Protocol Violation|2|||
125193582|NCT01430403|450330273|FG000|Overall Study|Withdrawal by Subject|9|||
125193583|NCT01430403|450330274|FG001|Overall Study|Withdrawal by Subject|1|||
125193584|NCT01430403|450330275|FG002|Overall Study|Withdrawal by Subject|3|||
125193585|NCT00403481|450330276|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
125193586|NCT00403481|450330276|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
125193587|NCT00403481|450330276|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
125193588|NCT00403481|450330276|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
125193589|NCT00403481|450330276|FG000|Olm 40 mg|Adverse Event|2|||
125193590|NCT00403481|450330276|FG000|Olm 40 mg|Protocol Violation|1|||
125193591|NCT00403481|450330276|FG000|Olm 40 mg|Withdrawal by Subject|1|||
125193592|NCT00403481|450330276|FG000|Olm 40 mg|Other|1|||
125193593|NCT00403481|450330276|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
125193594|NCT00403481|450330276|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
125193595|NCT00403481|450330276|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
125193596|NCT00403481|450330276|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
125193597|NCT00403481|450330276|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
125193598|NCT00403481|450330276|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
125193599|NCT02099110|450330279|FG000|Overall Study|Protocol Violation|2|||
125193600|NCT02099110|450330280|FG001|Overall Study|Protocol Violation|1|||
125193601|NCT02099110|450330281|FG002|Overall Study|Protocol Violation|0|||
125193602|NCT02099110|450330282|FG003|Overall Study|Protocol Violation|3|||
125193603|NCT02099110|450330283|FG004|Overall Study|Protocol Violation|1|||
125193604|NCT02099110|450330279|FG000|Overall Study|Participant moved|1|||
125193605|NCT02099110|450330280|FG001|Overall Study|Participant moved|1|||
125193606|NCT02099110|450330281|FG002|Overall Study|Participant moved|1|||
125193607|NCT02099110|450330282|FG003|Overall Study|Participant moved|0|||
125193608|NCT02099110|450330283|FG004|Overall Study|Participant moved|2|||
125193609|NCT02099110|450330279|FG000|Overall Study|Withdrawal by Subject|7|||
125193610|NCT02099110|450330280|FG001|Overall Study|Withdrawal by Subject|11|||
125193611|NCT02099110|450330281|FG002|Overall Study|Withdrawal by Subject|13|||
125246389|NCT03259308|450526781|FG001|Overall Study|Adverse Event|4|||
125394449|NCT02884089|451077737|FG000|Washout Period 3|Lost to Follow-up|0|||
125193612|NCT02099110|450330282|FG003|Overall Study|Withdrawal by Subject|9|||
125193613|NCT02099110|450330283|FG004|Overall Study|Withdrawal by Subject|13|||
125193614|NCT02099110|450330279|FG000|Overall Study|Adverse Event|3|||
125193615|NCT02099110|450330280|FG001|Overall Study|Adverse Event|5|||
125193616|NCT02099110|450330281|FG002|Overall Study|Adverse Event|2|||
125193617|NCT02099110|450330282|FG003|Overall Study|Adverse Event|3|||
125193618|NCT02099110|450330283|FG004|Overall Study|Adverse Event|2|||
125193619|NCT02099110|450330279|FG000|Overall Study|Lost to Follow-up|6|||
125246390|NCT03259308|450526782|FG002|Overall Study|Adverse Event|1|||
125246391|NCT03259308|450526780|FG000|Overall Study|Withdrawal by Subject|2|||
125394450|NCT02884089|451077738|FG001|Washout Period 3|Lost to Follow-up|0|||
125193620|NCT02099110|450330280|FG001|Overall Study|Lost to Follow-up|12|||
125193621|NCT02099110|450330281|FG002|Overall Study|Lost to Follow-up|11|||
125193622|NCT02099110|450330282|FG003|Overall Study|Lost to Follow-up|5|||
125193623|NCT02099110|450330283|FG004|Overall Study|Lost to Follow-up|6|||
125193624|NCT02099110|450330279|FG000|Overall Study|Death|0|||
125193625|NCT02099110|450330280|FG001|Overall Study|Death|1|||
125193626|NCT02099110|450330281|FG002|Overall Study|Death|0|||
125193627|NCT02099110|450330282|FG003|Overall Study|Death|0|||
125193628|NCT02099110|450330283|FG004|Overall Study|Death|0|||
125193629|NCT02099110|450330279|FG000|Overall Study|Screen failure|0|||
125443554|NCT02561455|451252174|FG003|Overall Study|Withdrawal by Subject|0|||
125443555|NCT02561455|451252171|FG000|Overall Study|Disease Progression|0|||
125193630|NCT02099110|450330280|FG001|Overall Study|Screen failure|0|||
125193631|NCT02099110|450330281|FG002|Overall Study|Screen failure|0|||
125193632|NCT02099110|450330282|FG003|Overall Study|Screen failure|0|||
125193633|NCT02099110|450330283|FG004|Overall Study|Screen failure|1|||
125193634|NCT02099110|450330279|FG000|Overall Study|Non-compliance with study drug|2|||
125193635|NCT02099110|450330280|FG001|Overall Study|Non-compliance with study drug|0|||
125193636|NCT02099110|450330281|FG002|Overall Study|Non-compliance with study drug|0|||
125193637|NCT02099110|450330282|FG003|Overall Study|Non-compliance with study drug|0|||
125193638|NCT02099110|450330283|FG004|Overall Study|Non-compliance with study drug|1|||
125193639|NCT02099110|450330279|FG000|Overall Study|Physician Decision|3|||
125193640|NCT02099110|450330280|FG001|Overall Study|Physician Decision|0|||
125193641|NCT02099110|450330281|FG002|Overall Study|Physician Decision|1|||
125193642|NCT02099110|450330282|FG003|Overall Study|Physician Decision|2|||
125193643|NCT02099110|450330283|FG004|Overall Study|Physician Decision|1|||
125193644|NCT02887248|450330287|FG000|Overall Study|Withdrawal by Subject|1|||
125193645|NCT02887248|450330287|FG000|Overall Study|Adverse Event|1|||
125193646|NCT02887248|450330287|FG000|Overall Study|Progressive Disease|1|||
125193647|NCT01166438|450330288|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
125193648|NCT01166438|450330289|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
125193649|NCT01166438|450330288|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
125193650|NCT01166438|450330289|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
125193651|NCT01166438|450330288|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
125193652|NCT01166438|450330289|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
125193653|NCT01166438|450330288|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
125193654|NCT01166438|450330289|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
125193655|NCT01166438|450330288|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
125193656|NCT01166438|450330289|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
125193657|NCT01166438|450330288|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
125193658|NCT01166438|450330289|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
125193659|NCT01377922|450330294|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
125193660|NCT01377922|450330295|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
125193661|NCT03170362|450330296|FG000|Overall Study|Death|2|||
125193662|NCT03170362|450330297|FG001|Overall Study|Death|2|||
125193663|NCT03170362|450330296|FG000|Overall Study|Withdrawal by Subject|23|||
125193664|NCT03170362|450330297|FG001|Overall Study|Withdrawal by Subject|22|||
125193665|NCT03170362|450330296|FG000|Overall Study|Lost to Follow-up|187|||
125193666|NCT03170362|450330297|FG001|Overall Study|Lost to Follow-up|167|||
125193667|NCT03682848|450330298|FG000|Overall Study|Withdrawal by Subject|2|||
125193668|NCT03682848|450330298|FG000|Overall Study|Site closed|5|||
125193669|NCT03682848|450330298|FG000|Overall Study|Protocol Deviation|1|||
125193670|NCT03682848|450330298|FG000|Overall Study|Adverse Event|1|||
125193671|NCT00454363|450330299|FG000|Overall Study|Adverse Event|1|||
125193672|NCT00454363|450330300|FG001|Overall Study|Adverse Event|2|||
125193673|NCT00454363|450330299|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
125193674|NCT00454363|450330300|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
125193675|NCT03482453|450330301|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193676|NCT03482453|450330302|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193677|NCT03482453|450330303|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125443556|NCT02561455|451252172|FG001|Overall Study|Disease Progression|1|||
125193678|NCT03482453|450330304|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193679|NCT03482453|450330305|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193680|NCT03482453|450330306|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193681|NCT03482453|450330307|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193682|NCT03482453|450330308|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193683|NCT03482453|450330309|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193684|NCT03482453|450330310|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193685|NCT03482453|450330311|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
125193686|NCT03482453|450330312|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
125193687|NCT02547220|450330318|FG000|Overall Study|Withdrawal by Subject|1|||
125193688|NCT02547220|450330319|FG001|Overall Study|Withdrawal by Subject|0|||
125193689|NCT02547220|450330318|FG000|Overall Study|Study terminated by sponsor|18|||
125193690|NCT02547220|450330319|FG001|Overall Study|Study terminated by sponsor|20|||
125193691|NCT00550043|450330320|FG000|Overall Study|Adverse Event|0|||
125193692|NCT00550043|450330321|FG001|Overall Study|Adverse Event|0|||
125193693|NCT00550043|450330322|FG002|Overall Study|Adverse Event|0|||
125193694|NCT00550043|450330323|FG003|Overall Study|Adverse Event|1|||
125193695|NCT00550043|450330324|FG004|Overall Study|Adverse Event|1|||
125193696|NCT00550043|450330320|FG000|Overall Study|Subject Withdrew Consent|0|||
125193697|NCT00550043|450330321|FG001|Overall Study|Subject Withdrew Consent|2|||
125193698|NCT00550043|450330322|FG002|Overall Study|Subject Withdrew Consent|1|||
125193699|NCT00550043|450330323|FG003|Overall Study|Subject Withdrew Consent|0|||
125193700|NCT00550043|450330324|FG004|Overall Study|Subject Withdrew Consent|0|||
125193701|NCT00550043|450330320|FG000|Overall Study|Other Reasons- Unspecified|0|||
125193702|NCT00550043|450330321|FG001|Overall Study|Other Reasons- Unspecified|1|||
125193703|NCT00550043|450330322|FG002|Overall Study|Other Reasons- Unspecified|0|||
125193704|NCT00550043|450330323|FG003|Overall Study|Other Reasons- Unspecified|1|||
125193705|NCT00550043|450330324|FG004|Overall Study|Other Reasons- Unspecified|0|||
125193706|NCT02887183|450330326|FG000|Overall Study|Adverse Event|44|||
125193707|NCT02887183|450330326|FG000|Overall Study|Death|30|||
125193708|NCT02887183|450330326|FG000|Overall Study|Pregnancy|1|||
125193709|NCT02887183|450330326|FG000|Overall Study|Protocol Violation|6|||
125193710|NCT02887183|450330326|FG000|Overall Study|Technical Problems|2|||
125193711|NCT02887183|450330326|FG000|Overall Study|Lost to Follow-up|13|||
125193712|NCT02887183|450330326|FG000|Overall Study|Physician Decision|10|||
125193713|NCT02887183|450330326|FG000|Overall Study|Withdrawal by Subject|35|||
125193714|NCT03300505|450332035|FG000|Overall Study|Death|0|||
125193715|NCT03300505|450332036|FG001|Overall Study|Death|1|||
125193716|NCT03300505|450332037|FG002|Overall Study|Death|0|||
125193717|NCT03300505|450332035|FG000|Overall Study|Withdrawal by Subject|0|||
125193718|NCT03300505|450332036|FG001|Overall Study|Withdrawal by Subject|1|||
125193719|NCT03300505|450332037|FG002|Overall Study|Withdrawal by Subject|1|||
125193720|NCT03300505|450332035|FG000|Overall Study|Sponsor Termination|0|||
125193721|NCT03300505|450332036|FG001|Overall Study|Sponsor Termination|1|||
125193722|NCT03300505|450332037|FG002|Overall Study|Sponsor Termination|0|||
125193723|NCT03300505|450332035|FG000|Overall Study|Adverse Event|0|||
125193724|NCT03300505|450332036|FG001|Overall Study|Adverse Event|0|||
125193725|NCT03300505|450332037|FG002|Overall Study|Adverse Event|2|||
125193726|NCT05119595|450332038|FG000|Overall Study|Death|1|||
125193727|NCT05119595|450332038|FG000|Overall Study|Lost to Follow-up|7|||
125193728|NCT00679029|450332039|FG000|Overall Study|Adverse Event|3|||
125193729|NCT00679029|450332039|FG000|Overall Study|Withdrawal by Subject|1|||
125193730|NCT00679029|450332039|FG000|Overall Study|Lost to Follow-up|1|||
125193731|NCT03483961|450332040|FG000|Overall Study|Lost to Follow-up|7|||
125193732|NCT03483961|450332041|FG001|Overall Study|Lost to Follow-up|6|||
125193733|NCT03483961|450332042|FG002|Overall Study|Lost to Follow-up|6|||
125193734|NCT03483961|450332043|FG003|Overall Study|Lost to Follow-up|6|||
125193735|NCT03483961|450332044|FG004|Overall Study|Lost to Follow-up|6|||
125193736|NCT03483961|450332045|FG005|Overall Study|Lost to Follow-up|4|||
125193737|NCT03483961|450332046|FG006|Overall Study|Lost to Follow-up|4|||
125193738|NCT03483961|450332047|FG007|Overall Study|Lost to Follow-up|11|||
125193739|NCT03483961|450332048|FG008|Overall Study|Lost to Follow-up|1|||
125193740|NCT03483961|450332049|FG009|Overall Study|Lost to Follow-up|0|||
125193741|NCT03483961|450332040|FG000|Overall Study|Withdrawal by Subject|3|||
125193742|NCT03483961|450332041|FG001|Overall Study|Withdrawal by Subject|4|||
125193743|NCT03483961|450332042|FG002|Overall Study|Withdrawal by Subject|5|||
125193744|NCT03483961|450332043|FG003|Overall Study|Withdrawal by Subject|3|||
125193745|NCT03483961|450332044|FG004|Overall Study|Withdrawal by Subject|4|||
125193746|NCT03483961|450332045|FG005|Overall Study|Withdrawal by Subject|2|||
125193747|NCT03483961|450332046|FG006|Overall Study|Withdrawal by Subject|1|||
125193748|NCT03483961|450332047|FG007|Overall Study|Withdrawal by Subject|2|||
125193749|NCT03483961|450332048|FG008|Overall Study|Withdrawal by Subject|1|||
125193750|NCT03483961|450332049|FG009|Overall Study|Withdrawal by Subject|0|||
125193751|NCT03483961|450332040|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
125193752|NCT03483961|450332041|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193753|NCT03483961|450332042|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193754|NCT03483961|450332043|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193755|NCT03483961|450332044|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193756|NCT03483961|450332045|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193757|NCT03483961|450332046|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193758|NCT03483961|450332047|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193759|NCT03483961|450332048|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193760|NCT03483961|450332049|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
125193761|NCT03483961|450332040|FG000|Overall Study|Adverse Event|0|||
125193762|NCT03483961|450332041|FG001|Overall Study|Adverse Event|0|||
125246392|NCT03259308|450526781|FG001|Overall Study|Withdrawal by Subject|1|||
125246393|NCT03259308|450526782|FG002|Overall Study|Withdrawal by Subject|3|||
125246394|NCT03259308|450526780|FG000|Overall Study|Lost to Follow-up|0|||
125246395|NCT03259308|450526781|FG001|Overall Study|Lost to Follow-up|0|||
125246396|NCT03259308|450526782|FG002|Overall Study|Lost to Follow-up|1|||
125246397|NCT03259308|450526780|FG000|Overall Study|Pregnancy|0|||
125246398|NCT03259308|450526781|FG001|Overall Study|Pregnancy|0|||
125246399|NCT03259308|450526782|FG002|Overall Study|Pregnancy|1|||
125246400|NCT03259308|450526780|FG000|Overall Study|Protocol Deviation|0|||
125246401|NCT03259308|450526781|FG001|Overall Study|Protocol Deviation|3|||
125246402|NCT03259308|450526782|FG002|Overall Study|Protocol Deviation|0|||
125246403|NCT03259308|450526780|FG000|Overall Study|Lack of Efficacy|0|||
125246404|NCT03259308|450526781|FG001|Overall Study|Lack of Efficacy|0|||
125246405|NCT03259308|450526782|FG002|Overall Study|Lack of Efficacy|1|||
125246406|NCT00694122|450526783|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
125246407|NCT00694122|450526784|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
125246408|NCT00694122|450526783|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
125246409|NCT00694122|450526784|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
125246410|NCT00694122|450526783|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
125246411|NCT00694122|450526784|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
125246412|NCT01727154|450526787|FG000|Overall Study|Death|17|||
125246413|NCT01727154|450526787|FG000|Overall Study|Withdrawal by Subject|14|||
125246414|NCT01727154|450526787|FG000|Overall Study|Subject Withdrew Consent|18|||
125246415|NCT01727154|450526787|FG000|Overall Study|Study Terminated|6|||
125246416|NCT01727154|450526787|FG000|Overall Study|No Discontinuation Documentation|4|||
125246417|NCT00003474|450526788|FG000|Overall Study|Not Evaluable|14|||
125246418|NCT03020888|450526791|FG000|Overall Study|Physician Decision|4|||
125246419|NCT03020888|450526791|FG000|Overall Study|Withdrawal by Subject|6|||
125246420|NCT03020888|450526791|FG000|Overall Study|Insurance coverage|2|||
125246421|NCT03020888|450526791|FG000|Overall Study|Lost to Follow-up|1|||
125246422|NCT01198548|450526798|FG000|Overall Study|Disease Progression|9|||
125246423|NCT01198548|450526798|FG000|Overall Study|Administrative Decision|1|||
125246424|NCT01245062|450526800|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
125246425|NCT01245062|450526801|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
125246426|NCT01245062|450526802|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
125246427|NCT01245062|450526800|FG000|Randomization and Crossover Phase|Physician Decision|2|||
125246428|NCT01245062|450526801|FG001|Randomization and Crossover Phase|Physician Decision|4|||
125246429|NCT01245062|450526802|FG002|Randomization and Crossover Phase|Physician Decision|0|||
125246430|NCT01245062|450526800|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
125246431|NCT01245062|450526801|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
125246432|NCT01245062|450526802|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
125246433|NCT01245062|450526800|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
125246434|NCT01245062|450526801|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
125246435|NCT01245062|450526802|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
125246436|NCT01245062|450526800|FG000|Cross-over Phase|Lost to Follow-up|0|||
125246437|NCT01245062|450526801|FG001|Cross-over Phase|Lost to Follow-up|0|||
125246438|NCT01245062|450526802|FG002|Cross-over Phase|Lost to Follow-up|1|||
125246439|NCT01245062|450526800|FG000|Cross-over Phase|Physician Decision|0|||
125246440|NCT01245062|450526801|FG001|Cross-over Phase|Physician Decision|0|||
125246441|NCT01245062|450526802|FG002|Cross-over Phase|Physician Decision|1|||
125246442|NCT01245062|450526800|FG000|Cross-over Phase|Withdrew Consent|0|||
125246443|NCT01245062|450526801|FG001|Cross-over Phase|Withdrew Consent|0|||
125246444|NCT01245062|450526802|FG002|Cross-over Phase|Withdrew Consent|4|||
125394451|NCT02884089|451077739|FG002|Washout Period 3|Lost to Follow-up|0|||
125394452|NCT02884089|451077740|FG003|Washout Period 3|Lost to Follow-up|1|||
125394453|NCT02884089|451077737|FG000|Period 4|Withdrawal by Subject|0|||
125394454|NCT02884089|451077738|FG001|Period 4|Withdrawal by Subject|1|||
125394455|NCT02884089|451077739|FG002|Period 4|Withdrawal by Subject|0|||
125394456|NCT02884089|451077740|FG003|Period 4|Withdrawal by Subject|0|||
125246445|NCT01245062|450526800|FG000|Cross-over Phase|Study closed/ terminated|0|||
125246446|NCT01245062|450526801|FG001|Cross-over Phase|Study closed/ terminated|0|||
125246447|NCT01245062|450526802|FG002|Cross-over Phase|Study closed/ terminated|11|||
125246448|NCT06025695|450526803|FG000|Overall Study|Adverse Event|5|||
125394457|NCT02884089|451077737|FG000|Period 4|Lost to Follow-up|1|||
125394458|NCT02884089|451077738|FG001|Period 4|Lost to Follow-up|0|||
125394459|NCT02884089|451077739|FG002|Period 4|Lost to Follow-up|0|||
125246449|NCT06025695|450526804|FG001|Overall Study|Adverse Event|6|||
125246450|NCT06025695|450526803|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
125246451|NCT06025695|450526804|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
125246452|NCT06025695|450526803|FG000|Overall Study|Other|23|||
125246453|NCT06025695|450526804|FG001|Overall Study|Other|19|||
125246454|NCT06025695|450526803|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
125246455|NCT06025695|450526804|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
125246456|NCT03834883|450526805|FG000|Second Treatment|Withdrawal by Subject|1|||
125394460|NCT02884089|451077740|FG003|Period 4|Lost to Follow-up|0|||
125394461|NCT02884089|451077737|FG000|Follow-up Visit|Withdrawal by Subject|1|||
125193763|NCT03483961|450332042|FG002|Overall Study|Adverse Event|1|||
125193764|NCT03483961|450332043|FG003|Overall Study|Adverse Event|0|||
125193765|NCT03483961|450332044|FG004|Overall Study|Adverse Event|0|||
125193766|NCT03483961|450332045|FG005|Overall Study|Adverse Event|0|||
125193767|NCT03483961|450332046|FG006|Overall Study|Adverse Event|0|||
125193768|NCT03483961|450332047|FG007|Overall Study|Adverse Event|0|||
125193769|NCT03483961|450332048|FG008|Overall Study|Adverse Event|0|||
125193770|NCT03483961|450332049|FG009|Overall Study|Adverse Event|0|||
125193771|NCT01108341|450332052|FG000|Overall Study|Death|2|||
125193772|NCT01108341|450332052|FG000|Overall Study|Withdrawal by Subject|1|||
125193773|NCT01108341|450332052|FG000|Overall Study|Lost to Follow-up|1|||
125193774|NCT01108341|450332052|FG000|Overall Study|Other|1|||
125193775|NCT00267969|450332053|FG000|Controlled Period|Adverse Event|6|||
125193776|NCT00267969|450332054|FG001|Controlled Period|Adverse Event|0|||
125193777|NCT00267969|450332055|FG002|Controlled Period|Adverse Event|2|||
125193778|NCT00267969|450332056|FG003|Controlled Period|Adverse Event|0|||
125193779|NCT00267969|450332057|FG004|Controlled Period|Adverse Event|0|||
125193780|NCT00267969|450332058|FG005|Controlled Period|Adverse Event|0|||
125193781|NCT00267969|450332059|FG006|Controlled Period|Adverse Event|0|||
125193782|NCT00267969|450332053|FG000|Controlled Period|Lack of Efficacy|3|||
125193783|NCT00267969|450332054|FG001|Controlled Period|Lack of Efficacy|0|||
125193784|NCT00267969|450332055|FG002|Controlled Period|Lack of Efficacy|1|||
125193785|NCT00267969|450332056|FG003|Controlled Period|Lack of Efficacy|0|||
125193786|NCT00267969|450332057|FG004|Controlled Period|Lack of Efficacy|0|||
125193787|NCT00267969|450332058|FG005|Controlled Period|Lack of Efficacy|0|||
125193788|NCT00267969|450332059|FG006|Controlled Period|Lack of Efficacy|0|||
125193789|NCT00267969|450332053|FG000|Controlled Period|Lost to Follow-up|1|||
125193790|NCT00267969|450332054|FG001|Controlled Period|Lost to Follow-up|0|||
125193791|NCT00267969|450332055|FG002|Controlled Period|Lost to Follow-up|1|||
125193792|NCT00267969|450332056|FG003|Controlled Period|Lost to Follow-up|0|||
125193793|NCT00267969|450332057|FG004|Controlled Period|Lost to Follow-up|0|||
125193794|NCT00267969|450332058|FG005|Controlled Period|Lost to Follow-up|0|||
125193795|NCT00267969|450332059|FG006|Controlled Period|Lost to Follow-up|0|||
125193796|NCT00267969|450332053|FG000|Controlled Period|Randomized but not treated|0|||
125193797|NCT00267969|450332054|FG001|Controlled Period|Randomized but not treated|0|||
125193798|NCT00267969|450332055|FG002|Controlled Period|Randomized but not treated|1|||
125193799|NCT00267969|450332056|FG003|Controlled Period|Randomized but not treated|0|||
125193800|NCT00267969|450332057|FG004|Controlled Period|Randomized but not treated|0|||
125193801|NCT00267969|450332058|FG005|Controlled Period|Randomized but not treated|0|||
125193802|NCT00267969|450332059|FG006|Controlled Period|Randomized but not treated|0|||
125193803|NCT00267969|450332053|FG000|Controlled Period|Other|2|||
125193804|NCT00267969|450332054|FG001|Controlled Period|Other|1|||
125193805|NCT00267969|450332055|FG002|Controlled Period|Other|6|||
125193806|NCT00267969|450332056|FG003|Controlled Period|Other|0|||
125193807|NCT00267969|450332057|FG004|Controlled Period|Other|0|||
125193808|NCT00267969|450332058|FG005|Controlled Period|Other|0|||
125193809|NCT00267969|450332059|FG006|Controlled Period|Other|0|||
125193810|NCT00267969|450332053|FG000|After Controlled Period|Adverse Event|0|||
125193811|NCT00267969|450332054|FG001|After Controlled Period|Adverse Event|0|||
125193812|NCT00267969|450332055|FG002|After Controlled Period|Adverse Event|0|||
125193813|NCT00267969|450332056|FG003|After Controlled Period|Adverse Event|7|||
125193814|NCT00267969|450332057|FG004|After Controlled Period|Adverse Event|8|||
125193815|NCT00267969|450332058|FG005|After Controlled Period|Adverse Event|23|||
125193816|NCT00267969|450332059|FG006|After Controlled Period|Adverse Event|21|||
125394462|NCT02884089|451077738|FG001|Follow-up Visit|Withdrawal by Subject|0|||
125394463|NCT02884089|451077739|FG002|Follow-up Visit|Withdrawal by Subject|0|||
125193817|NCT00267969|450332053|FG000|After Controlled Period|Death|0|||
125193818|NCT00267969|450332054|FG001|After Controlled Period|Death|0|||
125193819|NCT00267969|450332055|FG002|After Controlled Period|Death|0|||
125193820|NCT00267969|450332056|FG003|After Controlled Period|Death|1|||
125193821|NCT00267969|450332057|FG004|After Controlled Period|Death|2|||
125193822|NCT00267969|450332058|FG005|After Controlled Period|Death|0|||
125193823|NCT00267969|450332059|FG006|After Controlled Period|Death|1|||
125193824|NCT00267969|450332053|FG000|After Controlled Period|Lack of Efficacy|0|||
125193825|NCT00267969|450332054|FG001|After Controlled Period|Lack of Efficacy|0|||
125193826|NCT00267969|450332055|FG002|After Controlled Period|Lack of Efficacy|0|||
125394464|NCT02884089|451077740|FG003|Follow-up Visit|Withdrawal by Subject|1|||
125394465|NCT01631474|451077741|FG000|Overall Study|Lost to Follow-up|8|||
125193827|NCT00267969|450332056|FG003|After Controlled Period|Lack of Efficacy|10|||
125193828|NCT00267969|450332057|FG004|After Controlled Period|Lack of Efficacy|6|||
125193829|NCT00267969|450332058|FG005|After Controlled Period|Lack of Efficacy|28|||
125193830|NCT00267969|450332059|FG006|After Controlled Period|Lack of Efficacy|15|||
125193831|NCT00267969|450332053|FG000|After Controlled Period|Lost to Follow-up|0|||
125193832|NCT00267969|450332054|FG001|After Controlled Period|Lost to Follow-up|0|||
125193833|NCT00267969|450332055|FG002|After Controlled Period|Lost to Follow-up|0|||
125193834|NCT00267969|450332056|FG003|After Controlled Period|Lost to Follow-up|5|||
125193835|NCT00267969|450332057|FG004|After Controlled Period|Lost to Follow-up|8|||
125394466|NCT01631474|451077742|FG001|Overall Study|Lost to Follow-up|5|||
125394467|NCT01631474|451077743|FG002|Overall Study|Lost to Follow-up|7|||
125394468|NCT01631474|451077744|FG003|Overall Study|Lost to Follow-up|5|||
125394469|NCT01631474|451077745|FG004|Overall Study|Lost to Follow-up|5|||
125394470|NCT01631474|451077741|FG000|Overall Study|Withdrawal by Subject|4|||
125394471|NCT01631474|451077742|FG001|Overall Study|Withdrawal by Subject|4|||
125394472|NCT01631474|451077743|FG002|Overall Study|Withdrawal by Subject|2|||
125394473|NCT01631474|451077744|FG003|Overall Study|Withdrawal by Subject|6|||
125394474|NCT01631474|451077745|FG004|Overall Study|Withdrawal by Subject|5|||
125394475|NCT01631474|451077741|FG000|Overall Study|Lack of Efficacy|2|||
125394476|NCT01631474|451077742|FG001|Overall Study|Lack of Efficacy|2|||
125394477|NCT01631474|451077743|FG002|Overall Study|Lack of Efficacy|0|||
125394478|NCT01631474|451077744|FG003|Overall Study|Lack of Efficacy|0|||
125394479|NCT01631474|451077745|FG004|Overall Study|Lack of Efficacy|2|||
125394480|NCT01631474|451077741|FG000|Overall Study|Noncompliance with Study Drug|0|||
125443557|NCT02561455|451252173|FG002|Overall Study|Disease Progression|0|||
125443558|NCT02561455|451252174|FG003|Overall Study|Disease Progression|0|||
125443559|NCT00627042|451252177|FG000|Overall Study|Withdrawal by Subject|2|||
125443560|NCT03583541|451252183|FG000|Overall Study|Lost to Follow-up|31|||
125443561|NCT03583541|451252184|FG001|Overall Study|Lost to Follow-up|65|||
125443562|NCT01686932|451252188|FG000|Period 1|Adverse Event|1|||
125443563|NCT01686932|451252189|FG001|Period 1|Adverse Event|1|||
125443564|NCT01364727|451252190|FG000|Overall Study|Not Eligible|2|||
125443565|NCT01990300|451252193|FG000|Overall Study|Case Report Forms Uncollected|89|||
125443566|NCT01990300|451252193|FG000|Overall Study|Protocol Deviation|53|||
125443567|NCT00393094|451252196|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
125443568|NCT00393094|451252196|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
125443569|NCT03653416|451252197|FG000|Overall Study|Protocol Violation|6|||
125443570|NCT03653416|451252198|FG001|Overall Study|Protocol Violation|1|||
125443571|NCT02788006|451252199|FG000|Overall Study|Patient not treated|1|||
125443572|NCT03050398|451252200|FG000|Overall Study|Study terminated by sponsor|8|||
125443573|NCT00598481|451252201|FG000|Treatment|Physician Decision|1|||
125443574|NCT03523871|451252202|FG000|Overall Study|Death|1|||
125443575|NCT01994720|451252203|FG000|Overall Study|Withdrawal by Subject|46|||
125443576|NCT01994720|451252204|FG001|Overall Study|Withdrawal by Subject|56|||
125443577|NCT01991197|451252205|FG000|Overall Study|Lost to Follow-up|1|||
125443578|NCT01991197|451252206|FG001|Overall Study|Lost to Follow-up|1|||
125443579|NCT01991197|451252205|FG000|Overall Study|Physician Decision|0|||
125443580|NCT01991197|451252206|FG001|Overall Study|Physician Decision|2|||
125443581|NCT01991197|451252205|FG000|Overall Study|Withdrawal by Subject|2|||
125443582|NCT01991197|451252206|FG001|Overall Study|Withdrawal by Subject|0|||
125443583|NCT04285229|451252210|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
125443584|NCT04285229|451252211|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125443585|NCT04285229|451252212|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125443586|NCT04285229|451252213|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125443587|NCT04285229|451252214|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125443588|NCT04285229|451252215|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125443589|NCT04285229|451252210|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
125443590|NCT04285229|451252211|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
125443591|NCT04285229|451252212|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
125443592|NCT04285229|451252213|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
125443593|NCT04285229|451252214|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
125443594|NCT04285229|451252215|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
125443595|NCT04285229|451252210|FG000|Extended Treatment Period|Adverse Event|0|||
125443596|NCT04285229|451252211|FG001|Extended Treatment Period|Adverse Event|0|||
125443597|NCT04285229|451252212|FG002|Extended Treatment Period|Adverse Event|0|||
125443598|NCT04285229|451252213|FG003|Extended Treatment Period|Adverse Event|1|||
125443599|NCT04285229|451252214|FG004|Extended Treatment Period|Adverse Event|0|||
125443600|NCT04285229|451252215|FG005|Extended Treatment Period|Adverse Event|0|||
125443601|NCT04285229|451252210|FG000|Extended Treatment Period|Physician Decision|0|||
125443602|NCT04285229|451252211|FG001|Extended Treatment Period|Physician Decision|0|||
125443603|NCT04285229|451252212|FG002|Extended Treatment Period|Physician Decision|1|||
125443604|NCT04285229|451252213|FG003|Extended Treatment Period|Physician Decision|0|||
125443605|NCT04285229|451252214|FG004|Extended Treatment Period|Physician Decision|0|||
125443606|NCT04285229|451252215|FG005|Extended Treatment Period|Physician Decision|0|||
125443607|NCT04285229|451252210|FG000|Follow-up Period|Adverse Event|0|||
125443608|NCT04285229|451252211|FG001|Follow-up Period|Adverse Event|0|||
125443609|NCT04285229|451252212|FG002|Follow-up Period|Adverse Event|0|||
125443610|NCT04285229|451252213|FG003|Follow-up Period|Adverse Event|0|||
125443611|NCT04285229|451252214|FG004|Follow-up Period|Adverse Event|1|||
125443612|NCT04285229|451252215|FG005|Follow-up Period|Adverse Event|4|||
125443613|NCT04285229|451252210|FG000|Follow-up Period|Withdrawal by Subject|0|||
125443614|NCT04285229|451252211|FG001|Follow-up Period|Withdrawal by Subject|0|||
125443615|NCT04285229|451252212|FG002|Follow-up Period|Withdrawal by Subject|0|||
125443616|NCT04285229|451252213|FG003|Follow-up Period|Withdrawal by Subject|0|||
125246457|NCT03834883|450526806|FG001|Second Treatment|Withdrawal by Subject|0|||
125246458|NCT03834883|450526807|FG002|Second Treatment|Withdrawal by Subject|0|||
125246459|NCT03834883|450526808|FG003|Second Treatment|Withdrawal by Subject|0|||
125246460|NCT03834883|450526805|FG000|Second Treatment|COVID-19 pandemic|1|||
125246461|NCT03834883|450526806|FG001|Second Treatment|COVID-19 pandemic|0|||
125246462|NCT03834883|450526807|FG002|Second Treatment|COVID-19 pandemic|1|||
125246463|NCT03834883|450526808|FG003|Second Treatment|COVID-19 pandemic|1|||
125246464|NCT02487199|450526811|FG000|Overall Study|Withdrew Consent|0|||
125246465|NCT02487199|450526812|FG001|Overall Study|Withdrew Consent|1|||
125246466|NCT00853047|450526813|FG000|Core Phase|Participant Request|0|||
125246467|NCT00853047|450526814|FG001|Core Phase|Participant Request|0|||
125246468|NCT00853047|450526815|FG002|Core Phase|Participant Request|0|||
125246469|NCT00853047|450526816|FG003|Core Phase|Participant Request|1|||
125246470|NCT00853047|450526817|FG004|Core Phase|Participant Request|0|||
125246471|NCT00853047|450526818|FG005|Core Phase|Participant Request|0|||
125246472|NCT00853047|450526813|FG000|Open-Label Extension Phase|Participant Request|0|||
125246473|NCT00853047|450526814|FG001|Open-Label Extension Phase|Participant Request|0|||
125246474|NCT00853047|450526815|FG002|Open-Label Extension Phase|Participant Request|0|||
125246475|NCT00853047|450526816|FG003|Open-Label Extension Phase|Participant Request|0|||
125246476|NCT00853047|450526817|FG004|Open-Label Extension Phase|Participant Request|0|||
125246477|NCT00853047|450526818|FG005|Open-Label Extension Phase|Participant Request|7|||
125246478|NCT00853047|450526813|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
125246479|NCT00853047|450526814|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
125246480|NCT00853047|450526815|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
125246481|NCT00853047|450526816|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
125246482|NCT00853047|450526817|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
125246483|NCT00853047|450526818|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
125246484|NCT00853047|450526813|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
125246485|NCT00853047|450526814|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
125246486|NCT00853047|450526815|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
125246487|NCT00853047|450526816|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
125246488|NCT00853047|450526817|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
125246489|NCT00853047|450526818|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
125246490|NCT00853047|450526813|FG000|Open-Label Extension Phase|Investigator Decision|0|||
125246491|NCT00853047|450526814|FG001|Open-Label Extension Phase|Investigator Decision|0|||
125246492|NCT00853047|450526815|FG002|Open-Label Extension Phase|Investigator Decision|0|||
125246493|NCT00853047|450526816|FG003|Open-Label Extension Phase|Investigator Decision|0|||
125246494|NCT00853047|450526817|FG004|Open-Label Extension Phase|Investigator Decision|0|||
125246495|NCT00853047|450526818|FG005|Open-Label Extension Phase|Investigator Decision|1|||
125246496|NCT00853047|450526813|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
125246497|NCT00853047|450526814|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
125246498|NCT00853047|450526815|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
125246499|NCT00853047|450526816|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
125246500|NCT00853047|450526817|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
125246501|NCT00853047|450526818|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
125246502|NCT00160615|450528433|FG000|Overall Study|Adverse Event|5|||
125246503|NCT00160615|450528434|FG001|Overall Study|Adverse Event|12|||
125246504|NCT00160615|450528433|FG000|Overall Study|Withdrawal by Subject|0|||
125246505|NCT00160615|450528434|FG001|Overall Study|Withdrawal by Subject|2|||
125193836|NCT00267969|450332058|FG005|After Controlled Period|Lost to Follow-up|9|||
125193837|NCT00267969|450332059|FG006|After Controlled Period|Lost to Follow-up|10|||
125193838|NCT00267969|450332053|FG000|After Controlled Period|Other|0|||
125193839|NCT00267969|450332054|FG001|After Controlled Period|Other|0|||
125193840|NCT00267969|450332055|FG002|After Controlled Period|Other|0|||
125193841|NCT00267969|450332056|FG003|After Controlled Period|Other|13|||
125193842|NCT00267969|450332057|FG004|After Controlled Period|Other|11|||
125193843|NCT00267969|450332058|FG005|After Controlled Period|Other|22|||
125193844|NCT00267969|450332059|FG006|After Controlled Period|Other|25|||
125193845|NCT02308540|450332064|FG000|Overall Study|Lost to Follow-up|0|||
125193846|NCT02308540|450332065|FG001|Overall Study|Lost to Follow-up|0|||
125193847|NCT02308540|450332066|FG002|Overall Study|Lost to Follow-up|0|||
125193848|NCT02308540|450332067|FG003|Overall Study|Lost to Follow-up|0|||
125193849|NCT02308540|450332068|FG004|Overall Study|Lost to Follow-up|0|||
125193850|NCT02308540|450332069|FG005|Overall Study|Lost to Follow-up|1|||
125193851|NCT02285166|450332070|FG000|Overall Study|Case Report Forms Uncollected|564|||
125193852|NCT02285166|450332070|FG000|Overall Study|Protocol Deviation|402|||
125193853|NCT00384839|450332073|FG000|Overall Study|Adverse Event|4|||
125193854|NCT00384839|450332073|FG000|Overall Study|Investigator Request|1|||
125246506|NCT00160615|450528433|FG000|Overall Study|Lack of Efficacy|11|||
125246507|NCT00160615|450528434|FG001|Overall Study|Lack of Efficacy|23|||
125246508|NCT00160615|450528433|FG000|Overall Study|Patient decision|1|||
125246509|NCT00160615|450528434|FG001|Overall Study|Patient decision|2|||
125246510|NCT00160615|450528433|FG000|Overall Study|Investigator decision|1|||
125246511|NCT00160615|450528434|FG001|Overall Study|Investigator decision|1|||
125246512|NCT00160615|450528433|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
125394481|NCT01631474|451077742|FG001|Overall Study|Noncompliance with Study Drug|0|||
125394482|NCT01631474|451077743|FG002|Overall Study|Noncompliance with Study Drug|0|||
125394483|NCT01631474|451077744|FG003|Overall Study|Noncompliance with Study Drug|0|||
125394484|NCT01631474|451077745|FG004|Overall Study|Noncompliance with Study Drug|1|||
125394485|NCT01631474|451077741|FG000|Overall Study|Adverse Event|0|||
125394486|NCT01631474|451077742|FG001|Overall Study|Adverse Event|1|||
125394487|NCT01631474|451077743|FG002|Overall Study|Adverse Event|0|||
125394488|NCT01631474|451077744|FG003|Overall Study|Adverse Event|0|||
125394489|NCT01631474|451077745|FG004|Overall Study|Adverse Event|0|||
125394490|NCT02624284|451077746|FG000|Overall Study|Withdrawal by Subject|3|||
125394491|NCT02624284|451077747|FG001|Overall Study|Withdrawal by Subject|6|||
125394492|NCT02624284|451077748|FG002|Overall Study|Withdrawal by Subject|3|||
125394493|NCT02624284|451077746|FG000|Overall Study|Protocol Violation|9|||
125394494|NCT02624284|451077747|FG001|Overall Study|Protocol Violation|10|||
125394495|NCT02624284|451077748|FG002|Overall Study|Protocol Violation|7|||
125394496|NCT02624284|451077746|FG000|Overall Study|Revealed exclusionary condition|2|||
125394497|NCT02624284|451077747|FG001|Overall Study|Revealed exclusionary condition|2|||
125394498|NCT02624284|451077748|FG002|Overall Study|Revealed exclusionary condition|0|||
125394499|NCT02624284|451077746|FG000|Overall Study|Adverse Event|0|||
125394500|NCT02624284|451077747|FG001|Overall Study|Adverse Event|0|||
125394501|NCT02624284|451077748|FG002|Overall Study|Adverse Event|1|||
125394502|NCT02487394|451077749|FG000|Phase 1|Withdrawal by Subject|0|||
125394503|NCT02487394|451077750|FG001|Phase 1|Withdrawal by Subject|1|||
125394504|NCT01641367|451077754|FG000|Cohorts|Death|18|||
125394505|NCT01641367|451077755|FG001|Cohorts|Death|1|||
125394506|NCT01641367|451077756|FG002|Cohorts|Death|2|||
125394507|NCT01641367|451077757|FG003|Cohorts|Death|0|||
125394508|NCT01641367|451077758|FG004|Cohorts|Death|1|||
125394509|NCT01641367|451077759|FG005|Cohorts|Death|1|||
125394510|NCT01641367|451077760|FG006|Cohorts|Death|0|||
125394511|NCT01641367|451077761|FG007|Cohorts|Death|0|||
125394512|NCT01641367|451077754|FG000|Cohorts|Lost to Follow-up|16|||
125394513|NCT01641367|451077755|FG001|Cohorts|Lost to Follow-up|0|||
125394514|NCT01641367|451077756|FG002|Cohorts|Lost to Follow-up|2|||
125394515|NCT01641367|451077757|FG003|Cohorts|Lost to Follow-up|0|||
125394516|NCT01641367|451077758|FG004|Cohorts|Lost to Follow-up|2|||
125394517|NCT01641367|451077759|FG005|Cohorts|Lost to Follow-up|0|||
125394518|NCT01641367|451077760|FG006|Cohorts|Lost to Follow-up|0|||
125394519|NCT01641367|451077761|FG007|Cohorts|Lost to Follow-up|0|||
125394520|NCT01641367|451077754|FG000|Randomized Adherence Intervention|Death|0|||
125394521|NCT01641367|451077755|FG001|Randomized Adherence Intervention|Death|0|||
125394522|NCT01641367|451077756|FG002|Randomized Adherence Intervention|Death|0|||
125394523|NCT01641367|451077757|FG003|Randomized Adherence Intervention|Death|0|||
125394524|NCT01641367|451077758|FG004|Randomized Adherence Intervention|Death|0|||
125394525|NCT01641367|451077759|FG005|Randomized Adherence Intervention|Death|0|||
125394526|NCT01641367|451077760|FG006|Randomized Adherence Intervention|Death|11|||
125394527|NCT01641367|451077761|FG007|Randomized Adherence Intervention|Death|12|||
125394528|NCT01641367|451077754|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
125394529|NCT01641367|451077755|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
125394530|NCT01641367|451077756|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
125394531|NCT01641367|451077757|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
125394532|NCT01641367|451077758|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
125394533|NCT01641367|451077759|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
125394534|NCT01641367|451077760|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
125394535|NCT01641367|451077761|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
125394536|NCT03100825|451077762|FG000|Overall Study|Participant/Guardian Decision|7|||
125394537|NCT03100825|451077762|FG000|Overall Study|Physician Decision|1|||
125394538|NCT02586493|451077771|FG000|Overall Study|Adverse Event|4|||
125394539|NCT02586493|451077771|FG000|Overall Study|Protocol Violation|6|||
125394540|NCT02586493|451077771|FG000|Overall Study|Lost to Follow-up|1|||
125394541|NCT02586493|451077771|FG000|Overall Study|Withdrawal by Subject|1|||
125394542|NCT01675882|451077772|FG000|Overall Study|Adverse Event|0|||
125394543|NCT01675882|451077773|FG001|Overall Study|Adverse Event|2|||
125394544|NCT01675882|451077774|FG002|Overall Study|Adverse Event|1|||
125394545|NCT01675882|451077775|FG003|Overall Study|Adverse Event|0|||
125394546|NCT01675882|451077772|FG000|Overall Study|Participant unwilling to continue|2|||
125394547|NCT01675882|451077773|FG001|Overall Study|Participant unwilling to continue|4|||
125394548|NCT01675882|451077774|FG002|Overall Study|Participant unwilling to continue|2|||
125394549|NCT01675882|451077775|FG003|Overall Study|Participant unwilling to continue|1|||
125394550|NCT01675882|451077772|FG000|Overall Study|Lost to Follow-up|0|||
125394551|NCT01675882|451077773|FG001|Overall Study|Lost to Follow-up|1|||
125394552|NCT01675882|451077774|FG002|Overall Study|Lost to Follow-up|0|||
125394553|NCT01675882|451077775|FG003|Overall Study|Lost to Follow-up|0|||
125394554|NCT01675882|451077772|FG000|Overall Study|Non-compliance|0|||
125394555|NCT01675882|451077773|FG001|Overall Study|Non-compliance|0|||
125394556|NCT01675882|451077774|FG002|Overall Study|Non-compliance|0|||
125394557|NCT01675882|451077775|FG003|Overall Study|Non-compliance|1|||
125394558|NCT00735371|451077779|FG000|Overall Study|Adverse Event|3|||
125394559|NCT00735371|451077780|FG001|Overall Study|Adverse Event|3|||
125394560|NCT00735371|451077781|FG002|Overall Study|Adverse Event|4|||
125394561|NCT00735371|451077782|FG003|Overall Study|Adverse Event|1|||
125394562|NCT00735371|451077779|FG000|Overall Study|Protocol Violation|2|||
125394563|NCT00735371|451077780|FG001|Overall Study|Protocol Violation|2|||
125394564|NCT00735371|451077781|FG002|Overall Study|Protocol Violation|0|||
125394565|NCT00735371|451077782|FG003|Overall Study|Protocol Violation|3|||
125394566|NCT00735371|451077779|FG000|Overall Study|Withdrawal by Subject|0|||
125394567|NCT00735371|451077780|FG001|Overall Study|Withdrawal by Subject|2|||
125394568|NCT00735371|451077781|FG002|Overall Study|Withdrawal by Subject|2|||
125394569|NCT00735371|451077782|FG003|Overall Study|Withdrawal by Subject|0|||
125394570|NCT00735371|451077779|FG000|Overall Study|Lost to Follow-up|1|||
125394571|NCT00735371|451077780|FG001|Overall Study|Lost to Follow-up|1|||
125394572|NCT00735371|451077781|FG002|Overall Study|Lost to Follow-up|3|||
125394573|NCT00735371|451077782|FG003|Overall Study|Lost to Follow-up|1|||
125394574|NCT00735371|451077779|FG000|Overall Study|Lack of Efficacy|4|||
125394575|NCT00735371|451077780|FG001|Overall Study|Lack of Efficacy|2|||
125394576|NCT00735371|451077781|FG002|Overall Study|Lack of Efficacy|0|||
125246513|NCT00160615|450528434|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
125246514|NCT00160615|450528433|FG000|Overall Study|Switch to surgical treatment|0|||
125246515|NCT00160615|450528434|FG001|Overall Study|Switch to surgical treatment|2|||
125246516|NCT00160615|450528433|FG000|Overall Study|Non-compliance was suspected|0|||
125246517|NCT00160615|450528434|FG001|Overall Study|Non-compliance was suspected|1|||
125246518|NCT00160615|450528433|FG000|Overall Study|Poor compliance|0|||
125246519|NCT00160615|450528434|FG001|Overall Study|Poor compliance|1|||
125246520|NCT03166631|450528435|FG000|Overall Study|Progressive disease|2|||
125246521|NCT03166631|450528436|FG001|Overall Study|Progressive disease|1|||
125246522|NCT03166631|450528437|FG002|Overall Study|Progressive disease|3|||
125246523|NCT03166631|450528438|FG003|Overall Study|Progressive disease|4|||
125246524|NCT03166631|450528439|FG004|Overall Study|Progressive disease|2|||
125246525|NCT03166631|450528440|FG005|Overall Study|Progressive disease|2|||
125246526|NCT03166631|450528441|FG006|Overall Study|Progressive disease|5|||
125246527|NCT03166631|450528442|FG007|Overall Study|Progressive disease|6|||
125246528|NCT03166631|450528443|FG008|Overall Study|Progressive disease|11|||
125246529|NCT03166631|450528444|FG009|Overall Study|Progressive disease|5|||
125246530|NCT03166631|450528445|FG010|Overall Study|Progressive disease|7|||
125246531|NCT03166631|450528435|FG000|Overall Study|Physician Decision|0|||
125246532|NCT03166631|450528436|FG001|Overall Study|Physician Decision|0|||
125246533|NCT03166631|450528437|FG002|Overall Study|Physician Decision|0|||
125246534|NCT03166631|450528438|FG003|Overall Study|Physician Decision|0|||
125246535|NCT03166631|450528439|FG004|Overall Study|Physician Decision|0|||
125246536|NCT03166631|450528440|FG005|Overall Study|Physician Decision|0|||
125246537|NCT03166631|450528441|FG006|Overall Study|Physician Decision|1|||
125246538|NCT03166631|450528442|FG007|Overall Study|Physician Decision|0|||
125246539|NCT03166631|450528443|FG008|Overall Study|Physician Decision|1|||
125246540|NCT03166631|450528444|FG009|Overall Study|Physician Decision|0|||
125246541|NCT03166631|450528445|FG010|Overall Study|Physician Decision|1|||
125246542|NCT03166631|450528435|FG000|Overall Study|Death|0|||
125246543|NCT03166631|450528436|FG001|Overall Study|Death|0|||
125246544|NCT03166631|450528437|FG002|Overall Study|Death|0|||
125246545|NCT03166631|450528438|FG003|Overall Study|Death|0|||
125246546|NCT03166631|450528439|FG004|Overall Study|Death|1|||
125246547|NCT03166631|450528440|FG005|Overall Study|Death|0|||
125246548|NCT03166631|450528441|FG006|Overall Study|Death|1|||
125246549|NCT03166631|450528442|FG007|Overall Study|Death|0|||
125246550|NCT03166631|450528443|FG008|Overall Study|Death|0|||
125246551|NCT03166631|450528444|FG009|Overall Study|Death|0|||
125246552|NCT03166631|450528445|FG010|Overall Study|Death|0|||
125246553|NCT03166631|450528435|FG000|Overall Study|Adverse Event|1|||
125246554|NCT03166631|450528436|FG001|Overall Study|Adverse Event|0|||
125246555|NCT03166631|450528437|FG002|Overall Study|Adverse Event|0|||
125246556|NCT03166631|450528438|FG003|Overall Study|Adverse Event|0|||
125246557|NCT03166631|450528439|FG004|Overall Study|Adverse Event|0|||
125246558|NCT03166631|450528440|FG005|Overall Study|Adverse Event|1|||
125394577|NCT00735371|451077782|FG003|Overall Study|Lack of Efficacy|4|||
125394578|NCT00735371|451077779|FG000|Overall Study|Sponsor Decision|3|||
125394579|NCT00735371|451077780|FG001|Overall Study|Sponsor Decision|1|||
125394580|NCT00735371|451077781|FG002|Overall Study|Sponsor Decision|0|||
125246559|NCT03166631|450528441|FG006|Overall Study|Adverse Event|1|||
125246560|NCT03166631|450528442|FG007|Overall Study|Adverse Event|0|||
125246561|NCT03166631|450528443|FG008|Overall Study|Adverse Event|1|||
125246562|NCT03166631|450528444|FG009|Overall Study|Adverse Event|2|||
125246563|NCT03166631|450528445|FG010|Overall Study|Adverse Event|1|||
125246564|NCT03166631|450528435|FG000|Overall Study|Withdrawal by Subject|0|||
125246565|NCT03166631|450528436|FG001|Overall Study|Withdrawal by Subject|0|||
125246566|NCT03166631|450528437|FG002|Overall Study|Withdrawal by Subject|0|||
125246567|NCT03166631|450528438|FG003|Overall Study|Withdrawal by Subject|0|||
125246568|NCT03166631|450528439|FG004|Overall Study|Withdrawal by Subject|0|||
125246569|NCT03166631|450528440|FG005|Overall Study|Withdrawal by Subject|0|||
125246570|NCT03166631|450528441|FG006|Overall Study|Withdrawal by Subject|0|||
125394581|NCT00735371|451077782|FG003|Overall Study|Sponsor Decision|1|||
125394582|NCT00735371|451077779|FG000|Overall Study|Protocol Violation|0|||
125394583|NCT00735371|451077780|FG001|Overall Study|Protocol Violation|1|||
125394584|NCT00735371|451077781|FG002|Overall Study|Protocol Violation|2|||
125394585|NCT00735371|451077782|FG003|Overall Study|Protocol Violation|0|||
125394586|NCT00735371|451077779|FG000|Overall Study|Prior Vyvanse Exposure|1|||
125394587|NCT00735371|451077780|FG001|Overall Study|Prior Vyvanse Exposure|1|||
125394588|NCT00735371|451077781|FG002|Overall Study|Prior Vyvanse Exposure|0|||
125394589|NCT00735371|451077782|FG003|Overall Study|Prior Vyvanse Exposure|0|||
125394590|NCT00735371|451077779|FG000|Overall Study|Exclusion criteria|1|||
125394591|NCT00735371|451077780|FG001|Overall Study|Exclusion criteria|0|||
125394592|NCT00735371|451077781|FG002|Overall Study|Exclusion criteria|0|||
125394593|NCT00735371|451077782|FG003|Overall Study|Exclusion criteria|0|||
125394594|NCT00994448|451077783|FG000|Overall Study|Adverse Event|1|||
125394595|NCT00994448|451077784|FG001|Overall Study|Adverse Event|0|||
125193855|NCT00384839|450332073|FG000|Overall Study|Patient Request|1|||
125193856|NCT00384839|450332073|FG000|Overall Study|Ineligible|2|||
125193857|NCT00443079|450332074|FG000|Overall Study|Lost to Follow-up|0|||
125193858|NCT00443079|450332075|FG001|Overall Study|Lost to Follow-up|1|||
125193859|NCT02649439|450332076|FG000|Overall Study|Switched to alternative treatment|6|||
125193860|NCT02649439|450332077|FG001|Overall Study|Switched to alternative treatment|4|||
125193861|NCT02649439|450332076|FG000|Overall Study|Patient decision|1|||
125193862|NCT02649439|450332077|FG001|Overall Study|Patient decision|0|||
125193863|NCT02649439|450332076|FG000|Overall Study|Patient going out of country|1|||
125193864|NCT02649439|450332077|FG001|Overall Study|Patient going out of country|0|||
125193865|NCT02649439|450332076|FG000|Overall Study|To start finasteride|1|||
125193866|NCT02649439|450332077|FG001|Overall Study|To start finasteride|0|||
125193867|NCT02649439|450332076|FG000|Overall Study|Physician Decision|1|||
125193868|NCT02649439|450332077|FG001|Overall Study|Physician Decision|0|||
125193869|NCT02649439|450332076|FG000|Overall Study|Disease progression on study|12|||
125193870|NCT02649439|450332077|FG001|Overall Study|Disease progression on study|13|||
125193871|NCT02649439|450332076|FG000|Overall Study|Refused further treatment|1|||
125193872|NCT02649439|450332077|FG001|Overall Study|Refused further treatment|0|||
125193873|NCT02649439|450332076|FG000|Overall Study|Refused further follow up|2|||
125193874|NCT02649439|450332077|FG001|Overall Study|Refused further follow up|7|||
125193875|NCT02649439|450332076|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
125193876|NCT02649439|450332077|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
125193877|NCT02649439|450332076|FG000|Overall Study|No treatment, per protocol|1|||
125193878|NCT02649439|450332077|FG001|Overall Study|No treatment, per protocol|0|||
125193879|NCT02649439|450332076|FG000|Overall Study|PSA DT makes ineligible|0|||
125193880|NCT02649439|450332077|FG001|Overall Study|PSA DT makes ineligible|1|||
125193881|NCT02649439|450332076|FG000|Overall Study|Rising PSA No Mets|0|||
125193882|NCT02649439|450332077|FG001|Overall Study|Rising PSA No Mets|1|||
125193883|NCT02649439|450332076|FG000|Overall Study|Rising PSA|0|||
125193884|NCT02649439|450332077|FG001|Overall Study|Rising PSA|1|||
125193885|NCT02649439|450332076|FG000|Overall Study|Signed follow up protocol|0|||
125193886|NCT02649439|450332077|FG001|Overall Study|Signed follow up protocol|1|||
125193887|NCT02714595|450332079|FG000|Overall Study|Lost to Follow-up|1|||
125193888|NCT02714595|450332080|FG001|Overall Study|Lost to Follow-up|0|||
125193889|NCT02714595|450332079|FG000|Overall Study|Withdrawal by Subject|1|||
125193890|NCT02714595|450332080|FG001|Overall Study|Withdrawal by Subject|2|||
125193891|NCT02714595|450332079|FG000|Overall Study|Lack of Efficacy|0|||
125193892|NCT02714595|450332080|FG001|Overall Study|Lack of Efficacy|1|||
125193893|NCT02714595|450332079|FG000|Overall Study|Death|30|||
125193894|NCT02714595|450332080|FG001|Overall Study|Death|9|||
125193895|NCT02714595|450332079|FG000|Overall Study|Other-Miscellaneous|0|||
125193896|NCT02714595|450332080|FG001|Overall Study|Other-Miscellaneous|1|||
125193897|NCT00713258|450332081|FG000|Overall Study|Adverse Event|2|||
125193898|NCT00713258|450332082|FG001|Overall Study|Adverse Event|4|||
125193899|NCT00713258|450332081|FG000|Overall Study|Non-Compliance|2|||
125193900|NCT00713258|450332082|FG001|Overall Study|Non-Compliance|1|||
125193901|NCT00713258|450332081|FG000|Overall Study|Other|1|||
125193902|NCT00713258|450332082|FG001|Overall Study|Other|1|||
125394596|NCT00994448|451077783|FG000|Overall Study|Lost to Follow-up|5|||
125394597|NCT00994448|451077784|FG001|Overall Study|Lost to Follow-up|1|||
125394598|NCT00994448|451077783|FG000|Overall Study|Withdrawal by Subject|1|||
125394599|NCT00994448|451077784|FG001|Overall Study|Withdrawal by Subject|1|||
125193903|NCT01053663|450332083|FG000|Overall Study|Death|2|||
125193904|NCT01053663|450332083|FG000|Overall Study|Lost to Follow-up|1|||
125193905|NCT01053663|450332083|FG000|Overall Study|Poor IV Access|1|||
125193906|NCT01053663|450332083|FG000|Overall Study|Transferred to Another Hospital|1|||
125193907|NCT01053663|450332083|FG000|Overall Study|Negative Influenza Diagnosis|1|||
125193908|NCT03533114|450332084|FG000|Overall|Adverse Event|16|||
125193909|NCT03533114|450332085|FG001|Overall|Adverse Event|11|||
125193910|NCT03533114|450332084|FG000|Overall|Consent Withdrawal by Participant|7|||
125193911|NCT03533114|450332085|FG001|Overall|Consent Withdrawal by Participant|6|||
125193912|NCT03533114|450332084|FG000|Overall|Lack of Efficacy|5|||
125193913|NCT03533114|450332085|FG001|Overall|Lack of Efficacy|3|||
125394600|NCT00994448|451077783|FG000|Overall Study|Physician Decision|1|||
125394601|NCT00994448|451077784|FG001|Overall Study|Physician Decision|0|||
125394602|NCT01604343|451077787|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
125394603|NCT01604343|451077788|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
125394604|NCT01604343|451077789|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
125394605|NCT01604343|451077790|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
125394606|NCT01604343|451077791|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
125394607|NCT01604343|451077787|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
125394608|NCT01604343|451077788|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
125394609|NCT01604343|451077789|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
125394610|NCT01604343|451077790|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
125394611|NCT01604343|451077791|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
125394612|NCT01604343|451077787|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
125394613|NCT01604343|451077788|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
125394614|NCT01604343|451077789|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
125394615|NCT01604343|451077790|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
125394616|NCT01604343|451077791|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
125394617|NCT01604343|451077787|FG000|Prior to W52 Administration(Through W52)|Death|5|||
125394618|NCT01604343|451077788|FG001|Prior to W52 Administration(Through W52)|Death|0|||
125394619|NCT01604343|451077789|FG002|Prior to W52 Administration(Through W52)|Death|2|||
125394620|NCT01604343|451077790|FG003|Prior to W52 Administration(Through W52)|Death|0|||
125394621|NCT01604343|451077791|FG004|Prior to W52 Administration(Through W52)|Death|4|||
125394622|NCT01604343|451077787|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
125394623|NCT01604343|451077788|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
125394624|NCT01604343|451077789|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
125394625|NCT01604343|451077790|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
125394626|NCT01604343|451077791|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
125394627|NCT01604343|451077787|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
125394628|NCT01604343|451077788|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
125394629|NCT01604343|451077789|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
125394630|NCT01604343|451077790|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
125394631|NCT01604343|451077791|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
125394632|NCT01604343|451077787|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
125394633|NCT01604343|451077788|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
125394634|NCT01604343|451077789|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
125394635|NCT01604343|451077790|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
125394636|NCT01604343|451077791|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
125394637|NCT01604343|451077787|FG000|Prior to W52 Administration(Through W52)|Other|15|||
125394638|NCT01604343|451077788|FG001|Prior to W52 Administration(Through W52)|Other|0|||
125394639|NCT01604343|451077789|FG002|Prior to W52 Administration(Through W52)|Other|10|||
125394640|NCT01604343|451077790|FG003|Prior to W52 Administration(Through W52)|Other|0|||
125394641|NCT01604343|451077791|FG004|Prior to W52 Administration(Through W52)|Other|6|||
125394642|NCT01604343|451077787|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
125394643|NCT01604343|451077788|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
125394644|NCT01604343|451077789|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
125394645|NCT01604343|451077790|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
125394646|NCT01604343|451077791|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
125394647|NCT01604343|451077787|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
125394648|NCT01604343|451077788|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
125394649|NCT01604343|451077789|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
125193914|NCT03533114|450332084|FG000|Overall|Lost to Follow-up|1|||
125193915|NCT03533114|450332085|FG001|Overall|Lost to Follow-up|1|||
125193916|NCT03533114|450332084|FG000|Overall|Physician Decision|0|||
125193917|NCT03533114|450332085|FG001|Overall|Physician Decision|2|||
125193918|NCT03533114|450332084|FG000|Overall|Protocol deviation|1|||
125193919|NCT03533114|450332085|FG001|Overall|Protocol deviation|1|||
125193920|NCT03533114|450332084|FG000|Overall|Failure to meet randomization criteria|1|||
125193921|NCT03533114|450332085|FG001|Overall|Failure to meet randomization criteria|2|||
125193922|NCT03533114|450332084|FG000|Overall|Non-Compliance with study drug|0|||
125193923|NCT03533114|450332085|FG001|Overall|Non-Compliance with study drug|1|||
125193924|NCT03533114|450332084|FG000|Overall|Other|0|||
125394650|NCT01604343|451077790|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
125394651|NCT01604343|451077791|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
125394652|NCT01604343|451077787|FG000|Week 52 to Week 104|Adverse Event|0|||
125394653|NCT01604343|451077788|FG001|Week 52 to Week 104|Adverse Event|12|||
125443617|NCT04285229|451252214|FG004|Follow-up Period|Withdrawal by Subject|0|||
125193925|NCT03533114|450332085|FG001|Overall|Other|1|||
125193926|NCT03533114|450332084|FG000|Open Label Titration and Optimization|Adverse Event|11|||
125193927|NCT03533114|450332085|FG001|Open Label Titration and Optimization|Adverse Event|8|||
125394654|NCT01604343|451077789|FG002|Week 52 to Week 104|Adverse Event|26|||
125394655|NCT01604343|451077790|FG003|Week 52 to Week 104|Adverse Event|21|||
125394656|NCT01604343|451077791|FG004|Week 52 to Week 104|Adverse Event|27|||
125394657|NCT01604343|451077787|FG000|Week 52 to Week 104|Death|0|||
125394658|NCT01604343|451077788|FG001|Week 52 to Week 104|Death|4|||
125394659|NCT01604343|451077789|FG002|Week 52 to Week 104|Death|2|||
125394660|NCT01604343|451077790|FG003|Week 52 to Week 104|Death|5|||
125394661|NCT01604343|451077791|FG004|Week 52 to Week 104|Death|0|||
125394662|NCT01604343|451077787|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
125394663|NCT01604343|451077788|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
125193928|NCT03533114|450332084|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
125193929|NCT03533114|450332085|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
125193930|NCT03533114|450332084|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
125193931|NCT03533114|450332085|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
125193932|NCT03533114|450332084|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
125193933|NCT03533114|450332085|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
125193934|NCT03533114|450332084|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
125193935|NCT03533114|450332085|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
125193936|NCT03533114|450332084|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
125193937|NCT03533114|450332085|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
125193938|NCT03533114|450332084|FG000|Stable Dose|Adverse Event|0|||
125193939|NCT03533114|450332085|FG001|Stable Dose|Adverse Event|2|||
125193940|NCT03533114|450332084|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
125193941|NCT03533114|450332085|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
125193942|NCT03533114|450332084|FG000|Stable Dose|Lack of Efficacy|1|||
125193943|NCT03533114|450332085|FG001|Stable Dose|Lack of Efficacy|0|||
125193944|NCT03533114|450332084|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
125193945|NCT03533114|450332085|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
125193946|NCT03533114|450332084|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
125193947|NCT03533114|450332085|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
125193948|NCT03533114|450332084|FG000|Open-Label Safety Extension|Adverse Event|3|||
125193949|NCT03533114|450332085|FG001|Open-Label Safety Extension|Adverse Event|0|||
125246571|NCT03166631|450528442|FG007|Overall Study|Withdrawal by Subject|0|||
125246572|NCT03166631|450528443|FG008|Overall Study|Withdrawal by Subject|1|||
125246573|NCT03166631|450528444|FG009|Overall Study|Withdrawal by Subject|1|||
125246574|NCT03166631|450528445|FG010|Overall Study|Withdrawal by Subject|0|||
125246575|NCT00567580|450528448|FG000|Overall Study|Protocol Violation|28|||
125246576|NCT00567580|450528449|FG001|Overall Study|Protocol Violation|24|||
125246577|NCT00567580|450528450|FG002|Overall Study|Protocol Violation|24|||
125246578|NCT03197935|450528453|FG000|Overall Study|Death due to any cause|26|||
125246579|NCT03197935|450528454|FG001|Overall Study|Death due to any cause|15|||
125246580|NCT03197935|450528453|FG000|Overall Study|Lost to Follow-up|3|||
125246581|NCT03197935|450528454|FG001|Overall Study|Lost to Follow-up|5|||
125246582|NCT03197935|450528453|FG000|Overall Study|Physician Decision|2|||
125246583|NCT03197935|450528454|FG001|Overall Study|Physician Decision|1|||
125246584|NCT03197935|450528453|FG000|Overall Study|Withdrawal by Subject|16|||
125246585|NCT03197935|450528454|FG001|Overall Study|Withdrawal by Subject|8|||
125246586|NCT00762788|450528455|FG000|Overall Study|Lost to Follow-up|26|||
125246587|NCT00762788|450528456|FG001|Overall Study|Lost to Follow-up|37|||
125246588|NCT00762788|450528457|FG002|Overall Study|Lost to Follow-up|21|||
125246589|NCT00762788|450528458|FG003|Overall Study|Lost to Follow-up|26|||
125246590|NCT00762788|450528459|FG004|Overall Study|Lost to Follow-up|13|||
125246591|NCT00762788|450528460|FG005|Overall Study|Lost to Follow-up|21|||
125246592|NCT03073109|450528461|FG000|Overall Study|Adverse Event|0|||
125246593|NCT03073109|450528462|FG001|Overall Study|Adverse Event|1|||
125246594|NCT03073109|450528461|FG000|Overall Study|Other|2|||
125246595|NCT03073109|450528462|FG001|Overall Study|Other|0|||
125246596|NCT03073109|450528461|FG000|Overall Study|Lost to Follow-up|8|||
125246597|NCT03073109|450528462|FG001|Overall Study|Lost to Follow-up|1|||
125246598|NCT05938010|450528463|FG000|Overall Study|Lost to Follow-up|2|||
125246599|NCT01562444|450528467|FG000|Overall Study|Did not meet entry criteria|2|||
125394664|NCT01604343|451077789|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
125246600|NCT01562444|450528468|FG001|Overall Study|Did not meet entry criteria|0|||
125246601|NCT01562444|450528469|FG002|Overall Study|Did not meet entry criteria|3|||
125246602|NCT01562444|450528467|FG000|Overall Study|Did not comply with blood draw schedule|1|||
125246603|NCT01562444|450528468|FG001|Overall Study|Did not comply with blood draw schedule|0|||
125246604|NCT01562444|450528469|FG002|Overall Study|Did not comply with blood draw schedule|1|||
125193950|NCT03533114|450332084|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
125193951|NCT03533114|450332085|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
125246605|NCT01562444|450528467|FG000|Overall Study|Unavailable serological results|0|||
125246606|NCT01562444|450528468|FG001|Overall Study|Unavailable serological results|2|||
125246607|NCT01562444|450528469|FG002|Overall Study|Unavailable serological results|2|||
125246608|NCT01562444|450528467|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
125246609|NCT01562444|450528468|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
125394665|NCT01604343|451077790|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
125394666|NCT01604343|451077791|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
125394667|NCT01604343|451077787|FG000|Week 52 to Week 104|Physician Decision|0|||
125394668|NCT01604343|451077788|FG001|Week 52 to Week 104|Physician Decision|1|||
125394669|NCT01604343|451077789|FG002|Week 52 to Week 104|Physician Decision|0|||
125394670|NCT01604343|451077790|FG003|Week 52 to Week 104|Physician Decision|0|||
125394671|NCT01604343|451077791|FG004|Week 52 to Week 104|Physician Decision|2|||
125394672|NCT01604343|451077787|FG000|Week 52 to Week 104|Pregnancy|0|||
125394673|NCT01604343|451077788|FG001|Week 52 to Week 104|Pregnancy|0|||
125394674|NCT01604343|451077789|FG002|Week 52 to Week 104|Pregnancy|1|||
125394675|NCT01604343|451077790|FG003|Week 52 to Week 104|Pregnancy|2|||
125394676|NCT01604343|451077791|FG004|Week 52 to Week 104|Pregnancy|1|||
125394677|NCT01604343|451077787|FG000|Week 52 to Week 104|Other|0|||
125394678|NCT01604343|451077788|FG001|Week 52 to Week 104|Other|11|||
125193952|NCT03533114|450332084|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
125193953|NCT03533114|450332085|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
125394679|NCT01604343|451077789|FG002|Week 52 to Week 104|Other|11|||
125193954|NCT03533114|450332084|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
125193955|NCT03533114|450332085|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
125193956|NCT03533114|450332084|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
125193957|NCT03533114|450332085|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
125193958|NCT01862250|450332086|FG000|Overall Study|Adverse Event|4|||
125193959|NCT01028014|450332090|FG000|Overall Study|Lost to Follow-up|1|||
125193960|NCT01028014|450332091|FG001|Overall Study|Lost to Follow-up|2|||
125193961|NCT01028014|450332092|FG002|Overall Study|Lost to Follow-up|0|||
125193962|NCT01028014|450332093|FG003|Overall Study|Lost to Follow-up|1|||
125193963|NCT01028014|450332094|FG004|Overall Study|Lost to Follow-up|1|||
125193964|NCT01028014|450332095|FG005|Overall Study|Lost to Follow-up|2|||
125193965|NCT02423343|450332096|FG000|Overall Study|Withdrawal by Subject|0|||
125193966|NCT02423343|450332097|FG001|Overall Study|Withdrawal by Subject|1|||
125193967|NCT02423343|450332098|FG002|Overall Study|Withdrawal by Subject|0|||
125193968|NCT02423343|450332099|FG003|Overall Study|Withdrawal by Subject|0|||
125394680|NCT01604343|451077790|FG003|Week 52 to Week 104|Other|6|||
125394681|NCT01604343|451077791|FG004|Week 52 to Week 104|Other|3|||
125394682|NCT01604343|451077787|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
125394683|NCT01604343|451077788|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
125394684|NCT01604343|451077789|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
125193969|NCT02423343|450332100|FG004|Overall Study|Withdrawal by Subject|0|||
125193970|NCT02423343|450332101|FG005|Overall Study|Withdrawal by Subject|0|||
125193971|NCT02423343|450332096|FG000|Overall Study|Progressive Disease|0|||
125193972|NCT02423343|450332097|FG001|Overall Study|Progressive Disease|0|||
125193973|NCT02423343|450332098|FG002|Overall Study|Progressive Disease|0|||
125193974|NCT02423343|450332099|FG003|Overall Study|Progressive Disease|0|||
125193975|NCT02423343|450332100|FG004|Overall Study|Progressive Disease|2|||
125193976|NCT02423343|450332101|FG005|Overall Study|Progressive Disease|0|||
125193977|NCT02423343|450332096|FG000|Overall Study|Adverse Event|0|||
125193978|NCT02423343|450332097|FG001|Overall Study|Adverse Event|0|||
125193979|NCT02423343|450332098|FG002|Overall Study|Adverse Event|0|||
125193980|NCT02423343|450332099|FG003|Overall Study|Adverse Event|0|||
125193981|NCT02423343|450332100|FG004|Overall Study|Adverse Event|2|||
125193982|NCT02423343|450332101|FG005|Overall Study|Adverse Event|0|||
125193983|NCT02423343|450332096|FG000|Overall Study|Death|0|||
125193984|NCT02423343|450332097|FG001|Overall Study|Death|0|||
125193985|NCT02423343|450332098|FG002|Overall Study|Death|0|||
125193986|NCT02423343|450332099|FG003|Overall Study|Death|0|||
125193987|NCT02423343|450332100|FG004|Overall Study|Death|1|||
125193988|NCT02423343|450332101|FG005|Overall Study|Death|0|||
125193989|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
125193990|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
125193991|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
125193992|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
125193993|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
125193994|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
125394685|NCT01604343|451077790|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
125193995|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
125193996|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
125193997|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
125193998|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
125193999|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
125194000|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
125194001|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
125194002|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
125194003|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
125194004|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
125194005|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
125194006|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
125194007|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
125194008|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
125394686|NCT01604343|451077791|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
125394687|NCT01604343|451077787|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
125394688|NCT01604343|451077788|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
125394689|NCT01604343|451077789|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
125394690|NCT01604343|451077790|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
125394691|NCT01604343|451077791|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
125394692|NCT01604343|451077787|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
125394693|NCT01604343|451077788|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
125394694|NCT01604343|451077789|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
125394695|NCT01604343|451077790|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
125394696|NCT01604343|451077791|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
125394697|NCT00436748|451077794|FG000|Overall Study|Ineligibility Determined|1|||
125394698|NCT00436748|451077795|FG001|Overall Study|Ineligibility Determined|1|||
125394699|NCT00436748|451077794|FG000|Overall Study|Adverse Event|0|||
125394700|NCT00436748|451077795|FG001|Overall Study|Adverse Event|2|||
125394701|NCT00436748|451077794|FG000|Overall Study|Consent Withdrawn|1|||
125394702|NCT00436748|451077795|FG001|Overall Study|Consent Withdrawn|4|||
125394703|NCT00436748|451077794|FG000|Overall Study|Administrative Decision|1|||
125394704|NCT00436748|451077795|FG001|Overall Study|Administrative Decision|0|||
125394705|NCT00436748|451077794|FG000|Overall Study|Lost to Follow-up|0|||
125394706|NCT00436748|451077795|FG001|Overall Study|Lost to Follow-up|1|||
125394707|NCT00436748|451077794|FG000|Overall Study|Protocol-specified Criteria|5|||
125394708|NCT00436748|451077795|FG001|Overall Study|Protocol-specified Criteria|4|||
125394709|NCT00436748|451077794|FG000|Overall Study|Other|3|||
125394710|NCT00436748|451077795|FG001|Overall Study|Other|0|||
125394711|NCT01610791|451077796|FG000|Overall Study|Lost to Follow-up|7|||
125394712|NCT01610791|451077796|FG000|Overall Study|Adverse Event|6|||
125394713|NCT01610791|451077796|FG000|Overall Study|Physician Decision|1|||
125394714|NCT01610791|451077796|FG000|Overall Study|Adverse event and Investigator decision|1|||
125246610|NCT01562444|450528469|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
125246611|NCT01562444|450528467|FG000|Overall Study|Protocol forbidden medication|1|||
125246612|NCT01562444|450528468|FG001|Overall Study|Protocol forbidden medication|0|||
125246613|NCT01562444|450528469|FG002|Overall Study|Protocol forbidden medication|0|||
125246614|NCT02568423|450528480|FG000|Overall Study|Lost to Follow-up|0|||
125246615|NCT02568423|450528481|FG001|Overall Study|Lost to Follow-up|2|||
125246616|NCT02568423|450528482|FG002|Overall Study|Lost to Follow-up|0|||
125246617|NCT02568423|450528483|FG003|Overall Study|Lost to Follow-up|0|||
125246618|NCT02568423|450528484|FG004|Overall Study|Lost to Follow-up|0|||
125246619|NCT02568423|450528485|FG005|Overall Study|Lost to Follow-up|0|||
125246620|NCT02568423|450528486|FG006|Overall Study|Lost to Follow-up|0|||
125246621|NCT02568423|450528487|FG007|Overall Study|Lost to Follow-up|0|||
125246622|NCT02568423|450528480|FG000|Overall Study|Physician Decision|0|||
125246623|NCT02568423|450528481|FG001|Overall Study|Physician Decision|0|||
125246624|NCT02568423|450528482|FG002|Overall Study|Physician Decision|0|||
125246625|NCT02568423|450528483|FG003|Overall Study|Physician Decision|0|||
125246626|NCT02568423|450528484|FG004|Overall Study|Physician Decision|0|||
125246627|NCT02568423|450528485|FG005|Overall Study|Physician Decision|1|||
125246628|NCT02568423|450528486|FG006|Overall Study|Physician Decision|0|||
125246629|NCT02568423|450528487|FG007|Overall Study|Physician Decision|0|||
125246630|NCT01027416|450528489|FG000|Overall Study|Withdrawal by Subject|0|||
125246631|NCT01027416|450528490|FG001|Overall Study|Withdrawal by Subject|1|||
125246632|NCT01027416|450528489|FG000|Overall Study|Physician Decision|1|||
125246633|NCT01027416|450528490|FG001|Overall Study|Physician Decision|4|||
125246634|NCT00676052|450528492|FG000|Overall Study|Adverse Event|0|||
125246635|NCT00676052|450528493|FG001|Overall Study|Adverse Event|1|||
125246636|NCT00676052|450528494|FG002|Overall Study|Adverse Event|1|||
125246637|NCT00676052|450528495|FG003|Overall Study|Adverse Event|2|||
125246638|NCT00676052|450528496|FG004|Overall Study|Adverse Event|2|||
125246639|NCT00676052|450528497|FG005|Overall Study|Adverse Event|2|||
125246640|NCT00676052|450528492|FG000|Overall Study|Lack of Efficacy|2|||
125246641|NCT00676052|450528493|FG001|Overall Study|Lack of Efficacy|2|||
125246642|NCT00676052|450528494|FG002|Overall Study|Lack of Efficacy|1|||
125394715|NCT01610791|451077796|FG000|Overall Study|Death|1|||
125246643|NCT00676052|450528495|FG003|Overall Study|Lack of Efficacy|1|||
125246644|NCT00676052|450528496|FG004|Overall Study|Lack of Efficacy|2|||
125394716|NCT01610791|451077796|FG000|Overall Study|Not determined|5|||
125246645|NCT00676052|450528497|FG005|Overall Study|Lack of Efficacy|1|||
125394717|NCT02711800|451077798|FG000|Overall Study|Lost to Follow-up|1|||
125394718|NCT02711800|451077798|FG000|Overall Study|Withdrawal by Subject|1|||
125394719|NCT05040152|451077801|FG000|Overall Study|Withdrawal by Subject|5|||
125246646|NCT00676052|450528492|FG000|Overall Study|Protocol Violation|5|||
125246647|NCT00676052|450528493|FG001|Overall Study|Protocol Violation|3|||
125246648|NCT00676052|450528494|FG002|Overall Study|Protocol Violation|2|||
125246649|NCT00676052|450528495|FG003|Overall Study|Protocol Violation|2|||
125246650|NCT00676052|450528496|FG004|Overall Study|Protocol Violation|1|||
125246651|NCT00676052|450528497|FG005|Overall Study|Protocol Violation|2|||
125394720|NCT05040152|451077802|FG001|Overall Study|Withdrawal by Subject|0|||
125394721|NCT05040152|451077801|FG000|Overall Study|Lost to Follow-up|0|||
125394722|NCT05040152|451077802|FG001|Overall Study|Lost to Follow-up|2|||
125394723|NCT00314574|451077809|FG000|Overall Study|Death|3|||
125394724|NCT00314574|451077810|FG001|Overall Study|Death|0|||
125394725|NCT00314574|451077809|FG000|Overall Study|Adverse Event|11|||
125394726|NCT00314574|451077810|FG001|Overall Study|Adverse Event|16|||
125394727|NCT00314574|451077809|FG000|Overall Study|Lost to Follow-up|19|||
125394728|NCT00314574|451077810|FG001|Overall Study|Lost to Follow-up|25|||
125394729|NCT00314574|451077809|FG000|Overall Study|Withdrawal by Subject|33|||
125394730|NCT00314574|451077810|FG001|Overall Study|Withdrawal by Subject|22|||
125394731|NCT00314574|451077809|FG000|Overall Study|Physician Decision|22|||
125394732|NCT00314574|451077810|FG001|Overall Study|Physician Decision|15|||
125394733|NCT00314574|451077809|FG000|Overall Study|Pregnancy|6|||
125194009|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
125194010|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
125194011|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
125194012|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
125194013|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
125194014|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
125194015|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
125194016|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
125194017|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
125194018|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
125194019|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
125194020|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
125194021|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
125194022|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
125194023|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
125194024|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
125194025|NCT02016105|450332102|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
125194026|NCT02016105|450332103|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
125194027|NCT02016105|450332104|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
125194028|NCT02016105|450332105|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
125194029|NCT02016105|450332106|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
125194030|NCT02016105|450332107|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
125194031|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
125194032|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
125194033|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
125194034|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
125194035|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
125194036|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
125194037|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
125194038|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
125194039|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
125194040|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
125194041|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
125194042|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
125194043|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
125194044|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
125194045|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
125194046|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
125194047|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
125194048|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
125194049|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Death|0|||
125194050|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Death|0|||
125194051|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Death|0|||
125194052|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Death|0|||
125194053|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Death|0|||
125194054|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Death|1|||
125194055|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
125194056|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
125194057|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
125394734|NCT00314574|451077810|FG001|Overall Study|Pregnancy|4|||
125394735|NCT00314574|451077809|FG000|Overall Study|Data unknown at database lock|0|||
125394736|NCT00314574|451077810|FG001|Overall Study|Data unknown at database lock|1|||
125194058|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
125194059|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
125194060|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
125194061|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
125194062|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
125194063|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
125194064|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
125194065|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
125194066|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
125194067|NCT02016105|450332102|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
125194068|NCT02016105|450332103|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
125394737|NCT00449956|451077811|FG000|Overall Study|Adverse Event|7|||
125394738|NCT00449956|451077812|FG001|Overall Study|Adverse Event|1|||
125246652|NCT00676052|450528492|FG000|Overall Study|Lost to Follow-up|0|||
125246653|NCT00676052|450528493|FG001|Overall Study|Lost to Follow-up|0|||
125246654|NCT00676052|450528494|FG002|Overall Study|Lost to Follow-up|0|||
125246655|NCT00676052|450528495|FG003|Overall Study|Lost to Follow-up|0|||
125246656|NCT00676052|450528496|FG004|Overall Study|Lost to Follow-up|1|||
125246657|NCT00676052|450528497|FG005|Overall Study|Lost to Follow-up|0|||
125246658|NCT00676052|450528492|FG000|Overall Study|Physician Decision|1|||
125246659|NCT00676052|450528493|FG001|Overall Study|Physician Decision|1|||
125246660|NCT00676052|450528494|FG002|Overall Study|Physician Decision|1|||
125246661|NCT00676052|450528495|FG003|Overall Study|Physician Decision|0|||
125246662|NCT00676052|450528496|FG004|Overall Study|Physician Decision|0|||
125246663|NCT00676052|450528497|FG005|Overall Study|Physician Decision|1|||
125246664|NCT00676052|450528492|FG000|Overall Study|Withdrawal by Subject|1|||
125246665|NCT00676052|450528493|FG001|Overall Study|Withdrawal by Subject|0|||
125246666|NCT00676052|450528494|FG002|Overall Study|Withdrawal by Subject|1|||
125246667|NCT00676052|450528495|FG003|Overall Study|Withdrawal by Subject|0|||
125246668|NCT00676052|450528496|FG004|Overall Study|Withdrawal by Subject|0|||
125246669|NCT00676052|450528497|FG005|Overall Study|Withdrawal by Subject|0|||
125246670|NCT02930941|450528498|FG000|Overall Study|Lost to Follow-up|1|||
125246671|NCT02930941|450528499|FG001|Overall Study|Lost to Follow-up|2|||
125246672|NCT00289978|450528502|FG000|Overall Study|Withdrawal by Subject|31|||
125246673|NCT00289978|450528503|FG001|Overall Study|Withdrawal by Subject|17|||
125246674|NCT00289978|450528504|FG002|Overall Study|Withdrawal by Subject|28|||
125246675|NCT00289978|450528502|FG000|Overall Study|Adverse Event|22|||
125246676|NCT00289978|450528503|FG001|Overall Study|Adverse Event|13|||
125246677|NCT00289978|450528504|FG002|Overall Study|Adverse Event|18|||
125246678|NCT00289978|450528502|FG000|Overall Study|Lack of Efficacy|13|||
125246679|NCT00289978|450528503|FG001|Overall Study|Lack of Efficacy|6|||
125246680|NCT00289978|450528504|FG002|Overall Study|Lack of Efficacy|25|||
125246681|NCT00289978|450528502|FG000|Overall Study|Abnormal laboratory value(s)|20|||
125246682|NCT00289978|450528503|FG001|Overall Study|Abnormal laboratory value(s)|9|||
125246683|NCT00289978|450528504|FG002|Overall Study|Abnormal laboratory value(s)|1|||
125246684|NCT00289978|450528502|FG000|Overall Study|Lost to Follow-up|3|||
125246685|NCT00289978|450528503|FG001|Overall Study|Lost to Follow-up|5|||
125246686|NCT00289978|450528504|FG002|Overall Study|Lost to Follow-up|7|||
125246687|NCT00289978|450528502|FG000|Overall Study|Protocol Violation|5|||
125246688|NCT00289978|450528503|FG001|Overall Study|Protocol Violation|5|||
125246689|NCT00289978|450528504|FG002|Overall Study|Protocol Violation|4|||
125246690|NCT00289978|450528502|FG000|Overall Study|Abnormal test procedure result(s)|2|||
125246691|NCT00289978|450528503|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125246692|NCT00289978|450528504|FG002|Overall Study|Abnormal test procedure result(s)|1|||
125246693|NCT00289978|450528502|FG000|Overall Study|Death|1|||
125246694|NCT00289978|450528503|FG001|Overall Study|Death|0|||
125246695|NCT00289978|450528504|FG002|Overall Study|Death|2|||
125246696|NCT01967277|450528506|FG000|Overall Study|Lost to Follow-up|1|||
125246697|NCT01967277|450528507|FG001|Overall Study|Lost to Follow-up|2|||
125246698|NCT01967277|450528506|FG000|Overall Study|Unrelated illness|0|||
125246699|NCT01967277|450528507|FG001|Overall Study|Unrelated illness|1|||
125246700|NCT00103506|450528514|FG000|Overall Study|Study closed by sponsor|34|||
125246701|NCT00103506|450528515|FG001|Overall Study|Study closed by sponsor|37|||
125246702|NCT00103506|450528514|FG000|Overall Study|Death|257|||
125246703|NCT00103506|450528515|FG001|Overall Study|Death|253|||
125246704|NCT00103506|450528514|FG000|Overall Study|Lost to Follow-up|13|||
125246705|NCT00103506|450528515|FG001|Overall Study|Lost to Follow-up|13|||
125246706|NCT00103506|450528514|FG000|Overall Study|Withdrawal by Subject|18|||
125246707|NCT00103506|450528515|FG001|Overall Study|Withdrawal by Subject|21|||
125246708|NCT00585585|450528516|FG000|Overall Study|Adverse Event|1|||
125246709|NCT00585169|450528517|FG000|Overall Study|Withdrawal by Subject|1|||
125246710|NCT00710970|450528518|FG000|Overall Study|Never took drug|3|||
125246711|NCT01028560|450528519|FG000|Overall Study|Lack of Efficacy|3|||
125246712|NCT01028560|450528520|FG001|Overall Study|Lack of Efficacy|6|||
125246713|NCT01028560|450528519|FG000|Overall Study|Withdrawal by Subject|7|||
125394739|NCT00449956|451077813|FG002|Overall Study|Adverse Event|6|||
125246714|NCT01028560|450528520|FG001|Overall Study|Withdrawal by Subject|12|||
125246715|NCT03055221|450528521|FG000|Overall Study|Adverse Event|2|||
125246716|NCT03055221|450528521|FG000|Overall Study|Withdrawal by Subject|4|||
125246717|NCT03055221|450528521|FG000|Overall Study|Death|6|||
125246718|NCT03055221|450528521|FG000|Overall Study|Physician Decision|1|||
125246719|NCT03055221|450528521|FG000|Overall Study|Study terminated by Sponsor|3|||
125246720|NCT03055221|450528521|FG000|Overall Study|Lost to Follow-up|4|||
125246721|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
125246722|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
125246723|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
125246724|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
125246725|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
125246726|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
125394740|NCT00449956|451077811|FG000|Overall Study|Lack of Efficacy|0|||
125194069|NCT02016105|450332104|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
125194070|NCT02016105|450332105|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
125394741|NCT00449956|451077812|FG001|Overall Study|Lack of Efficacy|0|||
125394742|NCT00449956|451077813|FG002|Overall Study|Lack of Efficacy|1|||
125394743|NCT00449956|451077811|FG000|Overall Study|Protocol Violation|1|||
125394744|NCT00449956|451077812|FG001|Overall Study|Protocol Violation|1|||
125394745|NCT00449956|451077813|FG002|Overall Study|Protocol Violation|1|||
125394746|NCT00449956|451077811|FG000|Overall Study|Withdrawal by Subject|0|||
125394747|NCT00449956|451077812|FG001|Overall Study|Withdrawal by Subject|1|||
125394748|NCT00449956|451077813|FG002|Overall Study|Withdrawal by Subject|0|||
125394749|NCT00449956|451077811|FG000|Overall Study|Physician Decision|2|||
125394750|NCT00449956|451077812|FG001|Overall Study|Physician Decision|1|||
125394751|NCT00449956|451077813|FG002|Overall Study|Physician Decision|1|||
125394752|NCT02086110|451077814|FG000|Overall Study|Withdrawal by Subject|1|||
125394753|NCT02086110|451077815|FG001|Overall Study|Withdrawal by Subject|1|||
125394754|NCT01869192|451077816|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
125394755|NCT01869192|451077817|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
125394756|NCT01869192|451077816|FG000|Postoperative Chemotherapy|Physician Decision|0|||
125443618|NCT04285229|451252215|FG005|Follow-up Period|Withdrawal by Subject|5|||
125443619|NCT04285229|451252210|FG000|Follow-up Period|Covid-19|0|||
125443620|NCT04285229|451252211|FG001|Follow-up Period|Covid-19|0|||
125443621|NCT04285229|451252212|FG002|Follow-up Period|Covid-19|0|||
125443622|NCT04285229|451252213|FG003|Follow-up Period|Covid-19|0|||
125443623|NCT04285229|451252214|FG004|Follow-up Period|Covid-19|0|||
125443624|NCT04285229|451252215|FG005|Follow-up Period|Covid-19|2|||
125443625|NCT04285229|451252210|FG000|Follow-up Period|Physician Decision|0|||
125443626|NCT04285229|451252211|FG001|Follow-up Period|Physician Decision|0|||
125443627|NCT04285229|451252212|FG002|Follow-up Period|Physician Decision|0|||
125443628|NCT04285229|451252213|FG003|Follow-up Period|Physician Decision|0|||
125443629|NCT04285229|451252214|FG004|Follow-up Period|Physician Decision|0|||
125443630|NCT04285229|451252215|FG005|Follow-up Period|Physician Decision|1|||
125443631|NCT02397460|451252216|FG000|Treatment Period 2|Adverse Event|0|||
125443632|NCT02397460|451252217|FG001|Treatment Period 2|Adverse Event|0|||
125443633|NCT02397460|451252218|FG002|Treatment Period 2|Adverse Event|0|||
125443634|NCT02397460|451252219|FG003|Treatment Period 2|Adverse Event|0|||
125443635|NCT02397460|451252220|FG004|Treatment Period 2|Adverse Event|0|||
125443636|NCT02397460|451252221|FG005|Treatment Period 2|Adverse Event|0|||
125194071|NCT02016105|450332106|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
125194072|NCT02016105|450332107|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
125194073|NCT02016105|450332102|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
125194074|NCT02016105|450332103|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
125194075|NCT02016105|450332104|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
125194076|NCT02016105|450332105|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
125194077|NCT02016105|450332106|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
125194078|NCT02016105|450332107|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
125194079|NCT02016105|450332102|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
125194080|NCT02016105|450332103|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
125194081|NCT02016105|450332104|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
125194082|NCT02016105|450332105|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
125194083|NCT02016105|450332106|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
125194084|NCT02016105|450332107|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
125194085|NCT02016105|450332102|FG000|EXTENSION PERIOD|Adverse Event|0|||
125194086|NCT02016105|450332103|FG001|EXTENSION PERIOD|Adverse Event|0|||
125194087|NCT02016105|450332104|FG002|EXTENSION PERIOD|Adverse Event|2|||
125194088|NCT02016105|450332105|FG003|EXTENSION PERIOD|Adverse Event|0|||
125194089|NCT02016105|450332106|FG004|EXTENSION PERIOD|Adverse Event|1|||
125194090|NCT02016105|450332107|FG005|EXTENSION PERIOD|Adverse Event|0|||
125194091|NCT02016105|450332102|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
125194092|NCT02016105|450332103|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
125194093|NCT02016105|450332104|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
125194094|NCT02016105|450332105|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
125194095|NCT02016105|450332106|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
125194096|NCT02016105|450332107|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
125443637|NCT02397460|451252222|FG006|Treatment Period 2|Adverse Event|0|||
125443638|NCT02397460|451252223|FG007|Treatment Period 2|Adverse Event|1|||
125443639|NCT02397460|451252216|FG000|Treatment Period 4|Adverse Event|0|||
125443640|NCT02397460|451252217|FG001|Treatment Period 4|Adverse Event|1|||
125443641|NCT02397460|451252218|FG002|Treatment Period 4|Adverse Event|0|||
125443642|NCT02397460|451252219|FG003|Treatment Period 4|Adverse Event|0|||
125194097|NCT02016105|450332102|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
125194098|NCT02016105|450332103|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
125194099|NCT02016105|450332104|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
125194100|NCT02016105|450332105|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
125394757|NCT01869192|451077817|FG001|Postoperative Chemotherapy|Physician Decision|2|||
125394758|NCT00423891|451077821|FG000|Enrolled|Withdrawal by Subject|0|||
125443643|NCT02397460|451252220|FG004|Treatment Period 4|Adverse Event|0|||
125443644|NCT02397460|451252221|FG005|Treatment Period 4|Adverse Event|0|||
125194101|NCT02016105|450332106|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
125194102|NCT02016105|450332107|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
125194103|NCT02016105|450332102|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
125194104|NCT02016105|450332103|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
125194105|NCT02016105|450332104|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
125194106|NCT02016105|450332105|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
125194107|NCT02016105|450332106|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
125194108|NCT02016105|450332107|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
125194109|NCT02247440|450332108|FG000|Overall Study|Withdrawal by Subject|1|||
125194110|NCT02247440|450332108|FG000|Overall Study|Lack of Efficacy|3|||
125194111|NCT02751450|450332112|FG000|Overall Study|Adverse Event|1|||
125194112|NCT02751450|450332113|FG001|Overall Study|Adverse Event|0|||
125194113|NCT01290679|450332114|FG000|Overall Study|Adverse Event|2|||
125194114|NCT01290679|450332115|FG001|Overall Study|Adverse Event|0|||
125194115|NCT01290679|450332114|FG000|Overall Study|Lost to Follow-up|8|||
125194116|NCT01290679|450332115|FG001|Overall Study|Lost to Follow-up|10|||
125194117|NCT01290679|450332114|FG000|Overall Study|Protocol Violation|0|||
125194118|NCT01290679|450332115|FG001|Overall Study|Protocol Violation|1|||
125194119|NCT01290679|450332114|FG000|Overall Study|Withdrawal by Subject|6|||
125194120|NCT01290679|450332115|FG001|Overall Study|Withdrawal by Subject|5|||
125246727|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
125246728|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
125246729|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
125246730|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
125246731|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
125246732|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
125246733|NCT01243424|450528522|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
125246734|NCT01243424|450528523|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
125246735|NCT01243424|450528522|FG000|Discontinuation From Treatment|Not treated|5|||
125246736|NCT01243424|450528523|FG001|Discontinuation From Treatment|Not treated|4|||
125246737|NCT01243424|450528522|FG000|Discontinuation From Treatment|Adverse Event|457|||
125246738|NCT01243424|450528523|FG001|Discontinuation From Treatment|Adverse Event|523|||
125246739|NCT01243424|450528522|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
125246740|NCT01243424|450528523|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
125246741|NCT01243424|450528522|FG000|Discontinuation From Treatment|Protocol Violation|46|||
125246742|NCT01243424|450528523|FG001|Discontinuation From Treatment|Protocol Violation|47|||
125246743|NCT01243424|450528522|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
125246744|NCT01243424|450528523|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
125246745|NCT01243424|450528522|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
125246746|NCT01243424|450528523|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
125246747|NCT01243424|450528522|FG000|Discontinuation From Treatment|Other than listed above|230|||
125246748|NCT01243424|450528523|FG001|Discontinuation From Treatment|Other than listed above|211|||
125246749|NCT00397930|450528526|FG000|Overall Study|Personal reasons|14|||
125246750|NCT00397930|450528527|FG001|Overall Study|Personal reasons|8|||
125246751|NCT00397930|450528526|FG000|Overall Study|Other medical|9|||
125246752|NCT00397930|450528527|FG001|Overall Study|Other medical|4|||
125246753|NCT00397930|450528526|FG000|Overall Study|Unknown reasons|9|||
125246754|NCT00397930|450528527|FG001|Overall Study|Unknown reasons|14|||
125246755|NCT00397930|450528526|FG000|Overall Study|Noncompliant|3|||
125246756|NCT00397930|450528527|FG001|Overall Study|Noncompliant|2|||
125246757|NCT00397930|450528526|FG000|Overall Study|Too time-consuming|2|||
125194121|NCT01290679|450332114|FG000|Overall Study|Subject Entered Another Trial|0|||
125194122|NCT01290679|450332115|FG001|Overall Study|Subject Entered Another Trial|5|||
125194123|NCT00562302|450332116|FG000|Overall Study|Lost to Follow-up|3|||
125194124|NCT00562302|450332117|FG001|Overall Study|Lost to Follow-up|3|||
125246758|NCT00397930|450528527|FG001|Overall Study|Too time-consuming|9|||
125246759|NCT00397930|450528526|FG000|Overall Study|Started own yoga program|1|||
125246760|NCT00397930|450528527|FG001|Overall Study|Started own yoga program|1|||
125246761|NCT00397930|450528526|FG000|Overall Study|Did not want to be in control group|0|||
125246762|NCT00397930|450528527|FG001|Overall Study|Did not want to be in control group|1|||
125246763|NCT00397930|450528526|FG000|Overall Study|Withdrawal by Subject|0|||
125194125|NCT00562302|450332116|FG000|Overall Study|Adverse Event|0|||
125194126|NCT00562302|450332117|FG001|Overall Study|Adverse Event|6|||
125194127|NCT00562302|450332116|FG000|Overall Study|Non-compliance|1|||
125194128|NCT00562302|450332117|FG001|Overall Study|Non-compliance|2|||
125194129|NCT00562302|450332116|FG000|Overall Study|Withdrawal by Subject|7|||
125246764|NCT00397930|450528527|FG001|Overall Study|Withdrawal by Subject|8|||
125246765|NCT00397930|450528526|FG000|Overall Study|Missing data|0|||
125246766|NCT00397930|450528527|FG001|Overall Study|Missing data|4|||
125246767|NCT01960842|450528528|FG000|Overall Study|Adverse Event|1|||
125246768|NCT01960842|450528528|FG000|Overall Study|Withdrawal by Subject|2|||
125246769|NCT02391584|450528529|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
125194130|NCT00562302|450332117|FG001|Overall Study|Withdrawal by Subject|8|||
125394759|NCT00423891|451077822|FG001|Enrolled|Withdrawal by Subject|0|||
125394760|NCT00423891|451077823|FG002|Enrolled|Withdrawal by Subject|1|||
125394761|NCT00423891|451077821|FG000|Enrolled|Lost to Follow-up|0|||
125394762|NCT00423891|451077822|FG001|Enrolled|Lost to Follow-up|0|||
125394763|NCT00423891|451077823|FG002|Enrolled|Lost to Follow-up|1|||
125394764|NCT00423891|451077821|FG000|Enrolled|No longer met criteria|11|||
125394765|NCT00423891|451077822|FG001|Enrolled|No longer met criteria|2|||
125394766|NCT00423891|451077823|FG002|Enrolled|No longer met criteria|1|||
125394767|NCT00423891|451077821|FG000|Treatment|Withdrawal by Subject|1|||
125394768|NCT00423891|451077822|FG001|Treatment|Withdrawal by Subject|0|||
125394769|NCT00423891|451077823|FG002|Treatment|Withdrawal by Subject|0|||
125394770|NCT00423891|451077821|FG000|Treatment|Lost to Follow-up|1|||
125394771|NCT00423891|451077822|FG001|Treatment|Lost to Follow-up|0|||
125394772|NCT00423891|451077823|FG002|Treatment|Lost to Follow-up|0|||
125394773|NCT00423891|451077821|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
125394774|NCT00423891|451077822|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
125394775|NCT00423891|451077823|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
125394776|NCT00423891|451077821|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
125394777|NCT00423891|451077822|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
125394778|NCT00423891|451077823|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
125394779|NCT00414661|451077824|FG000|Overall Study|Death|2|||
125394780|NCT00414661|451077825|FG001|Overall Study|Death|5|||
125394781|NCT00414661|451077826|FG002|Overall Study|Death|0|||
125194131|NCT00562302|450332116|FG000|Overall Study|Death|1|||
125194132|NCT00562302|450332117|FG001|Overall Study|Death|2|||
125194133|NCT00562302|450332116|FG000|Overall Study|Lung resection prior to study completion|7|||
125194134|NCT00562302|450332117|FG001|Overall Study|Lung resection prior to study completion|7|||
125194135|NCT00562302|450332116|FG000|Overall Study|Not stated|1|||
125194136|NCT00562302|450332117|FG001|Overall Study|Not stated|4|||
125194137|NCT03124407|450332123|FG000|Overall Study|Lost to Follow-up|1|||
125194138|NCT03124407|450332124|FG001|Overall Study|Lost to Follow-up|0|||
125194139|NCT03124407|450332125|FG002|Overall Study|Lost to Follow-up|0|||
125194140|NCT03124407|450332126|FG003|Overall Study|Lost to Follow-up|0|||
125194141|NCT03124407|450332123|FG000|Overall Study|Adverse Event|0|||
125194142|NCT03124407|450332124|FG001|Overall Study|Adverse Event|0|||
125194143|NCT03124407|450332125|FG002|Overall Study|Adverse Event|1|||
125194144|NCT03124407|450332126|FG003|Overall Study|Adverse Event|0|||
125194145|NCT01860040|450332129|FG000|Overall Study|Withdrawal by Subject|1|||
125194146|NCT01860040|450332130|FG001|Overall Study|Withdrawal by Subject|0|||
125194147|NCT02821754|450332131|FG000|Overall Study|Procedure not required prior to amendment change|13|||
125194148|NCT02821754|450332132|FG001|Overall Study|Procedure not required prior to amendment change|11|||
125194149|NCT02821754|450332133|FG002|Overall Study|Procedure not required prior to amendment change|0|||
125194150|NCT02821754|450332131|FG000|Overall Study|Participant's Clinical status|2|||
125194151|NCT02821754|450332132|FG001|Overall Study|Participant's Clinical status|0|||
125194152|NCT02821754|450332133|FG002|Overall Study|Participant's Clinical status|0|||
125194153|NCT02821754|450332131|FG000|Overall Study|Participant removed for noncompliance|1|||
125194154|NCT02821754|450332132|FG001|Overall Study|Participant removed for noncompliance|0|||
125194155|NCT02821754|450332133|FG002|Overall Study|Participant removed for noncompliance|0|||
125194156|NCT02821754|450332131|FG000|Overall Study|Drug not available.|0|||
125194157|NCT02821754|450332132|FG001|Overall Study|Drug not available.|0|||
125194158|NCT02821754|450332133|FG002|Overall Study|Drug not available.|1|||
125194159|NCT02821754|450332131|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
125194160|NCT02821754|450332132|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
125194161|NCT02821754|450332133|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
125194162|NCT00994461|450332143|FG000|Overall Study|Adverse Event|2|||
125194163|NCT00994461|450332144|FG001|Overall Study|Adverse Event|1|||
125194164|NCT00994461|450332145|FG002|Overall Study|Adverse Event|0|||
125194165|NCT02347813|450332147|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
125194166|NCT02347813|450332148|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
125194167|NCT02347813|450332147|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
125443645|NCT02397460|451252222|FG006|Treatment Period 4|Adverse Event|0|||
125443646|NCT02397460|451252223|FG007|Treatment Period 4|Adverse Event|0|||
125194168|NCT02347813|450332148|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
125194169|NCT02837731|450332151|FG000|Allocation|Admitted to General Floor|3|||
125194170|NCT02837731|450332152|FG001|Allocation|Admitted to General Floor|4|||
125194171|NCT02837731|450332151|FG000|Allocation|Immediate surgery/withdrew|2|||
125194172|NCT02837731|450332152|FG001|Allocation|Immediate surgery/withdrew|0|||
125443647|NCT02397460|451252216|FG000|Treatment Period 4|Physician Decision|0|||
125194173|NCT02837731|450332151|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
125194174|NCT02837731|450332152|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
125194175|NCT02837731|450332151|FG000|Allocation|Withdrawal by Subject|2|||
125394782|NCT00414661|451077827|FG003|Overall Study|Death|0|||
125394783|NCT00414661|451077824|FG000|Overall Study|Lost to Follow-up|1|||
125394784|NCT00414661|451077825|FG001|Overall Study|Lost to Follow-up|4|||
125394785|NCT00414661|451077826|FG002|Overall Study|Lost to Follow-up|0|||
125246770|NCT02391584|450528530|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
125246771|NCT02391584|450528529|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
125246772|NCT02391584|450528530|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
125246773|NCT02391584|450528529|FG000|3 Month|Lost to Follow-up|1|||
125246774|NCT02391584|450528530|FG001|3 Month|Lost to Follow-up|0|||
125246775|NCT02391584|450528529|FG000|6 Month|Withdrawal by Subject|1|||
125246776|NCT02391584|450528530|FG001|6 Month|Withdrawal by Subject|0|||
125246777|NCT02391584|450528529|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
125246778|NCT02391584|450528530|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
125246779|NCT00617903|450528544|FG000|Overall Study|Withdrawal by Subject|2|||
125246780|NCT00617903|450528545|FG001|Overall Study|Withdrawal by Subject|3|||
125246781|NCT00617903|450528544|FG000|Overall Study|Lost to Follow-up|1|||
125246782|NCT00617903|450528545|FG001|Overall Study|Lost to Follow-up|1|||
125246783|NCT00617903|450528544|FG000|Overall Study|Lack of Efficacy|0|||
125246784|NCT00617903|450528545|FG001|Overall Study|Lack of Efficacy|1|||
125246785|NCT00617903|450528544|FG000|Overall Study|Adverse Event|0|||
125246786|NCT00617903|450528545|FG001|Overall Study|Adverse Event|1|||
125246787|NCT00617903|450528544|FG000|Overall Study|noncompliance|0|||
125246788|NCT00617903|450528545|FG001|Overall Study|noncompliance|1|||
125194176|NCT02837731|450332152|FG001|Allocation|Withdrawal by Subject|0|||
125194177|NCT02837731|450332151|FG000|Allocation|Device not available|1|||
125194178|NCT02837731|450332152|FG001|Allocation|Device not available|0|||
125194179|NCT02837731|450332151|FG000|Allocation|Protocol not implemented|7|||
125194180|NCT02837731|450332152|FG001|Allocation|Protocol not implemented|0|||
125194181|NCT02837731|450332151|FG000|Allocation|Moribund/Do not resuscitate|2|||
125194182|NCT02837731|450332152|FG001|Allocation|Moribund/Do not resuscitate|0|||
125194183|NCT02837731|450332151|FG000|Allocation|Did not meet sepsis criteria|1|||
125194184|NCT02837731|450332152|FG001|Allocation|Did not meet sepsis criteria|2|||
125194185|NCT02837731|450332151|FG000|Allocation|Known aortic abnormalities|0|||
125246789|NCT05156125|450528546|FG000|Overall Study|Lack of Efficacy|1|||
125194186|NCT02837731|450332152|FG001|Allocation|Known aortic abnormalities|1|||
125194187|NCT01119859|450332153|FG000|Overall Study|Adverse Event|9|||
125194188|NCT01119859|450332154|FG001|Overall Study|Adverse Event|10|||
125194189|NCT01119859|450332153|FG000|Overall Study|Death|2|||
125194190|NCT01119859|450332154|FG001|Overall Study|Death|0|||
125194191|NCT01119859|450332153|FG000|Overall Study|Insufficient therapeutic response|7|||
125194192|NCT01119859|450332154|FG001|Overall Study|Insufficient therapeutic response|14|||
125194193|NCT01119859|450332153|FG000|Overall Study|Refused treatment|3|||
125194194|NCT01119859|450332154|FG001|Overall Study|Refused treatment|6|||
125194195|NCT01119859|450332153|FG000|Overall Study|Failure to return|3|||
125194196|NCT01119859|450332154|FG001|Overall Study|Failure to return|0|||
125194197|NCT00603473|450332155|FG000|Overall Study|Adverse Event|4|||
125194198|NCT00603473|450332155|FG000|Overall Study|Lack of Efficacy|4|||
125194199|NCT00603473|450332155|FG000|Overall Study|Protocol Violation|1|||
125194200|NCT02644668|450332156|FG000|Overall Study|Adverse Event|2|||
125194201|NCT02644668|450332157|FG001|Overall Study|Adverse Event|0|||
125194202|NCT02644668|450332158|FG002|Overall Study|Adverse Event|1|||
125194203|NCT02644668|450332156|FG000|Overall Study|Protocol Violation|0|||
125194204|NCT02644668|450332157|FG001|Overall Study|Protocol Violation|0|||
125194205|NCT02644668|450332158|FG002|Overall Study|Protocol Violation|1|||
125194206|NCT02644668|450332156|FG000|Overall Study|Withdrawal by Subject|0|||
125194207|NCT02644668|450332157|FG001|Overall Study|Withdrawal by Subject|0|||
125194208|NCT02644668|450332158|FG002|Overall Study|Withdrawal by Subject|1|||
125194209|NCT01134939|450332162|FG000|Overall Study|Adverse Event|9|||
125194210|NCT01134939|450332163|FG001|Overall Study|Adverse Event|3|||
125194211|NCT01134939|450332164|FG002|Overall Study|Adverse Event|4|||
125194212|NCT01134939|450332165|FG003|Overall Study|Adverse Event|5|||
125194213|NCT01134939|450332166|FG004|Overall Study|Adverse Event|5|||
125194214|NCT01134939|450332167|FG005|Overall Study|Adverse Event|5|||
125194215|NCT01134939|450332168|FG006|Overall Study|Adverse Event|1|||
125194216|NCT01134939|450332169|FG007|Overall Study|Adverse Event|0|||
125194217|NCT01134939|450332162|FG000|Overall Study|Lack of Efficacy|2|||
125246790|NCT05156125|450528547|FG001|Overall Study|Lack of Efficacy|1|||
125246791|NCT05156125|450528548|FG002|Overall Study|Lack of Efficacy|1|||
125246792|NCT05156125|450528546|FG000|Overall Study|Physician Decision|0|||
125246793|NCT05156125|450528547|FG001|Overall Study|Physician Decision|0|||
125246794|NCT05156125|450528548|FG002|Overall Study|Physician Decision|1|||
125246795|NCT05156125|450528546|FG000|Overall Study|Non-compliance|0|||
125246796|NCT05156125|450528547|FG001|Overall Study|Non-compliance|1|||
125246797|NCT05156125|450528548|FG002|Overall Study|Non-compliance|1|||
125246798|NCT05156125|450528546|FG000|Overall Study|Withdrawal by Subject|0|||
125246799|NCT05156125|450528547|FG001|Overall Study|Withdrawal by Subject|0|||
125246800|NCT05156125|450528548|FG002|Overall Study|Withdrawal by Subject|1|||
125194218|NCT01134939|450332163|FG001|Overall Study|Lack of Efficacy|5|||
125194219|NCT01134939|450332164|FG002|Overall Study|Lack of Efficacy|1|||
125194220|NCT01134939|450332165|FG003|Overall Study|Lack of Efficacy|0|||
125194221|NCT01134939|450332166|FG004|Overall Study|Lack of Efficacy|3|||
125194222|NCT01134939|450332167|FG005|Overall Study|Lack of Efficacy|0|||
125194223|NCT01134939|450332168|FG006|Overall Study|Lack of Efficacy|1|||
125394786|NCT00414661|451077827|FG003|Overall Study|Lost to Follow-up|1|||
125394787|NCT00414661|451077824|FG000|Overall Study|Withdrawal by Subject|5|||
125394788|NCT00414661|451077825|FG001|Overall Study|Withdrawal by Subject|2|||
125394789|NCT00414661|451077826|FG002|Overall Study|Withdrawal by Subject|2|||
125394790|NCT00414661|451077827|FG003|Overall Study|Withdrawal by Subject|2|||
125394791|NCT00414661|451077824|FG000|Overall Study|Other|6|||
125394792|NCT00414661|451077825|FG001|Overall Study|Other|3|||
125394793|NCT00414661|451077826|FG002|Overall Study|Other|0|||
125394794|NCT00414661|451077827|FG003|Overall Study|Other|0|||
125194224|NCT01134939|450332169|FG007|Overall Study|Lack of Efficacy|0|||
125246801|NCT05156125|450528546|FG000|Overall Study|Adverse Event|2|||
125246802|NCT05156125|450528547|FG001|Overall Study|Adverse Event|1|||
125246803|NCT05156125|450528548|FG002|Overall Study|Adverse Event|0|||
125246804|NCT03123588|450528554|FG000|Overall Study|Study Terminated by Sponsor|2|||
125246805|NCT03123588|450528555|FG001|Overall Study|Study Terminated by Sponsor|5|||
125246806|NCT03123588|450528554|FG000|Overall Study|Withdrawal by Subject|1|||
125246807|NCT03123588|450528555|FG001|Overall Study|Withdrawal by Subject|0|||
125246808|NCT03123588|450528554|FG000|Overall Study|Adverse Event|1|||
125246809|NCT03123588|450528555|FG001|Overall Study|Adverse Event|0|||
125246810|NCT03123588|450528554|FG000|Overall Study|Physician Decision|2|||
125246811|NCT03123588|450528555|FG001|Overall Study|Physician Decision|1|||
125246812|NCT01698008|450528558|FG000|Overall Study|Withdrawal by Subject|1|||
125246813|NCT01698008|450528559|FG001|Overall Study|Withdrawal by Subject|2|||
125246814|NCT01755637|450528562|FG000|Period 1|Adverse Event|0|||
125246815|NCT01755637|450528563|FG001|Period 1|Adverse Event|1|||
125246816|NCT01814332|450528565|FG000|Overall Study|Adverse Event|8|||
125246817|NCT01814332|450528566|FG001|Overall Study|Adverse Event|3|||
125246818|NCT01814332|450528565|FG000|Overall Study|Withdrawal by Subject|3|||
125246819|NCT01814332|450528566|FG001|Overall Study|Withdrawal by Subject|8|||
125246820|NCT01814332|450528565|FG000|Overall Study|Protocol Violation|0|||
125194225|NCT01134939|450332162|FG000|Overall Study|Lost to Follow-up|2|||
125194226|NCT01134939|450332163|FG001|Overall Study|Lost to Follow-up|3|||
125194227|NCT01134939|450332164|FG002|Overall Study|Lost to Follow-up|0|||
125246821|NCT01814332|450528566|FG001|Overall Study|Protocol Violation|4|||
125246822|NCT01814332|450528565|FG000|Overall Study|Lost to Follow-up|5|||
125246823|NCT01814332|450528566|FG001|Overall Study|Lost to Follow-up|1|||
125246824|NCT02959892|450528567|FG000|Overall Study|PET tracer synthesis failure|1|||
125246825|NCT02959892|450528568|FG001|Overall Study|PET tracer synthesis failure|0|||
125246826|NCT02959892|450528567|FG000|Overall Study|Study termination|0|||
125194228|NCT01134939|450332165|FG003|Overall Study|Lost to Follow-up|1|||
125194229|NCT01134939|450332166|FG004|Overall Study|Lost to Follow-up|2|||
125194230|NCT01134939|450332167|FG005|Overall Study|Lost to Follow-up|1|||
125194231|NCT01134939|450332168|FG006|Overall Study|Lost to Follow-up|0|||
125194232|NCT01134939|450332169|FG007|Overall Study|Lost to Follow-up|0|||
125194233|NCT01134939|450332162|FG000|Overall Study|Death|0|||
125194234|NCT01134939|450332163|FG001|Overall Study|Death|1|||
125194235|NCT01134939|450332164|FG002|Overall Study|Death|0|||
125194236|NCT01134939|450332165|FG003|Overall Study|Death|0|||
125194237|NCT01134939|450332166|FG004|Overall Study|Death|0|||
125194238|NCT01134939|450332167|FG005|Overall Study|Death|0|||
125194239|NCT01134939|450332168|FG006|Overall Study|Death|0|||
125194240|NCT01134939|450332169|FG007|Overall Study|Death|0|||
125194241|NCT01134939|450332162|FG000|Overall Study|Termination page not available|4|||
125194242|NCT01134939|450332163|FG001|Overall Study|Termination page not available|6|||
125194243|NCT01134939|450332164|FG002|Overall Study|Termination page not available|5|||
125194244|NCT01134939|450332165|FG003|Overall Study|Termination page not available|8|||
125194245|NCT01134939|450332166|FG004|Overall Study|Termination page not available|0|||
125194246|NCT01134939|450332167|FG005|Overall Study|Termination page not available|3|||
125194247|NCT01134939|450332168|FG006|Overall Study|Termination page not available|7|||
125194248|NCT01134939|450332169|FG007|Overall Study|Termination page not available|0|||
125194249|NCT00733421|450332170|FG000|Overall Study|Withdrawal by Subject|1|||
125194250|NCT00733421|450332171|FG001|Overall Study|Withdrawal by Subject|1|||
125194251|NCT03478644|450332175|FG000|Phase 2|Withdrawal by Subject|2|||
125194252|NCT03478644|450332176|FG001|Phase 2|Withdrawal by Subject|1|||
125194253|NCT03478644|450332175|FG000|Phase 2|Lost to Follow-up|1|||
125194254|NCT03478644|450332176|FG001|Phase 2|Lost to Follow-up|0|||
125246827|NCT02959892|450528568|FG001|Overall Study|Study termination|1|||
125246828|NCT02346370|450528571|FG000|Overall Study|Not treated|1|||
125246829|NCT02346370|450528572|FG001|Overall Study|Not treated|0|||
125246830|NCT02346370|450528573|FG002|Overall Study|Not treated|0|||
125246831|NCT02346370|450528571|FG000|Overall Study|Withdrawal of consent|1|||
125246832|NCT02346370|450528572|FG001|Overall Study|Withdrawal of consent|0|||
125394795|NCT00357370|451077828|FG000|Cohort 2|Lack of Efficacy|0|||
125194255|NCT00789698|450332177|FG000|Overall Study|Lack of Efficacy|10|||
125194256|NCT00789698|450332178|FG001|Overall Study|Lack of Efficacy|4|||
125194257|NCT00789698|450332179|FG002|Overall Study|Lack of Efficacy|5|||
125194258|NCT00789698|450332180|FG003|Overall Study|Lack of Efficacy|18|||
125246833|NCT02346370|450528573|FG002|Overall Study|Withdrawal of consent|0|||
125394796|NCT00357370|451077829|FG001|Cohort 2|Lack of Efficacy|2|||
125394797|NCT00357370|451077830|FG002|Cohort 2|Lack of Efficacy|1|||
125194259|NCT00789698|450332177|FG000|Overall Study|Adverse Event|5|||
125194260|NCT00789698|450332178|FG001|Overall Study|Adverse Event|5|||
125194261|NCT00789698|450332179|FG002|Overall Study|Adverse Event|3|||
125194262|NCT00789698|450332180|FG003|Overall Study|Adverse Event|4|||
125194263|NCT00789698|450332177|FG000|Overall Study|Lost to Follow-up|5|||
125194264|NCT00789698|450332178|FG001|Overall Study|Lost to Follow-up|5|||
125194265|NCT00789698|450332179|FG002|Overall Study|Lost to Follow-up|2|||
125194266|NCT00789698|450332180|FG003|Overall Study|Lost to Follow-up|9|||
125194267|NCT00789698|450332177|FG000|Overall Study|Protocol Violation|6|||
125194268|NCT00789698|450332178|FG001|Overall Study|Protocol Violation|1|||
125194269|NCT00789698|450332179|FG002|Overall Study|Protocol Violation|2|||
125194270|NCT00789698|450332180|FG003|Overall Study|Protocol Violation|1|||
125194271|NCT00789698|450332177|FG000|Overall Study|Withdrawal by Subject|14|||
125194272|NCT00789698|450332178|FG001|Overall Study|Withdrawal by Subject|15|||
125394798|NCT00357370|451077828|FG000|Cohort 2|Adverse Event|1|||
125194273|NCT00789698|450332179|FG002|Overall Study|Withdrawal by Subject|12|||
125194274|NCT00789698|450332180|FG003|Overall Study|Withdrawal by Subject|19|||
125194275|NCT00789698|450332177|FG000|Overall Study|Administrative|0|||
125194276|NCT00789698|450332178|FG001|Overall Study|Administrative|3|||
125194277|NCT00789698|450332179|FG002|Overall Study|Administrative|3|||
125194278|NCT00789698|450332180|FG003|Overall Study|Administrative|1|||
125194279|NCT00596817|450332181|FG000|Open-label Period|Adverse Event|0|||
125246834|NCT02346370|450528571|FG000|Overall Study|Death|1|||
125246835|NCT02346370|450528572|FG001|Overall Study|Death|3|||
125246836|NCT02346370|450528573|FG002|Overall Study|Death|1|||
125246837|NCT02346370|450528571|FG000|Overall Study|Sponsor discontinued study|5|||
125246838|NCT02346370|450528572|FG001|Overall Study|Sponsor discontinued study|0|||
125246839|NCT02346370|450528573|FG002|Overall Study|Sponsor discontinued study|2|||
125246840|NCT02346370|450528571|FG000|Overall Study|Radiologic progression|0|||
125394799|NCT00357370|451077829|FG001|Cohort 2|Adverse Event|1|||
125394800|NCT00357370|451077830|FG002|Cohort 2|Adverse Event|1|||
125394801|NCT00357370|451077828|FG000|Cohort 2|Lost to Follow-up|0|||
125394802|NCT00357370|451077829|FG001|Cohort 2|Lost to Follow-up|1|||
125394803|NCT00357370|451077830|FG002|Cohort 2|Lost to Follow-up|0|||
125394804|NCT00357370|451077828|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
125394805|NCT00357370|451077829|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
125394806|NCT00357370|451077830|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
125394807|NCT00357370|451077828|FG000|Cohort 2|Withdrawal by Subject|0|||
125394808|NCT00357370|451077829|FG001|Cohort 2|Withdrawal by Subject|2|||
125394809|NCT00357370|451077830|FG002|Cohort 2|Withdrawal by Subject|0|||
125394810|NCT01828034|451077833|FG000|Overall Study|Withdrawal by Subject|0|||
125394811|NCT01828034|451077834|FG001|Overall Study|Withdrawal by Subject|0|||
125394812|NCT01828034|451077835|FG002|Overall Study|Withdrawal by Subject|0|||
125394813|NCT01828034|451077836|FG003|Overall Study|Withdrawal by Subject|1|||
125394814|NCT01988571|451077837|FG000|Overall Study|Death|3|||
125394815|NCT01988571|451077838|FG001|Overall Study|Death|1|||
125394816|NCT01988571|451077837|FG000|Overall Study|Physician Decision|2|||
125394817|NCT01988571|451077838|FG001|Overall Study|Physician Decision|1|||
125394818|NCT01988571|451077837|FG000|Overall Study|Lost to Follow-up|3|||
125394819|NCT01988571|451077838|FG001|Overall Study|Lost to Follow-up|0|||
125394820|NCT01988571|451077837|FG000|Overall Study|Withdrawal by Subject|31|||
125394821|NCT01988571|451077838|FG001|Overall Study|Withdrawal by Subject|33|||
125394822|NCT00004412|451077839|FG000|Randomized Period|Moved to Crossover Period|3|||
125394823|NCT00004412|451077840|FG001|Randomized Period|Moved to Crossover Period|0|||
125394824|NCT00004412|451077841|FG002|Randomized Period|Moved to Crossover Period|0|||
125394825|NCT00937547|451077843|FG000|Overall Study|misdiagnosis|1|||
125246841|NCT02346370|450528572|FG001|Overall Study|Radiologic progression|0|||
125246842|NCT02346370|450528573|FG002|Overall Study|Radiologic progression|1|||
125246843|NCT02346370|450528571|FG000|Overall Study|Physician Decision|0|||
125246844|NCT02346370|450528572|FG001|Overall Study|Physician Decision|1|||
125246845|NCT02346370|450528573|FG002|Overall Study|Physician Decision|0|||
125394826|NCT00937547|451077844|FG001|Overall Study|misdiagnosis|6|||
125246846|NCT03528577|450528574|FG000|Sequence 1|Failed Spirometry|1|||
125246847|NCT03528577|450528574|FG000|Sequence 1|Restricted medication|1|||
125394827|NCT00937547|451077845|FG002|Overall Study|misdiagnosis|7|||
125394828|NCT00404352|451077847|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
125194280|NCT00596817|450332182|FG001|Open-label Period|Adverse Event|49|||
125194281|NCT00596817|450332181|FG000|Open-label Period|Lack of Efficacy|0|||
125194282|NCT00596817|450332182|FG001|Open-label Period|Lack of Efficacy|33|||
125194283|NCT00596817|450332181|FG000|Open-label Period|Other Reasons|0|||
125246848|NCT03528577|450528574|FG000|Sequence 2|Adverse Event|1|||
125246849|NCT03528577|450528574|FG000|Sequence 2|Withdrawal by Subject|1|||
125246850|NCT03528577|450528574|FG000|Sequence 2|Failed Spirometry|1|||
125394829|NCT00404352|451077848|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
125394830|NCT00404352|451077849|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
125394831|NCT00404352|451077850|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
125394832|NCT00404352|451077851|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
125394833|NCT00404352|451077852|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
125194284|NCT00596817|450332182|FG001|Open-label Period|Other Reasons|65|||
125194285|NCT00596817|450332181|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
125394834|NCT00404352|451077853|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
125394835|NCT00404352|451077854|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
125394836|NCT00404352|451077855|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
125394837|NCT00404352|451077847|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
125394838|NCT00404352|451077848|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
125394839|NCT00404352|451077849|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
125394840|NCT00404352|451077850|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
125394841|NCT00404352|451077851|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
125394842|NCT00404352|451077852|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
125394843|NCT00404352|451077853|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
125394844|NCT00404352|451077854|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
125394845|NCT00404352|451077855|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
125394846|NCT00404352|451077847|FG000|Double Blind (up to 24 Month)|Death|0|||
125394847|NCT00404352|451077848|FG001|Double Blind (up to 24 Month)|Death|0|||
125394848|NCT00404352|451077849|FG002|Double Blind (up to 24 Month)|Death|1|||
125394849|NCT00404352|451077850|FG003|Double Blind (up to 24 Month)|Death|0|||
125394850|NCT00404352|451077851|FG004|Double Blind (up to 24 Month)|Death|0|||
125394851|NCT00404352|451077852|FG005|Double Blind (up to 24 Month)|Death|0|||
125394852|NCT00404352|451077853|FG006|Double Blind (up to 24 Month)|Death|0|||
125394853|NCT00404352|451077854|FG007|Double Blind (up to 24 Month)|Death|0|||
125394854|NCT00404352|451077855|FG008|Double Blind (up to 24 Month)|Death|0|||
125394855|NCT00404352|451077847|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
125394856|NCT00404352|451077848|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
125394857|NCT00404352|451077849|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
125394858|NCT00404352|451077850|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
125394859|NCT00404352|451077851|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
125394860|NCT00404352|451077852|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
125394861|NCT00404352|451077853|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
125394862|NCT00404352|451077854|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
125394863|NCT00404352|451077855|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
125394864|NCT00404352|451077847|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
125394865|NCT00404352|451077848|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
125394866|NCT00404352|451077849|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
125394867|NCT00404352|451077850|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
125394868|NCT00404352|451077851|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
125394869|NCT00404352|451077852|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
125394870|NCT00404352|451077853|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
125394871|NCT00404352|451077854|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
125394872|NCT00404352|451077855|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
125394873|NCT00404352|451077847|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
125394874|NCT00404352|451077848|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
125394875|NCT00404352|451077849|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
125394876|NCT00404352|451077850|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
125394877|NCT00404352|451077851|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
125394878|NCT00404352|451077852|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
125394879|NCT00404352|451077853|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
125394880|NCT00404352|451077854|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
125394881|NCT00404352|451077855|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
125394882|NCT00404352|451077847|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
125394883|NCT00404352|451077848|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
125394884|NCT00404352|451077849|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
125394885|NCT00404352|451077850|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
125394886|NCT00404352|451077851|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
125394887|NCT00404352|451077852|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
125394888|NCT00404352|451077853|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
125394889|NCT00404352|451077854|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
125394890|NCT00404352|451077855|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
125394891|NCT00404352|451077847|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
125194286|NCT00596817|450332182|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
125194287|NCT00596817|450332181|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
125194288|NCT00596817|450332182|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
125194289|NCT00596817|450332181|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
125394892|NCT00404352|451077848|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
125394893|NCT00404352|451077849|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
125394894|NCT00404352|451077850|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
125394895|NCT00404352|451077851|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
125194290|NCT00596817|450332182|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
125394896|NCT00404352|451077852|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
125394897|NCT00404352|451077853|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
125394898|NCT00404352|451077854|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
125394899|NCT00404352|451077855|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
125394900|NCT00404352|451077847|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125394901|NCT00404352|451077848|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
125394902|NCT00404352|451077849|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125394903|NCT00404352|451077850|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125394904|NCT00404352|451077851|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125394905|NCT00404352|451077852|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125394906|NCT00404352|451077853|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125394907|NCT00404352|451077854|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125394908|NCT00404352|451077855|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
125394909|NCT00404352|451077847|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
125394910|NCT00404352|451077848|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
125394911|NCT00404352|451077849|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
125394912|NCT00404352|451077850|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
125394913|NCT00404352|451077851|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
125394914|NCT00404352|451077852|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
125394915|NCT00404352|451077853|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
125394916|NCT00404352|451077854|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
125394917|NCT00404352|451077855|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
125394918|NCT00404352|451077847|FG000|Double Blind (up to 24 Month)|Other|0|||
125394919|NCT00404352|451077848|FG001|Double Blind (up to 24 Month)|Other|1|||
125394920|NCT00404352|451077849|FG002|Double Blind (up to 24 Month)|Other|0|||
125394921|NCT00404352|451077850|FG003|Double Blind (up to 24 Month)|Other|0|||
125394922|NCT00404352|451077851|FG004|Double Blind (up to 24 Month)|Other|0|||
125394923|NCT00404352|451077852|FG005|Double Blind (up to 24 Month)|Other|0|||
125394924|NCT00404352|451077853|FG006|Double Blind (up to 24 Month)|Other|0|||
125394925|NCT00404352|451077854|FG007|Double Blind (up to 24 Month)|Other|0|||
125194291|NCT00596817|450332181|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
125194292|NCT00596817|450332182|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
125394926|NCT00404352|451077855|FG008|Double Blind (up to 24 Month)|Other|0|||
125394927|NCT00404352|451077847|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
125394928|NCT00404352|451077848|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
125394929|NCT00404352|451077849|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
125394930|NCT00404352|451077850|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
125394931|NCT00404352|451077851|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
125394932|NCT00404352|451077852|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
125394933|NCT00404352|451077853|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
125394934|NCT00404352|451077854|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
125394935|NCT00404352|451077855|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
125394936|NCT00404352|451077847|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
125394937|NCT00404352|451077848|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
125394938|NCT00404352|451077849|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
125394939|NCT00404352|451077850|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
125394940|NCT00404352|451077851|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
125394941|NCT00404352|451077852|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
125394942|NCT00404352|451077853|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
125394943|NCT00404352|451077854|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
125394944|NCT00404352|451077855|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
125394945|NCT00404352|451077847|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125394946|NCT00404352|451077848|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125394947|NCT00404352|451077849|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125394948|NCT00404352|451077850|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125394949|NCT00404352|451077851|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
125394950|NCT00404352|451077852|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125394951|NCT00404352|451077853|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125194293|NCT00596817|450332181|FG000|Double-blind Period|Adverse Event|5|||
125194294|NCT00596817|450332182|FG001|Double-blind Period|Adverse Event|16|||
125194295|NCT00596817|450332181|FG000|Double-blind Period|Lack of Efficacy|52|||
125194296|NCT00596817|450332182|FG001|Double-blind Period|Lack of Efficacy|28|||
125194297|NCT00596817|450332181|FG000|Double-blind Period|Non-compliance With Study Product|3|||
125194298|NCT00596817|450332182|FG001|Double-blind Period|Non-compliance With Study Product|4|||
125194299|NCT00596817|450332181|FG000|Double-blind Period|Protocol Violation|11|||
125194300|NCT00596817|450332182|FG001|Double-blind Period|Protocol Violation|8|||
125394952|NCT00404352|451077854|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125394953|NCT00404352|451077855|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
125394954|NCT00404352|451077847|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125194301|NCT00596817|450332181|FG000|Double-blind Period|Withdrawal of Consent|7|||
125394955|NCT00404352|451077848|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125394956|NCT00404352|451077849|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125394957|NCT00404352|451077850|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125394958|NCT00404352|451077851|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125394959|NCT00404352|451077852|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
125394960|NCT00404352|451077853|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125394961|NCT00404352|451077854|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125394962|NCT00404352|451077855|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
125394963|NCT00404352|451077847|FG000|Open Label (up to 24 Month)|Disease progression|0|||
125394964|NCT00404352|451077848|FG001|Open Label (up to 24 Month)|Disease progression|0|||
125394965|NCT00404352|451077849|FG002|Open Label (up to 24 Month)|Disease progression|0|||
125394966|NCT00404352|451077850|FG003|Open Label (up to 24 Month)|Disease progression|1|||
125394967|NCT00404352|451077851|FG004|Open Label (up to 24 Month)|Disease progression|0|||
125394968|NCT00404352|451077852|FG005|Open Label (up to 24 Month)|Disease progression|0|||
125394969|NCT00404352|451077853|FG006|Open Label (up to 24 Month)|Disease progression|0|||
125394970|NCT00404352|451077854|FG007|Open Label (up to 24 Month)|Disease progression|0|||
125394971|NCT00404352|451077855|FG008|Open Label (up to 24 Month)|Disease progression|0|||
125394972|NCT00404352|451077847|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125394973|NCT00404352|451077848|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125394974|NCT00404352|451077849|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125394975|NCT00404352|451077850|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125394976|NCT00404352|451077851|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125394977|NCT00404352|451077852|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125394978|NCT00404352|451077853|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
125394979|NCT00404352|451077854|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
125394980|NCT00404352|451077855|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
125394981|NCT00404352|451077847|FG000|Open Label Extension (up to 36 Months)|Other|0|||
125394982|NCT00404352|451077848|FG001|Open Label Extension (up to 36 Months)|Other|0|||
125394983|NCT00404352|451077849|FG002|Open Label Extension (up to 36 Months)|Other|0|||
125394984|NCT00404352|451077850|FG003|Open Label Extension (up to 36 Months)|Other|0|||
125394985|NCT00404352|451077851|FG004|Open Label Extension (up to 36 Months)|Other|0|||
125394986|NCT00404352|451077852|FG005|Open Label Extension (up to 36 Months)|Other|0|||
125394987|NCT00404352|451077853|FG006|Open Label Extension (up to 36 Months)|Other|0|||
125394988|NCT00404352|451077854|FG007|Open Label Extension (up to 36 Months)|Other|0|||
125394989|NCT00404352|451077855|FG008|Open Label Extension (up to 36 Months)|Other|2|||
125394990|NCT02346136|451077858|FG000|Overall Study|Withdrawal by Subject|7|||
125394991|NCT02346136|451077859|FG001|Overall Study|Withdrawal by Subject|5|||
125394992|NCT02346136|451077858|FG000|Overall Study|Death|1|||
125394993|NCT02346136|451077859|FG001|Overall Study|Death|0|||
125394994|NCT02346136|451077858|FG000|Overall Study|Study termination|14|||
125394995|NCT02346136|451077859|FG001|Overall Study|Study termination|18|||
125394996|NCT02308735|451077862|FG000|Overall Study|Physician Decision|2|||
125394997|NCT02308735|451077863|FG001|Overall Study|Physician Decision|0|||
125394998|NCT02308735|451077864|FG002|Overall Study|Physician Decision|0|||
125394999|NCT02308735|451077865|FG003|Overall Study|Physician Decision|2|||
125395000|NCT00453999|451077866|FG000|Overall Study|Adverse Event|1|||
125395001|NCT00453999|451077867|FG001|Overall Study|Adverse Event|2|||
125395002|NCT00453999|451077868|FG002|Overall Study|Adverse Event|1|||
125246851|NCT03528577|450528574|FG000|Sequence 3|Failed Spirometry|1|||
125246852|NCT03528577|450528574|FG000|Sequence 4|Failed Spirometry|2|||
125246853|NCT03528577|450528574|FG000|Sequence 4|Adverse Event|1|||
125246854|NCT04882215|450528575|FG000|Overall Study|Withdrawal by Subject|5|||
125246855|NCT04882215|450528576|FG001|Overall Study|Withdrawal by Subject|0|||
125246856|NCT04098302|450528577|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
125246857|NCT04098302|450528578|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
125246858|NCT04098302|450528579|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
125246859|NCT04098302|450528580|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
125246860|NCT04098302|450528577|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
125246861|NCT04098302|450528578|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
125395003|NCT00453999|451077866|FG000|Overall Study|Lost to Follow-up|0|||
125395004|NCT00453999|451077867|FG001|Overall Study|Lost to Follow-up|1|||
125395005|NCT00453999|451077868|FG002|Overall Study|Lost to Follow-up|1|||
125395006|NCT00453999|451077866|FG000|Overall Study|Withdrawal by Subject|2|||
125395007|NCT00453999|451077867|FG001|Overall Study|Withdrawal by Subject|1|||
125395008|NCT00453999|451077868|FG002|Overall Study|Withdrawal by Subject|1|||
125246862|NCT04098302|450528579|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
125246863|NCT04098302|450528580|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
125395009|NCT00453999|451077866|FG000|Overall Study|Subject Request|2|||
125395010|NCT00453999|451077867|FG001|Overall Study|Subject Request|1|||
125395011|NCT00453999|451077868|FG002|Overall Study|Subject Request|0|||
125395012|NCT00696137|451077877|FG000|Overall Study|Withdrawal by Subject|2|||
125395013|NCT03742141|451077884|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
125395014|NCT02376166|451077885|FG000|Overall Study|Adverse Event|1|||
125194302|NCT00596817|450332182|FG001|Double-blind Period|Withdrawal of Consent|3|||
125194303|NCT00596817|450332181|FG000|Double-blind Period|Lost to Follow-up|0|||
125194304|NCT00596817|450332182|FG001|Double-blind Period|Lost to Follow-up|2|||
125194305|NCT00596817|450332181|FG000|Double-blind Period|Other Reasons|10|||
125194306|NCT00596817|450332182|FG001|Double-blind Period|Other Reasons|18|||
125194307|NCT04402138|450333395|FG000|Overall Study|Progressive Disease|2|||
125194308|NCT04402138|450333395|FG000|Overall Study|Adverse Event|1|||
125194309|NCT03056638|450333398|FG000|Overall Study|Death|1|||
125194310|NCT03056638|450333399|FG001|Overall Study|Death|0|||
125194311|NCT03508726|450333400|FG000|Overall Study|Withdrawal by Subject|0|||
125194312|NCT03508726|450333401|FG001|Overall Study|Withdrawal by Subject|1|||
125194313|NCT04411810|450333405|FG000|Overall Study|Screen failure|1|||
125194314|NCT04411810|450333405|FG000|Overall Study|Withdrawal by Subject|1|||
125194315|NCT03981926|450333406|FG000|Overall Study|Lost to Follow-up|5|||
125194316|NCT03981926|450333407|FG001|Overall Study|Lost to Follow-up|9|||
125194317|NCT01920958|450333408|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
125194318|NCT00610155|450333409|FG000|Period 1|Withdrawal by Subject|0|||
125194319|NCT00610155|450333410|FG001|Period 1|Withdrawal by Subject|0|||
125194320|NCT00610155|450333411|FG002|Period 1|Withdrawal by Subject|1|||
125194321|NCT00610155|450333412|FG003|Period 1|Withdrawal by Subject|0|||
125194322|NCT00610155|450333413|FG004|Period 1|Withdrawal by Subject|0|||
125194323|NCT00610155|450333414|FG005|Period 1|Withdrawal by Subject|0|||
125194324|NCT00610155|450333409|FG000|Period 3|Adverse Event|1|||
125194325|NCT00610155|450333410|FG001|Period 3|Adverse Event|0|||
125194326|NCT00610155|450333411|FG002|Period 3|Adverse Event|0|||
125194327|NCT00610155|450333412|FG003|Period 3|Adverse Event|0|||
125194328|NCT00610155|450333413|FG004|Period 3|Adverse Event|0|||
125194329|NCT00610155|450333414|FG005|Period 3|Adverse Event|0|||
125194330|NCT01560234|450333415|FG000|Overall Study|Lost to Follow-up|3|||
125194331|NCT01560234|450333416|FG001|Overall Study|Lost to Follow-up|0|||
125194332|NCT01560234|450333417|FG002|Overall Study|Lost to Follow-up|1|||
125194333|NCT01560234|450333418|FG003|Overall Study|Lost to Follow-up|0|||
125194334|NCT01560234|450333419|FG004|Overall Study|Lost to Follow-up|0|||
125194335|NCT01560234|450333420|FG005|Overall Study|Lost to Follow-up|2|||
125194336|NCT01560234|450333421|FG006|Overall Study|Lost to Follow-up|0|||
125194337|NCT01560234|450333422|FG007|Overall Study|Lost to Follow-up|2|||
125194338|NCT01718535|450333423|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
125194339|NCT01718535|450333424|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
125194340|NCT01718535|450333425|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
125194341|NCT01718535|450333426|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
125194342|NCT01718535|450333427|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
125194343|NCT01718535|450333428|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
125194344|NCT01718535|450333429|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
125194345|NCT01718535|450333430|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
125194346|NCT01718535|450333431|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
125194347|NCT01718535|450333432|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
125194348|NCT01073605|450333436|FG000|Overall Study|Ongoing at Cutoff Date|1|||
125194349|NCT01073605|450333437|FG001|Overall Study|Ongoing at Cutoff Date|1|||
125194350|NCT01073605|450333438|FG002|Overall Study|Ongoing at Cutoff Date|0|||
125194351|NCT01073605|450333436|FG000|Overall Study|Adverse Event|2|||
125194352|NCT01073605|450333437|FG001|Overall Study|Adverse Event|1|||
125194353|NCT01073605|450333438|FG002|Overall Study|Adverse Event|0|||
125194354|NCT01073605|450333436|FG000|Overall Study|Lost to Follow-up|3|||
125194355|NCT01073605|450333437|FG001|Overall Study|Lost to Follow-up|4|||
125194356|NCT01073605|450333438|FG002|Overall Study|Lost to Follow-up|9|||
125194357|NCT01073605|450333436|FG000|Overall Study|Other|25|||
125194358|NCT01073605|450333437|FG001|Overall Study|Other|21|||
125194359|NCT01073605|450333438|FG002|Overall Study|Other|29|||
125194360|NCT01073605|450333436|FG000|Overall Study|Withdrawal by Subject|31|||
125194361|NCT01073605|450333437|FG001|Overall Study|Withdrawal by Subject|39|||
125194362|NCT01073605|450333438|FG002|Overall Study|Withdrawal by Subject|22|||
125194363|NCT01073605|450333436|FG000|Overall Study|Randomized But Not Treated|0|||
125194364|NCT01073605|450333437|FG001|Overall Study|Randomized But Not Treated|1|||
125194365|NCT01073605|450333438|FG002|Overall Study|Randomized But Not Treated|1|||
125194366|NCT01284348|450333439|FG000|Overall Study|Death|1|||
125194367|NCT01284348|450333440|FG001|Overall Study|Death|1|||
125194368|NCT01284348|450333439|FG000|Overall Study|Withdrew consent|0|||
125246864|NCT04098302|450528577|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
125194369|NCT01284348|450333440|FG001|Overall Study|Withdrew consent|1|||
125194370|NCT01284348|450333439|FG000|Overall Study|Status not recorded|9|||
125194371|NCT01284348|450333440|FG001|Overall Study|Status not recorded|10|||
125246865|NCT04098302|450528578|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
125194372|NCT02035202|450333444|FG000|Overall Study|Lost to Follow-up|8|||
125194373|NCT02035202|450333445|FG001|Overall Study|Lost to Follow-up|16|||
125194374|NCT02035202|450333446|FG002|Overall Study|Lost to Follow-up|2|||
125194375|NCT00083759|450333447|FG000|Overall Study|Adverse Event|5|||
125246866|NCT04098302|450528579|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
125395015|NCT02376166|451077885|FG000|Overall Study|Discontinued metformin early|2|||
125395016|NCT04180020|451077886|FG000|Overall Study|missed visit|18|||
125395017|NCT04180020|451077887|FG001|Overall Study|missed visit|16|||
125395018|NCT04180020|451077886|FG000|Overall Study|Death|2|||
125395019|NCT04180020|451077887|FG001|Overall Study|Death|3|||
125395020|NCT04180020|451077886|FG000|Overall Study|Withdrawal by Subject|1|||
125395021|NCT04180020|451077887|FG001|Overall Study|Withdrawal by Subject|5|||
125395022|NCT04180020|451077886|FG000|Overall Study|incarcerated|1|||
125395023|NCT04180020|451077887|FG001|Overall Study|incarcerated|1|||
125395024|NCT04180020|451077886|FG000|Overall Study|Physician Decision|0|||
125395025|NCT04180020|451077887|FG001|Overall Study|Physician Decision|2|||
125395026|NCT02917031|451077894|FG000|Overall Study|Reason not specified|7|||
125395027|NCT02917031|451077895|FG001|Overall Study|Reason not specified|5|||
125395028|NCT02917031|451077896|FG002|Overall Study|Reason not specified|6|||
125395029|NCT02917031|451077894|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
125395030|NCT02917031|451077895|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
125395031|NCT02917031|451077896|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
125395032|NCT02917031|451077894|FG000|Overall Study|Withdrawal by Subject|3|||
125395033|NCT02917031|451077895|FG001|Overall Study|Withdrawal by Subject|3|||
125395034|NCT02917031|451077896|FG002|Overall Study|Withdrawal by Subject|0|||
125395035|NCT02917031|451077894|FG000|Overall Study|Physician Decision|1|||
125395036|NCT02917031|451077895|FG001|Overall Study|Physician Decision|0|||
125395037|NCT02917031|451077896|FG002|Overall Study|Physician Decision|0|||
125395038|NCT02917031|451077894|FG000|Overall Study|Adverse Event|4|||
125395039|NCT02917031|451077895|FG001|Overall Study|Adverse Event|1|||
125395040|NCT02917031|451077896|FG002|Overall Study|Adverse Event|5|||
125395041|NCT02917031|451077894|FG000|Overall Study|Death|2|||
125395042|NCT02917031|451077895|FG001|Overall Study|Death|3|||
125395043|NCT02917031|451077896|FG002|Overall Study|Death|4|||
125395044|NCT02565381|451079445|FG000|Overall Study|Lost to Follow-up|1|||
125395045|NCT02565381|451079446|FG001|Overall Study|Lost to Follow-up|0|||
125395046|NCT02565381|451079447|FG002|Overall Study|Lost to Follow-up|1|||
125395047|NCT01852292|451079454|FG000|Overall Study|Untreated - did not receive study drug|3|||
125395048|NCT01852292|451079455|FG001|Overall Study|Untreated - did not receive study drug|1|||
125395049|NCT01852292|451079454|FG000|Overall Study|Death|9|||
125395050|NCT01852292|451079455|FG001|Overall Study|Death|8|||
125395051|NCT01852292|451079454|FG000|Overall Study|Patient/guardian decision|8|||
125395052|NCT01852292|451079455|FG001|Overall Study|Patient/guardian decision|4|||
125395053|NCT01852292|451079454|FG000|Overall Study|Adverse Event|8|||
125395054|NCT01852292|451079455|FG001|Overall Study|Adverse Event|11|||
125395055|NCT01852292|451079454|FG000|Overall Study|Physician Decision|6|||
125395056|NCT01852292|451079455|FG001|Overall Study|Physician Decision|2|||
125395057|NCT01852292|451079454|FG000|Overall Study|Protocol Violation|2|||
125395058|NCT01852292|451079455|FG001|Overall Study|Protocol Violation|0|||
125395059|NCT01852292|451079454|FG000|Overall Study|Non-compliance with study treatment|1|||
125395060|NCT01852292|451079455|FG001|Overall Study|Non-compliance with study treatment|0|||
125395061|NCT01852292|451079454|FG000|Overall Study|Study terminated by Sponsor|0|||
125395062|NCT01852292|451079455|FG001|Overall Study|Study terminated by Sponsor|1|||
125395063|NCT01852292|451079454|FG000|Overall Study|Progressive disease|42|||
125395064|NCT01852292|451079455|FG001|Overall Study|Progressive disease|52|||
125395065|NCT02388737|451079456|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
125395066|NCT02388737|451079457|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
125395067|NCT02388737|451079458|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
125395068|NCT02388737|451079456|FG000|Overall Study|Major Protocol Deviation|18|||
125395069|NCT02388737|451079457|FG001|Overall Study|Major Protocol Deviation|25|||
125395070|NCT02388737|451079458|FG002|Overall Study|Major Protocol Deviation|22|||
125395071|NCT02388737|451079456|FG000|Overall Study|Lost to Follow-up|5|||
125395072|NCT02388737|451079457|FG001|Overall Study|Lost to Follow-up|1|||
125395073|NCT02388737|451079458|FG002|Overall Study|Lost to Follow-up|4|||
125395074|NCT02388737|451079456|FG000|Overall Study|Voluntary Withdrawal|10|||
125395075|NCT02388737|451079457|FG001|Overall Study|Voluntary Withdrawal|18|||
125395076|NCT02388737|451079458|FG002|Overall Study|Voluntary Withdrawal|17|||
125395077|NCT02388737|451079456|FG000|Overall Study|Lack of Efficacy|3|||
125395078|NCT02388737|451079457|FG001|Overall Study|Lack of Efficacy|0|||
125395079|NCT02388737|451079458|FG002|Overall Study|Lack of Efficacy|3|||
125395080|NCT02388737|451079456|FG000|Overall Study|Reason Not Specified|5|||
125395081|NCT02388737|451079457|FG001|Overall Study|Reason Not Specified|5|||
125395082|NCT02388737|451079458|FG002|Overall Study|Reason Not Specified|4|||
125395083|NCT03299842|451079459|FG000|Overall Study|Caregiver withdrew consent|2|||
125395084|NCT03299842|451079459|FG000|Overall Study|Child would not keep the watch on|3|||
125395085|NCT01816139|451079460|FG000|Overall Study|Adverse Event|6|||
125395086|NCT01816139|451079461|FG001|Overall Study|Adverse Event|8|||
125395087|NCT01816139|451079460|FG000|Overall Study|Lack of Efficacy|1|||
125395088|NCT01816139|451079461|FG001|Overall Study|Lack of Efficacy|2|||
125395089|NCT01816139|451079460|FG000|Overall Study|Lost to Follow-up|5|||
125395090|NCT01816139|451079461|FG001|Overall Study|Lost to Follow-up|3|||
125395091|NCT01816139|451079460|FG000|Overall Study|Withdrew Consent|6|||
125395092|NCT01816139|451079461|FG001|Overall Study|Withdrew Consent|4|||
125395093|NCT01816139|451079460|FG000|Overall Study|Protocol Violation|6|||
125395094|NCT01816139|451079461|FG001|Overall Study|Protocol Violation|3|||
125395095|NCT01816139|451079460|FG000|Overall Study|Reason not Specified|4|||
125395096|NCT01816139|451079461|FG001|Overall Study|Reason not Specified|2|||
125395097|NCT02554656|451079464|FG000|Overall Study|Protocol Violation|3|||
125395098|NCT00749463|451079469|FG000|Overall Study|Adverse Event|0|||
125395099|NCT00749463|451079470|FG001|Overall Study|Adverse Event|4|||
125395100|NCT00749463|451079471|FG002|Overall Study|Adverse Event|1|||
125395101|NCT00749463|451079469|FG000|Overall Study|Withdrawal by Subject|1|||
125395102|NCT00749463|451079470|FG001|Overall Study|Withdrawal by Subject|0|||
125395103|NCT00749463|451079471|FG002|Overall Study|Withdrawal by Subject|0|||
125395104|NCT03643562|451079476|FG000|Overall Study|Adverse Event|1|||
125395105|NCT03643562|451079477|FG001|Overall Study|Adverse Event|0|||
125395106|NCT03643562|451079476|FG000|Overall Study|Lack of Efficacy|0|||
125395107|NCT03643562|451079477|FG001|Overall Study|Lack of Efficacy|1|||
125395108|NCT03643562|451079476|FG000|Overall Study|Physician Decision|0|||
125395109|NCT03643562|451079477|FG001|Overall Study|Physician Decision|1|||
125395110|NCT03643562|451079476|FG000|Overall Study|Study Terminated by Sponsor|2|||
125395111|NCT03643562|451079477|FG001|Overall Study|Study Terminated by Sponsor|10|||
125395112|NCT03643562|451079476|FG000|Overall Study|Withdrawal by Subject|2|||
125395113|NCT03643562|451079477|FG001|Overall Study|Withdrawal by Subject|2|||
125395114|NCT03643562|451079476|FG000|Overall Study|Other than specified|3|||
125395115|NCT03643562|451079477|FG001|Overall Study|Other than specified|2|||
125395116|NCT01982253|451079480|FG000|Overall Study|Withdrawal by Subject|1|||
125395117|NCT01982253|451079481|FG001|Overall Study|Withdrawal by Subject|0|||
125395118|NCT01982253|451079482|FG002|Overall Study|Withdrawal by Subject|0|||
125395119|NCT01982253|451079480|FG000|Overall Study|Study terminated by sponsor|1|||
125395120|NCT01982253|451079481|FG001|Overall Study|Study terminated by sponsor|4|||
125395121|NCT01982253|451079482|FG002|Overall Study|Study terminated by sponsor|4|||
125395122|NCT02919670|451079484|FG000|Overall Study|Only 17 participants met compliance|43|||
125395123|NCT02919670|451079485|FG001|Overall Study|Only 17 participants met compliance|39|||
125395124|NCT04206293|451079486|FG000|Overall Study|Consent withdrawal|1|||
125395125|NCT01454934|451079489|FG000|Overall Study|Clinical progression|28|||
125395126|NCT01454934|451079490|FG001|Overall Study|Clinical progression|25|||
125395127|NCT01454934|451079489|FG000|Overall Study|Other|6|||
125395128|NCT01454934|451079490|FG001|Overall Study|Other|17|||
125395129|NCT01454934|451079489|FG000|Overall Study|Adverse Event|28|||
125395130|NCT01454934|451079490|FG001|Overall Study|Adverse Event|24|||
125395131|NCT01454934|451079489|FG000|Overall Study|Withdrawn consent|2|||
125395132|NCT01454934|451079490|FG001|Overall Study|Withdrawn consent|5|||
125395133|NCT01454934|451079489|FG000|Overall Study|Withdrawal by Subject|11|||
125395134|NCT01454934|451079490|FG001|Overall Study|Withdrawal by Subject|15|||
125395135|NCT01454934|451079489|FG000|Overall Study|Disease progression|194|||
125395136|NCT01454934|451079490|FG001|Overall Study|Disease progression|181|||
125395137|NCT01454934|451079489|FG000|Overall Study|Lost to Follow-up|0|||
125395138|NCT01454934|451079490|FG001|Overall Study|Lost to Follow-up|1|||
125395139|NCT01454934|451079489|FG000|Overall Study|Not treated|1|||
125395140|NCT01454934|451079490|FG001|Overall Study|Not treated|2|||
125395141|NCT00826267|451079502|FG000|Overall Study|Other Adverse Event|1|||
125395142|NCT00826267|451079503|FG001|Overall Study|Other Adverse Event|0|||
125395143|NCT00826267|451079504|FG002|Overall Study|Other Adverse Event|0|||
125395144|NCT01143090|451079515|FG000|Overall Study|Lack of Efficacy|2|||
125395145|NCT01143090|451079515|FG000|Overall Study|Adverse Event|17|||
125395146|NCT01143090|451079515|FG000|Overall Study|Lost to Follow-up|9|||
125395147|NCT01143090|451079515|FG000|Overall Study|Protocol Violation|2|||
125395148|NCT01143090|451079515|FG000|Overall Study|Withdrawal by Subject|18|||
125395149|NCT01143090|451079515|FG000|Overall Study|Non-compliance with study drug|1|||
125395150|NCT01143090|451079515|FG000|Overall Study|Failure to meet eligibility criteria|1|||
125395151|NCT01143090|451079515|FG000|Overall Study|Administrative|1|||
125395152|NCT01461096|451079521|FG000|Overall Study|Death|3|||
125395153|NCT01461096|451079522|FG001|Overall Study|Death|6|||
125395154|NCT01461096|451079521|FG000|Overall Study|Severe debilitation, unable to continue|1|||
125395155|NCT01461096|451079522|FG001|Overall Study|Severe debilitation, unable to continue|1|||
125395156|NCT01461096|451079521|FG000|Overall Study|Subj not able to get to clinic|15|||
125395157|NCT01461096|451079522|FG001|Overall Study|Subj not able to get to clinic|13|||
125395158|NCT01461096|451079521|FG000|Overall Study|Site is closing|27|||
125395159|NCT01461096|451079522|FG001|Overall Study|Site is closing|30|||
125395160|NCT01461096|451079521|FG000|Overall Study|Withdrawal by Subject|5|||
125395161|NCT01461096|451079522|FG001|Overall Study|Withdrawal by Subject|3|||
125395162|NCT01461096|451079521|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
125395163|NCT01461096|451079522|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
125395164|NCT01461096|451079521|FG000|Overall Study|Lost to Follow-up|8|||
125395165|NCT01461096|451079522|FG001|Overall Study|Lost to Follow-up|4|||
125395166|NCT00855309|451079529|FG000|Overall Study|patient never recieved drug|1|||
125395167|NCT00855309|451079530|FG001|Overall Study|patient never recieved drug|0|||
125395168|NCT00829296|451079531|FG000|Overall Study|Adverse Event|5|||
125395169|NCT00829296|451079532|FG001|Overall Study|Adverse Event|4|||
125395170|NCT00582933|451079534|FG000|Overall Study|Physician Decision|3|||
125395171|NCT03837899|451079537|FG000|Overall Study|Death|6|||
125395172|NCT03837899|451079538|FG001|Overall Study|Death|8|||
125395173|NCT03837899|451079539|FG002|Overall Study|Death|3|||
125395174|NCT03837899|451079540|FG003|Overall Study|Death|7|||
125395175|NCT03837899|451079541|FG004|Overall Study|Death|8|||
125395176|NCT03837899|451079542|FG005|Overall Study|Death|7|||
125395177|NCT03837899|451079537|FG000|Overall Study|Moved to post-trial access program|0|||
125395178|NCT03837899|451079538|FG001|Overall Study|Moved to post-trial access program|1|||
125395179|NCT03837899|451079539|FG002|Overall Study|Moved to post-trial access program|0|||
125395180|NCT03837899|451079540|FG003|Overall Study|Moved to post-trial access program|0|||
125395181|NCT03837899|451079541|FG004|Overall Study|Moved to post-trial access program|0|||
125395182|NCT03837899|451079542|FG005|Overall Study|Moved to post-trial access program|0|||
125395183|NCT03837899|451079537|FG000|Overall Study|Other|0|||
125395184|NCT03837899|451079538|FG001|Overall Study|Other|0|||
125395185|NCT03837899|451079539|FG002|Overall Study|Other|0|||
125395186|NCT03837899|451079540|FG003|Overall Study|Other|0|||
125395187|NCT03837899|451079541|FG004|Overall Study|Other|0|||
125395188|NCT03837899|451079542|FG005|Overall Study|Other|2|||
125246867|NCT04098302|450528580|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
125246868|NCT04098302|450528577|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
125246869|NCT04098302|450528578|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
125246870|NCT04098302|450528579|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
125246871|NCT04098302|450528580|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
125246872|NCT04098302|450528577|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
125246873|NCT04098302|450528578|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
125246874|NCT04098302|450528579|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
125246875|NCT04098302|450528580|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
125246876|NCT04098302|450528577|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
125246877|NCT04098302|450528578|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
125246878|NCT04098302|450528579|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
125246879|NCT04098302|450528580|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
125246880|NCT04098302|450528577|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
125246881|NCT04098302|450528578|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
125246882|NCT04098302|450528579|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
125246883|NCT04098302|450528580|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
125246884|NCT04098302|450528577|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
125246885|NCT04098302|450528578|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
125246886|NCT04098302|450528579|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
125246887|NCT04098302|450528580|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
125246888|NCT01290731|450528584|FG000|Overall Study|Withdrawal by Subject|1|||
125246889|NCT01399099|450528585|FG000|Overall Study|Lost to Follow-up|14|||
125246890|NCT01399099|450528585|FG000|Overall Study|Physician Decision|1|||
125246891|NCT01399099|450528585|FG000|Overall Study|Protocol Violation|1|||
125246892|NCT01399099|450528585|FG000|Overall Study|Skin Irritation|13|||
125246893|NCT01399099|450528585|FG000|Overall Study|Infection|1|||
125246894|NCT01399099|450528585|FG000|Overall Study|Miscellaneous|4|||
125246895|NCT01668537|450528586|FG000|Overall Study|Request to Discontinue Prematurely|1|||
125246896|NCT01668537|450528587|FG001|Overall Study|Request to Discontinue Prematurely|1|||
125246897|NCT01668537|450528586|FG000|Overall Study|Subject unwilling/unable to comply|5|||
125246898|NCT01668537|450528587|FG001|Overall Study|Subject unwilling/unable to comply|0|||
125246899|NCT01668537|450528586|FG000|Overall Study|Reason Precludes Participation|1|||
125246900|NCT01668537|450528587|FG001|Overall Study|Reason Precludes Participation|0|||
125246901|NCT01668537|450528586|FG000|Overall Study|Lost to Follow-up|13|||
125246902|NCT01668537|450528587|FG001|Overall Study|Lost to Follow-up|6|||
125246903|NCT01668537|450528586|FG000|Overall Study|Other|2|||
125246904|NCT01668537|450528587|FG001|Overall Study|Other|3|||
125246905|NCT05064800|450528588|FG000|Period 3|Withdrawal by Subject|0|||
125246906|NCT05064800|450528589|FG001|Period 3|Withdrawal by Subject|0|||
125395189|NCT03837899|451079537|FG000|Overall Study|Lost to Follow-up|0|||
125395190|NCT03837899|451079538|FG001|Overall Study|Lost to Follow-up|1|||
125246907|NCT05064800|450528590|FG002|Period 3|Withdrawal by Subject|0|||
125246908|NCT05064800|450528591|FG003|Period 3|Withdrawal by Subject|0|||
125246909|NCT05064800|450528592|FG004|Period 3|Withdrawal by Subject|1|||
125246910|NCT05064800|450528593|FG005|Period 3|Withdrawal by Subject|0|||
125246911|NCT04477486|450528594|FG000|Overall Study|Death|2|||
125395191|NCT03837899|451079539|FG002|Overall Study|Lost to Follow-up|0|||
125395192|NCT03837899|451079540|FG003|Overall Study|Lost to Follow-up|0|||
125395193|NCT03837899|451079541|FG004|Overall Study|Lost to Follow-up|0|||
125395194|NCT03837899|451079542|FG005|Overall Study|Lost to Follow-up|0|||
125395195|NCT03837899|451079537|FG000|Overall Study|Withdrawal by Subject|0|||
125395196|NCT03837899|451079538|FG001|Overall Study|Withdrawal by Subject|0|||
125395197|NCT03837899|451079539|FG002|Overall Study|Withdrawal by Subject|0|||
125395198|NCT03837899|451079540|FG003|Overall Study|Withdrawal by Subject|1|||
125246912|NCT04477486|450528594|FG000|Overall Study|Ongoing at Time of Analysis|11|||
125246913|NCT02497755|450528595|FG000|Overall Study|Protocol Violation|1|||
125246914|NCT02497755|450528596|FG001|Overall Study|Protocol Violation|0|||
125246915|NCT02547935|450528605|FG000|Overall Study|Other|0|||
125246916|NCT02547935|450528606|FG001|Overall Study|Other|1|||
125246917|NCT02547935|450528607|FG002|Overall Study|Other|0|||
125246918|NCT02547935|450528605|FG000|Overall Study|Withdrawal by Subject|2|||
125246919|NCT02547935|450528606|FG001|Overall Study|Withdrawal by Subject|3|||
125246920|NCT02547935|450528607|FG002|Overall Study|Withdrawal by Subject|4|||
125246921|NCT02547935|450528605|FG000|Overall Study|Screen Failure|2|||
125246922|NCT02547935|450528606|FG001|Overall Study|Screen Failure|0|||
125246923|NCT02547935|450528607|FG002|Overall Study|Screen Failure|0|||
125246924|NCT02547935|450528605|FG000|Overall Study|Physician Decision|0|||
125246925|NCT02547935|450528606|FG001|Overall Study|Physician Decision|1|||
125246926|NCT02547935|450528607|FG002|Overall Study|Physician Decision|0|||
125246927|NCT02547935|450528605|FG000|Overall Study|Lost to Follow-up|0|||
125246928|NCT02547935|450528606|FG001|Overall Study|Lost to Follow-up|2|||
125246929|NCT02547935|450528607|FG002|Overall Study|Lost to Follow-up|1|||
125246930|NCT02547935|450528605|FG000|Overall Study|Death|1|||
125246931|NCT02547935|450528606|FG001|Overall Study|Death|1|||
125246932|NCT02547935|450528607|FG002|Overall Study|Death|0|||
125246933|NCT03554473|450530896|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
125246934|NCT03554473|450530897|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
125246935|NCT03554473|450530898|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
125246936|NCT03554473|450530896|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
125246937|NCT03554473|450530897|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
125246938|NCT03554473|450530898|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
125246939|NCT03554473|450530896|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
125246940|NCT03554473|450530897|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
125246941|NCT03554473|450530898|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
125246942|NCT04971837|450530902|FG000|Overall Study|Long Term Illness|1|||
125246943|NCT04971837|450530902|FG000|Overall Study|BMI too low|9|||
125246944|NCT04971837|450530902|FG000|Overall Study|geographic location|1|||
125246945|NCT04971837|450530902|FG000|Overall Study|Discontinued scheduling conflict|1|||
125246946|NCT00382070|450530903|FG000|Overall Study|No follow up data mapped to Other|17|||
125246947|NCT00382070|450530904|FG001|Overall Study|No follow up data mapped to Other|19|||
125246948|NCT00382070|450530903|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
125246949|NCT00382070|450530904|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
125246950|NCT00382070|450530903|FG000|Overall Study|No clinical assessment|9|||
125246951|NCT00382070|450530904|FG001|Overall Study|No clinical assessment|11|||
125246952|NCT00284934|450530910|FG000|Overall Study|Adverse Event|1|||
125246953|NCT00284934|450530911|FG001|Overall Study|Adverse Event|2|||
125246954|NCT00284934|450530910|FG000|Overall Study|Other reasons|3|||
125246955|NCT00284934|450530911|FG001|Overall Study|Other reasons|1|||
125246956|NCT01245751|450530912|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
125246957|NCT01245751|450530913|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
125246958|NCT01245751|450530914|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
125246959|NCT01245751|450530915|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
125246960|NCT01245751|450530912|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
125246961|NCT01245751|450530913|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
125246962|NCT01245751|450530914|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
125246963|NCT01245751|450530915|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
125246964|NCT01245751|450530912|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
125246965|NCT01245751|450530913|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
125246966|NCT01245751|450530914|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
125246967|NCT01245751|450530915|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
125246968|NCT05788328|450530916|FG000|Treatment Period 4 (5 Days)|Other|1|||
125246969|NCT05788328|450530916|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
125246970|NCT02082483|450530917|FG000|Overall Study|Lost to Follow-up|1|||
125443648|NCT02397460|451252217|FG001|Treatment Period 4|Physician Decision|0|||
125246971|NCT02082483|450530918|FG001|Overall Study|Lost to Follow-up|1|||
125246972|NCT02082483|450530917|FG000|Overall Study|Withdrawal by Subject|2|||
125246973|NCT02082483|450530918|FG001|Overall Study|Withdrawal by Subject|1|||
125246974|NCT02082483|450530917|FG000|Overall Study|Physician Decision|1|||
125246975|NCT02082483|450530918|FG001|Overall Study|Physician Decision|1|||
125246976|NCT02082483|450530917|FG000|Overall Study|Death|2|||
125246977|NCT02082483|450530918|FG001|Overall Study|Death|3|||
125246978|NCT00145327|450530920|FG000|Overall Study|Withdrawal by Subject|77|||
125246979|NCT00145327|450530921|FG001|Overall Study|Withdrawal by Subject|72|||
125246980|NCT00145327|450530922|FG002|Overall Study|Withdrawal by Subject|164|||
125246981|NCT00145327|450530920|FG000|Overall Study|Death|26|||
125246982|NCT00145327|450530921|FG001|Overall Study|Death|18|||
125246983|NCT00145327|450530922|FG002|Overall Study|Death|30|||
125246984|NCT00145327|450530920|FG000|Overall Study|Adverse Event|14|||
125246985|NCT00145327|450530921|FG001|Overall Study|Adverse Event|11|||
125246986|NCT00145327|450530922|FG002|Overall Study|Adverse Event|22|||
125246987|NCT00145327|450530920|FG000|Overall Study|Lost to Follow-up|9|||
125246988|NCT00145327|450530921|FG001|Overall Study|Lost to Follow-up|14|||
125246989|NCT00145327|450530922|FG002|Overall Study|Lost to Follow-up|14|||
125246990|NCT00145327|450530920|FG000|Overall Study|Administrative problems|12|||
125246991|NCT00145327|450530921|FG001|Overall Study|Administrative problems|9|||
125246992|NCT00145327|450530922|FG002|Overall Study|Administrative problems|13|||
125246993|NCT00145327|450530920|FG000|Overall Study|Protocol Violation|2|||
125246994|NCT00145327|450530921|FG001|Overall Study|Protocol Violation|0|||
125246995|NCT00145327|450530922|FG002|Overall Study|Protocol Violation|2|||
125246996|NCT00145327|450530920|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125246997|NCT00145327|450530921|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125246998|NCT00145327|450530922|FG002|Overall Study|Abnormal laboratory value(s)|2|||
125246999|NCT00145327|450530920|FG000|Overall Study|Missing - not stated|1|||
125247000|NCT00145327|450530921|FG001|Overall Study|Missing - not stated|0|||
125247001|NCT00145327|450530922|FG002|Overall Study|Missing - not stated|1|||
125247002|NCT02802865|450530923|FG000|Overall Study|Pregnancy|1|||
125247003|NCT02802865|450530924|FG001|Overall Study|Pregnancy|1|||
125247004|NCT02802865|450530923|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
125247005|NCT02802865|450530924|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
125247006|NCT00985192|450530926|FG000|Overall Study|Withdrawal by Subject|1|||
125247007|NCT00985192|450530926|FG000|Overall Study|Disease Progression|1|||
125247008|NCT00985192|450530926|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
125247009|NCT01454063|450530927|FG000|Randomized|Adverse Event|1|||
125247010|NCT01454063|450530928|FG001|Randomized|Adverse Event|1|||
125247011|NCT01454063|450530927|FG000|Randomized|Protocol Violation|0|||
125247012|NCT01454063|450530928|FG001|Randomized|Protocol Violation|1|||
125247013|NCT00509600|450530932|FG000|Overall Study|Adverse Event|1|||
125247014|NCT03055195|450530933|FG000|Overall Study|Lack of Efficacy|1|||
125247015|NCT03055195|450530934|FG001|Overall Study|Lack of Efficacy|0|||
125247016|NCT03055195|450530933|FG000|Overall Study|Withdrawal by Subject|6|||
125247017|NCT03055195|450530934|FG001|Overall Study|Withdrawal by Subject|7|||
125247018|NCT03055195|450530933|FG000|Overall Study|Study Terminated by Sponsor|2|||
125247019|NCT03055195|450530934|FG001|Overall Study|Study Terminated by Sponsor|6|||
125247020|NCT03055195|450530933|FG000|Overall Study|Protocol Violation|2|||
125247021|NCT03055195|450530934|FG001|Overall Study|Protocol Violation|1|||
125247022|NCT03055195|450530933|FG000|Overall Study|Physician Decision|1|||
125247023|NCT03055195|450530934|FG001|Overall Study|Physician Decision|0|||
125247024|NCT00720083|450530935|FG000|Overall Study|Ineligible|1|||
125247025|NCT00720083|450530936|FG001|Overall Study|Ineligible|2|||
125247026|NCT01441414|450530944|FG000|Overall Study|Participant died|9|||
125247027|NCT01441414|450530944|FG000|Overall Study|Other reasons|3|||
125247028|NCT01441414|450530944|FG000|Overall Study|Study terminated by sponsor|2|||
125247029|NCT01441414|450530944|FG000|Overall Study|Subject refused further follow-up|1|||
125247030|NCT01773889|450530945|FG000|Overall Study|lack of funding|2|||
125247031|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
125247032|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
125247033|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
125247034|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
125247035|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
125247036|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
125247037|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
125247038|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
125247039|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
125247040|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
125247041|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
125247042|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
125247043|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
125247044|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
125395199|NCT03837899|451079541|FG004|Overall Study|Withdrawal by Subject|0|||
125247045|NCT00976391|450530946|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
125247046|NCT00976391|450530947|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
125247047|NCT00976391|450530946|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
125247048|NCT00976391|450530947|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
125247049|NCT00976391|450530946|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
125247050|NCT00976391|450530947|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
125247051|NCT00976391|450530946|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
125247052|NCT00976391|450530947|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
125247053|NCT00976391|450530946|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
125247054|NCT00976391|450530947|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
125247055|NCT00976391|450530946|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
125247056|NCT00976391|450530947|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
125395200|NCT03837899|451079542|FG005|Overall Study|Withdrawal by Subject|0|||
125247057|NCT00976391|450530946|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
125247058|NCT00976391|450530947|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
125247059|NCT02018887|450530948|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
125247060|NCT02018887|450530949|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247061|NCT02018887|450530950|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247062|NCT02018887|450530951|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247063|NCT02018887|450530952|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247064|NCT02018887|450530953|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247065|NCT02018887|450530954|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247066|NCT02018887|450530955|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247067|NCT02018887|450530956|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247068|NCT02018887|450530957|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247069|NCT02018887|450530958|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
125247070|NCT02018887|450530948|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247071|NCT02018887|450530949|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247072|NCT02018887|450530950|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247073|NCT02018887|450530951|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247074|NCT02018887|450530952|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
125247075|NCT02018887|450530953|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247076|NCT02018887|450530954|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
125247077|NCT02018887|450530955|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
125247078|NCT02018887|450530956|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247079|NCT02018887|450530957|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247080|NCT02018887|450530958|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
125247081|NCT02018887|450530948|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
125247082|NCT02018887|450530949|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
125247083|NCT02018887|450530950|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
125247084|NCT02018887|450530951|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
125247085|NCT02018887|450530952|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
125247086|NCT02018887|450530953|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
125247087|NCT02018887|450530954|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
125247088|NCT02018887|450530955|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
125247089|NCT02018887|450530956|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
125247090|NCT02018887|450530957|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
125395201|NCT03837899|451079537|FG000|Overall Study|Study specific discontinuation criteria|0|||
125395202|NCT03837899|451079538|FG001|Overall Study|Study specific discontinuation criteria|1|||
125395203|NCT03837899|451079539|FG002|Overall Study|Study specific discontinuation criteria|0|||
125395204|NCT03837899|451079540|FG003|Overall Study|Study specific discontinuation criteria|0|||
125395205|NCT03837899|451079541|FG004|Overall Study|Study specific discontinuation criteria|3|||
125395206|NCT03837899|451079542|FG005|Overall Study|Study specific discontinuation criteria|1|||
125395207|NCT01465464|451079543|FG000|Overall Study|Adverse Event|96|||
125395208|NCT01465464|451079544|FG001|Overall Study|Adverse Event|49|||
125395209|NCT01465464|451079543|FG000|Overall Study|Lack of Efficacy|139|||
125395210|NCT01465464|451079544|FG001|Overall Study|Lack of Efficacy|190|||
125395211|NCT01465464|451079543|FG000|Overall Study|Physician Decision|13|||
125395212|NCT01465464|451079544|FG001|Overall Study|Physician Decision|5|||
125395213|NCT01465464|451079543|FG000|Overall Study|Protocol Violation|1|||
125395214|NCT01465464|451079544|FG001|Overall Study|Protocol Violation|1|||
125395215|NCT01465464|451079543|FG000|Overall Study|Withdrawal by Subject|46|||
125395216|NCT01465464|451079544|FG001|Overall Study|Withdrawal by Subject|30|||
125395217|NCT01465464|451079543|FG000|Overall Study|Other|9|||
125395218|NCT01465464|451079544|FG001|Overall Study|Other|3|||
125395219|NCT01465464|451079543|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
125395220|NCT01465464|451079544|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
125194376|NCT00083759|450333448|FG001|Overall Study|Adverse Event|3|||
125194377|NCT00083759|450333447|FG000|Overall Study|Lost to Follow-up|1|||
125194378|NCT00083759|450333448|FG001|Overall Study|Lost to Follow-up|0|||
125194379|NCT00083759|450333447|FG000|Overall Study|Death|1|||
125194380|NCT00083759|450333448|FG001|Overall Study|Death|1|||
125194381|NCT00083759|450333447|FG000|Overall Study|Inadequate Therapeutic Response|32|||
125194382|NCT00083759|450333448|FG001|Overall Study|Inadequate Therapeutic Response|35|||
125194383|NCT00083759|450333447|FG000|Overall Study|Subject Withdrew Consent|2|||
125194384|NCT00083759|450333448|FG001|Overall Study|Subject Withdrew Consent|2|||
125194385|NCT00083759|450333447|FG000|Overall Study|Non-Compliance|1|||
125247091|NCT02018887|450530958|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
125395221|NCT00785486|451079545|FG000|Midazolam Alone|Withdrawal by Subject|1|||
125395222|NCT01554618|451079549|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
125395223|NCT01554618|451079550|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
125194386|NCT00083759|450333448|FG001|Overall Study|Non-Compliance|0|||
125194387|NCT00083759|450333447|FG000|Overall Study|Sponsor's Discretion|28|||
125247092|NCT02018887|450530948|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
125247093|NCT02018887|450530949|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
125247094|NCT02018887|450530950|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
125247095|NCT02018887|450530951|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
125194388|NCT00083759|450333448|FG001|Overall Study|Sponsor's Discretion|29|||
125395224|NCT01554618|451079549|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
125395225|NCT01554618|451079550|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
125395226|NCT01554618|451079549|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
125395227|NCT01554618|451079550|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
125395228|NCT01554618|451079549|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
125395229|NCT01554618|451079550|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
125395230|NCT01554618|451079549|FG000|Open-Label Extension Period|Physician Decision|0|||
125395231|NCT01554618|451079550|FG001|Open-Label Extension Period|Physician Decision|1|||
125395232|NCT01554618|451079549|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
125395233|NCT01554618|451079550|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
125395234|NCT01116232|451079552|FG000|Overall Study|Progressive diease|4|||
125395235|NCT02357940|451079553|FG000|Overall Study|Adverse Event|0|||
125395236|NCT02357940|451079554|FG001|Overall Study|Adverse Event|1|||
125443649|NCT02397460|451252218|FG002|Treatment Period 4|Physician Decision|0|||
125443650|NCT02397460|451252219|FG003|Treatment Period 4|Physician Decision|0|||
125194389|NCT00083759|450333447|FG000|Overall Study|Other|14|||
125194390|NCT00083759|450333448|FG001|Overall Study|Other|13|||
125194391|NCT02875613|450333452|FG000|Overall Study|Withdrawal by Subject|1|||
125194392|NCT02875613|450333452|FG000|Overall Study|Screen Failure|1|||
125194393|NCT03645395|450333462|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
125194394|NCT03645395|450333463|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
125194395|NCT03645395|450333464|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
125194396|NCT03645395|450333465|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
125194397|NCT03645395|450333462|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
125194398|NCT03645395|450333463|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
125194399|NCT03645395|450333464|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
125194400|NCT03645395|450333465|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
125194401|NCT03645395|450333462|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
125194402|NCT03645395|450333463|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
125194403|NCT03645395|450333464|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
125194404|NCT03645395|450333465|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
125194405|NCT03645395|450333462|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
125194406|NCT03645395|450333463|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
125194407|NCT03645395|450333464|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
125194408|NCT03645395|450333465|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
125194409|NCT01057810|450333466|FG000|Overall Study|Disease progression|156|||
125194410|NCT01057810|450333467|FG001|Overall Study|Disease progression|197|||
125194411|NCT01057810|450333466|FG000|Overall Study|Study drug toxicity|5|||
125194412|NCT01057810|450333467|FG001|Overall Study|Study drug toxicity|114|||
125194413|NCT01057810|450333466|FG000|Overall Study|Adverse event unrelated to study drug|13|||
125194414|NCT01057810|450333467|FG001|Overall Study|Adverse event unrelated to study drug|29|||
125194415|NCT01057810|450333466|FG000|Overall Study|Withdrawal by Subject|10|||
125194416|NCT01057810|450333467|FG001|Overall Study|Withdrawal by Subject|25|||
125194417|NCT01057810|450333466|FG000|Overall Study|Death|2|||
125194418|NCT01057810|450333467|FG001|Overall Study|Death|12|||
125194419|NCT01057810|450333466|FG000|Overall Study|Maximum clinical benefit|5|||
125194420|NCT01057810|450333467|FG001|Overall Study|Maximum clinical benefit|5|||
125194421|NCT01057810|450333466|FG000|Overall Study|Poor/non-compliance|0|||
125194422|NCT01057810|450333467|FG001|Overall Study|Poor/non-compliance|1|||
125194423|NCT01057810|450333466|FG000|Overall Study|No longer met study criteria|0|||
125194424|NCT01057810|450333467|FG001|Overall Study|No longer met study criteria|1|||
125194425|NCT01057810|450333466|FG000|Overall Study|Other|7|||
125194426|NCT01057810|450333467|FG001|Overall Study|Other|14|||
125194427|NCT02088905|450333468|FG000|Overall Study|Withdrawal by Subject|5|||
125194428|NCT02088905|450333469|FG001|Overall Study|Withdrawal by Subject|1|||
125194429|NCT04606394|450333471|FG000|Overall Study|Withdrawal by Subject|3|||
125194430|NCT04606394|450333471|FG000|Overall Study|Exclusion criteria screen failure|12|||
125194431|NCT04481789|450333474|FG000|Period 1|Withdrawal by Subject|1|||
125194432|NCT04481789|450333475|FG001|Period 1|Withdrawal by Subject|0|||
125194433|NCT04481789|450333476|FG002|Period 1|Withdrawal by Subject|0|||
125194434|NCT04481789|450333477|FG003|Period 1|Withdrawal by Subject|0|||
125194435|NCT04481789|450333478|FG004|Period 1|Withdrawal by Subject|0|||
125194436|NCT04481789|450333479|FG005|Period 1|Withdrawal by Subject|0|||
125194437|NCT04657198|450333488|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
125194438|NCT04657198|450333489|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
125194439|NCT04657198|450333490|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
125395237|NCT02357940|451079553|FG000|Overall Study|Investigator's judgement|0|||
125194440|NCT03793842|450333491|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
125194441|NCT03793842|450333492|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
125194442|NCT03793842|450333491|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
125194443|NCT03793842|450333492|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
125194444|NCT00427921|450333498|FG000|Overall Study|Adverse Event|26|||
125194445|NCT00427921|450333498|FG000|Overall Study|Withdrawal by Subject|4|||
125194446|NCT00427921|450333498|FG000|Overall Study|Lost to Follow-up|2|||
125194447|NCT00427921|450333498|FG000|Overall Study|Other reason not specified|10|||
125194448|NCT00427921|450333498|FG000|Overall Study|Adverse Event + Hospitalization|1|||
125194449|NCT00427921|450333498|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
125194450|NCT00427921|450333498|FG000|Overall Study|Adverse Event + No Response|1|||
125194451|NCT00427921|450333498|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
125194452|NCT00427921|450333498|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
125194453|NCT00427921|450333498|FG000|Overall Study|Adverse Event + Lost Response|1|||
125194454|NCT00427921|450333498|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
125194455|NCT00427921|450333498|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
125194456|NCT00900159|450333499|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
125194457|NCT00900159|450333500|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
125194458|NCT01075256|450333501|FG000|Overall Study|Withdrawal by Subject|1|||
125194459|NCT01075256|450333502|FG001|Overall Study|Withdrawal by Subject|0|||
125194460|NCT01075256|450333503|FG002|Overall Study|Withdrawal by Subject|0|||
125194461|NCT02858583|450333506|FG000|Overall Study|Declined consent|1|||
125194462|NCT02858583|450333507|FG001|Overall Study|Declined consent|1|||
125194463|NCT00347009|450333508|FG000|Overall Study|Death|1|||
125194464|NCT00347009|450333508|FG000|Overall Study|Adverse Event|6|||
125194465|NCT00347009|450333508|FG000|Overall Study|Withdrawal by Subject|3|||
125194466|NCT00347009|450333508|FG000|Overall Study|Physician Decision|5|||
125194467|NCT00347009|450333508|FG000|Overall Study|Lost to Follow-up|4|||
125194468|NCT00347009|450333508|FG000|Overall Study|Protocol Violation|2|||
125194469|NCT00347009|450333508|FG000|Overall Study|Adverse Laboratory Experience|1|||
125194470|NCT00347009|450333508|FG000|Overall Study|Insufficient Viral Suppression|3|||
125194471|NCT00347009|450333508|FG000|Overall Study|Increased ALT/HBV DNA|1|||
125194472|NCT00347009|450333508|FG000|Overall Study|Serious Adverse Event|1|||
125194473|NCT01029782|450333510|FG000|Overall Study|Lost to Follow-up|2|||
125194474|NCT01029782|450333511|FG001|Overall Study|Lost to Follow-up|2|||
125194475|NCT01029782|450333510|FG000|Overall Study|Diagnosis changed|1|||
125194476|NCT01029782|450333511|FG001|Overall Study|Diagnosis changed|1|||
125194477|NCT01029782|450333510|FG000|Overall Study|Adverse Event|0|||
125194478|NCT01029782|450333511|FG001|Overall Study|Adverse Event|1|||
125194479|NCT01029782|450333510|FG000|Overall Study|Physician Decision|0|||
125194480|NCT01029782|450333511|FG001|Overall Study|Physician Decision|1|||
125194481|NCT01029782|450333510|FG000|Overall Study|Protocol Violation|0|||
125194482|NCT01029782|450333511|FG001|Overall Study|Protocol Violation|2|||
125194483|NCT01029782|450333510|FG000|Overall Study|Withdrawal by Subject|0|||
125194484|NCT01029782|450333511|FG001|Overall Study|Withdrawal by Subject|1|||
125194485|NCT02195869|450333513|FG000|Overall Study|cGVHD Progression|5|||
125194486|NCT02195869|450333513|FG000|Overall Study|Malignancy Progression/relapse|2|||
125194487|NCT02195869|450333513|FG000|Overall Study|Adverse Event|15|||
125194488|NCT02195869|450333513|FG000|Overall Study|Withdrawal by Subject|7|||
125194489|NCT02195869|450333513|FG000|Overall Study|Physician Decision|4|||
125194490|NCT02195869|450333513|FG000|Overall Study|Study Terminated by Sponsor|7|||
125194491|NCT02195869|450333513|FG000|Overall Study|Noncompliance with study drug|2|||
125194492|NCT01515865|450334894|FG000|Part A (Open-label)|Other|3|||
125194493|NCT01515865|450334895|FG001|Part A (Open-label)|Other|0|||
125194494|NCT01515865|450334896|FG002|Part A (Open-label)|Other|0|||
125194495|NCT01515865|450334894|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
125194496|NCT01515865|450334895|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
125194497|NCT01515865|450334896|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
125194498|NCT01515865|450334894|FG000|Part B (Open-label)|Other|1|||
125194499|NCT01515865|450334895|FG001|Part B (Open-label)|Other|0|||
125194500|NCT01515865|450334896|FG002|Part B (Open-label)|Other|0|||
125194501|NCT03691207|450334897|FG000|Overall Study|Death|41|||
125194502|NCT03691207|450334898|FG001|Overall Study|Death|26|||
125194503|NCT03691207|450334897|FG000|Overall Study|Lost to Follow-up|1|||
125194504|NCT03691207|450334898|FG001|Overall Study|Lost to Follow-up|1|||
125194505|NCT03691207|450334897|FG000|Overall Study|Withdrawal by Subject|2|||
125194506|NCT03691207|450334898|FG001|Overall Study|Withdrawal by Subject|8|||
125194507|NCT03691207|450334897|FG000|Overall Study|Sponsor decision|1|||
125194508|NCT03691207|450334898|FG001|Overall Study|Sponsor decision|7|||
125194509|NCT01736397|450334900|FG000|Overall Study|Lack of Efficacy|1|||
125194510|NCT01736397|450334901|FG001|Overall Study|Lack of Efficacy|11|||
125194511|NCT01736397|450334900|FG000|Overall Study|Withdrawal by Subject|6|||
125194512|NCT01736397|450334901|FG001|Overall Study|Withdrawal by Subject|5|||
125194513|NCT01736397|450334900|FG000|Overall Study|Lost to Follow-up|0|||
125194514|NCT01736397|450334901|FG001|Overall Study|Lost to Follow-up|1|||
125194515|NCT01736397|450334900|FG000|Overall Study|Adverse Event|6|||
125194516|NCT01736397|450334901|FG001|Overall Study|Adverse Event|3|||
125194517|NCT01736397|450334900|FG000|Overall Study|Not stated|1|||
125194518|NCT01736397|450334901|FG001|Overall Study|Not stated|4|||
125194519|NCT02448537|450334904|FG000|Overall Study|Withdrawal by Subject|1|||
125194520|NCT02448537|450334905|FG001|Overall Study|Withdrawal by Subject|1|||
125194521|NCT02448537|450334906|FG002|Overall Study|Withdrawal by Subject|1|||
125194522|NCT04696055|450334909|FG000|Overall Study|Adverse Event|10|||
125247096|NCT02018887|450530952|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
125247097|NCT02018887|450530953|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
125247098|NCT02018887|450530954|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
125247099|NCT02018887|450530955|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
125247100|NCT02018887|450530956|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
125247101|NCT02018887|450530957|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
125247102|NCT02018887|450530958|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
125247103|NCT01058005|450530959|FG000|Overall Study|Adverse Event|0|||
125247104|NCT01058005|450530960|FG001|Overall Study|Adverse Event|2|||
125247105|NCT01058005|450530961|FG002|Overall Study|Adverse Event|1|||
125247106|NCT01058005|450530959|FG000|Overall Study|Physician Decision|2|||
125247107|NCT01058005|450530960|FG001|Overall Study|Physician Decision|2|||
125247108|NCT01058005|450530961|FG002|Overall Study|Physician Decision|0|||
125247109|NCT01058005|450530959|FG000|Overall Study|Withdrawal by Subject|4|||
125247110|NCT01058005|450530960|FG001|Overall Study|Withdrawal by Subject|5|||
125247111|NCT01058005|450530961|FG002|Overall Study|Withdrawal by Subject|11|||
125247112|NCT01058005|450530959|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
125247113|NCT01058005|450530960|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
125247114|NCT01058005|450530961|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
125247115|NCT01058005|450530959|FG000|Overall Study|Reason Missing|5|||
125247116|NCT01058005|450530960|FG001|Overall Study|Reason Missing|3|||
125247117|NCT01058005|450530961|FG002|Overall Study|Reason Missing|1|||
125247118|NCT00927186|450530962|FG000|12 Months Primary Study|Adverse Event|5|||
125247119|NCT00927186|450530963|FG001|12 Months Primary Study|Adverse Event|2|||
125247120|NCT00927186|450530962|FG000|12 Months Primary Study|Lost to Follow-up|1|||
125247121|NCT00927186|450530963|FG001|12 Months Primary Study|Lost to Follow-up|0|||
125247122|NCT00927186|450530962|FG000|12 Months Primary Study|Protocol Violation|0|||
125247123|NCT00927186|450530963|FG001|12 Months Primary Study|Protocol Violation|1|||
125247124|NCT00927186|450530962|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
125247125|NCT00927186|450530963|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
125247126|NCT01145222|450530964|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
125247127|NCT01145222|450530965|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
125247128|NCT01145222|450530966|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
125247129|NCT01145222|450530967|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
125247130|NCT01145222|450530964|FG000|Overall Study|Poor bowel preparation|0|||
125247131|NCT01145222|450530965|FG001|Overall Study|Poor bowel preparation|0|||
125247132|NCT01145222|450530966|FG002|Overall Study|Poor bowel preparation|0|||
125247133|NCT01145222|450530967|FG003|Overall Study|Poor bowel preparation|1|||
125247134|NCT01421134|450530968|FG000|Overall Study|Adverse Event|3|||
125247135|NCT01421134|450530969|FG001|Overall Study|Adverse Event|5|||
125247136|NCT01421134|450530968|FG000|Overall Study|Lack of Efficacy|2|||
125247137|NCT01421134|450530969|FG001|Overall Study|Lack of Efficacy|4|||
125247138|NCT01421134|450530968|FG000|Overall Study|Protocol Violation|0|||
125247139|NCT01421134|450530969|FG001|Overall Study|Protocol Violation|3|||
125247140|NCT01421134|450530968|FG000|Overall Study|Withdrawal by Subject|1|||
125247141|NCT01421134|450530969|FG001|Overall Study|Withdrawal by Subject|1|||
125247142|NCT01421134|450530968|FG000|Overall Study|Administrative|0|||
125247143|NCT01421134|450530969|FG001|Overall Study|Administrative|1|||
125247144|NCT01421134|450530968|FG000|Overall Study|Lost to Follow-up|1|||
125247145|NCT01421134|450530969|FG001|Overall Study|Lost to Follow-up|1|||
125247146|NCT04263532|450530971|FG000|Overall Study|Withdrawal by Subject|2|||
125247147|NCT04263532|450530972|FG001|Overall Study|Withdrawal by Subject|0|||
125247148|NCT01851369|450530977|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247149|NCT01851369|450530978|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247150|NCT01851369|450530979|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247151|NCT01851369|450530980|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247152|NCT01851369|450530981|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247153|NCT01851369|450530982|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
125247154|NCT01851369|450530983|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247155|NCT01851369|450530984|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125443651|NCT02397460|451252220|FG004|Treatment Period 4|Physician Decision|1|||
125443652|NCT02397460|451252221|FG005|Treatment Period 4|Physician Decision|0|||
125443653|NCT02397460|451252222|FG006|Treatment Period 4|Physician Decision|0|||
125247156|NCT01851369|450530985|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247157|NCT01851369|450530986|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247158|NCT01851369|450530987|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247159|NCT01851369|450530988|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247160|NCT01851369|450530989|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
125247161|NCT02453191|450530990|FG000|Overall Study|Withdrawal by Subject|1|||
125247162|NCT03364686|450530991|FG000|Overall Study|Physician Decision|2|||
125194523|NCT04696055|450334910|FG001|Overall Study|Adverse Event|2|||
125194524|NCT04696055|450334909|FG000|Overall Study|Death|4|||
125194525|NCT04696055|450334910|FG001|Overall Study|Death|0|||
125194526|NCT04696055|450334909|FG000|Overall Study|Other|7|||
125194527|NCT04696055|450334910|FG001|Overall Study|Other|2|||
125194528|NCT04696055|450334909|FG000|Overall Study|Physician Decision|3|||
125194529|NCT04696055|450334910|FG001|Overall Study|Physician Decision|0|||
125194530|NCT04696055|450334909|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
125194531|NCT04696055|450334910|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
125194532|NCT04696055|450334909|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
125194533|NCT04696055|450334910|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
125194534|NCT04696055|450334909|FG000|Overall Study|Subject Decision|1|||
125194535|NCT04696055|450334910|FG001|Overall Study|Subject Decision|2|||
125194536|NCT00379080|450334915|FG000|Overall Study|Withdrawal by Subject|0|||
125194537|NCT00379080|450334916|FG001|Overall Study|Withdrawal by Subject|4|||
125194538|NCT00379080|450334917|FG002|Overall Study|Withdrawal by Subject|0|||
125194539|NCT00857896|450334922|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
125395238|NCT02357940|451079554|FG001|Overall Study|Investigator's judgement|1|||
125395239|NCT02275481|451079555|FG000|Overall Study|Death|2|||
125395240|NCT02275481|451079556|FG001|Overall Study|Death|1|||
125395241|NCT02275481|451079555|FG000|Overall Study|Lost to Follow-up|2|||
125395242|NCT02275481|451079556|FG001|Overall Study|Lost to Follow-up|0|||
125395243|NCT02275481|451079555|FG000|Overall Study|Withdrawal by Subject|3|||
125395244|NCT02275481|451079556|FG001|Overall Study|Withdrawal by Subject|0|||
125395245|NCT02275481|451079555|FG000|Overall Study|all other reasons combined|2|||
125395246|NCT02275481|451079556|FG001|Overall Study|all other reasons combined|1|||
125194540|NCT01091662|450334924|FG000|Overall Study|Adverse Event|1|||
125194541|NCT01091662|450334925|FG001|Overall Study|Adverse Event|9|||
125194542|NCT01091662|450334924|FG000|Overall Study|Physician Decision|1|||
125194543|NCT01091662|450334925|FG001|Overall Study|Physician Decision|1|||
125194544|NCT01091662|450334924|FG000|Overall Study|Withdrawal by Subject|7|||
125247163|NCT02336503|450530994|FG000|Overall Study|Lost to Follow-up|0|||
125247164|NCT02336503|450530995|FG001|Overall Study|Lost to Follow-up|3|||
125247165|NCT02336503|450530996|FG002|Overall Study|Lost to Follow-up|0|||
125247166|NCT02336503|450530997|FG003|Overall Study|Lost to Follow-up|2|||
125247167|NCT02336503|450530994|FG000|Overall Study|Withdrawal by Subject|2|||
125247168|NCT02336503|450530995|FG001|Overall Study|Withdrawal by Subject|0|||
125247169|NCT02336503|450530996|FG002|Overall Study|Withdrawal by Subject|0|||
125247170|NCT02336503|450530997|FG003|Overall Study|Withdrawal by Subject|4|||
125247171|NCT02336503|450530994|FG000|Overall Study|Adverse Event|0|||
125247172|NCT02336503|450530995|FG001|Overall Study|Adverse Event|0|||
125247173|NCT02336503|450530996|FG002|Overall Study|Adverse Event|1|||
125247174|NCT02336503|450530997|FG003|Overall Study|Adverse Event|0|||
125247175|NCT01543503|450530998|FG000|Overall Study|Lost to Follow-up|32|||
125247176|NCT01543503|450530999|FG001|Overall Study|Lost to Follow-up|36|||
125247177|NCT01543503|450530998|FG000|Overall Study|Adverse Event|9|||
125247178|NCT01543503|450530999|FG001|Overall Study|Adverse Event|13|||
125247179|NCT01543503|450530998|FG000|Overall Study|Lack of Efficacy|4|||
125247180|NCT01543503|450530999|FG001|Overall Study|Lack of Efficacy|16|||
125247181|NCT01543503|450530998|FG000|Overall Study|Participant withdrew informed consent|8|||
125247182|NCT01543503|450530999|FG001|Overall Study|Participant withdrew informed consent|10|||
125247183|NCT01543503|450530998|FG000|Overall Study|Change of jobs|0|||
125247184|NCT01543503|450530999|FG001|Overall Study|Change of jobs|1|||
125247185|NCT01543503|450530998|FG000|Overall Study|Intolerance to the biologic treatment|0|||
125247186|NCT01543503|450530999|FG001|Overall Study|Intolerance to the biologic treatment|1|||
125395247|NCT02275481|451079555|FG000|Overall Study|Physician Decision|0|||
125395248|NCT02275481|451079556|FG001|Overall Study|Physician Decision|1|||
125247187|NCT01543503|450530998|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
125247188|NCT01543503|450530999|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
125247189|NCT01543503|450530998|FG000|Overall Study|Participant did not complete last visit|0|||
125247190|NCT01543503|450530999|FG001|Overall Study|Participant did not complete last visit|2|||
125247191|NCT01543503|450530998|FG000|Overall Study|Refused to continue treatment|7|||
125247192|NCT01543503|450530999|FG001|Overall Study|Refused to continue treatment|0|||
125395249|NCT01393405|451079562|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
125395250|NCT01393405|451079563|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
125395251|NCT01393405|451079564|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
125194545|NCT01091662|450334925|FG001|Overall Study|Withdrawal by Subject|6|||
125194546|NCT01091662|450334924|FG000|Overall Study|met exit criteria|7|||
125194547|NCT01091662|450334925|FG001|Overall Study|met exit criteria|13|||
125194548|NCT01091662|450334924|FG000|Overall Study|met exclusion criteria|1|||
125194549|NCT01091662|450334925|FG001|Overall Study|met exclusion criteria|0|||
125194550|NCT01091662|450334924|FG000|Overall Study|Lost to Follow-up|0|||
125194551|NCT01091662|450334925|FG001|Overall Study|Lost to Follow-up|1|||
125194552|NCT01091662|450334924|FG000|Overall Study|Pregnancy|0|||
125247193|NCT01543503|450530998|FG000|Overall Study|Incorrect medication received|1|||
125247194|NCT01543503|450530999|FG001|Overall Study|Incorrect medication received|0|||
125247195|NCT01543503|450530998|FG000|Overall Study|Participant moved to another city|2|||
125247196|NCT01543503|450530999|FG001|Overall Study|Participant moved to another city|0|||
125247197|NCT01543503|450530998|FG000|Overall Study|Participant will not return for visits|0|||
125247198|NCT01543503|450530999|FG001|Overall Study|Participant will not return for visits|2|||
125247199|NCT01543503|450530998|FG000|Overall Study|Participant transferred to another city|1|||
125247200|NCT01543503|450530999|FG001|Overall Study|Participant transferred to another city|0|||
125247201|NCT01543503|450530998|FG000|Overall Study|Participant moved to Scotland|1|||
125247202|NCT01543503|450530999|FG001|Overall Study|Participant moved to Scotland|0|||
125247203|NCT01543503|450530998|FG000|Overall Study|Participant decision to stop treatment|1|||
125247204|NCT01543503|450530999|FG001|Overall Study|Participant decision to stop treatment|0|||
125247205|NCT01543503|450530998|FG000|Overall Study|Investigator did not wish to participate|1|||
125247206|NCT01543503|450530999|FG001|Overall Study|Investigator did not wish to participate|1|||
125247207|NCT01543503|450530998|FG000|Overall Study|Participant recruited after closing date|0|||
125247208|NCT01543503|450530999|FG001|Overall Study|Participant recruited after closing date|1|||
125247209|NCT01543503|450530998|FG000|Overall Study|Site stopped participation|5|||
125247210|NCT01543503|450530999|FG001|Overall Study|Site stopped participation|1|||
125247211|NCT01543503|450530998|FG000|Overall Study|Participant did not attend a visit|1|||
125247212|NCT01543503|450530999|FG001|Overall Study|Participant did not attend a visit|0|||
125247213|NCT01543503|450530998|FG000|Overall Study|Moved to other rheumatologic site|0|||
125247214|NCT01543503|450530999|FG001|Overall Study|Moved to other rheumatologic site|1|||
125247215|NCT01543503|450530998|FG000|Overall Study|Participant consented to another study|0|||
125247216|NCT01543503|450530999|FG001|Overall Study|Participant consented to another study|2|||
125247217|NCT01543503|450530998|FG000|Overall Study|Participant went to United States|1|||
125247218|NCT01543503|450530999|FG001|Overall Study|Participant went to United States|0|||
125247219|NCT01543503|450530998|FG000|Overall Study|Screen failure|1|||
125247220|NCT01543503|450530999|FG001|Overall Study|Screen failure|0|||
125247221|NCT01936974|450531002|FG000|Overall Study|Physician Decision|2|||
125247222|NCT01936974|450531003|FG001|Overall Study|Physician Decision|5|||
125247223|NCT04584554|450531006|FG000|Overall Study|Withdrawal by Subject|2|||
125247224|NCT04584554|450531007|FG001|Overall Study|Withdrawal by Subject|2|||
125247225|NCT00063999|450531008|FG000|Overall Study|Withdrawal by Subject|1|||
125247226|NCT00063999|450531009|FG001|Overall Study|Withdrawal by Subject|0|||
125247227|NCT00063999|450531008|FG000|Overall Study|Ineligible|44|||
125247228|NCT00063999|450531009|FG001|Overall Study|Ineligible|24|||
125247229|NCT03767894|450531010|FG000|Overall Study|Withdrawal by Subject|1|||
125247230|NCT04243837|450531011|FG000|Overall Study|Adverse Event|2|||
125247231|NCT04243837|450531012|FG001|Overall Study|Adverse Event|1|||
125247232|NCT04243837|450531011|FG000|Overall Study|Withdrawal by Subject|4|||
125247233|NCT04243837|450531012|FG001|Overall Study|Withdrawal by Subject|2|||
125247234|NCT04243837|450531011|FG000|Overall Study|Covid-19 lock down|1|||
125247235|NCT04243837|450531012|FG001|Overall Study|Covid-19 lock down|0|||
125247236|NCT04243837|450531011|FG000|Overall Study|Study Terminated by Sponsor|11|||
125247237|NCT04243837|450531012|FG001|Overall Study|Study Terminated by Sponsor|12|||
125247238|NCT02280499|450531013|FG000|Overall Study|Death|14|||
125247239|NCT02280499|450531013|FG000|Overall Study|Lost to Follow-up|42|||
125247240|NCT02280499|450531013|FG000|Overall Study|Adverse Event|5|||
125247241|NCT00977561|450531021|FG000|Overall Study|Death|3|||
125247242|NCT00977561|450531022|FG001|Overall Study|Death|2|||
125247243|NCT00977561|450531021|FG000|Overall Study|Study terminated|0|||
125247244|NCT00977561|450531022|FG001|Overall Study|Study terminated|2|||
125247245|NCT00977561|450531021|FG000|Overall Study|Other|2|||
125247246|NCT00977561|450531022|FG001|Overall Study|Other|0|||
125247247|NCT01968785|450531025|FG000|Overall Study|Withdrawal by Subject|1|||
125247248|NCT01968785|450531026|FG001|Overall Study|Withdrawal by Subject|0|||
125247249|NCT04000724|450531033|FG000|Overall Study|Withdrawal by Subject|5|||
125247250|NCT04000724|450531034|FG001|Overall Study|Withdrawal by Subject|3|||
125247251|NCT04000724|450531035|FG002|Overall Study|Withdrawal by Subject|4|||
125247252|NCT04000724|450531033|FG000|Overall Study|Lost to Follow-up|11|||
125247253|NCT04000724|450531034|FG001|Overall Study|Lost to Follow-up|7|||
125247254|NCT04000724|450531035|FG002|Overall Study|Lost to Follow-up|13|||
125247255|NCT00455455|450531036|FG000|Washout|Withdrawal by Subject|0|||
125247256|NCT00455455|450531037|FG001|Washout|Withdrawal by Subject|1|||
125247257|NCT00455455|450531036|FG000|Washout|Withdrawal by Subject|1|||
125247258|NCT00455455|450531037|FG001|Washout|Withdrawal by Subject|0|||
125247259|NCT01827943|450531038|FG000|Overall Study|Protocol Violation|8|||
125247260|NCT01827943|450531038|FG000|Overall Study|Never treated because of an rapid progression|1|||
125395252|NCT01393405|451079562|FG000|Induction Period (week1-16)|Adverse Event|16|||
125395253|NCT01393405|451079563|FG001|Induction Period (week1-16)|Adverse Event|0|||
125247261|NCT04689009|450531039|FG000|Overall Study|Adverse Event|1|||
125247262|NCT04689009|450531040|FG001|Overall Study|Adverse Event|0|||
125247263|NCT04689009|450531039|FG000|Overall Study|Lost to Follow-up|1|||
125247264|NCT04689009|450531040|FG001|Overall Study|Lost to Follow-up|2|||
125247265|NCT04689009|450531039|FG000|Overall Study|Withdrawal by Subject|4|||
125247266|NCT04689009|450531040|FG001|Overall Study|Withdrawal by Subject|3|||
125247267|NCT04689009|450531039|FG000|Overall Study|Protocol Violation|1|||
125194553|NCT01091662|450334925|FG001|Overall Study|Pregnancy|1|||
125194554|NCT01091662|450334924|FG000|Overall Study|Protocol Violation|0|||
125194555|NCT01091662|450334925|FG001|Overall Study|Protocol Violation|2|||
125194556|NCT01091662|450334924|FG000|Overall Study|unable to swallow capsule|0|||
125194557|NCT01091662|450334925|FG001|Overall Study|unable to swallow capsule|1|||
125194558|NCT04109391|450334926|FG000|Overall Study|Adverse Event|2|||
125194559|NCT04109391|450334927|FG001|Overall Study|Adverse Event|2|||
125194560|NCT04109391|450334928|FG002|Overall Study|Adverse Event|0|||
125194561|NCT04109391|450334926|FG000|Overall Study|Withdrawal by Subject|2|||
125194562|NCT04109391|450334927|FG001|Overall Study|Withdrawal by Subject|0|||
125194563|NCT04109391|450334928|FG002|Overall Study|Withdrawal by Subject|0|||
125194564|NCT04109391|450334926|FG000|Overall Study|Pregnancy|1|||
125194565|NCT04109391|450334927|FG001|Overall Study|Pregnancy|0|||
125194566|NCT04109391|450334928|FG002|Overall Study|Pregnancy|0|||
125194567|NCT04109391|450334926|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
125194568|NCT04109391|450334927|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
125194569|NCT04109391|450334928|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
125194570|NCT04109391|450334926|FG000|Overall Study|Lost to Follow-up|0|||
125194571|NCT04109391|450334927|FG001|Overall Study|Lost to Follow-up|0|||
125194572|NCT04109391|450334928|FG002|Overall Study|Lost to Follow-up|1|||
125194573|NCT04109391|450334926|FG000|Overall Study|Lack of Efficacy|2|||
125194574|NCT04109391|450334927|FG001|Overall Study|Lack of Efficacy|2|||
125194575|NCT04109391|450334928|FG002|Overall Study|Lack of Efficacy|3|||
125194576|NCT01222520|450334929|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
125194577|NCT01222520|450334930|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
125194578|NCT01222520|450334929|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
125194579|NCT01222520|450334930|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
125194580|NCT01222520|450334929|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
125194581|NCT01222520|450334930|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
125194582|NCT01222520|450334929|FG000|Double-blind Period|Adverse Event|0|||
125194583|NCT01222520|450334930|FG001|Double-blind Period|Adverse Event|1|||
125194584|NCT01222520|450334929|FG000|Double-blind Period|Lack of Efficacy|0|||
125194585|NCT01222520|450334930|FG001|Double-blind Period|Lack of Efficacy|1|||
125194586|NCT01222520|450334929|FG000|Double-blind Period|Study medication stolen|1|||
125194587|NCT01222520|450334930|FG001|Double-blind Period|Study medication stolen|0|||
125194588|NCT01089608|450334933|FG000|Overall Study|Adverse Event|0|||
125194589|NCT01089608|450334934|FG001|Overall Study|Adverse Event|4|||
125194590|NCT01089608|450334933|FG000|Overall Study|Lost to Follow-up|0|||
125194591|NCT01089608|450334934|FG001|Overall Study|Lost to Follow-up|2|||
125194592|NCT00955955|450334935|FG000|Overall Study|Lost to Follow-up|2|||
125194593|NCT00955955|450334936|FG001|Overall Study|Lost to Follow-up|0|||
125194594|NCT00955955|450334937|FG002|Overall Study|Lost to Follow-up|0|||
125194595|NCT03423173|450334938|FG000|Overall Study|Randomized but not vaccinated|1|||
125194596|NCT03423173|450334939|FG001|Overall Study|Randomized but not vaccinated|0|||
125194597|NCT03423173|450334940|FG002|Overall Study|Randomized but not vaccinated|2|||
125194598|NCT03423173|450334941|FG003|Overall Study|Randomized but not vaccinated|1|||
125194599|NCT03423173|450334938|FG000|Overall Study|Adverse Event|1|||
125194600|NCT03423173|450334939|FG001|Overall Study|Adverse Event|1|||
125194601|NCT03423173|450334940|FG002|Overall Study|Adverse Event|1|||
125194602|NCT03423173|450334941|FG003|Overall Study|Adverse Event|1|||
125194603|NCT03423173|450334938|FG000|Overall Study|Lost to Follow-up|10|||
125194604|NCT03423173|450334939|FG001|Overall Study|Lost to Follow-up|19|||
125194605|NCT03423173|450334940|FG002|Overall Study|Lost to Follow-up|17|||
125194606|NCT03423173|450334941|FG003|Overall Study|Lost to Follow-up|22|||
125194607|NCT03423173|450334938|FG000|Overall Study|Withdrawal of consent|4|||
125194608|NCT03423173|450334939|FG001|Overall Study|Withdrawal of consent|10|||
125194609|NCT03423173|450334940|FG002|Overall Study|Withdrawal of consent|4|||
125194610|NCT03423173|450334941|FG003|Overall Study|Withdrawal of consent|5|||
125194611|NCT03423173|450334938|FG000|Overall Study|Death|1|||
125194612|NCT03423173|450334939|FG001|Overall Study|Death|0|||
125194613|NCT03423173|450334940|FG002|Overall Study|Death|0|||
125194614|NCT03423173|450334941|FG003|Overall Study|Death|0|||
125194615|NCT03423173|450334938|FG000|Overall Study|Reason not Specified|2|||
125194616|NCT03423173|450334939|FG001|Overall Study|Reason not Specified|5|||
125194617|NCT03423173|450334940|FG002|Overall Study|Reason not Specified|3|||
125194618|NCT03423173|450334941|FG003|Overall Study|Reason not Specified|1|||
125194619|NCT02920008|450334942|FG000|Overall Study|Death|117|||
125194620|NCT02920008|450334943|FG001|Overall Study|Death|127|||
125194621|NCT02920008|450334942|FG000|Overall Study|Withdrawal by Subject|3|||
125194622|NCT02920008|450334943|FG001|Overall Study|Withdrawal by Subject|6|||
125194623|NCT02920008|450334942|FG000|Overall Study|Lost to Follow-up|0|||
125194624|NCT02920008|450334943|FG001|Overall Study|Lost to Follow-up|1|||
125194625|NCT02737930|450334944|FG000|Overall Study|Withdrawal by Subject|0|||
125194626|NCT02737930|450334945|FG001|Overall Study|Withdrawal by Subject|1|||
125194627|NCT03169881|450334946|FG000|Overall Study|Incomplete Follow-up|10|||
125194628|NCT03169881|450334947|FG001|Overall Study|Incomplete Follow-up|15|||
125194629|NCT03169881|450334946|FG000|Overall Study|Lost to Follow-up|18|||
125194630|NCT03169881|450334947|FG001|Overall Study|Lost to Follow-up|20|||
125194631|NCT03169881|450334946|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
125194632|NCT03169881|450334947|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
125194633|NCT03852264|450334948|FG000|Third Research Visit|Lost to Follow-up|1|||
125194634|NCT03852264|450334949|FG001|Third Research Visit|Lost to Follow-up|0|||
125194635|NCT00729157|450334956|FG000|Overall Study|Withdrawal by Subject|1|||
125194636|NCT02217410|450334957|FG000|Overall Study|Graft Loss|0|||
125194637|NCT02217410|450334958|FG001|Overall Study|Graft Loss|0|||
125194638|NCT02217410|450334959|FG002|Overall Study|Graft Loss|2|||
125194639|NCT02217410|450334957|FG000|Overall Study|Withdrawal by Subject|0|||
125194640|NCT02217410|450334958|FG001|Overall Study|Withdrawal by Subject|0|||
125194641|NCT02217410|450334959|FG002|Overall Study|Withdrawal by Subject|2|||
125194642|NCT02217410|450334957|FG000|Overall Study|Lost to Follow-up|0|||
125194643|NCT02217410|450334958|FG001|Overall Study|Lost to Follow-up|0|||
125194644|NCT02217410|450334959|FG002|Overall Study|Lost to Follow-up|1|||
125194645|NCT02217410|450334957|FG000|Overall Study|Lack of Efficacy|0|||
125194646|NCT02217410|450334958|FG001|Overall Study|Lack of Efficacy|1|||
125194647|NCT02217410|450334959|FG002|Overall Study|Lack of Efficacy|0|||
125194648|NCT02217410|450334957|FG000|Overall Study|Physician Decision|1|||
125194649|NCT02217410|450334958|FG001|Overall Study|Physician Decision|3|||
125194650|NCT02217410|450334959|FG002|Overall Study|Physician Decision|0|||
125194651|NCT00661609|450334961|FG000|Overall Study|Adverse Event|4|||
125194652|NCT00661609|450334961|FG000|Overall Study|Death|20|||
125194653|NCT00661609|450334961|FG000|Overall Study|Withdrawal by Subject|2|||
125194654|NCT00661609|450334961|FG000|Overall Study|PI Decision|1|||
125194655|NCT00661609|450334961|FG000|Overall Study|Survival follow up stage discontinued|11|||
125194656|NCT00661609|450334961|FG000|Overall Study|Disease progression|3|||
125194657|NCT00637000|450334962|FG000|Overall Study|Withdrawal by Subject|4|||
125194658|NCT00637000|450334963|FG001|Overall Study|Withdrawal by Subject|3|||
125194659|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
125194660|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
125194661|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
125194662|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
125194663|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
125194664|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
125194665|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
125194666|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
125194667|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
125194668|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
125194669|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
125194670|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
125194671|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
125194672|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
125194673|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
125194674|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
125194675|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
125194676|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
125194677|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
125194678|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
125194679|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
125194680|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
125194681|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
125194682|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
125194683|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
125194684|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
125194685|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
125194686|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
125194687|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
125194688|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
125194689|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
125194690|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
125194691|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
125194692|NCT00839527|450334966|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
125194693|NCT00839527|450334967|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
125194694|NCT00839527|450334968|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
125194695|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
125194696|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
125194697|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
125395254|NCT01393405|451079564|FG002|Induction Period (week1-16)|Adverse Event|0|||
125395255|NCT01393405|451079562|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
125247268|NCT04689009|450531040|FG001|Overall Study|Protocol Violation|0|||
125247269|NCT00545948|450531042|FG000|Overall Study|Not Treated|1|||
125247270|NCT00545948|450531043|FG001|Overall Study|Not Treated|1|||
125247271|NCT00545948|450531044|FG002|Overall Study|Not Treated|7|||
125247272|NCT03467945|450531045|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125247273|NCT03467945|450531046|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125247274|NCT03467945|450531047|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125247275|NCT03467945|450531048|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125247276|NCT03467945|450531045|FG000|Treatment Period 3|Withdrawal by Subject|1|||
125247277|NCT03467945|450531046|FG001|Treatment Period 3|Withdrawal by Subject|0|||
125247278|NCT03467945|450531047|FG002|Treatment Period 3|Withdrawal by Subject|2|||
125247279|NCT03467945|450531048|FG003|Treatment Period 3|Withdrawal by Subject|1|||
125247280|NCT02187055|450531051|FG000|Overall Study|Lack of Efficacy|10|||
125247281|NCT02187055|450531052|FG001|Overall Study|Lack of Efficacy|3|||
125247282|NCT02187055|450531053|FG002|Overall Study|Lack of Efficacy|7|||
125247283|NCT02187055|450531051|FG000|Overall Study|Lost to Follow-up|2|||
125247284|NCT02187055|450531052|FG001|Overall Study|Lost to Follow-up|7|||
125247285|NCT02187055|450531053|FG002|Overall Study|Lost to Follow-up|3|||
125247286|NCT02187055|450531051|FG000|Overall Study|No longer meets eligibility criteria|0|||
125247287|NCT02187055|450531052|FG001|Overall Study|No longer meets eligibility criteria|2|||
125247288|NCT02187055|450531053|FG002|Overall Study|No longer meets eligibility criteria|0|||
125247289|NCT02187055|450531051|FG000|Overall Study|No longer willing to participate|6|||
125247290|NCT02187055|450531052|FG001|Overall Study|No longer willing to participate|8|||
125247291|NCT02187055|450531053|FG002|Overall Study|No longer willing to participate|10|||
125247292|NCT02187055|450531051|FG000|Overall Study|Other|5|||
125247293|NCT02187055|450531052|FG001|Overall Study|Other|6|||
125247294|NCT02187055|450531053|FG002|Overall Study|Other|3|||
125247295|NCT02187055|450531051|FG000|Overall Study|Protocol Violation|9|||
125247296|NCT02187055|450531052|FG001|Overall Study|Protocol Violation|9|||
125247297|NCT02187055|450531053|FG002|Overall Study|Protocol Violation|4|||
125247298|NCT02187055|450531051|FG000|Overall Study|Pregnancy|3|||
125247299|NCT02187055|450531052|FG001|Overall Study|Pregnancy|1|||
125247300|NCT02187055|450531053|FG002|Overall Study|Pregnancy|0|||
125247301|NCT02187055|450531051|FG000|Overall Study|Withdrawal by Subject|11|||
125247302|NCT02187055|450531052|FG001|Overall Study|Withdrawal by Subject|11|||
125247303|NCT02187055|450531053|FG002|Overall Study|Withdrawal by Subject|11|||
125247304|NCT02187055|450531051|FG000|Overall Study|Adverse Event|21|||
125247305|NCT02187055|450531052|FG001|Overall Study|Adverse Event|26|||
125247306|NCT02187055|450531053|FG002|Overall Study|Adverse Event|36|||
125247307|NCT02187055|450531051|FG000|Overall Study|Death|2|||
125247308|NCT02187055|450531052|FG001|Overall Study|Death|0|||
125247309|NCT02187055|450531053|FG002|Overall Study|Death|0|||
125247310|NCT03520387|450531056|FG000|Pre-Randomization|Withdrawal by Subject|1|||
125247311|NCT03520387|450531057|FG001|Pre-Randomization|Withdrawal by Subject|0|||
125247312|NCT03520387|450531058|FG002|Pre-Randomization|Withdrawal by Subject|0|||
125247313|NCT03520387|450531059|FG003|Pre-Randomization|Withdrawal by Subject|0|||
125247314|NCT03520387|450531060|FG004|Pre-Randomization|Withdrawal by Subject|0|||
125247315|NCT03520387|450531056|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
125247316|NCT03520387|450531057|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
125247317|NCT03520387|450531058|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
125247318|NCT03520387|450531059|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
125247319|NCT03520387|450531060|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
125247320|NCT03336866|450531061|FG000|Overall Study|Lost to Follow-up|2|||
125247321|NCT03336866|450531062|FG001|Overall Study|Lost to Follow-up|0|||
125247322|NCT03336866|450531063|FG002|Overall Study|Lost to Follow-up|3|||
125247323|NCT03336866|450531061|FG000|Overall Study|Withdrawal by Subject|1|||
125247324|NCT03336866|450531062|FG001|Overall Study|Withdrawal by Subject|1|||
125247325|NCT03336866|450531063|FG002|Overall Study|Withdrawal by Subject|0|||
125247326|NCT03336866|450531061|FG000|Overall Study|Noncompliance with clinic house rules|0|||
125247327|NCT03336866|450531062|FG001|Overall Study|Noncompliance with clinic house rules|0|||
125247328|NCT03336866|450531063|FG002|Overall Study|Noncompliance with clinic house rules|1|||
125247329|NCT00541775|450531064|FG000|Overall Study|Adverse Event|3|||
125247330|NCT00541775|450531065|FG001|Overall Study|Adverse Event|2|||
125247331|NCT00541775|450531066|FG002|Overall Study|Adverse Event|1|||
125247332|NCT00541775|450531064|FG000|Overall Study|Lack of Efficacy|0|||
125247333|NCT00541775|450531065|FG001|Overall Study|Lack of Efficacy|0|||
125395256|NCT01393405|451079563|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
125395257|NCT01393405|451079564|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
125395258|NCT01393405|451079562|FG000|Maintenance Period Week|Lack of Efficacy|0|||
125247334|NCT00541775|450531066|FG002|Overall Study|Lack of Efficacy|3|||
125247335|NCT00541775|450531064|FG000|Overall Study|Lost to Follow-up|0|||
125247336|NCT00541775|450531065|FG001|Overall Study|Lost to Follow-up|0|||
125247337|NCT00541775|450531066|FG002|Overall Study|Lost to Follow-up|2|||
125247338|NCT00541775|450531064|FG000|Overall Study|Protocol Violation|1|||
125247339|NCT00541775|450531065|FG001|Overall Study|Protocol Violation|0|||
125247340|NCT00541775|450531066|FG002|Overall Study|Protocol Violation|0|||
125443654|NCT02397460|451252223|FG007|Treatment Period 4|Physician Decision|0|||
125443655|NCT02213055|451252224|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
125443656|NCT02213055|451252225|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
125443657|NCT02213055|451252224|FG000|Overall Study|Protocol was not Followed during Study|1|||
125443658|NCT02213055|451252225|FG001|Overall Study|Protocol was not Followed during Study|0|||
125443659|NCT02213055|451252224|FG000|Overall Study|Documentation Issue at Enrollment|1|||
125443660|NCT02213055|451252225|FG001|Overall Study|Documentation Issue at Enrollment|0|||
125443661|NCT02213055|451252224|FG000|Overall Study|Documentation Issue during Study|10|||
125443662|NCT02213055|451252225|FG001|Overall Study|Documentation Issue during Study|0|||
125443663|NCT02213055|451252224|FG000|Overall Study|Did not have Live Lice|8|||
125443664|NCT02213055|451252225|FG001|Overall Study|Did not have Live Lice|0|||
125443665|NCT02213055|451252224|FG000|Overall Study|Had another Treatment during the Study|3|||
125443666|NCT02213055|451252225|FG001|Overall Study|Had another Treatment during the Study|0|||
125443667|NCT02213055|451252224|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
125443668|NCT02213055|451252225|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
125443669|NCT02213055|451252224|FG000|Overall Study|Did not Return to School|5|||
125443670|NCT02213055|451252225|FG001|Overall Study|Did not Return to School|0|||
125395259|NCT01393405|451079563|FG001|Maintenance Period Week|Lack of Efficacy|22|||
125395260|NCT01393405|451079564|FG002|Maintenance Period Week|Lack of Efficacy|22|||
125395261|NCT01393405|451079562|FG000|Maintenance Period Week|Adverse Event|0|||
125395262|NCT01393405|451079563|FG001|Maintenance Period Week|Adverse Event|5|||
125395263|NCT01393405|451079564|FG002|Maintenance Period Week|Adverse Event|2|||
125395264|NCT01393405|451079562|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
125395265|NCT01393405|451079563|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
125395266|NCT01393405|451079564|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
125395267|NCT01393405|451079562|FG000|Maintenance Period Week|Lost to Follow-up|0|||
125395268|NCT01393405|451079563|FG001|Maintenance Period Week|Lost to Follow-up|1|||
125395269|NCT01393405|451079564|FG002|Maintenance Period Week|Lost to Follow-up|0|||
125395270|NCT00717769|451079567|FG000|Overall Study|Adverse Event|9|||
125395271|NCT00717769|451079568|FG001|Overall Study|Adverse Event|6|||
125395272|NCT00717769|451079569|FG002|Overall Study|Adverse Event|1|||
125395273|NCT00717769|451079567|FG000|Overall Study|Lack of compliance|0|||
125395274|NCT00717769|451079568|FG001|Overall Study|Lack of compliance|2|||
125395275|NCT00717769|451079569|FG002|Overall Study|Lack of compliance|0|||
125395276|NCT00717769|451079567|FG000|Overall Study|Lost to Follow-up|3|||
125395277|NCT00717769|451079568|FG001|Overall Study|Lost to Follow-up|4|||
125395278|NCT00717769|451079569|FG002|Overall Study|Lost to Follow-up|0|||
125247341|NCT00541775|450531064|FG000|Overall Study|Withdrawal by Subject and Other|5|||
125247342|NCT00541775|450531065|FG001|Overall Study|Withdrawal by Subject and Other|0|||
125247343|NCT00541775|450531066|FG002|Overall Study|Withdrawal by Subject and Other|2|||
125247344|NCT00032487|450531067|FG000|Overall Study|Withdrawal by Subject|67|||
125247345|NCT00032487|450531068|FG001|Overall Study|Withdrawal by Subject|43|||
125247346|NCT00032487|450531067|FG000|Overall Study|Adverse Event|3|||
125247347|NCT00032487|450531068|FG001|Overall Study|Adverse Event|7|||
125247348|NCT00032487|450531067|FG000|Overall Study|Lost to Follow-up|57|||
125247349|NCT00032487|450531068|FG001|Overall Study|Lost to Follow-up|58|||
125247350|NCT00032487|450531067|FG000|Overall Study|Had other reason|12|||
125247351|NCT00032487|450531068|FG001|Overall Study|Had other reason|12|||
125247352|NCT02975700|450531069|FG000|Overall Study|Adverse Event|1|||
125247353|NCT02975700|450531069|FG000|Overall Study|Progressive disease|3|||
125247354|NCT02975700|450531069|FG000|Overall Study|Failed screening criteria|2|||
125247355|NCT01541254|450531071|FG000|Overall Study|Withdrawal by Subject|1|||
125247356|NCT01541254|450531071|FG000|Overall Study|excluded - metal allergy|1|||
125247357|NCT01541254|450531071|FG000|Overall Study|enrolled after study closed|1|||
125247358|NCT01541254|450531071|FG000|Overall Study|GI bleed prior to procedure|1|||
125247359|NCT01541254|450531071|FG000|Overall Study|stent not required|1|||
125395279|NCT00717769|451079567|FG000|Overall Study|Lack of Efficacy|1|||
125395280|NCT00717769|451079568|FG001|Overall Study|Lack of Efficacy|2|||
125395281|NCT00717769|451079569|FG002|Overall Study|Lack of Efficacy|0|||
125395282|NCT00717769|451079567|FG000|Overall Study|Protocol Violation|0|||
125395283|NCT00717769|451079568|FG001|Overall Study|Protocol Violation|2|||
125395284|NCT00717769|451079569|FG002|Overall Study|Protocol Violation|0|||
125395285|NCT00717769|451079567|FG000|Overall Study|Sponsor decision|1|||
125247360|NCT01541254|450531071|FG000|Overall Study|alternate stent used|1|||
125247361|NCT05660538|450531072|FG000|Overall Study|Adverse Event|0|||
125395286|NCT00717769|451079568|FG001|Overall Study|Sponsor decision|0|||
125395287|NCT00717769|451079569|FG002|Overall Study|Sponsor decision|10|||
125395288|NCT00717769|451079567|FG000|Overall Study|Withdrew consent|2|||
125395289|NCT00717769|451079568|FG001|Overall Study|Withdrew consent|2|||
125395290|NCT00717769|451079569|FG002|Overall Study|Withdrew consent|0|||
125395291|NCT03350503|451079572|FG000|Overall Study|Adverse Event|5|||
125395292|NCT03350503|451079572|FG000|Overall Study|Withdrawal by Subject|5|||
125395293|NCT03350503|451079572|FG000|Overall Study|Continuation impossible due to move|4|||
125443671|NCT00231894|451252226|FG000|Overall Study|Withdrawal by Subject|1|||
125247362|NCT05660538|450531073|FG001|Overall Study|Adverse Event|0|||
125395294|NCT03350503|451079572|FG000|Overall Study|Physician Decision|3|||
125395295|NCT01399593|451079575|FG000|Overall Study|Physician Decision|1|||
125395296|NCT01399593|451079576|FG001|Overall Study|Physician Decision|0|||
125395297|NCT01399593|451079575|FG000|Overall Study|Adverse Event|1|||
125395298|NCT01399593|451079576|FG001|Overall Study|Adverse Event|0|||
125395299|NCT01399593|451079575|FG000|Overall Study|Death|1|||
125395300|NCT01399593|451079576|FG001|Overall Study|Death|1|||
125194698|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
125194699|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
125194700|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
125194701|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
125194702|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
125194703|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
125194704|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
125194705|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
125194706|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
125194707|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
125194708|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
125194709|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
125194710|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
125194711|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
125194712|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
125194713|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
125194714|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
125194715|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
125194716|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
125194717|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
125194718|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
125194719|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
125194720|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
125194721|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
125194722|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
125194723|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
125194724|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
125194725|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
125194726|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
125194727|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
125194728|NCT00839527|450334966|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
125194729|NCT00839527|450334967|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
125194730|NCT00839527|450334968|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
125194731|NCT01855243|450334969|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
125194732|NCT01855243|450334970|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
125194733|NCT01855243|450334971|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
125194734|NCT01704651|450334976|FG000|Overall Study|Pre-op withdrawal by subject|1|||
125194735|NCT01704651|450334977|FG001|Overall Study|Pre-op withdrawal by subject|1|||
125194736|NCT01704651|450334976|FG000|Overall Study|Pre-op change in treatment plan|1|||
125194737|NCT01704651|450334977|FG001|Overall Study|Pre-op change in treatment plan|4|||
125194738|NCT01704651|450334976|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
125194739|NCT01704651|450334977|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
125194740|NCT01704651|450334976|FG000|Overall Study|Post-op did not have laparotomy|2|||
125194741|NCT01704651|450334977|FG001|Overall Study|Post-op did not have laparotomy|1|||
125194742|NCT03315286|450334978|FG000|Overall Study|Lost to Follow-up|0|||
125194743|NCT03315286|450334979|FG001|Overall Study|Lost to Follow-up|3|||
125194744|NCT03315286|450334978|FG000|Overall Study|Withdrawal by Subject|1|||
125194745|NCT03315286|450334979|FG001|Overall Study|Withdrawal by Subject|0|||
125194746|NCT03315286|450334978|FG000|Overall Study|Protocol Violation|0|||
125194747|NCT03315286|450334979|FG001|Overall Study|Protocol Violation|1|||
125194748|NCT03075891|450334980|FG000|Overall Study|Withdrawal by Subject|3|||
125194749|NCT03075891|450334981|FG001|Overall Study|Withdrawal by Subject|6|||
125194750|NCT03075891|450334980|FG000|Overall Study|Lost to Follow-up|1|||
125194751|NCT03075891|450334981|FG001|Overall Study|Lost to Follow-up|0|||
125194752|NCT03075891|450334980|FG000|Overall Study|Pregnancy|3|||
125194753|NCT03075891|450334981|FG001|Overall Study|Pregnancy|1|||
125194754|NCT03075891|450334980|FG000|Overall Study|visits not performed (no time)|1|||
125194755|NCT03075891|450334981|FG001|Overall Study|visits not performed (no time)|0|||
125194756|NCT03075891|450334980|FG000|Overall Study|Drug abuse relapse issue|0|||
125194757|NCT03075891|450334981|FG001|Overall Study|Drug abuse relapse issue|1|||
125395301|NCT01399593|451079575|FG000|Overall Study|Transplantectomy|0|||
125395302|NCT01399593|451079576|FG001|Overall Study|Transplantectomy|1|||
125395303|NCT00344773|451079580|FG000|Overall Study|Adverse Event|2|||
125395304|NCT00344773|451079580|FG000|Overall Study|Objective Disease Progression|16|||
125395305|NCT00344773|451079580|FG000|Overall Study|Withdrawal by Subject|1|||
125395306|NCT00344773|451079580|FG000|Overall Study|Not Eligible for the study|2|||
125395307|NCT02141074|451079582|FG000|Pre-prophylaxis|Adverse Event|3|||
125395308|NCT02141074|451079583|FG001|Pre-prophylaxis|Adverse Event|0|||
125395309|NCT02141074|451079582|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
125395310|NCT02141074|451079583|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
125395311|NCT02141074|451079582|FG000|Prophylaxis|Adverse Event|0|||
125395312|NCT02141074|451079583|FG001|Prophylaxis|Adverse Event|4|||
125395313|NCT02141074|451079582|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
125395314|NCT02141074|451079583|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
125395315|NCT02141074|451079582|FG000|Prophylaxis|Withdrawal by Subject|0|||
125395316|NCT02141074|451079583|FG001|Prophylaxis|Withdrawal by Subject|1|||
125395317|NCT06023394|451079585|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
125395318|NCT06023394|451079586|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
125395319|NCT06023394|451079585|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
125395320|NCT06023394|451079586|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
125395321|NCT06023394|451079585|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
125395322|NCT06023394|451079586|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
125395323|NCT06023394|451079585|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
125395324|NCT06023394|451079586|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
125395325|NCT02283788|451079588|FG000|Overall Study|Adverse Event|1|||
125395326|NCT02283788|451079589|FG001|Overall Study|Adverse Event|3|||
125395327|NCT02283788|451079590|FG002|Overall Study|Adverse Event|5|||
125247363|NCT05660538|450531074|FG002|Overall Study|Adverse Event|1|||
125247364|NCT05660538|450531075|FG003|Overall Study|Adverse Event|0|||
125247365|NCT05660538|450531072|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
125247366|NCT05660538|450531073|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
125247367|NCT05660538|450531074|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
125247368|NCT05660538|450531075|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
125247369|NCT05660538|450531072|FG000|Overall Study|Lost to Follow-up|0|||
125247370|NCT05660538|450531073|FG001|Overall Study|Lost to Follow-up|0|||
125247371|NCT05660538|450531074|FG002|Overall Study|Lost to Follow-up|1|||
125247372|NCT05660538|450531075|FG003|Overall Study|Lost to Follow-up|1|||
125247373|NCT05660538|450531072|FG000|Overall Study|Death|0|||
125247374|NCT05660538|450531073|FG001|Overall Study|Death|0|||
125247375|NCT05660538|450531074|FG002|Overall Study|Death|1|||
125247376|NCT05660538|450531075|FG003|Overall Study|Death|0|||
125247377|NCT05660538|450531072|FG000|Overall Study|Physician Decision|0|||
125247378|NCT05660538|450531073|FG001|Overall Study|Physician Decision|0|||
125247379|NCT05660538|450531074|FG002|Overall Study|Physician Decision|0|||
125247380|NCT05660538|450531075|FG003|Overall Study|Physician Decision|1|||
125247381|NCT05660538|450531072|FG000|Overall Study|Sponsor Decision|1|||
125247382|NCT05660538|450531073|FG001|Overall Study|Sponsor Decision|0|||
125247383|NCT05660538|450531074|FG002|Overall Study|Sponsor Decision|0|||
125247384|NCT05660538|450531075|FG003|Overall Study|Sponsor Decision|0|||
125247385|NCT05660538|450531072|FG000|Overall Study|Other|1|||
125247386|NCT05660538|450531073|FG001|Overall Study|Other|0|||
125247387|NCT05660538|450531074|FG002|Overall Study|Other|0|||
125247388|NCT05660538|450531075|FG003|Overall Study|Other|1|||
125247389|NCT05660538|450531072|FG000|Overall Study|Randomized but did not receive study drug|1|||
125247390|NCT05660538|450531073|FG001|Overall Study|Randomized but did not receive study drug|0|||
125247391|NCT05660538|450531074|FG002|Overall Study|Randomized but did not receive study drug|0|||
125247392|NCT05660538|450531075|FG003|Overall Study|Randomized but did not receive study drug|1|||
125247393|NCT05660538|450531072|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
125247394|NCT05660538|450531073|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
125247395|NCT05660538|450531074|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
125247396|NCT05660538|450531075|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
125247397|NCT04518410|450531077|FG000|Overall Study|Lost to Follow-up|1|||
125247398|NCT04518410|450531078|FG001|Overall Study|Lost to Follow-up|1|||
125247399|NCT04518410|450531079|FG002|Overall Study|Lost to Follow-up|8|||
125247400|NCT04518410|450531080|FG003|Overall Study|Lost to Follow-up|5|||
125247401|NCT04518410|450531081|FG004|Overall Study|Lost to Follow-up|92|||
125247402|NCT04518410|450531082|FG005|Overall Study|Lost to Follow-up|25|||
125247403|NCT04518410|450531083|FG006|Overall Study|Lost to Follow-up|25|||
125247404|NCT04518410|450531084|FG007|Overall Study|Lost to Follow-up|3|||
125247405|NCT04518410|450531085|FG008|Overall Study|Lost to Follow-up|2|||
125247406|NCT04518410|450531086|FG009|Overall Study|Lost to Follow-up|13|||
125247407|NCT04518410|450531087|FG010|Overall Study|Lost to Follow-up|9|||
125247408|NCT04518410|450531088|FG011|Overall Study|Lost to Follow-up|13|||
125395328|NCT02283788|451079591|FG003|Overall Study|Adverse Event|1|||
125395329|NCT02283788|451079588|FG000|Overall Study|Withdrawal by Subject|0|||
125194758|NCT03075891|450334980|FG000|Overall Study|Participant requiring study withdrawal|0|||
125194759|NCT03075891|450334981|FG001|Overall Study|Participant requiring study withdrawal|1|||
125194760|NCT03075891|450334980|FG000|Overall Study|Adverse event, non-fatal|1|||
125194761|NCT03075891|450334981|FG001|Overall Study|Adverse event, non-fatal|4|||
125194762|NCT00828568|450334985|FG000|Randomized|Withdrawal by Subject|1|||
125194763|NCT00828568|450334986|FG001|Randomized|Withdrawal by Subject|0|||
125194764|NCT00828568|450334987|FG002|Randomized|Withdrawal by Subject|2|||
125194765|NCT00828568|450334985|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
125194766|NCT00828568|450334986|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
125194767|NCT00828568|450334987|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
125194768|NCT00828568|450334985|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
125194769|NCT00828568|450334986|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
125194770|NCT00828568|450334987|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
125194771|NCT00828568|450334985|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
125194772|NCT00828568|450334986|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
125194773|NCT00828568|450334987|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
125194774|NCT00828568|450334985|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
125194775|NCT00828568|450334986|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
125194776|NCT00828568|450334987|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
125194777|NCT00634803|450334988|FG000|Overall Study|Lost to Follow-up|6|||
125194778|NCT00634803|450334989|FG001|Overall Study|Lost to Follow-up|7|||
125194779|NCT00634803|450334990|FG002|Overall Study|Lost to Follow-up|7|||
125194780|NCT00396656|450334991|FG000|First Treatment Period|Withdrawal by Subject|0|||
125194781|NCT00396656|450334992|FG001|First Treatment Period|Withdrawal by Subject|2|||
125194782|NCT00396656|450334991|FG000|Second Treatment Period|Adverse Event|0|||
125194783|NCT00396656|450334992|FG001|Second Treatment Period|Adverse Event|1|||
125194784|NCT00364923|450334993|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
125194785|NCT00364923|450334993|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
125194786|NCT03474731|450334994|FG000|Overall Study|Withdrawal by Subject|36|||
125194787|NCT03474731|450334995|FG001|Overall Study|Withdrawal by Subject|29|||
125194788|NCT03474731|450334996|FG002|Overall Study|Withdrawal by Subject|11|||
125194789|NCT03474731|450334997|FG003|Overall Study|Withdrawal by Subject|27|||
125194790|NCT03474731|450334994|FG000|Overall Study|COVID|0|||
125194791|NCT03474731|450334995|FG001|Overall Study|COVID|23|||
125194792|NCT03474731|450334996|FG002|Overall Study|COVID|0|||
125194793|NCT03474731|450334997|FG003|Overall Study|COVID|0|||
125194794|NCT03474731|450334994|FG000|Overall Study|Participant moved from area|1|||
125194795|NCT03474731|450334995|FG001|Overall Study|Participant moved from area|0|||
125194796|NCT03474731|450334996|FG002|Overall Study|Participant moved from area|0|||
125194797|NCT03474731|450334997|FG003|Overall Study|Participant moved from area|0|||
125194798|NCT03474731|450334994|FG000|Overall Study|Lost to Follow-up|11|||
125194799|NCT03474731|450334995|FG001|Overall Study|Lost to Follow-up|3|||
125194800|NCT03474731|450334996|FG002|Overall Study|Lost to Follow-up|18|||
125194801|NCT03474731|450334997|FG003|Overall Study|Lost to Follow-up|17|||
125194802|NCT03474731|450334994|FG000|Overall Study|Death|0|||
125194803|NCT03474731|450334995|FG001|Overall Study|Death|1|||
125194804|NCT03474731|450334996|FG002|Overall Study|Death|0|||
125194805|NCT03474731|450334997|FG003|Overall Study|Death|0|||
125194806|NCT03474731|450334994|FG000|Overall Study|Participant Removed|0|||
125194807|NCT03474731|450334995|FG001|Overall Study|Participant Removed|0|||
125194808|NCT03474731|450334996|FG002|Overall Study|Participant Removed|0|||
125247409|NCT04518410|450531089|FG012|Overall Study|Lost to Follow-up|9|||
125247410|NCT04518410|450531090|FG013|Overall Study|Lost to Follow-up|13|||
125247411|NCT04518410|450531091|FG014|Overall Study|Lost to Follow-up|8|||
125247412|NCT04518410|450531092|FG015|Overall Study|Lost to Follow-up|10|||
125247413|NCT04518410|450531093|FG016|Overall Study|Lost to Follow-up|6|||
125247414|NCT04518410|450531094|FG017|Overall Study|Lost to Follow-up|13|||
125247415|NCT04518410|450531095|FG018|Overall Study|Lost to Follow-up|21|||
125247416|NCT04518410|450531096|FG019|Overall Study|Lost to Follow-up|6|||
125247417|NCT04518410|450531097|FG020|Overall Study|Lost to Follow-up|7|||
125194809|NCT03474731|450334997|FG003|Overall Study|Participant Removed|1|||
125194810|NCT00766636|450334998|FG000|Overall Study|Withdrawal by Subject|1|||
125194811|NCT00766636|450334999|FG001|Overall Study|Withdrawal by Subject|1|||
125194812|NCT00766636|450334998|FG000|Overall Study|Incomplete Treatment|0|||
125194813|NCT00766636|450334999|FG001|Overall Study|Incomplete Treatment|1|||
125194814|NCT00766636|450334998|FG000|Overall Study|Adverse Event|1|||
125194815|NCT00766636|450334999|FG001|Overall Study|Adverse Event|0|||
125247418|NCT04518410|450531098|FG021|Overall Study|Lost to Follow-up|21|||
125247419|NCT04518410|450531099|FG022|Overall Study|Lost to Follow-up|1|||
125247420|NCT04518410|450531100|FG023|Overall Study|Lost to Follow-up|7|||
125194816|NCT00766636|450334998|FG000|Overall Study|Disease Progression|1|||
125194817|NCT00766636|450334999|FG001|Overall Study|Disease Progression|0|||
125194818|NCT02477332|450335000|FG000|Overall Study|Adverse Event|0|||
125194819|NCT02477332|450335001|FG001|Overall Study|Adverse Event|1|||
125247421|NCT04518410|450531101|FG024|Overall Study|Lost to Follow-up|6|||
125247422|NCT04518410|450531077|FG000|Overall Study|Withdrawal by Subject|1|||
125247423|NCT04518410|450531078|FG001|Overall Study|Withdrawal by Subject|2|||
125247424|NCT04518410|450531079|FG002|Overall Study|Withdrawal by Subject|2|||
125247425|NCT04518410|450531080|FG003|Overall Study|Withdrawal by Subject|3|||
125247426|NCT04518410|450531081|FG004|Overall Study|Withdrawal by Subject|20|||
125247427|NCT04518410|450531082|FG005|Overall Study|Withdrawal by Subject|20|||
125247428|NCT04518410|450531083|FG006|Overall Study|Withdrawal by Subject|25|||
125247429|NCT04518410|450531084|FG007|Overall Study|Withdrawal by Subject|6|||
125247430|NCT04518410|450531085|FG008|Overall Study|Withdrawal by Subject|1|||
125247431|NCT04518410|450531086|FG009|Overall Study|Withdrawal by Subject|12|||
125247432|NCT04518410|450531087|FG010|Overall Study|Withdrawal by Subject|5|||
125247433|NCT04518410|450531088|FG011|Overall Study|Withdrawal by Subject|7|||
125247434|NCT04518410|450531089|FG012|Overall Study|Withdrawal by Subject|2|||
125247435|NCT04518410|450531090|FG013|Overall Study|Withdrawal by Subject|13|||
125247436|NCT04518410|450531091|FG014|Overall Study|Withdrawal by Subject|4|||
125247437|NCT04518410|450531092|FG015|Overall Study|Withdrawal by Subject|9|||
125247438|NCT04518410|450531093|FG016|Overall Study|Withdrawal by Subject|0|||
125247439|NCT04518410|450531094|FG017|Overall Study|Withdrawal by Subject|15|||
125247440|NCT04518410|450531095|FG018|Overall Study|Withdrawal by Subject|12|||
125247441|NCT04518410|450531096|FG019|Overall Study|Withdrawal by Subject|9|||
125247442|NCT04518410|450531097|FG020|Overall Study|Withdrawal by Subject|14|||
125247443|NCT04518410|450531098|FG021|Overall Study|Withdrawal by Subject|3|||
125194820|NCT02477332|450335002|FG002|Overall Study|Adverse Event|1|||
125194821|NCT02477332|450335003|FG003|Overall Study|Adverse Event|2|||
125194822|NCT02477332|450335004|FG004|Overall Study|Adverse Event|1|||
125194823|NCT02477332|450335005|FG005|Overall Study|Adverse Event|2|||
125194824|NCT02477332|450335000|FG000|Overall Study|Lack of Efficacy|1|||
125194825|NCT02477332|450335001|FG001|Overall Study|Lack of Efficacy|2|||
125194826|NCT02477332|450335002|FG002|Overall Study|Lack of Efficacy|1|||
125194827|NCT02477332|450335003|FG003|Overall Study|Lack of Efficacy|2|||
125194828|NCT02477332|450335004|FG004|Overall Study|Lack of Efficacy|1|||
125194829|NCT02477332|450335005|FG005|Overall Study|Lack of Efficacy|1|||
125194830|NCT02477332|450335000|FG000|Overall Study|Non-compliance with study treatment|0|||
125194831|NCT02477332|450335001|FG001|Overall Study|Non-compliance with study treatment|1|||
125194832|NCT02477332|450335002|FG002|Overall Study|Non-compliance with study treatment|2|||
125194833|NCT02477332|450335003|FG003|Overall Study|Non-compliance with study treatment|0|||
125194834|NCT02477332|450335004|FG004|Overall Study|Non-compliance with study treatment|0|||
125194835|NCT02477332|450335005|FG005|Overall Study|Non-compliance with study treatment|0|||
125194836|NCT02477332|450335000|FG000|Overall Study|Pregnancy|0|||
125194837|NCT02477332|450335001|FG001|Overall Study|Pregnancy|0|||
125194838|NCT02477332|450335002|FG002|Overall Study|Pregnancy|0|||
125194839|NCT02477332|450335003|FG003|Overall Study|Pregnancy|1|||
125194840|NCT02477332|450335004|FG004|Overall Study|Pregnancy|0|||
125194841|NCT02477332|450335005|FG005|Overall Study|Pregnancy|0|||
125194842|NCT02477332|450335000|FG000|Overall Study|Protocol Violation|2|||
125194843|NCT02477332|450335001|FG001|Overall Study|Protocol Violation|0|||
125194844|NCT02477332|450335002|FG002|Overall Study|Protocol Violation|3|||
125194845|NCT02477332|450335003|FG003|Overall Study|Protocol Violation|3|||
125194846|NCT02477332|450335004|FG004|Overall Study|Protocol Violation|1|||
125194847|NCT02477332|450335005|FG005|Overall Study|Protocol Violation|1|||
125194848|NCT02477332|450335000|FG000|Overall Study|Technical problems|0|||
125194849|NCT02477332|450335001|FG001|Overall Study|Technical problems|0|||
125194850|NCT02477332|450335002|FG002|Overall Study|Technical problems|1|||
125194851|NCT02477332|450335003|FG003|Overall Study|Technical problems|0|||
125194852|NCT02477332|450335004|FG004|Overall Study|Technical problems|0|||
125194853|NCT02477332|450335005|FG005|Overall Study|Technical problems|0|||
125194854|NCT02477332|450335000|FG000|Overall Study|Lost to Follow-up|0|||
125194855|NCT02477332|450335001|FG001|Overall Study|Lost to Follow-up|0|||
125194856|NCT02477332|450335002|FG002|Overall Study|Lost to Follow-up|2|||
125194857|NCT02477332|450335003|FG003|Overall Study|Lost to Follow-up|0|||
125194858|NCT02477332|450335004|FG004|Overall Study|Lost to Follow-up|0|||
125194859|NCT02477332|450335005|FG005|Overall Study|Lost to Follow-up|0|||
125194860|NCT02477332|450335000|FG000|Overall Study|Physician Decision|0|||
125194861|NCT02477332|450335001|FG001|Overall Study|Physician Decision|0|||
125194862|NCT02477332|450335002|FG002|Overall Study|Physician Decision|1|||
125247444|NCT04518410|450531099|FG022|Overall Study|Withdrawal by Subject|2|||
125247445|NCT04518410|450531100|FG023|Overall Study|Withdrawal by Subject|9|||
125395330|NCT02283788|451079589|FG001|Overall Study|Withdrawal by Subject|1|||
125194863|NCT02477332|450335003|FG003|Overall Study|Physician Decision|3|||
125194864|NCT02477332|450335004|FG004|Overall Study|Physician Decision|0|||
125194865|NCT02477332|450335005|FG005|Overall Study|Physician Decision|1|||
125194866|NCT02477332|450335000|FG000|Overall Study|Withdrawal by Subject|0|||
125194867|NCT02477332|450335001|FG001|Overall Study|Withdrawal by Subject|3|||
125194868|NCT02477332|450335002|FG002|Overall Study|Withdrawal by Subject|1|||
125194869|NCT02477332|450335003|FG003|Overall Study|Withdrawal by Subject|2|||
125247446|NCT04518410|450531101|FG024|Overall Study|Withdrawal by Subject|8|||
125194870|NCT02477332|450335004|FG004|Overall Study|Withdrawal by Subject|1|||
125194871|NCT02477332|450335005|FG005|Overall Study|Withdrawal by Subject|0|||
125194872|NCT02549287|450335006|FG000|Overall Study|Lost to Follow-up|65|||
125194873|NCT02549287|450335007|FG001|Overall Study|Lost to Follow-up|26|||
125194874|NCT02549287|450335006|FG000|Overall Study|Withdrawal by Subject|15|||
125194875|NCT02549287|450335007|FG001|Overall Study|Withdrawal by Subject|6|||
125194876|NCT00765336|450335008|FG000|Overall Study|Protocol Violation|4|||
125194877|NCT00765336|450335009|FG001|Overall Study|Protocol Violation|2|||
125194878|NCT00765336|450335008|FG000|Overall Study|Withdrawal by Subject|6|||
125194879|NCT00765336|450335009|FG001|Overall Study|Withdrawal by Subject|4|||
125194880|NCT00765336|450335008|FG000|Overall Study|Lost to Follow-up|7|||
125194881|NCT00765336|450335009|FG001|Overall Study|Lost to Follow-up|9|||
125194882|NCT00765336|450335008|FG000|Overall Study|Adverse Event|2|||
125194883|NCT00765336|450335009|FG001|Overall Study|Adverse Event|1|||
125194884|NCT01972438|450335010|FG000|Baseline-Month 3 Crossover Period|Death|1|||
125194885|NCT01972438|450335011|FG001|Baseline-Month 3 Crossover Period|Death|0|||
125194886|NCT01972438|450335010|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
125194887|NCT01972438|450335011|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
125194888|NCT01972438|450335010|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
125194889|NCT01972438|450335011|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
125194890|NCT01972438|450335010|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
125194891|NCT01972438|450335011|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
125194892|NCT01972438|450335010|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
125194893|NCT01972438|450335011|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
125194894|NCT01972438|450335010|FG000|Months 6-12 Study Period|Death|1|||
125194895|NCT01972438|450335011|FG001|Months 6-12 Study Period|Death|0|||
125194896|NCT01972438|450335010|FG000|Months 6-12 Study Period|Early Study Closure|2|||
125194897|NCT01972438|450335011|FG001|Months 6-12 Study Period|Early Study Closure|2|||
125194898|NCT01972438|450335010|FG000|Post Month 12 Study Period|Early Study Closure|3|||
125194899|NCT01972438|450335011|FG001|Post Month 12 Study Period|Early Study Closure|4|||
125194900|NCT01186692|450335016|FG000|Overall Study|Not Catheterized|11|||
125194901|NCT01186692|450335016|FG000|Overall Study|Futher testing contraindicated implant|19|||
125194902|NCT01186692|450335016|FG000|Overall Study|Adverse Event|2|||
125194903|NCT04463251|450335017|FG000|Overall Study|Death|1|||
125194904|NCT04463251|450335018|FG001|Overall Study|Death|0|||
125194905|NCT04463251|450335019|FG002|Overall Study|Death|1|||
125194906|NCT04463251|450335017|FG000|Overall Study|Adverse Event|0|||
125194907|NCT04463251|450335018|FG001|Overall Study|Adverse Event|1|||
125194908|NCT04463251|450335019|FG002|Overall Study|Adverse Event|0|||
125194909|NCT04463251|450335017|FG000|Overall Study|Lost to Follow-up|0|||
125194910|NCT04463251|450335018|FG001|Overall Study|Lost to Follow-up|1|||
125194911|NCT04463251|450335019|FG002|Overall Study|Lost to Follow-up|0|||
125194912|NCT04463251|450335017|FG000|Overall Study|Withdrawal by Subject|0|||
125194913|NCT04463251|450335018|FG001|Overall Study|Withdrawal by Subject|2|||
125194914|NCT04463251|450335019|FG002|Overall Study|Withdrawal by Subject|2|||
125194915|NCT04520997|450335025|FG000|Overall Study|Lost to Follow-up|1|||
125194916|NCT04520997|450335026|FG001|Overall Study|Lost to Follow-up|1|||
125194917|NCT04520997|450335025|FG000|Overall Study|Withdrawal by Subject|1|||
125194918|NCT04520997|450335026|FG001|Overall Study|Withdrawal by Subject|0|||
125194919|NCT04520997|450335025|FG000|Overall Study|Not Treated|0|||
125194920|NCT04520997|450335026|FG001|Overall Study|Not Treated|1|||
125194921|NCT02981082|450335027|FG000|Overall Study|Withdrawal by Subject|2|||
125194922|NCT02981082|450335028|FG001|Overall Study|Withdrawal by Subject|0|||
125194923|NCT02981082|450335027|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
125194924|NCT02981082|450335028|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
125194925|NCT02981082|450335027|FG000|Overall Study|Adverse Event|0|||
125194926|NCT02981082|450335028|FG001|Overall Study|Adverse Event|1|||
125194927|NCT05367973|450335029|FG000|Overall Study|Adverse Event|0|||
125194928|NCT05367973|450335030|FG001|Overall Study|Adverse Event|2|||
125194929|NCT01314872|450335034|FG000|Treatment Period 1|Protocol Violation|2|||
125194930|NCT01314872|450335035|FG001|Treatment Period 1|Protocol Violation|1|||
125194931|NCT01314872|450335036|FG002|Treatment Period 1|Protocol Violation|1|||
125194932|NCT01314872|450335037|FG003|Treatment Period 1|Protocol Violation|0|||
125194933|NCT01314872|450335038|FG004|Treatment Period 1|Protocol Violation|1|||
125194934|NCT01314872|450335039|FG005|Treatment Period 1|Protocol Violation|0|||
125194935|NCT01314872|450335040|FG006|Treatment Period 1|Protocol Violation|0|||
125194936|NCT01314872|450335041|FG007|Treatment Period 1|Protocol Violation|0|||
125194937|NCT01314872|450335042|FG008|Treatment Period 1|Protocol Violation|0|||
125194938|NCT01314872|450335043|FG009|Treatment Period 1|Protocol Violation|1|||
125194939|NCT01314872|450335044|FG010|Treatment Period 1|Protocol Violation|1|||
125194940|NCT01314872|450335045|FG011|Treatment Period 1|Protocol Violation|0|||
125194941|NCT01314872|450335046|FG012|Treatment Period 1|Protocol Violation|0|||
125194942|NCT01314872|450335047|FG013|Treatment Period 1|Protocol Violation|0|||
125194943|NCT01314872|450335048|FG014|Treatment Period 1|Protocol Violation|0|||
125194944|NCT01314872|450335034|FG000|Treatment Period 1|Physician Decision|0|||
125194945|NCT01314872|450335035|FG001|Treatment Period 1|Physician Decision|1|||
125194946|NCT01314872|450335036|FG002|Treatment Period 1|Physician Decision|0|||
125194947|NCT01314872|450335037|FG003|Treatment Period 1|Physician Decision|1|||
125194948|NCT01314872|450335038|FG004|Treatment Period 1|Physician Decision|0|||
125194949|NCT01314872|450335039|FG005|Treatment Period 1|Physician Decision|0|||
125194950|NCT01314872|450335040|FG006|Treatment Period 1|Physician Decision|0|||
125194951|NCT01314872|450335041|FG007|Treatment Period 1|Physician Decision|0|||
125194952|NCT01314872|450335042|FG008|Treatment Period 1|Physician Decision|0|||
125247447|NCT04518410|450531077|FG000|Overall Study|Other|1|||
125247448|NCT04518410|450531078|FG001|Overall Study|Other|0|||
125247449|NCT04518410|450531079|FG002|Overall Study|Other|0|||
125247450|NCT04518410|450531080|FG003|Overall Study|Other|1|||
125247451|NCT04518410|450531081|FG004|Overall Study|Other|6|||
125247452|NCT04518410|450531082|FG005|Overall Study|Other|6|||
125247453|NCT04518410|450531083|FG006|Overall Study|Other|5|||
125247454|NCT04518410|450531084|FG007|Overall Study|Other|2|||
125247455|NCT04518410|450531085|FG008|Overall Study|Other|0|||
125247456|NCT04518410|450531086|FG009|Overall Study|Other|1|||
125247457|NCT04518410|450531087|FG010|Overall Study|Other|0|||
125247458|NCT04518410|450531088|FG011|Overall Study|Other|2|||
125247459|NCT04518410|450531089|FG012|Overall Study|Other|0|||
125247460|NCT04518410|450531090|FG013|Overall Study|Other|0|||
125247461|NCT04518410|450531091|FG014|Overall Study|Other|0|||
125247462|NCT04518410|450531092|FG015|Overall Study|Other|3|||
125247463|NCT04518410|450531093|FG016|Overall Study|Other|1|||
125247464|NCT04518410|450531094|FG017|Overall Study|Other|1|||
125247465|NCT04518410|450531095|FG018|Overall Study|Other|1|||
125247466|NCT04518410|450531096|FG019|Overall Study|Other|0|||
125247467|NCT04518410|450531097|FG020|Overall Study|Other|1|||
125247468|NCT04518410|450531098|FG021|Overall Study|Other|0|||
125247469|NCT04518410|450531099|FG022|Overall Study|Other|1|||
125247470|NCT04518410|450531100|FG023|Overall Study|Other|2|||
125247471|NCT04518410|450531101|FG024|Overall Study|Other|2|||
125247472|NCT04518410|450531077|FG000|Overall Study|Protocol Violation|0|||
125247473|NCT04518410|450531078|FG001|Overall Study|Protocol Violation|0|||
125395331|NCT02283788|451079590|FG002|Overall Study|Withdrawal by Subject|0|||
125395332|NCT02283788|451079591|FG003|Overall Study|Withdrawal by Subject|1|||
125395333|NCT02970968|451081590|FG000|Overall Study|Withdrawal by Subject|3|||
125395334|NCT02970968|451081591|FG001|Overall Study|Withdrawal by Subject|3|||
125395335|NCT02970968|451081590|FG000|Overall Study|Adverse Event|1|||
125395336|NCT02970968|451081591|FG001|Overall Study|Adverse Event|2|||
125395337|NCT02970968|451081590|FG000|Overall Study|Lost to Follow-up|1|||
125395338|NCT02970968|451081591|FG001|Overall Study|Lost to Follow-up|1|||
125395339|NCT02970968|451081590|FG000|Overall Study|Non-Compliance|0|||
125395340|NCT02970968|451081591|FG001|Overall Study|Non-Compliance|1|||
125395341|NCT01332149|451081592|FG000|Overall Study|Adverse Event|11|||
125395342|NCT01332149|451081593|FG001|Overall Study|Adverse Event|9|||
125395343|NCT01332149|451081592|FG000|Overall Study|Other unspecified|5|||
125395344|NCT01332149|451081593|FG001|Overall Study|Other unspecified|7|||
125395345|NCT01332149|451081592|FG000|Overall Study|Protocol Violation|1|||
125395346|NCT01332149|451081593|FG001|Overall Study|Protocol Violation|3|||
125395347|NCT01332149|451081592|FG000|Overall Study|Withdrawal by Subject|4|||
125395348|NCT01332149|451081593|FG001|Overall Study|Withdrawal by Subject|5|||
125395349|NCT01332149|451081592|FG000|Overall Study|Lost to Follow-up|1|||
125395350|NCT01332149|451081593|FG001|Overall Study|Lost to Follow-up|1|||
125395351|NCT01332149|451081592|FG000|Overall Study|Insufficient clinical response|4|||
125395352|NCT01332149|451081593|FG001|Overall Study|Insufficient clinical response|7|||
125395353|NCT01332149|451081592|FG000|Overall Study|Did not meet entrance criteria|3|||
125395354|NCT01332149|451081593|FG001|Overall Study|Did not meet entrance criteria|4|||
125395355|NCT01332149|451081592|FG000|Overall Study|Randomized but not treated|1|||
125395356|NCT01332149|451081593|FG001|Overall Study|Randomized but not treated|2|||
125194953|NCT01314872|450335043|FG009|Treatment Period 1|Physician Decision|1|||
125194954|NCT01314872|450335044|FG010|Treatment Period 1|Physician Decision|0|||
125194955|NCT01314872|450335045|FG011|Treatment Period 1|Physician Decision|0|||
125194956|NCT01314872|450335046|FG012|Treatment Period 1|Physician Decision|0|||
125247474|NCT04518410|450531079|FG002|Overall Study|Protocol Violation|0|||
125194957|NCT01314872|450335047|FG013|Treatment Period 1|Physician Decision|0|||
125247475|NCT04518410|450531080|FG003|Overall Study|Protocol Violation|2|||
125247476|NCT04518410|450531081|FG004|Overall Study|Protocol Violation|17|||
125247477|NCT04518410|450531082|FG005|Overall Study|Protocol Violation|1|||
125395357|NCT04615949|451081594|FG000|Overall Study|Withdrawal by Subject|2|||
125395358|NCT04615949|451081595|FG001|Overall Study|Withdrawal by Subject|4|||
125395359|NCT04615949|451081594|FG000|Overall Study|Lost to Follow-up|2|||
125395360|NCT04615949|451081595|FG001|Overall Study|Lost to Follow-up|2|||
125395361|NCT04615949|451081594|FG000|Overall Study|Death|0|||
125395362|NCT04615949|451081595|FG001|Overall Study|Death|2|||
125395363|NCT00697346|451081596|FG000|Overall Study|Adverse Event|4|||
125194958|NCT01314872|450335048|FG014|Treatment Period 1|Physician Decision|0|||
125247478|NCT04518410|450531083|FG006|Overall Study|Protocol Violation|2|||
125247479|NCT04518410|450531084|FG007|Overall Study|Protocol Violation|1|||
125395364|NCT00697346|451081597|FG001|Overall Study|Adverse Event|5|||
125247480|NCT04518410|450531085|FG008|Overall Study|Protocol Violation|0|||
125247481|NCT04518410|450531086|FG009|Overall Study|Protocol Violation|0|||
125247482|NCT04518410|450531087|FG010|Overall Study|Protocol Violation|0|||
125395365|NCT00697346|451081598|FG002|Overall Study|Adverse Event|0|||
125395366|NCT00697346|451081596|FG000|Overall Study|Progressive Disease|19|||
125395367|NCT00697346|451081597|FG001|Overall Study|Progressive Disease|18|||
125395368|NCT00697346|451081598|FG002|Overall Study|Progressive Disease|0|||
125395369|NCT00697346|451081596|FG000|Overall Study|Symptomatic Deterioration|0|||
125395370|NCT00697346|451081597|FG001|Overall Study|Symptomatic Deterioration|1|||
125395371|NCT00697346|451081598|FG002|Overall Study|Symptomatic Deterioration|0|||
125395372|NCT00697346|451081596|FG000|Overall Study|Withdrawal by Subject|2|||
125395373|NCT00697346|451081597|FG001|Overall Study|Withdrawal by Subject|2|||
125395374|NCT00697346|451081598|FG002|Overall Study|Withdrawal by Subject|0|||
125395375|NCT00697346|451081596|FG000|Overall Study|Reason not Specified|3|||
125395376|NCT00697346|451081597|FG001|Overall Study|Reason not Specified|0|||
125395377|NCT00697346|451081598|FG002|Overall Study|Reason not Specified|1|||
125395378|NCT01886833|451081603|FG000|Overall Study|IgA not available from both periods|204|||
125395379|NCT02223767|451081611|FG000|Overall Study|Withdrawal by Subject|4|||
125395380|NCT02223767|451081612|FG001|Overall Study|Withdrawal by Subject|4|||
125395381|NCT00333229|451081615|FG000|Overall Study|Lack of Efficacy|0|||
125395382|NCT00333229|451081616|FG001|Overall Study|Lack of Efficacy|1|||
125395383|NCT00348556|451081617|FG000|Overall Study|Adverse Event|1|||
125395384|NCT00240071|451081618|FG000|Overall Study|Withdrawal by Subject|3|||
125395385|NCT01944059|451081619|FG000|Overall Study|Lost to Follow-up|1|||
125395386|NCT01944059|451081619|FG000|Overall Study|Physician Decision|3|||
125395387|NCT01944059|451081619|FG000|Overall Study|Withdrawal by Subject|1|||
125395388|NCT01944059|451081619|FG000|Overall Study|Adverse Event|2|||
125395389|NCT00463060|451081630|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
125395390|NCT00463060|451081630|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
125395391|NCT01802775|451081633|FG000|Overall Study|Death|0|||
125395392|NCT01802775|451081634|FG001|Overall Study|Death|3|||
125395393|NCT01802775|451081633|FG000|Overall Study|Reason not provided|0|||
125395394|NCT01802775|451081634|FG001|Overall Study|Reason not provided|1|||
125395395|NCT01802775|451081633|FG000|Overall Study|Physician Decision|1|||
125395396|NCT01802775|451081634|FG001|Overall Study|Physician Decision|0|||
125395397|NCT01802775|451081633|FG000|Overall Study|Adverse Event|1|||
125395398|NCT01802775|451081634|FG001|Overall Study|Adverse Event|1|||
125395399|NCT01802775|451081633|FG000|Overall Study|Withdrawal by Subject|3|||
125395400|NCT01802775|451081634|FG001|Overall Study|Withdrawal by Subject|5|||
125395401|NCT01802775|451081633|FG000|Overall Study|Lost to Follow-up|1|||
125395402|NCT01802775|451081634|FG001|Overall Study|Lost to Follow-up|2|||
125395403|NCT00782210|451081642|FG000|Overall Study|Adverse Event|21|||
125395404|NCT00782210|451081643|FG001|Overall Study|Adverse Event|17|||
125395405|NCT00782210|451081644|FG002|Overall Study|Adverse Event|16|||
125395406|NCT00782210|451081642|FG000|Overall Study|Lost to Follow-up|2|||
125395407|NCT00782210|451081643|FG001|Overall Study|Lost to Follow-up|1|||
125395408|NCT00782210|451081644|FG002|Overall Study|Lost to Follow-up|2|||
125395409|NCT00782210|451081642|FG000|Overall Study|Withdrawal by Subject|11|||
125395410|NCT00782210|451081643|FG001|Overall Study|Withdrawal by Subject|8|||
125395411|NCT00782210|451081644|FG002|Overall Study|Withdrawal by Subject|11|||
125395412|NCT00782210|451081642|FG000|Overall Study|Non compliance with protocol|0|||
125395413|NCT00782210|451081643|FG001|Overall Study|Non compliance with protocol|3|||
125395414|NCT00782210|451081644|FG002|Overall Study|Non compliance with protocol|2|||
125395415|NCT00782210|451081642|FG000|Overall Study|Lack of Efficacy|13|||
125395416|NCT00782210|451081643|FG001|Overall Study|Lack of Efficacy|4|||
125395417|NCT00782210|451081644|FG002|Overall Study|Lack of Efficacy|1|||
125395418|NCT00782210|451081642|FG000|Overall Study|Other reason not described above|3|||
125395419|NCT00782210|451081643|FG001|Overall Study|Other reason not described above|2|||
125194959|NCT01314872|450335034|FG000|Treatment Period 1|Lack of Efficacy|1|||
125194960|NCT01314872|450335035|FG001|Treatment Period 1|Lack of Efficacy|0|||
125194961|NCT01314872|450335036|FG002|Treatment Period 1|Lack of Efficacy|0|||
125194962|NCT01314872|450335037|FG003|Treatment Period 1|Lack of Efficacy|0|||
125194963|NCT01314872|450335038|FG004|Treatment Period 1|Lack of Efficacy|0|||
125194964|NCT01314872|450335039|FG005|Treatment Period 1|Lack of Efficacy|1|||
125194965|NCT01314872|450335040|FG006|Treatment Period 1|Lack of Efficacy|0|||
125194966|NCT01314872|450335041|FG007|Treatment Period 1|Lack of Efficacy|2|||
125194967|NCT01314872|450335042|FG008|Treatment Period 1|Lack of Efficacy|0|||
125194968|NCT01314872|450335043|FG009|Treatment Period 1|Lack of Efficacy|0|||
125194969|NCT01314872|450335044|FG010|Treatment Period 1|Lack of Efficacy|0|||
125194970|NCT01314872|450335045|FG011|Treatment Period 1|Lack of Efficacy|0|||
125194971|NCT01314872|450335046|FG012|Treatment Period 1|Lack of Efficacy|0|||
125395420|NCT00782210|451081644|FG002|Overall Study|Other reason not described above|3|||
125395421|NCT00048542|451081648|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
125395422|NCT00048542|451081649|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
125395423|NCT00048542|451081650|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125395424|NCT00048542|451081651|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
125395425|NCT00048542|451081652|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
125395426|NCT00048542|451081653|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
125395427|NCT00048542|451081654|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
125395428|NCT00048542|451081655|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
125247483|NCT04518410|450531088|FG011|Overall Study|Protocol Violation|0|||
125247484|NCT04518410|450531089|FG012|Overall Study|Protocol Violation|0|||
125247485|NCT04518410|450531090|FG013|Overall Study|Protocol Violation|0|||
125247486|NCT04518410|450531091|FG014|Overall Study|Protocol Violation|0|||
125194972|NCT01314872|450335047|FG013|Treatment Period 1|Lack of Efficacy|0|||
125247487|NCT04518410|450531092|FG015|Overall Study|Protocol Violation|0|||
125247488|NCT04518410|450531093|FG016|Overall Study|Protocol Violation|1|||
125247489|NCT04518410|450531094|FG017|Overall Study|Protocol Violation|1|||
125247490|NCT04518410|450531095|FG018|Overall Study|Protocol Violation|0|||
125247491|NCT04518410|450531096|FG019|Overall Study|Protocol Violation|0|||
125247492|NCT04518410|450531097|FG020|Overall Study|Protocol Violation|1|||
125247493|NCT04518410|450531098|FG021|Overall Study|Protocol Violation|2|||
125247494|NCT04518410|450531099|FG022|Overall Study|Protocol Violation|0|||
125247495|NCT04518410|450531100|FG023|Overall Study|Protocol Violation|3|||
125247496|NCT04518410|450531101|FG024|Overall Study|Protocol Violation|0|||
125247497|NCT04518410|450531077|FG000|Overall Study|Death|0|||
125247498|NCT04518410|450531078|FG001|Overall Study|Death|0|||
125247499|NCT04518410|450531079|FG002|Overall Study|Death|0|||
125194973|NCT01314872|450335048|FG014|Treatment Period 1|Lack of Efficacy|0|||
125194974|NCT01314872|450335034|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
125194975|NCT01314872|450335035|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
125194976|NCT01314872|450335036|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
125194977|NCT01314872|450335037|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
125194978|NCT01314872|450335038|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
125194979|NCT01314872|450335039|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
125194980|NCT01314872|450335040|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
125194981|NCT01314872|450335041|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
125194982|NCT01314872|450335042|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
125194983|NCT01314872|450335043|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
125194984|NCT01314872|450335044|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
125194985|NCT01314872|450335045|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
125194986|NCT01314872|450335046|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
125194987|NCT01314872|450335047|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
125194988|NCT01314872|450335048|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
125194989|NCT01314872|450335034|FG000|Treatment Period 1|Withdrawal by Subject|3|||
125194990|NCT01314872|450335035|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125194991|NCT01314872|450335036|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125194992|NCT01314872|450335037|FG003|Treatment Period 1|Withdrawal by Subject|2|||
125194993|NCT01314872|450335038|FG004|Treatment Period 1|Withdrawal by Subject|3|||
125194994|NCT01314872|450335039|FG005|Treatment Period 1|Withdrawal by Subject|1|||
125194995|NCT01314872|450335040|FG006|Treatment Period 1|Withdrawal by Subject|3|||
125194996|NCT01314872|450335041|FG007|Treatment Period 1|Withdrawal by Subject|2|||
125194997|NCT01314872|450335042|FG008|Treatment Period 1|Withdrawal by Subject|2|||
125194998|NCT01314872|450335043|FG009|Treatment Period 1|Withdrawal by Subject|2|||
125194999|NCT01314872|450335044|FG010|Treatment Period 1|Withdrawal by Subject|1|||
125195000|NCT01314872|450335045|FG011|Treatment Period 1|Withdrawal by Subject|0|||
125195001|NCT01314872|450335046|FG012|Treatment Period 1|Withdrawal by Subject|0|||
125247500|NCT04518410|450531080|FG003|Overall Study|Death|0|||
125247501|NCT04518410|450531081|FG004|Overall Study|Death|12|||
125247502|NCT04518410|450531082|FG005|Overall Study|Death|2|||
125247503|NCT04518410|450531083|FG006|Overall Study|Death|11|||
125247504|NCT04518410|450531084|FG007|Overall Study|Death|0|||
125247505|NCT04518410|450531085|FG008|Overall Study|Death|1|||
125247506|NCT04518410|450531086|FG009|Overall Study|Death|0|||
125247507|NCT04518410|450531087|FG010|Overall Study|Death|0|||
125247508|NCT04518410|450531088|FG011|Overall Study|Death|0|||
125247509|NCT04518410|450531089|FG012|Overall Study|Death|0|||
125247510|NCT04518410|450531090|FG013|Overall Study|Death|1|||
125247511|NCT04518410|450531091|FG014|Overall Study|Death|1|||
125247512|NCT04518410|450531092|FG015|Overall Study|Death|0|||
125247513|NCT04518410|450531093|FG016|Overall Study|Death|0|||
125195002|NCT01314872|450335047|FG013|Treatment Period 1|Withdrawal by Subject|0|||
125195003|NCT01314872|450335048|FG014|Treatment Period 1|Withdrawal by Subject|0|||
125195004|NCT01314872|450335034|FG000|Treatment Period 1|Lost to Follow-up|0|||
125195005|NCT01314872|450335035|FG001|Treatment Period 1|Lost to Follow-up|1|||
125247514|NCT04518410|450531094|FG017|Overall Study|Death|1|||
125247515|NCT04518410|450531095|FG018|Overall Study|Death|4|||
125247516|NCT04518410|450531096|FG019|Overall Study|Death|4|||
125247517|NCT04518410|450531097|FG020|Overall Study|Death|1|||
125247518|NCT04518410|450531098|FG021|Overall Study|Death|0|||
125247519|NCT04518410|450531099|FG022|Overall Study|Death|0|||
125247520|NCT04518410|450531100|FG023|Overall Study|Death|0|||
125395429|NCT00048542|451081648|FG000|Double-Blind Phase|Protocol Violation|0|||
125247521|NCT04518410|450531101|FG024|Overall Study|Death|0|||
125247522|NCT04518410|450531077|FG000|Overall Study|Requirement to start alternative therapy|0|||
125247523|NCT04518410|450531078|FG001|Overall Study|Requirement to start alternative therapy|0|||
125247524|NCT04518410|450531079|FG002|Overall Study|Requirement to start alternative therapy|1|||
125247525|NCT04518410|450531080|FG003|Overall Study|Requirement to start alternative therapy|0|||
125195006|NCT01314872|450335036|FG002|Treatment Period 1|Lost to Follow-up|2|||
125195007|NCT01314872|450335037|FG003|Treatment Period 1|Lost to Follow-up|2|||
125195008|NCT01314872|450335038|FG004|Treatment Period 1|Lost to Follow-up|1|||
125195009|NCT01314872|450335039|FG005|Treatment Period 1|Lost to Follow-up|1|||
125247526|NCT04518410|450531081|FG004|Overall Study|Requirement to start alternative therapy|0|||
125247527|NCT04518410|450531082|FG005|Overall Study|Requirement to start alternative therapy|0|||
125247528|NCT04518410|450531083|FG006|Overall Study|Requirement to start alternative therapy|0|||
125247529|NCT04518410|450531084|FG007|Overall Study|Requirement to start alternative therapy|0|||
125247530|NCT04518410|450531085|FG008|Overall Study|Requirement to start alternative therapy|0|||
125247531|NCT04518410|450531086|FG009|Overall Study|Requirement to start alternative therapy|0|||
125247532|NCT04518410|450531087|FG010|Overall Study|Requirement to start alternative therapy|0|||
125247533|NCT04518410|450531088|FG011|Overall Study|Requirement to start alternative therapy|0|||
125247534|NCT04518410|450531089|FG012|Overall Study|Requirement to start alternative therapy|0|||
125247535|NCT04518410|450531090|FG013|Overall Study|Requirement to start alternative therapy|0|||
125247536|NCT04518410|450531091|FG014|Overall Study|Requirement to start alternative therapy|0|||
125247537|NCT04518410|450531092|FG015|Overall Study|Requirement to start alternative therapy|0|||
125247538|NCT04518410|450531093|FG016|Overall Study|Requirement to start alternative therapy|0|||
125247539|NCT04518410|450531094|FG017|Overall Study|Requirement to start alternative therapy|0|||
125247540|NCT04518410|450531095|FG018|Overall Study|Requirement to start alternative therapy|0|||
125247541|NCT04518410|450531096|FG019|Overall Study|Requirement to start alternative therapy|0|||
125247542|NCT04518410|450531097|FG020|Overall Study|Requirement to start alternative therapy|0|||
125247543|NCT04518410|450531098|FG021|Overall Study|Requirement to start alternative therapy|0|||
125247544|NCT04518410|450531099|FG022|Overall Study|Requirement to start alternative therapy|0|||
125247545|NCT04518410|450531100|FG023|Overall Study|Requirement to start alternative therapy|0|||
125247546|NCT04518410|450531101|FG024|Overall Study|Requirement to start alternative therapy|0|||
125247547|NCT04518410|450531077|FG000|Overall Study|Randomized but not treated|0|||
125195010|NCT01314872|450335040|FG006|Treatment Period 1|Lost to Follow-up|1|||
125247548|NCT04518410|450531078|FG001|Overall Study|Randomized but not treated|0|||
125247549|NCT04518410|450531079|FG002|Overall Study|Randomized but not treated|0|||
125247550|NCT04518410|450531080|FG003|Overall Study|Randomized but not treated|2|||
125247551|NCT04518410|450531081|FG004|Overall Study|Randomized but not treated|6|||
125247552|NCT04518410|450531082|FG005|Overall Study|Randomized but not treated|4|||
125247553|NCT04518410|450531083|FG006|Overall Study|Randomized but not treated|3|||
125247554|NCT04518410|450531084|FG007|Overall Study|Randomized but not treated|3|||
125247555|NCT04518410|450531085|FG008|Overall Study|Randomized but not treated|0|||
125195011|NCT01314872|450335041|FG007|Treatment Period 1|Lost to Follow-up|1|||
125195012|NCT01314872|450335042|FG008|Treatment Period 1|Lost to Follow-up|1|||
125195013|NCT01314872|450335043|FG009|Treatment Period 1|Lost to Follow-up|0|||
125195014|NCT01314872|450335044|FG010|Treatment Period 1|Lost to Follow-up|0|||
125195015|NCT01314872|450335045|FG011|Treatment Period 1|Lost to Follow-up|0|||
125195016|NCT01314872|450335046|FG012|Treatment Period 1|Lost to Follow-up|0|||
125195017|NCT01314872|450335047|FG013|Treatment Period 1|Lost to Follow-up|0|||
125195018|NCT01314872|450335048|FG014|Treatment Period 1|Lost to Follow-up|0|||
125195019|NCT01314872|450335034|FG000|Period 2|Protocol Violation|0|||
125195020|NCT01314872|450335035|FG001|Period 2|Protocol Violation|0|||
125195021|NCT01314872|450335036|FG002|Period 2|Protocol Violation|0|||
125195022|NCT01314872|450335037|FG003|Period 2|Protocol Violation|0|||
125247556|NCT04518410|450531086|FG009|Overall Study|Randomized but not treated|4|||
125247557|NCT04518410|450531087|FG010|Overall Study|Randomized but not treated|0|||
125247558|NCT04518410|450531088|FG011|Overall Study|Randomized but not treated|0|||
125247559|NCT04518410|450531089|FG012|Overall Study|Randomized but not treated|1|||
125247560|NCT04518410|450531090|FG013|Overall Study|Randomized but not treated|3|||
125247561|NCT04518410|450531091|FG014|Overall Study|Randomized but not treated|3|||
125247562|NCT04518410|450531092|FG015|Overall Study|Randomized but not treated|3|||
125247563|NCT04518410|450531093|FG016|Overall Study|Randomized but not treated|4|||
125247564|NCT04518410|450531094|FG017|Overall Study|Randomized but not treated|5|||
125247565|NCT04518410|450531095|FG018|Overall Study|Randomized but not treated|4|||
125247566|NCT04518410|450531096|FG019|Overall Study|Randomized but not treated|0|||
125195023|NCT01314872|450335038|FG004|Period 2|Protocol Violation|0|||
125247567|NCT04518410|450531097|FG020|Overall Study|Randomized but not treated|0|||
125247568|NCT04518410|450531098|FG021|Overall Study|Randomized but not treated|5|||
125195024|NCT01314872|450335039|FG005|Period 2|Protocol Violation|0|||
125247569|NCT04518410|450531099|FG022|Overall Study|Randomized but not treated|0|||
125247570|NCT04518410|450531100|FG023|Overall Study|Randomized but not treated|3|||
125247571|NCT04518410|450531101|FG024|Overall Study|Randomized but not treated|1|||
125247572|NCT04518410|450531077|FG000|Overall Study|Screen Fail but Randomized|0|||
125247573|NCT04518410|450531078|FG001|Overall Study|Screen Fail but Randomized|0|||
125247574|NCT04518410|450531079|FG002|Overall Study|Screen Fail but Randomized|0|||
125247575|NCT04518410|450531080|FG003|Overall Study|Screen Fail but Randomized|0|||
125247576|NCT04518410|450531081|FG004|Overall Study|Screen Fail but Randomized|2|||
125195025|NCT01314872|450335040|FG006|Period 2|Protocol Violation|0|||
125195026|NCT01314872|450335041|FG007|Period 2|Protocol Violation|0|||
125195027|NCT01314872|450335042|FG008|Period 2|Protocol Violation|0|||
125395430|NCT00048542|451081649|FG001|Double-Blind Phase|Protocol Violation|0|||
125395431|NCT00048542|451081650|FG002|Double-Blind Phase|Protocol Violation|1|||
125395432|NCT00048542|451081651|FG003|Double-Blind Phase|Protocol Violation|0|||
125395433|NCT00048542|451081652|FG004|Double-Blind Phase|Protocol Violation|0|||
125395434|NCT00048542|451081653|FG005|Double-Blind Phase|Protocol Violation|0|||
125395435|NCT00048542|451081654|FG006|Double-Blind Phase|Protocol Violation|0|||
125395436|NCT00048542|451081655|FG007|Double-Blind Phase|Protocol Violation|0|||
125395437|NCT00048542|451081648|FG000|Double-Blind Phase|Sponsor request or decision|2|||
125395438|NCT00048542|451081649|FG001|Double-Blind Phase|Sponsor request or decision|0|||
125395439|NCT00048542|451081650|FG002|Double-Blind Phase|Sponsor request or decision|0|||
125395440|NCT00048542|451081651|FG003|Double-Blind Phase|Sponsor request or decision|0|||
125395441|NCT00048542|451081652|FG004|Double-Blind Phase|Sponsor request or decision|0|||
125395442|NCT00048542|451081653|FG005|Double-Blind Phase|Sponsor request or decision|0|||
125395443|NCT00048542|451081654|FG006|Double-Blind Phase|Sponsor request or decision|0|||
125395444|NCT00048542|451081655|FG007|Double-Blind Phase|Sponsor request or decision|0|||
125395445|NCT00048542|451081648|FG000|Double-Blind Phase|Randomized in error|1|||
125395446|NCT00048542|451081649|FG001|Double-Blind Phase|Randomized in error|0|||
125395447|NCT00048542|451081650|FG002|Double-Blind Phase|Randomized in error|0|||
125195028|NCT01314872|450335043|FG009|Period 2|Protocol Violation|0|||
125195029|NCT01314872|450335044|FG010|Period 2|Protocol Violation|0|||
125195030|NCT01314872|450335045|FG011|Period 2|Protocol Violation|3|||
125195031|NCT01314872|450335046|FG012|Period 2|Protocol Violation|3|||
125195032|NCT01314872|450335047|FG013|Period 2|Protocol Violation|2|||
125195033|NCT01314872|450335048|FG014|Period 2|Protocol Violation|0|||
125195034|NCT01314872|450335034|FG000|Period 2|Non-compliance with study drug|0|||
125195035|NCT01314872|450335035|FG001|Period 2|Non-compliance with study drug|0|||
125195036|NCT01314872|450335036|FG002|Period 2|Non-compliance with study drug|0|||
125195037|NCT01314872|450335037|FG003|Period 2|Non-compliance with study drug|0|||
125195038|NCT01314872|450335038|FG004|Period 2|Non-compliance with study drug|0|||
125195039|NCT01314872|450335039|FG005|Period 2|Non-compliance with study drug|0|||
125195040|NCT01314872|450335040|FG006|Period 2|Non-compliance with study drug|0|||
125195041|NCT01314872|450335041|FG007|Period 2|Non-compliance with study drug|0|||
125195042|NCT01314872|450335042|FG008|Period 2|Non-compliance with study drug|0|||
125195043|NCT01314872|450335043|FG009|Period 2|Non-compliance with study drug|0|||
125195044|NCT01314872|450335044|FG010|Period 2|Non-compliance with study drug|0|||
125195045|NCT01314872|450335045|FG011|Period 2|Non-compliance with study drug|3|||
125195046|NCT01314872|450335046|FG012|Period 2|Non-compliance with study drug|3|||
125195047|NCT01314872|450335047|FG013|Period 2|Non-compliance with study drug|1|||
125195048|NCT01314872|450335048|FG014|Period 2|Non-compliance with study drug|2|||
125195049|NCT01314872|450335034|FG000|Period 2|Lack of Efficacy|0|||
125195050|NCT01314872|450335035|FG001|Period 2|Lack of Efficacy|0|||
125195051|NCT01314872|450335036|FG002|Period 2|Lack of Efficacy|0|||
125195052|NCT01314872|450335037|FG003|Period 2|Lack of Efficacy|0|||
125195053|NCT01314872|450335038|FG004|Period 2|Lack of Efficacy|0|||
125195054|NCT01314872|450335039|FG005|Period 2|Lack of Efficacy|0|||
125195055|NCT01314872|450335040|FG006|Period 2|Lack of Efficacy|0|||
125195056|NCT01314872|450335041|FG007|Period 2|Lack of Efficacy|0|||
125195057|NCT01314872|450335042|FG008|Period 2|Lack of Efficacy|0|||
125195058|NCT01314872|450335043|FG009|Period 2|Lack of Efficacy|0|||
125195059|NCT01314872|450335044|FG010|Period 2|Lack of Efficacy|0|||
125195060|NCT01314872|450335045|FG011|Period 2|Lack of Efficacy|7|||
125195061|NCT01314872|450335046|FG012|Period 2|Lack of Efficacy|12|||
125195062|NCT01314872|450335047|FG013|Period 2|Lack of Efficacy|9|||
125195063|NCT01314872|450335048|FG014|Period 2|Lack of Efficacy|2|||
125195064|NCT01314872|450335034|FG000|Period 2|Pregnancy|0|||
125195065|NCT01314872|450335035|FG001|Period 2|Pregnancy|0|||
125195066|NCT01314872|450335036|FG002|Period 2|Pregnancy|0|||
125195067|NCT01314872|450335037|FG003|Period 2|Pregnancy|0|||
125195068|NCT01314872|450335038|FG004|Period 2|Pregnancy|0|||
125195069|NCT01314872|450335039|FG005|Period 2|Pregnancy|0|||
125195070|NCT01314872|450335040|FG006|Period 2|Pregnancy|0|||
125195071|NCT01314872|450335041|FG007|Period 2|Pregnancy|0|||
125195072|NCT01314872|450335042|FG008|Period 2|Pregnancy|0|||
125195073|NCT01314872|450335043|FG009|Period 2|Pregnancy|0|||
125195074|NCT01314872|450335044|FG010|Period 2|Pregnancy|0|||
125195075|NCT01314872|450335045|FG011|Period 2|Pregnancy|0|||
125195076|NCT01314872|450335046|FG012|Period 2|Pregnancy|0|||
125195077|NCT01314872|450335047|FG013|Period 2|Pregnancy|0|||
125195078|NCT01314872|450335048|FG014|Period 2|Pregnancy|1|||
125195079|NCT01314872|450335034|FG000|Period 2|Study terminated by Sponsor|0|||
125195080|NCT01314872|450335035|FG001|Period 2|Study terminated by Sponsor|0|||
125195081|NCT01314872|450335036|FG002|Period 2|Study terminated by Sponsor|0|||
125195082|NCT01314872|450335037|FG003|Period 2|Study terminated by Sponsor|0|||
125195083|NCT01314872|450335038|FG004|Period 2|Study terminated by Sponsor|0|||
125195084|NCT01314872|450335039|FG005|Period 2|Study terminated by Sponsor|0|||
125195085|NCT01314872|450335040|FG006|Period 2|Study terminated by Sponsor|0|||
125195086|NCT01314872|450335041|FG007|Period 2|Study terminated by Sponsor|0|||
125195087|NCT01314872|450335042|FG008|Period 2|Study terminated by Sponsor|0|||
125395448|NCT00048542|451081651|FG003|Double-Blind Phase|Randomized in error|0|||
125195088|NCT01314872|450335043|FG009|Period 2|Study terminated by Sponsor|0|||
125195089|NCT01314872|450335044|FG010|Period 2|Study terminated by Sponsor|0|||
125195090|NCT01314872|450335045|FG011|Period 2|Study terminated by Sponsor|2|||
125195091|NCT01314872|450335046|FG012|Period 2|Study terminated by Sponsor|2|||
125195092|NCT01314872|450335047|FG013|Period 2|Study terminated by Sponsor|3|||
125195093|NCT01314872|450335048|FG014|Period 2|Study terminated by Sponsor|0|||
125195094|NCT01314872|450335034|FG000|Period 2|Adverse event, non-fatal|0|||
125195095|NCT01314872|450335035|FG001|Period 2|Adverse event, non-fatal|0|||
125195096|NCT01314872|450335036|FG002|Period 2|Adverse event, non-fatal|0|||
125195097|NCT01314872|450335037|FG003|Period 2|Adverse event, non-fatal|0|||
125195098|NCT01314872|450335038|FG004|Period 2|Adverse event, non-fatal|0|||
125195099|NCT01314872|450335039|FG005|Period 2|Adverse event, non-fatal|0|||
125247577|NCT04518410|450531082|FG005|Overall Study|Screen Fail but Randomized|0|||
125247578|NCT04518410|450531083|FG006|Overall Study|Screen Fail but Randomized|0|||
125247579|NCT04518410|450531084|FG007|Overall Study|Screen Fail but Randomized|0|||
125247580|NCT04518410|450531085|FG008|Overall Study|Screen Fail but Randomized|0|||
125247581|NCT04518410|450531086|FG009|Overall Study|Screen Fail but Randomized|0|||
125247582|NCT04518410|450531087|FG010|Overall Study|Screen Fail but Randomized|0|||
125247583|NCT04518410|450531088|FG011|Overall Study|Screen Fail but Randomized|0|||
125247584|NCT04518410|450531089|FG012|Overall Study|Screen Fail but Randomized|0|||
125247585|NCT04518410|450531090|FG013|Overall Study|Screen Fail but Randomized|0|||
125247586|NCT04518410|450531091|FG014|Overall Study|Screen Fail but Randomized|0|||
125247587|NCT04518410|450531092|FG015|Overall Study|Screen Fail but Randomized|0|||
125247588|NCT04518410|450531093|FG016|Overall Study|Screen Fail but Randomized|0|||
125247589|NCT04518410|450531094|FG017|Overall Study|Screen Fail but Randomized|0|||
125247590|NCT04518410|450531095|FG018|Overall Study|Screen Fail but Randomized|0|||
125247591|NCT04518410|450531096|FG019|Overall Study|Screen Fail but Randomized|0|||
125247592|NCT04518410|450531097|FG020|Overall Study|Screen Fail but Randomized|0|||
125247593|NCT04518410|450531098|FG021|Overall Study|Screen Fail but Randomized|0|||
125247594|NCT04518410|450531099|FG022|Overall Study|Screen Fail but Randomized|0|||
125247595|NCT04518410|450531100|FG023|Overall Study|Screen Fail but Randomized|0|||
125247596|NCT04518410|450531101|FG024|Overall Study|Screen Fail but Randomized|0|||
125247597|NCT04518410|450531077|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247598|NCT04518410|450531078|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247599|NCT04518410|450531079|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247600|NCT04518410|450531080|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247601|NCT04518410|450531081|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
125247602|NCT04518410|450531082|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
125247603|NCT04518410|450531083|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
125247604|NCT04518410|450531084|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
125247605|NCT04518410|450531085|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
125395449|NCT00048542|451081652|FG004|Double-Blind Phase|Randomized in error|0|||
125395450|NCT00048542|451081653|FG005|Double-Blind Phase|Randomized in error|0|||
125395451|NCT00048542|451081654|FG006|Double-Blind Phase|Randomized in error|0|||
125395452|NCT00048542|451081655|FG007|Double-Blind Phase|Randomized in error|0|||
125395453|NCT00048542|451081648|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
125395454|NCT00048542|451081649|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
125395455|NCT00048542|451081650|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
125395456|NCT00048542|451081651|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
125395457|NCT00048542|451081652|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
125395458|NCT00048542|451081653|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
125395459|NCT00048542|451081654|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
125395460|NCT00048542|451081655|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
125395461|NCT00048542|451081648|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
125395462|NCT00048542|451081649|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
125395463|NCT00048542|451081650|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
125395464|NCT00048542|451081651|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
125395465|NCT00048542|451081652|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
125395466|NCT00048542|451081653|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
125395467|NCT00048542|451081654|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
125395468|NCT00048542|451081655|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
125195100|NCT01314872|450335040|FG006|Period 2|Adverse event, non-fatal|0|||
125395469|NCT00048542|451081648|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
125195101|NCT01314872|450335041|FG007|Period 2|Adverse event, non-fatal|0|||
125195102|NCT01314872|450335042|FG008|Period 2|Adverse event, non-fatal|0|||
125195103|NCT01314872|450335043|FG009|Period 2|Adverse event, non-fatal|0|||
125195104|NCT01314872|450335044|FG010|Period 2|Adverse event, non-fatal|0|||
125195105|NCT01314872|450335045|FG011|Period 2|Adverse event, non-fatal|13|||
125395470|NCT00048542|451081649|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
125395471|NCT00048542|451081650|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
125395472|NCT00048542|451081651|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
125395473|NCT00048542|451081652|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
125395474|NCT00048542|451081653|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
125395475|NCT00048542|451081654|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
125395476|NCT00048542|451081655|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
125395477|NCT00048542|451081648|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
125395478|NCT00048542|451081649|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
125443672|NCT00231894|451252227|FG001|Overall Study|Withdrawal by Subject|1|||
125443673|NCT02025205|451252228|FG000|Overall Study|Withdrawal by Subject|1|||
125443674|NCT02025205|451252229|FG001|Overall Study|Withdrawal by Subject|1|||
125443675|NCT02025205|451252228|FG000|Overall Study|Protocol Violation|2|||
125443676|NCT02025205|451252229|FG001|Overall Study|Protocol Violation|1|||
125443677|NCT02025205|451252228|FG000|Overall Study|Death|0|||
125443678|NCT02025205|451252229|FG001|Overall Study|Death|1|||
125443679|NCT01767129|451252230|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
125443680|NCT01767129|451252231|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
125443681|NCT03389893|451252232|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
125443682|NCT03389893|451252233|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
125443683|NCT03389893|451252234|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
125443684|NCT03389893|451252235|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
125443685|NCT03389893|451252232|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
125443686|NCT03389893|451252233|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
125443687|NCT03389893|451252234|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
125443688|NCT03389893|451252235|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
125443689|NCT03389893|451252232|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
125443690|NCT03389893|451252233|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
125443691|NCT03389893|451252234|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
125443692|NCT03389893|451252235|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
125443693|NCT03389893|451252232|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
125443694|NCT03389893|451252233|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
125443695|NCT03389893|451252234|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
125443696|NCT03389893|451252235|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
125443697|NCT01024751|451252239|FG000|Enrolled Participants|Ineligible at baseline|3|||
125443698|NCT01024751|451252240|FG001|Enrolled Participants|Ineligible at baseline|4|||
125443699|NCT01024751|451252239|FG000|Eligible Participants|Withdrawal by Subject|0|||
125443700|NCT01024751|451252240|FG001|Eligible Participants|Withdrawal by Subject|1|||
125443701|NCT01024751|451252239|FG000|Eligible Participants|Lost to Follow-up|0|||
125443702|NCT01024751|451252240|FG001|Eligible Participants|Lost to Follow-up|1|||
125443703|NCT01024751|451252239|FG000|Eligible Participants|Ineligible|0|||
125443704|NCT01024751|451252240|FG001|Eligible Participants|Ineligible|1|||
125443705|NCT01232556|451252241|FG000|Overall Study|Withdrawal by Subject|21|||
125443706|NCT01232556|451252242|FG001|Overall Study|Withdrawal by Subject|17|||
125443707|NCT01232556|451252241|FG000|Overall Study|Death|97|||
125443708|NCT01232556|451252242|FG001|Overall Study|Death|97|||
125443709|NCT01232556|451252241|FG000|Overall Study|Lost to Follow-up|0|||
125443710|NCT01232556|451252242|FG001|Overall Study|Lost to Follow-up|2|||
125443711|NCT01232556|451252241|FG000|Overall Study|Terminated by Sponsor|35|||
125443712|NCT01232556|451252242|FG001|Overall Study|Terminated by Sponsor|51|||
125443713|NCT01232556|451252241|FG000|Overall Study|Other|6|||
125443714|NCT01232556|451252242|FG001|Overall Study|Other|4|||
125443715|NCT01473420|451252244|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
125443716|NCT01473420|451252245|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
125443717|NCT01473420|451252244|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
125443718|NCT01473420|451252245|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
125443719|NCT01473420|451252244|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
125443720|NCT01473420|451252245|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
125443721|NCT01473420|451252244|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
125443722|NCT01473420|451252245|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
125443723|NCT01473420|451252244|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
125443724|NCT01473420|451252245|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
125443725|NCT01473420|451252244|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
125443726|NCT01473420|451252245|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
125443727|NCT01473420|451252244|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
125443728|NCT01473420|451252245|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
125395479|NCT00048542|451081650|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
125443729|NCT01473420|451252244|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
125443730|NCT01473420|451252245|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
125195106|NCT01314872|450335046|FG012|Period 2|Adverse event, non-fatal|16|||
125195107|NCT01314872|450335047|FG013|Period 2|Adverse event, non-fatal|24|||
125395480|NCT00048542|451081651|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
125395481|NCT00048542|451081652|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
125395482|NCT00048542|451081653|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
125395483|NCT00048542|451081654|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
125395484|NCT00048542|451081655|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
125395485|NCT00048542|451081648|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
125395486|NCT00048542|451081649|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
125395487|NCT00048542|451081650|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
125395488|NCT00048542|451081651|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
125395489|NCT00048542|451081652|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
125395490|NCT00048542|451081653|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
125395491|NCT00048542|451081654|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
125395492|NCT00048542|451081655|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
125195108|NCT01314872|450335048|FG014|Period 2|Adverse event, non-fatal|9|||
125195109|NCT01314872|450335034|FG000|Period 2|Withdrawal by Subject|0|||
125195110|NCT01314872|450335035|FG001|Period 2|Withdrawal by Subject|0|||
125195111|NCT01314872|450335036|FG002|Period 2|Withdrawal by Subject|0|||
125195112|NCT01314872|450335037|FG003|Period 2|Withdrawal by Subject|0|||
125195113|NCT01314872|450335038|FG004|Period 2|Withdrawal by Subject|0|||
125195114|NCT01314872|450335039|FG005|Period 2|Withdrawal by Subject|0|||
125195115|NCT01314872|450335040|FG006|Period 2|Withdrawal by Subject|0|||
125195116|NCT01314872|450335041|FG007|Period 2|Withdrawal by Subject|0|||
125195117|NCT01314872|450335042|FG008|Period 2|Withdrawal by Subject|0|||
125195118|NCT01314872|450335043|FG009|Period 2|Withdrawal by Subject|0|||
125195119|NCT01314872|450335044|FG010|Period 2|Withdrawal by Subject|0|||
125195120|NCT01314872|450335045|FG011|Period 2|Withdrawal by Subject|14|||
125195121|NCT01314872|450335046|FG012|Period 2|Withdrawal by Subject|17|||
125195122|NCT01314872|450335047|FG013|Period 2|Withdrawal by Subject|12|||
125195123|NCT01314872|450335048|FG014|Period 2|Withdrawal by Subject|4|||
125195124|NCT01314872|450335034|FG000|Period 2|Lost to Follow-up|0|||
125195125|NCT01314872|450335035|FG001|Period 2|Lost to Follow-up|0|||
125195126|NCT01314872|450335036|FG002|Period 2|Lost to Follow-up|0|||
125195127|NCT01314872|450335037|FG003|Period 2|Lost to Follow-up|0|||
125195128|NCT01314872|450335038|FG004|Period 2|Lost to Follow-up|0|||
125195129|NCT01314872|450335039|FG005|Period 2|Lost to Follow-up|0|||
125195130|NCT01314872|450335040|FG006|Period 2|Lost to Follow-up|0|||
125195131|NCT01314872|450335041|FG007|Period 2|Lost to Follow-up|0|||
125195132|NCT01314872|450335042|FG008|Period 2|Lost to Follow-up|0|||
125195133|NCT01314872|450335043|FG009|Period 2|Lost to Follow-up|0|||
125195134|NCT01314872|450335044|FG010|Period 2|Lost to Follow-up|0|||
125195135|NCT01314872|450335045|FG011|Period 2|Lost to Follow-up|6|||
125195136|NCT01314872|450335046|FG012|Period 2|Lost to Follow-up|7|||
125195137|NCT01314872|450335047|FG013|Period 2|Lost to Follow-up|2|||
125195138|NCT01314872|450335048|FG014|Period 2|Lost to Follow-up|6|||
125195139|NCT03232931|450336620|FG000|Overall Study|Physician Decision|1|||
125195140|NCT03232931|450336621|FG001|Overall Study|Physician Decision|1|||
125195141|NCT03232931|450336620|FG000|Overall Study|Withdrawal by Subject|6|||
125195142|NCT03232931|450336621|FG001|Overall Study|Withdrawal by Subject|0|||
125195143|NCT03232931|450336620|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
125195144|NCT03232931|450336621|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
125195145|NCT03232931|450336620|FG000|Overall Study|Parent did not record voice|1|||
125195146|NCT03232931|450336621|FG001|Overall Study|Parent did not record voice|2|||
125195147|NCT03232931|450336620|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
125195148|NCT03232931|450336621|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
125195149|NCT04925557|450336622|FG000|Overall Study|Study closed|5|||
125195150|NCT04925557|450336623|FG001|Overall Study|Study closed|3|||
125195151|NCT05488470|450336624|FG000|Overall Study|Physician Decision|2|||
125195152|NCT05488470|450336624|FG000|Overall Study|Withdrawal by Subject|1|||
125195153|NCT05488470|450336624|FG000|Overall Study|Death|1|||
125195154|NCT00068393|450336625|FG000|Overall Study|Adverse Event|2|||
125195155|NCT00068393|450336625|FG000|Overall Study|Death|3|||
125195156|NCT00068393|450336625|FG000|Overall Study|Withdrawal by Subject|3|||
125195157|NCT00068393|450336625|FG000|Overall Study|Alternative treatment|1|||
125195158|NCT00068393|450336625|FG000|Overall Study|Quality of life worsening|1|||
125195159|NCT04981470|450336634|FG000|Overall Study|Device failure in all 4 patients|4|||
125195160|NCT04390503|450336636|FG000|Overall Study|Physician Decision|2|||
125195161|NCT04390503|450336637|FG001|Overall Study|Physician Decision|1|||
125195162|NCT04390503|450336636|FG000|Overall Study|Adverse Event|1|||
125195163|NCT04390503|450336637|FG001|Overall Study|Adverse Event|0|||
125195164|NCT00468481|450336638|FG000|Overall Study|Adverse Event|13|||
125195165|NCT00468481|450336639|FG001|Overall Study|Adverse Event|3|||
125195166|NCT00468481|450336638|FG000|Overall Study|Lost to Follow-up|25|||
125195167|NCT00468481|450336639|FG001|Overall Study|Lost to Follow-up|8|||
125195168|NCT00468481|450336638|FG000|Overall Study|Pregnancy|2|||
125195169|NCT00468481|450336639|FG001|Overall Study|Pregnancy|0|||
125395493|NCT00048542|451081648|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
125247606|NCT04518410|450531086|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
125247607|NCT04518410|450531087|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
125247608|NCT04518410|450531088|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247609|NCT04518410|450531089|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247610|NCT04518410|450531090|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
125247611|NCT04518410|450531091|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
125247612|NCT04518410|450531092|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
125247613|NCT04518410|450531093|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
125247614|NCT04518410|450531094|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
125247615|NCT04518410|450531095|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
125247616|NCT04518410|450531096|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
125247617|NCT04518410|450531097|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
125247618|NCT04518410|450531098|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
125395494|NCT00048542|451081649|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
125195170|NCT00468481|450336638|FG000|Overall Study|Protocol Violation|18|||
125195171|NCT00468481|450336639|FG001|Overall Study|Protocol Violation|8|||
125195172|NCT00468481|450336638|FG000|Overall Study|Withdrawal by Subject|12|||
125195173|NCT00468481|450336639|FG001|Overall Study|Withdrawal by Subject|3|||
125195174|NCT00468481|450336638|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
125195175|NCT00468481|450336639|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
125195176|NCT00468481|450336638|FG000|Overall Study|Prohibited Medication|1|||
125195177|NCT00468481|450336639|FG001|Overall Study|Prohibited Medication|1|||
125195178|NCT00468481|450336638|FG000|Overall Study|Egg Donor|1|||
125195179|NCT00468481|450336639|FG001|Overall Study|Egg Donor|0|||
125195180|NCT00468481|450336638|FG000|Overall Study|Moved out of area|4|||
125195181|NCT00468481|450336639|FG001|Overall Study|Moved out of area|1|||
125195182|NCT00468481|450336638|FG000|Overall Study|Non-Compliance|5|||
125195183|NCT00468481|450336639|FG001|Overall Study|Non-Compliance|0|||
125195184|NCT00468481|450336638|FG000|Overall Study|Other|6|||
125195185|NCT00468481|450336639|FG001|Overall Study|Other|0|||
125195186|NCT00593684|450336641|FG000|Overall Study|Death|2|||
125195187|NCT00593684|450336642|FG001|Overall Study|Death|1|||
125195188|NCT00734162|450336643|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
125195189|NCT00734162|450336644|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
125195190|NCT00734162|450336645|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
125195191|NCT00734162|450336646|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
125195192|NCT00734162|450336643|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
125195193|NCT00734162|450336644|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
125195194|NCT00734162|450336645|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
125195195|NCT00734162|450336646|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
125195196|NCT00734162|450336643|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
125195197|NCT00734162|450336644|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
125195198|NCT00734162|450336645|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
125195199|NCT00734162|450336646|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
125195200|NCT00734162|450336643|FG000|Open-Label Phase|Withdrew Consent|1|||
125195201|NCT00734162|450336644|FG001|Open-Label Phase|Withdrew Consent|0|||
125195202|NCT00734162|450336645|FG002|Open-Label Phase|Withdrew Consent|1|||
125195203|NCT00734162|450336646|FG003|Open-Label Phase|Withdrew Consent|1|||
125195204|NCT00734162|450336643|FG000|Open-Label Phase|Lost to Follow-up|1|||
125195205|NCT00734162|450336644|FG001|Open-Label Phase|Lost to Follow-up|2|||
125195206|NCT00734162|450336645|FG002|Open-Label Phase|Lost to Follow-up|0|||
125195207|NCT00734162|450336646|FG003|Open-Label Phase|Lost to Follow-up|1|||
125195208|NCT00734162|450336643|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
125195209|NCT00734162|450336644|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
125195210|NCT00734162|450336645|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
125195211|NCT00734162|450336646|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
125195212|NCT00596687|450336647|FG000|Overall Study|< 24 hours of insulin treatment|8|||
125195213|NCT00596687|450336648|FG001|Overall Study|< 24 hours of insulin treatment|6|||
125195214|NCT00596687|450336647|FG000|Overall Study|continuous insulin infusion during TPN|2|||
125195215|NCT00596687|450336648|FG001|Overall Study|continuous insulin infusion during TPN|1|||
125195216|NCT00596687|450336647|FG000|Overall Study|Withdrawal by Subject|3|||
125195217|NCT00596687|450336648|FG001|Overall Study|Withdrawal by Subject|1|||
125195218|NCT00596687|450336647|FG000|Overall Study|cancelled surgery|1|||
125195219|NCT00596687|450336648|FG001|Overall Study|cancelled surgery|1|||
125247619|NCT04518410|450531099|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
125247620|NCT04518410|450531100|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
125247621|NCT04518410|450531101|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
125247622|NCT04518410|450531077|FG000|Overall Study|Dual Enrolled Subject|0|||
125247623|NCT04518410|450531078|FG001|Overall Study|Dual Enrolled Subject|0|||
125247624|NCT04518410|450531079|FG002|Overall Study|Dual Enrolled Subject|0|||
125247625|NCT04518410|450531080|FG003|Overall Study|Dual Enrolled Subject|0|||
125247626|NCT04518410|450531081|FG004|Overall Study|Dual Enrolled Subject|0|||
125247627|NCT04518410|450531082|FG005|Overall Study|Dual Enrolled Subject|0|||
125247628|NCT04518410|450531083|FG006|Overall Study|Dual Enrolled Subject|0|||
125247629|NCT04518410|450531084|FG007|Overall Study|Dual Enrolled Subject|0|||
125247630|NCT04518410|450531085|FG008|Overall Study|Dual Enrolled Subject|0|||
125247631|NCT04518410|450531086|FG009|Overall Study|Dual Enrolled Subject|0|||
125247632|NCT04518410|450531087|FG010|Overall Study|Dual Enrolled Subject|0|||
125247633|NCT04518410|450531088|FG011|Overall Study|Dual Enrolled Subject|0|||
125247634|NCT04518410|450531089|FG012|Overall Study|Dual Enrolled Subject|0|||
125247635|NCT04518410|450531090|FG013|Overall Study|Dual Enrolled Subject|0|||
125247636|NCT04518410|450531091|FG014|Overall Study|Dual Enrolled Subject|0|||
125247637|NCT04518410|450531092|FG015|Overall Study|Dual Enrolled Subject|0|||
125247638|NCT04518410|450531093|FG016|Overall Study|Dual Enrolled Subject|0|||
125247639|NCT04518410|450531094|FG017|Overall Study|Dual Enrolled Subject|1|||
125247640|NCT04518410|450531095|FG018|Overall Study|Dual Enrolled Subject|0|||
125247641|NCT04518410|450531096|FG019|Overall Study|Dual Enrolled Subject|0|||
125247642|NCT04518410|450531097|FG020|Overall Study|Dual Enrolled Subject|0|||
125247643|NCT04518410|450531098|FG021|Overall Study|Dual Enrolled Subject|0|||
125247644|NCT04518410|450531099|FG022|Overall Study|Dual Enrolled Subject|0|||
125247645|NCT04518410|450531100|FG023|Overall Study|Dual Enrolled Subject|0|||
125247646|NCT04518410|450531101|FG024|Overall Study|Dual Enrolled Subject|0|||
125247647|NCT05737745|450531102|FG000|Overall Study|Withdrawal by Subject|0|||
125247648|NCT05737745|450531103|FG001|Overall Study|Withdrawal by Subject|6|||
125247649|NCT05737745|450531104|FG002|Overall Study|Withdrawal by Subject|1|||
125247650|NCT04289298|450532665|FG000|Overall Study|Lost to Follow-up|5|||
125247651|NCT04289298|450532666|FG001|Overall Study|Lost to Follow-up|0|||
125247652|NCT04289298|450532665|FG000|Overall Study|Withdrawal by Subject|2|||
125247653|NCT04289298|450532666|FG001|Overall Study|Withdrawal by Subject|0|||
125247654|NCT01108796|450532668|FG000|Overall Study|Adverse Event|0|||
125247655|NCT01108796|450532669|FG001|Overall Study|Adverse Event|1|||
125247656|NCT01108796|450532668|FG000|Overall Study|Lost to Follow-up|7|||
125247657|NCT01108796|450532669|FG001|Overall Study|Lost to Follow-up|6|||
125247658|NCT00454142|450532670|FG000|Overall Study|Withdrawal by Subject|1|||
125247659|NCT02545127|450532677|FG000|Overall Study|Lost to Follow-up|1|||
125247660|NCT02545127|450532678|FG001|Overall Study|Lost to Follow-up|0|||
125247661|NCT00520572|450532679|FG000|Overall Study|Adverse Event|9|||
125247662|NCT00520572|450532680|FG001|Overall Study|Adverse Event|3|||
125247663|NCT00520572|450532681|FG002|Overall Study|Adverse Event|6|||
125247664|NCT00520572|450532682|FG003|Overall Study|Adverse Event|9|||
125247665|NCT00520572|450532683|FG004|Overall Study|Adverse Event|7|||
125247666|NCT00520572|450532684|FG005|Overall Study|Adverse Event|2|||
125247667|NCT00520572|450532679|FG000|Overall Study|Withdrawal by Subject|0|||
125247668|NCT00520572|450532680|FG001|Overall Study|Withdrawal by Subject|9|||
125247669|NCT00520572|450532681|FG002|Overall Study|Withdrawal by Subject|5|||
125247670|NCT00520572|450532682|FG003|Overall Study|Withdrawal by Subject|2|||
125247671|NCT00520572|450532683|FG004|Overall Study|Withdrawal by Subject|2|||
125247672|NCT00520572|450532684|FG005|Overall Study|Withdrawal by Subject|0|||
125247673|NCT00520572|450532679|FG000|Overall Study|Protocol Violation|0|||
125247674|NCT00520572|450532680|FG001|Overall Study|Protocol Violation|0|||
125247675|NCT00520572|450532681|FG002|Overall Study|Protocol Violation|1|||
125247676|NCT00520572|450532682|FG003|Overall Study|Protocol Violation|0|||
125247677|NCT00520572|450532683|FG004|Overall Study|Protocol Violation|0|||
125247678|NCT00520572|450532684|FG005|Overall Study|Protocol Violation|0|||
125247679|NCT00520572|450532679|FG000|Overall Study|Lack of Efficacy|1|||
125247680|NCT00520572|450532680|FG001|Overall Study|Lack of Efficacy|1|||
125247681|NCT00520572|450532681|FG002|Overall Study|Lack of Efficacy|1|||
125247682|NCT00520572|450532682|FG003|Overall Study|Lack of Efficacy|2|||
125247683|NCT00520572|450532683|FG004|Overall Study|Lack of Efficacy|1|||
125247684|NCT00520572|450532684|FG005|Overall Study|Lack of Efficacy|0|||
125247685|NCT00520572|450532679|FG000|Overall Study|Lost to Follow-up|0|||
125247686|NCT00520572|450532680|FG001|Overall Study|Lost to Follow-up|0|||
125247687|NCT00520572|450532681|FG002|Overall Study|Lost to Follow-up|0|||
125247688|NCT00520572|450532682|FG003|Overall Study|Lost to Follow-up|0|||
125247689|NCT00520572|450532683|FG004|Overall Study|Lost to Follow-up|1|||
125247690|NCT00520572|450532684|FG005|Overall Study|Lost to Follow-up|0|||
125247691|NCT00520572|450532679|FG000|Overall Study|Incorrect enrollment|1|||
125247692|NCT00520572|450532680|FG001|Overall Study|Incorrect enrollment|0|||
125247693|NCT00520572|450532681|FG002|Overall Study|Incorrect enrollment|1|||
125247694|NCT00520572|450532682|FG003|Overall Study|Incorrect enrollment|0|||
125195220|NCT03831113|450336651|FG000|Overall Study|Withdrawal by Subject|0|||
125195221|NCT03831113|450336652|FG001|Overall Study|Withdrawal by Subject|2|||
125195222|NCT03831113|450336651|FG000|Overall Study|Protocol Violation|0|||
125195223|NCT03831113|450336652|FG001|Overall Study|Protocol Violation|9|||
125195224|NCT01068730|450336653|FG000|Period 3|Personal reason|1|||
125195225|NCT01068730|450336654|FG001|Period 3|Personal reason|0|||
125195226|NCT01068730|450336655|FG002|Period 3|Personal reason|0|||
125195227|NCT01068730|450336656|FG003|Period 3|Personal reason|0|||
125195228|NCT01068730|450336653|FG000|Period 4|Family emergency|0|||
125195229|NCT01068730|450336654|FG001|Period 4|Family emergency|1|||
125195230|NCT01068730|450336655|FG002|Period 4|Family emergency|0|||
125195231|NCT01068730|450336656|FG003|Period 4|Family emergency|0|||
125195232|NCT01270464|450336659|FG000|Overall Study|Protocol Violation|4|||
125195233|NCT01270464|450336660|FG001|Overall Study|Protocol Violation|3|||
125195234|NCT01270464|450336661|FG002|Overall Study|Protocol Violation|2|||
125195235|NCT01270464|450336659|FG000|Overall Study|Lack of Efficacy|2|||
125195236|NCT01270464|450336660|FG001|Overall Study|Lack of Efficacy|3|||
125195237|NCT01270464|450336661|FG002|Overall Study|Lack of Efficacy|1|||
125195238|NCT01270464|450336659|FG000|Overall Study|Adverse Event|9|||
125195239|NCT01270464|450336660|FG001|Overall Study|Adverse Event|1|||
125195240|NCT01270464|450336661|FG002|Overall Study|Adverse Event|7|||
125195241|NCT01270464|450336659|FG000|Overall Study|Withdrawal by Subject|2|||
125195242|NCT01270464|450336660|FG001|Overall Study|Withdrawal by Subject|1|||
125195243|NCT01270464|450336661|FG002|Overall Study|Withdrawal by Subject|4|||
125195244|NCT01270464|450336659|FG000|Overall Study|Lost to Follow-up|2|||
125195245|NCT01270464|450336660|FG001|Overall Study|Lost to Follow-up|3|||
125195246|NCT01270464|450336661|FG002|Overall Study|Lost to Follow-up|1|||
125195247|NCT01270464|450336659|FG000|Overall Study|Other|1|||
125195248|NCT01270464|450336660|FG001|Overall Study|Other|1|||
125195249|NCT01270464|450336661|FG002|Overall Study|Other|3|||
125195250|NCT04725812|450336663|FG000|Overall Study|Withdrawal by Subject|1|||
125195251|NCT03969901|450336666|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125195252|NCT03969901|450336667|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125195253|NCT03969901|450336668|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125195254|NCT03969901|450336669|FG003|Overall Study|Withdrawal by parent/guardian|0|||
125195255|NCT03969901|450336670|FG004|Overall Study|Withdrawal by parent/guardian|1|||
125195256|NCT03969901|450336671|FG005|Overall Study|Withdrawal by parent/guardian|0|||
125195257|NCT03969901|450336672|FG006|Overall Study|Withdrawal by parent/guardian|0|||
125195258|NCT03969901|450336673|FG007|Overall Study|Withdrawal by parent/guardian|1|||
125195259|NCT03969901|450336674|FG008|Overall Study|Withdrawal by parent/guardian|1|||
125195260|NCT03969901|450336675|FG009|Overall Study|Withdrawal by parent/guardian|0|||
125195261|NCT02589626|450336682|FG000|Overall Study|Other than the reason specified|1|||
125195262|NCT02589626|450336683|FG001|Overall Study|Other than the reason specified|0|||
125195263|NCT02589626|450336682|FG000|Overall Study|Withdrawal by Subject|1|||
125195264|NCT02589626|450336683|FG001|Overall Study|Withdrawal by Subject|1|||
125195265|NCT02589626|450336682|FG000|Overall Study|Adverse Event|1|||
125195266|NCT02589626|450336683|FG001|Overall Study|Adverse Event|1|||
125195267|NCT02564900|450336684|FG000|Dose Escalation|Progressive disease per RECIST|2|||
125195268|NCT02564900|450336685|FG001|Dose Escalation|Progressive disease per RECIST|3|||
125195269|NCT02564900|450336686|FG002|Dose Escalation|Progressive disease per RECIST|3|||
125195270|NCT02564900|450336687|FG003|Dose Escalation|Progressive disease per RECIST|3|||
125195271|NCT02564900|450336688|FG004|Dose Escalation|Progressive disease per RECIST|3|||
125195272|NCT02564900|450336689|FG005|Dose Escalation|Progressive disease per RECIST|1|||
125195273|NCT02564900|450336690|FG006|Dose Escalation|Progressive disease per RECIST|0|||
125195274|NCT02564900|450336691|FG007|Dose Escalation|Progressive disease per RECIST|0|||
125195275|NCT02564900|450336692|FG008|Dose Escalation|Progressive disease per RECIST|0|||
125195276|NCT02564900|450336693|FG009|Dose Escalation|Progressive disease per RECIST|0|||
125195277|NCT02564900|450336694|FG010|Dose Escalation|Progressive disease per RECIST|0|||
125195278|NCT02564900|450336695|FG011|Dose Escalation|Progressive disease per RECIST|0|||
125195279|NCT02564900|450336696|FG012|Dose Escalation|Progressive disease per RECIST|0|||
125195280|NCT02564900|450336697|FG013|Dose Escalation|Progressive disease per RECIST|0|||
125195281|NCT02564900|450336698|FG014|Dose Escalation|Progressive disease per RECIST|0|||
125195282|NCT02564900|450336684|FG000|Dose Escalation|Ongoing|1|||
125195283|NCT02564900|450336685|FG001|Dose Escalation|Ongoing|0|||
125195284|NCT02564900|450336686|FG002|Dose Escalation|Ongoing|0|||
125195285|NCT02564900|450336687|FG003|Dose Escalation|Ongoing|2|||
125195286|NCT02564900|450336688|FG004|Dose Escalation|Ongoing|2|||
125195287|NCT02564900|450336689|FG005|Dose Escalation|Ongoing|2|||
125195288|NCT02564900|450336690|FG006|Dose Escalation|Ongoing|0|||
125195289|NCT02564900|450336691|FG007|Dose Escalation|Ongoing|0|||
125195290|NCT02564900|450336692|FG008|Dose Escalation|Ongoing|0|||
125195291|NCT02564900|450336693|FG009|Dose Escalation|Ongoing|0|||
125195292|NCT02564900|450336694|FG010|Dose Escalation|Ongoing|0|||
125195293|NCT02564900|450336695|FG011|Dose Escalation|Ongoing|0|||
125195294|NCT02564900|450336696|FG012|Dose Escalation|Ongoing|0|||
125195295|NCT02564900|450336697|FG013|Dose Escalation|Ongoing|0|||
125195296|NCT02564900|450336698|FG014|Dose Escalation|Ongoing|0|||
125195297|NCT02564900|450336684|FG000|Dose Escalation|Adverse Event|0|||
125395495|NCT00048542|451081650|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
125247695|NCT00520572|450532683|FG004|Overall Study|Incorrect enrollment|1|||
125247696|NCT00520572|450532684|FG005|Overall Study|Incorrect enrollment|0|||
125247697|NCT00520572|450532679|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
125247698|NCT00520572|450532680|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
125247699|NCT00520572|450532681|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
125395496|NCT00048542|451081651|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
125395497|NCT00048542|451081652|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
125395498|NCT00048542|451081653|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
125195298|NCT02564900|450336685|FG001|Dose Escalation|Adverse Event|0|||
125195299|NCT02564900|450336686|FG002|Dose Escalation|Adverse Event|0|||
125195300|NCT02564900|450336687|FG003|Dose Escalation|Adverse Event|1|||
125195301|NCT02564900|450336688|FG004|Dose Escalation|Adverse Event|1|||
125195302|NCT02564900|450336689|FG005|Dose Escalation|Adverse Event|3|||
125195303|NCT02564900|450336690|FG006|Dose Escalation|Adverse Event|0|||
125195304|NCT02564900|450336691|FG007|Dose Escalation|Adverse Event|0|||
125195305|NCT02564900|450336692|FG008|Dose Escalation|Adverse Event|0|||
125195306|NCT02564900|450336693|FG009|Dose Escalation|Adverse Event|0|||
125195307|NCT02564900|450336694|FG010|Dose Escalation|Adverse Event|0|||
125195308|NCT02564900|450336695|FG011|Dose Escalation|Adverse Event|0|||
125195309|NCT02564900|450336696|FG012|Dose Escalation|Adverse Event|0|||
125195310|NCT02564900|450336697|FG013|Dose Escalation|Adverse Event|0|||
125195311|NCT02564900|450336698|FG014|Dose Escalation|Adverse Event|0|||
125195312|NCT02564900|450336684|FG000|Dose Expansion|Progressive disease per RECIST|0|||
125195313|NCT02564900|450336685|FG001|Dose Expansion|Progressive disease per RECIST|0|||
125195314|NCT02564900|450336686|FG002|Dose Expansion|Progressive disease per RECIST|0|||
125195315|NCT02564900|450336687|FG003|Dose Expansion|Progressive disease per RECIST|0|||
125195316|NCT02564900|450336688|FG004|Dose Expansion|Progressive disease per RECIST|0|||
125195317|NCT02564900|450336689|FG005|Dose Expansion|Progressive disease per RECIST|0|||
125195318|NCT02564900|450336690|FG006|Dose Expansion|Progressive disease per RECIST|19|||
125195319|NCT02564900|450336691|FG007|Dose Expansion|Progressive disease per RECIST|17|||
125195320|NCT02564900|450336692|FG008|Dose Expansion|Progressive disease per RECIST|8|||
125195321|NCT02564900|450336693|FG009|Dose Expansion|Progressive disease per RECIST|16|||
125195322|NCT02564900|450336694|FG010|Dose Expansion|Progressive disease per RECIST|13|||
125195323|NCT02564900|450336695|FG011|Dose Expansion|Progressive disease per RECIST|19|||
125195324|NCT02564900|450336696|FG012|Dose Expansion|Progressive disease per RECIST|10|||
125195325|NCT02564900|450336697|FG013|Dose Expansion|Progressive disease per RECIST|13|||
125195326|NCT02564900|450336698|FG014|Dose Expansion|Progressive disease per RECIST|11|||
125195327|NCT02564900|450336684|FG000|Dose Expansion|Clinical progression|0|||
125195328|NCT02564900|450336685|FG001|Dose Expansion|Clinical progression|0|||
125195329|NCT02564900|450336686|FG002|Dose Expansion|Clinical progression|0|||
125195330|NCT02564900|450336687|FG003|Dose Expansion|Clinical progression|0|||
125195331|NCT02564900|450336688|FG004|Dose Expansion|Clinical progression|0|||
125195332|NCT02564900|450336689|FG005|Dose Expansion|Clinical progression|0|||
125195333|NCT02564900|450336690|FG006|Dose Expansion|Clinical progression|5|||
125195334|NCT02564900|450336691|FG007|Dose Expansion|Clinical progression|12|||
125195335|NCT02564900|450336692|FG008|Dose Expansion|Clinical progression|0|||
125195336|NCT02564900|450336693|FG009|Dose Expansion|Clinical progression|3|||
125195337|NCT02564900|450336694|FG010|Dose Expansion|Clinical progression|2|||
125195338|NCT02564900|450336695|FG011|Dose Expansion|Clinical progression|0|||
125195339|NCT02564900|450336696|FG012|Dose Expansion|Clinical progression|1|||
125195340|NCT02564900|450336697|FG013|Dose Expansion|Clinical progression|3|||
125195341|NCT02564900|450336698|FG014|Dose Expansion|Clinical progression|1|||
125195342|NCT02564900|450336684|FG000|Dose Expansion|Adverse Event|0|||
125195343|NCT02564900|450336685|FG001|Dose Expansion|Adverse Event|0|||
125195344|NCT02564900|450336686|FG002|Dose Expansion|Adverse Event|0|||
125195345|NCT02564900|450336687|FG003|Dose Expansion|Adverse Event|0|||
125195346|NCT02564900|450336688|FG004|Dose Expansion|Adverse Event|0|||
125195347|NCT02564900|450336689|FG005|Dose Expansion|Adverse Event|0|||
125195348|NCT02564900|450336690|FG006|Dose Expansion|Adverse Event|9|||
125195349|NCT02564900|450336691|FG007|Dose Expansion|Adverse Event|22|||
125195350|NCT02564900|450336692|FG008|Dose Expansion|Adverse Event|0|||
125195351|NCT02564900|450336693|FG009|Dose Expansion|Adverse Event|11|||
125195352|NCT02564900|450336694|FG010|Dose Expansion|Adverse Event|0|||
125195353|NCT02564900|450336695|FG011|Dose Expansion|Adverse Event|5|||
125195354|NCT02564900|450336696|FG012|Dose Expansion|Adverse Event|2|||
125195355|NCT02564900|450336697|FG013|Dose Expansion|Adverse Event|2|||
125195356|NCT02564900|450336698|FG014|Dose Expansion|Adverse Event|1|||
125195357|NCT02564900|450336684|FG000|Dose Expansion|Ongoing|0|||
125195358|NCT02564900|450336685|FG001|Dose Expansion|Ongoing|0|||
125195359|NCT02564900|450336686|FG002|Dose Expansion|Ongoing|0|||
125195360|NCT02564900|450336687|FG003|Dose Expansion|Ongoing|0|||
125195361|NCT02564900|450336688|FG004|Dose Expansion|Ongoing|0|||
125195362|NCT02564900|450336689|FG005|Dose Expansion|Ongoing|0|||
125195363|NCT02564900|450336690|FG006|Dose Expansion|Ongoing|9|||
125195364|NCT02564900|450336691|FG007|Dose Expansion|Ongoing|10|||
125247700|NCT00520572|450532682|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
125247701|NCT00520572|450532683|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
125247702|NCT00520572|450532684|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
125247703|NCT00520572|450532679|FG000|Overall Study|Long break in taking Medication|0|||
125247704|NCT00520572|450532680|FG001|Overall Study|Long break in taking Medication|0|||
125247705|NCT00520572|450532681|FG002|Overall Study|Long break in taking Medication|0|||
125247706|NCT00520572|450532682|FG003|Overall Study|Long break in taking Medication|1|||
125247707|NCT00520572|450532683|FG004|Overall Study|Long break in taking Medication|0|||
125247708|NCT00520572|450532684|FG005|Overall Study|Long break in taking Medication|0|||
125247709|NCT00520572|450532679|FG000|Overall Study|Did not receive Treatment|1|||
125247710|NCT00520572|450532680|FG001|Overall Study|Did not receive Treatment|0|||
125247711|NCT00520572|450532681|FG002|Overall Study|Did not receive Treatment|1|||
125247712|NCT00520572|450532682|FG003|Overall Study|Did not receive Treatment|0|||
125247713|NCT00520572|450532683|FG004|Overall Study|Did not receive Treatment|0|||
125247714|NCT00520572|450532684|FG005|Overall Study|Did not receive Treatment|0|||
125247715|NCT03315689|450532685|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
125247716|NCT03315689|450532686|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
125247717|NCT03315689|450532685|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
125247718|NCT03315689|450532686|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
125247719|NCT03315689|450532685|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
125247720|NCT03315689|450532686|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
125247721|NCT01783015|450532687|FG000|Blinded Treatment|Adverse Event|0|||
125247722|NCT01783015|450532688|FG001|Blinded Treatment|Adverse Event|1|||
125247723|NCT01783015|450532689|FG002|Blinded Treatment|Adverse Event|0|||
125247724|NCT01783015|450532687|FG000|Blinded Treatment|Protocol Violation|0|||
125247725|NCT01783015|450532688|FG001|Blinded Treatment|Protocol Violation|1|||
125247726|NCT01783015|450532689|FG002|Blinded Treatment|Protocol Violation|0|||
125247727|NCT01783015|450532687|FG000|Blinded Treatment|Withdrawal by Subject|0|||
125247728|NCT01783015|450532688|FG001|Blinded Treatment|Withdrawal by Subject|1|||
125247729|NCT01783015|450532689|FG002|Blinded Treatment|Withdrawal by Subject|0|||
125247730|NCT01783015|450532687|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
125247731|NCT01783015|450532688|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
125247732|NCT01783015|450532689|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
125247733|NCT01783015|450532687|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
125247734|NCT01783015|450532688|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
125247735|NCT01783015|450532689|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
125247736|NCT00669331|450532690|FG000|Randomisation to First Dose|Adverse Event|1|||
125247737|NCT00669331|450532691|FG001|Randomisation to First Dose|Adverse Event|0|||
125247738|NCT00669331|450532690|FG000|Randomisation to First Dose|Protocol Violation|1|||
125247739|NCT00669331|450532691|FG001|Randomisation to First Dose|Protocol Violation|0|||
125247740|NCT00669331|450532690|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
125247741|NCT00669331|450532691|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
125247742|NCT00669331|450532690|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
125247743|NCT00669331|450532691|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
125247744|NCT00669331|450532690|FG000|Randomisation to First Dose|Death|1|||
125247745|NCT00669331|450532691|FG001|Randomisation to First Dose|Death|0|||
125247746|NCT00669331|450532690|FG000|Randomisation to First Dose|Sponsor decision|0|||
125247747|NCT00669331|450532691|FG001|Randomisation to First Dose|Sponsor decision|1|||
125247748|NCT00669331|450532690|FG000|Randomisation to First Dose|Randomised in error|3|||
125247749|NCT00669331|450532691|FG001|Randomisation to First Dose|Randomised in error|10|||
125247750|NCT00669331|450532690|FG000|Blinded Treatment Period|Adverse Event|16|||
125247751|NCT00669331|450532691|FG001|Blinded Treatment Period|Adverse Event|10|||
125247752|NCT00669331|450532690|FG000|Blinded Treatment Period|Protocol Violation|1|||
125247753|NCT00669331|450532691|FG001|Blinded Treatment Period|Protocol Violation|1|||
125247754|NCT00669331|450532690|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
125247755|NCT00669331|450532691|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
125247756|NCT00669331|450532690|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
125247757|NCT00669331|450532691|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
125247758|NCT00669331|450532690|FG000|Blinded Treatment Period|Death|0|||
125247759|NCT00669331|450532691|FG001|Blinded Treatment Period|Death|2|||
125247760|NCT00669331|450532690|FG000|Blinded Treatment Period|Physician Decision|3|||
125247761|NCT00669331|450532691|FG001|Blinded Treatment Period|Physician Decision|3|||
125247762|NCT00669331|450532690|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
125247763|NCT00669331|450532691|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
125247764|NCT03794544|450532692|FG000|Overall Study|Withdrawal by Subject|1|||
125247765|NCT03794544|450532693|FG001|Overall Study|Withdrawal by Subject|1|||
125247766|NCT03794544|450532694|FG002|Overall Study|Withdrawal by Subject|0|||
125247767|NCT03794544|450532695|FG003|Overall Study|Withdrawal by Subject|0|||
125247768|NCT03794544|450532692|FG000|Overall Study|Death|0|||
125247769|NCT03794544|450532693|FG001|Overall Study|Death|0|||
125247770|NCT03794544|450532694|FG002|Overall Study|Death|0|||
125247771|NCT03794544|450532695|FG003|Overall Study|Death|1|||
125247772|NCT03794544|450532692|FG000|Overall Study|Lost to Follow-up|0|||
125247773|NCT03794544|450532693|FG001|Overall Study|Lost to Follow-up|1|||
125247774|NCT03794544|450532694|FG002|Overall Study|Lost to Follow-up|1|||
125247775|NCT03794544|450532695|FG003|Overall Study|Lost to Follow-up|0|||
125247776|NCT03794544|450532692|FG000|Overall Study|Other|0|||
125247777|NCT03794544|450532693|FG001|Overall Study|Other|1|||
125247778|NCT03794544|450532694|FG002|Overall Study|Other|0|||
125247779|NCT03794544|450532695|FG003|Overall Study|Other|0|||
125247780|NCT00120250|450532699|FG000|Overall Study|Lost to Follow-up|1|||
125247781|NCT00120250|450532700|FG001|Overall Study|Lost to Follow-up|1|||
125247782|NCT00120250|450532699|FG000|Overall Study|Protocol Violation|0|||
125247783|NCT00120250|450532700|FG001|Overall Study|Protocol Violation|1|||
125247784|NCT01964560|450532707|FG000|Overall Study|Adverse Event|23|||
125247785|NCT01964560|450532707|FG000|Overall Study|Lack of Efficacy|46|||
125247786|NCT01964560|450532707|FG000|Overall Study|Protocol deviation|2|||
125247787|NCT01964560|450532707|FG000|Overall Study|Lost to Follow-up|4|||
125247788|NCT01964560|450532707|FG000|Overall Study|Withdrawal by Subject|64|||
125247789|NCT01964560|450532707|FG000|Overall Study|Surgery-hemispherotomy|1|||
125247790|NCT01964560|450532707|FG000|Overall Study|Surgery|1|||
125247791|NCT01964560|450532707|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
125247792|NCT01964560|450532707|FG000|Overall Study|Patient and Investigator choice|1|||
125247793|NCT01964560|450532707|FG000|Overall Study|Patient was prescribed CBD|1|||
125247794|NCT01964560|450532707|FG000|Overall Study|Participant moved to another country|1|||
125247795|NCT00710554|450532708|FG000|Overall Study|Adverse Event|24|||
125247796|NCT00710554|450532709|FG001|Overall Study|Adverse Event|7|||
125247797|NCT00710554|450532708|FG000|Overall Study|Withdrawal by Subject|7|||
125247798|NCT00710554|450532709|FG001|Overall Study|Withdrawal by Subject|3|||
125247799|NCT00710554|450532708|FG000|Overall Study|Lost to Follow-up|7|||
125247800|NCT00710554|450532709|FG001|Overall Study|Lost to Follow-up|1|||
125247801|NCT00710554|450532708|FG000|Overall Study|Lack of Efficacy|11|||
125247802|NCT00710554|450532709|FG001|Overall Study|Lack of Efficacy|12|||
125247803|NCT00710554|450532708|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
125247804|NCT00710554|450532709|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
125247805|NCT01433978|450532710|FG000|Core Study|Adverse Event, Non-Fatal|0|||
125247806|NCT01433978|450532711|FG001|Core Study|Adverse Event, Non-Fatal|1|||
125247807|NCT01433978|450532712|FG002|Core Study|Adverse Event, Non-Fatal|0|||
125247808|NCT01433978|450532710|FG000|Core Study|Lack of Efficacy|5|||
125247809|NCT01433978|450532711|FG001|Core Study|Lack of Efficacy|1|||
125247810|NCT01433978|450532712|FG002|Core Study|Lack of Efficacy|0|||
125247811|NCT01433978|450532710|FG000|Core Study|Study Terminated by Sponsor|6|||
125247812|NCT01433978|450532711|FG001|Core Study|Study Terminated by Sponsor|9|||
125247813|NCT01433978|450532712|FG002|Core Study|Study Terminated by Sponsor|0|||
125247814|NCT01433978|450532710|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
125247815|NCT01433978|450532711|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
125247816|NCT01433978|450532712|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
125247817|NCT01433978|450532710|FG000|Extension Phase|Lack of Efficacy|0|||
125247818|NCT01433978|450532711|FG001|Extension Phase|Lack of Efficacy|0|||
125247819|NCT01433978|450532712|FG002|Extension Phase|Lack of Efficacy|1|||
125247820|NCT01433978|450532710|FG000|Extension Phase|Study Terminated by Sponsor|0|||
125247821|NCT01433978|450532711|FG001|Extension Phase|Study Terminated by Sponsor|0|||
125247822|NCT01433978|450532712|FG002|Extension Phase|Study Terminated by Sponsor|4|||
125247823|NCT00378560|450532713|FG000|Overall Study|Adverse Event|1|||
125195365|NCT02564900|450336692|FG008|Dose Expansion|Ongoing|11|||
125195366|NCT02564900|450336693|FG009|Dose Expansion|Ongoing|3|||
125195367|NCT02564900|450336694|FG010|Dose Expansion|Ongoing|0|||
125195368|NCT02564900|450336695|FG011|Dose Expansion|Ongoing|0|||
125195369|NCT02564900|450336696|FG012|Dose Expansion|Ongoing|4|||
125195370|NCT02564900|450336697|FG013|Dose Expansion|Ongoing|0|||
125195371|NCT02564900|450336698|FG014|Dose Expansion|Ongoing|6|||
125195372|NCT02564900|450336684|FG000|Dose Expansion|Death|0|||
125195373|NCT02564900|450336685|FG001|Dose Expansion|Death|0|||
125195374|NCT02564900|450336686|FG002|Dose Expansion|Death|0|||
125195375|NCT02564900|450336687|FG003|Dose Expansion|Death|0|||
125195376|NCT02564900|450336688|FG004|Dose Expansion|Death|0|||
125195377|NCT02564900|450336689|FG005|Dose Expansion|Death|0|||
125195378|NCT02564900|450336690|FG006|Dose Expansion|Death|1|||
125195379|NCT02564900|450336691|FG007|Dose Expansion|Death|0|||
125195380|NCT02564900|450336692|FG008|Dose Expansion|Death|0|||
125195381|NCT02564900|450336693|FG009|Dose Expansion|Death|0|||
125247824|NCT00378560|450532714|FG001|Overall Study|Adverse Event|0|||
125247825|NCT00378560|450532713|FG000|Overall Study|Lost to Follow-up|24|||
125247826|NCT00378560|450532714|FG001|Overall Study|Lost to Follow-up|29|||
125247827|NCT00378560|450532713|FG000|Overall Study|Protocol Violation|2|||
125247828|NCT00378560|450532714|FG001|Overall Study|Protocol Violation|0|||
125247829|NCT00378560|450532713|FG000|Overall Study|Withdrawal by Subject|17|||
125247830|NCT00378560|450532714|FG001|Overall Study|Withdrawal by Subject|21|||
125195382|NCT02564900|450336694|FG010|Dose Expansion|Death|1|||
125195383|NCT02564900|450336695|FG011|Dose Expansion|Death|0|||
125195384|NCT02564900|450336696|FG012|Dose Expansion|Death|1|||
125195385|NCT02564900|450336697|FG013|Dose Expansion|Death|1|||
125195386|NCT02564900|450336698|FG014|Dose Expansion|Death|0|||
125195387|NCT02564900|450336684|FG000|Dose Expansion|Withdrawal by Subject|0|||
125195388|NCT02564900|450336685|FG001|Dose Expansion|Withdrawal by Subject|0|||
125195389|NCT02564900|450336686|FG002|Dose Expansion|Withdrawal by Subject|0|||
125195390|NCT02564900|450336687|FG003|Dose Expansion|Withdrawal by Subject|0|||
125195391|NCT02564900|450336688|FG004|Dose Expansion|Withdrawal by Subject|0|||
125195392|NCT02564900|450336689|FG005|Dose Expansion|Withdrawal by Subject|0|||
125195393|NCT02564900|450336690|FG006|Dose Expansion|Withdrawal by Subject|4|||
125195394|NCT02564900|450336691|FG007|Dose Expansion|Withdrawal by Subject|0|||
125195395|NCT02564900|450336692|FG008|Dose Expansion|Withdrawal by Subject|0|||
125195396|NCT02564900|450336693|FG009|Dose Expansion|Withdrawal by Subject|0|||
125195397|NCT02564900|450336694|FG010|Dose Expansion|Withdrawal by Subject|1|||
125195398|NCT02564900|450336695|FG011|Dose Expansion|Withdrawal by Subject|0|||
125195399|NCT02564900|450336696|FG012|Dose Expansion|Withdrawal by Subject|0|||
125195400|NCT02564900|450336697|FG013|Dose Expansion|Withdrawal by Subject|1|||
125195401|NCT02564900|450336698|FG014|Dose Expansion|Withdrawal by Subject|1|||
125195402|NCT02564900|450336684|FG000|Dose Expansion|Other|0|||
125195403|NCT02564900|450336685|FG001|Dose Expansion|Other|0|||
125195404|NCT02564900|450336686|FG002|Dose Expansion|Other|0|||
125247831|NCT00378560|450532713|FG000|Overall Study|Moved|4|||
125247832|NCT00378560|450532714|FG001|Overall Study|Moved|3|||
125247833|NCT00378560|450532713|FG000|Overall Study|Pregnancy|7|||
125247834|NCT00378560|450532714|FG001|Overall Study|Pregnancy|5|||
125247835|NCT00378560|450532713|FG000|Overall Study|Laboratory test values abnormal|1|||
125247836|NCT00378560|450532714|FG001|Overall Study|Laboratory test values abnormal|0|||
125247837|NCT02852434|450532715|FG000|Overall Study|Withdrawal by Subject|0|||
125247838|NCT02852434|450532716|FG001|Overall Study|Withdrawal by Subject|1|||
125247839|NCT02852434|450532715|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
125247840|NCT02852434|450532716|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
125247841|NCT01011283|450532720|FG000|Overall Study|Adverse Event|4|||
125247842|NCT01011283|450532721|FG001|Overall Study|Adverse Event|2|||
125247843|NCT01011283|450532720|FG000|Overall Study|Progressive Disease|0|||
125247844|NCT01011283|450532721|FG001|Overall Study|Progressive Disease|2|||
125247845|NCT01011283|450532720|FG000|Overall Study|Terminated by Sponsor|5|||
125247846|NCT01011283|450532721|FG001|Overall Study|Terminated by Sponsor|5|||
125247847|NCT01011283|450532720|FG000|Overall Study|Other|2|||
125247848|NCT01011283|450532721|FG001|Overall Study|Other|2|||
125247849|NCT04865978|450532725|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
125247850|NCT04865978|450532726|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
125247851|NCT03835117|450532727|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
125247852|NCT03835117|450532728|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
125247853|NCT00609973|450532730|FG000|Overall Study|Adverse Event|2|||
125247854|NCT00609973|450532731|FG001|Overall Study|Adverse Event|1|||
125247855|NCT00609973|450532730|FG000|Overall Study|Protocol Violation|4|||
125247856|NCT00609973|450532731|FG001|Overall Study|Protocol Violation|3|||
125247857|NCT00609973|450532730|FG000|Overall Study|Lost to Follow-up|2|||
125247858|NCT00609973|450532731|FG001|Overall Study|Lost to Follow-up|1|||
125247859|NCT00609973|450532730|FG000|Overall Study|Withdrawal by Subject|0|||
125247860|NCT00609973|450532731|FG001|Overall Study|Withdrawal by Subject|1|||
125247861|NCT00191152|450532733|FG000|Initial Treatment|Adverse Event|43|||
125247862|NCT00191152|450532734|FG001|Initial Treatment|Adverse Event|67|||
125247863|NCT00191152|450532733|FG000|Initial Treatment|Physician Decision|40|||
125247864|NCT00191152|450532734|FG001|Initial Treatment|Physician Decision|31|||
125247865|NCT00191152|450532733|FG000|Initial Treatment|Withdrawal by Subject|40|||
125247866|NCT00191152|450532734|FG001|Initial Treatment|Withdrawal by Subject|28|||
125247867|NCT00191152|450532733|FG000|Initial Treatment|Lost to Follow-up|0|||
125247868|NCT00191152|450532734|FG001|Initial Treatment|Lost to Follow-up|6|||
125247869|NCT00191152|450532733|FG000|Initial Treatment|Other|18|||
125247870|NCT00191152|450532734|FG001|Initial Treatment|Other|21|||
125247871|NCT00191152|450532733|FG000|Crossover Treatment|Adverse Event|8|||
125247872|NCT00191152|450532734|FG001|Crossover Treatment|Adverse Event|8|||
125247873|NCT00191152|450532733|FG000|Crossover Treatment|Physician Decision|7|||
125247874|NCT00191152|450532734|FG001|Crossover Treatment|Physician Decision|7|||
125247875|NCT00191152|450532733|FG000|Crossover Treatment|Withdrawal by Subject|6|||
125247876|NCT00191152|450532734|FG001|Crossover Treatment|Withdrawal by Subject|9|||
125247877|NCT00191152|450532733|FG000|Crossover Treatment|Lost to Follow-up|2|||
125247878|NCT00191152|450532734|FG001|Crossover Treatment|Lost to Follow-up|1|||
125195405|NCT02564900|450336687|FG003|Dose Expansion|Other|0|||
125195406|NCT02564900|450336688|FG004|Dose Expansion|Other|0|||
125195407|NCT02564900|450336689|FG005|Dose Expansion|Other|0|||
125195408|NCT02564900|450336690|FG006|Dose Expansion|Other|1|||
125195409|NCT02564900|450336691|FG007|Dose Expansion|Other|0|||
125195410|NCT02564900|450336692|FG008|Dose Expansion|Other|1|||
125247879|NCT00191152|450532733|FG000|Crossover Treatment|Other|4|||
125195411|NCT02564900|450336693|FG009|Dose Expansion|Other|0|||
125195412|NCT02564900|450336694|FG010|Dose Expansion|Other|0|||
125247880|NCT00191152|450532734|FG001|Crossover Treatment|Other|3|||
125247881|NCT00114777|450532738|FG000|Randomization to Month 36|Death|10|||
125195413|NCT02564900|450336695|FG011|Dose Expansion|Other|0|||
125195414|NCT02564900|450336696|FG012|Dose Expansion|Other|0|||
125195415|NCT02564900|450336697|FG013|Dose Expansion|Other|0|||
125195416|NCT02564900|450336698|FG014|Dose Expansion|Other|1|||
125195417|NCT02564900|450336684|FG000|Dose Expansion|Did not receive treatment|0|||
125195418|NCT02564900|450336685|FG001|Dose Expansion|Did not receive treatment|0|||
125195419|NCT02564900|450336686|FG002|Dose Expansion|Did not receive treatment|0|||
125195420|NCT02564900|450336687|FG003|Dose Expansion|Did not receive treatment|0|||
125195421|NCT02564900|450336688|FG004|Dose Expansion|Did not receive treatment|0|||
125195422|NCT02564900|450336689|FG005|Dose Expansion|Did not receive treatment|0|||
125195423|NCT02564900|450336690|FG006|Dose Expansion|Did not receive treatment|1|||
125195424|NCT02564900|450336691|FG007|Dose Expansion|Did not receive treatment|1|||
125195425|NCT02564900|450336692|FG008|Dose Expansion|Did not receive treatment|0|||
125195426|NCT02564900|450336693|FG009|Dose Expansion|Did not receive treatment|0|||
125195427|NCT02564900|450336694|FG010|Dose Expansion|Did not receive treatment|0|||
125195428|NCT02564900|450336695|FG011|Dose Expansion|Did not receive treatment|0|||
125195429|NCT02564900|450336696|FG012|Dose Expansion|Did not receive treatment|0|||
125195430|NCT02564900|450336697|FG013|Dose Expansion|Did not receive treatment|0|||
125195431|NCT02564900|450336698|FG014|Dose Expansion|Did not receive treatment|1|||
125195432|NCT00892151|450336699|FG000|Overall Study|Protocol Violation|1|||
125195433|NCT04075682|450336702|FG000|Overall Study|Lost to Follow-up|5|||
125195434|NCT04075682|450336703|FG001|Overall Study|Lost to Follow-up|5|||
125195435|NCT04075682|450336704|FG002|Overall Study|Lost to Follow-up|2|||
125195436|NCT04075682|450336705|FG003|Overall Study|Lost to Follow-up|2|||
125195437|NCT04075682|450336702|FG000|Overall Study|Withdrawal by Subject|1|||
125195438|NCT04075682|450336703|FG001|Overall Study|Withdrawal by Subject|0|||
125195439|NCT04075682|450336704|FG002|Overall Study|Withdrawal by Subject|1|||
125195440|NCT04075682|450336705|FG003|Overall Study|Withdrawal by Subject|0|||
125195441|NCT04075682|450336702|FG000|Overall Study|Protocol Violation|0|||
125195442|NCT04075682|450336703|FG001|Overall Study|Protocol Violation|1|||
125195443|NCT04075682|450336704|FG002|Overall Study|Protocol Violation|1|||
125195444|NCT04075682|450336705|FG003|Overall Study|Protocol Violation|0|||
125195445|NCT04075682|450336702|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
125195446|NCT04075682|450336703|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
125195447|NCT04075682|450336704|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
125195448|NCT04075682|450336705|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
125195449|NCT04075682|450336702|FG000|Overall Study|Lost study phone the first day of study participation|0|||
125395499|NCT00048542|451081654|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
125395500|NCT00048542|451081655|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
125395501|NCT00048542|451081648|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
125395502|NCT00048542|451081649|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
125395503|NCT00048542|451081650|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
125395504|NCT00048542|451081651|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
125395505|NCT00048542|451081652|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
125395506|NCT00048542|451081653|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
125395507|NCT00048542|451081654|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
125395508|NCT00048542|451081655|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
125395509|NCT00048542|451081648|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
125395510|NCT00048542|451081649|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
125395511|NCT00048542|451081650|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
125395512|NCT00048542|451081651|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
125195450|NCT04075682|450336703|FG001|Overall Study|Lost study phone the first day of study participation|1|||
125195451|NCT04075682|450336704|FG002|Overall Study|Lost study phone the first day of study participation|0|||
125195452|NCT04075682|450336705|FG003|Overall Study|Lost study phone the first day of study participation|0|||
125195453|NCT00887315|450336706|FG000|Overall Study|Study termination|7|||
125195454|NCT00887315|450336707|FG001|Overall Study|Study termination|4|||
125195455|NCT00619892|450336708|FG000|Overall Study|Adverse Event|3|||
125195456|NCT00619892|450336709|FG001|Overall Study|Adverse Event|0|||
125195457|NCT00619892|450336708|FG000|Overall Study|Lost to Follow-up|0|||
125195458|NCT00619892|450336709|FG001|Overall Study|Lost to Follow-up|1|||
125395513|NCT00048542|451081652|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
125195459|NCT00619892|450336708|FG000|Overall Study|Intercurrent illness|0|||
125195460|NCT00619892|450336709|FG001|Overall Study|Intercurrent illness|1|||
125195461|NCT00280397|450336711|FG000|Overall Study|Adverse Event|1|||
125195462|NCT02257489|450336714|FG000|Overall Study|Withdrawal by Subject|0|||
125195463|NCT02257489|450336715|FG001|Overall Study|Withdrawal by Subject|0|||
125195464|NCT02257489|450336716|FG002|Overall Study|Withdrawal by Subject|0|||
125195465|NCT02257489|450336717|FG003|Overall Study|Withdrawal by Subject|1|||
125195466|NCT02257489|450336718|FG004|Overall Study|Withdrawal by Subject|0|||
125195467|NCT02257489|450336719|FG005|Overall Study|Withdrawal by Subject|0|||
125195468|NCT02257489|450336720|FG006|Overall Study|Withdrawal by Subject|0|||
125195469|NCT02257489|450336721|FG007|Overall Study|Withdrawal by Subject|0|||
125247882|NCT00114777|450532739|FG001|Randomization to Month 36|Death|4|||
125247883|NCT00114777|450532740|FG002|Randomization to Month 36|Death|3|||
125247884|NCT00114777|450532738|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
125247885|NCT00114777|450532739|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
125247886|NCT00114777|450532740|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
125247887|NCT00114777|450532738|FG000|Randomization to Month 36|Lack of Efficacy|19|||
125247888|NCT00114777|450532739|FG001|Randomization to Month 36|Lack of Efficacy|15|||
125247889|NCT00114777|450532740|FG002|Randomization to Month 36|Lack of Efficacy|17|||
125247890|NCT00114777|450532738|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
125247891|NCT00114777|450532739|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
125247892|NCT00114777|450532740|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
125247893|NCT00114777|450532738|FG000|Randomization to Month 36|Adverse Event|34|||
125247894|NCT00114777|450532739|FG001|Randomization to Month 36|Adverse Event|35|||
125247895|NCT00114777|450532740|FG002|Randomization to Month 36|Adverse Event|44|||
125247896|NCT00114777|450532738|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
125247897|NCT00114777|450532739|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
125247898|NCT00114777|450532740|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
125247899|NCT00114777|450532738|FG000|Randomization to Month 36|Other|9|||
125247900|NCT00114777|450532739|FG001|Randomization to Month 36|Other|3|||
125247901|NCT00114777|450532740|FG002|Randomization to Month 36|Other|12|||
125247902|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Death|8|||
125247903|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Death|13|||
125247904|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Death|7|||
125247905|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
125247906|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
125247907|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
125247908|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
125247909|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
125247910|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
125195470|NCT02257489|450336722|FG008|Overall Study|Withdrawal by Subject|0|||
125195471|NCT03200704|450336724|FG000|Overall Study|Withdrawal by Subject|1|||
125195472|NCT03706430|450336726|FG000|Overall Study|No A-Line placed|5|||
125195473|NCT03706430|450336726|FG000|Overall Study|Subject had gel nail polish|1|||
125195474|NCT03706430|450336726|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
125195475|NCT03706430|450336726|FG000|Overall Study|Cancelled Case|6|||
125195476|NCT03706430|450336726|FG000|Overall Study|Physician Decision|2|||
125195477|NCT00478777|450336727|FG000|Overall Study|Adverse Event|29|||
125195478|NCT00478777|450336727|FG000|Overall Study|Lack of Efficacy|23|||
125195479|NCT00478777|450336727|FG000|Overall Study|Withdrawal by Subject|4|||
125195480|NCT00478777|450336727|FG000|Overall Study|Death|3|||
125195481|NCT00478777|450336727|FG000|Overall Study|Protocol Violation|3|||
125195482|NCT00478777|450336727|FG000|Overall Study|Lost to Follow-up|3|||
125195483|NCT00478777|450336727|FG000|Overall Study|Physician Decision|1|||
125195484|NCT00478777|450336727|FG000|Overall Study|Intolerance of therapy|1|||
125195485|NCT00478777|450336727|FG000|Overall Study|Lack of compliance|1|||
125195486|NCT00478777|450336727|FG000|Overall Study|Lymphocytes infusion|1|||
125195487|NCT00478777|450336727|FG000|Overall Study|End of therapy|2|||
125195488|NCT00478777|450336727|FG000|Overall Study|Not treated with lenalidomide|6|||
125195489|NCT01218087|450336728|FG000|Overall Study|Death|2|||
125195490|NCT01218087|450336729|FG001|Overall Study|Death|1|||
125195491|NCT01218087|450336728|FG000|Overall Study|Withdrawal by Subject|5|||
125195492|NCT01218087|450336729|FG001|Overall Study|Withdrawal by Subject|0|||
125195493|NCT01218087|450336728|FG000|Overall Study|Transferred|8|||
125195494|NCT01218087|450336729|FG001|Overall Study|Transferred|5|||
125195495|NCT00552396|450336730|FG000|Overall Study|protocol withdrawal criteria|3|||
125195496|NCT00552396|450336731|FG001|Overall Study|protocol withdrawal criteria|3|||
125195497|NCT00552396|450336732|FG002|Overall Study|protocol withdrawal criteria|3|||
125195498|NCT00552396|450336733|FG003|Overall Study|protocol withdrawal criteria|6|||
125195499|NCT00552396|450336734|FG004|Overall Study|protocol withdrawal criteria|3|||
125195500|NCT00552396|450336735|FG005|Overall Study|protocol withdrawal criteria|3|||
125195501|NCT00552396|450336736|FG006|Overall Study|protocol withdrawal criteria|9|||
125195502|NCT01323387|450336737|FG000|Overall Study|Withdrawal by Subject|41|||
125195503|NCT01323387|450336737|FG000|Overall Study|Radiographic Data Unavailable|1|||
125195504|NCT01323387|450336737|FG000|Overall Study|Revision|14|||
125195505|NCT01323387|450336737|FG000|Overall Study|Protocol Violation|12|||
125195506|NCT01323387|450336737|FG000|Overall Study|Randomized but Never Treated|16|||
125195507|NCT04185220|450336738|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
125195508|NCT04185220|450336739|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
125247911|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
125247912|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
125247913|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
125195509|NCT04185220|450336738|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
125247914|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
125247915|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
125247916|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
125247917|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
125247918|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
125247919|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
125247920|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
125247921|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
125247922|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
125247923|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
125247924|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
125247925|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
125247926|NCT00114777|450532738|FG000|Long-Term Extension to Month 84|Other|2|||
125247927|NCT00114777|450532739|FG001|Long-Term Extension to Month 84|Other|0|||
125247928|NCT00114777|450532740|FG002|Long-Term Extension to Month 84|Other|2|||
125247929|NCT00629239|450532741|FG000|Overall Study|Adverse Event|7|||
125247930|NCT00629239|450532742|FG001|Overall Study|Adverse Event|4|||
125247931|NCT00629239|450532741|FG000|Overall Study|Physician Decision|1|||
125247932|NCT00629239|450532742|FG001|Overall Study|Physician Decision|0|||
125247933|NCT02460380|450532743|FG000|Overall Study|Withdrawal by Subject|10|||
125247934|NCT02460380|450532744|FG001|Overall Study|Withdrawal by Subject|5|||
125247935|NCT03566550|450532750|FG000|Overall Study|Withdrawal by Subject|0|||
125247936|NCT03566550|450532751|FG001|Overall Study|Withdrawal by Subject|1|||
125247937|NCT00052715|450532758|FG000|Overall Study|wrong histology|1|||
125247938|NCT01210443|450532759|FG000|Overall Study|Study terminated by sponsor|2|||
125247939|NCT02807181|450532760|FG000|Overall Study|Death|28|||
125247940|NCT02807181|450532761|FG001|Overall Study|Death|24|||
125247941|NCT02807181|450532760|FG000|Overall Study|Withdrawal by Subject|1|||
125247942|NCT02807181|450532761|FG001|Overall Study|Withdrawal by Subject|1|||
125247943|NCT02807181|450532760|FG000|Overall Study|Lost to Follow-up|0|||
125247944|NCT02807181|450532761|FG001|Overall Study|Lost to Follow-up|2|||
125247945|NCT02807181|450532760|FG000|Overall Study|Subject decision|1|||
125247946|NCT02807181|450532761|FG001|Overall Study|Subject decision|0|||
125247947|NCT02807181|450532760|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
125247948|NCT02807181|450532761|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
125247949|NCT02807181|450532760|FG000|Overall Study|In Study|3|||
125247950|NCT02807181|450532761|FG001|Overall Study|In Study|3|||
125247951|NCT02807181|450532760|FG000|Overall Study|Post Progression|3|||
125247952|NCT02807181|450532761|FG001|Overall Study|Post Progression|2|||
125247953|NCT01063881|450532762|FG000|Overall Study|Adverse Event|12|||
125247954|NCT01063881|450532763|FG001|Overall Study|Adverse Event|2|||
125247955|NCT01063881|450532764|FG002|Overall Study|Adverse Event|0|||
125247956|NCT01063881|450532762|FG000|Overall Study|Lost to Follow-up|13|||
125247957|NCT01063881|450532763|FG001|Overall Study|Lost to Follow-up|7|||
125247958|NCT01063881|450532764|FG002|Overall Study|Lost to Follow-up|1|||
125247959|NCT01063881|450532762|FG000|Overall Study|Withdrawal by Subject|25|||
125247960|NCT01063881|450532763|FG001|Overall Study|Withdrawal by Subject|1|||
125247961|NCT01063881|450532764|FG002|Overall Study|Withdrawal by Subject|0|||
125247962|NCT01063881|450532762|FG000|Overall Study|Reason for not completed not specified|5|||
125247963|NCT01063881|450532763|FG001|Overall Study|Reason for not completed not specified|1|||
125247964|NCT01063881|450532764|FG002|Overall Study|Reason for not completed not specified|0|||
125247965|NCT01309100|450532765|FG000|Overall Study|Protocol Violation|1|||
125247966|NCT01309100|450532765|FG000|Overall Study|Positive Slit lamp finding|1|||
125247967|NCT04146909|450532773|FG000|Overall Study|Withdrawal by Subject|3|||
125247968|NCT04146909|450532773|FG000|Overall Study|Did not qualify after consented|1|||
125247969|NCT03808909|450532774|FG000|Overall Study|Lost to Follow-up|3|||
125247970|NCT03808909|450532775|FG001|Overall Study|Lost to Follow-up|0|||
125247971|NCT03335566|450532776|FG000|Overall Study|Adverse Event|0|||
125247972|NCT03335566|450532777|FG001|Overall Study|Adverse Event|1|||
125247973|NCT03335566|450532776|FG000|Overall Study|Lost to Follow-up|1|||
125247974|NCT03335566|450532777|FG001|Overall Study|Lost to Follow-up|0|||
125247975|NCT03335566|450532776|FG000|Overall Study|Technical Problems|1|||
125247976|NCT03335566|450532777|FG001|Overall Study|Technical Problems|0|||
125247977|NCT03335566|450532776|FG000|Overall Study|Protocol Violation|1|||
125247978|NCT03335566|450532777|FG001|Overall Study|Protocol Violation|0|||
125247979|NCT03335566|450532776|FG000|Overall Study|Other than specified above|1|||
125395514|NCT00048542|451081653|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
125395515|NCT00048542|451081654|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
125247980|NCT03335566|450532777|FG001|Overall Study|Other than specified above|2|||
125247981|NCT01084135|450532778|FG000|20 Week|Physician Decision|0|||
125247982|NCT01084135|450532779|FG001|20 Week|Physician Decision|1|||
125247983|NCT00663351|450532780|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
125247984|NCT00663351|450532781|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
125247985|NCT00663351|450532780|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
125195510|NCT04185220|450336739|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
125195511|NCT00767455|450336745|FG000|Overall Study|Investigator error|19|||
125195512|NCT00022698|450336749|FG000|Overall Study|Adverse Event|5|||
125195513|NCT00022698|450336750|FG001|Overall Study|Adverse Event|9|||
125195514|NCT00022698|450336749|FG000|Overall Study|Death|0|||
125195515|NCT00022698|450336750|FG001|Overall Study|Death|2|||
125195516|NCT00022698|450336749|FG000|Overall Study|Failure to return|0|||
125195517|NCT00022698|450336750|FG001|Overall Study|Failure to return|1|||
125195518|NCT00022698|450336749|FG000|Overall Study|Refused treatment|0|||
125195519|NCT00022698|450336750|FG001|Overall Study|Refused treatment|2|||
125195520|NCT00022698|450336749|FG000|Overall Study|Insufficient therapeutic response|2|||
125247986|NCT00663351|450532781|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
125247987|NCT00663351|450532780|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
125247988|NCT00663351|450532781|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
125247989|NCT00663351|450532780|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
125247990|NCT00663351|450532781|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
125247991|NCT00663351|450532780|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
125247992|NCT00663351|450532781|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
125247993|NCT00663351|450532780|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
125247994|NCT00663351|450532781|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
125247995|NCT02362412|450532782|FG000|Treatment Period III|Lost to Follow-up|0|||
125247996|NCT02362412|450532783|FG001|Treatment Period III|Lost to Follow-up|1|||
125247997|NCT03462563|450532784|FG000|Overall Study|Death|1|||
125247998|NCT03462563|450532785|FG001|Overall Study|Death|1|||
125247999|NCT03462563|450532784|FG000|Overall Study|Termination of study|2|||
125248000|NCT03462563|450532785|FG001|Overall Study|Termination of study|1|||
125248001|NCT03462563|450532784|FG000|Overall Study|Adverse Event|1|||
125248002|NCT03462563|450532785|FG001|Overall Study|Adverse Event|3|||
125248003|NCT03462563|450532784|FG000|Overall Study|Unspecified reason|10|||
125248004|NCT03462563|450532785|FG001|Overall Study|Unspecified reason|12|||
125248005|NCT03462563|450532784|FG000|Overall Study|Physician Decision|1|||
125248006|NCT03462563|450532785|FG001|Overall Study|Physician Decision|0|||
125248007|NCT05103332|450532786|FG000|Overall Study|Lost to Follow-up|0|||
125248008|NCT05103332|450532787|FG001|Overall Study|Lost to Follow-up|2|||
125248009|NCT05103332|450532788|FG002|Overall Study|Lost to Follow-up|1|||
125248010|NCT05103332|450532789|FG003|Overall Study|Lost to Follow-up|0|||
125248011|NCT05103332|450532790|FG004|Overall Study|Lost to Follow-up|0|||
125248012|NCT05103332|450532791|FG005|Overall Study|Lost to Follow-up|2|||
125248013|NCT05103332|450532786|FG000|Overall Study|Physician Decision|0|||
125248014|NCT05103332|450532787|FG001|Overall Study|Physician Decision|1|||
125248015|NCT05103332|450532788|FG002|Overall Study|Physician Decision|0|||
125248016|NCT05103332|450532789|FG003|Overall Study|Physician Decision|1|||
125248017|NCT05103332|450532790|FG004|Overall Study|Physician Decision|0|||
125248018|NCT05103332|450532791|FG005|Overall Study|Physician Decision|0|||
125248019|NCT05103332|450532786|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
125248020|NCT05103332|450532787|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
125248021|NCT05103332|450532788|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
125248022|NCT05103332|450532789|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
125248023|NCT05103332|450532790|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
125248024|NCT05103332|450532791|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
125248025|NCT05103332|450532786|FG000|Overall Study|Unspeccified|0|||
125248026|NCT05103332|450532787|FG001|Overall Study|Unspeccified|0|||
125248027|NCT05103332|450532788|FG002|Overall Study|Unspeccified|0|||
125248028|NCT05103332|450532789|FG003|Overall Study|Unspeccified|1|||
125248029|NCT05103332|450532790|FG004|Overall Study|Unspeccified|0|||
125248030|NCT05103332|450532791|FG005|Overall Study|Unspeccified|0|||
125248031|NCT02218268|450532792|FG000|24 Hour Washout|Physician Decision|11|||
125248032|NCT02218268|450532793|FG001|24 Hour Washout|Physician Decision|9|||
125248033|NCT03651336|450532794|FG000|Overall Study|Withdrawal by Subject|4|||
125248034|NCT01740427|450532795|FG000|Overall Study|Objective Progression or Relapse|286|||
125395516|NCT00048542|451081655|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
125195521|NCT00022698|450336750|FG001|Overall Study|Insufficient therapeutic response|14|||
125248035|NCT01740427|450532796|FG001|Overall Study|Objective Progression or Relapse|172|||
125248036|NCT01740427|450532795|FG000|Overall Study|Adverse Event|32|||
125248037|NCT01740427|450532796|FG001|Overall Study|Adverse Event|9|||
125248038|NCT01740427|450532795|FG000|Overall Study|Global Deterioration of Health Status|28|||
125248039|NCT01740427|450532796|FG001|Overall Study|Global Deterioration of Health Status|12|||
125248040|NCT01740427|450532795|FG000|Overall Study|Participant Refused Continued Treatment|27|||
125248041|NCT01740427|450532796|FG001|Overall Study|Participant Refused Continued Treatment|15|||
125248042|NCT01740427|450532795|FG000|Overall Study|Unspecified reasons|52|||
125248043|NCT01740427|450532796|FG001|Overall Study|Unspecified reasons|8|||
125248044|NCT01740427|450532795|FG000|Overall Study|Death|10|||
125195522|NCT00022698|450336749|FG000|Overall Study|Administrative /other|1|||
125248045|NCT01740427|450532796|FG001|Overall Study|Death|3|||
125248046|NCT01740427|450532795|FG000|Overall Study|Protocol Violation|5|||
125248047|NCT01740427|450532796|FG001|Overall Study|Protocol Violation|3|||
125248048|NCT01740427|450532795|FG000|Overall Study|Lost to Follow-up|3|||
125248049|NCT01740427|450532796|FG001|Overall Study|Lost to Follow-up|0|||
125248050|NCT01740427|450532795|FG000|Overall Study|Site Terminated by Sponsor|1|||
125248051|NCT01740427|450532796|FG001|Overall Study|Site Terminated by Sponsor|0|||
125248052|NCT04796207|450532799|FG000|Overall Study|Lost to Follow-up|7|||
125248053|NCT04796207|450532800|FG001|Overall Study|Lost to Follow-up|2|||
125248054|NCT00362609|450532801|FG000|Overall Study|Withdrawal by Subject|0|||
125248055|NCT00362609|450532802|FG001|Overall Study|Withdrawal by Subject|1|||
125248056|NCT00362609|450532801|FG000|Overall Study|Protocol Violation|0|||
125248057|NCT00362609|450532802|FG001|Overall Study|Protocol Violation|1|||
125248058|NCT01800058|450532811|FG000|Overall Study|Lost to Follow-up|1|||
125248059|NCT02186171|450532812|FG000|Overall Study|Withdrawal by Subject|1|||
125248060|NCT02186171|450532813|FG001|Overall Study|Withdrawal by Subject|9|||
125248061|NCT02186171|450532812|FG000|Overall Study|Lost to Follow-up|2|||
125248062|NCT02186171|450532813|FG001|Overall Study|Lost to Follow-up|2|||
125248063|NCT02186171|450532812|FG000|Overall Study|Death|1|||
125248064|NCT02186171|450532813|FG001|Overall Study|Death|2|||
125248065|NCT02186171|450532812|FG000|Overall Study|Protocol-specified Criteria|0|||
125248066|NCT02186171|450532813|FG001|Overall Study|Protocol-specified Criteria|2|||
125248067|NCT05206604|450534097|FG000|Overall Study|Non-compliance with study drug|0|||
125248068|NCT05206604|450534098|FG001|Overall Study|Non-compliance with study drug|0|||
125248069|NCT05206604|450534099|FG002|Overall Study|Non-compliance with study drug|0|||
125248070|NCT05206604|450534100|FG003|Overall Study|Non-compliance with study drug|0|||
125248071|NCT05206604|450534101|FG004|Overall Study|Non-compliance with study drug|0|||
125248072|NCT05206604|450534102|FG005|Overall Study|Non-compliance with study drug|1|||
125248073|NCT05206604|450534103|FG006|Overall Study|Non-compliance with study drug|0|||
125248074|NCT05206604|450534104|FG007|Overall Study|Non-compliance with study drug|0|||
125248075|NCT03735498|450534105|FG000|Overall Study|Withdrawal by Subject|3|||
125248076|NCT03735498|450534105|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
125248077|NCT03787212|450534107|FG000|Period 1|Study Termination|2|||
125248078|NCT03787212|450534108|FG001|Period 1|Study Termination|2|||
125248079|NCT02014103|450534109|FG000|Overall Study|Protocol Violation|7|||
125248080|NCT02014103|450534110|FG001|Overall Study|Protocol Violation|7|||
125248081|NCT02014103|450534109|FG000|Overall Study|Adverse Event|1|||
125248082|NCT02014103|450534110|FG001|Overall Study|Adverse Event|0|||
125248083|NCT02014103|450534109|FG000|Overall Study|Lost venous access|1|||
125248084|NCT02014103|450534110|FG001|Overall Study|Lost venous access|0|||
125248085|NCT02014103|450534109|FG000|Overall Study|Withdrawal by Subject|0|||
125248086|NCT02014103|450534110|FG001|Overall Study|Withdrawal by Subject|2|||
125248087|NCT00620035|450534111|FG000|Overall Study|Adverse Event|106|||
125248088|NCT00620035|450534111|FG000|Overall Study|Withdrawal of Informed Consent|1|||
125248089|NCT00620035|450534111|FG000|Overall Study|Other Reason|38|||
125248090|NCT04193176|450534113|FG000|Overall Study|Withdrawal by Subject|6|||
125248091|NCT04193176|450534114|FG001|Overall Study|Withdrawal by Subject|10|||
125248092|NCT01629563|450534115|FG000|Overall Study|Adverse Event|16|||
125248093|NCT01629563|450534116|FG001|Overall Study|Adverse Event|16|||
125248094|NCT01629563|450534115|FG000|Overall Study|Death|2|||
125248095|NCT01629563|450534116|FG001|Overall Study|Death|0|||
125248096|NCT01629563|450534115|FG000|Overall Study|Lack of Efficacy|2|||
125248097|NCT01629563|450534116|FG001|Overall Study|Lack of Efficacy|3|||
125248098|NCT01629563|450534115|FG000|Overall Study|Lost to Follow-up|1|||
125248099|NCT01629563|450534116|FG001|Overall Study|Lost to Follow-up|0|||
125248100|NCT01629563|450534115|FG000|Overall Study|Pregnancy|1|||
125248101|NCT01629563|450534116|FG001|Overall Study|Pregnancy|2|||
125248102|NCT01629563|450534115|FG000|Overall Study|Protocol Violation|0|||
125248103|NCT01629563|450534116|FG001|Overall Study|Protocol Violation|1|||
125248104|NCT01629563|450534115|FG000|Overall Study|Withdrawal by Subject|27|||
125248105|NCT01629563|450534116|FG001|Overall Study|Withdrawal by Subject|20|||
125248106|NCT01629563|450534115|FG000|Overall Study|surgery|0|||
125248107|NCT01629563|450534116|FG001|Overall Study|surgery|3|||
125248108|NCT01629563|450534115|FG000|Overall Study|Lack of return of menses|12|||
125248109|NCT01629563|450534116|FG001|Overall Study|Lack of return of menses|7|||
125248110|NCT01629563|450534115|FG000|Overall Study|Protocol Violation|0|||
125248111|NCT01629563|450534116|FG001|Overall Study|Protocol Violation|1|||
125248112|NCT02370394|450534117|FG000|Overall Study|Lost to Follow-up|2|||
125248113|NCT02370394|450534118|FG001|Overall Study|Lost to Follow-up|1|||
125248114|NCT02370394|450534117|FG000|Overall Study|Withdrawal by Subject|0|||
125248115|NCT02370394|450534118|FG001|Overall Study|Withdrawal by Subject|1|||
125248116|NCT01902303|450534120|FG000|Overall Study|Adverse Event|0|||
125248117|NCT01902303|450534121|FG001|Overall Study|Adverse Event|1|||
125248118|NCT01902303|450534120|FG000|Overall Study|Lost to Follow-up|0|||
125248119|NCT01902303|450534121|FG001|Overall Study|Lost to Follow-up|1|||
125248120|NCT01902303|450534120|FG000|Overall Study|Protocol Violation|2|||
125248121|NCT01902303|450534121|FG001|Overall Study|Protocol Violation|2|||
125248122|NCT01902303|450534120|FG000|Overall Study|subject lost investigational product|0|||
125248123|NCT01902303|450534121|FG001|Overall Study|subject lost investigational product|1|||
125248124|NCT01902303|450534120|FG000|Overall Study|Did not develop a cold sore|21|||
125248125|NCT01902303|450534121|FG001|Overall Study|Did not develop a cold sore|19|||
125248126|NCT02821000|450534122|FG000|Overall Study|Death|89|||
125248127|NCT02821000|450534122|FG000|Overall Study|Sponsor Decision|12|||
125248128|NCT02821000|450534122|FG000|Overall Study|Withdrawal by Subject|2|||
125248129|NCT00394472|450534130|FG000|Overall Study|Protocol Violation|1|||
125248130|NCT00394472|450534131|FG001|Overall Study|Protocol Violation|3|||
125248131|NCT00394472|450534130|FG000|Overall Study|incorrect enrolment|4|||
125248132|NCT00394472|450534131|FG001|Overall Study|incorrect enrolment|2|||
125248133|NCT00394472|450534130|FG000|Overall Study|Adverse Event|4|||
125248134|NCT00394472|450534131|FG001|Overall Study|Adverse Event|2|||
125248135|NCT00394472|450534130|FG000|Overall Study|Withdrawal by Subject|0|||
125248136|NCT00394472|450534131|FG001|Overall Study|Withdrawal by Subject|2|||
125248137|NCT00394472|450534130|FG000|Overall Study|Physician Decision|0|||
125248138|NCT00394472|450534131|FG001|Overall Study|Physician Decision|1|||
125248139|NCT00394472|450534130|FG000|Overall Study|Lost to Follow-up|0|||
125248140|NCT00394472|450534131|FG001|Overall Study|Lost to Follow-up|1|||
125248141|NCT02181621|450534132|FG000|Overall Study|Adverse Event|1|||
125248142|NCT02181621|450534133|FG001|Overall Study|Adverse Event|0|||
125248143|NCT02181621|450534132|FG000|Overall Study|Previously Enrolled|0|||
125248144|NCT02181621|450534133|FG001|Overall Study|Previously Enrolled|1|||
125248145|NCT02181621|450534132|FG000|Overall Study|Enrollment Hold|1|||
125248146|NCT02181621|450534133|FG001|Overall Study|Enrollment Hold|1|||
125248147|NCT00960856|450534134|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
125248148|NCT00960856|450534135|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
125248149|NCT00960856|450534136|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
125248150|NCT00960856|450534137|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
125248151|NCT00960856|450534134|FG000|Washout Period of 7 Days|Adverse Event|0|||
125248152|NCT00960856|450534135|FG001|Washout Period of 7 Days|Adverse Event|0|||
125248153|NCT00960856|450534136|FG002|Washout Period of 7 Days|Adverse Event|1|||
125248154|NCT00960856|450534137|FG003|Washout Period of 7 Days|Adverse Event|0|||
125248155|NCT03387046|450534139|FG000|Overall Study|Adverse Event|1|||
125248156|NCT03387046|450534140|FG001|Overall Study|Adverse Event|1|||
125248157|NCT01301001|450534152|FG000|First Intervention|Lost to Follow-up|4|||
125248158|NCT01301001|450534153|FG001|First Intervention|Lost to Follow-up|4|||
125248159|NCT01301001|450534152|FG000|First Intervention|Withdrawal by Subject|1|||
125248160|NCT01301001|450534153|FG001|First Intervention|Withdrawal by Subject|4|||
125248161|NCT01301001|450534152|FG000|First Intervention|Adverse Event|5|||
125248162|NCT01301001|450534153|FG001|First Intervention|Adverse Event|0|||
125248163|NCT01301001|450534152|FG000|First Intervention|Protocol Violation|0|||
125248164|NCT01301001|450534153|FG001|First Intervention|Protocol Violation|1|||
125248165|NCT01301001|450534152|FG000|Second Intervention|Adverse Event|2|||
125248166|NCT01301001|450534153|FG001|Second Intervention|Adverse Event|0|||
125248167|NCT01301001|450534152|FG000|Second Intervention|Withdrawal by Subject|2|||
125248168|NCT01301001|450534153|FG001|Second Intervention|Withdrawal by Subject|0|||
125248169|NCT01560988|450534154|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
125248170|NCT01560988|450534155|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
125248171|NCT01560988|450534154|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
125248172|NCT01560988|450534155|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
125248173|NCT01560988|450534154|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
125248174|NCT01560988|450534155|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
125248175|NCT01346709|450534156|FG000|Overall Study|Protocol Violation|35|||
125248176|NCT01346709|450534156|FG000|Overall Study|Lost to Follow-up|31|||
125248177|NCT01346709|450534156|FG000|Overall Study|Missing data in candidate risk factor|285|||
125248178|NCT00458705|450534161|FG000|Overall Study|Adverse Event|4|||
125248179|NCT00458705|450534161|FG000|Overall Study|Not Treated|1|||
125248180|NCT02565186|450534162|FG000|Overall Study|Adverse Event|113|||
125395517|NCT00048542|451081648|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
125395518|NCT00048542|451081649|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
125395519|NCT00048542|451081650|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
125395520|NCT00048542|451081651|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
125395521|NCT00048542|451081652|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
125248181|NCT02565186|450534163|FG001|Overall Study|Adverse Event|148|||
125248182|NCT02565186|450534162|FG000|Overall Study|Lost to Follow-up|102|||
125248183|NCT02565186|450534163|FG001|Overall Study|Lost to Follow-up|93|||
125248184|NCT02565186|450534162|FG000|Overall Study|Non-Compliance|57|||
125248185|NCT02565186|450534163|FG001|Overall Study|Non-Compliance|55|||
125248186|NCT02565186|450534162|FG000|Overall Study|Withdrawal by Subject|229|||
125248187|NCT02565186|450534163|FG001|Overall Study|Withdrawal by Subject|214|||
125248188|NCT02565186|450534162|FG000|Overall Study|Physician Decision|18|||
125248189|NCT02565186|450534163|FG001|Overall Study|Physician Decision|16|||
125248190|NCT02565186|450534162|FG000|Overall Study|Sponsor Request|5|||
125248191|NCT02565186|450534163|FG001|Overall Study|Sponsor Request|9|||
125248192|NCT02565186|450534162|FG000|Overall Study|Missing|1|||
125248193|NCT02565186|450534163|FG001|Overall Study|Missing|0|||
125395522|NCT00048542|451081653|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
125395523|NCT00048542|451081654|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
125395524|NCT00048542|451081655|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
125395525|NCT00048542|451081648|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
125395526|NCT00048542|451081649|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
125395527|NCT00048542|451081650|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
125195523|NCT00022698|450336750|FG001|Overall Study|Administrative /other|7|||
125195524|NCT03425396|450336751|FG000|Overall Study|Lost to Follow-up|2|||
125195525|NCT03425396|450336752|FG001|Overall Study|Lost to Follow-up|5|||
125195526|NCT03425396|450336753|FG002|Overall Study|Lost to Follow-up|2|||
125195527|NCT03425396|450336754|FG003|Overall Study|Lost to Follow-up|0|||
125195528|NCT03425396|450336755|FG004|Overall Study|Lost to Follow-up|0|||
125195529|NCT03425396|450336751|FG000|Overall Study|Withdrawal by Subject|0|||
125195530|NCT03425396|450336752|FG001|Overall Study|Withdrawal by Subject|1|||
125195531|NCT03425396|450336753|FG002|Overall Study|Withdrawal by Subject|0|||
125195532|NCT03425396|450336754|FG003|Overall Study|Withdrawal by Subject|1|||
125195533|NCT03425396|450336755|FG004|Overall Study|Withdrawal by Subject|0|||
125195534|NCT03425396|450336751|FG000|Overall Study|Other|0|||
125195535|NCT03425396|450336752|FG001|Overall Study|Other|1|||
125195536|NCT03425396|450336753|FG002|Overall Study|Other|1|||
125195537|NCT03425396|450336754|FG003|Overall Study|Other|0|||
125195538|NCT03425396|450336755|FG004|Overall Study|Other|1|||
125195539|NCT03689374|450336757|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
125195540|NCT03689374|450336758|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
125195541|NCT03689374|450336759|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
125195542|NCT03689374|450336757|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
125195543|NCT03689374|450336758|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
125195544|NCT03689374|450336759|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
125195545|NCT03689374|450336757|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
125195546|NCT03689374|450336758|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
125195547|NCT03689374|450336759|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
125195548|NCT03689374|450336757|FG000|Treatment Period (Week 0 to 52)|Death|0|||
125195549|NCT03689374|450336758|FG001|Treatment Period (Week 0 to 52)|Death|11|||
125195550|NCT03689374|450336759|FG002|Treatment Period (Week 0 to 52)|Death|1|||
125195551|NCT05088603|450337881|FG000|Overall Study|Protocol Violation|6|||
125195552|NCT05088603|450337882|FG001|Overall Study|Protocol Violation|1|||
125195553|NCT00594100|450337885|FG000|Procedure|Technical Failure|9|||
125195554|NCT00594100|450337885|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
125195555|NCT00594100|450337885|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
125195556|NCT00594100|450337885|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
125195557|NCT03981900|450337886|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
125195558|NCT03981900|450337886|FG000|Overall Study|Adverse Event|5|||
125195559|NCT03981900|450337886|FG000|Overall Study|Protocol Violation|1|||
125195560|NCT03981900|450337886|FG000|Overall Study|Withdrawal by Subject|7|||
125195561|NCT03981900|450337886|FG000|Overall Study|Lost to Follow-up|46|||
125195562|NCT03981900|450337886|FG000|Overall Study|Decision of the researcher|3|||
125195563|NCT03981900|450337886|FG000|Overall Study|Death|3|||
125195564|NCT03981900|450337886|FG000|Overall Study|Other|5|||
125195565|NCT02162719|450337887|FG000|Overall Study|Death|41|||
125195566|NCT02162719|450337888|FG001|Overall Study|Death|46|||
125195567|NCT02162719|450337887|FG000|Overall Study|Lost to Follow-up|1|||
125195568|NCT02162719|450337888|FG001|Overall Study|Lost to Follow-up|3|||
125195569|NCT02162719|450337887|FG000|Overall Study|Disease Progression|2|||
125195570|NCT02162719|450337888|FG001|Overall Study|Disease Progression|1|||
125195571|NCT02162719|450337887|FG000|Overall Study|Withdrawal by Subject|8|||
125195572|NCT02162719|450337888|FG001|Overall Study|Withdrawal by Subject|2|||
125195573|NCT02162719|450337887|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
125195574|NCT02162719|450337888|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
125195575|NCT01931475|450337891|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
125195576|NCT01931475|450337892|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
125195577|NCT01931475|450337891|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
125395528|NCT00048542|451081651|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
125443731|NCT01473420|451252244|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
125195578|NCT01931475|450337892|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
125195579|NCT01931475|450337891|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
125195580|NCT01931475|450337892|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
125195581|NCT01931475|450337891|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
125195582|NCT01931475|450337892|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
125443732|NCT01473420|451252245|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
125195583|NCT01931475|450337891|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
125195584|NCT01931475|450337892|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
125195585|NCT01931475|450337891|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
125195586|NCT01931475|450337892|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
125195587|NCT01931475|450337891|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
125195588|NCT01931475|450337892|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
125195589|NCT01931475|450337891|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
125195590|NCT01931475|450337892|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
125195591|NCT01931475|450337891|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
125195592|NCT01931475|450337892|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
125195593|NCT01931475|450337891|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
125195594|NCT01931475|450337892|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
125195595|NCT01931475|450337891|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
125195596|NCT01931475|450337892|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
125195597|NCT04292912|450337895|FG000|Overall Study|Physician Decision|1|||
125195598|NCT04292912|450337895|FG000|Overall Study|Protocol Violation|6|||
125195599|NCT05338502|450337905|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
125195600|NCT05338502|450337906|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
125195601|NCT05338502|450337907|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
125195602|NCT05338502|450337905|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
125195603|NCT05338502|450337906|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
125195604|NCT05338502|450337907|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
125195605|NCT03575793|450337914|FG000|Overall Study|Withdrawal by Subject|0|||
125195606|NCT03575793|450337915|FG001|Overall Study|Withdrawal by Subject|1|||
125195607|NCT03575793|450337914|FG000|Overall Study|Never Treated|0|||
125195608|NCT03575793|450337915|FG001|Overall Study|Never Treated|2|||
125195609|NCT01250873|450337916|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
125195610|NCT01250873|450337916|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
125195611|NCT02278939|450337917|FG000|Overall Study|lack of time|1|||
125195612|NCT02278939|450337918|FG001|Overall Study|lack of time|0|||
125195613|NCT02278939|450337917|FG000|Overall Study|Lost to Follow-up|1|||
125195614|NCT02278939|450337918|FG001|Overall Study|Lost to Follow-up|1|||
125195615|NCT02278939|450337917|FG000|Overall Study|death in family|1|||
125195616|NCT02278939|450337918|FG001|Overall Study|death in family|0|||
125195617|NCT02278939|450337917|FG000|Overall Study|family emergency unable to commit|2|||
125195618|NCT02278939|450337918|FG001|Overall Study|family emergency unable to commit|0|||
125195619|NCT01127451|450337923|FG000|Overall Study|Other|2|||
125195620|NCT01127451|450337924|FG001|Overall Study|Other|1|||
125195621|NCT01127451|450337923|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
125195622|NCT01127451|450337924|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
125195623|NCT01127451|450337923|FG000|Overall Study|Death|22|||
125195624|NCT01127451|450337924|FG001|Overall Study|Death|17|||
125195625|NCT01127451|450337923|FG000|Overall Study|Lost to Follow-up|3|||
125195626|NCT01127451|450337924|FG001|Overall Study|Lost to Follow-up|0|||
125195627|NCT01127451|450337923|FG000|Overall Study|Administrative Reason by Sponsor|2|||
125195628|NCT01127451|450337924|FG001|Overall Study|Administrative Reason by Sponsor|2|||
125195629|NCT00930774|450337925|FG000|Overall Study|Withdrawal by Subject|1|||
125195630|NCT00930774|450337926|FG001|Overall Study|Withdrawal by Subject|9|||
125195631|NCT00930774|450337927|FG002|Overall Study|Withdrawal by Subject|2|||
125195632|NCT00930774|450337928|FG003|Overall Study|Withdrawal by Subject|0|||
125195633|NCT01680861|450337929|FG000|Early Post-transplant Period|Protocol Violation|1|||
125195634|NCT01680861|450337930|FG001|Early Post-transplant Period|Protocol Violation|1|||
125195635|NCT01940887|450337933|FG000|Year 1|Protocol Violation|0|||
125195636|NCT01940887|450337934|FG001|Year 1|Protocol Violation|1|||
125195637|NCT01940887|450337933|FG000|Year 1|Physician Decision|7|||
125195638|NCT01940887|450337934|FG001|Year 1|Physician Decision|3|||
125195639|NCT01940887|450337933|FG000|Year 1|Death|5|||
125195640|NCT01940887|450337934|FG001|Year 1|Death|3|||
125195641|NCT01940887|450337933|FG000|Year 1|Adverse Event|7|||
125195642|NCT01940887|450337934|FG001|Year 1|Adverse Event|6|||
125195643|NCT01940887|450337933|FG000|Year 1|Withdrawal by Subject|18|||
125195644|NCT01940887|450337934|FG001|Year 1|Withdrawal by Subject|9|||
125195645|NCT01940887|450337933|FG000|Year 1|Lost to Follow-up|2|||
125195646|NCT01940887|450337934|FG001|Year 1|Lost to Follow-up|1|||
125195647|NCT01940887|450337933|FG000|Year 2|Physician Decision|8|||
125195648|NCT01940887|450337934|FG001|Year 2|Physician Decision|1|||
125195649|NCT01940887|450337933|FG000|Year 2|Death|0|||
125195650|NCT01940887|450337934|FG001|Year 2|Death|2|||
125195651|NCT01940887|450337933|FG000|Year 2|Sponsor Decision, early termination|192|||
125195652|NCT01940887|450337934|FG001|Year 2|Sponsor Decision, early termination|203|||
125195653|NCT01940887|450337933|FG000|Year 2|Adverse Event|8|||
125195654|NCT01940887|450337934|FG001|Year 2|Adverse Event|2|||
125195655|NCT01940887|450337933|FG000|Year 2|Withdrawal by Subject|8|||
125195656|NCT01940887|450337934|FG001|Year 2|Withdrawal by Subject|8|||
125195657|NCT01940887|450337933|FG000|Year 2|Lost to Follow-up|1|||
125195658|NCT01940887|450337934|FG001|Year 2|Lost to Follow-up|6|||
125195659|NCT02475265|450337937|FG000|Overall Study|Physician Decision|1|||
125395529|NCT00048542|451081652|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
125395530|NCT00048542|451081653|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
125395531|NCT00048542|451081654|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
125395532|NCT00048542|451081655|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
125395533|NCT00048542|451081648|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
125395534|NCT00048542|451081649|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
125395535|NCT00048542|451081650|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
125395536|NCT00048542|451081651|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
125395537|NCT00048542|451081652|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
125395538|NCT00048542|451081653|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
125395539|NCT00048542|451081654|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
125395540|NCT00048542|451081655|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
125395541|NCT00578175|451081656|FG000|Overall Study|Adverse Event|0|||
125395542|NCT00578175|451081657|FG001|Overall Study|Adverse Event|1|||
125395543|NCT00578175|451081658|FG002|Overall Study|Adverse Event|1|||
125395544|NCT00578175|451081656|FG000|Overall Study|Other reasons|70|||
125395545|NCT00578175|451081657|FG001|Overall Study|Other reasons|42|||
125395546|NCT00578175|451081658|FG002|Overall Study|Other reasons|23|||
125395547|NCT02272413|451081660|FG000|Randomized Through Treatment Start|Not treated|3|||
125395548|NCT02272413|451081661|FG001|Randomized Through Treatment Start|Not treated|5|||
125395549|NCT02272413|451081660|FG000|Pre-switch Period|Adverse Event|38|||
125395550|NCT02272413|451081661|FG001|Pre-switch Period|Adverse Event|37|||
125395551|NCT02272413|451081660|FG000|Pre-switch Period|Death|26|||
125395552|NCT02272413|451081661|FG001|Pre-switch Period|Death|26|||
125395553|NCT02272413|451081660|FG000|Pre-switch Period|Withdrawal by Subject|27|||
125395554|NCT02272413|451081661|FG001|Pre-switch Period|Withdrawal by Subject|15|||
125395555|NCT02272413|451081660|FG000|Pre-switch Period|Physician Decision|6|||
125395556|NCT02272413|451081661|FG001|Pre-switch Period|Physician Decision|18|||
125395557|NCT02272413|451081660|FG000|Pre-switch Period|Progressive disease|185|||
125395558|NCT02272413|451081661|FG001|Pre-switch Period|Progressive disease|173|||
125395559|NCT02272413|451081660|FG000|Pre-switch Period|Lost to Follow-up|0|||
125395560|NCT02272413|451081661|FG001|Pre-switch Period|Lost to Follow-up|2|||
125395561|NCT02272413|451081660|FG000|Pre-switch Period|Protocol Violation|1|||
125395562|NCT02272413|451081661|FG001|Pre-switch Period|Protocol Violation|0|||
125395563|NCT02272413|451081660|FG000|Pre-switch Period|Other than listed|10|||
125395564|NCT02272413|451081661|FG001|Pre-switch Period|Other than listed|11|||
125395565|NCT02272413|451081660|FG000|Post-switch Period|Adverse Event|4|||
125395566|NCT02272413|451081661|FG001|Post-switch Period|Adverse Event|4|||
125395567|NCT02272413|451081660|FG000|Post-switch Period|Death|3|||
125395568|NCT02272413|451081661|FG001|Post-switch Period|Death|2|||
125395569|NCT02272413|451081660|FG000|Post-switch Period|Withdrawal by Subject|1|||
125395570|NCT02272413|451081661|FG001|Post-switch Period|Withdrawal by Subject|2|||
125395571|NCT02272413|451081660|FG000|Post-switch Period|Physician Decision|1|||
125395572|NCT02272413|451081661|FG001|Post-switch Period|Physician Decision|1|||
125395573|NCT02272413|451081660|FG000|Post-switch Period|Progressive disease|21|||
125395574|NCT02272413|451081661|FG001|Post-switch Period|Progressive disease|21|||
125395575|NCT02272413|451081660|FG000|Post-switch Period|Study terminated by sponsor|8|||
125395576|NCT02272413|451081661|FG001|Post-switch Period|Study terminated by sponsor|11|||
125395577|NCT02272413|451081660|FG000|Post-switch Period|Other than listed|4|||
125395578|NCT02272413|451081661|FG001|Post-switch Period|Other than listed|5|||
125195660|NCT02475265|450337937|FG000|Overall Study|Withdrawal by Subject|2|||
125395579|NCT02126969|451081662|FG000|Overall Study|Withdrawal by Subject|1|||
125395580|NCT02126969|451081663|FG001|Overall Study|Withdrawal by Subject|2|||
125395581|NCT01533246|451081664|FG000|Overall Study|Adverse Event|1|||
125395582|NCT01533246|451081664|FG000|Overall Study|Withdrawal by Subject|1|||
125395583|NCT04370691|451081667|FG000|Overall Study|Pending visit|48|||
125395584|NCT04370691|451081667|FG000|Overall Study|Have Not Reached Lower Window|15|||
125395585|NCT04370691|451081667|FG000|Overall Study|Termination|14|||
125395586|NCT04370691|451081667|FG000|Overall Study|Missed or Overdue|10|||
125395587|NCT03013543|451081670|FG000|Overall Study|Withdrawal by Subject|0|||
125395588|NCT03013543|451081671|FG001|Overall Study|Withdrawal by Subject|2|||
125395589|NCT03013543|451081672|FG002|Overall Study|Withdrawal by Subject|0|||
125395590|NCT03013543|451081673|FG003|Overall Study|Withdrawal by Subject|5|||
125395591|NCT03013543|451081674|FG004|Overall Study|Withdrawal by Subject|6|||
125395592|NCT03013543|451081675|FG005|Overall Study|Withdrawal by Subject|2|||
125195661|NCT01598090|450337938|FG000|Treatment Period|Poor/non-compliance|0|||
125195662|NCT01598090|450337939|FG001|Treatment Period|Poor/non-compliance|2|||
125195663|NCT01598090|450337940|FG002|Treatment Period|Poor/non-compliance|0|||
125395593|NCT03013543|451081676|FG006|Overall Study|Withdrawal by Subject|3|||
125195664|NCT01598090|450337938|FG000|Treatment Period|No longer meet study criteria|0|||
125195665|NCT01598090|450337939|FG001|Treatment Period|No longer meet study criteria|1|||
125395594|NCT03013543|451081677|FG007|Overall Study|Withdrawal by Subject|1|||
125395595|NCT03013543|451081678|FG008|Overall Study|Withdrawal by Subject|0|||
125395596|NCT03013543|451081679|FG009|Overall Study|Withdrawal by Subject|4|||
125248194|NCT02565186|450534162|FG000|Overall Study|Did Not Receive Study Drug|55|||
125248195|NCT02565186|450534163|FG001|Overall Study|Did Not Receive Study Drug|86|||
125248196|NCT00337194|450534164|FG000|Overall Study|Adverse Event|5|||
125248197|NCT00337194|450534165|FG001|Overall Study|Adverse Event|1|||
125248198|NCT00337194|450534164|FG000|Overall Study|Death|2|||
125248199|NCT00337194|450534165|FG001|Overall Study|Death|0|||
125248200|NCT00337194|450534164|FG000|Overall Study|Withdrawal by Subject|1|||
125248201|NCT00337194|450534165|FG001|Overall Study|Withdrawal by Subject|0|||
125248202|NCT00337194|450534164|FG000|Overall Study|Disease progression|1|||
125248203|NCT00337194|450534165|FG001|Overall Study|Disease progression|2|||
125248204|NCT00337194|450534164|FG000|Overall Study|Subsequent non-protocol therapy|3|||
125248205|NCT00337194|450534165|FG001|Overall Study|Subsequent non-protocol therapy|1|||
125248206|NCT03188705|450534166|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
125248207|NCT03188705|450534166|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
125248208|NCT01174459|450534167|FG000|Overall Study|case report form (CRF) not collected|5|||
125248209|NCT01623752|450534168|FG000|Phase 1 (78 Weeks)|No Data|249|||
125395597|NCT03013543|451081670|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
125395598|NCT03013543|451081671|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
125395599|NCT03013543|451081672|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
125248210|NCT01623752|450534169|FG001|Phase 1 (78 Weeks)|No Data|66|||
125248211|NCT01623752|450534170|FG002|Phase 1 (78 Weeks)|No Data|2|||
125248212|NCT01623752|450534168|FG000|Phase 1 (78 Weeks)|Other|33|||
125248213|NCT01623752|450534169|FG001|Phase 1 (78 Weeks)|Other|20|||
125248214|NCT01623752|450534170|FG002|Phase 1 (78 Weeks)|Other|0|||
125248215|NCT01623752|450534168|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
125248216|NCT01623752|450534169|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
125248217|NCT01623752|450534170|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
125248218|NCT01623752|450534168|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
125248219|NCT01623752|450534169|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
125248220|NCT01623752|450534170|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
125248221|NCT01623752|450534168|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
125248222|NCT01623752|450534169|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
125248223|NCT01623752|450534170|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
125248224|NCT01623752|450534168|FG000|Phase 2 (78 Weeks)|Other|5|||
125248225|NCT01623752|450534169|FG001|Phase 2 (78 Weeks)|Other|1|||
125248226|NCT01623752|450534170|FG002|Phase 2 (78 Weeks)|Other|0|||
125248227|NCT01623752|450534168|FG000|Phase 2 (78 Weeks)|No Data|43|||
125248228|NCT01623752|450534169|FG001|Phase 2 (78 Weeks)|No Data|11|||
125248229|NCT01623752|450534170|FG002|Phase 2 (78 Weeks)|No Data|0|||
125248230|NCT01623752|450534168|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
125248231|NCT01623752|450534169|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
125248232|NCT01623752|450534170|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
125248233|NCT03994120|450534171|FG000|Overall Study|Lost to Follow-up|3|||
125248234|NCT03994120|450534172|FG001|Overall Study|Lost to Follow-up|1|||
125248235|NCT03511066|450534173|FG000|Overall Study|Withdrawal by Subject|1|||
125248236|NCT03511066|450534174|FG001|Overall Study|Withdrawal by Subject|2|||
125248237|NCT03511066|450534175|FG002|Overall Study|Withdrawal by Subject|3|||
125248238|NCT03511066|450534173|FG000|Overall Study|Lost to Follow-up|2|||
125248239|NCT03511066|450534174|FG001|Overall Study|Lost to Follow-up|3|||
125248240|NCT03511066|450534175|FG002|Overall Study|Lost to Follow-up|0|||
125248241|NCT00165698|450534178|FG000|Overall Study|Adverse Event|2|||
125248242|NCT00165698|450534179|FG001|Overall Study|Adverse Event|10|||
125248243|NCT00165698|450534178|FG000|Overall Study|Lost to Follow-up|2|||
125248244|NCT00165698|450534179|FG001|Overall Study|Lost to Follow-up|2|||
125248245|NCT00165698|450534178|FG000|Overall Study|Withdrawal by Subject|2|||
125248246|NCT00165698|450534179|FG001|Overall Study|Withdrawal by Subject|1|||
125248247|NCT00165698|450534178|FG000|Overall Study|Protocol Violation|1|||
125248248|NCT00165698|450534179|FG001|Overall Study|Protocol Violation|0|||
125248249|NCT00165698|450534178|FG000|Overall Study|Not Taken/Lost the medicine|1|||
125248250|NCT00165698|450534179|FG001|Overall Study|Not Taken/Lost the medicine|2|||
125248251|NCT03679884|450534180|FG000|Overall Study|Other|12|||
125248252|NCT03679884|450534181|FG001|Overall Study|Other|12|||
125248253|NCT03679884|450534182|FG002|Overall Study|Other|12|||
125248254|NCT03679884|450534183|FG003|Overall Study|Other|7|||
125248255|NCT03679884|450534184|FG004|Overall Study|Other|8|||
125248256|NCT03679884|450534180|FG000|Overall Study|Lack of Efficacy|15|||
125248257|NCT03679884|450534181|FG001|Overall Study|Lack of Efficacy|29|||
125248258|NCT03679884|450534182|FG002|Overall Study|Lack of Efficacy|13|||
125248259|NCT03679884|450534183|FG003|Overall Study|Lack of Efficacy|29|||
125248260|NCT03679884|450534184|FG004|Overall Study|Lack of Efficacy|10|||
125248261|NCT03679884|450534180|FG000|Overall Study|Death|1|||
125248262|NCT03679884|450534181|FG001|Overall Study|Death|0|||
125395600|NCT03013543|451081673|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
125248263|NCT03679884|450534182|FG002|Overall Study|Death|0|||
125248264|NCT03679884|450534183|FG003|Overall Study|Death|0|||
125248265|NCT03679884|450534184|FG004|Overall Study|Death|0|||
125248266|NCT03679884|450534180|FG000|Overall Study|Adverse Event|2|||
125248267|NCT03679884|450534181|FG001|Overall Study|Adverse Event|10|||
125395601|NCT03013543|451081674|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
125248268|NCT03679884|450534182|FG002|Overall Study|Adverse Event|9|||
125248269|NCT03679884|450534183|FG003|Overall Study|Adverse Event|6|||
125248270|NCT03679884|450534184|FG004|Overall Study|Adverse Event|6|||
125248271|NCT03679884|450534180|FG000|Overall Study|Withdrawal by Subject|12|||
125248272|NCT03679884|450534181|FG001|Overall Study|Withdrawal by Subject|23|||
125248273|NCT03679884|450534182|FG002|Overall Study|Withdrawal by Subject|8|||
125248274|NCT03679884|450534183|FG003|Overall Study|Withdrawal by Subject|8|||
125248275|NCT03679884|450534184|FG004|Overall Study|Withdrawal by Subject|9|||
125248276|NCT03679884|450534180|FG000|Overall Study|Lost to Follow-up|1|||
125248277|NCT03679884|450534181|FG001|Overall Study|Lost to Follow-up|4|||
125248278|NCT03679884|450534182|FG002|Overall Study|Lost to Follow-up|2|||
125248279|NCT03679884|450534183|FG003|Overall Study|Lost to Follow-up|0|||
125248280|NCT03679884|450534184|FG004|Overall Study|Lost to Follow-up|3|||
125248281|NCT01107457|450534185|FG000|Part A|Adverse Event|1|||
125248282|NCT01107457|450534186|FG001|Part A|Adverse Event|2|||
125248283|NCT01107457|450534187|FG002|Part A|Adverse Event|1|||
125248284|NCT01107457|450534188|FG003|Part A|Adverse Event|0|||
125248285|NCT01107457|450534189|FG004|Part A|Adverse Event|0|||
125248286|NCT01107457|450534190|FG005|Part A|Adverse Event|0|||
125248287|NCT01107457|450534185|FG000|Part A|Withdrawal by Subject|3|||
125248288|NCT01107457|450534186|FG001|Part A|Withdrawal by Subject|3|||
125248289|NCT01107457|450534187|FG002|Part A|Withdrawal by Subject|0|||
125248290|NCT01107457|450534188|FG003|Part A|Withdrawal by Subject|3|||
125248291|NCT01107457|450534189|FG004|Part A|Withdrawal by Subject|1|||
125248292|NCT01107457|450534190|FG005|Part A|Withdrawal by Subject|0|||
125248293|NCT01107457|450534185|FG000|Part A|Lost to Follow-up|0|||
125248294|NCT01107457|450534186|FG001|Part A|Lost to Follow-up|1|||
125248295|NCT01107457|450534187|FG002|Part A|Lost to Follow-up|0|||
125248296|NCT01107457|450534188|FG003|Part A|Lost to Follow-up|0|||
125248297|NCT01107457|450534189|FG004|Part A|Lost to Follow-up|0|||
125248298|NCT01107457|450534190|FG005|Part A|Lost to Follow-up|0|||
125395602|NCT03013543|451081675|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
125395603|NCT03013543|451081676|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
125395604|NCT03013543|451081677|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
125395605|NCT03013543|451081678|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
125395606|NCT03013543|451081679|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
125395607|NCT03013543|451081670|FG000|Overall Study|Other|0|||
125395608|NCT03013543|451081671|FG001|Overall Study|Other|0|||
125395609|NCT03013543|451081672|FG002|Overall Study|Other|2|||
125395610|NCT03013543|451081673|FG003|Overall Study|Other|0|||
125395611|NCT03013543|451081674|FG004|Overall Study|Other|2|||
125395612|NCT03013543|451081675|FG005|Overall Study|Other|0|||
125395613|NCT03013543|451081676|FG006|Overall Study|Other|0|||
125395614|NCT03013543|451081677|FG007|Overall Study|Other|0|||
125395615|NCT03013543|451081678|FG008|Overall Study|Other|1|||
125395616|NCT03013543|451081679|FG009|Overall Study|Other|0|||
125395617|NCT03013543|451081670|FG000|Overall Study|Adverse Event|0|||
125395618|NCT03013543|451081671|FG001|Overall Study|Adverse Event|0|||
125395619|NCT03013543|451081672|FG002|Overall Study|Adverse Event|0|||
125395620|NCT03013543|451081673|FG003|Overall Study|Adverse Event|3|||
125395621|NCT03013543|451081674|FG004|Overall Study|Adverse Event|2|||
125395622|NCT03013543|451081675|FG005|Overall Study|Adverse Event|1|||
125395623|NCT03013543|451081676|FG006|Overall Study|Adverse Event|3|||
125395624|NCT03013543|451081677|FG007|Overall Study|Adverse Event|8|||
125395625|NCT03013543|451081678|FG008|Overall Study|Adverse Event|0|||
125395626|NCT03013543|451081679|FG009|Overall Study|Adverse Event|2|||
125395627|NCT03013543|451081670|FG000|Overall Study|Death|0|||
125395628|NCT03013543|451081671|FG001|Overall Study|Death|0|||
125395629|NCT03013543|451081672|FG002|Overall Study|Death|0|||
125395630|NCT03013543|451081673|FG003|Overall Study|Death|1|||
125395631|NCT03013543|451081674|FG004|Overall Study|Death|0|||
125395632|NCT03013543|451081675|FG005|Overall Study|Death|0|||
125395633|NCT03013543|451081676|FG006|Overall Study|Death|0|||
125395634|NCT03013543|451081677|FG007|Overall Study|Death|0|||
125443733|NCT01473420|451252244|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
125248299|NCT01107457|450534185|FG000|Part A|Lack of Efficacy|1|||
125248300|NCT01107457|450534186|FG001|Part A|Lack of Efficacy|0|||
125248301|NCT01107457|450534187|FG002|Part A|Lack of Efficacy|0|||
125248302|NCT01107457|450534188|FG003|Part A|Lack of Efficacy|0|||
125248303|NCT01107457|450534189|FG004|Part A|Lack of Efficacy|0|||
125248304|NCT01107457|450534190|FG005|Part A|Lack of Efficacy|0|||
125248305|NCT01107457|450534185|FG000|Part A|Protocol Violation|0|||
125248306|NCT01107457|450534186|FG001|Part A|Protocol Violation|1|||
125248307|NCT01107457|450534187|FG002|Part A|Protocol Violation|0|||
125248308|NCT01107457|450534188|FG003|Part A|Protocol Violation|0|||
125395635|NCT03013543|451081678|FG008|Overall Study|Death|0|||
125395636|NCT03013543|451081679|FG009|Overall Study|Death|0|||
125395637|NCT03013543|451081670|FG000|Overall Study|Lack of Efficacy|0|||
125395638|NCT03013543|451081671|FG001|Overall Study|Lack of Efficacy|0|||
125395639|NCT03013543|451081672|FG002|Overall Study|Lack of Efficacy|0|||
125395640|NCT03013543|451081673|FG003|Overall Study|Lack of Efficacy|1|||
125395641|NCT03013543|451081674|FG004|Overall Study|Lack of Efficacy|0|||
125395642|NCT03013543|451081675|FG005|Overall Study|Lack of Efficacy|0|||
125195666|NCT01598090|450337940|FG002|Treatment Period|No longer meet study criteria|0|||
125195667|NCT01598090|450337938|FG000|Treatment Period|Lack of Efficacy|5|||
125195668|NCT01598090|450337939|FG001|Treatment Period|Lack of Efficacy|14|||
125195669|NCT01598090|450337940|FG002|Treatment Period|Lack of Efficacy|6|||
125195670|NCT01598090|450337938|FG000|Treatment Period|Adverse Event|2|||
125195671|NCT01598090|450337939|FG001|Treatment Period|Adverse Event|33|||
125195672|NCT01598090|450337940|FG002|Treatment Period|Adverse Event|17|||
125195673|NCT01598090|450337938|FG000|Treatment Period|Other reasons|0|||
125195674|NCT01598090|450337939|FG001|Treatment Period|Other reasons|4|||
125195675|NCT01598090|450337940|FG002|Treatment Period|Other reasons|1|||
125195676|NCT01598090|450337938|FG000|Treatment Period|Withdrawal by Subject|3|||
125195677|NCT01598090|450337939|FG001|Treatment Period|Withdrawal by Subject|13|||
125195678|NCT01598090|450337940|FG002|Treatment Period|Withdrawal by Subject|10|||
125195679|NCT01598090|450337938|FG000|Treatment Period|Lost to Follow-up|1|||
125195680|NCT01598090|450337939|FG001|Treatment Period|Lost to Follow-up|5|||
125195681|NCT01598090|450337940|FG002|Treatment Period|Lost to Follow-up|1|||
125195682|NCT01598090|450337938|FG000|Follow-up Period|Death|0|||
125195683|NCT01598090|450337939|FG001|Follow-up Period|Death|1|||
125195684|NCT01598090|450337940|FG002|Follow-up Period|Death|0|||
125195685|NCT01598090|450337938|FG000|Follow-up Period|No longer required per protocol|1|||
125195686|NCT01598090|450337939|FG001|Follow-up Period|No longer required per protocol|3|||
125195687|NCT01598090|450337940|FG002|Follow-up Period|No longer required per protocol|2|||
125195688|NCT01598090|450337938|FG000|Follow-up Period|Not reported|0|||
125195689|NCT01598090|450337939|FG001|Follow-up Period|Not reported|10|||
125195690|NCT01598090|450337940|FG002|Follow-up Period|Not reported|4|||
125195691|NCT01598090|450337938|FG000|Follow-up Period|Withdrawal by Subject|0|||
125195692|NCT01598090|450337939|FG001|Follow-up Period|Withdrawal by Subject|3|||
125195693|NCT01598090|450337940|FG002|Follow-up Period|Withdrawal by Subject|2|||
125195694|NCT01598090|450337938|FG000|Follow-up Period|Other reasons|2|||
125195695|NCT01598090|450337939|FG001|Follow-up Period|Other reasons|8|||
125195696|NCT01598090|450337940|FG002|Follow-up Period|Other reasons|8|||
125195697|NCT01598090|450337938|FG000|Follow-up Period|Lost to Follow-up|2|||
125195698|NCT01598090|450337939|FG001|Follow-up Period|Lost to Follow-up|10|||
125195699|NCT01598090|450337940|FG002|Follow-up Period|Lost to Follow-up|12|||
125195700|NCT04087720|450337950|FG000|Overall Study|Withdrawal by Subject|2|||
125195701|NCT04087720|450337950|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
125195702|NCT00520533|450337953|FG000|Overall Study|Death|1|||
125195703|NCT00520533|450337953|FG000|Overall Study|Suspension of the study for safety reasons|1|||
125195704|NCT00520533|450337953|FG000|Overall Study|Withdrawal by Subject|1|||
125195705|NCT00520533|450337953|FG000|Overall Study|Physician Decision|1|||
125195706|NCT02438826|450337954|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
125195707|NCT02438826|450337955|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
125248309|NCT01107457|450534189|FG004|Part A|Protocol Violation|0|||
125248310|NCT01107457|450534190|FG005|Part A|Protocol Violation|0|||
125248311|NCT01107457|450534185|FG000|Part B and C|Adverse Event|0|||
125248312|NCT01107457|450534186|FG001|Part B and C|Adverse Event|0|||
125248313|NCT01107457|450534187|FG002|Part B and C|Adverse Event|0|||
125248314|NCT01107457|450534188|FG003|Part B and C|Adverse Event|0|||
125248315|NCT01107457|450534189|FG004|Part B and C|Adverse Event|0|||
125248316|NCT01107457|450534190|FG005|Part B and C|Adverse Event|12|||
125248317|NCT01107457|450534185|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
125248318|NCT01107457|450534186|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
125248319|NCT01107457|450534187|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
125248320|NCT01107457|450534188|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
125248321|NCT01107457|450534189|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
125248322|NCT01107457|450534190|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
125248323|NCT01107457|450534185|FG000|Part B and C|Physician Decision|0|||
125248324|NCT01107457|450534186|FG001|Part B and C|Physician Decision|0|||
125248325|NCT01107457|450534187|FG002|Part B and C|Physician Decision|0|||
125248326|NCT01107457|450534188|FG003|Part B and C|Physician Decision|0|||
125248327|NCT01107457|450534189|FG004|Part B and C|Physician Decision|0|||
125248328|NCT01107457|450534190|FG005|Part B and C|Physician Decision|3|||
125395643|NCT03013543|451081676|FG006|Overall Study|Lack of Efficacy|0|||
125395644|NCT03013543|451081677|FG007|Overall Study|Lack of Efficacy|0|||
125395645|NCT03013543|451081678|FG008|Overall Study|Lack of Efficacy|0|||
125195708|NCT02438826|450337956|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
125195709|NCT02438826|450337957|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
125195710|NCT02438826|450337954|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
125195711|NCT02438826|450337955|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125195712|NCT02438826|450337956|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125195713|NCT02438826|450337957|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125195714|NCT02438826|450337954|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
125195715|NCT02438826|450337955|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
125195716|NCT02438826|450337956|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
125248329|NCT01107457|450534185|FG000|Part B and C|Lack of Efficacy|0|||
125248330|NCT01107457|450534186|FG001|Part B and C|Lack of Efficacy|0|||
125395646|NCT03013543|451081679|FG009|Overall Study|Lack of Efficacy|0|||
125395647|NCT03013543|451081670|FG000|Overall Study|Lost to Follow-up|0|||
125395648|NCT03013543|451081671|FG001|Overall Study|Lost to Follow-up|0|||
125395649|NCT03013543|451081672|FG002|Overall Study|Lost to Follow-up|0|||
125395650|NCT03013543|451081673|FG003|Overall Study|Lost to Follow-up|1|||
125395651|NCT03013543|451081674|FG004|Overall Study|Lost to Follow-up|0|||
125395652|NCT03013543|451081675|FG005|Overall Study|Lost to Follow-up|0|||
125395653|NCT03013543|451081676|FG006|Overall Study|Lost to Follow-up|1|||
125395654|NCT03013543|451081677|FG007|Overall Study|Lost to Follow-up|0|||
125395655|NCT03013543|451081678|FG008|Overall Study|Lost to Follow-up|0|||
125395656|NCT03013543|451081679|FG009|Overall Study|Lost to Follow-up|2|||
125395657|NCT03013543|451081670|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125395658|NCT03013543|451081671|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125395659|NCT03013543|451081672|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125395660|NCT03013543|451081673|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125395661|NCT03013543|451081674|FG004|Overall Study|Non-Compliance With Study Drug|0|||
125395662|NCT03013543|451081675|FG005|Overall Study|Non-Compliance With Study Drug|0|||
125395663|NCT03013543|451081676|FG006|Overall Study|Non-Compliance With Study Drug|0|||
125395664|NCT03013543|451081677|FG007|Overall Study|Non-Compliance With Study Drug|0|||
125395665|NCT03013543|451081678|FG008|Overall Study|Non-Compliance With Study Drug|1|||
125395666|NCT03013543|451081679|FG009|Overall Study|Non-Compliance With Study Drug|0|||
125395667|NCT03013543|451081670|FG000|Overall Study|Physician Decision|0|||
125395668|NCT03013543|451081671|FG001|Overall Study|Physician Decision|0|||
125395669|NCT03013543|451081672|FG002|Overall Study|Physician Decision|0|||
125395670|NCT03013543|451081673|FG003|Overall Study|Physician Decision|0|||
125395671|NCT03013543|451081674|FG004|Overall Study|Physician Decision|1|||
125395672|NCT03013543|451081675|FG005|Overall Study|Physician Decision|0|||
125395673|NCT03013543|451081676|FG006|Overall Study|Physician Decision|0|||
125395674|NCT03013543|451081677|FG007|Overall Study|Physician Decision|0|||
125395675|NCT03013543|451081678|FG008|Overall Study|Physician Decision|0|||
125395676|NCT03013543|451081679|FG009|Overall Study|Physician Decision|0|||
125395677|NCT03013543|451081670|FG000|Overall Study|Protocol Violation|0|||
125395678|NCT03013543|451081671|FG001|Overall Study|Protocol Violation|0|||
125395679|NCT03013543|451081672|FG002|Overall Study|Protocol Violation|0|||
125395680|NCT03013543|451081673|FG003|Overall Study|Protocol Violation|0|||
125395681|NCT03013543|451081674|FG004|Overall Study|Protocol Violation|0|||
125395682|NCT03013543|451081675|FG005|Overall Study|Protocol Violation|0|||
125395683|NCT03013543|451081676|FG006|Overall Study|Protocol Violation|0|||
125395684|NCT03013543|451081677|FG007|Overall Study|Protocol Violation|0|||
125395685|NCT03013543|451081678|FG008|Overall Study|Protocol Violation|0|||
125395686|NCT03013543|451081679|FG009|Overall Study|Protocol Violation|1|||
125395687|NCT04225923|451081680|FG000|Overall Study|Protocol Violation|1|||
125395688|NCT04225923|451081681|FG001|Overall Study|Protocol Violation|0|||
125395689|NCT04225923|451081682|FG002|Overall Study|Protocol Violation|1|||
125395690|NCT04225923|451081680|FG000|Overall Study|Withdrawal by Subject|4|||
125395691|NCT04225923|451081681|FG001|Overall Study|Withdrawal by Subject|1|||
125395692|NCT04225923|451081682|FG002|Overall Study|Withdrawal by Subject|3|||
125395693|NCT04225923|451081680|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
125395694|NCT04225923|451081681|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
125395695|NCT04225923|451081682|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
125395696|NCT01417481|451081683|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
125395697|NCT01417481|451081684|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
125395698|NCT04960228|451081685|FG000|Overall Study|Withdrawal by Subject|216|||
125395699|NCT04960228|451081686|FG001|Overall Study|Withdrawal by Subject|35|||
125395700|NCT04960228|451081685|FG000|Overall Study|Failed attention check|69|||
125395701|NCT04960228|451081686|FG001|Overall Study|Failed attention check|148|||
125395702|NCT04960228|451081685|FG000|Overall Study|Flagged for response quality by Dynata|3|||
125395703|NCT04960228|451081686|FG001|Overall Study|Flagged for response quality by Dynata|3|||
125395704|NCT04116710|451081689|FG000|Overall Study|Death|4|||
125395705|NCT04116710|451081690|FG001|Overall Study|Death|6|||
125395706|NCT04116710|451081691|FG002|Overall Study|Death|3|||
125395707|NCT04116710|451081692|FG003|Overall Study|Death|1|||
125395708|NCT04116710|451081689|FG000|Overall Study|Withdrawal by Subject|0|||
125395709|NCT04116710|451081690|FG001|Overall Study|Withdrawal by Subject|0|||
125395710|NCT04116710|451081691|FG002|Overall Study|Withdrawal by Subject|0|||
125395711|NCT04116710|451081692|FG003|Overall Study|Withdrawal by Subject|1|||
125395712|NCT01077960|451081695|FG000|Overall Study|Adverse Event|6|||
125395713|NCT01077960|451081695|FG000|Overall Study|Protocol Violation|3|||
125395714|NCT01077960|451081695|FG000|Overall Study|Lost to Follow-up|5|||
125395715|NCT01077960|451081695|FG000|Overall Study|Subject decision|1|||
125395716|NCT01077960|451081695|FG000|Overall Study|Reason unspecified|1|||
125395717|NCT01371656|451081696|FG000|Overall Study|Death|7|||
125395718|NCT01371656|451081697|FG001|Overall Study|Death|4|||
125395719|NCT01371656|451081696|FG000|Overall Study|Physician Decision|46|||
125395720|NCT01371656|451081697|FG001|Overall Study|Physician Decision|7|||
125395721|NCT01371656|451081696|FG000|Overall Study|Withdrawal by Subject|7|||
125248331|NCT01107457|450534187|FG002|Part B and C|Lack of Efficacy|0|||
125248332|NCT01107457|450534188|FG003|Part B and C|Lack of Efficacy|0|||
125248333|NCT01107457|450534189|FG004|Part B and C|Lack of Efficacy|0|||
125248334|NCT01107457|450534190|FG005|Part B and C|Lack of Efficacy|7|||
125248335|NCT01107457|450534185|FG000|Part B and C|Lost to Follow-up|0|||
125248336|NCT01107457|450534186|FG001|Part B and C|Lost to Follow-up|0|||
125248337|NCT01107457|450534187|FG002|Part B and C|Lost to Follow-up|0|||
125248338|NCT01107457|450534188|FG003|Part B and C|Lost to Follow-up|0|||
125248339|NCT01107457|450534189|FG004|Part B and C|Lost to Follow-up|0|||
125248340|NCT01107457|450534190|FG005|Part B and C|Lost to Follow-up|10|||
125248341|NCT01107457|450534185|FG000|Part B and C|Protocol Violation|0|||
125248342|NCT01107457|450534186|FG001|Part B and C|Protocol Violation|0|||
125248343|NCT01107457|450534187|FG002|Part B and C|Protocol Violation|0|||
125248344|NCT01107457|450534188|FG003|Part B and C|Protocol Violation|0|||
125248345|NCT01107457|450534189|FG004|Part B and C|Protocol Violation|0|||
125248346|NCT01107457|450534190|FG005|Part B and C|Protocol Violation|1|||
125248347|NCT01107457|450534185|FG000|Part B and C|Sponsor Decision|0|||
125248348|NCT01107457|450534186|FG001|Part B and C|Sponsor Decision|0|||
125248349|NCT01107457|450534187|FG002|Part B and C|Sponsor Decision|0|||
125248350|NCT01107457|450534188|FG003|Part B and C|Sponsor Decision|0|||
125248351|NCT01107457|450534189|FG004|Part B and C|Sponsor Decision|0|||
125248352|NCT01107457|450534190|FG005|Part B and C|Sponsor Decision|66|||
125248353|NCT01107457|450534185|FG000|Part B and C|Withdrawal by Subject|0|||
125248354|NCT01107457|450534186|FG001|Part B and C|Withdrawal by Subject|0|||
125248355|NCT01107457|450534187|FG002|Part B and C|Withdrawal by Subject|0|||
125248356|NCT01107457|450534188|FG003|Part B and C|Withdrawal by Subject|0|||
125248357|NCT01107457|450534189|FG004|Part B and C|Withdrawal by Subject|0|||
125248358|NCT01107457|450534190|FG005|Part B and C|Withdrawal by Subject|16|||
125248359|NCT01107457|450534185|FG000|Part B and C|Clinical Relapse|0|||
125248360|NCT01107457|450534186|FG001|Part B and C|Clinical Relapse|0|||
125248361|NCT01107457|450534187|FG002|Part B and C|Clinical Relapse|0|||
125248362|NCT01107457|450534188|FG003|Part B and C|Clinical Relapse|0|||
125248363|NCT01107457|450534189|FG004|Part B and C|Clinical Relapse|0|||
125248364|NCT01107457|450534190|FG005|Part B and C|Clinical Relapse|4|||
125248365|NCT01026038|450534191|FG000|Overall Study|Lost to Follow-up|1|||
125248366|NCT01026038|450534192|FG001|Overall Study|Lost to Follow-up|1|||
125248367|NCT01026038|450534193|FG002|Overall Study|Lost to Follow-up|0|||
125248368|NCT03601052|450534194|FG000|Overall Study|Lost to Follow-up|2|||
125248369|NCT00837330|450534195|FG000|Overall Study|Lost to Follow-up|1|||
125248370|NCT00837330|450534196|FG001|Overall Study|Lost to Follow-up|3|||
125248371|NCT01227395|450534197|FG000|Overall Study|Protocol Violation|0|||
125248372|NCT01227395|450534198|FG001|Overall Study|Protocol Violation|1|||
125248373|NCT00105508|450534203|FG000|Overall Study|Prephase Dropout|1|||
125248374|NCT00105508|450534204|FG001|Overall Study|Prephase Dropout|0|||
125248375|NCT00105508|450534203|FG000|Overall Study|Adverse Event|16|||
125248376|NCT00105508|450534204|FG001|Overall Study|Adverse Event|19|||
125248377|NCT00105508|450534203|FG000|Overall Study|Insufficient Efficacy|1|||
125248378|NCT00105508|450534204|FG001|Overall Study|Insufficient Efficacy|0|||
125248379|NCT00105508|450534203|FG000|Overall Study|Withdrawal by Subject|10|||
125248380|NCT00105508|450534204|FG001|Overall Study|Withdrawal by Subject|6|||
125248381|NCT00105508|450534203|FG000|Overall Study|Lost to Follow-up|3|||
125248382|NCT00105508|450534204|FG001|Overall Study|Lost to Follow-up|0|||
125248383|NCT00105508|450534203|FG000|Overall Study|Protocol Violation|1|||
125248384|NCT00105508|450534204|FG001|Overall Study|Protocol Violation|2|||
125248385|NCT00105508|450534203|FG000|Overall Study|Other|8|||
125248386|NCT00105508|450534204|FG001|Overall Study|Other|9|||
125248387|NCT00086307|450534205|FG000|Overall Study|Lack of Efficacy|1|||
125248388|NCT00086307|450534206|FG001|Overall Study|Lack of Efficacy|1|||
125248389|NCT00086307|450534207|FG002|Overall Study|Lack of Efficacy|2|||
125248390|NCT00086307|450534205|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
125248391|NCT00086307|450534206|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
125248392|NCT00086307|450534207|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
125248393|NCT00086307|450534205|FG000|Overall Study|Nausea and headaches|0|||
125248394|NCT00086307|450534206|FG001|Overall Study|Nausea and headaches|0|||
125248395|NCT00086307|450534207|FG002|Overall Study|Nausea and headaches|1|||
125248396|NCT00086307|450534205|FG000|Overall Study|Constipation and sleepiness|0|||
125248397|NCT00086307|450534206|FG001|Overall Study|Constipation and sleepiness|0|||
125248398|NCT00086307|450534207|FG002|Overall Study|Constipation and sleepiness|1|||
125248399|NCT00086307|450534205|FG000|Overall Study|Suicidal ideation|0|||
125248400|NCT00086307|450534206|FG001|Overall Study|Suicidal ideation|0|||
125248401|NCT00086307|450534207|FG002|Overall Study|Suicidal ideation|1|||
125248402|NCT00086307|450534205|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
125248403|NCT00086307|450534206|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
125248404|NCT00086307|450534207|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
125248405|NCT00086307|450534205|FG000|Overall Study|Withdrawal by Subject|0|||
125248406|NCT00086307|450534206|FG001|Overall Study|Withdrawal by Subject|0|||
125248407|NCT00086307|450534207|FG002|Overall Study|Withdrawal by Subject|2|||
125248408|NCT00683384|450534208|FG000|Overall Study|Death|1|||
125195717|NCT02438826|450337957|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
125195718|NCT02438826|450337954|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
125195719|NCT02438826|450337955|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
125195720|NCT02438826|450337956|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
125195721|NCT02438826|450337957|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
125195722|NCT02438826|450337954|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
125195723|NCT02438826|450337955|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
125195724|NCT02438826|450337956|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
125195725|NCT02438826|450337957|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
125195726|NCT02438826|450337954|FG000|Open-Label Treatment Phase|Adverse Event|11|||
125195727|NCT02438826|450337955|FG001|Open-Label Treatment Phase|Adverse Event|6|||
125195728|NCT02438826|450337956|FG002|Open-Label Treatment Phase|Adverse Event|0|||
125195729|NCT02438826|450337957|FG003|Open-Label Treatment Phase|Adverse Event|0|||
125248409|NCT00683384|450534208|FG000|Overall Study|Adverse Event|1|||
125248410|NCT00120874|450534210|FG000|Overall Study|Death|0|||
125248411|NCT00120874|450534211|FG001|Overall Study|Death|1|||
125248412|NCT00300495|450534218|FG000|Overall Study|Protocol Violation|4|||
125248413|NCT00300495|450534219|FG001|Overall Study|Protocol Violation|1|||
125248414|NCT03632720|450534220|FG000|Overall Study|Adverse Event|2|||
125248415|NCT03632720|450534221|FG001|Overall Study|Adverse Event|0|||
125248416|NCT03632720|450534222|FG002|Overall Study|Adverse Event|0|||
125248417|NCT03632720|450534220|FG000|Overall Study|Lost to Follow-up|0|||
125248418|NCT03632720|450534221|FG001|Overall Study|Lost to Follow-up|1|||
125248419|NCT03632720|450534222|FG002|Overall Study|Lost to Follow-up|0|||
125248420|NCT03632720|450534220|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
125248421|NCT03632720|450534221|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
125248422|NCT03632720|450534222|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
125248423|NCT03632720|450534220|FG000|Overall Study|Screen failure|0|||
125248424|NCT03632720|450534221|FG001|Overall Study|Screen failure|1|||
125248425|NCT03632720|450534222|FG002|Overall Study|Screen failure|0|||
125248426|NCT00682435|450534223|FG000|Overall Study|Insufficient data|5|||
125248427|NCT00682435|450534223|FG000|Overall Study|Erroneously enrolled twice|2|||
125248428|NCT00290238|450534224|FG000|Overall Study|Study terminated|27|||
125248429|NCT00290238|450534225|FG001|Overall Study|Study terminated|27|||
125248430|NCT00290238|450534224|FG000|Overall Study|Lost to Follow-up|0|||
125248431|NCT00290238|450534225|FG001|Overall Study|Lost to Follow-up|1|||
125248432|NCT00290238|450534224|FG000|Overall Study|Withdrawal by Subject|15|||
125248433|NCT00290238|450534225|FG001|Overall Study|Withdrawal by Subject|13|||
125248434|NCT06868667|450534226|FG000|Overall Study|Death|0|||
125248435|NCT06868667|450534227|FG001|Overall Study|Death|4|||
125248436|NCT06868667|450534226|FG000|Overall Study|Lost to Follow-up|0|||
125248437|NCT06868667|450534227|FG001|Overall Study|Lost to Follow-up|1|||
125248438|NCT06868667|450534226|FG000|Overall Study|Withdrawal by Subject|1|||
125248439|NCT06868667|450534227|FG001|Overall Study|Withdrawal by Subject|0|||
125248440|NCT06868667|450534226|FG000|Overall Study|Ongoing|9|||
125248441|NCT06868667|450534227|FG001|Overall Study|Ongoing|9|||
125248442|NCT05330429|450534228|FG000|Overall Study|Study Terminated by Sponsor|4|||
125248443|NCT05330429|450534229|FG001|Overall Study|Study Terminated by Sponsor|33|||
125248444|NCT05330429|450534230|FG002|Overall Study|Study Terminated by Sponsor|12|||
125248445|NCT05330429|450534228|FG000|Overall Study|Death|5|||
125248446|NCT05330429|450534229|FG001|Overall Study|Death|2|||
125248447|NCT05330429|450534230|FG002|Overall Study|Death|4|||
125248448|NCT05330429|450534228|FG000|Overall Study|Withdrew Consent|0|||
125248449|NCT05330429|450534229|FG001|Overall Study|Withdrew Consent|5|||
125248450|NCT05330429|450534230|FG002|Overall Study|Withdrew Consent|4|||
125195730|NCT02438826|450337954|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
125195731|NCT02438826|450337955|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
125195732|NCT02438826|450337956|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
125195733|NCT02438826|450337957|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
125195734|NCT02438826|450337954|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
125195735|NCT02438826|450337955|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
125248451|NCT05330429|450534228|FG000|Overall Study|Investigator's Discretion|0|||
125248452|NCT05330429|450534229|FG001|Overall Study|Investigator's Discretion|1|||
125248453|NCT05330429|450534230|FG002|Overall Study|Investigator's Discretion|3|||
125248454|NCT05330429|450534228|FG000|Overall Study|Subject Decision|1|||
125248455|NCT05330429|450534229|FG001|Overall Study|Subject Decision|2|||
125248456|NCT05330429|450534230|FG002|Overall Study|Subject Decision|0|||
125248457|NCT05330429|450534228|FG000|Overall Study|Lost to Follow-up|0|||
125248458|NCT05330429|450534229|FG001|Overall Study|Lost to Follow-up|1|||
125248459|NCT05330429|450534230|FG002|Overall Study|Lost to Follow-up|0|||
125248460|NCT06097273|450534231|FG000|Overall Study|Death|2|||
125248461|NCT06097273|450534232|FG001|Overall Study|Death|1|||
125248462|NCT06097273|450534233|FG002|Overall Study|Death|2|||
125248463|NCT06097273|450534234|FG003|Overall Study|Death|2|||
125248464|NCT06097273|450534231|FG000|Overall Study|Lost to Follow-up|27|||
125248465|NCT06097273|450534232|FG001|Overall Study|Lost to Follow-up|18|||
125248466|NCT06097273|450534233|FG002|Overall Study|Lost to Follow-up|36|||
125195736|NCT02438826|450337956|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
125195737|NCT02438826|450337957|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
125195738|NCT02438826|450337954|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
125195739|NCT02438826|450337955|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
125195740|NCT02438826|450337956|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
125195741|NCT02438826|450337957|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
125195742|NCT02438826|450337954|FG000|Post-Treatment Phase|Adverse Event|3|||
125195743|NCT02438826|450337955|FG001|Post-Treatment Phase|Adverse Event|0|||
125195744|NCT02438826|450337956|FG002|Post-Treatment Phase|Adverse Event|0|||
125248467|NCT06097273|450534234|FG003|Overall Study|Lost to Follow-up|31|||
125248468|NCT06097273|450534231|FG000|Overall Study|Physician Decision|0|||
125248469|NCT06097273|450534232|FG001|Overall Study|Physician Decision|1|||
125248470|NCT06097273|450534233|FG002|Overall Study|Physician Decision|0|||
125248471|NCT06097273|450534234|FG003|Overall Study|Physician Decision|3|||
125248472|NCT06097273|450534231|FG000|Overall Study|Protocol Violation|1|||
125248473|NCT06097273|450534232|FG001|Overall Study|Protocol Violation|1|||
125248474|NCT06097273|450534233|FG002|Overall Study|Protocol Violation|2|||
125248475|NCT06097273|450534234|FG003|Overall Study|Protocol Violation|1|||
125248476|NCT06097273|450534231|FG000|Overall Study|Withdrawal by Subject|14|||
125248477|NCT06097273|450534232|FG001|Overall Study|Withdrawal by Subject|11|||
125248478|NCT06097273|450534233|FG002|Overall Study|Withdrawal by Subject|14|||
125248479|NCT06097273|450534234|FG003|Overall Study|Withdrawal by Subject|15|||
125248480|NCT06097273|450534231|FG000|Overall Study|Other Than Specified|7|||
125248481|NCT06097273|450534232|FG001|Overall Study|Other Than Specified|3|||
125248482|NCT06097273|450534233|FG002|Overall Study|Other Than Specified|11|||
125248483|NCT06097273|450534234|FG003|Overall Study|Other Than Specified|6|||
125248484|NCT03882801|450535937|FG000|Period 1|Adverse Event|0|||
125248485|NCT03882801|450535938|FG001|Period 1|Adverse Event|1|||
125248486|NCT03882801|450535937|FG000|Period 1|Non-compliance with study drug|1|||
125248487|NCT03882801|450535938|FG001|Period 1|Non-compliance with study drug|1|||
125248488|NCT03882801|450535937|FG000|Period 1|Never treated with study drug|1|||
125248489|NCT03882801|450535938|FG001|Period 1|Never treated with study drug|0|||
125248490|NCT03882801|450535937|FG000|Washout Period|Physician Decision|0|||
125248491|NCT03882801|450535938|FG001|Washout Period|Physician Decision|1|||
125248492|NCT03882801|450535937|FG000|Period 2|Non-compliance with study drug|0|||
125248493|NCT03882801|450535938|FG001|Period 2|Non-compliance with study drug|1|||
125248494|NCT03548415|450535942|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
125248495|NCT03548415|450535943|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
125248496|NCT03548415|450535944|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
125248497|NCT03548415|450535945|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
125248498|NCT03548415|450535946|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
125248499|NCT01803737|450535947|FG000|Overall Study|Lack of Time|1|||
125248500|NCT01803737|450535948|FG001|Overall Study|Lack of Time|0|||
125248501|NCT01803737|450535947|FG000|Overall Study|Medical Reason|0|||
125248502|NCT01803737|450535948|FG001|Overall Study|Medical Reason|1|||
125248503|NCT01803737|450535947|FG000|Overall Study|Lost to Follow-up|0|||
125248504|NCT01803737|450535948|FG001|Overall Study|Lost to Follow-up|2|||
125248505|NCT01748552|450535951|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
125248506|NCT01748552|450535952|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
125248507|NCT01748552|450535953|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
125248508|NCT01748552|450535954|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
125248509|NCT01748552|450535955|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
125248510|NCT01748552|450535956|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
125248511|NCT01748552|450535957|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
125248512|NCT01748552|450535958|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
125248513|NCT01748552|450535959|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
125248514|NCT01748552|450535960|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
125248515|NCT01748552|450535961|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
125248516|NCT01748552|450535962|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
125248517|NCT01748552|450535951|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248518|NCT01748552|450535952|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248519|NCT01748552|450535953|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248520|NCT01748552|450535954|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248521|NCT01748552|450535955|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248522|NCT01748552|450535956|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125195745|NCT02438826|450337957|FG003|Post-Treatment Phase|Adverse Event|0|||
125195746|NCT02438826|450337954|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
125248523|NCT01748552|450535957|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
125248524|NCT01748552|450535958|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
125248525|NCT01748552|450535959|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
125248526|NCT01748552|450535960|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125195747|NCT02438826|450337955|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
125195748|NCT02438826|450337956|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
125195749|NCT02438826|450337957|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
125195750|NCT02438826|450337954|FG000|Post-Treatment Phase|Physician Decision|1|||
125195751|NCT02438826|450337955|FG001|Post-Treatment Phase|Physician Decision|0|||
125195752|NCT02438826|450337956|FG002|Post-Treatment Phase|Physician Decision|0|||
125195753|NCT02438826|450337957|FG003|Post-Treatment Phase|Physician Decision|0|||
125195754|NCT02438826|450337954|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
125195755|NCT02438826|450337955|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
125195756|NCT02438826|450337956|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
125195757|NCT02438826|450337957|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
125195758|NCT02553499|450337960|FG000|Overall Study|Adverse Event|0|||
125195759|NCT02553499|450337961|FG001|Overall Study|Adverse Event|0|||
125195760|NCT02553499|450337962|FG002|Overall Study|Adverse Event|0|||
125195761|NCT02553499|450337963|FG003|Overall Study|Adverse Event|0|||
125195762|NCT02553499|450337964|FG004|Overall Study|Adverse Event|0|||
125195763|NCT02553499|450337965|FG005|Overall Study|Adverse Event|0|||
125195764|NCT02553499|450337966|FG006|Overall Study|Adverse Event|1|||
125195765|NCT02553499|450337967|FG007|Overall Study|Adverse Event|1|||
125195766|NCT02553499|450337968|FG008|Overall Study|Adverse Event|0|||
125195767|NCT02553499|450337969|FG009|Overall Study|Adverse Event|0|||
125195768|NCT02553499|450337970|FG010|Overall Study|Adverse Event|0|||
125195769|NCT02553499|450337971|FG011|Overall Study|Adverse Event|0|||
125195770|NCT02553499|450337972|FG012|Overall Study|Adverse Event|0|||
125195771|NCT02553499|450337973|FG013|Overall Study|Adverse Event|1|||
125195772|NCT02553499|450337960|FG000|Overall Study|Death|0|||
125195773|NCT02553499|450337961|FG001|Overall Study|Death|1|||
125195774|NCT02553499|450337962|FG002|Overall Study|Death|1|||
125195775|NCT02553499|450337963|FG003|Overall Study|Death|0|||
125195776|NCT02553499|450337964|FG004|Overall Study|Death|1|||
125195777|NCT02553499|450337965|FG005|Overall Study|Death|2|||
125195778|NCT02553499|450337966|FG006|Overall Study|Death|0|||
125195779|NCT02553499|450337967|FG007|Overall Study|Death|0|||
125195780|NCT02553499|450337968|FG008|Overall Study|Death|0|||
125195781|NCT02553499|450337969|FG009|Overall Study|Death|0|||
125195782|NCT02553499|450337970|FG010|Overall Study|Death|1|||
125195783|NCT02553499|450337971|FG011|Overall Study|Death|0|||
125195784|NCT02553499|450337972|FG012|Overall Study|Death|0|||
125195785|NCT02553499|450337973|FG013|Overall Study|Death|0|||
125195786|NCT02553499|450337960|FG000|Overall Study|Lost to Follow-up|0|||
125195787|NCT02553499|450337961|FG001|Overall Study|Lost to Follow-up|0|||
125195788|NCT02553499|450337962|FG002|Overall Study|Lost to Follow-up|0|||
125195789|NCT02553499|450337963|FG003|Overall Study|Lost to Follow-up|0|||
125195790|NCT02553499|450337964|FG004|Overall Study|Lost to Follow-up|0|||
125195791|NCT02553499|450337965|FG005|Overall Study|Lost to Follow-up|0|||
125195792|NCT02553499|450337966|FG006|Overall Study|Lost to Follow-up|1|||
125195793|NCT02553499|450337967|FG007|Overall Study|Lost to Follow-up|0|||
125195794|NCT02553499|450337968|FG008|Overall Study|Lost to Follow-up|0|||
125195795|NCT02553499|450337969|FG009|Overall Study|Lost to Follow-up|0|||
125195796|NCT02553499|450337970|FG010|Overall Study|Lost to Follow-up|0|||
125195797|NCT02553499|450337971|FG011|Overall Study|Lost to Follow-up|0|||
125195798|NCT02553499|450337972|FG012|Overall Study|Lost to Follow-up|0|||
125195799|NCT02553499|450337973|FG013|Overall Study|Lost to Follow-up|0|||
125195800|NCT02553499|450337960|FG000|Overall Study|Physician Decision|0|||
125195801|NCT02553499|450337961|FG001|Overall Study|Physician Decision|1|||
125195802|NCT02553499|450337962|FG002|Overall Study|Physician Decision|1|||
125195803|NCT02553499|450337963|FG003|Overall Study|Physician Decision|0|||
125195804|NCT02553499|450337964|FG004|Overall Study|Physician Decision|1|||
125195805|NCT02553499|450337965|FG005|Overall Study|Physician Decision|0|||
125195806|NCT02553499|450337966|FG006|Overall Study|Physician Decision|0|||
125195807|NCT02553499|450337967|FG007|Overall Study|Physician Decision|1|||
125195808|NCT02553499|450337968|FG008|Overall Study|Physician Decision|1|||
125195809|NCT02553499|450337969|FG009|Overall Study|Physician Decision|2|||
125195810|NCT02553499|450337970|FG010|Overall Study|Physician Decision|1|||
125195811|NCT02553499|450337971|FG011|Overall Study|Physician Decision|3|||
125195812|NCT02553499|450337972|FG012|Overall Study|Physician Decision|1|||
125195813|NCT02553499|450337973|FG013|Overall Study|Physician Decision|0|||
125195814|NCT02553499|450337960|FG000|Overall Study|Progressive Disease|0|||
125195815|NCT02553499|450337961|FG001|Overall Study|Progressive Disease|0|||
125195816|NCT02553499|450337962|FG002|Overall Study|Progressive Disease|0|||
125195817|NCT02553499|450337963|FG003|Overall Study|Progressive Disease|2|||
125195818|NCT02553499|450337964|FG004|Overall Study|Progressive Disease|1|||
125195819|NCT02553499|450337965|FG005|Overall Study|Progressive Disease|1|||
125195820|NCT02553499|450337966|FG006|Overall Study|Progressive Disease|1|||
125195821|NCT02553499|450337967|FG007|Overall Study|Progressive Disease|0|||
125195822|NCT02553499|450337968|FG008|Overall Study|Progressive Disease|0|||
125195823|NCT02553499|450337969|FG009|Overall Study|Progressive Disease|1|||
125195824|NCT02553499|450337970|FG010|Overall Study|Progressive Disease|0|||
125195825|NCT02553499|450337971|FG011|Overall Study|Progressive Disease|0|||
125195826|NCT02553499|450337972|FG012|Overall Study|Progressive Disease|2|||
125195827|NCT02553499|450337973|FG013|Overall Study|Progressive Disease|1|||
125248527|NCT01748552|450535961|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248528|NCT01748552|450535962|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
125248529|NCT00004228|450535965|FG000|Overall Study|Adverse Event|0|||
125248530|NCT00004228|450535966|FG001|Overall Study|Adverse Event|1|||
125248531|NCT00004228|450535967|FG002|Overall Study|Adverse Event|0|||
125248532|NCT00004228|450535968|FG003|Overall Study|Adverse Event|0|||
125248533|NCT00004228|450535969|FG004|Overall Study|Adverse Event|1|||
125248534|NCT00004228|450535970|FG005|Overall Study|Adverse Event|0|||
125248535|NCT00004228|450535971|FG006|Overall Study|Adverse Event|0|||
125248536|NCT00004228|450535965|FG000|Overall Study|Death|0|||
125248537|NCT00004228|450535966|FG001|Overall Study|Death|1|||
125248538|NCT00004228|450535967|FG002|Overall Study|Death|2|||
125248539|NCT00004228|450535968|FG003|Overall Study|Death|0|||
125248540|NCT00004228|450535969|FG004|Overall Study|Death|1|||
125248541|NCT00004228|450535970|FG005|Overall Study|Death|0|||
125248542|NCT00004228|450535971|FG006|Overall Study|Death|0|||
125248543|NCT00004228|450535965|FG000|Overall Study|Lack of Efficacy|1|||
125248544|NCT00004228|450535966|FG001|Overall Study|Lack of Efficacy|6|||
125248545|NCT00004228|450535967|FG002|Overall Study|Lack of Efficacy|5|||
125248546|NCT00004228|450535968|FG003|Overall Study|Lack of Efficacy|3|||
125248547|NCT00004228|450535969|FG004|Overall Study|Lack of Efficacy|9|||
125248548|NCT00004228|450535970|FG005|Overall Study|Lack of Efficacy|8|||
125248549|NCT00004228|450535971|FG006|Overall Study|Lack of Efficacy|4|||
125248550|NCT00004228|450535965|FG000|Overall Study|Lost to Follow-up|0|||
125248551|NCT00004228|450535966|FG001|Overall Study|Lost to Follow-up|0|||
125248552|NCT00004228|450535967|FG002|Overall Study|Lost to Follow-up|1|||
125248553|NCT00004228|450535968|FG003|Overall Study|Lost to Follow-up|0|||
125248554|NCT00004228|450535969|FG004|Overall Study|Lost to Follow-up|0|||
125248555|NCT00004228|450535970|FG005|Overall Study|Lost to Follow-up|0|||
125248556|NCT00004228|450535971|FG006|Overall Study|Lost to Follow-up|0|||
125248557|NCT00004228|450535965|FG000|Overall Study|Physician Decision|1|||
125248558|NCT00004228|450535966|FG001|Overall Study|Physician Decision|0|||
125248559|NCT00004228|450535967|FG002|Overall Study|Physician Decision|3|||
125248560|NCT00004228|450535968|FG003|Overall Study|Physician Decision|2|||
125248561|NCT00004228|450535969|FG004|Overall Study|Physician Decision|1|||
125248562|NCT00004228|450535970|FG005|Overall Study|Physician Decision|1|||
125248563|NCT00004228|450535971|FG006|Overall Study|Physician Decision|1|||
125248564|NCT00004228|450535965|FG000|Overall Study|Protocol Violation|0|||
125248565|NCT00004228|450535966|FG001|Overall Study|Protocol Violation|5|||
125248566|NCT00004228|450535967|FG002|Overall Study|Protocol Violation|2|||
125248567|NCT00004228|450535968|FG003|Overall Study|Protocol Violation|1|||
125248568|NCT00004228|450535969|FG004|Overall Study|Protocol Violation|1|||
125248569|NCT00004228|450535970|FG005|Overall Study|Protocol Violation|2|||
125248570|NCT00004228|450535971|FG006|Overall Study|Protocol Violation|0|||
125248571|NCT00004228|450535965|FG000|Overall Study|Withdrawal by Subject|3|||
125248572|NCT00004228|450535966|FG001|Overall Study|Withdrawal by Subject|0|||
125248573|NCT00004228|450535967|FG002|Overall Study|Withdrawal by Subject|1|||
125248574|NCT00004228|450535968|FG003|Overall Study|Withdrawal by Subject|0|||
125248575|NCT00004228|450535969|FG004|Overall Study|Withdrawal by Subject|2|||
125248576|NCT00004228|450535970|FG005|Overall Study|Withdrawal by Subject|1|||
125248577|NCT00004228|450535971|FG006|Overall Study|Withdrawal by Subject|2|||
125248578|NCT00004228|450535965|FG000|Overall Study|Other|0|||
125248579|NCT00004228|450535966|FG001|Overall Study|Other|0|||
125248580|NCT00004228|450535967|FG002|Overall Study|Other|1|||
125248581|NCT00004228|450535968|FG003|Overall Study|Other|0|||
125248582|NCT00004228|450535969|FG004|Overall Study|Other|0|||
125248583|NCT00004228|450535970|FG005|Overall Study|Other|0|||
125248584|NCT00004228|450535971|FG006|Overall Study|Other|0|||
125248585|NCT00004228|450535965|FG000|Overall Study|ineligible|4|||
125248586|NCT00004228|450535966|FG001|Overall Study|ineligible|2|||
125248587|NCT00004228|450535967|FG002|Overall Study|ineligible|4|||
125248588|NCT00004228|450535968|FG003|Overall Study|ineligible|1|||
125248589|NCT00004228|450535969|FG004|Overall Study|ineligible|1|||
125395722|NCT01371656|451081697|FG001|Overall Study|Withdrawal by Subject|0|||
125395723|NCT01371656|451081696|FG000|Overall Study|Ineligible|4|||
125248590|NCT00004228|450535970|FG005|Overall Study|ineligible|2|||
125248591|NCT00004228|450535971|FG006|Overall Study|ineligible|5|||
125248592|NCT02533674|450535972|FG000|Dose Level I|Progressive disease|1|||
125248593|NCT02533674|450535973|FG001|Dose Level I|Progressive disease|0|||
125248594|NCT02533674|450535974|FG002|Dose Level I|Progressive disease|0|||
125395724|NCT01371656|451081697|FG001|Overall Study|Ineligible|3|||
125395725|NCT01537783|451081698|FG000|Overall Study|Lost to Follow-up|11|||
125248595|NCT02533674|450535975|FG003|Dose Level I|Progressive disease|0|||
125248596|NCT02533674|450535976|FG004|Dose Level I|Progressive disease|0|||
125248597|NCT02533674|450535977|FG005|Dose Level I|Progressive disease|0|||
125248598|NCT02533674|450535978|FG006|Dose Level I|Progressive disease|0|||
125248599|NCT02533674|450535979|FG007|Dose Level I|Progressive disease|0|||
125248600|NCT02533674|450535972|FG000|Dose Level I|Withdrawal by Subject|1|||
125248601|NCT02533674|450535973|FG001|Dose Level I|Withdrawal by Subject|0|||
125248602|NCT02533674|450535974|FG002|Dose Level I|Withdrawal by Subject|0|||
125248603|NCT02533674|450535975|FG003|Dose Level I|Withdrawal by Subject|0|||
125248604|NCT02533674|450535976|FG004|Dose Level I|Withdrawal by Subject|0|||
125248605|NCT02533674|450535977|FG005|Dose Level I|Withdrawal by Subject|0|||
125248606|NCT02533674|450535978|FG006|Dose Level I|Withdrawal by Subject|0|||
125248607|NCT02533674|450535979|FG007|Dose Level I|Withdrawal by Subject|0|||
125248608|NCT02533674|450535972|FG000|Dose Level I|Physician Decision|1|||
125248609|NCT02533674|450535973|FG001|Dose Level I|Physician Decision|0|||
125248610|NCT02533674|450535974|FG002|Dose Level I|Physician Decision|0|||
125248611|NCT02533674|450535975|FG003|Dose Level I|Physician Decision|0|||
125248612|NCT02533674|450535976|FG004|Dose Level I|Physician Decision|0|||
125248613|NCT02533674|450535977|FG005|Dose Level I|Physician Decision|0|||
125248614|NCT02533674|450535978|FG006|Dose Level I|Physician Decision|0|||
125248615|NCT02533674|450535979|FG007|Dose Level I|Physician Decision|0|||
125248616|NCT02533674|450535972|FG000|Dose Level I|Death|1|||
125248617|NCT02533674|450535973|FG001|Dose Level I|Death|0|||
125248618|NCT02533674|450535974|FG002|Dose Level I|Death|0|||
125248619|NCT02533674|450535975|FG003|Dose Level I|Death|0|||
125248620|NCT02533674|450535976|FG004|Dose Level I|Death|0|||
125248621|NCT02533674|450535977|FG005|Dose Level I|Death|0|||
125248622|NCT02533674|450535978|FG006|Dose Level I|Death|0|||
125248623|NCT02533674|450535979|FG007|Dose Level I|Death|0|||
125248624|NCT02533674|450535972|FG000|Dose Level I|Never Treated|1|||
125248625|NCT02533674|450535973|FG001|Dose Level I|Never Treated|0|||
125248626|NCT02533674|450535974|FG002|Dose Level I|Never Treated|0|||
125248627|NCT02533674|450535975|FG003|Dose Level I|Never Treated|0|||
125248628|NCT02533674|450535976|FG004|Dose Level I|Never Treated|0|||
125248629|NCT02533674|450535977|FG005|Dose Level I|Never Treated|0|||
125248630|NCT02533674|450535978|FG006|Dose Level I|Never Treated|0|||
125248631|NCT02533674|450535979|FG007|Dose Level I|Never Treated|0|||
125248632|NCT02533674|450535972|FG000|Dose Level II|Progressive disease|0|||
125248633|NCT02533674|450535973|FG001|Dose Level II|Progressive disease|3|||
125248634|NCT02533674|450535974|FG002|Dose Level II|Progressive disease|0|||
125395726|NCT01537783|451081699|FG001|Overall Study|Lost to Follow-up|2|||
125395727|NCT00291668|451081704|FG000|Overall Study|Lack of Efficacy|1|||
125395728|NCT00291668|451081705|FG001|Overall Study|Lack of Efficacy|0|||
125395729|NCT00291668|451081706|FG002|Overall Study|Lack of Efficacy|0|||
125395730|NCT00291668|451081704|FG000|Overall Study|SAE, non-fatal|1|||
125395731|NCT00291668|451081705|FG001|Overall Study|SAE, non-fatal|1|||
125395732|NCT00291668|451081706|FG002|Overall Study|SAE, non-fatal|1|||
125395733|NCT00291668|451081704|FG000|Overall Study|AE, non-serious non-fatal|1|||
125395734|NCT00291668|451081705|FG001|Overall Study|AE, non-serious non-fatal|0|||
125395735|NCT00291668|451081706|FG002|Overall Study|AE, non-serious non-fatal|0|||
125395736|NCT00291668|451081704|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125395737|NCT00291668|451081705|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
125395738|NCT00291668|451081706|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
125395739|NCT00313612|451081707|FG000|Overall Study|Patient never received treatment|0|||
125395740|NCT00313612|451081708|FG001|Overall Study|Patient never received treatment|1|||
125395741|NCT00451035|451081709|FG000|Overall Study|Disease progression|11|||
125395742|NCT00451035|451081709|FG000|Overall Study|Death|3|||
125395743|NCT00451035|451081709|FG000|Overall Study|New anti-neoplastic therapy|3|||
125395744|NCT02540954|451081714|FG000|Overall Study|Physician Decision|3|||
125395745|NCT02540954|451081715|FG001|Overall Study|Physician Decision|1|||
125395746|NCT02540954|451081714|FG000|Overall Study|Withdrawal by Subject|6|||
125395747|NCT02540954|451081715|FG001|Overall Study|Withdrawal by Subject|5|||
125395748|NCT02540954|451081714|FG000|Overall Study|Lost to Follow-up|1|||
125395749|NCT02540954|451081715|FG001|Overall Study|Lost to Follow-up|1|||
125395750|NCT02540954|451081714|FG000|Overall Study|Adverse Event|4|||
125395751|NCT02540954|451081715|FG001|Overall Study|Adverse Event|2|||
125395752|NCT02540954|451081714|FG000|Overall Study|Death|0|||
125395753|NCT02540954|451081715|FG001|Overall Study|Death|3|||
125395754|NCT02540954|451081714|FG000|Overall Study|Treatment failure|1|||
125395755|NCT02540954|451081715|FG001|Overall Study|Treatment failure|0|||
125395756|NCT02540954|451081714|FG000|Overall Study|Other reason|4|||
125395757|NCT02540954|451081715|FG001|Overall Study|Other reason|2|||
125395758|NCT01393743|451081716|FG000|Core Study|Adverse Event|5|||
125395759|NCT01393743|451081717|FG001|Core Study|Adverse Event|9|||
125395760|NCT01393743|451081718|FG002|Core Study|Adverse Event|0|||
125395761|NCT01393743|451081716|FG000|Core Study|Lost to Follow-up|1|||
125395762|NCT01393743|451081717|FG001|Core Study|Lost to Follow-up|1|||
125248635|NCT02533674|450535975|FG003|Dose Level II|Progressive disease|0|||
125248636|NCT02533674|450535976|FG004|Dose Level II|Progressive disease|0|||
125248637|NCT02533674|450535977|FG005|Dose Level II|Progressive disease|0|||
125248638|NCT02533674|450535978|FG006|Dose Level II|Progressive disease|0|||
125248639|NCT02533674|450535979|FG007|Dose Level II|Progressive disease|0|||
125248640|NCT02533674|450535972|FG000|Dose Level II|Withdrawal by Subject|0|||
125248641|NCT02533674|450535973|FG001|Dose Level II|Withdrawal by Subject|1|||
125248642|NCT02533674|450535974|FG002|Dose Level II|Withdrawal by Subject|0|||
125248643|NCT02533674|450535975|FG003|Dose Level II|Withdrawal by Subject|0|||
125395763|NCT01393743|451081718|FG002|Core Study|Lost to Follow-up|0|||
125395764|NCT01393743|451081716|FG000|Core Study|Participant's Choice|2|||
125248644|NCT02533674|450535976|FG004|Dose Level II|Withdrawal by Subject|0|||
125248645|NCT02533674|450535977|FG005|Dose Level II|Withdrawal by Subject|0|||
125248646|NCT02533674|450535978|FG006|Dose Level II|Withdrawal by Subject|0|||
125248647|NCT02533674|450535979|FG007|Dose Level II|Withdrawal by Subject|0|||
125248648|NCT02533674|450535972|FG000|Dose Level II|Treatment-related AE|0|||
125248649|NCT02533674|450535973|FG001|Dose Level II|Treatment-related AE|1|||
125248650|NCT02533674|450535974|FG002|Dose Level II|Treatment-related AE|0|||
125248651|NCT02533674|450535975|FG003|Dose Level II|Treatment-related AE|0|||
125248652|NCT02533674|450535976|FG004|Dose Level II|Treatment-related AE|0|||
125248653|NCT02533674|450535977|FG005|Dose Level II|Treatment-related AE|0|||
125248654|NCT02533674|450535978|FG006|Dose Level II|Treatment-related AE|0|||
125248655|NCT02533674|450535979|FG007|Dose Level II|Treatment-related AE|0|||
125248656|NCT02533674|450535972|FG000|Dose Level II|Physician Decision|0|||
125248657|NCT02533674|450535973|FG001|Dose Level II|Physician Decision|1|||
125248658|NCT02533674|450535974|FG002|Dose Level II|Physician Decision|0|||
125248659|NCT02533674|450535975|FG003|Dose Level II|Physician Decision|0|||
125248660|NCT02533674|450535976|FG004|Dose Level II|Physician Decision|0|||
125248661|NCT02533674|450535977|FG005|Dose Level II|Physician Decision|0|||
125248662|NCT02533674|450535978|FG006|Dose Level II|Physician Decision|0|||
125248663|NCT02533674|450535979|FG007|Dose Level II|Physician Decision|0|||
125248664|NCT02533674|450535972|FG000|Dose Level II|Non-treatment-related AE|0|||
125248665|NCT02533674|450535973|FG001|Dose Level II|Non-treatment-related AE|1|||
125248666|NCT02533674|450535974|FG002|Dose Level II|Non-treatment-related AE|0|||
125248667|NCT02533674|450535975|FG003|Dose Level II|Non-treatment-related AE|0|||
125248668|NCT02533674|450535976|FG004|Dose Level II|Non-treatment-related AE|0|||
125248669|NCT02533674|450535977|FG005|Dose Level II|Non-treatment-related AE|0|||
125248670|NCT02533674|450535978|FG006|Dose Level II|Non-treatment-related AE|0|||
125248671|NCT02533674|450535979|FG007|Dose Level II|Non-treatment-related AE|0|||
125248672|NCT02533674|450535972|FG000|Dose Level III|Progressive disease|0|||
125248673|NCT02533674|450535973|FG001|Dose Level III|Progressive disease|0|||
125248674|NCT02533674|450535974|FG002|Dose Level III|Progressive disease|2|||
125248675|NCT02533674|450535975|FG003|Dose Level III|Progressive disease|0|||
125248676|NCT02533674|450535976|FG004|Dose Level III|Progressive disease|0|||
125248677|NCT02533674|450535977|FG005|Dose Level III|Progressive disease|0|||
125248678|NCT02533674|450535978|FG006|Dose Level III|Progressive disease|0|||
125248679|NCT02533674|450535979|FG007|Dose Level III|Progressive disease|0|||
125248680|NCT02533674|450535972|FG000|Dose Level III|Withdrawal by Subject|0|||
125248681|NCT02533674|450535973|FG001|Dose Level III|Withdrawal by Subject|0|||
125248682|NCT02533674|450535974|FG002|Dose Level III|Withdrawal by Subject|1|||
125248683|NCT02533674|450535975|FG003|Dose Level III|Withdrawal by Subject|0|||
125248684|NCT02533674|450535976|FG004|Dose Level III|Withdrawal by Subject|0|||
125248685|NCT02533674|450535977|FG005|Dose Level III|Withdrawal by Subject|0|||
125248686|NCT02533674|450535978|FG006|Dose Level III|Withdrawal by Subject|0|||
125248687|NCT02533674|450535979|FG007|Dose Level III|Withdrawal by Subject|0|||
125248688|NCT02533674|450535972|FG000|Dose Level III|Treatment-related AE|0|||
125248689|NCT02533674|450535973|FG001|Dose Level III|Treatment-related AE|0|||
125248690|NCT02533674|450535974|FG002|Dose Level III|Treatment-related AE|1|||
125248691|NCT02533674|450535975|FG003|Dose Level III|Treatment-related AE|0|||
125248692|NCT02533674|450535976|FG004|Dose Level III|Treatment-related AE|0|||
125248693|NCT02533674|450535977|FG005|Dose Level III|Treatment-related AE|0|||
125248694|NCT02533674|450535978|FG006|Dose Level III|Treatment-related AE|0|||
125248695|NCT02533674|450535979|FG007|Dose Level III|Treatment-related AE|0|||
125248696|NCT02533674|450535972|FG000|Dose Level IV|Progressive disease|0|||
125248697|NCT02533674|450535973|FG001|Dose Level IV|Progressive disease|0|||
125248698|NCT02533674|450535974|FG002|Dose Level IV|Progressive disease|0|||
125248699|NCT02533674|450535975|FG003|Dose Level IV|Progressive disease|3|||
125248700|NCT02533674|450535976|FG004|Dose Level IV|Progressive disease|0|||
125248701|NCT02533674|450535977|FG005|Dose Level IV|Progressive disease|0|||
125248702|NCT02533674|450535978|FG006|Dose Level IV|Progressive disease|0|||
125248703|NCT02533674|450535979|FG007|Dose Level IV|Progressive disease|0|||
125248704|NCT02533674|450535972|FG000|Dose Level IV|Withdrawal by Subject|0|||
125248705|NCT02533674|450535973|FG001|Dose Level IV|Withdrawal by Subject|0|||
125248706|NCT02533674|450535974|FG002|Dose Level IV|Withdrawal by Subject|0|||
125248707|NCT02533674|450535975|FG003|Dose Level IV|Withdrawal by Subject|1|||
125248708|NCT02533674|450535976|FG004|Dose Level IV|Withdrawal by Subject|0|||
125248709|NCT02533674|450535977|FG005|Dose Level IV|Withdrawal by Subject|0|||
125248710|NCT02533674|450535978|FG006|Dose Level IV|Withdrawal by Subject|0|||
125248711|NCT02533674|450535979|FG007|Dose Level IV|Withdrawal by Subject|0|||
125248712|NCT02533674|450535972|FG000|Dose Level IV|Physician Decision|0|||
125248713|NCT02533674|450535973|FG001|Dose Level IV|Physician Decision|0|||
125248714|NCT02533674|450535974|FG002|Dose Level IV|Physician Decision|0|||
125248715|NCT02533674|450535975|FG003|Dose Level IV|Physician Decision|1|||
125248716|NCT02533674|450535976|FG004|Dose Level IV|Physician Decision|0|||
125248717|NCT02533674|450535977|FG005|Dose Level IV|Physician Decision|0|||
125248718|NCT02533674|450535978|FG006|Dose Level IV|Physician Decision|0|||
125248719|NCT02533674|450535979|FG007|Dose Level IV|Physician Decision|0|||
125248720|NCT02533674|450535972|FG000|Dose Level V|Progressive disease|0|||
125248721|NCT02533674|450535973|FG001|Dose Level V|Progressive disease|0|||
125248722|NCT02533674|450535974|FG002|Dose Level V|Progressive disease|0|||
125248723|NCT02533674|450535975|FG003|Dose Level V|Progressive disease|0|||
125248724|NCT02533674|450535976|FG004|Dose Level V|Progressive disease|3|||
125248725|NCT02533674|450535977|FG005|Dose Level V|Progressive disease|0|||
125248726|NCT02533674|450535978|FG006|Dose Level V|Progressive disease|0|||
125248727|NCT02533674|450535979|FG007|Dose Level V|Progressive disease|0|||
125248728|NCT02533674|450535972|FG000|Dose Level V|Withdrawal by Subject|0|||
125248729|NCT02533674|450535973|FG001|Dose Level V|Withdrawal by Subject|0|||
125248730|NCT02533674|450535974|FG002|Dose Level V|Withdrawal by Subject|0|||
125248731|NCT02533674|450535975|FG003|Dose Level V|Withdrawal by Subject|0|||
125248732|NCT02533674|450535976|FG004|Dose Level V|Withdrawal by Subject|1|||
125248733|NCT02533674|450535977|FG005|Dose Level V|Withdrawal by Subject|0|||
125248734|NCT02533674|450535978|FG006|Dose Level V|Withdrawal by Subject|0|||
125248735|NCT02533674|450535979|FG007|Dose Level V|Withdrawal by Subject|0|||
125248736|NCT02533674|450535972|FG000|Dose Level V|Physician Decision|0|||
125248737|NCT02533674|450535973|FG001|Dose Level V|Physician Decision|0|||
125248738|NCT02533674|450535974|FG002|Dose Level V|Physician Decision|0|||
125248739|NCT02533674|450535975|FG003|Dose Level V|Physician Decision|0|||
125248740|NCT02533674|450535976|FG004|Dose Level V|Physician Decision|1|||
125248741|NCT02533674|450535977|FG005|Dose Level V|Physician Decision|0|||
125248742|NCT02533674|450535978|FG006|Dose Level V|Physician Decision|0|||
125248743|NCT02533674|450535979|FG007|Dose Level V|Physician Decision|0|||
125248744|NCT02533674|450535972|FG000|Dose Level VI|Progressive disease|0|||
125248745|NCT02533674|450535973|FG001|Dose Level VI|Progressive disease|0|||
125248746|NCT02533674|450535974|FG002|Dose Level VI|Progressive disease|0|||
125248747|NCT02533674|450535975|FG003|Dose Level VI|Progressive disease|0|||
125248748|NCT02533674|450535976|FG004|Dose Level VI|Progressive disease|0|||
125248749|NCT02533674|450535977|FG005|Dose Level VI|Progressive disease|7|||
125248750|NCT02533674|450535978|FG006|Dose Level VI|Progressive disease|0|||
125248751|NCT02533674|450535979|FG007|Dose Level VI|Progressive disease|0|||
125248752|NCT02533674|450535972|FG000|Dose Level VI|Withdrawal by Subject|0|||
125248753|NCT02533674|450535973|FG001|Dose Level VI|Withdrawal by Subject|0|||
125248754|NCT02533674|450535974|FG002|Dose Level VI|Withdrawal by Subject|0|||
125248755|NCT02533674|450535975|FG003|Dose Level VI|Withdrawal by Subject|0|||
125248756|NCT02533674|450535976|FG004|Dose Level VI|Withdrawal by Subject|0|||
125248757|NCT02533674|450535977|FG005|Dose Level VI|Withdrawal by Subject|1|||
125248758|NCT02533674|450535978|FG006|Dose Level VI|Withdrawal by Subject|0|||
125248759|NCT02533674|450535979|FG007|Dose Level VI|Withdrawal by Subject|0|||
125248760|NCT02533674|450535972|FG000|Dose Level VI|Treatment-related AE|0|||
125248761|NCT02533674|450535973|FG001|Dose Level VI|Treatment-related AE|0|||
125248762|NCT02533674|450535974|FG002|Dose Level VI|Treatment-related AE|0|||
125248763|NCT02533674|450535975|FG003|Dose Level VI|Treatment-related AE|0|||
125248764|NCT02533674|450535976|FG004|Dose Level VI|Treatment-related AE|0|||
125248765|NCT02533674|450535977|FG005|Dose Level VI|Treatment-related AE|1|||
125248766|NCT02533674|450535978|FG006|Dose Level VI|Treatment-related AE|0|||
125248767|NCT02533674|450535979|FG007|Dose Level VI|Treatment-related AE|0|||
125248768|NCT02533674|450535972|FG000|Dose Level VII|Progressive disease|0|||
125248769|NCT02533674|450535973|FG001|Dose Level VII|Progressive disease|0|||
125248770|NCT02533674|450535974|FG002|Dose Level VII|Progressive disease|0|||
125248771|NCT02533674|450535975|FG003|Dose Level VII|Progressive disease|0|||
125248772|NCT02533674|450535976|FG004|Dose Level VII|Progressive disease|0|||
125248773|NCT02533674|450535977|FG005|Dose Level VII|Progressive disease|0|||
125248774|NCT02533674|450535978|FG006|Dose Level VII|Progressive disease|10|||
125248775|NCT02533674|450535979|FG007|Dose Level VII|Progressive disease|0|||
125248776|NCT02533674|450535972|FG000|Dose Level VII|Withdrawal by Subject|0|||
125248777|NCT02533674|450535973|FG001|Dose Level VII|Withdrawal by Subject|0|||
125248778|NCT02533674|450535974|FG002|Dose Level VII|Withdrawal by Subject|0|||
125248779|NCT02533674|450535975|FG003|Dose Level VII|Withdrawal by Subject|0|||
125248780|NCT02533674|450535976|FG004|Dose Level VII|Withdrawal by Subject|0|||
125248781|NCT02533674|450535977|FG005|Dose Level VII|Withdrawal by Subject|0|||
125248782|NCT02533674|450535978|FG006|Dose Level VII|Withdrawal by Subject|3|||
125248783|NCT02533674|450535979|FG007|Dose Level VII|Withdrawal by Subject|0|||
125248784|NCT02533674|450535972|FG000|Dose Level VII|Treatment-related AE|0|||
125248785|NCT02533674|450535973|FG001|Dose Level VII|Treatment-related AE|0|||
125248786|NCT02533674|450535974|FG002|Dose Level VII|Treatment-related AE|0|||
125248787|NCT02533674|450535975|FG003|Dose Level VII|Treatment-related AE|0|||
125248788|NCT02533674|450535976|FG004|Dose Level VII|Treatment-related AE|0|||
125248789|NCT02533674|450535977|FG005|Dose Level VII|Treatment-related AE|0|||
125248790|NCT02533674|450535978|FG006|Dose Level VII|Treatment-related AE|1|||
125248791|NCT02533674|450535979|FG007|Dose Level VII|Treatment-related AE|0|||
125248792|NCT02533674|450535972|FG000|Dose Level VII|Death|0|||
125248793|NCT02533674|450535973|FG001|Dose Level VII|Death|0|||
125248794|NCT02533674|450535974|FG002|Dose Level VII|Death|0|||
125248795|NCT02533674|450535975|FG003|Dose Level VII|Death|0|||
125248796|NCT02533674|450535976|FG004|Dose Level VII|Death|0|||
125248797|NCT02533674|450535977|FG005|Dose Level VII|Death|0|||
125248798|NCT02533674|450535978|FG006|Dose Level VII|Death|2|||
125248799|NCT02533674|450535979|FG007|Dose Level VII|Death|0|||
125248800|NCT02533674|450535972|FG000|Dose Level VIII|Progressive disease|0|||
125248801|NCT02533674|450535973|FG001|Dose Level VIII|Progressive disease|0|||
125248802|NCT02533674|450535974|FG002|Dose Level VIII|Progressive disease|0|||
125248803|NCT02533674|450535975|FG003|Dose Level VIII|Progressive disease|0|||
125248804|NCT02533674|450535976|FG004|Dose Level VIII|Progressive disease|0|||
125248805|NCT02533674|450535977|FG005|Dose Level VIII|Progressive disease|0|||
125248806|NCT02533674|450535978|FG006|Dose Level VIII|Progressive disease|0|||
125248807|NCT02533674|450535979|FG007|Dose Level VIII|Progressive disease|3|||
125248808|NCT02533674|450535972|FG000|Dose Level VIII|Withdrawal by Subject|0|||
125248809|NCT02533674|450535973|FG001|Dose Level VIII|Withdrawal by Subject|0|||
125248810|NCT02533674|450535974|FG002|Dose Level VIII|Withdrawal by Subject|0|||
125248811|NCT02533674|450535975|FG003|Dose Level VIII|Withdrawal by Subject|0|||
125248812|NCT02533674|450535976|FG004|Dose Level VIII|Withdrawal by Subject|0|||
125248813|NCT02533674|450535977|FG005|Dose Level VIII|Withdrawal by Subject|0|||
125248814|NCT02533674|450535978|FG006|Dose Level VIII|Withdrawal by Subject|0|||
125248815|NCT02533674|450535979|FG007|Dose Level VIII|Withdrawal by Subject|1|||
125248816|NCT02533674|450535972|FG000|Dose Level VIII|Treatment-related AE|0|||
125248817|NCT02533674|450535973|FG001|Dose Level VIII|Treatment-related AE|0|||
125248818|NCT02533674|450535974|FG002|Dose Level VIII|Treatment-related AE|0|||
125248819|NCT02533674|450535975|FG003|Dose Level VIII|Treatment-related AE|0|||
125248820|NCT02533674|450535976|FG004|Dose Level VIII|Treatment-related AE|0|||
125248821|NCT02533674|450535977|FG005|Dose Level VIII|Treatment-related AE|0|||
125248822|NCT02533674|450535978|FG006|Dose Level VIII|Treatment-related AE|0|||
125248823|NCT02533674|450535979|FG007|Dose Level VIII|Treatment-related AE|1|||
125248824|NCT02533674|450535972|FG000|Dose Level VIII|Never treated|0|||
125248825|NCT02533674|450535973|FG001|Dose Level VIII|Never treated|0|||
125248826|NCT02533674|450535974|FG002|Dose Level VIII|Never treated|0|||
125248827|NCT02533674|450535975|FG003|Dose Level VIII|Never treated|0|||
125248828|NCT02533674|450535976|FG004|Dose Level VIII|Never treated|0|||
125248829|NCT02533674|450535977|FG005|Dose Level VIII|Never treated|0|||
125248830|NCT02533674|450535978|FG006|Dose Level VIII|Never treated|0|||
125248831|NCT02533674|450535979|FG007|Dose Level VIII|Never treated|1|||
125248832|NCT01292473|450535983|FG000|Overall Study|Adverse Event|1|||
125248833|NCT01292473|450535984|FG001|Overall Study|Adverse Event|0|||
125248834|NCT01292473|450535985|FG002|Overall Study|Adverse Event|1|||
125248835|NCT01292473|450535986|FG003|Overall Study|Adverse Event|1|||
125248836|NCT01292473|450535983|FG000|Overall Study|Lost to Follow-up|1|||
125248837|NCT01292473|450535984|FG001|Overall Study|Lost to Follow-up|1|||
125248838|NCT01292473|450535985|FG002|Overall Study|Lost to Follow-up|2|||
125248839|NCT01292473|450535986|FG003|Overall Study|Lost to Follow-up|2|||
125248840|NCT01292473|450535983|FG000|Overall Study|Withdrawal by Subject|3|||
125248841|NCT01292473|450535984|FG001|Overall Study|Withdrawal by Subject|4|||
125248842|NCT01292473|450535985|FG002|Overall Study|Withdrawal by Subject|3|||
125248843|NCT01292473|450535986|FG003|Overall Study|Withdrawal by Subject|3|||
125248844|NCT01292473|450535983|FG000|Overall Study|Physician Decision|0|||
125248845|NCT01292473|450535984|FG001|Overall Study|Physician Decision|1|||
125248846|NCT01292473|450535985|FG002|Overall Study|Physician Decision|0|||
125248847|NCT01292473|450535986|FG003|Overall Study|Physician Decision|0|||
125248848|NCT01292473|450535983|FG000|Overall Study|Disease Progression|0|||
125248849|NCT01292473|450535984|FG001|Overall Study|Disease Progression|1|||
125248850|NCT01292473|450535985|FG002|Overall Study|Disease Progression|3|||
125248851|NCT01292473|450535986|FG003|Overall Study|Disease Progression|6|||
125248852|NCT01717859|450535990|FG000|Overall Study|Adverse Event|5|||
125248853|NCT01717859|450535990|FG000|Overall Study|Moved out of state|1|||
125248854|NCT01717859|450535990|FG000|Overall Study|Patient concerned about mental health|1|||
125248855|NCT01717859|450535990|FG000|Overall Study|Lost to Follow-up|1|||
125248856|NCT01717859|450535990|FG000|Overall Study|Withdrawal by Subject|2|||
125248857|NCT04389671|450535991|FG000|Overall Study|Death|7|||
125248858|NCT01111292|450535992|FG000|Treatment|Physician Decision|1|||
125248859|NCT01111292|450535993|FG001|Treatment|Physician Decision|1|||
125248860|NCT05463705|450535997|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
125248861|NCT05463705|450535998|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
125248862|NCT05463705|450535999|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
125248863|NCT05463705|450536000|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
125248864|NCT05463705|450536001|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
125248865|NCT05463705|450536002|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
125248866|NCT01530997|450536008|FG000|Overall Study|Physician Decision|1|||
125248867|NCT01530997|450536008|FG000|Overall Study|Withdrawal by Subject|1|||
125248868|NCT02181738|450536011|FG000|Overall Study|Participant Withdrew Consent|2|||
125248869|NCT02181738|450536012|FG001|Overall Study|Participant Withdrew Consent|1|||
125248870|NCT02181738|450536013|FG002|Overall Study|Participant Withdrew Consent|1|||
125248871|NCT02181738|450536014|FG003|Overall Study|Participant Withdrew Consent|1|||
125248872|NCT02181738|450536011|FG000|Overall Study|Lost to Follow-up|1|||
125248873|NCT02181738|450536012|FG001|Overall Study|Lost to Follow-up|2|||
125248874|NCT02181738|450536013|FG002|Overall Study|Lost to Follow-up|1|||
125248875|NCT02181738|450536014|FG003|Overall Study|Lost to Follow-up|1|||
125248876|NCT02181738|450536011|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
125248877|NCT02181738|450536012|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
125248878|NCT02181738|450536013|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
125248879|NCT02181738|450536014|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
125248880|NCT02181738|450536011|FG000|Overall Study|Poor/Non-Compliance|1|||
125248881|NCT02181738|450536012|FG001|Overall Study|Poor/Non-Compliance|0|||
125395765|NCT01393743|451081717|FG001|Core Study|Participant's Choice|3|||
125395766|NCT01393743|451081718|FG002|Core Study|Participant's Choice|0|||
125395767|NCT01393743|451081716|FG000|Core Study|Inadequate therapeutic effect|2|||
125395768|NCT01393743|451081717|FG001|Core Study|Inadequate therapeutic effect|0|||
125395769|NCT01393743|451081718|FG002|Core Study|Inadequate therapeutic effect|0|||
125395770|NCT01393743|451081716|FG000|Extension Phase|Adverse Event|0|||
125395771|NCT01393743|451081717|FG001|Extension Phase|Adverse Event|0|||
125395772|NCT01393743|451081718|FG002|Extension Phase|Adverse Event|12|||
125195828|NCT02553499|450337960|FG000|Overall Study|Study Terminated by Sponsor|0|||
125195829|NCT02553499|450337961|FG001|Overall Study|Study Terminated by Sponsor|0|||
125195830|NCT02553499|450337962|FG002|Overall Study|Study Terminated by Sponsor|0|||
125195831|NCT02553499|450337963|FG003|Overall Study|Study Terminated by Sponsor|0|||
125195832|NCT02553499|450337964|FG004|Overall Study|Study Terminated by Sponsor|0|||
125195833|NCT02553499|450337965|FG005|Overall Study|Study Terminated by Sponsor|0|||
125195834|NCT02553499|450337966|FG006|Overall Study|Study Terminated by Sponsor|0|||
125195835|NCT02553499|450337967|FG007|Overall Study|Study Terminated by Sponsor|0|||
125195836|NCT02553499|450337968|FG008|Overall Study|Study Terminated by Sponsor|1|||
125195837|NCT02553499|450337969|FG009|Overall Study|Study Terminated by Sponsor|0|||
125195838|NCT02553499|450337970|FG010|Overall Study|Study Terminated by Sponsor|0|||
125195839|NCT02553499|450337971|FG011|Overall Study|Study Terminated by Sponsor|0|||
125195840|NCT02553499|450337972|FG012|Overall Study|Study Terminated by Sponsor|0|||
125195841|NCT02553499|450337973|FG013|Overall Study|Study Terminated by Sponsor|0|||
125195842|NCT02553499|450337960|FG000|Overall Study|Withdrawal by Subject|2|||
125195843|NCT02553499|450337961|FG001|Overall Study|Withdrawal by Subject|0|||
125195844|NCT02553499|450337962|FG002|Overall Study|Withdrawal by Subject|0|||
125195845|NCT02553499|450337963|FG003|Overall Study|Withdrawal by Subject|0|||
125195846|NCT02553499|450337964|FG004|Overall Study|Withdrawal by Subject|0|||
125195847|NCT02553499|450337965|FG005|Overall Study|Withdrawal by Subject|0|||
125195848|NCT02553499|450337966|FG006|Overall Study|Withdrawal by Subject|0|||
125195849|NCT02553499|450337967|FG007|Overall Study|Withdrawal by Subject|1|||
125195850|NCT02553499|450337968|FG008|Overall Study|Withdrawal by Subject|1|||
125195851|NCT02553499|450337969|FG009|Overall Study|Withdrawal by Subject|0|||
125248882|NCT02181738|450536013|FG002|Overall Study|Poor/Non-Compliance|2|||
125248883|NCT02181738|450536014|FG003|Overall Study|Poor/Non-Compliance|1|||
125248884|NCT02181738|450536011|FG000|Overall Study|Disease Progression|28|||
125248885|NCT02181738|450536012|FG001|Overall Study|Disease Progression|35|||
125248886|NCT02181738|450536013|FG002|Overall Study|Disease Progression|40|||
125248887|NCT02181738|450536014|FG003|Overall Study|Disease Progression|0|||
125248888|NCT02181738|450536011|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
125248889|NCT02181738|450536012|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
125248890|NCT02181738|450536013|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
125248891|NCT02181738|450536014|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
125248892|NCT02181738|450536011|FG000|Overall Study|Study Drug Toxicity|6|||
125248893|NCT02181738|450536012|FG001|Overall Study|Study Drug Toxicity|11|||
125248894|NCT02181738|450536013|FG002|Overall Study|Study Drug Toxicity|8|||
125248895|NCT02181738|450536014|FG003|Overall Study|Study Drug Toxicity|1|||
125248896|NCT02181738|450536011|FG000|Overall Study|Other Reasons|14|||
125248897|NCT02181738|450536012|FG001|Overall Study|Other Reasons|16|||
125248898|NCT02181738|450536013|FG002|Overall Study|Other Reasons|28|||
125248899|NCT02181738|450536014|FG003|Overall Study|Other Reasons|0|||
125248900|NCT02181738|450536011|FG000|Overall Study|Maximum Clinical Benefit|3|||
125248901|NCT02181738|450536012|FG001|Overall Study|Maximum Clinical Benefit|0|||
125248902|NCT02181738|450536013|FG002|Overall Study|Maximum Clinical Benefit|1|||
125248903|NCT02181738|450536014|FG003|Overall Study|Maximum Clinical Benefit|0|||
125248904|NCT02181738|450536011|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
125248905|NCT02181738|450536012|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
125248906|NCT02181738|450536013|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
125248907|NCT02181738|450536014|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
125395773|NCT01393743|451081716|FG000|Extension Phase|Lost to Follow-up|0|||
125395774|NCT01393743|451081717|FG001|Extension Phase|Lost to Follow-up|0|||
125195852|NCT02553499|450337970|FG010|Overall Study|Withdrawal by Subject|1|||
125248908|NCT01691482|450536018|FG000|Treatment Period 2|Adverse Event|0|||
125248909|NCT01691482|450536019|FG001|Treatment Period 2|Adverse Event|1|||
125248910|NCT01691482|450536018|FG000|Treatment Period 2|Protocol Violation|1|||
125248911|NCT01691482|450536019|FG001|Treatment Period 2|Protocol Violation|1|||
125395775|NCT01393743|451081718|FG002|Extension Phase|Lost to Follow-up|2|||
125195853|NCT02553499|450337971|FG011|Overall Study|Withdrawal by Subject|0|||
125195854|NCT02553499|450337972|FG012|Overall Study|Withdrawal by Subject|0|||
125195855|NCT02553499|450337973|FG013|Overall Study|Withdrawal by Subject|0|||
125395776|NCT01393743|451081716|FG000|Extension Phase|Participant choice|0|||
125395777|NCT01393743|451081717|FG001|Extension Phase|Participant choice|0|||
125395778|NCT01393743|451081718|FG002|Extension Phase|Participant choice|16|||
125395779|NCT01393743|451081716|FG000|Extension Phase|Inadequate therapeutic effect|0|||
125395780|NCT01393743|451081717|FG001|Extension Phase|Inadequate therapeutic effect|0|||
125395781|NCT01393743|451081718|FG002|Extension Phase|Inadequate therapeutic effect|7|||
125395782|NCT01393743|451081716|FG000|Extension Phase|Withdrawal by Subject|0|||
125395783|NCT01393743|451081717|FG001|Extension Phase|Withdrawal by Subject|0|||
125395784|NCT01393743|451081718|FG002|Extension Phase|Withdrawal by Subject|8|||
125395785|NCT01393743|451081716|FG000|Extension Phase|Pregnancy|0|||
125395786|NCT01393743|451081717|FG001|Extension Phase|Pregnancy|0|||
125395787|NCT01393743|451081718|FG002|Extension Phase|Pregnancy|1|||
125395788|NCT01393743|451081716|FG000|Extension Phase|Other|0|||
125395789|NCT01393743|451081717|FG001|Extension Phase|Other|0|||
125395790|NCT01393743|451081718|FG002|Extension Phase|Other|14|||
125395791|NCT02321462|451081719|FG000|Overall Study|Withdrawal by Subject|5|||
125395792|NCT02321462|451081720|FG001|Overall Study|Withdrawal by Subject|2|||
125395793|NCT02321462|451081719|FG000|Overall Study|Subject withdrawn before any treatment|1|||
125395794|NCT02321462|451081720|FG001|Overall Study|Subject withdrawn before any treatment|1|||
125395795|NCT03829046|451081736|FG000|Overall Study|Withdrawal by Subject|1|||
125395796|NCT03829046|451081737|FG001|Overall Study|Withdrawal by Subject|0|||
125395797|NCT00989833|451081739|FG000|Overall Study|Lost to Follow-up|0|||
125395798|NCT00989833|451081740|FG001|Overall Study|Lost to Follow-up|1|||
125395799|NCT00989833|451081741|FG002|Overall Study|Lost to Follow-up|0|||
125395800|NCT00989833|451081739|FG000|Overall Study|Protocol Violation|1|||
125395801|NCT00989833|451081740|FG001|Overall Study|Protocol Violation|2|||
125395802|NCT00989833|451081741|FG002|Overall Study|Protocol Violation|1|||
125395803|NCT00989833|451081739|FG000|Overall Study|Withdrawal by Subject|0|||
125395804|NCT00989833|451081740|FG001|Overall Study|Withdrawal by Subject|0|||
125395805|NCT00989833|451081741|FG002|Overall Study|Withdrawal by Subject|1|||
125395806|NCT00989833|451081739|FG000|Overall Study|Incorrectly randomized|1|||
125395807|NCT00989833|451081740|FG001|Overall Study|Incorrectly randomized|0|||
125395808|NCT00989833|451081741|FG002|Overall Study|Incorrectly randomized|0|||
125395809|NCT00244712|451081744|FG000|Overall Study|Adverse Event|20|||
125395810|NCT00244712|451081745|FG001|Overall Study|Adverse Event|21|||
125395811|NCT00244712|451081744|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
125395812|NCT00244712|451081745|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
125395813|NCT00244712|451081744|FG000|Overall Study|Lack of Compliance|10|||
125395814|NCT00244712|451081745|FG001|Overall Study|Lack of Compliance|11|||
125395815|NCT00244712|451081744|FG000|Overall Study|Lost to Follow-up|45|||
125395816|NCT00244712|451081745|FG001|Overall Study|Lost to Follow-up|52|||
125395817|NCT00244712|451081744|FG000|Overall Study|Withdrawal by Subject|13|||
125395818|NCT00244712|451081745|FG001|Overall Study|Withdrawal by Subject|23|||
125395819|NCT00244712|451081744|FG000|Overall Study|Protocol Violation, disease progression|13|||
125395820|NCT00244712|451081745|FG001|Overall Study|Protocol Violation, disease progression|11|||
125395821|NCT00500370|451081746|FG000|Overall Study|Adverse Event|9|||
125395822|NCT00500370|451081747|FG001|Overall Study|Adverse Event|3|||
125395823|NCT00500370|451081746|FG000|Overall Study|Lost to Follow-up|10|||
125395824|NCT00500370|451081747|FG001|Overall Study|Lost to Follow-up|10|||
125395825|NCT00500370|451081746|FG000|Overall Study|Protocol Violation|2|||
125395826|NCT00500370|451081747|FG001|Overall Study|Protocol Violation|4|||
125395827|NCT00500370|451081746|FG000|Overall Study|Sponsor Decision|2|||
125395828|NCT00500370|451081747|FG001|Overall Study|Sponsor Decision|0|||
125395829|NCT00500370|451081746|FG000|Overall Study|Subject Decision|10|||
125395830|NCT00500370|451081747|FG001|Overall Study|Subject Decision|17|||
125395831|NCT01282424|451081748|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
125395832|NCT01282424|451081748|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
125395833|NCT01282424|451081748|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
125395834|NCT01282424|451081748|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
125395835|NCT01282424|451081748|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
125395836|NCT01282424|451081748|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
125395837|NCT01282424|451081748|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
125395838|NCT01282424|451081748|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
125395839|NCT00714259|451081749|FG000|Overall Study|Death|2|||
125395840|NCT05627518|451081750|FG000|Treatment Period 1|Adverse Event|0|||
125395841|NCT05627518|451081751|FG001|Treatment Period 1|Adverse Event|0|||
125395842|NCT05627518|451081752|FG002|Treatment Period 1|Adverse Event|1|||
125395843|NCT05627518|451081753|FG003|Treatment Period 1|Adverse Event|0|||
125395844|NCT05627518|451081754|FG004|Treatment Period 1|Adverse Event|0|||
125395845|NCT05627518|451081755|FG005|Treatment Period 1|Adverse Event|0|||
125395846|NCT05627518|451081756|FG006|Treatment Period 1|Adverse Event|0|||
125395847|NCT05627518|451081757|FG007|Treatment Period 1|Adverse Event|1|||
125395848|NCT05627518|451081750|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125395849|NCT05627518|451081751|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125395850|NCT05627518|451081752|FG002|Treatment Period 1|Withdrawal by Subject|1|||
125395851|NCT05627518|451081753|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125248912|NCT00183391|450536020|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
125248913|NCT00183391|450536021|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
125248914|NCT00183391|450536020|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
125248915|NCT00183391|450536021|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
125248916|NCT01986751|450536022|FG000|Overall Study|improperly consented|10|||
125248917|NCT01986751|450536023|FG001|Overall Study|improperly consented|2|||
125248918|NCT01478087|450536024|FG000|Overall Study|due to sponsor closing study|1|||
125248919|NCT04576949|450536025|FG000|Overall Study|Adverse Event|1|||
125248920|NCT04576949|450536026|FG001|Overall Study|Adverse Event|3|||
125248921|NCT04576949|450536027|FG002|Overall Study|Adverse Event|2|||
125248922|NCT04576949|450536025|FG000|Overall Study|Withdrawal by Subject|41|||
125248923|NCT04576949|450536026|FG001|Overall Study|Withdrawal by Subject|26|||
125248924|NCT04576949|450536027|FG002|Overall Study|Withdrawal by Subject|18|||
125248925|NCT04576949|450536025|FG000|Overall Study|Physician Decision|3|||
125248926|NCT04576949|450536026|FG001|Overall Study|Physician Decision|0|||
125248927|NCT04576949|450536027|FG002|Overall Study|Physician Decision|0|||
125248928|NCT04576949|450536025|FG000|Overall Study|Death|0|||
125248929|NCT04576949|450536026|FG001|Overall Study|Death|1|||
125248930|NCT04576949|450536027|FG002|Overall Study|Death|0|||
125248931|NCT04576949|450536025|FG000|Overall Study|Lost to Follow-up|29|||
125248932|NCT04576949|450536026|FG001|Overall Study|Lost to Follow-up|37|||
125248933|NCT04576949|450536027|FG002|Overall Study|Lost to Follow-up|24|||
125248934|NCT04576949|450536025|FG000|Overall Study|Other, Not Specified|2|||
125248935|NCT04576949|450536026|FG001|Overall Study|Other, Not Specified|3|||
125248936|NCT04576949|450536027|FG002|Overall Study|Other, Not Specified|1|||
125248937|NCT04576949|450536025|FG000|Overall Study|Other|1|||
125248938|NCT04576949|450536026|FG001|Overall Study|Other|0|||
125248939|NCT04576949|450536027|FG002|Overall Study|Other|0|||
125248940|NCT00407030|450536028|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
125248941|NCT00407030|450536029|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
125248942|NCT00407030|450536030|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
125248943|NCT00407030|450536028|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
125248944|NCT00407030|450536029|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
125248945|NCT00407030|450536030|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
125248946|NCT00407030|450536028|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
125248947|NCT00407030|450536029|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
125248948|NCT00407030|450536030|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
125248949|NCT00407030|450536028|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
125248950|NCT00407030|450536029|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
125248951|NCT00407030|450536030|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
125248952|NCT00407030|450536028|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
125248953|NCT00407030|450536029|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
125248954|NCT00407030|450536030|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
125248955|NCT00407030|450536028|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
125195856|NCT01726270|450337976|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
125195857|NCT01726270|450337976|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
125195858|NCT01726270|450337976|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
125195859|NCT01726270|450337976|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
125195860|NCT01726270|450337976|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
125195861|NCT01726270|450337976|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
125195862|NCT02073929|450337989|FG000|Overall Study|Lost to Follow-up|2|||
125195863|NCT02073929|450337990|FG001|Overall Study|Lost to Follow-up|1|||
125195864|NCT02073929|450337989|FG000|Overall Study|Adverse Event|2|||
125195865|NCT02073929|450337990|FG001|Overall Study|Adverse Event|1|||
125195866|NCT02073929|450337989|FG000|Overall Study|Withdrawal by Subject|0|||
125195867|NCT02073929|450337990|FG001|Overall Study|Withdrawal by Subject|1|||
125195868|NCT03319732|450337994|FG000|Overall Study|Adverse Event|40|||
125195869|NCT03319732|450337994|FG000|Overall Study|Withdrawal by Subject|50|||
125195870|NCT03319732|450337994|FG000|Overall Study|MS relapse|10|||
125195871|NCT03319732|450337994|FG000|Overall Study|reason not specified|5|||
125195872|NCT03887442|450337995|FG000|Overall Study|Adverse Event|1|||
125195873|NCT03887442|450337996|FG001|Overall Study|Adverse Event|0|||
125195874|NCT00430573|450337997|FG000|Overall Study|Withdrawal by Subject|5|||
125195875|NCT00072280|450337998|FG000|Treatment|Found ineligible|1|||
125195876|NCT00072280|450337999|FG001|Treatment|Found ineligible|2|||
125195877|NCT00072280|450337998|FG000|Follow-up|Early termination of study|2|||
125195878|NCT00072280|450337999|FG001|Follow-up|Early termination of study|2|||
125195879|NCT05020665|450338000|FG000|Overall Study|Study terminated by Sponsor|5|||
125195880|NCT05020665|450338001|FG001|Overall Study|Study terminated by Sponsor|4|||
125195881|NCT05020665|450338000|FG000|Overall Study|Death|2|||
125195882|NCT05020665|450338001|FG001|Overall Study|Death|1|||
125248956|NCT00407030|450536029|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
125248957|NCT00407030|450536030|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
125248958|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
125248959|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
125248960|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
125248961|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
125248962|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
125248963|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
125248964|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
125248965|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
125248966|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
125248967|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
125248968|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
125195883|NCT05020665|450338000|FG000|Overall Study|Physician Decision|0|||
125248969|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
125248970|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
125248971|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
125248972|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
125248973|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
125248974|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
125248975|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
125248976|NCT00407030|450536028|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
125248977|NCT00407030|450536029|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
125248978|NCT00407030|450536030|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
125248979|NCT01489358|450536031|FG000|Overall Study|Lost to Follow-up|0|||
125248980|NCT01489358|450536032|FG001|Overall Study|Lost to Follow-up|0|||
125248981|NCT01489358|450536033|FG002|Overall Study|Lost to Follow-up|2|||
125248982|NCT00736476|450536034|FG000|Overall Study|Adverse Event|1|||
125248983|NCT00736476|450536035|FG001|Overall Study|Adverse Event|0|||
125248984|NCT03518203|450536041|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
125248985|NCT03518203|450536041|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
125248986|NCT02829957|450536042|FG000|Overall Study|Lost to Follow-up|2|||
125248987|NCT02829957|450536043|FG001|Overall Study|Lost to Follow-up|1|||
125248988|NCT04560309|450536045|FG000|Overall Study|Meet drop out criteria|1|||
125248989|NCT04560309|450536046|FG001|Overall Study|Meet drop out criteria|1|||
125248990|NCT05085405|450536047|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
125248991|NCT05085405|450536048|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
125248992|NCT05085405|450536049|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
125248993|NCT05085405|450536050|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
125195884|NCT05020665|450338001|FG001|Overall Study|Physician Decision|1|||
125195885|NCT05020665|450338000|FG000|Overall Study|Withdrawal by Subject|0|||
125195886|NCT05020665|450338001|FG001|Overall Study|Withdrawal by Subject|1|||
125195887|NCT05020665|450338000|FG000|Overall Study|Reason not specified|1|||
125195888|NCT05020665|450338001|FG001|Overall Study|Reason not specified|0|||
125195889|NCT02504827|450338002|FG000|Overall Study|Could not produce sputum|1|||
125195890|NCT00877487|450338010|FG000|Open-label Treatment Phase|Adverse Event|1|||
125195891|NCT00877487|450338011|FG001|Open-label Treatment Phase|Adverse Event|0|||
125195892|NCT00877487|450338010|FG000|Open-label Treatment Phase|Protocol Violation|3|||
125195893|NCT00877487|450338011|FG001|Open-label Treatment Phase|Protocol Violation|0|||
125195894|NCT00877487|450338010|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
125195895|NCT00877487|450338011|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
125195896|NCT00877487|450338010|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
125195897|NCT00877487|450338011|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
125195898|NCT00877487|450338010|FG000|Open-label Treatment Phase|Out of country for business|1|||
125195899|NCT00877487|450338011|FG001|Open-label Treatment Phase|Out of country for business|0|||
125195900|NCT00877487|450338010|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
125195901|NCT00877487|450338011|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
125195902|NCT00877487|450338010|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
125195903|NCT00877487|450338011|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
125195904|NCT00877487|450338010|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
125195905|NCT00877487|450338011|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
125195906|NCT00877487|450338010|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
125195907|NCT00877487|450338011|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
125195908|NCT03070002|450338012|FG000|Follow up for 2 Years|Death|1|||
125195909|NCT04740827|450338017|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
125195910|NCT04740827|450338018|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
125195911|NCT04740827|450338017|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
125248994|NCT05085405|450536051|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
125248995|NCT05085405|450536052|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
125195912|NCT04740827|450338018|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
125395852|NCT05627518|451081754|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125395853|NCT05627518|451081755|FG005|Treatment Period 1|Withdrawal by Subject|1|||
125395854|NCT05627518|451081756|FG006|Treatment Period 1|Withdrawal by Subject|0|||
125395855|NCT05627518|451081757|FG007|Treatment Period 1|Withdrawal by Subject|0|||
125395856|NCT05627518|451081750|FG000|Treatment Period 1|Protocol Violation|0|||
125395857|NCT05627518|451081751|FG001|Treatment Period 1|Protocol Violation|0|||
125395858|NCT05627518|451081752|FG002|Treatment Period 1|Protocol Violation|0|||
125395859|NCT05627518|451081753|FG003|Treatment Period 1|Protocol Violation|0|||
125395860|NCT05627518|451081754|FG004|Treatment Period 1|Protocol Violation|0|||
125395861|NCT05627518|451081755|FG005|Treatment Period 1|Protocol Violation|0|||
125395862|NCT05627518|451081756|FG006|Treatment Period 1|Protocol Violation|6|||
125395863|NCT05627518|451081757|FG007|Treatment Period 1|Protocol Violation|6|||
125395864|NCT05627518|451081750|FG000|Treatment Period 2|Adverse Event|1|||
125395865|NCT05627518|451081751|FG001|Treatment Period 2|Adverse Event|0|||
125395866|NCT05627518|451081752|FG002|Treatment Period 2|Adverse Event|0|||
125395867|NCT05627518|451081753|FG003|Treatment Period 2|Adverse Event|0|||
125395868|NCT05627518|451081754|FG004|Treatment Period 2|Adverse Event|0|||
125395869|NCT05627518|451081755|FG005|Treatment Period 2|Adverse Event|0|||
125395870|NCT05627518|451081756|FG006|Treatment Period 2|Adverse Event|0|||
125395871|NCT05627518|451081757|FG007|Treatment Period 2|Adverse Event|0|||
125395872|NCT05627518|451081750|FG000|Treatment Period 2|Withdrawal by Subject|1|||
125395873|NCT05627518|451081751|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125395874|NCT05627518|451081752|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125395875|NCT05627518|451081753|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125395876|NCT05627518|451081754|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125395877|NCT05627518|451081755|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125395878|NCT05627518|451081756|FG006|Treatment Period 2|Withdrawal by Subject|0|||
125195913|NCT04740827|450338017|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
125195914|NCT04740827|450338018|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
125395879|NCT05627518|451081757|FG007|Treatment Period 2|Withdrawal by Subject|0|||
125395880|NCT04804813|451081758|FG000|Overall Study|Protocol Violation|2|||
125395881|NCT04804813|451081759|FG001|Overall Study|Protocol Violation|0|||
125395882|NCT04804813|451081758|FG000|Overall Study|Withdrawal by Subject|1|||
125395883|NCT04804813|451081759|FG001|Overall Study|Withdrawal by Subject|0|||
125395884|NCT02777125|451081765|FG000|Overall Study|Consent form violation|14|||
125395885|NCT02777125|451081766|FG001|Overall Study|Consent form violation|12|||
125395886|NCT02777125|451081765|FG000|Overall Study|Assent form violation|21|||
125395887|NCT02777125|451081766|FG001|Overall Study|Assent form violation|23|||
125395888|NCT02777125|451081765|FG000|Overall Study|Protocol Violation|8|||
125395889|NCT02777125|451081766|FG001|Overall Study|Protocol Violation|12|||
125395890|NCT00574405|451082952|FG000|Overall Study|Withdrawal by Subject|3|||
125395891|NCT00574405|451082953|FG001|Overall Study|Withdrawal by Subject|2|||
125395892|NCT01336738|451082954|FG000|Overall Study|Adverse Event|0|||
125395893|NCT01336738|451082955|FG001|Overall Study|Adverse Event|3|||
125395894|NCT01336738|451082956|FG002|Overall Study|Adverse Event|2|||
125395895|NCT01336738|451082957|FG003|Overall Study|Adverse Event|1|||
125395896|NCT01336738|451082958|FG004|Overall Study|Adverse Event|3|||
125395897|NCT01336738|451082954|FG000|Overall Study|Lost to Follow-up|2|||
125395898|NCT01336738|451082955|FG001|Overall Study|Lost to Follow-up|1|||
125395899|NCT01336738|451082956|FG002|Overall Study|Lost to Follow-up|2|||
125395900|NCT01336738|451082957|FG003|Overall Study|Lost to Follow-up|2|||
125395901|NCT01336738|451082958|FG004|Overall Study|Lost to Follow-up|2|||
125395902|NCT01336738|451082954|FG000|Overall Study|Did not meet entrance criteria|0|||
125395903|NCT01336738|451082955|FG001|Overall Study|Did not meet entrance criteria|1|||
125395904|NCT01336738|451082956|FG002|Overall Study|Did not meet entrance criteria|0|||
125395905|NCT01336738|451082957|FG003|Overall Study|Did not meet entrance criteria|0|||
125395906|NCT01336738|451082958|FG004|Overall Study|Did not meet entrance criteria|0|||
125395907|NCT01336738|451082954|FG000|Overall Study|Protocol Violation|0|||
125395908|NCT01336738|451082955|FG001|Overall Study|Protocol Violation|1|||
125395909|NCT01336738|451082956|FG002|Overall Study|Protocol Violation|0|||
125395910|NCT01336738|451082957|FG003|Overall Study|Protocol Violation|0|||
125395911|NCT01336738|451082958|FG004|Overall Study|Protocol Violation|0|||
125395912|NCT01336738|451082954|FG000|Overall Study|Withdrawal by Subject|2|||
125395913|NCT01336738|451082955|FG001|Overall Study|Withdrawal by Subject|0|||
125395914|NCT01336738|451082956|FG002|Overall Study|Withdrawal by Subject|2|||
125395915|NCT01336738|451082957|FG003|Overall Study|Withdrawal by Subject|1|||
125395916|NCT01336738|451082958|FG004|Overall Study|Withdrawal by Subject|1|||
125395917|NCT01336738|451082954|FG000|Overall Study|Other|3|||
125395918|NCT01336738|451082955|FG001|Overall Study|Other|3|||
125395919|NCT01336738|451082956|FG002|Overall Study|Other|2|||
125195915|NCT04740827|450338017|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
125395920|NCT01336738|451082957|FG003|Overall Study|Other|3|||
125395921|NCT01336738|451082958|FG004|Overall Study|Other|4|||
125395922|NCT03003520|451082960|FG000|Overall Study|Adverse Event|9|||
125195916|NCT04740827|450338018|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
125395923|NCT03003520|451082961|FG001|Overall Study|Adverse Event|0|||
125395924|NCT03003520|451082960|FG000|Overall Study|Death|1|||
125248996|NCT05085405|450536047|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
125248997|NCT05085405|450536048|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
125248998|NCT05085405|450536049|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
125248999|NCT05085405|450536050|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
125249000|NCT05085405|450536051|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
125249001|NCT05085405|450536052|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
125249002|NCT01370538|450536055|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
125249003|NCT01370538|450536056|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
125249004|NCT01370538|450536055|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125249005|NCT01370538|450536056|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125249006|NCT01370538|450536055|FG000|Overall Study|Adverse Event|1|||
125249007|NCT01370538|450536056|FG001|Overall Study|Adverse Event|0|||
125249008|NCT01370538|450536055|FG000|Overall Study|Protocol Violation|8|||
125249009|NCT01370538|450536056|FG001|Overall Study|Protocol Violation|5|||
125249010|NCT01370538|450536055|FG000|Overall Study|Development of study specific withdrawal|1|||
125249011|NCT01370538|450536056|FG001|Overall Study|Development of study specific withdrawal|1|||
125249012|NCT01370538|450536055|FG000|Overall Study|Lost to follow up|6|||
125249013|NCT01370538|450536056|FG001|Overall Study|Lost to follow up|10|||
125249014|NCT04193527|450536057|FG000|Overall Study|Other|1|||
125249015|NCT04193527|450536058|FG001|Overall Study|Other|1|||
125249016|NCT04193527|450536059|FG002|Overall Study|Other|0|||
125249017|NCT02366130|450536060|FG000|Overall Study|Withdrawal by Subject|3|||
125249018|NCT02366130|450536060|FG000|Overall Study|Ineligible|6|||
125249019|NCT00567112|450536061|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
125249020|NCT00567112|450536062|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
125249021|NCT00567112|450536063|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
125249022|NCT00567112|450536061|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
125249023|NCT00567112|450536062|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
125249024|NCT00567112|450536063|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
125249025|NCT00567112|450536061|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
125395925|NCT03003520|451082961|FG001|Overall Study|Death|0|||
125395926|NCT03003520|451082960|FG000|Overall Study|Other reasons|4|||
125395927|NCT03003520|451082961|FG001|Overall Study|Other reasons|0|||
125395928|NCT03003520|451082960|FG000|Overall Study|Withdrawal by Subject|6|||
125395929|NCT03003520|451082961|FG001|Overall Study|Withdrawal by Subject|0|||
125395930|NCT03003520|451082960|FG000|Overall Study|Progressive disease|9|||
125395931|NCT03003520|451082961|FG001|Overall Study|Progressive disease|1|||
125395932|NCT05458856|451082964|FG000|Overall Study|Withdrawal by Subject|5|||
125395933|NCT05458856|451082964|FG000|Overall Study|Death|4|||
125395934|NCT05458856|451082964|FG000|Overall Study|Protocol Deviation|3|||
125395935|NCT05458856|451082964|FG000|Overall Study|Physician Decision|1|||
125395936|NCT05084053|451082965|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
125395937|NCT05084053|451082966|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
125395938|NCT05084053|451082967|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
125395939|NCT05084053|451082968|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
125395940|NCT05084053|451082965|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
125395941|NCT05084053|451082966|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
125195917|NCT04740827|450338017|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
125195918|NCT04740827|450338018|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
125195919|NCT04740827|450338017|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
125195920|NCT04740827|450338018|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
125195921|NCT01435018|450339869|FG000|Overall Study|Death|37|||
125195922|NCT01435018|450339870|FG001|Overall Study|Death|18|||
125195923|NCT01435018|450339871|FG002|Overall Study|Death|25|||
125195924|NCT01435018|450339869|FG000|Overall Study|Site is closing|4|||
125195925|NCT01435018|450339870|FG001|Overall Study|Site is closing|9|||
125195926|NCT01435018|450339871|FG002|Overall Study|Site is closing|7|||
125195927|NCT01435018|450339869|FG000|Overall Study|Withdrew consent|0|||
125195928|NCT01435018|450339870|FG001|Overall Study|Withdrew consent|3|||
125195929|NCT01435018|450339871|FG002|Overall Study|Withdrew consent|1|||
125195930|NCT01435018|450339869|FG000|Overall Study|Not willing to adhere to requirements|0|||
125195931|NCT01435018|450339870|FG001|Overall Study|Not willing to adhere to requirements|2|||
125195932|NCT01435018|450339871|FG002|Overall Study|Not willing to adhere to requirements|3|||
125195933|NCT01435018|450339869|FG000|Overall Study|Not able to get to clinic|2|||
125249026|NCT00567112|450536062|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
125249027|NCT00567112|450536063|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
125249028|NCT04595370|450536074|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
125249029|NCT04595370|450536075|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
125249030|NCT04595370|450536076|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
125395942|NCT05084053|451082967|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
125195934|NCT01435018|450339870|FG001|Overall Study|Not able to get to clinic|0|||
125195935|NCT01435018|450339871|FG002|Overall Study|Not able to get to clinic|2|||
125195936|NCT01435018|450339869|FG000|Overall Study|Severe debilitation, unable to continue|0|||
125195937|NCT01435018|450339870|FG001|Overall Study|Severe debilitation, unable to continue|0|||
125195938|NCT01435018|450339871|FG002|Overall Study|Severe debilitation, unable to continue|1|||
125195939|NCT01435018|450339869|FG000|Overall Study|Unable to contact participant/parent|1|||
125195940|NCT01435018|450339870|FG001|Overall Study|Unable to contact participant/parent|1|||
125195941|NCT01435018|450339871|FG002|Overall Study|Unable to contact participant/parent|1|||
125195942|NCT01435018|450339869|FG000|Overall Study|Enrollment Violation|0|||
125195943|NCT01435018|450339870|FG001|Overall Study|Enrollment Violation|1|||
125195944|NCT01435018|450339871|FG002|Overall Study|Enrollment Violation|0|||
125195945|NCT01435018|450339869|FG000|Overall Study|Never started chemotherapy|3|||
125195946|NCT01435018|450339870|FG001|Overall Study|Never started chemotherapy|0|||
125195947|NCT01435018|450339871|FG002|Overall Study|Never started chemotherapy|1|||
125195950|NCT03806933|450339874|FG000|Main Period|Physician Decision|0|||
125195951|NCT03806933|450339875|FG001|Main Period|Physician Decision|0|||
125195952|NCT03806933|450339876|FG002|Main Period|Physician Decision|0|||
125195953|NCT03806933|450339877|FG003|Main Period|Physician Decision|1|||
125195954|NCT03806933|450339874|FG000|Main Period|Pregnancy|0|||
125195955|NCT03806933|450339875|FG001|Main Period|Pregnancy|0|||
125195956|NCT03806933|450339876|FG002|Main Period|Pregnancy|1|||
125195957|NCT03806933|450339877|FG003|Main Period|Pregnancy|0|||
125195958|NCT03806933|450339874|FG000|Main Period|Withdrawal by Subject|2|||
125195959|NCT03806933|450339875|FG001|Main Period|Withdrawal by Subject|1|||
125195960|NCT03806933|450339876|FG002|Main Period|Withdrawal by Subject|1|||
125195961|NCT03806933|450339877|FG003|Main Period|Withdrawal by Subject|2|||
125195962|NCT03806933|450339874|FG000|Main Period|Lost to Follow-up|2|||
125195963|NCT03806933|450339875|FG001|Main Period|Lost to Follow-up|2|||
125195964|NCT03806933|450339876|FG002|Main Period|Lost to Follow-up|0|||
125195965|NCT03806933|450339877|FG003|Main Period|Lost to Follow-up|0|||
125195966|NCT03806933|450339874|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
125195967|NCT03806933|450339875|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
125195968|NCT03806933|450339876|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
125195969|NCT03806933|450339877|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
125195970|NCT00078767|450339878|FG000|Overall Study|Withdrawal by Subject|1|||
125195971|NCT00078767|450339879|FG001|Overall Study|Withdrawal by Subject|1|||
125195972|NCT02282631|450339880|FG000|Overall Study|Lost to Follow-up|2|||
125195973|NCT02282631|450339881|FG001|Overall Study|Lost to Follow-up|0|||
125195974|NCT00831311|450339884|FG000|Overall Study|Definitive Contraindication|3|||
125195975|NCT00831311|450339885|FG001|Overall Study|Definitive Contraindication|3|||
125195976|NCT00831311|450339884|FG000|Overall Study|Lost to Follow-up|3|||
125195977|NCT00831311|450339885|FG001|Overall Study|Lost to Follow-up|0|||
125195978|NCT00831311|450339884|FG000|Overall Study|Physician Decision|0|||
125195979|NCT00831311|450339885|FG001|Overall Study|Physician Decision|1|||
125195980|NCT00831311|450339884|FG000|Overall Study|Withdrawal by Subject|6|||
125195981|NCT00831311|450339885|FG001|Overall Study|Withdrawal by Subject|4|||
125195982|NCT01841762|450339887|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
125195983|NCT01841762|450339887|FG000|Treatment Period|Adverse Event|16|||
125195984|NCT01841762|450339887|FG000|Treatment Period|Death|1|||
125195985|NCT01841762|450339887|FG000|Treatment Period|Withdrawal by Subject|7|||
125195986|NCT01841762|450339887|FG000|Treatment Period|Lost to Follow-up|1|||
125195987|NCT01841762|450339887|FG000|Treatment Period|Physician Decision|2|||
125195988|NCT01841762|450339887|FG000|Treatment Period|Other, including non-compliance|5|||
125195989|NCT01841762|450339887|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
125195990|NCT01841762|450339887|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
125195991|NCT01841762|450339887|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
125195992|NCT01841762|450339887|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
125195993|NCT01868438|450339888|FG000|First Intervention|Withdrawal by Subject|5|||
125195994|NCT01868438|450339889|FG001|First Intervention|Withdrawal by Subject|1|||
125195995|NCT01868438|450339888|FG000|First Intervention|Lost to Follow-up|2|||
125195996|NCT01868438|450339889|FG001|First Intervention|Lost to Follow-up|3|||
125195997|NCT01868438|450339888|FG000|First Intervention|Meeting the non-redosing criteria|0|||
125195998|NCT01868438|450339889|FG001|First Intervention|Meeting the non-redosing criteria|1|||
125195999|NCT01868438|450339888|FG000|Second Intervention|Adverse Event|3|||
125196000|NCT01868438|450339889|FG001|Second Intervention|Adverse Event|3|||
125196001|NCT03260244|450339890|FG000|Overall Study|Death|19|||
125196002|NCT03260244|450339890|FG000|Overall Study|Lost to Follow-up|60|||
125196003|NCT03260244|450339890|FG000|Overall Study|Withdrawal by Subject|48|||
125196004|NCT03260244|450339890|FG000|Overall Study|Procedure Not Performed|21|||
125196005|NCT03260244|450339890|FG000|Overall Study|Enrollment Criteria Not Met|31|||
125196006|NCT03260244|450339890|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
125395943|NCT05084053|451082968|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
125395944|NCT05084053|451082965|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
125395945|NCT05084053|451082966|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
125196007|NCT03260244|450339890|FG000|Overall Study|Subject Noncompliance|6|||
125395946|NCT05084053|451082967|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
125196008|NCT03260244|450339890|FG000|Overall Study|No inducible Arrhythmia|2|||
125196009|NCT03260244|450339890|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
125395947|NCT05084053|451082968|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
125395948|NCT01920932|451082969|FG000|Overall Study|Death|1|||
125395949|NCT01920932|451082969|FG000|Overall Study|Withdrawal of consent|1|||
125395950|NCT00071812|451082970|FG000|24-Week Double-Blind Period|Adverse Event|2|||
125395951|NCT00071812|451082971|FG001|24-Week Double-Blind Period|Adverse Event|3|||
125395952|NCT00071812|451082972|FG002|24-Week Double-Blind Period|Adverse Event|4|||
125395953|NCT00071812|451082973|FG003|24-Week Double-Blind Period|Adverse Event|4|||
125395954|NCT00071812|451082970|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
125395955|NCT00071812|451082971|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
125395956|NCT00071812|451082972|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
125395957|NCT00071812|451082973|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
125395958|NCT00071812|451082970|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
125395959|NCT00071812|451082971|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
125395960|NCT00071812|451082972|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
125395961|NCT00071812|451082973|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
125395962|NCT00071812|451082970|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
125395963|NCT00071812|451082971|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
125395964|NCT00071812|451082972|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
125395965|NCT00071812|451082973|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
125395966|NCT00071812|451082970|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
125395967|NCT00071812|451082971|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
125395968|NCT00071812|451082972|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
125395969|NCT00071812|451082973|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
125395970|NCT00071812|451082970|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
125395971|NCT00071812|451082971|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
125395972|NCT00071812|451082972|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
125395973|NCT00071812|451082973|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
125395974|NCT00071812|451082970|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
125395975|NCT00071812|451082971|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
125395976|NCT00071812|451082972|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
125395977|NCT00071812|451082973|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
125395978|NCT00071812|451082970|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
125395979|NCT00071812|451082971|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
125395980|NCT00071812|451082972|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
125395981|NCT00071812|451082973|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
125395982|NCT00071812|451082970|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125395983|NCT00071812|451082971|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125395984|NCT00071812|451082972|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125395985|NCT00071812|451082973|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
125395986|NCT00071812|451082970|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
125395987|NCT00071812|451082971|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
125395988|NCT00071812|451082972|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
125395989|NCT00071812|451082973|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
125395990|NCT05168475|451082974|FG000|Period 1|Protocol Violation|1|||
125395991|NCT05168475|451082974|FG000|Period 1|IMP shortage|2|||
125395992|NCT05168475|451082974|FG000|Period 1|Not randomised|2|||
125395993|NCT05168475|451082974|FG000|Period 2|IMP shortage|1|||
125395994|NCT01589822|451082975|FG000|Overall Study|Withdrawal by Subject|1|||
125395995|NCT01589822|451082976|FG001|Overall Study|Withdrawal by Subject|2|||
125395996|NCT01589822|451082977|FG002|Overall Study|Withdrawal by Subject|0|||
125395997|NCT01589822|451082975|FG000|Overall Study|Death|1|||
125395998|NCT01589822|451082976|FG001|Overall Study|Death|0|||
125395999|NCT01589822|451082977|FG002|Overall Study|Death|0|||
125396000|NCT01589822|451082975|FG000|Overall Study|Missed 90 day visit|2|||
125396001|NCT01589822|451082976|FG001|Overall Study|Missed 90 day visit|1|||
125396002|NCT01589822|451082977|FG002|Overall Study|Missed 90 day visit|1|||
125396003|NCT01140477|451082978|FG000|Overall Study|Lost to Follow-up|4|||
125396004|NCT01140477|451082979|FG001|Overall Study|Lost to Follow-up|0|||
125396005|NCT01140477|451082978|FG000|Overall Study|Withdrawal by Subject|1|||
125396006|NCT01140477|451082979|FG001|Overall Study|Withdrawal by Subject|4|||
125396007|NCT01140477|451082978|FG000|Overall Study|Surgical complication preventing implant|2|||
125396008|NCT01140477|451082979|FG001|Overall Study|Surgical complication preventing implant|0|||
125396009|NCT01140477|451082978|FG000|Overall Study|Death|1|||
125196010|NCT03260244|450339890|FG000|Overall Study|Screen Failure|2|||
125196011|NCT03260244|450339890|FG000|Overall Study|Treated Off Label|69|||
125396010|NCT01140477|451082979|FG001|Overall Study|Death|1|||
125396011|NCT01140477|451082978|FG000|Overall Study|Subject explanted|0|||
125396012|NCT01140477|451082979|FG001|Overall Study|Subject explanted|1|||
125396013|NCT01945489|451082986|FG000|Cycle 1|Adverse Event|2|||
125396014|NCT01945489|451082987|FG001|Cycle 1|Adverse Event|0|||
125396015|NCT01945489|451082986|FG000|Cycle 1|Lost to Follow-up|4|||
125249031|NCT04595370|450536077|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
125249032|NCT04595370|450536078|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
125249033|NCT04595370|450536079|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
125249034|NCT04595370|450536074|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
125249035|NCT04595370|450536075|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
125249036|NCT04595370|450536076|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
125249037|NCT04595370|450536077|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
125249038|NCT04595370|450536078|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
125249039|NCT04595370|450536079|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
125249040|NCT04595370|450536074|FG000|Overall Study|Adverse Event|0|||
125249041|NCT04595370|450536075|FG001|Overall Study|Adverse Event|4|||
125249042|NCT04595370|450536076|FG002|Overall Study|Adverse Event|3|||
125249043|NCT04595370|450536077|FG003|Overall Study|Adverse Event|1|||
125249044|NCT04595370|450536078|FG004|Overall Study|Adverse Event|1|||
125249045|NCT04595370|450536079|FG005|Overall Study|Adverse Event|1|||
125249046|NCT04595370|450536074|FG000|Overall Study|Withdrawal of Consent|1|||
125249047|NCT04595370|450536075|FG001|Overall Study|Withdrawal of Consent|1|||
125249048|NCT04595370|450536076|FG002|Overall Study|Withdrawal of Consent|1|||
125249049|NCT04595370|450536077|FG003|Overall Study|Withdrawal of Consent|0|||
125249050|NCT04595370|450536078|FG004|Overall Study|Withdrawal of Consent|0|||
125249051|NCT04595370|450536079|FG005|Overall Study|Withdrawal of Consent|0|||
125249052|NCT04595370|450536074|FG000|Overall Study|Death|0|||
125249053|NCT04595370|450536075|FG001|Overall Study|Death|1|||
125249054|NCT04595370|450536076|FG002|Overall Study|Death|0|||
125249055|NCT04595370|450536077|FG003|Overall Study|Death|0|||
125249056|NCT04595370|450536078|FG004|Overall Study|Death|1|||
125249057|NCT04595370|450536079|FG005|Overall Study|Death|0|||
125249058|NCT04595370|450536074|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125249059|NCT04595370|450536075|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125249060|NCT04595370|450536076|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
125249061|NCT04595370|450536077|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125396016|NCT01945489|451082987|FG001|Cycle 1|Lost to Follow-up|0|||
125396017|NCT01945489|451082986|FG000|Cycle 1|Personal Reasons|4|||
125396018|NCT01945489|451082987|FG001|Cycle 1|Personal Reasons|2|||
125396019|NCT01945489|451082986|FG000|Cycle 1|Protocol Violation|0|||
125396020|NCT01945489|451082987|FG001|Cycle 1|Protocol Violation|1|||
125396021|NCT01945489|451082986|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
125396022|NCT01945489|451082987|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
125396023|NCT01945489|451082986|FG000|Cycle 2|Adverse Event|1|||
125396024|NCT01945489|451082987|FG001|Cycle 2|Adverse Event|0|||
125396025|NCT01945489|451082986|FG000|Cycle 2|Lost to Follow-up|0|||
125396026|NCT01945489|451082987|FG001|Cycle 2|Lost to Follow-up|1|||
125396027|NCT03569371|451082988|FG000|Overall Study|Lack of Efficacy|1|||
125396028|NCT03569371|451082988|FG000|Overall Study|Lost to Follow-up|1|||
125396029|NCT03569371|451082988|FG000|Overall Study|Adverse Event|1|||
125396030|NCT01236755|451082989|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
125396031|NCT01236755|451082989|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
125396032|NCT01236755|451082989|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
125396033|NCT01236755|451082989|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
125396034|NCT01539226|451082992|FG000|Overall Study|Withdrawal by Subject|24|||
125396035|NCT01539226|451082993|FG001|Overall Study|Withdrawal by Subject|54|||
125396036|NCT01539226|451082992|FG000|Overall Study|Lost to Follow-up|20|||
125396037|NCT01539226|451082993|FG001|Overall Study|Lost to Follow-up|54|||
125396038|NCT01539226|451082992|FG000|Overall Study|Death|1|||
125396039|NCT01539226|451082993|FG001|Overall Study|Death|2|||
125396040|NCT01539226|451082992|FG000|Overall Study|Adverse Event|2|||
125396041|NCT01539226|451082993|FG001|Overall Study|Adverse Event|0|||
125396042|NCT01539226|451082992|FG000|Overall Study|Pregnancy|13|||
125396043|NCT01539226|451082993|FG001|Overall Study|Pregnancy|29|||
125249062|NCT04595370|450536078|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125249063|NCT04595370|450536079|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125396044|NCT01539226|451082992|FG000|Overall Study|inappropriate enrollment|0|||
125396045|NCT01539226|451082993|FG001|Overall Study|inappropriate enrollment|1|||
125396046|NCT01539226|451082992|FG000|Overall Study|Multiple Reasons|3|||
125396047|NCT01539226|451082993|FG001|Overall Study|Multiple Reasons|1|||
125396048|NCT01539226|451082992|FG000|Overall Study|not HIV seroconversion-related|93|||
125396049|NCT01539226|451082993|FG001|Overall Study|not HIV seroconversion-related|176|||
125249064|NCT04595370|450536074|FG000|Overall Study|Withdrawal by Subject|0|||
125249065|NCT04595370|450536075|FG001|Overall Study|Withdrawal by Subject|0|||
125249066|NCT04595370|450536076|FG002|Overall Study|Withdrawal by Subject|1|||
125249067|NCT04595370|450536077|FG003|Overall Study|Withdrawal by Subject|0|||
125396050|NCT01539226|451082992|FG000|Overall Study|HIV seroconversion-related|55|||
125396051|NCT01539226|451082993|FG001|Overall Study|HIV seroconversion-related|80|||
125396052|NCT01539226|451082992|FG000|Overall Study|Non-compliance|6|||
125396053|NCT01539226|451082993|FG001|Overall Study|Non-compliance|8|||
125196012|NCT03260244|450339890|FG000|Overall Study|No Radiofrequency Ablation|14|||
125196013|NCT03528369|450339893|FG000|Overall Study|Withdrawal by Subject|2|||
125196014|NCT03528369|450339894|FG001|Overall Study|Withdrawal by Subject|0|||
125196015|NCT03528369|450339895|FG002|Overall Study|Withdrawal by Subject|0|||
125196016|NCT03528369|450339893|FG000|Overall Study|Lost to Follow-up|1|||
125196017|NCT03528369|450339894|FG001|Overall Study|Lost to Follow-up|0|||
125196018|NCT03528369|450339895|FG002|Overall Study|Lost to Follow-up|0|||
125196019|NCT03528369|450339893|FG000|Overall Study|Adverse Event|0|||
125196020|NCT03528369|450339894|FG001|Overall Study|Adverse Event|1|||
125196021|NCT03528369|450339895|FG002|Overall Study|Adverse Event|0|||
125196022|NCT00160706|450339896|FG000|Overall Study|Adverse Event|53|||
125196023|NCT00160706|450339896|FG000|Overall Study|Adverse Event and Other Reason|105|||
125196024|NCT00160706|450339896|FG000|Overall Study|Protocol Violation|3|||
125196025|NCT00160706|450339896|FG000|Overall Study|Withdrawal by Subject|41|||
125196026|NCT00160706|450339896|FG000|Overall Study|Withdrawal by Subject and Other|12|||
125196027|NCT00160706|450339896|FG000|Overall Study|Physician Decision|10|||
125196028|NCT00160706|450339896|FG000|Overall Study|Physician Decision and Other|3|||
125196029|NCT00160706|450339896|FG000|Overall Study|Lost to Follow-up|4|||
125196030|NCT00160706|450339896|FG000|Overall Study|Lost to Follow-up and Other|1|||
125196031|NCT00160706|450339896|FG000|Overall Study|Lack of Efficacy|42|||
125196032|NCT00160706|450339896|FG000|Overall Study|Lack of Efficacy and Other|1|||
125196033|NCT00160706|450339896|FG000|Overall Study|Other Reason|11|||
125196034|NCT03214380|450339897|FG000|Lead-in|Adverse Event|3|||
125196035|NCT03214380|450339898|FG001|Lead-in|Adverse Event|0|||
125196036|NCT03214380|450339899|FG002|Lead-in|Adverse Event|0|||
125196037|NCT03214380|450339900|FG003|Lead-in|Adverse Event|1|||
125196038|NCT03214380|450339901|FG004|Lead-in|Adverse Event|0|||
125196039|NCT03214380|450339902|FG005|Lead-in|Adverse Event|0|||
125196040|NCT03214380|450339897|FG000|Lead-in|Lost to Follow-up|4|||
125196041|NCT03214380|450339898|FG001|Lead-in|Lost to Follow-up|0|||
125196042|NCT03214380|450339899|FG002|Lead-in|Lost to Follow-up|0|||
125196043|NCT03214380|450339900|FG003|Lead-in|Lost to Follow-up|1|||
125196044|NCT03214380|450339901|FG004|Lead-in|Lost to Follow-up|0|||
125196045|NCT03214380|450339902|FG005|Lead-in|Lost to Follow-up|0|||
125196046|NCT03214380|450339897|FG000|Lead-in|Eligibility Criteria|3|||
125196047|NCT03214380|450339898|FG001|Lead-in|Eligibility Criteria|0|||
125196048|NCT03214380|450339899|FG002|Lead-in|Eligibility Criteria|0|||
125196049|NCT03214380|450339900|FG003|Lead-in|Eligibility Criteria|0|||
125196050|NCT03214380|450339901|FG004|Lead-in|Eligibility Criteria|0|||
125196051|NCT03214380|450339902|FG005|Lead-in|Eligibility Criteria|0|||
125196052|NCT03214380|450339897|FG000|Lead-in|Physician Decision|6|||
125196053|NCT03214380|450339898|FG001|Lead-in|Physician Decision|0|||
125196054|NCT03214380|450339899|FG002|Lead-in|Physician Decision|0|||
125196055|NCT03214380|450339900|FG003|Lead-in|Physician Decision|0|||
125196056|NCT03214380|450339901|FG004|Lead-in|Physician Decision|0|||
125196057|NCT03214380|450339902|FG005|Lead-in|Physician Decision|0|||
125196058|NCT03214380|450339897|FG000|Lead-in|Protocol Deviation|7|||
125196059|NCT03214380|450339898|FG001|Lead-in|Protocol Deviation|0|||
125196060|NCT03214380|450339899|FG002|Lead-in|Protocol Deviation|0|||
125196061|NCT03214380|450339900|FG003|Lead-in|Protocol Deviation|3|||
125196062|NCT03214380|450339901|FG004|Lead-in|Protocol Deviation|0|||
125196063|NCT03214380|450339902|FG005|Lead-in|Protocol Deviation|0|||
125196064|NCT03214380|450339897|FG000|Lead-in|Withdrawal by Subject|41|||
125196065|NCT03214380|450339898|FG001|Lead-in|Withdrawal by Subject|0|||
125196066|NCT03214380|450339899|FG002|Lead-in|Withdrawal by Subject|0|||
125196067|NCT03214380|450339900|FG003|Lead-in|Withdrawal by Subject|14|||
125196068|NCT03214380|450339901|FG004|Lead-in|Withdrawal by Subject|0|||
125196069|NCT03214380|450339902|FG005|Lead-in|Withdrawal by Subject|0|||
125196070|NCT03214380|450339897|FG000|Lead-in|Family Emergency|1|||
125196071|NCT03214380|450339898|FG001|Lead-in|Family Emergency|0|||
125196072|NCT03214380|450339899|FG002|Lead-in|Family Emergency|0|||
125196073|NCT03214380|450339900|FG003|Lead-in|Family Emergency|0|||
125196074|NCT03214380|450339901|FG004|Lead-in|Family Emergency|0|||
125196075|NCT03214380|450339902|FG005|Lead-in|Family Emergency|0|||
125196076|NCT03214380|450339897|FG000|Lead-in|Natural Disaster|9|||
125196077|NCT03214380|450339898|FG001|Lead-in|Natural Disaster|0|||
125196078|NCT03214380|450339899|FG002|Lead-in|Natural Disaster|0|||
125196079|NCT03214380|450339900|FG003|Lead-in|Natural Disaster|0|||
125196080|NCT03214380|450339901|FG004|Lead-in|Natural Disaster|0|||
125196081|NCT03214380|450339902|FG005|Lead-in|Natural Disaster|0|||
125196082|NCT03214380|450339897|FG000|Lead-in|Non Compliance|1|||
125196083|NCT03214380|450339898|FG001|Lead-in|Non Compliance|0|||
125196084|NCT03214380|450339899|FG002|Lead-in|Non Compliance|0|||
125196085|NCT03214380|450339900|FG003|Lead-in|Non Compliance|0|||
125196086|NCT03214380|450339901|FG004|Lead-in|Non Compliance|0|||
125196087|NCT03214380|450339902|FG005|Lead-in|Non Compliance|0|||
125196088|NCT03214380|450339897|FG000|Lead-in|Participant Schedule|2|||
125196089|NCT03214380|450339898|FG001|Lead-in|Participant Schedule|0|||
125196090|NCT03214380|450339899|FG002|Lead-in|Participant Schedule|0|||
125196091|NCT03214380|450339900|FG003|Lead-in|Participant Schedule|0|||
125196092|NCT03214380|450339901|FG004|Lead-in|Participant Schedule|0|||
125196093|NCT03214380|450339902|FG005|Lead-in|Participant Schedule|0|||
125196094|NCT03214380|450339897|FG000|Treatment Period|Adverse Event|0|||
125249068|NCT04595370|450536078|FG004|Overall Study|Withdrawal by Subject|2|||
125249069|NCT04595370|450536079|FG005|Overall Study|Withdrawal by Subject|0|||
125249070|NCT04595370|450536074|FG000|Overall Study|Lost to Follow-up|0|||
125249071|NCT04595370|450536075|FG001|Overall Study|Lost to Follow-up|0|||
125249072|NCT04595370|450536076|FG002|Overall Study|Lost to Follow-up|0|||
125249073|NCT04595370|450536077|FG003|Overall Study|Lost to Follow-up|0|||
125249074|NCT04595370|450536078|FG004|Overall Study|Lost to Follow-up|1|||
125249075|NCT04595370|450536079|FG005|Overall Study|Lost to Follow-up|0|||
125249076|NCT04595370|450536074|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
125249077|NCT04595370|450536075|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
125249078|NCT04595370|450536076|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
125249079|NCT04595370|450536077|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
125249080|NCT04595370|450536078|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
125249081|NCT04595370|450536079|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
125249082|NCT01945242|450536080|FG000|Overall Study|Physician Decision|3|||
125249083|NCT01945242|450536081|FG001|Overall Study|Physician Decision|3|||
125249084|NCT05661734|450536084|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
125249085|NCT05661734|450536084|FG000|Overall Study|Lost to Follow-up|13|||
125249086|NCT05661734|450536084|FG000|Overall Study|Enrolled but not dosed|2|||
125249087|NCT01125748|450536085|FG000|Overall Study|Adverse Event|0|||
125249088|NCT01125748|450536086|FG001|Overall Study|Adverse Event|2|||
125249089|NCT01125748|450536085|FG000|Overall Study|Lost to Follow-up|0|||
125249090|NCT01125748|450536086|FG001|Overall Study|Lost to Follow-up|1|||
125249091|NCT01125748|450536085|FG000|Overall Study|Physician Decision|8|||
125249092|NCT01125748|450536086|FG001|Overall Study|Physician Decision|7|||
125249093|NCT01125748|450536085|FG000|Overall Study|Patient Decision to Withdraw|2|||
125249094|NCT01125748|450536086|FG001|Overall Study|Patient Decision to Withdraw|4|||
125249095|NCT02405962|450536087|FG000|Overall Study|Lost to Follow-up|1|||
125249096|NCT02405962|450536088|FG001|Overall Study|Lost to Follow-up|4|||
125249097|NCT02405962|450536087|FG000|Overall Study|A participant has moved to another place|0|||
125249098|NCT02405962|450536088|FG001|Overall Study|A participant has moved to another place|1|||
125249099|NCT01028391|450536089|FG000|Overall Study|Adverse Event|4|||
125249100|NCT01028391|450536090|FG001|Overall Study|Adverse Event|0|||
125249101|NCT01028391|450536089|FG000|Overall Study|Lack of Efficacy|0|||
125249102|NCT01028391|450536090|FG001|Overall Study|Lack of Efficacy|2|||
125249103|NCT01028391|450536089|FG000|Overall Study|Lost to Follow-up|3|||
125249104|NCT01028391|450536090|FG001|Overall Study|Lost to Follow-up|4|||
125249105|NCT01028391|450536089|FG000|Overall Study|Physician Decision|0|||
125249106|NCT01028391|450536090|FG001|Overall Study|Physician Decision|1|||
125249107|NCT01028391|450536089|FG000|Overall Study|Withdrawal by Subject|6|||
125249108|NCT01028391|450536090|FG001|Overall Study|Withdrawal by Subject|3|||
125249109|NCT01028391|450536089|FG000|Overall Study|Needed excluded medication|1|||
125249110|NCT01028391|450536090|FG001|Overall Study|Needed excluded medication|1|||
125249111|NCT01184118|450536091|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
125249112|NCT01184118|450536091|FG000|Overall Study|No physiologic confirmation of asthma|8|||
125249113|NCT01184118|450536091|FG000|Overall Study|FEV1 <60% predicted|2|||
125249114|NCT01184118|450536091|FG000|Overall Study|Exclusionary medical condition|2|||
125249115|NCT01184118|450536091|FG000|Overall Study|Withdrawal by Subject|5|||
125249116|NCT01049828|450536099|FG000|Overall Study|Claustrophibia and Frustration|2|||
125249117|NCT02946996|450536103|FG000|Overall Study|non-evaluable|3|||
125249118|NCT02946996|450536104|FG001|Overall Study|non-evaluable|6|||
125249119|NCT02946996|450536105|FG002|Overall Study|non-evaluable|5|||
125249120|NCT03572218|450536108|FG000|Overall Study|Lost to Follow-up|3|||
125249121|NCT03572218|450536109|FG001|Overall Study|Lost to Follow-up|2|||
125249122|NCT03572218|450536108|FG000|Overall Study|No longer available for study visits|2|||
125249123|NCT03572218|450536109|FG001|Overall Study|No longer available for study visits|1|||
125249124|NCT03572218|450536108|FG000|Overall Study|No longer interested|1|||
125249125|NCT03572218|450536109|FG001|Overall Study|No longer interested|2|||
125249126|NCT00286455|450536110|FG000|Overall Study|Hyperglycemia rescue|19|||
125249127|NCT00286455|450536111|FG001|Overall Study|Hyperglycemia rescue|13|||
125249128|NCT00286455|450536112|FG002|Overall Study|Hyperglycemia rescue|10|||
125249129|NCT00286455|450536110|FG000|Overall Study|Adverse Event|1|||
125249130|NCT00286455|450536111|FG001|Overall Study|Adverse Event|3|||
125249131|NCT00286455|450536112|FG002|Overall Study|Adverse Event|2|||
125249132|NCT00286455|450536110|FG000|Overall Study|Lost to Follow-up|0|||
125249133|NCT00286455|450536111|FG001|Overall Study|Lost to Follow-up|3|||
125249134|NCT00286455|450536112|FG002|Overall Study|Lost to Follow-up|3|||
125249135|NCT00286455|450536110|FG000|Overall Study|Physician Decision|3|||
125249136|NCT00286455|450536111|FG001|Overall Study|Physician Decision|0|||
125249137|NCT00286455|450536112|FG002|Overall Study|Physician Decision|2|||
125249138|NCT00286455|450536110|FG000|Overall Study|Protocol Violation|1|||
125249139|NCT00286455|450536111|FG001|Overall Study|Protocol Violation|1|||
125249140|NCT00286455|450536112|FG002|Overall Study|Protocol Violation|0|||
125249141|NCT00286455|450536110|FG000|Overall Study|Participant Non-compliance|1|||
125249142|NCT00286455|450536111|FG001|Overall Study|Participant Non-compliance|0|||
125196095|NCT03214380|450339898|FG001|Treatment Period|Adverse Event|1|||
125196096|NCT03214380|450339899|FG002|Treatment Period|Adverse Event|1|||
125196097|NCT03214380|450339900|FG003|Treatment Period|Adverse Event|0|||
125196098|NCT03214380|450339901|FG004|Treatment Period|Adverse Event|1|||
125196099|NCT03214380|450339902|FG005|Treatment Period|Adverse Event|0|||
125196100|NCT03214380|450339897|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
125196101|NCT03214380|450339898|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
125196102|NCT03214380|450339899|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
125196103|NCT03214380|450339900|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
125196104|NCT03214380|450339901|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
125196105|NCT03214380|450339902|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
125196106|NCT03214380|450339897|FG000|Treatment Period|Withdrawal by Subject|0|||
125196107|NCT03214380|450339898|FG001|Treatment Period|Withdrawal by Subject|10|||
125196108|NCT03214380|450339899|FG002|Treatment Period|Withdrawal by Subject|8|||
125196109|NCT03214380|450339900|FG003|Treatment Period|Withdrawal by Subject|0|||
125196110|NCT03214380|450339901|FG004|Treatment Period|Withdrawal by Subject|7|||
125196111|NCT03214380|450339902|FG005|Treatment Period|Withdrawal by Subject|11|||
125196112|NCT03214380|450339897|FG000|Treatment Period|Death|0|||
125196113|NCT03214380|450339898|FG001|Treatment Period|Death|1|||
125196114|NCT03214380|450339899|FG002|Treatment Period|Death|2|||
125196115|NCT03214380|450339900|FG003|Treatment Period|Death|0|||
125196116|NCT03214380|450339901|FG004|Treatment Period|Death|0|||
125196117|NCT03214380|450339902|FG005|Treatment Period|Death|0|||
125196118|NCT03214380|450339897|FG000|Treatment Period|Lost to Follow-up|0|||
125196119|NCT03214380|450339898|FG001|Treatment Period|Lost to Follow-up|6|||
125196120|NCT03214380|450339899|FG002|Treatment Period|Lost to Follow-up|3|||
125196121|NCT03214380|450339900|FG003|Treatment Period|Lost to Follow-up|0|||
125196122|NCT03214380|450339901|FG004|Treatment Period|Lost to Follow-up|0|||
125196123|NCT03214380|450339902|FG005|Treatment Period|Lost to Follow-up|0|||
125196124|NCT03214380|450339897|FG000|Treatment Period|Participant schedule|0|||
125196125|NCT03214380|450339898|FG001|Treatment Period|Participant schedule|0|||
125196126|NCT03214380|450339899|FG002|Treatment Period|Participant schedule|1|||
125196127|NCT03214380|450339900|FG003|Treatment Period|Participant schedule|0|||
125196128|NCT03214380|450339901|FG004|Treatment Period|Participant schedule|0|||
125196129|NCT03214380|450339902|FG005|Treatment Period|Participant schedule|0|||
125196130|NCT03214380|450339897|FG000|Treatment Period|Treatment Interruption|0|||
125196131|NCT03214380|450339898|FG001|Treatment Period|Treatment Interruption|0|||
125196132|NCT03214380|450339899|FG002|Treatment Period|Treatment Interruption|1|||
125196133|NCT03214380|450339900|FG003|Treatment Period|Treatment Interruption|0|||
125196134|NCT03214380|450339901|FG004|Treatment Period|Treatment Interruption|0|||
125196135|NCT03214380|450339902|FG005|Treatment Period|Treatment Interruption|0|||
125196136|NCT03555565|450339903|FG000|Overall Study|Case Report Forms Uncollected|2|||
125196137|NCT03555565|450339903|FG000|Overall Study|Protocol Deviation|13|||
125196138|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
125196139|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
125196140|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
125196141|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
125196142|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
125196143|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
125196144|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
125196145|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
125196146|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Death|0|||
125196147|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Death|1|||
125196148|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
125196149|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
125196150|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
125196151|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
125196152|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
125196153|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
125196154|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
125196155|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
125196156|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
125196157|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
125196158|NCT00394836|450339904|FG000|Teatment or Follow-up Phase|Non compliance|0|||
125196159|NCT00394836|450339905|FG001|Teatment or Follow-up Phase|Non compliance|1|||
125249143|NCT00286455|450536112|FG002|Overall Study|Participant Non-compliance|0|||
125396054|NCT02643251|451082994|FG000|Overall Study|Adverse Event|3|||
125396055|NCT02643251|451082995|FG001|Overall Study|Adverse Event|1|||
125396056|NCT02643251|451082994|FG000|Overall Study|Withdrawal by Subject|2|||
125196160|NCT00394836|450339904|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
125196161|NCT00394836|450339905|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
125396057|NCT02643251|451082995|FG001|Overall Study|Withdrawal by Subject|0|||
125396058|NCT02643251|451082994|FG000|Overall Study|Lost to Follow-up|4|||
125196162|NCT00394836|450339904|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
125196163|NCT00394836|450339905|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
125196164|NCT00394836|450339904|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
125196165|NCT00394836|450339905|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
125196166|NCT00394836|450339904|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
125196167|NCT00394836|450339905|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
125196168|NCT01163851|450339911|FG000|Overall Study|Site Closure|0|||
125196169|NCT01163851|450339912|FG001|Overall Study|Site Closure|1|||
125196170|NCT01163851|450339911|FG000|Overall Study|Enrolled but not treated|1|||
125196171|NCT01163851|450339912|FG001|Overall Study|Enrolled but not treated|0|||
125196172|NCT03192306|450339915|FG000|Overall Study|Did not treat cold sore during study|149|||
125196173|NCT03192306|450339916|FG001|Overall Study|Did not treat cold sore during study|143|||
125196174|NCT03192306|450339915|FG000|Overall Study|Withdrawal by Subject|1|||
125196175|NCT03192306|450339916|FG001|Overall Study|Withdrawal by Subject|1|||
125196176|NCT03192306|450339915|FG000|Overall Study|Lost to Follow-up|1|||
125196177|NCT03192306|450339916|FG001|Overall Study|Lost to Follow-up|0|||
125196178|NCT03192306|450339915|FG000|Overall Study|Protocol Violation|1|||
125196179|NCT03192306|450339916|FG001|Overall Study|Protocol Violation|1|||
125196180|NCT01289639|450339924|FG000|Overall Study|Lost to Follow-up|1|||
125196181|NCT01289639|450339925|FG001|Overall Study|Lost to Follow-up|0|||
125196182|NCT01289639|450339926|FG002|Overall Study|Lost to Follow-up|0|||
125196183|NCT02780713|450339927|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
125196184|NCT02780713|450339928|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
125196185|NCT02780713|450339929|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
125196186|NCT02780713|450339930|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
125196187|NCT02780713|450339931|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
125196188|NCT02111577|450339932|FG000|Overall Study|Protocol Violation|2|||
125196189|NCT02111577|450339933|FG001|Overall Study|Protocol Violation|0|||
125196190|NCT02111577|450339932|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
125196191|NCT02111577|450339933|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
125196192|NCT02111577|450339932|FG000|Overall Study|Failure to produce study treatment|6|||
125196193|NCT02111577|450339933|FG001|Overall Study|Failure to produce study treatment|0|||
125196194|NCT02111577|450339932|FG000|Overall Study|Death|518|||
125196195|NCT02111577|450339933|FG001|Overall Study|Death|254|||
125196196|NCT02111577|450339932|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
125196197|NCT02111577|450339933|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
125196198|NCT02111577|450339932|FG000|Overall Study|Adverse Event|1|||
125196199|NCT02111577|450339933|FG001|Overall Study|Adverse Event|1|||
125196200|NCT02111577|450339932|FG000|Overall Study|Withdrawal by Subject|51|||
125196201|NCT02111577|450339933|FG001|Overall Study|Withdrawal by Subject|23|||
125196202|NCT02111577|450339932|FG000|Overall Study|Disease progression|0|||
125196203|NCT02111577|450339933|FG001|Overall Study|Disease progression|1|||
125196204|NCT02111577|450339932|FG000|Overall Study|Lost to Follow-up|19|||
125196205|NCT02111577|450339933|FG001|Overall Study|Lost to Follow-up|10|||
125196206|NCT02042950|450339934|FG000|Overall Study|Progressive Disease|4|||
125196207|NCT02429778|450339937|FG000|Overall Study|Lost to Follow-up|2|||
125196208|NCT02429778|450339938|FG001|Overall Study|Lost to Follow-up|0|||
125196209|NCT02429778|450339937|FG000|Overall Study|Withdrawal by Subject|5|||
125196210|NCT02429778|450339938|FG001|Overall Study|Withdrawal by Subject|0|||
125196211|NCT01981954|450339945|FG000|Titration Period|Protocol Deviation|1|||
125196212|NCT01981954|450339945|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
125196213|NCT03655470|450339946|FG000|Overall Study|Lost to Follow-up|6|||
125196214|NCT03655470|450339947|FG001|Overall Study|Lost to Follow-up|7|||
125196215|NCT03063086|450339951|FG000|Overall Study|technical problems|1|||
125196216|NCT03063086|450339952|FG001|Overall Study|technical problems|0|||
125196217|NCT03063086|450339953|FG002|Overall Study|technical problems|0|||
125196218|NCT03063086|450339954|FG003|Overall Study|technical problems|0|||
125196219|NCT03063086|450339955|FG004|Overall Study|technical problems|0|||
125196220|NCT03063086|450339956|FG005|Overall Study|technical problems|0|||
125196221|NCT03063086|450339951|FG000|Overall Study|Adverse Event|1|||
125196222|NCT03063086|450339952|FG001|Overall Study|Adverse Event|1|||
125196223|NCT03063086|450339953|FG002|Overall Study|Adverse Event|1|||
125196224|NCT03063086|450339954|FG003|Overall Study|Adverse Event|1|||
125196225|NCT03063086|450339955|FG004|Overall Study|Adverse Event|0|||
125196226|NCT03063086|450339956|FG005|Overall Study|Adverse Event|0|||
125196227|NCT03063086|450339951|FG000|Overall Study|subject/guardian decision|1|||
125249144|NCT00286455|450536110|FG000|Overall Study|Withdrawal by Subject|0|||
125249145|NCT00286455|450536111|FG001|Overall Study|Withdrawal by Subject|8|||
125196228|NCT03063086|450339952|FG001|Overall Study|subject/guardian decision|0|||
125196229|NCT03063086|450339953|FG002|Overall Study|subject/guardian decision|0|||
125196230|NCT03063086|450339954|FG003|Overall Study|subject/guardian decision|0|||
125196231|NCT03063086|450339955|FG004|Overall Study|subject/guardian decision|0|||
125196232|NCT03063086|450339956|FG005|Overall Study|subject/guardian decision|0|||
125196233|NCT03063086|450339951|FG000|Overall Study|Non-compliance with study treatment|0|||
125196234|NCT03063086|450339952|FG001|Overall Study|Non-compliance with study treatment|0|||
125396059|NCT02643251|451082995|FG001|Overall Study|Lost to Follow-up|1|||
125396060|NCT02643251|451082994|FG000|Overall Study|Protocol Violation|1|||
125396061|NCT02643251|451082995|FG001|Overall Study|Protocol Violation|0|||
125396062|NCT02643251|451082994|FG000|Overall Study|PI Decision to terminate patient|1|||
125396063|NCT02643251|451082995|FG001|Overall Study|PI Decision to terminate patient|0|||
125396064|NCT02365636|451082997|FG000|Overall Study|Adverse Event|3|||
125396065|NCT02365636|451082998|FG001|Overall Study|Adverse Event|3|||
125396066|NCT02365636|451082999|FG002|Overall Study|Adverse Event|2|||
125396067|NCT02365636|451082997|FG000|Overall Study|Protocol Violation|1|||
125396068|NCT02365636|451082998|FG001|Overall Study|Protocol Violation|4|||
125396069|NCT02365636|451082999|FG002|Overall Study|Protocol Violation|0|||
125396070|NCT02365636|451082997|FG000|Overall Study|Lost to Follow-up|0|||
125396071|NCT02365636|451082998|FG001|Overall Study|Lost to Follow-up|0|||
125396072|NCT02365636|451082999|FG002|Overall Study|Lost to Follow-up|1|||
125396073|NCT02365636|451082997|FG000|Overall Study|Other|2|||
125396074|NCT02365636|451082998|FG001|Overall Study|Other|0|||
125396075|NCT02365636|451082999|FG002|Overall Study|Other|0|||
125396076|NCT01782313|451083008|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
125396077|NCT01782313|451083008|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
125396078|NCT01782313|451083008|FG000|Treated Cycle 3|Progressive Disease|21|||
125396079|NCT01782313|451083008|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
125396080|NCT01782313|451083008|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
125396081|NCT01782313|451083008|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
125396082|NCT01782313|451083008|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
125396083|NCT01782313|451083008|FG000|Survival Follow up|Lost to Follow-up|1|||
125396084|NCT02506816|451083009|FG000|Overall Study|Adverse Event|3|||
125396085|NCT01067352|451083014|FG000|Overall Study|Withdrawal by Subject|1|||
125396086|NCT01067352|451083015|FG001|Overall Study|Withdrawal by Subject|2|||
125443734|NCT01473420|451252245|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
125443735|NCT01473420|451252244|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
125443736|NCT01473420|451252245|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
125443737|NCT01473420|451252244|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
125443738|NCT01473420|451252245|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
125443739|NCT01473420|451252244|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
125443740|NCT01473420|451252245|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
125443741|NCT01141660|451252252|FG000|Overall Study|Physician Decision|0|||
125443742|NCT01141660|451252253|FG001|Overall Study|Physician Decision|12|||
125443743|NCT01848834|451252254|FG000|Overall Study|Adverse Event|3|||
125443744|NCT01848834|451252255|FG001|Overall Study|Adverse Event|11|||
125443745|NCT01848834|451252256|FG002|Overall Study|Adverse Event|3|||
125443746|NCT01848834|451252257|FG003|Overall Study|Adverse Event|5|||
125443747|NCT01848834|451252258|FG004|Overall Study|Adverse Event|9|||
125443748|NCT01848834|451252254|FG000|Overall Study|Death|2|||
125443749|NCT01848834|451252255|FG001|Overall Study|Death|11|||
125443750|NCT01848834|451252256|FG002|Overall Study|Death|1|||
125443751|NCT01848834|451252257|FG003|Overall Study|Death|8|||
125443752|NCT01848834|451252258|FG004|Overall Study|Death|27|||
125443753|NCT01848834|451252254|FG000|Overall Study|Excluded Medication|5|||
125443754|NCT01848834|451252255|FG001|Overall Study|Excluded Medication|4|||
125443755|NCT01848834|451252256|FG002|Overall Study|Excluded Medication|3|||
125443756|NCT01848834|451252257|FG003|Overall Study|Excluded Medication|6|||
125443757|NCT01848834|451252258|FG004|Overall Study|Excluded Medication|6|||
125443758|NCT01848834|451252254|FG000|Overall Study|Lost to Follow-up|5|||
125443759|NCT01848834|451252255|FG001|Overall Study|Lost to Follow-up|5|||
125443760|NCT01848834|451252256|FG002|Overall Study|Lost to Follow-up|3|||
125443761|NCT01848834|451252257|FG003|Overall Study|Lost to Follow-up|0|||
125443762|NCT01848834|451252258|FG004|Overall Study|Lost to Follow-up|3|||
125443763|NCT01848834|451252254|FG000|Overall Study|Physician Decision|1|||
125443764|NCT01848834|451252255|FG001|Overall Study|Physician Decision|3|||
125443765|NCT01848834|451252256|FG002|Overall Study|Physician Decision|4|||
125443766|NCT01848834|451252257|FG003|Overall Study|Physician Decision|0|||
125443767|NCT01848834|451252258|FG004|Overall Study|Physician Decision|11|||
125443768|NCT01848834|451252254|FG000|Overall Study|Protocol Violation|0|||
125443769|NCT01848834|451252255|FG001|Overall Study|Protocol Violation|0|||
125443770|NCT01848834|451252256|FG002|Overall Study|Protocol Violation|0|||
125443771|NCT01848834|451252257|FG003|Overall Study|Protocol Violation|0|||
125443772|NCT01848834|451252258|FG004|Overall Study|Protocol Violation|1|||
125443773|NCT01848834|451252254|FG000|Overall Study|Sponsor Decision|1|||
125443774|NCT01848834|451252255|FG001|Overall Study|Sponsor Decision|1|||
125443775|NCT01848834|451252256|FG002|Overall Study|Sponsor Decision|0|||
125443776|NCT01848834|451252257|FG003|Overall Study|Sponsor Decision|1|||
125443777|NCT01848834|451252258|FG004|Overall Study|Sponsor Decision|1|||
125443778|NCT01848834|451252254|FG000|Overall Study|Withdrawal by Subject|2|||
125443779|NCT01848834|451252255|FG001|Overall Study|Withdrawal by Subject|13|||
125443780|NCT01848834|451252256|FG002|Overall Study|Withdrawal by Subject|10|||
125443781|NCT01848834|451252257|FG003|Overall Study|Withdrawal by Subject|6|||
125396087|NCT01067352|451083016|FG002|Overall Study|Withdrawal by Subject|1|||
125396088|NCT01067352|451083014|FG000|Overall Study|Physician Decision|0|||
125443782|NCT01848834|451252258|FG004|Overall Study|Withdrawal by Subject|36|||
125396089|NCT01067352|451083015|FG001|Overall Study|Physician Decision|1|||
125396090|NCT01067352|451083016|FG002|Overall Study|Physician Decision|0|||
125396091|NCT01096784|451083017|FG000|Overall Study|Withdrawal by Subject|2|||
125396092|NCT01096784|451083018|FG001|Overall Study|Withdrawal by Subject|1|||
125396093|NCT01096784|451083017|FG000|Overall Study|Adverse Event|11|||
125396094|NCT01096784|451083018|FG001|Overall Study|Adverse Event|9|||
125396095|NCT01096784|451083017|FG000|Overall Study|Protocol Deviation|2|||
125396096|NCT01096784|451083018|FG001|Overall Study|Protocol Deviation|2|||
125396097|NCT01096784|451083017|FG000|Overall Study|Administrative Decision|0|||
125396098|NCT01096784|451083018|FG001|Overall Study|Administrative Decision|1|||
125396099|NCT01096784|451083017|FG000|Overall Study|Other Unspecified|0|||
125396100|NCT01096784|451083018|FG001|Overall Study|Other Unspecified|1|||
125396101|NCT03761628|451083019|FG000|Overall Study|Withdrawal by Subject|3|||
125396102|NCT03761628|451083019|FG000|Overall Study|Physician Decision|1|||
125396103|NCT03761628|451083019|FG000|Overall Study|Pregnancy|1|||
125396104|NCT03761628|451083019|FG000|Overall Study|Lost to Follow-up|1|||
125396105|NCT03064126|451083020|FG000|Overall Study|Death|40|||
125396106|NCT03064126|451083021|FG001|Overall Study|Death|16|||
125396107|NCT03064126|451083022|FG002|Overall Study|Death|4|||
125396108|NCT03064126|451083023|FG003|Overall Study|Death|2|||
125396109|NCT03064126|451083020|FG000|Overall Study|Withdrawal by Subject|17|||
125396110|NCT03064126|451083021|FG001|Overall Study|Withdrawal by Subject|9|||
125396111|NCT03064126|451083022|FG002|Overall Study|Withdrawal by Subject|0|||
125396112|NCT03064126|451083023|FG003|Overall Study|Withdrawal by Subject|2|||
125396113|NCT03064126|451083020|FG000|Overall Study|Lost to Follow-up|7|||
125396114|NCT03064126|451083021|FG001|Overall Study|Lost to Follow-up|3|||
125396115|NCT03064126|451083022|FG002|Overall Study|Lost to Follow-up|0|||
125396116|NCT03064126|451083023|FG003|Overall Study|Lost to Follow-up|0|||
125396117|NCT03064126|451083020|FG000|Overall Study|Adverse Event|2|||
125396118|NCT03064126|451083021|FG001|Overall Study|Adverse Event|0|||
125396119|NCT03064126|451083022|FG002|Overall Study|Adverse Event|0|||
125396120|NCT03064126|451083023|FG003|Overall Study|Adverse Event|0|||
125396121|NCT03064126|451083020|FG000|Overall Study|Physician Decision|3|||
125396122|NCT03064126|451083021|FG001|Overall Study|Physician Decision|0|||
125396123|NCT03064126|451083022|FG002|Overall Study|Physician Decision|0|||
125396124|NCT03064126|451083023|FG003|Overall Study|Physician Decision|0|||
125396125|NCT03064126|451083020|FG000|Overall Study|Other reason for early termination|3|||
125396126|NCT03064126|451083021|FG001|Overall Study|Other reason for early termination|2|||
125396127|NCT03064126|451083022|FG002|Overall Study|Other reason for early termination|0|||
125396128|NCT03064126|451083023|FG003|Overall Study|Other reason for early termination|0|||
125396129|NCT03064126|451083020|FG000|Overall Study|Missed Visit|3|||
125396130|NCT03064126|451083021|FG001|Overall Study|Missed Visit|1|||
125196235|NCT03063086|450339953|FG002|Overall Study|Non-compliance with study treatment|0|||
125196236|NCT03063086|450339954|FG003|Overall Study|Non-compliance with study treatment|1|||
125196237|NCT03063086|450339955|FG004|Overall Study|Non-compliance with study treatment|0|||
125196238|NCT03063086|450339956|FG005|Overall Study|Non-compliance with study treatment|1|||
125196239|NCT03063086|450339951|FG000|Overall Study|Physician Decision|0|||
125196240|NCT03063086|450339952|FG001|Overall Study|Physician Decision|0|||
125196241|NCT03063086|450339953|FG002|Overall Study|Physician Decision|0|||
125196242|NCT03063086|450339954|FG003|Overall Study|Physician Decision|1|||
125196243|NCT03063086|450339955|FG004|Overall Study|Physician Decision|0|||
125196244|NCT03063086|450339956|FG005|Overall Study|Physician Decision|0|||
125196245|NCT04590586|450339957|FG000|Overall Study|Death|7|||
125196246|NCT04590586|450339958|FG001|Overall Study|Death|1|||
125196247|NCT04590586|450339959|FG002|Overall Study|Death|37|||
125196248|NCT04590586|450339960|FG003|Overall Study|Death|34|||
125196249|NCT04590586|450339961|FG004|Overall Study|Death|19|||
125196250|NCT04590586|450339962|FG005|Overall Study|Death|3|||
125196251|NCT04590586|450339957|FG000|Overall Study|Lost to Follow-up|3|||
125196252|NCT04590586|450339958|FG001|Overall Study|Lost to Follow-up|0|||
125196253|NCT04590586|450339959|FG002|Overall Study|Lost to Follow-up|11|||
125196254|NCT04590586|450339960|FG003|Overall Study|Lost to Follow-up|11|||
125196255|NCT04590586|450339961|FG004|Overall Study|Lost to Follow-up|6|||
125196256|NCT04590586|450339962|FG005|Overall Study|Lost to Follow-up|0|||
125196257|NCT04590586|450339957|FG000|Overall Study|Withdrawal by Subject|0|||
125196258|NCT04590586|450339958|FG001|Overall Study|Withdrawal by Subject|0|||
125196259|NCT04590586|450339959|FG002|Overall Study|Withdrawal by Subject|6|||
125196260|NCT04590586|450339960|FG003|Overall Study|Withdrawal by Subject|0|||
125196261|NCT04590586|450339961|FG004|Overall Study|Withdrawal by Subject|3|||
125196262|NCT04590586|450339962|FG005|Overall Study|Withdrawal by Subject|0|||
125196263|NCT04590586|450339957|FG000|Overall Study|Other|3|||
125196264|NCT04590586|450339958|FG001|Overall Study|Other|0|||
125196265|NCT04590586|450339959|FG002|Overall Study|Other|1|||
125196266|NCT04590586|450339960|FG003|Overall Study|Other|1|||
125196267|NCT04590586|450339961|FG004|Overall Study|Other|2|||
125196268|NCT04590586|450339962|FG005|Overall Study|Other|1|||
125196269|NCT02218736|450339963|FG000|Overall Study|Withdrawal by Subject|10|||
125196270|NCT02218736|450339964|FG001|Overall Study|Withdrawal by Subject|9|||
125196271|NCT02218736|450339963|FG000|Overall Study|Protocol Violation|2|||
125196272|NCT02218736|450339964|FG001|Overall Study|Protocol Violation|0|||
125249146|NCT00286455|450536112|FG002|Overall Study|Withdrawal by Subject|7|||
125249147|NCT04359680|450538134|FG000|Overall Study|Withdrawal by Subject|29|||
125249148|NCT04359680|450538135|FG001|Overall Study|Withdrawal by Subject|24|||
125249149|NCT04359680|450538134|FG000|Overall Study|Adverse Event|6|||
125249150|NCT04359680|450538135|FG001|Overall Study|Adverse Event|2|||
125249151|NCT04359680|450538134|FG000|Overall Study|Lost to Follow-up|56|||
125249152|NCT04359680|450538135|FG001|Overall Study|Lost to Follow-up|59|||
125249153|NCT04359680|450538134|FG000|Overall Study|Protocol Violation|3|||
125249154|NCT04359680|450538135|FG001|Overall Study|Protocol Violation|5|||
125249155|NCT04359680|450538134|FG000|Overall Study|Physician Decision|1|||
125249156|NCT04359680|450538135|FG001|Overall Study|Physician Decision|1|||
125249157|NCT04359680|450538134|FG000|Overall Study|Sponsor Decision|0|||
125249158|NCT04359680|450538135|FG001|Overall Study|Sponsor Decision|1|||
125249159|NCT03931785|450538136|FG000|Overall Study|Lost to Follow-up|4|||
125249160|NCT03931785|450538137|FG001|Overall Study|Lost to Follow-up|1|||
125249161|NCT03931785|450538138|FG002|Overall Study|Lost to Follow-up|4|||
125249162|NCT03931785|450538139|FG003|Overall Study|Lost to Follow-up|3|||
125249163|NCT03931785|450538136|FG000|Overall Study|Adverse Event|1|||
125249164|NCT03931785|450538137|FG001|Overall Study|Adverse Event|0|||
125249165|NCT03931785|450538138|FG002|Overall Study|Adverse Event|3|||
125249166|NCT03931785|450538139|FG003|Overall Study|Adverse Event|4|||
125249167|NCT03931785|450538136|FG000|Overall Study|Protocol Violation|0|||
125249168|NCT03931785|450538137|FG001|Overall Study|Protocol Violation|1|||
125249169|NCT03931785|450538138|FG002|Overall Study|Protocol Violation|0|||
125249170|NCT03931785|450538139|FG003|Overall Study|Protocol Violation|0|||
125249171|NCT03931785|450538136|FG000|Overall Study|Noncompliance With Study drug|0|||
125249172|NCT03931785|450538137|FG001|Overall Study|Noncompliance With Study drug|1|||
125249173|NCT03931785|450538138|FG002|Overall Study|Noncompliance With Study drug|0|||
125249174|NCT03931785|450538139|FG003|Overall Study|Noncompliance With Study drug|0|||
125249175|NCT03931785|450538136|FG000|Overall Study|Other Not specified|0|||
125249176|NCT03931785|450538137|FG001|Overall Study|Other Not specified|2|||
125249177|NCT03931785|450538138|FG002|Overall Study|Other Not specified|2|||
125249178|NCT03931785|450538139|FG003|Overall Study|Other Not specified|2|||
125249179|NCT03931785|450538136|FG000|Overall Study|Withdrawal by Subject|0|||
125249180|NCT03931785|450538137|FG001|Overall Study|Withdrawal by Subject|2|||
125249181|NCT03931785|450538138|FG002|Overall Study|Withdrawal by Subject|4|||
125249182|NCT03931785|450538139|FG003|Overall Study|Withdrawal by Subject|1|||
125249183|NCT03931785|450538136|FG000|Overall Study|Pregnancy|0|||
125249184|NCT03931785|450538137|FG001|Overall Study|Pregnancy|0|||
125249185|NCT03931785|450538138|FG002|Overall Study|Pregnancy|0|||
125249186|NCT03931785|450538139|FG003|Overall Study|Pregnancy|1|||
125249187|NCT04605588|450538143|FG000|Overall Study|Withdrawal by Subject|1|||
125249188|NCT04605588|450538144|FG001|Overall Study|Withdrawal by Subject|0|||
125249189|NCT01230814|450538145|FG000|Overall Study|Lost to Follow-up|11|||
125249190|NCT01230814|450538146|FG001|Overall Study|Lost to Follow-up|3|||
125249191|NCT01230814|450538145|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
125249192|NCT01230814|450538146|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
125249193|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
125249194|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
125249195|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
125249196|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
125249197|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
125249198|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
125249199|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
125249200|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
125249201|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
125396131|NCT03064126|451083022|FG002|Overall Study|Missed Visit|0|||
125396132|NCT03064126|451083023|FG003|Overall Study|Missed Visit|0|||
125396133|NCT00486265|451083027|FG000|Overall Study|Adverse Event|1|||
125396134|NCT00486265|451083027|FG000|Overall Study|Lack of Efficacy|8|||
125396135|NCT01452412|451083028|FG000|Overall Study|Withdrawal by Subject|15|||
125396136|NCT01452412|451083029|FG001|Overall Study|Withdrawal by Subject|11|||
125396137|NCT01452412|451083028|FG000|Overall Study|Adverse Event|4|||
125249202|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
125249203|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
125249204|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
125249205|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
125249206|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
125249207|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
125249208|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
125396138|NCT01452412|451083029|FG001|Overall Study|Adverse Event|3|||
125249209|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
125249210|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
125249211|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
125249212|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
125249213|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
125249214|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
125249215|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
125249216|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
125249217|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
125249218|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
125249219|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
125249220|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
125249221|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
125249222|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
125249223|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
125249224|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
125249225|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
125249226|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
125249227|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
125249228|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
125249229|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
125249230|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
125249231|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
125249232|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
125249233|NCT02596893|450538149|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
125249234|NCT02596893|450538150|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
125249235|NCT02596893|450538151|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
125249236|NCT02596893|450538152|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
125249237|NCT01529112|450538155|FG000|Overall Study|Adverse Event|2|||
125249238|NCT01529112|450538156|FG001|Overall Study|Adverse Event|0|||
125249239|NCT01529112|450538155|FG000|Overall Study|Death|59|||
125249240|NCT01529112|450538156|FG001|Overall Study|Death|38|||
125249241|NCT01529112|450538155|FG000|Overall Study|Protocol Violation|1|||
125249242|NCT01529112|450538156|FG001|Overall Study|Protocol Violation|0|||
125249243|NCT01529112|450538155|FG000|Overall Study|Withdrawal by Subject|7|||
125249244|NCT01529112|450538156|FG001|Overall Study|Withdrawal by Subject|3|||
125249245|NCT02255279|450538157|FG000|Overall Study|Lost to Follow-up|2|||
125249246|NCT02255279|450538158|FG001|Overall Study|Lost to Follow-up|2|||
125249247|NCT02255279|450538157|FG000|Overall Study|Protocol Violation|0|||
125249248|NCT02255279|450538158|FG001|Overall Study|Protocol Violation|1|||
125249249|NCT02255279|450538157|FG000|Overall Study|Withdrawal by Subject|3|||
125249250|NCT02255279|450538158|FG001|Overall Study|Withdrawal by Subject|6|||
125249251|NCT03607695|450538159|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
125249252|NCT03607695|450538159|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
125249253|NCT02741193|450538160|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
125249254|NCT02741193|450538160|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
125249255|NCT02502383|450538161|FG000|Overall Study|Lost to Follow-up|130|||
125249256|NCT02502383|450538162|FG001|Overall Study|Lost to Follow-up|131|||
125249257|NCT02502383|450538161|FG000|Overall Study|Withdrawal by Subject|31|||
125249258|NCT02502383|450538162|FG001|Overall Study|Withdrawal by Subject|24|||
125249259|NCT00363467|450538163|FG000|Overall Study|Physician Decision|1|||
125249260|NCT00903344|450538164|FG000|Overall Study|Pregnancy|2|||
125249261|NCT00903344|450538165|FG001|Overall Study|Pregnancy|3|||
125396139|NCT01452412|451083028|FG000|Overall Study|Lost to Follow-up|5|||
125196273|NCT05481125|450339965|FG000|Overall Study|Adverse Event|1|||
125196274|NCT05481125|450339966|FG001|Overall Study|Adverse Event|0|||
125196275|NCT05481125|450339965|FG000|Overall Study|Lost to Follow-up|0|||
125196276|NCT05481125|450339966|FG001|Overall Study|Lost to Follow-up|1|||
125196277|NCT05481125|450339965|FG000|Overall Study|Withdrawal by Subject|0|||
125196278|NCT05481125|450339966|FG001|Overall Study|Withdrawal by Subject|1|||
125196279|NCT02244463|450339969|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
125196280|NCT02244463|450339970|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
125196281|NCT02244463|450339971|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
125196282|NCT02244463|450339972|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
125196283|NCT02244463|450339973|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
125196284|NCT02244463|450339974|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
125249262|NCT00903344|450538164|FG000|Overall Study|Lost to Follow-up|3|||
125249263|NCT00903344|450538165|FG001|Overall Study|Lost to Follow-up|0|||
125249264|NCT01524705|450538166|FG000|Overall Study|Adverse Event|2|||
125249265|NCT01524705|450538167|FG001|Overall Study|Adverse Event|0|||
125249266|NCT01524705|450538166|FG000|Overall Study|Death|1|||
125396140|NCT01452412|451083029|FG001|Overall Study|Lost to Follow-up|3|||
125249267|NCT01524705|450538167|FG001|Overall Study|Death|0|||
125249268|NCT01524705|450538166|FG000|Overall Study|Lost to Follow-up|0|||
125249269|NCT01524705|450538167|FG001|Overall Study|Lost to Follow-up|1|||
125249270|NCT01524705|450538166|FG000|Overall Study|Withdrawal by Subject|0|||
125249271|NCT01524705|450538167|FG001|Overall Study|Withdrawal by Subject|1|||
125249272|NCT01524705|450538166|FG000|Overall Study|Pancreatic Cancer|0|||
125249273|NCT01524705|450538167|FG001|Overall Study|Pancreatic Cancer|1|||
125249274|NCT01530256|450538170|FG000|Overall Study|Death|2|||
125249275|NCT00527748|450538171|FG000|Overall Study|Other|3|||
125249276|NCT01093885|450538175|FG000|Overall Study|Adverse Event|4|||
125249277|NCT01093885|450538175|FG000|Overall Study|Lost to Follow-up|1|||
125249278|NCT04621786|450538176|FG000|Overall Study|Lost to Follow-up|9|||
125249279|NCT04621786|450538176|FG000|Overall Study|Protocol Violation|3|||
125249280|NCT02123511|450538177|FG000|Overall Study|Cancelled treatment|1|||
125249281|NCT02123511|450538178|FG001|Overall Study|Cancelled treatment|0|||
125249282|NCT02123511|450538177|FG000|Overall Study|Incomplete data|1|||
125249283|NCT02123511|450538178|FG001|Overall Study|Incomplete data|3|||
125249284|NCT02123511|450538177|FG000|Overall Study|Ineligible|0|||
125249285|NCT02123511|450538178|FG001|Overall Study|Ineligible|1|||
125249286|NCT01975285|450538181|FG000|Overall Study|Failed Block and follow up|2|||
125249287|NCT01975285|450538182|FG001|Overall Study|Failed Block and follow up|2|||
125249288|NCT00604383|450538187|FG000|Overall Study|Withdrawal by Subject|33|||
125249289|NCT00604383|450538188|FG001|Overall Study|Withdrawal by Subject|31|||
125249290|NCT00604383|450538187|FG000|Overall Study|Lost to Follow-up|24|||
125249291|NCT00604383|450538188|FG001|Overall Study|Lost to Follow-up|19|||
125249292|NCT00604383|450538187|FG000|Overall Study|Death|14|||
125249293|NCT00604383|450538188|FG001|Overall Study|Death|22|||
125249294|NCT00604383|450538187|FG000|Overall Study|Adverse Event|16|||
125249295|NCT00604383|450538188|FG001|Overall Study|Adverse Event|9|||
125249296|NCT00604383|450538187|FG000|Overall Study|Physician Decision|0|||
125249297|NCT00604383|450538188|FG001|Overall Study|Physician Decision|3|||
125249298|NCT00474968|450538191|FG000|Overall Study|Withdrawal by Subject|8|||
125249299|NCT00474968|450538192|FG001|Overall Study|Withdrawal by Subject|7|||
125249300|NCT00474968|450538191|FG000|Overall Study|Protocol Violation|9|||
125249301|NCT00474968|450538192|FG001|Overall Study|Protocol Violation|8|||
125249302|NCT00474968|450538191|FG000|Overall Study|Sample not collected|1|||
125249303|NCT00474968|450538192|FG001|Overall Study|Sample not collected|1|||
125249304|NCT01750281|450538193|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
125249305|NCT01750281|450538194|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
125249306|NCT01750281|450538195|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
125249307|NCT01750281|450538193|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
125249308|NCT01750281|450538194|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
125249309|NCT01750281|450538195|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
125249310|NCT01750281|450538193|FG000|Overall Study|Did not receive treatment|0|||
125249311|NCT01750281|450538194|FG001|Overall Study|Did not receive treatment|1|||
125249312|NCT01750281|450538195|FG002|Overall Study|Did not receive treatment|0|||
125249313|NCT00281580|450538197|FG000|Overall Study|Adverse Event|2|||
125249314|NCT00281580|450538198|FG001|Overall Study|Adverse Event|0|||
125249315|NCT00281580|450538199|FG002|Overall Study|Adverse Event|2|||
125249316|NCT00281580|450538200|FG003|Overall Study|Adverse Event|4|||
125249317|NCT00281580|450538201|FG004|Overall Study|Adverse Event|1|||
125249318|NCT00281580|450538202|FG005|Overall Study|Adverse Event|0|||
125249319|NCT00281580|450538203|FG006|Overall Study|Adverse Event|1|||
125396141|NCT01452412|451083028|FG000|Overall Study|Death|1|||
125396142|NCT01452412|451083029|FG001|Overall Study|Death|0|||
125396143|NCT01452412|451083028|FG000|Overall Study|Initiated dialysis|1|||
125396144|NCT01452412|451083029|FG001|Overall Study|Initiated dialysis|0|||
125196285|NCT02244463|450339969|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
125196286|NCT02244463|450339970|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
125196287|NCT02244463|450339971|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
125196288|NCT02244463|450339972|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
125196289|NCT02244463|450339973|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
125196290|NCT02244463|450339974|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
125196291|NCT02244463|450339969|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
125196292|NCT02244463|450339970|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
125196293|NCT02244463|450339971|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
125196294|NCT02244463|450339972|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
125249320|NCT00281580|450538204|FG007|Overall Study|Adverse Event|0|||
125249321|NCT00281580|450538205|FG008|Overall Study|Adverse Event|1|||
125249322|NCT00281580|450538206|FG009|Overall Study|Adverse Event|6|||
125249323|NCT00281580|450538207|FG010|Overall Study|Adverse Event|0|||
125249324|NCT00281580|450538208|FG011|Overall Study|Adverse Event|5|||
125249325|NCT00281580|450538209|FG012|Overall Study|Adverse Event|8|||
125249326|NCT00281580|450538210|FG013|Overall Study|Adverse Event|2|||
125249327|NCT00281580|450538211|FG014|Overall Study|Adverse Event|3|||
125249328|NCT00281580|450538212|FG015|Overall Study|Adverse Event|3|||
125249329|NCT00281580|450538197|FG000|Overall Study|Protocol Violation|0|||
125249330|NCT00281580|450538198|FG001|Overall Study|Protocol Violation|0|||
125249331|NCT00281580|450538199|FG002|Overall Study|Protocol Violation|1|||
125249332|NCT00281580|450538200|FG003|Overall Study|Protocol Violation|1|||
125249333|NCT00281580|450538201|FG004|Overall Study|Protocol Violation|0|||
125249334|NCT00281580|450538202|FG005|Overall Study|Protocol Violation|0|||
125249335|NCT00281580|450538203|FG006|Overall Study|Protocol Violation|1|||
125196295|NCT02244463|450339973|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
125249336|NCT00281580|450538204|FG007|Overall Study|Protocol Violation|0|||
125249337|NCT00281580|450538205|FG008|Overall Study|Protocol Violation|2|||
125249338|NCT00281580|450538206|FG009|Overall Study|Protocol Violation|0|||
125249339|NCT00281580|450538207|FG010|Overall Study|Protocol Violation|1|||
125249340|NCT00281580|450538208|FG011|Overall Study|Protocol Violation|2|||
125249341|NCT00281580|450538209|FG012|Overall Study|Protocol Violation|0|||
125249342|NCT00281580|450538210|FG013|Overall Study|Protocol Violation|1|||
125249343|NCT00281580|450538211|FG014|Overall Study|Protocol Violation|1|||
125396145|NCT01452412|451083028|FG000|Overall Study|Other|2|||
125196296|NCT02244463|450339974|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
125196297|NCT02244463|450339969|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
125196298|NCT02244463|450339970|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
125196299|NCT02244463|450339971|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
125196300|NCT02244463|450339972|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
125196301|NCT02244463|450339973|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
125196302|NCT02244463|450339974|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
125196303|NCT02244463|450339969|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
125196304|NCT02244463|450339970|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
125196305|NCT02244463|450339971|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
125196306|NCT02244463|450339972|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
125196307|NCT02244463|450339973|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
125196308|NCT02244463|450339974|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
125196309|NCT02244463|450339969|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
125196310|NCT02244463|450339970|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
125196311|NCT02244463|450339971|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
125196312|NCT02244463|450339972|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
125196313|NCT02244463|450339973|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
125196314|NCT02244463|450339974|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
125196315|NCT02244463|450339969|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
125196316|NCT02244463|450339970|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
125196317|NCT02244463|450339971|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
125196318|NCT02244463|450339972|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
125196319|NCT02244463|450339973|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
125196320|NCT02244463|450339974|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
125196321|NCT02244463|450339969|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
125196322|NCT02244463|450339970|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
125196323|NCT02244463|450339971|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
125196324|NCT02244463|450339972|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
125196325|NCT02244463|450339973|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
125196326|NCT02244463|450339974|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
125196327|NCT02244463|450339969|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
125196328|NCT02244463|450339970|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
125196329|NCT02244463|450339971|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
125196330|NCT02244463|450339972|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
125196331|NCT02244463|450339973|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
125196332|NCT02244463|450339974|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
125196333|NCT02244463|450339969|FG000|Period 5: Phase II|Disease Progression|0|||
125196334|NCT02244463|450339970|FG001|Period 5: Phase II|Disease Progression|0|||
125196335|NCT02244463|450339971|FG002|Period 5: Phase II|Disease Progression|0|||
125196336|NCT02244463|450339972|FG003|Period 5: Phase II|Disease Progression|0|||
125196337|NCT02244463|450339973|FG004|Period 5: Phase II|Disease Progression|10|||
125196338|NCT02244463|450339974|FG005|Period 5: Phase II|Disease Progression|11|||
125196339|NCT02244463|450339969|FG000|Period 5: Phase II|Physician Decision|0|||
125196340|NCT02244463|450339970|FG001|Period 5: Phase II|Physician Decision|0|||
125196341|NCT02244463|450339971|FG002|Period 5: Phase II|Physician Decision|0|||
125196342|NCT02244463|450339972|FG003|Period 5: Phase II|Physician Decision|0|||
125196343|NCT02244463|450339973|FG004|Period 5: Phase II|Physician Decision|3|||
125196344|NCT02244463|450339974|FG005|Period 5: Phase II|Physician Decision|2|||
125196345|NCT02244463|450339969|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
125196346|NCT02244463|450339970|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
125196347|NCT02244463|450339971|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
125196348|NCT02244463|450339972|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
125249344|NCT00281580|450538212|FG015|Overall Study|Protocol Violation|3|||
125249345|NCT00281580|450538197|FG000|Overall Study|Withdrawal by Subject|3|||
125249346|NCT00281580|450538198|FG001|Overall Study|Withdrawal by Subject|0|||
125396146|NCT01452412|451083029|FG001|Overall Study|Other|0|||
125396147|NCT03029624|451083030|FG000|Overall Study|Adverse Event|1|||
125396148|NCT03029624|451083030|FG000|Overall Study|Withdrawal by Subject|1|||
125396149|NCT03029624|451083030|FG000|Overall Study|Lack of Efficacy|1|||
125196349|NCT02244463|450339973|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
125196350|NCT02244463|450339974|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
125196351|NCT02244463|450339969|FG000|Period 5: Phase II|Intercurrent Illness|0|||
125196352|NCT02244463|450339970|FG001|Period 5: Phase II|Intercurrent Illness|0|||
125196353|NCT02244463|450339971|FG002|Period 5: Phase II|Intercurrent Illness|0|||
125196354|NCT02244463|450339972|FG003|Period 5: Phase II|Intercurrent Illness|0|||
125196355|NCT02244463|450339973|FG004|Period 5: Phase II|Intercurrent Illness|2|||
125196356|NCT02244463|450339974|FG005|Period 5: Phase II|Intercurrent Illness|0|||
125196357|NCT02244463|450339969|FG000|Period 5: Phase II|Adverse Event|0|||
125196358|NCT02244463|450339970|FG001|Period 5: Phase II|Adverse Event|0|||
125196359|NCT02244463|450339971|FG002|Period 5: Phase II|Adverse Event|0|||
125196360|NCT02244463|450339972|FG003|Period 5: Phase II|Adverse Event|0|||
125196361|NCT02244463|450339973|FG004|Period 5: Phase II|Adverse Event|0|||
125196362|NCT02244463|450339974|FG005|Period 5: Phase II|Adverse Event|2|||
125196363|NCT02244463|450339969|FG000|Period 5: Phase II|Still On treatment|0|||
125196364|NCT02244463|450339970|FG001|Period 5: Phase II|Still On treatment|0|||
125196365|NCT02244463|450339971|FG002|Period 5: Phase II|Still On treatment|0|||
125196366|NCT02244463|450339972|FG003|Period 5: Phase II|Still On treatment|0|||
125196367|NCT02244463|450339973|FG004|Period 5: Phase II|Still On treatment|0|||
125196368|NCT02244463|450339974|FG005|Period 5: Phase II|Still On treatment|3|||
125196369|NCT01769508|450339975|FG000|Overall Study|Death|3|||
125196370|NCT01769508|450339975|FG000|Overall Study|Withdrawal by Subject|1|||
125196371|NCT01769508|450339975|FG000|Overall Study|Adverse Event|1|||
125196372|NCT01769508|450339975|FG000|Overall Study|Lost to Follow-up|1|||
125196373|NCT03615144|450339976|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
125196374|NCT03615144|450339977|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
125196375|NCT04791319|450339980|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
125196376|NCT04791319|450339981|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
125196377|NCT04791319|450339982|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
125196378|NCT04791319|450339983|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
125196379|NCT04791319|450339984|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196380|NCT04791319|450339985|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196381|NCT04791319|450339986|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196382|NCT04791319|450339987|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196383|NCT04791319|450339988|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196384|NCT04791319|450339989|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196385|NCT04791319|450339990|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
125196386|NCT04791319|450339980|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
125196387|NCT04791319|450339981|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196388|NCT04791319|450339982|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
125196389|NCT04791319|450339983|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
125196390|NCT04791319|450339984|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196391|NCT04791319|450339985|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196392|NCT04791319|450339986|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196393|NCT04791319|450339987|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196394|NCT04791319|450339988|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196395|NCT04791319|450339989|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196396|NCT04791319|450339990|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
125196397|NCT04791319|450339980|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
125196398|NCT04791319|450339981|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
125196399|NCT04791319|450339982|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
125196400|NCT04791319|450339983|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
125196401|NCT04791319|450339984|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196402|NCT04791319|450339985|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196403|NCT04791319|450339986|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196404|NCT04791319|450339987|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196405|NCT04791319|450339988|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196406|NCT04791319|450339989|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196407|NCT04791319|450339990|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
125196408|NCT04791319|450339980|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
125196409|NCT04791319|450339981|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
125196410|NCT04791319|450339982|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
125196411|NCT04791319|450339983|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
125196412|NCT04791319|450339984|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125396150|NCT03029624|451083030|FG000|Overall Study|MRI need|2|||
125396151|NCT01640366|451083033|FG000|Overall Study|Withdrawal by Subject|1|||
125196413|NCT04791319|450339985|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125196414|NCT04791319|450339986|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125196415|NCT04791319|450339987|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125196416|NCT04791319|450339988|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125196417|NCT04791319|450339989|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125196418|NCT04791319|450339990|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
125196419|NCT04791319|450339980|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196420|NCT04791319|450339981|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196421|NCT04791319|450339982|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196422|NCT04791319|450339983|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
125196423|NCT04791319|450339984|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196424|NCT04791319|450339985|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196425|NCT04791319|450339986|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196426|NCT04791319|450339987|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196427|NCT04791319|450339988|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196428|NCT04791319|450339989|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196429|NCT04791319|450339990|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
125196430|NCT04791319|450339980|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196431|NCT04791319|450339981|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196432|NCT04791319|450339982|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196433|NCT04791319|450339983|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196434|NCT04791319|450339984|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
125196435|NCT04791319|450339985|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
125196436|NCT04791319|450339986|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
125196437|NCT04791319|450339987|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196438|NCT04791319|450339988|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196439|NCT04791319|450339989|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
125196440|NCT04791319|450339990|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
125196441|NCT04791319|450339980|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196442|NCT04791319|450339981|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196443|NCT04791319|450339982|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196444|NCT04791319|450339983|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196445|NCT04791319|450339984|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196446|NCT04791319|450339985|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196447|NCT04791319|450339986|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196448|NCT04791319|450339987|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196449|NCT04791319|450339988|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196450|NCT04791319|450339989|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
125196451|NCT04791319|450339990|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
125196452|NCT04791319|450339980|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
125196453|NCT04791319|450339981|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
125196454|NCT04791319|450339982|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
125196455|NCT04791319|450339983|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
125196456|NCT04791319|450339984|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
125196457|NCT04791319|450339985|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
125196458|NCT04791319|450339986|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
125196459|NCT04791319|450339987|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
125196460|NCT04791319|450339988|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
125196461|NCT04791319|450339989|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
125196462|NCT04791319|450339990|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
125196463|NCT04791319|450339980|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
125196464|NCT04791319|450339981|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
125196465|NCT04791319|450339982|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
125196466|NCT04791319|450339983|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
125196467|NCT04791319|450339984|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
125196468|NCT04791319|450339985|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
125196469|NCT04791319|450339986|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
125196470|NCT04791319|450339987|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
125196471|NCT04791319|450339988|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
125196472|NCT04791319|450339989|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
125249347|NCT00281580|450538199|FG002|Overall Study|Withdrawal by Subject|1|||
125249348|NCT00281580|450538200|FG003|Overall Study|Withdrawal by Subject|1|||
125249349|NCT00281580|450538201|FG004|Overall Study|Withdrawal by Subject|1|||
125249350|NCT00281580|450538202|FG005|Overall Study|Withdrawal by Subject|2|||
125249351|NCT00281580|450538203|FG006|Overall Study|Withdrawal by Subject|2|||
125249352|NCT00281580|450538204|FG007|Overall Study|Withdrawal by Subject|0|||
125249353|NCT00281580|450538205|FG008|Overall Study|Withdrawal by Subject|1|||
125249354|NCT00281580|450538206|FG009|Overall Study|Withdrawal by Subject|4|||
125249355|NCT00281580|450538207|FG010|Overall Study|Withdrawal by Subject|1|||
125249356|NCT00281580|450538208|FG011|Overall Study|Withdrawal by Subject|1|||
125249357|NCT00281580|450538209|FG012|Overall Study|Withdrawal by Subject|2|||
125249358|NCT00281580|450538210|FG013|Overall Study|Withdrawal by Subject|2|||
125249359|NCT00281580|450538211|FG014|Overall Study|Withdrawal by Subject|1|||
125249360|NCT00281580|450538212|FG015|Overall Study|Withdrawal by Subject|5|||
125249361|NCT00281580|450538197|FG000|Overall Study|Lack of Efficacy|2|||
125249362|NCT00281580|450538198|FG001|Overall Study|Lack of Efficacy|1|||
125249363|NCT00281580|450538199|FG002|Overall Study|Lack of Efficacy|1|||
125249364|NCT00281580|450538200|FG003|Overall Study|Lack of Efficacy|6|||
125249365|NCT00281580|450538201|FG004|Overall Study|Lack of Efficacy|2|||
125249366|NCT00281580|450538202|FG005|Overall Study|Lack of Efficacy|0|||
125249367|NCT00281580|450538203|FG006|Overall Study|Lack of Efficacy|0|||
125249368|NCT00281580|450538204|FG007|Overall Study|Lack of Efficacy|0|||
125249369|NCT00281580|450538205|FG008|Overall Study|Lack of Efficacy|0|||
125249370|NCT00281580|450538206|FG009|Overall Study|Lack of Efficacy|0|||
125249371|NCT00281580|450538207|FG010|Overall Study|Lack of Efficacy|0|||
125249372|NCT00281580|450538208|FG011|Overall Study|Lack of Efficacy|1|||
125249373|NCT00281580|450538209|FG012|Overall Study|Lack of Efficacy|0|||
125249374|NCT00281580|450538210|FG013|Overall Study|Lack of Efficacy|2|||
125249375|NCT00281580|450538211|FG014|Overall Study|Lack of Efficacy|1|||
125249376|NCT00281580|450538212|FG015|Overall Study|Lack of Efficacy|0|||
125249377|NCT00281580|450538197|FG000|Overall Study|Lost to Follow-up|0|||
125249378|NCT00281580|450538198|FG001|Overall Study|Lost to Follow-up|0|||
125249379|NCT00281580|450538199|FG002|Overall Study|Lost to Follow-up|0|||
125249380|NCT00281580|450538200|FG003|Overall Study|Lost to Follow-up|3|||
125249381|NCT00281580|450538201|FG004|Overall Study|Lost to Follow-up|0|||
125249382|NCT00281580|450538202|FG005|Overall Study|Lost to Follow-up|1|||
125249383|NCT00281580|450538203|FG006|Overall Study|Lost to Follow-up|0|||
125249384|NCT00281580|450538204|FG007|Overall Study|Lost to Follow-up|1|||
125249385|NCT00281580|450538205|FG008|Overall Study|Lost to Follow-up|2|||
125249386|NCT00281580|450538206|FG009|Overall Study|Lost to Follow-up|1|||
125249387|NCT00281580|450538207|FG010|Overall Study|Lost to Follow-up|1|||
125249388|NCT00281580|450538208|FG011|Overall Study|Lost to Follow-up|0|||
125249389|NCT00281580|450538209|FG012|Overall Study|Lost to Follow-up|1|||
125249390|NCT00281580|450538210|FG013|Overall Study|Lost to Follow-up|0|||
125249391|NCT00281580|450538211|FG014|Overall Study|Lost to Follow-up|0|||
125249392|NCT00281580|450538212|FG015|Overall Study|Lost to Follow-up|0|||
125249393|NCT00281580|450538197|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
125249394|NCT00281580|450538198|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
125249395|NCT00281580|450538199|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
125249396|NCT00281580|450538200|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
125249397|NCT00281580|450538201|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
125249398|NCT00281580|450538202|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
125249399|NCT00281580|450538203|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
125249400|NCT00281580|450538204|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
125249401|NCT00281580|450538205|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
125249402|NCT00281580|450538206|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
125249403|NCT00281580|450538207|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
125249404|NCT00281580|450538208|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
125249405|NCT00281580|450538209|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
125249406|NCT00281580|450538210|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
125249407|NCT00281580|450538211|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
125249408|NCT00281580|450538212|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
125249409|NCT01122680|450538213|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
125249410|NCT01122680|450538214|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
125249411|NCT01122680|450538215|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
125249412|NCT01122680|450538216|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
125249413|NCT01122680|450538213|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
125249414|NCT01122680|450538214|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
125249415|NCT01122680|450538215|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
125249416|NCT01122680|450538216|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
125249417|NCT01122680|450538213|FG000|Period 1 (4 Weeks)|Other|1|||
125249418|NCT01122680|450538214|FG001|Period 1 (4 Weeks)|Other|1|||
125249419|NCT01122680|450538215|FG002|Period 1 (4 Weeks)|Other|0|||
125249420|NCT01122680|450538216|FG003|Period 1 (4 Weeks)|Other|0|||
125249421|NCT01122680|450538213|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
125249422|NCT01122680|450538214|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
125249423|NCT01122680|450538215|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
125249424|NCT01122680|450538216|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
125249425|NCT01122680|450538213|FG000|Period 2 (4 Weeks)|Other|1|||
125249426|NCT01122680|450538214|FG001|Period 2 (4 Weeks)|Other|0|||
125249427|NCT01122680|450538215|FG002|Period 2 (4 Weeks)|Other|0|||
125249428|NCT01122680|450538216|FG003|Period 2 (4 Weeks)|Other|0|||
125249429|NCT01122680|450538213|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
125249430|NCT01122680|450538214|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
125249431|NCT01122680|450538215|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
125249432|NCT01122680|450538216|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
125249433|NCT01122680|450538213|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125249434|NCT01122680|450538214|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
125249435|NCT01122680|450538215|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125249436|NCT01122680|450538216|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
125249437|NCT01550965|450538217|FG000|Overall Study|Adverse Event|26|||
125249438|NCT01550965|450538217|FG000|Overall Study|Withdrawal by Subject|10|||
125249439|NCT01550965|450538217|FG000|Overall Study|Lost to Follow-up|2|||
125249440|NCT01550965|450538217|FG000|Overall Study|Lack of Efficacy|59|||
125249441|NCT01550965|450538217|FG000|Overall Study|Other|13|||
125249442|NCT03016403|450538220|FG000|Baseline|Death|5|||
125249443|NCT03016403|450538221|FG001|Baseline|Death|8|||
125249444|NCT03016403|450538222|FG002|Baseline|Death|1|||
125249445|NCT03016403|450538223|FG003|Baseline|Death|0|||
125249446|NCT03016403|450538220|FG000|Baseline|Withdrawal by Subject|2|||
125249447|NCT03016403|450538221|FG001|Baseline|Withdrawal by Subject|8|||
125249448|NCT03016403|450538222|FG002|Baseline|Withdrawal by Subject|4|||
125249449|NCT03016403|450538223|FG003|Baseline|Withdrawal by Subject|10|||
125249450|NCT03016403|450538220|FG000|Baseline|Lost to Follow-up|9|||
125249451|NCT03016403|450538221|FG001|Baseline|Lost to Follow-up|11|||
125249452|NCT03016403|450538222|FG002|Baseline|Lost to Follow-up|6|||
125249453|NCT03016403|450538223|FG003|Baseline|Lost to Follow-up|24|||
125249454|NCT03016403|450538220|FG000|6-week Follow-up|Death|1|||
125249455|NCT03016403|450538221|FG001|6-week Follow-up|Death|4|||
125249456|NCT03016403|450538222|FG002|6-week Follow-up|Death|0|||
125249457|NCT03016403|450538223|FG003|6-week Follow-up|Death|0|||
125249458|NCT03016403|450538220|FG000|6-week Follow-up|Lost to Follow-up|2|||
125249459|NCT03016403|450538221|FG001|6-week Follow-up|Lost to Follow-up|7|||
125249460|NCT03016403|450538222|FG002|6-week Follow-up|Lost to Follow-up|4|||
125249461|NCT03016403|450538223|FG003|6-week Follow-up|Lost to Follow-up|8|||
125249462|NCT03016403|450538220|FG000|6-week Follow-up|Withdrawal by Subject|0|||
125249463|NCT03016403|450538221|FG001|6-week Follow-up|Withdrawal by Subject|2|||
125249464|NCT03016403|450538222|FG002|6-week Follow-up|Withdrawal by Subject|0|||
125249465|NCT03016403|450538223|FG003|6-week Follow-up|Withdrawal by Subject|1|||
125249466|NCT03016403|450538220|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
125249467|NCT03016403|450538221|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
125249468|NCT03016403|450538222|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
125249469|NCT03016403|450538223|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
125249470|NCT03016403|450538220|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
125249471|NCT03016403|450538221|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
125249472|NCT03016403|450538222|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
125249473|NCT03016403|450538223|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
125249474|NCT03016403|450538220|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
125249475|NCT03016403|450538221|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
125249476|NCT03016403|450538222|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
125249477|NCT03016403|450538223|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
125249478|NCT00225758|450538224|FG000|Overall Study|Adverse Event|4|||
125249479|NCT00564070|450538225|FG000|Overall Study|Lost to Follow-up|9|||
125249480|NCT00564070|450538226|FG001|Overall Study|Lost to Follow-up|7|||
125249481|NCT00564070|450538225|FG000|Overall Study|Worsening depression, referred to care|3|||
125249482|NCT00564070|450538226|FG001|Overall Study|Worsening depression, referred to care|0|||
125249483|NCT03142334|450538230|FG000|Overall Study|Death|18|||
125249484|NCT03142334|450538231|FG001|Overall Study|Death|33|||
125249485|NCT03142334|450538230|FG000|Overall Study|Withdrawal by Subject|15|||
125249486|NCT03142334|450538231|FG001|Overall Study|Withdrawal by Subject|11|||
125249487|NCT03142334|450538230|FG000|Overall Study|Ongoing on trial follow up|463|||
125249488|NCT03142334|450538231|FG001|Overall Study|Ongoing on trial follow up|454|||
125249489|NCT03071965|450538232|FG000|Overall Study|Adverse Event|0|||
125249490|NCT03071965|450538233|FG001|Overall Study|Adverse Event|0|||
125249491|NCT03071965|450538234|FG002|Overall Study|Adverse Event|1|||
125396152|NCT01640366|451083033|FG000|Overall Study|Protocol Violation|16|||
125249492|NCT03071965|450538235|FG003|Overall Study|Adverse Event|0|||
125249493|NCT03071965|450538232|FG000|Overall Study|Death|0|||
125249494|NCT03071965|450538233|FG001|Overall Study|Death|0|||
125249495|NCT03071965|450538234|FG002|Overall Study|Death|1|||
125249496|NCT03071965|450538235|FG003|Overall Study|Death|1|||
125249497|NCT03071965|450538232|FG000|Overall Study|COVID-19|0|||
125249498|NCT03071965|450538233|FG001|Overall Study|COVID-19|1|||
125249499|NCT03071965|450538234|FG002|Overall Study|COVID-19|0|||
125396153|NCT01640366|451083033|FG000|Overall Study|Lost to Follow-up|5|||
125396154|NCT02722928|451083036|FG000|Overall Study|Standard CT was not as required per prot|5|||
125396155|NCT02722928|451083037|FG001|Overall Study|Standard CT was not as required per prot|13|||
125396156|NCT02722928|451083036|FG000|Overall Study|Required Intraoperative MRI|5|||
125396157|NCT02722928|451083037|FG001|Overall Study|Required Intraoperative MRI|7|||
125396158|NCT02281552|451083038|FG000|Overall Study|Medication error|1|||
125396159|NCT02281552|451083039|FG001|Overall Study|Medication error|0|||
125396160|NCT02281552|451083038|FG000|Overall Study|Insufficient clinical response|0|||
125396161|NCT02281552|451083039|FG001|Overall Study|Insufficient clinical response|1|||
125249500|NCT03071965|450538235|FG003|Overall Study|COVID-19|1|||
125249501|NCT03071965|450538232|FG000|Overall Study|Other Health Reason|0|||
125249502|NCT03071965|450538233|FG001|Overall Study|Other Health Reason|0|||
125249503|NCT03071965|450538234|FG002|Overall Study|Other Health Reason|0|||
125249504|NCT03071965|450538235|FG003|Overall Study|Other Health Reason|1|||
125249505|NCT01217047|450538236|FG000|Overall Study|Lost to Follow-up|0|||
125249506|NCT01217047|450538237|FG001|Overall Study|Lost to Follow-up|1|||
125249507|NCT01217047|450538238|FG002|Overall Study|Lost to Follow-up|0|||
125249508|NCT05529173|450538239|FG000|Overall Study|Physician Decision|3|||
125249509|NCT05529173|450538240|FG001|Overall Study|Physician Decision|6|||
125249510|NCT05529173|450538239|FG000|Overall Study|Sample shipment delay more than one day|4|||
125249511|NCT05529173|450538240|FG001|Overall Study|Sample shipment delay more than one day|0|||
125249512|NCT05587998|450538241|FG000|Overall Study|Withdrawal by Subject|1|||
125249513|NCT05587998|450538242|FG001|Overall Study|Withdrawal by Subject|1|||
125249514|NCT05587998|450538241|FG000|Overall Study|Not treated|3|||
125249515|NCT05587998|450538242|FG001|Overall Study|Not treated|1|||
125249516|NCT05587998|450538241|FG000|Overall Study|Non-compliance with study procedures|0|||
125249517|NCT05587998|450538242|FG001|Overall Study|Non-compliance with study procedures|1|||
125249518|NCT03892915|450538246|FG000|Overall Study|Lost to Follow-up|6|||
125249519|NCT03892915|450538247|FG001|Overall Study|Lost to Follow-up|12|||
125249520|NCT03892915|450538246|FG000|Overall Study|Death|0|||
125249521|NCT03892915|450538247|FG001|Overall Study|Death|2|||
125249522|NCT03892915|450538246|FG000|Overall Study|Withdrawal by Subject|1|||
125249523|NCT03892915|450538247|FG001|Overall Study|Withdrawal by Subject|1|||
125249524|NCT03892915|450538246|FG000|Overall Study|unsuccessful delivery|13|||
125249525|NCT03892915|450538247|FG001|Overall Study|unsuccessful delivery|18|||
125249526|NCT01181128|450538248|FG000|Overall Study|Withdrawal by Subject|2|||
125249527|NCT01181128|450538249|FG001|Overall Study|Withdrawal by Subject|2|||
125249528|NCT01181128|450538250|FG002|Overall Study|Withdrawal by Subject|0|||
125249529|NCT01181128|450538248|FG000|Overall Study|Death|1|||
125249530|NCT01181128|450538249|FG001|Overall Study|Death|0|||
125249531|NCT01181128|450538250|FG002|Overall Study|Death|0|||
125249532|NCT01181128|450538248|FG000|Overall Study|Physician Decision|2|||
125249533|NCT01181128|450538249|FG001|Overall Study|Physician Decision|0|||
125249534|NCT01181128|450538250|FG002|Overall Study|Physician Decision|0|||
125249535|NCT01181128|450538248|FG000|Overall Study|Adverse Event|0|||
125249536|NCT01181128|450538249|FG001|Overall Study|Adverse Event|2|||
125249537|NCT01181128|450538250|FG002|Overall Study|Adverse Event|0|||
125249538|NCT01181128|450538248|FG000|Overall Study|Other|1|||
125249539|NCT01181128|450538249|FG001|Overall Study|Other|1|||
125249540|NCT01181128|450538250|FG002|Overall Study|Other|1|||
125249541|NCT01362270|450538253|FG000|Overall Study|Withdrawal by Subject|1|||
125249542|NCT01362270|450538254|FG001|Overall Study|Withdrawal by Subject|0|||
125249543|NCT01362270|450538253|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
125249544|NCT01362270|450538254|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
125443783|NCT02040090|451252261|FG000|Overall Study|Adverse Event|2|||
125249545|NCT01362270|450538253|FG000|Overall Study|Met excl. criteria before 1st session|1|||
125249546|NCT01362270|450538254|FG001|Overall Study|Met excl. criteria before 1st session|1|||
125249547|NCT02318277|450538255|FG000|Overall Study|Physician Decision|0|||
125249548|NCT02318277|450538256|FG001|Overall Study|Physician Decision|0|||
125249549|NCT02318277|450538257|FG002|Overall Study|Physician Decision|0|||
125249550|NCT02318277|450538258|FG003|Overall Study|Physician Decision|0|||
125249551|NCT02318277|450538259|FG004|Overall Study|Physician Decision|0|||
125249552|NCT02318277|450538260|FG005|Overall Study|Physician Decision|0|||
125249553|NCT02318277|450538261|FG006|Overall Study|Physician Decision|0|||
125249554|NCT02318277|450538262|FG007|Overall Study|Physician Decision|1|||
125396162|NCT02281552|451083038|FG000|Overall Study|Adverse Event|3|||
125396163|NCT02281552|451083039|FG001|Overall Study|Adverse Event|9|||
125249555|NCT02318277|450538255|FG000|Overall Study|Other|0|||
125249556|NCT02318277|450538256|FG001|Overall Study|Other|0|||
125249557|NCT02318277|450538257|FG002|Overall Study|Other|0|||
125249558|NCT02318277|450538258|FG003|Overall Study|Other|0|||
125249559|NCT02318277|450538259|FG004|Overall Study|Other|0|||
125249560|NCT02318277|450538260|FG005|Overall Study|Other|0|||
125249561|NCT02318277|450538261|FG006|Overall Study|Other|1|||
125249562|NCT02318277|450538262|FG007|Overall Study|Other|0|||
125249563|NCT02318277|450538255|FG000|Overall Study|Withdrawal by Subject|0|||
125249564|NCT02318277|450538256|FG001|Overall Study|Withdrawal by Subject|0|||
125249565|NCT02318277|450538257|FG002|Overall Study|Withdrawal by Subject|1|||
125249566|NCT02318277|450538258|FG003|Overall Study|Withdrawal by Subject|0|||
125249567|NCT02318277|450538259|FG004|Overall Study|Withdrawal by Subject|1|||
125249568|NCT02318277|450538260|FG005|Overall Study|Withdrawal by Subject|1|||
125249569|NCT02318277|450538261|FG006|Overall Study|Withdrawal by Subject|6|||
125249570|NCT02318277|450538262|FG007|Overall Study|Withdrawal by Subject|14|||
125249571|NCT02318277|450538255|FG000|Overall Study|Participant trial terminated by sponsor|0|||
125249572|NCT02318277|450538256|FG001|Overall Study|Participant trial terminated by sponsor|0|||
125249573|NCT02318277|450538257|FG002|Overall Study|Participant trial terminated by sponsor|1|||
125249574|NCT02318277|450538258|FG003|Overall Study|Participant trial terminated by sponsor|0|||
125249575|NCT02318277|450538259|FG004|Overall Study|Participant trial terminated by sponsor|1|||
125249576|NCT02318277|450538260|FG005|Overall Study|Participant trial terminated by sponsor|2|||
125249577|NCT02318277|450538261|FG006|Overall Study|Participant trial terminated by sponsor|5|||
125249578|NCT02318277|450538262|FG007|Overall Study|Participant trial terminated by sponsor|16|||
125249579|NCT02318277|450538255|FG000|Overall Study|Lost to Follow-up|1|||
125249580|NCT02318277|450538256|FG001|Overall Study|Lost to Follow-up|0|||
125196473|NCT04791319|450339990|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
125249581|NCT02318277|450538257|FG002|Overall Study|Lost to Follow-up|1|||
125249582|NCT02318277|450538258|FG003|Overall Study|Lost to Follow-up|0|||
125249583|NCT02318277|450538259|FG004|Overall Study|Lost to Follow-up|0|||
125249584|NCT02318277|450538260|FG005|Overall Study|Lost to Follow-up|0|||
125249585|NCT02318277|450538261|FG006|Overall Study|Lost to Follow-up|3|||
125249586|NCT02318277|450538262|FG007|Overall Study|Lost to Follow-up|4|||
125249587|NCT02318277|450538255|FG000|Overall Study|Death|5|||
125249588|NCT02318277|450538256|FG001|Overall Study|Death|3|||
125249589|NCT02318277|450538257|FG002|Overall Study|Death|1|||
125249590|NCT02318277|450538258|FG003|Overall Study|Death|4|||
125249591|NCT02318277|450538259|FG004|Overall Study|Death|6|||
125249592|NCT02318277|450538260|FG005|Overall Study|Death|5|||
125249593|NCT02318277|450538261|FG006|Overall Study|Death|34|||
125196474|NCT02587598|450339991|FG000|Overall Study|Death|4|||
125196475|NCT02587598|450339992|FG001|Overall Study|Death|8|||
125196476|NCT02587598|450339993|FG002|Overall Study|Death|4|||
125196477|NCT02587598|450339994|FG003|Overall Study|Death|16|||
125196478|NCT02587598|450339995|FG004|Overall Study|Death|9|||
125196479|NCT02587598|450339996|FG005|Overall Study|Death|4|||
125196480|NCT02587598|450339997|FG006|Overall Study|Death|6|||
125196481|NCT02587598|450339998|FG007|Overall Study|Death|7|||
125196482|NCT02587598|450339999|FG008|Overall Study|Death|9|||
125196483|NCT02587598|450340000|FG009|Overall Study|Death|1|||
125196484|NCT02587598|450340001|FG010|Overall Study|Death|3|||
125196485|NCT02587598|450339991|FG000|Overall Study|Study Terminated by the Sponsor|0|||
125196486|NCT02587598|450339992|FG001|Overall Study|Study Terminated by the Sponsor|1|||
125196487|NCT02587598|450339993|FG002|Overall Study|Study Terminated by the Sponsor|0|||
125196488|NCT02587598|450339994|FG003|Overall Study|Study Terminated by the Sponsor|3|||
125196489|NCT02587598|450339995|FG004|Overall Study|Study Terminated by the Sponsor|0|||
125196490|NCT02587598|450339996|FG005|Overall Study|Study Terminated by the Sponsor|1|||
125196491|NCT02587598|450339997|FG006|Overall Study|Study Terminated by the Sponsor|0|||
125196492|NCT02587598|450339998|FG007|Overall Study|Study Terminated by the Sponsor|0|||
125196493|NCT02587598|450339999|FG008|Overall Study|Study Terminated by the Sponsor|0|||
125196494|NCT02587598|450340000|FG009|Overall Study|Study Terminated by the Sponsor|1|||
125196495|NCT02587598|450340001|FG010|Overall Study|Study Terminated by the Sponsor|6|||
125196496|NCT02587598|450339991|FG000|Overall Study|Reason for study withdrawal not specified|0|||
125196497|NCT02587598|450339992|FG001|Overall Study|Reason for study withdrawal not specified|1|||
125196498|NCT02587598|450339993|FG002|Overall Study|Reason for study withdrawal not specified|0|||
125196499|NCT02587598|450339994|FG003|Overall Study|Reason for study withdrawal not specified|0|||
125196500|NCT02587598|450339995|FG004|Overall Study|Reason for study withdrawal not specified|0|||
125196501|NCT02587598|450339996|FG005|Overall Study|Reason for study withdrawal not specified|0|||
125196502|NCT02587598|450339997|FG006|Overall Study|Reason for study withdrawal not specified|0|||
125196503|NCT02587598|450339998|FG007|Overall Study|Reason for study withdrawal not specified|0|||
125196504|NCT02587598|450339999|FG008|Overall Study|Reason for study withdrawal not specified|0|||
125196505|NCT02587598|450340000|FG009|Overall Study|Reason for study withdrawal not specified|0|||
125196506|NCT02587598|450340001|FG010|Overall Study|Reason for study withdrawal not specified|0|||
125196507|NCT02587598|450339991|FG000|Overall Study|Withdrawal by Subject|0|||
125196508|NCT02587598|450339992|FG001|Overall Study|Withdrawal by Subject|1|||
125196509|NCT02587598|450339993|FG002|Overall Study|Withdrawal by Subject|0|||
125196510|NCT02587598|450339994|FG003|Overall Study|Withdrawal by Subject|2|||
125196511|NCT02587598|450339995|FG004|Overall Study|Withdrawal by Subject|3|||
125249594|NCT02318277|450538262|FG007|Overall Study|Death|58|||
125249595|NCT02318277|450538255|FG000|Overall Study|Transitioned to Hospice|0|||
125249596|NCT02318277|450538256|FG001|Overall Study|Transitioned to Hospice|0|||
125249597|NCT02318277|450538257|FG002|Overall Study|Transitioned to Hospice|0|||
125249598|NCT02318277|450538258|FG003|Overall Study|Transitioned to Hospice|0|||
125196512|NCT02587598|450339996|FG005|Overall Study|Withdrawal by Subject|1|||
125196513|NCT02587598|450339997|FG006|Overall Study|Withdrawal by Subject|0|||
125196514|NCT02587598|450339998|FG007|Overall Study|Withdrawal by Subject|0|||
125249599|NCT02318277|450538259|FG004|Overall Study|Transitioned to Hospice|0|||
125396164|NCT04656132|451083040|FG000|Overall Study|Lost to Follow-up|4|||
125396165|NCT04656132|451083040|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
125396166|NCT00677807|451083041|FG000|Overall Study|Adverse Event|4|||
125396167|NCT00677807|451083042|FG001|Overall Study|Adverse Event|1|||
125396168|NCT00677807|451083043|FG002|Overall Study|Adverse Event|6|||
125396169|NCT00677807|451083041|FG000|Overall Study|Lack of Efficacy|0|||
125396170|NCT00677807|451083042|FG001|Overall Study|Lack of Efficacy|0|||
125396171|NCT00677807|451083043|FG002|Overall Study|Lack of Efficacy|2|||
125396172|NCT00677807|451083041|FG000|Overall Study|Participant no longer needs study drug|0|||
125396173|NCT00677807|451083042|FG001|Overall Study|Participant no longer needs study drug|0|||
125396174|NCT00677807|451083043|FG002|Overall Study|Participant no longer needs study drug|1|||
125396175|NCT00677807|451083041|FG000|Overall Study|Withdrawal by Subject|10|||
125396176|NCT00677807|451083042|FG001|Overall Study|Withdrawal by Subject|3|||
125396177|NCT00677807|451083043|FG002|Overall Study|Withdrawal by Subject|6|||
125396178|NCT00677807|451083041|FG000|Overall Study|Lost to Follow-up|2|||
125396179|NCT00677807|451083042|FG001|Overall Study|Lost to Follow-up|2|||
125396180|NCT00677807|451083043|FG002|Overall Study|Lost to Follow-up|2|||
125396181|NCT00677807|451083041|FG000|Overall Study|Administrative problems|1|||
125396182|NCT00677807|451083042|FG001|Overall Study|Administrative problems|1|||
125396183|NCT00677807|451083043|FG002|Overall Study|Administrative problems|2|||
125396184|NCT00677807|451083041|FG000|Overall Study|Death|0|||
125396185|NCT00677807|451083042|FG001|Overall Study|Death|1|||
125396186|NCT00677807|451083043|FG002|Overall Study|Death|1|||
125396187|NCT00677807|451083041|FG000|Overall Study|Protocol Deviation|1|||
125396188|NCT00677807|451083042|FG001|Overall Study|Protocol Deviation|3|||
125396189|NCT00677807|451083043|FG002|Overall Study|Protocol Deviation|0|||
125396190|NCT04365699|451083044|FG000|Overall Study|Death|2|||
125396191|NCT04365699|451083045|FG001|Overall Study|Death|5|||
125396192|NCT04365699|451083046|FG002|Overall Study|Death|15|||
125396193|NCT04019041|451083047|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
125396194|NCT04019041|451083048|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
125396195|NCT04019041|451083049|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
125396196|NCT04019041|451083050|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
125396197|NCT04019041|451083051|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
125396198|NCT04019041|451083052|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
125396199|NCT04019041|451083047|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
125396200|NCT04019041|451083048|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
125396201|NCT04019041|451083049|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
125396202|NCT04019041|451083050|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
125396203|NCT04019041|451083051|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
125396204|NCT04019041|451083052|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
125396205|NCT04019041|451083047|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
125396206|NCT04019041|451083048|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
125396207|NCT04019041|451083049|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
125396208|NCT04019041|451083050|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
125396209|NCT04019041|451083051|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
125396210|NCT04019041|451083052|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
125196515|NCT02587598|450339999|FG008|Overall Study|Withdrawal by Subject|0|||
125196516|NCT02587598|450340000|FG009|Overall Study|Withdrawal by Subject|1|||
125196517|NCT02587598|450340001|FG010|Overall Study|Withdrawal by Subject|2|||
125196518|NCT02587598|450339991|FG000|Overall Study|Physician Decision|0|||
125196519|NCT02587598|450339992|FG001|Overall Study|Physician Decision|0|||
125196520|NCT02587598|450339993|FG002|Overall Study|Physician Decision|0|||
125196521|NCT02587598|450339994|FG003|Overall Study|Physician Decision|0|||
125196522|NCT02587598|450339995|FG004|Overall Study|Physician Decision|0|||
125196523|NCT02587598|450339996|FG005|Overall Study|Physician Decision|0|||
125196524|NCT02587598|450339997|FG006|Overall Study|Physician Decision|0|||
125196525|NCT02587598|450339998|FG007|Overall Study|Physician Decision|0|||
125196526|NCT02587598|450339999|FG008|Overall Study|Physician Decision|0|||
125196527|NCT02587598|450340000|FG009|Overall Study|Physician Decision|0|||
125196528|NCT02587598|450340001|FG010|Overall Study|Physician Decision|3|||
125196529|NCT02353442|450340004|FG000|Overall Study|Withdrawal by Subject|3|||
125196530|NCT02353442|450340005|FG001|Overall Study|Withdrawal by Subject|4|||
125196531|NCT00679289|450340007|FG000|Overall Study|Progressive disease|4|||
125196532|NCT00679289|450340008|FG001|Overall Study|Progressive disease|5|||
125196533|NCT00679289|450340009|FG002|Overall Study|Progressive disease|18|||
125196534|NCT00679289|450340007|FG000|Overall Study|Withdrawal by Subject|0|||
125196535|NCT00679289|450340008|FG001|Overall Study|Withdrawal by Subject|1|||
125196536|NCT00679289|450340009|FG002|Overall Study|Withdrawal by Subject|1|||
125196537|NCT00679289|450340007|FG000|Overall Study|Adverse Event|0|||
125396211|NCT04019041|451083047|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
125196538|NCT00679289|450340008|FG001|Overall Study|Adverse Event|0|||
125196539|NCT00679289|450340009|FG002|Overall Study|Adverse Event|3|||
125196540|NCT00679289|450340007|FG000|Overall Study|Physician Decision|1|||
125196541|NCT00679289|450340008|FG001|Overall Study|Physician Decision|0|||
125249600|NCT02318277|450538260|FG005|Overall Study|Transitioned to Hospice|1|||
125249601|NCT02318277|450538261|FG006|Overall Study|Transitioned to Hospice|0|||
125249602|NCT02318277|450538262|FG007|Overall Study|Transitioned to Hospice|0|||
125249603|NCT01520714|450538263|FG000|Overall Study|Protocol Violation|0|||
125249604|NCT01520714|450538264|FG001|Overall Study|Protocol Violation|3|||
125249605|NCT01520714|450538263|FG000|Overall Study|Adverse Event|0|||
125249606|NCT01520714|450538264|FG001|Overall Study|Adverse Event|2|||
125249607|NCT01520714|450538263|FG000|Overall Study|Lack of Efficacy|0|||
125249608|NCT01520714|450538264|FG001|Overall Study|Lack of Efficacy|1|||
125249609|NCT00395512|450538265|FG000|Overall Study|Adverse Event|3|||
125249610|NCT00395512|450538266|FG001|Overall Study|Adverse Event|8|||
125249611|NCT00395512|450538267|FG002|Overall Study|Adverse Event|6|||
125249612|NCT00395512|450538268|FG003|Overall Study|Adverse Event|6|||
125249613|NCT00395512|450538265|FG000|Overall Study|Protocol Violation|2|||
125249614|NCT00395512|450538266|FG001|Overall Study|Protocol Violation|3|||
125249615|NCT00395512|450538267|FG002|Overall Study|Protocol Violation|6|||
125249616|NCT00395512|450538268|FG003|Overall Study|Protocol Violation|7|||
125249617|NCT00395512|450538265|FG000|Overall Study|Lost to Follow-up|2|||
125249618|NCT00395512|450538266|FG001|Overall Study|Lost to Follow-up|6|||
125249619|NCT00395512|450538267|FG002|Overall Study|Lost to Follow-up|5|||
125249620|NCT00395512|450538268|FG003|Overall Study|Lost to Follow-up|5|||
125249621|NCT00395512|450538265|FG000|Overall Study|Withdrawal by Subject|6|||
125249622|NCT00395512|450538266|FG001|Overall Study|Withdrawal by Subject|5|||
125249623|NCT00395512|450538267|FG002|Overall Study|Withdrawal by Subject|5|||
125249624|NCT00395512|450538268|FG003|Overall Study|Withdrawal by Subject|12|||
125249625|NCT00395512|450538265|FG000|Overall Study|Physician Decision|6|||
125249626|NCT00395512|450538266|FG001|Overall Study|Physician Decision|4|||
125249627|NCT00395512|450538267|FG002|Overall Study|Physician Decision|2|||
125249628|NCT00395512|450538268|FG003|Overall Study|Physician Decision|2|||
125249629|NCT00395512|450538265|FG000|Overall Study|Other|1|||
125249630|NCT00395512|450538266|FG001|Overall Study|Other|1|||
125249631|NCT00395512|450538267|FG002|Overall Study|Other|0|||
125249632|NCT00395512|450538268|FG003|Overall Study|Other|0|||
125249633|NCT00395512|450538265|FG000|Overall Study|Hyperglycemic Rescue|18|||
125249634|NCT00395512|450538266|FG001|Overall Study|Hyperglycemic Rescue|10|||
125249635|NCT00395512|450538267|FG002|Overall Study|Hyperglycemic Rescue|4|||
125249636|NCT00395512|450538268|FG003|Overall Study|Hyperglycemic Rescue|6|||
125249637|NCT00754559|450538271|FG000|Overall Study|Adverse Event|15|||
125249638|NCT00754559|450538271|FG000|Overall Study|Protocol Violation|11|||
125249639|NCT00754559|450538271|FG000|Overall Study|Lack of Efficacy|10|||
125249640|NCT00754559|450538271|FG000|Overall Study|Lost to Follow-up|2|||
125249641|NCT00754559|450538271|FG000|Overall Study|Administrative reason|1|||
125249642|NCT00754559|450538271|FG000|Overall Study|Other|5|||
125249643|NCT00754559|450538271|FG000|Overall Study|Withdrawal by Subject|3|||
125249644|NCT01663987|450538272|FG000|Overall Study|Adverse Event|7|||
125249645|NCT01663987|450538273|FG001|Overall Study|Adverse Event|2|||
125249646|NCT01663987|450538272|FG000|Overall Study|Lost to Follow-up|1|||
125249647|NCT01663987|450538273|FG001|Overall Study|Lost to Follow-up|1|||
125249648|NCT01663987|450538272|FG000|Overall Study|Withdrawal by Subject|2|||
125249649|NCT01663987|450538273|FG001|Overall Study|Withdrawal by Subject|3|||
125249650|NCT01663987|450538272|FG000|Overall Study|Other reason not defined above|3|||
125249651|NCT01663987|450538273|FG001|Overall Study|Other reason not defined above|0|||
125249652|NCT03721965|450538275|FG000|Overall Study|Death|1|||
125249653|NCT03721965|450538275|FG000|Overall Study|Study Terminated by Sponsor|1|||
125249654|NCT04913675|450538276|FG000|Main Study (Up to Week 36)|Death|0|||
125249655|NCT04913675|450538277|FG001|Main Study (Up to Week 36)|Death|2|||
125249656|NCT04913675|450538278|FG002|Main Study (Up to Week 36)|Death|2|||
125249657|NCT04913675|450538279|FG003|Main Study (Up to Week 36)|Death|0|||
125249658|NCT04913675|450538276|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
125249659|NCT04913675|450538277|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
125249660|NCT04913675|450538278|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
125249661|NCT04913675|450538279|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
125249662|NCT04913675|450538276|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
125249663|NCT04913675|450538277|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
125249664|NCT04913675|450538278|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
125249665|NCT04913675|450538279|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
125249666|NCT04913675|450538276|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
125249667|NCT04913675|450538277|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
125396212|NCT04019041|451083048|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
125396213|NCT04019041|451083049|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
125249668|NCT04913675|450538278|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
125249669|NCT04913675|450538279|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
125249670|NCT04913675|450538276|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
125249671|NCT04913675|450538277|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
125249672|NCT04913675|450538278|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
125249673|NCT04913675|450538279|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
125443784|NCT02040090|451252262|FG001|Overall Study|Adverse Event|0|||
125443785|NCT02040090|451252261|FG000|Overall Study|Physician Decision|1|||
125443786|NCT02040090|451252262|FG001|Overall Study|Physician Decision|0|||
125443787|NCT02040090|451252261|FG000|Overall Study|Withdrawal by Subject|0|||
125443788|NCT02040090|451252262|FG001|Overall Study|Withdrawal by Subject|1|||
125443789|NCT02040090|451252261|FG000|Overall Study|Lost to Follow-up|0|||
125443790|NCT02040090|451252262|FG001|Overall Study|Lost to Follow-up|1|||
125443791|NCT03259373|451252263|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
125443792|NCT03259373|451252264|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
125443793|NCT03259373|451252263|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
125443794|NCT03259373|451252264|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
125443795|NCT03259373|451252263|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
125443796|NCT03259373|451252264|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
125443797|NCT03259373|451252263|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
125443798|NCT03259373|451252264|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
125443799|NCT03259373|451252263|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
125443800|NCT03259373|451252264|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
125443801|NCT03259373|451252263|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
125443802|NCT03259373|451252264|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
125443803|NCT04894903|451252265|FG000|Overall Study|Death|1|||
125443804|NCT04894903|451252266|FG001|Overall Study|Death|0|||
125443805|NCT04894903|451252265|FG000|Overall Study|Pregnancy|1|||
125443806|NCT04894903|451252266|FG001|Overall Study|Pregnancy|0|||
125443807|NCT04894903|451252265|FG000|Overall Study|Withdrawal by Subject|1|||
125443808|NCT04894903|451252266|FG001|Overall Study|Withdrawal by Subject|1|||
125443809|NCT04894903|451252265|FG000|Overall Study|moved or exited health system|1|||
125443810|NCT04894903|451252266|FG001|Overall Study|moved or exited health system|3|||
125443811|NCT00519636|451252269|FG000|Treatment Period 1|Adverse Event|1|||
125443812|NCT00519636|451252270|FG001|Treatment Period 1|Adverse Event|0|||
125443813|NCT00519636|451252271|FG002|Treatment Period 1|Adverse Event|1|||
125443814|NCT00519636|451252272|FG003|Treatment Period 1|Adverse Event|0|||
125443815|NCT00519636|451252269|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
125443816|NCT00519636|451252270|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
125443817|NCT00519636|451252271|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
125443818|NCT00519636|451252272|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
125443819|NCT00519636|451252269|FG000|Washout Period|Adverse Event|2|||
125443820|NCT00519636|451252270|FG001|Washout Period|Adverse Event|1|||
125443821|NCT00519636|451252271|FG002|Washout Period|Adverse Event|1|||
125443822|NCT00519636|451252272|FG003|Washout Period|Adverse Event|0|||
125443823|NCT00519636|451252269|FG000|Washout Period|Lost to Follow-up|1|||
125443824|NCT00519636|451252270|FG001|Washout Period|Lost to Follow-up|0|||
125443825|NCT00519636|451252271|FG002|Washout Period|Lost to Follow-up|0|||
125443826|NCT00519636|451252272|FG003|Washout Period|Lost to Follow-up|0|||
125443827|NCT00519636|451252269|FG000|Washout Period|Protocol Violation|0|||
125196542|NCT00679289|450340009|FG002|Overall Study|Physician Decision|1|||
125196543|NCT01355575|450340011|FG000|Overall Study|Withdrawal by Subject|2|||
125196544|NCT01094301|450340016|FG000|Trial Stage|Withdrawal by Subject|1|||
125196545|NCT01094301|450340016|FG000|Implant Stage|Adverse Event|1|||
125196546|NCT01094301|450340016|FG000|Implant Stage|Protocol Violation|1|||
125196547|NCT01094301|450340016|FG000|Implant Stage|Withdrawal by Subject|2|||
125196548|NCT01094301|450340016|FG000|Implant Stage|No return of pain|4|||
125196549|NCT00582608|450340017|FG000|Overall Study|Not Treated|7|||
125196550|NCT00582608|450340017|FG000|Overall Study|Patient Ineligible|1|||
125196551|NCT00582608|450340017|FG000|Overall Study|Lack of accrual|4|||
125196552|NCT03386994|450340022|FG000|Overall Study|Lung transplant|1|||
125196553|NCT03386994|450340022|FG000|Overall Study|Adverse Event|14|||
125196554|NCT03386994|450340022|FG000|Overall Study|Lost to Follow-up|4|||
125196555|NCT03386994|450340022|FG000|Overall Study|Withdrawal by Subject|3|||
125196556|NCT03386994|450340022|FG000|Overall Study|Death|16|||
125196557|NCT01732640|450340023|FG000|Overall Study|Adverse Event|0|||
125196558|NCT01732640|450340024|FG001|Overall Study|Adverse Event|1|||
125196559|NCT01732640|450340023|FG000|Overall Study|Death|0|||
125196560|NCT01732640|450340024|FG001|Overall Study|Death|1|||
125196561|NCT00712543|450340025|FG000|Day 8-14|Lost to Follow-up|0|||
125196562|NCT00712543|450340026|FG001|Day 8-14|Lost to Follow-up|2|||
125196563|NCT02702388|450340027|FG000|Overall Study|Disease Progression|18|||
125196564|NCT02702388|450340028|FG001|Overall Study|Disease Progression|25|||
125196565|NCT02702388|450340027|FG000|Overall Study|Withdrawal by Subject|9|||
125196566|NCT02702388|450340028|FG001|Overall Study|Withdrawal by Subject|7|||
125196567|NCT02702388|450340027|FG000|Overall Study|Adverse Event|11|||
125196568|NCT02702388|450340028|FG001|Overall Study|Adverse Event|15|||
125196569|NCT02702388|450340027|FG000|Overall Study|Other|2|||
125249674|NCT02489045|450538280|FG000|Overall Study|unable to collect usable data|53|||
125249675|NCT02489045|450538280|FG000|Follow-up|Lost to Follow-up|10|||
125396214|NCT04019041|451083050|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
125396215|NCT04019041|451083051|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
125396216|NCT04019041|451083052|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
125396217|NCT04019041|451083047|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
125396218|NCT04019041|451083048|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
125396219|NCT04019041|451083049|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
125396220|NCT04019041|451083050|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
125396221|NCT04019041|451083051|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
125396222|NCT04019041|451083052|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
125396223|NCT04019041|451083047|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
125396224|NCT04019041|451083048|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
125396225|NCT04019041|451083049|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
125396226|NCT04019041|451083050|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
125396227|NCT04019041|451083051|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
125396228|NCT04019041|451083052|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
125396229|NCT04019041|451083047|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
125396230|NCT04019041|451083048|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
125396231|NCT04019041|451083049|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
125396232|NCT04019041|451083050|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
125396233|NCT04019041|451083051|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
125396234|NCT04019041|451083052|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
125396235|NCT04019041|451083047|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
125396236|NCT04019041|451083048|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
125396237|NCT04019041|451083049|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
125396238|NCT04019041|451083050|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
125396239|NCT04019041|451083051|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
125396240|NCT04019041|451083052|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
125396241|NCT04019041|451083047|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125396242|NCT04019041|451083048|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125396243|NCT04019041|451083049|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125396244|NCT04019041|451083050|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125396245|NCT04019041|451083051|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
125396246|NCT04019041|451083052|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
125396247|NCT00314366|451083053|FG000|Overall Study|not treated due to patient medical condi|1|||
125396248|NCT00314366|451083054|FG001|Overall Study|not treated due to patient medical condi|0|||
125396249|NCT00834912|451083059|FG000|Treatment Period 1|Adverse Event|0|||
125396250|NCT00834912|451083060|FG001|Treatment Period 1|Adverse Event|1|||
125396251|NCT00834912|451083061|FG002|Treatment Period 1|Adverse Event|0|||
125396252|NCT00834912|451083062|FG003|Treatment Period 1|Adverse Event|1|||
125396253|NCT00834912|451083063|FG004|Treatment Period 1|Adverse Event|0|||
125396254|NCT00834912|451083064|FG005|Treatment Period 1|Adverse Event|0|||
125249676|NCT01341990|450538281|FG000|Overall Study|Adverse Event|0|||
125249677|NCT01341990|450538282|FG001|Overall Study|Adverse Event|1|||
125249678|NCT01341990|450538281|FG000|Overall Study|Torn Study Lens|1|||
125249679|NCT01341990|450538282|FG001|Overall Study|Torn Study Lens|0|||
125249680|NCT01341990|450538281|FG000|Overall Study|Withdrawal by Subject|2|||
125249681|NCT01341990|450538282|FG001|Overall Study|Withdrawal by Subject|0|||
125249682|NCT01751685|450538284|FG000|6-mo Followup|Missed study visit|1|||
125249683|NCT01751685|450538285|FG001|6-mo Followup|Missed study visit|0|||
125249684|NCT01751685|450538284|FG000|6-mo Followup|Withdrawal by Subject|2|||
125249685|NCT01751685|450538285|FG001|6-mo Followup|Withdrawal by Subject|2|||
125249686|NCT01751685|450538284|FG000|6-mo Followup|Lost to Follow-up|0|||
125249687|NCT01751685|450538285|FG001|6-mo Followup|Lost to Follow-up|1|||
125249688|NCT01751685|450538284|FG000|12-mo Followup|Lost to Follow-up|5|||
125249689|NCT01751685|450538285|FG001|12-mo Followup|Lost to Follow-up|0|||
125396255|NCT00834912|451083059|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125396256|NCT00834912|451083060|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125396257|NCT00834912|451083061|FG002|Treatment Period 2|Withdrawal by Subject|1|||
125249690|NCT01348490|450538292|FG000|Overall Study|Death|1|||
125396258|NCT00834912|451083062|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125396259|NCT00834912|451083063|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125396260|NCT00834912|451083064|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125396261|NCT03044197|451083065|FG000|Overall Study|Withdrawal by Subject|3|||
125396262|NCT03044197|451083066|FG001|Overall Study|Withdrawal by Subject|1|||
125249691|NCT01348490|450538292|FG000|Overall Study|Adverse Event|3|||
125249692|NCT01348490|450538292|FG000|Overall Study|Consent withdrawn|7|||
125249693|NCT01348490|450538292|FG000|Overall Study|Disease progression|3|||
125249694|NCT01348490|450538292|FG000|Overall Study|Lost to Follow-up|1|||
125249695|NCT01348490|450538292|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
125249696|NCT01348490|450538292|FG000|Overall Study|Other Unspecified|8|||
125249697|NCT01117350|450538294|FG000|Comparative Period|Not Treated|5|||
125249698|NCT01117350|450538295|FG001|Comparative Period|Not Treated|8|||
125249699|NCT01117350|450538294|FG000|Comparative Period|Adverse Event|6|||
125249700|NCT01117350|450538295|FG001|Comparative Period|Adverse Event|33|||
125249701|NCT01117350|450538294|FG000|Comparative Period|Lost to Follow-up|11|||
125249702|NCT01117350|450538295|FG001|Comparative Period|Lost to Follow-up|7|||
125249703|NCT01117350|450538294|FG000|Comparative Period|Withdrawal by Subject|9|||
125249704|NCT01117350|450538295|FG001|Comparative Period|Withdrawal by Subject|13|||
125249705|NCT01117350|450538294|FG000|Comparative Period|Protocol Violation|8|||
125249706|NCT01117350|450538295|FG001|Comparative Period|Protocol Violation|12|||
125249707|NCT01117350|450538294|FG000|Comparative Period|Lack of Efficacy|1|||
125249708|NCT01117350|450538295|FG001|Comparative Period|Lack of Efficacy|0|||
125196570|NCT02702388|450340028|FG001|Overall Study|Other|4|||
125196571|NCT02729051|450340029|FG000|Overall Study|Adverse Event|21|||
125196572|NCT02729051|450340030|FG001|Overall Study|Adverse Event|11|||
125196573|NCT02729051|450340029|FG000|Overall Study|Lack of Efficacy|1|||
125196574|NCT02729051|450340030|FG001|Overall Study|Lack of Efficacy|1|||
125196575|NCT02729051|450340029|FG000|Overall Study|Lost to Follow-up|1|||
125196576|NCT02729051|450340030|FG001|Overall Study|Lost to Follow-up|2|||
125196577|NCT02729051|450340029|FG000|Overall Study|Physician Decision|1|||
125196578|NCT02729051|450340030|FG001|Overall Study|Physician Decision|1|||
125196579|NCT02729051|450340029|FG000|Overall Study|Withdrawal by Subject|6|||
125196580|NCT02729051|450340030|FG001|Overall Study|Withdrawal by Subject|17|||
125196581|NCT02147158|450340040|FG000|Treatment Course 1|Adverse Event|1|||
125196582|NCT02147158|450340041|FG001|Treatment Course 1|Adverse Event|4|||
125196583|NCT02147158|450340042|FG002|Treatment Course 1|Adverse Event|3|||
125196584|NCT02147158|450340043|FG003|Treatment Course 1|Adverse Event|4|||
125196585|NCT02147158|450340044|FG004|Treatment Course 1|Adverse Event|1|||
125196586|NCT02147158|450340045|FG005|Treatment Course 1|Adverse Event|2|||
125196587|NCT02147158|450340040|FG000|Treatment Course 1|Lost to Follow-up|2|||
125196588|NCT02147158|450340041|FG001|Treatment Course 1|Lost to Follow-up|4|||
125196589|NCT02147158|450340042|FG002|Treatment Course 1|Lost to Follow-up|3|||
125196590|NCT02147158|450340043|FG003|Treatment Course 1|Lost to Follow-up|3|||
125196591|NCT02147158|450340044|FG004|Treatment Course 1|Lost to Follow-up|2|||
125196592|NCT02147158|450340045|FG005|Treatment Course 1|Lost to Follow-up|4|||
125196593|NCT02147158|450340040|FG000|Treatment Course 1|Protocol Violation|0|||
125196594|NCT02147158|450340041|FG001|Treatment Course 1|Protocol Violation|0|||
125196595|NCT02147158|450340042|FG002|Treatment Course 1|Protocol Violation|1|||
125196596|NCT02147158|450340043|FG003|Treatment Course 1|Protocol Violation|1|||
125196597|NCT02147158|450340044|FG004|Treatment Course 1|Protocol Violation|0|||
125196598|NCT02147158|450340045|FG005|Treatment Course 1|Protocol Violation|0|||
125196599|NCT02147158|450340040|FG000|Treatment Course 1|Withdrawal of Consent|1|||
125196600|NCT02147158|450340041|FG001|Treatment Course 1|Withdrawal of Consent|1|||
125196601|NCT02147158|450340042|FG002|Treatment Course 1|Withdrawal of Consent|1|||
125196602|NCT02147158|450340043|FG003|Treatment Course 1|Withdrawal of Consent|5|||
125196603|NCT02147158|450340044|FG004|Treatment Course 1|Withdrawal of Consent|3|||
125196604|NCT02147158|450340045|FG005|Treatment Course 1|Withdrawal of Consent|2|||
125196605|NCT02147158|450340040|FG000|Off-Treatment Interval 1|Adverse Event|1|||
125196606|NCT02147158|450340041|FG001|Off-Treatment Interval 1|Adverse Event|0|||
125196607|NCT02147158|450340042|FG002|Off-Treatment Interval 1|Adverse Event|0|||
125196608|NCT02147158|450340043|FG003|Off-Treatment Interval 1|Adverse Event|1|||
125196609|NCT02147158|450340044|FG004|Off-Treatment Interval 1|Adverse Event|0|||
125196610|NCT02147158|450340045|FG005|Off-Treatment Interval 1|Adverse Event|0|||
125196611|NCT02147158|450340040|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
125196612|NCT02147158|450340041|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
125196613|NCT02147158|450340042|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
125196614|NCT02147158|450340043|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
125196615|NCT02147158|450340044|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
125196616|NCT02147158|450340045|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
125196617|NCT02147158|450340040|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
125196618|NCT02147158|450340041|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
125249709|NCT01117350|450538294|FG000|Comparative Period|Physician Decision|0|||
125249710|NCT01117350|450538295|FG001|Comparative Period|Physician Decision|1|||
125196619|NCT02147158|450340042|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
125196620|NCT02147158|450340043|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
125196621|NCT02147158|450340044|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
125196622|NCT02147158|450340045|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
125196623|NCT02147158|450340040|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
125196624|NCT02147158|450340041|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
125196625|NCT02147158|450340042|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
125196626|NCT02147158|450340043|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
125196627|NCT02147158|450340044|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
125196628|NCT02147158|450340045|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
125249711|NCT01117350|450538294|FG000|Comparative Period|Move to another city/country|2|||
125443828|NCT00519636|451252270|FG001|Washout Period|Protocol Violation|0|||
125443829|NCT00519636|451252271|FG002|Washout Period|Protocol Violation|1|||
125443830|NCT00519636|451252272|FG003|Washout Period|Protocol Violation|2|||
125443831|NCT00519636|451252269|FG000|Washout Period|Withdrawal by Subject|1|||
125443832|NCT00519636|451252270|FG001|Washout Period|Withdrawal by Subject|0|||
125443833|NCT00519636|451252271|FG002|Washout Period|Withdrawal by Subject|1|||
125443834|NCT00519636|451252272|FG003|Washout Period|Withdrawal by Subject|0|||
125443835|NCT00519636|451252269|FG000|Washout Period|Failed to meet continuation criteria|14|||
125443836|NCT00519636|451252270|FG001|Washout Period|Failed to meet continuation criteria|11|||
125443837|NCT00519636|451252271|FG002|Washout Period|Failed to meet continuation criteria|9|||
125443838|NCT00519636|451252272|FG003|Washout Period|Failed to meet continuation criteria|3|||
125443839|NCT00519636|451252269|FG000|Washout Period|Out of pollen area > 48 hours|1|||
125443840|NCT00519636|451252270|FG001|Washout Period|Out of pollen area > 48 hours|0|||
125443841|NCT00519636|451252271|FG002|Washout Period|Out of pollen area > 48 hours|0|||
125443842|NCT00519636|451252272|FG003|Washout Period|Out of pollen area > 48 hours|0|||
125443843|NCT00519636|451252269|FG000|Washout Period|Participating in study at another site|1|||
125443844|NCT00519636|451252270|FG001|Washout Period|Participating in study at another site|0|||
125443845|NCT00519636|451252271|FG002|Washout Period|Participating in study at another site|0|||
125443846|NCT00519636|451252272|FG003|Washout Period|Participating in study at another site|0|||
125443847|NCT00519636|451252269|FG000|Washout Period|Non-compliant|0|||
125443848|NCT00519636|451252270|FG001|Washout Period|Non-compliant|1|||
125443849|NCT00519636|451252271|FG002|Washout Period|Non-compliant|0|||
125443850|NCT00519636|451252272|FG003|Washout Period|Non-compliant|0|||
125443851|NCT00519636|451252269|FG000|Washout Period|Per doctors request|0|||
125443852|NCT00519636|451252270|FG001|Washout Period|Per doctors request|1|||
125443853|NCT00519636|451252271|FG002|Washout Period|Per doctors request|0|||
125443854|NCT00519636|451252272|FG003|Washout Period|Per doctors request|0|||
125443855|NCT00519636|451252269|FG000|Washout Period|Subject randomized in error|0|||
125443856|NCT00519636|451252270|FG001|Washout Period|Subject randomized in error|0|||
125443857|NCT00519636|451252271|FG002|Washout Period|Subject randomized in error|1|||
125443858|NCT00519636|451252272|FG003|Washout Period|Subject randomized in error|0|||
125443859|NCT00519636|451252269|FG000|Washout Period|Prohibited medications|0|||
125443860|NCT00519636|451252270|FG001|Washout Period|Prohibited medications|0|||
125443861|NCT00519636|451252271|FG002|Washout Period|Prohibited medications|1|||
125443862|NCT00519636|451252272|FG003|Washout Period|Prohibited medications|0|||
125443863|NCT00519636|451252269|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
125443864|NCT00519636|451252270|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
125443865|NCT00519636|451252271|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
125443866|NCT00519636|451252272|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
125443867|NCT00519636|451252269|FG000|Treatment Period 2|Subject randomized in error|0|||
125443868|NCT00519636|451252270|FG001|Treatment Period 2|Subject randomized in error|1|||
125443869|NCT00519636|451252271|FG002|Treatment Period 2|Subject randomized in error|0|||
125443870|NCT00519636|451252272|FG003|Treatment Period 2|Subject randomized in error|0|||
125443871|NCT00519636|451252269|FG000|Treatment Period 2|Per doctors request|0|||
125443872|NCT00519636|451252270|FG001|Treatment Period 2|Per doctors request|0|||
125443873|NCT00519636|451252271|FG002|Treatment Period 2|Per doctors request|1|||
125443874|NCT00519636|451252272|FG003|Treatment Period 2|Per doctors request|0|||
125443875|NCT00519636|451252269|FG000|Treatment Period 2|Subject misrandomized|0|||
125443876|NCT00519636|451252270|FG001|Treatment Period 2|Subject misrandomized|0|||
125443877|NCT00519636|451252271|FG002|Treatment Period 2|Subject misrandomized|0|||
125443878|NCT00519636|451252272|FG003|Treatment Period 2|Subject misrandomized|1|||
125443879|NCT00519636|451252269|FG000|Post Study Period|Subject randomized in error|0|||
125443880|NCT00519636|451252270|FG001|Post Study Period|Subject randomized in error|0|||
125443881|NCT00519636|451252271|FG002|Post Study Period|Subject randomized in error|0|||
125443882|NCT00519636|451252272|FG003|Post Study Period|Subject randomized in error|1|||
125443883|NCT02169830|451253860|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
125443884|NCT02169830|451253861|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
125443885|NCT02169830|451253862|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
125443886|NCT02169830|451253860|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
125443887|NCT02169830|451253861|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
125443888|NCT02169830|451253862|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
125443889|NCT02169830|451253860|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
125443890|NCT02169830|451253861|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
125249712|NCT01117350|450538295|FG001|Comparative Period|Move to another city/country|1|||
125249713|NCT01117350|450538294|FG000|Extension Period|Not included in extension, not treated|0|||
125249714|NCT01117350|450538295|FG001|Extension Period|Not included in extension, not treated|50|||
125249715|NCT01117350|450538294|FG000|Extension Period|Adverse Event|0|||
125249716|NCT01117350|450538295|FG001|Extension Period|Adverse Event|2|||
125443891|NCT02169830|451253862|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
125443892|NCT02169830|451253860|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
125443893|NCT02169830|451253861|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
125396263|NCT01083433|451084998|FG000|Overall Study|Lost to Follow-up|2|||
125396264|NCT01083433|451084999|FG001|Overall Study|Lost to Follow-up|1|||
125396265|NCT01083433|451085000|FG002|Overall Study|Lost to Follow-up|1|||
125396266|NCT01083433|451084998|FG000|Overall Study|Withdrawal by Subject|0|||
125396267|NCT01083433|451084999|FG001|Overall Study|Withdrawal by Subject|5|||
125396268|NCT01083433|451085000|FG002|Overall Study|Withdrawal by Subject|3|||
125396269|NCT01083433|451084998|FG000|Overall Study|Pregnancy|0|||
125396270|NCT01083433|451084999|FG001|Overall Study|Pregnancy|0|||
125396271|NCT01083433|451085000|FG002|Overall Study|Pregnancy|1|||
125396272|NCT01581593|451085001|FG000|Overall Study|Withdrawal by Subject|1|||
125396273|NCT04982029|451085002|FG000|Overall Study|Lost to Follow-up|2|||
125396274|NCT04982029|451085003|FG001|Overall Study|Lost to Follow-up|3|||
125396275|NCT04127786|451085004|FG000|Primary Series|Adverse Event|1|||
125396276|NCT04127786|451085005|FG001|Primary Series|Adverse Event|0|||
125396277|NCT04127786|451085006|FG002|Primary Series|Adverse Event|0|||
125396278|NCT04127786|451085007|FG003|Primary Series|Adverse Event|1|||
125396279|NCT04127786|451085008|FG004|Primary Series|Adverse Event|0|||
125396280|NCT04127786|451085009|FG005|Primary Series|Adverse Event|1|||
125396281|NCT04127786|451085004|FG000|Primary Series|Protocol Violation|5|||
125396282|NCT04127786|451085005|FG001|Primary Series|Protocol Violation|3|||
125396283|NCT04127786|451085006|FG002|Primary Series|Protocol Violation|4|||
125396284|NCT04127786|451085007|FG003|Primary Series|Protocol Violation|3|||
125396285|NCT04127786|451085008|FG004|Primary Series|Protocol Violation|2|||
125396286|NCT04127786|451085009|FG005|Primary Series|Protocol Violation|0|||
125396287|NCT04127786|451085004|FG000|Primary Series|Withdrawal by Subject|0|||
125396288|NCT04127786|451085005|FG001|Primary Series|Withdrawal by Subject|0|||
125396289|NCT04127786|451085006|FG002|Primary Series|Withdrawal by Subject|0|||
125396290|NCT04127786|451085007|FG003|Primary Series|Withdrawal by Subject|1|||
125396291|NCT04127786|451085008|FG004|Primary Series|Withdrawal by Subject|0|||
125396292|NCT04127786|451085009|FG005|Primary Series|Withdrawal by Subject|0|||
125396293|NCT04127786|451085004|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
125396294|NCT04127786|451085005|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
125396295|NCT04127786|451085006|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
125396296|NCT04127786|451085007|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
125396297|NCT04127786|451085008|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
125396298|NCT04127786|451085009|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
125396299|NCT04127786|451085004|FG000|Booster Phase|Withdrawal by Subject|2|||
125396300|NCT04127786|451085005|FG001|Booster Phase|Withdrawal by Subject|0|||
125396301|NCT04127786|451085006|FG002|Booster Phase|Withdrawal by Subject|0|||
125396302|NCT04127786|451085007|FG003|Booster Phase|Withdrawal by Subject|0|||
125396303|NCT04127786|451085008|FG004|Booster Phase|Withdrawal by Subject|0|||
125396304|NCT04127786|451085009|FG005|Booster Phase|Withdrawal by Subject|0|||
125396305|NCT03568942|451085012|FG000|Overall Study|Family emergency|1|||
125396306|NCT03568942|451085012|FG000|Overall Study|Lost to Follow-up|1|||
125396307|NCT00358527|451085013|FG000|Overall Study|Adverse Event|4|||
125396308|NCT00358527|451085014|FG001|Overall Study|Adverse Event|0|||
125396309|NCT00358527|451085013|FG000|Overall Study|Withdrawal by Subject|1|||
125396310|NCT00358527|451085014|FG001|Overall Study|Withdrawal by Subject|1|||
125396311|NCT00358527|451085013|FG000|Overall Study|Non-compliance with protocol|6|||
125396312|NCT00358527|451085014|FG001|Overall Study|Non-compliance with protocol|1|||
125396313|NCT00358527|451085013|FG000|Overall Study|Administrative|2|||
125396314|NCT00358527|451085014|FG001|Overall Study|Administrative|1|||
125396315|NCT04144166|451085015|FG000|Overall Study|Discharged before study start|1|||
125396316|NCT04144166|451085015|FG000|Overall Study|Pregnancy|1|||
125396317|NCT04144166|451085015|FG000|Overall Study|Nail polish could not be removed from finger|1|||
125396318|NCT04904185|451085017|FG000|Overall Study|Expansion failure|1|||
125396319|NCT04904185|451085018|FG001|Overall Study|Expansion failure|0|||
125396320|NCT04904185|451085017|FG000|Overall Study|Late response on prior treatment|1|||
125396321|NCT04904185|451085018|FG001|Overall Study|Late response on prior treatment|0|||
125396322|NCT02433834|451085020|FG000|Overall Study|Protocol-specified criteria|7|||
125396323|NCT02433834|451085020|FG000|Overall Study|Protocol Violation|3|||
125396324|NCT02433834|451085020|FG000|Overall Study|Lost to Follow-up|6|||
125396325|NCT02433834|451085020|FG000|Overall Study|Withdrawal by Subject|14|||
125396326|NCT02433834|451085020|FG000|Overall Study|Adverse Event|6|||
125396327|NCT02433834|451085020|FG000|Overall Study|Physician Decision|1|||
125396328|NCT00640510|451085021|FG000|Overall Study|Lack of Efficacy|0|||
125396329|NCT00640510|451085022|FG001|Overall Study|Lack of Efficacy|1|||
125396330|NCT00640510|451085021|FG000|Overall Study|Protocol Violation|1|||
125396331|NCT00640510|451085022|FG001|Overall Study|Protocol Violation|0|||
125396332|NCT00640510|451085021|FG000|Overall Study|Physician Decision|0|||
125396333|NCT00640510|451085022|FG001|Overall Study|Physician Decision|1|||
125396334|NCT01956110|451085023|FG000|Overall Study|Protocol Violation|25|||
125396335|NCT01956110|451085024|FG001|Overall Study|Protocol Violation|11|||
125396336|NCT01956110|451085023|FG000|Overall Study|Adverse Event|9|||
125396337|NCT01956110|451085024|FG001|Overall Study|Adverse Event|10|||
125396338|NCT01956110|451085023|FG000|Overall Study|Personal reasons|1|||
125396339|NCT01956110|451085024|FG001|Overall Study|Personal reasons|1|||
125396340|NCT01467076|451085027|FG000|Overall Study|Lost to Follow-up|1|||
125396341|NCT01467076|451085028|FG001|Overall Study|Lost to Follow-up|0|||
125396342|NCT01467076|451085029|FG002|Overall Study|Lost to Follow-up|0|||
125396343|NCT00418691|451085031|FG000|Overall Study|Lost to Follow-up|1|||
125396344|NCT00418691|451085032|FG001|Overall Study|Lost to Follow-up|2|||
125396345|NCT00418691|451085033|FG002|Overall Study|Lost to Follow-up|3|||
125396346|NCT00418691|451085031|FG000|Overall Study|Started new medication voiding entry|0|||
125396347|NCT00418691|451085032|FG001|Overall Study|Started new medication voiding entry|0|||
125396348|NCT00418691|451085033|FG002|Overall Study|Started new medication voiding entry|1|||
125396349|NCT00418691|451085031|FG000|Overall Study|Progressive Disease|1|||
125396350|NCT00418691|451085032|FG001|Overall Study|Progressive Disease|0|||
125396351|NCT00418691|451085033|FG002|Overall Study|Progressive Disease|1|||
125396352|NCT05923229|451085034|FG000|Overall Study|Withdrawal by Subject|3|||
125396353|NCT05923229|451085035|FG001|Overall Study|Withdrawal by Subject|0|||
125396354|NCT05923229|451085034|FG000|Overall Study|Health related|2|||
125396355|NCT05923229|451085035|FG001|Overall Study|Health related|1|||
125396356|NCT05288556|451085039|FG000|Overall Study|Protocol Violation|1|||
125396357|NCT05288556|451085039|FG000|Overall Study|Withdrawal by Subject|1|||
125396358|NCT02465528|451085040|FG000|Overall Study|Progressive disease|0|||
125396359|NCT02465528|451085041|FG001|Overall Study|Progressive disease|2|||
125396360|NCT02465528|451085042|FG002|Overall Study|Progressive disease|9|||
125396361|NCT02465528|451085043|FG003|Overall Study|Progressive disease|4|||
125396362|NCT02465528|451085040|FG000|Overall Study|Study terminated by sponsor|1|||
125396363|NCT02465528|451085041|FG001|Overall Study|Study terminated by sponsor|2|||
125396364|NCT02465528|451085042|FG002|Overall Study|Study terminated by sponsor|0|||
125396365|NCT02465528|451085043|FG003|Overall Study|Study terminated by sponsor|0|||
125396366|NCT02465528|451085040|FG000|Overall Study|Withdrawal by Subject|0|||
125396367|NCT02465528|451085041|FG001|Overall Study|Withdrawal by Subject|0|||
125396368|NCT02465528|451085042|FG002|Overall Study|Withdrawal by Subject|2|||
125396369|NCT02465528|451085043|FG003|Overall Study|Withdrawal by Subject|0|||
125396370|NCT02465528|451085040|FG000|Overall Study|Adverse Event|0|||
125396371|NCT02465528|451085041|FG001|Overall Study|Adverse Event|0|||
125396372|NCT02465528|451085042|FG002|Overall Study|Adverse Event|0|||
125396373|NCT02465528|451085043|FG003|Overall Study|Adverse Event|1|||
125396374|NCT02465528|451085040|FG000|Overall Study|Physician Decision|0|||
125396375|NCT02465528|451085041|FG001|Overall Study|Physician Decision|0|||
125396376|NCT02465528|451085042|FG002|Overall Study|Physician Decision|1|||
125396377|NCT02465528|451085043|FG003|Overall Study|Physician Decision|0|||
125396378|NCT03907683|451085046|FG000|Overall Study|Pregnancy|1|||
125396379|NCT03907683|451085046|FG000|Overall Study|Withdrawal by Subject|1|||
125396380|NCT03400332|451085048|FG000|Pre-Treatment|Other reasons|0|||
125396381|NCT03400332|451085049|FG001|Pre-Treatment|Other reasons|0|||
125396382|NCT03400332|451085050|FG002|Pre-Treatment|Other reasons|0|||
125396383|NCT03400332|451085051|FG003|Pre-Treatment|Other reasons|0|||
125396384|NCT03400332|451085052|FG004|Pre-Treatment|Other reasons|0|||
125396385|NCT03400332|451085053|FG005|Pre-Treatment|Other reasons|0|||
125396386|NCT03400332|451085054|FG006|Pre-Treatment|Other reasons|0|||
125396387|NCT03400332|451085055|FG007|Pre-Treatment|Other reasons|0|||
125396388|NCT03400332|451085056|FG008|Pre-Treatment|Other reasons|1|||
125396389|NCT03400332|451085048|FG000|Pre-Treatment|No longer met study criteria|0|||
125396390|NCT03400332|451085049|FG001|Pre-Treatment|No longer met study criteria|0|||
125396391|NCT03400332|451085050|FG002|Pre-Treatment|No longer met study criteria|0|||
125396392|NCT03400332|451085051|FG003|Pre-Treatment|No longer met study criteria|0|||
125396393|NCT03400332|451085052|FG004|Pre-Treatment|No longer met study criteria|0|||
125396394|NCT03400332|451085053|FG005|Pre-Treatment|No longer met study criteria|0|||
125396395|NCT03400332|451085054|FG006|Pre-Treatment|No longer met study criteria|0|||
125396396|NCT03400332|451085055|FG007|Pre-Treatment|No longer met study criteria|0|||
125396397|NCT03400332|451085056|FG008|Pre-Treatment|No longer met study criteria|1|||
125396398|NCT03400332|451085048|FG000|Pre-Treatment|Withdrawal by Subject|0|||
125396399|NCT03400332|451085049|FG001|Pre-Treatment|Withdrawal by Subject|0|||
125396400|NCT03400332|451085050|FG002|Pre-Treatment|Withdrawal by Subject|0|||
125396401|NCT03400332|451085051|FG003|Pre-Treatment|Withdrawal by Subject|0|||
125396402|NCT03400332|451085052|FG004|Pre-Treatment|Withdrawal by Subject|0|||
125396403|NCT03400332|451085053|FG005|Pre-Treatment|Withdrawal by Subject|0|||
125396404|NCT03400332|451085054|FG006|Pre-Treatment|Withdrawal by Subject|0|||
125396405|NCT03400332|451085055|FG007|Pre-Treatment|Withdrawal by Subject|0|||
125396406|NCT03400332|451085056|FG008|Pre-Treatment|Withdrawal by Subject|1|||
125396407|NCT03400332|451085048|FG000|Treatment|Participant withdrew consent|2|||
125396408|NCT03400332|451085049|FG001|Treatment|Participant withdrew consent|2|||
125396409|NCT03400332|451085050|FG002|Treatment|Participant withdrew consent|0|||
125396410|NCT03400332|451085051|FG003|Treatment|Participant withdrew consent|0|||
125396411|NCT03400332|451085052|FG004|Treatment|Participant withdrew consent|3|||
125396412|NCT03400332|451085053|FG005|Treatment|Participant withdrew consent|3|||
125396413|NCT03400332|451085054|FG006|Treatment|Participant withdrew consent|1|||
125396414|NCT03400332|451085055|FG007|Treatment|Participant withdrew consent|1|||
125396415|NCT03400332|451085056|FG008|Treatment|Participant withdrew consent|1|||
125396416|NCT03400332|451085048|FG000|Treatment|Other reasons|0|||
125396417|NCT03400332|451085049|FG001|Treatment|Other reasons|1|||
125396418|NCT03400332|451085050|FG002|Treatment|Other reasons|1|||
125396419|NCT03400332|451085051|FG003|Treatment|Other reasons|0|||
125196629|NCT02147158|450340040|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
125196630|NCT02147158|450340041|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
125196631|NCT02147158|450340042|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
125196632|NCT02147158|450340043|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
125196633|NCT02147158|450340044|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
125196634|NCT02147158|450340045|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
125196635|NCT02147158|450340040|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
125196636|NCT02147158|450340041|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
125196637|NCT02147158|450340042|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
125196638|NCT02147158|450340043|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
125196639|NCT02147158|450340044|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
125196640|NCT02147158|450340045|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
125196641|NCT02147158|450340040|FG000|Treatment Course 2|Adverse Event|0|||
125196642|NCT02147158|450340041|FG001|Treatment Course 2|Adverse Event|4|||
125196643|NCT02147158|450340042|FG002|Treatment Course 2|Adverse Event|2|||
125196644|NCT02147158|450340043|FG003|Treatment Course 2|Adverse Event|1|||
125196645|NCT02147158|450340044|FG004|Treatment Course 2|Adverse Event|0|||
125196646|NCT02147158|450340045|FG005|Treatment Course 2|Adverse Event|1|||
125196647|NCT02147158|450340040|FG000|Treatment Course 2|Withdrawal of Consent|0|||
125196648|NCT02147158|450340041|FG001|Treatment Course 2|Withdrawal of Consent|1|||
125196649|NCT02147158|450340042|FG002|Treatment Course 2|Withdrawal of Consent|2|||
125196650|NCT02147158|450340043|FG003|Treatment Course 2|Withdrawal of Consent|3|||
125196651|NCT02147158|450340044|FG004|Treatment Course 2|Withdrawal of Consent|0|||
125196652|NCT02147158|450340045|FG005|Treatment Course 2|Withdrawal of Consent|0|||
125196653|NCT02147158|450340040|FG000|Treatment Course 2|Lost to Follow-up|1|||
125196654|NCT02147158|450340041|FG001|Treatment Course 2|Lost to Follow-up|0|||
125196655|NCT02147158|450340042|FG002|Treatment Course 2|Lost to Follow-up|1|||
125196656|NCT02147158|450340043|FG003|Treatment Course 2|Lost to Follow-up|1|||
125196657|NCT02147158|450340044|FG004|Treatment Course 2|Lost to Follow-up|0|||
125196658|NCT02147158|450340045|FG005|Treatment Course 2|Lost to Follow-up|1|||
125196659|NCT02147158|450340040|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
125196660|NCT02147158|450340041|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
125196661|NCT02147158|450340042|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
125196662|NCT02147158|450340043|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
125196663|NCT02147158|450340044|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
125196664|NCT02147158|450340045|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
125196665|NCT02147158|450340040|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
125196666|NCT02147158|450340041|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
125196667|NCT02147158|450340042|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
125196668|NCT02147158|450340043|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
125196669|NCT02147158|450340044|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
125196670|NCT02147158|450340045|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
125196671|NCT02147158|450340040|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
125196672|NCT02147158|450340041|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
125196673|NCT02147158|450340042|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
125196674|NCT02147158|450340043|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
125196675|NCT02147158|450340044|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
125196676|NCT02147158|450340045|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
125196677|NCT02147158|450340040|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
125196678|NCT02147158|450340041|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
125196679|NCT02147158|450340042|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
125196680|NCT02147158|450340043|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
125196681|NCT02147158|450340044|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
125196682|NCT02147158|450340045|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
125196683|NCT02147158|450340040|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
125196684|NCT02147158|450340041|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
125196685|NCT02147158|450340042|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
125196686|NCT02147158|450340043|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
125196687|NCT02147158|450340044|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
125196688|NCT02147158|450340045|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
125196689|NCT03033602|450340046|FG000|Overall Study|Withdrawal by Subject|11|||
125196690|NCT03033602|450340047|FG001|Overall Study|Withdrawal by Subject|21|||
125196691|NCT03033602|450340046|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
125196692|NCT03033602|450340047|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
125196693|NCT01441765|450340048|FG000|Overall Study|Death|1|||
125196694|NCT01441765|450340049|FG001|Overall Study|Death|0|||
125396420|NCT03400332|451085052|FG004|Treatment|Other reasons|3|||
125396421|NCT03400332|451085053|FG005|Treatment|Other reasons|1|||
125396422|NCT03400332|451085054|FG006|Treatment|Other reasons|2|||
125396423|NCT03400332|451085055|FG007|Treatment|Other reasons|0|||
125396424|NCT03400332|451085056|FG008|Treatment|Other reasons|1|||
125196695|NCT04445714|450340050|FG000|Overall Study|Discontinuation of the study|14|||
125196696|NCT04445714|450340050|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
125196697|NCT04445714|450340050|FG000|Overall Study|Withdrawal of Informed Consent|8|||
125196698|NCT02805660|450340051|FG000|Overall Study|Death|5|||
125196699|NCT02805660|450340052|FG001|Overall Study|Death|2|||
125196700|NCT02805660|450340053|FG002|Overall Study|Death|9|||
125196701|NCT02805660|450340054|FG003|Overall Study|Death|5|||
125196702|NCT02805660|450340055|FG004|Overall Study|Death|0|||
125196703|NCT02805660|450340056|FG005|Overall Study|Death|14|||
125196704|NCT02805660|450340057|FG006|Overall Study|Death|12|||
125196705|NCT02805660|450340051|FG000|Overall Study|Lost to Follow-up|0|||
125196706|NCT02805660|450340052|FG001|Overall Study|Lost to Follow-up|1|||
125196707|NCT02805660|450340053|FG002|Overall Study|Lost to Follow-up|1|||
125196708|NCT02805660|450340054|FG003|Overall Study|Lost to Follow-up|2|||
125196709|NCT02805660|450340055|FG004|Overall Study|Lost to Follow-up|0|||
125196710|NCT02805660|450340056|FG005|Overall Study|Lost to Follow-up|0|||
125196711|NCT02805660|450340057|FG006|Overall Study|Lost to Follow-up|0|||
125196712|NCT02805660|450340051|FG000|Overall Study|Withdrawal by Subject|0|||
125196713|NCT02805660|450340052|FG001|Overall Study|Withdrawal by Subject|0|||
125196714|NCT02805660|450340053|FG002|Overall Study|Withdrawal by Subject|0|||
125196715|NCT02805660|450340054|FG003|Overall Study|Withdrawal by Subject|3|||
125196716|NCT02805660|450340055|FG004|Overall Study|Withdrawal by Subject|1|||
125196717|NCT02805660|450340056|FG005|Overall Study|Withdrawal by Subject|0|||
125196718|NCT02805660|450340057|FG006|Overall Study|Withdrawal by Subject|2|||
125196719|NCT02805660|450340051|FG000|Overall Study|Study terminated by Sponsor|0|||
125196720|NCT02805660|450340052|FG001|Overall Study|Study terminated by Sponsor|0|||
125196721|NCT02805660|450340053|FG002|Overall Study|Study terminated by Sponsor|1|||
125196722|NCT02805660|450340054|FG003|Overall Study|Study terminated by Sponsor|4|||
125196723|NCT02805660|450340055|FG004|Overall Study|Study terminated by Sponsor|2|||
125196724|NCT02805660|450340056|FG005|Overall Study|Study terminated by Sponsor|3|||
125196725|NCT02805660|450340057|FG006|Overall Study|Study terminated by Sponsor|1|||
125196726|NCT02805660|450340051|FG000|Overall Study|Miscellaneous|0|||
125196727|NCT02805660|450340052|FG001|Overall Study|Miscellaneous|1|||
125196728|NCT02805660|450340053|FG002|Overall Study|Miscellaneous|0|||
125196729|NCT02805660|450340054|FG003|Overall Study|Miscellaneous|4|||
125196730|NCT02805660|450340055|FG004|Overall Study|Miscellaneous|0|||
125196731|NCT02805660|450340056|FG005|Overall Study|Miscellaneous|6|||
125196732|NCT02805660|450340057|FG006|Overall Study|Miscellaneous|4|||
125196733|NCT01684943|450340058|FG000|Overall Study|Inadequate Venous Access|3|||
125196734|NCT01684943|450340059|FG001|Overall Study|Inadequate Venous Access|0|||
125196735|NCT01684943|450340060|FG002|Overall Study|Inadequate Venous Access|0|||
125196736|NCT01684943|450340058|FG000|Overall Study|Principal Investigator Determination|1|||
125196737|NCT01684943|450340059|FG001|Overall Study|Principal Investigator Determination|0|||
125196738|NCT01684943|450340060|FG002|Overall Study|Principal Investigator Determination|0|||
125196739|NCT01684943|450340058|FG000|Overall Study|Excluded from Analysis|1|||
125196740|NCT01684943|450340059|FG001|Overall Study|Excluded from Analysis|1|||
125196741|NCT01684943|450340060|FG002|Overall Study|Excluded from Analysis|1|||
125196742|NCT01684943|450340058|FG000|Overall Study|Lost to Follow-up|3|||
125196743|NCT01684943|450340059|FG001|Overall Study|Lost to Follow-up|0|||
125196744|NCT01684943|450340060|FG002|Overall Study|Lost to Follow-up|0|||
125196745|NCT01684943|450340058|FG000|Overall Study|Planning Pregnancy|1|||
125196746|NCT01684943|450340059|FG001|Overall Study|Planning Pregnancy|0|||
125196747|NCT01684943|450340060|FG002|Overall Study|Planning Pregnancy|0|||
125196748|NCT01190410|450341943|FG000|Overall Study|Adverse Event|0|||
125196749|NCT01190410|450341944|FG001|Overall Study|Adverse Event|3|||
125196750|NCT01190410|450341943|FG000|Overall Study|Lack of Efficacy|0|||
125196751|NCT01190410|450341944|FG001|Overall Study|Lack of Efficacy|2|||
125196752|NCT01190410|450341943|FG000|Overall Study|Withdrawal by Subject|0|||
125196753|NCT01190410|450341944|FG001|Overall Study|Withdrawal by Subject|2|||
125196754|NCT01190410|450341943|FG000|Overall Study|Administrative decision|1|||
125196755|NCT01190410|450341944|FG001|Overall Study|Administrative decision|0|||
125196756|NCT01190410|450341943|FG000|Overall Study|PI discretion|0|||
125196757|NCT01190410|450341944|FG001|Overall Study|PI discretion|2|||
125196758|NCT01399047|450341945|FG000|Overall Study|Withdrawal by Subject|0|||
125196759|NCT01399047|450341946|FG001|Overall Study|Withdrawal by Subject|1|||
125196760|NCT00504725|450341954|FG000|Overall Study|Protocol Violation|1|||
125196761|NCT00504725|450341955|FG001|Overall Study|Protocol Violation|0|||
125196762|NCT00769067|450341957|FG000|Overall Study|Death|89|||
125196763|NCT00769067|450341958|FG001|Overall Study|Death|86|||
125196764|NCT00769067|450341957|FG000|Overall Study|Lost to Follow-up|3|||
125196765|NCT00769067|450341958|FG001|Overall Study|Lost to Follow-up|1|||
125196766|NCT00769067|450341957|FG000|Overall Study|Study terminated by sponsor|1|||
125196767|NCT00769067|450341958|FG001|Overall Study|Study terminated by sponsor|3|||
125196768|NCT00769067|450341957|FG000|Overall Study|Other|1|||
125196769|NCT00769067|450341958|FG001|Overall Study|Other|3|||
125196770|NCT00769067|450341957|FG000|Overall Study|Withdrawal by Subject|0|||
125196771|NCT00769067|450341958|FG001|Overall Study|Withdrawal by Subject|1|||
125196772|NCT03625466|450341959|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
125249717|NCT01117350|450538294|FG000|Extension Period|Protocol Violation|0|||
125249718|NCT01117350|450538295|FG001|Extension Period|Protocol Violation|2|||
125249719|NCT01117350|450538294|FG000|Extension Period|Lost to Follow-up|0|||
125249720|NCT01117350|450538295|FG001|Extension Period|Lost to Follow-up|2|||
125249721|NCT01117350|450538294|FG000|Extension Period|Withdrawal by Subject|0|||
125249722|NCT01117350|450538295|FG001|Extension Period|Withdrawal by Subject|3|||
125249723|NCT01117350|450538294|FG000|Extension Period|Lack of Efficacy|0|||
125249724|NCT01117350|450538295|FG001|Extension Period|Lack of Efficacy|2|||
125196773|NCT03625466|450341960|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
125196774|NCT03625466|450341961|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
125196775|NCT03625466|450341959|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
125196776|NCT03625466|450341960|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
125196777|NCT03625466|450341961|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
125196778|NCT03625466|450341959|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
125196779|NCT03625466|450341960|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
125196780|NCT03625466|450341961|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
125196781|NCT00809471|450341962|FG000|Overall Study|Protocol non-compliance|15|||
125196782|NCT00809471|450341963|FG001|Overall Study|Protocol non-compliance|15|||
125196783|NCT00809471|450341964|FG002|Overall Study|Protocol non-compliance|6|||
125196784|NCT00809471|450341962|FG000|Overall Study|Lost to Follow-up|4|||
125196785|NCT00809471|450341963|FG001|Overall Study|Lost to Follow-up|2|||
125196786|NCT00809471|450341964|FG002|Overall Study|Lost to Follow-up|9|||
125196787|NCT00809471|450341962|FG000|Overall Study|Adverse Event|0|||
125196788|NCT00809471|450341963|FG001|Overall Study|Adverse Event|2|||
125196789|NCT00809471|450341964|FG002|Overall Study|Adverse Event|2|||
125196790|NCT00809471|450341962|FG000|Overall Study|Requirement for restricted medication|1|||
125196791|NCT00809471|450341963|FG001|Overall Study|Requirement for restricted medication|1|||
125196792|NCT00809471|450341964|FG002|Overall Study|Requirement for restricted medication|0|||
125196793|NCT00956592|450341968|FG000|Overall Study|Protocol Violation|1|||
125196794|NCT00956592|450341969|FG001|Overall Study|Protocol Violation|3|||
125196795|NCT02028767|450341971|FG000|Treatment Period 2|Non compliant with protocol|1|||
125196796|NCT02028767|450341972|FG001|Treatment Period 2|Non compliant with protocol|0|||
125196797|NCT02028767|450341971|FG000|Treatment Period 2|Reason other than those specified above|1|||
125196798|NCT02028767|450341972|FG001|Treatment Period 2|Reason other than those specified above|0|||
125196799|NCT01942486|450341973|FG000|Overall Study|Lost to Follow-up|27|||
125196800|NCT03521115|450341974|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
125196801|NCT03521115|450341975|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
125196802|NCT03521115|450341974|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
125196803|NCT03521115|450341975|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
125196804|NCT01471340|450341976|FG000|Overall Study|Death|5|||
125196805|NCT01471340|450341977|FG001|Overall Study|Death|4|||
125196806|NCT01471340|450341976|FG000|Overall Study|Lost to Follow-up|0|||
125196807|NCT01471340|450341977|FG001|Overall Study|Lost to Follow-up|1|||
125196808|NCT01471340|450341976|FG000|Overall Study|Investigational site closure|0|||
125196809|NCT01471340|450341977|FG001|Overall Study|Investigational site closure|1|||
125196810|NCT01471340|450341976|FG000|Overall Study|Invalid informed consent|1|||
125196811|NCT01471340|450341977|FG001|Overall Study|Invalid informed consent|0|||
125196812|NCT00526669|450341978|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
125196813|NCT00526669|450341979|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
125196814|NCT00526669|450341978|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
125196815|NCT00526669|450341979|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
125196816|NCT00526669|450341978|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
125196817|NCT00526669|450341979|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
125196818|NCT00526669|450341978|FG000|Combined Treatment Phase|Death|0|||
125196819|NCT00526669|450341979|FG001|Combined Treatment Phase|Death|2|||
125196820|NCT03499899|450341981|FG000|Overall Study|Adverse Event|2|||
125196821|NCT03499899|450341982|FG001|Overall Study|Adverse Event|3|||
125196822|NCT03499899|450341983|FG002|Overall Study|Adverse Event|3|||
125196823|NCT03499899|450341981|FG000|Overall Study|Death|0|||
125196824|NCT03499899|450341982|FG001|Overall Study|Death|0|||
125196825|NCT03499899|450341983|FG002|Overall Study|Death|1|||
125196826|NCT03499899|450341981|FG000|Overall Study|Physician Decision|3|||
125196827|NCT03499899|450341982|FG001|Overall Study|Physician Decision|6|||
125196828|NCT03499899|450341983|FG002|Overall Study|Physician Decision|6|||
125196829|NCT03499899|450341981|FG000|Overall Study|Progressive disease|15|||
125196830|NCT03499899|450341982|FG001|Overall Study|Progressive disease|23|||
125196831|NCT03499899|450341983|FG002|Overall Study|Progressive disease|23|||
125249725|NCT01117350|450538294|FG000|Extension Period|Inclusion criteria not respected|0|||
125249726|NCT01117350|450538295|FG001|Extension Period|Inclusion criteria not respected|1|||
125396425|NCT03400332|451085048|FG000|Treatment|Lost to Follow-up|0|||
125196832|NCT03499899|450341981|FG000|Overall Study|Patient decision|0|||
125196833|NCT03499899|450341982|FG001|Overall Study|Patient decision|1|||
125249727|NCT01117350|450538294|FG000|Extension Period|Prohibited medication|0|||
125443894|NCT02169830|451253862|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
125443895|NCT02169830|451253860|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
125443896|NCT02169830|451253861|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
125443897|NCT02169830|451253862|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
125443898|NCT03615482|451253863|FG000|Overall Study|Death|1|||
125443899|NCT03615482|451253864|FG001|Overall Study|Death|0|||
125443900|NCT03615482|451253863|FG000|Overall Study|Lost to Follow-up|7|||
125443901|NCT03615482|451253864|FG001|Overall Study|Lost to Follow-up|7|||
125443902|NCT03615482|451253863|FG000|Overall Study|Physician Decision|2|||
125443903|NCT03615482|451253864|FG001|Overall Study|Physician Decision|3|||
125443904|NCT03615482|451253863|FG000|Overall Study|Withdrawal by Subject|7|||
125443905|NCT03615482|451253864|FG001|Overall Study|Withdrawal by Subject|7|||
125249728|NCT01117350|450538295|FG001|Extension Period|Prohibited medication|1|||
125249729|NCT00800384|450538297|FG000|Overall Study|Withdrawal by Subject|24|||
125249730|NCT00800384|450538298|FG001|Overall Study|Withdrawal by Subject|17|||
125249731|NCT00800384|450538297|FG000|Overall Study|Lost to Follow-up|17|||
125443906|NCT02018861|451253867|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
125443907|NCT02018861|451253868|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
125443908|NCT02018861|451253869|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
125443909|NCT02018861|451253870|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
125443910|NCT02018861|451253871|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
125443911|NCT02018861|451253872|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
125443912|NCT02018861|451253873|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
125443913|NCT02018861|451253874|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
125443914|NCT02018861|451253875|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
125443915|NCT02018861|451253876|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
125443916|NCT02018861|451253867|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125443917|NCT02018861|451253868|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125443918|NCT02018861|451253869|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125443919|NCT02018861|451253870|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
125443920|NCT02018861|451253871|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
125443921|NCT02018861|451253872|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125443922|NCT02018861|451253873|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125443923|NCT02018861|451253874|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125443924|NCT02018861|451253875|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125443925|NCT02018861|451253876|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
125443926|NCT02018861|451253867|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
125443927|NCT02018861|451253868|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
125443928|NCT02018861|451253869|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
125443929|NCT02018861|451253870|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
125443930|NCT02018861|451253871|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
125443931|NCT02018861|451253872|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
125443932|NCT02018861|451253873|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
125443933|NCT02018861|451253874|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
125443934|NCT02018861|451253875|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
125443935|NCT02018861|451253876|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
125443936|NCT02018861|451253867|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
125443937|NCT02018861|451253868|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
125443938|NCT02018861|451253869|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
125443939|NCT02018861|451253870|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
125443940|NCT02018861|451253871|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
125443941|NCT02018861|451253872|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
125443942|NCT02018861|451253873|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
125443943|NCT02018861|451253874|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
125443944|NCT02018861|451253875|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
125443945|NCT02018861|451253876|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
125443946|NCT02018861|451253867|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125443947|NCT02018861|451253868|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125443948|NCT02018861|451253869|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
125443949|NCT02018861|451253870|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
125443950|NCT02018861|451253871|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125443951|NCT02018861|451253872|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125443952|NCT02018861|451253873|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125443953|NCT02018861|451253874|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125249732|NCT00800384|450538298|FG001|Overall Study|Lost to Follow-up|26|||
125443954|NCT02018861|451253875|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125443955|NCT02018861|451253876|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
125396426|NCT03400332|451085049|FG001|Treatment|Lost to Follow-up|1|||
125396427|NCT03400332|451085050|FG002|Treatment|Lost to Follow-up|0|||
125396428|NCT03400332|451085051|FG003|Treatment|Lost to Follow-up|0|||
125396429|NCT03400332|451085052|FG004|Treatment|Lost to Follow-up|0|||
125396430|NCT03400332|451085053|FG005|Treatment|Lost to Follow-up|0|||
125396431|NCT03400332|451085054|FG006|Treatment|Lost to Follow-up|0|||
125396432|NCT03400332|451085055|FG007|Treatment|Lost to Follow-up|0|||
125396433|NCT03400332|451085056|FG008|Treatment|Lost to Follow-up|0|||
125196834|NCT03499899|450341983|FG002|Overall Study|Patient decision|1|||
125196835|NCT03499899|450341981|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
125196836|NCT03499899|450341982|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
125196837|NCT03499899|450341983|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
125196838|NCT01893281|450341984|FG000|Overall Study|Adverse Event|1|||
125396434|NCT03400332|451085048|FG000|Treatment|Death|3|||
125396435|NCT03400332|451085049|FG001|Treatment|Death|1|||
125396436|NCT03400332|451085050|FG002|Treatment|Death|2|||
125396437|NCT03400332|451085051|FG003|Treatment|Death|3|||
125396438|NCT03400332|451085052|FG004|Treatment|Death|6|||
125396439|NCT03400332|451085053|FG005|Treatment|Death|2|||
125396440|NCT03400332|451085054|FG006|Treatment|Death|1|||
125396441|NCT03400332|451085055|FG007|Treatment|Death|3|||
125396442|NCT03400332|451085056|FG008|Treatment|Death|6|||
125396443|NCT04476017|451085059|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
125396444|NCT04476017|451085060|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
125396445|NCT02704364|451085061|FG000|Overall Study|Adverse Event|1|||
125396446|NCT02704364|451085062|FG001|Overall Study|Adverse Event|1|||
125396447|NCT02704364|451085063|FG002|Overall Study|Adverse Event|0|||
125396448|NCT02704364|451085061|FG000|Overall Study|Noncompliance with study drug|1|||
125396449|NCT02704364|451085062|FG001|Overall Study|Noncompliance with study drug|1|||
125396450|NCT02704364|451085063|FG002|Overall Study|Noncompliance with study drug|0|||
125396451|NCT02704364|451085061|FG000|Overall Study|Other|0|||
125396452|NCT02704364|451085062|FG001|Overall Study|Other|1|||
125396453|NCT02704364|451085063|FG002|Overall Study|Other|1|||
125396454|NCT02975934|451085064|FG000|Treatment Phase|Never initiated study drug|0|||
125396455|NCT02975934|451085065|FG001|Treatment Phase|Never initiated study drug|5|||
125396456|NCT02975934|451085066|FG002|Treatment Phase|Never initiated study drug|0|||
125396457|NCT02075840|451085067|FG000|Overall Study|Withdrawal by Subject|13|||
125396458|NCT02075840|451085068|FG001|Overall Study|Withdrawal by Subject|22|||
125396459|NCT02075840|451085067|FG000|Overall Study|Reason not specified|1|||
125396460|NCT02075840|451085068|FG001|Overall Study|Reason not specified|0|||
125396461|NCT02075840|451085067|FG000|Overall Study|Adverse Event|0|||
125396462|NCT02075840|451085068|FG001|Overall Study|Adverse Event|2|||
125396463|NCT02075840|451085067|FG000|Overall Study|Death|35|||
125396464|NCT02075840|451085068|FG001|Overall Study|Death|40|||
125396465|NCT02075840|451085067|FG000|Overall Study|Lost to Follow-up|3|||
125396466|NCT02075840|451085068|FG001|Overall Study|Lost to Follow-up|2|||
125396467|NCT02075840|451085067|FG000|Overall Study|Physician Decision|1|||
125396468|NCT02075840|451085068|FG001|Overall Study|Physician Decision|3|||
125396469|NCT02075840|451085067|FG000|Overall Study|Ongoing at CCOD|99|||
125396470|NCT02075840|451085068|FG001|Overall Study|Ongoing at CCOD|82|||
125396471|NCT00846742|451085069|FG000|Overall Study|Withdrawal by Subject|1|||
125396472|NCT02775344|451085071|FG000|Overall Study|No ovarian cyst identified|3|||
125396473|NCT02775344|451085072|FG001|Overall Study|No ovarian cyst identified|2|||
125396474|NCT03909165|451085083|FG000|Overall Study|Physician Decision|0|||
125396475|NCT03909165|451085084|FG001|Overall Study|Physician Decision|1|||
125396476|NCT03909165|451085085|FG002|Overall Study|Physician Decision|0|||
125396477|NCT03909165|451085086|FG003|Overall Study|Physician Decision|0|||
125396478|NCT03909165|451085087|FG004|Overall Study|Physician Decision|0|||
125396479|NCT03909165|451085083|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125396480|NCT03909165|451085084|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125396481|NCT03909165|451085085|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125196839|NCT01893281|450341984|FG000|Overall Study|Protocol Violation|1|||
125196840|NCT01893281|450341984|FG000|Overall Study|Withdrawal by Subject|1|||
125196841|NCT04016779|450341991|FG000|Overall Study|Adverse Event|9|||
125196842|NCT04016779|450341992|FG001|Overall Study|Adverse Event|17|||
125196843|NCT04016779|450341991|FG000|Overall Study|Lack of Efficacy|4|||
125196844|NCT04016779|450341992|FG001|Overall Study|Lack of Efficacy|1|||
125196845|NCT04016779|450341991|FG000|Overall Study|Lost to Follow-up|5|||
125196846|NCT04016779|450341992|FG001|Overall Study|Lost to Follow-up|14|||
125196847|NCT04016779|450341991|FG000|Overall Study|Physician Decision|1|||
125196848|NCT04016779|450341992|FG001|Overall Study|Physician Decision|3|||
125396482|NCT03909165|451085086|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125396483|NCT03909165|451085087|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125396484|NCT03909165|451085083|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
125443956|NCT02018861|451253867|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125396485|NCT03909165|451085084|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
125396486|NCT03909165|451085085|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
125249733|NCT01027754|450539585|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
125249734|NCT01027754|450539586|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
125249735|NCT01027754|450539585|FG000|Overall Study|Withdrawal by Subject|0|||
125249736|NCT01027754|450539586|FG001|Overall Study|Withdrawal by Subject|5|||
125249737|NCT00326495|450539587|FG000|Overall Study|Switched to alternative treatment|1|||
125249738|NCT00326495|450539587|FG000|Overall Study|Disease progression before treatment|1|||
125249739|NCT00326495|450539587|FG000|Overall Study|Refused further treatment|2|||
125249740|NCT00326495|450539587|FG000|Overall Study|Subject off study before assessment|1|||
125249741|NCT03280615|450539589|FG000|Overall Study|Lost to Follow-up|1|||
125249742|NCT03280615|450539590|FG001|Overall Study|Lost to Follow-up|2|||
125249743|NCT03280615|450539589|FG000|Overall Study|Adverse Event|1|||
125249744|NCT03280615|450539590|FG001|Overall Study|Adverse Event|1|||
125249745|NCT03280615|450539589|FG000|Overall Study|Withdrawal by Subject|2|||
125249746|NCT03280615|450539590|FG001|Overall Study|Withdrawal by Subject|2|||
125249747|NCT00432991|450539593|FG000|Overall Study|Protocol Violation|7|||
125249748|NCT00432991|450539594|FG001|Overall Study|Protocol Violation|12|||
125249749|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
125249750|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
125249751|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
125249752|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
125249753|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
125249754|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
125249755|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
125249756|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
125249757|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
125249758|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
125249759|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
125249760|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
125249761|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
125249762|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
125249763|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
125249764|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
125249765|NCT01755156|450539595|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
125249766|NCT01755156|450539596|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
125249767|NCT01755156|450539595|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
125249768|NCT01755156|450539596|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
125249769|NCT01755156|450539595|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
125249770|NCT01755156|450539596|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
125249771|NCT00090402|450539597|FG000|Overall Study|Death|1|||
125249772|NCT00090402|450539598|FG001|Overall Study|Death|1|||
125249773|NCT00090402|450539599|FG002|Overall Study|Death|0|||
125249774|NCT00090402|450539597|FG000|Overall Study|subject moved|0|||
125249775|NCT00090402|450539598|FG001|Overall Study|subject moved|1|||
125249776|NCT00090402|450539599|FG002|Overall Study|subject moved|0|||
125196849|NCT04016779|450341991|FG000|Overall Study|Withdrawal by Subject|6|||
125196850|NCT04016779|450341992|FG001|Overall Study|Withdrawal by Subject|8|||
125196851|NCT04016779|450341991|FG000|Overall Study|Non-compliance with Study Drug|2|||
125196852|NCT04016779|450341992|FG001|Overall Study|Non-compliance with Study Drug|3|||
125196853|NCT04016779|450341991|FG000|Overall Study|Other, Multiple categories|17|||
125196854|NCT04016779|450341992|FG001|Overall Study|Other, Multiple categories|17|||
125196855|NCT02295020|450341996|FG000|Overall Study|Adverse Event|0|||
125196856|NCT02295020|450341997|FG001|Overall Study|Adverse Event|1|||
125196857|NCT02295020|450341996|FG000|Overall Study|Withdrawal by Subject|3|||
125196858|NCT02295020|450341997|FG001|Overall Study|Withdrawal by Subject|2|||
125196859|NCT00355147|450342000|FG000|Overall Study|Lost to Follow-up|10|||
125196860|NCT00355147|450342001|FG001|Overall Study|Lost to Follow-up|8|||
125196861|NCT00355147|450342000|FG000|Overall Study|Withdrawal by Subject|8|||
125196862|NCT00355147|450342001|FG001|Overall Study|Withdrawal by Subject|12|||
125196863|NCT02828124|450342002|FG000|Overall Study|Disease Progression|1|||
125196864|NCT02828124|450342003|FG001|Overall Study|Disease Progression|2|||
125196865|NCT02828124|450342004|FG002|Overall Study|Disease Progression|1|||
125196866|NCT02828124|450342005|FG003|Overall Study|Disease Progression|4|||
125196867|NCT02828124|450342002|FG000|Overall Study|AE Unrelated to Study Drug|0|||
125196868|NCT02828124|450342003|FG001|Overall Study|AE Unrelated to Study Drug|0|||
125196869|NCT02828124|450342004|FG002|Overall Study|AE Unrelated to Study Drug|0|||
125196870|NCT02828124|450342005|FG003|Overall Study|AE Unrelated to Study Drug|1|||
125196871|NCT02828124|450342002|FG000|Overall Study|Subject Withdrew Consent|0|||
125196872|NCT02828124|450342003|FG001|Overall Study|Subject Withdrew Consent|0|||
125196873|NCT02828124|450342004|FG002|Overall Study|Subject Withdrew Consent|0|||
125249777|NCT00090402|450539597|FG000|Overall Study|stopped taking study medication|1|||
125249778|NCT00090402|450539598|FG001|Overall Study|stopped taking study medication|0|||
125249779|NCT00090402|450539599|FG002|Overall Study|stopped taking study medication|1|||
125249780|NCT03048019|450539603|FG000|Overall Study|Adverse Event|1|||
125249781|NCT03048019|450539604|FG001|Overall Study|Adverse Event|0|||
125249782|NCT02004275|450539605|FG000|Phase 1|Ineligible|0|||
125443957|NCT02018861|451253868|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125443958|NCT02018861|451253869|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125396487|NCT03909165|451085086|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
125396488|NCT03909165|451085087|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
125396489|NCT03909165|451085083|FG000|Overall Study|Previous Drug Exposure|0|||
125396490|NCT03909165|451085084|FG001|Overall Study|Previous Drug Exposure|0|||
125396491|NCT03909165|451085085|FG002|Overall Study|Previous Drug Exposure|1|||
125396492|NCT03909165|451085086|FG003|Overall Study|Previous Drug Exposure|0|||
125396493|NCT03909165|451085087|FG004|Overall Study|Previous Drug Exposure|0|||
125396494|NCT03909165|451085083|FG000|Overall Study|Early Discharge|1|||
125396495|NCT03909165|451085084|FG001|Overall Study|Early Discharge|0|||
125396496|NCT03909165|451085085|FG002|Overall Study|Early Discharge|0|||
125396497|NCT03909165|451085086|FG003|Overall Study|Early Discharge|0|||
125396498|NCT03909165|451085087|FG004|Overall Study|Early Discharge|0|||
125396499|NCT04627064|451085089|FG000|Overall Study|Progressive disease|8|||
125396500|NCT04627064|451085090|FG001|Overall Study|Progressive disease|0|||
125396501|NCT04627064|451085089|FG000|Overall Study|Withdrawal by Subject|2|||
125396502|NCT04627064|451085090|FG001|Overall Study|Withdrawal by Subject|0|||
125396503|NCT04627064|451085089|FG000|Overall Study|Physician Decision|1|||
125396504|NCT04627064|451085090|FG001|Overall Study|Physician Decision|0|||
125396505|NCT02018458|451085091|FG000|Overall Study|Death|4|||
125396506|NCT04033159|451085094|FG000|Washout Period|Physician Decision|0|||
125396507|NCT04033159|451085095|FG001|Washout Period|Physician Decision|1|||
125396508|NCT04033159|451085096|FG002|Washout Period|Physician Decision|0|||
125396509|NCT04033159|451085094|FG000|Washout Period|Study terminated by Sponsor|0|||
125396510|NCT04033159|451085095|FG001|Washout Period|Study terminated by Sponsor|7|||
125396511|NCT04033159|451085096|FG002|Washout Period|Study terminated by Sponsor|0|||
125396512|NCT04033159|451085094|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
125396513|NCT04033159|451085095|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
125396514|NCT04033159|451085096|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
125396515|NCT00354172|451085101|FG000|Overall Study|Did not receive transplant|1|||
125396516|NCT03491150|451085105|FG000|Overall Study|Adverse Event|1|||
125396517|NCT03491150|451085106|FG001|Overall Study|Adverse Event|0|||
125396518|NCT03491150|451085105|FG000|Overall Study|Study Terminated by Sponsor|74|||
125396519|NCT03491150|451085106|FG001|Overall Study|Study Terminated by Sponsor|70|||
125396520|NCT03491150|451085105|FG000|Overall Study|Other|0|||
125396521|NCT03491150|451085106|FG001|Overall Study|Other|1|||
125396522|NCT03491150|451085105|FG000|Overall Study|Withdrawal by Subject|1|||
125396523|NCT03491150|451085106|FG001|Overall Study|Withdrawal by Subject|2|||
125396524|NCT01800916|451085107|FG000|Test Period 1 (1 Week)|Convex product user|0|||
125396525|NCT01800916|451085108|FG001|Test Period 1 (1 Week)|Convex product user|0|||
125396526|NCT01800916|451085109|FG002|Test Period 1 (1 Week)|Convex product user|0|||
125396527|NCT01800916|451085110|FG003|Test Period 1 (1 Week)|Convex product user|1|||
125396528|NCT01800916|451085111|FG004|Test Period 1 (1 Week)|Convex product user|0|||
125396529|NCT01800916|451085112|FG005|Test Period 1 (1 Week)|Convex product user|0|||
125396530|NCT01800916|451085113|FG006|Test Period 1 (1 Week)|Convex product user|0|||
125396531|NCT01800916|451085114|FG007|Test Period 1 (1 Week)|Convex product user|0|||
125396532|NCT01800916|451085115|FG008|Test Period 1 (1 Week)|Convex product user|0|||
125396533|NCT01800916|451085107|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
125396534|NCT01800916|451085108|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
125396535|NCT01800916|451085109|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
125396536|NCT01800916|451085110|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
125396537|NCT01800916|451085111|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
125396538|NCT01800916|451085112|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
125396539|NCT01800916|451085113|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
125396540|NCT01800916|451085114|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
125396541|NCT01800916|451085115|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
125396542|NCT00727714|451085116|FG000|Overall Study|Lost to Follow-up|2|||
125396543|NCT00325234|451085117|FG000|Overall Study|Adverse Event|10|||
125443959|NCT02018861|451253870|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125196874|NCT02828124|450342005|FG003|Overall Study|Subject Withdrew Consent|1|||
125396544|NCT00325234|451085118|FG001|Overall Study|Adverse Event|7|||
125396545|NCT00325234|451085117|FG000|Overall Study|Death due to Study Disease|1|||
125396546|NCT00325234|451085118|FG001|Overall Study|Death due to Study Disease|0|||
125396547|NCT00325234|451085117|FG000|Overall Study|Entry Criteria Not Met|1|||
125396548|NCT00325234|451085118|FG001|Overall Study|Entry Criteria Not Met|2|||
125396549|NCT00325234|451085117|FG000|Overall Study|Subject Decision|6|||
125396550|NCT00325234|451085118|FG001|Overall Study|Subject Decision|8|||
125396551|NCT00325234|451085117|FG000|Overall Study|Physician Decision|17|||
125396552|NCT00325234|451085118|FG001|Overall Study|Physician Decision|12|||
125249783|NCT02004275|450539606|FG001|Phase 1|Ineligible|0|||
125396553|NCT00325234|451085117|FG000|Overall Study|Progressive Disease|34|||
125396554|NCT00325234|451085118|FG001|Overall Study|Progressive Disease|37|||
125396555|NCT01234467|451085119|FG000|Overall Study|Adverse Event|3|||
125249784|NCT02004275|450539607|FG002|Phase 1|Ineligible|0|||
125249785|NCT02004275|450539608|FG003|Phase 1|Ineligible|1|||
125249786|NCT02004275|450539609|FG004|Phase 1|Ineligible|1|||
125249787|NCT02004275|450539610|FG005|Phase 1|Ineligible|0|||
125249788|NCT02004275|450539605|FG000|Phase 1|Protocol Violation|0|||
125249789|NCT02004275|450539606|FG001|Phase 1|Protocol Violation|0|||
125249790|NCT02004275|450539607|FG002|Phase 1|Protocol Violation|0|||
125249791|NCT02004275|450539608|FG003|Phase 1|Protocol Violation|1|||
125249792|NCT02004275|450539609|FG004|Phase 1|Protocol Violation|0|||
125249793|NCT02004275|450539610|FG005|Phase 1|Protocol Violation|5|||
125249794|NCT02004275|450539605|FG000|Phase 2 Part 1|Ineligible|6|||
125249795|NCT02004275|450539606|FG001|Phase 2 Part 1|Ineligible|9|||
125249796|NCT02004275|450539607|FG002|Phase 2 Part 1|Ineligible|0|||
125249797|NCT02004275|450539608|FG003|Phase 2 Part 1|Ineligible|0|||
125249798|NCT02004275|450539609|FG004|Phase 2 Part 1|Ineligible|0|||
125249799|NCT02004275|450539610|FG005|Phase 2 Part 1|Ineligible|0|||
125249800|NCT02004275|450539605|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
125249801|NCT02004275|450539606|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
125249802|NCT02004275|450539607|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
125249803|NCT02004275|450539608|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
125249804|NCT02004275|450539609|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
125249805|NCT02004275|450539610|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
125249806|NCT00292370|450539611|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
125249807|NCT00292370|450539612|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
125249808|NCT00292370|450539613|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
125249809|NCT00292370|450539611|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
125249810|NCT00292370|450539612|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
125249811|NCT00292370|450539613|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
125249812|NCT00292370|450539611|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
125249813|NCT00292370|450539612|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
125249814|NCT00292370|450539613|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
125249815|NCT00292370|450539611|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
125249816|NCT00292370|450539612|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
125249817|NCT00292370|450539613|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
125249818|NCT00292370|450539611|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
125249819|NCT00292370|450539612|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
125249820|NCT00292370|450539613|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
125249821|NCT00292370|450539611|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
125249822|NCT00292370|450539612|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
125249823|NCT00292370|450539613|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
125249824|NCT01716559|450539614|FG000|Overall Study|Adverse Event|11|||
125249825|NCT01716559|450539614|FG000|Overall Study|Death|21|||
125249826|NCT01716559|450539614|FG000|Overall Study|Withdrawal by Subject|4|||
125249827|NCT01716559|450539614|FG000|Overall Study|Other withdrawal reason|75|||
125249828|NCT04821245|450539616|FG000|Overall Study|Withdrawal by Subject|3|||
125249829|NCT04821245|450539616|FG000|Overall Study|Physician Decision|1|||
125249830|NCT04821245|450539616|FG000|Overall Study|Protocol Violation|5|||
125249831|NCT01133977|450539619|FG000|Overall Study|Adverse Event|0|||
125249832|NCT01133977|450539620|FG001|Overall Study|Adverse Event|0|||
125249833|NCT01133977|450539621|FG002|Overall Study|Adverse Event|1|||
125249834|NCT01133977|450539622|FG003|Overall Study|Adverse Event|0|||
125249835|NCT01133977|450539623|FG004|Overall Study|Adverse Event|0|||
125249836|NCT01133977|450539619|FG000|Overall Study|Death|1|||
125249837|NCT01133977|450539620|FG001|Overall Study|Death|1|||
125249838|NCT01133977|450539621|FG002|Overall Study|Death|1|||
125249839|NCT01133977|450539622|FG003|Overall Study|Death|7|||
125249840|NCT01133977|450539623|FG004|Overall Study|Death|3|||
125249841|NCT01133977|450539619|FG000|Overall Study|Started a New Line of Therapy|2|||
125249842|NCT01133977|450539620|FG001|Overall Study|Started a New Line of Therapy|6|||
125249843|NCT01133977|450539621|FG002|Overall Study|Started a New Line of Therapy|4|||
125249844|NCT01133977|450539622|FG003|Overall Study|Started a New Line of Therapy|25|||
125249845|NCT01133977|450539623|FG004|Overall Study|Started a New Line of Therapy|33|||
125249846|NCT01133977|450539619|FG000|Overall Study|Lost to Follow-up|0|||
125249847|NCT01133977|450539620|FG001|Overall Study|Lost to Follow-up|0|||
125396556|NCT01234467|451085119|FG000|Overall Study|Death|2|||
125396557|NCT01234467|451085119|FG000|Overall Study|Withdrawal by Subject|2|||
125249848|NCT01133977|450539621|FG002|Overall Study|Lost to Follow-up|0|||
125249849|NCT01133977|450539622|FG003|Overall Study|Lost to Follow-up|2|||
125249850|NCT01133977|450539623|FG004|Overall Study|Lost to Follow-up|1|||
125249851|NCT01133977|450539619|FG000|Overall Study|Withdrawal by Subject|0|||
125249852|NCT01133977|450539620|FG001|Overall Study|Withdrawal by Subject|0|||
125249853|NCT01133977|450539621|FG002|Overall Study|Withdrawal by Subject|0|||
125249854|NCT01133977|450539622|FG003|Overall Study|Withdrawal by Subject|5|||
125249855|NCT01133977|450539623|FG004|Overall Study|Withdrawal by Subject|1|||
125249856|NCT00662038|450539624|FG000|Overall Study|Reason not specified|3|||
125396558|NCT01234467|451085119|FG000|Overall Study|Disease Progression|2|||
125396559|NCT01234467|451085119|FG000|Overall Study|Clinical deterioration|1|||
125396560|NCT01234467|451085119|FG000|Overall Study|Physician Decision|1|||
125396561|NCT01234467|451085119|FG000|Overall Study|Other complicating disease (stroke)|1|||
125396562|NCT01639040|451085120|FG000|Overall Study|Adverse Event|1|||
125396563|NCT01639040|451085121|FG001|Overall Study|Adverse Event|0|||
125396564|NCT01479621|451085122|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
125396565|NCT01479621|451085123|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125396566|NCT01479621|451085124|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125396567|NCT01479621|451085125|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125396568|NCT01479621|451085126|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125396569|NCT01479621|451085127|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125396570|NCT01479621|451085128|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
125396571|NCT01479621|451085122|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
125396572|NCT01479621|451085123|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125396573|NCT01479621|451085124|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125396574|NCT01479621|451085125|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125396575|NCT01479621|451085126|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125396576|NCT01479621|451085127|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125396577|NCT01479621|451085128|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
125396578|NCT01479621|451085122|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
125396579|NCT01479621|451085123|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125396580|NCT01479621|451085124|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125396581|NCT01479621|451085125|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125396582|NCT01479621|451085126|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125396583|NCT01479621|451085127|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125396584|NCT01479621|451085128|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
125396585|NCT01479621|451085122|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
125396586|NCT01479621|451085123|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125396587|NCT01479621|451085124|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125396588|NCT01479621|451085125|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125396589|NCT01479621|451085126|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125396590|NCT01479621|451085127|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125396591|NCT01479621|451085128|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
125396592|NCT01479621|451085122|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
125396593|NCT01479621|451085123|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125396594|NCT01479621|451085124|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125396595|NCT01479621|451085125|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125396596|NCT01479621|451085126|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125396597|NCT01479621|451085127|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125396598|NCT01479621|451085128|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
125396599|NCT01479621|451085122|FG000|Treatment Period|Adverse Event|0|||
125396600|NCT01479621|451085123|FG001|Treatment Period|Adverse Event|0|||
125396601|NCT01479621|451085124|FG002|Treatment Period|Adverse Event|0|||
125396602|NCT01479621|451085125|FG003|Treatment Period|Adverse Event|0|||
125396603|NCT01479621|451085126|FG004|Treatment Period|Adverse Event|1|||
125396604|NCT01479621|451085127|FG005|Treatment Period|Adverse Event|2|||
125396605|NCT01479621|451085128|FG006|Treatment Period|Adverse Event|2|||
125396606|NCT01479621|451085122|FG000|Treatment Period|Withdrawal by Subject|0|||
125396607|NCT01479621|451085123|FG001|Treatment Period|Withdrawal by Subject|4|||
125396608|NCT01479621|451085124|FG002|Treatment Period|Withdrawal by Subject|2|||
125396609|NCT01479621|451085125|FG003|Treatment Period|Withdrawal by Subject|2|||
125396610|NCT01479621|451085126|FG004|Treatment Period|Withdrawal by Subject|5|||
125396611|NCT01479621|451085127|FG005|Treatment Period|Withdrawal by Subject|5|||
125396612|NCT01479621|451085128|FG006|Treatment Period|Withdrawal by Subject|1|||
125396613|NCT01479621|451085122|FG000|Treatment Period|Physician Decision|0|||
125396614|NCT01479621|451085123|FG001|Treatment Period|Physician Decision|0|||
125396615|NCT01479621|451085124|FG002|Treatment Period|Physician Decision|0|||
125396616|NCT01479621|451085125|FG003|Treatment Period|Physician Decision|0|||
125396617|NCT01479621|451085126|FG004|Treatment Period|Physician Decision|1|||
125396618|NCT01479621|451085127|FG005|Treatment Period|Physician Decision|1|||
125396619|NCT01479621|451085128|FG006|Treatment Period|Physician Decision|0|||
125396620|NCT01479621|451085122|FG000|Treatment Period|Non-compliance to study drug|0|||
125396621|NCT01479621|451085123|FG001|Treatment Period|Non-compliance to study drug|1|||
125396622|NCT01479621|451085124|FG002|Treatment Period|Non-compliance to study drug|0|||
125396623|NCT01479621|451085125|FG003|Treatment Period|Non-compliance to study drug|0|||
125396624|NCT01479621|451085126|FG004|Treatment Period|Non-compliance to study drug|0|||
125396625|NCT01479621|451085127|FG005|Treatment Period|Non-compliance to study drug|0|||
125249857|NCT00662038|450539624|FG000|Overall Study|Withdrawn consent|22|||
125249858|NCT00662038|450539624|FG000|Overall Study|Withdrawal by Subject|83|||
125249859|NCT00662038|450539624|FG000|Overall Study|Sponsor decision|1|||
125249860|NCT00662038|450539624|FG000|Overall Study|Physician Decision|19|||
125249861|NCT00662038|450539624|FG000|Overall Study|Lung transplantation|44|||
125249862|NCT00662038|450539624|FG000|Overall Study|Lost to Follow-up|1|||
125249863|NCT00662038|450539624|FG000|Overall Study|Death|95|||
125249864|NCT00662038|450539624|FG000|Overall Study|Adverse Event|358|||
125249865|NCT00662038|450539624|FG000|Overall Study|Continued treatment|5|||
125249866|NCT00397046|450539629|FG000|Overall Study|Disease Progression|3|||
125249867|NCT00397046|450539630|FG001|Overall Study|Disease Progression|3|||
125249868|NCT00397046|450539631|FG002|Overall Study|Disease Progression|10|||
125249869|NCT00397046|450539632|FG003|Overall Study|Disease Progression|5|||
125249870|NCT04189588|450539637|FG000|Overall Study|Death|0|||
125249871|NCT04189588|450539638|FG001|Overall Study|Death|1|||
125249872|NCT04189588|450539637|FG000|Overall Study|Lost to Follow-up|0|||
125249873|NCT04189588|450539638|FG001|Overall Study|Lost to Follow-up|1|||
125249874|NCT00576407|450539639|FG000|Overall Study|Death|7|||
125249875|NCT00576407|450539639|FG000|Overall Study|Physician Decision|1|||
125249876|NCT00621322|450539640|FG000|Overall Study|Lost to Follow-up|0|||
125249877|NCT00621322|450539641|FG001|Overall Study|Lost to Follow-up|0|||
125249878|NCT00621322|450539642|FG002|Overall Study|Lost to Follow-up|0|||
125249879|NCT00621322|450539643|FG003|Overall Study|Lost to Follow-up|0|||
125249880|NCT00621322|450539644|FG004|Overall Study|Lost to Follow-up|1|||
125249881|NCT00621322|450539645|FG005|Overall Study|Lost to Follow-up|0|||
125249882|NCT00621322|450539640|FG000|Overall Study|Physician Decision|0|||
125249883|NCT00621322|450539641|FG001|Overall Study|Physician Decision|0|||
125249884|NCT00621322|450539642|FG002|Overall Study|Physician Decision|1|||
125249885|NCT00621322|450539643|FG003|Overall Study|Physician Decision|1|||
125249886|NCT00621322|450539644|FG004|Overall Study|Physician Decision|0|||
125249887|NCT00621322|450539645|FG005|Overall Study|Physician Decision|0|||
125249888|NCT00621322|450539640|FG000|Overall Study|Withdrawal by Subject|0|||
125249889|NCT00621322|450539641|FG001|Overall Study|Withdrawal by Subject|0|||
125249890|NCT00621322|450539642|FG002|Overall Study|Withdrawal by Subject|0|||
125249891|NCT00621322|450539643|FG003|Overall Study|Withdrawal by Subject|1|||
125249892|NCT00621322|450539644|FG004|Overall Study|Withdrawal by Subject|0|||
125249893|NCT00621322|450539645|FG005|Overall Study|Withdrawal by Subject|2|||
125249894|NCT00621322|450539640|FG000|Overall Study|Migrated/moved from study area|1|||
125249895|NCT00621322|450539641|FG001|Overall Study|Migrated/moved from study area|0|||
125249896|NCT00621322|450539642|FG002|Overall Study|Migrated/moved from study area|1|||
125249897|NCT00621322|450539643|FG003|Overall Study|Migrated/moved from study area|1|||
125249898|NCT00621322|450539644|FG004|Overall Study|Migrated/moved from study area|0|||
125249899|NCT00621322|450539645|FG005|Overall Study|Migrated/moved from study area|2|||
125249900|NCT00756444|450539646|FG000|Overall Study|Adverse Event|1|||
125249901|NCT00756444|450539647|FG001|Overall Study|Adverse Event|1|||
125249902|NCT00756444|450539646|FG000|Overall Study|Withdrawal by Subject|6|||
125249903|NCT00756444|450539647|FG001|Overall Study|Withdrawal by Subject|8|||
125249904|NCT00756444|450539646|FG000|Overall Study|Lost to Follow-up|0|||
125249905|NCT00756444|450539647|FG001|Overall Study|Lost to Follow-up|1|||
125249906|NCT00756444|450539646|FG000|Overall Study|Death|5|||
125249907|NCT00756444|450539647|FG001|Overall Study|Death|4|||
125249908|NCT00756444|450539646|FG000|Overall Study|Disease Progression|2|||
125249909|NCT00756444|450539647|FG001|Overall Study|Disease Progression|7|||
125249910|NCT00756444|450539646|FG000|Overall Study|Ineligibility Determined|1|||
125249911|NCT00756444|450539647|FG001|Overall Study|Ineligibility Determined|0|||
125249912|NCT01655069|450539651|FG000|Overall Study|Physician Decision|0|||
125249913|NCT01655069|450539652|FG001|Overall Study|Physician Decision|0|||
125249914|NCT01655069|450539653|FG002|Overall Study|Physician Decision|0|||
125249915|NCT01655069|450539654|FG003|Overall Study|Physician Decision|1|||
125249916|NCT01655069|450539651|FG000|Overall Study|Adverse Event|6|||
125249917|NCT01655069|450539652|FG001|Overall Study|Adverse Event|7|||
125249918|NCT01655069|450539653|FG002|Overall Study|Adverse Event|2|||
125249919|NCT01655069|450539654|FG003|Overall Study|Adverse Event|3|||
125249920|NCT01655069|450539651|FG000|Overall Study|Lack of Efficacy|0|||
125249921|NCT01655069|450539652|FG001|Overall Study|Lack of Efficacy|1|||
125249922|NCT01655069|450539653|FG002|Overall Study|Lack of Efficacy|0|||
125249923|NCT01655069|450539654|FG003|Overall Study|Lack of Efficacy|0|||
125249924|NCT01655069|450539651|FG000|Overall Study|No Treatment Needed|0|||
125249925|NCT01655069|450539652|FG001|Overall Study|No Treatment Needed|1|||
125249926|NCT01655069|450539653|FG002|Overall Study|No Treatment Needed|0|||
125249927|NCT01655069|450539654|FG003|Overall Study|No Treatment Needed|0|||
125249928|NCT01655069|450539651|FG000|Overall Study|Withdrawal by Subject|2|||
125249929|NCT01655069|450539652|FG001|Overall Study|Withdrawal by Subject|3|||
125249930|NCT01655069|450539653|FG002|Overall Study|Withdrawal by Subject|0|||
125249931|NCT01655069|450539654|FG003|Overall Study|Withdrawal by Subject|0|||
125249932|NCT06399471|450539655|FG000|Overall Study|Withdrawal by Subject|1|||
125249933|NCT04034056|450539656|FG000|Overall Study|Withdrawal by Subject|2|||
125249934|NCT04034056|450539656|FG000|Overall Study|Reason Not Specified|13|||
125249935|NCT04034056|450539656|FG000|Overall Study|Adverse Event|56|||
125443960|NCT02018861|451253871|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
125443961|NCT02018861|451253872|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125443962|NCT02018861|451253873|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125196875|NCT06586788|450342008|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
125196876|NCT03514485|450342009|FG000|Overall Study|Lost to Follow-up|5|||
125196877|NCT03514485|450342010|FG001|Overall Study|Lost to Follow-up|3|||
125196878|NCT03514485|450342011|FG002|Overall Study|Lost to Follow-up|2|||
125196879|NCT03514485|450342012|FG003|Overall Study|Lost to Follow-up|0|||
125196880|NCT03514485|450342013|FG004|Overall Study|Lost to Follow-up|1|||
125196881|NCT03514485|450342014|FG005|Overall Study|Lost to Follow-up|4|||
125196882|NCT03514485|450342009|FG000|Overall Study|Withdrawal by Subject|0|||
125196883|NCT03514485|450342010|FG001|Overall Study|Withdrawal by Subject|1|||
125196884|NCT03514485|450342011|FG002|Overall Study|Withdrawal by Subject|3|||
125196885|NCT03514485|450342012|FG003|Overall Study|Withdrawal by Subject|1|||
125196886|NCT03514485|450342013|FG004|Overall Study|Withdrawal by Subject|2|||
125196887|NCT03514485|450342014|FG005|Overall Study|Withdrawal by Subject|1|||
125196888|NCT00791661|450342015|FG000|7 Day Wash-out|Adverse Event|0|||
125196889|NCT00791661|450342016|FG001|7 Day Wash-out|Adverse Event|0|||
125196890|NCT00791661|450342017|FG002|7 Day Wash-out|Adverse Event|1|||
125196891|NCT00791661|450342015|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
125196892|NCT00791661|450342016|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
125196893|NCT00791661|450342017|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
125196894|NCT00492648|450342018|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
125196895|NCT00492648|450342019|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
125196896|NCT00595517|450342022|FG000|Overall Study|Adverse Event|6|||
125196897|NCT00595517|450342022|FG000|Overall Study|Withdrawal by Subject|4|||
125196898|NCT00595517|450342022|FG000|Overall Study|Protocol Violation|2|||
125196899|NCT00595517|450342022|FG000|Overall Study|Recurrence of ulcer|5|||
125196900|NCT00595517|450342022|FG000|Overall Study|usage of prohibited treatment|1|||
125196901|NCT00595517|450342022|FG000|Overall Study|No intention to attend regularly|1|||
125196902|NCT04105218|450342028|FG000|Overall Study|Withdrawal by Subject|3|||
125196903|NCT04105218|450342029|FG001|Overall Study|Withdrawal by Subject|2|||
125196904|NCT04105218|450342028|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
125196905|NCT04105218|450342029|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
125196906|NCT04105218|450342028|FG000|Overall Study|Failed screening tests|2|||
125196907|NCT04105218|450342029|FG001|Overall Study|Failed screening tests|1|||
125196908|NCT01167881|450342032|FG000|Overall Study|Adverse Event|47|||
125196909|NCT01167881|450342033|FG001|Overall Study|Adverse Event|51|||
125196910|NCT01167881|450342032|FG000|Overall Study|Lack of Efficacy|4|||
125196911|NCT01167881|450342033|FG001|Overall Study|Lack of Efficacy|7|||
125196912|NCT01167881|450342032|FG000|Overall Study|Non compliant with protocol|9|||
125196913|NCT01167881|450342033|FG001|Overall Study|Non compliant with protocol|18|||
125196914|NCT01167881|450342032|FG000|Overall Study|Lost to Follow-up|19|||
125196915|NCT01167881|450342033|FG001|Overall Study|Lost to Follow-up|20|||
125196916|NCT01167881|450342032|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
125196917|NCT01167881|450342033|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
125196918|NCT01167881|450342032|FG000|Overall Study|Not treated|4|||
125196919|NCT01167881|450342033|FG001|Overall Study|Not treated|0|||
125196920|NCT01167881|450342032|FG000|Overall Study|Other not defined above|31|||
125196921|NCT01167881|450342033|FG001|Overall Study|Other not defined above|55|||
125196922|NCT01435460|450342034|FG000|Overall Study|Adverse Event|2|||
125196923|NCT01435460|450342035|FG001|Overall Study|Adverse Event|1|||
125196924|NCT01435460|450342034|FG000|Overall Study|Lost to Follow-up|6|||
125196925|NCT01435460|450342035|FG001|Overall Study|Lost to Follow-up|1|||
125196926|NCT01435460|450342034|FG000|Overall Study|Withdrawal by Subject|1|||
125196927|NCT01435460|450342035|FG001|Overall Study|Withdrawal by Subject|3|||
125196928|NCT01435460|450342034|FG000|Overall Study|Protocol Violation|0|||
125196929|NCT01435460|450342035|FG001|Overall Study|Protocol Violation|1|||
125196930|NCT01435460|450342034|FG000|Overall Study|Did not meet eligibility criteria|2|||
125196931|NCT01435460|450342035|FG001|Overall Study|Did not meet eligibility criteria|0|||
125196932|NCT01706939|450342036|FG000|Pre Randomization|Screen Failure|1|||
125196933|NCT01706939|450342037|FG001|Pre Randomization|Screen Failure|0|||
125196934|NCT01706939|450342038|FG002|Pre Randomization|Screen Failure|0|||
125249936|NCT03225989|450539657|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
125196935|NCT01706939|450342036|FG000|Pre Randomization|Ineligible for Randomization|1|||
125196936|NCT01706939|450342037|FG001|Pre Randomization|Ineligible for Randomization|0|||
125196937|NCT01706939|450342038|FG002|Pre Randomization|Ineligible for Randomization|0|||
125196938|NCT01706939|450342036|FG000|Pre Randomization|Withdrawal by Subject|1|||
125196939|NCT01706939|450342037|FG001|Pre Randomization|Withdrawal by Subject|0|||
125196940|NCT01706939|450342038|FG002|Pre Randomization|Withdrawal by Subject|0|||
125196941|NCT01706939|450342036|FG000|Randomization|Insufficient QoL survey compliance|0|||
125196942|NCT01706939|450342037|FG001|Randomization|Insufficient QoL survey compliance|1|||
125196943|NCT01706939|450342038|FG002|Randomization|Insufficient QoL survey compliance|1|||
125249937|NCT03225989|450539658|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
125249938|NCT03225989|450539659|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
125249939|NCT03225989|450539657|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
125249940|NCT03225989|450539658|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
125249941|NCT03225989|450539659|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
125249942|NCT03225989|450539657|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
125249943|NCT03225989|450539658|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
125249944|NCT03225989|450539659|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
125249945|NCT03225989|450539657|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
125249946|NCT03225989|450539658|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
125249947|NCT03225989|450539659|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
125249948|NCT03225989|450539657|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
125249949|NCT03225989|450539658|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
125249950|NCT03225989|450539659|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
125196944|NCT01706939|450342036|FG000|Randomization|Progression of disease|0|||
125196945|NCT01706939|450342037|FG001|Randomization|Progression of disease|2|||
125249951|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
125249952|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
125249953|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
125249954|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
125249955|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
125249956|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
125249957|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
125249958|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
125249959|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
125249960|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
125249961|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
125249962|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
125249963|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
125249964|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
125249965|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
125249966|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
125249967|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
125249968|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
125249969|NCT03225989|450539657|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
125249970|NCT03225989|450539658|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
125249971|NCT03225989|450539659|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
125249972|NCT00601107|450539660|FG000|Overall Study|Adverse Event|0|||
125249973|NCT00601107|450539661|FG001|Overall Study|Adverse Event|1|||
125249974|NCT00601107|450539662|FG002|Overall Study|Adverse Event|3|||
125249975|NCT00601107|450539663|FG003|Overall Study|Adverse Event|0|||
125249976|NCT00601107|450539660|FG000|Overall Study|Withdrawal by Subject|5|||
125249977|NCT00601107|450539661|FG001|Overall Study|Withdrawal by Subject|4|||
125249978|NCT00601107|450539662|FG002|Overall Study|Withdrawal by Subject|7|||
125249979|NCT00601107|450539663|FG003|Overall Study|Withdrawal by Subject|4|||
125249980|NCT00601107|450539660|FG000|Overall Study|Lost to Follow-up|3|||
125249981|NCT00601107|450539661|FG001|Overall Study|Lost to Follow-up|3|||
125249982|NCT00601107|450539662|FG002|Overall Study|Lost to Follow-up|0|||
125249983|NCT00601107|450539663|FG003|Overall Study|Lost to Follow-up|3|||
125249984|NCT00601107|450539660|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
125249985|NCT00601107|450539661|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
125249986|NCT00601107|450539662|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
125249987|NCT00601107|450539663|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
125249988|NCT00601107|450539660|FG000|Overall Study|Worsening of Psoriasis|4|||
125249989|NCT00601107|450539661|FG001|Overall Study|Worsening of Psoriasis|1|||
125396626|NCT01479621|451085128|FG006|Treatment Period|Non-compliance to study drug|1|||
125396627|NCT01479621|451085122|FG000|Treatment Period|Protocol Violation|0|||
125396628|NCT01479621|451085123|FG001|Treatment Period|Protocol Violation|9|||
125396629|NCT01479621|451085124|FG002|Treatment Period|Protocol Violation|6|||
125196946|NCT01706939|450342038|FG002|Randomization|Progression of disease|1|||
125196947|NCT01894100|450342047|FG000|Overall Study|Lost to Follow-up|0|||
125196948|NCT01894100|450342048|FG001|Overall Study|Lost to Follow-up|1|||
125196949|NCT01894100|450342047|FG000|Overall Study|Withdrawal by Subject|3|||
125196950|NCT01894100|450342048|FG001|Overall Study|Withdrawal by Subject|0|||
125196951|NCT02235077|450342053|FG000|Overall Study|Death|5|||
125196952|NCT02235077|450342054|FG001|Overall Study|Death|7|||
125196953|NCT02235077|450342053|FG000|Overall Study|Lost to Follow-up|5|||
125196954|NCT02235077|450342054|FG001|Overall Study|Lost to Follow-up|6|||
125196955|NCT02235077|450342053|FG000|Overall Study|Withdrawal by Subject|8|||
125196956|NCT02235077|450342054|FG001|Overall Study|Withdrawal by Subject|5|||
125196957|NCT02235077|450342053|FG000|Overall Study|Physician Decision|0|||
125196958|NCT02235077|450342054|FG001|Overall Study|Physician Decision|1|||
125196959|NCT04013672|450342055|FG000|Overall Study|Withdrawal by Subject|3|||
125196960|NCT04013672|450342056|FG001|Overall Study|Withdrawal by Subject|0|||
125196961|NCT04013672|450342055|FG000|Overall Study|Death|1|||
125196962|NCT04013672|450342056|FG001|Overall Study|Death|0|||
125196963|NCT04013672|450342055|FG000|Overall Study|Physician Decision|5|||
125196964|NCT04013672|450342056|FG001|Overall Study|Physician Decision|0|||
125196965|NCT00586820|450342057|FG000|Overall Study|Unsuccessful PCI|1|||
125196966|NCT00586820|450342058|FG001|Overall Study|Unsuccessful PCI|0|||
125196967|NCT00101166|450342061|FG000|Overall Study|progressive disease|10|||
125196968|NCT01868022|450342062|FG000|Overall Study|Withdrawal by Subject|0|||
125196969|NCT01868022|450342063|FG001|Overall Study|Withdrawal by Subject|0|||
125196970|NCT01868022|450342064|FG002|Overall Study|Withdrawal by Subject|1|||
125196971|NCT01868022|450342065|FG003|Overall Study|Withdrawal by Subject|1|||
125196972|NCT01868022|450342066|FG004|Overall Study|Withdrawal by Subject|0|||
125196973|NCT01868022|450342067|FG005|Overall Study|Withdrawal by Subject|0|||
125196974|NCT01868022|450342068|FG006|Overall Study|Withdrawal by Subject|0|||
125196975|NCT01868022|450342069|FG007|Overall Study|Withdrawal by Subject|1|||
125196976|NCT01868022|450342070|FG008|Overall Study|Withdrawal by Subject|0|||
125196977|NCT01868022|450342062|FG000|Overall Study|Adverse Event|0|||
125196978|NCT01868022|450342063|FG001|Overall Study|Adverse Event|0|||
125196979|NCT01868022|450342064|FG002|Overall Study|Adverse Event|0|||
125196980|NCT01868022|450342065|FG003|Overall Study|Adverse Event|0|||
125196981|NCT01868022|450342066|FG004|Overall Study|Adverse Event|2|||
125196982|NCT01868022|450342067|FG005|Overall Study|Adverse Event|0|||
125196983|NCT01868022|450342068|FG006|Overall Study|Adverse Event|0|||
125196984|NCT01868022|450342069|FG007|Overall Study|Adverse Event|2|||
125196985|NCT01868022|450342070|FG008|Overall Study|Adverse Event|2|||
125196986|NCT01868022|450342062|FG000|Overall Study|Physician Decision|0|||
125196987|NCT01868022|450342063|FG001|Overall Study|Physician Decision|0|||
125196988|NCT01868022|450342064|FG002|Overall Study|Physician Decision|0|||
125196989|NCT01868022|450342065|FG003|Overall Study|Physician Decision|0|||
125196990|NCT01868022|450342066|FG004|Overall Study|Physician Decision|0|||
125196991|NCT01868022|450342067|FG005|Overall Study|Physician Decision|1|||
125196992|NCT01868022|450342068|FG006|Overall Study|Physician Decision|0|||
125196993|NCT01868022|450342069|FG007|Overall Study|Physician Decision|2|||
125196994|NCT01868022|450342070|FG008|Overall Study|Physician Decision|0|||
125196995|NCT01868022|450342062|FG000|Overall Study|Study closed/terminated|0|||
125196996|NCT01868022|450342063|FG001|Overall Study|Study closed/terminated|0|||
125196997|NCT01868022|450342064|FG002|Overall Study|Study closed/terminated|0|||
125196998|NCT01868022|450342065|FG003|Overall Study|Study closed/terminated|0|||
125196999|NCT01868022|450342066|FG004|Overall Study|Study closed/terminated|0|||
125197000|NCT01868022|450342067|FG005|Overall Study|Study closed/terminated|0|||
125197001|NCT01868022|450342068|FG006|Overall Study|Study closed/terminated|0|||
125197002|NCT01868022|450342069|FG007|Overall Study|Study closed/terminated|1|||
125197003|NCT01868022|450342070|FG008|Overall Study|Study closed/terminated|0|||
125197004|NCT01868022|450342062|FG000|Overall Study|Ongoing|0|||
125197005|NCT01868022|450342063|FG001|Overall Study|Ongoing|0|||
125197006|NCT01868022|450342064|FG002|Overall Study|Ongoing|0|||
125197007|NCT01868022|450342065|FG003|Overall Study|Ongoing|0|||
125197008|NCT01868022|450342066|FG004|Overall Study|Ongoing|0|||
125197009|NCT01868022|450342067|FG005|Overall Study|Ongoing|0|||
125249990|NCT00601107|450539662|FG002|Overall Study|Worsening of Psoriasis|1|||
125249991|NCT00601107|450539663|FG003|Overall Study|Worsening of Psoriasis|4|||
125249992|NCT00601107|450539660|FG000|Overall Study|Undefined|1|||
125249993|NCT00601107|450539661|FG001|Overall Study|Undefined|0|||
125249994|NCT00601107|450539662|FG002|Overall Study|Undefined|1|||
125249995|NCT00601107|450539663|FG003|Overall Study|Undefined|0|||
125249996|NCT03722030|450539665|FG000|Overall Study|Withdrawal by Subject|1|||
125249997|NCT03722030|450539666|FG001|Overall Study|Withdrawal by Subject|0|||
125249998|NCT00147537|450539667|FG000|Phase 1b|Death|0|||
125249999|NCT00147537|450539668|FG001|Phase 1b|Death|1|||
125250000|NCT00147537|450539669|FG002|Phase 1b|Death|2|||
125250001|NCT00147537|450539670|FG003|Phase 1b|Death|1|||
125250002|NCT00147537|450539671|FG004|Phase 1b|Death|2|||
125250003|NCT00147537|450539672|FG005|Phase 1b|Death|2|||
125250004|NCT00147537|450539673|FG006|Phase 1b|Death|1|||
125197010|NCT01868022|450342068|FG006|Overall Study|Ongoing|0|||
125197011|NCT01868022|450342069|FG007|Overall Study|Ongoing|3|||
125197012|NCT01868022|450342070|FG008|Overall Study|Ongoing|0|||
125197013|NCT00686829|450342071|FG000|Overall Study|Adverse Event|5|||
125197014|NCT00686829|450342071|FG000|Overall Study|Lack of Efficacy|6|||
125197015|NCT00686829|450342071|FG000|Overall Study|Lost to Follow-up|4|||
125250005|NCT00147537|450539674|FG007|Phase 1b|Death|3|||
125250006|NCT00147537|450539675|FG008|Phase 1b|Death|9|||
125250007|NCT00147537|450539676|FG009|Phase 1b|Death|0|||
125250008|NCT00147537|450539677|FG010|Phase 1b|Death|0|||
125197016|NCT00686829|450342071|FG000|Overall Study|Withdrawal by Subject|14|||
125250009|NCT00147537|450539667|FG000|Phase 1b|Lost to Follow-up|2|||
125250010|NCT00147537|450539668|FG001|Phase 1b|Lost to Follow-up|1|||
125250011|NCT00147537|450539669|FG002|Phase 1b|Lost to Follow-up|0|||
125443963|NCT02018861|451253874|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125443964|NCT02018861|451253875|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125443965|NCT02018861|451253876|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
125443966|NCT02018861|451253867|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125443967|NCT02018861|451253868|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125443968|NCT02018861|451253869|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125443969|NCT02018861|451253870|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
125443970|NCT02018861|451253871|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
125443971|NCT02018861|451253872|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
125443972|NCT02018861|451253873|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125443973|NCT02018861|451253874|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125443974|NCT02018861|451253875|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125443975|NCT02018861|451253876|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
125443976|NCT02018861|451253867|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125443977|NCT02018861|451253868|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125443978|NCT02018861|451253869|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125443979|NCT02018861|451253870|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
125443980|NCT02018861|451253871|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
125443981|NCT02018861|451253872|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125443982|NCT02018861|451253873|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125443983|NCT02018861|451253874|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125443984|NCT02018861|451253875|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125443985|NCT02018861|451253876|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
125443986|NCT02018861|451253867|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125443987|NCT02018861|451253868|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125443988|NCT02018861|451253869|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125443989|NCT02018861|451253870|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125443990|NCT02018861|451253871|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125443991|NCT02018861|451253872|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125443992|NCT02018861|451253873|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
125443993|NCT02018861|451253874|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
125443994|NCT02018861|451253875|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125443995|NCT02018861|451253876|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
125443996|NCT02018861|451253867|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125443997|NCT02018861|451253868|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125443998|NCT02018861|451253869|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125443999|NCT02018861|451253870|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125444000|NCT02018861|451253871|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125444001|NCT02018861|451253872|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125444002|NCT02018861|451253873|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
125444003|NCT02018861|451253874|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
125444004|NCT02018861|451253875|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125444005|NCT02018861|451253876|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
125197017|NCT00686829|450342071|FG000|Overall Study|Protocol Violation|3|||
125444006|NCT02018861|451253867|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125197018|NCT00686829|450342071|FG000|Overall Study|Sponsor discontinued VCV|47|||
125197019|NCT01217476|450342074|FG000|Overall Study|Adverse Event|6|||
125197020|NCT01217476|450342075|FG001|Overall Study|Adverse Event|1|||
125197021|NCT01217476|450342074|FG000|Overall Study|Physician Decision|0|||
125197022|NCT01217476|450342075|FG001|Overall Study|Physician Decision|1|||
125197023|NCT01217476|450342074|FG000|Overall Study|Withdrawal by Subject|3|||
125197024|NCT01217476|450342075|FG001|Overall Study|Withdrawal by Subject|3|||
125197025|NCT01217476|450342074|FG000|Overall Study|Surgery on the Target Limb|0|||
125197026|NCT01217476|450342075|FG001|Overall Study|Surgery on the Target Limb|2|||
125197027|NCT01217476|450342074|FG000|Overall Study|Protocol Deviation|1|||
125197028|NCT01217476|450342075|FG001|Overall Study|Protocol Deviation|0|||
125197029|NCT01217476|450342074|FG000|Overall Study|Other|2|||
125197030|NCT01217476|450342075|FG001|Overall Study|Other|0|||
125197031|NCT01672710|450342076|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
125197032|NCT01672710|450342077|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
125197033|NCT01672710|450342076|FG000|3 Month Follow up|Lost to Follow-up|2|||
125197034|NCT01672710|450342077|FG001|3 Month Follow up|Lost to Follow-up|3|||
125197035|NCT01672710|450342076|FG000|3 Month Follow up|follow up due after termination date|4|||
125197036|NCT01672710|450342077|FG001|3 Month Follow up|follow up due after termination date|1|||
125197037|NCT02122887|450342078|FG000|Overall Study|Withdrawal by Subject|20|||
125197038|NCT02122887|450342079|FG001|Overall Study|Withdrawal by Subject|2|||
125444007|NCT02018861|451253868|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125444008|NCT02018861|451253869|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125444009|NCT02018861|451253870|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125197039|NCT03652636|450343854|FG000|Overall Study|Withdrawal by Subject|7|||
125197040|NCT00076752|450343858|FG000|Overall Study|Death|2|||
125197041|NCT00076752|450343858|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
125197042|NCT03728426|450343859|FG000|Overall Study|Death|3|||
125197043|NCT02048826|450343862|FG000|Overall Study|Withdrawal by Subject|1|||
125197044|NCT02048826|450343863|FG001|Overall Study|Withdrawal by Subject|0|||
125197045|NCT04470544|450343864|FG000|Overall Study|Withdrawal by Subject|4|||
125197046|NCT04470544|450343865|FG001|Overall Study|Withdrawal by Subject|6|||
125197047|NCT03436693|450343866|FG000|Overall Study|Adverse Event|22|||
125197048|NCT03436693|450343867|FG001|Overall Study|Adverse Event|10|||
125197049|NCT03436693|450343866|FG000|Overall Study|Physician Decision|3|||
125197050|NCT03436693|450343867|FG001|Overall Study|Physician Decision|3|||
125197051|NCT03436693|450343866|FG000|Overall Study|Withdrawal by Subject|4|||
125197052|NCT03436693|450343867|FG001|Overall Study|Withdrawal by Subject|13|||
125197053|NCT03436693|450343866|FG000|Overall Study|Progressive Disease|1|||
125197054|NCT03436693|450343867|FG001|Overall Study|Progressive Disease|1|||
125197055|NCT00654875|450343870|FG000|Overall Study|Adverse Event|5|||
125197056|NCT00654875|450343871|FG001|Overall Study|Adverse Event|5|||
125197057|NCT00654875|450343870|FG000|Overall Study|Withdrawal by Subject|4|||
125197058|NCT00654875|450343871|FG001|Overall Study|Withdrawal by Subject|4|||
125197059|NCT00654875|450343870|FG000|Overall Study|Protocol Violation|3|||
125197060|NCT00654875|450343871|FG001|Overall Study|Protocol Violation|3|||
125197061|NCT00654875|450343870|FG000|Overall Study|Lack of Efficacy|2|||
125197062|NCT00654875|450343871|FG001|Overall Study|Lack of Efficacy|2|||
125197063|NCT00654875|450343870|FG000|Overall Study|Lost to Follow-up|1|||
125197064|NCT00654875|450343871|FG001|Overall Study|Lost to Follow-up|3|||
125197065|NCT00654875|450343870|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
125197066|NCT00654875|450343871|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
125197067|NCT00654875|450343870|FG000|Overall Study|Administrative Problems|1|||
125197068|NCT00654875|450343871|FG001|Overall Study|Administrative Problems|0|||
125197069|NCT04967885|450343872|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
125197070|NCT04967885|450343873|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
125197071|NCT04967885|450343872|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
125197072|NCT04967885|450343873|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
125197073|NCT04967885|450343872|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
125197074|NCT04967885|450343873|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
125197075|NCT04967885|450343872|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
125197076|NCT04967885|450343873|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
125197077|NCT04967885|450343872|FG000|EMI-II Intervention|Lost to Follow-up|14|||
125197078|NCT04967885|450343873|FG001|EMI-II Intervention|Lost to Follow-up|10|||
125197079|NCT01011465|450343874|FG000|Overall Study|Withdrawal by Subject|2|||
125197080|NCT01011465|450343875|FG001|Overall Study|Withdrawal by Subject|1|||
125197081|NCT01011465|450343876|FG002|Overall Study|Withdrawal by Subject|0|||
125197082|NCT01011465|450343877|FG003|Overall Study|Withdrawal by Subject|0|||
125197083|NCT01011465|450343878|FG004|Overall Study|Withdrawal by Subject|1|||
125197084|NCT01011465|450343879|FG005|Overall Study|Withdrawal by Subject|0|||
125197085|NCT01011465|450343880|FG006|Overall Study|Withdrawal by Subject|1|||
125197086|NCT01011465|450343881|FG007|Overall Study|Withdrawal by Subject|0|||
125197087|NCT00723008|450343883|FG000|Enrollment|Lost to Follow-up|1|||
125197088|NCT00723008|450343884|FG001|Enrollment|Lost to Follow-up|0|||
125197089|NCT00723008|450343883|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
125197090|NCT00723008|450343884|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
125197091|NCT00723008|450343883|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
125197092|NCT00723008|450343884|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
125197093|NCT00723008|450343883|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
125197094|NCT00723008|450343884|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
125197095|NCT00723008|450343883|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
125197096|NCT00723008|450343884|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
125197097|NCT00723008|450343883|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
125197098|NCT00723008|450343884|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
125197099|NCT01014988|450343886|FG000|Overall Study|Adverse Event|20|||
125197100|NCT01014988|450343887|FG001|Overall Study|Adverse Event|0|||
125197101|NCT01014988|450343888|FG002|Overall Study|Adverse Event|1|||
125197102|NCT01014988|450343889|FG003|Overall Study|Adverse Event|0|||
125197103|NCT01014988|450343890|FG004|Overall Study|Adverse Event|1|||
125197104|NCT01014988|450343891|FG005|Overall Study|Adverse Event|3|||
125197105|NCT01014988|450343886|FG000|Overall Study|Lost to Follow-up|1|||
125197106|NCT01014988|450343887|FG001|Overall Study|Lost to Follow-up|0|||
125197107|NCT01014988|450343888|FG002|Overall Study|Lost to Follow-up|1|||
125197108|NCT01014988|450343889|FG003|Overall Study|Lost to Follow-up|0|||
125197109|NCT01014988|450343890|FG004|Overall Study|Lost to Follow-up|0|||
125197110|NCT01014988|450343891|FG005|Overall Study|Lost to Follow-up|0|||
125197111|NCT01014988|450343886|FG000|Overall Study|Physician Decision|1|||
125444010|NCT02018861|451253871|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125444011|NCT02018861|451253872|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125444012|NCT02018861|451253873|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125444013|NCT02018861|451253874|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125444014|NCT02018861|451253875|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
125444015|NCT02018861|451253876|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
125444016|NCT02018861|451253867|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125444017|NCT02018861|451253868|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125444018|NCT02018861|451253869|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125444019|NCT02018861|451253870|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125444020|NCT02018861|451253871|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125444021|NCT02018861|451253872|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125197112|NCT01014988|450343887|FG001|Overall Study|Physician Decision|0|||
125197113|NCT01014988|450343888|FG002|Overall Study|Physician Decision|0|||
125250012|NCT00147537|450539670|FG003|Phase 1b|Lost to Follow-up|0|||
125197114|NCT01014988|450343889|FG003|Overall Study|Physician Decision|0|||
125197115|NCT01014988|450343890|FG004|Overall Study|Physician Decision|0|||
125197116|NCT01014988|450343891|FG005|Overall Study|Physician Decision|0|||
125197117|NCT01014988|450343886|FG000|Overall Study|Withdrawal by Subject|1|||
125197118|NCT01014988|450343887|FG001|Overall Study|Withdrawal by Subject|0|||
125197119|NCT01014988|450343888|FG002|Overall Study|Withdrawal by Subject|0|||
125197120|NCT01014988|450343889|FG003|Overall Study|Withdrawal by Subject|0|||
125197121|NCT01014988|450343890|FG004|Overall Study|Withdrawal by Subject|0|||
125197122|NCT01014988|450343891|FG005|Overall Study|Withdrawal by Subject|0|||
125197123|NCT01683266|450343893|FG000|Overall Study|Adverse Event|5|||
125197124|NCT01683266|450343894|FG001|Overall Study|Adverse Event|4|||
125197125|NCT01683266|450343893|FG000|Overall Study|Lack of Efficacy|5|||
125197126|NCT01683266|450343894|FG001|Overall Study|Lack of Efficacy|2|||
125197127|NCT01683266|450343893|FG000|Overall Study|Protocol Violation|13|||
125197128|NCT01683266|450343894|FG001|Overall Study|Protocol Violation|6|||
125197129|NCT01683266|450343893|FG000|Overall Study|Personal Reason|17|||
125197130|NCT01683266|450343894|FG001|Overall Study|Personal Reason|25|||
125197131|NCT01683266|450343893|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
125197132|NCT01683266|450343894|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
125197133|NCT01683266|450343893|FG000|Overall Study|Lost to Follow-up|5|||
125197134|NCT01683266|450343894|FG001|Overall Study|Lost to Follow-up|0|||
125197135|NCT01683266|450343893|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
125197136|NCT01683266|450343894|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
125197137|NCT01683266|450343893|FG000|Overall Study|Nonserious Hypoglycemia|0|||
125197138|NCT01683266|450343894|FG001|Overall Study|Nonserious Hypoglycemia|3|||
125197139|NCT01683266|450343893|FG000|Overall Study|Perceived Lack of Efficacy|1|||
125197140|NCT01683266|450343894|FG001|Overall Study|Perceived Lack of Efficacy|1|||
125197141|NCT01683266|450343893|FG000|Overall Study|Possibly Hypoglycemia|1|||
125197142|NCT01683266|450343894|FG001|Overall Study|Possibly Hypoglycemia|0|||
125197143|NCT01683266|450343893|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
125197144|NCT01683266|450343894|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
125197145|NCT00886743|450343897|FG000|Overall Study|Adverse Event|3|||
125197146|NCT00886743|450343897|FG000|Overall Study|Other|1|||
125197147|NCT05217641|450343901|FG000|Overall Study|Lost to Follow-up|1|||
125197148|NCT05217641|450343902|FG001|Overall Study|Lost to Follow-up|1|||
125197149|NCT05217641|450343903|FG002|Overall Study|Lost to Follow-up|0|||
125197150|NCT05217641|450343904|FG003|Overall Study|Lost to Follow-up|1|||
125197151|NCT05217641|450343905|FG004|Overall Study|Lost to Follow-up|1|||
125197152|NCT05217641|450343906|FG005|Overall Study|Lost to Follow-up|0|||
125197153|NCT05217641|450343901|FG000|Overall Study|Withdrawal by Subject|0|||
125197154|NCT05217641|450343902|FG001|Overall Study|Withdrawal by Subject|0|||
125197155|NCT05217641|450343903|FG002|Overall Study|Withdrawal by Subject|0|||
125197156|NCT05217641|450343904|FG003|Overall Study|Withdrawal by Subject|3|||
125197157|NCT05217641|450343905|FG004|Overall Study|Withdrawal by Subject|1|||
125197158|NCT05217641|450343906|FG005|Overall Study|Withdrawal by Subject|0|||
125197159|NCT05217641|450343901|FG000|Overall Study|Other: participant did not specify reason|0|||
125197160|NCT05217641|450343902|FG001|Overall Study|Other: participant did not specify reason|0|||
125197161|NCT05217641|450343903|FG002|Overall Study|Other: participant did not specify reason|0|||
125197162|NCT05217641|450343904|FG003|Overall Study|Other: participant did not specify reason|0|||
125197163|NCT05217641|450343905|FG004|Overall Study|Other: participant did not specify reason|1|||
125250013|NCT00147537|450539671|FG004|Phase 1b|Lost to Follow-up|0|||
125197164|NCT05217641|450343906|FG005|Overall Study|Other: participant did not specify reason|0|||
125197165|NCT05217641|450343901|FG000|Overall Study|Extended Follow up|1|||
125250014|NCT00147537|450539672|FG005|Phase 1b|Lost to Follow-up|0|||
125197166|NCT05217641|450343902|FG001|Overall Study|Extended Follow up|1|||
125197167|NCT05217641|450343903|FG002|Overall Study|Extended Follow up|0|||
125197168|NCT05217641|450343904|FG003|Overall Study|Extended Follow up|0|||
125197169|NCT05217641|450343905|FG004|Overall Study|Extended Follow up|1|||
125197170|NCT05217641|450343906|FG005|Overall Study|Extended Follow up|0|||
125444022|NCT02018861|451253873|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125444023|NCT02018861|451253874|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125444024|NCT02018861|451253875|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
125444025|NCT02018861|451253876|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
125444026|NCT02018861|451253867|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125444027|NCT02018861|451253868|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125444028|NCT02018861|451253869|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125444029|NCT02018861|451253870|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125444030|NCT02018861|451253871|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125444031|NCT02018861|451253872|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125444032|NCT02018861|451253873|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125444033|NCT02018861|451253874|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125444034|NCT02018861|451253875|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
125444035|NCT02018861|451253876|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
125444036|NCT01474512|451253880|FG000|Induction Period|Adverse Event|6|||
125444037|NCT01474512|451253881|FG001|Induction Period|Adverse Event|10|||
125444038|NCT01474512|451253882|FG002|Induction Period|Adverse Event|10|||
125444039|NCT01474512|451253883|FG003|Induction Period|Adverse Event|0|||
125197171|NCT00626821|450343911|FG000|Overall Study|Adverse Event|44|||
125197172|NCT00626821|450343911|FG000|Overall Study|Protocol Violation|33|||
125197173|NCT00626821|450343911|FG000|Overall Study|Withdrawal by Subject|10|||
125197174|NCT00626821|450343911|FG000|Overall Study|Physician Decision|9|||
125197175|NCT00626821|450343911|FG000|Overall Study|Product dysfunction|21|||
125197176|NCT00626821|450343911|FG000|Overall Study|other/unknown reason|104|||
125197177|NCT02632409|450343912|FG000|Randomized|AE unrelated to study Drug|0|||
125197178|NCT02632409|450343913|FG001|Randomized|AE unrelated to study Drug|1|||
125197179|NCT02632409|450343912|FG000|Randomized|Participant withdrew consent|2|||
125197180|NCT02632409|450343913|FG001|Randomized|Participant withdrew consent|1|||
125197181|NCT02632409|450343912|FG000|Randomized|No Longer meets study criteria|5|||
125197182|NCT02632409|450343913|FG001|Randomized|No Longer meets study criteria|0|||
125197183|NCT02632409|450343912|FG000|Randomized|other reasons|1|||
125197184|NCT02632409|450343913|FG001|Randomized|other reasons|0|||
125197185|NCT02632409|450343912|FG000|Treatment Period|Ongoing Treatment|20|||
125197186|NCT02632409|450343913|FG001|Treatment Period|Ongoing Treatment|21|||
125197187|NCT02632409|450343912|FG000|Treatment Period|Disease Recurrence|147|||
125197188|NCT02632409|450343913|FG001|Treatment Period|Disease Recurrence|90|||
125197189|NCT02632409|450343912|FG000|Treatment Period|Study Drug Toxicity|8|||
125197190|NCT02632409|450343913|FG001|Treatment Period|Study Drug Toxicity|49|||
125197191|NCT02632409|450343912|FG000|Treatment Period|Death|1|||
125197192|NCT02632409|450343913|FG001|Treatment Period|Death|0|||
125197193|NCT02632409|450343912|FG000|Treatment Period|AE unrelated to study drug|15|||
125197194|NCT02632409|450343913|FG001|Treatment Period|AE unrelated to study drug|16|||
125197195|NCT02632409|450343912|FG000|Treatment Period|Request to discontinue treatment|4|||
125197196|NCT02632409|450343913|FG001|Treatment Period|Request to discontinue treatment|19|||
125197197|NCT02632409|450343912|FG000|Treatment Period|Participant withdrew consent|7|||
125197198|NCT02632409|450343913|FG001|Treatment Period|Participant withdrew consent|5|||
125197199|NCT02632409|450343912|FG000|Treatment Period|Lost to Follow-up|0|||
125197200|NCT02632409|450343913|FG001|Treatment Period|Lost to Follow-up|1|||
125197201|NCT02632409|450343912|FG000|Treatment Period|Maximum clinical benefit|1|||
125197202|NCT02632409|450343913|FG001|Treatment Period|Maximum clinical benefit|0|||
125197203|NCT02632409|450343912|FG000|Treatment Period|No longer meets study criteria|3|||
125197204|NCT02632409|450343913|FG001|Treatment Period|No longer meets study criteria|0|||
125197205|NCT02632409|450343912|FG000|Treatment Period|Administrative Reason by sponsor|0|||
125197206|NCT02632409|450343913|FG001|Treatment Period|Administrative Reason by sponsor|1|||
125197207|NCT02632409|450343912|FG000|Treatment Period|Other Reasons|10|||
125197208|NCT02632409|450343913|FG001|Treatment Period|Other Reasons|6|||
125197209|NCT00537316|450343914|FG000|Part 1|Adverse Event|7|||
125197210|NCT00537316|450343915|FG001|Part 1|Adverse Event|11|||
125197211|NCT00537316|450343916|FG002|Part 1|Adverse Event|8|||
125197212|NCT00537316|450343917|FG003|Part 1|Adverse Event|0|||
125197213|NCT00537316|450343918|FG004|Part 1|Adverse Event|0|||
125197214|NCT00537316|450343919|FG005|Part 1|Adverse Event|0|||
125197215|NCT00537316|450343920|FG006|Part 1|Adverse Event|0|||
125197216|NCT00537316|450343914|FG000|Part 1|Protocol defined clinical event|1|||
125197217|NCT00537316|450343915|FG001|Part 1|Protocol defined clinical event|0|||
125197218|NCT00537316|450343916|FG002|Part 1|Protocol defined clinical event|0|||
125197219|NCT00537316|450343917|FG003|Part 1|Protocol defined clinical event|0|||
125197220|NCT00537316|450343918|FG004|Part 1|Protocol defined clinical event|0|||
125197221|NCT00537316|450343919|FG005|Part 1|Protocol defined clinical event|0|||
125197222|NCT00537316|450343920|FG006|Part 1|Protocol defined clinical event|0|||
125197223|NCT00537316|450343914|FG000|Part 1|Lost to Follow-up|1|||
125197224|NCT00537316|450343915|FG001|Part 1|Lost to Follow-up|0|||
125197225|NCT00537316|450343916|FG002|Part 1|Lost to Follow-up|0|||
125197226|NCT00537316|450343917|FG003|Part 1|Lost to Follow-up|0|||
125250015|NCT00147537|450539673|FG006|Phase 1b|Lost to Follow-up|2|||
125250016|NCT00147537|450539674|FG007|Phase 1b|Lost to Follow-up|0|||
125250017|NCT00147537|450539675|FG008|Phase 1b|Lost to Follow-up|1|||
125250018|NCT00147537|450539676|FG009|Phase 1b|Lost to Follow-up|0|||
125250019|NCT00147537|450539677|FG010|Phase 1b|Lost to Follow-up|0|||
125250020|NCT00147537|450539667|FG000|Phase 1b|Other|0|||
125250021|NCT00147537|450539668|FG001|Phase 1b|Other|0|||
125250022|NCT00147537|450539669|FG002|Phase 1b|Other|2|||
125250023|NCT00147537|450539670|FG003|Phase 1b|Other|1|||
125250024|NCT00147537|450539671|FG004|Phase 1b|Other|1|||
125250025|NCT00147537|450539672|FG005|Phase 1b|Other|1|||
125250026|NCT00147537|450539673|FG006|Phase 1b|Other|14|||
125250027|NCT00147537|450539674|FG007|Phase 1b|Other|4|||
125250028|NCT00147537|450539675|FG008|Phase 1b|Other|4|||
125250029|NCT00147537|450539676|FG009|Phase 1b|Other|0|||
125250030|NCT00147537|450539677|FG010|Phase 1b|Other|0|||
125250031|NCT00147537|450539667|FG000|Phase 1b|Withdrawal by Subject|0|||
125250032|NCT00147537|450539668|FG001|Phase 1b|Withdrawal by Subject|0|||
125250033|NCT00147537|450539669|FG002|Phase 1b|Withdrawal by Subject|0|||
125250034|NCT00147537|450539670|FG003|Phase 1b|Withdrawal by Subject|0|||
125250035|NCT00147537|450539671|FG004|Phase 1b|Withdrawal by Subject|0|||
125250036|NCT00147537|450539672|FG005|Phase 1b|Withdrawal by Subject|0|||
125250037|NCT00147537|450539673|FG006|Phase 1b|Withdrawal by Subject|0|||
125250038|NCT00147537|450539674|FG007|Phase 1b|Withdrawal by Subject|0|||
125250039|NCT00147537|450539675|FG008|Phase 1b|Withdrawal by Subject|2|||
125250040|NCT00147537|450539676|FG009|Phase 1b|Withdrawal by Subject|0|||
125250041|NCT00147537|450539677|FG010|Phase 1b|Withdrawal by Subject|0|||
125250042|NCT00147537|450539667|FG000|Phase 1b|Randomized but not treated|0|||
125250043|NCT00147537|450539668|FG001|Phase 1b|Randomized but not treated|0|||
125250044|NCT00147537|450539669|FG002|Phase 1b|Randomized but not treated|0|||
125250045|NCT00147537|450539670|FG003|Phase 1b|Randomized but not treated|0|||
125250046|NCT00147537|450539671|FG004|Phase 1b|Randomized but not treated|0|||
125250047|NCT00147537|450539672|FG005|Phase 1b|Randomized but not treated|0|||
125250048|NCT00147537|450539673|FG006|Phase 1b|Randomized but not treated|1|||
125250049|NCT00147537|450539674|FG007|Phase 1b|Randomized but not treated|0|||
125250050|NCT00147537|450539675|FG008|Phase 1b|Randomized but not treated|1|||
125250051|NCT00147537|450539676|FG009|Phase 1b|Randomized but not treated|0|||
125250052|NCT00147537|450539677|FG010|Phase 1b|Randomized but not treated|0|||
125250053|NCT00147537|450539667|FG000|Phase 2|Death|0|||
125250054|NCT00147537|450539668|FG001|Phase 2|Death|0|||
125250055|NCT00147537|450539669|FG002|Phase 2|Death|0|||
125250056|NCT00147537|450539670|FG003|Phase 2|Death|0|||
125250057|NCT00147537|450539671|FG004|Phase 2|Death|0|||
125250058|NCT00147537|450539672|FG005|Phase 2|Death|0|||
125250059|NCT00147537|450539673|FG006|Phase 2|Death|0|||
125250060|NCT00147537|450539674|FG007|Phase 2|Death|0|||
125250061|NCT00147537|450539675|FG008|Phase 2|Death|0|||
125250062|NCT00147537|450539676|FG009|Phase 2|Death|85|||
125250063|NCT00147537|450539677|FG010|Phase 2|Death|31|||
125250064|NCT00147537|450539667|FG000|Phase 2|Lost to Follow-up|0|||
125250065|NCT00147537|450539668|FG001|Phase 2|Lost to Follow-up|0|||
125250066|NCT00147537|450539669|FG002|Phase 2|Lost to Follow-up|0|||
125250067|NCT00147537|450539670|FG003|Phase 2|Lost to Follow-up|0|||
125250068|NCT00147537|450539671|FG004|Phase 2|Lost to Follow-up|0|||
125250069|NCT00147537|450539672|FG005|Phase 2|Lost to Follow-up|0|||
125250070|NCT00147537|450539673|FG006|Phase 2|Lost to Follow-up|0|||
125250071|NCT00147537|450539674|FG007|Phase 2|Lost to Follow-up|0|||
125250072|NCT00147537|450539675|FG008|Phase 2|Lost to Follow-up|0|||
125250073|NCT00147537|450539676|FG009|Phase 2|Lost to Follow-up|12|||
125250074|NCT00147537|450539677|FG010|Phase 2|Lost to Follow-up|4|||
125250075|NCT00147537|450539667|FG000|Phase 2|Other|0|||
125250076|NCT00147537|450539668|FG001|Phase 2|Other|0|||
125250077|NCT00147537|450539669|FG002|Phase 2|Other|0|||
125250078|NCT00147537|450539670|FG003|Phase 2|Other|0|||
125250079|NCT00147537|450539671|FG004|Phase 2|Other|0|||
125250080|NCT00147537|450539672|FG005|Phase 2|Other|0|||
125250081|NCT00147537|450539673|FG006|Phase 2|Other|0|||
125250082|NCT00147537|450539674|FG007|Phase 2|Other|0|||
125250083|NCT00147537|450539675|FG008|Phase 2|Other|0|||
125250084|NCT00147537|450539676|FG009|Phase 2|Other|47|||
125250085|NCT00147537|450539677|FG010|Phase 2|Other|12|||
125250086|NCT00147537|450539667|FG000|Phase 2|Withdrawal by Subject|0|||
125250087|NCT00147537|450539668|FG001|Phase 2|Withdrawal by Subject|0|||
125250088|NCT00147537|450539669|FG002|Phase 2|Withdrawal by Subject|0|||
125250089|NCT00147537|450539670|FG003|Phase 2|Withdrawal by Subject|0|||
125250090|NCT00147537|450539671|FG004|Phase 2|Withdrawal by Subject|0|||
125250091|NCT00147537|450539672|FG005|Phase 2|Withdrawal by Subject|0|||
125250092|NCT00147537|450539673|FG006|Phase 2|Withdrawal by Subject|0|||
125250093|NCT00147537|450539674|FG007|Phase 2|Withdrawal by Subject|0|||
125250094|NCT00147537|450539675|FG008|Phase 2|Withdrawal by Subject|0|||
125250095|NCT00147537|450539676|FG009|Phase 2|Withdrawal by Subject|16|||
125250096|NCT00147537|450539677|FG010|Phase 2|Withdrawal by Subject|4|||
125250097|NCT00147537|450539667|FG000|Phase 2|Randomized but not treated|0|||
125250098|NCT00147537|450539668|FG001|Phase 2|Randomized but not treated|0|||
125250099|NCT00147537|450539669|FG002|Phase 2|Randomized but not treated|0|||
125250100|NCT00147537|450539670|FG003|Phase 2|Randomized but not treated|0|||
125444040|NCT01474512|451253884|FG004|Induction Period|Adverse Event|0|||
125444041|NCT01474512|451253885|FG005|Induction Period|Adverse Event|0|||
125444042|NCT01474512|451253886|FG006|Induction Period|Adverse Event|0|||
125444043|NCT01474512|451253887|FG007|Induction Period|Adverse Event|0|||
125444044|NCT01474512|451253888|FG008|Induction Period|Adverse Event|0|||
125444045|NCT01474512|451253889|FG009|Induction Period|Adverse Event|0|||
125444046|NCT01474512|451253890|FG010|Induction Period|Adverse Event|0|||
125444047|NCT01474512|451253891|FG011|Induction Period|Adverse Event|0|||
125444048|NCT01474512|451253892|FG012|Induction Period|Adverse Event|0|||
125444049|NCT01474512|451253893|FG013|Induction Period|Adverse Event|0|||
125444050|NCT01474512|451253894|FG014|Induction Period|Adverse Event|0|||
125444051|NCT01474512|451253895|FG015|Induction Period|Adverse Event|0|||
125444052|NCT01474512|451253896|FG016|Induction Period|Adverse Event|0|||
125444053|NCT01474512|451253897|FG017|Induction Period|Adverse Event|0|||
125444054|NCT01474512|451253880|FG000|Induction Period|Lack of Efficacy|7|||
125444055|NCT01474512|451253881|FG001|Induction Period|Lack of Efficacy|1|||
125444056|NCT01474512|451253882|FG002|Induction Period|Lack of Efficacy|0|||
125444057|NCT01474512|451253883|FG003|Induction Period|Lack of Efficacy|0|||
125444058|NCT01474512|451253884|FG004|Induction Period|Lack of Efficacy|0|||
125444059|NCT01474512|451253885|FG005|Induction Period|Lack of Efficacy|0|||
125444060|NCT01474512|451253886|FG006|Induction Period|Lack of Efficacy|0|||
125444061|NCT01474512|451253887|FG007|Induction Period|Lack of Efficacy|0|||
125444062|NCT01474512|451253888|FG008|Induction Period|Lack of Efficacy|0|||
125444063|NCT01474512|451253889|FG009|Induction Period|Lack of Efficacy|0|||
125444064|NCT01474512|451253890|FG010|Induction Period|Lack of Efficacy|0|||
125444065|NCT01474512|451253891|FG011|Induction Period|Lack of Efficacy|0|||
125444066|NCT01474512|451253892|FG012|Induction Period|Lack of Efficacy|0|||
125444067|NCT01474512|451253893|FG013|Induction Period|Lack of Efficacy|0|||
125444068|NCT01474512|451253894|FG014|Induction Period|Lack of Efficacy|0|||
125444069|NCT01474512|451253895|FG015|Induction Period|Lack of Efficacy|0|||
125444070|NCT01474512|451253896|FG016|Induction Period|Lack of Efficacy|0|||
125444071|NCT01474512|451253897|FG017|Induction Period|Lack of Efficacy|0|||
125444072|NCT01474512|451253880|FG000|Induction Period|Withdrawal by Subject|6|||
125444073|NCT01474512|451253881|FG001|Induction Period|Withdrawal by Subject|6|||
125444074|NCT01474512|451253882|FG002|Induction Period|Withdrawal by Subject|5|||
125444075|NCT01474512|451253883|FG003|Induction Period|Withdrawal by Subject|0|||
125444076|NCT01474512|451253884|FG004|Induction Period|Withdrawal by Subject|0|||
125444077|NCT01474512|451253885|FG005|Induction Period|Withdrawal by Subject|0|||
125444078|NCT01474512|451253886|FG006|Induction Period|Withdrawal by Subject|0|||
125444079|NCT01474512|451253887|FG007|Induction Period|Withdrawal by Subject|0|||
125444080|NCT01474512|451253888|FG008|Induction Period|Withdrawal by Subject|0|||
125444081|NCT01474512|451253889|FG009|Induction Period|Withdrawal by Subject|0|||
125444082|NCT01474512|451253890|FG010|Induction Period|Withdrawal by Subject|0|||
125444083|NCT01474512|451253891|FG011|Induction Period|Withdrawal by Subject|0|||
125444084|NCT01474512|451253892|FG012|Induction Period|Withdrawal by Subject|0|||
125444085|NCT01474512|451253893|FG013|Induction Period|Withdrawal by Subject|0|||
125444086|NCT01474512|451253894|FG014|Induction Period|Withdrawal by Subject|0|||
125444087|NCT01474512|451253895|FG015|Induction Period|Withdrawal by Subject|0|||
125444088|NCT01474512|451253896|FG016|Induction Period|Withdrawal by Subject|0|||
125444089|NCT01474512|451253897|FG017|Induction Period|Withdrawal by Subject|0|||
125444090|NCT01474512|451253880|FG000|Induction Period|Protocol Violation|3|||
125444091|NCT01474512|451253881|FG001|Induction Period|Protocol Violation|6|||
125444092|NCT01474512|451253882|FG002|Induction Period|Protocol Violation|0|||
125444093|NCT01474512|451253883|FG003|Induction Period|Protocol Violation|0|||
125444094|NCT01474512|451253884|FG004|Induction Period|Protocol Violation|0|||
125444095|NCT01474512|451253885|FG005|Induction Period|Protocol Violation|0|||
125444096|NCT01474512|451253886|FG006|Induction Period|Protocol Violation|0|||
125444097|NCT01474512|451253887|FG007|Induction Period|Protocol Violation|0|||
125444098|NCT01474512|451253888|FG008|Induction Period|Protocol Violation|0|||
125444099|NCT01474512|451253889|FG009|Induction Period|Protocol Violation|0|||
125444100|NCT01474512|451253890|FG010|Induction Period|Protocol Violation|0|||
125444101|NCT01474512|451253891|FG011|Induction Period|Protocol Violation|0|||
125444102|NCT01474512|451253892|FG012|Induction Period|Protocol Violation|0|||
125444103|NCT01474512|451253893|FG013|Induction Period|Protocol Violation|0|||
125250101|NCT00147537|450539671|FG004|Phase 2|Randomized but not treated|0|||
125444104|NCT01474512|451253894|FG014|Induction Period|Protocol Violation|0|||
125444105|NCT01474512|451253895|FG015|Induction Period|Protocol Violation|0|||
125444106|NCT01474512|451253896|FG016|Induction Period|Protocol Violation|0|||
125444107|NCT01474512|451253897|FG017|Induction Period|Protocol Violation|0|||
125444108|NCT01474512|451253880|FG000|Induction Period|Sponsor Decision|1|||
125444109|NCT01474512|451253881|FG001|Induction Period|Sponsor Decision|1|||
125444110|NCT01474512|451253882|FG002|Induction Period|Sponsor Decision|1|||
125444111|NCT01474512|451253883|FG003|Induction Period|Sponsor Decision|0|||
125444112|NCT01474512|451253884|FG004|Induction Period|Sponsor Decision|0|||
125444113|NCT01474512|451253885|FG005|Induction Period|Sponsor Decision|0|||
125250102|NCT00147537|450539672|FG005|Phase 2|Randomized but not treated|0|||
125444114|NCT01474512|451253886|FG006|Induction Period|Sponsor Decision|0|||
125444115|NCT01474512|451253887|FG007|Induction Period|Sponsor Decision|0|||
125250103|NCT00147537|450539673|FG006|Phase 2|Randomized but not treated|0|||
125250104|NCT00147537|450539674|FG007|Phase 2|Randomized but not treated|0|||
125250105|NCT00147537|450539675|FG008|Phase 2|Randomized but not treated|0|||
125250106|NCT00147537|450539676|FG009|Phase 2|Randomized but not treated|1|||
125250107|NCT00147537|450539677|FG010|Phase 2|Randomized but not treated|1|||
125250108|NCT02006654|450539679|FG000|Overall Study|Withdrawal before treatment|4|||
125250109|NCT02006654|450539680|FG001|Overall Study|Withdrawal before treatment|2|||
125250110|NCT02006654|450539679|FG000|Overall Study|Adverse Event|16|||
125250111|NCT02006654|450539680|FG001|Overall Study|Adverse Event|17|||
125250112|NCT02006654|450539679|FG000|Overall Study|Death|1|||
125250113|NCT02006654|450539680|FG001|Overall Study|Death|0|||
125250114|NCT02006654|450539679|FG000|Overall Study|Withdrawal by Subject|14|||
125250115|NCT02006654|450539680|FG001|Overall Study|Withdrawal by Subject|12|||
125250116|NCT02006654|450539679|FG000|Overall Study|Protocol Violation|5|||
125250117|NCT02006654|450539680|FG001|Overall Study|Protocol Violation|8|||
125250118|NCT02006654|450539679|FG000|Overall Study|Lost to Follow-up|1|||
125250119|NCT02006654|450539680|FG001|Overall Study|Lost to Follow-up|0|||
125250120|NCT02006654|450539679|FG000|Overall Study|patient's will|2|||
125250121|NCT02006654|450539680|FG001|Overall Study|patient's will|1|||
125250122|NCT02006654|450539679|FG000|Overall Study|insufficient compliance|1|||
125250123|NCT02006654|450539680|FG001|Overall Study|insufficient compliance|0|||
125250124|NCT02006654|450539679|FG000|Overall Study|worsening cognitive condition|0|||
125250125|NCT02006654|450539680|FG001|Overall Study|worsening cognitive condition|1|||
125250126|NCT02006654|450539679|FG000|Overall Study|faecal incontinence|0|||
125250127|NCT02006654|450539680|FG001|Overall Study|faecal incontinence|1|||
125250128|NCT02006654|450539679|FG000|Overall Study|mood disorder|0|||
125250129|NCT02006654|450539680|FG001|Overall Study|mood disorder|1|||
125250130|NCT02006654|450539679|FG000|Overall Study|disallowed medication|1|||
125250131|NCT02006654|450539680|FG001|Overall Study|disallowed medication|0|||
125250132|NCT02006654|450539679|FG000|Overall Study|moving out of state|0|||
125250133|NCT02006654|450539680|FG001|Overall Study|moving out of state|1|||
125250134|NCT00478140|450539681|FG000|Overall Study|Clinical Disease Progression|1|||
125250135|NCT00676689|450539684|FG000|Overall Study|Screen Failure|2|||
125250136|NCT00676689|450539684|FG000|Overall Study|Death|2|||
125250137|NCT00676689|450539684|FG000|Overall Study|Lost to Follow-up|4|||
125250138|NCT00676689|450539684|FG000|Overall Study|Physician Decision|1|||
125250139|NCT00676689|450539684|FG000|Overall Study|Withdrawal by Subject|3|||
125250140|NCT00676689|450539684|FG000|Overall Study|Continuing FU|49|||
125250141|NCT03438656|450539685|FG000|Overall Study|Lost to Follow-up|2|||
125250142|NCT00563316|450539688|FG000|Overall Study|Adverse Event|2|||
125250143|NCT00563316|450539688|FG000|Overall Study|Physician Decision|1|||
125250144|NCT00563316|450539688|FG000|Overall Study|Lost to Follow-up|2|||
125250145|NCT00563316|450539688|FG000|Overall Study|Death|1|||
125250146|NCT00563316|450539688|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
125250147|NCT00563316|450539688|FG000|Overall Study|Other|1|||
125250148|NCT04401293|450539694|FG000|Overall Study|Withdrawal by Subject|1|||
125250149|NCT04401293|450539695|FG001|Overall Study|Withdrawal by Subject|3|||
125250150|NCT00694161|450539696|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
125250151|NCT00694161|450539696|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
125250152|NCT00694161|450539696|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
125250153|NCT03111732|450539697|FG000|Overall Study|Enrolled in different study|1|||
125250154|NCT03111732|450539697|FG000|Overall Study|Progressive disease|3|||
125250155|NCT03111732|450539697|FG000|Overall Study|Withdrawal by Subject|1|||
125250156|NCT01108055|450539698|FG000|Overall Study|Ineligible|11|||
125250157|NCT01108055|450539698|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
125250158|NCT03339453|450539701|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
125250159|NCT03339453|450539702|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
125250160|NCT02151604|450539705|FG000|Overall Study|Lost to Follow-up|3|||
125250161|NCT02151604|450539705|FG000|Overall Study|Withdrawal by Subject|2|||
125250162|NCT02151604|450539705|FG000|Overall Study|Physician Decision|3|||
125250163|NCT02151604|450539705|FG000|Overall Study|Death|1|||
125250164|NCT04495478|450539706|FG000|Overall Study|Withdrawal by Subject|0|||
125250165|NCT04495478|450539707|FG001|Overall Study|Withdrawal by Subject|0|||
125250166|NCT04495478|450539708|FG002|Overall Study|Withdrawal by Subject|0|||
125250167|NCT04495478|450539709|FG003|Overall Study|Withdrawal by Subject|1|||
125250168|NCT04495478|450539710|FG004|Overall Study|Withdrawal by Subject|0|||
125250169|NCT04495478|450539711|FG005|Overall Study|Withdrawal by Subject|0|||
125250170|NCT04495478|450539712|FG006|Overall Study|Withdrawal by Subject|0|||
125250171|NCT04495478|450539706|FG000|Overall Study|Physician Decision|0|||
125250172|NCT04495478|450539707|FG001|Overall Study|Physician Decision|1|||
125250173|NCT04495478|450539708|FG002|Overall Study|Physician Decision|0|||
125250174|NCT04495478|450539709|FG003|Overall Study|Physician Decision|0|||
125250175|NCT04495478|450539710|FG004|Overall Study|Physician Decision|1|||
125250176|NCT04495478|450539711|FG005|Overall Study|Physician Decision|0|||
125250177|NCT04495478|450539712|FG006|Overall Study|Physician Decision|0|||
125250178|NCT03312114|450541673|FG000|Overall Study|All the five enrolled dropped out of the|5|||
125250179|NCT00944645|450541674|FG000|Period 2|Adverse Event|1|||
125250180|NCT00944645|450541675|FG001|Period 2|Adverse Event|0|||
125250181|NCT00944645|450541674|FG000|Period 2|Lost to Follow-up|0|||
125250182|NCT00944645|450541675|FG001|Period 2|Lost to Follow-up|3|||
125250183|NCT00944645|450541674|FG000|Period 2|Withdrawal by Subject|7|||
125250184|NCT00944645|450541675|FG001|Period 2|Withdrawal by Subject|6|||
125250185|NCT03537729|450541676|FG000|Overall Study|Death|2|||
125250186|NCT03537729|450541677|FG001|Overall Study|Death|2|||
125250187|NCT03537729|450541678|FG002|Overall Study|Death|7|||
125250188|NCT03537729|450541676|FG000|Overall Study|Withdrawal by Subject|3|||
125250189|NCT03537729|450541677|FG001|Overall Study|Withdrawal by Subject|3|||
125250190|NCT03537729|450541678|FG002|Overall Study|Withdrawal by Subject|0|||
125250191|NCT03537729|450541676|FG000|Overall Study|Subject Moved|8|||
125250192|NCT03537729|450541677|FG001|Overall Study|Subject Moved|5|||
125250193|NCT03537729|450541678|FG002|Overall Study|Subject Moved|4|||
125250194|NCT03537729|450541676|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
125250195|NCT03537729|450541677|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
125250196|NCT03537729|450541678|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
125250197|NCT03537729|450541676|FG000|Overall Study|COVID-19 Site Restrictions|11|||
125250198|NCT03537729|450541677|FG001|Overall Study|COVID-19 Site Restrictions|15|||
125250199|NCT03537729|450541678|FG002|Overall Study|COVID-19 Site Restrictions|18|||
125250200|NCT03537729|450541676|FG000|Overall Study|Decline in Health|5|||
125250201|NCT03537729|450541677|FG001|Overall Study|Decline in Health|9|||
125250202|NCT03537729|450541678|FG002|Overall Study|Decline in Health|4|||
125250203|NCT03537729|450541676|FG000|Overall Study|Determined Ineligible|0|||
125250204|NCT03537729|450541677|FG001|Overall Study|Determined Ineligible|0|||
125250205|NCT03537729|450541678|FG002|Overall Study|Determined Ineligible|1|||
125250206|NCT02562040|450541680|FG000|Overall Study|Lost to Follow-up|20|||
125250207|NCT02562040|450541681|FG001|Overall Study|Lost to Follow-up|28|||
125250208|NCT02562040|450541680|FG000|Overall Study|Withdrawal by Subject|8|||
125250209|NCT02562040|450541681|FG001|Overall Study|Withdrawal by Subject|7|||
125250210|NCT02562040|450541680|FG000|Overall Study|Adverse Event|1|||
125250211|NCT02562040|450541681|FG001|Overall Study|Adverse Event|0|||
125250212|NCT01654250|450541682|FG000|Overall Study|Lost to Follow-up|1|||
125250213|NCT01654250|450541683|FG001|Overall Study|Lost to Follow-up|0|||
125250214|NCT01862029|450541684|FG000|Overall Study|Physician Decision|1|||
125250215|NCT00504556|450541685|FG000|Overall Study|Adverse Event|11|||
125250216|NCT00504556|450541686|FG001|Overall Study|Adverse Event|11|||
125250217|NCT00504556|450541687|FG002|Overall Study|Adverse Event|14|||
125250218|NCT00504556|450541688|FG003|Overall Study|Adverse Event|13|||
125250219|NCT00504556|450541689|FG004|Overall Study|Adverse Event|5|||
125250220|NCT00504556|450541685|FG000|Overall Study|Death|3|||
125250221|NCT00504556|450541686|FG001|Overall Study|Death|3|||
125250222|NCT00504556|450541687|FG002|Overall Study|Death|1|||
125250223|NCT00504556|450541688|FG003|Overall Study|Death|0|||
125250224|NCT00504556|450541689|FG004|Overall Study|Death|2|||
125250225|NCT00504556|450541685|FG000|Overall Study|Protocol Violation|1|||
125250226|NCT00504556|450541686|FG001|Overall Study|Protocol Violation|3|||
125250227|NCT00504556|450541687|FG002|Overall Study|Protocol Violation|2|||
125250228|NCT00504556|450541688|FG003|Overall Study|Protocol Violation|1|||
125250229|NCT00504556|450541689|FG004|Overall Study|Protocol Violation|2|||
125250230|NCT00504556|450541685|FG000|Overall Study|Lost to Follow-up|0|||
125250231|NCT00504556|450541686|FG001|Overall Study|Lost to Follow-up|0|||
125250232|NCT00504556|450541687|FG002|Overall Study|Lost to Follow-up|1|||
125250233|NCT00504556|450541688|FG003|Overall Study|Lost to Follow-up|1|||
125250234|NCT00504556|450541689|FG004|Overall Study|Lost to Follow-up|1|||
125250235|NCT00504556|450541685|FG000|Overall Study|Withdrawal by Subject|16|||
125250236|NCT00504556|450541686|FG001|Overall Study|Withdrawal by Subject|16|||
125250237|NCT00504556|450541687|FG002|Overall Study|Withdrawal by Subject|7|||
125250238|NCT00504556|450541688|FG003|Overall Study|Withdrawal by Subject|8|||
125250239|NCT00504556|450541689|FG004|Overall Study|Withdrawal by Subject|12|||
125250240|NCT00504556|450541685|FG000|Overall Study|administrative reasons|0|||
125250241|NCT00504556|450541686|FG001|Overall Study|administrative reasons|2|||
125250242|NCT00504556|450541687|FG002|Overall Study|administrative reasons|2|||
125250243|NCT00504556|450541688|FG003|Overall Study|administrative reasons|1|||
125250244|NCT00504556|450541689|FG004|Overall Study|administrative reasons|2|||
125250245|NCT00504556|450541685|FG000|Overall Study|did not meet entry criteria|2|||
125250246|NCT00504556|450541686|FG001|Overall Study|did not meet entry criteria|0|||
125250247|NCT00504556|450541687|FG002|Overall Study|did not meet entry criteria|1|||
125250248|NCT00504556|450541688|FG003|Overall Study|did not meet entry criteria|1|||
125250249|NCT00504556|450541689|FG004|Overall Study|did not meet entry criteria|0|||
125250250|NCT00504556|450541685|FG000|Overall Study|data monitor committee decision|0|||
125250251|NCT00504556|450541686|FG001|Overall Study|data monitor committee decision|0|||
125250252|NCT00504556|450541687|FG002|Overall Study|data monitor committee decision|0|||
125250253|NCT00504556|450541688|FG003|Overall Study|data monitor committee decision|100|||
125250254|NCT00504556|450541689|FG004|Overall Study|data monitor committee decision|0|||
125250255|NCT00504556|450541685|FG000|Overall Study|Other|2|||
125250256|NCT00504556|450541686|FG001|Overall Study|Other|2|||
125250257|NCT00504556|450541687|FG002|Overall Study|Other|2|||
125250258|NCT00504556|450541688|FG003|Overall Study|Other|3|||
125444116|NCT01474512|451253888|FG008|Induction Period|Sponsor Decision|0|||
125444117|NCT01474512|451253889|FG009|Induction Period|Sponsor Decision|0|||
125444118|NCT01474512|451253890|FG010|Induction Period|Sponsor Decision|0|||
125250259|NCT00504556|450541689|FG004|Overall Study|Other|0|||
125250260|NCT00504556|450541685|FG000|Overall Study|not in safety analysis set|0|||
125250261|NCT00504556|450541686|FG001|Overall Study|not in safety analysis set|1|||
125250262|NCT00504556|450541687|FG002|Overall Study|not in safety analysis set|1|||
125250263|NCT00504556|450541688|FG003|Overall Study|not in safety analysis set|0|||
125250264|NCT00504556|450541689|FG004|Overall Study|not in safety analysis set|1|||
125250265|NCT01013870|450541690|FG000|Overall Study|Lost to Follow-up|1|||
125250266|NCT01013870|450541691|FG001|Overall Study|Lost to Follow-up|3|||
125250267|NCT01386645|450541692|FG000|Overall Study|Physician Decision|0|||
125250268|NCT01386645|450541693|FG001|Overall Study|Physician Decision|0|||
125250269|NCT01386645|450541694|FG002|Overall Study|Physician Decision|1|||
125250270|NCT01386645|450541692|FG000|Overall Study|Withdrawal by Subject|0|||
125250271|NCT01386645|450541693|FG001|Overall Study|Withdrawal by Subject|1|||
125250272|NCT01386645|450541694|FG002|Overall Study|Withdrawal by Subject|1|||
125250273|NCT03142451|450541704|FG000|Overall Study|Adverse Event|5|||
125250274|NCT03142451|450541705|FG001|Overall Study|Adverse Event|2|||
125250275|NCT03142451|450541704|FG000|Overall Study|Lost to Follow-up|25|||
125250276|NCT03142451|450541705|FG001|Overall Study|Lost to Follow-up|8|||
125250277|NCT03142451|450541704|FG000|Overall Study|Participant request|24|||
125250278|NCT03142451|450541705|FG001|Overall Study|Participant request|12|||
125250279|NCT03142451|450541704|FG000|Overall Study|Protocol Violation|3|||
125250280|NCT03142451|450541705|FG001|Overall Study|Protocol Violation|1|||
125250281|NCT03142451|450541704|FG000|Overall Study|Other|1|||
125250282|NCT03142451|450541705|FG001|Overall Study|Other|1|||
125250283|NCT02773537|450541723|FG000|Overall Study|Lost to Follow-up|0|||
125250284|NCT02773537|450541724|FG001|Overall Study|Lost to Follow-up|1|||
125250285|NCT02773537|450541725|FG002|Overall Study|Lost to Follow-up|4|||
125250286|NCT01840163|450541726|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
125250287|NCT01840163|450541727|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
125250288|NCT01840163|450541726|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
125250289|NCT01840163|450541727|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
125250290|NCT01840163|450541726|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
125250291|NCT01840163|450541727|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
125250292|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
125250293|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
125250294|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
125250295|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
125250296|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
125250297|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
125250298|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
125250299|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
125250300|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
125250301|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
125250302|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
125250303|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
125250304|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Other|6|||
125250305|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Other|3|||
125250306|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Other|0|||
125250307|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
125250308|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
125250309|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
125250310|NCT03636269|450541732|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
125250311|NCT03636269|450541733|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
125250312|NCT03636269|450541734|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
125250313|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Adverse Event|0|||
125250314|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Adverse Event|0|||
125250315|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Adverse Event|21|||
125250316|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
125250317|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
125250318|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
125250319|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
125250320|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
125250321|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
125250322|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
125250323|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
125444119|NCT01474512|451253891|FG011|Induction Period|Sponsor Decision|0|||
125444120|NCT01474512|451253892|FG012|Induction Period|Sponsor Decision|0|||
125250324|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
125444121|NCT01474512|451253893|FG013|Induction Period|Sponsor Decision|0|||
125197227|NCT00537316|450343918|FG004|Part 1|Lost to Follow-up|0|||
125197228|NCT00537316|450343919|FG005|Part 1|Lost to Follow-up|0|||
125197229|NCT00537316|450343920|FG006|Part 1|Lost to Follow-up|0|||
125197230|NCT00537316|450343914|FG000|Part 1|Withdrawal by Subject|3|||
125197231|NCT00537316|450343915|FG001|Part 1|Withdrawal by Subject|8|||
125197232|NCT00537316|450343916|FG002|Part 1|Withdrawal by Subject|4|||
125197233|NCT00537316|450343917|FG003|Part 1|Withdrawal by Subject|0|||
125197234|NCT00537316|450343918|FG004|Part 1|Withdrawal by Subject|0|||
125197235|NCT00537316|450343919|FG005|Part 1|Withdrawal by Subject|0|||
125197236|NCT00537316|450343920|FG006|Part 1|Withdrawal by Subject|0|||
125197237|NCT00537316|450343914|FG000|Part 1|Protocol Violation|1|||
125197238|NCT00537316|450343915|FG001|Part 1|Protocol Violation|5|||
125197239|NCT00537316|450343916|FG002|Part 1|Protocol Violation|1|||
125197240|NCT00537316|450343917|FG003|Part 1|Protocol Violation|0|||
125197241|NCT00537316|450343918|FG004|Part 1|Protocol Violation|0|||
125197242|NCT00537316|450343919|FG005|Part 1|Protocol Violation|0|||
125197243|NCT00537316|450343920|FG006|Part 1|Protocol Violation|0|||
125197244|NCT00537316|450343914|FG000|Part 1|Did not meet protocol eligibility|1|||
125197245|NCT00537316|450343915|FG001|Part 1|Did not meet protocol eligibility|3|||
125197246|NCT00537316|450343916|FG002|Part 1|Did not meet protocol eligibility|2|||
125197247|NCT00537316|450343917|FG003|Part 1|Did not meet protocol eligibility|0|||
125197248|NCT00537316|450343918|FG004|Part 1|Did not meet protocol eligibility|0|||
125197249|NCT00537316|450343919|FG005|Part 1|Did not meet protocol eligibility|0|||
125197250|NCT00537316|450343920|FG006|Part 1|Did not meet protocol eligibility|0|||
125197251|NCT00537316|450343914|FG000|Part 1|Administrative|0|||
125197252|NCT00537316|450343915|FG001|Part 1|Administrative|0|||
125197253|NCT00537316|450343916|FG002|Part 1|Administrative|2|||
125197254|NCT00537316|450343917|FG003|Part 1|Administrative|0|||
125197255|NCT00537316|450343918|FG004|Part 1|Administrative|0|||
125197256|NCT00537316|450343919|FG005|Part 1|Administrative|0|||
125197257|NCT00537316|450343920|FG006|Part 1|Administrative|0|||
125197258|NCT00537316|450343914|FG000|Part 2|Never entered follow-up|0|||
125197259|NCT00537316|450343915|FG001|Part 2|Never entered follow-up|0|||
125197260|NCT00537316|450343916|FG002|Part 2|Never entered follow-up|0|||
125197261|NCT00537316|450343917|FG003|Part 2|Never entered follow-up|0|||
125197262|NCT00537316|450343918|FG004|Part 2|Never entered follow-up|0|||
125197263|NCT00537316|450343919|FG005|Part 2|Never entered follow-up|0|||
125197264|NCT00537316|450343920|FG006|Part 2|Never entered follow-up|1|||
125197265|NCT00537316|450343914|FG000|Part 2|Adverse Event|4|||
125197266|NCT00537316|450343915|FG001|Part 2|Adverse Event|0|||
125197267|NCT00537316|450343916|FG002|Part 2|Adverse Event|2|||
125197268|NCT00537316|450343917|FG003|Part 2|Adverse Event|0|||
125197269|NCT00537316|450343918|FG004|Part 2|Adverse Event|0|||
125197270|NCT00537316|450343919|FG005|Part 2|Adverse Event|0|||
125197271|NCT00537316|450343920|FG006|Part 2|Adverse Event|0|||
125197272|NCT00537316|450343914|FG000|Part 2|Lost to Follow-up|1|||
125197273|NCT00537316|450343915|FG001|Part 2|Lost to Follow-up|0|||
125197274|NCT00537316|450343916|FG002|Part 2|Lost to Follow-up|2|||
125197275|NCT00537316|450343917|FG003|Part 2|Lost to Follow-up|0|||
125197276|NCT00537316|450343918|FG004|Part 2|Lost to Follow-up|0|||
125197277|NCT00537316|450343919|FG005|Part 2|Lost to Follow-up|0|||
125197278|NCT00537316|450343920|FG006|Part 2|Lost to Follow-up|0|||
125197279|NCT00537316|450343914|FG000|Part 2|Withdrawal by Subject|5|||
125197280|NCT00537316|450343915|FG001|Part 2|Withdrawal by Subject|1|||
125197281|NCT00537316|450343916|FG002|Part 2|Withdrawal by Subject|4|||
125197282|NCT00537316|450343917|FG003|Part 2|Withdrawal by Subject|0|||
125197283|NCT00537316|450343918|FG004|Part 2|Withdrawal by Subject|0|||
125197284|NCT00537316|450343919|FG005|Part 2|Withdrawal by Subject|0|||
125197285|NCT00537316|450343920|FG006|Part 2|Withdrawal by Subject|0|||
125197286|NCT00537316|450343914|FG000|Part 2|Administrative|16|||
125197287|NCT00537316|450343915|FG001|Part 2|Administrative|8|||
125197288|NCT00537316|450343916|FG002|Part 2|Administrative|24|||
125197289|NCT00537316|450343917|FG003|Part 2|Administrative|3|||
125197290|NCT00537316|450343918|FG004|Part 2|Administrative|1|||
125197291|NCT00537316|450343919|FG005|Part 2|Administrative|4|||
125197292|NCT00537316|450343920|FG006|Part 2|Administrative|1|||
125197293|NCT01867710|450343921|FG000|Overall Study|Death|25|||
125197294|NCT01867710|450343922|FG001|Overall Study|Death|15|||
125197295|NCT01867710|450343923|FG002|Overall Study|Death|27|||
125197296|NCT01867710|450343924|FG003|Overall Study|Death|20|||
125197297|NCT01867710|450343921|FG000|Overall Study|Lost to Follow-up|3|||
125197298|NCT01867710|450343922|FG001|Overall Study|Lost to Follow-up|4|||
125197299|NCT01867710|450343923|FG002|Overall Study|Lost to Follow-up|3|||
125197300|NCT01867710|450343924|FG003|Overall Study|Lost to Follow-up|2|||
125197301|NCT01867710|450343921|FG000|Overall Study|Withdrawal of consent|2|||
125197302|NCT01867710|450343922|FG001|Overall Study|Withdrawal of consent|5|||
125197303|NCT01867710|450343923|FG002|Overall Study|Withdrawal of consent|1|||
125197304|NCT01867710|450343924|FG003|Overall Study|Withdrawal of consent|2|||
125197305|NCT01867710|450343921|FG000|Overall Study|Study Terminated by Sponsor|9|||
125250325|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Administrative|0|||
125197306|NCT01867710|450343922|FG001|Overall Study|Study Terminated by Sponsor|13|||
125197307|NCT01867710|450343923|FG002|Overall Study|Study Terminated by Sponsor|8|||
125197308|NCT01867710|450343924|FG003|Overall Study|Study Terminated by Sponsor|16|||
125250326|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Administrative|0|||
125250327|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Administrative|36|||
125250328|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Other|0|||
125250329|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Other|0|||
125250330|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Other|9|||
125250331|NCT03636269|450541732|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
125250332|NCT03636269|450541733|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
125250333|NCT03636269|450541734|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
125250334|NCT03774810|450541736|FG000|Phase 1|Lack of Efficacy|21|||
125250335|NCT03774810|450541737|FG001|Phase 1|Lack of Efficacy|0|||
125250336|NCT03774810|450541738|FG002|Phase 1|Lack of Efficacy|0|||
125250337|NCT03774810|450541739|FG003|Phase 1|Lack of Efficacy|0|||
125250338|NCT03774810|450541740|FG004|Phase 1|Lack of Efficacy|0|||
125250339|NCT03774810|450541736|FG000|Phase 1|Withdrawal by Subject|9|||
125250340|NCT03774810|450541737|FG001|Phase 1|Withdrawal by Subject|0|||
125250341|NCT03774810|450541738|FG002|Phase 1|Withdrawal by Subject|0|||
125250342|NCT03774810|450541739|FG003|Phase 1|Withdrawal by Subject|0|||
125250343|NCT03774810|450541740|FG004|Phase 1|Withdrawal by Subject|0|||
125250344|NCT03774810|450541736|FG000|Phase 1|Lost to Follow-up|2|||
125250345|NCT03774810|450541737|FG001|Phase 1|Lost to Follow-up|0|||
125250346|NCT03774810|450541738|FG002|Phase 1|Lost to Follow-up|0|||
125250347|NCT03774810|450541739|FG003|Phase 1|Lost to Follow-up|0|||
125250348|NCT03774810|450541740|FG004|Phase 1|Lost to Follow-up|0|||
125250349|NCT03774810|450541736|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
125250350|NCT03774810|450541737|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
125250351|NCT03774810|450541738|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
125250352|NCT03774810|450541739|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
125250353|NCT03774810|450541740|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
125250354|NCT03774810|450541736|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
125250355|NCT03774810|450541737|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
125250356|NCT03774810|450541738|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
125250357|NCT03774810|450541739|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
125250358|NCT03774810|450541740|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
125250359|NCT03774810|450541736|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
125250360|NCT03774810|450541737|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
125250361|NCT03774810|450541738|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
125250362|NCT03774810|450541739|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
125250363|NCT03774810|450541740|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
125250364|NCT03774810|450541736|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
125250365|NCT03774810|450541737|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
125250366|NCT03774810|450541738|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
125250367|NCT03774810|450541739|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
125250368|NCT03774810|450541740|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
125250369|NCT03774810|450541736|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
125250370|NCT03774810|450541737|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
125250371|NCT03774810|450541738|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
125250372|NCT03774810|450541739|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
125250373|NCT03774810|450541740|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
125250374|NCT03774810|450541736|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
125250375|NCT03774810|450541737|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
125250376|NCT03774810|450541738|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
125250377|NCT03774810|450541739|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
125250378|NCT03774810|450541740|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
125250379|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
125250380|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
125250381|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
125250382|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
125250383|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
125250384|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
125250385|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
125250386|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
125250387|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
125250388|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
125250389|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
125250390|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
125250391|NCT00290758|450541743|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
125250392|NCT00290758|450541744|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
125250393|NCT00290758|450541743|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
125250394|NCT00290758|450541744|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
125250395|NCT03436420|450541745|FG000|Overall Study|Lack of Efficacy|3|||
125444122|NCT01474512|451253894|FG014|Induction Period|Sponsor Decision|0|||
125250396|NCT04914000|450541746|FG000|Overall Study|Lost to Follow-up|8|||
125250397|NCT04914000|450541746|FG000|Overall Study|Withdrawal by Subject|1|||
125250398|NCT01429623|450541747|FG000|Overall Study|Death|1|||
125250399|NCT01429623|450541748|FG001|Overall Study|Death|0|||
125250400|NCT01429623|450541747|FG000|Overall Study|Adverse Event|7|||
125250401|NCT01429623|450541748|FG001|Overall Study|Adverse Event|14|||
125250402|NCT01429623|450541747|FG000|Overall Study|Withdrawal by Subject|19|||
125250403|NCT01429623|450541748|FG001|Overall Study|Withdrawal by Subject|13|||
125250404|NCT01429623|450541747|FG000|Overall Study|Physician Decision|2|||
125250405|NCT01429623|450541748|FG001|Overall Study|Physician Decision|3|||
125250406|NCT01429623|450541747|FG000|Overall Study|Protocol Violation|3|||
125250407|NCT01429623|450541748|FG001|Overall Study|Protocol Violation|2|||
125250408|NCT01429623|450541747|FG000|Overall Study|Assorted|1|||
125250409|NCT01429623|450541748|FG001|Overall Study|Assorted|2|||
125250410|NCT01429623|450541747|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
125250411|NCT01429623|450541748|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
125250412|NCT01429623|450541747|FG000|Overall Study|No post baseline data|4|||
125250413|NCT01429623|450541748|FG001|Overall Study|No post baseline data|4|||
125250414|NCT01896986|450541750|FG000|Overall Study|samples lost|14|||
125250415|NCT01896986|450541751|FG001|Overall Study|samples lost|23|||
125250416|NCT01061710|450541757|FG000|Overall Study|Protocol Violation|14|||
125250417|NCT03757715|450541758|FG000|Overall Study|Lost to Follow-up|4|||
125250418|NCT03757715|450541759|FG001|Overall Study|Lost to Follow-up|9|||
125250419|NCT03757715|450541758|FG000|Overall Study|Withdrawal by Subject|1|||
125250420|NCT03757715|450541759|FG001|Overall Study|Withdrawal by Subject|1|||
125250421|NCT03156621|450541760|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
125250422|NCT03156621|450541761|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
125250423|NCT03156621|450541760|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
125250424|NCT03156621|450541761|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
125250425|NCT03302936|450541762|FG000|Overall Study|Protocol Violation|3|||
125250426|NCT03302936|450541763|FG001|Overall Study|Protocol Violation|4|||
125250427|NCT01259024|450541767|FG000|Overall Study|Physician Decision|1|||
125250428|NCT01657500|450541768|FG000|Overall Study|set impropperly matched|3|||
125250429|NCT01657500|450541769|FG001|Overall Study|set impropperly matched|3|||
125250430|NCT01657500|450541768|FG000|Overall Study|Lost to Follow-up|2|||
125250431|NCT01657500|450541769|FG001|Overall Study|Lost to Follow-up|2|||
125250432|NCT00986102|450541773|FG000|Overall Study|Lost to Follow-up|0|||
125250433|NCT00986102|450541774|FG001|Overall Study|Lost to Follow-up|1|||
125250434|NCT00986102|450541775|FG002|Overall Study|Lost to Follow-up|0|||
125250435|NCT00986102|450541776|FG003|Overall Study|Lost to Follow-up|1|||
125250436|NCT00986102|450541773|FG000|Overall Study|Withdrawal by Subject|1|||
125250437|NCT00986102|450541774|FG001|Overall Study|Withdrawal by Subject|1|||
125250438|NCT00986102|450541775|FG002|Overall Study|Withdrawal by Subject|0|||
125250439|NCT00986102|450541776|FG003|Overall Study|Withdrawal by Subject|0|||
125250440|NCT06083493|450541777|FG000|Overall Study|Technical issues with the interventional device|2|||
125250441|NCT06083493|450541778|FG001|Overall Study|Technical issues with the interventional device|2|||
125250442|NCT06083493|450541777|FG000|Overall Study|Performed incorrect visual task|1|||
125250443|NCT06083493|450541778|FG001|Overall Study|Performed incorrect visual task|0|||
125250444|NCT06083493|450541777|FG000|Overall Study|Insufficient baseline performance|0|||
125250445|NCT06083493|450541778|FG001|Overall Study|Insufficient baseline performance|1|||
125250446|NCT03093870|450541779|FG000|Overall Study|Withdrawal by Subject|2|||
125250447|NCT03093870|450541780|FG001|Overall Study|Withdrawal by Subject|6|||
125250448|NCT03093870|450541781|FG002|Overall Study|Withdrawal by Subject|5|||
125250449|NCT03093870|450541779|FG000|Overall Study|Death|1|||
125250450|NCT03093870|450541780|FG001|Overall Study|Death|35|||
125250451|NCT03093870|450541781|FG002|Overall Study|Death|35|||
125250452|NCT03093870|450541779|FG000|Overall Study|Radiographic disease progression|10|||
125250453|NCT03093870|450541780|FG001|Overall Study|Radiographic disease progression|0|||
125250454|NCT03093870|450541781|FG002|Overall Study|Radiographic disease progression|0|||
125250455|NCT03093870|450541779|FG000|Overall Study|Clinical disease progression|1|||
125250456|NCT03093870|450541780|FG001|Overall Study|Clinical disease progression|0|||
125250457|NCT03093870|450541781|FG002|Overall Study|Clinical disease progression|0|||
125250458|NCT03093870|450541779|FG000|Overall Study|Physician Decision|2|||
125250459|NCT03093870|450541780|FG001|Overall Study|Physician Decision|0|||
125250460|NCT03093870|450541781|FG002|Overall Study|Physician Decision|0|||
125250461|NCT03093870|450541779|FG000|Overall Study|Adverse Event|7|||
125250462|NCT03093870|450541780|FG001|Overall Study|Adverse Event|0|||
125250463|NCT03093870|450541781|FG002|Overall Study|Adverse Event|0|||
125250464|NCT03093870|450541779|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
125250465|NCT03093870|450541780|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
125250466|NCT03093870|450541781|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
125250467|NCT03093870|450541779|FG000|Overall Study|Lost to Follow-up|0|||
125250468|NCT03093870|450541780|FG001|Overall Study|Lost to Follow-up|0|||
125250469|NCT03093870|450541781|FG002|Overall Study|Lost to Follow-up|1|||
125250470|NCT04008069|450541782|FG000|Open-Label Period|Adverse Event|1|||
125250471|NCT04008069|450541783|FG001|Open-Label Period|Adverse Event|0|||
125250472|NCT04008069|450541784|FG002|Open-Label Period|Adverse Event|0|||
125250473|NCT04008069|450541782|FG000|Open-Label Period|Lack of Efficacy|4|||
125250474|NCT04008069|450541783|FG001|Open-Label Period|Lack of Efficacy|0|||
125250475|NCT04008069|450541784|FG002|Open-Label Period|Lack of Efficacy|0|||
125250476|NCT04008069|450541782|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
125250477|NCT04008069|450541783|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
125250478|NCT04008069|450541784|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
125250479|NCT04008069|450541782|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
125250480|NCT04008069|450541783|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
125250481|NCT04008069|450541784|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
125250482|NCT02134028|450541785|FG000|Overall Study|Lack of Efficacy|1|||
125396630|NCT01479621|451085125|FG003|Treatment Period|Protocol Violation|5|||
125396631|NCT01479621|451085126|FG004|Treatment Period|Protocol Violation|2|||
125396632|NCT01479621|451085127|FG005|Treatment Period|Protocol Violation|10|||
125396633|NCT01479621|451085128|FG006|Treatment Period|Protocol Violation|6|||
125396634|NCT01479621|451085122|FG000|Treatment Period|Pregnancy|0|||
125396635|NCT01479621|451085123|FG001|Treatment Period|Pregnancy|0|||
125396636|NCT01479621|451085124|FG002|Treatment Period|Pregnancy|2|||
125396637|NCT01479621|451085125|FG003|Treatment Period|Pregnancy|0|||
125396638|NCT01479621|451085126|FG004|Treatment Period|Pregnancy|0|||
125396639|NCT01479621|451085127|FG005|Treatment Period|Pregnancy|0|||
125396640|NCT01479621|451085128|FG006|Treatment Period|Pregnancy|0|||
125396641|NCT01479621|451085122|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
125396642|NCT01479621|451085123|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
125396643|NCT01479621|451085124|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
125396644|NCT01479621|451085125|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
125396645|NCT01479621|451085126|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
125396646|NCT01479621|451085127|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
125396647|NCT01479621|451085128|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
125396648|NCT01479621|451085122|FG000|Treatment Period|Lost to Follow-up|0|||
125396649|NCT01479621|451085123|FG001|Treatment Period|Lost to Follow-up|0|||
125396650|NCT01479621|451085124|FG002|Treatment Period|Lost to Follow-up|1|||
125396651|NCT01479621|451085125|FG003|Treatment Period|Lost to Follow-up|0|||
125396652|NCT01479621|451085126|FG004|Treatment Period|Lost to Follow-up|2|||
125396653|NCT01479621|451085127|FG005|Treatment Period|Lost to Follow-up|2|||
125396654|NCT01479621|451085128|FG006|Treatment Period|Lost to Follow-up|1|||
125396655|NCT01479621|451085122|FG000|Treatment Period|Met stopping criteria|0|||
125396656|NCT01479621|451085123|FG001|Treatment Period|Met stopping criteria|8|||
125396657|NCT01479621|451085124|FG002|Treatment Period|Met stopping criteria|7|||
125396658|NCT01479621|451085125|FG003|Treatment Period|Met stopping criteria|4|||
125396659|NCT01479621|451085126|FG004|Treatment Period|Met stopping criteria|9|||
125396660|NCT01479621|451085127|FG005|Treatment Period|Met stopping criteria|20|||
125396661|NCT01479621|451085128|FG006|Treatment Period|Met stopping criteria|6|||
125396662|NCT00058825|451085129|FG000|Overall Study|Relapse|9|||
125396663|NCT00058825|451085129|FG000|Overall Study|Progressive Disease|5|||
125396664|NCT00058825|451085129|FG000|Overall Study|Graft Failure|5|||
125396665|NCT00058825|451085129|FG000|Overall Study|Death|3|||
125396666|NCT04399161|451085130|FG000|Overall Study|Withdrawal by Subject|1|||
125396667|NCT04399161|451085131|FG001|Overall Study|Withdrawal by Subject|0|||
125396668|NCT04399161|451085132|FG002|Overall Study|Withdrawal by Subject|2|||
125396669|NCT04399161|451085130|FG000|Overall Study|Protocol Violation|1|||
125396670|NCT04399161|451085131|FG001|Overall Study|Protocol Violation|2|||
125396671|NCT04399161|451085132|FG002|Overall Study|Protocol Violation|0|||
125396672|NCT00477672|451085133|FG000|Overall Study|Adverse Event|3|||
125396673|NCT00477672|451085134|FG001|Overall Study|Adverse Event|5|||
125396674|NCT00477672|451085135|FG002|Overall Study|Adverse Event|6|||
125396675|NCT00477672|451085133|FG000|Overall Study|Death|0|||
125396676|NCT00477672|451085134|FG001|Overall Study|Death|1|||
125396677|NCT00477672|451085135|FG002|Overall Study|Death|0|||
125396678|NCT00477672|451085133|FG000|Overall Study|Disease progression|0|||
125396679|NCT00477672|451085134|FG001|Overall Study|Disease progression|1|||
125396680|NCT00477672|451085135|FG002|Overall Study|Disease progression|0|||
125396681|NCT00477672|451085133|FG000|Overall Study|Physician Decision|1|||
125396682|NCT00477672|451085134|FG001|Overall Study|Physician Decision|0|||
125396683|NCT00477672|451085135|FG002|Overall Study|Physician Decision|0|||
125396684|NCT00477672|451085133|FG000|Overall Study|Protocol noncompliance|0|||
125396685|NCT00477672|451085134|FG001|Overall Study|Protocol noncompliance|2|||
125396686|NCT00477672|451085135|FG002|Overall Study|Protocol noncompliance|0|||
125396687|NCT00477672|451085133|FG000|Overall Study|Consent withdrawn|2|||
125396688|NCT00477672|451085134|FG001|Overall Study|Consent withdrawn|5|||
125396689|NCT00477672|451085135|FG002|Overall Study|Consent withdrawn|10|||
125396690|NCT00477672|451085133|FG000|Overall Study|Discretion of Sponsor|1|||
125396691|NCT00477672|451085134|FG001|Overall Study|Discretion of Sponsor|2|||
125396692|NCT00477672|451085135|FG002|Overall Study|Discretion of Sponsor|0|||
125396693|NCT00838565|451085138|FG000|Overall Study|Withdrawal by Subject|0|||
125396694|NCT00838565|451085139|FG001|Overall Study|Withdrawal by Subject|0|||
125396695|NCT00838565|451085140|FG002|Overall Study|Withdrawal by Subject|1|||
125396696|NCT00838565|451085141|FG003|Overall Study|Withdrawal by Subject|0|||
125396697|NCT00838565|451085142|FG004|Overall Study|Withdrawal by Subject|0|||
125396698|NCT00838565|451085143|FG005|Overall Study|Withdrawal by Subject|2|||
125396699|NCT00838565|451085138|FG000|Overall Study|Other|0|||
125396700|NCT00838565|451085139|FG001|Overall Study|Other|2|||
125396701|NCT00838565|451085140|FG002|Overall Study|Other|0|||
125396702|NCT00838565|451085141|FG003|Overall Study|Other|0|||
125396703|NCT00838565|451085142|FG004|Overall Study|Other|0|||
125396704|NCT00838565|451085143|FG005|Overall Study|Other|0|||
125396705|NCT00838565|451085138|FG000|Overall Study|Randomized but not Treated|0|||
125396706|NCT00838565|451085139|FG001|Overall Study|Randomized but not Treated|1|||
125396707|NCT00838565|451085140|FG002|Overall Study|Randomized but not Treated|0|||
125396708|NCT00838565|451085141|FG003|Overall Study|Randomized but not Treated|0|||
125396709|NCT00838565|451085142|FG004|Overall Study|Randomized but not Treated|0|||
125396710|NCT00838565|451085143|FG005|Overall Study|Randomized but not Treated|0|||
125396711|NCT03571516|451085144|FG000|Overall Study|Severe diarrhea|1|||
125396712|NCT03571516|451085145|FG001|Overall Study|Severe diarrhea|0|||
125396713|NCT03571516|451085144|FG000|Overall Study|Withdrawal by Subject|0|||
125396714|NCT03571516|451085145|FG001|Overall Study|Withdrawal by Subject|1|||
125396715|NCT04011410|451085150|FG000|Overall Study|Withdrawal by Subject|1|||
125396716|NCT01838642|451085152|FG000|Overall Study|Died on study|1|||
125396717|NCT01398956|451085153|FG000|Overall Study|Withdrawal by Subject|4|||
125396718|NCT01398956|451085153|FG000|Overall Study|AE, non-serious non-fatal|4|||
125396719|NCT01398956|451085153|FG000|Overall Study|Withdrawal Criteria No.3|1|||
125396720|NCT01398956|451085153|FG000|Overall Study|Subject moved a long distance|1|||
125396721|NCT01557400|451085154|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
125396722|NCT01557400|451085154|FG000|Overall Study|Adverse Event|3|||
125396723|NCT01557400|451085154|FG000|Overall Study|Lost to Follow-up|5|||
125396724|NCT01557400|451085154|FG000|Overall Study|Withdrawal by Subject|9|||
125396725|NCT01434290|451085157|FG000|Overall Study|Protocol Violation|6|||
125396726|NCT01434290|451085158|FG001|Overall Study|Protocol Violation|3|||
125396727|NCT01434290|451085157|FG000|Overall Study|No protocol treatment|2|||
125396728|NCT01434290|451085158|FG001|Overall Study|No protocol treatment|4|||
125396729|NCT01224639|451085159|FG000|Overall Study|Withdrawal by Subject|0|||
125396730|NCT01224639|451085160|FG001|Overall Study|Withdrawal by Subject|0|||
125396731|NCT01224639|451085161|FG002|Overall Study|Withdrawal by Subject|0|||
125396732|NCT01224639|451085162|FG003|Overall Study|Withdrawal by Subject|0|||
125396733|NCT01224639|451085163|FG004|Overall Study|Withdrawal by Subject|2|||
125396734|NCT01224639|451085164|FG005|Overall Study|Withdrawal by Subject|0|||
125396735|NCT01224639|451085165|FG006|Overall Study|Withdrawal by Subject|1|||
125396736|NCT01224639|451085166|FG007|Overall Study|Withdrawal by Subject|1|||
125396737|NCT01224639|451085159|FG000|Overall Study|Adverse Event|0|||
125396738|NCT01224639|451085160|FG001|Overall Study|Adverse Event|0|||
125396739|NCT01224639|451085161|FG002|Overall Study|Adverse Event|0|||
125396740|NCT01224639|451085162|FG003|Overall Study|Adverse Event|0|||
125396741|NCT01224639|451085163|FG004|Overall Study|Adverse Event|0|||
125396742|NCT01224639|451085164|FG005|Overall Study|Adverse Event|0|||
125396743|NCT01224639|451085165|FG006|Overall Study|Adverse Event|0|||
125396744|NCT01224639|451085166|FG007|Overall Study|Adverse Event|1|||
125396745|NCT03465878|451085167|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
125396746|NCT03465878|451085168|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
125396747|NCT03465878|451085169|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
125396748|NCT03465878|451085170|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
125396749|NCT03465878|451085167|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
125396750|NCT03465878|451085168|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
125396751|NCT03465878|451085169|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
125396752|NCT03465878|451085170|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
125396753|NCT03465878|451085167|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
125396754|NCT03465878|451085168|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
125396755|NCT03465878|451085169|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
125396756|NCT03465878|451085170|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
125396757|NCT01806896|451085171|FG000|Overall Study|Adverse Event|2|||
125396758|NCT01806896|451085172|FG001|Overall Study|Adverse Event|0|||
125396759|NCT01806896|451085171|FG000|Overall Study|Other|1|||
125396760|NCT01806896|451085172|FG001|Overall Study|Other|0|||
125396761|NCT05308901|451086857|FG000|Overall Study|Death|6|||
125396762|NCT00978731|451086858|FG000|Overall Study|Death|4|||
125396763|NCT00978731|451086859|FG001|Overall Study|Death|1|||
125396764|NCT00978731|451086860|FG002|Overall Study|Death|1|||
125396765|NCT00978731|451086861|FG003|Overall Study|Death|0|||
125396766|NCT00978731|451086858|FG000|Overall Study|Lost to Follow-up|0|||
125396767|NCT00978731|451086859|FG001|Overall Study|Lost to Follow-up|0|||
125396768|NCT00978731|451086860|FG002|Overall Study|Lost to Follow-up|0|||
125396769|NCT00978731|451086861|FG003|Overall Study|Lost to Follow-up|1|||
125250483|NCT02134028|450541786|FG001|Overall Study|Lack of Efficacy|0|||
125250484|NCT02134028|450541787|FG002|Overall Study|Lack of Efficacy|3|||
125250485|NCT02134028|450541788|FG003|Overall Study|Lack of Efficacy|2|||
125250486|NCT02134028|450541789|FG004|Overall Study|Lack of Efficacy|1|||
125250487|NCT02134028|450541790|FG005|Overall Study|Lack of Efficacy|2|||
125250488|NCT02134028|450541791|FG006|Overall Study|Lack of Efficacy|1|||
125250489|NCT02134028|450541792|FG007|Overall Study|Lack of Efficacy|0|||
125250490|NCT02134028|450541785|FG000|Overall Study|Poor compliance to protocol|1|||
125250491|NCT02134028|450541786|FG001|Overall Study|Poor compliance to protocol|1|||
125250492|NCT02134028|450541787|FG002|Overall Study|Poor compliance to protocol|3|||
125250493|NCT02134028|450541788|FG003|Overall Study|Poor compliance to protocol|7|||
125250494|NCT02134028|450541789|FG004|Overall Study|Poor compliance to protocol|1|||
125250495|NCT02134028|450541790|FG005|Overall Study|Poor compliance to protocol|1|||
125250496|NCT02134028|450541791|FG006|Overall Study|Poor compliance to protocol|0|||
125250497|NCT02134028|450541792|FG007|Overall Study|Poor compliance to protocol|0|||
125250498|NCT02134028|450541785|FG000|Overall Study|Other unspecified|4|||
125250499|NCT02134028|450541786|FG001|Overall Study|Other unspecified|22|||
125250500|NCT02134028|450541787|FG002|Overall Study|Other unspecified|33|||
125250501|NCT02134028|450541788|FG003|Overall Study|Other unspecified|64|||
125250502|NCT02134028|450541789|FG004|Overall Study|Other unspecified|8|||
125250503|NCT02134028|450541790|FG005|Overall Study|Other unspecified|6|||
125250504|NCT02134028|450541791|FG006|Overall Study|Other unspecified|2|||
125250505|NCT02134028|450541792|FG007|Overall Study|Other unspecified|1|||
125250506|NCT02134028|450541785|FG000|Overall Study|Adverse Event|3|||
125250507|NCT02134028|450541786|FG001|Overall Study|Adverse Event|19|||
125250508|NCT02134028|450541787|FG002|Overall Study|Adverse Event|13|||
125250509|NCT02134028|450541788|FG003|Overall Study|Adverse Event|32|||
125250510|NCT02134028|450541789|FG004|Overall Study|Adverse Event|4|||
125250511|NCT02134028|450541790|FG005|Overall Study|Adverse Event|5|||
125250512|NCT02134028|450541791|FG006|Overall Study|Adverse Event|1|||
125250513|NCT02134028|450541792|FG007|Overall Study|Adverse Event|2|||
125250514|NCT00819832|450541795|FG000|Overall Study|Sponsor Termination of Study|3|||
125250515|NCT00819832|450541796|FG001|Overall Study|Sponsor Termination of Study|0|||
125250516|NCT00819832|450541797|FG002|Overall Study|Sponsor Termination of Study|0|||
125250517|NCT00819832|450541798|FG003|Overall Study|Sponsor Termination of Study|0|||
125250518|NCT00819832|450541799|FG004|Overall Study|Sponsor Termination of Study|0|||
125250519|NCT00819832|450541800|FG005|Overall Study|Sponsor Termination of Study|0|||
125250520|NCT01260311|450541808|FG000|Overall Study|Adverse Event|11|||
125250521|NCT01260311|450541808|FG000|Overall Study|Lack of Efficacy|4|||
125250522|NCT01260311|450541808|FG000|Overall Study|Lost to Follow-up|25|||
125250523|NCT01260311|450541808|FG000|Overall Study|Withdrawal by Subject|6|||
125250524|NCT01260311|450541808|FG000|Overall Study|Financial Constraints|77|||
125250525|NCT01260311|450541808|FG000|Overall Study|Gone to Province|2|||
125250526|NCT01260311|450541808|FG000|Overall Study|Medication Stopped|1|||
125250527|NCT01260311|450541808|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
125250528|NCT01452789|450541809|FG000|Overall Study|Withdrawal by Subject|3|||
125250529|NCT01452789|450541810|FG001|Overall Study|Withdrawal by Subject|2|||
125250530|NCT00066170|450541811|FG000|Overall Study|Adverse Event|2|||
125250531|NCT00066170|450541812|FG001|Overall Study|Adverse Event|4|||
125250532|NCT00066170|450541813|FG002|Overall Study|Adverse Event|1|||
125250533|NCT00066170|450541814|FG003|Overall Study|Adverse Event|7|||
125250534|NCT00066170|450541811|FG000|Overall Study|Serious Adverse Event|0|||
125250535|NCT00066170|450541812|FG001|Overall Study|Serious Adverse Event|0|||
125250536|NCT00066170|450541813|FG002|Overall Study|Serious Adverse Event|1|||
125250537|NCT00066170|450541814|FG003|Overall Study|Serious Adverse Event|1|||
125250538|NCT00066170|450541811|FG000|Overall Study|Lost to Follow-up|0|||
125250539|NCT00066170|450541812|FG001|Overall Study|Lost to Follow-up|1|||
125250540|NCT00066170|450541813|FG002|Overall Study|Lost to Follow-up|0|||
125250541|NCT00066170|450541814|FG003|Overall Study|Lost to Follow-up|0|||
125250542|NCT00066170|450541811|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
125250543|NCT00066170|450541812|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
125444123|NCT01474512|451253895|FG015|Induction Period|Sponsor Decision|0|||
125250544|NCT00066170|450541813|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
125250545|NCT00066170|450541814|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
125250546|NCT00066170|450541811|FG000|Overall Study|Protocol Violation|3|||
125250547|NCT00066170|450541812|FG001|Overall Study|Protocol Violation|0|||
125250548|NCT00066170|450541813|FG002|Overall Study|Protocol Violation|0|||
125444124|NCT01474512|451253896|FG016|Induction Period|Sponsor Decision|0|||
125250549|NCT00066170|450541814|FG003|Overall Study|Protocol Violation|0|||
125250550|NCT00066170|450541811|FG000|Overall Study|Other|1|||
125250551|NCT00066170|450541812|FG001|Overall Study|Other|5|||
125250552|NCT00066170|450541813|FG002|Overall Study|Other|2|||
125250553|NCT00066170|450541814|FG003|Overall Study|Other|0|||
125250554|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Adverse Event|14|||
125250555|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Adverse Event|27|||
125250556|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Adverse Event|60|||
125250557|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Adverse Event|0|||
125444125|NCT01474512|451253897|FG017|Induction Period|Sponsor Decision|0|||
125197309|NCT01867710|450343921|FG000|Overall Study|Biochemical progression|0|||
125197310|NCT01867710|450343922|FG001|Overall Study|Biochemical progression|1|||
125197311|NCT01867710|450343923|FG002|Overall Study|Biochemical progression|0|||
125197312|NCT01867710|450343924|FG003|Overall Study|Biochemical progression|0|||
125197313|NCT01867710|450343921|FG000|Overall Study|Clinical progression|0|||
125197314|NCT01867710|450343922|FG001|Overall Study|Clinical progression|0|||
125197315|NCT01867710|450343923|FG002|Overall Study|Clinical progression|1|||
125197316|NCT01867710|450343924|FG003|Overall Study|Clinical progression|0|||
125197317|NCT01867710|450343921|FG000|Overall Study|Disease progression|1|||
125197318|NCT01867710|450343922|FG001|Overall Study|Disease progression|0|||
125197319|NCT01867710|450343923|FG002|Overall Study|Disease progression|0|||
125197320|NCT01867710|450343924|FG003|Overall Study|Disease progression|0|||
125197321|NCT01867710|450343921|FG000|Overall Study|Patient decision|0|||
125197322|NCT01867710|450343922|FG001|Overall Study|Patient decision|0|||
125197323|NCT01867710|450343923|FG002|Overall Study|Patient decision|0|||
125197324|NCT01867710|450343924|FG003|Overall Study|Patient decision|1|||
125197325|NCT01867710|450343921|FG000|Overall Study|Patient to follow subsequent treatment|0|||
125197326|NCT01867710|450343922|FG001|Overall Study|Patient to follow subsequent treatment|1|||
125197327|NCT01867710|450343923|FG002|Overall Study|Patient to follow subsequent treatment|0|||
125197328|NCT01867710|450343924|FG003|Overall Study|Patient to follow subsequent treatment|0|||
125197329|NCT01867710|450343921|FG000|Overall Study|Progressive disease|1|||
125197330|NCT01867710|450343922|FG001|Overall Study|Progressive disease|0|||
125197331|NCT01867710|450343923|FG002|Overall Study|Progressive disease|0|||
125197332|NCT01867710|450343924|FG003|Overall Study|Progressive disease|0|||
125197333|NCT01867710|450343921|FG000|Overall Study|Protocol Violation|0|||
125197334|NCT01867710|450343922|FG001|Overall Study|Protocol Violation|0|||
125197335|NCT01867710|450343923|FG002|Overall Study|Protocol Violation|0|||
125197336|NCT01867710|450343924|FG003|Overall Study|Protocol Violation|1|||
125197337|NCT01867710|450343921|FG000|Overall Study|PSA-progression|0|||
125197338|NCT01867710|450343922|FG001|Overall Study|PSA-progression|1|||
125197339|NCT01867710|450343923|FG002|Overall Study|PSA-progression|0|||
125197340|NCT01867710|450343924|FG003|Overall Study|PSA-progression|0|||
125197341|NCT01867710|450343921|FG000|Overall Study|Study medication no longer effective|0|||
125197342|NCT01867710|450343922|FG001|Overall Study|Study medication no longer effective|1|||
125197343|NCT01867710|450343923|FG002|Overall Study|Study medication no longer effective|0|||
125197344|NCT01867710|450343924|FG003|Overall Study|Study medication no longer effective|0|||
125197345|NCT01062113|450343925|FG000|Overall Study|Adverse Event|1|||
125197346|NCT01062113|450343926|FG001|Overall Study|Adverse Event|0|||
125197347|NCT01062113|450343927|FG002|Overall Study|Adverse Event|0|||
125197348|NCT01062113|450343925|FG000|Overall Study|Lack of Efficacy|38|||
125197349|NCT01062113|450343926|FG001|Overall Study|Lack of Efficacy|22|||
125197350|NCT01062113|450343927|FG002|Overall Study|Lack of Efficacy|31|||
125197351|NCT01062113|450343925|FG000|Overall Study|Withdrawal by Subject|1|||
125197352|NCT01062113|450343926|FG001|Overall Study|Withdrawal by Subject|0|||
125197353|NCT01062113|450343927|FG002|Overall Study|Withdrawal by Subject|0|||
125197354|NCT01082211|450343938|FG000|Overall Study|Protocol Violation|4|||
125197355|NCT01082211|450343938|FG000|Overall Study|No protocol treatment received|3|||
125197356|NCT03702010|450343941|FG000|Follow-up (30days)|Lack of Efficacy|2|||
125197357|NCT03702010|450343942|FG001|Follow-up (30days)|Lack of Efficacy|2|||
125197358|NCT01137110|450343949|FG000|Overall Study|Protocol Violation|1|||
125197359|NCT01137110|450343950|FG001|Overall Study|Protocol Violation|0|||
125197360|NCT02394340|450343957|FG000|Overall Study|Failed drug screen test|1|||
125197361|NCT02394340|450343957|FG000|Overall Study|Adverse Event|1|||
125197362|NCT00256854|450343958|FG000|Overall Study|Withdrawal by Subject|2|||
125197363|NCT00256854|450343959|FG001|Overall Study|Withdrawal by Subject|3|||
125197364|NCT00256854|450343960|FG002|Overall Study|Withdrawal by Subject|0|||
125197365|NCT00256854|450343961|FG003|Overall Study|Withdrawal by Subject|0|||
125197366|NCT00256854|450343962|FG004|Overall Study|Withdrawal by Subject|0|||
125197367|NCT00256854|450343963|FG005|Overall Study|Withdrawal by Subject|0|||
125197368|NCT00256854|450343958|FG000|Overall Study|Lack of Efficacy|1|||
125197369|NCT00256854|450343959|FG001|Overall Study|Lack of Efficacy|0|||
125197370|NCT00256854|450343960|FG002|Overall Study|Lack of Efficacy|0|||
125197371|NCT00256854|450343961|FG003|Overall Study|Lack of Efficacy|0|||
125197372|NCT00256854|450343962|FG004|Overall Study|Lack of Efficacy|0|||
125197373|NCT00256854|450343963|FG005|Overall Study|Lack of Efficacy|0|||
125197374|NCT00256854|450343958|FG000|Overall Study|Protocol Violation|0|||
125197375|NCT00256854|450343959|FG001|Overall Study|Protocol Violation|1|||
125197376|NCT00256854|450343960|FG002|Overall Study|Protocol Violation|1|||
125197377|NCT00256854|450343961|FG003|Overall Study|Protocol Violation|1|||
125197378|NCT00256854|450343962|FG004|Overall Study|Protocol Violation|0|||
125197379|NCT00256854|450343963|FG005|Overall Study|Protocol Violation|0|||
125197380|NCT00256854|450343958|FG000|Overall Study|Adverse Event|0|||
125197381|NCT00256854|450343959|FG001|Overall Study|Adverse Event|0|||
125444126|NCT01474512|451253880|FG000|Induction Period|Lost to Follow-up|1|||
125197382|NCT00256854|450343960|FG002|Overall Study|Adverse Event|2|||
125197383|NCT00256854|450343961|FG003|Overall Study|Adverse Event|2|||
125250558|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Adverse Event|0|||
125250559|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Pregnancy|0|||
125250560|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Pregnancy|7|||
125250561|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Pregnancy|9|||
125250562|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Pregnancy|0|||
125250563|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Pregnancy|0|||
125250564|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
125250565|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
125250566|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
125250567|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
125250568|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
125250569|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
125250570|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
125250571|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
125250572|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
125250573|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
125250574|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Death|1|||
125250575|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Death|2|||
125250576|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Death|2|||
125250577|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Death|0|||
125250578|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Death|0|||
125250579|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
125250580|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
125250581|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
125250582|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
125250583|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
125250584|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
125250585|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
125250586|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
125250587|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
125250588|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
125250589|NCT00098293|450541815|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
125250590|NCT00098293|450541816|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
125250591|NCT00098293|450541817|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
125250592|NCT00098293|450541818|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
125250593|NCT00098293|450541819|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
125250594|NCT00098293|450541815|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
125250595|NCT00098293|450541816|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
125250596|NCT00098293|450541817|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
125250597|NCT00098293|450541818|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
125250598|NCT00098293|450541819|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
125250599|NCT00098293|450541815|FG000|Open-label (OL) Phase|Adverse Event|0|||
125250600|NCT00098293|450541816|FG001|Open-label (OL) Phase|Adverse Event|3|||
125250601|NCT00098293|450541817|FG002|Open-label (OL) Phase|Adverse Event|7|||
125250602|NCT00098293|450541818|FG003|Open-label (OL) Phase|Adverse Event|6|||
125250603|NCT00098293|450541819|FG004|Open-label (OL) Phase|Adverse Event|0|||
125250604|NCT00098293|450541815|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
125250605|NCT00098293|450541816|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
125250606|NCT00098293|450541817|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
125250607|NCT00098293|450541818|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
125250608|NCT00098293|450541819|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
125250609|NCT00098293|450541815|FG000|Open-label (OL) Phase|Pregnancy|0|||
125250610|NCT00098293|450541816|FG001|Open-label (OL) Phase|Pregnancy|1|||
125250611|NCT00098293|450541817|FG002|Open-label (OL) Phase|Pregnancy|0|||
125250612|NCT00098293|450541818|FG003|Open-label (OL) Phase|Pregnancy|3|||
125250613|NCT00098293|450541819|FG004|Open-label (OL) Phase|Pregnancy|0|||
125250614|NCT00098293|450541815|FG000|Open-label (OL) Phase|Protocol Violation|0|||
125250615|NCT00098293|450541816|FG001|Open-label (OL) Phase|Protocol Violation|6|||
125250616|NCT00098293|450541817|FG002|Open-label (OL) Phase|Protocol Violation|13|||
125250617|NCT00098293|450541818|FG003|Open-label (OL) Phase|Protocol Violation|16|||
125250618|NCT00098293|450541819|FG004|Open-label (OL) Phase|Protocol Violation|0|||
125250619|NCT00098293|450541815|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
125250620|NCT00098293|450541816|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
125250621|NCT00098293|450541817|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
125250622|NCT00098293|450541818|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
125250623|NCT00098293|450541819|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
125250624|NCT00098293|450541815|FG000|Open-label (OL) Phase|Death|0|||
125250625|NCT00098293|450541816|FG001|Open-label (OL) Phase|Death|2|||
125250626|NCT00098293|450541817|FG002|Open-label (OL) Phase|Death|3|||
125250627|NCT00098293|450541818|FG003|Open-label (OL) Phase|Death|0|||
125250628|NCT00098293|450541819|FG004|Open-label (OL) Phase|Death|0|||
125250629|NCT00098293|450541815|FG000|Supplemental Phase (SP)|Death|0|||
125250630|NCT00098293|450541816|FG001|Supplemental Phase (SP)|Death|0|||
125250631|NCT00098293|450541817|FG002|Supplemental Phase (SP)|Death|0|||
125250632|NCT00098293|450541818|FG003|Supplemental Phase (SP)|Death|0|||
125250633|NCT00098293|450541819|FG004|Supplemental Phase (SP)|Death|1|||
125250634|NCT00098293|450541815|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
125250635|NCT00098293|450541816|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
125250636|NCT00098293|450541817|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
125250637|NCT00098293|450541818|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
125250638|NCT00098293|450541819|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
125250639|NCT00098293|450541815|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
125250640|NCT00098293|450541816|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
125250641|NCT00098293|450541817|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
125250642|NCT00098293|450541818|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
125250643|NCT00098293|450541819|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
125250644|NCT00098293|450541815|FG000|Supplemental Phase (SP)|Other|0|||
125250645|NCT00098293|450541816|FG001|Supplemental Phase (SP)|Other|0|||
125250646|NCT00098293|450541817|FG002|Supplemental Phase (SP)|Other|0|||
125250647|NCT00098293|450541818|FG003|Supplemental Phase (SP)|Other|0|||
125250648|NCT00098293|450541819|FG004|Supplemental Phase (SP)|Other|22|||
125250649|NCT01370642|450541820|FG000|Overall Study|Adverse Event|2|||
125250650|NCT01370642|450541821|FG001|Overall Study|Adverse Event|1|||
125250651|NCT01370642|450541822|FG002|Overall Study|Adverse Event|1|||
125250652|NCT01370642|450541820|FG000|Overall Study|Detectable HCV RNA|0|||
125250653|NCT01370642|450541821|FG001|Overall Study|Detectable HCV RNA|0|||
125250654|NCT01370642|450541822|FG002|Overall Study|Detectable HCV RNA|22|||
125250655|NCT01370642|450541820|FG000|Overall Study|Lost to Follow-up|0|||
125250656|NCT01370642|450541821|FG001|Overall Study|Lost to Follow-up|0|||
125250657|NCT01370642|450541822|FG002|Overall Study|Lost to Follow-up|1|||
125250658|NCT01370642|450541820|FG000|Overall Study|Physician Decision|4|||
125250659|NCT01370642|450541821|FG001|Overall Study|Physician Decision|1|||
125250660|NCT01370642|450541822|FG002|Overall Study|Physician Decision|2|||
125250661|NCT01370642|450541820|FG000|Overall Study|Withdrawal by Subject|2|||
125250662|NCT01370642|450541821|FG001|Overall Study|Withdrawal by Subject|4|||
125250663|NCT01370642|450541822|FG002|Overall Study|Withdrawal by Subject|3|||
125250664|NCT01796470|450541823|FG000|Overall Study|Adverse Event|4|||
125250665|NCT01796470|450541824|FG001|Overall Study|Adverse Event|2|||
125250666|NCT01796470|450541825|FG002|Overall Study|Adverse Event|2|||
125250667|NCT01796470|450541826|FG003|Overall Study|Adverse Event|1|||
125250668|NCT01796470|450541827|FG004|Overall Study|Adverse Event|3|||
125250669|NCT01796470|450541823|FG000|Overall Study|Death|2|||
125250670|NCT01796470|450541824|FG001|Overall Study|Death|0|||
125250671|NCT01796470|450541825|FG002|Overall Study|Death|0|||
125250672|NCT01796470|450541826|FG003|Overall Study|Death|0|||
125250673|NCT01796470|450541827|FG004|Overall Study|Death|1|||
125250674|NCT01796470|450541823|FG000|Overall Study|Initiated New Therapy|9|||
125250675|NCT01796470|450541824|FG001|Overall Study|Initiated New Therapy|0|||
125250676|NCT01796470|450541825|FG002|Overall Study|Initiated New Therapy|0|||
125250677|NCT01796470|450541826|FG003|Overall Study|Initiated New Therapy|0|||
125250678|NCT01796470|450541827|FG004|Overall Study|Initiated New Therapy|2|||
125250679|NCT01796470|450541823|FG000|Overall Study|Lost to Follow-up|0|||
125250680|NCT01796470|450541824|FG001|Overall Study|Lost to Follow-up|1|||
125250681|NCT01796470|450541825|FG002|Overall Study|Lost to Follow-up|0|||
125250682|NCT01796470|450541826|FG003|Overall Study|Lost to Follow-up|0|||
125250683|NCT01796470|450541827|FG004|Overall Study|Lost to Follow-up|0|||
125250684|NCT01796470|450541823|FG000|Overall Study|Physician Decision|5|||
125250685|NCT01796470|450541824|FG001|Overall Study|Physician Decision|4|||
125250686|NCT01796470|450541825|FG002|Overall Study|Physician Decision|1|||
125250687|NCT01796470|450541826|FG003|Overall Study|Physician Decision|0|||
125250688|NCT01796470|450541827|FG004|Overall Study|Physician Decision|1|||
125250689|NCT01796470|450541823|FG000|Overall Study|Progressive Disease|7|||
125250690|NCT01796470|450541824|FG001|Overall Study|Progressive Disease|7|||
125250691|NCT01796470|450541825|FG002|Overall Study|Progressive Disease|3|||
125250692|NCT01796470|450541826|FG003|Overall Study|Progressive Disease|2|||
125250693|NCT01796470|450541827|FG004|Overall Study|Progressive Disease|0|||
125396770|NCT00978731|451086858|FG000|Overall Study|Adverse Event|5|||
125396771|NCT00978731|451086859|FG001|Overall Study|Adverse Event|2|||
125396772|NCT00978731|451086860|FG002|Overall Study|Adverse Event|0|||
125250694|NCT01796470|450541823|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
125250695|NCT01796470|450541824|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
125250696|NCT01796470|450541825|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
125250697|NCT01796470|450541826|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
125250698|NCT01796470|450541827|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
125250699|NCT01796470|450541823|FG000|Overall Study|Withdrawal by Subject|7|||
125250700|NCT01796470|450541824|FG001|Overall Study|Withdrawal by Subject|0|||
125250701|NCT01796470|450541825|FG002|Overall Study|Withdrawal by Subject|0|||
125250702|NCT01796470|450541826|FG003|Overall Study|Withdrawal by Subject|0|||
125250703|NCT01796470|450541827|FG004|Overall Study|Withdrawal by Subject|1|||
125250704|NCT01927861|450541834|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
125250705|NCT01927861|450541835|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
125250706|NCT01927861|450541834|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
125396773|NCT00978731|451086861|FG003|Overall Study|Adverse Event|0|||
125250707|NCT01927861|450541835|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
125250708|NCT00987935|450541836|FG000|Overall Study|Progressive disease|3|||
125250709|NCT00987935|450541837|FG001|Overall Study|Progressive disease|2|||
125250710|NCT00987935|450541838|FG002|Overall Study|Progressive disease|3|||
125250711|NCT00987935|450541839|FG003|Overall Study|Progressive disease|2|||
125250712|NCT00987935|450541840|FG004|Overall Study|Progressive disease|5|||
125250713|NCT00987935|450541841|FG005|Overall Study|Progressive disease|3|||
125250714|NCT00987935|450541842|FG006|Overall Study|Progressive disease|9|||
125250715|NCT00987935|450541843|FG007|Overall Study|Progressive disease|48|||
125250716|NCT00987935|450541844|FG008|Overall Study|Progressive disease|23|||
125250717|NCT00987935|450541836|FG000|Overall Study|Adverse Event|0|||
125250718|NCT00987935|450541837|FG001|Overall Study|Adverse Event|1|||
125250719|NCT00987935|450541838|FG002|Overall Study|Adverse Event|0|||
125250720|NCT00987935|450541839|FG003|Overall Study|Adverse Event|1|||
125250721|NCT00987935|450541840|FG004|Overall Study|Adverse Event|1|||
125250722|NCT00987935|450541841|FG005|Overall Study|Adverse Event|0|||
125250723|NCT00987935|450541842|FG006|Overall Study|Adverse Event|2|||
125250724|NCT00987935|450541843|FG007|Overall Study|Adverse Event|10|||
125250725|NCT00987935|450541844|FG008|Overall Study|Adverse Event|6|||
125250726|NCT00987935|450541836|FG000|Overall Study|Refused to continue taking trial med.|1|||
125250727|NCT00987935|450541837|FG001|Overall Study|Refused to continue taking trial med.|0|||
125250728|NCT00987935|450541838|FG002|Overall Study|Refused to continue taking trial med.|0|||
125250729|NCT00987935|450541839|FG003|Overall Study|Refused to continue taking trial med.|0|||
125250730|NCT00987935|450541840|FG004|Overall Study|Refused to continue taking trial med.|1|||
125250731|NCT00987935|450541841|FG005|Overall Study|Refused to continue taking trial med.|0|||
125250732|NCT00987935|450541842|FG006|Overall Study|Refused to continue taking trial med.|4|||
125250733|NCT00987935|450541843|FG007|Overall Study|Refused to continue taking trial med.|4|||
125250734|NCT00987935|450541844|FG008|Overall Study|Refused to continue taking trial med.|2|||
125250735|NCT00987935|450541836|FG000|Overall Study|Reason other than those specified above|0|||
125250736|NCT00987935|450541837|FG001|Overall Study|Reason other than those specified above|0|||
125250737|NCT00987935|450541838|FG002|Overall Study|Reason other than those specified above|0|||
125250738|NCT00987935|450541839|FG003|Overall Study|Reason other than those specified above|0|||
125250739|NCT00987935|450541840|FG004|Overall Study|Reason other than those specified above|0|||
125250740|NCT00987935|450541841|FG005|Overall Study|Reason other than those specified above|0|||
125250741|NCT00987935|450541842|FG006|Overall Study|Reason other than those specified above|0|||
125250742|NCT00987935|450541843|FG007|Overall Study|Reason other than those specified above|0|||
125250743|NCT00987935|450541844|FG008|Overall Study|Reason other than those specified above|1|||
125250744|NCT01089543|450541845|FG000|Overall Study|Withdrawal by Subject|2|||
125250745|NCT01089543|450541846|FG001|Overall Study|Withdrawal by Subject|3|||
125250746|NCT01089543|450541847|FG002|Overall Study|Withdrawal by Subject|3|||
125250747|NCT01089543|450541848|FG003|Overall Study|Withdrawal by Subject|1|||
125250748|NCT01089543|450541845|FG000|Overall Study|Physician Decision|1|||
125250749|NCT01089543|450541846|FG001|Overall Study|Physician Decision|0|||
125250750|NCT01089543|450541847|FG002|Overall Study|Physician Decision|0|||
125250751|NCT01089543|450541848|FG003|Overall Study|Physician Decision|1|||
125250752|NCT01089543|450541845|FG000|Overall Study|Adverse Event|0|||
125250753|NCT01089543|450541846|FG001|Overall Study|Adverse Event|1|||
125250754|NCT01089543|450541847|FG002|Overall Study|Adverse Event|0|||
125250755|NCT01089543|450541848|FG003|Overall Study|Adverse Event|0|||
125250756|NCT01248468|450541850|FG000|Overall Study|Administrative problem|1|||
125250757|NCT01248468|450541851|FG001|Overall Study|Administrative problem|0|||
125250758|NCT01248468|450541852|FG002|Overall Study|Administrative problem|0|||
125250759|NCT01248468|450541850|FG000|Overall Study|Lost to Follow-up|9|||
125250760|NCT01248468|450541851|FG001|Overall Study|Lost to Follow-up|12|||
125250761|NCT01248468|450541852|FG002|Overall Study|Lost to Follow-up|4|||
125250762|NCT01248468|450541850|FG000|Overall Study|Pregnancy|1|||
125250763|NCT01248468|450541851|FG001|Overall Study|Pregnancy|0|||
125250764|NCT01248468|450541852|FG002|Overall Study|Pregnancy|0|||
125250765|NCT01248468|450541850|FG000|Overall Study|Withdrawal by Subject|4|||
125250766|NCT01248468|450541851|FG001|Overall Study|Withdrawal by Subject|2|||
125250767|NCT01248468|450541852|FG002|Overall Study|Withdrawal by Subject|0|||
125250768|NCT00345592|450541853|FG000|Overall Study|Death|14|||
125444127|NCT01474512|451253881|FG001|Induction Period|Lost to Follow-up|0|||
125250769|NCT00345592|450541854|FG001|Overall Study|Death|16|||
125250770|NCT00345592|450541853|FG000|Overall Study|Withdrawal by Subject|11|||
125250771|NCT00345592|450541854|FG001|Overall Study|Withdrawal by Subject|8|||
125250772|NCT02176525|450541856|FG000|Overall Study|Adverse Event|0|||
125250773|NCT02176525|450541857|FG001|Overall Study|Adverse Event|0|||
125250774|NCT02176525|450541858|FG002|Overall Study|Adverse Event|0|||
125250775|NCT02176525|450541859|FG003|Overall Study|Adverse Event|1|||
125250776|NCT02176525|450541860|FG004|Overall Study|Adverse Event|1|||
125250777|NCT02176525|450541861|FG005|Overall Study|Adverse Event|0|||
125250778|NCT02176525|450541862|FG006|Overall Study|Adverse Event|1|||
125250779|NCT02176525|450541863|FG007|Overall Study|Adverse Event|0|||
125250780|NCT02176525|450541856|FG000|Overall Study|not treated|1|||
125250781|NCT02176525|450541857|FG001|Overall Study|not treated|0|||
125250782|NCT02176525|450541858|FG002|Overall Study|not treated|0|||
125250783|NCT02176525|450541859|FG003|Overall Study|not treated|0|||
125250784|NCT02176525|450541860|FG004|Overall Study|not treated|0|||
125250785|NCT02176525|450541861|FG005|Overall Study|not treated|1|||
125250786|NCT02176525|450541862|FG006|Overall Study|not treated|0|||
125250787|NCT02176525|450541863|FG007|Overall Study|not treated|0|||
125250788|NCT00468546|450541864|FG000|Week 24 Analysis|Lack of Efficacy|83|||
125250789|NCT00468546|450541865|FG001|Week 24 Analysis|Lack of Efficacy|37|||
125250790|NCT00468546|450541864|FG000|Week 24 Analysis|Refused treatment|5|||
125250791|NCT00468546|450541865|FG001|Week 24 Analysis|Refused treatment|5|||
125250792|NCT00468546|450541864|FG000|Week 24 Analysis|Adverse Event|1|||
125250793|NCT00468546|450541865|FG001|Week 24 Analysis|Adverse Event|8|||
125250794|NCT00468546|450541864|FG000|Week 24 Analysis|Failure to return|3|||
125250795|NCT00468546|450541865|FG001|Week 24 Analysis|Failure to return|4|||
125250796|NCT00468546|450541864|FG000|Week 24 Analysis|Rescue therapy|2|||
125250797|NCT00468546|450541865|FG001|Week 24 Analysis|Rescue therapy|0|||
125250798|NCT00468546|450541864|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
125250799|NCT00468546|450541865|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
125250800|NCT00468546|450541864|FG000|Week 24 Analysis|Due to clinical hold|1|||
125250801|NCT00468546|450541865|FG001|Week 24 Analysis|Due to clinical hold|0|||
125250802|NCT00468546|450541864|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
125250803|NCT00468546|450541865|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
125250804|NCT00468546|450541864|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
125250805|NCT00468546|450541865|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
125250806|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
125250807|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
125250808|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Death|1|||
125250809|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Death|0|||
125250810|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
125250811|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
125250812|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
125250813|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
125250814|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
125250815|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
125250816|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
125250817|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
125250818|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
125250819|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
125250820|NCT00468546|450541864|FG000|Week 24 to Week 104 Analysis|Other|17|||
125250821|NCT00468546|450541865|FG001|Week 24 to Week 104 Analysis|Other|14|||
125250822|NCT00450749|450541871|FG000|Overall Study|Withdrawal by Subject|0|||
125250823|NCT00450749|450541872|FG001|Overall Study|Withdrawal by Subject|0|||
125250824|NCT00450749|450541873|FG002|Overall Study|Withdrawal by Subject|2|||
125250825|NCT00450749|450541871|FG000|Overall Study|Noncompliant|0|||
125250826|NCT00450749|450541872|FG001|Overall Study|Noncompliant|1|||
125250827|NCT00450749|450541873|FG002|Overall Study|Noncompliant|0|||
125250828|NCT01245049|450541874|FG000|Overall Study|Migrated/moved from study area|0|||
125250829|NCT01245049|450541875|FG001|Overall Study|Migrated/moved from study area|1|||
125250830|NCT01245049|450541874|FG000|Overall Study|Withdrawal by Subject|0|||
125250831|NCT01245049|450541875|FG001|Overall Study|Withdrawal by Subject|1|||
125250832|NCT01245049|450541874|FG000|Overall Study|Lost to Follow-up|1|||
125250833|NCT01245049|450541875|FG001|Overall Study|Lost to Follow-up|2|||
125250834|NCT01213251|450544041|FG000|Overall Study|Death|2|||
125250835|NCT01213251|450544042|FG001|Overall Study|Death|1|||
125250836|NCT01213251|450544043|FG002|Overall Study|Death|2|||
125250837|NCT01213251|450544041|FG000|Overall Study|Exit|3|||
125250838|NCT01213251|450544042|FG001|Overall Study|Exit|2|||
125250839|NCT01213251|450544043|FG002|Overall Study|Exit|8|||
125250840|NCT01213251|450544041|FG000|Overall Study|Protocol Violation|1|||
125250841|NCT01213251|450544042|FG001|Overall Study|Protocol Violation|1|||
125250842|NCT01213251|450544043|FG002|Overall Study|Protocol Violation|0|||
125250843|NCT01213251|450544041|FG000|Overall Study|Missed 18-Month Follow-up|0|||
125250844|NCT01213251|450544042|FG001|Overall Study|Missed 18-Month Follow-up|0|||
125250845|NCT01213251|450544043|FG002|Overall Study|Missed 18-Month Follow-up|1|||
125250846|NCT02529488|450544044|FG000|Overall Study|Adverse Event|1|||
125250847|NCT02529488|450544044|FG000|Overall Study|Death|3|||
125250848|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
125250849|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
125250850|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
125250851|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
125250852|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
125250853|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
125250854|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
125250855|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
125250856|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
125197384|NCT00256854|450343962|FG004|Overall Study|Adverse Event|0|||
125250857|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
125250858|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
125250859|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
125250860|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
125250861|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
125250862|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
125250863|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
125250864|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
125250865|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
125250866|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
125250867|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
125250868|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
125250869|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
125250870|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
125250871|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
125197385|NCT00256854|450343963|FG005|Overall Study|Adverse Event|1|||
125197386|NCT00256854|450343958|FG000|Overall Study|Not compliant with the study drug|0|||
125197387|NCT00256854|450343959|FG001|Overall Study|Not compliant with the study drug|0|||
125197388|NCT00256854|450343960|FG002|Overall Study|Not compliant with the study drug|0|||
125197389|NCT00256854|450343961|FG003|Overall Study|Not compliant with the study drug|0|||
125197390|NCT00256854|450343962|FG004|Overall Study|Not compliant with the study drug|1|||
125197391|NCT00256854|450343963|FG005|Overall Study|Not compliant with the study drug|0|||
125197392|NCT02004886|450343964|FG000|Overall Study|Adverse Event|0|||
125197393|NCT02004886|450343965|FG001|Overall Study|Adverse Event|1|||
125197394|NCT02004886|450343966|FG002|Overall Study|Adverse Event|0|||
125197395|NCT02004886|450343967|FG003|Overall Study|Adverse Event|0|||
125197396|NCT02004886|450343964|FG000|Overall Study|Unable to attend future visits|1|||
125197397|NCT02004886|450343965|FG001|Overall Study|Unable to attend future visits|0|||
125197398|NCT02004886|450343966|FG002|Overall Study|Unable to attend future visits|0|||
125197399|NCT02004886|450343967|FG003|Overall Study|Unable to attend future visits|0|||
125197400|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
125197401|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
125197402|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
125197403|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
125197404|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
125250872|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
125250873|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
125250874|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
125250875|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
125250876|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
125250877|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
125250878|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
125250879|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
125250880|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
125250881|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
125250882|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
125250883|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
125250884|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
125250885|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
125250886|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
125250887|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
125250888|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
125250889|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
125250890|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
125250891|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
125250892|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
125250893|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
125250894|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
125250895|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
125250896|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
125250897|NCT01557244|450544049|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
125250898|NCT01557244|450544050|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
125250899|NCT01557244|450544051|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
125250900|NCT01557244|450544052|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
125250901|NCT01557244|450544053|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
125250902|NCT01557244|450544054|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
125250903|NCT01557244|450544055|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
125250904|NCT01557244|450544049|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
125250905|NCT01557244|450544050|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
125250906|NCT01557244|450544051|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
125250907|NCT01557244|450544052|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
125250908|NCT01557244|450544053|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
125250909|NCT01557244|450544054|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
125250910|NCT01557244|450544055|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
125250911|NCT01557244|450544049|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
125250912|NCT01557244|450544050|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
125250913|NCT01557244|450544051|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
125250914|NCT01557244|450544052|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
125250915|NCT01557244|450544053|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
125250916|NCT01557244|450544054|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
125250917|NCT01557244|450544055|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
125250918|NCT01557244|450544049|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
125250919|NCT01557244|450544050|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
125250920|NCT01557244|450544051|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
125250921|NCT01557244|450544052|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
125250922|NCT01557244|450544053|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
125250923|NCT01557244|450544054|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
125250924|NCT01557244|450544055|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
125250925|NCT01557244|450544049|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
125250926|NCT01557244|450544050|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
125250927|NCT01557244|450544051|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
125250928|NCT01557244|450544052|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
125250929|NCT01557244|450544053|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
125250930|NCT01557244|450544054|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
125250931|NCT01557244|450544055|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
125250932|NCT01428713|450544056|FG000|Overall Study|Non-compliance|2|||
125250933|NCT01428713|450544057|FG001|Overall Study|Non-compliance|2|||
125250934|NCT01428713|450544056|FG000|Overall Study|Withdrawal by Subject|1|||
125250935|NCT01428713|450544057|FG001|Overall Study|Withdrawal by Subject|1|||
125250936|NCT01428713|450544056|FG000|Overall Study|Adverse Event|0|||
125250937|NCT01428713|450544057|FG001|Overall Study|Adverse Event|2|||
125250938|NCT00862277|450544058|FG000|Overall Study|Protocol Violation|1|||
125250939|NCT00862277|450544059|FG001|Overall Study|Protocol Violation|2|||
125250940|NCT00862277|450544060|FG002|Overall Study|Protocol Violation|5|||
125250941|NCT00871000|450544061|FG000|Overall Study|Withdrawal by Subject|1|||
125250942|NCT00871000|450544062|FG001|Overall Study|Withdrawal by Subject|0|||
125250943|NCT01052428|450544063|FG000|Overall Study|Death|1|||
125250944|NCT01052428|450544064|FG001|Overall Study|Death|0|||
125250945|NCT01052428|450544063|FG000|Overall Study|Withdrawal by Subject|0|||
125250946|NCT01052428|450544064|FG001|Overall Study|Withdrawal by Subject|1|||
125250947|NCT03400787|450544065|FG000|Overall Study|Lost to Follow-up|1|||
125250948|NCT03400787|450544066|FG001|Overall Study|Lost to Follow-up|0|||
125250949|NCT03400787|450544065|FG000|Overall Study|Death|1|||
125250950|NCT03400787|450544066|FG001|Overall Study|Death|0|||
125250951|NCT03400787|450544065|FG000|Overall Study|Protocol Violation|0|||
125250952|NCT03400787|450544066|FG001|Overall Study|Protocol Violation|2|||
125250953|NCT03400787|450544065|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
125250954|NCT03400787|450544066|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
125250955|NCT04432298|450544072|FG000|Overall Study|Other than specified|1|||
125250956|NCT04432298|450544073|FG001|Overall Study|Other than specified|0|||
125250957|NCT04432298|450544072|FG000|Overall Study|Lost to Follow-up|0|||
125250958|NCT04432298|450544073|FG001|Overall Study|Lost to Follow-up|1|||
125250959|NCT04432298|450544072|FG000|Overall Study|Death|3|||
125250960|NCT04432298|450544073|FG001|Overall Study|Death|2|||
125250961|NCT04432298|450544072|FG000|Overall Study|Withdrawal by Subject|2|||
125250962|NCT04432298|450544073|FG001|Overall Study|Withdrawal by Subject|0|||
125250963|NCT02365064|450544076|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
125250964|NCT02365064|450544077|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
125250965|NCT02365064|450544076|FG000|Overall Study|Withdrawal by Subject|6|||
125250966|NCT02365064|450544077|FG001|Overall Study|Withdrawal by Subject|9|||
125250967|NCT02365064|450544076|FG000|Overall Study|Treatment intolerance|2|||
125396774|NCT00978731|451086858|FG000|Overall Study|Participant's request|1|||
125396775|NCT00978731|451086859|FG001|Overall Study|Participant's request|0|||
125396776|NCT00978731|451086860|FG002|Overall Study|Participant's request|0|||
125396777|NCT00978731|451086861|FG003|Overall Study|Participant's request|0|||
125396778|NCT00978731|451086858|FG000|Overall Study|Administrative reason|3|||
125396779|NCT00978731|451086859|FG001|Overall Study|Administrative reason|3|||
125396780|NCT00978731|451086860|FG002|Overall Study|Administrative reason|1|||
125396781|NCT00978731|451086861|FG003|Overall Study|Administrative reason|0|||
125396782|NCT00978731|451086858|FG000|Overall Study|Deterioration without progression|0|||
125396783|NCT00978731|451086859|FG001|Overall Study|Deterioration without progression|1|||
125396784|NCT00978731|451086860|FG002|Overall Study|Deterioration without progression|0|||
125396785|NCT00978731|451086861|FG003|Overall Study|Deterioration without progression|0|||
125396786|NCT00978731|451086858|FG000|Overall Study|Disease progression/relapse|5|||
125396787|NCT00978731|451086859|FG001|Overall Study|Disease progression/relapse|4|||
125396788|NCT00978731|451086860|FG002|Overall Study|Disease progression/relapse|2|||
125396789|NCT00978731|451086861|FG003|Overall Study|Disease progression/relapse|2|||
125396790|NCT00978731|451086858|FG000|Overall Study|Study closure|3|||
125396791|NCT00978731|451086859|FG001|Overall Study|Study closure|4|||
125396792|NCT00978731|451086860|FG002|Overall Study|Study closure|1|||
125396793|NCT00978731|451086861|FG003|Overall Study|Study closure|1|||
125396794|NCT00978731|451086858|FG000|Overall Study|No response|1|||
125396795|NCT00978731|451086859|FG001|Overall Study|No response|0|||
125396796|NCT00978731|451086860|FG002|Overall Study|No response|0|||
125396797|NCT00978731|451086861|FG003|Overall Study|No response|0|||
125396798|NCT01896895|451086862|FG000|Double-blind MP|Physician Decision|0|||
125396799|NCT01896895|451086863|FG001|Double-blind MP|Physician Decision|0|||
125396800|NCT01896895|451086864|FG002|Double-blind MP|Physician Decision|1|||
125396801|NCT01896895|451086865|FG003|Double-blind MP|Physician Decision|0|||
125396802|NCT01896895|451086862|FG000|Double-blind MP|Withdrawal by Subject|0|||
125396803|NCT01896895|451086863|FG001|Double-blind MP|Withdrawal by Subject|2|||
125396804|NCT01896895|451086864|FG002|Double-blind MP|Withdrawal by Subject|1|||
125396805|NCT01896895|451086865|FG003|Double-blind MP|Withdrawal by Subject|0|||
125396806|NCT01896895|451086862|FG000|Double-blind MP|Lost to Follow-up|1|||
125396807|NCT01896895|451086863|FG001|Double-blind MP|Lost to Follow-up|0|||
125396808|NCT01896895|451086864|FG002|Double-blind MP|Lost to Follow-up|1|||
125396809|NCT01896895|451086865|FG003|Double-blind MP|Lost to Follow-up|0|||
125396810|NCT00773175|451086868|FG000|Overall Study|Adverse Event|2|||
125396811|NCT00773175|451086869|FG001|Overall Study|Adverse Event|0|||
125396812|NCT00773175|451086868|FG000|Overall Study|Consent Withdrawn|0|||
125396813|NCT00773175|451086869|FG001|Overall Study|Consent Withdrawn|2|||
125396814|NCT01904604|451086872|FG000|Overall Study|Withdrew before receiving dosing|0|||
125396815|NCT01904604|451086873|FG001|Overall Study|Withdrew before receiving dosing|1|||
125396816|NCT01904604|451086874|FG002|Overall Study|Withdrew before receiving dosing|0|||
125396817|NCT01904604|451086872|FG000|Overall Study|Non-compliance|1|||
125396818|NCT01904604|451086873|FG001|Overall Study|Non-compliance|0|||
125396819|NCT01904604|451086874|FG002|Overall Study|Non-compliance|0|||
125396820|NCT01904604|451086872|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
125396821|NCT01904604|451086873|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
125396822|NCT01904604|451086874|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
125396823|NCT01904604|451086872|FG000|Overall Study|Patch site reactions|1|||
125396824|NCT01904604|451086873|FG001|Overall Study|Patch site reactions|1|||
125396825|NCT01904604|451086874|FG002|Overall Study|Patch site reactions|0|||
125396826|NCT01904604|451086872|FG000|Overall Study|Increased syncope|0|||
125396827|NCT01904604|451086873|FG001|Overall Study|Increased syncope|1|||
125396828|NCT01904604|451086874|FG002|Overall Study|Increased syncope|0|||
125250968|NCT02365064|450544077|FG001|Overall Study|Treatment intolerance|4|||
125250969|NCT02451007|450544080|FG000|Overall Study|Withdrawal by Subject|4|||
125250970|NCT02451007|450544080|FG000|Overall Study|Adverse Event|1|||
125250971|NCT02451007|450544080|FG000|Overall Study|Disease Progression|2|||
125250972|NCT00348374|450544081|FG000|Overall Study|Adverse Event|1|||
125250973|NCT00348374|450544082|FG001|Overall Study|Adverse Event|4|||
125250974|NCT00348374|450544081|FG000|Overall Study|Lost to Follow-up|1|||
125250975|NCT00348374|450544082|FG001|Overall Study|Lost to Follow-up|3|||
125250976|NCT00348374|450544081|FG000|Overall Study|Withdrawal by Subject|5|||
125250977|NCT00348374|450544082|FG001|Overall Study|Withdrawal by Subject|5|||
125250978|NCT00348374|450544081|FG000|Overall Study|Other|11|||
125396829|NCT01904604|451086872|FG000|Overall Study|Unrelated illness|0|||
125396830|NCT01904604|451086873|FG001|Overall Study|Unrelated illness|1|||
125396831|NCT01904604|451086874|FG002|Overall Study|Unrelated illness|0|||
125396832|NCT01904604|451086872|FG000|Overall Study|Passed Week 52 OFC|1|||
125396833|NCT01904604|451086873|FG001|Overall Study|Passed Week 52 OFC|0|||
125250979|NCT00348374|450544082|FG001|Overall Study|Other|12|||
125250980|NCT00348374|450544081|FG000|Overall Study|ongoing at date of cutoff|1|||
125250981|NCT00348374|450544082|FG001|Overall Study|ongoing at date of cutoff|1|||
125396834|NCT01904604|451086874|FG002|Overall Study|Passed Week 52 OFC|0|||
125250982|NCT00348374|450544081|FG000|Overall Study|randomized but did not receive treatment|0|||
125396835|NCT01904604|451086872|FG000|Overall Study|Withdrawal by Subject|1|||
125250983|NCT00348374|450544082|FG001|Overall Study|randomized but did not receive treatment|7|||
125250984|NCT02595437|450544091|FG000|Triferic Via IV|Withdrawal by Subject|1|||
125250985|NCT02070380|450544092|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
125250986|NCT02070380|450544093|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
125250987|NCT02070380|450544094|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
125250988|NCT02070380|450544095|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
125250989|NCT02070380|450544092|FG000|Second Injection|Image sets missing or technically inadeq|0|||
125250990|NCT02070380|450544093|FG001|Second Injection|Image sets missing or technically inadeq|1|||
125250991|NCT02070380|450544094|FG002|Second Injection|Image sets missing or technically inadeq|0|||
125250992|NCT02070380|450544095|FG003|Second Injection|Image sets missing or technically inadeq|0|||
125250993|NCT02070380|450544092|FG000|Second Injection|Protocol Violation|0|||
125250994|NCT02070380|450544093|FG001|Second Injection|Protocol Violation|1|||
125250995|NCT02070380|450544094|FG002|Second Injection|Protocol Violation|1|||
125250996|NCT02070380|450544095|FG003|Second Injection|Protocol Violation|5|||
125250997|NCT02242903|450544099|FG000|Overall Study|Withdrawal by Subject|1|||
125250998|NCT02242903|450544100|FG001|Overall Study|Withdrawal by Subject|0|||
125250999|NCT02242903|450544101|FG002|Overall Study|Withdrawal by Subject|0|||
125251000|NCT02242903|450544102|FG003|Overall Study|Withdrawal by Subject|0|||
125251001|NCT02242903|450544103|FG004|Overall Study|Withdrawal by Subject|0|||
125251002|NCT02242903|450544104|FG005|Overall Study|Withdrawal by Subject|0|||
125251003|NCT02242903|450544105|FG006|Overall Study|Withdrawal by Subject|0|||
125444128|NCT01474512|451253882|FG002|Induction Period|Lost to Follow-up|2|||
125444129|NCT01474512|451253883|FG003|Induction Period|Lost to Follow-up|0|||
125444130|NCT01474512|451253884|FG004|Induction Period|Lost to Follow-up|0|||
125444131|NCT01474512|451253885|FG005|Induction Period|Lost to Follow-up|0|||
125444132|NCT01474512|451253886|FG006|Induction Period|Lost to Follow-up|0|||
125444133|NCT01474512|451253887|FG007|Induction Period|Lost to Follow-up|0|||
125444134|NCT01474512|451253888|FG008|Induction Period|Lost to Follow-up|0|||
125444135|NCT01474512|451253889|FG009|Induction Period|Lost to Follow-up|0|||
125444136|NCT01474512|451253890|FG010|Induction Period|Lost to Follow-up|0|||
125444137|NCT01474512|451253891|FG011|Induction Period|Lost to Follow-up|0|||
125444138|NCT01474512|451253892|FG012|Induction Period|Lost to Follow-up|0|||
125444139|NCT01474512|451253893|FG013|Induction Period|Lost to Follow-up|0|||
125444140|NCT01474512|451253894|FG014|Induction Period|Lost to Follow-up|0|||
125444141|NCT01474512|451253895|FG015|Induction Period|Lost to Follow-up|0|||
125444142|NCT01474512|451253896|FG016|Induction Period|Lost to Follow-up|0|||
125444143|NCT01474512|451253897|FG017|Induction Period|Lost to Follow-up|0|||
125444144|NCT01474512|451253880|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125444145|NCT01474512|451253881|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125444146|NCT01474512|451253882|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125444147|NCT01474512|451253883|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
125444148|NCT01474512|451253884|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
125444149|NCT01474512|451253885|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
125444150|NCT01474512|451253886|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
125444151|NCT01474512|451253887|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125251004|NCT02105012|450544108|FG000|Overall Study|Withdrawal by Subject|11|||
125251005|NCT02105012|450544108|FG000|Overall Study|Protocol Specified Criteria|9|||
125251006|NCT02105012|450544108|FG000|Overall Study|Lost to Follow-up|4|||
125251007|NCT02105012|450544108|FG000|Overall Study|Protocol Violation|4|||
125251008|NCT02105012|450544108|FG000|Overall Study|Physician Decision|3|||
125251009|NCT02105012|450544108|FG000|Overall Study|Adverse Event|1|||
125251010|NCT02105012|450544108|FG000|Overall Study|Lack of Efficacy|1|||
125251011|NCT00493285|450544109|FG000|Overall Study|Lost to Follow-up|0|||
125251012|NCT00493285|450544110|FG001|Overall Study|Lost to Follow-up|0|||
125251013|NCT00493285|450544111|FG002|Overall Study|Lost to Follow-up|0|||
125251014|NCT00493285|450544112|FG003|Overall Study|Lost to Follow-up|0|||
125251015|NCT00493285|450544113|FG004|Overall Study|Lost to Follow-up|1|||
125251016|NCT00493285|450544114|FG005|Overall Study|Lost to Follow-up|0|||
125251017|NCT04535362|450544115|FG000|Overall Study|Lost to Follow-up|3|||
125251018|NCT04535362|450544116|FG001|Overall Study|Lost to Follow-up|1|||
125251019|NCT03791060|450544117|FG000|Overall Study|Withdrawal by Subject|1|||
125251020|NCT02619812|450544122|FG000|Overall Study|Withdrawal by Subject|0|||
125251021|NCT02619812|450544123|FG001|Overall Study|Withdrawal by Subject|0|||
125251022|NCT02619812|450544124|FG002|Overall Study|Withdrawal by Subject|1|||
125251023|NCT02619812|450544125|FG003|Overall Study|Withdrawal by Subject|2|||
125251024|NCT00981175|450544126|FG000|Primary Dose Vaccination|Adverse Event|1|||
125251025|NCT00981175|450544127|FG001|Primary Dose Vaccination|Adverse Event|0|||
125251026|NCT00981175|450544126|FG000|Primary Dose Vaccination|Protocol Violation|0|||
125444152|NCT01474512|451253888|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125444153|NCT01474512|451253889|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125444154|NCT01474512|451253890|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125251027|NCT00981175|450544127|FG001|Primary Dose Vaccination|Protocol Violation|1|||
125251028|NCT00981175|450544126|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
125251029|NCT00981175|450544127|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
125251030|NCT00981175|450544126|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
125251031|NCT00981175|450544127|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
125251032|NCT01658735|450544130|FG000|Overall Study|Lack of Efficacy|1|||
125251033|NCT01658735|450544131|FG001|Overall Study|Lack of Efficacy|0|||
125251034|NCT01658735|450544132|FG002|Overall Study|Lack of Efficacy|1|||
125251035|NCT01658735|450544130|FG000|Overall Study|Lost to Follow-up|1|||
125251036|NCT01658735|450544131|FG001|Overall Study|Lost to Follow-up|1|||
125251037|NCT01658735|450544132|FG002|Overall Study|Lost to Follow-up|0|||
125251038|NCT01658735|450544130|FG000|Overall Study|Protocol Violation|0|||
125251039|NCT01658735|450544131|FG001|Overall Study|Protocol Violation|1|||
125251040|NCT01658735|450544132|FG002|Overall Study|Protocol Violation|0|||
125251041|NCT01658735|450544130|FG000|Overall Study|Withdrawal by Subject|3|||
125251042|NCT01658735|450544131|FG001|Overall Study|Withdrawal by Subject|5|||
125251043|NCT01658735|450544132|FG002|Overall Study|Withdrawal by Subject|3|||
125251044|NCT01379937|450544133|FG000|Overall Study|Protocol Violation|0|||
125251045|NCT01379937|450544134|FG001|Overall Study|Protocol Violation|0|||
125251046|NCT01379937|450544135|FG002|Overall Study|Protocol Violation|0|||
125251047|NCT01379937|450544136|FG003|Overall Study|Protocol Violation|1|||
125251048|NCT01379937|450544133|FG000|Overall Study|Consent withdrawal|0|||
125251049|NCT01379937|450544134|FG001|Overall Study|Consent withdrawal|1|||
125251050|NCT01379937|450544135|FG002|Overall Study|Consent withdrawal|0|||
125251051|NCT01379937|450544136|FG003|Overall Study|Consent withdrawal|0|||
125251052|NCT01379937|450544133|FG000|Overall Study|Lost to Follow-up|1|||
125251053|NCT01379937|450544134|FG001|Overall Study|Lost to Follow-up|2|||
125251054|NCT01379937|450544135|FG002|Overall Study|Lost to Follow-up|2|||
125251055|NCT01379937|450544136|FG003|Overall Study|Lost to Follow-up|0|||
125251056|NCT01104870|450544137|FG000|Overall Study|Adverse Event|1|||
125251057|NCT01104870|450544138|FG001|Overall Study|Adverse Event|1|||
125251058|NCT01104870|450544139|FG002|Overall Study|Adverse Event|0|||
125251059|NCT01104870|450544137|FG000|Overall Study|Death|0|||
125251060|NCT01104870|450544138|FG001|Overall Study|Death|0|||
125251061|NCT01104870|450544139|FG002|Overall Study|Death|1|||
125251062|NCT01104870|450544137|FG000|Overall Study|Withdrawal by Subject|0|||
125251063|NCT01104870|450544138|FG001|Overall Study|Withdrawal by Subject|0|||
125251064|NCT01104870|450544139|FG002|Overall Study|Withdrawal by Subject|1|||
125251065|NCT00079781|450544151|FG000|Pre-implant Period|Withdrawal by Subject|2|||
125251066|NCT00079781|450544152|FG001|Pre-implant Period|Withdrawal by Subject|0|||
125251067|NCT00079781|450544153|FG002|Pre-implant Period|Withdrawal by Subject|0|||
125251068|NCT00079781|450544151|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
125251069|NCT00079781|450544152|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
125251070|NCT00079781|450544153|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
125251071|NCT00079781|450544151|FG000|Follow-up Period|Withdrawal by Subject|3|||
125251072|NCT00079781|450544152|FG001|Follow-up Period|Withdrawal by Subject|0|||
125251073|NCT00079781|450544153|FG002|Follow-up Period|Withdrawal by Subject|1|||
125251074|NCT00079781|450544151|FG000|Follow-up Period|Lost to Follow-up|1|||
125251075|NCT00079781|450544152|FG001|Follow-up Period|Lost to Follow-up|0|||
125251076|NCT00079781|450544153|FG002|Follow-up Period|Lost to Follow-up|0|||
125251077|NCT00079781|450544151|FG000|Follow-up Period|Death|0|||
125251078|NCT00079781|450544152|FG001|Follow-up Period|Death|0|||
125251079|NCT00079781|450544153|FG002|Follow-up Period|Death|1|||
125251080|NCT04641975|450544154|FG000|Overall Study|Protocol Violation|1|||
125251081|NCT04641975|450544155|FG001|Overall Study|Protocol Violation|2|||
125251082|NCT04641975|450544156|FG002|Overall Study|Protocol Violation|0|||
125251083|NCT04641975|450544157|FG003|Overall Study|Protocol Violation|0|||
125251084|NCT04641975|450544154|FG000|Overall Study|Adverse Event|0|||
125251085|NCT04641975|450544155|FG001|Overall Study|Adverse Event|0|||
125251086|NCT04641975|450544156|FG002|Overall Study|Adverse Event|1|||
125251087|NCT04641975|450544157|FG003|Overall Study|Adverse Event|1|||
125251088|NCT04641975|450544154|FG000|Overall Study|Withdrawal by Subject|1|||
125251089|NCT04641975|450544155|FG001|Overall Study|Withdrawal by Subject|0|||
125251090|NCT04641975|450544156|FG002|Overall Study|Withdrawal by Subject|0|||
125251091|NCT04641975|450544157|FG003|Overall Study|Withdrawal by Subject|0|||
125251092|NCT02067156|450544160|FG000|Overall Study|Lost to Follow-up|4|||
125251093|NCT03596983|450544161|FG000|Overall Study|Withdrawal by Subject|3|||
125251094|NCT05287685|450544162|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
125251095|NCT05287685|450544163|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
125251096|NCT05287685|450544162|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
125251097|NCT05287685|450544163|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
125251098|NCT01340170|450544170|FG000|Overall Study|Lost to Follow-up|2|||
125444155|NCT01474512|451253891|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125444156|NCT01474512|451253892|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125251099|NCT01340170|450544171|FG001|Overall Study|Lost to Follow-up|4|||
125251100|NCT01340170|450544172|FG002|Overall Study|Lost to Follow-up|0|||
125251101|NCT01340170|450544170|FG000|Overall Study|Implant failure|1|||
125251102|NCT01340170|450544171|FG001|Overall Study|Implant failure|3|||
125251103|NCT01340170|450544172|FG002|Overall Study|Implant failure|0|||
125251104|NCT00472641|450544174|FG000|Overall Study|Lack of Efficacy|3|||
125251105|NCT00472641|450544174|FG000|Overall Study|Adverse Event|3|||
125251106|NCT00472641|450544174|FG000|Overall Study|Lost to Follow-up|1|||
125251107|NCT03721107|450544175|FG000|Overall Study|Adverse Event|1|||
125251108|NCT03721107|450544176|FG001|Overall Study|Adverse Event|1|||
125251109|NCT03721107|450544177|FG002|Overall Study|Adverse Event|6|||
125251110|NCT03721107|450544178|FG003|Overall Study|Adverse Event|5|||
125251111|NCT03721107|450544175|FG000|Overall Study|Lost to Follow-up|2|||
125251112|NCT03721107|450544176|FG001|Overall Study|Lost to Follow-up|0|||
125251113|NCT03721107|450544177|FG002|Overall Study|Lost to Follow-up|3|||
125251114|NCT03721107|450544178|FG003|Overall Study|Lost to Follow-up|0|||
125251115|NCT03721107|450544175|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
125251116|NCT03721107|450544176|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
125251117|NCT03721107|450544177|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
125251118|NCT03721107|450544178|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
125251119|NCT03721107|450544175|FG000|Overall Study|Physician Decision|0|||
125251120|NCT03721107|450544176|FG001|Overall Study|Physician Decision|1|||
125251121|NCT03721107|450544177|FG002|Overall Study|Physician Decision|0|||
125251122|NCT03721107|450544178|FG003|Overall Study|Physician Decision|0|||
125251123|NCT03721107|450544175|FG000|Overall Study|Pregnancy|0|||
125251124|NCT03721107|450544176|FG001|Overall Study|Pregnancy|0|||
125251125|NCT03721107|450544177|FG002|Overall Study|Pregnancy|1|||
125251126|NCT03721107|450544178|FG003|Overall Study|Pregnancy|0|||
125251127|NCT03721107|450544175|FG000|Overall Study|Withdrawal by Subject|1|||
125251128|NCT03721107|450544176|FG001|Overall Study|Withdrawal by Subject|1|||
125251129|NCT03721107|450544177|FG002|Overall Study|Withdrawal by Subject|5|||
125251130|NCT03721107|450544178|FG003|Overall Study|Withdrawal by Subject|5|||
125251131|NCT03721107|450544175|FG000|Overall Study|Other|1|||
125251132|NCT03721107|450544176|FG001|Overall Study|Other|0|||
125251133|NCT03721107|450544177|FG002|Overall Study|Other|0|||
125251134|NCT03721107|450544178|FG003|Overall Study|Other|1|||
125251135|NCT01189227|450544179|FG000|Overall Study|Study terminated due to low accrual|6|||
125251136|NCT01189227|450544180|FG001|Overall Study|Study terminated due to low accrual|3|||
125251137|NCT01608308|450544186|FG000|Overall Study|pretreatment medical and billing reasons|0|||
125251138|NCT01608308|450544187|FG001|Overall Study|pretreatment medical and billing reasons|2|||
125251139|NCT04648241|450544188|FG000|Overall Study|Lost to Follow-up|1|||
125251140|NCT04648241|450544189|FG001|Overall Study|Lost to Follow-up|0|||
125251141|NCT05259722|450544190|FG000|Overall Study|Adverse Event|2|||
125251142|NCT05259722|450544191|FG001|Overall Study|Adverse Event|24|||
125251143|NCT05259722|450544190|FG000|Overall Study|Lost to Follow-up|5|||
125251144|NCT05259722|450544191|FG001|Overall Study|Lost to Follow-up|1|||
125251145|NCT05259722|450544190|FG000|Overall Study|Lack of Efficacy|8|||
125251146|NCT05259722|450544191|FG001|Overall Study|Lack of Efficacy|26|||
125251147|NCT05259722|450544190|FG000|Overall Study|Withdrawal by Subject|15|||
125251148|NCT05259722|450544191|FG001|Overall Study|Withdrawal by Subject|33|||
125251149|NCT05259722|450544190|FG000|Overall Study|Various reasons|3|||
125251150|NCT05259722|450544191|FG001|Overall Study|Various reasons|9|||
125251151|NCT05259722|450544190|FG000|Overall Study|Not exposed to IMP|1|||
125251152|NCT05259722|450544191|FG001|Overall Study|Not exposed to IMP|12|||
125251153|NCT05259722|450544190|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
125251154|NCT05259722|450544191|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
125251155|NCT00962650|450544192|FG000|Overall Study|Transgastric DP was not completed|2|||
125251156|NCT02268851|450544194|FG000|Overall Study|Death|0|||
125251157|NCT02268851|450544195|FG001|Overall Study|Death|0|||
125251158|NCT02268851|450544196|FG002|Overall Study|Death|0|||
125251159|NCT02268851|450544197|FG003|Overall Study|Death|1|||
125251160|NCT02268851|450544198|FG004|Overall Study|Death|2|||
125251161|NCT02268851|450544199|FG005|Overall Study|Death|1|||
125251162|NCT02268851|450544194|FG000|Overall Study|Adverse Event|0|||
125251163|NCT02268851|450544195|FG001|Overall Study|Adverse Event|0|||
125251164|NCT02268851|450544196|FG002|Overall Study|Adverse Event|0|||
125251165|NCT02268851|450544197|FG003|Overall Study|Adverse Event|0|||
125251166|NCT02268851|450544198|FG004|Overall Study|Adverse Event|2|||
125251167|NCT02268851|450544199|FG005|Overall Study|Adverse Event|2|||
125251168|NCT02268851|450544194|FG000|Overall Study|Withdrawal by Subject|0|||
125251169|NCT02268851|450544195|FG001|Overall Study|Withdrawal by Subject|0|||
125251170|NCT02268851|450544196|FG002|Overall Study|Withdrawal by Subject|0|||
125251171|NCT02268851|450544197|FG003|Overall Study|Withdrawal by Subject|2|||
125396836|NCT01904604|451086873|FG001|Overall Study|Withdrawal by Subject|2|||
125396837|NCT01904604|451086874|FG002|Overall Study|Withdrawal by Subject|0|||
125396838|NCT01904604|451086872|FG000|Overall Study|Participant Relocated|1|||
125396839|NCT01904604|451086873|FG001|Overall Study|Participant Relocated|1|||
125396840|NCT01904604|451086874|FG002|Overall Study|Participant Relocated|1|||
125396841|NCT01904604|451086872|FG000|Overall Study|Lost to Follow-up|0|||
125396842|NCT01904604|451086873|FG001|Overall Study|Lost to Follow-up|0|||
125251172|NCT02268851|450544198|FG004|Overall Study|Withdrawal by Subject|0|||
125396843|NCT01904604|451086874|FG002|Overall Study|Lost to Follow-up|1|||
125251173|NCT02268851|450544199|FG005|Overall Study|Withdrawal by Subject|1|||
125251174|NCT02268851|450544194|FG000|Overall Study|Progressive Disease|1|||
125251175|NCT02268851|450544195|FG001|Overall Study|Progressive Disease|3|||
125251176|NCT02268851|450544196|FG002|Overall Study|Progressive Disease|0|||
125251177|NCT02268851|450544197|FG003|Overall Study|Progressive Disease|0|||
125251178|NCT02268851|450544198|FG004|Overall Study|Progressive Disease|1|||
125251179|NCT02268851|450544199|FG005|Overall Study|Progressive Disease|4|||
125251180|NCT02268851|450544194|FG000|Overall Study|Physician Decision|0|||
125251181|NCT02268851|450544195|FG001|Overall Study|Physician Decision|0|||
125251182|NCT02268851|450544196|FG002|Overall Study|Physician Decision|1|||
125251183|NCT02268851|450544197|FG003|Overall Study|Physician Decision|0|||
125251184|NCT02268851|450544198|FG004|Overall Study|Physician Decision|0|||
125251185|NCT02268851|450544199|FG005|Overall Study|Physician Decision|1|||
125251186|NCT02268851|450544194|FG000|Overall Study|Patient Compliance|0|||
125251187|NCT02268851|450544195|FG001|Overall Study|Patient Compliance|0|||
125251188|NCT02268851|450544196|FG002|Overall Study|Patient Compliance|0|||
125251189|NCT02268851|450544197|FG003|Overall Study|Patient Compliance|0|||
125251190|NCT02268851|450544198|FG004|Overall Study|Patient Compliance|1|||
125251191|NCT02268851|450544199|FG005|Overall Study|Patient Compliance|1|||
125251192|NCT02268851|450544194|FG000|Overall Study|Co-Morbid Condition|0|||
125251193|NCT02268851|450544195|FG001|Overall Study|Co-Morbid Condition|0|||
125251194|NCT02268851|450544196|FG002|Overall Study|Co-Morbid Condition|0|||
125251195|NCT02268851|450544197|FG003|Overall Study|Co-Morbid Condition|0|||
125251196|NCT02268851|450544198|FG004|Overall Study|Co-Morbid Condition|1|||
125251197|NCT02268851|450544199|FG005|Overall Study|Co-Morbid Condition|1|||
125251198|NCT02539394|450544200|FG000|Overall Study|Protocol Violation|1|||
125251199|NCT02539394|450544201|FG001|Overall Study|Protocol Violation|3|||
125251200|NCT02539394|450544200|FG000|Overall Study|Lost to Follow-up|1|||
125251201|NCT02539394|450544201|FG001|Overall Study|Lost to Follow-up|2|||
125251202|NCT02539394|450544200|FG000|Overall Study|Incomplete dataset|6|||
125251203|NCT02539394|450544201|FG001|Overall Study|Incomplete dataset|6|||
125251204|NCT02205359|450544202|FG000|Overall Study|Death|293|||
125251205|NCT02205359|450544203|FG001|Overall Study|Death|327|||
125251206|NCT02205359|450544202|FG000|Overall Study|Lost to Follow-up|182|||
125251207|NCT02205359|450544203|FG001|Overall Study|Lost to Follow-up|162|||
125251208|NCT02205359|450544202|FG000|Overall Study|Physician Decision|51|||
125251209|NCT02205359|450544203|FG001|Overall Study|Physician Decision|53|||
125251210|NCT02205359|450544202|FG000|Overall Study|Withdrawal by Subject|167|||
125251211|NCT02205359|450544203|FG001|Overall Study|Withdrawal by Subject|169|||
125251212|NCT00236197|450544204|FG000|Overall Study|Withdrawal by Subject|3|||
125251213|NCT00236197|450544205|FG001|Overall Study|Withdrawal by Subject|2|||
125251214|NCT00236197|450544204|FG000|Overall Study|Lost to Follow-up|1|||
125251215|NCT00236197|450544205|FG001|Overall Study|Lost to Follow-up|5|||
125251216|NCT00236197|450544204|FG000|Overall Study|Protocol Violation|0|||
125251217|NCT00236197|450544205|FG001|Overall Study|Protocol Violation|3|||
125251218|NCT00236197|450544204|FG000|Overall Study|Medication non-compliance|1|||
125251219|NCT00236197|450544205|FG001|Overall Study|Medication non-compliance|2|||
125251220|NCT00236197|450544204|FG000|Overall Study|Other|0|||
125251221|NCT00236197|450544205|FG001|Overall Study|Other|2|||
125251222|NCT00992394|450544208|FG000|Overall Study|Lack of Efficacy|6|||
125251223|NCT00992394|450544209|FG001|Overall Study|Lack of Efficacy|3|||
125251224|NCT00992394|450544208|FG000|Overall Study|Adverse Event|4|||
125251225|NCT00992394|450544209|FG001|Overall Study|Adverse Event|5|||
125251226|NCT00992394|450544208|FG000|Overall Study|Withdrawal by Subject|8|||
125251227|NCT00992394|450544209|FG001|Overall Study|Withdrawal by Subject|2|||
125251228|NCT00992394|450544208|FG000|Overall Study|Physician Decision|1|||
125251229|NCT00992394|450544209|FG001|Overall Study|Physician Decision|0|||
125251230|NCT00992394|450544208|FG000|Overall Study|Protocol Violation|2|||
125251231|NCT00992394|450544209|FG001|Overall Study|Protocol Violation|4|||
125251232|NCT00992394|450544208|FG000|Overall Study|Lost to Follow-up|2|||
125251233|NCT00992394|450544209|FG001|Overall Study|Lost to Follow-up|0|||
125251234|NCT00992394|450544208|FG000|Overall Study|Other event|1|||
125251235|NCT00992394|450544209|FG001|Overall Study|Other event|0|||
125251236|NCT00537082|450544210|FG000|Overall Study|Adverse Event|6|||
125251237|NCT00537082|450544211|FG001|Overall Study|Adverse Event|6|||
125251238|NCT00537082|450544212|FG002|Overall Study|Adverse Event|3|||
125251239|NCT00537082|450544210|FG000|Overall Study|Protocol Violation|0|||
125251240|NCT00537082|450544211|FG001|Overall Study|Protocol Violation|2|||
125251241|NCT00537082|450544212|FG002|Overall Study|Protocol Violation|1|||
125251242|NCT00537082|450544210|FG000|Overall Study|Lack of Efficacy|0|||
125251243|NCT00537082|450544211|FG001|Overall Study|Lack of Efficacy|0|||
125251244|NCT00537082|450544212|FG002|Overall Study|Lack of Efficacy|2|||
125251245|NCT00537082|450544210|FG000|Overall Study|Withdrawal by Subject|0|||
125251246|NCT00537082|450544211|FG001|Overall Study|Withdrawal by Subject|1|||
125251247|NCT00537082|450544212|FG002|Overall Study|Withdrawal by Subject|0|||
125251248|NCT00537082|450544210|FG000|Overall Study|Discontinued before initiating treatment|3|||
125251249|NCT00537082|450544211|FG001|Overall Study|Discontinued before initiating treatment|0|||
125251250|NCT00537082|450544212|FG002|Overall Study|Discontinued before initiating treatment|0|||
125251251|NCT00655746|450544213|FG000|Overall Study|Withdrawal by Subject|1|||
125251252|NCT01793129|450545936|FG000|Overall Study|Lost to Follow-up|3|||
125251253|NCT01793129|450545937|FG001|Overall Study|Lost to Follow-up|7|||
125251254|NCT01793129|450545936|FG000|Overall Study|Withdrawal by Subject|0|||
125251255|NCT01793129|450545937|FG001|Overall Study|Withdrawal by Subject|2|||
125251256|NCT01926509|450545940|FG000|Overall Study|vital sign met discontinuation criteria|1|||
125251257|NCT01926509|450545941|FG001|Overall Study|vital sign met discontinuation criteria|0|||
125251258|NCT01926509|450545942|FG002|Overall Study|vital sign met discontinuation criteria|0|||
125251259|NCT01926509|450545943|FG003|Overall Study|vital sign met discontinuation criteria|0|||
125251260|NCT03004183|450545944|FG000|Overall Study|Adverse Event|7|||
125251261|NCT03004183|450545944|FG000|Overall Study|Lost to Follow-up|1|||
125251262|NCT03004183|450545944|FG000|Overall Study|Physician Decision|40|||
125251263|NCT03004183|450545944|FG000|Overall Study|Withdrawal by Subject|1|||
125251264|NCT03004183|450545944|FG000|Overall Study|COVID-19|1|||
125197405|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
125197406|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
125197407|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
125197408|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
125197409|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
125197410|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Death|1|||
125197411|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Death|0|||
125197412|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
125197413|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
125197414|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
125197415|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
125197416|NCT01876784|450343970|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
125197417|NCT01876784|450343971|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
125197418|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
125197419|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
125197420|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Adverse Event|2|||
125197421|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Adverse Event|6|||
125197422|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
125197423|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
125197424|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Progressive disease|4|||
125197425|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Progressive disease|35|||
125197426|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
125197427|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
125197428|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
125197429|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
125197430|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Death|0|||
125197431|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Death|1|||
125197432|NCT01876784|450343970|FG000|Open-label Period (31 Months)|Other than specified above|9|||
125197433|NCT01876784|450343971|FG001|Open-label Period (31 Months)|Other than specified above|18|||
125197434|NCT03605862|450343972|FG000|Overall Study|Withdrawal by Subject|12|||
125197435|NCT03605862|450343973|FG001|Overall Study|Withdrawal by Subject|9|||
125197436|NCT03605862|450343972|FG000|Overall Study|Adverse Event|2|||
125197437|NCT03605862|450343973|FG001|Overall Study|Adverse Event|1|||
125197438|NCT03605862|450343972|FG000|Overall Study|Physician Decision|3|||
125197439|NCT03605862|450343973|FG001|Overall Study|Physician Decision|1|||
125197440|NCT03605862|450343972|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
125197441|NCT03605862|450343973|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
125197442|NCT01194531|450343974|FG000|Overall Study|Withdrawal by Subject|1|||
125197443|NCT01194531|450343975|FG001|Overall Study|Withdrawal by Subject|0|||
125197444|NCT01194531|450343974|FG000|Overall Study|Protocol Violation|4|||
125197445|NCT01194531|450343975|FG001|Overall Study|Protocol Violation|1|||
125197446|NCT01194531|450343974|FG000|Overall Study|Physician Decision|0|||
125197447|NCT01194531|450343975|FG001|Overall Study|Physician Decision|2|||
125197448|NCT03891862|450343976|FG000|Open-label Period|Adverse Event|2|||
125197449|NCT03891862|450343977|FG001|Open-label Period|Adverse Event|0|||
125197450|NCT03891862|450343978|FG002|Open-label Period|Adverse Event|0|||
125197451|NCT03891862|450343976|FG000|Open-label Period|Protocol Violation|5|||
125197452|NCT03891862|450343977|FG001|Open-label Period|Protocol Violation|0|||
125197453|NCT03891862|450343978|FG002|Open-label Period|Protocol Violation|0|||
125197454|NCT03891862|450343976|FG000|Open-label Period|Withdrawal by Subject|6|||
125197455|NCT03891862|450343977|FG001|Open-label Period|Withdrawal by Subject|0|||
125197456|NCT03891862|450343978|FG002|Open-label Period|Withdrawal by Subject|0|||
125251265|NCT03681093|450545945|FG000|Overall Study|Subject decision|0|||
125396844|NCT00145509|451086879|FG000|Overall Study|Adverse Event|10|||
125396845|NCT00145509|451086880|FG001|Overall Study|Adverse Event|3|||
125396846|NCT00145509|451086879|FG000|Overall Study|Lack of Efficacy|3|||
125396847|NCT00145509|451086880|FG001|Overall Study|Lack of Efficacy|1|||
125396848|NCT00145509|451086879|FG000|Overall Study|Lost to Follow-up|5|||
125396849|NCT00145509|451086880|FG001|Overall Study|Lost to Follow-up|9|||
125396850|NCT00145509|451086879|FG000|Overall Study|Withdrew Consent|2|||
125396851|NCT00145509|451086880|FG001|Overall Study|Withdrew Consent|7|||
125251266|NCT03681093|450545946|FG001|Overall Study|Subject decision|2|||
125251267|NCT03681093|450545947|FG002|Overall Study|Subject decision|1|||
125251268|NCT02698787|450545948|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
125251269|NCT02698787|450545949|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
125251270|NCT01882829|450545953|FG000|Overall Study|Adverse Event|4|||
125251271|NCT01882829|450545953|FG000|Overall Study|Protocol Violation|1|||
125251272|NCT01882829|450545953|FG000|Overall Study|Withdrawal by Subject|1|||
125251273|NCT01313676|450545956|FG000|Overall Study|Adverse Event|395|||
125251274|NCT01313676|450545957|FG001|Overall Study|Adverse Event|365|||
125251275|NCT01313676|450545958|FG002|Overall Study|Adverse Event|372|||
125251276|NCT01313676|450545959|FG003|Overall Study|Adverse Event|333|||
125251277|NCT01313676|450545956|FG000|Overall Study|Lack of Efficacy|98|||
125251278|NCT01313676|450545957|FG001|Overall Study|Lack of Efficacy|90|||
125251279|NCT01313676|450545958|FG002|Overall Study|Lack of Efficacy|65|||
125251280|NCT01313676|450545959|FG003|Overall Study|Lack of Efficacy|46|||
125251281|NCT01313676|450545956|FG000|Overall Study|Protocol Violation|37|||
125251282|NCT01313676|450545957|FG001|Overall Study|Protocol Violation|44|||
125251283|NCT01313676|450545958|FG002|Overall Study|Protocol Violation|46|||
125251284|NCT01313676|450545959|FG003|Overall Study|Protocol Violation|44|||
125251285|NCT01313676|450545956|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
125251286|NCT01313676|450545957|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
125251287|NCT01313676|450545958|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
125251288|NCT01313676|450545959|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
125251289|NCT01313676|450545956|FG000|Overall Study|Study Closed/terminated|7|||
125251290|NCT01313676|450545957|FG001|Overall Study|Study Closed/terminated|6|||
125251291|NCT01313676|450545958|FG002|Overall Study|Study Closed/terminated|9|||
125251292|NCT01313676|450545959|FG003|Overall Study|Study Closed/terminated|9|||
125251293|NCT01313676|450545956|FG000|Overall Study|Lost to Follow-up|0|||
125251294|NCT01313676|450545957|FG001|Overall Study|Lost to Follow-up|0|||
125251295|NCT01313676|450545958|FG002|Overall Study|Lost to Follow-up|1|||
125251296|NCT01313676|450545959|FG003|Overall Study|Lost to Follow-up|0|||
125251297|NCT01313676|450545956|FG000|Overall Study|Physician Decision|53|||
125251298|NCT01313676|450545957|FG001|Overall Study|Physician Decision|64|||
125251299|NCT01313676|450545958|FG002|Overall Study|Physician Decision|62|||
125251300|NCT01313676|450545959|FG003|Overall Study|Physician Decision|48|||
125251301|NCT01313676|450545956|FG000|Overall Study|Decision by Participant or Proxy|643|||
125251302|NCT01313676|450545957|FG001|Overall Study|Decision by Participant or Proxy|527|||
125251303|NCT01313676|450545958|FG002|Overall Study|Decision by Participant or Proxy|515|||
125251304|NCT01313676|450545959|FG003|Overall Study|Decision by Participant or Proxy|492|||
125251305|NCT01313676|450545956|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
125251306|NCT01313676|450545957|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
125251307|NCT01313676|450545958|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
125251308|NCT01313676|450545959|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
125251309|NCT01313676|450545956|FG000|Overall Study|Investigator Site Closed|12|||
125251310|NCT01313676|450545957|FG001|Overall Study|Investigator Site Closed|11|||
125251311|NCT01313676|450545958|FG002|Overall Study|Investigator Site Closed|15|||
125251312|NCT01313676|450545959|FG003|Overall Study|Investigator Site Closed|10|||
125251313|NCT01313676|450545956|FG000|Overall Study|Missing|1|||
125251314|NCT01313676|450545957|FG001|Overall Study|Missing|1|||
125251315|NCT01313676|450545958|FG002|Overall Study|Missing|1|||
125251316|NCT01313676|450545959|FG003|Overall Study|Missing|0|||
125251317|NCT02469961|450545961|FG000|Overall Study|Physician Decision|4|||
125251318|NCT02469961|450545962|FG001|Overall Study|Physician Decision|1|||
125251319|NCT05130281|450545966|FG000|Overall Study|Withdrawal by Subject|0|||
125251320|NCT05130281|450545967|FG001|Overall Study|Withdrawal by Subject|0|||
125251321|NCT05130281|450545968|FG002|Overall Study|Withdrawal by Subject|1|||
125251322|NCT06844812|450545969|FG000|Overall Study|Lost to Follow-up|5|||
125251323|NCT06844812|450545969|FG000|Overall Study|stigmatization concerns|2|||
125251324|NCT06844812|450545969|FG000|Overall Study|medication refusal|2|||
125251325|NCT06844812|450545969|FG000|Overall Study|concerns about possible side effects|2|||
125251326|NCT06844812|450545969|FG000|Overall Study|wanting to seek another specialist opinion|2|||
125251327|NCT06844812|450545969|FG000|Overall Study|side effects (dizziness)|1|||
125251328|NCT00368849|450545972|FG000|Overall Study|Withdrawal by Subject|0|||
125251329|NCT00368849|450545973|FG001|Overall Study|Withdrawal by Subject|1|||
125251330|NCT00368849|450545972|FG000|Overall Study|Physician Decision|0|||
125251331|NCT00368849|450545973|FG001|Overall Study|Physician Decision|1|||
125251332|NCT01699685|450545977|FG000|Period 1|Adverse Event|1|||
125251333|NCT01699685|450545978|FG001|Period 1|Adverse Event|1|||
125251334|NCT01699685|450545977|FG000|Period 1|Medical or ethical, noncompliance|2|||
125251335|NCT01699685|450545978|FG001|Period 1|Medical or ethical, noncompliance|0|||
125444157|NCT01474512|451253893|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125444158|NCT01474512|451253894|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125251336|NCT01699685|450545977|FG000|Period 1|Other|0|||
125251337|NCT01699685|450545978|FG001|Period 1|Other|1|||
125251338|NCT01699685|450545977|FG000|Period 1|Patient request|0|||
125251339|NCT01699685|450545978|FG001|Period 1|Patient request|1|||
125251340|NCT01699685|450545977|FG000|Period 2|Lost to Follow-up|1|||
125251341|NCT01699685|450545978|FG001|Period 2|Lost to Follow-up|0|||
125251342|NCT03635996|450545979|FG000|Overall Study|Study terminated by Sponsor|94|||
125251343|NCT03635996|450545979|FG000|Overall Study|Withdrawal by Subject|20|||
125251344|NCT03635996|450545979|FG000|Overall Study|Ablation|26|||
125251345|NCT03635996|450545979|FG000|Overall Study|Adverse Event|7|||
125251346|NCT03635996|450545979|FG000|Overall Study|Physician Decision|3|||
125251347|NCT03635996|450545979|FG000|Overall Study|Prohibited medication|5|||
125251348|NCT03635996|450545979|FG000|Overall Study|Did not meet eligibility criteria|5|||
125251349|NCT03635996|450545979|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
125251350|NCT03635996|450545979|FG000|Overall Study|Protocol Violation|1|||
125251351|NCT03635996|450545979|FG000|Overall Study|Lost to Follow-up|1|||
125251352|NCT05058456|450545980|FG000|Overall Study|Death|1|||
125251353|NCT05058456|450545980|FG000|Overall Study|End of Study data not yet due for release|34|||
125251354|NCT02933151|450545981|FG000|Overall Study|Lost to Follow-up|19|||
125251355|NCT02933151|450545982|FG001|Overall Study|Lost to Follow-up|18|||
125251356|NCT02933151|450545981|FG000|Overall Study|Death|1732|||
125251357|NCT02933151|450545982|FG001|Overall Study|Death|1827|||
125251358|NCT02933151|450545981|FG000|Overall Study|Transplant|210|||
125251359|NCT02933151|450545982|FG001|Overall Study|Transplant|278|||
125251360|NCT02933151|450545981|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
125251361|NCT02933151|450545982|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
125251362|NCT02933151|450545981|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
125251363|NCT02933151|450545982|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
125251364|NCT02933151|450545981|FG000|Overall Study|Recovered Kidney Function|47|||
125251365|NCT02933151|450545982|FG001|Overall Study|Recovered Kidney Function|29|||
125251366|NCT01034657|450545996|FG000|Core Phase|Withdrawal by Subject|1|||
125251367|NCT01034657|450545997|FG001|Core Phase|Withdrawal by Subject|0|||
125251368|NCT01034657|450545998|FG002|Core Phase|Withdrawal by Subject|0|||
125251369|NCT01034657|450545996|FG000|Core Phase|Lack of Efficacy|2|||
125251370|NCT01034657|450545997|FG001|Core Phase|Lack of Efficacy|0|||
125251371|NCT01034657|450545998|FG002|Core Phase|Lack of Efficacy|0|||
125251372|NCT01034657|450545996|FG000|Core Phase|Abnormal laboratory value|1|||
125251373|NCT01034657|450545997|FG001|Core Phase|Abnormal laboratory value|0|||
125251374|NCT01034657|450545998|FG002|Core Phase|Abnormal laboratory value|0|||
125251375|NCT01034657|450545996|FG000|Core Phase|Adverse Event|8|||
125251376|NCT01034657|450545997|FG001|Core Phase|Adverse Event|0|||
125251377|NCT01034657|450545998|FG002|Core Phase|Adverse Event|0|||
125251378|NCT01034657|450545996|FG000|Core Phase|Protocol Violation|2|||
125251379|NCT01034657|450545997|FG001|Core Phase|Protocol Violation|0|||
125251380|NCT01034657|450545998|FG002|Core Phase|Protocol Violation|0|||
125251381|NCT01034657|450545996|FG000|Randomized Phase|Withdrawal by Subject|0|||
125251382|NCT01034657|450545997|FG001|Randomized Phase|Withdrawal by Subject|2|||
125251383|NCT01034657|450545998|FG002|Randomized Phase|Withdrawal by Subject|0|||
125251384|NCT01034657|450545996|FG000|Randomized Phase|Lack of Efficacy|5|||
125251385|NCT01034657|450545997|FG001|Randomized Phase|Lack of Efficacy|1|||
125251386|NCT01034657|450545998|FG002|Randomized Phase|Lack of Efficacy|0|||
125251387|NCT01034657|450545996|FG000|Randomized Phase|Abnormal laboratory value|0|||
125251388|NCT01034657|450545997|FG001|Randomized Phase|Abnormal laboratory value|1|||
125251389|NCT01034657|450545998|FG002|Randomized Phase|Abnormal laboratory value|0|||
125251390|NCT01034657|450545996|FG000|Randomized Phase|Adverse Event|0|||
125251391|NCT01034657|450545997|FG001|Randomized Phase|Adverse Event|2|||
125251392|NCT01034657|450545998|FG002|Randomized Phase|Adverse Event|1|||
125251393|NCT01791205|450545999|FG000|Phase II|Lack of Efficacy|6|||
125251394|NCT01791205|450546000|FG001|Phase II|Lack of Efficacy|0|||
125251395|NCT01791205|450545999|FG000|Phase II|Adverse Event|2|||
125251396|NCT01791205|450546000|FG001|Phase II|Adverse Event|0|||
125251397|NCT01791205|450545999|FG000|Phase II|Safety|1|||
125251398|NCT01791205|450546000|FG001|Phase II|Safety|0|||
125251399|NCT01791205|450545999|FG000|Phase II|Lost to Follow-up|1|||
125251400|NCT01791205|450546000|FG001|Phase II|Lost to Follow-up|0|||
125251401|NCT01791205|450545999|FG000|Phase II|Remission of disease|1|||
125251402|NCT01791205|450546000|FG001|Phase II|Remission of disease|0|||
125251403|NCT01791205|450545999|FG000|Phase II|Physician's decision|1|||
125251404|NCT01791205|450546000|FG001|Phase II|Physician's decision|0|||
125251405|NCT04985682|450546003|FG000|Overall Study|Withdrawal by Subject|1|||
125251406|NCT01546987|450546006|FG000|Overall Study|Protocol Violation|3|||
125251407|NCT01546987|450546007|FG001|Overall Study|Protocol Violation|4|||
125251408|NCT03878602|450546012|FG000|Overall Study|cord blood donation|7|||
125251409|NCT03878602|450546013|FG001|Overall Study|cord blood donation|1|||
125251410|NCT03878602|450546012|FG000|Overall Study|incomplete data collection|2|||
125251411|NCT03878602|450546013|FG001|Overall Study|incomplete data collection|0|||
125251412|NCT00452530|450546014|FG000|Overall Study|Death|1|||
125251413|NCT00452530|450546015|FG001|Overall Study|Death|0|||
125251414|NCT00452530|450546014|FG000|Overall Study|Adverse Event|40|||
125251415|NCT00452530|450546015|FG001|Overall Study|Adverse Event|44|||
125251416|NCT00452530|450546014|FG000|Overall Study|Withdrawal by Subject|68|||
125251417|NCT00452530|450546015|FG001|Overall Study|Withdrawal by Subject|57|||
125251418|NCT00452530|450546014|FG000|Overall Study|Lost to Follow-up|1|||
125251419|NCT00452530|450546015|FG001|Overall Study|Lost to Follow-up|0|||
125251420|NCT00452530|450546014|FG000|Overall Study|Poor compliance/noncompliance|1|||
125251421|NCT00452530|450546015|FG001|Overall Study|Poor compliance/noncompliance|2|||
125251422|NCT00452530|450546014|FG000|Overall Study|No longer met study criteria|18|||
125251423|NCT00452530|450546015|FG001|Overall Study|No longer met study criteria|22|||
125251424|NCT00452530|450546014|FG000|Overall Study|Other|7|||
125251425|NCT00452530|450546015|FG001|Overall Study|Other|11|||
125251426|NCT02191397|450546016|FG000|Overall Study|Adverse Event|28|||
125251427|NCT02191397|450546017|FG001|Overall Study|Adverse Event|17|||
125251428|NCT02191397|450546016|FG000|Overall Study|Lack of Efficacy|10|||
125251429|NCT02191397|450546017|FG001|Overall Study|Lack of Efficacy|5|||
125251430|NCT02191397|450546016|FG000|Overall Study|Protocol Violation|0|||
125251431|NCT02191397|450546017|FG001|Overall Study|Protocol Violation|3|||
125251432|NCT02191397|450546016|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
125251433|NCT02191397|450546017|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
125251434|NCT02191397|450546016|FG000|Overall Study|Lost to Follow-up|10|||
125251435|NCT02191397|450546017|FG001|Overall Study|Lost to Follow-up|11|||
125251436|NCT02191397|450546016|FG000|Overall Study|Physician Decision|8|||
125251437|NCT02191397|450546017|FG001|Overall Study|Physician Decision|3|||
125251438|NCT02191397|450546016|FG000|Overall Study|Withdrawal by Subject|22|||
125251439|NCT02191397|450546017|FG001|Overall Study|Withdrawal by Subject|27|||
125251440|NCT04629521|450546018|FG000|Overall Study|Death|1|||
125251441|NCT04629521|450546018|FG000|Overall Study|Lost to Follow-up|3|||
125251442|NCT04629521|450546018|FG000|Overall Study|Subject withdrew consent|3|||
125251443|NCT04629521|450546018|FG000|Overall Study|Enrolled in error|1|||
125251444|NCT01618708|450546019|FG000|Overall Study|Adverse Event|10|||
125251445|NCT01618708|450546020|FG001|Overall Study|Adverse Event|10|||
125251446|NCT01618708|450546019|FG000|Overall Study|Lost to Follow-up|3|||
125251447|NCT01618708|450546020|FG001|Overall Study|Lost to Follow-up|3|||
125251448|NCT01618708|450546019|FG000|Overall Study|Withdrawal by Subject|17|||
125251449|NCT01618708|450546020|FG001|Overall Study|Withdrawal by Subject|22|||
125251450|NCT01618708|450546019|FG000|Overall Study|Lack of Efficacy|8|||
125251451|NCT01618708|450546020|FG001|Overall Study|Lack of Efficacy|8|||
125251452|NCT01618708|450546019|FG000|Overall Study|Technical problems|2|||
125251453|NCT01618708|450546020|FG001|Overall Study|Technical problems|0|||
125251454|NCT01618708|450546019|FG000|Overall Study|Other than specified above|1|||
125251455|NCT01618708|450546020|FG001|Overall Study|Other than specified above|1|||
125251456|NCT01618708|450546019|FG000|Overall Study|Randomized but not treated|3|||
125251457|NCT01618708|450546020|FG001|Overall Study|Randomized but not treated|2|||
125251458|NCT02554474|450546023|FG000|Overall Study|Protocol Violation|1|||
125251459|NCT02554474|450546024|FG001|Overall Study|Protocol Violation|1|||
125251460|NCT02554474|450546023|FG000|Overall Study|Health issue not related to the study|1|||
125251461|NCT02554474|450546024|FG001|Overall Study|Health issue not related to the study|0|||
125251462|NCT02554474|450546023|FG000|Overall Study|Withdrawal by Subject|1|||
125251463|NCT02554474|450546024|FG001|Overall Study|Withdrawal by Subject|1|||
125251464|NCT03211832|450546025|FG000|Overall Study|No longer with agency|32|||
125251465|NCT03211832|450546026|FG001|Overall Study|No longer with agency|49|||
125251466|NCT03211832|450546027|FG002|Overall Study|No longer with agency|30|||
125251467|NCT03211832|450546025|FG000|Overall Study|Declined survey|3|||
125251468|NCT03211832|450546026|FG001|Overall Study|Declined survey|3|||
125251469|NCT03211832|450546027|FG002|Overall Study|Declined survey|2|||
125251470|NCT03211832|450546025|FG000|Overall Study|Not available during data collection|1|||
125251471|NCT03211832|450546026|FG001|Overall Study|Not available during data collection|0|||
125251472|NCT03211832|450546027|FG002|Overall Study|Not available during data collection|2|||
125251473|NCT02991859|450546031|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251474|NCT02991859|450546032|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
125251475|NCT02991859|450546033|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251476|NCT02991859|450546034|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251477|NCT02991859|450546035|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
125251478|NCT02991859|450546036|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251479|NCT02991859|450546037|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251480|NCT02991859|450546038|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251481|NCT02991859|450546039|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251482|NCT02991859|450546040|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251483|NCT02991859|450546041|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251484|NCT02991859|450546042|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251485|NCT02991859|450546043|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251486|NCT02991859|450546044|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251487|NCT02991859|450546045|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251488|NCT02991859|450546046|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251489|NCT02991859|450546047|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
125251490|NCT02991859|450546031|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251491|NCT02991859|450546032|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251492|NCT02991859|450546033|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251493|NCT02991859|450546034|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251494|NCT02991859|450546035|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251495|NCT02991859|450546036|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251496|NCT02991859|450546037|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251497|NCT02991859|450546038|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251498|NCT02991859|450546039|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251499|NCT02991859|450546040|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251500|NCT02991859|450546041|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251501|NCT02991859|450546042|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251502|NCT02991859|450546043|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
125251503|NCT02991859|450546044|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
125251504|NCT02991859|450546045|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251505|NCT02991859|450546046|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251506|NCT02991859|450546047|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
125251507|NCT02991859|450546031|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251508|NCT02991859|450546032|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251509|NCT02991859|450546033|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251510|NCT02991859|450546034|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251511|NCT02991859|450546035|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251512|NCT02991859|450546036|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
125251513|NCT02991859|450546037|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251514|NCT02991859|450546038|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251515|NCT02991859|450546039|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251516|NCT02991859|450546040|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251517|NCT02991859|450546041|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251518|NCT02991859|450546042|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251519|NCT02991859|450546043|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251520|NCT02991859|450546044|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251521|NCT02991859|450546045|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251522|NCT02991859|450546046|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251523|NCT02991859|450546047|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
125251524|NCT02991859|450546031|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251525|NCT02991859|450546032|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251526|NCT02991859|450546033|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251527|NCT02991859|450546034|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251528|NCT02991859|450546035|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251529|NCT02991859|450546036|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251530|NCT02991859|450546037|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251531|NCT02991859|450546038|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251532|NCT02991859|450546039|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251533|NCT02991859|450546040|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
125251534|NCT02991859|450546041|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251535|NCT02991859|450546042|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251536|NCT02991859|450546043|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251537|NCT02991859|450546044|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251538|NCT02991859|450546045|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251539|NCT02991859|450546046|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251540|NCT02991859|450546047|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
125251541|NCT02991859|450546031|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251542|NCT02991859|450546032|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251543|NCT02991859|450546033|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251544|NCT02991859|450546034|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251545|NCT02991859|450546035|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251546|NCT02991859|450546036|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251547|NCT02991859|450546037|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251548|NCT02991859|450546038|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251549|NCT02991859|450546039|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
125251550|NCT02991859|450546040|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251551|NCT02991859|450546041|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251552|NCT02991859|450546042|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251553|NCT02991859|450546043|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251554|NCT02991859|450546044|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251555|NCT02991859|450546045|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251556|NCT02991859|450546046|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251557|NCT02991859|450546047|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
125251558|NCT01065766|450546048|FG000|Overall Study|Assessed before the contracted date|1|||
125251559|NCT01065766|450546048|FG000|Overall Study|Contraindication to administration|6|||
125251560|NCT01065766|450546048|FG000|Overall Study|Violated dosage/administration|25|||
125251561|NCT04223687|450546055|FG000|Overall Study|Missing primary outcome|1|||
125251562|NCT04223687|450546056|FG001|Overall Study|Missing primary outcome|0|||
125251563|NCT00425854|450546057|FG000|Overall Study|Progressive Disease|19|||
125251564|NCT00425854|450546058|FG001|Overall Study|Progressive Disease|12|||
125251565|NCT00425854|450546057|FG000|Overall Study|Dose reduction toxicity AE|8|||
125251566|NCT00425854|450546058|FG001|Overall Study|Dose reduction toxicity AE|7|||
125251567|NCT00425854|450546057|FG000|Overall Study|Other Adverse Event|2|||
125251568|NCT00425854|450546058|FG001|Overall Study|Other Adverse Event|2|||
125251569|NCT05652140|450546062|FG000|Overall Study|Lost to Follow-up|7|||
125251570|NCT05652140|450546063|FG001|Overall Study|Lost to Follow-up|16|||
125251571|NCT05652140|450546064|FG002|Overall Study|Lost to Follow-up|22|||
125251572|NCT05652140|450546065|FG003|Overall Study|Lost to Follow-up|31|||
125251573|NCT06048705|450546068|FG000|Overall Study|Physician Decision|1|||
125251574|NCT06048705|450546069|FG001|Overall Study|Physician Decision|0|||
125251575|NCT06048705|450546070|FG002|Overall Study|Physician Decision|0|||
125251576|NCT06048705|450546068|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
125251577|NCT06048705|450546069|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
125251578|NCT06048705|450546070|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
125251579|NCT06048705|450546068|FG000|Overall Study|Death prior to lymphodepletion|0|||
125251580|NCT06048705|450546069|FG001|Overall Study|Death prior to lymphodepletion|0|||
125251581|NCT06048705|450546070|FG002|Overall Study|Death prior to lymphodepletion|1|||
125251582|NCT01016015|450546071|FG000|Overall Study|Not Treated|3|||
125251583|NCT01016015|450546071|FG000|Overall Study|Withdrawal by Subject|1|||
125251584|NCT01016015|450546071|FG000|Overall Study|Adverse Event|15|||
125251585|NCT02057666|450546072|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
125251586|NCT02057666|450546073|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
125251587|NCT02057666|450546072|FG000|Double Blind Treatment Period|Poor tolerability|7|||
125251588|NCT02057666|450546073|FG001|Double Blind Treatment Period|Poor tolerability|2|||
125251589|NCT02057666|450546072|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
125251590|NCT02057666|450546073|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
125251591|NCT02057666|450546072|FG000|Double Blind Treatment Period|Physician Decision|1|||
125251592|NCT02057666|450546073|FG001|Double Blind Treatment Period|Physician Decision|0|||
125251593|NCT02057666|450546072|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
125251594|NCT02057666|450546073|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
125251595|NCT02057666|450546072|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
125251596|NCT02057666|450546073|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
125251597|NCT02057666|450546072|FG000|Double Blind Treatment Period|Sponsor's request|70|||
125251598|NCT02057666|450546073|FG001|Double Blind Treatment Period|Sponsor's request|34|||
125251599|NCT02057666|450546072|FG000|Open-Label Treatment Period|Poor tolerability|0|||
125251600|NCT02057666|450546073|FG001|Open-Label Treatment Period|Poor tolerability|1|||
125251601|NCT02057666|450546072|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
125251602|NCT02057666|450546073|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
125251603|NCT02057666|450546072|FG000|Open-Label Treatment Period|Sponsor's request|0|||
125251604|NCT02057666|450546073|FG001|Open-Label Treatment Period|Sponsor's request|4|||
125251605|NCT00498485|450546078|FG000|Overall Study|Adverse Event|1|||
125251606|NCT00498485|450546079|FG001|Overall Study|Adverse Event|5|||
125251607|NCT01539525|450546080|FG000|Overall Study|Lost to Follow-up|19|||
125251608|NCT01539525|450546081|FG001|Overall Study|Lost to Follow-up|12|||
125251609|NCT01539525|450546082|FG002|Overall Study|Lost to Follow-up|11|||
125251610|NCT01539525|450546080|FG000|Overall Study|Withdrawal by Subject|0|||
125251611|NCT01539525|450546081|FG001|Overall Study|Withdrawal by Subject|3|||
125251612|NCT01539525|450546082|FG002|Overall Study|Withdrawal by Subject|2|||
125251613|NCT01539525|450546080|FG000|Overall Study|Protocol Violation|1|||
125251614|NCT01539525|450546081|FG001|Overall Study|Protocol Violation|1|||
125251615|NCT01539525|450546082|FG002|Overall Study|Protocol Violation|4|||
125251616|NCT01712074|450546083|FG000|Placebo Run-in Period|Adverse Event|2|||
125251617|NCT01712074|450546084|FG001|Placebo Run-in Period|Adverse Event|0|||
125251618|NCT01712074|450546085|FG002|Placebo Run-in Period|Adverse Event|0|||
125251619|NCT01712074|450546083|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
125251620|NCT01712074|450546084|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
125251621|NCT01712074|450546085|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
125251622|NCT01712074|450546083|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
125251623|NCT01712074|450546084|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
125251624|NCT01712074|450546085|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
125251625|NCT01712074|450546083|FG000|Placebo Run-in Period|Other|1|||
125251626|NCT01712074|450546084|FG001|Placebo Run-in Period|Other|0|||
125251627|NCT01712074|450546085|FG002|Placebo Run-in Period|Other|0|||
125251628|NCT01712074|450546083|FG000|Placebo Run-in Period|No longer willing to participate|1|||
125251629|NCT01712074|450546084|FG001|Placebo Run-in Period|No longer willing to participate|0|||
125251630|NCT01712074|450546085|FG002|Placebo Run-in Period|No longer willing to participate|0|||
125251631|NCT01712074|450546083|FG000|Double Blind Period|Adverse Event|0|||
125251632|NCT01712074|450546084|FG001|Double Blind Period|Adverse Event|2|||
125251633|NCT01712074|450546085|FG002|Double Blind Period|Adverse Event|1|||
125251634|NCT01712074|450546083|FG000|Double Blind Period|No longer willing to participate|0|||
125251635|NCT01712074|450546084|FG001|Double Blind Period|No longer willing to participate|2|||
125251636|NCT01712074|450546085|FG002|Double Blind Period|No longer willing to participate|4|||
125251637|NCT01712074|450546083|FG000|Double Blind Period|Death|0|||
125251638|NCT01712074|450546084|FG001|Double Blind Period|Death|1|||
125251639|NCT01712074|450546085|FG002|Double Blind Period|Death|0|||
125251640|NCT01712074|450546083|FG000|Double Blind Period|Lost to Follow-up|0|||
125251641|NCT01712074|450546084|FG001|Double Blind Period|Lost to Follow-up|2|||
125251642|NCT01712074|450546085|FG002|Double Blind Period|Lost to Follow-up|1|||
125251643|NCT01712074|450546083|FG000|Double Blind Period|Other|0|||
125251644|NCT01712074|450546084|FG001|Double Blind Period|Other|4|||
125251645|NCT01712074|450546085|FG002|Double Blind Period|Other|1|||
125251646|NCT01712074|450546083|FG000|Double Blind Period|Protocol Violation|0|||
125251647|NCT01712074|450546084|FG001|Double Blind Period|Protocol Violation|0|||
125251648|NCT01712074|450546085|FG002|Double Blind Period|Protocol Violation|1|||
125251649|NCT01712074|450546083|FG000|Double Blind Period|No longer met eligibility criteria|0|||
125251650|NCT01712074|450546084|FG001|Double Blind Period|No longer met eligibility criteria|3|||
125251651|NCT01712074|450546085|FG002|Double Blind Period|No longer met eligibility criteria|0|||
125251652|NCT01472835|450546088|FG000|Overall Study|Lost to Follow-up|2|||
125251653|NCT01472835|450546089|FG001|Overall Study|Lost to Follow-up|0|||
125251654|NCT02792257|450546095|FG000|Overall Study|Lost to Follow-up|3|||
125251655|NCT02792257|450546096|FG001|Overall Study|Lost to Follow-up|4|||
125251656|NCT02792257|450546095|FG000|Overall Study|Allergy|0|||
125251657|NCT02792257|450546096|FG001|Overall Study|Allergy|1|||
125251658|NCT02792257|450546095|FG000|Overall Study|Protocol Violation|2|||
125251659|NCT02792257|450546096|FG001|Overall Study|Protocol Violation|0|||
125251660|NCT02792257|450546095|FG000|Overall Study|Excessive Agitation|0|||
125251661|NCT02792257|450546096|FG001|Overall Study|Excessive Agitation|1|||
125251662|NCT02792257|450546095|FG000|Overall Study|Not Feeling Well|0|||
125251663|NCT02792257|450546096|FG001|Overall Study|Not Feeling Well|1|||
125251664|NCT00553475|450546097|FG000|Overall Study|Adverse Event|7|||
125251665|NCT00553475|450546098|FG001|Overall Study|Adverse Event|17|||
125251666|NCT00553475|450546099|FG002|Overall Study|Adverse Event|13|||
125251667|NCT00553475|450546097|FG000|Overall Study|Lack of Efficacy|7|||
125251668|NCT00553475|450546098|FG001|Overall Study|Lack of Efficacy|1|||
125251669|NCT00553475|450546099|FG002|Overall Study|Lack of Efficacy|0|||
125251670|NCT00553475|450546097|FG000|Overall Study|Withdrawal by Subject|1|||
125251671|NCT00553475|450546098|FG001|Overall Study|Withdrawal by Subject|1|||
125251672|NCT00553475|450546099|FG002|Overall Study|Withdrawal by Subject|0|||
125251673|NCT00553475|450546097|FG000|Overall Study|Physician Decision|1|||
125251674|NCT00553475|450546098|FG001|Overall Study|Physician Decision|0|||
125251675|NCT00553475|450546099|FG002|Overall Study|Physician Decision|0|||
125251676|NCT00553475|450546097|FG000|Overall Study|Due to moving|0|||
125251677|NCT00553475|450546098|FG001|Overall Study|Due to moving|1|||
125251678|NCT00553475|450546099|FG002|Overall Study|Due to moving|0|||
125251679|NCT01905683|450546102|FG000|Overall Study|Protocol Violation|1|||
125251680|NCT01905683|450546102|FG000|Overall Study|Re-injection criteria not met; others|13|||
125251681|NCT01905683|450546102|FG000|Overall Study|Physician Decision|1|||
125251682|NCT01905683|450546102|FG000|Overall Study|Lack of Efficacy|8|||
125251683|NCT01905683|450546102|FG000|Overall Study|Withdrawal by Subject|20|||
125251684|NCT01905683|450546102|FG000|Overall Study|Adverse Event|4|||
125251685|NCT01905683|450546102|FG000|Overall Study|Lost to Follow-up|4|||
125251686|NCT02568254|450546104|FG000|Period 2|Adverse Event|0|||
125251687|NCT02568254|450546105|FG001|Period 2|Adverse Event|0|||
125251688|NCT02568254|450546106|FG002|Period 2|Adverse Event|1|||
125251689|NCT02568254|450546107|FG003|Period 2|Adverse Event|0|||
125251690|NCT02568254|450546108|FG004|Period 2|Adverse Event|0|||
125251691|NCT02568254|450546109|FG005|Period 2|Adverse Event|0|||
125251692|NCT02568254|450546104|FG000|Period 3|Unstatisfactory Lens fitting|0|||
125251693|NCT02568254|450546105|FG001|Period 3|Unstatisfactory Lens fitting|0|||
125251694|NCT02568254|450546106|FG002|Period 3|Unstatisfactory Lens fitting|0|||
125251695|NCT02568254|450546107|FG003|Period 3|Unstatisfactory Lens fitting|0|||
125251696|NCT02568254|450546108|FG004|Period 3|Unstatisfactory Lens fitting|1|||
125251697|NCT02568254|450546109|FG005|Period 3|Unstatisfactory Lens fitting|0|||
125251698|NCT01832038|450548041|FG000|Overall Study|Death|5|||
125251699|NCT01832038|450548041|FG000|Overall Study|Adverse Event|50|||
125251700|NCT01832038|450548041|FG000|Overall Study|Lack of Efficacy|81|||
125251701|NCT01832038|450548041|FG000|Overall Study|Protocol Violation|7|||
125251702|NCT01832038|450548041|FG000|Overall Study|Lost to Follow-up|10|||
125251703|NCT01832038|450548041|FG000|Overall Study|Withdrawal by Subject|49|||
125251704|NCT01832038|450548041|FG000|Overall Study|Visit non-compliance|2|||
125251705|NCT01832038|450548041|FG000|Overall Study|Subject refused to return visit|2|||
125251706|NCT01832038|450548041|FG000|Overall Study|Not convenient to come back to site|2|||
125251707|NCT01832038|450548041|FG000|Overall Study|Participant was asked to quit|5|||
125251708|NCT01832038|450548041|FG000|Overall Study|Back home|1|||
125251709|NCT01832038|450548041|FG000|Overall Study|Pregnancy|1|||
125251710|NCT01832038|450548041|FG000|Overall Study|Low compliance|3|||
125251711|NCT01832038|450548041|FG000|Overall Study|Prohibit procedure|2|||
125251712|NCT01832038|450548041|FG000|Overall Study|Not possible to visit the hospital|1|||
125251713|NCT01832038|450548041|FG000|Overall Study|Changes of implementation system|3|||
125251714|NCT01832038|450548041|FG000|Overall Study|Plan to pregnancy|7|||
125251715|NCT01832038|450548041|FG000|Overall Study|Bad mood and has suicidal thought|1|||
125251716|NCT01832038|450548041|FG000|Overall Study|Prohibited concomitant medication|1|||
125251717|NCT01832038|450548041|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
125251718|NCT01832038|450548041|FG000|Overall Study|Subject considered the efficacy was poor|1|||
125251719|NCT00101400|450548046|FG000|Survival Follow-Up|Alive|7|||
125251720|NCT05333965|450548067|FG000|First Intervention|Adverse Event|0|||
125251721|NCT05333965|450548068|FG001|First Intervention|Adverse Event|1|||
125251722|NCT05333965|450548067|FG000|First Intervention|Withdrawal by Subject|0|||
125251723|NCT05333965|450548068|FG001|First Intervention|Withdrawal by Subject|1|||
125251724|NCT00382863|450548069|FG000|Overall Study|Death|9|||
125251725|NCT00382863|450548070|FG001|Overall Study|Death|9|||
125251726|NCT00382863|450548069|FG000|Overall Study|Lost to Follow-up|1|||
125251727|NCT00382863|450548070|FG001|Overall Study|Lost to Follow-up|2|||
125251728|NCT00382863|450548069|FG000|Overall Study|Withdrawal by Subject|5|||
125251729|NCT00382863|450548070|FG001|Overall Study|Withdrawal by Subject|25|||
125251730|NCT02168439|450548071|FG000|Overall Study|Protocol Violation|0|||
125251731|NCT02168439|450548072|FG001|Overall Study|Protocol Violation|2|||
125251732|NCT00605657|450548074|FG000|Overall Study|Adverse Event|1|||
125251733|NCT00605657|450548074|FG000|Overall Study|Protocol Violation|1|||
125251734|NCT02180672|450548075|FG000|Overall Study|Lost to Follow-up|5|||
125251735|NCT02180672|450548076|FG001|Overall Study|Lost to Follow-up|7|||
125251736|NCT02837952|450548077|FG000|Overall Study|Adverse Event|0|||
125251737|NCT02837952|450548078|FG001|Overall Study|Adverse Event|1|||
125251738|NCT02837952|450548077|FG000|Overall Study|Withdrawal by Subject|4|||
125251739|NCT02837952|450548078|FG001|Overall Study|Withdrawal by Subject|5|||
125251740|NCT02837952|450548077|FG000|Overall Study|Medication Error|1|||
125251741|NCT02837952|450548078|FG001|Overall Study|Medication Error|0|||
125251742|NCT01362530|450548079|FG000|Base Study (Cycle 1)|Adverse Event|2|||
125251743|NCT01362530|450548080|FG001|Base Study (Cycle 1)|Adverse Event|0|||
125251744|NCT01362530|450548079|FG000|Base Study (Cycle 1)|Physician Decision|0|||
125251745|NCT01362530|450548080|FG001|Base Study (Cycle 1)|Physician Decision|1|||
125251746|NCT01362530|450548079|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
125251747|NCT01362530|450548080|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
125251748|NCT01362530|450548079|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
125251749|NCT01362530|450548080|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
125251750|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
125251751|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
125251752|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
125251753|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
125251754|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
125251755|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
125251756|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
125251757|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
125251758|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
125251759|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
125251760|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
125251761|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
125251762|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
125251763|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
125251764|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
125251765|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
125251766|NCT01362530|450548079|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
125251767|NCT01362530|450548080|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
125251768|NCT03021005|450548092|FG000|Overall Study|Lost to Follow-up|39|||
125251769|NCT03021005|450548093|FG001|Overall Study|Lost to Follow-up|26|||
125251770|NCT00276380|450548094|FG000|Overall Study|Adverse Event|5|||
125251771|NCT00276380|450548095|FG001|Overall Study|Adverse Event|3|||
125251772|NCT00276380|450548094|FG000|Overall Study|Lost to Follow-up|1|||
125251773|NCT00276380|450548095|FG001|Overall Study|Lost to Follow-up|1|||
125251774|NCT00276380|450548094|FG000|Overall Study|Withdrawal by Subject|3|||
125251775|NCT00276380|450548095|FG001|Overall Study|Withdrawal by Subject|6|||
125251776|NCT00276380|450548094|FG000|Overall Study|Death|5|||
125251777|NCT00276380|450548095|FG001|Overall Study|Death|3|||
125251778|NCT00276380|450548094|FG000|Overall Study|Abnormal aPPT Levels|0|||
125251779|NCT00276380|450548095|FG001|Overall Study|Abnormal aPPT Levels|1|||
125251780|NCT03473301|450548096|FG000|Overall Study|Protocol Violation|4|||
125251781|NCT03473301|450548097|FG001|Overall Study|Protocol Violation|0|||
125251782|NCT03473301|450548098|FG002|Overall Study|Protocol Violation|0|||
125251783|NCT03473301|450548096|FG000|Overall Study|Withdrawal by Subject|0|||
125251784|NCT03473301|450548097|FG001|Overall Study|Withdrawal by Subject|1|||
125251785|NCT03473301|450548098|FG002|Overall Study|Withdrawal by Subject|0|||
125251786|NCT03473301|450548096|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
125251787|NCT03473301|450548097|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
125251788|NCT03473301|450548098|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
125251789|NCT04829214|450548099|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
125251790|NCT04829214|450548100|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
125251791|NCT04829214|450548099|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
125251792|NCT04829214|450548100|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
125251793|NCT02571244|450548102|FG000|Overall Study|Lost to Follow-up|0|||
125251794|NCT02571244|450548103|FG001|Overall Study|Lost to Follow-up|1|||
125251795|NCT02571244|450548102|FG000|Overall Study|Unable to reach out post discharge|3|||
125251796|NCT02571244|450548103|FG001|Overall Study|Unable to reach out post discharge|0|||
125251797|NCT01696214|450548105|FG000|Overall Study|Lost to Follow-up|1|||
125251798|NCT01696214|450548106|FG001|Overall Study|Lost to Follow-up|0|||
125251799|NCT01696214|450548107|FG002|Overall Study|Lost to Follow-up|0|||
125251800|NCT01696214|450548108|FG003|Overall Study|Lost to Follow-up|0|||
125251801|NCT01905267|450548110|FG000|Overall Study|Physician Decision|2|||
125251802|NCT01905267|450548111|FG001|Overall Study|Physician Decision|2|||
125251803|NCT03888482|450548112|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
125251804|NCT03888482|450548113|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
125251805|NCT03888482|450548112|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
125251806|NCT03888482|450548113|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
125251807|NCT01630811|450548116|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
125251808|NCT01630811|450548117|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
125251809|NCT04818086|450548120|FG000|Overall Study|Physician Decision|1|||
125251810|NCT04818086|450548121|FG001|Overall Study|Physician Decision|0|||
125251811|NCT04818086|450548120|FG000|Overall Study|Withdrawal by Subject|0|||
125251812|NCT04818086|450548121|FG001|Overall Study|Withdrawal by Subject|1|||
125251813|NCT01725308|450548123|FG000|Treatment Period I|Did Not Receive Drug|1|||
125251814|NCT01725308|450548124|FG001|Treatment Period I|Did Not Receive Drug|0|||
125251815|NCT01725308|450548125|FG002|Treatment Period I|Did Not Receive Drug|0|||
125251816|NCT01725308|450548123|FG000|Treatment Period I|Adverse Event|5|||
125251817|NCT01725308|450548124|FG001|Treatment Period I|Adverse Event|4|||
125251818|NCT01725308|450548125|FG002|Treatment Period I|Adverse Event|21|||
125251819|NCT01725308|450548123|FG000|Treatment Period I|Insufficient Response|7|||
125251820|NCT01725308|450548124|FG001|Treatment Period I|Insufficient Response|0|||
125444159|NCT01474512|451253895|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125444160|NCT01474512|451253896|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125251821|NCT01725308|450548125|FG002|Treatment Period I|Insufficient Response|5|||
125251822|NCT01725308|450548123|FG000|Treatment Period I|Worsening of the Target Disease|8|||
125251823|NCT01725308|450548124|FG001|Treatment Period I|Worsening of the Target Disease|0|||
125251824|NCT01725308|450548125|FG002|Treatment Period I|Worsening of the Target Disease|2|||
125251825|NCT01725308|450548123|FG000|Treatment Period I|Changes in the Episodes|3|||
125197457|NCT03891862|450343976|FG000|Open-label Period|Death|1|||
125197458|NCT03891862|450343977|FG001|Open-label Period|Death|0|||
125197459|NCT03891862|450343978|FG002|Open-label Period|Death|0|||
125197460|NCT03891862|450343976|FG000|Open-label Period|Lost to Follow-up|2|||
125197461|NCT03891862|450343977|FG001|Open-label Period|Lost to Follow-up|0|||
125197462|NCT03891862|450343978|FG002|Open-label Period|Lost to Follow-up|0|||
125197463|NCT03891862|450343976|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
125197464|NCT03891862|450343977|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
125197465|NCT03891862|450343978|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
125197466|NCT03891862|450343976|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
125197467|NCT03891862|450343977|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
125197468|NCT03891862|450343978|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
125197469|NCT03891862|450343976|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
125197470|NCT03891862|450343977|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
125197471|NCT03891862|450343978|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
125197472|NCT03891862|450343976|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
125197473|NCT03891862|450343977|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
125197474|NCT03891862|450343978|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
125197475|NCT05239494|450343979|FG000|Overall Study|Lost to Follow-up|1|||
125197476|NCT01053962|450343980|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
125251826|NCT01725308|450548124|FG001|Treatment Period I|Changes in the Episodes|0|||
125251827|NCT01725308|450548125|FG002|Treatment Period I|Changes in the Episodes|2|||
125251828|NCT01725308|450548123|FG000|Treatment Period I|Withdrawal of Consent|12|||
125251829|NCT01725308|450548124|FG001|Treatment Period I|Withdrawal of Consent|7|||
125251830|NCT01725308|450548125|FG002|Treatment Period I|Withdrawal of Consent|5|||
125251831|NCT01725308|450548123|FG000|Treatment Period I|Lost to Follow-up|3|||
125251832|NCT01725308|450548124|FG001|Treatment Period I|Lost to Follow-up|2|||
125251833|NCT01725308|450548125|FG002|Treatment Period I|Lost to Follow-up|2|||
125251834|NCT01725308|450548123|FG000|Treatment Period I|Protocol Deviations|3|||
125251835|NCT01725308|450548124|FG001|Treatment Period I|Protocol Deviations|1|||
125251836|NCT01725308|450548125|FG002|Treatment Period I|Protocol Deviations|1|||
125251837|NCT01725308|450548123|FG000|Treatment Period I|Miscellaneous|2|||
125251838|NCT01725308|450548124|FG001|Treatment Period I|Miscellaneous|0|||
125251839|NCT01725308|450548125|FG002|Treatment Period I|Miscellaneous|3|||
125251840|NCT01725308|450548123|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
125251841|NCT01725308|450548124|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
125251842|NCT01725308|450548125|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
125251843|NCT01725308|450548123|FG000|Treatment Period II|Did Not Receive Drug|4|||
125251844|NCT01725308|450548124|FG001|Treatment Period II|Did Not Receive Drug|0|||
125251845|NCT01725308|450548125|FG002|Treatment Period II|Did Not Receive Drug|0|||
125251846|NCT01725308|450548123|FG000|Treatment Period II|Adverse Event|13|||
125251847|NCT01725308|450548124|FG001|Treatment Period II|Adverse Event|8|||
125251848|NCT01725308|450548125|FG002|Treatment Period II|Adverse Event|20|||
125251849|NCT01725308|450548123|FG000|Treatment Period II|Insufficient Response|2|||
125251850|NCT01725308|450548124|FG001|Treatment Period II|Insufficient Response|4|||
125251851|NCT01725308|450548125|FG002|Treatment Period II|Insufficient Response|6|||
125251852|NCT01725308|450548123|FG000|Treatment Period II|Worsening of the Target Disease|1|||
125251853|NCT01725308|450548124|FG001|Treatment Period II|Worsening of the Target Disease|4|||
125251854|NCT01725308|450548125|FG002|Treatment Period II|Worsening of the Target Disease|2|||
125251855|NCT01725308|450548123|FG000|Treatment Period II|Changes in the Episodes|1|||
125251856|NCT01725308|450548124|FG001|Treatment Period II|Changes in the Episodes|0|||
125251857|NCT01725308|450548125|FG002|Treatment Period II|Changes in the Episodes|5|||
125251858|NCT01725308|450548123|FG000|Treatment Period II|Withdrawal of Consent|28|||
125251859|NCT01725308|450548124|FG001|Treatment Period II|Withdrawal of Consent|2|||
125251860|NCT01725308|450548125|FG002|Treatment Period II|Withdrawal of Consent|16|||
125251861|NCT01725308|450548123|FG000|Treatment Period II|Lost to Follow-up|1|||
125251862|NCT01725308|450548124|FG001|Treatment Period II|Lost to Follow-up|5|||
125251863|NCT01725308|450548125|FG002|Treatment Period II|Lost to Follow-up|3|||
125251864|NCT01725308|450548123|FG000|Treatment Period II|Protocol Deviations|0|||
125251865|NCT01725308|450548124|FG001|Treatment Period II|Protocol Deviations|0|||
125251866|NCT01725308|450548125|FG002|Treatment Period II|Protocol Deviations|1|||
125251867|NCT01725308|450548123|FG000|Treatment Period II|Miscellaneous|5|||
125251868|NCT01725308|450548124|FG001|Treatment Period II|Miscellaneous|3|||
125251869|NCT01725308|450548125|FG002|Treatment Period II|Miscellaneous|7|||
125251870|NCT04128228|450548126|FG000|Overall Study|Withdrawal by Subject|3|||
125251871|NCT04128228|450548127|FG001|Overall Study|Withdrawal by Subject|3|||
125251872|NCT04128228|450548128|FG002|Overall Study|Withdrawal by Subject|0|||
125251873|NCT04128228|450548129|FG003|Overall Study|Withdrawal by Subject|0|||
125251874|NCT04128228|450548126|FG000|Overall Study|noncompliance|2|||
125251875|NCT04128228|450548127|FG001|Overall Study|noncompliance|2|||
125251876|NCT04128228|450548128|FG002|Overall Study|noncompliance|0|||
125251877|NCT04128228|450548129|FG003|Overall Study|noncompliance|0|||
125251878|NCT03511209|450548130|FG000|Overall Study|Withdrawal by Subject|2|||
125251879|NCT03511209|450548131|FG001|Overall Study|Withdrawal by Subject|4|||
125251880|NCT03511209|450548130|FG000|Overall Study|Death|1|||
125251881|NCT03511209|450548131|FG001|Overall Study|Death|0|||
125251882|NCT03511209|450548130|FG000|Overall Study|Lost to Follow-up|0|||
125251883|NCT03511209|450548131|FG001|Overall Study|Lost to Follow-up|2|||
125251884|NCT03163264|450548132|FG000|Overall Study|Withdrawal by Subject|13|||
125251885|NCT03163264|450548133|FG001|Overall Study|Withdrawal by Subject|3|||
125251886|NCT03163264|450548134|FG002|Overall Study|Withdrawal by Subject|4|||
125251887|NCT03163264|450548135|FG003|Overall Study|Withdrawal by Subject|2|||
125251888|NCT03163264|450548132|FG000|Overall Study|Lost to Follow-up|17|||
125251889|NCT03163264|450548133|FG001|Overall Study|Lost to Follow-up|20|||
125251890|NCT03163264|450548134|FG002|Overall Study|Lost to Follow-up|0|||
125251891|NCT03163264|450548135|FG003|Overall Study|Lost to Follow-up|0|||
125251892|NCT03163264|450548132|FG000|Overall Study|Death|0|||
125251893|NCT03163264|450548133|FG001|Overall Study|Death|2|||
125251894|NCT03163264|450548134|FG002|Overall Study|Death|0|||
125251895|NCT03163264|450548135|FG003|Overall Study|Death|0|||
125251896|NCT01602666|450548136|FG000|Induction Chemotherapy|Death|2|||
125251897|NCT01602666|450548137|FG001|Induction Chemotherapy|Death|1|||
125251898|NCT01602666|450548136|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
125251899|NCT01602666|450548137|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
125251900|NCT01602666|450548136|FG000|Induction Chemotherapy|Physician Decision|12|||
125251901|NCT01602666|450548137|FG001|Induction Chemotherapy|Physician Decision|5|||
125251902|NCT01602666|450548136|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
125251903|NCT01602666|450548137|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
125251904|NCT01602666|450548136|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
125251905|NCT01602666|450548137|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
125251906|NCT01602666|450548136|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
125251907|NCT01602666|450548137|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
125251908|NCT01602666|450548136|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
125251909|NCT01602666|450548137|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
125251910|NCT01602666|450548136|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
125251911|NCT01602666|450548137|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
125251912|NCT01602666|450548136|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
125251913|NCT01602666|450548137|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
125251914|NCT01602666|450548136|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
125251915|NCT01602666|450548137|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
125251916|NCT01602666|450548136|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
125251917|NCT01602666|450548137|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
125251918|NCT00215657|450548142|FG000|Overall Study|Adverse Event|5|||
125251919|NCT00215657|450548143|FG001|Overall Study|Adverse Event|1|||
125251920|NCT00215657|450548144|FG002|Overall Study|Adverse Event|3|||
125251921|NCT00215657|450548145|FG003|Overall Study|Adverse Event|0|||
125251922|NCT00215657|450548146|FG004|Overall Study|Adverse Event|3|||
125251923|NCT00215657|450548147|FG005|Overall Study|Adverse Event|1|||
125251924|NCT00215657|450548148|FG006|Overall Study|Adverse Event|0|||
125251925|NCT00215657|450548149|FG007|Overall Study|Adverse Event|3|||
125251926|NCT00215657|450548142|FG000|Overall Study|Withdrawal by Subject|6|||
125251927|NCT00215657|450548143|FG001|Overall Study|Withdrawal by Subject|3|||
125251928|NCT00215657|450548144|FG002|Overall Study|Withdrawal by Subject|3|||
125251929|NCT00215657|450548145|FG003|Overall Study|Withdrawal by Subject|1|||
125251930|NCT00215657|450548146|FG004|Overall Study|Withdrawal by Subject|6|||
125251931|NCT00215657|450548147|FG005|Overall Study|Withdrawal by Subject|1|||
125251932|NCT00215657|450548148|FG006|Overall Study|Withdrawal by Subject|10|||
125251933|NCT00215657|450548149|FG007|Overall Study|Withdrawal by Subject|3|||
125251934|NCT00215657|450548142|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
125197477|NCT01053962|450343981|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
125197478|NCT01053962|450343982|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
125197479|NCT01053962|450343983|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
125197480|NCT01053962|450343984|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
125197481|NCT01053962|450343980|FG000|Pretreatment Period|Venipuncture Failure|0|||
125197482|NCT01053962|450343981|FG001|Pretreatment Period|Venipuncture Failure|0|||
125197483|NCT01053962|450343982|FG002|Pretreatment Period|Venipuncture Failure|1|||
125197484|NCT01053962|450343983|FG003|Pretreatment Period|Venipuncture Failure|0|||
125197485|NCT01053962|450343984|FG004|Pretreatment Period|Venipuncture Failure|0|||
125197486|NCT01053962|450343980|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
125197487|NCT01053962|450343981|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
125197488|NCT01053962|450343982|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
125197489|NCT01053962|450343983|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
125197490|NCT01053962|450343984|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
125197491|NCT01053962|450343980|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
125197492|NCT01053962|450343981|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
125197493|NCT01053962|450343982|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
125197494|NCT01053962|450343983|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
125197495|NCT01053962|450343984|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
125197496|NCT01053962|450343980|FG000|Treatment Period|Lack of Efficacy|0|||
125197497|NCT01053962|450343981|FG001|Treatment Period|Lack of Efficacy|0|||
125197498|NCT01053962|450343982|FG002|Treatment Period|Lack of Efficacy|0|||
125197499|NCT01053962|450343983|FG003|Treatment Period|Lack of Efficacy|0|||
125197500|NCT01053962|450343984|FG004|Treatment Period|Lack of Efficacy|1|||
125197501|NCT01053962|450343980|FG000|Treatment Period|Adverse Event|0|||
125197502|NCT01053962|450343981|FG001|Treatment Period|Adverse Event|0|||
125197503|NCT01053962|450343982|FG002|Treatment Period|Adverse Event|0|||
125197504|NCT01053962|450343983|FG003|Treatment Period|Adverse Event|0|||
125197505|NCT01053962|450343984|FG004|Treatment Period|Adverse Event|1|||
125197506|NCT01053962|450343980|FG000|Treatment Period|Withdrawal by Subject|0|||
125251935|NCT00215657|450548143|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
125251936|NCT00215657|450548144|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
125251937|NCT00215657|450548145|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
125251938|NCT00215657|450548146|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
125251939|NCT00215657|450548147|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
125251940|NCT00215657|450548148|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
125251941|NCT00215657|450548149|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
125251942|NCT00215657|450548142|FG000|Overall Study|Insufficient testosterone response|5|||
125251943|NCT00215657|450548143|FG001|Overall Study|Insufficient testosterone response|4|||
125251944|NCT00215657|450548144|FG002|Overall Study|Insufficient testosterone response|1|||
125251945|NCT00215657|450548145|FG003|Overall Study|Insufficient testosterone response|12|||
125251946|NCT00215657|450548146|FG004|Overall Study|Insufficient testosterone response|8|||
125251947|NCT00215657|450548147|FG005|Overall Study|Insufficient testosterone response|12|||
125251948|NCT00215657|450548148|FG006|Overall Study|Insufficient testosterone response|4|||
125197507|NCT01053962|450343981|FG001|Treatment Period|Withdrawal by Subject|0|||
125251949|NCT00215657|450548149|FG007|Overall Study|Insufficient testosterone response|7|||
125251950|NCT00215657|450548142|FG000|Overall Study|Other|3|||
125251951|NCT00215657|450548143|FG001|Overall Study|Other|1|||
125251952|NCT00215657|450548144|FG002|Overall Study|Other|2|||
125251953|NCT00215657|450548145|FG003|Overall Study|Other|3|||
125251954|NCT00215657|450548146|FG004|Overall Study|Other|5|||
125251955|NCT00215657|450548147|FG005|Overall Study|Other|4|||
125251956|NCT00215657|450548148|FG006|Overall Study|Other|6|||
125251957|NCT00215657|450548149|FG007|Overall Study|Other|1|||
125251958|NCT03769467|450548150|FG000|Overall Study|Adverse Event|1|||
125251959|NCT03769467|450548151|FG001|Overall Study|Adverse Event|1|||
125251960|NCT03769467|450548152|FG002|Overall Study|Adverse Event|0|||
125251961|NCT03769467|450548150|FG000|Overall Study|Death|3|||
125251962|NCT03769467|450548151|FG001|Overall Study|Death|3|||
125251963|NCT03769467|450548152|FG002|Overall Study|Death|0|||
125251964|NCT03769467|450548150|FG000|Overall Study|Study Terminated By Sponsor|2|||
125251965|NCT03769467|450548151|FG001|Overall Study|Study Terminated By Sponsor|1|||
125251966|NCT03769467|450548152|FG002|Overall Study|Study Terminated By Sponsor|0|||
125251967|NCT03769467|450548150|FG000|Overall Study|Withdrawal by Subject|0|||
125251968|NCT03769467|450548151|FG001|Overall Study|Withdrawal by Subject|1|||
125251969|NCT03769467|450548152|FG002|Overall Study|Withdrawal by Subject|0|||
125251970|NCT02614066|450548153|FG000|Overall Study|Death|6|||
125251971|NCT02614066|450548154|FG001|Overall Study|Death|14|||
125251972|NCT02614066|450548155|FG002|Overall Study|Death|11|||
125251973|NCT02614066|450548156|FG003|Overall Study|Death|29|||
125251974|NCT02614066|450548153|FG000|Overall Study|Full consent withdrawn|0|||
125251975|NCT02614066|450548154|FG001|Overall Study|Full consent withdrawn|1|||
125251976|NCT02614066|450548155|FG002|Overall Study|Full consent withdrawn|0|||
125251977|NCT02614066|450548156|FG003|Overall Study|Full consent withdrawn|8|||
125251978|NCT02614066|450548153|FG000|Overall Study|Lost to Follow-up|0|||
125251979|NCT02614066|450548154|FG001|Overall Study|Lost to Follow-up|2|||
125251980|NCT02614066|450548155|FG002|Overall Study|Lost to Follow-up|2|||
125251981|NCT02614066|450548156|FG003|Overall Study|Lost to Follow-up|2|||
125251982|NCT02614066|450548153|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
125251983|NCT02614066|450548154|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
125251984|NCT02614066|450548155|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
125251985|NCT02614066|450548156|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
125251986|NCT02614066|450548153|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
125251987|NCT02614066|450548154|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
125251988|NCT02614066|450548155|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
125251989|NCT02614066|450548156|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
125251990|NCT02614066|450548153|FG000|Overall Study|Reason not specified|0|||
125251991|NCT02614066|450548154|FG001|Overall Study|Reason not specified|2|||
125251992|NCT02614066|450548155|FG002|Overall Study|Reason not specified|1|||
125251993|NCT02614066|450548156|FG003|Overall Study|Reason not specified|1|||
125251994|NCT04565756|450548157|FG000|Overall Study|Withdrawal by Subject|0|||
125251995|NCT04565756|450548158|FG001|Overall Study|Withdrawal by Subject|0|||
125251996|NCT04565756|450548159|FG002|Overall Study|Withdrawal by Subject|0|||
125251997|NCT04565756|450548160|FG003|Overall Study|Withdrawal by Subject|0|||
125197508|NCT01053962|450343982|FG002|Treatment Period|Withdrawal by Subject|0|||
125197509|NCT01053962|450343983|FG003|Treatment Period|Withdrawal by Subject|0|||
125197510|NCT01053962|450343984|FG004|Treatment Period|Withdrawal by Subject|1|||
125197511|NCT01053962|450343980|FG000|Treatment Period|Noncompliance with protocol|1|||
125197512|NCT01053962|450343981|FG001|Treatment Period|Noncompliance with protocol|0|||
125197513|NCT01053962|450343982|FG002|Treatment Period|Noncompliance with protocol|0|||
125197514|NCT01053962|450343983|FG003|Treatment Period|Noncompliance with protocol|0|||
125197515|NCT01053962|450343984|FG004|Treatment Period|Noncompliance with protocol|0|||
125197516|NCT00937040|450343985|FG000|Overall Study|Adverse Event|5|||
125197517|NCT00937040|450343986|FG001|Overall Study|Adverse Event|8|||
125197518|NCT00937040|450343985|FG000|Overall Study|Lost to Follow-up|12|||
125197519|NCT00937040|450343986|FG001|Overall Study|Lost to Follow-up|12|||
125251998|NCT04565756|450548161|FG004|Overall Study|Withdrawal by Subject|1|||
125251999|NCT04565756|450548162|FG005|Overall Study|Withdrawal by Subject|0|||
125252000|NCT04565756|450548157|FG000|Overall Study|Protocol Violation|0|||
125252001|NCT04565756|450548158|FG001|Overall Study|Protocol Violation|0|||
125197520|NCT00937040|450343985|FG000|Overall Study|Protocol Violation|3|||
125197521|NCT00937040|450343986|FG001|Overall Study|Protocol Violation|0|||
125197522|NCT00937040|450343985|FG000|Overall Study|Withdrawal by Subject|13|||
125252002|NCT04565756|450548159|FG002|Overall Study|Protocol Violation|0|||
125252003|NCT04565756|450548160|FG003|Overall Study|Protocol Violation|0|||
125252004|NCT04565756|450548161|FG004|Overall Study|Protocol Violation|0|||
125252005|NCT04565756|450548162|FG005|Overall Study|Protocol Violation|1|||
125252006|NCT03069937|450548171|FG000|Overall Study|Second primary malignancy noted|1|||
125252007|NCT00968968|450548172|FG000|Overall Study|Study closed/terminated|10|||
125252008|NCT00968968|450548173|FG001|Overall Study|Study closed/terminated|10|||
125252009|NCT00968968|450548172|FG000|Overall Study|Protocol defined stopping criteria|3|||
125252010|NCT00968968|450548173|FG001|Overall Study|Protocol defined stopping criteria|1|||
125252011|NCT00968968|450548172|FG000|Overall Study|Withdrawal by Subject|2|||
125252012|NCT00968968|450548173|FG001|Overall Study|Withdrawal by Subject|0|||
125252013|NCT00968968|450548172|FG000|Overall Study|Physician Decision|1|||
125252014|NCT00968968|450548173|FG001|Overall Study|Physician Decision|2|||
125252015|NCT00968968|450548172|FG000|Overall Study|Lost to Follow-up|0|||
125252016|NCT00968968|450548173|FG001|Overall Study|Lost to Follow-up|1|||
125252017|NCT03624036|450548174|FG000|Overall Study|Death|2|||
125252018|NCT03624036|450548175|FG001|Overall Study|Death|3|||
125252019|NCT03624036|450548176|FG002|Overall Study|Death|0|||
125252020|NCT03624036|450548177|FG003|Overall Study|Death|1|||
125252021|NCT03624036|450548174|FG000|Overall Study|Withdrawal by Subject|1|||
125252022|NCT03624036|450548175|FG001|Overall Study|Withdrawal by Subject|0|||
125252023|NCT03624036|450548176|FG002|Overall Study|Withdrawal by Subject|1|||
125252024|NCT03624036|450548177|FG003|Overall Study|Withdrawal by Subject|0|||
125252025|NCT03624036|450548174|FG000|Overall Study|Enrolled but Never Treated|1|||
125252026|NCT03624036|450548175|FG001|Overall Study|Enrolled but Never Treated|0|||
125252027|NCT03624036|450548176|FG002|Overall Study|Enrolled but Never Treated|0|||
125252028|NCT03624036|450548177|FG003|Overall Study|Enrolled but Never Treated|0|||
125252029|NCT03624036|450548174|FG000|Overall Study|Reason not Specified|3|||
125252030|NCT03624036|450548175|FG001|Overall Study|Reason not Specified|0|||
125252031|NCT03624036|450548176|FG002|Overall Study|Reason not Specified|2|||
125252032|NCT03624036|450548177|FG003|Overall Study|Reason not Specified|2|||
125252033|NCT01185366|450548178|FG000|First Line Therapy|Insurance Coverage Denied|1|||
125252034|NCT01185366|450548179|FG001|First Line Therapy|Insurance Coverage Denied|1|||
125252035|NCT01185366|450548178|FG000|First Line Therapy|Withdrawal by Subject|1|||
125252036|NCT01185366|450548179|FG001|First Line Therapy|Withdrawal by Subject|0|||
125252037|NCT01185366|450548178|FG000|First Line Therapy|Lack of Metastatic Site|1|||
125252038|NCT01185366|450548179|FG001|First Line Therapy|Lack of Metastatic Site|0|||
125252039|NCT01185366|450548178|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
125252040|NCT01185366|450548179|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
125252041|NCT01185366|450548178|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
125252042|NCT01185366|450548179|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
125252043|NCT01185366|450548178|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
125252044|NCT01185366|450548179|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
125252045|NCT01185366|450548178|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
125252046|NCT01185366|450548179|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
125252047|NCT02774278|450548180|FG000|Overall Study|Lack of Efficacy|199|||
125252048|NCT02774278|450548180|FG000|Overall Study|Death|29|||
125252049|NCT02774278|450548180|FG000|Overall Study|Adverse event/intercurrent illness|16|||
125252050|NCT02774278|450548180|FG000|Overall Study|Refused treatment/did not cooperate|9|||
125252051|NCT02774278|450548180|FG000|Overall Study|Administrative reasons|6|||
125252052|NCT02774278|450548180|FG000|Overall Study|Withdrawal by Subject|3|||
125252053|NCT02774278|450548180|FG000|Overall Study|Protocol Violation|2|||
125252054|NCT00127933|450548187|FG000|Overall Study|Randomized but not dosed|1|||
125252055|NCT00127933|450548188|FG001|Overall Study|Randomized but not dosed|0|||
125252056|NCT01783938|450548190|FG000|Overall Study|Disease Progression|18|||
125252057|NCT01783938|450548191|FG001|Overall Study|Disease Progression|41|||
125252058|NCT01783938|450548190|FG000|Overall Study|Study Drug Toxicity|27|||
125252059|NCT01783938|450548191|FG001|Overall Study|Study Drug Toxicity|14|||
125252060|NCT01783938|450548190|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
125252061|NCT01783938|450548191|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
125252062|NCT01783938|450548190|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
125197523|NCT00937040|450343986|FG001|Overall Study|Withdrawal by Subject|7|||
125197524|NCT00937040|450343985|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
125197525|NCT00937040|450343986|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
125197526|NCT00937040|450343985|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
125197527|NCT00937040|450343986|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
125197528|NCT02294396|450343987|FG000|Overall Study|Adverse Event|26|||
125197529|NCT02294396|450343988|FG001|Overall Study|Adverse Event|25|||
125197530|NCT02294396|450343989|FG002|Overall Study|Adverse Event|21|||
125197531|NCT02294396|450343990|FG003|Overall Study|Adverse Event|24|||
125197532|NCT02294396|450343987|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
125197533|NCT02294396|450343988|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
125197534|NCT02294396|450343989|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
125197535|NCT02294396|450343990|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
125197536|NCT02294396|450343987|FG000|Overall Study|Withdrawal by Subject|8|||
125197537|NCT02294396|450343988|FG001|Overall Study|Withdrawal by Subject|6|||
125197538|NCT02294396|450343989|FG002|Overall Study|Withdrawal by Subject|6|||
125252063|NCT01783938|450548191|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
125252064|NCT01783938|450548190|FG000|Overall Study|Participant Withdrew Consent|2|||
125252065|NCT01783938|450548191|FG001|Overall Study|Participant Withdrew Consent|0|||
125197539|NCT02294396|450343990|FG003|Overall Study|Withdrawal by Subject|8|||
125444161|NCT01474512|451253897|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
125444162|NCT01474512|451253880|FG000|Maintenance Period|Adverse Event|0|||
125444163|NCT01474512|451253881|FG001|Maintenance Period|Adverse Event|0|||
125444164|NCT01474512|451253882|FG002|Maintenance Period|Adverse Event|0|||
125444165|NCT01474512|451253883|FG003|Maintenance Period|Adverse Event|4|||
125444166|NCT01474512|451253884|FG004|Maintenance Period|Adverse Event|2|||
125444167|NCT01474512|451253885|FG005|Maintenance Period|Adverse Event|7|||
125444168|NCT01474512|451253886|FG006|Maintenance Period|Adverse Event|0|||
125444169|NCT01474512|451253887|FG007|Maintenance Period|Adverse Event|19|||
125444170|NCT01474512|451253888|FG008|Maintenance Period|Adverse Event|1|||
125444171|NCT01474512|451253889|FG009|Maintenance Period|Adverse Event|3|||
125444172|NCT01474512|451253890|FG010|Maintenance Period|Adverse Event|0|||
125444173|NCT01474512|451253891|FG011|Maintenance Period|Adverse Event|0|||
125444174|NCT01474512|451253892|FG012|Maintenance Period|Adverse Event|0|||
125444175|NCT01474512|451253893|FG013|Maintenance Period|Adverse Event|0|||
125444176|NCT01474512|451253894|FG014|Maintenance Period|Adverse Event|0|||
125444177|NCT01474512|451253895|FG015|Maintenance Period|Adverse Event|0|||
125444178|NCT01474512|451253896|FG016|Maintenance Period|Adverse Event|0|||
125444179|NCT01474512|451253897|FG017|Maintenance Period|Adverse Event|0|||
125444180|NCT01474512|451253880|FG000|Maintenance Period|Withdrawal by Subject|0|||
125444181|NCT01474512|451253881|FG001|Maintenance Period|Withdrawal by Subject|0|||
125444182|NCT01474512|451253882|FG002|Maintenance Period|Withdrawal by Subject|0|||
125444183|NCT01474512|451253883|FG003|Maintenance Period|Withdrawal by Subject|6|||
125444184|NCT01474512|451253884|FG004|Maintenance Period|Withdrawal by Subject|2|||
125444185|NCT01474512|451253885|FG005|Maintenance Period|Withdrawal by Subject|3|||
125444186|NCT01474512|451253886|FG006|Maintenance Period|Withdrawal by Subject|1|||
125444187|NCT01474512|451253887|FG007|Maintenance Period|Withdrawal by Subject|6|||
125252066|NCT01783938|450548190|FG000|Overall Study|Maximum Clinical Benefit|1|||
125252067|NCT01783938|450548191|FG001|Overall Study|Maximum Clinical Benefit|0|||
125252068|NCT01783938|450548190|FG000|Overall Study|Other Reasons|3|||
125252069|NCT01783938|450548191|FG001|Overall Study|Other Reasons|1|||
125252070|NCT03072875|450548196|FG000|Overall Study|Lost to Follow-up|1|||
125252071|NCT03478787|450548197|FG000|Overall Study|Adverse Event|5|||
125252072|NCT03478787|450548198|FG001|Overall Study|Adverse Event|1|||
125252073|NCT03478787|450548197|FG000|Overall Study|Protocol Violation|3|||
125252074|NCT03478787|450548198|FG001|Overall Study|Protocol Violation|0|||
125252075|NCT03478787|450548197|FG000|Overall Study|Lack of Efficacy|7|||
125252076|NCT03478787|450548198|FG001|Overall Study|Lack of Efficacy|1|||
125252077|NCT03478787|450548197|FG000|Overall Study|Lost to Follow-up|9|||
125252078|NCT03478787|450548198|FG001|Overall Study|Lost to Follow-up|5|||
125252079|NCT03478787|450548197|FG000|Overall Study|Withdrawal by Subject|2|||
125252080|NCT03478787|450548198|FG001|Overall Study|Withdrawal by Subject|6|||
125252081|NCT03478787|450548197|FG000|Overall Study|Other, Not Specified|3|||
125252082|NCT03478787|450548198|FG001|Overall Study|Other, Not Specified|0|||
125252083|NCT02413346|450548201|FG000|Overall Study|Adverse Event|6|||
125252084|NCT02413346|450548202|FG001|Overall Study|Adverse Event|6|||
125252085|NCT02413346|450548201|FG000|Overall Study|Withdrawal by Subject|30|||
125252086|NCT02413346|450548202|FG001|Overall Study|Withdrawal by Subject|40|||
125252087|NCT02413346|450548201|FG000|Overall Study|Lost to Follow-up|17|||
125252088|NCT02413346|450548202|FG001|Overall Study|Lost to Follow-up|21|||
125252089|NCT02413346|450548201|FG000|Overall Study|Protocol Violation|2|||
125252090|NCT02413346|450548202|FG001|Overall Study|Protocol Violation|0|||
125252091|NCT02413346|450548201|FG000|Overall Study|Other Miscellaneous Reasons|4|||
125252092|NCT02413346|450548202|FG001|Overall Study|Other Miscellaneous Reasons|3|||
125252093|NCT01316900|450548221|FG000|Overall Study|Adverse Event|10|||
125252094|NCT01316900|450548222|FG001|Overall Study|Adverse Event|10|||
125252095|NCT01316900|450548223|FG002|Overall Study|Adverse Event|15|||
125252096|NCT01316900|450548224|FG003|Overall Study|Adverse Event|9|||
125252097|NCT01316900|450548221|FG000|Overall Study|Lack of Efficacy|17|||
125252098|NCT01316900|450548222|FG001|Overall Study|Lack of Efficacy|9|||
125252099|NCT01316900|450548223|FG002|Overall Study|Lack of Efficacy|5|||
125252100|NCT01316900|450548224|FG003|Overall Study|Lack of Efficacy|7|||
125252101|NCT01316900|450548221|FG000|Overall Study|Protocol Violation|7|||
125252102|NCT01316900|450548222|FG001|Overall Study|Protocol Violation|1|||
125252103|NCT01316900|450548223|FG002|Overall Study|Protocol Violation|4|||
125252104|NCT01316900|450548224|FG003|Overall Study|Protocol Violation|0|||
125252105|NCT01316900|450548221|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
125252106|NCT01316900|450548222|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
125252107|NCT01316900|450548223|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
125444188|NCT01474512|451253888|FG008|Maintenance Period|Withdrawal by Subject|3|||
125252108|NCT01316900|450548224|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
125252109|NCT01316900|450548221|FG000|Overall Study|Lost to Follow-up|1|||
125252110|NCT01316900|450548222|FG001|Overall Study|Lost to Follow-up|0|||
125252111|NCT01316900|450548223|FG002|Overall Study|Lost to Follow-up|1|||
125252112|NCT01316900|450548224|FG003|Overall Study|Lost to Follow-up|1|||
125252113|NCT01316900|450548221|FG000|Overall Study|Withdrawal by Subject|7|||
125252114|NCT01316900|450548222|FG001|Overall Study|Withdrawal by Subject|8|||
125444189|NCT01474512|451253889|FG009|Maintenance Period|Withdrawal by Subject|1|||
125444190|NCT01474512|451253890|FG010|Maintenance Period|Withdrawal by Subject|0|||
125252115|NCT01316900|450548223|FG002|Overall Study|Withdrawal by Subject|6|||
125252116|NCT01316900|450548224|FG003|Overall Study|Withdrawal by Subject|9|||
125252117|NCT01684033|450548227|FG000|Period 1, First 30 Days|Adverse Event|1|||
125252118|NCT01684033|450548228|FG001|Period 1, First 30 Days|Adverse Event|1|||
125252119|NCT01684033|450548227|FG000|Period 1, First 30 Days|Noncompliance|1|||
125252120|NCT01684033|450548228|FG001|Period 1, First 30 Days|Noncompliance|0|||
125252121|NCT01684033|450548227|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
125252122|NCT01684033|450548228|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
125252123|NCT01684033|450548227|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
125252124|NCT01684033|450548228|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
125252125|NCT01684033|450548227|FG000|Period 2, Second 30 Days|Adverse Event|1|||
125252126|NCT01684033|450548228|FG001|Period 2, Second 30 Days|Adverse Event|0|||
125252127|NCT00089583|450548231|FG000|Overall Study|Adverse Event|0|||
125252128|NCT00089583|450548232|FG001|Overall Study|Adverse Event|3|||
125252129|NCT00089583|450548231|FG000|Overall Study|Insufficient Viral Load Response|5|||
125252130|NCT00089583|450548232|FG001|Overall Study|Insufficient Viral Load Response|5|||
125252131|NCT00089583|450548231|FG000|Overall Study|Withdrawal by Subject|0|||
125252132|NCT00089583|450548232|FG001|Overall Study|Withdrawal by Subject|4|||
125252133|NCT00089583|450548231|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
125252134|NCT00089583|450548232|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
125444191|NCT01474512|451253891|FG011|Maintenance Period|Withdrawal by Subject|0|||
125444192|NCT01474512|451253892|FG012|Maintenance Period|Withdrawal by Subject|0|||
125444193|NCT01474512|451253893|FG013|Maintenance Period|Withdrawal by Subject|0|||
125444194|NCT01474512|451253894|FG014|Maintenance Period|Withdrawal by Subject|0|||
125444195|NCT01474512|451253895|FG015|Maintenance Period|Withdrawal by Subject|0|||
125444196|NCT01474512|451253896|FG016|Maintenance Period|Withdrawal by Subject|0|||
125444197|NCT01474512|451253897|FG017|Maintenance Period|Withdrawal by Subject|0|||
125444198|NCT01474512|451253880|FG000|Maintenance Period|Lost to Follow-up|0|||
125444199|NCT01474512|451253881|FG001|Maintenance Period|Lost to Follow-up|0|||
125444200|NCT01474512|451253882|FG002|Maintenance Period|Lost to Follow-up|0|||
125444201|NCT01474512|451253883|FG003|Maintenance Period|Lost to Follow-up|3|||
125252135|NCT00089583|450548231|FG000|Overall Study|Participant Refused Study Medication|0|||
125252136|NCT00089583|450548232|FG001|Overall Study|Participant Refused Study Medication|2|||
125252137|NCT00089583|450548231|FG000|Overall Study|Non-Compliance|0|||
125252138|NCT00089583|450548232|FG001|Overall Study|Non-Compliance|4|||
125252139|NCT00089583|450548231|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
125252140|NCT00089583|450548232|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
125252141|NCT00089583|450548231|FG000|Overall Study|Participant Management Criteria Met|0|||
125252142|NCT00089583|450548232|FG001|Overall Study|Participant Management Criteria Met|1|||
125252143|NCT00089583|450548231|FG000|Overall Study|Reason Not Provided|0|||
125252144|NCT00089583|450548232|FG001|Overall Study|Reason Not Provided|1|||
125252145|NCT00089583|450548231|FG000|Overall Study|Protocol Violation|0|||
125252146|NCT00089583|450548232|FG001|Overall Study|Protocol Violation|3|||
125252147|NCT00089583|450548231|FG000|Overall Study|Principal Investigator Decision|0|||
125252148|NCT00089583|450548232|FG001|Overall Study|Principal Investigator Decision|10|||
125252149|NCT00089583|450548231|FG000|Overall Study|Start of Disallowed Medication|0|||
125252150|NCT00089583|450548232|FG001|Overall Study|Start of Disallowed Medication|1|||
125252151|NCT00089583|450548231|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
125252152|NCT00089583|450548232|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
125252153|NCT00089583|450548231|FG000|Overall Study|Participant Incarcerated|0|||
125252154|NCT00089583|450548232|FG001|Overall Study|Participant Incarcerated|1|||
125252155|NCT00507507|450548233|FG000|Treatment Period|Lost to Follow-up|0|||
125252156|NCT00507507|450548234|FG001|Treatment Period|Lost to Follow-up|2|||
125252157|NCT00507507|450548233|FG000|Treatment Period|Physician Decision|4|||
125252158|NCT00507507|450548234|FG001|Treatment Period|Physician Decision|1|||
125252159|NCT00507507|450548233|FG000|Treatment Period|Protocol Violation|1|||
125252160|NCT00507507|450548234|FG001|Treatment Period|Protocol Violation|2|||
125252161|NCT00507507|450548233|FG000|Treatment Period|Adverse Event|1|||
125252162|NCT00507507|450548234|FG001|Treatment Period|Adverse Event|1|||
125252163|NCT00507507|450548233|FG000|Treatment Period|Withdrawal by Subject|46|||
125252164|NCT00507507|450548234|FG001|Treatment Period|Withdrawal by Subject|47|||
125252165|NCT00507507|450548233|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
125252166|NCT00507507|450548234|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
125252167|NCT00507507|450548233|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
125252168|NCT00507507|450548234|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
125252169|NCT00507507|450548233|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
125252170|NCT00507507|450548234|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
125444202|NCT01474512|451253884|FG004|Maintenance Period|Lost to Follow-up|3|||
125444203|NCT01474512|451253885|FG005|Maintenance Period|Lost to Follow-up|0|||
125444204|NCT01474512|451253886|FG006|Maintenance Period|Lost to Follow-up|0|||
125444205|NCT01474512|451253887|FG007|Maintenance Period|Lost to Follow-up|2|||
125444206|NCT01474512|451253888|FG008|Maintenance Period|Lost to Follow-up|1|||
125444207|NCT01474512|451253889|FG009|Maintenance Period|Lost to Follow-up|1|||
125444208|NCT01474512|451253890|FG010|Maintenance Period|Lost to Follow-up|0|||
125444209|NCT01474512|451253891|FG011|Maintenance Period|Lost to Follow-up|0|||
125444210|NCT01474512|451253892|FG012|Maintenance Period|Lost to Follow-up|0|||
125444211|NCT01474512|451253893|FG013|Maintenance Period|Lost to Follow-up|0|||
125444212|NCT01474512|451253894|FG014|Maintenance Period|Lost to Follow-up|0|||
125444213|NCT01474512|451253895|FG015|Maintenance Period|Lost to Follow-up|0|||
125444214|NCT01474512|451253896|FG016|Maintenance Period|Lost to Follow-up|0|||
125444215|NCT01474512|451253897|FG017|Maintenance Period|Lost to Follow-up|0|||
125444216|NCT01474512|451253880|FG000|Maintenance Period|Death|0|||
125444217|NCT01474512|451253881|FG001|Maintenance Period|Death|0|||
125444218|NCT01474512|451253882|FG002|Maintenance Period|Death|0|||
125444219|NCT01474512|451253883|FG003|Maintenance Period|Death|0|||
125444220|NCT01474512|451253884|FG004|Maintenance Period|Death|0|||
125444221|NCT01474512|451253885|FG005|Maintenance Period|Death|2|||
125444222|NCT01474512|451253886|FG006|Maintenance Period|Death|0|||
125444223|NCT01474512|451253887|FG007|Maintenance Period|Death|0|||
125444224|NCT01474512|451253888|FG008|Maintenance Period|Death|0|||
125444225|NCT01474512|451253889|FG009|Maintenance Period|Death|0|||
125444226|NCT01474512|451253890|FG010|Maintenance Period|Death|0|||
125444227|NCT01474512|451253891|FG011|Maintenance Period|Death|0|||
125444228|NCT01474512|451253892|FG012|Maintenance Period|Death|0|||
125444229|NCT01474512|451253893|FG013|Maintenance Period|Death|0|||
125444230|NCT01474512|451253894|FG014|Maintenance Period|Death|0|||
125444231|NCT01474512|451253895|FG015|Maintenance Period|Death|0|||
125444232|NCT01474512|451253896|FG016|Maintenance Period|Death|0|||
125444233|NCT01474512|451253897|FG017|Maintenance Period|Death|0|||
125444234|NCT01474512|451253880|FG000|Maintenance Period|Physician Decision|0|||
125444235|NCT01474512|451253881|FG001|Maintenance Period|Physician Decision|0|||
125444236|NCT01474512|451253882|FG002|Maintenance Period|Physician Decision|0|||
125444237|NCT01474512|451253883|FG003|Maintenance Period|Physician Decision|0|||
125444238|NCT01474512|451253884|FG004|Maintenance Period|Physician Decision|0|||
125444239|NCT01474512|451253885|FG005|Maintenance Period|Physician Decision|1|||
125444240|NCT01474512|451253886|FG006|Maintenance Period|Physician Decision|0|||
125444241|NCT01474512|451253887|FG007|Maintenance Period|Physician Decision|2|||
125444242|NCT01474512|451253888|FG008|Maintenance Period|Physician Decision|0|||
125252171|NCT02916433|450548235|FG000|Overall Study|Withdrawal by Subject|1|||
125252172|NCT02916433|450548236|FG001|Overall Study|Withdrawal by Subject|0|||
125252173|NCT02916433|450548235|FG000|Overall Study|Physician Decision|1|||
125252174|NCT02916433|450548236|FG001|Overall Study|Physician Decision|0|||
125252175|NCT01412983|450548237|FG000|1st Period|Ineligible|0|||
125252176|NCT01412983|450548238|FG001|1st Period|Ineligible|1|||
125252177|NCT01412983|450548237|FG000|1st Period|Positive slit lamp finding|0|||
125252178|NCT01412983|450548238|FG001|1st Period|Positive slit lamp finding|1|||
125252179|NCT01412983|450548237|FG000|1st Period|Unacceptable lens movement|0|||
125252180|NCT01412983|450548238|FG001|1st Period|Unacceptable lens movement|1|||
125252181|NCT01412983|450548237|FG000|1st Period|Inability to maintain wear|0|||
125252182|NCT01412983|450548238|FG001|1st Period|Inability to maintain wear|1|||
125252183|NCT01623154|450548239|FG000|Overall Study|Did not drink Pranactin Citric|4|||
125252184|NCT00890097|450548240|FG000|Overall Study|Adverse Event|21|||
125252185|NCT00890097|450548241|FG001|Overall Study|Adverse Event|32|||
125252186|NCT00890097|450548242|FG002|Overall Study|Adverse Event|28|||
125444243|NCT01474512|451253889|FG009|Maintenance Period|Physician Decision|0|||
125444244|NCT01474512|451253890|FG010|Maintenance Period|Physician Decision|0|||
125252187|NCT00890097|450548240|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
125252188|NCT00890097|450548241|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
125252189|NCT00890097|450548242|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
125252190|NCT00890097|450548240|FG000|Overall Study|Withdrew Consent|9|||
125252191|NCT00890097|450548241|FG001|Overall Study|Withdrew Consent|6|||
125252192|NCT00890097|450548242|FG002|Overall Study|Withdrew Consent|9|||
125252193|NCT00890097|450548240|FG000|Overall Study|Lost to Follow-up|5|||
125252194|NCT00890097|450548241|FG001|Overall Study|Lost to Follow-up|5|||
125252195|NCT00890097|450548242|FG002|Overall Study|Lost to Follow-up|5|||
125252196|NCT00890097|450548240|FG000|Overall Study|Noncompliance|0|||
125252197|NCT00890097|450548241|FG001|Overall Study|Noncompliance|4|||
125252198|NCT00890097|450548242|FG002|Overall Study|Noncompliance|4|||
125252199|NCT00890097|450548240|FG000|Overall Study|Sponsor Decision|7|||
125252200|NCT00890097|450548241|FG001|Overall Study|Sponsor Decision|11|||
125252201|NCT00890097|450548242|FG002|Overall Study|Sponsor Decision|7|||
125444245|NCT01474512|451253891|FG011|Maintenance Period|Physician Decision|0|||
125444246|NCT01474512|451253892|FG012|Maintenance Period|Physician Decision|0|||
125444247|NCT01474512|451253893|FG013|Maintenance Period|Physician Decision|0|||
125444248|NCT01474512|451253894|FG014|Maintenance Period|Physician Decision|0|||
125444249|NCT01474512|451253895|FG015|Maintenance Period|Physician Decision|0|||
125252202|NCT00890097|450548240|FG000|Overall Study|Did not attend final visit|2|||
125444250|NCT01474512|451253896|FG016|Maintenance Period|Physician Decision|0|||
125444251|NCT01474512|451253897|FG017|Maintenance Period|Physician Decision|0|||
125444252|NCT01474512|451253880|FG000|Maintenance Period|Clinical Relapse|0|||
125444253|NCT01474512|451253881|FG001|Maintenance Period|Clinical Relapse|0|||
125444254|NCT01474512|451253882|FG002|Maintenance Period|Clinical Relapse|0|||
125252203|NCT00890097|450548241|FG001|Overall Study|Did not attend final visit|3|||
125252204|NCT00890097|450548242|FG002|Overall Study|Did not attend final visit|0|||
125252205|NCT00890097|450548240|FG000|Overall Study|Subject Decision|3|||
125252206|NCT00890097|450548241|FG001|Overall Study|Subject Decision|2|||
125252207|NCT00890097|450548242|FG002|Overall Study|Subject Decision|6|||
125252208|NCT00890097|450548240|FG000|Overall Study|Randomization Error|2|||
125252209|NCT00890097|450548241|FG001|Overall Study|Randomization Error|0|||
125252210|NCT00890097|450548242|FG002|Overall Study|Randomization Error|0|||
125252211|NCT00890097|450548240|FG000|Overall Study|Failed inclusion criteria|3|||
125252212|NCT00890097|450548241|FG001|Overall Study|Failed inclusion criteria|4|||
125252213|NCT00890097|450548242|FG002|Overall Study|Failed inclusion criteria|0|||
125252214|NCT00890097|450548240|FG000|Overall Study|Transportation|0|||
125252215|NCT00890097|450548241|FG001|Overall Study|Transportation|2|||
125252216|NCT00890097|450548242|FG002|Overall Study|Transportation|0|||
125252217|NCT00890097|450548240|FG000|Overall Study|Subject Moved|0|||
125252218|NCT00890097|450548241|FG001|Overall Study|Subject Moved|4|||
125252219|NCT00890097|450548242|FG002|Overall Study|Subject Moved|0|||
125252220|NCT00890097|450548240|FG000|Overall Study|Protocol Deviation|1|||
125252221|NCT00890097|450548241|FG001|Overall Study|Protocol Deviation|1|||
125252222|NCT00890097|450548242|FG002|Overall Study|Protocol Deviation|1|||
125252223|NCT00954538|450548243|FG000|Part III|Withdrawal by Subject|0|||
125252224|NCT00954538|450548244|FG001|Part III|Withdrawal by Subject|0|||
125252225|NCT00954538|450548245|FG002|Part III|Withdrawal by Subject|0|||
125252226|NCT00954538|450548246|FG003|Part III|Withdrawal by Subject|0|||
125252227|NCT00954538|450548247|FG004|Part III|Withdrawal by Subject|1|||
125252228|NCT00954538|450548248|FG005|Part III|Withdrawal by Subject|0|||
125252229|NCT03178942|450548252|FG000|Overall Study|Withdrawal by Subject|2|||
125252230|NCT03178942|450548253|FG001|Overall Study|Withdrawal by Subject|0|||
125252231|NCT03178942|450548252|FG000|Overall Study|Lost to Follow-up|1|||
125252232|NCT03178942|450548253|FG001|Overall Study|Lost to Follow-up|2|||
125252233|NCT01657942|450548254|FG000|Overall Study|Alternative Treatment|7|||
125252234|NCT01657942|450548254|FG000|Overall Study|Lost to Follow-up|1|||
125252235|NCT03061214|450548258|FG000|Overall Study|Withdrawal by Subject|21|||
125252236|NCT03061214|450548259|FG001|Overall Study|Withdrawal by Subject|26|||
125252237|NCT03061214|450548260|FG002|Overall Study|Withdrawal by Subject|9|||
125252238|NCT03061214|450548258|FG000|Overall Study|Lost to Follow-up|3|||
125252239|NCT03061214|450548259|FG001|Overall Study|Lost to Follow-up|1|||
125444255|NCT01474512|451253883|FG003|Maintenance Period|Clinical Relapse|1|||
125444256|NCT01474512|451253884|FG004|Maintenance Period|Clinical Relapse|0|||
125444257|NCT01474512|451253885|FG005|Maintenance Period|Clinical Relapse|0|||
125444258|NCT01474512|451253886|FG006|Maintenance Period|Clinical Relapse|0|||
125444259|NCT01474512|451253887|FG007|Maintenance Period|Clinical Relapse|0|||
125444260|NCT01474512|451253888|FG008|Maintenance Period|Clinical Relapse|0|||
125444261|NCT01474512|451253889|FG009|Maintenance Period|Clinical Relapse|0|||
125444262|NCT01474512|451253890|FG010|Maintenance Period|Clinical Relapse|0|||
125444263|NCT01474512|451253891|FG011|Maintenance Period|Clinical Relapse|0|||
125444264|NCT01474512|451253892|FG012|Maintenance Period|Clinical Relapse|0|||
125444265|NCT01474512|451253893|FG013|Maintenance Period|Clinical Relapse|0|||
125444266|NCT01474512|451253894|FG014|Maintenance Period|Clinical Relapse|0|||
125444267|NCT01474512|451253895|FG015|Maintenance Period|Clinical Relapse|0|||
125444268|NCT01474512|451253896|FG016|Maintenance Period|Clinical Relapse|0|||
125444269|NCT01474512|451253897|FG017|Maintenance Period|Clinical Relapse|0|||
125444270|NCT01474512|451253880|FG000|Maintenance Period|Lack of Efficacy|0|||
125444271|NCT01474512|451253881|FG001|Maintenance Period|Lack of Efficacy|0|||
125444272|NCT01474512|451253882|FG002|Maintenance Period|Lack of Efficacy|0|||
125444273|NCT01474512|451253883|FG003|Maintenance Period|Lack of Efficacy|1|||
125444274|NCT01474512|451253884|FG004|Maintenance Period|Lack of Efficacy|0|||
125444275|NCT01474512|451253885|FG005|Maintenance Period|Lack of Efficacy|0|||
125444276|NCT01474512|451253886|FG006|Maintenance Period|Lack of Efficacy|0|||
125444277|NCT01474512|451253887|FG007|Maintenance Period|Lack of Efficacy|11|||
125444278|NCT01474512|451253888|FG008|Maintenance Period|Lack of Efficacy|11|||
125444279|NCT01474512|451253889|FG009|Maintenance Period|Lack of Efficacy|12|||
125444280|NCT01474512|451253890|FG010|Maintenance Period|Lack of Efficacy|0|||
125252240|NCT03061214|450548260|FG002|Overall Study|Lost to Follow-up|1|||
125252241|NCT03061214|450548258|FG000|Overall Study|Death|1|||
125444281|NCT01474512|451253891|FG011|Maintenance Period|Lack of Efficacy|0|||
125444282|NCT01474512|451253892|FG012|Maintenance Period|Lack of Efficacy|0|||
125444283|NCT01474512|451253893|FG013|Maintenance Period|Lack of Efficacy|0|||
125444284|NCT01474512|451253894|FG014|Maintenance Period|Lack of Efficacy|0|||
125444285|NCT01474512|451253895|FG015|Maintenance Period|Lack of Efficacy|0|||
125444286|NCT01474512|451253896|FG016|Maintenance Period|Lack of Efficacy|0|||
125252242|NCT03061214|450548259|FG001|Overall Study|Death|1|||
125252243|NCT03061214|450548260|FG002|Overall Study|Death|0|||
125252244|NCT00107614|450550206|FG000|Overall Study|Physician Decision|10|||
125252245|NCT00107614|450550206|FG000|Overall Study|Death|2|||
125444287|NCT01474512|451253897|FG017|Maintenance Period|Lack of Efficacy|0|||
125252246|NCT02715856|450550210|FG000|Overall Study|Software Issues|12|||
125252247|NCT02715856|450550211|FG001|Overall Study|Software Issues|7|||
125444288|NCT01474512|451253880|FG000|Maintenance Period|Protocol Violation|0|||
125444289|NCT01474512|451253881|FG001|Maintenance Period|Protocol Violation|0|||
125444290|NCT01474512|451253882|FG002|Maintenance Period|Protocol Violation|0|||
125444291|NCT01474512|451253883|FG003|Maintenance Period|Protocol Violation|1|||
125444292|NCT01474512|451253884|FG004|Maintenance Period|Protocol Violation|0|||
125444293|NCT01474512|451253885|FG005|Maintenance Period|Protocol Violation|0|||
125444294|NCT01474512|451253886|FG006|Maintenance Period|Protocol Violation|0|||
125444295|NCT01474512|451253887|FG007|Maintenance Period|Protocol Violation|1|||
125444296|NCT01474512|451253888|FG008|Maintenance Period|Protocol Violation|0|||
125444297|NCT01474512|451253889|FG009|Maintenance Period|Protocol Violation|1|||
125444298|NCT01474512|451253890|FG010|Maintenance Period|Protocol Violation|0|||
125444299|NCT01474512|451253891|FG011|Maintenance Period|Protocol Violation|0|||
125444300|NCT01474512|451253892|FG012|Maintenance Period|Protocol Violation|0|||
125444301|NCT01474512|451253893|FG013|Maintenance Period|Protocol Violation|0|||
125444302|NCT01474512|451253894|FG014|Maintenance Period|Protocol Violation|0|||
125444303|NCT01474512|451253895|FG015|Maintenance Period|Protocol Violation|0|||
125444304|NCT01474512|451253896|FG016|Maintenance Period|Protocol Violation|0|||
125252248|NCT02715856|450550210|FG000|Overall Study|Death|6|||
125252249|NCT02715856|450550211|FG001|Overall Study|Death|5|||
125252250|NCT02715856|450550210|FG000|Overall Study|Non- Compliant|0|||
125252251|NCT02715856|450550211|FG001|Overall Study|Non- Compliant|40|||
125252252|NCT01772693|450550212|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
125252253|NCT01772693|450550213|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
125252254|NCT01772693|450550212|FG000|Overall Study|Withdrawal by Subject|2|||
125252255|NCT01772693|450550213|FG001|Overall Study|Withdrawal by Subject|0|||
125252256|NCT01772693|450550212|FG000|Overall Study|Alternative Treatment|2|||
125252257|NCT01772693|450550213|FG001|Overall Study|Alternative Treatment|0|||
125252258|NCT02094885|450550216|FG000|Overall Study|Death|1|||
125252259|NCT02094885|450550217|FG001|Overall Study|Death|5|||
125252260|NCT02094885|450550216|FG000|Overall Study|Withdrawn due to age|1|||
125252261|NCT02094885|450550217|FG001|Overall Study|Withdrawn due to age|0|||
125252262|NCT00215553|450550226|FG000|Overall Study|Adverse Event|0|||
125252263|NCT00215553|450550227|FG001|Overall Study|Adverse Event|1|||
125252264|NCT00215553|450550228|FG002|Overall Study|Adverse Event|2|||
125252265|NCT00215553|450550229|FG003|Overall Study|Adverse Event|1|||
125252266|NCT00215553|450550230|FG004|Overall Study|Adverse Event|2|||
125252267|NCT00215553|450550231|FG005|Overall Study|Adverse Event|6|||
125252268|NCT00215553|450550232|FG006|Overall Study|Adverse Event|0|||
125252269|NCT00756314|450550233|FG000|Overall Study|Lost to Follow-up|2|||
125252270|NCT00756314|450550234|FG001|Overall Study|Lost to Follow-up|59|||
125252271|NCT02605967|450550236|FG000|Overall Study|subject / guardian decision|1|||
125252272|NCT02605967|450550237|FG001|Overall Study|subject / guardian decision|2|||
125252273|NCT02605967|450550236|FG000|Overall Study|Physician Decision|10|||
125252274|NCT02605967|450550237|FG001|Overall Study|Physician Decision|1|||
125252275|NCT02605967|450550236|FG000|Overall Study|Death|4|||
125252276|NCT02605967|450550237|FG001|Overall Study|Death|2|||
125252277|NCT02605967|450550236|FG000|Overall Study|Adverse Event|1|||
125252278|NCT02605967|450550237|FG001|Overall Study|Adverse Event|0|||
125252279|NCT02605967|450550236|FG000|Overall Study|progressive disease|66|||
125252280|NCT02605967|450550237|FG001|Overall Study|progressive disease|35|||
125252281|NCT00159874|450550242|FG000|Overall Study|Adverse Event|2|||
125252282|NCT00159874|450550243|FG001|Overall Study|Adverse Event|2|||
125252283|NCT00159874|450550244|FG002|Overall Study|Adverse Event|5|||
125252284|NCT00159874|450550245|FG003|Overall Study|Adverse Event|1|||
125252285|NCT00159874|450550246|FG004|Overall Study|Adverse Event|1|||
125252286|NCT00159874|450550247|FG005|Overall Study|Adverse Event|2|||
125252287|NCT00159874|450550248|FG006|Overall Study|Adverse Event|0|||
125444305|NCT01474512|451253897|FG017|Maintenance Period|Protocol Violation|0|||
125444306|NCT01474512|451253880|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
125444307|NCT01474512|451253881|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
125444308|NCT01474512|451253882|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
125252288|NCT00159874|450550242|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
125252289|NCT00159874|450550243|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
125252290|NCT00159874|450550244|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
125252291|NCT00159874|450550245|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
125252292|NCT00159874|450550246|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
125252293|NCT00159874|450550247|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
125252294|NCT00159874|450550248|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
125444309|NCT01474512|451253883|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
125252295|NCT00159874|450550242|FG000|Overall Study|Lack of Efficacy|2|||
125252296|NCT00159874|450550243|FG001|Overall Study|Lack of Efficacy|0|||
125252297|NCT00159874|450550244|FG002|Overall Study|Lack of Efficacy|1|||
125252298|NCT00159874|450550245|FG003|Overall Study|Lack of Efficacy|1|||
125252299|NCT00159874|450550246|FG004|Overall Study|Lack of Efficacy|0|||
125252300|NCT00159874|450550247|FG005|Overall Study|Lack of Efficacy|3|||
125252301|NCT00159874|450550248|FG006|Overall Study|Lack of Efficacy|0|||
125252302|NCT00159874|450550242|FG000|Overall Study|Lost to Follow-up|1|||
125252303|NCT00159874|450550243|FG001|Overall Study|Lost to Follow-up|0|||
125252304|NCT00159874|450550244|FG002|Overall Study|Lost to Follow-up|3|||
125252305|NCT00159874|450550245|FG003|Overall Study|Lost to Follow-up|0|||
125252306|NCT00159874|450550246|FG004|Overall Study|Lost to Follow-up|1|||
125197540|NCT02294396|450343987|FG000|Overall Study|Lost to Follow-up|0|||
125197541|NCT02294396|450343988|FG001|Overall Study|Lost to Follow-up|0|||
125197542|NCT02294396|450343989|FG002|Overall Study|Lost to Follow-up|1|||
125197543|NCT02294396|450343990|FG003|Overall Study|Lost to Follow-up|1|||
125197544|NCT02294396|450343987|FG000|Overall Study|Protocol Deviation|3|||
125197545|NCT02294396|450343988|FG001|Overall Study|Protocol Deviation|2|||
125197546|NCT02294396|450343989|FG002|Overall Study|Protocol Deviation|2|||
125197547|NCT02294396|450343990|FG003|Overall Study|Protocol Deviation|1|||
125197548|NCT02294396|450343987|FG000|Overall Study|Miscellaneous|2|||
125197549|NCT02294396|450343988|FG001|Overall Study|Miscellaneous|0|||
125197550|NCT02294396|450343989|FG002|Overall Study|Miscellaneous|5|||
125197551|NCT02294396|450343990|FG003|Overall Study|Miscellaneous|2|||
125197552|NCT02120833|450343991|FG000|Overall Study|Adverse Event|1|||
125197553|NCT02120833|450343992|FG001|Overall Study|Adverse Event|0|||
125197554|NCT02120833|450343991|FG000|Overall Study|Withdrawal by Subject|2|||
125197555|NCT02120833|450343992|FG001|Overall Study|Withdrawal by Subject|0|||
125197556|NCT02120833|450343991|FG000|Overall Study|Lost to Follow-up|1|||
125197557|NCT02120833|450343992|FG001|Overall Study|Lost to Follow-up|1|||
125197558|NCT03502070|450343993|FG000|Overall Study|Withdrawal by Subject|1|||
125197559|NCT03502070|450343993|FG000|Overall Study|Screen Failure|1|||
125197560|NCT01046903|450343998|FG000|Overall Study|Lost to Follow-up|16|||
125197561|NCT01046903|450343998|FG000|Overall Study|Adverse Event|4|||
125197562|NCT01046903|450343998|FG000|Overall Study|Withdrawal by Subject|3|||
125197563|NCT01046903|450343998|FG000|Overall Study|Other|5|||
125197564|NCT01668173|450344004|FG000|Overall Study|Adverse Event|3|||
125197565|NCT01668173|450344004|FG000|Overall Study|Trial suspension|4|||
125197566|NCT01628198|450344005|FG000|Overall Study|Lost to Follow-up|7|||
125197567|NCT01628198|450344005|FG000|Overall Study|Withdrawal by Subject|10|||
125197568|NCT01628198|450344005|FG000|Overall Study|Screen failure|1|||
125197569|NCT04999163|450344006|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
125197570|NCT04999163|450344007|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
125197571|NCT04999163|450344006|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
125197572|NCT04999163|450344007|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
125197573|NCT04999163|450344006|FG000|Overall Study|Withdrawal by Subject|1|||
125197574|NCT04999163|450344007|FG001|Overall Study|Withdrawal by Subject|0|||
125197575|NCT00378508|450345818|FG000|Overall Study|Withdrawal by Subject|1|||
125197576|NCT00378508|450345819|FG001|Overall Study|Withdrawal by Subject|3|||
125197577|NCT00378508|450345818|FG000|Overall Study|Lost to Follow-up|1|||
125197578|NCT00378508|450345819|FG001|Overall Study|Lost to Follow-up|0|||
125197579|NCT01283334|450345820|FG000|Overall Study|Withdrawal by Subject|1|||
125197580|NCT01283334|450345820|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
125197581|NCT01283334|450345820|FG000|Overall Study|Adverse Event|4|||
125197582|NCT01283334|450345820|FG000|Overall Study|Physician Decision|1|||
125197583|NCT03467217|450345821|FG000|Overall Study|Trial stopped early|5|||
125197584|NCT03467217|450345822|FG001|Overall Study|Trial stopped early|2|||
125197585|NCT03467217|450345821|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
125197586|NCT03467217|450345822|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
125197587|NCT03467217|450345821|FG000|Overall Study|Lost to Follow-up|0|||
125197588|NCT03467217|450345822|FG001|Overall Study|Lost to Follow-up|2|||
125197589|NCT03233529|450345826|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
125197590|NCT03233529|450345826|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
125197591|NCT01177293|450345827|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
125197592|NCT01177293|450345828|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
125197593|NCT01905553|450345831|FG000|Period 2|Adverse Event|1|||
125197594|NCT01905553|450345832|FG001|Period 2|Adverse Event|0|||
125197595|NCT03854370|450345836|FG000|Overall Study|samples not collected|1|||
125197596|NCT03854370|450345837|FG001|Overall Study|samples not collected|1|||
125197597|NCT03854370|450345838|FG002|Overall Study|samples not collected|1|||
125197598|NCT03854370|450345839|FG003|Overall Study|samples not collected|1|||
125197599|NCT00452673|450345840|FG000|Dose Escalation Period|Disease Progression|6|||
125252307|NCT00159874|450550247|FG005|Overall Study|Lost to Follow-up|2|||
125197600|NCT00452673|450345841|FG001|Dose Escalation Period|Disease Progression|6|||
125197601|NCT00452673|450345842|FG002|Dose Escalation Period|Disease Progression|2|||
125197602|NCT00452673|450345843|FG003|Dose Escalation Period|Disease Progression|6|||
125197603|NCT00452673|450345844|FG004|Dose Escalation Period|Disease Progression|0|||
125197604|NCT00452673|450345840|FG000|Dose Escalation Period|study drug toxicity|1|||
125197605|NCT00452673|450345841|FG001|Dose Escalation Period|study drug toxicity|3|||
125197606|NCT00452673|450345842|FG002|Dose Escalation Period|study drug toxicity|3|||
125197607|NCT00452673|450345843|FG003|Dose Escalation Period|study drug toxicity|1|||
125197608|NCT00452673|450345844|FG004|Dose Escalation Period|study drug toxicity|0|||
125197609|NCT00452673|450345840|FG000|Dose Escalation Period|Other|0|||
125197610|NCT00452673|450345841|FG001|Dose Escalation Period|Other|0|||
125252308|NCT00159874|450550248|FG006|Overall Study|Lost to Follow-up|1|||
125252309|NCT00159874|450550242|FG000|Overall Study|Other|8|||
125252310|NCT00159874|450550243|FG001|Overall Study|Other|8|||
125252311|NCT00159874|450550244|FG002|Overall Study|Other|8|||
125252312|NCT00159874|450550245|FG003|Overall Study|Other|0|||
125252313|NCT00159874|450550246|FG004|Overall Study|Other|2|||
125396852|NCT00145509|451086879|FG000|Overall Study|Reason not provided|2|||
125396853|NCT00145509|451086880|FG001|Overall Study|Reason not provided|1|||
125197611|NCT00452673|450345842|FG002|Dose Escalation Period|Other|1|||
125197612|NCT00452673|450345843|FG003|Dose Escalation Period|Other|0|||
125197613|NCT00452673|450345844|FG004|Dose Escalation Period|Other|0|||
125197614|NCT00452673|450345840|FG000|Dose Escalation Period|Adverse Event|0|||
125197615|NCT00452673|450345841|FG001|Dose Escalation Period|Adverse Event|0|||
125197616|NCT00452673|450345842|FG002|Dose Escalation Period|Adverse Event|0|||
125197617|NCT00452673|450345843|FG003|Dose Escalation Period|Adverse Event|1|||
125197618|NCT00452673|450345844|FG004|Dose Escalation Period|Adverse Event|0|||
125197619|NCT00452673|450345840|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
125197620|NCT00452673|450345841|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
125197621|NCT00452673|450345842|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
125197622|NCT00452673|450345843|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
125197623|NCT00452673|450345844|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
125197624|NCT00452673|450345840|FG000|Dose Expansion Period|Disease Progression|0|||
125197625|NCT00452673|450345841|FG001|Dose Expansion Period|Disease Progression|0|||
125197626|NCT00452673|450345842|FG002|Dose Expansion Period|Disease Progression|0|||
125197627|NCT00452673|450345843|FG003|Dose Expansion Period|Disease Progression|0|||
125197628|NCT00452673|450345844|FG004|Dose Expansion Period|Disease Progression|19|||
125197629|NCT00452673|450345840|FG000|Dose Expansion Period|Other|0|||
125197630|NCT00452673|450345841|FG001|Dose Expansion Period|Other|0|||
125197631|NCT00452673|450345842|FG002|Dose Expansion Period|Other|0|||
125197632|NCT00452673|450345843|FG003|Dose Expansion Period|Other|0|||
125197633|NCT00452673|450345844|FG004|Dose Expansion Period|Other|2|||
125197634|NCT02656290|450345845|FG000|Overall Study|Lost to Follow-up|1|||
125197635|NCT02656290|450345845|FG000|Overall Study|Reintervention|3|||
125197636|NCT01608087|450345848|FG000|Overall Study|Lost to Follow-up|0|||
125197637|NCT01608087|450345849|FG001|Overall Study|Lost to Follow-up|1|||
125197638|NCT01608087|450345850|FG002|Overall Study|Lost to Follow-up|0|||
125197639|NCT01608087|450345848|FG000|Overall Study|Other Reason|0|||
125197640|NCT01608087|450345849|FG001|Overall Study|Other Reason|1|||
125197641|NCT01608087|450345850|FG002|Overall Study|Other Reason|0|||
125197642|NCT00348595|450345851|FG000|Overall Study|Adverse Event|5|||
125197643|NCT00348595|450345852|FG001|Overall Study|Adverse Event|8|||
125197644|NCT03991299|450345855|FG000|Overall Study|Study closed, sponsor decision|3|||
125197645|NCT03991299|450345855|FG000|Overall Study|Withdrawal by Subject|1|||
125197646|NCT04304235|450345856|FG000|Overall Study|incomplete triage data|0|||
125197647|NCT04304235|450345857|FG001|Overall Study|incomplete triage data|69|||
125197648|NCT04304235|450345858|FG002|Overall Study|incomplete triage data|0|||
125197649|NCT04304235|450345859|FG003|Overall Study|incomplete triage data|0|||
125197650|NCT04304235|450345860|FG004|Overall Study|incomplete triage data|289|||
125197651|NCT04304235|450345861|FG005|Overall Study|incomplete triage data|123|||
125197652|NCT04304235|450345862|FG006|Overall Study|incomplete triage data|65|||
125197653|NCT04429555|450345867|FG000|Overall Study|Death|0|||
125197654|NCT04429555|450345868|FG001|Overall Study|Death|2|||
125197655|NCT04429555|450345867|FG000|Overall Study|Other|2|||
125197656|NCT04429555|450345868|FG001|Overall Study|Other|0|||
125197657|NCT00231114|450345869|FG000|Randomized|Withdrawal by Subject|6|||
125197658|NCT00231114|450345870|FG001|Randomized|Withdrawal by Subject|3|||
125197659|NCT00231114|450345869|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
125197660|NCT00231114|450345870|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
125197661|NCT00231114|450345869|FG000|Post-Treatment Period|Lost to Follow-up|6|||
125197662|NCT00231114|450345870|FG001|Post-Treatment Period|Lost to Follow-up|1|||
125197663|NCT00231114|450345869|FG000|Post-Treatment Period|Physician Decision|1|||
125197664|NCT00231114|450345870|FG001|Post-Treatment Period|Physician Decision|0|||
125197665|NCT00231114|450345869|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
125197666|NCT00231114|450345870|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
125197667|NCT00712881|450345872|FG000|Overall Study|Adverse Event|3|||
125197668|NCT00712881|450345873|FG001|Overall Study|Adverse Event|3|||
125197669|NCT00712881|450345872|FG000|Overall Study|Withdrawal by Subject|1|||
125197670|NCT00712881|450345873|FG001|Overall Study|Withdrawal by Subject|1|||
125197671|NCT00712881|450345872|FG000|Overall Study|Disease Progression|2|||
125197672|NCT00712881|450345873|FG001|Overall Study|Disease Progression|1|||
125197673|NCT00712881|450345872|FG000|Overall Study|Lost to Follow-up|1|||
125396854|NCT04145895|451086883|FG000|Overall Study|Physician Decision|2|||
125197674|NCT00712881|450345873|FG001|Overall Study|Lost to Follow-up|1|||
125197675|NCT00712881|450345872|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
125197676|NCT00712881|450345873|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
125197677|NCT00712881|450345872|FG000|Overall Study|Protocol Violation|1|||
125252314|NCT00159874|450550247|FG005|Overall Study|Other|1|||
125252315|NCT00159874|450550248|FG006|Overall Study|Other|3|||
125252316|NCT00159874|450550242|FG000|Overall Study|Protocol Violation|0|||
125252317|NCT00159874|450550243|FG001|Overall Study|Protocol Violation|5|||
125252318|NCT00159874|450550244|FG002|Overall Study|Protocol Violation|2|||
125252319|NCT00159874|450550245|FG003|Overall Study|Protocol Violation|0|||
125252320|NCT00159874|450550246|FG004|Overall Study|Protocol Violation|0|||
125252321|NCT00159874|450550247|FG005|Overall Study|Protocol Violation|0|||
125252322|NCT00159874|450550248|FG006|Overall Study|Protocol Violation|0|||
125252323|NCT00159874|450550242|FG000|Overall Study|Death|3|||
125252324|NCT00159874|450550243|FG001|Overall Study|Death|8|||
125252325|NCT00159874|450550244|FG002|Overall Study|Death|15|||
125252326|NCT00159874|450550245|FG003|Overall Study|Death|0|||
125252327|NCT00159874|450550246|FG004|Overall Study|Death|1|||
125252328|NCT00159874|450550247|FG005|Overall Study|Death|2|||
125252329|NCT00159874|450550248|FG006|Overall Study|Death|0|||
125252330|NCT00159874|450550242|FG000|Overall Study|Withdrawal by Subject|2|||
125252331|NCT00159874|450550243|FG001|Overall Study|Withdrawal by Subject|6|||
125252332|NCT00159874|450550244|FG002|Overall Study|Withdrawal by Subject|8|||
125252333|NCT00159874|450550245|FG003|Overall Study|Withdrawal by Subject|4|||
125252334|NCT00159874|450550246|FG004|Overall Study|Withdrawal by Subject|3|||
125252335|NCT00159874|450550247|FG005|Overall Study|Withdrawal by Subject|2|||
125252336|NCT00159874|450550248|FG006|Overall Study|Withdrawal by Subject|1|||
125252337|NCT00159874|450550242|FG000|Overall Study|Pregnancy|1|||
125252338|NCT00159874|450550243|FG001|Overall Study|Pregnancy|1|||
125252339|NCT00159874|450550244|FG002|Overall Study|Pregnancy|0|||
125252340|NCT00159874|450550245|FG003|Overall Study|Pregnancy|0|||
125252341|NCT00159874|450550246|FG004|Overall Study|Pregnancy|0|||
125252342|NCT00159874|450550247|FG005|Overall Study|Pregnancy|0|||
125252343|NCT00159874|450550248|FG006|Overall Study|Pregnancy|0|||
125252344|NCT01475825|450550252|FG000|Overall Study|Adverse Event|41|||
125252345|NCT01475825|450550253|FG001|Overall Study|Adverse Event|15|||
125252346|NCT01475825|450550254|FG002|Overall Study|Adverse Event|27|||
125252347|NCT01475825|450550255|FG003|Overall Study|Adverse Event|11|||
125252348|NCT01475825|450550252|FG000|Overall Study|Death|1|||
125252349|NCT01475825|450550253|FG001|Overall Study|Death|0|||
125252350|NCT01475825|450550254|FG002|Overall Study|Death|1|||
125252351|NCT01475825|450550255|FG003|Overall Study|Death|0|||
125252352|NCT01475825|450550252|FG000|Overall Study|Lack of Efficacy|0|||
125252353|NCT01475825|450550253|FG001|Overall Study|Lack of Efficacy|0|||
125252354|NCT01475825|450550254|FG002|Overall Study|Lack of Efficacy|1|||
125252355|NCT01475825|450550255|FG003|Overall Study|Lack of Efficacy|0|||
125252356|NCT01475825|450550252|FG000|Overall Study|Lost to Follow-up|0|||
125252357|NCT01475825|450550253|FG001|Overall Study|Lost to Follow-up|0|||
125252358|NCT01475825|450550254|FG002|Overall Study|Lost to Follow-up|3|||
125252359|NCT01475825|450550255|FG003|Overall Study|Lost to Follow-up|1|||
125252360|NCT01475825|450550252|FG000|Overall Study|Non-compliance with Study Drug|1|||
125252361|NCT01475825|450550253|FG001|Overall Study|Non-compliance with Study Drug|2|||
125252362|NCT01475825|450550254|FG002|Overall Study|Non-compliance with Study Drug|4|||
125252363|NCT01475825|450550255|FG003|Overall Study|Non-compliance with Study Drug|0|||
125252364|NCT01475825|450550252|FG000|Overall Study|Other: Not available|0|||
125252365|NCT01475825|450550253|FG001|Overall Study|Other: Not available|0|||
125252366|NCT01475825|450550254|FG002|Overall Study|Other: Not available|2|||
125252367|NCT01475825|450550255|FG003|Overall Study|Other: Not available|0|||
125252368|NCT01475825|450550252|FG000|Overall Study|Protocol Violation|1|||
125252369|NCT01475825|450550253|FG001|Overall Study|Protocol Violation|0|||
125252370|NCT01475825|450550254|FG002|Overall Study|Protocol Violation|0|||
125252371|NCT01475825|450550255|FG003|Overall Study|Protocol Violation|0|||
125252372|NCT01475825|450550252|FG000|Overall Study|Physician Decision|0|||
125252373|NCT01475825|450550253|FG001|Overall Study|Physician Decision|1|||
125252374|NCT01475825|450550254|FG002|Overall Study|Physician Decision|0|||
125252375|NCT01475825|450550255|FG003|Overall Study|Physician Decision|0|||
125252376|NCT01475825|450550252|FG000|Overall Study|Withdrawal by Subject|8|||
125252377|NCT01475825|450550253|FG001|Overall Study|Withdrawal by Subject|3|||
125252378|NCT01475825|450550254|FG002|Overall Study|Withdrawal by Subject|11|||
125252379|NCT01475825|450550255|FG003|Overall Study|Withdrawal by Subject|7|||
125252380|NCT01475825|450550252|FG000|Overall Study|Did not enter OLC|15|||
125252381|NCT01475825|450550253|FG001|Overall Study|Did not enter OLC|11|||
125252382|NCT01475825|450550254|FG002|Overall Study|Did not enter OLC|15|||
125252383|NCT01475825|450550255|FG003|Overall Study|Did not enter OLC|11|||
125252384|NCT00309946|450550258|FG000|Overall Study|Withdrawal by Subject|1|||
125252385|NCT05071027|450550259|FG000|Overall Study|Lost to Follow-up|1|||
125252386|NCT05071027|450550260|FG001|Overall Study|Lost to Follow-up|4|||
125252387|NCT04135352|450550261|FG000|Overall Study|Not treated-randomization error|0|||
125252388|NCT04135352|450550262|FG001|Overall Study|Not treated-randomization error|0|||
125252389|NCT04135352|450550263|FG002|Overall Study|Not treated-randomization error|1|||
125252390|NCT04135352|450550264|FG003|Overall Study|Not treated-randomization error|0|||
125252391|NCT04135352|450550265|FG004|Overall Study|Not treated-randomization error|0|||
125252392|NCT04135352|450550266|FG005|Overall Study|Not treated-randomization error|0|||
125252393|NCT04135352|450550267|FG006|Overall Study|Not treated-randomization error|0|||
125252394|NCT04135352|450550268|FG007|Overall Study|Not treated-randomization error|0|||
125252395|NCT04135352|450550261|FG000|Overall Study|Withdrawal by Subject|0|||
125252396|NCT04135352|450550262|FG001|Overall Study|Withdrawal by Subject|0|||
125252397|NCT04135352|450550263|FG002|Overall Study|Withdrawal by Subject|2|||
125252398|NCT04135352|450550264|FG003|Overall Study|Withdrawal by Subject|0|||
125252399|NCT04135352|450550265|FG004|Overall Study|Withdrawal by Subject|0|||
125252400|NCT04135352|450550266|FG005|Overall Study|Withdrawal by Subject|0|||
125252401|NCT04135352|450550267|FG006|Overall Study|Withdrawal by Subject|0|||
125252402|NCT04135352|450550268|FG007|Overall Study|Withdrawal by Subject|0|||
125252403|NCT04135352|450550261|FG000|Overall Study|Sponsor Decision|0|||
125252404|NCT04135352|450550262|FG001|Overall Study|Sponsor Decision|0|||
125252405|NCT04135352|450550263|FG002|Overall Study|Sponsor Decision|2|||
125252406|NCT04135352|450550264|FG003|Overall Study|Sponsor Decision|5|||
125252407|NCT04135352|450550265|FG004|Overall Study|Sponsor Decision|1|||
125252408|NCT04135352|450550266|FG005|Overall Study|Sponsor Decision|4|||
125252409|NCT04135352|450550267|FG006|Overall Study|Sponsor Decision|0|||
125252410|NCT04135352|450550268|FG007|Overall Study|Sponsor Decision|0|||
125252411|NCT04135352|450550261|FG000|Overall Study|Physician Decision|0|||
125252412|NCT04135352|450550262|FG001|Overall Study|Physician Decision|0|||
125252413|NCT04135352|450550263|FG002|Overall Study|Physician Decision|1|||
125252414|NCT04135352|450550264|FG003|Overall Study|Physician Decision|0|||
125252415|NCT04135352|450550265|FG004|Overall Study|Physician Decision|1|||
125252416|NCT04135352|450550266|FG005|Overall Study|Physician Decision|0|||
125252417|NCT04135352|450550267|FG006|Overall Study|Physician Decision|0|||
125252418|NCT04135352|450550268|FG007|Overall Study|Physician Decision|0|||
125197678|NCT00712881|450345873|FG001|Overall Study|Protocol Violation|1|||
125197679|NCT00712881|450345872|FG000|Overall Study|Randomized but not treated|1|||
125197680|NCT00712881|450345873|FG001|Overall Study|Randomized but not treated|0|||
125197681|NCT03990571|450345875|FG000|Overall Study|Withdrawal by Subject|1|||
125197682|NCT03990571|450345875|FG000|Overall Study|Insurance Issues|3|||
125197683|NCT03990571|450345875|FG000|Overall Study|Covid Restrictions|2|||
125197684|NCT04143594|450345877|FG000|Overall Study|Withdrew consent|3|||
125197685|NCT04143594|450345878|FG001|Overall Study|Withdrew consent|10|||
125197686|NCT04143594|450345879|FG002|Overall Study|Withdrew consent|3|||
125197687|NCT04143594|450345880|FG003|Overall Study|Withdrew consent|1|||
125197688|NCT04143594|450345877|FG000|Overall Study|Lost to Follow-up|3|||
125197689|NCT04143594|450345878|FG001|Overall Study|Lost to Follow-up|5|||
125197690|NCT04143594|450345879|FG002|Overall Study|Lost to Follow-up|11|||
125197691|NCT04143594|450345880|FG003|Overall Study|Lost to Follow-up|0|||
125197692|NCT04143594|450345877|FG000|Overall Study|Investigator's discretion|2|||
125197693|NCT04143594|450345878|FG001|Overall Study|Investigator's discretion|2|||
125197694|NCT04143594|450345879|FG002|Overall Study|Investigator's discretion|0|||
125197695|NCT04143594|450345880|FG003|Overall Study|Investigator's discretion|0|||
125197696|NCT04143594|450345877|FG000|Overall Study|Randomized but never treated|0|||
125197697|NCT04143594|450345878|FG001|Overall Study|Randomized but never treated|0|||
125197698|NCT04143594|450345879|FG002|Overall Study|Randomized but never treated|0|||
125197699|NCT04143594|450345880|FG003|Overall Study|Randomized but never treated|1|||
125197700|NCT04143594|450345877|FG000|Overall Study|Death|1|||
125197701|NCT04143594|450345878|FG001|Overall Study|Death|0|||
125197702|NCT04143594|450345879|FG002|Overall Study|Death|1|||
125197703|NCT04143594|450345880|FG003|Overall Study|Death|0|||
125197704|NCT04143594|450345877|FG000|Overall Study|Adverse Event|1|||
125197705|NCT04143594|450345878|FG001|Overall Study|Adverse Event|0|||
125197706|NCT04143594|450345879|FG002|Overall Study|Adverse Event|0|||
125197707|NCT04143594|450345880|FG003|Overall Study|Adverse Event|0|||
125197708|NCT04143594|450345877|FG000|Overall Study|Pregnancy|0|||
125197709|NCT04143594|450345878|FG001|Overall Study|Pregnancy|0|||
125197710|NCT04143594|450345879|FG002|Overall Study|Pregnancy|1|||
125197711|NCT04143594|450345880|FG003|Overall Study|Pregnancy|0|||
125197712|NCT04143594|450345877|FG000|Overall Study|Lack of Efficacy|1|||
125197713|NCT04143594|450345878|FG001|Overall Study|Lack of Efficacy|1|||
125197714|NCT04143594|450345879|FG002|Overall Study|Lack of Efficacy|0|||
125197715|NCT04143594|450345880|FG003|Overall Study|Lack of Efficacy|0|||
125197716|NCT00638443|450345881|FG000|First Intervention|Adverse Event|2|||
125197717|NCT00638443|450345882|FG001|First Intervention|Adverse Event|1|||
125197718|NCT00834639|450345884|FG000|Second Intervention|Physician Decision|0|||
125197719|NCT00834639|450345885|FG001|Second Intervention|Physician Decision|2|||
125197720|NCT04603482|450345886|FG000|Overall Study|Lost to Follow-up|15|||
125444310|NCT01474512|451253884|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
125197721|NCT04603482|450345887|FG001|Overall Study|Lost to Follow-up|15|||
125197722|NCT04603482|450345888|FG002|Overall Study|Lost to Follow-up|15|||
125197723|NCT01054196|450345890|FG000|Overall Study|Physician Decision|0|||
125197724|NCT01054196|450345891|FG001|Overall Study|Physician Decision|0|||
125197725|NCT01054196|450345892|FG002|Overall Study|Physician Decision|0|||
125197726|NCT01054196|450345893|FG003|Overall Study|Physician Decision|1|||
125252419|NCT04135352|450550261|FG000|Overall Study|Death|3|||
125252420|NCT04135352|450550262|FG001|Overall Study|Death|4|||
125252421|NCT04135352|450550263|FG002|Overall Study|Death|7|||
125252422|NCT04135352|450550264|FG003|Overall Study|Death|0|||
125197727|NCT01054196|450345894|FG004|Overall Study|Physician Decision|0|||
125252423|NCT04135352|450550265|FG004|Overall Study|Death|3|||
125252424|NCT04135352|450550266|FG005|Overall Study|Death|1|||
125252425|NCT04135352|450550267|FG006|Overall Study|Death|0|||
125252426|NCT04135352|450550268|FG007|Overall Study|Death|0|||
125252427|NCT00511199|450550269|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
125252428|NCT00511199|450550270|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
125252429|NCT00511199|450550269|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
125252430|NCT00511199|450550270|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
125252431|NCT00511199|450550269|FG000|Overall Study|Withdrawal of Informed Consent|19|||
125252432|NCT00511199|450550270|FG001|Overall Study|Withdrawal of Informed Consent|4|||
125252433|NCT00511199|450550269|FG000|Overall Study|Pregnancy|6|||
125252434|NCT00511199|450550270|FG001|Overall Study|Pregnancy|3|||
125252435|NCT00511199|450550269|FG000|Overall Study|Pregnancy Wish|16|||
125252436|NCT00511199|450550270|FG001|Overall Study|Pregnancy Wish|8|||
125252437|NCT00511199|450550269|FG000|Overall Study|Lost to Follow-up|40|||
125252438|NCT00511199|450550270|FG001|Overall Study|Lost to Follow-up|17|||
125252439|NCT00511199|450550269|FG000|Overall Study|Other Reason|78|||
125252440|NCT00511199|450550270|FG001|Overall Study|Other Reason|37|||
125252441|NCT02739828|450550276|FG000|Overall Study|Adverse Event|1|||
125252442|NCT02739828|450550276|FG000|Overall Study|Lost to Follow-up|4|||
125252443|NCT02314247|450550277|FG000|Overall Study|Adverse Event|2|||
125252444|NCT02314247|450550278|FG001|Overall Study|Adverse Event|1|||
125252445|NCT02314247|450550279|FG002|Overall Study|Adverse Event|0|||
125252446|NCT02314247|450550277|FG000|Overall Study|Withdrawal by Subject|1|||
125252447|NCT02314247|450550278|FG001|Overall Study|Withdrawal by Subject|3|||
125252448|NCT02314247|450550279|FG002|Overall Study|Withdrawal by Subject|1|||
125252449|NCT02314247|450550277|FG000|Overall Study|Progression of Disease|6|||
125252450|NCT02314247|450550278|FG001|Overall Study|Progression of Disease|2|||
125252451|NCT02314247|450550279|FG002|Overall Study|Progression of Disease|0|||
125252452|NCT01953354|450550280|FG000|Overall Study|Withdrawal by Subject|0|||
125252453|NCT01953354|450550281|FG001|Overall Study|Withdrawal by Subject|1|||
125252454|NCT01953354|450550280|FG000|Overall Study|Decision of Sponsor|0|||
125252455|NCT01953354|450550281|FG001|Overall Study|Decision of Sponsor|1|||
125252456|NCT01953354|450550280|FG000|Overall Study|Disease Exacerbation|1|||
125252457|NCT01953354|450550281|FG001|Overall Study|Disease Exacerbation|0|||
125252458|NCT01392495|450550282|FG000|Overall Study|Death|3|||
125252459|NCT01392495|450550282|FG000|Overall Study|Administrative problems|8|||
125252460|NCT01392495|450550282|FG000|Overall Study|Withdrawal by Subject|2|||
125252461|NCT01392495|450550282|FG000|Overall Study|Adverse Event|3|||
125252462|NCT01570192|450550283|FG000|Overall Study|no qualifying organism|6|||
125252463|NCT01570192|450550284|FG001|Overall Study|no qualifying organism|12|||
125252464|NCT01570192|450550283|FG000|Overall Study|changed to palliative care|1|||
125252465|NCT01570192|450550284|FG001|Overall Study|changed to palliative care|0|||
125252466|NCT01570192|450550283|FG000|Overall Study|Physician Decision|0|||
125252467|NCT01570192|450550284|FG001|Overall Study|Physician Decision|1|||
125252468|NCT02965976|450550285|FG000|Overall Study|Withdrawal by Subject|2|||
125252469|NCT02965976|450550286|FG001|Overall Study|Withdrawal by Subject|0|||
125252470|NCT00806026|450550287|FG000|Overall Study|Death|0|||
125252471|NCT00806026|450550288|FG001|Overall Study|Death|0|||
125252472|NCT00806026|450550289|FG002|Overall Study|Death|0|||
125252473|NCT00806026|450550290|FG003|Overall Study|Death|1|||
125252474|NCT00806026|450550291|FG004|Overall Study|Death|0|||
125252475|NCT00806026|450550292|FG005|Overall Study|Death|0|||
125252476|NCT00806026|450550287|FG000|Overall Study|Did not meet entrance criteria|4|||
125252477|NCT00806026|450550288|FG001|Overall Study|Did not meet entrance criteria|1|||
125252478|NCT00806026|450550289|FG002|Overall Study|Did not meet entrance criteria|2|||
125252479|NCT00806026|450550290|FG003|Overall Study|Did not meet entrance criteria|1|||
125252480|NCT00806026|450550291|FG004|Overall Study|Did not meet entrance criteria|0|||
125252481|NCT00806026|450550292|FG005|Overall Study|Did not meet entrance criteria|0|||
125252482|NCT00806026|450550287|FG000|Overall Study|Lack of Efficacy|5|||
125252483|NCT00806026|450550288|FG001|Overall Study|Lack of Efficacy|18|||
125252484|NCT00806026|450550289|FG002|Overall Study|Lack of Efficacy|13|||
125252485|NCT00806026|450550290|FG003|Overall Study|Lack of Efficacy|4|||
125252486|NCT00806026|450550291|FG004|Overall Study|Lack of Efficacy|8|||
125252487|NCT00806026|450550292|FG005|Overall Study|Lack of Efficacy|7|||
125252488|NCT00806026|450550287|FG000|Overall Study|Lost to Follow-up|8|||
125252489|NCT00806026|450550288|FG001|Overall Study|Lost to Follow-up|15|||
125252490|NCT00806026|450550289|FG002|Overall Study|Lost to Follow-up|8|||
125252491|NCT00806026|450550290|FG003|Overall Study|Lost to Follow-up|2|||
125252492|NCT00806026|450550291|FG004|Overall Study|Lost to Follow-up|6|||
125252493|NCT00806026|450550292|FG005|Overall Study|Lost to Follow-up|6|||
125252494|NCT00806026|450550287|FG000|Overall Study|Withdrawal by Subject|14|||
125252495|NCT00806026|450550288|FG001|Overall Study|Withdrawal by Subject|17|||
125252496|NCT00806026|450550289|FG002|Overall Study|Withdrawal by Subject|9|||
125252497|NCT00806026|450550290|FG003|Overall Study|Withdrawal by Subject|2|||
125252498|NCT00806026|450550291|FG004|Overall Study|Withdrawal by Subject|5|||
125252499|NCT00806026|450550292|FG005|Overall Study|Withdrawal by Subject|3|||
125252500|NCT00806026|450550287|FG000|Overall Study|Other|3|||
125252501|NCT00806026|450550288|FG001|Overall Study|Other|6|||
125252502|NCT00806026|450550289|FG002|Overall Study|Other|8|||
125252503|NCT00806026|450550290|FG003|Overall Study|Other|2|||
125252504|NCT00806026|450550291|FG004|Overall Study|Other|0|||
125252505|NCT00806026|450550292|FG005|Overall Study|Other|4|||
125252506|NCT00806026|450550287|FG000|Overall Study|Protocol Violation|6|||
125252507|NCT00806026|450550288|FG001|Overall Study|Protocol Violation|9|||
125252508|NCT00806026|450550289|FG002|Overall Study|Protocol Violation|9|||
125252509|NCT00806026|450550290|FG003|Overall Study|Protocol Violation|0|||
125252510|NCT00806026|450550291|FG004|Overall Study|Protocol Violation|2|||
125252511|NCT00806026|450550292|FG005|Overall Study|Protocol Violation|3|||
125252512|NCT00806026|450550287|FG000|Overall Study|Adverse Event|52|||
125252513|NCT00806026|450550288|FG001|Overall Study|Adverse Event|35|||
125252514|NCT00806026|450550289|FG002|Overall Study|Adverse Event|44|||
125252515|NCT00806026|450550290|FG003|Overall Study|Adverse Event|17|||
125252516|NCT00806026|450550291|FG004|Overall Study|Adverse Event|9|||
125252517|NCT00806026|450550292|FG005|Overall Study|Adverse Event|9|||
125252518|NCT01687595|450550293|FG000|Overall Study|Withdrawal by Subject|8|||
125197728|NCT01054196|450345895|FG005|Overall Study|Physician Decision|0|||
125197729|NCT01054196|450345896|FG006|Overall Study|Physician Decision|1|||
125197730|NCT00179673|450345897|FG000|Overall Study|Adverse Event|7|||
125197731|NCT00179673|450345897|FG000|Overall Study|Lack of Efficacy|15|||
125197732|NCT00179673|450345897|FG000|Overall Study|Withdrawal by Subject|3|||
125197733|NCT00179673|450345897|FG000|Overall Study|Death|4|||
125197734|NCT00179673|450345897|FG000|Overall Study|Other Observations and options|14|||
125197735|NCT00282113|450345898|FG000|Overall Study|Removed at parents request|1|||
125197736|NCT00282113|450345899|FG001|Overall Study|Removed at parents request|0|||
125197737|NCT00282113|450345900|FG002|Overall Study|Removed at parents request|0|||
125197738|NCT02949843|450345901|FG000|Overall Study|Withdrawal by Subject|0|||
125197739|NCT02949843|450345902|FG001|Overall Study|Withdrawal by Subject|1|||
125197740|NCT02949843|450345903|FG002|Overall Study|Withdrawal by Subject|1|||
125197741|NCT02253316|450345905|FG000|Consolidation|Progression|4|||
125197742|NCT02253316|450345906|FG001|Consolidation|Progression|0|||
125197743|NCT02253316|450345907|FG002|Consolidation|Progression|0|||
125197744|NCT02253316|450345905|FG000|Consolidation|Non-Compliance|1|||
125197745|NCT02253316|450345906|FG001|Consolidation|Non-Compliance|0|||
125197746|NCT02253316|450345907|FG002|Consolidation|Non-Compliance|0|||
125197747|NCT02253316|450345905|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
125197748|NCT02253316|450345906|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
125197749|NCT02253316|450345907|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
125197750|NCT02253316|450345905|FG000|Consolidation|Secondary Malignancy|2|||
125197751|NCT02253316|450345906|FG001|Consolidation|Secondary Malignancy|0|||
125197752|NCT02253316|450345907|FG002|Consolidation|Secondary Malignancy|0|||
125197753|NCT02253316|450345905|FG000|Consolidation|Adverse Event|7|||
125197754|NCT02253316|450345906|FG001|Consolidation|Adverse Event|0|||
125197755|NCT02253316|450345907|FG002|Consolidation|Adverse Event|0|||
125197756|NCT02253316|450345905|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
125197757|NCT02253316|450345906|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
125197758|NCT02253316|450345907|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
125197759|NCT02253316|450345905|FG000|Maintenance|Physician Decision|0|||
125197760|NCT02253316|450345906|FG001|Maintenance|Physician Decision|7|||
125197761|NCT02253316|450345907|FG002|Maintenance|Physician Decision|16|||
125197762|NCT02253316|450345905|FG000|Maintenance|Non-Compliance|0|||
125197763|NCT02253316|450345906|FG001|Maintenance|Non-Compliance|1|||
125197764|NCT02253316|450345907|FG002|Maintenance|Non-Compliance|1|||
125197765|NCT02253316|450345905|FG000|Maintenance|Secondary Malignancy|0|||
125197766|NCT02253316|450345906|FG001|Maintenance|Secondary Malignancy|2|||
125197767|NCT02253316|450345907|FG002|Maintenance|Secondary Malignancy|6|||
125197768|NCT02253316|450345905|FG000|Maintenance|Adverse Event|0|||
125197769|NCT02253316|450345906|FG001|Maintenance|Adverse Event|8|||
125197770|NCT02253316|450345907|FG002|Maintenance|Adverse Event|12|||
125197771|NCT02253316|450345905|FG000|Maintenance|Still receiving active treatment|0|||
125197772|NCT02253316|450345906|FG001|Maintenance|Still receiving active treatment|5|||
125197773|NCT02253316|450345907|FG002|Maintenance|Still receiving active treatment|0|||
125197774|NCT02107859|450345915|FG000|Overall Study|Withdrawal by Subject|14|||
125197775|NCT02107859|450345915|FG000|Overall Study|Adverse Event|3|||
125197776|NCT02107859|450345915|FG000|Overall Study|Study closure|41|||
125197777|NCT02107859|450345915|FG000|Overall Study|Other than specified|3|||
125197778|NCT00135512|450345916|FG000|Overall Study|Adverse Event|56|||
125197779|NCT00135512|450345916|FG000|Overall Study|Lack of Efficacy|25|||
125197780|NCT00135512|450345916|FG000|Overall Study|Other|42|||
125197781|NCT04439214|450345917|FG000|Overall Study|Adverse Event|13|||
125197782|NCT04439214|450345917|FG000|Overall Study|Disease progression|16|||
125197783|NCT04439214|450345917|FG000|Overall Study|Death|1|||
125197784|NCT04439214|450345917|FG000|Overall Study|Withdrawal by Subject|2|||
125197785|NCT04439214|450345917|FG000|Overall Study|Declining health|1|||
125197786|NCT04439214|450345917|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
125197787|NCT04439214|450345917|FG000|Overall Study|Ineligible|5|||
125197788|NCT04152837|450345918|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
125252519|NCT01687595|450550294|FG001|Overall Study|Withdrawal by Subject|0|||
125252520|NCT01687595|450550293|FG000|Overall Study|Lost to Follow-up|3|||
125252521|NCT01687595|450550294|FG001|Overall Study|Lost to Follow-up|1|||
125252522|NCT01687595|450550293|FG000|Overall Study|Investigator's decision|1|||
125252523|NCT01687595|450550294|FG001|Overall Study|Investigator's decision|0|||
125252524|NCT01687595|450550293|FG000|Overall Study|Sponsor's decision|1|||
125252525|NCT01687595|450550294|FG001|Overall Study|Sponsor's decision|0|||
125252526|NCT01687595|450550293|FG000|Overall Study|Noncompliance|1|||
125252527|NCT01687595|450550294|FG001|Overall Study|Noncompliance|2|||
125252528|NCT01687595|450550293|FG000|Overall Study|Other than specified|56|||
125252529|NCT01687595|450550294|FG001|Overall Study|Other than specified|7|||
125252530|NCT00489359|450550297|FG000|Overall Study|Death|0|||
125252531|NCT00489359|450550298|FG001|Overall Study|Death|2|||
125252532|NCT00489359|450550297|FG000|Overall Study|Progressive Disease|5|||
125252533|NCT00489359|450550298|FG001|Overall Study|Progressive Disease|6|||
125252534|NCT00489359|450550297|FG000|Overall Study|Lost to Follow-up|1|||
125252535|NCT00489359|450550298|FG001|Overall Study|Lost to Follow-up|0|||
125252536|NCT00489359|450550297|FG000|Overall Study|Withdrawal by Subject|1|||
125252537|NCT00489359|450550298|FG001|Overall Study|Withdrawal by Subject|5|||
125252538|NCT00489359|450550297|FG000|Overall Study|Adverse Event|0|||
125252539|NCT00489359|450550298|FG001|Overall Study|Adverse Event|16|||
125252540|NCT03180138|450550299|FG000|Overall Study|Mobile-phone could not be verified|2|||
125252541|NCT03180138|450550300|FG001|Overall Study|Mobile-phone could not be verified|13|||
125252542|NCT03180138|450550301|FG002|Overall Study|Mobile-phone could not be verified|15|||
125252543|NCT03180138|450550299|FG000|Overall Study|No prior immunization records|17|||
125252544|NCT03180138|450550300|FG001|Overall Study|No prior immunization records|0|||
125252545|NCT03180138|450550301|FG002|Overall Study|No prior immunization records|6|||
125252546|NCT03180138|450550299|FG000|Overall Study|Found to be >24 mon after randomization|3|||
125252547|NCT03180138|450550300|FG001|Overall Study|Found to be >24 mon after randomization|0|||
125252548|NCT03180138|450550301|FG002|Overall Study|Found to be >24 mon after randomization|3|||
125252549|NCT02100644|450550303|FG000|LTG Escalation Phase|Adverse Event|9|||
125252550|NCT02100644|450550304|FG001|LTG Escalation Phase|Adverse Event|0|||
125252551|NCT02100644|450550305|FG002|LTG Escalation Phase|Adverse Event|0|||
125252552|NCT02100644|450550303|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
125252553|NCT02100644|450550304|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
125252554|NCT02100644|450550305|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
125252555|NCT02100644|450550303|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
125252556|NCT02100644|450550304|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
125252557|NCT02100644|450550305|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
125252558|NCT00728182|450550306|FG000|Overall Study|Adverse Event|1|||
125252559|NCT00728182|450550307|FG001|Overall Study|Adverse Event|0|||
125252560|NCT00728182|450550306|FG000|Overall Study|Lost to Follow-up|2|||
125252561|NCT00728182|450550307|FG001|Overall Study|Lost to Follow-up|0|||
125252562|NCT00728182|450550306|FG000|Overall Study|Death|0|||
125252563|NCT00728182|450550307|FG001|Overall Study|Death|2|||
125252564|NCT00728182|450550306|FG000|Overall Study|Protocol Noncompliance|0|||
125252565|NCT00728182|450550307|FG001|Overall Study|Protocol Noncompliance|1|||
125252566|NCT01898091|450550309|FG000|Overall Study|Lost to Follow-up|1|||
125252567|NCT01898091|450550310|FG001|Overall Study|Lost to Follow-up|1|||
125252568|NCT01898091|450550309|FG000|Overall Study|Withdrawal by Subject|1|||
125252569|NCT01898091|450550310|FG001|Overall Study|Withdrawal by Subject|5|||
125252570|NCT04754399|450550314|FG000|Overall Study|Adverse Event|5|||
125252571|NCT04754399|450550314|FG000|Overall Study|Withdrawal by Subject|6|||
125252572|NCT00231465|450550315|FG000|Overall Study|Completed only one cycle|1|||
125252573|NCT00231465|450550315|FG000|Overall Study|Did not have follow up CT scans|1|||
125252574|NCT00025233|450550316|FG000|Overall Study|Ineligible: wrong cell type|1|||
125252575|NCT00025233|450550316|FG000|Overall Study|Ineligible: wrong primary|1|||
125252576|NCT00025233|450550316|FG000|Overall Study|Ineligible: improper prior treatment|1|||
125252577|NCT00025233|450550316|FG000|Overall Study|Never treated|1|||
125252578|NCT00930176|450550318|FG000|Overall Study|Death|1|||
125252579|NCT00401830|450550322|FG000|Overall Study|Adverse Event|10|||
125252580|NCT00401830|450550323|FG001|Overall Study|Adverse Event|18|||
125252581|NCT00401830|450550322|FG000|Overall Study|Lack of Efficacy|11|||
125252582|NCT00401830|450550323|FG001|Overall Study|Lack of Efficacy|5|||
125252583|NCT00401830|450550322|FG000|Overall Study|Withdrawal by Subject|4|||
125252584|NCT00401830|450550323|FG001|Overall Study|Withdrawal by Subject|3|||
125252585|NCT00401830|450550322|FG000|Overall Study|Protocol Violation|3|||
125252586|NCT00401830|450550323|FG001|Overall Study|Protocol Violation|3|||
125252587|NCT00401830|450550322|FG000|Overall Study|Non-compliance with drug study|1|||
125252588|NCT00401830|450550323|FG001|Overall Study|Non-compliance with drug study|0|||
125252589|NCT00401830|450550322|FG000|Overall Study|Lost to Follow-up|1|||
125252590|NCT00401830|450550323|FG001|Overall Study|Lost to Follow-up|3|||
125252591|NCT00401830|450550322|FG000|Overall Study|Other: Personal / Family problems|1|||
125252592|NCT00401830|450550323|FG001|Overall Study|Other: Personal / Family problems|0|||
125252593|NCT01943825|450550324|FG000|Overall Study|Lost to Follow-up|9|||
125252594|NCT01943825|450550325|FG001|Overall Study|Lost to Follow-up|3|||
125252595|NCT01943825|450550326|FG002|Overall Study|Lost to Follow-up|12|||
125252596|NCT01943825|450550327|FG003|Overall Study|Lost to Follow-up|8|||
125252597|NCT01943825|450550324|FG000|Overall Study|Withdrawal by Subject|1|||
125252598|NCT01943825|450550325|FG001|Overall Study|Withdrawal by Subject|0|||
125252599|NCT01943825|450550326|FG002|Overall Study|Withdrawal by Subject|3|||
125252600|NCT01943825|450550327|FG003|Overall Study|Withdrawal by Subject|2|||
125252601|NCT01943825|450550324|FG000|Overall Study|Other than specified above|0|||
125252602|NCT01943825|450550325|FG001|Overall Study|Other than specified above|1|||
125252603|NCT01943825|450550326|FG002|Overall Study|Other than specified above|0|||
125252604|NCT01943825|450550327|FG003|Overall Study|Other than specified above|1|||
125252605|NCT00452400|450550328|FG000|Overall Study|Adverse Event|1|||
125252606|NCT00452400|450550329|FG001|Overall Study|Adverse Event|1|||
125252607|NCT00452400|450550330|FG002|Overall Study|Adverse Event|5|||
125252608|NCT00452400|450550331|FG003|Overall Study|Adverse Event|0|||
125252609|NCT00452400|450550332|FG004|Overall Study|Adverse Event|2|||
125252610|NCT00452400|450550328|FG000|Overall Study|Protocol Violation|0|||
125252611|NCT00452400|450550329|FG001|Overall Study|Protocol Violation|0|||
125252612|NCT00452400|450550330|FG002|Overall Study|Protocol Violation|1|||
125252613|NCT00452400|450550331|FG003|Overall Study|Protocol Violation|0|||
125252614|NCT00452400|450550332|FG004|Overall Study|Protocol Violation|0|||
125252615|NCT00452400|450550328|FG000|Overall Study|Lost to Follow-up|1|||
125252616|NCT00452400|450550329|FG001|Overall Study|Lost to Follow-up|0|||
125252617|NCT00452400|450550330|FG002|Overall Study|Lost to Follow-up|0|||
125252618|NCT00452400|450550331|FG003|Overall Study|Lost to Follow-up|0|||
125252619|NCT00452400|450550332|FG004|Overall Study|Lost to Follow-up|0|||
125252620|NCT00452400|450550328|FG000|Overall Study|Withdrawal by Subject|1|||
125252621|NCT00452400|450550329|FG001|Overall Study|Withdrawal by Subject|0|||
125252622|NCT00452400|450550330|FG002|Overall Study|Withdrawal by Subject|1|||
125252623|NCT00452400|450550331|FG003|Overall Study|Withdrawal by Subject|0|||
125252624|NCT00452400|450550332|FG004|Overall Study|Withdrawal by Subject|0|||
125252625|NCT00452400|450550328|FG000|Overall Study|Lack of Efficacy|2|||
125252626|NCT00452400|450550329|FG001|Overall Study|Lack of Efficacy|0|||
125252627|NCT00452400|450550330|FG002|Overall Study|Lack of Efficacy|0|||
125252628|NCT00452400|450550331|FG003|Overall Study|Lack of Efficacy|0|||
125252629|NCT00452400|450550332|FG004|Overall Study|Lack of Efficacy|0|||
125252630|NCT00452400|450550328|FG000|Overall Study|Other reasons not listed above|0|||
125252631|NCT00452400|450550329|FG001|Overall Study|Other reasons not listed above|0|||
125252632|NCT00452400|450550330|FG002|Overall Study|Other reasons not listed above|0|||
125252633|NCT00452400|450550331|FG003|Overall Study|Other reasons not listed above|1|||
125252634|NCT00452400|450550332|FG004|Overall Study|Other reasons not listed above|1|||
125252635|NCT01720602|450550333|FG000|Overall Study|Adverse Event|3|||
125252636|NCT01720602|450550333|FG000|Overall Study|Progressive disease on therapy|2|||
125252637|NCT03378635|450550335|FG000|Overall Study|Adverse Event|1|||
125252638|NCT03378635|450550336|FG001|Overall Study|Adverse Event|0|||
125252639|NCT03378635|450550337|FG002|Overall Study|Adverse Event|0|||
125252640|NCT03378635|450550335|FG000|Overall Study|Withdrawal by Subject|1|||
125252641|NCT03378635|450550336|FG001|Overall Study|Withdrawal by Subject|0|||
125252642|NCT03378635|450550337|FG002|Overall Study|Withdrawal by Subject|0|||
125252643|NCT03425188|450550339|FG000|Overall Study|Withdrawal by Subject|1|||
125252644|NCT00562861|450550342|FG000|Overall Study|Adverse Event|1|||
125252645|NCT00562861|450550343|FG001|Overall Study|Adverse Event|1|||
125252646|NCT00562861|450550342|FG000|Overall Study|Lack of Efficacy|5|||
125252647|NCT00562861|450550343|FG001|Overall Study|Lack of Efficacy|5|||
125252648|NCT00562861|450550342|FG000|Overall Study|noncompliance, moved|7|||
125252649|NCT00562861|450550343|FG001|Overall Study|noncompliance, moved|2|||
125252650|NCT00562861|450550342|FG000|Overall Study|Lost to Follow-up|7|||
125197789|NCT04152837|450345918|FG000|Maintenance Period|Adverse Event|1|||
125197790|NCT04152837|450345918|FG000|Maintenance Period|Withdrawal by Subject|1|||
125197791|NCT04152837|450345918|FG000|Maintenance Period|Sponsor Termination of Study|2|||
125197792|NCT01295827|450345923|FG000|Overall Study|Adverse Event|1|||
125197793|NCT01295827|450345924|FG001|Overall Study|Adverse Event|2|||
125197794|NCT01295827|450345925|FG002|Overall Study|Adverse Event|2|||
125197795|NCT01295827|450345926|FG003|Overall Study|Adverse Event|1|||
125252651|NCT00562861|450550343|FG001|Overall Study|Lost to Follow-up|3|||
125197796|NCT01295827|450345927|FG004|Overall Study|Adverse Event|1|||
125197797|NCT01295827|450345928|FG005|Overall Study|Adverse Event|4|||
125197798|NCT01295827|450345929|FG006|Overall Study|Adverse Event|15|||
125252652|NCT01694771|450550344|FG000|Overall Study|Adverse Event|18|||
125252653|NCT01694771|450550345|FG001|Overall Study|Adverse Event|16|||
125252654|NCT01694771|450550344|FG000|Overall Study|Lack of Efficacy|1|||
125252655|NCT01694771|450550345|FG001|Overall Study|Lack of Efficacy|0|||
125252656|NCT01694771|450550344|FG000|Overall Study|Non compliance protocol|7|||
125252657|NCT01694771|450550345|FG001|Overall Study|Non compliance protocol|6|||
125252658|NCT01694771|450550344|FG000|Overall Study|Lost to Follow-up|2|||
125252659|NCT01694771|450550345|FG001|Overall Study|Lost to Follow-up|3|||
125252660|NCT01694771|450550344|FG000|Overall Study|Consent withdrawn|7|||
125252661|NCT01694771|450550345|FG001|Overall Study|Consent withdrawn|9|||
125252662|NCT01694771|450550344|FG000|Overall Study|Other reasons|5|||
125252663|NCT01694771|450550345|FG001|Overall Study|Other reasons|6|||
125197799|NCT01295827|450345930|FG007|Overall Study|Adverse Event|49|||
125197800|NCT01295827|450345931|FG008|Overall Study|Adverse Event|22|||
125197801|NCT01295827|450345932|FG009|Overall Study|Adverse Event|7|||
125197802|NCT01295827|450345933|FG010|Overall Study|Adverse Event|50|||
125197803|NCT01295827|450345934|FG011|Overall Study|Adverse Event|21|||
125197804|NCT01295827|450345935|FG012|Overall Study|Adverse Event|0|||
125197805|NCT01295827|450345936|FG013|Overall Study|Adverse Event|0|||
125197806|NCT01295827|450345937|FG014|Overall Study|Adverse Event|0|||
125197807|NCT01295827|450345923|FG000|Overall Study|Lost to Follow-up|0|||
125197808|NCT01295827|450345924|FG001|Overall Study|Lost to Follow-up|0|||
125197809|NCT01295827|450345925|FG002|Overall Study|Lost to Follow-up|3|||
125197810|NCT01295827|450345926|FG003|Overall Study|Lost to Follow-up|0|||
125197811|NCT01295827|450345927|FG004|Overall Study|Lost to Follow-up|1|||
125197812|NCT01295827|450345928|FG005|Overall Study|Lost to Follow-up|0|||
125197813|NCT01295827|450345929|FG006|Overall Study|Lost to Follow-up|4|||
125197814|NCT01295827|450345930|FG007|Overall Study|Lost to Follow-up|8|||
125197815|NCT01295827|450345931|FG008|Overall Study|Lost to Follow-up|7|||
125197816|NCT01295827|450345932|FG009|Overall Study|Lost to Follow-up|4|||
125197817|NCT01295827|450345933|FG010|Overall Study|Lost to Follow-up|7|||
125197818|NCT01295827|450345934|FG011|Overall Study|Lost to Follow-up|3|||
125197819|NCT01295827|450345935|FG012|Overall Study|Lost to Follow-up|0|||
125197820|NCT01295827|450345936|FG013|Overall Study|Lost to Follow-up|0|||
125197821|NCT01295827|450345937|FG014|Overall Study|Lost to Follow-up|0|||
125197822|NCT01295827|450345923|FG000|Overall Study|Not Reported|0|||
125197823|NCT01295827|450345924|FG001|Overall Study|Not Reported|0|||
125197824|NCT01295827|450345925|FG002|Overall Study|Not Reported|0|||
125197825|NCT01295827|450345926|FG003|Overall Study|Not Reported|1|||
125197826|NCT01295827|450345927|FG004|Overall Study|Not Reported|0|||
125197827|NCT01295827|450345928|FG005|Overall Study|Not Reported|0|||
125197828|NCT01295827|450345929|FG006|Overall Study|Not Reported|24|||
125197829|NCT01295827|450345930|FG007|Overall Study|Not Reported|58|||
125197830|NCT01295827|450345931|FG008|Overall Study|Not Reported|41|||
125197831|NCT01295827|450345932|FG009|Overall Study|Not Reported|2|||
125197832|NCT01295827|450345933|FG010|Overall Study|Not Reported|23|||
125197833|NCT01295827|450345934|FG011|Overall Study|Not Reported|13|||
125197834|NCT01295827|450345935|FG012|Overall Study|Not Reported|0|||
125197835|NCT01295827|450345936|FG013|Overall Study|Not Reported|0|||
125197836|NCT01295827|450345937|FG014|Overall Study|Not Reported|0|||
125197837|NCT01295827|450345923|FG000|Overall Study|Progressive Disease|2|||
125197838|NCT01295827|450345924|FG001|Overall Study|Progressive Disease|1|||
125197839|NCT01295827|450345925|FG002|Overall Study|Progressive Disease|5|||
125197840|NCT01295827|450345926|FG003|Overall Study|Progressive Disease|2|||
125197841|NCT01295827|450345927|FG004|Overall Study|Progressive Disease|0|||
125197842|NCT01295827|450345928|FG005|Overall Study|Progressive Disease|1|||
125197843|NCT01295827|450345929|FG006|Overall Study|Progressive Disease|87|||
125252664|NCT00289900|450550349|FG000|Overall Study|Adverse Event|28|||
125252665|NCT00289900|450550350|FG001|Overall Study|Adverse Event|40|||
125252666|NCT00289900|450550351|FG002|Overall Study|Adverse Event|13|||
125252667|NCT00289900|450550352|FG003|Overall Study|Adverse Event|19|||
125252668|NCT00289900|450550353|FG004|Overall Study|Adverse Event|20|||
125252669|NCT00289900|450550354|FG005|Overall Study|Adverse Event|33|||
125252670|NCT00289900|450550349|FG000|Overall Study|Lost to Follow-up|7|||
125252671|NCT00289900|450550350|FG001|Overall Study|Lost to Follow-up|7|||
125252672|NCT00289900|450550351|FG002|Overall Study|Lost to Follow-up|8|||
125252673|NCT00289900|450550352|FG003|Overall Study|Lost to Follow-up|8|||
125252674|NCT00289900|450550353|FG004|Overall Study|Lost to Follow-up|4|||
125252675|NCT00289900|450550354|FG005|Overall Study|Lost to Follow-up|8|||
125197844|NCT01295827|450345930|FG007|Overall Study|Progressive Disease|144|||
125197845|NCT01295827|450345931|FG008|Overall Study|Progressive Disease|85|||
125197846|NCT01295827|450345932|FG009|Overall Study|Progressive Disease|40|||
125197847|NCT01295827|450345933|FG010|Overall Study|Progressive Disease|175|||
125197848|NCT01295827|450345934|FG011|Overall Study|Progressive Disease|136|||
125252676|NCT00289900|450550349|FG000|Overall Study|Participant had flushing|18|||
125252677|NCT00289900|450550350|FG001|Overall Study|Participant had flushing|42|||
125197849|NCT01295827|450345935|FG012|Overall Study|Progressive Disease|0|||
125197850|NCT01295827|450345936|FG013|Overall Study|Progressive Disease|0|||
125197851|NCT01295827|450345937|FG014|Overall Study|Progressive Disease|0|||
125197852|NCT01295827|450345923|FG000|Overall Study|Screen Failure|0|||
125197853|NCT01295827|450345924|FG001|Overall Study|Screen Failure|0|||
125197854|NCT01295827|450345925|FG002|Overall Study|Screen Failure|0|||
125197855|NCT01295827|450345926|FG003|Overall Study|Screen Failure|0|||
125197856|NCT01295827|450345927|FG004|Overall Study|Screen Failure|0|||
125197857|NCT01295827|450345928|FG005|Overall Study|Screen Failure|0|||
125197858|NCT01295827|450345929|FG006|Overall Study|Screen Failure|2|||
125197859|NCT01295827|450345930|FG007|Overall Study|Screen Failure|2|||
125252678|NCT00289900|450550351|FG002|Overall Study|Participant had flushing|1|||
125252679|NCT00289900|450550352|FG003|Overall Study|Participant had flushing|2|||
125197860|NCT01295827|450345931|FG008|Overall Study|Screen Failure|2|||
125197861|NCT01295827|450345932|FG009|Overall Study|Screen Failure|0|||
125197862|NCT01295827|450345933|FG010|Overall Study|Screen Failure|1|||
125252680|NCT00289900|450550353|FG004|Overall Study|Participant had flushing|0|||
125197863|NCT01295827|450345934|FG011|Overall Study|Screen Failure|0|||
125197864|NCT01295827|450345935|FG012|Overall Study|Screen Failure|0|||
125197865|NCT01295827|450345936|FG013|Overall Study|Screen Failure|0|||
125197866|NCT01295827|450345937|FG014|Overall Study|Screen Failure|0|||
125197867|NCT01295827|450345923|FG000|Overall Study|Withdrawal by Subject|1|||
125197868|NCT01295827|450345924|FG001|Overall Study|Withdrawal by Subject|0|||
125197869|NCT01295827|450345925|FG002|Overall Study|Withdrawal by Subject|2|||
125197870|NCT01295827|450345926|FG003|Overall Study|Withdrawal by Subject|0|||
125197871|NCT01295827|450345927|FG004|Overall Study|Withdrawal by Subject|0|||
125197872|NCT01295827|450345928|FG005|Overall Study|Withdrawal by Subject|1|||
125197873|NCT01295827|450345929|FG006|Overall Study|Withdrawal by Subject|13|||
125197874|NCT01295827|450345930|FG007|Overall Study|Withdrawal by Subject|35|||
125197875|NCT01295827|450345931|FG008|Overall Study|Withdrawal by Subject|11|||
125197876|NCT01295827|450345932|FG009|Overall Study|Withdrawal by Subject|2|||
125197877|NCT01295827|450345933|FG010|Overall Study|Withdrawal by Subject|18|||
125197878|NCT01295827|450345934|FG011|Overall Study|Withdrawal by Subject|13|||
125197879|NCT01295827|450345935|FG012|Overall Study|Withdrawal by Subject|0|||
125197880|NCT01295827|450345936|FG013|Overall Study|Withdrawal by Subject|0|||
125197881|NCT01295827|450345937|FG014|Overall Study|Withdrawal by Subject|0|||
125197882|NCT01295827|450345923|FG000|Overall Study|Other|0|||
125197883|NCT01295827|450345924|FG001|Overall Study|Other|0|||
125197884|NCT01295827|450345925|FG002|Overall Study|Other|0|||
125197885|NCT01295827|450345926|FG003|Overall Study|Other|0|||
125197886|NCT01295827|450345927|FG004|Overall Study|Other|0|||
125197887|NCT01295827|450345928|FG005|Overall Study|Other|0|||
125197888|NCT01295827|450345929|FG006|Overall Study|Other|1|||
125197889|NCT01295827|450345930|FG007|Overall Study|Other|1|||
125197890|NCT01295827|450345931|FG008|Overall Study|Other|1|||
125197891|NCT01295827|450345932|FG009|Overall Study|Other|0|||
125197892|NCT01295827|450345933|FG010|Overall Study|Other|2|||
125197893|NCT01295827|450345934|FG011|Overall Study|Other|0|||
125197894|NCT01295827|450345935|FG012|Overall Study|Other|0|||
125197895|NCT01295827|450345936|FG013|Overall Study|Other|0|||
125197896|NCT01295827|450345937|FG014|Overall Study|Other|0|||
125197897|NCT00746564|450345938|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
125197898|NCT03226769|450345942|FG000|Overall Study|Withdrawal by Subject|0|||
125197899|NCT03226769|450345943|FG001|Overall Study|Withdrawal by Subject|1|||
125197900|NCT01827267|450345944|FG000|Overall Study|Did not receive study drug|1|||
125197901|NCT01827267|450345945|FG001|Overall Study|Did not receive study drug|1|||
125197902|NCT01827267|450345944|FG000|Overall Study|Physician Decision|1|||
125197903|NCT01827267|450345945|FG001|Overall Study|Physician Decision|0|||
125197904|NCT01827267|450345944|FG000|Overall Study|Disease Progression|1|||
125197905|NCT01827267|450345945|FG001|Overall Study|Disease Progression|1|||
125197906|NCT01827267|450345944|FG000|Overall Study|Sponsor Discontinued Study|2|||
125197907|NCT01827267|450345945|FG001|Overall Study|Sponsor Discontinued Study|8|||
125197908|NCT01827267|450345944|FG000|Overall Study|Still on study|0|||
125197909|NCT01827267|450345945|FG001|Overall Study|Still on study|2|||
125197910|NCT01516008|450345952|FG000|Overall Study|Adverse Event|0|||
125197911|NCT01516008|450345953|FG001|Overall Study|Adverse Event|2|||
125197912|NCT01516008|450345954|FG002|Overall Study|Adverse Event|7|||
125197913|NCT01516008|450345952|FG000|Overall Study|Lack of Efficacy|44|||
125197914|NCT01516008|450345953|FG001|Overall Study|Lack of Efficacy|14|||
125197915|NCT01516008|450345954|FG002|Overall Study|Lack of Efficacy|10|||
125197916|NCT01516008|450345952|FG000|Overall Study|Protocol Violation|1|||
125197917|NCT01516008|450345953|FG001|Overall Study|Protocol Violation|0|||
125197918|NCT01516008|450345954|FG002|Overall Study|Protocol Violation|0|||
125197919|NCT01516008|450345952|FG000|Overall Study|Reason not specified|0|||
125197920|NCT01516008|450345953|FG001|Overall Study|Reason not specified|0|||
125197921|NCT01516008|450345954|FG002|Overall Study|Reason not specified|1|||
125197922|NCT00813813|450345957|FG000|Overall Study|Withdrawal by Subject|1|||
125197923|NCT00813813|450345958|FG001|Overall Study|Withdrawal by Subject|1|||
125197924|NCT00813813|450345957|FG000|Overall Study|Lost to Follow-up|2|||
125197925|NCT00813813|450345958|FG001|Overall Study|Lost to Follow-up|7|||
125197926|NCT00813813|450345957|FG000|Overall Study|Other|0|||
125197927|NCT00813813|450345958|FG001|Overall Study|Other|1|||
125197928|NCT00986921|450345959|FG000|Overall Study|Physician Decision|1|||
125197929|NCT00986921|450345960|FG001|Overall Study|Physician Decision|0|||
125197930|NCT00833482|450345961|FG000|Days 11-20|Adverse Event|0|||
125197931|NCT00833482|450345962|FG001|Days 11-20|Adverse Event|2|||
125197932|NCT00833482|450345963|FG002|Days 11-20|Adverse Event|0|||
125197933|NCT00833482|450345964|FG003|Days 11-20|Adverse Event|0|||
125197934|NCT00833482|450345965|FG004|Days 11-20|Adverse Event|0|||
125197935|NCT00833482|450345966|FG005|Days 11-20|Adverse Event|0|||
125197936|NCT00833482|450345961|FG000|Days 11-20|Withdrawal by Subject|0|||
125197937|NCT00833482|450345962|FG001|Days 11-20|Withdrawal by Subject|1|||
125197938|NCT00833482|450345963|FG002|Days 11-20|Withdrawal by Subject|0|||
125197939|NCT00833482|450345964|FG003|Days 11-20|Withdrawal by Subject|0|||
125197940|NCT00833482|450345965|FG004|Days 11-20|Withdrawal by Subject|0|||
125197941|NCT00833482|450345966|FG005|Days 11-20|Withdrawal by Subject|0|||
125197942|NCT00833482|450345961|FG000|Days 21-30|Adverse Event|0|||
125197943|NCT00833482|450345962|FG001|Days 21-30|Adverse Event|0|||
125197944|NCT00833482|450345963|FG002|Days 21-30|Adverse Event|1|||
125197945|NCT00833482|450345964|FG003|Days 21-30|Adverse Event|0|||
125252681|NCT00289900|450550354|FG005|Overall Study|Participant had flushing|4|||
125252682|NCT00289900|450550349|FG000|Overall Study|Other|0|||
125252683|NCT00289900|450550350|FG001|Overall Study|Other|0|||
125252684|NCT00289900|450550351|FG002|Overall Study|Other|0|||
125252685|NCT00289900|450550352|FG003|Overall Study|Other|5|||
125252686|NCT00289900|450550353|FG004|Overall Study|Other|1|||
125252687|NCT00289900|450550354|FG005|Overall Study|Other|0|||
125252688|NCT00289900|450550349|FG000|Overall Study|Participant moved|1|||
125252689|NCT00289900|450550350|FG001|Overall Study|Participant moved|0|||
125252690|NCT00289900|450550351|FG002|Overall Study|Participant moved|0|||
125252691|NCT00289900|450550352|FG003|Overall Study|Participant moved|1|||
125252692|NCT00289900|450550353|FG004|Overall Study|Participant moved|1|||
125252693|NCT00289900|450550354|FG005|Overall Study|Participant moved|1|||
125252694|NCT00289900|450550349|FG000|Overall Study|Withdrawal by Subject|10|||
125252695|NCT00289900|450550350|FG001|Overall Study|Withdrawal by Subject|21|||
125252696|NCT00289900|450550351|FG002|Overall Study|Withdrawal by Subject|8|||
125252697|NCT00289900|450550352|FG003|Overall Study|Withdrawal by Subject|18|||
125252698|NCT00289900|450550353|FG004|Overall Study|Withdrawal by Subject|12|||
125252699|NCT00289900|450550354|FG005|Overall Study|Withdrawal by Subject|11|||
125252700|NCT00289900|450550349|FG000|Overall Study|Protocol Violation|3|||
125252701|NCT00289900|450550350|FG001|Overall Study|Protocol Violation|9|||
125252702|NCT00289900|450550351|FG002|Overall Study|Protocol Violation|2|||
125252703|NCT00289900|450550352|FG003|Overall Study|Protocol Violation|6|||
125252704|NCT00289900|450550353|FG004|Overall Study|Protocol Violation|7|||
125252705|NCT00289900|450550354|FG005|Overall Study|Protocol Violation|4|||
125252706|NCT00289900|450550349|FG000|Overall Study|site terminated|1|||
125252707|NCT00289900|450550350|FG001|Overall Study|site terminated|0|||
125252708|NCT00289900|450550351|FG002|Overall Study|site terminated|1|||
125252709|NCT00289900|450550352|FG003|Overall Study|site terminated|0|||
125252710|NCT00289900|450550353|FG004|Overall Study|site terminated|0|||
125252711|NCT00289900|450550354|FG005|Overall Study|site terminated|0|||
125252712|NCT00289900|450550349|FG000|Overall Study|Not treated|0|||
125252713|NCT00289900|450550350|FG001|Overall Study|Not treated|1|||
125252714|NCT00289900|450550351|FG002|Overall Study|Not treated|0|||
125252715|NCT00289900|450550352|FG003|Overall Study|Not treated|0|||
125252716|NCT00289900|450550353|FG004|Overall Study|Not treated|0|||
125252717|NCT00289900|450550354|FG005|Overall Study|Not treated|0|||
125252718|NCT01152385|450550355|FG000|Overall Study|Withdrawal by Subject|3|||
125197946|NCT00833482|450345965|FG004|Days 21-30|Adverse Event|0|||
125197947|NCT00833482|450345966|FG005|Days 21-30|Adverse Event|0|||
125197948|NCT00833482|450345961|FG000|Days 21-30|Withdrawal by Subject|0|||
125197949|NCT00833482|450345962|FG001|Days 21-30|Withdrawal by Subject|0|||
125197950|NCT00833482|450345963|FG002|Days 21-30|Withdrawal by Subject|0|||
125197951|NCT00833482|450345964|FG003|Days 21-30|Withdrawal by Subject|0|||
125197952|NCT00833482|450345965|FG004|Days 21-30|Withdrawal by Subject|1|||
125197953|NCT00833482|450345966|FG005|Days 21-30|Withdrawal by Subject|0|||
125197954|NCT02778074|450345967|FG000|Overall Study|Lost to Follow-up|7|||
125197955|NCT02778074|450345968|FG001|Overall Study|Lost to Follow-up|10|||
125197956|NCT03489707|450345975|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
125197957|NCT03489707|450345976|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
125197958|NCT03489707|450345975|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
125197959|NCT03489707|450345976|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
125197960|NCT01817582|450345977|FG000|Overall Study|Withdrawal by Subject|0|||
125197961|NCT01817582|450345978|FG001|Overall Study|Withdrawal by Subject|1|||
125197962|NCT01817582|450345979|FG002|Overall Study|Withdrawal by Subject|0|||
125197963|NCT01817582|450345977|FG000|Overall Study|Participant revealed masked treatment|1|||
125197964|NCT01817582|450345978|FG001|Overall Study|Participant revealed masked treatment|0|||
125197965|NCT01817582|450345979|FG002|Overall Study|Participant revealed masked treatment|0|||
125197966|NCT01817582|450345977|FG000|Overall Study|Randomized but exclusion criteria met|1|||
125197967|NCT01817582|450345978|FG001|Overall Study|Randomized but exclusion criteria met|0|||
125197968|NCT01817582|450345979|FG002|Overall Study|Randomized but exclusion criteria met|0|||
125197969|NCT03963232|450345982|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
125197970|NCT03963232|450345983|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
125197971|NCT03963232|450345982|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
125197972|NCT03963232|450345983|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
125197973|NCT03963232|450345982|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
125197974|NCT03963232|450345983|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
125252719|NCT01152385|450550356|FG001|Overall Study|Withdrawal by Subject|1|||
125252720|NCT01152385|450550357|FG002|Overall Study|Withdrawal by Subject|1|||
125252721|NCT01152385|450550358|FG003|Overall Study|Withdrawal by Subject|1|||
125252722|NCT01152385|450550355|FG000|Overall Study|Protocol Violation|0|||
125252723|NCT01152385|450550356|FG001|Overall Study|Protocol Violation|0|||
125252724|NCT01152385|450550357|FG002|Overall Study|Protocol Violation|0|||
125252725|NCT01152385|450550358|FG003|Overall Study|Protocol Violation|1|||
125197975|NCT03963232|450345982|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
125197976|NCT03963232|450345983|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
125197977|NCT03963232|450345982|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
125197978|NCT03963232|450345983|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
125197979|NCT03963232|450345982|FG000|Open-Label Treatment Phase|Adverse Event|1|||
125197980|NCT03963232|450345983|FG001|Open-Label Treatment Phase|Adverse Event|2|||
125197981|NCT03963232|450345982|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
125197982|NCT03963232|450345983|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
125197983|NCT03963232|450345982|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
125197984|NCT03963232|450345983|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
125197985|NCT03963232|450345982|FG000|Open-Label Treatment Phase|Pregnancy|1|||
125197986|NCT03963232|450345983|FG001|Open-Label Treatment Phase|Pregnancy|0|||
125197987|NCT03963232|450345982|FG000|Follow-up Phase|Withdrawal by Subject|7|||
125197988|NCT03963232|450345983|FG001|Follow-up Phase|Withdrawal by Subject|5|||
125197989|NCT03963232|450345982|FG000|Follow-up Phase|Protocol Violation|0|||
125197990|NCT03963232|450345983|FG001|Follow-up Phase|Protocol Violation|2|||
125197991|NCT03963232|450345982|FG000|Follow-up Phase|Adverse Event|0|||
125197992|NCT03963232|450345983|FG001|Follow-up Phase|Adverse Event|1|||
125197993|NCT03963232|450345982|FG000|Follow-up Phase|Lost to Follow-up|0|||
125197994|NCT03963232|450345983|FG001|Follow-up Phase|Lost to Follow-up|1|||
125197995|NCT03617770|450345984|FG000|Overall Study|Lost to Follow-up|1|||
125197996|NCT03617770|450345985|FG001|Overall Study|Lost to Follow-up|0|||
125197997|NCT00356135|450345986|FG000|Overall Study|Protocol Violation|1|||
125197998|NCT00356135|450345987|FG001|Overall Study|Protocol Violation|0|||
125197999|NCT00356135|450345988|FG002|Overall Study|Protocol Violation|0|||
125198000|NCT00356135|450345986|FG000|Overall Study|Adverse Event|1|||
125198001|NCT00356135|450345987|FG001|Overall Study|Adverse Event|0|||
125198002|NCT00356135|450345988|FG002|Overall Study|Adverse Event|0|||
125198003|NCT00356135|450345986|FG000|Overall Study|Lost to Follow-up|0|||
125198004|NCT00356135|450345987|FG001|Overall Study|Lost to Follow-up|0|||
125198005|NCT00356135|450345988|FG002|Overall Study|Lost to Follow-up|1|||
125198006|NCT00356135|450345986|FG000|Overall Study|Physician Decision|1|||
125198007|NCT00356135|450345987|FG001|Overall Study|Physician Decision|1|||
125198008|NCT00356135|450345988|FG002|Overall Study|Physician Decision|1|||
125198009|NCT00356135|450345986|FG000|Overall Study|Subject non-compliance|1|||
125198010|NCT00356135|450345987|FG001|Overall Study|Subject non-compliance|1|||
125198011|NCT00356135|450345988|FG002|Overall Study|Subject non-compliance|3|||
125198012|NCT03512210|450345990|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
125198013|NCT03512210|450345990|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
125198014|NCT03512210|450345990|FG000|Step 2:Post-MINMON|Death|2|||
125198015|NCT03512210|450345990|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
125198016|NCT03512210|450345990|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
125198017|NCT05270395|450345999|FG000|Overall Study|Lost to Follow-up|2|||
125198018|NCT05270395|450346000|FG001|Overall Study|Lost to Follow-up|2|||
125198019|NCT05270395|450345999|FG000|Overall Study|Death|1|||
125198020|NCT05270395|450346000|FG001|Overall Study|Death|2|||
125198021|NCT05270395|450345999|FG000|Overall Study|Study Team Withdrew|1|||
125198022|NCT05270395|450346000|FG001|Overall Study|Study Team Withdrew|0|||
125198023|NCT03725761|450346001|FG000|Overall Study|still on study|1|||
125198024|NCT01936181|450348015|FG000|Randomised, Double-blind|Adverse Event|27|||
125252726|NCT01152385|450550355|FG000|Overall Study|Adverse Event|1|||
125252727|NCT01152385|450550356|FG001|Overall Study|Adverse Event|1|||
125252728|NCT01152385|450550357|FG002|Overall Study|Adverse Event|0|||
125252729|NCT01152385|450550358|FG003|Overall Study|Adverse Event|0|||
125198025|NCT01936181|450348016|FG001|Randomised, Double-blind|Adverse Event|21|||
125198026|NCT01936181|450348017|FG002|Randomised, Double-blind|Adverse Event|0|||
125198027|NCT01936181|450348018|FG003|Randomised, Double-blind|Adverse Event|0|||
125198028|NCT01936181|450348015|FG000|Randomised, Double-blind|Protocol Violation|1|||
125198029|NCT01936181|450348016|FG001|Randomised, Double-blind|Protocol Violation|5|||
125198030|NCT01936181|450348017|FG002|Randomised, Double-blind|Protocol Violation|0|||
125252730|NCT01152385|450550355|FG000|Overall Study|Study-specific withdrawal criteria|1|||
125252731|NCT01152385|450550356|FG001|Overall Study|Study-specific withdrawal criteria|1|||
125252732|NCT01152385|450550357|FG002|Overall Study|Study-specific withdrawal criteria|2|||
125198031|NCT01936181|450348018|FG003|Randomised, Double-blind|Protocol Violation|0|||
125252733|NCT01152385|450550358|FG003|Overall Study|Study-specific withdrawal criteria|0|||
125252734|NCT01152385|450550355|FG000|Overall Study|Other|4|||
125252735|NCT01152385|450550356|FG001|Overall Study|Other|3|||
125252736|NCT01152385|450550357|FG002|Overall Study|Other|2|||
125252737|NCT01152385|450550358|FG003|Overall Study|Other|3|||
125198032|NCT01936181|450348015|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
125198033|NCT01936181|450348016|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
125198034|NCT01936181|450348017|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
125198035|NCT01936181|450348018|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
125198036|NCT01936181|450348015|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
125198037|NCT01936181|450348016|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
125252738|NCT02656173|450550359|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
125252739|NCT02656173|450550360|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
125252740|NCT02656173|450550359|FG000|Overall Study|Adverse Event|7|||
125252741|NCT02656173|450550360|FG001|Overall Study|Adverse Event|5|||
125252742|NCT02656173|450550359|FG000|Overall Study|Withdrawal by Subject|1|||
125252743|NCT02656173|450550360|FG001|Overall Study|Withdrawal by Subject|3|||
125252744|NCT02656173|450550359|FG000|Overall Study|Protocol Violation|0|||
125252745|NCT02656173|450550360|FG001|Overall Study|Protocol Violation|1|||
125252746|NCT02656173|450550359|FG000|Overall Study|Miscellaneous|2|||
125252747|NCT02656173|450550360|FG001|Overall Study|Miscellaneous|0|||
125252748|NCT01064622|450550361|FG000|Randomized Phase II|Withdrawal by Subject|2|||
125252749|NCT01064622|450550362|FG001|Randomized Phase II|Withdrawal by Subject|2|||
125252750|NCT01064622|450550361|FG000|Randomized Phase II|Protocol Violation|0|||
125252751|NCT01064622|450550362|FG001|Randomized Phase II|Protocol Violation|1|||
125252752|NCT03927846|450550368|FG000|Overall Study|Lost to Follow-up|10|||
125252753|NCT03927846|450550369|FG001|Overall Study|Lost to Follow-up|11|||
125252754|NCT03289741|450550370|FG000|Overall Study|Adverse Event|1|||
125252755|NCT03289741|450550371|FG001|Overall Study|Adverse Event|1|||
125252756|NCT03289741|450550370|FG000|Overall Study|Physician Decision|2|||
125252757|NCT03289741|450550371|FG001|Overall Study|Physician Decision|2|||
125252758|NCT03289741|450550370|FG000|Overall Study|Withdrawal by Subject|1|||
125252759|NCT03289741|450550371|FG001|Overall Study|Withdrawal by Subject|0|||
125252760|NCT02037984|450550376|FG000|Overall Study|Lack of Efficacy|0|||
125252761|NCT02037984|450550377|FG001|Overall Study|Lack of Efficacy|0|||
125198038|NCT01936181|450348017|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
125198039|NCT01936181|450348018|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
125198040|NCT01936181|450348015|FG000|Randomised, Double-blind|Pregnancy|0|||
125198041|NCT01936181|450348016|FG001|Randomised, Double-blind|Pregnancy|1|||
125198042|NCT01936181|450348017|FG002|Randomised, Double-blind|Pregnancy|0|||
125198043|NCT01936181|450348018|FG003|Randomised, Double-blind|Pregnancy|0|||
125198044|NCT01936181|450348015|FG000|Randomised, Double-blind|Physician Decision|4|||
125198045|NCT01936181|450348016|FG001|Randomised, Double-blind|Physician Decision|4|||
125198046|NCT01936181|450348017|FG002|Randomised, Double-blind|Physician Decision|0|||
125198047|NCT01936181|450348018|FG003|Randomised, Double-blind|Physician Decision|0|||
125198048|NCT01936181|450348015|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
125198049|NCT01936181|450348016|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
125198050|NCT01936181|450348017|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
125198051|NCT01936181|450348018|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
125198052|NCT01936181|450348015|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
125198053|NCT01936181|450348016|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
125198054|NCT01936181|450348017|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
125198055|NCT01936181|450348018|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
125198056|NCT01936181|450348015|FG000|Transition-extension|Adverse Event|3|||
125198057|NCT01936181|450348016|FG001|Transition-extension|Adverse Event|0|||
125198058|NCT01936181|450348017|FG002|Transition-extension|Adverse Event|3|||
125198059|NCT01936181|450348018|FG003|Transition-extension|Adverse Event|1|||
125198060|NCT01936181|450348015|FG000|Transition-extension|Lost to Follow-up|3|||
125198061|NCT01936181|450348016|FG001|Transition-extension|Lost to Follow-up|0|||
125198062|NCT01936181|450348017|FG002|Transition-extension|Lost to Follow-up|1|||
125198063|NCT01936181|450348018|FG003|Transition-extension|Lost to Follow-up|2|||
125198064|NCT01936181|450348015|FG000|Transition-extension|Physician Decision|2|||
125198065|NCT01936181|450348016|FG001|Transition-extension|Physician Decision|0|||
125198066|NCT01936181|450348017|FG002|Transition-extension|Physician Decision|0|||
125198067|NCT01936181|450348018|FG003|Transition-extension|Physician Decision|1|||
125198068|NCT01936181|450348015|FG000|Transition-extension|Withdrawal by Subject|7|||
125198069|NCT01936181|450348016|FG001|Transition-extension|Withdrawal by Subject|0|||
125198070|NCT01936181|450348017|FG002|Transition-extension|Withdrawal by Subject|2|||
125198071|NCT01936181|450348018|FG003|Transition-extension|Withdrawal by Subject|1|||
125198072|NCT00970632|450348019|FG000|Overall Study|Adverse Event|2|||
125198073|NCT00970632|450348020|FG001|Overall Study|Adverse Event|2|||
125198074|NCT00970632|450348021|FG002|Overall Study|Adverse Event|1|||
125198075|NCT00970632|450348019|FG000|Overall Study|Lack of Efficacy|3|||
125198076|NCT00970632|450348020|FG001|Overall Study|Lack of Efficacy|0|||
125198077|NCT00970632|450348021|FG002|Overall Study|Lack of Efficacy|0|||
125198078|NCT00970632|450348019|FG000|Overall Study|Lost to Follow-up|3|||
125198079|NCT00970632|450348020|FG001|Overall Study|Lost to Follow-up|0|||
125252762|NCT02037984|450550378|FG002|Overall Study|Lack of Efficacy|3|||
125252763|NCT02037984|450550379|FG003|Overall Study|Lack of Efficacy|10|||
125252764|NCT02037984|450550380|FG004|Overall Study|Lack of Efficacy|2|||
125252765|NCT02037984|450550381|FG005|Overall Study|Lack of Efficacy|2|||
125252766|NCT02037984|450550382|FG006|Overall Study|Lack of Efficacy|4|||
125252767|NCT02037984|450550383|FG007|Overall Study|Lack of Efficacy|3|||
125252768|NCT02037984|450550376|FG000|Overall Study|Lost to Follow-up|1|||
125252769|NCT02037984|450550377|FG001|Overall Study|Lost to Follow-up|0|||
125198080|NCT00970632|450348021|FG002|Overall Study|Lost to Follow-up|2|||
125198081|NCT00970632|450348019|FG000|Overall Study|Protocol Violation|8|||
125252770|NCT02037984|450550378|FG002|Overall Study|Lost to Follow-up|3|||
125198082|NCT00970632|450348020|FG001|Overall Study|Protocol Violation|5|||
125198083|NCT00970632|450348021|FG002|Overall Study|Protocol Violation|8|||
125198084|NCT00970632|450348019|FG000|Overall Study|Withdrawal by Subject|7|||
125198085|NCT00970632|450348020|FG001|Overall Study|Withdrawal by Subject|6|||
125198086|NCT00970632|450348021|FG002|Overall Study|Withdrawal by Subject|4|||
125198087|NCT00970632|450348019|FG000|Overall Study|Entry criteria not met|0|||
125198088|NCT00970632|450348020|FG001|Overall Study|Entry criteria not met|2|||
125198089|NCT00970632|450348021|FG002|Overall Study|Entry criteria not met|2|||
125198090|NCT00970632|450348019|FG000|Overall Study|Sponsor decision|1|||
125198091|NCT00970632|450348020|FG001|Overall Study|Sponsor decision|0|||
125198092|NCT00970632|450348021|FG002|Overall Study|Sponsor decision|1|||
125198093|NCT02817516|450348022|FG000|Overall Study|Other|0|||
125198094|NCT02817516|450348023|FG001|Overall Study|Other|0|||
125198095|NCT02817516|450348024|FG002|Overall Study|Other|1|||
125198096|NCT02817516|450348025|FG003|Overall Study|Other|0|||
125198097|NCT00748189|450348026|FG000|Overall Study|Death|99|||
125198098|NCT00748189|450348027|FG001|Overall Study|Death|84|||
125198099|NCT00748189|450348026|FG000|Overall Study|Withdrawal by Subject|23|||
125198100|NCT00748189|450348027|FG001|Overall Study|Withdrawal by Subject|29|||
125198101|NCT00748189|450348026|FG000|Overall Study|Physician Decision|16|||
125198102|NCT00748189|450348027|FG001|Overall Study|Physician Decision|5|||
125198103|NCT00748189|450348026|FG000|Overall Study|Lost to Follow-up|8|||
125198104|NCT00748189|450348027|FG001|Overall Study|Lost to Follow-up|15|||
125198105|NCT00748189|450348026|FG000|Overall Study|Study terminated by Sponsor|70|||
125198106|NCT00748189|450348027|FG001|Overall Study|Study terminated by Sponsor|79|||
125198107|NCT01424514|450348028|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
125198108|NCT01424514|450348029|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
125198109|NCT01424514|450348028|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
125198110|NCT01424514|450348029|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
125198111|NCT02653170|450348030|FG000|Overall Study|Withdrawal by Subject|3|||
125198112|NCT02653170|450348031|FG001|Overall Study|Withdrawal by Subject|8|||
125198113|NCT02653170|450348032|FG002|Overall Study|Withdrawal by Subject|3|||
125198114|NCT02653170|450348030|FG000|Overall Study|withdrawn by study team|2|||
125198115|NCT02653170|450348031|FG001|Overall Study|withdrawn by study team|4|||
125198116|NCT02653170|450348032|FG002|Overall Study|withdrawn by study team|5|||
125198117|NCT02653170|450348030|FG000|Overall Study|Lost to Follow-up|12|||
125198118|NCT02653170|450348031|FG001|Overall Study|Lost to Follow-up|4|||
125198119|NCT02653170|450348032|FG002|Overall Study|Lost to Follow-up|10|||
125198120|NCT01194999|450348038|FG000|Overall Study|Lost to Follow-up|17|||
125198121|NCT05835011|450348039|FG000|Overall Study|Study Terminated by the Sponsor|1|||
125198122|NCT05835011|450348039|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
125198123|NCT04720911|450348044|FG000|Overall Study|Withdrawal by Subject|0|||
125198124|NCT04720911|450348045|FG001|Overall Study|Withdrawal by Subject|1|||
125198125|NCT04720911|450348046|FG002|Overall Study|Withdrawal by Subject|0|||
125198126|NCT00090220|450348047|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
125198127|NCT00090220|450348048|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
125198128|NCT00090220|450348049|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
125198129|NCT00090220|450348050|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
125198130|NCT00090220|450348051|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
125198131|NCT00090220|450348052|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
125198132|NCT00090220|450348047|FG000|Base Study Vaccination Period|Adverse Event|6|||
125198133|NCT00090220|450348048|FG001|Base Study Vaccination Period|Adverse Event|1|||
125198134|NCT00090220|450348049|FG002|Base Study Vaccination Period|Adverse Event|0|||
125198135|NCT00090220|450348050|FG003|Base Study Vaccination Period|Adverse Event|0|||
125198136|NCT00090220|450348051|FG004|Base Study Vaccination Period|Adverse Event|0|||
125198137|NCT00090220|450348052|FG005|Base Study Vaccination Period|Adverse Event|0|||
125198138|NCT00090220|450348047|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
125252771|NCT02037984|450550379|FG003|Overall Study|Lost to Follow-up|5|||
125252772|NCT02037984|450550380|FG004|Overall Study|Lost to Follow-up|2|||
125252773|NCT02037984|450550381|FG005|Overall Study|Lost to Follow-up|2|||
125252774|NCT02037984|450550382|FG006|Overall Study|Lost to Follow-up|2|||
125252775|NCT02037984|450550383|FG007|Overall Study|Lost to Follow-up|4|||
125252776|NCT02037984|450550376|FG000|Overall Study|Physician Decision|0|||
125252777|NCT02037984|450550377|FG001|Overall Study|Physician Decision|0|||
125198139|NCT00090220|450348048|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
125198140|NCT00090220|450348049|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
125198141|NCT00090220|450348050|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
125198142|NCT00090220|450348051|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
125198143|NCT00090220|450348052|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
125198144|NCT00090220|450348047|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
125198145|NCT00090220|450348048|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
125198146|NCT00090220|450348049|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
125252778|NCT02037984|450550378|FG002|Overall Study|Physician Decision|0|||
125252779|NCT02037984|450550379|FG003|Overall Study|Physician Decision|0|||
125444311|NCT01474512|451253885|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
125198147|NCT00090220|450348050|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
125198148|NCT00090220|450348051|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
125198149|NCT00090220|450348052|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
125198150|NCT00090220|450348047|FG000|Base Study Vaccination Period|Patient Moved|6|||
125198151|NCT00090220|450348048|FG001|Base Study Vaccination Period|Patient Moved|2|||
125198152|NCT00090220|450348049|FG002|Base Study Vaccination Period|Patient Moved|0|||
125198153|NCT00090220|450348050|FG003|Base Study Vaccination Period|Patient Moved|0|||
125198154|NCT00090220|450348051|FG004|Base Study Vaccination Period|Patient Moved|0|||
125198155|NCT00090220|450348052|FG005|Base Study Vaccination Period|Patient Moved|0|||
125198156|NCT00090220|450348047|FG000|Base Study Vaccination Period|Other|4|||
125198157|NCT00090220|450348048|FG001|Base Study Vaccination Period|Other|4|||
125198158|NCT00090220|450348049|FG002|Base Study Vaccination Period|Other|0|||
125198159|NCT00090220|450348050|FG003|Base Study Vaccination Period|Other|0|||
125198160|NCT00090220|450348051|FG004|Base Study Vaccination Period|Other|0|||
125198161|NCT00090220|450348052|FG005|Base Study Vaccination Period|Other|0|||
125198162|NCT00090220|450348047|FG000|Base Study Follow-up Period|Adverse Event|6|||
125198163|NCT00090220|450348048|FG001|Base Study Follow-up Period|Adverse Event|1|||
125198164|NCT00090220|450348049|FG002|Base Study Follow-up Period|Adverse Event|0|||
125198165|NCT00090220|450348050|FG003|Base Study Follow-up Period|Adverse Event|0|||
125198166|NCT00090220|450348051|FG004|Base Study Follow-up Period|Adverse Event|0|||
125198167|NCT00090220|450348052|FG005|Base Study Follow-up Period|Adverse Event|0|||
125198168|NCT00090220|450348047|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
125198169|NCT00090220|450348048|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
125198170|NCT00090220|450348049|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
125198171|NCT00090220|450348050|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
125198172|NCT00090220|450348051|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
125198173|NCT00090220|450348052|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
125198174|NCT00090220|450348047|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
125198175|NCT00090220|450348048|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
125198176|NCT00090220|450348049|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
125198177|NCT00090220|450348050|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
125198178|NCT00090220|450348051|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
125198179|NCT00090220|450348052|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
125198180|NCT00090220|450348047|FG000|Base Study Follow-up Period|Patient Moved|20|||
125198181|NCT00090220|450348048|FG001|Base Study Follow-up Period|Patient Moved|28|||
125198182|NCT00090220|450348049|FG002|Base Study Follow-up Period|Patient Moved|0|||
125198183|NCT00090220|450348050|FG003|Base Study Follow-up Period|Patient Moved|0|||
125198184|NCT00090220|450348051|FG004|Base Study Follow-up Period|Patient Moved|0|||
125198185|NCT00090220|450348052|FG005|Base Study Follow-up Period|Patient Moved|0|||
125198186|NCT00090220|450348047|FG000|Base Study Follow-up Period|Other|19|||
125198187|NCT00090220|450348048|FG001|Base Study Follow-up Period|Other|21|||
125198188|NCT00090220|450348049|FG002|Base Study Follow-up Period|Other|0|||
125198189|NCT00090220|450348050|FG003|Base Study Follow-up Period|Other|0|||
125198190|NCT00090220|450348051|FG004|Base Study Follow-up Period|Other|0|||
125198191|NCT00090220|450348052|FG005|Base Study Follow-up Period|Other|0|||
125198192|NCT00090220|450348047|FG000|Extension 1 (EXT1)|Adverse Event|0|||
125198193|NCT00090220|450348048|FG001|Extension 1 (EXT1)|Adverse Event|0|||
125198194|NCT00090220|450348049|FG002|Extension 1 (EXT1)|Adverse Event|4|||
125198195|NCT00090220|450348050|FG003|Extension 1 (EXT1)|Adverse Event|0|||
125198196|NCT00090220|450348051|FG004|Extension 1 (EXT1)|Adverse Event|0|||
125198197|NCT00090220|450348052|FG005|Extension 1 (EXT1)|Adverse Event|0|||
125198198|NCT00090220|450348047|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
125198199|NCT00090220|450348048|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
125198200|NCT00090220|450348049|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
125198201|NCT00090220|450348050|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
125198202|NCT00090220|450348051|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
125198203|NCT00090220|450348052|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
125198204|NCT00090220|450348047|FG000|Extension 1 (EXT1)|Moved|0|||
125198205|NCT00090220|450348048|FG001|Extension 1 (EXT1)|Moved|0|||
125198206|NCT00090220|450348049|FG002|Extension 1 (EXT1)|Moved|2|||
125198207|NCT00090220|450348050|FG003|Extension 1 (EXT1)|Moved|1|||
125198208|NCT00090220|450348051|FG004|Extension 1 (EXT1)|Moved|0|||
125198209|NCT00090220|450348052|FG005|Extension 1 (EXT1)|Moved|0|||
125198210|NCT00090220|450348047|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
125198211|NCT00090220|450348048|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
125198212|NCT00090220|450348049|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
125198213|NCT00090220|450348050|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
125252780|NCT02037984|450550380|FG004|Overall Study|Physician Decision|0|||
125198214|NCT00090220|450348051|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
125198215|NCT00090220|450348052|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
125198216|NCT00090220|450348047|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
125198217|NCT00090220|450348048|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
125198218|NCT00090220|450348049|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
125198219|NCT00090220|450348050|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
125198220|NCT00090220|450348051|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
125198221|NCT00090220|450348052|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
125198222|NCT00090220|450348047|FG000|Extension 1 (EXT1)|Other reason|0|||
125198223|NCT00090220|450348048|FG001|Extension 1 (EXT1)|Other reason|0|||
125198224|NCT00090220|450348049|FG002|Extension 1 (EXT1)|Other reason|2|||
125198225|NCT00090220|450348050|FG003|Extension 1 (EXT1)|Other reason|0|||
125198226|NCT00090220|450348051|FG004|Extension 1 (EXT1)|Other reason|0|||
125198227|NCT00090220|450348052|FG005|Extension 1 (EXT1)|Other reason|0|||
125198228|NCT00090220|450348047|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125198229|NCT00090220|450348048|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125198230|NCT00090220|450348049|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125198231|NCT00090220|450348050|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
125198232|NCT00090220|450348051|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
125198233|NCT00090220|450348052|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
125198234|NCT00090220|450348047|FG000|Long-term Follow-up (EXT2)|Death|0|||
125198235|NCT00090220|450348048|FG001|Long-term Follow-up (EXT2)|Death|0|||
125198236|NCT00090220|450348049|FG002|Long-term Follow-up (EXT2)|Death|0|||
125198237|NCT00090220|450348050|FG003|Long-term Follow-up (EXT2)|Death|0|||
125198238|NCT00090220|450348051|FG004|Long-term Follow-up (EXT2)|Death|1|||
125198239|NCT00090220|450348052|FG005|Long-term Follow-up (EXT2)|Death|1|||
125198240|NCT00090220|450348047|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125198241|NCT00090220|450348048|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125198242|NCT00090220|450348049|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125198243|NCT00090220|450348050|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
125198244|NCT00090220|450348051|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
125198245|NCT00090220|450348052|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
125198246|NCT00090220|450348047|FG000|Long-term Follow-up (EXT2)|Other|0|||
125198247|NCT00090220|450348048|FG001|Long-term Follow-up (EXT2)|Other|0|||
125198248|NCT00090220|450348049|FG002|Long-term Follow-up (EXT2)|Other|0|||
125198249|NCT00090220|450348050|FG003|Long-term Follow-up (EXT2)|Other|0|||
125198250|NCT00090220|450348051|FG004|Long-term Follow-up (EXT2)|Other|1|||
125198251|NCT00090220|450348052|FG005|Long-term Follow-up (EXT2)|Other|0|||
125198252|NCT00941863|450348053|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
125198253|NCT00941863|450348054|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
125198254|NCT00941863|450348055|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
125198255|NCT00941863|450348056|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
125198256|NCT00941863|450348057|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
125198257|NCT00941863|450348053|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
125198258|NCT00941863|450348054|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
125198259|NCT00941863|450348055|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
125198260|NCT00941863|450348056|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
125198261|NCT00941863|450348057|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
125198262|NCT00941863|450348053|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
125198263|NCT00941863|450348054|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
125198264|NCT00941863|450348055|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
125198265|NCT00941863|450348056|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
125198266|NCT00941863|450348057|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
125198267|NCT00941863|450348053|FG000|Until Primary Completion Date (PCD)|Death|0|||
125198268|NCT00941863|450348054|FG001|Until Primary Completion Date (PCD)|Death|0|||
125198269|NCT00941863|450348055|FG002|Until Primary Completion Date (PCD)|Death|1|||
125198270|NCT00941863|450348056|FG003|Until Primary Completion Date (PCD)|Death|2|||
125198271|NCT00941863|450348057|FG004|Until Primary Completion Date (PCD)|Death|7|||
125198272|NCT00941863|450348053|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
125198273|NCT00941863|450348054|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
125198274|NCT00941863|450348055|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
125198275|NCT00941863|450348056|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
125198276|NCT00941863|450348057|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
125198277|NCT00941863|450348053|FG000|Continued After PCD|Withdrawal by Subject|0|||
125198278|NCT00941863|450348054|FG001|Continued After PCD|Withdrawal by Subject|0|||
125198279|NCT00941863|450348055|FG002|Continued After PCD|Withdrawal by Subject|0|||
125198280|NCT00941863|450348056|FG003|Continued After PCD|Withdrawal by Subject|0|||
125198281|NCT00941863|450348057|FG004|Continued After PCD|Withdrawal by Subject|1|||
125198282|NCT00941863|450348053|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
125198283|NCT00941863|450348054|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
125198284|NCT00941863|450348055|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
125198285|NCT00941863|450348056|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
125198286|NCT00941863|450348057|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
125198287|NCT05113979|450348060|FG000|Overall Study|Death|2|||
125198288|NCT05113979|450348060|FG000|Overall Study|Lost to Follow-up|1|||
125198289|NCT03557931|450348063|FG000|Overall Study|Adverse Event|4|||
125198290|NCT03557931|450348064|FG001|Overall Study|Adverse Event|6|||
125198291|NCT03557931|450348065|FG002|Overall Study|Adverse Event|1|||
125198292|NCT03557931|450348063|FG000|Overall Study|Lost to Follow-up|4|||
125198293|NCT03557931|450348064|FG001|Overall Study|Lost to Follow-up|4|||
125198294|NCT03557931|450348065|FG002|Overall Study|Lost to Follow-up|1|||
125198295|NCT03557931|450348063|FG000|Overall Study|Protocol Violation|1|||
125198296|NCT03557931|450348064|FG001|Overall Study|Protocol Violation|4|||
125198297|NCT03557931|450348065|FG002|Overall Study|Protocol Violation|1|||
125198298|NCT03557931|450348063|FG000|Overall Study|Withdrawal by Subject|14|||
125198299|NCT03557931|450348064|FG001|Overall Study|Withdrawal by Subject|0|||
125198300|NCT03557931|450348065|FG002|Overall Study|Withdrawal by Subject|7|||
125198301|NCT03557931|450348063|FG000|Overall Study|Miscellaneous|8|||
125198302|NCT03557931|450348064|FG001|Overall Study|Miscellaneous|5|||
125198303|NCT03557931|450348065|FG002|Overall Study|Miscellaneous|3|||
125198304|NCT02829723|450348068|FG000|Overall Study|Adverse Event|0|||
125198305|NCT02829723|450348069|FG001|Overall Study|Adverse Event|0|||
125198306|NCT02829723|450348070|FG002|Overall Study|Adverse Event|1|||
125198307|NCT02829723|450348071|FG003|Overall Study|Adverse Event|1|||
125198308|NCT02829723|450348072|FG004|Overall Study|Adverse Event|0|||
125198309|NCT02829723|450348073|FG005|Overall Study|Adverse Event|0|||
125198310|NCT02829723|450348074|FG006|Overall Study|Adverse Event|0|||
125198311|NCT02829723|450348075|FG007|Overall Study|Adverse Event|1|||
125198312|NCT02829723|450348076|FG008|Overall Study|Adverse Event|0|||
125198313|NCT02829723|450348077|FG009|Overall Study|Adverse Event|0|||
125198314|NCT02829723|450348078|FG010|Overall Study|Adverse Event|0|||
125198315|NCT02829723|450348079|FG011|Overall Study|Adverse Event|0|||
125198316|NCT02829723|450348080|FG012|Overall Study|Adverse Event|0|||
125198317|NCT02829723|450348081|FG013|Overall Study|Adverse Event|0|||
125198318|NCT02829723|450348082|FG014|Overall Study|Adverse Event|1|||
125198319|NCT02829723|450348083|FG015|Overall Study|Adverse Event|1|||
125198320|NCT02829723|450348084|FG016|Overall Study|Adverse Event|1|||
125198321|NCT02829723|450348085|FG017|Overall Study|Adverse Event|2|||
125198322|NCT02829723|450348086|FG018|Overall Study|Adverse Event|1|||
125198323|NCT02829723|450348087|FG019|Overall Study|Adverse Event|1|||
125198324|NCT02829723|450348088|FG020|Overall Study|Adverse Event|3|||
125198325|NCT02829723|450348089|FG021|Overall Study|Adverse Event|0|||
125198326|NCT02829723|450348090|FG022|Overall Study|Adverse Event|0|||
125198327|NCT02829723|450348091|FG023|Overall Study|Adverse Event|1|||
125198328|NCT02829723|450348092|FG024|Overall Study|Adverse Event|1|||
125198329|NCT02829723|450348093|FG025|Overall Study|Adverse Event|3|||
125198330|NCT02829723|450348094|FG026|Overall Study|Adverse Event|5|||
125198331|NCT02829723|450348068|FG000|Overall Study|Death|1|||
125198332|NCT02829723|450348069|FG001|Overall Study|Death|0|||
125198333|NCT02829723|450348070|FG002|Overall Study|Death|1|||
125198334|NCT02829723|450348071|FG003|Overall Study|Death|1|||
125198335|NCT02829723|450348072|FG004|Overall Study|Death|0|||
125198336|NCT02829723|450348073|FG005|Overall Study|Death|0|||
125198337|NCT02829723|450348074|FG006|Overall Study|Death|2|||
125198338|NCT02829723|450348075|FG007|Overall Study|Death|0|||
125198339|NCT02829723|450348076|FG008|Overall Study|Death|1|||
125198340|NCT02829723|450348077|FG009|Overall Study|Death|0|||
125198341|NCT02829723|450348078|FG010|Overall Study|Death|0|||
125198342|NCT02829723|450348079|FG011|Overall Study|Death|0|||
125198343|NCT02829723|450348080|FG012|Overall Study|Death|2|||
125198344|NCT02829723|450348081|FG013|Overall Study|Death|1|||
125198345|NCT02829723|450348082|FG014|Overall Study|Death|0|||
125198346|NCT02829723|450348083|FG015|Overall Study|Death|0|||
125198347|NCT02829723|450348084|FG016|Overall Study|Death|0|||
125198348|NCT02829723|450348085|FG017|Overall Study|Death|0|||
125198349|NCT02829723|450348086|FG018|Overall Study|Death|0|||
125198350|NCT02829723|450348087|FG019|Overall Study|Death|0|||
125198351|NCT02829723|450348088|FG020|Overall Study|Death|0|||
125198352|NCT02829723|450348089|FG021|Overall Study|Death|2|||
125198353|NCT02829723|450348090|FG022|Overall Study|Death|0|||
125198354|NCT02829723|450348091|FG023|Overall Study|Death|0|||
125198355|NCT02829723|450348092|FG024|Overall Study|Death|0|||
125198356|NCT02829723|450348093|FG025|Overall Study|Death|1|||
125198357|NCT02829723|450348094|FG026|Overall Study|Death|2|||
125198358|NCT02829723|450348068|FG000|Overall Study|Physician Decision|0|||
125198359|NCT02829723|450348069|FG001|Overall Study|Physician Decision|0|||
125198360|NCT02829723|450348070|FG002|Overall Study|Physician Decision|0|||
125198361|NCT02829723|450348071|FG003|Overall Study|Physician Decision|0|||
125198362|NCT02829723|450348072|FG004|Overall Study|Physician Decision|0|||
125198363|NCT02829723|450348073|FG005|Overall Study|Physician Decision|0|||
125198364|NCT02829723|450348074|FG006|Overall Study|Physician Decision|0|||
125198365|NCT02829723|450348075|FG007|Overall Study|Physician Decision|0|||
125198366|NCT02829723|450348076|FG008|Overall Study|Physician Decision|0|||
125198367|NCT02829723|450348077|FG009|Overall Study|Physician Decision|1|||
125198368|NCT02829723|450348078|FG010|Overall Study|Physician Decision|1|||
125198369|NCT02829723|450348079|FG011|Overall Study|Physician Decision|0|||
125198370|NCT02829723|450348080|FG012|Overall Study|Physician Decision|0|||
125198371|NCT02829723|450348081|FG013|Overall Study|Physician Decision|1|||
125198372|NCT02829723|450348082|FG014|Overall Study|Physician Decision|0|||
125198373|NCT02829723|450348083|FG015|Overall Study|Physician Decision|0|||
125198374|NCT02829723|450348084|FG016|Overall Study|Physician Decision|2|||
125252781|NCT02037984|450550381|FG005|Overall Study|Physician Decision|0|||
125252782|NCT02037984|450550382|FG006|Overall Study|Physician Decision|1|||
125252783|NCT02037984|450550383|FG007|Overall Study|Physician Decision|0|||
125252784|NCT02037984|450550376|FG000|Overall Study|Protocol Violation|0|||
125252785|NCT02037984|450550377|FG001|Overall Study|Protocol Violation|0|||
125252786|NCT02037984|450550378|FG002|Overall Study|Protocol Violation|0|||
125252787|NCT02037984|450550379|FG003|Overall Study|Protocol Violation|0|||
125252788|NCT02037984|450550380|FG004|Overall Study|Protocol Violation|0|||
125252789|NCT02037984|450550381|FG005|Overall Study|Protocol Violation|1|||
125252790|NCT02037984|450550382|FG006|Overall Study|Protocol Violation|2|||
125198375|NCT02829723|450348085|FG017|Overall Study|Physician Decision|0|||
125198376|NCT02829723|450348086|FG018|Overall Study|Physician Decision|0|||
125198377|NCT02829723|450348087|FG019|Overall Study|Physician Decision|0|||
125198378|NCT02829723|450348088|FG020|Overall Study|Physician Decision|0|||
125198379|NCT02829723|450348089|FG021|Overall Study|Physician Decision|0|||
125198380|NCT02829723|450348090|FG022|Overall Study|Physician Decision|1|||
125198381|NCT02829723|450348091|FG023|Overall Study|Physician Decision|1|||
125198382|NCT02829723|450348092|FG024|Overall Study|Physician Decision|1|||
125198383|NCT02829723|450348093|FG025|Overall Study|Physician Decision|1|||
125198384|NCT02829723|450348094|FG026|Overall Study|Physician Decision|3|||
125198385|NCT02829723|450348068|FG000|Overall Study|Progressive disease|4|||
125198386|NCT02829723|450348069|FG001|Overall Study|Progressive disease|6|||
125198387|NCT02829723|450348070|FG002|Overall Study|Progressive disease|3|||
125198388|NCT02829723|450348071|FG003|Overall Study|Progressive disease|3|||
125198389|NCT02829723|450348072|FG004|Overall Study|Progressive disease|3|||
125198390|NCT02829723|450348073|FG005|Overall Study|Progressive disease|5|||
125198391|NCT02829723|450348074|FG006|Overall Study|Progressive disease|4|||
125198392|NCT02829723|450348075|FG007|Overall Study|Progressive disease|6|||
125198393|NCT02829723|450348076|FG008|Overall Study|Progressive disease|8|||
125198394|NCT02829723|450348077|FG009|Overall Study|Progressive disease|4|||
125198395|NCT02829723|450348078|FG010|Overall Study|Progressive disease|9|||
125198396|NCT02829723|450348079|FG011|Overall Study|Progressive disease|0|||
125198397|NCT02829723|450348080|FG012|Overall Study|Progressive disease|3|||
125198398|NCT02829723|450348081|FG013|Overall Study|Progressive disease|4|||
125198399|NCT02829723|450348082|FG014|Overall Study|Progressive disease|2|||
125198400|NCT02829723|450348083|FG015|Overall Study|Progressive disease|4|||
125198401|NCT02829723|450348084|FG016|Overall Study|Progressive disease|5|||
125198402|NCT02829723|450348085|FG017|Overall Study|Progressive disease|3|||
125198403|NCT02829723|450348086|FG018|Overall Study|Progressive disease|4|||
125198404|NCT02829723|450348087|FG019|Overall Study|Progressive disease|4|||
125198405|NCT02829723|450348088|FG020|Overall Study|Progressive disease|7|||
125198406|NCT02829723|450348089|FG021|Overall Study|Progressive disease|6|||
125198407|NCT02829723|450348090|FG022|Overall Study|Progressive disease|3|||
125198408|NCT02829723|450348091|FG023|Overall Study|Progressive disease|3|||
125198409|NCT02829723|450348092|FG024|Overall Study|Progressive disease|3|||
125198410|NCT02829723|450348093|FG025|Overall Study|Progressive disease|16|||
125198411|NCT02829723|450348094|FG026|Overall Study|Progressive disease|10|||
125198412|NCT02829723|450348068|FG000|Overall Study|Subject/guardian decision|0|||
125198413|NCT02829723|450348069|FG001|Overall Study|Subject/guardian decision|1|||
125198414|NCT02829723|450348070|FG002|Overall Study|Subject/guardian decision|0|||
125252791|NCT02037984|450550383|FG007|Overall Study|Protocol Violation|0|||
125252792|NCT02037984|450550376|FG000|Overall Study|Technical Problems|0|||
125252793|NCT02037984|450550377|FG001|Overall Study|Technical Problems|0|||
125252794|NCT02037984|450550378|FG002|Overall Study|Technical Problems|3|||
125252795|NCT02037984|450550379|FG003|Overall Study|Technical Problems|3|||
125252796|NCT02037984|450550380|FG004|Overall Study|Technical Problems|2|||
125252797|NCT02037984|450550381|FG005|Overall Study|Technical Problems|3|||
125252798|NCT02037984|450550382|FG006|Overall Study|Technical Problems|4|||
125252799|NCT02037984|450550383|FG007|Overall Study|Technical Problems|2|||
125252800|NCT02037984|450550376|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125252801|NCT02037984|450550377|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125252802|NCT02037984|450550378|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
125252803|NCT02037984|450550379|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
125252804|NCT02037984|450550380|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
125252805|NCT02037984|450550381|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
125252806|NCT02037984|450550382|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
125252807|NCT02037984|450550383|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
125252808|NCT02037984|450550376|FG000|Overall Study|Withdrawal by Subject|0|||
125252809|NCT02037984|450550377|FG001|Overall Study|Withdrawal by Subject|0|||
125252810|NCT02037984|450550378|FG002|Overall Study|Withdrawal by Subject|0|||
125252811|NCT02037984|450550379|FG003|Overall Study|Withdrawal by Subject|1|||
125252812|NCT02037984|450550380|FG004|Overall Study|Withdrawal by Subject|1|||
125252813|NCT02037984|450550381|FG005|Overall Study|Withdrawal by Subject|3|||
125252814|NCT02037984|450550382|FG006|Overall Study|Withdrawal by Subject|0|||
125252815|NCT02037984|450550383|FG007|Overall Study|Withdrawal by Subject|1|||
125252816|NCT00974233|450550384|FG000|Induction Chemoimmunotherapy|Death|2|||
125252817|NCT00974233|450550384|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
125252818|NCT00974233|450550384|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
125396855|NCT04145895|451086884|FG001|Overall Study|Physician Decision|0|||
125252819|NCT00974233|450550384|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
125252820|NCT00974233|450550384|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
125252821|NCT00974233|450550384|FG000|Maintenance Lenalidomide|Adverse Event|8|||
125252822|NCT01691092|450550385|FG000|Overall Study|Lost to Follow-up|10|||
125252823|NCT01691092|450550385|FG000|Overall Study|Physician Decision|4|||
125252824|NCT01691092|450550385|FG000|Overall Study|Withdrawal by Subject|3|||
125252825|NCT01691092|450550385|FG000|Overall Study|non-compliance|3|||
125444312|NCT01474512|451253886|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
125252826|NCT01691092|450550385|FG000|Overall Study|used for different study|2|||
125252827|NCT01691092|450550385|FG000|Overall Study|screen fail|19|||
125252828|NCT01569763|450552116|FG000|Overall Study|Lack of Efficacy|2|||
125252829|NCT01569763|450552117|FG001|Overall Study|Lack of Efficacy|7|||
125252830|NCT01569763|450552116|FG000|Overall Study|Adverse Event|1|||
125252831|NCT01569763|450552117|FG001|Overall Study|Adverse Event|0|||
125252832|NCT03211858|450552119|FG000|Overall Study|Adverse Event|8|||
125252833|NCT03211858|450552120|FG001|Overall Study|Adverse Event|6|||
125252834|NCT03211858|450552119|FG000|Overall Study|Lack of Efficacy|0|||
125252835|NCT03211858|450552120|FG001|Overall Study|Lack of Efficacy|4|||
125252836|NCT03211858|450552119|FG000|Overall Study|Poor compliance to protocol|6|||
125252837|NCT03211858|450552120|FG001|Overall Study|Poor compliance to protocol|2|||
125252838|NCT03211858|450552119|FG000|Overall Study|Non-serious Hypoglycemia|1|||
125252839|NCT03211858|450552120|FG001|Overall Study|Non-serious Hypoglycemia|0|||
125252840|NCT03211858|450552119|FG000|Overall Study|Other than specified above|22|||
125252841|NCT03211858|450552120|FG001|Overall Study|Other than specified above|21|||
125252842|NCT03810365|450552122|FG000|Overall Study|Lost to Follow-up|2|||
125252843|NCT03810365|450552123|FG001|Overall Study|Lost to Follow-up|2|||
125252844|NCT03810365|450552122|FG000|Overall Study|Withdrawal by Subject|4|||
125252845|NCT03810365|450552123|FG001|Overall Study|Withdrawal by Subject|5|||
125252846|NCT00185614|450552128|FG000|Inter-treatment Period|Physician Decision|1|||
125252847|NCT00185614|450552128|FG000|Inter-treatment Period|Relapse|2|||
125252848|NCT00185614|450552128|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
125252849|NCT03160573|450552129|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
125252850|NCT03160573|450552130|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
125252851|NCT03160573|450552131|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
125252852|NCT03160573|450552132|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
125252853|NCT02402907|450552136|FG000|Overall Study|Delivered vaginally|9|||
125252854|NCT02402907|450552137|FG001|Overall Study|Delivered vaginally|3|||
125252855|NCT02402907|450552136|FG000|Overall Study|Delivered outside of Sinai|1|||
125252856|NCT02402907|450552137|FG001|Overall Study|Delivered outside of Sinai|1|||
125252857|NCT02402907|450552136|FG000|Overall Study|Lost to follow up after C-Section|10|||
125252858|NCT02402907|450552137|FG001|Overall Study|Lost to follow up after C-Section|23|||
125252859|NCT01423084|450552140|FG000|Overall Study|Adverse Event|0|||
125252860|NCT01423084|450552141|FG001|Overall Study|Adverse Event|1|||
125252861|NCT01423084|450552140|FG000|Overall Study|Withdrawal by Subject|2|||
125252862|NCT01423084|450552141|FG001|Overall Study|Withdrawal by Subject|3|||
125252863|NCT00661687|450552142|FG000|Overall Study|Study related symptoms and complaints|5|||
125252864|NCT00661687|450552142|FG000|Overall Study|Positive slit lamp findings|4|||
125252865|NCT00661687|450552142|FG000|Overall Study|Inability to maintain wearing schedule|3|||
125252866|NCT00661687|450552142|FG000|Overall Study|Physician Decision|1|||
125252867|NCT00661687|450552142|FG000|Overall Study|Adverse Event|2|||
125252868|NCT02462057|450552143|FG000|Overall Study|Left Vitality|32|||
125252869|NCT02462057|450552144|FG001|Overall Study|Left Vitality|27|||
125252870|NCT02462057|450552145|FG002|Overall Study|Left Vitality|23|||
125252871|NCT02462057|450552146|FG003|Overall Study|Left Vitality|35|||
125252872|NCT02462057|450552147|FG004|Overall Study|Left Vitality|33|||
125252873|NCT02462057|450552143|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
125252874|NCT02462057|450552144|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
125252875|NCT02462057|450552145|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
125252876|NCT02462057|450552146|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
125252877|NCT02462057|450552147|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
125252878|NCT02336555|450552148|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125444313|NCT01474512|451253887|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
125252879|NCT02336555|450552149|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
125444314|NCT01474512|451253888|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
125444315|NCT01474512|451253889|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
125444316|NCT01474512|451253890|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
125252880|NCT02336555|450552148|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
125252881|NCT02336555|450552149|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
125252882|NCT02336555|450552148|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
125252883|NCT02336555|450552149|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
125252884|NCT01633112|450552150|FG000|Overall Study|Lack of Efficacy|1|||
125252885|NCT01633112|450552151|FG001|Overall Study|Lack of Efficacy|6|||
125252886|NCT01633112|450552152|FG002|Overall Study|Lack of Efficacy|13|||
125252887|NCT01633112|450552150|FG000|Overall Study|Abnormal laboratory value(s)|3|||
125252888|NCT01633112|450552151|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125252889|NCT01633112|450552152|FG002|Overall Study|Abnormal laboratory value(s)|0|||
125252890|NCT01633112|450552150|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125252891|NCT01633112|450552151|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125252892|NCT01633112|450552152|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125252893|NCT01633112|450552150|FG000|Overall Study|Administrative problems|1|||
125252894|NCT01633112|450552151|FG001|Overall Study|Administrative problems|2|||
125252895|NCT01633112|450552152|FG002|Overall Study|Administrative problems|5|||
125252896|NCT01633112|450552150|FG000|Overall Study|Adverse Event|16|||
125252897|NCT01633112|450552151|FG001|Overall Study|Adverse Event|18|||
125252898|NCT01633112|450552152|FG002|Overall Study|Adverse Event|20|||
125252899|NCT01633112|450552150|FG000|Overall Study|Lost to Follow-up|7|||
125252900|NCT01633112|450552151|FG001|Overall Study|Lost to Follow-up|19|||
125252901|NCT01633112|450552152|FG002|Overall Study|Lost to Follow-up|6|||
125252902|NCT01633112|450552150|FG000|Overall Study|Protocol Violation|4|||
125252903|NCT01633112|450552151|FG001|Overall Study|Protocol Violation|0|||
125252904|NCT01633112|450552152|FG002|Overall Study|Protocol Violation|2|||
125252905|NCT01633112|450552150|FG000|Overall Study|Subject no longer requires study drug|0|||
125252906|NCT01633112|450552151|FG001|Overall Study|Subject no longer requires study drug|0|||
125252907|NCT01633112|450552152|FG002|Overall Study|Subject no longer requires study drug|1|||
125252908|NCT01633112|450552150|FG000|Overall Study|Withdrawal by Subject|20|||
125252909|NCT01633112|450552151|FG001|Overall Study|Withdrawal by Subject|12|||
125252910|NCT01633112|450552152|FG002|Overall Study|Withdrawal by Subject|41|||
125252911|NCT01633112|450552150|FG000|Overall Study|missing Study Completion CRF|1|||
125252912|NCT01633112|450552151|FG001|Overall Study|missing Study Completion CRF|1|||
125252913|NCT01633112|450552152|FG002|Overall Study|missing Study Completion CRF|4|||
125252914|NCT01959919|450552153|FG000|Overall Study|Did not meet the eligibility criteria|2|||
125252915|NCT01908699|450552154|FG000|Overall Study|Adverse Event|8|||
125252916|NCT01908699|450552155|FG001|Overall Study|Adverse Event|12|||
125252917|NCT01908699|450552154|FG000|Overall Study|Lack of Efficacy|2|||
125252918|NCT01908699|450552155|FG001|Overall Study|Lack of Efficacy|2|||
125252919|NCT01908699|450552154|FG000|Overall Study|Lost to Follow-up|2|||
125252920|NCT01908699|450552155|FG001|Overall Study|Lost to Follow-up|4|||
125252921|NCT01908699|450552154|FG000|Overall Study|Physician Decision|8|||
125252922|NCT01908699|450552155|FG001|Overall Study|Physician Decision|8|||
125252923|NCT01908699|450552154|FG000|Overall Study|Withdrawal by Subject|15|||
125252924|NCT01908699|450552155|FG001|Overall Study|Withdrawal by Subject|10|||
125252925|NCT01908699|450552154|FG000|Overall Study|Pregnancy|0|||
125252926|NCT01908699|450552155|FG001|Overall Study|Pregnancy|1|||
125252927|NCT01908699|450552154|FG000|Overall Study|Randomized in Error|1|||
125252928|NCT01908699|450552155|FG001|Overall Study|Randomized in Error|0|||
125252929|NCT01908699|450552154|FG000|Overall Study|Death|9|||
125252930|NCT01908699|450552155|FG001|Overall Study|Death|12|||
125252931|NCT01908699|450552154|FG000|Overall Study|Progressive Disease|30|||
125252932|NCT01908699|450552155|FG001|Overall Study|Progressive Disease|29|||
125252933|NCT01697501|450552156|FG000|Overall Study|Protocol Violation|2|||
125252934|NCT00889005|450552159|FG000|Overall Study|Lost to Follow-up|4|||
125252935|NCT00889005|450552160|FG001|Overall Study|Lost to Follow-up|2|||
125252936|NCT00889005|450552159|FG000|Overall Study|Withdrawal by Subject|4|||
125252937|NCT00889005|450552160|FG001|Overall Study|Withdrawal by Subject|0|||
125252938|NCT00128492|450552161|FG000|Overall Study|AE unrelated to study|2|||
125252939|NCT00128492|450552162|FG001|Overall Study|AE unrelated to study|9|||
125444317|NCT01474512|451253891|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
125252940|NCT00128492|450552161|FG000|Overall Study|Study drug intolerance (AE)|2|||
125252941|NCT00128492|450552162|FG001|Overall Study|Study drug intolerance (AE)|8|||
125252942|NCT00128492|450552161|FG000|Overall Study|AE related to study|1|||
125252943|NCT00128492|450552162|FG001|Overall Study|AE related to study|4|||
125252944|NCT00128492|450552161|FG000|Overall Study|Death|1|||
125252945|NCT00128492|450552162|FG001|Overall Study|Death|0|||
125252946|NCT00128492|450552161|FG000|Overall Study|Lost to Follow-up|1|||
125252947|NCT00128492|450552162|FG001|Overall Study|Lost to Follow-up|5|||
125252948|NCT00128492|450552161|FG000|Overall Study|Noncompliance|0|||
125252949|NCT00128492|450552162|FG001|Overall Study|Noncompliance|5|||
125252950|NCT00128492|450552161|FG000|Overall Study|Personal or administrative|10|||
125252951|NCT00128492|450552162|FG001|Overall Study|Personal or administrative|22|||
125252952|NCT00128492|450552161|FG000|Overall Study|Withdrawal by Subject|3|||
125252953|NCT00128492|450552162|FG001|Overall Study|Withdrawal by Subject|5|||
125252954|NCT00128492|450552161|FG000|Overall Study|Pregnancy|0|||
125252955|NCT00128492|450552162|FG001|Overall Study|Pregnancy|1|||
125252956|NCT00692237|450552166|FG000|Overall Study|Withdrawal by Subject|1|||
125252957|NCT00692237|450552167|FG001|Overall Study|Withdrawal by Subject|3|||
125444318|NCT01474512|451253892|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
125252958|NCT00692237|450552166|FG000|Overall Study|Adverse Event|0|||
125252959|NCT00692237|450552167|FG001|Overall Study|Adverse Event|1|||
125252960|NCT01347086|450552171|FG000|Overall Study|failed screening visit|0|||
125252961|NCT01347086|450552172|FG001|Overall Study|failed screening visit|0|||
125252962|NCT01347086|450552173|FG002|Overall Study|failed screening visit|1|||
125252963|NCT01347086|450552174|FG003|Overall Study|failed screening visit|0|||
125252964|NCT01347086|450552175|FG004|Overall Study|failed screening visit|0|||
125252965|NCT01347086|450552176|FG005|Overall Study|failed screening visit|0|||
125252966|NCT01347086|450552177|FG006|Overall Study|failed screening visit|1|||
125252967|NCT01347086|450552178|FG007|Overall Study|failed screening visit|1|||
125252968|NCT01347086|450552179|FG008|Overall Study|failed screening visit|0|||
125252969|NCT01347086|450552180|FG009|Overall Study|failed screening visit|1|||
125252970|NCT00395447|450552182|FG000|Overall Study|Death|37|||
125252971|NCT00395447|450552183|FG001|Overall Study|Death|32|||
125252972|NCT00395447|450552182|FG000|Overall Study|Lost to Follow-up|52|||
125252973|NCT00395447|450552183|FG001|Overall Study|Lost to Follow-up|43|||
125252974|NCT00395447|450552182|FG000|Overall Study|Withdrawal by Subject|24|||
125252975|NCT00395447|450552183|FG001|Overall Study|Withdrawal by Subject|19|||
125252976|NCT00395447|450552182|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
125252977|NCT00395447|450552183|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
125252978|NCT03111108|450552185|FG000|Overall Study|Death|0|||
125252979|NCT03111108|450552186|FG001|Overall Study|Death|1|||
125252980|NCT03111108|450552185|FG000|Overall Study|Withdrawal by Subject|1|||
125252981|NCT03111108|450552186|FG001|Overall Study|Withdrawal by Subject|0|||
125252982|NCT02771145|450552187|FG000|Overall Study|Adverse Event|3|||
125252983|NCT02771145|450552187|FG000|Overall Study|Lost to Follow-up|1|||
125252984|NCT02264821|450552188|FG000|Overall Study|Protocol Violation|1|||
125252985|NCT02264821|450552189|FG001|Overall Study|Protocol Violation|3|||
125252986|NCT02264821|450552190|FG002|Overall Study|Protocol Violation|6|||
125252987|NCT02662582|450552191|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
125252988|NCT02662582|450552192|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
125252989|NCT02662582|450552191|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
125252990|NCT02662582|450552192|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
125252991|NCT02662582|450552191|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
125252992|NCT02662582|450552192|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
125252993|NCT02662582|450552191|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125252994|NCT02662582|450552192|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125252995|NCT01903733|450552193|FG000|Overall Study|Death|23|||
125252996|NCT01903733|450552194|FG001|Overall Study|Death|54|||
125252997|NCT01903733|450552195|FG002|Overall Study|Death|30|||
125252998|NCT01903733|450552196|FG003|Overall Study|Death|98|||
125252999|NCT01903733|450552193|FG000|Overall Study|Participant refused further follow-up|35|||
125253000|NCT01903733|450552194|FG001|Overall Study|Participant refused further follow-up|38|||
125253001|NCT01903733|450552195|FG002|Overall Study|Participant refused further follow-up|13|||
125253002|NCT01903733|450552196|FG003|Overall Study|Participant refused further follow-up|9|||
125253003|NCT01903733|450552193|FG000|Overall Study|Lost to Follow-up|18|||
125253004|NCT01903733|450552194|FG001|Overall Study|Lost to Follow-up|19|||
125253005|NCT01903733|450552195|FG002|Overall Study|Lost to Follow-up|6|||
125253006|NCT01903733|450552196|FG003|Overall Study|Lost to Follow-up|9|||
125253007|NCT01903733|450552193|FG000|Overall Study|Other|10|||
125253008|NCT01903733|450552194|FG001|Overall Study|Other|15|||
125253009|NCT01903733|450552195|FG002|Overall Study|Other|12|||
125253010|NCT01903733|450552196|FG003|Overall Study|Other|3|||
125253011|NCT01903733|450552193|FG000|Overall Study|Missing|2|||
125253012|NCT01903733|450552194|FG001|Overall Study|Missing|0|||
125253013|NCT01903733|450552195|FG002|Overall Study|Missing|0|||
125253014|NCT01903733|450552196|FG003|Overall Study|Missing|0|||
125253015|NCT01903733|450552193|FG000|Overall Study|Investigator request|18|||
125253016|NCT01903733|450552194|FG001|Overall Study|Investigator request|0|||
125253017|NCT01903733|450552195|FG002|Overall Study|Investigator request|0|||
125253018|NCT01903733|450552196|FG003|Overall Study|Investigator request|0|||
125253019|NCT02395627|450552197|FG000|Overall Study|Withdrawal by Subject|0|||
125253020|NCT02395627|450552198|FG001|Overall Study|Withdrawal by Subject|2|||
125253021|NCT02395627|450552199|FG002|Overall Study|Withdrawal by Subject|0|||
125253022|NCT02395627|450552197|FG000|Overall Study|Did not receive pembrolizumab|3|||
125253023|NCT02395627|450552198|FG001|Overall Study|Did not receive pembrolizumab|1|||
125253024|NCT02395627|450552199|FG002|Overall Study|Did not receive pembrolizumab|0|||
125253025|NCT02852005|450552201|FG000|Overall Study|Lost to Follow-up|0|||
125253026|NCT02852005|450552202|FG001|Overall Study|Lost to Follow-up|0|||
125253027|NCT02852005|450552203|FG002|Overall Study|Lost to Follow-up|0|||
125253028|NCT02852005|450552204|FG003|Overall Study|Lost to Follow-up|0|||
125253029|NCT02852005|450552205|FG004|Overall Study|Lost to Follow-up|1|||
125253030|NCT02852005|450552201|FG000|Overall Study|Withdrawal by Subject|1|||
125253031|NCT02852005|450552202|FG001|Overall Study|Withdrawal by Subject|0|||
125253032|NCT02852005|450552203|FG002|Overall Study|Withdrawal by Subject|0|||
125253033|NCT02852005|450552204|FG003|Overall Study|Withdrawal by Subject|0|||
125253034|NCT02852005|450552205|FG004|Overall Study|Withdrawal by Subject|0|||
125253035|NCT02294019|450552207|FG000|Overall Study|Adverse Event|2|||
125253036|NCT02294019|450552207|FG000|Overall Study|Protocol Violation|68|||
125253037|NCT02294019|450552207|FG000|Overall Study|Lost to Follow-up|31|||
125253038|NCT02294019|450552207|FG000|Overall Study|Other|1|||
125253039|NCT02294019|450552207|FG000|Overall Study|Withdrawal by Subject|1|||
125253040|NCT02369159|450552208|FG000|Overall Study|Adverse Event|0|||
125253041|NCT02369159|450552209|FG001|Overall Study|Adverse Event|1|||
125253042|NCT02369159|450552208|FG000|Overall Study|Lost to Follow-up|1|||
125253043|NCT02369159|450552209|FG001|Overall Study|Lost to Follow-up|1|||
125253044|NCT02369159|450552208|FG000|Overall Study|Withdrawal by Subject|7|||
125253045|NCT02369159|450552209|FG001|Overall Study|Withdrawal by Subject|0|||
125253046|NCT03769116|450552210|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
125253047|NCT03769116|450552211|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
125253048|NCT03769116|450552210|FG000|Part 3 - Open Label|Physician Decision|1|||
125253049|NCT03769116|450552211|FG001|Part 3 - Open Label|Physician Decision|0|||
125253050|NCT03769116|450552210|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
125253051|NCT03769116|450552211|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
125253052|NCT01887600|450552219|FG000|Overall Study|Death|39|||
125253053|NCT01887600|450552220|FG001|Overall Study|Death|16|||
125253054|NCT01887600|450552219|FG000|Overall Study|Lack of Efficacy|3|||
125253055|NCT01887600|450552220|FG001|Overall Study|Lack of Efficacy|26|||
125253056|NCT01887600|450552219|FG000|Overall Study|Lost to Follow-up|5|||
125253057|NCT01887600|450552220|FG001|Overall Study|Lost to Follow-up|1|||
125253058|NCT01887600|450552219|FG000|Overall Study|Physician Decision|7|||
125253059|NCT01887600|450552220|FG001|Overall Study|Physician Decision|8|||
125253060|NCT01887600|450552219|FG000|Overall Study|Protocol Deviation|3|||
125253061|NCT01887600|450552220|FG001|Overall Study|Protocol Deviation|0|||
125253062|NCT01887600|450552219|FG000|Overall Study|Withdrawal by Subject|58|||
125253063|NCT01887600|450552220|FG001|Overall Study|Withdrawal by Subject|52|||
125253064|NCT01887600|450552219|FG000|Overall Study|Adverse Event|21|||
125253065|NCT01887600|450552220|FG001|Overall Study|Adverse Event|9|||
125253066|NCT01887600|450552219|FG000|Overall Study|Non-compliance with study drug|3|||
125253067|NCT01887600|450552220|FG001|Overall Study|Non-compliance with study drug|0|||
125253068|NCT01887600|450552219|FG000|Overall Study|Miscellaneous|6|||
125253069|NCT01887600|450552220|FG001|Overall Study|Miscellaneous|2|||
125253070|NCT01887600|450552219|FG000|Overall Study|Progressive Disease|1|||
125253071|NCT01887600|450552220|FG001|Overall Study|Progressive Disease|0|||
125253072|NCT03688139|450552221|FG000|Overall Study|Lost to Follow-up|2|||
125253073|NCT03688139|450552222|FG001|Overall Study|Lost to Follow-up|0|||
125253074|NCT03688139|450552221|FG000|Overall Study|Physician Decision|0|||
125253075|NCT03688139|450552222|FG001|Overall Study|Physician Decision|1|||
125253076|NCT03688139|450552221|FG000|Overall Study|Withdrawal by Subject|2|||
125253077|NCT03688139|450552222|FG001|Overall Study|Withdrawal by Subject|3|||
125253078|NCT01390584|450552229|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
125253079|NCT01390584|450552230|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
125253080|NCT01390584|450552231|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
125253081|NCT01835431|450552232|FG000|Overall Study|Adverse Event|1|||
125253082|NCT01835431|450552233|FG001|Overall Study|Adverse Event|0|||
125253083|NCT01835431|450552232|FG000|Overall Study|other|0|||
125253084|NCT01835431|450552233|FG001|Overall Study|other|2|||
125253085|NCT01835431|450552232|FG000|Overall Study|Withdrawal by Subject|6|||
125253086|NCT01835431|450552233|FG001|Overall Study|Withdrawal by Subject|10|||
125253087|NCT01835431|450552232|FG000|Overall Study|Protocol Violation|1|||
125253088|NCT01835431|450552233|FG001|Overall Study|Protocol Violation|0|||
125253089|NCT00655356|450552234|FG000|Overall Study|Withdrawal by Subject|3|||
125253090|NCT00655356|450552235|FG001|Overall Study|Withdrawal by Subject|4|||
125253091|NCT00655356|450552234|FG000|Overall Study|Sponsor Request|10|||
125253092|NCT00655356|450552235|FG001|Overall Study|Sponsor Request|4|||
125253093|NCT00655356|450552234|FG000|Overall Study|Adverse Event|1|||
125253094|NCT00655356|450552235|FG001|Overall Study|Adverse Event|1|||
125253095|NCT00655356|450552234|FG000|Overall Study|Protocol Violation|2|||
125253096|NCT00655356|450552235|FG001|Overall Study|Protocol Violation|1|||
125253097|NCT00655356|450552234|FG000|Overall Study|Other Reason|1|||
125253098|NCT00655356|450552235|FG001|Overall Study|Other Reason|0|||
125253099|NCT04634331|450552236|FG000|Overall Study|Withdrawal by Subject|2|||
125253100|NCT04634331|450552237|FG001|Overall Study|Withdrawal by Subject|2|||
125253101|NCT02496156|450552238|FG000|Overall Study|Lost to Follow-up|5|||
125253102|NCT02496156|450552239|FG001|Overall Study|Lost to Follow-up|0|||
125253103|NCT02496156|450552238|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
125253104|NCT02496156|450552239|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
125253105|NCT03760666|450552240|FG000|Overall Study|Adverse Event|2|||
125253106|NCT03760666|450552241|FG001|Overall Study|Adverse Event|4|||
125253107|NCT03760666|450552242|FG002|Overall Study|Adverse Event|1|||
125253108|NCT03760666|450552240|FG000|Overall Study|AML Disease Progression|3|||
125253109|NCT03760666|450552241|FG001|Overall Study|AML Disease Progression|3|||
125253110|NCT03760666|450552242|FG002|Overall Study|AML Disease Progression|0|||
125253111|NCT03760666|450552240|FG000|Overall Study|Physician Decision|0|||
125253112|NCT03760666|450552241|FG001|Overall Study|Physician Decision|3|||
125253113|NCT03760666|450552242|FG002|Overall Study|Physician Decision|0|||
125253114|NCT03760666|450552240|FG000|Overall Study|Withdrawal by Subject|0|||
125253115|NCT03760666|450552241|FG001|Overall Study|Withdrawal by Subject|1|||
125253116|NCT03760666|450552242|FG002|Overall Study|Withdrawal by Subject|0|||
125253117|NCT04349098|450552243|FG000|Overall Study|Death|16|||
125253118|NCT04349098|450552244|FG001|Overall Study|Death|8|||
125253119|NCT04349098|450552243|FG000|Overall Study|Lost to Follow-up|11|||
125253120|NCT04349098|450552244|FG001|Overall Study|Lost to Follow-up|8|||
125253121|NCT04349098|450552243|FG000|Overall Study|Withdrawal by Subject|8|||
125253122|NCT04349098|450552244|FG001|Overall Study|Withdrawal by Subject|5|||
125253123|NCT04349098|450552243|FG000|Overall Study|Other|3|||
125253124|NCT04349098|450552244|FG001|Overall Study|Other|5|||
125253125|NCT01703221|450552245|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
125253126|NCT01703221|450552246|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
125253127|NCT01703221|450552247|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
125253128|NCT01703221|450552245|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
125253129|NCT01703221|450552246|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
125253130|NCT01703221|450552247|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
125253131|NCT01703221|450552245|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
125253132|NCT01703221|450552246|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125253133|NCT01703221|450552247|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125253134|NCT01703221|450552245|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
125253135|NCT01703221|450552246|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
125253136|NCT01703221|450552247|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
125253137|NCT01703221|450552245|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
125253138|NCT01703221|450552246|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
125253139|NCT01703221|450552247|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
125253140|NCT01703221|450552245|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
125253141|NCT01703221|450552246|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
125253142|NCT01703221|450552247|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
125253143|NCT01703221|450552245|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
125253144|NCT01703221|450552246|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
125253145|NCT01703221|450552247|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
125253146|NCT01703221|450552245|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
125253147|NCT01703221|450552246|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
125253148|NCT01703221|450552247|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
125253149|NCT05486065|450552248|FG000|Overall Study|Withdrawal by Subject|1|||
125253150|NCT05486065|450552249|FG001|Overall Study|Withdrawal by Subject|5|||
125253151|NCT05486065|450552250|FG002|Overall Study|Withdrawal by Subject|4|||
125253152|NCT05486065|450552251|FG003|Overall Study|Withdrawal by Subject|3|||
125253153|NCT05486065|450552248|FG000|Overall Study|Lost to Follow-up|4|||
125253154|NCT05486065|450552249|FG001|Overall Study|Lost to Follow-up|2|||
125253155|NCT05486065|450552250|FG002|Overall Study|Lost to Follow-up|2|||
125253156|NCT05486065|450552251|FG003|Overall Study|Lost to Follow-up|2|||
125253157|NCT05486065|450552248|FG000|Overall Study|Physician Decision|0|||
125253158|NCT05486065|450552249|FG001|Overall Study|Physician Decision|1|||
125253159|NCT05486065|450552250|FG002|Overall Study|Physician Decision|1|||
125253160|NCT05486065|450552251|FG003|Overall Study|Physician Decision|0|||
125253161|NCT05486065|450552248|FG000|Overall Study|Failure to meet randomization criteria|0|||
125253162|NCT05486065|450552249|FG001|Overall Study|Failure to meet randomization criteria|0|||
125253163|NCT05486065|450552250|FG002|Overall Study|Failure to meet randomization criteria|0|||
125253164|NCT05486065|450552251|FG003|Overall Study|Failure to meet randomization criteria|1|||
125253165|NCT03878069|450552252|FG000|Overall Study|Death|0|||
125253166|NCT03878069|450552253|FG001|Overall Study|Death|1|||
125253167|NCT03878069|450552254|FG002|Overall Study|Death|0|||
125253168|NCT00834587|450552255|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
125253169|NCT00834587|450552256|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
125253170|NCT00176254|450552257|FG000|Overall Study|Lost to Follow-up|1|||
125253171|NCT03810495|450552258|FG000|Overall Study|Lost to Follow-up|2|||
125253172|NCT03810495|450552258|FG000|Overall Study|Withdrawal by Subject|1|||
125253173|NCT02536339|450552260|FG000|Overall Study|Death|20|||
125253174|NCT02536339|450552260|FG000|Overall Study|Withdrawal by Subject|3|||
125253175|NCT02536339|450552260|FG000|Overall Study|Lost to Follow-up|2|||
125253176|NCT02536339|450552260|FG000|Overall Study|Treatment discontinued|2|||
125253177|NCT02536339|450552260|FG000|Overall Study|Physician Decision|1|||
125253178|NCT03449147|450552261|FG000|52-week Treatment Period|Death|0|||
125253179|NCT03449147|450552262|FG001|52-week Treatment Period|Death|1|||
125253180|NCT03449147|450552263|FG002|52-week Treatment Period|Death|0|||
125253181|NCT03449147|450552261|FG000|52-week Treatment Period|Lost to Follow-up|6|||
125253182|NCT03449147|450552262|FG001|52-week Treatment Period|Lost to Follow-up|2|||
125253183|NCT03449147|450552263|FG002|52-week Treatment Period|Lost to Follow-up|5|||
125253184|NCT03449147|450552261|FG000|52-week Treatment Period|Other|0|||
125253185|NCT03449147|450552262|FG001|52-week Treatment Period|Other|1|||
125253186|NCT03449147|450552263|FG002|52-week Treatment Period|Other|2|||
125396856|NCT04145895|451086883|FG000|Overall Study|Withdrawal by Subject|0|||
125396857|NCT04145895|451086884|FG001|Overall Study|Withdrawal by Subject|2|||
125396858|NCT01481116|451086885|FG000|Overall Study|Adverse Event|26|||
125396859|NCT01481116|451086886|FG001|Overall Study|Adverse Event|26|||
125396860|NCT01481116|451086887|FG002|Overall Study|Adverse Event|42|||
125396861|NCT01481116|451086885|FG000|Overall Study|Major Protocol Deviation|3|||
125396862|NCT01481116|451086886|FG001|Overall Study|Major Protocol Deviation|7|||
125253187|NCT03449147|450552261|FG000|52-week Treatment Period|Physician Decision|1|||
125253188|NCT03449147|450552262|FG001|52-week Treatment Period|Physician Decision|0|||
125253189|NCT03449147|450552263|FG002|52-week Treatment Period|Physician Decision|3|||
125253190|NCT03449147|450552261|FG000|52-week Treatment Period|Screen Failure|1|||
125253191|NCT03449147|450552262|FG001|52-week Treatment Period|Screen Failure|2|||
125253192|NCT03449147|450552263|FG002|52-week Treatment Period|Screen Failure|0|||
125253193|NCT03449147|450552261|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
125253194|NCT03449147|450552262|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
125253195|NCT03449147|450552263|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
125253196|NCT03449147|450552261|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
125253197|NCT03449147|450552262|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
125253198|NCT03449147|450552263|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
125253199|NCT03449147|450552261|FG000|12-Week Off-Treatment Durability Period|Other|0|||
125253200|NCT03449147|450552262|FG001|12-Week Off-Treatment Durability Period|Other|1|||
125253201|NCT03449147|450552263|FG002|12-Week Off-Treatment Durability Period|Other|0|||
125253202|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
125253203|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
125253204|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
125253205|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Adverse Event|5|||
125253206|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Adverse Event|1|||
125253207|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Adverse Event|0|||
125253208|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
125253209|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
125253210|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
125253211|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Death|8|||
125253212|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Death|24|||
125253213|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Death|0|||
125253214|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
125253215|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
125253216|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
125253217|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
125253218|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
125253219|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
125253220|NCT02931539|450552266|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
125253221|NCT02931539|450552267|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
125253222|NCT02931539|450552268|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
125253223|NCT02931539|450552266|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
125253224|NCT02931539|450552267|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
125253225|NCT02931539|450552268|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
125253226|NCT02730169|450553678|FG000|Overall Study|Protocol Violation|1|||
125253227|NCT02730169|450553679|FG001|Overall Study|Protocol Violation|0|||
125253228|NCT02730169|450553680|FG002|Overall Study|Protocol Violation|0|||
125253229|NCT02730169|450553681|FG003|Overall Study|Protocol Violation|1|||
125253230|NCT02730169|450553678|FG000|Overall Study|Adverse Event|2|||
125253231|NCT02730169|450553679|FG001|Overall Study|Adverse Event|3|||
125253232|NCT02730169|450553680|FG002|Overall Study|Adverse Event|3|||
125253233|NCT02730169|450553681|FG003|Overall Study|Adverse Event|0|||
125253234|NCT02730169|450553678|FG000|Overall Study|Adverse Event of Special Interest|0|||
125253235|NCT02730169|450553679|FG001|Overall Study|Adverse Event of Special Interest|1|||
125253236|NCT02730169|450553680|FG002|Overall Study|Adverse Event of Special Interest|2|||
125253237|NCT02730169|450553681|FG003|Overall Study|Adverse Event of Special Interest|0|||
125253238|NCT02730169|450553678|FG000|Overall Study|Withdrawal by Subject|6|||
125253239|NCT02730169|450553679|FG001|Overall Study|Withdrawal by Subject|11|||
125253240|NCT02730169|450553680|FG002|Overall Study|Withdrawal by Subject|6|||
125253241|NCT02730169|450553681|FG003|Overall Study|Withdrawal by Subject|8|||
125253242|NCT02730169|450553678|FG000|Overall Study|Lost to Follow-up|5|||
125253243|NCT02730169|450553679|FG001|Overall Study|Lost to Follow-up|6|||
125253244|NCT02730169|450553680|FG002|Overall Study|Lost to Follow-up|5|||
125253245|NCT02730169|450553681|FG003|Overall Study|Lost to Follow-up|6|||
125253246|NCT02730169|450553678|FG000|Overall Study|Other|0|||
125253247|NCT02730169|450553679|FG001|Overall Study|Other|0|||
125253248|NCT02730169|450553680|FG002|Overall Study|Other|1|||
125253249|NCT02730169|450553681|FG003|Overall Study|Other|1|||
125253250|NCT02144337|450553688|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
125253251|NCT02144337|450553689|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
125253252|NCT02144337|450553688|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
125253253|NCT02144337|450553689|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
125253254|NCT02144337|450553688|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
125253255|NCT02144337|450553689|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
125253256|NCT02144337|450553688|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
125253257|NCT02144337|450553689|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
125253258|NCT02144337|450553688|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
125253259|NCT02144337|450553689|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
125253260|NCT01730729|450553690|FG000|Overall Study|Adverse Event|1|||
125253261|NCT01730729|450553690|FG000|Overall Study|Death|1|||
125253262|NCT01730729|450553690|FG000|Overall Study|Progressive Disease|12|||
125253263|NCT00449787|450553691|FG000|Overall Study|Lost to Follow-up|10|||
125253264|NCT00449787|450553692|FG001|Overall Study|Lost to Follow-up|8|||
125253265|NCT00449787|450553691|FG000|Overall Study|Did not require medication|95|||
125253266|NCT00449787|450553692|FG001|Overall Study|Did not require medication|92|||
125253267|NCT03701074|450553693|FG000|Overall Study|Physician Decision|1|||
125253268|NCT03701074|450553694|FG001|Overall Study|Physician Decision|0|||
125253269|NCT03574389|450553698|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
125253270|NCT03574389|450553699|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
125253271|NCT03574389|450553700|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
125253272|NCT03574389|450553701|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
125253273|NCT03574389|450553702|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
125253274|NCT03574389|450553703|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
125253275|NCT03574389|450553704|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
125253276|NCT03574389|450553698|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
125253277|NCT03574389|450553699|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
125253278|NCT03574389|450553700|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
125253279|NCT03574389|450553701|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
125253280|NCT03574389|450553702|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
125253281|NCT03574389|450553703|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
125253282|NCT03574389|450553704|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
125253283|NCT03574389|450553698|FG000|Vaccination Period|Other|6|||
125253284|NCT03574389|450553699|FG001|Vaccination Period|Other|0|||
125253285|NCT03574389|450553700|FG002|Vaccination Period|Other|0|||
125253286|NCT03574389|450553701|FG003|Vaccination Period|Other|0|||
125253287|NCT03574389|450553702|FG004|Vaccination Period|Other|0|||
125253288|NCT03574389|450553703|FG005|Vaccination Period|Other|0|||
125253289|NCT03574389|450553704|FG006|Vaccination Period|Other|0|||
125253290|NCT03574389|450553698|FG000|Vaccination Period|Adverse Event|0|||
125253291|NCT03574389|450553699|FG001|Vaccination Period|Adverse Event|1|||
125253292|NCT03574389|450553700|FG002|Vaccination Period|Adverse Event|0|||
125253293|NCT03574389|450553701|FG003|Vaccination Period|Adverse Event|0|||
125253294|NCT03574389|450553702|FG004|Vaccination Period|Adverse Event|0|||
125253295|NCT03574389|450553703|FG005|Vaccination Period|Adverse Event|0|||
125253296|NCT03574389|450553704|FG006|Vaccination Period|Adverse Event|0|||
125253297|NCT03574389|450553698|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
125253298|NCT03574389|450553699|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
125253299|NCT03574389|450553700|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
125253300|NCT03574389|450553701|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
125253301|NCT03574389|450553702|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
125253302|NCT03574389|450553703|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
125253303|NCT03574389|450553704|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
125253304|NCT01682603|450553705|FG000|Overall Study|Lost to Follow-up|3|||
125253305|NCT00993473|450553706|FG000|Overall Study|Adverse Event|0|||
125253306|NCT00993473|450553707|FG001|Overall Study|Adverse Event|2|||
125253307|NCT00993473|450553706|FG000|Overall Study|Protocol Violation|1|||
125253308|NCT00993473|450553707|FG001|Overall Study|Protocol Violation|2|||
125253309|NCT00993473|450553706|FG000|Overall Study|Lost to Follow-up|1|||
125253310|NCT00993473|450553707|FG001|Overall Study|Lost to Follow-up|0|||
125253311|NCT00993473|450553706|FG000|Overall Study|Withdrawal by Subject|1|||
125253312|NCT00993473|450553707|FG001|Overall Study|Withdrawal by Subject|5|||
125253313|NCT00993473|450553706|FG000|Overall Study|Technical problem with CGM device|0|||
125253314|NCT00993473|450553707|FG001|Overall Study|Technical problem with CGM device|1|||
125253315|NCT00993473|450553706|FG000|Overall Study|Family event|1|||
125253316|NCT00993473|450553707|FG001|Overall Study|Family event|0|||
125253317|NCT03707821|450553708|FG000|Overall Study|Protocol Violation|0|||
125253318|NCT03707821|450553709|FG001|Overall Study|Protocol Violation|1|||
125253319|NCT03707821|450553708|FG000|Overall Study|Unsatisfactory Visual Response|1|||
125253320|NCT03707821|450553709|FG001|Overall Study|Unsatisfactory Visual Response|0|||
125253321|NCT03707821|450553708|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
125253322|NCT03707821|450553709|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
125253323|NCT05122143|450553710|FG000|Overall Study|Adverse Event|1|||
125253324|NCT05122143|450553711|FG001|Overall Study|Adverse Event|0|||
125253325|NCT05122143|450553712|FG002|Overall Study|Adverse Event|0|||
125253326|NCT05122143|450553713|FG003|Overall Study|Adverse Event|0|||
125253327|NCT05122143|450553714|FG004|Overall Study|Adverse Event|1|||
125253328|NCT05122143|450553715|FG005|Overall Study|Adverse Event|0|||
125253329|NCT05122143|450553710|FG000|Overall Study|Protocol non-compliance|0|||
125253330|NCT05122143|450553711|FG001|Overall Study|Protocol non-compliance|0|||
125253331|NCT05122143|450553712|FG002|Overall Study|Protocol non-compliance|1|||
125253332|NCT05122143|450553713|FG003|Overall Study|Protocol non-compliance|0|||
125253333|NCT05122143|450553714|FG004|Overall Study|Protocol non-compliance|0|||
125253334|NCT05122143|450553715|FG005|Overall Study|Protocol non-compliance|0|||
125253335|NCT05122143|450553710|FG000|Overall Study|Covid contact|0|||
125253336|NCT05122143|450553711|FG001|Overall Study|Covid contact|0|||
125253337|NCT05122143|450553712|FG002|Overall Study|Covid contact|0|||
125253338|NCT05122143|450553713|FG003|Overall Study|Covid contact|0|||
125253339|NCT05122143|450553714|FG004|Overall Study|Covid contact|1|||
125253340|NCT05122143|450553715|FG005|Overall Study|Covid contact|0|||
125253341|NCT03766906|450553716|FG000|Overall Study|Withdrawal by Subject|6|||
125253342|NCT02624687|450553717|FG000|Overall Study|Withdrawal by Subject|1|||
125253343|NCT02624687|450553718|FG001|Overall Study|Withdrawal by Subject|1|||
125253344|NCT02624687|450553717|FG000|Overall Study|medical leave from work|0|||
125253345|NCT02624687|450553718|FG001|Overall Study|medical leave from work|1|||
125253346|NCT00552279|450553719|FG000|Overall Study|Adverse Event|0|||
125253347|NCT00552279|450553720|FG001|Overall Study|Adverse Event|1|||
125253348|NCT00552279|450553719|FG000|Overall Study|Withdrawal by Subject|12|||
125253349|NCT00552279|450553720|FG001|Overall Study|Withdrawal by Subject|1|||
125253350|NCT00552279|450553719|FG000|Overall Study|Lost to Follow-up|1|||
125253351|NCT00552279|450553720|FG001|Overall Study|Lost to Follow-up|0|||
125253352|NCT00552279|450553719|FG000|Overall Study|Other|1|||
125253353|NCT00552279|450553720|FG001|Overall Study|Other|1|||
125253354|NCT01651208|450553722|FG000|Overall Study|Lost to Follow-up|14|||
125253355|NCT01651208|450553723|FG001|Overall Study|Lost to Follow-up|16|||
125253356|NCT00836901|450553724|FG000|First Intervention|Withdrawal by Subject|1|||
125253357|NCT00836901|450553725|FG001|First Intervention|Withdrawal by Subject|0|||
125253358|NCT05463952|450553726|FG000|Treatment|Progressive disease|4|||
125253359|NCT05463952|450553726|FG000|Treatment|Ongoing|2|||
125253360|NCT05261490|450553727|FG000|Overall Study|Other|1|||
125253361|NCT05261490|450553728|FG001|Overall Study|Other|0|||
125253362|NCT05261490|450553729|FG002|Overall Study|Other|0|||
125253363|NCT05261490|450553727|FG000|Overall Study|Study Terminated by Sponsor|1|||
125253364|NCT05261490|450553728|FG001|Overall Study|Study Terminated by Sponsor|1|||
125253365|NCT05261490|450553729|FG002|Overall Study|Study Terminated by Sponsor|4|||
125253366|NCT05261490|450553727|FG000|Overall Study|Death|1|||
125253367|NCT05261490|450553728|FG001|Overall Study|Death|2|||
125253368|NCT05261490|450553729|FG002|Overall Study|Death|0|||
125253369|NCT04191733|450553742|FG000|Overall Study|Withdrawn due to study closure|13|||
125253370|NCT04191733|450553743|FG001|Overall Study|Withdrawn due to study closure|14|||
125253371|NCT04191733|450553742|FG000|Overall Study|Withdrawal by Subject|2|||
125253372|NCT04191733|450553743|FG001|Overall Study|Withdrawal by Subject|4|||
125253373|NCT04191733|450553742|FG000|Overall Study|Physician Decision|1|||
125253374|NCT04191733|450553743|FG001|Overall Study|Physician Decision|1|||
125253375|NCT04191733|450553742|FG000|Overall Study|Lost to Follow-up|5|||
125253376|NCT04191733|450553743|FG001|Overall Study|Lost to Follow-up|6|||
125253377|NCT04191733|450553742|FG000|Overall Study|Death|0|||
125253378|NCT04191733|450553743|FG001|Overall Study|Death|1|||
125253379|NCT01714063|450553749|FG000|Overall Study|Equipment malfunction|2|||
125253380|NCT01646216|450553750|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
125253381|NCT01646216|450553751|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
125253382|NCT01646216|450553750|FG000|Overall Study|Did not complete training|0|||
125253383|NCT01646216|450553751|FG001|Overall Study|Did not complete training|2|||
125253384|NCT01646216|450553750|FG000|Overall Study|Investigator decision|1|||
125253385|NCT01646216|450553751|FG001|Overall Study|Investigator decision|1|||
125253386|NCT02633527|450553752|FG000|Overall Study|Failed to meet eligibility|0|||
125253387|NCT02633527|450553753|FG001|Overall Study|Failed to meet eligibility|1|||
125253388|NCT02633527|450553754|FG002|Overall Study|Failed to meet eligibility|1|||
125253389|NCT02633527|450553755|FG003|Overall Study|Failed to meet eligibility|0|||
125253390|NCT02633527|450553756|FG004|Overall Study|Failed to meet eligibility|1|||
125253391|NCT02633527|450553752|FG000|Overall Study|Adverse Event|0|||
125253392|NCT02633527|450553753|FG001|Overall Study|Adverse Event|4|||
125253393|NCT02633527|450553754|FG002|Overall Study|Adverse Event|3|||
125253394|NCT02633527|450553755|FG003|Overall Study|Adverse Event|1|||
125253395|NCT02633527|450553756|FG004|Overall Study|Adverse Event|5|||
125253396|NCT02633527|450553752|FG000|Overall Study|Lost to Follow-up|1|||
125253397|NCT02633527|450553753|FG001|Overall Study|Lost to Follow-up|2|||
125253398|NCT02633527|450553754|FG002|Overall Study|Lost to Follow-up|5|||
125253399|NCT02633527|450553755|FG003|Overall Study|Lost to Follow-up|5|||
125253400|NCT02633527|450553756|FG004|Overall Study|Lost to Follow-up|4|||
125253401|NCT02633527|450553752|FG000|Overall Study|Withdrawal by Subject|0|||
125253402|NCT02633527|450553753|FG001|Overall Study|Withdrawal by Subject|3|||
125253403|NCT02633527|450553754|FG002|Overall Study|Withdrawal by Subject|5|||
125253404|NCT02633527|450553755|FG003|Overall Study|Withdrawal by Subject|4|||
125253405|NCT02633527|450553756|FG004|Overall Study|Withdrawal by Subject|4|||
125253406|NCT02633527|450553752|FG000|Overall Study|Protocol Violation|0|||
125253407|NCT02633527|450553753|FG001|Overall Study|Protocol Violation|1|||
125253408|NCT02633527|450553754|FG002|Overall Study|Protocol Violation|1|||
125253409|NCT02633527|450553755|FG003|Overall Study|Protocol Violation|1|||
125253410|NCT02633527|450553756|FG004|Overall Study|Protocol Violation|1|||
125253411|NCT02633527|450553752|FG000|Overall Study|Physician Decision|0|||
125253412|NCT02633527|450553753|FG001|Overall Study|Physician Decision|0|||
125253413|NCT02633527|450553754|FG002|Overall Study|Physician Decision|0|||
125253414|NCT02633527|450553755|FG003|Overall Study|Physician Decision|0|||
125253415|NCT02633527|450553756|FG004|Overall Study|Physician Decision|1|||
125253416|NCT02633527|450553752|FG000|Overall Study|Administrative reason|1|||
125253417|NCT02633527|450553753|FG001|Overall Study|Administrative reason|0|||
125253418|NCT02633527|450553754|FG002|Overall Study|Administrative reason|0|||
125253419|NCT02633527|450553755|FG003|Overall Study|Administrative reason|1|||
125253420|NCT02633527|450553756|FG004|Overall Study|Administrative reason|0|||
125253421|NCT02633527|450553752|FG000|Overall Study|Multiple reasons|1|||
125253422|NCT02633527|450553753|FG001|Overall Study|Multiple reasons|0|||
125253423|NCT02633527|450553754|FG002|Overall Study|Multiple reasons|2|||
125253424|NCT02633527|450553755|FG003|Overall Study|Multiple reasons|2|||
125253425|NCT02633527|450553756|FG004|Overall Study|Multiple reasons|1|||
125253426|NCT01681849|450553759|FG000|Overall Study|Protocol Violation|2|||
125253427|NCT01681849|450553760|FG001|Overall Study|Protocol Violation|0|||
125253428|NCT01681849|450553761|FG002|Overall Study|Protocol Violation|0|||
125253429|NCT01681849|450553759|FG000|Overall Study|Withdrawal by Subject|3|||
125253430|NCT01681849|450553760|FG001|Overall Study|Withdrawal by Subject|5|||
125253431|NCT01681849|450553761|FG002|Overall Study|Withdrawal by Subject|33|||
125253432|NCT01681849|450553759|FG000|Overall Study|Lost to Follow-up|3|||
125253433|NCT01681849|450553760|FG001|Overall Study|Lost to Follow-up|2|||
125253434|NCT01681849|450553761|FG002|Overall Study|Lost to Follow-up|6|||
125253435|NCT02420314|450553764|FG000|Overall Study|Withdrawal by Subject|1|||
125253436|NCT02420314|450553764|FG000|Overall Study|Protocol Violation|1|||
125253437|NCT03760068|450553765|FG000|Overall Study|Withdrawal by Subject|7|||
125253438|NCT03760068|450553766|FG001|Overall Study|Withdrawal by Subject|8|||
125253439|NCT03760068|450553765|FG000|Overall Study|Adverse Event|1|||
125253440|NCT03760068|450553766|FG001|Overall Study|Adverse Event|2|||
125253441|NCT03760068|450553765|FG000|Overall Study|Administrative Decision by Sponsor|0|||
125253442|NCT03760068|450553766|FG001|Overall Study|Administrative Decision by Sponsor|2|||
125253443|NCT03760068|450553765|FG000|Overall Study|Physician Decision|1|||
125253444|NCT03760068|450553766|FG001|Overall Study|Physician Decision|2|||
125253445|NCT03760068|450553765|FG000|Overall Study|Lost to Follow-up|4|||
125253446|NCT03760068|450553766|FG001|Overall Study|Lost to Follow-up|9|||
125253447|NCT03760068|450553765|FG000|Overall Study|Subject Moved Out of State|1|||
125253448|NCT03760068|450553766|FG001|Overall Study|Subject Moved Out of State|0|||
125253449|NCT03460704|450553770|FG000|Overall Study|Withdrawal by Subject|11|||
125253450|NCT03460704|450553771|FG001|Overall Study|Withdrawal by Subject|14|||
125253451|NCT03460704|450553770|FG000|Overall Study|Study terminated by the Sponsor|29|||
125253452|NCT03460704|450553771|FG001|Overall Study|Study terminated by the Sponsor|19|||
125253453|NCT03460704|450553770|FG000|Overall Study|Adverse Event|10|||
125253454|NCT03460704|450553771|FG001|Overall Study|Adverse Event|5|||
125253455|NCT03460704|450553770|FG000|Overall Study|Death|3|||
125253456|NCT03460704|450553771|FG001|Overall Study|Death|2|||
125253457|NCT03460704|450553770|FG000|Overall Study|Non-Compliance with Study Drug|3|||
125253458|NCT03460704|450553771|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125253459|NCT03460704|450553770|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125253460|NCT03460704|450553771|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
125253461|NCT03460704|450553770|FG000|Overall Study|Other|2|||
125253462|NCT03460704|450553771|FG001|Overall Study|Other|1|||
125253463|NCT02913326|450553776|FG000|Overall Study|Reason not listed|0|||
125253464|NCT02913326|450553777|FG001|Overall Study|Reason not listed|1|||
125253465|NCT02913326|450553776|FG000|Overall Study|Lost to Follow-up|0|||
125253466|NCT02913326|450553777|FG001|Overall Study|Lost to Follow-up|1|||
125253467|NCT02913326|450553776|FG000|Overall Study|Adverse Event|1|||
125253468|NCT02913326|450553777|FG001|Overall Study|Adverse Event|0|||
125253469|NCT01767857|450553778|FG000|Overall Study|Adverse Event|27|||
125253470|NCT01767857|450553779|FG001|Overall Study|Adverse Event|7|||
125253471|NCT01767857|450553778|FG000|Overall Study|Death|28|||
125253472|NCT01767857|450553779|FG001|Overall Study|Death|13|||
125253473|NCT01767857|450553778|FG000|Overall Study|Lack of Efficacy|299|||
125253474|NCT01767857|450553779|FG001|Overall Study|Lack of Efficacy|151|||
125253475|NCT01767857|450553778|FG000|Overall Study|Lost to Follow-up|1|||
125253476|NCT01767857|450553779|FG001|Overall Study|Lost to Follow-up|1|||
125253477|NCT01767857|450553778|FG000|Overall Study|Withdrawal by Subject|38|||
125253478|NCT01767857|450553779|FG001|Overall Study|Withdrawal by Subject|18|||
125253479|NCT01767857|450553778|FG000|Overall Study|Physician Decision|17|||
125253480|NCT01767857|450553779|FG001|Overall Study|Physician Decision|10|||
125253481|NCT01767857|450553778|FG000|Overall Study|Protocol Terminated|1|||
125253482|NCT01767857|450553779|FG001|Overall Study|Protocol Terminated|0|||
125253483|NCT01767857|450553778|FG000|Overall Study|Randomized But Never Treated|19|||
125253484|NCT01767857|450553779|FG001|Overall Study|Randomized But Never Treated|13|||
125253485|NCT04126174|450553780|FG000|Overall Study|Lost to Follow-up|3|||
125253486|NCT04126174|450553781|FG001|Overall Study|Lost to Follow-up|3|||
125253487|NCT01514422|450553784|FG000|Overall Study|Lost to Follow-up|1|||
125253488|NCT00420056|450553797|FG000|Overall Study|Objective progression or relapse|17|||
125253489|NCT01044459|450553806|FG000|Overall Study|Withdrawal by Subject|21|||
125253490|NCT01044459|450553807|FG001|Overall Study|Withdrawal by Subject|28|||
125253491|NCT01044459|450553806|FG000|Overall Study|Terminated by Sponsor|22|||
125253492|NCT01044459|450553807|FG001|Overall Study|Terminated by Sponsor|21|||
125253493|NCT01044459|450553806|FG000|Overall Study|Adverse Event|22|||
125253494|NCT01044459|450553807|FG001|Overall Study|Adverse Event|20|||
125253495|NCT01044459|450553806|FG000|Overall Study|Lack of Efficacy|23|||
125253496|NCT01044459|450553807|FG001|Overall Study|Lack of Efficacy|12|||
125253497|NCT01044459|450553806|FG000|Overall Study|Protocol Violation|11|||
125253498|NCT01044459|450553807|FG001|Overall Study|Protocol Violation|16|||
125253499|NCT01044459|450553806|FG000|Overall Study|Other Reason|7|||
125253500|NCT01044459|450553807|FG001|Overall Study|Other Reason|14|||
125253501|NCT01044459|450553806|FG000|Overall Study|COPD exacerbation|9|||
125253502|NCT01044459|450553807|FG001|Overall Study|COPD exacerbation|8|||
125253503|NCT01044459|450553806|FG000|Overall Study|Lost to Follow-up|18|||
125253504|NCT01044459|450553807|FG001|Overall Study|Lost to Follow-up|12|||
125253505|NCT04105725|450553808|FG000|Primary Intervention|Lost to Follow-up|0|||
125253506|NCT04105725|450553809|FG001|Primary Intervention|Lost to Follow-up|2|||
125253507|NCT04105725|450553808|FG000|Primary Intervention|Withdrawal by Subject|0|||
125253508|NCT04105725|450553809|FG001|Primary Intervention|Withdrawal by Subject|1|||
125253509|NCT00480025|450553810|FG000|Overall Study|Protocol Violation|12|||
125253510|NCT00480025|450553811|FG001|Overall Study|Protocol Violation|7|||
125253511|NCT00480025|450553810|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
125253512|NCT00480025|450553811|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
125253513|NCT00480025|450553810|FG000|Overall Study|Disease Progression / Recurrence|449|||
125253514|NCT00480025|450553811|FG001|Overall Study|Disease Progression / Recurrence|224|||
125253515|NCT00480025|450553810|FG000|Overall Study|Adverse Event|44|||
125253516|NCT00480025|450553811|FG001|Overall Study|Adverse Event|12|||
125253517|NCT00480025|450553810|FG000|Overall Study|Other|70|||
125253518|NCT00480025|450553811|FG001|Overall Study|Other|29|||
125253519|NCT00480025|450553810|FG000|Overall Study|SAE including intercurrent illness|76|||
125253520|NCT00480025|450553811|FG001|Overall Study|SAE including intercurrent illness|42|||
125253521|NCT03726879|450553816|FG000|Overall Study|Death|11|||
125253522|NCT03726879|450553817|FG001|Overall Study|Death|13|||
125253523|NCT03726879|450553816|FG000|Overall Study|Physician Decision|0|||
125253524|NCT03726879|450553817|FG001|Overall Study|Physician Decision|2|||
125253525|NCT03726879|450553816|FG000|Overall Study|Protocol Violation|0|||
125253526|NCT03726879|450553817|FG001|Overall Study|Protocol Violation|1|||
125253527|NCT03726879|450553816|FG000|Overall Study|Withdrawal by Subject|5|||
125253528|NCT03726879|450553817|FG001|Overall Study|Withdrawal by Subject|6|||
125253529|NCT03726879|450553816|FG000|Overall Study|TSH result is unstable|0|||
125253530|NCT03726879|450553817|FG001|Overall Study|TSH result is unstable|1|||
125253531|NCT03726879|450553816|FG000|Overall Study|Disease relapse|1|||
125253532|NCT03726879|450553817|FG001|Overall Study|Disease relapse|0|||
125253533|NCT03726879|450553816|FG000|Overall Study|Lost to Follow-up|3|||
125253534|NCT03726879|450553817|FG001|Overall Study|Lost to Follow-up|0|||
125253535|NCT02766478|450553818|FG000|Overall Study|Withdrawal by Subject|1|||
125253536|NCT02766478|450553819|FG001|Overall Study|Withdrawal by Subject|1|||
125253537|NCT05626686|450553820|FG000|Overall Study|Protocol Violation|3|||
125253538|NCT05626686|450553820|FG000|Overall Study|Withdrawal by Subject|3|||
125253539|NCT01093573|450553821|FG000|Overall Study|Physician Decision|0|||
125253540|NCT01093573|450553822|FG001|Overall Study|Physician Decision|0|||
125253541|NCT01093573|450553823|FG002|Overall Study|Physician Decision|1|||
125253542|NCT01093573|450553821|FG000|Overall Study|Insurance Denied|0|||
125253543|NCT01093573|450553822|FG001|Overall Study|Insurance Denied|0|||
125253544|NCT01093573|450553823|FG002|Overall Study|Insurance Denied|1|||
125253545|NCT02457546|450555474|FG000|Overall Study|Other reasons|4|||
125253546|NCT02457546|450555475|FG001|Overall Study|Other reasons|1|||
125253547|NCT02457546|450555474|FG000|Overall Study|Refused to complete study/procedures|1|||
125253548|NCT02457546|450555475|FG001|Overall Study|Refused to complete study/procedures|1|||
125253549|NCT02457546|450555474|FG000|Overall Study|Lost to Follow-up|4|||
125253550|NCT02457546|450555475|FG001|Overall Study|Lost to Follow-up|1|||
125253551|NCT02457546|450555474|FG000|Overall Study|Adverse Event|0|||
125253552|NCT02457546|450555475|FG001|Overall Study|Adverse Event|1|||
125253553|NCT05069415|450555476|FG000|Overall Study|Withdrawal by Subject|2|||
125253554|NCT05069415|450555477|FG001|Overall Study|Withdrawal by Subject|0|||
125253555|NCT05069415|450555476|FG000|Overall Study|Adverse Event|2|||
125253556|NCT05069415|450555477|FG001|Overall Study|Adverse Event|0|||
125253557|NCT00203242|450555480|FG000|Overall Study|Lost to Follow-up|1|||
125253558|NCT00866775|450555481|FG000|Overall Study|Adverse Event|5|||
125253559|NCT00866775|450555482|FG001|Overall Study|Adverse Event|19|||
125253560|NCT00866775|450555481|FG000|Overall Study|Death|1|||
125253561|NCT00866775|450555482|FG001|Overall Study|Death|0|||
125253562|NCT00866775|450555481|FG000|Overall Study|Lost to Follow-up|0|||
125253563|NCT00866775|450555482|FG001|Overall Study|Lost to Follow-up|4|||
125253564|NCT00866775|450555481|FG000|Overall Study|Physician Decision|0|||
125253565|NCT00866775|450555482|FG001|Overall Study|Physician Decision|3|||
125253566|NCT00866775|450555481|FG000|Overall Study|Protocol Violation|3|||
125253567|NCT00866775|450555482|FG001|Overall Study|Protocol Violation|4|||
125253568|NCT00866775|450555481|FG000|Overall Study|Withdrawal by Subject|4|||
125396863|NCT01481116|451086887|FG002|Overall Study|Major Protocol Deviation|1|||
125396864|NCT01481116|451086885|FG000|Overall Study|Lost to Follow-up|8|||
125396865|NCT01481116|451086886|FG001|Overall Study|Lost to Follow-up|12|||
125396866|NCT01481116|451086887|FG002|Overall Study|Lost to Follow-up|11|||
125396867|NCT01481116|451086885|FG000|Overall Study|Withdrawal by Subject|37|||
125396868|NCT01481116|451086886|FG001|Overall Study|Withdrawal by Subject|33|||
125396869|NCT01481116|451086887|FG002|Overall Study|Withdrawal by Subject|37|||
125396870|NCT01481116|451086885|FG000|Overall Study|Study Termination|730|||
125396871|NCT01481116|451086886|FG001|Overall Study|Study Termination|729|||
125396872|NCT01481116|451086887|FG002|Overall Study|Study Termination|713|||
125396873|NCT01481116|451086885|FG000|Overall Study|Pregnancy|0|||
125396874|NCT01481116|451086886|FG001|Overall Study|Pregnancy|0|||
125396875|NCT01481116|451086887|FG002|Overall Study|Pregnancy|1|||
125396876|NCT01481116|451086885|FG000|Overall Study|Lack of Efficacy|3|||
125396877|NCT01481116|451086886|FG001|Overall Study|Lack of Efficacy|3|||
125396878|NCT01481116|451086887|FG002|Overall Study|Lack of Efficacy|1|||
125396879|NCT01481116|451086885|FG000|Overall Study|Contraindications|1|||
125396880|NCT01481116|451086886|FG001|Overall Study|Contraindications|1|||
125396881|NCT01481116|451086887|FG002|Overall Study|Contraindications|0|||
125396882|NCT01481116|451086885|FG000|Overall Study|Other|1|||
125396883|NCT01481116|451086886|FG001|Overall Study|Other|1|||
125396884|NCT01481116|451086887|FG002|Overall Study|Other|0|||
125396885|NCT01481116|451086885|FG000|Overall Study|Participant Started Taking Glipizide|1|||
125396886|NCT01481116|451086886|FG001|Overall Study|Participant Started Taking Glipizide|0|||
125396887|NCT01481116|451086887|FG002|Overall Study|Participant Started Taking Glipizide|0|||
125396888|NCT01481116|451086885|FG000|Overall Study|Participant Moved Out of Area|2|||
125396889|NCT01481116|451086886|FG001|Overall Study|Participant Moved Out of Area|0|||
125396890|NCT01481116|451086887|FG002|Overall Study|Participant Moved Out of Area|1|||
125396891|NCT01481116|451086885|FG000|Overall Study|Participant Moved Out of Country|1|||
125396892|NCT01481116|451086886|FG001|Overall Study|Participant Moved Out of Country|0|||
125396893|NCT01481116|451086887|FG002|Overall Study|Participant Moved Out of Country|1|||
125396894|NCT01481116|451086885|FG000|Overall Study|Investigator Decision|3|||
125396895|NCT01481116|451086886|FG001|Overall Study|Investigator Decision|2|||
125396896|NCT01481116|451086887|FG002|Overall Study|Investigator Decision|1|||
125396897|NCT01481116|451086885|FG000|Overall Study|Sponsor Decision|0|||
125396898|NCT01481116|451086886|FG001|Overall Study|Sponsor Decision|1|||
125396899|NCT01481116|451086887|FG002|Overall Study|Sponsor Decision|3|||
125396900|NCT01481116|451086885|FG000|Overall Study|Non-Compliant With Study Drug|0|||
125396901|NCT01481116|451086886|FG001|Overall Study|Non-Compliant With Study Drug|1|||
125396902|NCT01481116|451086887|FG002|Overall Study|Non-Compliant With Study Drug|1|||
125396903|NCT01481116|451086885|FG000|Overall Study|Investigator's Discretion|2|||
125396904|NCT01481116|451086886|FG001|Overall Study|Investigator's Discretion|0|||
125396905|NCT01481116|451086887|FG002|Overall Study|Investigator's Discretion|0|||
125396906|NCT01481116|451086885|FG000|Overall Study|Death|2|||
125396907|NCT01481116|451086886|FG001|Overall Study|Death|1|||
125396908|NCT01481116|451086887|FG002|Overall Study|Death|0|||
125396909|NCT01481116|451086885|FG000|Overall Study|Hypoglycemic Event|4|||
125396910|NCT01481116|451086886|FG001|Overall Study|Hypoglycemic Event|0|||
125396911|NCT01481116|451086887|FG002|Overall Study|Hypoglycemic Event|0|||
125396912|NCT02789176|451086888|FG000|Overall Study|Death|0|||
125396913|NCT02789176|451086889|FG001|Overall Study|Death|0|||
125396914|NCT02789176|451086890|FG002|Overall Study|Death|3|||
125396915|NCT02789176|451086891|FG003|Overall Study|Death|0|||
125396916|NCT02789176|451086888|FG000|Overall Study|Withdrawal by Subject|0|||
125396917|NCT02789176|451086889|FG001|Overall Study|Withdrawal by Subject|0|||
125396918|NCT02789176|451086890|FG002|Overall Study|Withdrawal by Subject|1|||
125396919|NCT02789176|451086891|FG003|Overall Study|Withdrawal by Subject|0|||
125396920|NCT02789176|451086888|FG000|Overall Study|Lost to Follow-up|8|||
125396921|NCT02789176|451086889|FG001|Overall Study|Lost to Follow-up|2|||
125396922|NCT02789176|451086890|FG002|Overall Study|Lost to Follow-up|6|||
125396923|NCT02789176|451086891|FG003|Overall Study|Lost to Follow-up|1|||
125396924|NCT00596011|451086892|FG000|Overall Study|Withdrawal by Subject|2|||
125396925|NCT00596011|451086893|FG001|Overall Study|Withdrawal by Subject|3|||
125396926|NCT00596011|451086892|FG000|Overall Study|Adverse Event|11|||
125396927|NCT00596011|451086893|FG001|Overall Study|Adverse Event|7|||
125396928|NCT00192075|451086894|FG000|Overall Study|Disease Progression|23|||
125396929|NCT00192075|451086895|FG001|Overall Study|Disease Progression|6|||
125396930|NCT00192075|451086894|FG000|Overall Study|Adverse Event|1|||
125396931|NCT00192075|451086895|FG001|Overall Study|Adverse Event|3|||
125396932|NCT00192075|451086894|FG000|Overall Study|Death|0|||
125396933|NCT00192075|451086895|FG001|Overall Study|Death|1|||
125396934|NCT00192075|451086894|FG000|Overall Study|Lack of Efficacy|0|||
125396935|NCT00192075|451086895|FG001|Overall Study|Lack of Efficacy|0|||
125396936|NCT00192075|451086894|FG000|Overall Study|Physician Decision|3|||
125396937|NCT00192075|451086895|FG001|Overall Study|Physician Decision|0|||
125396938|NCT00192075|451086894|FG000|Overall Study|Withdrawal by Subject|5|||
125396939|NCT00192075|451086895|FG001|Overall Study|Withdrawal by Subject|5|||
125396940|NCT00192075|451086894|FG000|Overall Study|Patient Non-Compliance|0|||
125396941|NCT00192075|451086895|FG001|Overall Study|Patient Non-Compliance|1|||
125253569|NCT00866775|450555482|FG001|Overall Study|Withdrawal by Subject|4|||
125253570|NCT00866775|450555481|FG000|Overall Study|met exit criteria|23|||
125253571|NCT00866775|450555482|FG001|Overall Study|met exit criteria|17|||
125253572|NCT00866775|450555481|FG000|Overall Study|discontinued due to communication error|0|||
125253573|NCT00866775|450555482|FG001|Overall Study|discontinued due to communication error|1|||
125253574|NCT01500135|450555483|FG000|Overall Study|Withdrawal of Consent|4|||
125253575|NCT01500135|450555484|FG001|Overall Study|Withdrawal of Consent|0|||
125253576|NCT01500135|450555483|FG000|Overall Study|Lost to Follow-up|6|||
125253577|NCT01500135|450555484|FG001|Overall Study|Lost to Follow-up|4|||
125253578|NCT01500135|450555483|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
125253579|NCT01500135|450555484|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
125253580|NCT01500135|450555483|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
125253581|NCT01500135|450555484|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
125253582|NCT01500135|450555483|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
125253583|NCT01500135|450555484|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
125253584|NCT01500135|450555483|FG000|Overall Study|Participant was a Safety Concern|1|||
125253585|NCT01500135|450555484|FG001|Overall Study|Participant was a Safety Concern|0|||
125253586|NCT01500135|450555483|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
125253587|NCT01500135|450555484|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
125253588|NCT01661595|450555485|FG000|Phase 1: Week 0-4|Adverse Event|1|||
125253589|NCT01661595|450555486|FG001|Phase 1: Week 0-4|Adverse Event|0|||
125253590|NCT01661595|450555487|FG002|Phase 1: Week 0-4|Adverse Event|0|||
125253591|NCT01661595|450555488|FG003|Phase 1: Week 0-4|Adverse Event|0|||
125253592|NCT01661595|450555485|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
125253593|NCT01661595|450555486|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
125253594|NCT01661595|450555487|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
125253595|NCT01661595|450555488|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
125253596|NCT00912509|450555489|FG000|Overall Study|Lost to Follow-up|1|||
125253597|NCT00912509|450555490|FG001|Overall Study|Lost to Follow-up|0|||
125253598|NCT00912509|450555489|FG000|Overall Study|Lack of Efficacy|4|||
125253599|NCT00912509|450555490|FG001|Overall Study|Lack of Efficacy|3|||
125253600|NCT03439072|450555491|FG000|Overall Study|Withdrawal by Subject|2|||
125253601|NCT03439072|450555492|FG001|Overall Study|Withdrawal by Subject|3|||
125253602|NCT03439072|450555491|FG000|Overall Study|Physician Decision|0|||
125253603|NCT03439072|450555492|FG001|Overall Study|Physician Decision|1|||
125253604|NCT01537432|450555494|FG000|Overall Study|Lost to Follow-up|3|||
125253605|NCT01537432|450555495|FG001|Overall Study|Lost to Follow-up|1|||
125253606|NCT01537432|450555494|FG000|Overall Study|Withdrawal by Subject|0|||
125253607|NCT01537432|450555495|FG001|Overall Study|Withdrawal by Subject|1|||
125253608|NCT01537432|450555494|FG000|Overall Study|Administrative problems|1|||
125253609|NCT01537432|450555495|FG001|Overall Study|Administrative problems|0|||
125253610|NCT01537432|450555494|FG000|Overall Study|Adverse Event|1|||
125253611|NCT01537432|450555495|FG001|Overall Study|Adverse Event|0|||
125253612|NCT01537432|450555494|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125253613|NCT01537432|450555495|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125253614|NCT05166902|450555496|FG000|First Intervention|Lost to Follow-up|0|||
125253615|NCT05166902|450555497|FG001|First Intervention|Lost to Follow-up|1|||
125253616|NCT01998477|450555498|FG000|Overall Study|Lost to Follow-up|4|||
125253617|NCT01998477|450555499|FG001|Overall Study|Lost to Follow-up|5|||
125253618|NCT01998477|450555498|FG000|Overall Study|Withdrawal by Subject|6|||
125253619|NCT01998477|450555499|FG001|Overall Study|Withdrawal by Subject|0|||
125253620|NCT00779909|450555500|FG000|Overall Study|Lost to Follow-up|1|||
125253621|NCT00779909|450555501|FG001|Overall Study|Lost to Follow-up|0|||
125253622|NCT00779909|450555502|FG002|Overall Study|Lost to Follow-up|0|||
125253623|NCT00779909|450555503|FG003|Overall Study|Lost to Follow-up|1|||
125253624|NCT00779909|450555500|FG000|Overall Study|Withdrawal by Subject|0|||
125253625|NCT00779909|450555501|FG001|Overall Study|Withdrawal by Subject|1|||
125253626|NCT00779909|450555502|FG002|Overall Study|Withdrawal by Subject|0|||
125253627|NCT00779909|450555503|FG003|Overall Study|Withdrawal by Subject|0|||
125253628|NCT03523585|450555504|FG000|Overall Study|Progressive Disease|174|||
125253629|NCT03523585|450555505|FG001|Overall Study|Progressive Disease|64|||
125253630|NCT03523585|450555506|FG002|Overall Study|Progressive Disease|77|||
125253631|NCT03523585|450555504|FG000|Overall Study|Adverse Event|74|||
125253632|NCT03523585|450555505|FG001|Overall Study|Adverse Event|5|||
125253633|NCT03523585|450555506|FG002|Overall Study|Adverse Event|9|||
125253634|NCT03523585|450555504|FG000|Overall Study|Withdrawal by Subject|30|||
125253635|NCT03523585|450555505|FG001|Overall Study|Withdrawal by Subject|11|||
125253636|NCT03523585|450555506|FG002|Overall Study|Withdrawal by Subject|6|||
125253637|NCT03523585|450555504|FG000|Overall Study|Clinical Progression|23|||
125253638|NCT03523585|450555505|FG001|Overall Study|Clinical Progression|5|||
125253639|NCT03523585|450555506|FG002|Overall Study|Clinical Progression|10|||
125253640|NCT03523585|450555504|FG000|Overall Study|Death|4|||
125253641|NCT03523585|450555505|FG001|Overall Study|Death|0|||
125253642|NCT03523585|450555506|FG002|Overall Study|Death|1|||
125253643|NCT03523585|450555504|FG000|Overall Study|Physician Decision|2|||
125253644|NCT03523585|450555505|FG001|Overall Study|Physician Decision|1|||
125253645|NCT03523585|450555506|FG002|Overall Study|Physician Decision|0|||
125253646|NCT03523585|450555504|FG000|Overall Study|Lost to Follow-up|1|||
125253647|NCT03523585|450555505|FG001|Overall Study|Lost to Follow-up|0|||
125253648|NCT03523585|450555506|FG002|Overall Study|Lost to Follow-up|0|||
125253649|NCT03523585|450555504|FG000|Overall Study|Miscellaneous|1|||
125253650|NCT03523585|450555505|FG001|Overall Study|Miscellaneous|0|||
125253651|NCT03523585|450555506|FG002|Overall Study|Miscellaneous|0|||
125253652|NCT03523585|450555504|FG000|Overall Study|Protocol Deviation|1|||
125253653|NCT03523585|450555505|FG001|Overall Study|Protocol Deviation|0|||
125253654|NCT03523585|450555506|FG002|Overall Study|Protocol Deviation|1|||
125253655|NCT03523585|450555504|FG000|Overall Study|Randomized But Not Treated|2|||
125253656|NCT03523585|450555505|FG001|Overall Study|Randomized But Not Treated|4|||
125253657|NCT03523585|450555506|FG002|Overall Study|Randomized But Not Treated|3|||
125253658|NCT05345405|450555507|FG000|Overall Study|Withdrawal by Subject|2|||
125253659|NCT05345405|450555508|FG001|Overall Study|Withdrawal by Subject|0|||
125253660|NCT05345405|450555509|FG002|Overall Study|Withdrawal by Subject|0|||
125253661|NCT05345405|450555507|FG000|Overall Study|Did not meet eligibility criteria|0|||
125253662|NCT05345405|450555508|FG001|Overall Study|Did not meet eligibility criteria|2|||
125253663|NCT05345405|450555509|FG002|Overall Study|Did not meet eligibility criteria|0|||
125253664|NCT05345405|450555507|FG000|Overall Study|Lost to Follow-up|0|||
125253665|NCT05345405|450555508|FG001|Overall Study|Lost to Follow-up|0|||
125253666|NCT05345405|450555509|FG002|Overall Study|Lost to Follow-up|1|||
125253667|NCT02872142|450555519|FG000|Overall Study|Adverse Event|2|||
125253668|NCT02872142|450555519|FG000|Overall Study|Death|1|||
125253669|NCT02872142|450555519|FG000|Overall Study|Participant Decision|3|||
125253670|NCT01903720|450555520|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
125253671|NCT01903720|450555520|FG000|Overall Study|Adverse Event|1|||
125253672|NCT01903720|450555520|FG000|Overall Study|Rescinding of informed consent|2|||
125253673|NCT01903720|450555520|FG000|Overall Study|Lost to Follow-up|2|||
125253674|NCT01903720|450555520|FG000|Overall Study|Treatment with alternative drug|1|||
125253675|NCT02244957|450555521|FG000|Overall Study|Lack of Efficacy|1|||
125253676|NCT02244957|450555522|FG001|Overall Study|Lack of Efficacy|0|||
125253677|NCT02150863|450555523|FG000|Overall Study|Lost to Follow-up|0|||
125253678|NCT02150863|450555524|FG001|Overall Study|Lost to Follow-up|1|||
125253679|NCT02150863|450555525|FG002|Overall Study|Lost to Follow-up|0|||
125253680|NCT00830336|450555526|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
125253681|NCT00830336|450555527|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
125253682|NCT01853280|450555534|FG000|Overall Study|Lack of Efficacy|2|||
125253683|NCT01853280|450555535|FG001|Overall Study|Lack of Efficacy|2|||
125253684|NCT01853280|450555534|FG000|Overall Study|Lost to Follow-up|0|||
125253685|NCT01853280|450555535|FG001|Overall Study|Lost to Follow-up|1|||
125253686|NCT01853280|450555534|FG000|Overall Study|Physician Decision|0|||
125253687|NCT01853280|450555535|FG001|Overall Study|Physician Decision|1|||
125253688|NCT01853280|450555534|FG000|Overall Study|Withdrawal by Subject|0|||
125253689|NCT01853280|450555535|FG001|Overall Study|Withdrawal by Subject|1|||
125253690|NCT01853280|450555534|FG000|Overall Study|Ineligible|0|||
125253691|NCT01853280|450555535|FG001|Overall Study|Ineligible|1|||
125253692|NCT00104884|450555536|FG000|Overall Study|Disease progression|4|||
125253693|NCT03032484|450555537|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
125253694|NCT03032484|450555538|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
125253695|NCT03032484|450555537|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
125253696|NCT03032484|450555538|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
125253697|NCT01229111|450555539|FG000|Overall Study|Death|1|||
125253698|NCT01689649|450555542|FG000|Overall Study|Lack of Efficacy|3|||
125253699|NCT01689649|450555542|FG000|Overall Study|Non-compliance|11|||
125253700|NCT01689649|450555542|FG000|Overall Study|Protocol Violation|3|||
125253701|NCT01689649|450555542|FG000|Overall Study|Lost to Follow-up|5|||
125253702|NCT04893811|450555543|FG000|Vaccination Phase|Death|1|||
125253703|NCT04893811|450555544|FG001|Vaccination Phase|Death|0|||
125253704|NCT04893811|450555543|FG000|Vaccination Phase|Lost to Follow-up|1|||
125253705|NCT04893811|450555544|FG001|Vaccination Phase|Lost to Follow-up|1|||
125253706|NCT04893811|450555543|FG000|Vaccination Phase|Protocol Violation|2|||
125253707|NCT04893811|450555544|FG001|Vaccination Phase|Protocol Violation|0|||
125253708|NCT04893811|450555543|FG000|Vaccination Phase|Withdrawal by Subject|2|||
125253709|NCT04893811|450555544|FG001|Vaccination Phase|Withdrawal by Subject|1|||
125253710|NCT04893811|450555543|FG000|Vaccination Phase|Other|0|||
125253711|NCT04893811|450555544|FG001|Vaccination Phase|Other|1|||
125253712|NCT04893811|450555543|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
125253713|NCT04893811|450555544|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
125253714|NCT04893811|450555543|FG000|Follow-up Phase|Lost to Follow-up|0|||
125253715|NCT04893811|450555544|FG001|Follow-up Phase|Lost to Follow-up|1|||
125253716|NCT03268499|450555545|FG000|Overall Study|Withdrawal by Subject|2|||
125253717|NCT03268499|450555546|FG001|Overall Study|Withdrawal by Subject|1|||
125253718|NCT03760081|450555550|FG000|Overall Study|Miscellaneous|0|||
125253719|NCT03760081|450555551|FG001|Overall Study|Miscellaneous|1|||
125253720|NCT03760081|450555550|FG000|Overall Study|Progressive Disease|5|||
125253721|NCT03760081|450555551|FG001|Overall Study|Progressive Disease|10|||
125253722|NCT03760081|450555550|FG000|Overall Study|Death|1|||
125444319|NCT01474512|451253893|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
125444320|NCT01474512|451253894|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
125444321|NCT01474512|451253895|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
125444322|NCT01474512|451253896|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
125444323|NCT01474512|451253897|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
125444324|NCT01474512|451253880|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
125444325|NCT01474512|451253881|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
125444326|NCT01474512|451253882|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
125444327|NCT01474512|451253883|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
125444328|NCT01474512|451253884|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
125444329|NCT01474512|451253885|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
125444330|NCT01474512|451253886|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
125444331|NCT01474512|451253887|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
125444332|NCT01474512|451253888|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
125444333|NCT01474512|451253889|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
125444334|NCT01474512|451253890|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
125444335|NCT01474512|451253891|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
125444336|NCT01474512|451253892|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
125444337|NCT01474512|451253893|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
125444338|NCT01474512|451253894|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
125444339|NCT01474512|451253895|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
125444340|NCT01474512|451253896|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
125444341|NCT01474512|451253897|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
125444342|NCT01474512|451253880|FG000|Long-Term Extension Period|Adverse Event|0|||
125444343|NCT01474512|451253881|FG001|Long-Term Extension Period|Adverse Event|0|||
125444344|NCT01474512|451253882|FG002|Long-Term Extension Period|Adverse Event|0|||
125444345|NCT01474512|451253883|FG003|Long-Term Extension Period|Adverse Event|0|||
125444346|NCT01474512|451253884|FG004|Long-Term Extension Period|Adverse Event|0|||
125444347|NCT01474512|451253885|FG005|Long-Term Extension Period|Adverse Event|0|||
125444348|NCT01474512|451253886|FG006|Long-Term Extension Period|Adverse Event|0|||
125444349|NCT01474512|451253887|FG007|Long-Term Extension Period|Adverse Event|0|||
125444350|NCT01474512|451253888|FG008|Long-Term Extension Period|Adverse Event|0|||
125444351|NCT01474512|451253889|FG009|Long-Term Extension Period|Adverse Event|0|||
125444352|NCT01474512|451253890|FG010|Long-Term Extension Period|Adverse Event|0|||
125444353|NCT01474512|451253891|FG011|Long-Term Extension Period|Adverse Event|1|||
125444354|NCT01474512|451253892|FG012|Long-Term Extension Period|Adverse Event|57|||
125444355|NCT01474512|451253893|FG013|Long-Term Extension Period|Adverse Event|58|||
125444356|NCT01474512|451253894|FG014|Long-Term Extension Period|Adverse Event|0|||
125444357|NCT01474512|451253895|FG015|Long-Term Extension Period|Adverse Event|0|||
125444358|NCT01474512|451253896|FG016|Long-Term Extension Period|Adverse Event|0|||
125444359|NCT01474512|451253897|FG017|Long-Term Extension Period|Adverse Event|0|||
125444360|NCT01474512|451253880|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
125444361|NCT01474512|451253881|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
125444362|NCT01474512|451253882|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
125444363|NCT01474512|451253883|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
125444364|NCT01474512|451253884|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
125444365|NCT01474512|451253885|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
125444366|NCT01474512|451253886|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
125444367|NCT01474512|451253887|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
125444368|NCT01474512|451253888|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
125444369|NCT01474512|451253889|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
125444370|NCT01474512|451253890|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
125444371|NCT01474512|451253891|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
125444372|NCT01474512|451253892|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
125444373|NCT01474512|451253893|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
125444374|NCT01474512|451253894|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
125444375|NCT01474512|451253895|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
125444376|NCT01474512|451253896|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
125444377|NCT01474512|451253897|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
125444378|NCT01474512|451253880|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
125444379|NCT01474512|451253881|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
125444380|NCT01474512|451253882|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
125253723|NCT03760081|450555551|FG001|Overall Study|Death|1|||
125253724|NCT03533491|450555552|FG000|Overall Study|Lost to Follow-up|2|||
125253725|NCT01725282|450555558|FG000|Overall Study|Adverse Event|1|||
125253726|NCT01725282|450555559|FG001|Overall Study|Adverse Event|3|||
125444381|NCT01474512|451253883|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
125444382|NCT01474512|451253884|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
125444383|NCT01474512|451253885|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
125444384|NCT01474512|451253886|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
125253727|NCT01725282|450555560|FG002|Overall Study|Adverse Event|6|||
125253728|NCT01725282|450555561|FG003|Overall Study|Adverse Event|4|||
125253729|NCT01725282|450555558|FG000|Overall Study|Exacerbation of Target Disease|1|||
125253730|NCT01725282|450555559|FG001|Overall Study|Exacerbation of Target Disease|0|||
125253731|NCT01725282|450555560|FG002|Overall Study|Exacerbation of Target Disease|0|||
125253732|NCT01725282|450555561|FG003|Overall Study|Exacerbation of Target Disease|1|||
125253733|NCT01725282|450555558|FG000|Overall Study|Met Exclusion Criteria|0|||
125253734|NCT01725282|450555559|FG001|Overall Study|Met Exclusion Criteria|0|||
125253735|NCT01725282|450555560|FG002|Overall Study|Met Exclusion Criteria|1|||
125253736|NCT01725282|450555561|FG003|Overall Study|Met Exclusion Criteria|0|||
125253737|NCT01725282|450555558|FG000|Overall Study|Study Site Withdrawal|0|||
125253738|NCT01725282|450555559|FG001|Overall Study|Study Site Withdrawal|1|||
125253739|NCT01725282|450555560|FG002|Overall Study|Study Site Withdrawal|0|||
125253740|NCT01725282|450555561|FG003|Overall Study|Study Site Withdrawal|0|||
125253741|NCT01725282|450555558|FG000|Overall Study|Withdrawal by Subject|0|||
125253742|NCT01725282|450555559|FG001|Overall Study|Withdrawal by Subject|0|||
125253743|NCT01725282|450555560|FG002|Overall Study|Withdrawal by Subject|1|||
125253744|NCT01725282|450555561|FG003|Overall Study|Withdrawal by Subject|1|||
125253745|NCT01725282|450555558|FG000|Overall Study|Lack of Efficacy|0|||
125253746|NCT01725282|450555559|FG001|Overall Study|Lack of Efficacy|1|||
125253747|NCT01725282|450555560|FG002|Overall Study|Lack of Efficacy|0|||
125253748|NCT01725282|450555561|FG003|Overall Study|Lack of Efficacy|1|||
125253749|NCT04064567|450555562|FG000|Overall Study|Lost to Follow-up|23|||
125253750|NCT04064567|450555563|FG001|Overall Study|Lost to Follow-up|22|||
125253751|NCT04064567|450555562|FG000|Overall Study|Withdrawal by Subject|0|||
125253752|NCT04064567|450555563|FG001|Overall Study|Withdrawal by Subject|1|||
125253753|NCT04064567|450555562|FG000|Overall Study|Reincarcerated|7|||
125253754|NCT04064567|450555563|FG001|Overall Study|Reincarcerated|10|||
125253755|NCT04064567|450555562|FG000|Overall Study|Moved out of U.S.|0|||
125253756|NCT04064567|450555563|FG001|Overall Study|Moved out of U.S.|1|||
125253757|NCT04576481|450555564|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
125253758|NCT04576481|450555565|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
125253759|NCT04576481|450555566|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
125253760|NCT04576481|450555567|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
125253761|NCT00595075|450555569|FG000|Overall Study|Withdrawal by Subject|1|||
125253762|NCT00595075|450555570|FG001|Overall Study|Withdrawal by Subject|0|||
125253763|NCT01946880|450555571|FG000|Overall Study|Lost to Follow-up|1|||
125253764|NCT01946880|450555572|FG001|Overall Study|Lost to Follow-up|0|||
125253765|NCT01946880|450555571|FG000|Overall Study|Physician Decision|1|||
125253766|NCT01946880|450555572|FG001|Overall Study|Physician Decision|1|||
125253767|NCT01946880|450555571|FG000|Overall Study|Withdrawal by Subject|3|||
125253768|NCT01946880|450555572|FG001|Overall Study|Withdrawal by Subject|2|||
125253769|NCT01946880|450555571|FG000|Overall Study|Met Primary Endpoint|1|||
125253770|NCT01946880|450555572|FG001|Overall Study|Met Primary Endpoint|0|||
125253771|NCT01946880|450555571|FG000|Overall Study|Personal and Family Issues|1|||
125253772|NCT01946880|450555572|FG001|Overall Study|Personal and Family Issues|0|||
125253773|NCT01682720|450555575|FG000|Overall Study|Randomized but Not Treated|0|||
125253774|NCT01682720|450555576|FG001|Overall Study|Randomized but Not Treated|1|||
125253775|NCT01682720|450555577|FG002|Overall Study|Randomized but Not Treated|1|||
125253776|NCT01682720|450555578|FG003|Overall Study|Randomized but Not Treated|0|||
125253777|NCT01682720|450555575|FG000|Overall Study|Terminated by Sponsor|83|||
125253778|NCT01682720|450555576|FG001|Overall Study|Terminated by Sponsor|0|||
125253779|NCT01682720|450555577|FG002|Overall Study|Terminated by Sponsor|0|||
125253780|NCT01682720|450555578|FG003|Overall Study|Terminated by Sponsor|0|||
125253781|NCT01682720|450555575|FG000|Overall Study|Efficacy Failure|0|||
125253782|NCT01682720|450555576|FG001|Overall Study|Efficacy Failure|3|||
125253783|NCT01682720|450555577|FG002|Overall Study|Efficacy Failure|3|||
125253784|NCT01682720|450555578|FG003|Overall Study|Efficacy Failure|30|||
125253785|NCT01682720|450555575|FG000|Overall Study|Lost to Follow-up|1|||
125253786|NCT01682720|450555576|FG001|Overall Study|Lost to Follow-up|1|||
125253787|NCT01682720|450555577|FG002|Overall Study|Lost to Follow-up|0|||
125253788|NCT01682720|450555578|FG003|Overall Study|Lost to Follow-up|6|||
125253789|NCT01682720|450555575|FG000|Overall Study|Subject Withdrew Consent|0|||
125253790|NCT01682720|450555576|FG001|Overall Study|Subject Withdrew Consent|0|||
125253791|NCT01682720|450555577|FG002|Overall Study|Subject Withdrew Consent|2|||
125253792|NCT01682720|450555578|FG003|Overall Study|Subject Withdrew Consent|2|||
125253793|NCT01682720|450555575|FG000|Overall Study|Adverse Event|1|||
125253794|NCT01682720|450555576|FG001|Overall Study|Adverse Event|0|||
125253795|NCT01682720|450555577|FG002|Overall Study|Adverse Event|1|||
125253796|NCT01682720|450555578|FG003|Overall Study|Adverse Event|1|||
125253797|NCT04204902|450555579|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
125253798|NCT04204902|450555580|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
125253799|NCT06091956|450555583|FG000|Overall Study|Withdrawal by Subject|1|||
125253800|NCT06091956|450555583|FG000|Overall Study|Complicating Disease|1|||
125253801|NCT04525183|450555592|FG000|Overall Study|Withdrawal by Subject|0|||
125253802|NCT04525183|450555593|FG001|Overall Study|Withdrawal by Subject|0|||
125253803|NCT04525183|450555594|FG002|Overall Study|Withdrawal by Subject|3|||
125444385|NCT01474512|451253887|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
125444386|NCT01474512|451253888|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
125444387|NCT01474512|451253889|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
125253804|NCT04525183|450555592|FG000|Overall Study|Study non-compliance|0|||
125253805|NCT04525183|450555593|FG001|Overall Study|Study non-compliance|0|||
125253806|NCT04525183|450555594|FG002|Overall Study|Study non-compliance|1|||
125253807|NCT04525183|450555592|FG000|Overall Study|Recurrent disease before starting on study|0|||
125253808|NCT04525183|450555593|FG001|Overall Study|Recurrent disease before starting on study|0|||
125253809|NCT04525183|450555594|FG002|Overall Study|Recurrent disease before starting on study|1|||
125253810|NCT00979407|450555595|FG000|Overall Study|Withdrawal by Subject|3|||
125253811|NCT00979407|450555596|FG001|Overall Study|Withdrawal by Subject|4|||
125253812|NCT00979407|450555595|FG000|Overall Study|Lost to Follow-up|3|||
125253813|NCT00979407|450555596|FG001|Overall Study|Lost to Follow-up|3|||
125253814|NCT01166646|450555597|FG000|Overall Study|Protocol Violation|0|||
125253815|NCT01166646|450555598|FG001|Overall Study|Protocol Violation|1|||
125253816|NCT01166646|450555597|FG000|Overall Study|Adverse Event|1|||
125253817|NCT01166646|450555598|FG001|Overall Study|Adverse Event|0|||
125253818|NCT01335685|450555600|FG000|Overall Study|Study Terminated by Sponsor|2|||
125253819|NCT01335685|450555601|FG001|Overall Study|Study Terminated by Sponsor|1|||
125253820|NCT01335685|450555602|FG002|Overall Study|Study Terminated by Sponsor|1|||
125253821|NCT01335685|450555603|FG003|Overall Study|Study Terminated by Sponsor|10|||
125253822|NCT01335685|450555604|FG004|Overall Study|Study Terminated by Sponsor|0|||
125253823|NCT01335685|450555605|FG005|Overall Study|Study Terminated by Sponsor|4|||
125253824|NCT01335685|450555606|FG006|Overall Study|Study Terminated by Sponsor|2|||
125253825|NCT01335685|450555607|FG007|Overall Study|Study Terminated by Sponsor|3|||
125253826|NCT01335685|450555600|FG000|Overall Study|Withdrawal by Subject|1|||
125253827|NCT01335685|450555601|FG001|Overall Study|Withdrawal by Subject|0|||
125253828|NCT01335685|450555602|FG002|Overall Study|Withdrawal by Subject|0|||
125253829|NCT01335685|450555603|FG003|Overall Study|Withdrawal by Subject|1|||
125253830|NCT01335685|450555604|FG004|Overall Study|Withdrawal by Subject|0|||
125253831|NCT01335685|450555605|FG005|Overall Study|Withdrawal by Subject|0|||
125253832|NCT01335685|450555606|FG006|Overall Study|Withdrawal by Subject|0|||
125253833|NCT01335685|450555607|FG007|Overall Study|Withdrawal by Subject|0|||
125253834|NCT01335685|450555600|FG000|Overall Study|Reason not Specified|0|||
125253835|NCT01335685|450555601|FG001|Overall Study|Reason not Specified|0|||
125253836|NCT01335685|450555602|FG002|Overall Study|Reason not Specified|1|||
125253837|NCT01335685|450555603|FG003|Overall Study|Reason not Specified|0|||
125253838|NCT01335685|450555604|FG004|Overall Study|Reason not Specified|0|||
125253839|NCT01335685|450555605|FG005|Overall Study|Reason not Specified|1|||
125253840|NCT01335685|450555606|FG006|Overall Study|Reason not Specified|0|||
125253841|NCT01335685|450555607|FG007|Overall Study|Reason not Specified|0|||
125253842|NCT03777020|450555612|FG000|Overall Study|Withdrawal by Subject|4|||
125253843|NCT03777020|450555613|FG001|Overall Study|Withdrawal by Subject|4|||
125253844|NCT03777020|450555612|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
125253845|NCT03777020|450555613|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
125253846|NCT00489476|450555614|FG000|Overall Study|Lost to Follow-up|0|||
125253847|NCT00489476|450555615|FG001|Overall Study|Lost to Follow-up|1|||
125253848|NCT00489476|450555616|FG002|Overall Study|Lost to Follow-up|0|||
125253849|NCT00489476|450555617|FG003|Overall Study|Lost to Follow-up|0|||
125253850|NCT00581100|450556894|FG000|Overall Study|Death|1|||
125253851|NCT00581100|450556895|FG001|Overall Study|Death|0|||
125253852|NCT00581100|450556894|FG000|Overall Study|Adverse Event|2|||
125253853|NCT00581100|450556895|FG001|Overall Study|Adverse Event|1|||
125253854|NCT00581100|450556894|FG000|Overall Study|Withdrawal by Subject|1|||
125253855|NCT00581100|450556895|FG001|Overall Study|Withdrawal by Subject|4|||
125253856|NCT00581100|450556894|FG000|Overall Study|Other|3|||
125253857|NCT00581100|450556895|FG001|Overall Study|Other|0|||
125253858|NCT04744831|450556896|FG000|Overall Study|Progressive Disease|31|||
125253859|NCT04744831|450556897|FG001|Overall Study|Progressive Disease|27|||
125253860|NCT04744831|450556898|FG002|Overall Study|Progressive Disease|25|||
125253861|NCT04744831|450556896|FG000|Overall Study|Adverse Event|3|||
125253862|NCT04744831|450556897|FG001|Overall Study|Adverse Event|3|||
125253863|NCT04744831|450556898|FG002|Overall Study|Adverse Event|3|||
125253864|NCT04744831|450556896|FG000|Overall Study|Clinical Progression|3|||
125253865|NCT04744831|450556897|FG001|Overall Study|Clinical Progression|2|||
125253866|NCT04744831|450556898|FG002|Overall Study|Clinical Progression|5|||
125253867|NCT04744831|450556896|FG000|Overall Study|Other|0|||
125253868|NCT04744831|450556897|FG001|Overall Study|Other|2|||
125253869|NCT04744831|450556898|FG002|Overall Study|Other|1|||
125253870|NCT04744831|450556896|FG000|Overall Study|Death|0|||
125253871|NCT04744831|450556897|FG001|Overall Study|Death|2|||
125253872|NCT04744831|450556898|FG002|Overall Study|Death|1|||
125253873|NCT04616196|450556908|FG000|Overall Study|Progressive Disease|3|||
125253874|NCT04616196|450556909|FG001|Overall Study|Progressive Disease|0|||
125253875|NCT04616196|450556910|FG002|Overall Study|Progressive Disease|4|||
125253876|NCT04616196|450556911|FG003|Overall Study|Progressive Disease|1|||
125253877|NCT04616196|450556908|FG000|Overall Study|Death|2|||
125253878|NCT04616196|450556909|FG001|Overall Study|Death|4|||
125253879|NCT04616196|450556910|FG002|Overall Study|Death|1|||
125253880|NCT04616196|450556911|FG003|Overall Study|Death|0|||
125253881|NCT04616196|450556908|FG000|Overall Study|Withdrawal by Subject|0|||
125253882|NCT04616196|450556909|FG001|Overall Study|Withdrawal by Subject|2|||
125253883|NCT04616196|450556910|FG002|Overall Study|Withdrawal by Subject|0|||
125253884|NCT04616196|450556911|FG003|Overall Study|Withdrawal by Subject|0|||
125253885|NCT04616196|450556908|FG000|Overall Study|Lost to Follow-up|1|||
125253886|NCT04616196|450556909|FG001|Overall Study|Lost to Follow-up|0|||
125253887|NCT04616196|450556910|FG002|Overall Study|Lost to Follow-up|0|||
125253888|NCT04616196|450556911|FG003|Overall Study|Lost to Follow-up|0|||
125253889|NCT04616196|450556908|FG000|Overall Study|Sponsor request|2|||
125253890|NCT04616196|450556909|FG001|Overall Study|Sponsor request|1|||
125253891|NCT04616196|450556910|FG002|Overall Study|Sponsor request|1|||
125253892|NCT04616196|450556911|FG003|Overall Study|Sponsor request|2|||
125253893|NCT05401409|450556912|FG000|Overall Study|Lost to Follow-up|1|||
125253894|NCT05401409|450556913|FG001|Overall Study|Lost to Follow-up|0|||
125253895|NCT02371889|450556914|FG000|Overall Study|Adverse medication effect|11|||
125253896|NCT02371889|450556915|FG001|Overall Study|Adverse medication effect|2|||
125253897|NCT02371889|450556914|FG000|Overall Study|Lost to Follow-up|6|||
125253898|NCT02371889|450556915|FG001|Overall Study|Lost to Follow-up|5|||
125253899|NCT02371889|450556914|FG000|Overall Study|Personal time constraints|2|||
125253900|NCT02371889|450556915|FG001|Overall Study|Personal time constraints|4|||
125253901|NCT02371889|450556914|FG000|Overall Study|Lack of Efficacy|0|||
125253902|NCT02371889|450556915|FG001|Overall Study|Lack of Efficacy|2|||
125253903|NCT02371889|450556914|FG000|Overall Study|Relapse|0|||
125253904|NCT02371889|450556915|FG001|Overall Study|Relapse|1|||
125253905|NCT05520333|450556916|FG000|Overall Study|Lost to Follow-up|3|||
125253906|NCT05520333|450556917|FG001|Overall Study|Lost to Follow-up|6|||
125253907|NCT02579759|450556918|FG000|Overall Study|Protocol Violation|2|||
125253908|NCT02579759|450556919|FG001|Overall Study|Protocol Violation|0|||
125253909|NCT02579759|450556920|FG002|Overall Study|Protocol Violation|0|||
125253910|NCT02579759|450556918|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
125253911|NCT02579759|450556919|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
125253912|NCT02579759|450556920|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
125253913|NCT02579759|450556918|FG000|Overall Study|BfArM hold|13|||
125253914|NCT02579759|450556919|FG001|Overall Study|BfArM hold|12|||
125253915|NCT02579759|450556920|FG002|Overall Study|BfArM hold|12|||
125253916|NCT02579759|450556918|FG000|Overall Study|Sponsor stopped Dose 2|0|||
125253917|NCT02579759|450556919|FG001|Overall Study|Sponsor stopped Dose 2|41|||
125253918|NCT02579759|450556920|FG002|Overall Study|Sponsor stopped Dose 2|0|||
125253919|NCT02579759|450556918|FG000|Overall Study|Non compliance|0|||
125253920|NCT02579759|450556919|FG001|Overall Study|Non compliance|1|||
125253921|NCT02579759|450556920|FG002|Overall Study|Non compliance|0|||
125253922|NCT02579759|450556918|FG000|Overall Study|Pregnancy|0|||
125253923|NCT02579759|450556919|FG001|Overall Study|Pregnancy|1|||
125253924|NCT02579759|450556920|FG002|Overall Study|Pregnancy|0|||
125253925|NCT02579759|450556918|FG000|Overall Study|Inclusion/exclusion criteria|0|||
125253926|NCT02579759|450556919|FG001|Overall Study|Inclusion/exclusion criteria|0|||
125253927|NCT02579759|450556920|FG002|Overall Study|Inclusion/exclusion criteria|1|||
125253928|NCT02579759|450556918|FG000|Overall Study|Adverse Event|4|||
125253929|NCT02579759|450556919|FG001|Overall Study|Adverse Event|3|||
125253930|NCT02579759|450556920|FG002|Overall Study|Adverse Event|1|||
125253931|NCT02579759|450556918|FG000|Overall Study|Withdrawal by Subject|3|||
125253932|NCT02579759|450556919|FG001|Overall Study|Withdrawal by Subject|3|||
125253933|NCT02579759|450556920|FG002|Overall Study|Withdrawal by Subject|5|||
125253934|NCT02579759|450556918|FG000|Overall Study|Lost to Follow-up|2|||
125253935|NCT02579759|450556919|FG001|Overall Study|Lost to Follow-up|2|||
125253936|NCT02579759|450556920|FG002|Overall Study|Lost to Follow-up|2|||
125253937|NCT02410200|450556923|FG000|Overall Study|Adverse Event|2|||
125253938|NCT03412591|450556924|FG000|Overall Study|Withdrawal by Subject|1|||
125253939|NCT03412591|450556925|FG001|Overall Study|Withdrawal by Subject|8|||
125253940|NCT03412591|450556924|FG000|Overall Study|Adverse Event|0|||
125253941|NCT03412591|450556925|FG001|Overall Study|Adverse Event|1|||
125253942|NCT00814983|450556926|FG000|Overall Study|Screen failure|1|||
125253943|NCT00814983|450556927|FG001|Overall Study|Screen failure|0|||
125253944|NCT00814983|450556926|FG000|Overall Study|Withdrawal by Subject|1|||
125253945|NCT00814983|450556927|FG001|Overall Study|Withdrawal by Subject|0|||
125253946|NCT00814983|450556926|FG000|Overall Study|Graft failure|1|||
125253947|NCT00814983|450556927|FG001|Overall Study|Graft failure|0|||
125253948|NCT04157738|450556928|FG000|Overall Study|Moved out of state|0|||
125253949|NCT04157738|450556929|FG001|Overall Study|Moved out of state|2|||
125253950|NCT04157738|450556928|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
125253951|NCT04157738|450556929|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
125253952|NCT00160563|450556930|FG000|Overall Study|Adverse Event|1|||
125253953|NCT00160563|450556931|FG001|Overall Study|Adverse Event|1|||
125253954|NCT00160563|450556932|FG002|Overall Study|Adverse Event|1|||
125253955|NCT00160563|450556930|FG000|Overall Study|Lost to Follow-up|1|||
125253956|NCT00160563|450556931|FG001|Overall Study|Lost to Follow-up|1|||
125253957|NCT00160563|450556932|FG002|Overall Study|Lost to Follow-up|2|||
125253958|NCT00160563|450556930|FG000|Overall Study|Protocol Violation|0|||
125253959|NCT00160563|450556931|FG001|Overall Study|Protocol Violation|0|||
125253960|NCT00160563|450556932|FG002|Overall Study|Protocol Violation|3|||
125253961|NCT00160563|450556930|FG000|Overall Study|Withdrawal by Subject|1|||
125396942|NCT00192075|451086894|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
125396943|NCT00192075|451086895|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
125396944|NCT00192075|451086894|FG000|Overall Study|Other|5|||
125396945|NCT00192075|451086895|FG001|Overall Study|Other|2|||
125396946|NCT00779675|451086896|FG000|Treatment Period|Adverse Event|87|||
125396947|NCT00779675|451086896|FG000|Treatment Period|Treatment Failure|80|||
125396948|NCT00779675|451086896|FG000|Treatment Period|Transferred to Another Study|38|||
125396949|NCT00779675|451086896|FG000|Treatment Period|Lost to Follow-up|23|||
125396950|NCT00779675|451086896|FG000|Treatment Period|Withdrawal by Subject|46|||
125396951|NCT00779675|451086896|FG000|Treatment Period|Protocol Violation|54|||
125396952|NCT00779675|451086896|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
125396953|NCT00779675|451086896|FG000|Treatment Period|Administrative|3|||
125396954|NCT00779675|451086896|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
125396955|NCT00779675|451086896|FG000|Extended Treatment Period|Protocol Violation|13|||
125396956|NCT00779675|451086896|FG000|Extended Treatment Period|Adverse Event|6|||
125396957|NCT00779675|451086896|FG000|Extended Treatment Period|Treatment Failure|11|||
125396958|NCT00779675|451086896|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
125396959|NCT00779675|451086896|FG000|Extended Treatment Period|Lost to Follow-up|6|||
125396960|NCT02821962|451086899|FG000|Overall Study|Lost to Follow-up|2|||
125396961|NCT02821962|451086900|FG001|Overall Study|Lost to Follow-up|0|||
125396962|NCT00355238|451086908|FG000|Overall Study|Adverse event unrelated to study drug|2|||
125396963|NCT00355238|451086909|FG001|Overall Study|Adverse event unrelated to study drug|2|||
125396964|NCT00355238|451086910|FG002|Overall Study|Adverse event unrelated to study drug|0|||
125396965|NCT00355238|451086911|FG003|Overall Study|Adverse event unrelated to study drug|1|||
125396966|NCT00355238|451086908|FG000|Overall Study|Death|1|||
125396967|NCT00355238|451086909|FG001|Overall Study|Death|0|||
125396968|NCT00355238|451086910|FG002|Overall Study|Death|0|||
125396969|NCT00355238|451086911|FG003|Overall Study|Death|0|||
125396970|NCT00355238|451086908|FG000|Overall Study|Disease progression|37|||
125396971|NCT00355238|451086909|FG001|Overall Study|Disease progression|36|||
125396972|NCT00355238|451086910|FG002|Overall Study|Disease progression|16|||
125396973|NCT00355238|451086911|FG003|Overall Study|Disease progression|11|||
125396974|NCT00355238|451086908|FG000|Overall Study|Study drug toxicity|11|||
125396975|NCT00355238|451086909|FG001|Overall Study|Study drug toxicity|7|||
125396976|NCT00355238|451086910|FG002|Overall Study|Study drug toxicity|5|||
125396977|NCT00355238|451086911|FG003|Overall Study|Study drug toxicity|2|||
125396978|NCT00355238|451086908|FG000|Overall Study|Participant withdrew consent|3|||
125396979|NCT00355238|451086909|FG001|Overall Study|Participant withdrew consent|1|||
125396980|NCT00355238|451086910|FG002|Overall Study|Participant withdrew consent|0|||
125396981|NCT00355238|451086911|FG003|Overall Study|Participant withdrew consent|0|||
125396982|NCT00355238|451086908|FG000|Overall Study|Participant request to discontinue study treatment|1|||
125396983|NCT00355238|451086909|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125396984|NCT00355238|451086910|FG002|Overall Study|Participant request to discontinue study treatment|1|||
125396985|NCT00355238|451086911|FG003|Overall Study|Participant request to discontinue study treatment|0|||
125396986|NCT00910715|451086918|FG000|Overall Study|Lost to Follow-up|22|||
125396987|NCT00910715|451086919|FG001|Overall Study|Lost to Follow-up|26|||
125396988|NCT00910715|451086920|FG002|Overall Study|Lost to Follow-up|0|||
125396989|NCT03795610|451086922|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
125396990|NCT03795610|451086922|FG000|Overall Study|Withdrawal by Subject|1|||
125396991|NCT03795610|451086922|FG000|Overall Study|Screen Failure (Unknown)|1|||
125396992|NCT04098458|451086946|FG000|Overall Study|Death|1|||
125396993|NCT04098458|451086946|FG000|Overall Study|did not meet study inclusion criteria|3|||
125396994|NCT00006489|451086947|FG000|Overall Study|Adverse Event|3|||
125396995|NCT00006489|451086948|FG001|Overall Study|Adverse Event|2|||
125396996|NCT00006489|451086949|FG002|Overall Study|Adverse Event|4|||
125396997|NCT00006489|451086950|FG003|Overall Study|Adverse Event|3|||
125396998|NCT00006489|451086947|FG000|Overall Study|Withdrawal by Subject|10|||
125396999|NCT00006489|451086948|FG001|Overall Study|Withdrawal by Subject|9|||
125397000|NCT00006489|451086949|FG002|Overall Study|Withdrawal by Subject|9|||
125397001|NCT00006489|451086950|FG003|Overall Study|Withdrawal by Subject|6|||
125397002|NCT00006489|451086947|FG000|Overall Study|Scheduling Conflict|0|||
125397003|NCT00006489|451086948|FG001|Overall Study|Scheduling Conflict|3|||
125397004|NCT00006489|451086949|FG002|Overall Study|Scheduling Conflict|2|||
125397005|NCT00006489|451086950|FG003|Overall Study|Scheduling Conflict|1|||
125397006|NCT00006489|451086947|FG000|Overall Study|Death|0|||
125397007|NCT00006489|451086948|FG001|Overall Study|Death|0|||
125397008|NCT00006489|451086949|FG002|Overall Study|Death|0|||
125397009|NCT00006489|451086950|FG003|Overall Study|Death|1|||
125397010|NCT03762083|451086951|FG000|Overall Study|Withdrawal by Subject|2|||
125397011|NCT03762083|451086951|FG000|Overall Study|Physician Decision|1|||
125397012|NCT00116558|451086952|FG000|Overall Study|Death|11|||
125253962|NCT00160563|450556931|FG001|Overall Study|Withdrawal by Subject|2|||
125253963|NCT00160563|450556932|FG002|Overall Study|Withdrawal by Subject|3|||
125253964|NCT00160563|450556930|FG000|Overall Study|Other (listed in the study report)|48|||
125253965|NCT00160563|450556931|FG001|Overall Study|Other (listed in the study report)|40|||
125253966|NCT00160563|450556932|FG002|Overall Study|Other (listed in the study report)|81|||
125253967|NCT00160563|450556930|FG000|Overall Study|Missing reason|0|||
125253968|NCT00160563|450556931|FG001|Overall Study|Missing reason|1|||
125253969|NCT00160563|450556932|FG002|Overall Study|Missing reason|0|||
125253970|NCT00347269|450556938|FG000|Overall Study|Lost to Follow-up|74|||
125253971|NCT00347269|450556939|FG001|Overall Study|Lost to Follow-up|65|||
125253972|NCT00347269|450556938|FG000|Overall Study|Withdrawal by Subject|18|||
125253973|NCT00347269|450556939|FG001|Overall Study|Withdrawal by Subject|38|||
125253974|NCT00347269|450556938|FG000|Overall Study|Death|2|||
125253975|NCT00347269|450556939|FG001|Overall Study|Death|3|||
125253976|NCT00456365|450556953|FG000|Overall Study|Lost to Follow-up|1|||
125253977|NCT00456365|450556954|FG001|Overall Study|Lost to Follow-up|3|||
125253978|NCT00456365|450556953|FG000|Overall Study|Withdrawal by Subject|4|||
125253979|NCT00456365|450556954|FG001|Overall Study|Withdrawal by Subject|7|||
125253980|NCT00456365|450556953|FG000|Overall Study|Pregnancy|1|||
125253981|NCT00456365|450556954|FG001|Overall Study|Pregnancy|1|||
125253982|NCT00456365|450556953|FG000|Overall Study|oncologic diagnosis|1|||
125253983|NCT00456365|450556954|FG001|Overall Study|oncologic diagnosis|1|||
125253984|NCT05451329|450556955|FG000|Overall Study|Adverse Event|1|||
125253985|NCT05451329|450556956|FG001|Overall Study|Adverse Event|1|||
125253986|NCT05451329|450556957|FG002|Overall Study|Adverse Event|0|||
125253987|NCT05451329|450556955|FG000|Overall Study|Withdrawal by Subject|1|||
125253988|NCT05451329|450556956|FG001|Overall Study|Withdrawal by Subject|0|||
125253989|NCT05451329|450556957|FG002|Overall Study|Withdrawal by Subject|0|||
125253990|NCT05451329|450556955|FG000|Overall Study|Investigational Product Lot exchange|1|||
125253991|NCT05451329|450556956|FG001|Overall Study|Investigational Product Lot exchange|1|||
125253992|NCT05451329|450556957|FG002|Overall Study|Investigational Product Lot exchange|0|||
125253993|NCT02202577|450556958|FG000|Overall Study|Lost to Follow-up|6|||
125253994|NCT02202577|450556959|FG001|Overall Study|Lost to Follow-up|16|||
125253995|NCT02202577|450556958|FG000|Overall Study|Protocol Violation|7|||
125253996|NCT02202577|450556959|FG001|Overall Study|Protocol Violation|3|||
125253997|NCT00069953|450556960|FG000|Overall Study|Protocol Violation|2|||
125253998|NCT02034565|450556961|FG000|Overall Study|Adverse Event|1|||
125253999|NCT02034565|450556962|FG001|Overall Study|Adverse Event|0|||
125254000|NCT00113373|450556963|FG000|Overall Study|Ineligible: wrong primary|1|||
125254001|NCT00113373|450556963|FG000|Overall Study|Ineligible: second primary|1|||
125254002|NCT00113373|450556963|FG000|Overall Study|Never Treated|1|||
125254003|NCT00829868|450556964|FG000|Washout|Physician Decision|1|||
125254004|NCT00829868|450556965|FG001|Washout|Physician Decision|0|||
125254005|NCT02799043|450556967|FG000|Overall Study|Adverse Event|0|||
125254006|NCT02799043|450556968|FG001|Overall Study|Adverse Event|1|||
125254007|NCT02799043|450556967|FG000|Overall Study|Death|1|||
125254008|NCT02799043|450556968|FG001|Overall Study|Death|1|||
125254009|NCT02799043|450556967|FG000|Overall Study|Lost to Follow-up|3|||
125254010|NCT02799043|450556968|FG001|Overall Study|Lost to Follow-up|6|||
125254011|NCT02799043|450556967|FG000|Overall Study|Withdrawal by Subject|4|||
125254012|NCT02799043|450556968|FG001|Overall Study|Withdrawal by Subject|4|||
125254013|NCT02799043|450556967|FG000|Overall Study|Moved to different country|0|||
125254014|NCT02799043|450556968|FG001|Overall Study|Moved to different country|1|||
125254015|NCT02799043|450556967|FG000|Overall Study|Trial Screen Failure|1|||
125254016|NCT02799043|450556968|FG001|Overall Study|Trial Screen Failure|0|||
125254017|NCT02799043|450556967|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
125254018|NCT02799043|450556968|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
125254019|NCT01848457|450556973|FG000|Overall Study|Death|1|||
125254020|NCT01848457|450556974|FG001|Overall Study|Death|0|||
125254021|NCT01848457|450556975|FG002|Overall Study|Death|0|||
125254022|NCT01848457|450556976|FG003|Overall Study|Death|0|||
125254023|NCT00803049|450556977|FG000|Overall Study|Adverse Event|21|||
125254024|NCT00803049|450556978|FG001|Overall Study|Adverse Event|33|||
125254025|NCT00803049|450556979|FG002|Overall Study|Adverse Event|13|||
125254026|NCT00803049|450556980|FG003|Overall Study|Adverse Event|27|||
125254027|NCT00803049|450556977|FG000|Overall Study|Lack of Efficacy|10|||
125254028|NCT00803049|450556978|FG001|Overall Study|Lack of Efficacy|19|||
125254029|NCT00803049|450556979|FG002|Overall Study|Lack of Efficacy|6|||
125254030|NCT00803049|450556980|FG003|Overall Study|Lack of Efficacy|13|||
125254031|NCT00803049|450556977|FG000|Overall Study|Lost to Follow-up|0|||
125254032|NCT00803049|450556978|FG001|Overall Study|Lost to Follow-up|2|||
125254033|NCT00803049|450556979|FG002|Overall Study|Lost to Follow-up|0|||
125254034|NCT00803049|450556980|FG003|Overall Study|Lost to Follow-up|3|||
125254035|NCT00803049|450556977|FG000|Overall Study|Death|2|||
125397013|NCT00116558|451086953|FG001|Overall Study|Death|5|||
125254036|NCT00803049|450556978|FG001|Overall Study|Death|1|||
125254037|NCT00803049|450556979|FG002|Overall Study|Death|0|||
125254038|NCT00803049|450556980|FG003|Overall Study|Death|2|||
125254039|NCT00803049|450556977|FG000|Overall Study|Progressive Disease|6|||
125397014|NCT00116558|451086954|FG002|Overall Study|Death|3|||
125254040|NCT00803049|450556978|FG001|Overall Study|Progressive Disease|10|||
125254041|NCT00803049|450556979|FG002|Overall Study|Progressive Disease|6|||
125254042|NCT00803049|450556980|FG003|Overall Study|Progressive Disease|6|||
125254043|NCT00803049|450556977|FG000|Overall Study|Withdrawal by Subject|19|||
125254044|NCT00803049|450556978|FG001|Overall Study|Withdrawal by Subject|43|||
125254045|NCT00803049|450556979|FG002|Overall Study|Withdrawal by Subject|16|||
125254046|NCT00803049|450556980|FG003|Overall Study|Withdrawal by Subject|44|||
125254047|NCT00803049|450556977|FG000|Overall Study|Protocol Violation|0|||
125254048|NCT00803049|450556978|FG001|Overall Study|Protocol Violation|1|||
125254049|NCT00803049|450556979|FG002|Overall Study|Protocol Violation|1|||
125254050|NCT00803049|450556980|FG003|Overall Study|Protocol Violation|0|||
125254051|NCT00803049|450556977|FG000|Overall Study|Randomized and Not Treated|0|||
125254052|NCT00803049|450556978|FG001|Overall Study|Randomized and Not Treated|0|||
125254053|NCT00803049|450556979|FG002|Overall Study|Randomized and Not Treated|0|||
125254054|NCT00803049|450556980|FG003|Overall Study|Randomized and Not Treated|2|||
125254055|NCT00803049|450556977|FG000|Overall Study|Other than Specified Above|3|||
125254056|NCT00803049|450556978|FG001|Overall Study|Other than Specified Above|9|||
125254057|NCT00803049|450556979|FG002|Overall Study|Other than Specified Above|2|||
125254058|NCT00803049|450556980|FG003|Overall Study|Other than Specified Above|5|||
125254059|NCT01421459|450556981|FG000|Overall Study|Adverse Event|6|||
125254060|NCT01421459|450556982|FG001|Overall Study|Adverse Event|10|||
125254061|NCT01421459|450556981|FG000|Overall Study|Death|1|||
125254062|NCT01421459|450556982|FG001|Overall Study|Death|1|||
125254063|NCT01421459|450556981|FG000|Overall Study|Lack of Efficacy|1|||
125254064|NCT01421459|450556982|FG001|Overall Study|Lack of Efficacy|2|||
125254065|NCT01421459|450556981|FG000|Overall Study|Lost to Follow-up|8|||
125254066|NCT01421459|450556982|FG001|Overall Study|Lost to Follow-up|9|||
125254067|NCT01421459|450556981|FG000|Overall Study|Physician Decision|9|||
125254068|NCT01421459|450556982|FG001|Overall Study|Physician Decision|9|||
125254069|NCT01421459|450556981|FG000|Overall Study|Protocol Violation|8|||
125254070|NCT01421459|450556982|FG001|Overall Study|Protocol Violation|5|||
125254071|NCT01421459|450556981|FG000|Overall Study|Withdrawal by Subject|12|||
125254072|NCT01421459|450556982|FG001|Overall Study|Withdrawal by Subject|16|||
125254073|NCT04439903|450556993|FG000|Overall Study|Withdrawal by Subject|2|||
125254074|NCT04439903|450556993|FG000|Overall Study|Screen Failure|1|||
125254075|NCT04003142|450556998|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
125254076|NCT04003142|450556999|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
125254077|NCT04003142|450557000|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
125254078|NCT04003142|450557001|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
125254079|NCT04003142|450557002|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
125254080|NCT04003142|450556998|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
125254081|NCT04003142|450556999|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
125254082|NCT04003142|450557000|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
125254083|NCT04003142|450557001|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
125254084|NCT04003142|450557002|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
125254085|NCT04003142|450556998|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
125254086|NCT04003142|450556999|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
125254087|NCT04003142|450557000|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
125254088|NCT04003142|450557001|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
125254089|NCT04003142|450557002|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
125254090|NCT04003142|450556998|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
125254091|NCT04003142|450556999|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
125254092|NCT04003142|450557000|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
125254093|NCT04003142|450557001|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
125254094|NCT04003142|450557002|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
125254095|NCT04003142|450556998|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
125254096|NCT04003142|450556999|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
125254097|NCT04003142|450557000|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
125254098|NCT04003142|450557001|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
125254099|NCT04003142|450557002|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
125254100|NCT04003142|450556998|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
125254101|NCT04003142|450556999|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
125254102|NCT04003142|450557000|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
125254103|NCT04003142|450557001|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
125254104|NCT04003142|450557002|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
125254105|NCT04003142|450556998|FG000|Extension Period (40 Weeks)|Death|0|||
125254106|NCT04003142|450556999|FG001|Extension Period (40 Weeks)|Death|0|||
125254107|NCT04003142|450557000|FG002|Extension Period (40 Weeks)|Death|0|||
125254108|NCT04003142|450557001|FG003|Extension Period (40 Weeks)|Death|0|||
125254109|NCT04003142|450557002|FG004|Extension Period (40 Weeks)|Death|1|||
125254110|NCT04003142|450556998|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
125254111|NCT04003142|450556999|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
125254112|NCT04003142|450557000|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
125254113|NCT04003142|450557001|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
125254114|NCT04003142|450557002|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
125254115|NCT04003142|450556998|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
125254116|NCT04003142|450556999|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
125254117|NCT04003142|450557000|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
125254118|NCT04003142|450557001|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
125254119|NCT04003142|450557002|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
125254120|NCT04003142|450556998|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
125254121|NCT04003142|450556999|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
125254122|NCT04003142|450557000|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
125254123|NCT04003142|450557001|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
125254124|NCT04003142|450557002|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
125254125|NCT04003142|450556998|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
125254126|NCT04003142|450556999|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
125254127|NCT04003142|450557000|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
125254128|NCT04003142|450557001|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
125254129|NCT04003142|450557002|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
125254130|NCT04042311|450557003|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
125254131|NCT04042311|450557003|FG000|Overall Study|Unable to tolerate|4|||
125254132|NCT04042311|450557003|FG000|Overall Study|Concurrent illness|2|||
125254133|NCT04042311|450557003|FG000|Overall Study|Adverse Event|2|||
125254134|NCT04042311|450557003|FG000|Overall Study|No longer meeting inclusion criteria|2|||
125254135|NCT04042311|450557003|FG000|Overall Study|No reason given|1|||
125254136|NCT04042311|450557003|FG000|Overall Study|Withdrawal by Subject|4|||
125254137|NCT03382873|450557004|FG000|Overall Study|Lost to Follow-up|9|||
125254138|NCT03382873|450557005|FG001|Overall Study|Lost to Follow-up|10|||
125254139|NCT03382873|450557004|FG000|Overall Study|Withdrawal by Subject|6|||
125254140|NCT03382873|450557005|FG001|Overall Study|Withdrawal by Subject|11|||
125254141|NCT03382873|450557004|FG000|Overall Study|Visit not completed due to pandemic|16|||
125254142|NCT03382873|450557005|FG001|Overall Study|Visit not completed due to pandemic|41|||
125254143|NCT03996395|450557008|FG000|Overall Study|Lost to Follow-up|4|||
125254144|NCT03996395|450557008|FG000|Overall Study|Withdrawal by Subject|1|||
125444388|NCT01474512|451253890|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
125254145|NCT03996395|450557008|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
125254146|NCT02061085|450557011|FG000|Overall Study|Adverse Event|8|||
125254147|NCT03247673|450557012|FG000|Overall Study|Withdrawal by Subject|1|||
125254148|NCT03247673|450557013|FG001|Overall Study|Withdrawal by Subject|0|||
125254149|NCT03247673|450557014|FG002|Overall Study|Withdrawal by Subject|3|||
125254150|NCT03247673|450557012|FG000|Overall Study|Lost to Follow-up|0|||
125254151|NCT03247673|450557013|FG001|Overall Study|Lost to Follow-up|0|||
125254152|NCT03247673|450557014|FG002|Overall Study|Lost to Follow-up|1|||
125254153|NCT02097225|450557015|FG000|Dose Level 4|Adverse Event|0|||
125254154|NCT02097225|450557016|FG001|Dose Level 4|Adverse Event|0|||
125254155|NCT02097225|450557017|FG002|Dose Level 4|Adverse Event|0|||
125254156|NCT02097225|450557018|FG003|Dose Level 4|Adverse Event|0|||
125254157|NCT02097225|450557019|FG004|Dose Level 4|Adverse Event|1|||
125254158|NCT01027351|450557021|FG000|Overall Study|Withdrawal by Subject|1|||
125254159|NCT01027351|450557022|FG001|Overall Study|Withdrawal by Subject|0|||
125254160|NCT01027351|450557023|FG002|Overall Study|Withdrawal by Subject|1|||
125254161|NCT01027351|450557024|FG003|Overall Study|Withdrawal by Subject|0|||
125254162|NCT01027351|450557025|FG004|Overall Study|Withdrawal by Subject|3|||
125254163|NCT01027351|450557026|FG005|Overall Study|Withdrawal by Subject|5|||
125254164|NCT01027351|450557021|FG000|Overall Study|Lost to Follow-up|1|||
125254165|NCT01027351|450557022|FG001|Overall Study|Lost to Follow-up|1|||
125254166|NCT01027351|450557023|FG002|Overall Study|Lost to Follow-up|0|||
125254167|NCT01027351|450557024|FG003|Overall Study|Lost to Follow-up|1|||
125254168|NCT01027351|450557025|FG004|Overall Study|Lost to Follow-up|6|||
125254169|NCT01027351|450557026|FG005|Overall Study|Lost to Follow-up|0|||
125254170|NCT01027351|450557021|FG000|Overall Study|Inappropriate enrollment|0|||
125254171|NCT01027351|450557022|FG001|Overall Study|Inappropriate enrollment|0|||
125254172|NCT01027351|450557023|FG002|Overall Study|Inappropriate enrollment|0|||
125254173|NCT01027351|450557024|FG003|Overall Study|Inappropriate enrollment|0|||
125254174|NCT01027351|450557025|FG004|Overall Study|Inappropriate enrollment|1|||
125254175|NCT01027351|450557026|FG005|Overall Study|Inappropriate enrollment|0|||
125254176|NCT01027351|450557021|FG000|Overall Study|Protocol Violation|1|||
125254177|NCT01027351|450557022|FG001|Overall Study|Protocol Violation|0|||
125254178|NCT01027351|450557023|FG002|Overall Study|Protocol Violation|0|||
125254179|NCT01027351|450557024|FG003|Overall Study|Protocol Violation|1|||
125254180|NCT01027351|450557025|FG004|Overall Study|Protocol Violation|1|||
125444389|NCT01474512|451253891|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
125444390|NCT01474512|451253892|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
125254181|NCT01027351|450557026|FG005|Overall Study|Protocol Violation|0|||
125254182|NCT02757963|450557027|FG000|Overall Study|Adverse Event|3|||
125254183|NCT02757963|450557027|FG000|Overall Study|Reached Stopping Criteria|1054|||
125254184|NCT02757963|450557027|FG000|Overall Study|Lost to Follow-up|5|||
125254185|NCT02757963|450557027|FG000|Overall Study|Physician Decision|1|||
125254186|NCT02757963|450557027|FG000|Overall Study|Withdrawal by Subject|34|||
125254187|NCT02971137|450557028|FG000|Overall Study|Lost to Follow-up|44|||
125254188|NCT02971137|450557029|FG001|Overall Study|Lost to Follow-up|56|||
125254189|NCT00911157|450557030|FG000|Overall Study|Adverse Event|4|||
125254190|NCT00911157|450557031|FG001|Overall Study|Adverse Event|1|||
125254191|NCT00911157|450557030|FG000|Overall Study|Withdrawal by Subject|1|||
125254192|NCT00911157|450557031|FG001|Overall Study|Withdrawal by Subject|1|||
125254193|NCT00911157|450557030|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
125254194|NCT00911157|450557031|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
125254195|NCT00911157|450557030|FG000|Overall Study|Need to treat for lung cancer|1|||
125254196|NCT00911157|450557031|FG001|Overall Study|Need to treat for lung cancer|0|||
125254197|NCT04755231|450557032|FG000|Overall Study|Lost to Follow-up|5|||
125254198|NCT04755231|450557032|FG000|Overall Study|Withdrawal by Subject|5|||
125254199|NCT04650893|450557033|FG000|Overall Study|Lost to Follow-up|11|||
125254200|NCT04650893|450557034|FG001|Overall Study|Lost to Follow-up|10|||
125254201|NCT04650893|450557035|FG002|Overall Study|Lost to Follow-up|11|||
125254202|NCT05346640|450557043|FG000|Overall Study|Lack of Efficacy|2|||
125254203|NCT05346640|450557043|FG000|Overall Study|Lost to Follow-up|14|||
125254204|NCT05346640|450557043|FG000|Overall Study|Protocol Violation|4|||
125254205|NCT05346640|450557043|FG000|Overall Study|Withdrawal by Subject|2|||
125254206|NCT05346640|450557043|FG000|Overall Study|Physiological Complications|3|||
125254207|NCT05346640|450557043|FG000|Overall Study|Other Reason|3|||
125254208|NCT01197300|450558950|FG000|Overall Study|Lost to Follow-up|0|||
125254209|NCT01197300|450558951|FG001|Overall Study|Lost to Follow-up|1|||
125254210|NCT01197300|450558950|FG000|Overall Study|Protocol Violation|0|||
125254211|NCT01197300|450558951|FG001|Overall Study|Protocol Violation|1|||
125254212|NCT02113878|450558952|FG000|Overall Study|Adverse Event|1|||
125254213|NCT02113878|450558953|FG001|Overall Study|Adverse Event|0|||
125254214|NCT02113878|450558952|FG000|Overall Study|Withdrawal by Subject|1|||
125254215|NCT02113878|450558953|FG001|Overall Study|Withdrawal by Subject|0|||
125254216|NCT02113878|450558952|FG000|Overall Study|patient non-compliance|1|||
125254217|NCT02113878|450558953|FG001|Overall Study|patient non-compliance|0|||
125254218|NCT04129398|450558956|FG000|Overall Study|Physician Decision|2|||
125254219|NCT03058952|450558957|FG000|Overall Study|Adverse Event|1|||
125254220|NCT03058952|450558958|FG001|Overall Study|Adverse Event|0|||
125254221|NCT03058952|450558957|FG000|Overall Study|Lost to Follow-up|15|||
125254222|NCT03058952|450558958|FG001|Overall Study|Lost to Follow-up|15|||
125254223|NCT03058952|450558957|FG000|Overall Study|Withdrawal by Subject|7|||
125254224|NCT03058952|450558958|FG001|Overall Study|Withdrawal by Subject|11|||
125254225|NCT03837509|450558961|FG000|Phase 1|Death|5|||
125254226|NCT03837509|450558962|FG001|Phase 1|Death|2|||
125254227|NCT03837509|450558963|FG002|Phase 1|Death|0|||
125254228|NCT03837509|450558964|FG003|Phase 1|Death|0|||
125254229|NCT03837509|450558965|FG004|Phase 1|Death|0|||
125254230|NCT03837509|450558961|FG000|Phase 2|Death|0|||
125254231|NCT03837509|450558962|FG001|Phase 2|Death|0|||
125254232|NCT03837509|450558963|FG002|Phase 2|Death|0|||
125254233|NCT03837509|450558964|FG003|Phase 2|Death|1|||
125254234|NCT03837509|450558965|FG004|Phase 2|Death|1|||
125254235|NCT01251965|450558966|FG000|Overall Study|Participant/physician decision|1|||
125254236|NCT01251965|450558967|FG001|Overall Study|Participant/physician decision|2|||
125254237|NCT01251965|450558968|FG002|Overall Study|Participant/physician decision|0|||
125254238|NCT01251965|450558966|FG000|Overall Study|Death|0|||
125254239|NCT01251965|450558967|FG001|Overall Study|Death|0|||
125254240|NCT01251965|450558968|FG002|Overall Study|Death|11|||
125254241|NCT02363283|450558969|FG000|Overall Study|Withdrawal by Subject|1|||
125254242|NCT02363283|450558969|FG000|Overall Study|Not eligible due to transaminitis|1|||
125254243|NCT00530257|450558975|FG000|Overall Study|Lost to Follow-up|1|||
125254244|NCT01897896|450558976|FG000|Overall Study|Death|1|||
125254245|NCT01897896|450558977|FG001|Overall Study|Death|0|||
125254246|NCT01897896|450558976|FG000|Overall Study|Adverse Event|11|||
125254247|NCT01897896|450558977|FG001|Overall Study|Adverse Event|1|||
125254248|NCT01897896|450558976|FG000|Overall Study|Lost to Follow-up|1|||
125254249|NCT01897896|450558977|FG001|Overall Study|Lost to Follow-up|0|||
125254250|NCT01897896|450558976|FG000|Overall Study|Non-compliance with study drug dosing|1|||
125254251|NCT01897896|450558977|FG001|Overall Study|Non-compliance with study drug dosing|1|||
125254252|NCT01897896|450558976|FG000|Overall Study|Withdrawal by Subject|7|||
125254253|NCT01897896|450558977|FG001|Overall Study|Withdrawal by Subject|1|||
125254254|NCT01897896|450558976|FG000|Overall Study|Require drug that interfere with study|1|||
125254255|NCT01897896|450558977|FG001|Overall Study|Require drug that interfere with study|4|||
125254256|NCT01897896|450558976|FG000|Overall Study|Protocol Violation|1|||
125254257|NCT01897896|450558977|FG001|Overall Study|Protocol Violation|1|||
125254258|NCT01897896|450558976|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
125254259|NCT01897896|450558977|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
125254260|NCT01897896|450558976|FG000|Overall Study|Caregiver can no longer participate|0|||
125254261|NCT01897896|450558977|FG001|Overall Study|Caregiver can no longer participate|2|||
125254262|NCT01897896|450558976|FG000|Overall Study|Other than specified|2|||
125254263|NCT01897896|450558977|FG001|Overall Study|Other than specified|1|||
125254264|NCT02801578|450558996|FG000|Overall Study|Adverse Event|2|||
125254265|NCT00668642|450558997|FG000|First Off-cycle|Cancer progression|1|||
125254266|NCT00668642|450558998|FG001|First Off-cycle|Cancer progression|0|||
125254267|NCT00668642|450558997|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
125254268|NCT00668642|450558998|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
125254269|NCT02003898|450558999|FG000|Overall Study|Death|3|||
125254270|NCT02003898|450558999|FG000|Overall Study|Lost to Follow-up|12|||
125254271|NCT02003898|450558999|FG000|Overall Study|Withdrawal by Subject|52|||
125254272|NCT02272985|450559000|FG000|Overall Study|Withdrawal by Subject|1|||
125254273|NCT02272985|450559000|FG000|Overall Study|hip fracture|1|||
125254274|NCT02272985|450559000|FG000|Overall Study|kidney transplantation|1|||
125254275|NCT03682367|450559003|FG000|Overall Study|Protocol Violation|2|||
125254276|NCT03682367|450559004|FG001|Overall Study|Protocol Violation|1|||
125254277|NCT03682367|450559003|FG000|Overall Study|Closed Study Early|0|||
125254278|NCT03682367|450559004|FG001|Overall Study|Closed Study Early|3|||
125254279|NCT00770679|450559005|FG000|Overall Study|Lost to Follow-up|3|||
125254280|NCT00770679|450559005|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
125254281|NCT00129974|450559006|FG000|Overall Study|Other|1|||
125254282|NCT00414609|450559007|FG000|Core Study|Adverse Event|9|||
125254283|NCT00414609|450559008|FG001|Core Study|Adverse Event|11|||
125254284|NCT00414609|450559009|FG002|Core Study|Adverse Event|0|||
125254285|NCT00414609|450559007|FG000|Core Study|Abnormal laboratory values|0|||
125254286|NCT00414609|450559008|FG001|Core Study|Abnormal laboratory values|1|||
125254287|NCT00414609|450559009|FG002|Core Study|Abnormal laboratory values|0|||
125254288|NCT00414609|450559007|FG000|Core Study|Abnormal test procedure results|1|||
125254289|NCT00414609|450559008|FG001|Core Study|Abnormal test procedure results|1|||
125254290|NCT00414609|450559009|FG002|Core Study|Abnormal test procedure results|0|||
125254291|NCT00414609|450559007|FG000|Core Study|Protocol deviation|0|||
125254292|NCT00414609|450559008|FG001|Core Study|Protocol deviation|1|||
125254293|NCT00414609|450559009|FG002|Core Study|Protocol deviation|0|||
125254294|NCT00414609|450559007|FG000|Core Study|Patient withdrew consent|10|||
125254295|NCT00414609|450559008|FG001|Core Study|Patient withdrew consent|11|||
125254296|NCT00414609|450559009|FG002|Core Study|Patient withdrew consent|0|||
125254297|NCT00414609|450559007|FG000|Core Study|Lost to Follow-up|7|||
125254298|NCT00414609|450559008|FG001|Core Study|Lost to Follow-up|4|||
125254299|NCT00414609|450559009|FG002|Core Study|Lost to Follow-up|0|||
125254300|NCT00414609|450559007|FG000|Core Study|Administrative problems|0|||
125254301|NCT00414609|450559008|FG001|Core Study|Administrative problems|2|||
125254302|NCT00414609|450559009|FG002|Core Study|Administrative problems|0|||
125254303|NCT00414609|450559007|FG000|Core Study|Death|7|||
125254304|NCT00414609|450559008|FG001|Core Study|Death|14|||
125254305|NCT00414609|450559009|FG002|Core Study|Death|0|||
125254306|NCT00414609|450559007|FG000|Extension Study|Adverse Event|0|||
125254307|NCT00414609|450559008|FG001|Extension Study|Adverse Event|0|||
125254308|NCT00414609|450559009|FG002|Extension Study|Adverse Event|14|||
125254309|NCT00414609|450559007|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
125254310|NCT00414609|450559008|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
125254311|NCT00414609|450559009|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
125254312|NCT00414609|450559007|FG000|Extension Study|Withdrawal by Subject|0|||
125254313|NCT00414609|450559008|FG001|Extension Study|Withdrawal by Subject|0|||
125254314|NCT00414609|450559009|FG002|Extension Study|Withdrawal by Subject|13|||
125254315|NCT00414609|450559007|FG000|Extension Study|Lost to Follow-up|0|||
125254316|NCT00414609|450559008|FG001|Extension Study|Lost to Follow-up|0|||
125254317|NCT00414609|450559009|FG002|Extension Study|Lost to Follow-up|10|||
125254318|NCT00414609|450559007|FG000|Extension Study|Administrative problems|0|||
125254319|NCT00414609|450559008|FG001|Extension Study|Administrative problems|0|||
125254320|NCT00414609|450559009|FG002|Extension Study|Administrative problems|1|||
125254321|NCT00414609|450559007|FG000|Extension Study|Death|0|||
125254322|NCT00414609|450559008|FG001|Extension Study|Death|0|||
125254323|NCT00414609|450559009|FG002|Extension Study|Death|17|||
125254324|NCT03627468|450559014|FG000|Overall Study|Adverse Event|5|||
125254325|NCT03627468|450559015|FG001|Overall Study|Adverse Event|33|||
125254326|NCT03627468|450559014|FG000|Overall Study|Withdrawal by Subject|13|||
125254327|NCT03627468|450559015|FG001|Overall Study|Withdrawal by Subject|23|||
125444391|NCT01474512|451253893|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
125444392|NCT01474512|451253894|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
125444393|NCT01474512|451253895|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
125444394|NCT01474512|451253896|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
125254328|NCT03627468|450559014|FG000|Overall Study|Physician Decision|1|||
125254329|NCT03627468|450559015|FG001|Overall Study|Physician Decision|0|||
125254330|NCT03627468|450559014|FG000|Overall Study|Protocol Violation|0|||
125254331|NCT03627468|450559015|FG001|Overall Study|Protocol Violation|2|||
125254332|NCT03627468|450559014|FG000|Overall Study|Lost to Follow-up|10|||
125254333|NCT03627468|450559015|FG001|Overall Study|Lost to Follow-up|16|||
125254334|NCT03627468|450559014|FG000|Overall Study|Death|1|||
125254335|NCT03627468|450559015|FG001|Overall Study|Death|0|||
125254336|NCT03627468|450559014|FG000|Overall Study|Pregnancy|1|||
125254337|NCT03627468|450559015|FG001|Overall Study|Pregnancy|1|||
125254338|NCT03627468|450559014|FG000|Overall Study|Lack of Efficacy|0|||
125254339|NCT03627468|450559015|FG001|Overall Study|Lack of Efficacy|2|||
125254340|NCT03627468|450559014|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
125254341|NCT03627468|450559015|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
125254342|NCT01047540|450559016|FG000|Overall Study|Protocol Violation|1|||
125254343|NCT01047540|450559017|FG001|Overall Study|Protocol Violation|0|||
125254344|NCT01047540|450559018|FG002|Overall Study|Protocol Violation|0|||
125254345|NCT01047540|450559019|FG003|Overall Study|Protocol Violation|0|||
125254346|NCT01047540|450559020|FG004|Overall Study|Protocol Violation|0|||
125254347|NCT01047540|450559016|FG000|Overall Study|Lost to Follow-up|1|||
125254348|NCT01047540|450559017|FG001|Overall Study|Lost to Follow-up|0|||
125254349|NCT01047540|450559018|FG002|Overall Study|Lost to Follow-up|0|||
125254350|NCT01047540|450559019|FG003|Overall Study|Lost to Follow-up|0|||
125254351|NCT01047540|450559020|FG004|Overall Study|Lost to Follow-up|0|||
125254352|NCT01047540|450559016|FG000|Overall Study|Withdrawal by Subject|1|||
125254353|NCT01047540|450559017|FG001|Overall Study|Withdrawal by Subject|0|||
125254354|NCT01047540|450559018|FG002|Overall Study|Withdrawal by Subject|3|||
125254355|NCT01047540|450559019|FG003|Overall Study|Withdrawal by Subject|0|||
125254356|NCT01047540|450559020|FG004|Overall Study|Withdrawal by Subject|1|||
125254357|NCT01047540|450559016|FG000|Overall Study|Pregnancy|1|||
125254358|NCT01047540|450559017|FG001|Overall Study|Pregnancy|0|||
125254359|NCT01047540|450559018|FG002|Overall Study|Pregnancy|0|||
125254360|NCT01047540|450559019|FG003|Overall Study|Pregnancy|0|||
125254361|NCT01047540|450559020|FG004|Overall Study|Pregnancy|0|||
125254362|NCT01047540|450559016|FG000|Overall Study|Adverse Event|1|||
125254363|NCT01047540|450559017|FG001|Overall Study|Adverse Event|0|||
125254364|NCT01047540|450559018|FG002|Overall Study|Adverse Event|0|||
125254365|NCT01047540|450559019|FG003|Overall Study|Adverse Event|0|||
125254366|NCT01047540|450559020|FG004|Overall Study|Adverse Event|0|||
125254367|NCT01437189|450559024|FG000|Overall Study|Adverse Event|3|||
125254368|NCT01437189|450559024|FG000|Overall Study|Lack of Efficacy|4|||
125254369|NCT01437189|450559024|FG000|Overall Study|Withdrawal by Subject|8|||
125254370|NCT03654326|450559025|FG000|Overall Study|Withdrawal by Subject|5|||
125254371|NCT03654326|450559026|FG001|Overall Study|Withdrawal by Subject|3|||
125254372|NCT03654326|450559025|FG000|Overall Study|Physician Decision|0|||
125254373|NCT03654326|450559026|FG001|Overall Study|Physician Decision|1|||
125254374|NCT03654326|450559025|FG000|Overall Study|Unable to adhere to study schedule|0|||
125254375|NCT03654326|450559026|FG001|Overall Study|Unable to adhere to study schedule|1|||
125254376|NCT03654326|450559025|FG000|Overall Study|Lost to Follow-up|1|||
125254377|NCT03654326|450559026|FG001|Overall Study|Lost to Follow-up|1|||
125254378|NCT04102514|450559027|FG000|Overall Study|Death|3|||
125254379|NCT04102514|450559028|FG001|Overall Study|Death|0|||
125254380|NCT04102514|450559029|FG002|Overall Study|Death|0|||
125254381|NCT04102514|450559030|FG003|Overall Study|Death|0|||
125254382|NCT04102514|450559027|FG000|Overall Study|Lost to Follow-up|0|||
125254383|NCT04102514|450559028|FG001|Overall Study|Lost to Follow-up|0|||
125254384|NCT04102514|450559029|FG002|Overall Study|Lost to Follow-up|3|||
125254385|NCT04102514|450559030|FG003|Overall Study|Lost to Follow-up|0|||
125254386|NCT04102514|450559027|FG000|Overall Study|Physician Decision|0|||
125254387|NCT04102514|450559028|FG001|Overall Study|Physician Decision|0|||
125254388|NCT04102514|450559029|FG002|Overall Study|Physician Decision|1|||
125254389|NCT04102514|450559030|FG003|Overall Study|Physician Decision|0|||
125254390|NCT04102514|450559027|FG000|Overall Study|Withdrawal by Subject|7|||
125254391|NCT04102514|450559028|FG001|Overall Study|Withdrawal by Subject|13|||
125254392|NCT04102514|450559029|FG002|Overall Study|Withdrawal by Subject|7|||
125254393|NCT04102514|450559030|FG003|Overall Study|Withdrawal by Subject|14|||
125254394|NCT04102514|450559027|FG000|Overall Study|Moved to longterm care facility|6|||
125254395|NCT04102514|450559028|FG001|Overall Study|Moved to longterm care facility|0|||
125254396|NCT04102514|450559029|FG002|Overall Study|Moved to longterm care facility|4|||
125254397|NCT04102514|450559030|FG003|Overall Study|Moved to longterm care facility|0|||
125254398|NCT00835549|450559031|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
125254399|NCT00835549|450559032|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125254400|NCT00835042|450559033|FG000|First Intervention|Withdrawal by Subject|3|||
125254401|NCT00835042|450559034|FG001|First Intervention|Withdrawal by Subject|0|||
125254402|NCT00835042|450559033|FG000|First Intervention|Adverse Event|1|||
125254403|NCT00835042|450559034|FG001|First Intervention|Adverse Event|2|||
125254404|NCT00835042|450559033|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
125254405|NCT00835042|450559034|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
125254406|NCT00619918|450559035|FG000|Overall Study|Withdrawal by Subject|4|||
125254407|NCT00619918|450559036|FG001|Overall Study|Withdrawal by Subject|3|||
125254408|NCT00619918|450559035|FG000|Overall Study|Physician Decision|2|||
125254409|NCT00619918|450559036|FG001|Overall Study|Physician Decision|4|||
125254410|NCT00619918|450559035|FG000|Overall Study|Transfer to outside facility|3|||
125254411|NCT00619918|450559036|FG001|Overall Study|Transfer to outside facility|3|||
125254412|NCT00619918|450559035|FG000|Overall Study|Left before receiving first dose|7|||
125254413|NCT00619918|450559036|FG001|Overall Study|Left before receiving first dose|6|||
125254414|NCT00619918|450559035|FG000|Overall Study|ICU admission|4|||
125254415|NCT00619918|450559036|FG001|Overall Study|ICU admission|6|||
125254416|NCT05524948|450559056|FG000|Overall Study|Withdrawal by Subject|1|||
125254417|NCT05524948|450559057|FG001|Overall Study|Withdrawal by Subject|0|||
125254418|NCT05524948|450559056|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
125254419|NCT05524948|450559057|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
125254420|NCT04661839|450559062|FG000|Overall Study|Not Treated|0|||
125254421|NCT04661839|450559063|FG001|Overall Study|Not Treated|0|||
125254422|NCT04661839|450559064|FG002|Overall Study|Not Treated|1|||
125254423|NCT04661839|450559065|FG003|Overall Study|Not Treated|0|||
125254424|NCT04661839|450559062|FG000|Overall Study|Lost to Follow-up|1|||
125254425|NCT04661839|450559063|FG001|Overall Study|Lost to Follow-up|0|||
125254426|NCT04661839|450559064|FG002|Overall Study|Lost to Follow-up|0|||
125254427|NCT04661839|450559065|FG003|Overall Study|Lost to Follow-up|1|||
125254428|NCT02758626|450559067|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
125254429|NCT02758626|450559068|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
125254430|NCT02758626|450559067|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
125254431|NCT02758626|450559068|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
125254432|NCT02758626|450559067|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
125254433|NCT02758626|450559068|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
125254434|NCT02758626|450559067|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
125254435|NCT02758626|450559068|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
125254436|NCT00855166|450559069|FG000|Overall Study|Adverse Event|0|||
125254437|NCT00855166|450559070|FG001|Overall Study|Adverse Event|2|||
125254438|NCT00855166|450559069|FG000|Overall Study|Death|0|||
125254439|NCT00855166|450559070|FG001|Overall Study|Death|1|||
125254440|NCT00855166|450559069|FG000|Overall Study|Withdrawal by Subject|1|||
125254441|NCT00855166|450559070|FG001|Overall Study|Withdrawal by Subject|4|||
125254442|NCT00855166|450559069|FG000|Overall Study|Poor/non-compliance|2|||
125254443|NCT00855166|450559070|FG001|Overall Study|Poor/non-compliance|0|||
125254444|NCT00855166|450559069|FG000|Overall Study|Administrative reasons by sponsor|1|||
125254445|NCT00855166|450559070|FG001|Overall Study|Administrative reasons by sponsor|0|||
125254446|NCT00855166|450559069|FG000|Overall Study|Subject no longer meets study criteria|1|||
125254447|NCT00855166|450559070|FG001|Overall Study|Subject no longer meets study criteria|1|||
125254448|NCT01272219|450559073|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
125254449|NCT01272219|450559074|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
125254450|NCT01272219|450559075|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
125254451|NCT01272219|450559076|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
125254452|NCT01272219|450559077|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
125254453|NCT01272219|450559078|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
125254454|NCT01272219|450559073|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
125254455|NCT01272219|450559074|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
125254456|NCT01272219|450559075|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
125254457|NCT01272219|450559076|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
125254458|NCT01272219|450559077|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
125254459|NCT01272219|450559078|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
125254460|NCT01272219|450559073|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
125254461|NCT01272219|450559074|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
125254462|NCT01272219|450559075|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
125254463|NCT01272219|450559076|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
125254464|NCT01272219|450559077|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
125254465|NCT01272219|450559078|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
125254466|NCT01272219|450559073|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
125254467|NCT01272219|450559074|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
125254468|NCT01272219|450559075|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
125254469|NCT01272219|450559076|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
125254470|NCT01272219|450559077|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
125254471|NCT01272219|450559078|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
125254472|NCT01272219|450559073|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
125254473|NCT01272219|450559074|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
125254474|NCT01272219|450559075|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
125254475|NCT01272219|450559076|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
125254476|NCT01272219|450559077|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
125254477|NCT01272219|450559078|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
125254478|NCT01272219|450559073|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
125254479|NCT01272219|450559074|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
125254480|NCT01272219|450559075|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
125254481|NCT01272219|450559076|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
125254482|NCT01272219|450559077|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
125254483|NCT01272219|450559078|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
125254484|NCT01272219|450559073|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
125254485|NCT01272219|450559074|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
125254486|NCT01272219|450559075|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
125254487|NCT01272219|450559076|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
125254488|NCT01272219|450559077|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
125254489|NCT01272219|450559078|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
125254490|NCT01272219|450559073|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
125254491|NCT01272219|450559074|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
125254492|NCT01272219|450559075|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
125254493|NCT01272219|450559076|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
125254494|NCT01272219|450559077|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
125254495|NCT01272219|450559078|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
125254496|NCT01272219|450559073|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
125254497|NCT01272219|450559074|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
125254498|NCT01272219|450559075|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
125254499|NCT01272219|450559076|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
125254500|NCT01272219|450559077|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
125254501|NCT01272219|450559078|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
125254502|NCT01272219|450559073|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
125254503|NCT01272219|450559074|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
125254504|NCT01272219|450559075|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
125254505|NCT01272219|450559076|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
125254506|NCT01272219|450559077|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
125254507|NCT01272219|450559078|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
125254508|NCT01272219|450559073|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
125254509|NCT01272219|450559074|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
125254510|NCT01272219|450559075|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
125254511|NCT01272219|450559076|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
125254512|NCT01272219|450559077|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
125254513|NCT01272219|450559078|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
125254514|NCT01272219|450559073|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
125254515|NCT01272219|450559074|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
125254516|NCT01272219|450559075|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
125254517|NCT01272219|450559076|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
125254518|NCT01272219|450559077|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
125254519|NCT01272219|450559078|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
125254520|NCT01272219|450559073|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
125254521|NCT01272219|450559074|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
125254522|NCT01272219|450559075|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
125254523|NCT01272219|450559076|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
125254524|NCT01272219|450559077|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
125254525|NCT01272219|450559078|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
125254526|NCT01272219|450559073|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
125254527|NCT01272219|450559074|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
125254528|NCT01272219|450559075|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
125254529|NCT01272219|450559076|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
125254530|NCT01272219|450559077|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
125254531|NCT01272219|450559078|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
125254532|NCT01272219|450559073|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
125254533|NCT01272219|450559074|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
125254534|NCT01272219|450559075|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
125254535|NCT01272219|450559076|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
125254536|NCT01272219|450559077|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
125254537|NCT01272219|450559078|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
125254538|NCT01272219|450559073|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
125254539|NCT01272219|450559074|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
125254540|NCT01272219|450559075|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
125254541|NCT01272219|450559076|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
125254542|NCT01272219|450559077|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
125254543|NCT01272219|450559078|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
125254544|NCT03131479|450559079|FG000|Overall Study|Adverse Event|0|||
125254545|NCT03131479|450559080|FG001|Overall Study|Adverse Event|0|||
125254546|NCT03131479|450559081|FG002|Overall Study|Adverse Event|1|||
125254547|NCT03131479|450559082|FG003|Overall Study|Adverse Event|1|||
125254548|NCT03131479|450559083|FG004|Overall Study|Adverse Event|0|||
125254549|NCT03131479|450559079|FG000|Overall Study|Subject/Guardian Decision|0|||
125254550|NCT03131479|450559080|FG001|Overall Study|Subject/Guardian Decision|0|||
125254551|NCT03131479|450559081|FG002|Overall Study|Subject/Guardian Decision|0|||
125254552|NCT03131479|450559082|FG003|Overall Study|Subject/Guardian Decision|1|||
125254553|NCT03131479|450559083|FG004|Overall Study|Subject/Guardian Decision|0|||
125254554|NCT02899754|450559086|FG000|Overall Study|Lost to Follow-up|7|||
125254555|NCT02899754|450559087|FG001|Overall Study|Lost to Follow-up|9|||
125254556|NCT04818229|450559088|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
125254557|NCT04818229|450559089|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
125254558|NCT04818229|450559090|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
125254559|NCT04818229|450559088|FG000|Overall Study|Adverse Event|3|||
125254560|NCT04818229|450559089|FG001|Overall Study|Adverse Event|1|||
125254561|NCT04818229|450559090|FG002|Overall Study|Adverse Event|1|||
125254562|NCT04818229|450559088|FG000|Overall Study|Withdrawal by Subject|0|||
125254563|NCT04818229|450559089|FG001|Overall Study|Withdrawal by Subject|0|||
125254564|NCT04818229|450559090|FG002|Overall Study|Withdrawal by Subject|2|||
125254565|NCT04818229|450559088|FG000|Overall Study|Lost to Follow-up|0|||
125254566|NCT04818229|450559089|FG001|Overall Study|Lost to Follow-up|0|||
125254567|NCT04818229|450559090|FG002|Overall Study|Lost to Follow-up|1|||
125254568|NCT03186378|450559091|FG000|Overall Study|Lost to Follow-up|1|||
125254569|NCT03186378|450559092|FG001|Overall Study|Lost to Follow-up|0|||
125254570|NCT02514746|450559093|FG000|Overall Study|Chronically Ill|1|||
125254571|NCT02514746|450559094|FG001|Overall Study|Chronically Ill|2|||
125254572|NCT02514746|450559093|FG000|Overall Study|Physician Decision|4|||
125254573|NCT02514746|450559094|FG001|Overall Study|Physician Decision|2|||
125254574|NCT02514746|450559093|FG000|Overall Study|Withdrawal by Subject|12|||
125254575|NCT02514746|450559094|FG001|Overall Study|Withdrawal by Subject|10|||
125254576|NCT02514746|450559093|FG000|Overall Study|Other|5|||
125254577|NCT02514746|450559094|FG001|Overall Study|Other|1|||
125254578|NCT02181413|450559095|FG000|Overall Study|Withdrawal by Subject|45|||
125254579|NCT02181413|450559096|FG001|Overall Study|Withdrawal by Subject|61|||
125254580|NCT02181413|450559095|FG000|Overall Study|Reason Not Specified|2|||
125254581|NCT02181413|450559096|FG001|Overall Study|Reason Not Specified|5|||
125254582|NCT02181413|450559095|FG000|Overall Study|Lost to Follow-up|8|||
125254583|NCT02181413|450559096|FG001|Overall Study|Lost to Follow-up|7|||
125254584|NCT00050011|450559098|FG000|Overall Study|Adverse Event|41|||
125254585|NCT00050011|450559099|FG001|Overall Study|Adverse Event|46|||
125254586|NCT00050011|450559098|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125254587|NCT00050011|450559099|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125254588|NCT00050011|450559098|FG000|Overall Study|Abnormal test procedure results|0|||
125254589|NCT00050011|450559099|FG001|Overall Study|Abnormal test procedure results|1|||
125254590|NCT00050011|450559098|FG000|Overall Study|Lack of Efficacy|16|||
125254591|NCT00050011|450559099|FG001|Overall Study|Lack of Efficacy|21|||
125254592|NCT00050011|450559098|FG000|Overall Study|Participant condition no longer required|1|||
125254593|NCT00050011|450559099|FG001|Overall Study|Participant condition no longer required|0|||
125254594|NCT00050011|450559098|FG000|Overall Study|Protocol Violation|4|||
125254595|NCT00050011|450559099|FG001|Overall Study|Protocol Violation|10|||
125254596|NCT00050011|450559098|FG000|Overall Study|Withdrawal by Subject|34|||
125254597|NCT00050011|450559099|FG001|Overall Study|Withdrawal by Subject|26|||
125254598|NCT00050011|450559098|FG000|Overall Study|Lost to Follow-up|7|||
125254599|NCT00050011|450559099|FG001|Overall Study|Lost to Follow-up|9|||
125254600|NCT00050011|450559098|FG000|Overall Study|Administrative problems|10|||
125254601|NCT00050011|450559099|FG001|Overall Study|Administrative problems|6|||
125254602|NCT00050011|450559098|FG000|Overall Study|Death|7|||
125254603|NCT00050011|450559099|FG001|Overall Study|Death|4|||
125254604|NCT00050011|450559098|FG000|Overall Study|Unknown - Reason is missing|0|||
125254605|NCT00050011|450559099|FG001|Overall Study|Unknown - Reason is missing|2|||
125254606|NCT04903093|450559106|FG000|Overall Study|Withdrawal by Subject|0|||
125254607|NCT04903093|450559107|FG001|Overall Study|Withdrawal by Subject|0|||
125254608|NCT04903093|450559108|FG002|Overall Study|Withdrawal by Subject|0|||
125254609|NCT04903093|450559109|FG003|Overall Study|Withdrawal by Subject|1|||
125254610|NCT04903093|450559110|FG004|Overall Study|Withdrawal by Subject|0|||
125254611|NCT04903093|450559111|FG005|Overall Study|Withdrawal by Subject|0|||
125254612|NCT03973489|450559117|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
125254613|NCT03973489|450559118|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
125254614|NCT03973489|450559119|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
125254615|NCT03973489|450559120|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
125254616|NCT03973489|450559121|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
125254617|NCT03973489|450559122|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
125254618|NCT03973489|450559123|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
125254619|NCT03973489|450559124|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
125254620|NCT03973489|450559117|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
125254621|NCT03973489|450559118|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
125254622|NCT03973489|450559119|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
125254623|NCT03973489|450559120|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
125254624|NCT03973489|450559121|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
125254625|NCT03973489|450559122|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
125254626|NCT03973489|450559123|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
125254627|NCT03973489|450559124|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
125254628|NCT03973489|450559117|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
125254629|NCT03973489|450559118|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
125254630|NCT03973489|450559119|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
125254631|NCT03973489|450559120|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
125254632|NCT03973489|450559121|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
125254633|NCT03973489|450559122|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
125254634|NCT03973489|450559123|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
125254635|NCT03973489|450559124|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
125254636|NCT03973489|450559117|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
125254637|NCT03973489|450559118|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
125254638|NCT03973489|450559119|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
125254639|NCT03973489|450559120|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
125254640|NCT03973489|450559121|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
125254641|NCT03973489|450559122|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
125254642|NCT03973489|450559123|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
125254643|NCT03973489|450559124|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
125254644|NCT03973489|450559117|FG000|Second Intervention (1 Day)|Adverse Event|0|||
125254645|NCT03973489|450559118|FG001|Second Intervention (1 Day)|Adverse Event|0|||
125254646|NCT03973489|450559119|FG002|Second Intervention (1 Day)|Adverse Event|0|||
125254647|NCT03973489|450559120|FG003|Second Intervention (1 Day)|Adverse Event|1|||
125254648|NCT03973489|450559121|FG004|Second Intervention (1 Day)|Adverse Event|0|||
125254649|NCT03973489|450559122|FG005|Second Intervention (1 Day)|Adverse Event|0|||
125254650|NCT03973489|450559123|FG006|Second Intervention (1 Day)|Adverse Event|0|||
125254651|NCT03973489|450559124|FG007|Second Intervention (1 Day)|Adverse Event|0|||
125254652|NCT00392288|450559125|FG000|Overall Study|Adverse Event|17|||
125254653|NCT00392288|450559126|FG001|Overall Study|Adverse Event|7|||
125254654|NCT00392288|450559127|FG002|Overall Study|Adverse Event|8|||
125254655|NCT00392288|450559125|FG000|Overall Study|Lack of Efficacy|8|||
125254656|NCT00392288|450559126|FG001|Overall Study|Lack of Efficacy|5|||
125254657|NCT00392288|450559127|FG002|Overall Study|Lack of Efficacy|3|||
125254658|NCT00392288|450559125|FG000|Overall Study|Protocol Violation|1|||
125254659|NCT00392288|450559126|FG001|Overall Study|Protocol Violation|3|||
125254660|NCT00392288|450559127|FG002|Overall Study|Protocol Violation|1|||
125254661|NCT00392288|450559125|FG000|Overall Study|Lost to Follow-up|1|||
125254662|NCT00392288|450559126|FG001|Overall Study|Lost to Follow-up|1|||
125254663|NCT00392288|450559127|FG002|Overall Study|Lost to Follow-up|1|||
125254664|NCT00392288|450559125|FG000|Overall Study|Withdrawal by Subject|1|||
125254665|NCT00392288|450559126|FG001|Overall Study|Withdrawal by Subject|0|||
125254666|NCT00392288|450559127|FG002|Overall Study|Withdrawal by Subject|2|||
125254667|NCT00392288|450559125|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
125254668|NCT00392288|450559126|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
125254669|NCT00392288|450559127|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
125254670|NCT00392288|450559125|FG000|Overall Study|Other|3|||
125254671|NCT00392288|450559126|FG001|Overall Study|Other|4|||
125254672|NCT00392288|450559127|FG002|Overall Study|Other|1|||
125254673|NCT02544763|450559128|FG000|Overall Study|Adverse Event|8|||
125254674|NCT02544763|450559129|FG001|Overall Study|Adverse Event|8|||
125254675|NCT02544763|450559130|FG002|Overall Study|Adverse Event|0|||
125254676|NCT02544763|450559128|FG000|Overall Study|Withdrawn by parent/guardian|1|||
125254677|NCT02544763|450559129|FG001|Overall Study|Withdrawn by parent/guardian|1|||
125254678|NCT02544763|450559130|FG002|Overall Study|Withdrawn by parent/guardian|1|||
125254679|NCT02544763|450559128|FG000|Overall Study|Met withdrawal criteria|0|||
125254680|NCT02544763|450559129|FG001|Overall Study|Met withdrawal criteria|2|||
125254681|NCT02544763|450559130|FG002|Overall Study|Met withdrawal criteria|0|||
125254682|NCT02544763|450559128|FG000|Overall Study|Physician Decision|0|||
125254683|NCT02544763|450559129|FG001|Overall Study|Physician Decision|1|||
125254684|NCT02544763|450559130|FG002|Overall Study|Physician Decision|0|||
125254685|NCT02544763|450559128|FG000|Overall Study|Difficulties taking IMP|1|||
125254686|NCT02544763|450559129|FG001|Overall Study|Difficulties taking IMP|0|||
125254687|NCT02544763|450559130|FG002|Overall Study|Difficulties taking IMP|0|||
125254688|NCT02613507|450559137|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
125254689|NCT02613507|450559138|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
125254690|NCT02613507|450559137|FG000|Pre-Treamtent|Participant withdrew consent|0|||
125254691|NCT02613507|450559138|FG001|Pre-Treamtent|Participant withdrew consent|4|||
125254692|NCT02613507|450559137|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
125254693|NCT02613507|450559138|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
125254694|NCT02613507|450559137|FG000|Treatment|Not reported|3|||
125254695|NCT02613507|450559138|FG001|Treatment|Not reported|0|||
125254696|NCT02613507|450559137|FG000|Treatment|Other reasons|8|||
125254697|NCT02613507|450559138|FG001|Treatment|Other reasons|0|||
125254698|NCT02613507|450559137|FG000|Treatment|Participant no longer meets criteria|3|||
125254699|NCT02613507|450559138|FG001|Treatment|Participant no longer meets criteria|0|||
125254700|NCT02613507|450559137|FG000|Treatment|Maximum clinical benefit|5|||
125254701|NCT02613507|450559138|FG001|Treatment|Maximum clinical benefit|10|||
125254702|NCT02613507|450559137|FG000|Treatment|Lost to Follow-up|1|||
125254703|NCT02613507|450559138|FG001|Treatment|Lost to Follow-up|0|||
125254704|NCT02613507|450559137|FG000|Treatment|Participant withdrew consent|0|||
125254705|NCT02613507|450559138|FG001|Treatment|Participant withdrew consent|2|||
125254706|NCT02613507|450559137|FG000|Treatment|Participant request to discontinue study treatment|13|||
125254707|NCT02613507|450559138|FG001|Treatment|Participant request to discontinue study treatment|17|||
125254708|NCT02613507|450559137|FG000|Treatment|Adverse event unrelated to study drug|20|||
125254709|NCT02613507|450559138|FG001|Treatment|Adverse event unrelated to study drug|3|||
125254710|NCT02613507|450559137|FG000|Treatment|Death|2|||
125254711|NCT02613507|450559138|FG001|Treatment|Death|0|||
125254712|NCT02613507|450559137|FG000|Treatment|Study drug toxicity|19|||
125254713|NCT02613507|450559138|FG001|Treatment|Study drug toxicity|14|||
125254714|NCT02613507|450559137|FG000|Treatment|Disease progression|263|||
125254715|NCT02613507|450559138|FG001|Treatment|Disease progression|110|||
125254716|NCT03941093|450559139|FG000|Overall Study|Protocol Violation|0|||
125254717|NCT03941093|450559140|FG001|Overall Study|Protocol Violation|1|||
125254718|NCT03941093|450559139|FG000|Overall Study|Withdrawal by Subject|9|||
125254719|NCT03941093|450559140|FG001|Overall Study|Withdrawal by Subject|6|||
125254720|NCT00590317|450560471|FG000|Overall Study|Lack of Efficacy|1|||
125254721|NCT00590317|450560472|FG001|Overall Study|Lack of Efficacy|5|||
125254722|NCT00003907|450560479|FG000|Overall Study|Adverse Event|2|||
125254723|NCT00003907|450560480|FG001|Overall Study|Adverse Event|11|||
125254724|NCT00003907|450560479|FG000|Overall Study|Death|2|||
125254725|NCT00003907|450560480|FG001|Overall Study|Death|0|||
125254726|NCT00003907|450560479|FG000|Overall Study|Withdrawal by Subject|1|||
125254727|NCT00003907|450560480|FG001|Overall Study|Withdrawal by Subject|3|||
125254728|NCT00003907|450560479|FG000|Overall Study|Progressive disease|4|||
125254729|NCT00003907|450560480|FG001|Overall Study|Progressive disease|4|||
125254730|NCT00003907|450560479|FG000|Overall Study|Complicating disease|1|||
125254731|NCT00003907|450560480|FG001|Overall Study|Complicating disease|0|||
125254732|NCT00003907|450560479|FG000|Overall Study|Other|1|||
125254733|NCT00003907|450560480|FG001|Overall Study|Other|3|||
125254734|NCT00003907|450560479|FG000|Overall Study|ineligible or not treated|2|||
125254735|NCT00003907|450560480|FG001|Overall Study|ineligible or not treated|2|||
125254736|NCT01517178|450560481|FG000|Period 1|Adverse Event|1|||
125254737|NCT01517178|450560482|FG001|Period 1|Adverse Event|2|||
125254738|NCT01517178|450560481|FG000|Period 1|Lack of Efficacy|0|||
125254739|NCT01517178|450560482|FG001|Period 1|Lack of Efficacy|1|||
125254740|NCT01517178|450560481|FG000|Period 1|E.g. study termination|3|||
125254741|NCT01517178|450560482|FG001|Period 1|E.g. study termination|1|||
125254742|NCT01517178|450560481|FG000|Period 1|Withdrawal by Subject|0|||
125254743|NCT01517178|450560482|FG001|Period 1|Withdrawal by Subject|1|||
125254744|NCT01517178|450560481|FG000|Period 2|Adverse Event|1|||
125254745|NCT01517178|450560482|FG001|Period 2|Adverse Event|0|||
125254746|NCT01517178|450560481|FG000|Period 2|Withdrawal by Subject|3|||
125254747|NCT01517178|450560482|FG001|Period 2|Withdrawal by Subject|0|||
125254748|NCT01517178|450560481|FG000|Period 2|E.g. study termination|2|||
125254749|NCT01517178|450560482|FG001|Period 2|E.g. study termination|2|||
125254750|NCT01050218|450560489|FG000|Overall Study|Adverse Event|37|||
125254751|NCT01050218|450560489|FG000|Overall Study|Lack of Efficacy|8|||
125254752|NCT01050218|450560489|FG000|Overall Study|Protocol Violation|3|||
125254753|NCT01050218|450560489|FG000|Overall Study|Withdrawal by Subject|18|||
125254754|NCT01050218|450560489|FG000|Overall Study|Discontinued by sponsor|18|||
125254755|NCT01050218|450560489|FG000|Overall Study|Compliance|2|||
125254756|NCT01050218|450560489|FG000|Overall Study|Failed to return|7|||
125254757|NCT01050218|450560489|FG000|Overall Study|Serious Adverse Event|1|||
125254758|NCT01050218|450560489|FG000|Overall Study|Family emergency|1|||
125254759|NCT01149460|450560490|FG000|Overall Study|Withdrawal by Subject|0|||
125254760|NCT01149460|450560491|FG001|Overall Study|Withdrawal by Subject|2|||
125254761|NCT00266032|450560492|FG000|Treatment|Adverse Event|42|||
125254762|NCT00266032|450560493|FG001|Treatment|Adverse Event|26|||
125254763|NCT00266032|450560494|FG002|Treatment|Adverse Event|10|||
125254764|NCT00266032|450560492|FG000|Treatment|Lost to Follow-up|19|||
125254765|NCT00266032|450560493|FG001|Treatment|Lost to Follow-up|4|||
125254766|NCT00266032|450560494|FG002|Treatment|Lost to Follow-up|2|||
125254767|NCT00266032|450560492|FG000|Treatment|Pregnancy|3|||
125254768|NCT00266032|450560493|FG001|Treatment|Pregnancy|2|||
125254769|NCT00266032|450560494|FG002|Treatment|Pregnancy|2|||
125254770|NCT00266032|450560492|FG000|Treatment|Protocol Violation|6|||
125254771|NCT00266032|450560493|FG001|Treatment|Protocol Violation|14|||
125254772|NCT00266032|450560494|FG002|Treatment|Protocol Violation|13|||
125254773|NCT00266032|450560492|FG000|Treatment|Withdrawal by Subject|28|||
125254774|NCT00266032|450560493|FG001|Treatment|Withdrawal by Subject|13|||
125254775|NCT00266032|450560494|FG002|Treatment|Withdrawal by Subject|12|||
125254776|NCT00266032|450560492|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
125254777|NCT00266032|450560493|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
125254778|NCT00266032|450560494|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
125254779|NCT00266032|450560492|FG000|Open-label Safety Extension|Adverse Event|5|||
125254780|NCT00266032|450560493|FG001|Open-label Safety Extension|Adverse Event|0|||
125254781|NCT00266032|450560494|FG002|Open-label Safety Extension|Adverse Event|4|||
125254782|NCT00266032|450560492|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
125254783|NCT00266032|450560493|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
125254784|NCT00266032|450560494|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
125254785|NCT00266032|450560492|FG000|Open-label Safety Extension|Pregnancy|4|||
125254786|NCT00266032|450560493|FG001|Open-label Safety Extension|Pregnancy|1|||
125254787|NCT00266032|450560494|FG002|Open-label Safety Extension|Pregnancy|2|||
125254788|NCT00266032|450560492|FG000|Open-label Safety Extension|Protocol Violation|1|||
125254789|NCT00266032|450560493|FG001|Open-label Safety Extension|Protocol Violation|3|||
125254790|NCT00266032|450560494|FG002|Open-label Safety Extension|Protocol Violation|2|||
125254791|NCT00266032|450560492|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
125254792|NCT00266032|450560493|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
125254793|NCT00266032|450560494|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
125254794|NCT00266032|450560492|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
125254795|NCT00266032|450560493|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
125254796|NCT00266032|450560494|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
125254797|NCT01514357|450560498|FG000|Overall Study|Screen failure|2|||
125254798|NCT01514357|450560499|FG001|Overall Study|Screen failure|0|||
125254799|NCT01514357|450560498|FG000|Overall Study|Withdrawal by Subject|2|||
125254800|NCT01514357|450560499|FG001|Overall Study|Withdrawal by Subject|0|||
125254801|NCT00752219|450560500|FG000|Overall Study|Clinical failure|0|||
125254802|NCT00752219|450560501|FG001|Overall Study|Clinical failure|1|||
125254803|NCT00752219|450560500|FG000|Overall Study|Adverse Event|5|||
125254804|NCT00752219|450560501|FG001|Overall Study|Adverse Event|3|||
125254805|NCT00752219|450560500|FG000|Overall Study|Protocol deviation|1|||
125254806|NCT00752219|450560501|FG001|Overall Study|Protocol deviation|0|||
125254807|NCT00752219|450560500|FG000|Overall Study|Lost to Follow-up|1|||
125254808|NCT00752219|450560501|FG001|Overall Study|Lost to Follow-up|2|||
125254809|NCT00752219|450560500|FG000|Overall Study|Randomized but not treated|1|||
125254810|NCT00752219|450560501|FG001|Overall Study|Randomized but not treated|0|||
125254811|NCT00752219|450560500|FG000|Overall Study|Other|3|||
125254812|NCT00752219|450560501|FG001|Overall Study|Other|0|||
125254813|NCT04691115|450560504|FG000|Overall Study|Withdrawal by Subject|0|||
125254814|NCT04691115|450560505|FG001|Overall Study|Withdrawal by Subject|0|||
125254815|NCT04691115|450560506|FG002|Overall Study|Withdrawal by Subject|0|||
125254816|NCT04691115|450560507|FG003|Overall Study|Withdrawal by Subject|0|||
125254817|NCT04691115|450560508|FG004|Overall Study|Withdrawal by Subject|0|||
125254818|NCT04691115|450560509|FG005|Overall Study|Withdrawal by Subject|1|||
125254819|NCT04691115|450560510|FG006|Overall Study|Withdrawal by Subject|0|||
125254820|NCT04691115|450560511|FG007|Overall Study|Withdrawal by Subject|0|||
125254821|NCT04691115|450560512|FG008|Overall Study|Withdrawal by Subject|0|||
125254822|NCT04691115|450560513|FG009|Overall Study|Withdrawal by Subject|0|||
125254823|NCT04691115|450560514|FG010|Overall Study|Withdrawal by Subject|0|||
125254824|NCT04691115|450560515|FG011|Overall Study|Withdrawal by Subject|0|||
125254825|NCT04691115|450560516|FG012|Overall Study|Withdrawal by Subject|0|||
125254826|NCT04691115|450560517|FG013|Overall Study|Withdrawal by Subject|0|||
125254827|NCT02096354|450560522|FG000|Overall Study|Physician Decision|4|||
125254828|NCT02096354|450560523|FG001|Overall Study|Physician Decision|5|||
125254829|NCT02096354|450560524|FG002|Overall Study|Physician Decision|0|||
125254830|NCT02096354|450560522|FG000|Overall Study|Withdrawal by Subject|3|||
125254831|NCT02096354|450560523|FG001|Overall Study|Withdrawal by Subject|1|||
125254832|NCT02096354|450560524|FG002|Overall Study|Withdrawal by Subject|0|||
125254833|NCT02096354|450560522|FG000|Overall Study|Adverse Event|7|||
125254834|NCT02096354|450560523|FG001|Overall Study|Adverse Event|4|||
125254835|NCT02096354|450560524|FG002|Overall Study|Adverse Event|0|||
125254836|NCT02096354|450560522|FG000|Overall Study|Ineligible|0|||
125254837|NCT02096354|450560523|FG001|Overall Study|Ineligible|0|||
125254838|NCT02096354|450560524|FG002|Overall Study|Ineligible|11|||
125254839|NCT03715829|450560525|FG000|Dose Ranging Period|Adverse Event|2|||
125254840|NCT03715829|450560526|FG001|Dose Ranging Period|Adverse Event|4|||
125254841|NCT03715829|450560527|FG002|Dose Ranging Period|Adverse Event|5|||
125254842|NCT03715829|450560528|FG003|Dose Ranging Period|Adverse Event|2|||
125254843|NCT03715829|450560529|FG004|Dose Ranging Period|Adverse Event|3|||
125254844|NCT03715829|450560530|FG005|Dose Ranging Period|Adverse Event|3|||
125254845|NCT03715829|450560531|FG006|Dose Ranging Period|Adverse Event|0|||
125254846|NCT03715829|450560532|FG007|Dose Ranging Period|Adverse Event|0|||
125254847|NCT03715829|450560533|FG008|Dose Ranging Period|Adverse Event|0|||
125254848|NCT03715829|450560534|FG009|Dose Ranging Period|Adverse Event|0|||
125254849|NCT03715829|450560535|FG010|Dose Ranging Period|Adverse Event|0|||
125254850|NCT03715829|450560525|FG000|Dose Ranging Period|Lack of Efficacy|0|||
125254851|NCT03715829|450560526|FG001|Dose Ranging Period|Lack of Efficacy|1|||
125254852|NCT03715829|450560527|FG002|Dose Ranging Period|Lack of Efficacy|0|||
125254853|NCT03715829|450560528|FG003|Dose Ranging Period|Lack of Efficacy|1|||
125254854|NCT03715829|450560529|FG004|Dose Ranging Period|Lack of Efficacy|0|||
125254855|NCT03715829|450560530|FG005|Dose Ranging Period|Lack of Efficacy|0|||
125254856|NCT03715829|450560531|FG006|Dose Ranging Period|Lack of Efficacy|0|||
125254857|NCT03715829|450560532|FG007|Dose Ranging Period|Lack of Efficacy|0|||
125254858|NCT03715829|450560533|FG008|Dose Ranging Period|Lack of Efficacy|0|||
125254859|NCT03715829|450560534|FG009|Dose Ranging Period|Lack of Efficacy|0|||
125254860|NCT03715829|450560535|FG010|Dose Ranging Period|Lack of Efficacy|0|||
125254861|NCT03715829|450560525|FG000|Dose Ranging Period|Lost to Follow-up|2|||
125254862|NCT03715829|450560526|FG001|Dose Ranging Period|Lost to Follow-up|0|||
125254863|NCT03715829|450560527|FG002|Dose Ranging Period|Lost to Follow-up|1|||
125254864|NCT03715829|450560528|FG003|Dose Ranging Period|Lost to Follow-up|1|||
125254865|NCT03715829|450560529|FG004|Dose Ranging Period|Lost to Follow-up|1|||
125254866|NCT03715829|450560530|FG005|Dose Ranging Period|Lost to Follow-up|2|||
125254867|NCT03715829|450560531|FG006|Dose Ranging Period|Lost to Follow-up|0|||
125254868|NCT03715829|450560532|FG007|Dose Ranging Period|Lost to Follow-up|0|||
125254869|NCT03715829|450560533|FG008|Dose Ranging Period|Lost to Follow-up|0|||
125254870|NCT03715829|450560534|FG009|Dose Ranging Period|Lost to Follow-up|0|||
125254871|NCT03715829|450560535|FG010|Dose Ranging Period|Lost to Follow-up|0|||
125254872|NCT03715829|450560525|FG000|Dose Ranging Period|Protocol Violation|0|||
125254873|NCT03715829|450560526|FG001|Dose Ranging Period|Protocol Violation|0|||
125254874|NCT03715829|450560527|FG002|Dose Ranging Period|Protocol Violation|0|||
125254875|NCT03715829|450560528|FG003|Dose Ranging Period|Protocol Violation|1|||
125254876|NCT03715829|450560529|FG004|Dose Ranging Period|Protocol Violation|0|||
125254877|NCT03715829|450560530|FG005|Dose Ranging Period|Protocol Violation|0|||
125254878|NCT03715829|450560531|FG006|Dose Ranging Period|Protocol Violation|0|||
125254879|NCT03715829|450560532|FG007|Dose Ranging Period|Protocol Violation|0|||
125254880|NCT03715829|450560533|FG008|Dose Ranging Period|Protocol Violation|0|||
125254881|NCT03715829|450560534|FG009|Dose Ranging Period|Protocol Violation|0|||
125254882|NCT03715829|450560535|FG010|Dose Ranging Period|Protocol Violation|0|||
125254883|NCT03715829|450560525|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
125254884|NCT03715829|450560526|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
125254885|NCT03715829|450560527|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
125254886|NCT03715829|450560528|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
125254887|NCT03715829|450560529|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
125254888|NCT03715829|450560530|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
125254889|NCT03715829|450560531|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
125254890|NCT03715829|450560532|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
125254891|NCT03715829|450560533|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
125254892|NCT03715829|450560534|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
125254893|NCT03715829|450560535|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
125254894|NCT03715829|450560525|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254895|NCT03715829|450560526|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254896|NCT03715829|450560527|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
125254897|NCT03715829|450560528|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254898|NCT03715829|450560529|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254899|NCT03715829|450560530|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254900|NCT03715829|450560531|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254901|NCT03715829|450560532|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254902|NCT03715829|450560533|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254903|NCT03715829|450560534|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254904|NCT03715829|450560535|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
125254905|NCT03715829|450560525|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254906|NCT03715829|450560526|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254907|NCT03715829|450560527|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
125254908|NCT03715829|450560528|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254909|NCT03715829|450560529|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
125254910|NCT03715829|450560530|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254911|NCT03715829|450560531|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254912|NCT03715829|450560532|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254913|NCT03715829|450560533|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254914|NCT03715829|450560534|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254915|NCT03715829|450560535|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
125254916|NCT03715829|450560525|FG000|Dose Ranging Period|Other|0|||
125254917|NCT03715829|450560526|FG001|Dose Ranging Period|Other|0|||
125254918|NCT03715829|450560527|FG002|Dose Ranging Period|Other|2|||
125254919|NCT03715829|450560528|FG003|Dose Ranging Period|Other|0|||
125444395|NCT01474512|451253897|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
125444396|NCT01474512|451253880|FG000|Long-Term Extension Period|Physician Decision|0|||
125254920|NCT03715829|450560529|FG004|Dose Ranging Period|Other|0|||
125254921|NCT03715829|450560530|FG005|Dose Ranging Period|Other|3|||
125254922|NCT03715829|450560531|FG006|Dose Ranging Period|Other|0|||
125254923|NCT03715829|450560532|FG007|Dose Ranging Period|Other|0|||
125254924|NCT03715829|450560533|FG008|Dose Ranging Period|Other|0|||
125254925|NCT03715829|450560534|FG009|Dose Ranging Period|Other|0|||
125254926|NCT03715829|450560535|FG010|Dose Ranging Period|Other|0|||
125254927|NCT03715829|450560525|FG000|Extension Period|Adverse Event|0|||
125254928|NCT03715829|450560526|FG001|Extension Period|Adverse Event|0|||
125444397|NCT01474512|451253881|FG001|Long-Term Extension Period|Physician Decision|0|||
125444398|NCT01474512|451253882|FG002|Long-Term Extension Period|Physician Decision|0|||
125444399|NCT01474512|451253883|FG003|Long-Term Extension Period|Physician Decision|0|||
125444400|NCT01474512|451253884|FG004|Long-Term Extension Period|Physician Decision|0|||
125444401|NCT01474512|451253885|FG005|Long-Term Extension Period|Physician Decision|0|||
125444402|NCT01474512|451253886|FG006|Long-Term Extension Period|Physician Decision|0|||
125444403|NCT01474512|451253887|FG007|Long-Term Extension Period|Physician Decision|0|||
125444404|NCT01474512|451253888|FG008|Long-Term Extension Period|Physician Decision|0|||
125444405|NCT01474512|451253889|FG009|Long-Term Extension Period|Physician Decision|0|||
125444406|NCT01474512|451253890|FG010|Long-Term Extension Period|Physician Decision|0|||
125444407|NCT01474512|451253891|FG011|Long-Term Extension Period|Physician Decision|0|||
125444408|NCT01474512|451253892|FG012|Long-Term Extension Period|Physician Decision|21|||
125444409|NCT01474512|451253893|FG013|Long-Term Extension Period|Physician Decision|21|||
125444410|NCT01474512|451253894|FG014|Long-Term Extension Period|Physician Decision|0|||
125444411|NCT01474512|451253895|FG015|Long-Term Extension Period|Physician Decision|0|||
125444412|NCT01474512|451253896|FG016|Long-Term Extension Period|Physician Decision|0|||
125444413|NCT01474512|451253897|FG017|Long-Term Extension Period|Physician Decision|0|||
125444414|NCT01474512|451253880|FG000|Long-Term Extension Period|Clinical Relapse|0|||
125444415|NCT01474512|451253881|FG001|Long-Term Extension Period|Clinical Relapse|0|||
125444416|NCT01474512|451253882|FG002|Long-Term Extension Period|Clinical Relapse|0|||
125444417|NCT01474512|451253883|FG003|Long-Term Extension Period|Clinical Relapse|0|||
125444418|NCT01474512|451253884|FG004|Long-Term Extension Period|Clinical Relapse|0|||
125444419|NCT01474512|451253885|FG005|Long-Term Extension Period|Clinical Relapse|0|||
125444420|NCT01474512|451253886|FG006|Long-Term Extension Period|Clinical Relapse|0|||
125444421|NCT01474512|451253887|FG007|Long-Term Extension Period|Clinical Relapse|0|||
125444422|NCT01474512|451253888|FG008|Long-Term Extension Period|Clinical Relapse|0|||
125444423|NCT01474512|451253889|FG009|Long-Term Extension Period|Clinical Relapse|0|||
125444424|NCT01474512|451253890|FG010|Long-Term Extension Period|Clinical Relapse|0|||
125444425|NCT01474512|451253891|FG011|Long-Term Extension Period|Clinical Relapse|0|||
125444426|NCT01474512|451253892|FG012|Long-Term Extension Period|Clinical Relapse|9|||
125444427|NCT01474512|451253893|FG013|Long-Term Extension Period|Clinical Relapse|9|||
125444428|NCT01474512|451253894|FG014|Long-Term Extension Period|Clinical Relapse|0|||
125444429|NCT01474512|451253895|FG015|Long-Term Extension Period|Clinical Relapse|0|||
125444430|NCT01474512|451253896|FG016|Long-Term Extension Period|Clinical Relapse|0|||
125444431|NCT01474512|451253897|FG017|Long-Term Extension Period|Clinical Relapse|0|||
125444432|NCT01474512|451253880|FG000|Long-Term Extension Period|Death|0|||
125444433|NCT01474512|451253881|FG001|Long-Term Extension Period|Death|0|||
125444434|NCT01474512|451253882|FG002|Long-Term Extension Period|Death|0|||
125444435|NCT01474512|451253883|FG003|Long-Term Extension Period|Death|0|||
125444436|NCT01474512|451253884|FG004|Long-Term Extension Period|Death|0|||
125444437|NCT01474512|451253885|FG005|Long-Term Extension Period|Death|0|||
125444438|NCT01474512|451253886|FG006|Long-Term Extension Period|Death|0|||
125444439|NCT01474512|451253887|FG007|Long-Term Extension Period|Death|0|||
125444440|NCT01474512|451253888|FG008|Long-Term Extension Period|Death|0|||
125444441|NCT01474512|451253889|FG009|Long-Term Extension Period|Death|0|||
125444442|NCT01474512|451253890|FG010|Long-Term Extension Period|Death|0|||
125444443|NCT01474512|451253891|FG011|Long-Term Extension Period|Death|0|||
125444444|NCT01474512|451253892|FG012|Long-Term Extension Period|Death|9|||
125444445|NCT01474512|451253893|FG013|Long-Term Extension Period|Death|9|||
125444446|NCT01474512|451253894|FG014|Long-Term Extension Period|Death|0|||
125444447|NCT01474512|451253895|FG015|Long-Term Extension Period|Death|0|||
125444448|NCT01474512|451253896|FG016|Long-Term Extension Period|Death|0|||
125444449|NCT01474512|451253897|FG017|Long-Term Extension Period|Death|0|||
125444450|NCT01474512|451253880|FG000|Long-Term Extension Period|Sponsor Decision|0|||
125444451|NCT01474512|451253881|FG001|Long-Term Extension Period|Sponsor Decision|0|||
125444452|NCT01474512|451253882|FG002|Long-Term Extension Period|Sponsor Decision|0|||
125444453|NCT01474512|451253883|FG003|Long-Term Extension Period|Sponsor Decision|0|||
125444454|NCT01474512|451253884|FG004|Long-Term Extension Period|Sponsor Decision|0|||
125254929|NCT03715829|450560527|FG002|Extension Period|Adverse Event|0|||
125444455|NCT01474512|451253885|FG005|Long-Term Extension Period|Sponsor Decision|0|||
125444456|NCT01474512|451253886|FG006|Long-Term Extension Period|Sponsor Decision|0|||
125444457|NCT01474512|451253887|FG007|Long-Term Extension Period|Sponsor Decision|0|||
125444458|NCT01474512|451253888|FG008|Long-Term Extension Period|Sponsor Decision|0|||
125444459|NCT01474512|451253889|FG009|Long-Term Extension Period|Sponsor Decision|0|||
125444460|NCT01474512|451253890|FG010|Long-Term Extension Period|Sponsor Decision|0|||
125444461|NCT01474512|451253891|FG011|Long-Term Extension Period|Sponsor Decision|0|||
125444462|NCT01474512|451253892|FG012|Long-Term Extension Period|Sponsor Decision|6|||
125444463|NCT01474512|451253893|FG013|Long-Term Extension Period|Sponsor Decision|6|||
125444464|NCT01474512|451253894|FG014|Long-Term Extension Period|Sponsor Decision|0|||
125444465|NCT01474512|451253895|FG015|Long-Term Extension Period|Sponsor Decision|0|||
125444466|NCT01474512|451253896|FG016|Long-Term Extension Period|Sponsor Decision|0|||
125254930|NCT03715829|450560528|FG003|Extension Period|Adverse Event|0|||
125254931|NCT03715829|450560529|FG004|Extension Period|Adverse Event|0|||
125254932|NCT03715829|450560530|FG005|Extension Period|Adverse Event|0|||
125254933|NCT03715829|450560531|FG006|Extension Period|Adverse Event|3|||
125254934|NCT03715829|450560532|FG007|Extension Period|Adverse Event|1|||
125254935|NCT03715829|450560533|FG008|Extension Period|Adverse Event|6|||
125254936|NCT03715829|450560534|FG009|Extension Period|Adverse Event|0|||
125254937|NCT03715829|450560535|FG010|Extension Period|Adverse Event|0|||
125254938|NCT03715829|450560525|FG000|Extension Period|Lack of Efficacy|0|||
125254939|NCT03715829|450560526|FG001|Extension Period|Lack of Efficacy|0|||
125254940|NCT03715829|450560527|FG002|Extension Period|Lack of Efficacy|0|||
125254941|NCT03715829|450560528|FG003|Extension Period|Lack of Efficacy|0|||
125254942|NCT03715829|450560529|FG004|Extension Period|Lack of Efficacy|0|||
125254943|NCT03715829|450560530|FG005|Extension Period|Lack of Efficacy|0|||
125254944|NCT03715829|450560531|FG006|Extension Period|Lack of Efficacy|1|||
125254945|NCT03715829|450560532|FG007|Extension Period|Lack of Efficacy|9|||
125254946|NCT03715829|450560533|FG008|Extension Period|Lack of Efficacy|2|||
125254947|NCT03715829|450560534|FG009|Extension Period|Lack of Efficacy|0|||
125254948|NCT03715829|450560535|FG010|Extension Period|Lack of Efficacy|0|||
125254949|NCT03715829|450560525|FG000|Extension Period|Lost to Follow-up|0|||
125254950|NCT03715829|450560526|FG001|Extension Period|Lost to Follow-up|0|||
125254951|NCT03715829|450560527|FG002|Extension Period|Lost to Follow-up|0|||
125254952|NCT03715829|450560528|FG003|Extension Period|Lost to Follow-up|0|||
125254953|NCT03715829|450560529|FG004|Extension Period|Lost to Follow-up|0|||
125254954|NCT03715829|450560530|FG005|Extension Period|Lost to Follow-up|0|||
125254955|NCT03715829|450560531|FG006|Extension Period|Lost to Follow-up|0|||
125254956|NCT03715829|450560532|FG007|Extension Period|Lost to Follow-up|0|||
125254957|NCT03715829|450560533|FG008|Extension Period|Lost to Follow-up|2|||
125254958|NCT03715829|450560534|FG009|Extension Period|Lost to Follow-up|0|||
125254959|NCT03715829|450560535|FG010|Extension Period|Lost to Follow-up|0|||
125254960|NCT03715829|450560525|FG000|Extension Period|Protocol Violation|0|||
125254961|NCT03715829|450560526|FG001|Extension Period|Protocol Violation|0|||
125254962|NCT03715829|450560527|FG002|Extension Period|Protocol Violation|0|||
125254963|NCT03715829|450560528|FG003|Extension Period|Protocol Violation|0|||
125254964|NCT03715829|450560529|FG004|Extension Period|Protocol Violation|0|||
125254965|NCT03715829|450560530|FG005|Extension Period|Protocol Violation|0|||
125254966|NCT03715829|450560531|FG006|Extension Period|Protocol Violation|0|||
125254967|NCT03715829|450560532|FG007|Extension Period|Protocol Violation|0|||
125254968|NCT03715829|450560533|FG008|Extension Period|Protocol Violation|1|||
125254969|NCT03715829|450560534|FG009|Extension Period|Protocol Violation|0|||
125254970|NCT03715829|450560535|FG010|Extension Period|Protocol Violation|0|||
125254971|NCT03715829|450560525|FG000|Extension Period|Withdrawal by Subject|0|||
125254972|NCT03715829|450560526|FG001|Extension Period|Withdrawal by Subject|0|||
125254973|NCT03715829|450560527|FG002|Extension Period|Withdrawal by Subject|0|||
125254974|NCT03715829|450560528|FG003|Extension Period|Withdrawal by Subject|0|||
125254975|NCT03715829|450560529|FG004|Extension Period|Withdrawal by Subject|0|||
125254976|NCT03715829|450560530|FG005|Extension Period|Withdrawal by Subject|0|||
125254977|NCT03715829|450560531|FG006|Extension Period|Withdrawal by Subject|3|||
125254978|NCT03715829|450560532|FG007|Extension Period|Withdrawal by Subject|3|||
125254979|NCT03715829|450560533|FG008|Extension Period|Withdrawal by Subject|12|||
125254980|NCT03715829|450560534|FG009|Extension Period|Withdrawal by Subject|3|||
125254981|NCT03715829|450560535|FG010|Extension Period|Withdrawal by Subject|0|||
125254982|NCT03715829|450560525|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254983|NCT03715829|450560526|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254984|NCT03715829|450560527|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254985|NCT03715829|450560528|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254986|NCT03715829|450560529|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254987|NCT03715829|450560530|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254988|NCT03715829|450560531|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254989|NCT03715829|450560532|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
125254990|NCT03715829|450560533|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
125254991|NCT03715829|450560534|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254992|NCT03715829|450560535|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
125254993|NCT03715829|450560525|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
125254994|NCT03715829|450560526|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
125254995|NCT03715829|450560527|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
125254996|NCT03715829|450560528|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
125254997|NCT03715829|450560529|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
125254998|NCT03715829|450560530|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
125254999|NCT03715829|450560531|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
125255000|NCT03715829|450560532|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
125255001|NCT03715829|450560533|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
125255002|NCT03715829|450560534|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
125255003|NCT03715829|450560535|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
125444467|NCT01474512|451253897|FG017|Long-Term Extension Period|Sponsor Decision|0|||
125444468|NCT01474512|451253880|FG000|Long-Term Extension Period|Protocol Violation|0|||
125444469|NCT01474512|451253881|FG001|Long-Term Extension Period|Protocol Violation|0|||
125444470|NCT01474512|451253882|FG002|Long-Term Extension Period|Protocol Violation|0|||
125444471|NCT01474512|451253883|FG003|Long-Term Extension Period|Protocol Violation|0|||
125444472|NCT01474512|451253884|FG004|Long-Term Extension Period|Protocol Violation|0|||
125444473|NCT01474512|451253885|FG005|Long-Term Extension Period|Protocol Violation|0|||
125444474|NCT01474512|451253886|FG006|Long-Term Extension Period|Protocol Violation|0|||
125444475|NCT01474512|451253887|FG007|Long-Term Extension Period|Protocol Violation|0|||
125444476|NCT01474512|451253888|FG008|Long-Term Extension Period|Protocol Violation|0|||
125444477|NCT01474512|451253889|FG009|Long-Term Extension Period|Protocol Violation|0|||
125444478|NCT01474512|451253890|FG010|Long-Term Extension Period|Protocol Violation|0|||
125444479|NCT01474512|451253891|FG011|Long-Term Extension Period|Protocol Violation|0|||
125444480|NCT01474512|451253892|FG012|Long-Term Extension Period|Protocol Violation|5|||
125444481|NCT01474512|451253893|FG013|Long-Term Extension Period|Protocol Violation|5|||
125444482|NCT01474512|451253894|FG014|Long-Term Extension Period|Protocol Violation|0|||
125444483|NCT01474512|451253895|FG015|Long-Term Extension Period|Protocol Violation|0|||
125444484|NCT01474512|451253896|FG016|Long-Term Extension Period|Protocol Violation|0|||
125444485|NCT01474512|451253897|FG017|Long-Term Extension Period|Protocol Violation|0|||
125444486|NCT01474512|451253880|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444487|NCT01474512|451253881|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444488|NCT01474512|451253882|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444489|NCT01474512|451253883|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444490|NCT01474512|451253884|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444491|NCT01474512|451253885|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444492|NCT01474512|451253886|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444493|NCT01474512|451253887|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444494|NCT01474512|451253888|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444495|NCT01474512|451253889|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444496|NCT01474512|451253890|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444497|NCT01474512|451253891|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444498|NCT01474512|451253892|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
125444499|NCT01474512|451253893|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
125444500|NCT01474512|451253894|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444501|NCT01474512|451253895|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444502|NCT01474512|451253896|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444503|NCT01474512|451253897|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
125444504|NCT01474512|451253880|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444505|NCT01474512|451253881|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444506|NCT01474512|451253882|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444507|NCT01474512|451253883|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444508|NCT01474512|451253884|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444509|NCT01474512|451253885|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444510|NCT01474512|451253886|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444511|NCT01474512|451253887|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444512|NCT01474512|451253888|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444513|NCT01474512|451253889|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444514|NCT01474512|451253890|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444515|NCT01474512|451253891|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
125444516|NCT01474512|451253892|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444517|NCT01474512|451253893|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444518|NCT01474512|451253894|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444519|NCT01474512|451253895|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444520|NCT01474512|451253896|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444521|NCT01474512|451253897|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
125444522|NCT01474512|451253880|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
125444523|NCT01474512|451253881|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
125444524|NCT01474512|451253882|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
125444525|NCT01474512|451253883|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
125444526|NCT01474512|451253884|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
125444527|NCT01474512|451253885|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
125444528|NCT01474512|451253886|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
125444529|NCT01474512|451253887|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
125444530|NCT01474512|451253888|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
125444531|NCT01474512|451253889|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
125444532|NCT01474512|451253890|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
125444533|NCT01474512|451253891|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
125444534|NCT01474512|451253892|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
125255004|NCT03715829|450560525|FG000|Extension Period|Other|0|||
125255005|NCT03715829|450560526|FG001|Extension Period|Other|0|||
125255006|NCT03715829|450560527|FG002|Extension Period|Other|0|||
125255007|NCT03715829|450560528|FG003|Extension Period|Other|0|||
125255008|NCT03715829|450560529|FG004|Extension Period|Other|0|||
125255009|NCT03715829|450560530|FG005|Extension Period|Other|0|||
125255010|NCT03715829|450560531|FG006|Extension Period|Other|1|||
125255011|NCT03715829|450560532|FG007|Extension Period|Other|2|||
125255012|NCT03715829|450560533|FG008|Extension Period|Other|4|||
125255013|NCT03715829|450560534|FG009|Extension Period|Other|0|||
125255014|NCT03715829|450560535|FG010|Extension Period|Other|0|||
125255015|NCT03579719|450560536|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
125255016|NCT03253627|450560539|FG000|Overall Study|Lost to Follow-up|1|||
125255017|NCT03253627|450560540|FG001|Overall Study|Lost to Follow-up|2|||
125255018|NCT03253627|450560539|FG000|Overall Study|Withdrawal by Subject|0|||
125255019|NCT03253627|450560540|FG001|Overall Study|Withdrawal by Subject|2|||
125255020|NCT03253627|450560539|FG000|Overall Study|Inability to complete MRI|1|||
125255021|NCT03253627|450560540|FG001|Overall Study|Inability to complete MRI|0|||
125255022|NCT01922895|450560544|FG000|Overall Study|Death|0|||
125255023|NCT01922895|450560545|FG001|Overall Study|Death|1|||
125255024|NCT01922895|450560544|FG000|Overall Study|Withdrawal by Subject|1|||
125255025|NCT01922895|450560545|FG001|Overall Study|Withdrawal by Subject|2|||
125255026|NCT01922895|450560544|FG000|Overall Study|Lost to Follow-up|5|||
125255027|NCT01922895|450560545|FG001|Overall Study|Lost to Follow-up|11|||
125255028|NCT01916226|450560546|FG000|Overall Study|Adverse Event|1|||
125255029|NCT01916226|450560547|FG001|Overall Study|Adverse Event|0|||
125255030|NCT01916226|450560548|FG002|Overall Study|Adverse Event|1|||
125255031|NCT01916226|450560549|FG003|Overall Study|Adverse Event|1|||
125255032|NCT01916226|450560546|FG000|Overall Study|Lack of Efficacy|0|||
125255033|NCT01916226|450560547|FG001|Overall Study|Lack of Efficacy|0|||
125255034|NCT01916226|450560548|FG002|Overall Study|Lack of Efficacy|2|||
125255035|NCT01916226|450560549|FG003|Overall Study|Lack of Efficacy|1|||
125255036|NCT01916226|450560546|FG000|Overall Study|Protocol Violation|0|||
125255037|NCT01916226|450560547|FG001|Overall Study|Protocol Violation|1|||
125255038|NCT01916226|450560548|FG002|Overall Study|Protocol Violation|0|||
125255039|NCT01916226|450560549|FG003|Overall Study|Protocol Violation|1|||
125255040|NCT01916226|450560546|FG000|Overall Study|Physician Decision|0|||
125255041|NCT01916226|450560547|FG001|Overall Study|Physician Decision|0|||
125255042|NCT01916226|450560548|FG002|Overall Study|Physician Decision|0|||
125255043|NCT01916226|450560549|FG003|Overall Study|Physician Decision|1|||
125255044|NCT03163667|450560550|FG000|Overall Study|Death|15|||
125255045|NCT03163667|450560551|FG001|Overall Study|Death|27|||
125255046|NCT03163667|450560550|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
125255047|NCT03163667|450560551|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
125255048|NCT02940223|450560557|FG000|Overall Study|Failed Requirement|2|||
125255049|NCT02940223|450560558|FG001|Overall Study|Failed Requirement|0|||
125255050|NCT01422382|450560562|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
125255051|NCT01813357|450560563|FG000|Overall Study|Lost to Follow-up|5|||
125255052|NCT01813357|450560564|FG001|Overall Study|Lost to Follow-up|6|||
125255053|NCT03773562|450560565|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
125255054|NCT03773562|450560565|FG000|Overall Study|Lost to Follow-up|10|||
125444535|NCT01474512|451253893|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
125255055|NCT03773562|450560565|FG000|Overall Study|Withdrawal by Subject|1|||
125255056|NCT04082364|450560568|FG000|Overall Study|Death|23|||
125255057|NCT04082364|450560569|FG001|Overall Study|Death|1|||
125255058|NCT04082364|450560570|FG002|Overall Study|Death|1|||
125255059|NCT04082364|450560571|FG003|Overall Study|Death|2|||
125255060|NCT04082364|450560572|FG004|Overall Study|Death|1|||
125255061|NCT04082364|450560568|FG000|Overall Study|Lost to Follow-up|1|||
125255062|NCT04082364|450560569|FG001|Overall Study|Lost to Follow-up|0|||
125444536|NCT01474512|451253894|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
125444537|NCT01474512|451253895|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
125255063|NCT04082364|450560570|FG002|Overall Study|Lost to Follow-up|0|||
125255064|NCT04082364|450560571|FG003|Overall Study|Lost to Follow-up|0|||
125444538|NCT01474512|451253896|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
125255065|NCT04082364|450560572|FG004|Overall Study|Lost to Follow-up|1|||
125255066|NCT04082364|450560568|FG000|Overall Study|Physician Decision|1|||
125255067|NCT04082364|450560569|FG001|Overall Study|Physician Decision|1|||
125255068|NCT04082364|450560570|FG002|Overall Study|Physician Decision|0|||
125255069|NCT04082364|450560571|FG003|Overall Study|Physician Decision|2|||
125255070|NCT04082364|450560572|FG004|Overall Study|Physician Decision|1|||
125255071|NCT04082364|450560568|FG000|Overall Study|Withdrawal by Subject|1|||
125444539|NCT01474512|451253897|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
125255072|NCT04082364|450560569|FG001|Overall Study|Withdrawal by Subject|1|||
125255073|NCT04082364|450560570|FG002|Overall Study|Withdrawal by Subject|0|||
125255074|NCT04082364|450560571|FG003|Overall Study|Withdrawal by Subject|0|||
125255075|NCT04082364|450560572|FG004|Overall Study|Withdrawal by Subject|1|||
125255076|NCT04082364|450560568|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
125255077|NCT04082364|450560569|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
125444540|NCT01474512|451253880|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444541|NCT01474512|451253881|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444542|NCT01474512|451253882|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444543|NCT01474512|451253883|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444544|NCT01474512|451253884|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444545|NCT01474512|451253885|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444546|NCT01474512|451253886|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444547|NCT01474512|451253887|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444548|NCT01474512|451253888|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444549|NCT01474512|451253889|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444550|NCT01474512|451253890|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444551|NCT01474512|451253891|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444552|NCT01474512|451253892|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444553|NCT01474512|451253893|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
125444554|NCT01474512|451253894|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
125444555|NCT01474512|451253895|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
125444556|NCT01474512|451253896|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
125444557|NCT01474512|451253897|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
125444558|NCT01474512|451253880|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444559|NCT01474512|451253881|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444560|NCT01474512|451253882|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444561|NCT01474512|451253883|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444562|NCT01474512|451253884|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444563|NCT01474512|451253885|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444564|NCT01474512|451253886|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444565|NCT01474512|451253887|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444566|NCT01474512|451253888|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444567|NCT01474512|451253889|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444568|NCT01474512|451253890|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444569|NCT01474512|451253891|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444570|NCT01474512|451253892|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444571|NCT01474512|451253893|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
125444572|NCT01474512|451253894|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
125444573|NCT01474512|451253895|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
125444574|NCT01474512|451253896|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
125444575|NCT01474512|451253897|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
125444576|NCT01474512|451253880|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444577|NCT01474512|451253881|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444578|NCT01474512|451253882|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444579|NCT01474512|451253883|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444580|NCT01474512|451253884|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444581|NCT01474512|451253885|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444582|NCT01474512|451253886|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444583|NCT01474512|451253887|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444584|NCT01474512|451253888|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444585|NCT01474512|451253889|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444586|NCT01474512|451253890|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444587|NCT01474512|451253891|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444588|NCT01474512|451253892|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444589|NCT01474512|451253893|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444590|NCT01474512|451253894|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444591|NCT01474512|451253895|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
125444592|NCT01474512|451253896|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
125444593|NCT01474512|451253897|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
125444594|NCT01474512|451253880|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
125444595|NCT01474512|451253881|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
125444596|NCT01474512|451253882|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
125444597|NCT01474512|451253883|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
125444598|NCT01474512|451253884|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
125444599|NCT01474512|451253885|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
125255078|NCT04082364|450560570|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
125255079|NCT04082364|450560571|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
125255080|NCT04082364|450560572|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
125444600|NCT01474512|451253886|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
125444601|NCT01474512|451253887|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
125444602|NCT01474512|451253888|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
125444603|NCT01474512|451253889|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
125444604|NCT01474512|451253890|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
125444605|NCT01474512|451253891|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
125444606|NCT01474512|451253892|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
125444607|NCT01474512|451253893|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
125255081|NCT04082364|450560568|FG000|Overall Study|Disease progression|0|||
125255082|NCT04082364|450560569|FG001|Overall Study|Disease progression|0|||
125255083|NCT04082364|450560570|FG002|Overall Study|Disease progression|0|||
125255084|NCT04082364|450560571|FG003|Overall Study|Disease progression|1|||
125255085|NCT04082364|450560572|FG004|Overall Study|Disease progression|0|||
125255086|NCT04806373|450560574|FG000|Overall Study|Withdrawal by Subject|1|||
125255087|NCT04806373|450560575|FG001|Overall Study|Withdrawal by Subject|1|||
125255088|NCT03301415|450560578|FG000|Overall Study|Lost to Follow-up|2|||
125255089|NCT03301415|450560578|FG000|Overall Study|Unable to comply with visit schedule|2|||
125255090|NCT00421408|450560582|FG000|Overall Study|Lost to Follow-up|30|||
125255091|NCT00421408|450560583|FG001|Overall Study|Lost to Follow-up|20|||
125255092|NCT00421408|450560582|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
125255093|NCT00421408|450560583|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
125255094|NCT04091438|450560584|FG000|Treatment Period 1 (1 Day)|Other|1|||
125255095|NCT04091438|450560585|FG001|Treatment Period 1 (1 Day)|Other|0|||
125255096|NCT04091438|450560584|FG000|Washout Period (1 Day)|Protocol deviation|0|||
125255097|NCT04091438|450560585|FG001|Washout Period (1 Day)|Protocol deviation|1|||
125255098|NCT04091438|450560584|FG000|Washout Period (1 Day)|Other|0|||
125255099|NCT04091438|450560585|FG001|Washout Period (1 Day)|Other|1|||
125255100|NCT00787800|450560589|FG000|Overall Study|Withdrawal by Subject|3|||
125255101|NCT00787800|450560590|FG001|Overall Study|Withdrawal by Subject|5|||
125255102|NCT00787800|450560589|FG000|Overall Study|Death|0|||
125255103|NCT00787800|450560590|FG001|Overall Study|Death|2|||
125255104|NCT04309500|450560593|FG000|Overall Study|Lost to Follow-up|1|||
125255105|NCT04309500|450560594|FG001|Overall Study|Lost to Follow-up|0|||
125255106|NCT04309500|450560595|FG002|Overall Study|Lost to Follow-up|0|||
125255107|NCT04309500|450560596|FG003|Overall Study|Lost to Follow-up|0|||
125255108|NCT00913835|450560597|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
125255109|NCT00913835|450560598|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
125255110|NCT00913835|450560597|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
125255111|NCT00913835|450560598|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
125255112|NCT00913835|450560597|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
125255113|NCT00913835|450560598|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
125255114|NCT00913835|450560597|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
125255115|NCT00913835|450560598|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
125255116|NCT00913835|450560597|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
125255117|NCT00913835|450560598|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
125255118|NCT01308788|450560599|FG000|2-year Treatment|medication change by treating physician|4|||
125255119|NCT01308788|450560600|FG001|2-year Treatment|medication change by treating physician|11|||
125255120|NCT02414841|450560601|FG000|Overall Study|Withdrawal by Subject|7|||
125255121|NCT02414841|450560602|FG001|Overall Study|Withdrawal by Subject|5|||
125255122|NCT02414841|450560601|FG000|Overall Study|Lost to Follow-up|13|||
125255123|NCT02414841|450560602|FG001|Overall Study|Lost to Follow-up|6|||
125255124|NCT02414841|450560601|FG000|Overall Study|Death|17|||
125255125|NCT02414841|450560602|FG001|Overall Study|Death|14|||
125255126|NCT02414841|450560601|FG000|Overall Study|Received a Kidney Transplant|13|||
125255127|NCT02414841|450560602|FG001|Overall Study|Received a Kidney Transplant|4|||
125255128|NCT02414841|450560601|FG000|Overall Study|Randomized But Not Treated|6|||
125255129|NCT02414841|450560602|FG001|Overall Study|Randomized But Not Treated|4|||
125255130|NCT03249558|450560605|FG000|Overall Study|Lost to Follow-up|2|||
125255131|NCT03249558|450560606|FG001|Overall Study|Lost to Follow-up|1|||
125255132|NCT03249558|450560607|FG002|Overall Study|Lost to Follow-up|4|||
125255133|NCT03249558|450560605|FG000|Overall Study|Physician Decision|1|||
125255134|NCT03249558|450560606|FG001|Overall Study|Physician Decision|0|||
125255135|NCT03249558|450560607|FG002|Overall Study|Physician Decision|0|||
125255136|NCT03249558|450560605|FG000|Overall Study|Withdrawal by Subject|6|||
125255137|NCT03249558|450560606|FG001|Overall Study|Withdrawal by Subject|5|||
125255138|NCT03249558|450560607|FG002|Overall Study|Withdrawal by Subject|7|||
125255139|NCT03249558|450560605|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
125255140|NCT03249558|450560606|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
125255141|NCT03249558|450560607|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
125255142|NCT03249558|450560605|FG000|Overall Study|Protocol Violation|1|||
125444608|NCT01474512|451253894|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
125444609|NCT01474512|451253895|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
125255143|NCT03249558|450560606|FG001|Overall Study|Protocol Violation|1|||
125255144|NCT03249558|450560607|FG002|Overall Study|Protocol Violation|2|||
125255145|NCT05943990|450560608|FG000|Overall Study|Study Terminated by Sponsor|0|||
125255146|NCT05943990|450560609|FG001|Overall Study|Study Terminated by Sponsor|0|||
125255147|NCT05943990|450560610|FG002|Overall Study|Study Terminated by Sponsor|1|||
125255148|NCT02657356|450561564|FG000|Overall Study|Death|1|||
125255149|NCT02657356|450561565|FG001|Overall Study|Death|0|||
125255150|NCT02657356|450561564|FG000|Overall Study|Withdrawal by Subject|5|||
125255151|NCT02657356|450561565|FG001|Overall Study|Withdrawal by Subject|6|||
125255152|NCT02657356|450561564|FG000|Overall Study|Terminated by Sponsor|8|||
125255153|NCT02657356|450561565|FG001|Overall Study|Terminated by Sponsor|5|||
125255154|NCT02657356|450561564|FG000|Overall Study|Rolled over to EAP study|6|||
125255155|NCT02657356|450561565|FG001|Overall Study|Rolled over to EAP study|4|||
125255156|NCT03379870|450561566|FG000|Overall Study|Lost to Follow-up|1|||
125255157|NCT03379870|450561567|FG001|Overall Study|Lost to Follow-up|0|||
125255158|NCT03379870|450561566|FG000|Overall Study|Protocol Violation|1|||
125255159|NCT03379870|450561567|FG001|Overall Study|Protocol Violation|1|||
125255160|NCT01394185|450561568|FG000|Overall Study|Withdrawal by Subject|2|||
125255161|NCT01394185|450561569|FG001|Overall Study|Withdrawal by Subject|0|||
125255162|NCT01394185|450561570|FG002|Overall Study|Withdrawal by Subject|0|||
125255163|NCT01394185|450561571|FG003|Overall Study|Withdrawal by Subject|0|||
125255164|NCT01394185|450561572|FG004|Overall Study|Withdrawal by Subject|1|||
125255165|NCT01394185|450561573|FG005|Overall Study|Withdrawal by Subject|0|||
125255166|NCT01394185|450561568|FG000|Overall Study|Change in protocol|3|||
125255167|NCT01394185|450561569|FG001|Overall Study|Change in protocol|0|||
125255168|NCT01394185|450561570|FG002|Overall Study|Change in protocol|0|||
125255169|NCT01394185|450561571|FG003|Overall Study|Change in protocol|0|||
125255170|NCT01394185|450561572|FG004|Overall Study|Change in protocol|3|||
125255171|NCT01394185|450561573|FG005|Overall Study|Change in protocol|0|||
125255172|NCT01394185|450561568|FG000|Overall Study|Protocol Violation|1|||
125255173|NCT01394185|450561569|FG001|Overall Study|Protocol Violation|0|||
125255174|NCT01394185|450561570|FG002|Overall Study|Protocol Violation|0|||
125255175|NCT01394185|450561571|FG003|Overall Study|Protocol Violation|1|||
125255176|NCT01394185|450561572|FG004|Overall Study|Protocol Violation|0|||
125255177|NCT01394185|450561573|FG005|Overall Study|Protocol Violation|1|||
125255178|NCT02904265|450561574|FG000|Overall Study|Physician Decision|1|||
125255179|NCT02904265|450561575|FG001|Overall Study|Physician Decision|2|||
125255180|NCT00267488|450561580|FG000|Overall Study|Sponsor Terminated Study|9|||
125255181|NCT00267488|450561580|FG000|Overall Study|Protocol Violation|1|||
125255182|NCT00267488|450561580|FG000|Overall Study|Other (Disease Progression)|1|||
125255183|NCT01557569|450561581|FG000|Overall Study|Adverse Event|2|||
125255184|NCT01557569|450561582|FG001|Overall Study|Adverse Event|0|||
125255185|NCT01557569|450561581|FG000|Overall Study|high blood pressure|0|||
125255186|NCT01557569|450561582|FG001|Overall Study|high blood pressure|1|||
125255187|NCT01557569|450561581|FG000|Overall Study|Withdrawal by Subject|3|||
125255188|NCT01557569|450561582|FG001|Overall Study|Withdrawal by Subject|5|||
125255189|NCT01557569|450561581|FG000|Overall Study|noncompliance with rules of residential|0|||
125255190|NCT01557569|450561582|FG001|Overall Study|noncompliance with rules of residential|1|||
125255191|NCT02254460|450561583|FG000|Overall Study|Adverse Event|1|||
125255192|NCT02254460|450561584|FG001|Overall Study|Adverse Event|0|||
125255193|NCT01817777|450561587|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
125255194|NCT01817777|450561588|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
125255195|NCT01817777|450561589|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
125255196|NCT01817777|450561587|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
125255197|NCT01817777|450561588|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
125255198|NCT01817777|450561589|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
125255199|NCT01817777|450561587|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
125255200|NCT01817777|450561588|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
125255201|NCT01817777|450561589|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
125255202|NCT01817777|450561587|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
125255203|NCT01817777|450561588|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
125255204|NCT01817777|450561589|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
125255205|NCT01817777|450561587|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
125255206|NCT01817777|450561588|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
125255207|NCT01817777|450561589|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
125255208|NCT00557440|450561590|FG000|Treatment Period 1|Adverse Event|0|||
125255209|NCT00557440|450561591|FG001|Treatment Period 1|Adverse Event|0|||
125255210|NCT00557440|450561592|FG002|Treatment Period 1|Adverse Event|1|||
125255211|NCT03524157|450561593|FG000|Overall Study|cytology not readable|0|||
125255212|NCT03524157|450561594|FG001|Overall Study|cytology not readable|0|||
125255213|NCT03524157|450561595|FG002|Overall Study|cytology not readable|1|||
125255214|NCT01592747|450561596|FG000|Overall Study|Loss of Therapeutic Response|107|||
125255215|NCT01592747|450561597|FG001|Overall Study|Loss of Therapeutic Response|108|||
125255216|NCT01592747|450561598|FG002|Overall Study|Loss of Therapeutic Response|100|||
125255217|NCT01592747|450561596|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
125255218|NCT01592747|450561597|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
125255219|NCT01592747|450561598|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
125255220|NCT01592747|450561596|FG000|Overall Study|Adverse Event|1|||
125255221|NCT01592747|450561597|FG001|Overall Study|Adverse Event|0|||
125255222|NCT01592747|450561598|FG002|Overall Study|Adverse Event|0|||
125255223|NCT01592747|450561596|FG000|Overall Study|Protocol Violation|4|||
125255224|NCT01592747|450561597|FG001|Overall Study|Protocol Violation|0|||
125255225|NCT01592747|450561598|FG002|Overall Study|Protocol Violation|4|||
125255226|NCT01592747|450561596|FG000|Overall Study|Lack of Efficacy|0|||
125255227|NCT01592747|450561597|FG001|Overall Study|Lack of Efficacy|1|||
125255228|NCT01592747|450561598|FG002|Overall Study|Lack of Efficacy|0|||
125255229|NCT01592747|450561596|FG000|Overall Study|Withdrawal by Subject|2|||
125444610|NCT01474512|451253896|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
125444611|NCT01474512|451253897|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
125444612|NCT01474512|451253880|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444613|NCT01474512|451253881|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444614|NCT01474512|451253882|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444615|NCT01474512|451253883|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444616|NCT01474512|451253884|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444617|NCT01474512|451253885|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444618|NCT01474512|451253886|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444619|NCT01474512|451253887|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444620|NCT01474512|451253888|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444621|NCT01474512|451253889|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444622|NCT01474512|451253890|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444623|NCT01474512|451253891|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444624|NCT01474512|451253892|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444625|NCT01474512|451253893|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444626|NCT01474512|451253894|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444627|NCT01474512|451253895|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
125444628|NCT01474512|451253896|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
125444629|NCT01474512|451253897|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
125444630|NCT01474512|451253880|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
125444631|NCT01474512|451253881|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
125444632|NCT01474512|451253882|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
125444633|NCT01474512|451253883|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
125444634|NCT01474512|451253884|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
125255230|NCT01592747|450561597|FG001|Overall Study|Withdrawal by Subject|0|||
125255231|NCT01592747|450561598|FG002|Overall Study|Withdrawal by Subject|2|||
125255232|NCT01592747|450561596|FG000|Overall Study|Lost to Follow-up|1|||
125255233|NCT01592747|450561597|FG001|Overall Study|Lost to Follow-up|0|||
125255234|NCT01592747|450561598|FG002|Overall Study|Lost to Follow-up|1|||
125255235|NCT01592747|450561596|FG000|Overall Study|Other Reasons|1|||
125255236|NCT01592747|450561597|FG001|Overall Study|Other Reasons|1|||
125255237|NCT01592747|450561598|FG002|Overall Study|Other Reasons|0|||
125255238|NCT02853136|450561599|FG000|Wash-out|Adverse Event|0|||
125255239|NCT02853136|450561600|FG001|Wash-out|Adverse Event|0|||
125255240|NCT02853136|450561601|FG002|Wash-out|Adverse Event|0|||
125255241|NCT02853136|450561602|FG003|Wash-out|Adverse Event|1|||
125255242|NCT00867334|450561603|FG000|Overall Study|Withdrawal by Subject|0|||
125255243|NCT00867334|450561604|FG001|Overall Study|Withdrawal by Subject|1|||
125255244|NCT00867334|450561603|FG000|Overall Study|Withdrawal by Subject|1|||
125255245|NCT00867334|450561604|FG001|Overall Study|Withdrawal by Subject|0|||
125255246|NCT00867334|450561603|FG000|Overall Study|Withdrawal by Subject|1|||
125255247|NCT00867334|450561604|FG001|Overall Study|Withdrawal by Subject|0|||
125255248|NCT05418426|450561606|FG000|Overall Study|Adverse Event|0|||
125255249|NCT05418426|450561607|FG001|Overall Study|Adverse Event|1|||
125255250|NCT05418426|450561608|FG002|Overall Study|Adverse Event|0|||
125255251|NCT05418426|450561606|FG000|Overall Study|Withdrawal by Subject|0|||
125255252|NCT05418426|450561607|FG001|Overall Study|Withdrawal by Subject|1|||
125255253|NCT05418426|450561608|FG002|Overall Study|Withdrawal by Subject|0|||
125255254|NCT05418426|450561606|FG000|Overall Study|Protocol Violation|0|||
125255255|NCT05418426|450561607|FG001|Overall Study|Protocol Violation|0|||
125255256|NCT05418426|450561608|FG002|Overall Study|Protocol Violation|1|||
125255257|NCT04620668|450561609|FG000|Overall Study|Withdrawal by Subject|2|||
125255258|NCT04620668|450561610|FG001|Overall Study|Withdrawal by Subject|0|||
125255259|NCT04620668|450561609|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
125255260|NCT04620668|450561610|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
125255261|NCT04620668|450561609|FG000|Overall Study|Removed before analysis: missing data|2|||
125255262|NCT04620668|450561610|FG001|Overall Study|Removed before analysis: missing data|0|||
125255263|NCT04620668|450561609|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
125255264|NCT04620668|450561610|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
125255265|NCT04620668|450561609|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
125444635|NCT01474512|451253885|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
125444636|NCT01474512|451253886|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
125444637|NCT01474512|451253887|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
125444638|NCT01474512|451253888|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
125444639|NCT01474512|451253889|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
125444640|NCT01474512|451253890|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
125255266|NCT04620668|450561610|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
125255267|NCT02951819|450561615|FG000|Overall Study|Death|9|||
125444641|NCT01474512|451253891|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
125255268|NCT02951819|450561616|FG001|Overall Study|Death|7|||
125255269|NCT02951819|450561615|FG000|Overall Study|Withdrawal by Subject|3|||
125255270|NCT02951819|450561616|FG001|Overall Study|Withdrawal by Subject|0|||
125255271|NCT02951819|450561615|FG000|Overall Study|Adverse Event|1|||
125255272|NCT02951819|450561616|FG001|Overall Study|Adverse Event|0|||
125255273|NCT02951819|450561615|FG000|Overall Study|Lack of Efficacy|4|||
125255274|NCT02951819|450561616|FG001|Overall Study|Lack of Efficacy|0|||
125255275|NCT02951819|450561615|FG000|Overall Study|Lost to Follow-up|1|||
125255276|NCT02951819|450561616|FG001|Overall Study|Lost to Follow-up|0|||
125255277|NCT02951819|450561615|FG000|Overall Study|Progressive Disease|1|||
125255278|NCT02951819|450561616|FG001|Overall Study|Progressive Disease|0|||
125255279|NCT02951819|450561615|FG000|Overall Study|Other|9|||
125255280|NCT02951819|450561616|FG001|Overall Study|Other|0|||
125255281|NCT05810597|450561619|FG000|Period 1|Adverse Event|2|||
125255282|NCT05810597|450561620|FG001|Period 1|Adverse Event|0|||
125255283|NCT05810597|450561619|FG000|Period 1|Physician Decision|1|||
125255284|NCT05810597|450561620|FG001|Period 1|Physician Decision|0|||
125255285|NCT05021224|450561621|FG000|Overall Study|Did not complete all survey items|4|||
125255286|NCT05021224|450561622|FG001|Overall Study|Did not complete all survey items|1|||
125255287|NCT05021224|450561623|FG002|Overall Study|Did not complete all survey items|0|||
125255288|NCT05021224|450561624|FG003|Overall Study|Did not complete all survey items|2|||
125255289|NCT02412436|450561625|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
125255290|NCT02412436|450561625|FG000|Overall Study|Lost to Follow-up|6|||
125255291|NCT02412436|450561625|FG000|Overall Study|Unable to get to clinic|3|||
125255292|NCT02412436|450561625|FG000|Overall Study|Death|1|||
125255293|NCT02412436|450561625|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
125255294|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
125255295|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125255296|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125255297|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125255298|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
125255299|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
125255300|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125255301|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125255302|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125255303|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
125255304|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
125255305|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125255306|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125255307|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125255308|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
125255309|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
125255310|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
125255311|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
125255312|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
125255313|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
125255314|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
125255315|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
125255316|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
125255317|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
125255318|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
125255319|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
125255320|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
125255321|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
125255322|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
125255323|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
125255324|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
125255325|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125255326|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125255327|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125255328|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
125255329|NCT01111552|450561626|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
125255330|NCT01111552|450561627|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
125255331|NCT01111552|450561628|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
125255332|NCT01111552|450561629|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
125255333|NCT01111552|450561630|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
125255334|NCT01111552|450561626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125255335|NCT01111552|450561627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125255336|NCT01111552|450561628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125255337|NCT01111552|450561629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
125255338|NCT01111552|450561630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
125255339|NCT01111552|450561626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
125255340|NCT01111552|450561627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
125444642|NCT01474512|451253892|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
125444643|NCT01474512|451253893|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
125444644|NCT01474512|451253894|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
125444645|NCT01474512|451253895|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
125444646|NCT01474512|451253896|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
125444647|NCT01474512|451253897|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
125444648|NCT01474512|451253880|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444649|NCT01474512|451253881|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444650|NCT01474512|451253882|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444651|NCT01474512|451253883|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444652|NCT01474512|451253884|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444653|NCT01474512|451253885|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444654|NCT01474512|451253886|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444655|NCT01474512|451253887|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444656|NCT01474512|451253888|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444657|NCT01474512|451253889|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444658|NCT01474512|451253890|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444659|NCT01474512|451253891|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444660|NCT01474512|451253892|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444661|NCT01474512|451253893|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444662|NCT01474512|451253894|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
125444663|NCT01474512|451253895|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444664|NCT01474512|451253896|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
125444665|NCT01474512|451253897|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
125444666|NCT01474512|451253880|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444667|NCT01474512|451253881|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444668|NCT01474512|451253882|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444669|NCT01474512|451253883|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444670|NCT01474512|451253884|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444671|NCT01474512|451253885|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444672|NCT01474512|451253886|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444673|NCT01474512|451253887|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444674|NCT01474512|451253888|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444675|NCT01474512|451253889|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444676|NCT01474512|451253890|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444677|NCT01474512|451253891|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444678|NCT01474512|451253892|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444679|NCT01474512|451253893|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444680|NCT01474512|451253894|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
125444681|NCT01474512|451253895|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444682|NCT01474512|451253896|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
125444683|NCT01474512|451253897|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
125444684|NCT01474512|451253880|FG000|Post-Treatment Follow-Up|Death|0|||
125444685|NCT01474512|451253881|FG001|Post-Treatment Follow-Up|Death|0|||
125444686|NCT01474512|451253882|FG002|Post-Treatment Follow-Up|Death|0|||
125444687|NCT01474512|451253883|FG003|Post-Treatment Follow-Up|Death|0|||
125444688|NCT01474512|451253884|FG004|Post-Treatment Follow-Up|Death|0|||
125444689|NCT01474512|451253885|FG005|Post-Treatment Follow-Up|Death|0|||
125444690|NCT01474512|451253886|FG006|Post-Treatment Follow-Up|Death|0|||
125444691|NCT01474512|451253887|FG007|Post-Treatment Follow-Up|Death|0|||
125444692|NCT01474512|451253888|FG008|Post-Treatment Follow-Up|Death|0|||
125444693|NCT01474512|451253889|FG009|Post-Treatment Follow-Up|Death|0|||
125444694|NCT01474512|451253890|FG010|Post-Treatment Follow-Up|Death|0|||
125444695|NCT01474512|451253891|FG011|Post-Treatment Follow-Up|Death|0|||
125444696|NCT01474512|451253892|FG012|Post-Treatment Follow-Up|Death|0|||
125444697|NCT01474512|451253893|FG013|Post-Treatment Follow-Up|Death|0|||
125444698|NCT01474512|451253894|FG014|Post-Treatment Follow-Up|Death|0|||
125444699|NCT01474512|451253895|FG015|Post-Treatment Follow-Up|Death|0|||
125444700|NCT01474512|451253896|FG016|Post-Treatment Follow-Up|Death|1|||
125255341|NCT01111552|450561628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
125255342|NCT01111552|450561629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
125255343|NCT01111552|450561630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
125255344|NCT01111552|450561626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
125255345|NCT01111552|450561627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
125444701|NCT01474512|451253897|FG017|Post-Treatment Follow-Up|Death|0|||
125444702|NCT01890967|451253900|FG000|Overall Study|Adverse Event|3|||
125444703|NCT01890967|451253901|FG001|Overall Study|Adverse Event|3|||
125444704|NCT01890967|451253902|FG002|Overall Study|Adverse Event|3|||
125444705|NCT01890967|451253903|FG003|Overall Study|Adverse Event|2|||
125444706|NCT01890967|451253904|FG004|Overall Study|Adverse Event|1|||
125444707|NCT01890967|451253905|FG005|Overall Study|Adverse Event|7|||
125255346|NCT01111552|450561628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
125255347|NCT01111552|450561629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
125255348|NCT01111552|450561630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
125255349|NCT01111552|450561626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
125255350|NCT01111552|450561627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
125255351|NCT01111552|450561628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
125255352|NCT01111552|450561629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
125255353|NCT01111552|450561630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
125255354|NCT01111552|450561626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
125255355|NCT01111552|450561627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
125255356|NCT01111552|450561628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
125255357|NCT01111552|450561629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
125255358|NCT01111552|450561630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
125255359|NCT01111552|450561626|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125255360|NCT01111552|450561627|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125255361|NCT01111552|450561628|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
125255362|NCT01111552|450561629|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125255363|NCT01111552|450561630|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
125255364|NCT04090749|450561631|FG000|Open Label Pilot|Lost to Follow-up|1|||
125255365|NCT04090749|450561632|FG001|Open Label Pilot|Lost to Follow-up|0|||
125255366|NCT04090749|450561633|FG002|Open Label Pilot|Lost to Follow-up|0|||
125255367|NCT04090749|450561631|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
125255368|NCT04090749|450561632|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
125255369|NCT04090749|450561633|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
125255370|NCT04090749|450561631|FG000|Pilot Trial|Lost to Follow-up|0|||
125255371|NCT04090749|450561632|FG001|Pilot Trial|Lost to Follow-up|1|||
125255372|NCT04090749|450561633|FG002|Pilot Trial|Lost to Follow-up|1|||
125255373|NCT02528305|450561634|FG000|Overall Study|Withdrawal by Subject|1|||
125255374|NCT02528305|450561634|FG000|Overall Study|Adverse Event|1|||
125255375|NCT02528305|450561634|FG000|Overall Study|Physician Decision|1|||
125255376|NCT02184442|450561635|FG000|Overall Study|Death|61|||
125255377|NCT02184442|450561636|FG001|Overall Study|Death|65|||
125255378|NCT02184442|450561635|FG000|Overall Study|Withdrawal by Subject|3|||
125255379|NCT02184442|450561636|FG001|Overall Study|Withdrawal by Subject|11|||
125255380|NCT01852214|450561637|FG000|Period 1|Adverse Event|1|||
125255381|NCT01852214|450561638|FG001|Period 1|Adverse Event|2|||
125255382|NCT01852214|450561637|FG000|Period 1|Withdrawal by Subject|0|||
125255383|NCT01852214|450561638|FG001|Period 1|Withdrawal by Subject|1|||
125255384|NCT01852214|450561637|FG000|Washout Period|Withdrawal by Subject|0|||
125255385|NCT01852214|450561638|FG001|Washout Period|Withdrawal by Subject|1|||
125255386|NCT02691494|450561641|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
125255387|NCT02691494|450561642|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
125255388|NCT02691494|450561643|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
125255389|NCT02691494|450561641|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
125255390|NCT02691494|450561642|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
125255391|NCT02691494|450561643|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
125255392|NCT02691494|450561641|FG000|Post-Treatment Follow-Up Period|Other|2|||
125255393|NCT02691494|450561642|FG001|Post-Treatment Follow-Up Period|Other|1|||
125255394|NCT02691494|450561643|FG002|Post-Treatment Follow-Up Period|Other|1|||
125255395|NCT02691494|450561641|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
125255396|NCT02691494|450561642|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
125255397|NCT02691494|450561643|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
125255398|NCT02691494|450561641|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
125255399|NCT02691494|450561642|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
125255400|NCT02691494|450561643|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
125255401|NCT00637156|450561644|FG000|Overall Study|Withdrawal by Subject|0|||
125255402|NCT00637156|450561645|FG001|Overall Study|Withdrawal by Subject|7|||
125255403|NCT00637156|450561644|FG000|Overall Study|Death|0|||
125255404|NCT00637156|450561645|FG001|Overall Study|Death|1|||
125255405|NCT00637156|450561644|FG000|Overall Study|Lost to Follow-up|10|||
125255406|NCT00637156|450561645|FG001|Overall Study|Lost to Follow-up|16|||
125255407|NCT00461812|450561646|FG000|Overall Study|study terminated|10|||
125255408|NCT03193437|450561647|FG000|Overall Study|Adverse Event|4|||
125255409|NCT03193437|450561647|FG000|Overall Study|Withdrawal by Subject|2|||
125255410|NCT03193437|450561647|FG000|Overall Study|Disease Progression|2|||
125255411|NCT05487378|450561648|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
125255412|NCT05487378|450561649|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
125255413|NCT05487378|450561648|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
125444708|NCT01890967|451253900|FG000|Overall Study|Death|1|||
125255414|NCT05487378|450561649|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
125255415|NCT00964678|450561664|FG000|Overall Study|Physician Decision|4|||
125444709|NCT01890967|451253901|FG001|Overall Study|Death|0|||
125255416|NCT03359395|450561667|FG000|First Intervention A / B|Withdrawal by Subject|1|||
125255417|NCT03359395|450561668|FG001|First Intervention A / B|Withdrawal by Subject|0|||
125255418|NCT03359395|450561667|FG000|First Intervention A / B|Lost to Follow-up|2|||
125255419|NCT03359395|450561668|FG001|First Intervention A / B|Lost to Follow-up|3|||
125255420|NCT03359395|450561667|FG000|Second Intervention B/A|Exclusion criteria|0|||
125255421|NCT03359395|450561668|FG001|Second Intervention B/A|Exclusion criteria|1|||
125255422|NCT03359395|450561667|FG000|Second Intervention B/A|Lost to Follow-up|3|||
125255423|NCT03359395|450561668|FG001|Second Intervention B/A|Lost to Follow-up|2|||
125255424|NCT03164356|450561669|FG000|Overall Study|Lost to Follow-up|1|||
125255425|NCT03164356|450561670|FG001|Overall Study|Lost to Follow-up|1|||
125255426|NCT03164356|450561671|FG002|Overall Study|Lost to Follow-up|2|||
125255427|NCT03164356|450561672|FG003|Overall Study|Lost to Follow-up|1|||
125255428|NCT03164356|450561669|FG000|Overall Study|Physician Decision|0|||
125255429|NCT03164356|450561670|FG001|Overall Study|Physician Decision|0|||
125255430|NCT03164356|450561671|FG002|Overall Study|Physician Decision|3|||
125255431|NCT03164356|450561672|FG003|Overall Study|Physician Decision|0|||
125255432|NCT03164356|450561669|FG000|Overall Study|Protocol Violation|2|||
125255433|NCT03164356|450561670|FG001|Overall Study|Protocol Violation|1|||
125255434|NCT03164356|450561671|FG002|Overall Study|Protocol Violation|0|||
125255435|NCT03164356|450561672|FG003|Overall Study|Protocol Violation|0|||
125255436|NCT03164356|450561669|FG000|Overall Study|Withdrawal by Subject|1|||
125255437|NCT03164356|450561670|FG001|Overall Study|Withdrawal by Subject|0|||
125255438|NCT03164356|450561671|FG002|Overall Study|Withdrawal by Subject|0|||
125255439|NCT03164356|450561672|FG003|Overall Study|Withdrawal by Subject|0|||
125255440|NCT03164356|450561669|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
125255441|NCT03164356|450561670|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
125255442|NCT03164356|450561671|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
125255443|NCT03164356|450561672|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
125255444|NCT03164356|450561669|FG000|Overall Study|Subject Incarcerated|0|||
125255445|NCT03164356|450561670|FG001|Overall Study|Subject Incarcerated|1|||
125255446|NCT03164356|450561671|FG002|Overall Study|Subject Incarcerated|0|||
125255447|NCT03164356|450561672|FG003|Overall Study|Subject Incarcerated|0|||
125255448|NCT03164356|450561669|FG000|Overall Study|Prosthetist unable to participate|0|||
125255449|NCT03164356|450561670|FG001|Overall Study|Prosthetist unable to participate|2|||
125255450|NCT03164356|450561671|FG002|Overall Study|Prosthetist unable to participate|1|||
125255451|NCT03164356|450561672|FG003|Overall Study|Prosthetist unable to participate|0|||
125255452|NCT00561821|450561673|FG000|Overall Study|Not treated|0|||
125255453|NCT00561821|450561674|FG001|Overall Study|Not treated|0|||
125255454|NCT00561821|450561675|FG002|Overall Study|Not treated|1|||
125255455|NCT00561821|450561676|FG003|Overall Study|Not treated|0|||
125255456|NCT00561821|450561673|FG000|Overall Study|Withdrawal by Subject|0|||
125255457|NCT00561821|450561674|FG001|Overall Study|Withdrawal by Subject|1|||
125255458|NCT00561821|450561675|FG002|Overall Study|Withdrawal by Subject|0|||
125255459|NCT00561821|450561676|FG003|Overall Study|Withdrawal by Subject|2|||
125255460|NCT00561821|450561673|FG000|Overall Study|Reasons not related to trial|2|||
125255461|NCT00561821|450561674|FG001|Overall Study|Reasons not related to trial|1|||
125255462|NCT00561821|450561675|FG002|Overall Study|Reasons not related to trial|0|||
125255463|NCT00561821|450561676|FG003|Overall Study|Reasons not related to trial|0|||
125255464|NCT00561821|450561673|FG000|Overall Study|Other (reason not specified)|1|||
125255465|NCT00561821|450561674|FG001|Overall Study|Other (reason not specified)|1|||
125255466|NCT00561821|450561675|FG002|Overall Study|Other (reason not specified)|0|||
125255467|NCT00561821|450561676|FG003|Overall Study|Other (reason not specified)|0|||
125255468|NCT00561821|450561673|FG000|Overall Study|Adverse Event|2|||
125255469|NCT00561821|450561674|FG001|Overall Study|Adverse Event|3|||
125255470|NCT00561821|450561675|FG002|Overall Study|Adverse Event|1|||
125255471|NCT00561821|450561676|FG003|Overall Study|Adverse Event|1|||
125255472|NCT02520154|450561678|FG000|Overall Study|Death|1|||
125255473|NCT02520154|450561678|FG000|Overall Study|Withdrawal by Subject|2|||
125255474|NCT02520154|450561678|FG000|Overall Study|Physician Decision|2|||
125303085|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
125303086|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303087|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303088|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303089|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
125303090|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303091|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303092|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303093|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
125303094|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303095|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303096|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303097|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125444710|NCT01890967|451253902|FG002|Overall Study|Death|0|||
125255475|NCT03443401|450562973|FG000|Overall Study|Lost to Follow-up|13|||
125255476|NCT03443401|450562973|FG000|Overall Study|Influential outlier|1|||
125255477|NCT00137449|450562974|FG000|Overall Study|Disease Progression|8|||
125255478|NCT00137449|450562975|FG001|Overall Study|Disease Progression|13|||
125255479|NCT00137449|450562974|FG000|Overall Study|Death|4|||
125255480|NCT00137449|450562975|FG001|Overall Study|Death|3|||
125255481|NCT00137449|450562974|FG000|Overall Study|Adverse Event|3|||
125255482|NCT00137449|450562975|FG001|Overall Study|Adverse Event|1|||
125255483|NCT00137449|450562974|FG000|Overall Study|Withdrawal by Subject|1|||
125255484|NCT00137449|450562975|FG001|Overall Study|Withdrawal by Subject|1|||
125255485|NCT01356940|450562976|FG000|First Intervention (28 Days)|Adverse Event|1|||
125255486|NCT01356940|450562977|FG001|First Intervention (28 Days)|Adverse Event|0|||
125255487|NCT01356940|450562976|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
125255488|NCT01356940|450562977|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
125255489|NCT00505687|450562980|FG000|Overall Study|Important protocol violation|2|||
125255490|NCT00505687|450562980|FG000|Overall Study|Lack of Efficacy|15|||
125255491|NCT00505687|450562980|FG000|Overall Study|Adverse Event|48|||
125255492|NCT00505687|450562980|FG000|Overall Study|Subject withdrew consent|15|||
125255493|NCT00505687|450562980|FG000|Overall Study|Lost to Follow-up|1|||
125255494|NCT00505687|450562980|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
125255495|NCT00505687|450562980|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
125255496|NCT00505687|450562980|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
125255497|NCT00505687|450562980|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
125255498|NCT00505687|450562980|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
125255499|NCT00505687|450562980|FG000|Overall Study|Other: Disease Progression|1|||
125255500|NCT00505687|450562980|FG000|Overall Study|Other: As Per Sponsor|8|||
125255501|NCT00278161|450562981|FG000|Overall Study|Death|11|||
125255502|NCT00443456|450562982|FG000|Overall Study|Adverse Event|16|||
125255503|NCT00443456|450562982|FG000|Overall Study|Move|1|||
125255504|NCT00443456|450562982|FG000|Overall Study|Withdrawal by Subject|1|||
125255505|NCT02157610|450562983|FG000|Overall Study|Death|4|||
125255506|NCT02157610|450562984|FG001|Overall Study|Death|4|||
125255507|NCT00124657|450562985|FG000|Overall Study|Toxicity|0|||
125255508|NCT00124657|450562986|FG001|Overall Study|Toxicity|0|||
125255509|NCT00124657|450562987|FG002|Overall Study|Toxicity|1|||
125255510|NCT00124657|450562985|FG000|Overall Study|Non-compliance|1|||
125255511|NCT00124657|450562986|FG001|Overall Study|Non-compliance|0|||
125255512|NCT00124657|450562987|FG002|Overall Study|Non-compliance|4|||
125255513|NCT00124657|450562985|FG000|Overall Study|Progressive disease|14|||
125255514|NCT00124657|450562986|FG001|Overall Study|Progressive disease|5|||
125255515|NCT00124657|450562987|FG002|Overall Study|Progressive disease|27|||
125255516|NCT00124657|450562985|FG000|Overall Study|Intercurrent illness|1|||
125255517|NCT00124657|450562986|FG001|Overall Study|Intercurrent illness|0|||
125255518|NCT00124657|450562987|FG002|Overall Study|Intercurrent illness|0|||
125255519|NCT01935947|450562988|FG000|Overall Study|Adverse Event|0|||
125255520|NCT01935947|450562989|FG001|Overall Study|Adverse Event|2|||
125255521|NCT01935947|450562990|FG002|Overall Study|Adverse Event|0|||
125255522|NCT01935947|450562988|FG000|Overall Study|Diease Progression|2|||
125255523|NCT01935947|450562989|FG001|Overall Study|Diease Progression|2|||
125255524|NCT01935947|450562990|FG002|Overall Study|Diease Progression|2|||
125255525|NCT01935947|450562988|FG000|Overall Study|Death|1|||
125255526|NCT01935947|450562989|FG001|Overall Study|Death|0|||
125255527|NCT01935947|450562990|FG002|Overall Study|Death|0|||
125255528|NCT04507763|450562991|FG000|Overall Study|Participants did not meet entrance criteria|201|||
125255529|NCT03427619|450562992|FG000|Overall Study|Physician Decision|3|||
125255530|NCT03427619|450562992|FG000|Overall Study|Withdrawal by Subject|4|||
125255531|NCT03427619|450562992|FG000|Overall Study|Lost to Follow-up|5|||
125255532|NCT03427619|450562992|FG000|Overall Study|Administrative|4|||
125255533|NCT03427619|450562992|FG000|Overall Study|Other|2|||
125255534|NCT03427619|450562992|FG000|Overall Study|Unknown or Missing Completion Status|48|||
125255535|NCT00425555|450562993|FG000|Overall Study|Withdrawal by Subject|11|||
125255536|NCT00425555|450562994|FG001|Overall Study|Withdrawal by Subject|8|||
125255537|NCT00425555|450562993|FG000|Overall Study|Lost to Follow-up|0|||
125255538|NCT00425555|450562994|FG001|Overall Study|Lost to Follow-up|1|||
125255539|NCT00425555|450562993|FG000|Overall Study|Administrative problems|3|||
125255540|NCT00425555|450562994|FG001|Overall Study|Administrative problems|0|||
125255541|NCT00425555|450562993|FG000|Overall Study|Death|1|||
125255542|NCT00425555|450562994|FG001|Overall Study|Death|2|||
125255543|NCT00425555|450562993|FG000|Overall Study|New cancer therapy|2|||
125255544|NCT00425555|450562994|FG001|Overall Study|New cancer therapy|1|||
125255545|NCT00425555|450562993|FG000|Overall Study|Disease progression|36|||
125255546|NCT00425555|450562994|FG001|Overall Study|Disease progression|33|||
125255547|NCT00425555|450562993|FG000|Overall Study|Adverse Event|25|||
125255548|NCT00425555|450562994|FG001|Overall Study|Adverse Event|15|||
125255549|NCT00425555|450562993|FG000|Overall Study|Protocol Violation|1|||
125255550|NCT00425555|450562994|FG001|Overall Study|Protocol Violation|0|||
125255551|NCT05763381|450562995|FG000|Overall Study|Lost to Follow-up|2|||
125255552|NCT05763381|450562996|FG001|Overall Study|Lost to Follow-up|3|||
125255553|NCT05763381|450562995|FG000|Overall Study|Withdrawal by Subject|1|||
125444711|NCT01890967|451253903|FG003|Overall Study|Death|0|||
125444712|NCT01890967|451253904|FG004|Overall Study|Death|0|||
125444713|NCT01890967|451253905|FG005|Overall Study|Death|0|||
125444714|NCT01890967|451253900|FG000|Overall Study|Lost to Follow-up|1|||
125444715|NCT01890967|451253901|FG001|Overall Study|Lost to Follow-up|1|||
125444716|NCT01890967|451253902|FG002|Overall Study|Lost to Follow-up|1|||
125444717|NCT01890967|451253903|FG003|Overall Study|Lost to Follow-up|1|||
125444718|NCT01890967|451253904|FG004|Overall Study|Lost to Follow-up|0|||
125444719|NCT01890967|451253905|FG005|Overall Study|Lost to Follow-up|1|||
125444720|NCT01890967|451253900|FG000|Overall Study|Protocol Violation|0|||
125444721|NCT01890967|451253901|FG001|Overall Study|Protocol Violation|3|||
125444722|NCT01890967|451253902|FG002|Overall Study|Protocol Violation|3|||
125444723|NCT01890967|451253903|FG003|Overall Study|Protocol Violation|2|||
125444724|NCT01890967|451253904|FG004|Overall Study|Protocol Violation|4|||
125444725|NCT01890967|451253905|FG005|Overall Study|Protocol Violation|1|||
125444726|NCT01890967|451253900|FG000|Overall Study|Sponsor Decision|2|||
125444727|NCT01890967|451253901|FG001|Overall Study|Sponsor Decision|0|||
125444728|NCT01890967|451253902|FG002|Overall Study|Sponsor Decision|1|||
125444729|NCT01890967|451253903|FG003|Overall Study|Sponsor Decision|3|||
125444730|NCT01890967|451253904|FG004|Overall Study|Sponsor Decision|2|||
125444731|NCT01890967|451253905|FG005|Overall Study|Sponsor Decision|3|||
125444732|NCT01890967|451253900|FG000|Overall Study|Withdrawal by Subject|3|||
125444733|NCT01890967|451253901|FG001|Overall Study|Withdrawal by Subject|4|||
125444734|NCT01890967|451253902|FG002|Overall Study|Withdrawal by Subject|2|||
125444735|NCT01890967|451253903|FG003|Overall Study|Withdrawal by Subject|3|||
125444736|NCT01890967|451253904|FG004|Overall Study|Withdrawal by Subject|3|||
125444737|NCT01890967|451253905|FG005|Overall Study|Withdrawal by Subject|1|||
125444738|NCT03685708|451253909|FG000|Overall Study|Withdrawal by Subject|0|||
125444739|NCT03685708|451253910|FG001|Overall Study|Withdrawal by Subject|0|||
125444740|NCT03685708|451253911|FG002|Overall Study|Withdrawal by Subject|1|||
125444741|NCT03685708|451253909|FG000|Overall Study|Screen Fail|0|||
125444742|NCT03685708|451253910|FG001|Overall Study|Screen Fail|1|||
125444743|NCT03685708|451253911|FG002|Overall Study|Screen Fail|1|||
125444744|NCT03685708|451253909|FG000|Overall Study|COVID 19 Pandemic|1|||
125444745|NCT03685708|451253910|FG001|Overall Study|COVID 19 Pandemic|1|||
125444746|NCT03685708|451253911|FG002|Overall Study|COVID 19 Pandemic|6|||
125444747|NCT03685708|451253909|FG000|Overall Study|Disease Progression|0|||
125255554|NCT05763381|450562996|FG001|Overall Study|Withdrawal by Subject|2|||
125255555|NCT01674062|450562997|FG000|Overall Study|Insufficient Therapeutic Response|56|||
125255556|NCT01674062|450562998|FG001|Overall Study|Insufficient Therapeutic Response|26|||
125255557|NCT01674062|450562997|FG000|Overall Study|Other|8|||
125255558|NCT01674062|450562998|FG001|Overall Study|Other|1|||
125255559|NCT01674062|450562997|FG000|Overall Study|Adverse Event|1|||
125255560|NCT01674062|450562998|FG001|Overall Study|Adverse Event|1|||
125255561|NCT01674062|450562997|FG000|Overall Study|Death|0|||
125255562|NCT01674062|450562998|FG001|Overall Study|Death|1|||
125255563|NCT01674062|450562997|FG000|Overall Study|Programming Error|1|||
125255564|NCT01674062|450562998|FG001|Overall Study|Programming Error|0|||
125255565|NCT01443026|450563002|FG000|Overall Study|Physician Decision|1|||
125255566|NCT01443026|450563003|FG001|Overall Study|Physician Decision|0|||
125255567|NCT01443026|450563002|FG000|Overall Study|Death|0|||
125255568|NCT01443026|450563003|FG001|Overall Study|Death|1|||
125255569|NCT01443026|450563002|FG000|Overall Study|Withdrawal by Subject|0|||
125255570|NCT01443026|450563003|FG001|Overall Study|Withdrawal by Subject|3|||
125255571|NCT01443026|450563002|FG000|Overall Study|Lost to Follow-up|2|||
125255572|NCT01443026|450563003|FG001|Overall Study|Lost to Follow-up|1|||
125255573|NCT00581919|450563004|FG000|Overall Study|Adverse Event|8|||
125255574|NCT00581919|450563004|FG000|Overall Study|Death|1|||
125444748|NCT03685708|451253910|FG001|Overall Study|Disease Progression|0|||
125444749|NCT03685708|451253911|FG002|Overall Study|Disease Progression|1|||
125444750|NCT01058863|451253915|FG000|Overall Study|Lost to Follow-up|1|||
125255575|NCT00581919|450563004|FG000|Overall Study|Disease Progression|10|||
125255576|NCT00581919|450563004|FG000|Overall Study|Physician Decision|1|||
125255577|NCT00581919|450563004|FG000|Overall Study|Other Complicating Disease|1|||
125255578|NCT00581919|450563004|FG000|Overall Study|Started Non-Protocol Therapy|2|||
125255579|NCT00581919|450563004|FG000|Overall Study|Withdrawal by Subject|1|||
125255580|NCT02655601|450563005|FG000|Overall Study|Adverse Event|0|||
125255581|NCT02655601|450563006|FG001|Overall Study|Adverse Event|0|||
125255582|NCT02655601|450563007|FG002|Overall Study|Adverse Event|0|||
125255583|NCT02655601|450563008|FG003|Overall Study|Adverse Event|1|||
125444751|NCT01058863|451253915|FG000|Overall Study|Withdrawal by Subject|1|||
125444752|NCT01058863|451253915|FG000|Overall Study|Sponsor requested withdrawal|1|||
125444753|NCT01058863|451253915|FG000|Overall Study|Randomized in error|1|||
125444754|NCT00681187|451253916|FG000|Overall Study|Withdrawal by Subject|1|||
125444755|NCT00681187|451253917|FG001|Overall Study|Withdrawal by Subject|0|||
125444756|NCT00681187|451253916|FG000|Overall Study|Death|0|||
125444757|NCT00681187|451253917|FG001|Overall Study|Death|1|||
125444758|NCT00681187|451253916|FG000|Overall Study|Adverse Event|0|||
125444759|NCT00681187|451253917|FG001|Overall Study|Adverse Event|1|||
125444760|NCT04230980|451253918|FG000|Overall Study|Lost to Follow-up|1|||
125255584|NCT02655601|450563009|FG004|Overall Study|Adverse Event|1|||
125255585|NCT02655601|450563010|FG005|Overall Study|Adverse Event|0|||
125255586|NCT02655601|450563005|FG000|Overall Study|Physician Decision|0|||
125255587|NCT02655601|450563006|FG001|Overall Study|Physician Decision|0|||
125255588|NCT02655601|450563007|FG002|Overall Study|Physician Decision|0|||
125255589|NCT02655601|450563008|FG003|Overall Study|Physician Decision|0|||
125255590|NCT02655601|450563009|FG004|Overall Study|Physician Decision|1|||
125255591|NCT02655601|450563010|FG005|Overall Study|Physician Decision|1|||
125255592|NCT02655601|450563005|FG000|Overall Study|Withdrawal by Subject|0|||
125255593|NCT02655601|450563006|FG001|Overall Study|Withdrawal by Subject|0|||
125255594|NCT02655601|450563007|FG002|Overall Study|Withdrawal by Subject|0|||
125255595|NCT02655601|450563008|FG003|Overall Study|Withdrawal by Subject|0|||
125255596|NCT02655601|450563009|FG004|Overall Study|Withdrawal by Subject|4|||
125255597|NCT02655601|450563010|FG005|Overall Study|Withdrawal by Subject|8|||
125255598|NCT02655601|450563005|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
125255599|NCT02655601|450563006|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
125255600|NCT02655601|450563007|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
125255601|NCT02655601|450563008|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
125255602|NCT02655601|450563009|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
125255603|NCT02655601|450563010|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
125255604|NCT03829683|450563015|FG000|Overall Study|Lost to Follow-up|1|||
125255605|NCT03829683|450563016|FG001|Overall Study|Lost to Follow-up|0|||
125255606|NCT03829683|450563015|FG000|Overall Study|Physician Decision|3|||
125255607|NCT03829683|450563016|FG001|Overall Study|Physician Decision|1|||
125255608|NCT03829683|450563015|FG000|Overall Study|Withdrawal by Subject|0|||
125255609|NCT03829683|450563016|FG001|Overall Study|Withdrawal by Subject|1|||
125255610|NCT03829683|450563015|FG000|Overall Study|Discharge from hospital|1|||
125255611|NCT03829683|450563016|FG001|Overall Study|Discharge from hospital|0|||
125255612|NCT02796651|450563020|FG000|Overall Study|Adverse Event|6|||
125255613|NCT02796651|450563020|FG000|Overall Study|Lost to Follow-up|1|||
125255614|NCT02796651|450563020|FG000|Overall Study|Withdrawal by Subject|4|||
125255615|NCT02796651|450563020|FG000|Overall Study|Protocol Violation|4|||
125255616|NCT02796651|450563020|FG000|Overall Study|Lack of Efficacy|1|||
125255617|NCT02796651|450563020|FG000|Overall Study|Other|10|||
125255618|NCT05430919|450563024|FG000|Overall Study|Protocol Violation|0|||
125255619|NCT05430919|450563025|FG001|Overall Study|Protocol Violation|0|||
125255620|NCT05430919|450563026|FG002|Overall Study|Protocol Violation|1|||
125397015|NCT00116558|451086952|FG000|Overall Study|Withdrawal by Subject|17|||
125397016|NCT00116558|451086953|FG001|Overall Study|Withdrawal by Subject|3|||
125397017|NCT00116558|451086954|FG002|Overall Study|Withdrawal by Subject|12|||
125397018|NCT00116558|451086952|FG000|Overall Study|disease progression|3|||
125397019|NCT00116558|451086953|FG001|Overall Study|disease progression|7|||
125397020|NCT00116558|451086954|FG002|Overall Study|disease progression|18|||
125397021|NCT02027844|451086955|FG000|Overall Study|Withdrawal by Subject|3|||
125444761|NCT04230980|451253919|FG001|Overall Study|Lost to Follow-up|2|||
125444762|NCT04230980|451253918|FG000|Overall Study|Adverse Event|0|||
125444763|NCT04230980|451253919|FG001|Overall Study|Adverse Event|1|||
125255621|NCT05430919|450563027|FG003|Overall Study|Protocol Violation|0|||
125255622|NCT05430919|450563024|FG000|Overall Study|Lost to Follow-up|0|||
125255623|NCT05430919|450563025|FG001|Overall Study|Lost to Follow-up|1|||
125255624|NCT05430919|450563026|FG002|Overall Study|Lost to Follow-up|0|||
125255625|NCT05430919|450563027|FG003|Overall Study|Lost to Follow-up|0|||
125255626|NCT05430919|450563024|FG000|Overall Study|Withdrawal by Subject|3|||
125255627|NCT05430919|450563025|FG001|Overall Study|Withdrawal by Subject|0|||
125255628|NCT05430919|450563026|FG002|Overall Study|Withdrawal by Subject|0|||
125255629|NCT05430919|450563027|FG003|Overall Study|Withdrawal by Subject|1|||
125255630|NCT05014919|450563028|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
125255631|NCT05014919|450563029|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
125255632|NCT05014919|450563030|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
125255633|NCT05014919|450563028|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
125255634|NCT05014919|450563029|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
125255635|NCT05014919|450563030|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
125255636|NCT05014919|450563028|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
125255637|NCT05014919|450563029|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
125255638|NCT05014919|450563030|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
125255639|NCT05014919|450563028|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
125255640|NCT05014919|450563029|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
125255641|NCT05014919|450563030|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
125255642|NCT05014919|450563028|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
125255643|NCT05014919|450563029|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
125255644|NCT05014919|450563030|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
125255645|NCT05014919|450563028|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
125397022|NCT02027844|451086956|FG001|Overall Study|Withdrawal by Subject|2|||
125444764|NCT01708187|451253923|FG000|Overall Study|Lost to Follow-up|0|||
125255646|NCT05014919|450563029|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
125255647|NCT05014919|450563030|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
125255648|NCT05014919|450563028|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
125255649|NCT05014919|450563029|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
125255650|NCT05014919|450563030|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
125255651|NCT05014919|450563028|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
125255652|NCT05014919|450563029|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
125255653|NCT05014919|450563030|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
125255654|NCT02971163|450563033|FG000|Overall Study|Lost to Follow-up|4|||
125255655|NCT02971163|450563034|FG001|Overall Study|Lost to Follow-up|2|||
125255656|NCT01491919|450563035|FG000|Overall Study|Insufficient PK sampling|1|||
125255657|NCT01491919|450563036|FG001|Overall Study|Insufficient PK sampling|2|||
125255658|NCT01491919|450563037|FG002|Overall Study|Insufficient PK sampling|1|||
125255659|NCT02871219|450563038|FG000|Overall Study|Adverse Event|15|||
125255660|NCT02871219|450563038|FG000|Overall Study|Death|3|||
125255661|NCT02871219|450563038|FG000|Overall Study|Progression|3|||
125255662|NCT02871219|450563038|FG000|Overall Study|Infections|7|||
125255663|NCT02871219|450563038|FG000|Overall Study|Infusion Related|4|||
125255664|NCT02298946|450563042|FG000|Overall Study|Did not receive treatment|2|||
125255665|NCT02298946|450563043|FG001|Overall Study|Did not receive treatment|0|||
125255666|NCT02298946|450563042|FG000|Overall Study|Unevaluable|2|||
125255667|NCT02298946|450563043|FG001|Overall Study|Unevaluable|1|||
125255668|NCT05375929|450563051|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
125255669|NCT05375929|450563052|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
125255670|NCT05375929|450563053|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
125255671|NCT05375929|450563054|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
125255672|NCT05375929|450563051|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
125255673|NCT05375929|450563052|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
125255674|NCT05375929|450563053|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
125255675|NCT05375929|450563054|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
125255676|NCT05375929|450563051|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
125255677|NCT05375929|450563052|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
125255678|NCT05375929|450563053|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
125255679|NCT05375929|450563054|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
125255680|NCT05375929|450563051|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
125255681|NCT05375929|450563052|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
125255682|NCT05375929|450563053|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
125255683|NCT05375929|450563054|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
125255684|NCT05375929|450563051|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
125255685|NCT05375929|450563052|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
125255686|NCT05375929|450563053|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
125255687|NCT05375929|450563054|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
125255688|NCT05375929|450563051|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
125255689|NCT05375929|450563052|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
125255690|NCT05375929|450563053|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
125255691|NCT05375929|450563054|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
125255692|NCT05375929|450563051|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
125255693|NCT05375929|450563052|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
125255694|NCT05375929|450563053|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
125255695|NCT05375929|450563054|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
125255696|NCT05375929|450563051|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
125255697|NCT05375929|450563052|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
125255698|NCT05375929|450563053|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
125255699|NCT05375929|450563054|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
125255700|NCT05375929|450563051|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
125255701|NCT05375929|450563052|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
125255702|NCT05375929|450563053|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
125255703|NCT05375929|450563054|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
125255704|NCT05375929|450563051|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
125255705|NCT05375929|450563052|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
125255706|NCT05375929|450563053|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
125255707|NCT05375929|450563054|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
125255708|NCT00773461|450563059|FG000|Overall Study|Adverse Event|1|||
125255709|NCT00773461|450563060|FG001|Overall Study|Adverse Event|3|||
125255710|NCT00773461|450563059|FG000|Overall Study|Withdrawal by Subject|4|||
125255711|NCT00773461|450563060|FG001|Overall Study|Withdrawal by Subject|1|||
125255712|NCT00322218|450563063|FG000|Overall Study|Death|3|||
125255713|NCT00322218|450563064|FG001|Overall Study|Death|6|||
125444765|NCT01708187|451253924|FG001|Overall Study|Lost to Follow-up|1|||
125444766|NCT03055832|451253926|FG000|Week 2|Withdrawal by Subject|1|||
125444767|NCT03055832|451253927|FG001|Week 2|Withdrawal by Subject|0|||
125444768|NCT01152554|451253928|FG000|Overall Study|Withdrawal by Subject|73|||
125444769|NCT01152554|451253929|FG001|Overall Study|Withdrawal by Subject|28|||
125444770|NCT01152554|451253928|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
125444771|NCT01152554|451253929|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
125444772|NCT01152554|451253928|FG000|Overall Study|Adverse Event|67|||
125444773|NCT01152554|451253929|FG001|Overall Study|Adverse Event|14|||
125444774|NCT01152554|451253928|FG000|Overall Study|Severe non-compliance to protocol|36|||
125444775|NCT01152554|451253929|FG001|Overall Study|Severe non-compliance to protocol|14|||
125444776|NCT01152554|451253928|FG000|Overall Study|Condition under investigation worsened|5|||
125444777|NCT01152554|451253929|FG001|Overall Study|Condition under investigation worsened|2|||
125444778|NCT01152554|451253928|FG000|Overall Study|Lack of Efficacy|20|||
125444779|NCT01152554|451253929|FG001|Overall Study|Lack of Efficacy|3|||
125444780|NCT01152554|451253928|FG000|Overall Study|Study-specific withdrawal criteria|17|||
125444781|NCT01152554|451253929|FG001|Overall Study|Study-specific withdrawal criteria|8|||
125444782|NCT01152554|451253928|FG000|Overall Study|Lost to Follow-up|87|||
125444783|NCT01152554|451253929|FG001|Overall Study|Lost to Follow-up|32|||
125444784|NCT01152554|451253928|FG000|Overall Study|Other|28|||
125444785|NCT01152554|451253929|FG001|Overall Study|Other|8|||
125444786|NCT01152554|451253928|FG000|Overall Study|Death|1|||
125444787|NCT01152554|451253929|FG001|Overall Study|Death|1|||
125444788|NCT02117544|451253930|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
125444789|NCT02117544|451253931|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
125444790|NCT01439711|451253932|FG000|Overall Study|Ineligible|13|||
125444791|NCT01439711|451253932|FG000|Overall Study|Cancel|3|||
125444792|NCT01439711|451253932|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
125444793|NCT01439711|451253932|FG000|Overall Study|Adverse Event|5|||
125444794|NCT01439711|451253932|FG000|Overall Study|Withdrawal by Subject|3|||
125444795|NCT01439711|451253932|FG000|Overall Study|Progression During Active Tx|3|||
125444796|NCT01439711|451253932|FG000|Overall Study|Noncompliance|3|||
125444797|NCT01439711|451253932|FG000|Overall Study|No MRI|9|||
125444798|NCT01012973|451253933|FG000|Overall Study|Adverse Event|5|||
125444799|NCT01012973|451253934|FG001|Overall Study|Adverse Event|5|||
125444800|NCT01012973|451253933|FG000|Overall Study|Lack of Efficacy|0|||
125444801|NCT01012973|451253934|FG001|Overall Study|Lack of Efficacy|5|||
125444802|NCT01012973|451253933|FG000|Overall Study|Lost to Follow-up|1|||
125444803|NCT01012973|451253934|FG001|Overall Study|Lost to Follow-up|0|||
125444804|NCT01012973|451253933|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
125444805|NCT01012973|451253934|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
125444806|NCT01012973|451253933|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
125444807|NCT01012973|451253934|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
125444808|NCT01012973|451253933|FG000|Overall Study|Protocol Violation|5|||
125255714|NCT01385995|450563066|FG000|Period 1, 2 Months|Physician Decision|1|||
125255715|NCT01385995|450563067|FG001|Period 1, 2 Months|Physician Decision|0|||
125255716|NCT00112385|450563068|FG000|Overall Study|Lost to Follow-up|1|||
125255717|NCT00112385|450563069|FG001|Overall Study|Lost to Follow-up|0|||
125255718|NCT00112385|450563068|FG000|Overall Study|Withdrawal by Subject|0|||
125255719|NCT00112385|450563069|FG001|Overall Study|Withdrawal by Subject|1|||
125255720|NCT00908141|450563081|FG000|Overall Study|Withdrawal by Subject|0|||
125255721|NCT00908141|450563082|FG001|Overall Study|Withdrawal by Subject|1|||
125255722|NCT00980044|450564440|FG000|Overall Study|Withdrawal by Subject|5|||
125255723|NCT00980044|450564441|FG001|Overall Study|Withdrawal by Subject|7|||
125255724|NCT00980044|450564442|FG002|Overall Study|Withdrawal by Subject|3|||
125255725|NCT00980044|450564440|FG000|Overall Study|Protocol Violation|0|||
125255726|NCT00980044|450564441|FG001|Overall Study|Protocol Violation|0|||
125255727|NCT00980044|450564442|FG002|Overall Study|Protocol Violation|2|||
125255728|NCT02254291|450564443|FG000|Overall Study|Withdrawal by Subject|0|||
125255729|NCT02254291|450564444|FG001|Overall Study|Withdrawal by Subject|3|||
125255730|NCT02254291|450564445|FG002|Overall Study|Withdrawal by Subject|1|||
125255731|NCT02254291|450564443|FG000|Overall Study|Missing follow-up information|0|||
125255732|NCT02254291|450564444|FG001|Overall Study|Missing follow-up information|0|||
125444809|NCT01012973|451253934|FG001|Overall Study|Protocol Violation|2|||
125444810|NCT01012973|451253933|FG000|Overall Study|Withdrawal by Subject|4|||
125444811|NCT01012973|451253934|FG001|Overall Study|Withdrawal by Subject|6|||
125444812|NCT02448719|451253935|FG000|Overall Study|Withdrawal by Subject|0|||
125444813|NCT02448719|451253936|FG001|Overall Study|Withdrawal by Subject|0|||
125255733|NCT02254291|450564445|FG002|Overall Study|Missing follow-up information|1|||
125444814|NCT02448719|451253937|FG002|Overall Study|Withdrawal by Subject|0|||
125444815|NCT02448719|451253938|FG003|Overall Study|Withdrawal by Subject|0|||
125444816|NCT02448719|451253939|FG004|Overall Study|Withdrawal by Subject|1|||
125444817|NCT02448719|451253940|FG005|Overall Study|Withdrawal by Subject|0|||
125444818|NCT02448719|451253941|FG006|Overall Study|Withdrawal by Subject|0|||
125444819|NCT02448719|451253942|FG007|Overall Study|Withdrawal by Subject|0|||
125444820|NCT02448719|451253943|FG008|Overall Study|Withdrawal by Subject|0|||
125444821|NCT02448719|451253944|FG009|Overall Study|Withdrawal by Subject|0|||
125444822|NCT02448719|451253945|FG010|Overall Study|Withdrawal by Subject|0|||
125444823|NCT00388362|451253949|FG000|Enrolled|Ineligible|1|||
125444824|NCT00388362|451253949|FG000|Enrolled|Adverse Event|9|||
125444825|NCT00388362|451253949|FG000|Enrolled|Death|1|||
125444826|NCT00388362|451253949|FG000|Enrolled|Loss insurance|1|||
125444827|NCT00388362|451253949|FG000|Enrolled|Withdrawal by Subject|1|||
125444828|NCT00388362|451253949|FG000|Remained on Study Median of 514 Days|Death|2|||
125444829|NCT00209027|451253950|FG000|Overall Study|study terminated|10|||
125444830|NCT00209027|451253951|FG001|Overall Study|study terminated|0|||
125444831|NCT01932996|451253952|FG000|Overall Study|Protocol Violation|2|||
125444832|NCT01932996|451253953|FG001|Overall Study|Protocol Violation|0|||
125444833|NCT02806336|451253954|FG000|Overall Study|Physician Decision|1|||
125444834|NCT02806336|451253955|FG001|Overall Study|Physician Decision|0|||
125444835|NCT02806336|451253954|FG000|Overall Study|Withdrawal by Subject|2|||
125444836|NCT02806336|451253955|FG001|Overall Study|Withdrawal by Subject|4|||
125444837|NCT02806336|451253954|FG000|Overall Study|COVID-19 research shut down|3|||
125444838|NCT02806336|451253955|FG001|Overall Study|COVID-19 research shut down|4|||
125444839|NCT02806336|451253954|FG000|Overall Study|Lack of Efficacy|0|||
125444840|NCT02806336|451253955|FG001|Overall Study|Lack of Efficacy|1|||
125444841|NCT00895843|451253962|FG000|Overall Study|Protocol Violation|12|||
125444842|NCT00895843|451253963|FG001|Overall Study|Protocol Violation|12|||
125444843|NCT04963062|451253971|FG000|Overall Study|withdrew by the study team|4|||
125444844|NCT04963062|451253972|FG001|Overall Study|withdrew by the study team|2|||
125444845|NCT03873246|451253973|FG000|Overall Study|Adverse Event|1|||
125444846|NCT03873246|451253974|FG001|Overall Study|Adverse Event|3|||
125444847|NCT03873246|451253975|FG002|Overall Study|Adverse Event|3|||
125444848|NCT03873246|451253973|FG000|Overall Study|Lost to Follow-up|4|||
125444849|NCT03873246|451253974|FG001|Overall Study|Lost to Follow-up|4|||
125444850|NCT03873246|451253975|FG002|Overall Study|Lost to Follow-up|5|||
125444851|NCT03873246|451253973|FG000|Overall Study|Protocol Violation|0|||
125444852|NCT03873246|451253974|FG001|Overall Study|Protocol Violation|1|||
125444853|NCT03873246|451253975|FG002|Overall Study|Protocol Violation|0|||
125444854|NCT03873246|451253973|FG000|Overall Study|Withdrawal by Subject|0|||
125444855|NCT03873246|451253974|FG001|Overall Study|Withdrawal by Subject|4|||
125444856|NCT03873246|451253975|FG002|Overall Study|Withdrawal by Subject|1|||
125444857|NCT01857323|451253976|FG000|Overall Study|Adverse Event|1|||
125444858|NCT01857323|451253976|FG000|Overall Study|Withdrawal by Subject|3|||
125444859|NCT01857323|451253976|FG000|Overall Study|Non-compliance|1|||
125444860|NCT01857323|451253976|FG000|Overall Study|Protocol Violation|6|||
125444861|NCT01857323|451253976|FG000|Overall Study|Lost to Follow-up|1|||
125444862|NCT01857323|451253976|FG000|Overall Study|Other|4|||
125444863|NCT01857323|451253976|FG000|Overall Study|Did not complete 180 doses|48|||
125444864|NCT03658811|451253977|FG000|Overall Study|Lost to Follow-up|3|||
125255734|NCT00833703|450564457|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
125255735|NCT00833703|450564458|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
125255736|NCT01904279|450564459|FG000|Overall Study|Lack of Efficacy|2|||
125255737|NCT01904279|450564460|FG001|Overall Study|Lack of Efficacy|3|||
125255738|NCT01904279|450564459|FG000|Overall Study|Withdrawal by Subject|1|||
125255739|NCT01904279|450564460|FG001|Overall Study|Withdrawal by Subject|0|||
125255740|NCT02489279|450564463|FG000|Overall Study|Lost to Follow-up|12|||
125255741|NCT02489279|450564464|FG001|Overall Study|Lost to Follow-up|10|||
125255742|NCT02263547|450564465|FG000|Overall Study|Adverse Event|1|||
125255743|NCT02263547|450564465|FG000|Overall Study|Lost to Follow-up|2|||
125255744|NCT00095576|450564466|FG000|Overall Study|Adverse Event|5|||
125255745|NCT00095576|450564467|FG001|Overall Study|Adverse Event|3|||
125255746|NCT00095576|450564466|FG000|Overall Study|Lost to Follow-up|233|||
125255747|NCT00095576|450564467|FG001|Overall Study|Lost to Follow-up|229|||
125255748|NCT00095576|450564466|FG000|Overall Study|Protocol Violation|1|||
125255749|NCT00095576|450564467|FG001|Overall Study|Protocol Violation|0|||
125255750|NCT00095576|450564466|FG000|Overall Study|Withdrawal by Subject|34|||
125255751|NCT00095576|450564467|FG001|Overall Study|Withdrawal by Subject|47|||
125255752|NCT00095576|450564466|FG000|Overall Study|Option to switch to a rollover study|1097|||
125255753|NCT00095576|450564467|FG001|Overall Study|Option to switch to a rollover study|1099|||
125444865|NCT00946647|451253981|FG000|Phase 1 Part|Adverse Event|2|||
125444866|NCT00946647|451253982|FG001|Phase 1 Part|Adverse Event|5|||
125444867|NCT00946647|451253983|FG002|Phase 1 Part|Adverse Event|3|||
125444868|NCT00946647|451253984|FG003|Phase 1 Part|Adverse Event|0|||
125444869|NCT00946647|451253985|FG004|Phase 1 Part|Adverse Event|0|||
125444870|NCT00946647|451253981|FG000|Phase 1 Part|Disease progression|3|||
125255754|NCT00095576|450564466|FG000|Overall Study|Site terminated|75|||
125255755|NCT00095576|450564467|FG001|Overall Study|Site terminated|67|||
125444871|NCT00946647|451253982|FG001|Phase 1 Part|Disease progression|6|||
125444872|NCT00946647|451253983|FG002|Phase 1 Part|Disease progression|1|||
125444873|NCT00946647|451253984|FG003|Phase 1 Part|Disease progression|0|||
125444874|NCT00946647|451253985|FG004|Phase 1 Part|Disease progression|0|||
125255756|NCT00095576|450564466|FG000|Overall Study|Subject moved|30|||
125444875|NCT00946647|451253981|FG000|Phase 1 Part|Withdrawal by Subject|1|||
125444876|NCT00946647|451253982|FG001|Phase 1 Part|Withdrawal by Subject|4|||
125444877|NCT00946647|451253983|FG002|Phase 1 Part|Withdrawal by Subject|3|||
125444878|NCT00946647|451253984|FG003|Phase 1 Part|Withdrawal by Subject|0|||
125444879|NCT00946647|451253985|FG004|Phase 1 Part|Withdrawal by Subject|0|||
125444880|NCT00946647|451253981|FG000|Phase 1 Part|Abnormal values|0|||
125444881|NCT00946647|451253982|FG001|Phase 1 Part|Abnormal values|2|||
125444882|NCT00946647|451253983|FG002|Phase 1 Part|Abnormal values|0|||
125444883|NCT00946647|451253984|FG003|Phase 1 Part|Abnormal values|0|||
125444884|NCT00946647|451253985|FG004|Phase 1 Part|Abnormal values|0|||
125444885|NCT00946647|451253981|FG000|Phase 1 Part|Reason missing|0|||
125444886|NCT00946647|451253982|FG001|Phase 1 Part|Reason missing|1|||
125444887|NCT00946647|451253983|FG002|Phase 1 Part|Reason missing|0|||
125444888|NCT00946647|451253984|FG003|Phase 1 Part|Reason missing|0|||
125255757|NCT00095576|450564467|FG001|Overall Study|Subject moved|36|||
125255758|NCT01344356|450564468|FG000|Overall Study|Physician Decision|0|||
125255759|NCT01344356|450564469|FG001|Overall Study|Physician Decision|3|||
125255760|NCT01344356|450564468|FG000|Overall Study|Lost to Follow-up|0|||
125255761|NCT01344356|450564469|FG001|Overall Study|Lost to Follow-up|6|||
125255762|NCT00586157|450564470|FG000|First Intervention|Worsening behavior|1|||
125255763|NCT00586157|450564471|FG001|First Intervention|Worsening behavior|0|||
125255764|NCT00586157|450564470|FG000|Second Intervention|Withdrawal by Subject|1|||
125255765|NCT00586157|450564471|FG001|Second Intervention|Withdrawal by Subject|0|||
125255766|NCT00586157|450564470|FG000|Second Intervention|Worsening behavior|1|||
125255767|NCT00586157|450564471|FG001|Second Intervention|Worsening behavior|0|||
125255768|NCT00586157|450564470|FG000|Second Intervention|Adverse Event|0|||
125255769|NCT00586157|450564471|FG001|Second Intervention|Adverse Event|1|||
125255770|NCT02014467|450564474|FG000|Overall Study|Adverse Event|4|||
125255771|NCT02014467|450564475|FG001|Overall Study|Adverse Event|0|||
125255772|NCT02014467|450564474|FG000|Overall Study|Protocol Violation|3|||
125255773|NCT02014467|450564475|FG001|Overall Study|Protocol Violation|0|||
125255774|NCT02014467|450564474|FG000|Overall Study|Physician Decision|2|||
125255775|NCT02014467|450564475|FG001|Overall Study|Physician Decision|3|||
125255776|NCT02014467|450564474|FG000|Overall Study|Withdrawal by Subject|16|||
125255777|NCT02014467|450564475|FG001|Overall Study|Withdrawal by Subject|4|||
125255778|NCT00831389|450564479|FG000|Overall Study|Withdrawal by Subject|0|||
125255779|NCT00831389|450564480|FG001|Overall Study|Withdrawal by Subject|1|||
125255780|NCT01378195|450564482|FG000|Overall Study|Lost to Follow-up|29|||
125255781|NCT01378195|450564483|FG001|Overall Study|Lost to Follow-up|18|||
125255782|NCT00841815|450564490|FG000|Washout|Withdrawal by Subject|0|||
125255783|NCT00841815|450564491|FG001|Washout|Withdrawal by Subject|1|||
125255784|NCT01148771|450564493|FG000|Washout Period|Withdrawal by Subject|0|||
125255785|NCT01148771|450564494|FG001|Washout Period|Withdrawal by Subject|1|||
125255786|NCT03787615|450564495|FG000|Overall Study|Withdrawal by Subject|2|||
125255787|NCT03787615|450564495|FG000|Overall Study|Lost to Follow-up|2|||
125255788|NCT03464461|450564496|FG000|Overall Study|exclusionary medication given ,|1|||
125255789|NCT03464461|450564497|FG001|Overall Study|exclusionary medication given ,|2|||
125255790|NCT03464461|450564498|FG002|Overall Study|exclusionary medication given ,|0|||
125255791|NCT03464461|450564496|FG000|Overall Study|Physician Decision|0|||
125255792|NCT03464461|450564497|FG001|Overall Study|Physician Decision|1|||
125255793|NCT03464461|450564498|FG002|Overall Study|Physician Decision|0|||
125255794|NCT03685149|450564500|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
125255795|NCT03685149|450564501|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
125255796|NCT03685149|450564500|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125255797|NCT03685149|450564501|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
125255798|NCT03685149|450564500|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
125255799|NCT03685149|450564501|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
125255800|NCT02609503|450564502|FG000|Overall Study|Adverse Event|1|||
125255801|NCT02609503|450564502|FG000|Overall Study|Death|1|||
125255802|NCT02609503|450564502|FG000|Overall Study|Withdrawal by Subject|1|||
125255803|NCT02609503|450564502|FG000|Overall Study|Disease progression|1|||
125255804|NCT03647137|450564503|FG000|Overall Study|Scan Limitation|2|||
125255805|NCT03647137|450564504|FG001|Overall Study|Scan Limitation|1|||
125255806|NCT03647137|450564505|FG002|Overall Study|Scan Limitation|1|||
125255807|NCT03647137|450564506|FG003|Overall Study|Scan Limitation|2|||
125255808|NCT02226653|450564507|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
125255809|NCT02226653|450564508|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
125255810|NCT02226653|450564507|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
125444889|NCT00946647|451253985|FG004|Phase 1 Part|Reason missing|0|||
125444890|NCT00946647|451253981|FG000|Phase ll Part|Untreated|0|||
125444891|NCT00946647|451253982|FG001|Phase ll Part|Untreated|0|||
125255811|NCT02226653|450564508|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
125255812|NCT04876391|450564510|FG000|Overall Study|Withdrawal by Subject|1|||
125255813|NCT04876391|450564511|FG001|Overall Study|Withdrawal by Subject|10|||
125255814|NCT04876391|450564510|FG000|Overall Study|Lost to Follow-up|2|||
125255815|NCT04876391|450564511|FG001|Overall Study|Lost to Follow-up|4|||
125444892|NCT00946647|451253983|FG002|Phase ll Part|Untreated|0|||
125444893|NCT00946647|451253984|FG003|Phase ll Part|Untreated|0|||
125255816|NCT04876391|450564510|FG000|Overall Study|Lack of Efficacy|0|||
125444894|NCT00946647|451253985|FG004|Phase ll Part|Untreated|2|||
125255817|NCT04876391|450564511|FG001|Overall Study|Lack of Efficacy|2|||
125255818|NCT04876391|450564510|FG000|Overall Study|Adverse Event|3|||
125255819|NCT04876391|450564511|FG001|Overall Study|Adverse Event|1|||
125255820|NCT04876391|450564510|FG000|Overall Study|Patient non-compliance|0|||
125255821|NCT04876391|450564511|FG001|Overall Study|Patient non-compliance|1|||
125255822|NCT04876391|450564510|FG000|Overall Study|Personal reasons|0|||
125255823|NCT04876391|450564511|FG001|Overall Study|Personal reasons|1|||
125255824|NCT04876391|450564510|FG000|Overall Study|Withdrawn as per protocol|2|||
125255825|NCT04876391|450564511|FG001|Overall Study|Withdrawn as per protocol|2|||
125255826|NCT00209131|450564517|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
125255827|NCT00209131|450564518|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
125255828|NCT05360784|450564519|FG000|Overall Study|Discontinued|25|||
125255829|NCT05360784|450564520|FG001|Overall Study|Discontinued|11|||
125255830|NCT05142306|450564521|FG000|Overall Study|Withdrawal by Subject|0|||
125255831|NCT05142306|450564522|FG001|Overall Study|Withdrawal by Subject|0|||
125255832|NCT05142306|450564523|FG002|Overall Study|Withdrawal by Subject|1|||
125255833|NCT02251041|450564524|FG000|Overall Study|Did not receive intervention|15|||
125255834|NCT02251041|450564525|FG001|Overall Study|Did not receive intervention|4|||
125255835|NCT04079920|450564526|FG000|Overall Study|Adverse event, not related to study drug|2|||
125255836|NCT04079920|450564526|FG000|Overall Study|Adverse event related to study drug|10|||
125255837|NCT04079920|450564526|FG000|Overall Study|Death|2|||
125255838|NCT04079920|450564526|FG000|Overall Study|Lost to Follow-up|22|||
125255839|NCT04079920|450564526|FG000|Overall Study|Physician Decision|1|||
125255840|NCT04079920|450564526|FG000|Overall Study|Withdrawal by Subject|11|||
125255841|NCT04918771|450564527|FG000|Overall Study|Withdrawal by Subject|4|||
125255842|NCT04918771|450564528|FG001|Overall Study|Withdrawal by Subject|5|||
125255843|NCT04918771|450564527|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
125255844|NCT04918771|450564528|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
125255845|NCT00680914|450564533|FG000|Overall Study|Consent withdrawal|6|||
125255846|NCT00680914|450564534|FG001|Overall Study|Consent withdrawal|3|||
125255847|NCT00680914|450564533|FG000|Overall Study|Lost to Follow-up|4|||
125255848|NCT00680914|450564534|FG001|Overall Study|Lost to Follow-up|0|||
125255849|NCT00680914|450564533|FG000|Overall Study|serious adverse event (SAE)|0|||
125255850|NCT00680914|450564534|FG001|Overall Study|serious adverse event (SAE)|1|||
125255851|NCT00539500|450564535|FG000|Overall Study|Disease Progression|1|||
125255852|NCT00539500|450564535|FG000|Overall Study|Lost to Follow-up|2|||
125255853|NCT01299961|450564538|FG000|Overall Study|Adverse Event|3|||
125255854|NCT01299961|450564538|FG000|Overall Study|Lack of Efficacy|2|||
125255855|NCT01299961|450564538|FG000|Overall Study|Lost to Follow-up|1|||
125255856|NCT02904096|450564539|FG000|Overall Study|Adverse Event|1|||
125255857|NCT02904096|450564540|FG001|Overall Study|Adverse Event|0|||
125255858|NCT02904096|450564539|FG000|Overall Study|Withdrawal by Subject|4|||
125255859|NCT02904096|450564540|FG001|Overall Study|Withdrawal by Subject|3|||
125255860|NCT02904096|450564539|FG000|Overall Study|Lost to Follow-up|10|||
125255861|NCT02904096|450564540|FG001|Overall Study|Lost to Follow-up|17|||
125255862|NCT02904096|450564539|FG000|Overall Study|Non-compliant|3|||
125255863|NCT02904096|450564540|FG001|Overall Study|Non-compliant|1|||
125255864|NCT02904096|450564539|FG000|Overall Study|Sponsor instructed|1|||
125255865|NCT02904096|450564540|FG001|Overall Study|Sponsor instructed|0|||
125255866|NCT05305651|450564541|FG000|Overall Study|Death|1|||
125255867|NCT05305651|450564541|FG000|Overall Study|Withdrawal by Subject|4|||
125255868|NCT05305651|450564541|FG000|Overall Study|Lost to Follow-up|4|||
125255869|NCT00526799|450564542|FG000|Overall Study|Withdrawal by Subject|1|||
125255870|NCT00526799|450564543|FG001|Overall Study|Withdrawal by Subject|0|||
125255871|NCT00526799|450564542|FG000|Overall Study|Intercurrent Complicating Disease|0|||
125255872|NCT00526799|450564543|FG001|Overall Study|Intercurrent Complicating Disease|1|||
125255873|NCT04003389|450564544|FG000|Overall Study|Adverse Event|27|||
125255874|NCT04003389|450564545|FG001|Overall Study|Adverse Event|34|||
125255875|NCT04003389|450564546|FG002|Overall Study|Adverse Event|28|||
125255876|NCT04003389|450564544|FG000|Overall Study|Lost to Follow-up|39|||
125255877|NCT04003389|450564545|FG001|Overall Study|Lost to Follow-up|30|||
125255878|NCT04003389|450564546|FG002|Overall Study|Lost to Follow-up|33|||
125444895|NCT00946647|451253981|FG000|Phase ll Part|Adverse Event|0|||
125255879|NCT04003389|450564544|FG000|Overall Study|Protocol Violation|1|||
125255880|NCT04003389|450564545|FG001|Overall Study|Protocol Violation|6|||
125255881|NCT04003389|450564546|FG002|Overall Study|Protocol Violation|5|||
125255882|NCT04003389|450564544|FG000|Overall Study|Withdrawal by Subject|119|||
125255883|NCT04003389|450564545|FG001|Overall Study|Withdrawal by Subject|79|||
125255884|NCT04003389|450564546|FG002|Overall Study|Withdrawal by Subject|85|||
125255885|NCT04003389|450564544|FG000|Overall Study|Miscellaneous|14|||
125255886|NCT04003389|450564545|FG001|Overall Study|Miscellaneous|11|||
125255887|NCT04003389|450564546|FG002|Overall Study|Miscellaneous|14|||
125255888|NCT04003389|450564544|FG000|Overall Study|Participant did not receive study drug|1|||
125255889|NCT04003389|450564545|FG001|Overall Study|Participant did not receive study drug|0|||
125255890|NCT04003389|450564546|FG002|Overall Study|Participant did not receive study drug|0|||
125255891|NCT04629196|450564547|FG000|Overall Study|Subject discontinued study drug|1|||
125255892|NCT04629196|450564548|FG001|Overall Study|Subject discontinued study drug|0|||
125255893|NCT04629196|450564547|FG000|Overall Study|Subject study drug dosing increased|1|||
125255894|NCT04629196|450564548|FG001|Overall Study|Subject study drug dosing increased|1|||
125255895|NCT04629196|450564547|FG000|Overall Study|Withdrawal by Subject|1|||
125255896|NCT04629196|450564548|FG001|Overall Study|Withdrawal by Subject|2|||
125255897|NCT01450631|450564552|FG000|Overall Study|Lost to Follow-up|2|||
125255898|NCT01450631|450564553|FG001|Overall Study|Lost to Follow-up|4|||
125255899|NCT01450631|450564552|FG000|Overall Study|Withdrawal by Subject|1|||
125255900|NCT01450631|450564553|FG001|Overall Study|Withdrawal by Subject|0|||
125255901|NCT00835354|450564554|FG000|First Intervention|Adverse Event|0|||
125255902|NCT00835354|450564555|FG001|First Intervention|Adverse Event|1|||
125255925|NCT03204812|450564558|FG000|Overall Study|Adverse Event|3|||
125255926|NCT03648372|450564559|FG000|Overall Study|Withdrawal by Subject|2|||
125255927|NCT03648372|450564560|FG001|Overall Study|Withdrawal by Subject|0|||
125255928|NCT03648372|450564561|FG002|Overall Study|Withdrawal by Subject|0|||
125255929|NCT03648372|450564562|FG003|Overall Study|Withdrawal by Subject|0|||
125255930|NCT03648372|450564563|FG004|Overall Study|Withdrawal by Subject|0|||
125255931|NCT03648372|450564564|FG005|Overall Study|Withdrawal by Subject|1|||
125255932|NCT03648372|450564565|FG006|Overall Study|Withdrawal by Subject|2|||
125255933|NCT03648372|450564566|FG007|Overall Study|Withdrawal by Subject|0|||
125255934|NCT03648372|450564567|FG008|Overall Study|Withdrawal by Subject|0|||
125255935|NCT03648372|450564568|FG009|Overall Study|Withdrawal by Subject|0|||
125255936|NCT03648372|450564569|FG010|Overall Study|Withdrawal by Subject|2|||
125255937|NCT03648372|450564570|FG011|Overall Study|Withdrawal by Subject|0|||
125255938|NCT03648372|450564571|FG012|Overall Study|Withdrawal by Subject|2|||
125255939|NCT03648372|450564572|FG013|Overall Study|Withdrawal by Subject|0|||
125255940|NCT03648372|450564573|FG014|Overall Study|Withdrawal by Subject|0|||
125255941|NCT03648372|450564574|FG015|Overall Study|Withdrawal by Subject|0|||
125255942|NCT03648372|450564575|FG016|Overall Study|Withdrawal by Subject|1|||
125255943|NCT03648372|450564576|FG017|Overall Study|Withdrawal by Subject|0|||
125255944|NCT03648372|450564577|FG018|Overall Study|Withdrawal by Subject|0|||
125255945|NCT03648372|450564578|FG019|Overall Study|Withdrawal by Subject|0|||
125255946|NCT03648372|450564579|FG020|Overall Study|Withdrawal by Subject|0|||
125255947|NCT03648372|450564559|FG000|Overall Study|Progressive Disease|2|||
125255948|NCT03648372|450564560|FG001|Overall Study|Progressive Disease|3|||
125255949|NCT03648372|450564561|FG002|Overall Study|Progressive Disease|4|||
125255950|NCT03648372|450564562|FG003|Overall Study|Progressive Disease|3|||
125255951|NCT03648372|450564563|FG004|Overall Study|Progressive Disease|2|||
125255952|NCT03648372|450564564|FG005|Overall Study|Progressive Disease|2|||
125255953|NCT03648372|450564565|FG006|Overall Study|Progressive Disease|3|||
125255954|NCT03648372|450564566|FG007|Overall Study|Progressive Disease|3|||
125255955|NCT03648372|450564567|FG008|Overall Study|Progressive Disease|5|||
125255956|NCT03648372|450564568|FG009|Overall Study|Progressive Disease|5|||
125255957|NCT03648372|450564569|FG010|Overall Study|Progressive Disease|2|||
125255958|NCT03648372|450564570|FG011|Overall Study|Progressive Disease|3|||
125397023|NCT02027844|451086957|FG002|Overall Study|Withdrawal by Subject|1|||
125255959|NCT03648372|450564571|FG012|Overall Study|Progressive Disease|3|||
125255960|NCT03648372|450564572|FG013|Overall Study|Progressive Disease|3|||
125255961|NCT03648372|450564573|FG014|Overall Study|Progressive Disease|6|||
125255962|NCT03648372|450564574|FG015|Overall Study|Progressive Disease|0|||
125255963|NCT03648372|450564575|FG016|Overall Study|Progressive Disease|0|||
125255964|NCT03648372|450564576|FG017|Overall Study|Progressive Disease|0|||
125255965|NCT03648372|450564577|FG018|Overall Study|Progressive Disease|0|||
125255966|NCT03648372|450564578|FG019|Overall Study|Progressive Disease|0|||
125255967|NCT03648372|450564579|FG020|Overall Study|Progressive Disease|0|||
125255968|NCT03648372|450564559|FG000|Overall Study|Other|0|||
125255969|NCT03648372|450564560|FG001|Overall Study|Other|0|||
125255970|NCT03648372|450564561|FG002|Overall Study|Other|0|||
125255971|NCT03648372|450564562|FG003|Overall Study|Other|0|||
125255972|NCT03648372|450564563|FG004|Overall Study|Other|1|||
125255973|NCT03648372|450564564|FG005|Overall Study|Other|0|||
125255974|NCT03648372|450564565|FG006|Overall Study|Other|0|||
125255975|NCT03648372|450564566|FG007|Overall Study|Other|0|||
125255976|NCT03648372|450564567|FG008|Overall Study|Other|0|||
125255977|NCT03648372|450564568|FG009|Overall Study|Other|0|||
125255978|NCT03648372|450564569|FG010|Overall Study|Other|1|||
125255979|NCT03648372|450564570|FG011|Overall Study|Other|2|||
125255980|NCT03648372|450564571|FG012|Overall Study|Other|1|||
125255981|NCT03648372|450564572|FG013|Overall Study|Other|3|||
125255982|NCT03648372|450564573|FG014|Overall Study|Other|0|||
125255983|NCT03648372|450564574|FG015|Overall Study|Other|5|||
125255984|NCT03648372|450564575|FG016|Overall Study|Other|1|||
125255985|NCT03648372|450564576|FG017|Overall Study|Other|5|||
125255986|NCT03648372|450564577|FG018|Overall Study|Other|0|||
125255987|NCT03648372|450564578|FG019|Overall Study|Other|1|||
125255988|NCT03648372|450564579|FG020|Overall Study|Other|0|||
125255989|NCT03648372|450564559|FG000|Overall Study|Lost to Follow-up|0|||
125255990|NCT03648372|450564560|FG001|Overall Study|Lost to Follow-up|0|||
125255991|NCT03648372|450564561|FG002|Overall Study|Lost to Follow-up|0|||
125255992|NCT03648372|450564562|FG003|Overall Study|Lost to Follow-up|0|||
125255993|NCT03648372|450564563|FG004|Overall Study|Lost to Follow-up|0|||
125255994|NCT03648372|450564564|FG005|Overall Study|Lost to Follow-up|0|||
125255995|NCT03648372|450564565|FG006|Overall Study|Lost to Follow-up|0|||
125255996|NCT03648372|450564566|FG007|Overall Study|Lost to Follow-up|0|||
125255997|NCT03648372|450564567|FG008|Overall Study|Lost to Follow-up|0|||
125255998|NCT03648372|450564568|FG009|Overall Study|Lost to Follow-up|0|||
125255999|NCT03648372|450564569|FG010|Overall Study|Lost to Follow-up|0|||
125256000|NCT03648372|450564570|FG011|Overall Study|Lost to Follow-up|0|||
125256001|NCT03648372|450564571|FG012|Overall Study|Lost to Follow-up|0|||
125256002|NCT03648372|450564572|FG013|Overall Study|Lost to Follow-up|1|||
125256003|NCT03648372|450564573|FG014|Overall Study|Lost to Follow-up|0|||
125256004|NCT03648372|450564574|FG015|Overall Study|Lost to Follow-up|1|||
125256005|NCT03648372|450564575|FG016|Overall Study|Lost to Follow-up|0|||
125256006|NCT03648372|450564576|FG017|Overall Study|Lost to Follow-up|1|||
125256007|NCT03648372|450564577|FG018|Overall Study|Lost to Follow-up|0|||
125256008|NCT03648372|450564578|FG019|Overall Study|Lost to Follow-up|0|||
125256009|NCT03648372|450564579|FG020|Overall Study|Lost to Follow-up|0|||
125256010|NCT03648372|450564559|FG000|Overall Study|Start of a New Systemic Treatment|0|||
125256011|NCT03648372|450564560|FG001|Overall Study|Start of a New Systemic Treatment|0|||
125256012|NCT03648372|450564561|FG002|Overall Study|Start of a New Systemic Treatment|0|||
125256013|NCT03648372|450564562|FG003|Overall Study|Start of a New Systemic Treatment|0|||
125256014|NCT03648372|450564563|FG004|Overall Study|Start of a New Systemic Treatment|0|||
125256015|NCT03648372|450564564|FG005|Overall Study|Start of a New Systemic Treatment|0|||
125256016|NCT03648372|450564565|FG006|Overall Study|Start of a New Systemic Treatment|0|||
125256017|NCT03648372|450564566|FG007|Overall Study|Start of a New Systemic Treatment|2|||
125256018|NCT03648372|450564567|FG008|Overall Study|Start of a New Systemic Treatment|0|||
125256019|NCT03648372|450564568|FG009|Overall Study|Start of a New Systemic Treatment|0|||
125256020|NCT03648372|450564569|FG010|Overall Study|Start of a New Systemic Treatment|1|||
125256021|NCT03648372|450564570|FG011|Overall Study|Start of a New Systemic Treatment|0|||
125256022|NCT03648372|450564571|FG012|Overall Study|Start of a New Systemic Treatment|0|||
125256023|NCT03648372|450564572|FG013|Overall Study|Start of a New Systemic Treatment|0|||
125256024|NCT03648372|450564573|FG014|Overall Study|Start of a New Systemic Treatment|0|||
125256025|NCT03648372|450564574|FG015|Overall Study|Start of a New Systemic Treatment|0|||
125256026|NCT03648372|450564575|FG016|Overall Study|Start of a New Systemic Treatment|0|||
125256027|NCT03648372|450564576|FG017|Overall Study|Start of a New Systemic Treatment|0|||
125256028|NCT03648372|450564577|FG018|Overall Study|Start of a New Systemic Treatment|0|||
125256029|NCT03648372|450564578|FG019|Overall Study|Start of a New Systemic Treatment|0|||
125256030|NCT03648372|450564579|FG020|Overall Study|Start of a New Systemic Treatment|0|||
125256031|NCT04280783|450565973|FG000|Overall Study|Family issues unrelated to the study.|1|||
125256032|NCT04280783|450565974|FG001|Overall Study|Family issues unrelated to the study.|0|||
125256033|NCT04280783|450565973|FG000|Overall Study|Withdrawal by Subject|0|||
125256034|NCT04280783|450565974|FG001|Overall Study|Withdrawal by Subject|1|||
125256035|NCT05654181|450565975|FG000|Overall Study|Adverse Event|1|||
125256036|NCT05654181|450565976|FG001|Overall Study|Adverse Event|0|||
125256037|NCT05654181|450565977|FG002|Overall Study|Adverse Event|0|||
125256038|NCT05654181|450565978|FG003|Overall Study|Adverse Event|0|||
125256039|NCT05654181|450565979|FG004|Overall Study|Adverse Event|0|||
125256040|NCT05654181|450565980|FG005|Overall Study|Adverse Event|0|||
125256041|NCT05654181|450565981|FG006|Overall Study|Adverse Event|0|||
125256042|NCT05654181|450565982|FG007|Overall Study|Adverse Event|1|||
125256043|NCT05654181|450565983|FG008|Overall Study|Adverse Event|0|||
125256044|NCT05654181|450565984|FG009|Overall Study|Adverse Event|0|||
125256045|NCT05654181|450565975|FG000|Overall Study|Withdrawal by Subject|0|||
125256046|NCT05654181|450565976|FG001|Overall Study|Withdrawal by Subject|0|||
125256047|NCT05654181|450565977|FG002|Overall Study|Withdrawal by Subject|0|||
125256048|NCT05654181|450565978|FG003|Overall Study|Withdrawal by Subject|0|||
125256049|NCT05654181|450565979|FG004|Overall Study|Withdrawal by Subject|0|||
125256050|NCT05654181|450565980|FG005|Overall Study|Withdrawal by Subject|0|||
125256051|NCT05654181|450565981|FG006|Overall Study|Withdrawal by Subject|0|||
125256052|NCT05654181|450565982|FG007|Overall Study|Withdrawal by Subject|1|||
125397024|NCT02027844|451086955|FG000|Overall Study|Lost to Follow-up|0|||
125397025|NCT02027844|451086956|FG001|Overall Study|Lost to Follow-up|2|||
125397026|NCT02027844|451086957|FG002|Overall Study|Lost to Follow-up|1|||
125397027|NCT02027844|451086955|FG000|Overall Study|Protocol Violation|0|||
125397028|NCT02027844|451086956|FG001|Overall Study|Protocol Violation|2|||
125397029|NCT02027844|451086957|FG002|Overall Study|Protocol Violation|0|||
125397030|NCT02027844|451086955|FG000|Overall Study|Incomlete data|2|||
125397031|NCT02027844|451086956|FG001|Overall Study|Incomlete data|0|||
125397032|NCT02027844|451086957|FG002|Overall Study|Incomlete data|0|||
125397033|NCT00378014|451086958|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
125397034|NCT00378014|451086959|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
125397035|NCT00378014|451086958|FG000|Core (Randomization to Month 11)|Graft loss|1|||
125397036|NCT00378014|451086959|FG001|Core (Randomization to Month 11)|Graft loss|2|||
125397037|NCT00378014|451086958|FG000|Core (Randomization to Month 11)|Death|5|||
125397038|NCT00378014|451086959|FG001|Core (Randomization to Month 11)|Death|3|||
125397039|NCT00378014|451086958|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
125397040|NCT00378014|451086959|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
125397041|NCT00378014|451086958|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
125397042|NCT00378014|451086959|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
125397043|NCT00378014|451086958|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
125397044|NCT00378014|451086959|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
125397045|NCT00378014|451086958|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
125397046|NCT00378014|451086959|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
125397047|NCT00378014|451086958|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
125397048|NCT00378014|451086959|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
125397049|NCT00378014|451086958|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
125444896|NCT00946647|451253982|FG001|Phase ll Part|Adverse Event|0|||
125256053|NCT05654181|450565983|FG008|Overall Study|Withdrawal by Subject|0|||
125256054|NCT05654181|450565984|FG009|Overall Study|Withdrawal by Subject|0|||
125256055|NCT05654181|450565975|FG000|Overall Study|Other|0|||
125256056|NCT05654181|450565976|FG001|Overall Study|Other|0|||
125256057|NCT05654181|450565977|FG002|Overall Study|Other|0|||
125256058|NCT05654181|450565978|FG003|Overall Study|Other|0|||
125256059|NCT05654181|450565979|FG004|Overall Study|Other|1|||
125256060|NCT05654181|450565980|FG005|Overall Study|Other|1|||
125256061|NCT05654181|450565981|FG006|Overall Study|Other|0|||
125256062|NCT05654181|450565982|FG007|Overall Study|Other|0|||
125256063|NCT05654181|450565983|FG008|Overall Study|Other|0|||
125256064|NCT05654181|450565984|FG009|Overall Study|Other|0|||
125256065|NCT04101331|450565985|FG000|Overall Study|Adverse Event|9|||
125256066|NCT04101331|450565985|FG000|Overall Study|Disease progression|82|||
125256067|NCT04101331|450565985|FG000|Overall Study|Withdrawal by Subject|1|||
125256068|NCT04101331|450565985|FG000|Overall Study|Investigator decision|6|||
125256069|NCT04101331|450565985|FG000|Overall Study|Death|6|||
125256070|NCT04101331|450565985|FG000|Overall Study|Allogenic transplant|1|||
125256071|NCT04110145|450565986|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
125256072|NCT04110145|450565987|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
125256073|NCT04110145|450565988|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
125256074|NCT04110145|450565989|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
125256075|NCT04110145|450565990|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
125256076|NCT00488293|450565994|FG000|Overall Study|Lost to Follow-up|28|||
125256077|NCT00488293|450565995|FG001|Overall Study|Lost to Follow-up|25|||
125256078|NCT00488293|450565994|FG000|Overall Study|Withdrawal by Subject|5|||
125256079|NCT00488293|450565995|FG001|Overall Study|Withdrawal by Subject|3|||
125256080|NCT00488293|450565994|FG000|Overall Study|Death|2|||
125256081|NCT00488293|450565995|FG001|Overall Study|Death|1|||
125256082|NCT00488293|450565994|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
125256083|NCT00488293|450565995|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
125256084|NCT00500331|450565996|FG000|Overall Study|Adverse Event|0|||
125256085|NCT00500331|450565997|FG001|Overall Study|Adverse Event|2|||
125256086|NCT00500331|450565998|FG002|Overall Study|Adverse Event|0|||
125256087|NCT00500331|450565999|FG003|Overall Study|Adverse Event|1|||
125397050|NCT00378014|451086959|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
125397051|NCT00378014|451086958|FG000|Extension (Month 12 to Month 59)|Death|1|||
125397052|NCT00378014|451086959|FG001|Extension (Month 12 to Month 59)|Death|2|||
125397053|NCT00378014|451086958|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
125444897|NCT00946647|451253983|FG002|Phase ll Part|Adverse Event|0|||
125256088|NCT00500331|450566000|FG004|Overall Study|Adverse Event|2|||
125256089|NCT00500331|450566001|FG005|Overall Study|Adverse Event|2|||
125256090|NCT00500331|450566002|FG006|Overall Study|Adverse Event|0|||
125444898|NCT00946647|451253984|FG003|Phase ll Part|Adverse Event|10|||
125444899|NCT00946647|451253985|FG004|Phase ll Part|Adverse Event|6|||
125444900|NCT00946647|451253981|FG000|Phase ll Part|Withdrawal by Subject|0|||
125444901|NCT00946647|451253982|FG001|Phase ll Part|Withdrawal by Subject|0|||
125256091|NCT00500331|450565996|FG000|Overall Study|Lost to Follow-up|1|||
125256092|NCT00500331|450565997|FG001|Overall Study|Lost to Follow-up|1|||
125256093|NCT00500331|450565998|FG002|Overall Study|Lost to Follow-up|1|||
125256094|NCT00500331|450565999|FG003|Overall Study|Lost to Follow-up|2|||
125256095|NCT00500331|450566000|FG004|Overall Study|Lost to Follow-up|1|||
125256096|NCT00500331|450566001|FG005|Overall Study|Lost to Follow-up|0|||
125256097|NCT00500331|450566002|FG006|Overall Study|Lost to Follow-up|0|||
125256098|NCT00500331|450565996|FG000|Overall Study|Protocol Violation|3|||
125256099|NCT00500331|450565997|FG001|Overall Study|Protocol Violation|1|||
125256100|NCT00500331|450565998|FG002|Overall Study|Protocol Violation|1|||
125256101|NCT00500331|450565999|FG003|Overall Study|Protocol Violation|0|||
125256102|NCT00500331|450566000|FG004|Overall Study|Protocol Violation|1|||
125256103|NCT00500331|450566001|FG005|Overall Study|Protocol Violation|1|||
125256104|NCT00500331|450566002|FG006|Overall Study|Protocol Violation|1|||
125256105|NCT00500331|450565996|FG000|Overall Study|Withdrawal by Subject|4|||
125256106|NCT00500331|450565997|FG001|Overall Study|Withdrawal by Subject|0|||
125256107|NCT00500331|450565998|FG002|Overall Study|Withdrawal by Subject|1|||
125256108|NCT00500331|450565999|FG003|Overall Study|Withdrawal by Subject|5|||
125256109|NCT00500331|450566000|FG004|Overall Study|Withdrawal by Subject|0|||
125256110|NCT00500331|450566001|FG005|Overall Study|Withdrawal by Subject|1|||
125256111|NCT00500331|450566002|FG006|Overall Study|Withdrawal by Subject|1|||
125256112|NCT00500331|450565996|FG000|Overall Study|Lack of Efficacy|3|||
125256113|NCT00500331|450565997|FG001|Overall Study|Lack of Efficacy|1|||
125256114|NCT00500331|450565998|FG002|Overall Study|Lack of Efficacy|0|||
125256115|NCT00500331|450565999|FG003|Overall Study|Lack of Efficacy|0|||
125256116|NCT00500331|450566000|FG004|Overall Study|Lack of Efficacy|0|||
125256117|NCT00500331|450566001|FG005|Overall Study|Lack of Efficacy|0|||
125256118|NCT00500331|450566002|FG006|Overall Study|Lack of Efficacy|0|||
125256119|NCT00500331|450565996|FG000|Overall Study|Liver function test abnormality|0|||
125256120|NCT00500331|450565997|FG001|Overall Study|Liver function test abnormality|0|||
125256121|NCT00500331|450565998|FG002|Overall Study|Liver function test abnormality|1|||
125256122|NCT00500331|450565999|FG003|Overall Study|Liver function test abnormality|0|||
125256123|NCT00500331|450566000|FG004|Overall Study|Liver function test abnormality|0|||
125256124|NCT00500331|450566001|FG005|Overall Study|Liver function test abnormality|0|||
125256125|NCT00500331|450566002|FG006|Overall Study|Liver function test abnormality|0|||
125256126|NCT00500331|450565996|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
125256127|NCT00500331|450565997|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
125256128|NCT00500331|450565998|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
125256129|NCT00500331|450565999|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
125256130|NCT00500331|450566000|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
125256131|NCT00500331|450566001|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
125256132|NCT00500331|450566002|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
125256133|NCT00500331|450565996|FG000|Overall Study|Didn't return for continuation of study|1|||
125256134|NCT00500331|450565997|FG001|Overall Study|Didn't return for continuation of study|0|||
125256135|NCT00500331|450565998|FG002|Overall Study|Didn't return for continuation of study|0|||
125256136|NCT00500331|450565999|FG003|Overall Study|Didn't return for continuation of study|0|||
125256137|NCT00500331|450566000|FG004|Overall Study|Didn't return for continuation of study|0|||
125256138|NCT00500331|450566001|FG005|Overall Study|Didn't return for continuation of study|0|||
125256139|NCT00500331|450566002|FG006|Overall Study|Didn't return for continuation of study|0|||
125256140|NCT00500331|450565996|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
125256141|NCT00500331|450565997|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
125256142|NCT00500331|450565998|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
125256143|NCT00500331|450565999|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
125256144|NCT00500331|450566000|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
125256145|NCT00500331|450566001|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
125256146|NCT00500331|450566002|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
125397054|NCT00378014|451086959|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
125397055|NCT00378014|451086958|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
125397056|NCT00378014|451086959|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
125397057|NCT00378014|451086958|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
125397058|NCT00378014|451086959|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
125256147|NCT00500331|450565996|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
125397059|NCT00378014|451086958|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
125397060|NCT00378014|451086959|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
125397061|NCT02287896|451086973|FG000|Second Injection Visit|Withdrawal by Subject|0|||
125397062|NCT02287896|451086974|FG001|Second Injection Visit|Withdrawal by Subject|1|||
125397063|NCT00559962|451086975|FG000|Overall Study|Adverse Event|1|||
125256148|NCT00500331|450565997|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
125256149|NCT00500331|450565998|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
125256150|NCT00500331|450565999|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
125256151|NCT00500331|450566000|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
125256152|NCT00500331|450566001|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
125256153|NCT00500331|450566002|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
125256154|NCT00500331|450565996|FG000|Overall Study|Participant was randomized by mistake|1|||
125256155|NCT00500331|450565997|FG001|Overall Study|Participant was randomized by mistake|0|||
125256156|NCT00500331|450565998|FG002|Overall Study|Participant was randomized by mistake|0|||
125256157|NCT00500331|450565999|FG003|Overall Study|Participant was randomized by mistake|0|||
125256158|NCT00500331|450566000|FG004|Overall Study|Participant was randomized by mistake|0|||
125256159|NCT00500331|450566001|FG005|Overall Study|Participant was randomized by mistake|0|||
125256160|NCT00500331|450566002|FG006|Overall Study|Participant was randomized by mistake|0|||
125256161|NCT00500331|450565996|FG000|Overall Study|Diabetologist nurse in the study|0|||
125256162|NCT00500331|450565997|FG001|Overall Study|Diabetologist nurse in the study|0|||
125256163|NCT00500331|450565998|FG002|Overall Study|Diabetologist nurse in the study|1|||
125256164|NCT00500331|450565999|FG003|Overall Study|Diabetologist nurse in the study|0|||
125256165|NCT00500331|450566000|FG004|Overall Study|Diabetologist nurse in the study|0|||
125256166|NCT00500331|450566001|FG005|Overall Study|Diabetologist nurse in the study|0|||
125256167|NCT00500331|450566002|FG006|Overall Study|Diabetologist nurse in the study|0|||
125256168|NCT00500331|450565996|FG000|Overall Study|State ban of biological samples export|0|||
125256169|NCT00500331|450565997|FG001|Overall Study|State ban of biological samples export|0|||
125256170|NCT00500331|450565998|FG002|Overall Study|State ban of biological samples export|0|||
125256171|NCT00500331|450565999|FG003|Overall Study|State ban of biological samples export|1|||
125256172|NCT00500331|450566000|FG004|Overall Study|State ban of biological samples export|0|||
125256173|NCT00500331|450566001|FG005|Overall Study|State ban of biological samples export|0|||
125256174|NCT00500331|450566002|FG006|Overall Study|State ban of biological samples export|0|||
125256175|NCT00500331|450565996|FG000|Overall Study|Protocol violated|0|||
125256176|NCT00500331|450565997|FG001|Overall Study|Protocol violated|0|||
125256177|NCT00500331|450565998|FG002|Overall Study|Protocol violated|0|||
125256178|NCT00500331|450565999|FG003|Overall Study|Protocol violated|1|||
125256179|NCT00500331|450566000|FG004|Overall Study|Protocol violated|0|||
125256180|NCT00500331|450566001|FG005|Overall Study|Protocol violated|0|||
125256181|NCT00500331|450566002|FG006|Overall Study|Protocol violated|0|||
125256182|NCT03436732|450566003|FG000|Overall Study|Not treated-enrolled in different study|1|||
125256183|NCT03436732|450566004|FG001|Overall Study|Not treated-enrolled in different study|0|||
125256184|NCT03436732|450566003|FG000|Overall Study|Off study after cycle 1|1|||
125256185|NCT03436732|450566004|FG001|Overall Study|Off study after cycle 1|0|||
125256186|NCT03436732|450566003|FG000|Overall Study|Adverse Event|2|||
125256187|NCT03436732|450566004|FG001|Overall Study|Adverse Event|0|||
125256188|NCT03436732|450566003|FG000|Overall Study|Death|0|||
125256189|NCT03436732|450566004|FG001|Overall Study|Death|1|||
125256190|NCT03345550|450566005|FG000|Overall Study|Withdrawal by Subject|1|||
125256191|NCT03345550|450566006|FG001|Overall Study|Withdrawal by Subject|0|||
125256192|NCT03345550|450566005|FG000|Overall Study|Lost to Follow-up|4|||
125256193|NCT03345550|450566006|FG001|Overall Study|Lost to Follow-up|5|||
125256194|NCT05538728|450566007|FG000|Overall Study|Withdrawal by Subject|1|||
125256195|NCT05538728|450566008|FG001|Overall Study|Withdrawal by Subject|1|||
125256196|NCT00959049|450566009|FG000|Overall Study|Adverse Event|1|||
125256197|NCT00959049|450566010|FG001|Overall Study|Adverse Event|0|||
125256198|NCT00959049|450566011|FG002|Overall Study|Adverse Event|0|||
125256199|NCT00959049|450566012|FG003|Overall Study|Adverse Event|0|||
125256200|NCT00959049|450566013|FG004|Overall Study|Adverse Event|0|||
125256201|NCT00959049|450566014|FG005|Overall Study|Adverse Event|0|||
125256202|NCT00959049|450566009|FG000|Overall Study|Lost to Follow-up|17|||
125256203|NCT00959049|450566010|FG001|Overall Study|Lost to Follow-up|5|||
125256204|NCT00959049|450566011|FG002|Overall Study|Lost to Follow-up|1|||
125256205|NCT00959049|450566012|FG003|Overall Study|Lost to Follow-up|10|||
125256206|NCT00959049|450566013|FG004|Overall Study|Lost to Follow-up|9|||
125256207|NCT00959049|450566014|FG005|Overall Study|Lost to Follow-up|1|||
125256208|NCT00959049|450566009|FG000|Overall Study|Contraindicated medication|0|||
125256209|NCT00959049|450566010|FG001|Overall Study|Contraindicated medication|0|||
125397064|NCT00559962|451086976|FG001|Overall Study|Adverse Event|7|||
125397065|NCT00559962|451086977|FG002|Overall Study|Adverse Event|8|||
125397066|NCT00559962|451086978|FG003|Overall Study|Adverse Event|5|||
125256210|NCT00959049|450566011|FG002|Overall Study|Contraindicated medication|0|||
125256211|NCT00959049|450566012|FG003|Overall Study|Contraindicated medication|1|||
125256212|NCT00959049|450566013|FG004|Overall Study|Contraindicated medication|0|||
125256213|NCT00959049|450566014|FG005|Overall Study|Contraindicated medication|0|||
125256214|NCT00959049|450566009|FG000|Overall Study|Withdrawal by Subject|0|||
125256215|NCT00959049|450566010|FG001|Overall Study|Withdrawal by Subject|2|||
125256216|NCT00959049|450566011|FG002|Overall Study|Withdrawal by Subject|0|||
125256217|NCT00959049|450566012|FG003|Overall Study|Withdrawal by Subject|0|||
125397067|NCT00559962|451086979|FG004|Overall Study|Adverse Event|11|||
125397068|NCT00559962|451086980|FG005|Overall Study|Adverse Event|4|||
125444902|NCT00946647|451253983|FG002|Phase ll Part|Withdrawal by Subject|0|||
125444903|NCT00946647|451253984|FG003|Phase ll Part|Withdrawal by Subject|8|||
125444904|NCT00946647|451253985|FG004|Phase ll Part|Withdrawal by Subject|6|||
125444905|NCT00946647|451253981|FG000|Phase ll Part|Administrative problems|0|||
125444906|NCT00946647|451253982|FG001|Phase ll Part|Administrative problems|0|||
125444907|NCT00946647|451253983|FG002|Phase ll Part|Administrative problems|0|||
125444908|NCT00946647|451253984|FG003|Phase ll Part|Administrative problems|3|||
125444909|NCT00946647|451253985|FG004|Phase ll Part|Administrative problems|8|||
125444910|NCT00946647|451253981|FG000|Phase ll Part|Death|0|||
125444911|NCT00946647|451253982|FG001|Phase ll Part|Death|0|||
125444912|NCT00946647|451253983|FG002|Phase ll Part|Death|0|||
125444913|NCT00946647|451253984|FG003|Phase ll Part|Death|7|||
125444914|NCT00946647|451253985|FG004|Phase ll Part|Death|4|||
125444915|NCT00946647|451253981|FG000|Phase ll Part|Disease progression|0|||
125444916|NCT00946647|451253982|FG001|Phase ll Part|Disease progression|0|||
125444917|NCT00946647|451253983|FG002|Phase ll Part|Disease progression|0|||
125444918|NCT00946647|451253984|FG003|Phase ll Part|Disease progression|6|||
125444919|NCT00946647|451253985|FG004|Phase ll Part|Disease progression|14|||
125444920|NCT00946647|451253981|FG000|Phase ll Part|Protocol Violation|0|||
125444921|NCT00946647|451253982|FG001|Phase ll Part|Protocol Violation|0|||
125444922|NCT00946647|451253983|FG002|Phase ll Part|Protocol Violation|0|||
125444923|NCT00946647|451253984|FG003|Phase ll Part|Protocol Violation|4|||
125444924|NCT00946647|451253985|FG004|Phase ll Part|Protocol Violation|2|||
125444925|NCT00946647|451253981|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
125444926|NCT00946647|451253982|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
125444927|NCT00946647|451253983|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
125444928|NCT00946647|451253984|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
125444929|NCT00946647|451253985|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
125444930|NCT01368211|451253986|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
125444931|NCT01368211|451253987|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
125444932|NCT01987830|451253989|FG000|Overall Study|Never received baseline scan|1|||
125444933|NCT03990363|451253990|FG000|Overall Study|Withdrawal by Subject|10|||
125444934|NCT03990363|451253991|FG001|Overall Study|Withdrawal by Subject|9|||
125444935|NCT03990363|451253992|FG002|Overall Study|Withdrawal by Subject|18|||
125444936|NCT03990363|451253993|FG003|Overall Study|Withdrawal by Subject|11|||
125444937|NCT03990363|451253994|FG004|Overall Study|Withdrawal by Subject|9|||
125444938|NCT03990363|451253990|FG000|Overall Study|Physician Decision|1|||
125444939|NCT03990363|451253991|FG001|Overall Study|Physician Decision|0|||
125444940|NCT03990363|451253992|FG002|Overall Study|Physician Decision|0|||
125444941|NCT03990363|451253993|FG003|Overall Study|Physician Decision|0|||
125444942|NCT03990363|451253994|FG004|Overall Study|Physician Decision|0|||
125444943|NCT03990363|451253990|FG000|Overall Study|Adverse Event|1|||
125444944|NCT03990363|451253991|FG001|Overall Study|Adverse Event|3|||
125444945|NCT03990363|451253992|FG002|Overall Study|Adverse Event|2|||
125444946|NCT03990363|451253993|FG003|Overall Study|Adverse Event|2|||
125444947|NCT03990363|451253994|FG004|Overall Study|Adverse Event|0|||
125444948|NCT03990363|451253990|FG000|Overall Study|Death|14|||
125444949|NCT03990363|451253991|FG001|Overall Study|Death|8|||
125444950|NCT03990363|451253992|FG002|Overall Study|Death|14|||
125444951|NCT03990363|451253993|FG003|Overall Study|Death|10|||
125444952|NCT03990363|451253994|FG004|Overall Study|Death|11|||
125444953|NCT03990363|451253990|FG000|Overall Study|Failure to meet randomization criteria|0|||
125444954|NCT03990363|451253991|FG001|Overall Study|Failure to meet randomization criteria|1|||
125444955|NCT03990363|451253992|FG002|Overall Study|Failure to meet randomization criteria|1|||
125397069|NCT00559962|451086981|FG006|Overall Study|Adverse Event|4|||
125397070|NCT00559962|451086982|FG007|Overall Study|Adverse Event|2|||
125397071|NCT00559962|451086975|FG000|Overall Study|Lost to Follow-up|0|||
125397072|NCT00559962|451086976|FG001|Overall Study|Lost to Follow-up|1|||
125397073|NCT00559962|451086977|FG002|Overall Study|Lost to Follow-up|0|||
125397074|NCT00559962|451086978|FG003|Overall Study|Lost to Follow-up|0|||
125397075|NCT00559962|451086979|FG004|Overall Study|Lost to Follow-up|0|||
125397076|NCT00559962|451086980|FG005|Overall Study|Lost to Follow-up|0|||
125397077|NCT00559962|451086981|FG006|Overall Study|Lost to Follow-up|0|||
125397078|NCT00559962|451086982|FG007|Overall Study|Lost to Follow-up|0|||
125397079|NCT00559962|451086975|FG000|Overall Study|Withdrawal by Subject|1|||
125397080|NCT00559962|451086976|FG001|Overall Study|Withdrawal by Subject|1|||
125397081|NCT00559962|451086977|FG002|Overall Study|Withdrawal by Subject|2|||
125397082|NCT00559962|451086978|FG003|Overall Study|Withdrawal by Subject|0|||
125397083|NCT00559962|451086979|FG004|Overall Study|Withdrawal by Subject|3|||
125397084|NCT00559962|451086980|FG005|Overall Study|Withdrawal by Subject|1|||
125397085|NCT00559962|451086981|FG006|Overall Study|Withdrawal by Subject|0|||
125397086|NCT00559962|451086982|FG007|Overall Study|Withdrawal by Subject|2|||
125397087|NCT00559962|451086975|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
125397088|NCT00559962|451086976|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
125397089|NCT00559962|451086977|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
125444956|NCT03990363|451253993|FG003|Overall Study|Failure to meet randomization criteria|0|||
125256218|NCT00959049|450566013|FG004|Overall Study|Withdrawal by Subject|0|||
125256219|NCT00959049|450566014|FG005|Overall Study|Withdrawal by Subject|0|||
125256220|NCT00567502|450566015|FG000|Overall Study|Lost to Follow-up|91|||
125256221|NCT00567502|450566016|FG001|Overall Study|Lost to Follow-up|14|||
125256222|NCT00567502|450566017|FG002|Overall Study|Lost to Follow-up|351|||
125256223|NCT00567502|450566018|FG003|Overall Study|Lost to Follow-up|2|||
125256224|NCT00567502|450566015|FG000|Overall Study|Death|65|||
125256225|NCT00567502|450566016|FG001|Overall Study|Death|16|||
125256226|NCT00567502|450566017|FG002|Overall Study|Death|360|||
125256227|NCT00567502|450566018|FG003|Overall Study|Death|5|||
125256228|NCT00567502|450566015|FG000|Overall Study|Other|64|||
125256229|NCT00567502|450566016|FG001|Overall Study|Other|2|||
125256230|NCT00567502|450566017|FG002|Overall Study|Other|134|||
125256231|NCT00567502|450566018|FG003|Overall Study|Other|6|||
125256232|NCT00567502|450566015|FG000|Overall Study|Participant request|12|||
125256233|NCT00567502|450566016|FG001|Overall Study|Participant request|1|||
125256234|NCT00567502|450566017|FG002|Overall Study|Participant request|33|||
125256235|NCT00567502|450566018|FG003|Overall Study|Participant request|1|||
125256236|NCT00567502|450566015|FG000|Overall Study|Sponsor request|9|||
125256237|NCT00567502|450566016|FG001|Overall Study|Sponsor request|0|||
125256238|NCT00567502|450566017|FG002|Overall Study|Sponsor request|30|||
125256239|NCT00567502|450566018|FG003|Overall Study|Sponsor request|1|||
125256240|NCT00567502|450566015|FG000|Overall Study|Never Initiated Treatment|0|||
125256241|NCT00567502|450566016|FG001|Overall Study|Never Initiated Treatment|0|||
125256242|NCT00567502|450566017|FG002|Overall Study|Never Initiated Treatment|0|||
125256243|NCT00567502|450566018|FG003|Overall Study|Never Initiated Treatment|72|||
125256244|NCT00337168|450566019|FG000|Overall Study|Death|5|||
125397090|NCT00559962|451086978|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
125397091|NCT00559962|451086979|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
125397092|NCT00559962|451086980|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
125256245|NCT00337168|450566019|FG000|Overall Study|Not protocol specified|2|||
125256246|NCT00337168|450566019|FG000|Overall Study|Did not start therapy|1|||
125256247|NCT01230060|450566025|FG000|Overall Study|Withdrawal by Subject|1|||
125256248|NCT01052779|450566027|FG000|Overall Study|Adverse Event|1|||
125256249|NCT01052779|450566028|FG001|Overall Study|Adverse Event|4|||
125256250|NCT01052779|450566027|FG000|Overall Study|Withdrawal by Subject|1|||
125256251|NCT01052779|450566028|FG001|Overall Study|Withdrawal by Subject|2|||
125256252|NCT01052779|450566027|FG000|Overall Study|Other-Protocol Violation|1|||
125256253|NCT01052779|450566028|FG001|Overall Study|Other-Protocol Violation|1|||
125256254|NCT01052779|450566027|FG000|Overall Study|Other-Surgery|0|||
125256255|NCT01052779|450566028|FG001|Overall Study|Other-Surgery|2|||
125256256|NCT01052779|450566027|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
125256257|NCT01052779|450566028|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
125256258|NCT03802916|450566029|FG000|Overall Study|Adverse Event|0|||
125256259|NCT03802916|450566030|FG001|Overall Study|Adverse Event|1|||
125256260|NCT03802916|450566029|FG000|Overall Study|Withdrawal by Subject|0|||
125256261|NCT03802916|450566030|FG001|Overall Study|Withdrawal by Subject|1|||
125256262|NCT03663582|450566031|FG000|Overall Study|Physician Decision|1|||
125397093|NCT00559962|451086981|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
125397094|NCT00559962|451086982|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
125397095|NCT04889625|451086983|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
125397096|NCT04889625|451086984|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
125397097|NCT04889625|451086983|FG000|Period 1|Subject out of window|0|||
125397098|NCT04889625|451086984|FG001|Period 1|Subject out of window|1|||
125397099|NCT04889625|451086983|FG000|Period 1|Wrong add power dispensed|0|||
125397100|NCT04889625|451086984|FG001|Period 1|Wrong add power dispensed|1|||
125397101|NCT04889625|451086983|FG000|Period 1|Discontinued due to fitting guide error|1|||
125397102|NCT04889625|451086984|FG001|Period 1|Discontinued due to fitting guide error|1|||
125397103|NCT04889625|451086983|FG000|Period 2|Test article no longer available|1|||
125397104|NCT04889625|451086984|FG001|Period 2|Test article no longer available|0|||
125397105|NCT04889625|451086983|FG000|Period 2|Incorrect lens dispensed|1|||
125397106|NCT04889625|451086984|FG001|Period 2|Incorrect lens dispensed|0|||
125397107|NCT04889625|451086983|FG000|Period 2|Wrong add power dispensed|0|||
125397108|NCT04889625|451086984|FG001|Period 2|Wrong add power dispensed|1|||
125397109|NCT03746522|451086994|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
125397110|NCT03746522|451086995|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
125397111|NCT03746522|451086996|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
125444957|NCT03990363|451253994|FG004|Overall Study|Failure to meet randomization criteria|0|||
125444958|NCT03990363|451253990|FG000|Overall Study|Lost to Follow-up|0|||
125256263|NCT00480532|450566032|FG000|Overall Study|Withdrawal by Subject|2|||
125256264|NCT00480532|450566033|FG001|Overall Study|Withdrawal by Subject|4|||
125256265|NCT00480532|450566034|FG002|Overall Study|Withdrawal by Subject|3|||
125256266|NCT00480532|450566035|FG003|Overall Study|Withdrawal by Subject|1|||
125256267|NCT00480532|450566032|FG000|Overall Study|Protocol Violation|0|||
125256268|NCT00480532|450566033|FG001|Overall Study|Protocol Violation|0|||
125256269|NCT00480532|450566034|FG002|Overall Study|Protocol Violation|1|||
125256270|NCT00480532|450566035|FG003|Overall Study|Protocol Violation|0|||
125256271|NCT03242434|450566045|FG000|Overall Study|Death|0|||
125256272|NCT03242434|450566046|FG001|Overall Study|Death|2|||
125256273|NCT02367885|450566047|FG000|Overall Study|Lost to Follow-up|1|||
125256274|NCT02367885|450566048|FG001|Overall Study|Lost to Follow-up|0|||
125256275|NCT02367885|450566049|FG002|Overall Study|Lost to Follow-up|0|||
125256276|NCT02367885|450566047|FG000|Overall Study|Withdrawal by Subject|1|||
125256277|NCT02367885|450566048|FG001|Overall Study|Withdrawal by Subject|0|||
125256278|NCT02367885|450566049|FG002|Overall Study|Withdrawal by Subject|0|||
125256279|NCT01602484|450566050|FG000|Overall Study|Airway issues unrelated to study|0|||
125256280|NCT01602484|450566051|FG001|Overall Study|Airway issues unrelated to study|1|||
125256281|NCT03729609|450566052|FG000|Overall Study|Protocol Violation|1|||
125256282|NCT00605189|450566059|FG000|Overall Study|Adverse Event|1|||
125256283|NCT00605189|450566060|FG001|Overall Study|Adverse Event|0|||
125256284|NCT00605189|450566061|FG002|Overall Study|Adverse Event|0|||
125256285|NCT00605189|450566059|FG000|Overall Study|Other|2|||
125256286|NCT00605189|450566060|FG001|Overall Study|Other|2|||
125256287|NCT00605189|450566061|FG002|Overall Study|Other|0|||
125256288|NCT02697448|450566062|FG000|Overall Study|Protocol Violation|2|||
125256289|NCT02697448|450566063|FG001|Overall Study|Protocol Violation|4|||
125256290|NCT02697448|450566062|FG000|Overall Study|Clinical concerns during ablation|1|||
125256291|NCT02697448|450566063|FG001|Overall Study|Clinical concerns during ablation|1|||
125256292|NCT02697448|450566062|FG000|Overall Study|No data collected|2|||
125256293|NCT02697448|450566063|FG001|Overall Study|No data collected|0|||
125256294|NCT05473715|450566064|FG000|Overall Study|Trial terminate|2|||
125256295|NCT05473715|450566065|FG001|Overall Study|Trial terminate|1|||
125256296|NCT02919618|450566069|FG000|Overall Study|Death|1|||
125256297|NCT02592863|450566070|FG000|Overall Study|Withdrawal by Subject|2|||
125256298|NCT02592863|450566071|FG001|Overall Study|Withdrawal by Subject|2|||
125256299|NCT02592863|450566070|FG000|Overall Study|Lost to Follow-up|1|||
125256300|NCT02592863|450566071|FG001|Overall Study|Lost to Follow-up|1|||
125256301|NCT02743221|450566072|FG000|Overall Study|Progressive disease|29|||
125256302|NCT02743221|450566073|FG001|Overall Study|Progressive disease|38|||
125256303|NCT02743221|450566072|FG000|Overall Study|Adverse Event|17|||
125256304|NCT02743221|450566073|FG001|Overall Study|Adverse Event|14|||
125256305|NCT02743221|450566072|FG000|Overall Study|non medical reason|8|||
125256306|NCT02743221|450566073|FG001|Overall Study|non medical reason|2|||
125256307|NCT02743221|450566072|FG000|Overall Study|Physician Decision|2|||
125256308|NCT02743221|450566073|FG001|Overall Study|Physician Decision|5|||
125256309|NCT02743221|450566072|FG000|Overall Study|Patient not eligible, not treated|0|||
125256310|NCT02743221|450566073|FG001|Overall Study|Patient not eligible, not treated|1|||
125256311|NCT04770285|450566075|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
125256312|NCT04770285|450566076|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
125256313|NCT04770285|450566075|FG000|Overall Study|Lack of Efficacy|0|||
125256314|NCT04770285|450566076|FG001|Overall Study|Lack of Efficacy|1|||
125256315|NCT04770285|450566075|FG000|Overall Study|Lost to Follow-up|11|||
125256316|NCT04770285|450566076|FG001|Overall Study|Lost to Follow-up|8|||
125256317|NCT04770285|450566075|FG000|Overall Study|Protocol Deviation|6|||
125256318|NCT04770285|450566076|FG001|Overall Study|Protocol Deviation|6|||
125256319|NCT04770285|450566075|FG000|Overall Study|Technical Problem|0|||
125256320|NCT04770285|450566076|FG001|Overall Study|Technical Problem|1|||
125256321|NCT04770285|450566075|FG000|Overall Study|Withdrawal by Subject|9|||
125256322|NCT04770285|450566076|FG001|Overall Study|Withdrawal by Subject|8|||
125256323|NCT04770285|450566075|FG000|Overall Study|Reason Not Specified|0|||
125256324|NCT04770285|450566076|FG001|Overall Study|Reason Not Specified|1|||
125256325|NCT03766399|450566077|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256326|NCT03766399|450566078|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256327|NCT03766399|450566079|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256328|NCT03766399|450566080|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256329|NCT03766399|450566081|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256330|NCT03766399|450566082|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256331|NCT03766399|450566083|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256332|NCT03766399|450566084|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256333|NCT03766399|450566085|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256334|NCT03766399|450566086|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256335|NCT03766399|450566087|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256336|NCT03766399|450566088|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125397112|NCT03746522|451086994|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
125256337|NCT03766399|450566089|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256338|NCT03766399|450566090|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
125397113|NCT03746522|451086995|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
125256339|NCT03766399|450566091|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256340|NCT03766399|450566092|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256341|NCT03766399|450566093|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256342|NCT03766399|450566094|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
125256343|NCT03411044|450566095|FG000|Overall Study|Death|30|||
125256344|NCT03411044|450566095|FG000|Overall Study|Withdrawal by Subject|48|||
125256345|NCT03411044|450566095|FG000|Overall Study|Lost to Follow-up|78|||
125256346|NCT03411044|450566095|FG000|Overall Study|Adverse Event|30|||
125256347|NCT03411044|450566095|FG000|Overall Study|Missing status|4|||
125256348|NCT01969409|450566096|FG000|Overall Study|Death|2|||
125256349|NCT01969409|450566097|FG001|Overall Study|Death|2|||
125397114|NCT03746522|451086996|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
125397115|NCT03746522|451086994|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
125397116|NCT03746522|451086995|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
125397117|NCT03746522|451086996|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
125397118|NCT03746522|451086994|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
125397119|NCT03746522|451086995|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
125397120|NCT03746522|451086996|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
125397121|NCT03746522|451086994|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
125397122|NCT03746522|451086995|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
125397123|NCT03746522|451086996|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
125397124|NCT03047135|451087000|FG000|Overall Study|Still being treated|3|||
125397125|NCT00323414|451087001|FG000|Overall Study|Withdrawal by Subject|0|||
125397126|NCT00323414|451087002|FG001|Overall Study|Withdrawal by Subject|1|||
125397127|NCT02552316|451087004|FG000|Overall Study|Withdrawal by Subject|1|||
125397128|NCT02552316|451087004|FG000|Overall Study|Withdrawal due to non-compliance|1|||
125397129|NCT02659020|451087005|FG000|Overall Study|Adverse Event|0|||
125397130|NCT02659020|451087006|FG001|Overall Study|Adverse Event|0|||
125397131|NCT02659020|451087007|FG002|Overall Study|Adverse Event|0|||
125397132|NCT02659020|451087008|FG003|Overall Study|Adverse Event|2|||
125397133|NCT02659020|451087009|FG004|Overall Study|Adverse Event|0|||
125397134|NCT02659020|451087010|FG005|Overall Study|Adverse Event|0|||
125397135|NCT02659020|451087011|FG006|Overall Study|Adverse Event|2|||
125397136|NCT02659020|451087005|FG000|Overall Study|Lost to Follow-up|1|||
125397137|NCT02659020|451087006|FG001|Overall Study|Lost to Follow-up|2|||
125397138|NCT02659020|451087007|FG002|Overall Study|Lost to Follow-up|1|||
125397139|NCT02659020|451087008|FG003|Overall Study|Lost to Follow-up|6|||
125397140|NCT02659020|451087009|FG004|Overall Study|Lost to Follow-up|1|||
125397141|NCT02659020|451087010|FG005|Overall Study|Lost to Follow-up|5|||
125397142|NCT02659020|451087011|FG006|Overall Study|Lost to Follow-up|0|||
125397143|NCT02659020|451087005|FG000|Overall Study|Physician Decision|0|||
125397144|NCT02659020|451087006|FG001|Overall Study|Physician Decision|0|||
125397145|NCT02659020|451087007|FG002|Overall Study|Physician Decision|0|||
125397146|NCT02659020|451087008|FG003|Overall Study|Physician Decision|1|||
125397147|NCT02659020|451087009|FG004|Overall Study|Physician Decision|1|||
125397148|NCT02659020|451087010|FG005|Overall Study|Physician Decision|0|||
125397149|NCT02659020|451087011|FG006|Overall Study|Physician Decision|1|||
125397150|NCT02659020|451087005|FG000|Overall Study|Withdrawal by Subject|2|||
125397151|NCT02659020|451087006|FG001|Overall Study|Withdrawal by Subject|1|||
125397152|NCT02659020|451087007|FG002|Overall Study|Withdrawal by Subject|0|||
125397153|NCT02659020|451087008|FG003|Overall Study|Withdrawal by Subject|3|||
125397154|NCT02659020|451087009|FG004|Overall Study|Withdrawal by Subject|3|||
125397155|NCT02659020|451087010|FG005|Overall Study|Withdrawal by Subject|6|||
125397156|NCT02659020|451087011|FG006|Overall Study|Withdrawal by Subject|3|||
125397157|NCT02659020|451087005|FG000|Overall Study|Progressive Disease|0|||
125397158|NCT02659020|451087006|FG001|Overall Study|Progressive Disease|0|||
125397159|NCT02659020|451087007|FG002|Overall Study|Progressive Disease|0|||
125397160|NCT02659020|451087008|FG003|Overall Study|Progressive Disease|4|||
125397161|NCT02659020|451087009|FG004|Overall Study|Progressive Disease|1|||
125397162|NCT02659020|451087010|FG005|Overall Study|Progressive Disease|0|||
125397163|NCT02659020|451087011|FG006|Overall Study|Progressive Disease|2|||
125397164|NCT04382911|451087012|FG000|Overall Study|unable to be imaged prior to surgery|2|||
125397165|NCT01585766|451087013|FG000|Overall Study|Withdrawal by Subject|0|||
125397166|NCT01585766|451087014|FG001|Overall Study|Withdrawal by Subject|1|||
125397167|NCT01585766|451087015|FG002|Overall Study|Withdrawal by Subject|1|||
125397168|NCT01585766|451087016|FG003|Overall Study|Withdrawal by Subject|0|||
125256350|NCT01969409|450566096|FG000|Overall Study|Transplant|1|||
125397169|NCT01585766|451087017|FG004|Overall Study|Withdrawal by Subject|0|||
125397170|NCT01585766|451087018|FG005|Overall Study|Withdrawal by Subject|0|||
125397171|NCT01585766|451087013|FG000|Overall Study|Death|0|||
125256351|NCT01969409|450566097|FG001|Overall Study|Transplant|1|||
125397172|NCT01585766|451087014|FG001|Overall Study|Death|1|||
125397173|NCT01585766|451087015|FG002|Overall Study|Death|0|||
125397174|NCT01585766|451087016|FG003|Overall Study|Death|0|||
125397175|NCT01585766|451087017|FG004|Overall Study|Death|0|||
125397176|NCT01585766|451087018|FG005|Overall Study|Death|0|||
125397177|NCT01585766|451087013|FG000|Overall Study|Physician Decision|0|||
125397178|NCT01585766|451087014|FG001|Overall Study|Physician Decision|0|||
125397179|NCT01585766|451087015|FG002|Overall Study|Physician Decision|1|||
125397180|NCT01585766|451087016|FG003|Overall Study|Physician Decision|0|||
125397181|NCT01585766|451087017|FG004|Overall Study|Physician Decision|0|||
125256352|NCT01969409|450566096|FG000|Overall Study|Withdrawal by Subject|0|||
125444959|NCT03990363|451253991|FG001|Overall Study|Lost to Follow-up|0|||
125444960|NCT03990363|451253992|FG002|Overall Study|Lost to Follow-up|0|||
125444961|NCT03990363|451253993|FG003|Overall Study|Lost to Follow-up|1|||
125444962|NCT03990363|451253994|FG004|Overall Study|Lost to Follow-up|2|||
125444963|NCT03990363|451253990|FG000|Overall Study|Non-compliance with study drug|2|||
125444964|NCT03990363|451253991|FG001|Overall Study|Non-compliance with study drug|1|||
125444965|NCT03990363|451253992|FG002|Overall Study|Non-compliance with study drug|2|||
125444966|NCT03990363|451253993|FG003|Overall Study|Non-compliance with study drug|0|||
125444967|NCT03990363|451253994|FG004|Overall Study|Non-compliance with study drug|0|||
125444968|NCT03990363|451253990|FG000|Overall Study|Study terminated by sponsor|0|||
125444969|NCT03990363|451253991|FG001|Overall Study|Study terminated by sponsor|1|||
125444970|NCT03990363|451253992|FG002|Overall Study|Study terminated by sponsor|0|||
125444971|NCT03990363|451253993|FG003|Overall Study|Study terminated by sponsor|0|||
125444972|NCT03990363|451253994|FG004|Overall Study|Study terminated by sponsor|0|||
125444973|NCT03990363|451253990|FG000|Overall Study|Site terminated by sponsor|2|||
125444974|NCT03990363|451253991|FG001|Overall Study|Site terminated by sponsor|1|||
125444975|NCT03990363|451253992|FG002|Overall Study|Site terminated by sponsor|2|||
125444976|NCT03990363|451253993|FG003|Overall Study|Site terminated by sponsor|0|||
125444977|NCT03990363|451253994|FG004|Overall Study|Site terminated by sponsor|2|||
125444978|NCT03990363|451253990|FG000|Overall Study|Not categorized|5|||
125444979|NCT03990363|451253991|FG001|Overall Study|Not categorized|5|||
125444980|NCT03990363|451253992|FG002|Overall Study|Not categorized|3|||
125444981|NCT03990363|451253993|FG003|Overall Study|Not categorized|2|||
125444982|NCT03990363|451253994|FG004|Overall Study|Not categorized|2|||
125444983|NCT01349660|451253998|FG000|Overall Study|Still Receiving Study Treatment|0|||
125444984|NCT01349660|451253999|FG001|Overall Study|Still Receiving Study Treatment|0|||
125444985|NCT01349660|451254000|FG002|Overall Study|Still Receiving Study Treatment|1|||
125444986|NCT01349660|451253998|FG000|Overall Study|Disease Progression|2|||
125444987|NCT01349660|451253999|FG001|Overall Study|Disease Progression|4|||
125444988|NCT01349660|451254000|FG002|Overall Study|Disease Progression|50|||
125444989|NCT01349660|451253998|FG000|Overall Study|Adverse Event|1|||
125444990|NCT01349660|451253999|FG001|Overall Study|Adverse Event|1|||
125444991|NCT01349660|451254000|FG002|Overall Study|Adverse Event|12|||
125444992|NCT01349660|451253998|FG000|Overall Study|Withdrawal by Subject|2|||
125444993|NCT01349660|451253999|FG001|Overall Study|Withdrawal by Subject|0|||
125444994|NCT01349660|451254000|FG002|Overall Study|Withdrawal by Subject|9|||
125444995|NCT01349660|451253998|FG000|Overall Study|Death|1|||
125444996|NCT01349660|451253999|FG001|Overall Study|Death|1|||
125444997|NCT01349660|451254000|FG002|Overall Study|Death|0|||
125444998|NCT01349660|451253998|FG000|Overall Study|Non-Permitted Interventions|0|||
125444999|NCT01349660|451253999|FG001|Overall Study|Non-Permitted Interventions|0|||
125445000|NCT01349660|451254000|FG002|Overall Study|Non-Permitted Interventions|2|||
125445001|NCT01349660|451253998|FG000|Overall Study|Study Compliance|0|||
125445002|NCT01349660|451253999|FG001|Overall Study|Study Compliance|0|||
125445003|NCT01349660|451254000|FG002|Overall Study|Study Compliance|1|||
125445004|NCT01349660|451253998|FG000|Overall Study|Declining Performance Status|0|||
125445005|NCT01349660|451253999|FG001|Overall Study|Declining Performance Status|0|||
125445006|NCT01349660|451254000|FG002|Overall Study|Declining Performance Status|1|||
125445007|NCT05764239|451254002|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
125445008|NCT05764239|451254002|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
125445009|NCT05764239|451254002|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
125445010|NCT05764239|451254002|FG000|DEP (Part 1)|Adverse Event|1|||
125445011|NCT05764239|451254002|FG000|DEP (Part 1)|Lost to Follow-up|1|||
125445012|NCT05764239|451254002|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
125445013|NCT05764239|451254002|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
125445014|NCT05764239|451254002|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
125445015|NCT05764239|451254002|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
125445016|NCT00057811|451254003|FG000|Overall Study|Lack of Efficacy|1|||
125445017|NCT00057811|451254004|FG001|Overall Study|Lack of Efficacy|4|||
125445018|NCT00057811|451254003|FG000|Overall Study|Physician Decision|1|||
125445019|NCT00057811|451254004|FG001|Overall Study|Physician Decision|0|||
125445020|NCT00057811|451254003|FG000|Overall Study|Withdrawal by Subject|3|||
125445021|NCT00057811|451254004|FG001|Overall Study|Withdrawal by Subject|4|||
125445022|NCT00057811|451254003|FG000|Overall Study|Ineligible|4|||
125445023|NCT00057811|451254004|FG001|Overall Study|Ineligible|2|||
125445024|NCT00057811|451254003|FG000|Overall Study|Inevaluable|1|||
125445025|NCT00057811|451254004|FG001|Overall Study|Inevaluable|2|||
125445026|NCT00556374|451254005|FG000|Overall Study|Withdrawal by Subject|235|||
125445027|NCT00556374|451254006|FG001|Overall Study|Withdrawal by Subject|205|||
125445028|NCT00556374|451254005|FG000|Overall Study|Death|158|||
125445029|NCT00556374|451254006|FG001|Overall Study|Death|127|||
125445030|NCT00556374|451254005|FG000|Overall Study|Lost to Follow-up|24|||
125445031|NCT00556374|451254006|FG001|Overall Study|Lost to Follow-up|17|||
125445032|NCT00556374|451254005|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
125445033|NCT00556374|451254006|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
125445034|NCT00663962|451254007|FG000|Overall Study|somnolence|1|||
125445035|NCT00663962|451254008|FG001|Overall Study|somnolence|0|||
125445036|NCT02846558|451254015|FG000|Overall Study|Adverse Event|1|||
125256353|NCT01969409|450566097|FG001|Overall Study|Withdrawal by Subject|1|||
125256354|NCT03078868|450566100|FG000|Overall Study|Physician Decision|3|||
125256355|NCT01435356|450566101|FG000|Overall Study|Adverse Event|2|||
125256356|NCT01435356|450566102|FG001|Overall Study|Adverse Event|0|||
125256357|NCT01435356|450566101|FG000|Overall Study|Disease progression/recurrence|17|||
125256358|NCT01435356|450566102|FG001|Overall Study|Disease progression/recurrence|10|||
125445037|NCT02846558|451254016|FG001|Overall Study|Adverse Event|0|||
125445038|NCT02846558|451254017|FG002|Overall Study|Adverse Event|0|||
125256359|NCT01435356|450566101|FG000|Overall Study|Protocol Violation|0|||
125256360|NCT01435356|450566102|FG001|Overall Study|Protocol Violation|1|||
125256361|NCT01435356|450566101|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
125256362|NCT01435356|450566102|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
125256363|NCT01435356|450566101|FG000|Overall Study|Withdrawal by Subject|1|||
125256364|NCT01435356|450566102|FG001|Overall Study|Withdrawal by Subject|1|||
125256365|NCT01435356|450566101|FG000|Overall Study|Facial palsy|1|||
125256366|NCT01435356|450566102|FG001|Overall Study|Facial palsy|0|||
125256367|NCT01435356|450566101|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
125256368|NCT01435356|450566102|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
125256369|NCT01435356|450566101|FG000|Overall Study|Physician Decision|1|||
125256370|NCT01435356|450566102|FG001|Overall Study|Physician Decision|0|||
125256371|NCT01435356|450566101|FG000|Overall Study|Patient decision|3|||
125256372|NCT01435356|450566102|FG001|Overall Study|Patient decision|0|||
125256373|NCT01435356|450566101|FG000|Overall Study|Patient moved to another city|1|||
125256374|NCT01435356|450566102|FG001|Overall Study|Patient moved to another city|1|||
125256375|NCT00437073|450566103|FG000|Overall Study|Sponsor Terminated Study|1|||
125256376|NCT00437073|450566104|FG001|Overall Study|Sponsor Terminated Study|0|||
125256377|NCT00437073|450566103|FG000|Overall Study|Physician Decision|0|||
125256378|NCT00437073|450566104|FG001|Overall Study|Physician Decision|1|||
125256379|NCT04221438|450566107|FG000|Overall Study|Adverse Event|1|||
125256380|NCT04221438|450566107|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
125256381|NCT03673176|450568027|FG000|Overall Study|Death prior to intervention|1|||
125256382|NCT03673176|450568027|FG000|Overall Study|Death following intervention|3|||
125256383|NCT03673176|450568027|FG000|Overall Study|Withdrawal by Subject|1|||
125256384|NCT02439957|450568028|FG000|Overall Study|Study Terminated|3|||
125256385|NCT02439957|450568029|FG001|Overall Study|Study Terminated|3|||
125256386|NCT00666263|450568030|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
125256387|NCT00666263|450568031|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
125256388|NCT00666263|450568030|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
125256389|NCT00666263|450568031|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
125256390|NCT00666263|450568030|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
125256391|NCT00666263|450568031|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
125256392|NCT01225952|450568033|FG000|Overall Study|Lost to Follow-up|1|||
125256393|NCT01225952|450568034|FG001|Overall Study|Lost to Follow-up|0|||
125256394|NCT01225952|450568035|FG002|Overall Study|Lost to Follow-up|0|||
125256395|NCT01225952|450568033|FG000|Overall Study|Study Eye Explanted|0|||
125256396|NCT01225952|450568034|FG001|Overall Study|Study Eye Explanted|0|||
125256397|NCT01225952|450568035|FG002|Overall Study|Study Eye Explanted|1|||
125256398|NCT01225952|450568033|FG000|Overall Study|Withdrawal by Subject|4|||
125256399|NCT01225952|450568034|FG001|Overall Study|Withdrawal by Subject|4|||
125256400|NCT01225952|450568035|FG002|Overall Study|Withdrawal by Subject|5|||
125256401|NCT01225952|450568033|FG000|Overall Study|Surgical complications|1|||
125256402|NCT01225952|450568034|FG001|Overall Study|Surgical complications|0|||
125256403|NCT01225952|450568035|FG002|Overall Study|Surgical complications|0|||
125256404|NCT02378480|450568036|FG000|Overall Study|Physician Decision|1|||
125256405|NCT02378480|450568037|FG001|Overall Study|Physician Decision|1|||
125256406|NCT02378480|450568036|FG000|Overall Study|Death|1|||
125256407|NCT02378480|450568037|FG001|Overall Study|Death|2|||
125256408|NCT02378480|450568036|FG000|Overall Study|Randomized, but Not Treated|6|||
125256409|NCT02378480|450568037|FG001|Overall Study|Randomized, but Not Treated|4|||
125256410|NCT02378480|450568036|FG000|Overall Study|Adverse Event|0|||
125256411|NCT02378480|450568037|FG001|Overall Study|Adverse Event|1|||
125256412|NCT02378480|450568036|FG000|Overall Study|Missed EOT/PTE Visit|1|||
125256413|NCT02378480|450568037|FG001|Overall Study|Missed EOT/PTE Visit|2|||
125256414|NCT02378480|450568036|FG000|Overall Study|Withdrawal by Subject|9|||
125256415|NCT02378480|450568037|FG001|Overall Study|Withdrawal by Subject|4|||
125256416|NCT02378480|450568036|FG000|Overall Study|Lost to Follow-up|10|||
125256417|NCT02378480|450568037|FG001|Overall Study|Lost to Follow-up|18|||
125256418|NCT01217892|450568038|FG000|Overall Study|Adverse Event|1|||
125256419|NCT01217892|450568039|FG001|Overall Study|Adverse Event|1|||
125256420|NCT01217892|450568040|FG002|Overall Study|Adverse Event|1|||
125445039|NCT02846558|451254018|FG003|Overall Study|Adverse Event|0|||
125445040|NCT02846558|451254015|FG000|Overall Study|Withdrawal by Subject|5|||
125256421|NCT01217892|450568041|FG003|Overall Study|Adverse Event|0|||
125256422|NCT01217892|450568038|FG000|Overall Study|Withdrawal by Subject|0|||
125256423|NCT01217892|450568039|FG001|Overall Study|Withdrawal by Subject|2|||
125256424|NCT01217892|450568040|FG002|Overall Study|Withdrawal by Subject|1|||
125256425|NCT01217892|450568041|FG003|Overall Study|Withdrawal by Subject|0|||
125397182|NCT01585766|451087018|FG005|Overall Study|Physician Decision|0|||
125397183|NCT02385799|451087019|FG000|Overall Study|Lost to Follow-up|1|||
125397184|NCT02385799|451087020|FG001|Overall Study|Lost to Follow-up|2|||
125397185|NCT02385799|451087019|FG000|Overall Study|Adverse Event|4|||
125397186|NCT02385799|451087020|FG001|Overall Study|Adverse Event|2|||
125397187|NCT02385799|451087019|FG000|Overall Study|Withdrawal by Subject|0|||
125397188|NCT02385799|451087020|FG001|Overall Study|Withdrawal by Subject|4|||
125397189|NCT02130765|451087022|FG000|Overall Study|Did not receive treatment|4|||
125397190|NCT02130765|451087023|FG001|Overall Study|Did not receive treatment|0|||
125397191|NCT02130765|451087024|FG002|Overall Study|Did not receive treatment|0|||
125397192|NCT02130765|451087025|FG003|Overall Study|Did not receive treatment|0|||
125397193|NCT00376168|451087032|FG000|Overall Study|Adverse Event|1|||
125397194|NCT00376168|451087033|FG001|Overall Study|Adverse Event|1|||
125397195|NCT00376168|451087032|FG000|Overall Study|Pregnancy|1|||
125397196|NCT00376168|451087033|FG001|Overall Study|Pregnancy|0|||
125397197|NCT02350309|451087034|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
125397198|NCT02350309|451087035|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
125397199|NCT02350309|451087036|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
125397200|NCT02350309|451087037|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
125397201|NCT02350309|451087038|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
125397202|NCT02350309|451087039|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
125397203|NCT02350309|451087034|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
125397204|NCT02350309|451087035|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
125397205|NCT02350309|451087036|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
125397206|NCT02350309|451087037|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
125397207|NCT02350309|451087038|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
125397208|NCT02350309|451087039|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
125397209|NCT02244580|451087040|FG000|Overall Study|No cancer tissues available|241|||
125397210|NCT01455012|451087041|FG000|Overall Study|Adverse Event|0|||
125397211|NCT01455012|451087042|FG001|Overall Study|Adverse Event|2|||
125397212|NCT01455012|451087041|FG000|Overall Study|Lack of Efficacy|6|||
125397213|NCT01455012|451087042|FG001|Overall Study|Lack of Efficacy|1|||
125397214|NCT01455012|451087041|FG000|Overall Study|Withdrawal by Subject|3|||
125397215|NCT01455012|451087042|FG001|Overall Study|Withdrawal by Subject|1|||
125397216|NCT01455012|451087041|FG000|Overall Study|Unknown reason|2|||
125397217|NCT01455012|451087042|FG001|Overall Study|Unknown reason|0|||
125397218|NCT01215227|451087043|FG000|Overall Study|Adverse Event|11|||
125397219|NCT01215227|451087044|FG001|Overall Study|Adverse Event|11|||
125397220|NCT01215227|451087045|FG002|Overall Study|Adverse Event|4|||
125397221|NCT01215227|451087046|FG003|Overall Study|Adverse Event|8|||
125397222|NCT01215227|451087047|FG004|Overall Study|Adverse Event|7|||
125397223|NCT01215227|451087048|FG005|Overall Study|Adverse Event|6|||
125397224|NCT01215227|451087043|FG000|Overall Study|Treatment Failure|8|||
125397225|NCT01215227|451087044|FG001|Overall Study|Treatment Failure|4|||
125397226|NCT01215227|451087045|FG002|Overall Study|Treatment Failure|1|||
125397227|NCT01215227|451087046|FG003|Overall Study|Treatment Failure|5|||
125397228|NCT01215227|451087047|FG004|Overall Study|Treatment Failure|1|||
125397229|NCT01215227|451087048|FG005|Overall Study|Treatment Failure|1|||
125397230|NCT01215227|451087043|FG000|Overall Study|Lost to Follow-up|1|||
125397231|NCT01215227|451087044|FG001|Overall Study|Lost to Follow-up|4|||
125397232|NCT01215227|451087045|FG002|Overall Study|Lost to Follow-up|1|||
125397233|NCT01215227|451087046|FG003|Overall Study|Lost to Follow-up|1|||
125397234|NCT01215227|451087047|FG004|Overall Study|Lost to Follow-up|1|||
125397235|NCT01215227|451087048|FG005|Overall Study|Lost to Follow-up|2|||
125397236|NCT01215227|451087043|FG000|Overall Study|Subject Withdrew Consent|16|||
125397237|NCT01215227|451087044|FG001|Overall Study|Subject Withdrew Consent|20|||
125397238|NCT01215227|451087045|FG002|Overall Study|Subject Withdrew Consent|7|||
125397239|NCT01215227|451087046|FG003|Overall Study|Subject Withdrew Consent|10|||
125397240|NCT01215227|451087047|FG004|Overall Study|Subject Withdrew Consent|11|||
125397241|NCT01215227|451087048|FG005|Overall Study|Subject Withdrew Consent|8|||
125397242|NCT01215227|451087043|FG000|Overall Study|Non-Compliance With Protocol|2|||
125397243|NCT01215227|451087044|FG001|Overall Study|Non-Compliance With Protocol|6|||
125397244|NCT01215227|451087045|FG002|Overall Study|Non-Compliance With Protocol|1|||
125397245|NCT01215227|451087046|FG003|Overall Study|Non-Compliance With Protocol|0|||
125397246|NCT01215227|451087047|FG004|Overall Study|Non-Compliance With Protocol|0|||
125397247|NCT01215227|451087048|FG005|Overall Study|Non-Compliance With Protocol|0|||
125397248|NCT01215227|451087043|FG000|Overall Study|Administrative|83|||
125397249|NCT01215227|451087044|FG001|Overall Study|Administrative|73|||
125397250|NCT01215227|451087045|FG002|Overall Study|Administrative|42|||
125397251|NCT01215227|451087046|FG003|Overall Study|Administrative|24|||
125397252|NCT01215227|451087047|FG004|Overall Study|Administrative|28|||
125397253|NCT01215227|451087048|FG005|Overall Study|Administrative|40|||
125397254|NCT01215227|451087043|FG000|Overall Study|Missing Status|0|||
125397255|NCT01215227|451087044|FG001|Overall Study|Missing Status|1|||
125397256|NCT01215227|451087045|FG002|Overall Study|Missing Status|0|||
125445041|NCT02846558|451254016|FG001|Overall Study|Withdrawal by Subject|4|||
125445042|NCT02846558|451254017|FG002|Overall Study|Withdrawal by Subject|2|||
125445043|NCT02846558|451254018|FG003|Overall Study|Withdrawal by Subject|2|||
125445044|NCT02846558|451254015|FG000|Overall Study|Lost to Follow-up|2|||
125445045|NCT02846558|451254016|FG001|Overall Study|Lost to Follow-up|0|||
125256426|NCT01217892|450568038|FG000|Overall Study|Lab value|1|||
125256427|NCT01217892|450568039|FG001|Overall Study|Lab value|0|||
125256428|NCT01217892|450568040|FG002|Overall Study|Lab value|1|||
125256429|NCT01217892|450568041|FG003|Overall Study|Lab value|0|||
125256430|NCT01217892|450568038|FG000|Overall Study|Subject no longer meets study criteria|5|||
125256431|NCT01217892|450568039|FG001|Overall Study|Subject no longer meets study criteria|2|||
125256432|NCT01217892|450568040|FG002|Overall Study|Subject no longer meets study criteria|4|||
125256433|NCT01217892|450568041|FG003|Overall Study|Subject no longer meets study criteria|8|||
125256434|NCT01217892|450568038|FG000|Overall Study|Incorrect enrollment|0|||
125256435|NCT01217892|450568039|FG001|Overall Study|Incorrect enrollment|1|||
125256436|NCT01217892|450568040|FG002|Overall Study|Incorrect enrollment|1|||
125256437|NCT01217892|450568041|FG003|Overall Study|Incorrect enrollment|0|||
125256438|NCT01217892|450568038|FG000|Overall Study|Poor/Non-Compliance|0|||
125256439|NCT01217892|450568039|FG001|Overall Study|Poor/Non-Compliance|0|||
125256440|NCT01217892|450568040|FG002|Overall Study|Poor/Non-Compliance|1|||
125256441|NCT01217892|450568041|FG003|Overall Study|Poor/Non-Compliance|0|||
125256442|NCT01285102|450568042|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
125256443|NCT01905540|450568043|FG000|Period 3|Other|1|||
125256444|NCT01905540|450568044|FG001|Period 3|Other|0|||
125256445|NCT01905540|450568045|FG002|Period 3|Other|1|||
125256446|NCT01905540|450568046|FG003|Period 3|Other|1|||
125256447|NCT02743962|450568049|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
125256448|NCT02743962|450568050|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
125256449|NCT02327169|450568054|FG000|Overall Study|Progressive Disease|1|||
125256450|NCT02327169|450568055|FG001|Overall Study|Progressive Disease|3|||
125256451|NCT02327169|450568056|FG002|Overall Study|Progressive Disease|4|||
125256452|NCT02327169|450568057|FG003|Overall Study|Progressive Disease|3|||
125256453|NCT02327169|450568058|FG004|Overall Study|Progressive Disease|4|||
125256454|NCT02327169|450568059|FG005|Overall Study|Progressive Disease|3|||
125256455|NCT02327169|450568060|FG006|Overall Study|Progressive Disease|3|||
125256456|NCT02327169|450568061|FG007|Overall Study|Progressive Disease|3|||
125256457|NCT02327169|450568062|FG008|Overall Study|Progressive Disease|4|||
125256458|NCT02327169|450568063|FG009|Overall Study|Progressive Disease|4|||
125256459|NCT02327169|450568064|FG010|Overall Study|Progressive Disease|4|||
125256460|NCT02327169|450568065|FG011|Overall Study|Progressive Disease|3|||
125256461|NCT02327169|450568066|FG012|Overall Study|Progressive Disease|1|||
125256462|NCT02327169|450568067|FG013|Overall Study|Progressive Disease|3|||
125256463|NCT02327169|450568068|FG014|Overall Study|Progressive Disease|3|||
125256464|NCT02327169|450568054|FG000|Overall Study|Adverse Event|2|||
125256465|NCT02327169|450568055|FG001|Overall Study|Adverse Event|0|||
125256466|NCT02327169|450568056|FG002|Overall Study|Adverse Event|1|||
125256467|NCT02327169|450568057|FG003|Overall Study|Adverse Event|0|||
125256468|NCT02327169|450568058|FG004|Overall Study|Adverse Event|1|||
125256469|NCT02327169|450568059|FG005|Overall Study|Adverse Event|0|||
125256470|NCT02327169|450568060|FG006|Overall Study|Adverse Event|0|||
125256471|NCT02327169|450568061|FG007|Overall Study|Adverse Event|0|||
125256472|NCT02327169|450568062|FG008|Overall Study|Adverse Event|0|||
125256473|NCT02327169|450568063|FG009|Overall Study|Adverse Event|2|||
125256474|NCT02327169|450568064|FG010|Overall Study|Adverse Event|0|||
125256475|NCT02327169|450568065|FG011|Overall Study|Adverse Event|3|||
125256476|NCT02327169|450568066|FG012|Overall Study|Adverse Event|0|||
125256477|NCT02327169|450568067|FG013|Overall Study|Adverse Event|2|||
125256478|NCT02327169|450568068|FG014|Overall Study|Adverse Event|1|||
125256479|NCT02327169|450568054|FG000|Overall Study|Symptomatic Deterioration|0|||
125256480|NCT02327169|450568055|FG001|Overall Study|Symptomatic Deterioration|0|||
125256481|NCT02327169|450568056|FG002|Overall Study|Symptomatic Deterioration|1|||
125256482|NCT02327169|450568057|FG003|Overall Study|Symptomatic Deterioration|0|||
125256483|NCT02327169|450568058|FG004|Overall Study|Symptomatic Deterioration|1|||
125256484|NCT02327169|450568059|FG005|Overall Study|Symptomatic Deterioration|1|||
125256485|NCT02327169|450568060|FG006|Overall Study|Symptomatic Deterioration|0|||
125256486|NCT02327169|450568061|FG007|Overall Study|Symptomatic Deterioration|0|||
125256487|NCT02327169|450568062|FG008|Overall Study|Symptomatic Deterioration|2|||
125256488|NCT02327169|450568063|FG009|Overall Study|Symptomatic Deterioration|1|||
125256489|NCT02327169|450568064|FG010|Overall Study|Symptomatic Deterioration|0|||
125256490|NCT02327169|450568065|FG011|Overall Study|Symptomatic Deterioration|0|||
125256491|NCT02327169|450568066|FG012|Overall Study|Symptomatic Deterioration|0|||
125256492|NCT02327169|450568067|FG013|Overall Study|Symptomatic Deterioration|2|||
125256493|NCT02327169|450568068|FG014|Overall Study|Symptomatic Deterioration|1|||
125256494|NCT02327169|450568054|FG000|Overall Study|Reason Not Specified|0|||
125256495|NCT02327169|450568055|FG001|Overall Study|Reason Not Specified|0|||
125256496|NCT02327169|450568056|FG002|Overall Study|Reason Not Specified|1|||
125256497|NCT02327169|450568057|FG003|Overall Study|Reason Not Specified|0|||
125256498|NCT02327169|450568058|FG004|Overall Study|Reason Not Specified|0|||
125256499|NCT02327169|450568059|FG005|Overall Study|Reason Not Specified|0|||
125256500|NCT02327169|450568060|FG006|Overall Study|Reason Not Specified|0|||
125256501|NCT02327169|450568061|FG007|Overall Study|Reason Not Specified|0|||
125256502|NCT02327169|450568062|FG008|Overall Study|Reason Not Specified|0|||
125256503|NCT02327169|450568063|FG009|Overall Study|Reason Not Specified|1|||
125256504|NCT02327169|450568064|FG010|Overall Study|Reason Not Specified|2|||
125256505|NCT02327169|450568065|FG011|Overall Study|Reason Not Specified|1|||
125256506|NCT02327169|450568066|FG012|Overall Study|Reason Not Specified|0|||
125256507|NCT02327169|450568067|FG013|Overall Study|Reason Not Specified|0|||
125256508|NCT02327169|450568068|FG014|Overall Study|Reason Not Specified|2|||
125256509|NCT02327169|450568054|FG000|Overall Study|Withdrawal by Subject|1|||
125256510|NCT02327169|450568055|FG001|Overall Study|Withdrawal by Subject|0|||
125256511|NCT02327169|450568056|FG002|Overall Study|Withdrawal by Subject|0|||
125256512|NCT02327169|450568057|FG003|Overall Study|Withdrawal by Subject|0|||
125256513|NCT02327169|450568058|FG004|Overall Study|Withdrawal by Subject|1|||
125256514|NCT02327169|450568059|FG005|Overall Study|Withdrawal by Subject|0|||
125256515|NCT02327169|450568060|FG006|Overall Study|Withdrawal by Subject|0|||
125256516|NCT02327169|450568061|FG007|Overall Study|Withdrawal by Subject|1|||
125256517|NCT02327169|450568062|FG008|Overall Study|Withdrawal by Subject|0|||
125256518|NCT02327169|450568063|FG009|Overall Study|Withdrawal by Subject|0|||
125256519|NCT02327169|450568064|FG010|Overall Study|Withdrawal by Subject|0|||
125256520|NCT02327169|450568065|FG011|Overall Study|Withdrawal by Subject|0|||
125256521|NCT02327169|450568066|FG012|Overall Study|Withdrawal by Subject|0|||
125256522|NCT02327169|450568067|FG013|Overall Study|Withdrawal by Subject|0|||
125256523|NCT02327169|450568068|FG014|Overall Study|Withdrawal by Subject|3|||
125256524|NCT02327169|450568054|FG000|Overall Study|Lost to Follow-up|0|||
125256525|NCT02327169|450568055|FG001|Overall Study|Lost to Follow-up|0|||
125256526|NCT02327169|450568056|FG002|Overall Study|Lost to Follow-up|0|||
125256527|NCT02327169|450568057|FG003|Overall Study|Lost to Follow-up|0|||
125256528|NCT02327169|450568058|FG004|Overall Study|Lost to Follow-up|1|||
125256529|NCT02327169|450568059|FG005|Overall Study|Lost to Follow-up|0|||
125256530|NCT02327169|450568060|FG006|Overall Study|Lost to Follow-up|0|||
125256531|NCT02327169|450568061|FG007|Overall Study|Lost to Follow-up|0|||
125256532|NCT02327169|450568062|FG008|Overall Study|Lost to Follow-up|0|||
125256533|NCT02327169|450568063|FG009|Overall Study|Lost to Follow-up|0|||
125256534|NCT02327169|450568064|FG010|Overall Study|Lost to Follow-up|0|||
125256535|NCT02327169|450568065|FG011|Overall Study|Lost to Follow-up|0|||
125256536|NCT02327169|450568066|FG012|Overall Study|Lost to Follow-up|0|||
125256537|NCT02327169|450568067|FG013|Overall Study|Lost to Follow-up|0|||
125256538|NCT02327169|450568068|FG014|Overall Study|Lost to Follow-up|0|||
125256539|NCT01381679|450568072|FG000|Overall Study|Adverse Event|3|||
125256540|NCT01381679|450568072|FG000|Overall Study|Lost to Follow-up|885|||
125256541|NCT04023487|450568073|FG000|Overall Study|Lost to Follow-up|5|||
125256542|NCT04023487|450568074|FG001|Overall Study|Lost to Follow-up|4|||
125256543|NCT04023487|450568073|FG000|Overall Study|Pregnancy|1|||
125256544|NCT04023487|450568074|FG001|Overall Study|Pregnancy|2|||
125256545|NCT04023487|450568073|FG000|Overall Study|Withdrawal by Subject|4|||
125256546|NCT04023487|450568074|FG001|Overall Study|Withdrawal by Subject|5|||
125256547|NCT04023487|450568073|FG000|Overall Study|Partially completed testing|8|||
125256548|NCT04023487|450568074|FG001|Overall Study|Partially completed testing|4|||
125256549|NCT02014376|450568077|FG000|Overall Study|Adverse Event|1|||
125256550|NCT02014376|450568078|FG001|Overall Study|Adverse Event|1|||
125256551|NCT02014376|450568079|FG002|Overall Study|Adverse Event|0|||
125256552|NCT02014376|450568077|FG000|Overall Study|Lost to Follow-up|2|||
125256553|NCT02014376|450568078|FG001|Overall Study|Lost to Follow-up|0|||
125256554|NCT02014376|450568079|FG002|Overall Study|Lost to Follow-up|0|||
125256555|NCT01051661|450568085|FG000|Overall Study|Adverse Event|1|||
125256556|NCT01051661|450568086|FG001|Overall Study|Adverse Event|1|||
125256557|NCT01051661|450568087|FG002|Overall Study|Adverse Event|1|||
125256558|NCT01051661|450568088|FG003|Overall Study|Adverse Event|1|||
125256559|NCT01051661|450568089|FG004|Overall Study|Adverse Event|0|||
125256560|NCT01051661|450568090|FG005|Overall Study|Adverse Event|0|||
125256561|NCT01051661|450568085|FG000|Overall Study|Lost to Follow-up|13|||
125256562|NCT01051661|450568086|FG001|Overall Study|Lost to Follow-up|22|||
125256563|NCT01051661|450568087|FG002|Overall Study|Lost to Follow-up|15|||
125256564|NCT01051661|450568088|FG003|Overall Study|Lost to Follow-up|17|||
125256565|NCT01051661|450568089|FG004|Overall Study|Lost to Follow-up|10|||
125256566|NCT01051661|450568090|FG005|Overall Study|Lost to Follow-up|24|||
125256567|NCT01051661|450568085|FG000|Overall Study|Migrated/moved from study area|1|||
125256568|NCT01051661|450568086|FG001|Overall Study|Migrated/moved from study area|6|||
125256569|NCT01051661|450568087|FG002|Overall Study|Migrated/moved from study area|6|||
125256570|NCT01051661|450568088|FG003|Overall Study|Migrated/moved from study area|8|||
125256571|NCT01051661|450568089|FG004|Overall Study|Migrated/moved from study area|7|||
125256572|NCT01051661|450568090|FG005|Overall Study|Migrated/moved from study area|3|||
125256573|NCT01051661|450568085|FG000|Overall Study|Refused blood sampling|0|||
125256574|NCT01051661|450568086|FG001|Overall Study|Refused blood sampling|0|||
125256575|NCT01051661|450568087|FG002|Overall Study|Refused blood sampling|0|||
125256576|NCT01051661|450568088|FG003|Overall Study|Refused blood sampling|0|||
125256577|NCT01051661|450568089|FG004|Overall Study|Refused blood sampling|0|||
125256578|NCT01051661|450568090|FG005|Overall Study|Refused blood sampling|1|||
125256579|NCT01051661|450568085|FG000|Overall Study|Data not reliable|1|||
125256580|NCT01051661|450568086|FG001|Overall Study|Data not reliable|0|||
125256581|NCT01051661|450568087|FG002|Overall Study|Data not reliable|0|||
125256582|NCT01051661|450568088|FG003|Overall Study|Data not reliable|0|||
125256583|NCT01051661|450568089|FG004|Overall Study|Data not reliable|0|||
125256584|NCT01051661|450568090|FG005|Overall Study|Data not reliable|1|||
125256585|NCT01051661|450568085|FG000|Overall Study|Unable to attend visit(s)|2|||
125256586|NCT01051661|450568086|FG001|Overall Study|Unable to attend visit(s)|4|||
125256587|NCT01051661|450568087|FG002|Overall Study|Unable to attend visit(s)|2|||
125256588|NCT01051661|450568088|FG003|Overall Study|Unable to attend visit(s)|1|||
125256589|NCT01051661|450568089|FG004|Overall Study|Unable to attend visit(s)|3|||
125256590|NCT01051661|450568090|FG005|Overall Study|Unable to attend visit(s)|2|||
125256591|NCT01051661|450568085|FG000|Overall Study|Consent not received from both parents|0|||
125256592|NCT01051661|450568086|FG001|Overall Study|Consent not received from both parents|0|||
125256593|NCT01051661|450568087|FG002|Overall Study|Consent not received from both parents|0|||
125256594|NCT01051661|450568088|FG003|Overall Study|Consent not received from both parents|0|||
125256595|NCT01051661|450568089|FG004|Overall Study|Consent not received from both parents|0|||
125256596|NCT01051661|450568090|FG005|Overall Study|Consent not received from both parents|1|||
125256597|NCT01051661|450568085|FG000|Overall Study|Failure to comply with protocol|0|||
125256598|NCT01051661|450568086|FG001|Overall Study|Failure to comply with protocol|0|||
125256599|NCT01051661|450568087|FG002|Overall Study|Failure to comply with protocol|2|||
125256600|NCT01051661|450568088|FG003|Overall Study|Failure to comply with protocol|0|||
125256601|NCT01051661|450568089|FG004|Overall Study|Failure to comply with protocol|0|||
125256602|NCT01051661|450568090|FG005|Overall Study|Failure to comply with protocol|0|||
125256603|NCT01051661|450568085|FG000|Overall Study|Subject lost legal representation|0|||
125256604|NCT01051661|450568086|FG001|Overall Study|Subject lost legal representation|0|||
125256605|NCT01051661|450568087|FG002|Overall Study|Subject lost legal representation|0|||
125256606|NCT01051661|450568088|FG003|Overall Study|Subject lost legal representation|0|||
125256607|NCT01051661|450568089|FG004|Overall Study|Subject lost legal representation|1|||
125256608|NCT01051661|450568090|FG005|Overall Study|Subject lost legal representation|0|||
125256609|NCT01051661|450568085|FG000|Overall Study|Protocol Violation|0|||
125256610|NCT01051661|450568086|FG001|Overall Study|Protocol Violation|0|||
125256611|NCT01051661|450568087|FG002|Overall Study|Protocol Violation|0|||
125256612|NCT01051661|450568088|FG003|Overall Study|Protocol Violation|1|||
125256613|NCT01051661|450568089|FG004|Overall Study|Protocol Violation|2|||
125256614|NCT01051661|450568090|FG005|Overall Study|Protocol Violation|1|||
125256615|NCT01051661|450568085|FG000|Overall Study|Withdrawal by Subject|16|||
125256616|NCT01051661|450568086|FG001|Overall Study|Withdrawal by Subject|30|||
125256617|NCT01051661|450568087|FG002|Overall Study|Withdrawal by Subject|13|||
125256618|NCT01051661|450568088|FG003|Overall Study|Withdrawal by Subject|28|||
125256619|NCT01051661|450568089|FG004|Overall Study|Withdrawal by Subject|12|||
125256620|NCT01051661|450568090|FG005|Overall Study|Withdrawal by Subject|34|||
125256621|NCT04642079|450568091|FG000|Overall Study|Lost to Follow-up|2|||
125256622|NCT04642079|450568092|FG001|Overall Study|Lost to Follow-up|5|||
125256623|NCT04642079|450568093|FG002|Overall Study|Lost to Follow-up|2|||
125256624|NCT04642079|450568094|FG003|Overall Study|Lost to Follow-up|0|||
125256625|NCT04642079|450568091|FG000|Overall Study|Withdrawal by Subject|0|||
125256626|NCT04642079|450568092|FG001|Overall Study|Withdrawal by Subject|4|||
125256627|NCT04642079|450568093|FG002|Overall Study|Withdrawal by Subject|1|||
125256628|NCT04642079|450568094|FG003|Overall Study|Withdrawal by Subject|2|||
125256629|NCT04642079|450568091|FG000|Overall Study|Other|0|||
125256630|NCT04642079|450568092|FG001|Overall Study|Other|0|||
125256631|NCT04642079|450568093|FG002|Overall Study|Other|0|||
125397257|NCT01215227|451087046|FG003|Overall Study|Missing Status|0|||
125397258|NCT01215227|451087047|FG004|Overall Study|Missing Status|0|||
125397259|NCT01215227|451087048|FG005|Overall Study|Missing Status|0|||
125397260|NCT01215227|451087043|FG000|Overall Study|Randomized but not treated|0|||
125397261|NCT01215227|451087044|FG001|Overall Study|Randomized but not treated|0|||
125397262|NCT01215227|451087045|FG002|Overall Study|Randomized but not treated|1|||
125397263|NCT01215227|451087046|FG003|Overall Study|Randomized but not treated|1|||
125256632|NCT04642079|450568094|FG003|Overall Study|Other|1|||
125256633|NCT04642079|450568091|FG000|Overall Study|No longer met eligibility criteria|1|||
125256634|NCT04642079|450568092|FG001|Overall Study|No longer met eligibility criteria|0|||
125256635|NCT04642079|450568093|FG002|Overall Study|No longer met eligibility criteria|1|||
125256636|NCT04642079|450568094|FG003|Overall Study|No longer met eligibility criteria|1|||
125256637|NCT03038620|450568097|FG000|Overall Study|Lost to Follow-up|18|||
125256638|NCT03038620|450568098|FG001|Overall Study|Lost to Follow-up|23|||
125256639|NCT03038620|450568097|FG000|Overall Study|Withdrawal by Subject|0|||
125256640|NCT03038620|450568098|FG001|Overall Study|Withdrawal by Subject|15|||
125256641|NCT03038620|450568097|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
125256642|NCT03038620|450568098|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
125397264|NCT01215227|451087047|FG004|Overall Study|Randomized but not treated|0|||
125397265|NCT01215227|451087048|FG005|Overall Study|Randomized but not treated|1|||
125397266|NCT02253810|451087049|FG000|Overall Study|Withdrawal by Subject|2|||
125397267|NCT02253810|451087050|FG001|Overall Study|Withdrawal by Subject|1|||
125256643|NCT04875533|450568104|FG000|Overall Study|Adverse Event|6|||
125256644|NCT04875533|450568105|FG001|Overall Study|Adverse Event|4|||
125256645|NCT04875533|450568104|FG000|Overall Study|Protocol Violation|4|||
125256646|NCT04875533|450568105|FG001|Overall Study|Protocol Violation|0|||
125256647|NCT04875533|450568104|FG000|Overall Study|Withdrawal by Subject|8|||
125256648|NCT04875533|450568105|FG001|Overall Study|Withdrawal by Subject|5|||
125256649|NCT04875533|450568104|FG000|Overall Study|No longer meets eligibility criteria|1|||
125256650|NCT04875533|450568105|FG001|Overall Study|No longer meets eligibility criteria|0|||
125256651|NCT04875533|450568104|FG000|Overall Study|Other|0|||
125256652|NCT04875533|450568105|FG001|Overall Study|Other|2|||
125256653|NCT02657343|450568109|FG000|Overall Study|Death|0|||
125256654|NCT02657343|450568110|FG001|Overall Study|Death|2|||
125256655|NCT02657343|450568111|FG002|Overall Study|Death|0|||
125256656|NCT02657343|450568112|FG003|Overall Study|Death|0|||
125256657|NCT02657343|450568113|FG004|Overall Study|Death|0|||
125256658|NCT02657343|450568114|FG005|Overall Study|Death|0|||
125256659|NCT02657343|450568109|FG000|Overall Study|Patient went to hospice|1|||
125256660|NCT02657343|450568110|FG001|Overall Study|Patient went to hospice|0|||
125256661|NCT02657343|450568111|FG002|Overall Study|Patient went to hospice|0|||
125256662|NCT02657343|450568112|FG003|Overall Study|Patient went to hospice|0|||
125256663|NCT02657343|450568113|FG004|Overall Study|Patient went to hospice|0|||
125256664|NCT02657343|450568114|FG005|Overall Study|Patient went to hospice|0|||
125256665|NCT02657343|450568109|FG000|Overall Study|Withdrawal by Subject|0|||
125256666|NCT02657343|450568110|FG001|Overall Study|Withdrawal by Subject|0|||
125256667|NCT02657343|450568111|FG002|Overall Study|Withdrawal by Subject|0|||
125256668|NCT02657343|450568112|FG003|Overall Study|Withdrawal by Subject|0|||
125256669|NCT02657343|450568113|FG004|Overall Study|Withdrawal by Subject|1|||
125256670|NCT02657343|450568114|FG005|Overall Study|Withdrawal by Subject|0|||
125256671|NCT02011542|450568116|FG000|Overall Study|Physician Decision|1|||
125256672|NCT00982280|450568120|FG000|Observation Period|Not eligible to be dosed|19|||
125256673|NCT00982280|450568120|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
125256674|NCT00982280|450568120|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
125256675|NCT00982280|450568120|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
125256676|NCT00982280|450568120|FG000|Maintenance Period|Adverse Event|1|||
125256677|NCT01979185|450568121|FG000|Period 2|Other|0|||
125256678|NCT01979185|450568122|FG001|Period 2|Other|1|||
125256679|NCT00980798|450568123|FG000|Overall Study|Adverse Event|7|||
125256680|NCT00980798|450568124|FG001|Overall Study|Adverse Event|36|||
125256681|NCT00980798|450568123|FG000|Overall Study|Lack of Efficacy|16|||
125256682|NCT00980798|450568124|FG001|Overall Study|Lack of Efficacy|5|||
125256683|NCT00980798|450568123|FG000|Overall Study|Lost to Follow-up|0|||
125256684|NCT00980798|450568124|FG001|Overall Study|Lost to Follow-up|1|||
125256685|NCT00980798|450568123|FG000|Overall Study|Physician Decision|2|||
125256686|NCT00980798|450568124|FG001|Overall Study|Physician Decision|1|||
125256687|NCT00980798|450568123|FG000|Overall Study|Withdrawal by Subject|8|||
125256688|NCT00980798|450568124|FG001|Overall Study|Withdrawal by Subject|11|||
125256689|NCT00980798|450568123|FG000|Overall Study|Other|0|||
125256690|NCT00980798|450568124|FG001|Overall Study|Other|1|||
125256691|NCT04724837|450568125|FG000|Overall Study|Other|4|||
125256692|NCT04724837|450568126|FG001|Overall Study|Other|16|||
125256693|NCT04724837|450568127|FG002|Overall Study|Other|0|||
125256694|NCT04724837|450568125|FG000|Overall Study|Withdrawal by Subject|2|||
125256695|NCT04724837|450568126|FG001|Overall Study|Withdrawal by Subject|9|||
125256696|NCT04724837|450568127|FG002|Overall Study|Withdrawal by Subject|9|||
125256697|NCT04724837|450568125|FG000|Overall Study|Adverse Event|2|||
125256698|NCT04724837|450568126|FG001|Overall Study|Adverse Event|7|||
125256699|NCT04724837|450568127|FG002|Overall Study|Adverse Event|4|||
125256700|NCT04724837|450568125|FG000|Overall Study|Lost to Follow-up|0|||
125256701|NCT04724837|450568126|FG001|Overall Study|Lost to Follow-up|1|||
125256702|NCT04724837|450568127|FG002|Overall Study|Lost to Follow-up|3|||
125256703|NCT04724837|450568125|FG000|Overall Study|Physician Decision|1|||
125256704|NCT04724837|450568126|FG001|Overall Study|Physician Decision|2|||
125256705|NCT04724837|450568127|FG002|Overall Study|Physician Decision|0|||
125397268|NCT02253810|451087049|FG000|Overall Study|Unknown concomitant procedure|3|||
125397269|NCT02253810|451087050|FG001|Overall Study|Unknown concomitant procedure|2|||
125256706|NCT04724837|450568125|FG000|Overall Study|Death|0|||
125256707|NCT04724837|450568126|FG001|Overall Study|Death|0|||
125256708|NCT04724837|450568127|FG002|Overall Study|Death|1|||
125256709|NCT04724837|450568125|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
125256710|NCT04724837|450568126|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
125256711|NCT04724837|450568127|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
125256712|NCT04724837|450568125|FG000|Overall Study|Study Terminated by Sponsor|0|||
125256713|NCT04724837|450568126|FG001|Overall Study|Study Terminated by Sponsor|1|||
125256714|NCT04724837|450568127|FG002|Overall Study|Study Terminated by Sponsor|0|||
125256715|NCT00522379|450568128|FG000|Overall Study|Adverse Event|12|||
125256716|NCT00522379|450568129|FG001|Overall Study|Adverse Event|15|||
125397270|NCT03925727|451087059|FG000|Overall Study|Adverse Event|4|||
125256717|NCT00522379|450568130|FG002|Overall Study|Adverse Event|12|||
125256718|NCT00522379|450568131|FG003|Overall Study|Adverse Event|5|||
125256719|NCT00522379|450568132|FG004|Overall Study|Adverse Event|17|||
125256720|NCT00522379|450568128|FG000|Overall Study|Lack of Efficacy|3|||
125256721|NCT00522379|450568129|FG001|Overall Study|Lack of Efficacy|0|||
125256722|NCT00522379|450568130|FG002|Overall Study|Lack of Efficacy|2|||
125256723|NCT00522379|450568131|FG003|Overall Study|Lack of Efficacy|2|||
125256724|NCT00522379|450568132|FG004|Overall Study|Lack of Efficacy|7|||
125256725|NCT00522379|450568128|FG000|Overall Study|Withdrawal by Subject|2|||
125256726|NCT00522379|450568129|FG001|Overall Study|Withdrawal by Subject|3|||
125256727|NCT00522379|450568130|FG002|Overall Study|Withdrawal by Subject|1|||
125256728|NCT00522379|450568131|FG003|Overall Study|Withdrawal by Subject|2|||
125256729|NCT00522379|450568132|FG004|Overall Study|Withdrawal by Subject|0|||
125256730|NCT00522379|450568128|FG000|Overall Study|Protocol Violation|1|||
125256731|NCT00522379|450568129|FG001|Overall Study|Protocol Violation|1|||
125256732|NCT00522379|450568130|FG002|Overall Study|Protocol Violation|2|||
125256733|NCT00522379|450568131|FG003|Overall Study|Protocol Violation|0|||
125256734|NCT00522379|450568132|FG004|Overall Study|Protocol Violation|0|||
125256735|NCT00522379|450568128|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
125256736|NCT00522379|450568129|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
125256737|NCT00522379|450568130|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
125256738|NCT00522379|450568131|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
125256739|NCT00522379|450568132|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
125256740|NCT00522379|450568128|FG000|Overall Study|Lost to Follow-up|1|||
125256741|NCT00522379|450568129|FG001|Overall Study|Lost to Follow-up|0|||
125256742|NCT00522379|450568130|FG002|Overall Study|Lost to Follow-up|4|||
125256743|NCT00522379|450568131|FG003|Overall Study|Lost to Follow-up|2|||
125256744|NCT00522379|450568132|FG004|Overall Study|Lost to Follow-up|2|||
125256745|NCT00522379|450568128|FG000|Overall Study|Randomization error|0|||
125256746|NCT00522379|450568129|FG001|Overall Study|Randomization error|0|||
125256747|NCT00522379|450568130|FG002|Overall Study|Randomization error|0|||
125256748|NCT00522379|450568131|FG003|Overall Study|Randomization error|0|||
125256749|NCT00522379|450568132|FG004|Overall Study|Randomization error|1|||
125256750|NCT00522379|450568128|FG000|Overall Study|Dispensing error|1|||
125256751|NCT00522379|450568129|FG001|Overall Study|Dispensing error|0|||
125256752|NCT00522379|450568130|FG002|Overall Study|Dispensing error|0|||
125256753|NCT00522379|450568131|FG003|Overall Study|Dispensing error|1|||
125256754|NCT00522379|450568132|FG004|Overall Study|Dispensing error|0|||
125256755|NCT00522379|450568128|FG000|Overall Study|Subject Moved|1|||
125256756|NCT00522379|450568129|FG001|Overall Study|Subject Moved|1|||
125256757|NCT00522379|450568130|FG002|Overall Study|Subject Moved|0|||
125256758|NCT00522379|450568131|FG003|Overall Study|Subject Moved|0|||
125256759|NCT00522379|450568132|FG004|Overall Study|Subject Moved|0|||
125256760|NCT00522379|450568128|FG000|Overall Study|Sponsor Request|0|||
125256761|NCT00522379|450568129|FG001|Overall Study|Sponsor Request|1|||
125256762|NCT00522379|450568130|FG002|Overall Study|Sponsor Request|0|||
125256763|NCT00522379|450568131|FG003|Overall Study|Sponsor Request|0|||
125256764|NCT00522379|450568132|FG004|Overall Study|Sponsor Request|0|||
125256765|NCT00522379|450568128|FG000|Overall Study|Family Problem|0|||
125256766|NCT00522379|450568129|FG001|Overall Study|Family Problem|0|||
125256767|NCT00522379|450568130|FG002|Overall Study|Family Problem|1|||
125256768|NCT00522379|450568131|FG003|Overall Study|Family Problem|0|||
125256769|NCT00522379|450568132|FG004|Overall Study|Family Problem|0|||
125256770|NCT00522379|450568128|FG000|Overall Study|Site Closed|0|||
125256771|NCT00522379|450568129|FG001|Overall Study|Site Closed|0|||
125256772|NCT00522379|450568130|FG002|Overall Study|Site Closed|0|||
125256773|NCT00522379|450568131|FG003|Overall Study|Site Closed|1|||
125256774|NCT00522379|450568132|FG004|Overall Study|Site Closed|0|||
125256775|NCT00522379|450568128|FG000|Overall Study|Subject Withdrawal|0|||
125256776|NCT00522379|450568129|FG001|Overall Study|Subject Withdrawal|0|||
125256777|NCT00522379|450568130|FG002|Overall Study|Subject Withdrawal|0|||
125256778|NCT00522379|450568131|FG003|Overall Study|Subject Withdrawal|1|||
125256779|NCT00522379|450568132|FG004|Overall Study|Subject Withdrawal|0|||
125256780|NCT00967499|450568137|FG000|Overall Study|Adverse Event|0|||
125256781|NCT00967499|450568138|FG001|Overall Study|Adverse Event|1|||
125256782|NCT00967499|450568137|FG000|Overall Study|Protocol Violation|1|||
125256783|NCT00967499|450568138|FG001|Overall Study|Protocol Violation|0|||
125256784|NCT00967499|450568137|FG000|Overall Study|Sponsor Decision|1|||
125256785|NCT00967499|450568138|FG001|Overall Study|Sponsor Decision|0|||
125256786|NCT00967499|450568137|FG000|Overall Study|Randomized but not treated|63|||
125256787|NCT00967499|450568138|FG001|Overall Study|Randomized but not treated|59|||
125256788|NCT02607722|450568140|FG000|Overall Study|No data reliability|1|||
125256789|NCT02607722|450568140|FG000|Overall Study|no patient visit|18|||
125256790|NCT02607722|450568140|FG000|Overall Study|missing info in CRF|13|||
125256791|NCT02607722|450568140|FG000|Overall Study|Withdrawal by Subject|616|||
125256792|NCT02607722|450568140|FG000|Overall Study|Lost to Follow-up|312|||
125256793|NCT02607722|450568140|FG000|Overall Study|Improved|22|||
125256794|NCT02607722|450568140|FG000|Overall Study|Lack of Efficacy|316|||
125256795|NCT02607722|450568140|FG000|Overall Study|Adverse Event|2553|||
125256796|NCT02607722|450568140|FG000|Overall Study|Not treated|1|||
125256797|NCT02607722|450568140|FG000|Overall Study|No CRF collected|138|||
125256798|NCT02607722|450568140|FG000|Overall Study|without CRF|4225|||
125256799|NCT02607722|450568140|FG000|Overall Study|Physician Decision|367|||
125256800|NCT04562090|450568141|FG000|Overall Study|Withdrawal by Subject|3|||
125256801|NCT04562090|450568142|FG001|Overall Study|Withdrawal by Subject|4|||
125256802|NCT04562090|450568141|FG000|Overall Study|Protocol Violation|2|||
125256803|NCT04562090|450568142|FG001|Overall Study|Protocol Violation|0|||
125256804|NCT04562090|450568141|FG000|Overall Study|Lack of Efficacy|0|||
125256805|NCT04562090|450568142|FG001|Overall Study|Lack of Efficacy|1|||
125256806|NCT04562090|450568141|FG000|Overall Study|Adverse Event|1|||
125256807|NCT04562090|450568142|FG001|Overall Study|Adverse Event|4|||
125256808|NCT04562090|450568141|FG000|Overall Study|Miscellaneous|0|||
125256809|NCT04562090|450568142|FG001|Overall Study|Miscellaneous|3|||
125256810|NCT03633058|450568143|FG000|Overall Study|Adverse Event|0|||
125256811|NCT03633058|450568144|FG001|Overall Study|Adverse Event|0|||
125256812|NCT03633058|450568145|FG002|Overall Study|Adverse Event|1|||
125256813|NCT03633058|450568146|FG003|Overall Study|Adverse Event|0|||
125256814|NCT03034044|450568147|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
125256815|NCT03312543|450568148|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
125256816|NCT03312543|450568149|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
125256817|NCT03312543|450568148|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
125256818|NCT03312543|450568149|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
125256819|NCT03312543|450568148|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
125256820|NCT03312543|450568149|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
125256821|NCT03312543|450568148|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
125256822|NCT03312543|450568149|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
125256823|NCT03312543|450568148|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
125256824|NCT03312543|450568149|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
125256825|NCT03312543|450568148|FG000|Regression (Week 12 to Week 24)|Death|0|||
125256826|NCT03312543|450568149|FG001|Regression (Week 12 to Week 24)|Death|1|||
125256827|NCT05535972|450568150|FG000|Overall Study|Withdrawal by Subject|31|||
125256828|NCT05535972|450568150|FG000|Overall Study|Lost to Follow-up|5|||
125256829|NCT05535972|450568150|FG000|Overall Study|Adverse Event|6|||
125256830|NCT05535972|450568150|FG000|Overall Study|Protocol Deviation|2|||
125256831|NCT02402647|450568153|FG000|Overall Study|Lost to Follow-up|13|||
125256832|NCT02402647|450568154|FG001|Overall Study|Lost to Follow-up|7|||
125256833|NCT02402647|450568153|FG000|Overall Study|Protocol Violation|1|||
125256834|NCT02402647|450568154|FG001|Overall Study|Protocol Violation|1|||
125256835|NCT02402647|450568153|FG000|Overall Study|scheduled and timed out|2|||
125256836|NCT02402647|450568154|FG001|Overall Study|scheduled and timed out|1|||
125256837|NCT02402647|450568153|FG000|Overall Study|medical illness|2|||
125256838|NCT02402647|450568154|FG001|Overall Study|medical illness|4|||
125256839|NCT02402647|450568153|FG000|Overall Study|Moved|2|||
125256840|NCT02402647|450568154|FG001|Overall Study|Moved|0|||
125256841|NCT02402647|450568153|FG000|Overall Study|loved one illness|1|||
125256842|NCT02402647|450568154|FG001|Overall Study|loved one illness|0|||
125256843|NCT02402647|450568153|FG000|Overall Study|deceased preexisting condition|2|||
125256844|NCT02402647|450568154|FG001|Overall Study|deceased preexisting condition|0|||
125256845|NCT02402647|450568153|FG000|Overall Study|Other|2|||
125256846|NCT02402647|450568154|FG001|Overall Study|Other|1|||
125256847|NCT04197583|450568155|FG000|Overall Study|Study Stent Replacement|34|||
125256848|NCT04197583|450568156|FG001|Overall Study|Study Stent Replacement|8|||
125256849|NCT04197583|450568155|FG000|Overall Study|Lost to Follow-up|14|||
125256850|NCT04197583|450568156|FG001|Overall Study|Lost to Follow-up|3|||
125256851|NCT04197583|450568155|FG000|Overall Study|Death|3|||
125256852|NCT04197583|450568156|FG001|Overall Study|Death|0|||
125256853|NCT04197583|450568155|FG000|Overall Study|Physician Decision|1|||
125256854|NCT04197583|450568156|FG001|Overall Study|Physician Decision|0|||
125256855|NCT04197583|450568155|FG000|Overall Study|Withdrawal by Subject|1|||
125256856|NCT04197583|450568156|FG001|Overall Study|Withdrawal by Subject|1|||
125256857|NCT04197583|450568155|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
125256858|NCT04197583|450568156|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
125397271|NCT03925727|451087060|FG001|Overall Study|Adverse Event|0|||
125256859|NCT04197583|450568155|FG000|Overall Study|Screen Failure|0|||
125256860|NCT04197583|450568156|FG001|Overall Study|Screen Failure|20|||
125256861|NCT05852470|450568158|FG000|Overall Study|Withdrawal by Subject|0|||
125256862|NCT05852470|450568159|FG001|Overall Study|Withdrawal by Subject|1|||
125256863|NCT04134936|450568160|FG000|Overall Study|Adverse Event|3|||
125256864|NCT04134936|450568161|FG001|Overall Study|Adverse Event|2|||
125256865|NCT04134936|450568160|FG000|Overall Study|Withdrawal by Subject|2|||
125256866|NCT04134936|450568161|FG001|Overall Study|Withdrawal by Subject|3|||
125256867|NCT04134936|450568160|FG000|Overall Study|Physician Decision|0|||
125256868|NCT04134936|450568161|FG001|Overall Study|Physician Decision|1|||
125256869|NCT04134936|450568160|FG000|Overall Study|Progressive disease, joined another trial|1|||
125256870|NCT04134936|450568161|FG001|Overall Study|Progressive disease, joined another trial|0|||
125256871|NCT04134936|450568160|FG000|Overall Study|Progressive disease|1|||
125256872|NCT04134936|450568161|FG001|Overall Study|Progressive disease|0|||
125256873|NCT00323622|450568164|FG000|Overall Study|Other|30|||
125256874|NCT00323622|450568165|FG001|Overall Study|Other|91|||
125256875|NCT00323622|450568166|FG002|Overall Study|Other|4|||
125256876|NCT00323622|450568167|FG003|Overall Study|Other|12|||
125256877|NCT00323622|450568168|FG004|Overall Study|Other|32|||
125256878|NCT00323622|450568169|FG005|Overall Study|Other|74|||
125256879|NCT00323622|450568170|FG006|Overall Study|Other|5|||
125256880|NCT00323622|450568171|FG007|Overall Study|Other|13|||
125256881|NCT00323622|450568164|FG000|Overall Study|Death|1|||
125256882|NCT00323622|450568165|FG001|Overall Study|Death|1|||
125256883|NCT00323622|450568166|FG002|Overall Study|Death|0|||
125256884|NCT00323622|450568167|FG003|Overall Study|Death|0|||
125256885|NCT00323622|450568168|FG004|Overall Study|Death|7|||
125256886|NCT00323622|450568169|FG005|Overall Study|Death|0|||
125256887|NCT00323622|450568170|FG006|Overall Study|Death|0|||
125256888|NCT00323622|450568171|FG007|Overall Study|Death|2|||
125256889|NCT02420717|450568172|FG000|Overall Study|Did not receive all study medication|2|||
125256890|NCT02420717|450568173|FG001|Overall Study|Did not receive all study medication|0|||
125256891|NCT02420717|450568174|FG002|Overall Study|Did not receive all study medication|0|||
125256892|NCT04191135|450568185|FG000|Induction Treatment|Not Treated|2|||
125256893|NCT04191135|450568186|FG001|Induction Treatment|Not Treated|0|||
125256894|NCT04191135|450568187|FG002|Induction Treatment|Not Treated|0|||
125256895|NCT04191135|450568185|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
125256896|NCT04191135|450568186|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
125256897|NCT04191135|450568187|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
125256898|NCT04191135|450568185|FG000|Induction Treatment|Adverse Event|25|||
125256899|NCT04191135|450568186|FG001|Induction Treatment|Adverse Event|0|||
125256900|NCT04191135|450568187|FG002|Induction Treatment|Adverse Event|0|||
125256901|NCT04191135|450568185|FG000|Induction Treatment|Clinical Progression|8|||
125256902|NCT04191135|450568186|FG001|Induction Treatment|Clinical Progression|0|||
125256903|NCT04191135|450568187|FG002|Induction Treatment|Clinical Progression|0|||
125256904|NCT04191135|450568185|FG000|Induction Treatment|Excluded Medication|1|||
125256905|NCT04191135|450568186|FG001|Induction Treatment|Excluded Medication|0|||
125256906|NCT04191135|450568187|FG002|Induction Treatment|Excluded Medication|0|||
125256907|NCT04191135|450568185|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
125256908|NCT04191135|450568186|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
125256909|NCT04191135|450568187|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
125256910|NCT04191135|450568185|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
125256911|NCT04191135|450568186|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
125256912|NCT04191135|450568187|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
125256913|NCT04191135|450568185|FG000|Induction Treatment|Physician Decision|2|||
125256914|NCT04191135|450568186|FG001|Induction Treatment|Physician Decision|0|||
125256915|NCT04191135|450568187|FG002|Induction Treatment|Physician Decision|0|||
125256916|NCT04191135|450568185|FG000|Induction Treatment|Progressive Disease|135|||
125256917|NCT04191135|450568186|FG001|Induction Treatment|Progressive Disease|0|||
125256918|NCT04191135|450568187|FG002|Induction Treatment|Progressive Disease|0|||
125256919|NCT04191135|450568185|FG000|Induction Treatment|Protocol Violation|10|||
125256920|NCT04191135|450568186|FG001|Induction Treatment|Protocol Violation|0|||
125256921|NCT04191135|450568187|FG002|Induction Treatment|Protocol Violation|0|||
125256922|NCT04191135|450568185|FG000|Induction Treatment|Withdrawal by Subject|4|||
125256923|NCT04191135|450568186|FG001|Induction Treatment|Withdrawal by Subject|0|||
125256924|NCT04191135|450568187|FG002|Induction Treatment|Withdrawal by Subject|0|||
125256925|NCT04191135|450568185|FG000|Randomized Treatment|Death|0|||
125256926|NCT04191135|450568186|FG001|Randomized Treatment|Death|50|||
125256927|NCT04191135|450568187|FG002|Randomized Treatment|Death|54|||
125256928|NCT04191135|450568185|FG000|Randomized Treatment|Lost to Follow-up|0|||
125256929|NCT04191135|450568186|FG001|Randomized Treatment|Lost to Follow-up|0|||
125256930|NCT04191135|450568187|FG002|Randomized Treatment|Lost to Follow-up|1|||
125256931|NCT04191135|450568185|FG000|Randomized Treatment|Withdrawal by Subject|0|||
125256932|NCT04191135|450568186|FG001|Randomized Treatment|Withdrawal by Subject|2|||
125256933|NCT04191135|450568187|FG002|Randomized Treatment|Withdrawal by Subject|0|||
125256934|NCT04191135|450568185|FG000|Randomized Treatment|Ongoing in Trial|0|||
125256935|NCT04191135|450568186|FG001|Randomized Treatment|Ongoing in Trial|83|||
125256936|NCT04191135|450568187|FG002|Randomized Treatment|Ongoing in Trial|81|||
125256937|NCT03514134|450569587|FG000|Overall Study|Lost to Follow-up|0|||
125256938|NCT03514134|450569588|FG001|Overall Study|Lost to Follow-up|1|||
125256939|NCT02471144|450569589|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
125256940|NCT02471144|450569590|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
125256941|NCT02471144|450569591|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
125256942|NCT02471144|450569592|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
125256943|NCT02471144|450569593|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
125256944|NCT02471144|450569594|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
125256945|NCT02471144|450569595|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
125256946|NCT02471144|450569596|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
125256947|NCT02471144|450569597|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
125445046|NCT02846558|451254017|FG002|Overall Study|Lost to Follow-up|0|||
125445047|NCT02846558|451254018|FG003|Overall Study|Lost to Follow-up|0|||
125445048|NCT00810641|451254022|FG000|Overall Study|Withdrawal by Subject|0|||
125445049|NCT00810641|451254023|FG001|Overall Study|Withdrawal by Subject|1|||
125445050|NCT00810641|451254024|FG002|Overall Study|Withdrawal by Subject|2|||
125445051|NCT02684903|451254033|FG000|Overall Study|COVID-19 shutdown of lab|4|||
125445052|NCT02684903|451254034|FG001|Overall Study|COVID-19 shutdown of lab|6|||
125445053|NCT02684903|451254033|FG000|Overall Study|Lost to Follow-up|31|||
125445054|NCT02684903|451254034|FG001|Overall Study|Lost to Follow-up|41|||
125445055|NCT00904150|451254035|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
125445056|NCT00904150|451254036|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
125445057|NCT00904150|451254035|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
125445058|NCT00904150|451254036|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
125445059|NCT01475786|451254037|FG000|Overall Study|Adverse Event|0|||
125445060|NCT01475786|451254038|FG001|Overall Study|Adverse Event|1|||
125445061|NCT01475786|451254039|FG002|Overall Study|Adverse Event|0|||
125445062|NCT01475786|451254037|FG000|Overall Study|Lost to Follow-up|1|||
125445063|NCT01475786|451254038|FG001|Overall Study|Lost to Follow-up|2|||
125445064|NCT01475786|451254039|FG002|Overall Study|Lost to Follow-up|1|||
125445065|NCT01475786|451254037|FG000|Overall Study|Withdrawal by Subject|0|||
125445066|NCT01475786|451254038|FG001|Overall Study|Withdrawal by Subject|1|||
125445067|NCT01475786|451254039|FG002|Overall Study|Withdrawal by Subject|1|||
125445068|NCT01475786|451254037|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
125445069|NCT01475786|451254038|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
125445070|NCT01475786|451254039|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
125445071|NCT04129580|451255782|FG000|Overall Study|Lost to Follow-up|14|||
125445072|NCT04129580|451255783|FG001|Overall Study|Lost to Follow-up|25|||
125445073|NCT04212169|451255786|FG000|Overall Study|Adverse Event|0|||
125445074|NCT04212169|451255787|FG001|Overall Study|Adverse Event|0|||
125445075|NCT04212169|451255788|FG002|Overall Study|Adverse Event|0|||
125445076|NCT04212169|451255789|FG003|Overall Study|Adverse Event|2|||
125445077|NCT04212169|451255786|FG000|Overall Study|Lost to Follow-up|1|||
125445078|NCT04212169|451255787|FG001|Overall Study|Lost to Follow-up|0|||
125445079|NCT04212169|451255788|FG002|Overall Study|Lost to Follow-up|0|||
125445080|NCT04212169|451255789|FG003|Overall Study|Lost to Follow-up|2|||
125445081|NCT04212169|451255786|FG000|Overall Study|Withdrawal by Subject|10|||
125445082|NCT04212169|451255787|FG001|Overall Study|Withdrawal by Subject|2|||
125445083|NCT04212169|451255788|FG002|Overall Study|Withdrawal by Subject|5|||
125445084|NCT04212169|451255789|FG003|Overall Study|Withdrawal by Subject|7|||
125445085|NCT04212169|451255786|FG000|Overall Study|Other reason, unspecified|3|||
125445086|NCT04212169|451255787|FG001|Overall Study|Other reason, unspecified|1|||
125445087|NCT04212169|451255788|FG002|Overall Study|Other reason, unspecified|0|||
125445088|NCT04212169|451255789|FG003|Overall Study|Other reason, unspecified|2|||
125445089|NCT02718417|451255791|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
125445090|NCT02718417|451255792|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
125445091|NCT02718417|451255793|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
125445092|NCT02718417|451255791|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
125445093|NCT02718417|451255792|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
125445094|NCT02718417|451255793|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
125445095|NCT02718417|451255791|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
125445096|NCT02718417|451255792|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
125445097|NCT02718417|451255793|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
125445098|NCT02718417|451255791|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
125445099|NCT02718417|451255792|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
125445100|NCT02718417|451255793|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
125445101|NCT02718417|451255791|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
125445102|NCT02718417|451255792|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
125445103|NCT02718417|451255793|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
125445104|NCT02718417|451255791|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
125445105|NCT02718417|451255792|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
125445106|NCT02718417|451255793|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
125445107|NCT02718417|451255791|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
125445108|NCT02718417|451255792|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
125445109|NCT02718417|451255793|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
125445110|NCT02718417|451255791|FG000|Chemotherapy Phase (CP)|Other|2|||
125445111|NCT02718417|451255792|FG001|Chemotherapy Phase (CP)|Other|0|||
125445112|NCT02718417|451255793|FG002|Chemotherapy Phase (CP)|Other|1|||
125445113|NCT02718417|451255791|FG000|Maintenance Phase (MP)|Adverse Event|21|||
125445114|NCT02718417|451255792|FG001|Maintenance Phase (MP)|Adverse Event|26|||
125445115|NCT02718417|451255793|FG002|Maintenance Phase (MP)|Adverse Event|0|||
125445116|NCT02718417|451255791|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
125445117|NCT02718417|451255792|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
125256948|NCT02471144|450569598|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
125256949|NCT02471144|450569599|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
125256950|NCT02471144|450569589|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256951|NCT02471144|450569590|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256952|NCT02471144|450569591|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256953|NCT02471144|450569592|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
125256954|NCT02471144|450569593|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256955|NCT02471144|450569594|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256956|NCT02471144|450569595|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256957|NCT02471144|450569596|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256958|NCT02471144|450569597|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256959|NCT02471144|450569598|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256960|NCT02471144|450569599|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
125256961|NCT02471144|450569589|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256962|NCT02471144|450569590|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256963|NCT02471144|450569591|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
125256964|NCT02471144|450569592|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256965|NCT02471144|450569593|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256966|NCT02471144|450569594|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256967|NCT02471144|450569595|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256968|NCT02471144|450569596|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256969|NCT02471144|450569597|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256970|NCT02471144|450569598|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256971|NCT02471144|450569599|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
125256972|NCT02471144|450569589|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
125256973|NCT02471144|450569590|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
125256974|NCT02471144|450569591|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256975|NCT02471144|450569592|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256976|NCT02471144|450569593|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256977|NCT02471144|450569594|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256978|NCT02471144|450569595|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256979|NCT02471144|450569596|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256980|NCT02471144|450569597|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256981|NCT02471144|450569598|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256982|NCT02471144|450569599|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
125256983|NCT02471144|450569589|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256984|NCT02471144|450569590|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256985|NCT02471144|450569591|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256986|NCT02471144|450569592|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256987|NCT02471144|450569593|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
125397272|NCT03925727|451087061|FG002|Overall Study|Adverse Event|3|||
125397273|NCT03925727|451087059|FG000|Overall Study|Protocol Violation|1|||
125397274|NCT03925727|451087060|FG001|Overall Study|Protocol Violation|2|||
125397275|NCT03925727|451087061|FG002|Overall Study|Protocol Violation|2|||
125397276|NCT03925727|451087059|FG000|Overall Study|Withdrawal by Subject|3|||
125397277|NCT03925727|451087060|FG001|Overall Study|Withdrawal by Subject|2|||
125397278|NCT03925727|451087061|FG002|Overall Study|Withdrawal by Subject|4|||
125397279|NCT03925727|451087059|FG000|Overall Study|Administrative Reasons|3|||
125397280|NCT03925727|451087060|FG001|Overall Study|Administrative Reasons|1|||
125397281|NCT03925727|451087061|FG002|Overall Study|Administrative Reasons|2|||
125397282|NCT03925727|451087059|FG000|Overall Study|Randomized in error or Disqualified|8|||
125397283|NCT03925727|451087060|FG001|Overall Study|Randomized in error or Disqualified|1|||
125397284|NCT03925727|451087061|FG002|Overall Study|Randomized in error or Disqualified|7|||
125397285|NCT00213148|451087062|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
125397286|NCT00213148|451087063|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
125397287|NCT00213148|451087064|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
125397288|NCT00213148|451087065|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
125397289|NCT00213148|451087066|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
125397290|NCT00213148|451087062|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
125397291|NCT00213148|451087063|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
125397292|NCT00213148|451087064|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
125397293|NCT00213148|451087065|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
125397294|NCT00213148|451087066|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
125397295|NCT00213148|451087062|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
125397296|NCT00213148|451087063|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
125397297|NCT00213148|451087064|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
125397298|NCT00213148|451087065|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
125397299|NCT00213148|451087066|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
125397300|NCT00213148|451087062|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
125397301|NCT00213148|451087063|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
125445118|NCT02718417|451255793|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
125445119|NCT02718417|451255791|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
125445120|NCT02718417|451255792|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
125445121|NCT02718417|451255793|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
125445122|NCT02718417|451255791|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
125445123|NCT02718417|451255792|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
125445124|NCT02718417|451255793|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
125445125|NCT02718417|451255791|FG000|Maintenance Phase (MP)|Physician's decision|6|||
125445126|NCT02718417|451255792|FG001|Maintenance Phase (MP)|Physician's decision|7|||
125445127|NCT02718417|451255793|FG002|Maintenance Phase (MP)|Physician's decision|0|||
125445128|NCT02718417|451255791|FG000|Maintenance Phase (MP)|Progressive disease|100|||
125445129|NCT02718417|451255792|FG001|Maintenance Phase (MP)|Progressive disease|88|||
125445130|NCT02718417|451255793|FG002|Maintenance Phase (MP)|Progressive disease|0|||
125256988|NCT02471144|450569594|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256989|NCT02471144|450569595|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
125256990|NCT02471144|450569596|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125397302|NCT00213148|451087064|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
125397303|NCT00213148|451087065|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
125397304|NCT00213148|451087066|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
125397305|NCT00213148|451087062|FG000|Cycle 1 (1 Month)|Other|3|||
125397306|NCT00213148|451087063|FG001|Cycle 1 (1 Month)|Other|0|||
125397307|NCT00213148|451087064|FG002|Cycle 1 (1 Month)|Other|2|||
125397308|NCT00213148|451087065|FG003|Cycle 1 (1 Month)|Other|2|||
125397309|NCT00213148|451087066|FG004|Cycle 1 (1 Month)|Other|7|||
125397310|NCT00213148|451087062|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125397311|NCT00213148|451087063|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125397312|NCT00213148|451087064|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125397313|NCT00213148|451087065|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
125397314|NCT00213148|451087066|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125397315|NCT00213148|451087062|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
125397316|NCT00213148|451087063|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
125397317|NCT00213148|451087064|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
125397318|NCT00213148|451087065|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
125397319|NCT00213148|451087066|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
125397320|NCT00213148|451087062|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
125397321|NCT00213148|451087063|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
125397322|NCT00213148|451087064|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
125397323|NCT00213148|451087065|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
125397324|NCT00213148|451087066|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
125397325|NCT00213148|451087062|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
125397326|NCT00213148|451087063|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
125397327|NCT00213148|451087064|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
125397328|NCT00213148|451087065|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
125397329|NCT00213148|451087066|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
125397330|NCT00213148|451087062|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
125397331|NCT00213148|451087063|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
125397332|NCT00213148|451087064|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
125397333|NCT00213148|451087065|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
125397334|NCT00213148|451087066|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
125397335|NCT00213148|451087062|FG000|Cycle 2 (1 Month)|Other|2|||
125397336|NCT00213148|451087063|FG001|Cycle 2 (1 Month)|Other|1|||
125397337|NCT00213148|451087064|FG002|Cycle 2 (1 Month)|Other|2|||
125397338|NCT00213148|451087065|FG003|Cycle 2 (1 Month)|Other|8|||
125397339|NCT00213148|451087066|FG004|Cycle 2 (1 Month)|Other|7|||
125397340|NCT00213148|451087062|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125397341|NCT00213148|451087063|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
125397342|NCT00213148|451087064|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125397343|NCT00213148|451087065|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125397344|NCT00213148|451087066|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
125397345|NCT00213148|451087062|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
125397346|NCT00213148|451087063|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
125397347|NCT00213148|451087064|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
125397348|NCT00213148|451087065|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
125397349|NCT00213148|451087066|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
125397350|NCT00213148|451087062|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
125397351|NCT00213148|451087063|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
125397352|NCT00213148|451087064|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
125397353|NCT00213148|451087065|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
125397354|NCT00213148|451087066|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
125397355|NCT00213148|451087062|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
125445131|NCT02718417|451255791|FG000|Maintenance Phase (MP)|Other|2|||
125445132|NCT02718417|451255792|FG001|Maintenance Phase (MP)|Other|1|||
125256991|NCT02471144|450569597|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
125256992|NCT02471144|450569598|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256993|NCT02471144|450569599|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
125256994|NCT02471144|450569589|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125256995|NCT02471144|450569590|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125256996|NCT02471144|450569591|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125256997|NCT02471144|450569592|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125256998|NCT02471144|450569593|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125256999|NCT02471144|450569594|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
125257000|NCT02471144|450569595|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125257001|NCT02471144|450569596|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125257002|NCT02471144|450569597|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
125257003|NCT02471144|450569598|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125257004|NCT02471144|450569599|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
125257005|NCT02471144|450569589|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257006|NCT02471144|450569590|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257007|NCT02471144|450569591|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257008|NCT02471144|450569592|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257009|NCT02471144|450569593|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257010|NCT02471144|450569594|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257011|NCT02471144|450569595|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257012|NCT02471144|450569596|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257013|NCT02471144|450569597|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
125257014|NCT02471144|450569598|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257015|NCT02471144|450569599|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
125257016|NCT02471144|450569589|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257017|NCT02471144|450569590|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257018|NCT02471144|450569591|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257019|NCT02471144|450569592|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257020|NCT02471144|450569593|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257021|NCT02471144|450569594|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257022|NCT02471144|450569595|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257023|NCT02471144|450569596|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
125257024|NCT02471144|450569597|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
125257025|NCT02471144|450569598|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257026|NCT02471144|450569599|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
125257027|NCT02471144|450569589|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257028|NCT02471144|450569590|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257029|NCT02471144|450569591|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257030|NCT02471144|450569592|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257031|NCT02471144|450569593|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257032|NCT02471144|450569594|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257033|NCT02471144|450569595|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257034|NCT02471144|450569596|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257035|NCT02471144|450569597|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
125257036|NCT02471144|450569598|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
125257037|NCT02471144|450569599|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
125257038|NCT02471144|450569589|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257039|NCT02471144|450569590|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257040|NCT02471144|450569591|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257041|NCT02471144|450569592|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257042|NCT02471144|450569593|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257043|NCT02471144|450569594|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257044|NCT02471144|450569595|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257045|NCT02471144|450569596|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257046|NCT02471144|450569597|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257047|NCT02471144|450569598|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
125257048|NCT02471144|450569599|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
125257049|NCT02471144|450569589|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257050|NCT02471144|450569590|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257051|NCT02471144|450569591|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257052|NCT02471144|450569592|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257053|NCT02471144|450569593|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257054|NCT02471144|450569594|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257055|NCT02471144|450569595|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257056|NCT02471144|450569596|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257057|NCT02471144|450569597|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257058|NCT02471144|450569598|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
125257059|NCT02471144|450569599|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
125257060|NCT02471144|450569589|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257061|NCT02471144|450569590|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257062|NCT02471144|450569591|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257063|NCT02471144|450569592|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257064|NCT02471144|450569593|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257065|NCT02471144|450569594|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257066|NCT02471144|450569595|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257067|NCT02471144|450569596|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257068|NCT02471144|450569597|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
125257069|NCT02471144|450569598|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
125257070|NCT02471144|450569599|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
125257071|NCT02471144|450569589|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257072|NCT02471144|450569590|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257073|NCT02471144|450569591|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257074|NCT02471144|450569592|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257075|NCT02471144|450569593|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257076|NCT02471144|450569594|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257077|NCT02471144|450569595|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257078|NCT02471144|450569596|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257079|NCT02471144|450569597|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257080|NCT02471144|450569598|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
125257081|NCT02471144|450569599|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
125257082|NCT02471144|450569589|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257083|NCT02471144|450569590|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257084|NCT02471144|450569591|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257085|NCT02471144|450569592|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257086|NCT02471144|450569593|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257087|NCT02471144|450569594|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257088|NCT02471144|450569595|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257089|NCT02471144|450569596|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257090|NCT02471144|450569597|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
125257091|NCT02471144|450569598|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
125257092|NCT02471144|450569599|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
125257093|NCT00003645|450569600|FG000|Overall Study|Death|4|||
125257094|NCT00003645|450569601|FG001|Overall Study|Death|1|||
125257095|NCT00003645|450569600|FG000|Overall Study|Lost to Follow-up|7|||
125257096|NCT00003645|450569601|FG001|Overall Study|Lost to Follow-up|8|||
125257097|NCT00003645|450569600|FG000|Overall Study|Withdrawal by Subject|1|||
125257098|NCT00003645|450569601|FG001|Overall Study|Withdrawal by Subject|3|||
125257099|NCT03768336|450569604|FG000|Overall Study|Lost to Follow-up|3|||
125257100|NCT03768336|450569605|FG001|Overall Study|Lost to Follow-up|2|||
125257101|NCT03768336|450569604|FG000|Overall Study|Became Ineligible|2|||
125257102|NCT03768336|450569605|FG001|Overall Study|Became Ineligible|0|||
125257103|NCT03768336|450569604|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
125257104|NCT03768336|450569605|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
125257105|NCT03768336|450569604|FG000|Overall Study|Missed final survey (post-treatment|0|||
125257106|NCT03768336|450569605|FG001|Overall Study|Missed final survey (post-treatment|1|||
125257107|NCT03502681|450569608|FG000|Overall Study|Adverse Event|1|||
125257108|NCT03502681|450569609|FG001|Overall Study|Adverse Event|1|||
125257109|NCT03502681|450569608|FG000|Overall Study|Disease Progression|2|||
125257110|NCT03502681|450569609|FG001|Overall Study|Disease Progression|1|||
125257111|NCT06790303|450569610|FG000|Overall Study|Study Terminated by sponsor|4|||
125257112|NCT06790303|450569610|FG000|Overall Study|Death|4|||
125257113|NCT02374255|450569619|FG000|Overall Study|Withdrawal by Subject|2|||
125257114|NCT02374255|450569620|FG001|Overall Study|Withdrawal by Subject|0|||
125257115|NCT02374255|450569621|FG002|Overall Study|Withdrawal by Subject|0|||
125257116|NCT02374255|450569622|FG003|Overall Study|Withdrawal by Subject|0|||
125257117|NCT02093520|450569623|FG000|Overall Study|Not treated|6|||
125257118|NCT02093520|450569624|FG001|Overall Study|Not treated|22|||
125257119|NCT03014089|450569625|FG000|Overall Study|Withdrawal by Subject|0|||
125257120|NCT03014089|450569626|FG001|Overall Study|Withdrawal by Subject|1|||
125257121|NCT03014089|450569627|FG002|Overall Study|Withdrawal by Subject|1|||
125257122|NCT03014089|450569628|FG003|Overall Study|Withdrawal by Subject|1|||
125257123|NCT03014089|450569625|FG000|Overall Study|Lost to Follow-up|1|||
125257124|NCT03014089|450569626|FG001|Overall Study|Lost to Follow-up|0|||
125257125|NCT03014089|450569627|FG002|Overall Study|Lost to Follow-up|0|||
125257126|NCT03014089|450569628|FG003|Overall Study|Lost to Follow-up|0|||
125257127|NCT03014089|450569625|FG000|Overall Study|Adverse Event|1|||
125257128|NCT03014089|450569626|FG001|Overall Study|Adverse Event|0|||
125257129|NCT03014089|450569627|FG002|Overall Study|Adverse Event|1|||
125257130|NCT03014089|450569628|FG003|Overall Study|Adverse Event|0|||
125257131|NCT00321932|450569630|FG000|Overall Study|Death|3|||
125257132|NCT00321932|450569631|FG001|Overall Study|Death|6|||
125257133|NCT00321932|450569630|FG000|Overall Study|Withdrawal by Subject|3|||
125257134|NCT00321932|450569631|FG001|Overall Study|Withdrawal by Subject|6|||
125257135|NCT00321932|450569630|FG000|Overall Study|Early relapse|2|||
125257136|NCT00321932|450569631|FG001|Overall Study|Early relapse|8|||
125257137|NCT00321932|450569630|FG000|Overall Study|Missing data|2|||
125257138|NCT00321932|450569631|FG001|Overall Study|Missing data|1|||
125257139|NCT03257657|450569632|FG000|Overall Study|Lost to Follow-up|0|||
125257140|NCT03257657|450569633|FG001|Overall Study|Lost to Follow-up|3|||
125257141|NCT03257657|450569632|FG000|Overall Study|Withdrawn|0|||
125257142|NCT03257657|450569633|FG001|Overall Study|Withdrawn|1|||
125257143|NCT03257657|450569632|FG000|Overall Study|Noted not eligible right after enrolled|0|||
125257144|NCT03257657|450569633|FG001|Overall Study|Noted not eligible right after enrolled|1|||
125257145|NCT01992757|450569648|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
125257146|NCT04992273|450569649|FG000|Overall Study|Lost to Follow-up|0|||
125257147|NCT04992273|450569650|FG001|Overall Study|Lost to Follow-up|1|||
125257148|NCT00688740|450569651|FG000|Overall Study|Adverse Event|45|||
125257149|NCT00688740|450569652|FG001|Overall Study|Adverse Event|8|||
125257150|NCT00688740|450569651|FG000|Overall Study|Death|2|||
125257151|NCT00688740|450569652|FG001|Overall Study|Death|2|||
125257152|NCT00688740|450569651|FG000|Overall Study|Lost to Follow-up|0|||
125257153|NCT00688740|450569652|FG001|Overall Study|Lost to Follow-up|1|||
125257154|NCT00688740|450569651|FG000|Overall Study|Consent Withdrawn|17|||
125257155|NCT00688740|450569652|FG001|Overall Study|Consent Withdrawn|17|||
125257156|NCT00688740|450569651|FG000|Overall Study|Breast Cancer Relapse|1|||
125257157|NCT00688740|450569652|FG001|Overall Study|Breast Cancer Relapse|4|||
125257158|NCT00688740|450569651|FG000|Overall Study|Violation of Inclusion Criteria|1|||
125257159|NCT00688740|450569652|FG001|Overall Study|Violation of Inclusion Criteria|3|||
125257160|NCT00856557|450569655|FG000|Overall Study|No patients with contextual flags|12|||
125257161|NCT00856557|450569656|FG001|Overall Study|No patients with contextual flags|16|||
125257162|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
125257163|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
125257164|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
125257165|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
125257166|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
125257167|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
125257168|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
125257169|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
125257170|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
125257171|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
125257172|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
125257173|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
125257174|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
125257175|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
125257176|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
125257177|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
125257178|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
125257179|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
125257180|NCT01432444|450569657|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
125257181|NCT01432444|450569658|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
125257182|NCT01432444|450569659|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
125257183|NCT01432444|450569657|FG000|Treatment Phase|Lost to Follow-up|0|||
125257184|NCT01432444|450569658|FG001|Treatment Phase|Lost to Follow-up|33|||
125257185|NCT01432444|450569659|FG002|Treatment Phase|Lost to Follow-up|0|||
125257186|NCT01432444|450569657|FG000|Treatment Phase|Adverse Event|0|||
125257187|NCT01432444|450569658|FG001|Treatment Phase|Adverse Event|37|||
125257188|NCT01432444|450569659|FG002|Treatment Phase|Adverse Event|0|||
125257189|NCT01432444|450569657|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
125257190|NCT01432444|450569658|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
125257191|NCT01432444|450569659|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
125257192|NCT01432444|450569657|FG000|Treatment Phase|Physician Decision|0|||
125257193|NCT01432444|450569658|FG001|Treatment Phase|Physician Decision|5|||
125257194|NCT01432444|450569659|FG002|Treatment Phase|Physician Decision|0|||
125257195|NCT01432444|450569657|FG000|Treatment Phase|Withdrawal by Subject|0|||
125257196|NCT01432444|450569658|FG001|Treatment Phase|Withdrawal by Subject|41|||
125257197|NCT01432444|450569659|FG002|Treatment Phase|Withdrawal by Subject|0|||
125257198|NCT01432444|450569657|FG000|Treatment Phase|Protocol Deviation|0|||
125257199|NCT01432444|450569658|FG001|Treatment Phase|Protocol Deviation|3|||
125257200|NCT01432444|450569659|FG002|Treatment Phase|Protocol Deviation|0|||
125445133|NCT02718417|451255793|FG002|Maintenance Phase (MP)|Other|0|||
125445134|NCT02718417|451255791|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
125445135|NCT02718417|451255792|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
125445136|NCT02718417|451255793|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
125445137|NCT02718417|451255791|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
125445138|NCT02718417|451255792|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
125445139|NCT02718417|451255793|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
125445140|NCT02718417|451255791|FG000|Observation Phase (OP)|Adverse Event|0|||
125445141|NCT02718417|451255792|FG001|Observation Phase (OP)|Adverse Event|0|||
125445142|NCT02718417|451255793|FG002|Observation Phase (OP)|Adverse Event|1|||
125445143|NCT02718417|451255791|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
125445144|NCT02718417|451255792|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
125445145|NCT02718417|451255793|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
125445146|NCT02718417|451255791|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
125445147|NCT02718417|451255792|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
125445148|NCT02718417|451255793|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
125445149|NCT02718417|451255791|FG000|Observation Phase (OP)|Physician Decision|0|||
125445150|NCT02718417|451255792|FG001|Observation Phase (OP)|Physician Decision|0|||
125445151|NCT02718417|451255793|FG002|Observation Phase (OP)|Physician Decision|9|||
125445152|NCT02718417|451255791|FG000|Observation Phase (OP)|Progressive disease|0|||
125445153|NCT02718417|451255792|FG001|Observation Phase (OP)|Progressive disease|0|||
125445154|NCT02718417|451255793|FG002|Observation Phase (OP)|Progressive disease|92|||
125445155|NCT02718417|451255791|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
125445156|NCT02718417|451255792|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
125445157|NCT02718417|451255793|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
125445158|NCT02718417|451255791|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
125445159|NCT02718417|451255792|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
125445160|NCT02718417|451255793|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
125445161|NCT02718417|451255791|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
125445162|NCT02718417|451255792|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
125445163|NCT02718417|451255793|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
125445164|NCT02718417|451255791|FG000|Observation Phase (OP)|Other|0|||
125445165|NCT02718417|451255792|FG001|Observation Phase (OP)|Other|0|||
125445166|NCT02718417|451255793|FG002|Observation Phase (OP)|Other|7|||
125445167|NCT02718417|451255791|FG000|Follow-up Phase|Adverse Event|3|||
125445168|NCT02718417|451255792|FG001|Follow-up Phase|Adverse Event|1|||
125257201|NCT01432444|450569657|FG000|Treatment Phase|Lack of Efficacy|0|||
125257202|NCT01432444|450569658|FG001|Treatment Phase|Lack of Efficacy|10|||
125445169|NCT02718417|451255793|FG002|Follow-up Phase|Adverse Event|1|||
125445170|NCT02718417|451255791|FG000|Follow-up Phase|Other|4|||
125445171|NCT02718417|451255792|FG001|Follow-up Phase|Other|6|||
125445172|NCT02718417|451255793|FG002|Follow-up Phase|Other|4|||
125445173|NCT02718417|451255791|FG000|Follow-up Phase|Withdrawal by Subject|19|||
125445174|NCT02718417|451255792|FG001|Follow-up Phase|Withdrawal by Subject|17|||
125445175|NCT02718417|451255793|FG002|Follow-up Phase|Withdrawal by Subject|5|||
125445176|NCT02718417|451255791|FG000|Follow-up Phase|Study terminated by sponsor|100|||
125445177|NCT02718417|451255792|FG001|Follow-up Phase|Study terminated by sponsor|138|||
125445178|NCT02718417|451255793|FG002|Follow-up Phase|Study terminated by sponsor|6|||
125445179|NCT02718417|451255791|FG000|Follow-up Phase|Lost to Follow-up|2|||
125445180|NCT02718417|451255792|FG001|Follow-up Phase|Lost to Follow-up|3|||
125445181|NCT02718417|451255793|FG002|Follow-up Phase|Lost to Follow-up|0|||
125445182|NCT02718417|451255791|FG000|Follow-up Phase|Death leading to discontinuation|7|||
125445183|NCT02718417|451255792|FG001|Follow-up Phase|Death leading to discontinuation|7|||
125445184|NCT02718417|451255793|FG002|Follow-up Phase|Death leading to discontinuation|3|||
125445185|NCT02718417|451255791|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
125445186|NCT02718417|451255792|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
125445187|NCT02718417|451255793|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
125445188|NCT02718417|451255791|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
125257203|NCT01432444|450569659|FG002|Treatment Phase|Lack of Efficacy|0|||
125257204|NCT01432444|450569657|FG000|Extension Phase|Lost to Follow-up|0|||
125257205|NCT01432444|450569658|FG001|Extension Phase|Lost to Follow-up|0|||
125445189|NCT02718417|451255792|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
125445190|NCT02718417|451255793|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
125445191|NCT02718417|451255791|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
125445192|NCT02718417|451255792|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
125445193|NCT02718417|451255793|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
125445194|NCT02718417|451255791|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
125257206|NCT01432444|450569659|FG002|Extension Phase|Lost to Follow-up|17|||
125257207|NCT01432444|450569657|FG000|Extension Phase|Adverse Event|0|||
125445195|NCT02718417|451255792|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
125445196|NCT02718417|451255793|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
125257208|NCT01432444|450569658|FG001|Extension Phase|Adverse Event|0|||
125257209|NCT01432444|450569659|FG002|Extension Phase|Adverse Event|10|||
125257210|NCT01432444|450569657|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
125257211|NCT01432444|450569658|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
125257212|NCT01432444|450569659|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
125257213|NCT01432444|450569657|FG000|Extension Phase|Met Withdrawal Criteria|0|||
125257214|NCT01432444|450569658|FG001|Extension Phase|Met Withdrawal Criteria|0|||
125257215|NCT01432444|450569659|FG002|Extension Phase|Met Withdrawal Criteria|144|||
125257216|NCT01432444|450569657|FG000|Extension Phase|Physician Decision|0|||
125257217|NCT01432444|450569658|FG001|Extension Phase|Physician Decision|0|||
125257218|NCT01432444|450569659|FG002|Extension Phase|Physician Decision|1|||
125397356|NCT00213148|451087063|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
125397357|NCT00213148|451087064|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
125397358|NCT00213148|451087065|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
125397359|NCT00213148|451087066|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
125397360|NCT00213148|451087062|FG000|Cycle 3 (1 Month)|Other|0|||
125397361|NCT00213148|451087063|FG001|Cycle 3 (1 Month)|Other|0|||
125257219|NCT01432444|450569657|FG000|Extension Phase|Withdrawal by Subject|0|||
125257220|NCT01432444|450569658|FG001|Extension Phase|Withdrawal by Subject|0|||
125257221|NCT01432444|450569659|FG002|Extension Phase|Withdrawal by Subject|13|||
125257222|NCT02301897|450569660|FG000|Treatment Course 1|Non-Compliance|0|||
125257223|NCT02301897|450569661|FG001|Treatment Course 1|Non-Compliance|0|||
125257224|NCT02301897|450569662|FG002|Treatment Course 1|Non-Compliance|1|||
125257225|NCT02301897|450569660|FG000|Treatment Course 1|Adverse Event|1|||
125257226|NCT02301897|450569661|FG001|Treatment Course 1|Adverse Event|1|||
125257227|NCT02301897|450569662|FG002|Treatment Course 1|Adverse Event|0|||
125257228|NCT02301897|450569660|FG000|Treatment Course 1|Lost to Follow-up|1|||
125257229|NCT02301897|450569661|FG001|Treatment Course 1|Lost to Follow-up|2|||
125257230|NCT02301897|450569662|FG002|Treatment Course 1|Lost to Follow-up|1|||
125257231|NCT02301897|450569660|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
125257232|NCT02301897|450569661|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
125257233|NCT02301897|450569662|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
125257234|NCT02301897|450569660|FG000|Treatment Course 1|Withdrawal by Subject|0|||
125257235|NCT02301897|450569661|FG001|Treatment Course 1|Withdrawal by Subject|0|||
125257236|NCT02301897|450569662|FG002|Treatment Course 1|Withdrawal by Subject|2|||
125257237|NCT02301897|450569660|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
125257238|NCT02301897|450569661|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
125257239|NCT02301897|450569662|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
125257240|NCT02301897|450569660|FG000|Treatment Course 2|Lost to Follow-up|0|||
125257241|NCT02301897|450569661|FG001|Treatment Course 2|Lost to Follow-up|2|||
125257242|NCT02301897|450569662|FG002|Treatment Course 2|Lost to Follow-up|0|||
125257243|NCT02301897|450569660|FG000|Treatment Course 2|Pregnancy|0|||
125257244|NCT02301897|450569661|FG001|Treatment Course 2|Pregnancy|1|||
125257245|NCT02301897|450569662|FG002|Treatment Course 2|Pregnancy|1|||
125257246|NCT02301897|450569660|FG000|Treatment Course 2|Withdrawal by Subject|0|||
125257247|NCT02301897|450569661|FG001|Treatment Course 2|Withdrawal by Subject|2|||
125257248|NCT02301897|450569662|FG002|Treatment Course 2|Withdrawal by Subject|0|||
125257249|NCT02301897|450569660|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
125257250|NCT02301897|450569661|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
125257251|NCT02301897|450569662|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
125257252|NCT03283241|450569663|FG000|Overall Study|Adverse Event|4|||
125257253|NCT03283241|450569664|FG001|Overall Study|Adverse Event|1|||
125257254|NCT03283241|450569663|FG000|Overall Study|Withdrawal by Subject|0|||
125257255|NCT03283241|450569664|FG001|Overall Study|Withdrawal by Subject|1|||
125257256|NCT03283241|450569663|FG000|Overall Study|Subject relocated to Finland|0|||
125257257|NCT03283241|450569664|FG001|Overall Study|Subject relocated to Finland|1|||
125257258|NCT00478257|450569665|FG000|Overall Study|Withdrawal by Subject|8|||
125397362|NCT00213148|451087064|FG002|Cycle 3 (1 Month)|Other|1|||
125397363|NCT00213148|451087065|FG003|Cycle 3 (1 Month)|Other|1|||
125397364|NCT00213148|451087066|FG004|Cycle 3 (1 Month)|Other|0|||
125397365|NCT00558103|451087067|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
125397366|NCT00558103|451087068|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
125397367|NCT00558103|451087069|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
125397368|NCT00558103|451087070|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
125397369|NCT00558103|451087071|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
125397370|NCT00558103|451087072|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
125397371|NCT00558103|451087067|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
125397372|NCT00558103|451087068|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
125257259|NCT00478257|450569666|FG001|Overall Study|Withdrawal by Subject|3|||
125257260|NCT03931330|450569667|FG000|Overall Study|Physician Decision|1|||
125257261|NCT03412929|450569668|FG000|Overall Study|Protocol Violation|3|||
125397373|NCT00558103|451087069|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
125397374|NCT00558103|451087070|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
125397375|NCT00558103|451087071|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
125397376|NCT00558103|451087072|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
125397377|NCT00558103|451087067|FG000|Randomized Treatment Phase|Disease Progression|1|||
125257262|NCT00023595|450569673|FG000|5 Year Follow up|Lost to Follow-up|2|||
125257263|NCT00023595|450569674|FG001|5 Year Follow up|Lost to Follow-up|2|||
125257264|NCT00023595|450569675|FG002|5 Year Follow up|Lost to Follow-up|1|||
125257265|NCT00023595|450569676|FG003|5 Year Follow up|Lost to Follow-up|7|||
125257266|NCT00023595|450569677|FG004|5 Year Follow up|Lost to Follow-up|3|||
125257267|NCT00023595|450569673|FG000|10 Year Follow up|Lost to Follow-up|12|||
125257268|NCT00023595|450569674|FG001|10 Year Follow up|Lost to Follow-up|10|||
125257269|NCT00023595|450569675|FG002|10 Year Follow up|Lost to Follow-up|3|||
125257270|NCT00023595|450569676|FG003|10 Year Follow up|Lost to Follow-up|0|||
125257271|NCT00023595|450569677|FG004|10 Year Follow up|Lost to Follow-up|0|||
125257272|NCT01472185|450569678|FG000|Overall Study|Randomized but Not Treated|0|||
125257273|NCT01472185|450569679|FG001|Overall Study|Randomized but Not Treated|1|||
125257274|NCT01472185|450569678|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
125257275|NCT01472185|450569679|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
125257276|NCT01472185|450569678|FG000|Overall Study|Hyperglycemia|5|||
125257277|NCT01472185|450569679|FG001|Overall Study|Hyperglycemia|2|||
125257278|NCT01472185|450569678|FG000|Overall Study|Investigator's Discretion|3|||
125257279|NCT01472185|450569679|FG001|Overall Study|Investigator's Discretion|1|||
125257280|NCT01472185|450569678|FG000|Overall Study|Lost to Follow-up|4|||
125257281|NCT01472185|450569679|FG001|Overall Study|Lost to Follow-up|1|||
125257282|NCT01472185|450569678|FG000|Overall Study|Protocol Violation|5|||
125257283|NCT01472185|450569679|FG001|Overall Study|Protocol Violation|1|||
125257284|NCT01472185|450569678|FG000|Overall Study|Subject Noncompliance|8|||
125257285|NCT01472185|450569679|FG001|Overall Study|Subject Noncompliance|15|||
125257286|NCT01472185|450569678|FG000|Overall Study|Subject Withdrew Consent|6|||
125257287|NCT01472185|450569679|FG001|Overall Study|Subject Withdrew Consent|3|||
125257288|NCT00635050|450569684|FG000|Overall Study|Withdrawal by Subject|1|||
125257289|NCT00759395|450569685|FG000|Overall Study|Adverse Event|1|||
125257290|NCT00759395|450569686|FG001|Overall Study|Adverse Event|0|||
125257291|NCT00759395|450569685|FG000|Overall Study|Withdrawal by Subject|1|||
125257292|NCT00759395|450569686|FG001|Overall Study|Withdrawal by Subject|0|||
125257293|NCT00759395|450569685|FG000|Overall Study|Lack of Efficacy|0|||
125257294|NCT00759395|450569686|FG001|Overall Study|Lack of Efficacy|2|||
125257295|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
125257296|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
125257297|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
125257298|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
125257299|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
125257300|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
125257301|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
125257302|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
125257303|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
125257304|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
125257305|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
125257306|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
125257307|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
125257308|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
125257309|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
125257310|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
125257311|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
125257312|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
125257313|NCT00086515|450569687|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
125257314|NCT00086515|450569688|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
125257315|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
125257316|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
125257317|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
125257318|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
125257319|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
125257320|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
125257321|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
125257322|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
125257323|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
125257324|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
125257325|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
125303098|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
125303099|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303100|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303101|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303102|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
125303103|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303104|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125257326|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
125257327|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
125257328|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
125257329|NCT00086515|450569687|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
125257330|NCT00086515|450569688|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
125257331|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
125257332|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
125257333|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
125257334|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
125257335|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
125257336|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
125257337|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
125257338|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
125257339|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
125257340|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
125257341|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
125257342|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
125257343|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
125257344|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
125257345|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
125257346|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
125257347|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
125257348|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
125257349|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
125257350|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
125257351|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
125257352|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
125257353|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
125257354|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
125257355|NCT00086515|450569687|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
125257356|NCT00086515|450569688|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
125257357|NCT00049543|450569689|FG000|Overall Study|still on treatment|2|||
125257358|NCT00049543|450569690|FG001|Overall Study|still on treatment|9|||
125257359|NCT02106832|450569691|FG000|Overall Study|Adverse Event|1|||
125257360|NCT02106832|450569692|FG001|Overall Study|Adverse Event|2|||
125257361|NCT02106832|450569693|FG002|Overall Study|Adverse Event|3|||
125257362|NCT02106832|450569694|FG003|Overall Study|Adverse Event|0|||
125257363|NCT02106832|450569691|FG000|Overall Study|Death|4|||
125257364|NCT02106832|450569692|FG001|Overall Study|Death|4|||
125257365|NCT02106832|450569693|FG002|Overall Study|Death|1|||
125257366|NCT02106832|450569694|FG003|Overall Study|Death|4|||
125257367|NCT02106832|450569691|FG000|Overall Study|Deterioration of general conditions|0|||
125257368|NCT02106832|450569692|FG001|Overall Study|Deterioration of general conditions|0|||
125257369|NCT02106832|450569693|FG002|Overall Study|Deterioration of general conditions|1|||
125257370|NCT02106832|450569694|FG003|Overall Study|Deterioration of general conditions|0|||
125257371|NCT02106832|450569691|FG000|Overall Study|Lost to Follow-up|0|||
125257372|NCT02106832|450569692|FG001|Overall Study|Lost to Follow-up|1|||
125257373|NCT02106832|450569693|FG002|Overall Study|Lost to Follow-up|1|||
125257374|NCT02106832|450569694|FG003|Overall Study|Lost to Follow-up|3|||
125257375|NCT02106832|450569691|FG000|Overall Study|Physician Decision|1|||
125257376|NCT02106832|450569692|FG001|Overall Study|Physician Decision|0|||
125257377|NCT02106832|450569693|FG002|Overall Study|Physician Decision|0|||
125257378|NCT02106832|450569694|FG003|Overall Study|Physician Decision|0|||
125257379|NCT02106832|450569691|FG000|Overall Study|Protocol Violation|0|||
125257380|NCT02106832|450569692|FG001|Overall Study|Protocol Violation|0|||
125257381|NCT02106832|450569693|FG002|Overall Study|Protocol Violation|0|||
125257382|NCT02106832|450569694|FG003|Overall Study|Protocol Violation|1|||
125257383|NCT02106832|450569691|FG000|Overall Study|Withdrawal by Subject|17|||
125257384|NCT02106832|450569692|FG001|Overall Study|Withdrawal by Subject|17|||
125257385|NCT02106832|450569693|FG002|Overall Study|Withdrawal by Subject|10|||
125257386|NCT02106832|450569694|FG003|Overall Study|Withdrawal by Subject|7|||
125257387|NCT02106832|450569691|FG000|Overall Study|Technical problems|0|||
125257388|NCT02106832|450569692|FG001|Overall Study|Technical problems|1|||
125257389|NCT02106832|450569693|FG002|Overall Study|Technical problems|0|||
125257390|NCT02106832|450569694|FG003|Overall Study|Technical problems|0|||
125257391|NCT03485157|450569695|FG000|Double Blind Phase|Lost to Follow-up|4|||
125257392|NCT03485157|450569696|FG001|Double Blind Phase|Lost to Follow-up|4|||
125257393|NCT03485157|450569695|FG000|Double Blind Phase|Adverse Event|2|||
125257394|NCT03485157|450569696|FG001|Double Blind Phase|Adverse Event|1|||
125257395|NCT03485157|450569695|FG000|Double Blind Phase|Withdrawal by Subject|6|||
125257396|NCT03485157|450569696|FG001|Double Blind Phase|Withdrawal by Subject|9|||
125257397|NCT03485157|450569695|FG000|Double Blind Phase|Removal by PI|3|||
125257398|NCT03485157|450569696|FG001|Double Blind Phase|Removal by PI|7|||
125257399|NCT03485157|450569695|FG000|Open Label Phase|Lost to Follow-up|1|||
125257400|NCT03485157|450569696|FG001|Open Label Phase|Lost to Follow-up|2|||
125257401|NCT03485157|450569695|FG000|Open Label Phase|Adverse Event|0|||
125257402|NCT03485157|450569696|FG001|Open Label Phase|Adverse Event|1|||
125257403|NCT03485157|450569695|FG000|Open Label Phase|Withdrawal by Subject|1|||
125257404|NCT03485157|450569696|FG001|Open Label Phase|Withdrawal by Subject|2|||
125257405|NCT03485157|450569695|FG000|Open Label Phase|Removal by PI|2|||
125257406|NCT03485157|450569696|FG001|Open Label Phase|Removal by PI|0|||
125257407|NCT00265122|450569697|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
125257408|NCT00265122|450569698|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
125257409|NCT00265122|450569699|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
125257410|NCT00265122|450569700|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
125257411|NCT00265122|450569701|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
125257412|NCT00265122|450569702|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
125257413|NCT00265122|450569697|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
125257414|NCT00265122|450569698|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
125257415|NCT00265122|450569699|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
125257416|NCT00265122|450569700|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
125257417|NCT00265122|450569701|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
125257418|NCT00265122|450569702|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
125257419|NCT00265122|450569697|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
125257420|NCT00265122|450569698|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
125257421|NCT00265122|450569699|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
125257422|NCT00265122|450569700|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
125257423|NCT00265122|450569701|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
125257424|NCT00265122|450569702|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
125257425|NCT00265122|450569697|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
125257426|NCT00265122|450569698|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
125257427|NCT00265122|450569699|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
125257428|NCT00265122|450569700|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
125257429|NCT00265122|450569701|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
125257430|NCT00265122|450569702|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
125257431|NCT00265122|450569697|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
125257432|NCT00265122|450569698|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
125257433|NCT00265122|450569699|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
125257434|NCT00265122|450569700|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
125257435|NCT00265122|450569701|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
125257436|NCT00265122|450569702|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
125257437|NCT00265122|450569697|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
125257438|NCT00265122|450569698|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
125257439|NCT00265122|450569699|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
125397378|NCT00558103|451087068|FG001|Randomized Treatment Phase|Disease Progression|0|||
125397379|NCT00558103|451087069|FG002|Randomized Treatment Phase|Disease Progression|1|||
125397380|NCT00558103|451087070|FG003|Randomized Treatment Phase|Disease Progression|0|||
125397381|NCT00558103|451087071|FG004|Randomized Treatment Phase|Disease Progression|0|||
125397382|NCT00558103|451087072|FG005|Randomized Treatment Phase|Disease Progression|0|||
125397383|NCT00558103|451087067|FG000|Randomized Treatment Phase|Adverse Event|0|||
125397384|NCT00558103|451087068|FG001|Randomized Treatment Phase|Adverse Event|0|||
125397385|NCT00558103|451087069|FG002|Randomized Treatment Phase|Adverse Event|0|||
125397386|NCT00558103|451087070|FG003|Randomized Treatment Phase|Adverse Event|1|||
125397387|NCT00558103|451087071|FG004|Randomized Treatment Phase|Adverse Event|1|||
125397388|NCT00558103|451087072|FG005|Randomized Treatment Phase|Adverse Event|0|||
125397389|NCT00558103|451087067|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
125397390|NCT00558103|451087068|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
125397391|NCT00558103|451087069|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
125397392|NCT00558103|451087070|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
125397393|NCT00558103|451087071|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
125257440|NCT00265122|450569700|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
125257441|NCT00265122|450569701|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
125257442|NCT00265122|450569702|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
125257443|NCT05205616|450569709|FG000|Overall Study|Lost to Follow-up|4|||
125257444|NCT05205616|450569710|FG001|Overall Study|Lost to Follow-up|4|||
125257445|NCT00663260|450569716|FG000|Overall Study|Lack of Efficacy|2|||
125257446|NCT00663260|450569717|FG001|Overall Study|Lack of Efficacy|0|||
125257447|NCT00663260|450569718|FG002|Overall Study|Lack of Efficacy|0|||
125257448|NCT00663260|450569716|FG000|Overall Study|Adverse Event|12|||
125257449|NCT00663260|450569717|FG001|Overall Study|Adverse Event|7|||
125257450|NCT00663260|450569718|FG002|Overall Study|Adverse Event|6|||
125257451|NCT00663260|450569716|FG000|Overall Study|Withdrawal by Subject|3|||
125397394|NCT00558103|451087072|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
125397395|NCT00558103|451087067|FG000|Monotherapy Extension Phase|Disease Progression|0|||
125397396|NCT00558103|451087068|FG001|Monotherapy Extension Phase|Disease Progression|0|||
125257452|NCT00663260|450569717|FG001|Overall Study|Withdrawal by Subject|1|||
125257453|NCT00663260|450569718|FG002|Overall Study|Withdrawal by Subject|6|||
125257454|NCT00663260|450569716|FG000|Overall Study|Death|1|||
125257455|NCT00663260|450569717|FG001|Overall Study|Death|0|||
125257456|NCT00663260|450569718|FG002|Overall Study|Death|1|||
125257457|NCT00663260|450569716|FG000|Overall Study|Lost to Follow-up|0|||
125257458|NCT00663260|450569717|FG001|Overall Study|Lost to Follow-up|1|||
125257459|NCT00663260|450569718|FG002|Overall Study|Lost to Follow-up|0|||
125257460|NCT00663260|450569716|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
125257461|NCT00663260|450569717|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
125257462|NCT00663260|450569718|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
125257463|NCT02231580|450569727|FG000|Overall Study|Adverse Event|5|||
125257464|NCT02231580|450569728|FG001|Overall Study|Adverse Event|0|||
125257465|NCT03620981|450569729|FG000|Overall Study|Adverse Event|14|||
125257466|NCT03620981|450569730|FG001|Overall Study|Adverse Event|38|||
125257467|NCT03620981|450569731|FG002|Overall Study|Adverse Event|25|||
125257468|NCT03620981|450569729|FG000|Overall Study|Lack of Efficacy|2|||
125257469|NCT03620981|450569730|FG001|Overall Study|Lack of Efficacy|1|||
125257470|NCT03620981|450569731|FG002|Overall Study|Lack of Efficacy|1|||
125257471|NCT03620981|450569729|FG000|Overall Study|Physician Decision|7|||
125257472|NCT03620981|450569730|FG001|Overall Study|Physician Decision|4|||
125257473|NCT03620981|450569731|FG002|Overall Study|Physician Decision|4|||
125257474|NCT03620981|450569729|FG000|Overall Study|Protocol Violation|1|||
125257475|NCT03620981|450569730|FG001|Overall Study|Protocol Violation|2|||
125257476|NCT03620981|450569731|FG002|Overall Study|Protocol Violation|1|||
125257477|NCT03620981|450569729|FG000|Overall Study|Withdrawal by Legal Representative|2|||
125257478|NCT03620981|450569730|FG001|Overall Study|Withdrawal by Legal Representative|1|||
125257479|NCT03620981|450569731|FG002|Overall Study|Withdrawal by Legal Representative|1|||
125257480|NCT03620981|450569729|FG000|Overall Study|Withdrawal by Care Giver|2|||
125257481|NCT03620981|450569730|FG001|Overall Study|Withdrawal by Care Giver|0|||
125257482|NCT03620981|450569731|FG002|Overall Study|Withdrawal by Care Giver|1|||
125257483|NCT03620981|450569729|FG000|Overall Study|Non-compliance with Study Drug|1|||
125257484|NCT03620981|450569730|FG001|Overall Study|Non-compliance with Study Drug|1|||
125257485|NCT03620981|450569731|FG002|Overall Study|Non-compliance with Study Drug|0|||
125257486|NCT03238196|450569734|FG000|Overall Study|Adverse Event|3|||
125257487|NCT03238196|450569735|FG001|Overall Study|Adverse Event|0|||
125257488|NCT03238196|450569736|FG002|Overall Study|Adverse Event|2|||
125257489|NCT03238196|450569737|FG003|Overall Study|Adverse Event|2|||
125257490|NCT03238196|450569734|FG000|Overall Study|Withdrawal by Subject|4|||
125257491|NCT03238196|450569735|FG001|Overall Study|Withdrawal by Subject|1|||
125257492|NCT03238196|450569736|FG002|Overall Study|Withdrawal by Subject|1|||
125257493|NCT03238196|450569737|FG003|Overall Study|Withdrawal by Subject|0|||
125257494|NCT03238196|450569734|FG000|Overall Study|Disease progression|14|||
125257495|NCT03238196|450569735|FG001|Overall Study|Disease progression|2|||
125257496|NCT03238196|450569736|FG002|Overall Study|Disease progression|3|||
125257497|NCT03238196|450569737|FG003|Overall Study|Disease progression|2|||
125257498|NCT03238196|450569734|FG000|Overall Study|Still on treatment|1|||
125257499|NCT03238196|450569735|FG001|Overall Study|Still on treatment|0|||
125257500|NCT03238196|450569736|FG002|Overall Study|Still on treatment|0|||
125257501|NCT03238196|450569737|FG003|Overall Study|Still on treatment|0|||
125257502|NCT04938427|450569738|FG000|Overall Study|Adverse Event|5|||
125257503|NCT04938427|450569739|FG001|Overall Study|Adverse Event|19|||
125257504|NCT04938427|450569738|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
125257505|NCT04938427|450569739|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125257506|NCT04938427|450569738|FG000|Overall Study|Withdrawal by Subject|1|||
125257507|NCT04938427|450569739|FG001|Overall Study|Withdrawal by Subject|0|||
125257508|NCT04938427|450569738|FG000|Overall Study|Reason Not Specified|2|||
125257509|NCT04938427|450569739|FG001|Overall Study|Reason Not Specified|1|||
125257510|NCT03977155|450571538|FG000|Overall Study|Adverse Event|3|||
125257511|NCT03977155|450571539|FG001|Overall Study|Adverse Event|0|||
125257512|NCT03977155|450571540|FG002|Overall Study|Adverse Event|0|||
125257513|NCT03977155|450571538|FG000|Overall Study|Lost to Follow-up|0|||
125257514|NCT03977155|450571539|FG001|Overall Study|Lost to Follow-up|1|||
125257515|NCT03977155|450571540|FG002|Overall Study|Lost to Follow-up|0|||
125257516|NCT03977155|450571538|FG000|Overall Study|Withdrawal by Subject|1|||
125257517|NCT03977155|450571539|FG001|Overall Study|Withdrawal by Subject|1|||
125257518|NCT03977155|450571540|FG002|Overall Study|Withdrawal by Subject|2|||
125257519|NCT03977155|450571538|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
125257520|NCT03977155|450571539|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
125257521|NCT03977155|450571540|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
125257522|NCT00936936|450571541|FG000|Overall Study|Adverse Event|7|||
125257523|NCT00936936|450571542|FG001|Overall Study|Adverse Event|1|||
125257524|NCT00936936|450571541|FG000|Overall Study|Disease Progression|2|||
125257525|NCT00936936|450571542|FG001|Overall Study|Disease Progression|2|||
125257526|NCT00936936|450571541|FG000|Overall Study|Unrelated|3|||
125257527|NCT00936936|450571542|FG001|Overall Study|Unrelated|1|||
125257528|NCT01373281|450571543|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
125257529|NCT01373281|450571544|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
125257530|NCT01373281|450571543|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
125257531|NCT01373281|450571544|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
125257532|NCT01373281|450571543|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
125257533|NCT01373281|450571544|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
125257534|NCT01373281|450571543|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
125257535|NCT01373281|450571544|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
125257536|NCT01373281|450571543|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
125257537|NCT01373281|450571544|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
125257538|NCT01373281|450571543|FG000|Surveillance Expansion Period|Protocol Violation|9|||
125257539|NCT01373281|450571544|FG001|Surveillance Expansion Period|Protocol Violation|1|||
125257540|NCT01373281|450571543|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
125257541|NCT01373281|450571544|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
125257542|NCT01373281|450571543|FG000|Surveillance Expansion Period|Serious adverse event|3|||
125257543|NCT01373281|450571544|FG001|Surveillance Expansion Period|Serious adverse event|4|||
125257544|NCT01444781|450571545|FG000|Overall Study|Lost to Follow-up|0|||
125257545|NCT01444781|450571546|FG001|Overall Study|Lost to Follow-up|3|||
125257546|NCT01444781|450571547|FG002|Overall Study|Lost to Follow-up|1|||
125257547|NCT01444781|450571545|FG000|Overall Study|Withdrawal by Subject|3|||
125257548|NCT01444781|450571546|FG001|Overall Study|Withdrawal by Subject|1|||
125257549|NCT01444781|450571547|FG002|Overall Study|Withdrawal by Subject|2|||
125257550|NCT03033784|450571548|FG000|Overall Study|Anxiety related to MRI scanner|0|||
125257551|NCT03033784|450571549|FG001|Overall Study|Anxiety related to MRI scanner|1|||
125257552|NCT03033784|450571550|FG002|Overall Study|Anxiety related to MRI scanner|0|||
125257553|NCT03033784|450571551|FG003|Overall Study|Anxiety related to MRI scanner|0|||
125257554|NCT03033784|450571552|FG004|Overall Study|Anxiety related to MRI scanner|0|||
125257555|NCT03033784|450571553|FG005|Overall Study|Anxiety related to MRI scanner|0|||
125257556|NCT03033784|450571554|FG006|Overall Study|Anxiety related to MRI scanner|0|||
125257557|NCT03033784|450571555|FG007|Overall Study|Anxiety related to MRI scanner|0|||
125257558|NCT03033784|450571556|FG008|Overall Study|Anxiety related to MRI scanner|0|||
125257559|NCT03033784|450571557|FG009|Overall Study|Anxiety related to MRI scanner|0|||
125257560|NCT03033784|450571558|FG010|Overall Study|Anxiety related to MRI scanner|0|||
125257561|NCT03033784|450571559|FG011|Overall Study|Anxiety related to MRI scanner|0|||
125257562|NCT03033784|450571560|FG012|Overall Study|Anxiety related to MRI scanner|0|||
125257563|NCT03033784|450571548|FG000|Overall Study|Withdrawal by Subject|0|||
125257564|NCT03033784|450571549|FG001|Overall Study|Withdrawal by Subject|0|||
125257565|NCT03033784|450571550|FG002|Overall Study|Withdrawal by Subject|0|||
125257566|NCT03033784|450571551|FG003|Overall Study|Withdrawal by Subject|0|||
125257567|NCT03033784|450571552|FG004|Overall Study|Withdrawal by Subject|0|||
125257568|NCT03033784|450571553|FG005|Overall Study|Withdrawal by Subject|0|||
125257569|NCT03033784|450571554|FG006|Overall Study|Withdrawal by Subject|0|||
125257570|NCT03033784|450571555|FG007|Overall Study|Withdrawal by Subject|0|||
125257571|NCT03033784|450571556|FG008|Overall Study|Withdrawal by Subject|0|||
125257572|NCT03033784|450571557|FG009|Overall Study|Withdrawal by Subject|0|||
125257573|NCT03033784|450571558|FG010|Overall Study|Withdrawal by Subject|0|||
125257574|NCT03033784|450571559|FG011|Overall Study|Withdrawal by Subject|0|||
125257575|NCT03033784|450571560|FG012|Overall Study|Withdrawal by Subject|2|||
125257576|NCT03332056|450571561|FG000|Overall Study|Incomplete questionnaires|8|||
125257577|NCT03332056|450571562|FG001|Overall Study|Incomplete questionnaires|9|||
125257578|NCT03332056|450571561|FG000|Overall Study|Passed stone prior to surgery date|1|||
125257579|NCT03332056|450571562|FG001|Overall Study|Passed stone prior to surgery date|0|||
125257580|NCT03332056|450571561|FG000|Overall Study|Did not require a ureteral stent|0|||
125257581|NCT03332056|450571562|FG001|Overall Study|Did not require a ureteral stent|1|||
125257582|NCT00851084|450571563|FG000|Overall Study|Randomized but not treated|1|||
125257583|NCT00851084|450571564|FG001|Overall Study|Randomized but not treated|0|||
125257584|NCT00851084|450571563|FG000|Overall Study|Adverse Event|26|||
125257585|NCT00851084|450571564|FG001|Overall Study|Adverse Event|36|||
125257586|NCT00851084|450571563|FG000|Overall Study|Disease progression|52|||
125257587|NCT00851084|450571564|FG001|Overall Study|Disease progression|47|||
125257588|NCT00851084|450571563|FG000|Overall Study|Poor compliance to protocol|1|||
125257589|NCT00851084|450571564|FG001|Overall Study|Poor compliance to protocol|1|||
125257590|NCT00851084|450571563|FG000|Overall Study|Physician Decision|13|||
125257591|NCT00851084|450571564|FG001|Overall Study|Physician Decision|14|||
125257592|NCT00851084|450571563|FG000|Overall Study|Consent withdrawn|0|||
125257593|NCT00851084|450571564|FG001|Overall Study|Consent withdrawn|2|||
125397397|NCT00558103|451087069|FG002|Monotherapy Extension Phase|Disease Progression|0|||
125397398|NCT00558103|451087070|FG003|Monotherapy Extension Phase|Disease Progression|0|||
125397399|NCT00558103|451087071|FG004|Monotherapy Extension Phase|Disease Progression|0|||
125397400|NCT00558103|451087072|FG005|Monotherapy Extension Phase|Disease Progression|8|||
125397401|NCT00293384|451089175|FG000|Overall Study|Non-compliance|2|||
125397402|NCT00293384|451089175|FG000|Overall Study|Missed dosage/study drug|1|||
125397403|NCT00293384|451089175|FG000|Overall Study|Ineligible|2|||
125397404|NCT01302964|451089176|FG000|Overall Study|Adverse Event|1|||
125257594|NCT00851084|450571563|FG000|Overall Study|Withdrawal by Subject|11|||
125257595|NCT00851084|450571564|FG001|Overall Study|Withdrawal by Subject|12|||
125257596|NCT00851084|450571563|FG000|Overall Study|Metastatic surgery|6|||
125257597|NCT00851084|450571564|FG001|Overall Study|Metastatic surgery|6|||
125257598|NCT00851084|450571563|FG000|Overall Study|Other|7|||
125257599|NCT00851084|450571564|FG001|Overall Study|Other|1|||
125257600|NCT00734032|450571565|FG000|Overall Study|Adverse Event|0|||
125257601|NCT00734032|450571566|FG001|Overall Study|Adverse Event|1|||
125257602|NCT00734032|450571567|FG002|Overall Study|Adverse Event|0|||
125257603|NCT00734032|450571568|FG003|Overall Study|Adverse Event|0|||
125257604|NCT03360344|450571573|FG000|Overall Study|Withdrawal by Subject|0|||
125257605|NCT03360344|450571574|FG001|Overall Study|Withdrawal by Subject|1|||
125257606|NCT03360344|450571575|FG002|Overall Study|Withdrawal by Subject|1|||
125257607|NCT00133705|450571580|FG000|Overall Study|Withdrawal by Subject|2|||
125257608|NCT00133705|450571581|FG001|Overall Study|Withdrawal by Subject|3|||
125257609|NCT03847519|450571591|FG000|Overall Study|Death|5|||
125257610|NCT03847519|450571592|FG001|Overall Study|Death|8|||
125257611|NCT03847519|450571593|FG002|Overall Study|Death|1|||
125257612|NCT03847519|450571591|FG000|Overall Study|Lost to Follow-up|1|||
125257613|NCT03847519|450571592|FG001|Overall Study|Lost to Follow-up|2|||
125257614|NCT03847519|450571593|FG002|Overall Study|Lost to Follow-up|0|||
125257615|NCT03847519|450571591|FG000|Overall Study|Study Terminated by Sponsor|0|||
125257616|NCT03847519|450571592|FG001|Overall Study|Study Terminated by Sponsor|3|||
125257617|NCT03847519|450571593|FG002|Overall Study|Study Terminated by Sponsor|2|||
125257618|NCT02314923|450571594|FG000|Overall Study|Death|0|||
125257619|NCT02314923|450571595|FG001|Overall Study|Death|0|||
125257620|NCT02314923|450571596|FG002|Overall Study|Death|0|||
125257621|NCT02314923|450571597|FG003|Overall Study|Death|1|||
125257622|NCT02314923|450571598|FG004|Overall Study|Death|0|||
125257623|NCT02314923|450571599|FG005|Overall Study|Death|0|||
125257624|NCT02314923|450571600|FG006|Overall Study|Death|0|||
125257625|NCT02314923|450571601|FG007|Overall Study|Death|0|||
125257626|NCT02314923|450571602|FG008|Overall Study|Death|0|||
125257627|NCT02314923|450571603|FG009|Overall Study|Death|0|||
125257628|NCT02314923|450571594|FG000|Overall Study|Lost to Follow-up|2|||
125257629|NCT02314923|450571595|FG001|Overall Study|Lost to Follow-up|3|||
125257630|NCT02314923|450571596|FG002|Overall Study|Lost to Follow-up|1|||
125257631|NCT02314923|450571597|FG003|Overall Study|Lost to Follow-up|0|||
125257632|NCT02314923|450571598|FG004|Overall Study|Lost to Follow-up|0|||
125257633|NCT02314923|450571599|FG005|Overall Study|Lost to Follow-up|0|||
125257634|NCT02314923|450571600|FG006|Overall Study|Lost to Follow-up|3|||
125257635|NCT02314923|450571601|FG007|Overall Study|Lost to Follow-up|4|||
125257636|NCT02314923|450571602|FG008|Overall Study|Lost to Follow-up|2|||
125257637|NCT02314923|450571603|FG009|Overall Study|Lost to Follow-up|0|||
125257638|NCT02314923|450571594|FG000|Overall Study|Withdrawal by Subject|0|||
125257639|NCT02314923|450571595|FG001|Overall Study|Withdrawal by Subject|0|||
125257640|NCT02314923|450571596|FG002|Overall Study|Withdrawal by Subject|1|||
125257641|NCT02314923|450571597|FG003|Overall Study|Withdrawal by Subject|0|||
125257642|NCT02314923|450571598|FG004|Overall Study|Withdrawal by Subject|1|||
125257643|NCT02314923|450571599|FG005|Overall Study|Withdrawal by Subject|0|||
125257644|NCT02314923|450571600|FG006|Overall Study|Withdrawal by Subject|1|||
125257645|NCT02314923|450571601|FG007|Overall Study|Withdrawal by Subject|0|||
125257646|NCT02314923|450571602|FG008|Overall Study|Withdrawal by Subject|0|||
125257647|NCT02314923|450571603|FG009|Overall Study|Withdrawal by Subject|0|||
125257648|NCT02314923|450571594|FG000|Overall Study|Physician Decision|0|||
125257649|NCT02314923|450571595|FG001|Overall Study|Physician Decision|1|||
125257650|NCT02314923|450571596|FG002|Overall Study|Physician Decision|0|||
125257651|NCT02314923|450571597|FG003|Overall Study|Physician Decision|0|||
125257652|NCT02314923|450571598|FG004|Overall Study|Physician Decision|0|||
125257653|NCT02314923|450571599|FG005|Overall Study|Physician Decision|0|||
125257654|NCT02314923|450571600|FG006|Overall Study|Physician Decision|0|||
125257655|NCT02314923|450571601|FG007|Overall Study|Physician Decision|0|||
125397405|NCT01302964|451089177|FG001|Overall Study|Adverse Event|0|||
125397406|NCT04300296|451089178|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
125397407|NCT04300296|451089179|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
125397408|NCT04300296|451089180|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
125397409|NCT04300296|451089181|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
125397410|NCT04300296|451089182|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
125397411|NCT04300296|451089183|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
125257656|NCT02314923|450571602|FG008|Overall Study|Physician Decision|0|||
125257657|NCT02314923|450571603|FG009|Overall Study|Physician Decision|0|||
125257658|NCT02314923|450571594|FG000|Overall Study|Participant unavailable|0|||
125257659|NCT02314923|450571595|FG001|Overall Study|Participant unavailable|0|||
125257660|NCT02314923|450571596|FG002|Overall Study|Participant unavailable|0|||
125257661|NCT02314923|450571597|FG003|Overall Study|Participant unavailable|0|||
125257662|NCT02314923|450571598|FG004|Overall Study|Participant unavailable|0|||
125257663|NCT02314923|450571599|FG005|Overall Study|Participant unavailable|1|||
125257664|NCT02314923|450571600|FG006|Overall Study|Participant unavailable|0|||
125257665|NCT02314923|450571601|FG007|Overall Study|Participant unavailable|0|||
125257666|NCT02314923|450571602|FG008|Overall Study|Participant unavailable|0|||
125257667|NCT02314923|450571603|FG009|Overall Study|Participant unavailable|0|||
125257668|NCT02314923|450571594|FG000|Overall Study|Screen failure|0|||
125257669|NCT02314923|450571595|FG001|Overall Study|Screen failure|0|||
125257670|NCT02314923|450571596|FG002|Overall Study|Screen failure|0|||
125257671|NCT02314923|450571597|FG003|Overall Study|Screen failure|0|||
125257672|NCT02314923|450571598|FG004|Overall Study|Screen failure|0|||
125257673|NCT02314923|450571599|FG005|Overall Study|Screen failure|0|||
125257674|NCT02314923|450571600|FG006|Overall Study|Screen failure|1|||
125257675|NCT02314923|450571601|FG007|Overall Study|Screen failure|0|||
125257676|NCT02314923|450571602|FG008|Overall Study|Screen failure|0|||
125257677|NCT02314923|450571603|FG009|Overall Study|Screen failure|0|||
125257678|NCT02314923|450571594|FG000|Overall Study|Participant relocation|1|||
125257679|NCT02314923|450571595|FG001|Overall Study|Participant relocation|0|||
125257680|NCT02314923|450571596|FG002|Overall Study|Participant relocation|0|||
125257681|NCT02314923|450571597|FG003|Overall Study|Participant relocation|0|||
125257682|NCT02314923|450571598|FG004|Overall Study|Participant relocation|0|||
125257683|NCT02314923|450571599|FG005|Overall Study|Participant relocation|0|||
125257684|NCT02314923|450571600|FG006|Overall Study|Participant relocation|0|||
125257685|NCT02314923|450571601|FG007|Overall Study|Participant relocation|1|||
125257686|NCT02314923|450571602|FG008|Overall Study|Participant relocation|0|||
125257687|NCT02314923|450571603|FG009|Overall Study|Participant relocation|0|||
125257688|NCT00725985|450571604|FG000|ITP- Treatment Disposition|Adverse Event|20|||
125257689|NCT00725985|450571605|FG001|ITP- Treatment Disposition|Adverse Event|10|||
125257690|NCT00725985|450571606|FG002|ITP- Treatment Disposition|Adverse Event|5|||
125257691|NCT00725985|450571607|FG003|ITP- Treatment Disposition|Adverse Event|0|||
125257692|NCT00725985|450571608|FG004|ITP- Treatment Disposition|Adverse Event|0|||
125257693|NCT00725985|450571609|FG005|ITP- Treatment Disposition|Adverse Event|0|||
125257694|NCT00725985|450571610|FG006|ITP- Treatment Disposition|Adverse Event|0|||
125257695|NCT00725985|450571611|FG007|ITP- Treatment Disposition|Adverse Event|0|||
125257696|NCT00725985|450571612|FG008|ITP- Treatment Disposition|Adverse Event|0|||
125257697|NCT00725985|450571613|FG009|ITP- Treatment Disposition|Adverse Event|0|||
125257698|NCT00725985|450571614|FG010|ITP- Treatment Disposition|Adverse Event|0|||
125257699|NCT00725985|450571615|FG011|ITP- Treatment Disposition|Adverse Event|0|||
125257700|NCT00725985|450571604|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257701|NCT00725985|450571605|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257702|NCT00725985|450571606|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
125257703|NCT00725985|450571607|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257704|NCT00725985|450571608|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257705|NCT00725985|450571609|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257706|NCT00725985|450571610|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257707|NCT00725985|450571611|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257708|NCT00725985|450571612|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257709|NCT00725985|450571613|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257710|NCT00725985|450571614|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257711|NCT00725985|450571615|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
125257712|NCT00725985|450571604|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
125257713|NCT00725985|450571605|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
125257714|NCT00725985|450571606|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
125257715|NCT00725985|450571607|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
125257716|NCT00725985|450571608|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
125257717|NCT00725985|450571609|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
125257718|NCT00725985|450571610|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
125257719|NCT00725985|450571611|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
125257720|NCT00725985|450571612|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
125257721|NCT00725985|450571613|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
125257722|NCT00725985|450571614|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
125257723|NCT00725985|450571615|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
125257724|NCT00725985|450571604|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
125257725|NCT00725985|450571605|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
125257726|NCT00725985|450571606|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
125257727|NCT00725985|450571607|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
125257728|NCT00725985|450571608|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
125257729|NCT00725985|450571609|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
125397412|NCT04300296|451089178|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
125397413|NCT04300296|451089179|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
125397414|NCT04300296|451089180|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
125397415|NCT04300296|451089181|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
125397416|NCT04300296|451089182|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
125257730|NCT00725985|450571610|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
125257731|NCT00725985|450571611|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
125257732|NCT00725985|450571612|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
125257733|NCT00725985|450571613|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
125257734|NCT00725985|450571614|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
125257735|NCT00725985|450571615|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
125257736|NCT00725985|450571604|FG000|ITP- Treatment Disposition|Other|50|||
125257737|NCT00725985|450571605|FG001|ITP- Treatment Disposition|Other|38|||
125257738|NCT00725985|450571606|FG002|ITP- Treatment Disposition|Other|24|||
125257739|NCT00725985|450571607|FG003|ITP- Treatment Disposition|Other|0|||
125257740|NCT00725985|450571608|FG004|ITP- Treatment Disposition|Other|0|||
125257741|NCT00725985|450571609|FG005|ITP- Treatment Disposition|Other|0|||
125257742|NCT00725985|450571610|FG006|ITP- Treatment Disposition|Other|0|||
125257743|NCT00725985|450571611|FG007|ITP- Treatment Disposition|Other|0|||
125257744|NCT00725985|450571612|FG008|ITP- Treatment Disposition|Other|0|||
125257745|NCT00725985|450571613|FG009|ITP- Treatment Disposition|Other|0|||
125257746|NCT00725985|450571614|FG010|ITP- Treatment Disposition|Other|0|||
125257747|NCT00725985|450571615|FG011|ITP- Treatment Disposition|Other|0|||
125257748|NCT00725985|450571604|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257749|NCT00725985|450571605|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257750|NCT00725985|450571606|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257751|NCT00725985|450571607|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
125257752|NCT00725985|450571608|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
125257753|NCT00725985|450571609|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
125257754|NCT00725985|450571610|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257755|NCT00725985|450571611|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257756|NCT00725985|450571612|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257757|NCT00725985|450571613|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257758|NCT00725985|450571614|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257759|NCT00725985|450571615|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
125257760|NCT00725985|450571604|FG000|OLMP (Up to 96 Weeks)|Death|0|||
125257761|NCT00725985|450571605|FG001|OLMP (Up to 96 Weeks)|Death|0|||
125257762|NCT00725985|450571606|FG002|OLMP (Up to 96 Weeks)|Death|0|||
125257763|NCT00725985|450571607|FG003|OLMP (Up to 96 Weeks)|Death|0|||
125257764|NCT00725985|450571608|FG004|OLMP (Up to 96 Weeks)|Death|1|||
125257765|NCT00725985|450571609|FG005|OLMP (Up to 96 Weeks)|Death|0|||
125257766|NCT00725985|450571610|FG006|OLMP (Up to 96 Weeks)|Death|0|||
125257767|NCT00725985|450571611|FG007|OLMP (Up to 96 Weeks)|Death|0|||
125257768|NCT00725985|450571612|FG008|OLMP (Up to 96 Weeks)|Death|0|||
125257769|NCT00725985|450571613|FG009|OLMP (Up to 96 Weeks)|Death|0|||
125257770|NCT00725985|450571614|FG010|OLMP (Up to 96 Weeks)|Death|0|||
125257771|NCT00725985|450571615|FG011|OLMP (Up to 96 Weeks)|Death|0|||
125257772|NCT00725985|450571604|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257773|NCT00725985|450571605|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257774|NCT00725985|450571606|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257775|NCT00725985|450571607|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
125257776|NCT00725985|450571608|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257777|NCT00725985|450571609|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257778|NCT00725985|450571610|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257779|NCT00725985|450571611|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257780|NCT00725985|450571612|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257781|NCT00725985|450571613|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257782|NCT00725985|450571614|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257783|NCT00725985|450571615|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
125257784|NCT00725985|450571604|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257785|NCT00725985|450571605|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257786|NCT00725985|450571606|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257787|NCT00725985|450571607|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257788|NCT00725985|450571608|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257789|NCT00725985|450571609|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
125257790|NCT00725985|450571610|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257791|NCT00725985|450571611|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257792|NCT00725985|450571612|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257793|NCT00725985|450571613|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257794|NCT00725985|450571614|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257795|NCT00725985|450571615|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
125257796|NCT00725985|450571604|FG000|OLMP (Up to 96 Weeks)|Other|0|||
125257797|NCT00725985|450571605|FG001|OLMP (Up to 96 Weeks)|Other|0|||
125257798|NCT00725985|450571606|FG002|OLMP (Up to 96 Weeks)|Other|0|||
125257799|NCT00725985|450571607|FG003|OLMP (Up to 96 Weeks)|Other|15|||
125257800|NCT00725985|450571608|FG004|OLMP (Up to 96 Weeks)|Other|20|||
125257801|NCT00725985|450571609|FG005|OLMP (Up to 96 Weeks)|Other|44|||
125257802|NCT00725985|450571610|FG006|OLMP (Up to 96 Weeks)|Other|0|||
125257803|NCT00725985|450571611|FG007|OLMP (Up to 96 Weeks)|Other|0|||
125257804|NCT00725985|450571612|FG008|OLMP (Up to 96 Weeks)|Other|0|||
125257805|NCT00725985|450571613|FG009|OLMP (Up to 96 Weeks)|Other|0|||
125257806|NCT00725985|450571614|FG010|OLMP (Up to 96 Weeks)|Other|0|||
125257807|NCT00725985|450571615|FG011|OLMP (Up to 96 Weeks)|Other|0|||
125257808|NCT00725985|450571604|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125445197|NCT02718417|451255791|FG000|Long-term Follow-up Phase|Other|0|||
125445198|NCT02718417|451255792|FG001|Long-term Follow-up Phase|Other|2|||
125445199|NCT02718417|451255793|FG002|Long-term Follow-up Phase|Other|0|||
125445200|NCT04006366|451255794|FG000|Overall Study|Withdrawal by Subject|1|||
125445201|NCT01440049|451255798|FG000|Overall Study|Adverse Event|5|||
125445202|NCT02268552|451255799|FG000|Part 1|Death|1|||
125445203|NCT02268552|451255800|FG001|Part 1|Death|1|||
125445204|NCT02268552|451255801|FG002|Part 1|Death|1|||
125445205|NCT02268552|451255802|FG003|Part 1|Death|2|||
125445206|NCT02268552|451255803|FG004|Part 1|Death|0|||
125445207|NCT02268552|451255804|FG005|Part 1|Death|0|||
125445208|NCT02268552|451255805|FG006|Part 1|Death|0|||
125445209|NCT02268552|451255799|FG000|Part 1|Subject/guardian decision|0|||
125445210|NCT02268552|451255800|FG001|Part 1|Subject/guardian decision|0|||
125445211|NCT02268552|451255801|FG002|Part 1|Subject/guardian decision|0|||
125445212|NCT02268552|451255802|FG003|Part 1|Subject/guardian decision|1|||
125445213|NCT02268552|451255803|FG004|Part 1|Subject/guardian decision|0|||
125445214|NCT02268552|451255804|FG005|Part 1|Subject/guardian decision|0|||
125445215|NCT02268552|451255805|FG006|Part 1|Subject/guardian decision|0|||
125445216|NCT02268552|451255799|FG000|Part 2|Death|0|||
125445217|NCT02268552|451255800|FG001|Part 2|Death|0|||
125445218|NCT02268552|451255801|FG002|Part 2|Death|0|||
125445219|NCT02268552|451255802|FG003|Part 2|Death|0|||
125445220|NCT02268552|451255803|FG004|Part 2|Death|0|||
125445221|NCT02268552|451255804|FG005|Part 2|Death|0|||
125445222|NCT02268552|451255805|FG006|Part 2|Death|2|||
125445223|NCT02268552|451255799|FG000|Part 2|Subject/guardian decision|0|||
125445224|NCT02268552|451255800|FG001|Part 2|Subject/guardian decision|0|||
125445225|NCT02268552|451255801|FG002|Part 2|Subject/guardian decision|0|||
125445226|NCT02268552|451255802|FG003|Part 2|Subject/guardian decision|0|||
125445227|NCT02268552|451255803|FG004|Part 2|Subject/guardian decision|0|||
125445228|NCT02268552|451255804|FG005|Part 2|Subject/guardian decision|0|||
125445229|NCT02268552|451255805|FG006|Part 2|Subject/guardian decision|1|||
125445230|NCT02268552|451255799|FG000|Part 3 Extension|Death|0|||
125445231|NCT02268552|451255800|FG001|Part 3 Extension|Death|1|||
125445232|NCT02268552|451255801|FG002|Part 3 Extension|Death|1|||
125445233|NCT02268552|451255802|FG003|Part 3 Extension|Death|1|||
125445234|NCT02268552|451255803|FG004|Part 3 Extension|Death|1|||
125445235|NCT02268552|451255804|FG005|Part 3 Extension|Death|1|||
125445236|NCT02268552|451255805|FG006|Part 3 Extension|Death|0|||
125445237|NCT02268552|451255799|FG000|Part 3 Extension|Early termination of trial|1|||
125445238|NCT02268552|451255800|FG001|Part 3 Extension|Early termination of trial|0|||
125445239|NCT02268552|451255801|FG002|Part 3 Extension|Early termination of trial|0|||
125445240|NCT02268552|451255802|FG003|Part 3 Extension|Early termination of trial|0|||
125445241|NCT02268552|451255803|FG004|Part 3 Extension|Early termination of trial|2|||
125445242|NCT02268552|451255804|FG005|Part 3 Extension|Early termination of trial|9|||
125445243|NCT02268552|451255805|FG006|Part 3 Extension|Early termination of trial|11|||
125445244|NCT02268552|451255799|FG000|Part 3 Extension|Subject/guardian decision|0|||
125445245|NCT02268552|451255800|FG001|Part 3 Extension|Subject/guardian decision|0|||
125445246|NCT02268552|451255801|FG002|Part 3 Extension|Subject/guardian decision|0|||
125445247|NCT02268552|451255802|FG003|Part 3 Extension|Subject/guardian decision|0|||
125445248|NCT02268552|451255803|FG004|Part 3 Extension|Subject/guardian decision|0|||
125445249|NCT02268552|451255804|FG005|Part 3 Extension|Subject/guardian decision|0|||
125445250|NCT02268552|451255805|FG006|Part 3 Extension|Subject/guardian decision|1|||
125445251|NCT00997243|451255806|FG000|Overall Study|Early termination of study by sponsor|7|||
125445252|NCT03415022|451255811|FG000|Overall Study|Withdrawal by Subject|1|||
125445253|NCT03415022|451255812|FG001|Overall Study|Withdrawal by Subject|2|||
125445254|NCT03415022|451255811|FG000|Overall Study|COVID-19 Suspension|2|||
125445255|NCT03415022|451255812|FG001|Overall Study|COVID-19 Suspension|3|||
125445256|NCT03415022|451255811|FG000|Overall Study|Lost to Follow-up|2|||
125445257|NCT03415022|451255812|FG001|Overall Study|Lost to Follow-up|0|||
125257809|NCT00725985|450571605|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257810|NCT00725985|450571606|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257811|NCT00725985|450571607|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125445258|NCT04466618|451255813|FG000|Overall Study|Withdrawal by Subject|0|||
125445259|NCT04466618|451255814|FG001|Overall Study|Withdrawal by Subject|1|||
125445260|NCT00280293|451255820|FG000|Overall Study|Protocol Violation|3|||
125445261|NCT00280293|451255821|FG001|Overall Study|Protocol Violation|0|||
125445262|NCT00280293|451255820|FG000|Overall Study|Physician Decision|5|||
125445263|NCT00280293|451255821|FG001|Overall Study|Physician Decision|4|||
125445264|NCT00280293|451255820|FG000|Overall Study|Lost to Follow-up|14|||
125445265|NCT00280293|451255821|FG001|Overall Study|Lost to Follow-up|12|||
125445266|NCT00280293|451255820|FG000|Overall Study|Withdrawal by Subject|3|||
125445267|NCT00280293|451255821|FG001|Overall Study|Withdrawal by Subject|5|||
125445268|NCT00280293|451255820|FG000|Overall Study|Incarceration/Legal Reasons|1|||
125445269|NCT00280293|451255821|FG001|Overall Study|Incarceration/Legal Reasons|1|||
125445270|NCT00280293|451255820|FG000|Overall Study|Adverse Event|0|||
125445271|NCT00280293|451255821|FG001|Overall Study|Adverse Event|1|||
125445272|NCT01458249|451255826|FG000|Overall Study|Not treated|1|||
125445273|NCT01458249|451255826|FG000|Overall Study|Adverse Event|4|||
125397417|NCT04300296|451089183|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
125397418|NCT04300296|451089178|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
125397419|NCT04300296|451089179|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
125397420|NCT04300296|451089180|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
125397421|NCT04300296|451089181|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
125397422|NCT04300296|451089182|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
125397423|NCT04300296|451089183|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
125397424|NCT04300296|451089178|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
125397425|NCT04300296|451089179|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
125397426|NCT04300296|451089180|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
125397427|NCT04300296|451089181|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
125397428|NCT04300296|451089182|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
125397429|NCT04300296|451089183|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
125397430|NCT04300296|451089178|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
125397431|NCT04300296|451089179|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
125397432|NCT04300296|451089180|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
125397433|NCT04300296|451089181|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
125397434|NCT04300296|451089182|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
125397435|NCT04300296|451089183|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
125397436|NCT04300296|451089178|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
125397437|NCT04300296|451089179|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
125397438|NCT04300296|451089180|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
125397439|NCT04300296|451089181|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
125397440|NCT04300296|451089182|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
125397441|NCT04300296|451089183|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
125397442|NCT04300296|451089178|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
125397443|NCT04300296|451089179|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
125397444|NCT04300296|451089180|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
125397445|NCT04300296|451089181|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
125397446|NCT04300296|451089182|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
125397447|NCT04300296|451089183|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
125397448|NCT03325166|451089184|FG000|Overall Study|Adverse Event|1|||
125397449|NCT01633944|451089185|FG000|Open-label Titration Phase|Adverse Event|109|||
125397450|NCT01633944|451089186|FG001|Open-label Titration Phase|Adverse Event|0|||
125397451|NCT01633944|451089187|FG002|Open-label Titration Phase|Adverse Event|0|||
125397452|NCT01633944|451089185|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
125397453|NCT01633944|451089186|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
125397454|NCT01633944|451089187|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
125397455|NCT01633944|451089185|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
125397456|NCT01633944|451089186|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
125397457|NCT01633944|451089187|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
125397458|NCT01633944|451089185|FG000|Open-label Titration Phase|Protocol Violation|24|||
125397459|NCT01633944|451089186|FG001|Open-label Titration Phase|Protocol Violation|0|||
125397460|NCT01633944|451089187|FG002|Open-label Titration Phase|Protocol Violation|0|||
125397461|NCT01633944|451089185|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
125397462|NCT01633944|451089186|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
125397463|NCT01633944|451089187|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
125397464|NCT01633944|451089185|FG000|Open-label Titration Phase|Other|68|||
125397465|NCT01633944|451089186|FG001|Open-label Titration Phase|Other|0|||
125397466|NCT01633944|451089187|FG002|Open-label Titration Phase|Other|0|||
125397467|NCT01633944|451089185|FG000|Double-blind Treatment Phase|Adverse Event|0|||
125397468|NCT01633944|451089186|FG001|Double-blind Treatment Phase|Adverse Event|13|||
125397469|NCT01633944|451089187|FG002|Double-blind Treatment Phase|Adverse Event|7|||
125397470|NCT01633944|451089185|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
125397471|NCT01633944|451089186|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
125397472|NCT01633944|451089187|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
125397473|NCT01633944|451089185|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
125397474|NCT01633944|451089186|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
125397475|NCT01633944|451089187|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
125397476|NCT01633944|451089185|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
125397477|NCT01633944|451089186|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
125397478|NCT01633944|451089187|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
125397479|NCT01633944|451089185|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
125397480|NCT01633944|451089186|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
125397481|NCT01633944|451089187|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
125397482|NCT01633944|451089185|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
125397483|NCT01633944|451089186|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
125257812|NCT00725985|450571608|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257813|NCT00725985|450571609|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257814|NCT00725985|450571610|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257815|NCT00725985|450571611|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
125257816|NCT00725985|450571612|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257817|NCT00725985|450571613|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257818|NCT00725985|450571614|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257819|NCT00725985|450571615|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
125257820|NCT00725985|450571604|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257821|NCT00725985|450571605|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257822|NCT00725985|450571606|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257823|NCT00725985|450571607|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257824|NCT00725985|450571608|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257825|NCT00725985|450571609|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257826|NCT00725985|450571610|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257827|NCT00725985|450571611|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257828|NCT00725985|450571612|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
125257829|NCT00725985|450571613|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257830|NCT00725985|450571614|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257831|NCT00725985|450571615|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
125257832|NCT00725985|450571604|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257833|NCT00725985|450571605|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257834|NCT00725985|450571606|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257835|NCT00725985|450571607|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257836|NCT00725985|450571608|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257837|NCT00725985|450571609|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257838|NCT00725985|450571610|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
125257839|NCT00725985|450571611|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
125257840|NCT00725985|450571612|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
125257841|NCT00725985|450571613|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257842|NCT00725985|450571614|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257843|NCT00725985|450571615|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
125257844|NCT00725985|450571604|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257845|NCT00725985|450571605|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257846|NCT00725985|450571606|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257847|NCT00725985|450571607|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257848|NCT00725985|450571608|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257849|NCT00725985|450571609|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257850|NCT00725985|450571610|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257851|NCT00725985|450571611|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257852|NCT00725985|450571612|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
125257853|NCT00725985|450571613|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
125257854|NCT00725985|450571614|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
125257855|NCT00725985|450571615|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
125257856|NCT04476784|450571616|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
125257857|NCT04476784|450571617|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
125257858|NCT00863304|450571618|FG000|Overall Study|Adverse Event|10|||
125257859|NCT00863304|450571619|FG001|Overall Study|Adverse Event|4|||
125257860|NCT00863304|450571620|FG002|Overall Study|Adverse Event|14|||
125257861|NCT00863304|450571621|FG003|Overall Study|Adverse Event|16|||
125257862|NCT00863304|450571618|FG000|Overall Study|Lost to Follow-up|1|||
125257863|NCT00863304|450571619|FG001|Overall Study|Lost to Follow-up|5|||
125257864|NCT00863304|450571620|FG002|Overall Study|Lost to Follow-up|4|||
125257865|NCT00863304|450571621|FG003|Overall Study|Lost to Follow-up|2|||
125257866|NCT00863304|450571618|FG000|Overall Study|Lack of Efficacy|57|||
125257867|NCT00863304|450571619|FG001|Overall Study|Lack of Efficacy|26|||
125257868|NCT00863304|450571620|FG002|Overall Study|Lack of Efficacy|30|||
125257869|NCT00863304|450571621|FG003|Overall Study|Lack of Efficacy|28|||
125257870|NCT00863304|450571618|FG000|Overall Study|Withdrawal by Subject|19|||
125257871|NCT00863304|450571619|FG001|Overall Study|Withdrawal by Subject|14|||
125257872|NCT00863304|450571620|FG002|Overall Study|Withdrawal by Subject|20|||
125257873|NCT00863304|450571621|FG003|Overall Study|Withdrawal by Subject|18|||
125257874|NCT00863304|450571618|FG000|Overall Study|Other|1|||
125257875|NCT00863304|450571619|FG001|Overall Study|Other|0|||
125257876|NCT00863304|450571620|FG002|Overall Study|Other|0|||
125257877|NCT00863304|450571621|FG003|Overall Study|Other|1|||
125257878|NCT00863304|450571618|FG000|Overall Study|Protocol Violation|2|||
125257879|NCT00863304|450571619|FG001|Overall Study|Protocol Violation|6|||
125257880|NCT00863304|450571620|FG002|Overall Study|Protocol Violation|2|||
125257881|NCT00863304|450571621|FG003|Overall Study|Protocol Violation|0|||
125257882|NCT00863304|450571618|FG000|Overall Study|Randomized, but not Treated|3|||
125257883|NCT00863304|450571619|FG001|Overall Study|Randomized, but not Treated|1|||
125257884|NCT00863304|450571620|FG002|Overall Study|Randomized, but not Treated|4|||
125445274|NCT01458249|451255826|FG000|Overall Study|Other|2|||
125445275|NCT01458249|451255826|FG000|Overall Study|Ongoing|1|||
125445276|NCT02056119|451255829|FG000|Overall Study|Death|1|||
125445277|NCT02056119|451255830|FG001|Overall Study|Death|2|||
125445278|NCT02056119|451255829|FG000|Overall Study|Intubated for less than 24 hrs|2|||
125445279|NCT02056119|451255830|FG001|Overall Study|Intubated for less than 24 hrs|7|||
125445280|NCT02056119|451255829|FG000|Overall Study|No aerosol treatments were given.|3|||
125445281|NCT02056119|451255830|FG001|Overall Study|No aerosol treatments were given.|2|||
125445282|NCT02056119|451255829|FG000|Overall Study|Received Metaneb treatment|0|||
125445283|NCT02056119|451255830|FG001|Overall Study|Received Metaneb treatment|2|||
125445284|NCT02056119|451255829|FG000|Overall Study|Protocol Violation|4|||
125445285|NCT02056119|451255830|FG001|Overall Study|Protocol Violation|7|||
125445286|NCT01348854|451255831|FG000|Overall Study|Lost to Follow-up|2|||
125445287|NCT01348854|451255832|FG001|Overall Study|Lost to Follow-up|1|||
125445288|NCT01348854|451255831|FG000|Overall Study|Withdrawal by Subject|1|||
125445289|NCT01348854|451255832|FG001|Overall Study|Withdrawal by Subject|0|||
125445290|NCT03220737|451255833|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
125445291|NCT03220737|451255834|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
125445292|NCT03220737|451255835|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
125445293|NCT03220737|451255836|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
125445294|NCT03220737|451255837|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
125445295|NCT03220737|451255838|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
125445296|NCT03220737|451255839|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
125445297|NCT03220737|451255833|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
125445298|NCT03220737|451255834|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
125445299|NCT03220737|451255835|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
125445300|NCT03220737|451255836|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
125445301|NCT03220737|451255837|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
125445302|NCT03220737|451255838|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
125445303|NCT03220737|451255839|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
125445304|NCT03220737|451255833|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
125445305|NCT03220737|451255834|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
125445306|NCT03220737|451255835|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
125445307|NCT03220737|451255836|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
125445308|NCT03220737|451255837|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
125445309|NCT03220737|451255838|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
125445310|NCT03220737|451255839|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
125445311|NCT03220737|451255833|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
125445312|NCT03220737|451255834|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
125445313|NCT03220737|451255835|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
125445314|NCT03220737|451255836|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
125445315|NCT03220737|451255837|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
125445316|NCT03220737|451255838|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
125445317|NCT03220737|451255839|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
125445318|NCT03220737|451255833|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125445319|NCT03220737|451255834|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125445320|NCT03220737|451255835|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125445321|NCT03220737|451255836|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125445322|NCT03220737|451255837|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
125445323|NCT03220737|451255838|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125445324|NCT03220737|451255839|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
125445325|NCT03220737|451255833|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
125445326|NCT03220737|451255834|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
125445327|NCT03220737|451255835|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
125445328|NCT03220737|451255836|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
125445329|NCT03220737|451255837|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
125445330|NCT03220737|451255838|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
125445331|NCT03220737|451255839|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
125445332|NCT03220737|451255833|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
125445333|NCT03220737|451255834|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
125445334|NCT03220737|451255835|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
125445335|NCT03220737|451255836|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
125445336|NCT03220737|451255837|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
125445337|NCT03220737|451255838|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
125445338|NCT03220737|451255839|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
125445339|NCT03220737|451255833|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
125445340|NCT03220737|451255834|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
125445341|NCT03220737|451255835|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
125445342|NCT03220737|451255836|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
125445343|NCT03220737|451255837|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
125445344|NCT03220737|451255838|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
125445345|NCT03220737|451255839|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
125445346|NCT01720797|451255840|FG000|Overall Study|Withdrawal by Subject|3|||
125445347|NCT01720797|451255841|FG001|Overall Study|Withdrawal by Subject|0|||
125445348|NCT04011384|451255848|FG000|Overall Study|Withdrawal by Subject|2|||
125445349|NCT04011384|451255849|FG001|Overall Study|Withdrawal by Subject|0|||
125445350|NCT00594932|451255851|FG000|First 3 Months|Withdrawal by Subject|1|||
125445351|NCT00594932|451255852|FG001|First 3 Months|Withdrawal by Subject|3|||
125445352|NCT00594932|451255851|FG000|Final 3 Months|Withdrawal by Subject|4|||
125445353|NCT00594932|451255852|FG001|Final 3 Months|Withdrawal by Subject|3|||
125445354|NCT01094171|451255853|FG000|Overall Study|Lost to Follow-up|2|||
125445355|NCT01094171|451255853|FG000|Overall Study|Informed consent withdrawal|4|||
125445356|NCT01094171|451255853|FG000|Overall Study|Migration from the study area|3|||
125445357|NCT01094171|451255853|FG000|Overall Study|Other|1|||
125445358|NCT01676220|451255854|FG000|Overall Study|Randomized But Not Treated|4|||
125445359|NCT01676220|451255855|FG001|Overall Study|Randomized But Not Treated|1|||
125445360|NCT01676220|451255854|FG000|Overall Study|Adverse Event|10|||
125445361|NCT01676220|451255855|FG001|Overall Study|Adverse Event|8|||
125445362|NCT01676220|451255854|FG000|Overall Study|Lack of Efficacy|2|||
125445363|NCT01676220|451255855|FG001|Overall Study|Lack of Efficacy|5|||
125445364|NCT01676220|451255854|FG000|Overall Study|Protocol Violation|11|||
125445365|NCT01676220|451255855|FG001|Overall Study|Protocol Violation|12|||
125445366|NCT01676220|451255854|FG000|Overall Study|Received Rescue Therapy|14|||
125445367|NCT01676220|451255855|FG001|Overall Study|Received Rescue Therapy|22|||
125445368|NCT01676220|451255854|FG000|Overall Study|Personal Reason|34|||
125445369|NCT01676220|451255855|FG001|Overall Study|Personal Reason|45|||
125445370|NCT01676220|451255854|FG000|Overall Study|Lost to Follow-up|11|||
125445371|NCT01676220|451255855|FG001|Overall Study|Lost to Follow-up|18|||
125397484|NCT01633944|451089187|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
125397485|NCT01633944|451089185|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
125397486|NCT01633944|451089186|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
125397487|NCT01633944|451089187|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
125397488|NCT01633944|451089185|FG000|Double-blind Treatment Phase|Other|0|||
125397489|NCT01633944|451089186|FG001|Double-blind Treatment Phase|Other|7|||
125397490|NCT01633944|451089187|FG002|Double-blind Treatment Phase|Other|0|||
125397491|NCT00701129|451089189|FG000|Overall Study|Death|2|||
125397492|NCT02412631|451089192|FG000|Overall Study|Adverse Event|1|||
125397493|NCT02412631|451089193|FG001|Overall Study|Adverse Event|2|||
125397494|NCT02412631|451089192|FG000|Overall Study|Lost to Follow-up|5|||
125397495|NCT02412631|451089193|FG001|Overall Study|Lost to Follow-up|9|||
125397496|NCT02412631|451089192|FG000|Overall Study|Withdrawal by Subject|9|||
125397497|NCT02412631|451089193|FG001|Overall Study|Withdrawal by Subject|3|||
125397498|NCT02412631|451089192|FG000|Overall Study|Early stop by FDA|5|||
125397499|NCT02412631|451089193|FG001|Overall Study|Early stop by FDA|2|||
125397500|NCT02412631|451089192|FG000|Overall Study|Unspecified reason|6|||
125397501|NCT02412631|451089193|FG001|Overall Study|Unspecified reason|8|||
125397502|NCT00958776|451089194|FG000|Overall Study|Adverse Event|0|||
125397503|NCT00958776|451089195|FG001|Overall Study|Adverse Event|1|||
125397504|NCT00958776|451089194|FG000|Overall Study|Physician Decision|1|||
125397505|NCT00958776|451089195|FG001|Overall Study|Physician Decision|0|||
125397506|NCT00958776|451089194|FG000|Overall Study|Lost to Follow-up|2|||
125397507|NCT00958776|451089195|FG001|Overall Study|Lost to Follow-up|6|||
125397508|NCT00958776|451089194|FG000|Overall Study|Withdrawal by Subject|7|||
125397509|NCT00958776|451089195|FG001|Overall Study|Withdrawal by Subject|16|||
125397510|NCT00958776|451089194|FG000|Overall Study|Protocol Violation|1|||
125397511|NCT00958776|451089195|FG001|Overall Study|Protocol Violation|1|||
125397512|NCT00958776|451089194|FG000|Overall Study|Death|2|||
125397513|NCT00958776|451089195|FG001|Overall Study|Death|1|||
125397514|NCT00958776|451089194|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
125397515|NCT00958776|451089195|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
125397516|NCT00958776|451089194|FG000|Overall Study|Missing|1|||
125397517|NCT00958776|451089195|FG001|Overall Study|Missing|1|||
125397518|NCT00976898|451089205|FG000|Overall Study|Protocol Violation|1|||
125397519|NCT00976898|451089205|FG000|Overall Study|Adverse Event|1|||
125397520|NCT00976898|451089205|FG000|Overall Study|Physician Decision|1|||
125397521|NCT00976898|451089205|FG000|Overall Study|Liver Transplant|1|||
125397522|NCT00976898|451089205|FG000|Overall Study|Progressive Disease|1|||
125397523|NCT05107128|451089206|FG000|Overall Study|Adverse Event|2|||
125445372|NCT01676220|451255854|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
125397524|NCT05107128|451089207|FG001|Overall Study|Adverse Event|0|||
125445373|NCT01676220|451255855|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
125445374|NCT01676220|451255854|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
125445375|NCT01676220|451255855|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
125397525|NCT05107128|451089206|FG000|Overall Study|Withdrawal by Subject|3|||
125397526|NCT05107128|451089207|FG001|Overall Study|Withdrawal by Subject|3|||
125445376|NCT01676220|451255854|FG000|Overall Study|Perceived Lack of Efficacy|3|||
125445377|NCT01676220|451255855|FG001|Overall Study|Perceived Lack of Efficacy|1|||
125445378|NCT01676220|451255854|FG000|Overall Study|Non Serious Hypoglycemia|2|||
125445379|NCT01676220|451255855|FG001|Overall Study|Non Serious Hypoglycemia|0|||
125445380|NCT01676220|451255854|FG000|Overall Study|No More Need of Insulin|1|||
125445381|NCT01676220|451255855|FG001|Overall Study|No More Need of Insulin|0|||
125445382|NCT04496167|451255856|FG000|Overall Study|Adverse Event|6|||
125445383|NCT04496167|451255857|FG001|Overall Study|Adverse Event|2|||
125445384|NCT04496167|451255856|FG000|Overall Study|Withdrawal by Subject|7|||
125445385|NCT04496167|451255857|FG001|Overall Study|Withdrawal by Subject|6|||
125445386|NCT04496167|451255856|FG000|Overall Study|Lost to Follow-up|3|||
125445387|NCT04496167|451255857|FG001|Overall Study|Lost to Follow-up|5|||
125445388|NCT04496167|451255856|FG000|Overall Study|Not Treated|1|||
125445389|NCT04496167|451255857|FG001|Overall Study|Not Treated|2|||
125445390|NCT04496167|451255856|FG000|Overall Study|Other Than Specified|1|||
125445391|NCT04496167|451255857|FG001|Overall Study|Other Than Specified|1|||
125445392|NCT02269943|451255858|FG000|Treatment Period|Death|0|||
125445393|NCT02269943|451255859|FG001|Treatment Period|Death|1|||
125445394|NCT02269943|451255858|FG000|Treatment Period|Adverse Event|1|||
125445395|NCT02269943|451255859|FG001|Treatment Period|Adverse Event|10|||
125445396|NCT02269943|451255858|FG000|Treatment Period|Progressive Disease|5|||
125445397|NCT02269943|451255859|FG001|Treatment Period|Progressive Disease|17|||
125445398|NCT02269943|451255858|FG000|Treatment Period|Symptomatic Deterioration|0|||
125445399|NCT02269943|451255859|FG001|Treatment Period|Symptomatic Deterioration|2|||
125445400|NCT02269943|451255858|FG000|Follow-Up Survival Period|Death|3|||
125445401|NCT02269943|451255859|FG001|Follow-Up Survival Period|Death|16|||
125445402|NCT02269943|451255858|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
125445403|NCT02269943|451255859|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
125445404|NCT02269943|451255858|FG000|Follow-Up Survival Period|Alive|2|||
125445405|NCT02269943|451255859|FG001|Follow-Up Survival Period|Alive|8|||
125445406|NCT03541642|451255860|FG000|Overall Study|Withdrawal by Subject|1|||
125445407|NCT03541642|451255861|FG001|Overall Study|Withdrawal by Subject|2|||
125445408|NCT03541642|451255860|FG000|Overall Study|Lost to Follow-up|16|||
125445409|NCT03541642|451255861|FG001|Overall Study|Lost to Follow-up|12|||
125445410|NCT03541642|451255860|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
125445411|NCT03541642|451255861|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
125445412|NCT01083160|451255866|FG000|Overall Study|Adverse Event|1|||
125445413|NCT01951092|451255869|FG000|Overall Study|Lost to Follow-up|10|||
125445414|NCT01951092|451255869|FG000|Overall Study|Incarceration|1|||
125445415|NCT01951092|451255869|FG000|Overall Study|Transfer of Care|1|||
125445416|NCT00918749|451255870|FG000|Overall Study|Adverse Event|1|||
125257885|NCT00863304|450571621|FG003|Overall Study|Randomized, but not Treated|1|||
125257886|NCT00863304|450571618|FG000|Overall Study|Entered extension study|101|||
125257887|NCT00863304|450571619|FG001|Overall Study|Entered extension study|129|||
125445417|NCT00918749|451255871|FG001|Overall Study|Adverse Event|0|||
125445418|NCT00918749|451255872|FG002|Overall Study|Adverse Event|1|||
125445419|NCT00918749|451255870|FG000|Overall Study|Lost to Follow-up|0|||
125445420|NCT00918749|451255871|FG001|Overall Study|Lost to Follow-up|0|||
125445421|NCT00918749|451255872|FG002|Overall Study|Lost to Follow-up|1|||
125445422|NCT00918749|451255870|FG000|Overall Study|Withdrawal by Subject|5|||
125445423|NCT00918749|451255871|FG001|Overall Study|Withdrawal by Subject|3|||
125445424|NCT00918749|451255872|FG002|Overall Study|Withdrawal by Subject|5|||
125445425|NCT00918749|451255870|FG000|Overall Study|No Study Medication Taken|1|||
125445426|NCT00918749|451255871|FG001|Overall Study|No Study Medication Taken|0|||
125445427|NCT00918749|451255872|FG002|Overall Study|No Study Medication Taken|0|||
125445428|NCT01712789|451255873|FG000|Overall Study|Lack of Efficacy|2|||
125445429|NCT01712789|451255873|FG000|Overall Study|Lost to Follow-up|1|||
125445430|NCT01712789|451255873|FG000|Overall Study|Progressive Disease|504|||
125445431|NCT01712789|451255873|FG000|Overall Study|Death|57|||
125445432|NCT01712789|451255873|FG000|Overall Study|Adverse Event|52|||
125445433|NCT01712789|451255873|FG000|Overall Study|Miscellaneous|31|||
125445434|NCT01712789|451255873|FG000|Overall Study|Withdrawal by Subject|21|||
125445435|NCT01712789|451255873|FG000|Overall Study|Transition to Commercial Treatment|8|||
125445436|NCT01712789|451255873|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
125445437|NCT00873093|451255874|FG000|Overall Study|Adverse Event|0|||
125445438|NCT00873093|451255875|FG001|Overall Study|Adverse Event|2|||
125257888|NCT00863304|450571620|FG002|Overall Study|Entered extension study|113|||
125257889|NCT00863304|450571621|FG003|Overall Study|Entered extension study|125|||
125257890|NCT06582732|450571622|FG000|Initial Study Period|Adverse Event|0|||
125257891|NCT06582732|450571623|FG001|Initial Study Period|Adverse Event|0|||
125445439|NCT00873093|451255876|FG002|Overall Study|Adverse Event|0|||
125445440|NCT00873093|451255877|FG003|Overall Study|Adverse Event|0|||
125445441|NCT00873093|451255878|FG004|Overall Study|Adverse Event|0|||
125445442|NCT00873093|451255874|FG000|Overall Study|Death|0|||
125445443|NCT00873093|451255875|FG001|Overall Study|Death|3|||
125445444|NCT00873093|451255876|FG002|Overall Study|Death|2|||
125445445|NCT00873093|451255877|FG003|Overall Study|Death|0|||
125445446|NCT00873093|451255878|FG004|Overall Study|Death|0|||
125445447|NCT00873093|451255874|FG000|Overall Study|Physician Decision|0|||
125445448|NCT00873093|451255875|FG001|Overall Study|Physician Decision|17|||
125445449|NCT00873093|451255876|FG002|Overall Study|Physician Decision|10|||
125445450|NCT00873093|451255877|FG003|Overall Study|Physician Decision|10|||
125445451|NCT00873093|451255878|FG004|Overall Study|Physician Decision|2|||
125445452|NCT00873093|451255874|FG000|Overall Study|Withdrawal by Subject|1|||
125257892|NCT06582732|450571624|FG002|Initial Study Period|Adverse Event|0|||
125257893|NCT06582732|450571625|FG003|Initial Study Period|Adverse Event|2|||
125257894|NCT06582732|450571626|FG004|Initial Study Period|Adverse Event|0|||
125257895|NCT06582732|450571627|FG005|Initial Study Period|Adverse Event|0|||
125257896|NCT06582732|450571628|FG006|Initial Study Period|Adverse Event|0|||
125257897|NCT06582732|450571622|FG000|Initial Study Period|Death|1|||
125257898|NCT06582732|450571623|FG001|Initial Study Period|Death|0|||
125257899|NCT06582732|450571624|FG002|Initial Study Period|Death|0|||
125257900|NCT06582732|450571625|FG003|Initial Study Period|Death|0|||
125257901|NCT06582732|450571626|FG004|Initial Study Period|Death|1|||
125257902|NCT06582732|450571627|FG005|Initial Study Period|Death|0|||
125257903|NCT06582732|450571628|FG006|Initial Study Period|Death|0|||
125257904|NCT06582732|450571622|FG000|Initial Study Period|Lost to Follow-up|0|||
125257905|NCT06582732|450571623|FG001|Initial Study Period|Lost to Follow-up|0|||
125257906|NCT06582732|450571624|FG002|Initial Study Period|Lost to Follow-up|2|||
125257907|NCT06582732|450571625|FG003|Initial Study Period|Lost to Follow-up|0|||
125257908|NCT06582732|450571626|FG004|Initial Study Period|Lost to Follow-up|0|||
125257909|NCT06582732|450571627|FG005|Initial Study Period|Lost to Follow-up|0|||
125257910|NCT06582732|450571628|FG006|Initial Study Period|Lost to Follow-up|0|||
125257911|NCT06582732|450571622|FG000|Initial Study Period|Withdrawal by Subject|0|||
125257912|NCT06582732|450571623|FG001|Initial Study Period|Withdrawal by Subject|1|||
125257913|NCT06582732|450571624|FG002|Initial Study Period|Withdrawal by Subject|0|||
125257914|NCT06582732|450571625|FG003|Initial Study Period|Withdrawal by Subject|1|||
125257915|NCT06582732|450571626|FG004|Initial Study Period|Withdrawal by Subject|3|||
125257916|NCT06582732|450571627|FG005|Initial Study Period|Withdrawal by Subject|1|||
125257917|NCT06582732|450571628|FG006|Initial Study Period|Withdrawal by Subject|2|||
125257918|NCT06582732|450571622|FG000|Initial Study Period|Moved Away|0|||
125257919|NCT06582732|450571623|FG001|Initial Study Period|Moved Away|0|||
125257920|NCT06582732|450571624|FG002|Initial Study Period|Moved Away|0|||
125257921|NCT06582732|450571625|FG003|Initial Study Period|Moved Away|0|||
125257922|NCT06582732|450571626|FG004|Initial Study Period|Moved Away|1|||
125257923|NCT06582732|450571627|FG005|Initial Study Period|Moved Away|0|||
125257924|NCT06582732|450571628|FG006|Initial Study Period|Moved Away|0|||
125257925|NCT02507934|450571629|FG000|Overall Study|Lost to Follow-up|2|||
125257926|NCT02507934|450571630|FG001|Overall Study|Lost to Follow-up|0|||
125257927|NCT02507934|450571629|FG000|Overall Study|Withdrawal by Subject|2|||
125257928|NCT02507934|450571630|FG001|Overall Study|Withdrawal by Subject|0|||
125257929|NCT03528902|450571633|FG000|Overall Study|Adverse Event|1|||
125257930|NCT03528902|450571634|FG001|Overall Study|Adverse Event|0|||
125445453|NCT00873093|451255875|FG001|Overall Study|Withdrawal by Subject|4|||
125445454|NCT00873093|451255876|FG002|Overall Study|Withdrawal by Subject|4|||
125257931|NCT05030766|450571635|FG000|Phase 1 Participants|Lost to Follow-up|12|||
125257932|NCT05030766|450571636|FG001|Phase 1 Participants|Lost to Follow-up|22|||
125257933|NCT05030766|450571637|FG002|Phase 1 Participants|Lost to Follow-up|0|||
125257934|NCT05030766|450571638|FG003|Phase 1 Participants|Lost to Follow-up|0|||
125257935|NCT05030766|450571635|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
125257936|NCT05030766|450571636|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
125257937|NCT05030766|450571637|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
125257938|NCT05030766|450571638|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
125257939|NCT05030766|450571635|FG000|Phase 2 Participants|Lost to Follow-up|0|||
125257940|NCT05030766|450571636|FG001|Phase 2 Participants|Lost to Follow-up|0|||
125257941|NCT05030766|450571637|FG002|Phase 2 Participants|Lost to Follow-up|6|||
125445455|NCT00873093|451255877|FG003|Overall Study|Withdrawal by Subject|0|||
125445456|NCT00873093|451255878|FG004|Overall Study|Withdrawal by Subject|0|||
125445457|NCT00873093|451255874|FG000|Overall Study|Ineligible|0|||
125257942|NCT05030766|450571638|FG003|Phase 2 Participants|Lost to Follow-up|2|||
125257943|NCT00645658|450571639|FG000|Overall Study|Withdrawal by Subject|1|||
125257944|NCT00645658|450571640|FG001|Overall Study|Withdrawal by Subject|0|||
125257945|NCT00645658|450571639|FG000|Overall Study|Did not complete all assesments|0|||
125257946|NCT00645658|450571640|FG001|Overall Study|Did not complete all assesments|2|||
125257947|NCT03605693|450571647|FG000|Overall Study|Lost to Follow-up|4|||
125257948|NCT03605693|450571648|FG001|Overall Study|Lost to Follow-up|0|||
125257949|NCT03605693|450571647|FG000|Overall Study|Physician Decision|1|||
125257950|NCT03605693|450571648|FG001|Overall Study|Physician Decision|0|||
125257951|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
125257952|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
125257953|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
125445458|NCT00873093|451255875|FG001|Overall Study|Ineligible|1|||
125257954|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
125257955|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
125257956|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
125257957|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
125257958|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
125257959|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
125257960|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
125257961|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
125257962|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
125257963|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
125257964|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
125257965|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
125257966|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
125257967|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
125257968|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
125257969|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
125257970|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
125257971|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
125257972|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
125257973|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
125257974|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
125257975|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
125257976|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
125257977|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
125257978|NCT03093415|450571651|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
125257979|NCT03093415|450571652|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
125257980|NCT03093415|450571653|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
125257981|NCT03093415|450571651|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
125257982|NCT03093415|450571652|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
125257983|NCT03093415|450571653|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
125257984|NCT03895372|450571654|FG000|Investigational Treatment Period|Adverse Event|1|||
125257985|NCT03895372|450571655|FG001|Investigational Treatment Period|Adverse Event|0|||
125257986|NCT03895372|450571656|FG002|Investigational Treatment Period|Adverse Event|0|||
125257987|NCT03895372|450571657|FG003|Investigational Treatment Period|Adverse Event|0|||
125257988|NCT03895372|450571658|FG004|Investigational Treatment Period|Adverse Event|0|||
125257989|NCT03895372|450571659|FG005|Investigational Treatment Period|Adverse Event|0|||
125257990|NCT03895372|450571660|FG006|Investigational Treatment Period|Adverse Event|4|||
125257991|NCT03895372|450571661|FG007|Investigational Treatment Period|Adverse Event|3|||
125257992|NCT03895372|450571654|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
125257993|NCT03895372|450571655|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
125257994|NCT03895372|450571656|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
125257995|NCT03895372|450571657|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
125257996|NCT03895372|450571658|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
125257997|NCT03895372|450571659|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
125257998|NCT03895372|450571660|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
125257999|NCT03895372|450571661|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
125258000|NCT03895372|450571654|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
125258001|NCT03895372|450571655|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
125258002|NCT03895372|450571656|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
125258003|NCT03895372|450571657|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
125258004|NCT03895372|450571658|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
125258005|NCT03895372|450571659|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
125258006|NCT03895372|450571660|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
125258007|NCT03895372|450571661|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
125258008|NCT03895372|450571654|FG000|Investigational Treatment Period|Other|0|||
125258009|NCT03895372|450571655|FG001|Investigational Treatment Period|Other|0|||
125258010|NCT03895372|450571656|FG002|Investigational Treatment Period|Other|0|||
125258011|NCT03895372|450571657|FG003|Investigational Treatment Period|Other|0|||
125258012|NCT03895372|450571658|FG004|Investigational Treatment Period|Other|0|||
125258013|NCT03895372|450571659|FG005|Investigational Treatment Period|Other|1|||
125258014|NCT03895372|450571660|FG006|Investigational Treatment Period|Other|0|||
125258015|NCT03895372|450571661|FG007|Investigational Treatment Period|Other|2|||
125258016|NCT03895372|450571654|FG000|Investigational Treatment Period|Protocol Violation|0|||
125258017|NCT03895372|450571655|FG001|Investigational Treatment Period|Protocol Violation|0|||
125258018|NCT03895372|450571656|FG002|Investigational Treatment Period|Protocol Violation|0|||
125258019|NCT03895372|450571657|FG003|Investigational Treatment Period|Protocol Violation|1|||
125258020|NCT03895372|450571658|FG004|Investigational Treatment Period|Protocol Violation|0|||
125258021|NCT03895372|450571659|FG005|Investigational Treatment Period|Protocol Violation|0|||
125258022|NCT03895372|450571660|FG006|Investigational Treatment Period|Protocol Violation|0|||
125258023|NCT03895372|450571661|FG007|Investigational Treatment Period|Protocol Violation|0|||
125258024|NCT03895372|450571654|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
125258025|NCT03895372|450571655|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
125258026|NCT03895372|450571656|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
125258027|NCT03895372|450571657|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
125258028|NCT03895372|450571658|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
125258029|NCT03895372|450571659|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
125258030|NCT03895372|450571660|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
125258031|NCT03895372|450571661|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
125258032|NCT03895372|450571654|FG000|Extension Treatment Period|Adverse Event|0|||
125258033|NCT03895372|450571655|FG001|Extension Treatment Period|Adverse Event|1|||
125258034|NCT03895372|450571656|FG002|Extension Treatment Period|Adverse Event|0|||
125258035|NCT03895372|450571657|FG003|Extension Treatment Period|Adverse Event|1|||
125258036|NCT03895372|450571658|FG004|Extension Treatment Period|Adverse Event|0|||
125258037|NCT03895372|450571659|FG005|Extension Treatment Period|Adverse Event|0|||
125258038|NCT03895372|450571660|FG006|Extension Treatment Period|Adverse Event|3|||
125258039|NCT03895372|450571661|FG007|Extension Treatment Period|Adverse Event|3|||
125258040|NCT03895372|450571654|FG000|Extension Treatment Period|Other|1|||
125258041|NCT03895372|450571655|FG001|Extension Treatment Period|Other|3|||
125258042|NCT03895372|450571656|FG002|Extension Treatment Period|Other|0|||
125258043|NCT03895372|450571657|FG003|Extension Treatment Period|Other|0|||
125258044|NCT03895372|450571658|FG004|Extension Treatment Period|Other|1|||
125258045|NCT03895372|450571659|FG005|Extension Treatment Period|Other|0|||
125258046|NCT03895372|450571660|FG006|Extension Treatment Period|Other|0|||
125258047|NCT03895372|450571661|FG007|Extension Treatment Period|Other|2|||
125258048|NCT03895372|450571654|FG000|Extension Treatment Period|Pregnancy|0|||
125258049|NCT03895372|450571655|FG001|Extension Treatment Period|Pregnancy|0|||
125258050|NCT03895372|450571656|FG002|Extension Treatment Period|Pregnancy|0|||
125258051|NCT03895372|450571657|FG003|Extension Treatment Period|Pregnancy|0|||
125258052|NCT03895372|450571658|FG004|Extension Treatment Period|Pregnancy|1|||
125258053|NCT03895372|450571659|FG005|Extension Treatment Period|Pregnancy|0|||
125258054|NCT03895372|450571660|FG006|Extension Treatment Period|Pregnancy|0|||
125258055|NCT03895372|450571661|FG007|Extension Treatment Period|Pregnancy|0|||
125258056|NCT03895372|450571654|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
125258057|NCT03895372|450571655|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
125258058|NCT03895372|450571656|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
125258059|NCT03895372|450571657|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
125258060|NCT03895372|450571658|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
125258061|NCT03895372|450571659|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
125258062|NCT03895372|450571660|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
125258063|NCT03895372|450571661|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
125258064|NCT03331354|450571664|FG000|Overall Study|Withdrawal by Subject|1|||
125258065|NCT03331354|450571665|FG001|Overall Study|Withdrawal by Subject|3|||
125258066|NCT03331354|450571664|FG000|Overall Study|Lost to Follow-up|3|||
125258067|NCT03331354|450571665|FG001|Overall Study|Lost to Follow-up|3|||
125258068|NCT03331354|450571664|FG000|Overall Study|Found employment before initiated active intervention|0|||
125258069|NCT03331354|450571665|FG001|Overall Study|Found employment before initiated active intervention|4|||
125258070|NCT05889468|450571672|FG000|Overall Study|Lost to Follow-up|9|||
125258071|NCT05889468|450571673|FG001|Overall Study|Lost to Follow-up|2|||
125258072|NCT05889468|450571672|FG000|Overall Study|Withdrawal by Subject|2|||
125258073|NCT05889468|450571673|FG001|Overall Study|Withdrawal by Subject|2|||
125258074|NCT01309230|450571674|FG000|Overall Study|Withdrawal by Subject|0|||
125258075|NCT01309230|450571675|FG001|Overall Study|Withdrawal by Subject|2|||
125258076|NCT01309230|450571674|FG000|Overall Study|Observation arm closed|0|||
125258077|NCT01309230|450571675|FG001|Overall Study|Observation arm closed|2|||
125258078|NCT03900650|450571680|FG000|Overall Study|Withdrawal by Subject|1|||
125258079|NCT03900650|450571681|FG001|Overall Study|Withdrawal by Subject|1|||
125258080|NCT03900650|450571682|FG002|Overall Study|Withdrawal by Subject|0|||
125258081|NCT03900650|450571683|FG003|Overall Study|Withdrawal by Subject|0|||
125258082|NCT03900650|450571680|FG000|Overall Study|Withdrawn by staff|1|||
125258083|NCT03900650|450571681|FG001|Overall Study|Withdrawn by staff|0|||
125258084|NCT03900650|450571682|FG002|Overall Study|Withdrawn by staff|0|||
125258085|NCT03900650|450571683|FG003|Overall Study|Withdrawn by staff|0|||
125258086|NCT00427700|450571684|FG000|Overall Study|Lost to Follow-up|2|||
125258087|NCT00427700|450571685|FG001|Overall Study|Lost to Follow-up|5|||
125258088|NCT00427700|450571684|FG000|Overall Study|no induction of menses|1|||
125258089|NCT00427700|450571685|FG001|Overall Study|no induction of menses|4|||
125258090|NCT00427700|450571684|FG000|Overall Study|Pregnancy|0|||
125258091|NCT00427700|450571685|FG001|Overall Study|Pregnancy|2|||
125445459|NCT00873093|451255876|FG002|Overall Study|Ineligible|0|||
125445460|NCT00873093|451255877|FG003|Overall Study|Ineligible|1|||
125445461|NCT00873093|451255878|FG004|Overall Study|Ineligible|0|||
125445462|NCT00136916|451255879|FG000|Overall Study|Never received study treatment|3|||
125445463|NCT00136916|451255880|FG001|Overall Study|Never received study treatment|5|||
125445464|NCT00136916|451255879|FG000|Overall Study|Death|1|||
125445465|NCT00136916|451255880|FG001|Overall Study|Death|3|||
125445466|NCT00136916|451255879|FG000|Overall Study|Adverse Event|27|||
125445467|NCT00136916|451255880|FG001|Overall Study|Adverse Event|8|||
125445468|NCT00136916|451255879|FG000|Overall Study|Laboratory abnormality|0|||
125445469|NCT00136916|451255880|FG001|Overall Study|Laboratory abnormality|1|||
125445470|NCT00136916|451255879|FG000|Overall Study|Lack of Efficacy|13|||
125445471|NCT00136916|451255880|FG001|Overall Study|Lack of Efficacy|3|||
125445472|NCT00136916|451255879|FG000|Overall Study|Lost to Follow-up|12|||
125445473|NCT00136916|451255880|FG001|Overall Study|Lost to Follow-up|14|||
125445474|NCT00136916|451255879|FG000|Overall Study|Withdrawal by Subject|44|||
125445475|NCT00136916|451255880|FG001|Overall Study|Withdrawal by Subject|46|||
125445476|NCT00136916|451255879|FG000|Overall Study|Other|22|||
125445477|NCT00136916|451255880|FG001|Overall Study|Other|24|||
125445478|NCT00136916|451255879|FG000|Overall Study|Discontinued in follow up period|3|||
125445479|NCT00136916|451255880|FG001|Overall Study|Discontinued in follow up period|0|||
125445480|NCT04242875|451255883|FG000|Overall Study|Adverse Event|2|||
125445481|NCT04172987|451255885|FG000|Lead In Period|Adverse Event|1|||
125445482|NCT04172987|451255885|FG000|Lead In Period|Protocol Violation|1|||
125445483|NCT04172987|451255885|FG000|Period 1|Physician Decision|1|||
125445484|NCT04172987|451255885|FG000|Period 2|Adverse Event|5|||
125445485|NCT04172987|451255885|FG000|Period 2|Dosing Termination by Sponsor|4|||
125445486|NCT04179461|451255886|FG000|Overall Study|Lost to Follow-up|4|||
125445487|NCT02107443|451255887|FG000|Overall Study|Death|42|||
125445488|NCT02107443|451255888|FG001|Overall Study|Death|30|||
125445489|NCT02107443|451255887|FG000|Overall Study|Study Protocol Violation|3|||
125445490|NCT02107443|451255888|FG001|Overall Study|Study Protocol Violation|1|||
125445491|NCT02107443|451255887|FG000|Overall Study|Registered but Not Eligible|0|||
125445492|NCT02107443|451255888|FG001|Overall Study|Registered but Not Eligible|1|||
125445493|NCT02107443|451255887|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
125445494|NCT02107443|451255888|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
125445495|NCT02107443|451255887|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
125445496|NCT02107443|451255888|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
125445497|NCT02107443|451255887|FG000|Overall Study|Withdrawal: Changed Mind|2|||
125445498|NCT02107443|451255888|FG001|Overall Study|Withdrawal: Changed Mind|0|||
125445499|NCT02107443|451255887|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
125445500|NCT02107443|451255888|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
125445501|NCT02107443|451255887|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
125445502|NCT02107443|451255888|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
125445503|NCT02107443|451255887|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
125445504|NCT02107443|451255888|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
125445505|NCT02107443|451255887|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
125445506|NCT02107443|451255888|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
125445507|NCT02107443|451255887|FG000|Overall Study|Withdrawal: Other Medical|9|||
125445508|NCT02107443|451255888|FG001|Overall Study|Withdrawal: Other Medical|5|||
125445509|NCT02107443|451255887|FG000|Overall Study|Withdrawal: Disease Progression|4|||
125445510|NCT02107443|451255888|FG001|Overall Study|Withdrawal: Disease Progression|2|||
125445511|NCT02107443|451255887|FG000|Overall Study|Withdrawal: Personal Issues|0|||
125445512|NCT02107443|451255888|FG001|Overall Study|Withdrawal: Personal Issues|3|||
125445513|NCT01513967|451255889|FG000|Overall Study|Pregnancy|0|||
125445514|NCT01513967|451255890|FG001|Overall Study|Pregnancy|0|||
125445515|NCT01513967|451255891|FG002|Overall Study|Pregnancy|0|||
125445516|NCT01513967|451255892|FG003|Overall Study|Pregnancy|0|||
125445517|NCT01513967|451255893|FG004|Overall Study|Pregnancy|0|||
125445518|NCT01513967|451255894|FG005|Overall Study|Pregnancy|0|||
125445519|NCT01513967|451255895|FG006|Overall Study|Pregnancy|1|||
125445520|NCT01513967|451255896|FG007|Overall Study|Pregnancy|0|||
125445521|NCT01513967|451255889|FG000|Overall Study|missed a study visit|0|||
125445522|NCT01513967|451255890|FG001|Overall Study|missed a study visit|0|||
125445523|NCT01513967|451255891|FG002|Overall Study|missed a study visit|0|||
125445524|NCT01513967|451255892|FG003|Overall Study|missed a study visit|0|||
125445525|NCT01513967|451255893|FG004|Overall Study|missed a study visit|0|||
125445526|NCT01513967|451255894|FG005|Overall Study|missed a study visit|0|||
125445527|NCT01513967|451255895|FG006|Overall Study|missed a study visit|1|||
125445528|NCT01513967|451255896|FG007|Overall Study|missed a study visit|0|||
125445529|NCT01513967|451255889|FG000|Overall Study|excluded due to positive drug screen|0|||
125445530|NCT01513967|451255890|FG001|Overall Study|excluded due to positive drug screen|0|||
125445531|NCT01513967|451255891|FG002|Overall Study|excluded due to positive drug screen|0|||
125445532|NCT01513967|451255892|FG003|Overall Study|excluded due to positive drug screen|0|||
125445533|NCT01513967|451255893|FG004|Overall Study|excluded due to positive drug screen|0|||
125445534|NCT01513967|451255894|FG005|Overall Study|excluded due to positive drug screen|0|||
125445535|NCT01513967|451255895|FG006|Overall Study|excluded due to positive drug screen|0|||
125258092|NCT04581395|450571686|FG000|Overall Study|Protocol Violation|4|||
125258093|NCT04581395|450571687|FG001|Overall Study|Protocol Violation|3|||
125258094|NCT04581395|450571688|FG002|Overall Study|Protocol Violation|2|||
125258095|NCT04581395|450571686|FG000|Overall Study|Physician Decision|0|||
125258096|NCT04581395|450571687|FG001|Overall Study|Physician Decision|1|||
125258097|NCT04581395|450571688|FG002|Overall Study|Physician Decision|0|||
125258098|NCT00815633|450571691|FG000|Overall Study|study terminated|1|||
125258099|NCT00721110|450571692|FG000|Overall Study|Ultram use|1|||
125258100|NCT00721110|450571693|FG001|Overall Study|Ultram use|0|||
125258101|NCT00721110|450571694|FG002|Overall Study|Ultram use|0|||
125258102|NCT00721110|450571695|FG003|Overall Study|Ultram use|0|||
125258103|NCT00721110|450571692|FG000|Overall Study|vertical incision|0|||
125258104|NCT00721110|450571693|FG001|Overall Study|vertical incision|0|||
125258105|NCT00721110|450571694|FG002|Overall Study|vertical incision|1|||
125258106|NCT00721110|450571695|FG003|Overall Study|vertical incision|0|||
125258107|NCT01554904|450571696|FG000|Overall Study|Withdrawal by Subject|3|||
125258108|NCT01554904|450571696|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
125258109|NCT01605097|450571697|FG000|Overall Study|Protocol Violation|1|||
125258110|NCT02038647|450571698|FG000|Overall Study|Progressive Disease|50|||
125258111|NCT02038647|450571699|FG001|Overall Study|Progressive Disease|59|||
125258112|NCT02038647|450571698|FG000|Overall Study|Adverse Event|18|||
125258113|NCT02038647|450571699|FG001|Overall Study|Adverse Event|10|||
125258114|NCT02038647|450571698|FG000|Overall Study|Symptomatic Deterioration|7|||
125258115|NCT02038647|450571699|FG001|Overall Study|Symptomatic Deterioration|7|||
125258116|NCT02038647|450571698|FG000|Overall Study|Withdrawal by Subject|5|||
125258117|NCT02038647|450571699|FG001|Overall Study|Withdrawal by Subject|2|||
125258118|NCT02038647|450571698|FG000|Overall Study|Not Reported|0|||
125258119|NCT02038647|450571699|FG001|Overall Study|Not Reported|1|||
125258120|NCT02038647|450571698|FG000|Overall Study|Ongoing at Datacut|9|||
125258121|NCT02038647|450571699|FG001|Overall Study|Ongoing at Datacut|10|||
125258122|NCT02757430|450571700|FG000|Overall Study|Physician Decision|6|||
125258123|NCT02757430|450571700|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
125258124|NCT02757430|450571700|FG000|Overall Study|No informed consent|1|||
125258125|NCT02757430|450571700|FG000|Overall Study|No procedure performed|2|||
125258126|NCT02082977|450571701|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
125258127|NCT02082977|450571702|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
125258128|NCT02082977|450571703|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
125258129|NCT02082977|450571704|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
125258130|NCT02082977|450571705|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
125258131|NCT02082977|450571706|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
125258132|NCT02082977|450571707|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
125258133|NCT02082977|450571708|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
125258134|NCT02082977|450571709|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
125258135|NCT02082977|450571710|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
125258136|NCT02082977|450571701|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258137|NCT02082977|450571702|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258138|NCT02082977|450571703|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258139|NCT02082977|450571704|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258140|NCT02082977|450571705|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258141|NCT02082977|450571706|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258142|NCT02082977|450571707|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258143|NCT02082977|450571708|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
125397527|NCT05107128|451089206|FG000|Overall Study|Withdrawal of Consent|0|||
125397528|NCT05107128|451089207|FG001|Overall Study|Withdrawal of Consent|1|||
125397529|NCT05107128|451089206|FG000|Overall Study|Reason Not Specified|2|||
125397530|NCT05107128|451089207|FG001|Overall Study|Reason Not Specified|0|||
125397531|NCT01470469|451089208|FG000|Overall Study|Withdrawal by Subject|4|||
125397532|NCT01470469|451089209|FG001|Overall Study|Withdrawal by Subject|6|||
125397533|NCT01470469|451089208|FG000|Overall Study|Lack of Efficacy|1|||
125397534|NCT01470469|451089209|FG001|Overall Study|Lack of Efficacy|7|||
125397535|NCT01470469|451089208|FG000|Overall Study|Adverse Event|0|||
125397536|NCT01470469|451089209|FG001|Overall Study|Adverse Event|7|||
125397537|NCT01470469|451089208|FG000|Overall Study|Lost to Follow-up|2|||
125445536|NCT01513967|451255896|FG007|Overall Study|excluded due to positive drug screen|2|||
125258144|NCT02082977|450571709|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258145|NCT02082977|450571710|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
125258146|NCT02082977|450571701|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258147|NCT02082977|450571702|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258148|NCT02082977|450571703|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258149|NCT02082977|450571704|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258150|NCT02082977|450571705|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125397538|NCT01470469|451089209|FG001|Overall Study|Lost to Follow-up|2|||
125445537|NCT01513967|451255889|FG000|Overall Study|Physician Decision|0|||
125258151|NCT02082977|450571706|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
125258152|NCT02082977|450571707|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125397539|NCT01470469|451089208|FG000|Overall Study|Protocol Violation|1|||
125445538|NCT01513967|451255890|FG001|Overall Study|Physician Decision|0|||
125445539|NCT01513967|451255891|FG002|Overall Study|Physician Decision|0|||
125445540|NCT01513967|451255892|FG003|Overall Study|Physician Decision|0|||
125445541|NCT01513967|451255893|FG004|Overall Study|Physician Decision|0|||
125445542|NCT01513967|451255894|FG005|Overall Study|Physician Decision|1|||
125445543|NCT01513967|451255895|FG006|Overall Study|Physician Decision|0|||
125445544|NCT01513967|451255896|FG007|Overall Study|Physician Decision|0|||
125445545|NCT02906202|451255897|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
125445546|NCT01563978|451255901|FG000|Overall Study|Physician Decision|1|||
125445547|NCT01563978|451255902|FG001|Overall Study|Physician Decision|0|||
125445548|NCT01563978|451255901|FG000|Overall Study|Lost to Follow-up|1|||
125445549|NCT01563978|451255902|FG001|Overall Study|Lost to Follow-up|0|||
125445550|NCT01563978|451255901|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
125445551|NCT01563978|451255902|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
125445552|NCT01563978|451255901|FG000|Overall Study|Adverse Event|1|||
125445553|NCT01563978|451255902|FG001|Overall Study|Adverse Event|2|||
125445554|NCT00729690|451255903|FG000|Overall Study|IT Catheter Malfunction|0|||
125445555|NCT00729690|451255904|FG001|Overall Study|IT Catheter Malfunction|2|||
125445556|NCT00729690|451255905|FG002|Overall Study|IT Catheter Malfunction|2|||
125445557|NCT04562779|451255908|FG000|Overall Study|Lost to Follow-up|7|||
125445558|NCT04562779|451255909|FG001|Overall Study|Lost to Follow-up|5|||
125445559|NCT04562779|451255910|FG002|Overall Study|Lost to Follow-up|10|||
125445560|NCT04562779|451255908|FG000|Overall Study|Protocol Violation|2|||
125445561|NCT04562779|451255909|FG001|Overall Study|Protocol Violation|2|||
125445562|NCT04562779|451255910|FG002|Overall Study|Protocol Violation|0|||
125445563|NCT00333138|451255911|FG000|Core Study (6 Months)|Adverse Event|4|||
125445564|NCT00333138|451255912|FG001|Core Study (6 Months)|Adverse Event|5|||
125445565|NCT00333138|451255913|FG002|Core Study (6 Months)|Adverse Event|8|||
125445566|NCT00333138|451255911|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
125445567|NCT00333138|451255912|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
125445568|NCT00333138|451255913|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
125258153|NCT02082977|450571708|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125397540|NCT01470469|451089209|FG001|Overall Study|Protocol Violation|1|||
125397541|NCT01470469|451089208|FG000|Overall Study|Other|2|||
125397542|NCT01470469|451089209|FG001|Overall Study|Other|1|||
125397543|NCT04988295|451089210|FG000|Overall Study|Withdrawal by Subject|9|||
125397544|NCT04988295|451089211|FG001|Overall Study|Withdrawal by Subject|29|||
125397545|NCT04988295|451089212|FG002|Overall Study|Withdrawal by Subject|6|||
125397546|NCT04988295|451089213|FG003|Overall Study|Withdrawal by Subject|0|||
125397547|NCT04988295|451089210|FG000|Overall Study|Lost to Follow-up|1|||
125397548|NCT04988295|451089211|FG001|Overall Study|Lost to Follow-up|0|||
125397549|NCT04988295|451089212|FG002|Overall Study|Lost to Follow-up|0|||
125397550|NCT04988295|451089213|FG003|Overall Study|Lost to Follow-up|0|||
125397551|NCT04988295|451089210|FG000|Overall Study|Study participation ongoing|186|||
125397552|NCT04988295|451089211|FG001|Overall Study|Study participation ongoing|169|||
125397553|NCT04988295|451089212|FG002|Overall Study|Study participation ongoing|99|||
125397554|NCT04988295|451089213|FG003|Overall Study|Study participation ongoing|119|||
125397555|NCT04649151|451089214|FG000|Overall Study|Pregnancy|0|||
125397556|NCT04649151|451089215|FG001|Overall Study|Pregnancy|0|||
125397557|NCT04649151|451089216|FG002|Overall Study|Pregnancy|0|||
125397558|NCT04649151|451089217|FG003|Overall Study|Pregnancy|0|||
125397559|NCT04649151|451089218|FG004|Overall Study|Pregnancy|3|||
125397560|NCT04649151|451089214|FG000|Overall Study|Physician Decision|10|||
125397561|NCT04649151|451089215|FG001|Overall Study|Physician Decision|0|||
125397562|NCT04649151|451089216|FG002|Overall Study|Physician Decision|0|||
125397563|NCT04649151|451089217|FG003|Overall Study|Physician Decision|1|||
125397564|NCT04649151|451089218|FG004|Overall Study|Physician Decision|1|||
125397565|NCT04649151|451089214|FG000|Overall Study|Protocol Deviation|25|||
125397566|NCT04649151|451089215|FG001|Overall Study|Protocol Deviation|3|||
125397567|NCT04649151|451089216|FG002|Overall Study|Protocol Deviation|0|||
125397568|NCT04649151|451089217|FG003|Overall Study|Protocol Deviation|0|||
125397569|NCT04649151|451089218|FG004|Overall Study|Protocol Deviation|0|||
125397570|NCT04649151|451089214|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
125397571|NCT04649151|451089215|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
125397572|NCT04649151|451089216|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
125397573|NCT04649151|451089217|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
125397574|NCT04649151|451089218|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
125397575|NCT04649151|451089214|FG000|Overall Study|Withdrawal by Subject|370|||
125397576|NCT04649151|451089215|FG001|Overall Study|Withdrawal by Subject|113|||
125397577|NCT04649151|451089216|FG002|Overall Study|Withdrawal by Subject|2|||
125397578|NCT04649151|451089217|FG003|Overall Study|Withdrawal by Subject|7|||
125397579|NCT04649151|451089218|FG004|Overall Study|Withdrawal by Subject|15|||
125397580|NCT04649151|451089214|FG000|Overall Study|Adverse Event|1|||
125397581|NCT04649151|451089215|FG001|Overall Study|Adverse Event|0|||
125397582|NCT04649151|451089216|FG002|Overall Study|Adverse Event|0|||
125397583|NCT04649151|451089217|FG003|Overall Study|Adverse Event|0|||
125397584|NCT04649151|451089218|FG004|Overall Study|Adverse Event|0|||
125445569|NCT00333138|451255911|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
125445570|NCT00333138|451255912|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
125445571|NCT00333138|451255913|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
125445572|NCT00333138|451255911|FG000|Core Study (6 Months)|Protocol Violation|1|||
125445573|NCT00333138|451255912|FG001|Core Study (6 Months)|Protocol Violation|0|||
125445574|NCT00333138|451255913|FG002|Core Study (6 Months)|Protocol Violation|1|||
125445575|NCT00333138|451255911|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
125445576|NCT00333138|451255912|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
125445577|NCT00333138|451255913|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
125445578|NCT00333138|451255911|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
125445579|NCT00333138|451255912|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
125445580|NCT00333138|451255913|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
125445581|NCT00333138|451255911|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
125445582|NCT00333138|451255912|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
125445583|NCT00333138|451255913|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
125445584|NCT00333138|451255911|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
125445585|NCT00333138|451255912|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
125445586|NCT00333138|451255913|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
125445587|NCT00333138|451255911|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
125445588|NCT00333138|451255912|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
125445589|NCT00333138|451255913|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
125445590|NCT00333138|451255911|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
125445591|NCT00333138|451255912|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
125445592|NCT00333138|451255913|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
125445593|NCT00333138|451255911|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
125445594|NCT00333138|451255912|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
125445595|NCT00333138|451255913|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
125445596|NCT00333138|451255911|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
125445597|NCT00333138|451255912|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
125445598|NCT00333138|451255913|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
125445599|NCT00333138|451255911|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
125445600|NCT00333138|451255912|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
125445601|NCT00333138|451255913|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
125445602|NCT00333138|451255911|FG000|Extension Study (Month6 to End of Study)|Death|0|||
125445603|NCT00333138|451255912|FG001|Extension Study (Month6 to End of Study)|Death|1|||
125445604|NCT00333138|451255913|FG002|Extension Study (Month6 to End of Study)|Death|0|||
125445605|NCT05593211|451255914|FG000|Overall Study|Withdrawal by Subject|1|||
125445606|NCT03077620|451255918|FG000|Overall Study|Unable to place lumbar catheter|1|||
125445607|NCT03077620|451255919|FG001|Overall Study|Unable to place lumbar catheter|0|||
125445608|NCT03077620|451255920|FG002|Overall Study|Unable to place lumbar catheter|1|||
125445609|NCT03077620|451255921|FG003|Overall Study|Unable to place lumbar catheter|0|||
125445610|NCT03077620|451255918|FG000|Overall Study|Withdrawal by Subject|0|||
125445611|NCT03077620|451255919|FG001|Overall Study|Withdrawal by Subject|1|||
125445612|NCT03077620|451255920|FG002|Overall Study|Withdrawal by Subject|0|||
125445613|NCT03077620|451255921|FG003|Overall Study|Withdrawal by Subject|0|||
125445614|NCT03077620|451255918|FG000|Overall Study|Physician Decision|0|||
125445615|NCT03077620|451255919|FG001|Overall Study|Physician Decision|0|||
125445616|NCT03077620|451255920|FG002|Overall Study|Physician Decision|1|||
125445617|NCT03077620|451255921|FG003|Overall Study|Physician Decision|0|||
125445618|NCT03225846|451255922|FG000|Overall Study|Adverse Event|0|||
125445619|NCT03225846|451255923|FG001|Overall Study|Adverse Event|0|||
125445620|NCT03225846|451255924|FG002|Overall Study|Adverse Event|0|||
125445621|NCT03225846|451255925|FG003|Overall Study|Adverse Event|0|||
125445622|NCT03225846|451255926|FG004|Overall Study|Adverse Event|0|||
125445623|NCT03225846|451255927|FG005|Overall Study|Adverse Event|0|||
125445624|NCT03225846|451255928|FG006|Overall Study|Adverse Event|6|||
125445625|NCT03225846|451255922|FG000|Overall Study|Withdrawal by Subject|0|||
125445626|NCT03225846|451255923|FG001|Overall Study|Withdrawal by Subject|1|||
125445627|NCT03225846|451255924|FG002|Overall Study|Withdrawal by Subject|0|||
125445628|NCT03225846|451255925|FG003|Overall Study|Withdrawal by Subject|0|||
125445629|NCT03225846|451255926|FG004|Overall Study|Withdrawal by Subject|0|||
125445630|NCT03225846|451255927|FG005|Overall Study|Withdrawal by Subject|0|||
125445631|NCT03225846|451255928|FG006|Overall Study|Withdrawal by Subject|0|||
125445632|NCT03225846|451255922|FG000|Overall Study|Death|0|||
125445633|NCT03225846|451255923|FG001|Overall Study|Death|1|||
125445634|NCT03225846|451255924|FG002|Overall Study|Death|0|||
125445635|NCT03225846|451255925|FG003|Overall Study|Death|0|||
125445636|NCT03225846|451255926|FG004|Overall Study|Death|0|||
125445637|NCT03225846|451255927|FG005|Overall Study|Death|0|||
125445638|NCT03225846|451255928|FG006|Overall Study|Death|0|||
125445639|NCT03225846|451255922|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
125258154|NCT02082977|450571709|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258155|NCT02082977|450571710|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
125258156|NCT02082977|450571701|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
125258157|NCT02082977|450571702|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
125258158|NCT02082977|450571703|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
125258159|NCT02082977|450571704|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
125258160|NCT02082977|450571705|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
125258161|NCT02082977|450571706|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
125258162|NCT02082977|450571707|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
125258163|NCT02082977|450571708|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
125258164|NCT02082977|450571709|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
125258165|NCT02082977|450571710|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
125258166|NCT02082977|450571701|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258167|NCT02082977|450571702|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258168|NCT02082977|450571703|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258169|NCT02082977|450571704|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258170|NCT02082977|450571705|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258171|NCT02082977|450571706|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258172|NCT02082977|450571707|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258173|NCT02082977|450571708|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
125258174|NCT02082977|450571709|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258175|NCT02082977|450571710|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
125258176|NCT05852340|450571711|FG000|Period 5|Not completing the meal|0|||
125258177|NCT05852340|450571712|FG001|Period 5|Not completing the meal|1|||
125258178|NCT05852340|450571713|FG002|Period 5|Not completing the meal|0|||
125258179|NCT05852340|450571714|FG003|Period 5|Not completing the meal|0|||
125258180|NCT05852340|450571711|FG000|Period 5|Adverse Event|0|||
125258181|NCT05852340|450571712|FG001|Period 5|Adverse Event|0|||
125258182|NCT05852340|450571713|FG002|Period 5|Adverse Event|0|||
125258183|NCT05852340|450571714|FG003|Period 5|Adverse Event|1|||
125258184|NCT01903863|450571715|FG000|Overall Study|Physician Decision|2|||
125258185|NCT01903863|450571716|FG001|Overall Study|Physician Decision|0|||
125258186|NCT01397253|450573019|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
125258187|NCT01397253|450573020|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
125258188|NCT01892189|450573021|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
125258189|NCT01892189|450573022|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
125258190|NCT01892189|450573023|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
125258191|NCT01892189|450573024|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
125258192|NCT01892189|450573025|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
125258193|NCT01892189|450573026|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
125258194|NCT01892189|450573027|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
125258195|NCT01892189|450573028|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
125258196|NCT01892189|450573029|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
125258197|NCT01892189|450573021|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125258198|NCT01892189|450573022|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125258199|NCT01892189|450573023|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
125258200|NCT01892189|450573024|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
125258201|NCT01892189|450573025|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125258202|NCT01892189|450573026|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125258203|NCT01892189|450573027|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
125258204|NCT01892189|450573028|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125258205|NCT01892189|450573029|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
125258206|NCT01892189|450573021|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258207|NCT01892189|450573022|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258208|NCT01892189|450573023|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258209|NCT01892189|450573024|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258210|NCT01892189|450573025|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258211|NCT01892189|450573026|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
125258212|NCT01892189|450573027|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258213|NCT01892189|450573028|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125445640|NCT03225846|451255923|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
125445641|NCT03225846|451255924|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
125258214|NCT01892189|450573029|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
125258215|NCT03440411|450573030|FG000|Overall Study|Adverse Event|0|||
125258216|NCT03440411|450573031|FG001|Overall Study|Adverse Event|0|||
125258217|NCT03440411|450573032|FG002|Overall Study|Adverse Event|1|||
125258218|NCT03440411|450573033|FG003|Overall Study|Adverse Event|0|||
125258219|NCT03440411|450573030|FG000|Overall Study|PD|2|||
125258220|NCT03440411|450573031|FG001|Overall Study|PD|1|||
125258221|NCT03440411|450573032|FG002|Overall Study|PD|1|||
125258222|NCT03440411|450573033|FG003|Overall Study|PD|1|||
125258223|NCT03440411|450573030|FG000|Overall Study|Withdrawal by Subject|1|||
125258224|NCT03440411|450573031|FG001|Overall Study|Withdrawal by Subject|0|||
125258225|NCT03440411|450573032|FG002|Overall Study|Withdrawal by Subject|0|||
125258226|NCT03440411|450573033|FG003|Overall Study|Withdrawal by Subject|0|||
125258227|NCT03440411|450573030|FG000|Overall Study|Closed study by sponsor|0|||
125258228|NCT03440411|450573031|FG001|Overall Study|Closed study by sponsor|0|||
125258229|NCT03440411|450573032|FG002|Overall Study|Closed study by sponsor|0|||
125258230|NCT03440411|450573033|FG003|Overall Study|Closed study by sponsor|1|||
125258231|NCT04484857|450573043|FG000|Overall Study|Adverse Event|2|||
125258232|NCT04484857|450573043|FG000|Overall Study|Death|10|||
125258233|NCT04484857|450573043|FG000|Overall Study|Withdrawal by Subject|3|||
125258234|NCT04484857|450573043|FG000|Overall Study|Transferred/Relocation|5|||
125258235|NCT04484857|450573043|FG000|Overall Study|Kidney Transplant|7|||
125258236|NCT04484857|450573043|FG000|Overall Study|Other than specified|4|||
125258237|NCT04484857|450573043|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
125258238|NCT01358734|450573045|FG000|Overall Study|Adverse Event|4|||
125258239|NCT01358734|450573046|FG001|Overall Study|Adverse Event|7|||
125258240|NCT01358734|450573047|FG002|Overall Study|Adverse Event|3|||
125258241|NCT01358734|450573045|FG000|Overall Study|Lack of Efficacy|0|||
125258242|NCT01358734|450573046|FG001|Overall Study|Lack of Efficacy|1|||
125258243|NCT01358734|450573047|FG002|Overall Study|Lack of Efficacy|3|||
125258244|NCT01358734|450573045|FG000|Overall Study|Withdrawal by Subject|1|||
125258245|NCT01358734|450573046|FG001|Overall Study|Withdrawal by Subject|6|||
125258246|NCT01358734|450573047|FG002|Overall Study|Withdrawal by Subject|3|||
125258247|NCT01358734|450573045|FG000|Overall Study|Death|3|||
125258248|NCT01358734|450573046|FG001|Overall Study|Death|7|||
125258249|NCT01358734|450573047|FG002|Overall Study|Death|2|||
125258250|NCT01358734|450573045|FG000|Overall Study|Progressive Disease|5|||
125258251|NCT01358734|450573046|FG001|Overall Study|Progressive Disease|13|||
125258252|NCT01358734|450573047|FG002|Overall Study|Progressive Disease|16|||
125258253|NCT01358734|450573045|FG000|Overall Study|Non-compliance with study drug|0|||
125258254|NCT01358734|450573046|FG001|Overall Study|Non-compliance with study drug|0|||
125258255|NCT01358734|450573047|FG002|Overall Study|Non-compliance with study drug|1|||
125258256|NCT01358734|450573045|FG000|Overall Study|Other|2|||
125258257|NCT01358734|450573046|FG001|Overall Study|Other|5|||
125258258|NCT01358734|450573047|FG002|Overall Study|Other|4|||
125258259|NCT01358734|450573045|FG000|Overall Study|Protocol Violation|0|||
125258260|NCT01358734|450573046|FG001|Overall Study|Protocol Violation|0|||
125258261|NCT01358734|450573047|FG002|Overall Study|Protocol Violation|2|||
125258262|NCT03322566|450573054|FG000|Overall Study|Death|34|||
125258263|NCT03322566|450573055|FG001|Overall Study|Death|35|||
125258264|NCT03322566|450573056|FG002|Overall Study|Death|23|||
125258265|NCT03322566|450573054|FG000|Overall Study|Physician Decision|6|||
125258266|NCT03322566|450573055|FG001|Overall Study|Physician Decision|7|||
125258267|NCT03322566|450573056|FG002|Overall Study|Physician Decision|2|||
125258268|NCT03322566|450573054|FG000|Overall Study|Withdrawal by Subject|4|||
125258269|NCT03322566|450573055|FG001|Overall Study|Withdrawal by Subject|3|||
125258270|NCT03322566|450573056|FG002|Overall Study|Withdrawal by Subject|6|||
125258271|NCT03322566|450573054|FG000|Overall Study|Lost to Follow-up|0|||
125258272|NCT03322566|450573055|FG001|Overall Study|Lost to Follow-up|0|||
125258273|NCT03322566|450573056|FG002|Overall Study|Lost to Follow-up|1|||
125258274|NCT03322566|450573054|FG000|Overall Study|Study terminated by sponsor|1|||
125258275|NCT03322566|450573055|FG001|Overall Study|Study terminated by sponsor|0|||
125258276|NCT03322566|450573056|FG002|Overall Study|Study terminated by sponsor|1|||
125258277|NCT02546323|450573060|FG000|Overall Study|Withdrawal by Subject|36|||
125258278|NCT02546323|450573061|FG001|Overall Study|Withdrawal by Subject|33|||
125258279|NCT02546323|450573060|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
125258280|NCT02546323|450573061|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
125258281|NCT02546323|450573060|FG000|Overall Study|Adverse Event|17|||
125258282|NCT02546323|450573061|FG001|Overall Study|Adverse Event|11|||
125258283|NCT02546323|450573060|FG000|Overall Study|Patient Specific Reasons|1|||
125258284|NCT02546323|450573061|FG001|Overall Study|Patient Specific Reasons|2|||
125258285|NCT02546323|450573060|FG000|Overall Study|Lost to Follow-up|2|||
125258286|NCT02546323|450573061|FG001|Overall Study|Lost to Follow-up|3|||
125258287|NCT02546323|450573060|FG000|Overall Study|Non-compliance with Study Drug|2|||
125258288|NCT02546323|450573061|FG001|Overall Study|Non-compliance with Study Drug|2|||
125258289|NCT02546323|450573060|FG000|Overall Study|Met Withdrawal Criteria|2|||
125258290|NCT02546323|450573061|FG001|Overall Study|Met Withdrawal Criteria|14|||
125258291|NCT01055028|450573062|FG000|Screening|Screen Failure|1|||
125258292|NCT01055028|450573063|FG001|Screening|Screen Failure|1|||
125258293|NCT01055028|450573062|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
125258294|NCT01055028|450573063|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
125258295|NCT01055028|450573062|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
125258296|NCT01055028|450573063|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
125258297|NCT01055028|450573062|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
125258298|NCT01055028|450573063|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
125258299|NCT03559530|450573064|FG000|Overall Study|non-location of medical records|44|||
125258300|NCT03559530|450573065|FG001|Overall Study|non-location of medical records|0|||
125258301|NCT03559530|450573064|FG000|Overall Study|culture results not considered for treat|29|||
125258302|NCT03559530|450573065|FG001|Overall Study|culture results not considered for treat|0|||
125258303|NCT03559530|450573064|FG000|Overall Study|duplicate cases|8|||
125258304|NCT03559530|450573065|FG001|Overall Study|duplicate cases|0|||
125258305|NCT03559530|450573064|FG000|Overall Study|other species of Acinetobacte|7|||
125258306|NCT03559530|450573065|FG001|Overall Study|other species of Acinetobacte|0|||
125258307|NCT03559530|450573064|FG000|Overall Study|contamination / colonization|3|||
125258308|NCT03559530|450573065|FG001|Overall Study|contamination / colonization|0|||
125258309|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
125258310|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
125258311|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
125258312|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
125258313|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
125258314|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
125258315|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
125258316|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
125258317|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
125258318|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
125258319|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
125258320|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
125258321|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
125258322|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
125258323|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
125258324|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
125258325|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
125258326|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
125258327|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
125258328|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
125258329|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
125258330|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
125258331|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
125258332|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
125258333|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
125258334|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
125258335|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
125258336|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
125258337|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
125258338|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
125258339|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
125258340|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
125258341|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
125258342|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
125258343|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
125258344|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
125258345|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
125258346|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
125258347|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
125258348|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
125258349|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
125258350|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
125258351|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
125258352|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
125258353|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
125258354|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
125445642|NCT03225846|451255925|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
125258355|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
125258356|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
125258357|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
125258358|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
125258359|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
125258360|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
125258361|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
125258362|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
125445643|NCT03225846|451255926|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
125258363|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
125258364|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
125258365|NCT01362790|450573066|FG000|Pilot Phase & Phase 2|Death on study|0|||
125258366|NCT01362790|450573067|FG001|Pilot Phase & Phase 2|Death on study|0|||
125258367|NCT01362790|450573068|FG002|Pilot Phase & Phase 2|Death on study|0|||
125258368|NCT01362790|450573069|FG003|Pilot Phase & Phase 2|Death on study|1|||
125258369|NCT01362790|450573070|FG004|Pilot Phase & Phase 2|Death on study|0|||
125445644|NCT03225846|451255927|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
125445645|NCT03225846|451255928|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
125445646|NCT03225846|451255922|FG000|Overall Study|Patient decision|0|||
125445647|NCT03225846|451255923|FG001|Overall Study|Patient decision|0|||
125445648|NCT03225846|451255924|FG002|Overall Study|Patient decision|0|||
125445649|NCT03225846|451255925|FG003|Overall Study|Patient decision|0|||
125445650|NCT03225846|451255926|FG004|Overall Study|Patient decision|0|||
125445651|NCT03225846|451255927|FG005|Overall Study|Patient decision|0|||
125445652|NCT03225846|451255928|FG006|Overall Study|Patient decision|1|||
125445653|NCT00238420|451255929|FG000|Overall Study|Protocol Violation|1|||
125445654|NCT00238420|451255930|FG001|Overall Study|Protocol Violation|1|||
125445655|NCT02102464|451255933|FG000|Randomized Study|Withdrawal by Subject|0|||
125445656|NCT02102464|451255934|FG001|Randomized Study|Withdrawal by Subject|1|||
125445657|NCT02102464|451255935|FG002|Randomized Study|Withdrawal by Subject|0|||
125445658|NCT04140890|451255936|FG000|Overall Study|Withdrawal by Subject|0|||
125445659|NCT04140890|451255937|FG001|Overall Study|Withdrawal by Subject|1|||
125445660|NCT03958630|451255938|FG000|Overall Study|Withdrawal by Subject|0|||
125445661|NCT03958630|451255939|FG001|Overall Study|Withdrawal by Subject|0|||
125445662|NCT03958630|451255940|FG002|Overall Study|Withdrawal by Subject|1|||
125445663|NCT03958630|451255938|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
125445664|NCT03958630|451255939|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
125445665|NCT03958630|451255940|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
125445666|NCT00245011|451255943|FG000|Overall Study|Lack of Efficacy|1|||
125445667|NCT03040687|451255944|FG000|Overall Study|Withdrawal by Subject|1|||
125445668|NCT03040687|451255945|FG001|Overall Study|Withdrawal by Subject|0|||
125445669|NCT03040687|451255946|FG002|Overall Study|Withdrawal by Subject|0|||
125445670|NCT00322868|451257638|FG000|Overall Study|disease progression|1|||
125445671|NCT02176928|451257641|FG000|Overall Study|Lost to Follow-up|2|||
125445672|NCT02176928|451257642|FG001|Overall Study|Lost to Follow-up|4|||
125445673|NCT00224133|451257647|FG000|Overall Study|Adverse Event|93|||
125445674|NCT00224133|451257647|FG000|Overall Study|Protocol Violation|6|||
125445675|NCT00224133|451257647|FG000|Overall Study|Withdrawal by Subject|33|||
125445676|NCT00224133|451257647|FG000|Overall Study|Lack of Efficacy|58|||
125445677|NCT00224133|451257647|FG000|Overall Study|Lost to Follow-up|21|||
125445678|NCT00224133|451257647|FG000|Overall Study|Physician Decision|1|||
125445679|NCT00224133|451257647|FG000|Overall Study|Other|14|||
125445680|NCT00795132|451257653|FG000|Overall Study|Death|1|||
125445681|NCT00795132|451257653|FG000|Overall Study|Relapse|2|||
125445682|NCT02451930|451257654|FG000|Overall Study|Death|0|||
125445683|NCT02451930|451257655|FG001|Overall Study|Death|15|||
125445684|NCT02451930|451257654|FG000|Overall Study|Lost to Follow-up|0|||
125445685|NCT02451930|451257655|FG001|Overall Study|Lost to Follow-up|3|||
125445686|NCT02451930|451257654|FG000|Overall Study|Sponsor Decision|2|||
125445687|NCT02451930|451257655|FG001|Overall Study|Sponsor Decision|10|||
125445688|NCT02451930|451257654|FG000|Overall Study|Withdrawal by Subject|0|||
125445689|NCT02451930|451257655|FG001|Overall Study|Withdrawal by Subject|1|||
125445690|NCT02451930|451257654|FG000|Overall Study|Other|0|||
125445691|NCT02451930|451257655|FG001|Overall Study|Other|1|||
125445692|NCT03018106|451257656|FG000|Overall Study|Lost to Follow-up|0|||
125445693|NCT03018106|451257657|FG001|Overall Study|Lost to Follow-up|1|||
125445694|NCT03619174|451257658|FG000|Overall Study|Lost to Follow-up|3|||
125258370|NCT01362790|450573071|FG005|Pilot Phase & Phase 2|Death on study|0|||
125258371|NCT01362790|450573072|FG006|Pilot Phase & Phase 2|Death on study|0|||
125258372|NCT01362790|450573066|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
125258373|NCT01362790|450573067|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
125258374|NCT01362790|450573068|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
125258375|NCT01362790|450573069|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
125258376|NCT01362790|450573070|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
125258377|NCT01362790|450573071|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
125258378|NCT01362790|450573072|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
125258379|NCT01362790|450573066|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
125258380|NCT01362790|450573067|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
125258381|NCT01362790|450573068|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
125258382|NCT01362790|450573069|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
125445695|NCT03619174|451257659|FG001|Overall Study|Lost to Follow-up|0|||
125445696|NCT03619174|451257658|FG000|Overall Study|Withdrawal by Subject|4|||
125445697|NCT03619174|451257659|FG001|Overall Study|Withdrawal by Subject|3|||
125445698|NCT03619174|451257658|FG000|Overall Study|Pregnancy|1|||
125445699|NCT03619174|451257659|FG001|Overall Study|Pregnancy|1|||
125445700|NCT03619174|451257658|FG000|Overall Study|Discomfort during treatment|1|||
125445701|NCT03619174|451257659|FG001|Overall Study|Discomfort during treatment|0|||
125445702|NCT03486899|451257660|FG000|Overall Study|Lost to Follow-up|4|||
125445703|NCT03486899|451257661|FG001|Overall Study|Lost to Follow-up|1|||
125445704|NCT03486899|451257662|FG002|Overall Study|Lost to Follow-up|4|||
125445705|NCT03486899|451257663|FG003|Overall Study|Lost to Follow-up|3|||
125445706|NCT03486899|451257660|FG000|Overall Study|Death|1|||
125445707|NCT03486899|451257661|FG001|Overall Study|Death|0|||
125445708|NCT03486899|451257662|FG002|Overall Study|Death|0|||
125258383|NCT01362790|450573070|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
125258384|NCT01362790|450573071|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
125258385|NCT01362790|450573072|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
125258386|NCT01362790|450573066|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
125258387|NCT01362790|450573067|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
125258388|NCT01362790|450573068|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
125258389|NCT01362790|450573069|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
125258390|NCT01362790|450573070|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
125258391|NCT01362790|450573071|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
125258392|NCT01362790|450573072|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
125258393|NCT02457065|450573073|FG000|Overall Study|Lost to Follow-up|9|||
125258394|NCT02457065|450573074|FG001|Overall Study|Lost to Follow-up|11|||
125258395|NCT05805150|450573076|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
125258396|NCT05805150|450573077|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
125258397|NCT01506726|450573083|FG000|Overall Study|Adverse Event|1|||
125258398|NCT01506726|450573084|FG001|Overall Study|Adverse Event|2|||
125258399|NCT04347538|450573088|FG000|Overall Study|Lost to Follow-up|4|||
125258400|NCT04347538|450573089|FG001|Overall Study|Lost to Follow-up|5|||
125258401|NCT04347538|450573090|FG002|Overall Study|Lost to Follow-up|7|||
125258402|NCT02135133|450573091|FG000|Overall Study|Adverse Event|10|||
125258403|NCT02135133|450573091|FG000|Overall Study|regulatory mandate|5|||
125258404|NCT05081843|450573092|FG000|Overall Study|Lost to Follow-up|135|||
125258405|NCT05081843|450573093|FG001|Overall Study|Lost to Follow-up|145|||
125258406|NCT02303821|450573094|FG000|Overall Study|Withdrawal by Subject|0|||
125258407|NCT02303821|450573095|FG001|Overall Study|Withdrawal by Subject|0|||
125258408|NCT02303821|450573096|FG002|Overall Study|Withdrawal by Subject|0|||
125258409|NCT02303821|450573097|FG003|Overall Study|Withdrawal by Subject|0|||
125258410|NCT02303821|450573098|FG004|Overall Study|Withdrawal by Subject|0|||
125258411|NCT02303821|450573099|FG005|Overall Study|Withdrawal by Subject|0|||
125258412|NCT02303821|450573100|FG006|Overall Study|Withdrawal by Subject|0|||
125258413|NCT02303821|450573101|FG007|Overall Study|Withdrawal by Subject|2|||
125258414|NCT02303821|450573094|FG000|Overall Study|Death|0|||
125258415|NCT02303821|450573095|FG001|Overall Study|Death|2|||
125258416|NCT02303821|450573096|FG002|Overall Study|Death|0|||
125258417|NCT02303821|450573097|FG003|Overall Study|Death|0|||
125258418|NCT02303821|450573098|FG004|Overall Study|Death|0|||
125258419|NCT02303821|450573099|FG005|Overall Study|Death|3|||
125258420|NCT02303821|450573100|FG006|Overall Study|Death|41|||
125258421|NCT02303821|450573101|FG007|Overall Study|Death|29|||
125258422|NCT02303821|450573094|FG000|Overall Study|Lost to Follow-up|0|||
125258423|NCT02303821|450573095|FG001|Overall Study|Lost to Follow-up|0|||
125258424|NCT02303821|450573096|FG002|Overall Study|Lost to Follow-up|0|||
125258425|NCT02303821|450573097|FG003|Overall Study|Lost to Follow-up|0|||
125258426|NCT02303821|450573098|FG004|Overall Study|Lost to Follow-up|0|||
125397585|NCT04649151|451089214|FG000|Overall Study|Lost to Follow-up|256|||
125397586|NCT04649151|451089215|FG001|Overall Study|Lost to Follow-up|29|||
125397587|NCT04649151|451089216|FG002|Overall Study|Lost to Follow-up|10|||
125397588|NCT04649151|451089217|FG003|Overall Study|Lost to Follow-up|3|||
125397589|NCT04649151|451089218|FG004|Overall Study|Lost to Follow-up|6|||
125397590|NCT04649151|451089214|FG000|Overall Study|Other than specified|59|||
125397591|NCT04649151|451089215|FG001|Overall Study|Other than specified|294|||
125397592|NCT04649151|451089216|FG002|Overall Study|Other than specified|0|||
125397593|NCT04649151|451089217|FG003|Overall Study|Other than specified|0|||
125397594|NCT04649151|451089218|FG004|Overall Study|Other than specified|4|||
125397595|NCT04649151|451089214|FG000|Overall Study|Death|0|||
125397596|NCT04649151|451089215|FG001|Overall Study|Death|0|||
125397597|NCT04649151|451089216|FG002|Overall Study|Death|0|||
125397598|NCT04649151|451089217|FG003|Overall Study|Death|0|||
125397599|NCT04649151|451089218|FG004|Overall Study|Death|1|||
125397600|NCT03752619|451089219|FG000|Overall Study|Lost to Follow-up|2|||
125397601|NCT03752619|451089220|FG001|Overall Study|Lost to Follow-up|1|||
125397602|NCT03752619|451089219|FG000|Overall Study|Withdrawal by Subject|1|||
125258427|NCT02303821|450573099|FG005|Overall Study|Lost to Follow-up|0|||
125258428|NCT02303821|450573100|FG006|Overall Study|Lost to Follow-up|1|||
125397603|NCT03752619|451089220|FG001|Overall Study|Withdrawal by Subject|1|||
125258429|NCT02303821|450573101|FG007|Overall Study|Lost to Follow-up|0|||
125258430|NCT02303821|450573094|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125258431|NCT02303821|450573095|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125258432|NCT02303821|450573096|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125397604|NCT03752619|451089219|FG000|Overall Study|Adverse Event|0|||
125258433|NCT02303821|450573097|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125258434|NCT02303821|450573098|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125258435|NCT02303821|450573099|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125258436|NCT02303821|450573100|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
125397605|NCT03752619|451089220|FG001|Overall Study|Adverse Event|1|||
125397606|NCT03362502|451089222|FG000|Overall Study|Death|0|||
125258437|NCT02303821|450573101|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
125258438|NCT02303821|450573094|FG000|Overall Study|Decision by sponsor|0|||
125258439|NCT02303821|450573095|FG001|Overall Study|Decision by sponsor|0|||
125258440|NCT02303821|450573096|FG002|Overall Study|Decision by sponsor|0|||
125258441|NCT02303821|450573097|FG003|Overall Study|Decision by sponsor|0|||
125258442|NCT02303821|450573098|FG004|Overall Study|Decision by sponsor|0|||
125258443|NCT02303821|450573099|FG005|Overall Study|Decision by sponsor|1|||
125258444|NCT02303821|450573100|FG006|Overall Study|Decision by sponsor|0|||
125258445|NCT02303821|450573101|FG007|Overall Study|Decision by sponsor|0|||
125258446|NCT02303821|450573094|FG000|Overall Study|Protocol-specified criteria|0|||
125258447|NCT02303821|450573095|FG001|Overall Study|Protocol-specified criteria|1|||
125258448|NCT02303821|450573096|FG002|Overall Study|Protocol-specified criteria|0|||
125258449|NCT02303821|450573097|FG003|Overall Study|Protocol-specified criteria|0|||
125258450|NCT02303821|450573098|FG004|Overall Study|Protocol-specified criteria|0|||
125258451|NCT02303821|450573099|FG005|Overall Study|Protocol-specified criteria|1|||
125258452|NCT02303821|450573100|FG006|Overall Study|Protocol-specified criteria|0|||
125258453|NCT02303821|450573101|FG007|Overall Study|Protocol-specified criteria|0|||
125258454|NCT04116489|450573114|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
125258455|NCT04116489|450573114|FG000|Overall Study|Withdrawal by Subject|1|||
125258456|NCT03734536|450573115|FG000|Overall Study|Withdrew Consent|1|||
125258457|NCT03734536|450573116|FG001|Overall Study|Withdrew Consent|5|||
125258458|NCT03734536|450573115|FG000|Overall Study|Lost to Follow-up|10|||
125258459|NCT03734536|450573116|FG001|Overall Study|Lost to Follow-up|7|||
125258460|NCT04727151|450573117|FG000|Overall Study|Death|0|||
125258461|NCT04727151|450573118|FG001|Overall Study|Death|0|||
125258462|NCT04727151|450573119|FG002|Overall Study|Death|0|||
125258463|NCT04727151|450573120|FG003|Overall Study|Death|0|||
125258464|NCT04727151|450573121|FG004|Overall Study|Death|3|||
125258465|NCT04727151|450573117|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
125258466|NCT04727151|450573118|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
125258467|NCT04727151|450573119|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
125258468|NCT04727151|450573120|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
125258469|NCT04727151|450573121|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
125258470|NCT01346592|450573123|FG000|Overall Study|Lost to Follow-up|62|||
125258471|NCT01346592|450573124|FG001|Overall Study|Lost to Follow-up|29|||
125258472|NCT01346592|450573125|FG002|Overall Study|Lost to Follow-up|29|||
125258473|NCT01346592|450573123|FG000|Overall Study|Protocol Violation|2|||
125258474|NCT01346592|450573124|FG001|Overall Study|Protocol Violation|1|||
125258475|NCT01346592|450573125|FG002|Overall Study|Protocol Violation|0|||
125258476|NCT01346592|450573123|FG000|Overall Study|Death|1|||
125258477|NCT01346592|450573124|FG001|Overall Study|Death|3|||
125258478|NCT01346592|450573125|FG002|Overall Study|Death|4|||
125258479|NCT01346592|450573123|FG000|Overall Study|Adverse Event|0|||
125258480|NCT01346592|450573124|FG001|Overall Study|Adverse Event|1|||
125258481|NCT01346592|450573125|FG002|Overall Study|Adverse Event|0|||
125258482|NCT01346592|450573123|FG000|Overall Study|Withdrawal by Subject|77|||
125258483|NCT01346592|450573124|FG001|Overall Study|Withdrawal by Subject|51|||
125258484|NCT01346592|450573125|FG002|Overall Study|Withdrawal by Subject|38|||
125258485|NCT01346592|450573123|FG000|Overall Study|Inappropriate enrollment|3|||
125258486|NCT01346592|450573124|FG001|Overall Study|Inappropriate enrollment|1|||
125258487|NCT01346592|450573125|FG002|Overall Study|Inappropriate enrollment|1|||
125258488|NCT01346592|450573123|FG000|Overall Study|Administrative reason|1|||
125258489|NCT01346592|450573124|FG001|Overall Study|Administrative reason|0|||
125258490|NCT01346592|450573125|FG002|Overall Study|Administrative reason|0|||
125258491|NCT01346592|450573123|FG000|Overall Study|Unable to Classify|7|||
125258492|NCT01346592|450573124|FG001|Overall Study|Unable to Classify|3|||
125258493|NCT01346592|450573125|FG002|Overall Study|Unable to Classify|6|||
125258494|NCT02679274|450573126|FG000|Overall Study|Withdrawal by Subject|1|||
125258495|NCT02679274|450573127|FG001|Overall Study|Withdrawal by Subject|0|||
125258496|NCT02038036|450573132|FG000|Core Study|Adverse Event|7|||
125258497|NCT02038036|450573133|FG001|Core Study|Adverse Event|7|||
125445709|NCT03486899|451257663|FG003|Overall Study|Death|1|||
125445710|NCT03486899|451257660|FG000|Overall Study|Adverse Event|0|||
125445711|NCT03486899|451257661|FG001|Overall Study|Adverse Event|2|||
125445712|NCT03486899|451257662|FG002|Overall Study|Adverse Event|0|||
125258498|NCT02038036|450573132|FG000|Core Study|Death|1|||
125258499|NCT02038036|450573133|FG001|Core Study|Death|1|||
125258500|NCT02038036|450573132|FG000|Core Study|Disease progression|2|||
125258501|NCT02038036|450573133|FG001|Core Study|Disease progression|2|||
125258502|NCT02038036|450573132|FG000|Core Study|Lost to Follow-up|0|||
125258503|NCT02038036|450573133|FG001|Core Study|Lost to Follow-up|1|||
125258504|NCT02038036|450573132|FG000|Core Study|Physician Decision|2|||
125258505|NCT02038036|450573133|FG001|Core Study|Physician Decision|1|||
125258506|NCT02038036|450573132|FG000|Core Study|Subject/guardian decision|0|||
125258507|NCT02038036|450573133|FG001|Core Study|Subject/guardian decision|1|||
125258508|NCT02038036|450573132|FG000|Core Study|Withdrawal by Subject|3|||
125258509|NCT02038036|450573133|FG001|Core Study|Withdrawal by Subject|1|||
125445713|NCT03486899|451257663|FG003|Overall Study|Adverse Event|2|||
125258510|NCT02038036|450573132|FG000|Crossover Period|Withdrawal by Subject|0|||
125445714|NCT03486899|451257660|FG000|Overall Study|Withdrawal by Subject|3|||
125445715|NCT03486899|451257661|FG001|Overall Study|Withdrawal by Subject|7|||
125445716|NCT03486899|451257662|FG002|Overall Study|Withdrawal by Subject|4|||
125445717|NCT03486899|451257663|FG003|Overall Study|Withdrawal by Subject|3|||
125445718|NCT03486899|451257660|FG000|Overall Study|Other Reasons|0|||
125445719|NCT03486899|451257661|FG001|Overall Study|Other Reasons|1|||
125445720|NCT03486899|451257662|FG002|Overall Study|Other Reasons|0|||
125445721|NCT03486899|451257663|FG003|Overall Study|Other Reasons|1|||
125445722|NCT01010217|451257664|FG000|Overall Study|Lost to Follow-up|4|||
125445723|NCT01010217|451257665|FG001|Overall Study|Lost to Follow-up|5|||
125445724|NCT01010217|451257666|FG002|Overall Study|Lost to Follow-up|1|||
125445725|NCT01010217|451257667|FG003|Overall Study|Lost to Follow-up|0|||
125445726|NCT01010217|451257668|FG004|Overall Study|Lost to Follow-up|0|||
125445727|NCT01010217|451257664|FG000|Overall Study|Withdrawal by Subject|1|||
125445728|NCT01010217|451257665|FG001|Overall Study|Withdrawal by Subject|0|||
125445729|NCT01010217|451257666|FG002|Overall Study|Withdrawal by Subject|0|||
125445730|NCT01010217|451257667|FG003|Overall Study|Withdrawal by Subject|0|||
125445731|NCT01010217|451257668|FG004|Overall Study|Withdrawal by Subject|0|||
125445732|NCT01010217|451257664|FG000|Overall Study|Physician Decision|0|||
125445733|NCT01010217|451257665|FG001|Overall Study|Physician Decision|0|||
125445734|NCT01010217|451257666|FG002|Overall Study|Physician Decision|0|||
125445735|NCT01010217|451257667|FG003|Overall Study|Physician Decision|6|||
125445736|NCT01010217|451257668|FG004|Overall Study|Physician Decision|3|||
125445737|NCT01782326|451257670|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
125445738|NCT01782326|451257671|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
125445739|NCT01782326|451257670|FG000|Planned Treatment Epoch|Death|29|||
125445740|NCT01782326|451257671|FG001|Planned Treatment Epoch|Death|30|||
125445741|NCT01782326|451257670|FG000|Planned Treatment Epoch|Physician Decision|18|||
125445742|NCT01782326|451257671|FG001|Planned Treatment Epoch|Physician Decision|16|||
125445743|NCT01782326|451257670|FG000|Planned Treatment Epoch|Protocol deviation|2|||
125445744|NCT01782326|451257671|FG001|Planned Treatment Epoch|Protocol deviation|3|||
125445745|NCT01782326|451257670|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
125445746|NCT01782326|451257671|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
125445747|NCT01782326|451257670|FG000|Planned Treatment Epoch|Technical problems|0|||
125445748|NCT01782326|451257671|FG001|Planned Treatment Epoch|Technical problems|4|||
125445749|NCT01782326|451257670|FG000|Double-blind Treatment|Adverse Event|129|||
125445750|NCT01782326|451257671|FG001|Double-blind Treatment|Adverse Event|145|||
125445751|NCT01782326|451257670|FG000|Double-blind Treatment|Subject/guardian decision|111|||
125445752|NCT01782326|451257671|FG001|Double-blind Treatment|Subject/guardian decision|125|||
125445753|NCT01782326|451257670|FG000|Double-blind Treatment|Lack of Efficacy|17|||
125445754|NCT01782326|451257671|FG001|Double-blind Treatment|Lack of Efficacy|22|||
125445755|NCT01782326|451257670|FG000|Double-blind Treatment|Physician Decision|13|||
125445756|NCT01782326|451257671|FG001|Double-blind Treatment|Physician Decision|16|||
125445757|NCT01782326|451257670|FG000|Double-blind Treatment|Protocol deviation|8|||
125445758|NCT01782326|451257671|FG001|Double-blind Treatment|Protocol deviation|7|||
125258511|NCT02038036|450573133|FG001|Crossover Period|Withdrawal by Subject|3|||
125258512|NCT02038036|450573132|FG000|Crossover Period|Adverse Event|0|||
125258513|NCT02038036|450573133|FG001|Crossover Period|Adverse Event|9|||
125258514|NCT02038036|450573132|FG000|Crossover Period|Death|0|||
125258515|NCT02038036|450573133|FG001|Crossover Period|Death|2|||
125258516|NCT02038036|450573132|FG000|Crossover Period|Disease progression|0|||
125258517|NCT02038036|450573133|FG001|Crossover Period|Disease progression|3|||
125258518|NCT02038036|450573132|FG000|Crossover Period|Lost to Follow-up|0|||
125258519|NCT02038036|450573133|FG001|Crossover Period|Lost to Follow-up|1|||
125258520|NCT02038036|450573132|FG000|Crossover Period|Physician Decision|0|||
125258521|NCT02038036|450573133|FG001|Crossover Period|Physician Decision|2|||
125258522|NCT03537508|450573141|FG000|Overall Study|Adverse Event|2|||
125445759|NCT01782326|451257670|FG000|Double-blind Treatment|Technical problems|0|||
125445760|NCT01782326|451257671|FG001|Double-blind Treatment|Technical problems|5|||
125445761|NCT00738530|451257684|FG000|Overall Study|Death|220|||
125258523|NCT03537508|450573142|FG001|Overall Study|Adverse Event|1|||
125258524|NCT03537508|450573141|FG000|Overall Study|Protocol Violation|65|||
125258525|NCT03537508|450573142|FG001|Overall Study|Protocol Violation|48|||
125258526|NCT03537508|450573141|FG000|Overall Study|Lost to Follow-up|86|||
125258527|NCT03537508|450573142|FG001|Overall Study|Lost to Follow-up|60|||
125258528|NCT03537508|450573141|FG000|Overall Study|Withdrawal by parent/guardian|263|||
125445762|NCT00738530|451257685|FG001|Overall Study|Death|224|||
125445763|NCT00738530|451257684|FG000|Overall Study|Lost to Follow-up|8|||
125445764|NCT00738530|451257685|FG001|Overall Study|Lost to Follow-up|6|||
125445765|NCT00738530|451257684|FG000|Overall Study|Withdrawal by Subject|6|||
125445766|NCT00738530|451257685|FG001|Overall Study|Withdrawal by Subject|8|||
125445767|NCT01628510|451257686|FG000|Overall Study|Withdrawal by Subject|0|||
125445768|NCT01628510|451257687|FG001|Overall Study|Withdrawal by Subject|4|||
125445769|NCT01628510|451257686|FG000|Overall Study|Death|3|||
125445770|NCT01628510|451257687|FG001|Overall Study|Death|1|||
125445771|NCT01653847|451257688|FG000|Overall Study|Withdrawal by Subject|1|||
125258529|NCT03537508|450573142|FG001|Overall Study|Withdrawal by parent/guardian|149|||
125258530|NCT01972659|450573143|FG000|Overall Study|Protocol Violation|2|||
125258531|NCT01972659|450573144|FG001|Overall Study|Protocol Violation|2|||
125258532|NCT01972659|450573143|FG000|Overall Study|problems realted to acceleromyograph|2|||
125258533|NCT01972659|450573144|FG001|Overall Study|problems realted to acceleromyograph|1|||
125258534|NCT04144517|450573148|FG000|Overall Study|Physician Decision|0|||
125258535|NCT04144517|450573149|FG001|Overall Study|Physician Decision|1|||
125258536|NCT04144517|450573148|FG000|Overall Study|Other|2|||
125258537|NCT04144517|450573149|FG001|Overall Study|Other|2|||
125258538|NCT04144517|450573148|FG000|Overall Study|Death|6|||
125258539|NCT04144517|450573149|FG001|Overall Study|Death|3|||
125258540|NCT00835367|450573155|FG000|Washout|Adverse Event|2|||
125258541|NCT00835367|450573156|FG001|Washout|Adverse Event|0|||
125258542|NCT00835367|450573155|FG000|Washout|Withdrawal by Subject|1|||
125258543|NCT00835367|450573156|FG001|Washout|Withdrawal by Subject|0|||
125258544|NCT00835367|450573155|FG000|Second Intervention|Adverse Event|1|||
125258545|NCT00835367|450573156|FG001|Second Intervention|Adverse Event|1|||
125258546|NCT02495883|450573157|FG000|Overall Study|Excessive head motion|1|||
125258547|NCT02495883|450573158|FG001|Overall Study|Excessive head motion|0|||
125258548|NCT00791648|450575127|FG000|Overall Study|Physician Decision|0|||
125258549|NCT00791648|450575128|FG001|Overall Study|Physician Decision|1|||
125258550|NCT00791648|450575127|FG000|Overall Study|Withdrawal by Subject|0|||
125258551|NCT00791648|450575128|FG001|Overall Study|Withdrawal by Subject|1|||
125258552|NCT04976777|450575129|FG000|Overall Study|COVID-19 Infection|1|||
125258553|NCT04976777|450575130|FG001|Overall Study|COVID-19 Infection|0|||
125258554|NCT00462826|450575131|FG000|Overall Study|Ineligible - second primary|1|||
125258555|NCT00462826|450575131|FG000|Overall Study|Ineligible - wrong cell type|1|||
125258556|NCT00462826|450575131|FG000|Overall Study|Ineligible - wrong primary|2|||
125258557|NCT00462826|450575131|FG000|Overall Study|Never treated|1|||
125258558|NCT02278003|450575132|FG000|Overall Study|Withdrawal by Subject|11|||
125258559|NCT02278003|450575133|FG001|Overall Study|Withdrawal by Subject|0|||
125258560|NCT02278003|450575132|FG000|Overall Study|Not Treated|1|||
125258561|NCT02278003|450575133|FG001|Overall Study|Not Treated|0|||
125258562|NCT02278003|450575132|FG000|Overall Study|Recognition task improperly completed|7|||
125258563|NCT02278003|450575133|FG001|Overall Study|Recognition task improperly completed|0|||
125258564|NCT03440385|450575148|FG000|Overall Study|Other Reason|4|||
125258565|NCT03440385|450575149|FG001|Overall Study|Other Reason|1|||
125258566|NCT03440385|450575148|FG000|Overall Study|Site Closed|1|||
125258567|NCT03440385|450575149|FG001|Overall Study|Site Closed|0|||
125258568|NCT03440385|450575148|FG000|Overall Study|Lost to Follow-up|2|||
125258569|NCT03440385|450575149|FG001|Overall Study|Lost to Follow-up|0|||
125258570|NCT03440385|450575148|FG000|Overall Study|Withdrawal by Subject|12|||
125258571|NCT03440385|450575149|FG001|Overall Study|Withdrawal by Subject|6|||
125258572|NCT03440385|450575148|FG000|Overall Study|Lack of Efficacy|9|||
125258573|NCT03440385|450575149|FG001|Overall Study|Lack of Efficacy|2|||
125258574|NCT03440385|450575148|FG000|Overall Study|Adverse Event|15|||
125258575|NCT03440385|450575149|FG001|Overall Study|Adverse Event|11|||
125258576|NCT04123704|450575150|FG000|Overall Study|Disease progression|2|||
125258577|NCT00939185|450575151|FG000|Overall Study|Adverse Event|3|||
125258578|NCT00939185|450575151|FG000|Overall Study|Lack of Efficacy|1|||
125258579|NCT00939185|450575151|FG000|Overall Study|Lost to Follow-up|6|||
125258580|NCT00939185|450575151|FG000|Overall Study|Other|3|||
125258581|NCT00939185|450575151|FG000|Overall Study|Withdrawal by Subject|2|||
125258582|NCT00939185|450575151|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
125258583|NCT00363298|450575152|FG000|First Study Week|Lack of Efficacy|6|||
125258584|NCT00363298|450575153|FG001|First Study Week|Lack of Efficacy|5|||
125258585|NCT00363298|450575152|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
125258586|NCT00363298|450575153|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
125258587|NCT00836706|450575157|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
125258588|NCT00836706|450575158|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
125258589|NCT02390076|450575163|FG000|Overall Study|Lost to Follow-up|2|||
125258590|NCT02390076|450575164|FG001|Overall Study|Lost to Follow-up|1|||
125258591|NCT02390076|450575165|FG002|Overall Study|Lost to Follow-up|4|||
125258592|NCT01822925|450575167|FG000|Overall Study|Adverse Event|1|||
125258593|NCT01822925|450575168|FG001|Overall Study|Adverse Event|1|||
125258594|NCT01822925|450575169|FG002|Overall Study|Adverse Event|1|||
125258595|NCT01822925|450575170|FG003|Overall Study|Adverse Event|1|||
125258596|NCT01822925|450575167|FG000|Overall Study|Lost to Follow-up|0|||
125258597|NCT01822925|450575168|FG001|Overall Study|Lost to Follow-up|1|||
125258598|NCT01822925|450575169|FG002|Overall Study|Lost to Follow-up|0|||
125258599|NCT01822925|450575170|FG003|Overall Study|Lost to Follow-up|0|||
125258600|NCT01822925|450575167|FG000|Overall Study|Protocol Violation|1|||
125258601|NCT01822925|450575168|FG001|Overall Study|Protocol Violation|0|||
125258602|NCT01822925|450575169|FG002|Overall Study|Protocol Violation|0|||
125258603|NCT01822925|450575170|FG003|Overall Study|Protocol Violation|1|||
125258604|NCT01822925|450575167|FG000|Overall Study|Withdrawal by Subject|2|||
125258605|NCT01822925|450575168|FG001|Overall Study|Withdrawal by Subject|0|||
125258606|NCT01822925|450575169|FG002|Overall Study|Withdrawal by Subject|2|||
125258607|NCT01822925|450575170|FG003|Overall Study|Withdrawal by Subject|2|||
125258608|NCT01822925|450575167|FG000|Overall Study|Taking prohibited medication|2|||
125258609|NCT01822925|450575168|FG001|Overall Study|Taking prohibited medication|0|||
125258610|NCT01822925|450575169|FG002|Overall Study|Taking prohibited medication|0|||
125258611|NCT01822925|450575170|FG003|Overall Study|Taking prohibited medication|1|||
125258612|NCT04617860|450575171|FG000|Overall Study|Adverse Event|0|||
125258613|NCT04617860|450575172|FG001|Overall Study|Adverse Event|2|||
125258614|NCT04617860|450575173|FG002|Overall Study|Adverse Event|2|||
125258615|NCT04617860|450575171|FG000|Overall Study|Withdrawal by Subject|0|||
125258616|NCT04617860|450575172|FG001|Overall Study|Withdrawal by Subject|0|||
125258617|NCT04617860|450575173|FG002|Overall Study|Withdrawal by Subject|2|||
125258618|NCT04617860|450575171|FG000|Overall Study|Physician Decision|0|||
125258619|NCT04617860|450575172|FG001|Overall Study|Physician Decision|1|||
125258620|NCT04617860|450575173|FG002|Overall Study|Physician Decision|0|||
125258621|NCT04617860|450575171|FG000|Overall Study|Sponsor Decision|0|||
125258622|NCT04617860|450575172|FG001|Overall Study|Sponsor Decision|3|||
125258623|NCT04617860|450575173|FG002|Overall Study|Sponsor Decision|1|||
125258624|NCT04617860|450575171|FG000|Overall Study|Termination of Study by Sponsor|8|||
125258625|NCT04617860|450575172|FG001|Overall Study|Termination of Study by Sponsor|4|||
125258626|NCT04617860|450575173|FG002|Overall Study|Termination of Study by Sponsor|13|||
125258627|NCT01182350|450575174|FG000|Overall Study|Adverse Event|5|||
125258628|NCT01182350|450575175|FG001|Overall Study|Adverse Event|0|||
125258629|NCT01182350|450575176|FG002|Overall Study|Adverse Event|0|||
125258630|NCT01182350|450575177|FG003|Overall Study|Adverse Event|0|||
125258631|NCT01182350|450575178|FG004|Overall Study|Adverse Event|0|||
125258632|NCT01182350|450575174|FG000|Overall Study|Disease Progression|15|||
125258633|NCT01182350|450575175|FG001|Overall Study|Disease Progression|12|||
125258634|NCT01182350|450575176|FG002|Overall Study|Disease Progression|0|||
125258635|NCT01182350|450575177|FG003|Overall Study|Disease Progression|1|||
125258636|NCT01182350|450575178|FG004|Overall Study|Disease Progression|0|||
125258637|NCT01182350|450575174|FG000|Overall Study|Death|0|||
125258638|NCT01182350|450575175|FG001|Overall Study|Death|1|||
125258639|NCT01182350|450575176|FG002|Overall Study|Death|1|||
125258640|NCT01182350|450575177|FG003|Overall Study|Death|0|||
125258641|NCT01182350|450575178|FG004|Overall Study|Death|0|||
125258642|NCT01182350|450575174|FG000|Overall Study|Withdrawal by Subject|3|||
125258643|NCT01182350|450575175|FG001|Overall Study|Withdrawal by Subject|1|||
125258644|NCT01182350|450575176|FG002|Overall Study|Withdrawal by Subject|0|||
125258645|NCT01182350|450575177|FG003|Overall Study|Withdrawal by Subject|1|||
125258646|NCT01182350|450575178|FG004|Overall Study|Withdrawal by Subject|0|||
125258647|NCT01182350|450575174|FG000|Overall Study|Alternative Therapy|2|||
125258648|NCT01182350|450575175|FG001|Overall Study|Alternative Therapy|0|||
125258649|NCT01182350|450575176|FG002|Overall Study|Alternative Therapy|1|||
125258650|NCT01182350|450575177|FG003|Overall Study|Alternative Therapy|0|||
125258651|NCT01182350|450575178|FG004|Overall Study|Alternative Therapy|0|||
125258652|NCT01182350|450575174|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
125258653|NCT01182350|450575175|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
125258654|NCT01182350|450575176|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
125258655|NCT01182350|450575177|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
125258656|NCT01182350|450575178|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
125258657|NCT01182350|450575174|FG000|Overall Study|Unevaluable for Biopsy|0|||
125258658|NCT01182350|450575175|FG001|Overall Study|Unevaluable for Biopsy|0|||
125258659|NCT01182350|450575176|FG002|Overall Study|Unevaluable for Biopsy|0|||
125258660|NCT01182350|450575177|FG003|Overall Study|Unevaluable for Biopsy|0|||
125258661|NCT01182350|450575178|FG004|Overall Study|Unevaluable for Biopsy|3|||
125258662|NCT03898180|450575179|FG000|Overall Study|Death|178|||
125258663|NCT03898180|450575180|FG001|Overall Study|Death|173|||
125258664|NCT03898180|450575179|FG000|Overall Study|Physician Decision|1|||
125258665|NCT03898180|450575180|FG001|Overall Study|Physician Decision|0|||
125258666|NCT03898180|450575179|FG000|Overall Study|Sponsor Decision|3|||
125258667|NCT03898180|450575180|FG001|Overall Study|Sponsor Decision|0|||
125258668|NCT03898180|450575179|FG000|Overall Study|Lost to Follow-up|1|||
125258669|NCT03898180|450575180|FG001|Overall Study|Lost to Follow-up|0|||
125258670|NCT03898180|450575179|FG000|Overall Study|Withdrawal by Subject|5|||
125258671|NCT03898180|450575180|FG001|Overall Study|Withdrawal by Subject|4|||
125258672|NCT01646827|450575181|FG000|Overall Study|Lost to Follow-up|0|||
125258673|NCT01646827|450575182|FG001|Overall Study|Lost to Follow-up|3|||
125258674|NCT01646827|450575181|FG000|Overall Study|Physician Decision|1|||
125397607|NCT03362502|451089223|FG001|Overall Study|Death|0|||
125258675|NCT01646827|450575182|FG001|Overall Study|Physician Decision|2|||
125258676|NCT01646827|450575181|FG000|Overall Study|Withdrawal by Subject|1|||
125258677|NCT01646827|450575182|FG001|Overall Study|Withdrawal by Subject|0|||
125258678|NCT00928668|450575183|FG000|Overall Study|Adverse Event|1|||
125258679|NCT00928668|450575184|FG001|Overall Study|Adverse Event|0|||
125258680|NCT00928668|450575185|FG002|Overall Study|Adverse Event|0|||
125258681|NCT00928668|450575186|FG003|Overall Study|Adverse Event|0|||
125397608|NCT03362502|451089224|FG002|Overall Study|Death|1|||
125258682|NCT00928668|450575187|FG004|Overall Study|Adverse Event|0|||
125258683|NCT00928668|450575183|FG000|Overall Study|Protocol Violation|0|||
125445772|NCT01653847|451257689|FG001|Overall Study|Withdrawal by Subject|0|||
125445773|NCT04707391|451257690|FG000|Overall Study|Adverse Event|5|||
125445774|NCT04707391|451257691|FG001|Overall Study|Adverse Event|8|||
125445775|NCT04707391|451257690|FG000|Overall Study|Lost to Follow-up|44|||
125445776|NCT04707391|451257691|FG001|Overall Study|Lost to Follow-up|31|||
125445777|NCT04707391|451257690|FG000|Overall Study|Protocol Violation|1|||
125445778|NCT04707391|451257691|FG001|Overall Study|Protocol Violation|5|||
125445779|NCT04707391|451257690|FG000|Overall Study|Withdrawal by Subject|27|||
125445780|NCT04707391|451257691|FG001|Overall Study|Withdrawal by Subject|25|||
125445781|NCT04707391|451257690|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
125445782|NCT04707391|451257691|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
125445783|NCT04707391|451257690|FG000|Overall Study|Other|0|||
125445784|NCT04707391|451257691|FG001|Overall Study|Other|2|||
125445785|NCT03246672|451257692|FG000|Overall Study|Lost to Follow-up|2|||
125445786|NCT01347645|451257693|FG000|Overall Study|Death|1|||
125445787|NCT01347645|451257694|FG001|Overall Study|Death|5|||
125445788|NCT01347645|451257695|FG002|Overall Study|Death|2|||
125445789|NCT01347645|451257696|FG003|Overall Study|Death|7|||
125445790|NCT01347645|451257697|FG004|Overall Study|Death|7|||
125445791|NCT01347645|451257693|FG000|Overall Study|Lost to Follow-up|1|||
125445792|NCT01347645|451257694|FG001|Overall Study|Lost to Follow-up|1|||
125445793|NCT01347645|451257695|FG002|Overall Study|Lost to Follow-up|0|||
125445794|NCT01347645|451257696|FG003|Overall Study|Lost to Follow-up|1|||
125445795|NCT01347645|451257697|FG004|Overall Study|Lost to Follow-up|1|||
125445796|NCT01347645|451257693|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
125445797|NCT01347645|451257694|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
125445798|NCT01347645|451257695|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
125445799|NCT01347645|451257696|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
125445800|NCT01347645|451257697|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
125445801|NCT01347645|451257693|FG000|Overall Study|Other|1|||
125445802|NCT01347645|451257694|FG001|Overall Study|Other|0|||
125445803|NCT01347645|451257695|FG002|Overall Study|Other|0|||
125445804|NCT01347645|451257696|FG003|Overall Study|Other|0|||
125445805|NCT01347645|451257697|FG004|Overall Study|Other|1|||
125445806|NCT01347645|451257693|FG000|Overall Study|Withdrawal by Subject|0|||
125445807|NCT01347645|451257694|FG001|Overall Study|Withdrawal by Subject|0|||
125445808|NCT01347645|451257695|FG002|Overall Study|Withdrawal by Subject|0|||
125445809|NCT01347645|451257696|FG003|Overall Study|Withdrawal by Subject|3|||
125445810|NCT01347645|451257697|FG004|Overall Study|Withdrawal by Subject|3|||
125445811|NCT01347645|451257693|FG000|Overall Study|Physician Decision|0|||
125445812|NCT01347645|451257694|FG001|Overall Study|Physician Decision|0|||
125445813|NCT01347645|451257695|FG002|Overall Study|Physician Decision|0|||
125445814|NCT01347645|451257696|FG003|Overall Study|Physician Decision|0|||
125445815|NCT01347645|451257697|FG004|Overall Study|Physician Decision|1|||
125445816|NCT01347645|451257693|FG000|Overall Study|Adverse Event|0|||
125445817|NCT01347645|451257694|FG001|Overall Study|Adverse Event|0|||
125445818|NCT01347645|451257695|FG002|Overall Study|Adverse Event|0|||
125445819|NCT01347645|451257696|FG003|Overall Study|Adverse Event|1|||
125445820|NCT01347645|451257697|FG004|Overall Study|Adverse Event|1|||
125445821|NCT01163149|451257699|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
125445822|NCT01163149|451257700|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
125445823|NCT01163149|451257701|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
125445824|NCT01163149|451257699|FG000|Extension Treatment Period|Adverse Event|0|||
125445825|NCT01163149|451257700|FG001|Extension Treatment Period|Adverse Event|1|||
125445826|NCT01163149|451257701|FG002|Extension Treatment Period|Adverse Event|0|||
125445827|NCT01163149|451257699|FG000|Extension Treatment Period|Noncompliance|0|||
125445828|NCT01163149|451257700|FG001|Extension Treatment Period|Noncompliance|0|||
125445829|NCT01163149|451257701|FG002|Extension Treatment Period|Noncompliance|1|||
125445830|NCT01923428|451257710|FG000|Overall Study|Adverse Event|8|||
125445831|NCT01923428|451257711|FG001|Overall Study|Adverse Event|6|||
125445832|NCT01923428|451257712|FG002|Overall Study|Adverse Event|3|||
125445833|NCT01923428|451257713|FG003|Overall Study|Adverse Event|3|||
125445834|NCT01923428|451257710|FG000|Overall Study|Withdrawal by Subject|5|||
125445835|NCT01923428|451257711|FG001|Overall Study|Withdrawal by Subject|3|||
125445836|NCT01923428|451257712|FG002|Overall Study|Withdrawal by Subject|0|||
125445837|NCT01923428|451257713|FG003|Overall Study|Withdrawal by Subject|4|||
125445838|NCT01923428|451257710|FG000|Overall Study|Lost to Follow-up|2|||
125445839|NCT01923428|451257711|FG001|Overall Study|Lost to Follow-up|1|||
125445840|NCT01923428|451257712|FG002|Overall Study|Lost to Follow-up|5|||
125445841|NCT01923428|451257713|FG003|Overall Study|Lost to Follow-up|0|||
125445842|NCT01923428|451257710|FG000|Overall Study|Protocol Violation|3|||
125445843|NCT01923428|451257711|FG001|Overall Study|Protocol Violation|0|||
125445844|NCT01923428|451257712|FG002|Overall Study|Protocol Violation|2|||
125445845|NCT01923428|451257713|FG003|Overall Study|Protocol Violation|1|||
125445846|NCT01923428|451257710|FG000|Overall Study|Non Compliance to treatment|1|||
125445847|NCT01923428|451257711|FG001|Overall Study|Non Compliance to treatment|2|||
125258684|NCT00928668|450575184|FG001|Overall Study|Protocol Violation|0|||
125258685|NCT00928668|450575185|FG002|Overall Study|Protocol Violation|0|||
125258686|NCT00928668|450575186|FG003|Overall Study|Protocol Violation|0|||
125258687|NCT00928668|450575187|FG004|Overall Study|Protocol Violation|1|||
125258688|NCT00928668|450575183|FG000|Overall Study|Withdrawal by Subject|0|||
125258689|NCT00928668|450575184|FG001|Overall Study|Withdrawal by Subject|1|||
125258690|NCT00928668|450575185|FG002|Overall Study|Withdrawal by Subject|1|||
125258691|NCT00928668|450575186|FG003|Overall Study|Withdrawal by Subject|0|||
125258692|NCT00928668|450575187|FG004|Overall Study|Withdrawal by Subject|0|||
125258693|NCT00928668|450575183|FG000|Overall Study|Other reasons not listed above|0|||
125258694|NCT00928668|450575184|FG001|Overall Study|Other reasons not listed above|0|||
125258695|NCT00928668|450575185|FG002|Overall Study|Other reasons not listed above|0|||
125258696|NCT00928668|450575186|FG003|Overall Study|Other reasons not listed above|1|||
125258697|NCT00928668|450575187|FG004|Overall Study|Other reasons not listed above|0|||
125258698|NCT01767987|450575191|FG000|Overall Study|Physician Decision|4|||
125258699|NCT01767987|450575192|FG001|Overall Study|Physician Decision|1|||
125258700|NCT03232567|450575193|FG000|Overall Study|Withdrawal by Subject|0|||
125258701|NCT03232567|450575194|FG001|Overall Study|Withdrawal by Subject|1|||
125258702|NCT03232567|450575195|FG002|Overall Study|Withdrawal by Subject|0|||
125258703|NCT03232567|450575196|FG003|Overall Study|Withdrawal by Subject|0|||
125258704|NCT05837481|450575197|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
125258705|NCT05837481|450575198|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
125258706|NCT03038087|450575201|FG000|Overall Study|lost data|1|||
125258707|NCT02284893|450575210|FG000|26 Week (Short Term)|Adverse Event|1|||
125258708|NCT02284893|450575211|FG001|26 Week (Short Term)|Adverse Event|9|||
125258709|NCT02284893|450575210|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
125258710|NCT02284893|450575211|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
125258711|NCT02284893|450575210|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
125258712|NCT02284893|450575211|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
125258713|NCT02284893|450575210|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
125258714|NCT02284893|450575211|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
125258715|NCT02284893|450575210|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
125258716|NCT02284893|450575211|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
125258717|NCT02284893|450575210|FG000|26 Week (Short Term)|Other|1|||
125258718|NCT02284893|450575211|FG001|26 Week (Short Term)|Other|1|||
125258719|NCT02284893|450575210|FG000|52 Week (Long Term)|Adverse Event|3|||
125258720|NCT02284893|450575211|FG001|52 Week (Long Term)|Adverse Event|1|||
125258721|NCT02284893|450575210|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
125258722|NCT02284893|450575211|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
125258723|NCT02284893|450575210|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
125258724|NCT02284893|450575211|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
125258725|NCT02284893|450575210|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
125258726|NCT02284893|450575211|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
125258727|NCT02284893|450575210|FG000|52 Week (Long Term)|Non-Compliance|2|||
125258728|NCT02284893|450575211|FG001|52 Week (Long Term)|Non-Compliance|3|||
125258729|NCT00105066|450575212|FG000|Overall Study|Adverse Event|2|||
125258730|NCT00105066|450575213|FG001|Overall Study|Adverse Event|5|||
125258731|NCT02259231|450575246|FG000|Overall Study|Adverse Event|1|||
125258732|NCT02259231|450575247|FG001|Overall Study|Adverse Event|1|||
125258733|NCT02259231|450575248|FG002|Overall Study|Adverse Event|2|||
125258734|NCT02259231|450575249|FG003|Overall Study|Adverse Event|0|||
125258735|NCT02259231|450575250|FG004|Overall Study|Adverse Event|0|||
125258736|NCT02259231|450575251|FG005|Overall Study|Adverse Event|0|||
125258737|NCT02259231|450575252|FG006|Overall Study|Adverse Event|0|||
125258738|NCT02259231|450575246|FG000|Overall Study|Progressive Disease|4|||
125258739|NCT02259231|450575247|FG001|Overall Study|Progressive Disease|5|||
125258740|NCT02259231|450575248|FG002|Overall Study|Progressive Disease|4|||
125258741|NCT02259231|450575249|FG003|Overall Study|Progressive Disease|5|||
125258742|NCT02259231|450575250|FG004|Overall Study|Progressive Disease|4|||
125258743|NCT02259231|450575251|FG005|Overall Study|Progressive Disease|5|||
125258744|NCT02259231|450575252|FG006|Overall Study|Progressive Disease|4|||
125258745|NCT02259231|450575246|FG000|Overall Study|Sponsor termination of study|1|||
125258746|NCT02259231|450575247|FG001|Overall Study|Sponsor termination of study|0|||
125258747|NCT02259231|450575248|FG002|Overall Study|Sponsor termination of study|0|||
125258748|NCT02259231|450575249|FG003|Overall Study|Sponsor termination of study|1|||
125445848|NCT01923428|451257712|FG002|Overall Study|Non Compliance to treatment|0|||
125258749|NCT02259231|450575250|FG004|Overall Study|Sponsor termination of study|2|||
125258750|NCT02259231|450575251|FG005|Overall Study|Sponsor termination of study|1|||
125258751|NCT02259231|450575252|FG006|Overall Study|Sponsor termination of study|1|||
125258752|NCT00847730|450575256|FG000|Overall Study|Multiple interruptions in therapy|8|||
125258753|NCT04507269|450575261|FG000|Overall Study|Withdrawal by Subject|1|||
125258754|NCT04507269|450575262|FG001|Overall Study|Withdrawal by Subject|1|||
125445849|NCT01923428|451257713|FG003|Overall Study|Non Compliance to treatment|1|||
125258755|NCT04507269|450575263|FG002|Overall Study|Withdrawal by Subject|0|||
125258756|NCT04507269|450575264|FG003|Overall Study|Withdrawal by Subject|0|||
125258757|NCT04507269|450575265|FG004|Overall Study|Withdrawal by Subject|0|||
125258758|NCT04507269|450575266|FG005|Overall Study|Withdrawal by Subject|0|||
125258759|NCT04507269|450575261|FG000|Overall Study|Lost to Follow-up|0|||
125258760|NCT04507269|450575262|FG001|Overall Study|Lost to Follow-up|0|||
125258761|NCT04507269|450575263|FG002|Overall Study|Lost to Follow-up|0|||
125258762|NCT04507269|450575264|FG003|Overall Study|Lost to Follow-up|0|||
125258763|NCT04507269|450575265|FG004|Overall Study|Lost to Follow-up|1|||
125258764|NCT04507269|450575266|FG005|Overall Study|Lost to Follow-up|0|||
125258765|NCT00071032|450575269|FG000|Overall Study|Lost to Follow-up|1|||
125258766|NCT00071032|450575270|FG001|Overall Study|Lost to Follow-up|1|||
125258767|NCT00071032|450575269|FG000|Overall Study|Withdrawal by Subject|8|||
125258768|NCT00071032|450575270|FG001|Overall Study|Withdrawal by Subject|6|||
125258769|NCT00071032|450575269|FG000|Overall Study|Missing Primary Outcome|0|||
125258770|NCT00071032|450575270|FG001|Overall Study|Missing Primary Outcome|1|||
125258771|NCT06071104|450575272|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
125258772|NCT03518060|450575273|FG000|Overall Study|Death|1|||
125258773|NCT03518060|450575273|FG000|Overall Study|Poor adherence|1|||
125258774|NCT03518060|450575273|FG000|Overall Study|Withdrawal of informed consent|2|||
125258775|NCT03518060|450575273|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
125258776|NCT03518060|450575273|FG000|Overall Study|Physician Decision|7|||
125258777|NCT03518060|450575273|FG000|Overall Study|Adverse drug reactions|23|||
125258778|NCT03518060|450575273|FG000|Overall Study|Withdrawal by Subject|25|||
125258779|NCT03518060|450575273|FG000|Overall Study|Lost to Follow-up|13|||
125258780|NCT02757768|450575289|FG000|Overall Study|Randomized Never Received Study Drug|3|||
125258781|NCT02757768|450575290|FG001|Overall Study|Randomized Never Received Study Drug|4|||
125258782|NCT02757768|450575289|FG000|Overall Study|Adverse Event|5|||
125258783|NCT02757768|450575290|FG001|Overall Study|Adverse Event|3|||
125258784|NCT02757768|450575289|FG000|Overall Study|Lack of Efficacy|2|||
125258785|NCT02757768|450575290|FG001|Overall Study|Lack of Efficacy|1|||
125258786|NCT02757768|450575289|FG000|Overall Study|Lost to Follow-up|1|||
125258787|NCT02757768|450575290|FG001|Overall Study|Lost to Follow-up|0|||
125258788|NCT02757768|450575289|FG000|Overall Study|Protocol Deviation|2|||
125258789|NCT02757768|450575290|FG001|Overall Study|Protocol Deviation|9|||
125258790|NCT02757768|450575289|FG000|Overall Study|Withdrawal by Subject|16|||
125258791|NCT02757768|450575290|FG001|Overall Study|Withdrawal by Subject|9|||
125258792|NCT02757768|450575289|FG000|Overall Study|Miscellaneous|4|||
125258793|NCT02757768|450575290|FG001|Overall Study|Miscellaneous|2|||
125258794|NCT00618787|450575304|FG000|Overall Study|Adverse Event|0|||
125258795|NCT00618787|450575305|FG001|Overall Study|Adverse Event|1|||
125258796|NCT00618787|450575304|FG000|Overall Study|Withdrawal by Subject|2|||
125258797|NCT00618787|450575305|FG001|Overall Study|Withdrawal by Subject|1|||
125258798|NCT00618787|450575304|FG000|Overall Study|Lost to Follow-up|1|||
125258799|NCT00618787|450575305|FG001|Overall Study|Lost to Follow-up|0|||
125258800|NCT01107886|450575306|FG000|Overall Study|Lost to Follow-up|15|||
125258801|NCT01107886|450575307|FG001|Overall Study|Lost to Follow-up|13|||
125258802|NCT01107886|450575306|FG000|Overall Study|Withdrawal by Subject|180|||
125258803|NCT01107886|450575307|FG001|Overall Study|Withdrawal by Subject|196|||
125258804|NCT01107886|450575306|FG000|Overall Study|Administrative withdrawal of consent|7|||
125258805|NCT01107886|450575307|FG001|Overall Study|Administrative withdrawal of consent|5|||
125258806|NCT01649869|450575312|FG000|Overall Study|Family member illness|1|||
125397609|NCT00433654|451089225|FG000|Overall Study|Death|4|||
125397610|NCT00433654|451089226|FG001|Overall Study|Death|0|||
125397611|NCT00433654|451089225|FG000|Overall Study|Missed visit|6|||
125397612|NCT00433654|451089226|FG001|Overall Study|Missed visit|3|||
125397613|NCT00433654|451089225|FG000|Overall Study|Subject not yet due for visit|4|||
125397614|NCT00433654|451089226|FG001|Overall Study|Subject not yet due for visit|0|||
125397615|NCT00433654|451089225|FG000|Overall Study|Withdrawal by Subject|1|||
125258807|NCT01649869|450575313|FG001|Overall Study|Family member illness|0|||
125258808|NCT01649869|450575312|FG000|Overall Study|Required treatment outside protocol|1|||
125258809|NCT01649869|450575313|FG001|Overall Study|Required treatment outside protocol|0|||
125397616|NCT00433654|451089226|FG001|Overall Study|Withdrawal by Subject|2|||
125397617|NCT01428193|451089227|FG000|Overall Study|Physician Decision|1|||
125397618|NCT01428193|451089227|FG000|Overall Study|Elevated screening liver enzymes|1|||
125397619|NCT01120210|451089231|FG000|MAIN INFUSION|Adverse Event|1|||
125258810|NCT01649869|450575312|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
125258811|NCT01649869|450575313|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
125258812|NCT02776735|450575314|FG000|Overall Study|Adverse Event|0|||
125258813|NCT02776735|450575315|FG001|Overall Study|Adverse Event|0|||
125258814|NCT02776735|450575316|FG002|Overall Study|Adverse Event|0|||
125397620|NCT01120210|451089232|FG001|MAIN INFUSION|Adverse Event|0|||
125397621|NCT01120210|451089231|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
125397622|NCT01120210|451089232|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
125258815|NCT02776735|450575317|FG003|Overall Study|Adverse Event|1|||
125397623|NCT02043015|451089243|FG000|Overall Study|Lost to Follow-up|4|||
125397624|NCT02043015|451089243|FG000|Overall Study|Withdrawal by Subject|4|||
125258816|NCT02776735|450575318|FG004|Overall Study|Adverse Event|0|||
125258817|NCT02776735|450575319|FG005|Overall Study|Adverse Event|1|||
125258818|NCT02776735|450575314|FG000|Overall Study|Lost to Follow-up|0|||
125258819|NCT02776735|450575315|FG001|Overall Study|Lost to Follow-up|0|||
125258820|NCT02776735|450575316|FG002|Overall Study|Lost to Follow-up|0|||
125258821|NCT02776735|450575317|FG003|Overall Study|Lost to Follow-up|1|||
125258822|NCT02776735|450575318|FG004|Overall Study|Lost to Follow-up|0|||
125258823|NCT02776735|450575319|FG005|Overall Study|Lost to Follow-up|0|||
125258824|NCT02776735|450575314|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125258825|NCT02776735|450575315|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125258826|NCT02776735|450575316|FG002|Overall Study|Withdrawal by parent/guardian|2|||
125258827|NCT02776735|450575317|FG003|Overall Study|Withdrawal by parent/guardian|2|||
125258828|NCT02776735|450575318|FG004|Overall Study|Withdrawal by parent/guardian|0|||
125258829|NCT02776735|450575319|FG005|Overall Study|Withdrawal by parent/guardian|0|||
125258830|NCT02776735|450575314|FG000|Overall Study|Withdrawal by Subject|1|||
125258831|NCT02776735|450575315|FG001|Overall Study|Withdrawal by Subject|0|||
125258832|NCT02776735|450575316|FG002|Overall Study|Withdrawal by Subject|0|||
125258833|NCT02776735|450575317|FG003|Overall Study|Withdrawal by Subject|0|||
125258834|NCT02776735|450575318|FG004|Overall Study|Withdrawal by Subject|0|||
125258835|NCT02776735|450575319|FG005|Overall Study|Withdrawal by Subject|1|||
125258836|NCT02776735|450575314|FG000|Overall Study|Other|0|||
125258837|NCT02776735|450575315|FG001|Overall Study|Other|0|||
125258838|NCT02776735|450575316|FG002|Overall Study|Other|3|||
125258839|NCT02776735|450575317|FG003|Overall Study|Other|0|||
125258840|NCT02776735|450575318|FG004|Overall Study|Other|0|||
125258841|NCT02776735|450575319|FG005|Overall Study|Other|0|||
125258850|NCT03552029|450576969|FG000|Overall Study|Death|3|||
125258851|NCT03552029|450576970|FG001|Overall Study|Death|0|||
125258852|NCT03552029|450576969|FG000|Overall Study|Adverse Event|1|||
125258853|NCT03552029|450576970|FG001|Overall Study|Adverse Event|0|||
125258854|NCT03552029|450576969|FG000|Overall Study|Lack of Efficacy|0|||
125258855|NCT03552029|450576970|FG001|Overall Study|Lack of Efficacy|2|||
125258856|NCT03552029|450576969|FG000|Overall Study|Physician Decision|0|||
125258857|NCT03552029|450576970|FG001|Overall Study|Physician Decision|1|||
125258858|NCT03552029|450576969|FG000|Overall Study|Study terminated by Sponsor|0|||
125258859|NCT03552029|450576970|FG001|Overall Study|Study terminated by Sponsor|1|||
125258860|NCT03552029|450576969|FG000|Overall Study|Other|0|||
125258861|NCT03552029|450576970|FG001|Overall Study|Other|2|||
125258862|NCT03468998|450576973|FG000|Overall Study|Withdrawal by Subject|1|||
125258863|NCT03468998|450576974|FG001|Overall Study|Withdrawal by Subject|1|||
125258864|NCT03468998|450576975|FG002|Overall Study|Withdrawal by Subject|0|||
125258865|NCT03468998|450576976|FG003|Overall Study|Withdrawal by Subject|4|||
125258866|NCT03468998|450576977|FG004|Overall Study|Withdrawal by Subject|1|||
125258867|NCT03468998|450576978|FG005|Overall Study|Withdrawal by Subject|0|||
125258868|NCT00633126|450576983|FG000|Overall Study|Did not receive full dose|1|||
125258869|NCT02297516|450576988|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
125258870|NCT02297516|450576989|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
125258871|NCT02297516|450576988|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
125258872|NCT02297516|450576989|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
125258873|NCT02297516|450576988|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
125258874|NCT02297516|450576989|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
125258875|NCT02332928|450576991|FG000|Overall Study|Withdrawal by Subject|0|||
125258876|NCT02332928|450576992|FG001|Overall Study|Withdrawal by Subject|2|||
125258877|NCT02332928|450576991|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
125258878|NCT02332928|450576992|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
125258879|NCT01425814|450576993|FG000|Period 1|Stability criteria not fulfilled|0|||
125258880|NCT01425814|450576994|FG001|Period 1|Stability criteria not fulfilled|1|||
125258881|NCT01425814|450576995|FG002|Period 1|Stability criteria not fulfilled|0|||
125258882|NCT01425814|450576996|FG003|Period 1|Stability criteria not fulfilled|0|||
125258883|NCT01425814|450576997|FG004|Period 1|Stability criteria not fulfilled|0|||
125258884|NCT01425814|450576998|FG005|Period 1|Stability criteria not fulfilled|0|||
125258885|NCT01425814|450576993|FG000|Period 2|Stability criteria not fulfilled|0|||
125258886|NCT01425814|450576994|FG001|Period 2|Stability criteria not fulfilled|1|||
125258887|NCT01425814|450576995|FG002|Period 2|Stability criteria not fulfilled|0|||
125258888|NCT01425814|450576996|FG003|Period 2|Stability criteria not fulfilled|0|||
125258889|NCT01425814|450576997|FG004|Period 2|Stability criteria not fulfilled|0|||
125258890|NCT01425814|450576998|FG005|Period 2|Stability criteria not fulfilled|0|||
125258891|NCT01425814|450576993|FG000|Period 3|Adverse Event|0|||
125445850|NCT01923428|451257710|FG000|Overall Study|Lack of Efficacy|0|||
125258892|NCT01425814|450576994|FG001|Period 3|Adverse Event|0|||
125258893|NCT01425814|450576995|FG002|Period 3|Adverse Event|0|||
125258894|NCT01425814|450576996|FG003|Period 3|Adverse Event|0|||
125258895|NCT01425814|450576997|FG004|Period 3|Adverse Event|0|||
125258896|NCT01425814|450576998|FG005|Period 3|Adverse Event|1|||
125258897|NCT01425814|450576993|FG000|Period 4|Adverse Event|1|||
125258898|NCT01425814|450576994|FG001|Period 4|Adverse Event|0|||
125258899|NCT01425814|450576995|FG002|Period 4|Adverse Event|1|||
125258900|NCT01425814|450576996|FG003|Period 4|Adverse Event|0|||
125258901|NCT01425814|450576997|FG004|Period 4|Adverse Event|0|||
125258902|NCT01425814|450576998|FG005|Period 4|Adverse Event|0|||
125258903|NCT01425814|450576993|FG000|Period 5|Stability criteria not fulfilled|0|||
125258904|NCT01425814|450576994|FG001|Period 5|Stability criteria not fulfilled|0|||
125258905|NCT01425814|450576995|FG002|Period 5|Stability criteria not fulfilled|1|||
125258906|NCT01425814|450576996|FG003|Period 5|Stability criteria not fulfilled|0|||
125258907|NCT01425814|450576997|FG004|Period 5|Stability criteria not fulfilled|0|||
125258908|NCT01425814|450576998|FG005|Period 5|Stability criteria not fulfilled|1|||
125258909|NCT00573768|450577003|FG000|Overall Study|Adverse Event|1|||
125258910|NCT00573768|450577004|FG001|Overall Study|Adverse Event|1|||
125258911|NCT00573768|450577005|FG002|Overall Study|Adverse Event|2|||
125258912|NCT00573768|450577003|FG000|Overall Study|Protocol Violation|1|||
125258913|NCT00573768|450577004|FG001|Overall Study|Protocol Violation|0|||
125258914|NCT00573768|450577005|FG002|Overall Study|Protocol Violation|1|||
125258915|NCT00573768|450577003|FG000|Overall Study|Withdrawal by Subject|0|||
125258916|NCT00573768|450577004|FG001|Overall Study|Withdrawal by Subject|1|||
125258917|NCT00573768|450577005|FG002|Overall Study|Withdrawal by Subject|0|||
125258918|NCT00573768|450577003|FG000|Overall Study|Lost to Follow-up|0|||
125258919|NCT00573768|450577004|FG001|Overall Study|Lost to Follow-up|0|||
125258920|NCT00573768|450577005|FG002|Overall Study|Lost to Follow-up|1|||
125258921|NCT03243084|450577006|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
125258922|NCT03243084|450577007|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
125258923|NCT02090764|450577010|FG000|Overall Study|Adverse Event|1|||
125258924|NCT02090764|450577011|FG001|Overall Study|Adverse Event|3|||
125258925|NCT02090764|450577010|FG000|Overall Study|Lack of Efficacy|0|||
125258926|NCT02090764|450577011|FG001|Overall Study|Lack of Efficacy|13|||
125258927|NCT02090764|450577010|FG000|Overall Study|Withdrawal by Subject|2|||
125258928|NCT02090764|450577011|FG001|Overall Study|Withdrawal by Subject|1|||
125258929|NCT02090764|450577010|FG000|Overall Study|Intercurrent illness and other|1|||
125258930|NCT02090764|450577011|FG001|Overall Study|Intercurrent illness and other|1|||
125258931|NCT02090764|450577010|FG000|Overall Study|Lost to Follow-up|2|||
125258932|NCT02090764|450577011|FG001|Overall Study|Lost to Follow-up|2|||
125258933|NCT02300233|450577013|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
125258934|NCT02300233|450577014|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
125258935|NCT02300233|450577015|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
125258936|NCT02300233|450577013|FG000|Overall Study|Withdrawal by Subject|1|||
125258937|NCT02300233|450577014|FG001|Overall Study|Withdrawal by Subject|0|||
125258938|NCT02300233|450577015|FG002|Overall Study|Withdrawal by Subject|3|||
125258939|NCT02300233|450577013|FG000|Overall Study|Investigator Judgement|0|||
125258940|NCT02300233|450577014|FG001|Overall Study|Investigator Judgement|0|||
125258941|NCT02300233|450577015|FG002|Overall Study|Investigator Judgement|1|||
125258942|NCT02300233|450577013|FG000|Overall Study|Reason Not Specified|0|||
125258943|NCT02300233|450577014|FG001|Overall Study|Reason Not Specified|0|||
125258944|NCT02300233|450577015|FG002|Overall Study|Reason Not Specified|5|||
125258945|NCT00833690|450577016|FG000|Overall Study|Withdrawal by Subject|1|||
125258946|NCT00833690|450577017|FG001|Overall Study|Withdrawal by Subject|0|||
125258947|NCT00833690|450577018|FG002|Overall Study|Withdrawal by Subject|0|||
125258948|NCT00833690|450577016|FG000|Overall Study|Discontinued study drug|3|||
125258949|NCT00833690|450577017|FG001|Overall Study|Discontinued study drug|2|||
125258950|NCT00833690|450577018|FG002|Overall Study|Discontinued study drug|0|||
125258951|NCT04752566|450577019|FG000|Overall Study|Protocol Violation|0|||
125258952|NCT04752566|450577020|FG001|Overall Study|Protocol Violation|1|||
125397625|NCT02043015|451089243|FG000|Overall Study|Removed once target enrollment reached|15|||
125258953|NCT04752566|450577019|FG000|Overall Study|Death|1|||
125258954|NCT04752566|450577020|FG001|Overall Study|Death|0|||
125258955|NCT04752566|450577019|FG000|Overall Study|Adverse Event|1|||
125258956|NCT04752566|450577020|FG001|Overall Study|Adverse Event|0|||
125258957|NCT04752566|450577019|FG000|Overall Study|Withdrawal by Subject|2|||
125258958|NCT04752566|450577020|FG001|Overall Study|Withdrawal by Subject|0|||
125258959|NCT04752566|450577019|FG000|Overall Study|Physician Decision|1|||
125258960|NCT04752566|450577020|FG001|Overall Study|Physician Decision|1|||
125258961|NCT02661815|450577021|FG000|Overall Study|Withdrawal by Subject|1|||
125258962|NCT02661815|450577022|FG001|Overall Study|Withdrawal by Subject|0|||
125258963|NCT02661815|450577023|FG002|Overall Study|Withdrawal by Subject|0|||
125258964|NCT02661815|450577024|FG003|Overall Study|Withdrawal by Subject|0|||
125258965|NCT01153516|450577025|FG000|Overall Study|Both subjects refused surgery|2|||
125258966|NCT01153516|450577026|FG001|Overall Study|Both subjects refused surgery|0|||
125258967|NCT00654355|450577032|FG000|Overall Study|Lost to Follow-up|2|||
125258968|NCT00654355|450577033|FG001|Overall Study|Lost to Follow-up|2|||
125258969|NCT01728246|450577034|FG000|Overall Study|Participant needed rescue medication|1|||
125258970|NCT01728246|450577035|FG001|Overall Study|Participant needed rescue medication|5|||
125258971|NCT01728246|450577034|FG000|Overall Study|Protocol Violation|1|||
125258972|NCT01728246|450577035|FG001|Overall Study|Protocol Violation|0|||
125258973|NCT01728246|450577034|FG000|Overall Study|Withdrawal by Subject|2|||
125258974|NCT01728246|450577035|FG001|Overall Study|Withdrawal by Subject|3|||
125258975|NCT01728246|450577034|FG000|Overall Study|Lost to Follow-up|23|||
125258976|NCT01728246|450577035|FG001|Overall Study|Lost to Follow-up|22|||
125258977|NCT01728246|450577034|FG000|Overall Study|Lack of Efficacy|1|||
125258978|NCT01728246|450577035|FG001|Overall Study|Lack of Efficacy|1|||
125258979|NCT01728246|450577034|FG000|Overall Study|Adverse Event|8|||
125258980|NCT01728246|450577035|FG001|Overall Study|Adverse Event|5|||
125258981|NCT01983111|450577036|FG000|Overall Study|Withdrawal by Subject|8|||
125258982|NCT01983111|450577037|FG001|Overall Study|Withdrawal by Subject|6|||
125258983|NCT01983111|450577036|FG000|Overall Study|Adverse Event|4|||
125258984|NCT01983111|450577037|FG001|Overall Study|Adverse Event|0|||
125258985|NCT01983111|450577036|FG000|Overall Study|Protocol Violation|0|||
125258986|NCT01983111|450577037|FG001|Overall Study|Protocol Violation|1|||
125258987|NCT03502200|450577038|FG000|Overall Study|Adverse Event|1|||
125258988|NCT03502200|450577039|FG001|Overall Study|Adverse Event|0|||
125258989|NCT03502200|450577038|FG000|Overall Study|Lost to Follow-up|36|||
125258990|NCT03502200|450577039|FG001|Overall Study|Lost to Follow-up|38|||
125258991|NCT03502200|450577038|FG000|Overall Study|Study Team Decision|1|||
125258992|NCT03502200|450577039|FG001|Overall Study|Study Team Decision|1|||
125258993|NCT03502200|450577038|FG000|Overall Study|Withdrawal by Subject|5|||
125258994|NCT03502200|450577039|FG001|Overall Study|Withdrawal by Subject|7|||
125258995|NCT03502200|450577038|FG000|Overall Study|Death|0|||
125258996|NCT03502200|450577039|FG001|Overall Study|Death|2|||
125258997|NCT00855335|450577040|FG000|Overall Study|Lost to Follow-up|0|||
125258998|NCT00855335|450577041|FG001|Overall Study|Lost to Follow-up|0|||
125258999|NCT00855335|450577042|FG002|Overall Study|Lost to Follow-up|3|||
125259000|NCT00855335|450577043|FG003|Overall Study|Lost to Follow-up|1|||
125259001|NCT00855335|450577044|FG004|Overall Study|Lost to Follow-up|0|||
125259002|NCT00855335|450577040|FG000|Overall Study|Withdrawal by Subject|0|||
125259003|NCT00855335|450577041|FG001|Overall Study|Withdrawal by Subject|0|||
125259004|NCT00855335|450577042|FG002|Overall Study|Withdrawal by Subject|0|||
125259005|NCT00855335|450577043|FG003|Overall Study|Withdrawal by Subject|1|||
125259006|NCT00855335|450577044|FG004|Overall Study|Withdrawal by Subject|0|||
125259007|NCT00855335|450577040|FG000|Overall Study|Adverse Event|2|||
125259008|NCT00855335|450577041|FG001|Overall Study|Adverse Event|0|||
125259009|NCT00855335|450577042|FG002|Overall Study|Adverse Event|0|||
125259010|NCT00855335|450577043|FG003|Overall Study|Adverse Event|0|||
125259011|NCT00855335|450577044|FG004|Overall Study|Adverse Event|0|||
125259012|NCT00855335|450577040|FG000|Overall Study|Physician Decision|1|||
125259013|NCT00855335|450577041|FG001|Overall Study|Physician Decision|1|||
125259014|NCT00855335|450577042|FG002|Overall Study|Physician Decision|0|||
125259015|NCT00855335|450577043|FG003|Overall Study|Physician Decision|0|||
125259016|NCT00855335|450577044|FG004|Overall Study|Physician Decision|0|||
125259017|NCT00855335|450577040|FG000|Overall Study|Other|2|||
125259018|NCT00855335|450577041|FG001|Overall Study|Other|1|||
125259019|NCT00855335|450577042|FG002|Overall Study|Other|2|||
125259020|NCT00855335|450577043|FG003|Overall Study|Other|5|||
125259021|NCT00855335|450577044|FG004|Overall Study|Other|1|||
125259022|NCT04380142|450577050|FG000|LD/CD Stabilization Period|Adverse Event|3|||
125259023|NCT04380142|450577051|FG001|LD/CD Stabilization Period|Adverse Event|0|||
125259024|NCT04380142|450577052|FG002|LD/CD Stabilization Period|Adverse Event|0|||
125259025|NCT04380142|450577050|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
125259026|NCT04380142|450577051|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
125259027|NCT04380142|450577052|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
125259028|NCT04380142|450577050|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
125259029|NCT04380142|450577051|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
125259030|NCT04380142|450577052|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
125259031|NCT04380142|450577050|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
125259032|NCT04380142|450577051|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
125259033|NCT04380142|450577052|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
125259034|NCT04380142|450577050|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
125259035|NCT04380142|450577051|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
125259036|NCT04380142|450577052|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
125259037|NCT04380142|450577050|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
125259038|NCT04380142|450577051|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
125259039|NCT04380142|450577052|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
125259040|NCT04380142|450577050|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125259041|NCT04380142|450577051|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125259042|NCT04380142|450577052|FG002|Double-Blind Treatment Period|Adverse Event|14|||
125259043|NCT04380142|450577050|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
125259044|NCT04380142|450577051|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
125259045|NCT04380142|450577052|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
125259046|NCT04380142|450577050|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
125259047|NCT04380142|450577051|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
125259048|NCT04380142|450577052|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
125259049|NCT04380142|450577050|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
125259050|NCT04380142|450577051|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
125259051|NCT04380142|450577052|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
125259052|NCT04380142|450577050|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
125259053|NCT04380142|450577051|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
125259054|NCT04380142|450577052|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
125259055|NCT04380142|450577050|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
125259056|NCT04380142|450577051|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
125259057|NCT04380142|450577052|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
125259058|NCT04716894|450577057|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
125259059|NCT04716894|450577057|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
125259060|NCT03773484|450577058|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
125259061|NCT01889251|450577059|FG000|Overall Study|Adverse Event|1|||
125259062|NCT01889251|450577060|FG001|Overall Study|Adverse Event|0|||
125259063|NCT01344226|450577068|FG000|Overall Study|Protocol Violation|2|||
125259064|NCT01344226|450577068|FG000|Overall Study|Withdrawal by Subject|3|||
125259065|NCT01344226|450577068|FG000|Overall Study|Lack of Efficacy|3|||
125259066|NCT03211416|450577070|FG000|Overall Study|Adverse Event|7|||
125259067|NCT03211416|450577070|FG000|Overall Study|Lack of Efficacy|2|||
125259068|NCT03211416|450577070|FG000|Overall Study|Physician Decision|1|||
125259069|NCT02302222|450577071|FG000|Overall Study|Physician Decision|0|||
125259070|NCT02302222|450577072|FG001|Overall Study|Physician Decision|4|||
125259071|NCT02302222|450577071|FG000|Overall Study|Lost to Follow-up|1|||
125259072|NCT02302222|450577072|FG001|Overall Study|Lost to Follow-up|0|||
125259073|NCT02302222|450577071|FG000|Overall Study|Treatment discontinued before day 5|0|||
125259074|NCT02302222|450577072|FG001|Overall Study|Treatment discontinued before day 5|1|||
125259075|NCT02302222|450577071|FG000|Overall Study|Withdrawn prior to any treatment|0|||
125259076|NCT02302222|450577072|FG001|Overall Study|Withdrawn prior to any treatment|1|||
125259077|NCT03781570|450577078|FG000|Overall Study|Technical Issues (equipment failure)|31|||
125259078|NCT03781570|450577078|FG000|Overall Study|Withdrawal by Subject|7|||
125259079|NCT03781570|450577078|FG000|Overall Study|Physical Constraints|11|||
125259080|NCT01107496|450577079|FG000|Overall Study|Adverse Event|1|||
125259081|NCT01107496|450577080|FG001|Overall Study|Adverse Event|0|||
125259082|NCT01107496|450577079|FG000|Overall Study|Lack of Efficacy|1|||
125259083|NCT01107496|450577080|FG001|Overall Study|Lack of Efficacy|0|||
125259084|NCT01107496|450577079|FG000|Overall Study|Protocol Violation|0|||
125259085|NCT01107496|450577080|FG001|Overall Study|Protocol Violation|1|||
125259086|NCT01107496|450577079|FG000|Overall Study|Lost to Follow-up|0|||
125259087|NCT01107496|450577080|FG001|Overall Study|Lost to Follow-up|1|||
125259088|NCT03709472|450577081|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
125259089|NCT03709472|450577082|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
125259090|NCT03709472|450577081|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
125259091|NCT03709472|450577082|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
125259092|NCT02496000|450577085|FG000|Overall Study|Withdrawal by Subject|1|||
125259093|NCT02496000|450577086|FG001|Overall Study|Withdrawal by Subject|2|||
125259094|NCT02496000|450577087|FG002|Overall Study|Withdrawal by Subject|0|||
125259095|NCT02496000|450577085|FG000|Overall Study|Lost to Follow-up|1|||
125259096|NCT02496000|450577086|FG001|Overall Study|Lost to Follow-up|0|||
125259097|NCT02496000|450577087|FG002|Overall Study|Lost to Follow-up|1|||
125259098|NCT02496000|450577085|FG000|Overall Study|Protocol Violation|0|||
125259099|NCT02496000|450577086|FG001|Overall Study|Protocol Violation|0|||
125259100|NCT02496000|450577087|FG002|Overall Study|Protocol Violation|1|||
125259101|NCT02496000|450577085|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
125259102|NCT02496000|450577086|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
125259103|NCT02496000|450577087|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
125259104|NCT02496000|450577085|FG000|Overall Study|undetermined|0|||
125259105|NCT02496000|450577086|FG001|Overall Study|undetermined|1|||
125259106|NCT02496000|450577087|FG002|Overall Study|undetermined|0|||
125259107|NCT02255656|450577088|FG000|Overall Study|Adverse Event|11|||
125259108|NCT02255656|450577088|FG000|Overall Study|Poor compliance to protocol|3|||
125259109|NCT02255656|450577088|FG000|Overall Study|Lost to Follow-up|30|||
125259110|NCT02255656|450577088|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
125259111|NCT02255656|450577088|FG000|Overall Study|Other|126|||
125259112|NCT01877278|450577089|FG000|Overall Study|Lost to Follow-up|3|||
125259113|NCT01877278|450577090|FG001|Overall Study|Lost to Follow-up|3|||
125259114|NCT01969058|450577091|FG000|Overall Study|Withdrawal by Subject|2|||
125259115|NCT01969058|450577092|FG001|Overall Study|Withdrawal by Subject|0|||
125259116|NCT01969058|450577091|FG000|Overall Study|Adverse Event|1|||
125259117|NCT01969058|450577092|FG001|Overall Study|Adverse Event|0|||
125259118|NCT04976855|450577093|FG000|Part I|Withdrawal by Subject|0|||
125259119|NCT04976855|450577094|FG001|Part I|Withdrawal by Subject|1|||
125259120|NCT04976855|450577095|FG002|Part I|Withdrawal by Subject|0|||
125259121|NCT04976855|450577096|FG003|Part I|Withdrawal by Subject|0|||
125259122|NCT04976855|450577097|FG004|Part I|Withdrawal by Subject|0|||
125259123|NCT04976855|450577098|FG005|Part I|Withdrawal by Subject|0|||
125259124|NCT04976855|450577099|FG006|Part I|Withdrawal by Subject|0|||
125259125|NCT04976855|450577093|FG000|Part II|Adverse Event|0|||
125259126|NCT04976855|450577094|FG001|Part II|Adverse Event|0|||
125259127|NCT04976855|450577095|FG002|Part II|Adverse Event|0|||
125259128|NCT04976855|450577096|FG003|Part II|Adverse Event|1|||
125259129|NCT04976855|450577097|FG004|Part II|Adverse Event|0|||
125259130|NCT04976855|450577098|FG005|Part II|Adverse Event|0|||
125259131|NCT04976855|450577099|FG006|Part II|Adverse Event|0|||
125259132|NCT04976855|450577093|FG000|Part II|Withdrawal by Subject|0|||
125259133|NCT04976855|450577094|FG001|Part II|Withdrawal by Subject|0|||
125259134|NCT04976855|450577095|FG002|Part II|Withdrawal by Subject|0|||
125259135|NCT04976855|450577096|FG003|Part II|Withdrawal by Subject|0|||
125259136|NCT04976855|450577097|FG004|Part II|Withdrawal by Subject|1|||
125259137|NCT04976855|450577098|FG005|Part II|Withdrawal by Subject|0|||
125259138|NCT04976855|450577099|FG006|Part II|Withdrawal by Subject|0|||
125259139|NCT04976855|450577093|FG000|Part II|Lost to Follow-up|0|||
125259140|NCT04976855|450577094|FG001|Part II|Lost to Follow-up|0|||
125259141|NCT04976855|450577095|FG002|Part II|Lost to Follow-up|0|||
125259142|NCT04976855|450577096|FG003|Part II|Lost to Follow-up|0|||
125259143|NCT04976855|450577097|FG004|Part II|Lost to Follow-up|0|||
125259144|NCT04976855|450577098|FG005|Part II|Lost to Follow-up|1|||
125259145|NCT04976855|450577099|FG006|Part II|Lost to Follow-up|0|||
125259146|NCT05318287|450577100|FG000|Overall Study|Lost to Follow-up|8|||
125259147|NCT05185453|450577101|FG000|Overall Study|Lost to Follow-up|13|||
125259148|NCT05185453|450577102|FG001|Overall Study|Lost to Follow-up|3|||
125259149|NCT02457793|450577109|FG000|Overall Study|Reason not specified|0|||
125259150|NCT02457793|450577110|FG001|Overall Study|Reason not specified|0|||
125259151|NCT02457793|450577111|FG002|Overall Study|Reason not specified|0|||
125259152|NCT02457793|450577112|FG003|Overall Study|Reason not specified|1|||
125259153|NCT02457793|450577113|FG004|Overall Study|Reason not specified|1|||
125259154|NCT02457793|450577114|FG005|Overall Study|Reason not specified|1|||
125259155|NCT02457793|450577109|FG000|Overall Study|Withdrawal by Subject|0|||
125259156|NCT02457793|450577110|FG001|Overall Study|Withdrawal by Subject|4|||
125259157|NCT02457793|450577111|FG002|Overall Study|Withdrawal by Subject|2|||
125259158|NCT02457793|450577112|FG003|Overall Study|Withdrawal by Subject|2|||
125259159|NCT02457793|450577113|FG004|Overall Study|Withdrawal by Subject|2|||
125259160|NCT02457793|450577114|FG005|Overall Study|Withdrawal by Subject|2|||
125259161|NCT02457793|450577109|FG000|Overall Study|Adverse Event|0|||
125259162|NCT02457793|450577110|FG001|Overall Study|Adverse Event|0|||
125259163|NCT02457793|450577111|FG002|Overall Study|Adverse Event|0|||
125259164|NCT02457793|450577112|FG003|Overall Study|Adverse Event|1|||
125259165|NCT02457793|450577113|FG004|Overall Study|Adverse Event|0|||
125259166|NCT02457793|450577114|FG005|Overall Study|Adverse Event|0|||
125259167|NCT02457793|450577109|FG000|Overall Study|Physician Decision|1|||
125259168|NCT02457793|450577110|FG001|Overall Study|Physician Decision|0|||
125259169|NCT02457793|450577111|FG002|Overall Study|Physician Decision|1|||
125259170|NCT02457793|450577112|FG003|Overall Study|Physician Decision|1|||
125259171|NCT02457793|450577113|FG004|Overall Study|Physician Decision|1|||
125259172|NCT02457793|450577114|FG005|Overall Study|Physician Decision|3|||
125259173|NCT00835172|450577121|FG000|Washout|Protocol Violation|0|||
125259174|NCT00835172|450577122|FG001|Washout|Protocol Violation|1|||
125259175|NCT04890509|450577123|FG000|Overall Study|Death|4|||
125259176|NCT04890509|450577124|FG001|Overall Study|Death|4|||
125259177|NCT03274466|450577125|FG000|Overall Study|Withdrawal by Subject|7|||
125259178|NCT03274466|450577126|FG001|Overall Study|Withdrawal by Subject|3|||
125259179|NCT03274466|450577125|FG000|Overall Study|Protocol Specified Withdrawal|5|||
125259180|NCT03274466|450577126|FG001|Overall Study|Protocol Specified Withdrawal|11|||
125259181|NCT03274466|450577125|FG000|Overall Study|Lost to Follow-up|5|||
125259182|NCT03274466|450577126|FG001|Overall Study|Lost to Follow-up|7|||
125259183|NCT03274466|450577125|FG000|Overall Study|Subject Non-compliance|0|||
125259184|NCT03274466|450577126|FG001|Overall Study|Subject Non-compliance|1|||
125259185|NCT03274466|450577125|FG000|Overall Study|Adverse Event|3|||
125259186|NCT03274466|450577126|FG001|Overall Study|Adverse Event|3|||
125259187|NCT03274466|450577125|FG000|Overall Study|Physician Decision|0|||
125259188|NCT03274466|450577126|FG001|Overall Study|Physician Decision|1|||
125259189|NCT03274466|450577125|FG000|Overall Study|Protocol Violation|3|||
125259190|NCT03274466|450577126|FG001|Overall Study|Protocol Violation|3|||
125259191|NCT00730327|450579362|FG000|Overall Study|Lost to Follow-up|14|||
125259192|NCT00730327|450579363|FG001|Overall Study|Lost to Follow-up|16|||
125259193|NCT00730327|450579362|FG000|Overall Study|Adverse Event|8|||
125259194|NCT00730327|450579363|FG001|Overall Study|Adverse Event|1|||
125259195|NCT00730327|450579362|FG000|Overall Study|Withdrawal by Subject|3|||
125259196|NCT00730327|450579363|FG001|Overall Study|Withdrawal by Subject|13|||
125259197|NCT00730327|450579362|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
125397626|NCT02043015|451089243|FG000|Overall Study|Participant moved away from study city|4|||
125397627|NCT02043015|451089243|FG000|Overall Study|Incarceration|1|||
125259198|NCT00730327|450579363|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
125259199|NCT02552225|450579364|FG000|Overall Study|Withdrawal by Subject|1|||
125259200|NCT02552225|450579365|FG001|Overall Study|Withdrawal by Subject|0|||
125259201|NCT02989857|450579366|FG000|Randomization Phase|Not Treated|3|||
125259202|NCT02989857|450579367|FG001|Randomization Phase|Not Treated|2|||
125259203|NCT02989857|450579368|FG002|Randomization Phase|Not Treated|0|||
125259204|NCT01168596|450579373|FG000|Overall Study|Withdrawal by Subject|3|||
125259205|NCT01168596|450579374|FG001|Overall Study|Withdrawal by Subject|1|||
125259206|NCT00876447|450579377|FG000|Overall Study|Other miscellaneous reasons|3|||
125259207|NCT00876447|450579378|FG001|Overall Study|Other miscellaneous reasons|8|||
125259208|NCT00876447|450579377|FG000|Overall Study|Site closure|19|||
125259209|NCT00876447|450579378|FG001|Overall Study|Site closure|14|||
125259210|NCT00876447|450579377|FG000|Overall Study|Protocol Violation|9|||
125259211|NCT00876447|450579378|FG001|Overall Study|Protocol Violation|3|||
125259212|NCT00876447|450579377|FG000|Overall Study|Personal reasons|30|||
125259213|NCT00876447|450579378|FG001|Overall Study|Personal reasons|28|||
125259214|NCT00876447|450579377|FG000|Overall Study|Lost to Follow-up|6|||
125259215|NCT00876447|450579378|FG001|Overall Study|Lost to Follow-up|15|||
125259216|NCT00876447|450579377|FG000|Overall Study|Pregnancy|4|||
125259217|NCT00876447|450579378|FG001|Overall Study|Pregnancy|2|||
125259218|NCT00876447|450579377|FG000|Overall Study|Lack of Efficacy|5|||
125259219|NCT00876447|450579378|FG001|Overall Study|Lack of Efficacy|3|||
125259220|NCT00876447|450579377|FG000|Overall Study|Adverse Event|4|||
125259221|NCT00876447|450579378|FG001|Overall Study|Adverse Event|8|||
125259222|NCT00366457|450579384|FG000|Overall Study|never began study therapy|2|||
125259223|NCT02538614|450579385|FG000|Overall Study|Progressive Disease|2|||
125259224|NCT00189423|450579390|FG000|Overall Study|Death|746|||
125259225|NCT00189423|450579391|FG001|Overall Study|Death|747|||
125259226|NCT00189423|450579390|FG000|Overall Study|Withdrawal by Subject|9|||
125259227|NCT00189423|450579391|FG001|Overall Study|Withdrawal by Subject|9|||
125259228|NCT00189423|450579390|FG000|Overall Study|Lost to Follow-up|10|||
125259229|NCT00189423|450579391|FG001|Overall Study|Lost to Follow-up|10|||
125259230|NCT04622592|450579394|FG000|Overall Study|Death|0|||
125259231|NCT04622592|450579395|FG001|Overall Study|Death|0|||
125259232|NCT04622592|450579396|FG002|Overall Study|Death|1|||
125259233|NCT04622592|450579397|FG003|Overall Study|Death|0|||
125259234|NCT04622592|450579398|FG004|Overall Study|Death|0|||
125259235|NCT04622592|450579399|FG005|Overall Study|Death|0|||
125259236|NCT04622592|450579400|FG006|Overall Study|Death|0|||
125259237|NCT04622592|450579401|FG007|Overall Study|Death|1|||
125259238|NCT04622592|450579394|FG000|Overall Study|Lost to Follow-up|0|||
125259239|NCT04622592|450579395|FG001|Overall Study|Lost to Follow-up|0|||
125259240|NCT04622592|450579396|FG002|Overall Study|Lost to Follow-up|0|||
125259241|NCT04622592|450579397|FG003|Overall Study|Lost to Follow-up|3|||
125259242|NCT04622592|450579398|FG004|Overall Study|Lost to Follow-up|1|||
125259243|NCT04622592|450579399|FG005|Overall Study|Lost to Follow-up|0|||
125259244|NCT04622592|450579400|FG006|Overall Study|Lost to Follow-up|2|||
125259245|NCT04622592|450579401|FG007|Overall Study|Lost to Follow-up|2|||
125259246|NCT04622592|450579394|FG000|Overall Study|Physician Decision|0|||
125259247|NCT04622592|450579395|FG001|Overall Study|Physician Decision|0|||
125259248|NCT04622592|450579396|FG002|Overall Study|Physician Decision|0|||
125259249|NCT04622592|450579397|FG003|Overall Study|Physician Decision|0|||
125259250|NCT04622592|450579398|FG004|Overall Study|Physician Decision|1|||
125259251|NCT04622592|450579399|FG005|Overall Study|Physician Decision|0|||
125259252|NCT04622592|450579400|FG006|Overall Study|Physician Decision|0|||
125259253|NCT04622592|450579401|FG007|Overall Study|Physician Decision|0|||
125397628|NCT04049760|451089245|FG000|Overall Study|Withdrawal by Subject|1|||
125397629|NCT02457598|451089246|FG000|Overall Study|Progressive Disease|2|||
125259254|NCT04622592|450579394|FG000|Overall Study|Withdrawal by Subject|1|||
125259255|NCT04622592|450579395|FG001|Overall Study|Withdrawal by Subject|0|||
125259256|NCT04622592|450579396|FG002|Overall Study|Withdrawal by Subject|2|||
125259257|NCT04622592|450579397|FG003|Overall Study|Withdrawal by Subject|0|||
125259258|NCT04622592|450579398|FG004|Overall Study|Withdrawal by Subject|0|||
125259259|NCT04622592|450579399|FG005|Overall Study|Withdrawal by Subject|0|||
125259260|NCT04622592|450579400|FG006|Overall Study|Withdrawal by Subject|1|||
125259261|NCT04622592|450579401|FG007|Overall Study|Withdrawal by Subject|4|||
125259262|NCT04622592|450579394|FG000|Overall Study|Other than specified above|0|||
125259263|NCT04622592|450579395|FG001|Overall Study|Other than specified above|0|||
125259264|NCT04622592|450579396|FG002|Overall Study|Other than specified above|1|||
125259265|NCT04622592|450579397|FG003|Overall Study|Other than specified above|0|||
125259266|NCT04622592|450579398|FG004|Overall Study|Other than specified above|0|||
125259267|NCT04622592|450579399|FG005|Overall Study|Other than specified above|0|||
125259268|NCT04622592|450579400|FG006|Overall Study|Other than specified above|0|||
125259269|NCT04622592|450579401|FG007|Overall Study|Other than specified above|0|||
125259270|NCT01497197|450579402|FG000|Overall Study|Lost to Follow-up|1|||
125259271|NCT01497197|450579403|FG001|Overall Study|Lost to Follow-up|0|||
125259272|NCT01497197|450579402|FG000|Overall Study|Protocol Violation|0|||
125259273|NCT01497197|450579403|FG001|Overall Study|Protocol Violation|2|||
125259274|NCT01497197|450579402|FG000|Overall Study|Withdrawal by Subject|2|||
125259275|NCT01497197|450579403|FG001|Overall Study|Withdrawal by Subject|1|||
125259276|NCT01497197|450579402|FG000|Overall Study|Excessive/lack of response to treatment|1|||
125259277|NCT01497197|450579403|FG001|Overall Study|Excessive/lack of response to treatment|0|||
125259278|NCT01497197|450579402|FG000|Overall Study|Risk of OHSS|1|||
125259279|NCT01497197|450579403|FG001|Overall Study|Risk of OHSS|0|||
125259280|NCT01497197|450579402|FG000|Overall Study|No oocytes retrieved|3|||
125259281|NCT01497197|450579403|FG001|Overall Study|No oocytes retrieved|2|||
125259282|NCT01497197|450579402|FG000|Overall Study|No fertilisation|6|||
125259283|NCT01497197|450579403|FG001|Overall Study|No fertilisation|5|||
125259284|NCT01497197|450579402|FG000|Overall Study|Intention to freeze all embryos|0|||
125259285|NCT01497197|450579403|FG001|Overall Study|Intention to freeze all embryos|1|||
125259286|NCT01497197|450579402|FG000|Overall Study|All embryos discarded|0|||
125259287|NCT01497197|450579403|FG001|Overall Study|All embryos discarded|3|||
125259288|NCT01497197|450579402|FG000|Overall Study|Other|3|||
125259289|NCT01497197|450579403|FG001|Overall Study|Other|1|||
125259290|NCT00565747|450579409|FG000|Overall Study|No embryo transfer|67|||
125259291|NCT00565747|450579410|FG001|Overall Study|No embryo transfer|73|||
125259292|NCT00183248|450579411|FG000|Overall Study|Lost to Follow-up|0|||
125259293|NCT00183248|450579412|FG001|Overall Study|Lost to Follow-up|1|||
125259294|NCT00183248|450579411|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
125259295|NCT00183248|450579412|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
125259296|NCT03309202|450579413|FG000|Overall Study|Lost to Follow-up|1|||
125259297|NCT03309202|450579414|FG001|Overall Study|Lost to Follow-up|0|||
125259298|NCT03309202|450579415|FG002|Overall Study|Lost to Follow-up|0|||
125259299|NCT03309202|450579416|FG003|Overall Study|Lost to Follow-up|0|||
125259300|NCT00415636|450579419|FG000|Overall Study|Symptomatic deterioration|1|||
125259301|NCT00415636|450579420|FG001|Overall Study|Symptomatic deterioration|0|||
125259302|NCT00415636|450579421|FG002|Overall Study|Symptomatic deterioration|1|||
125259303|NCT00415636|450579422|FG003|Overall Study|Symptomatic deterioration|2|||
125259304|NCT00415636|450579423|FG004|Overall Study|Symptomatic deterioration|0|||
125259305|NCT00415636|450579424|FG005|Overall Study|Symptomatic deterioration|1|||
125259306|NCT00415636|450579419|FG000|Overall Study|Adverse Event|0|||
125259307|NCT00415636|450579420|FG001|Overall Study|Adverse Event|0|||
125259308|NCT00415636|450579421|FG002|Overall Study|Adverse Event|0|||
125259309|NCT00415636|450579422|FG003|Overall Study|Adverse Event|1|||
125259310|NCT00415636|450579423|FG004|Overall Study|Adverse Event|1|||
125259311|NCT00415636|450579424|FG005|Overall Study|Adverse Event|0|||
125259312|NCT00415636|450579419|FG000|Overall Study|Withdrawal by Subject|0|||
125259313|NCT00415636|450579420|FG001|Overall Study|Withdrawal by Subject|0|||
125259314|NCT00415636|450579421|FG002|Overall Study|Withdrawal by Subject|0|||
125259315|NCT00415636|450579422|FG003|Overall Study|Withdrawal by Subject|0|||
125259316|NCT00415636|450579423|FG004|Overall Study|Withdrawal by Subject|1|||
125259317|NCT00415636|450579424|FG005|Overall Study|Withdrawal by Subject|0|||
125259318|NCT00415636|450579419|FG000|Overall Study|Disease progression|0|||
125259319|NCT00415636|450579420|FG001|Overall Study|Disease progression|0|||
125259320|NCT00415636|450579421|FG002|Overall Study|Disease progression|0|||
125259321|NCT00415636|450579422|FG003|Overall Study|Disease progression|3|||
125259322|NCT00415636|450579423|FG004|Overall Study|Disease progression|0|||
125259323|NCT00415636|450579424|FG005|Overall Study|Disease progression|1|||
125259324|NCT04734210|450579425|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
125259325|NCT04734210|450579426|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
125259326|NCT04734210|450579427|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
125259327|NCT04734210|450579425|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
125259328|NCT04734210|450579426|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
125259329|NCT04734210|450579427|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
125259330|NCT04734210|450579425|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
125397630|NCT02457598|451089247|FG001|Overall Study|Progressive Disease|2|||
125259331|NCT04734210|450579426|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
125259332|NCT04734210|450579427|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
125259333|NCT04734210|450579425|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
125259334|NCT04734210|450579426|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
125259335|NCT04734210|450579427|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
125259336|NCT02684461|450579428|FG000|Overall Study|Adverse Event|1|||
125259337|NCT02684461|450579429|FG001|Overall Study|Adverse Event|0|||
125259338|NCT02684461|450579430|FG002|Overall Study|Adverse Event|0|||
125259339|NCT02684461|450579428|FG000|Overall Study|Lack of Efficacy|1|||
125259340|NCT02684461|450579429|FG001|Overall Study|Lack of Efficacy|2|||
125259341|NCT02684461|450579430|FG002|Overall Study|Lack of Efficacy|0|||
125259342|NCT02138825|450579431|FG000|Main Study Treatment|Adverse Event|11|||
125397631|NCT02457598|451089248|FG002|Overall Study|Progressive Disease|1|||
125397632|NCT02457598|451089249|FG003|Overall Study|Progressive Disease|11|||
125397633|NCT02457598|451089250|FG004|Overall Study|Progressive Disease|7|||
125397634|NCT02457598|451089251|FG005|Overall Study|Progressive Disease|3|||
125397635|NCT02457598|451089252|FG006|Overall Study|Progressive Disease|2|||
125397636|NCT02457598|451089253|FG007|Overall Study|Progressive Disease|1|||
125397637|NCT02457598|451089254|FG008|Overall Study|Progressive Disease|1|||
125397638|NCT02457598|451089255|FG009|Overall Study|Progressive Disease|2|||
125397639|NCT02457598|451089256|FG010|Overall Study|Progressive Disease|45|||
125397640|NCT02457598|451089257|FG011|Overall Study|Progressive Disease|6|||
125397641|NCT02457598|451089258|FG012|Overall Study|Progressive Disease|2|||
125397642|NCT02457598|451089259|FG013|Overall Study|Progressive Disease|2|||
125397643|NCT02457598|451089260|FG014|Overall Study|Progressive Disease|10|||
125397644|NCT02457598|451089261|FG015|Overall Study|Progressive Disease|1|||
125397645|NCT02457598|451089262|FG016|Overall Study|Progressive Disease|1|||
125397646|NCT02457598|451089246|FG000|Overall Study|Investigator's Discretion|0|||
125397647|NCT02457598|451089247|FG001|Overall Study|Investigator's Discretion|2|||
125397648|NCT02457598|451089248|FG002|Overall Study|Investigator's Discretion|2|||
125397649|NCT02457598|451089249|FG003|Overall Study|Investigator's Discretion|2|||
125397650|NCT02457598|451089250|FG004|Overall Study|Investigator's Discretion|0|||
125397651|NCT02457598|451089251|FG005|Overall Study|Investigator's Discretion|0|||
125397652|NCT02457598|451089252|FG006|Overall Study|Investigator's Discretion|0|||
125397653|NCT02457598|451089253|FG007|Overall Study|Investigator's Discretion|1|||
125397654|NCT02457598|451089254|FG008|Overall Study|Investigator's Discretion|2|||
125397655|NCT02457598|451089255|FG009|Overall Study|Investigator's Discretion|0|||
125397656|NCT02457598|451089256|FG010|Overall Study|Investigator's Discretion|10|||
125397657|NCT02457598|451089257|FG011|Overall Study|Investigator's Discretion|2|||
125397658|NCT02457598|451089258|FG012|Overall Study|Investigator's Discretion|2|||
125397659|NCT02457598|451089259|FG013|Overall Study|Investigator's Discretion|1|||
125397660|NCT02457598|451089260|FG014|Overall Study|Investigator's Discretion|5|||
125397661|NCT02457598|451089261|FG015|Overall Study|Investigator's Discretion|0|||
125397662|NCT02457598|451089262|FG016|Overall Study|Investigator's Discretion|0|||
125397663|NCT02457598|451089246|FG000|Overall Study|Study Terminated by Sponsor|0|||
125397664|NCT02457598|451089247|FG001|Overall Study|Study Terminated by Sponsor|1|||
125397665|NCT02457598|451089248|FG002|Overall Study|Study Terminated by Sponsor|0|||
125397666|NCT02457598|451089249|FG003|Overall Study|Study Terminated by Sponsor|4|||
125397667|NCT02457598|451089250|FG004|Overall Study|Study Terminated by Sponsor|1|||
125397668|NCT02457598|451089251|FG005|Overall Study|Study Terminated by Sponsor|0|||
125397669|NCT02457598|451089252|FG006|Overall Study|Study Terminated by Sponsor|1|||
125397670|NCT02457598|451089253|FG007|Overall Study|Study Terminated by Sponsor|0|||
125397671|NCT02457598|451089254|FG008|Overall Study|Study Terminated by Sponsor|0|||
125397672|NCT02457598|451089255|FG009|Overall Study|Study Terminated by Sponsor|0|||
125397673|NCT02457598|451089256|FG010|Overall Study|Study Terminated by Sponsor|4|||
125397674|NCT02457598|451089257|FG011|Overall Study|Study Terminated by Sponsor|0|||
125397675|NCT02457598|451089258|FG012|Overall Study|Study Terminated by Sponsor|1|||
125397676|NCT02457598|451089259|FG013|Overall Study|Study Terminated by Sponsor|0|||
125397677|NCT02457598|451089260|FG014|Overall Study|Study Terminated by Sponsor|8|||
125397678|NCT02457598|451089261|FG015|Overall Study|Study Terminated by Sponsor|1|||
125397679|NCT02457598|451089262|FG016|Overall Study|Study Terminated by Sponsor|0|||
125397680|NCT02457598|451089246|FG000|Overall Study|Adverse Event|0|||
125397681|NCT02457598|451089247|FG001|Overall Study|Adverse Event|1|||
125397682|NCT02457598|451089248|FG002|Overall Study|Adverse Event|1|||
125397683|NCT02457598|451089249|FG003|Overall Study|Adverse Event|4|||
125397684|NCT02457598|451089250|FG004|Overall Study|Adverse Event|1|||
125397685|NCT02457598|451089251|FG005|Overall Study|Adverse Event|0|||
125397686|NCT02457598|451089252|FG006|Overall Study|Adverse Event|0|||
125397687|NCT02457598|451089253|FG007|Overall Study|Adverse Event|1|||
125397688|NCT02457598|451089254|FG008|Overall Study|Adverse Event|0|||
125397689|NCT02457598|451089255|FG009|Overall Study|Adverse Event|1|||
125397690|NCT02457598|451089256|FG010|Overall Study|Adverse Event|6|||
125397691|NCT02457598|451089257|FG011|Overall Study|Adverse Event|0|||
125397692|NCT02457598|451089258|FG012|Overall Study|Adverse Event|0|||
125397693|NCT02457598|451089259|FG013|Overall Study|Adverse Event|1|||
125397694|NCT02457598|451089260|FG014|Overall Study|Adverse Event|2|||
125397695|NCT02457598|451089261|FG015|Overall Study|Adverse Event|0|||
125397696|NCT02457598|451089262|FG016|Overall Study|Adverse Event|0|||
125397697|NCT02457598|451089246|FG000|Overall Study|Death|0|||
125397698|NCT02457598|451089247|FG001|Overall Study|Death|0|||
125397699|NCT02457598|451089248|FG002|Overall Study|Death|0|||
125397700|NCT02457598|451089249|FG003|Overall Study|Death|3|||
125397701|NCT02457598|451089250|FG004|Overall Study|Death|0|||
125397702|NCT02457598|451089251|FG005|Overall Study|Death|1|||
125397703|NCT02457598|451089252|FG006|Overall Study|Death|0|||
125397704|NCT02457598|451089253|FG007|Overall Study|Death|0|||
125397705|NCT02457598|451089254|FG008|Overall Study|Death|0|||
125397706|NCT02457598|451089255|FG009|Overall Study|Death|0|||
125397707|NCT02457598|451089256|FG010|Overall Study|Death|3|||
125397708|NCT02457598|451089257|FG011|Overall Study|Death|0|||
125397709|NCT02457598|451089258|FG012|Overall Study|Death|0|||
125397710|NCT02457598|451089259|FG013|Overall Study|Death|1|||
125397711|NCT02457598|451089260|FG014|Overall Study|Death|2|||
125397712|NCT02457598|451089261|FG015|Overall Study|Death|0|||
125397713|NCT02457598|451089262|FG016|Overall Study|Death|1|||
125397714|NCT02457598|451089246|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
125397715|NCT02457598|451089247|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
125397716|NCT02457598|451089248|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
125397717|NCT02457598|451089249|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
125397718|NCT02457598|451089250|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
125397719|NCT02457598|451089251|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
125397720|NCT02457598|451089252|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
125397721|NCT02457598|451089253|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
125397722|NCT02457598|451089254|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
125397723|NCT02457598|451089255|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
125397724|NCT02457598|451089256|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
125397725|NCT02457598|451089257|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
125397726|NCT02457598|451089258|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
125397727|NCT02457598|451089259|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
125397728|NCT02457598|451089260|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
125397729|NCT02457598|451089261|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
125397730|NCT02457598|451089262|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
125397731|NCT02457598|451089246|FG000|Overall Study|Withdrew Consent|0|||
125397732|NCT02457598|451089247|FG001|Overall Study|Withdrew Consent|0|||
125397733|NCT02457598|451089248|FG002|Overall Study|Withdrew Consent|0|||
125397734|NCT02457598|451089249|FG003|Overall Study|Withdrew Consent|0|||
125397735|NCT02457598|451089250|FG004|Overall Study|Withdrew Consent|0|||
125397736|NCT02457598|451089251|FG005|Overall Study|Withdrew Consent|0|||
125397737|NCT02457598|451089252|FG006|Overall Study|Withdrew Consent|0|||
125397738|NCT02457598|451089253|FG007|Overall Study|Withdrew Consent|2|||
125397739|NCT02457598|451089254|FG008|Overall Study|Withdrew Consent|0|||
125397740|NCT02457598|451089255|FG009|Overall Study|Withdrew Consent|0|||
125397741|NCT02457598|451089256|FG010|Overall Study|Withdrew Consent|3|||
125397742|NCT02457598|451089257|FG011|Overall Study|Withdrew Consent|0|||
125397743|NCT02457598|451089258|FG012|Overall Study|Withdrew Consent|0|||
125397744|NCT02457598|451089259|FG013|Overall Study|Withdrew Consent|1|||
125397745|NCT02457598|451089260|FG014|Overall Study|Withdrew Consent|0|||
125397746|NCT02457598|451089261|FG015|Overall Study|Withdrew Consent|0|||
125397747|NCT02457598|451089262|FG016|Overall Study|Withdrew Consent|0|||
125397748|NCT02457598|451089246|FG000|Overall Study|Unacceptable Toxicity|0|||
125397749|NCT02457598|451089247|FG001|Overall Study|Unacceptable Toxicity|0|||
125397750|NCT02457598|451089248|FG002|Overall Study|Unacceptable Toxicity|0|||
125397751|NCT02457598|451089249|FG003|Overall Study|Unacceptable Toxicity|0|||
125397752|NCT02457598|451089250|FG004|Overall Study|Unacceptable Toxicity|0|||
125397753|NCT02457598|451089251|FG005|Overall Study|Unacceptable Toxicity|0|||
125397754|NCT02457598|451089252|FG006|Overall Study|Unacceptable Toxicity|0|||
125397755|NCT02457598|451089253|FG007|Overall Study|Unacceptable Toxicity|0|||
125397756|NCT02457598|451089254|FG008|Overall Study|Unacceptable Toxicity|0|||
125397757|NCT02457598|451089255|FG009|Overall Study|Unacceptable Toxicity|0|||
125397758|NCT02457598|451089256|FG010|Overall Study|Unacceptable Toxicity|1|||
125397759|NCT02457598|451089257|FG011|Overall Study|Unacceptable Toxicity|0|||
125397760|NCT02457598|451089258|FG012|Overall Study|Unacceptable Toxicity|1|||
125397761|NCT02457598|451089259|FG013|Overall Study|Unacceptable Toxicity|1|||
125397762|NCT02457598|451089260|FG014|Overall Study|Unacceptable Toxicity|1|||
125397763|NCT02457598|451089261|FG015|Overall Study|Unacceptable Toxicity|0|||
125397764|NCT02457598|451089262|FG016|Overall Study|Unacceptable Toxicity|0|||
125397765|NCT02457598|451089246|FG000|Overall Study|Intercurrent Illness|0|||
125397766|NCT02457598|451089247|FG001|Overall Study|Intercurrent Illness|0|||
125397767|NCT02457598|451089248|FG002|Overall Study|Intercurrent Illness|0|||
125397768|NCT02457598|451089249|FG003|Overall Study|Intercurrent Illness|0|||
125397769|NCT02457598|451089250|FG004|Overall Study|Intercurrent Illness|0|||
125397770|NCT02457598|451089251|FG005|Overall Study|Intercurrent Illness|0|||
125397771|NCT02457598|451089252|FG006|Overall Study|Intercurrent Illness|0|||
125397772|NCT02457598|451089253|FG007|Overall Study|Intercurrent Illness|0|||
125397773|NCT02457598|451089254|FG008|Overall Study|Intercurrent Illness|0|||
125397774|NCT02457598|451089255|FG009|Overall Study|Intercurrent Illness|0|||
125397775|NCT02457598|451089256|FG010|Overall Study|Intercurrent Illness|1|||
125397776|NCT02457598|451089257|FG011|Overall Study|Intercurrent Illness|0|||
125259343|NCT02138825|450579432|FG001|Main Study Treatment|Adverse Event|3|||
125259344|NCT02138825|450579431|FG000|Main Study Treatment|Death|1|||
125259345|NCT02138825|450579432|FG001|Main Study Treatment|Death|2|||
125259346|NCT02138825|450579431|FG000|Main Study Treatment|Protocol Violation|2|||
125397777|NCT02457598|451089258|FG012|Overall Study|Intercurrent Illness|0|||
125259347|NCT02138825|450579432|FG001|Main Study Treatment|Protocol Violation|2|||
125259348|NCT02138825|450579431|FG000|Main Study Treatment|Sponsor decision|12|||
125397778|NCT02457598|451089259|FG013|Overall Study|Intercurrent Illness|0|||
125397779|NCT02457598|451089260|FG014|Overall Study|Intercurrent Illness|0|||
125259349|NCT02138825|450579432|FG001|Main Study Treatment|Sponsor decision|18|||
125259350|NCT02138825|450579431|FG000|Main Study Treatment|Study terminated by sponsor|10|||
125259351|NCT02138825|450579432|FG001|Main Study Treatment|Study terminated by sponsor|9|||
125259352|NCT02138825|450579431|FG000|Main Study Treatment|Withdrawal by Subject|3|||
125259353|NCT02138825|450579432|FG001|Main Study Treatment|Withdrawal by Subject|1|||
125259354|NCT02138825|450579431|FG000|Main Study Treatment|Medical decision|1|||
125259355|NCT02138825|450579432|FG001|Main Study Treatment|Medical decision|0|||
125259356|NCT02138825|450579431|FG000|Long-term Extension|Study termination by sponsor|32|||
125259357|NCT02138825|450579432|FG001|Long-term Extension|Study termination by sponsor|38|||
125259358|NCT02138825|450579431|FG000|Safety Follow-up|Adverse Event|4|||
125259359|NCT02138825|450579432|FG001|Safety Follow-up|Adverse Event|3|||
125259360|NCT02138825|450579431|FG000|Safety Follow-up|Death|11|||
125259361|NCT02138825|450579432|FG001|Safety Follow-up|Death|5|||
125259362|NCT02138825|450579431|FG000|Safety Follow-up|Withdrawal by Subject|5|||
125259363|NCT02138825|450579432|FG001|Safety Follow-up|Withdrawal by Subject|3|||
125259364|NCT02138825|450579431|FG000|Safety Follow-up|clinic worsening|1|||
125259365|NCT02138825|450579432|FG001|Safety Follow-up|clinic worsening|0|||
125259366|NCT02138825|450579431|FG000|Safety Follow-up|withdrawal by PI|1|||
125259367|NCT02138825|450579432|FG001|Safety Follow-up|withdrawal by PI|0|||
125259368|NCT02138825|450579431|FG000|Safety Follow-up|logistical difficulties|0|||
125259369|NCT02138825|450579432|FG001|Safety Follow-up|logistical difficulties|1|||
125259370|NCT02138825|450579431|FG000|Safety Follow-up|progressive disease|0|||
125259371|NCT02138825|450579432|FG001|Safety Follow-up|progressive disease|2|||
125259372|NCT02138825|450579431|FG000|Safety Follow-up|too unwell to attend the visit|0|||
125259373|NCT02138825|450579432|FG001|Safety Follow-up|too unwell to attend the visit|1|||
125259374|NCT02138825|450579431|FG000|Safety Follow-up|treatment unblinded|0|||
125259375|NCT02138825|450579432|FG001|Safety Follow-up|treatment unblinded|1|||
125259376|NCT02138825|450579431|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
125259377|NCT02138825|450579432|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
125259378|NCT05201807|450579436|FG000|Overall Study|Adverse Event|1|||
125259379|NCT05201807|450579436|FG000|Overall Study|COVID-19 Related|1|||
125259380|NCT01209767|450579437|FG000|Overall Study|Withdrawal by Subject|1|||
125259381|NCT01209767|450579437|FG000|Overall Study|Lost to Follow-up|3|||
125259382|NCT01702298|450579438|FG000|Overall Study|Withdrawal by Subject|1|||
125259383|NCT01029535|450579442|FG000|Overall Study|Lost to Follow-up|24|||
125259384|NCT01029535|450579442|FG000|Overall Study|Protocol Violation|2|||
125259385|NCT01029535|450579442|FG000|Overall Study|Participant Withdrew Consent|2|||
125259386|NCT01029535|450579442|FG000|Overall Study|Adverse Event|1|||
125259387|NCT01029535|450579442|FG000|Overall Study|Use of Another Treatment|1|||
125259388|NCT01029535|450579442|FG000|Overall Study|Death|1|||
125259389|NCT00904371|450579447|FG000|Overall Study|Adverse Event|2|||
125259390|NCT00904371|450579447|FG000|Overall Study|Lost to Follow-up|4|||
125259391|NCT00904371|450579447|FG000|Overall Study|Discontinued at target blood pressure|2|||
125259392|NCT00904371|450579447|FG000|Overall Study|Continued with Tritace|1|||
125259393|NCT00583219|450579448|FG000|Phase 2|Withdrawal by Subject|1|||
125259394|NCT05448950|450579449|FG000|Overall Study|Death|2|||
125259395|NCT05448950|450579449|FG000|Overall Study|Withdrawal by Subject|1|||
125259396|NCT05448950|450579449|FG000|Overall Study|AVG abandoned|4|||
125259397|NCT02836249|450579450|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
125259398|NCT02836249|450579451|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
125259399|NCT02836249|450579452|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
125259400|NCT02836249|450579453|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
125259401|NCT02836249|450579450|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
125259402|NCT02836249|450579451|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
125259403|NCT02836249|450579452|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
125259404|NCT02836249|450579453|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
125259405|NCT02836249|450579450|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
125259406|NCT02836249|450579451|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
125259407|NCT02836249|450579452|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
125259408|NCT02836249|450579453|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
125259409|NCT02836249|450579450|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125259410|NCT02836249|450579451|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
125259411|NCT02836249|450579452|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125259412|NCT02836249|450579453|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125259413|NCT02836249|450579450|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
125259414|NCT02836249|450579451|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
125259415|NCT02836249|450579452|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
125259416|NCT02836249|450579453|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
125259417|NCT02836249|450579450|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
125259418|NCT02836249|450579451|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
125259419|NCT02836249|450579452|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
125259420|NCT02836249|450579453|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
125259421|NCT02836249|450579450|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
125445851|NCT01923428|451257711|FG001|Overall Study|Lack of Efficacy|0|||
125259422|NCT02836249|450579451|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
125259423|NCT02836249|450579452|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
125259424|NCT02836249|450579453|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
125259425|NCT02836249|450579450|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
125259426|NCT02836249|450579451|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
125259427|NCT02836249|450579452|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
125259428|NCT02836249|450579453|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
125445852|NCT01923428|451257712|FG002|Overall Study|Lack of Efficacy|1|||
125259429|NCT02836249|450579450|FG000|Open-Label TAF Treatment Phase|Death|0|||
125259430|NCT02836249|450579451|FG001|Open-Label TAF Treatment Phase|Death|0|||
125259431|NCT02836249|450579452|FG002|Open-Label TAF Treatment Phase|Death|1|||
125259432|NCT02836249|450579453|FG003|Open-Label TAF Treatment Phase|Death|0|||
125259433|NCT02836249|450579450|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
125259434|NCT02836249|450579451|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
125259435|NCT02836249|450579452|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
125259436|NCT02836249|450579453|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
125259437|NCT02836249|450579450|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
125259438|NCT02836249|450579451|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
125259439|NCT02836249|450579452|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
125259440|NCT02836249|450579453|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
125259441|NCT02706392|450579455|FG000|Overall Study|Death|1|||
125259442|NCT02706392|450579456|FG001|Overall Study|Death|0|||
125259443|NCT02706392|450579457|FG002|Overall Study|Death|2|||
125259444|NCT02706392|450579458|FG003|Overall Study|Death|2|||
125259445|NCT02706392|450579459|FG004|Overall Study|Death|5|||
125259446|NCT02706392|450579460|FG005|Overall Study|Death|2|||
125259447|NCT00619866|450579463|FG000|Weeks 1 - 12|Adverse Event|0|||
125259448|NCT00619866|450579464|FG001|Weeks 1 - 12|Adverse Event|1|||
125259449|NCT00619866|450579465|FG002|Weeks 1 - 12|Adverse Event|2|||
125259450|NCT00619866|450579466|FG003|Weeks 1 - 12|Adverse Event|0|||
125259451|NCT00619866|450579467|FG004|Weeks 1 - 12|Adverse Event|0|||
125259452|NCT00619866|450579463|FG000|Weeks 1 - 12|Non-compliance|0|||
125259453|NCT00619866|450579464|FG001|Weeks 1 - 12|Non-compliance|0|||
125259454|NCT00619866|450579465|FG002|Weeks 1 - 12|Non-compliance|1|||
125259455|NCT00619866|450579466|FG003|Weeks 1 - 12|Non-compliance|0|||
125259456|NCT00619866|450579467|FG004|Weeks 1 - 12|Non-compliance|0|||
125259457|NCT00619866|450579463|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
125259458|NCT00619866|450579464|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
125259459|NCT00619866|450579465|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
125259460|NCT00619866|450579466|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
125259461|NCT00619866|450579467|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
125259462|NCT00619866|450579463|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
125259463|NCT00619866|450579464|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
125259464|NCT00619866|450579465|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
125259465|NCT00619866|450579466|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
125259466|NCT00619866|450579467|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
125259467|NCT00619866|450579463|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
125259468|NCT00619866|450579464|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
125259469|NCT00619866|450579465|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
125259470|NCT00619866|450579466|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
125259471|NCT00619866|450579467|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
125259472|NCT00619866|450579463|FG000|Weeks 1 - 12|Sponsor Decision|0|||
125259473|NCT00619866|450579464|FG001|Weeks 1 - 12|Sponsor Decision|1|||
125259474|NCT00619866|450579465|FG002|Weeks 1 - 12|Sponsor Decision|0|||
125259475|NCT00619866|450579466|FG003|Weeks 1 - 12|Sponsor Decision|0|||
125259476|NCT00619866|450579467|FG004|Weeks 1 - 12|Sponsor Decision|0|||
125259477|NCT00619866|450579463|FG000|Weeks 13 - 24|Adverse Event|0|||
125259478|NCT00619866|450579464|FG001|Weeks 13 - 24|Adverse Event|0|||
125259479|NCT00619866|450579465|FG002|Weeks 13 - 24|Adverse Event|2|||
125259480|NCT00619866|450579466|FG003|Weeks 13 - 24|Adverse Event|1|||
125259481|NCT00619866|450579467|FG004|Weeks 13 - 24|Adverse Event|0|||
125259482|NCT00619866|450579463|FG000|Weeks 13 - 24|Protocol Deviation|0|||
125259483|NCT00619866|450579464|FG001|Weeks 13 - 24|Protocol Deviation|0|||
125259484|NCT00619866|450579465|FG002|Weeks 13 - 24|Protocol Deviation|0|||
125259485|NCT00619866|450579466|FG003|Weeks 13 - 24|Protocol Deviation|1|||
125259486|NCT00619866|450579467|FG004|Weeks 13 - 24|Protocol Deviation|0|||
125259487|NCT00619866|450579463|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
125259488|NCT00619866|450579464|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
125259489|NCT00619866|450579465|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
125259490|NCT00619866|450579466|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
125259491|NCT00619866|450579467|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
125259492|NCT00619866|450579463|FG000|Weeks 13 - 24|Non-compliance|0|||
125259493|NCT00619866|450579464|FG001|Weeks 13 - 24|Non-compliance|1|||
125259494|NCT00619866|450579465|FG002|Weeks 13 - 24|Non-compliance|1|||
125259495|NCT00619866|450579466|FG003|Weeks 13 - 24|Non-compliance|0|||
125259496|NCT00619866|450579467|FG004|Weeks 13 - 24|Non-compliance|0|||
125259497|NCT00619866|450579463|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
125259498|NCT00619866|450579464|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
125259499|NCT00619866|450579465|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
125259500|NCT00619866|450579466|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
125259501|NCT00619866|450579467|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
125259502|NCT01968980|450579471|FG000|Overall Study|Death|0|||
125259503|NCT01968980|450579472|FG001|Overall Study|Death|1|||
125259504|NCT01968980|450579471|FG000|Overall Study|Adverse Event|1|||
125259505|NCT01968980|450579472|FG001|Overall Study|Adverse Event|3|||
125259506|NCT01968980|450579471|FG000|Overall Study|Does not meet entry criteria|1|||
125259507|NCT01968980|450579472|FG001|Overall Study|Does not meet entry criteria|3|||
125259508|NCT01968980|450579471|FG000|Overall Study|Withdrawal by Subject|13|||
125259509|NCT01968980|450579472|FG001|Overall Study|Withdrawal by Subject|5|||
125259510|NCT01968980|450579471|FG000|Overall Study|Other unspecified|1|||
125259511|NCT01968980|450579472|FG001|Overall Study|Other unspecified|2|||
125259512|NCT02589938|450579476|FG000|Overall Study|Withdrawal by Subject|11|||
125259513|NCT02589938|450579477|FG001|Overall Study|Withdrawal by Subject|5|||
125259514|NCT02589938|450579478|FG002|Overall Study|Withdrawal by Subject|6|||
125259515|NCT02589938|450579476|FG000|Overall Study|Lost to Follow-up|3|||
125259516|NCT02589938|450579477|FG001|Overall Study|Lost to Follow-up|3|||
125259517|NCT02589938|450579478|FG002|Overall Study|Lost to Follow-up|3|||
125259518|NCT02589938|450579476|FG000|Overall Study|Death|1|||
125259519|NCT02589938|450579477|FG001|Overall Study|Death|0|||
125259520|NCT02589938|450579478|FG002|Overall Study|Death|1|||
125259521|NCT02589938|450579476|FG000|Overall Study|Protocol Violation|6|||
125259522|NCT02589938|450579477|FG001|Overall Study|Protocol Violation|2|||
125259523|NCT02589938|450579478|FG002|Overall Study|Protocol Violation|3|||
125259524|NCT02589938|450579476|FG000|Overall Study|Physician Decision|1|||
125259525|NCT02589938|450579477|FG001|Overall Study|Physician Decision|0|||
125259526|NCT02589938|450579478|FG002|Overall Study|Physician Decision|0|||
125259527|NCT02589938|450579476|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
125259528|NCT02589938|450579477|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
125259529|NCT02589938|450579478|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
125259530|NCT02521285|450579479|FG000|Overall Study|Lost to Follow-up|1|||
125259531|NCT02521285|450579480|FG001|Overall Study|Lost to Follow-up|1|||
125259532|NCT02521285|450579479|FG000|Overall Study|Withdrawal by Subject|1|||
125259533|NCT02521285|450579480|FG001|Overall Study|Withdrawal by Subject|1|||
125259534|NCT02521285|450579479|FG000|Overall Study|Adverse Event|0|||
125259535|NCT02521285|450579480|FG001|Overall Study|Adverse Event|1|||
125259536|NCT00787150|450579481|FG000|Overall Study|Adverse Event|4|||
125259537|NCT00787150|450579482|FG001|Overall Study|Adverse Event|4|||
125259538|NCT00787150|450579483|FG002|Overall Study|Adverse Event|4|||
125259539|NCT00787150|450579481|FG000|Overall Study|Physician Decision|1|||
125259540|NCT00787150|450579482|FG001|Overall Study|Physician Decision|2|||
125259541|NCT00787150|450579483|FG002|Overall Study|Physician Decision|1|||
125259542|NCT00787150|450579481|FG000|Overall Study|Withdrawal by Subject|2|||
125259543|NCT00787150|450579482|FG001|Overall Study|Withdrawal by Subject|1|||
125259544|NCT00787150|450579483|FG002|Overall Study|Withdrawal by Subject|0|||
125259545|NCT00787150|450579481|FG000|Overall Study|Dosing incorrect study durg|2|||
125259546|NCT00787150|450579482|FG001|Overall Study|Dosing incorrect study durg|0|||
125259547|NCT00787150|450579483|FG002|Overall Study|Dosing incorrect study durg|0|||
125259548|NCT01849276|450579490|FG000|Followed for Survival for 5 Years|Death|1|||
125259549|NCT01849276|450579490|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
125259550|NCT00879398|450579493|FG000|Overall Study|Visit Stop|399|||
125259551|NCT00879398|450579493|FG000|Overall Study|Lack of Efficacy|64|||
125259552|NCT00879398|450579493|FG000|Overall Study|Adverse Event|41|||
125259553|NCT00879398|450579493|FG000|Overall Study|Other Reasons|171|||
125259554|NCT01722669|450579496|FG000|Overall Study|Withdrawal by Subject|0|||
125259555|NCT01722669|450579497|FG001|Overall Study|Withdrawal by Subject|0|||
125259556|NCT01722669|450579498|FG002|Overall Study|Withdrawal by Subject|0|||
125259557|NCT01722669|450579499|FG003|Overall Study|Withdrawal by Subject|0|||
125259558|NCT01722669|450579500|FG004|Overall Study|Withdrawal by Subject|0|||
125259559|NCT01722669|450579501|FG005|Overall Study|Withdrawal by Subject|2|||
125259560|NCT03559556|450579503|FG000|Overall Study|Withdrawal by Subject|1|||
125259561|NCT03012880|450579510|FG000|Overall Study|Withdrawal by Subject|1|||
125259562|NCT03012880|450579511|FG001|Overall Study|Withdrawal by Subject|0|||
125259563|NCT03012880|450579510|FG000|Overall Study|Ineligible|1|||
125259564|NCT03012880|450579511|FG001|Overall Study|Ineligible|0|||
125397780|NCT02457598|451089261|FG015|Overall Study|Intercurrent Illness|0|||
125397781|NCT02457598|451089262|FG016|Overall Study|Intercurrent Illness|0|||
125397782|NCT02457598|451089246|FG000|Overall Study|Protocol Violation|0|||
125397783|NCT02457598|451089247|FG001|Overall Study|Protocol Violation|0|||
125259565|NCT01587196|450579512|FG000|Overall Study|Lost to Follow-up|50|||
125259566|NCT01587196|450579512|FG000|Overall Study|Withdrawal by Subject|4|||
125259567|NCT02769481|450579513|FG000|Overall Study|Protocol Violation|1|||
125259568|NCT02769481|450579514|FG001|Overall Study|Protocol Violation|0|||
125259569|NCT02769481|450579513|FG000|Overall Study|Adverse Event|3|||
125259570|NCT02769481|450579514|FG001|Overall Study|Adverse Event|6|||
125259571|NCT02769481|450579513|FG000|Overall Study|Entry Criteria Not Met|1|||
125259572|NCT02769481|450579514|FG001|Overall Study|Entry Criteria Not Met|2|||
125259573|NCT02769481|450579513|FG000|Overall Study|Withdrawal by Subject|14|||
125259574|NCT02769481|450579514|FG001|Overall Study|Withdrawal by Subject|16|||
125259575|NCT02769481|450579513|FG000|Overall Study|Lost to Follow-up|9|||
125259576|NCT02769481|450579514|FG001|Overall Study|Lost to Follow-up|9|||
125259577|NCT02769481|450579513|FG000|Overall Study|Physician Decision|0|||
125259578|NCT02769481|450579514|FG001|Overall Study|Physician Decision|1|||
125259579|NCT02769481|450579513|FG000|Overall Study|Terminated by Sponsor|1|||
125259580|NCT02769481|450579514|FG001|Overall Study|Terminated by Sponsor|0|||
125259581|NCT02769481|450579513|FG000|Overall Study|Death|0|||
125259582|NCT02769481|450579514|FG001|Overall Study|Death|1|||
125259583|NCT02769481|450579513|FG000|Overall Study|Undefined|4|||
125259584|NCT02769481|450579514|FG001|Overall Study|Undefined|1|||
125259585|NCT03510715|450579515|FG000|Overall Study|Adverse Event|1|||
125259586|NCT03510715|450579516|FG001|Overall Study|Adverse Event|0|||
125259587|NCT00643279|450579527|FG000|Overall Study|Death|13|||
125259588|NCT00643279|450579528|FG001|Overall Study|Death|11|||
125259589|NCT00643279|450579527|FG000|Overall Study|Withdrawal by Subject|3|||
125259590|NCT00643279|450579528|FG001|Overall Study|Withdrawal by Subject|0|||
125259591|NCT00643279|450579527|FG000|Overall Study|Lost to Follow-up|0|||
125259592|NCT00643279|450579528|FG001|Overall Study|Lost to Follow-up|1|||
125259593|NCT00643279|450579527|FG000|Overall Study|Physician Decision|0|||
125259594|NCT00643279|450579528|FG001|Overall Study|Physician Decision|1|||
125259595|NCT05715827|450579529|FG000|Overall Study|Physician Decision|0|||
125259596|NCT05715827|450579530|FG001|Overall Study|Physician Decision|1|||
125259597|NCT05715827|450579529|FG000|Overall Study|console communication error|0|||
125259598|NCT05715827|450579530|FG001|Overall Study|console communication error|1|||
125259599|NCT03814044|450579531|FG000|Overall Study|Protocol deviation|1|||
125259600|NCT05929326|450579532|FG000|Overall Study|unqualified sample|2|||
125259601|NCT05929326|450579533|FG001|Overall Study|unqualified sample|3|||
125259602|NCT05929326|450579534|FG002|Overall Study|unqualified sample|7|||
125259603|NCT03557502|450579543|FG000|Protocol 2|Withdrawal by Subject|1|||
125259604|NCT03557502|450579544|FG001|Protocol 2|Withdrawal by Subject|1|||
125259605|NCT03557502|450579543|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
125259606|NCT03557502|450579544|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
125259607|NCT02333799|450580913|FG000|Treatment Period|Withdrawal by Subject|1|||
125259608|NCT02333799|450580913|FG000|Treatment Period|Death|6|||
125259609|NCT02333799|450580913|FG000|6 Month Follow Up Period|Physician Decision|1|||
125259610|NCT02333799|450580913|FG000|6 Month Follow Up Period|Death|1|||
125259611|NCT02333799|450580913|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
125259612|NCT02333799|450580913|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
125259613|NCT01657370|450580917|FG000|Overall Study|Withdrawal by Subject|0|||
125259614|NCT01657370|450580918|FG001|Overall Study|Withdrawal by Subject|0|||
125259615|NCT01657370|450580919|FG002|Overall Study|Withdrawal by Subject|1|||
125259616|NCT01657370|450580920|FG003|Overall Study|Withdrawal by Subject|0|||
125259617|NCT01657370|450580921|FG004|Overall Study|Withdrawal by Subject|0|||
125259618|NCT01657370|450580922|FG005|Overall Study|Withdrawal by Subject|1|||
125259619|NCT01657370|450580917|FG000|Overall Study|Physician Decision|2|||
125259620|NCT01657370|450580918|FG001|Overall Study|Physician Decision|3|||
125259621|NCT01657370|450580919|FG002|Overall Study|Physician Decision|1|||
125259622|NCT01657370|450580920|FG003|Overall Study|Physician Decision|2|||
125259623|NCT01657370|450580921|FG004|Overall Study|Physician Decision|5|||
125259624|NCT01657370|450580922|FG005|Overall Study|Physician Decision|0|||
125259625|NCT01657370|450580917|FG000|Overall Study|Lack of Qualifying Event|1|||
125259626|NCT01657370|450580918|FG001|Overall Study|Lack of Qualifying Event|0|||
125259627|NCT01657370|450580919|FG002|Overall Study|Lack of Qualifying Event|3|||
125259628|NCT01657370|450580920|FG003|Overall Study|Lack of Qualifying Event|2|||
125259629|NCT01657370|450580921|FG004|Overall Study|Lack of Qualifying Event|1|||
125259630|NCT01657370|450580922|FG005|Overall Study|Lack of Qualifying Event|2|||
125259631|NCT01657370|450580917|FG000|Overall Study|Adverse Event|0|||
125259632|NCT01657370|450580918|FG001|Overall Study|Adverse Event|0|||
125259633|NCT01657370|450580919|FG002|Overall Study|Adverse Event|0|||
125259634|NCT01657370|450580920|FG003|Overall Study|Adverse Event|0|||
125259635|NCT01657370|450580921|FG004|Overall Study|Adverse Event|1|||
125259636|NCT01657370|450580922|FG005|Overall Study|Adverse Event|0|||
125259637|NCT01657370|450580917|FG000|Overall Study|Protocol Violation|1|||
125259638|NCT01657370|450580918|FG001|Overall Study|Protocol Violation|1|||
125259639|NCT01657370|450580919|FG002|Overall Study|Protocol Violation|1|||
125259640|NCT01657370|450580920|FG003|Overall Study|Protocol Violation|1|||
125259641|NCT01657370|450580921|FG004|Overall Study|Protocol Violation|0|||
125259642|NCT01657370|450580922|FG005|Overall Study|Protocol Violation|0|||
125259643|NCT01657370|450580917|FG000|Overall Study|Lost to Follow-up|2|||
125259644|NCT01657370|450580918|FG001|Overall Study|Lost to Follow-up|0|||
125259645|NCT01657370|450580919|FG002|Overall Study|Lost to Follow-up|1|||
125259646|NCT01657370|450580920|FG003|Overall Study|Lost to Follow-up|0|||
125259647|NCT01657370|450580921|FG004|Overall Study|Lost to Follow-up|0|||
125259648|NCT01657370|450580922|FG005|Overall Study|Lost to Follow-up|1|||
125259649|NCT03021486|450580923|FG000|Overall Study|Withdrawal by Subject|1|||
125445853|NCT01923428|451257713|FG003|Overall Study|Lack of Efficacy|1|||
125445854|NCT01822353|451257714|FG000|Overall Study|Adverse Event|1|||
125445855|NCT01822353|451257715|FG001|Overall Study|Adverse Event|3|||
125445856|NCT01822353|451257716|FG002|Overall Study|Adverse Event|1|||
125445857|NCT01822353|451257714|FG000|Overall Study|Pregnancy|0|||
125445858|NCT01822353|451257715|FG001|Overall Study|Pregnancy|1|||
125445859|NCT01822353|451257716|FG002|Overall Study|Pregnancy|0|||
125445860|NCT01822353|451257714|FG000|Overall Study|Withdrawal by Subject|3|||
125445861|NCT01822353|451257715|FG001|Overall Study|Withdrawal by Subject|1|||
125445862|NCT01822353|451257716|FG002|Overall Study|Withdrawal by Subject|0|||
125445863|NCT02550873|451257717|FG000|Randomized Double Blind|Adverse Event|3|||
125445864|NCT02550873|451257718|FG001|Randomized Double Blind|Adverse Event|1|||
125445865|NCT02550873|451257719|FG002|Randomized Double Blind|Adverse Event|0|||
125445866|NCT02550873|451257717|FG000|Randomized Double Blind|Disease progression|1|||
125445867|NCT02550873|451257718|FG001|Randomized Double Blind|Disease progression|1|||
125445868|NCT02550873|451257719|FG002|Randomized Double Blind|Disease progression|0|||
125445869|NCT02550873|451257717|FG000|Open Label Extension|Study ongoing|0|||
125445870|NCT02550873|451257718|FG001|Open Label Extension|Study ongoing|0|||
125445871|NCT02550873|451257719|FG002|Open Label Extension|Study ongoing|111|||
125445872|NCT04320615|451257720|FG000|Overall Study|Withdrawal by Subject|4|||
125445873|NCT04320615|451257721|FG001|Overall Study|Withdrawal by Subject|10|||
125259650|NCT03021486|450580924|FG001|Overall Study|Withdrawal by Subject|1|||
125259651|NCT03021486|450580925|FG002|Overall Study|Withdrawal by Subject|3|||
125259652|NCT03021486|450580923|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
125259653|NCT03021486|450580924|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
125259654|NCT03021486|450580925|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
125259655|NCT04795531|450580926|FG000|Overall Study|Withdrawal by Subject|4|||
125259656|NCT04795531|450580927|FG001|Overall Study|Withdrawal by Subject|4|||
125259657|NCT04795531|450580926|FG000|Overall Study|Lost to Follow-up|0|||
125259658|NCT04795531|450580927|FG001|Overall Study|Lost to Follow-up|1|||
125259659|NCT04795531|450580926|FG000|Overall Study|Physician Decision|0|||
125259660|NCT04795531|450580927|FG001|Overall Study|Physician Decision|2|||
125259661|NCT04795531|450580926|FG000|Overall Study|Death|2|||
125259662|NCT04795531|450580927|FG001|Overall Study|Death|1|||
125259663|NCT04887831|450580928|FG000|Overall Study|Death|26|||
125259664|NCT04887831|450580929|FG001|Overall Study|Death|26|||
125259665|NCT04887831|450580928|FG000|Overall Study|Lost to Follow-up|0|||
125259666|NCT04887831|450580929|FG001|Overall Study|Lost to Follow-up|1|||
125259667|NCT04887831|450580928|FG000|Overall Study|Withdrawal by Subject|2|||
125259668|NCT04887831|450580929|FG001|Overall Study|Withdrawal by Subject|1|||
125259669|NCT04887831|450580928|FG000|Overall Study|Study Terminated by Sponsor|18|||
125259670|NCT04887831|450580929|FG001|Overall Study|Study Terminated by Sponsor|17|||
125259671|NCT04887831|450580928|FG000|Overall Study|Other|1|||
125259672|NCT04887831|450580929|FG001|Overall Study|Other|0|||
125259673|NCT04507204|450580932|FG000|Overall Study|Adverse Event|8|||
125259674|NCT04507204|450580933|FG001|Overall Study|Adverse Event|13|||
125259675|NCT04507204|450580932|FG000|Overall Study|Death|0|||
125259676|NCT04507204|450580933|FG001|Overall Study|Death|1|||
125259677|NCT04507204|450580932|FG000|Overall Study|Lost to Follow-up|15|||
125259678|NCT04507204|450580933|FG001|Overall Study|Lost to Follow-up|14|||
125259679|NCT04507204|450580932|FG000|Overall Study|Poor Compliance with Protocol|2|||
125259680|NCT04507204|450580933|FG001|Overall Study|Poor Compliance with Protocol|4|||
125259681|NCT04507204|450580932|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
125259682|NCT04507204|450580933|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
125259683|NCT04507204|450580932|FG000|Overall Study|Withdrawal of Patient Consent|21|||
125259684|NCT04507204|450580933|FG001|Overall Study|Withdrawal of Patient Consent|13|||
125259685|NCT01206517|450580936|FG000|Overall Study|Withdrawal by Subject|0|||
125259686|NCT01206517|450580937|FG001|Overall Study|Withdrawal by Subject|0|||
125259687|NCT01206517|450580938|FG002|Overall Study|Withdrawal by Subject|2|||
125259688|NCT01206517|450580939|FG003|Overall Study|Withdrawal by Subject|0|||
125259689|NCT01206517|450580940|FG004|Overall Study|Withdrawal by Subject|1|||
125259690|NCT01206517|450580941|FG005|Overall Study|Withdrawal by Subject|0|||
125259691|NCT03493958|450580942|FG000|Overall Study|Withdrawal by Subject|6|||
125259692|NCT03493958|450580942|FG000|Overall Study|Lost to Follow-up|7|||
125259693|NCT03493958|450580942|FG000|Overall Study|Did not complete all required study procedures|2|||
125259694|NCT04047446|450580943|FG000|Overall Study|Physician Decision|1|||
125259695|NCT04047446|450580944|FG001|Overall Study|Physician Decision|0|||
125259696|NCT02367456|450580945|FG000|Overall Study|Death|8|||
125259697|NCT02367456|450580946|FG001|Overall Study|Death|24|||
125259698|NCT02367456|450580947|FG002|Overall Study|Death|17|||
125259699|NCT02367456|450580945|FG000|Overall Study|Lost to Follow-up|1|||
125259700|NCT02367456|450580946|FG001|Overall Study|Lost to Follow-up|3|||
125445874|NCT04320615|451257720|FG000|Overall Study|Physician Decision|2|||
125445875|NCT04320615|451257721|FG001|Overall Study|Physician Decision|0|||
125445876|NCT04320615|451257720|FG000|Overall Study|Other|2|||
125445877|NCT04320615|451257721|FG001|Overall Study|Other|0|||
125445878|NCT04320615|451257720|FG000|Overall Study|Lost to Follow-up|5|||
125259701|NCT02367456|450580947|FG002|Overall Study|Lost to Follow-up|1|||
125259702|NCT02367456|450580945|FG000|Overall Study|Other reason|3|||
125259703|NCT02367456|450580946|FG001|Overall Study|Other reason|3|||
125259704|NCT02367456|450580947|FG002|Overall Study|Other reason|9|||
125259705|NCT02367456|450580945|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
125259706|NCT02367456|450580946|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
125259707|NCT02367456|450580947|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
125259708|NCT01198587|450580953|FG000|Overall Study|Lost to Follow-up|8|||
125259709|NCT01198587|450580954|FG001|Overall Study|Lost to Follow-up|0|||
125259710|NCT01198587|450580955|FG002|Overall Study|Lost to Follow-up|9|||
125259711|NCT01198587|450580956|FG003|Overall Study|Lost to Follow-up|0|||
125259712|NCT02095106|450580959|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
125259713|NCT02095106|450580960|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
125259714|NCT00553254|450580963|FG000|Overall Study|Death|3|||
125259715|NCT00553254|450580964|FG001|Overall Study|Death|6|||
125259716|NCT00553254|450580965|FG002|Overall Study|Death|25|||
125259717|NCT00553254|450580963|FG000|Overall Study|Lost to Follow-up|0|||
125259718|NCT00553254|450580964|FG001|Overall Study|Lost to Follow-up|0|||
125259719|NCT00553254|450580965|FG002|Overall Study|Lost to Follow-up|2|||
125259720|NCT00553254|450580963|FG000|Overall Study|Withdrawal by Subject|2|||
125259721|NCT00553254|450580964|FG001|Overall Study|Withdrawal by Subject|0|||
125259722|NCT00553254|450580965|FG002|Overall Study|Withdrawal by Subject|2|||
125259723|NCT00553254|450580963|FG000|Overall Study|Study terminated by Sponsor|0|||
125259724|NCT00553254|450580964|FG001|Overall Study|Study terminated by Sponsor|0|||
125259725|NCT00553254|450580965|FG002|Overall Study|Study terminated by Sponsor|1|||
125259726|NCT00553254|450580963|FG000|Overall Study|Other|1|||
125259727|NCT00553254|450580964|FG001|Overall Study|Other|0|||
125259728|NCT00553254|450580965|FG002|Overall Study|Other|13|||
125259729|NCT00754572|450580973|FG000|Overall Study|Adverse Event|19|||
125259730|NCT00754572|450580973|FG000|Overall Study|Other|39|||
125259731|NCT00754572|450580973|FG000|Overall Study|Protocol Violation|3|||
125259732|NCT00754572|450580973|FG000|Overall Study|Withdrawal by Subject|3|||
125259733|NCT00754572|450580973|FG000|Overall Study|Lack of Efficacy|2|||
125259734|NCT00754572|450580973|FG000|Overall Study|Death|1|||
125259735|NCT00754572|450580973|FG000|Overall Study|Administrative Reason|3|||
125259736|NCT00754572|450580973|FG000|Overall Study|Lost to Follow-up|1|||
125259737|NCT05134649|450580977|FG000|Overall Study|Lost to Follow-up|12|||
125259738|NCT05134649|450580977|FG000|Overall Study|Withdrawal by Subject|14|||
125259739|NCT05134649|450580977|FG000|Overall Study|Pregnancy|1|||
125259740|NCT05134649|450580977|FG000|Overall Study|Other, not specified|3|||
125259741|NCT01559935|450580978|FG000|Car Phase|Toxicity|4|||
125259742|NCT01559935|450580978|FG000|Car Phase|Death|1|||
125259743|NCT01559935|450580978|FG000|Car Phase|Lack of Efficacy|2|||
125259744|NCT01559935|450580978|FG000|Car Phase|Lost to Follow-up|1|||
125259745|NCT01559935|450580978|FG000|Car Phase|Physician Decision|1|||
125259746|NCT01559935|450580978|FG000|Car Phase|Withdrawal by Subject|2|||
125259747|NCT01559935|450580978|FG000|Car Phase|Per protocol|1|||
125259748|NCT01559935|450580978|FG000|Car Phase|Insurance|1|||
125259749|NCT01559935|450580978|FG000|Car Phase|non-compliance|1|||
125259750|NCT01559935|450580978|FG000|BiRD Phase|Toxicity|1|||
125259751|NCT01559935|450580978|FG000|BiRD Phase|Lack of Efficacy|1|||
125259752|NCT01559935|450580978|FG000|BiRD Phase|Withdrawal by Subject|2|||
125259753|NCT01559935|450580978|FG000|Maintenance Phase|Remains on study|28|||
125259754|NCT01559935|450580978|FG000|Maintenance Phase|Toxicity|1|||
125259755|NCT01559935|450580978|FG000|Maintenance Phase|Lack of Efficacy|18|||
125259756|NCT01559935|450580978|FG000|Maintenance Phase|Withdrawal by Subject|5|||
125259757|NCT01559935|450580978|FG000|Maintenance Phase|Non-compliance|2|||
125259758|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259759|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
125259760|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259761|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
125259762|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
125259763|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
125259764|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
125259765|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259766|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259767|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259768|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259769|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259770|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259771|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259772|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259773|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
125259774|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
125259775|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
125259776|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
125259777|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
125259778|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
125259779|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
125259780|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
125259781|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
125259782|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
125259783|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
125259784|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
125259785|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
125259786|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
125259787|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
125259788|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
125259789|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
125259790|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
125259791|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
125259792|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259793|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259794|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259795|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259796|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259797|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259798|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259799|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259800|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259801|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259802|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259803|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259804|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259805|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
125259806|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
125259807|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259808|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
125259809|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
125259810|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
125259811|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
125259812|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
125259813|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259814|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259815|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259816|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259817|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259818|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259819|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259820|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259821|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125259822|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259823|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259824|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259825|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
125259826|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259827|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259828|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
125259829|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259830|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259831|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259832|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259833|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259834|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259835|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259836|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259837|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
125259838|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259839|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259840|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
125259841|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259842|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259843|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259844|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259845|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259846|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259847|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259848|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259849|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259850|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125397784|NCT02457598|451089248|FG002|Overall Study|Protocol Violation|0|||
125397785|NCT02457598|451089249|FG003|Overall Study|Protocol Violation|0|||
125397786|NCT02457598|451089250|FG004|Overall Study|Protocol Violation|0|||
125397787|NCT02457598|451089251|FG005|Overall Study|Protocol Violation|0|||
125397788|NCT02457598|451089252|FG006|Overall Study|Protocol Violation|0|||
125397789|NCT02457598|451089253|FG007|Overall Study|Protocol Violation|0|||
125397790|NCT02457598|451089254|FG008|Overall Study|Protocol Violation|0|||
125397791|NCT02457598|451089255|FG009|Overall Study|Protocol Violation|0|||
125397792|NCT02457598|451089256|FG010|Overall Study|Protocol Violation|1|||
125397793|NCT02457598|451089257|FG011|Overall Study|Protocol Violation|0|||
125397794|NCT02457598|451089258|FG012|Overall Study|Protocol Violation|0|||
125397795|NCT02457598|451089259|FG013|Overall Study|Protocol Violation|0|||
125397796|NCT02457598|451089260|FG014|Overall Study|Protocol Violation|0|||
125397797|NCT02457598|451089261|FG015|Overall Study|Protocol Violation|0|||
125397798|NCT02457598|451089262|FG016|Overall Study|Protocol Violation|0|||
125397799|NCT01403974|451089263|FG000|Overall Study|Progressive disease according to RECIST|3|||
125397800|NCT01403974|451089264|FG001|Overall Study|Progressive disease according to RECIST|3|||
125397801|NCT01403974|451089265|FG002|Overall Study|Progressive disease according to RECIST|2|||
125397802|NCT01403974|451089266|FG003|Overall Study|Progressive disease according to RECIST|3|||
125397803|NCT01403974|451089267|FG004|Overall Study|Progressive disease according to RECIST|3|||
125397804|NCT01403974|451089268|FG005|Overall Study|Progressive disease according to RECIST|2|||
125397805|NCT01403974|451089269|FG006|Overall Study|Progressive disease according to RECIST|3|||
125397806|NCT01403974|451089270|FG007|Overall Study|Progressive disease according to RECIST|2|||
125397807|NCT01403974|451089271|FG008|Overall Study|Progressive disease according to RECIST|6|||
125397808|NCT01403974|451089272|FG009|Overall Study|Progressive disease according to RECIST|2|||
125397809|NCT01403974|451089273|FG010|Overall Study|Progressive disease according to RECIST|3|||
125397810|NCT01403974|451089274|FG011|Overall Study|Progressive disease according to RECIST|2|||
125397811|NCT01403974|451089275|FG012|Overall Study|Progressive disease according to RECIST|2|||
125397812|NCT01403974|451089276|FG013|Overall Study|Progressive disease according to RECIST|3|||
125397813|NCT01403974|451089277|FG014|Overall Study|Progressive disease according to RECIST|1|||
125397814|NCT01403974|451089278|FG015|Overall Study|Progressive disease according to RECIST|8|||
125397815|NCT01403974|451089263|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
125397816|NCT01403974|451089264|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
125397817|NCT01403974|451089265|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
125397818|NCT01403974|451089266|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
125397819|NCT01403974|451089267|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
125397820|NCT01403974|451089268|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
125397821|NCT01403974|451089269|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
125397822|NCT01403974|451089270|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
125397823|NCT01403974|451089271|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
125397824|NCT01403974|451089272|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
125397825|NCT01403974|451089273|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
125397826|NCT01403974|451089274|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
125397827|NCT01403974|451089275|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
125397828|NCT01403974|451089276|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
125397829|NCT01403974|451089277|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
125397830|NCT01403974|451089278|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
125397831|NCT01403974|451089263|FG000|Overall Study|Refused to continue study medication|0|||
125397832|NCT01403974|451089264|FG001|Overall Study|Refused to continue study medication|0|||
125397833|NCT01403974|451089265|FG002|Overall Study|Refused to continue study medication|0|||
125397834|NCT01403974|451089266|FG003|Overall Study|Refused to continue study medication|0|||
125397835|NCT01403974|451089267|FG004|Overall Study|Refused to continue study medication|0|||
125397836|NCT01403974|451089268|FG005|Overall Study|Refused to continue study medication|1|||
125397837|NCT01403974|451089269|FG006|Overall Study|Refused to continue study medication|0|||
125397838|NCT01403974|451089270|FG007|Overall Study|Refused to continue study medication|0|||
125397839|NCT01403974|451089271|FG008|Overall Study|Refused to continue study medication|1|||
125397840|NCT01403974|451089272|FG009|Overall Study|Refused to continue study medication|0|||
125397841|NCT01403974|451089273|FG010|Overall Study|Refused to continue study medication|1|||
125397842|NCT01403974|451089274|FG011|Overall Study|Refused to continue study medication|0|||
125397843|NCT01403974|451089275|FG012|Overall Study|Refused to continue study medication|0|||
125397844|NCT01403974|451089276|FG013|Overall Study|Refused to continue study medication|0|||
125445879|NCT04320615|451257721|FG001|Overall Study|Lost to Follow-up|23|||
125445880|NCT04320615|451257720|FG000|Overall Study|Death|35|||
125445881|NCT04320615|451257721|FG001|Overall Study|Death|71|||
125259851|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259852|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259853|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
125259854|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
125259855|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
125259856|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
125259857|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259858|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259859|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259860|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259861|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259862|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259863|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259864|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259865|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259866|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259867|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259868|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259869|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125259870|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
125259871|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
125259872|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
125259873|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
125259874|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
125259875|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
125259876|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
125259877|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
125259878|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
125259879|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
125259880|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
125259881|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
125259882|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
125259883|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
125259884|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
125259885|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
125259886|NCT02958865|450580979|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259887|NCT02958865|450580980|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259888|NCT02958865|450580981|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259889|NCT02958865|450580982|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259890|NCT02958865|450580983|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
125259891|NCT02958865|450580984|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259892|NCT02958865|450580985|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259893|NCT02958865|450580986|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259894|NCT02958865|450580987|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259895|NCT02958865|450580988|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259896|NCT02958865|450580989|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259897|NCT02958865|450580990|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259898|NCT02958865|450580991|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259899|NCT02958865|450580992|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259900|NCT02958865|450580993|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259901|NCT02958865|450580994|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125259902|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259903|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259904|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259905|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259906|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259907|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259908|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125259909|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
125259910|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
125259911|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
125259912|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
125445882|NCT01449721|451257722|FG000|Overall Study|Physician Decision|0|||
125445883|NCT01449721|451257723|FG001|Overall Study|Physician Decision|1|||
125445884|NCT01449721|451257722|FG000|Overall Study|Physician Decision|0|||
125259913|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
125445885|NCT01449721|451257723|FG001|Overall Study|Physician Decision|1|||
125445886|NCT03285711|451257724|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
125259914|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
125259915|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
125259916|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
125259917|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
125259918|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259919|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259920|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259921|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259922|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259923|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259924|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259925|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259926|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
125259927|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
125259928|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259929|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
125259930|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259931|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
125259932|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
125259933|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
125259934|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259935|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259936|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259937|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259938|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259939|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259940|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259941|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259942|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259943|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
125259944|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259945|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259946|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259947|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259948|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
125259949|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
125259950|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259951|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259952|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259953|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259954|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259955|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259956|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259957|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259958|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259959|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259960|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
125259961|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
125259962|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
125259963|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
125259964|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
125259965|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
125259966|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
125259967|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
125259968|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
125259969|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
125259970|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
125397845|NCT01403974|451089277|FG014|Overall Study|Refused to continue study medication|0|||
125397846|NCT01403974|451089278|FG015|Overall Study|Refused to continue study medication|4|||
125397847|NCT01403974|451089263|FG000|Overall Study|Adverse Event|0|||
125259971|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
125259972|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
125259973|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
125259974|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
125397848|NCT01403974|451089264|FG001|Overall Study|Adverse Event|0|||
125397849|NCT01403974|451089265|FG002|Overall Study|Adverse Event|1|||
125259975|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
125259976|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
125397850|NCT01403974|451089266|FG003|Overall Study|Adverse Event|0|||
125259977|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
125259978|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
125259979|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
125259980|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
125259981|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
125259982|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259983|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259984|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259985|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259986|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259987|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259988|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259989|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259990|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259991|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259992|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259993|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259994|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259995|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
125259996|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259997|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
125259998|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125259999|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260000|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260001|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260002|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260003|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260004|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260005|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260006|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260007|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260008|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260009|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260010|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260011|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
125260012|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260013|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
125260014|NCT02958865|450580979|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260015|NCT02958865|450580980|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260016|NCT02958865|450580981|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260017|NCT02958865|450580982|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260018|NCT02958865|450580983|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260019|NCT02958865|450580984|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260020|NCT02958865|450580985|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260021|NCT02958865|450580986|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260022|NCT02958865|450580987|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260023|NCT02958865|450580988|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
125260024|NCT02958865|450580989|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260025|NCT02958865|450580990|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260026|NCT02958865|450580991|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260027|NCT02958865|450580992|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260028|NCT02958865|450580993|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260029|NCT02958865|450580994|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
125260030|NCT01038323|450581008|FG000|Overall Study|Withdrawal by Subject|3|||
125260031|NCT01038323|450581009|FG001|Overall Study|Withdrawal by Subject|2|||
125260032|NCT01038323|450581010|FG002|Overall Study|Withdrawal by Subject|4|||
125260033|NCT01143402|450581011|FG000|Overall Study|Rapid clinical decline|1|||
125260034|NCT01143402|450581012|FG001|Overall Study|Rapid clinical decline|1|||
125260035|NCT01143402|450581013|FG002|Overall Study|Rapid clinical decline|0|||
125260036|NCT01143402|450581011|FG000|Overall Study|Not Treated|0|||
125260037|NCT01143402|450581012|FG001|Overall Study|Not Treated|0|||
125397851|NCT01403974|451089267|FG004|Overall Study|Adverse Event|0|||
125397852|NCT01403974|451089268|FG005|Overall Study|Adverse Event|0|||
125397853|NCT01403974|451089269|FG006|Overall Study|Adverse Event|0|||
125397854|NCT01403974|451089270|FG007|Overall Study|Adverse Event|1|||
125445887|NCT03285711|451257725|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
125445888|NCT03285711|451257726|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
125445889|NCT03285711|451257727|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
125445890|NCT03285711|451257724|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
125445891|NCT03285711|451257725|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
125445892|NCT03285711|451257726|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
125445893|NCT03285711|451257727|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
125445894|NCT03285711|451257724|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
125445895|NCT03285711|451257725|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
125445896|NCT03285711|451257726|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
125445897|NCT03285711|451257727|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
125445898|NCT03285711|451257724|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
125445899|NCT03285711|451257725|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
125445900|NCT03285711|451257726|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
125445901|NCT03285711|451257727|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
125445902|NCT02431533|451257728|FG000|Overall Study|Withdrawal by Subject|1|||
125445903|NCT02431533|451257729|FG001|Overall Study|Withdrawal by Subject|3|||
125445904|NCT02431533|451257728|FG000|Overall Study|Developed Exclusionary criteria|1|||
125445905|NCT02431533|451257729|FG001|Overall Study|Developed Exclusionary criteria|0|||
125445906|NCT00885495|451257734|FG000|Overall Study|Adverse Event|1|||
125445907|NCT00885495|451257735|FG001|Overall Study|Adverse Event|2|||
125445908|NCT00885495|451257734|FG000|Overall Study|Protocol Violation|0|||
125445909|NCT00885495|451257735|FG001|Overall Study|Protocol Violation|1|||
125445910|NCT00885495|451257734|FG000|Overall Study|Withdrawal by Subject|1|||
125445911|NCT00885495|451257735|FG001|Overall Study|Withdrawal by Subject|0|||
125445912|NCT01400893|451257736|FG000|Overall Study|Death|27|||
125445913|NCT01400893|451257737|FG001|Overall Study|Death|21|||
125445914|NCT01400893|451257736|FG000|Overall Study|Lost to Follow-up|0|||
125445915|NCT01400893|451257737|FG001|Overall Study|Lost to Follow-up|6|||
125445916|NCT02320721|451257747|FG000|Overall Study|Adverse Event|6|||
125445917|NCT02320721|451257748|FG001|Overall Study|Adverse Event|6|||
125445918|NCT02320721|451257747|FG000|Overall Study|Lack of Efficacy|2|||
125445919|NCT02320721|451257748|FG001|Overall Study|Lack of Efficacy|0|||
125445920|NCT02320721|451257747|FG000|Overall Study|Poor compliance to protocol|3|||
125445921|NCT02320721|451257748|FG001|Overall Study|Poor compliance to protocol|7|||
125445922|NCT02320721|451257747|FG000|Overall Study|Randomized but not treated|0|||
125445923|NCT02320721|451257748|FG001|Overall Study|Randomized but not treated|1|||
125445924|NCT02320721|451257747|FG000|Overall Study|Hypoglycemia|1|||
125445925|NCT02320721|451257748|FG001|Overall Study|Hypoglycemia|0|||
125445926|NCT02320721|451257747|FG000|Overall Study|Other than specified above|15|||
125445927|NCT02320721|451257748|FG001|Overall Study|Other than specified above|20|||
125445928|NCT04630756|451257749|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
125445929|NCT04630756|451257750|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
125445930|NCT04630756|451257751|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
125445931|NCT00847301|451257752|FG000|Overall Study|Adverse Event|35|||
125445932|NCT00847301|451257752|FG000|Overall Study|Switch to other anticoagulants|16|||
125445933|NCT00847301|451257752|FG000|Overall Study|Lost to Follow-up|1|||
125445934|NCT00847301|451257752|FG000|Overall Study|No prescription after hospital discharge|1|||
125445935|NCT00847301|451257752|FG000|Overall Study|Other reason not defined above|1|||
125445936|NCT00996580|451257753|FG000|Overall Study|Adverse Event|466|||
125445937|NCT00996580|451257753|FG000|Overall Study|Lost to Follow-up|480|||
125445938|NCT00996580|451257753|FG000|Overall Study|Noncompliance with the protocol|137|||
125445939|NCT00996580|451257753|FG000|Overall Study|Physician Decision|5|||
125445940|NCT00996580|451257753|FG000|Overall Study|Pregnancy|68|||
125445941|NCT00996580|451257753|FG000|Overall Study|Protocol Violation|16|||
125445942|NCT00996580|451257753|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
125445943|NCT00996580|451257753|FG000|Overall Study|Withdrawal by Subject|217|||
125445944|NCT00996580|451257753|FG000|Overall Study|Other|29|||
125445945|NCT03621982|451257754|FG000|Overall Study|Withdrawal by Subject|1|||
125445946|NCT03621982|451257755|FG001|Overall Study|Withdrawal by Subject|0|||
125445947|NCT03621982|451257756|FG002|Overall Study|Withdrawal by Subject|0|||
125445948|NCT03621982|451257757|FG003|Overall Study|Withdrawal by Subject|1|||
125445949|NCT03621982|451257758|FG004|Overall Study|Withdrawal by Subject|0|||
125445950|NCT03621982|451257759|FG005|Overall Study|Withdrawal by Subject|1|||
125445951|NCT03621982|451257760|FG006|Overall Study|Withdrawal by Subject|1|||
125445952|NCT03621982|451257761|FG007|Overall Study|Withdrawal by Subject|0|||
125445953|NCT03621982|451257762|FG008|Overall Study|Withdrawal by Subject|1|||
125445954|NCT03621982|451257763|FG009|Overall Study|Withdrawal by Subject|0|||
125445955|NCT03621982|451257764|FG010|Overall Study|Withdrawal by Subject|2|||
125445956|NCT03621982|451257765|FG011|Overall Study|Withdrawal by Subject|1|||
125445957|NCT03621982|451257766|FG012|Overall Study|Withdrawal by Subject|2|||
125445958|NCT03621982|451257767|FG013|Overall Study|Withdrawal by Subject|2|||
125445959|NCT03621982|451257754|FG000|Overall Study|Investigator/Sponsor decision|0|||
125260038|NCT01143402|450581013|FG002|Overall Study|Not Treated|1|||
125260039|NCT02526290|450581014|FG000|Overall Study|Adverse Event|3|||
125260040|NCT02526290|450581014|FG000|Overall Study|Withdrawal by Subject|4|||
125260041|NCT02526290|450581014|FG000|Overall Study|Physician Decision|1|||
125260042|NCT01380080|450581016|FG000|Overall Study|Death|36|||
125260043|NCT01380080|450581017|FG001|Overall Study|Death|44|||
125260044|NCT01380080|450581016|FG000|Overall Study|Site is closing|28|||
125260045|NCT01380080|450581017|FG001|Overall Study|Site is closing|31|||
125260046|NCT01380080|450581016|FG000|Overall Study|Not able to get to clinic|7|||
125260047|NCT01380080|450581017|FG001|Overall Study|Not able to get to clinic|1|||
125260048|NCT01380080|450581016|FG000|Overall Study|Not willing to adhere to requirements|6|||
125260049|NCT01380080|450581017|FG001|Overall Study|Not willing to adhere to requirements|2|||
125397855|NCT01403974|451089271|FG008|Overall Study|Adverse Event|0|||
125397856|NCT01403974|451089272|FG009|Overall Study|Adverse Event|0|||
125397857|NCT01403974|451089273|FG010|Overall Study|Adverse Event|0|||
125397858|NCT01403974|451089274|FG011|Overall Study|Adverse Event|0|||
125397859|NCT01403974|451089275|FG012|Overall Study|Adverse Event|1|||
125397860|NCT01403974|451089276|FG013|Overall Study|Adverse Event|0|||
125397861|NCT01403974|451089277|FG014|Overall Study|Adverse Event|0|||
125397862|NCT01403974|451089278|FG015|Overall Study|Adverse Event|0|||
125397863|NCT01403974|451089263|FG000|Overall Study|Other than specified|0|||
125397864|NCT01403974|451089264|FG001|Overall Study|Other than specified|0|||
125397865|NCT01403974|451089265|FG002|Overall Study|Other than specified|0|||
125397866|NCT01403974|451089266|FG003|Overall Study|Other than specified|0|||
125397867|NCT01403974|451089267|FG004|Overall Study|Other than specified|0|||
125397868|NCT01403974|451089268|FG005|Overall Study|Other than specified|0|||
125397869|NCT01403974|451089269|FG006|Overall Study|Other than specified|0|||
125397870|NCT01403974|451089270|FG007|Overall Study|Other than specified|0|||
125397871|NCT01403974|451089271|FG008|Overall Study|Other than specified|0|||
125397872|NCT01403974|451089272|FG009|Overall Study|Other than specified|1|||
125397873|NCT01403974|451089273|FG010|Overall Study|Other than specified|0|||
125397874|NCT01403974|451089274|FG011|Overall Study|Other than specified|1|||
125397875|NCT01403974|451089275|FG012|Overall Study|Other than specified|0|||
125397876|NCT01403974|451089276|FG013|Overall Study|Other than specified|0|||
125397877|NCT01403974|451089277|FG014|Overall Study|Other than specified|0|||
125397878|NCT01403974|451089278|FG015|Overall Study|Other than specified|0|||
125397879|NCT01526889|451089279|FG000|Treatment Period|Adverse Event|2|||
125397880|NCT01526889|451089280|FG001|Treatment Period|Adverse Event|0|||
125397881|NCT01526889|451089279|FG000|Treatment Extension Period|Administrative problems|1|||
125397882|NCT01526889|451089280|FG001|Treatment Extension Period|Administrative problems|0|||
125397883|NCT00974571|451089281|FG000|Overall Study|Adverse Event|31|||
125397884|NCT00974571|451089282|FG001|Overall Study|Adverse Event|4|||
125397885|NCT00974571|451089283|FG002|Overall Study|Adverse Event|27|||
125397886|NCT00974571|451089281|FG000|Overall Study|Lack of Efficacy|3|||
125397887|NCT00974571|451089282|FG001|Overall Study|Lack of Efficacy|2|||
125397888|NCT00974571|451089283|FG002|Overall Study|Lack of Efficacy|9|||
125397889|NCT00974571|451089281|FG000|Overall Study|Lost to Follow-up|2|||
125397890|NCT00974571|451089282|FG001|Overall Study|Lost to Follow-up|1|||
125397891|NCT00974571|451089283|FG002|Overall Study|Lost to Follow-up|2|||
125397892|NCT00974571|451089281|FG000|Overall Study|Protocol Violation|13|||
125397893|NCT00974571|451089282|FG001|Overall Study|Protocol Violation|4|||
125397894|NCT00974571|451089283|FG002|Overall Study|Protocol Violation|18|||
125397895|NCT00974571|451089281|FG000|Overall Study|Withdrawal by Subject|14|||
125397896|NCT00974571|451089282|FG001|Overall Study|Withdrawal by Subject|5|||
125397897|NCT00974571|451089283|FG002|Overall Study|Withdrawal by Subject|16|||
125397898|NCT00974571|451089281|FG000|Overall Study|Patient Moved|1|||
125397899|NCT00974571|451089282|FG001|Overall Study|Patient Moved|0|||
125397900|NCT00974571|451089283|FG002|Overall Study|Patient Moved|1|||
125397901|NCT00974571|451089281|FG000|Overall Study|Other|4|||
125397902|NCT00974571|451089282|FG001|Overall Study|Other|0|||
125397903|NCT00974571|451089283|FG002|Overall Study|Other|10|||
125397904|NCT01494610|451089297|FG000|Period 1|Withdrawal by Subject|1|||
125397905|NCT01494610|451089298|FG001|Period 1|Withdrawal by Subject|1|||
125397906|NCT01494610|451089297|FG000|Period 3|Adverse Event|1|||
125397907|NCT01494610|451089298|FG001|Period 3|Adverse Event|0|||
125397908|NCT01494610|451089297|FG000|Period 3|Withdrawal by Subject|1|||
125397909|NCT01494610|451089298|FG001|Period 3|Withdrawal by Subject|0|||
125397910|NCT01494610|451089297|FG000|Period 4|Protocol Violation|1|||
125397911|NCT01494610|451089298|FG001|Period 4|Protocol Violation|0|||
125397912|NCT00547703|451089301|FG000|Overall Study|Lost to Follow-up|1|||
125397913|NCT00547703|451089302|FG001|Overall Study|Lost to Follow-up|0|||
125260050|NCT01380080|450581016|FG000|Overall Study|Withdrawal by Subject|5|||
125260051|NCT01380080|450581017|FG001|Overall Study|Withdrawal by Subject|2|||
125260052|NCT01380080|450581016|FG000|Overall Study|Lost to Follow-up|3|||
125397914|NCT04951622|451089314|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
125397915|NCT04951622|451089315|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
125397916|NCT04951622|451089316|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
125397917|NCT04951622|451089317|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
125397918|NCT04951622|451089318|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
125260053|NCT01380080|450581017|FG001|Overall Study|Lost to Follow-up|3|||
125260054|NCT00210132|450581022|FG000|Overall Study|Protocol Violation|1|||
125260055|NCT00210132|450581023|FG001|Overall Study|Protocol Violation|4|||
125260056|NCT00432965|450581024|FG000|Overall Study|Lost to Follow-up|22|||
125260057|NCT00432965|450581025|FG001|Overall Study|Lost to Follow-up|19|||
125260058|NCT00432965|450581024|FG000|Overall Study|Withdrawal by Subject|13|||
125260059|NCT00432965|450581025|FG001|Overall Study|Withdrawal by Subject|13|||
125260060|NCT00432965|450581024|FG000|Overall Study|Physician Decision|14|||
125260061|NCT00432965|450581025|FG001|Overall Study|Physician Decision|13|||
125260062|NCT00432965|450581024|FG000|Overall Study|Lack of Efficacy|8|||
125260063|NCT00432965|450581025|FG001|Overall Study|Lack of Efficacy|13|||
125260064|NCT00432965|450581024|FG000|Overall Study|Non-compliance|7|||
125260065|NCT00432965|450581025|FG001|Overall Study|Non-compliance|0|||
125260066|NCT00432965|450581024|FG000|Overall Study|Adverse Event|22|||
125260067|NCT00432965|450581025|FG001|Overall Study|Adverse Event|19|||
125260068|NCT00432965|450581024|FG000|Overall Study|Death|3|||
125260069|NCT00432965|450581025|FG001|Overall Study|Death|4|||
125260070|NCT00432965|450581024|FG000|Overall Study|Exclusionary Methods|1|||
125260071|NCT00432965|450581025|FG001|Overall Study|Exclusionary Methods|2|||
125260072|NCT00432965|450581024|FG000|Overall Study|Incomplete Data|4|||
125260073|NCT00432965|450581025|FG001|Overall Study|Incomplete Data|3|||
125260074|NCT03636022|450581030|FG000|Overall Study|Withdrawal by Subject|1|||
125260075|NCT03636022|450581031|FG001|Overall Study|Withdrawal by Subject|3|||
125260076|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
125260077|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
125260078|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
125260079|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
125260080|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
125260081|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
125260082|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
125260083|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
125260084|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
125260085|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
125260086|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
125260087|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
125260088|NCT04532749|450581032|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
125260089|NCT04532749|450581033|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
125260090|NCT04532749|450581032|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
125260091|NCT04532749|450581033|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
125260092|NCT04532749|450581032|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
125260093|NCT04532749|450581033|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
125260094|NCT04532749|450581032|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
125260095|NCT04532749|450581033|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
125260096|NCT00642759|450581034|FG000|Overall Study|Protocol Violation|1|||
125260097|NCT03612570|450581039|FG000|Overall Study|Lost to Follow-up|1|||
125260098|NCT02255435|450582376|FG000|Overall Study|Patient's Limited Time Availability|0|||
125260099|NCT02255435|450582377|FG001|Overall Study|Patient's Limited Time Availability|0|||
125260100|NCT02255435|450582378|FG002|Overall Study|Patient's Limited Time Availability|0|||
125260101|NCT02255435|450582379|FG003|Overall Study|Patient's Limited Time Availability|0|||
125260102|NCT02255435|450582380|FG004|Overall Study|Patient's Limited Time Availability|0|||
125260103|NCT02255435|450582381|FG005|Overall Study|Patient's Limited Time Availability|0|||
125260104|NCT02255435|450582382|FG006|Overall Study|Patient's Limited Time Availability|0|||
125260105|NCT02255435|450582383|FG007|Overall Study|Patient's Limited Time Availability|1|||
125260106|NCT02255435|450582384|FG008|Overall Study|Patient's Limited Time Availability|0|||
125260107|NCT02255435|450582385|FG009|Overall Study|Patient's Limited Time Availability|0|||
125260108|NCT02255435|450582376|FG000|Overall Study|Withdrawal by Subject|0|||
125260109|NCT02255435|450582377|FG001|Overall Study|Withdrawal by Subject|0|||
125260110|NCT02255435|450582378|FG002|Overall Study|Withdrawal by Subject|0|||
125260111|NCT02255435|450582379|FG003|Overall Study|Withdrawal by Subject|0|||
125260112|NCT02255435|450582380|FG004|Overall Study|Withdrawal by Subject|0|||
125260113|NCT02255435|450582381|FG005|Overall Study|Withdrawal by Subject|0|||
125260114|NCT02255435|450582382|FG006|Overall Study|Withdrawal by Subject|0|||
125260115|NCT02255435|450582383|FG007|Overall Study|Withdrawal by Subject|0|||
125260116|NCT02255435|450582384|FG008|Overall Study|Withdrawal by Subject|1|||
125260117|NCT02255435|450582385|FG009|Overall Study|Withdrawal by Subject|4|||
125260118|NCT02255435|450582376|FG000|Overall Study|Administrative reasons|0|||
125260119|NCT02255435|450582377|FG001|Overall Study|Administrative reasons|0|||
125260120|NCT02255435|450582378|FG002|Overall Study|Administrative reasons|0|||
125260121|NCT02255435|450582379|FG003|Overall Study|Administrative reasons|0|||
125260122|NCT02255435|450582380|FG004|Overall Study|Administrative reasons|0|||
125260123|NCT02255435|450582381|FG005|Overall Study|Administrative reasons|0|||
125260124|NCT02255435|450582382|FG006|Overall Study|Administrative reasons|0|||
125260125|NCT02255435|450582383|FG007|Overall Study|Administrative reasons|0|||
125260126|NCT02255435|450582384|FG008|Overall Study|Administrative reasons|0|||
125260127|NCT02255435|450582385|FG009|Overall Study|Administrative reasons|2|||
125260128|NCT00442702|450582386|FG000|Titration Period|Adverse Event|2|||
125260129|NCT00442702|450582387|FG001|Titration Period|Adverse Event|0|||
125260130|NCT00442702|450582386|FG000|Titration Period|Death|3|||
125260131|NCT00442702|450582387|FG001|Titration Period|Death|2|||
125260132|NCT00442702|450582386|FG000|Titration Period|Insufficient Therapeutic Response|1|||
125260133|NCT00442702|450582387|FG001|Titration Period|Insufficient Therapeutic Response|0|||
125260134|NCT00442702|450582386|FG000|Titration Period|Refused Treatment|4|||
125260135|NCT00442702|450582387|FG001|Titration Period|Refused Treatment|1|||
125260136|NCT00442702|450582386|FG000|Titration Period|Failure to return|1|||
125260137|NCT00442702|450582387|FG001|Titration Period|Failure to return|0|||
125260138|NCT00442702|450582386|FG000|Titration Period|Hospitalized in another hospital|1|||
125260139|NCT00442702|450582387|FG001|Titration Period|Hospitalized in another hospital|0|||
125260140|NCT00442702|450582386|FG000|Evaluation Period|Adverse Event|1|||
125260141|NCT00442702|450582387|FG001|Evaluation Period|Adverse Event|0|||
125260142|NCT00442702|450582386|FG000|Evaluation Period|Death|1|||
125260143|NCT00442702|450582387|FG001|Evaluation Period|Death|1|||
125260144|NCT00442702|450582386|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
125260145|NCT00442702|450582387|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
125260146|NCT00442702|450582386|FG000|Evaluation Period|Refused treatment|1|||
125260147|NCT00442702|450582387|FG001|Evaluation Period|Refused treatment|1|||
125260148|NCT00442702|450582386|FG000|Evaluation Period|Renal transplant|0|||
125260149|NCT00442702|450582387|FG001|Evaluation Period|Renal transplant|1|||
125260150|NCT00442702|450582386|FG000|Evaluation Period|Failure to return|1|||
125260151|NCT00442702|450582387|FG001|Evaluation Period|Failure to return|0|||
125260152|NCT00442702|450582386|FG000|Evaluation Period|Site closure|0|||
125260153|NCT00442702|450582387|FG001|Evaluation Period|Site closure|1|||
125260154|NCT03580044|450582388|FG000|Overall Study|Death|2|||
125260155|NCT03580044|450582389|FG001|Overall Study|Death|1|||
125260156|NCT03580044|450582388|FG000|Overall Study|Withdrawal by Subject|1|||
125260157|NCT03580044|450582389|FG001|Overall Study|Withdrawal by Subject|1|||
125260158|NCT01664624|450582390|FG000|Overall Study|Adverse Event|0|||
125260159|NCT01664624|450582391|FG001|Overall Study|Adverse Event|1|||
125260160|NCT01664624|450582392|FG002|Overall Study|Adverse Event|0|||
125260161|NCT01664624|450582393|FG003|Overall Study|Adverse Event|0|||
125260162|NCT01500317|450582396|FG000|Overall Study|Withdrawal by Subject|3|||
125260163|NCT01500317|450582397|FG001|Overall Study|Withdrawal by Subject|2|||
125260164|NCT01500317|450582398|FG002|Overall Study|Withdrawal by Subject|0|||
125260165|NCT00335829|450582399|FG000|Overall Study|Withdrawal by Subject|1|||
125260166|NCT00335829|450582399|FG000|Overall Study|Lost to Follow-up|1|||
125260167|NCT00335829|450582399|FG000|Overall Study|Adverse Event|1|||
125260168|NCT04067011|450582401|FG000|Overall Study|Not Treated|8|||
125260169|NCT04067011|450582402|FG001|Overall Study|Not Treated|7|||
125260170|NCT04067011|450582403|FG002|Overall Study|Not Treated|5|||
125260171|NCT04067011|450582401|FG000|Overall Study|Adverse Event|2|||
125260172|NCT04067011|450582402|FG001|Overall Study|Adverse Event|1|||
125260173|NCT04067011|450582403|FG002|Overall Study|Adverse Event|0|||
125260174|NCT04067011|450582401|FG000|Overall Study|Withdrawal by Subject|6|||
125260175|NCT04067011|450582402|FG001|Overall Study|Withdrawal by Subject|2|||
125260176|NCT04067011|450582403|FG002|Overall Study|Withdrawal by Subject|1|||
125260177|NCT04067011|450582401|FG000|Overall Study|Lost to Follow-up|0|||
125260178|NCT04067011|450582402|FG001|Overall Study|Lost to Follow-up|0|||
125260179|NCT04067011|450582403|FG002|Overall Study|Lost to Follow-up|1|||
125260180|NCT04067011|450582401|FG000|Overall Study|Physician Decision|1|||
125260181|NCT04067011|450582402|FG001|Overall Study|Physician Decision|1|||
125260182|NCT04067011|450582403|FG002|Overall Study|Physician Decision|0|||
125260183|NCT04067011|450582401|FG000|Overall Study|Other Reasons|2|||
125260184|NCT04067011|450582402|FG001|Overall Study|Other Reasons|0|||
125260185|NCT04067011|450582403|FG002|Overall Study|Other Reasons|1|||
125260186|NCT04067011|450582401|FG000|Overall Study|Missing|0|||
125260187|NCT04067011|450582402|FG001|Overall Study|Missing|2|||
125260188|NCT04067011|450582403|FG002|Overall Study|Missing|0|||
125260189|NCT03746015|450582404|FG000|Overall Study|Withdrawal of Consent|1|||
125260190|NCT03746015|450582405|FG001|Overall Study|Withdrawal of Consent|0|||
125260191|NCT03746015|450582406|FG002|Overall Study|Withdrawal of Consent|0|||
125260192|NCT05209386|450582407|FG000|Overall Study|Withdrawal by Subject|8|||
125260193|NCT05209386|450582407|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
125260194|NCT04462471|450582408|FG000|Overall Study|Adverse Event|0|||
125260195|NCT04462471|450582409|FG001|Overall Study|Adverse Event|1|||
125260196|NCT04462471|450582410|FG002|Overall Study|Adverse Event|0|||
125260197|NCT04462471|450582411|FG003|Overall Study|Adverse Event|0|||
125260198|NCT04462471|450582408|FG000|Overall Study|Disease progression|1|||
125260199|NCT04462471|450582409|FG001|Overall Study|Disease progression|0|||
125260200|NCT04462471|450582410|FG002|Overall Study|Disease progression|0|||
125260201|NCT04462471|450582411|FG003|Overall Study|Disease progression|0|||
125260202|NCT01121757|450582420|FG000|First Drug|Death|1|||
125260203|NCT01121757|450582421|FG001|First Drug|Death|0|||
125260204|NCT01121757|450582420|FG000|First Drug|Disease Progression|0|||
125260205|NCT01121757|450582421|FG001|First Drug|Disease Progression|2|||
125260206|NCT01121757|450582420|FG000|Combination|Physician Decision|0|||
125260207|NCT01121757|450582421|FG001|Combination|Physician Decision|1|||
125260208|NCT01121757|450582420|FG000|Combination|Disease Progression|2|||
125260209|NCT01121757|450582421|FG001|Combination|Disease Progression|0|||
125260210|NCT04251533|450582422|FG000|Overall Study|Progressive disease|33|||
125260211|NCT04251533|450582423|FG001|Overall Study|Progressive disease|29|||
125260212|NCT04251533|450582424|FG002|Overall Study|Progressive disease|22|||
125260213|NCT04251533|450582422|FG000|Overall Study|Death|5|||
125260214|NCT04251533|450582423|FG001|Overall Study|Death|1|||
125260215|NCT04251533|450582424|FG002|Overall Study|Death|3|||
125260216|NCT04251533|450582422|FG000|Overall Study|Physician Decision|3|||
125260217|NCT04251533|450582423|FG001|Overall Study|Physician Decision|2|||
125260218|NCT04251533|450582424|FG002|Overall Study|Physician Decision|4|||
125260219|NCT04251533|450582422|FG000|Overall Study|Participant decision|1|||
125260220|NCT04251533|450582423|FG001|Overall Study|Participant decision|3|||
125260221|NCT04251533|450582424|FG002|Overall Study|Participant decision|1|||
125260222|NCT04251533|450582422|FG000|Overall Study|Adverse Event|2|||
125260223|NCT04251533|450582423|FG001|Overall Study|Adverse Event|1|||
125260224|NCT04251533|450582424|FG002|Overall Study|Adverse Event|1|||
125260225|NCT05901636|450582425|FG000|Overall Study|Lost to Follow-up|0|||
125260226|NCT05901636|450582426|FG001|Overall Study|Lost to Follow-up|1|||
125260227|NCT05901636|450582427|FG002|Overall Study|Lost to Follow-up|0|||
125260228|NCT05901636|450582428|FG003|Overall Study|Lost to Follow-up|1|||
125260229|NCT05901636|450582429|FG004|Overall Study|Lost to Follow-up|1|||
125260230|NCT05901636|450582430|FG005|Overall Study|Lost to Follow-up|3|||
125260231|NCT05901636|450582431|FG006|Overall Study|Lost to Follow-up|1|||
125260232|NCT05901636|450582425|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
125260233|NCT05901636|450582426|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
125260234|NCT05901636|450582427|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
125260235|NCT05901636|450582428|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
125260236|NCT05901636|450582429|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
125260237|NCT05901636|450582430|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
125260238|NCT05901636|450582431|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
125260239|NCT05901636|450582425|FG000|Overall Study|Withdrawal by Subject|1|||
125260240|NCT05901636|450582426|FG001|Overall Study|Withdrawal by Subject|1|||
125260241|NCT05901636|450582427|FG002|Overall Study|Withdrawal by Subject|0|||
125260242|NCT05901636|450582428|FG003|Overall Study|Withdrawal by Subject|0|||
125260243|NCT05901636|450582429|FG004|Overall Study|Withdrawal by Subject|1|||
125260244|NCT05901636|450582430|FG005|Overall Study|Withdrawal by Subject|1|||
125260245|NCT05901636|450582431|FG006|Overall Study|Withdrawal by Subject|0|||
125260246|NCT05901636|450582425|FG000|Overall Study|Other|0|||
125260247|NCT05901636|450582426|FG001|Overall Study|Other|0|||
125260248|NCT05901636|450582427|FG002|Overall Study|Other|1|||
125260249|NCT05901636|450582428|FG003|Overall Study|Other|1|||
125260250|NCT05901636|450582429|FG004|Overall Study|Other|0|||
125260251|NCT05901636|450582430|FG005|Overall Study|Other|0|||
125260252|NCT05901636|450582431|FG006|Overall Study|Other|0|||
125260253|NCT04583618|450582432|FG000|Overall Study|Adverse Event|0|||
125260254|NCT04583618|450582433|FG001|Overall Study|Adverse Event|0|||
125260255|NCT04583618|450582434|FG002|Overall Study|Adverse Event|1|||
125260256|NCT04583618|450582435|FG003|Overall Study|Adverse Event|0|||
125260257|NCT04583618|450582436|FG004|Overall Study|Adverse Event|0|||
125260258|NCT04583618|450582432|FG000|Overall Study|Protocol deviation|1|||
125260259|NCT04583618|450582433|FG001|Overall Study|Protocol deviation|1|||
125260260|NCT04583618|450582434|FG002|Overall Study|Protocol deviation|1|||
125260261|NCT04583618|450582435|FG003|Overall Study|Protocol deviation|0|||
125260262|NCT04583618|450582436|FG004|Overall Study|Protocol deviation|0|||
125260263|NCT04583618|450582432|FG000|Overall Study|Withdrawal by Subject|2|||
125260264|NCT04583618|450582433|FG001|Overall Study|Withdrawal by Subject|1|||
125260265|NCT04583618|450582434|FG002|Overall Study|Withdrawal by Subject|3|||
125260266|NCT04583618|450582435|FG003|Overall Study|Withdrawal by Subject|1|||
125260267|NCT04583618|450582436|FG004|Overall Study|Withdrawal by Subject|1|||
125260268|NCT04583618|450582432|FG000|Overall Study|Lost to Follow-up|0|||
125260269|NCT04583618|450582433|FG001|Overall Study|Lost to Follow-up|1|||
125260270|NCT04583618|450582434|FG002|Overall Study|Lost to Follow-up|3|||
125260271|NCT04583618|450582435|FG003|Overall Study|Lost to Follow-up|1|||
125260272|NCT04583618|450582436|FG004|Overall Study|Lost to Follow-up|1|||
125260273|NCT02711202|450582437|FG000|Overall Study|Adverse Event|3|||
125260274|NCT02711202|450582438|FG001|Overall Study|Adverse Event|0|||
125260275|NCT02711202|450582437|FG000|Overall Study|graft loss|1|||
125260276|NCT02711202|450582438|FG001|Overall Study|graft loss|0|||
125260277|NCT03189719|450582442|FG000|Overall Study|Death|325|||
125260278|NCT03189719|450582443|FG001|Overall Study|Death|361|||
125260279|NCT03189719|450582442|FG000|Overall Study|Physician Decision|1|||
125260280|NCT03189719|450582443|FG001|Overall Study|Physician Decision|0|||
125260281|NCT03189719|450582442|FG000|Overall Study|Sponsor Decision|40|||
125260282|NCT03189719|450582443|FG001|Overall Study|Sponsor Decision|12|||
125260283|NCT03189719|450582442|FG000|Overall Study|Withdrawal by Subject|7|||
125260284|NCT03189719|450582443|FG001|Overall Study|Withdrawal by Subject|3|||
125260285|NCT03448393|450582444|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260286|NCT03448393|450582445|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260287|NCT03448393|450582446|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
125260288|NCT03448393|450582447|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260289|NCT03448393|450582448|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260290|NCT03448393|450582449|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260291|NCT03448393|450582450|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260292|NCT03448393|450582451|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
125260293|NCT03448393|450582452|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
125260294|NCT03448393|450582444|FG000|Dose Expansion|Not treated - screen failure|0|||
125260295|NCT03448393|450582445|FG001|Dose Expansion|Not treated - screen failure|0|||
125260296|NCT03448393|450582446|FG002|Dose Expansion|Not treated - screen failure|0|||
125260297|NCT03448393|450582447|FG003|Dose Expansion|Not treated - screen failure|0|||
125260298|NCT03448393|450582448|FG004|Dose Expansion|Not treated - screen failure|0|||
125260299|NCT03448393|450582449|FG005|Dose Expansion|Not treated - screen failure|0|||
125260300|NCT03448393|450582450|FG006|Dose Expansion|Not treated - screen failure|0|||
125260301|NCT03448393|450582451|FG007|Dose Expansion|Not treated - screen failure|0|||
125260302|NCT03448393|450582452|FG008|Dose Expansion|Not treated - screen failure|7|||
125260303|NCT03330847|450582453|FG000|Overall Study|Patients ongoing study|62|||
125260304|NCT03330847|450582454|FG001|Overall Study|Patients ongoing study|65|||
125260305|NCT03330847|450582455|FG002|Overall Study|Patients ongoing study|15|||
125260306|NCT01355627|450582456|FG000|Overall Study|Request By the Patient to Discontinue|5|||
125260307|NCT01355627|450582457|FG001|Overall Study|Request By the Patient to Discontinue|7|||
125260308|NCT01355627|450582456|FG000|Overall Study|Lost to Follow-up|8|||
125260309|NCT01355627|450582457|FG001|Overall Study|Lost to Follow-up|7|||
125260310|NCT01355627|450582456|FG000|Overall Study|Fatal Adverse Event|19|||
125260311|NCT01355627|450582457|FG001|Overall Study|Fatal Adverse Event|23|||
125260312|NCT01355627|450582456|FG000|Overall Study|Other|1|||
125260313|NCT01355627|450582457|FG001|Overall Study|Other|1|||
125260314|NCT02293551|450582460|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
125260315|NCT02293551|450582461|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
125260316|NCT02293551|450582462|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
125260317|NCT02293551|450582463|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
125260318|NCT02293551|450582464|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
125260319|NCT02293551|450582465|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
125260320|NCT02293551|450582460|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
125260321|NCT02293551|450582461|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
125260322|NCT02293551|450582462|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
125260323|NCT02293551|450582463|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
125260324|NCT02293551|450582464|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
125260325|NCT02293551|450582465|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
125260326|NCT02293551|450582460|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
125260327|NCT02293551|450582461|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
125260328|NCT02293551|450582462|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
125260329|NCT02293551|450582463|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
125260330|NCT02293551|450582464|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
125260331|NCT02293551|450582465|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
125260332|NCT04756531|450582471|FG000|Overall Study|Adverse Event|0|||
125260333|NCT04756531|450582472|FG001|Overall Study|Adverse Event|0|||
125260334|NCT04756531|450582473|FG002|Overall Study|Adverse Event|0|||
125260335|NCT04756531|450582474|FG003|Overall Study|Adverse Event|0|||
125260336|NCT04756531|450582475|FG004|Overall Study|Adverse Event|1|||
125260337|NCT04756531|450582476|FG005|Overall Study|Adverse Event|0|||
125260338|NCT04756531|450582477|FG006|Overall Study|Adverse Event|0|||
125260339|NCT04756531|450582478|FG007|Overall Study|Adverse Event|0|||
125260340|NCT04756531|450582479|FG008|Overall Study|Adverse Event|0|||
125260341|NCT04756531|450582480|FG009|Overall Study|Adverse Event|0|||
125260342|NCT04756531|450582481|FG010|Overall Study|Adverse Event|0|||
125260343|NCT04756531|450582482|FG011|Overall Study|Adverse Event|0|||
125260344|NCT04756531|450582483|FG012|Overall Study|Adverse Event|0|||
125260345|NCT04756531|450582484|FG013|Overall Study|Adverse Event|0|||
125260346|NCT04756531|450582485|FG014|Overall Study|Adverse Event|0|||
125260347|NCT04756531|450582486|FG015|Overall Study|Adverse Event|0|||
125260348|NCT04756531|450582487|FG016|Overall Study|Adverse Event|0|||
125260349|NCT04756531|450582488|FG017|Overall Study|Adverse Event|0|||
125260350|NCT04756531|450582471|FG000|Overall Study|Withdrawal by Subject|0|||
125260351|NCT04756531|450582472|FG001|Overall Study|Withdrawal by Subject|0|||
125260352|NCT04756531|450582473|FG002|Overall Study|Withdrawal by Subject|0|||
125260353|NCT04756531|450582474|FG003|Overall Study|Withdrawal by Subject|0|||
125260354|NCT04756531|450582475|FG004|Overall Study|Withdrawal by Subject|0|||
125260355|NCT04756531|450582476|FG005|Overall Study|Withdrawal by Subject|0|||
125445960|NCT03621982|451257755|FG001|Overall Study|Investigator/Sponsor decision|0|||
125445961|NCT03621982|451257756|FG002|Overall Study|Investigator/Sponsor decision|0|||
125445962|NCT03621982|451257757|FG003|Overall Study|Investigator/Sponsor decision|0|||
125445963|NCT03621982|451257758|FG004|Overall Study|Investigator/Sponsor decision|0|||
125445964|NCT03621982|451257759|FG005|Overall Study|Investigator/Sponsor decision|0|||
125445965|NCT03621982|451257760|FG006|Overall Study|Investigator/Sponsor decision|0|||
125445966|NCT03621982|451257761|FG007|Overall Study|Investigator/Sponsor decision|0|||
125445967|NCT03621982|451257762|FG008|Overall Study|Investigator/Sponsor decision|0|||
125445968|NCT03621982|451257763|FG009|Overall Study|Investigator/Sponsor decision|0|||
125445969|NCT03621982|451257764|FG010|Overall Study|Investigator/Sponsor decision|0|||
125445970|NCT03621982|451257765|FG011|Overall Study|Investigator/Sponsor decision|4|||
125445971|NCT03621982|451257766|FG012|Overall Study|Investigator/Sponsor decision|0|||
125445972|NCT03621982|451257767|FG013|Overall Study|Investigator/Sponsor decision|2|||
125445973|NCT03621982|451257754|FG000|Overall Study|Death|2|||
125445974|NCT03621982|451257755|FG001|Overall Study|Death|4|||
125445975|NCT03621982|451257756|FG002|Overall Study|Death|4|||
125445976|NCT03621982|451257757|FG003|Overall Study|Death|3|||
125445977|NCT03621982|451257758|FG004|Overall Study|Death|8|||
125445978|NCT03621982|451257759|FG005|Overall Study|Death|4|||
125445979|NCT03621982|451257760|FG006|Overall Study|Death|6|||
125445980|NCT03621982|451257761|FG007|Overall Study|Death|3|||
125445981|NCT03621982|451257762|FG008|Overall Study|Death|0|||
125445982|NCT03621982|451257763|FG009|Overall Study|Death|3|||
125445983|NCT03621982|451257764|FG010|Overall Study|Death|8|||
125445984|NCT03621982|451257765|FG011|Overall Study|Death|4|||
125445985|NCT03621982|451257766|FG012|Overall Study|Death|2|||
125445986|NCT03621982|451257767|FG013|Overall Study|Death|2|||
125445987|NCT03621982|451257754|FG000|Overall Study|Lost to Follow-up|0|||
125445988|NCT03621982|451257755|FG001|Overall Study|Lost to Follow-up|0|||
125445989|NCT03621982|451257756|FG002|Overall Study|Lost to Follow-up|1|||
125445990|NCT03621982|451257757|FG003|Overall Study|Lost to Follow-up|0|||
125445991|NCT03621982|451257758|FG004|Overall Study|Lost to Follow-up|0|||
125445992|NCT03621982|451257759|FG005|Overall Study|Lost to Follow-up|0|||
125445993|NCT03621982|451257760|FG006|Overall Study|Lost to Follow-up|1|||
125445994|NCT03621982|451257761|FG007|Overall Study|Lost to Follow-up|0|||
125445995|NCT03621982|451257762|FG008|Overall Study|Lost to Follow-up|0|||
125445996|NCT03621982|451257763|FG009|Overall Study|Lost to Follow-up|1|||
125445997|NCT03621982|451257764|FG010|Overall Study|Lost to Follow-up|0|||
125445998|NCT03621982|451257765|FG011|Overall Study|Lost to Follow-up|0|||
125445999|NCT03621982|451257766|FG012|Overall Study|Lost to Follow-up|0|||
125446000|NCT03621982|451257767|FG013|Overall Study|Lost to Follow-up|0|||
125260356|NCT04756531|450582477|FG006|Overall Study|Withdrawal by Subject|1|||
125260357|NCT04756531|450582478|FG007|Overall Study|Withdrawal by Subject|0|||
125260358|NCT04756531|450582479|FG008|Overall Study|Withdrawal by Subject|0|||
125446001|NCT02036515|451257768|FG000|Overall Study|Adverse Event|1|||
125446002|NCT02036515|451257769|FG001|Overall Study|Adverse Event|1|||
125446003|NCT02036515|451257770|FG002|Overall Study|Adverse Event|2|||
125446004|NCT02036515|451257768|FG000|Overall Study|Lost to Follow-up|0|||
125446005|NCT02036515|451257769|FG001|Overall Study|Lost to Follow-up|2|||
125446006|NCT02036515|451257770|FG002|Overall Study|Lost to Follow-up|0|||
125446007|NCT02036515|451257768|FG000|Overall Study|Non-compliance with study drug|0|||
125446008|NCT02036515|451257769|FG001|Overall Study|Non-compliance with study drug|0|||
125446009|NCT02036515|451257770|FG002|Overall Study|Non-compliance with study drug|2|||
125446010|NCT02036515|451257768|FG000|Overall Study|Screen failure|0|||
125446011|NCT02036515|451257769|FG001|Overall Study|Screen failure|2|||
125446012|NCT02036515|451257770|FG002|Overall Study|Screen failure|0|||
125446013|NCT02036515|451257768|FG000|Overall Study|Withdrawal by Subject|4|||
125446014|NCT02036515|451257769|FG001|Overall Study|Withdrawal by Subject|7|||
125446015|NCT02036515|451257770|FG002|Overall Study|Withdrawal by Subject|9|||
125446016|NCT02036515|451257768|FG000|Overall Study|Hyperglycemia|0|||
125260359|NCT04756531|450582480|FG009|Overall Study|Withdrawal by Subject|0|||
125260360|NCT04756531|450582481|FG010|Overall Study|Withdrawal by Subject|0|||
125260361|NCT04756531|450582482|FG011|Overall Study|Withdrawal by Subject|0|||
125260362|NCT04756531|450582483|FG012|Overall Study|Withdrawal by Subject|0|||
125446017|NCT02036515|451257769|FG001|Overall Study|Hyperglycemia|0|||
125260363|NCT04756531|450582484|FG013|Overall Study|Withdrawal by Subject|0|||
125260364|NCT04756531|450582485|FG014|Overall Study|Withdrawal by Subject|0|||
125260365|NCT04756531|450582486|FG015|Overall Study|Withdrawal by Subject|0|||
125446018|NCT02036515|451257770|FG002|Overall Study|Hyperglycemia|1|||
125446019|NCT02325713|451257779|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446020|NCT02325713|451257780|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446021|NCT02325713|451257781|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446022|NCT02325713|451257782|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446023|NCT02325713|451257783|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446024|NCT02325713|451257784|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446025|NCT02325713|451257785|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446026|NCT02325713|451257786|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446027|NCT02325713|451257787|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125260366|NCT04756531|450582487|FG016|Overall Study|Withdrawal by Subject|0|||
125260367|NCT04756531|450582488|FG017|Overall Study|Withdrawal by Subject|0|||
125260368|NCT05643495|450582489|FG000|Overall Study|Adverse Event|0|||
125260369|NCT05643495|450582490|FG001|Overall Study|Adverse Event|1|||
125260370|NCT05643495|450582489|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
125260371|NCT05643495|450582490|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
125260372|NCT02257528|450582491|FG000|Overall Study|Never received study treatment|1|||
125260373|NCT06272383|450582492|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
125260374|NCT06272383|450582493|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
125260375|NCT04569084|450582498|FG000|Overall Study|Adverse Event|10|||
125260376|NCT04569084|450582499|FG001|Overall Study|Adverse Event|14|||
125260377|NCT04569084|450582498|FG000|Overall Study|Death|2|||
125260378|NCT04569084|450582499|FG001|Overall Study|Death|3|||
125260379|NCT04569084|450582498|FG000|Overall Study|Lost to Follow-up|1|||
125260380|NCT04569084|450582499|FG001|Overall Study|Lost to Follow-up|1|||
125260381|NCT04569084|450582498|FG000|Overall Study|Physician Decision|3|||
125260382|NCT04569084|450582499|FG001|Overall Study|Physician Decision|3|||
125260383|NCT04569084|450582498|FG000|Overall Study|Protocol Violation|2|||
125260384|NCT04569084|450582499|FG001|Overall Study|Protocol Violation|1|||
125260385|NCT04569084|450582498|FG000|Overall Study|Withdrawal by Subject|20|||
125260386|NCT04569084|450582499|FG001|Overall Study|Withdrawal by Subject|21|||
125260387|NCT04569084|450582498|FG000|Overall Study|Study terminated by sponsor|26|||
125260388|NCT04569084|450582499|FG001|Overall Study|Study terminated by sponsor|23|||
125260389|NCT04569084|450582498|FG000|Overall Study|Other|3|||
125260390|NCT04569084|450582499|FG001|Overall Study|Other|5|||
125260391|NCT01346176|450582500|FG000|Recruited|Protocol Violation|1|||
125260392|NCT01346176|450582501|FG001|Recruited|Protocol Violation|0|||
125260393|NCT01346176|450582502|FG002|Recruited|Protocol Violation|0|||
125260394|NCT01346176|450582500|FG000|Completed Advance Directive|Death|3|||
125260395|NCT01346176|450582501|FG001|Completed Advance Directive|Death|2|||
125260396|NCT01346176|450582502|FG002|Completed Advance Directive|Death|2|||
125260397|NCT01346176|450582500|FG000|Completed Advance Directive|Became Ineligible|3|||
125260398|NCT01346176|450582501|FG001|Completed Advance Directive|Became Ineligible|0|||
125260399|NCT01346176|450582502|FG002|Completed Advance Directive|Became Ineligible|1|||
125260400|NCT01346176|450582500|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
125260401|NCT01346176|450582501|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
125260402|NCT01346176|450582502|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
125260403|NCT01346176|450582500|FG000|Completed Satisfaction Survey|Death|3|||
125260404|NCT01346176|450582501|FG001|Completed Satisfaction Survey|Death|0|||
125260405|NCT01346176|450582502|FG002|Completed Satisfaction Survey|Death|2|||
125260406|NCT01346176|450582500|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
125260407|NCT01346176|450582501|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
125260408|NCT01346176|450582502|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
125260409|NCT01994876|450582503|FG000|Test Period 1|Withdrawal by Subject|0|||
125260410|NCT01994876|450582504|FG001|Test Period 1|Withdrawal by Subject|1|||
125260411|NCT01994876|450582503|FG000|Test Period 1|Adverse Event|0|||
125260412|NCT01994876|450582504|FG001|Test Period 1|Adverse Event|1|||
125260413|NCT01994876|450582503|FG000|Test Period 2|Adverse Event|1|||
125260414|NCT01994876|450582504|FG001|Test Period 2|Adverse Event|0|||
125260415|NCT01994876|450582503|FG000|Test Period 2|Protocol Violation|0|||
125260416|NCT01994876|450582504|FG001|Test Period 2|Protocol Violation|1|||
125260417|NCT01400412|450582505|FG000|Overall Study|Lost to Follow-up|4|||
125260418|NCT01400412|450582506|FG001|Overall Study|Lost to Follow-up|7|||
125260419|NCT01400412|450582505|FG000|Overall Study|Withdrawal by Subject|3|||
125260420|NCT01400412|450582506|FG001|Overall Study|Withdrawal by Subject|4|||
125260421|NCT01400412|450582505|FG000|Overall Study|Unable to complete|3|||
125260422|NCT01400412|450582506|FG001|Overall Study|Unable to complete|3|||
125397919|NCT04951622|451089314|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
125397920|NCT04951622|451089315|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
125397921|NCT04951622|451089316|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
125397922|NCT04951622|451089317|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
125397923|NCT04951622|451089318|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
125397924|NCT04951622|451089314|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
125397925|NCT04951622|451089315|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
125397926|NCT04951622|451089316|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
125397927|NCT04951622|451089317|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
125260423|NCT01400412|450582505|FG000|Overall Study|Never started study treatment|0|||
125260424|NCT01400412|450582506|FG001|Overall Study|Never started study treatment|3|||
125260425|NCT04043286|450583951|FG000|Overall Study|Withdrawal by Subject|2|||
125260426|NCT04043286|450583952|FG001|Overall Study|Withdrawal by Subject|2|||
125260427|NCT01323192|450583953|FG000|Overall Study|Adverse Event|6|||
125260428|NCT01323192|450583954|FG001|Overall Study|Adverse Event|1|||
125260429|NCT01323192|450583953|FG000|Overall Study|Withdrawal by Subject|3|||
125260430|NCT01323192|450583954|FG001|Overall Study|Withdrawal by Subject|1|||
125260431|NCT01323192|450583953|FG000|Overall Study|Noncompliance with study medication|0|||
125260432|NCT01323192|450583954|FG001|Overall Study|Noncompliance with study medication|3|||
125260433|NCT01323192|450583953|FG000|Overall Study|Nonmedical reasons|0|||
125260434|NCT01323192|450583954|FG001|Overall Study|Nonmedical reasons|1|||
125260435|NCT02296476|450583955|FG000|Overall Study|Disease Progression|6|||
125260436|NCT02296476|450583956|FG001|Overall Study|Disease Progression|4|||
125260437|NCT02296476|450583957|FG002|Overall Study|Disease Progression|2|||
125260438|NCT03122184|450583964|FG000|Overall Study|Lost to Follow-up|4|||
125260439|NCT03122184|450583965|FG001|Overall Study|Lost to Follow-up|6|||
125260440|NCT03122184|450583964|FG000|Overall Study|Withdrawal by Subject|3|||
125260441|NCT03122184|450583965|FG001|Overall Study|Withdrawal by Subject|0|||
125260442|NCT03122184|450583964|FG000|Overall Study|Terminated due to cognitive problem|1|||
125260443|NCT03122184|450583965|FG001|Overall Study|Terminated due to cognitive problem|0|||
125260444|NCT02835690|450583966|FG000|Overall Study|Death|12|||
125260445|NCT02835690|450583967|FG001|Overall Study|Death|11|||
125260446|NCT02835690|450583968|FG002|Overall Study|Death|13|||
125260447|NCT02835690|450583966|FG000|Overall Study|Transferred to Extension Study|2|||
125260448|NCT02835690|450583967|FG001|Overall Study|Transferred to Extension Study|2|||
125260449|NCT02835690|450583968|FG002|Overall Study|Transferred to Extension Study|1|||
125260450|NCT02835690|450583966|FG000|Overall Study|Did Not Continue on Extension Study|0|||
125260451|NCT02835690|450583967|FG001|Overall Study|Did Not Continue on Extension Study|0|||
125260452|NCT02835690|450583968|FG002|Overall Study|Did Not Continue on Extension Study|1|||
125260453|NCT02835690|450583966|FG000|Overall Study|Not Treated|0|||
125260454|NCT02835690|450583967|FG001|Overall Study|Not Treated|2|||
125260455|NCT02835690|450583968|FG002|Overall Study|Not Treated|0|||
125260456|NCT03674281|450583969|FG000|Overall Study|screen failure|2|||
125260457|NCT03674281|450583970|FG001|Overall Study|screen failure|0|||
125260458|NCT03674281|450583971|FG002|Overall Study|screen failure|0|||
125260459|NCT03674281|450583969|FG000|Overall Study|Withdrawal by Subject|1|||
125260460|NCT03674281|450583970|FG001|Overall Study|Withdrawal by Subject|3|||
125260461|NCT03674281|450583971|FG002|Overall Study|Withdrawal by Subject|3|||
125260462|NCT00710593|450583972|FG000|Overall Study|Incarceration|1|||
125260463|NCT00710593|450583973|FG001|Overall Study|Incarceration|0|||
125260464|NCT00710593|450583972|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
125260465|NCT00710593|450583973|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
125260466|NCT00710593|450583972|FG000|Overall Study|Lost to Follow-up|3|||
125260467|NCT00710593|450583973|FG001|Overall Study|Lost to Follow-up|1|||
125260468|NCT00710593|450583972|FG000|Overall Study|Moved out of area|1|||
125260469|NCT00710593|450583973|FG001|Overall Study|Moved out of area|0|||
125260470|NCT00710593|450583972|FG000|Overall Study|Failure to adhere or complete study eval|1|||
125260471|NCT00710593|450583973|FG001|Overall Study|Failure to adhere or complete study eval|1|||
125260472|NCT00710593|450583972|FG000|Overall Study|Protocol Violation|1|||
125260473|NCT00710593|450583973|FG001|Overall Study|Protocol Violation|1|||
125260474|NCT00710593|450583972|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
125260475|NCT00710593|450583973|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
125260476|NCT04490278|450583974|FG000|Overall Study|Lost to Follow-up|6|||
125260477|NCT02829996|450583977|FG000|Overall Study|Withdrawal by Subject|1|||
125260478|NCT02829996|450583978|FG001|Overall Study|Withdrawal by Subject|0|||
125260479|NCT02829996|450583979|FG002|Overall Study|Withdrawal by Subject|0|||
125260480|NCT02829996|450583980|FG003|Overall Study|Withdrawal by Subject|0|||
125260481|NCT02829996|450583981|FG004|Overall Study|Withdrawal by Subject|0|||
125260482|NCT01441960|450583982|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
125260483|NCT01441960|450583983|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
125260484|NCT01441960|450583982|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
125260485|NCT01441960|450583983|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
125260486|NCT01441960|450583982|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
125260487|NCT01441960|450583983|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
125260488|NCT02986074|450583985|FG000|First Trial Period|Adverse Event|1|||
125260489|NCT02986074|450583986|FG001|First Trial Period|Adverse Event|0|||
125260490|NCT02986074|450583987|FG002|First Trial Period|Adverse Event|0|||
125260491|NCT02986074|450583988|FG003|First Trial Period|Adverse Event|0|||
125260492|NCT02986074|450583985|FG000|Follow up Period|system explant|0|||
125260493|NCT02986074|450583986|FG001|Follow up Period|system explant|0|||
125260494|NCT02986074|450583987|FG002|Follow up Period|system explant|1|||
125260495|NCT02986074|450583988|FG003|Follow up Period|system explant|2|||
125260496|NCT02986074|450583985|FG000|Follow up Period|Physician Decision|0|||
125260497|NCT02986074|450583986|FG001|Follow up Period|Physician Decision|0|||
125260498|NCT02986074|450583987|FG002|Follow up Period|Physician Decision|0|||
125260499|NCT02986074|450583988|FG003|Follow up Period|Physician Decision|1|||
125260500|NCT00069641|450583993|FG000|Overall Study|Death|1|||
125260501|NCT00069641|450583994|FG001|Overall Study|Death|0|||
125260502|NCT00069641|450583995|FG002|Overall Study|Death|1|||
125260503|NCT03186638|450583996|FG000|Overall Study|Withdrawal by Subject|4|||
125260504|NCT03186638|450583997|FG001|Overall Study|Withdrawal by Subject|4|||
125260505|NCT03186638|450583996|FG000|Overall Study|Withdrawn due to medical problem|3|||
125260506|NCT03186638|450583997|FG001|Overall Study|Withdrawn due to medical problem|2|||
125260507|NCT03186638|450583996|FG000|Overall Study|Lost to Follow-up|1|||
125260508|NCT03186638|450583997|FG001|Overall Study|Lost to Follow-up|0|||
125260509|NCT01263119|450583998|FG000|Period 1|Protocol Violation|2|||
125260510|NCT01263119|450583998|FG000|Period 2|Adverse Event|2|||
125260511|NCT04573972|450583999|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
125260512|NCT04573972|450584000|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
125260513|NCT05067335|450584001|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
125260514|NCT05067335|450584002|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
125260515|NCT05067335|450584003|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
125260516|NCT05067335|450584004|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
125260517|NCT05067335|450584001|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
125260518|NCT05067335|450584002|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
125260519|NCT05067335|450584003|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
125260520|NCT05067335|450584004|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
125260521|NCT05067335|450584001|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
125260522|NCT05067335|450584002|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
125260523|NCT05067335|450584003|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
125260524|NCT05067335|450584004|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
125260525|NCT05067335|450584001|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
125260526|NCT05067335|450584002|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
125260527|NCT05067335|450584003|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
125260528|NCT05067335|450584004|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
125260529|NCT05067335|450584001|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
125260530|NCT05067335|450584002|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
125260531|NCT05067335|450584003|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
125260532|NCT05067335|450584004|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
125260533|NCT05067335|450584001|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
125260534|NCT05067335|450584002|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
125260535|NCT05067335|450584003|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
125260536|NCT05067335|450584004|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
125260537|NCT05067335|450584001|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
125260538|NCT05067335|450584002|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
125260539|NCT05067335|450584003|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
125260540|NCT05067335|450584004|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
125260541|NCT05067335|450584001|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
125260542|NCT05067335|450584002|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
125260543|NCT05067335|450584003|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
125260544|NCT05067335|450584004|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
125260545|NCT05067335|450584001|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
125260546|NCT05067335|450584002|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
125260547|NCT05067335|450584003|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
125260548|NCT05067335|450584004|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
125260549|NCT05067335|450584001|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
125260550|NCT05067335|450584002|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
125260551|NCT05067335|450584003|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
125260552|NCT05067335|450584004|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
125260553|NCT00261833|450584005|FG000|Overall Study|Death|1|||
125260554|NCT00261833|450584006|FG001|Overall Study|Death|3|||
125260555|NCT00261833|450584005|FG000|Overall Study|Adverse Event|1|||
125260556|NCT00261833|450584006|FG001|Overall Study|Adverse Event|4|||
125260557|NCT00261833|450584005|FG000|Overall Study|Withdrawal by Subject|5|||
125260558|NCT00261833|450584006|FG001|Overall Study|Withdrawal by Subject|7|||
125260559|NCT00261833|450584005|FG000|Overall Study|Protocol Violation|0|||
125260560|NCT00261833|450584006|FG001|Overall Study|Protocol Violation|1|||
125260561|NCT00261833|450584005|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
125260562|NCT00261833|450584006|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
125260563|NCT00261833|450584005|FG000|Overall Study|Lung transplantation|1|||
125397928|NCT04951622|451089318|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
125397929|NCT04951622|451089314|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
125397930|NCT04951622|451089315|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
125397931|NCT04951622|451089316|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
125397932|NCT04951622|451089317|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
125446028|NCT02325713|451257788|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446029|NCT02325713|451257789|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
125446030|NCT02325713|451257790|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446031|NCT02325713|451257791|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446032|NCT02325713|451257792|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446033|NCT02325713|451257793|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446034|NCT02325713|451257794|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
125446035|NCT02325713|451257779|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
125446036|NCT02325713|451257780|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125446037|NCT02325713|451257781|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125260564|NCT00261833|450584006|FG001|Overall Study|Lung transplantation|1|||
125260565|NCT00261833|450584005|FG000|Overall Study|Missing reason|1|||
125260566|NCT00261833|450584006|FG001|Overall Study|Missing reason|0|||
125260567|NCT00261833|450584005|FG000|Overall Study|Not interested in being participant|0|||
125260568|NCT00261833|450584006|FG001|Overall Study|Not interested in being participant|1|||
125260569|NCT00622726|450584007|FG000|March, 2008 to August, 2010|Death|5|||
125260570|NCT00622726|450584008|FG001|March, 2008 to August, 2010|Death|2|||
125260571|NCT00622726|450584007|FG000|August, 2010 to April, 2013|Death|1|||
125260572|NCT00622726|450584008|FG001|August, 2010 to April, 2013|Death|5|||
125260573|NCT01948427|450584009|FG000|Overall Study|Serious Adverse Event|3|||
125260574|NCT01948427|450584010|FG001|Overall Study|Serious Adverse Event|0|||
125397933|NCT04951622|451089318|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
125397934|NCT04951622|451089314|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
125397935|NCT04951622|451089315|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
125397936|NCT04951622|451089316|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
125397937|NCT04951622|451089317|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
125397938|NCT04951622|451089318|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
125397939|NCT04951622|451089314|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
125397940|NCT04951622|451089315|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
125397941|NCT04951622|451089316|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
125397942|NCT04951622|451089317|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
125397943|NCT04951622|451089318|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
125397944|NCT04951622|451089314|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
125397945|NCT04951622|451089315|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
125397946|NCT04951622|451089316|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
125397947|NCT04951622|451089317|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
125397948|NCT04951622|451089318|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
125397949|NCT04951622|451089314|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
125446038|NCT02325713|451257782|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125446039|NCT02325713|451257783|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125260575|NCT01948427|450584011|FG002|Overall Study|Serious Adverse Event|0|||
125260576|NCT01948427|450584012|FG003|Overall Study|Serious Adverse Event|0|||
125260577|NCT01948427|450584013|FG004|Overall Study|Serious Adverse Event|1|||
125260578|NCT01948427|450584009|FG000|Overall Study|Investigator Request|0|||
125260579|NCT01948427|450584010|FG001|Overall Study|Investigator Request|8|||
125260580|NCT01948427|450584011|FG002|Overall Study|Investigator Request|0|||
125260581|NCT01948427|450584012|FG003|Overall Study|Investigator Request|0|||
125260582|NCT01948427|450584013|FG004|Overall Study|Investigator Request|6|||
125260583|NCT01948427|450584009|FG000|Overall Study|Lost to Follow-up|1|||
125260584|NCT01948427|450584010|FG001|Overall Study|Lost to Follow-up|0|||
125260585|NCT01948427|450584011|FG002|Overall Study|Lost to Follow-up|0|||
125260586|NCT01948427|450584012|FG003|Overall Study|Lost to Follow-up|0|||
125260587|NCT01948427|450584013|FG004|Overall Study|Lost to Follow-up|4|||
125260588|NCT01948427|450584009|FG000|Overall Study|Withdrawal by Subject|2|||
125260589|NCT01948427|450584010|FG001|Overall Study|Withdrawal by Subject|0|||
125260590|NCT01948427|450584011|FG002|Overall Study|Withdrawal by Subject|0|||
125260591|NCT01948427|450584012|FG003|Overall Study|Withdrawal by Subject|0|||
125260592|NCT01948427|450584013|FG004|Overall Study|Withdrawal by Subject|1|||
125260593|NCT01948427|450584009|FG000|Overall Study|Other, Not Specified|1|||
125260594|NCT01948427|450584010|FG001|Overall Study|Other, Not Specified|9|||
125260595|NCT01948427|450584011|FG002|Overall Study|Other, Not Specified|0|||
125397950|NCT04951622|451089315|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
125446040|NCT02325713|451257784|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125260596|NCT01948427|450584012|FG003|Overall Study|Other, Not Specified|0|||
125260597|NCT01948427|450584013|FG004|Overall Study|Other, Not Specified|2|||
125260598|NCT00402987|450584014|FG000|Overall Study|Lack of Efficacy|0|||
125260599|NCT00402987|450584015|FG001|Overall Study|Lack of Efficacy|0|||
125260600|NCT00402987|450584016|FG002|Overall Study|Lack of Efficacy|1|||
125260601|NCT00402987|450584017|FG003|Overall Study|Lack of Efficacy|0|||
125260602|NCT05200845|450584029|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
125260603|NCT05200845|450584030|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
125260604|NCT05200845|450584031|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
125260605|NCT05200845|450584032|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
125260606|NCT05200845|450584029|FG000|Overall Study|Withdrawal by Subject|0|||
125260607|NCT05200845|450584030|FG001|Overall Study|Withdrawal by Subject|1|||
125260608|NCT05200845|450584031|FG002|Overall Study|Withdrawal by Subject|1|||
125260609|NCT05200845|450584032|FG003|Overall Study|Withdrawal by Subject|0|||
125260610|NCT02303262|450584033|FG000|Overall Study|Withdrawal by Subject|2|||
125260611|NCT04138056|450584034|FG000|Primary Study|Lost to Follow-up|3|||
125260612|NCT04138056|450584035|FG001|Primary Study|Lost to Follow-up|4|||
125260613|NCT04138056|450584036|FG002|Primary Study|Lost to Follow-up|1|||
125260614|NCT04138056|450584037|FG003|Primary Study|Lost to Follow-up|1|||
125260615|NCT04138056|450584038|FG004|Primary Study|Lost to Follow-up|4|||
125260616|NCT04138056|450584034|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
125260617|NCT04138056|450584035|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
125260618|NCT04138056|450584036|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
125260619|NCT04138056|450584037|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
125260620|NCT04138056|450584038|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
125260621|NCT04138056|450584034|FG000|Extension Study|Lost to Follow-up|1|||
125260622|NCT04138056|450584035|FG001|Extension Study|Lost to Follow-up|2|||
125260623|NCT04138056|450584036|FG002|Extension Study|Lost to Follow-up|1|||
125260624|NCT04138056|450584037|FG003|Extension Study|Lost to Follow-up|0|||
125260625|NCT04138056|450584038|FG004|Extension Study|Lost to Follow-up|1|||
125260626|NCT01215851|450584039|FG000|Treatment Period|Adverse Event|1|||
125260627|NCT01215851|450584040|FG001|Treatment Period|Adverse Event|1|||
125260628|NCT01215851|450584041|FG002|Treatment Period|Adverse Event|1|||
125260629|NCT01215851|450584042|FG003|Treatment Period|Adverse Event|3|||
125260630|NCT01215851|450584043|FG004|Treatment Period|Adverse Event|0|||
125260631|NCT01215851|450584044|FG005|Treatment Period|Adverse Event|1|||
125260632|NCT01215851|450584039|FG000|Follow up Period|Lost to Follow-up|0|||
125260633|NCT01215851|450584040|FG001|Follow up Period|Lost to Follow-up|0|||
125260634|NCT01215851|450584041|FG002|Follow up Period|Lost to Follow-up|0|||
125260635|NCT01215851|450584042|FG003|Follow up Period|Lost to Follow-up|0|||
125260636|NCT01215851|450584043|FG004|Follow up Period|Lost to Follow-up|0|||
125260637|NCT01215851|450584044|FG005|Follow up Period|Lost to Follow-up|1|||
125260638|NCT00862940|450584048|FG000|Overall Study|Adverse Event|15|||
125260639|NCT00862940|450584049|FG001|Overall Study|Adverse Event|12|||
125260640|NCT00862940|450584048|FG000|Overall Study|Lack of Efficacy|1|||
125260641|NCT00862940|450584049|FG001|Overall Study|Lack of Efficacy|3|||
125260642|NCT00862940|450584048|FG000|Overall Study|Protocol Violation|2|||
125260643|NCT00862940|450584049|FG001|Overall Study|Protocol Violation|5|||
125260644|NCT00862940|450584048|FG000|Overall Study|Withdrawal by Subject|4|||
125260645|NCT00862940|450584049|FG001|Overall Study|Withdrawal by Subject|6|||
125260646|NCT00862940|450584048|FG000|Overall Study|Non-compliance|4|||
125260647|NCT00862940|450584049|FG001|Overall Study|Non-compliance|0|||
125260648|NCT00862940|450584048|FG000|Overall Study|Lost to Follow-up|0|||
125260649|NCT00862940|450584049|FG001|Overall Study|Lost to Follow-up|1|||
125260650|NCT00862940|450584048|FG000|Overall Study|Administrative or other reason(s)|4|||
125260651|NCT00862940|450584049|FG001|Overall Study|Administrative or other reason(s)|3|||
125260652|NCT05552859|450584050|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
125260653|NCT05552859|450584051|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
125260654|NCT02581930|450584060|FG000|Overall Study|Withdrawal by Subject|1|||
125260655|NCT02581930|450584060|FG000|Overall Study|patient declined further treatment|1|||
125260656|NCT03983421|450585378|FG000|Overall Study|Lost to Follow-up|1|||
125260657|NCT03386773|450585379|FG000|Overall Study|Lost to Follow-up|24|||
125260658|NCT03386773|450585380|FG001|Overall Study|Lost to Follow-up|33|||
125260659|NCT03386773|450585379|FG000|Overall Study|Withdrawal by Subject|3|||
125260660|NCT03386773|450585380|FG001|Overall Study|Withdrawal by Subject|2|||
125260661|NCT03639610|450585381|FG000|Overall Study|Adverse Event|7|||
125260662|NCT03639610|450585382|FG001|Overall Study|Adverse Event|1|||
125260663|NCT03639610|450585383|FG002|Overall Study|Adverse Event|0|||
125260664|NCT03639610|450585381|FG000|Overall Study|Physician Decision|3|||
125260665|NCT03639610|450585382|FG001|Overall Study|Physician Decision|1|||
125260666|NCT03639610|450585383|FG002|Overall Study|Physician Decision|0|||
125260667|NCT03639610|450585381|FG000|Overall Study|Disease progression|8|||
125260668|NCT03639610|450585382|FG001|Overall Study|Disease progression|5|||
125260669|NCT03639610|450585383|FG002|Overall Study|Disease progression|3|||
125260670|NCT03639610|450585381|FG000|Overall Study|Study terminated by sponsor|2|||
125260671|NCT03639610|450585382|FG001|Overall Study|Study terminated by sponsor|1|||
125260672|NCT03639610|450585383|FG002|Overall Study|Study terminated by sponsor|1|||
125260673|NCT03639610|450585381|FG000|Overall Study|Patient request to stop treatment|1|||
125260674|NCT03639610|450585382|FG001|Overall Study|Patient request to stop treatment|2|||
125260675|NCT03639610|450585383|FG002|Overall Study|Patient request to stop treatment|0|||
125260676|NCT02410772|450585386|FG000|Overall Study|Death|3|||
125260677|NCT02410772|450585387|FG001|Overall Study|Death|4|||
125260678|NCT02410772|450585388|FG002|Overall Study|Death|8|||
125260679|NCT02410772|450585386|FG000|Overall Study|Lost to Follow-up|31|||
125260680|NCT02410772|450585387|FG001|Overall Study|Lost to Follow-up|23|||
125260681|NCT02410772|450585388|FG002|Overall Study|Lost to Follow-up|22|||
125260682|NCT02410772|450585386|FG000|Overall Study|Pregnancy|8|||
125260683|NCT02410772|450585387|FG001|Overall Study|Pregnancy|4|||
125260684|NCT02410772|450585388|FG002|Overall Study|Pregnancy|5|||
125260685|NCT02410772|450585386|FG000|Overall Study|Protocol Violation|8|||
125260686|NCT02410772|450585387|FG001|Overall Study|Protocol Violation|8|||
125260687|NCT02410772|450585388|FG002|Overall Study|Protocol Violation|4|||
125260688|NCT02410772|450585386|FG000|Overall Study|Baseline Drug Resistance|49|||
125260689|NCT02410772|450585387|FG001|Overall Study|Baseline Drug Resistance|40|||
125260690|NCT02410772|450585388|FG002|Overall Study|Baseline Drug Resistance|51|||
125260691|NCT02410772|450585386|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
125260692|NCT02410772|450585387|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
125260693|NCT02410772|450585388|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
125260694|NCT02410772|450585386|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
125260695|NCT02410772|450585387|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
125260696|NCT02410772|450585388|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
125260697|NCT01517984|450585391|FG000|Overall Study|Lost to Follow-up|0|||
125260698|NCT01517984|450585392|FG001|Overall Study|Lost to Follow-up|1|||
125260699|NCT01517984|450585393|FG002|Overall Study|Lost to Follow-up|0|||
125260700|NCT01517984|450585394|FG003|Overall Study|Lost to Follow-up|0|||
125260701|NCT01517984|450585391|FG000|Overall Study|Withdrawal by Subject|1|||
125260702|NCT01517984|450585392|FG001|Overall Study|Withdrawal by Subject|8|||
125260703|NCT01517984|450585393|FG002|Overall Study|Withdrawal by Subject|4|||
125260704|NCT01517984|450585394|FG003|Overall Study|Withdrawal by Subject|1|||
125260705|NCT01517984|450585391|FG000|Overall Study|Screen Failure|4|||
125260706|NCT01517984|450585392|FG001|Overall Study|Screen Failure|0|||
125260707|NCT01517984|450585393|FG002|Overall Study|Screen Failure|0|||
125260708|NCT01517984|450585394|FG003|Overall Study|Screen Failure|0|||
125260709|NCT01517984|450585391|FG000|Overall Study|Ineligible for randomization|0|||
125260710|NCT01517984|450585392|FG001|Overall Study|Ineligible for randomization|14|||
125260711|NCT01517984|450585393|FG002|Overall Study|Ineligible for randomization|0|||
125260712|NCT01517984|450585394|FG003|Overall Study|Ineligible for randomization|0|||
125260713|NCT01645176|450585395|FG000|Overall Study|Lack of Efficacy|4|||
125260714|NCT01645176|450585395|FG000|Overall Study|did not complete final MRI|1|||
125260715|NCT02234362|450585396|FG000|Overall Study|Not eligible after first screening visit|17|||
125260716|NCT02234362|450585396|FG000|Overall Study|Lost to Follow-up|6|||
125260717|NCT02234362|450585396|FG000|Overall Study|Withdrawal by Subject|3|||
125260718|NCT00560417|450585397|FG000|Overall Study|Adverse Event|3|||
125260719|NCT00560417|450585398|FG001|Overall Study|Adverse Event|2|||
125260720|NCT00560417|450585397|FG000|Overall Study|Entry Criteria Not Met|1|||
125260721|NCT00560417|450585398|FG001|Overall Study|Entry Criteria Not Met|0|||
125260722|NCT00560417|450585397|FG000|Overall Study|Lost to Follow-up|0|||
125260723|NCT00560417|450585398|FG001|Overall Study|Lost to Follow-up|1|||
125260724|NCT00560417|450585397|FG000|Overall Study|Physician Decision|2|||
125260725|NCT00560417|450585398|FG001|Overall Study|Physician Decision|6|||
125260726|NCT00560417|450585397|FG000|Overall Study|Protocol Violation|6|||
125260727|NCT00560417|450585398|FG001|Overall Study|Protocol Violation|5|||
125260728|NCT00560417|450585397|FG000|Overall Study|Sponsor Decision|2|||
125260729|NCT00560417|450585398|FG001|Overall Study|Sponsor Decision|0|||
125260730|NCT00560417|450585397|FG000|Overall Study|Withdrawal by Subject|3|||
125260731|NCT00560417|450585398|FG001|Overall Study|Withdrawal by Subject|3|||
125260732|NCT02164864|450585401|FG000|Overall Study|Trial disease worsening|7|||
125260733|NCT02164864|450585402|FG001|Overall Study|Trial disease worsening|5|||
125260734|NCT02164864|450585403|FG002|Overall Study|Trial disease worsening|1|||
125260735|NCT02164864|450585401|FG000|Overall Study|Other pre-existing disease worsening|6|||
125260736|NCT02164864|450585402|FG001|Overall Study|Other pre-existing disease worsening|4|||
125260737|NCT02164864|450585403|FG002|Overall Study|Other pre-existing disease worsening|9|||
125260738|NCT02164864|450585401|FG000|Overall Study|Other Adverse Event (AE)|52|||
125260739|NCT02164864|450585402|FG001|Overall Study|Other Adverse Event (AE)|32|||
125260740|NCT02164864|450585403|FG002|Overall Study|Other Adverse Event (AE)|49|||
125260741|NCT02164864|450585401|FG000|Overall Study|Protocol Violation|2|||
125446041|NCT02325713|451257785|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125446042|NCT02325713|451257786|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125260742|NCT02164864|450585402|FG001|Overall Study|Protocol Violation|4|||
125260743|NCT02164864|450585403|FG002|Overall Study|Protocol Violation|1|||
125260744|NCT02164864|450585401|FG000|Overall Study|Lost to Follow-up|4|||
125260745|NCT02164864|450585402|FG001|Overall Study|Lost to Follow-up|3|||
125260746|NCT02164864|450585403|FG002|Overall Study|Lost to Follow-up|2|||
125260747|NCT02164864|450585401|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
125260748|NCT02164864|450585402|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
125260749|NCT02164864|450585403|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
125260750|NCT02164864|450585401|FG000|Overall Study|Other than stated|3|||
125260751|NCT02164864|450585402|FG001|Overall Study|Other than stated|4|||
125260752|NCT02164864|450585403|FG002|Overall Study|Other than stated|14|||
125260753|NCT02569853|450585404|FG000|Overall Study|Adverse Event|2|||
125260754|NCT02569853|450585405|FG001|Overall Study|Adverse Event|0|||
125260755|NCT02569853|450585404|FG000|Overall Study|Withdrawal by Subject|3|||
125260756|NCT02569853|450585405|FG001|Overall Study|Withdrawal by Subject|2|||
125260757|NCT02569853|450585404|FG000|Overall Study|Lost to Follow-up|3|||
125260758|NCT02569853|450585405|FG001|Overall Study|Lost to Follow-up|3|||
125260759|NCT02569853|450585404|FG000|Overall Study|Protocol Violation|1|||
125260760|NCT02569853|450585405|FG001|Overall Study|Protocol Violation|1|||
125260761|NCT02569853|450585404|FG000|Overall Study|Did not experience migraine attack|10|||
125260762|NCT02569853|450585405|FG001|Overall Study|Did not experience migraine attack|7|||
125260763|NCT02569853|450585404|FG000|Overall Study|Physician Decision|1|||
125260764|NCT02569853|450585405|FG001|Overall Study|Physician Decision|1|||
125260765|NCT02434081|450585408|FG000|Overall Study|Death (never started treatment)|2|||
125260766|NCT02434081|450585408|FG000|Overall Study|Death|2|||
125260767|NCT02434081|450585408|FG000|Overall Study|Progression|20|||
125260768|NCT02434081|450585408|FG000|Overall Study|Adverse Event|20|||
125260769|NCT02434081|450585408|FG000|Overall Study|Physician Decision|2|||
125260770|NCT02434081|450585408|FG000|Overall Study|Withdrawal by Subject|1|||
125260771|NCT02434081|450585408|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
125260772|NCT01668004|450585409|FG000|Overall Study|Adverse Event|7|||
125260773|NCT01668004|450585409|FG000|Overall Study|Withdrawal by Subject|2|||
125260774|NCT01668004|450585409|FG000|Overall Study|Lost to Follow-up|5|||
125260775|NCT01668004|450585409|FG000|Overall Study|Lack of Efficacy|9|||
125260776|NCT01668004|450585409|FG000|Overall Study|Non-compliance with treatment|2|||
125260777|NCT00419744|450585410|FG000|Overall Study|Adverse Event|39|||
125260778|NCT00419744|450585411|FG001|Overall Study|Adverse Event|40|||
125260779|NCT00419744|450585412|FG002|Overall Study|Adverse Event|50|||
125260780|NCT00419744|450585410|FG000|Overall Study|Withdrawal by Subject|45|||
125260781|NCT00419744|450585411|FG001|Overall Study|Withdrawal by Subject|49|||
125260782|NCT00419744|450585412|FG002|Overall Study|Withdrawal by Subject|52|||
125260783|NCT00419744|450585410|FG000|Overall Study|Lost to Follow-up|8|||
125260784|NCT00419744|450585411|FG001|Overall Study|Lost to Follow-up|10|||
125260785|NCT00419744|450585412|FG002|Overall Study|Lost to Follow-up|6|||
125260786|NCT00419744|450585410|FG000|Overall Study|Protocol Violation|4|||
125260787|NCT00419744|450585411|FG001|Overall Study|Protocol Violation|7|||
125260788|NCT00419744|450585412|FG002|Overall Study|Protocol Violation|8|||
125260789|NCT00419744|450585410|FG000|Overall Study|Randomized in error|9|||
125260790|NCT00419744|450585411|FG001|Overall Study|Randomized in error|6|||
125260791|NCT00419744|450585412|FG002|Overall Study|Randomized in error|7|||
125260792|NCT00419744|450585410|FG000|Overall Study|Moving out of state|2|||
125260793|NCT00419744|450585411|FG001|Overall Study|Moving out of state|0|||
125260794|NCT00419744|450585412|FG002|Overall Study|Moving out of state|1|||
125260795|NCT00419744|450585410|FG000|Overall Study|Physician Decision|10|||
125260796|NCT00419744|450585411|FG001|Overall Study|Physician Decision|5|||
125260797|NCT00419744|450585412|FG002|Overall Study|Physician Decision|6|||
125260798|NCT00419744|450585410|FG000|Overall Study|Spirometry mouthpiece issues|0|||
125260799|NCT00419744|450585411|FG001|Overall Study|Spirometry mouthpiece issues|1|||
125260800|NCT00419744|450585412|FG002|Overall Study|Spirometry mouthpiece issues|2|||
125260801|NCT00419744|450585410|FG000|Overall Study|Incorrect medication kit dispensed|0|||
125260802|NCT00419744|450585411|FG001|Overall Study|Incorrect medication kit dispensed|0|||
125260803|NCT00419744|450585412|FG002|Overall Study|Incorrect medication kit dispensed|1|||
125260804|NCT02448381|450585417|FG000|Overall Study|Adverse Event|2|||
125260805|NCT02448381|450585418|FG001|Overall Study|Adverse Event|0|||
125260806|NCT02448381|450585417|FG000|Overall Study|Lost to Follow-up|16|||
125260807|NCT02448381|450585418|FG001|Overall Study|Lost to Follow-up|9|||
125260808|NCT02448381|450585417|FG000|Overall Study|Physician Decision|1|||
125260809|NCT02448381|450585418|FG001|Overall Study|Physician Decision|1|||
125260810|NCT02448381|450585417|FG000|Overall Study|Pregnancy|1|||
125260811|NCT02448381|450585418|FG001|Overall Study|Pregnancy|0|||
125260812|NCT02448381|450585417|FG000|Overall Study|Withdrawal by Subject|13|||
125260813|NCT02448381|450585418|FG001|Overall Study|Withdrawal by Subject|9|||
125260814|NCT02448381|450585417|FG000|Overall Study|Noncompliance with Study Procedures|2|||
125260815|NCT02448381|450585418|FG001|Overall Study|Noncompliance with Study Procedures|0|||
125260816|NCT02006927|450585419|FG000|Overall Study|Adverse Event|2|||
125260817|NCT02006927|450585419|FG000|Overall Study|Withdrawal by Subject|1|||
125260818|NCT02735200|450585420|FG000|Overall Study|Lost to Follow-up|0|||
125260819|NCT02735200|450585421|FG001|Overall Study|Lost to Follow-up|5|||
125446043|NCT02325713|451257787|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125260820|NCT02735200|450585420|FG000|Overall Study|Withdrawal by Subject|8|||
125260821|NCT02735200|450585421|FG001|Overall Study|Withdrawal by Subject|0|||
125260822|NCT00673920|450585422|FG000|Baseline up to Week 48|Withdrew consent|1|||
125260823|NCT00673920|450585423|FG001|Baseline up to Week 48|Withdrew consent|0|||
125260824|NCT00673920|450585424|FG002|Baseline up to Week 48|Withdrew consent|2|||
125260825|NCT00673920|450585425|FG003|Baseline up to Week 48|Withdrew consent|0|||
125260826|NCT00673920|450585426|FG004|Baseline up to Week 48|Withdrew consent|0|||
125260827|NCT00673920|450585427|FG005|Baseline up to Week 48|Withdrew consent|0|||
125260828|NCT00673920|450585428|FG006|Baseline up to Week 48|Withdrew consent|0|||
125260829|NCT00673920|450585429|FG007|Baseline up to Week 48|Withdrew consent|0|||
125260830|NCT00673920|450585422|FG000|Baseline up to Week 48|Refused treatment|1|||
125260831|NCT00673920|450585423|FG001|Baseline up to Week 48|Refused treatment|0|||
125260832|NCT00673920|450585424|FG002|Baseline up to Week 48|Refused treatment|0|||
125260833|NCT00673920|450585425|FG003|Baseline up to Week 48|Refused treatment|0|||
125260834|NCT00673920|450585426|FG004|Baseline up to Week 48|Refused treatment|0|||
125260835|NCT00673920|450585427|FG005|Baseline up to Week 48|Refused treatment|0|||
125260836|NCT00673920|450585428|FG006|Baseline up to Week 48|Refused treatment|0|||
125260837|NCT00673920|450585429|FG007|Baseline up to Week 48|Refused treatment|0|||
125260838|NCT00673920|450585422|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
125260839|NCT00673920|450585423|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
125260840|NCT00673920|450585424|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
125260841|NCT00673920|450585425|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
125260842|NCT00673920|450585426|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
125260843|NCT00673920|450585427|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
125260844|NCT00673920|450585428|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
125260845|NCT00673920|450585429|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
125260846|NCT00673920|450585422|FG000|Baseline up to Week 48|Protocol Violation|0|||
125260847|NCT00673920|450585423|FG001|Baseline up to Week 48|Protocol Violation|0|||
125260848|NCT00673920|450585424|FG002|Baseline up to Week 48|Protocol Violation|1|||
125260849|NCT00673920|450585425|FG003|Baseline up to Week 48|Protocol Violation|0|||
125260850|NCT00673920|450585426|FG004|Baseline up to Week 48|Protocol Violation|0|||
125260851|NCT00673920|450585427|FG005|Baseline up to Week 48|Protocol Violation|0|||
125260852|NCT00673920|450585428|FG006|Baseline up to Week 48|Protocol Violation|0|||
125260853|NCT00673920|450585429|FG007|Baseline up to Week 48|Protocol Violation|0|||
125260854|NCT00673920|450585422|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260855|NCT00673920|450585423|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260856|NCT00673920|450585424|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
125260857|NCT00673920|450585425|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260858|NCT00673920|450585426|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260859|NCT00673920|450585427|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260860|NCT00673920|450585428|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260861|NCT00673920|450585429|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
125260862|NCT00673920|450585422|FG000|Baseline up to Week 48|Administrative/Other|0|||
125260863|NCT00673920|450585423|FG001|Baseline up to Week 48|Administrative/Other|1|||
125260864|NCT00673920|450585424|FG002|Baseline up to Week 48|Administrative/Other|2|||
125260865|NCT00673920|450585425|FG003|Baseline up to Week 48|Administrative/Other|0|||
125260866|NCT00673920|450585426|FG004|Baseline up to Week 48|Administrative/Other|0|||
125260867|NCT00673920|450585427|FG005|Baseline up to Week 48|Administrative/Other|0|||
125260868|NCT00673920|450585428|FG006|Baseline up to Week 48|Administrative/Other|0|||
125260869|NCT00673920|450585429|FG007|Baseline up to Week 48|Administrative/Other|0|||
125260870|NCT00673920|450585422|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
125260871|NCT00673920|450585423|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
125260872|NCT00673920|450585424|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
125260873|NCT00673920|450585425|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
125260874|NCT00673920|450585426|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
125260875|NCT00673920|450585427|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
125260876|NCT00673920|450585428|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
125260877|NCT00673920|450585429|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
125260878|NCT00673920|450585422|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260879|NCT00673920|450585423|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260880|NCT00673920|450585424|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260881|NCT00673920|450585425|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260882|NCT00673920|450585426|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260883|NCT00673920|450585427|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260884|NCT00673920|450585428|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
125260885|NCT00673920|450585429|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
125260886|NCT00673920|450585422|FG000|Week 24 to Week 48|Failure to return|0|||
125260887|NCT00673920|450585423|FG001|Week 24 to Week 48|Failure to return|0|||
125260888|NCT00673920|450585424|FG002|Week 24 to Week 48|Failure to return|0|||
125397951|NCT04951622|451089316|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
125397952|NCT04951622|451089317|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
125397953|NCT04951622|451089318|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
125260889|NCT00673920|450585425|FG003|Week 24 to Week 48|Failure to return|0|||
125260890|NCT00673920|450585426|FG004|Week 24 to Week 48|Failure to return|0|||
125260891|NCT00673920|450585427|FG005|Week 24 to Week 48|Failure to return|1|||
125260892|NCT00673920|450585428|FG006|Week 24 to Week 48|Failure to return|0|||
125260893|NCT00673920|450585429|FG007|Week 24 to Week 48|Failure to return|0|||
125260894|NCT00673920|450585422|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260895|NCT00673920|450585423|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260896|NCT00673920|450585424|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260897|NCT00673920|450585425|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260898|NCT00673920|450585426|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260899|NCT00673920|450585427|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
125260900|NCT00673920|450585428|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260901|NCT00673920|450585429|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
125260902|NCT00673920|450585422|FG000|Week 24 to Week 48|Death|0|||
125260903|NCT00673920|450585423|FG001|Week 24 to Week 48|Death|0|||
125260904|NCT00673920|450585424|FG002|Week 24 to Week 48|Death|0|||
125260905|NCT00673920|450585425|FG003|Week 24 to Week 48|Death|0|||
125260906|NCT00673920|450585426|FG004|Week 24 to Week 48|Death|0|||
125260907|NCT00673920|450585427|FG005|Week 24 to Week 48|Death|1|||
125260908|NCT00673920|450585428|FG006|Week 24 to Week 48|Death|0|||
125260909|NCT00673920|450585429|FG007|Week 24 to Week 48|Death|0|||
125260910|NCT00673920|450585422|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
125260911|NCT00673920|450585423|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
125260912|NCT00673920|450585424|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
125260913|NCT00673920|450585425|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
125260914|NCT00673920|450585426|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
125260915|NCT00673920|450585427|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
125260916|NCT00673920|450585428|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
125260917|NCT00673920|450585429|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
125260918|NCT01164007|450585430|FG000|Overall Study|Adverse Event|5|||
125260919|NCT01164007|450585430|FG000|Overall Study|Progression of Disease|30|||
125260920|NCT01164007|450585430|FG000|Overall Study|Protocol Violation|1|||
125260921|NCT01164007|450585430|FG000|Overall Study|Withdrawal by Subject|1|||
125260922|NCT01164007|450585430|FG000|Overall Study|Medical Decision|3|||
125260923|NCT04856527|450585431|FG000|Overall Study|Unable to complete experimental task|2|||
125260924|NCT04856527|450585432|FG001|Overall Study|Unable to complete experimental task|0|||
125260925|NCT01816295|450585433|FG000|Double Blind Phase|Adverse Event|11|||
125260926|NCT01816295|450585434|FG001|Double Blind Phase|Adverse Event|8|||
125260927|NCT01816295|450585433|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
125260928|NCT01816295|450585434|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
125260929|NCT01816295|450585433|FG000|Double Blind Phase|Lost to Follow-up|3|||
125260930|NCT01816295|450585434|FG001|Double Blind Phase|Lost to Follow-up|5|||
125260931|NCT01816295|450585433|FG000|Double Blind Phase|Physician Decision|2|||
125260932|NCT01816295|450585434|FG001|Double Blind Phase|Physician Decision|2|||
125260933|NCT01816295|450585433|FG000|Double Blind Phase|Protocol Violation|17|||
125260934|NCT01816295|450585434|FG001|Double Blind Phase|Protocol Violation|11|||
125260935|NCT01816295|450585433|FG000|Double Blind Phase|Sponsor Decision|8|||
125260936|NCT01816295|450585434|FG001|Double Blind Phase|Sponsor Decision|8|||
125260937|NCT01816295|450585433|FG000|Double Blind Phase|Withdrawal by Subject|22|||
125260938|NCT01816295|450585434|FG001|Double Blind Phase|Withdrawal by Subject|20|||
125260939|NCT01816295|450585433|FG000|OLE Phase|Adverse Event|17|||
125260940|NCT01816295|450585434|FG001|OLE Phase|Adverse Event|15|||
125260941|NCT01816295|450585433|FG000|OLE Phase|Death|1|||
125260942|NCT01816295|450585434|FG001|OLE Phase|Death|0|||
125260943|NCT01816295|450585433|FG000|OLE Phase|Entry Criteria Not Met|3|||
125260944|NCT01816295|450585434|FG001|OLE Phase|Entry Criteria Not Met|5|||
125260945|NCT01816295|450585433|FG000|OLE Phase|Lost to Follow-up|5|||
125260946|NCT01816295|450585434|FG001|OLE Phase|Lost to Follow-up|5|||
125260947|NCT01816295|450585433|FG000|OLE Phase|Physician Decision|3|||
125260948|NCT01816295|450585434|FG001|OLE Phase|Physician Decision|1|||
125260949|NCT01816295|450585433|FG000|OLE Phase|Protocol Violation|4|||
125260950|NCT01816295|450585434|FG001|OLE Phase|Protocol Violation|4|||
125260951|NCT01816295|450585433|FG000|OLE Phase|Sponsor Decision|7|||
125260952|NCT01816295|450585434|FG001|OLE Phase|Sponsor Decision|9|||
125260953|NCT01816295|450585433|FG000|OLE Phase|Withdrawal by Subject|10|||
125260954|NCT01816295|450585434|FG001|OLE Phase|Withdrawal by Subject|10|||
125260955|NCT01816295|450585433|FG000|OLE Phase|Lack of Efficacy|3|||
125260956|NCT01816295|450585434|FG001|OLE Phase|Lack of Efficacy|7|||
125260957|NCT04165824|450585435|FG000|Overall Study|Adverse Event|23|||
125260958|NCT04165824|450585435|FG000|Overall Study|Physician Decision|1|||
125260959|NCT04165824|450585435|FG000|Overall Study|Withdrawal by Subject|17|||
125260960|NCT04165824|450585435|FG000|Overall Study|Other|5|||
125260961|NCT01823289|450585436|FG000|Overall Study|Lost to Follow-up|5|||
125260962|NCT01823289|450585436|FG000|Overall Study|Adverse Event|5|||
125260963|NCT01823289|450585436|FG000|Overall Study|Lack of Efficacy|1|||
125260964|NCT01823289|450585436|FG000|Overall Study|Physician Decision|9|||
125260965|NCT01823289|450585436|FG000|Overall Study|Administered contraindicated medicine|1|||
125260966|NCT01823289|450585436|FG000|Overall Study|Transaminase increased more than 3 times|1|||
125260967|NCT01823289|450585436|FG000|Overall Study|Drug affected efficacy and safety|1|||
125260968|NCT01823289|450585436|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
125260969|NCT01656161|450585444|FG000|Overall Study|Death|3|||
125260970|NCT01656161|450585444|FG000|Overall Study|Adverse Event|2|||
125260971|NCT01656161|450585444|FG000|Overall Study|Protocol Violation|1|||
125260972|NCT01656161|450585444|FG000|Overall Study|Withdrawal by Subject|1|||
125260973|NCT03510273|450585445|FG000|Overall Study|Withdrawal by Subject|2|||
125260974|NCT03510273|450585445|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
125260975|NCT03510273|450585445|FG000|Overall Study|Moved away from study area|4|||
125260976|NCT01276106|450585446|FG000|Overall Study|Adverse Event|3|||
125260977|NCT01276106|450585447|FG001|Overall Study|Adverse Event|3|||
125260978|NCT01276106|450585448|FG002|Overall Study|Adverse Event|11|||
125260979|NCT01276106|450585449|FG003|Overall Study|Adverse Event|3|||
125260980|NCT01276106|450585446|FG000|Overall Study|Withdrawal by Subject|6|||
125260981|NCT01276106|450585447|FG001|Overall Study|Withdrawal by Subject|3|||
125260982|NCT01276106|450585448|FG002|Overall Study|Withdrawal by Subject|1|||
125260983|NCT01276106|450585449|FG003|Overall Study|Withdrawal by Subject|6|||
125260984|NCT01276106|450585446|FG000|Overall Study|Lack of Efficacy|0|||
125260985|NCT01276106|450585447|FG001|Overall Study|Lack of Efficacy|1|||
125260986|NCT01276106|450585448|FG002|Overall Study|Lack of Efficacy|0|||
125260987|NCT01276106|450585449|FG003|Overall Study|Lack of Efficacy|1|||
125260988|NCT01276106|450585446|FG000|Overall Study|Lost to Follow-up|2|||
125260989|NCT01276106|450585447|FG001|Overall Study|Lost to Follow-up|1|||
125260990|NCT01276106|450585448|FG002|Overall Study|Lost to Follow-up|1|||
125260991|NCT01276106|450585449|FG003|Overall Study|Lost to Follow-up|0|||
125260992|NCT01276106|450585446|FG000|Overall Study|Physician Decision|0|||
125260993|NCT01276106|450585447|FG001|Overall Study|Physician Decision|0|||
125260994|NCT01276106|450585448|FG002|Overall Study|Physician Decision|1|||
125260995|NCT01276106|450585449|FG003|Overall Study|Physician Decision|1|||
125260996|NCT01276106|450585446|FG000|Overall Study|Protocol Violation|1|||
125260997|NCT01276106|450585447|FG001|Overall Study|Protocol Violation|1|||
125260998|NCT01276106|450585448|FG002|Overall Study|Protocol Violation|0|||
125260999|NCT01276106|450585449|FG003|Overall Study|Protocol Violation|2|||
125261000|NCT01276106|450585446|FG000|Overall Study|Insufficient therapeutic effects|0|||
125261001|NCT01276106|450585447|FG001|Overall Study|Insufficient therapeutic effects|0|||
125261002|NCT01276106|450585448|FG002|Overall Study|Insufficient therapeutic effects|2|||
125261003|NCT01276106|450585449|FG003|Overall Study|Insufficient therapeutic effects|0|||
125261004|NCT04079738|450585452|FG000|Study Treatment|Death|1|||
125261005|NCT04079738|450585453|FG001|Study Treatment|Death|0|||
125261006|NCT04079738|450585454|FG002|Study Treatment|Death|0|||
125261007|NCT04079738|450585455|FG003|Study Treatment|Death|0|||
125261008|NCT04079738|450585452|FG000|Study Treatment|Adverse Event|2|||
125261009|NCT04079738|450585453|FG001|Study Treatment|Adverse Event|0|||
125261010|NCT04079738|450585454|FG002|Study Treatment|Adverse Event|0|||
125261011|NCT04079738|450585455|FG003|Study Treatment|Adverse Event|0|||
125261012|NCT04079738|450585452|FG000|Study Treatment|withdrawal before treatment|1|||
125261013|NCT04079738|450585453|FG001|Study Treatment|withdrawal before treatment|0|||
125261014|NCT04079738|450585454|FG002|Study Treatment|withdrawal before treatment|0|||
125261015|NCT04079738|450585455|FG003|Study Treatment|withdrawal before treatment|0|||
125261016|NCT04079738|450585452|FG000|Study Treatment|symptomatic deterioration|2|||
125261017|NCT04079738|450585453|FG001|Study Treatment|symptomatic deterioration|0|||
125261018|NCT04079738|450585454|FG002|Study Treatment|symptomatic deterioration|0|||
125261019|NCT04079738|450585455|FG003|Study Treatment|symptomatic deterioration|0|||
125261020|NCT04079738|450585452|FG000|Study Treatment|Disease Progression|1|||
125261021|NCT04079738|450585453|FG001|Study Treatment|Disease Progression|0|||
125261022|NCT04079738|450585454|FG002|Study Treatment|Disease Progression|0|||
125261023|NCT04079738|450585455|FG003|Study Treatment|Disease Progression|0|||
125261024|NCT04079738|450585452|FG000|Study Treatment|withdrawal after treatment|1|||
125261025|NCT04079738|450585453|FG001|Study Treatment|withdrawal after treatment|0|||
125261026|NCT04079738|450585454|FG002|Study Treatment|withdrawal after treatment|0|||
125261027|NCT04079738|450585455|FG003|Study Treatment|withdrawal after treatment|0|||
125261028|NCT04079738|450585452|FG000|Follow up|Withdrawal by Subject|3|||
125261029|NCT04079738|450585453|FG001|Follow up|Withdrawal by Subject|0|||
125261030|NCT04079738|450585454|FG002|Follow up|Withdrawal by Subject|0|||
125261031|NCT04079738|450585455|FG003|Follow up|Withdrawal by Subject|0|||
125261032|NCT04079738|450585452|FG000|Follow up|Death|5|||
125446044|NCT02325713|451257788|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125446045|NCT02325713|451257789|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125446046|NCT02325713|451257790|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125261033|NCT04079738|450585453|FG001|Follow up|Death|0|||
125261034|NCT04079738|450585454|FG002|Follow up|Death|0|||
125261035|NCT04079738|450585455|FG003|Follow up|Death|0|||
125261036|NCT00867035|450585458|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
125261037|NCT00867035|450585459|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
125261038|NCT00867035|450585458|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
125261039|NCT00867035|450585459|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
125261040|NCT00789555|450585460|FG000|Overall Study|Protocol Amendment|78|||
125261041|NCT00789555|450585461|FG001|Overall Study|Protocol Amendment|76|||
125261042|NCT00789555|450585462|FG002|Overall Study|Protocol Amendment|80|||
125261043|NCT00789555|450585460|FG000|Overall Study|Adverse Event|17|||
125261044|NCT00789555|450585461|FG001|Overall Study|Adverse Event|7|||
125446047|NCT02325713|451257791|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125261045|NCT00789555|450585462|FG002|Overall Study|Adverse Event|10|||
125261046|NCT00789555|450585460|FG000|Overall Study|Lost to Follow-up|9|||
125261047|NCT00789555|450585461|FG001|Overall Study|Lost to Follow-up|10|||
125261048|NCT00789555|450585462|FG002|Overall Study|Lost to Follow-up|18|||
125261049|NCT00789555|450585460|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
125261050|NCT00789555|450585461|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
125261051|NCT00789555|450585462|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
125261052|NCT00789555|450585460|FG000|Overall Study|Treatment failure|11|||
125261053|NCT00789555|450585461|FG001|Overall Study|Treatment failure|8|||
125261054|NCT00789555|450585462|FG002|Overall Study|Treatment failure|12|||
125261055|NCT00789555|450585460|FG000|Overall Study|Protocol Violation|6|||
125261056|NCT00789555|450585461|FG001|Overall Study|Protocol Violation|9|||
125261057|NCT00789555|450585462|FG002|Overall Study|Protocol Violation|13|||
125261058|NCT00404248|450585463|FG000|Overall Study|pts declining status|0|||
125261059|NCT00404248|450585464|FG001|Overall Study|pts declining status|1|||
125261060|NCT00404248|450585465|FG002|Overall Study|pts declining status|0|||
125261061|NCT00404248|450585466|FG003|Overall Study|pts declining status|0|||
125261062|NCT00404248|450585467|FG004|Overall Study|pts declining status|0|||
125261063|NCT00404248|450585468|FG005|Overall Study|pts declining status|0|||
125261064|NCT00404248|450585469|FG006|Overall Study|pts declining status|0|||
125261065|NCT00404248|450585470|FG007|Overall Study|pts declining status|0|||
125261066|NCT00404248|450585471|FG008|Overall Study|pts declining status|0|||
125261067|NCT04646005|450585472|FG000|Overall Study|Adverse Event|1|||
125261068|NCT04646005|450585472|FG000|Overall Study|Progressive Disease|71|||
125261069|NCT04646005|450585472|FG000|Overall Study|Death|20|||
125261070|NCT04646005|450585472|FG000|Overall Study|Withdrawal by Subject|12|||
125261071|NCT04646005|450585472|FG000|Overall Study|Sponsor Request|9|||
125261072|NCT04398706|450585473|FG000|Overall Study|Adverse Event|0|||
125261073|NCT04398706|450585474|FG001|Overall Study|Adverse Event|0|||
125261074|NCT04398706|450585475|FG002|Overall Study|Adverse Event|0|||
125261075|NCT04398706|450585476|FG003|Overall Study|Adverse Event|0|||
125261076|NCT04398706|450585477|FG004|Overall Study|Adverse Event|0|||
125261077|NCT04398706|450585478|FG005|Overall Study|Adverse Event|1|||
125261078|NCT04398706|450585479|FG006|Overall Study|Adverse Event|1|||
125261079|NCT04398706|450585480|FG007|Overall Study|Adverse Event|0|||
125261080|NCT04398706|450585473|FG000|Overall Study|Lost to Follow-up|0|||
125261081|NCT04398706|450585474|FG001|Overall Study|Lost to Follow-up|1|||
125261082|NCT04398706|450585475|FG002|Overall Study|Lost to Follow-up|2|||
125261083|NCT04398706|450585476|FG003|Overall Study|Lost to Follow-up|1|||
125261084|NCT04398706|450585477|FG004|Overall Study|Lost to Follow-up|6|||
125261085|NCT04398706|450585478|FG005|Overall Study|Lost to Follow-up|3|||
125261086|NCT04398706|450585479|FG006|Overall Study|Lost to Follow-up|8|||
125261087|NCT04398706|450585480|FG007|Overall Study|Lost to Follow-up|2|||
125261088|NCT04398706|450585473|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125261089|NCT04398706|450585474|FG001|Overall Study|Withdrawal by parent/guardian|2|||
125261090|NCT04398706|450585475|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125261091|NCT04398706|450585476|FG003|Overall Study|Withdrawal by parent/guardian|2|||
125261092|NCT04398706|450585477|FG004|Overall Study|Withdrawal by parent/guardian|19|||
125261093|NCT04398706|450585478|FG005|Overall Study|Withdrawal by parent/guardian|23|||
125397954|NCT04951622|451089314|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
125397955|NCT04951622|451089315|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
125397956|NCT04951622|451089316|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
125397957|NCT04951622|451089317|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
125397958|NCT04951622|451089318|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
125397959|NCT04951622|451089314|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
125397960|NCT04951622|451089315|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
125397961|NCT04951622|451089316|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
125397962|NCT04951622|451089317|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
125397963|NCT04951622|451089318|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
125397964|NCT04951622|451089314|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
125397965|NCT04951622|451089315|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
125397966|NCT04951622|451089316|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
125397967|NCT04951622|451089317|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
125397968|NCT04951622|451089318|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
125397969|NCT04951622|451089314|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
125397970|NCT04951622|451089315|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
125397971|NCT04951622|451089316|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
125397972|NCT04951622|451089317|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
125397973|NCT04951622|451089318|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
125397974|NCT04951622|451089314|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
125397975|NCT04951622|451089315|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
125397976|NCT04951622|451089316|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
125261094|NCT04398706|450585479|FG006|Overall Study|Withdrawal by parent/guardian|13|||
125261095|NCT04398706|450585480|FG007|Overall Study|Withdrawal by parent/guardian|11|||
125261096|NCT04398706|450585473|FG000|Overall Study|Protocol deviation|0|||
125261097|NCT04398706|450585474|FG001|Overall Study|Protocol deviation|1|||
125261098|NCT04398706|450585475|FG002|Overall Study|Protocol deviation|0|||
125261099|NCT04398706|450585476|FG003|Overall Study|Protocol deviation|0|||
125261100|NCT04398706|450585477|FG004|Overall Study|Protocol deviation|6|||
125261101|NCT04398706|450585478|FG005|Overall Study|Protocol deviation|4|||
125261102|NCT04398706|450585479|FG006|Overall Study|Protocol deviation|6|||
125261103|NCT04398706|450585480|FG007|Overall Study|Protocol deviation|3|||
125261104|NCT02611037|450585481|FG000|Overall Study|Withdrawal prior to treatment|2|||
125261105|NCT02611037|450585482|FG001|Overall Study|Withdrawal prior to treatment|0|||
125261106|NCT04577404|450585483|FG000|Overall Study|Adverse Event|31|||
125261107|NCT04577404|450585483|FG000|Overall Study|Death|1|||
125261108|NCT04577404|450585483|FG000|Overall Study|Lack of Efficacy|3|||
125261109|NCT04577404|450585483|FG000|Overall Study|Physician Decision|7|||
125261110|NCT04577404|450585483|FG000|Overall Study|Withdrawal by Subject|21|||
125261111|NCT04577404|450585483|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
125261112|NCT04237584|450585490|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
125261113|NCT04237584|450585491|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
125261114|NCT04237584|450585492|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
125261115|NCT04237584|450585493|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
125261116|NCT04237584|450585490|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
125261117|NCT04237584|450585491|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
125261118|NCT04237584|450585492|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
125261119|NCT04237584|450585493|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
125261120|NCT04237584|450585490|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
125261121|NCT04237584|450585491|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
125261122|NCT04237584|450585492|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
125261123|NCT04237584|450585493|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
125261124|NCT04237584|450585490|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
125261125|NCT04237584|450585491|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
125261126|NCT04237584|450585492|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
125261127|NCT04237584|450585493|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
125261128|NCT04237584|450585490|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
125261129|NCT04237584|450585491|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
125261130|NCT04237584|450585492|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
125261131|NCT04237584|450585493|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
125261132|NCT03586973|450585494|FG000|Overall Study|Death|15|||
125261133|NCT03586973|450585495|FG001|Overall Study|Death|8|||
125261134|NCT03586973|450585494|FG000|Overall Study|Site Terminated by Sponsor|3|||
125261135|NCT03586973|450585495|FG001|Overall Study|Site Terminated by Sponsor|6|||
125261136|NCT03586973|450585494|FG000|Overall Study|Withdrawal by Subject|1|||
125261137|NCT03586973|450585495|FG001|Overall Study|Withdrawal by Subject|0|||
125261138|NCT03586973|450585494|FG000|Overall Study|Lost to Follow-up|1|||
125261139|NCT03586973|450585495|FG001|Overall Study|Lost to Follow-up|0|||
125261140|NCT03423979|450585496|FG000|Overall Study|Death|1|||
125261141|NCT05239221|450585497|FG000|Overall Study|Adverse Event|0|||
125261142|NCT05239221|450585498|FG001|Overall Study|Adverse Event|0|||
125261143|NCT05239221|450585499|FG002|Overall Study|Adverse Event|0|||
125261144|NCT05239221|450585500|FG003|Overall Study|Adverse Event|0|||
125261145|NCT05239221|450585501|FG004|Overall Study|Adverse Event|0|||
125261146|NCT05239221|450585502|FG005|Overall Study|Adverse Event|0|||
125261147|NCT05239221|450585503|FG006|Overall Study|Adverse Event|1|||
125261148|NCT05239221|450585504|FG007|Overall Study|Adverse Event|0|||
125261149|NCT05239221|450585505|FG008|Overall Study|Adverse Event|0|||
125261150|NCT05239221|450585506|FG009|Overall Study|Adverse Event|0|||
125261151|NCT05239221|450585507|FG010|Overall Study|Adverse Event|1|||
125261152|NCT05239221|450585508|FG011|Overall Study|Adverse Event|1|||
125261153|NCT05239221|450585509|FG012|Overall Study|Adverse Event|0|||
125261154|NCT05239221|450585510|FG013|Overall Study|Adverse Event|0|||
125261155|NCT05239221|450585511|FG014|Overall Study|Adverse Event|0|||
125261156|NCT05239221|450585512|FG015|Overall Study|Adverse Event|0|||
125261157|NCT05239221|450585497|FG000|Overall Study|Withdrawal by Subject|0|||
125261158|NCT05239221|450585498|FG001|Overall Study|Withdrawal by Subject|0|||
125261159|NCT05239221|450585499|FG002|Overall Study|Withdrawal by Subject|0|||
125261160|NCT05239221|450585500|FG003|Overall Study|Withdrawal by Subject|0|||
125261161|NCT05239221|450585501|FG004|Overall Study|Withdrawal by Subject|0|||
125261162|NCT05239221|450585502|FG005|Overall Study|Withdrawal by Subject|0|||
125261163|NCT05239221|450585503|FG006|Overall Study|Withdrawal by Subject|0|||
125261164|NCT05239221|450585504|FG007|Overall Study|Withdrawal by Subject|0|||
125261165|NCT05239221|450585505|FG008|Overall Study|Withdrawal by Subject|0|||
125261166|NCT05239221|450585506|FG009|Overall Study|Withdrawal by Subject|0|||
125261167|NCT05239221|450585507|FG010|Overall Study|Withdrawal by Subject|1|||
125261168|NCT05239221|450585508|FG011|Overall Study|Withdrawal by Subject|0|||
125261169|NCT05239221|450585509|FG012|Overall Study|Withdrawal by Subject|0|||
125261170|NCT05239221|450585510|FG013|Overall Study|Withdrawal by Subject|0|||
125261171|NCT05239221|450585511|FG014|Overall Study|Withdrawal by Subject|0|||
125261172|NCT05239221|450585512|FG015|Overall Study|Withdrawal by Subject|1|||
125261173|NCT02661672|450585513|FG000|Overall Study|Lost to Follow-up|1|||
125261174|NCT02661672|450585513|FG000|Overall Study|Death|4|||
125261175|NCT04696146|450587084|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
125261176|NCT04696146|450587085|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
125261177|NCT04696146|450587084|FG000|Overall Study|Off hours issue with product|1|||
125261178|NCT04696146|450587085|FG001|Overall Study|Off hours issue with product|0|||
125261179|NCT00529633|450587090|FG000|Overall Study|Withdrawal by Subject|1|||
125261180|NCT00529633|450587091|FG001|Overall Study|Withdrawal by Subject|1|||
125261181|NCT01576783|450587092|FG000|Overall Study|Change in Medical Care|1|||
125261182|NCT01576783|450587093|FG001|Overall Study|Change in Medical Care|0|||
125261183|NCT01576783|450587092|FG000|Overall Study|Lost to Follow-up|14|||
125261184|NCT01576783|450587093|FG001|Overall Study|Lost to Follow-up|16|||
125261185|NCT01576783|450587092|FG000|Overall Study|Withdrawal by Subject|5|||
125261186|NCT01576783|450587093|FG001|Overall Study|Withdrawal by Subject|1|||
125261187|NCT01897493|450587095|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
125261188|NCT05489328|450587096|FG000|Overall Study|Lost to Follow-up|0|||
125261189|NCT05489328|450587097|FG001|Overall Study|Lost to Follow-up|0|||
125261190|NCT05489328|450587098|FG002|Overall Study|Lost to Follow-up|1|||
125261191|NCT05489328|450587099|FG003|Overall Study|Lost to Follow-up|0|||
125261192|NCT05489328|450587100|FG004|Overall Study|Lost to Follow-up|2|||
125261193|NCT05489328|450587101|FG005|Overall Study|Lost to Follow-up|0|||
125261194|NCT05489328|450587102|FG006|Overall Study|Lost to Follow-up|0|||
125261195|NCT05489328|450587103|FG007|Overall Study|Lost to Follow-up|1|||
125261196|NCT05489328|450587104|FG008|Overall Study|Lost to Follow-up|0|||
125261197|NCT05489328|450587096|FG000|Overall Study|Withdrawal by Subject|0|||
125261198|NCT05489328|450587097|FG001|Overall Study|Withdrawal by Subject|0|||
125261199|NCT05489328|450587098|FG002|Overall Study|Withdrawal by Subject|0|||
125261200|NCT05489328|450587099|FG003|Overall Study|Withdrawal by Subject|0|||
125261201|NCT05489328|450587100|FG004|Overall Study|Withdrawal by Subject|0|||
125261202|NCT05489328|450587101|FG005|Overall Study|Withdrawal by Subject|0|||
125261203|NCT05489328|450587102|FG006|Overall Study|Withdrawal by Subject|1|||
125261204|NCT05489328|450587103|FG007|Overall Study|Withdrawal by Subject|1|||
125261205|NCT05489328|450587104|FG008|Overall Study|Withdrawal by Subject|0|||
125261206|NCT05489328|450587096|FG000|Overall Study|Other|0|||
125261207|NCT05489328|450587097|FG001|Overall Study|Other|0|||
125261208|NCT05489328|450587098|FG002|Overall Study|Other|0|||
125261209|NCT05489328|450587099|FG003|Overall Study|Other|0|||
125261210|NCT05489328|450587100|FG004|Overall Study|Other|0|||
125261211|NCT05489328|450587101|FG005|Overall Study|Other|0|||
125261212|NCT05489328|450587102|FG006|Overall Study|Other|0|||
125261213|NCT05489328|450587103|FG007|Overall Study|Other|1|||
125261214|NCT05489328|450587104|FG008|Overall Study|Other|1|||
125261215|NCT01083602|450587105|FG000|Overall Study|Adverse Event|11|||
125261216|NCT01083602|450587105|FG000|Overall Study|New Cancer Therapy|2|||
125261217|NCT01083602|450587105|FG000|Overall Study|Death|1|||
125261218|NCT01083602|450587105|FG000|Overall Study|Withdrawal by Subject|5|||
125261219|NCT01083602|450587105|FG000|Overall Study|Lack of Efficacy|36|||
125261220|NCT03698279|450587106|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125261221|NCT03698279|450587107|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125261222|NCT03698279|450587108|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125261223|NCT03698279|450587109|FG003|Overall Study|Withdrawal by parent/guardian|1|||
125261224|NCT03698279|450587110|FG004|Overall Study|Withdrawal by parent/guardian|0|||
125261225|NCT03698279|450587111|FG005|Overall Study|Withdrawal by parent/guardian|0|||
125261226|NCT03698279|450587106|FG000|Overall Study|Protocol deviation|1|||
125261227|NCT03698279|450587107|FG001|Overall Study|Protocol deviation|0|||
125261228|NCT03698279|450587108|FG002|Overall Study|Protocol deviation|1|||
125261229|NCT03698279|450587109|FG003|Overall Study|Protocol deviation|0|||
125261230|NCT03698279|450587110|FG004|Overall Study|Protocol deviation|0|||
125261231|NCT03698279|450587111|FG005|Overall Study|Protocol deviation|0|||
125261232|NCT03698279|450587106|FG000|Overall Study|Withdrawal by Subject|0|||
125261233|NCT03698279|450587107|FG001|Overall Study|Withdrawal by Subject|0|||
125261234|NCT03698279|450587108|FG002|Overall Study|Withdrawal by Subject|1|||
125261235|NCT03698279|450587109|FG003|Overall Study|Withdrawal by Subject|0|||
125261236|NCT03698279|450587110|FG004|Overall Study|Withdrawal by Subject|0|||
125261237|NCT03698279|450587111|FG005|Overall Study|Withdrawal by Subject|0|||
125261238|NCT03698279|450587106|FG000|Overall Study|Lost to Follow-up|3|||
125261239|NCT03698279|450587107|FG001|Overall Study|Lost to Follow-up|1|||
125261240|NCT03698279|450587108|FG002|Overall Study|Lost to Follow-up|4|||
125261241|NCT03698279|450587109|FG003|Overall Study|Lost to Follow-up|5|||
125261242|NCT03698279|450587110|FG004|Overall Study|Lost to Follow-up|0|||
125261243|NCT03698279|450587111|FG005|Overall Study|Lost to Follow-up|0|||
125261244|NCT01276704|450587114|FG000|Overall Study|Lost to Follow-up|2|||
125261245|NCT01276704|450587115|FG001|Overall Study|Lost to Follow-up|3|||
125261246|NCT01276704|450587114|FG000|Overall Study|Non-compliant|2|||
125261247|NCT01276704|450587115|FG001|Overall Study|Non-compliant|2|||
125261248|NCT01276704|450587114|FG000|Overall Study|Withdrawal by Subject|7|||
125261249|NCT01276704|450587115|FG001|Overall Study|Withdrawal by Subject|1|||
125261250|NCT01276704|450587114|FG000|Overall Study|Physician Decision|3|||
125261251|NCT01276704|450587115|FG001|Overall Study|Physician Decision|5|||
125261252|NCT02276040|450587116|FG000|Overall Study|Physician Decision|15|||
125261253|NCT02239926|450587117|FG000|Overall Study|Withdrawal by Subject|0|||
125261254|NCT02239926|450587118|FG001|Overall Study|Withdrawal by Subject|1|||
125261255|NCT03801525|450587119|FG000|Overall Study|Adverse Event|17|||
125261256|NCT03801525|450587120|FG001|Overall Study|Adverse Event|1|||
125261257|NCT03801525|450587121|FG002|Overall Study|Adverse Event|0|||
125261258|NCT03801525|450587119|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
125261259|NCT03801525|450587120|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
125261260|NCT03801525|450587121|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
125261261|NCT03801525|450587119|FG000|Overall Study|Death|29|||
125261262|NCT03801525|450587120|FG001|Overall Study|Death|1|||
125261263|NCT03801525|450587121|FG002|Overall Study|Death|4|||
125261264|NCT03801525|450587119|FG000|Overall Study|Disease Progression|6|||
125261265|NCT03801525|450587120|FG001|Overall Study|Disease Progression|0|||
125261266|NCT03801525|450587121|FG002|Overall Study|Disease Progression|1|||
125261267|NCT03801525|450587119|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
125261268|NCT03801525|450587120|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
125261269|NCT03801525|450587121|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
125261270|NCT03801525|450587119|FG000|Overall Study|Investigator Decision|18|||
125261271|NCT03801525|450587120|FG001|Overall Study|Investigator Decision|1|||
125397977|NCT04951622|451089317|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
125397978|NCT04951622|451089318|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
125397979|NCT04951622|451089314|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
125397980|NCT04951622|451089315|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
125397981|NCT04951622|451089316|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
125397982|NCT04951622|451089317|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
125397983|NCT04951622|451089318|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
125397984|NCT04951622|451089314|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
125397985|NCT04951622|451089315|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
125397986|NCT04951622|451089316|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
125397987|NCT04951622|451089317|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
125397988|NCT04951622|451089318|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
125397989|NCT04951622|451089314|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
125397990|NCT04951622|451089315|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
125397991|NCT04951622|451089316|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
125397992|NCT04951622|451089317|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
125397993|NCT04951622|451089318|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
125397994|NCT04951622|451089314|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
125397995|NCT04951622|451089315|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
125397996|NCT04951622|451089316|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
125397997|NCT04951622|451089317|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
125397998|NCT04951622|451089318|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
125397999|NCT04951622|451089314|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
125398000|NCT04951622|451089315|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
125398001|NCT04951622|451089316|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
125398002|NCT04951622|451089317|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
125398003|NCT04951622|451089318|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
125398004|NCT04951622|451089314|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
125398005|NCT04951622|451089315|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
125398006|NCT04951622|451089316|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
125398007|NCT04951622|451089317|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
125398008|NCT04951622|451089318|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
125398009|NCT04951622|451089314|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
125398010|NCT04951622|451089315|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
125398011|NCT04951622|451089316|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
125398012|NCT04951622|451089317|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
125398013|NCT04951622|451089318|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
125261272|NCT03801525|450587121|FG002|Overall Study|Investigator Decision|0|||
125261273|NCT03801525|450587119|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
125261274|NCT03801525|450587120|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
125261275|NCT03801525|450587121|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
125261276|NCT03801525|450587119|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
125261277|NCT03801525|450587120|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
125261278|NCT03801525|450587121|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
125261279|NCT03801525|450587119|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
125261280|NCT03801525|450587120|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
125261281|NCT03801525|450587121|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
125261282|NCT03801525|450587119|FG000|Overall Study|Withdrawal of Subject Consent|38|||
125261283|NCT03801525|450587120|FG001|Overall Study|Withdrawal of Subject Consent|2|||
125261284|NCT03801525|450587121|FG002|Overall Study|Withdrawal of Subject Consent|1|||
125261285|NCT03801525|450587119|FG000|Overall Study|Reason not Specified|4|||
125261286|NCT03801525|450587120|FG001|Overall Study|Reason not Specified|0|||
125261287|NCT03801525|450587121|FG002|Overall Study|Reason not Specified|4|||
125261288|NCT04388826|450587125|FG000|Overall Study|Lost to Follow-up|3|||
125261289|NCT04388826|450587126|FG001|Overall Study|Lost to Follow-up|2|||
125261290|NCT04388826|450587125|FG000|Overall Study|Adverse Event|1|||
125261291|NCT04388826|450587126|FG001|Overall Study|Adverse Event|0|||
125261292|NCT00329420|450587127|FG000|Re-induction Phase|Lack of Efficacy|0|||
125261293|NCT00329420|450587128|FG001|Re-induction Phase|Lack of Efficacy|1|||
125261294|NCT00329420|450587129|FG002|Re-induction Phase|Lack of Efficacy|0|||
125261295|NCT00329420|450587127|FG000|Re-induction Phase|Withdrawal of Consent|0|||
125261296|NCT00329420|450587128|FG001|Re-induction Phase|Withdrawal of Consent|0|||
125261297|NCT00329420|450587129|FG002|Re-induction Phase|Withdrawal of Consent|1|||
125261298|NCT00329420|450587127|FG000|Re-induction Phase|Did not respond to re-induction|6|||
125261299|NCT00329420|450587128|FG001|Re-induction Phase|Did not respond to re-induction|5|||
125261300|NCT00329420|450587129|FG002|Re-induction Phase|Did not respond to re-induction|7|||
125261301|NCT00329420|450587127|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
125261302|NCT00329420|450587128|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
125261303|NCT00329420|450587129|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
125261304|NCT00329420|450587127|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
125261305|NCT00329420|450587128|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
125261306|NCT00329420|450587129|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
125261307|NCT00329420|450587127|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
125261308|NCT00329420|450587128|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
125261309|NCT00329420|450587129|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
125261310|NCT02862574|450587130|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125261311|NCT02862574|450587131|FG001|Double-Blind Treatment Period|Adverse Event|1|||
125261312|NCT02862574|450587132|FG002|Double-Blind Treatment Period|Adverse Event|0|||
125261313|NCT02862574|450587130|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
125261314|NCT02862574|450587131|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
125261315|NCT02862574|450587132|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
125261316|NCT02862574|450587130|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
125261317|NCT02862574|450587131|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
125261318|NCT02862574|450587132|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
125261319|NCT00320606|450587142|FG000|Overall Study|Adverse Event|1|||
125261320|NCT00320606|450587142|FG000|Overall Study|Protocol Violation|1|||
125261321|NCT00320606|450587142|FG000|Overall Study|Withdrawal by Subject|1|||
125261322|NCT03984825|450587143|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
125261323|NCT03984825|450587143|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
125261324|NCT03984825|450587143|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
125446048|NCT02325713|451257792|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125446049|NCT02325713|451257793|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125446050|NCT02325713|451257794|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
125446051|NCT02325713|451257779|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446052|NCT02325713|451257780|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446053|NCT02325713|451257781|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125261325|NCT00399035|450587146|FG000|Overall Study|Death|289|||
125261326|NCT00399035|450587147|FG001|Overall Study|Death|141|||
125261327|NCT00399035|450587148|FG002|Overall Study|Death|234|||
125261328|NCT00399035|450587146|FG000|Overall Study|Lost to Follow-up|2|||
125261329|NCT00399035|450587147|FG001|Overall Study|Lost to Follow-up|1|||
125261330|NCT00399035|450587148|FG002|Overall Study|Lost to Follow-up|5|||
125261331|NCT00399035|450587146|FG000|Overall Study|Withdrawal by Subject|19|||
125261332|NCT00399035|450587147|FG001|Overall Study|Withdrawal by Subject|15|||
125261333|NCT00399035|450587148|FG002|Overall Study|Withdrawal by Subject|12|||
125261334|NCT00399035|450587146|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
125261335|NCT00399035|450587147|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
125261336|NCT00399035|450587148|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
125446054|NCT02325713|451257782|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446055|NCT02325713|451257783|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446056|NCT02325713|451257784|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446057|NCT02325713|451257785|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446058|NCT02325713|451257786|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446059|NCT02325713|451257787|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446060|NCT02325713|451257788|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
125446061|NCT02325713|451257789|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446062|NCT02325713|451257790|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446063|NCT02325713|451257791|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446064|NCT02325713|451257792|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446065|NCT02325713|451257793|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446066|NCT02325713|451257794|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
125446067|NCT02353832|451257795|FG000|Overall Study|Ineligible after enrollment|1|||
125446068|NCT02353832|451257795|FG000|Overall Study|Lost to Follow-up|1|||
125446069|NCT01354106|451257796|FG000|Overall Study|Withdrawal by Subject|2|||
125446070|NCT00107380|451259369|FG000|Overall Study|Adverse Event|7|||
125446071|NCT00107380|451259369|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
125446072|NCT00107380|451259369|FG000|Overall Study|Progression/relapse|4|||
125446073|NCT00107380|451259369|FG000|Overall Study|Death|3|||
125446074|NCT00107380|451259369|FG000|Overall Study|Other - not protocol specified|7|||
125446075|NCT00107380|451259369|FG000|Overall Study|Ineligible|2|||
125446076|NCT03673098|451259370|FG000|Overall Study|Lost to Follow-up|2|||
125446077|NCT03673098|451259371|FG001|Overall Study|Lost to Follow-up|3|||
125446078|NCT03673098|451259370|FG000|Overall Study|Withdrawal by Subject|6|||
125446079|NCT03673098|451259371|FG001|Overall Study|Withdrawal by Subject|1|||
125446080|NCT03673098|451259370|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
125446081|NCT03673098|451259371|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
125446082|NCT03531905|451259376|FG000|Overall Study|Withdrawal by Subject|3|||
125446083|NCT03531905|451259377|FG001|Overall Study|Withdrawal by Subject|3|||
125446084|NCT03531905|451259378|FG002|Overall Study|Withdrawal by Subject|2|||
125446085|NCT03531905|451259376|FG000|Overall Study|Lost to Follow-up|2|||
125446086|NCT03531905|451259377|FG001|Overall Study|Lost to Follow-up|2|||
125446087|NCT03531905|451259378|FG002|Overall Study|Lost to Follow-up|1|||
125446088|NCT03531905|451259376|FG000|Overall Study|Participant was out of town|1|||
125446089|NCT03531905|451259377|FG001|Overall Study|Participant was out of town|0|||
125446090|NCT03531905|451259378|FG002|Overall Study|Participant was out of town|0|||
125446091|NCT03531905|451259376|FG000|Overall Study|Could not speak with the participant|1|||
125446092|NCT03531905|451259377|FG001|Overall Study|Could not speak with the participant|0|||
125446093|NCT03531905|451259378|FG002|Overall Study|Could not speak with the participant|0|||
125446094|NCT01155726|451259379|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
125446095|NCT01155726|451259380|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
125446096|NCT01155726|451259381|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
125446097|NCT01155726|451259382|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
125446098|NCT01536262|451259383|FG000|Overall Study|Adverse Event|6|||
125446099|NCT01536262|451259384|FG001|Overall Study|Adverse Event|1|||
125446100|NCT01536262|451259385|FG002|Overall Study|Adverse Event|2|||
125446101|NCT01536262|451259383|FG000|Overall Study|Withdrawal by Subject|1|||
125446102|NCT01536262|451259384|FG001|Overall Study|Withdrawal by Subject|1|||
125446103|NCT01536262|451259385|FG002|Overall Study|Withdrawal by Subject|0|||
125446104|NCT01536262|451259383|FG000|Overall Study|Other than stated above|1|||
125446105|NCT01536262|451259384|FG001|Overall Study|Other than stated above|0|||
125446106|NCT01536262|451259385|FG002|Overall Study|Other than stated above|0|||
125446107|NCT01781611|451259389|FG000|Overall Study|Adverse Event|4|||
125446108|NCT01781611|451259390|FG001|Overall Study|Adverse Event|0|||
125446109|NCT03639675|451259391|FG000|Overall Study|Withdrawal by Subject|1|||
125446110|NCT02459587|451259392|FG000|3-Month Follow-up Assessment|Death|0|||
125446111|NCT02459587|451259393|FG001|3-Month Follow-up Assessment|Death|2|||
125446112|NCT02459587|451259392|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
125446113|NCT02459587|451259393|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
125446114|NCT02459587|451259392|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
125446115|NCT02459587|451259393|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
125446116|NCT02459587|451259392|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
125446117|NCT02459587|451259393|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
125446118|NCT02459587|451259392|FG000|6-month Follow-up Assessment|Death|2|||
125446119|NCT02459587|451259393|FG001|6-month Follow-up Assessment|Death|1|||
125446120|NCT02459587|451259392|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
125446121|NCT02459587|451259393|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
125446122|NCT02459587|451259392|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
125446123|NCT02459587|451259393|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
125446124|NCT02459587|451259392|FG000|12-month Follow-up Assessment|Death|2|||
125446125|NCT02459587|451259393|FG001|12-month Follow-up Assessment|Death|0|||
125261337|NCT00399035|450587146|FG000|Overall Study|Severe non-compliance with protocol|2|||
125398014|NCT04108208|451089319|FG000|Overall Study|Withdrawal by Subject|2|||
125398015|NCT04108208|451089320|FG001|Overall Study|Withdrawal by Subject|6|||
125398016|NCT04108208|451089319|FG000|Overall Study|other-ongoing|20|||
125398017|NCT04108208|451089320|FG001|Overall Study|other-ongoing|40|||
125398018|NCT04108208|451089319|FG000|Overall Study|Death|1|||
125398019|NCT04108208|451089320|FG001|Overall Study|Death|4|||
125398020|NCT04108208|451089319|FG000|Overall Study|Lost to Follow-up|2|||
125398021|NCT04108208|451089320|FG001|Overall Study|Lost to Follow-up|0|||
125398022|NCT01736696|451089323|FG000|Overall Study|Withdrawal by Subject|0|||
125398023|NCT01736696|451089324|FG001|Overall Study|Withdrawal by Subject|0|||
125398024|NCT01736696|451089325|FG002|Overall Study|Withdrawal by Subject|1|||
125398025|NCT01736696|451089326|FG003|Overall Study|Withdrawal by Subject|0|||
125398026|NCT01736696|451089327|FG004|Overall Study|Withdrawal by Subject|0|||
125398027|NCT01736696|451089328|FG005|Overall Study|Withdrawal by Subject|0|||
125398028|NCT01736696|451089329|FG006|Overall Study|Withdrawal by Subject|0|||
125398029|NCT02114879|451089330|FG000|Overall Study|Withdrawal by Subject|9|||
125398030|NCT02114879|451089331|FG001|Overall Study|Withdrawal by Subject|5|||
125398031|NCT02114879|451089330|FG000|Overall Study|Death|6|||
125398032|NCT02114879|451089331|FG001|Overall Study|Death|11|||
125398033|NCT02114879|451089330|FG000|Overall Study|Lost to Follow-up|4|||
125398034|NCT02114879|451089331|FG001|Overall Study|Lost to Follow-up|6|||
125398035|NCT02114879|451089330|FG000|Overall Study|Physician Decision|0|||
125398036|NCT02114879|451089331|FG001|Overall Study|Physician Decision|2|||
125398037|NCT00613509|451089332|FG000|Cycle 1|Adverse Event|2|||
125398038|NCT00613509|451089333|FG001|Cycle 1|Adverse Event|1|||
125398039|NCT00613509|451089332|FG000|Cycle 1|Disease Progression|2|||
125398040|NCT00613509|451089333|FG001|Cycle 1|Disease Progression|6|||
125398041|NCT00613509|451089332|FG000|Cycle 1|Unacceptable Toxicity|1|||
125398042|NCT00613509|451089333|FG001|Cycle 1|Unacceptable Toxicity|0|||
125398043|NCT00613509|451089332|FG000|Cycle 1|Other administrative reason|0|||
125398044|NCT00613509|451089333|FG001|Cycle 1|Other administrative reason|1|||
125398045|NCT03400033|451089342|FG000|Overall Study|Withdrawal by Subject|1|||
125398046|NCT03400033|451089343|FG001|Overall Study|Withdrawal by Subject|2|||
125398047|NCT02469610|451089346|FG000|Overall Study|Death|1|||
125398048|NCT02469610|451089347|FG001|Overall Study|Death|0|||
125398049|NCT02469610|451089346|FG000|Overall Study|Lost to Follow-up|1|||
125398050|NCT02469610|451089347|FG001|Overall Study|Lost to Follow-up|0|||
125398051|NCT02469610|451089346|FG000|Overall Study|exclusion criteria|2|||
125398052|NCT02469610|451089347|FG001|Overall Study|exclusion criteria|1|||
125398053|NCT02434770|451089348|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
125398054|NCT02434770|451089349|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
125398055|NCT02434770|451089350|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
125398056|NCT02434770|451089348|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
125398057|NCT02434770|451089349|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
125398058|NCT02434770|451089350|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
125398059|NCT02434770|451089348|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
125398060|NCT02434770|451089349|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
125398061|NCT02434770|451089350|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
125398062|NCT02434770|451089348|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
125398063|NCT02434770|451089349|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
125398064|NCT02434770|451089350|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
125398065|NCT02434770|451089348|FG000|Week 1 to Week 18|Death|1|||
125398066|NCT02434770|451089349|FG001|Week 1 to Week 18|Death|0|||
125398067|NCT02434770|451089350|FG002|Week 1 to Week 18|Death|0|||
125398068|NCT02434770|451089348|FG000|Week 18 to Week|Lost to Follow-up|2|||
125398069|NCT02434770|451089349|FG001|Week 18 to Week|Lost to Follow-up|2|||
125398070|NCT02434770|451089350|FG002|Week 18 to Week|Lost to Follow-up|1|||
125398071|NCT02434770|451089348|FG000|Week 18 to Week|Withdrawal by Subject|0|||
125398072|NCT02434770|451089349|FG001|Week 18 to Week|Withdrawal by Subject|0|||
125398073|NCT02434770|451089350|FG002|Week 18 to Week|Withdrawal by Subject|2|||
125398074|NCT02434770|451089348|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
125398075|NCT02434770|451089349|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
125398076|NCT02434770|451089350|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
125398077|NCT01574352|451089351|FG000|Overall Study|Withdrawal by Subject|6|||
125398078|NCT01574352|451089352|FG001|Overall Study|Withdrawal by Subject|13|||
125398079|NCT01574352|451089351|FG000|Overall Study|Injury in non-camp related sport|1|||
125398080|NCT01574352|451089352|FG001|Overall Study|Injury in non-camp related sport|0|||
125398081|NCT00245765|451089353|FG000|Overall Study|Adverse Event|1|||
125398082|NCT00245765|451089354|FG001|Overall Study|Adverse Event|1|||
125398083|NCT00245765|451089355|FG002|Overall Study|Adverse Event|0|||
125398084|NCT00245765|451089353|FG000|Overall Study|Lack of Efficacy|14|||
125398085|NCT00245765|451089354|FG001|Overall Study|Lack of Efficacy|7|||
125398086|NCT00245765|451089355|FG002|Overall Study|Lack of Efficacy|0|||
125398087|NCT00245765|451089353|FG000|Overall Study|Lost to Follow-up|1|||
125398088|NCT00245765|451089354|FG001|Overall Study|Lost to Follow-up|2|||
125398089|NCT00245765|451089355|FG002|Overall Study|Lost to Follow-up|0|||
125446126|NCT02459587|451259392|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
125261338|NCT00399035|450587147|FG001|Overall Study|Severe non-compliance with protocol|1|||
125261339|NCT00399035|450587148|FG002|Overall Study|Severe non-compliance with protocol|0|||
125261340|NCT02921256|450587155|FG000|Arm 1a v. Arm II|Adverse Event|6|||
125261341|NCT02921256|450587156|FG001|Arm 1a v. Arm II|Adverse Event|15|||
125261342|NCT02921256|450587157|FG002|Arm 1a v. Arm II|Adverse Event|0|||
125261343|NCT02921256|450587155|FG000|Arm 1a v. Arm II|Death|0|||
125261344|NCT02921256|450587156|FG001|Arm 1a v. Arm II|Death|2|||
125261345|NCT02921256|450587157|FG002|Arm 1a v. Arm II|Death|0|||
125398090|NCT00245765|451089353|FG000|Overall Study|Withdrawal by Subject|1|||
125398091|NCT00245765|451089354|FG001|Overall Study|Withdrawal by Subject|0|||
125398092|NCT00245765|451089355|FG002|Overall Study|Withdrawal by Subject|3|||
125398093|NCT00245765|451089353|FG000|Overall Study|Other reason|2|||
125398094|NCT00245765|451089354|FG001|Overall Study|Other reason|0|||
125398095|NCT00245765|451089355|FG002|Overall Study|Other reason|1|||
125398096|NCT00245765|451089353|FG000|Overall Study|Other|13|||
125398097|NCT00245765|451089354|FG001|Overall Study|Other|4|||
125398098|NCT00245765|451089355|FG002|Overall Study|Other|4|||
125398099|NCT00660348|451089356|FG000|Overall Study|Withdrawal by Subject|1|||
125398100|NCT00660348|451089357|FG001|Overall Study|Withdrawal by Subject|0|||
125398101|NCT03316872|451089361|FG000|Overall Study|Death|1|||
125398102|NCT04074317|451089364|FG000|Third Period|Withdrawal by Subject|0|||
125398103|NCT04074317|451089365|FG001|Third Period|Withdrawal by Subject|0|||
125398104|NCT04074317|451089366|FG002|Third Period|Withdrawal by Subject|0|||
125398105|NCT04074317|451089367|FG003|Third Period|Withdrawal by Subject|1|||
125398106|NCT04074317|451089368|FG004|Third Period|Withdrawal by Subject|0|||
125398107|NCT04074317|451089369|FG005|Third Period|Withdrawal by Subject|0|||
125398108|NCT03548584|451090902|FG000|Overall Study|Lost to Follow-up|0|||
125398109|NCT03548584|451090903|FG001|Overall Study|Lost to Follow-up|0|||
125398110|NCT03548584|451090904|FG002|Overall Study|Lost to Follow-up|1|||
125398111|NCT03548584|451090902|FG000|Overall Study|Adverse Event|1|||
125398112|NCT03548584|451090903|FG001|Overall Study|Adverse Event|11|||
125398113|NCT03548584|451090904|FG002|Overall Study|Adverse Event|5|||
125398114|NCT03548584|451090902|FG000|Overall Study|Site Terminated by Sponsor|1|||
125398115|NCT03548584|451090903|FG001|Overall Study|Site Terminated by Sponsor|3|||
125398116|NCT03548584|451090904|FG002|Overall Study|Site Terminated by Sponsor|2|||
125398117|NCT03548584|451090902|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
125398118|NCT03548584|451090903|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
125398119|NCT03548584|451090904|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
125398120|NCT03548584|451090902|FG000|Overall Study|Lack of Efficacy|0|||
125398121|NCT03548584|451090903|FG001|Overall Study|Lack of Efficacy|1|||
125398122|NCT03548584|451090904|FG002|Overall Study|Lack of Efficacy|0|||
125398123|NCT03548584|451090902|FG000|Overall Study|Non-compliance with Study Drug|0|||
125398124|NCT03548584|451090903|FG001|Overall Study|Non-compliance with Study Drug|1|||
125398125|NCT03548584|451090904|FG002|Overall Study|Non-compliance with Study Drug|0|||
125398126|NCT03548584|451090902|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
125398127|NCT03548584|451090903|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
125398128|NCT03548584|451090904|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
125398129|NCT01101841|451090907|FG000|Overall Study|Adverse Event|15|||
125398130|NCT01101841|451090908|FG001|Overall Study|Adverse Event|15|||
125398131|NCT01101841|451090907|FG000|Overall Study|Lost to Follow-up|9|||
125398132|NCT01101841|451090908|FG001|Overall Study|Lost to Follow-up|3|||
125398133|NCT01101841|451090907|FG000|Overall Study|Withdrawal by Subject|21|||
125398134|NCT01101841|451090908|FG001|Overall Study|Withdrawal by Subject|40|||
125398135|NCT01101841|451090907|FG000|Overall Study|Protocol Violation|1|||
125398136|NCT01101841|451090908|FG001|Overall Study|Protocol Violation|1|||
125398137|NCT01101841|451090907|FG000|Overall Study|Physician Decision|0|||
125398138|NCT01101841|451090908|FG001|Overall Study|Physician Decision|2|||
125398139|NCT01101841|451090907|FG000|Overall Study|Lack of Efficacy|0|||
125398140|NCT01101841|451090908|FG001|Overall Study|Lack of Efficacy|2|||
125398141|NCT01101841|451090907|FG000|Overall Study|Other|0|||
125398142|NCT01101841|451090908|FG001|Overall Study|Other|1|||
125398143|NCT01101841|451090907|FG000|Overall Study|Suicidality Tracking Scale|3|||
125398144|NCT01101841|451090908|FG001|Overall Study|Suicidality Tracking Scale|1|||
125398145|NCT01101841|451090907|FG000|Overall Study|Eligibility Criteria|1|||
125398146|NCT01101841|451090908|FG001|Overall Study|Eligibility Criteria|2|||
125398147|NCT00653224|451090911|FG000|Overall Study|Adverse Event|2|||
125398148|NCT00653224|451090912|FG001|Overall Study|Adverse Event|1|||
125398149|NCT00653224|451090911|FG000|Overall Study|Lack of Efficacy|1|||
125261346|NCT02921256|450587155|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
125398150|NCT00653224|451090912|FG001|Overall Study|Lack of Efficacy|2|||
125398151|NCT00653224|451090911|FG000|Overall Study|Loss of efficacy|1|||
125398152|NCT00653224|451090912|FG001|Overall Study|Loss of efficacy|0|||
125398153|NCT00653224|451090911|FG000|Overall Study|Lost to Follow-up|1|||
125398154|NCT00653224|451090912|FG001|Overall Study|Lost to Follow-up|0|||
125398155|NCT00653224|451090911|FG000|Overall Study|Other|2|||
125398156|NCT00653224|451090912|FG001|Overall Study|Other|4|||
125398157|NCT03633396|451090915|FG000|Overall Study|Withdrawal by Subject|4|||
125261347|NCT02921256|450587156|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
125261348|NCT02921256|450587157|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
125261349|NCT02921256|450587155|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
125261350|NCT02921256|450587156|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
125261351|NCT02921256|450587157|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
125261352|NCT02921256|450587155|FG000|Arm 1a v. Arm II|Physician Decision|1|||
125261353|NCT02921256|450587156|FG001|Arm 1a v. Arm II|Physician Decision|1|||
125261354|NCT02921256|450587157|FG002|Arm 1a v. Arm II|Physician Decision|0|||
125261355|NCT02921256|450587155|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
125261356|NCT02921256|450587156|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
125261357|NCT02921256|450587157|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
125261358|NCT02921256|450587155|FG000|Arm Ib v Arm III|Adverse Event|9|||
125261359|NCT02921256|450587156|FG001|Arm Ib v Arm III|Adverse Event|0|||
125261360|NCT02921256|450587157|FG002|Arm Ib v Arm III|Adverse Event|4|||
125261361|NCT02921256|450587155|FG000|Arm Ib v Arm III|Death|1|||
125261362|NCT02921256|450587156|FG001|Arm Ib v Arm III|Death|0|||
125261363|NCT02921256|450587157|FG002|Arm Ib v Arm III|Death|1|||
125261364|NCT02921256|450587155|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
125261365|NCT02921256|450587156|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
125261366|NCT02921256|450587157|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
125261367|NCT02921256|450587155|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
125261368|NCT02921256|450587156|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
125261369|NCT02921256|450587157|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
125261370|NCT02921256|450587155|FG000|Arm Ib v Arm III|Physician Decision|4|||
125261371|NCT02921256|450587156|FG001|Arm Ib v Arm III|Physician Decision|0|||
125261372|NCT02921256|450587157|FG002|Arm Ib v Arm III|Physician Decision|1|||
125261373|NCT02921256|450587155|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
125261374|NCT02921256|450587156|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
125398158|NCT03633396|451090916|FG001|Overall Study|Withdrawal by Subject|4|||
125398159|NCT03633396|451090915|FG000|Overall Study|Adverse Event|1|||
125398160|NCT03633396|451090916|FG001|Overall Study|Adverse Event|1|||
125398161|NCT03633396|451090915|FG000|Overall Study|Lack of Efficacy|1|||
125398162|NCT03633396|451090916|FG001|Overall Study|Lack of Efficacy|0|||
125398163|NCT03633396|451090915|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
125398164|NCT03633396|451090916|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
125398165|NCT01012817|451090917|FG000|Overall Study|Withdrawal by Subject|0|||
125398166|NCT01012817|451090918|FG001|Overall Study|Withdrawal by Subject|0|||
125398167|NCT01012817|451090919|FG002|Overall Study|Withdrawal by Subject|0|||
125398168|NCT01012817|451090920|FG003|Overall Study|Withdrawal by Subject|1|||
125398169|NCT01012817|451090921|FG004|Overall Study|Withdrawal by Subject|0|||
125398170|NCT01012817|451090922|FG005|Overall Study|Withdrawal by Subject|0|||
125398171|NCT01012817|451090923|FG006|Overall Study|Withdrawal by Subject|0|||
125398172|NCT01012817|451090924|FG007|Overall Study|Withdrawal by Subject|1|||
125398173|NCT01012817|451090925|FG008|Overall Study|Withdrawal by Subject|0|||
125398174|NCT01012817|451090926|FG009|Overall Study|Withdrawal by Subject|0|||
125398175|NCT01012817|451090927|FG010|Overall Study|Withdrawal by Subject|1|||
125398176|NCT01012817|451090928|FG011|Overall Study|Withdrawal by Subject|1|||
125398177|NCT01012817|451090929|FG012|Overall Study|Withdrawal by Subject|0|||
125398178|NCT01012817|451090930|FG013|Overall Study|Withdrawal by Subject|1|||
125398179|NCT01012817|451090917|FG000|Overall Study|Adverse Event|0|||
125398180|NCT01012817|451090918|FG001|Overall Study|Adverse Event|0|||
125398181|NCT01012817|451090919|FG002|Overall Study|Adverse Event|0|||
125398182|NCT01012817|451090920|FG003|Overall Study|Adverse Event|0|||
125398183|NCT01012817|451090921|FG004|Overall Study|Adverse Event|0|||
125398184|NCT01012817|451090922|FG005|Overall Study|Adverse Event|1|||
125398185|NCT01012817|451090923|FG006|Overall Study|Adverse Event|0|||
125398186|NCT01012817|451090924|FG007|Overall Study|Adverse Event|0|||
125398187|NCT01012817|451090925|FG008|Overall Study|Adverse Event|0|||
125398188|NCT01012817|451090926|FG009|Overall Study|Adverse Event|0|||
125398189|NCT01012817|451090927|FG010|Overall Study|Adverse Event|1|||
125398190|NCT01012817|451090928|FG011|Overall Study|Adverse Event|0|||
125398191|NCT01012817|451090929|FG012|Overall Study|Adverse Event|0|||
125398192|NCT01012817|451090930|FG013|Overall Study|Adverse Event|1|||
125398193|NCT04482179|451090935|FG000|Overall Study|Death|1|||
125398194|NCT04482179|451090936|FG001|Overall Study|Death|0|||
125398195|NCT04482179|451090935|FG000|Overall Study|Withdrawal by Subject|1|||
125398196|NCT04482179|451090936|FG001|Overall Study|Withdrawal by Subject|0|||
125398197|NCT04709237|451090937|FG000|Overall Study|Lost to Follow-up|1|||
125398198|NCT04709237|451090938|FG001|Overall Study|Lost to Follow-up|0|||
125398199|NCT04709237|451090939|FG002|Overall Study|Lost to Follow-up|0|||
125398200|NCT02489318|451090941|FG000|Randomized|Withdrawal by Subject|0|||
125261375|NCT02921256|450587157|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
125261376|NCT02943473|450587158|FG000|Overall Study|enrolled but not dosed|1|||
125261377|NCT02943473|450587158|FG000|Overall Study|screen failure|1|||
125261378|NCT02943473|450587158|FG000|Overall Study|Physician Decision|4|||
125261379|NCT04211363|450587159|FG000|Overall Study|Adverse Event|5|||
125398201|NCT02489318|451090942|FG001|Randomized|Withdrawal by Subject|1|||
125446127|NCT02459587|451259393|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
125261380|NCT04211363|450587160|FG001|Overall Study|Adverse Event|2|||
125261381|NCT04211363|450587159|FG000|Overall Study|Physician Decision|0|||
125261382|NCT04211363|450587160|FG001|Overall Study|Physician Decision|1|||
125261383|NCT04211363|450587159|FG000|Overall Study|Protocol Violation|1|||
125261384|NCT04211363|450587160|FG001|Overall Study|Protocol Violation|0|||
125261385|NCT04211363|450587159|FG000|Overall Study|Pregnancy|1|||
125261386|NCT04211363|450587160|FG001|Overall Study|Pregnancy|0|||
125261387|NCT04211363|450587159|FG000|Overall Study|Lost to Follow-up|12|||
125261388|NCT04211363|450587160|FG001|Overall Study|Lost to Follow-up|4|||
125261389|NCT04211363|450587159|FG000|Overall Study|Withdrawal by Subject|11|||
125261390|NCT04211363|450587160|FG001|Overall Study|Withdrawal by Subject|11|||
125261391|NCT04211363|450587159|FG000|Overall Study|Other|1|||
125261392|NCT04211363|450587160|FG001|Overall Study|Other|2|||
125261393|NCT03097289|450587161|FG000|Overall Study|Adverse Event|1|||
125261394|NCT03097289|450587161|FG000|Overall Study|Equipment failure|2|||
125261395|NCT03097289|450587161|FG000|Overall Study|Collected platelet product unusable|3|||
125261396|NCT01736917|450587162|FG000|Overall Study|Adverse Event|1|||
125261397|NCT01736917|450587162|FG000|Overall Study|Protocol Violation|10|||
125261398|NCT01911260|450587163|FG000|Supplementation Period|transference or evasion of school|7|||
125261399|NCT01911260|450587164|FG001|Supplementation Period|transference or evasion of school|9|||
125261400|NCT01911260|450587165|FG002|Supplementation Period|transference or evasion of school|7|||
125261401|NCT01911260|450587166|FG003|Supplementation Period|transference or evasion of school|6|||
125261402|NCT01911260|450587163|FG000|Supplementation Period|Adverse Event|2|||
125261403|NCT01911260|450587164|FG001|Supplementation Period|Adverse Event|0|||
125261404|NCT01911260|450587165|FG002|Supplementation Period|Adverse Event|1|||
125261405|NCT01911260|450587166|FG003|Supplementation Period|Adverse Event|0|||
125398202|NCT02489318|451090941|FG000|Treated|Adverse Event|19|||
125398203|NCT02489318|451090942|FG001|Treated|Adverse Event|62|||
125398204|NCT02489318|451090941|FG000|Treated|Death|13|||
125398205|NCT02489318|451090942|FG001|Treated|Death|11|||
125398206|NCT02489318|451090941|FG000|Treated|Physician Decision|4|||
125398207|NCT02489318|451090942|FG001|Treated|Physician Decision|6|||
125398208|NCT02489318|451090941|FG000|Treated|Protocol Violation|1|||
125398209|NCT02489318|451090942|FG001|Treated|Protocol Violation|2|||
125398210|NCT02489318|451090941|FG000|Treated|Withdrawal by Subject|37|||
125398211|NCT02489318|451090942|FG001|Treated|Withdrawal by Subject|36|||
125398212|NCT02489318|451090941|FG000|Treated|Other: Progressive Disease|245|||
125398213|NCT02489318|451090942|FG001|Treated|Other: Progressive Disease|138|||
125398214|NCT02489318|451090941|FG000|Treated|Other|0|||
125398215|NCT02489318|451090942|FG001|Treated|Other|2|||
125398216|NCT02489318|451090941|FG000|Treated|Ongoing|0|||
125398217|NCT02489318|451090942|FG001|Treated|Ongoing|267|||
125398218|NCT05723770|451090943|FG000|Overall Study|Lost to Follow-up|4|||
125398219|NCT05723770|451090943|FG000|Overall Study|Withdrawal by Subject|2|||
125398220|NCT01171898|451090944|FG000|Overall Study|Death|0|||
125398221|NCT01171898|451090945|FG001|Overall Study|Death|0|||
125398222|NCT01171898|451090946|FG002|Overall Study|Death|2|||
125398223|NCT01171898|451090947|FG003|Overall Study|Death|0|||
125398224|NCT01171898|451090944|FG000|Overall Study|Lost to Follow-up|0|||
125398225|NCT01171898|451090945|FG001|Overall Study|Lost to Follow-up|1|||
125398226|NCT01171898|451090946|FG002|Overall Study|Lost to Follow-up|1|||
125398227|NCT01171898|451090947|FG003|Overall Study|Lost to Follow-up|1|||
125398228|NCT01171898|451090944|FG000|Overall Study|Withdrawal by Subject|1|||
125398229|NCT01171898|451090945|FG001|Overall Study|Withdrawal by Subject|4|||
125398230|NCT01171898|451090946|FG002|Overall Study|Withdrawal by Subject|6|||
125398231|NCT01171898|451090947|FG003|Overall Study|Withdrawal by Subject|3|||
125398232|NCT01171898|451090944|FG000|Overall Study|Terminated by Sponsor|1|||
125398233|NCT01171898|451090945|FG001|Overall Study|Terminated by Sponsor|0|||
125398234|NCT01171898|451090946|FG002|Overall Study|Terminated by Sponsor|0|||
125398235|NCT01171898|451090947|FG003|Overall Study|Terminated by Sponsor|0|||
125398236|NCT01171898|451090944|FG000|Overall Study|Ongoing|1|||
125398237|NCT01171898|451090945|FG001|Overall Study|Ongoing|9|||
125398238|NCT01171898|451090946|FG002|Overall Study|Ongoing|3|||
125398239|NCT01171898|451090947|FG003|Overall Study|Ongoing|0|||
125398240|NCT01171898|451090944|FG000|Overall Study|Other|1|||
125398241|NCT01171898|451090945|FG001|Overall Study|Other|5|||
125398242|NCT01171898|451090946|FG002|Overall Study|Other|0|||
125398243|NCT01171898|451090947|FG003|Overall Study|Other|2|||
125398244|NCT00419562|451090948|FG000|Overall Study|Lost to Follow-up|12|||
125398245|NCT00419562|451090949|FG001|Overall Study|Lost to Follow-up|13|||
125398246|NCT00419562|451090948|FG000|Overall Study|Withdrawal by Subject|20|||
125398247|NCT00419562|451090949|FG001|Overall Study|Withdrawal by Subject|18|||
125398248|NCT00419562|451090948|FG000|Overall Study|Participant Institutionalized|1|||
125398249|NCT00419562|451090949|FG001|Overall Study|Participant Institutionalized|0|||
125398250|NCT00770120|451090958|FG000|Overall Study|Progression|31|||
125398251|NCT00770120|451090958|FG000|Overall Study|Adverse Event|11|||
125398252|NCT00770120|451090958|FG000|Overall Study|Not Protocol Specified|11|||
125398253|NCT00770120|451090958|FG000|Overall Study|Death|3|||
125398254|NCT00770120|451090958|FG000|Overall Study|Withdrawal by Subject|2|||
125261406|NCT01911260|450587163|FG000|Supplementation Period|refused to receive supplement|1|||
125261407|NCT01911260|450587164|FG001|Supplementation Period|refused to receive supplement|0|||
125261408|NCT01911260|450587165|FG002|Supplementation Period|refused to receive supplement|1|||
125261409|NCT01911260|450587166|FG003|Supplementation Period|refused to receive supplement|0|||
125261410|NCT01911260|450587163|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
125261411|NCT01911260|450587164|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
125261412|NCT01911260|450587165|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
125261413|NCT01911260|450587166|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
125261414|NCT01911260|450587163|FG000|Follow-up Period|transference or evasion of school|13|||
125261415|NCT01911260|450587164|FG001|Follow-up Period|transference or evasion of school|20|||
125261416|NCT01911260|450587165|FG002|Follow-up Period|transference or evasion of school|15|||
125261417|NCT01911260|450587166|FG003|Follow-up Period|transference or evasion of school|12|||
125261418|NCT01734902|450587171|FG000|Overall Study|Other than listed|0|||
125261419|NCT01734902|450587172|FG001|Overall Study|Other than listed|2|||
125261420|NCT01959932|450587173|FG000|Overall Study|Withdrawal by Subject|1|||
125261421|NCT01959932|450587174|FG001|Overall Study|Withdrawal by Subject|0|||
125261422|NCT01959932|450587175|FG002|Overall Study|Withdrawal by Subject|0|||
125261423|NCT00060944|450587178|FG000|Overall Study|Adverse Event|12|||
125261424|NCT00060944|450587179|FG001|Overall Study|Adverse Event|10|||
125261425|NCT00060944|450587178|FG000|Overall Study|Death|2|||
125261426|NCT00060944|450587179|FG001|Overall Study|Death|3|||
125261427|NCT00060944|450587178|FG000|Overall Study|Withdrawal by Subject|18|||
125261428|NCT00060944|450587179|FG001|Overall Study|Withdrawal by Subject|5|||
125261429|NCT00060944|450587178|FG000|Overall Study|Disease Progression|93|||
125261430|NCT00060944|450587179|FG001|Overall Study|Disease Progression|94|||
125261431|NCT00060944|450587178|FG000|Overall Study|Lost to Follow-up|1|||
125261432|NCT00060944|450587179|FG001|Overall Study|Lost to Follow-up|0|||
125261433|NCT00060944|450587178|FG000|Overall Study|Subject Ineligible To Continue|2|||
125261434|NCT00060944|450587179|FG001|Overall Study|Subject Ineligible To Continue|1|||
125261435|NCT00060944|450587178|FG000|Overall Study|Treatment Switch|0|||
125261436|NCT00060944|450587179|FG001|Overall Study|Treatment Switch|13|||
125261437|NCT00060944|450587178|FG000|Overall Study|Other|2|||
125261438|NCT00060944|450587179|FG001|Overall Study|Other|4|||
125261439|NCT00060944|450587178|FG000|Overall Study|randomized but not treated|6|||
125261440|NCT00060944|450587179|FG001|Overall Study|randomized but not treated|4|||
125261441|NCT00776230|450587183|FG000|Overall Study|Lost to Follow-up|2|||
125261442|NCT00776230|450587184|FG001|Overall Study|Lost to Follow-up|1|||
125261443|NCT00776230|450587185|FG002|Overall Study|Lost to Follow-up|5|||
125261444|NCT00776230|450587183|FG000|Overall Study|Not vaccinated at Day 0|1|||
125261445|NCT00776230|450587184|FG001|Overall Study|Not vaccinated at Day 0|0|||
125261446|NCT00776230|450587185|FG002|Overall Study|Not vaccinated at Day 0|0|||
125261447|NCT00776230|450587183|FG000|Overall Study|Withdrawal by Subject|0|||
125261448|NCT00776230|450587184|FG001|Overall Study|Withdrawal by Subject|1|||
125261449|NCT00776230|450587185|FG002|Overall Study|Withdrawal by Subject|0|||
125261450|NCT00776230|450587183|FG000|Overall Study|Subject missed Visit 4|0|||
125261451|NCT00776230|450587184|FG001|Overall Study|Subject missed Visit 4|1|||
125261452|NCT00776230|450587185|FG002|Overall Study|Subject missed Visit 4|0|||
125261453|NCT01242514|450587187|FG000|Overall Study|e.g., project closure|1042|||
125261454|NCT01242514|450587188|FG001|Overall Study|e.g., project closure|305|||
125261455|NCT01242514|450587189|FG002|Overall Study|e.g., project closure|171|||
125261456|NCT01242514|450587187|FG000|Overall Study|Subject decision|33|||
125261457|NCT01242514|450587188|FG001|Overall Study|Subject decision|8|||
125261458|NCT01242514|450587189|FG002|Overall Study|Subject decision|2|||
125261459|NCT01242514|450587187|FG000|Overall Study|Severe non-compliance to protocol|5|||
125261460|NCT01242514|450587188|FG001|Overall Study|Severe non-compliance to protocol|2|||
125261461|NCT01242514|450587189|FG002|Overall Study|Severe non-compliance to protocol|1|||
125261462|NCT01242514|450587187|FG000|Overall Study|Lack of therapeutic response|99|||
125261463|NCT01242514|450587188|FG001|Overall Study|Lack of therapeutic response|16|||
125261464|NCT01242514|450587189|FG002|Overall Study|Lack of therapeutic response|10|||
125261465|NCT01242514|450587187|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
125261466|NCT01242514|450587188|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
125261467|NCT01242514|450587189|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
125261468|NCT01242514|450587187|FG000|Overall Study|Lost to Follow-up|14|||
125261469|NCT01242514|450587188|FG001|Overall Study|Lost to Follow-up|5|||
125261470|NCT01242514|450587189|FG002|Overall Study|Lost to Follow-up|4|||
125398255|NCT00770120|451090958|FG000|Overall Study|Ineligible|1|||
125261471|NCT01242514|450587187|FG000|Overall Study|Adverse Event|129|||
125261472|NCT01242514|450587188|FG001|Overall Study|Adverse Event|18|||
125261473|NCT01242514|450587189|FG002|Overall Study|Adverse Event|19|||
125261474|NCT03110562|450587205|FG000|Initial Treatment Period|Disease Progression|1|||
125261475|NCT03110562|450587206|FG001|Initial Treatment Period|Disease Progression|1|||
125261476|NCT03110562|450587207|FG002|Initial Treatment Period|Disease Progression|0|||
125261477|NCT03110562|450587208|FG003|Initial Treatment Period|Disease Progression|0|||
125261478|NCT03110562|450587205|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
125261479|NCT03110562|450587206|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
125261480|NCT03110562|450587207|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
125261481|NCT03110562|450587208|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
125261482|NCT03110562|450587205|FG000|Initial Treatment Period|Adverse Event|1|||
125261483|NCT03110562|450587206|FG001|Initial Treatment Period|Adverse Event|0|||
125261484|NCT03110562|450587207|FG002|Initial Treatment Period|Adverse Event|0|||
125261485|NCT03110562|450587208|FG003|Initial Treatment Period|Adverse Event|0|||
125261486|NCT03110562|450587205|FG000|Initial Treatment Period|Death|74|||
125261487|NCT03110562|450587206|FG001|Initial Treatment Period|Death|82|||
125261488|NCT03110562|450587207|FG002|Initial Treatment Period|Death|0|||
125261489|NCT03110562|450587208|FG003|Initial Treatment Period|Death|0|||
125261490|NCT03110562|450587205|FG000|Initial Treatment Period|Lost to Follow-up|13|||
125261491|NCT03110562|450587206|FG001|Initial Treatment Period|Lost to Follow-up|8|||
125261492|NCT03110562|450587207|FG002|Initial Treatment Period|Lost to Follow-up|0|||
125261493|NCT03110562|450587208|FG003|Initial Treatment Period|Lost to Follow-up|0|||
125261494|NCT03110562|450587205|FG000|Initial Treatment Period|Protocol Deviation|1|||
125261495|NCT03110562|450587206|FG001|Initial Treatment Period|Protocol Deviation|0|||
125261496|NCT03110562|450587207|FG002|Initial Treatment Period|Protocol Deviation|0|||
125261497|NCT03110562|450587208|FG003|Initial Treatment Period|Protocol Deviation|0|||
125261498|NCT03110562|450587205|FG000|Initial Treatment Period|Physician Decision|2|||
125261499|NCT03110562|450587206|FG001|Initial Treatment Period|Physician Decision|1|||
125261500|NCT03110562|450587207|FG002|Initial Treatment Period|Physician Decision|0|||
125261501|NCT03110562|450587208|FG003|Initial Treatment Period|Physician Decision|0|||
125261502|NCT03110562|450587205|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
125261503|NCT03110562|450587206|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
125261504|NCT03110562|450587207|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
125261505|NCT03110562|450587208|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
125261506|NCT03110562|450587205|FG000|Initial Treatment Period|Other|5|||
125261507|NCT03110562|450587206|FG001|Initial Treatment Period|Other|4|||
125261508|NCT03110562|450587207|FG002|Initial Treatment Period|Other|0|||
125261509|NCT03110562|450587208|FG003|Initial Treatment Period|Other|0|||
125261510|NCT03110562|450587205|FG000|Initial Treatment Period|Randomized but never treated|0|||
125261511|NCT03110562|450587206|FG001|Initial Treatment Period|Randomized but never treated|3|||
125261512|NCT03110562|450587207|FG002|Initial Treatment Period|Randomized but never treated|0|||
125261513|NCT03110562|450587208|FG003|Initial Treatment Period|Randomized but never treated|0|||
125261514|NCT03110562|450587205|FG000|Crossover Period|Disease Progression|0|||
125261515|NCT03110562|450587206|FG001|Crossover Period|Disease Progression|0|||
125261516|NCT03110562|450587207|FG002|Crossover Period|Disease Progression|1|||
125261517|NCT03110562|450587208|FG003|Crossover Period|Disease Progression|0|||
125261518|NCT03110562|450587205|FG000|Crossover Period|Withdrawal by Subject|0|||
125261519|NCT03110562|450587206|FG001|Crossover Period|Withdrawal by Subject|0|||
125261520|NCT03110562|450587207|FG002|Crossover Period|Withdrawal by Subject|8|||
125261521|NCT03110562|450587208|FG003|Crossover Period|Withdrawal by Subject|6|||
125261522|NCT03110562|450587205|FG000|Crossover Period|Death|0|||
125261523|NCT03110562|450587206|FG001|Crossover Period|Death|0|||
125261524|NCT03110562|450587207|FG002|Crossover Period|Death|37|||
125261525|NCT03110562|450587208|FG003|Crossover Period|Death|3|||
125261526|NCT03110562|450587205|FG000|Crossover Period|Lost to Follow-up|0|||
125261527|NCT03110562|450587206|FG001|Crossover Period|Lost to Follow-up|0|||
125261528|NCT03110562|450587207|FG002|Crossover Period|Lost to Follow-up|0|||
125261529|NCT03110562|450587208|FG003|Crossover Period|Lost to Follow-up|1|||
125261530|NCT03110562|450587205|FG000|Crossover Period|Other|0|||
125261531|NCT03110562|450587206|FG001|Crossover Period|Other|0|||
125261532|NCT03110562|450587207|FG002|Crossover Period|Other|1|||
125261533|NCT03110562|450587208|FG003|Crossover Period|Other|1|||
125261534|NCT03110562|450587205|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
125261535|NCT03110562|450587206|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
125261536|NCT03110562|450587207|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
125261537|NCT03110562|450587208|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
125398256|NCT00770120|451090958|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
125398257|NCT00770120|451090958|FG000|Overall Study|Reason under Review|1|||
125261538|NCT02936323|450587209|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
125398258|NCT00480636|451090959|FG000|Overall Study|Death|12|||
125398259|NCT00480636|451090959|FG000|Overall Study|Lost to Follow-up|4|||
125261539|NCT02936323|450587210|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
125261540|NCT02936323|450587211|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
125261541|NCT02936323|450587212|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
125261542|NCT02936323|450587213|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
125261543|NCT02936323|450587214|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
125261544|NCT02936323|450587215|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
125261545|NCT02936323|450587216|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
125261546|NCT02936323|450587217|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
125261547|NCT02936323|450587218|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
125261548|NCT02936323|450587209|FG000|Phase 1 Dose Escalation|Death|2|||
125261549|NCT02936323|450587210|FG001|Phase 1 Dose Escalation|Death|1|||
125261550|NCT02936323|450587211|FG002|Phase 1 Dose Escalation|Death|3|||
125261551|NCT02936323|450587212|FG003|Phase 1 Dose Escalation|Death|1|||
125261552|NCT02936323|450587213|FG004|Phase 1 Dose Escalation|Death|2|||
125261553|NCT02936323|450587214|FG005|Phase 1 Dose Escalation|Death|3|||
125261554|NCT02936323|450587215|FG006|Phase 1 Dose Escalation|Death|3|||
125261555|NCT02936323|450587216|FG007|Phase 1 Dose Escalation|Death|0|||
125261556|NCT02936323|450587217|FG008|Phase 1 Dose Escalation|Death|0|||
125261557|NCT02936323|450587218|FG009|Phase 1 Dose Escalation|Death|0|||
125261558|NCT02936323|450587209|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261559|NCT02936323|450587210|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261560|NCT02936323|450587211|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261561|NCT02936323|450587212|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261562|NCT02936323|450587213|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261563|NCT02936323|450587214|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
125261564|NCT02936323|450587215|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261565|NCT02936323|450587216|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261566|NCT02936323|450587217|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261567|NCT02936323|450587218|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
125261568|NCT02936323|450587209|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261569|NCT02936323|450587210|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261570|NCT02936323|450587211|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261571|NCT02936323|450587212|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261572|NCT02936323|450587213|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261573|NCT02936323|450587214|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261574|NCT02936323|450587215|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
125261575|NCT02936323|450587216|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
125261576|NCT02936323|450587217|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
125261577|NCT02936323|450587218|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
125261578|NCT02936323|450587209|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
125261579|NCT02936323|450587210|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
125261580|NCT02936323|450587211|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
125261581|NCT02936323|450587212|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
125261582|NCT02936323|450587213|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
125261583|NCT02936323|450587214|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
125261584|NCT02936323|450587215|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
125261585|NCT02936323|450587216|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
125261586|NCT02936323|450587217|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
125261587|NCT02936323|450587218|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
125261588|NCT02936323|450587209|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261589|NCT02936323|450587210|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261590|NCT02936323|450587211|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261591|NCT02936323|450587212|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261592|NCT02936323|450587213|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261593|NCT02936323|450587214|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261594|NCT02936323|450587215|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261595|NCT02936323|450587216|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
125261596|NCT02936323|450587217|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
125261597|NCT02936323|450587218|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
125261598|NCT02936323|450587209|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261599|NCT02936323|450587210|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261600|NCT02936323|450587211|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261601|NCT02936323|450587212|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261602|NCT02936323|450587213|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261603|NCT02936323|450587214|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261604|NCT02936323|450587215|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261605|NCT02936323|450587216|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261606|NCT02936323|450587217|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
125261607|NCT02936323|450587218|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
125398260|NCT00480636|451090959|FG000|Overall Study|Other|2|||
125398261|NCT00480636|451090959|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
125398262|NCT02583256|451090960|FG000|Overall Study|Withdrawal by Subject|0|||
125398263|NCT02583256|451090961|FG001|Overall Study|Withdrawal by Subject|1|||
125261608|NCT02936323|450587209|FG000|Phase 2a Dose Expansion|Death|0|||
125261609|NCT02936323|450587210|FG001|Phase 2a Dose Expansion|Death|0|||
125261610|NCT02936323|450587211|FG002|Phase 2a Dose Expansion|Death|0|||
125261611|NCT02936323|450587212|FG003|Phase 2a Dose Expansion|Death|0|||
125261612|NCT02936323|450587213|FG004|Phase 2a Dose Expansion|Death|0|||
125398264|NCT02583256|451090962|FG002|Overall Study|Withdrawal by Subject|1|||
125261613|NCT02936323|450587214|FG005|Phase 2a Dose Expansion|Death|0|||
125261614|NCT02936323|450587215|FG006|Phase 2a Dose Expansion|Death|0|||
125261615|NCT02936323|450587216|FG007|Phase 2a Dose Expansion|Death|4|||
125261616|NCT02936323|450587217|FG008|Phase 2a Dose Expansion|Death|8|||
125261617|NCT02936323|450587218|FG009|Phase 2a Dose Expansion|Death|10|||
125261618|NCT05788991|450587219|FG000|Overall Study|Not treated with study medication|1|||
125261619|NCT05788991|450587220|FG001|Overall Study|Not treated with study medication|3|||
125261620|NCT05788991|450587219|FG000|Overall Study|Withdrawal by Subject|1|||
125261621|NCT05788991|450587220|FG001|Overall Study|Withdrawal by Subject|0|||
125261622|NCT05788991|450587219|FG000|Overall Study|Lack of Efficacy|0|||
125261623|NCT05788991|450587220|FG001|Overall Study|Lack of Efficacy|1|||
125261624|NCT05788991|450587219|FG000|Overall Study|Protocol Violation|1|||
125261625|NCT05788991|450587220|FG001|Overall Study|Protocol Violation|2|||
125261626|NCT05270863|450587221|FG000|Visit 2 First Intervention|Randomization error|0|||
125261627|NCT05270863|450587222|FG001|Visit 2 First Intervention|Randomization error|0|||
125261628|NCT05270863|450587223|FG002|Visit 2 First Intervention|Randomization error|0|||
125261629|NCT05270863|450587224|FG003|Visit 2 First Intervention|Randomization error|1|||
125261630|NCT05270863|450587225|FG004|Visit 2 First Intervention|Randomization error|0|||
125261631|NCT05270863|450587226|FG005|Visit 2 First Intervention|Randomization error|0|||
125261632|NCT05270863|450587221|FG000|First Washout|Withdrawal by Subject|0|||
125261633|NCT05270863|450587222|FG001|First Washout|Withdrawal by Subject|0|||
125261634|NCT05270863|450587223|FG002|First Washout|Withdrawal by Subject|0|||
125261635|NCT05270863|450587224|FG003|First Washout|Withdrawal by Subject|0|||
125261636|NCT05270863|450587225|FG004|First Washout|Withdrawal by Subject|1|||
125261637|NCT05270863|450587226|FG005|First Washout|Withdrawal by Subject|1|||
125261638|NCT05270863|450587221|FG000|First Washout|Lost to Follow-up|0|||
125261639|NCT05270863|450587222|FG001|First Washout|Lost to Follow-up|0|||
125261640|NCT05270863|450587223|FG002|First Washout|Lost to Follow-up|0|||
125261641|NCT05270863|450587224|FG003|First Washout|Lost to Follow-up|0|||
125261642|NCT05270863|450587225|FG004|First Washout|Lost to Follow-up|0|||
125261643|NCT05270863|450587226|FG005|First Washout|Lost to Follow-up|1|||
125261644|NCT05270863|450587221|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
125261645|NCT05270863|450587222|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
125261646|NCT05270863|450587223|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
125261647|NCT05270863|450587224|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
125261648|NCT05270863|450587225|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
125261649|NCT05270863|450587226|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
125261650|NCT05270863|450587221|FG000|Second Washout|Withdrawal by Subject|1|||
125261651|NCT05270863|450587222|FG001|Second Washout|Withdrawal by Subject|1|||
125261652|NCT05270863|450587223|FG002|Second Washout|Withdrawal by Subject|0|||
125261653|NCT05270863|450587224|FG003|Second Washout|Withdrawal by Subject|0|||
125261654|NCT05270863|450587225|FG004|Second Washout|Withdrawal by Subject|0|||
125261655|NCT05270863|450587226|FG005|Second Washout|Withdrawal by Subject|0|||
125261656|NCT05270863|450587221|FG000|Second Washout|Lost to Follow-up|0|||
125261657|NCT05270863|450587222|FG001|Second Washout|Lost to Follow-up|0|||
125261658|NCT05270863|450587223|FG002|Second Washout|Lost to Follow-up|0|||
125261659|NCT05270863|450587224|FG003|Second Washout|Lost to Follow-up|1|||
125261660|NCT05270863|450587225|FG004|Second Washout|Lost to Follow-up|0|||
125261661|NCT05270863|450587226|FG005|Second Washout|Lost to Follow-up|0|||
125261662|NCT04464473|450587227|FG000|Overall Study|New piercing could not be removed for scanning|0|||
125261663|NCT04464473|450587228|FG001|Overall Study|New piercing could not be removed for scanning|0|||
125261664|NCT04464473|450587229|FG002|Overall Study|New piercing could not be removed for scanning|0|||
125261665|NCT04464473|450587230|FG003|Overall Study|New piercing could not be removed for scanning|1|||
125261666|NCT04464473|450587231|FG004|Overall Study|New piercing could not be removed for scanning|0|||
125261667|NCT04464473|450587232|FG005|Overall Study|New piercing could not be removed for scanning|0|||
125261668|NCT04464473|450587227|FG000|Overall Study|Adverse Event|0|||
125261669|NCT04464473|450587228|FG001|Overall Study|Adverse Event|0|||
125261670|NCT04464473|450587229|FG002|Overall Study|Adverse Event|0|||
125261671|NCT04464473|450587230|FG003|Overall Study|Adverse Event|1|||
125261672|NCT04464473|450587231|FG004|Overall Study|Adverse Event|0|||
125261673|NCT04464473|450587232|FG005|Overall Study|Adverse Event|0|||
125261674|NCT04464473|450587227|FG000|Overall Study|Lost to Follow-up|0|||
125261675|NCT04464473|450587228|FG001|Overall Study|Lost to Follow-up|0|||
125261676|NCT04464473|450587229|FG002|Overall Study|Lost to Follow-up|0|||
125261677|NCT04464473|450587230|FG003|Overall Study|Lost to Follow-up|1|||
125261678|NCT04464473|450587231|FG004|Overall Study|Lost to Follow-up|0|||
125261679|NCT04464473|450587232|FG005|Overall Study|Lost to Follow-up|0|||
125261680|NCT01334918|450588392|FG000|Overall Study|Did not receive study drug|6|||
125261681|NCT01334918|450588393|FG001|Overall Study|Did not receive study drug|0|||
125261682|NCT01334918|450588392|FG000|Overall Study|Adverse Event|2|||
125261683|NCT01334918|450588393|FG001|Overall Study|Adverse Event|0|||
125261684|NCT01334918|450588392|FG000|Overall Study|Withdrawal by Subject|0|||
125261685|NCT01334918|450588393|FG001|Overall Study|Withdrawal by Subject|1|||
125261686|NCT00805389|450588394|FG000|Overall Study|Adverse Event|0|||
125261687|NCT00805389|450588395|FG001|Overall Study|Adverse Event|0|||
125261688|NCT00805389|450588396|FG002|Overall Study|Adverse Event|1|||
125446128|NCT02459587|451259392|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
125446129|NCT02459587|451259393|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
125446130|NCT02459587|451259392|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
125446131|NCT02459587|451259393|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
125446132|NCT02264574|451259394|FG000|Overall Study|Death|21|||
125446133|NCT02264574|451259395|FG001|Overall Study|Death|21|||
125446134|NCT02264574|451259394|FG000|Overall Study|Withdrawal by Subject|8|||
125446135|NCT02264574|451259395|FG001|Overall Study|Withdrawal by Subject|6|||
125446136|NCT02264574|451259394|FG000|Overall Study|Other, Not Specified|0|||
125446137|NCT02264574|451259395|FG001|Overall Study|Other, Not Specified|3|||
125446138|NCT01477749|451259397|FG000|Overall Study|Physician Decision|4|||
125446139|NCT02886728|451259401|FG000|Overall Study|Withdrew Consent|31|||
125446140|NCT02886728|451259402|FG001|Overall Study|Withdrew Consent|13|||
125446141|NCT02886728|451259403|FG002|Overall Study|Withdrew Consent|11|||
125446142|NCT02886728|451259404|FG003|Overall Study|Withdrew Consent|47|||
125446143|NCT02886728|451259401|FG000|Overall Study|Lost to Follow-up|12|||
125446144|NCT02886728|451259402|FG001|Overall Study|Lost to Follow-up|6|||
125261689|NCT00805389|450588397|FG003|Overall Study|Adverse Event|2|||
125261690|NCT00805389|450588398|FG004|Overall Study|Adverse Event|0|||
125261691|NCT00805389|450588394|FG000|Overall Study|Lost to Follow-up|4|||
125261692|NCT00805389|450588395|FG001|Overall Study|Lost to Follow-up|3|||
125261693|NCT00805389|450588396|FG002|Overall Study|Lost to Follow-up|6|||
125261694|NCT00805389|450588397|FG003|Overall Study|Lost to Follow-up|10|||
125261695|NCT00805389|450588398|FG004|Overall Study|Lost to Follow-up|9|||
125261696|NCT00805389|450588394|FG000|Overall Study|Protocol Violation|0|||
125261697|NCT00805389|450588395|FG001|Overall Study|Protocol Violation|0|||
125261698|NCT00805389|450588396|FG002|Overall Study|Protocol Violation|1|||
125261699|NCT00805389|450588397|FG003|Overall Study|Protocol Violation|0|||
125261700|NCT00805389|450588398|FG004|Overall Study|Protocol Violation|0|||
125261701|NCT00805389|450588394|FG000|Overall Study|Withdrawal by Subject|3|||
125261702|NCT00805389|450588395|FG001|Overall Study|Withdrawal by Subject|2|||
125261703|NCT00805389|450588396|FG002|Overall Study|Withdrawal by Subject|4|||
125261704|NCT00805389|450588397|FG003|Overall Study|Withdrawal by Subject|5|||
125261705|NCT00805389|450588398|FG004|Overall Study|Withdrawal by Subject|4|||
125261706|NCT02704208|450588401|FG000|Overall Study|Lost to Follow-up|42|||
125261707|NCT02704208|450588402|FG001|Overall Study|Lost to Follow-up|37|||
125261708|NCT02724839|450588405|FG000|Overall Study|Withdrawal by Subject|1|||
125261709|NCT02724839|450588406|FG001|Overall Study|Withdrawal by Subject|1|||
125261710|NCT02724839|450588407|FG002|Overall Study|Withdrawal by Subject|0|||
125261711|NCT02724839|450588405|FG000|Overall Study|Lost to Follow-up|0|||
125261712|NCT02724839|450588406|FG001|Overall Study|Lost to Follow-up|3|||
125261713|NCT02724839|450588407|FG002|Overall Study|Lost to Follow-up|2|||
125261714|NCT02724839|450588405|FG000|Overall Study|Physician Decision|0|||
125261715|NCT02724839|450588406|FG001|Overall Study|Physician Decision|0|||
125261716|NCT02724839|450588407|FG002|Overall Study|Physician Decision|3|||
125261717|NCT05878067|450588408|FG000|Overall Study|Lost to Follow-up|2|||
125261718|NCT00949533|450588409|FG000|Overall Study|Lost to Follow-up|0|||
125261719|NCT00949533|450588410|FG001|Overall Study|Lost to Follow-up|1|||
125261720|NCT00557193|450588411|FG000|Induction|Adverse Event|2|||
125261721|NCT00557193|450588412|FG001|Induction|Adverse Event|0|||
125261722|NCT00557193|450588413|FG002|Induction|Adverse Event|0|||
125261723|NCT00557193|450588414|FG003|Induction|Adverse Event|0|||
125261724|NCT00557193|450588415|FG004|Induction|Adverse Event|0|||
125261725|NCT00557193|450588416|FG005|Induction|Adverse Event|0|||
125261726|NCT00557193|450588411|FG000|Induction|Death|6|||
125261727|NCT00557193|450588412|FG001|Induction|Death|0|||
125261728|NCT00557193|450588413|FG002|Induction|Death|0|||
125261729|NCT00557193|450588414|FG003|Induction|Death|0|||
125261730|NCT00557193|450588415|FG004|Induction|Death|0|||
125261731|NCT00557193|450588416|FG005|Induction|Death|0|||
125261732|NCT00557193|450588411|FG000|Induction|Physician Decision|3|||
125261733|NCT00557193|450588412|FG001|Induction|Physician Decision|0|||
125446145|NCT02886728|451259403|FG002|Overall Study|Lost to Follow-up|13|||
125446146|NCT02886728|451259404|FG003|Overall Study|Lost to Follow-up|12|||
125446147|NCT02886728|451259401|FG000|Overall Study|Adverse Event|13|||
125261734|NCT00557193|450588413|FG002|Induction|Physician Decision|0|||
125261735|NCT00557193|450588414|FG003|Induction|Physician Decision|0|||
125261736|NCT00557193|450588415|FG004|Induction|Physician Decision|0|||
125261737|NCT00557193|450588416|FG005|Induction|Physician Decision|0|||
125261738|NCT00557193|450588411|FG000|Induction|Withdrawal by Subject|1|||
125261739|NCT00557193|450588412|FG001|Induction|Withdrawal by Subject|0|||
125261740|NCT00557193|450588413|FG002|Induction|Withdrawal by Subject|0|||
125261741|NCT00557193|450588414|FG003|Induction|Withdrawal by Subject|0|||
125261742|NCT00557193|450588415|FG004|Induction|Withdrawal by Subject|0|||
125261743|NCT00557193|450588416|FG005|Induction|Withdrawal by Subject|0|||
125261744|NCT00557193|450588411|FG000|Induction|Refusal of Further Protocol Therapy|2|||
125261745|NCT00557193|450588412|FG001|Induction|Refusal of Further Protocol Therapy|0|||
125261746|NCT00557193|450588413|FG002|Induction|Refusal of Further Protocol Therapy|0|||
125261747|NCT00557193|450588414|FG003|Induction|Refusal of Further Protocol Therapy|0|||
125261748|NCT00557193|450588415|FG004|Induction|Refusal of Further Protocol Therapy|0|||
125261749|NCT00557193|450588416|FG005|Induction|Refusal of Further Protocol Therapy|0|||
125261750|NCT00557193|450588411|FG000|Induction|Ineligible|8|||
125261751|NCT00557193|450588412|FG001|Induction|Ineligible|0|||
125261752|NCT00557193|450588413|FG002|Induction|Ineligible|0|||
125261753|NCT00557193|450588414|FG003|Induction|Ineligible|0|||
125261754|NCT00557193|450588415|FG004|Induction|Ineligible|0|||
125261755|NCT00557193|450588416|FG005|Induction|Ineligible|0|||
125261756|NCT00557193|450588411|FG000|Induction|Inevaluable for post Induction|2|||
125261757|NCT00557193|450588412|FG001|Induction|Inevaluable for post Induction|0|||
125261758|NCT00557193|450588413|FG002|Induction|Inevaluable for post Induction|0|||
125261759|NCT00557193|450588414|FG003|Induction|Inevaluable for post Induction|0|||
125261760|NCT00557193|450588415|FG004|Induction|Inevaluable for post Induction|0|||
125261761|NCT00557193|450588416|FG005|Induction|Inevaluable for post Induction|0|||
125261762|NCT00557193|450588411|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
125261763|NCT00557193|450588412|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
125261764|NCT00557193|450588413|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
125261765|NCT00557193|450588414|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
125261766|NCT00557193|450588415|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
125261767|NCT00557193|450588416|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
125261768|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
125261769|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
125261770|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
125261771|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
125261772|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
125261773|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
125261774|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
125261775|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
125261776|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
125261777|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
125261778|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
125261779|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
125261780|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
125261781|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
125261782|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
125261783|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
125261784|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
125261785|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
125261786|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
125261787|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
125261788|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
125261789|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
125261790|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
125261791|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
125398265|NCT02583256|451090963|FG003|Overall Study|Withdrawal by Subject|0|||
125398266|NCT02583256|451090960|FG000|Overall Study|Lost to Follow-up|1|||
125398267|NCT02583256|451090961|FG001|Overall Study|Lost to Follow-up|1|||
125398268|NCT02583256|451090962|FG002|Overall Study|Lost to Follow-up|0|||
125398269|NCT02583256|451090963|FG003|Overall Study|Lost to Follow-up|1|||
125398270|NCT02583256|451090960|FG000|Overall Study|Administrative/Other|2|||
125398271|NCT02583256|451090961|FG001|Overall Study|Administrative/Other|0|||
125398272|NCT02583256|451090962|FG002|Overall Study|Administrative/Other|1|||
125398273|NCT02583256|451090963|FG003|Overall Study|Administrative/Other|2|||
125398274|NCT04537806|451090966|FG000|Overall Study|Randomized but not treated|1|||
125398275|NCT04537806|451090967|FG001|Overall Study|Randomized but not treated|0|||
125398276|NCT04537806|451090966|FG000|Overall Study|Adverse Event|1|||
125398277|NCT04537806|451090967|FG001|Overall Study|Adverse Event|1|||
125398278|NCT05459129|451090968|FG000|Overall Study|Death|1|||
125398279|NCT05459129|451090969|FG001|Overall Study|Death|0|||
125398280|NCT05459129|451090968|FG000|Overall Study|Study Terminated By Sponsor|5|||
125398281|NCT05459129|451090969|FG001|Overall Study|Study Terminated By Sponsor|6|||
125398282|NCT04182100|451090970|FG000|Overall Study|Adverse Event|1|||
125398283|NCT04182100|451090970|FG000|Overall Study|Withdrawal by Subject|1|||
125261792|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
125261793|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
125261794|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
125261795|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
125261796|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
125261797|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
125261798|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
125398284|NCT04083976|451090972|FG000|Overall Study|Lost to Follow-up|3|||
125398285|NCT04083976|451090973|FG001|Overall Study|Lost to Follow-up|0|||
125261799|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
125261800|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
125261801|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
125261802|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
125261803|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
125261804|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
125261805|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
125261806|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
125261807|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
125261808|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
125261809|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
125261810|NCT00557193|450588411|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
125261811|NCT00557193|450588412|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
125261812|NCT00557193|450588413|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
125261813|NCT00557193|450588414|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
125261814|NCT00557193|450588415|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
125261815|NCT00557193|450588416|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
125261816|NCT00976456|450588417|FG000|Overall Study|Adverse Event|17|||
125261817|NCT00976456|450588418|FG001|Overall Study|Adverse Event|22|||
125261818|NCT00976456|450588417|FG000|Overall Study|Death|7|||
125261819|NCT00976456|450588418|FG001|Overall Study|Death|9|||
125261820|NCT00976456|450588417|FG000|Overall Study|Lack of Efficacy|5|||
125261821|NCT00976456|450588418|FG001|Overall Study|Lack of Efficacy|2|||
125261822|NCT00976456|450588417|FG000|Overall Study|Withdrawal by Subject|3|||
125261823|NCT00976456|450588418|FG001|Overall Study|Withdrawal by Subject|1|||
125261824|NCT00976456|450588417|FG000|Overall Study|screening failure, unknown|11|||
125261825|NCT00976456|450588418|FG001|Overall Study|screening failure, unknown|4|||
125261826|NCT02037529|450588419|FG000|Overall Study|Withdrawal by Subject|1|||
125261827|NCT02037529|450588420|FG001|Overall Study|Withdrawal by Subject|3|||
125261828|NCT02037529|450588419|FG000|Overall Study|Adverse Event|0|||
125261829|NCT02037529|450588420|FG001|Overall Study|Adverse Event|1|||
125261830|NCT02131766|450588421|FG000|Overall Study|Withdrawal by Subject|4|||
125261831|NCT00718315|450588422|FG000|Overall Study|Adverse Event|1|||
125261832|NCT00718315|450588423|FG001|Overall Study|Adverse Event|2|||
125261833|NCT00718315|450588424|FG002|Overall Study|Adverse Event|3|||
125261834|NCT00718315|450588422|FG000|Overall Study|Death|6|||
125261835|NCT00718315|450588423|FG001|Overall Study|Death|6|||
125261836|NCT00718315|450588424|FG002|Overall Study|Death|5|||
125261837|NCT00718315|450588422|FG000|Overall Study|Lost to Follow-up|2|||
125261838|NCT00718315|450588423|FG001|Overall Study|Lost to Follow-up|3|||
125261839|NCT00718315|450588424|FG002|Overall Study|Lost to Follow-up|4|||
125261840|NCT00718315|450588422|FG000|Overall Study|Protocol Violation|5|||
125261841|NCT00718315|450588423|FG001|Overall Study|Protocol Violation|5|||
125261842|NCT00718315|450588424|FG002|Overall Study|Protocol Violation|3|||
125261843|NCT00718315|450588422|FG000|Overall Study|Erlotinib dose decreased|4|||
125261844|NCT00718315|450588423|FG001|Overall Study|Erlotinib dose decreased|3|||
125261845|NCT00718315|450588424|FG002|Overall Study|Erlotinib dose decreased|1|||
125261846|NCT00718315|450588422|FG000|Overall Study|Use of Minocyclin|1|||
125261847|NCT00718315|450588423|FG001|Overall Study|Use of Minocyclin|1|||
125261848|NCT00718315|450588424|FG002|Overall Study|Use of Minocyclin|1|||
125261849|NCT00718315|450588422|FG000|Overall Study|Disease progression|0|||
125261850|NCT00718315|450588423|FG001|Overall Study|Disease progression|1|||
125261851|NCT00718315|450588424|FG002|Overall Study|Disease progression|1|||
125261852|NCT00718315|450588422|FG000|Overall Study|Other|0|||
125261853|NCT00718315|450588423|FG001|Overall Study|Other|0|||
125261854|NCT00718315|450588424|FG002|Overall Study|Other|1|||
125261855|NCT00718315|450588422|FG000|Overall Study|Use of ATB and Corticoids|0|||
125261856|NCT00718315|450588423|FG001|Overall Study|Use of ATB and Corticoids|1|||
125261857|NCT00718315|450588424|FG002|Overall Study|Use of ATB and Corticoids|2|||
125261858|NCT01170663|450588425|FG000|Overall Study|Lost to Follow-up|3|||
125261859|NCT01170663|450588426|FG001|Overall Study|Lost to Follow-up|9|||
125261860|NCT01170663|450588425|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
125261861|NCT01170663|450588426|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
125261862|NCT02746809|450588429|FG000|Enrollment|Inclusion Exclusion not met|9|||
125261863|NCT02746809|450588429|FG000|Enrollment|Withdrawal by Subject|1|||
125261864|NCT02746809|450588429|FG000|Enrollment|Expected Enrollment Met|2|||
125261865|NCT02746809|450588429|FG000|Procedure|Death|1|||
125261866|NCT02746809|450588429|FG000|1-Month|Death|5|||
125261867|NCT02746809|450588429|FG000|6-Month|Death|2|||
125261868|NCT02746809|450588429|FG000|6-Month|Withdrawal by Subject|1|||
125261869|NCT02746809|450588429|FG000|12-Month|Death|3|||
125261870|NCT02746809|450588429|FG000|12-Month|Withdrawal by Subject|2|||
125261871|NCT02746809|450588429|FG000|24-Month|Death|1|||
125261872|NCT02746809|450588429|FG000|24-Month|Withdrawal by Subject|1|||
125261873|NCT02746809|450588429|FG000|36-Month|Death|8|||
125261874|NCT02746809|450588429|FG000|36-Month|Withdrawal by Subject|1|||
125261875|NCT02746809|450588429|FG000|48-Month|Death|7|||
125261876|NCT02746809|450588429|FG000|48-Month|Withdrawal by Subject|1|||
125261877|NCT02746809|450588429|FG000|60-Month|Death|1|||
125261878|NCT02746809|450588429|FG000|60-Month|Lost to Follow-up|2|||
125261879|NCT00894387|450588432|FG000|Overall Study|Adverse Event|44|||
125261880|NCT00894387|450588433|FG001|Overall Study|Adverse Event|45|||
125261881|NCT00894387|450588432|FG000|Overall Study|Abnormal Laboratory values|2|||
125261882|NCT00894387|450588433|FG001|Overall Study|Abnormal Laboratory values|2|||
125261883|NCT00894387|450588432|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125261884|NCT00894387|450588433|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125261885|NCT00894387|450588432|FG000|Overall Study|Lost to Follow-up|3|||
125261886|NCT00894387|450588433|FG001|Overall Study|Lost to Follow-up|5|||
125261887|NCT00894387|450588432|FG000|Overall Study|Administrative problems|2|||
125261888|NCT00894387|450588433|FG001|Overall Study|Administrative problems|2|||
125261889|NCT00894387|450588432|FG000|Overall Study|Death|77|||
125261890|NCT00894387|450588433|FG001|Overall Study|Death|76|||
125261891|NCT00894387|450588432|FG000|Overall Study|Protocol Deviation|4|||
125261892|NCT00894387|450588433|FG001|Overall Study|Protocol Deviation|0|||
125261893|NCT00894387|450588432|FG000|Overall Study|Patient's request|25|||
125261894|NCT00894387|450588433|FG001|Overall Study|Patient's request|30|||
125261895|NCT00894387|450588432|FG000|Overall Study|Other (Missing)|5|||
125261896|NCT00894387|450588433|FG001|Overall Study|Other (Missing)|3|||
125261897|NCT00894387|450588432|FG000|Overall Study|Mis-randomized|13|||
125261898|NCT00894387|450588433|FG001|Overall Study|Mis-randomized|9|||
125261899|NCT00894387|450588432|FG000|Overall Study|GCP non-compliance|0|||
125261900|NCT00894387|450588433|FG001|Overall Study|GCP non-compliance|2|||
125261901|NCT01128569|450588434|FG000|Washout Period 1|Adverse Event|0|||
125261902|NCT01128569|450588435|FG001|Washout Period 1|Adverse Event|0|||
125261903|NCT01128569|450588436|FG002|Washout Period 1|Adverse Event|1|||
125261904|NCT01128569|450588437|FG003|Washout Period 1|Adverse Event|0|||
125261905|NCT01128569|450588438|FG004|Washout Period 1|Adverse Event|0|||
125261906|NCT01128569|450588439|FG005|Washout Period 1|Adverse Event|0|||
125261907|NCT01128569|450588434|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125261908|NCT01128569|450588435|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125261909|NCT01128569|450588436|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125261910|NCT01128569|450588437|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125261911|NCT01128569|450588438|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125261912|NCT01128569|450588439|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125261913|NCT02519842|450588440|FG000|Base Study: Cycle 1|Screening Failure|1|||
125261914|NCT02519842|450588441|FG001|Base Study: Cycle 1|Screening Failure|1|||
125261915|NCT02519842|450588442|FG002|Base Study: Cycle 1|Screening Failure|0|||
125261916|NCT02519842|450588440|FG000|Base Study: Cycle 1|Adverse Event|1|||
125261917|NCT02519842|450588441|FG001|Base Study: Cycle 1|Adverse Event|0|||
125261918|NCT02519842|450588442|FG002|Base Study: Cycle 1|Adverse Event|0|||
125261919|NCT02519842|450588440|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
125261920|NCT02519842|450588441|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
125261921|NCT02519842|450588442|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
125261922|NCT02519842|450588440|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
125261923|NCT02519842|450588441|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
125261924|NCT02519842|450588442|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
125261925|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
125398286|NCT04083976|451090974|FG002|Overall Study|Lost to Follow-up|0|||
125398287|NCT04083976|451090975|FG003|Overall Study|Lost to Follow-up|1|||
125398288|NCT04083976|451090972|FG000|Overall Study|Withdrawal by Subject|16|||
125398289|NCT04083976|451090973|FG001|Overall Study|Withdrawal by Subject|1|||
125398290|NCT04083976|451090974|FG002|Overall Study|Withdrawal by Subject|9|||
125398291|NCT04083976|451090975|FG003|Overall Study|Withdrawal by Subject|0|||
125398292|NCT04083976|451090972|FG000|Overall Study|Sponsor Decision|14|||
125398293|NCT04083976|451090973|FG001|Overall Study|Sponsor Decision|0|||
125398294|NCT04083976|451090974|FG002|Overall Study|Sponsor Decision|0|||
125261926|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
125261927|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
125261928|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
125261929|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
125261930|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
125261931|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125261932|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
125261933|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
125261934|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
125261935|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
125398295|NCT04083976|451090975|FG003|Overall Study|Sponsor Decision|7|||
125261936|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
125261937|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Death|0|||
125261938|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Death|0|||
125446148|NCT02886728|451259402|FG001|Overall Study|Adverse Event|5|||
125446149|NCT02886728|451259403|FG002|Overall Study|Adverse Event|5|||
125446150|NCT02886728|451259404|FG003|Overall Study|Adverse Event|11|||
125446151|NCT02886728|451259401|FG000|Overall Study|Investigator's Discretion|11|||
125446152|NCT02886728|451259402|FG001|Overall Study|Investigator's Discretion|7|||
125446153|NCT02886728|451259403|FG002|Overall Study|Investigator's Discretion|5|||
125446154|NCT02886728|451259404|FG003|Overall Study|Investigator's Discretion|11|||
125446155|NCT02886728|451259401|FG000|Overall Study|Death|3|||
125446156|NCT02886728|451259402|FG001|Overall Study|Death|1|||
125446157|NCT02886728|451259403|FG002|Overall Study|Death|0|||
125446158|NCT02886728|451259404|FG003|Overall Study|Death|0|||
125446159|NCT02886728|451259401|FG000|Overall Study|Protocol Violation|0|||
125446160|NCT02886728|451259402|FG001|Overall Study|Protocol Violation|0|||
125446161|NCT02886728|451259403|FG002|Overall Study|Protocol Violation|0|||
125446162|NCT02886728|451259404|FG003|Overall Study|Protocol Violation|4|||
125446163|NCT02886728|451259401|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125446164|NCT02886728|451259402|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125446165|NCT02886728|451259403|FG002|Overall Study|Non-Compliance with Study Drug|1|||
125446166|NCT02886728|451259404|FG003|Overall Study|Non-Compliance with Study Drug|0|||
125446167|NCT02886728|451259401|FG000|Overall Study|Pregnancy|0|||
125446168|NCT02886728|451259402|FG001|Overall Study|Pregnancy|0|||
125446169|NCT02886728|451259403|FG002|Overall Study|Pregnancy|1|||
125446170|NCT02886728|451259404|FG003|Overall Study|Pregnancy|0|||
125446171|NCT02886728|451259401|FG000|Overall Study|Randomized but Not Dosed|1|||
125446172|NCT02886728|451259402|FG001|Overall Study|Randomized but Not Dosed|0|||
125446173|NCT02886728|451259403|FG002|Overall Study|Randomized but Not Dosed|0|||
125446174|NCT02886728|451259404|FG003|Overall Study|Randomized but Not Dosed|2|||
125446175|NCT00884286|451259405|FG000|Overall Study|Progressive disease|21|||
125446176|NCT00884286|451259406|FG001|Overall Study|Progressive disease|28|||
125446177|NCT00884286|451259405|FG000|Overall Study|Toxicity|4|||
125446178|NCT00884286|451259406|FG001|Overall Study|Toxicity|1|||
125446179|NCT00884286|451259405|FG000|Overall Study|Death|2|||
125446180|NCT00884286|451259406|FG001|Overall Study|Death|2|||
125446181|NCT00884286|451259405|FG000|Overall Study|Physician Decision|1|||
125446182|NCT00884286|451259406|FG001|Overall Study|Physician Decision|0|||
125446183|NCT00884286|451259405|FG000|Overall Study|Septic shock|1|||
125446184|NCT00884286|451259406|FG001|Overall Study|Septic shock|0|||
125446185|NCT00884286|451259405|FG000|Overall Study|Thrombus in right auricle|1|||
125446186|NCT00884286|451259406|FG001|Overall Study|Thrombus in right auricle|0|||
125446187|NCT00884286|451259405|FG000|Overall Study|Not treated|2|||
125446188|NCT00884286|451259406|FG001|Overall Study|Not treated|1|||
125446189|NCT00884286|451259405|FG000|Overall Study|Comprised lung carcinoma|0|||
125446190|NCT00884286|451259406|FG001|Overall Study|Comprised lung carcinoma|1|||
125446191|NCT02724020|451259412|FG000|Overall Study|Death|16|||
125446192|NCT02724020|451259413|FG001|Overall Study|Death|18|||
125446193|NCT02724020|451259414|FG002|Overall Study|Death|19|||
125446194|NCT02724020|451259412|FG000|Overall Study|Lost to Follow-up|0|||
125446195|NCT02724020|451259413|FG001|Overall Study|Lost to Follow-up|3|||
125446196|NCT02724020|451259414|FG002|Overall Study|Lost to Follow-up|0|||
125446197|NCT02724020|451259412|FG000|Overall Study|Site Terminated by Sponsor|15|||
125446198|NCT02724020|451259413|FG001|Overall Study|Site Terminated by Sponsor|8|||
125446199|NCT02724020|451259414|FG002|Overall Study|Site Terminated by Sponsor|8|||
125446200|NCT02724020|451259412|FG000|Overall Study|Withdrawal by Subject|1|||
125446201|NCT02724020|451259413|FG001|Overall Study|Withdrawal by Subject|3|||
125446202|NCT02724020|451259414|FG002|Overall Study|Withdrawal by Subject|5|||
125446203|NCT00425503|451259415|FG000|Overall Study|Adverse Event|2|||
125446204|NCT00425503|451259415|FG000|Overall Study|Protocol Violation|1|||
125446205|NCT02118714|451259417|FG000|Overall Study|Lost to Follow-up|2|||
125446206|NCT02118714|451259417|FG000|Overall Study|Protocol Violation|1|||
125446207|NCT01310868|451259418|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
125446208|NCT02411591|451259419|FG000|Overall Study|Adverse Event|0|||
125446209|NCT02411591|451259420|FG001|Overall Study|Adverse Event|4|||
125446210|NCT02411591|451259421|FG002|Overall Study|Adverse Event|2|||
125446211|NCT02411591|451259419|FG000|Overall Study|Withdrawal by Subject|0|||
125446212|NCT02411591|451259420|FG001|Overall Study|Withdrawal by Subject|3|||
125446213|NCT02411591|451259421|FG002|Overall Study|Withdrawal by Subject|0|||
125446214|NCT02411591|451259419|FG000|Overall Study|Physician Decision|0|||
125446215|NCT02411591|451259420|FG001|Overall Study|Physician Decision|3|||
125446216|NCT02411591|451259421|FG002|Overall Study|Physician Decision|1|||
125446217|NCT02491892|451259422|FG000|Overall Study|Adverse Event|1|||
125446218|NCT02491892|451259423|FG001|Overall Study|Adverse Event|1|||
125446219|NCT02491892|451259422|FG000|Overall Study|Death|1|||
125446220|NCT02491892|451259423|FG001|Overall Study|Death|1|||
125446221|NCT02491892|451259422|FG000|Overall Study|Lack of Efficacy|37|||
125446222|NCT02491892|451259423|FG001|Overall Study|Lack of Efficacy|36|||
125446223|NCT02491892|451259422|FG000|Overall Study|Refused Treatment|1|||
125446224|NCT02491892|451259423|FG001|Overall Study|Refused Treatment|0|||
125446225|NCT02491892|451259422|FG000|Overall Study|Lost to Follow-up|1|||
125446226|NCT02491892|451259423|FG001|Overall Study|Lost to Follow-up|0|||
125446227|NCT04227340|451259424|FG000|Overall Study|Withdrawal by Subject|3|||
125446228|NCT01066156|451259425|FG000|Overall Study|ineligible|2|||
125446229|NCT01066156|451259425|FG000|Overall Study|Lost to Follow-up|7|||
125446230|NCT01066156|451259425|FG000|Overall Study|Withdrawal by Subject|1|||
125446231|NCT00661258|451259436|FG000|Overall Study|Death|1|||
125446232|NCT00661258|451259437|FG001|Overall Study|Death|0|||
125446233|NCT00661258|451259436|FG000|Overall Study|caught by police and in detox center|2|||
125261939|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Death|1|||
125261940|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
125446234|NCT00661258|451259437|FG001|Overall Study|caught by police and in detox center|1|||
125446235|NCT01628874|451259438|FG000|Overall Study|Physician Decision|1|||
125446236|NCT01628874|451259439|FG001|Overall Study|Physician Decision|1|||
125446237|NCT01628874|451259438|FG000|Overall Study|Age >4 months|4|||
125446238|NCT01628874|451259439|FG001|Overall Study|Age >4 months|2|||
125261941|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
125261942|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
125261943|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
125261944|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
125261945|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
125261946|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
125261947|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
125261948|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
125261949|NCT02519842|450588440|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
125261950|NCT02519842|450588441|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
125261951|NCT02519842|450588442|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
125261952|NCT01493414|450588448|FG000|Overall Study|Adverse Event|405|||
125261953|NCT01493414|450588448|FG000|Overall Study|Disease progression|204|||
125261954|NCT01493414|450588448|FG000|Overall Study|Death|101|||
125261955|NCT01493414|450588448|FG000|Overall Study|Physician Decision|93|||
125261956|NCT01493414|450588448|FG000|Overall Study|Withdrawal by Subject|79|||
125261957|NCT01493414|450588448|FG000|Overall Study|Protocol deviation|27|||
125261958|NCT01493414|450588448|FG000|Overall Study|Administrative problems|25|||
125261959|NCT01493414|450588448|FG000|Overall Study|Lost to Follow-up|16|||
125261960|NCT01977222|450588453|FG000|Overall Study|Withdrawal by Subject|1|||
125261961|NCT00945659|450588463|FG000|Overall Study|Lost to Follow-up|7|||
125261962|NCT00945659|450588464|FG001|Overall Study|Lost to Follow-up|20|||
125261963|NCT00945659|450588465|FG002|Overall Study|Lost to Follow-up|17|||
125261964|NCT04562116|450588466|FG000|Overall Study|Lost to Follow-up|1|||
125261965|NCT04562116|450588466|FG000|Overall Study|Withdrawal by Subject|3|||
125261966|NCT02412670|450588469|FG000|Overall Study|Adverse Event|4|||
125261967|NCT02412670|450588470|FG001|Overall Study|Adverse Event|1|||
125446239|NCT01670500|451259441|FG000|Overall Study|Withdrawal by Subject|1|||
125446240|NCT01670500|451259442|FG001|Overall Study|Withdrawal by Subject|0|||
125446241|NCT03473756|451259443|FG000|Overall Study|Withdrawal by Subject|1|||
125261968|NCT02412670|450588469|FG000|Overall Study|Physician Decision|1|||
125261969|NCT02412670|450588470|FG001|Overall Study|Physician Decision|0|||
125261970|NCT02412670|450588469|FG000|Overall Study|Withdrawal by Subject|1|||
125261971|NCT02412670|450588470|FG001|Overall Study|Withdrawal by Subject|0|||
125261972|NCT02412670|450588469|FG000|Overall Study|Ineligible|1|||
125261973|NCT02412670|450588470|FG001|Overall Study|Ineligible|0|||
125261974|NCT00654732|450588475|FG000|Overall Study|Adverse Event|4|||
125261975|NCT00654732|450588476|FG001|Overall Study|Adverse Event|6|||
125261976|NCT03342560|450588477|FG000|Overall Study|Lost to Follow-up|2|||
125261977|NCT03213509|450588478|FG000|Overall Study|Did not consent for verbal autopsy|4|||
125261978|NCT03213509|450588479|FG001|Overall Study|Did not consent for verbal autopsy|5|||
125261979|NCT04549454|450588490|FG000|T1 to T2|Lost to Follow-up|22|||
125261980|NCT04549454|450588491|FG001|T1 to T2|Lost to Follow-up|26|||
125261981|NCT04549454|450588490|FG000|T1 to T3|Lost to Follow-up|31|||
125261982|NCT04549454|450588491|FG001|T1 to T3|Lost to Follow-up|36|||
125261983|NCT00016354|450588494|FG000|Overall Study|Lack of Efficacy|0|||
125261984|NCT00016354|450588495|FG001|Overall Study|Lack of Efficacy|0|||
125261985|NCT00016354|450588496|FG002|Overall Study|Lack of Efficacy|0|||
125261986|NCT00016354|450588497|FG003|Overall Study|Lack of Efficacy|0|||
125261987|NCT00016354|450588498|FG004|Overall Study|Lack of Efficacy|0|||
125261988|NCT00016354|450588499|FG005|Overall Study|Lack of Efficacy|0|||
125261989|NCT00016354|450588500|FG006|Overall Study|Lack of Efficacy|0|||
125261990|NCT00016354|450588501|FG007|Overall Study|Lack of Efficacy|1|||
125261991|NCT02993263|450588504|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
125261992|NCT01405196|450588505|FG000|Overall Study|Study Terminated by Sponsor|0|||
125261993|NCT01405196|450588506|FG001|Overall Study|Study Terminated by Sponsor|0|||
125261994|NCT01405196|450588507|FG002|Overall Study|Study Terminated by Sponsor|9|||
125261995|NCT01405196|450588508|FG003|Overall Study|Study Terminated by Sponsor|0|||
125261996|NCT01405196|450588505|FG000|Overall Study|Other|2|||
125261997|NCT01405196|450588506|FG001|Overall Study|Other|2|||
125446242|NCT03473756|451259444|FG001|Overall Study|Withdrawal by Subject|4|||
125446243|NCT03473756|451259443|FG000|Overall Study|Adverse Event|6|||
125446244|NCT03473756|451259444|FG001|Overall Study|Adverse Event|7|||
125261998|NCT01405196|450588507|FG002|Overall Study|Other|5|||
125261999|NCT01405196|450588508|FG003|Overall Study|Other|0|||
125262000|NCT01405196|450588505|FG000|Overall Study|Withdrawal by Subject|4|||
125262001|NCT01405196|450588506|FG001|Overall Study|Withdrawal by Subject|6|||
125262002|NCT01405196|450588507|FG002|Overall Study|Withdrawal by Subject|3|||
125262003|NCT01405196|450588508|FG003|Overall Study|Withdrawal by Subject|6|||
125262004|NCT01405196|450588505|FG000|Overall Study|Adverse Event|2|||
125262005|NCT01405196|450588506|FG001|Overall Study|Adverse Event|2|||
125262006|NCT01405196|450588507|FG002|Overall Study|Adverse Event|0|||
125262007|NCT01405196|450588508|FG003|Overall Study|Adverse Event|2|||
125262008|NCT01405196|450588505|FG000|Overall Study|Death|1|||
125262009|NCT01405196|450588506|FG001|Overall Study|Death|0|||
125262010|NCT01405196|450588507|FG002|Overall Study|Death|3|||
125262011|NCT01405196|450588508|FG003|Overall Study|Death|0|||
125262012|NCT01405196|450588505|FG000|Overall Study|Lost to Follow-up|2|||
125262013|NCT01405196|450588506|FG001|Overall Study|Lost to Follow-up|2|||
125262014|NCT01405196|450588507|FG002|Overall Study|Lost to Follow-up|3|||
125262015|NCT01405196|450588508|FG003|Overall Study|Lost to Follow-up|1|||
125262016|NCT01729039|450588509|FG000|Overall Study|disqualified|2|||
125262017|NCT01729039|450588510|FG001|Overall Study|disqualified|5|||
125262018|NCT01729039|450588509|FG000|Overall Study|Withdrawal by Subject|8|||
125262019|NCT01729039|450588510|FG001|Overall Study|Withdrawal by Subject|7|||
125262020|NCT00698841|450588511|FG000|Overall Study|Withdrawal by Subject|2|||
125262021|NCT00698841|450588511|FG000|Overall Study|Adverse Event|3|||
125262022|NCT00698841|450588511|FG000|Overall Study|Disease progression|7|||
125262023|NCT00698841|450588511|FG000|Overall Study|Failure to meet eligibility criteria|2|||
125262024|NCT00698841|450588511|FG000|Overall Study|Study drug toxicity|2|||
125262025|NCT00698841|450588511|FG000|Overall Study|Other|2|||
125262026|NCT02114177|450589758|FG000|Overall Study|Lost to Follow-up|1|||
125262027|NCT02114177|450589759|FG001|Overall Study|Lost to Follow-up|2|||
125262028|NCT02114177|450589758|FG000|Overall Study|Withdrawal by Subject|6|||
125262029|NCT02114177|450589759|FG001|Overall Study|Withdrawal by Subject|1|||
125262030|NCT02114177|450589758|FG000|Overall Study|Other|2|||
125262031|NCT02114177|450589759|FG001|Overall Study|Other|1|||
125262032|NCT01585025|450589760|FG000|Overall Study|Withdrawal by Subject|0|||
125262033|NCT01585025|450589761|FG001|Overall Study|Withdrawal by Subject|3|||
125262034|NCT01585025|450589762|FG002|Overall Study|Withdrawal by Subject|4|||
125262035|NCT00582907|450589763|FG000|1st Course|Withdrawal by Subject|1|||
125262036|NCT00582907|450589764|FG001|1st Course|Withdrawal by Subject|0|||
125262037|NCT00582907|450589765|FG002|1st Course|Withdrawal by Subject|0|||
125262038|NCT00582907|450589766|FG003|1st Course|Withdrawal by Subject|0|||
125262039|NCT00582907|450589763|FG000|1st Course|Lost to Follow-up|0|||
125262040|NCT00582907|450589764|FG001|1st Course|Lost to Follow-up|0|||
125262041|NCT00582907|450589765|FG002|1st Course|Lost to Follow-up|0|||
125262042|NCT00582907|450589766|FG003|1st Course|Lost to Follow-up|1|||
125262043|NCT00582907|450589763|FG000|2nd Course|Lack of Efficacy|1|||
125262044|NCT00582907|450589764|FG001|2nd Course|Lack of Efficacy|0|||
125262045|NCT00582907|450589765|FG002|2nd Course|Lack of Efficacy|0|||
125262046|NCT00582907|450589766|FG003|2nd Course|Lack of Efficacy|0|||
125262047|NCT03610048|450589773|FG000|Overall Study|Study terminated by sponsor|84|||
125262048|NCT03610048|450589773|FG000|Overall Study|Adverse Event|32|||
125262049|NCT03610048|450589773|FG000|Overall Study|Withdrawal by Subject|31|||
125262050|NCT03610048|450589773|FG000|Overall Study|Lost to Follow-up|8|||
125262051|NCT03610048|450589773|FG000|Overall Study|Other|4|||
125262052|NCT03610048|450589773|FG000|Overall Study|Physician Decision|1|||
125262053|NCT03610048|450589773|FG000|Overall Study|Pregnancy|1|||
125262054|NCT01155050|450589774|FG000|Overall Study|Lost to Follow-up|15|||
125262055|NCT01155050|450589775|FG001|Overall Study|Lost to Follow-up|20|||
125262056|NCT01155050|450589776|FG002|Overall Study|Lost to Follow-up|19|||
125262057|NCT01155050|450589777|FG003|Overall Study|Lost to Follow-up|22|||
125262058|NCT01146613|450589779|FG000|Overall Study|Lost to Follow-up|3|||
125262059|NCT01146613|450589780|FG001|Overall Study|Lost to Follow-up|8|||
125262060|NCT01146613|450589779|FG000|Overall Study|Lack of Efficacy|0|||
125262061|NCT01146613|450589780|FG001|Overall Study|Lack of Efficacy|1|||
125262062|NCT01146613|450589779|FG000|Overall Study|Death|1|||
125262063|NCT01146613|450589780|FG001|Overall Study|Death|0|||
125262064|NCT01146613|450589779|FG000|Overall Study|Physician Decision|1|||
125262065|NCT01146613|450589780|FG001|Overall Study|Physician Decision|0|||
125262066|NCT01146613|450589779|FG000|Overall Study|Withdrawal by Subject|0|||
125262067|NCT01146613|450589780|FG001|Overall Study|Withdrawal by Subject|3|||
125262068|NCT01146613|450589779|FG000|Overall Study|schedule conflict|1|||
125262069|NCT01146613|450589780|FG001|Overall Study|schedule conflict|0|||
125262070|NCT01146613|450589779|FG000|Overall Study|Outpatient detox|1|||
125262071|NCT01146613|450589780|FG001|Overall Study|Outpatient detox|0|||
125262072|NCT01959529|450589781|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
125262073|NCT01959529|450589782|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
125262074|NCT01959529|450589781|FG000|Overall Study|Lost to Follow-up|4|||
125262075|NCT01959529|450589782|FG001|Overall Study|Lost to Follow-up|1|||
125262076|NCT01959529|450589781|FG000|Overall Study|Other|70|||
125262077|NCT01959529|450589782|FG001|Overall Study|Other|68|||
125262078|NCT01959529|450589781|FG000|Overall Study|Hypoglycaemia|1|||
125262079|NCT01959529|450589782|FG001|Overall Study|Hypoglycaemia|1|||
125262080|NCT01959529|450589781|FG000|Overall Study|Lack of glycaemic control|1|||
125262081|NCT01959529|450589782|FG001|Overall Study|Lack of glycaemic control|1|||
125262082|NCT00652834|450589783|FG000|Overall Study|Withdrawal by Subject|3|||
125262083|NCT00652834|450589783|FG000|Overall Study|Lost to Follow-up|2|||
125262084|NCT00854360|450589791|FG000|Overall Study|Adverse Event|0|||
125262085|NCT00854360|450589792|FG001|Overall Study|Adverse Event|1|||
125262086|NCT00854360|450589793|FG002|Overall Study|Adverse Event|2|||
125262087|NCT00854360|450589794|FG003|Overall Study|Adverse Event|6|||
125262088|NCT00854360|450589791|FG000|Overall Study|Withdrawal by Subject|0|||
125262089|NCT00854360|450589792|FG001|Overall Study|Withdrawal by Subject|0|||
125262090|NCT00854360|450589793|FG002|Overall Study|Withdrawal by Subject|0|||
125262091|NCT00854360|450589794|FG003|Overall Study|Withdrawal by Subject|1|||
125262092|NCT00854360|450589791|FG000|Overall Study|Pregnancy|0|||
125262093|NCT00854360|450589792|FG001|Overall Study|Pregnancy|1|||
125262094|NCT00854360|450589793|FG002|Overall Study|Pregnancy|0|||
125262095|NCT00854360|450589794|FG003|Overall Study|Pregnancy|0|||
125262096|NCT00854360|450589791|FG000|Overall Study|Lack of Efficacy|2|||
125262097|NCT00854360|450589792|FG001|Overall Study|Lack of Efficacy|1|||
125262098|NCT00854360|450589793|FG002|Overall Study|Lack of Efficacy|0|||
125262099|NCT00854360|450589794|FG003|Overall Study|Lack of Efficacy|0|||
125262100|NCT00854360|450589791|FG000|Overall Study|Other|0|||
125262101|NCT00854360|450589792|FG001|Overall Study|Other|0|||
125262102|NCT00854360|450589793|FG002|Overall Study|Other|0|||
125262103|NCT00854360|450589794|FG003|Overall Study|Other|3|||
125262104|NCT02441218|450589795|FG000|Overall Study|Death|503|||
125262105|NCT02441218|450589796|FG001|Overall Study|Death|553|||
125262106|NCT02441218|450589795|FG000|Overall Study|Withdrawal by Subject|73|||
125262107|NCT02441218|450589796|FG001|Overall Study|Withdrawal by Subject|58|||
125262108|NCT02441218|450589795|FG000|Overall Study|Lost to Follow-up|2|||
125262109|NCT02441218|450589796|FG001|Overall Study|Lost to Follow-up|1|||
125262110|NCT01541371|450589797|FG000|Overall Study|Withdrawal by Subject|14|||
125262111|NCT01541371|450589797|FG000|Overall Study|Lost to Follow-up|21|||
125262112|NCT01541371|450589797|FG000|Overall Study|Adverse Event|15|||
125262113|NCT01541371|450589797|FG000|Overall Study|Lack of Efficacy|12|||
125262114|NCT01541371|450589797|FG000|Overall Study|Protocol Violation|6|||
125262115|NCT01541371|450589797|FG000|Overall Study|Study medication non-compliance|3|||
125262116|NCT01541371|450589797|FG000|Overall Study|Other|6|||
125262117|NCT02271880|450589801|FG000|Overall Study|Premature discontinuation of study|3|||
125262118|NCT02271880|450589802|FG001|Overall Study|Premature discontinuation of study|4|||
125262119|NCT00806585|450589803|FG000|Overall Study|Study terminated by Sponsor|0|||
125262120|NCT00806585|450589804|FG001|Overall Study|Study terminated by Sponsor|0|||
125262121|NCT00806585|450589805|FG002|Overall Study|Study terminated by Sponsor|1|||
125262122|NCT00806585|450589806|FG003|Overall Study|Study terminated by Sponsor|2|||
125262123|NCT00806585|450589807|FG004|Overall Study|Study terminated by Sponsor|0|||
125262124|NCT00806585|450589803|FG000|Overall Study|Protocol Violation|3|||
125262125|NCT00806585|450589804|FG001|Overall Study|Protocol Violation|1|||
125262126|NCT00806585|450589805|FG002|Overall Study|Protocol Violation|2|||
125262127|NCT00806585|450589806|FG003|Overall Study|Protocol Violation|0|||
125262128|NCT00806585|450589807|FG004|Overall Study|Protocol Violation|0|||
125262129|NCT00806585|450589803|FG000|Overall Study|Physician Decision|0|||
125262130|NCT00806585|450589804|FG001|Overall Study|Physician Decision|2|||
125262131|NCT00806585|450589805|FG002|Overall Study|Physician Decision|3|||
125262132|NCT00806585|450589806|FG003|Overall Study|Physician Decision|0|||
125262133|NCT00806585|450589807|FG004|Overall Study|Physician Decision|1|||
125262134|NCT00806585|450589803|FG000|Overall Study|Lost to Follow-up|2|||
125262135|NCT00806585|450589804|FG001|Overall Study|Lost to Follow-up|1|||
125262136|NCT00806585|450589805|FG002|Overall Study|Lost to Follow-up|2|||
125262137|NCT00806585|450589806|FG003|Overall Study|Lost to Follow-up|2|||
125262138|NCT00806585|450589807|FG004|Overall Study|Lost to Follow-up|5|||
125262139|NCT00806585|450589803|FG000|Overall Study|Lack of Efficacy|1|||
125262140|NCT00806585|450589804|FG001|Overall Study|Lack of Efficacy|0|||
125262141|NCT00806585|450589805|FG002|Overall Study|Lack of Efficacy|0|||
125262142|NCT00806585|450589806|FG003|Overall Study|Lack of Efficacy|0|||
125398296|NCT04083976|451090972|FG000|Overall Study|Other|1|||
125262143|NCT00806585|450589807|FG004|Overall Study|Lack of Efficacy|0|||
125262144|NCT00806585|450589803|FG000|Overall Study|Adverse Event|1|||
125262145|NCT00806585|450589804|FG001|Overall Study|Adverse Event|5|||
125262146|NCT00806585|450589805|FG002|Overall Study|Adverse Event|3|||
125262147|NCT00806585|450589806|FG003|Overall Study|Adverse Event|4|||
125262148|NCT00806585|450589807|FG004|Overall Study|Adverse Event|2|||
125398297|NCT04083976|451090973|FG001|Overall Study|Other|0|||
125262149|NCT00806585|450589803|FG000|Overall Study|Withdrawal by Subject|10|||
125262150|NCT00806585|450589804|FG001|Overall Study|Withdrawal by Subject|8|||
125262151|NCT00806585|450589805|FG002|Overall Study|Withdrawal by Subject|9|||
125262152|NCT00806585|450589806|FG003|Overall Study|Withdrawal by Subject|3|||
125262153|NCT00806585|450589807|FG004|Overall Study|Withdrawal by Subject|11|||
125262154|NCT00806585|450589803|FG000|Overall Study|Completion status unknown|15|||
125262155|NCT00806585|450589804|FG001|Overall Study|Completion status unknown|14|||
125262156|NCT00806585|450589805|FG002|Overall Study|Completion status unknown|12|||
125262157|NCT00806585|450589806|FG003|Overall Study|Completion status unknown|4|||
125262158|NCT00806585|450589807|FG004|Overall Study|Completion status unknown|12|||
125262159|NCT00474903|450589808|FG000|Overall Study|Protocol Violation|1|||
125262160|NCT00474903|450589809|FG001|Overall Study|Protocol Violation|5|||
125262161|NCT00474903|450589810|FG002|Overall Study|Protocol Violation|2|||
125262162|NCT01936831|450589811|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262163|NCT01936831|450589812|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262164|NCT01936831|450589813|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262165|NCT01936831|450589814|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262166|NCT01936831|450589815|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262167|NCT01936831|450589816|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
125262168|NCT01936831|450589817|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262169|NCT01936831|450589818|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262170|NCT01936831|450589819|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
125262171|NCT03435380|450589820|FG000|Overall Study|Death|1|||
125262172|NCT03435380|450589821|FG001|Overall Study|Death|2|||
125262173|NCT03435380|450589822|FG002|Overall Study|Death|1|||
125262174|NCT03435380|450589820|FG000|Overall Study|Lost to Follow-up|12|||
125262175|NCT03435380|450589821|FG001|Overall Study|Lost to Follow-up|8|||
125262176|NCT03435380|450589822|FG002|Overall Study|Lost to Follow-up|6|||
125262177|NCT03435380|450589820|FG000|Overall Study|Physician Decision|1|||
125262178|NCT03435380|450589821|FG001|Overall Study|Physician Decision|0|||
125262179|NCT03435380|450589822|FG002|Overall Study|Physician Decision|0|||
125262180|NCT03435380|450589820|FG000|Overall Study|Withdrawal by Subject|0|||
125262181|NCT03435380|450589821|FG001|Overall Study|Withdrawal by Subject|1|||
125262182|NCT03435380|450589822|FG002|Overall Study|Withdrawal by Subject|1|||
125262183|NCT03435380|450589820|FG000|Overall Study|Ineligible|0|||
125262184|NCT03435380|450589821|FG001|Overall Study|Ineligible|1|||
125262185|NCT03435380|450589822|FG002|Overall Study|Ineligible|1|||
125262186|NCT02115321|450589832|FG000|Overall Study|Death|1|||
125262187|NCT02115321|450589833|FG001|Overall Study|Death|0|||
125262188|NCT02493764|450589834|FG000|Overall Study|Adverse Event|2|||
125262189|NCT02493764|450589835|FG001|Overall Study|Adverse Event|2|||
125262190|NCT02493764|450589834|FG000|Overall Study|Death|44|||
125262191|NCT02493764|450589835|FG001|Overall Study|Death|58|||
125262192|NCT02493764|450589834|FG000|Overall Study|Lost to Follow-up|2|||
125262193|NCT02493764|450589835|FG001|Overall Study|Lost to Follow-up|1|||
125262194|NCT02493764|450589834|FG000|Overall Study|Protocol Violation|6|||
125262195|NCT02493764|450589835|FG001|Overall Study|Protocol Violation|7|||
125262196|NCT02493764|450589834|FG000|Overall Study|Physician Decision|1|||
125262197|NCT02493764|450589835|FG001|Overall Study|Physician Decision|1|||
125262198|NCT02493764|450589834|FG000|Overall Study|Participant moved|17|||
125262199|NCT02493764|450589835|FG001|Overall Study|Participant moved|5|||
125262200|NCT02493764|450589834|FG000|Overall Study|Withdrawal parent/guardian|0|||
125262201|NCT02493764|450589835|FG001|Overall Study|Withdrawal parent/guardian|1|||
125262202|NCT02493764|450589834|FG000|Overall Study|Withdrawal by Subject|11|||
125262203|NCT02493764|450589835|FG001|Overall Study|Withdrawal by Subject|7|||
125262204|NCT03218917|450589837|FG000|Overall Study|Adverse Event|3|||
125262205|NCT03218917|450589838|FG001|Overall Study|Adverse Event|3|||
125262206|NCT03218917|450589839|FG002|Overall Study|Adverse Event|2|||
125262207|NCT03218917|450589837|FG000|Overall Study|Subject withdrew consent|2|||
125262208|NCT03218917|450589838|FG001|Overall Study|Subject withdrew consent|4|||
125262209|NCT03218917|450589839|FG002|Overall Study|Subject withdrew consent|10|||
125262210|NCT03218917|450589837|FG000|Overall Study|Physician Decision|0|||
125262211|NCT03218917|450589838|FG001|Overall Study|Physician Decision|1|||
125262212|NCT03218917|450589839|FG002|Overall Study|Physician Decision|1|||
125262213|NCT03218917|450589837|FG000|Overall Study|Lost to Follow-up|1|||
125262214|NCT03218917|450589838|FG001|Overall Study|Lost to Follow-up|0|||
125262215|NCT03218917|450589839|FG002|Overall Study|Lost to Follow-up|0|||
125262216|NCT03218917|450589837|FG000|Overall Study|Reason Missing|0|||
125262217|NCT03218917|450589838|FG001|Overall Study|Reason Missing|2|||
125262218|NCT03218917|450589839|FG002|Overall Study|Reason Missing|0|||
125262219|NCT03218917|450589837|FG000|Overall Study|Death|0|||
125262220|NCT03218917|450589838|FG001|Overall Study|Death|1|||
125262221|NCT03218917|450589839|FG002|Overall Study|Death|0|||
125262222|NCT03218917|450589837|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125262223|NCT03218917|450589838|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125262224|NCT03218917|450589839|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125262225|NCT01307449|450589840|FG000|Overall Study|Adverse Event|1|||
125262226|NCT01307449|450589841|FG001|Overall Study|Adverse Event|0|||
125262227|NCT01307449|450589842|FG002|Overall Study|Adverse Event|0|||
125262228|NCT01307449|450589843|FG003|Overall Study|Adverse Event|0|||
125262229|NCT01561976|450589844|FG000|Period 1|Adverse Event|0|||
125262230|NCT01561976|450589845|FG001|Period 1|Adverse Event|0|||
125262231|NCT01561976|450589846|FG002|Period 1|Adverse Event|1|||
125262232|NCT01561976|450589847|FG003|Period 1|Adverse Event|0|||
125262233|NCT01561976|450589848|FG004|Period 1|Adverse Event|0|||
125262234|NCT01561976|450589849|FG005|Period 1|Adverse Event|0|||
125262235|NCT01561976|450589844|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
125262236|NCT01561976|450589845|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
125446245|NCT03473756|451259443|FG000|Overall Study|Lack of Efficacy|3|||
125446246|NCT03473756|451259444|FG001|Overall Study|Lack of Efficacy|10|||
125446247|NCT03473756|451259443|FG000|Overall Study|Physician Decision|0|||
125446248|NCT03473756|451259444|FG001|Overall Study|Physician Decision|2|||
125446249|NCT03473756|451259443|FG000|Overall Study|End of study treatment|0|||
125446250|NCT03473756|451259444|FG001|Overall Study|End of study treatment|2|||
125446251|NCT03473756|451259443|FG000|Overall Study|Lost to Follow-up|0|||
125446252|NCT03473756|451259444|FG001|Overall Study|Lost to Follow-up|1|||
125446253|NCT02148718|451259445|FG000|Overall Study|Protocol Violation|26|||
125446254|NCT02148718|451259445|FG000|Overall Study|Discontinued Study Prematurely|5|||
125446255|NCT00003509|451259446|FG000|Overall Study|Not evaluable|5|||
125446256|NCT02711826|451259447|FG000|Overall Study|Physician Decision|0|||
125262237|NCT01561976|450589846|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
125262238|NCT01561976|450589847|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
125262239|NCT01561976|450589848|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
125446257|NCT02711826|451259448|FG001|Overall Study|Physician Decision|0|||
125446258|NCT02711826|451259449|FG002|Overall Study|Physician Decision|0|||
125446259|NCT02711826|451259450|FG003|Overall Study|Physician Decision|1|||
125446260|NCT02711826|451259451|FG004|Overall Study|Physician Decision|0|||
125446261|NCT02711826|451259447|FG000|Overall Study|Withdrawal by Subject|0|||
125446262|NCT02711826|451259448|FG001|Overall Study|Withdrawal by Subject|1|||
125446263|NCT02711826|451259449|FG002|Overall Study|Withdrawal by Subject|0|||
125446264|NCT02711826|451259450|FG003|Overall Study|Withdrawal by Subject|4|||
125446265|NCT02711826|451259451|FG004|Overall Study|Withdrawal by Subject|0|||
125446266|NCT02711826|451259447|FG000|Overall Study|Failure to manufacture cellular product|0|||
125446267|NCT02711826|451259448|FG001|Overall Study|Failure to manufacture cellular product|0|||
125446268|NCT02711826|451259449|FG002|Overall Study|Failure to manufacture cellular product|5|||
125446269|NCT02711826|451259450|FG003|Overall Study|Failure to manufacture cellular product|0|||
125262240|NCT01561976|450589849|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
125262241|NCT01561976|450589844|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125262242|NCT01561976|450589845|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125262243|NCT01561976|450589846|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125262244|NCT01561976|450589847|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125262245|NCT01561976|450589848|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
125262246|NCT01561976|450589849|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
125262247|NCT01561976|450589844|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
125262248|NCT01561976|450589845|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
125262249|NCT01561976|450589846|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
125262250|NCT01561976|450589847|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
125262251|NCT01561976|450589848|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
125262252|NCT01561976|450589849|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
125262253|NCT01463527|450589854|FG000|Overall Study|Protocol Violation|1|||
125262254|NCT01463527|450589855|FG001|Overall Study|Protocol Violation|1|||
125262255|NCT01463527|450589854|FG000|Overall Study|Crying >20% of sedation|5|||
125262256|NCT01463527|450589855|FG001|Overall Study|Crying >20% of sedation|6|||
125262257|NCT05136170|450589856|FG000|Overall Study|Withdrawal by Subject|2|||
125262258|NCT05136170|450589857|FG001|Overall Study|Withdrawal by Subject|2|||
125262259|NCT05136170|450589856|FG000|Overall Study|Can no longer make office visits|1|||
125262260|NCT05136170|450589857|FG001|Overall Study|Can no longer make office visits|0|||
125262261|NCT01788943|450589858|FG000|Overall Study|Withdrawal by Subject|1|||
125262262|NCT01788943|450589859|FG001|Overall Study|Withdrawal by Subject|0|||
125446270|NCT02711826|451259451|FG004|Overall Study|Failure to manufacture cellular product|0|||
125446271|NCT02711826|451259447|FG000|Overall Study|Infusion canceled for active infection|0|||
125446272|NCT02711826|451259448|FG001|Overall Study|Infusion canceled for active infection|1|||
125446273|NCT02711826|451259449|FG002|Overall Study|Infusion canceled for active infection|0|||
125446274|NCT02711826|451259450|FG003|Overall Study|Infusion canceled for active infection|0|||
125446275|NCT02711826|451259451|FG004|Overall Study|Infusion canceled for active infection|0|||
125446276|NCT02711826|451259447|FG000|Overall Study|Screen failures|0|||
125446277|NCT02711826|451259448|FG001|Overall Study|Screen failures|0|||
125446278|NCT02711826|451259449|FG002|Overall Study|Screen failures|0|||
125262263|NCT01119287|450589860|FG000|Overall Study|Patient Decision, not related to AE|0|||
125262264|NCT01119287|450589861|FG001|Overall Study|Patient Decision, not related to AE|0|||
125262265|NCT01119287|450589862|FG002|Overall Study|Patient Decision, not related to AE|2|||
125262266|NCT01119287|450589863|FG003|Overall Study|Patient Decision, not related to AE|2|||
125262267|NCT01119287|450589864|FG004|Overall Study|Patient Decision, not related to AE|1|||
125262268|NCT01119287|450589865|FG005|Overall Study|Patient Decision, not related to AE|0|||
125262269|NCT04403919|450589870|FG000|Overall Study|Lost to Follow-up|0|||
125262270|NCT04403919|450589871|FG001|Overall Study|Lost to Follow-up|0|||
125262271|NCT04403919|450589872|FG002|Overall Study|Lost to Follow-up|0|||
125262272|NCT04403919|450589873|FG003|Overall Study|Lost to Follow-up|1|||
125262273|NCT01612676|450589874|FG000|Overall Study|Adverse Event|2|||
125262274|NCT01612676|450589875|FG001|Overall Study|Adverse Event|3|||
125262275|NCT01612676|450589876|FG002|Overall Study|Adverse Event|1|||
125446279|NCT02711826|451259450|FG003|Overall Study|Screen failures|4|||
125446280|NCT02711826|451259451|FG004|Overall Study|Screen failures|0|||
125446281|NCT01960790|451259452|FG000|Overall Study|Survey forms could not be recovered|3|||
125446282|NCT01960790|451259452|FG000|Overall Study|Treat with Humira outside survey period|3|||
125446283|NCT01960790|451259452|FG000|Overall Study|Transferred to another hospital|4|||
125446284|NCT01960790|451259452|FG000|Overall Study|Unevaluable for safety|1|||
125446285|NCT02169219|451259455|FG000|Overall Study|Lack of Efficacy|6|||
125446286|NCT02886936|451259462|FG000|Overall Study|Lost to Follow-up|4|||
125446287|NCT02886936|451259463|FG001|Overall Study|Lost to Follow-up|3|||
125446288|NCT02886936|451259464|FG002|Overall Study|Lost to Follow-up|0|||
125446289|NCT04131907|451259466|FG000|Overall Study|Adverse Event|2|||
125446290|NCT04131907|451259467|FG001|Overall Study|Adverse Event|0|||
125446291|NCT04131907|451259468|FG002|Overall Study|Adverse Event|0|||
125446292|NCT04131907|451259466|FG000|Overall Study|Physician Decision|4|||
125446293|NCT04131907|451259467|FG001|Overall Study|Physician Decision|22|||
125446294|NCT04131907|451259468|FG002|Overall Study|Physician Decision|0|||
125446295|NCT04131907|451259466|FG000|Overall Study|Withdrawal by Subject|2|||
125262276|NCT01612676|450589877|FG003|Overall Study|Adverse Event|3|||
125262277|NCT01612676|450589874|FG000|Overall Study|Protocol Violation|0|||
125262278|NCT01612676|450589875|FG001|Overall Study|Protocol Violation|1|||
125262279|NCT01612676|450589876|FG002|Overall Study|Protocol Violation|0|||
125262280|NCT01612676|450589877|FG003|Overall Study|Protocol Violation|0|||
125446296|NCT04131907|451259467|FG001|Overall Study|Withdrawal by Subject|0|||
125446297|NCT04131907|451259468|FG002|Overall Study|Withdrawal by Subject|1|||
125446298|NCT04131907|451259466|FG000|Overall Study|Treatment failure|2|||
125446299|NCT04131907|451259467|FG001|Overall Study|Treatment failure|0|||
125446300|NCT04131907|451259468|FG002|Overall Study|Treatment failure|1|||
125446301|NCT04248465|451259469|FG000|Randomized-Controlled Period|Death|12|||
125446302|NCT04248465|451259470|FG001|Randomized-Controlled Period|Death|5|||
125446303|NCT04248465|451259469|FG000|Randomized-Controlled Period|Adverse Event|2|||
125446304|NCT04248465|451259470|FG001|Randomized-Controlled Period|Adverse Event|0|||
125446305|NCT04248465|451259469|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
125446306|NCT04248465|451259470|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
125446307|NCT04248465|451259469|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
125446308|NCT04248465|451259470|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
125446309|NCT04248465|451259469|FG000|Randomized-Controlled Period|Physician Decision|1|||
125446310|NCT04248465|451259470|FG001|Randomized-Controlled Period|Physician Decision|1|||
125446311|NCT04248465|451259469|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
125446312|NCT04248465|451259470|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
125446313|NCT04248465|451259469|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
125446314|NCT04248465|451259470|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
125446315|NCT04248465|451259469|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
125446316|NCT04248465|451259470|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
125446317|NCT05708846|451259471|FG000|Overall Study|Death|5|||
125446318|NCT05708846|451259471|FG000|Overall Study|Withdrawal by Subject|20|||
125446319|NCT00442286|451259472|FG000|Overall Study|Death|2|||
125446320|NCT00442286|451259473|FG001|Overall Study|Death|2|||
125446321|NCT00442286|451259472|FG000|Overall Study|Lost to Follow-up|1|||
125446322|NCT00442286|451259473|FG001|Overall Study|Lost to Follow-up|0|||
125446323|NCT00442286|451259472|FG000|Overall Study|Withdrawal by Subject|2|||
125446324|NCT00442286|451259473|FG001|Overall Study|Withdrawal by Subject|0|||
125446325|NCT00442286|451259472|FG000|Overall Study|System explanted|1|||
125446326|NCT00442286|451259473|FG001|Overall Study|System explanted|0|||
125446327|NCT00442286|451259472|FG000|Overall Study|Patient Injury|1|||
125446328|NCT00442286|451259473|FG001|Overall Study|Patient Injury|0|||
125446329|NCT01544582|451259474|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
125446330|NCT01544582|451259475|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
125446331|NCT01544582|451259476|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
125446332|NCT01544582|451259477|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
125446333|NCT01544582|451259474|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
125262281|NCT01156844|450589880|FG000|Overall Study|Adverse Event|0|||
125446334|NCT01544582|451259475|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
125446335|NCT01544582|451259476|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
125446336|NCT01544582|451259477|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
125446337|NCT01544582|451259474|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
125446338|NCT01544582|451259475|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
125446339|NCT01544582|451259476|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
125262282|NCT01156844|450589881|FG001|Overall Study|Adverse Event|0|||
125262283|NCT01156844|450589882|FG002|Overall Study|Adverse Event|1|||
125446340|NCT01544582|451259477|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
125446341|NCT01544582|451259474|FG000|Analysis Population|Physician Decision|0|||
125262284|NCT01156844|450589883|FG003|Overall Study|Adverse Event|1|||
125262285|NCT01156844|450589880|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125446342|NCT01544582|451259475|FG001|Analysis Population|Physician Decision|13|||
125446343|NCT01544582|451259476|FG002|Analysis Population|Physician Decision|10|||
125446344|NCT01544582|451259477|FG003|Analysis Population|Physician Decision|9|||
125446345|NCT01544582|451259474|FG000|Analysis Population|Safety Reason|0|||
125446346|NCT01544582|451259475|FG001|Analysis Population|Safety Reason|33|||
125446347|NCT01544582|451259476|FG002|Analysis Population|Safety Reason|31|||
125446348|NCT01544582|451259477|FG003|Analysis Population|Safety Reason|8|||
125446349|NCT01544582|451259474|FG000|Analysis Population|Effectiveness Reason|0|||
125446350|NCT01544582|451259475|FG001|Analysis Population|Effectiveness Reason|48|||
125446351|NCT01544582|451259476|FG002|Analysis Population|Effectiveness Reason|29|||
125446352|NCT01544582|451259477|FG003|Analysis Population|Effectiveness Reason|12|||
125446353|NCT01544582|451259474|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
125446354|NCT01544582|451259475|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
125446355|NCT01544582|451259476|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
125446356|NCT01544582|451259477|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
125446357|NCT01544582|451259474|FG000|Analysis Population|Lost to Follow-up|0|||
125446358|NCT01544582|451259475|FG001|Analysis Population|Lost to Follow-up|6|||
125446359|NCT01544582|451259476|FG002|Analysis Population|Lost to Follow-up|6|||
125446360|NCT01544582|451259477|FG003|Analysis Population|Lost to Follow-up|5|||
125446361|NCT01544582|451259474|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
125446362|NCT01544582|451259475|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
125446363|NCT01544582|451259476|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
125446364|NCT01544582|451259477|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
125446365|NCT01544582|451259474|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
125446366|NCT01544582|451259475|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
125446367|NCT01544582|451259476|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
125446368|NCT01544582|451259477|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
125446369|NCT01544582|451259474|FG000|Analysis Population|Intolerance|0|||
125446370|NCT01544582|451259475|FG001|Analysis Population|Intolerance|1|||
125446371|NCT01544582|451259476|FG002|Analysis Population|Intolerance|0|||
125446372|NCT01544582|451259477|FG003|Analysis Population|Intolerance|0|||
125446373|NCT01544582|451259474|FG000|Analysis Population|Liver Transplantation|0|||
125446374|NCT01544582|451259475|FG001|Analysis Population|Liver Transplantation|0|||
125446375|NCT01544582|451259476|FG002|Analysis Population|Liver Transplantation|1|||
125446376|NCT01544582|451259477|FG003|Analysis Population|Liver Transplantation|0|||
125446377|NCT01544582|451259474|FG000|Analysis Population|No Social Insurance|0|||
125446378|NCT01544582|451259475|FG001|Analysis Population|No Social Insurance|0|||
125446379|NCT01544582|451259476|FG002|Analysis Population|No Social Insurance|1|||
125446380|NCT01544582|451259477|FG003|Analysis Population|No Social Insurance|0|||
125446381|NCT01544582|451259474|FG000|Analysis Population|Poor Adherence|0|||
125446382|NCT01544582|451259475|FG001|Analysis Population|Poor Adherence|0|||
125446383|NCT01544582|451259476|FG002|Analysis Population|Poor Adherence|1|||
125446384|NCT01544582|451259477|FG003|Analysis Population|Poor Adherence|0|||
125446385|NCT01544582|451259474|FG000|Analysis Population|Poor Participant Compliance|0|||
125446386|NCT01544582|451259475|FG001|Analysis Population|Poor Participant Compliance|1|||
125446387|NCT01544582|451259476|FG002|Analysis Population|Poor Participant Compliance|0|||
125446388|NCT01544582|451259477|FG003|Analysis Population|Poor Participant Compliance|0|||
125446389|NCT01544582|451259474|FG000|Analysis Population|Programmed Surgery|0|||
125446390|NCT01544582|451259475|FG001|Analysis Population|Programmed Surgery|1|||
125446391|NCT01544582|451259476|FG002|Analysis Population|Programmed Surgery|0|||
125446392|NCT01544582|451259477|FG003|Analysis Population|Programmed Surgery|0|||
125446393|NCT01544582|451259474|FG000|Analysis Population|Participant in Jail|0|||
125446394|NCT01544582|451259475|FG001|Analysis Population|Participant in Jail|0|||
125446395|NCT01544582|451259476|FG002|Analysis Population|Participant in Jail|1|||
125446396|NCT01544582|451259477|FG003|Analysis Population|Participant in Jail|0|||
125446397|NCT03428815|451259478|FG000|Overall Study|Lost to Follow-up|2|||
125446398|NCT03428815|451259479|FG001|Overall Study|Lost to Follow-up|2|||
125446399|NCT03428815|451259478|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
125446400|NCT03428815|451259479|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
125262286|NCT01156844|450589881|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125262287|NCT01156844|450589882|FG002|Overall Study|Abnormal test procedure result(s)|2|||
125262288|NCT01156844|450589883|FG003|Overall Study|Abnormal test procedure result(s)|2|||
125262289|NCT01156844|450589880|FG000|Overall Study|Withdrawal by Subject|0|||
125262290|NCT01156844|450589881|FG001|Overall Study|Withdrawal by Subject|0|||
125446401|NCT03428815|451259478|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
125446402|NCT03428815|451259479|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
125446403|NCT01700348|451259480|FG000|Overall Study|Withdrawal by Subject|22|||
125446404|NCT01700348|451259480|FG000|Overall Study|Lost to Follow-up|1|||
125446405|NCT01778062|451259481|FG000|Overall Study|Adverse Event|1|||
125446406|NCT01778062|451259482|FG001|Overall Study|Adverse Event|3|||
125446407|NCT01778062|451259481|FG000|Overall Study|Consent Withdrawal|1|||
125446408|NCT01778062|451259482|FG001|Overall Study|Consent Withdrawal|5|||
125446409|NCT01778062|451259481|FG000|Overall Study|major protocol deviation|4|||
125446410|NCT01778062|451259482|FG001|Overall Study|major protocol deviation|3|||
125446411|NCT01824472|451259485|FG000|Overall Study|Lost to Follow-up|0|||
125446412|NCT01824472|451259486|FG001|Overall Study|Lost to Follow-up|0|||
125262291|NCT01156844|450589882|FG002|Overall Study|Withdrawal by Subject|2|||
125262292|NCT01156844|450589883|FG003|Overall Study|Withdrawal by Subject|2|||
125262293|NCT01156844|450589880|FG000|Overall Study|Lost to Follow-up|0|||
125262294|NCT01156844|450589881|FG001|Overall Study|Lost to Follow-up|0|||
125262295|NCT01156844|450589882|FG002|Overall Study|Lost to Follow-up|1|||
125262296|NCT01156844|450589883|FG003|Overall Study|Lost to Follow-up|0|||
125262297|NCT01156844|450589880|FG000|Overall Study|Administrative problems|0|||
125262298|NCT01156844|450589881|FG001|Overall Study|Administrative problems|1|||
125262299|NCT01156844|450589882|FG002|Overall Study|Administrative problems|0|||
125262300|NCT01156844|450589883|FG003|Overall Study|Administrative problems|1|||
125262301|NCT01156844|450589880|FG000|Overall Study|Protocol deviation|2|||
125262302|NCT01156844|450589881|FG001|Overall Study|Protocol deviation|0|||
125262303|NCT01156844|450589882|FG002|Overall Study|Protocol deviation|0|||
125262304|NCT01156844|450589883|FG003|Overall Study|Protocol deviation|0|||
125262305|NCT00107276|450589887|FG000|Overall Study|Progression|46|||
125262306|NCT00107276|450589887|FG000|Overall Study|Adverse Event|6|||
125262307|NCT00107276|450589887|FG000|Overall Study|M.D. decision|2|||
125262308|NCT00107276|450589887|FG000|Overall Study|Patient refusal|1|||
125262309|NCT00107276|450589887|FG000|Overall Study|Death|1|||
125262310|NCT00107276|450589887|FG000|Overall Study|Ineligible|16|||
125262311|NCT04846231|450589888|FG000|Overall Study|Lost to Follow-up|1|||
125262312|NCT04846231|450589889|FG001|Overall Study|Lost to Follow-up|0|||
125262313|NCT04846231|450589890|FG002|Overall Study|Lost to Follow-up|0|||
125262314|NCT04846231|450589891|FG003|Overall Study|Lost to Follow-up|0|||
125262315|NCT04846231|450589892|FG004|Overall Study|Lost to Follow-up|0|||
125262316|NCT04846231|450589893|FG005|Overall Study|Lost to Follow-up|0|||
125262317|NCT04846231|450589894|FG006|Overall Study|Lost to Follow-up|0|||
125262318|NCT04846231|450589895|FG007|Overall Study|Lost to Follow-up|1|||
125262319|NCT04846231|450589888|FG000|Overall Study|Withdrawal by Subject|0|||
125262320|NCT04846231|450589889|FG001|Overall Study|Withdrawal by Subject|1|||
125262321|NCT04846231|450589890|FG002|Overall Study|Withdrawal by Subject|2|||
125262322|NCT04846231|450589891|FG003|Overall Study|Withdrawal by Subject|1|||
125262323|NCT04846231|450589892|FG004|Overall Study|Withdrawal by Subject|0|||
125262324|NCT04846231|450589893|FG005|Overall Study|Withdrawal by Subject|0|||
125262325|NCT04846231|450589894|FG006|Overall Study|Withdrawal by Subject|0|||
125262326|NCT04846231|450589895|FG007|Overall Study|Withdrawal by Subject|0|||
125262327|NCT04846231|450589888|FG000|Overall Study|Protocol Violation|0|||
125262328|NCT04846231|450589889|FG001|Overall Study|Protocol Violation|1|||
125262329|NCT04846231|450589890|FG002|Overall Study|Protocol Violation|0|||
125262330|NCT04846231|450589891|FG003|Overall Study|Protocol Violation|0|||
125262331|NCT04846231|450589892|FG004|Overall Study|Protocol Violation|0|||
125262332|NCT04846231|450589893|FG005|Overall Study|Protocol Violation|0|||
125262333|NCT04846231|450589894|FG006|Overall Study|Protocol Violation|0|||
125262334|NCT04846231|450589895|FG007|Overall Study|Protocol Violation|0|||
125262335|NCT04846231|450589888|FG000|Overall Study|Adverse Event|0|||
125262336|NCT04846231|450589889|FG001|Overall Study|Adverse Event|0|||
125262337|NCT04846231|450589890|FG002|Overall Study|Adverse Event|0|||
125262338|NCT04846231|450589891|FG003|Overall Study|Adverse Event|0|||
125262339|NCT04846231|450589892|FG004|Overall Study|Adverse Event|0|||
125262340|NCT04846231|450589893|FG005|Overall Study|Adverse Event|0|||
125262341|NCT04846231|450589894|FG006|Overall Study|Adverse Event|1|||
125262342|NCT04846231|450589895|FG007|Overall Study|Adverse Event|1|||
125262343|NCT02980107|450589896|FG000|Overall Study|Withdrawal by Subject|51|||
125262344|NCT02980107|450589897|FG001|Overall Study|Withdrawal by Subject|62|||
125262345|NCT01448616|450589899|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
125262346|NCT01448616|450589900|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
125262347|NCT01448616|450589901|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
125262348|NCT01448616|450589902|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
125262349|NCT01448616|450589899|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
125262350|NCT01448616|450589900|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
125262351|NCT01448616|450589901|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
125262352|NCT01448616|450589902|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
125262353|NCT01448616|450589899|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
125262354|NCT01448616|450589900|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
125262355|NCT01448616|450589901|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
125262356|NCT01448616|450589902|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
125262357|NCT01448616|450589899|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
125262358|NCT01448616|450589900|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
125262359|NCT01448616|450589901|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
125262360|NCT01448616|450589902|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
125262361|NCT01448616|450589899|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
125262362|NCT01448616|450589900|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
125262363|NCT01448616|450589901|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
125262364|NCT01448616|450589902|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
125262365|NCT00397540|450589905|FG000|Overall Study|short follow-up duration < 12 months|1|||
125262366|NCT00397540|450589906|FG001|Overall Study|short follow-up duration < 12 months|0|||
125262367|NCT00485173|450589910|FG000|Overall Study|Death|4|||
125262368|NCT00485173|450589911|FG001|Overall Study|Death|3|||
125262369|NCT00485173|450589910|FG000|Overall Study|Lost to Follow-up|32|||
125262370|NCT00485173|450589911|FG001|Overall Study|Lost to Follow-up|61|||
125262371|NCT00746811|450589912|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
125262372|NCT00746811|450589913|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
125262373|NCT00829998|450589916|FG000|Washout|Adverse Event|0|||
125262374|NCT00829998|450589917|FG001|Washout|Adverse Event|1|||
125262375|NCT04712669|450589920|FG000|Double Blind Phase|Adverse Event|4|||
125262376|NCT04712669|450589921|FG001|Double Blind Phase|Adverse Event|4|||
125262377|NCT04712669|450589922|FG002|Double Blind Phase|Adverse Event|3|||
125262378|NCT04712669|450589923|FG003|Double Blind Phase|Adverse Event|0|||
125262379|NCT04712669|450589924|FG004|Double Blind Phase|Adverse Event|0|||
125262380|NCT04712669|450589925|FG005|Double Blind Phase|Adverse Event|0|||
125262381|NCT04712669|450589926|FG006|Double Blind Phase|Adverse Event|0|||
125262382|NCT04712669|450589927|FG007|Double Blind Phase|Adverse Event|0|||
125262383|NCT04712669|450589920|FG000|Double Blind Phase|Physician Decision|1|||
125262384|NCT04712669|450589921|FG001|Double Blind Phase|Physician Decision|0|||
125262385|NCT04712669|450589922|FG002|Double Blind Phase|Physician Decision|0|||
125262386|NCT04712669|450589923|FG003|Double Blind Phase|Physician Decision|0|||
125262387|NCT04712669|450589924|FG004|Double Blind Phase|Physician Decision|0|||
125262388|NCT04712669|450589925|FG005|Double Blind Phase|Physician Decision|0|||
125262389|NCT04712669|450589926|FG006|Double Blind Phase|Physician Decision|0|||
125262390|NCT04712669|450589927|FG007|Double Blind Phase|Physician Decision|0|||
125262391|NCT04712669|450589920|FG000|Double Blind Phase|Withdrawal by Subject|3|||
125262392|NCT04712669|450589921|FG001|Double Blind Phase|Withdrawal by Subject|6|||
125262393|NCT04712669|450589922|FG002|Double Blind Phase|Withdrawal by Subject|0|||
125262394|NCT04712669|450589923|FG003|Double Blind Phase|Withdrawal by Subject|0|||
125262395|NCT04712669|450589924|FG004|Double Blind Phase|Withdrawal by Subject|0|||
125262396|NCT04712669|450589925|FG005|Double Blind Phase|Withdrawal by Subject|0|||
125262397|NCT04712669|450589926|FG006|Double Blind Phase|Withdrawal by Subject|0|||
125262398|NCT04712669|450589927|FG007|Double Blind Phase|Withdrawal by Subject|0|||
125262399|NCT04712669|450589920|FG000|Double Blind Phase|Termination by Sponsor|0|||
125262400|NCT04712669|450589921|FG001|Double Blind Phase|Termination by Sponsor|0|||
125262401|NCT04712669|450589922|FG002|Double Blind Phase|Termination by Sponsor|1|||
125262402|NCT04712669|450589923|FG003|Double Blind Phase|Termination by Sponsor|0|||
125262403|NCT04712669|450589924|FG004|Double Blind Phase|Termination by Sponsor|0|||
125262404|NCT04712669|450589925|FG005|Double Blind Phase|Termination by Sponsor|0|||
125262405|NCT04712669|450589926|FG006|Double Blind Phase|Termination by Sponsor|0|||
125262406|NCT04712669|450589927|FG007|Double Blind Phase|Termination by Sponsor|0|||
125262407|NCT04712669|450589920|FG000|Open Label Phase|Adverse Event|0|||
125262408|NCT04712669|450589921|FG001|Open Label Phase|Adverse Event|0|||
125262409|NCT04712669|450589922|FG002|Open Label Phase|Adverse Event|0|||
125262410|NCT04712669|450589923|FG003|Open Label Phase|Adverse Event|1|||
125262411|NCT04712669|450589924|FG004|Open Label Phase|Adverse Event|1|||
125262412|NCT04712669|450589925|FG005|Open Label Phase|Adverse Event|3|||
125262413|NCT04712669|450589926|FG006|Open Label Phase|Adverse Event|1|||
125262414|NCT04712669|450589927|FG007|Open Label Phase|Adverse Event|2|||
125262415|NCT04712669|450589920|FG000|Open Label Phase|Death|0|||
125262416|NCT04712669|450589921|FG001|Open Label Phase|Death|0|||
125262417|NCT04712669|450589922|FG002|Open Label Phase|Death|0|||
125262418|NCT04712669|450589923|FG003|Open Label Phase|Death|1|||
125262419|NCT04712669|450589924|FG004|Open Label Phase|Death|0|||
125262420|NCT04712669|450589925|FG005|Open Label Phase|Death|0|||
125262421|NCT04712669|450589926|FG006|Open Label Phase|Death|0|||
125262422|NCT04712669|450589927|FG007|Open Label Phase|Death|0|||
125262423|NCT04712669|450589920|FG000|Open Label Phase|Lack of Efficacy|0|||
125262424|NCT04712669|450589921|FG001|Open Label Phase|Lack of Efficacy|0|||
125262425|NCT04712669|450589922|FG002|Open Label Phase|Lack of Efficacy|0|||
125262426|NCT04712669|450589923|FG003|Open Label Phase|Lack of Efficacy|0|||
125262427|NCT04712669|450589924|FG004|Open Label Phase|Lack of Efficacy|1|||
125262428|NCT04712669|450589925|FG005|Open Label Phase|Lack of Efficacy|0|||
125262429|NCT04712669|450589926|FG006|Open Label Phase|Lack of Efficacy|0|||
125262430|NCT04712669|450589927|FG007|Open Label Phase|Lack of Efficacy|0|||
125262431|NCT04712669|450589920|FG000|Open Label Phase|Lost to Follow-up|0|||
125262432|NCT04712669|450589921|FG001|Open Label Phase|Lost to Follow-up|0|||
125262433|NCT04712669|450589922|FG002|Open Label Phase|Lost to Follow-up|0|||
125262434|NCT04712669|450589923|FG003|Open Label Phase|Lost to Follow-up|0|||
125262435|NCT04712669|450589924|FG004|Open Label Phase|Lost to Follow-up|0|||
125262436|NCT04712669|450589925|FG005|Open Label Phase|Lost to Follow-up|0|||
125262437|NCT04712669|450589926|FG006|Open Label Phase|Lost to Follow-up|1|||
125262438|NCT04712669|450589927|FG007|Open Label Phase|Lost to Follow-up|1|||
125262439|NCT04712669|450589920|FG000|Open Label Phase|Physician Decision|0|||
125262440|NCT04712669|450589921|FG001|Open Label Phase|Physician Decision|0|||
125398298|NCT04083976|451090974|FG002|Overall Study|Other|1|||
125262441|NCT04712669|450589922|FG002|Open Label Phase|Physician Decision|0|||
125262442|NCT04712669|450589923|FG003|Open Label Phase|Physician Decision|1|||
125398299|NCT04083976|451090975|FG003|Overall Study|Other|0|||
125446413|NCT01824472|451259487|FG002|Overall Study|Lost to Follow-up|1|||
125446414|NCT01824472|451259485|FG000|Overall Study|Withdrawal by Subject|1|||
125446415|NCT01824472|451259486|FG001|Overall Study|Withdrawal by Subject|5|||
125446416|NCT01824472|451259487|FG002|Overall Study|Withdrawal by Subject|3|||
125446417|NCT01824472|451259485|FG000|Overall Study|Ineligible post randomization&screening|0|||
125446418|NCT01824472|451259486|FG001|Overall Study|Ineligible post randomization&screening|2|||
125446419|NCT01824472|451259487|FG002|Overall Study|Ineligible post randomization&screening|0|||
125446420|NCT01815736|451259488|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
125446421|NCT01815736|451259489|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
125446422|NCT01815736|451259488|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
125446423|NCT01815736|451259489|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
125446424|NCT01815736|451259488|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
125446425|NCT01815736|451259489|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
125446426|NCT01815736|451259488|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
125446427|NCT01815736|451259489|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
125446428|NCT01815736|451259488|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
125446429|NCT01815736|451259489|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
125446430|NCT01815736|451259488|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
125446431|NCT01815736|451259489|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
125446432|NCT01815736|451259488|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
125446433|NCT01815736|451259489|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
125446434|NCT01815736|451259488|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
125446435|NCT01815736|451259489|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
125446436|NCT01815736|451259488|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
125446437|NCT01815736|451259489|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
125446438|NCT01815736|451259488|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
125446439|NCT01815736|451259489|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
125446440|NCT01815736|451259488|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
125446441|NCT01815736|451259489|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
125446442|NCT01815736|451259488|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
125446443|NCT01815736|451259489|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
125446444|NCT01815736|451259488|FG000|Extension Treatment Phase- After Week 96|Death|1|||
125446445|NCT01815736|451259489|FG001|Extension Treatment Phase- After Week 96|Death|0|||
125446446|NCT03387514|451259491|FG000|Overall Study|Withdrawal by Subject|2|||
125446447|NCT03387514|451259491|FG000|Overall Study|Physician Decision|1|||
125446448|NCT03387514|451259491|FG000|Overall Study|Lost to Follow-up|2|||
125446449|NCT03317379|451259504|FG000|Overall Study|Lost to Follow-up|0|||
125446450|NCT03317379|451259505|FG001|Overall Study|Lost to Follow-up|3|||
125446451|NCT03317379|451259506|FG002|Overall Study|Lost to Follow-up|2|||
125446452|NCT04445155|451259507|FG000|Overall Study|Lost to Follow-up|11|||
125446453|NCT04445155|451259508|FG001|Overall Study|Lost to Follow-up|2|||
125446454|NCT04445155|451259509|FG002|Overall Study|Lost to Follow-up|3|||
125446455|NCT04445155|451259510|FG003|Overall Study|Lost to Follow-up|0|||
125446456|NCT04445155|451259507|FG000|Overall Study|Withdrawal by Subject|8|||
125446457|NCT04445155|451259508|FG001|Overall Study|Withdrawal by Subject|0|||
125446458|NCT04445155|451259509|FG002|Overall Study|Withdrawal by Subject|0|||
125446459|NCT04445155|451259510|FG003|Overall Study|Withdrawal by Subject|0|||
125262443|NCT04712669|450589924|FG004|Open Label Phase|Physician Decision|0|||
125262444|NCT04712669|450589925|FG005|Open Label Phase|Physician Decision|0|||
125262445|NCT04712669|450589926|FG006|Open Label Phase|Physician Decision|0|||
125262446|NCT04712669|450589927|FG007|Open Label Phase|Physician Decision|0|||
125262447|NCT04712669|450589920|FG000|Open Label Phase|Withdrawal by Subject|0|||
125262448|NCT04712669|450589921|FG001|Open Label Phase|Withdrawal by Subject|0|||
125262449|NCT04712669|450589922|FG002|Open Label Phase|Withdrawal by Subject|0|||
125262450|NCT04712669|450589923|FG003|Open Label Phase|Withdrawal by Subject|1|||
125262451|NCT04712669|450589924|FG004|Open Label Phase|Withdrawal by Subject|5|||
125262452|NCT04712669|450589925|FG005|Open Label Phase|Withdrawal by Subject|5|||
125262453|NCT04712669|450589926|FG006|Open Label Phase|Withdrawal by Subject|0|||
125262454|NCT04712669|450589927|FG007|Open Label Phase|Withdrawal by Subject|4|||
125262455|NCT04712669|450589920|FG000|Open Label Phase|Termination by Sponsor|0|||
125262456|NCT04712669|450589921|FG001|Open Label Phase|Termination by Sponsor|0|||
125262457|NCT04712669|450589922|FG002|Open Label Phase|Termination by Sponsor|0|||
125262458|NCT04712669|450589923|FG003|Open Label Phase|Termination by Sponsor|11|||
125262459|NCT04712669|450589924|FG004|Open Label Phase|Termination by Sponsor|9|||
125262460|NCT04712669|450589925|FG005|Open Label Phase|Termination by Sponsor|14|||
125262461|NCT04712669|450589926|FG006|Open Label Phase|Termination by Sponsor|0|||
125446460|NCT04445155|451259507|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
125446461|NCT04445155|451259508|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
125446462|NCT04445155|451259509|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
125262462|NCT04712669|450589927|FG007|Open Label Phase|Termination by Sponsor|14|||
125262463|NCT01819272|450591928|FG000|Overall Study|Adverse Event|1|||
125262464|NCT01819272|450591929|FG001|Overall Study|Adverse Event|0|||
125262465|NCT01819272|450591930|FG002|Overall Study|Adverse Event|0|||
125262466|NCT01819272|450591931|FG003|Overall Study|Adverse Event|2|||
125262467|NCT01819272|450591932|FG004|Overall Study|Adverse Event|0|||
125262468|NCT01819272|450591933|FG005|Overall Study|Adverse Event|0|||
125262469|NCT01819272|450591928|FG000|Overall Study|Lost to Follow-up|3|||
125262470|NCT01819272|450591929|FG001|Overall Study|Lost to Follow-up|0|||
125262471|NCT01819272|450591930|FG002|Overall Study|Lost to Follow-up|1|||
125262472|NCT01819272|450591931|FG003|Overall Study|Lost to Follow-up|0|||
125262473|NCT01819272|450591932|FG004|Overall Study|Lost to Follow-up|0|||
125262474|NCT01819272|450591933|FG005|Overall Study|Lost to Follow-up|3|||
125262475|NCT01819272|450591928|FG000|Overall Study|Protocol Violation|0|||
125262476|NCT01819272|450591929|FG001|Overall Study|Protocol Violation|0|||
125262477|NCT01819272|450591930|FG002|Overall Study|Protocol Violation|0|||
125262478|NCT01819272|450591931|FG003|Overall Study|Protocol Violation|1|||
125262479|NCT01819272|450591932|FG004|Overall Study|Protocol Violation|2|||
125262480|NCT01819272|450591933|FG005|Overall Study|Protocol Violation|3|||
125262481|NCT01819272|450591928|FG000|Overall Study|Physician Decision|0|||
125262482|NCT01819272|450591929|FG001|Overall Study|Physician Decision|1|||
125262483|NCT01819272|450591930|FG002|Overall Study|Physician Decision|0|||
125262484|NCT01819272|450591931|FG003|Overall Study|Physician Decision|0|||
125262485|NCT01819272|450591932|FG004|Overall Study|Physician Decision|0|||
125262486|NCT01819272|450591933|FG005|Overall Study|Physician Decision|0|||
125262487|NCT01819272|450591928|FG000|Overall Study|Withdrawal of Consent|0|||
125262488|NCT01819272|450591929|FG001|Overall Study|Withdrawal of Consent|1|||
125262489|NCT01819272|450591930|FG002|Overall Study|Withdrawal of Consent|2|||
125262490|NCT01819272|450591931|FG003|Overall Study|Withdrawal of Consent|1|||
125262491|NCT01819272|450591932|FG004|Overall Study|Withdrawal of Consent|0|||
125262492|NCT01819272|450591933|FG005|Overall Study|Withdrawal of Consent|1|||
125262493|NCT01819272|450591928|FG000|Overall Study|Loss of Glucose Control|2|||
125262494|NCT01819272|450591929|FG001|Overall Study|Loss of Glucose Control|1|||
125262495|NCT01819272|450591930|FG002|Overall Study|Loss of Glucose Control|0|||
125262496|NCT01819272|450591931|FG003|Overall Study|Loss of Glucose Control|1|||
125262497|NCT01819272|450591932|FG004|Overall Study|Loss of Glucose Control|2|||
125262498|NCT01819272|450591933|FG005|Overall Study|Loss of Glucose Control|0|||
125262499|NCT00503984|450591934|FG000|Overall Study|Protocol Violation|0|||
125262500|NCT00503984|450591935|FG001|Overall Study|Protocol Violation|1|||
125262501|NCT00503984|450591936|FG002|Overall Study|Protocol Violation|0|||
125262502|NCT00503984|450591937|FG003|Overall Study|Protocol Violation|0|||
125262503|NCT00503984|450591938|FG004|Overall Study|Protocol Violation|0|||
125262504|NCT00503984|450591939|FG005|Overall Study|Protocol Violation|0|||
125262505|NCT00503984|450591934|FG000|Overall Study|Adverse Event|0|||
125262506|NCT00503984|450591935|FG001|Overall Study|Adverse Event|1|||
125262507|NCT00503984|450591936|FG002|Overall Study|Adverse Event|0|||
125262508|NCT00503984|450591937|FG003|Overall Study|Adverse Event|0|||
125262509|NCT00503984|450591938|FG004|Overall Study|Adverse Event|0|||
125262510|NCT00503984|450591939|FG005|Overall Study|Adverse Event|0|||
125262511|NCT00503984|450591934|FG000|Overall Study|Death|0|||
125262512|NCT00503984|450591935|FG001|Overall Study|Death|0|||
125262513|NCT00503984|450591936|FG002|Overall Study|Death|0|||
125262514|NCT00503984|450591937|FG003|Overall Study|Death|0|||
125262515|NCT00503984|450591938|FG004|Overall Study|Death|1|||
125262516|NCT00503984|450591939|FG005|Overall Study|Death|0|||
125262517|NCT01246960|450591942|FG000|Overall Study|Lost to Follow-up|3|||
125262518|NCT01246960|450591943|FG001|Overall Study|Lost to Follow-up|1|||
125262519|NCT01246960|450591942|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
125262520|NCT01246960|450591943|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
125262521|NCT00140140|450591948|FG000|Overall Study|Unacceptable toxicity|1|||
125262522|NCT00140140|450591949|FG001|Overall Study|Unacceptable toxicity|1|||
125262523|NCT00140140|450591950|FG002|Overall Study|Unacceptable toxicity|2|||
125262524|NCT00140140|450591948|FG000|Overall Study|Physician Decision|1|||
125398300|NCT05358821|451090976|FG000|Overall Study|Withdrawal by Subject|0|||
125262525|NCT00140140|450591949|FG001|Overall Study|Physician Decision|1|||
125262526|NCT00140140|450591950|FG002|Overall Study|Physician Decision|0|||
125262527|NCT03376516|450591951|FG000|Overall Study|Not treated|1|||
125262528|NCT03376516|450591951|FG000|Overall Study|Consent withdrawn|1|||
125262529|NCT01359956|450591952|FG000|Overall Study|Death|58|||
125262530|NCT01359956|450591953|FG001|Overall Study|Death|60|||
125262531|NCT01359956|450591954|FG002|Overall Study|Death|66|||
125262532|NCT01359956|450591955|FG003|Overall Study|Death|57|||
125398301|NCT05358821|451090977|FG001|Overall Study|Withdrawal by Subject|1|||
125262533|NCT01359956|450591952|FG000|Overall Study|Lost to Follow-up|3|||
125262534|NCT01359956|450591953|FG001|Overall Study|Lost to Follow-up|4|||
125262535|NCT01359956|450591954|FG002|Overall Study|Lost to Follow-up|1|||
125262536|NCT01359956|450591955|FG003|Overall Study|Lost to Follow-up|1|||
125262537|NCT01784029|450591956|FG000|Overall Study|Lost to Follow-up|19|||
125262538|NCT01784029|450591957|FG001|Overall Study|Lost to Follow-up|20|||
125262539|NCT01784029|450591958|FG002|Overall Study|Lost to Follow-up|22|||
125446463|NCT04445155|451259510|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
125446464|NCT04445155|451259507|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
125446465|NCT04445155|451259508|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
125262540|NCT00639457|450591959|FG000|Overall Study|Withdrawal by Subject|2|||
125262541|NCT00639457|450591960|FG001|Overall Study|Withdrawal by Subject|3|||
125262542|NCT00370292|450591961|FG000|Overall Study|Disease Progression|4|||
125262543|NCT00370292|450591961|FG000|Overall Study|Adverse Event|7|||
125262544|NCT00370292|450591961|FG000|Overall Study|Physician Decision|2|||
125262545|NCT00276419|450591962|FG000|First Intervention|Adverse Event|1|||
125262546|NCT00276419|450591963|FG001|First Intervention|Adverse Event|0|||
125262547|NCT00276419|450591962|FG000|First Intervention|Withdrawal by Subject|0|||
125262548|NCT00276419|450591963|FG001|First Intervention|Withdrawal by Subject|2|||
125446466|NCT04445155|451259509|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
125446467|NCT04445155|451259510|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
125446468|NCT00550173|451259511|FG000|Overall Study|Death|45|||
125262549|NCT04778592|450591970|FG000|Overall Study|Adverse Event|1|||
125262550|NCT04778592|450591971|FG001|Overall Study|Adverse Event|2|||
125262551|NCT04778592|450591970|FG000|Overall Study|Withdrawal by Subject|1|||
125262552|NCT04778592|450591971|FG001|Overall Study|Withdrawal by Subject|2|||
125262553|NCT01192126|450591972|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
125262554|NCT01192126|450591973|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
125262555|NCT01192126|450591972|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
125262556|NCT01192126|450591973|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
125262557|NCT02660229|450591974|FG000|Overall Study|Adverse Event|2|||
125262558|NCT02660229|450591975|FG001|Overall Study|Adverse Event|0|||
125446469|NCT00550173|451259512|FG001|Overall Study|Death|38|||
125446470|NCT00550173|451259513|FG002|Overall Study|Death|50|||
125446471|NCT00550173|451259511|FG000|Overall Study|Physician Decision|1|||
125446472|NCT00550173|451259512|FG001|Overall Study|Physician Decision|2|||
125446473|NCT00550173|451259513|FG002|Overall Study|Physician Decision|2|||
125446474|NCT00550173|451259511|FG000|Overall Study|Withdrawal by Subject|9|||
125446475|NCT00550173|451259512|FG001|Overall Study|Withdrawal by Subject|12|||
125446476|NCT00550173|451259513|FG002|Overall Study|Withdrawal by Subject|17|||
125446477|NCT00550173|451259511|FG000|Overall Study|Sponsor Decision|13|||
125446478|NCT00550173|451259512|FG001|Overall Study|Sponsor Decision|7|||
125446479|NCT00550173|451259513|FG002|Overall Study|Sponsor Decision|1|||
125446480|NCT00550173|451259511|FG000|Overall Study|Lost to Follow-up|4|||
125446481|NCT00550173|451259512|FG001|Overall Study|Lost to Follow-up|4|||
125446482|NCT00550173|451259513|FG002|Overall Study|Lost to Follow-up|3|||
125446483|NCT01556243|451259514|FG000|Overall Study|Ineligible|34|||
125446484|NCT01556243|451259514|FG000|Overall Study|Converted to mastectomy|14|||
125446485|NCT01556243|451259514|FG000|Overall Study|Unable to achieve negative margins|2|||
125446486|NCT01556243|451259514|FG000|Overall Study|Withdrawal by Subject|16|||
125446487|NCT01388543|451259515|FG000|Day 14|Adverse Event|1|||
125446488|NCT01388543|451259516|FG001|Day 14|Adverse Event|4|||
125446489|NCT01213173|451259518|FG000|Overall Study|Protocol Violation|2|||
125446490|NCT01213173|451259519|FG001|Overall Study|Protocol Violation|0|||
125446491|NCT01213173|451259518|FG000|Overall Study|Adverse Event|4|||
125446492|NCT01213173|451259519|FG001|Overall Study|Adverse Event|8|||
125446493|NCT01213173|451259518|FG000|Overall Study|Withdrawal by Subject|5|||
125446494|NCT01213173|451259519|FG001|Overall Study|Withdrawal by Subject|5|||
125446495|NCT01213173|451259518|FG000|Overall Study|Incorrect Enrollment|1|||
125446496|NCT01213173|451259519|FG001|Overall Study|Incorrect Enrollment|3|||
125446497|NCT04880161|451259522|FG000|Overall Study|Withdrawal by Subject|1|||
125446498|NCT04880161|451259523|FG001|Overall Study|Withdrawal by Subject|0|||
125446499|NCT04880161|451259522|FG000|Overall Study|Lack of Compliance|1|||
125262559|NCT02660229|450591974|FG000|Overall Study|Withdrawal by Subject|0|||
125262560|NCT02660229|450591975|FG001|Overall Study|Withdrawal by Subject|1|||
125262561|NCT00399529|450591976|FG000|Overall Study|Off Study Prior to Treatment|2|||
125262562|NCT02133573|450591977|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
125262563|NCT02133573|450591978|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
125262564|NCT02133573|450591977|FG000|Overall Study|Child Deaths|3|||
125262565|NCT02133573|450591978|FG001|Overall Study|Child Deaths|5|||
125262566|NCT02133573|450591977|FG000|Overall Study|Child Declined Follow Ups|2|||
125262567|NCT02133573|450591978|FG001|Overall Study|Child Declined Follow Ups|1|||
125262568|NCT02133573|450591977|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
125446500|NCT04880161|451259523|FG001|Overall Study|Lack of Compliance|1|||
125446501|NCT04880161|451259522|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
125446502|NCT04880161|451259523|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
125446503|NCT04880161|451259522|FG000|Overall Study|Screen Failure|0|||
125446504|NCT04880161|451259523|FG001|Overall Study|Screen Failure|1|||
125446505|NCT00731042|451260999|FG000|Second Intervention|Did not meet inclusion criteria|0|||
125446506|NCT00731042|451261000|FG001|Second Intervention|Did not meet inclusion criteria|2|||
125446507|NCT02692235|451261001|FG000|Overall Study|Withdrawal by Subject|2|||
125262569|NCT02133573|450591978|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
125262570|NCT02431325|450591981|FG000|Overall Study|Adverse Event|3|||
125262571|NCT02431325|450591982|FG001|Overall Study|Adverse Event|0|||
125262572|NCT02431325|450591981|FG000|Overall Study|Lost to Follow-up|0|||
125262573|NCT02431325|450591982|FG001|Overall Study|Lost to Follow-up|1|||
125262574|NCT02431325|450591981|FG000|Overall Study|Withdrawal by Subject|1|||
125262575|NCT02431325|450591982|FG001|Overall Study|Withdrawal by Subject|2|||
125262576|NCT02431325|450591981|FG000|Overall Study|Declined to take study medication|1|||
125262577|NCT02431325|450591982|FG001|Overall Study|Declined to take study medication|0|||
125262578|NCT02431325|450591981|FG000|Overall Study|Withdrew before starting study medication|1|||
125262579|NCT02431325|450591982|FG001|Overall Study|Withdrew before starting study medication|0|||
125262580|NCT02431325|450591981|FG000|Overall Study|Placebo shortage|2|||
125262581|NCT02431325|450591982|FG001|Overall Study|Placebo shortage|0|||
125262582|NCT00744861|450591983|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
125262583|NCT00744861|450591984|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
125262584|NCT00744861|450591985|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
125262585|NCT00744861|450591986|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
125262586|NCT00744861|450591983|FG000|Feasibility Stage 1|Pregnancy|0|||
125262587|NCT00744861|450591984|FG001|Feasibility Stage 1|Pregnancy|1|||
125262588|NCT00744861|450591985|FG002|Feasibility Stage 1|Pregnancy|0|||
125262589|NCT00744861|450591986|FG003|Feasibility Stage 1|Pregnancy|0|||
125262590|NCT00744861|450591983|FG000|Pivotal Stage 2|Adverse Event|0|||
125262591|NCT00744861|450591984|FG001|Pivotal Stage 2|Adverse Event|0|||
125262592|NCT00744861|450591985|FG002|Pivotal Stage 2|Adverse Event|6|||
125262593|NCT00744861|450591986|FG003|Pivotal Stage 2|Adverse Event|11|||
125262594|NCT00744861|450591983|FG000|Pivotal Stage 2|Death|0|||
125262595|NCT00744861|450591984|FG001|Pivotal Stage 2|Death|0|||
125262596|NCT00744861|450591985|FG002|Pivotal Stage 2|Death|0|||
125262597|NCT00744861|450591986|FG003|Pivotal Stage 2|Death|1|||
125262598|NCT00744861|450591983|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
125262599|NCT00744861|450591984|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
125262600|NCT00744861|450591985|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
125262601|NCT00744861|450591986|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
125262602|NCT00744861|450591983|FG000|Pivotal Stage 2|Physician Decision|0|||
125262603|NCT00744861|450591984|FG001|Pivotal Stage 2|Physician Decision|0|||
125262604|NCT00744861|450591985|FG002|Pivotal Stage 2|Physician Decision|3|||
125262605|NCT00744861|450591986|FG003|Pivotal Stage 2|Physician Decision|1|||
125262606|NCT00744861|450591983|FG000|Pivotal Stage 2|Protocol Violation|0|||
125262607|NCT00744861|450591984|FG001|Pivotal Stage 2|Protocol Violation|0|||
125262608|NCT00744861|450591985|FG002|Pivotal Stage 2|Protocol Violation|0|||
125262609|NCT00744861|450591986|FG003|Pivotal Stage 2|Protocol Violation|1|||
125262610|NCT00744861|450591983|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
125262611|NCT00744861|450591984|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
125262612|NCT00744861|450591985|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
125262613|NCT00744861|450591986|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
125262614|NCT00744861|450591983|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
125262615|NCT00744861|450591984|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
125262616|NCT00744861|450591985|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
125262617|NCT00744861|450591986|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
125262618|NCT01567722|450591997|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
125262619|NCT01567722|450591998|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
125262620|NCT01567722|450591999|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
125262621|NCT01567722|450591997|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
125262622|NCT01567722|450591998|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
125398302|NCT05358821|451090978|FG002|Overall Study|Withdrawal by Subject|0|||
125398303|NCT05358821|451090976|FG000|Overall Study|Withdrawal of Consent|0|||
125398304|NCT05358821|451090977|FG001|Overall Study|Withdrawal of Consent|0|||
125398305|NCT05358821|451090978|FG002|Overall Study|Withdrawal of Consent|1|||
125398306|NCT02504372|451090979|FG000|Overall Study|Death|136|||
125398307|NCT02504372|451090980|FG001|Overall Study|Death|154|||
125262623|NCT01567722|450591999|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
125262624|NCT01567722|450591997|FG000|Overall Study|Protocol closure by the OCG|2|||
125262625|NCT01567722|450591998|FG001|Overall Study|Protocol closure by the OCG|0|||
125398308|NCT02504372|451090979|FG000|Overall Study|Lost to Follow-up|0|||
125262626|NCT01567722|450591999|FG002|Overall Study|Protocol closure by the OCG|0|||
125262627|NCT01567722|450591997|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
125262628|NCT01567722|450591998|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
125262629|NCT01567722|450591999|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
125262630|NCT00382174|450592000|FG000|Overall Study|Lost to Follow-up|1|||
125262631|NCT00382174|450592001|FG001|Overall Study|Lost to Follow-up|4|||
125262632|NCT00382174|450592002|FG002|Overall Study|Lost to Follow-up|5|||
125262633|NCT00382174|450592000|FG000|Overall Study|Adverse Event|1|||
125398309|NCT02504372|451090980|FG001|Overall Study|Lost to Follow-up|2|||
125446508|NCT02692235|451261002|FG001|Overall Study|Withdrawal by Subject|1|||
125446509|NCT02692235|451261001|FG000|Overall Study|Adverse Event|1|||
125446510|NCT02692235|451261002|FG001|Overall Study|Adverse Event|2|||
125446511|NCT00802841|451261003|FG000|Overall Study|Administrative problems|1|||
125446512|NCT00802841|451261004|FG001|Overall Study|Administrative problems|0|||
125446513|NCT00802841|451261003|FG000|Overall Study|Lost to Follow-up|2|||
125446514|NCT00802841|451261004|FG001|Overall Study|Lost to Follow-up|1|||
125446515|NCT00802841|451261003|FG000|Overall Study|Death|1|||
125446516|NCT00802841|451261004|FG001|Overall Study|Death|2|||
125446517|NCT00802841|451261003|FG000|Overall Study|Adverse Event|8|||
125446518|NCT00802841|451261004|FG001|Overall Study|Adverse Event|2|||
125446519|NCT00802841|451261003|FG000|Overall Study|Disease progression|7|||
125446520|NCT00802841|451261004|FG001|Overall Study|Disease progression|3|||
125446521|NCT00802841|451261003|FG000|Overall Study|Withdrawal by Subject|9|||
125446522|NCT00802841|451261004|FG001|Overall Study|Withdrawal by Subject|5|||
125446523|NCT00802841|451261003|FG000|Overall Study|Protocol deviation|2|||
125446524|NCT00802841|451261004|FG001|Overall Study|Protocol deviation|6|||
125446525|NCT00802841|451261003|FG000|Overall Study|Treatment duration completed|66|||
125446526|NCT00802841|451261004|FG001|Overall Study|Treatment duration completed|76|||
125446527|NCT02711995|451261007|FG000|Washout (90 Days)|Conflicting medication|1|||
125446528|NCT04990440|451261019|FG000|Overall Study|Sponsor's Decision|0|||
125446529|NCT04990440|451261020|FG001|Overall Study|Sponsor's Decision|0|||
125446530|NCT04990440|451261021|FG002|Overall Study|Sponsor's Decision|1|||
125446531|NCT03712098|451261022|FG000|Overall Study|Lost to Follow-up|3|||
125446532|NCT03712098|451261023|FG001|Overall Study|Lost to Follow-up|7|||
125446533|NCT03712098|451261022|FG000|Overall Study|Withdrawal by Subject|9|||
125446534|NCT03712098|451261023|FG001|Overall Study|Withdrawal by Subject|4|||
125446535|NCT03712098|451261022|FG000|Overall Study|Protocol Violation|2|||
125446536|NCT03712098|451261023|FG001|Overall Study|Protocol Violation|1|||
125446537|NCT00724061|451261026|FG000|Dose Escalation Phase|Adverse Event|2|||
125446538|NCT00724061|451261026|FG000|Dose Escalation Phase|Disease Progression|3|||
125446539|NCT00688259|451261031|FG000|Overall Study|Lost to Follow-up|2|||
125446540|NCT00688259|451261032|FG001|Overall Study|Lost to Follow-up|4|||
125446541|NCT00688259|451261031|FG000|Overall Study|Physician Decision|1|||
125446542|NCT00688259|451261032|FG001|Overall Study|Physician Decision|0|||
125446543|NCT00688259|451261031|FG000|Overall Study|Withdrawal by Subject|2|||
125446544|NCT00688259|451261032|FG001|Overall Study|Withdrawal by Subject|0|||
125446545|NCT00688259|451261031|FG000|Overall Study|Declined Interview|2|||
125446546|NCT00688259|451261032|FG001|Overall Study|Declined Interview|3|||
125446547|NCT00688259|451261031|FG000|Overall Study|Hospitalized at Follow-up|0|||
125446548|NCT00688259|451261032|FG001|Overall Study|Hospitalized at Follow-up|1|||
125446549|NCT02954575|451261033|FG000|Overall Study|Withdrawal by Subject|2|||
125446550|NCT02954575|451261033|FG000|Overall Study|Adverse Event|1|||
125446551|NCT01734382|451261035|FG000|Part 1|Adverse Event|2|||
125446552|NCT01734382|451261036|FG001|Part 1|Adverse Event|0|||
125446553|NCT01734382|451261037|FG002|Part 1|Adverse Event|0|||
125446554|NCT01734382|451261035|FG000|Part 2|Adverse Event|0|||
125446555|NCT01734382|451261036|FG001|Part 2|Adverse Event|0|||
125446556|NCT01734382|451261037|FG002|Part 2|Adverse Event|1|||
125446557|NCT01734382|451261035|FG000|Part 2|Lack of Efficacy|0|||
125446558|NCT01734382|451261036|FG001|Part 2|Lack of Efficacy|1|||
125446559|NCT01734382|451261037|FG002|Part 2|Lack of Efficacy|1|||
125446560|NCT01734382|451261035|FG000|Part 2|Other|0|||
125446561|NCT01734382|451261036|FG001|Part 2|Other|0|||
125446562|NCT01734382|451261037|FG002|Part 2|Other|1|||
125446563|NCT01734382|451261035|FG000|Part 2|Physician Decision|0|||
125446564|NCT01734382|451261036|FG001|Part 2|Physician Decision|0|||
125446565|NCT01734382|451261037|FG002|Part 2|Physician Decision|3|||
125446566|NCT01734382|451261035|FG000|Part 2|Protocol Violation|0|||
125446567|NCT01734382|451261036|FG001|Part 2|Protocol Violation|1|||
125446568|NCT01734382|451261037|FG002|Part 2|Protocol Violation|0|||
125446569|NCT01734382|451261035|FG000|Part 2|Withdrawal by Subject|0|||
125446570|NCT01734382|451261036|FG001|Part 2|Withdrawal by Subject|0|||
125446571|NCT01734382|451261037|FG002|Part 2|Withdrawal by Subject|1|||
125446572|NCT03890120|451261038|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
125446573|NCT03890120|451261039|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
125446574|NCT03890120|451261040|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
125446575|NCT03890120|451261041|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
125446576|NCT03890120|451261038|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
125446577|NCT03890120|451261039|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
125446578|NCT03890120|451261040|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
125446579|NCT03890120|451261041|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
125446580|NCT03890120|451261038|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
125446581|NCT03890120|451261039|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
125446582|NCT03890120|451261040|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
125446583|NCT03890120|451261041|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
125446584|NCT03890120|451261038|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
125446585|NCT03890120|451261039|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
125398310|NCT02504372|451090979|FG000|Overall Study|Withdrawal of consent|25|||
125398311|NCT02504372|451090980|FG001|Overall Study|Withdrawal of consent|16|||
125398312|NCT02504372|451090979|FG000|Overall Study|Participants ongoing|429|||
125398313|NCT02504372|451090980|FG001|Overall Study|Participants ongoing|415|||
125398314|NCT03901963|451090981|FG000|Overall Study|Lost to Follow-up|1|||
125398315|NCT03901963|451090982|FG001|Overall Study|Lost to Follow-up|1|||
125398316|NCT03901963|451090981|FG000|Overall Study|Physician Decision|1|||
125398317|NCT03901963|451090982|FG001|Overall Study|Physician Decision|2|||
125398318|NCT03901963|451090981|FG000|Overall Study|Protocol Violation|1|||
125398319|NCT03901963|451090982|FG001|Overall Study|Protocol Violation|1|||
125398320|NCT03901963|451090981|FG000|Overall Study|Withdrawal by Subject|4|||
125398321|NCT03901963|451090982|FG001|Overall Study|Withdrawal by Subject|11|||
125398322|NCT03901963|451090981|FG000|Overall Study|Ongoing|84|||
125398323|NCT03901963|451090982|FG001|Overall Study|Ongoing|73|||
125398324|NCT03901963|451090981|FG000|Overall Study|Randomized but not treated|3|||
125398325|NCT03901963|451090982|FG001|Overall Study|Randomized but not treated|3|||
125398326|NCT02703636|451090990|FG000|Overall Study|Adverse Event|14|||
125398327|NCT02703636|451090990|FG000|Overall Study|Study stopped by sponsor|1|||
125398328|NCT02703636|451090990|FG000|Overall Study|Withdrawal by Subject|1|||
125398329|NCT00393939|451090991|FG000|Overall Study|Protocol Violation|1|||
125398330|NCT00393939|451090992|FG001|Overall Study|Protocol Violation|1|||
125398331|NCT00393939|451090991|FG000|Overall Study|Lost to Follow-up|2|||
125398332|NCT00393939|451090992|FG001|Overall Study|Lost to Follow-up|4|||
125398333|NCT00393939|451090991|FG000|Overall Study|Death|10|||
125398334|NCT00393939|451090992|FG001|Overall Study|Death|4|||
125398335|NCT00393939|451090991|FG000|Overall Study|Sponsor|5|||
125398336|NCT00393939|451090992|FG001|Overall Study|Sponsor|13|||
125398337|NCT00393939|451090991|FG000|Overall Study|Objective progression or relapse|239|||
125398338|NCT00393939|451090992|FG001|Overall Study|Objective progression or relapse|223|||
125398339|NCT00393939|451090991|FG000|Overall Study|Withdrawal by Subject|2|||
125398340|NCT00393939|451090992|FG001|Overall Study|Withdrawal by Subject|7|||
125398341|NCT00393939|451090991|FG000|Overall Study|Other|37|||
125398342|NCT00393939|451090992|FG001|Overall Study|Other|45|||
125398343|NCT04334460|451090998|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
125398344|NCT04334460|451090999|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
125398345|NCT04334460|451090998|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
125398346|NCT04334460|451090999|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
125398347|NCT03995953|451091000|FG000|Overall Study|Death|3|||
125398348|NCT03995953|451091001|FG001|Overall Study|Death|0|||
125398349|NCT03995953|451091002|FG002|Overall Study|Death|3|||
125398350|NCT03995953|451091003|FG003|Overall Study|Death|0|||
125398351|NCT03995953|451091004|FG004|Overall Study|Death|3|||
125398352|NCT03995953|451091005|FG005|Overall Study|Death|0|||
125398353|NCT03995953|451091006|FG006|Overall Study|Death|0|||
125398354|NCT03995953|451091007|FG007|Overall Study|Death|0|||
125398355|NCT03995953|451091008|FG008|Overall Study|Death|1|||
125398356|NCT03995953|451091009|FG009|Overall Study|Death|0|||
125398357|NCT03995953|451091010|FG010|Overall Study|Death|0|||
125398358|NCT03995953|451091011|FG011|Overall Study|Death|0|||
125398359|NCT03995953|451091000|FG000|Overall Study|Lost to Follow-up|6|||
125398360|NCT03995953|451091001|FG001|Overall Study|Lost to Follow-up|54|||
125398361|NCT03995953|451091002|FG002|Overall Study|Lost to Follow-up|3|||
125398362|NCT03995953|451091003|FG003|Overall Study|Lost to Follow-up|32|||
125398363|NCT03995953|451091004|FG004|Overall Study|Lost to Follow-up|5|||
125398364|NCT03995953|451091005|FG005|Overall Study|Lost to Follow-up|44|||
125398365|NCT03995953|451091006|FG006|Overall Study|Lost to Follow-up|0|||
125398366|NCT03995953|451091007|FG007|Overall Study|Lost to Follow-up|31|||
125398367|NCT03995953|451091008|FG008|Overall Study|Lost to Follow-up|8|||
125398368|NCT03995953|451091009|FG009|Overall Study|Lost to Follow-up|36|||
125398369|NCT03995953|451091010|FG010|Overall Study|Lost to Follow-up|5|||
125398370|NCT03995953|451091011|FG011|Overall Study|Lost to Follow-up|41|||
125398371|NCT03995953|451091000|FG000|Overall Study|Withdrawal by Subject|4|||
125398372|NCT03995953|451091001|FG001|Overall Study|Withdrawal by Subject|0|||
125398373|NCT03995953|451091002|FG002|Overall Study|Withdrawal by Subject|1|||
125398374|NCT03995953|451091003|FG003|Overall Study|Withdrawal by Subject|0|||
125398375|NCT03995953|451091004|FG004|Overall Study|Withdrawal by Subject|1|||
125398376|NCT03995953|451091005|FG005|Overall Study|Withdrawal by Subject|0|||
125398377|NCT03995953|451091006|FG006|Overall Study|Withdrawal by Subject|1|||
125398378|NCT03995953|451091007|FG007|Overall Study|Withdrawal by Subject|0|||
125398379|NCT03995953|451091008|FG008|Overall Study|Withdrawal by Subject|3|||
125398380|NCT03995953|451091009|FG009|Overall Study|Withdrawal by Subject|0|||
125398381|NCT03995953|451091010|FG010|Overall Study|Withdrawal by Subject|3|||
125398382|NCT03995953|451091011|FG011|Overall Study|Withdrawal by Subject|0|||
125398383|NCT03995953|451091000|FG000|Overall Study|Health Issues|0|||
125398384|NCT03995953|451091001|FG001|Overall Study|Health Issues|0|||
125398385|NCT03995953|451091002|FG002|Overall Study|Health Issues|0|||
125398386|NCT03995953|451091003|FG003|Overall Study|Health Issues|0|||
125446586|NCT03890120|451261040|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
125446587|NCT03890120|451261041|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
125446588|NCT03890120|451261038|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
125446589|NCT03890120|451261039|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
125446590|NCT03890120|451261040|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
125262634|NCT00382174|450592001|FG001|Overall Study|Adverse Event|4|||
125262635|NCT00382174|450592002|FG002|Overall Study|Adverse Event|5|||
125262636|NCT00382174|450592000|FG000|Overall Study|Withdrawal by Subject|1|||
125262637|NCT00382174|450592001|FG001|Overall Study|Withdrawal by Subject|4|||
125262638|NCT00382174|450592002|FG002|Overall Study|Withdrawal by Subject|5|||
125262639|NCT00382174|450592000|FG000|Overall Study|Non compliance|1|||
125262640|NCT00382174|450592001|FG001|Overall Study|Non compliance|0|||
125262641|NCT00382174|450592002|FG002|Overall Study|Non compliance|1|||
125262642|NCT00382174|450592000|FG000|Overall Study|Physician Decision|0|||
125262643|NCT00382174|450592001|FG001|Overall Study|Physician Decision|2|||
125262644|NCT00382174|450592002|FG002|Overall Study|Physician Decision|2|||
125262645|NCT00382174|450592000|FG000|Overall Study|Failed to meet criteria|0|||
125262646|NCT00382174|450592001|FG001|Overall Study|Failed to meet criteria|1|||
125262647|NCT00382174|450592002|FG002|Overall Study|Failed to meet criteria|1|||
125262648|NCT00382174|450592000|FG000|Overall Study|Wounds merged|0|||
125262649|NCT00382174|450592001|FG001|Overall Study|Wounds merged|2|||
125262650|NCT00382174|450592002|FG002|Overall Study|Wounds merged|2|||
125262651|NCT02170064|450592008|FG000|Overall Study|Withdrawal by Subject|5|||
125262652|NCT02170064|450592009|FG001|Overall Study|Withdrawal by Subject|1|||
125262653|NCT02170064|450592010|FG002|Overall Study|Withdrawal by Subject|1|||
125262654|NCT02170064|450592008|FG000|Overall Study|Physician Decision|1|||
125262655|NCT02170064|450592009|FG001|Overall Study|Physician Decision|1|||
125262656|NCT02170064|450592010|FG002|Overall Study|Physician Decision|0|||
125262657|NCT03323164|450592011|FG000|Overall Study|Poor quality imaging/scans|2|||
125262658|NCT03323164|450592012|FG001|Overall Study|Poor quality imaging/scans|2|||
125262659|NCT03434834|450592013|FG000|Overall Study|unable to swallow OCT probe|16|||
125262660|NCT03508050|450592021|FG000|Overall Study|Pleural adhesions|1|||
125262661|NCT03508050|450592022|FG001|Overall Study|Pleural adhesions|0|||
125262662|NCT03508050|450592021|FG000|Overall Study|Mucus plug|1|||
125262663|NCT03508050|450592022|FG001|Overall Study|Mucus plug|0|||
125262664|NCT03508050|450592021|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
125262665|NCT03508050|450592022|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
125262666|NCT03508050|450592021|FG000|Overall Study|Sustained desaturation|0|||
125262667|NCT03508050|450592022|FG001|Overall Study|Sustained desaturation|1|||
125262668|NCT03710889|450592026|FG000|Overall Study|Adverse Event|2|||
125262669|NCT03710889|450592026|FG000|Overall Study|Protocol Deviation|1|||
125262670|NCT00570713|450592027|FG000|Overall Study|Adverse Event|16|||
125262671|NCT00570713|450592028|FG001|Overall Study|Adverse Event|9|||
125262672|NCT00570713|450592027|FG000|Overall Study|Death|7|||
125262673|NCT00570713|450592028|FG001|Overall Study|Death|7|||
125262674|NCT00570713|450592027|FG000|Overall Study|Lack of Efficacy|40|||
125262675|NCT00570713|450592028|FG001|Overall Study|Lack of Efficacy|49|||
125262676|NCT00570713|450592027|FG000|Overall Study|Physician Decision|2|||
125262677|NCT00570713|450592028|FG001|Overall Study|Physician Decision|2|||
125262678|NCT00570713|450592027|FG000|Overall Study|Withdrawal by Subject|3|||
125262679|NCT00570713|450592028|FG001|Overall Study|Withdrawal by Subject|3|||
125446591|NCT03890120|451261041|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
125446592|NCT03890120|451261038|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
125446593|NCT03890120|451261039|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
125446594|NCT03890120|451261040|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
125446595|NCT03890120|451261041|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
125262680|NCT00570713|450592027|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
125262681|NCT00570713|450592028|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
125262682|NCT04881760|450592029|FG000|Overall Study|Adverse Event|0|||
125262683|NCT04881760|450592030|FG001|Overall Study|Adverse Event|1|||
125262684|NCT04881760|450592031|FG002|Overall Study|Adverse Event|1|||
125262685|NCT04881760|450592032|FG003|Overall Study|Adverse Event|0|||
125262686|NCT04881760|450592033|FG004|Overall Study|Adverse Event|1|||
125262687|NCT04881760|450592034|FG005|Overall Study|Adverse Event|1|||
125262688|NCT04881760|450592035|FG006|Overall Study|Adverse Event|2|||
125262689|NCT04881760|450592029|FG000|Overall Study|Death|0|||
125262690|NCT04881760|450592030|FG001|Overall Study|Death|0|||
125262691|NCT04881760|450592031|FG002|Overall Study|Death|0|||
125262692|NCT04881760|450592032|FG003|Overall Study|Death|1|||
125262693|NCT04881760|450592033|FG004|Overall Study|Death|0|||
125262694|NCT04881760|450592034|FG005|Overall Study|Death|0|||
125262695|NCT04881760|450592035|FG006|Overall Study|Death|0|||
125262696|NCT04881760|450592029|FG000|Overall Study|Lost to Follow-up|5|||
125262697|NCT04881760|450592030|FG001|Overall Study|Lost to Follow-up|7|||
125262698|NCT04881760|450592031|FG002|Overall Study|Lost to Follow-up|5|||
125262699|NCT04881760|450592032|FG003|Overall Study|Lost to Follow-up|1|||
125262700|NCT04881760|450592033|FG004|Overall Study|Lost to Follow-up|2|||
125262701|NCT04881760|450592034|FG005|Overall Study|Lost to Follow-up|4|||
125262702|NCT04881760|450592035|FG006|Overall Study|Lost to Follow-up|4|||
125262703|NCT04881760|450592029|FG000|Overall Study|Withdrawal by Subject|13|||
125262704|NCT04881760|450592030|FG001|Overall Study|Withdrawal by Subject|1|||
125262705|NCT04881760|450592031|FG002|Overall Study|Withdrawal by Subject|1|||
125398387|NCT03995953|451091004|FG004|Overall Study|Health Issues|1|||
125398388|NCT03995953|451091005|FG005|Overall Study|Health Issues|0|||
125398389|NCT03995953|451091006|FG006|Overall Study|Health Issues|0|||
125398390|NCT03995953|451091007|FG007|Overall Study|Health Issues|0|||
125398391|NCT03995953|451091008|FG008|Overall Study|Health Issues|4|||
125398392|NCT03995953|451091009|FG009|Overall Study|Health Issues|0|||
125398393|NCT03995953|451091010|FG010|Overall Study|Health Issues|0|||
125398394|NCT03995953|451091011|FG011|Overall Study|Health Issues|0|||
125398395|NCT03995953|451091000|FG000|Overall Study|Relocated|11|||
125398396|NCT03995953|451091001|FG001|Overall Study|Relocated|0|||
125398397|NCT03995953|451091002|FG002|Overall Study|Relocated|16|||
125398398|NCT03995953|451091003|FG003|Overall Study|Relocated|0|||
125398399|NCT03995953|451091004|FG004|Overall Study|Relocated|14|||
125398400|NCT03995953|451091005|FG005|Overall Study|Relocated|0|||
125398401|NCT03995953|451091006|FG006|Overall Study|Relocated|16|||
125398402|NCT03995953|451091007|FG007|Overall Study|Relocated|0|||
125398403|NCT03995953|451091008|FG008|Overall Study|Relocated|14|||
125398404|NCT03995953|451091009|FG009|Overall Study|Relocated|0|||
125398405|NCT03995953|451091010|FG010|Overall Study|Relocated|15|||
125398406|NCT03995953|451091011|FG011|Overall Study|Relocated|0|||
125398407|NCT02948842|451091012|FG000|Overall Study|Withdrawal by Subject|4|||
125398408|NCT04181827|451091016|FG000|Overall Study|Ongoing|124|||
125398409|NCT04181827|451091017|FG001|Overall Study|Ongoing|157|||
125398410|NCT04181827|451091016|FG000|Overall Study|Death|82|||
125398411|NCT04181827|451091017|FG001|Overall Study|Death|50|||
125398412|NCT04181827|451091016|FG000|Overall Study|Lost to Follow-up|0|||
125398413|NCT04181827|451091017|FG001|Overall Study|Lost to Follow-up|1|||
125398414|NCT04181827|451091016|FG000|Overall Study|Withdrawal by Subject|5|||
125398415|NCT04181827|451091017|FG001|Overall Study|Withdrawal by Subject|0|||
125398416|NCT01256710|451091018|FG000|Overall Study|Death|449|||
125398417|NCT01256710|451091018|FG000|Overall Study|System Explant|67|||
125398418|NCT01256710|451091018|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
125398419|NCT01256710|451091018|FG000|Overall Study|Lost to Follow-up|67|||
125398420|NCT01256710|451091018|FG000|Overall Study|Withdrawal by Subject|29|||
125398421|NCT01256710|451091018|FG000|Overall Study|Physician Decision|9|||
125398422|NCT01256710|451091018|FG000|Overall Study|Subject Noncompliance|2|||
125398423|NCT01256710|451091018|FG000|Overall Study|Study Terminated by Sponsor|273|||
125398424|NCT02681302|451091019|FG000|Overall Study|Withdrawal by Subject|1|||
125398425|NCT02681302|451091020|FG001|Overall Study|Withdrawal by Subject|1|||
125398426|NCT02681302|451091021|FG002|Overall Study|Withdrawal by Subject|0|||
125398427|NCT02681302|451091022|FG003|Overall Study|Withdrawal by Subject|0|||
125398428|NCT02681302|451091023|FG004|Overall Study|Withdrawal by Subject|1|||
125398429|NCT02681302|451091024|FG005|Overall Study|Withdrawal by Subject|0|||
125398430|NCT02681302|451091019|FG000|Overall Study|Screen Failure|2|||
125398431|NCT02681302|451091020|FG001|Overall Study|Screen Failure|4|||
125398432|NCT02681302|451091021|FG002|Overall Study|Screen Failure|2|||
125398433|NCT02681302|451091022|FG003|Overall Study|Screen Failure|0|||
125398434|NCT02681302|451091023|FG004|Overall Study|Screen Failure|1|||
125398435|NCT02681302|451091024|FG005|Overall Study|Screen Failure|1|||
125398436|NCT02681302|451091019|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
125398437|NCT02681302|451091020|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
125398438|NCT02681302|451091021|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
125398439|NCT02681302|451091022|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
125398440|NCT02681302|451091023|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
125398441|NCT02681302|451091024|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
125398442|NCT02942017|451091025|FG000|Overall Study|Adverse Event|0|||
125398443|NCT02942017|451091026|FG001|Overall Study|Adverse Event|1|||
125262706|NCT04881760|450592032|FG003|Overall Study|Withdrawal by Subject|4|||
125398444|NCT02942017|451091025|FG000|Overall Study|Withdrawal by Subject|0|||
125398445|NCT02942017|451091026|FG001|Overall Study|Withdrawal by Subject|1|||
125398446|NCT02942017|451091025|FG000|Overall Study|Lost to Follow-up|1|||
125398447|NCT02942017|451091026|FG001|Overall Study|Lost to Follow-up|1|||
125398448|NCT02942017|451091025|FG000|Overall Study|Randomized but not dosed|1|||
125398449|NCT02942017|451091026|FG001|Overall Study|Randomized but not dosed|3|||
125398450|NCT05059600|451091029|FG000|Overall Study|Enrolled but not Treated|10|||
125398451|NCT02152995|451091030|FG000|Overall Study|Withdrawal by Subject|1|||
125398452|NCT02152995|451091031|FG001|Overall Study|Withdrawal by Subject|0|||
125262707|NCT04881760|450592033|FG004|Overall Study|Withdrawal by Subject|2|||
125398453|NCT04552587|451091033|FG000|Overall Study|Lost to Follow-up|4|||
125398454|NCT00480779|451091034|FG000|Overall Study|Other|2|||
125398455|NCT00480779|451091035|FG001|Overall Study|Other|0|||
125398456|NCT00480779|451091034|FG000|Overall Study|Job and Health-related|0|||
125398457|NCT00480779|451091035|FG001|Overall Study|Job and Health-related|3|||
125262708|NCT04881760|450592034|FG005|Overall Study|Withdrawal by Subject|1|||
125262709|NCT04881760|450592035|FG006|Overall Study|Withdrawal by Subject|2|||
125262710|NCT04881760|450592029|FG000|Overall Study|Randomized but Never Treated|0|||
125262711|NCT04881760|450592030|FG001|Overall Study|Randomized but Never Treated|0|||
125262712|NCT04881760|450592031|FG002|Overall Study|Randomized but Never Treated|0|||
125262713|NCT04881760|450592032|FG003|Overall Study|Randomized but Never Treated|1|||
125262714|NCT04881760|450592033|FG004|Overall Study|Randomized but Never Treated|0|||
125262715|NCT04881760|450592034|FG005|Overall Study|Randomized but Never Treated|0|||
125262716|NCT04881760|450592035|FG006|Overall Study|Randomized but Never Treated|0|||
125262717|NCT04881760|450592029|FG000|Overall Study|Inadvertent Enrollment|2|||
125262718|NCT04881760|450592030|FG001|Overall Study|Inadvertent Enrollment|0|||
125262719|NCT04881760|450592031|FG002|Overall Study|Inadvertent Enrollment|0|||
125262720|NCT04881760|450592032|FG003|Overall Study|Inadvertent Enrollment|0|||
125262721|NCT04881760|450592033|FG004|Overall Study|Inadvertent Enrollment|0|||
125262722|NCT04881760|450592034|FG005|Overall Study|Inadvertent Enrollment|0|||
125262723|NCT04881760|450592035|FG006|Overall Study|Inadvertent Enrollment|0|||
125262724|NCT04881760|450592029|FG000|Overall Study|Site Closure|0|||
125262725|NCT04881760|450592030|FG001|Overall Study|Site Closure|0|||
125262726|NCT04881760|450592031|FG002|Overall Study|Site Closure|0|||
125262727|NCT04881760|450592032|FG003|Overall Study|Site Closure|1|||
125262728|NCT04881760|450592033|FG004|Overall Study|Site Closure|0|||
125262729|NCT04881760|450592034|FG005|Overall Study|Site Closure|0|||
125262730|NCT04881760|450592035|FG006|Overall Study|Site Closure|0|||
125262731|NCT01538199|450592039|FG000|Overall Study|Lost to Follow-up|1|||
125262732|NCT01538199|450592040|FG001|Overall Study|Lost to Follow-up|2|||
125262733|NCT01538199|450592041|FG002|Overall Study|Lost to Follow-up|1|||
125262734|NCT01538199|450592042|FG003|Overall Study|Lost to Follow-up|0|||
125262735|NCT01538199|450592039|FG000|Overall Study|participant did not have time|1|||
125262736|NCT01538199|450592040|FG001|Overall Study|participant did not have time|0|||
125262737|NCT01538199|450592041|FG002|Overall Study|participant did not have time|0|||
125262738|NCT01538199|450592042|FG003|Overall Study|participant did not have time|2|||
125262739|NCT01538199|450592039|FG000|Overall Study|Lack of Efficacy|0|||
125262740|NCT01538199|450592040|FG001|Overall Study|Lack of Efficacy|1|||
125262741|NCT01538199|450592041|FG002|Overall Study|Lack of Efficacy|0|||
125262742|NCT01538199|450592042|FG003|Overall Study|Lack of Efficacy|0|||
125262743|NCT02081586|450592043|FG000|Overall Study|Lost to Follow-up|0|||
125262744|NCT02081586|450592044|FG001|Overall Study|Lost to Follow-up|1|||
125262745|NCT02081586|450592045|FG002|Overall Study|Lost to Follow-up|0|||
125262746|NCT02081586|450592046|FG003|Overall Study|Lost to Follow-up|1|||
125262747|NCT02081586|450592043|FG000|Overall Study|Head injury not related to study|0|||
125262748|NCT02081586|450592044|FG001|Overall Study|Head injury not related to study|0|||
125262749|NCT02081586|450592045|FG002|Overall Study|Head injury not related to study|1|||
125262750|NCT02081586|450592046|FG003|Overall Study|Head injury not related to study|0|||
125262751|NCT01677988|450592049|FG000|Overall Study|Lack of Efficacy|2|||
125262752|NCT00659425|450592053|FG000|Overall Study|Disease progression|1|||
125262753|NCT00659425|450592054|FG001|Overall Study|Disease progression|0|||
125262754|NCT00659425|450592055|FG002|Overall Study|Disease progression|0|||
125262755|NCT00659425|450592056|FG003|Overall Study|Disease progression|1|||
125262756|NCT00659425|450592057|FG004|Overall Study|Disease progression|0|||
125262757|NCT00659425|450592058|FG005|Overall Study|Disease progression|2|||
125262758|NCT00659425|450592059|FG006|Overall Study|Disease progression|4|||
125262759|NCT00659425|450592060|FG007|Overall Study|Disease progression|3|||
125262760|NCT00659425|450592061|FG008|Overall Study|Disease progression|5|||
125262761|NCT00659425|450592062|FG009|Overall Study|Disease progression|3|||
125262762|NCT00659425|450592053|FG000|Overall Study|Death|0|||
125262763|NCT00659425|450592054|FG001|Overall Study|Death|0|||
125262764|NCT00659425|450592055|FG002|Overall Study|Death|0|||
125262765|NCT00659425|450592056|FG003|Overall Study|Death|1|||
125262766|NCT00659425|450592057|FG004|Overall Study|Death|0|||
125262767|NCT00659425|450592058|FG005|Overall Study|Death|0|||
125262768|NCT00659425|450592059|FG006|Overall Study|Death|1|||
125262769|NCT00659425|450592060|FG007|Overall Study|Death|0|||
125262770|NCT00659425|450592061|FG008|Overall Study|Death|0|||
125262771|NCT00659425|450592062|FG009|Overall Study|Death|0|||
125262772|NCT00659425|450592053|FG000|Overall Study|Adverse Event|0|||
125262773|NCT00659425|450592054|FG001|Overall Study|Adverse Event|0|||
125262774|NCT00659425|450592055|FG002|Overall Study|Adverse Event|0|||
125262775|NCT00659425|450592056|FG003|Overall Study|Adverse Event|0|||
125262776|NCT00659425|450592057|FG004|Overall Study|Adverse Event|0|||
125262777|NCT00659425|450592058|FG005|Overall Study|Adverse Event|1|||
125262778|NCT00659425|450592059|FG006|Overall Study|Adverse Event|0|||
125262779|NCT00659425|450592060|FG007|Overall Study|Adverse Event|3|||
125262780|NCT00659425|450592061|FG008|Overall Study|Adverse Event|1|||
125262781|NCT00659425|450592062|FG009|Overall Study|Adverse Event|4|||
125262782|NCT00659425|450592053|FG000|Overall Study|Investigator Discretion|0|||
125262783|NCT00659425|450592054|FG001|Overall Study|Investigator Discretion|0|||
125262784|NCT00659425|450592055|FG002|Overall Study|Investigator Discretion|0|||
125262785|NCT00659425|450592056|FG003|Overall Study|Investigator Discretion|0|||
125262786|NCT00659425|450592057|FG004|Overall Study|Investigator Discretion|0|||
125262787|NCT00659425|450592058|FG005|Overall Study|Investigator Discretion|1|||
125262788|NCT00659425|450592059|FG006|Overall Study|Investigator Discretion|0|||
125262789|NCT00659425|450592060|FG007|Overall Study|Investigator Discretion|3|||
125262790|NCT00659425|450592061|FG008|Overall Study|Investigator Discretion|0|||
125262791|NCT00659425|450592062|FG009|Overall Study|Investigator Discretion|0|||
125262792|NCT00659425|450592053|FG000|Overall Study|Other|0|||
125262793|NCT00659425|450592054|FG001|Overall Study|Other|1|||
125262794|NCT00659425|450592055|FG002|Overall Study|Other|1|||
125262795|NCT00659425|450592056|FG003|Overall Study|Other|2|||
125262796|NCT00659425|450592057|FG004|Overall Study|Other|4|||
125262797|NCT00659425|450592058|FG005|Overall Study|Other|0|||
125262798|NCT00659425|450592059|FG006|Overall Study|Other|3|||
125262799|NCT00659425|450592060|FG007|Overall Study|Other|2|||
125262800|NCT00659425|450592061|FG008|Overall Study|Other|0|||
125262801|NCT00659425|450592062|FG009|Overall Study|Other|6|||
125262802|NCT00271544|450592063|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
125262803|NCT00271544|450592063|FG000|Overall Study|Model 4196 lead not attempted|9|||
125262804|NCT00271544|450592063|FG000|Overall Study|Implant not attempted|4|||
125262805|NCT03358030|450592064|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
125262806|NCT03358030|450592065|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
125262807|NCT03358030|450592066|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
125262808|NCT03358030|450592067|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
125262809|NCT03358030|450592064|FG000|Overall Study|Ineligibility|0|||
125262810|NCT03358030|450592065|FG001|Overall Study|Ineligibility|0|||
125262811|NCT03358030|450592066|FG002|Overall Study|Ineligibility|0|||
125262812|NCT03358030|450592067|FG003|Overall Study|Ineligibility|2|||
125262813|NCT03358030|450592064|FG000|Overall Study|Voluntary Withdrawal|1|||
125262814|NCT03358030|450592065|FG001|Overall Study|Voluntary Withdrawal|1|||
125262815|NCT03358030|450592066|FG002|Overall Study|Voluntary Withdrawal|3|||
125262816|NCT03358030|450592067|FG003|Overall Study|Voluntary Withdrawal|1|||
125262817|NCT03358030|450592064|FG000|Overall Study|Other|0|||
125262818|NCT03358030|450592065|FG001|Overall Study|Other|0|||
125262819|NCT03358030|450592066|FG002|Overall Study|Other|1|||
125262820|NCT03358030|450592067|FG003|Overall Study|Other|0|||
125262821|NCT00829244|450592068|FG000|Overall Study|Adverse Event|1|||
125262822|NCT00829244|450592069|FG001|Overall Study|Adverse Event|3|||
125262823|NCT00829244|450592068|FG000|Overall Study|Protocol Violation|1|||
125262824|NCT00829244|450592069|FG001|Overall Study|Protocol Violation|0|||
125262825|NCT00829244|450592068|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
125262826|NCT00829244|450592069|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
125262827|NCT00829244|450592068|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
125262828|NCT00829244|450592069|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
125262829|NCT00829244|450592068|FG000|Overall Study|No fertilization|2|||
125262830|NCT00829244|450592069|FG001|Overall Study|No fertilization|2|||
125262831|NCT00829244|450592068|FG000|Overall Study|All embryos discarded|0|||
125262832|NCT00829244|450592069|FG001|Overall Study|All embryos discarded|3|||
125262833|NCT00829244|450592068|FG000|Overall Study|No embryo cleavage|0|||
125262834|NCT00829244|450592069|FG001|Overall Study|No embryo cleavage|2|||
125262835|NCT02604511|450592070|FG000|Overall Study|Adverse Event|3|||
125262836|NCT02604511|450592070|FG000|Overall Study|Disease Progression|4|||
125262837|NCT02604511|450592070|FG000|Overall Study|Withdrawal by Subject|3|||
125262838|NCT02604511|450592070|FG000|Overall Study|Participant ineligible|1|||
125262839|NCT02604511|450592070|FG000|Overall Study|Intercurrent illness|1|||
125262840|NCT03770286|450592071|FG000|Overall Study|Lost to Follow-up|6|||
125262841|NCT03770286|450592072|FG001|Overall Study|Lost to Follow-up|4|||
125262842|NCT03770286|450592073|FG002|Overall Study|Lost to Follow-up|3|||
125262843|NCT03770286|450592071|FG000|Overall Study|Protocol Violation|1|||
125262844|NCT03770286|450592072|FG001|Overall Study|Protocol Violation|0|||
125262845|NCT03770286|450592073|FG002|Overall Study|Protocol Violation|2|||
125262846|NCT02505425|450592074|FG000|Overall Study|Lost to Follow-up|41|||
125262847|NCT02505425|450592075|FG001|Overall Study|Lost to Follow-up|61|||
125262848|NCT02505425|450592076|FG002|Overall Study|Lost to Follow-up|31|||
125262849|NCT02505425|450592077|FG003|Overall Study|Lost to Follow-up|19|||
125262850|NCT02505425|450592074|FG000|Overall Study|Withdrawal by Subject|39|||
125262851|NCT02505425|450592075|FG001|Overall Study|Withdrawal by Subject|9|||
125262852|NCT02505425|450592076|FG002|Overall Study|Withdrawal by Subject|19|||
125262853|NCT02505425|450592077|FG003|Overall Study|Withdrawal by Subject|7|||
125262854|NCT02505425|450592074|FG000|Overall Study|Death|8|||
125262855|NCT02505425|450592075|FG001|Overall Study|Death|12|||
125262856|NCT02505425|450592076|FG002|Overall Study|Death|0|||
125262857|NCT02505425|450592077|FG003|Overall Study|Death|0|||
125262858|NCT02297412|450592078|FG000|Overall Study|Canceled|1|||
125262859|NCT02297412|450592079|FG001|Overall Study|Canceled|1|||
125262860|NCT02031302|450592080|FG000|Overall Study|Death|115|||
125262861|NCT02031302|450592081|FG001|Overall Study|Death|0|||
125262862|NCT02031302|450592080|FG000|Overall Study|Not treated with study valve system|18|||
125262863|NCT02031302|450592081|FG001|Overall Study|Not treated with study valve system|0|||
125446596|NCT03890120|451261038|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
125446597|NCT03890120|451261039|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
125446598|NCT03890120|451261040|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
125446599|NCT03890120|451261041|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
125446600|NCT03890120|451261038|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
125446601|NCT03890120|451261039|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
125446602|NCT03890120|451261040|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
125446603|NCT03890120|451261041|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
125446604|NCT03890120|451261038|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
125446605|NCT03890120|451261039|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
125446606|NCT03890120|451261040|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
125446607|NCT03890120|451261041|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
125446608|NCT03890120|451261038|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
125446609|NCT03890120|451261039|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
125446610|NCT03890120|451261040|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
125446611|NCT03890120|451261041|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
125446612|NCT03890120|451261038|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
125446613|NCT03890120|451261039|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
125446614|NCT03890120|451261040|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
125446615|NCT03890120|451261041|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
125446616|NCT03890120|451261038|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
125446617|NCT03890120|451261039|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
125446618|NCT03890120|451261040|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
125446619|NCT03890120|451261041|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
125446620|NCT03890120|451261038|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
125446621|NCT03890120|451261039|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
125446622|NCT03890120|451261040|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
125446623|NCT03890120|451261041|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
125446624|NCT00683449|451261042|FG000|Overall Study|Lost to Follow-up|0|||
125446625|NCT00683449|451261043|FG001|Overall Study|Lost to Follow-up|1|||
125446626|NCT00683449|451261044|FG002|Overall Study|Lost to Follow-up|0|||
125446627|NCT00683449|451261045|FG003|Overall Study|Lost to Follow-up|0|||
125446628|NCT00683449|451261046|FG004|Overall Study|Lost to Follow-up|0|||
125446629|NCT00479674|451261051|FG000|Overall Study|Adverse Event|18|||
125446630|NCT00479674|451261051|FG000|Overall Study|Withdrawal by Subject|6|||
125446631|NCT00479674|451261051|FG000|Overall Study|Physician Decision|14|||
125446632|NCT00479674|451261051|FG000|Overall Study|none provided|3|||
125446633|NCT00146640|451261056|FG000|Overall Study|Adverse Event|12|||
125446634|NCT00146640|451261057|FG001|Overall Study|Adverse Event|10|||
125446635|NCT00146640|451261056|FG000|Overall Study|Medical Reasons|3|||
125446636|NCT00146640|451261057|FG001|Overall Study|Medical Reasons|0|||
125446637|NCT00146640|451261056|FG000|Overall Study|Non-Medical Reasons|8|||
125446638|NCT00146640|451261057|FG001|Overall Study|Non-Medical Reasons|4|||
125446639|NCT02059161|451261058|FG000|Overall Study|Pregnancy|0|||
125446640|NCT02059161|451261059|FG001|Overall Study|Pregnancy|2|||
125446641|NCT02059161|451261058|FG000|Overall Study|Adverse Event|2|||
125446642|NCT02059161|451261059|FG001|Overall Study|Adverse Event|6|||
125446643|NCT02059161|451261058|FG000|Overall Study|Lost to Follow-up|20|||
125446644|NCT02059161|451261059|FG001|Overall Study|Lost to Follow-up|12|||
125446645|NCT02059161|451261058|FG000|Overall Study|Physician Decision|4|||
125446646|NCT02059161|451261059|FG001|Overall Study|Physician Decision|4|||
125446647|NCT02059161|451261058|FG000|Overall Study|Protocol Violation|1|||
125446648|NCT02059161|451261059|FG001|Overall Study|Protocol Violation|1|||
125446649|NCT02059161|451261058|FG000|Overall Study|Withdrawal by Subject|16|||
125446650|NCT02059161|451261059|FG001|Overall Study|Withdrawal by Subject|13|||
125446651|NCT02059161|451261058|FG000|Overall Study|Randomized in error, no study drug|0|||
125446652|NCT02059161|451261059|FG001|Overall Study|Randomized in error, no study drug|1|||
125446653|NCT02059161|451261058|FG000|Overall Study|Non-compliance with study drug|6|||
125446654|NCT02059161|451261059|FG001|Overall Study|Non-compliance with study drug|2|||
125262864|NCT02031302|450592080|FG000|Overall Study|Missed Follow Up|27|||
125262865|NCT02031302|450592081|FG001|Overall Study|Missed Follow Up|0|||
125262866|NCT02031302|450592080|FG000|Overall Study|Lost to Follow-up|4|||
125262867|NCT02031302|450592081|FG001|Overall Study|Lost to Follow-up|0|||
125262868|NCT03950856|450592085|FG000|Overall Study|Death|1|||
125262869|NCT03950856|450592086|FG001|Overall Study|Death|2|||
125446655|NCT01237678|451261061|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
125446656|NCT01237678|451261062|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
125446657|NCT01237678|451261063|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
125446658|NCT01237678|451261061|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
125446659|NCT01237678|451261062|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
125446660|NCT01237678|451261063|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
125446661|NCT01237678|451261061|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
125262870|NCT03950856|450592087|FG002|Overall Study|Death|0|||
125262871|NCT03950856|450592088|FG003|Overall Study|Death|0|||
125262872|NCT03950856|450592085|FG000|Overall Study|Lost to Follow-up|5|||
125262873|NCT03950856|450592086|FG001|Overall Study|Lost to Follow-up|6|||
125262874|NCT03950856|450592087|FG002|Overall Study|Lost to Follow-up|8|||
125262875|NCT03950856|450592088|FG003|Overall Study|Lost to Follow-up|2|||
125398458|NCT04907032|451091037|FG000|Overall Study|Withdrawal by Subject|7|||
125262876|NCT03950856|450592085|FG000|Overall Study|Protocol Violation|2|||
125262877|NCT03950856|450592086|FG001|Overall Study|Protocol Violation|0|||
125262878|NCT03950856|450592087|FG002|Overall Study|Protocol Violation|0|||
125262879|NCT03950856|450592088|FG003|Overall Study|Protocol Violation|1|||
125262880|NCT03950856|450592085|FG000|Overall Study|Withdrawal by Subject|4|||
125262881|NCT03950856|450592086|FG001|Overall Study|Withdrawal by Subject|1|||
125262882|NCT03950856|450592087|FG002|Overall Study|Withdrawal by Subject|3|||
125262883|NCT03950856|450592088|FG003|Overall Study|Withdrawal by Subject|1|||
125262884|NCT03950856|450592085|FG000|Overall Study|Unable to phone|7|||
125262885|NCT03950856|450592086|FG001|Overall Study|Unable to phone|6|||
125262886|NCT03950856|450592087|FG002|Overall Study|Unable to phone|7|||
125262887|NCT03950856|450592088|FG003|Overall Study|Unable to phone|2|||
125262888|NCT05899829|450592089|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
125262889|NCT05899829|450592090|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
125262890|NCT05899829|450592089|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
125262891|NCT05899829|450592090|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
125262892|NCT02781558|450592094|FG000|Overall Study|Lost to Follow-up|2|||
125262893|NCT02781558|450592095|FG001|Overall Study|Lost to Follow-up|2|||
125262894|NCT02781558|450592094|FG000|Overall Study|Adverse Event|1|||
125262895|NCT02781558|450592095|FG001|Overall Study|Adverse Event|0|||
125262896|NCT00545779|450592096|FG000|Overall Study|Violation of selection criteria at entry|8|||
125262897|NCT00545779|450592096|FG000|Overall Study|Other protocol violation|1|||
125262898|NCT00545779|450592096|FG000|Overall Study|Did not cooperate|7|||
125262899|NCT00545779|450592096|FG000|Overall Study|Withdrawal by Subject|20|||
125262900|NCT00545779|450592096|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
125262901|NCT00545779|450592096|FG000|Overall Study|Failure to return|3|||
125262902|NCT03802396|450592097|FG000|Overall Study|Withdrawal by Subject|2|||
125262903|NCT03802396|450592098|FG001|Overall Study|Withdrawal by Subject|0|||
125262904|NCT03802396|450592097|FG000|Overall Study|Surgery Cancelled|1|||
125262905|NCT03802396|450592098|FG001|Overall Study|Surgery Cancelled|0|||
125262906|NCT02561962|450592102|FG000|Overall Study|Withdrawal by Subject|1|||
125262907|NCT02561962|450592103|FG001|Overall Study|Withdrawal by Subject|0|||
125262908|NCT02561962|450592104|FG002|Overall Study|Withdrawal by Subject|0|||
125262909|NCT02561962|450592105|FG003|Overall Study|Withdrawal by Subject|0|||
125262910|NCT02561962|450592106|FG004|Overall Study|Withdrawal by Subject|1|||
125262911|NCT02561962|450592107|FG005|Overall Study|Withdrawal by Subject|1|||
125398459|NCT04907032|451091038|FG001|Overall Study|Withdrawal by Subject|1|||
125398460|NCT02741115|451091046|FG000|Overall Study|Adverse Event|1|||
125262912|NCT02561962|450592108|FG006|Overall Study|Withdrawal by Subject|2|||
125262913|NCT02561962|450592109|FG007|Overall Study|Withdrawal by Subject|1|||
125262914|NCT02561962|450592110|FG008|Overall Study|Withdrawal by Subject|0|||
125262915|NCT02561962|450592102|FG000|Overall Study|Decision by sponsor|0|||
125262916|NCT02561962|450592103|FG001|Overall Study|Decision by sponsor|0|||
125262917|NCT02561962|450592104|FG002|Overall Study|Decision by sponsor|0|||
125262918|NCT02561962|450592105|FG003|Overall Study|Decision by sponsor|0|||
125262919|NCT02561962|450592106|FG004|Overall Study|Decision by sponsor|1|||
125262920|NCT02561962|450592107|FG005|Overall Study|Decision by sponsor|1|||
125262921|NCT02561962|450592108|FG006|Overall Study|Decision by sponsor|0|||
125262922|NCT02561962|450592109|FG007|Overall Study|Decision by sponsor|3|||
125262923|NCT02561962|450592110|FG008|Overall Study|Decision by sponsor|0|||
125262924|NCT02561962|450592102|FG000|Overall Study|Lost to Follow-up|0|||
125262925|NCT02561962|450592103|FG001|Overall Study|Lost to Follow-up|0|||
125262926|NCT02561962|450592104|FG002|Overall Study|Lost to Follow-up|0|||
125262927|NCT02561962|450592105|FG003|Overall Study|Lost to Follow-up|0|||
125262928|NCT02561962|450592106|FG004|Overall Study|Lost to Follow-up|0|||
125262929|NCT02561962|450592107|FG005|Overall Study|Lost to Follow-up|1|||
125262930|NCT02561962|450592108|FG006|Overall Study|Lost to Follow-up|0|||
125262931|NCT02561962|450592109|FG007|Overall Study|Lost to Follow-up|0|||
125262932|NCT02561962|450592110|FG008|Overall Study|Lost to Follow-up|0|||
125262933|NCT01150357|450592111|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
125262934|NCT01150357|450592112|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
125262935|NCT01150357|450592113|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
125398461|NCT02741115|451091047|FG001|Overall Study|Adverse Event|0|||
125262936|NCT01150357|450592111|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
125262937|NCT01150357|450592112|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
125262938|NCT01150357|450592113|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
125262939|NCT01150357|450592111|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
125262940|NCT01150357|450592112|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
125398462|NCT02741115|451091046|FG000|Overall Study|Lost to Follow-up|7|||
125446662|NCT01237678|451261062|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
125446663|NCT01237678|451261063|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
125446664|NCT01237678|451261061|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
125446665|NCT01237678|451261062|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
125446666|NCT01237678|451261063|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
125446667|NCT01237678|451261061|FG000|Phase II|Adverse Event|0|||
125446668|NCT01237678|451261062|FG001|Phase II|Adverse Event|39|||
125446669|NCT01237678|451261063|FG002|Phase II|Adverse Event|9|||
125446670|NCT01237678|451261061|FG000|Phase II|Death|0|||
125446671|NCT01237678|451261062|FG001|Phase II|Death|0|||
125446672|NCT01237678|451261063|FG002|Phase II|Death|2|||
125446673|NCT01237678|451261061|FG000|Phase II|Lack of Efficacy|0|||
125446674|NCT01237678|451261062|FG001|Phase II|Lack of Efficacy|25|||
125446675|NCT01237678|451261063|FG002|Phase II|Lack of Efficacy|3|||
125446676|NCT01237678|451261061|FG000|Phase II|Withdrawal by Subject|0|||
125446677|NCT01237678|451261062|FG001|Phase II|Withdrawal by Subject|1|||
125446678|NCT01237678|451261063|FG002|Phase II|Withdrawal by Subject|5|||
125446679|NCT01237678|451261061|FG000|Phase II|Completed Cycles 4-6|0|||
125446680|NCT01237678|451261062|FG001|Phase II|Completed Cycles 4-6|11|||
125446681|NCT01237678|451261063|FG002|Phase II|Completed Cycles 4-6|21|||
125446682|NCT01237678|451261061|FG000|Phase II|Sponsor Decision/Study Closed|0|||
125446683|NCT01237678|451261062|FG001|Phase II|Sponsor Decision/Study Closed|18|||
125446684|NCT01237678|451261063|FG002|Phase II|Sponsor Decision/Study Closed|7|||
125446685|NCT01237678|451261061|FG000|Phase II|Randomized but were not treated|0|||
125446686|NCT01237678|451261062|FG001|Phase II|Randomized but were not treated|4|||
125446687|NCT01237678|451261063|FG002|Phase II|Randomized but were not treated|3|||
125446688|NCT01723826|451261067|FG000|Overall Study|Adverse Event|4|||
125446689|NCT01723826|451261068|FG001|Overall Study|Adverse Event|1|||
125446690|NCT01723826|451261069|FG002|Overall Study|Adverse Event|4|||
125446691|NCT01723826|451261070|FG003|Overall Study|Adverse Event|5|||
125446692|NCT01723826|451261067|FG000|Overall Study|Death according to AE eCRF|2|||
125446693|NCT01723826|451261068|FG001|Overall Study|Death according to AE eCRF|3|||
125446694|NCT01723826|451261069|FG002|Overall Study|Death according to AE eCRF|3|||
125446695|NCT01723826|451261070|FG003|Overall Study|Death according to AE eCRF|7|||
125446696|NCT01723826|451261067|FG000|Overall Study|Lost to Follow-up|1|||
125446697|NCT01723826|451261068|FG001|Overall Study|Lost to Follow-up|3|||
125446698|NCT01723826|451261069|FG002|Overall Study|Lost to Follow-up|1|||
125446699|NCT01723826|451261070|FG003|Overall Study|Lost to Follow-up|1|||
125446700|NCT01723826|451261067|FG000|Overall Study|Non-compliance|0|||
125446701|NCT01723826|451261068|FG001|Overall Study|Non-compliance|1|||
125446702|NCT01723826|451261069|FG002|Overall Study|Non-compliance|3|||
125446703|NCT01723826|451261070|FG003|Overall Study|Non-compliance|3|||
125446704|NCT01723826|451261067|FG000|Overall Study|Non-compliance With Study Drug|0|||
125446705|NCT01723826|451261068|FG001|Overall Study|Non-compliance With Study Drug|1|||
125446706|NCT01723826|451261069|FG002|Overall Study|Non-compliance With Study Drug|0|||
125446707|NCT01723826|451261070|FG003|Overall Study|Non-compliance With Study Drug|0|||
125446708|NCT01723826|451261067|FG000|Overall Study|Other Reason|8|||
125446709|NCT01723826|451261068|FG001|Overall Study|Other Reason|6|||
125446710|NCT01723826|451261069|FG002|Overall Study|Other Reason|12|||
125446711|NCT01723826|451261070|FG003|Overall Study|Other Reason|14|||
125446712|NCT01723826|451261067|FG000|Overall Study|Physician Decision|1|||
125446713|NCT01723826|451261068|FG001|Overall Study|Physician Decision|3|||
125446714|NCT01723826|451261069|FG002|Overall Study|Physician Decision|4|||
125446715|NCT01723826|451261070|FG003|Overall Study|Physician Decision|11|||
125446716|NCT01723826|451261067|FG000|Overall Study|Protocol Violation|1|||
125446717|NCT01723826|451261068|FG001|Overall Study|Protocol Violation|1|||
125446718|NCT01723826|451261069|FG002|Overall Study|Protocol Violation|3|||
125446719|NCT01723826|451261070|FG003|Overall Study|Protocol Violation|1|||
125446720|NCT01723826|451261067|FG000|Overall Study|Withdrawal by Subject|10|||
125446721|NCT01723826|451261068|FG001|Overall Study|Withdrawal by Subject|17|||
125446722|NCT01723826|451261069|FG002|Overall Study|Withdrawal by Subject|27|||
125446723|NCT01723826|451261070|FG003|Overall Study|Withdrawal by Subject|48|||
125446724|NCT03023332|451261071|FG000|Overall Study|Withdrawal by Subject|10|||
125446725|NCT03023332|451261072|FG001|Overall Study|Withdrawal by Subject|5|||
125446726|NCT03023332|451261073|FG002|Overall Study|Withdrawal by Subject|4|||
125446727|NCT03023332|451261074|FG003|Overall Study|Withdrawal by Subject|7|||
125446728|NCT03023332|451261071|FG000|Overall Study|Lost to Follow-up|13|||
125446729|NCT03023332|451261072|FG001|Overall Study|Lost to Follow-up|16|||
125446730|NCT03023332|451261073|FG002|Overall Study|Lost to Follow-up|8|||
125446731|NCT03023332|451261074|FG003|Overall Study|Lost to Follow-up|13|||
125446732|NCT03023332|451261071|FG000|Overall Study|Death|1|||
125446733|NCT03023332|451261072|FG001|Overall Study|Death|0|||
125446734|NCT03023332|451261073|FG002|Overall Study|Death|0|||
125446735|NCT03023332|451261074|FG003|Overall Study|Death|0|||
125446736|NCT01818700|451261075|FG000|Overall Study|Adverse Event|67|||
125446737|NCT01818700|451261075|FG000|Overall Study|Lack of Efficacy|2|||
125446738|NCT01818700|451261075|FG000|Overall Study|Lost to Follow-up|5|||
125446739|NCT01818700|451261075|FG000|Overall Study|Withdrawal by Subject|27|||
125262941|NCT01150357|450592113|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
125262942|NCT01150357|450592111|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
125262943|NCT01150357|450592112|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
125262944|NCT01150357|450592113|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
125262945|NCT01150357|450592111|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
125262946|NCT01150357|450592112|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
125262947|NCT01150357|450592113|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
125262948|NCT01150357|450592111|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
125262949|NCT01150357|450592112|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
125262950|NCT01150357|450592113|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
125262951|NCT01150357|450592111|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
125262952|NCT01150357|450592112|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
125262953|NCT01150357|450592113|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
125262954|NCT01732536|450593743|FG000|Overall Study|Withdrawal by Subject|1|||
125262955|NCT01732536|450593744|FG001|Overall Study|Withdrawal by Subject|1|||
125262956|NCT01581684|450593747|FG000|Overall Study|Other reason not defined|0|||
125262957|NCT01581684|450593748|FG001|Overall Study|Other reason not defined|0|||
125262958|NCT01581684|450593749|FG002|Overall Study|Other reason not defined|0|||
125262959|NCT01581684|450593750|FG003|Overall Study|Other reason not defined|0|||
125262960|NCT01581684|450593751|FG004|Overall Study|Other reason not defined|0|||
125262961|NCT01581684|450593752|FG005|Overall Study|Other reason not defined|0|||
125262962|NCT01581684|450593753|FG006|Overall Study|Other reason not defined|0|||
125262963|NCT01581684|450593754|FG007|Overall Study|Other reason not defined|0|||
125262964|NCT01581684|450593755|FG008|Overall Study|Other reason not defined|1|||
125262965|NCT01581684|450593756|FG009|Overall Study|Other reason not defined|0|||
125262966|NCT03728933|450593757|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
125262967|NCT03728933|450593758|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125262968|NCT03728933|450593759|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125262969|NCT03728933|450593757|FG000|Overall Study|Withdrawal by Subject|0|||
125262970|NCT03728933|450593758|FG001|Overall Study|Withdrawal by Subject|0|||
125262971|NCT03728933|450593759|FG002|Overall Study|Withdrawal by Subject|1|||
125262972|NCT03728933|450593757|FG000|Overall Study|Lost to Follow-up|0|||
125262973|NCT03728933|450593758|FG001|Overall Study|Lost to Follow-up|1|||
125262974|NCT03728933|450593759|FG002|Overall Study|Lost to Follow-up|0|||
125262975|NCT03728933|450593757|FG000|Overall Study|Adverse Event|1|||
125262976|NCT03728933|450593758|FG001|Overall Study|Adverse Event|0|||
125262977|NCT03728933|450593759|FG002|Overall Study|Adverse Event|0|||
125398463|NCT02741115|451091047|FG001|Overall Study|Lost to Follow-up|4|||
125262978|NCT03235050|450593760|FG000|Overall Study|Adverse Event|0|||
125262979|NCT03235050|450593761|FG001|Overall Study|Adverse Event|0|||
125262980|NCT03235050|450593762|FG002|Overall Study|Adverse Event|1|||
125262981|NCT03235050|450593763|FG003|Overall Study|Adverse Event|4|||
125262982|NCT03235050|450593764|FG004|Overall Study|Adverse Event|1|||
125262983|NCT03235050|450593760|FG000|Overall Study|Death|0|||
125262984|NCT03235050|450593761|FG001|Overall Study|Death|0|||
125262985|NCT03235050|450593762|FG002|Overall Study|Death|0|||
125262986|NCT03235050|450593763|FG003|Overall Study|Death|2|||
125262987|NCT03235050|450593764|FG004|Overall Study|Death|1|||
125262988|NCT03235050|450593760|FG000|Overall Study|Lost to Follow-up|1|||
125262989|NCT03235050|450593761|FG001|Overall Study|Lost to Follow-up|2|||
125262990|NCT03235050|450593762|FG002|Overall Study|Lost to Follow-up|1|||
125262991|NCT03235050|450593763|FG003|Overall Study|Lost to Follow-up|2|||
125262992|NCT03235050|450593764|FG004|Overall Study|Lost to Follow-up|0|||
125262993|NCT03235050|450593760|FG000|Overall Study|Withdrawal by Subject|3|||
125262994|NCT03235050|450593761|FG001|Overall Study|Withdrawal by Subject|2|||
125262995|NCT03235050|450593762|FG002|Overall Study|Withdrawal by Subject|2|||
125262996|NCT03235050|450593763|FG003|Overall Study|Withdrawal by Subject|5|||
125262997|NCT03235050|450593764|FG004|Overall Study|Withdrawal by Subject|7|||
125262998|NCT03235050|450593760|FG000|Overall Study|Other reasons|0|||
125262999|NCT03235050|450593761|FG001|Overall Study|Other reasons|1|||
125263000|NCT03235050|450593762|FG002|Overall Study|Other reasons|0|||
125263001|NCT03235050|450593763|FG003|Overall Study|Other reasons|1|||
125263002|NCT03235050|450593764|FG004|Overall Study|Other reasons|2|||
125263003|NCT03545672|450593765|FG000|Overall Study|Uncertain diagnosis|2|||
125263004|NCT03545672|450593766|FG001|Overall Study|Uncertain diagnosis|1|||
125263005|NCT03545672|450593765|FG000|Overall Study|Protocol Violation|2|||
125263006|NCT03545672|450593766|FG001|Overall Study|Protocol Violation|2|||
125263007|NCT01628913|450593767|FG000|Overall Study|Adverse Event|12|||
125263008|NCT01628913|450593768|FG001|Overall Study|Adverse Event|5|||
125263009|NCT01628913|450593767|FG000|Overall Study|Disease Progression|11|||
125398464|NCT02741115|451091046|FG000|Overall Study|Withdrawal by Subject|4|||
125263010|NCT01628913|450593768|FG001|Overall Study|Disease Progression|14|||
125263011|NCT01628913|450593767|FG000|Overall Study|Protocol Violation|1|||
125263012|NCT01628913|450593768|FG001|Overall Study|Protocol Violation|0|||
125263013|NCT01628913|450593767|FG000|Overall Study|Death|1|||
125263014|NCT01628913|450593768|FG001|Overall Study|Death|0|||
125446740|NCT01818700|451261075|FG000|Overall Study|Protocol Violation|2|||
125446741|NCT01818700|451261075|FG000|Overall Study|Other|1|||
125446742|NCT02408549|451261078|FG000|Overall Study|Adverse Event|15|||
125446743|NCT02408549|451261078|FG000|Overall Study|Death|4|||
125446744|NCT02408549|451261078|FG000|Overall Study|Lack of Efficacy|17|||
125446745|NCT02408549|451261078|FG000|Overall Study|Protocol Violation|4|||
125446746|NCT02408549|451261078|FG000|Overall Study|Lost to Follow-up|6|||
125446747|NCT02408549|451261078|FG000|Overall Study|Consent withdrawn|30|||
125446748|NCT02408549|451261078|FG000|Overall Study|Neurology research program closing at site|1|||
125446749|NCT02408549|451261078|FG000|Overall Study|Site closure|1|||
125446750|NCT02408549|451261078|FG000|Overall Study|Pregnancy|1|||
125446751|NCT02408549|451261078|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
125446752|NCT02408549|451261078|FG000|Overall Study|Subject moved to another place, far from site|1|||
125446753|NCT02408549|451261078|FG000|Overall Study|Study terminated at site|1|||
125446754|NCT01272011|451261079|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
125446755|NCT01272011|451261080|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
125446756|NCT01272011|451261081|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
125446757|NCT02013687|451261082|FG000|Overall Study|Lost to Follow-up|0|||
125446758|NCT02013687|451261083|FG001|Overall Study|Lost to Follow-up|0|||
125446759|NCT02013687|451261084|FG002|Overall Study|Lost to Follow-up|1|||
125446760|NCT02013687|451261085|FG003|Overall Study|Lost to Follow-up|0|||
125446761|NCT02013687|451261082|FG000|Overall Study|Protocol Violation|0|||
125446762|NCT02013687|451261083|FG001|Overall Study|Protocol Violation|0|||
125446763|NCT02013687|451261084|FG002|Overall Study|Protocol Violation|0|||
125446764|NCT02013687|451261085|FG003|Overall Study|Protocol Violation|1|||
125446765|NCT02013687|451261082|FG000|Overall Study|Withdrawal by Subject|0|||
125446766|NCT02013687|451261083|FG001|Overall Study|Withdrawal by Subject|0|||
125446767|NCT02013687|451261084|FG002|Overall Study|Withdrawal by Subject|0|||
125446768|NCT02013687|451261085|FG003|Overall Study|Withdrawal by Subject|1|||
125446769|NCT02013687|451261082|FG000|Overall Study|Missed visits due to patient travel|0|||
125446770|NCT02013687|451261083|FG001|Overall Study|Missed visits due to patient travel|0|||
125446771|NCT02013687|451261084|FG002|Overall Study|Missed visits due to patient travel|1|||
125446772|NCT02013687|451261085|FG003|Overall Study|Missed visits due to patient travel|0|||
125446773|NCT01627340|451261086|FG000|Overall Study|Adverse Event|1|||
125446774|NCT01627340|451261087|FG001|Overall Study|Adverse Event|0|||
125446775|NCT01627340|451261086|FG000|Overall Study|Lost to Follow-up|8|||
125446776|NCT01627340|451261087|FG001|Overall Study|Lost to Follow-up|4|||
125446777|NCT01627340|451261086|FG000|Overall Study|Pregnancy|1|||
125446778|NCT01627340|451261087|FG001|Overall Study|Pregnancy|0|||
125446779|NCT01627340|451261086|FG000|Overall Study|Withdrawal by Subject|2|||
125446780|NCT01627340|451261087|FG001|Overall Study|Withdrawal by Subject|0|||
125446781|NCT01657032|451261088|FG000|Overall Study|Lost to Follow-up|0|||
125446782|NCT01657032|451261089|FG001|Overall Study|Lost to Follow-up|7|||
125446783|NCT03633903|451261090|FG000|Overall Study|Withdrawal by Subject|1|||
125446784|NCT03633903|451261091|FG001|Overall Study|Withdrawal by Subject|2|||
125263015|NCT01628913|450593767|FG000|Overall Study|study terminated by Sponsor|4|||
125263016|NCT01628913|450593768|FG001|Overall Study|study terminated by Sponsor|9|||
125263017|NCT01628913|450593767|FG000|Overall Study|Withdrawal by Subject|1|||
125263018|NCT01628913|450593768|FG001|Overall Study|Withdrawal by Subject|0|||
125263019|NCT01628913|450593767|FG000|Overall Study|Physician Decision|1|||
125263020|NCT01628913|450593768|FG001|Overall Study|Physician Decision|3|||
125263021|NCT02415556|450593769|FG000|Overall Study|Adverse Event|3|||
125263022|NCT02415556|450593770|FG001|Overall Study|Adverse Event|4|||
125263023|NCT02415556|450593771|FG002|Overall Study|Adverse Event|2|||
125263024|NCT02415556|450593772|FG003|Overall Study|Adverse Event|4|||
125263025|NCT02415556|450593769|FG000|Overall Study|Lost to Follow-up|4|||
125263026|NCT02415556|450593770|FG001|Overall Study|Lost to Follow-up|5|||
125263027|NCT02415556|450593771|FG002|Overall Study|Lost to Follow-up|4|||
125263028|NCT02415556|450593772|FG003|Overall Study|Lost to Follow-up|1|||
125263029|NCT02415556|450593769|FG000|Overall Study|Withdrawal by Subject|13|||
125263030|NCT02415556|450593770|FG001|Overall Study|Withdrawal by Subject|4|||
125263031|NCT02415556|450593771|FG002|Overall Study|Withdrawal by Subject|14|||
125263032|NCT02415556|450593772|FG003|Overall Study|Withdrawal by Subject|12|||
125263033|NCT02415556|450593769|FG000|Overall Study|Physician Decision|1|||
125263034|NCT02415556|450593770|FG001|Overall Study|Physician Decision|3|||
125446785|NCT03633903|451261090|FG000|Overall Study|Lost to Follow-up|5|||
125446786|NCT03633903|451261091|FG001|Overall Study|Lost to Follow-up|5|||
125446787|NCT05968482|451261092|FG000|First Crossover Period|Withdrawal by Subject|0|||
125446788|NCT05968482|451261093|FG001|First Crossover Period|Withdrawal by Subject|0|||
125446789|NCT05968482|451261094|FG002|First Crossover Period|Withdrawal by Subject|1|||
125446790|NCT05968482|451261095|FG003|First Crossover Period|Withdrawal by Subject|0|||
125446791|NCT05968482|451261096|FG004|First Crossover Period|Withdrawal by Subject|0|||
125446792|NCT05968482|451261097|FG005|First Crossover Period|Withdrawal by Subject|0|||
125263035|NCT02415556|450593771|FG002|Overall Study|Physician Decision|1|||
125263036|NCT02415556|450593772|FG003|Overall Study|Physician Decision|2|||
125263037|NCT02415556|450593769|FG000|Overall Study|Censored - study completion|4|||
125263038|NCT02415556|450593770|FG001|Overall Study|Censored - study completion|5|||
125263039|NCT02415556|450593771|FG002|Overall Study|Censored - study completion|1|||
125263040|NCT02415556|450593772|FG003|Overall Study|Censored - study completion|0|||
125263041|NCT02415556|450593769|FG000|Overall Study|Family-related issues|0|||
125263042|NCT02415556|450593770|FG001|Overall Study|Family-related issues|0|||
125263043|NCT02415556|450593771|FG002|Overall Study|Family-related issues|0|||
125263044|NCT02415556|450593772|FG003|Overall Study|Family-related issues|1|||
125263045|NCT00105534|450593773|FG000|Overall Study|Adverse Event|2|||
125263046|NCT00105534|450593774|FG001|Overall Study|Adverse Event|5|||
125263047|NCT00105534|450593773|FG000|Overall Study|Protocol Violation|1|||
125263048|NCT00105534|450593774|FG001|Overall Study|Protocol Violation|4|||
125263049|NCT00105534|450593773|FG000|Overall Study|Withdrawal by Subject|6|||
125263050|NCT00105534|450593774|FG001|Overall Study|Withdrawal by Subject|6|||
125263051|NCT00105534|450593773|FG000|Overall Study|Lost to Follow-up|5|||
125263052|NCT00105534|450593774|FG001|Overall Study|Lost to Follow-up|1|||
125263053|NCT00105534|450593773|FG000|Overall Study|Lack of Efficacy|7|||
125263054|NCT00105534|450593774|FG001|Overall Study|Lack of Efficacy|15|||
125263055|NCT00105534|450593773|FG000|Overall Study|Treatment unmasked|1|||
125263056|NCT00105534|450593774|FG001|Overall Study|Treatment unmasked|0|||
125263057|NCT00105534|450593773|FG000|Overall Study|Other Reason|0|||
125263058|NCT00105534|450593774|FG001|Overall Study|Other Reason|2|||
125263059|NCT01621178|450593775|FG000|Overall Study|Adverse Event|5|||
125263060|NCT01621178|450593776|FG001|Overall Study|Adverse Event|2|||
125263061|NCT01621178|450593777|FG002|Overall Study|Adverse Event|8|||
125263062|NCT01621178|450593775|FG000|Overall Study|Death|6|||
125263063|NCT01621178|450593776|FG001|Overall Study|Death|7|||
125263064|NCT01621178|450593777|FG002|Overall Study|Death|2|||
125263065|NCT01621178|450593775|FG000|Overall Study|Lost to Follow-up|1|||
125263066|NCT01621178|450593776|FG001|Overall Study|Lost to Follow-up|2|||
125263067|NCT01621178|450593777|FG002|Overall Study|Lost to Follow-up|1|||
125263068|NCT01621178|450593775|FG000|Overall Study|Withdrawal by Subject|14|||
125263069|NCT01621178|450593776|FG001|Overall Study|Withdrawal by Subject|17|||
125263070|NCT01621178|450593777|FG002|Overall Study|Withdrawal by Subject|18|||
125263071|NCT01621178|450593775|FG000|Overall Study|Physician Decision|5|||
125263072|NCT01621178|450593776|FG001|Overall Study|Physician Decision|2|||
125263073|NCT01621178|450593777|FG002|Overall Study|Physician Decision|7|||
125263074|NCT02935192|450593778|FG000|Overall Study|Withdrawal by Subject|8|||
125263075|NCT02935192|450593779|FG001|Overall Study|Withdrawal by Subject|4|||
125263076|NCT02465931|450593780|FG000|Overall Study|Lost to Follow-up|9|||
125263077|NCT02465931|450593781|FG001|Overall Study|Lost to Follow-up|11|||
125263078|NCT02465931|450593780|FG000|Overall Study|Protocol Violation|1|||
125263079|NCT02465931|450593781|FG001|Overall Study|Protocol Violation|0|||
125263080|NCT02465931|450593780|FG000|Overall Study|Withdrawal by Subject|1|||
125263081|NCT02465931|450593781|FG001|Overall Study|Withdrawal by Subject|0|||
125263082|NCT02896257|450593783|FG000|Providers|Without eligible patients|21|||
125263083|NCT02896257|450593784|FG001|Providers|Without eligible patients|28|||
125263084|NCT02896257|450593783|FG000|Patients|PFT entry criteria not met|43|||
125263085|NCT02896257|450593784|FG001|Patients|PFT entry criteria not met|50|||
125263086|NCT02896257|450593783|FG000|Patients|No capacity to review|8|||
125263087|NCT02896257|450593784|FG001|Patients|No capacity to review|11|||
125263088|NCT02896257|450593783|FG000|Patients|Appointment rescheduled/cancelled|5|||
125263089|NCT02896257|450593784|FG001|Patients|Appointment rescheduled/cancelled|7|||
125263090|NCT02896257|450593783|FG000|Patients|PCP not assigned a clinic|4|||
125263091|NCT02896257|450593784|FG001|Patients|PCP not assigned a clinic|0|||
125263092|NCT02896257|450593783|FG000|Patients|No history of COPD|0|||
125263093|NCT02896257|450593784|FG001|Patients|No history of COPD|1|||
125263094|NCT02896257|450593783|FG000|Patients|Deceased between review and index date|0|||
125263095|NCT02896257|450593784|FG001|Patients|Deceased between review and index date|1|||
125263096|NCT02896257|450593783|FG000|Patients|No ICS Rx upon review|1|||
125263097|NCT02896257|450593784|FG001|Patients|No ICS Rx upon review|1|||
125263098|NCT02896257|450593783|FG000|Patients|Protocol Violation|2|||
125263099|NCT02896257|450593784|FG001|Patients|Protocol Violation|1|||
125263100|NCT02896257|450593783|FG000|Patients|Hospice care|0|||
125263101|NCT02896257|450593784|FG001|Patients|Hospice care|1|||
125263102|NCT00492557|450593785|FG000|Overall Study|Subject request|12|||
125263103|NCT00492557|450593786|FG001|Overall Study|Subject request|11|||
125263104|NCT00492557|450593785|FG000|Overall Study|Protocol Violation|7|||
125263105|NCT00492557|450593786|FG001|Overall Study|Protocol Violation|8|||
125263106|NCT00492557|450593785|FG000|Overall Study|Other|2|||
125263107|NCT00492557|450593786|FG001|Overall Study|Other|2|||
125263108|NCT00492557|450593785|FG000|Overall Study|Death|1|||
125263109|NCT00492557|450593786|FG001|Overall Study|Death|1|||
125263110|NCT00492557|450593785|FG000|Overall Study|Adverse Event|1|||
125263111|NCT00492557|450593786|FG001|Overall Study|Adverse Event|0|||
125263112|NCT00492557|450593785|FG000|Overall Study|Failed to return|1|||
125263113|NCT00492557|450593786|FG001|Overall Study|Failed to return|0|||
125263114|NCT00492557|450593785|FG000|Overall Study|Lost to Follow-up|0|||
125263115|NCT00492557|450593786|FG001|Overall Study|Lost to Follow-up|1|||
125263116|NCT04102007|450593788|FG000|Overall Study|Adverse Event|4|||
125263117|NCT04102007|450593788|FG000|Overall Study|Lost to Follow-up|3|||
125263118|NCT04102007|450593788|FG000|Overall Study|Withdrawal by Subject|12|||
125263119|NCT04102007|450593788|FG000|Overall Study|Eligibility Violation|5|||
125263120|NCT04102007|450593788|FG000|Overall Study|Lack of Efficacy|6|||
125263121|NCT04102007|450593788|FG000|Overall Study|Protocol Deviation|5|||
125263122|NCT04102007|450593788|FG000|Overall Study|Protocol Compliance|1|||
125263123|NCT04102007|450593788|FG000|Overall Study|Withdrew Treatment|2|||
125263124|NCT04102007|450593788|FG000|Overall Study|Pregnancy|1|||
125263125|NCT00892008|450593791|FG000|Overall Study|Death|5|||
125263126|NCT00892008|450593791|FG000|Overall Study|Lack of Efficacy|3|||
125263127|NCT00892008|450593791|FG000|Overall Study|Lost to Follow-up|142|||
125263128|NCT00892008|450593791|FG000|Overall Study|Other|378|||
125263129|NCT00892008|450593791|FG000|Overall Study|Adverse Event|37|||
125263130|NCT00329030|450593792|FG000|Overall Study|Withdrawal by Subject|1|||
125263131|NCT00329030|450593793|FG001|Overall Study|Withdrawal by Subject|3|||
125263132|NCT00329030|450593792|FG000|Overall Study|Progressive Disease|6|||
125263133|NCT00329030|450593793|FG001|Overall Study|Progressive Disease|2|||
125263134|NCT00329030|450593792|FG000|Overall Study|Ineligible Pathology|1|||
125263135|NCT00329030|450593793|FG001|Overall Study|Ineligible Pathology|1|||
125263136|NCT01627691|450593794|FG000|Overall Study|Death|11|||
125263137|NCT01627691|450593794|FG000|Overall Study|Lost to Follow-up|3|||
125263138|NCT01627691|450593794|FG000|Overall Study|Withdrawal by Subject|1|||
125263139|NCT01627691|450593794|FG000|Overall Study|Missed the visit|3|||
125263140|NCT00181844|450593795|FG000|Signed Consent|Withdrawal by Subject|5|||
125263141|NCT00181844|450593795|FG000|Signed Consent|Did not meet entrance criteria|7|||
125263142|NCT00181844|450593795|FG000|Exposed to Study Medication|Adverse Event|10|||
125263143|NCT00181844|450593795|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
125263144|NCT00181844|450593795|FG000|Exposed to Study Medication|Non-compliance|2|||
125263145|NCT00181844|450593795|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
125263146|NCT00181844|450593795|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
125263147|NCT04661033|450593796|FG000|Overall Study|Adverse Event|0|||
125263148|NCT04661033|450593797|FG001|Overall Study|Adverse Event|0|||
125263149|NCT04661033|450593798|FG002|Overall Study|Adverse Event|1|||
125263150|NCT04661033|450593799|FG003|Overall Study|Adverse Event|0|||
125263151|NCT04661033|450593796|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
125263152|NCT04661033|450593797|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
125263153|NCT04661033|450593798|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
125263154|NCT04661033|450593799|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
125263155|NCT04661033|450593796|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
125263156|NCT04661033|450593797|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
125263157|NCT04661033|450593798|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
125263158|NCT04661033|450593799|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
125263159|NCT04661033|450593796|FG000|Overall Study|Early discontinuation as per PI|1|||
125263160|NCT04661033|450593797|FG001|Overall Study|Early discontinuation as per PI|0|||
125263161|NCT04661033|450593798|FG002|Overall Study|Early discontinuation as per PI|0|||
125263162|NCT04661033|450593799|FG003|Overall Study|Early discontinuation as per PI|0|||
125263163|NCT00565409|450593802|FG000|Period 1 Open Label|Adverse Event|17|||
125263164|NCT00565409|450593803|FG001|Period 1 Open Label|Adverse Event|0|||
125263165|NCT00565409|450593804|FG002|Period 1 Open Label|Adverse Event|0|||
125263166|NCT00565409|450593805|FG003|Period 1 Open Label|Adverse Event|0|||
125263167|NCT00565409|450593802|FG000|Period 1 Open Label|Death|2|||
125263168|NCT00565409|450593803|FG001|Period 1 Open Label|Death|0|||
125263169|NCT00565409|450593804|FG002|Period 1 Open Label|Death|0|||
125263170|NCT00565409|450593805|FG003|Period 1 Open Label|Death|0|||
125263171|NCT00565409|450593802|FG000|Period 1 Open Label|Lost to Follow-up|1|||
125263172|NCT00565409|450593803|FG001|Period 1 Open Label|Lost to Follow-up|0|||
125263173|NCT00565409|450593804|FG002|Period 1 Open Label|Lost to Follow-up|0|||
125263174|NCT00565409|450593805|FG003|Period 1 Open Label|Lost to Follow-up|0|||
125263175|NCT00565409|450593802|FG000|Period 1 Open Label|Other|21|||
125263176|NCT00565409|450593803|FG001|Period 1 Open Label|Other|0|||
125263177|NCT00565409|450593804|FG002|Period 1 Open Label|Other|0|||
125263178|NCT00565409|450593805|FG003|Period 1 Open Label|Other|0|||
125263179|NCT00565409|450593802|FG000|Period 1 Open Label|Protocol Violation|14|||
125263180|NCT00565409|450593803|FG001|Period 1 Open Label|Protocol Violation|0|||
125263181|NCT00565409|450593804|FG002|Period 1 Open Label|Protocol Violation|0|||
125263182|NCT00565409|450593805|FG003|Period 1 Open Label|Protocol Violation|0|||
125263183|NCT00565409|450593802|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
125263184|NCT00565409|450593803|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
125263185|NCT00565409|450593804|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
125263186|NCT00565409|450593805|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
125263187|NCT00565409|450593802|FG000|Period 1 Open Label|no conclusion of participation record|1|||
125263188|NCT00565409|450593803|FG001|Period 1 Open Label|no conclusion of participation record|0|||
125263189|NCT00565409|450593804|FG002|Period 1 Open Label|no conclusion of participation record|0|||
125263190|NCT00565409|450593805|FG003|Period 1 Open Label|no conclusion of participation record|0|||
125263191|NCT00565409|450593802|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
125263192|NCT00565409|450593803|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
125263193|NCT00565409|450593804|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
125263194|NCT00565409|450593805|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
125263195|NCT00565409|450593802|FG000|Period 2 Double-Blind|Adverse Event|0|||
125263196|NCT00565409|450593803|FG001|Period 2 Double-Blind|Adverse Event|7|||
125263197|NCT00565409|450593804|FG002|Period 2 Double-Blind|Adverse Event|4|||
125263198|NCT00565409|450593805|FG003|Period 2 Double-Blind|Adverse Event|5|||
125263199|NCT00565409|450593802|FG000|Period 2 Double-Blind|Death|0|||
125263200|NCT00565409|450593803|FG001|Period 2 Double-Blind|Death|2|||
125263201|NCT00565409|450593804|FG002|Period 2 Double-Blind|Death|0|||
125263202|NCT00565409|450593805|FG003|Period 2 Double-Blind|Death|0|||
125263203|NCT00565409|450593802|FG000|Period 2 Double-Blind|Protocol Violation|0|||
125263204|NCT00565409|450593803|FG001|Period 2 Double-Blind|Protocol Violation|4|||
125263205|NCT00565409|450593804|FG002|Period 2 Double-Blind|Protocol Violation|6|||
125263206|NCT00565409|450593805|FG003|Period 2 Double-Blind|Protocol Violation|2|||
125263207|NCT00565409|450593802|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
125263208|NCT00565409|450593803|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
125263209|NCT00565409|450593804|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
125263210|NCT00565409|450593805|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
125263211|NCT00565409|450593802|FG000|Period 2 Double-Blind|Other|0|||
125263212|NCT00565409|450593803|FG001|Period 2 Double-Blind|Other|4|||
125263213|NCT00565409|450593804|FG002|Period 2 Double-Blind|Other|5|||
125263214|NCT00565409|450593805|FG003|Period 2 Double-Blind|Other|9|||
125263215|NCT00565409|450593802|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
125263216|NCT00565409|450593803|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
125263217|NCT00565409|450593804|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
125263218|NCT00565409|450593805|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
125263219|NCT04064905|450593821|FG000|Overall Study|Lost to Follow-up|0|||
125263220|NCT04064905|450593822|FG001|Overall Study|Lost to Follow-up|3|||
125263221|NCT04064905|450593823|FG002|Overall Study|Lost to Follow-up|1|||
125263222|NCT04064905|450593824|FG003|Overall Study|Lost to Follow-up|4|||
125263223|NCT04064905|450593825|FG004|Overall Study|Lost to Follow-up|2|||
125263224|NCT02257684|450593828|FG000|Overall Study|Adverse Event|2|||
125263225|NCT02257684|450593828|FG000|Overall Study|Lack of Efficacy|1|||
125263226|NCT02257684|450593828|FG000|Overall Study|Sponsor's Decision|1|||
125263227|NCT01570387|450593829|FG000|Overall Study|Adverse Event|1|||
125263228|NCT01570387|450593830|FG001|Overall Study|Adverse Event|0|||
125263229|NCT01570387|450593831|FG002|Overall Study|Adverse Event|0|||
125263230|NCT01570387|450593832|FG003|Overall Study|Adverse Event|0|||
125263231|NCT01570387|450593829|FG000|Overall Study|Death|0|||
125263232|NCT01570387|450593830|FG001|Overall Study|Death|0|||
125263233|NCT01570387|450593831|FG002|Overall Study|Death|0|||
125263234|NCT01570387|450593832|FG003|Overall Study|Death|1|||
125263235|NCT01570387|450593829|FG000|Overall Study|Withdrawal by Subject|0|||
125263236|NCT01570387|450593830|FG001|Overall Study|Withdrawal by Subject|0|||
125263237|NCT01570387|450593831|FG002|Overall Study|Withdrawal by Subject|0|||
125263238|NCT01570387|450593832|FG003|Overall Study|Withdrawal by Subject|1|||
125263239|NCT01987557|450593833|FG000|Overall Study|Protocol Violation|1|||
125263240|NCT01987557|450593834|FG001|Overall Study|Protocol Violation|0|||
125263241|NCT01987557|450593835|FG002|Overall Study|Protocol Violation|1|||
125263242|NCT01987557|450593833|FG000|Overall Study|Withdrawal by Subject|2|||
125263243|NCT01987557|450593834|FG001|Overall Study|Withdrawal by Subject|1|||
125263244|NCT01987557|450593835|FG002|Overall Study|Withdrawal by Subject|2|||
125263245|NCT01987557|450593833|FG000|Overall Study|Adverse Event|0|||
125263246|NCT01987557|450593834|FG001|Overall Study|Adverse Event|2|||
125263247|NCT01987557|450593835|FG002|Overall Study|Adverse Event|0|||
125263248|NCT00431964|450593836|FG000|Overall Study|Adverse Event|1|||
125263249|NCT00431964|450593837|FG001|Overall Study|Adverse Event|0|||
125263250|NCT00431964|450593836|FG000|Overall Study|Lost to Follow-up|1|||
125446793|NCT05968482|451261092|FG000|First Crossover Period|Adverse Event|0|||
125446794|NCT05968482|451261093|FG001|First Crossover Period|Adverse Event|0|||
125446795|NCT05968482|451261094|FG002|First Crossover Period|Adverse Event|0|||
125446796|NCT05968482|451261095|FG003|First Crossover Period|Adverse Event|0|||
125446797|NCT05968482|451261096|FG004|First Crossover Period|Adverse Event|0|||
125446798|NCT05968482|451261097|FG005|First Crossover Period|Adverse Event|1|||
125446799|NCT05968482|451261092|FG000|Second Crossover Period|Withdrawal by Subject|0|||
125446800|NCT05968482|451261093|FG001|Second Crossover Period|Withdrawal by Subject|0|||
125263251|NCT00431964|450593837|FG001|Overall Study|Lost to Follow-up|2|||
125263252|NCT00431964|450593836|FG000|Overall Study|Physician Decision|2|||
125263253|NCT00431964|450593837|FG001|Overall Study|Physician Decision|2|||
125263254|NCT00431964|450593836|FG000|Overall Study|Withdrawal by Subject|2|||
125263255|NCT00431964|450593837|FG001|Overall Study|Withdrawal by Subject|1|||
125263256|NCT00431964|450593836|FG000|Overall Study|Parental Consent Withdrawn|0|||
125263257|NCT00431964|450593837|FG001|Overall Study|Parental Consent Withdrawn|2|||
125263258|NCT00431964|450593836|FG000|Overall Study|Due to Unstable Health|0|||
125446801|NCT05968482|451261094|FG002|Second Crossover Period|Withdrawal by Subject|0|||
125263259|NCT00431964|450593837|FG001|Overall Study|Due to Unstable Health|1|||
125263260|NCT01657305|450593839|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
125263261|NCT01657305|450593839|FG000|Overall Study|Withdrawal by Subject|4|||
125446802|NCT05968482|451261095|FG003|Second Crossover Period|Withdrawal by Subject|0|||
125446803|NCT05968482|451261096|FG004|Second Crossover Period|Withdrawal by Subject|1|||
125446804|NCT05968482|451261097|FG005|Second Crossover Period|Withdrawal by Subject|0|||
125446805|NCT05968482|451261092|FG000|Third Crossover Period|Adverse Event|0|||
125446806|NCT05968482|451261093|FG001|Third Crossover Period|Adverse Event|0|||
125446807|NCT05968482|451261094|FG002|Third Crossover Period|Adverse Event|0|||
125446808|NCT05968482|451261095|FG003|Third Crossover Period|Adverse Event|0|||
125446809|NCT05968482|451261096|FG004|Third Crossover Period|Adverse Event|1|||
125446810|NCT05968482|451261097|FG005|Third Crossover Period|Adverse Event|0|||
125446811|NCT05968482|451261092|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
125446812|NCT05968482|451261093|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
125446813|NCT05968482|451261094|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
125446814|NCT05968482|451261095|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
125446815|NCT05968482|451261096|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
125446816|NCT05968482|451261097|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
125446817|NCT02559817|451261098|FG000|Treatment Period|Adverse Event|1|||
125446818|NCT02559817|451261099|FG001|Treatment Period|Adverse Event|0|||
125446819|NCT02559817|451261100|FG002|Treatment Period|Adverse Event|1|||
125446820|NCT02559817|451261101|FG003|Treatment Period|Adverse Event|0|||
125446821|NCT02559817|451261102|FG004|Treatment Period|Adverse Event|0|||
125446822|NCT02559817|451261098|FG000|Treatment Period|Lack of Efficacy|0|||
125446823|NCT02559817|451261099|FG001|Treatment Period|Lack of Efficacy|1|||
125446824|NCT02559817|451261100|FG002|Treatment Period|Lack of Efficacy|0|||
125446825|NCT02559817|451261101|FG003|Treatment Period|Lack of Efficacy|0|||
125446826|NCT02559817|451261102|FG004|Treatment Period|Lack of Efficacy|0|||
125446827|NCT02559817|451261098|FG000|Treatment Period|Lost to Follow-up|0|||
125446828|NCT02559817|451261099|FG001|Treatment Period|Lost to Follow-up|1|||
125446829|NCT02559817|451261100|FG002|Treatment Period|Lost to Follow-up|0|||
125446830|NCT02559817|451261101|FG003|Treatment Period|Lost to Follow-up|1|||
125446831|NCT02559817|451261102|FG004|Treatment Period|Lost to Follow-up|0|||
125446832|NCT02559817|451261098|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
125446833|NCT02559817|451261099|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
125446834|NCT02559817|451261100|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
125446835|NCT02559817|451261101|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
125446836|NCT02559817|451261102|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
125446837|NCT02559817|451261098|FG000|Treatment Period|Protocol Violation|0|||
125446838|NCT02559817|451261099|FG001|Treatment Period|Protocol Violation|0|||
125446839|NCT02559817|451261100|FG002|Treatment Period|Protocol Violation|0|||
125446840|NCT02559817|451261101|FG003|Treatment Period|Protocol Violation|1|||
125446841|NCT02559817|451261102|FG004|Treatment Period|Protocol Violation|0|||
125446842|NCT00761774|451261107|FG000|Overall Study|Adverse Event|17|||
125446843|NCT00761774|451261107|FG000|Overall Study|Lack of Efficacy|37|||
125446844|NCT00761774|451261107|FG000|Overall Study|Lost to Follow-up|2|||
125446845|NCT00761774|451261107|FG000|Overall Study|Withdrawal by Subject|9|||
125446846|NCT00761774|451261107|FG000|Overall Study|Non-compliance|4|||
125446847|NCT00761774|451261107|FG000|Overall Study|End of study|2|||
125446848|NCT00761774|451261107|FG000|Overall Study|Reclassification of seizures|1|||
125446849|NCT00761774|451261107|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
125446850|NCT00761774|451261107|FG000|Overall Study|Sponsor decision|1|||
125446851|NCT00761774|451261107|FG000|Overall Study|Investigator clinical judgement|1|||
125446852|NCT00761774|451261107|FG000|Overall Study|Patient moved out of study area|1|||
125446853|NCT00761774|451261107|FG000|Overall Study|Coordinator leaving site|1|||
125446854|NCT00761774|451261107|FG000|Overall Study|Subject IP non-compliance|1|||
125446855|NCT00761774|451261107|FG000|Overall Study|IP stopped by hospital physician|1|||
125446856|NCT01925170|451261108|FG000|Overall Study|Unverified cancer status|53|||
125446857|NCT01077024|451261109|FG000|Overall Study|Lost to Follow-up|20|||
125263262|NCT01657305|450593839|FG000|Overall Study|Adverse Event|1|||
125263263|NCT01657305|450593839|FG000|Overall Study|Lost to Follow-up|1|||
125263264|NCT01657305|450593839|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
125263265|NCT04103450|450593840|FG000|Overall Study|Adverse Event|4|||
125263266|NCT04103450|450593841|FG001|Overall Study|Adverse Event|2|||
125446858|NCT01077024|451261110|FG001|Overall Study|Lost to Follow-up|14|||
125446859|NCT01077024|451261109|FG000|Overall Study|Withdrawal by Subject|0|||
125446860|NCT01077024|451261110|FG001|Overall Study|Withdrawal by Subject|2|||
125446861|NCT01077024|451261109|FG000|Overall Study|Incarcerated|7|||
125446862|NCT01077024|451261110|FG001|Overall Study|Incarcerated|8|||
125446863|NCT01077024|451261109|FG000|Overall Study|Other|4|||
125263267|NCT04103450|450593840|FG000|Overall Study|Lack of Efficacy|3|||
125446864|NCT01077024|451261110|FG001|Overall Study|Other|4|||
125446865|NCT01603121|451261111|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
125263268|NCT04103450|450593841|FG001|Overall Study|Lack of Efficacy|0|||
125446866|NCT01603121|451261112|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
125446867|NCT00577720|451261113|FG000|Overall Study|Adverse Event|2|||
125263269|NCT04103450|450593840|FG000|Overall Study|Withdrawal by Subject|5|||
125263270|NCT04103450|450593841|FG001|Overall Study|Withdrawal by Subject|3|||
125263271|NCT04103450|450593840|FG000|Overall Study|Lost to Follow-up|1|||
125263272|NCT04103450|450593841|FG001|Overall Study|Lost to Follow-up|2|||
125263273|NCT04103450|450593840|FG000|Overall Study|Physician Decision|1|||
125263274|NCT04103450|450593841|FG001|Overall Study|Physician Decision|2|||
125263275|NCT04103450|450593840|FG000|Overall Study|Protocol Violation|1|||
125263276|NCT04103450|450593841|FG001|Overall Study|Protocol Violation|0|||
125263277|NCT04103450|450593840|FG000|Overall Study|Other|1|||
125263278|NCT04103450|450593841|FG001|Overall Study|Other|1|||
125263279|NCT01696643|450593851|FG000|Overall Study|Adverse Event|15|||
125263280|NCT01696643|450593852|FG001|Overall Study|Adverse Event|7|||
125263281|NCT01696643|450593851|FG000|Overall Study|Death|1|||
125263282|NCT01696643|450593852|FG001|Overall Study|Death|2|||
125263283|NCT01696643|450593851|FG000|Overall Study|Lack of Efficacy|3|||
125263284|NCT01696643|450593852|FG001|Overall Study|Lack of Efficacy|0|||
125263285|NCT01696643|450593851|FG000|Overall Study|Lost to Follow-up|67|||
125263286|NCT01696643|450593852|FG001|Overall Study|Lost to Follow-up|67|||
125263287|NCT01696643|450593851|FG000|Overall Study|Physician Decision|3|||
125263288|NCT01696643|450593852|FG001|Overall Study|Physician Decision|2|||
125263289|NCT01696643|450593851|FG000|Overall Study|Pregnancy|0|||
125263290|NCT01696643|450593852|FG001|Overall Study|Pregnancy|1|||
125263291|NCT01696643|450593851|FG000|Overall Study|Protocol Violation|7|||
125263292|NCT01696643|450593852|FG001|Overall Study|Protocol Violation|7|||
125263293|NCT01696643|450593851|FG000|Overall Study|Study Terminated by Sponsor|286|||
125263294|NCT01696643|450593852|FG001|Overall Study|Study Terminated by Sponsor|294|||
125263295|NCT01696643|450593851|FG000|Overall Study|Withdrawal by Subject|142|||
125263296|NCT01696643|450593852|FG001|Overall Study|Withdrawal by Subject|149|||
125263297|NCT01696643|450593851|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
125263298|NCT01696643|450593852|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
125263299|NCT01696643|450593851|FG000|Overall Study|Site Error|2|||
125263300|NCT01696643|450593852|FG001|Overall Study|Site Error|1|||
125263301|NCT01696643|450593851|FG000|Overall Study|Participant Incarcerated|0|||
125263302|NCT01696643|450593852|FG001|Overall Study|Participant Incarcerated|1|||
125263303|NCT01696643|450593851|FG000|Overall Study|Medical Monitor Decision|0|||
125263304|NCT01696643|450593852|FG001|Overall Study|Medical Monitor Decision|2|||
125263305|NCT01696643|450593851|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
125263306|NCT01696643|450593852|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
125263307|NCT00518180|450593853|FG000|Overall Study|Withdrawal by Subject|29|||
125263308|NCT00518180|450593854|FG001|Overall Study|Withdrawal by Subject|30|||
125263309|NCT00518180|450593855|FG002|Overall Study|Withdrawal by Subject|42|||
125263310|NCT00518180|450593853|FG000|Overall Study|Lost to Follow-up|30|||
125263311|NCT00518180|450593854|FG001|Overall Study|Lost to Follow-up|28|||
125263312|NCT00518180|450593855|FG002|Overall Study|Lost to Follow-up|34|||
125263313|NCT00518180|450593853|FG000|Overall Study|Administrative reason|0|||
125263314|NCT00518180|450593854|FG001|Overall Study|Administrative reason|2|||
125263315|NCT00518180|450593855|FG002|Overall Study|Administrative reason|2|||
125263316|NCT00518180|450593853|FG000|Overall Study|Protocol Violation|5|||
125263317|NCT00518180|450593854|FG001|Overall Study|Protocol Violation|7|||
125263318|NCT00518180|450593855|FG002|Overall Study|Protocol Violation|4|||
125263319|NCT00518180|450593853|FG000|Overall Study|Unable to classify|0|||
125263320|NCT00518180|450593854|FG001|Overall Study|Unable to classify|2|||
125263321|NCT00518180|450593855|FG002|Overall Study|Unable to classify|0|||
125263322|NCT00518180|450593853|FG000|Overall Study|Adverse Event|1|||
125263323|NCT00518180|450593854|FG001|Overall Study|Adverse Event|0|||
125263324|NCT00518180|450593855|FG002|Overall Study|Adverse Event|0|||
125263325|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
125263326|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
125263327|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
125263328|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Death|0|||
125398465|NCT02741115|451091047|FG001|Overall Study|Withdrawal by Subject|2|||
125398466|NCT01707004|451093126|FG000|Overall Study|Physician Decision|3|||
125398467|NCT03756558|451093129|FG000|Overall Study|Death|1|||
125398468|NCT03756558|451093129|FG000|Overall Study|Lost to Follow-up|2|||
125263329|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Death|0|||
125263330|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Death|1|||
125263331|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
125263332|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
125263333|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
125263334|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
125263335|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
125263336|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
125263337|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
125263338|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
125263339|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
125263340|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Graft loss|0|||
125263341|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Graft loss|0|||
125446868|NCT00577720|451261114|FG001|Overall Study|Adverse Event|1|||
125263342|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Graft loss|7|||
125263343|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
125263344|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
125263345|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
125263346|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
125263347|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
125263348|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
125263349|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
125263350|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
125263351|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
125263352|NCT00956293|450593859|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
125263353|NCT00956293|450593860|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
125263354|NCT00956293|450593861|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
125263355|NCT00956293|450593859|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
125263356|NCT00956293|450593860|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
125263357|NCT00956293|450593861|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
125263358|NCT00956293|450593859|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
125263359|NCT00956293|450593860|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
125263360|NCT00956293|450593861|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
125263361|NCT00956293|450593859|FG000|Main Period (Randomization)|Adverse Event|0|||
125263362|NCT00956293|450593860|FG001|Main Period (Randomization)|Adverse Event|15|||
125263363|NCT00956293|450593861|FG002|Main Period (Randomization)|Adverse Event|0|||
125263364|NCT00956293|450593859|FG000|Follow-up Period|Follow-up period was terminated.|20|||
125263365|NCT00956293|450593860|FG001|Follow-up Period|Follow-up period was terminated.|32|||
125263366|NCT00956293|450593861|FG002|Follow-up Period|Follow-up period was terminated.|0|||
125263367|NCT02536664|450593862|FG000|Overall Study|Inadequate completion of documentation|2|||
125263368|NCT02536664|450593863|FG001|Overall Study|Inadequate completion of documentation|4|||
125263369|NCT02536664|450593862|FG000|Overall Study|Progression|13|||
125263370|NCT02536664|450593863|FG001|Overall Study|Progression|18|||
125263371|NCT02536664|450593862|FG000|Overall Study|Death due to lymphoma|2|||
125263372|NCT02536664|450593863|FG001|Overall Study|Death due to lymphoma|1|||
125263373|NCT02536664|450593862|FG000|Overall Study|Death due to other reason|3|||
125263374|NCT02536664|450593863|FG001|Overall Study|Death due to other reason|2|||
125263375|NCT02536664|450593862|FG000|Overall Study|Intolerability|8|||
125263376|NCT02536664|450593863|FG001|Overall Study|Intolerability|6|||
125263377|NCT02536664|450593862|FG000|Overall Study|Withdrawal by Subject|8|||
125263378|NCT02536664|450593863|FG001|Overall Study|Withdrawal by Subject|5|||
125263379|NCT02536664|450593862|FG000|Overall Study|Other|18|||
125263380|NCT02536664|450593863|FG001|Overall Study|Other|24|||
125263381|NCT02536664|450593862|FG000|Overall Study|Missing|53|||
125263382|NCT02536664|450593863|FG001|Overall Study|Missing|20|||
125263383|NCT03383666|450593864|FG000|Overall Study|Withdrawal by Subject|2|||
125263384|NCT03383666|450593864|FG000|Overall Study|Lost to Follow-up|2|||
125263385|NCT03961308|450593871|FG000|Overall Study|Withdrawal by Subject|1|||
125263386|NCT03961308|450593872|FG001|Overall Study|Withdrawal by Subject|0|||
125263387|NCT03961308|450593871|FG000|Overall Study|Other|1|||
125263388|NCT03961308|450593872|FG001|Overall Study|Other|0|||
125263389|NCT03961308|450593871|FG000|Overall Study|Lost to Follow-up|0|||
125263390|NCT03961308|450593872|FG001|Overall Study|Lost to Follow-up|1|||
125263391|NCT03961308|450593871|FG000|Overall Study|Adverse Event|0|||
125263392|NCT03961308|450593872|FG001|Overall Study|Adverse Event|1|||
125263393|NCT01174563|450593879|FG000|Overall Study|Progressive Disease|45|||
125263394|NCT01174563|450593879|FG000|Overall Study|Death|5|||
125263395|NCT01174563|450593879|FG000|Overall Study|Investigator's Discretion|5|||
125263396|NCT01174563|450593879|FG000|Overall Study|Participant Withdrew Consent|3|||
125263397|NCT01174563|450593879|FG000|Overall Study|Rash Adverse Event|1|||
125263398|NCT01174563|450593879|FG000|Overall Study|Sponsor's decision|1|||
125263399|NCT03402841|450593880|FG000|Overall Study|Withdrawal by Subject|3|||
125263400|NCT03402841|450593880|FG000|Overall Study|Lost to Follow-up|2|||
125263401|NCT03402841|450593880|FG000|Overall Study|Death|146|||
125263402|NCT01542788|450593885|FG000|Overall Study|Randomized but Not Treated|2|||
125263403|NCT01542788|450593886|FG001|Overall Study|Randomized but Not Treated|0|||
125263404|NCT01542788|450593885|FG000|Overall Study|Lack of Efficacy|41|||
125263405|NCT01542788|450593886|FG001|Overall Study|Lack of Efficacy|71|||
125263406|NCT01542788|450593885|FG000|Overall Study|Lost to Follow-up|5|||
125263407|NCT01542788|450593886|FG001|Overall Study|Lost to Follow-up|0|||
125263408|NCT01542788|450593885|FG000|Overall Study|Death|3|||
125263409|NCT01542788|450593886|FG001|Overall Study|Death|0|||
125263410|NCT01542788|450593885|FG000|Overall Study|Protocol Violation|2|||
125263411|NCT01542788|450593886|FG001|Overall Study|Protocol Violation|0|||
125263412|NCT01542788|450593885|FG000|Overall Study|Physician Decision|1|||
125263413|NCT01542788|450593886|FG001|Overall Study|Physician Decision|0|||
125263414|NCT01542788|450593885|FG000|Overall Study|Withdrawal by Subject|1|||
125263415|NCT01542788|450593886|FG001|Overall Study|Withdrawal by Subject|0|||
125263416|NCT01280968|450593887|FG000|Overall Study|Lost to Follow-up|8|||
125446869|NCT00577720|451261115|FG002|Overall Study|Adverse Event|0|||
125446870|NCT00577720|451261116|FG003|Overall Study|Adverse Event|4|||
125446871|NCT00577720|451261113|FG000|Overall Study|Lost to Follow-up|0|||
125446872|NCT00577720|451261114|FG001|Overall Study|Lost to Follow-up|0|||
125446873|NCT00577720|451261115|FG002|Overall Study|Lost to Follow-up|1|||
125446874|NCT00577720|451261116|FG003|Overall Study|Lost to Follow-up|0|||
125446875|NCT00577720|451261113|FG000|Overall Study|Protocol Violation|0|||
125398469|NCT03756558|451093129|FG000|Overall Study|Withdrawal by Subject|2|||
125398470|NCT02143414|451093130|FG000|Induction|Adverse Event|1|||
125398471|NCT02143414|451093131|FG001|Induction|Adverse Event|2|||
125398472|NCT02143414|451093130|FG000|Induction|Death|1|||
125398473|NCT02143414|451093131|FG001|Induction|Death|2|||
125398474|NCT02143414|451093130|FG000|Induction|Patient refusal|1|||
125398475|NCT02143414|451093131|FG001|Induction|Patient refusal|1|||
125398476|NCT02143414|451093130|FG000|Induction|Refractory|1|||
125398477|NCT02143414|451093131|FG001|Induction|Refractory|0|||
125398478|NCT02143414|451093130|FG000|Induction|Began alternative treatment|1|||
125398479|NCT02143414|451093131|FG001|Induction|Began alternative treatment|0|||
125398480|NCT02143414|451093130|FG000|Induction|Ineligible for postremission|5|||
125398481|NCT02143414|451093131|FG001|Induction|Ineligible for postremission|1|||
125398482|NCT02143414|451093130|FG000|Post-remission|Adverse Event|0|||
125398483|NCT02143414|451093131|FG001|Post-remission|Adverse Event|2|||
125398484|NCT02143414|451093130|FG000|Post-remission|Disease progression/relapse|5|||
125398485|NCT02143414|451093131|FG001|Post-remission|Disease progression/relapse|0|||
125398486|NCT02143414|451093130|FG000|Maintenance|Adverse Event|4|||
125398487|NCT02143414|451093131|FG001|Maintenance|Adverse Event|6|||
125398488|NCT02143414|451093130|FG000|Maintenance|Disease progression/relapse|3|||
125398489|NCT02143414|451093131|FG001|Maintenance|Disease progression/relapse|2|||
125398490|NCT02143414|451093130|FG000|Maintenance|Patient refusal|2|||
125398491|NCT02143414|451093131|FG001|Maintenance|Patient refusal|1|||
125398492|NCT02143414|451093130|FG000|Maintenance|Physician Decision|1|||
125398493|NCT02143414|451093131|FG001|Maintenance|Physician Decision|0|||
125398494|NCT02143414|451093130|FG000|Maintenance|Death|0|||
125398495|NCT02143414|451093131|FG001|Maintenance|Death|1|||
125398496|NCT02143414|451093130|FG000|Maintenance|On protocol treatment|0|||
125398497|NCT02143414|451093131|FG001|Maintenance|On protocol treatment|6|||
125398498|NCT00679341|451093132|FG000|Overall Study|Disease progression|42|||
125398499|NCT00679341|451093133|FG001|Overall Study|Disease progression|36|||
125398500|NCT00679341|451093132|FG000|Overall Study|Adverse Event|5|||
125398501|NCT00679341|451093133|FG001|Overall Study|Adverse Event|6|||
125398502|NCT00679341|451093132|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
125398503|NCT00679341|451093133|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
125398504|NCT00679341|451093132|FG000|Overall Study|Death|1|||
125398505|NCT00679341|451093133|FG001|Overall Study|Death|1|||
125398506|NCT00679341|451093132|FG000|Overall Study|Other|1|||
125398507|NCT00679341|451093133|FG001|Overall Study|Other|0|||
125398508|NCT00679341|451093132|FG000|Overall Study|Physician Decision|1|||
125398509|NCT00679341|451093133|FG001|Overall Study|Physician Decision|0|||
125398510|NCT00679341|451093132|FG000|Overall Study|Not treated|0|||
125398511|NCT00679341|451093133|FG001|Overall Study|Not treated|2|||
125398512|NCT00679341|451093132|FG000|Overall Study|Physician/patient decision to withdraw|0|||
125398513|NCT00679341|451093133|FG001|Overall Study|Physician/patient decision to withdraw|6|||
125398514|NCT01433263|451093136|FG000|Overall Study|Adverse Event|3|||
125398515|NCT01433263|451093137|FG001|Overall Study|Adverse Event|1|||
125398516|NCT01433263|451093136|FG000|Overall Study|Death|5|||
125398517|NCT01433263|451093137|FG001|Overall Study|Death|3|||
125398518|NCT01433263|451093136|FG000|Overall Study|Lost to Follow-up|0|||
125398519|NCT01433263|451093137|FG001|Overall Study|Lost to Follow-up|1|||
125398520|NCT01433263|451093136|FG000|Overall Study|Protocol Deviation|1|||
125398521|NCT01433263|451093137|FG001|Overall Study|Protocol Deviation|0|||
125398522|NCT01433263|451093136|FG000|Overall Study|Withdrawal by Subject|10|||
125398523|NCT01433263|451093137|FG001|Overall Study|Withdrawal by Subject|7|||
125398524|NCT03107988|451093138|FG000|Overall Study|Adverse Event|0|||
125398525|NCT03107988|451093139|FG001|Overall Study|Adverse Event|0|||
125398526|NCT03107988|451093140|FG002|Overall Study|Adverse Event|0|||
125398527|NCT03107988|451093141|FG003|Overall Study|Adverse Event|1|||
125398528|NCT03107988|451093142|FG004|Overall Study|Adverse Event|0|||
125398529|NCT03107988|451093143|FG005|Overall Study|Adverse Event|1|||
125398530|NCT03107988|451093144|FG006|Overall Study|Adverse Event|0|||
125398531|NCT03107988|451093145|FG007|Overall Study|Adverse Event|1|||
125398532|NCT03107988|451093146|FG008|Overall Study|Adverse Event|0|||
125398533|NCT03107988|451093147|FG009|Overall Study|Adverse Event|0|||
125398534|NCT03107988|451093148|FG010|Overall Study|Adverse Event|0|||
125398535|NCT03107988|451093149|FG011|Overall Study|Adverse Event|0|||
125398536|NCT03107988|451093150|FG012|Overall Study|Adverse Event|0|||
125398537|NCT03107988|451093138|FG000|Overall Study|Disease Progression or Relapse|1|||
125398538|NCT03107988|451093139|FG001|Overall Study|Disease Progression or Relapse|2|||
125398539|NCT03107988|451093140|FG002|Overall Study|Disease Progression or Relapse|2|||
125398540|NCT03107988|451093141|FG003|Overall Study|Disease Progression or Relapse|5|||
125446876|NCT00577720|451261114|FG001|Overall Study|Protocol Violation|0|||
125263417|NCT01280968|450593888|FG001|Overall Study|Lost to Follow-up|2|||
125263418|NCT01280968|450593887|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
125263419|NCT01280968|450593888|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
125263420|NCT01280968|450593887|FG000|Overall Study|Commuting Problems|2|||
125263421|NCT01280968|450593888|FG001|Overall Study|Commuting Problems|0|||
125263422|NCT01280968|450593887|FG000|Overall Study|Anxiety|2|||
125263423|NCT01280968|450593888|FG001|Overall Study|Anxiety|0|||
125263424|NCT01280968|450593887|FG000|Overall Study|Adverse Event|1|||
125263425|NCT01280968|450593888|FG001|Overall Study|Adverse Event|0|||
125398541|NCT03107988|451093142|FG004|Overall Study|Disease Progression or Relapse|1|||
125398542|NCT03107988|451093143|FG005|Overall Study|Disease Progression or Relapse|1|||
125398543|NCT03107988|451093144|FG006|Overall Study|Disease Progression or Relapse|0|||
125398544|NCT03107988|451093145|FG007|Overall Study|Disease Progression or Relapse|0|||
125398545|NCT03107988|451093146|FG008|Overall Study|Disease Progression or Relapse|0|||
125398546|NCT03107988|451093147|FG009|Overall Study|Disease Progression or Relapse|1|||
125398547|NCT03107988|451093148|FG010|Overall Study|Disease Progression or Relapse|4|||
125398548|NCT03107988|451093149|FG011|Overall Study|Disease Progression or Relapse|0|||
125398549|NCT03107988|451093150|FG012|Overall Study|Disease Progression or Relapse|0|||
125398550|NCT03107988|451093138|FG000|Overall Study|Ineligible|0|||
125398551|NCT03107988|451093139|FG001|Overall Study|Ineligible|0|||
125398552|NCT03107988|451093140|FG002|Overall Study|Ineligible|0|||
125398553|NCT03107988|451093141|FG003|Overall Study|Ineligible|0|||
125398554|NCT03107988|451093142|FG004|Overall Study|Ineligible|0|||
125398555|NCT03107988|451093143|FG005|Overall Study|Ineligible|0|||
125398556|NCT03107988|451093144|FG006|Overall Study|Ineligible|0|||
125398557|NCT03107988|451093145|FG007|Overall Study|Ineligible|0|||
125398558|NCT03107988|451093146|FG008|Overall Study|Ineligible|1|||
125398559|NCT03107988|451093147|FG009|Overall Study|Ineligible|0|||
125398560|NCT03107988|451093148|FG010|Overall Study|Ineligible|0|||
125398561|NCT03107988|451093149|FG011|Overall Study|Ineligible|0|||
125398562|NCT03107988|451093150|FG012|Overall Study|Ineligible|0|||
125398563|NCT01359592|451093151|FG000|Initial Registration|Adverse Event|1|||
125398564|NCT01359592|451093152|FG001|Initial Registration|Adverse Event|0|||
125398565|NCT01359592|451093153|FG002|Initial Registration|Adverse Event|0|||
125398566|NCT01359592|451093154|FG003|Initial Registration|Adverse Event|0|||
125398567|NCT01359592|451093151|FG000|Initial Registration|Death|1|||
125398568|NCT01359592|451093152|FG001|Initial Registration|Death|0|||
125398569|NCT01359592|451093153|FG002|Initial Registration|Death|0|||
125398570|NCT01359592|451093154|FG003|Initial Registration|Death|0|||
125398571|NCT01359592|451093151|FG000|Initial Registration|Other reason not protocol specified|1|||
125398572|NCT01359592|451093152|FG001|Initial Registration|Other reason not protocol specified|0|||
125398573|NCT01359592|451093153|FG002|Initial Registration|Other reason not protocol specified|0|||
125398574|NCT01359592|451093154|FG003|Initial Registration|Other reason not protocol specified|0|||
125398575|NCT01359592|451093151|FG000|Initial Registration|Ineligible|26|||
125398576|NCT01359592|451093152|FG001|Initial Registration|Ineligible|0|||
125398577|NCT01359592|451093153|FG002|Initial Registration|Ineligible|0|||
125398578|NCT01359592|451093154|FG003|Initial Registration|Ineligible|0|||
125398579|NCT01359592|451093151|FG000|PET-Directed Therapy|Adverse Event|0|||
125398580|NCT01359592|451093152|FG001|PET-Directed Therapy|Adverse Event|0|||
125398581|NCT01359592|451093153|FG002|PET-Directed Therapy|Adverse Event|1|||
125398582|NCT01359592|451093154|FG003|PET-Directed Therapy|Adverse Event|0|||
125398583|NCT01359592|451093151|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
125398584|NCT01359592|451093152|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
125398585|NCT01359592|451093153|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
125398586|NCT01359592|451093154|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
125398587|NCT01359592|451093151|FG000|PET-Directed Therapy|Ineligible|0|||
125398588|NCT01359592|451093152|FG001|PET-Directed Therapy|Ineligible|0|||
125398589|NCT01359592|451093153|FG002|PET-Directed Therapy|Ineligible|24|||
125398590|NCT01359592|451093154|FG003|PET-Directed Therapy|Ineligible|0|||
125398591|NCT00326612|451093155|FG000|Overall Study|They did not have a seizure requiring tx|129|||
125398592|NCT00326612|451093156|FG001|Overall Study|They did not have a seizure requiring tx|137|||
125398593|NCT00548808|451093157|FG000|Overall Study|Lost to Follow-up|9|||
125398594|NCT00548808|451093158|FG001|Overall Study|Lost to Follow-up|3|||
125398595|NCT00548808|451093157|FG000|Overall Study|Protocol Violation|8|||
125398596|NCT00548808|451093158|FG001|Overall Study|Protocol Violation|8|||
125398597|NCT00548808|451093157|FG000|Overall Study|Withdrawal by Subject|8|||
125398598|NCT00548808|451093158|FG001|Overall Study|Withdrawal by Subject|4|||
125398599|NCT00548808|451093157|FG000|Overall Study|Physician Decision|6|||
125398600|NCT00548808|451093158|FG001|Overall Study|Physician Decision|3|||
125398601|NCT00548808|451093157|FG000|Overall Study|Adverse Event|4|||
125398602|NCT00548808|451093158|FG001|Overall Study|Adverse Event|5|||
125398603|NCT00548808|451093157|FG000|Overall Study|Death|2|||
125398604|NCT00548808|451093158|FG001|Overall Study|Death|0|||
125398605|NCT00548808|451093157|FG000|Overall Study|Entry Criteria Not Met|2|||
125398606|NCT00548808|451093158|FG001|Overall Study|Entry Criteria Not Met|2|||
125398607|NCT00548808|451093157|FG000|Overall Study|Lack of Efficacy|2|||
125398608|NCT00548808|451093158|FG001|Overall Study|Lack of Efficacy|0|||
125263426|NCT01280968|450593887|FG000|Overall Study|Scheduling Conflicts|1|||
125263427|NCT01280968|450593888|FG001|Overall Study|Scheduling Conflicts|1|||
125263428|NCT01280968|450593887|FG000|Overall Study|Pre-existing Neurological Condition|1|||
125263429|NCT01280968|450593888|FG001|Overall Study|Pre-existing Neurological Condition|0|||
125263430|NCT01280968|450593887|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
125263431|NCT01280968|450593888|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
125263432|NCT04704193|450593889|FG000|Overall Study|Withdrawal by Subject|1|||
125263433|NCT00542178|450593890|FG000|Overall Study|did not complete year 4 follow-up|75|||
125263434|NCT00542178|450593891|FG001|Overall Study|did not complete year 4 follow-up|80|||
125263435|NCT00542178|450593892|FG002|Overall Study|did not complete year 4 follow-up|74|||
125263436|NCT00542178|450593893|FG003|Overall Study|did not complete year 4 follow-up|62|||
125263437|NCT00542178|450593894|FG004|Overall Study|did not complete year 4 follow-up|64|||
125263438|NCT00542178|450593895|FG005|Overall Study|did not complete year 4 follow-up|89|||
125263439|NCT00542178|450593896|FG006|Overall Study|did not complete year 4 follow-up|87|||
125263440|NCT00542178|450593897|FG007|Overall Study|did not complete year 4 follow-up|85|||
125263441|NCT03984188|450593903|FG000|Overall Study|Death|2|||
125263442|NCT03984188|450593904|FG001|Overall Study|Death|4|||
125263443|NCT03984188|450593903|FG000|Overall Study|Physician Decision|0|||
125263444|NCT03984188|450593904|FG001|Overall Study|Physician Decision|2|||
125263445|NCT03984188|450593903|FG000|Overall Study|Lost to Follow-up|3|||
125263446|NCT03984188|450593904|FG001|Overall Study|Lost to Follow-up|2|||
125263447|NCT03984188|450593903|FG000|Overall Study|Withdrawal by Subject|6|||
125263448|NCT03984188|450593904|FG001|Overall Study|Withdrawal by Subject|0|||
125263449|NCT01173679|450595333|FG000|Overall Study|Death|1|||
125263450|NCT01250054|450595334|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
125263451|NCT01250054|450595335|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
125263452|NCT02777086|450595336|FG000|Overall Study|Lost to Follow-up|96|||
125263453|NCT02777086|450595337|FG001|Overall Study|Lost to Follow-up|99|||
125263454|NCT01133665|450595342|FG000|Overall Study|Physician Decision|2|||
125263455|NCT02122380|450595343|FG000|First Intervention (30 Days)|Adverse Event|1|||
125263456|NCT02122380|450595344|FG001|First Intervention (30 Days)|Adverse Event|0|||
125263457|NCT02122380|450595343|FG000|First Intervention (30 Days)|Physician Decision|0|||
125263458|NCT02122380|450595344|FG001|First Intervention (30 Days)|Physician Decision|1|||
125263459|NCT02122380|450595343|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
125263460|NCT02122380|450595344|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
125263461|NCT02122380|450595343|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
125263462|NCT02122380|450595344|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
125263463|NCT02122380|450595343|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
125263464|NCT02122380|450595344|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
125263465|NCT00272792|450595345|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
125263466|NCT00272792|450595346|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
125263467|NCT00272792|450595345|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
125263468|NCT00272792|450595346|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
125263469|NCT00272792|450595345|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
125263470|NCT00272792|450595346|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
125263471|NCT00272792|450595345|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
125263472|NCT00272792|450595346|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
125263473|NCT02921789|450595347|FG000|Overall Study|Adverse Event|0|||
125263474|NCT02921789|450595348|FG001|Overall Study|Adverse Event|1|||
125263475|NCT02921789|450595347|FG000|Overall Study|Lost to Follow-up|1|||
125263476|NCT02921789|450595348|FG001|Overall Study|Lost to Follow-up|0|||
125263477|NCT02921789|450595347|FG000|Overall Study|Protocol Deviation|2|||
125263478|NCT02921789|450595348|FG001|Overall Study|Protocol Deviation|0|||
125263479|NCT02921789|450595347|FG000|Overall Study|Withdrawal by Subject|2|||
125263480|NCT02921789|450595348|FG001|Overall Study|Withdrawal by Subject|1|||
125263481|NCT02921789|450595347|FG000|Overall Study|Miscellaneous|3|||
125263482|NCT02921789|450595348|FG001|Overall Study|Miscellaneous|2|||
125263483|NCT04099277|450595349|FG000|Overall Study|Physician Decision|1|||
125263484|NCT04099277|450595349|FG000|Overall Study|Withdrawal by Subject|1|||
125263485|NCT00598650|450595352|FG000|Overall Study|Withdrawal by Subject|3|||
125263486|NCT00598650|450595352|FG000|Overall Study|Adverse Event|18|||
125263487|NCT00598650|450595352|FG000|Overall Study|No treatment for 3 weeks|1|||
125263488|NCT00598650|450595352|FG000|Overall Study|Not eligible|1|||
125263489|NCT00598650|450595352|FG000|Overall Study|Prohibited Concomitant Medication|2|||
125263490|NCT00598650|450595352|FG000|Overall Study|Physician Decision|2|||
125263491|NCT03423602|450595353|FG000|Overall Study|Death|1|||
125263492|NCT03423602|450595353|FG000|Overall Study|Lost to Follow-up|6|||
125263493|NCT03423602|450595353|FG000|Overall Study|Protocol Violation|1|||
125263494|NCT03423602|450595353|FG000|Overall Study|Withdrawal by Subject|4|||
125263495|NCT03423121|450595354|FG000|Overall Study|Lost to Follow-up|2|||
125263496|NCT03423121|450595355|FG001|Overall Study|Lost to Follow-up|6|||
125263497|NCT03423121|450595354|FG000|Overall Study|Adverse Event|1|||
125263498|NCT03423121|450595355|FG001|Overall Study|Adverse Event|0|||
125263499|NCT00560508|450595356|FG000|12 Week Double-blind Period|Adverse Event|3|||
125263500|NCT00560508|450595357|FG001|12 Week Double-blind Period|Adverse Event|2|||
125263501|NCT00560508|450595356|FG000|12 Week Double-blind Period|Protocol Violation|1|||
125263502|NCT00560508|450595357|FG001|12 Week Double-blind Period|Protocol Violation|0|||
125263503|NCT00560508|450595356|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
125263504|NCT00560508|450595357|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
125263505|NCT00560508|450595356|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
125263506|NCT00560508|450595357|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
125263507|NCT00560508|450595356|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
125263508|NCT00560508|450595357|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
125263509|NCT00560508|450595356|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
125263510|NCT00560508|450595357|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
125263511|NCT00560508|450595356|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
125263512|NCT00560508|450595357|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
125263513|NCT01354223|450595358|FG000|Overall Study|Withdrawal by Subject|3|||
125263514|NCT01354223|450595359|FG001|Overall Study|Withdrawal by Subject|1|||
125263515|NCT00948688|450595367|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
125263516|NCT00948688|450595368|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
125263517|NCT00948688|450595367|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
125263518|NCT00948688|450595368|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
125263519|NCT00948688|450595367|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
125263520|NCT00948688|450595368|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
125263521|NCT01493089|450595369|FG000|Overall Study|Protocol Violation|2|||
125263522|NCT01493089|450595370|FG001|Overall Study|Protocol Violation|2|||
125263523|NCT01493089|450595369|FG000|Overall Study|Withdrawal by Subject|1|||
125263524|NCT01493089|450595370|FG001|Overall Study|Withdrawal by Subject|0|||
125263525|NCT01493089|450595369|FG000|Overall Study|Physician Decision|0|||
125263526|NCT01493089|450595370|FG001|Overall Study|Physician Decision|1|||
125263527|NCT03012334|450595371|FG000|Period 1|Withdrawal by Subject|0|||
125263528|NCT03012334|450595372|FG001|Period 1|Withdrawal by Subject|0|||
125263529|NCT03012334|450595373|FG002|Period 1|Withdrawal by Subject|0|||
125263530|NCT03012334|450595374|FG003|Period 1|Withdrawal by Subject|0|||
125263531|NCT03012334|450595375|FG004|Period 1|Withdrawal by Subject|0|||
125263532|NCT03012334|450595376|FG005|Period 1|Withdrawal by Subject|0|||
125263533|NCT03012334|450595377|FG006|Period 1|Withdrawal by Subject|0|||
125263534|NCT03012334|450595378|FG007|Period 1|Withdrawal by Subject|0|||
125263535|NCT03012334|450595379|FG008|Period 1|Withdrawal by Subject|0|||
125263536|NCT03012334|450595380|FG009|Period 1|Withdrawal by Subject|1|||
125263537|NCT03012334|450595371|FG000|Period 2|Withdrawal by Subject|0|||
125263538|NCT03012334|450595372|FG001|Period 2|Withdrawal by Subject|1|||
125263539|NCT03012334|450595373|FG002|Period 2|Withdrawal by Subject|0|||
125263540|NCT03012334|450595374|FG003|Period 2|Withdrawal by Subject|0|||
125263541|NCT03012334|450595375|FG004|Period 2|Withdrawal by Subject|0|||
125263542|NCT03012334|450595376|FG005|Period 2|Withdrawal by Subject|0|||
125263543|NCT03012334|450595377|FG006|Period 2|Withdrawal by Subject|0|||
125263544|NCT03012334|450595378|FG007|Period 2|Withdrawal by Subject|0|||
125263545|NCT03012334|450595379|FG008|Period 2|Withdrawal by Subject|0|||
125263546|NCT03012334|450595380|FG009|Period 2|Withdrawal by Subject|0|||
125263547|NCT03012334|450595371|FG000|Period 2|Protocol Violation|0|||
125263548|NCT03012334|450595372|FG001|Period 2|Protocol Violation|0|||
125263549|NCT03012334|450595373|FG002|Period 2|Protocol Violation|1|||
125263550|NCT03012334|450595374|FG003|Period 2|Protocol Violation|0|||
125263551|NCT03012334|450595375|FG004|Period 2|Protocol Violation|0|||
125263552|NCT03012334|450595376|FG005|Period 2|Protocol Violation|0|||
125263553|NCT03012334|450595377|FG006|Period 2|Protocol Violation|0|||
125263554|NCT03012334|450595378|FG007|Period 2|Protocol Violation|1|||
125263555|NCT03012334|450595379|FG008|Period 2|Protocol Violation|0|||
125263556|NCT03012334|450595380|FG009|Period 2|Protocol Violation|0|||
125263557|NCT03012334|450595371|FG000|Period 4|Non-Compliance|0|||
125263558|NCT03012334|450595372|FG001|Period 4|Non-Compliance|0|||
125263559|NCT03012334|450595373|FG002|Period 4|Non-Compliance|0|||
125263560|NCT03012334|450595374|FG003|Period 4|Non-Compliance|0|||
125263561|NCT03012334|450595375|FG004|Period 4|Non-Compliance|0|||
125263562|NCT03012334|450595376|FG005|Period 4|Non-Compliance|0|||
125263563|NCT03012334|450595377|FG006|Period 4|Non-Compliance|1|||
125263564|NCT03012334|450595378|FG007|Period 4|Non-Compliance|0|||
125263565|NCT03012334|450595379|FG008|Period 4|Non-Compliance|0|||
125263566|NCT03012334|450595380|FG009|Period 4|Non-Compliance|0|||
125263567|NCT03012334|450595371|FG000|Period 4|Adverse Event|0|||
125263568|NCT03012334|450595372|FG001|Period 4|Adverse Event|0|||
125263569|NCT03012334|450595373|FG002|Period 4|Adverse Event|0|||
125263570|NCT03012334|450595374|FG003|Period 4|Adverse Event|0|||
125263571|NCT03012334|450595375|FG004|Period 4|Adverse Event|0|||
125263572|NCT03012334|450595376|FG005|Period 4|Adverse Event|0|||
125263573|NCT03012334|450595377|FG006|Period 4|Adverse Event|0|||
125263574|NCT03012334|450595378|FG007|Period 4|Adverse Event|0|||
125263575|NCT03012334|450595379|FG008|Period 4|Adverse Event|1|||
125263576|NCT03012334|450595380|FG009|Period 4|Adverse Event|0|||
125263577|NCT00325143|450595381|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
125446877|NCT00577720|451261115|FG002|Overall Study|Protocol Violation|0|||
125446878|NCT00577720|451261116|FG003|Overall Study|Protocol Violation|1|||
125446879|NCT00577720|451261113|FG000|Overall Study|Withdrawal by Subject|2|||
125446880|NCT00577720|451261114|FG001|Overall Study|Withdrawal by Subject|0|||
125446881|NCT00577720|451261115|FG002|Overall Study|Withdrawal by Subject|0|||
125446882|NCT00577720|451261116|FG003|Overall Study|Withdrawal by Subject|2|||
125446883|NCT02839681|451261119|FG000|Overall Study|Death|2|||
125446884|NCT01656759|451261120|FG000|Overall Study|Protocol Violation|2|||
125446885|NCT01656759|451261121|FG001|Overall Study|Protocol Violation|3|||
125446886|NCT02687919|451261122|FG000|Overall Study|Withdrawal by Subject|6|||
125446887|NCT02687919|451261123|FG001|Overall Study|Withdrawal by Subject|6|||
125446888|NCT02687919|451261122|FG000|Overall Study|Protocol Violation|2|||
125446889|NCT02687919|451261123|FG001|Overall Study|Protocol Violation|0|||
125446890|NCT02531438|451261124|FG000|Overall Study|Adverse Event|7|||
125446891|NCT02531438|451261125|FG001|Overall Study|Adverse Event|9|||
125446892|NCT02531438|451261124|FG000|Overall Study|Lost to Follow-up|0|||
125446893|NCT02531438|451261125|FG001|Overall Study|Lost to Follow-up|3|||
125446894|NCT02531438|451261124|FG000|Overall Study|Withdrawal by Subject|7|||
125446895|NCT02531438|451261125|FG001|Overall Study|Withdrawal by Subject|8|||
125446896|NCT02531438|451261124|FG000|Overall Study|Physician Decision|0|||
125446897|NCT02531438|451261125|FG001|Overall Study|Physician Decision|1|||
125446898|NCT02531438|451261124|FG000|Overall Study|Death|6|||
125446899|NCT02531438|451261125|FG001|Overall Study|Death|3|||
125446900|NCT02531438|451261124|FG000|Overall Study|Randomized, but Not Treated|4|||
125446901|NCT02531438|451261125|FG001|Overall Study|Randomized, but Not Treated|0|||
125446902|NCT02531438|451261124|FG000|Overall Study|Missed EOT/PTE Visit|5|||
125446903|NCT02531438|451261125|FG001|Overall Study|Missed EOT/PTE Visit|2|||
125446904|NCT02531438|451261124|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
125446905|NCT02531438|451261125|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
125446906|NCT00772928|451261126|FG000|Overall Study|Lost to Follow-up|9|||
125446907|NCT00772928|451261127|FG001|Overall Study|Lost to Follow-up|6|||
125446908|NCT00772928|451261126|FG000|Overall Study|Protocol Violation|10|||
125446909|NCT00772928|451261127|FG001|Overall Study|Protocol Violation|12|||
125446910|NCT00772928|451261126|FG000|Overall Study|Withdrawal by Subject|25|||
125446911|NCT00772928|451261127|FG001|Overall Study|Withdrawal by Subject|22|||
125446912|NCT00772928|451261126|FG000|Overall Study|Did not receive vaccine|0|||
125446913|NCT00772928|451261127|FG001|Overall Study|Did not receive vaccine|1|||
125446914|NCT03100838|451261129|FG000|Overall Study|Adverse Event|1|||
125446915|NCT03100838|451261130|FG001|Overall Study|Adverse Event|0|||
125446916|NCT03100838|451261131|FG002|Overall Study|Adverse Event|0|||
125446917|NCT03100838|451261132|FG003|Overall Study|Adverse Event|0|||
125446918|NCT03100838|451261129|FG000|Overall Study|Physician Decision|1|||
125446919|NCT03100838|451261130|FG001|Overall Study|Physician Decision|1|||
125446920|NCT03100838|451261131|FG002|Overall Study|Physician Decision|1|||
125446921|NCT03100838|451261132|FG003|Overall Study|Physician Decision|1|||
125446922|NCT03100838|451261129|FG000|Overall Study|Pregnancy|0|||
125446923|NCT03100838|451261130|FG001|Overall Study|Pregnancy|1|||
125446924|NCT03100838|451261131|FG002|Overall Study|Pregnancy|0|||
125446925|NCT03100838|451261132|FG003|Overall Study|Pregnancy|0|||
125446926|NCT03100838|451261129|FG000|Overall Study|Lost to Follow-up|0|||
125446927|NCT03100838|451261130|FG001|Overall Study|Lost to Follow-up|0|||
125446928|NCT03100838|451261131|FG002|Overall Study|Lost to Follow-up|1|||
125446929|NCT03100838|451261132|FG003|Overall Study|Lost to Follow-up|0|||
125446930|NCT00801242|451261133|FG000|Overall Study|Adverse Event|10|||
125446931|NCT00801242|451261133|FG000|Overall Study|Withdrawal by Subject|13|||
125446932|NCT00801242|451261133|FG000|Overall Study|Protocol Violation|5|||
125446933|NCT00801242|451261133|FG000|Overall Study|Physician Decision|3|||
125446934|NCT00801242|451261133|FG000|Overall Study|Lost to Follow-up|1|||
125446935|NCT00801242|451261133|FG000|Overall Study|Miscellaneous reasons|20|||
125446936|NCT02554513|451261135|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
125446937|NCT02554513|451261136|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
125446938|NCT00184028|451261139|FG000|Overall Study|Death|1|||
125446939|NCT00184028|451261139|FG000|Overall Study|Lack of Efficacy|4|||
125446940|NCT00184028|451261139|FG000|Overall Study|Adverse Event|2|||
125446941|NCT00184028|451261139|FG000|Overall Study|Withdrawal by Subject|1|||
125446942|NCT00184028|451261139|FG000|Overall Study|Non-compliance|2|||
125446943|NCT01354938|451261142|FG000|Overall Study|Lost to Follow-up|1|||
125446944|NCT02335268|451261143|FG000|Overall Study|Physician Decision|5|||
125446945|NCT02335268|451261144|FG001|Overall Study|Physician Decision|1|||
125446946|NCT02335268|451261143|FG000|Overall Study|Lack of Efficacy|2|||
125446947|NCT02335268|451261144|FG001|Overall Study|Lack of Efficacy|1|||
125446948|NCT02335268|451261143|FG000|Overall Study|Adverse Event|5|||
125446949|NCT02335268|451261144|FG001|Overall Study|Adverse Event|2|||
125446950|NCT02335268|451261143|FG000|Overall Study|increase blasts|2|||
125446951|NCT02335268|451261144|FG001|Overall Study|increase blasts|0|||
125446952|NCT02335268|451261143|FG000|Overall Study|Withdrawal by Subject|3|||
125446953|NCT02335268|451261144|FG001|Overall Study|Withdrawal by Subject|2|||
125446954|NCT01192295|451261148|FG000|Overall Study|Adverse Event|3|||
125446955|NCT01192295|451261149|FG001|Overall Study|Adverse Event|7|||
125263578|NCT00325143|450595381|FG000|Overall Study|Migrated/moved from study area|1|||
125263579|NCT00325143|450595381|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
125263580|NCT00325143|450595381|FG000|Overall Study|Withdrawal by Subject|8|||
125263581|NCT01870869|450595382|FG000|Overall Study|Implanted with nonstudy device|1|||
125263582|NCT01870869|450595383|FG001|Overall Study|Implanted with nonstudy device|3|||
125263583|NCT01870869|450595384|FG002|Overall Study|Implanted with nonstudy device|14|||
125263584|NCT01870869|450595385|FG003|Overall Study|Implanted with nonstudy device|4|||
125263585|NCT01870869|450595382|FG000|Overall Study|Death|0|||
125263586|NCT01870869|450595383|FG001|Overall Study|Death|0|||
125263587|NCT01870869|450595384|FG002|Overall Study|Death|7|||
125263588|NCT01870869|450595385|FG003|Overall Study|Death|1|||
125263589|NCT01870869|450595382|FG000|Overall Study|Subject choice|6|||
125263590|NCT01870869|450595383|FG001|Overall Study|Subject choice|2|||
125263591|NCT01870869|450595384|FG002|Overall Study|Subject choice|22|||
125263592|NCT01870869|450595385|FG003|Overall Study|Subject choice|8|||
125263593|NCT01870869|450595382|FG000|Overall Study|Lost to Follow-up|10|||
125263594|NCT01870869|450595383|FG001|Overall Study|Lost to Follow-up|2|||
125263595|NCT01870869|450595384|FG002|Overall Study|Lost to Follow-up|25|||
125263596|NCT01870869|450595385|FG003|Overall Study|Lost to Follow-up|3|||
125263597|NCT01870869|450595382|FG000|Overall Study|Reason not Specified|1|||
125263598|NCT01870869|450595383|FG001|Overall Study|Reason not Specified|2|||
125263599|NCT01870869|450595384|FG002|Overall Study|Reason not Specified|20|||
125263600|NCT01870869|450595385|FG003|Overall Study|Reason not Specified|4|||
125263601|NCT01870869|450595382|FG000|Overall Study|Not evaluable|10|||
125263602|NCT01870869|450595383|FG001|Overall Study|Not evaluable|5|||
125263603|NCT01870869|450595384|FG002|Overall Study|Not evaluable|42|||
125263604|NCT01870869|450595385|FG003|Overall Study|Not evaluable|10|||
125263605|NCT02286895|450595386|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
125263606|NCT02286895|450595387|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
125263607|NCT02286895|450595386|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
125263608|NCT02286895|450595387|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
125263609|NCT02286895|450595386|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
125263610|NCT02286895|450595387|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
125263611|NCT01073293|450595388|FG000|Overall Study|Lost to Follow-up|0|||
125263612|NCT01073293|450595389|FG001|Overall Study|Lost to Follow-up|1|||
125263613|NCT01073293|450595388|FG000|Overall Study|Withdrawal by Subject|5|||
125263614|NCT01073293|450595389|FG001|Overall Study|Withdrawal by Subject|10|||
125263615|NCT03036852|450595390|FG000|Overall Study|Death|2|||
125263616|NCT03036852|450595390|FG000|Overall Study|Lack of Efficacy|2|||
125263617|NCT03036852|450595390|FG000|Overall Study|Adverse Event|1|||
125263618|NCT03036852|450595390|FG000|Overall Study|Lost to Follow-up|1|||
125263619|NCT00002766|450595393|FG000|Overall Study|Withdrawal by Subject|0|||
125263620|NCT00002766|450595394|FG001|Overall Study|Withdrawal by Subject|1|||
125263621|NCT00002766|450595393|FG000|Overall Study|Patient Not Treated|1|||
125263622|NCT00002766|450595394|FG001|Overall Study|Patient Not Treated|2|||
125263623|NCT00002766|450595393|FG000|Overall Study|Adverse Event|1|||
125263624|NCT00002766|450595394|FG001|Overall Study|Adverse Event|1|||
125263625|NCT00002766|450595393|FG000|Overall Study|Protocol Violation|1|||
125263626|NCT00002766|450595394|FG001|Overall Study|Protocol Violation|0|||
125263627|NCT00077974|450595397|FG000|Overall Study|Adverse Event|22|||
125263628|NCT00077974|450595397|FG000|Overall Study|Protocol Violation|1|||
125263629|NCT00077974|450595397|FG000|Overall Study|Withdrawal by Subject|3|||
125263630|NCT00077974|450595397|FG000|Overall Study|Lack of Efficacy|76|||
125263631|NCT00077974|450595397|FG000|Overall Study|Decision of Sponsor|2|||
125263632|NCT00256126|450595398|FG000|Overall Study|Adverse Event|1|||
125263633|NCT00256126|450595399|FG001|Overall Study|Adverse Event|0|||
125263634|NCT00256126|450595398|FG000|Overall Study|Other|1|||
125263635|NCT00256126|450595399|FG001|Overall Study|Other|2|||
125263636|NCT02949011|450595408|FG000|Overall Study|Adverse Event|6|||
125263637|NCT02949011|450595409|FG001|Overall Study|Adverse Event|7|||
125263638|NCT02949011|450595410|FG002|Overall Study|Adverse Event|3|||
125263639|NCT02949011|450595408|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
125263640|NCT02949011|450595409|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
125263641|NCT02949011|450595410|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
125263642|NCT02949011|450595408|FG000|Overall Study|Protocol Deviation|5|||
125263643|NCT02949011|450595409|FG001|Overall Study|Protocol Deviation|3|||
125263644|NCT02949011|450595410|FG002|Overall Study|Protocol Deviation|3|||
125263645|NCT02949011|450595408|FG000|Overall Study|Lack of Efficacy|0|||
125263646|NCT02949011|450595409|FG001|Overall Study|Lack of Efficacy|2|||
125263647|NCT02949011|450595410|FG002|Overall Study|Lack of Efficacy|0|||
125263648|NCT02949011|450595408|FG000|Overall Study|Withdrawal by Subject|13|||
125263649|NCT02949011|450595409|FG001|Overall Study|Withdrawal by Subject|13|||
125263650|NCT02949011|450595410|FG002|Overall Study|Withdrawal by Subject|21|||
125263651|NCT02949011|450595408|FG000|Overall Study|Lost to Follow-up|7|||
125263652|NCT02949011|450595409|FG001|Overall Study|Lost to Follow-up|5|||
125263653|NCT02949011|450595410|FG002|Overall Study|Lost to Follow-up|5|||
125263654|NCT02949011|450595408|FG000|Overall Study|Death|0|||
125263655|NCT02949011|450595409|FG001|Overall Study|Death|0|||
125263656|NCT02949011|450595410|FG002|Overall Study|Death|1|||
125263657|NCT02949011|450595408|FG000|Overall Study|Miscellaneous|2|||
125263658|NCT02949011|450595409|FG001|Overall Study|Miscellaneous|4|||
125263659|NCT02949011|450595410|FG002|Overall Study|Miscellaneous|6|||
125263660|NCT00163189|450595411|FG000|Overall Study|Other|6|||
125263661|NCT00163189|450595411|FG000|Overall Study|Lost to Follow-up|1|||
125263662|NCT00163189|450595411|FG000|Overall Study|Protocol Violation|2|||
125263663|NCT00163189|450595411|FG000|Overall Study|Death|3|||
125263664|NCT00163189|450595411|FG000|Overall Study|Adverse Event|6|||
125263665|NCT00163189|450595411|FG000|Overall Study|Lack of Efficacy|7|||
125263666|NCT00163189|450595411|FG000|Overall Study|Study terminated by sponsor|11|||
125263667|NCT00163189|450595411|FG000|Overall Study|Withdrawal by Subject|11|||
125263668|NCT00163189|450595411|FG000|Overall Study|Did not meet continuation criterion|16|||
125263669|NCT02154061|450595412|FG000|Overall Study|Pregnancy|1|||
125263670|NCT02154061|450595413|FG001|Overall Study|Pregnancy|0|||
125263671|NCT02154061|450595412|FG000|Overall Study|enrolled but not vaccinated|1|||
125263672|NCT02154061|450595413|FG001|Overall Study|enrolled but not vaccinated|0|||
125263673|NCT00506142|450595414|FG000|Overall Study|Adverse Event|8|||
125263674|NCT00506142|450595415|FG001|Overall Study|Adverse Event|7|||
125263675|NCT00506142|450595414|FG000|Overall Study|Lack of Efficacy|21|||
125263676|NCT00506142|450595415|FG001|Overall Study|Lack of Efficacy|7|||
125263677|NCT00506142|450595414|FG000|Overall Study|Withdrawal by Subject|4|||
125263678|NCT00506142|450595415|FG001|Overall Study|Withdrawal by Subject|5|||
125263679|NCT00506142|450595414|FG000|Overall Study|Physician Decision|1|||
125263680|NCT00506142|450595415|FG001|Overall Study|Physician Decision|0|||
125263681|NCT00506142|450595414|FG000|Overall Study|New health condition|1|||
125263682|NCT00506142|450595415|FG001|Overall Study|New health condition|0|||
125263683|NCT00454116|450595416|FG000|Overall Study|Adverse Event|5|||
125263684|NCT00454116|450595417|FG001|Overall Study|Adverse Event|11|||
125263685|NCT00454116|450595418|FG002|Overall Study|Adverse Event|9|||
125263686|NCT00454116|450595416|FG000|Overall Study|Condition under investigation worsened|17|||
125263687|NCT00454116|450595417|FG001|Overall Study|Condition under investigation worsened|13|||
125263688|NCT00454116|450595418|FG002|Overall Study|Condition under investigation worsened|18|||
125263689|NCT00454116|450595416|FG000|Overall Study|Withdrawal by Subject|3|||
125263690|NCT00454116|450595417|FG001|Overall Study|Withdrawal by Subject|3|||
125263691|NCT00454116|450595418|FG002|Overall Study|Withdrawal by Subject|1|||
125263692|NCT00454116|450595416|FG000|Overall Study|Other|2|||
125263693|NCT00454116|450595417|FG001|Overall Study|Other|2|||
125263694|NCT00454116|450595418|FG002|Overall Study|Other|0|||
125263695|NCT01917318|450595421|FG000|First Treatment|Withdrawal by Subject|0|||
125263696|NCT01917318|450595422|FG001|First Treatment|Withdrawal by Subject|1|||
125263697|NCT01008618|450595423|FG000|Period 1 (Titration Period)|Physician Decision|2|||
125263698|NCT01008618|450595424|FG001|Period 1 (Titration Period)|Physician Decision|0|||
125263699|NCT01008618|450595425|FG002|Period 1 (Titration Period)|Physician Decision|0|||
125263700|NCT01008618|450595423|FG000|Period 1 (Titration Period)|Adverse Event|33|||
125263701|NCT01008618|450595424|FG001|Period 1 (Titration Period)|Adverse Event|0|||
125263702|NCT01008618|450595425|FG002|Period 1 (Titration Period)|Adverse Event|0|||
125263703|NCT01008618|450595423|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
125263704|NCT01008618|450595424|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
125263705|NCT01008618|450595425|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
125263706|NCT01008618|450595423|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
125263707|NCT01008618|450595424|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
125263708|NCT01008618|450595425|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
125263709|NCT01008618|450595423|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
125263710|NCT01008618|450595424|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
125263711|NCT01008618|450595425|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
125263712|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
125263713|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
125263714|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
125263715|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
125263716|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
125263717|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
125263718|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
125263719|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
125263720|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
125263721|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
125263722|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
125263723|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
125263724|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
125263725|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
125263726|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
125263727|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
125398609|NCT00548808|451093157|FG000|Overall Study|Sponsor Decision|1|||
125263728|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
125263729|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
125263730|NCT01008618|450595423|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
125263731|NCT01008618|450595424|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
125263732|NCT01008618|450595425|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
125263733|NCT00742625|450595426|FG000|Remission Induction|Progression|6|||
125263734|NCT00742625|450595426|FG000|Remission Induction|Failed induction|8|||
125263735|NCT00742625|450595426|FG000|Remission Induction|Adverse Event|3|||
125263736|NCT00742625|450595426|FG000|Remission Induction|Death|10|||
125263737|NCT00742625|450595426|FG000|Remission Induction|Refusal|5|||
125263738|NCT00742625|450595426|FG000|Remission Induction|Non protocol treatment|17|||
125263739|NCT00742625|450595426|FG000|Remission Induction|Other, not specified|5|||
125263740|NCT00742625|450595426|FG000|Consolidation|Progression|5|||
125263741|NCT00742625|450595426|FG000|Consolidation|Adverse Event|1|||
125263742|NCT00742625|450595426|FG000|Consolidation|Death|1|||
125263743|NCT00742625|450595426|FG000|Consolidation|Refused|1|||
125263744|NCT00742625|450595426|FG000|Consolidation|Non protocol therapy|13|||
125263745|NCT03338400|450595427|FG000|Overall Study|Lost to Follow-up|1|||
125263746|NCT03338400|450595428|FG001|Overall Study|Lost to Follow-up|2|||
125263747|NCT01865487|450595431|FG000|Overall Study|Lost to Follow-up|0|||
125263748|NCT01865487|450595432|FG001|Overall Study|Lost to Follow-up|0|||
125263749|NCT01865487|450595433|FG002|Overall Study|Lost to Follow-up|0|||
125263750|NCT01865487|450595434|FG003|Overall Study|Lost to Follow-up|1|||
125263751|NCT01865487|450595435|FG004|Overall Study|Lost to Follow-up|0|||
125263752|NCT01865487|450595436|FG005|Overall Study|Lost to Follow-up|0|||
125263753|NCT01865487|450595437|FG006|Overall Study|Lost to Follow-up|1|||
125263754|NCT01865487|450595438|FG007|Overall Study|Lost to Follow-up|0|||
125263755|NCT01865487|450595439|FG008|Overall Study|Lost to Follow-up|0|||
125263756|NCT01865487|450595440|FG009|Overall Study|Lost to Follow-up|0|||
125263757|NCT01865487|450595431|FG000|Overall Study|Withdrawal by Subject|0|||
125263758|NCT01865487|450595432|FG001|Overall Study|Withdrawal by Subject|0|||
125263759|NCT01865487|450595433|FG002|Overall Study|Withdrawal by Subject|0|||
125263760|NCT01865487|450595434|FG003|Overall Study|Withdrawal by Subject|0|||
125263761|NCT01865487|450595435|FG004|Overall Study|Withdrawal by Subject|1|||
125263762|NCT01865487|450595436|FG005|Overall Study|Withdrawal by Subject|0|||
125263763|NCT01865487|450595437|FG006|Overall Study|Withdrawal by Subject|0|||
125263764|NCT01865487|450595438|FG007|Overall Study|Withdrawal by Subject|0|||
125263765|NCT01865487|450595439|FG008|Overall Study|Withdrawal by Subject|0|||
125263766|NCT01865487|450595440|FG009|Overall Study|Withdrawal by Subject|0|||
125263767|NCT01213082|450595441|FG000|Overall Study|Lost to Follow-up|6|||
125263768|NCT01213082|450595442|FG001|Overall Study|Lost to Follow-up|7|||
125263769|NCT01213082|450595443|FG002|Overall Study|Lost to Follow-up|4|||
125263770|NCT01213082|450595441|FG000|Overall Study|Physician Decision|0|||
125263771|NCT01213082|450595442|FG001|Overall Study|Physician Decision|0|||
125263772|NCT01213082|450595443|FG002|Overall Study|Physician Decision|1|||
125263773|NCT03848416|450595449|FG000|Overall Study|Withdrawal by Subject|1|||
125263774|NCT03848416|450595450|FG001|Overall Study|Withdrawal by Subject|0|||
125263775|NCT03848416|450595451|FG002|Overall Study|Withdrawal by Subject|0|||
125263776|NCT03848416|450595449|FG000|Overall Study|Death|0|||
125263777|NCT03848416|450595450|FG001|Overall Study|Death|0|||
125263778|NCT03848416|450595451|FG002|Overall Study|Death|1|||
125263779|NCT02639390|450595452|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
125263780|NCT02639390|450595453|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
125263781|NCT01908140|450595454|FG000|Overall Study|Other or Progressive Disease|5|||
125263782|NCT01908140|450595455|FG001|Overall Study|Other or Progressive Disease|12|||
125263783|NCT01908140|450595454|FG000|Overall Study|Lack of Efficacy|7|||
125263784|NCT01908140|450595455|FG001|Overall Study|Lack of Efficacy|5|||
125263785|NCT01908140|450595454|FG000|Overall Study|Withdrawal by Subject|23|||
125263786|NCT01908140|450595455|FG001|Overall Study|Withdrawal by Subject|24|||
125263787|NCT01908140|450595454|FG000|Overall Study|Lost to Follow-up|1|||
125263788|NCT01908140|450595455|FG001|Overall Study|Lost to Follow-up|6|||
125263789|NCT01908140|450595454|FG000|Overall Study|Protocol Violation|8|||
125263790|NCT01908140|450595455|FG001|Overall Study|Protocol Violation|9|||
125263791|NCT01908140|450595454|FG000|Overall Study|Adverse Event|22|||
125263792|NCT01908140|450595455|FG001|Overall Study|Adverse Event|23|||
125263793|NCT01436110|450595456|FG000|Overall Study|Lack of Efficacy|23|||
125263794|NCT01436110|450595457|FG001|Overall Study|Lack of Efficacy|14|||
125263795|NCT01436110|450595458|FG002|Overall Study|Lack of Efficacy|9|||
125263796|NCT01436110|450595456|FG000|Overall Study|Withdrawal by Subject|6|||
125263797|NCT01436110|450595457|FG001|Overall Study|Withdrawal by Subject|8|||
125263798|NCT01436110|450595458|FG002|Overall Study|Withdrawal by Subject|4|||
125263799|NCT01436110|450595456|FG000|Overall Study|Adverse Event|2|||
125263800|NCT01436110|450595457|FG001|Overall Study|Adverse Event|1|||
125263801|NCT01436110|450595458|FG002|Overall Study|Adverse Event|2|||
125263802|NCT01436110|450595456|FG000|Overall Study|Physician Decision|3|||
125263803|NCT01436110|450595457|FG001|Overall Study|Physician Decision|1|||
125263804|NCT01436110|450595458|FG002|Overall Study|Physician Decision|1|||
125446956|NCT01192295|451261148|FG000|Overall Study|Withdrawal by Subject|3|||
125446957|NCT01192295|451261149|FG001|Overall Study|Withdrawal by Subject|4|||
125446958|NCT01192295|451261148|FG000|Overall Study|Lost to Follow-up|0|||
125446959|NCT01192295|451261149|FG001|Overall Study|Lost to Follow-up|1|||
125446960|NCT01192295|451261148|FG000|Overall Study|Lack of Efficacy|0|||
125446961|NCT01192295|451261149|FG001|Overall Study|Lack of Efficacy|5|||
125446962|NCT01192295|451261148|FG000|Overall Study|Administrative|4|||
125446963|NCT01192295|451261149|FG001|Overall Study|Administrative|6|||
125446964|NCT03785340|451261152|FG000|Overall Study|Lost to Follow-up|2|||
125446965|NCT03785340|451261153|FG001|Overall Study|Lost to Follow-up|0|||
125446966|NCT03785340|451261152|FG000|Overall Study|Adverse Event|1|||
125446967|NCT03785340|451261153|FG001|Overall Study|Adverse Event|0|||
125446968|NCT00333788|451261160|FG000|Overall Study|Adverse Event|44|||
125446969|NCT00333788|451261160|FG000|Overall Study|Lack of Efficacy|80|||
125446970|NCT00333788|451261160|FG000|Overall Study|Lost to Follow-up|2|||
125446971|NCT00333788|451261160|FG000|Overall Study|Withdrawal by Subject|24|||
125446972|NCT00333788|451261160|FG000|Overall Study|Other: Non-compliance|2|||
125446973|NCT00333788|451261160|FG000|Overall Study|Other: Moved|2|||
125446974|NCT00333788|451261160|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
125446975|NCT00333788|451261160|FG000|Overall Study|Other: Investigator decision|1|||
125446976|NCT00333788|451261160|FG000|Overall Study|Other: Quality of life concern|1|||
125446977|NCT00333788|451261160|FG000|Overall Study|Other: Sponsor decision|1|||
125446978|NCT00333788|451261160|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
125446979|NCT00333788|451261160|FG000|Overall Study|Other: Medical monitor decision|1|||
125446980|NCT00333788|451261160|FG000|Overall Study|Other: Physician decision|1|||
125446981|NCT00333788|451261160|FG000|Overall Study|Other: Signed consent for another study|1|||
125446982|NCT04951479|451261161|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
125446983|NCT00394095|451262644|FG000|Screening|Withdrawal by Subject|1|||
125446984|NCT00394095|451262645|FG001|Screening|Withdrawal by Subject|0|||
125446985|NCT00394095|451262644|FG000|Randomized|Withdrawal by Subject|5|||
125446986|NCT00394095|451262645|FG001|Randomized|Withdrawal by Subject|1|||
125446987|NCT00394095|451262644|FG000|Randomized|Adverse Event|1|||
125446988|NCT00394095|451262645|FG001|Randomized|Adverse Event|1|||
125446989|NCT00394095|451262644|FG000|Randomized|Overdose|1|||
125446990|NCT00394095|451262645|FG001|Randomized|Overdose|0|||
125446991|NCT00394095|451262644|FG000|Randomized|Lost to Follow-up|1|||
125446992|NCT00394095|451262645|FG001|Randomized|Lost to Follow-up|2|||
125446993|NCT01268059|451262650|FG000|Overall Study|Lost to Follow-up|0|||
125446994|NCT01268059|451262651|FG001|Overall Study|Lost to Follow-up|1|||
125446995|NCT01268059|451262652|FG002|Overall Study|Lost to Follow-up|0|||
125446996|NCT01268059|451262653|FG003|Overall Study|Lost to Follow-up|0|||
125446997|NCT01268059|451262650|FG000|Overall Study|Withdrawal by Subject|7|||
125446998|NCT01268059|451262651|FG001|Overall Study|Withdrawal by Subject|4|||
125446999|NCT01268059|451262652|FG002|Overall Study|Withdrawal by Subject|0|||
125447000|NCT01268059|451262653|FG003|Overall Study|Withdrawal by Subject|0|||
125447001|NCT01268059|451262650|FG000|Overall Study|Death|20|||
125447002|NCT01268059|451262651|FG001|Overall Study|Death|30|||
125447003|NCT01268059|451262652|FG002|Overall Study|Death|3|||
125447004|NCT01268059|451262653|FG003|Overall Study|Death|5|||
125447005|NCT01268059|451262650|FG000|Overall Study|Progression of disease|1|||
125263805|NCT01436110|450595456|FG000|Overall Study|Lost to Follow-up|1|||
125263806|NCT01436110|450595457|FG001|Overall Study|Lost to Follow-up|1|||
125263807|NCT01436110|450595458|FG002|Overall Study|Lost to Follow-up|3|||
125263808|NCT01436110|450595456|FG000|Overall Study|Protocol Violation|3|||
125263809|NCT01436110|450595457|FG001|Overall Study|Protocol Violation|1|||
125263810|NCT01436110|450595458|FG002|Overall Study|Protocol Violation|1|||
125263811|NCT01436110|450595456|FG000|Overall Study|Did Not Receive Trial Medication|1|||
125263812|NCT01436110|450595457|FG001|Overall Study|Did Not Receive Trial Medication|0|||
125263813|NCT01436110|450595458|FG002|Overall Study|Did Not Receive Trial Medication|3|||
125263814|NCT01088503|450595460|FG000|Overall Study|Withdrawal by Subject|118|||
125263815|NCT01088503|450595461|FG001|Overall Study|Withdrawal by Subject|327|||
125263816|NCT01088503|450595462|FG002|Overall Study|Withdrawal by Subject|10|||
125263817|NCT01088503|450595460|FG000|Overall Study|Death|64|||
125263818|NCT01088503|450595461|FG001|Overall Study|Death|358|||
125263819|NCT01088503|450595462|FG002|Overall Study|Death|7|||
125263820|NCT01531998|450595463|FG000|Overall Study|Withdrawal by Subject|3|||
125447006|NCT01268059|451262651|FG001|Overall Study|Progression of disease|0|||
125447007|NCT01268059|451262652|FG002|Overall Study|Progression of disease|0|||
125447008|NCT01268059|451262653|FG003|Overall Study|Progression of disease|0|||
125447009|NCT02819479|451262654|FG000|Overall Study|Adverse Event|2|||
125263821|NCT00186628|450595468|FG000|Overall Study|Death|2|||
125447010|NCT05310084|451262655|FG000|Overall Study|Withdrawal by Subject|2|||
125447011|NCT05310084|451262656|FG001|Overall Study|Withdrawal by Subject|3|||
125447012|NCT05310084|451262655|FG000|Overall Study|Participant availability|0|||
125447013|NCT05310084|451262656|FG001|Overall Study|Participant availability|4|||
125447014|NCT05310084|451262655|FG000|Overall Study|Lost to Follow-up|1|||
125263822|NCT00186628|450595468|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
125263823|NCT02927795|450595469|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
125263824|NCT02927795|450595469|FG000|Overall Study|Not Treated|4|||
125263825|NCT01076010|450595470|FG000|Overall Study|Death|15|||
125263826|NCT01076010|450595471|FG001|Overall Study|Death|1|||
125263827|NCT01076010|450595472|FG002|Overall Study|Death|0|||
125263828|NCT01076010|450595470|FG000|Overall Study|Adverse Event|7|||
125263829|NCT01076010|450595471|FG001|Overall Study|Adverse Event|2|||
125263830|NCT01076010|450595472|FG002|Overall Study|Adverse Event|0|||
125263831|NCT01076010|450595470|FG000|Overall Study|Progressive disease|90|||
125263832|NCT01076010|450595471|FG001|Overall Study|Progressive disease|30|||
125263833|NCT01076010|450595472|FG002|Overall Study|Progressive disease|1|||
125263834|NCT01076010|450595470|FG000|Overall Study|Lack of Efficacy|4|||
125263835|NCT01076010|450595471|FG001|Overall Study|Lack of Efficacy|0|||
125263836|NCT01076010|450595472|FG002|Overall Study|Lack of Efficacy|0|||
125263837|NCT01076010|450595470|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
125263838|NCT01076010|450595471|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
125263839|NCT01076010|450595472|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
125263840|NCT01076010|450595470|FG000|Overall Study|Significant Surgical Procedure|0|||
125263841|NCT01076010|450595471|FG001|Overall Study|Significant Surgical Procedure|1|||
125263842|NCT01076010|450595472|FG002|Overall Study|Significant Surgical Procedure|0|||
125263843|NCT01076010|450595470|FG000|Overall Study|Protocol Violation|0|||
125263844|NCT01076010|450595471|FG001|Overall Study|Protocol Violation|1|||
125263845|NCT01076010|450595472|FG002|Overall Study|Protocol Violation|0|||
125263846|NCT01076010|450595470|FG000|Overall Study|Noncompliance|1|||
125263847|NCT01076010|450595471|FG001|Overall Study|Noncompliance|1|||
125263848|NCT01076010|450595472|FG002|Overall Study|Noncompliance|0|||
125263849|NCT01076010|450595470|FG000|Overall Study|Withdrawal by Subject|3|||
125263850|NCT01076010|450595471|FG001|Overall Study|Withdrawal by Subject|0|||
125263851|NCT01076010|450595472|FG002|Overall Study|Withdrawal by Subject|1|||
125263852|NCT01076010|450595470|FG000|Overall Study|Other|5|||
125263853|NCT01076010|450595471|FG001|Overall Study|Other|2|||
125263854|NCT01076010|450595472|FG002|Overall Study|Other|0|||
125263855|NCT03440008|450595475|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
125263856|NCT03440008|450595476|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
125263857|NCT03440008|450595475|FG000|Overall Study|Withdrawal by Subject|1|||
125263858|NCT03440008|450595476|FG001|Overall Study|Withdrawal by Subject|0|||
125263859|NCT03498716|450595482|FG000|Overall Study|Withdrawal by Subject|88|||
125263860|NCT03498716|450595483|FG001|Overall Study|Withdrawal by Subject|73|||
125263861|NCT03498716|450595482|FG000|Overall Study|Study Terminated By Sponsor|933|||
125263862|NCT03498716|450595483|FG001|Overall Study|Study Terminated By Sponsor|927|||
125263863|NCT03498716|450595482|FG000|Overall Study|Lost to Follow-up|15|||
125263864|NCT03498716|450595483|FG001|Overall Study|Lost to Follow-up|26|||
125263865|NCT03498716|450595482|FG000|Overall Study|Disease Relapse|0|||
125263866|NCT03498716|450595483|FG001|Overall Study|Disease Relapse|1|||
125263867|NCT03498716|450595482|FG000|Overall Study|Death|58|||
125263868|NCT03498716|450595483|FG001|Overall Study|Death|72|||
125263869|NCT03498716|450595482|FG000|Overall Study|Physician Decision|4|||
125263870|NCT03498716|450595483|FG001|Overall Study|Physician Decision|2|||
125263871|NCT00760552|450595487|FG000|Overall Study|Death|2|||
125263872|NCT00760552|450595488|FG001|Overall Study|Death|0|||
125263873|NCT00760552|450595487|FG000|Overall Study|Lost to Follow-up|11|||
125263874|NCT00760552|450595488|FG001|Overall Study|Lost to Follow-up|10|||
125263875|NCT03507127|450595496|FG000|Overall Study|Withdrawal by Subject|1|||
125263876|NCT03507127|450595497|FG001|Overall Study|Withdrawal by Subject|0|||
125263877|NCT03507127|450595496|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
125263878|NCT03507127|450595497|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
125263879|NCT02271529|450595498|FG000|Overall Study|Withdrawal by Subject|1|||
125263880|NCT01492426|450597606|FG000|Treatment|Death|0|||
125263881|NCT01492426|450597607|FG001|Treatment|Death|1|||
125263882|NCT01492426|450597606|FG000|Treatment|Other|1|||
125263883|NCT01492426|450597607|FG001|Treatment|Other|0|||
125263884|NCT01492426|450597606|FG000|Treatment|Adverse Event|25|||
125263885|NCT01492426|450597607|FG001|Treatment|Adverse Event|25|||
125263886|NCT01492426|450597606|FG000|Treatment|Lack of Efficacy|38|||
125398610|NCT00548808|451093158|FG001|Overall Study|Sponsor Decision|1|||
125263887|NCT01492426|450597607|FG001|Treatment|Lack of Efficacy|5|||
125263888|NCT01492426|450597606|FG000|Treatment|Participant withdrew consent|1|||
125263889|NCT01492426|450597607|FG001|Treatment|Participant withdrew consent|2|||
125263890|NCT01492426|450597606|FG000|Treatment|Poor compliance/noncompliance|1|||
125263891|NCT01492426|450597607|FG001|Treatment|Poor compliance/noncompliance|0|||
125263892|NCT01492426|450597606|FG000|Treatment|Subject requested discontinue study drug|7|||
125263893|NCT01492426|450597607|FG001|Treatment|Subject requested discontinue study drug|3|||
125263894|NCT01492426|450597606|FG000|Treatment|Lost to Follow-up|9|||
125263895|NCT01492426|450597607|FG001|Treatment|Lost to Follow-up|4|||
125263896|NCT01492426|450597606|FG000|Treatment|Participant does not meet study criteria|1|||
125263897|NCT01492426|450597607|FG001|Treatment|Participant does not meet study criteria|0|||
125263898|NCT01492426|450597606|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
125398611|NCT00749775|451093159|FG000|Overall Study|Protocol Violation|24|||
125263899|NCT01492426|450597607|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
125263900|NCT01492426|450597606|FG000|Follow-Up|Death|1|||
125263901|NCT01492426|450597607|FG001|Follow-Up|Death|0|||
125263902|NCT01492426|450597606|FG000|Follow-Up|Other|4|||
125263903|NCT01492426|450597607|FG001|Follow-Up|Other|2|||
125263904|NCT01492426|450597606|FG000|Follow-Up|Participant Withdrew Consent|6|||
125263905|NCT01492426|450597607|FG001|Follow-Up|Participant Withdrew Consent|1|||
125263906|NCT01492426|450597606|FG000|Follow-Up|Lost to Follow-up|12|||
125263907|NCT01492426|450597607|FG001|Follow-Up|Lost to Follow-up|6|||
125263908|NCT00322049|450597608|FG000|Overall Study|Moved out of area|0|||
125263909|NCT00322049|450597609|FG001|Overall Study|Moved out of area|0|||
125263910|NCT00322049|450597610|FG002|Overall Study|Moved out of area|0|||
125263911|NCT00322049|450597611|FG003|Overall Study|Moved out of area|1|||
125263912|NCT00322049|450597608|FG000|Overall Study|Infected with Dengue during study|0|||
125263913|NCT00322049|450597609|FG001|Overall Study|Infected with Dengue during study|1|||
125263914|NCT00322049|450597610|FG002|Overall Study|Infected with Dengue during study|0|||
125263915|NCT00322049|450597611|FG003|Overall Study|Infected with Dengue during study|0|||
125263916|NCT01978145|450597612|FG000|Treatment Period 1|Adverse Event|1|||
125263917|NCT01978145|450597613|FG001|Treatment Period 1|Adverse Event|9|||
125263918|NCT01978145|450597612|FG000|Treatment Period 1|Physician Decision|1|||
125263919|NCT01978145|450597613|FG001|Treatment Period 1|Physician Decision|0|||
125263920|NCT01978145|450597612|FG000|Treatment Period 1|Withdrawal by Subject|5|||
125263921|NCT01978145|450597613|FG001|Treatment Period 1|Withdrawal by Subject|4|||
125263922|NCT01978145|450597612|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
125263923|NCT01978145|450597613|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
125263924|NCT01978145|450597612|FG000|Washout Period 1|Adverse Event|0|||
125263925|NCT01978145|450597613|FG001|Washout Period 1|Adverse Event|1|||
125263926|NCT01978145|450597612|FG000|Washout Period 1|Withdrawal by Subject|1|||
125263927|NCT01978145|450597613|FG001|Washout Period 1|Withdrawal by Subject|1|||
125263928|NCT01978145|450597612|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
125263929|NCT01978145|450597613|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
125263930|NCT01978145|450597612|FG000|Treatment Period 2|Adverse Event|3|||
125263931|NCT01978145|450597613|FG001|Treatment Period 2|Adverse Event|3|||
125263932|NCT01978145|450597612|FG000|Treatment Period 2|Protocol Violation|0|||
125263933|NCT01978145|450597613|FG001|Treatment Period 2|Protocol Violation|1|||
125263934|NCT01978145|450597612|FG000|Treatment Period 2|Lost to Follow-up|1|||
125263935|NCT01978145|450597613|FG001|Treatment Period 2|Lost to Follow-up|1|||
125263936|NCT01978145|450597612|FG000|Treatment Period 2|Withdrawal by Subject|7|||
125263937|NCT01978145|450597613|FG001|Treatment Period 2|Withdrawal by Subject|4|||
125263938|NCT01978145|450597612|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
125263939|NCT01978145|450597613|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
125263940|NCT02026011|450597614|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
125263941|NCT02026011|450597615|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
125263942|NCT02026011|450597614|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
125263943|NCT02026011|450597615|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
125263944|NCT02026011|450597614|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
125263945|NCT02026011|450597615|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
125263946|NCT02026011|450597614|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
125263947|NCT02026011|450597615|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
125263948|NCT01770743|450597616|FG000|Overall Study|Adverse Event|1|||
125263949|NCT01770743|450597617|FG001|Overall Study|Adverse Event|0|||
125263950|NCT01770743|450597618|FG002|Overall Study|Adverse Event|0|||
125263951|NCT01770743|450597619|FG003|Overall Study|Adverse Event|0|||
125263952|NCT01770743|450597620|FG004|Overall Study|Adverse Event|0|||
125263953|NCT01770743|450597616|FG000|Overall Study|Withdrawal by Subject|0|||
125263954|NCT01770743|450597617|FG001|Overall Study|Withdrawal by Subject|0|||
125263955|NCT01770743|450597618|FG002|Overall Study|Withdrawal by Subject|1|||
125263956|NCT01770743|450597619|FG003|Overall Study|Withdrawal by Subject|1|||
125263957|NCT01770743|450597620|FG004|Overall Study|Withdrawal by Subject|1|||
125263958|NCT01770743|450597616|FG000|Overall Study|Lost to Follow-up|0|||
125263959|NCT01770743|450597617|FG001|Overall Study|Lost to Follow-up|2|||
125263960|NCT01770743|450597618|FG002|Overall Study|Lost to Follow-up|0|||
125263961|NCT01770743|450597619|FG003|Overall Study|Lost to Follow-up|0|||
125263962|NCT01770743|450597620|FG004|Overall Study|Lost to Follow-up|1|||
125263963|NCT01770743|450597616|FG000|Overall Study|Sponsor Terminated Subject|1|||
125263964|NCT01770743|450597617|FG001|Overall Study|Sponsor Terminated Subject|0|||
125263965|NCT01770743|450597618|FG002|Overall Study|Sponsor Terminated Subject|0|||
125263966|NCT01770743|450597619|FG003|Overall Study|Sponsor Terminated Subject|1|||
125263967|NCT01770743|450597620|FG004|Overall Study|Sponsor Terminated Subject|0|||
125263968|NCT01770743|450597616|FG000|Overall Study|Moving Out of State|0|||
125263969|NCT01770743|450597617|FG001|Overall Study|Moving Out of State|1|||
125263970|NCT01770743|450597618|FG002|Overall Study|Moving Out of State|0|||
125263971|NCT01770743|450597619|FG003|Overall Study|Moving Out of State|0|||
125263972|NCT01770743|450597620|FG004|Overall Study|Moving Out of State|0|||
125263973|NCT00529243|450597621|FG000|Overall Study|Adverse Event|1|||
125263974|NCT00529243|450597621|FG000|Overall Study|Death|1|||
125263975|NCT00529243|450597621|FG000|Overall Study|Relocated|1|||
125263976|NCT02852967|450597626|FG000|Overall Study|Adverse Event|3|||
125263977|NCT02852967|450597627|FG001|Overall Study|Adverse Event|1|||
125263978|NCT02852967|450597628|FG002|Overall Study|Adverse Event|0|||
125263979|NCT02852967|450597629|FG003|Overall Study|Adverse Event|1|||
125263980|NCT02852967|450597630|FG004|Overall Study|Adverse Event|0|||
125263981|NCT02852967|450597626|FG000|Overall Study|Death|1|||
125263982|NCT02852967|450597627|FG001|Overall Study|Death|0|||
125263983|NCT02852967|450597628|FG002|Overall Study|Death|0|||
125263984|NCT02852967|450597629|FG003|Overall Study|Death|0|||
125263985|NCT02852967|450597630|FG004|Overall Study|Death|0|||
125263986|NCT02852967|450597626|FG000|Overall Study|Lost to Follow-up|1|||
125263987|NCT02852967|450597627|FG001|Overall Study|Lost to Follow-up|2|||
125263988|NCT02852967|450597628|FG002|Overall Study|Lost to Follow-up|3|||
125263989|NCT02852967|450597629|FG003|Overall Study|Lost to Follow-up|4|||
125263990|NCT02852967|450597630|FG004|Overall Study|Lost to Follow-up|4|||
125263991|NCT02852967|450597626|FG000|Overall Study|Withdrawal by Subject|6|||
125263992|NCT02852967|450597627|FG001|Overall Study|Withdrawal by Subject|12|||
125263993|NCT02852967|450597628|FG002|Overall Study|Withdrawal by Subject|7|||
125263994|NCT02852967|450597629|FG003|Overall Study|Withdrawal by Subject|10|||
125263995|NCT02852967|450597630|FG004|Overall Study|Withdrawal by Subject|10|||
125263996|NCT02852967|450597626|FG000|Overall Study|SAE|0|||
125263997|NCT02852967|450597627|FG001|Overall Study|SAE|0|||
125263998|NCT02852967|450597628|FG002|Overall Study|SAE|0|||
125263999|NCT02852967|450597629|FG003|Overall Study|SAE|3|||
125264000|NCT02852967|450597630|FG004|Overall Study|SAE|0|||
125264001|NCT02852967|450597626|FG000|Overall Study|Elevated Liver Enzymes|2|||
125264002|NCT02852967|450597627|FG001|Overall Study|Elevated Liver Enzymes|0|||
125264003|NCT02852967|450597628|FG002|Overall Study|Elevated Liver Enzymes|0|||
125264004|NCT02852967|450597629|FG003|Overall Study|Elevated Liver Enzymes|2|||
125264005|NCT02852967|450597630|FG004|Overall Study|Elevated Liver Enzymes|2|||
125264006|NCT02852967|450597626|FG000|Overall Study|Physician Decision|0|||
125264007|NCT02852967|450597627|FG001|Overall Study|Physician Decision|0|||
125264008|NCT02852967|450597628|FG002|Overall Study|Physician Decision|0|||
125264009|NCT02852967|450597629|FG003|Overall Study|Physician Decision|1|||
125264010|NCT02852967|450597630|FG004|Overall Study|Physician Decision|0|||
125264011|NCT02852967|450597626|FG000|Overall Study|Lack of Efficacy|0|||
125264012|NCT02852967|450597627|FG001|Overall Study|Lack of Efficacy|1|||
125264013|NCT02852967|450597628|FG002|Overall Study|Lack of Efficacy|0|||
125264014|NCT02852967|450597629|FG003|Overall Study|Lack of Efficacy|0|||
125264015|NCT02852967|450597630|FG004|Overall Study|Lack of Efficacy|0|||
125264016|NCT02852967|450597626|FG000|Overall Study|Non-compliance|0|||
125264017|NCT02852967|450597627|FG001|Overall Study|Non-compliance|0|||
125264018|NCT02852967|450597628|FG002|Overall Study|Non-compliance|1|||
125264019|NCT02852967|450597629|FG003|Overall Study|Non-compliance|1|||
125264020|NCT02852967|450597630|FG004|Overall Study|Non-compliance|0|||
125264021|NCT02852967|450597626|FG000|Overall Study|Dispensing Drug Violation|0|||
125264022|NCT02852967|450597627|FG001|Overall Study|Dispensing Drug Violation|0|||
125264023|NCT02852967|450597628|FG002|Overall Study|Dispensing Drug Violation|1|||
125264024|NCT02852967|450597629|FG003|Overall Study|Dispensing Drug Violation|0|||
125264025|NCT02852967|450597630|FG004|Overall Study|Dispensing Drug Violation|0|||
125264026|NCT02852967|450597626|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
125264027|NCT02852967|450597627|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
125264028|NCT02852967|450597628|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
125264029|NCT02852967|450597629|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
125264030|NCT02852967|450597630|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
125264031|NCT01693367|450597631|FG000|Overall Study|Withdrawal by Subject|1|||
125264032|NCT01693367|450597632|FG001|Overall Study|Withdrawal by Subject|1|||
125264033|NCT01693367|450597631|FG000|Overall Study|Physician Decision|0|||
125264034|NCT01693367|450597632|FG001|Overall Study|Physician Decision|1|||
125264035|NCT02136914|450597633|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
125264036|NCT02136914|450597634|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
125264037|NCT02136914|450597633|FG000|Overall Study|Withdrawal by Subject|3|||
125264038|NCT02136914|450597634|FG001|Overall Study|Withdrawal by Subject|10|||
125264039|NCT02136914|450597633|FG000|Overall Study|Subject Unwilling to Proceed|7|||
125264040|NCT02136914|450597634|FG001|Overall Study|Subject Unwilling to Proceed|2|||
125264041|NCT02136914|450597633|FG000|Overall Study|Lost to Follow-up|1|||
125264042|NCT02136914|450597634|FG001|Overall Study|Lost to Follow-up|1|||
125264043|NCT02136914|450597633|FG000|Overall Study|Did Not Receive Study Drug|2|||
125447015|NCT05310084|451262656|FG001|Overall Study|Lost to Follow-up|1|||
125264044|NCT02136914|450597634|FG001|Overall Study|Did Not Receive Study Drug|0|||
125264045|NCT02136914|450597633|FG000|Overall Study|Lack of Efficacy|1|||
125264046|NCT02136914|450597634|FG001|Overall Study|Lack of Efficacy|0|||
125264047|NCT02136914|450597633|FG000|Overall Study|Death|0|||
125264048|NCT02136914|450597634|FG001|Overall Study|Death|1|||
125264049|NCT05518461|450597641|FG000|Overall Study|Lost to Follow-up|25|||
125264050|NCT03179761|450597642|FG000|Overall Study|Death|2|||
125264051|NCT03179761|450597643|FG001|Overall Study|Death|5|||
125264052|NCT03179761|450597642|FG000|Overall Study|Lost to Follow-up|2|||
125264053|NCT03179761|450597643|FG001|Overall Study|Lost to Follow-up|2|||
125264054|NCT03179761|450597642|FG000|Overall Study|Protocol Violation|1|||
125264055|NCT03179761|450597643|FG001|Overall Study|Protocol Violation|0|||
125264056|NCT03179761|450597642|FG000|Overall Study|Withdrawal by Subject|1|||
125264057|NCT03179761|450597643|FG001|Overall Study|Withdrawal by Subject|4|||
125264058|NCT03179761|450597642|FG000|Overall Study|Investigator Request|0|||
125264059|NCT03179761|450597643|FG001|Overall Study|Investigator Request|2|||
125264060|NCT00448448|450597645|FG000|Overall Study|Withdrawal by Subject|13|||
125264061|NCT00448448|450597646|FG001|Overall Study|Withdrawal by Subject|2|||
125264062|NCT00448448|450597645|FG000|Overall Study|On protocol when study ended|83|||
125264063|NCT00448448|450597646|FG001|Overall Study|On protocol when study ended|36|||
125264064|NCT00448448|450597645|FG000|Overall Study|Lost to Follow-up|2|||
125264065|NCT00448448|450597646|FG001|Overall Study|Lost to Follow-up|1|||
125264066|NCT00448448|450597645|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
125264067|NCT00448448|450597646|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
125264068|NCT00448448|450597645|FG000|Overall Study|Signed consent lost|0|||
125264069|NCT00448448|450597646|FG001|Overall Study|Signed consent lost|1|||
125264070|NCT02284191|450597647|FG000|Overall Study|Withdrawal by Subject|1|||
125264071|NCT02284191|450597648|FG001|Overall Study|Withdrawal by Subject|3|||
125264072|NCT02284191|450597647|FG000|Overall Study|Lost to Follow-up|1|||
125264073|NCT02284191|450597648|FG001|Overall Study|Lost to Follow-up|0|||
125264074|NCT01188967|450597649|FG000|Overall Study|Withdrawal by Subject|1|||
125264075|NCT01188967|450597650|FG001|Overall Study|Withdrawal by Subject|1|||
125264076|NCT01188967|450597649|FG000|Overall Study|Physician Decision|1|||
125264077|NCT01188967|450597650|FG001|Overall Study|Physician Decision|1|||
125264078|NCT01188967|450597649|FG000|Overall Study|Lost to Follow-up|3|||
125264079|NCT01188967|450597650|FG001|Overall Study|Lost to Follow-up|2|||
125264080|NCT01832727|450597655|FG000|Overall Study|Adverse Event|4|||
125264081|NCT01832727|450597656|FG001|Overall Study|Adverse Event|6|||
125264082|NCT01832727|450597657|FG002|Overall Study|Adverse Event|1|||
125264083|NCT01832727|450597658|FG003|Overall Study|Adverse Event|0|||
125264084|NCT01832727|450597659|FG004|Overall Study|Adverse Event|1|||
125264085|NCT01832727|450597660|FG005|Overall Study|Adverse Event|1|||
125264086|NCT01832727|450597661|FG006|Overall Study|Adverse Event|2|||
125264087|NCT01832727|450597662|FG007|Overall Study|Adverse Event|1|||
125264088|NCT01832727|450597663|FG008|Overall Study|Adverse Event|9|||
125264089|NCT01832727|450597655|FG000|Overall Study|Disease progression|3|||
125264090|NCT01832727|450597656|FG001|Overall Study|Disease progression|0|||
125264091|NCT01832727|450597657|FG002|Overall Study|Disease progression|2|||
125264092|NCT01832727|450597658|FG003|Overall Study|Disease progression|1|||
125264093|NCT01832727|450597659|FG004|Overall Study|Disease progression|3|||
125264094|NCT01832727|450597660|FG005|Overall Study|Disease progression|3|||
125264095|NCT01832727|450597661|FG006|Overall Study|Disease progression|6|||
125264096|NCT01832727|450597662|FG007|Overall Study|Disease progression|2|||
125264097|NCT01832727|450597663|FG008|Overall Study|Disease progression|7|||
125264098|NCT01832727|450597655|FG000|Overall Study|Lost to Follow-up|0|||
125264099|NCT01832727|450597656|FG001|Overall Study|Lost to Follow-up|0|||
125264100|NCT01832727|450597657|FG002|Overall Study|Lost to Follow-up|0|||
125264101|NCT01832727|450597658|FG003|Overall Study|Lost to Follow-up|1|||
125264102|NCT01832727|450597659|FG004|Overall Study|Lost to Follow-up|0|||
125264103|NCT01832727|450597660|FG005|Overall Study|Lost to Follow-up|0|||
125264104|NCT01832727|450597661|FG006|Overall Study|Lost to Follow-up|0|||
125264105|NCT01832727|450597662|FG007|Overall Study|Lost to Follow-up|0|||
125264106|NCT01832727|450597663|FG008|Overall Study|Lost to Follow-up|0|||
125264107|NCT01832727|450597655|FG000|Overall Study|Physician Decision|1|||
125264108|NCT01832727|450597656|FG001|Overall Study|Physician Decision|0|||
125264109|NCT01832727|450597657|FG002|Overall Study|Physician Decision|0|||
125264110|NCT01832727|450597658|FG003|Overall Study|Physician Decision|1|||
125264111|NCT01832727|450597659|FG004|Overall Study|Physician Decision|0|||
125264112|NCT01832727|450597660|FG005|Overall Study|Physician Decision|1|||
125264113|NCT01832727|450597661|FG006|Overall Study|Physician Decision|0|||
125264114|NCT01832727|450597662|FG007|Overall Study|Physician Decision|0|||
125264115|NCT01832727|450597663|FG008|Overall Study|Physician Decision|0|||
125264116|NCT01832727|450597655|FG000|Overall Study|Withdrawal by Subject|1|||
125264117|NCT01832727|450597656|FG001|Overall Study|Withdrawal by Subject|1|||
125264118|NCT01832727|450597657|FG002|Overall Study|Withdrawal by Subject|0|||
125264119|NCT01832727|450597658|FG003|Overall Study|Withdrawal by Subject|1|||
125264120|NCT01832727|450597659|FG004|Overall Study|Withdrawal by Subject|0|||
125264121|NCT01832727|450597660|FG005|Overall Study|Withdrawal by Subject|1|||
125264122|NCT01832727|450597661|FG006|Overall Study|Withdrawal by Subject|0|||
125447016|NCT05310084|451262655|FG000|Overall Study|Adverse Event|1|||
125264123|NCT01832727|450597662|FG007|Overall Study|Withdrawal by Subject|2|||
125264124|NCT01832727|450597663|FG008|Overall Study|Withdrawal by Subject|1|||
125264125|NCT01832727|450597655|FG000|Overall Study|Study terminated by sponsor|0|||
125447017|NCT05310084|451262656|FG001|Overall Study|Adverse Event|1|||
125264126|NCT01832727|450597656|FG001|Overall Study|Study terminated by sponsor|0|||
125264127|NCT01832727|450597657|FG002|Overall Study|Study terminated by sponsor|0|||
125264128|NCT01832727|450597658|FG003|Overall Study|Study terminated by sponsor|0|||
125264129|NCT01832727|450597659|FG004|Overall Study|Study terminated by sponsor|0|||
125264130|NCT01832727|450597660|FG005|Overall Study|Study terminated by sponsor|0|||
125264131|NCT01832727|450597661|FG006|Overall Study|Study terminated by sponsor|0|||
125264132|NCT01832727|450597662|FG007|Overall Study|Study terminated by sponsor|1|||
125264133|NCT01832727|450597663|FG008|Overall Study|Study terminated by sponsor|1|||
125264134|NCT02216526|450597664|FG000|Overall Study|Adverse Event|1|||
125264135|NCT02216526|450597665|FG001|Overall Study|Adverse Event|1|||
125264136|NCT02216526|450597666|FG002|Overall Study|Adverse Event|0|||
125264137|NCT02216526|450597664|FG000|Overall Study|Death|0|||
125264138|NCT02216526|450597665|FG001|Overall Study|Death|1|||
125264139|NCT02216526|450597666|FG002|Overall Study|Death|3|||
125264140|NCT02216526|450597664|FG000|Overall Study|Protocol Violation|2|||
125264141|NCT02216526|450597665|FG001|Overall Study|Protocol Violation|0|||
125264142|NCT02216526|450597666|FG002|Overall Study|Protocol Violation|2|||
125264143|NCT02216526|450597664|FG000|Overall Study|Hospitalization|2|||
125264144|NCT02216526|450597665|FG001|Overall Study|Hospitalization|1|||
125264145|NCT02216526|450597666|FG002|Overall Study|Hospitalization|3|||
125264146|NCT04436744|450597670|FG000|Overall Study|Adverse Event|1|||
125264147|NCT04436744|450597671|FG001|Overall Study|Adverse Event|1|||
125264148|NCT04436744|450597670|FG000|Overall Study|Death|1|||
125264149|NCT04436744|450597671|FG001|Overall Study|Death|0|||
125264150|NCT04436744|450597670|FG000|Overall Study|Lost to Follow-up|0|||
125264151|NCT04436744|450597671|FG001|Overall Study|Lost to Follow-up|2|||
125264152|NCT04436744|450597670|FG000|Overall Study|Physician Decision|0|||
125264153|NCT04436744|450597671|FG001|Overall Study|Physician Decision|1|||
125264154|NCT04436744|450597670|FG000|Overall Study|Progressive Disease|0|||
125264155|NCT04436744|450597671|FG001|Overall Study|Progressive Disease|4|||
125264156|NCT04436744|450597670|FG000|Overall Study|Protocol Deviation|1|||
125264157|NCT04436744|450597671|FG001|Overall Study|Protocol Deviation|1|||
125264158|NCT04436744|450597670|FG000|Overall Study|Withdrawal by Subject|1|||
125264159|NCT04436744|450597671|FG001|Overall Study|Withdrawal by Subject|2|||
125264160|NCT01133847|450597675|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
125264161|NCT01133847|450597676|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
125264162|NCT01133847|450597677|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
125264163|NCT01133847|450597675|FG000|Follow-Up Phase|Lost to Follow-up|1|||
125264164|NCT01133847|450597676|FG001|Follow-Up Phase|Lost to Follow-up|3|||
125264165|NCT01133847|450597677|FG002|Follow-Up Phase|Lost to Follow-up|7|||
125264166|NCT01463033|450597678|FG000|Overall Study|Lost to Follow-up|4|||
125264167|NCT01463033|450597679|FG001|Overall Study|Lost to Follow-up|4|||
125264168|NCT01463033|450597678|FG000|Overall Study|Death|3|||
125264169|NCT01463033|450597679|FG001|Overall Study|Death|2|||
125264170|NCT00967616|450597680|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
125264171|NCT00967616|450597681|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
125264172|NCT00967616|450597680|FG000|Overall Study|Death|0|||
125264173|NCT00967616|450597681|FG001|Overall Study|Death|3|||
125264174|NCT00967616|450597680|FG000|Overall Study|Withdrawal by Subject|8|||
125264175|NCT00967616|450597681|FG001|Overall Study|Withdrawal by Subject|4|||
125264176|NCT00967616|450597680|FG000|Overall Study|Progressive Disease|31|||
125264177|NCT00967616|450597681|FG001|Overall Study|Progressive Disease|18|||
125264178|NCT00967616|450597680|FG000|Overall Study|Other|8|||
125264179|NCT00967616|450597681|FG001|Overall Study|Other|8|||
125264180|NCT00967616|450597680|FG000|Overall Study|Protocol Violation|1|||
125264181|NCT00967616|450597681|FG001|Overall Study|Protocol Violation|0|||
125264182|NCT01368614|450597682|FG000|Screening Period|Screen Failure|58|||
125264183|NCT01368614|450597683|FG001|Screening Period|Screen Failure|0|||
125264184|NCT01368614|450597684|FG002|Screening Period|Screen Failure|0|||
125264185|NCT01368614|450597685|FG003|Screening Period|Screen Failure|0|||
125264186|NCT01368614|450597682|FG000|Study Period|Withdrawal by Subject|0|||
125264187|NCT01368614|450597683|FG001|Study Period|Withdrawal by Subject|1|||
125264188|NCT01368614|450597684|FG002|Study Period|Withdrawal by Subject|1|||
125264189|NCT01368614|450597685|FG003|Study Period|Withdrawal by Subject|3|||
125398612|NCT00749775|451093159|FG000|Overall Study|Lost to Follow-up|36|||
125398613|NCT00749775|451093159|FG000|Overall Study|No visit after first day of treatment|44|||
125264190|NCT01368614|450597682|FG000|Study Period|Lost to Follow-up|0|||
125264191|NCT01368614|450597683|FG001|Study Period|Lost to Follow-up|0|||
125264192|NCT01368614|450597684|FG002|Study Period|Lost to Follow-up|1|||
125264193|NCT01368614|450597685|FG003|Study Period|Lost to Follow-up|0|||
125264194|NCT02951780|450597686|FG000|Period 1|Adverse Event|0|||
125264195|NCT02951780|450597687|FG001|Period 1|Adverse Event|0|||
125264196|NCT02951780|450597688|FG002|Period 1|Adverse Event|0|||
125264197|NCT02951780|450597689|FG003|Period 1|Adverse Event|1|||
125264198|NCT02951780|450597690|FG004|Period 1|Adverse Event|0|||
125264199|NCT02951780|450597691|FG005|Period 1|Adverse Event|0|||
125264200|NCT02951780|450597692|FG006|Period 1|Adverse Event|0|||
125264201|NCT02951780|450597693|FG007|Period 1|Adverse Event|0|||
125264202|NCT02951780|450597694|FG008|Period 1|Adverse Event|0|||
125264203|NCT02951780|450597686|FG000|Period 1|Scheduling Conflicts|0|||
125264204|NCT02951780|450597687|FG001|Period 1|Scheduling Conflicts|0|||
125264205|NCT02951780|450597688|FG002|Period 1|Scheduling Conflicts|0|||
125264206|NCT02951780|450597689|FG003|Period 1|Scheduling Conflicts|0|||
125264207|NCT02951780|450597690|FG004|Period 1|Scheduling Conflicts|0|||
125447018|NCT05310084|451262655|FG000|Overall Study|Randomized but not vaccinated|4|||
125447019|NCT05310084|451262656|FG001|Overall Study|Randomized but not vaccinated|2|||
125447020|NCT01646320|451262665|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
125447021|NCT01646320|451262666|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
125447022|NCT01646320|451262665|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
125447023|NCT01646320|451262666|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
125447024|NCT01646320|451262665|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
125447025|NCT01646320|451262666|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
125447026|NCT01646320|451262665|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
125447027|NCT01646320|451262666|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
125447028|NCT01646320|451262665|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
125447029|NCT01646320|451262666|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
125447030|NCT01646320|451262665|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
125447031|NCT01646320|451262666|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
125447032|NCT01646320|451262665|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
125447033|NCT01646320|451262666|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
125447034|NCT01646320|451262665|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
125447035|NCT01646320|451262666|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
125447036|NCT01646320|451262665|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
125447037|NCT01646320|451262666|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
125447038|NCT01646320|451262665|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
125447039|NCT01646320|451262666|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
125447040|NCT01646320|451262665|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
125447041|NCT01646320|451262666|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
125447042|NCT01489020|451262667|FG000|Overall Study|Withdrawal by Subject|1|||
125447043|NCT01489020|451262668|FG001|Overall Study|Withdrawal by Subject|0|||
125447044|NCT01489020|451262669|FG002|Overall Study|Withdrawal by Subject|0|||
125447045|NCT01489020|451262670|FG003|Overall Study|Withdrawal by Subject|0|||
125447046|NCT01489020|451262671|FG004|Overall Study|Withdrawal by Subject|0|||
125447047|NCT01489020|451262672|FG005|Overall Study|Withdrawal by Subject|0|||
125447048|NCT01489020|451262667|FG000|Overall Study|Adverse Event|0|||
125447049|NCT01489020|451262668|FG001|Overall Study|Adverse Event|0|||
125447050|NCT01489020|451262669|FG002|Overall Study|Adverse Event|3|||
125447051|NCT01489020|451262670|FG003|Overall Study|Adverse Event|0|||
125447052|NCT01489020|451262671|FG004|Overall Study|Adverse Event|3|||
125447053|NCT01489020|451262672|FG005|Overall Study|Adverse Event|0|||
125447054|NCT01489020|451262667|FG000|Overall Study|Concomitant disease|0|||
125447055|NCT01489020|451262668|FG001|Overall Study|Concomitant disease|0|||
125447056|NCT01489020|451262669|FG002|Overall Study|Concomitant disease|0|||
125447057|NCT01489020|451262670|FG003|Overall Study|Concomitant disease|0|||
125447058|NCT01489020|451262671|FG004|Overall Study|Concomitant disease|3|||
125447059|NCT01489020|451262672|FG005|Overall Study|Concomitant disease|0|||
125447060|NCT02424344|451262673|FG000|Overall Study|Lack of Efficacy|0|||
125447061|NCT02424344|451262674|FG001|Overall Study|Lack of Efficacy|1|||
125447062|NCT02424344|451262673|FG000|Overall Study|Withdrawal by Subject|2|||
125447063|NCT02424344|451262674|FG001|Overall Study|Withdrawal by Subject|1|||
125447064|NCT02424344|451262673|FG000|Overall Study|Lost to Follow-up|1|||
125447065|NCT02424344|451262674|FG001|Overall Study|Lost to Follow-up|0|||
125447066|NCT02424344|451262673|FG000|Overall Study|Adverse Event|4|||
125447067|NCT02424344|451262674|FG001|Overall Study|Adverse Event|8|||
125264208|NCT02951780|450597691|FG005|Period 1|Scheduling Conflicts|0|||
125264209|NCT02951780|450597692|FG006|Period 1|Scheduling Conflicts|0|||
125264210|NCT02951780|450597693|FG007|Period 1|Scheduling Conflicts|1|||
125264211|NCT02951780|450597694|FG008|Period 1|Scheduling Conflicts|0|||
125264212|NCT02951780|450597686|FG000|Period 2|Scheduling Conflicts|0|||
125264213|NCT02951780|450597687|FG001|Period 2|Scheduling Conflicts|0|||
125447068|NCT01174550|451262675|FG000|Overall Study|Death|75|||
125447069|NCT01174550|451262676|FG001|Overall Study|Death|74|||
125447070|NCT01174550|451262675|FG000|Overall Study|Lost to Follow-up|652|||
125447071|NCT01174550|451262676|FG001|Overall Study|Lost to Follow-up|510|||
125447072|NCT01174550|451262675|FG000|Overall Study|Withdrawal by Subject|543|||
125447073|NCT01174550|451262676|FG001|Overall Study|Withdrawal by Subject|289|||
125447074|NCT05257837|451262677|FG000|Overall Study|Excluded (did not find the guns)|4|||
125264214|NCT02951780|450597688|FG002|Period 2|Scheduling Conflicts|0|||
125264215|NCT02951780|450597689|FG003|Period 2|Scheduling Conflicts|0|||
125447075|NCT05257837|451262678|FG001|Overall Study|Excluded (did not find the guns)|2|||
125447076|NCT05257837|451262679|FG002|Overall Study|Excluded (did not find the guns)|4|||
125447077|NCT05257837|451262680|FG003|Overall Study|Excluded (did not find the guns)|0|||
125447078|NCT01625338|451262681|FG000|Overall Study|Enrolled but not Treated|0|||
125447079|NCT01625338|451262682|FG001|Overall Study|Enrolled but not Treated|0|||
125447080|NCT01625338|451262683|FG002|Overall Study|Enrolled but not Treated|1|||
125264216|NCT02951780|450597690|FG004|Period 2|Scheduling Conflicts|0|||
125447081|NCT01625338|451262681|FG000|Overall Study|Efficacy Failure|27|||
125264217|NCT02951780|450597691|FG005|Period 2|Scheduling Conflicts|0|||
125264218|NCT02951780|450597692|FG006|Period 2|Scheduling Conflicts|0|||
125264219|NCT02951780|450597693|FG007|Period 2|Scheduling Conflicts|1|||
125264220|NCT02951780|450597694|FG008|Period 2|Scheduling Conflicts|0|||
125264221|NCT01374425|450597695|FG000|Overall Study|Radiographic Disease Progression|86|||
125264222|NCT01374425|450597696|FG001|Overall Study|Radiographic Disease Progression|81|||
125264223|NCT01374425|450597695|FG000|Overall Study|Clinical Disease Progression|9|||
125264224|NCT01374425|450597696|FG001|Overall Study|Clinical Disease Progression|6|||
125264225|NCT01374425|450597695|FG000|Overall Study|Adverse Event|29|||
125264226|NCT01374425|450597696|FG001|Overall Study|Adverse Event|18|||
125264227|NCT01374425|450597695|FG000|Overall Study|Death (Progression of Disease)|1|||
125264228|NCT01374425|450597696|FG001|Overall Study|Death (Progression of Disease)|0|||
125264229|NCT01374425|450597695|FG000|Overall Study|Death (Adverse Event)|2|||
125264230|NCT01374425|450597696|FG001|Overall Study|Death (Adverse Event)|4|||
125264231|NCT01374425|450597695|FG000|Overall Study|Withdrawal by Subject|6|||
125264232|NCT01374425|450597696|FG001|Overall Study|Withdrawal by Subject|7|||
125264233|NCT01374425|450597695|FG000|Overall Study|Refused Treatment|10|||
125264234|NCT01374425|450597696|FG001|Overall Study|Refused Treatment|24|||
125264235|NCT01374425|450597695|FG000|Overall Study|Protocol Violation|2|||
125264236|NCT01374425|450597696|FG001|Overall Study|Protocol Violation|3|||
125264237|NCT01374425|450597695|FG000|Overall Study|Sponsor Decision|0|||
125264238|NCT01374425|450597696|FG001|Overall Study|Sponsor Decision|1|||
125264239|NCT01374425|450597695|FG000|Overall Study|Lost to Follow-up|2|||
125264240|NCT01374425|450597696|FG001|Overall Study|Lost to Follow-up|1|||
125264241|NCT01374425|450597695|FG000|Overall Study|Other|41|||
125264242|NCT01374425|450597696|FG001|Overall Study|Other|43|||
125264243|NCT02359903|450597697|FG000|Overall Study|Adverse Event|0|||
125264244|NCT02359903|450597698|FG001|Overall Study|Adverse Event|2|||
125264245|NCT00546481|450597699|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
125264246|NCT00546481|450597700|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
125264247|NCT00546481|450597701|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
125264248|NCT00546481|450597699|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
125264249|NCT00546481|450597700|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
125264250|NCT00546481|450597701|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
125264251|NCT00546481|450597699|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
125264252|NCT00546481|450597700|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
125264253|NCT00546481|450597701|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
125264254|NCT00546481|450597699|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
125264255|NCT00546481|450597700|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
125398614|NCT00749775|451093159|FG000|Overall Study|No drug administration|3|||
125398615|NCT01400841|451093160|FG000|Initial Study Phase (6 Months)|Death|1|||
125398616|NCT01400841|451093160|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
125398617|NCT00326911|451093161|FG000|Overall Study|Hospitalization prior to treatment|0|||
125398618|NCT00326911|451093162|FG001|Overall Study|Hospitalization prior to treatment|1|||
125398619|NCT00326911|451093161|FG000|Overall Study|Physician decision prior to treatment|1|||
125398620|NCT00326911|451093162|FG001|Overall Study|Physician decision prior to treatment|0|||
125398621|NCT00326911|451093161|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
125398622|NCT00326911|451093162|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
125398623|NCT03019627|451093167|FG000|Overall Study|Adverse Event|8|||
125398624|NCT03019627|451093168|FG001|Overall Study|Adverse Event|0|||
125398625|NCT03019627|451093167|FG000|Overall Study|Unrelated to adverse event|1|||
125398626|NCT03019627|451093168|FG001|Overall Study|Unrelated to adverse event|3|||
125398627|NCT03019627|451093167|FG000|Overall Study|Lost to Follow-up|2|||
125398628|NCT03019627|451093168|FG001|Overall Study|Lost to Follow-up|1|||
125398629|NCT03019627|451093167|FG000|Overall Study|not compliance|2|||
125398630|NCT03019627|451093168|FG001|Overall Study|not compliance|2|||
125398631|NCT03019627|451093167|FG000|Overall Study|Other|2|||
125398632|NCT03019627|451093168|FG001|Overall Study|Other|2|||
125398633|NCT03364049|451093169|FG000|Overall Study|Death|6|||
125398634|NCT03364049|451093170|FG001|Overall Study|Death|4|||
125398635|NCT03364049|451093171|FG002|Overall Study|Death|5|||
125398636|NCT03364049|451093172|FG003|Overall Study|Death|14|||
125398637|NCT03364049|451093169|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
125398638|NCT03364049|451093170|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
125264256|NCT00546481|450597701|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
125264257|NCT00546481|450597699|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
125264258|NCT00546481|450597700|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
125264259|NCT00546481|450597701|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
125264260|NCT00546481|450597699|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
125264261|NCT00546481|450597700|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
125264262|NCT00546481|450597701|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
125398639|NCT03364049|451093171|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
125264263|NCT00546481|450597699|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
125264264|NCT00546481|450597700|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
125264265|NCT00546481|450597701|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
125264266|NCT00546481|450597699|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
125264267|NCT00546481|450597700|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
125264268|NCT00546481|450597701|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
125264269|NCT00546481|450597699|FG000|Maintenance Phase (CERA)|Other Reason|0|||
125264270|NCT00546481|450597700|FG001|Maintenance Phase (CERA)|Other Reason|0|||
125264271|NCT00546481|450597701|FG002|Maintenance Phase (CERA)|Other Reason|1|||
125264272|NCT01240863|450597704|FG000|Open-label Titration Period|Adverse Event|47|||
125264273|NCT01240863|450597705|FG001|Open-label Titration Period|Adverse Event|0|||
125264274|NCT01240863|450597706|FG002|Open-label Titration Period|Adverse Event|0|||
125264275|NCT01240863|450597704|FG000|Open-label Titration Period|Lack of Efficacy|19|||
125264276|NCT01240863|450597705|FG001|Open-label Titration Period|Lack of Efficacy|0|||
125264277|NCT01240863|450597706|FG002|Open-label Titration Period|Lack of Efficacy|0|||
125264278|NCT01240863|450597704|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
125264279|NCT01240863|450597705|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
125264280|NCT01240863|450597706|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
125264281|NCT01240863|450597704|FG000|Open-label Titration Period|Protocol Violation|7|||
125264282|NCT01240863|450597705|FG001|Open-label Titration Period|Protocol Violation|0|||
125264283|NCT01240863|450597706|FG002|Open-label Titration Period|Protocol Violation|0|||
125264284|NCT01240863|450597704|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
125264285|NCT01240863|450597705|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
125264286|NCT01240863|450597706|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
125264287|NCT01240863|450597704|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
125264288|NCT01240863|450597705|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
125264289|NCT01240863|450597706|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
125264290|NCT01240863|450597704|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
125264291|NCT01240863|450597705|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
125264292|NCT01240863|450597706|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
125264293|NCT01240863|450597704|FG000|Open-label Titration Period|Other|7|||
125264294|NCT01240863|450597705|FG001|Open-label Titration Period|Other|0|||
125264295|NCT01240863|450597706|FG002|Open-label Titration Period|Other|0|||
125264296|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
125264297|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
125264298|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
125264299|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
125264300|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
125264301|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
125264302|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
125264303|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
125264304|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
125264305|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
125264306|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
125264307|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
125264308|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
125264309|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
125264310|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
125264311|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
125264312|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
125264313|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
125264314|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
125264315|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
125264316|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
125264317|NCT01240863|450597704|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
125264318|NCT01240863|450597705|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
125264319|NCT01240863|450597706|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
125264320|NCT03783780|450597711|FG000|Overall Study|Withdrawn prior to completion|1|||
125264321|NCT03768427|450597712|FG000|Overall Study|Death|0|||
125264322|NCT03768427|450597713|FG001|Overall Study|Death|0|||
125264323|NCT03768427|450597714|FG002|Overall Study|Death|1|||
125264324|NCT03768427|450597715|FG003|Overall Study|Death|0|||
125447082|NCT01625338|451262682|FG001|Overall Study|Efficacy Failure|39|||
125447083|NCT01625338|451262683|FG002|Overall Study|Efficacy Failure|31|||
125447084|NCT01625338|451262681|FG000|Overall Study|Lost to Follow-up|3|||
125447085|NCT01625338|451262682|FG001|Overall Study|Lost to Follow-up|3|||
125264325|NCT03768427|450597712|FG000|Overall Study|Lost to Follow-up|2|||
125264326|NCT03768427|450597713|FG001|Overall Study|Lost to Follow-up|0|||
125264327|NCT03768427|450597714|FG002|Overall Study|Lost to Follow-up|0|||
125264328|NCT03768427|450597715|FG003|Overall Study|Lost to Follow-up|0|||
125264329|NCT03768427|450597712|FG000|Overall Study|Physician Decision|3|||
125264330|NCT03768427|450597713|FG001|Overall Study|Physician Decision|2|||
125264331|NCT03768427|450597714|FG002|Overall Study|Physician Decision|4|||
125264332|NCT03768427|450597715|FG003|Overall Study|Physician Decision|4|||
125264333|NCT03768427|450597712|FG000|Overall Study|Withdrawal by Subject|7|||
125264334|NCT03768427|450597713|FG001|Overall Study|Withdrawal by Subject|2|||
125264335|NCT03768427|450597714|FG002|Overall Study|Withdrawal by Subject|6|||
125264336|NCT03768427|450597715|FG003|Overall Study|Withdrawal by Subject|7|||
125264337|NCT00776789|450597716|FG000|Overall Study|Consent refusal|2|||
125264338|NCT00776789|450597717|FG001|Overall Study|Consent refusal|2|||
125264339|NCT00776789|450597716|FG000|Overall Study|Poor quality video|1|||
125264340|NCT00776789|450597717|FG001|Overall Study|Poor quality video|1|||
125264341|NCT02629861|450597723|FG000|Overall Study|Adverse Event|7|||
125264342|NCT02629861|450597724|FG001|Overall Study|Adverse Event|5|||
125264343|NCT02629861|450597725|FG002|Overall Study|Adverse Event|4|||
125264344|NCT02629861|450597723|FG000|Overall Study|Withdrawal by Subject|5|||
125264345|NCT02629861|450597724|FG001|Overall Study|Withdrawal by Subject|8|||
125264346|NCT02629861|450597725|FG002|Overall Study|Withdrawal by Subject|13|||
125264347|NCT02629861|450597723|FG000|Overall Study|Protocol Violation|2|||
125264348|NCT02629861|450597724|FG001|Overall Study|Protocol Violation|3|||
125264349|NCT02629861|450597725|FG002|Overall Study|Protocol Violation|7|||
125264350|NCT02629861|450597723|FG000|Overall Study|Lost to Follow-up|12|||
125264351|NCT02629861|450597724|FG001|Overall Study|Lost to Follow-up|9|||
125264352|NCT02629861|450597725|FG002|Overall Study|Lost to Follow-up|4|||
125264353|NCT02629861|450597723|FG000|Overall Study|Other|1|||
125264354|NCT02629861|450597724|FG001|Overall Study|Other|1|||
125264355|NCT02629861|450597725|FG002|Overall Study|Other|0|||
125264356|NCT02629861|450597723|FG000|Overall Study|Pregnancy|2|||
125264357|NCT02629861|450597724|FG001|Overall Study|Pregnancy|1|||
125264358|NCT02629861|450597725|FG002|Overall Study|Pregnancy|0|||
125264359|NCT00907621|450597729|FG000|Overall Study|Lost to Follow-up|6|||
125264360|NCT00907621|450597730|FG001|Overall Study|Lost to Follow-up|3|||
125264361|NCT00907621|450597729|FG000|Overall Study|intercurrent febrile illness|1|||
125264362|NCT00907621|450597730|FG001|Overall Study|intercurrent febrile illness|1|||
125264363|NCT00902330|450597733|FG000|Overall Study|Too overwhelmed by treatment|2|||
125264364|NCT00902330|450597734|FG001|Overall Study|Too overwhelmed by treatment|5|||
125264365|NCT00902330|450597733|FG000|Overall Study|Adverse Event|1|||
125264366|NCT00902330|450597734|FG001|Overall Study|Adverse Event|0|||
125264367|NCT00902330|450597733|FG000|Overall Study|No post baseline data|1|||
125264368|NCT00902330|450597734|FG001|Overall Study|No post baseline data|0|||
125264369|NCT00165789|450597735|FG000|Overall Study|Adverse Event|0|||
125264370|NCT00165789|450597736|FG001|Overall Study|Adverse Event|3|||
125264371|NCT00165789|450597737|FG002|Overall Study|Adverse Event|0|||
125264372|NCT00165789|450597738|FG003|Overall Study|Adverse Event|12|||
125264373|NCT00165789|450597735|FG000|Overall Study|Withdrawal by Subject|0|||
125264374|NCT00165789|450597736|FG001|Overall Study|Withdrawal by Subject|1|||
125264375|NCT00165789|450597737|FG002|Overall Study|Withdrawal by Subject|1|||
125264376|NCT00165789|450597738|FG003|Overall Study|Withdrawal by Subject|2|||
125264377|NCT01816048|450597739|FG000|Overall Study|Adverse Event|1|||
125264378|NCT01816048|450597739|FG000|Overall Study|Death|1|||
125264379|NCT01816048|450597739|FG000|Overall Study|Withdrawal by Subject|1|||
125264380|NCT01816048|450597739|FG000|Overall Study|Disease Progression|3|||
125264381|NCT04290624|450597740|FG000|Overall Study|Adverse Event|1|||
125264382|NCT04290624|450597741|FG001|Overall Study|Adverse Event|0|||
125264383|NCT00656370|450597746|FG000|Overall Study|Screen Failures|7|||
125264384|NCT00656370|450597746|FG000|Overall Study|Alternates|3|||
125264385|NCT01816984|450597747|FG000|Overall Study|declining health status|1|||
125264386|NCT01342094|450597750|FG000|Overall Study|Adverse Event|5|||
125264387|NCT01342094|450597751|FG001|Overall Study|Adverse Event|0|||
125264388|NCT01342094|450597750|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
125264389|NCT01342094|450597751|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
125264390|NCT01342094|450597750|FG000|Overall Study|Withdrawal by Subject|0|||
125264391|NCT01342094|450597751|FG001|Overall Study|Withdrawal by Subject|2|||
125264392|NCT02121509|450597752|FG000|Washout Period (35 Days)|Adverse Event|1|||
125264393|NCT02121509|450597753|FG001|Washout Period (35 Days)|Adverse Event|1|||
125264394|NCT02121509|450597754|FG002|Washout Period (35 Days)|Adverse Event|0|||
125264395|NCT02121509|450597755|FG003|Washout Period (35 Days)|Adverse Event|0|||
125264396|NCT02121509|450597752|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
125264397|NCT02121509|450597753|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
125264398|NCT02121509|450597754|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
125264399|NCT02121509|450597755|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
125264400|NCT02121509|450597752|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
125264401|NCT02121509|450597753|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
125264402|NCT02121509|450597754|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
125264403|NCT02121509|450597755|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
125447086|NCT01625338|451262683|FG002|Overall Study|Lost to Follow-up|2|||
125447087|NCT01625338|451262681|FG000|Overall Study|Investigator Decision|0|||
125447088|NCT01625338|451262682|FG001|Overall Study|Investigator Decision|2|||
125447089|NCT01625338|451262683|FG002|Overall Study|Investigator Decision|1|||
125447090|NCT01625338|451262681|FG000|Overall Study|Subject Withdrew Consent|1|||
125447091|NCT01625338|451262682|FG001|Overall Study|Subject Withdrew Consent|0|||
125447092|NCT01625338|451262683|FG002|Overall Study|Subject Withdrew Consent|2|||
125447093|NCT01625338|451262681|FG000|Overall Study|Adverse Event|1|||
125447094|NCT01625338|451262682|FG001|Overall Study|Adverse Event|0|||
125447095|NCT01625338|451262683|FG002|Overall Study|Adverse Event|1|||
125447096|NCT01625338|451262681|FG000|Overall Study|Study Discontinued by Sponsor|0|||
125447097|NCT01625338|451262682|FG001|Overall Study|Study Discontinued by Sponsor|0|||
125447098|NCT01625338|451262683|FG002|Overall Study|Study Discontinued by Sponsor|1|||
125447099|NCT02485353|451262684|FG000|Overall Study|Death|1|||
125447100|NCT02485353|451262684|FG000|Overall Study|Disease Progression|1|||
125447101|NCT01021332|451262685|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
125447102|NCT01021332|451262685|FG000|Overall Study|Adverse Event|43|||
125447103|NCT01021332|451262685|FG000|Overall Study|Lack of Efficacy|19|||
125447104|NCT01021332|451262685|FG000|Overall Study|Withdrawal of Consent|23|||
125447105|NCT01021332|451262685|FG000|Overall Study|Lost to Follow-up|4|||
125447106|NCT01021332|451262685|FG000|Overall Study|Protocol Violation|9|||
125447107|NCT01021332|451262685|FG000|Overall Study|Miscellaneous|3|||
125447108|NCT03487666|451262688|FG000|Overall Study|Disease progression|4|||
125447109|NCT03487666|451262689|FG001|Overall Study|Disease progression|2|||
125447110|NCT03487666|451262690|FG002|Overall Study|Disease progression|0|||
125447111|NCT03487666|451262688|FG000|Overall Study|Adverse Event|0|||
125447112|NCT03487666|451262689|FG001|Overall Study|Adverse Event|0|||
125447113|NCT03487666|451262690|FG002|Overall Study|Adverse Event|1|||
125447114|NCT05343455|451262693|FG000|Overall Study|Withdrawal by Subject|4|||
125447115|NCT05343455|451262694|FG001|Overall Study|Withdrawal by Subject|9|||
125447116|NCT05343455|451262695|FG002|Overall Study|Withdrawal by Subject|7|||
125447117|NCT05343455|451262693|FG000|Overall Study|Adverse Event|2|||
125447118|NCT05343455|451262694|FG001|Overall Study|Adverse Event|1|||
125447119|NCT05343455|451262695|FG002|Overall Study|Adverse Event|2|||
125447120|NCT05343455|451262693|FG000|Overall Study|Lost to Follow-up|1|||
125447121|NCT05343455|451262694|FG001|Overall Study|Lost to Follow-up|1|||
125447122|NCT05343455|451262695|FG002|Overall Study|Lost to Follow-up|3|||
125447123|NCT05343455|451262693|FG000|Overall Study|Pregnancy|1|||
125447124|NCT05343455|451262694|FG001|Overall Study|Pregnancy|0|||
125447125|NCT05343455|451262695|FG002|Overall Study|Pregnancy|0|||
125447126|NCT05343455|451262693|FG000|Overall Study|Physician Decision|0|||
125447127|NCT05343455|451262694|FG001|Overall Study|Physician Decision|0|||
125447128|NCT05343455|451262695|FG002|Overall Study|Physician Decision|1|||
125447129|NCT05343455|451262693|FG000|Overall Study|Protocol Violation|0|||
125447130|NCT05343455|451262694|FG001|Overall Study|Protocol Violation|1|||
125447131|NCT05343455|451262695|FG002|Overall Study|Protocol Violation|1|||
125447132|NCT02748512|451262700|FG000|Overall Study|Lost to Follow-up|1|||
125447133|NCT02748512|451262701|FG001|Overall Study|Lost to Follow-up|1|||
125447134|NCT00765362|451262703|FG000|Overall Study|Death|9|||
125264404|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
125264405|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
125264406|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
125264407|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
125264408|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
125264409|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
125264410|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
125264411|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
125264412|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
125264413|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
125264414|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
125264415|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
125264416|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
125264417|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
125264418|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
125447135|NCT00765362|451262703|FG000|Overall Study|Adverse Event|2|||
125447136|NCT00765362|451262703|FG000|Overall Study|Protocol Violation|18|||
125447137|NCT00765362|451262703|FG000|Overall Study|Withdrawal by Subject|13|||
125447138|NCT00765362|451262703|FG000|Overall Study|Lost to Follow-up|95|||
125447139|NCT03930186|451262704|FG000|Weeks 0 to 16|Adverse Event|6|||
125447140|NCT03930186|451262704|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
125447141|NCT03930186|451262704|FG000|Weeks 16 to 32|Adverse Event|1|||
125447142|NCT03930186|451262704|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
125447143|NCT00557505|451262707|FG000|Overall Study|Death|0|||
125447144|NCT00557505|451262708|FG001|Overall Study|Death|0|||
125447145|NCT00557505|451262709|FG002|Overall Study|Death|0|||
125447146|NCT00557505|451262710|FG003|Overall Study|Death|0|||
125447147|NCT00557505|451262711|FG004|Overall Study|Death|0|||
125447148|NCT00557505|451262712|FG005|Overall Study|Death|0|||
125264419|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
125264420|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
125264421|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
125264422|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
125264423|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
125264424|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
125264425|NCT04021290|450597762|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
125264426|NCT04021290|450597763|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
125264427|NCT04021290|450597764|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
125264428|NCT04021290|450597762|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
125264429|NCT04021290|450597763|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
125264430|NCT04021290|450597764|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
125264431|NCT04021290|450597762|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
125264432|NCT04021290|450597763|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
125264433|NCT04021290|450597764|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
125264434|NCT04021290|450597762|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
125264435|NCT04021290|450597763|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
125264436|NCT04021290|450597764|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
125264437|NCT04021290|450597762|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
125264438|NCT04021290|450597763|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
125264439|NCT04021290|450597764|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
125264440|NCT00636181|450597765|FG000|Overall Study|Withdrawal by Subject|8|||
125264441|NCT00636181|450597766|FG001|Overall Study|Withdrawal by Subject|6|||
125264442|NCT00636181|450597767|FG002|Overall Study|Withdrawal by Subject|10|||
125264443|NCT03069716|450597770|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
125264444|NCT03069716|450597771|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
125264445|NCT03069716|450597772|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
125264446|NCT03069716|450597770|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
125264447|NCT03069716|450597771|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
125264448|NCT03069716|450597772|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
125264449|NCT03069716|450597770|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
125264450|NCT03069716|450597771|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
125264451|NCT03069716|450597772|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
125264452|NCT03069716|450597770|FG000|Randomized Treatment|Withdrawal by Subject|0|||
125264453|NCT03069716|450597771|FG001|Randomized Treatment|Withdrawal by Subject|2|||
125264454|NCT03069716|450597772|FG002|Randomized Treatment|Withdrawal by Subject|0|||
125264455|NCT05076045|450597778|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
125264456|NCT05076045|450597779|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
125264457|NCT03391882|450597780|FG000|Study Overall|Adverse Event|3|||
125264458|NCT03391882|450597781|FG001|Study Overall|Adverse Event|6|||
125264459|NCT03391882|450597782|FG002|Study Overall|Adverse Event|1|||
125264460|NCT03391882|450597783|FG003|Study Overall|Adverse Event|1|||
125264461|NCT03391882|450597784|FG004|Study Overall|Adverse Event|3|||
125264462|NCT03391882|450597785|FG005|Study Overall|Adverse Event|1|||
125264463|NCT03391882|450597780|FG000|Study Overall|Lack of Efficacy|13|||
125264464|NCT03391882|450597781|FG001|Study Overall|Lack of Efficacy|9|||
125264465|NCT03391882|450597782|FG002|Study Overall|Lack of Efficacy|0|||
125264466|NCT03391882|450597783|FG003|Study Overall|Lack of Efficacy|0|||
125264467|NCT03391882|450597784|FG004|Study Overall|Lack of Efficacy|0|||
125264468|NCT03391882|450597785|FG005|Study Overall|Lack of Efficacy|0|||
125264469|NCT03391882|450597780|FG000|Study Overall|Withdrawal by Subject|3|||
125264470|NCT03391882|450597781|FG001|Study Overall|Withdrawal by Subject|3|||
125264471|NCT03391882|450597782|FG002|Study Overall|Withdrawal by Subject|2|||
125264472|NCT03391882|450597783|FG003|Study Overall|Withdrawal by Subject|2|||
125264473|NCT03391882|450597784|FG004|Study Overall|Withdrawal by Subject|1|||
125264474|NCT03391882|450597785|FG005|Study Overall|Withdrawal by Subject|3|||
125264475|NCT03391882|450597780|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
125264476|NCT03391882|450597781|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
125264477|NCT03391882|450597782|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
125264478|NCT03391882|450597783|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
125264479|NCT03391882|450597784|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
125264480|NCT03391882|450597785|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
125264481|NCT03391882|450597780|FG000|Study Overall|Protocol Violation|1|||
125264482|NCT03391882|450597781|FG001|Study Overall|Protocol Violation|0|||
125264483|NCT03391882|450597782|FG002|Study Overall|Protocol Violation|0|||
125264484|NCT03391882|450597783|FG003|Study Overall|Protocol Violation|0|||
125264485|NCT03391882|450597784|FG004|Study Overall|Protocol Violation|0|||
125264486|NCT03391882|450597785|FG005|Study Overall|Protocol Violation|0|||
125264487|NCT03391882|450597780|FG000|Part A - Titration Phase|Adverse Event|3|||
125264488|NCT03391882|450597781|FG001|Part A - Titration Phase|Adverse Event|6|||
125264489|NCT03391882|450597782|FG002|Part A - Titration Phase|Adverse Event|0|||
125264490|NCT03391882|450597783|FG003|Part A - Titration Phase|Adverse Event|0|||
125264491|NCT03391882|450597784|FG004|Part A - Titration Phase|Adverse Event|0|||
125264492|NCT03391882|450597785|FG005|Part A - Titration Phase|Adverse Event|0|||
125264493|NCT03391882|450597780|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
125264494|NCT03391882|450597781|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
125264495|NCT03391882|450597782|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
125264496|NCT03391882|450597783|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
125264497|NCT03391882|450597784|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
125264498|NCT03391882|450597785|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
125264499|NCT03391882|450597780|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
125264500|NCT03391882|450597781|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
125264501|NCT03391882|450597782|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
125264502|NCT03391882|450597783|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
125264503|NCT03391882|450597784|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
125264504|NCT03391882|450597785|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
125264505|NCT03391882|450597780|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
125264506|NCT03391882|450597781|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
125264507|NCT03391882|450597782|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
125264508|NCT03391882|450597783|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
125264509|NCT03391882|450597784|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
125264510|NCT03391882|450597785|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
125264511|NCT03391882|450597780|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
125264512|NCT03391882|450597781|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
125264513|NCT03391882|450597782|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
125264514|NCT03391882|450597783|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
125264515|NCT03391882|450597784|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
125264516|NCT03391882|450597785|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
125264517|NCT03391882|450597780|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
125264518|NCT03391882|450597781|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
125264519|NCT03391882|450597782|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
125264520|NCT03391882|450597783|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
125264521|NCT03391882|450597784|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
125264522|NCT03391882|450597785|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
125264523|NCT03391882|450597780|FG000|Part B - Treatment Phase|Adverse Event|0|||
125264524|NCT03391882|450597781|FG001|Part B - Treatment Phase|Adverse Event|0|||
125264525|NCT03391882|450597782|FG002|Part B - Treatment Phase|Adverse Event|1|||
125264526|NCT03391882|450597783|FG003|Part B - Treatment Phase|Adverse Event|1|||
125264527|NCT03391882|450597784|FG004|Part B - Treatment Phase|Adverse Event|3|||
125264528|NCT03391882|450597785|FG005|Part B - Treatment Phase|Adverse Event|1|||
125264529|NCT03391882|450597780|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
125264530|NCT03391882|450597781|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
125264531|NCT03391882|450597782|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
125264532|NCT03391882|450597783|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
125264533|NCT03391882|450597784|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
125264534|NCT03391882|450597785|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
125264535|NCT03913130|450597786|FG000|Overall Study|Sponsor Decision|1|||
125264536|NCT01085214|450597789|FG000|Overall Study|Alternate treatment required|1|||
125264537|NCT01634152|450597790|FG000|Overall Study|Adverse Event|2|||
125264538|NCT01634152|450597791|FG001|Overall Study|Adverse Event|0|||
125264539|NCT01634152|450597792|FG002|Overall Study|Adverse Event|2|||
125264540|NCT01634152|450597790|FG000|Overall Study|Consent withdrawn not due to AE|1|||
125264541|NCT01634152|450597791|FG001|Overall Study|Consent withdrawn not due to AE|0|||
125264542|NCT01634152|450597792|FG002|Overall Study|Consent withdrawn not due to AE|1|||
125264543|NCT01634152|450597790|FG000|Overall Study|Not treated|0|||
125264544|NCT01634152|450597791|FG001|Overall Study|Not treated|1|||
125264545|NCT01634152|450597792|FG002|Overall Study|Not treated|0|||
125264546|NCT01634152|450597790|FG000|Overall Study|Other reason not defined above|1|||
125264547|NCT01634152|450597791|FG001|Overall Study|Other reason not defined above|0|||
125264548|NCT01634152|450597792|FG002|Overall Study|Other reason not defined above|1|||
125264549|NCT01152437|450597809|FG000|Overall Study|Other Adverse Event|8|||
125264550|NCT01152437|450597810|FG001|Overall Study|Other Adverse Event|1|||
125264551|NCT01152437|450597811|FG002|Overall Study|Other Adverse Event|7|||
125264552|NCT01152437|450597809|FG000|Overall Study|Not treated|0|||
125264553|NCT01152437|450597810|FG001|Overall Study|Not treated|1|||
125264554|NCT01152437|450597811|FG002|Overall Study|Not treated|2|||
125264555|NCT01152437|450597809|FG000|Overall Study|Progressive disease|27|||
125447149|NCT00557505|451262713|FG006|Overall Study|Death|0|||
125264556|NCT01152437|450597810|FG001|Overall Study|Progressive disease|13|||
125264557|NCT01152437|450597811|FG002|Overall Study|Progressive disease|32|||
125264558|NCT01152437|450597809|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
125264559|NCT01152437|450597810|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
125264560|NCT01152437|450597811|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
125264561|NCT01985022|450597812|FG000|Overall Study|Lost to Follow-up|0|||
125264562|NCT01985022|450597813|FG001|Overall Study|Lost to Follow-up|1|||
125264563|NCT01985022|450597812|FG000|Overall Study|Protocol Violation|0|||
125264564|NCT01985022|450597813|FG001|Overall Study|Protocol Violation|1|||
125264565|NCT01985022|450597812|FG000|Overall Study|Withdrawal by Subject|4|||
125264566|NCT01985022|450597813|FG001|Overall Study|Withdrawal by Subject|1|||
125264567|NCT00279214|450597814|FG000|Overall Study|Physician Decision|3|||
125264568|NCT00279214|450597815|FG001|Overall Study|Physician Decision|2|||
125264569|NCT01214837|450597816|FG000|Overall Study|Death|0|||
125264570|NCT01214837|450597817|FG001|Overall Study|Death|0|||
125264571|NCT01214837|450597818|FG002|Overall Study|Death|1|||
125264572|NCT01214837|450597816|FG000|Overall Study|Adverse Event|1|||
125264573|NCT01214837|450597817|FG001|Overall Study|Adverse Event|2|||
125264574|NCT01214837|450597818|FG002|Overall Study|Adverse Event|1|||
125264575|NCT01214837|450597816|FG000|Overall Study|Withdrawal by Subject|27|||
125264576|NCT01214837|450597817|FG001|Overall Study|Withdrawal by Subject|36|||
125264577|NCT01214837|450597818|FG002|Overall Study|Withdrawal by Subject|28|||
125264578|NCT01214837|450597816|FG000|Overall Study|Lost to Follow-up|20|||
125264579|NCT01214837|450597817|FG001|Overall Study|Lost to Follow-up|15|||
125264580|NCT01214837|450597818|FG002|Overall Study|Lost to Follow-up|21|||
125264581|NCT01214837|450597816|FG000|Overall Study|Inappropriate Enrolment|0|||
125264582|NCT01214837|450597817|FG001|Overall Study|Inappropriate Enrolment|1|||
125264583|NCT01214837|450597818|FG002|Overall Study|Inappropriate Enrolment|2|||
125264584|NCT01214837|450597816|FG000|Overall Study|Administrative Reason|2|||
125264585|NCT01214837|450597817|FG001|Overall Study|Administrative Reason|6|||
125264586|NCT01214837|450597818|FG002|Overall Study|Administrative Reason|4|||
125264587|NCT01214837|450597816|FG000|Overall Study|Protocol Violation|3|||
125264588|NCT01214837|450597817|FG001|Overall Study|Protocol Violation|1|||
125264589|NCT01214837|450597818|FG002|Overall Study|Protocol Violation|5|||
125264590|NCT01214837|450597816|FG000|Overall Study|Unable to Classify|1|||
125264591|NCT01214837|450597817|FG001|Overall Study|Unable to Classify|3|||
125264592|NCT01214837|450597818|FG002|Overall Study|Unable to Classify|0|||
125264593|NCT00457626|450597819|FG000|Overall Study|Adverse Event|3|||
125264594|NCT00457626|450597819|FG000|Overall Study|Administrative Problems|2|||
125264595|NCT00457626|450597819|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
125264596|NCT03549338|450599887|FG000|Overall Study|Progressive Disease|1|||
125264597|NCT03549338|450599888|FG001|Overall Study|Progressive Disease|0|||
125264598|NCT03549338|450599889|FG002|Overall Study|Progressive Disease|0|||
125264599|NCT03549338|450599887|FG000|Overall Study|Clinical Progression|0|||
125264600|NCT03549338|450599888|FG001|Overall Study|Clinical Progression|1|||
125264601|NCT03549338|450599889|FG002|Overall Study|Clinical Progression|0|||
125264602|NCT00269113|450599890|FG000|Overall Study|Adverse Event|14|||
125264603|NCT00269113|450599891|FG001|Overall Study|Adverse Event|7|||
125264604|NCT00269113|450599890|FG000|Overall Study|Lack of Efficacy|35|||
125264605|NCT00269113|450599891|FG001|Overall Study|Lack of Efficacy|18|||
125264606|NCT00269113|450599890|FG000|Overall Study|Early Improvement|2|||
125264607|NCT00269113|450599891|FG001|Overall Study|Early Improvement|0|||
125264608|NCT00269113|450599890|FG000|Overall Study|Withdrawal by Subject|0|||
125264609|NCT00269113|450599891|FG001|Overall Study|Withdrawal by Subject|2|||
125264610|NCT00269113|450599890|FG000|Overall Study|Death|6|||
125264611|NCT00269113|450599891|FG001|Overall Study|Death|2|||
125264612|NCT00269113|450599890|FG000|Overall Study|Lost to Follow-up|2|||
125264613|NCT00269113|450599891|FG001|Overall Study|Lost to Follow-up|1|||
125264614|NCT00269113|450599890|FG000|Overall Study|Protocol Violation|15|||
125264615|NCT00269113|450599891|FG001|Overall Study|Protocol Violation|5|||
125398640|NCT03364049|451093172|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
125398641|NCT03364049|451093169|FG000|Overall Study|Withdrawal by Subject|0|||
125398642|NCT03364049|451093170|FG001|Overall Study|Withdrawal by Subject|1|||
125398643|NCT03364049|451093171|FG002|Overall Study|Withdrawal by Subject|1|||
125398644|NCT03364049|451093172|FG003|Overall Study|Withdrawal by Subject|1|||
125398645|NCT02953821|451093173|FG000|Overall Study|Adverse Event|0|||
125398646|NCT02953821|451093174|FG001|Overall Study|Adverse Event|4|||
125398647|NCT02953821|451093173|FG000|Overall Study|Death|1|||
125264616|NCT00269113|450599890|FG000|Overall Study|Other|0|||
125264617|NCT00269113|450599891|FG001|Overall Study|Other|2|||
125264618|NCT00652743|450599892|FG000|Months 12-18|Lost to Follow-up|1|||
125398648|NCT02953821|451093174|FG001|Overall Study|Death|0|||
125264619|NCT00652743|450599893|FG001|Months 12-18|Lost to Follow-up|2|||
125264620|NCT00652743|450599894|FG002|Months 12-18|Lost to Follow-up|7|||
125264621|NCT00652743|450599892|FG000|Months 24-30|Other|5|||
125264622|NCT00652743|450599893|FG001|Months 24-30|Other|1|||
125264623|NCT00652743|450599894|FG002|Months 24-30|Other|11|||
125264624|NCT00652743|450599892|FG000|Months 36-42|Serious Adverse Events|0|||
125264625|NCT00652743|450599893|FG001|Months 36-42|Serious Adverse Events|1|||
125264626|NCT00652743|450599894|FG002|Months 36-42|Serious Adverse Events|1|||
125264627|NCT00652743|450599892|FG000|Months 36-42|Withdrawal by Subject|1|||
125264628|NCT00652743|450599893|FG001|Months 36-42|Withdrawal by Subject|1|||
125264629|NCT00652743|450599894|FG002|Months 36-42|Withdrawal by Subject|0|||
125264630|NCT00652743|450599892|FG000|Months 36-42|Lost to Follow-up|0|||
125264631|NCT00652743|450599893|FG001|Months 36-42|Lost to Follow-up|1|||
125398649|NCT02953821|451093173|FG000|Overall Study|Progressive Disease|5|||
125264632|NCT00652743|450599894|FG002|Months 36-42|Lost to Follow-up|0|||
125264633|NCT00652743|450599892|FG000|Months 36-42|Migrated/moved from study area|1|||
125264634|NCT00652743|450599893|FG001|Months 36-42|Migrated/moved from study area|0|||
125264635|NCT00652743|450599894|FG002|Months 36-42|Migrated/moved from study area|0|||
125264636|NCT00652743|450599892|FG000|Months 36-42|Other|4|||
125264637|NCT00652743|450599893|FG001|Months 36-42|Other|2|||
125264638|NCT00652743|450599894|FG002|Months 36-42|Other|8|||
125264639|NCT00755807|450599897|FG000|Acute Phase|Adverse Event|16|||
125264640|NCT00755807|450599898|FG001|Acute Phase|Adverse Event|5|||
125264641|NCT00755807|450599897|FG000|Acute Phase|Protocol Violation|1|||
125264642|NCT00755807|450599898|FG001|Acute Phase|Protocol Violation|3|||
125264643|NCT00755807|450599897|FG000|Acute Phase|Withdrawal by Subject|1|||
125264644|NCT00755807|450599898|FG001|Acute Phase|Withdrawal by Subject|2|||
125264645|NCT00755807|450599897|FG000|Acute Phase|Lack of Efficacy|0|||
125264646|NCT00755807|450599898|FG001|Acute Phase|Lack of Efficacy|1|||
125264647|NCT00755807|450599897|FG000|Acute Phase|Physician Decision|0|||
125264648|NCT00755807|450599898|FG001|Acute Phase|Physician Decision|1|||
125264649|NCT00755807|450599897|FG000|Open-label Extension Phase|Adverse Event|7|||
125264650|NCT00755807|450599898|FG001|Open-label Extension Phase|Adverse Event|7|||
125264651|NCT00755807|450599897|FG000|Open-label Extension Phase|Protocol Violation|5|||
125264652|NCT00755807|450599898|FG001|Open-label Extension Phase|Protocol Violation|2|||
125264653|NCT00755807|450599897|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
125264654|NCT00755807|450599898|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
125264655|NCT00755807|450599897|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
125264656|NCT00755807|450599898|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
125264657|NCT00755807|450599897|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
125264658|NCT00755807|450599898|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
125264659|NCT00755807|450599897|FG000|Open-label Extension Phase|Sponsor Decision|0|||
125264660|NCT00755807|450599898|FG001|Open-label Extension Phase|Sponsor Decision|1|||
125264661|NCT05111145|450599903|FG000|Overall Study|Commercial drug is available for participant|76|||
125264662|NCT05111145|450599903|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
125264663|NCT02336815|450599904|FG000|Overall Study|Disease Progression|45|||
125264664|NCT02336815|450599905|FG001|Overall Study|Disease Progression|70|||
125264665|NCT02336815|450599904|FG000|Overall Study|Adverse Event|18|||
125264666|NCT02336815|450599905|FG001|Overall Study|Adverse Event|39|||
125264667|NCT02336815|450599904|FG000|Overall Study|Physician Decision|11|||
125264668|NCT02336815|450599905|FG001|Overall Study|Physician Decision|4|||
125264669|NCT02336815|450599904|FG000|Overall Study|Withdrawal by Subject|3|||
125264670|NCT02336815|450599905|FG001|Overall Study|Withdrawal by Subject|2|||
125264671|NCT02336815|450599904|FG000|Overall Study|Lost to Follow-up|1|||
125264672|NCT02336815|450599905|FG001|Overall Study|Lost to Follow-up|3|||
125264673|NCT02336815|450599904|FG000|Overall Study|Other|1|||
125264674|NCT02336815|450599905|FG001|Overall Study|Other|5|||
125264675|NCT00952705|450599906|FG000|Overall Study|Lost to Follow-up|24|||
125264676|NCT00952705|450599907|FG001|Overall Study|Lost to Follow-up|8|||
125264677|NCT00952705|450599908|FG002|Overall Study|Lost to Follow-up|9|||
125264678|NCT00952705|450599906|FG000|Overall Study|Withdrawal by Subject|2|||
125264679|NCT00952705|450599907|FG001|Overall Study|Withdrawal by Subject|1|||
125264680|NCT00952705|450599908|FG002|Overall Study|Withdrawal by Subject|1|||
125264681|NCT00952705|450599906|FG000|Overall Study|Death|2|||
125264682|NCT00952705|450599907|FG001|Overall Study|Death|0|||
125264683|NCT00952705|450599908|FG002|Overall Study|Death|0|||
125264684|NCT00952705|450599906|FG000|Overall Study|Incarcerated post dose|5|||
125264685|NCT00952705|450599907|FG001|Overall Study|Incarcerated post dose|0|||
125264686|NCT00952705|450599908|FG002|Overall Study|Incarcerated post dose|0|||
125264687|NCT00952705|450599906|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
125264688|NCT00952705|450599907|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
125264689|NCT00952705|450599908|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
125264690|NCT03759600|450599910|FG000|Overall Study|Adverse Event|2|||
125264691|NCT03759600|450599910|FG000|Overall Study|Progressive Disease|15|||
125264692|NCT03759600|450599910|FG000|Overall Study|Site Terminated by Sponsor|3|||
125264693|NCT05173974|450599911|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
125264694|NCT05173974|450599912|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
125264695|NCT05173974|450599913|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
125264696|NCT05173974|450599914|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
125264697|NCT05173974|450599911|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
125264698|NCT05173974|450599912|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
125447150|NCT00557505|451262714|FG007|Overall Study|Death|0|||
125264699|NCT05173974|450599913|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
125264700|NCT05173974|450599914|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
125264701|NCT03289143|450599916|FG000|Overall Study|Caregiver Unavailability|1|||
125264702|NCT03289143|450599917|FG001|Overall Study|Caregiver Unavailability|1|||
125264703|NCT03289143|450599918|FG002|Overall Study|Caregiver Unavailability|0|||
125264704|NCT03289143|450599919|FG003|Overall Study|Caregiver Unavailability|0|||
125264705|NCT03289143|450599916|FG000|Overall Study|Research Department Closure|0|||
125447151|NCT00557505|451262715|FG008|Overall Study|Death|1|||
125264706|NCT03289143|450599917|FG001|Overall Study|Research Department Closure|0|||
125264707|NCT03289143|450599918|FG002|Overall Study|Research Department Closure|1|||
125264708|NCT03289143|450599919|FG003|Overall Study|Research Department Closure|0|||
125264709|NCT03289143|450599916|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
125264710|NCT03289143|450599917|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
125264711|NCT03289143|450599918|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
125264712|NCT03289143|450599919|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
125264713|NCT03289143|450599916|FG000|Overall Study|Medical Monitor Decision|1|||
125264714|NCT03289143|450599917|FG001|Overall Study|Medical Monitor Decision|0|||
125264715|NCT03289143|450599918|FG002|Overall Study|Medical Monitor Decision|0|||
125264716|NCT03289143|450599919|FG003|Overall Study|Medical Monitor Decision|0|||
125264717|NCT03289143|450599916|FG000|Overall Study|Participant Non-Compliance|0|||
125264718|NCT03289143|450599917|FG001|Overall Study|Participant Non-Compliance|0|||
125264719|NCT03289143|450599918|FG002|Overall Study|Participant Non-Compliance|1|||
125264720|NCT03289143|450599919|FG003|Overall Study|Participant Non-Compliance|0|||
125264721|NCT03289143|450599916|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
125264722|NCT03289143|450599917|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
125264723|NCT03289143|450599918|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
125264724|NCT03289143|450599919|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
125264725|NCT03289143|450599916|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
125264726|NCT03289143|450599917|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
125264727|NCT03289143|450599918|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
125264728|NCT03289143|450599919|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
125264729|NCT03289143|450599916|FG000|Overall Study|Caregiver Passed Away|1|||
125264730|NCT03289143|450599917|FG001|Overall Study|Caregiver Passed Away|0|||
125264731|NCT03289143|450599918|FG002|Overall Study|Caregiver Passed Away|0|||
125264732|NCT03289143|450599919|FG003|Overall Study|Caregiver Passed Away|0|||
125264733|NCT03289143|450599916|FG000|Overall Study|Physician Decision|0|||
125264734|NCT03289143|450599917|FG001|Overall Study|Physician Decision|2|||
125264735|NCT03289143|450599918|FG002|Overall Study|Physician Decision|2|||
125264736|NCT03289143|450599919|FG003|Overall Study|Physician Decision|2|||
125264737|NCT03289143|450599916|FG000|Overall Study|Protocol Deviation|2|||
125264738|NCT03289143|450599917|FG001|Overall Study|Protocol Deviation|1|||
125264739|NCT03289143|450599918|FG002|Overall Study|Protocol Deviation|3|||
125264740|NCT03289143|450599919|FG003|Overall Study|Protocol Deviation|1|||
125264741|NCT03289143|450599916|FG000|Overall Study|Study Terminated By Sponsor|101|||
125264742|NCT03289143|450599917|FG001|Overall Study|Study Terminated By Sponsor|75|||
125264743|NCT03289143|450599918|FG002|Overall Study|Study Terminated By Sponsor|100|||
125264744|NCT03289143|450599919|FG003|Overall Study|Study Terminated By Sponsor|69|||
125264745|NCT03289143|450599916|FG000|Overall Study|Withdrawal by Subject|14|||
125264746|NCT03289143|450599917|FG001|Overall Study|Withdrawal by Subject|6|||
125264747|NCT03289143|450599918|FG002|Overall Study|Withdrawal by Subject|14|||
125264748|NCT03289143|450599919|FG003|Overall Study|Withdrawal by Subject|12|||
125264749|NCT03289143|450599916|FG000|Overall Study|Adverse Event|10|||
125264750|NCT03289143|450599917|FG001|Overall Study|Adverse Event|7|||
125398650|NCT02953821|451093174|FG001|Overall Study|Progressive Disease|1|||
125398651|NCT02953821|451093173|FG000|Overall Study|Lost to Follow-up|2|||
125398652|NCT02953821|451093174|FG001|Overall Study|Lost to Follow-up|0|||
125264751|NCT03289143|450599918|FG002|Overall Study|Adverse Event|6|||
125264752|NCT03289143|450599919|FG003|Overall Study|Adverse Event|5|||
125264753|NCT03289143|450599916|FG000|Overall Study|Death|2|||
125264754|NCT03289143|450599917|FG001|Overall Study|Death|0|||
125264755|NCT03289143|450599918|FG002|Overall Study|Death|2|||
125264756|NCT03289143|450599919|FG003|Overall Study|Death|1|||
125264757|NCT03289143|450599916|FG000|Overall Study|Lost to Follow-up|2|||
125264758|NCT03289143|450599917|FG001|Overall Study|Lost to Follow-up|1|||
125264759|NCT03289143|450599918|FG002|Overall Study|Lost to Follow-up|1|||
125264760|NCT03289143|450599919|FG003|Overall Study|Lost to Follow-up|0|||
125264761|NCT03289143|450599916|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
125264762|NCT03289143|450599917|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
125264763|NCT03289143|450599918|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
125264764|NCT03289143|450599919|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
125264765|NCT03289143|450599916|FG000|Overall Study|Withdrawal by Caregiver|0|||
125264766|NCT03289143|450599917|FG001|Overall Study|Withdrawal by Caregiver|1|||
125264767|NCT03289143|450599918|FG002|Overall Study|Withdrawal by Caregiver|0|||
125264768|NCT03289143|450599919|FG003|Overall Study|Withdrawal by Caregiver|0|||
125264769|NCT03289143|450599916|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
125264770|NCT03289143|450599917|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
125264771|NCT03289143|450599918|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
125264772|NCT03289143|450599919|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
125264773|NCT03289143|450599916|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
125264774|NCT03289143|450599917|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
125398653|NCT02953821|451093173|FG000|Overall Study|Physician Decision|1|||
125264775|NCT03289143|450599918|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
125264776|NCT03289143|450599919|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
125264777|NCT03257358|450599920|FG000|Overall Study|Adverse Event|25|||
125264778|NCT03257358|450599921|FG001|Overall Study|Adverse Event|12|||
125264779|NCT03257358|450599920|FG000|Overall Study|Lack of Efficacy|1|||
125264780|NCT03257358|450599921|FG001|Overall Study|Lack of Efficacy|1|||
125264781|NCT03257358|450599920|FG000|Overall Study|Lost to Follow-up|12|||
125264782|NCT03257358|450599921|FG001|Overall Study|Lost to Follow-up|4|||
125264783|NCT03257358|450599920|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
125264784|NCT03257358|450599921|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
125264785|NCT03257358|450599920|FG000|Overall Study|Physician Decision|2|||
125264786|NCT03257358|450599921|FG001|Overall Study|Physician Decision|2|||
125264787|NCT03257358|450599920|FG000|Overall Study|Protocol Violation|5|||
125264788|NCT03257358|450599921|FG001|Overall Study|Protocol Violation|3|||
125264789|NCT03257358|450599920|FG000|Overall Study|Technical problems|4|||
125264790|NCT03257358|450599921|FG001|Overall Study|Technical problems|1|||
125264791|NCT03257358|450599920|FG000|Overall Study|Withdrawal by Subject|8|||
125264792|NCT03257358|450599921|FG001|Overall Study|Withdrawal by Subject|3|||
125264793|NCT03257358|450599920|FG000|Overall Study|Withdrawal of informed consent|9|||
125264794|NCT03257358|450599921|FG001|Overall Study|Withdrawal of informed consent|5|||
125264795|NCT03257358|450599920|FG000|Overall Study|New therapy for study indication|1|||
125264796|NCT03257358|450599921|FG001|Overall Study|New therapy for study indication|0|||
125264797|NCT03257358|450599920|FG000|Overall Study|No longer requires treatment|0|||
125264798|NCT03257358|450599921|FG001|Overall Study|No longer requires treatment|1|||
125264799|NCT00730756|450599922|FG000|Overall Study|Adverse Event|2|||
125264800|NCT00730756|450599923|FG001|Overall Study|Adverse Event|0|||
125264801|NCT00730756|450599922|FG000|Overall Study|Lack of Efficacy|1|||
125264802|NCT00730756|450599923|FG001|Overall Study|Lack of Efficacy|1|||
125264803|NCT00730756|450599922|FG000|Overall Study|Protocol Deviation|1|||
125264804|NCT00730756|450599923|FG001|Overall Study|Protocol Deviation|2|||
125264805|NCT00730756|450599922|FG000|Overall Study|Lost to Follow-up|0|||
125264806|NCT00730756|450599923|FG001|Overall Study|Lost to Follow-up|1|||
125264807|NCT00730756|450599922|FG000|Overall Study|Withdrew Consent|0|||
125264808|NCT00730756|450599923|FG001|Overall Study|Withdrew Consent|1|||
125264809|NCT00305877|450599924|FG000|Overall Study|Lack of Efficacy|6|||
125264810|NCT00305877|450599925|FG001|Overall Study|Lack of Efficacy|9|||
125264811|NCT00305877|450599924|FG000|Overall Study|Adverse Event|9|||
125264812|NCT00305877|450599925|FG001|Overall Study|Adverse Event|14|||
125264813|NCT00305877|450599924|FG000|Overall Study|Death|0|||
125264814|NCT00305877|450599925|FG001|Overall Study|Death|1|||
125264815|NCT00305877|450599924|FG000|Overall Study|Withdrawal by Subject|4|||
125264816|NCT00305877|450599925|FG001|Overall Study|Withdrawal by Subject|2|||
125264817|NCT00305877|450599924|FG000|Overall Study|Physician Decision|1|||
125264818|NCT00305877|450599925|FG001|Overall Study|Physician Decision|1|||
125264819|NCT00305877|450599924|FG000|Overall Study|Never start treatment|2|||
125264820|NCT00305877|450599925|FG001|Overall Study|Never start treatment|5|||
125264821|NCT00305877|450599924|FG000|Overall Study|Ineligible|2|||
125264822|NCT00305877|450599925|FG001|Overall Study|Ineligible|1|||
125264823|NCT00305877|450599924|FG000|Overall Study|Transportation issue with daily RT|0|||
125264824|NCT00305877|450599925|FG001|Overall Study|Transportation issue with daily RT|1|||
125264825|NCT01126190|450599928|FG000|Double-Blind Phase|Death|0|||
125264826|NCT01126190|450599929|FG001|Double-Blind Phase|Death|1|||
125264827|NCT01126190|450599930|FG002|Double-Blind Phase|Death|0|||
125264828|NCT01126190|450599928|FG000|Double-Blind Phase|Adverse Event|1|||
125264829|NCT01126190|450599929|FG001|Double-Blind Phase|Adverse Event|2|||
125264830|NCT01126190|450599930|FG002|Double-Blind Phase|Adverse Event|0|||
125264831|NCT01126190|450599928|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
125264832|NCT01126190|450599929|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
125264833|NCT01126190|450599930|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125264834|NCT01126190|450599928|FG000|Double-Blind Phase|Request of Investigator|1|||
125264835|NCT01126190|450599929|FG001|Double-Blind Phase|Request of Investigator|0|||
125264836|NCT01126190|450599930|FG002|Double-Blind Phase|Request of Investigator|0|||
125264837|NCT01126190|450599928|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
125264838|NCT01126190|450599929|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
125264839|NCT01126190|450599930|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
125264840|NCT01126190|450599928|FG000|Double-Blind Phase|Non-compliance|1|||
125264841|NCT01126190|450599929|FG001|Double-Blind Phase|Non-compliance|0|||
125264842|NCT01126190|450599930|FG002|Double-Blind Phase|Non-compliance|0|||
125264843|NCT01126190|450599928|FG000|Double-Blind Phase|Lost to Follow-up|1|||
125264844|NCT01126190|450599929|FG001|Double-Blind Phase|Lost to Follow-up|3|||
125264845|NCT01126190|450599930|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125264846|NCT01126190|450599928|FG000|Open-Label Phase|Death|0|||
125264847|NCT01126190|450599929|FG001|Open-Label Phase|Death|0|||
125264848|NCT01126190|450599930|FG002|Open-Label Phase|Death|1|||
125264849|NCT01126190|450599928|FG000|Open-Label Phase|Adverse Event|0|||
125264850|NCT01126190|450599929|FG001|Open-Label Phase|Adverse Event|0|||
125264851|NCT01126190|450599930|FG002|Open-Label Phase|Adverse Event|4|||
125447152|NCT00557505|451262707|FG000|Overall Study|Adverse Event|0|||
125447153|NCT00557505|451262708|FG001|Overall Study|Adverse Event|0|||
125264852|NCT01126190|450599928|FG000|Open-Label Phase|Withdrawal by Subject|0|||
125264853|NCT01126190|450599929|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125264854|NCT01126190|450599930|FG002|Open-Label Phase|Withdrawal by Subject|6|||
125264855|NCT00524121|450599931|FG000|Overall Study|Disease progression|6|||
125264856|NCT00524121|450599931|FG000|Overall Study|Adverse Event|4|||
125264857|NCT00524121|450599931|FG000|Overall Study|Patient refused|2|||
125264858|NCT00524121|450599931|FG000|Overall Study|Other|1|||
125264859|NCT00524121|450599931|FG000|Overall Study|Death|1|||
125264860|NCT00524121|450599931|FG000|Overall Study|Not treated (became ineligible)|4|||
125264861|NCT00524121|450599931|FG000|Overall Study|Not treated (changed mind)|1|||
125264862|NCT01114737|450599932|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
125264863|NCT01114737|450599933|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
125264864|NCT01114737|450599932|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
125264865|NCT01114737|450599933|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
125264866|NCT01114737|450599932|FG000|Randomized Treatment Period|Pregnancy|1|||
125264867|NCT01114737|450599933|FG001|Randomized Treatment Period|Pregnancy|0|||
125264868|NCT01114737|450599932|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
125264869|NCT01114737|450599933|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
125264870|NCT01114737|450599932|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
125264871|NCT01114737|450599933|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
125264872|NCT01114737|450599932|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
125264873|NCT01114737|450599933|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
125264874|NCT01446874|450599934|FG000|Overall Study|Not eligible|1|||
125264875|NCT01446874|450599935|FG001|Overall Study|Not eligible|0|||
125264876|NCT01446874|450599936|FG002|Overall Study|Not eligible|0|||
125264877|NCT01446874|450599934|FG000|Overall Study|No surgery/No qualifying surgery|1|||
125264878|NCT01446874|450599935|FG001|Overall Study|No surgery/No qualifying surgery|0|||
125264879|NCT01446874|450599936|FG002|Overall Study|No surgery/No qualifying surgery|12|||
125264880|NCT01446874|450599934|FG000|Overall Study|Non-compliance|0|||
125264881|NCT01446874|450599935|FG001|Overall Study|Non-compliance|4|||
125264882|NCT01446874|450599936|FG002|Overall Study|Non-compliance|0|||
125264883|NCT01446874|450599934|FG000|Overall Study|Antibiotics for pre-op infection|0|||
125264884|NCT01446874|450599935|FG001|Overall Study|Antibiotics for pre-op infection|0|||
125264885|NCT01446874|450599936|FG002|Overall Study|Antibiotics for pre-op infection|2|||
125264886|NCT01446874|450599934|FG000|Overall Study|Withdrawal by Subject|0|||
125264887|NCT01446874|450599935|FG001|Overall Study|Withdrawal by Subject|0|||
125264888|NCT01446874|450599936|FG002|Overall Study|Withdrawal by Subject|4|||
125264889|NCT00457392|450599937|FG000|Overall Study|Objective Progression or Relapse|229|||
125264890|NCT00457392|450599938|FG001|Overall Study|Objective Progression or Relapse|296|||
125264891|NCT00457392|450599937|FG000|Overall Study|Death|106|||
125264892|NCT00457392|450599938|FG001|Overall Study|Death|106|||
125264893|NCT00457392|450599937|FG000|Overall Study|Adverse Event|84|||
125264894|NCT00457392|450599938|FG001|Overall Study|Adverse Event|41|||
125264895|NCT00457392|450599937|FG000|Overall Study|Global Deterioration of Health Status|22|||
125264896|NCT00457392|450599938|FG001|Overall Study|Global Deterioration of Health Status|8|||
125264897|NCT00457392|450599937|FG000|Overall Study|Withdrawal by Subject|14|||
125264898|NCT00457392|450599938|FG001|Overall Study|Withdrawal by Subject|8|||
125264899|NCT00457392|450599937|FG000|Overall Study|Lost to Follow-up|6|||
125264900|NCT00457392|450599938|FG001|Overall Study|Lost to Follow-up|7|||
125264901|NCT00457392|450599937|FG000|Overall Study|Protocol Violation|4|||
125264902|NCT00457392|450599938|FG001|Overall Study|Protocol Violation|3|||
125264903|NCT00457392|450599937|FG000|Overall Study|Other|7|||
125264904|NCT00457392|450599938|FG001|Overall Study|Other|4|||
125264905|NCT00457392|450599937|FG000|Overall Study|Study Terminated by Sponsor|1|||
125264906|NCT00457392|450599938|FG001|Overall Study|Study Terminated by Sponsor|4|||
125264907|NCT00457392|450599937|FG000|Overall Study|Randomized, Not Treated|7|||
125264908|NCT00457392|450599938|FG001|Overall Study|Randomized, Not Treated|3|||
125264909|NCT01135992|450599939|FG000|Overall Study|Adverse Event|1|||
125264910|NCT01135992|450599939|FG000|Overall Study|Lack of Efficacy|1|||
125264911|NCT01135992|450599939|FG000|Overall Study|Protocol Violation|2|||
125264912|NCT01135992|450599939|FG000|Overall Study|Withdrawal criteria|10|||
125264913|NCT01135992|450599939|FG000|Overall Study|Unclassified|7|||
125264914|NCT01977898|450599940|FG000|Overall Study|Non functioning catheter|1|||
125264915|NCT01977898|450599941|FG001|Overall Study|Non functioning catheter|1|||
125264916|NCT01466491|450599943|FG000|Overall Study|Protocol Violation|0|||
125264917|NCT01466491|450599944|FG001|Overall Study|Protocol Violation|3|||
125264918|NCT01466491|450599945|FG002|Overall Study|Protocol Violation|2|||
125264919|NCT01466491|450599946|FG003|Overall Study|Protocol Violation|0|||
125264920|NCT01466491|450599943|FG000|Overall Study|Missing Data|0|||
125264921|NCT01466491|450599944|FG001|Overall Study|Missing Data|0|||
125264922|NCT01466491|450599945|FG002|Overall Study|Missing Data|1|||
125264923|NCT01466491|450599946|FG003|Overall Study|Missing Data|0|||
125264924|NCT02727322|450599947|FG000|Overall Study|Withdrawal by Subject|1|||
125264925|NCT02727322|450599948|FG001|Overall Study|Withdrawal by Subject|1|||
125264926|NCT02727322|450599947|FG000|Overall Study|Protocol Violation|1|||
125264927|NCT02727322|450599948|FG001|Overall Study|Protocol Violation|0|||
125264928|NCT01123148|450599955|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
125264929|NCT01123148|450599955|FG000|Overall Study|Didn't meet milestone criteria|1|||
125264930|NCT00355030|450599956|FG000|Study Period 1 Treatment|Adverse Event|1|||
125264931|NCT00355030|450599957|FG001|Study Period 1 Treatment|Adverse Event|1|||
125264932|NCT00355030|450599956|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
125264933|NCT00355030|450599957|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
125264934|NCT00355030|450599956|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
125264935|NCT00355030|450599957|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
125264936|NCT00355030|450599956|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
125264937|NCT00355030|450599957|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
125447154|NCT00557505|451262709|FG002|Overall Study|Adverse Event|1|||
125264938|NCT00355030|450599956|FG000|Study Period 1 Treatment|Physician Decision|0|||
125264939|NCT00355030|450599957|FG001|Study Period 1 Treatment|Physician Decision|1|||
125264940|NCT00355030|450599956|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
125264941|NCT00355030|450599957|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
125264942|NCT00355030|450599956|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
125264943|NCT00355030|450599957|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
125264944|NCT00355030|450599956|FG000|Study Period 1 Treatment|Other|2|||
125264945|NCT00355030|450599957|FG001|Study Period 1 Treatment|Other|6|||
125264946|NCT00355030|450599956|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
125264947|NCT00355030|450599957|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
125264948|NCT00355030|450599956|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
125264949|NCT00355030|450599957|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
125264950|NCT01049373|450599958|FG000|Overall Study|Protocol Violation|9|||
125264951|NCT01049373|450599959|FG001|Overall Study|Protocol Violation|9|||
125264952|NCT01049373|450599958|FG000|Overall Study|Withdrawal by Subject|8|||
125264953|NCT01049373|450599959|FG001|Overall Study|Withdrawal by Subject|5|||
125264954|NCT01049373|450599958|FG000|Overall Study|Adverse Event|3|||
125264955|NCT01049373|450599959|FG001|Overall Study|Adverse Event|3|||
125264956|NCT01049373|450599958|FG000|Overall Study|Lost to Follow-up|9|||
125264957|NCT01049373|450599959|FG001|Overall Study|Lost to Follow-up|4|||
125264958|NCT01049373|450599958|FG000|Overall Study|no evaluable study values|9|||
125264959|NCT01049373|450599959|FG001|Overall Study|no evaluable study values|21|||
125264960|NCT01049373|450599958|FG000|Overall Study|Other|1|||
125264961|NCT01049373|450599959|FG001|Overall Study|Other|1|||
125264962|NCT01049373|450599958|FG000|Overall Study|Non-cooperation|0|||
125264963|NCT01049373|450599959|FG001|Overall Study|Non-cooperation|1|||
125264964|NCT00339040|450599960|FG000|Stage I|Not able to attend clinic|1|||
125264965|NCT00339040|450599961|FG001|Stage I|Not able to attend clinic|0|||
125264966|NCT00339040|450599960|FG000|Stage I|Protocol Violation|1|||
125264967|NCT00339040|450599961|FG001|Stage I|Protocol Violation|1|||
125264968|NCT00339040|450599960|FG000|Stage II|Lost to Follow-up|3|||
125264969|NCT00339040|450599961|FG001|Stage II|Lost to Follow-up|0|||
125264970|NCT00339040|450599960|FG000|Stage II|Withdrawal by Subject|1|||
125264971|NCT00339040|450599961|FG001|Stage II|Withdrawal by Subject|2|||
125264972|NCT00339040|450599960|FG000|Stage II|Protocol Violation|3|||
125264973|NCT00339040|450599961|FG001|Stage II|Protocol Violation|0|||
125264974|NCT00339040|450599960|FG000|Stage II|Not able to attend clinic|1|||
125264975|NCT00339040|450599961|FG001|Stage II|Not able to attend clinic|0|||
125264976|NCT00339040|450599960|FG000|Stage II|Site closing|2|||
125264977|NCT00339040|450599961|FG001|Stage II|Site closing|0|||
125264978|NCT00812955|450599966|FG000|Overall Study|Adverse Event|7|||
125264979|NCT00812955|450599967|FG001|Overall Study|Adverse Event|6|||
125264980|NCT00812955|450599968|FG002|Overall Study|Adverse Event|3|||
125264981|NCT00812955|450599969|FG003|Overall Study|Adverse Event|4|||
125264982|NCT00812955|450599966|FG000|Overall Study|Lost to Follow-up|2|||
125264983|NCT00812955|450599967|FG001|Overall Study|Lost to Follow-up|1|||
125264984|NCT00812955|450599968|FG002|Overall Study|Lost to Follow-up|1|||
125264985|NCT00812955|450599969|FG003|Overall Study|Lost to Follow-up|2|||
125264986|NCT00812955|450599966|FG000|Overall Study|Withdrawal by Subject|1|||
125264987|NCT00812955|450599967|FG001|Overall Study|Withdrawal by Subject|0|||
125264988|NCT00812955|450599968|FG002|Overall Study|Withdrawal by Subject|1|||
125264989|NCT00812955|450599969|FG003|Overall Study|Withdrawal by Subject|2|||
125264990|NCT00812955|450599966|FG000|Overall Study|randomized in error|0|||
125264991|NCT00812955|450599967|FG001|Overall Study|randomized in error|0|||
125264992|NCT00812955|450599968|FG002|Overall Study|randomized in error|1|||
125264993|NCT00812955|450599969|FG003|Overall Study|randomized in error|0|||
125264994|NCT02391311|450599970|FG000|Overall Study|Lost to Follow-up|2|||
125264995|NCT02391311|450599971|FG001|Overall Study|Lost to Follow-up|1|||
125264996|NCT02391311|450599970|FG000|Overall Study|deemed ineligible after baseline|1|||
125264997|NCT02391311|450599971|FG001|Overall Study|deemed ineligible after baseline|1|||
125264998|NCT01815424|450599974|FG000|Week 0 to 16|Adverse Event|1|||
125264999|NCT01815424|450599975|FG001|Week 0 to 16|Adverse Event|3|||
125265000|NCT01815424|450599976|FG002|Week 0 to 16|Adverse Event|3|||
125447155|NCT00557505|451262710|FG003|Overall Study|Adverse Event|0|||
125265001|NCT01815424|450599977|FG003|Week 0 to 16|Adverse Event|0|||
125265002|NCT01815424|450599978|FG004|Week 0 to 16|Adverse Event|0|||
125265003|NCT01815424|450599974|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
125265004|NCT01815424|450599975|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
125265005|NCT01815424|450599976|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
125265006|NCT01815424|450599977|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
125265007|NCT01815424|450599978|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
125265008|NCT01815424|450599974|FG000|Week 0 to 16|Lost to Follow-up|0|||
125265009|NCT01815424|450599975|FG001|Week 0 to 16|Lost to Follow-up|1|||
125265010|NCT01815424|450599976|FG002|Week 0 to 16|Lost to Follow-up|0|||
125265011|NCT01815424|450599977|FG003|Week 0 to 16|Lost to Follow-up|0|||
125265012|NCT01815424|450599978|FG004|Week 0 to 16|Lost to Follow-up|0|||
125265013|NCT01815424|450599974|FG000|Week 0 to 16|Withdrawal by Subject|0|||
125265014|NCT01815424|450599975|FG001|Week 0 to 16|Withdrawal by Subject|0|||
125265015|NCT01815424|450599976|FG002|Week 0 to 16|Withdrawal by Subject|1|||
125265016|NCT01815424|450599977|FG003|Week 0 to 16|Withdrawal by Subject|0|||
125265017|NCT01815424|450599978|FG004|Week 0 to 16|Withdrawal by Subject|0|||
125265018|NCT01815424|450599974|FG000|Week 0 to 16|Other|1|||
125265019|NCT01815424|450599975|FG001|Week 0 to 16|Other|0|||
125265020|NCT01815424|450599976|FG002|Week 0 to 16|Other|3|||
125265021|NCT01815424|450599977|FG003|Week 0 to 16|Other|0|||
125265022|NCT01815424|450599978|FG004|Week 0 to 16|Other|0|||
125265023|NCT01815424|450599974|FG000|Week 0 to 16|Protocol Violation|1|||
125265024|NCT01815424|450599975|FG001|Week 0 to 16|Protocol Violation|0|||
125265025|NCT01815424|450599976|FG002|Week 0 to 16|Protocol Violation|0|||
125265026|NCT01815424|450599977|FG003|Week 0 to 16|Protocol Violation|0|||
125265027|NCT01815424|450599978|FG004|Week 0 to 16|Protocol Violation|0|||
125265028|NCT01815424|450599974|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
125265029|NCT01815424|450599975|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
125265030|NCT01815424|450599976|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
125265031|NCT01815424|450599977|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
125265032|NCT01815424|450599978|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
125265033|NCT01815424|450599974|FG000|Week 16 to 52|Other|0|||
125265034|NCT01815424|450599975|FG001|Week 16 to 52|Other|1|||
125265035|NCT01815424|450599976|FG002|Week 16 to 52|Other|0|||
125265036|NCT01815424|450599977|FG003|Week 16 to 52|Other|0|||
125265037|NCT01815424|450599978|FG004|Week 16 to 52|Other|0|||
125265038|NCT01815424|450599974|FG000|Week 16 to 52|Adverse Event|0|||
125265039|NCT01815424|450599975|FG001|Week 16 to 52|Adverse Event|0|||
125265040|NCT01815424|450599976|FG002|Week 16 to 52|Adverse Event|0|||
125265041|NCT01815424|450599977|FG003|Week 16 to 52|Adverse Event|0|||
125265042|NCT01815424|450599978|FG004|Week 16 to 52|Adverse Event|1|||
125265043|NCT01815424|450599974|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
125265044|NCT01815424|450599975|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
125265045|NCT01815424|450599976|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
125265046|NCT01815424|450599977|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
125265047|NCT01815424|450599978|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
125265048|NCT01815424|450599974|FG000|Week 16 to 52|Lost to Follow-up|0|||
125265049|NCT01815424|450599975|FG001|Week 16 to 52|Lost to Follow-up|2|||
125265050|NCT01815424|450599976|FG002|Week 16 to 52|Lost to Follow-up|0|||
125265051|NCT01815424|450599977|FG003|Week 16 to 52|Lost to Follow-up|2|||
125265052|NCT01815424|450599978|FG004|Week 16 to 52|Lost to Follow-up|1|||
125265053|NCT01815424|450599974|FG000|Week 16 to 52|Withdrawal by Subject|1|||
125265054|NCT01815424|450599975|FG001|Week 16 to 52|Withdrawal by Subject|2|||
125265055|NCT01815424|450599976|FG002|Week 16 to 52|Withdrawal by Subject|0|||
125265056|NCT01815424|450599977|FG003|Week 16 to 52|Withdrawal by Subject|0|||
125265057|NCT01815424|450599978|FG004|Week 16 to 52|Withdrawal by Subject|0|||
125265058|NCT01309204|450599979|FG000|Overall Study|Adverse Event|48|||
125265059|NCT01309204|450599980|FG001|Overall Study|Adverse Event|58|||
125265060|NCT01309204|450599979|FG000|Overall Study|Lost to Follow-up|2|||
125265061|NCT01309204|450599980|FG001|Overall Study|Lost to Follow-up|2|||
125265062|NCT01309204|450599979|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
125265063|NCT01309204|450599980|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
125265064|NCT01309204|450599979|FG000|Overall Study|Inadequate control of IOP|4|||
125265065|NCT01309204|450599980|FG001|Overall Study|Inadequate control of IOP|4|||
125265066|NCT01309204|450599979|FG000|Overall Study|Other|4|||
125265067|NCT01309204|450599980|FG001|Overall Study|Other|1|||
125265068|NCT03046446|450599981|FG000|Overall Study|Lack of Efficacy|7|||
125265069|NCT03046446|450599981|FG000|Overall Study|Adverse Event|6|||
125265070|NCT03046446|450599981|FG000|Overall Study|Lost to Follow-up|3|||
125265071|NCT03046446|450599981|FG000|Overall Study|Withdrawal by Subject|14|||
125265072|NCT03046446|450599981|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
125265073|NCT03046446|450599981|FG000|Overall Study|Disease Progression (see caveats)|25|||
125398654|NCT02953821|451093174|FG001|Overall Study|Physician Decision|1|||
125265074|NCT03046446|450599981|FG000|Overall Study|Non OA related knee surgery|1|||
125265075|NCT00925002|450599982|FG000|Overall Study|Other|1|||
125265076|NCT00925002|450599983|FG001|Overall Study|Other|4|||
125265077|NCT00925002|450599984|FG002|Overall Study|Other|0|||
125447156|NCT00557505|451262711|FG004|Overall Study|Adverse Event|0|||
125447157|NCT00557505|451262712|FG005|Overall Study|Adverse Event|0|||
125447158|NCT00557505|451262713|FG006|Overall Study|Adverse Event|1|||
125447159|NCT00557505|451262714|FG007|Overall Study|Adverse Event|0|||
125447160|NCT00557505|451262715|FG008|Overall Study|Adverse Event|0|||
125447161|NCT00557505|451262707|FG000|Overall Study|Global deterioration of health|1|||
125447162|NCT00557505|451262708|FG001|Overall Study|Global deterioration of health|0|||
125447163|NCT00557505|451262709|FG002|Overall Study|Global deterioration of health|0|||
125447164|NCT00557505|451262710|FG003|Overall Study|Global deterioration of health|0|||
125447165|NCT00557505|451262711|FG004|Overall Study|Global deterioration of health|0|||
125447166|NCT00557505|451262712|FG005|Overall Study|Global deterioration of health|0|||
125447167|NCT00557505|451262713|FG006|Overall Study|Global deterioration of health|0|||
125447168|NCT00557505|451262714|FG007|Overall Study|Global deterioration of health|0|||
125447169|NCT00557505|451262715|FG008|Overall Study|Global deterioration of health|0|||
125447170|NCT00557505|451262707|FG000|Overall Study|Objective progression or relapse|2|||
125447171|NCT00557505|451262708|FG001|Overall Study|Objective progression or relapse|3|||
125447172|NCT00557505|451262709|FG002|Overall Study|Objective progression or relapse|3|||
125447173|NCT00557505|451262710|FG003|Overall Study|Objective progression or relapse|2|||
125447174|NCT00557505|451262711|FG004|Overall Study|Objective progression or relapse|2|||
125447175|NCT00557505|451262712|FG005|Overall Study|Objective progression or relapse|3|||
125447176|NCT00557505|451262713|FG006|Overall Study|Objective progression or relapse|2|||
125447177|NCT00557505|451262714|FG007|Overall Study|Objective progression or relapse|5|||
125447178|NCT00557505|451262715|FG008|Overall Study|Objective progression or relapse|15|||
125447179|NCT00557505|451262707|FG000|Overall Study|Withdrawal by Subject|0|||
125447180|NCT00557505|451262708|FG001|Overall Study|Withdrawal by Subject|0|||
125447181|NCT00557505|451262709|FG002|Overall Study|Withdrawal by Subject|0|||
125447182|NCT00557505|451262710|FG003|Overall Study|Withdrawal by Subject|1|||
125447183|NCT00557505|451262711|FG004|Overall Study|Withdrawal by Subject|0|||
125447184|NCT00557505|451262712|FG005|Overall Study|Withdrawal by Subject|0|||
125447185|NCT00557505|451262713|FG006|Overall Study|Withdrawal by Subject|0|||
125447186|NCT00557505|451262714|FG007|Overall Study|Withdrawal by Subject|0|||
125447187|NCT00557505|451262715|FG008|Overall Study|Withdrawal by Subject|1|||
125447188|NCT03019458|451262716|FG000|Overall Study|Death|0|||
125447189|NCT03019458|451262717|FG001|Overall Study|Death|1|||
125447190|NCT00031447|451262720|FG000|Overall Study|Lost to Follow-up|0|||
125447191|NCT00031447|451262721|FG001|Overall Study|Lost to Follow-up|1|||
125447192|NCT00031447|451262720|FG000|Overall Study|Non-compliant|1|||
125447193|NCT00031447|451262721|FG001|Overall Study|Non-compliant|1|||
125447194|NCT00031447|451262720|FG000|Overall Study|Re-activation of Disease|2|||
125447195|NCT00031447|451262721|FG001|Overall Study|Re-activation of Disease|1|||
125447196|NCT00031447|451262720|FG000|Overall Study|Disruption of blinded study drug supply|7|||
125447197|NCT00031447|451262721|FG001|Overall Study|Disruption of blinded study drug supply|4|||
125447198|NCT01636362|451262722|FG000|Overall Study|Physician Decision|6|||
125447199|NCT01636362|451262722|FG000|Overall Study|Subject healed, not returning|1|||
125447200|NCT01636362|451262722|FG000|Overall Study|Withdrawal by Subject|1|||
125447201|NCT01244763|451262723|FG000|Overall Study|Adverse Event|1|||
125447202|NCT01244763|451262724|FG001|Overall Study|Adverse Event|0|||
125447203|NCT01244763|451262725|FG002|Overall Study|Adverse Event|0|||
125447204|NCT01244763|451262726|FG003|Overall Study|Adverse Event|0|||
125447205|NCT01244763|451262727|FG004|Overall Study|Adverse Event|0|||
125447206|NCT01244763|451262728|FG005|Overall Study|Adverse Event|1|||
125447207|NCT01244763|451262723|FG000|Overall Study|Death|1|||
125447208|NCT01244763|451262724|FG001|Overall Study|Death|0|||
125447209|NCT01244763|451262725|FG002|Overall Study|Death|1|||
125447210|NCT01244763|451262726|FG003|Overall Study|Death|0|||
125447211|NCT01244763|451262727|FG004|Overall Study|Death|2|||
125447212|NCT01244763|451262728|FG005|Overall Study|Death|0|||
125447213|NCT01244763|451262723|FG000|Overall Study|Physician Decision|0|||
125447214|NCT01244763|451262724|FG001|Overall Study|Physician Decision|0|||
125447215|NCT01244763|451262725|FG002|Overall Study|Physician Decision|1|||
125447216|NCT01244763|451262726|FG003|Overall Study|Physician Decision|0|||
125447217|NCT01244763|451262727|FG004|Overall Study|Physician Decision|0|||
125447218|NCT01244763|451262728|FG005|Overall Study|Physician Decision|0|||
125447219|NCT01244763|451262723|FG000|Overall Study|Withdrawal by Subject|1|||
125447220|NCT01244763|451262724|FG001|Overall Study|Withdrawal by Subject|2|||
125447221|NCT01244763|451262725|FG002|Overall Study|Withdrawal by Subject|0|||
125447222|NCT01244763|451262726|FG003|Overall Study|Withdrawal by Subject|1|||
125447223|NCT01244763|451262727|FG004|Overall Study|Withdrawal by Subject|1|||
125447224|NCT01244763|451262728|FG005|Overall Study|Withdrawal by Subject|2|||
125447225|NCT01244763|451262723|FG000|Overall Study|Lost to Follow-up|0|||
125447226|NCT01244763|451262724|FG001|Overall Study|Lost to Follow-up|1|||
125447227|NCT01244763|451262725|FG002|Overall Study|Lost to Follow-up|0|||
125447228|NCT01244763|451262726|FG003|Overall Study|Lost to Follow-up|0|||
125447229|NCT01244763|451262727|FG004|Overall Study|Lost to Follow-up|0|||
125447230|NCT01244763|451262728|FG005|Overall Study|Lost to Follow-up|0|||
125447231|NCT01244763|451262723|FG000|Overall Study|Enrolled into the Extension Study|0|||
125447232|NCT01244763|451262724|FG001|Overall Study|Enrolled into the Extension Study|0|||
125265078|NCT00925002|450599982|FG000|Overall Study|Death|1|||
125265079|NCT00925002|450599983|FG001|Overall Study|Death|1|||
125265080|NCT00925002|450599984|FG002|Overall Study|Death|5|||
125265081|NCT00925002|450599982|FG000|Overall Study|Adverse Event|3|||
125265082|NCT00925002|450599983|FG001|Overall Study|Adverse Event|1|||
125265083|NCT00925002|450599984|FG002|Overall Study|Adverse Event|2|||
125265084|NCT00925002|450599982|FG000|Overall Study|Participant withdrew consent|1|||
125265085|NCT00925002|450599983|FG001|Overall Study|Participant withdrew consent|3|||
125265086|NCT00925002|450599984|FG002|Overall Study|Participant withdrew consent|3|||
125265087|NCT02808897|450599985|FG000|Overall Study|Lost to Follow-up|9|||
125265088|NCT02808897|450599986|FG001|Overall Study|Lost to Follow-up|11|||
125265089|NCT01496287|450599987|FG000|Overall Study|Lost to Follow-up|1|||
125265090|NCT01496287|450599987|FG000|Overall Study|Incomplete anesthesia|5|||
125265091|NCT00305448|450599988|FG000|Overall Study|Protocol Violation|0|||
125265092|NCT00305448|450599989|FG001|Overall Study|Protocol Violation|1|||
125265093|NCT00305448|450599990|FG002|Overall Study|Protocol Violation|0|||
125265094|NCT00305448|450599988|FG000|Overall Study|Withdrawal by Subject|2|||
125265095|NCT00305448|450599989|FG001|Overall Study|Withdrawal by Subject|0|||
125265096|NCT00305448|450599990|FG002|Overall Study|Withdrawal by Subject|1|||
125265097|NCT00305448|450599988|FG000|Overall Study|Adverse Event|1|||
125265098|NCT00305448|450599989|FG001|Overall Study|Adverse Event|0|||
125265099|NCT00305448|450599990|FG002|Overall Study|Adverse Event|1|||
125265100|NCT00305448|450599988|FG000|Overall Study|Disease Progression|27|||
125265101|NCT00305448|450599989|FG001|Overall Study|Disease Progression|31|||
125265102|NCT00305448|450599990|FG002|Overall Study|Disease Progression|28|||
125265103|NCT00305448|450599988|FG000|Overall Study|Subjective Disease Progression|1|||
125265104|NCT00305448|450599989|FG001|Overall Study|Subjective Disease Progression|2|||
125265105|NCT00305448|450599990|FG002|Overall Study|Subjective Disease Progression|2|||
125265106|NCT00305448|450599988|FG000|Overall Study|Tumor Marker Elevation|0|||
125265107|NCT00305448|450599989|FG001|Overall Study|Tumor Marker Elevation|0|||
125265108|NCT00305448|450599990|FG002|Overall Study|Tumor Marker Elevation|1|||
125265109|NCT00328172|450599991|FG000|Overall Study|Adverse Event|3|||
125265110|NCT00328172|450599992|FG001|Overall Study|Adverse Event|2|||
125265111|NCT00328172|450599993|FG002|Overall Study|Adverse Event|1|||
125265112|NCT00328172|450599994|FG003|Overall Study|Adverse Event|2|||
125265113|NCT00328172|450599995|FG004|Overall Study|Adverse Event|1|||
125265114|NCT00328172|450599991|FG000|Overall Study|Protocol Violation|0|||
125265115|NCT00328172|450599992|FG001|Overall Study|Protocol Violation|1|||
125265116|NCT00328172|450599993|FG002|Overall Study|Protocol Violation|1|||
125265117|NCT00328172|450599994|FG003|Overall Study|Protocol Violation|0|||
125265118|NCT00328172|450599995|FG004|Overall Study|Protocol Violation|0|||
125265119|NCT00328172|450599991|FG000|Overall Study|Lost to Follow-up|1|||
125265120|NCT00328172|450599992|FG001|Overall Study|Lost to Follow-up|1|||
125265121|NCT00328172|450599993|FG002|Overall Study|Lost to Follow-up|2|||
125265122|NCT00328172|450599994|FG003|Overall Study|Lost to Follow-up|1|||
125265123|NCT00328172|450599995|FG004|Overall Study|Lost to Follow-up|1|||
125265124|NCT00328172|450599991|FG000|Overall Study|Withdrawal by Subject|1|||
125265125|NCT00328172|450599992|FG001|Overall Study|Withdrawal by Subject|1|||
125265126|NCT00328172|450599993|FG002|Overall Study|Withdrawal by Subject|1|||
125265127|NCT00328172|450599994|FG003|Overall Study|Withdrawal by Subject|6|||
125265128|NCT00328172|450599995|FG004|Overall Study|Withdrawal by Subject|0|||
125265129|NCT00328172|450599991|FG000|Overall Study|Lack of Efficacy|14|||
125265130|NCT00328172|450599992|FG001|Overall Study|Lack of Efficacy|9|||
125265131|NCT00328172|450599993|FG002|Overall Study|Lack of Efficacy|4|||
125265132|NCT00328172|450599994|FG003|Overall Study|Lack of Efficacy|4|||
125265133|NCT00328172|450599995|FG004|Overall Study|Lack of Efficacy|3|||
125265134|NCT00328172|450599991|FG000|Overall Study|Other reason (not specified)|3|||
125265135|NCT00328172|450599992|FG001|Overall Study|Other reason (not specified)|0|||
125447233|NCT01244763|451262725|FG002|Overall Study|Enrolled into the Extension Study|0|||
125265136|NCT00328172|450599993|FG002|Overall Study|Other reason (not specified)|1|||
125265137|NCT00328172|450599994|FG003|Overall Study|Other reason (not specified)|0|||
125265138|NCT00328172|450599995|FG004|Overall Study|Other reason (not specified)|0|||
125265139|NCT00558636|450600000|FG000|Treatment|Adverse Event|9|||
125265140|NCT00558636|450600001|FG001|Treatment|Adverse Event|2|||
125265141|NCT00558636|450600000|FG000|Treatment|Withdrawal by Subject|2|||
125265142|NCT00558636|450600001|FG001|Treatment|Withdrawal by Subject|0|||
125265143|NCT00558636|450600000|FG000|Treatment|Premature termination of the study|35|||
125265144|NCT00558636|450600001|FG001|Treatment|Premature termination of the study|37|||
125265145|NCT00558636|450600000|FG000|Treatment|Disease progression|1|||
125265146|NCT00558636|450600001|FG001|Treatment|Disease progression|5|||
125265147|NCT00558636|450600000|FG000|Follow-up|Premature termination of the study|12|||
125265148|NCT00558636|450600001|FG001|Follow-up|Premature termination of the study|7|||
125265149|NCT01990742|450600002|FG000|Overall Study|Withdrawal by facility|407|||
125265150|NCT01990742|450600003|FG001|Overall Study|Withdrawal by facility|1083|||
125265151|NCT01990742|450600002|FG000|Overall Study|Facility closed|0|||
125265152|NCT01990742|450600003|FG001|Overall Study|Facility closed|270|||
125265153|NCT03443687|450600004|FG000|Overall Study|Lost to Follow-up|3|||
125265154|NCT03443687|450600005|FG001|Overall Study|Lost to Follow-up|5|||
125265155|NCT03443687|450600004|FG000|Overall Study|Withdrawal by Subject|1|||
125265156|NCT03443687|450600005|FG001|Overall Study|Withdrawal by Subject|0|||
125265157|NCT03443687|450600004|FG000|Overall Study|Discontinued intervention|1|||
125265158|NCT03443687|450600005|FG001|Overall Study|Discontinued intervention|1|||
125265159|NCT04108273|450600006|FG000|Overall Study|COVID Pandemic|1|||
125265160|NCT04108273|450600007|FG001|Overall Study|COVID Pandemic|0|||
125265161|NCT02897115|450600011|FG000|Overall Study|Early termination of study by sponsor|11|||
125265162|NCT02897115|450600012|FG001|Overall Study|Early termination of study by sponsor|8|||
125265163|NCT00487981|450600013|FG000|Overall Study|Hypothyroidism diagnosis|1|||
125265164|NCT02808429|450600018|FG000|Overall Study|Lost to Follow-up|1|||
125265165|NCT02808429|450600019|FG001|Overall Study|Lost to Follow-up|0|||
125265166|NCT02808429|450600020|FG002|Overall Study|Lost to Follow-up|0|||
125265167|NCT02808429|450600018|FG000|Overall Study|Protocol Violation|0|||
125265168|NCT02808429|450600019|FG001|Overall Study|Protocol Violation|1|||
125265169|NCT02808429|450600020|FG002|Overall Study|Protocol Violation|0|||
125265170|NCT02808429|450600018|FG000|Overall Study|Premature study termination by sponsor|2|||
125265171|NCT02808429|450600019|FG001|Overall Study|Premature study termination by sponsor|0|||
125265172|NCT02808429|450600020|FG002|Overall Study|Premature study termination by sponsor|1|||
125265173|NCT02808429|450600018|FG000|Overall Study|Relocation|0|||
125265174|NCT02808429|450600019|FG001|Overall Study|Relocation|0|||
125265175|NCT02808429|450600020|FG002|Overall Study|Relocation|1|||
125265176|NCT00698828|450600024|FG000|Overall Study|Adverse Event|3|||
125265177|NCT00698828|450600025|FG001|Overall Study|Adverse Event|4|||
125265178|NCT00698828|450600026|FG002|Overall Study|Adverse Event|4|||
125265179|NCT00698828|450600024|FG000|Overall Study|Death|0|||
125265180|NCT00698828|450600025|FG001|Overall Study|Death|0|||
125265181|NCT00698828|450600026|FG002|Overall Study|Death|1|||
125265182|NCT00698828|450600024|FG000|Overall Study|Exacerbation of COPD|1|||
125265183|NCT00698828|450600025|FG001|Overall Study|Exacerbation of COPD|3|||
125265184|NCT00698828|450600026|FG002|Overall Study|Exacerbation of COPD|0|||
125265185|NCT00698828|450600024|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
125265186|NCT00698828|450600025|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
125265187|NCT00698828|450600026|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
125265188|NCT00698828|450600024|FG000|Overall Study|Investigator/Sponsor decision|1|||
125265189|NCT00698828|450600025|FG001|Overall Study|Investigator/Sponsor decision|0|||
125398655|NCT02953821|451093173|FG000|Overall Study|Withdrawal by Subject|3|||
125398656|NCT02953821|451093174|FG001|Overall Study|Withdrawal by Subject|3|||
125398657|NCT02953821|451093173|FG000|Overall Study|Change of address|0|||
125398658|NCT02953821|451093174|FG001|Overall Study|Change of address|1|||
125398659|NCT02953821|451093173|FG000|Overall Study|Lack of Efficacy|1|||
125398660|NCT02953821|451093174|FG001|Overall Study|Lack of Efficacy|0|||
125265190|NCT00698828|450600026|FG002|Overall Study|Investigator/Sponsor decision|2|||
125265191|NCT00698828|450600024|FG000|Overall Study|Lost to Follow-up|1|||
125265192|NCT00698828|450600025|FG001|Overall Study|Lost to Follow-up|1|||
125265193|NCT00698828|450600026|FG002|Overall Study|Lost to Follow-up|0|||
125265194|NCT00698828|450600024|FG000|Overall Study|Withdrew consent|0|||
125265195|NCT00698828|450600025|FG001|Overall Study|Withdrew consent|7|||
125265196|NCT00698828|450600026|FG002|Overall Study|Withdrew consent|4|||
125265197|NCT00698828|450600024|FG000|Overall Study|Withdrew consent (not treated)|2|||
125265198|NCT00698828|450600025|FG001|Overall Study|Withdrew consent (not treated)|0|||
125265199|NCT00698828|450600026|FG002|Overall Study|Withdrew consent (not treated)|0|||
125265200|NCT02013609|450600027|FG000|Overall Study|Withdrawal by Subject|9|||
125265201|NCT02013609|450600027|FG000|Overall Study|Lost to Follow-up|3|||
125265202|NCT02013609|450600027|FG000|Overall Study|Adverse Event|3|||
125265203|NCT02013609|450600027|FG000|Overall Study|Met Withdrawal Criteria|3|||
125265204|NCT00856609|450600028|FG000|Overall Study|Adverse Event|1|||
125265205|NCT00856609|450600029|FG001|Overall Study|Adverse Event|0|||
125265206|NCT00783432|450600030|FG000|Overall Study|Adverse Event|22|||
125265207|NCT00783432|450600031|FG001|Overall Study|Adverse Event|17|||
125265208|NCT00783432|450600030|FG000|Overall Study|Lack of Efficacy|20|||
125265209|NCT00783432|450600031|FG001|Overall Study|Lack of Efficacy|21|||
125265210|NCT00783432|450600030|FG000|Overall Study|Lost to Follow-up|11|||
125265211|NCT00783432|450600031|FG001|Overall Study|Lost to Follow-up|6|||
125265212|NCT00783432|450600030|FG000|Overall Study|Withdrawal by Subject|23|||
125265213|NCT00783432|450600031|FG001|Overall Study|Withdrawal by Subject|20|||
125265214|NCT00783432|450600030|FG000|Overall Study|subject moved|3|||
125265215|NCT00783432|450600031|FG001|Overall Study|subject moved|5|||
125265216|NCT00783432|450600030|FG000|Overall Study|Protocol Violation|6|||
125265217|NCT00783432|450600031|FG001|Overall Study|Protocol Violation|9|||
125265218|NCT03273907|450600032|FG000|Overall Study|Death|1|||
125398661|NCT02953821|451093173|FG000|Overall Study|Out of state for indeterminate time|0|||
125398662|NCT02953821|451093174|FG001|Overall Study|Out of state for indeterminate time|1|||
125265219|NCT03273907|450600032|FG000|Overall Study|Lost to Follow-up|4|||
125265220|NCT03273907|450600032|FG000|Overall Study|Withdrawal by Subject|2|||
125265221|NCT03273907|450600032|FG000|Overall Study|COVID 19|2|||
125265222|NCT02581891|450600034|FG000|Overall Study|Adverse Event|4|||
125265223|NCT02581891|450600035|FG001|Overall Study|Adverse Event|6|||
125265224|NCT02581891|450600034|FG000|Overall Study|Death|3|||
125447234|NCT01244763|451262726|FG003|Overall Study|Enrolled into the Extension Study|0|||
125447235|NCT01244763|451262727|FG004|Overall Study|Enrolled into the Extension Study|0|||
125447236|NCT01244763|451262728|FG005|Overall Study|Enrolled into the Extension Study|1|||
125265225|NCT02581891|450600035|FG001|Overall Study|Death|4|||
125265226|NCT02581891|450600034|FG000|Overall Study|Lost to Follow-up|1|||
125265227|NCT02581891|450600035|FG001|Overall Study|Lost to Follow-up|2|||
125265228|NCT02581891|450600034|FG000|Overall Study|Physician Decision|0|||
125265229|NCT02581891|450600035|FG001|Overall Study|Physician Decision|1|||
125265230|NCT02581891|450600034|FG000|Overall Study|Withdrawal by Subject|4|||
125265231|NCT02581891|450600035|FG001|Overall Study|Withdrawal by Subject|5|||
125265232|NCT02581891|450600034|FG000|Overall Study|Other Reasons|3|||
125265233|NCT02581891|450600035|FG001|Overall Study|Other Reasons|1|||
125265234|NCT02581891|450600034|FG000|Overall Study|Discontinued during followup|1|||
125265235|NCT02581891|450600035|FG001|Overall Study|Discontinued during followup|0|||
125265236|NCT04828707|450600036|FG000|Overall Study|Lost to Follow-up|3|||
125265237|NCT04828707|450600037|FG001|Overall Study|Lost to Follow-up|2|||
125265238|NCT04828707|450600036|FG000|Overall Study|Withdrawal by Subject|2|||
125265239|NCT04828707|450600037|FG001|Overall Study|Withdrawal by Subject|1|||
125265240|NCT03139448|450600038|FG000|Overall Study|Lack of Efficacy|6|||
125265241|NCT03139448|450600039|FG001|Overall Study|Lack of Efficacy|7|||
125265242|NCT03139448|450600038|FG000|Overall Study|Location of procedure changed|2|||
125265243|NCT03139448|450600039|FG001|Overall Study|Location of procedure changed|8|||
125265244|NCT03139448|450600038|FG000|Overall Study|Withdrawal by Subject|3|||
125265245|NCT03139448|450600039|FG001|Overall Study|Withdrawal by Subject|6|||
125265246|NCT03139448|450600038|FG000|Overall Study|Screen fail|1|||
125265247|NCT03139448|450600039|FG001|Overall Study|Screen fail|3|||
125265248|NCT03139448|450600038|FG000|Overall Study|Physician Decision|0|||
125265249|NCT03139448|450600039|FG001|Overall Study|Physician Decision|2|||
125265250|NCT00523978|450600040|FG000|Overall Study|Withdrawal by Subject|3|||
125265251|NCT00523978|450600041|FG001|Overall Study|Withdrawal by Subject|7|||
125265252|NCT00523978|450600040|FG000|Overall Study|Screen Failures|5|||
125265253|NCT00523978|450600041|FG001|Overall Study|Screen Failures|1|||
125265254|NCT00523978|450600040|FG000|Overall Study|Death|1|||
125265255|NCT00523978|450600041|FG001|Overall Study|Death|0|||
125265256|NCT00696878|450600042|FG000|Overall Study|Adverse Event|8|||
125265257|NCT00696878|450600042|FG000|Overall Study|Withdrawal by Subject|87|||
125265258|NCT00696878|450600042|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
125265259|NCT00696878|450600042|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
125265260|NCT00696878|450600042|FG000|Overall Study|Trial stopped|32|||
125265261|NCT00696878|450600042|FG000|Overall Study|Other reason (not specified)|55|||
125265262|NCT02712788|450600043|FG000|Overall Study|Physician Decision|1|||
125265263|NCT02712788|450600044|FG001|Overall Study|Physician Decision|0|||
125265264|NCT02712788|450600043|FG000|Overall Study|Protocol Violation|1|||
125265265|NCT02712788|450600044|FG001|Overall Study|Protocol Violation|0|||
125265266|NCT00940602|450600045|FG000|Overall Study|Administrative problems|1|||
125265267|NCT00940602|450600046|FG001|Overall Study|Administrative problems|1|||
125265268|NCT00940602|450600045|FG000|Overall Study|Patient/guardian decision|13|||
125265269|NCT00940602|450600046|FG001|Overall Study|Patient/guardian decision|28|||
125265270|NCT00940602|450600045|FG000|Overall Study|Physician Decision|8|||
125265271|NCT00940602|450600046|FG001|Overall Study|Physician Decision|5|||
125265272|NCT00940602|450600045|FG000|Overall Study|Pregnancy|1|||
125265273|NCT00940602|450600046|FG001|Overall Study|Pregnancy|0|||
125265274|NCT00940602|450600045|FG000|Overall Study|Protocol Deviation (untreated)|1|||
125265275|NCT00940602|450600046|FG001|Overall Study|Protocol Deviation (untreated)|0|||
125265276|NCT00940602|450600045|FG000|Overall Study|Disease progression|8|||
125265277|NCT00940602|450600046|FG001|Overall Study|Disease progression|2|||
125265278|NCT00940602|450600045|FG000|Overall Study|Death|38|||
125265279|NCT00940602|450600046|FG001|Overall Study|Death|19|||
125265280|NCT00940602|450600045|FG000|Overall Study|Lost to Follow-up|3|||
125265281|NCT00940602|450600046|FG001|Overall Study|Lost to Follow-up|1|||
125265282|NCT00940602|450600045|FG000|Overall Study|Patient withdrew consent|26|||
125265283|NCT00940602|450600046|FG001|Overall Study|Patient withdrew consent|13|||
125265284|NCT00940602|450600045|FG000|Overall Study|Adverse Event|7|||
125265285|NCT00940602|450600046|FG001|Overall Study|Adverse Event|2|||
125265286|NCT00940602|450600045|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
125265287|NCT00940602|450600046|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
125265288|NCT01880957|450600047|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
125265289|NCT01880957|450600048|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
125265290|NCT01880957|450600047|FG000|Overall Study|Lost to Follow-up|11|||
125265291|NCT01880957|450600048|FG001|Overall Study|Lost to Follow-up|0|||
125265292|NCT01880957|450600047|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
125265293|NCT01880957|450600048|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
125265294|NCT00575666|450600051|FG000|Overall Study|Withdrawal by Subject|3|||
125265295|NCT00575666|450600052|FG001|Overall Study|Withdrawal by Subject|2|||
125265296|NCT00575666|450600051|FG000|Overall Study|Physician Decision|1|||
125265297|NCT00575666|450600052|FG001|Overall Study|Physician Decision|1|||
125447237|NCT01561079|451262732|FG000|Overall Study|Physician Decision|17|||
125447238|NCT01561079|451262732|FG000|Overall Study|Withdrawal by Subject|59|||
125447239|NCT01561079|451262732|FG000|Overall Study|Protocol Violation|2|||
125447240|NCT00664521|451262738|FG000|Overall Study|Adverse Event|4|||
125447241|NCT00664521|451262739|FG001|Overall Study|Adverse Event|1|||
125447242|NCT00664521|451262738|FG000|Overall Study|Lost to Follow-up|1|||
125447243|NCT00664521|451262739|FG001|Overall Study|Lost to Follow-up|0|||
125447244|NCT00664521|451262738|FG000|Overall Study|Other|1|||
125447245|NCT00664521|451262739|FG001|Overall Study|Other|0|||
125447246|NCT02459964|451262740|FG000|Overall Study|Withdrawal by Subject|0|||
125447247|NCT02459964|451262741|FG001|Overall Study|Withdrawal by Subject|0|||
125447248|NCT02459964|451262742|FG002|Overall Study|Withdrawal by Subject|1|||
125447249|NCT02459964|451262740|FG000|Overall Study|Abnormal EKG changes|0|||
125447250|NCT02459964|451262741|FG001|Overall Study|Abnormal EKG changes|0|||
125447251|NCT02459964|451262742|FG002|Overall Study|Abnormal EKG changes|1|||
125447252|NCT00367237|451262743|FG000|Overall Study|Adverse Event|7|||
125447253|NCT00367237|451262744|FG001|Overall Study|Adverse Event|2|||
125447254|NCT00367237|451262743|FG000|Overall Study|Lost to Follow-up|1|||
125447255|NCT00367237|451262744|FG001|Overall Study|Lost to Follow-up|0|||
125447256|NCT00367237|451262743|FG000|Overall Study|Withdrawal by Subject|0|||
125447257|NCT00367237|451262744|FG001|Overall Study|Withdrawal by Subject|4|||
125447258|NCT00367237|451262743|FG000|Overall Study|Protocol Violation|2|||
125447259|NCT00367237|451262744|FG001|Overall Study|Protocol Violation|5|||
125447260|NCT02800928|451262747|FG000|Overall Study|Withdrawal by Subject|1|||
125447261|NCT02800928|451262748|FG001|Overall Study|Withdrawal by Subject|1|||
125447262|NCT02800928|451262747|FG000|Overall Study|Protocol Violation|1|||
125447263|NCT02800928|451262748|FG001|Overall Study|Protocol Violation|1|||
125447264|NCT00953160|451262761|FG000|Overall Study|Lost to Follow-up|23|||
125447265|NCT00953160|451262761|FG000|Overall Study|Withdrawal by Subject|4|||
125447266|NCT00570661|451262768|FG000|Overall Study|Disease worsening|5|||
125447267|NCT00570661|451262768|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
125447268|NCT00570661|451262768|FG000|Overall Study|Adverse Event|1|||
125265298|NCT00508482|450600053|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
125265299|NCT00508482|450600054|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
125265300|NCT00508482|450600055|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
125265301|NCT00508482|450600053|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
125265302|NCT00508482|450600054|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
125265303|NCT00508482|450600055|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
125265304|NCT00508482|450600053|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
125265305|NCT00508482|450600054|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
125265306|NCT00508482|450600055|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
125265307|NCT02289469|450600056|FG000|Overall Study|Unable to match a control|6|||
125265308|NCT02289469|450600057|FG001|Overall Study|Unable to match a control|0|||
125265309|NCT01944020|450601657|FG000|Overall Study|Withdrawal by Subject|5|||
125265310|NCT01944020|450601658|FG001|Overall Study|Withdrawal by Subject|0|||
125265311|NCT00110214|450601663|FG000|Overall Study|Never started treatment|21|||
125265312|NCT00110214|450601664|FG001|Overall Study|Never started treatment|20|||
125265313|NCT00110214|450601663|FG000|Overall Study|Disease progression or death|260|||
125265314|NCT00110214|450601664|FG001|Overall Study|Disease progression or death|151|||
125265315|NCT00110214|450601663|FG000|Overall Study|Adverse Event|115|||
125265316|NCT00110214|450601664|FG001|Overall Study|Adverse Event|192|||
125265317|NCT00110214|450601663|FG000|Overall Study|Refused further treatment|52|||
125265318|NCT00110214|450601664|FG001|Overall Study|Refused further treatment|65|||
125265319|NCT00110214|450601663|FG000|Overall Study|Other (not specified)|61|||
125398663|NCT02953821|451093173|FG000|Overall Study|No improvement|0|||
125398664|NCT02953821|451093174|FG001|Overall Study|No improvement|1|||
125398665|NCT02953821|451093173|FG000|Overall Study|Refused follow-up visit|2|||
125398666|NCT02953821|451093174|FG001|Overall Study|Refused follow-up visit|1|||
125398667|NCT02103478|451093175|FG000|Overall Study|Adverse Event|0|||
125398668|NCT02103478|451093176|FG001|Overall Study|Adverse Event|0|||
125398669|NCT02103478|451093177|FG002|Overall Study|Adverse Event|1|||
125398670|NCT02103478|451093178|FG003|Overall Study|Adverse Event|1|||
125398671|NCT02103478|451093179|FG004|Overall Study|Adverse Event|2|||
125398672|NCT02103478|451093180|FG005|Overall Study|Adverse Event|1|||
125398673|NCT02103478|451093181|FG006|Overall Study|Adverse Event|0|||
125398674|NCT02103478|451093182|FG007|Overall Study|Adverse Event|0|||
125398675|NCT02103478|451093183|FG008|Overall Study|Adverse Event|0|||
125398676|NCT02103478|451093175|FG000|Overall Study|Death|2|||
125398677|NCT02103478|451093176|FG001|Overall Study|Death|2|||
125265320|NCT00110214|450601664|FG001|Overall Study|Other (not specified)|75|||
125265321|NCT00811954|450601666|FG000|Overall Study|Death|10|||
125398678|NCT02103478|451093177|FG002|Overall Study|Death|1|||
125398679|NCT02103478|451093178|FG003|Overall Study|Death|1|||
125398680|NCT02103478|451093179|FG004|Overall Study|Death|5|||
125447269|NCT01052662|451262771|FG000|Overall Study|Lost to Follow-up|15|||
125447270|NCT01052662|451262772|FG001|Overall Study|Lost to Follow-up|13|||
125447271|NCT01052662|451262773|FG002|Overall Study|Lost to Follow-up|18|||
125265322|NCT00811954|450601667|FG001|Overall Study|Death|6|||
125265323|NCT00811954|450601668|FG002|Overall Study|Death|13|||
125265324|NCT00811954|450601666|FG000|Overall Study|Lost to Follow-up|29|||
125265325|NCT00811954|450601667|FG001|Overall Study|Lost to Follow-up|23|||
125265326|NCT00811954|450601668|FG002|Overall Study|Lost to Follow-up|34|||
125265327|NCT00811954|450601666|FG000|Overall Study|Not able to get to clinic|28|||
125265328|NCT00811954|450601667|FG001|Overall Study|Not able to get to clinic|35|||
125265329|NCT00811954|450601668|FG002|Overall Study|Not able to get to clinic|30|||
125265330|NCT00811954|450601666|FG000|Overall Study|Not willing to adhere to requirements|12|||
125265331|NCT00811954|450601667|FG001|Overall Study|Not willing to adhere to requirements|2|||
125265332|NCT00811954|450601668|FG002|Overall Study|Not willing to adhere to requirements|16|||
125265333|NCT00811954|450601666|FG000|Overall Study|Withdraw consent prior study completion|4|||
125265334|NCT00811954|450601667|FG001|Overall Study|Withdraw consent prior study completion|6|||
125265335|NCT00811954|450601668|FG002|Overall Study|Withdraw consent prior study completion|5|||
125265336|NCT00811954|450601666|FG000|Overall Study|Site Closure|4|||
125265337|NCT00811954|450601667|FG001|Overall Study|Site Closure|0|||
125265338|NCT00811954|450601668|FG002|Overall Study|Site Closure|1|||
125265339|NCT00811954|450601666|FG000|Overall Study|Severe Debilitation|2|||
125265340|NCT00811954|450601667|FG001|Overall Study|Severe Debilitation|0|||
125265341|NCT00811954|450601668|FG002|Overall Study|Severe Debilitation|1|||
125265342|NCT00811954|450601666|FG000|Overall Study|Complete Protocol: No follow-up|0|||
125265343|NCT00811954|450601667|FG001|Overall Study|Complete Protocol: No follow-up|0|||
125265344|NCT00811954|450601668|FG002|Overall Study|Complete Protocol: No follow-up|1|||
125265345|NCT01016067|450601669|FG000|Overall Study|Lost to Follow-up|1|||
125265346|NCT01016067|450601670|FG001|Overall Study|Lost to Follow-up|2|||
125265347|NCT01016067|450601669|FG000|Overall Study|Physician Decision|1|||
125265348|NCT01016067|450601670|FG001|Overall Study|Physician Decision|1|||
125265349|NCT01016067|450601669|FG000|Overall Study|Withdrew due to Relocation|0|||
125265350|NCT01016067|450601670|FG001|Overall Study|Withdrew due to Relocation|1|||
125265351|NCT01534481|450601677|FG000|Overall Study|Lost to Follow-up|29|||
125265352|NCT01534481|450601678|FG001|Overall Study|Lost to Follow-up|24|||
125265353|NCT01534481|450601677|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
125265354|NCT01534481|450601678|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
125265355|NCT01130337|450601679|FG000|Overall Study|Withdrawal by Subject|3|||
125265356|NCT01130337|450601679|FG000|Overall Study|Principal investigator decision|1|||
125265357|NCT01130337|450601679|FG000|Overall Study|Death|1|||
125265358|NCT01130337|450601679|FG000|Overall Study|Disease progression|1|||
125265359|NCT01130337|450601679|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
125265360|NCT01130337|450601679|FG000|Overall Study|Surgical resection (R2)|1|||
125265361|NCT05525910|450601680|FG000|Period 4|Per sponsor due to study timelines|0|||
125265362|NCT05525910|450601681|FG001|Period 4|Per sponsor due to study timelines|0|||
125265363|NCT05525910|450601682|FG002|Period 4|Per sponsor due to study timelines|1|||
125265364|NCT05525910|450601683|FG003|Period 4|Per sponsor due to study timelines|1|||
125265365|NCT05525910|450601684|FG004|Period 4|Per sponsor due to study timelines|1|||
125265366|NCT03886493|450601685|FG000|Overall Study|Adverse Event|1|||
125265367|NCT03326063|450601686|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
125265368|NCT03326063|450601687|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
125265369|NCT02750514|450601688|FG000|Track 1|Disease progression|20|||
125265370|NCT02750514|450601689|FG001|Track 1|Disease progression|1|||
125265371|NCT02750514|450601690|FG002|Track 1|Disease progression|0|||
125265372|NCT02750514|450601691|FG003|Track 1|Disease progression|1|||
125265373|NCT02750514|450601692|FG004|Track 1|Disease progression|0|||
125265374|NCT02750514|450601688|FG000|Track 1|Adverse event unrelated to study drug|1|||
125265375|NCT02750514|450601689|FG001|Track 1|Adverse event unrelated to study drug|0|||
125265376|NCT02750514|450601690|FG002|Track 1|Adverse event unrelated to study drug|0|||
125265377|NCT02750514|450601691|FG003|Track 1|Adverse event unrelated to study drug|0|||
125265378|NCT02750514|450601692|FG004|Track 1|Adverse event unrelated to study drug|0|||
125265379|NCT02750514|450601688|FG000|Track 1|Study drug toxicity|4|||
125265380|NCT02750514|450601689|FG001|Track 1|Study drug toxicity|1|||
125265381|NCT02750514|450601690|FG002|Track 1|Study drug toxicity|0|||
125265382|NCT02750514|450601691|FG003|Track 1|Study drug toxicity|1|||
125265383|NCT02750514|450601692|FG004|Track 1|Study drug toxicity|0|||
125265384|NCT02750514|450601688|FG000|Track 1|Participant request to discontinue|1|||
125265385|NCT02750514|450601689|FG001|Track 1|Participant request to discontinue|0|||
125265386|NCT02750514|450601690|FG002|Track 1|Participant request to discontinue|0|||
125265387|NCT02750514|450601691|FG003|Track 1|Participant request to discontinue|0|||
125265388|NCT02750514|450601692|FG004|Track 1|Participant request to discontinue|0|||
125265389|NCT02750514|450601688|FG000|Track 1|Other reasons|1|||
125265390|NCT02750514|450601689|FG001|Track 1|Other reasons|0|||
125265391|NCT02750514|450601690|FG002|Track 1|Other reasons|0|||
125265392|NCT02750514|450601691|FG003|Track 1|Other reasons|0|||
125265393|NCT02750514|450601692|FG004|Track 1|Other reasons|0|||
125265394|NCT02750514|450601688|FG000|Track 2|Disease progression|4|||
125265395|NCT02750514|450601689|FG001|Track 2|Disease progression|5|||
125265396|NCT02750514|450601690|FG002|Track 2|Disease progression|2|||
125265397|NCT02750514|450601691|FG003|Track 2|Disease progression|5|||
125265398|NCT02750514|450601692|FG004|Track 2|Disease progression|0|||
125265399|NCT02750514|450601688|FG000|Track 2|Adverse event unrelated to study drug|1|||
125265400|NCT02750514|450601689|FG001|Track 2|Adverse event unrelated to study drug|0|||
125265401|NCT02750514|450601690|FG002|Track 2|Adverse event unrelated to study drug|0|||
125265402|NCT02750514|450601691|FG003|Track 2|Adverse event unrelated to study drug|0|||
125265403|NCT02750514|450601692|FG004|Track 2|Adverse event unrelated to study drug|0|||
125265404|NCT02750514|450601688|FG000|Track 2|Study drug toxicity|1|||
125265405|NCT02750514|450601689|FG001|Track 2|Study drug toxicity|2|||
125265406|NCT02750514|450601690|FG002|Track 2|Study drug toxicity|0|||
125265407|NCT02750514|450601691|FG003|Track 2|Study drug toxicity|2|||
125265408|NCT02750514|450601692|FG004|Track 2|Study drug toxicity|0|||
125265409|NCT02750514|450601688|FG000|Track 2|Participant withdrew consent|0|||
125265410|NCT02750514|450601689|FG001|Track 2|Participant withdrew consent|1|||
125265411|NCT02750514|450601690|FG002|Track 2|Participant withdrew consent|0|||
125265412|NCT02750514|450601691|FG003|Track 2|Participant withdrew consent|0|||
125265413|NCT02750514|450601692|FG004|Track 2|Participant withdrew consent|0|||
125265414|NCT02750514|450601688|FG000|Track 3|Disease progression|0|||
125265415|NCT02750514|450601689|FG001|Track 3|Disease progression|24|||
125265416|NCT02750514|450601690|FG002|Track 3|Disease progression|13|||
125265417|NCT02750514|450601691|FG003|Track 3|Disease progression|14|||
125265418|NCT02750514|450601692|FG004|Track 3|Disease progression|0|||
125265419|NCT02750514|450601688|FG000|Track 3|Adverse event unrelated to study drug|0|||
125265420|NCT02750514|450601689|FG001|Track 3|Adverse event unrelated to study drug|1|||
125265421|NCT02750514|450601690|FG002|Track 3|Adverse event unrelated to study drug|1|||
125265422|NCT02750514|450601691|FG003|Track 3|Adverse event unrelated to study drug|1|||
125265423|NCT02750514|450601692|FG004|Track 3|Adverse event unrelated to study drug|0|||
125265424|NCT02750514|450601688|FG000|Track 3|Study drug toxicity|0|||
125265425|NCT02750514|450601689|FG001|Track 3|Study drug toxicity|3|||
125265426|NCT02750514|450601690|FG002|Track 3|Study drug toxicity|0|||
125265427|NCT02750514|450601691|FG003|Track 3|Study drug toxicity|1|||
125265428|NCT02750514|450601692|FG004|Track 3|Study drug toxicity|0|||
125265429|NCT02750514|450601688|FG000|Track 3|Participant request to discontinue|0|||
125265430|NCT02750514|450601689|FG001|Track 3|Participant request to discontinue|2|||
125265431|NCT02750514|450601690|FG002|Track 3|Participant request to discontinue|0|||
125265432|NCT02750514|450601691|FG003|Track 3|Participant request to discontinue|0|||
125265433|NCT02750514|450601692|FG004|Track 3|Participant request to discontinue|0|||
125265434|NCT02750514|450601688|FG000|Track 3|Participant withdrew consent|0|||
125265435|NCT02750514|450601689|FG001|Track 3|Participant withdrew consent|3|||
125265436|NCT02750514|450601690|FG002|Track 3|Participant withdrew consent|1|||
125265437|NCT02750514|450601691|FG003|Track 3|Participant withdrew consent|0|||
125265438|NCT02750514|450601692|FG004|Track 3|Participant withdrew consent|0|||
125265439|NCT02750514|450601688|FG000|Track 3|Other reasons|0|||
125265440|NCT02750514|450601689|FG001|Track 3|Other reasons|3|||
125265441|NCT02750514|450601690|FG002|Track 3|Other reasons|0|||
125265442|NCT02750514|450601691|FG003|Track 3|Other reasons|0|||
125265443|NCT02750514|450601692|FG004|Track 3|Other reasons|0|||
125265444|NCT02750514|450601688|FG000|Track 4|Study drug toxicity|0|||
125265445|NCT02750514|450601689|FG001|Track 4|Study drug toxicity|6|||
125265446|NCT02750514|450601690|FG002|Track 4|Study drug toxicity|0|||
125265447|NCT02750514|450601691|FG003|Track 4|Study drug toxicity|5|||
125265448|NCT02750514|450601692|FG004|Track 4|Study drug toxicity|0|||
125265449|NCT02750514|450601688|FG000|Track 4|Participant request to discontinue|0|||
125265450|NCT02750514|450601689|FG001|Track 4|Participant request to discontinue|1|||
125265451|NCT02750514|450601690|FG002|Track 4|Participant request to discontinue|0|||
125265452|NCT02750514|450601691|FG003|Track 4|Participant request to discontinue|1|||
125265453|NCT02750514|450601692|FG004|Track 4|Participant request to discontinue|0|||
125265454|NCT02750514|450601688|FG000|Track 4|Participant withdrew consent|0|||
125265455|NCT02750514|450601689|FG001|Track 4|Participant withdrew consent|1|||
125265456|NCT02750514|450601690|FG002|Track 4|Participant withdrew consent|0|||
125265457|NCT02750514|450601691|FG003|Track 4|Participant withdrew consent|0|||
125265458|NCT02750514|450601692|FG004|Track 4|Participant withdrew consent|0|||
125265459|NCT02750514|450601688|FG000|Track 4|Other reasons|0|||
125265460|NCT02750514|450601689|FG001|Track 4|Other reasons|5|||
125265461|NCT02750514|450601690|FG002|Track 4|Other reasons|0|||
125265462|NCT02750514|450601691|FG003|Track 4|Other reasons|3|||
125265463|NCT02750514|450601692|FG004|Track 4|Other reasons|0|||
125265464|NCT02750514|450601688|FG000|Track 4|Disease progression|0|||
125265465|NCT02750514|450601689|FG001|Track 4|Disease progression|33|||
125265466|NCT02750514|450601690|FG002|Track 4|Disease progression|0|||
125265467|NCT02750514|450601691|FG003|Track 4|Disease progression|32|||
125265468|NCT02750514|450601692|FG004|Track 4|Disease progression|0|||
125265469|NCT02750514|450601688|FG000|Track 4|Adverse event unrelated to study drug|0|||
125265470|NCT02750514|450601689|FG001|Track 4|Adverse event unrelated to study drug|5|||
125265471|NCT02750514|450601690|FG002|Track 4|Adverse event unrelated to study drug|0|||
125265472|NCT02750514|450601691|FG003|Track 4|Adverse event unrelated to study drug|0|||
125265473|NCT02750514|450601692|FG004|Track 4|Adverse event unrelated to study drug|0|||
125265474|NCT02750514|450601688|FG000|Track 4|Death|0|||
125265475|NCT02750514|450601689|FG001|Track 4|Death|0|||
125265476|NCT02750514|450601690|FG002|Track 4|Death|0|||
125265477|NCT02750514|450601691|FG003|Track 4|Death|1|||
125265478|NCT02750514|450601692|FG004|Track 4|Death|0|||
125265479|NCT02750514|450601688|FG000|Track 5|Disease progression|0|||
125265480|NCT02750514|450601689|FG001|Track 5|Disease progression|0|||
125265481|NCT02750514|450601690|FG002|Track 5|Disease progression|0|||
125265482|NCT02750514|450601691|FG003|Track 5|Disease progression|0|||
125265483|NCT02750514|450601692|FG004|Track 5|Disease progression|34|||
125265484|NCT02750514|450601688|FG000|Track 5|Adverse event unrelated to study drug|0|||
125265485|NCT02750514|450601689|FG001|Track 5|Adverse event unrelated to study drug|0|||
125265486|NCT02750514|450601690|FG002|Track 5|Adverse event unrelated to study drug|0|||
125265487|NCT02750514|450601691|FG003|Track 5|Adverse event unrelated to study drug|0|||
125265488|NCT02750514|450601692|FG004|Track 5|Adverse event unrelated to study drug|2|||
125265489|NCT02750514|450601688|FG000|Track 5|Study drug toxicity|0|||
125265490|NCT02750514|450601689|FG001|Track 5|Study drug toxicity|0|||
125265491|NCT02750514|450601690|FG002|Track 5|Study drug toxicity|0|||
125265492|NCT02750514|450601691|FG003|Track 5|Study drug toxicity|0|||
125265493|NCT02750514|450601692|FG004|Track 5|Study drug toxicity|2|||
125265494|NCT02750514|450601688|FG000|Track 5|Participant request to discontinue|0|||
125265495|NCT02750514|450601689|FG001|Track 5|Participant request to discontinue|0|||
125265496|NCT02750514|450601690|FG002|Track 5|Participant request to discontinue|0|||
125265497|NCT02750514|450601691|FG003|Track 5|Participant request to discontinue|0|||
125265498|NCT02750514|450601692|FG004|Track 5|Participant request to discontinue|3|||
125265499|NCT02750514|450601688|FG000|Track 5|Other reasons|0|||
125265500|NCT02750514|450601689|FG001|Track 5|Other reasons|0|||
125265501|NCT02750514|450601690|FG002|Track 5|Other reasons|0|||
125265502|NCT02750514|450601691|FG003|Track 5|Other reasons|0|||
125265503|NCT02750514|450601692|FG004|Track 5|Other reasons|2|||
125265504|NCT02553629|450601693|FG000|Overall Study|Logistic reasons|3|||
125265505|NCT02553629|450601694|FG001|Overall Study|Logistic reasons|6|||
125265506|NCT01812057|450601695|FG000|Overall Study|Protocol Violation|1|||
125265507|NCT01812057|450601696|FG001|Overall Study|Protocol Violation|0|||
125265508|NCT01812057|450601695|FG000|Overall Study|Physician Decision|1|||
125265509|NCT01812057|450601696|FG001|Overall Study|Physician Decision|0|||
125265510|NCT01882465|450601699|FG000|Period 1|Lens Discomfort|0|||
125265511|NCT01882465|450601700|FG001|Period 1|Lens Discomfort|0|||
125265512|NCT01882465|450601701|FG002|Period 1|Lens Discomfort|0|||
125265513|NCT01882465|450601702|FG003|Period 1|Lens Discomfort|1|||
125265514|NCT01882465|450601703|FG004|Period 1|Lens Discomfort|0|||
125265515|NCT01882465|450601704|FG005|Period 1|Lens Discomfort|0|||
125265516|NCT01882465|450601705|FG006|Period 1|Lens Discomfort|0|||
125265517|NCT01882465|450601699|FG000|Period 1|Withdrawal by Subject|0|||
125265518|NCT01882465|450601700|FG001|Period 1|Withdrawal by Subject|0|||
125265519|NCT01882465|450601701|FG002|Period 1|Withdrawal by Subject|0|||
125265520|NCT01882465|450601702|FG003|Period 1|Withdrawal by Subject|0|||
125265521|NCT01882465|450601703|FG004|Period 1|Withdrawal by Subject|0|||
125265522|NCT01882465|450601704|FG005|Period 1|Withdrawal by Subject|0|||
125265523|NCT01882465|450601705|FG006|Period 1|Withdrawal by Subject|1|||
125265524|NCT01882465|450601699|FG000|Period 2|Protocol Violation|0|||
125265525|NCT01882465|450601700|FG001|Period 2|Protocol Violation|0|||
125265526|NCT01882465|450601701|FG002|Period 2|Protocol Violation|0|||
125265527|NCT01882465|450601702|FG003|Period 2|Protocol Violation|0|||
125265528|NCT01882465|450601703|FG004|Period 2|Protocol Violation|1|||
125265529|NCT01882465|450601704|FG005|Period 2|Protocol Violation|0|||
125265530|NCT01882465|450601705|FG006|Period 2|Protocol Violation|0|||
125265531|NCT02259114|450601710|FG000|Overall Study|Progressive Disease|14|||
125265532|NCT02259114|450601711|FG001|Overall Study|Progressive Disease|2|||
125265533|NCT02259114|450601712|FG002|Overall Study|Progressive Disease|10|||
125265534|NCT02259114|450601713|FG003|Overall Study|Progressive Disease|2|||
125265535|NCT02259114|450601714|FG004|Overall Study|Progressive Disease|5|||
125265536|NCT02259114|450601710|FG000|Overall Study|Adverse Event|2|||
125265537|NCT02259114|450601711|FG001|Overall Study|Adverse Event|1|||
125447272|NCT01052662|451262771|FG000|Overall Study|Withdrawal by Subject|3|||
125447273|NCT01052662|451262772|FG001|Overall Study|Withdrawal by Subject|2|||
125265538|NCT02259114|450601712|FG002|Overall Study|Adverse Event|0|||
125265539|NCT02259114|450601713|FG003|Overall Study|Adverse Event|0|||
125265540|NCT02259114|450601714|FG004|Overall Study|Adverse Event|1|||
125265541|NCT02259114|450601710|FG000|Overall Study|Death|3|||
125265542|NCT02259114|450601711|FG001|Overall Study|Death|0|||
125265543|NCT02259114|450601712|FG002|Overall Study|Death|1|||
125265544|NCT02259114|450601713|FG003|Overall Study|Death|0|||
125265545|NCT02259114|450601714|FG004|Overall Study|Death|0|||
125265546|NCT02259114|450601710|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
125265547|NCT02259114|450601711|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
125265548|NCT02259114|450601712|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
125265549|NCT02259114|450601713|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
125265550|NCT02259114|450601714|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
125265551|NCT02259114|450601710|FG000|Overall Study|Withdrawal by Subject|0|||
125265552|NCT02259114|450601711|FG001|Overall Study|Withdrawal by Subject|0|||
125447274|NCT01052662|451262773|FG002|Overall Study|Withdrawal by Subject|1|||
125447275|NCT01052662|451262771|FG000|Overall Study|Pharmacy issue|1|||
125447276|NCT01052662|451262772|FG001|Overall Study|Pharmacy issue|3|||
125447277|NCT01052662|451262773|FG002|Overall Study|Pharmacy issue|3|||
125447278|NCT01052662|451262771|FG000|Overall Study|Adverse Event|1|||
125447279|NCT01052662|451262772|FG001|Overall Study|Adverse Event|1|||
125447280|NCT01052662|451262773|FG002|Overall Study|Adverse Event|0|||
125447281|NCT01052662|451262771|FG000|Overall Study|Legal Problem|2|||
125447282|NCT01052662|451262772|FG001|Overall Study|Legal Problem|0|||
125447283|NCT01052662|451262773|FG002|Overall Study|Legal Problem|0|||
125447284|NCT01052662|451262771|FG000|Overall Study|Administrative|0|||
125447285|NCT01052662|451262772|FG001|Overall Study|Administrative|3|||
125447286|NCT01052662|451262773|FG002|Overall Study|Administrative|0|||
125447287|NCT02015663|451262775|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
125447288|NCT02015663|451262776|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
125447289|NCT02015663|451262775|FG000|Overall Study|Withdrawal by Subject|1|||
125447290|NCT02015663|451262776|FG001|Overall Study|Withdrawal by Subject|0|||
125447291|NCT02015663|451262775|FG000|Overall Study|Protocol Violation|0|||
125447292|NCT02015663|451262776|FG001|Overall Study|Protocol Violation|1|||
125447293|NCT02015663|451262775|FG000|Overall Study|Adverse Event|3|||
125447294|NCT02015663|451262776|FG001|Overall Study|Adverse Event|0|||
125447295|NCT02015663|451262775|FG000|Overall Study|Administrative problems|10|||
125265553|NCT02259114|450601712|FG002|Overall Study|Withdrawal by Subject|1|||
125265554|NCT02259114|450601713|FG003|Overall Study|Withdrawal by Subject|1|||
125265555|NCT02259114|450601714|FG004|Overall Study|Withdrawal by Subject|0|||
125265556|NCT02259114|450601710|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
125265557|NCT02259114|450601711|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
125265558|NCT02259114|450601712|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
125265559|NCT02259114|450601713|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
125265560|NCT02259114|450601714|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
125265561|NCT02259114|450601710|FG000|Overall Study|Not Treated|1|||
125265562|NCT02259114|450601711|FG001|Overall Study|Not Treated|0|||
125265563|NCT02259114|450601712|FG002|Overall Study|Not Treated|0|||
125265564|NCT02259114|450601713|FG003|Overall Study|Not Treated|0|||
125265565|NCT02259114|450601714|FG004|Overall Study|Not Treated|0|||
125265566|NCT03937479|450601715|FG000|Overall Study|Adverse Event|2|||
125265567|NCT03937479|450601716|FG001|Overall Study|Adverse Event|3|||
125265568|NCT03937479|450601717|FG002|Overall Study|Adverse Event|0|||
125265569|NCT03937479|450601718|FG003|Overall Study|Adverse Event|0|||
125265570|NCT03937479|450601719|FG004|Overall Study|Adverse Event|1|||
125265571|NCT03937479|450601715|FG000|Overall Study|Withdrawal by Subject|3|||
125265572|NCT03937479|450601716|FG001|Overall Study|Withdrawal by Subject|5|||
125265573|NCT03937479|450601717|FG002|Overall Study|Withdrawal by Subject|2|||
125265574|NCT03937479|450601718|FG003|Overall Study|Withdrawal by Subject|2|||
125265575|NCT03937479|450601719|FG004|Overall Study|Withdrawal by Subject|1|||
125265576|NCT03937479|450601715|FG000|Overall Study|Protocol Violation|5|||
125265577|NCT03937479|450601716|FG001|Overall Study|Protocol Violation|6|||
125265578|NCT03937479|450601717|FG002|Overall Study|Protocol Violation|4|||
125265579|NCT03937479|450601718|FG003|Overall Study|Protocol Violation|3|||
125265580|NCT03937479|450601719|FG004|Overall Study|Protocol Violation|2|||
125265581|NCT03937479|450601715|FG000|Overall Study|Lost to Follow-up|0|||
125265582|NCT03937479|450601716|FG001|Overall Study|Lost to Follow-up|1|||
125265583|NCT03937479|450601717|FG002|Overall Study|Lost to Follow-up|0|||
125265584|NCT03937479|450601718|FG003|Overall Study|Lost to Follow-up|1|||
125265585|NCT03937479|450601719|FG004|Overall Study|Lost to Follow-up|0|||
125265586|NCT03937479|450601715|FG000|Overall Study|Physician Decision|0|||
125265587|NCT03937479|450601716|FG001|Overall Study|Physician Decision|0|||
125265588|NCT03937479|450601717|FG002|Overall Study|Physician Decision|1|||
125265589|NCT03937479|450601718|FG003|Overall Study|Physician Decision|0|||
125265590|NCT03937479|450601719|FG004|Overall Study|Physician Decision|1|||
125265591|NCT01378117|450601723|FG000|Overall Study|withdrawal|2|||
125265592|NCT01378117|450601724|FG001|Overall Study|withdrawal|1|||
125265593|NCT01378117|450601725|FG002|Overall Study|withdrawal|2|||
125447296|NCT02015663|451262776|FG001|Overall Study|Administrative problems|11|||
125447297|NCT00419003|451262777|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
125447298|NCT00419003|451262778|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
125265594|NCT01378117|450601723|FG000|Overall Study|discharged before med given|2|||
125265595|NCT01378117|450601724|FG001|Overall Study|discharged before med given|0|||
125265596|NCT01378117|450601725|FG002|Overall Study|discharged before med given|1|||
125265597|NCT02961244|450601726|FG000|Overall Study|Protocol Violation|0|||
125265598|NCT02961244|450601727|FG001|Overall Study|Protocol Violation|1|||
125265599|NCT02961244|450601726|FG000|Overall Study|Withdrawal by Subject|1|||
125265600|NCT02961244|450601727|FG001|Overall Study|Withdrawal by Subject|2|||
125265601|NCT02961244|450601726|FG000|Overall Study|Surgery plan change after study approval|0|||
125447299|NCT00419003|451262777|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
125265602|NCT02961244|450601727|FG001|Overall Study|Surgery plan change after study approval|2|||
125265603|NCT02961244|450601726|FG000|Overall Study|Lost to Follow-up|0|||
125265604|NCT02961244|450601727|FG001|Overall Study|Lost to Follow-up|2|||
125265605|NCT02961244|450601726|FG000|Overall Study|İnadequate data|0|||
125265606|NCT02961244|450601727|FG001|Overall Study|İnadequate data|2|||
125265607|NCT01854528|450601728|FG000|Overall Study|Adverse Event|0|||
125265608|NCT01854528|450601729|FG001|Overall Study|Adverse Event|4|||
125265609|NCT01854528|450601728|FG000|Overall Study|Withdrawal by Subject|0|||
125265610|NCT01854528|450601729|FG001|Overall Study|Withdrawal by Subject|2|||
125265611|NCT01854528|450601728|FG000|Overall Study|Virologic Failure|0|||
125265612|NCT01854528|450601729|FG001|Overall Study|Virologic Failure|9|||
125265613|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
125265614|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
125265615|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
125265616|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
125265617|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
125265618|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
125265619|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
125265620|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
125265621|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
125265622|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
125265623|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
125265624|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
125265625|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
125265626|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
125265627|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
125265628|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
125265629|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
125265630|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
125265631|NCT03789292|450601730|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
125265632|NCT03789292|450601731|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
125265633|NCT03789292|450601732|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
125265634|NCT03789292|450601730|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
125265635|NCT03789292|450601731|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
125265636|NCT03789292|450601732|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
125265637|NCT03789292|450601730|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
125265638|NCT03789292|450601731|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
125265639|NCT03789292|450601732|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
125265640|NCT03789292|450601730|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
125265641|NCT03789292|450601731|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
125265642|NCT03789292|450601732|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
125265643|NCT03789292|450601730|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
125265644|NCT03789292|450601731|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
125265645|NCT03789292|450601732|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
125265646|NCT03789292|450601730|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
125265647|NCT03789292|450601731|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
125265648|NCT03789292|450601732|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
125265649|NCT03789292|450601730|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
125265650|NCT03789292|450601731|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
125265651|NCT03789292|450601732|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
125265652|NCT01904721|450601734|FG000|Overall Study|Other Reasons|0|||
125265653|NCT01904721|450601735|FG001|Overall Study|Other Reasons|0|||
125265654|NCT01904721|450601736|FG002|Overall Study|Other Reasons|1|||
125265655|NCT01904721|450601737|FG003|Overall Study|Other Reasons|1|||
125265656|NCT01904721|450601738|FG004|Overall Study|Other Reasons|2|||
125265657|NCT01904721|450601739|FG005|Overall Study|Other Reasons|2|||
125265658|NCT01904721|450601740|FG006|Overall Study|Other Reasons|2|||
125265659|NCT01904721|450601734|FG000|Overall Study|Personal Reasons|0|||
125265660|NCT01904721|450601735|FG001|Overall Study|Personal Reasons|0|||
125265661|NCT01904721|450601736|FG002|Overall Study|Personal Reasons|0|||
125265662|NCT01904721|450601737|FG003|Overall Study|Personal Reasons|0|||
125265663|NCT01904721|450601738|FG004|Overall Study|Personal Reasons|2|||
125265664|NCT01904721|450601739|FG005|Overall Study|Personal Reasons|3|||
125265665|NCT01904721|450601740|FG006|Overall Study|Personal Reasons|3|||
125265666|NCT01904721|450601734|FG000|Overall Study|Lost to Follow-up|0|||
125265667|NCT01904721|450601735|FG001|Overall Study|Lost to Follow-up|0|||
125265668|NCT01904721|450601736|FG002|Overall Study|Lost to Follow-up|0|||
125265669|NCT01904721|450601737|FG003|Overall Study|Lost to Follow-up|0|||
125265670|NCT01904721|450601738|FG004|Overall Study|Lost to Follow-up|1|||
125265671|NCT01904721|450601739|FG005|Overall Study|Lost to Follow-up|3|||
125398681|NCT02103478|451093180|FG005|Overall Study|Death|15|||
125398682|NCT02103478|451093181|FG006|Overall Study|Death|14|||
125265672|NCT01904721|450601740|FG006|Overall Study|Lost to Follow-up|1|||
125265673|NCT01904721|450601734|FG000|Overall Study|Lack of Efficacy|0|||
125265674|NCT01904721|450601735|FG001|Overall Study|Lack of Efficacy|0|||
125265675|NCT01904721|450601736|FG002|Overall Study|Lack of Efficacy|0|||
125265676|NCT01904721|450601737|FG003|Overall Study|Lack of Efficacy|0|||
125265677|NCT01904721|450601738|FG004|Overall Study|Lack of Efficacy|0|||
125265678|NCT01904721|450601739|FG005|Overall Study|Lack of Efficacy|0|||
125265679|NCT01904721|450601740|FG006|Overall Study|Lack of Efficacy|1|||
125265680|NCT01904721|450601734|FG000|Overall Study|Adverse Event|0|||
125265681|NCT01904721|450601735|FG001|Overall Study|Adverse Event|0|||
125265682|NCT01904721|450601736|FG002|Overall Study|Adverse Event|0|||
125265683|NCT01904721|450601737|FG003|Overall Study|Adverse Event|0|||
125265684|NCT01904721|450601738|FG004|Overall Study|Adverse Event|3|||
125265685|NCT01904721|450601739|FG005|Overall Study|Adverse Event|1|||
125265686|NCT01904721|450601740|FG006|Overall Study|Adverse Event|0|||
125265687|NCT01082614|450601741|FG000|Overall Study|Adverse Event|1|||
125265688|NCT01082614|450601742|FG001|Overall Study|Adverse Event|4|||
125265689|NCT01082614|450601741|FG000|Overall Study|Equipment Malfunction|0|||
125265690|NCT01082614|450601742|FG001|Overall Study|Equipment Malfunction|1|||
125265691|NCT01082614|450601741|FG000|Overall Study|Physician Decision|2|||
125265692|NCT01082614|450601742|FG001|Overall Study|Physician Decision|0|||
125265693|NCT00811720|450601746|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
125265694|NCT00811720|450601747|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
125265695|NCT00811720|450601746|FG000|All Treated Patients|Adverse Event|20|||
125265696|NCT00811720|450601747|FG001|All Treated Patients|Adverse Event|62|||
125265697|NCT00811720|450601746|FG000|All Treated Patients|Lack of Efficacy|22|||
125265698|NCT00811720|450601747|FG001|All Treated Patients|Lack of Efficacy|18|||
125265699|NCT00811720|450601746|FG000|All Treated Patients|Non-compliance|0|||
125265700|NCT00811720|450601747|FG001|All Treated Patients|Non-compliance|14|||
125265701|NCT00811720|450601746|FG000|All Treated Patients|Protocol Violation|9|||
125265702|NCT00811720|450601747|FG001|All Treated Patients|Protocol Violation|16|||
125265703|NCT00811720|450601746|FG000|All Treated Patients|Withdrawal by Subject|28|||
125265704|NCT00811720|450601747|FG001|All Treated Patients|Withdrawal by Subject|34|||
125265705|NCT00811720|450601746|FG000|All Treated Patients|Lost to Follow-up|10|||
125398683|NCT02103478|451093182|FG007|Overall Study|Death|10|||
125398684|NCT02103478|451093183|FG008|Overall Study|Death|11|||
125398685|NCT02103478|451093175|FG000|Overall Study|Progressive Disease|2|||
125398686|NCT02103478|451093176|FG001|Overall Study|Progressive Disease|1|||
125398687|NCT02103478|451093177|FG002|Overall Study|Progressive Disease|2|||
125398688|NCT02103478|451093178|FG003|Overall Study|Progressive Disease|0|||
125398689|NCT02103478|451093179|FG004|Overall Study|Progressive Disease|9|||
125398690|NCT02103478|451093180|FG005|Overall Study|Progressive Disease|1|||
125398691|NCT02103478|451093181|FG006|Overall Study|Progressive Disease|2|||
125398692|NCT02103478|451093182|FG007|Overall Study|Progressive Disease|0|||
125398693|NCT02103478|451093183|FG008|Overall Study|Progressive Disease|1|||
125398694|NCT02103478|451093175|FG000|Overall Study|Withdrawal by Subject|2|||
125398695|NCT02103478|451093176|FG001|Overall Study|Withdrawal by Subject|0|||
125398696|NCT02103478|451093177|FG002|Overall Study|Withdrawal by Subject|0|||
125398697|NCT02103478|451093178|FG003|Overall Study|Withdrawal by Subject|4|||
125398698|NCT02103478|451093179|FG004|Overall Study|Withdrawal by Subject|0|||
125398699|NCT02103478|451093180|FG005|Overall Study|Withdrawal by Subject|0|||
125398700|NCT02103478|451093181|FG006|Overall Study|Withdrawal by Subject|1|||
125398701|NCT02103478|451093182|FG007|Overall Study|Withdrawal by Subject|1|||
125398702|NCT02103478|451093183|FG008|Overall Study|Withdrawal by Subject|0|||
125398703|NCT02103478|451093175|FG000|Overall Study|Lost to Follow-up|0|||
125398704|NCT02103478|451093176|FG001|Overall Study|Lost to Follow-up|0|||
125398705|NCT02103478|451093177|FG002|Overall Study|Lost to Follow-up|0|||
125398706|NCT02103478|451093178|FG003|Overall Study|Lost to Follow-up|0|||
125398707|NCT02103478|451093179|FG004|Overall Study|Lost to Follow-up|0|||
125398708|NCT02103478|451093180|FG005|Overall Study|Lost to Follow-up|0|||
125398709|NCT02103478|451093181|FG006|Overall Study|Lost to Follow-up|0|||
125398710|NCT02103478|451093182|FG007|Overall Study|Lost to Follow-up|1|||
125398711|NCT02103478|451093183|FG008|Overall Study|Lost to Follow-up|0|||
125398712|NCT02103478|451093175|FG000|Overall Study|Other|1|||
125265706|NCT00811720|450601747|FG001|All Treated Patients|Lost to Follow-up|16|||
125398713|NCT02103478|451093176|FG001|Overall Study|Other|3|||
125398714|NCT02103478|451093177|FG002|Overall Study|Other|2|||
125398715|NCT02103478|451093178|FG003|Overall Study|Other|0|||
125398716|NCT02103478|451093179|FG004|Overall Study|Other|3|||
125398717|NCT02103478|451093180|FG005|Overall Study|Other|8|||
125398718|NCT02103478|451093181|FG006|Overall Study|Other|8|||
125398719|NCT02103478|451093182|FG007|Overall Study|Other|4|||
125398720|NCT02103478|451093183|FG008|Overall Study|Other|2|||
125265707|NCT00811720|450601746|FG000|All Treated Patients|Other Reason|7|||
125265708|NCT00811720|450601747|FG001|All Treated Patients|Other Reason|4|||
125398721|NCT03219333|451093184|FG000|Overall Study|Withdrawal by Subject|9|||
125265709|NCT01077063|450601748|FG000|Overall Study|Adverse Event|3|||
125265710|NCT01077063|450601749|FG001|Overall Study|Adverse Event|0|||
125398722|NCT03219333|451093185|FG001|Overall Study|Withdrawal by Subject|4|||
125265711|NCT01077063|450601748|FG000|Overall Study|Death|1|||
125265712|NCT01077063|450601749|FG001|Overall Study|Death|1|||
125265713|NCT01077063|450601748|FG000|Overall Study|Withdrawal by Subject|0|||
125265714|NCT01077063|450601749|FG001|Overall Study|Withdrawal by Subject|2|||
125265715|NCT02750930|450601750|FG000|Overall Study|Study closed/terminated|8|||
125265716|NCT03894891|450601751|FG000|Overall Study|Withdrawal by Subject|1|||
125265717|NCT03894891|450601751|FG000|Overall Study|Completed protocol treatment per protocol|5|||
125265718|NCT00553631|450601753|FG000|Overall Study|Withdrawal by Subject|0|||
125265719|NCT00553631|450601754|FG001|Overall Study|Withdrawal by Subject|1|||
125265720|NCT00553631|450601753|FG000|Overall Study|Lost to Follow-up|1|||
125265721|NCT00553631|450601754|FG001|Overall Study|Lost to Follow-up|0|||
125265722|NCT02761642|450601755|FG000|Overall Study|Did not Receive Study Treatment|3|||
125265723|NCT02761642|450601755|FG000|Overall Study|Adverse Event|13|||
125265724|NCT02761642|450601755|FG000|Overall Study|Withdrawal by Subject|2|||
125265725|NCT02761642|450601755|FG000|Overall Study|Non-compliant|7|||
125265726|NCT02761642|450601755|FG000|Overall Study|Death|3|||
125265727|NCT02761642|450601755|FG000|Overall Study|Lack of Efficacy|20|||
125265728|NCT02761642|450601755|FG000|Overall Study|Physician Decision|1|||
125265729|NCT02761642|450601755|FG000|Overall Study|Reason Unspecified|21|||
125265730|NCT00950651|450601756|FG000|Overall Study|Adverse Event|17|||
125265731|NCT00950651|450601757|FG001|Overall Study|Adverse Event|20|||
125265732|NCT00950651|450601756|FG000|Overall Study|Death|1|||
125265733|NCT00950651|450601757|FG001|Overall Study|Death|0|||
125265734|NCT00950651|450601756|FG000|Overall Study|Lack of Efficacy|2|||
125265735|NCT00950651|450601757|FG001|Overall Study|Lack of Efficacy|2|||
125265736|NCT00950651|450601756|FG000|Overall Study|Protocol Violation|3|||
125398723|NCT03219333|451093184|FG000|Overall Study|Lost to Follow-up|1|||
125398724|NCT03219333|451093185|FG001|Overall Study|Lost to Follow-up|1|||
125398725|NCT03219333|451093184|FG000|Overall Study|Death|104|||
125398726|NCT03219333|451093185|FG001|Overall Study|Death|72|||
125398727|NCT03219333|451093184|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
125398728|NCT03219333|451093185|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
125398729|NCT03219333|451093184|FG000|Overall Study|Other|2|||
125398730|NCT03219333|451093185|FG001|Overall Study|Other|2|||
125398731|NCT04530552|451093188|FG000|Overall Study|Physician Decision|0|||
125398732|NCT04530552|451093189|FG001|Overall Study|Physician Decision|1|||
125398733|NCT04530552|451093188|FG000|Overall Study|Withdrawal by Subject|0|||
125398734|NCT04530552|451093189|FG001|Overall Study|Withdrawal by Subject|1|||
125398735|NCT04530552|451093188|FG000|Overall Study|Adverse Event|0|||
125398736|NCT04530552|451093189|FG001|Overall Study|Adverse Event|1|||
125398737|NCT04530552|451093188|FG000|Overall Study|No surgery|0|||
125398738|NCT04530552|451093189|FG001|Overall Study|No surgery|1|||
125398739|NCT03748641|451093190|FG000|Overall Study|Ongoing|155|||
125398740|NCT03748641|451093191|FG001|Overall Study|Ongoing|148|||
125398741|NCT03748641|451093192|FG002|Overall Study|Ongoing|66|||
125398742|NCT03748641|451093193|FG003|Overall Study|Ongoing|79|||
125398743|NCT03748641|451093194|FG004|Overall Study|Ongoing|84|||
125398744|NCT03748641|451093190|FG000|Overall Study|Death|54|||
125398745|NCT03748641|451093191|FG001|Overall Study|Death|59|||
125398746|NCT03748641|451093192|FG002|Overall Study|Death|51|||
125398747|NCT03748641|451093193|FG003|Overall Study|Death|42|||
125398748|NCT03748641|451093194|FG004|Overall Study|Death|9|||
125398749|NCT03748641|451093190|FG000|Overall Study|Lost to Follow-up|0|||
125398750|NCT03748641|451093191|FG001|Overall Study|Lost to Follow-up|2|||
125398751|NCT03748641|451093192|FG002|Overall Study|Lost to Follow-up|1|||
125398752|NCT03748641|451093193|FG003|Overall Study|Lost to Follow-up|0|||
125398753|NCT03748641|451093194|FG004|Overall Study|Lost to Follow-up|0|||
125398754|NCT03748641|451093190|FG000|Overall Study|Withdrawal by Subject|3|||
125398755|NCT03748641|451093191|FG001|Overall Study|Withdrawal by Subject|2|||
125398756|NCT03748641|451093192|FG002|Overall Study|Withdrawal by Subject|5|||
125398757|NCT03748641|451093193|FG003|Overall Study|Withdrawal by Subject|3|||
125398758|NCT03748641|451093194|FG004|Overall Study|Withdrawal by Subject|2|||
125398759|NCT06034496|451093195|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
125398760|NCT06034496|451093196|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
125398761|NCT06034496|451093195|FG000|Overall Study|Withdrawal by Subject|5|||
125398762|NCT06034496|451093196|FG001|Overall Study|Withdrawal by Subject|4|||
125398763|NCT04397263|451093199|FG000|Overall Study|Withdrawal by Subject|2|||
125398764|NCT03277261|451093202|FG000|Overall Study|Adverse Event|17|||
125398765|NCT03277261|451093203|FG001|Overall Study|Adverse Event|1|||
125265737|NCT00950651|450601757|FG001|Overall Study|Protocol Violation|4|||
125265738|NCT00950651|450601756|FG000|Overall Study|Withdrawal by Subject|8|||
125398766|NCT03277261|451093202|FG000|Overall Study|Participant Withdrawal of Consent|6|||
125398767|NCT03277261|451093203|FG001|Overall Study|Participant Withdrawal of Consent|15|||
125398768|NCT03277261|451093202|FG000|Overall Study|Investigator / Sponsor Decision|4|||
125398769|NCT03277261|451093203|FG001|Overall Study|Investigator / Sponsor Decision|2|||
125265739|NCT00950651|450601757|FG001|Overall Study|Withdrawal by Subject|9|||
125398770|NCT03277261|451093202|FG000|Overall Study|Pregnancy|2|||
125265740|NCT02850978|450601762|FG000|Overall Study|Uncollectable CRF|27|||
125265741|NCT02850978|450601762|FG000|Overall Study|No visit since the first visit|35|||
125265742|NCT02850978|450601762|FG000|Overall Study|Adverse Event|81|||
125265743|NCT02850978|450601762|FG000|Overall Study|Lack of Efficacy|40|||
125265744|NCT02850978|450601762|FG000|Overall Study|Improvement in condition|34|||
125265745|NCT02850978|450601762|FG000|Overall Study|Lost to Follow-up|121|||
125265746|NCT02850978|450601762|FG000|Overall Study|Reason not listed|88|||
125265747|NCT03188263|450601766|FG000|Overall Study|Withdrawal by Subject|3|||
125265748|NCT03188263|450601767|FG001|Overall Study|Withdrawal by Subject|0|||
125265749|NCT03188263|450601766|FG000|Overall Study|Physician Decision|1|||
125265750|NCT03188263|450601767|FG001|Overall Study|Physician Decision|0|||
125265751|NCT01030822|450601768|FG000|Overall Study|Moved/migrated from study area|6|||
125265752|NCT01030822|450601769|FG001|Overall Study|Moved/migrated from study area|7|||
125265753|NCT01030822|450601770|FG002|Overall Study|Moved/migrated from study area|3|||
125265754|NCT01030822|450601768|FG000|Overall Study|Withdrawal by Subject|16|||
125265755|NCT01030822|450601769|FG001|Overall Study|Withdrawal by Subject|13|||
125265756|NCT01030822|450601770|FG002|Overall Study|Withdrawal by Subject|16|||
125265757|NCT01030822|450601768|FG000|Overall Study|Lost to Follow-up|9|||
125265758|NCT01030822|450601769|FG001|Overall Study|Lost to Follow-up|4|||
125265759|NCT01030822|450601770|FG002|Overall Study|Lost to Follow-up|7|||
125265760|NCT00539240|450601771|FG000|Overall Study|Withdrawal by Subject|0|||
125265761|NCT00539240|450601772|FG001|Overall Study|Withdrawal by Subject|2|||
125265762|NCT00539240|450601773|FG002|Overall Study|Withdrawal by Subject|0|||
125265763|NCT00539240|450601771|FG000|Overall Study|Protocol Violation|1|||
125265764|NCT00539240|450601772|FG001|Overall Study|Protocol Violation|1|||
125265765|NCT00539240|450601773|FG002|Overall Study|Protocol Violation|4|||
125265766|NCT00539240|450601771|FG000|Overall Study|Lost to Follow-up|2|||
125265767|NCT00539240|450601772|FG001|Overall Study|Lost to Follow-up|3|||
125265768|NCT00539240|450601773|FG002|Overall Study|Lost to Follow-up|1|||
125265769|NCT00539240|450601771|FG000|Overall Study|Adverse Event|3|||
125265770|NCT00539240|450601772|FG001|Overall Study|Adverse Event|1|||
125265771|NCT00539240|450601773|FG002|Overall Study|Adverse Event|10|||
125265772|NCT01055613|450601775|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
125265773|NCT01055613|450601776|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125265774|NCT01055613|450601775|FG000|Overall Study|Unacceptable lens fit|1|||
125265775|NCT01055613|450601776|FG001|Overall Study|Unacceptable lens fit|0|||
125265776|NCT01055613|450601775|FG000|Overall Study|Discomfort|2|||
125265777|NCT01055613|450601776|FG001|Overall Study|Discomfort|1|||
125265778|NCT01055613|450601775|FG000|Overall Study|Lost to Follow-up|1|||
125265779|NCT01055613|450601776|FG001|Overall Study|Lost to Follow-up|1|||
125265780|NCT01055613|450601775|FG000|Overall Study|Protocol Violation|1|||
125265781|NCT01055613|450601776|FG001|Overall Study|Protocol Violation|1|||
125265782|NCT01055613|450601775|FG000|Overall Study|Subject Disinterest|1|||
125265783|NCT01055613|450601776|FG001|Overall Study|Subject Disinterest|1|||
125265784|NCT02765399|450601777|FG000|Overall Study|Nausea|1|||
125265785|NCT02765399|450601778|FG001|Overall Study|Nausea|0|||
125265786|NCT01182298|450601787|FG000|Overall Study|Lack of Efficacy|4|||
125265787|NCT01182298|450601787|FG000|Overall Study|Withdrawal by Subject|2|||
125265788|NCT04540367|450601801|FG000|Overall Study|Withdrawal by Subject|0|||
125265789|NCT04540367|450601802|FG001|Overall Study|Withdrawal by Subject|0|||
125265790|NCT04540367|450601803|FG002|Overall Study|Withdrawal by Subject|0|||
125265791|NCT04540367|450601804|FG003|Overall Study|Withdrawal by Subject|2|||
125265792|NCT04540367|450601801|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
125265793|NCT04540367|450601802|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
125265794|NCT04540367|450601803|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
125265795|NCT04540367|450601804|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
125265796|NCT04540367|450601801|FG000|Overall Study|Adverse Event|0|||
125265797|NCT04540367|450601802|FG001|Overall Study|Adverse Event|0|||
125265798|NCT04540367|450601803|FG002|Overall Study|Adverse Event|1|||
125265799|NCT04540367|450601804|FG003|Overall Study|Adverse Event|1|||
125265800|NCT03958331|450601806|FG000|Overall Study|Withdrawal by Subject|3|||
125265801|NCT03958331|450601807|FG001|Overall Study|Withdrawal by Subject|1|||
125265802|NCT03958331|450601808|FG002|Overall Study|Withdrawal by Subject|5|||
125265803|NCT03958331|450601806|FG000|Overall Study|Weaned from medicine|2|||
125398771|NCT03277261|451093203|FG001|Overall Study|Pregnancy|0|||
125398772|NCT03277261|451093202|FG000|Overall Study|Lost to Follow-up|2|||
125265804|NCT03958331|450601807|FG001|Overall Study|Weaned from medicine|0|||
125265805|NCT03958331|450601808|FG002|Overall Study|Weaned from medicine|0|||
125265806|NCT03958331|450601806|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
125265807|NCT03958331|450601807|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
125265808|NCT03958331|450601808|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
125265809|NCT04422431|450601811|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
125265810|NCT04422431|450601811|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
125265811|NCT04422431|450601811|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
125265812|NCT04422431|450601811|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
125265813|NCT04422431|450601811|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
125265814|NCT04422431|450601811|FG000|Extension Period (48 Weeks)|Other than specified|2|||
125265815|NCT02317627|450601814|FG000|Overall Study|Withdrawal by Subject|0|||
125265816|NCT02317627|450601815|FG001|Overall Study|Withdrawal by Subject|1|||
125265817|NCT02317627|450601816|FG002|Overall Study|Withdrawal by Subject|1|||
125265818|NCT02317627|450601814|FG000|Overall Study|Lost to Follow-up|2|||
125265819|NCT02317627|450601815|FG001|Overall Study|Lost to Follow-up|0|||
125265820|NCT02317627|450601816|FG002|Overall Study|Lost to Follow-up|0|||
125265821|NCT02317627|450601814|FG000|Overall Study|Stopped by Investigator|0|||
125265822|NCT02317627|450601815|FG001|Overall Study|Stopped by Investigator|1|||
125265823|NCT02317627|450601816|FG002|Overall Study|Stopped by Investigator|0|||
125265824|NCT02317627|450601814|FG000|Overall Study|Adverse Event|0|||
125265825|NCT02317627|450601815|FG001|Overall Study|Adverse Event|2|||
125265826|NCT02317627|450601816|FG002|Overall Study|Adverse Event|3|||
125265827|NCT02317627|450601814|FG000|Overall Study|Non-compliance with study drug|0|||
125265828|NCT02317627|450601815|FG001|Overall Study|Non-compliance with study drug|1|||
125265829|NCT02317627|450601816|FG002|Overall Study|Non-compliance with study drug|0|||
125265830|NCT01088906|450601818|FG000|Overall Study|Inclusion error|1|||
125265831|NCT01088906|450601818|FG000|Overall Study|Did not receive study treatment|3|||
125265832|NCT01088906|450601818|FG000|Overall Study|Missing data|1|||
125265833|NCT00027560|450601819|FG000|Overall Study|Withdrawal by Subject|1|||
125265834|NCT03384875|450601820|FG000|Overall Study|Death|1|||
125265835|NCT03384875|450601821|FG001|Overall Study|Death|1|||
125265836|NCT03384875|450601822|FG002|Overall Study|Death|0|||
125265837|NCT03384875|450601820|FG000|Overall Study|Reason not provided|1|||
125265838|NCT03384875|450601821|FG001|Overall Study|Reason not provided|0|||
125265839|NCT03384875|450601822|FG002|Overall Study|Reason not provided|0|||
125265840|NCT01772550|450603182|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
125265841|NCT01772550|450603183|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
125265842|NCT01772550|450603184|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
125265843|NCT01772550|450603182|FG000|Overall Study|Adverse Event|0|||
125265844|NCT01772550|450603183|FG001|Overall Study|Adverse Event|0|||
125265845|NCT01772550|450603184|FG002|Overall Study|Adverse Event|1|||
125265846|NCT03374358|450603187|FG000|Overall Study|Withdrawal by Subject|0|||
125265847|NCT03374358|450603188|FG001|Overall Study|Withdrawal by Subject|2|||
125265848|NCT03183063|450603189|FG000|Overall Study|Withdrawal by Subject|2|||
125265849|NCT03183063|450603190|FG001|Overall Study|Withdrawal by Subject|0|||
125265850|NCT03183063|450603191|FG002|Overall Study|Withdrawal by Subject|0|||
125265851|NCT03183063|450603189|FG000|Overall Study|Physician Decision|3|||
125265852|NCT03183063|450603190|FG001|Overall Study|Physician Decision|4|||
125265853|NCT03183063|450603191|FG002|Overall Study|Physician Decision|4|||
125265854|NCT01127633|450603192|FG000|Overall Study|Adverse Event|74|||
125265855|NCT01127633|450603193|FG001|Overall Study|Adverse Event|73|||
125265856|NCT01127633|450603192|FG000|Overall Study|Death|40|||
125265857|NCT01127633|450603193|FG001|Overall Study|Death|43|||
125265858|NCT01127633|450603192|FG000|Overall Study|Lost to Follow-up|4|||
125265859|NCT01127633|450603193|FG001|Overall Study|Lost to Follow-up|0|||
125265860|NCT01127633|450603192|FG000|Overall Study|Parent/Caregiver Decision|246|||
125265861|NCT01127633|450603193|FG001|Overall Study|Parent/Caregiver Decision|228|||
125265862|NCT01127633|450603192|FG000|Overall Study|Physician Decision|60|||
125265863|NCT01127633|450603193|FG001|Overall Study|Physician Decision|45|||
125265864|NCT01127633|450603192|FG000|Overall Study|Withdrawal by Subject|57|||
125265865|NCT01127633|450603193|FG001|Overall Study|Withdrawal by Subject|72|||
125265866|NCT01127633|450603192|FG000|Overall Study|Sponsor Decision|163|||
125265867|NCT01127633|450603193|FG001|Overall Study|Sponsor Decision|195|||
125265868|NCT01127633|450603192|FG000|Overall Study|Protocol Violation|8|||
125265869|NCT01127633|450603193|FG001|Overall Study|Protocol Violation|16|||
125265870|NCT01127633|450603192|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
125265871|NCT01127633|450603193|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
125265872|NCT01127633|450603192|FG000|Overall Study|Not treated|1|||
125265873|NCT01127633|450603193|FG001|Overall Study|Not treated|0|||
125265874|NCT00688467|450603195|FG000|Treatment Period 1|Adverse Event|2|||
125447300|NCT00419003|451262778|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
125447301|NCT00162942|451262779|FG000|Overall Study|Adverse Event|10|||
125265875|NCT00688467|450603196|FG001|Treatment Period 1|Adverse Event|1|||
125447302|NCT00162942|451262780|FG001|Overall Study|Adverse Event|6|||
125447303|NCT00162942|451262779|FG000|Overall Study|Death|1|||
125265876|NCT00688467|450603195|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
125265877|NCT00688467|450603196|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
125265878|NCT00688467|450603195|FG000|Treatment Period 2|Protocol Violation|0|||
125265879|NCT00688467|450603196|FG001|Treatment Period 2|Protocol Violation|1|||
125265880|NCT00688467|450603195|FG000|Treatment Period 2|Adverse Event|0|||
125265881|NCT00688467|450603196|FG001|Treatment Period 2|Adverse Event|1|||
125265882|NCT00690794|450603199|FG000|Overall Study|Adverse Event|12|||
125265883|NCT00690794|450603200|FG001|Overall Study|Adverse Event|10|||
125265884|NCT00690794|450603199|FG000|Overall Study|Lost to Follow-up|1|||
125265885|NCT00690794|450603200|FG001|Overall Study|Lost to Follow-up|4|||
125265886|NCT00690794|450603199|FG000|Overall Study|Withdrawal by Subject|0|||
125265887|NCT00690794|450603200|FG001|Overall Study|Withdrawal by Subject|9|||
125265888|NCT00690794|450603199|FG000|Overall Study|Protocol Violation|6|||
125265889|NCT00690794|450603200|FG001|Overall Study|Protocol Violation|7|||
125265890|NCT00690794|450603199|FG000|Overall Study|Noncompliance|1|||
125265891|NCT00690794|450603200|FG001|Overall Study|Noncompliance|2|||
125265892|NCT00690794|450603199|FG000|Overall Study|Other not specified|1|||
125265893|NCT00690794|450603200|FG001|Overall Study|Other not specified|3|||
125265894|NCT01823107|450603201|FG000|Overall Study|Withdrawal by Subject|1|||
125265895|NCT01343888|450603202|FG000|Overall Study|Adverse Event|12|||
125265896|NCT01343888|450603203|FG001|Overall Study|Adverse Event|22|||
125265897|NCT01343888|450603204|FG002|Overall Study|Adverse Event|5|||
125265898|NCT01343888|450603202|FG000|Overall Study|Lack of Efficacy|9|||
125265899|NCT01343888|450603203|FG001|Overall Study|Lack of Efficacy|9|||
125265900|NCT01343888|450603204|FG002|Overall Study|Lack of Efficacy|13|||
125265901|NCT01343888|450603202|FG000|Overall Study|Lost to Follow-up|0|||
125265902|NCT01343888|450603203|FG001|Overall Study|Lost to Follow-up|2|||
125265903|NCT01343888|450603204|FG002|Overall Study|Lost to Follow-up|1|||
125265904|NCT01343888|450603202|FG000|Overall Study|Protocol Violation|0|||
125265905|NCT01343888|450603203|FG001|Overall Study|Protocol Violation|2|||
125265906|NCT01343888|450603204|FG002|Overall Study|Protocol Violation|0|||
125265907|NCT01343888|450603202|FG000|Overall Study|Withdrawal by Subject|4|||
125265908|NCT01343888|450603203|FG001|Overall Study|Withdrawal by Subject|4|||
125265909|NCT01343888|450603204|FG002|Overall Study|Withdrawal by Subject|2|||
125265910|NCT01343888|450603202|FG000|Overall Study|other than stated above|0|||
125265911|NCT01343888|450603203|FG001|Overall Study|other than stated above|0|||
125265912|NCT01343888|450603204|FG002|Overall Study|other than stated above|1|||
125265913|NCT00800735|450603207|FG000|Overall Study|Administrative/Other|2|||
125265914|NCT00800735|450603207|FG000|Overall Study|Insufficient Therapeutic Response|2|||
125265915|NCT00800735|450603207|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
125265916|NCT00800735|450603207|FG000|Overall Study|Withdrew Consent|3|||
125265917|NCT02805790|450603208|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
125265918|NCT02805790|450603209|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
125265919|NCT04460183|450603210|FG000|Overall Study|Lost to Follow-up|3|||
125265920|NCT04460183|450603211|FG001|Overall Study|Lost to Follow-up|1|||
125265921|NCT04460183|450603210|FG000|Overall Study|Withdrawal by Subject|1|||
125265922|NCT04460183|450603211|FG001|Overall Study|Withdrawal by Subject|0|||
125265923|NCT00856323|450603212|FG000|Overall Study|Withdrawal by Subject|2|||
125265924|NCT01847092|450603213|FG000|Overall Study|Adverse Event|12|||
125265925|NCT01847092|450603214|FG001|Overall Study|Adverse Event|3|||
125265926|NCT01847092|450603213|FG000|Overall Study|Withdrawal by Subject|5|||
125265927|NCT01847092|450603214|FG001|Overall Study|Withdrawal by Subject|5|||
125265928|NCT01847092|450603213|FG000|Overall Study|Protocol Specified|8|||
125265929|NCT01847092|450603214|FG001|Overall Study|Protocol Specified|0|||
125265930|NCT01847092|450603213|FG000|Overall Study|Physician Decision|1|||
125265931|NCT01847092|450603214|FG001|Overall Study|Physician Decision|1|||
125265932|NCT01847092|450603213|FG000|Overall Study|Protocol Violation|0|||
125265933|NCT01847092|450603214|FG001|Overall Study|Protocol Violation|2|||
125265934|NCT00825994|450603215|FG000|Overall Study|Withdrawal by Subject|2|||
125265935|NCT00825994|450603215|FG000|Overall Study|Lost to Follow-up|1|||
125265936|NCT00825994|450603215|FG000|Overall Study|Protocol Violation|1|||
125265937|NCT00825994|450603215|FG000|Overall Study|Placebo Responder at V2|1|||
125265938|NCT01331681|450603216|FG000|Overall Study|Adverse Event|10|||
125265939|NCT01331681|450603217|FG001|Overall Study|Adverse Event|13|||
125265940|NCT01331681|450603218|FG002|Overall Study|Adverse Event|10|||
125265941|NCT01331681|450603216|FG000|Overall Study|Death|6|||
125265942|NCT01331681|450603217|FG001|Overall Study|Death|6|||
125265943|NCT01331681|450603218|FG002|Overall Study|Death|2|||
125265944|NCT01331681|450603216|FG000|Overall Study|Lack of Efficacy|0|||
125265945|NCT01331681|450603217|FG001|Overall Study|Lack of Efficacy|1|||
125265946|NCT01331681|450603218|FG002|Overall Study|Lack of Efficacy|0|||
125265947|NCT01331681|450603216|FG000|Overall Study|Withdrawal by Subject|12|||
125265948|NCT01331681|450603217|FG001|Overall Study|Withdrawal by Subject|8|||
125265949|NCT01331681|450603218|FG002|Overall Study|Withdrawal by Subject|15|||
125398773|NCT03277261|451093203|FG001|Overall Study|Lost to Follow-up|2|||
125265950|NCT01331681|450603216|FG000|Overall Study|Protocol Violation|1|||
125398774|NCT03277261|451093202|FG000|Overall Study|Lack of Efficacy|2|||
125265951|NCT01331681|450603217|FG001|Overall Study|Protocol Violation|1|||
125265952|NCT01331681|450603218|FG002|Overall Study|Protocol Violation|0|||
125265953|NCT01331681|450603216|FG000|Overall Study|Lost to Follow-up|2|||
125265954|NCT01331681|450603217|FG001|Overall Study|Lost to Follow-up|4|||
125265955|NCT01331681|450603218|FG002|Overall Study|Lost to Follow-up|1|||
125265956|NCT01331681|450603216|FG000|Overall Study|Physician Decision|2|||
125265957|NCT01331681|450603217|FG001|Overall Study|Physician Decision|0|||
125265958|NCT01331681|450603218|FG002|Overall Study|Physician Decision|4|||
125265959|NCT01331681|450603216|FG000|Overall Study|Therapeutic procedure required|1|||
125265960|NCT01331681|450603217|FG001|Overall Study|Therapeutic procedure required|0|||
125265961|NCT01331681|450603218|FG002|Overall Study|Therapeutic procedure required|0|||
125265962|NCT01331681|450603216|FG000|Overall Study|Sponsor decision|1|||
125265963|NCT01331681|450603217|FG001|Overall Study|Sponsor decision|1|||
125265964|NCT01331681|450603218|FG002|Overall Study|Sponsor decision|0|||
125265965|NCT01331681|450603216|FG000|Overall Study|Switching to other therapy|0|||
125265966|NCT01331681|450603217|FG001|Overall Study|Switching to other therapy|0|||
125265967|NCT01331681|450603218|FG002|Overall Study|Switching to other therapy|1|||
125265968|NCT01331681|450603216|FG000|Overall Study|Not Received Study Treatment|0|||
125265969|NCT01331681|450603217|FG001|Overall Study|Not Received Study Treatment|0|||
125265970|NCT01331681|450603218|FG002|Overall Study|Not Received Study Treatment|2|||
125265971|NCT00658541|450603220|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
125265972|NCT00658541|450603221|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125265973|NCT00658541|450603220|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
125265974|NCT00658541|450603221|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
125265975|NCT01063348|450603222|FG000|Overall Study|Lost to Follow-up|3|||
125265976|NCT01063348|450603223|FG001|Overall Study|Lost to Follow-up|10|||
125265977|NCT01876381|450603224|FG000|Overall Study|Lack of Efficacy|5|||
125265978|NCT01876381|450603224|FG000|Overall Study|Physician Decision|1|||
125265979|NCT01876381|450603224|FG000|Overall Study|Withdrawal by Subject|1|||
125265980|NCT02394561|450603225|FG000|CORE Phase|Adverse Event|7|||
125265981|NCT02394561|450603226|FG001|CORE Phase|Adverse Event|9|||
125265982|NCT02394561|450603225|FG000|CORE Phase|Death|0|||
125265983|NCT02394561|450603226|FG001|CORE Phase|Death|1|||
125265984|NCT02394561|450603225|FG000|CORE Phase|Pregnancy|1|||
125265985|NCT02394561|450603226|FG001|CORE Phase|Pregnancy|0|||
125265986|NCT02394561|450603225|FG000|CORE Phase|Lost to Follow-up|1|||
125265987|NCT02394561|450603226|FG001|CORE Phase|Lost to Follow-up|0|||
125265988|NCT02394561|450603225|FG000|CORE Phase|Physician Decision|1|||
125265989|NCT02394561|450603226|FG001|CORE Phase|Physician Decision|1|||
125265990|NCT02394561|450603225|FG000|CORE Phase|Withdrawal by Subject|2|||
125265991|NCT02394561|450603226|FG001|CORE Phase|Withdrawal by Subject|2|||
125265992|NCT02394561|450603225|FG000|CORE Phase|Lack of Efficacy|1|||
125265993|NCT02394561|450603226|FG001|CORE Phase|Lack of Efficacy|6|||
125265994|NCT02394561|450603225|FG000|Extension Phase|Adverse Event|6|||
125265995|NCT02394561|450603226|FG001|Extension Phase|Adverse Event|1|||
125265996|NCT02394561|450603225|FG000|Extension Phase|Death|0|||
125265997|NCT02394561|450603226|FG001|Extension Phase|Death|1|||
125265998|NCT02394561|450603225|FG000|Extension Phase|Protocol Violation|1|||
125265999|NCT02394561|450603226|FG001|Extension Phase|Protocol Violation|0|||
125266000|NCT02394561|450603225|FG000|Extension Phase|Lost to Follow-up|1|||
125266001|NCT02394561|450603226|FG001|Extension Phase|Lost to Follow-up|0|||
125266002|NCT02394561|450603225|FG000|Extension Phase|Physician Decision|0|||
125266003|NCT02394561|450603226|FG001|Extension Phase|Physician Decision|2|||
125266004|NCT02394561|450603225|FG000|Extension Phase|Withdrawal by Subject|0|||
125266005|NCT02394561|450603226|FG001|Extension Phase|Withdrawal by Subject|5|||
125266006|NCT02394561|450603225|FG000|Extension Phase|Lack of Efficacy|3|||
125266007|NCT02394561|450603226|FG001|Extension Phase|Lack of Efficacy|3|||
125266008|NCT00501644|450603227|FG000|Overall Study|Adverse Event|4|||
125266009|NCT00501644|450603227|FG000|Overall Study|Withdrawal by Subject|1|||
125266010|NCT04577781|450603228|FG000|Overall Study|Adverse Event|2|||
125266011|NCT04577781|450603229|FG001|Overall Study|Adverse Event|2|||
125266012|NCT04577781|450603228|FG000|Overall Study|Physician Decision|1|||
125266013|NCT04577781|450603229|FG001|Overall Study|Physician Decision|0|||
125266014|NCT01957865|450603230|FG000|Overall Study|Found HIV negative|0|||
125266015|NCT01957865|450603231|FG001|Overall Study|Found HIV negative|0|||
125266016|NCT01957865|450603232|FG002|Overall Study|Found HIV negative|1|||
125266017|NCT01957865|450603230|FG000|Overall Study|Lost to Follow-up|0|||
125266018|NCT01957865|450603231|FG001|Overall Study|Lost to Follow-up|2|||
125266019|NCT01957865|450603232|FG002|Overall Study|Lost to Follow-up|2|||
125266020|NCT02756403|450603240|FG000|Overall Study|Unable to swallow medication|0|||
125266021|NCT02756403|450603241|FG001|Overall Study|Unable to swallow medication|1|||
125266022|NCT02756403|450603242|FG002|Overall Study|Unable to swallow medication|1|||
125447304|NCT00162942|451262780|FG001|Overall Study|Death|0|||
125266023|NCT02756403|450603243|FG003|Overall Study|Unable to swallow medication|1|||
125266024|NCT02756403|450603240|FG000|Overall Study|Did not complete Procedure|0|||
125266025|NCT02756403|450603241|FG001|Overall Study|Did not complete Procedure|1|||
125447305|NCT00162942|451262779|FG000|Overall Study|Withdrawal by Subject|3|||
125266026|NCT02756403|450603242|FG002|Overall Study|Did not complete Procedure|0|||
125266027|NCT02756403|450603243|FG003|Overall Study|Did not complete Procedure|0|||
125266028|NCT02756403|450603240|FG000|Overall Study|Changed Mind About Procedure|0|||
125266029|NCT02756403|450603241|FG001|Overall Study|Changed Mind About Procedure|0|||
125266030|NCT02756403|450603242|FG002|Overall Study|Changed Mind About Procedure|1|||
125266031|NCT02756403|450603243|FG003|Overall Study|Changed Mind About Procedure|0|||
125266032|NCT02756403|450603240|FG000|Overall Study|Protocol Violation|0|||
125266033|NCT02756403|450603241|FG001|Overall Study|Protocol Violation|1|||
125266034|NCT02756403|450603242|FG002|Overall Study|Protocol Violation|0|||
125266035|NCT02756403|450603243|FG003|Overall Study|Protocol Violation|1|||
125266036|NCT01644643|450603244|FG000|Overall Study|Death|1|||
125266037|NCT01644643|450603245|FG001|Overall Study|Death|0|||
125266038|NCT01644643|450603246|FG002|Overall Study|Death|3|||
125266039|NCT01644643|450603247|FG003|Overall Study|Death|3|||
125266040|NCT01644643|450603244|FG000|Overall Study|Lost to Follow-up|0|||
125266041|NCT01644643|450603245|FG001|Overall Study|Lost to Follow-up|0|||
125266042|NCT01644643|450603246|FG002|Overall Study|Lost to Follow-up|0|||
125266043|NCT01644643|450603247|FG003|Overall Study|Lost to Follow-up|4|||
125266044|NCT01644643|450603244|FG000|Overall Study|Withdrawal by Subject|1|||
125266045|NCT01644643|450603245|FG001|Overall Study|Withdrawal by Subject|0|||
125266046|NCT01644643|450603246|FG002|Overall Study|Withdrawal by Subject|2|||
125266047|NCT01644643|450603247|FG003|Overall Study|Withdrawal by Subject|1|||
125266048|NCT01644643|450603244|FG000|Overall Study|Other Eligibility criteria|0|||
125266049|NCT01644643|450603245|FG001|Overall Study|Other Eligibility criteria|0|||
125266050|NCT01644643|450603246|FG002|Overall Study|Other Eligibility criteria|0|||
125266051|NCT01644643|450603247|FG003|Overall Study|Other Eligibility criteria|2|||
125266052|NCT00114127|450603249|FG000|Overall Study|Adverse Event|2|||
125266053|NCT00114127|450603250|FG001|Overall Study|Adverse Event|1|||
125266054|NCT00114127|450603249|FG000|Overall Study|Lost to Follow-up|1|||
125266055|NCT00114127|450603250|FG001|Overall Study|Lost to Follow-up|0|||
125266056|NCT00114127|450603249|FG000|Overall Study|Withdrawal by Subject|1|||
125266057|NCT00114127|450603250|FG001|Overall Study|Withdrawal by Subject|3|||
125266058|NCT00699413|450603251|FG000|Overall Study|Withdrawal by Subject|0|||
125266059|NCT00699413|450603252|FG001|Overall Study|Withdrawal by Subject|2|||
125266060|NCT00699413|450603251|FG000|Overall Study|Study terminated by sponsor|4|||
125266061|NCT00699413|450603252|FG001|Overall Study|Study terminated by sponsor|2|||
125266062|NCT00881894|450603253|FG000|Overall Study|Consent withdrawn|0|||
125266063|NCT00881894|450603254|FG001|Overall Study|Consent withdrawn|1|||
125266064|NCT00881894|450603253|FG000|Overall Study|Other reasons for premature termination|1|||
125266065|NCT00881894|450603254|FG001|Overall Study|Other reasons for premature termination|2|||
125266066|NCT00421148|450603255|FG000|Overall Study|Lost to Follow-up|0|||
125266067|NCT00421148|450603256|FG001|Overall Study|Lost to Follow-up|0|||
125266068|NCT00421148|450603257|FG002|Overall Study|Lost to Follow-up|0|||
125266069|NCT00421148|450603258|FG003|Overall Study|Lost to Follow-up|0|||
125266070|NCT00421148|450603259|FG004|Overall Study|Lost to Follow-up|0|||
125266071|NCT00421148|450603260|FG005|Overall Study|Lost to Follow-up|0|||
125266072|NCT00421148|450603261|FG006|Overall Study|Lost to Follow-up|0|||
125266073|NCT00421148|450603262|FG007|Overall Study|Lost to Follow-up|0|||
125266074|NCT00421148|450603263|FG008|Overall Study|Lost to Follow-up|0|||
125266075|NCT00421148|450603264|FG009|Overall Study|Lost to Follow-up|0|||
125266076|NCT00421148|450603265|FG010|Overall Study|Lost to Follow-up|0|||
125266077|NCT00421148|450603266|FG011|Overall Study|Lost to Follow-up|0|||
125266078|NCT00421148|450603267|FG012|Overall Study|Lost to Follow-up|0|||
125266079|NCT00421148|450603268|FG013|Overall Study|Lost to Follow-up|0|||
125266080|NCT00421148|450603269|FG014|Overall Study|Lost to Follow-up|0|||
125266081|NCT00421148|450603270|FG015|Overall Study|Lost to Follow-up|0|||
125266082|NCT00421148|450603271|FG016|Overall Study|Lost to Follow-up|0|||
125266083|NCT00421148|450603272|FG017|Overall Study|Lost to Follow-up|1|||
125266084|NCT00421148|450603273|FG018|Overall Study|Lost to Follow-up|0|||
125266085|NCT00421148|450603274|FG019|Overall Study|Lost to Follow-up|0|||
125266086|NCT00421148|450603255|FG000|Overall Study|Withdrawal by Subject|0|||
125266087|NCT00421148|450603256|FG001|Overall Study|Withdrawal by Subject|0|||
125266088|NCT00421148|450603257|FG002|Overall Study|Withdrawal by Subject|0|||
125266089|NCT00421148|450603258|FG003|Overall Study|Withdrawal by Subject|0|||
125266090|NCT00421148|450603259|FG004|Overall Study|Withdrawal by Subject|0|||
125266091|NCT00421148|450603260|FG005|Overall Study|Withdrawal by Subject|0|||
125266092|NCT00421148|450603261|FG006|Overall Study|Withdrawal by Subject|0|||
125266093|NCT00421148|450603262|FG007|Overall Study|Withdrawal by Subject|0|||
125266094|NCT00421148|450603263|FG008|Overall Study|Withdrawal by Subject|0|||
125266095|NCT00421148|450603264|FG009|Overall Study|Withdrawal by Subject|0|||
125266096|NCT00421148|450603265|FG010|Overall Study|Withdrawal by Subject|0|||
125266097|NCT00421148|450603266|FG011|Overall Study|Withdrawal by Subject|0|||
125266098|NCT00421148|450603267|FG012|Overall Study|Withdrawal by Subject|0|||
125266099|NCT00421148|450603268|FG013|Overall Study|Withdrawal by Subject|0|||
125266100|NCT00421148|450603269|FG014|Overall Study|Withdrawal by Subject|0|||
125266101|NCT00421148|450603270|FG015|Overall Study|Withdrawal by Subject|0|||
125266102|NCT00421148|450603271|FG016|Overall Study|Withdrawal by Subject|0|||
125266103|NCT00421148|450603272|FG017|Overall Study|Withdrawal by Subject|1|||
125266104|NCT00421148|450603273|FG018|Overall Study|Withdrawal by Subject|0|||
125447306|NCT00162942|451262780|FG001|Overall Study|Withdrawal by Subject|6|||
125266105|NCT00421148|450603274|FG019|Overall Study|Withdrawal by Subject|0|||
125266106|NCT00421148|450603255|FG000|Overall Study|Protocol Violation|0|||
125266107|NCT00421148|450603256|FG001|Overall Study|Protocol Violation|0|||
125266108|NCT00421148|450603257|FG002|Overall Study|Protocol Violation|0|||
125266109|NCT00421148|450603258|FG003|Overall Study|Protocol Violation|0|||
125266110|NCT00421148|450603259|FG004|Overall Study|Protocol Violation|0|||
125266111|NCT00421148|450603260|FG005|Overall Study|Protocol Violation|1|||
125266112|NCT00421148|450603261|FG006|Overall Study|Protocol Violation|0|||
125266113|NCT00421148|450603262|FG007|Overall Study|Protocol Violation|0|||
125266114|NCT00421148|450603263|FG008|Overall Study|Protocol Violation|0|||
125266115|NCT00421148|450603264|FG009|Overall Study|Protocol Violation|0|||
125266116|NCT00421148|450603265|FG010|Overall Study|Protocol Violation|0|||
125266117|NCT00421148|450603266|FG011|Overall Study|Protocol Violation|0|||
125266118|NCT00421148|450603267|FG012|Overall Study|Protocol Violation|0|||
125266119|NCT00421148|450603268|FG013|Overall Study|Protocol Violation|0|||
125266120|NCT00421148|450603269|FG014|Overall Study|Protocol Violation|0|||
125266121|NCT00421148|450603270|FG015|Overall Study|Protocol Violation|0|||
125266122|NCT00421148|450603271|FG016|Overall Study|Protocol Violation|0|||
125266123|NCT00421148|450603272|FG017|Overall Study|Protocol Violation|0|||
125266124|NCT00421148|450603273|FG018|Overall Study|Protocol Violation|1|||
125266125|NCT00421148|450603274|FG019|Overall Study|Protocol Violation|0|||
125266126|NCT00469833|450603276|FG000|Overall Study|No IV access|2|||
125266127|NCT01253369|450603277|FG000|Overall Study|Adverse Event|4|||
125266128|NCT01253369|450603277|FG000|Overall Study|Withdrawal by Subject|2|||
125266129|NCT01253369|450603277|FG000|Overall Study|Death|1|||
125266130|NCT01253369|450603277|FG000|Overall Study|Progressive disease|23|||
125266131|NCT01253369|450603277|FG000|Overall Study|Not Evaluable|3|||
125266132|NCT03289533|450603278|FG000|Overall Study|Death|12|||
125266133|NCT03289533|450603278|FG000|Overall Study|Terminated from study by sponsor|10|||
125266134|NCT04016714|450603279|FG000|Overall Study|Death|1|||
125266135|NCT04016714|450603280|FG001|Overall Study|Death|0|||
125266136|NCT04016714|450603279|FG000|Overall Study|Lost to Follow-up|3|||
125266137|NCT04016714|450603280|FG001|Overall Study|Lost to Follow-up|1|||
125266138|NCT04016714|450603279|FG000|Overall Study|Physician Decision|3|||
125266139|NCT04016714|450603280|FG001|Overall Study|Physician Decision|3|||
125266140|NCT04016714|450603279|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
125266141|NCT04016714|450603280|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
125266142|NCT01822665|450603287|FG000|Overall Study|Adverse Event|3|||
125266143|NCT01822665|450603287|FG000|Overall Study|Other Reason|5|||
125266144|NCT00959907|450603289|FG000|Overall Study|Protocol Violation|0|||
125266145|NCT00959907|450603290|FG001|Overall Study|Protocol Violation|1|||
125266146|NCT00959907|450603289|FG000|Overall Study|Adverse Event|1|||
125266147|NCT00959907|450603290|FG001|Overall Study|Adverse Event|0|||
125266148|NCT00959907|450603289|FG000|Overall Study|Withdrawal by Subject|2|||
125266149|NCT00959907|450603290|FG001|Overall Study|Withdrawal by Subject|0|||
125266150|NCT01171677|450603292|FG000|Overall Study|Withdrawal by Subject|0|||
125266151|NCT01171677|450603293|FG001|Overall Study|Withdrawal by Subject|3|||
125266152|NCT01171677|450603292|FG000|Overall Study|Adverse Event|1|||
125266153|NCT01171677|450603293|FG001|Overall Study|Adverse Event|0|||
125266154|NCT01171677|450603292|FG000|Overall Study|completed <70% IntenSati classes|5|||
125266155|NCT01171677|450603293|FG001|Overall Study|completed <70% IntenSati classes|0|||
125266156|NCT01847443|450603294|FG000|Study Period 1|Withdrawal by Subject|0|||
125266157|NCT01847443|450603295|FG001|Study Period 1|Withdrawal by Subject|1|||
125266158|NCT01847443|450603296|FG002|Study Period 1|Withdrawal by Subject|0|||
125266159|NCT01847443|450603297|FG003|Study Period 1|Withdrawal by Subject|0|||
125266160|NCT01847443|450603294|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
125266161|NCT01847443|450603295|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
125266162|NCT01847443|450603296|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
125266163|NCT01847443|450603297|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
125266164|NCT01847443|450603294|FG000|Washout Period Before Study Period 2|Other reason|1|||
125266165|NCT01847443|450603295|FG001|Washout Period Before Study Period 2|Other reason|0|||
125266166|NCT01847443|450603296|FG002|Washout Period Before Study Period 2|Other reason|0|||
125266167|NCT01847443|450603297|FG003|Washout Period Before Study Period 2|Other reason|0|||
125266168|NCT01847443|450603294|FG000|Washout Period Before Study Period 3|Other reason|1|||
125266169|NCT01847443|450603295|FG001|Washout Period Before Study Period 3|Other reason|0|||
125266170|NCT01847443|450603296|FG002|Washout Period Before Study Period 3|Other reason|0|||
125266171|NCT01847443|450603297|FG003|Washout Period Before Study Period 3|Other reason|0|||
125266172|NCT01847443|450603294|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
125266173|NCT01847443|450603295|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
125266174|NCT01847443|450603296|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
125266175|NCT01847443|450603297|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
125266176|NCT01847443|450603294|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
125266177|NCT01847443|450603295|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
125266178|NCT01847443|450603296|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
125266179|NCT01847443|450603297|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
125266180|NCT03571971|450603298|FG000|Overall Study|Lost to Follow-up|2|||
125266181|NCT03571971|450603299|FG001|Overall Study|Lost to Follow-up|2|||
125266182|NCT03571971|450603298|FG000|Overall Study|Protocol Violation|2|||
125398775|NCT03277261|451093203|FG001|Overall Study|Lack of Efficacy|2|||
125398776|NCT03277261|451093202|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
125398777|NCT03277261|451093203|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
125266183|NCT03571971|450603299|FG001|Overall Study|Protocol Violation|3|||
125266184|NCT03571971|450603298|FG000|Overall Study|Withdrawal by Subject|2|||
125266185|NCT03571971|450603299|FG001|Overall Study|Withdrawal by Subject|0|||
125266186|NCT03571971|450603298|FG000|Overall Study|Incomplete primary outcome data|2|||
125266187|NCT03571971|450603299|FG001|Overall Study|Incomplete primary outcome data|0|||
125266188|NCT04046939|450603309|FG000|Primary Assessment Period|Adverse Event|1|||
125266189|NCT04046939|450603310|FG001|Primary Assessment Period|Adverse Event|0|||
125266190|NCT04046939|450603311|FG002|Primary Assessment Period|Adverse Event|0|||
125266191|NCT04046939|450603312|FG003|Primary Assessment Period|Adverse Event|0|||
125266192|NCT04046939|450603309|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
125266193|NCT04046939|450603310|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
125266194|NCT04046939|450603311|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
125266195|NCT04046939|450603312|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
125266196|NCT04046939|450603309|FG000|Primary Assessment Period|Physician Decision|0|||
125266197|NCT04046939|450603310|FG001|Primary Assessment Period|Physician Decision|0|||
125266198|NCT04046939|450603311|FG002|Primary Assessment Period|Physician Decision|1|||
125266199|NCT04046939|450603312|FG003|Primary Assessment Period|Physician Decision|0|||
125266200|NCT04046939|450603309|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
125266201|NCT04046939|450603310|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
125266202|NCT04046939|450603311|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
125266203|NCT04046939|450603312|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
125266204|NCT00403130|450603313|FG000|2 Years From Start of Treatment|Not Eligible|3|||
125266205|NCT00403130|450603313|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
125266206|NCT00403130|450603313|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
125266207|NCT00403130|450603313|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
125266208|NCT00806260|450603314|FG000|Period 1 (1 Day)|Adverse Event|0|||
125266209|NCT00806260|450603315|FG001|Period 1 (1 Day)|Adverse Event|0|||
125266210|NCT00806260|450603316|FG002|Period 1 (1 Day)|Adverse Event|0|||
125266211|NCT00806260|450603317|FG003|Period 1 (1 Day)|Adverse Event|0|||
125266212|NCT00806260|450603318|FG004|Period 1 (1 Day)|Adverse Event|3|||
125266213|NCT00806260|450603319|FG005|Period 1 (1 Day)|Adverse Event|0|||
125266214|NCT00806260|450603314|FG000|Period 2|Adverse Event|0|||
125266215|NCT00806260|450603315|FG001|Period 2|Adverse Event|0|||
125266216|NCT00806260|450603316|FG002|Period 2|Adverse Event|0|||
125266217|NCT00806260|450603317|FG003|Period 2|Adverse Event|1|||
125266218|NCT00806260|450603318|FG004|Period 2|Adverse Event|0|||
125266219|NCT00806260|450603319|FG005|Period 2|Adverse Event|0|||
125266220|NCT00806260|450603314|FG000|Period 2|Protocol Violation|1|||
125266221|NCT00806260|450603315|FG001|Period 2|Protocol Violation|0|||
125266222|NCT00806260|450603316|FG002|Period 2|Protocol Violation|1|||
125266223|NCT00806260|450603317|FG003|Period 2|Protocol Violation|0|||
125266224|NCT00806260|450603318|FG004|Period 2|Protocol Violation|0|||
125266225|NCT00806260|450603319|FG005|Period 2|Protocol Violation|0|||
125266226|NCT00806260|450603314|FG000|Period 2|Need to take concomitant medication|1|||
125266227|NCT00806260|450603315|FG001|Period 2|Need to take concomitant medication|0|||
125266228|NCT00806260|450603316|FG002|Period 2|Need to take concomitant medication|0|||
125266229|NCT00806260|450603317|FG003|Period 2|Need to take concomitant medication|0|||
125266230|NCT00806260|450603318|FG004|Period 2|Need to take concomitant medication|0|||
125266231|NCT00806260|450603319|FG005|Period 2|Need to take concomitant medication|0|||
125266232|NCT00806260|450603314|FG000|Period 2|sponsor request|0|||
125266233|NCT00806260|450603315|FG001|Period 2|sponsor request|0|||
125266234|NCT00806260|450603316|FG002|Period 2|sponsor request|1|||
125266235|NCT00806260|450603317|FG003|Period 2|sponsor request|1|||
125266236|NCT00806260|450603318|FG004|Period 2|sponsor request|0|||
125266237|NCT00806260|450603319|FG005|Period 2|sponsor request|0|||
125266238|NCT00806260|450603314|FG000|Period 3|Protocol Violation|0|||
125266239|NCT00806260|450603315|FG001|Period 3|Protocol Violation|1|||
125266240|NCT00806260|450603316|FG002|Period 3|Protocol Violation|1|||
125266241|NCT00806260|450603317|FG003|Period 3|Protocol Violation|0|||
125266242|NCT00806260|450603318|FG004|Period 3|Protocol Violation|0|||
125266243|NCT00806260|450603319|FG005|Period 3|Protocol Violation|0|||
125266244|NCT00806260|450603314|FG000|Period 3|Pregnancy|1|||
125266245|NCT00806260|450603315|FG001|Period 3|Pregnancy|0|||
125266246|NCT00806260|450603316|FG002|Period 3|Pregnancy|0|||
125266247|NCT00806260|450603317|FG003|Period 3|Pregnancy|0|||
125266248|NCT00806260|450603318|FG004|Period 3|Pregnancy|0|||
125447307|NCT00162942|451262779|FG000|Overall Study|Physician Decision|1|||
125266249|NCT00806260|450603319|FG005|Period 3|Pregnancy|0|||
125266250|NCT03559270|450603320|FG000|Overall Study|Adverse Event|6|||
125266251|NCT03559270|450603321|FG001|Overall Study|Adverse Event|5|||
125266252|NCT03559270|450603322|FG002|Overall Study|Adverse Event|3|||
125266253|NCT03559270|450603323|FG003|Overall Study|Adverse Event|0|||
125266254|NCT03559270|450603320|FG000|Overall Study|Lack of Efficacy|34|||
125266255|NCT03559270|450603321|FG001|Overall Study|Lack of Efficacy|52|||
125266256|NCT03559270|450603322|FG002|Overall Study|Lack of Efficacy|37|||
125266257|NCT03559270|450603323|FG003|Overall Study|Lack of Efficacy|2|||
125266258|NCT03559270|450603320|FG000|Overall Study|Death|0|||
125266259|NCT03559270|450603321|FG001|Overall Study|Death|2|||
125266260|NCT03559270|450603322|FG002|Overall Study|Death|0|||
125266261|NCT03559270|450603323|FG003|Overall Study|Death|0|||
125266262|NCT03559270|450603320|FG000|Overall Study|Lost to Follow-up|16|||
125266263|NCT03559270|450603321|FG001|Overall Study|Lost to Follow-up|4|||
125266264|NCT03559270|450603322|FG002|Overall Study|Lost to Follow-up|12|||
125266265|NCT03559270|450603323|FG003|Overall Study|Lost to Follow-up|3|||
125266266|NCT03559270|450603320|FG000|Overall Study|Sponsor Decision|38|||
125266267|NCT03559270|450603321|FG001|Overall Study|Sponsor Decision|31|||
125266268|NCT03559270|450603322|FG002|Overall Study|Sponsor Decision|35|||
125266269|NCT03559270|450603323|FG003|Overall Study|Sponsor Decision|18|||
125266270|NCT03559270|450603320|FG000|Overall Study|Withdrawal by Subject|19|||
125266271|NCT03559270|450603321|FG001|Overall Study|Withdrawal by Subject|21|||
125266272|NCT03559270|450603322|FG002|Overall Study|Withdrawal by Subject|18|||
125266273|NCT03559270|450603323|FG003|Overall Study|Withdrawal by Subject|7|||
125266274|NCT03559270|450603320|FG000|Overall Study|Physician Decision|3|||
125266275|NCT03559270|450603321|FG001|Overall Study|Physician Decision|2|||
125266276|NCT03559270|450603322|FG002|Overall Study|Physician Decision|1|||
125266277|NCT03559270|450603323|FG003|Overall Study|Physician Decision|0|||
125266278|NCT03559270|450603320|FG000|Overall Study|Pregnancy|0|||
125266279|NCT03559270|450603321|FG001|Overall Study|Pregnancy|1|||
125266280|NCT03559270|450603322|FG002|Overall Study|Pregnancy|0|||
125266281|NCT03559270|450603323|FG003|Overall Study|Pregnancy|0|||
125266282|NCT03559270|450603320|FG000|Overall Study|Protocol Violation|1|||
125266283|NCT03559270|450603321|FG001|Overall Study|Protocol Violation|0|||
125266284|NCT03559270|450603322|FG002|Overall Study|Protocol Violation|2|||
125266285|NCT03559270|450603323|FG003|Overall Study|Protocol Violation|0|||
125266286|NCT02735421|450604841|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
125266287|NCT02735421|450604841|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
125266288|NCT02735421|450604841|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
125266289|NCT02735421|450604841|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
125266290|NCT02735421|450604841|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
125266291|NCT02735421|450604841|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
125266292|NCT02735421|450604841|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
125266293|NCT05010070|450604842|FG000|Overall Study|Lost to Follow-up|1|||
125266294|NCT05010070|450604842|FG000|Overall Study|Withdrawal by Subject|1|||
125266295|NCT00939107|450604843|FG000|Overall Study|Lost to Follow-up|14|||
125266296|NCT00939107|450604844|FG001|Overall Study|Lost to Follow-up|12|||
125266297|NCT03247829|450604850|FG000|Overall Study|Death|3|||
125266298|NCT03247829|450604851|FG001|Overall Study|Death|4|||
125266299|NCT03247829|450604850|FG000|Overall Study|Enter Hospice Care|1|||
125266300|NCT03247829|450604851|FG001|Overall Study|Enter Hospice Care|0|||
125266301|NCT03247829|450604850|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
125266302|NCT03247829|450604851|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
125266303|NCT03247829|450604850|FG000|Overall Study|LVAD Explant|1|||
125266304|NCT03247829|450604851|FG001|Overall Study|LVAD Explant|1|||
125266305|NCT03247829|450604850|FG000|Overall Study|Transplant|1|||
125266306|NCT03247829|450604851|FG001|Overall Study|Transplant|1|||
125266307|NCT01783444|450604852|FG000|Treatment Phase|Adverse Event|9|||
125266308|NCT01783444|450604853|FG001|Treatment Phase|Adverse Event|20|||
125266309|NCT01783444|450604854|FG002|Treatment Phase|Adverse Event|19|||
125266310|NCT01783444|450604852|FG000|Treatment Phase|Disease Progression|76|||
125266311|NCT01783444|450604853|FG001|Treatment Phase|Disease Progression|66|||
125266312|NCT01783444|450604854|FG002|Treatment Phase|Disease Progression|64|||
125266313|NCT01783444|450604852|FG000|Treatment Phase|Death|2|||
125266314|NCT01783444|450604853|FG001|Treatment Phase|Death|2|||
125266315|NCT01783444|450604854|FG002|Treatment Phase|Death|2|||
125266316|NCT01783444|450604852|FG000|Treatment Phase|Protocol Violation|1|||
125266317|NCT01783444|450604853|FG001|Treatment Phase|Protocol Violation|1|||
125266318|NCT01783444|450604854|FG002|Treatment Phase|Protocol Violation|2|||
125266319|NCT01783444|450604852|FG000|Treatment Phase|Withdrawal by Subject|6|||
125266320|NCT01783444|450604853|FG001|Treatment Phase|Withdrawal by Subject|8|||
125266321|NCT01783444|450604854|FG002|Treatment Phase|Withdrawal by Subject|9|||
125266322|NCT01783444|450604852|FG000|Treatment Phase|Administrative problems|2|||
125266323|NCT01783444|450604853|FG001|Treatment Phase|Administrative problems|0|||
125266324|NCT01783444|450604854|FG002|Treatment Phase|Administrative problems|1|||
125266325|NCT01783444|450604852|FG000|Treatment Phase|Physician Decision|8|||
125266326|NCT01783444|450604853|FG001|Treatment Phase|Physician Decision|6|||
125266327|NCT01783444|450604854|FG002|Treatment Phase|Physician Decision|5|||
125266328|NCT01783444|450604852|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
125266329|NCT01783444|450604853|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
125266330|NCT01783444|450604854|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
125266331|NCT01783444|450604852|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
125266332|NCT01783444|450604853|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
125266333|NCT01783444|450604854|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
125266334|NCT01783444|450604852|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
125266335|NCT01783444|450604853|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
125398778|NCT02365597|451093207|FG000|Overall Study|Lost to Follow-up|0|||
125398779|NCT02365597|451093208|FG001|Overall Study|Lost to Follow-up|1|||
125266336|NCT01783444|450604854|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
125266337|NCT01783444|450604852|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
125266338|NCT01783444|450604853|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
125266339|NCT01783444|450604854|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
125266340|NCT01783444|450604852|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
125266341|NCT01783444|450604853|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
125266342|NCT01783444|450604854|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
125266343|NCT01783444|450604852|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
125266344|NCT01783444|450604853|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
125266345|NCT01783444|450604854|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
125266346|NCT00427011|450604863|FG000|Overall Study|Adverse Event|10|||
125266347|NCT00427011|450604863|FG000|Overall Study|Withdrawal by Subject|1|||
125266348|NCT00427011|450604863|FG000|Overall Study|Lack of Efficacy|2|||
125266349|NCT00427011|450604863|FG000|Overall Study|Other|12|||
125266350|NCT01047007|450604864|FG000|Overall Study|Adverse Event|0|||
125266351|NCT01047007|450604865|FG001|Overall Study|Adverse Event|2|||
125266352|NCT01047007|450604866|FG002|Overall Study|Adverse Event|1|||
125266353|NCT01047007|450604867|FG003|Overall Study|Adverse Event|0|||
125266354|NCT01047007|450604864|FG000|Overall Study|Progressive Disease|2|||
125266355|NCT01047007|450604865|FG001|Overall Study|Progressive Disease|4|||
125266356|NCT01047007|450604866|FG002|Overall Study|Progressive Disease|1|||
125266357|NCT01047007|450604867|FG003|Overall Study|Progressive Disease|0|||
125266358|NCT04776161|450604868|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
125266359|NCT04776161|450604869|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
125266360|NCT04776161|450604870|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
125266361|NCT04776161|450604868|FG000|Overall Study|Withdrawal by Subject|1|||
125266362|NCT04776161|450604869|FG001|Overall Study|Withdrawal by Subject|0|||
125266363|NCT04776161|450604870|FG002|Overall Study|Withdrawal by Subject|1|||
125266364|NCT04776161|450604868|FG000|Overall Study|Adverse Event|0|||
125266365|NCT04776161|450604869|FG001|Overall Study|Adverse Event|1|||
125266366|NCT04776161|450604870|FG002|Overall Study|Adverse Event|1|||
125266367|NCT01334554|450604871|FG000|Overall Study|Adverse Event|4|||
125266368|NCT01334554|450604872|FG001|Overall Study|Adverse Event|2|||
125266369|NCT02393859|450604874|FG000|Overall Study|Decision by Sponsor|2|||
125266370|NCT02393859|450604875|FG001|Overall Study|Decision by Sponsor|4|||
125266371|NCT02393859|450604874|FG000|Overall Study|Withdrawal by Subject|11|||
125266372|NCT02393859|450604875|FG001|Overall Study|Withdrawal by Subject|6|||
125266373|NCT02393859|450604874|FG000|Overall Study|Death|27|||
125266374|NCT02393859|450604875|FG001|Overall Study|Death|10|||
125266375|NCT02393859|450604874|FG000|Overall Study|Lost to Follow-up|1|||
125266376|NCT02393859|450604875|FG001|Overall Study|Lost to Follow-up|1|||
125266377|NCT00954447|450604876|FG000|Overall Study|Adverse Event|33|||
125266378|NCT00954447|450604877|FG001|Overall Study|Adverse Event|25|||
125266379|NCT00954447|450604876|FG000|Overall Study|Lack of Efficacy|17|||
125266380|NCT00954447|450604877|FG001|Overall Study|Lack of Efficacy|3|||
125266381|NCT00954447|450604876|FG000|Overall Study|Protocol Violation|5|||
125266382|NCT00954447|450604877|FG001|Overall Study|Protocol Violation|7|||
125266383|NCT00954447|450604876|FG000|Overall Study|Lost to Follow-up|8|||
125266384|NCT00954447|450604877|FG001|Overall Study|Lost to Follow-up|14|||
125266385|NCT00954447|450604876|FG000|Overall Study|Withdrawal by Subject|26|||
125266386|NCT00954447|450604877|FG001|Overall Study|Withdrawal by Subject|21|||
125266387|NCT00954447|450604876|FG000|Overall Study|Other|21|||
125266388|NCT00954447|450604877|FG001|Overall Study|Other|18|||
125266389|NCT04592341|450604878|FG000|Overall Study|Physician Decision|5|||
125266390|NCT04592341|450604878|FG000|Overall Study|Study Terminated by Sponsor|5|||
125266391|NCT04592341|450604878|FG000|Overall Study|Withdrawal by Subject|53|||
125266392|NCT04592341|450604878|FG000|Overall Study|Lost to Follow-up|3|||
125266393|NCT04592341|450604878|FG000|Overall Study|Death|1|||
125266394|NCT04592341|450604878|FG000|Overall Study|Adverse Event|5|||
125266395|NCT04592341|450604878|FG000|Overall Study|other|4|||
125266396|NCT00692003|450604879|FG000|Overall Study|Sponsor Decision|5|||
125266397|NCT00692003|450604880|FG001|Overall Study|Sponsor Decision|1|||
125266398|NCT01248793|450604881|FG000|Overall Study|Lost to Follow-up|0|||
125266399|NCT01248793|450604882|FG001|Overall Study|Lost to Follow-up|1|||
125266400|NCT01248793|450604881|FG000|Overall Study|Adverse Event|1|||
125266401|NCT01248793|450604882|FG001|Overall Study|Adverse Event|1|||
125266402|NCT01248793|450604881|FG000|Overall Study|Protocol Violation|0|||
125266403|NCT01248793|450604882|FG001|Overall Study|Protocol Violation|1|||
125266404|NCT01248793|450604881|FG000|Overall Study|Withdrawal by Subject|3|||
125266405|NCT01248793|450604882|FG001|Overall Study|Withdrawal by Subject|3|||
125266406|NCT00517699|450604883|FG000|Overall Study|Withdrawal by Subject|1|||
125447308|NCT00162942|451262780|FG001|Overall Study|Physician Decision|0|||
125447309|NCT00162942|451262779|FG000|Overall Study|Enter Open-Label Study|76|||
125266407|NCT00517699|450604883|FG000|Overall Study|Lack of Efficacy|1|||
125266408|NCT00517699|450604883|FG000|Overall Study|Administrative error|1|||
125266409|NCT00517699|450604883|FG000|Overall Study|Study terminated by Sponsor|2|||
125266410|NCT02332187|450604886|FG000|Overall Study|Withdrawal by Subject|2|||
125266411|NCT02332187|450604887|FG001|Overall Study|Withdrawal by Subject|2|||
125266412|NCT02332187|450604886|FG000|Overall Study|Adverse Event|0|||
125266413|NCT02332187|450604887|FG001|Overall Study|Adverse Event|1|||
125266414|NCT01840943|450604888|FG000|Overall Study|Withdrawal by Subject|5|||
125266415|NCT01840943|450604889|FG001|Overall Study|Withdrawal by Subject|6|||
125266416|NCT01840943|450604888|FG000|Overall Study|Physician Decision|4|||
125266417|NCT01840943|450604889|FG001|Overall Study|Physician Decision|2|||
125266418|NCT01840943|450604888|FG000|Overall Study|Lost to Follow-up|4|||
125266419|NCT01840943|450604889|FG001|Overall Study|Lost to Follow-up|4|||
125266420|NCT02580877|450604892|FG000|Overall Study|Withdrawal by Subject|1|||
125266421|NCT02580877|450604893|FG001|Overall Study|Withdrawal by Subject|3|||
125266422|NCT02580877|450604892|FG000|Overall Study|Adverse Event|0|||
125266423|NCT02580877|450604893|FG001|Overall Study|Adverse Event|1|||
125266424|NCT00980148|450604894|FG000|Overall Study|Discharged from facility|89|||
125266425|NCT00980148|450604895|FG001|Overall Study|Discharged from facility|96|||
125266426|NCT00980148|450604894|FG000|Overall Study|Received other antichlamydia treatment|20|||
125266427|NCT00980148|450604895|FG001|Overall Study|Received other antichlamydia treatment|14|||
125266428|NCT00980148|450604894|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
125266429|NCT00980148|450604895|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
125266430|NCT00980148|450604894|FG000|Overall Study|Various other reasons|8|||
125266431|NCT00980148|450604895|FG001|Overall Study|Various other reasons|9|||
125266432|NCT00551031|450604896|FG000|Overall Study|Adverse Event|0|||
125266433|NCT00551031|450604897|FG001|Overall Study|Adverse Event|1|||
125266434|NCT00551031|450604898|FG002|Overall Study|Adverse Event|0|||
125266435|NCT00551031|450604899|FG003|Overall Study|Adverse Event|0|||
125266436|NCT00551031|450604900|FG004|Overall Study|Adverse Event|0|||
125266437|NCT00551031|450604896|FG000|Overall Study|Protocol Violation|1|||
125266438|NCT00551031|450604897|FG001|Overall Study|Protocol Violation|1|||
125266439|NCT00551031|450604898|FG002|Overall Study|Protocol Violation|0|||
125266440|NCT00551031|450604899|FG003|Overall Study|Protocol Violation|0|||
125266441|NCT00551031|450604900|FG004|Overall Study|Protocol Violation|0|||
125266442|NCT00551031|450604896|FG000|Overall Study|Lost to Follow-up|0|||
125266443|NCT00551031|450604897|FG001|Overall Study|Lost to Follow-up|1|||
125266444|NCT00551031|450604898|FG002|Overall Study|Lost to Follow-up|0|||
125266445|NCT00551031|450604899|FG003|Overall Study|Lost to Follow-up|1|||
125266446|NCT00551031|450604900|FG004|Overall Study|Lost to Follow-up|1|||
125266447|NCT00551031|450604896|FG000|Overall Study|Withdrawal by Subject|0|||
125266448|NCT00551031|450604897|FG001|Overall Study|Withdrawal by Subject|4|||
125266449|NCT00551031|450604898|FG002|Overall Study|Withdrawal by Subject|1|||
125266450|NCT00551031|450604899|FG003|Overall Study|Withdrawal by Subject|2|||
125266451|NCT00551031|450604900|FG004|Overall Study|Withdrawal by Subject|0|||
125266452|NCT00551031|450604896|FG000|Overall Study|Serious Adverse Event|0|||
125266453|NCT00551031|450604897|FG001|Overall Study|Serious Adverse Event|2|||
125266454|NCT00551031|450604898|FG002|Overall Study|Serious Adverse Event|1|||
125266455|NCT00551031|450604899|FG003|Overall Study|Serious Adverse Event|0|||
125266456|NCT00551031|450604900|FG004|Overall Study|Serious Adverse Event|0|||
125266457|NCT00551031|450604896|FG000|Overall Study|Did not receive vaccine|1|||
125266458|NCT00551031|450604897|FG001|Overall Study|Did not receive vaccine|2|||
125266459|NCT00551031|450604898|FG002|Overall Study|Did not receive vaccine|0|||
125266460|NCT00551031|450604899|FG003|Overall Study|Did not receive vaccine|0|||
125266461|NCT00551031|450604900|FG004|Overall Study|Did not receive vaccine|0|||
125266462|NCT02903823|450604901|FG000|Overall Study|Physician Decision|5|||
125266463|NCT02903823|450604901|FG000|Overall Study|Could not advance catheter|1|||
125266464|NCT02903823|450604901|FG000|Overall Study|Catheter dislodgement|1|||
125266465|NCT01747915|450604902|FG000|Overall Study|Other|1|||
125266466|NCT01747915|450604903|FG001|Overall Study|Other|1|||
125266467|NCT01747915|450604904|FG002|Overall Study|Other|1|||
125266468|NCT01747915|450604902|FG000|Overall Study|Adverse Event|8|||
125266469|NCT01747915|450604903|FG001|Overall Study|Adverse Event|5|||
125266470|NCT01747915|450604904|FG002|Overall Study|Adverse Event|2|||
125266471|NCT01747915|450604902|FG000|Overall Study|Death|0|||
125266472|NCT01747915|450604903|FG001|Overall Study|Death|0|||
125266473|NCT01747915|450604904|FG002|Overall Study|Death|1|||
125266474|NCT01747915|450604902|FG000|Overall Study|Lack of Efficacy|0|||
125266475|NCT01747915|450604903|FG001|Overall Study|Lack of Efficacy|1|||
125266476|NCT01747915|450604904|FG002|Overall Study|Lack of Efficacy|0|||
125266477|NCT01747915|450604902|FG000|Overall Study|Lost to Follow-up|1|||
125266478|NCT01747915|450604903|FG001|Overall Study|Lost to Follow-up|0|||
125266479|NCT01747915|450604904|FG002|Overall Study|Lost to Follow-up|0|||
125266480|NCT01747915|450604902|FG000|Overall Study|Withdrawal by Subject|4|||
125266481|NCT01747915|450604903|FG001|Overall Study|Withdrawal by Subject|4|||
125266482|NCT01747915|450604904|FG002|Overall Study|Withdrawal by Subject|1|||
125266483|NCT01747915|450604902|FG000|Overall Study|Protocol Violation|1|||
125266484|NCT01747915|450604903|FG001|Overall Study|Protocol Violation|0|||
125266485|NCT01747915|450604904|FG002|Overall Study|Protocol Violation|0|||
125266486|NCT01747915|450604902|FG000|Overall Study|Pregnancy|0|||
125266487|NCT01747915|450604903|FG001|Overall Study|Pregnancy|0|||
125266488|NCT01747915|450604904|FG002|Overall Study|Pregnancy|1|||
125266489|NCT03341637|450604905|FG000|Overall Study|Lost to Follow-up|1|||
125266490|NCT03341637|450604906|FG001|Overall Study|Lost to Follow-up|0|||
125266491|NCT03341637|450604905|FG000|Overall Study|Withdrawal by Subject|3|||
125266492|NCT03341637|450604906|FG001|Overall Study|Withdrawal by Subject|3|||
125266493|NCT03341637|450604905|FG000|Overall Study|Reason not Specified|1|||
125266494|NCT03341637|450604906|FG001|Overall Study|Reason not Specified|1|||
125266495|NCT00887159|450604907|FG000|Overall Study|Disease progression|6|||
125266496|NCT00887159|450604908|FG001|Overall Study|Disease progression|39|||
125266497|NCT00887159|450604909|FG002|Overall Study|Disease progression|33|||
125266498|NCT00887159|450604907|FG000|Overall Study|Adverse Event|3|||
125266499|NCT00887159|450604908|FG001|Overall Study|Adverse Event|4|||
125266500|NCT00887159|450604909|FG002|Overall Study|Adverse Event|17|||
125266501|NCT00887159|450604907|FG000|Overall Study|Death|2|||
125266502|NCT00887159|450604908|FG001|Overall Study|Death|2|||
125266503|NCT00887159|450604909|FG002|Overall Study|Death|0|||
125266504|NCT00887159|450604907|FG000|Overall Study|Withdrawal by Subject|4|||
125266505|NCT00887159|450604908|FG001|Overall Study|Withdrawal by Subject|4|||
125266506|NCT00887159|450604909|FG002|Overall Study|Withdrawal by Subject|2|||
125266507|NCT00887159|450604907|FG000|Overall Study|Alternative therapy|2|||
125266508|NCT00887159|450604908|FG001|Overall Study|Alternative therapy|0|||
125266509|NCT00887159|450604909|FG002|Overall Study|Alternative therapy|0|||
125266510|NCT00887159|450604907|FG000|Overall Study|Physician Decision|1|||
125266511|NCT00887159|450604908|FG001|Overall Study|Physician Decision|1|||
125266512|NCT00887159|450604909|FG002|Overall Study|Physician Decision|0|||
125266513|NCT00887159|450604907|FG000|Overall Study|Sympomatic deterioration|1|||
125266514|NCT00887159|450604908|FG001|Overall Study|Sympomatic deterioration|0|||
125266515|NCT00887159|450604909|FG002|Overall Study|Sympomatic deterioration|0|||
125266516|NCT00887159|450604907|FG000|Overall Study|Treatment delayed|1|||
125266517|NCT00887159|450604908|FG001|Overall Study|Treatment delayed|1|||
125266518|NCT00887159|450604909|FG002|Overall Study|Treatment delayed|0|||
125266519|NCT00887159|450604907|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
125266520|NCT00887159|450604908|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
125266521|NCT00887159|450604909|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
125266522|NCT00887159|450604907|FG000|Overall Study|Received more tx instead of observation|1|||
125266523|NCT00887159|450604908|FG001|Overall Study|Received more tx instead of observation|0|||
125266524|NCT00887159|450604909|FG002|Overall Study|Received more tx instead of observation|0|||
125266525|NCT00887159|450604907|FG000|Overall Study|Ineligible|5|||
125266526|NCT00887159|450604908|FG001|Overall Study|Ineligible|1|||
125266527|NCT00887159|450604909|FG002|Overall Study|Ineligible|0|||
125266528|NCT00887159|450604907|FG000|Overall Study|Never started assigned therapy|3|||
125266529|NCT00887159|450604908|FG001|Overall Study|Never started assigned therapy|3|||
125266530|NCT00887159|450604909|FG002|Overall Study|Never started assigned therapy|4|||
125266531|NCT03500211|450604914|FG000|Overall Study|Withdrawal by Subject|1|||
125266532|NCT03500211|450604915|FG001|Overall Study|Withdrawal by Subject|1|||
125266533|NCT01119443|450604920|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
125266534|NCT01119443|450604921|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
125266535|NCT00775268|450604922|FG000|Baseline|Drug not synthesize dose|1|||
125266536|NCT00775268|450604923|FG001|Baseline|Drug not synthesize dose|0|||
125266537|NCT00775268|450604922|FG000|Baseline|Not treated-ineligible per CT|0|||
125266538|NCT00775268|450604923|FG001|Baseline|Not treated-ineligible per CT|1|||
125266539|NCT00775268|450604922|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
125266540|NCT00775268|450604923|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
125266541|NCT00775268|450604922|FG000|After Completion|Participant missed scan appointment|1|||
125266542|NCT00775268|450604923|FG001|After Completion|Participant missed scan appointment|0|||
125266543|NCT03604497|450604924|FG000|Overall Study|Protocol Violation|52|||
125266544|NCT01194245|450604926|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
125266545|NCT01194245|450604927|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
125266546|NCT01194245|450604928|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
125266547|NCT01194245|450604929|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
125266548|NCT01194245|450604930|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
125266549|NCT01194245|450604926|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
125266550|NCT01194245|450604927|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
125266551|NCT01194245|450604928|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
125266552|NCT01194245|450604929|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
125266553|NCT01194245|450604930|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
125266554|NCT01194245|450604926|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
125266555|NCT01194245|450604927|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
125266556|NCT01194245|450604928|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
125266557|NCT01194245|450604929|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
125266558|NCT01194245|450604930|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
125266559|NCT01194245|450604926|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
125266560|NCT01194245|450604927|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
125266561|NCT01194245|450604928|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
125266562|NCT01194245|450604929|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
125266563|NCT01194245|450604930|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
125447310|NCT00162942|451262780|FG001|Overall Study|Enter Open-Label Study|35|||
125266564|NCT01194245|450604926|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125266565|NCT01194245|450604927|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125266566|NCT01194245|450604928|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125266567|NCT01194245|450604929|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125266568|NCT01194245|450604930|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
125266569|NCT01194245|450604926|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125266570|NCT01194245|450604927|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125266571|NCT01194245|450604928|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
125266572|NCT01194245|450604929|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
125266573|NCT01194245|450604930|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
125266574|NCT00269087|450604931|FG000|Overall Study|Adverse Event|20|||
125266575|NCT00269087|450604931|FG000|Overall Study|Withdrawal by Subject|1|||
125266576|NCT00269087|450604931|FG000|Overall Study|Exacerbation of COPD|13|||
125266577|NCT00041470|450604935|FG000|Overall Study|Loss of Funding|38|||
125266578|NCT00461708|450604936|FG000|Overall Study|Adverse Event|17|||
125266579|NCT00461708|450604937|FG001|Overall Study|Adverse Event|7|||
125266580|NCT00461708|450604936|FG000|Overall Study|Lack of Efficacy|68|||
125266581|NCT00461708|450604937|FG001|Overall Study|Lack of Efficacy|20|||
125266582|NCT00461708|450604936|FG000|Overall Study|Physician Decision|10|||
125266583|NCT00461708|450604937|FG001|Overall Study|Physician Decision|4|||
125266584|NCT00461708|450604936|FG000|Overall Study|Withdrawal by Subject|8|||
125266585|NCT00461708|450604937|FG001|Overall Study|Withdrawal by Subject|2|||
125266586|NCT00461708|450604936|FG000|Overall Study|Other|4|||
125266587|NCT00461708|450604937|FG001|Overall Study|Other|4|||
125266588|NCT00461708|450604936|FG000|Overall Study|Death|8|||
125266589|NCT00461708|450604937|FG001|Overall Study|Death|1|||
125266590|NCT02803203|450604938|FG000|Overall Study|Adverse Event|4|||
125266591|NCT02803203|450604938|FG000|Overall Study|Death|4|||
125266592|NCT02803203|450604938|FG000|Overall Study|Progressive disease|29|||
125266593|NCT02803203|450604938|FG000|Overall Study|Withdrawal by Subject|8|||
125266594|NCT02803203|450604938|FG000|Overall Study|Complete resection of target disease|2|||
125266595|NCT02803203|450604938|FG000|Overall Study|Switched to commercial Osi|1|||
125266596|NCT02803203|450604938|FG000|Overall Study|Participant moved away|1|||
125266597|NCT02230189|450604945|FG000|Overall Study|Withdrawal by Subject|3|||
125266598|NCT02230189|450604946|FG001|Overall Study|Withdrawal by Subject|0|||
125266599|NCT02230189|450604947|FG002|Overall Study|Withdrawal by Subject|1|||
125266600|NCT02230189|450604945|FG000|Overall Study|Lost to Follow-up|1|||
125266601|NCT02230189|450604946|FG001|Overall Study|Lost to Follow-up|0|||
125266602|NCT02230189|450604947|FG002|Overall Study|Lost to Follow-up|0|||
125266603|NCT02230189|450604945|FG000|Overall Study|Physician Decision|1|||
125266604|NCT02230189|450604946|FG001|Overall Study|Physician Decision|0|||
125266605|NCT02230189|450604947|FG002|Overall Study|Physician Decision|0|||
125266606|NCT01193101|450604951|FG000|Overall Study|Adverse Event|0|||
125266607|NCT01193101|450604952|FG001|Overall Study|Adverse Event|1|||
125266608|NCT01193101|450604953|FG002|Overall Study|Adverse Event|1|||
125266609|NCT01193101|450604954|FG003|Overall Study|Adverse Event|3|||
125266610|NCT01193101|450604951|FG000|Overall Study|Lack of Efficacy|3|||
125266611|NCT01193101|450604952|FG001|Overall Study|Lack of Efficacy|1|||
125266612|NCT01193101|450604953|FG002|Overall Study|Lack of Efficacy|0|||
125266613|NCT01193101|450604954|FG003|Overall Study|Lack of Efficacy|8|||
125266614|NCT01193101|450604951|FG000|Overall Study|Withdrawal by Subject|2|||
125266615|NCT01193101|450604952|FG001|Overall Study|Withdrawal by Subject|4|||
125266616|NCT01193101|450604953|FG002|Overall Study|Withdrawal by Subject|1|||
125266617|NCT01193101|450604954|FG003|Overall Study|Withdrawal by Subject|1|||
125266618|NCT01193101|450604951|FG000|Overall Study|Administrative problems|0|||
125266619|NCT01193101|450604952|FG001|Overall Study|Administrative problems|0|||
125266620|NCT01193101|450604953|FG002|Overall Study|Administrative problems|1|||
125266621|NCT01193101|450604954|FG003|Overall Study|Administrative problems|0|||
125266622|NCT01193101|450604951|FG000|Overall Study|Abnormal test procedure results|0|||
125266623|NCT01193101|450604952|FG001|Overall Study|Abnormal test procedure results|1|||
125266624|NCT01193101|450604953|FG002|Overall Study|Abnormal test procedure results|0|||
125266625|NCT01193101|450604954|FG003|Overall Study|Abnormal test procedure results|0|||
125266626|NCT02347085|450604957|FG000|Overall Study|Adverse Event|2|||
125266627|NCT02347085|450604957|FG000|Overall Study|Lack of Efficacy|1|||
125266628|NCT02347085|450604957|FG000|Overall Study|Withdrawal by Subject|4|||
125266629|NCT02347085|450604957|FG000|Overall Study|Lost to Follow-up|1|||
125266630|NCT02347085|450604957|FG000|Overall Study|Protocol Criteria|2|||
125266631|NCT02834819|450604958|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
125266632|NCT02834819|450604959|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
125266633|NCT00527618|450604962|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
125266634|NCT00527618|450604963|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
125266635|NCT00527618|450604962|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
125266636|NCT00527618|450604963|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
125266637|NCT00527618|450604962|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
125266638|NCT00527618|450604963|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
125398780|NCT02365597|451093209|FG002|Overall Study|Lost to Follow-up|0|||
125266639|NCT00527618|450604962|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
125266640|NCT00527618|450604963|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
125266641|NCT00527618|450604962|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
125266642|NCT00527618|450604963|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
125266643|NCT00527618|450604962|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
125266644|NCT00527618|450604963|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
125266645|NCT00363311|450604974|FG000|Overall Study|Adverse Event|6|||
125266646|NCT00363311|450604975|FG001|Overall Study|Adverse Event|4|||
125266647|NCT00363311|450604974|FG000|Overall Study|Lost to Follow-up|3|||
125266648|NCT00363311|450604975|FG001|Overall Study|Lost to Follow-up|0|||
125266649|NCT00363311|450604974|FG000|Overall Study|Protocol Violation|1|||
125266650|NCT00363311|450604975|FG001|Overall Study|Protocol Violation|2|||
125266651|NCT00363311|450604974|FG000|Overall Study|Withdrawal by Subject|12|||
125266652|NCT00363311|450604975|FG001|Overall Study|Withdrawal by Subject|6|||
125266653|NCT00363311|450604974|FG000|Overall Study|Physician Decision|1|||
125266654|NCT00363311|450604975|FG001|Overall Study|Physician Decision|1|||
125266655|NCT00363311|450604974|FG000|Overall Study|Sponsor Terminated Study|2|||
125266656|NCT00363311|450604975|FG001|Overall Study|Sponsor Terminated Study|2|||
125266657|NCT00363311|450604974|FG000|Overall Study|Disease Progression|46|||
125266658|NCT00363311|450604975|FG001|Overall Study|Disease Progression|26|||
125266659|NCT00363311|450604974|FG000|Overall Study|Non-Compliance|1|||
125266660|NCT00363311|450604975|FG001|Overall Study|Non-Compliance|1|||
125266661|NCT00363311|450604974|FG000|Overall Study|Participant Refused Biopsy|1|||
125266662|NCT00363311|450604975|FG001|Overall Study|Participant Refused Biopsy|0|||
125266663|NCT00363311|450604974|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
125266664|NCT00363311|450604975|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
125266665|NCT00363311|450604974|FG000|Overall Study|Participant Opted for Treatment|1|||
125266666|NCT00363311|450604975|FG001|Overall Study|Participant Opted for Treatment|0|||
125266667|NCT00363311|450604974|FG000|Overall Study|Participant Moved to Another Country|1|||
125266668|NCT00363311|450604975|FG001|Overall Study|Participant Moved to Another Country|0|||
125266669|NCT00363311|450604974|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
125266670|NCT00363311|450604975|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
125266671|NCT00363311|450604974|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
125266672|NCT00363311|450604975|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
125266673|NCT00363311|450604974|FG000|Overall Study|Participant Moved to Louisiana|0|||
125266674|NCT00363311|450604975|FG001|Overall Study|Participant Moved to Louisiana|1|||
125266675|NCT00120627|450604978|FG000|Overall Study|Withdrawal by Subject|5|||
125266676|NCT00120627|450604979|FG001|Overall Study|Withdrawal by Subject|5|||
125266677|NCT01508910|450604980|FG000|Treatment|Death|2|||
125266678|NCT01508910|450604981|FG001|Treatment|Death|3|||
125266679|NCT01508910|450604982|FG002|Treatment|Death|2|||
125266680|NCT01508910|450604983|FG003|Treatment|Death|0|||
125266681|NCT01508910|450604980|FG000|Treatment|Lost to Follow-up|0|||
125266682|NCT01508910|450604981|FG001|Treatment|Lost to Follow-up|0|||
125266683|NCT01508910|450604982|FG002|Treatment|Lost to Follow-up|2|||
125266684|NCT01508910|450604983|FG003|Treatment|Lost to Follow-up|1|||
125266685|NCT01508910|450604980|FG000|Treatment|Withdrawal by Subject|0|||
125266686|NCT01508910|450604981|FG001|Treatment|Withdrawal by Subject|1|||
125266687|NCT01508910|450604982|FG002|Treatment|Withdrawal by Subject|6|||
125266688|NCT01508910|450604983|FG003|Treatment|Withdrawal by Subject|1|||
125266689|NCT01508910|450604980|FG000|Treatment|Sponsor Decision|0|||
125266690|NCT01508910|450604981|FG001|Treatment|Sponsor Decision|0|||
125266691|NCT01508910|450604982|FG002|Treatment|Sponsor Decision|0|||
125266692|NCT01508910|450604983|FG003|Treatment|Sponsor Decision|1|||
125266693|NCT01595529|450604984|FG000|Overall Study|Adverse Event|2|||
125266694|NCT01595529|450604985|FG001|Overall Study|Adverse Event|0|||
125266695|NCT01595529|450604984|FG000|Overall Study|Subject Non-Compliant|2|||
125266696|NCT01595529|450604985|FG001|Overall Study|Subject Non-Compliant|0|||
125447311|NCT00162942|451262779|FG000|Overall Study|Alternate Therapy|6|||
125447312|NCT00162942|451262780|FG001|Overall Study|Alternate Therapy|2|||
125447313|NCT00162942|451262779|FG000|Overall Study|Lack of Efficacy|1|||
125447314|NCT00162942|451262780|FG001|Overall Study|Lack of Efficacy|0|||
125266697|NCT01595529|450604984|FG000|Overall Study|Lost to Follow-up|8|||
125266698|NCT01595529|450604985|FG001|Overall Study|Lost to Follow-up|14|||
125266699|NCT01595529|450604984|FG000|Overall Study|Protocol Violation|1|||
125266700|NCT01595529|450604985|FG001|Overall Study|Protocol Violation|2|||
125266701|NCT01595529|450604984|FG000|Overall Study|Physician Decision|1|||
125266702|NCT01595529|450604985|FG001|Overall Study|Physician Decision|0|||
125266703|NCT01595529|450604984|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
125266704|NCT01595529|450604985|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
125447315|NCT00162942|451262779|FG000|Overall Study|Flare During Active Treatment|7|||
125266705|NCT01595529|450604984|FG000|Overall Study|Administrative Decision|1|||
125266706|NCT01595529|450604985|FG001|Overall Study|Administrative Decision|0|||
125266707|NCT01595529|450604984|FG000|Overall Study|Entry Failure/Screening Failure|6|||
125266708|NCT01595529|450604985|FG001|Overall Study|Entry Failure/Screening Failure|1|||
125266709|NCT00730886|450604986|FG000|Overall Study|Lost to Follow-up|1|||
125266710|NCT00730886|450604987|FG001|Overall Study|Lost to Follow-up|0|||
125266711|NCT00730886|450604986|FG000|Overall Study|Physician Decision|1|||
125266712|NCT00730886|450604987|FG001|Overall Study|Physician Decision|0|||
125266713|NCT01991483|450604988|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
125266714|NCT01991483|450604989|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
125266715|NCT01991483|450604990|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
125266716|NCT01991483|450604991|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
125266717|NCT01991483|450604988|FG000|Dose Level 600 mg|Physician Decision|0|||
125266718|NCT01991483|450604989|FG001|Dose Level 600 mg|Physician Decision|0|||
125266719|NCT01991483|450604990|FG002|Dose Level 600 mg|Physician Decision|1|||
125266720|NCT01991483|450604991|FG003|Dose Level 600 mg|Physician Decision|0|||
125266721|NCT01991483|450604988|FG000|Dose Level 1000 mg|Protocol Violation|0|||
125266722|NCT01991483|450604989|FG001|Dose Level 1000 mg|Protocol Violation|0|||
125266723|NCT01991483|450604990|FG002|Dose Level 1000 mg|Protocol Violation|0|||
125266724|NCT01991483|450604991|FG003|Dose Level 1000 mg|Protocol Violation|1|||
125266725|NCT01932788|450604998|FG000|Overall Study|Protocol Violation|18|||
125266726|NCT01932788|450604999|FG001|Overall Study|Protocol Violation|0|||
125266727|NCT01932788|450604998|FG000|Overall Study|Lost to Follow-up|18|||
125266728|NCT01932788|450604999|FG001|Overall Study|Lost to Follow-up|46|||
125266729|NCT01932788|450604998|FG000|Overall Study|Lack of Efficacy|2|||
125266730|NCT01932788|450604999|FG001|Overall Study|Lack of Efficacy|0|||
125266731|NCT01932788|450604998|FG000|Overall Study|Withdrawal by Subject|0|||
125266732|NCT01932788|450604999|FG001|Overall Study|Withdrawal by Subject|5|||
125266733|NCT04819113|450605000|FG000|Overall Study|Withdrawal by parent/guardian|3|||
125266734|NCT04819113|450605000|FG000|Overall Study|Lost to Follow-up|1|||
125266735|NCT04819113|450605000|FG000|Overall Study|Withdrawn before vaccination|2|||
125266736|NCT00833027|450605001|FG000|Overall Study|Adverse Event|33|||
125266737|NCT00833027|450605001|FG000|Overall Study|Death|1|||
125266738|NCT00833027|450605001|FG000|Overall Study|Lack of Efficacy|12|||
125266739|NCT00833027|450605001|FG000|Overall Study|Lost to Follow-up|24|||
125266740|NCT00833027|450605001|FG000|Overall Study|Protocol Violation|115|||
125266741|NCT00833027|450605001|FG000|Overall Study|Withdrawal by Subject|16|||
125266742|NCT00833027|450605001|FG000|Overall Study|Missing|10|||
125266743|NCT02806414|450605008|FG000|Overall Study|Lost to Follow-up|2|||
125266744|NCT03092479|450605011|FG000|Overall Study|Lost to Follow-up|3|||
125266745|NCT03092479|450605012|FG001|Overall Study|Lost to Follow-up|2|||
125266746|NCT03092479|450605011|FG000|Overall Study|Withdrawal by Subject|4|||
125266747|NCT03092479|450605012|FG001|Overall Study|Withdrawal by Subject|0|||
125266748|NCT00441272|450606908|FG000|Overall Study|Study terminated prior to enrollment|25|||
125266749|NCT00441272|450606909|FG001|Overall Study|Study terminated prior to enrollment|25|||
125266750|NCT01856322|450606910|FG000|Overall Study|off study due to lack of accrual|0|||
125266751|NCT01856322|450606911|FG001|Overall Study|off study due to lack of accrual|0|||
125266752|NCT01856322|450606912|FG002|Overall Study|off study due to lack of accrual|3|||
125266753|NCT02364037|450606916|FG000|Overall Study|Withdrawal by Subject|7|||
125266754|NCT02364037|450606917|FG001|Overall Study|Withdrawal by Subject|4|||
125266755|NCT02364037|450606916|FG000|Overall Study|Lost to Follow-up|37|||
125266756|NCT02364037|450606917|FG001|Overall Study|Lost to Follow-up|49|||
125266757|NCT04567524|450606918|FG000|Overall Study|Adverse Event|1|||
125266758|NCT04567524|450606919|FG001|Overall Study|Adverse Event|1|||
125266759|NCT04567524|450606920|FG002|Overall Study|Adverse Event|0|||
125266760|NCT04567524|450606921|FG003|Overall Study|Adverse Event|0|||
125266761|NCT04567524|450606918|FG000|Overall Study|Withdrawal by Subject|2|||
125266762|NCT04567524|450606919|FG001|Overall Study|Withdrawal by Subject|0|||
125266763|NCT04567524|450606920|FG002|Overall Study|Withdrawal by Subject|0|||
125266764|NCT04567524|450606921|FG003|Overall Study|Withdrawal by Subject|1|||
125266765|NCT01639469|450606925|FG000|Overall Study|Death|4|||
125266766|NCT01639469|450606926|FG001|Overall Study|Death|2|||
125266767|NCT01639469|450606925|FG000|Overall Study|Lost to Follow-up|1|||
125266768|NCT01639469|450606926|FG001|Overall Study|Lost to Follow-up|1|||
125266769|NCT00420381|450606927|FG000|Overall Study|Protocol Violation|1|||
125266770|NCT02078752|450606930|FG000|Overall Study|Death|0|||
125266771|NCT02078752|450606931|FG001|Overall Study|Death|3|||
125266772|NCT02078752|450606932|FG002|Overall Study|Death|0|||
125266773|NCT02078752|450606933|FG003|Overall Study|Death|0|||
125266774|NCT02078752|450606934|FG004|Overall Study|Death|0|||
125266775|NCT02078752|450606935|FG005|Overall Study|Death|1|||
125266776|NCT02078752|450606936|FG006|Overall Study|Death|0|||
125266777|NCT02078752|450606937|FG007|Overall Study|Death|1|||
125266778|NCT02078752|450606938|FG008|Overall Study|Death|0|||
125266779|NCT02078752|450606939|FG009|Overall Study|Death|4|||
125266780|NCT02078752|450606930|FG000|Overall Study|Lost to Follow-up|1|||
125266781|NCT02078752|450606931|FG001|Overall Study|Lost to Follow-up|0|||
125266782|NCT02078752|450606932|FG002|Overall Study|Lost to Follow-up|0|||
125266783|NCT02078752|450606933|FG003|Overall Study|Lost to Follow-up|1|||
125266784|NCT02078752|450606934|FG004|Overall Study|Lost to Follow-up|0|||
125266785|NCT02078752|450606935|FG005|Overall Study|Lost to Follow-up|0|||
125266786|NCT02078752|450606936|FG006|Overall Study|Lost to Follow-up|0|||
125266787|NCT02078752|450606937|FG007|Overall Study|Lost to Follow-up|0|||
125266788|NCT02078752|450606938|FG008|Overall Study|Lost to Follow-up|0|||
125266789|NCT02078752|450606939|FG009|Overall Study|Lost to Follow-up|0|||
125266790|NCT02078752|450606930|FG000|Overall Study|Withdrawal by Subject|1|||
125266791|NCT02078752|450606931|FG001|Overall Study|Withdrawal by Subject|1|||
125266792|NCT02078752|450606932|FG002|Overall Study|Withdrawal by Subject|1|||
125266793|NCT02078752|450606933|FG003|Overall Study|Withdrawal by Subject|1|||
125266794|NCT02078752|450606934|FG004|Overall Study|Withdrawal by Subject|0|||
125266795|NCT02078752|450606935|FG005|Overall Study|Withdrawal by Subject|3|||
125266796|NCT02078752|450606936|FG006|Overall Study|Withdrawal by Subject|2|||
125266797|NCT02078752|450606937|FG007|Overall Study|Withdrawal by Subject|1|||
125266798|NCT02078752|450606938|FG008|Overall Study|Withdrawal by Subject|0|||
125266799|NCT02078752|450606939|FG009|Overall Study|Withdrawal by Subject|1|||
125266800|NCT02078752|450606930|FG000|Overall Study|Other|0|||
125266801|NCT02078752|450606931|FG001|Overall Study|Other|3|||
125266802|NCT02078752|450606932|FG002|Overall Study|Other|0|||
125266803|NCT02078752|450606933|FG003|Overall Study|Other|0|||
125266804|NCT02078752|450606934|FG004|Overall Study|Other|1|||
125266805|NCT02078752|450606935|FG005|Overall Study|Other|0|||
125266806|NCT02078752|450606936|FG006|Overall Study|Other|0|||
125266807|NCT02078752|450606937|FG007|Overall Study|Other|1|||
125266808|NCT02078752|450606938|FG008|Overall Study|Other|0|||
125266809|NCT02078752|450606939|FG009|Overall Study|Other|0|||
125266810|NCT02078752|450606930|FG000|Overall Study|Study terminated by sponsor|0|||
125266811|NCT02078752|450606931|FG001|Overall Study|Study terminated by sponsor|0|||
125266812|NCT02078752|450606932|FG002|Overall Study|Study terminated by sponsor|0|||
125266813|NCT02078752|450606933|FG003|Overall Study|Study terminated by sponsor|0|||
125266814|NCT02078752|450606934|FG004|Overall Study|Study terminated by sponsor|0|||
125266815|NCT02078752|450606935|FG005|Overall Study|Study terminated by sponsor|0|||
125266816|NCT02078752|450606936|FG006|Overall Study|Study terminated by sponsor|0|||
125266817|NCT02078752|450606937|FG007|Overall Study|Study terminated by sponsor|0|||
125266818|NCT02078752|450606938|FG008|Overall Study|Study terminated by sponsor|0|||
125266819|NCT02078752|450606939|FG009|Overall Study|Study terminated by sponsor|5|||
125266820|NCT00616642|450606949|FG000|Overall Study|Withdrawal by Subject|0|||
125266821|NCT00616642|450606950|FG001|Overall Study|Withdrawal by Subject|1|||
125266822|NCT00589797|450606957|FG000|Overall Study|Death|1|||
125266823|NCT00589797|450606958|FG001|Overall Study|Death|0|||
125266824|NCT00589797|450606957|FG000|Overall Study|Lost to Follow-up|12|||
125266825|NCT00589797|450606958|FG001|Overall Study|Lost to Follow-up|9|||
125266826|NCT00589797|450606957|FG000|Overall Study|Physician Decision|8|||
125266827|NCT00589797|450606958|FG001|Overall Study|Physician Decision|3|||
125266828|NCT00589797|450606957|FG000|Overall Study|Withdrawal by Subject|6|||
125266829|NCT00589797|450606958|FG001|Overall Study|Withdrawal by Subject|5|||
125266830|NCT00589797|450606957|FG000|Overall Study|Non-Randomized Training Subjects|46|||
125266831|NCT00589797|450606958|FG001|Overall Study|Non-Randomized Training Subjects|6|||
125266832|NCT01881009|450606959|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
125266833|NCT01881009|450606960|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
125266834|NCT02141672|450606961|FG000|Overall Study|Adverse Event|0|||
125266835|NCT02141672|450606962|FG001|Overall Study|Adverse Event|1|||
125266836|NCT02141672|450606963|FG002|Overall Study|Adverse Event|0|||
125266837|NCT02141672|450606961|FG000|Overall Study|Death|10|||
125266838|NCT02141672|450606962|FG001|Overall Study|Death|2|||
125266839|NCT02141672|450606963|FG002|Overall Study|Death|1|||
125266840|NCT02141672|450606961|FG000|Overall Study|Lack of Efficacy|0|||
125266841|NCT02141672|450606962|FG001|Overall Study|Lack of Efficacy|0|||
125266842|NCT02141672|450606963|FG002|Overall Study|Lack of Efficacy|2|||
125266843|NCT02141672|450606961|FG000|Overall Study|Lost to Follow-up|1|||
125266844|NCT02141672|450606962|FG001|Overall Study|Lost to Follow-up|1|||
125266845|NCT02141672|450606963|FG002|Overall Study|Lost to Follow-up|3|||
125266846|NCT02141672|450606961|FG000|Overall Study|Physician Decision|1|||
125266847|NCT02141672|450606962|FG001|Overall Study|Physician Decision|2|||
125266848|NCT02141672|450606963|FG002|Overall Study|Physician Decision|5|||
125266849|NCT02141672|450606961|FG000|Overall Study|Protocol Violation|0|||
125266850|NCT02141672|450606962|FG001|Overall Study|Protocol Violation|0|||
125266851|NCT02141672|450606963|FG002|Overall Study|Protocol Violation|1|||
125266852|NCT02141672|450606961|FG000|Overall Study|Withdrawal by Subject|3|||
125266853|NCT02141672|450606962|FG001|Overall Study|Withdrawal by Subject|2|||
125266854|NCT02141672|450606963|FG002|Overall Study|Withdrawal by Subject|5|||
125266855|NCT02141672|450606961|FG000|Overall Study|refused to follow-up|1|||
125266856|NCT02141672|450606962|FG001|Overall Study|refused to follow-up|0|||
125266857|NCT02141672|450606963|FG002|Overall Study|refused to follow-up|1|||
125266858|NCT00332696|450606971|FG000|Overall Study|Death|24|||
125266859|NCT00332696|450606972|FG001|Overall Study|Death|14|||
125266860|NCT00332696|450606971|FG000|Overall Study|Insufficient therapeutic effect|4|||
125266861|NCT00332696|450606972|FG001|Overall Study|Insufficient therapeutic effect|11|||
125266862|NCT00332696|450606971|FG000|Overall Study|Adverse Event|1|||
125266863|NCT00332696|450606972|FG001|Overall Study|Adverse Event|2|||
125266864|NCT00332696|450606971|FG000|Overall Study|Condition does not justify treatment|0|||
125266865|NCT00332696|450606972|FG001|Overall Study|Condition does not justify treatment|2|||
125266866|NCT00332696|450606971|FG000|Overall Study|Lost to Follow-up|0|||
125266867|NCT00332696|450606972|FG001|Overall Study|Lost to Follow-up|1|||
125266868|NCT00332696|450606971|FG000|Overall Study|Withdrawal by Subject|1|||
125266869|NCT00332696|450606972|FG001|Overall Study|Withdrawal by Subject|0|||
125266870|NCT01061385|450606974|FG000|Overall Study|Lost to Follow-up|1|||
125266871|NCT01061385|450606975|FG001|Overall Study|Lost to Follow-up|0|||
125266872|NCT01061385|450606974|FG000|Overall Study|subject decision not related to AE|0|||
125266873|NCT01061385|450606975|FG001|Overall Study|subject decision not related to AE|1|||
125266874|NCT00533429|450606976|FG000|Overall Study|Adverse Event|3|||
125266875|NCT00533429|450606977|FG001|Overall Study|Adverse Event|1|||
125266876|NCT00533429|450606976|FG000|Overall Study|Death|1|||
125266877|NCT00533429|450606977|FG001|Overall Study|Death|0|||
125266878|NCT00533429|450606976|FG000|Overall Study|Withdrawal by Subject|2|||
125266879|NCT00533429|450606977|FG001|Overall Study|Withdrawal by Subject|0|||
125266880|NCT00533429|450606976|FG000|Overall Study|Progressive Disease|12|||
125266881|NCT00533429|450606977|FG001|Overall Study|Progressive Disease|13|||
125266882|NCT00533429|450606976|FG000|Overall Study|Symptomatic deterioration|1|||
125266883|NCT00533429|450606977|FG001|Overall Study|Symptomatic deterioration|2|||
125266884|NCT01464879|450606978|FG000|Overall Study|Physician Decision|1|||
125266885|NCT01464879|450606978|FG000|Overall Study|Non-compliance|1|||
125266886|NCT00244621|450606979|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
125266887|NCT00244621|450606980|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
125266888|NCT00244621|450606981|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
125266889|NCT00244621|450606979|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
125266890|NCT00244621|450606980|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
125266891|NCT00244621|450606981|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125266892|NCT00244621|450606979|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
125266893|NCT00244621|450606980|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
125266894|NCT00244621|450606981|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
125266895|NCT00244621|450606979|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
125266896|NCT00244621|450606980|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
125266897|NCT00244621|450606981|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
125266898|NCT00244621|450606979|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
125266899|NCT00244621|450606980|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
125266900|NCT00244621|450606981|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
125266901|NCT00244621|450606979|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
125266902|NCT00244621|450606980|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
125266903|NCT00244621|450606981|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
125266904|NCT00244621|450606979|FG000|Open-label Treatment Period|Adverse Event|0|||
125266905|NCT00244621|450606980|FG001|Open-label Treatment Period|Adverse Event|0|||
125266906|NCT00244621|450606981|FG002|Open-label Treatment Period|Adverse Event|1|||
125266907|NCT00244621|450606979|FG000|Open-label Treatment Period|Moved abroad|0|||
125266908|NCT00244621|450606980|FG001|Open-label Treatment Period|Moved abroad|0|||
125266909|NCT00244621|450606981|FG002|Open-label Treatment Period|Moved abroad|1|||
125266910|NCT01824290|450606982|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
125266911|NCT01824290|450606983|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
125266912|NCT01824290|450606984|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
125266913|NCT01824290|450606985|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
125266914|NCT01824290|450606982|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
125266915|NCT01824290|450606983|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
125266916|NCT01824290|450606984|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
125266917|NCT01824290|450606985|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
125266918|NCT01824290|450606982|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
125266919|NCT01824290|450606983|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
125266920|NCT01824290|450606984|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
125266921|NCT01824290|450606985|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
125266922|NCT01824290|450606982|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
125266923|NCT01824290|450606983|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
125266924|NCT01824290|450606984|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
125266925|NCT01824290|450606985|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
125266926|NCT01824290|450606982|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
125266927|NCT01824290|450606983|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
125266928|NCT01824290|450606984|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
125266929|NCT01824290|450606985|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
125266930|NCT01824290|450606982|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
125266931|NCT01824290|450606983|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
125266932|NCT01824290|450606984|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
125266933|NCT01824290|450606985|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
125266934|NCT00800982|450606986|FG000|Overall Study|Lost to Follow-up|1|||
125266935|NCT00800982|450606987|FG001|Overall Study|Lost to Follow-up|2|||
125266936|NCT00800982|450606986|FG000|Overall Study|Withdrawal by Subject|0|||
125266937|NCT00800982|450606987|FG001|Overall Study|Withdrawal by Subject|1|||
125266938|NCT00800982|450606986|FG000|Overall Study|Patient moved out of state|1|||
125266939|NCT00800982|450606987|FG001|Overall Study|Patient moved out of state|0|||
125266940|NCT00648037|450606990|FG000|Overall Study|Not Treated|1|||
125266941|NCT00648037|450606990|FG000|Overall Study|Withdrawal by Subject|1|||
125266942|NCT00648037|450606990|FG000|Overall Study|Adverse Event|11|||
125266943|NCT00648037|450606990|FG000|Overall Study|Relapse|2|||
125266944|NCT00648037|450606990|FG000|Overall Study|Other|1|||
125266945|NCT02967679|450606991|FG000|Overall Study|Adverse Event|1|||
125266946|NCT00003631|450606994|FG000|Overall Study|Patient not treated|1|||
125266947|NCT00003631|450606995|FG001|Overall Study|Patient not treated|0|||
125266948|NCT00003631|450606996|FG002|Overall Study|Patient not treated|1|||
125266949|NCT00003631|450606994|FG000|Overall Study|Protocol Violation|1|||
125266950|NCT00003631|450606995|FG001|Overall Study|Protocol Violation|0|||
125266951|NCT00003631|450606996|FG002|Overall Study|Protocol Violation|0|||
125266952|NCT00003631|450606994|FG000|Overall Study|Adverse Event|1|||
125266953|NCT00003631|450606995|FG001|Overall Study|Adverse Event|1|||
125266954|NCT00003631|450606996|FG002|Overall Study|Adverse Event|5|||
125266955|NCT00003631|450606994|FG000|Overall Study|Death|0|||
125266956|NCT00003631|450606995|FG001|Overall Study|Death|0|||
125266957|NCT00003631|450606996|FG002|Overall Study|Death|1|||
125266958|NCT00003631|450606994|FG000|Overall Study|Evaluable for toxicity only|0|||
125266959|NCT00003631|450606995|FG001|Overall Study|Evaluable for toxicity only|0|||
125266960|NCT00003631|450606996|FG002|Overall Study|Evaluable for toxicity only|2|||
125266961|NCT00600067|450606997|FG000|Overall Study|Adverse Event|0|||
125266962|NCT00600067|450606998|FG001|Overall Study|Adverse Event|1|||
125266963|NCT00600067|450606997|FG000|Overall Study|Lost to Follow-up|2|||
125266964|NCT00600067|450606998|FG001|Overall Study|Lost to Follow-up|3|||
125266965|NCT00600067|450606997|FG000|Overall Study|protocol non-compliance|0|||
125266966|NCT00600067|450606998|FG001|Overall Study|protocol non-compliance|3|||
125266967|NCT00600067|450606997|FG000|Overall Study|Lack of Efficacy|1|||
125266968|NCT00600067|450606998|FG001|Overall Study|Lack of Efficacy|0|||
125266969|NCT04339413|450607001|FG000|Overall Study|Reason Not Specified|2|||
125266970|NCT04339413|450607002|FG001|Overall Study|Reason Not Specified|7|||
125266971|NCT04339413|450607001|FG000|Overall Study|Study Terminated by Sponsor|30|||
125266972|NCT04339413|450607002|FG001|Overall Study|Study Terminated by Sponsor|33|||
125266973|NCT04339413|450607001|FG000|Overall Study|Progressive Disease|9|||
125266974|NCT04339413|450607002|FG001|Overall Study|Progressive Disease|6|||
125266975|NCT04339413|450607001|FG000|Overall Study|Withdrawal by Subject|9|||
125266976|NCT04339413|450607002|FG001|Overall Study|Withdrawal by Subject|10|||
125266977|NCT04339413|450607001|FG000|Overall Study|Physician Decision|3|||
125266978|NCT04339413|450607002|FG001|Overall Study|Physician Decision|1|||
125266979|NCT04339413|450607001|FG000|Overall Study|Death|2|||
125266980|NCT04339413|450607002|FG001|Overall Study|Death|0|||
125266981|NCT04339413|450607001|FG000|Overall Study|Adverse Event|3|||
125266982|NCT04339413|450607002|FG001|Overall Study|Adverse Event|0|||
125266983|NCT00401843|450607006|FG000|Overall Study|Achieved Complete Response|1|||
125266984|NCT00401843|450607007|FG001|Overall Study|Achieved Complete Response|5|||
125266985|NCT00401843|450607008|FG002|Overall Study|Achieved Complete Response|11|||
125266986|NCT00401843|450607006|FG000|Overall Study|Adverse Event|7|||
125266987|NCT00401843|450607007|FG001|Overall Study|Adverse Event|26|||
125266988|NCT00401843|450607008|FG002|Overall Study|Adverse Event|27|||
125266989|NCT00401843|450607006|FG000|Overall Study|Death|0|||
125266990|NCT00401843|450607007|FG001|Overall Study|Death|8|||
125266991|NCT00401843|450607008|FG002|Overall Study|Death|10|||
125266992|NCT00401843|450607006|FG000|Overall Study|Disease progression|10|||
125266993|NCT00401843|450607007|FG001|Overall Study|Disease progression|60|||
125266994|NCT00401843|450607008|FG002|Overall Study|Disease progression|49|||
125266995|NCT00401843|450607006|FG000|Overall Study|End of Study|1|||
125266996|NCT00401843|450607007|FG001|Overall Study|End of Study|1|||
125266997|NCT00401843|450607008|FG002|Overall Study|End of Study|2|||
125266998|NCT00401843|450607006|FG000|Overall Study|Lost to Follow-up|0|||
125266999|NCT00401843|450607007|FG001|Overall Study|Lost to Follow-up|0|||
125267000|NCT00401843|450607008|FG002|Overall Study|Lost to Follow-up|2|||
125267001|NCT00401843|450607006|FG000|Overall Study|Other Unspecified|0|||
125267002|NCT00401843|450607007|FG001|Overall Study|Other Unspecified|3|||
125267003|NCT00401843|450607008|FG002|Overall Study|Other Unspecified|5|||
125267004|NCT00401843|450607006|FG000|Overall Study|Physician Decision|0|||
125267005|NCT00401843|450607007|FG001|Overall Study|Physician Decision|16|||
125267006|NCT00401843|450607008|FG002|Overall Study|Physician Decision|10|||
125267007|NCT00401843|450607006|FG000|Overall Study|Protocol Violation|0|||
125267008|NCT00401843|450607007|FG001|Overall Study|Protocol Violation|0|||
125267009|NCT00401843|450607008|FG002|Overall Study|Protocol Violation|1|||
125267010|NCT00401843|450607006|FG000|Overall Study|Withdrawal by Subject|1|||
125267011|NCT00401843|450607007|FG001|Overall Study|Withdrawal by Subject|5|||
125267012|NCT00401843|450607008|FG002|Overall Study|Withdrawal by Subject|5|||
125267013|NCT00401843|450607006|FG000|Overall Study|Withdrawal of consent to study agent|1|||
125267014|NCT00401843|450607007|FG001|Overall Study|Withdrawal of consent to study agent|15|||
125267015|NCT00401843|450607008|FG002|Overall Study|Withdrawal of consent to study agent|17|||
125267016|NCT00401843|450607006|FG000|Overall Study|Randomized but not Treated|0|||
125267017|NCT00401843|450607007|FG001|Overall Study|Randomized but not Treated|2|||
125267018|NCT00401843|450607008|FG002|Overall Study|Randomized but not Treated|3|||
125267019|NCT00401843|450607006|FG000|Overall Study|Received incorrect treatment|0|||
125267020|NCT00401843|450607007|FG001|Overall Study|Received incorrect treatment|3|||
125267021|NCT00401843|450607008|FG002|Overall Study|Received incorrect treatment|0|||
125267022|NCT02103062|450607009|FG000|Overall Study|Adverse Event|1|||
125267023|NCT02103062|450607010|FG001|Overall Study|Adverse Event|2|||
125267024|NCT02103062|450607009|FG000|Overall Study|Progressive Disease|17|||
125267025|NCT02103062|450607010|FG001|Overall Study|Progressive Disease|20|||
125267026|NCT02103062|450607009|FG000|Overall Study|Death|0|||
125267027|NCT02103062|450607010|FG001|Overall Study|Death|1|||
125267028|NCT02030821|450607012|FG000|Overall Study|Physician Decision|2|||
125267029|NCT02030821|450607013|FG001|Overall Study|Physician Decision|2|||
125267030|NCT02030821|450607014|FG002|Overall Study|Physician Decision|5|||
125267031|NCT02030821|450607015|FG003|Overall Study|Physician Decision|2|||
125267032|NCT03192137|450607016|FG000|Overall Study|Adverse Event|10|||
125267033|NCT03192137|450607017|FG001|Overall Study|Adverse Event|11|||
125267034|NCT03192137|450607016|FG000|Overall Study|Physician Decision|1|||
125267035|NCT03192137|450607017|FG001|Overall Study|Physician Decision|0|||
125267036|NCT03192137|450607016|FG000|Overall Study|Lack of Efficacy|20|||
125267037|NCT03192137|450607017|FG001|Overall Study|Lack of Efficacy|37|||
125267038|NCT03192137|450607016|FG000|Overall Study|Withdrawal by Subject|3|||
125267039|NCT03192137|450607017|FG001|Overall Study|Withdrawal by Subject|3|||
125267040|NCT03192137|450607016|FG000|Overall Study|Protocol Violation|4|||
125267041|NCT03192137|450607017|FG001|Overall Study|Protocol Violation|3|||
125267042|NCT03192137|450607016|FG000|Overall Study|Surgery Cancelled|4|||
125267043|NCT03192137|450607017|FG001|Overall Study|Surgery Cancelled|1|||
125267044|NCT03192137|450607016|FG000|Overall Study|Other - Various Administrative Reasons|8|||
125267045|NCT03192137|450607017|FG001|Overall Study|Other - Various Administrative Reasons|3|||
125267046|NCT00657267|450607020|FG000|Overall Study|Progressive disease|45|||
125267047|NCT00657267|450607020|FG000|Overall Study|Adverse Event|9|||
125267048|NCT02737501|450607024|FG000|Randomized Phase|Died|41|||
125267049|NCT02737501|450607025|FG001|Randomized Phase|Died|29|||
125267050|NCT02737501|450607026|FG002|Randomized Phase|Died|0|||
125267051|NCT02737501|450607024|FG000|Randomized Phase|Withdrawal by Subject|16|||
125267052|NCT02737501|450607025|FG001|Randomized Phase|Withdrawal by Subject|6|||
125267053|NCT02737501|450607026|FG002|Randomized Phase|Withdrawal by Subject|0|||
125267054|NCT02737501|450607024|FG000|Randomized Phase|Lost to Follow-up|0|||
125267055|NCT02737501|450607025|FG001|Randomized Phase|Lost to Follow-up|1|||
125267056|NCT02737501|450607026|FG002|Randomized Phase|Lost to Follow-up|0|||
125267057|NCT02737501|450607024|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
125267058|NCT02737501|450607025|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
125267059|NCT02737501|450607026|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
125267060|NCT02737501|450607024|FG000|Randomized Phase|Reason not Specified|1|||
125267061|NCT02737501|450607025|FG001|Randomized Phase|Reason not Specified|1|||
125267062|NCT02737501|450607026|FG002|Randomized Phase|Reason not Specified|0|||
125267063|NCT02737501|450607024|FG000|Randomized Phase|Never Treated|1|||
125267064|NCT02737501|450607025|FG001|Randomized Phase|Never Treated|1|||
125267065|NCT02737501|450607026|FG002|Randomized Phase|Never Treated|0|||
125267066|NCT02737501|450607024|FG000|Crossover Phase|Died|0|||
125267067|NCT02737501|450607025|FG001|Crossover Phase|Died|0|||
125267068|NCT02737501|450607026|FG002|Crossover Phase|Died|22|||
125267069|NCT02737501|450607024|FG000|Crossover Phase|Withdrew Consent|0|||
125267070|NCT02737501|450607025|FG001|Crossover Phase|Withdrew Consent|0|||
125267071|NCT02737501|450607026|FG002|Crossover Phase|Withdrew Consent|9|||
125267072|NCT02737501|450607024|FG000|Crossover Phase|Physician Decision|0|||
125267073|NCT02737501|450607025|FG001|Crossover Phase|Physician Decision|0|||
125267074|NCT02737501|450607026|FG002|Crossover Phase|Physician Decision|1|||
125267075|NCT02737501|450607024|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
125267076|NCT02737501|450607025|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
125267077|NCT02737501|450607026|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
125267078|NCT01261975|450607027|FG000|Overall Study|Surgical complication|1|||
125267079|NCT00716274|450607028|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
125398781|NCT02365597|451093210|FG003|Overall Study|Lost to Follow-up|1|||
125398782|NCT02365597|451093207|FG000|Overall Study|Withdrawal by Subject|1|||
125398783|NCT02365597|451093208|FG001|Overall Study|Withdrawal by Subject|8|||
125398784|NCT02365597|451093209|FG002|Overall Study|Withdrawal by Subject|5|||
125267080|NCT00716274|450607029|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
125267081|NCT00716274|450607030|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
125267082|NCT00716274|450607031|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
125267083|NCT00716274|450607032|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
125398785|NCT02365597|451093210|FG003|Overall Study|Withdrawal by Subject|1|||
125267084|NCT00716274|450607033|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
125267085|NCT00716274|450607028|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
125267086|NCT00716274|450607029|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
125267087|NCT00716274|450607030|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
125267088|NCT00716274|450607031|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
125267089|NCT00716274|450607032|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
125267090|NCT00716274|450607033|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
125398786|NCT02365597|451093207|FG000|Overall Study|Sponsor's decision|1|||
125447316|NCT00162942|451262780|FG001|Overall Study|Flare During Active Treatment|3|||
125447317|NCT00162942|451262779|FG000|Overall Study|2 or more consecutive treatments missed|1|||
125447318|NCT00162942|451262780|FG001|Overall Study|2 or more consecutive treatments missed|0|||
125447319|NCT01253200|451262781|FG000|Overall Study|Death|1|||
125447320|NCT01253200|451262782|FG001|Overall Study|Death|0|||
125447321|NCT01253200|451262783|FG002|Overall Study|Death|0|||
125447322|NCT01253200|451262784|FG003|Overall Study|Death|0|||
125447323|NCT01253200|451262785|FG004|Overall Study|Death|0|||
125447324|NCT01253200|451262781|FG000|Overall Study|Lost to Follow-up|1|||
125447325|NCT01253200|451262782|FG001|Overall Study|Lost to Follow-up|1|||
125447326|NCT01253200|451262783|FG002|Overall Study|Lost to Follow-up|0|||
125447327|NCT01253200|451262784|FG003|Overall Study|Lost to Follow-up|0|||
125447328|NCT01253200|451262785|FG004|Overall Study|Lost to Follow-up|0|||
125447329|NCT01253200|451262781|FG000|Overall Study|Withdrawal by Subject|2|||
125267091|NCT00716274|450607028|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
125267092|NCT00716274|450607029|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
125267093|NCT00716274|450607030|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
125267094|NCT00716274|450607031|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
125267095|NCT00716274|450607032|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
125267096|NCT00716274|450607033|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
125267097|NCT00716274|450607028|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
125267098|NCT00716274|450607029|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
125267099|NCT00716274|450607030|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
125267100|NCT00716274|450607031|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
125267101|NCT00716274|450607032|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
125267102|NCT00716274|450607033|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
125267103|NCT00716274|450607028|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
125267104|NCT00716274|450607029|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
125267105|NCT00716274|450607030|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
125398787|NCT02365597|451093208|FG001|Overall Study|Sponsor's decision|3|||
125398788|NCT02365597|451093209|FG002|Overall Study|Sponsor's decision|13|||
125398789|NCT02365597|451093210|FG003|Overall Study|Sponsor's decision|0|||
125398790|NCT02365597|451093207|FG000|Overall Study|Other|0|||
125398791|NCT02365597|451093208|FG001|Overall Study|Other|4|||
125398792|NCT02365597|451093209|FG002|Overall Study|Other|0|||
125398793|NCT02365597|451093210|FG003|Overall Study|Other|0|||
125398794|NCT02365597|451093207|FG000|Overall Study|Enrolled but not treated|0|||
125398795|NCT02365597|451093208|FG001|Overall Study|Enrolled but not treated|1|||
125398796|NCT02365597|451093209|FG002|Overall Study|Enrolled but not treated|1|||
125398797|NCT02365597|451093210|FG003|Overall Study|Enrolled but not treated|0|||
125398798|NCT02365597|451093207|FG000|Overall Study|Ongoing|0|||
125398799|NCT02365597|451093208|FG001|Overall Study|Ongoing|0|||
125398800|NCT02365597|451093209|FG002|Overall Study|Ongoing|0|||
125398801|NCT02365597|451093210|FG003|Overall Study|Ongoing|17|||
125398802|NCT00499603|451093211|FG000|Overall Study|Adverse Event|0|||
125398803|NCT00499603|451093212|FG001|Overall Study|Adverse Event|1|||
125398804|NCT05179421|451093213|FG000|First Infusion Day|Adverse Event|1|||
125398805|NCT05179421|451093214|FG001|First Infusion Day|Adverse Event|0|||
125398806|NCT05132127|451093216|FG000|Overall Study|Adverse Event|1|||
125398807|NCT03473743|451093217|FG000|Overall Study|Withdrawal by Subject|0|||
125398808|NCT03473743|451093218|FG001|Overall Study|Withdrawal by Subject|0|||
125398809|NCT03473743|451093219|FG002|Overall Study|Withdrawal by Subject|0|||
125398810|NCT03473743|451093220|FG003|Overall Study|Withdrawal by Subject|0|||
125398811|NCT03473743|451093221|FG004|Overall Study|Withdrawal by Subject|0|||
125398812|NCT03473743|451093222|FG005|Overall Study|Withdrawal by Subject|0|||
125398813|NCT03473743|451093223|FG006|Overall Study|Withdrawal by Subject|0|||
125398814|NCT03473743|451093224|FG007|Overall Study|Withdrawal by Subject|3|||
125398815|NCT03473743|451093217|FG000|Overall Study|Other|0|||
125398816|NCT03473743|451093218|FG001|Overall Study|Other|0|||
125398817|NCT03473743|451093219|FG002|Overall Study|Other|0|||
125398818|NCT03473743|451093220|FG003|Overall Study|Other|1|||
125398819|NCT03473743|451093221|FG004|Overall Study|Other|0|||
125398820|NCT03473743|451093222|FG005|Overall Study|Other|0|||
125398821|NCT03473743|451093223|FG006|Overall Study|Other|0|||
125398822|NCT03473743|451093224|FG007|Overall Study|Other|0|||
125398823|NCT03473743|451093217|FG000|Overall Study|Ongoing|0|||
125398824|NCT03473743|451093218|FG001|Overall Study|Ongoing|0|||
125398825|NCT03473743|451093219|FG002|Overall Study|Ongoing|6|||
125398826|NCT03473743|451093220|FG003|Overall Study|Ongoing|8|||
125447330|NCT01253200|451262782|FG001|Overall Study|Withdrawal by Subject|0|||
125447331|NCT01253200|451262783|FG002|Overall Study|Withdrawal by Subject|0|||
125267106|NCT00716274|450607031|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
125398827|NCT03473743|451093221|FG004|Overall Study|Ongoing|1|||
125398828|NCT03473743|451093222|FG005|Overall Study|Ongoing|1|||
125398829|NCT03473743|451093223|FG006|Overall Study|Ongoing|22|||
125398830|NCT03473743|451093224|FG007|Overall Study|Ongoing|24|||
125398831|NCT03473743|451093217|FG000|Overall Study|Randomized but not treated|0|||
125398832|NCT03473743|451093218|FG001|Overall Study|Randomized but not treated|0|||
125447332|NCT01253200|451262784|FG003|Overall Study|Withdrawal by Subject|0|||
125267107|NCT00716274|450607032|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
125267108|NCT00716274|450607033|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
125267109|NCT00716274|450607028|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
125267110|NCT00716274|450607029|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
125267111|NCT00716274|450607030|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
125267112|NCT00716274|450607031|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
125267113|NCT00716274|450607032|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
125267114|NCT00716274|450607033|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
125267115|NCT00716274|450607028|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
125267116|NCT00716274|450607029|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
125267117|NCT00716274|450607030|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
125267118|NCT00716274|450607031|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
125267119|NCT00716274|450607032|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
125267120|NCT00716274|450607033|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
125267121|NCT00716274|450607028|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
125267122|NCT00716274|450607029|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
125267123|NCT00716274|450607030|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
125267124|NCT00716274|450607031|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
125267125|NCT00716274|450607032|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
125267126|NCT00716274|450607033|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
125267127|NCT00716274|450607028|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
125267128|NCT00716274|450607029|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
125267129|NCT00716274|450607030|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
125267130|NCT00716274|450607031|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
125267131|NCT00716274|450607032|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
125267132|NCT00716274|450607033|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
125267133|NCT00716274|450607028|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
125267134|NCT00716274|450607029|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
125267135|NCT00716274|450607030|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
125267136|NCT00716274|450607031|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
125267137|NCT00716274|450607032|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
125267138|NCT00716274|450607033|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
125267139|NCT04067492|450607036|FG000|Overall Study|Lost to Follow-up|0|||
125267140|NCT04067492|450607037|FG001|Overall Study|Lost to Follow-up|0|||
125267141|NCT04067492|450607038|FG002|Overall Study|Lost to Follow-up|0|||
125267142|NCT04067492|450607039|FG003|Overall Study|Lost to Follow-up|0|||
125267143|NCT04067492|450607040|FG004|Overall Study|Lost to Follow-up|0|||
125267144|NCT04067492|450607041|FG005|Overall Study|Lost to Follow-up|1|||
125267145|NCT04067492|450607036|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
125267146|NCT04067492|450607037|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
125267147|NCT04067492|450607038|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
125267148|NCT04067492|450607039|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
125267149|NCT04067492|450607040|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
125267150|NCT04067492|450607041|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
125267151|NCT04067492|450607036|FG000|Overall Study|COVID-19 epidemiological situation|0|||
125267152|NCT04067492|450607037|FG001|Overall Study|COVID-19 epidemiological situation|0|||
125267153|NCT04067492|450607038|FG002|Overall Study|COVID-19 epidemiological situation|0|||
125267154|NCT04067492|450607039|FG003|Overall Study|COVID-19 epidemiological situation|1|||
125267155|NCT04067492|450607040|FG004|Overall Study|COVID-19 epidemiological situation|0|||
125267156|NCT04067492|450607041|FG005|Overall Study|COVID-19 epidemiological situation|0|||
125267157|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Death|2|||
125267158|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
125267159|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
125267160|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Physician Decision|1|||
125267161|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
125267162|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
125267163|NCT00786422|450607042|FG000|Rivaroxaban Treatment|Adverse Event|2|||
125267164|NCT00786422|450607042|FG000|Follow-up Period|Death|1|||
125267165|NCT00786422|450607042|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
125267166|NCT00543985|450607045|FG000|Overall Study|Withdrawal by Subject|4|||
125267167|NCT02015039|450607046|FG000|Overall Study|Not eligible|0|||
125267168|NCT02015039|450607047|FG001|Overall Study|Not eligible|1|||
125267169|NCT04570384|450607048|FG000|Overall Study|Adverse Event|2|||
125267170|NCT04570384|450607049|FG001|Overall Study|Adverse Event|1|||
125267171|NCT04570384|450607048|FG000|Overall Study|Death|2|||
125398833|NCT03473743|451093219|FG002|Overall Study|Randomized but not treated|0|||
125267172|NCT04570384|450607049|FG001|Overall Study|Death|5|||
125267173|NCT04570384|450607048|FG000|Overall Study|Lost to Follow-up|1|||
125267174|NCT04570384|450607049|FG001|Overall Study|Lost to Follow-up|0|||
125267175|NCT04570384|450607048|FG000|Overall Study|Other|1|||
125267176|NCT04570384|450607049|FG001|Overall Study|Other|0|||
125398834|NCT03473743|451093220|FG003|Overall Study|Randomized but not treated|0|||
125267177|NCT04570384|450607048|FG000|Overall Study|Protocol Violation|0|||
125267178|NCT04570384|450607049|FG001|Overall Study|Protocol Violation|1|||
125267179|NCT04570384|450607048|FG000|Overall Study|Sponsor Decision|1|||
125267180|NCT04570384|450607049|FG001|Overall Study|Sponsor Decision|0|||
125267181|NCT04570384|450607048|FG000|Overall Study|Withdrawal by Subject|4|||
125267182|NCT04570384|450607049|FG001|Overall Study|Withdrawal by Subject|2|||
125267183|NCT01673126|450607050|FG000|Overall Study|change of diagnosis|4|||
125267184|NCT01673126|450607051|FG001|Overall Study|change of diagnosis|3|||
125267185|NCT00237042|450607052|FG000|Treatment|Became ineligible post-randomization|0|||
125267186|NCT00237042|450607053|FG001|Treatment|Became ineligible post-randomization|1|||
125267187|NCT00237042|450607054|FG002|Treatment|Became ineligible post-randomization|16|||
125267188|NCT00237042|450607052|FG000|Treatment|Moved out of state|1|||
125267189|NCT00237042|450607053|FG001|Treatment|Moved out of state|1|||
125267190|NCT00237042|450607054|FG002|Treatment|Moved out of state|1|||
125267191|NCT00237042|450607052|FG000|Treatment|Completed no treatment|5|||
125267192|NCT00237042|450607053|FG001|Treatment|Completed no treatment|5|||
125267193|NCT00237042|450607054|FG002|Treatment|Completed no treatment|21|||
125267194|NCT00237042|450607052|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
125267195|NCT00237042|450607053|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
125267196|NCT00237042|450607054|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
125267197|NCT00237042|450607052|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
125267198|NCT00237042|450607053|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
125398835|NCT03473743|451093221|FG004|Overall Study|Randomized but not treated|0|||
125398836|NCT03473743|451093222|FG005|Overall Study|Randomized but not treated|0|||
125398837|NCT03473743|451093223|FG006|Overall Study|Randomized but not treated|1|||
125398838|NCT03473743|451093224|FG007|Overall Study|Randomized but not treated|1|||
125398839|NCT02052739|451093230|FG000|Overall Study|Withdrew due to Adverse Event|3|||
125398840|NCT02052739|451093231|FG001|Overall Study|Withdrew due to Adverse Event|0|||
125398841|NCT02052739|451093230|FG000|Overall Study|Participant Died|2|||
125398842|NCT02052739|451093231|FG001|Overall Study|Participant Died|1|||
125398843|NCT05619692|451093232|FG000|Overall Study|Adverse Event|2|||
125398844|NCT05619692|451093233|FG001|Overall Study|Adverse Event|2|||
125447333|NCT01253200|451262785|FG004|Overall Study|Withdrawal by Subject|0|||
125447334|NCT01253200|451262781|FG000|Overall Study|Protocol Violation|1|||
125447335|NCT01253200|451262782|FG001|Overall Study|Protocol Violation|4|||
125447336|NCT01253200|451262783|FG002|Overall Study|Protocol Violation|0|||
125447337|NCT01253200|451262784|FG003|Overall Study|Protocol Violation|0|||
125447338|NCT01253200|451262785|FG004|Overall Study|Protocol Violation|5|||
125447339|NCT01253200|451262781|FG000|Overall Study|intents|10|||
125447340|NCT01253200|451262782|FG001|Overall Study|intents|10|||
125447341|NCT01253200|451262783|FG002|Overall Study|intents|1|||
125447342|NCT01253200|451262784|FG003|Overall Study|intents|3|||
125447343|NCT01253200|451262785|FG004|Overall Study|intents|0|||
125447344|NCT01253200|451262781|FG000|Overall Study|Attempts|6|||
125447345|NCT01253200|451262782|FG001|Overall Study|Attempts|4|||
125447346|NCT01253200|451262783|FG002|Overall Study|Attempts|1|||
125398845|NCT05619692|451093232|FG000|Overall Study|Withdrawal by Participant|3|||
125447347|NCT01253200|451262784|FG003|Overall Study|Attempts|2|||
125447348|NCT01253200|451262785|FG004|Overall Study|Attempts|0|||
125447349|NCT01700530|451262788|FG000|Overall Study|Withdrawal by Subject|0|||
125267199|NCT00237042|450607054|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
125267200|NCT01897532|450607061|FG000|Discontinuation From Treatment|Not Treated|7|||
125267201|NCT01897532|450607062|FG001|Discontinuation From Treatment|Not Treated|5|||
125267202|NCT01897532|450607061|FG000|Discontinuation From Treatment|Other reason than specified|196|||
125267203|NCT01897532|450607062|FG001|Discontinuation From Treatment|Other reason than specified|176|||
125267204|NCT01897532|450607061|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
125267205|NCT01897532|450607062|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
125267206|NCT01897532|450607061|FG000|Discontinuation From Treatment|Non compliance|24|||
125267207|NCT01897532|450607062|FG001|Discontinuation From Treatment|Non compliance|15|||
125267208|NCT01897532|450607061|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
125267209|NCT01897532|450607062|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
125267210|NCT01897532|450607061|FG000|Discontinuation From Trial|Not Treated|7|||
125267211|NCT01897532|450607062|FG001|Discontinuation From Trial|Not Treated|5|||
125267212|NCT01897532|450607061|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
125267213|NCT01897532|450607062|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
125267214|NCT03132467|450607063|FG000|Overall Study|Adverse Event|2|||
125267215|NCT03132467|450607063|FG000|Overall Study|Withdrawal by Subject|2|||
125267216|NCT00038948|450607064|FG000|Overall Study|Adverse Event|131|||
125267217|NCT00038948|450607065|FG001|Overall Study|Adverse Event|43|||
125267218|NCT00038948|450607064|FG000|Overall Study|Lost to Follow-up|4|||
125267219|NCT00038948|450607065|FG001|Overall Study|Lost to Follow-up|4|||
125267220|NCT00038948|450607064|FG000|Overall Study|Nonmedical event|5|||
125267221|NCT00038948|450607065|FG001|Overall Study|Nonmedical event|7|||
125267222|NCT00038948|450607064|FG000|Overall Study|Withdrawal by Subject|23|||
125447350|NCT01700530|451262789|FG001|Overall Study|Withdrawal by Subject|3|||
125447351|NCT01700530|451262790|FG002|Overall Study|Withdrawal by Subject|1|||
125447352|NCT03289455|451262795|FG000|Overall Study|Death|1|||
125447353|NCT03289455|451262796|FG001|Overall Study|Death|0|||
125447354|NCT03289455|451262797|FG002|Overall Study|Death|0|||
125447355|NCT03289455|451262795|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
125447356|NCT03289455|451262796|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
125447357|NCT03289455|451262797|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
125447358|NCT03289455|451262795|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
125447359|NCT03289455|451262796|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
125447360|NCT03289455|451262797|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
125447361|NCT03289455|451262795|FG000|Overall Study|Progressive disease|3|||
125447362|NCT03289455|451262796|FG001|Overall Study|Progressive disease|4|||
125447363|NCT03289455|451262797|FG002|Overall Study|Progressive disease|5|||
125447364|NCT00777803|451264738|FG000|Overall Study|Lost to Follow-up|12|||
125447365|NCT00777803|451264739|FG001|Overall Study|Lost to Follow-up|5|||
125447366|NCT00777803|451264738|FG000|Overall Study|Adverse Event|1|||
125447367|NCT00777803|451264739|FG001|Overall Study|Adverse Event|0|||
125447368|NCT00777803|451264738|FG000|Overall Study|Non-compliance|2|||
125447369|NCT00777803|451264739|FG001|Overall Study|Non-compliance|2|||
125447370|NCT01115998|451264740|FG000|Overall Study|Lost to Follow-up|6|||
125447371|NCT01115998|451264741|FG001|Overall Study|Lost to Follow-up|6|||
125447372|NCT03850444|451264742|FG000|Overall Study|Adverse Event|16|||
125447373|NCT03850444|451264743|FG001|Overall Study|Adverse Event|10|||
125447374|NCT03850444|451264742|FG000|Overall Study|Death|87|||
125447375|NCT03850444|451264743|FG001|Overall Study|Death|107|||
125447376|NCT03850444|451264742|FG000|Overall Study|Lost to Follow-up|1|||
125447377|NCT03850444|451264743|FG001|Overall Study|Lost to Follow-up|1|||
125447378|NCT03850444|451264742|FG000|Overall Study|Withdrawal by Subject|1|||
125447379|NCT03850444|451264743|FG001|Overall Study|Withdrawal by Subject|5|||
125447380|NCT03850444|451264742|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
125447381|NCT03850444|451264743|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
125447382|NCT04096365|451264744|FG000|Overall Study|Adverse Event|1|||
125447383|NCT01598987|451264746|FG000|Baseline to Month 12|Administrative problems|2|||
125447384|NCT01598987|451264746|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
125447385|NCT01598987|451264746|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
125447386|NCT01598987|451264746|FG000|Baseline to 24 Month|Administrative problems|2|||
125447387|NCT01598987|451264746|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
125447388|NCT02107274|451264747|FG000|Treatment vs. Placebo|Adverse Event|3|||
125447389|NCT02107274|451264748|FG001|Treatment vs. Placebo|Adverse Event|0|||
125447390|NCT02107274|451264747|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
125447391|NCT02107274|451264748|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
125447392|NCT02107274|451264747|FG000|Control Phase|Lost to Follow-up|1|||
125447393|NCT02107274|451264748|FG001|Control Phase|Lost to Follow-up|1|||
125447394|NCT02107274|451264747|FG000|Control Phase|Death|2|||
125447395|NCT02107274|451264748|FG001|Control Phase|Death|0|||
125447396|NCT02107274|451264747|FG000|Control Phase|Adverse Event|0|||
125447397|NCT02107274|451264748|FG001|Control Phase|Adverse Event|1|||
125447398|NCT01036087|451264749|FG000|Overall Study|Adverse Event|2|||
125447399|NCT01036087|451264749|FG000|Overall Study|Lack of Efficacy|1|||
125447400|NCT05406791|451264750|FG000|Overall Study|Lost to Follow-up|13|||
125447401|NCT05406791|451264751|FG001|Overall Study|Lost to Follow-up|10|||
125447402|NCT00519779|451264753|FG000|Overall Study|Withdrawal by Subject|0|||
125447403|NCT00519779|451264754|FG001|Overall Study|Withdrawal by Subject|1|||
125447404|NCT03330119|451264755|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
125447405|NCT03330119|451264756|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
125447406|NCT00550732|451264765|FG000|Overall Study|Death|4|||
125447407|NCT00550732|451264765|FG000|Overall Study|Withdrawal by Subject|2|||
125447408|NCT00550732|451264765|FG000|Overall Study|Physician Decision|2|||
125447409|NCT00550732|451264765|FG000|Overall Study|Lost to Follow-up|1|||
125267223|NCT00038948|450607065|FG001|Overall Study|Withdrawal by Subject|10|||
125267224|NCT00038948|450607064|FG000|Overall Study|Protocol Violation|3|||
125267225|NCT00038948|450607065|FG001|Overall Study|Protocol Violation|7|||
125267226|NCT00038948|450607064|FG000|Overall Study|Lack of Efficacy|3|||
125267227|NCT00038948|450607065|FG001|Overall Study|Lack of Efficacy|6|||
125267228|NCT01404234|450607068|FG000|Overall Study|Withdrawal by Subject|2|||
125447410|NCT00550732|451264765|FG000|Overall Study|Palliative care|1|||
125447411|NCT00550732|451264765|FG000|Overall Study|Adverse Event|1|||
125267229|NCT02670473|450607069|FG000|Overall Study|Withdrawal by Subject|1|||
125447412|NCT03302910|451264770|FG000|Overall Study|Protocol Violation|1|||
125447413|NCT03302910|451264771|FG001|Overall Study|Protocol Violation|0|||
125447414|NCT04004208|451264772|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125267230|NCT05223673|450607070|FG000|Overall Study|Protocol Violation|1|||
125447415|NCT04004208|451264773|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125447416|NCT04004208|451264772|FG000|Overall Study|Death|3|||
125447417|NCT04004208|451264773|FG001|Overall Study|Death|0|||
125267231|NCT05223673|450607070|FG000|Overall Study|Study termination|6|||
125447418|NCT04004208|451264772|FG000|Overall Study|COVID-19 pandemic|1|||
125447419|NCT04004208|451264773|FG001|Overall Study|COVID-19 pandemic|0|||
125447420|NCT04004208|451264772|FG000|Overall Study|Physician Decision|1|||
125447421|NCT04004208|451264773|FG001|Overall Study|Physician Decision|0|||
125447422|NCT04004208|451264772|FG000|Overall Study|Adverse Event|1|||
125447423|NCT04004208|451264773|FG001|Overall Study|Adverse Event|1|||
125447424|NCT02400307|451264775|FG000|Overall Study|Enrolled and Never Dosed|1|||
125447425|NCT02400307|451264776|FG001|Overall Study|Enrolled and Never Dosed|0|||
125447426|NCT01113463|451264777|FG000|Overall Study|Physician Decision|5|||
125447427|NCT03293485|451264779|FG000|Overall Study|Death|1|||
125447428|NCT03293485|451264779|FG000|Overall Study|Screen Failure|2|||
125447429|NCT03293485|451264779|FG000|Overall Study|Withdrawal by Subject|2|||
125447430|NCT00087490|451264780|FG000|Overall Study|Death|6|||
125447431|NCT00087490|451264781|FG001|Overall Study|Death|4|||
125447432|NCT00087490|451264780|FG000|Overall Study|Adverse Event|3|||
125447433|NCT00087490|451264781|FG001|Overall Study|Adverse Event|8|||
125447434|NCT00087490|451264780|FG000|Overall Study|Lack of Efficacy|0|||
125447435|NCT00087490|451264781|FG001|Overall Study|Lack of Efficacy|2|||
125447436|NCT00087490|451264780|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
125447437|NCT00087490|451264781|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
125447438|NCT00087490|451264780|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
125447439|NCT00087490|451264781|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
125447440|NCT00087490|451264780|FG000|Overall Study|Randomized but not treated|7|||
125447441|NCT00087490|451264781|FG001|Overall Study|Randomized but not treated|18|||
125447442|NCT02034435|451264782|FG000|Overall Study|Withdrawal by Subject|1|||
125447443|NCT02034435|451264783|FG001|Overall Study|Withdrawal by Subject|0|||
125447444|NCT02034435|451264784|FG002|Overall Study|Withdrawal by Subject|0|||
125447445|NCT02034435|451264785|FG003|Overall Study|Withdrawal by Subject|0|||
125447446|NCT02034435|451264782|FG000|Overall Study|Illness|0|||
125447447|NCT02034435|451264783|FG001|Overall Study|Illness|2|||
125447448|NCT02034435|451264784|FG002|Overall Study|Illness|0|||
125447449|NCT02034435|451264785|FG003|Overall Study|Illness|0|||
125447450|NCT02034435|451264782|FG000|Overall Study|Inadequate IV access|1|||
125447451|NCT02034435|451264783|FG001|Overall Study|Inadequate IV access|0|||
125447452|NCT02034435|451264784|FG002|Overall Study|Inadequate IV access|0|||
125447453|NCT02034435|451264785|FG003|Overall Study|Inadequate IV access|1|||
125447454|NCT03379233|451264786|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
125447455|NCT03379233|451264787|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
125447456|NCT02300311|451264788|FG000|Overall Study|Other than the reason specified|1|||
125447457|NCT02300311|451264789|FG001|Overall Study|Other than the reason specified|0|||
125447458|NCT02300311|451264788|FG000|Overall Study|Refused to continue taking medication|18|||
125447459|NCT02300311|451264789|FG001|Overall Study|Refused to continue taking medication|0|||
125447460|NCT02015195|451264795|FG000|Overall Study|Adverse Event|0|||
125447461|NCT02015195|451264796|FG001|Overall Study|Adverse Event|0|||
125447462|NCT02015195|451264797|FG002|Overall Study|Adverse Event|0|||
125447463|NCT02015195|451264798|FG003|Overall Study|Adverse Event|1|||
125447464|NCT02015195|451264799|FG004|Overall Study|Adverse Event|0|||
125447465|NCT02015195|451264800|FG005|Overall Study|Adverse Event|0|||
125447466|NCT02015195|451264801|FG006|Overall Study|Adverse Event|0|||
125447467|NCT01318811|451264802|FG000|Overall Study|Physician Decision|1|||
125447468|NCT01318811|451264803|FG001|Overall Study|Physician Decision|1|||
125447469|NCT01318811|451264802|FG000|Overall Study|CRRT stopped for head CT|0|||
125447470|NCT01318811|451264803|FG001|Overall Study|CRRT stopped for head CT|1|||
125447471|NCT01318811|451264802|FG000|Overall Study|Death|0|||
125447472|NCT01318811|451264803|FG001|Overall Study|Death|1|||
125447473|NCT01318811|451264802|FG000|Overall Study|CRRT stopped for head MRI|0|||
125447474|NCT01318811|451264803|FG001|Overall Study|CRRT stopped for head MRI|1|||
125447475|NCT00811187|451264804|FG000|Overall Study|Unable to place device / procedure abort|3|||
125447476|NCT00811187|451264805|FG001|Overall Study|Unable to place device / procedure abort|3|||
125447477|NCT00131911|451264806|FG000|Overall Study|Withdrawal by Subject|1|||
125447478|NCT00131911|451264807|FG001|Overall Study|Withdrawal by Subject|0|||
125447479|NCT00329303|451264808|FG000|Overall Study|Lack of Efficacy|1|||
125447480|NCT00329303|451264809|FG001|Overall Study|Lack of Efficacy|0|||
125447481|NCT00329303|451264808|FG000|Overall Study|Decision of the sponsor|0|||
125447482|NCT00329303|451264809|FG001|Overall Study|Decision of the sponsor|1|||
125447483|NCT00329303|451264808|FG000|Overall Study|Patient no longer available|1|||
125447484|NCT00329303|451264809|FG001|Overall Study|Patient no longer available|0|||
125447485|NCT00329303|451264808|FG000|Overall Study|Patient relocated|0|||
125447486|NCT00329303|451264809|FG001|Overall Study|Patient relocated|1|||
125447487|NCT00994279|451264814|FG000|Overall Study|Withdrawal by Subject|2|||
125447488|NCT00994279|451264815|FG001|Overall Study|Withdrawal by Subject|2|||
125447489|NCT00994279|451264814|FG000|Overall Study|Toxicity|1|||
125447490|NCT00994279|451264815|FG001|Overall Study|Toxicity|0|||
125447491|NCT00994279|451264814|FG000|Overall Study|Multiple reasons|1|||
125447492|NCT00994279|451264815|FG001|Overall Study|Multiple reasons|3|||
125447493|NCT01606189|451264816|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
125447494|NCT01606189|451264817|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
125447495|NCT01606189|451264818|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
125267232|NCT00937495|450608885|FG000|Overall Study|Protocol Violation|2|||
125267233|NCT00443703|450608886|FG000|Overall Study|Never Treated|3|||
125267234|NCT00443703|450608887|FG001|Overall Study|Never Treated|1|||
125267235|NCT00443703|450608886|FG000|Overall Study|Adverse Event|7|||
125267236|NCT00443703|450608887|FG001|Overall Study|Adverse Event|3|||
125267237|NCT00443703|450608886|FG000|Overall Study|Lack of Efficacy|3|||
125267238|NCT00443703|450608887|FG001|Overall Study|Lack of Efficacy|1|||
125267239|NCT00443703|450608886|FG000|Overall Study|Lost to Follow-up|0|||
125267240|NCT00443703|450608887|FG001|Overall Study|Lost to Follow-up|4|||
125267241|NCT00443703|450608886|FG000|Overall Study|Physician Decision|4|||
125267242|NCT00443703|450608887|FG001|Overall Study|Physician Decision|2|||
125267243|NCT00443703|450608886|FG000|Overall Study|Protocol Violation|1|||
125267244|NCT00443703|450608887|FG001|Overall Study|Protocol Violation|1|||
125267245|NCT00443703|450608886|FG000|Overall Study|Withdrawal by Subject|9|||
125267246|NCT00443703|450608887|FG001|Overall Study|Withdrawal by Subject|6|||
125267247|NCT00443703|450608886|FG000|Overall Study|Progressive Disease|1|||
125267248|NCT00443703|450608887|FG001|Overall Study|Progressive Disease|0|||
125267249|NCT00661830|450608890|FG000|Overall Study|Death|37|||
125267250|NCT00661830|450608891|FG001|Overall Study|Death|33|||
125267251|NCT00661830|450608890|FG000|Overall Study|Lost to Follow-up|1|||
125267252|NCT00661830|450608891|FG001|Overall Study|Lost to Follow-up|3|||
125267253|NCT00661830|450608890|FG000|Overall Study|Withdrawal by Subject|1|||
125267254|NCT00661830|450608891|FG001|Overall Study|Withdrawal by Subject|1|||
125267255|NCT00661830|450608890|FG000|Overall Study|Other reason|1|||
125267256|NCT00661830|450608891|FG001|Overall Study|Other reason|5|||
125267257|NCT00488514|450608892|FG000|Overall Study|Adverse Event|41|||
125267258|NCT00488514|450608892|FG000|Overall Study|Lost to Follow-up|44|||
125267259|NCT00488514|450608892|FG000|Overall Study|Protocol Violation|32|||
125267260|NCT00488514|450608892|FG000|Overall Study|Withdrawal by Subject|106|||
125267261|NCT00488514|450608892|FG000|Overall Study|Lack of Efficacy|28|||
125267262|NCT00488514|450608892|FG000|Overall Study|Did not meet criteria for treatment|30|||
125267263|NCT00488514|450608892|FG000|Overall Study|Postive drug screen|1|||
125267264|NCT00488514|450608892|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
125267265|NCT00488514|450608892|FG000|Overall Study|Investigator decision|1|||
125267266|NCT00488514|450608892|FG000|Overall Study|Participant had too few migraines|5|||
125267267|NCT00488514|450608892|FG000|Overall Study|Increase in number of migraines|2|||
125267268|NCT00488514|450608892|FG000|Overall Study|Increased use of concomitant medication|1|||
125267269|NCT01669902|450608893|FG000|Overall Study|Adverse Event|11|||
125267270|NCT01669902|450608893|FG000|Overall Study|Lack of Efficacy|10|||
125267271|NCT01669902|450608893|FG000|Overall Study|Other|8|||
125267272|NCT01535287|450608896|FG000|Overall Study|drug not prepared in time|5|||
125267273|NCT01535287|450608897|FG001|Overall Study|drug not prepared in time|6|||
125267274|NCT01475721|450608904|FG000|Overall Study|Death|3|||
125267275|NCT01475721|450608905|FG001|Overall Study|Death|6|||
125267276|NCT01475721|450608904|FG000|Overall Study|Withdrawal by Subject|8|||
125267277|NCT01475721|450608905|FG001|Overall Study|Withdrawal by Subject|8|||
125267278|NCT00803738|450608906|FG000|Overall Study|Adverse Event|3|||
125267279|NCT00803738|450608907|FG001|Overall Study|Adverse Event|5|||
125267280|NCT00803738|450608906|FG000|Overall Study|Lost to Follow-up|4|||
125267281|NCT00803738|450608907|FG001|Overall Study|Lost to Follow-up|4|||
125267282|NCT00803738|450608906|FG000|Overall Study|Protocol Violation|18|||
125267283|NCT00803738|450608907|FG001|Overall Study|Protocol Violation|10|||
125267284|NCT00803738|450608906|FG000|Overall Study|Withdrawal by Subject|1|||
125267285|NCT00803738|450608907|FG001|Overall Study|Withdrawal by Subject|4|||
125267286|NCT00803738|450608906|FG000|Overall Study|Lack of Efficacy|10|||
125267287|NCT00803738|450608907|FG001|Overall Study|Lack of Efficacy|16|||
125267288|NCT00803738|450608906|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
125267289|NCT00803738|450608907|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
125267290|NCT00803738|450608906|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
125267291|NCT00803738|450608907|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
125267292|NCT00387088|450608908|FG000|Overall Study|Adverse Event|143|||
125267293|NCT00387088|450608909|FG001|Overall Study|Adverse Event|156|||
125267294|NCT00387088|450608908|FG000|Overall Study|Protocol Violation|47|||
125267295|NCT00387088|450608909|FG001|Overall Study|Protocol Violation|35|||
125267296|NCT00387088|450608908|FG000|Overall Study|Withdrawal by Subject|20|||
125267297|NCT00387088|450608909|FG001|Overall Study|Withdrawal by Subject|35|||
125267298|NCT00387088|450608908|FG000|Overall Study|Lack of Efficacy|28|||
125267299|NCT00387088|450608909|FG001|Overall Study|Lack of Efficacy|67|||
125267300|NCT00387088|450608908|FG000|Overall Study|Lost to Follow-up|22|||
125267301|NCT00387088|450608909|FG001|Overall Study|Lost to Follow-up|28|||
125267302|NCT00387088|450608908|FG000|Overall Study|Other|58|||
125267303|NCT00387088|450608909|FG001|Overall Study|Other|52|||
125267304|NCT02848092|450608912|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
125267305|NCT02848092|450608913|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
125267306|NCT02848092|450608912|FG000|1-month Post-training Follow-up|Adverse Event|2|||
125267307|NCT02848092|450608913|FG001|1-month Post-training Follow-up|Adverse Event|1|||
125267308|NCT02848092|450608912|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
125267309|NCT02848092|450608913|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
125267310|NCT02848092|450608912|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
125267311|NCT02848092|450608913|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
125267312|NCT02848092|450608912|FG000|1-month Post-training Follow-up|fatigue|0|||
125267313|NCT02848092|450608913|FG001|1-month Post-training Follow-up|fatigue|1|||
125267314|NCT02848092|450608912|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
125267315|NCT02848092|450608913|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
125267316|NCT02848092|450608912|FG000|6-month Post-training Follow-up|Adverse Event|1|||
125267317|NCT02848092|450608913|FG001|6-month Post-training Follow-up|Adverse Event|1|||
125267318|NCT02848092|450608912|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
125267319|NCT02848092|450608913|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
125267320|NCT02848092|450608912|FG000|6-month Post-training Follow-up|frustrated with task|1|||
125267321|NCT02848092|450608913|FG001|6-month Post-training Follow-up|frustrated with task|0|||
125267322|NCT02848092|450608912|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
125267323|NCT02848092|450608913|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
125267324|NCT02848092|450608912|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
125267325|NCT02848092|450608913|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
125267326|NCT02329743|450608917|FG000|Overall Study|Adverse Event|1|||
125267327|NCT02329743|450608918|FG001|Overall Study|Adverse Event|1|||
125267328|NCT02329743|450608919|FG002|Overall Study|Adverse Event|3|||
125267329|NCT02329743|450608917|FG000|Overall Study|Lost to Follow-up|1|||
125267330|NCT02329743|450608918|FG001|Overall Study|Lost to Follow-up|0|||
125267331|NCT02329743|450608919|FG002|Overall Study|Lost to Follow-up|1|||
125267332|NCT02329743|450608917|FG000|Overall Study|Withdrawal by Subject|4|||
125267333|NCT02329743|450608918|FG001|Overall Study|Withdrawal by Subject|4|||
125267334|NCT02329743|450608919|FG002|Overall Study|Withdrawal by Subject|1|||
125267335|NCT02329743|450608917|FG000|Overall Study|Other|0|||
125267336|NCT02329743|450608918|FG001|Overall Study|Other|2|||
125267337|NCT02329743|450608919|FG002|Overall Study|Other|3|||
125267338|NCT01428219|450608931|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
125267339|NCT00592631|450608934|FG000|Overall Study|Lost to Follow-up|0|||
125267340|NCT00592631|450608935|FG001|Overall Study|Lost to Follow-up|2|||
125267341|NCT03745768|450608937|FG000|Overall Study|discontinued study|2|||
125267342|NCT03745768|450608938|FG001|Overall Study|discontinued study|0|||
125267343|NCT00443118|450608939|FG000|Overall Study|unknown primary outcome|3|||
125267344|NCT00443118|450608940|FG001|Overall Study|unknown primary outcome|1|||
125267345|NCT00443118|450608941|FG002|Overall Study|unknown primary outcome|0|||
125267346|NCT00443118|450608939|FG000|Overall Study|Withdrawal by Subject|1|||
125267347|NCT00443118|450608940|FG001|Overall Study|Withdrawal by Subject|0|||
125267348|NCT00443118|450608941|FG002|Overall Study|Withdrawal by Subject|0|||
125267349|NCT01023217|450608944|FG000|Overall Study|Withdrawal by Subject|1|||
125267350|NCT01023217|450608945|FG001|Overall Study|Withdrawal by Subject|0|||
125267351|NCT01106157|450608946|FG000|Overall Study|Withdrawal by Subject|1|||
125267352|NCT01106157|450608947|FG001|Overall Study|Withdrawal by Subject|0|||
125267353|NCT01673646|450608951|FG000|Overall Study|Adverse Event|2|||
125267354|NCT01673646|450608952|FG001|Overall Study|Adverse Event|1|||
125267355|NCT01673646|450608953|FG002|Overall Study|Adverse Event|1|||
125267356|NCT01673646|450608951|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125267357|NCT01673646|450608952|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125267358|NCT01673646|450608953|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125267359|NCT01673646|450608951|FG000|Overall Study|Condition no longer requires study drug|0|||
125267360|NCT01673646|450608952|FG001|Overall Study|Condition no longer requires study drug|1|||
125267361|NCT01673646|450608953|FG002|Overall Study|Condition no longer requires study drug|0|||
125267362|NCT01673646|450608951|FG000|Overall Study|Withdrawal by Subject|0|||
125267363|NCT01673646|450608952|FG001|Overall Study|Withdrawal by Subject|2|||
125267364|NCT01673646|450608953|FG002|Overall Study|Withdrawal by Subject|2|||
125267365|NCT01673646|450608951|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
125267366|NCT01673646|450608952|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
125267367|NCT01673646|450608953|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
125267368|NCT02651116|450608954|FG000|Overall Study|Adverse Event|0|||
125267369|NCT02651116|450608955|FG001|Overall Study|Adverse Event|1|||
125267370|NCT02651116|450608954|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
125267371|NCT02651116|450608955|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
125267372|NCT02457247|450608956|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
125267373|NCT02457247|450608957|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
125267374|NCT02457247|450608958|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
125267375|NCT02457247|450608959|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
125267376|NCT02457247|450608956|FG000|Period 1|Significant Protocol Deviation|1|||
125267377|NCT02457247|450608957|FG001|Period 1|Significant Protocol Deviation|1|||
125267378|NCT02457247|450608958|FG002|Period 1|Significant Protocol Deviation|0|||
125267379|NCT02457247|450608959|FG003|Period 1|Significant Protocol Deviation|0|||
125267380|NCT02457247|450608956|FG000|Period 1|Voluntary Withdrawal|1|||
125267381|NCT02457247|450608957|FG001|Period 1|Voluntary Withdrawal|0|||
125267382|NCT02457247|450608958|FG002|Period 1|Voluntary Withdrawal|0|||
125267383|NCT02457247|450608959|FG003|Period 1|Voluntary Withdrawal|0|||
125267384|NCT02457247|450608956|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
125267385|NCT02457247|450608957|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
125267386|NCT02457247|450608958|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
125267387|NCT02457247|450608959|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
125267388|NCT02457247|450608956|FG000|Period 2|Significant Protocol Deviation|1|||
125267389|NCT02457247|450608957|FG001|Period 2|Significant Protocol Deviation|0|||
125267390|NCT02457247|450608958|FG002|Period 2|Significant Protocol Deviation|0|||
125267391|NCT02457247|450608959|FG003|Period 2|Significant Protocol Deviation|0|||
125267392|NCT02457247|450608956|FG000|Period 2|Lost to Follow-up|0|||
125267393|NCT02457247|450608957|FG001|Period 2|Lost to Follow-up|1|||
125267394|NCT02457247|450608958|FG002|Period 2|Lost to Follow-up|0|||
125267395|NCT02457247|450608959|FG003|Period 2|Lost to Follow-up|0|||
125267396|NCT02457247|450608956|FG000|Period 2|Voluntary Withdrawal|1|||
125267397|NCT02457247|450608957|FG001|Period 2|Voluntary Withdrawal|1|||
125267398|NCT02457247|450608958|FG002|Period 2|Voluntary Withdrawal|0|||
125267399|NCT02457247|450608959|FG003|Period 2|Voluntary Withdrawal|0|||
125267400|NCT01492088|450608960|FG000|Overall Study|Withdrawal by Patient|0|||
125267401|NCT01492088|450608961|FG001|Overall Study|Withdrawal by Patient|2|||
125267402|NCT01492088|450608962|FG002|Overall Study|Withdrawal by Patient|0|||
125267403|NCT01492088|450608960|FG000|Overall Study|Death|1|||
125267404|NCT01492088|450608961|FG001|Overall Study|Death|6|||
125267405|NCT01492088|450608962|FG002|Overall Study|Death|2|||
125267406|NCT01492088|450608960|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
125267407|NCT01492088|450608961|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
125267408|NCT01492088|450608962|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
125267409|NCT01492088|450608960|FG000|Overall Study|Alive at Last Follow-up|0|||
125267410|NCT01492088|450608961|FG001|Overall Study|Alive at Last Follow-up|6|||
125267411|NCT01492088|450608962|FG002|Overall Study|Alive at Last Follow-up|11|||
125267412|NCT03824392|450608963|FG000|Overall Study|Adverse Event|1|||
125267413|NCT03824392|450608964|FG001|Overall Study|Adverse Event|0|||
125267414|NCT03824392|450608965|FG002|Overall Study|Adverse Event|0|||
125267415|NCT03824392|450608966|FG003|Overall Study|Adverse Event|0|||
125267416|NCT03824392|450608963|FG000|Overall Study|Investigator Decision|0|||
125267417|NCT03824392|450608964|FG001|Overall Study|Investigator Decision|1|||
125267418|NCT03824392|450608965|FG002|Overall Study|Investigator Decision|0|||
125267419|NCT03824392|450608966|FG003|Overall Study|Investigator Decision|0|||
125267420|NCT03824392|450608963|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
125267421|NCT03824392|450608964|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
125267422|NCT03824392|450608965|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
125267423|NCT03824392|450608966|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
125267424|NCT00127855|450608967|FG000|Primary Vaccination Course|Adverse Event|0|||
125267425|NCT00127855|450608968|FG001|Primary Vaccination Course|Adverse Event|0|||
125267426|NCT00127855|450608969|FG002|Primary Vaccination Course|Adverse Event|1|||
125267427|NCT00127855|450608970|FG003|Primary Vaccination Course|Adverse Event|0|||
125267428|NCT00127855|450608971|FG004|Primary Vaccination Course|Adverse Event|0|||
125267429|NCT00127855|450608967|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
125267430|NCT00127855|450608968|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
125267431|NCT00127855|450608969|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
125267432|NCT00127855|450608970|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
125267433|NCT00127855|450608971|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
125267434|NCT00127855|450608967|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
125267435|NCT00127855|450608968|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
125267436|NCT00127855|450608969|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
125267437|NCT00127855|450608970|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
125267438|NCT00127855|450608971|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
125267439|NCT00127855|450608967|FG000|Primary Vaccination Course|Other|0|||
125267440|NCT00127855|450608968|FG001|Primary Vaccination Course|Other|0|||
125267441|NCT00127855|450608969|FG002|Primary Vaccination Course|Other|0|||
125267442|NCT00127855|450608970|FG003|Primary Vaccination Course|Other|0|||
125267443|NCT00127855|450608971|FG004|Primary Vaccination Course|Other|1|||
125267444|NCT02343302|450608972|FG000|Overall Study|Physician Decision|1|||
125267445|NCT02343302|450608973|FG001|Overall Study|Physician Decision|1|||
125267446|NCT01887717|450608974|FG000|Overall Study|Withdrawal by Subject|1|||
125267447|NCT01887717|450608975|FG001|Overall Study|Withdrawal by Subject|7|||
125267448|NCT01887717|450608974|FG000|Overall Study|Physician Decision|0|||
125267449|NCT01887717|450608975|FG001|Overall Study|Physician Decision|2|||
125267450|NCT01887717|450608974|FG000|Overall Study|Administrative reasons|5|||
125267451|NCT01887717|450608975|FG001|Overall Study|Administrative reasons|2|||
125267452|NCT02655887|450608976|FG000|Overall Study|Lost to Follow-up|3|||
125267453|NCT02655887|450608976|FG000|Overall Study|Death|4|||
125267454|NCT02655887|450608976|FG000|Overall Study|Withdrawal by Subject|3|||
125267455|NCT02655887|450608976|FG000|Overall Study|Missed 12-month follow-up visit|4|||
125267456|NCT03637491|450608977|FG000|Overall Study|Death|9|||
125267457|NCT03637491|450608978|FG001|Overall Study|Death|9|||
125267458|NCT03637491|450608979|FG002|Overall Study|Death|5|||
125267459|NCT03637491|450608980|FG003|Overall Study|Death|3|||
125267460|NCT03637491|450608977|FG000|Overall Study|Lost to Follow-up|0|||
125267461|NCT03637491|450608978|FG001|Overall Study|Lost to Follow-up|1|||
125267462|NCT03637491|450608979|FG002|Overall Study|Lost to Follow-up|0|||
125267463|NCT03637491|450608980|FG003|Overall Study|Lost to Follow-up|1|||
125267464|NCT03637491|450608977|FG000|Overall Study|Study Terminated By Sponsor|0|||
125267465|NCT03637491|450608978|FG001|Overall Study|Study Terminated By Sponsor|2|||
125267466|NCT03637491|450608979|FG002|Overall Study|Study Terminated By Sponsor|1|||
125267467|NCT03637491|450608980|FG003|Overall Study|Study Terminated By Sponsor|0|||
125267468|NCT03637491|450608977|FG000|Overall Study|Withdrawal by Subject|1|||
125267469|NCT03637491|450608978|FG001|Overall Study|Withdrawal by Subject|0|||
125267470|NCT03637491|450608979|FG002|Overall Study|Withdrawal by Subject|1|||
125267471|NCT03637491|450608980|FG003|Overall Study|Withdrawal by Subject|2|||
125267472|NCT00532844|450608981|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
125267473|NCT00532844|450608982|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
125267474|NCT00532844|450608981|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
125398846|NCT05619692|451093233|FG001|Overall Study|Withdrawal by Participant|4|||
125398847|NCT05619692|451093232|FG000|Overall Study|Lost to Follow-up|2|||
125398848|NCT05619692|451093233|FG001|Overall Study|Lost to Follow-up|1|||
125267475|NCT00532844|450608982|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
125267476|NCT00532844|450608981|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
125267477|NCT00532844|450608982|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
125267478|NCT00532844|450608981|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
125267479|NCT00532844|450608982|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
125267480|NCT00532844|450608981|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
125267481|NCT00532844|450608982|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
125267482|NCT04389866|450608986|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
125267483|NCT04389866|450608987|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
125267484|NCT03465722|450608991|FG000|Overall Study|Withdrawal by Subject|21|||
125267485|NCT03465722|450608992|FG001|Overall Study|Withdrawal by Subject|14|||
125267486|NCT03465722|450608991|FG000|Overall Study|Death|89|||
125267487|NCT03465722|450608992|FG001|Overall Study|Death|87|||
125267488|NCT03465722|450608991|FG000|Overall Study|Lost to Follow-up|5|||
125267489|NCT03465722|450608992|FG001|Overall Study|Lost to Follow-up|3|||
125267490|NCT03465722|450608991|FG000|Overall Study|Administrative/Other|33|||
125267491|NCT03465722|450608992|FG001|Overall Study|Administrative/Other|32|||
125267492|NCT03465722|450608991|FG000|Overall Study|Not treated|1|||
125267493|NCT03465722|450608992|FG001|Overall Study|Not treated|2|||
125267494|NCT03465722|450608991|FG000|Overall Study|Sponsor decision|91|||
125267495|NCT03465722|450608992|FG001|Overall Study|Sponsor decision|98|||
125267496|NCT01490918|450608993|FG000|Overall Study|Lost to Follow-up|2|||
125267497|NCT01490918|450608994|FG001|Overall Study|Lost to Follow-up|1|||
125267498|NCT01490918|450608995|FG002|Overall Study|Lost to Follow-up|0|||
125267499|NCT01490918|450608993|FG000|Overall Study|Withdrawal by Subject|7|||
125267500|NCT01490918|450608994|FG001|Overall Study|Withdrawal by Subject|8|||
125267501|NCT01490918|450608995|FG002|Overall Study|Withdrawal by Subject|3|||
125267502|NCT01490918|450608993|FG000|Overall Study|Adverse Event|0|||
125267503|NCT01490918|450608994|FG001|Overall Study|Adverse Event|0|||
125267504|NCT01490918|450608995|FG002|Overall Study|Adverse Event|1|||
125267505|NCT01490918|450608993|FG000|Overall Study|other cause|4|||
125267506|NCT01490918|450608994|FG001|Overall Study|other cause|5|||
125267507|NCT01490918|450608995|FG002|Overall Study|other cause|8|||
125267508|NCT04940130|450609003|FG000|Overall Study|Travel|1|||
125267509|NCT04940130|450609004|FG001|Overall Study|Travel|0|||
125267510|NCT04940130|450609005|FG002|Overall Study|Travel|2|||
125267511|NCT04940130|450609003|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
125267512|NCT04940130|450609004|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
125267513|NCT04940130|450609005|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
125267514|NCT04940130|450609003|FG000|Overall Study|Adverse Event|0|||
125267515|NCT04940130|450609004|FG001|Overall Study|Adverse Event|0|||
125267516|NCT04940130|450609005|FG002|Overall Study|Adverse Event|2|||
125267517|NCT04940130|450609003|FG000|Overall Study|Disease progression/treatment failure|0|||
125267518|NCT04940130|450609004|FG001|Overall Study|Disease progression/treatment failure|0|||
125267519|NCT04940130|450609005|FG002|Overall Study|Disease progression/treatment failure|1|||
125267520|NCT04940130|450609003|FG000|Overall Study|Participant refusal|0|||
125267521|NCT04940130|450609004|FG001|Overall Study|Participant refusal|0|||
125267522|NCT04940130|450609005|FG002|Overall Study|Participant refusal|1|||
125267523|NCT02240121|450609006|FG000|Overall Study|Protocol Violation|1|||
125267524|NCT02240121|450609007|FG001|Overall Study|Protocol Violation|2|||
125267525|NCT02240121|450609006|FG000|Overall Study|Physician Decision|0|||
125267526|NCT02240121|450609007|FG001|Overall Study|Physician Decision|1|||
125267527|NCT02240121|450609006|FG000|Overall Study|Change in protocol interpretation|1|||
125267528|NCT02240121|450609007|FG001|Overall Study|Change in protocol interpretation|0|||
125267529|NCT02240121|450609006|FG000|Overall Study|Lack of Efficacy|2|||
125267530|NCT02240121|450609007|FG001|Overall Study|Lack of Efficacy|3|||
125267531|NCT02240121|450609006|FG000|Overall Study|Site closed|1|||
125447496|NCT01606189|451264819|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
125447497|NCT01606189|451264820|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
125447498|NCT01606189|451264821|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
125447499|NCT01606189|451264816|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
125447500|NCT01606189|451264817|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
125447501|NCT01606189|451264818|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
125447502|NCT01606189|451264819|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
125447503|NCT01606189|451264820|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
125447504|NCT01606189|451264821|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
125447505|NCT02162732|451264822|FG000|Overall Study|Biopsy not performed.|18|||
125267532|NCT02240121|450609007|FG001|Overall Study|Site closed|1|||
125267533|NCT02240121|450609006|FG000|Overall Study|Pregnancy|1|||
125267534|NCT02240121|450609007|FG001|Overall Study|Pregnancy|0|||
125267535|NCT02240121|450609006|FG000|Overall Study|Adverse Event|2|||
125267536|NCT02240121|450609007|FG001|Overall Study|Adverse Event|4|||
125267537|NCT02240121|450609006|FG000|Overall Study|Withdrawal by Subject|6|||
125267538|NCT02240121|450609007|FG001|Overall Study|Withdrawal by Subject|2|||
125267539|NCT02240121|450609006|FG000|Overall Study|Lost to Follow-up|3|||
125267540|NCT02240121|450609007|FG001|Overall Study|Lost to Follow-up|4|||
125267541|NCT02240121|450609006|FG000|Overall Study|Other than specified|1|||
125267542|NCT02240121|450609007|FG001|Overall Study|Other than specified|3|||
125267543|NCT01925768|450609010|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
125267544|NCT01925768|450609011|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125267545|NCT01925768|450609010|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
125267546|NCT01925768|450609011|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
125267547|NCT01925768|450609010|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
125267548|NCT01925768|450609011|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
125267549|NCT01925768|450609010|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
125267550|NCT01925768|450609011|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
125267551|NCT01925768|450609010|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
125267552|NCT01925768|450609011|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
125267553|NCT01925768|450609010|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
125267554|NCT01925768|450609011|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
125267555|NCT01925768|450609010|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
125267556|NCT01925768|450609011|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
125267557|NCT01925768|450609010|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
125267558|NCT01925768|450609011|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
125267559|NCT01925768|450609010|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
125267560|NCT01925768|450609011|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
125267561|NCT01925768|450609010|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
125267562|NCT01925768|450609011|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
125267563|NCT01925768|450609010|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
125267564|NCT01925768|450609011|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
125267565|NCT00251693|450609014|FG000|Overall Study|Adverse Event|17|||
125267566|NCT00251693|450609015|FG001|Overall Study|Adverse Event|9|||
125267567|NCT00251693|450609016|FG002|Overall Study|Adverse Event|9|||
125267568|NCT00251693|450609014|FG000|Overall Study|Protocol Violation|2|||
125267569|NCT00251693|450609015|FG001|Overall Study|Protocol Violation|0|||
125267570|NCT00251693|450609016|FG002|Overall Study|Protocol Violation|2|||
125267571|NCT00251693|450609014|FG000|Overall Study|Lost to Follow-up|12|||
125267572|NCT00251693|450609015|FG001|Overall Study|Lost to Follow-up|7|||
125267573|NCT00251693|450609016|FG002|Overall Study|Lost to Follow-up|8|||
125267574|NCT00251693|450609014|FG000|Overall Study|Withdrawal by Subject|11|||
125267575|NCT00251693|450609015|FG001|Overall Study|Withdrawal by Subject|17|||
125267576|NCT00251693|450609016|FG002|Overall Study|Withdrawal by Subject|14|||
125267577|NCT00251693|450609014|FG000|Overall Study|Lack of Efficacy|0|||
125267578|NCT00251693|450609015|FG001|Overall Study|Lack of Efficacy|1|||
125267579|NCT00251693|450609016|FG002|Overall Study|Lack of Efficacy|0|||
125267580|NCT00251693|450609014|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
125267581|NCT00251693|450609015|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
125267582|NCT00251693|450609016|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
125267583|NCT00251693|450609014|FG000|Overall Study|Noncompliant|0|||
125267584|NCT00251693|450609015|FG001|Overall Study|Noncompliant|0|||
125267585|NCT00251693|450609016|FG002|Overall Study|Noncompliant|2|||
125267586|NCT00251693|450609014|FG000|Overall Study|Possible Barrett's esophagus|3|||
125267587|NCT00251693|450609015|FG001|Overall Study|Possible Barrett's esophagus|5|||
125267588|NCT00251693|450609016|FG002|Overall Study|Possible Barrett's esophagus|2|||
125267589|NCT00251693|450609014|FG000|Overall Study|Subject request/subject unavailable|1|||
125267590|NCT00251693|450609015|FG001|Overall Study|Subject request/subject unavailable|2|||
125267591|NCT00251693|450609016|FG002|Overall Study|Subject request/subject unavailable|0|||
125267592|NCT00251693|450609014|FG000|Overall Study|Abnormal laboratory findings|0|||
125267593|NCT00251693|450609015|FG001|Overall Study|Abnormal laboratory findings|0|||
125267594|NCT00251693|450609016|FG002|Overall Study|Abnormal laboratory findings|1|||
125267595|NCT02779777|450609017|FG000|Overall Study|Disease Progression|1|||
125267596|NCT02779777|450609018|FG001|Overall Study|Disease Progression|0|||
125267597|NCT02779777|450609019|FG002|Overall Study|Disease Progression|0|||
125267598|NCT02779777|450609017|FG000|Overall Study|Adverse Event|3|||
125267599|NCT02779777|450609018|FG001|Overall Study|Adverse Event|1|||
125267600|NCT02779777|450609019|FG002|Overall Study|Adverse Event|0|||
125267601|NCT02779777|450609017|FG000|Overall Study|Physician Decision|9|||
125267602|NCT02779777|450609018|FG001|Overall Study|Physician Decision|0|||
125447506|NCT01167023|451264823|FG000|Overall Study|Lost to Follow-up|0|||
125447507|NCT01167023|451264824|FG001|Overall Study|Lost to Follow-up|1|||
125447508|NCT01167023|451264825|FG002|Overall Study|Lost to Follow-up|1|||
125447509|NCT01167023|451264823|FG000|Overall Study|Screen Failure|0|||
125447510|NCT01167023|451264824|FG001|Overall Study|Screen Failure|1|||
125447511|NCT01167023|451264825|FG002|Overall Study|Screen Failure|0|||
125447512|NCT01167023|451264823|FG000|Overall Study|Sponsor Decision|0|||
125447513|NCT01167023|451264824|FG001|Overall Study|Sponsor Decision|1|||
125267603|NCT02779777|450609019|FG002|Overall Study|Physician Decision|1|||
125267604|NCT02779777|450609017|FG000|Overall Study|Withdrawal by Subject|1|||
125267605|NCT02779777|450609018|FG001|Overall Study|Withdrawal by Subject|0|||
125267606|NCT02779777|450609019|FG002|Overall Study|Withdrawal by Subject|0|||
125267607|NCT04571060|450609020|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
125267608|NCT04571060|450609021|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
125267609|NCT04571060|450609020|FG000|Overall Study|Never treated migraine|47|||
125267610|NCT04571060|450609021|FG001|Overall Study|Never treated migraine|36|||
125267611|NCT04571060|450609020|FG000|Overall Study|Protocol Violation|4|||
125267612|NCT04571060|450609021|FG001|Overall Study|Protocol Violation|2|||
125267613|NCT04571060|450609020|FG000|Overall Study|Withdrawal by Subject|6|||
125267614|NCT04571060|450609021|FG001|Overall Study|Withdrawal by Subject|2|||
125267615|NCT04571060|450609020|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
125267616|NCT04571060|450609021|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
125267617|NCT00087698|450609027|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
125267618|NCT00087698|450609027|FG000|Overall Study|Death from Other Causes|3|||
125267619|NCT00087698|450609027|FG000|Overall Study|Adverse Event|4|||
125267620|NCT00087698|450609027|FG000|Overall Study|Withdrawal by Subject|4|||
125267621|NCT00087698|450609027|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
125267622|NCT00087698|450609027|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
125267623|NCT00087698|450609027|FG000|Overall Study|Clinical Relapse|1|||
125267624|NCT00087698|450609027|FG000|Overall Study|Death from Study Disease|2|||
125267625|NCT00087698|450609027|FG000|Overall Study|Death from Study Drug Toxicity|2|||
125267626|NCT00087698|450609027|FG000|Overall Study|Protocol Violation|1|||
125267627|NCT01900665|450609042|FG000|Placebo Controlled Period|Death|9|||
125267628|NCT01900665|450609043|FG001|Placebo Controlled Period|Death|16|||
125267629|NCT01900665|450609042|FG000|Placebo Controlled Period|Adverse Event|48|||
125267630|NCT01900665|450609043|FG001|Placebo Controlled Period|Adverse Event|39|||
125267631|NCT01900665|450609042|FG000|Placebo Controlled Period|Protocol Violation|1|||
125267632|NCT01900665|450609043|FG001|Placebo Controlled Period|Protocol Violation|7|||
125267633|NCT01900665|450609042|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
125267634|NCT01900665|450609043|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
125267635|NCT01900665|450609042|FG000|Placebo Controlled Period|Physician Decision|11|||
125267636|NCT01900665|450609043|FG001|Placebo Controlled Period|Physician Decision|7|||
125267637|NCT01900665|450609042|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
125267638|NCT01900665|450609043|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
125267639|NCT01900665|450609042|FG000|Placebo Controlled Period|Caregiver Decision|33|||
125267640|NCT01900665|450609043|FG001|Placebo Controlled Period|Caregiver Decision|41|||
125267641|NCT01900665|450609042|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
125267642|NCT01900665|450609043|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
125267643|NCT01900665|450609042|FG000|Open Label Period|Adverse Event|16|||
125267644|NCT01900665|450609043|FG001|Open Label Period|Adverse Event|20|||
125267645|NCT01900665|450609042|FG000|Open Label Period|Death|5|||
125267646|NCT01900665|450609043|FG001|Open Label Period|Death|6|||
125267647|NCT01900665|450609042|FG000|Open Label Period|Lost to Follow-up|1|||
125267648|NCT01900665|450609043|FG001|Open Label Period|Lost to Follow-up|1|||
125267649|NCT01900665|450609042|FG000|Open Label Period|Parent/Caregiver Decision|33|||
125267650|NCT01900665|450609043|FG001|Open Label Period|Parent/Caregiver Decision|34|||
125267651|NCT01900665|450609042|FG000|Open Label Period|Physician Decision|4|||
125267652|NCT01900665|450609043|FG001|Open Label Period|Physician Decision|4|||
125267653|NCT01900665|450609042|FG000|Open Label Period|Protocol Violation|0|||
125267654|NCT01900665|450609043|FG001|Open Label Period|Protocol Violation|1|||
125267655|NCT01900665|450609042|FG000|Open Label Period|Sponsor Decision|802|||
125267656|NCT01900665|450609043|FG001|Open Label Period|Sponsor Decision|765|||
125267657|NCT01900665|450609042|FG000|Open Label Period|Withdrawal by Subject|20|||
125267658|NCT01900665|450609043|FG001|Open Label Period|Withdrawal by Subject|28|||
125447514|NCT01167023|451264825|FG002|Overall Study|Sponsor Decision|0|||
125267659|NCT04749745|450609047|FG000|Overall Study|Withdrawal by Subject|1|||
125267660|NCT04749745|450609048|FG001|Overall Study|Withdrawal by Subject|0|||
125267661|NCT03816176|450609053|FG000|Overall Study|Miscellaneous|5|||
125267662|NCT03816176|450609053|FG000|Overall Study|Lack of Efficacy|4|||
125267663|NCT03816176|450609053|FG000|Overall Study|Adverse Event|3|||
125267664|NCT04472650|450610128|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
125267665|NCT04472650|450610129|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
125267666|NCT00288015|450610134|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
125267667|NCT00288015|450610134|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
125267668|NCT00288015|450610134|FG000|First Response Assessment|Withdrawal by Subject|1|||
125267669|NCT00288015|450610134|FG000|First Response Assessment|Death|1|||
125267670|NCT00288015|450610134|FG000|First Response Assessment|Physician Decision|2|||
125267671|NCT00288015|450610134|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
125267672|NCT00288015|450610134|FG000|Follow up for Survival x 2 Years|Death|13|||
125267673|NCT00288015|450610134|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
125267674|NCT00288015|450610134|FG000|Follow up for Survival x 2 Years|Other|9|||
125267675|NCT01333722|450610135|FG000|Overall Study|Lack of Efficacy|0|||
125267676|NCT01333722|450610136|FG001|Overall Study|Lack of Efficacy|2|||
125267677|NCT01333722|450610135|FG000|Overall Study|Withdrawal by Subject|0|||
125267678|NCT01333722|450610136|FG001|Overall Study|Withdrawal by Subject|1|||
125267679|NCT02477527|450610139|FG000|Overall Study|Lost to Follow-up|2|||
125267680|NCT02477527|450610139|FG000|Overall Study|Withdrawal by Subject|1|||
125267681|NCT02477527|450610139|FG000|Overall Study|Screen Failure|3|||
125267682|NCT02383862|450610142|FG000|3 Month Follow up|Lost to Follow-up|23|||
125267683|NCT02383862|450610143|FG001|3 Month Follow up|Lost to Follow-up|21|||
125267684|NCT01833494|450610144|FG000|Overall Study|Adverse Event|24|||
125267685|NCT01833494|450610144|FG000|Overall Study|Physician Decision|6|||
125267686|NCT01833494|450610144|FG000|Overall Study|Withdrawal by Subject|6|||
125267687|NCT01833494|450610144|FG000|Overall Study|Decrease in serum phosphorus|4|||
125267688|NCT01833494|450610144|FG000|Overall Study|Decrease in serum calcium|4|||
125267689|NCT01833494|450610144|FG000|Overall Study|Increase in serum ferritin|1|||
125267690|NCT01694433|450610145|FG000|Overall Study|Adverse Event|7|||
125267691|NCT01694433|450610146|FG001|Overall Study|Adverse Event|0|||
125267692|NCT01694433|450610145|FG000|Overall Study|Physician Decision|1|||
125267693|NCT01694433|450610146|FG001|Overall Study|Physician Decision|0|||
125267694|NCT01694433|450610145|FG000|Overall Study|Withdrawal by Subject|3|||
125267695|NCT01694433|450610146|FG001|Overall Study|Withdrawal by Subject|4|||
125267696|NCT00374595|450610149|FG000|Overall Study|Death|23|||
125267697|NCT00374595|450610149|FG000|Overall Study|Withdrawal by Subject|39|||
125267698|NCT00374595|450610149|FG000|Overall Study|Lost to Follow-up|3|||
125267699|NCT00374595|450610149|FG000|Overall Study|too much time commitment|1|||
125267700|NCT00374595|450610149|FG000|Overall Study|transfer care to other clinical site|1|||
125267701|NCT00374595|450610149|FG000|Overall Study|relocation|3|||
125267702|NCT01664247|450610151|FG000|Overall Study|Adverse Event|5|||
125267703|NCT01664247|450610152|FG001|Overall Study|Adverse Event|3|||
125267704|NCT01664247|450610151|FG000|Overall Study|Protocol Violation|3|||
125267705|NCT01664247|450610152|FG001|Overall Study|Protocol Violation|5|||
125267706|NCT01664247|450610151|FG000|Overall Study|Withdrawal Criteria|1|||
125267707|NCT01664247|450610152|FG001|Overall Study|Withdrawal Criteria|4|||
125267708|NCT01664247|450610151|FG000|Overall Study|Unclassified|5|||
125267709|NCT01664247|450610152|FG001|Overall Study|Unclassified|29|||
125267710|NCT03064074|450610157|FG000|Overall Study|Physician Decision|0|||
125267711|NCT03064074|450610158|FG001|Overall Study|Physician Decision|0|||
125267712|NCT03064074|450610159|FG002|Overall Study|Physician Decision|0|||
125267713|NCT03064074|450610160|FG003|Overall Study|Physician Decision|1|||
125267714|NCT01118780|450610165|FG000|Overall Study|Adverse Event|15|||
125267715|NCT01118780|450610166|FG001|Overall Study|Adverse Event|15|||
125267716|NCT01118780|450610165|FG000|Overall Study|Death|1|||
125267717|NCT01118780|450610166|FG001|Overall Study|Death|0|||
125267718|NCT01118780|450610165|FG000|Overall Study|Lack of Efficacy|2|||
125267719|NCT01118780|450610166|FG001|Overall Study|Lack of Efficacy|6|||
125267720|NCT01118780|450610165|FG000|Overall Study|Physician Decision|2|||
125267721|NCT01118780|450610166|FG001|Overall Study|Physician Decision|0|||
125267722|NCT01118780|450610165|FG000|Overall Study|Protocol Violation|3|||
125267723|NCT01118780|450610166|FG001|Overall Study|Protocol Violation|6|||
125267724|NCT01118780|450610165|FG000|Overall Study|Withdrawal by Subject|13|||
125267725|NCT01118780|450610166|FG001|Overall Study|Withdrawal by Subject|8|||
125267726|NCT03962855|450610177|FG000|Overall Study|Death|0|||
125267727|NCT03962855|450610178|FG001|Overall Study|Death|1|||
125267728|NCT03962855|450610177|FG000|Overall Study|Lost to Follow-up|0|||
125267729|NCT03962855|450610178|FG001|Overall Study|Lost to Follow-up|1|||
125267730|NCT03962855|450610177|FG000|Overall Study|Adverse Event|0|||
125267731|NCT03962855|450610178|FG001|Overall Study|Adverse Event|1|||
125267732|NCT03962855|450610177|FG000|Overall Study|Physician Decision|0|||
125267733|NCT03962855|450610178|FG001|Overall Study|Physician Decision|2|||
125267734|NCT02379052|450610179|FG000|Overall Study|Protocol Violation|0|||
125267735|NCT02379052|450610180|FG001|Overall Study|Protocol Violation|1|||
125267736|NCT02379052|450610179|FG000|Overall Study|Adverse Event|0|||
125267737|NCT02379052|450610180|FG001|Overall Study|Adverse Event|1|||
125267738|NCT02379052|450610179|FG000|Overall Study|Physician Decision|1|||
125267739|NCT02379052|450610180|FG001|Overall Study|Physician Decision|1|||
125267740|NCT02379052|450610179|FG000|Overall Study|Withdrawal by Subject|2|||
125267741|NCT02379052|450610180|FG001|Overall Study|Withdrawal by Subject|0|||
125267742|NCT02379052|450610179|FG000|Overall Study|Lost to Follow-up|2|||
125267743|NCT02379052|450610180|FG001|Overall Study|Lost to Follow-up|1|||
125267744|NCT02379052|450610179|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
125267745|NCT02379052|450610180|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
125267746|NCT02379052|450610179|FG000|Overall Study|Subject was Incarcerated|0|||
125267747|NCT02379052|450610180|FG001|Overall Study|Subject was Incarcerated|1|||
125267748|NCT04419467|450610183|FG000|Overall Study|Not treated with IP|0|||
125267749|NCT04419467|450610184|FG001|Overall Study|Not treated with IP|0|||
125267750|NCT04419467|450610185|FG002|Overall Study|Not treated with IP|2|||
125267751|NCT04419467|450610183|FG000|Overall Study|Adverse Event|0|||
125267752|NCT04419467|450610184|FG001|Overall Study|Adverse Event|2|||
125267753|NCT04419467|450610185|FG002|Overall Study|Adverse Event|0|||
125267754|NCT04419467|450610183|FG000|Overall Study|Death|1|||
125267755|NCT04419467|450610184|FG001|Overall Study|Death|0|||
125267756|NCT04419467|450610185|FG002|Overall Study|Death|0|||
125267757|NCT04419467|450610183|FG000|Overall Study|Lost to Follow-up|0|||
125267758|NCT04419467|450610184|FG001|Overall Study|Lost to Follow-up|1|||
125267759|NCT04419467|450610185|FG002|Overall Study|Lost to Follow-up|2|||
125267760|NCT04419467|450610183|FG000|Overall Study|Withdrawal by Subject|0|||
125267761|NCT04419467|450610184|FG001|Overall Study|Withdrawal by Subject|0|||
125267762|NCT04419467|450610185|FG002|Overall Study|Withdrawal by Subject|4|||
125267763|NCT04419467|450610183|FG000|Overall Study|Pandemic related|0|||
125267764|NCT04419467|450610184|FG001|Overall Study|Pandemic related|0|||
125267765|NCT04419467|450610185|FG002|Overall Study|Pandemic related|1|||
125267766|NCT04419467|450610183|FG000|Overall Study|Reason not known|1|||
125267767|NCT04419467|450610184|FG001|Overall Study|Reason not known|0|||
125267768|NCT04419467|450610185|FG002|Overall Study|Reason not known|0|||
125267769|NCT00442416|450610188|FG000|Overall Study|Adverse Event|4|||
125267770|NCT00442416|450610189|FG001|Overall Study|Adverse Event|1|||
125267771|NCT00442416|450610188|FG000|Overall Study|Death|1|||
125267772|NCT00442416|450610189|FG001|Overall Study|Death|0|||
125267773|NCT00442416|450610188|FG000|Overall Study|Lack of Efficacy|2|||
125267774|NCT00442416|450610189|FG001|Overall Study|Lack of Efficacy|0|||
125267775|NCT00442416|450610188|FG000|Overall Study|Protocol Violation|2|||
125267776|NCT00442416|450610189|FG001|Overall Study|Protocol Violation|3|||
125267777|NCT00442416|450610188|FG000|Overall Study|Withdrew consent|1|||
125267778|NCT00442416|450610189|FG001|Overall Study|Withdrew consent|2|||
125267779|NCT00442416|450610188|FG000|Overall Study|Administrative/Other|27|||
125267780|NCT00442416|450610189|FG001|Overall Study|Administrative/Other|33|||
125267781|NCT01284959|450610192|FG000|Overall Study|Withdrawal by Subject|1|||
125267782|NCT01284959|450610193|FG001|Overall Study|Withdrawal by Subject|0|||
125267783|NCT01284959|450610194|FG002|Overall Study|Withdrawal by Subject|0|||
125267784|NCT01284959|450610192|FG000|Overall Study|Adverse Event|0|||
125267785|NCT01284959|450610193|FG001|Overall Study|Adverse Event|0|||
125267786|NCT01284959|450610194|FG002|Overall Study|Adverse Event|1|||
125267787|NCT00003869|450610196|FG000|Overall Study|Adverse Event|14|||
125267788|NCT00003869|450610197|FG001|Overall Study|Adverse Event|3|||
125267789|NCT00003869|450610196|FG000|Overall Study|Withdrawal by Subject|21|||
125267790|NCT00003869|450610197|FG001|Overall Study|Withdrawal by Subject|3|||
125267791|NCT00003869|450610196|FG000|Overall Study|Death|1|||
125267792|NCT00003869|450610197|FG001|Overall Study|Death|2|||
125267793|NCT00003869|450610196|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
125267794|NCT00003869|450610197|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
125267795|NCT03364231|450610198|FG000|Overall Study|Adverse Event|1|||
125267796|NCT03364231|450610199|FG001|Overall Study|Adverse Event|4|||
125267797|NCT03364231|450610198|FG000|Overall Study|Death|1|||
125267798|NCT03364231|450610199|FG001|Overall Study|Death|0|||
125267799|NCT03364231|450610198|FG000|Overall Study|Investigator Decision|2|||
125267800|NCT03364231|450610199|FG001|Overall Study|Investigator Decision|2|||
125267801|NCT03364231|450610198|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
125267802|NCT03364231|450610199|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
125267803|NCT03364231|450610198|FG000|Overall Study|Withdrawal of Subject Consent|1|||
125267804|NCT03364231|450610199|FG001|Overall Study|Withdrawal of Subject Consent|0|||
125267805|NCT03364231|450610198|FG000|Overall Study|Reason Not Specified|1|||
125267806|NCT03364231|450610199|FG001|Overall Study|Reason Not Specified|0|||
125267807|NCT03364231|450610198|FG000|Overall Study|Disease Progression|0|||
125267808|NCT03364231|450610199|FG001|Overall Study|Disease Progression|6|||
125267809|NCT04068922|450610200|FG000|Overall Study|Lost to Follow-up|5|||
125267810|NCT04068922|450610200|FG000|Overall Study|Withdrawal by Subject|7|||
125267811|NCT04068922|450610200|FG000|Overall Study|Adverse Event|1|||
125267812|NCT01070979|450610208|FG000|Overall Study|Adverse Event|2|||
125267813|NCT01070979|450610209|FG001|Overall Study|Adverse Event|3|||
125267814|NCT01070979|450610210|FG002|Overall Study|Adverse Event|3|||
125267815|NCT01070979|450610208|FG000|Overall Study|Lost to Follow-up|2|||
125267816|NCT01070979|450610209|FG001|Overall Study|Lost to Follow-up|1|||
125267817|NCT01070979|450610210|FG002|Overall Study|Lost to Follow-up|1|||
125267818|NCT01070979|450610208|FG000|Overall Study|Protocol Violation|0|||
125267819|NCT01070979|450610209|FG001|Overall Study|Protocol Violation|2|||
125267820|NCT01070979|450610210|FG002|Overall Study|Protocol Violation|6|||
125267821|NCT01070979|450610208|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
125267822|NCT01070979|450610209|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
125267823|NCT01070979|450610210|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
125267824|NCT01070979|450610208|FG000|Overall Study|Withdrawal by Subject|3|||
125267825|NCT01070979|450610209|FG001|Overall Study|Withdrawal by Subject|1|||
125267826|NCT01070979|450610210|FG002|Overall Study|Withdrawal by Subject|1|||
125267827|NCT01070979|450610208|FG000|Overall Study|No study drug taken|0|||
125267828|NCT01070979|450610209|FG001|Overall Study|No study drug taken|1|||
125267829|NCT01070979|450610210|FG002|Overall Study|No study drug taken|0|||
125267830|NCT00444106|450610213|FG000|Overall Study|Lost to Follow-up|2|||
125267831|NCT00444106|450610214|FG001|Overall Study|Lost to Follow-up|1|||
125267832|NCT00444106|450610215|FG002|Overall Study|Lost to Follow-up|0|||
125267833|NCT00444106|450610213|FG000|Overall Study|Abnormal Test Procedure Results|0|||
125267834|NCT00444106|450610214|FG001|Overall Study|Abnormal Test Procedure Results|0|||
125267835|NCT00444106|450610215|FG002|Overall Study|Abnormal Test Procedure Results|1|||
125267836|NCT04749914|450610216|FG000|Period 1|Adverse Event|1|||
125267837|NCT04749914|450610217|FG001|Period 1|Adverse Event|0|||
125267838|NCT04749914|450610218|FG002|Period 1|Adverse Event|0|||
125267839|NCT04749914|450610219|FG003|Period 1|Adverse Event|0|||
125267840|NCT04749914|450610216|FG000|Period 1|Withdrawal by Subject|1|||
125267841|NCT04749914|450610217|FG001|Period 1|Withdrawal by Subject|0|||
125267842|NCT04749914|450610218|FG002|Period 1|Withdrawal by Subject|1|||
125267843|NCT04749914|450610219|FG003|Period 1|Withdrawal by Subject|0|||
125267844|NCT01913327|450610222|FG000|Overall Study|Withdrawal by Subject|0|||
125267845|NCT01913327|450610223|FG001|Overall Study|Withdrawal by Subject|1|||
125267846|NCT01074931|450610228|FG000|Overall Study|Economic reasons|1|||
125267847|NCT01074931|450610228|FG000|Overall Study|Death|5|||
125267848|NCT00953706|450610229|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
125267849|NCT00953706|450610230|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
125267850|NCT00953706|450610231|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
125267851|NCT00953706|450610232|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
125267852|NCT00953706|450610229|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
125267853|NCT00953706|450610230|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
125267854|NCT00953706|450610231|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
125267855|NCT00953706|450610232|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
125267856|NCT00953706|450610229|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
125267857|NCT00953706|450610230|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
125267858|NCT00953706|450610231|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
125267859|NCT00953706|450610232|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
125267860|NCT00953706|450610229|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
125267861|NCT00953706|450610230|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
125267862|NCT00953706|450610231|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
125267863|NCT00953706|450610232|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
125267864|NCT00953706|450610229|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
125267865|NCT00953706|450610230|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
125267866|NCT00953706|450610231|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
125267867|NCT00953706|450610232|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
125267868|NCT00953706|450610229|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
125267869|NCT00953706|450610230|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
125267870|NCT00953706|450610231|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
125267871|NCT00953706|450610232|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
125267872|NCT00953706|450610229|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
125267873|NCT00953706|450610230|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
125267874|NCT00953706|450610231|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
125267875|NCT00953706|450610232|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
125267876|NCT00953706|450610229|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
125267877|NCT00953706|450610230|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
125267878|NCT00953706|450610231|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
125267879|NCT00953706|450610232|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
125267880|NCT00953706|450610229|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
125267881|NCT00953706|450610230|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
125267882|NCT00953706|450610231|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
125267883|NCT00953706|450610232|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
125267884|NCT00953706|450610229|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
125267885|NCT00953706|450610230|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
125267886|NCT00953706|450610231|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
125267887|NCT00953706|450610232|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
125267888|NCT00953706|450610229|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
125267889|NCT00953706|450610230|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
125267890|NCT00953706|450610231|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
125267891|NCT00953706|450610232|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
125267892|NCT02137070|450610234|FG000|Overall Study|Adverse Event|12|||
125267893|NCT02137070|450610235|FG001|Overall Study|Adverse Event|3|||
125267894|NCT02137070|450610234|FG000|Overall Study|Death|2|||
125267895|NCT02137070|450610235|FG001|Overall Study|Death|0|||
125267896|NCT02137070|450610234|FG000|Overall Study|Lost to Follow-up|24|||
125267897|NCT02137070|450610235|FG001|Overall Study|Lost to Follow-up|9|||
125267898|NCT02137070|450610234|FG000|Overall Study|Physician Decision|0|||
125267899|NCT02137070|450610235|FG001|Overall Study|Physician Decision|1|||
125267900|NCT02137070|450610234|FG000|Overall Study|Protocol Violation|18|||
125267901|NCT02137070|450610235|FG001|Overall Study|Protocol Violation|4|||
125267902|NCT02137070|450610234|FG000|Overall Study|Withdrawal by Subject|18|||
125267903|NCT02137070|450610235|FG001|Overall Study|Withdrawal by Subject|1|||
125267904|NCT02112656|450610236|FG000|Overall Study|Death|78|||
125267905|NCT02112656|450610237|FG001|Overall Study|Death|82|||
125267906|NCT02112656|450610236|FG000|Overall Study|Withdrawal by Subject|9|||
125267907|NCT02112656|450610237|FG001|Overall Study|Withdrawal by Subject|11|||
125267908|NCT02112656|450610236|FG000|Overall Study|Lost to Follow-up|2|||
125267909|NCT02112656|450610237|FG001|Overall Study|Lost to Follow-up|4|||
125267910|NCT02112656|450610236|FG000|Overall Study|Noncompliance|1|||
125267911|NCT02112656|450610237|FG001|Overall Study|Noncompliance|2|||
125267912|NCT03761056|450610238|FG000|Overall Study|Death|8|||
125267913|NCT03761056|450610238|FG000|Overall Study|Enrolled but never treated|2|||
125267914|NCT03761056|450610238|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
125267915|NCT03761056|450610238|FG000|Overall Study|Investigator decision|1|||
125267916|NCT03965403|450610243|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
125267917|NCT01979614|450611594|FG000|Overall Study|Adverse Event|1|||
125267918|NCT01979614|450611595|FG001|Overall Study|Adverse Event|1|||
125267919|NCT00756275|450611596|FG000|Overall Study|Lost to Follow-up|25|||
125267920|NCT00756275|450611597|FG001|Overall Study|Lost to Follow-up|21|||
125267921|NCT00756275|450611596|FG000|Overall Study|Withdrawal by Subject|4|||
125267922|NCT00756275|450611597|FG001|Overall Study|Withdrawal by Subject|7|||
125267923|NCT00938912|450611600|FG000|Overall Study|Withdrawal by Subject|28|||
125267924|NCT00938912|450611600|FG000|Overall Study|Lost to Follow-up|4|||
125267925|NCT00938912|450611600|FG000|Overall Study|Lack of Efficacy|43|||
125267926|NCT00938912|450611600|FG000|Overall Study|Adverse event, non-fatal|24|||
125267927|NCT00938912|450611600|FG000|Overall Study|Adverse event, fatal|1|||
125267928|NCT00938912|450611600|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
125267929|NCT00938912|450611600|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
125267930|NCT00938912|450611600|FG000|Overall Study|Participant needed prohibit medication|1|||
125267931|NCT00938912|450611600|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
125267932|NCT00938912|450611600|FG000|Overall Study|Did not meet Eligibility criteria|1|||
125267933|NCT00938912|450611600|FG000|Overall Study|Participant relocated not related to AE|1|||
125267934|NCT00938912|450611600|FG000|Overall Study|Participant moved to another city|1|||
125267935|NCT00938912|450611600|FG000|Overall Study|Participant experienced break through seizures|1|||
125267936|NCT00938912|450611600|FG000|Overall Study|No longer wished to participate in the study|1|||
125267937|NCT00938912|450611600|FG000|Overall Study|Protocol Deviation|2|||
125267938|NCT00456755|450611601|FG000|Overall Study|Lost to Follow-up|2|||
125267939|NCT00456755|450611602|FG001|Overall Study|Lost to Follow-up|1|||
125267940|NCT06164691|450611603|FG000|Overall Study|Withdrawal by Subject|2|||
125267941|NCT06164691|450611604|FG001|Overall Study|Withdrawal by Subject|0|||
125267942|NCT06164691|450611605|FG002|Overall Study|Withdrawal by Subject|0|||
125267943|NCT03432494|450611624|FG000|Overall Study|Death|1|||
125267944|NCT03432494|450611624|FG000|Overall Study|Noncompliance|1|||
125398849|NCT05619692|451093232|FG000|Overall Study|Randomized but not treated|1|||
125398850|NCT05619692|451093233|FG001|Overall Study|Randomized but not treated|3|||
125398851|NCT05267054|451093234|FG000|Overall Study|Death|13|||
125398852|NCT05267054|451093235|FG001|Overall Study|Death|14|||
125398853|NCT05267054|451093234|FG000|Overall Study|Study Ended by Sponsor|9|||
125267945|NCT00856635|450611625|FG000|Overall Study|Lost to Follow-up|2|||
125267946|NCT00856635|450611626|FG001|Overall Study|Lost to Follow-up|5|||
125267947|NCT00856635|450611625|FG000|Overall Study|Pregnancy|1|||
125267948|NCT00856635|450611626|FG001|Overall Study|Pregnancy|0|||
125398854|NCT05267054|451093235|FG001|Overall Study|Study Ended by Sponsor|13|||
125267949|NCT00856635|450611625|FG000|Overall Study|Withdrawal by Subject|3|||
125267950|NCT00856635|450611626|FG001|Overall Study|Withdrawal by Subject|1|||
125267951|NCT00856635|450611625|FG000|Overall Study|Serious Adverse Event|1|||
125267952|NCT00856635|450611626|FG001|Overall Study|Serious Adverse Event|0|||
125267953|NCT00856635|450611625|FG000|Overall Study|Other|1|||
125267954|NCT00856635|450611626|FG001|Overall Study|Other|0|||
125267955|NCT00856635|450611625|FG000|Overall Study|Discontinued at Randomization|2|||
125267956|NCT00856635|450611626|FG001|Overall Study|Discontinued at Randomization|2|||
125267957|NCT01244035|450611627|FG000|Part 1: Period 1|Adverse Event|0|||
125267958|NCT01244035|450611628|FG001|Part 1: Period 1|Adverse Event|0|||
125267959|NCT01244035|450611629|FG002|Part 1: Period 1|Adverse Event|0|||
125267960|NCT01244035|450611630|FG003|Part 1: Period 1|Adverse Event|0|||
125267961|NCT01244035|450611631|FG004|Part 1: Period 1|Adverse Event|0|||
125267962|NCT01244035|450611632|FG005|Part 1: Period 1|Adverse Event|1|||
125267963|NCT01244035|450611627|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
125267964|NCT01244035|450611628|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
125267965|NCT01244035|450611629|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
125267966|NCT01244035|450611630|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
125267967|NCT01244035|450611631|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
125267968|NCT01244035|450611632|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
125267969|NCT01244035|450611627|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
125267970|NCT01244035|450611628|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
125267971|NCT01244035|450611629|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
125267972|NCT01244035|450611630|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
125267973|NCT01244035|450611631|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
125267974|NCT01244035|450611632|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
125267975|NCT01244035|450611627|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
125267976|NCT01244035|450611628|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
125267977|NCT01244035|450611629|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
125267978|NCT01244035|450611630|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
125267979|NCT01244035|450611631|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
125267980|NCT01244035|450611632|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
125267981|NCT01244035|450611627|FG000|Part 1: Period 3|Adverse Event|0|||
125267982|NCT01244035|450611628|FG001|Part 1: Period 3|Adverse Event|0|||
125267983|NCT01244035|450611629|FG002|Part 1: Period 3|Adverse Event|0|||
125267984|NCT01244035|450611630|FG003|Part 1: Period 3|Adverse Event|0|||
125267985|NCT01244035|450611631|FG004|Part 1: Period 3|Adverse Event|0|||
125267986|NCT01244035|450611632|FG005|Part 1: Period 3|Adverse Event|1|||
125267987|NCT01244035|450611627|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
125267988|NCT01244035|450611628|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
125267989|NCT01244035|450611629|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
125267990|NCT01244035|450611630|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
125267991|NCT01244035|450611631|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
125267992|NCT01244035|450611632|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
125267993|NCT01244035|450611627|FG000|Part 1: Period 3|Protocol Deviation|0|||
125267994|NCT01244035|450611628|FG001|Part 1: Period 3|Protocol Deviation|1|||
125267995|NCT01244035|450611629|FG002|Part 1: Period 3|Protocol Deviation|0|||
125267996|NCT01244035|450611630|FG003|Part 1: Period 3|Protocol Deviation|0|||
125267997|NCT01244035|450611631|FG004|Part 1: Period 3|Protocol Deviation|0|||
125267998|NCT01244035|450611632|FG005|Part 1: Period 3|Protocol Deviation|0|||
125267999|NCT01696773|450611633|FG000|Days 15-27, Washout|Adverse Event|1|||
125268000|NCT01696773|450611634|FG001|Days 15-27, Washout|Adverse Event|0|||
125268001|NCT02370368|450611637|FG000|Overall Study|Adverse Event|1|||
125268002|NCT02370368|450611638|FG001|Overall Study|Adverse Event|2|||
125268003|NCT02370368|450611637|FG000|Overall Study|Withdrawal by Subject|5|||
125268004|NCT02370368|450611638|FG001|Overall Study|Withdrawal by Subject|4|||
125268005|NCT00347932|450611641|FG000|Overall Study|Adverse Event|4|||
125268006|NCT00347932|450611642|FG001|Overall Study|Adverse Event|5|||
125268007|NCT00347932|450611641|FG000|Overall Study|Lack of Efficacy|3|||
125268008|NCT00347932|450611642|FG001|Overall Study|Lack of Efficacy|14|||
125268009|NCT00347932|450611641|FG000|Overall Study|Lost to Follow-up|10|||
125268010|NCT00347932|450611642|FG001|Overall Study|Lost to Follow-up|9|||
125268011|NCT00347932|450611641|FG000|Overall Study|Withdrawal by Subject|10|||
125268012|NCT00347932|450611642|FG001|Overall Study|Withdrawal by Subject|16|||
125268013|NCT00347932|450611641|FG000|Overall Study|Did not meet inclusion criteria|4|||
125268014|NCT00347932|450611642|FG001|Overall Study|Did not meet inclusion criteria|8|||
125268015|NCT04512001|450611643|FG000|Week 0 to Week 24|Adverse Event|14|||
125268016|NCT04512001|450611644|FG001|Week 0 to Week 24|Adverse Event|10|||
125268017|NCT04512001|450611645|FG002|Week 0 to Week 24|Adverse Event|0|||
125268018|NCT04512001|450611646|FG003|Week 0 to Week 24|Adverse Event|0|||
125268019|NCT04512001|450611647|FG004|Week 0 to Week 24|Adverse Event|0|||
125268020|NCT04512001|450611643|FG000|Week 0 to Week 24|Death|0|||
125268021|NCT04512001|450611644|FG001|Week 0 to Week 24|Death|2|||
125268022|NCT04512001|450611645|FG002|Week 0 to Week 24|Death|0|||
125268023|NCT04512001|450611646|FG003|Week 0 to Week 24|Death|0|||
125268024|NCT04512001|450611647|FG004|Week 0 to Week 24|Death|0|||
125268025|NCT04512001|450611643|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
125268026|NCT04512001|450611644|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
125268027|NCT04512001|450611645|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
125268028|NCT04512001|450611646|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
125268029|NCT04512001|450611647|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
125268030|NCT04512001|450611643|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
125268031|NCT04512001|450611644|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
125268032|NCT04512001|450611645|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
125268033|NCT04512001|450611646|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
125268034|NCT04512001|450611647|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
125268035|NCT04512001|450611643|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
125268036|NCT04512001|450611644|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
125268037|NCT04512001|450611645|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
125268038|NCT04512001|450611646|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
125268039|NCT04512001|450611647|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
125268040|NCT04512001|450611643|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
125268041|NCT04512001|450611644|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
125268042|NCT04512001|450611645|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
125268043|NCT04512001|450611646|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
125268044|NCT04512001|450611647|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
125268045|NCT04512001|450611643|FG000|Week 24 to Week 63|Adverse Event|0|||
125268046|NCT04512001|450611644|FG001|Week 24 to Week 63|Adverse Event|0|||
125268047|NCT04512001|450611645|FG002|Week 24 to Week 63|Adverse Event|13|||
125268048|NCT04512001|450611646|FG003|Week 24 to Week 63|Adverse Event|8|||
125268049|NCT04512001|450611647|FG004|Week 24 to Week 63|Adverse Event|6|||
125268050|NCT04512001|450611643|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
125268051|NCT04512001|450611644|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
125268052|NCT04512001|450611645|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
125268053|NCT04512001|450611646|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
125268054|NCT04512001|450611647|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
125268055|NCT04512001|450611643|FG000|Week 24 to Week 63|Death|0|||
125268056|NCT04512001|450611644|FG001|Week 24 to Week 63|Death|0|||
125268057|NCT04512001|450611645|FG002|Week 24 to Week 63|Death|0|||
125268058|NCT04512001|450611646|FG003|Week 24 to Week 63|Death|1|||
125268059|NCT04512001|450611647|FG004|Week 24 to Week 63|Death|1|||
125268060|NCT04512001|450611643|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
125268061|NCT04512001|450611644|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
125268062|NCT04512001|450611645|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
125268063|NCT04512001|450611646|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
125268064|NCT04512001|450611647|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
125268065|NCT04512001|450611643|FG000|Week 24 to Week 63|Miscellaneous|0|||
125268066|NCT04512001|450611644|FG001|Week 24 to Week 63|Miscellaneous|0|||
125268067|NCT04512001|450611645|FG002|Week 24 to Week 63|Miscellaneous|3|||
125268068|NCT04512001|450611646|FG003|Week 24 to Week 63|Miscellaneous|2|||
125268069|NCT04512001|450611647|FG004|Week 24 to Week 63|Miscellaneous|1|||
125268070|NCT03389308|450611650|FG000|Overall Study|Withdrawal by Subject|5|||
125268071|NCT03389308|450611650|FG000|Overall Study|Lost to Follow-up|3|||
125268072|NCT03389308|450611650|FG000|Overall Study|Adverse Event|2|||
125268073|NCT03389308|450611650|FG000|Overall Study|Sponsor Request|2|||
125268074|NCT03198767|450611651|FG000|Overall Study|Protocol Violation|0|||
125268075|NCT03198767|450611652|FG001|Overall Study|Protocol Violation|0|||
125268076|NCT03198767|450611653|FG002|Overall Study|Protocol Violation|0|||
125268077|NCT03198767|450611654|FG003|Overall Study|Protocol Violation|6|||
125268078|NCT03198767|450611655|FG004|Overall Study|Protocol Violation|0|||
125268079|NCT03198767|450611656|FG005|Overall Study|Protocol Violation|0|||
125268080|NCT03198767|450611657|FG006|Overall Study|Protocol Violation|0|||
125268081|NCT00570323|450611658|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
125268082|NCT00570323|450611659|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
125268083|NCT00570323|450611658|FG000|Started Treatment After Randomization|Protocol Violation|1|||
125268084|NCT00570323|450611659|FG001|Started Treatment After Randomization|Protocol Violation|0|||
125398855|NCT05267054|451093234|FG000|Overall Study|Lost to Follow-up|1|||
125398856|NCT05267054|451093235|FG001|Overall Study|Lost to Follow-up|1|||
125398857|NCT05267054|451093234|FG000|Overall Study|Withdrawal by Subject|1|||
125398858|NCT05267054|451093235|FG001|Overall Study|Withdrawal by Subject|1|||
125398859|NCT01552226|451093236|FG000|Overall Study|Withdrawal by Subject|4|||
125398860|NCT01552226|451093237|FG001|Overall Study|Withdrawal by Subject|4|||
125268085|NCT00570323|450611658|FG000|Started Treatment After Randomization|Physician Decision|1|||
125268086|NCT00570323|450611659|FG001|Started Treatment After Randomization|Physician Decision|0|||
125268087|NCT00570323|450611658|FG000|Complete Study After Start|Lost to Follow-up|0|||
125398861|NCT04697628|451093238|FG000|Overall Study|Withdrawal by Subject|17|||
125398862|NCT04697628|451093239|FG001|Overall Study|Withdrawal by Subject|23|||
125398863|NCT04697628|451093238|FG000|Overall Study|Lost to Follow-up|0|||
125268088|NCT00570323|450611659|FG001|Complete Study After Start|Lost to Follow-up|1|||
125268089|NCT00570323|450611658|FG000|Complete Study After Start|Withdrawal by Subject|2|||
125268090|NCT00570323|450611659|FG001|Complete Study After Start|Withdrawal by Subject|0|||
125268091|NCT00570323|450611658|FG000|Complete Study After Start|Physician Decision|1|||
125268092|NCT00570323|450611659|FG001|Complete Study After Start|Physician Decision|0|||
125447515|NCT01167023|451264823|FG000|Overall Study|Withdrawal by Subject|0|||
125447516|NCT01167023|451264824|FG001|Overall Study|Withdrawal by Subject|0|||
125447517|NCT01167023|451264825|FG002|Overall Study|Withdrawal by Subject|1|||
125447518|NCT00410384|451264826|FG000|Overall Study|Withdrawal by Subject|28|||
125268093|NCT04232943|450611660|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
125268094|NCT04232943|450611661|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
125268095|NCT04232943|450611662|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
125268096|NCT04232943|450611660|FG000|Overall Study|Withdrawal by Subject|1|||
125447519|NCT00410384|451264827|FG001|Overall Study|Withdrawal by Subject|17|||
125447520|NCT00410384|451264828|FG002|Overall Study|Withdrawal by Subject|20|||
125447521|NCT00410384|451264826|FG000|Overall Study|Adverse Event|23|||
125447522|NCT00410384|451264827|FG001|Overall Study|Adverse Event|18|||
125447523|NCT00410384|451264828|FG002|Overall Study|Adverse Event|23|||
125447524|NCT00410384|451264826|FG000|Overall Study|Lack of Efficacy|20|||
125447525|NCT00410384|451264827|FG001|Overall Study|Lack of Efficacy|12|||
125447526|NCT00410384|451264828|FG002|Overall Study|Lack of Efficacy|17|||
125447527|NCT00410384|451264826|FG000|Overall Study|Lack of Compliance|2|||
125447528|NCT00410384|451264827|FG001|Overall Study|Lack of Compliance|2|||
125268097|NCT04232943|450611661|FG001|Overall Study|Withdrawal by Subject|1|||
125268098|NCT04232943|450611662|FG002|Overall Study|Withdrawal by Subject|0|||
125268099|NCT03896477|450611665|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
125268100|NCT03896477|450611666|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
125268101|NCT03896477|450611667|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
125268102|NCT03896477|450611665|FG000|Overall Study|Parent Requested Withdrawal|8|||
125268103|NCT03896477|450611666|FG001|Overall Study|Parent Requested Withdrawal|12|||
125268104|NCT03896477|450611667|FG002|Overall Study|Parent Requested Withdrawal|9|||
125268105|NCT03896477|450611665|FG000|Overall Study|Adverse Event|0|||
125268106|NCT03896477|450611666|FG001|Overall Study|Adverse Event|0|||
125268107|NCT03896477|450611667|FG002|Overall Study|Adverse Event|1|||
125268108|NCT03896477|450611665|FG000|Overall Study|Death|1|||
125268109|NCT03896477|450611666|FG001|Overall Study|Death|0|||
125268110|NCT03896477|450611667|FG002|Overall Study|Death|0|||
125268111|NCT03896477|450611665|FG000|Overall Study|Other|5|||
125268112|NCT03896477|450611666|FG001|Overall Study|Other|6|||
125268113|NCT03896477|450611667|FG002|Overall Study|Other|7|||
125268114|NCT03896477|450611665|FG000|Overall Study|Lost to Follow-up|2|||
125268115|NCT03896477|450611666|FG001|Overall Study|Lost to Follow-up|1|||
125268116|NCT03896477|450611667|FG002|Overall Study|Lost to Follow-up|1|||
125268117|NCT01791517|450611668|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
125268118|NCT01791517|450611669|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
125268119|NCT01791517|450611670|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
125268120|NCT01791517|450611671|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
125268121|NCT01791517|450611672|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
125268122|NCT01791517|450611673|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
125268123|NCT01791517|450611674|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
125268124|NCT01791517|450611675|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
125268125|NCT01791517|450611676|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
125268126|NCT01791517|450611677|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
125268127|NCT01791517|450611678|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
125268128|NCT01791517|450611679|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
125268129|NCT01791517|450611668|FG000|Phase I: Period 1|Adverse Event|0|||
125268130|NCT01791517|450611669|FG001|Phase I: Period 1|Adverse Event|0|||
125268131|NCT01791517|450611670|FG002|Phase I: Period 1|Adverse Event|1|||
125268132|NCT01791517|450611671|FG003|Phase I: Period 1|Adverse Event|1|||
125268133|NCT01791517|450611672|FG004|Phase I: Period 1|Adverse Event|0|||
125268134|NCT01791517|450611673|FG005|Phase I: Period 1|Adverse Event|0|||
125268135|NCT01791517|450611674|FG006|Phase I: Period 1|Adverse Event|0|||
125268136|NCT01791517|450611675|FG007|Phase I: Period 1|Adverse Event|0|||
125268137|NCT01791517|450611676|FG008|Phase I: Period 1|Adverse Event|0|||
125268138|NCT01791517|450611677|FG009|Phase I: Period 1|Adverse Event|0|||
125268139|NCT01791517|450611678|FG010|Phase I: Period 1|Adverse Event|0|||
125268140|NCT01791517|450611679|FG011|Phase I: Period 1|Adverse Event|0|||
125268141|NCT01791517|450611668|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
125268142|NCT01791517|450611669|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125447529|NCT00410384|451264828|FG002|Overall Study|Lack of Compliance|2|||
125268143|NCT01791517|450611670|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268144|NCT01791517|450611671|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268145|NCT01791517|450611672|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268146|NCT01791517|450611673|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125447530|NCT00410384|451264826|FG000|Overall Study|Lost to Follow-up|4|||
125447531|NCT00410384|451264827|FG001|Overall Study|Lost to Follow-up|6|||
125447532|NCT00410384|451264828|FG002|Overall Study|Lost to Follow-up|6|||
125268147|NCT01791517|450611674|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268148|NCT01791517|450611675|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268149|NCT01791517|450611676|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268150|NCT01791517|450611677|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125447533|NCT00410384|451264826|FG000|Overall Study|Protocol Violation|6|||
125268151|NCT01791517|450611678|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268152|NCT01791517|450611679|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
125268153|NCT01791517|450611668|FG000|Phase I: Period 1|Protocol Violation|0|||
125268154|NCT01791517|450611669|FG001|Phase I: Period 1|Protocol Violation|1|||
125268155|NCT01791517|450611670|FG002|Phase I: Period 1|Protocol Violation|0|||
125268156|NCT01791517|450611671|FG003|Phase I: Period 1|Protocol Violation|0|||
125268157|NCT01791517|450611672|FG004|Phase I: Period 1|Protocol Violation|0|||
125268158|NCT01791517|450611673|FG005|Phase I: Period 1|Protocol Violation|0|||
125268159|NCT01791517|450611674|FG006|Phase I: Period 1|Protocol Violation|0|||
125268160|NCT01791517|450611675|FG007|Phase I: Period 1|Protocol Violation|0|||
125268161|NCT01791517|450611676|FG008|Phase I: Period 1|Protocol Violation|0|||
125268162|NCT01791517|450611677|FG009|Phase I: Period 1|Protocol Violation|0|||
125268163|NCT01791517|450611678|FG010|Phase I: Period 1|Protocol Violation|0|||
125268164|NCT01791517|450611679|FG011|Phase I: Period 1|Protocol Violation|0|||
125268165|NCT01791517|450611668|FG000|Phase I: Period 1|Lost to Follow-up|0|||
125268166|NCT01791517|450611669|FG001|Phase I: Period 1|Lost to Follow-up|0|||
125268167|NCT01791517|450611670|FG002|Phase I: Period 1|Lost to Follow-up|0|||
125268168|NCT01791517|450611671|FG003|Phase I: Period 1|Lost to Follow-up|1|||
125268169|NCT01791517|450611672|FG004|Phase I: Period 1|Lost to Follow-up|0|||
125268170|NCT01791517|450611673|FG005|Phase I: Period 1|Lost to Follow-up|0|||
125268171|NCT01791517|450611674|FG006|Phase I: Period 1|Lost to Follow-up|1|||
125268172|NCT01791517|450611675|FG007|Phase I: Period 1|Lost to Follow-up|0|||
125268173|NCT01791517|450611676|FG008|Phase I: Period 1|Lost to Follow-up|1|||
125268174|NCT01791517|450611677|FG009|Phase I: Period 1|Lost to Follow-up|1|||
125268175|NCT01791517|450611678|FG010|Phase I: Period 1|Lost to Follow-up|0|||
125268176|NCT01791517|450611679|FG011|Phase I: Period 1|Lost to Follow-up|0|||
125268177|NCT01791517|450611668|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268178|NCT01791517|450611669|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268179|NCT01791517|450611670|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268180|NCT01791517|450611671|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268181|NCT01791517|450611672|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268182|NCT01791517|450611673|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268183|NCT01791517|450611674|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268184|NCT01791517|450611675|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268185|NCT01791517|450611676|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268186|NCT01791517|450611677|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268187|NCT01791517|450611678|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
125268188|NCT01791517|450611679|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
125268189|NCT01791517|450611668|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
125268190|NCT01791517|450611669|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268191|NCT01791517|450611670|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268192|NCT01791517|450611671|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268193|NCT01791517|450611672|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268194|NCT01791517|450611673|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268195|NCT01791517|450611674|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268196|NCT01791517|450611675|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268197|NCT01791517|450611676|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268198|NCT01791517|450611677|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268199|NCT01791517|450611678|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268200|NCT01791517|450611679|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
125268201|NCT01791517|450611668|FG000|Phase I: Period 2|Protocol Violation|0|||
125268202|NCT01791517|450611669|FG001|Phase I: Period 2|Protocol Violation|0|||
125268203|NCT01791517|450611670|FG002|Phase I: Period 2|Protocol Violation|0|||
125268204|NCT01791517|450611671|FG003|Phase I: Period 2|Protocol Violation|1|||
125268205|NCT01791517|450611672|FG004|Phase I: Period 2|Protocol Violation|0|||
125268206|NCT01791517|450611673|FG005|Phase I: Period 2|Protocol Violation|0|||
125268207|NCT01791517|450611674|FG006|Phase I: Period 2|Protocol Violation|0|||
125268208|NCT01791517|450611675|FG007|Phase I: Period 2|Protocol Violation|0|||
125268209|NCT01791517|450611676|FG008|Phase I: Period 2|Protocol Violation|0|||
125268210|NCT01791517|450611677|FG009|Phase I: Period 2|Protocol Violation|0|||
125447534|NCT00410384|451264827|FG001|Overall Study|Protocol Violation|6|||
125447535|NCT00410384|451264828|FG002|Overall Study|Protocol Violation|6|||
125268211|NCT01791517|450611678|FG010|Phase I: Period 2|Protocol Violation|0|||
125268212|NCT01791517|450611679|FG011|Phase I: Period 2|Protocol Violation|0|||
125447536|NCT00410384|451264826|FG000|Overall Study|Physician Decision|3|||
125447537|NCT00410384|451264827|FG001|Overall Study|Physician Decision|3|||
125447538|NCT00410384|451264828|FG002|Overall Study|Physician Decision|4|||
125268213|NCT01791517|450611668|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
125268214|NCT01791517|450611669|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
125268215|NCT01791517|450611670|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
125447539|NCT00410384|451264826|FG000|Overall Study|Other|3|||
125268216|NCT01791517|450611671|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
125268217|NCT01791517|450611672|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
125268218|NCT01791517|450611673|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
125447540|NCT00410384|451264827|FG001|Overall Study|Other|8|||
125268219|NCT01791517|450611674|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
125268220|NCT01791517|450611675|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
125268221|NCT01791517|450611676|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
125268222|NCT01791517|450611677|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
125268223|NCT01791517|450611678|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
125268224|NCT01791517|450611679|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
125268225|NCT01791517|450611668|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268226|NCT01791517|450611669|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268227|NCT01791517|450611670|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268228|NCT01791517|450611671|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268229|NCT01791517|450611672|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268230|NCT01791517|450611673|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268231|NCT01791517|450611674|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268232|NCT01791517|450611675|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268233|NCT01791517|450611676|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268234|NCT01791517|450611677|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268235|NCT01791517|450611678|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
125268236|NCT01791517|450611679|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
125268237|NCT01791517|450611668|FG000|Phase I: Period 2|Lens Discomfort|0|||
125268238|NCT01791517|450611669|FG001|Phase I: Period 2|Lens Discomfort|0|||
125268239|NCT01791517|450611670|FG002|Phase I: Period 2|Lens Discomfort|0|||
125268240|NCT01791517|450611671|FG003|Phase I: Period 2|Lens Discomfort|0|||
125268241|NCT01791517|450611672|FG004|Phase I: Period 2|Lens Discomfort|0|||
125268242|NCT01791517|450611673|FG005|Phase I: Period 2|Lens Discomfort|1|||
125268243|NCT01791517|450611674|FG006|Phase I: Period 2|Lens Discomfort|0|||
125268244|NCT01791517|450611675|FG007|Phase I: Period 2|Lens Discomfort|0|||
125268245|NCT01791517|450611676|FG008|Phase I: Period 2|Lens Discomfort|0|||
125268246|NCT01791517|450611677|FG009|Phase I: Period 2|Lens Discomfort|0|||
125268247|NCT01791517|450611678|FG010|Phase I: Period 2|Lens Discomfort|0|||
125268248|NCT01791517|450611679|FG011|Phase I: Period 2|Lens Discomfort|0|||
125268249|NCT01791517|450611668|FG000|Phase I: Period 2|Lost to Follow-up|0|||
125268250|NCT01791517|450611669|FG001|Phase I: Period 2|Lost to Follow-up|3|||
125268251|NCT01791517|450611670|FG002|Phase I: Period 2|Lost to Follow-up|2|||
125268252|NCT01791517|450611671|FG003|Phase I: Period 2|Lost to Follow-up|0|||
125268253|NCT01791517|450611672|FG004|Phase I: Period 2|Lost to Follow-up|0|||
125268254|NCT01791517|450611673|FG005|Phase I: Period 2|Lost to Follow-up|0|||
125268255|NCT01791517|450611674|FG006|Phase I: Period 2|Lost to Follow-up|0|||
125268256|NCT01791517|450611675|FG007|Phase I: Period 2|Lost to Follow-up|0|||
125268257|NCT01791517|450611676|FG008|Phase I: Period 2|Lost to Follow-up|0|||
125268258|NCT01791517|450611677|FG009|Phase I: Period 2|Lost to Follow-up|0|||
125268259|NCT01791517|450611678|FG010|Phase I: Period 2|Lost to Follow-up|0|||
125268260|NCT01791517|450611679|FG011|Phase I: Period 2|Lost to Follow-up|0|||
125268261|NCT01791517|450611668|FG000|Phase I: Period 3|Lens Discomfort|0|||
125268262|NCT01791517|450611669|FG001|Phase I: Period 3|Lens Discomfort|0|||
125268263|NCT01791517|450611670|FG002|Phase I: Period 3|Lens Discomfort|0|||
125268264|NCT01791517|450611671|FG003|Phase I: Period 3|Lens Discomfort|0|||
125268265|NCT01791517|450611672|FG004|Phase I: Period 3|Lens Discomfort|0|||
125268266|NCT01791517|450611673|FG005|Phase I: Period 3|Lens Discomfort|0|||
125268267|NCT01791517|450611674|FG006|Phase I: Period 3|Lens Discomfort|0|||
125268268|NCT01791517|450611675|FG007|Phase I: Period 3|Lens Discomfort|0|||
125268269|NCT01791517|450611676|FG008|Phase I: Period 3|Lens Discomfort|0|||
125268270|NCT01791517|450611677|FG009|Phase I: Period 3|Lens Discomfort|0|||
125268271|NCT01791517|450611678|FG010|Phase I: Period 3|Lens Discomfort|0|||
125268272|NCT01791517|450611679|FG011|Phase I: Period 3|Lens Discomfort|1|||
125268273|NCT01791517|450611668|FG000|Phase I: Period 3|Lost to Follow-up|0|||
125268274|NCT01791517|450611669|FG001|Phase I: Period 3|Lost to Follow-up|1|||
125268275|NCT01791517|450611670|FG002|Phase I: Period 3|Lost to Follow-up|0|||
125268276|NCT01791517|450611671|FG003|Phase I: Period 3|Lost to Follow-up|0|||
125268277|NCT01791517|450611672|FG004|Phase I: Period 3|Lost to Follow-up|1|||
125268278|NCT01791517|450611673|FG005|Phase I: Period 3|Lost to Follow-up|0|||
125268279|NCT01791517|450611674|FG006|Phase I: Period 3|Lost to Follow-up|0|||
125268280|NCT01791517|450611675|FG007|Phase I: Period 3|Lost to Follow-up|0|||
125268281|NCT01791517|450611676|FG008|Phase I: Period 3|Lost to Follow-up|0|||
125268282|NCT01791517|450611677|FG009|Phase I: Period 3|Lost to Follow-up|0|||
125268283|NCT01791517|450611678|FG010|Phase I: Period 3|Lost to Follow-up|0|||
125268284|NCT01791517|450611679|FG011|Phase I: Period 3|Lost to Follow-up|0|||
125268285|NCT01791517|450611668|FG000|Phase I: Period 3|Adverse Event|0|||
125268286|NCT01791517|450611669|FG001|Phase I: Period 3|Adverse Event|0|||
125268287|NCT01791517|450611670|FG002|Phase I: Period 3|Adverse Event|0|||
125268288|NCT01791517|450611671|FG003|Phase I: Period 3|Adverse Event|1|||
125268289|NCT01791517|450611672|FG004|Phase I: Period 3|Adverse Event|0|||
125268290|NCT01791517|450611673|FG005|Phase I: Period 3|Adverse Event|0|||
125268291|NCT01791517|450611674|FG006|Phase I: Period 3|Adverse Event|0|||
125268292|NCT01791517|450611675|FG007|Phase I: Period 3|Adverse Event|0|||
125268293|NCT01791517|450611676|FG008|Phase I: Period 3|Adverse Event|0|||
125268294|NCT01791517|450611677|FG009|Phase I: Period 3|Adverse Event|0|||
125268295|NCT01791517|450611678|FG010|Phase I: Period 3|Adverse Event|0|||
125268296|NCT01791517|450611679|FG011|Phase I: Period 3|Adverse Event|0|||
125268297|NCT01791517|450611668|FG000|Phase II|Lost to Follow-up|1|||
125268298|NCT01791517|450611669|FG001|Phase II|Lost to Follow-up|0|||
125268299|NCT01791517|450611670|FG002|Phase II|Lost to Follow-up|1|||
125268300|NCT01791517|450611671|FG003|Phase II|Lost to Follow-up|0|||
125268301|NCT01791517|450611672|FG004|Phase II|Lost to Follow-up|1|||
125268302|NCT01791517|450611673|FG005|Phase II|Lost to Follow-up|2|||
125268303|NCT01791517|450611674|FG006|Phase II|Lost to Follow-up|0|||
125268304|NCT01791517|450611675|FG007|Phase II|Lost to Follow-up|1|||
125268305|NCT01791517|450611676|FG008|Phase II|Lost to Follow-up|1|||
125268306|NCT01791517|450611677|FG009|Phase II|Lost to Follow-up|1|||
125268307|NCT01791517|450611678|FG010|Phase II|Lost to Follow-up|0|||
125268308|NCT01791517|450611679|FG011|Phase II|Lost to Follow-up|0|||
125268309|NCT01791517|450611668|FG000|Phase II|Withdrawal by Subject|1|||
125268310|NCT01791517|450611669|FG001|Phase II|Withdrawal by Subject|0|||
125268311|NCT01791517|450611670|FG002|Phase II|Withdrawal by Subject|0|||
125268312|NCT01791517|450611671|FG003|Phase II|Withdrawal by Subject|0|||
125268313|NCT01791517|450611672|FG004|Phase II|Withdrawal by Subject|0|||
125268314|NCT01791517|450611673|FG005|Phase II|Withdrawal by Subject|2|||
125268315|NCT01791517|450611674|FG006|Phase II|Withdrawal by Subject|0|||
125268316|NCT01791517|450611675|FG007|Phase II|Withdrawal by Subject|1|||
125268317|NCT01791517|450611676|FG008|Phase II|Withdrawal by Subject|0|||
125268318|NCT01791517|450611677|FG009|Phase II|Withdrawal by Subject|0|||
125268319|NCT01791517|450611678|FG010|Phase II|Withdrawal by Subject|1|||
125268320|NCT01791517|450611679|FG011|Phase II|Withdrawal by Subject|0|||
125268321|NCT01791517|450611668|FG000|Phase II|Lack of Efficacy|0|||
125268322|NCT01791517|450611669|FG001|Phase II|Lack of Efficacy|0|||
125268323|NCT01791517|450611670|FG002|Phase II|Lack of Efficacy|0|||
125268324|NCT01791517|450611671|FG003|Phase II|Lack of Efficacy|0|||
125268325|NCT01791517|450611672|FG004|Phase II|Lack of Efficacy|1|||
125268326|NCT01791517|450611673|FG005|Phase II|Lack of Efficacy|0|||
125268327|NCT01791517|450611674|FG006|Phase II|Lack of Efficacy|0|||
125268328|NCT01791517|450611675|FG007|Phase II|Lack of Efficacy|0|||
125268329|NCT01791517|450611676|FG008|Phase II|Lack of Efficacy|0|||
125268330|NCT01791517|450611677|FG009|Phase II|Lack of Efficacy|0|||
125268331|NCT01791517|450611678|FG010|Phase II|Lack of Efficacy|0|||
125268332|NCT01791517|450611679|FG011|Phase II|Lack of Efficacy|0|||
125268333|NCT01791517|450611668|FG000|Phase II|Adverse Event|0|||
125268334|NCT01791517|450611669|FG001|Phase II|Adverse Event|0|||
125268335|NCT01791517|450611670|FG002|Phase II|Adverse Event|0|||
125268336|NCT01791517|450611671|FG003|Phase II|Adverse Event|0|||
125268337|NCT01791517|450611672|FG004|Phase II|Adverse Event|0|||
125268338|NCT01791517|450611673|FG005|Phase II|Adverse Event|0|||
125268339|NCT01791517|450611674|FG006|Phase II|Adverse Event|2|||
125268340|NCT01791517|450611675|FG007|Phase II|Adverse Event|1|||
125268341|NCT01791517|450611676|FG008|Phase II|Adverse Event|0|||
125268342|NCT01791517|450611677|FG009|Phase II|Adverse Event|1|||
125268343|NCT01791517|450611678|FG010|Phase II|Adverse Event|0|||
125268344|NCT01791517|450611679|FG011|Phase II|Adverse Event|0|||
125268345|NCT01791517|450611668|FG000|Phase II|Lens Handling Difficulties|0|||
125268346|NCT01791517|450611669|FG001|Phase II|Lens Handling Difficulties|0|||
125268347|NCT01791517|450611670|FG002|Phase II|Lens Handling Difficulties|0|||
125268348|NCT01791517|450611671|FG003|Phase II|Lens Handling Difficulties|0|||
125268349|NCT01791517|450611672|FG004|Phase II|Lens Handling Difficulties|0|||
125268350|NCT01791517|450611673|FG005|Phase II|Lens Handling Difficulties|0|||
125268351|NCT01791517|450611674|FG006|Phase II|Lens Handling Difficulties|0|||
125268352|NCT01791517|450611675|FG007|Phase II|Lens Handling Difficulties|0|||
125398864|NCT04697628|451093239|FG001|Overall Study|Lost to Follow-up|4|||
125398865|NCT04697628|451093238|FG000|Overall Study|On-going in study|122|||
125398866|NCT04697628|451093239|FG001|Overall Study|On-going in study|91|||
125398867|NCT03604692|451093240|FG000|Overall Study|Investigator's Decision|0|||
125398868|NCT03604692|451093241|FG001|Overall Study|Investigator's Decision|0|||
125398869|NCT03604692|451093242|FG002|Overall Study|Investigator's Decision|0|||
125398870|NCT03604692|451093243|FG003|Overall Study|Investigator's Decision|1|||
125398871|NCT03604692|451093244|FG004|Overall Study|Investigator's Decision|0|||
125398872|NCT03604692|451093245|FG005|Overall Study|Investigator's Decision|7|||
125398873|NCT03604692|451093240|FG000|Overall Study|Withdrawal by Subject|0|||
125398874|NCT03604692|451093241|FG001|Overall Study|Withdrawal by Subject|0|||
125398875|NCT03604692|451093242|FG002|Overall Study|Withdrawal by Subject|0|||
125398876|NCT03604692|451093243|FG003|Overall Study|Withdrawal by Subject|0|||
125398877|NCT03604692|451093244|FG004|Overall Study|Withdrawal by Subject|0|||
125268353|NCT01791517|450611676|FG008|Phase II|Lens Handling Difficulties|1|||
125268354|NCT01791517|450611677|FG009|Phase II|Lens Handling Difficulties|0|||
125398878|NCT03604692|451093245|FG005|Overall Study|Withdrawal by Subject|2|||
125398879|NCT03604692|451093240|FG000|Overall Study|Progressive Disease|1|||
125268355|NCT01791517|450611678|FG010|Phase II|Lens Handling Difficulties|0|||
125268356|NCT01791517|450611679|FG011|Phase II|Lens Handling Difficulties|0|||
125268357|NCT01791517|450611668|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
125268358|NCT01791517|450611669|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
125268359|NCT01791517|450611670|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
125268360|NCT01791517|450611671|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
125268361|NCT01791517|450611672|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
125268362|NCT01791517|450611673|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
125268363|NCT01791517|450611674|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
125268364|NCT01791517|450611675|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
125268365|NCT01791517|450611676|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
125268366|NCT01791517|450611677|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
125268367|NCT01791517|450611678|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
125268368|NCT01791517|450611679|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
125268369|NCT01791517|450611668|FG000|Phase II|Pre-Existing Ocular Issue|0|||
125268370|NCT01791517|450611669|FG001|Phase II|Pre-Existing Ocular Issue|0|||
125268371|NCT01791517|450611670|FG002|Phase II|Pre-Existing Ocular Issue|0|||
125268372|NCT01791517|450611671|FG003|Phase II|Pre-Existing Ocular Issue|0|||
125268373|NCT01791517|450611672|FG004|Phase II|Pre-Existing Ocular Issue|0|||
125268374|NCT01791517|450611673|FG005|Phase II|Pre-Existing Ocular Issue|0|||
125268375|NCT01791517|450611674|FG006|Phase II|Pre-Existing Ocular Issue|0|||
125268376|NCT01791517|450611675|FG007|Phase II|Pre-Existing Ocular Issue|0|||
125268377|NCT01791517|450611676|FG008|Phase II|Pre-Existing Ocular Issue|0|||
125268378|NCT01791517|450611677|FG009|Phase II|Pre-Existing Ocular Issue|0|||
125268379|NCT01791517|450611678|FG010|Phase II|Pre-Existing Ocular Issue|0|||
125268380|NCT01791517|450611679|FG011|Phase II|Pre-Existing Ocular Issue|1|||
125268381|NCT04011735|450611680|FG000|Overall Study|Withdrawal by Subject|1|||
125268382|NCT04011735|450611681|FG001|Overall Study|Withdrawal by Subject|0|||
125268383|NCT04011735|450611682|FG002|Overall Study|Withdrawal by Subject|1|||
125268384|NCT04011735|450611680|FG000|Overall Study|Met exclusion criteria after study entry|0|||
125268385|NCT04011735|450611681|FG001|Overall Study|Met exclusion criteria after study entry|1|||
125268386|NCT04011735|450611682|FG002|Overall Study|Met exclusion criteria after study entry|0|||
125268387|NCT02298868|450611683|FG000|Overall Study|Adverse Event|1|||
125268388|NCT02298868|450611683|FG000|Overall Study|Death|1|||
125268389|NCT02298868|450611683|FG000|Overall Study|Patient underwent transplant|1|||
125268390|NCT01000506|450611684|FG000|Overall Study|Adverse Event|6|||
125268391|NCT01000506|450611685|FG001|Overall Study|Adverse Event|5|||
125268392|NCT01000506|450611686|FG002|Overall Study|Adverse Event|8|||
125268393|NCT01000506|450611687|FG003|Overall Study|Adverse Event|9|||
125268394|NCT01000506|450611684|FG000|Overall Study|Lack of Efficacy|8|||
125268395|NCT01000506|450611685|FG001|Overall Study|Lack of Efficacy|6|||
125268396|NCT01000506|450611686|FG002|Overall Study|Lack of Efficacy|4|||
125268397|NCT01000506|450611687|FG003|Overall Study|Lack of Efficacy|4|||
125268398|NCT01000506|450611684|FG000|Overall Study|Protocol Violation|1|||
125268399|NCT01000506|450611685|FG001|Overall Study|Protocol Violation|1|||
125268400|NCT01000506|450611686|FG002|Overall Study|Protocol Violation|0|||
125268401|NCT01000506|450611687|FG003|Overall Study|Protocol Violation|0|||
125268402|NCT01000506|450611684|FG000|Overall Study|Lost to Follow-up|1|||
125268403|NCT01000506|450611685|FG001|Overall Study|Lost to Follow-up|1|||
125268404|NCT01000506|450611686|FG002|Overall Study|Lost to Follow-up|4|||
125268405|NCT01000506|450611687|FG003|Overall Study|Lost to Follow-up|0|||
125268406|NCT01000506|450611684|FG000|Overall Study|Physician Decision|1|||
125268407|NCT01000506|450611685|FG001|Overall Study|Physician Decision|3|||
125268408|NCT01000506|450611686|FG002|Overall Study|Physician Decision|3|||
125268409|NCT01000506|450611687|FG003|Overall Study|Physician Decision|3|||
125268410|NCT01000506|450611684|FG000|Overall Study|Withdrawal by Subject|11|||
125268411|NCT01000506|450611685|FG001|Overall Study|Withdrawal by Subject|8|||
125268412|NCT01000506|450611686|FG002|Overall Study|Withdrawal by Subject|2|||
125268413|NCT01000506|450611687|FG003|Overall Study|Withdrawal by Subject|7|||
125268414|NCT00739310|450611688|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
125268415|NCT00739310|450611688|FG000|Overall Study|Withdrawal by Subject|1|||
125268416|NCT00739310|450611688|FG000|Overall Study|Lost to Follow-up|2|||
125268417|NCT01071954|450611689|FG000|Overall Study|Noncompliance|4|||
125268418|NCT01071954|450611689|FG000|Overall Study|Adverse Event|1|||
125268419|NCT01071954|450611689|FG000|Overall Study|Withdrawal by Subject|11|||
125268420|NCT01071954|450611689|FG000|Overall Study|Requirement for Alternative Therapy|5|||
125268421|NCT01071954|450611689|FG000|Overall Study|Administrative Decision|5|||
125268422|NCT01071954|450611689|FG000|Overall Study|Protocol Specified Criteria|1|||
125268423|NCT00590967|450611690|FG000|Overall Study|Withdrawal by Subject|1|||
125268424|NCT00590967|450611691|FG001|Overall Study|Withdrawal by Subject|1|||
125268425|NCT00590967|450611690|FG000|Overall Study|Ineligible|1|||
125268426|NCT00590967|450611691|FG001|Overall Study|Ineligible|0|||
125268427|NCT00590967|450611690|FG000|Overall Study|Poor performance status|0|||
125268428|NCT00590967|450611691|FG001|Overall Study|Poor performance status|1|||
125268429|NCT00590967|450611690|FG000|Overall Study|Non-compliant|0|||
125268430|NCT00590967|450611691|FG001|Overall Study|Non-compliant|2|||
125268431|NCT00590967|450611690|FG000|Overall Study|Did not sign consent form|0|||
125268432|NCT00590967|450611691|FG001|Overall Study|Did not sign consent form|1|||
125268433|NCT00590967|450611690|FG000|Overall Study|Did not receive chemo per protocol|1|||
125268434|NCT00590967|450611691|FG001|Overall Study|Did not receive chemo per protocol|0|||
125268435|NCT01847755|450611692|FG000|Overall Study|Adverse Event|2|||
125268436|NCT01847755|450611692|FG000|Overall Study|Withdrawal by Subject|2|||
125268437|NCT01847755|450611692|FG000|Overall Study|Physician Decision|1|||
125268438|NCT00920556|450611693|FG000|Overall Study|Adverse Event|16|||
125268439|NCT00920556|450611693|FG000|Overall Study|Physician Decision|7|||
125268440|NCT00920556|450611693|FG000|Overall Study|Withdrawal by Subject|1|||
125268441|NCT04245709|450611694|FG000|Overall Study|Adverse Event|13|||
125268442|NCT04245709|450611694|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
125268443|NCT02185534|450611696|FG000|First Period|Withdrawal by Subject|0|||
125268444|NCT02185534|450611697|FG001|First Period|Withdrawal by Subject|0|||
125268445|NCT02185534|450611698|FG002|First Period|Withdrawal by Subject|0|||
125268446|NCT02185534|450611699|FG003|First Period|Withdrawal by Subject|1|||
125268447|NCT02185534|450611700|FG004|First Period|Withdrawal by Subject|0|||
125268448|NCT02185534|450611701|FG005|First Period|Withdrawal by Subject|0|||
125268449|NCT02185534|450611696|FG000|First Washout Period|Withdrawal by Subject|1|||
125268450|NCT02185534|450611697|FG001|First Washout Period|Withdrawal by Subject|0|||
125268451|NCT02185534|450611698|FG002|First Washout Period|Withdrawal by Subject|0|||
125268452|NCT02185534|450611699|FG003|First Washout Period|Withdrawal by Subject|0|||
125268453|NCT02185534|450611700|FG004|First Washout Period|Withdrawal by Subject|1|||
125447541|NCT00410384|451264828|FG002|Overall Study|Other|4|||
125447542|NCT02049437|451264831|FG000|Period 1|Adverse Event|1|||
125447543|NCT02049437|451264832|FG001|Period 1|Adverse Event|1|||
125447544|NCT02049437|451264831|FG000|Period 1|Adverse Event|1|||
125447545|NCT02049437|451264832|FG001|Period 1|Adverse Event|0|||
125447546|NCT00630539|451264833|FG000|Overall Study|Adverse Event|1|||
125268454|NCT02185534|450611701|FG005|First Washout Period|Withdrawal by Subject|0|||
125268455|NCT02185534|450611696|FG000|First Washout Period|Protocol Violation|0|||
125268456|NCT02185534|450611697|FG001|First Washout Period|Protocol Violation|0|||
125268457|NCT02185534|450611698|FG002|First Washout Period|Protocol Violation|0|||
125268458|NCT02185534|450611699|FG003|First Washout Period|Protocol Violation|0|||
125268459|NCT02185534|450611700|FG004|First Washout Period|Protocol Violation|0|||
125268460|NCT02185534|450611701|FG005|First Washout Period|Protocol Violation|1|||
125268461|NCT02041299|450611702|FG000|Overall Study|Adverse Event|9|||
125268462|NCT02041299|450611703|FG001|Overall Study|Adverse Event|3|||
125268463|NCT02041299|450611702|FG000|Overall Study|Lost to Follow-up|4|||
125268464|NCT02041299|450611703|FG001|Overall Study|Lost to Follow-up|1|||
125268465|NCT02041299|450611702|FG000|Overall Study|Physician Decision|1|||
125268466|NCT02041299|450611703|FG001|Overall Study|Physician Decision|1|||
125268467|NCT02041299|450611702|FG000|Overall Study|Withdrawal by Subject|13|||
125398880|NCT03604692|451093241|FG001|Overall Study|Progressive Disease|0|||
125398881|NCT03604692|451093242|FG002|Overall Study|Progressive Disease|1|||
125398882|NCT03604692|451093243|FG003|Overall Study|Progressive Disease|0|||
125398883|NCT03604692|451093244|FG004|Overall Study|Progressive Disease|3|||
125398884|NCT03604692|451093245|FG005|Overall Study|Progressive Disease|4|||
125398885|NCT03604692|451093240|FG000|Overall Study|Difficulty Coming into Site|0|||
125398886|NCT03604692|451093241|FG001|Overall Study|Difficulty Coming into Site|0|||
125398887|NCT03604692|451093242|FG002|Overall Study|Difficulty Coming into Site|0|||
125398888|NCT03604692|451093243|FG003|Overall Study|Difficulty Coming into Site|0|||
125398889|NCT03604692|451093244|FG004|Overall Study|Difficulty Coming into Site|0|||
125398890|NCT03604692|451093245|FG005|Overall Study|Difficulty Coming into Site|1|||
125398891|NCT03604692|451093240|FG000|Overall Study|Death|0|||
125398892|NCT03604692|451093241|FG001|Overall Study|Death|0|||
125398893|NCT03604692|451093242|FG002|Overall Study|Death|1|||
125398894|NCT03604692|451093243|FG003|Overall Study|Death|0|||
125398895|NCT03604692|451093244|FG004|Overall Study|Death|0|||
125398896|NCT03604692|451093245|FG005|Overall Study|Death|0|||
125398897|NCT03604692|451093240|FG000|Overall Study|Drug Intolerance|0|||
125398898|NCT03604692|451093241|FG001|Overall Study|Drug Intolerance|0|||
125398899|NCT03604692|451093242|FG002|Overall Study|Drug Intolerance|0|||
125398900|NCT03604692|451093243|FG003|Overall Study|Drug Intolerance|1|||
125398901|NCT03604692|451093244|FG004|Overall Study|Drug Intolerance|0|||
125398902|NCT03604692|451093245|FG005|Overall Study|Drug Intolerance|0|||
125398903|NCT03604692|451093240|FG000|Overall Study|Noncompliance with follow-up visit|0|||
125398904|NCT03604692|451093241|FG001|Overall Study|Noncompliance with follow-up visit|0|||
125398905|NCT03604692|451093242|FG002|Overall Study|Noncompliance with follow-up visit|0|||
125447547|NCT00630539|451264834|FG001|Overall Study|Adverse Event|3|||
125447548|NCT00630539|451264835|FG002|Overall Study|Adverse Event|1|||
125268468|NCT02041299|450611703|FG001|Overall Study|Withdrawal by Subject|7|||
125268469|NCT02041299|450611702|FG000|Overall Study|Protocol Violation|11|||
125268470|NCT02041299|450611703|FG001|Overall Study|Protocol Violation|4|||
125398906|NCT03604692|451093243|FG003|Overall Study|Noncompliance with follow-up visit|1|||
125398907|NCT03604692|451093244|FG004|Overall Study|Noncompliance with follow-up visit|0|||
125398908|NCT03604692|451093245|FG005|Overall Study|Noncompliance with follow-up visit|0|||
125398909|NCT03604692|451093240|FG000|Overall Study|Not Treated|0|||
125398910|NCT03604692|451093241|FG001|Overall Study|Not Treated|0|||
125398911|NCT03604692|451093242|FG002|Overall Study|Not Treated|0|||
125398912|NCT03604692|451093243|FG003|Overall Study|Not Treated|0|||
125398913|NCT03604692|451093244|FG004|Overall Study|Not Treated|1|||
125398914|NCT03604692|451093245|FG005|Overall Study|Not Treated|0|||
125447549|NCT00630539|451264836|FG003|Overall Study|Adverse Event|2|||
125447550|NCT00630539|451264833|FG000|Overall Study|Withdrawal by Subject|0|||
125447551|NCT00630539|451264834|FG001|Overall Study|Withdrawal by Subject|1|||
125447552|NCT00630539|451264835|FG002|Overall Study|Withdrawal by Subject|0|||
125268471|NCT02041299|450611702|FG000|Overall Study|Termination of the study|7|||
125268472|NCT02041299|450611703|FG001|Overall Study|Termination of the study|3|||
125447553|NCT00630539|451264836|FG003|Overall Study|Withdrawal by Subject|1|||
125447554|NCT04833855|451264840|FG000|Overall Study|Decision by sponsor|0|||
125268473|NCT02041299|450611702|FG000|Overall Study|Required bone marrow transplant|0|||
125268474|NCT02041299|450611703|FG001|Overall Study|Required bone marrow transplant|1|||
125268475|NCT02041299|450611702|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
125268476|NCT02041299|450611703|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
125268477|NCT02389465|450611704|FG000|Overall Study|Lost to Follow-up|1|||
125268478|NCT02389465|450611705|FG001|Overall Study|Lost to Follow-up|3|||
125268479|NCT02389465|450611706|FG002|Overall Study|Lost to Follow-up|3|||
125268480|NCT02389465|450611707|FG003|Overall Study|Lost to Follow-up|0|||
125268481|NCT02389465|450611704|FG000|Overall Study|Physician Decision|0|||
125268482|NCT02389465|450611705|FG001|Overall Study|Physician Decision|0|||
125268483|NCT02389465|450611706|FG002|Overall Study|Physician Decision|0|||
125268484|NCT02389465|450611707|FG003|Overall Study|Physician Decision|1|||
125268485|NCT02389465|450611704|FG000|Overall Study|Withdrawal by Subject|0|||
125268486|NCT02389465|450611705|FG001|Overall Study|Withdrawal by Subject|1|||
125268487|NCT02389465|450611706|FG002|Overall Study|Withdrawal by Subject|2|||
125268488|NCT02389465|450611707|FG003|Overall Study|Withdrawal by Subject|2|||
125268489|NCT00846846|450611708|FG000|Overall Study|Death|56|||
125268490|NCT00846846|450611708|FG000|Overall Study|Withdrawal by Subject|19|||
125268491|NCT04179305|450611714|FG000|Overall Study|Death|1|||
125268492|NCT04179305|450611715|FG001|Overall Study|Death|1|||
125268493|NCT04179305|450611716|FG002|Overall Study|Death|0|||
125268494|NCT04179305|450611717|FG003|Overall Study|Death|0|||
125268495|NCT04179305|450611714|FG000|Overall Study|Lost to Follow-up|1|||
125268496|NCT04179305|450611715|FG001|Overall Study|Lost to Follow-up|1|||
125268497|NCT04179305|450611716|FG002|Overall Study|Lost to Follow-up|0|||
125268498|NCT04179305|450611717|FG003|Overall Study|Lost to Follow-up|0|||
125268499|NCT04179305|450611714|FG000|Overall Study|Withdrawal by Subject|0|||
125268500|NCT04179305|450611715|FG001|Overall Study|Withdrawal by Subject|1|||
125268501|NCT04179305|450611716|FG002|Overall Study|Withdrawal by Subject|0|||
125268502|NCT04179305|450611717|FG003|Overall Study|Withdrawal by Subject|0|||
125268503|NCT04179305|450611714|FG000|Overall Study|Did not have scan|1|||
125268504|NCT04179305|450611715|FG001|Overall Study|Did not have scan|0|||
125268505|NCT04179305|450611716|FG002|Overall Study|Did not have scan|0|||
125268506|NCT04179305|450611717|FG003|Overall Study|Did not have scan|0|||
125268507|NCT04179305|450611714|FG000|Overall Study|In hospice care|3|||
125268508|NCT04179305|450611715|FG001|Overall Study|In hospice care|0|||
125268509|NCT04179305|450611716|FG002|Overall Study|In hospice care|0|||
125268510|NCT04179305|450611717|FG003|Overall Study|In hospice care|0|||
125268511|NCT00503425|450611720|FG000|Overall Study|Participant files lost|6|||
125268512|NCT00503425|450611720|FG000|Overall Study|Adverse Event|5|||
125268513|NCT00503425|450611720|FG000|Overall Study|Lack of Efficacy|25|||
125268514|NCT00503425|450611720|FG000|Overall Study|Withdrawal by Subject|8|||
125268515|NCT00503425|450611720|FG000|Overall Study|Lost to Follow-up|3|||
125268516|NCT00503425|450611720|FG000|Overall Study|Death|3|||
125268517|NCT00503425|450611720|FG000|Overall Study|Missing Data/Unknown|4|||
125268518|NCT00326599|450611721|FG000|Overall Study|Withdrawal by Subject|1|||
125268519|NCT00326599|450611722|FG001|Overall Study|Withdrawal by Subject|0|||
125268520|NCT00326599|450611723|FG002|Overall Study|Withdrawal by Subject|5|||
125268521|NCT00326599|450611724|FG003|Overall Study|Withdrawal by Subject|2|||
125268522|NCT00326599|450611721|FG000|Overall Study|Adverse Event|1|||
125268523|NCT00326599|450611722|FG001|Overall Study|Adverse Event|0|||
125268524|NCT00326599|450611723|FG002|Overall Study|Adverse Event|32|||
125268525|NCT00326599|450611724|FG003|Overall Study|Adverse Event|3|||
125268526|NCT00326599|450611721|FG000|Overall Study|Disease Progression|3|||
125447555|NCT04833855|451264841|FG001|Overall Study|Decision by sponsor|1|||
125447556|NCT04833855|451264842|FG002|Overall Study|Decision by sponsor|0|||
125268527|NCT00326599|450611722|FG001|Overall Study|Disease Progression|1|||
125268528|NCT00326599|450611723|FG002|Overall Study|Disease Progression|13|||
125268529|NCT00326599|450611724|FG003|Overall Study|Disease Progression|11|||
125268530|NCT00326599|450611721|FG000|Overall Study|Alternate Treatment|1|||
125268531|NCT00326599|450611722|FG001|Overall Study|Alternate Treatment|0|||
125268532|NCT00326599|450611723|FG002|Overall Study|Alternate Treatment|0|||
125268533|NCT00326599|450611724|FG003|Overall Study|Alternate Treatment|0|||
125268534|NCT00326599|450611721|FG000|Overall Study|Death|0|||
125268535|NCT00326599|450611722|FG001|Overall Study|Death|0|||
125268536|NCT00326599|450611723|FG002|Overall Study|Death|1|||
125268537|NCT00326599|450611724|FG003|Overall Study|Death|2|||
125268538|NCT00326599|450611721|FG000|Overall Study|Other Unspecified Reason|0|||
125268539|NCT00326599|450611722|FG001|Overall Study|Other Unspecified Reason|0|||
125268540|NCT00326599|450611723|FG002|Overall Study|Other Unspecified Reason|2|||
125268541|NCT00326599|450611724|FG003|Overall Study|Other Unspecified Reason|1|||
125268542|NCT00142792|450611725|FG000|Overall Study|Death|0|||
125268543|NCT00142792|450611726|FG001|Overall Study|Death|0|||
125447557|NCT04833855|451264843|FG003|Overall Study|Decision by sponsor|0|||
125398915|NCT01946204|451093246|FG000|Overall Study|Death|38|||
125398916|NCT01946204|451093247|FG001|Overall Study|Death|59|||
125398917|NCT01946204|451093246|FG000|Overall Study|Withdrawal by Subject|37|||
125398918|NCT01946204|451093247|FG001|Overall Study|Withdrawal by Subject|50|||
125398919|NCT01946204|451093246|FG000|Overall Study|Lost to Follow-up|3|||
125398920|NCT01946204|451093247|FG001|Overall Study|Lost to Follow-up|7|||
125398921|NCT01946204|451093246|FG000|Overall Study|Ongoing|316|||
125398922|NCT01946204|451093247|FG001|Overall Study|Ongoing|687|||
125398923|NCT01946204|451093246|FG000|Overall Study|Other|7|||
125398924|NCT01946204|451093247|FG001|Overall Study|Other|3|||
125398925|NCT03466411|451093248|FG000|Overall Study|Lost to Follow-up|0|||
125398926|NCT03466411|451093249|FG001|Overall Study|Lost to Follow-up|1|||
125398927|NCT03466411|451093250|FG002|Overall Study|Lost to Follow-up|1|||
125398928|NCT03466411|451093251|FG003|Overall Study|Lost to Follow-up|0|||
125398929|NCT03466411|451093252|FG004|Overall Study|Lost to Follow-up|0|||
125398930|NCT03466411|451093253|FG005|Overall Study|Lost to Follow-up|0|||
125398931|NCT03466411|451093254|FG006|Overall Study|Lost to Follow-up|1|||
125398932|NCT03466411|451093255|FG007|Overall Study|Lost to Follow-up|1|||
125398933|NCT03466411|451093256|FG008|Overall Study|Lost to Follow-up|0|||
125398934|NCT03466411|451093257|FG009|Overall Study|Lost to Follow-up|1|||
125398935|NCT03466411|451093258|FG010|Overall Study|Lost to Follow-up|1|||
125398936|NCT03466411|451093259|FG011|Overall Study|Lost to Follow-up|1|||
125398937|NCT03466411|451093260|FG012|Overall Study|Lost to Follow-up|0|||
125398938|NCT03466411|451093248|FG000|Overall Study|Withdrawal by Subject|14|||
125398939|NCT03466411|451093249|FG001|Overall Study|Withdrawal by Subject|7|||
125447558|NCT04833855|451264840|FG000|Overall Study|Withdrawal by Subject|4|||
125447559|NCT04833855|451264841|FG001|Overall Study|Withdrawal by Subject|1|||
125268544|NCT00142792|450611727|FG002|Overall Study|Death|1|||
125268545|NCT00142792|450611725|FG000|Overall Study|Withdrawal by Subject|3|||
125268546|NCT00142792|450611726|FG001|Overall Study|Withdrawal by Subject|2|||
125268547|NCT00142792|450611727|FG002|Overall Study|Withdrawal by Subject|3|||
125268548|NCT00142792|450611725|FG000|Overall Study|Lost to Follow-up|8|||
125268549|NCT00142792|450611726|FG001|Overall Study|Lost to Follow-up|11|||
125268550|NCT00142792|450611727|FG002|Overall Study|Lost to Follow-up|7|||
125268551|NCT00142792|450611725|FG000|Overall Study|No category|1|||
125268552|NCT00142792|450611726|FG001|Overall Study|No category|2|||
125268553|NCT00142792|450611727|FG002|Overall Study|No category|1|||
125268554|NCT00437268|450611728|FG000|Overall Study|Adverse Event|1|||
125268555|NCT00437268|450611729|FG001|Overall Study|Adverse Event|1|||
125268556|NCT00437268|450611728|FG000|Overall Study|Withdrawal by Subject|2|||
125268557|NCT00437268|450611729|FG001|Overall Study|Withdrawal by Subject|2|||
125268558|NCT00437268|450611728|FG000|Overall Study|Progressive disease|9|||
125268559|NCT00437268|450611729|FG001|Overall Study|Progressive disease|9|||
125268560|NCT00437268|450611728|FG000|Overall Study|Physician Decision|1|||
125268561|NCT00437268|450611729|FG001|Overall Study|Physician Decision|0|||
125268562|NCT00437268|450611728|FG000|Overall Study|Death|0|||
125268563|NCT00437268|450611729|FG001|Overall Study|Death|1|||
125268564|NCT00444925|450611730|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
125268565|NCT00444925|450611731|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
125268566|NCT00444925|450611732|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
125268567|NCT00444925|450611730|FG000|Double-blind Treatment Period|Death|2|||
125268568|NCT00444925|450611731|FG001|Double-blind Treatment Period|Death|0|||
125268569|NCT00444925|450611732|FG002|Double-blind Treatment Period|Death|0|||
125268570|NCT00444925|450611730|FG000|Double-blind Treatment Period|Adverse Event|6|||
125268571|NCT00444925|450611731|FG001|Double-blind Treatment Period|Adverse Event|28|||
125268572|NCT00444925|450611732|FG002|Double-blind Treatment Period|Adverse Event|44|||
125268573|NCT00444925|450611730|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
125268574|NCT00444925|450611731|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
125268575|NCT00444925|450611732|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
125268576|NCT00444925|450611730|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
125268577|NCT00444925|450611731|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
125268578|NCT00444925|450611732|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
125268579|NCT00444925|450611730|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
125268580|NCT00444925|450611731|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
125268581|NCT00444925|450611732|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
125268582|NCT00444925|450611730|FG000|Double-blind Treatment Period|Other|7|||
125268583|NCT00444925|450611731|FG001|Double-blind Treatment Period|Other|7|||
125268584|NCT00444925|450611732|FG002|Double-blind Treatment Period|Other|12|||
125268585|NCT03484429|450611736|FG000|Overall Study|Withdrawal by Subject|1|||
125398940|NCT03466411|451093250|FG002|Overall Study|Withdrawal by Subject|8|||
125398941|NCT03466411|451093251|FG003|Overall Study|Withdrawal by Subject|4|||
125398942|NCT03466411|451093252|FG004|Overall Study|Withdrawal by Subject|6|||
125398943|NCT03466411|451093253|FG005|Overall Study|Withdrawal by Subject|3|||
125398944|NCT03466411|451093254|FG006|Overall Study|Withdrawal by Subject|6|||
125398945|NCT03466411|451093255|FG007|Overall Study|Withdrawal by Subject|9|||
125398946|NCT03466411|451093256|FG008|Overall Study|Withdrawal by Subject|6|||
125447560|NCT04833855|451264842|FG002|Overall Study|Withdrawal by Subject|3|||
125268586|NCT03484429|450611737|FG001|Overall Study|Withdrawal by Subject|0|||
125268587|NCT03484429|450611736|FG000|Overall Study|Adverse Event|2|||
125268588|NCT03484429|450611737|FG001|Overall Study|Adverse Event|0|||
125268589|NCT00943761|450611738|FG000|Overall Study|Lost to Follow-up|2|||
125268590|NCT00943761|450611739|FG001|Overall Study|Lost to Follow-up|0|||
125268591|NCT00943761|450611738|FG000|Overall Study|Withdrawal by Subject|2|||
125268592|NCT00943761|450611739|FG001|Overall Study|Withdrawal by Subject|1|||
125268593|NCT00714948|450611742|FG000|Overall Study|Adverse Event|2|||
125268594|NCT01342926|450611743|FG000|Overall Study|Adverse Event|5|||
125268595|NCT01342926|450611744|FG001|Overall Study|Adverse Event|8|||
125268596|NCT01342926|450611745|FG002|Overall Study|Adverse Event|10|||
125268597|NCT01342926|450611746|FG003|Overall Study|Adverse Event|7|||
125268598|NCT01342926|450611743|FG000|Overall Study|Lost to Follow-up|0|||
125268599|NCT01342926|450611744|FG001|Overall Study|Lost to Follow-up|1|||
125268600|NCT01342926|450611745|FG002|Overall Study|Lost to Follow-up|1|||
125268601|NCT01342926|450611746|FG003|Overall Study|Lost to Follow-up|0|||
125268602|NCT01342926|450611743|FG000|Overall Study|Investigator Discretion|2|||
125268603|NCT01342926|450611744|FG001|Overall Study|Investigator Discretion|2|||
125268604|NCT01342926|450611745|FG002|Overall Study|Investigator Discretion|0|||
125268605|NCT01342926|450611746|FG003|Overall Study|Investigator Discretion|0|||
125268606|NCT01342926|450611743|FG000|Overall Study|Withdrawal by Subject|2|||
125268607|NCT01342926|450611744|FG001|Overall Study|Withdrawal by Subject|4|||
125268608|NCT01342926|450611745|FG002|Overall Study|Withdrawal by Subject|3|||
125268609|NCT01342926|450611746|FG003|Overall Study|Withdrawal by Subject|5|||
125268610|NCT03382912|450611747|FG000|Overall Study|Physician Decision|0|||
125268611|NCT03382912|450611748|FG001|Overall Study|Physician Decision|1|||
125268612|NCT03382912|450611747|FG000|Overall Study|Sponsor Decision|6|||
125268613|NCT03382912|450611748|FG001|Overall Study|Sponsor Decision|6|||
125268614|NCT03382912|450611747|FG000|Overall Study|Withdrawal by Subject|0|||
125268615|NCT03382912|450611748|FG001|Overall Study|Withdrawal by Subject|5|||
125268616|NCT05653700|450611749|FG000|Overall Study|Non Responders|9|||
125268617|NCT05653700|450611750|FG001|Overall Study|Non Responders|0|||
125268618|NCT02573948|450611753|FG000|Longitudinal Cohort|Death|9|||
125268619|NCT02573948|450611753|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
125268620|NCT02573948|450611753|FG000|Longitudinal Cohort|Incarcerated|25|||
125268621|NCT00707993|450611754|FG000|Overall Study|Adverse Event|16|||
125268622|NCT00707993|450611755|FG001|Overall Study|Adverse Event|20|||
125268623|NCT00707993|450611754|FG000|Overall Study|Protocol Violation|4|||
125268624|NCT00707993|450611755|FG001|Overall Study|Protocol Violation|7|||
125268625|NCT00707993|450611754|FG000|Overall Study|Lost to Follow-up|0|||
125268626|NCT00707993|450611755|FG001|Overall Study|Lost to Follow-up|4|||
125268627|NCT00707993|450611754|FG000|Overall Study|Withdrawal by Subject|12|||
125268628|NCT00707993|450611755|FG001|Overall Study|Withdrawal by Subject|16|||
125268629|NCT00707993|450611754|FG000|Overall Study|Hyperglycemic Rescue|55|||
125268630|NCT00707993|450611755|FG001|Overall Study|Hyperglycemic Rescue|47|||
125268631|NCT00707993|450611754|FG000|Overall Study|Other|2|||
125268632|NCT00707993|450611755|FG001|Overall Study|Other|0|||
125268633|NCT05414175|450611760|FG000|Overall Study|Withdrawal by Subject|1|||
125268634|NCT05414175|450611760|FG000|Overall Study|Other Reasons|1|||
125268635|NCT00552071|450613587|FG000|Overall Study|Adverse Event|1|||
125268636|NCT00552071|450613588|FG001|Overall Study|Adverse Event|0|||
125268637|NCT00552071|450613587|FG000|Overall Study|Lack of Efficacy|1|||
125268638|NCT00552071|450613588|FG001|Overall Study|Lack of Efficacy|0|||
125268639|NCT00552071|450613587|FG000|Overall Study|Physician Decision|1|||
125268640|NCT00552071|450613588|FG001|Overall Study|Physician Decision|0|||
125268641|NCT00552071|450613587|FG000|Overall Study|Pregnancy|1|||
125268642|NCT00552071|450613588|FG001|Overall Study|Pregnancy|0|||
125268643|NCT00552071|450613587|FG000|Overall Study|Death|0|||
125268644|NCT00552071|450613588|FG001|Overall Study|Death|1|||
125268645|NCT00552071|450613587|FG000|Overall Study|Withdrawal by Subject|0|||
125268646|NCT00552071|450613588|FG001|Overall Study|Withdrawal by Subject|1|||
125268647|NCT00532129|450613589|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
125268648|NCT00532129|450613589|FG000|Treatment Period|Physician Decision|15|||
125268649|NCT00532129|450613589|FG000|Treatment Period|Disease progression|3|||
125268650|NCT00532129|450613589|FG000|Treatment Period|Protocol Violation|1|||
125268651|NCT00532129|450613589|FG000|Treatment Period|Other|5|||
125268652|NCT00532129|450613589|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
125268653|NCT00532129|450613589|FG000|Follow-up Period|Disease progression|57|||
125268654|NCT00532129|450613589|FG000|Follow-up Period|Lost to Follow-up|1|||
125268655|NCT00532129|450613589|FG000|Follow-up Period|Other|6|||
125268656|NCT02237001|450613590|FG000|Overall Study|Lost to Follow-up|2|||
125268657|NCT02237001|450613590|FG000|Overall Study|Withdrawal by Subject|1|||
125447561|NCT04833855|451264843|FG003|Overall Study|Withdrawal by Subject|1|||
125268658|NCT02237001|450613590|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
125268659|NCT02237001|450613590|FG000|Overall Study|Re-operation|4|||
125268660|NCT02237001|450613590|FG000|Overall Study|Incarceration|1|||
125268661|NCT00342628|450613591|FG000|Overall Study|Withdrawal by Subject|19|||
125268662|NCT00342628|450613592|FG001|Overall Study|Withdrawal by Subject|19|||
125447562|NCT04833855|451264840|FG000|Overall Study|Lost to Follow-up|1|||
125268663|NCT00342628|450613593|FG002|Overall Study|Withdrawal by Subject|18|||
125268664|NCT00342628|450613591|FG000|Overall Study|Death|1|||
125268665|NCT00342628|450613592|FG001|Overall Study|Death|1|||
125268666|NCT00342628|450613593|FG002|Overall Study|Death|0|||
125268667|NCT00342628|450613591|FG000|Overall Study|moved residence|0|||
125268668|NCT00342628|450613592|FG001|Overall Study|moved residence|1|||
125268669|NCT00342628|450613593|FG002|Overall Study|moved residence|1|||
125268670|NCT03427814|450613594|FG000|Overall Study|Withdrawal by Subject|4|||
125268671|NCT03427814|450613595|FG001|Overall Study|Withdrawal by Subject|4|||
125268672|NCT03427814|450613594|FG000|Overall Study|Lost to Follow-up|0|||
125268673|NCT03427814|450613595|FG001|Overall Study|Lost to Follow-up|2|||
125268674|NCT03427814|450613594|FG000|Overall Study|Death|42|||
125268675|NCT03427814|450613595|FG001|Overall Study|Death|31|||
125268676|NCT03427814|450613594|FG000|Overall Study|Sponsor's Decision|1|||
125268677|NCT03427814|450613595|FG001|Overall Study|Sponsor's Decision|0|||
125268678|NCT03427814|450613594|FG000|Overall Study|Investigator's Decision|1|||
125268679|NCT03427814|450613595|FG001|Overall Study|Investigator's Decision|2|||
125268680|NCT03427814|450613594|FG000|Overall Study|Disease progression|1|||
125268681|NCT03427814|450613595|FG001|Overall Study|Disease progression|0|||
125268682|NCT03427814|450613594|FG000|Overall Study|Treatment Completed|0|||
125268683|NCT03427814|450613595|FG001|Overall Study|Treatment Completed|1|||
125268684|NCT03427814|450613594|FG000|Overall Study|Sponsor's Decision to End study|21|||
125268685|NCT03427814|450613595|FG001|Overall Study|Sponsor's Decision to End study|25|||
125268686|NCT03427814|450613594|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
125398947|NCT03466411|451093257|FG009|Overall Study|Withdrawal by Subject|11|||
125398948|NCT03466411|451093258|FG010|Overall Study|Withdrawal by Subject|14|||
125268687|NCT03427814|450613595|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
125268688|NCT03145064|450613596|FG000|Overall Study|Death|24|||
125268689|NCT03145064|450613596|FG000|Overall Study|Lost to Follow-up|3|||
125268690|NCT03145064|450613596|FG000|Overall Study|Withdrawal by Subject|6|||
125268691|NCT03145064|450613596|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
125268692|NCT03145064|450613596|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
125268693|NCT03846427|450613597|FG000|Overall Study|Death|13|||
125268694|NCT03846427|450613597|FG000|Overall Study|Withdrawal by Subject|3|||
125268695|NCT03846427|450613597|FG000|Overall Study|Physician Decision|1|||
125268696|NCT01693250|450613598|FG000|Overall Study|Lost to Follow-up|2|||
125268697|NCT01693250|450613599|FG001|Overall Study|Lost to Follow-up|2|||
125268698|NCT00628446|450613600|FG000|Overall Study|Lost to Follow-up|3|||
125268699|NCT00628446|450613600|FG000|Overall Study|Withdrawal by Subject|1|||
125268700|NCT00628446|450613600|FG000|Overall Study|Protocol Violation|3|||
125268701|NCT01396187|450613601|FG000|Overall Study|Adverse Event|0|||
125268702|NCT01396187|450613602|FG001|Overall Study|Adverse Event|1|||
125268703|NCT01396187|450613603|FG002|Overall Study|Adverse Event|0|||
125268704|NCT01396187|450613604|FG003|Overall Study|Adverse Event|0|||
125268705|NCT01396187|450613605|FG004|Overall Study|Adverse Event|0|||
125268706|NCT01396187|450613601|FG000|Overall Study|Withdrawal by Subject|0|||
125268707|NCT01396187|450613602|FG001|Overall Study|Withdrawal by Subject|1|||
125268708|NCT01396187|450613603|FG002|Overall Study|Withdrawal by Subject|1|||
125268709|NCT01396187|450613604|FG003|Overall Study|Withdrawal by Subject|0|||
125268710|NCT01396187|450613605|FG004|Overall Study|Withdrawal by Subject|0|||
125268711|NCT01396187|450613601|FG000|Overall Study|Other|1|||
125398949|NCT03466411|451093259|FG011|Overall Study|Withdrawal by Subject|12|||
125398950|NCT03466411|451093260|FG012|Overall Study|Withdrawal by Subject|7|||
125268712|NCT01396187|450613602|FG001|Overall Study|Other|1|||
125268713|NCT01396187|450613603|FG002|Overall Study|Other|0|||
125268714|NCT01396187|450613604|FG003|Overall Study|Other|0|||
125268715|NCT01396187|450613605|FG004|Overall Study|Other|1|||
125398951|NCT03466411|451093248|FG000|Overall Study|Other|1|||
125398952|NCT03466411|451093249|FG001|Overall Study|Other|1|||
125398953|NCT03466411|451093250|FG002|Overall Study|Other|0|||
125398954|NCT03466411|451093251|FG003|Overall Study|Other|1|||
125398955|NCT03466411|451093252|FG004|Overall Study|Other|2|||
125268716|NCT04971967|450613609|FG000|Overall Study|Lost to Follow-up|6|||
125268717|NCT04971967|450613610|FG001|Overall Study|Lost to Follow-up|7|||
125268718|NCT00682929|450613613|FG000|Overall Study|Adverse Event|4|||
125268719|NCT00682929|450613614|FG001|Overall Study|Adverse Event|1|||
125268720|NCT00682929|450613615|FG002|Overall Study|Adverse Event|1|||
125268721|NCT00682929|450613613|FG000|Overall Study|Withdrawal by Subject|1|||
125268722|NCT00682929|450613614|FG001|Overall Study|Withdrawal by Subject|2|||
125268723|NCT00682929|450613615|FG002|Overall Study|Withdrawal by Subject|1|||
125268724|NCT00682929|450613613|FG000|Overall Study|dosing compliance < 80%|0|||
125268725|NCT00682929|450613614|FG001|Overall Study|dosing compliance < 80%|2|||
125268726|NCT00682929|450613615|FG002|Overall Study|dosing compliance < 80%|0|||
125268727|NCT00682929|450613613|FG000|Overall Study|lag in DEA renewal|1|||
125398956|NCT03466411|451093253|FG005|Overall Study|Other|0|||
125398957|NCT03466411|451093254|FG006|Overall Study|Other|0|||
125268728|NCT00682929|450613614|FG001|Overall Study|lag in DEA renewal|0|||
125268729|NCT00682929|450613615|FG002|Overall Study|lag in DEA renewal|0|||
125398958|NCT03466411|451093255|FG007|Overall Study|Other|0|||
125268730|NCT01462929|450613616|FG000|Overall Study|Adverse Event|3|||
125268731|NCT01462929|450613617|FG001|Overall Study|Adverse Event|3|||
125268732|NCT01462929|450613618|FG002|Overall Study|Adverse Event|4|||
125268733|NCT01462929|450613616|FG000|Overall Study|Withdrawal by Subject|2|||
125268734|NCT01462929|450613617|FG001|Overall Study|Withdrawal by Subject|1|||
125268735|NCT01462929|450613618|FG002|Overall Study|Withdrawal by Subject|0|||
125268736|NCT01462929|450613616|FG000|Overall Study|Lack of Efficacy|0|||
125268737|NCT01462929|450613617|FG001|Overall Study|Lack of Efficacy|0|||
125268738|NCT01462929|450613618|FG002|Overall Study|Lack of Efficacy|1|||
125268739|NCT04072835|450613619|FG000|Overall Study|Overall trial ended|603|||
125268740|NCT04072835|450613619|FG000|Overall Study|Ablation|97|||
125268741|NCT04072835|450613619|FG000|Overall Study|Withdrawal of consent|66|||
125268742|NCT04072835|450613619|FG000|Overall Study|Physician Decision|50|||
125268743|NCT04072835|450613619|FG000|Overall Study|Lost to Follow-up|39|||
125268744|NCT04072835|450613619|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
125268745|NCT04072835|450613619|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
125268746|NCT04072835|450613619|FG000|Overall Study|Adverse Event|25|||
125268747|NCT04072835|450613619|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
125268748|NCT04072835|450613619|FG000|Overall Study|Death|11|||
125268749|NCT04072835|450613619|FG000|Overall Study|Participant felt the drug did not work|8|||
125268750|NCT04072835|450613619|FG000|Overall Study|Participant tolerability|5|||
125268751|NCT04072835|450613619|FG000|Overall Study|Missing|5|||
125268752|NCT04072835|450613619|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
125268753|NCT04072835|450613619|FG000|Overall Study|Pregnancy|3|||
125268754|NCT04723355|450613620|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
125268755|NCT04723355|450613620|FG000|Overall Study|Errors in the informed consent form|2|||
125268756|NCT00841776|450613623|FG000|Overall Study|Lack of Efficacy|0|||
125268757|NCT00841776|450613624|FG001|Overall Study|Lack of Efficacy|1|||
125268758|NCT00841776|450613623|FG000|Overall Study|Lost to Follow-up|2|||
125268759|NCT00841776|450613624|FG001|Overall Study|Lost to Follow-up|1|||
125268760|NCT00841776|450613623|FG000|Overall Study|Withdrawal by Subject|0|||
125268761|NCT00841776|450613624|FG001|Overall Study|Withdrawal by Subject|1|||
125268762|NCT01306643|450613626|FG000|Overall Study|Adverse Event|5|||
125268763|NCT01306643|450613626|FG000|Overall Study|Disease Progression|7|||
125268764|NCT01306643|450613626|FG000|Overall Study|Other: Change in Eligibility Status|1|||
125268765|NCT02071771|450613627|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
125268766|NCT02071771|450613628|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
125268767|NCT02071771|450613627|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
125268768|NCT02071771|450613628|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
125268769|NCT02479880|450613632|FG000|Overall Study|Study Terminated by Sponsor|13|||
125268770|NCT02479880|450613633|FG001|Overall Study|Study Terminated by Sponsor|12|||
125268771|NCT02479880|450613632|FG000|Overall Study|Pregnancy|0|||
125268772|NCT02479880|450613633|FG001|Overall Study|Pregnancy|1|||
125268773|NCT00355368|450613634|FG000|Overall Study|Protocol Violation|8|||
125268774|NCT00355368|450613635|FG001|Overall Study|Protocol Violation|7|||
125268775|NCT00355368|450613634|FG000|Overall Study|cardiac arrest prior to intubation|2|||
125268776|NCT00355368|450613635|FG001|Overall Study|cardiac arrest prior to intubation|2|||
125268777|NCT01349673|450613636|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
125268778|NCT01349673|450613636|FG000|Overall Study|No Longer Qualified For Study|1|||
125268779|NCT01349673|450613636|FG000|Overall Study|Site Closure|10|||
125268780|NCT01349673|450613636|FG000|Overall Study|Withdrawal by Subject|21|||
125268781|NCT01349673|450613636|FG000|Overall Study|Lost to Follow-up|6|||
125268782|NCT01349673|450613636|FG000|Overall Study|Adverse Event|17|||
125268783|NCT01349673|450613636|FG000|Overall Study|Study Terminated By Sponsor|50|||
125268784|NCT01349673|450613636|FG000|Overall Study|Lack of Efficacy|8|||
125268785|NCT03688919|450613639|FG000|Overall Study|Lost to Follow-up|2|||
125268786|NCT03688919|450613640|FG001|Overall Study|Lost to Follow-up|1|||
125268787|NCT03688919|450613639|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
125268788|NCT03688919|450613640|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
125268789|NCT00506779|450613644|FG000|Overall Study|Withdrawal by Subject|1|||
125268790|NCT00506779|450613645|FG001|Overall Study|Withdrawal by Subject|0|||
125268791|NCT00506779|450613646|FG002|Overall Study|Withdrawal by Subject|1|||
125268792|NCT00506779|450613647|FG003|Overall Study|Withdrawal by Subject|0|||
125268793|NCT00506779|450613644|FG000|Overall Study|Adverse Event|0|||
125268794|NCT00506779|450613645|FG001|Overall Study|Adverse Event|1|||
125268795|NCT00506779|450613646|FG002|Overall Study|Adverse Event|1|||
125268796|NCT00506779|450613647|FG003|Overall Study|Adverse Event|1|||
125268797|NCT02639247|450613648|FG000|Overall Study|Lost to Follow-up|2|||
125268798|NCT02639247|450613649|FG001|Overall Study|Lost to Follow-up|1|||
125268799|NCT02639247|450613648|FG000|Overall Study|Death|2|||
125268800|NCT02639247|450613649|FG001|Overall Study|Death|0|||
125268801|NCT02639247|450613648|FG000|Overall Study|Withdrew Consent|0|||
125268802|NCT02639247|450613649|FG001|Overall Study|Withdrew Consent|1|||
125268803|NCT02639247|450613648|FG000|Overall Study|Protocol Violation|1|||
125268804|NCT02639247|450613649|FG001|Overall Study|Protocol Violation|0|||
125268805|NCT03462758|450613650|FG000|Overall Study|Chose no or other method of contraception|20|||
125268806|NCT03462758|450613651|FG001|Overall Study|Chose no or other method of contraception|23|||
125268807|NCT03462758|450613650|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
125268808|NCT03462758|450613651|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
125268809|NCT03462758|450613650|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
125268810|NCT03462758|450613651|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
125268811|NCT03462758|450613650|FG000|Overall Study|Medical contraindication|2|||
125268812|NCT03462758|450613651|FG001|Overall Study|Medical contraindication|2|||
125268813|NCT03462758|450613650|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
125268814|NCT03462758|450613651|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
125268815|NCT02820844|450613652|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
125268816|NCT02820844|450613653|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
125268817|NCT02820844|450613654|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
125268818|NCT02820844|450613655|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
125268819|NCT02820844|450613656|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
125268820|NCT02820844|450613657|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
125268821|NCT02820844|450613652|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
125268822|NCT02820844|450613653|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
125268823|NCT02820844|450613654|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
125268824|NCT02820844|450613655|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
125268825|NCT02820844|450613656|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
125268826|NCT02820844|450613657|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
125268827|NCT02820844|450613652|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
125268828|NCT02820844|450613653|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
125268829|NCT02820844|450613654|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
125268830|NCT02820844|450613655|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
125268831|NCT02820844|450613656|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
125268832|NCT02820844|450613657|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
125268833|NCT02820844|450613652|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
125268834|NCT02820844|450613653|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
125268835|NCT02820844|450613654|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
125268836|NCT02820844|450613655|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
125268837|NCT02820844|450613656|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
125268838|NCT02820844|450613657|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
125268839|NCT02820844|450613652|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
125268840|NCT02820844|450613653|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
125268841|NCT02820844|450613654|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
125268842|NCT02820844|450613655|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
125268843|NCT02820844|450613656|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
125268844|NCT02820844|450613657|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
125268845|NCT02820844|450613652|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
125268846|NCT02820844|450613653|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
125268847|NCT02820844|450613654|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
125268848|NCT02820844|450613655|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
125268849|NCT02820844|450613656|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
125268850|NCT02820844|450613657|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
125268851|NCT02820844|450613652|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
125268852|NCT02820844|450613653|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
125268853|NCT02820844|450613654|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
125268854|NCT02820844|450613655|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
125268855|NCT02820844|450613656|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
125268856|NCT02820844|450613657|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
125268857|NCT02820844|450613652|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268858|NCT02820844|450613653|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268859|NCT02820844|450613654|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
125268860|NCT02820844|450613655|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
125268861|NCT02820844|450613656|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268862|NCT02820844|450613657|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268863|NCT02820844|450613652|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
125268864|NCT02820844|450613653|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
125268865|NCT02820844|450613654|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
125268866|NCT02820844|450613655|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
125447563|NCT04833855|451264841|FG001|Overall Study|Lost to Follow-up|0|||
125268867|NCT02820844|450613656|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
125268868|NCT02820844|450613657|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
125447564|NCT04833855|451264842|FG002|Overall Study|Lost to Follow-up|2|||
125268869|NCT02820844|450613652|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268870|NCT02820844|450613653|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268871|NCT02820844|450613654|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268872|NCT02820844|450613655|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268873|NCT02820844|450613656|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
125268874|NCT02820844|450613657|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
125268875|NCT02266147|450613658|FG000|PART 1: Dose Escalation|Physician Decision|0|||
125268876|NCT02266147|450613659|FG001|PART 1: Dose Escalation|Physician Decision|0|||
125268877|NCT02266147|450613660|FG002|PART 1: Dose Escalation|Physician Decision|1|||
125268878|NCT02266147|450613661|FG003|PART 1: Dose Escalation|Physician Decision|0|||
125268879|NCT02266147|450613658|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
125268880|NCT02266147|450613659|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
125268881|NCT02266147|450613660|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
125268882|NCT02266147|450613661|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
125268883|NCT02266147|450613658|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
125268884|NCT02266147|450613659|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
125268885|NCT02266147|450613660|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
125268886|NCT02266147|450613661|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
125268887|NCT02266147|450613658|FG000|PART 1: Dose Escalation|Other|1|||
125268888|NCT02266147|450613659|FG001|PART 1: Dose Escalation|Other|1|||
125268889|NCT02266147|450613660|FG002|PART 1: Dose Escalation|Other|0|||
125268890|NCT02266147|450613661|FG003|PART 1: Dose Escalation|Other|0|||
125268891|NCT02266147|450613658|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
125268892|NCT02266147|450613659|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
125268893|NCT02266147|450613660|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
125268894|NCT02266147|450613661|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
125268895|NCT02266147|450613658|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
125268896|NCT02266147|450613659|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
125268897|NCT02266147|450613660|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
125268898|NCT02266147|450613661|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
125268899|NCT00413660|450613662|FG000|Up To Week 12|Adverse Event|1|||
125268900|NCT00413660|450613663|FG001|Up To Week 12|Adverse Event|3|||
125268901|NCT00413660|450613664|FG002|Up To Week 12|Adverse Event|1|||
125268902|NCT00413660|450613665|FG003|Up To Week 12|Adverse Event|4|||
125268903|NCT00413660|450613666|FG004|Up To Week 12|Adverse Event|6|||
125268904|NCT00413660|450613667|FG005|Up To Week 12|Adverse Event|4|||
125268905|NCT00413660|450613668|FG006|Up To Week 12|Adverse Event|1|||
125268906|NCT00413660|450613669|FG007|Up To Week 12|Adverse Event|0|||
125268907|NCT00413660|450613670|FG008|Up To Week 12|Adverse Event|0|||
125268908|NCT00413660|450613671|FG009|Up To Week 12|Adverse Event|0|||
125268909|NCT00413660|450613672|FG010|Up To Week 12|Adverse Event|0|||
125268910|NCT00413660|450613662|FG000|Up To Week 12|Lack of Efficacy|2|||
125268911|NCT00413660|450613663|FG001|Up To Week 12|Lack of Efficacy|0|||
125268912|NCT00413660|450613664|FG002|Up To Week 12|Lack of Efficacy|0|||
125268913|NCT00413660|450613665|FG003|Up To Week 12|Lack of Efficacy|0|||
125268914|NCT00413660|450613666|FG004|Up To Week 12|Lack of Efficacy|0|||
125268915|NCT00413660|450613667|FG005|Up To Week 12|Lack of Efficacy|0|||
125268916|NCT00413660|450613668|FG006|Up To Week 12|Lack of Efficacy|5|||
125268917|NCT00413660|450613669|FG007|Up To Week 12|Lack of Efficacy|0|||
125268918|NCT00413660|450613670|FG008|Up To Week 12|Lack of Efficacy|0|||
125268919|NCT00413660|450613671|FG009|Up To Week 12|Lack of Efficacy|0|||
125268920|NCT00413660|450613672|FG010|Up To Week 12|Lack of Efficacy|0|||
125268921|NCT00413660|450613662|FG000|Up To Week 12|Lost to Follow-up|0|||
125268922|NCT00413660|450613663|FG001|Up To Week 12|Lost to Follow-up|1|||
125268923|NCT00413660|450613664|FG002|Up To Week 12|Lost to Follow-up|0|||
125268924|NCT00413660|450613665|FG003|Up To Week 12|Lost to Follow-up|0|||
125268925|NCT00413660|450613666|FG004|Up To Week 12|Lost to Follow-up|1|||
125268926|NCT00413660|450613667|FG005|Up To Week 12|Lost to Follow-up|0|||
125268927|NCT00413660|450613668|FG006|Up To Week 12|Lost to Follow-up|0|||
125268928|NCT00413660|450613669|FG007|Up To Week 12|Lost to Follow-up|0|||
125268929|NCT00413660|450613670|FG008|Up To Week 12|Lost to Follow-up|0|||
125268930|NCT00413660|450613671|FG009|Up To Week 12|Lost to Follow-up|0|||
125268931|NCT00413660|450613672|FG010|Up To Week 12|Lost to Follow-up|0|||
125268932|NCT00413660|450613662|FG000|Up To Week 12|Withdrawal by Subject|0|||
125268933|NCT00413660|450613663|FG001|Up To Week 12|Withdrawal by Subject|2|||
125268934|NCT00413660|450613664|FG002|Up To Week 12|Withdrawal by Subject|0|||
125268935|NCT00413660|450613665|FG003|Up To Week 12|Withdrawal by Subject|2|||
125268936|NCT00413660|450613666|FG004|Up To Week 12|Withdrawal by Subject|0|||
125268937|NCT00413660|450613667|FG005|Up To Week 12|Withdrawal by Subject|2|||
125268938|NCT00413660|450613668|FG006|Up To Week 12|Withdrawal by Subject|2|||
125268939|NCT00413660|450613669|FG007|Up To Week 12|Withdrawal by Subject|0|||
125268940|NCT00413660|450613670|FG008|Up To Week 12|Withdrawal by Subject|0|||
125398959|NCT03466411|451093256|FG008|Overall Study|Other|0|||
125268941|NCT00413660|450613671|FG009|Up To Week 12|Withdrawal by Subject|0|||
125268942|NCT00413660|450613672|FG010|Up To Week 12|Withdrawal by Subject|0|||
125268943|NCT00413660|450613662|FG000|Up To Week 12|Randomized, Not Treated|1|||
125268944|NCT00413660|450613663|FG001|Up To Week 12|Randomized, Not Treated|0|||
125268945|NCT00413660|450613664|FG002|Up To Week 12|Randomized, Not Treated|0|||
125268946|NCT00413660|450613665|FG003|Up To Week 12|Randomized, Not Treated|1|||
125268947|NCT00413660|450613666|FG004|Up To Week 12|Randomized, Not Treated|0|||
125268948|NCT00413660|450613667|FG005|Up To Week 12|Randomized, Not Treated|0|||
125268949|NCT00413660|450613668|FG006|Up To Week 12|Randomized, Not Treated|0|||
125268950|NCT00413660|450613669|FG007|Up To Week 12|Randomized, Not Treated|0|||
125268951|NCT00413660|450613670|FG008|Up To Week 12|Randomized, Not Treated|0|||
125268952|NCT00413660|450613671|FG009|Up To Week 12|Randomized, Not Treated|0|||
125268953|NCT00413660|450613672|FG010|Up To Week 12|Randomized, Not Treated|0|||
125268954|NCT00413660|450613662|FG000|Up To Week 12|Other|3|||
125268955|NCT00413660|450613663|FG001|Up To Week 12|Other|1|||
125268956|NCT00413660|450613664|FG002|Up To Week 12|Other|6|||
125268957|NCT00413660|450613665|FG003|Up To Week 12|Other|1|||
125268958|NCT00413660|450613666|FG004|Up To Week 12|Other|2|||
125268959|NCT00413660|450613667|FG005|Up To Week 12|Other|4|||
125268960|NCT00413660|450613668|FG006|Up To Week 12|Other|3|||
125268961|NCT00413660|450613669|FG007|Up To Week 12|Other|0|||
125268962|NCT00413660|450613670|FG008|Up To Week 12|Other|0|||
125268963|NCT00413660|450613671|FG009|Up To Week 12|Other|0|||
125268964|NCT00413660|450613672|FG010|Up To Week 12|Other|0|||
125268965|NCT00413660|450613662|FG000|Post Week 12|Adverse Event|2|||
125268966|NCT00413660|450613663|FG001|Post Week 12|Adverse Event|0|||
125268967|NCT00413660|450613664|FG002|Post Week 12|Adverse Event|2|||
125268968|NCT00413660|450613665|FG003|Post Week 12|Adverse Event|1|||
125268969|NCT00413660|450613666|FG004|Post Week 12|Adverse Event|4|||
125268970|NCT00413660|450613667|FG005|Post Week 12|Adverse Event|2|||
125268971|NCT00413660|450613668|FG006|Post Week 12|Adverse Event|2|||
125268972|NCT00413660|450613669|FG007|Post Week 12|Adverse Event|0|||
125268973|NCT00413660|450613670|FG008|Post Week 12|Adverse Event|0|||
125268974|NCT00413660|450613671|FG009|Post Week 12|Adverse Event|0|||
125268975|NCT00413660|450613672|FG010|Post Week 12|Adverse Event|0|||
125268976|NCT00413660|450613662|FG000|Post Week 12|Lack of Efficacy|0|||
125268977|NCT00413660|450613663|FG001|Post Week 12|Lack of Efficacy|0|||
125268978|NCT00413660|450613664|FG002|Post Week 12|Lack of Efficacy|1|||
125268979|NCT00413660|450613665|FG003|Post Week 12|Lack of Efficacy|0|||
125268980|NCT00413660|450613666|FG004|Post Week 12|Lack of Efficacy|0|||
125268981|NCT00413660|450613667|FG005|Post Week 12|Lack of Efficacy|0|||
125268982|NCT00413660|450613668|FG006|Post Week 12|Lack of Efficacy|0|||
125268983|NCT00413660|450613669|FG007|Post Week 12|Lack of Efficacy|0|||
125268984|NCT00413660|450613670|FG008|Post Week 12|Lack of Efficacy|0|||
125268985|NCT00413660|450613671|FG009|Post Week 12|Lack of Efficacy|1|||
125268986|NCT00413660|450613672|FG010|Post Week 12|Lack of Efficacy|0|||
125268987|NCT00413660|450613662|FG000|Post Week 12|Lost to Follow-up|0|||
125268988|NCT00413660|450613663|FG001|Post Week 12|Lost to Follow-up|1|||
125268989|NCT00413660|450613664|FG002|Post Week 12|Lost to Follow-up|1|||
125268990|NCT00413660|450613665|FG003|Post Week 12|Lost to Follow-up|0|||
125268991|NCT00413660|450613666|FG004|Post Week 12|Lost to Follow-up|0|||
125268992|NCT00413660|450613667|FG005|Post Week 12|Lost to Follow-up|0|||
125268993|NCT00413660|450613668|FG006|Post Week 12|Lost to Follow-up|0|||
125268994|NCT00413660|450613669|FG007|Post Week 12|Lost to Follow-up|0|||
125268995|NCT00413660|450613670|FG008|Post Week 12|Lost to Follow-up|0|||
125268996|NCT00413660|450613671|FG009|Post Week 12|Lost to Follow-up|0|||
125268997|NCT00413660|450613672|FG010|Post Week 12|Lost to Follow-up|0|||
125268998|NCT00413660|450613662|FG000|Post Week 12|Withdrawal by Subject|0|||
125268999|NCT00413660|450613663|FG001|Post Week 12|Withdrawal by Subject|1|||
125269000|NCT00413660|450613664|FG002|Post Week 12|Withdrawal by Subject|1|||
125269001|NCT00413660|450613665|FG003|Post Week 12|Withdrawal by Subject|0|||
125269002|NCT00413660|450613666|FG004|Post Week 12|Withdrawal by Subject|1|||
125269003|NCT00413660|450613667|FG005|Post Week 12|Withdrawal by Subject|0|||
125269004|NCT00413660|450613668|FG006|Post Week 12|Withdrawal by Subject|0|||
125269005|NCT00413660|450613669|FG007|Post Week 12|Withdrawal by Subject|0|||
125269006|NCT00413660|450613670|FG008|Post Week 12|Withdrawal by Subject|0|||
125269007|NCT00413660|450613671|FG009|Post Week 12|Withdrawal by Subject|0|||
125269008|NCT00413660|450613672|FG010|Post Week 12|Withdrawal by Subject|1|||
125269009|NCT00413660|450613662|FG000|Post Week 12|Other|1|||
125269010|NCT00413660|450613663|FG001|Post Week 12|Other|2|||
125269011|NCT00413660|450613664|FG002|Post Week 12|Other|3|||
125269012|NCT00413660|450613665|FG003|Post Week 12|Other|0|||
125269013|NCT00413660|450613666|FG004|Post Week 12|Other|1|||
125269014|NCT00413660|450613667|FG005|Post Week 12|Other|1|||
125269015|NCT00413660|450613668|FG006|Post Week 12|Other|1|||
125269016|NCT00413660|450613669|FG007|Post Week 12|Other|0|||
125269017|NCT00413660|450613670|FG008|Post Week 12|Other|0|||
125269018|NCT00413660|450613671|FG009|Post Week 12|Other|0|||
125269019|NCT00413660|450613672|FG010|Post Week 12|Other|0|||
125269020|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
125269021|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
125269022|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
125269023|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
125269024|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
125269025|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
125269026|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
125269027|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
125269028|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
125269029|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
125269030|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
125269031|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
125269032|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
125269033|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
125269034|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
125269035|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
125269036|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
125269037|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
125269038|NCT02831855|450613675|FG000|Open Label Phase (24 Weeks)|Other|4|||
125269039|NCT02831855|450613676|FG001|Open Label Phase (24 Weeks)|Other|0|||
125269040|NCT02831855|450613677|FG002|Open Label Phase (24 Weeks)|Other|0|||
125269041|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
125269042|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
125269043|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
125269044|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Death|0|||
125269045|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Death|0|||
125269046|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Death|2|||
125269047|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
125269048|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
125269049|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
125269050|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
125269051|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
125269052|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
125269053|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
125269054|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
125269055|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
125269056|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Other|0|||
125269057|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Other|2|||
125269058|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Other|5|||
125269059|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
125269060|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
125269061|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
125269062|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
125269063|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
125269064|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
125269065|NCT02831855|450613675|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
125269066|NCT02831855|450613676|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
125269067|NCT02831855|450613677|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
125269068|NCT01722994|450613678|FG000|Overall Study|Missing data|25|||
125269069|NCT01722994|450613679|FG001|Overall Study|Missing data|17|||
125269070|NCT01803880|450613683|FG000|Overall Study|Adverse Event|1|||
125269071|NCT01803880|450613684|FG001|Overall Study|Adverse Event|0|||
125269072|NCT01803880|450613685|FG002|Overall Study|Adverse Event|0|||
125269073|NCT01803880|450613683|FG000|Overall Study|Withdrawal by Subject|1|||
125269074|NCT01803880|450613684|FG001|Overall Study|Withdrawal by Subject|1|||
125269075|NCT01803880|450613685|FG002|Overall Study|Withdrawal by Subject|4|||
125269076|NCT01803880|450613683|FG000|Overall Study|Physician Decision|0|||
125269077|NCT01803880|450613684|FG001|Overall Study|Physician Decision|0|||
125269078|NCT01803880|450613685|FG002|Overall Study|Physician Decision|1|||
125269079|NCT01803880|450613683|FG000|Overall Study|Unable to return for follow-up visits|0|||
125269080|NCT01803880|450613684|FG001|Overall Study|Unable to return for follow-up visits|1|||
125269081|NCT01803880|450613685|FG002|Overall Study|Unable to return for follow-up visits|2|||
125269082|NCT01803880|450613683|FG000|Overall Study|Lost to Follow-up|1|||
125269083|NCT01803880|450613684|FG001|Overall Study|Lost to Follow-up|2|||
125269084|NCT01803880|450613685|FG002|Overall Study|Lost to Follow-up|3|||
125269085|NCT01803880|450613683|FG000|Overall Study|Protocol Violation|1|||
125269086|NCT01803880|450613684|FG001|Overall Study|Protocol Violation|0|||
125269087|NCT01803880|450613685|FG002|Overall Study|Protocol Violation|0|||
125269088|NCT01803880|450613683|FG000|Overall Study|Early study termination|0|||
125269089|NCT01803880|450613684|FG001|Overall Study|Early study termination|6|||
125269090|NCT01803880|450613685|FG002|Overall Study|Early study termination|5|||
125269091|NCT01803880|450613683|FG000|Overall Study|Incomplete data entry by sites|2|||
125269092|NCT01803880|450613684|FG001|Overall Study|Incomplete data entry by sites|0|||
125269093|NCT01803880|450613685|FG002|Overall Study|Incomplete data entry by sites|0|||
125269094|NCT02954887|450613686|FG000|Overall Study|Withdrawal by Subject|3|||
125269095|NCT02954887|450613686|FG000|Overall Study|Lack of Efficacy|3|||
125269096|NCT02954887|450613686|FG000|Overall Study|Other|1|||
125269097|NCT01459666|450613688|FG000|Overall Study|PI left institution|5|||
125269098|NCT01459666|450613689|FG001|Overall Study|PI left institution|4|||
125269099|NCT01152788|450613691|FG000|Overall Study|Withdrawal by Subject|0|||
125269100|NCT01152788|450613692|FG001|Overall Study|Withdrawal by Subject|3|||
125269101|NCT01152788|450613691|FG000|Overall Study|No treatment|0|||
125269102|NCT01152788|450613692|FG001|Overall Study|No treatment|1|||
125269103|NCT00889707|450613695|FG000|Overall Study|Adverse Event|1|||
125269104|NCT00889707|450613696|FG001|Overall Study|Adverse Event|0|||
125269105|NCT00889707|450613695|FG000|Overall Study|Withdrawal by Subject|4|||
125269106|NCT00889707|450613696|FG001|Overall Study|Withdrawal by Subject|3|||
125269107|NCT00889707|450613695|FG000|Overall Study|Lost to Follow-up|0|||
125269108|NCT00889707|450613696|FG001|Overall Study|Lost to Follow-up|2|||
125269109|NCT00889707|450613695|FG000|Overall Study|Lack of Efficacy|2|||
125269110|NCT00889707|450613696|FG001|Overall Study|Lack of Efficacy|5|||
125269111|NCT02268383|450613704|FG000|Overall Study|Death|12|||
125269112|NCT02268383|450613704|FG000|Overall Study|Lost to Follow-up|2|||
125269113|NCT02268383|450613704|FG000|Overall Study|Withdrawal by Subject|9|||
125269114|NCT02268383|450613704|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
125269115|NCT02268383|450613704|FG000|Overall Study|Protocol deviation|3|||
125269116|NCT02268383|450613704|FG000|Overall Study|Sponsor decision|22|||
125269117|NCT02268383|450613704|FG000|Overall Study|Not reported|12|||
125269118|NCT02708680|450613705|FG000|Overall Study|Withdrawal by Subject|4|||
125269119|NCT02708680|450613706|FG001|Overall Study|Withdrawal by Subject|12|||
125269120|NCT02708680|450613707|FG002|Overall Study|Withdrawal by Subject|12|||
125269121|NCT02708680|450613705|FG000|Overall Study|Death|4|||
125269122|NCT02708680|450613706|FG001|Overall Study|Death|19|||
125269123|NCT02708680|450613707|FG002|Overall Study|Death|21|||
125269124|NCT02708680|450613705|FG000|Overall Study|Lost to Follow-up|0|||
125269125|NCT02708680|450613706|FG001|Overall Study|Lost to Follow-up|3|||
125269126|NCT02708680|450613707|FG002|Overall Study|Lost to Follow-up|3|||
125269127|NCT02708680|450613705|FG000|Overall Study|Study Terminated By Sponsor|0|||
125269128|NCT02708680|450613706|FG001|Overall Study|Study Terminated By Sponsor|5|||
125269129|NCT02708680|450613707|FG002|Overall Study|Study Terminated By Sponsor|4|||
125269130|NCT02708680|450613705|FG000|Overall Study|Other than Specified|0|||
125269131|NCT02708680|450613706|FG001|Overall Study|Other than Specified|0|||
125269132|NCT02708680|450613707|FG002|Overall Study|Other than Specified|1|||
125269133|NCT02708680|450613705|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
125269134|NCT02708680|450613706|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
125269135|NCT02708680|450613707|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
125269136|NCT04162470|450613708|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
125269137|NCT05588440|450613711|FG000|Overall Study|Sponsor Decision|2|||
125269138|NCT05588440|450613712|FG001|Overall Study|Sponsor Decision|0|||
125269139|NCT05588440|450613713|FG002|Overall Study|Sponsor Decision|1|||
125269140|NCT05588440|450613711|FG000|Overall Study|Death|1|||
125269141|NCT05588440|450613712|FG001|Overall Study|Death|1|||
125269142|NCT05588440|450613713|FG002|Overall Study|Death|1|||
125269143|NCT05588440|450613711|FG000|Overall Study|Screen Fail|0|||
125269144|NCT05588440|450613712|FG001|Overall Study|Screen Fail|1|||
125269145|NCT05588440|450613713|FG002|Overall Study|Screen Fail|1|||
125269146|NCT05588440|450613711|FG000|Overall Study|Withdrawal by Subject|0|||
125269147|NCT05588440|450613712|FG001|Overall Study|Withdrawal by Subject|0|||
125269148|NCT05588440|450613713|FG002|Overall Study|Withdrawal by Subject|1|||
125269149|NCT01544348|450613718|FG000|Overall Study|Lost to Follow-up|1|||
125269150|NCT01544348|450613719|FG001|Overall Study|Lost to Follow-up|0|||
125269151|NCT01544348|450613720|FG002|Overall Study|Lost to Follow-up|0|||
125269152|NCT01544348|450613721|FG003|Overall Study|Lost to Follow-up|0|||
125269153|NCT01544348|450613722|FG004|Overall Study|Lost to Follow-up|0|||
125269154|NCT01544348|450613723|FG005|Overall Study|Lost to Follow-up|0|||
125269155|NCT01544348|450613724|FG006|Overall Study|Lost to Follow-up|1|||
125269156|NCT01544348|450613725|FG007|Overall Study|Lost to Follow-up|0|||
125269157|NCT01544348|450613718|FG000|Overall Study|Withdrawal by Subject|1|||
125269158|NCT01544348|450613719|FG001|Overall Study|Withdrawal by Subject|0|||
125269159|NCT01544348|450613720|FG002|Overall Study|Withdrawal by Subject|0|||
125269160|NCT01544348|450613721|FG003|Overall Study|Withdrawal by Subject|0|||
125269161|NCT01544348|450613722|FG004|Overall Study|Withdrawal by Subject|1|||
125269162|NCT01544348|450613723|FG005|Overall Study|Withdrawal by Subject|2|||
125269163|NCT01544348|450613724|FG006|Overall Study|Withdrawal by Subject|1|||
125269164|NCT01544348|450613725|FG007|Overall Study|Withdrawal by Subject|0|||
125269165|NCT01544348|450613718|FG000|Overall Study|Physician Decision|0|||
125269166|NCT01544348|450613719|FG001|Overall Study|Physician Decision|0|||
125269167|NCT01544348|450613720|FG002|Overall Study|Physician Decision|0|||
125269168|NCT01544348|450613721|FG003|Overall Study|Physician Decision|0|||
125269169|NCT01544348|450613722|FG004|Overall Study|Physician Decision|0|||
125269170|NCT01544348|450613723|FG005|Overall Study|Physician Decision|1|||
125269171|NCT01544348|450613724|FG006|Overall Study|Physician Decision|0|||
125269172|NCT01544348|450613725|FG007|Overall Study|Physician Decision|0|||
125269173|NCT01445847|450613726|FG000|Overall Study|Protocol Violation|13|||
125269174|NCT01445847|450613727|FG001|Overall Study|Protocol Violation|14|||
125269175|NCT01445847|450613726|FG000|Overall Study|Missed Data|1|||
125269176|NCT01445847|450613727|FG001|Overall Study|Missed Data|0|||
125269177|NCT04790279|450615641|FG000|Overall Study|Did not meet medication start criteria|27|||
125269178|NCT04790279|450615642|FG001|Overall Study|Did not meet medication start criteria|15|||
125269179|NCT04790279|450615641|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
125269180|NCT04790279|450615642|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
125269181|NCT04790279|450615641|FG000|Overall Study|Protocol Violation|8|||
125269182|NCT04790279|450615642|FG001|Overall Study|Protocol Violation|3|||
125269183|NCT04790279|450615641|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
125269184|NCT04790279|450615642|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
125269185|NCT00810277|450615655|FG000|Overall Study|Adverse Event|1|||
125269186|NCT00678288|450615662|FG000|Overall Study|Adverse Event|0|||
125269187|NCT00678288|450615663|FG001|Overall Study|Adverse Event|2|||
125269188|NCT00678288|450615662|FG000|Overall Study|Withdrawal by Subject|1|||
125269189|NCT00678288|450615663|FG001|Overall Study|Withdrawal by Subject|1|||
125269190|NCT00678288|450615662|FG000|Overall Study|Study terminated by the sponsor|2|||
125269191|NCT00678288|450615663|FG001|Overall Study|Study terminated by the sponsor|0|||
125269192|NCT00678288|450615662|FG000|Overall Study|Not compliant with study medication|0|||
125269193|NCT00678288|450615663|FG001|Overall Study|Not compliant with study medication|1|||
125269194|NCT00678288|450615662|FG000|Overall Study|Switch to commercial drug|0|||
125269195|NCT00678288|450615663|FG001|Overall Study|Switch to commercial drug|1|||
125269196|NCT00678288|450615662|FG000|Overall Study|Reason not reported|1|||
125269197|NCT00678288|450615663|FG001|Overall Study|Reason not reported|0|||
125269198|NCT00678288|450615662|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
125269199|NCT00678288|450615663|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
125269200|NCT02549989|450615664|FG000|Overall Study|Adverse Event|4|||
125269201|NCT02549989|450615664|FG000|Overall Study|Death|1|||
125269202|NCT02549989|450615664|FG000|Overall Study|Lack of Efficacy|19|||
125269203|NCT02549989|450615664|FG000|Overall Study|Withdrawal by Subject|3|||
125269204|NCT00972023|450615665|FG000|Overall Study|Withdrawal by Subject|1|||
125269205|NCT02628444|450615666|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
125269206|NCT02628444|450615667|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269207|NCT02628444|450615668|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269208|NCT02628444|450615669|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269209|NCT02628444|450615670|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269210|NCT02628444|450615671|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269211|NCT02628444|450615672|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269212|NCT02628444|450615673|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269213|NCT02628444|450615674|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
125269214|NCT02628444|450615666|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269215|NCT02628444|450615667|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
125269216|NCT02628444|450615668|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
125269217|NCT02628444|450615669|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269218|NCT02628444|450615670|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269219|NCT02628444|450615671|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269220|NCT02628444|450615672|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269221|NCT02628444|450615673|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269222|NCT02628444|450615674|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
125269223|NCT02628444|450615666|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
125269224|NCT02628444|450615667|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
125269225|NCT02628444|450615668|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
125398960|NCT03466411|451093257|FG009|Overall Study|Other|1|||
125398961|NCT03466411|451093258|FG010|Overall Study|Other|2|||
125269226|NCT02628444|450615669|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269227|NCT02628444|450615670|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269228|NCT02628444|450615671|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269229|NCT02628444|450615672|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269230|NCT02628444|450615673|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
125398962|NCT03466411|451093259|FG011|Overall Study|Other|0|||
125398963|NCT03466411|451093260|FG012|Overall Study|Other|0|||
125398964|NCT03466411|451093248|FG000|Overall Study|Randomized but not Treated|0|||
125398965|NCT03466411|451093249|FG001|Overall Study|Randomized but not Treated|0|||
125398966|NCT03466411|451093250|FG002|Overall Study|Randomized but not Treated|0|||
125398967|NCT03466411|451093251|FG003|Overall Study|Randomized but not Treated|0|||
125447565|NCT04833855|451264843|FG003|Overall Study|Lost to Follow-up|2|||
125269231|NCT02628444|450615674|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269232|NCT02628444|450615666|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
125269233|NCT02628444|450615667|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
125269234|NCT02628444|450615668|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
125269235|NCT02628444|450615669|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
125269236|NCT02628444|450615670|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
125269237|NCT02628444|450615671|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
125269238|NCT02628444|450615672|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
125269239|NCT02628444|450615673|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
125269240|NCT02628444|450615674|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
125269241|NCT02628444|450615666|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
125269242|NCT02628444|450615667|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
125269243|NCT02628444|450615668|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
125269244|NCT02628444|450615669|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
125269245|NCT02628444|450615670|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
125269246|NCT02628444|450615671|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
125269247|NCT02628444|450615672|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
125269248|NCT02628444|450615673|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
125269249|NCT02628444|450615674|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
125269250|NCT02628444|450615666|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269251|NCT02628444|450615667|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269252|NCT02628444|450615668|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269253|NCT02628444|450615669|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
125269254|NCT02628444|450615670|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269255|NCT02628444|450615671|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269256|NCT02628444|450615672|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269257|NCT02628444|450615673|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269258|NCT02628444|450615674|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
125269259|NCT02628444|450615666|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
125269260|NCT02628444|450615667|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
125269261|NCT02628444|450615668|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
125269262|NCT02628444|450615669|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
125269263|NCT02628444|450615670|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
125269264|NCT02628444|450615671|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
125269265|NCT02628444|450615672|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
125269266|NCT02628444|450615673|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
125269267|NCT02628444|450615674|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
125269268|NCT02628444|450615666|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269269|NCT02628444|450615667|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269270|NCT02628444|450615668|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
125269271|NCT02628444|450615669|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
125269272|NCT02628444|450615670|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
125269273|NCT02628444|450615671|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
125269274|NCT02628444|450615672|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
125269275|NCT02628444|450615673|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
125269276|NCT02628444|450615674|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
125269277|NCT02628444|450615666|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
125269278|NCT02628444|450615667|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
125269279|NCT02628444|450615668|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
125269280|NCT02628444|450615669|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
125269281|NCT02628444|450615670|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
125269282|NCT02628444|450615671|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
125269283|NCT02628444|450615672|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
125269284|NCT02628444|450615673|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
125269285|NCT02628444|450615674|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
125269286|NCT02628444|450615666|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
125269287|NCT02628444|450615667|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
125269288|NCT02628444|450615668|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
125269289|NCT02628444|450615669|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
125269290|NCT02628444|450615670|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
125447566|NCT04833855|451264840|FG000|Overall Study|Protocol specified criteria|0|||
125447567|NCT04833855|451264841|FG001|Overall Study|Protocol specified criteria|0|||
125269291|NCT02628444|450615671|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
125269292|NCT02628444|450615672|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
125269293|NCT02628444|450615673|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
125269294|NCT02628444|450615674|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
125269295|NCT00784368|450615677|FG000|Overall Study|Physician Decision|0|||
125269296|NCT00784368|450615678|FG001|Overall Study|Physician Decision|0|||
125269297|NCT00784368|450615679|FG002|Overall Study|Physician Decision|6|||
125269298|NCT00784368|450615677|FG000|Overall Study|Lack of Efficacy|2|||
125269299|NCT00784368|450615678|FG001|Overall Study|Lack of Efficacy|0|||
125269300|NCT00784368|450615679|FG002|Overall Study|Lack of Efficacy|1|||
125269301|NCT00784368|450615677|FG000|Overall Study|Adverse Event|6|||
125269302|NCT00784368|450615678|FG001|Overall Study|Adverse Event|9|||
125269303|NCT00784368|450615679|FG002|Overall Study|Adverse Event|2|||
125269304|NCT00784368|450615677|FG000|Overall Study|Diagnosis of fever|0|||
125269305|NCT00784368|450615678|FG001|Overall Study|Diagnosis of fever|0|||
125269306|NCT00784368|450615679|FG002|Overall Study|Diagnosis of fever|1|||
125269307|NCT00784368|450615677|FG000|Overall Study|Worsening of complications|0|||
125269308|NCT00784368|450615678|FG001|Overall Study|Worsening of complications|0|||
125269309|NCT00784368|450615679|FG002|Overall Study|Worsening of complications|1|||
125269310|NCT00784368|450615677|FG000|Overall Study|Worsening of symptoms|0|||
125269311|NCT00784368|450615678|FG001|Overall Study|Worsening of symptoms|1|||
125269312|NCT00784368|450615679|FG002|Overall Study|Worsening of symptoms|0|||
125269313|NCT00784368|450615677|FG000|Overall Study|Withdrawal of informed consent|0|||
125269314|NCT00784368|450615678|FG001|Overall Study|Withdrawal of informed consent|1|||
125269315|NCT00784368|450615679|FG002|Overall Study|Withdrawal of informed consent|0|||
125269316|NCT02079909|450615680|FG000|Overall Study|Adverse Event|23|||
125269317|NCT02079909|450615681|FG001|Overall Study|Adverse Event|23|||
125269318|NCT02079909|450615682|FG002|Overall Study|Adverse Event|7|||
125269319|NCT02079909|450615680|FG000|Overall Study|Withdrawal by Subject|9|||
125269320|NCT02079909|450615681|FG001|Overall Study|Withdrawal by Subject|17|||
125269321|NCT02079909|450615682|FG002|Overall Study|Withdrawal by Subject|4|||
125269322|NCT02079909|450615680|FG000|Overall Study|Lost to Follow-up|2|||
125269323|NCT02079909|450615681|FG001|Overall Study|Lost to Follow-up|3|||
125269324|NCT02079909|450615682|FG002|Overall Study|Lost to Follow-up|1|||
125269325|NCT02079909|450615680|FG000|Overall Study|Death|2|||
125269326|NCT02079909|450615681|FG001|Overall Study|Death|2|||
125269327|NCT02079909|450615682|FG002|Overall Study|Death|0|||
125269328|NCT02079909|450615680|FG000|Overall Study|Lack of Efficacy|0|||
125269329|NCT02079909|450615681|FG001|Overall Study|Lack of Efficacy|0|||
125269330|NCT02079909|450615682|FG002|Overall Study|Lack of Efficacy|1|||
125269331|NCT02079909|450615680|FG000|Overall Study|Protocol Violation|0|||
125269332|NCT02079909|450615681|FG001|Overall Study|Protocol Violation|1|||
125269333|NCT02079909|450615682|FG002|Overall Study|Protocol Violation|1|||
125269334|NCT02079909|450615680|FG000|Overall Study|Physician Decision|0|||
125269335|NCT02079909|450615681|FG001|Overall Study|Physician Decision|1|||
125269336|NCT02079909|450615682|FG002|Overall Study|Physician Decision|1|||
125269337|NCT02079909|450615680|FG000|Overall Study|Relocation etc.|2|||
125269338|NCT02079909|450615681|FG001|Overall Study|Relocation etc.|2|||
125269339|NCT02079909|450615682|FG002|Overall Study|Relocation etc.|3|||
125269340|NCT00720356|450615687|FG000|Registration to Study|Determined to have methylated MGMT|67|||
125269341|NCT00720356|450615687|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
125269342|NCT00720356|450615687|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
125269343|NCT00720356|450615687|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
125269344|NCT00720356|450615687|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
125269345|NCT00720356|450615687|FG000|Follow up Until Death|Withdrawal by Subject|1|||
125269346|NCT00720356|450615687|FG000|Follow up Until Death|Alive at last data collection|4|||
125269347|NCT01713582|450615690|FG000|Overall Study|Disease progression|3|||
125269348|NCT01713582|450615691|FG001|Overall Study|Disease progression|3|||
125269349|NCT01713582|450615692|FG002|Overall Study|Disease progression|3|||
125269350|NCT01713582|450615693|FG003|Overall Study|Disease progression|2|||
125269351|NCT01713582|450615694|FG004|Overall Study|Disease progression|3|||
125269352|NCT01713582|450615695|FG005|Overall Study|Disease progression|3|||
125269353|NCT01713582|450615696|FG006|Overall Study|Disease progression|3|||
125269354|NCT01713582|450615697|FG007|Overall Study|Disease progression|3|||
125269355|NCT01713582|450615698|FG008|Overall Study|Disease progression|3|||
125269356|NCT01713582|450615699|FG009|Overall Study|Disease progression|11|||
125269357|NCT01713582|450615700|FG010|Overall Study|Disease progression|10|||
125269358|NCT01713582|450615701|FG011|Overall Study|Disease progression|5|||
125269359|NCT01713582|450615702|FG012|Overall Study|Disease progression|3|||
125269360|NCT01713582|450615703|FG013|Overall Study|Disease progression|3|||
125398968|NCT03466411|451093252|FG004|Overall Study|Randomized but not Treated|0|||
125398969|NCT03466411|451093253|FG005|Overall Study|Randomized but not Treated|0|||
125269361|NCT01713582|450615704|FG014|Overall Study|Disease progression|6|||
125269362|NCT01713582|450615705|FG015|Overall Study|Disease progression|6|||
125269363|NCT01713582|450615706|FG016|Overall Study|Disease progression|5|||
125269364|NCT01713582|450615707|FG017|Overall Study|Disease progression|2|||
125269365|NCT01713582|450615708|FG018|Overall Study|Disease progression|3|||
125269366|NCT01713582|450615709|FG019|Overall Study|Disease progression|5|||
125269367|NCT01713582|450615710|FG020|Overall Study|Disease progression|15|||
125269368|NCT01713582|450615690|FG000|Overall Study|Death|0|||
125269369|NCT01713582|450615691|FG001|Overall Study|Death|0|||
125269370|NCT01713582|450615692|FG002|Overall Study|Death|0|||
125269371|NCT01713582|450615693|FG003|Overall Study|Death|1|||
125269372|NCT01713582|450615694|FG004|Overall Study|Death|1|||
125269373|NCT01713582|450615695|FG005|Overall Study|Death|3|||
125269374|NCT01713582|450615696|FG006|Overall Study|Death|3|||
125269375|NCT01713582|450615697|FG007|Overall Study|Death|2|||
125269376|NCT01713582|450615698|FG008|Overall Study|Death|3|||
125269377|NCT01713582|450615699|FG009|Overall Study|Death|4|||
125269378|NCT01713582|450615700|FG010|Overall Study|Death|3|||
125269379|NCT01713582|450615701|FG011|Overall Study|Death|0|||
125269380|NCT01713582|450615702|FG012|Overall Study|Death|0|||
125269381|NCT01713582|450615703|FG013|Overall Study|Death|0|||
125269382|NCT01713582|450615704|FG014|Overall Study|Death|0|||
125269383|NCT01713582|450615705|FG015|Overall Study|Death|0|||
125269384|NCT01713582|450615706|FG016|Overall Study|Death|0|||
125269385|NCT01713582|450615707|FG017|Overall Study|Death|0|||
125269386|NCT01713582|450615708|FG018|Overall Study|Death|0|||
125269387|NCT01713582|450615709|FG019|Overall Study|Death|0|||
125269388|NCT01713582|450615710|FG020|Overall Study|Death|0|||
125269389|NCT01713582|450615690|FG000|Overall Study|Adverse event-related|0|||
125269390|NCT01713582|450615691|FG001|Overall Study|Adverse event-related|0|||
125269391|NCT01713582|450615692|FG002|Overall Study|Adverse event-related|0|||
125269392|NCT01713582|450615693|FG003|Overall Study|Adverse event-related|0|||
125269393|NCT01713582|450615694|FG004|Overall Study|Adverse event-related|0|||
125269394|NCT01713582|450615695|FG005|Overall Study|Adverse event-related|0|||
125269395|NCT01713582|450615696|FG006|Overall Study|Adverse event-related|0|||
125269396|NCT01713582|450615697|FG007|Overall Study|Adverse event-related|0|||
125269397|NCT01713582|450615698|FG008|Overall Study|Adverse event-related|0|||
125269398|NCT01713582|450615699|FG009|Overall Study|Adverse event-related|1|||
125269399|NCT01713582|450615700|FG010|Overall Study|Adverse event-related|1|||
125269400|NCT01713582|450615701|FG011|Overall Study|Adverse event-related|0|||
125269401|NCT01713582|450615702|FG012|Overall Study|Adverse event-related|0|||
125269402|NCT01713582|450615703|FG013|Overall Study|Adverse event-related|0|||
125269403|NCT01713582|450615704|FG014|Overall Study|Adverse event-related|0|||
125269404|NCT01713582|450615705|FG015|Overall Study|Adverse event-related|0|||
125269405|NCT01713582|450615706|FG016|Overall Study|Adverse event-related|0|||
125269406|NCT01713582|450615707|FG017|Overall Study|Adverse event-related|0|||
125269407|NCT01713582|450615708|FG018|Overall Study|Adverse event-related|1|||
125269408|NCT01713582|450615709|FG019|Overall Study|Adverse event-related|0|||
125269409|NCT01713582|450615710|FG020|Overall Study|Adverse event-related|0|||
125269410|NCT01713582|450615690|FG000|Overall Study|Adverse event-unrelated|0|||
125269411|NCT01713582|450615691|FG001|Overall Study|Adverse event-unrelated|0|||
125269412|NCT01713582|450615692|FG002|Overall Study|Adverse event-unrelated|0|||
125269413|NCT01713582|450615693|FG003|Overall Study|Adverse event-unrelated|0|||
125269414|NCT01713582|450615694|FG004|Overall Study|Adverse event-unrelated|0|||
125269415|NCT01713582|450615695|FG005|Overall Study|Adverse event-unrelated|1|||
125269416|NCT01713582|450615696|FG006|Overall Study|Adverse event-unrelated|1|||
125269417|NCT01713582|450615697|FG007|Overall Study|Adverse event-unrelated|1|||
125269418|NCT01713582|450615698|FG008|Overall Study|Adverse event-unrelated|0|||
125269419|NCT01713582|450615699|FG009|Overall Study|Adverse event-unrelated|0|||
125269420|NCT01713582|450615700|FG010|Overall Study|Adverse event-unrelated|0|||
125269421|NCT01713582|450615701|FG011|Overall Study|Adverse event-unrelated|0|||
125269422|NCT01713582|450615702|FG012|Overall Study|Adverse event-unrelated|0|||
125269423|NCT01713582|450615703|FG013|Overall Study|Adverse event-unrelated|1|||
125269424|NCT01713582|450615704|FG014|Overall Study|Adverse event-unrelated|1|||
125269425|NCT01713582|450615705|FG015|Overall Study|Adverse event-unrelated|0|||
125269426|NCT01713582|450615706|FG016|Overall Study|Adverse event-unrelated|0|||
125269427|NCT01713582|450615707|FG017|Overall Study|Adverse event-unrelated|0|||
125269428|NCT01713582|450615708|FG018|Overall Study|Adverse event-unrelated|0|||
125269429|NCT01713582|450615709|FG019|Overall Study|Adverse event-unrelated|0|||
125269430|NCT01713582|450615710|FG020|Overall Study|Adverse event-unrelated|0|||
125269431|NCT01713582|450615690|FG000|Overall Study|Withdrawal of consent|0|||
125269432|NCT01713582|450615691|FG001|Overall Study|Withdrawal of consent|0|||
125269433|NCT01713582|450615692|FG002|Overall Study|Withdrawal of consent|1|||
125269434|NCT01713582|450615693|FG003|Overall Study|Withdrawal of consent|0|||
125269435|NCT01713582|450615694|FG004|Overall Study|Withdrawal of consent|0|||
125269436|NCT01713582|450615695|FG005|Overall Study|Withdrawal of consent|1|||
125398970|NCT03466411|451093254|FG006|Overall Study|Randomized but not Treated|1|||
125398971|NCT03466411|451093255|FG007|Overall Study|Randomized but not Treated|0|||
125269437|NCT01713582|450615696|FG006|Overall Study|Withdrawal of consent|0|||
125269438|NCT01713582|450615697|FG007|Overall Study|Withdrawal of consent|0|||
125269439|NCT01713582|450615698|FG008|Overall Study|Withdrawal of consent|0|||
125269440|NCT01713582|450615699|FG009|Overall Study|Withdrawal of consent|1|||
125269441|NCT01713582|450615700|FG010|Overall Study|Withdrawal of consent|0|||
125269442|NCT01713582|450615701|FG011|Overall Study|Withdrawal of consent|0|||
125269443|NCT01713582|450615702|FG012|Overall Study|Withdrawal of consent|0|||
125269444|NCT01713582|450615703|FG013|Overall Study|Withdrawal of consent|0|||
125269445|NCT01713582|450615704|FG014|Overall Study|Withdrawal of consent|0|||
125269446|NCT01713582|450615705|FG015|Overall Study|Withdrawal of consent|0|||
125269447|NCT01713582|450615706|FG016|Overall Study|Withdrawal of consent|0|||
125269448|NCT01713582|450615707|FG017|Overall Study|Withdrawal of consent|0|||
125269449|NCT01713582|450615708|FG018|Overall Study|Withdrawal of consent|1|||
125269450|NCT01713582|450615709|FG019|Overall Study|Withdrawal of consent|0|||
125269451|NCT01713582|450615710|FG020|Overall Study|Withdrawal of consent|0|||
125269452|NCT01713582|450615690|FG000|Overall Study|Lack of Efficacy|0|||
125269453|NCT01713582|450615691|FG001|Overall Study|Lack of Efficacy|0|||
125269454|NCT01713582|450615692|FG002|Overall Study|Lack of Efficacy|0|||
125269455|NCT01713582|450615693|FG003|Overall Study|Lack of Efficacy|0|||
125269456|NCT01713582|450615694|FG004|Overall Study|Lack of Efficacy|0|||
125269457|NCT01713582|450615695|FG005|Overall Study|Lack of Efficacy|0|||
125269458|NCT01713582|450615696|FG006|Overall Study|Lack of Efficacy|0|||
125269459|NCT01713582|450615697|FG007|Overall Study|Lack of Efficacy|0|||
125269460|NCT01713582|450615698|FG008|Overall Study|Lack of Efficacy|0|||
125269461|NCT01713582|450615699|FG009|Overall Study|Lack of Efficacy|1|||
125269462|NCT01713582|450615700|FG010|Overall Study|Lack of Efficacy|2|||
125269463|NCT01713582|450615701|FG011|Overall Study|Lack of Efficacy|0|||
125269464|NCT01713582|450615702|FG012|Overall Study|Lack of Efficacy|0|||
125269465|NCT01713582|450615703|FG013|Overall Study|Lack of Efficacy|0|||
125269466|NCT01713582|450615704|FG014|Overall Study|Lack of Efficacy|0|||
125269467|NCT01713582|450615705|FG015|Overall Study|Lack of Efficacy|0|||
125269468|NCT01713582|450615706|FG016|Overall Study|Lack of Efficacy|0|||
125269469|NCT01713582|450615707|FG017|Overall Study|Lack of Efficacy|0|||
125269470|NCT01713582|450615708|FG018|Overall Study|Lack of Efficacy|0|||
125269471|NCT01713582|450615709|FG019|Overall Study|Lack of Efficacy|0|||
125269472|NCT01713582|450615710|FG020|Overall Study|Lack of Efficacy|0|||
125269473|NCT01713582|450615690|FG000|Overall Study|Withdrawal by Subject|0|||
125269474|NCT01713582|450615691|FG001|Overall Study|Withdrawal by Subject|0|||
125269475|NCT01713582|450615692|FG002|Overall Study|Withdrawal by Subject|0|||
125269476|NCT01713582|450615693|FG003|Overall Study|Withdrawal by Subject|0|||
125269477|NCT01713582|450615694|FG004|Overall Study|Withdrawal by Subject|0|||
125269478|NCT01713582|450615695|FG005|Overall Study|Withdrawal by Subject|0|||
125269479|NCT01713582|450615696|FG006|Overall Study|Withdrawal by Subject|0|||
125269480|NCT01713582|450615697|FG007|Overall Study|Withdrawal by Subject|0|||
125269481|NCT01713582|450615698|FG008|Overall Study|Withdrawal by Subject|0|||
125269482|NCT01713582|450615699|FG009|Overall Study|Withdrawal by Subject|0|||
125269483|NCT01713582|450615700|FG010|Overall Study|Withdrawal by Subject|0|||
125269484|NCT01713582|450615701|FG011|Overall Study|Withdrawal by Subject|0|||
125269485|NCT01713582|450615702|FG012|Overall Study|Withdrawal by Subject|0|||
125269486|NCT01713582|450615703|FG013|Overall Study|Withdrawal by Subject|0|||
125269487|NCT01713582|450615704|FG014|Overall Study|Withdrawal by Subject|0|||
125269488|NCT01713582|450615705|FG015|Overall Study|Withdrawal by Subject|0|||
125269489|NCT01713582|450615706|FG016|Overall Study|Withdrawal by Subject|0|||
125269490|NCT01713582|450615707|FG017|Overall Study|Withdrawal by Subject|1|||
125398972|NCT03466411|451093256|FG008|Overall Study|Randomized but not Treated|0|||
125398973|NCT03466411|451093257|FG009|Overall Study|Randomized but not Treated|0|||
125269491|NCT01713582|450615708|FG018|Overall Study|Withdrawal by Subject|0|||
125269492|NCT01713582|450615709|FG019|Overall Study|Withdrawal by Subject|0|||
125269493|NCT01713582|450615710|FG020|Overall Study|Withdrawal by Subject|0|||
125269494|NCT01713582|450615690|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
125269495|NCT01713582|450615691|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
125269496|NCT01713582|450615692|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
125269497|NCT01713582|450615693|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
125269498|NCT01713582|450615694|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
125269499|NCT01713582|450615695|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
125269500|NCT01713582|450615696|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
125269501|NCT01713582|450615697|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
125269502|NCT01713582|450615698|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
125269503|NCT01713582|450615699|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
125269504|NCT01713582|450615700|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
125269505|NCT01713582|450615701|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
125269506|NCT01713582|450615702|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
125269507|NCT01713582|450615703|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
125269508|NCT01713582|450615704|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
125269509|NCT01713582|450615705|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
125269510|NCT01713582|450615706|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
125398974|NCT03466411|451093258|FG010|Overall Study|Randomized but not Treated|0|||
125269511|NCT01713582|450615707|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
125269512|NCT01713582|450615708|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
125269513|NCT01713582|450615709|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
125269514|NCT01713582|450615710|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
125269515|NCT01713582|450615690|FG000|Overall Study|Disease progression and adverse event|0|||
125269516|NCT01713582|450615691|FG001|Overall Study|Disease progression and adverse event|0|||
125269517|NCT01713582|450615692|FG002|Overall Study|Disease progression and adverse event|0|||
125269518|NCT01713582|450615693|FG003|Overall Study|Disease progression and adverse event|0|||
125269519|NCT01713582|450615694|FG004|Overall Study|Disease progression and adverse event|0|||
125269520|NCT01713582|450615695|FG005|Overall Study|Disease progression and adverse event|0|||
125269521|NCT01713582|450615696|FG006|Overall Study|Disease progression and adverse event|0|||
125269522|NCT01713582|450615697|FG007|Overall Study|Disease progression and adverse event|0|||
125269523|NCT01713582|450615698|FG008|Overall Study|Disease progression and adverse event|0|||
125269524|NCT01713582|450615699|FG009|Overall Study|Disease progression and adverse event|0|||
125269525|NCT01713582|450615700|FG010|Overall Study|Disease progression and adverse event|0|||
125269526|NCT01713582|450615701|FG011|Overall Study|Disease progression and adverse event|0|||
125269527|NCT01713582|450615702|FG012|Overall Study|Disease progression and adverse event|0|||
125269528|NCT01713582|450615703|FG013|Overall Study|Disease progression and adverse event|0|||
125269529|NCT01713582|450615704|FG014|Overall Study|Disease progression and adverse event|0|||
125269530|NCT01713582|450615705|FG015|Overall Study|Disease progression and adverse event|0|||
125269531|NCT01713582|450615706|FG016|Overall Study|Disease progression and adverse event|1|||
125269532|NCT01713582|450615707|FG017|Overall Study|Disease progression and adverse event|0|||
125269533|NCT01713582|450615708|FG018|Overall Study|Disease progression and adverse event|0|||
125269534|NCT01713582|450615709|FG019|Overall Study|Disease progression and adverse event|0|||
125269535|NCT01713582|450615710|FG020|Overall Study|Disease progression and adverse event|0|||
125269536|NCT04551898|450615713|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
125269537|NCT04551898|450615714|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
125269538|NCT04551898|450615715|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
125269539|NCT04551898|450615716|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
125269540|NCT04551898|450615713|FG000|Overall Study|Withdrawal by Subject|5|||
125269541|NCT04551898|450615714|FG001|Overall Study|Withdrawal by Subject|1|||
125269542|NCT04551898|450615715|FG002|Overall Study|Withdrawal by Subject|2|||
125269543|NCT04551898|450615716|FG003|Overall Study|Withdrawal by Subject|2|||
125269544|NCT04551898|450615713|FG000|Overall Study|Lost to Follow-up|2|||
125269545|NCT04551898|450615714|FG001|Overall Study|Lost to Follow-up|1|||
125269546|NCT04551898|450615715|FG002|Overall Study|Lost to Follow-up|2|||
125269547|NCT04551898|450615716|FG003|Overall Study|Lost to Follow-up|2|||
125269548|NCT04551898|450615713|FG000|Overall Study|Death|1|||
125269549|NCT04551898|450615714|FG001|Overall Study|Death|0|||
125269550|NCT04551898|450615715|FG002|Overall Study|Death|0|||
125269551|NCT04551898|450615716|FG003|Overall Study|Death|0|||
125269552|NCT04551898|450615713|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
125269553|NCT04551898|450615714|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
125269554|NCT04551898|450615715|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
125269555|NCT04551898|450615716|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
125269556|NCT01898286|450615719|FG000|Overall Study|Withdrawal by Subject|1|||
125269557|NCT01898286|450615719|FG000|Overall Study|Protocol Violation|1|||
125269558|NCT01898286|450615719|FG000|Overall Study|Lost to Follow-up|1|||
125269559|NCT02257242|450615720|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
125269560|NCT02257242|450615721|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269561|NCT02257242|450615722|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269562|NCT02257242|450615723|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269563|NCT02257242|450615724|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269564|NCT02257242|450615725|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269565|NCT02257242|450615726|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269566|NCT02257242|450615727|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269567|NCT02257242|450615728|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
125269568|NCT01650831|450615734|FG000|Overall Study|Screen failure|1|||
125269569|NCT01048242|450615738|FG000|Overall Study|See study flow chart|4|||
125269570|NCT01048242|450615739|FG001|Overall Study|See study flow chart|2|||
125269571|NCT02964273|450615740|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
125269572|NCT02964273|450615741|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
125269573|NCT02964273|450615742|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
125269574|NCT02964273|450615743|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
125269575|NCT02964273|450615740|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
125269576|NCT02964273|450615741|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
125269577|NCT02964273|450615742|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
125269578|NCT02964273|450615743|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
125269579|NCT02964273|450615740|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
125269580|NCT02964273|450615741|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
125269581|NCT02964273|450615742|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
125269582|NCT02964273|450615743|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
125269583|NCT02964273|450615740|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
125269584|NCT02964273|450615741|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
125269585|NCT02964273|450615742|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
125269586|NCT02964273|450615743|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
125269587|NCT02964273|450615740|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
125269588|NCT02964273|450615741|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
125269589|NCT02964273|450615742|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
125269590|NCT02964273|450615743|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
125269591|NCT02964273|450615740|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
125269592|NCT02964273|450615741|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
125269593|NCT02964273|450615742|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
125269594|NCT02964273|450615743|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
125269595|NCT03333928|450615745|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
125269596|NCT03333928|450615746|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
125269597|NCT03333928|450615747|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
125269598|NCT03333928|450615745|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
125269599|NCT03333928|450615746|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
125269600|NCT03333928|450615747|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
125269601|NCT03333928|450615745|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
125269602|NCT03333928|450615746|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
125269603|NCT03333928|450615747|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
125269604|NCT03333928|450615745|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
125269605|NCT03333928|450615746|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
125269606|NCT03333928|450615747|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
125269607|NCT03333928|450615745|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
125269608|NCT03333928|450615746|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
125269609|NCT03333928|450615747|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
125269610|NCT03333928|450615745|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
125269611|NCT03333928|450615746|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
125269612|NCT03333928|450615747|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
125269613|NCT03333928|450615745|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
125269614|NCT03333928|450615746|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
125269615|NCT03333928|450615747|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
125269616|NCT03333928|450615745|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
125269617|NCT03333928|450615746|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
125269618|NCT03333928|450615747|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
125269619|NCT01453036|450615748|FG000|Overall Study|Lost to Follow-up|26|||
125269620|NCT01453036|450615749|FG001|Overall Study|Lost to Follow-up|115|||
125269621|NCT01453036|450615750|FG002|Overall Study|Lost to Follow-up|31|||
125398975|NCT03466411|451093259|FG011|Overall Study|Randomized but not Treated|0|||
125398976|NCT03466411|451093260|FG012|Overall Study|Randomized but not Treated|0|||
125398977|NCT03778931|451093261|FG000|Overall Study|Withdrawal by Subject|12|||
125398978|NCT03778931|451093262|FG001|Overall Study|Withdrawal by Subject|25|||
125398979|NCT03778931|451093261|FG000|Overall Study|Physician Decision|1|||
125398980|NCT03778931|451093262|FG001|Overall Study|Physician Decision|3|||
125398981|NCT03778931|451093261|FG000|Overall Study|Participant Noncompliance|1|||
125398982|NCT03778931|451093262|FG001|Overall Study|Participant Noncompliance|1|||
125398983|NCT03778931|451093261|FG000|Overall Study|Lost to Follow-up|4|||
125447568|NCT04833855|451264842|FG002|Overall Study|Protocol specified criteria|2|||
125447569|NCT04833855|451264843|FG003|Overall Study|Protocol specified criteria|1|||
125447570|NCT03682536|451264845|FG000|Randomization|Withdrawal by Subject|0|||
125447571|NCT03682536|451264846|FG001|Randomization|Withdrawal by Subject|2|||
125398984|NCT03778931|451093262|FG001|Overall Study|Lost to Follow-up|1|||
125398985|NCT03778931|451093261|FG000|Overall Study|Death|69|||
125398986|NCT03778931|451093262|FG001|Overall Study|Death|79|||
125398987|NCT00006184|451093263|FG000|Overall Study|Death|1|||
125398988|NCT00006184|451093264|FG001|Overall Study|Death|0|||
125398989|NCT02161718|451093269|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
125447572|NCT03682536|451264845|FG000|Treatment|Other Reasons|8|||
125398990|NCT02161718|451093270|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
125398991|NCT02161718|451093271|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
125269622|NCT00559104|450615751|FG000|Overall Study|Lack of Efficacy|9|||
125269623|NCT00559104|450615752|FG001|Overall Study|Lack of Efficacy|0|||
125269624|NCT01336712|450615753|FG000|Overall Study|Death|2|||
125269625|NCT01336712|450615753|FG000|Overall Study|Lack of Efficacy|1|||
125269626|NCT00620373|450615755|FG000|Overall Study|Unverified cancer status|33|||
125269627|NCT00399568|450615756|FG000|Overall Study|Adverse Event|1|||
125269628|NCT00399568|450615757|FG001|Overall Study|Adverse Event|2|||
125269629|NCT00399568|450615756|FG000|Overall Study|Withdrawal by Subject|7|||
125269630|NCT00399568|450615757|FG001|Overall Study|Withdrawal by Subject|3|||
125269631|NCT00399568|450615756|FG000|Overall Study|Protocol non-compliance|2|||
125269632|NCT00399568|450615757|FG001|Overall Study|Protocol non-compliance|2|||
125269633|NCT00399568|450615756|FG000|Overall Study|Lost to Follow-up|2|||
125269634|NCT00399568|450615757|FG001|Overall Study|Lost to Follow-up|2|||
125269635|NCT03073525|450615758|FG000|Overall Study|Withdrawal by Subject|0|||
125269636|NCT03073525|450615759|FG001|Overall Study|Withdrawal by Subject|0|||
125269637|NCT03073525|450615760|FG002|Overall Study|Withdrawal by Subject|3|||
125269638|NCT03692403|450615761|FG000|Overall Study|Withdrawal by Subject|1|||
125269639|NCT03692403|450615762|FG001|Overall Study|Withdrawal by Subject|0|||
125269640|NCT03692403|450615763|FG002|Overall Study|Withdrawal by Subject|1|||
125269641|NCT03692403|450615764|FG003|Overall Study|Withdrawal by Subject|0|||
125269642|NCT03692403|450615761|FG000|Overall Study|Adverse Event|0|||
125269643|NCT03692403|450615762|FG001|Overall Study|Adverse Event|0|||
125269644|NCT03692403|450615763|FG002|Overall Study|Adverse Event|0|||
125269645|NCT03692403|450615764|FG003|Overall Study|Adverse Event|1|||
125269646|NCT03692403|450615761|FG000|Overall Study|Pregnancy|0|||
125269647|NCT03692403|450615762|FG001|Overall Study|Pregnancy|1|||
125269648|NCT03692403|450615763|FG002|Overall Study|Pregnancy|0|||
125269649|NCT03692403|450615764|FG003|Overall Study|Pregnancy|0|||
125269650|NCT03692403|450615761|FG000|Overall Study|Other|0|||
125269651|NCT03692403|450615762|FG001|Overall Study|Other|0|||
125269652|NCT03692403|450615763|FG002|Overall Study|Other|1|||
125269653|NCT03692403|450615764|FG003|Overall Study|Other|0|||
125269654|NCT02776683|450615765|FG000|Pre-switch Period|Protocol Violation|1|||
125269655|NCT02776683|450615766|FG001|Pre-switch Period|Protocol Violation|0|||
125269656|NCT02776683|450615765|FG000|Pre-switch Period|Adverse Event|21|||
125269657|NCT02776683|450615766|FG001|Pre-switch Period|Adverse Event|0|||
125269658|NCT02776683|450615765|FG000|Pre-switch Period|Withdrawal by Subject|9|||
125269659|NCT02776683|450615766|FG001|Pre-switch Period|Withdrawal by Subject|0|||
125269660|NCT02776683|450615765|FG000|Pre-switch Period|Physician Decision|7|||
125269661|NCT02776683|450615766|FG001|Pre-switch Period|Physician Decision|0|||
125269662|NCT02776683|450615765|FG000|Pre-switch Period|Progressive disease|39|||
125269663|NCT02776683|450615766|FG001|Pre-switch Period|Progressive disease|0|||
125269664|NCT02776683|450615765|FG000|Pre-switch Period|Other than listed|3|||
125269665|NCT02776683|450615766|FG001|Pre-switch Period|Other than listed|0|||
125269666|NCT02776683|450615765|FG000|Post-switch Period|Adverse Event|0|||
125269667|NCT02776683|450615766|FG001|Post-switch Period|Adverse Event|3|||
125269668|NCT02776683|450615765|FG000|Post-switch Period|Withdrawal by Subject|0|||
125269669|NCT02776683|450615766|FG001|Post-switch Period|Withdrawal by Subject|2|||
125269670|NCT02776683|450615765|FG000|Post-switch Period|Physician Decision|0|||
125269671|NCT02776683|450615766|FG001|Post-switch Period|Physician Decision|3|||
125269672|NCT02776683|450615765|FG000|Post-switch Period|Progressive disease|0|||
125269673|NCT02776683|450615766|FG001|Post-switch Period|Progressive disease|20|||
125269674|NCT02776683|450615765|FG000|Post-switch Period|Other than listed|0|||
125269675|NCT02776683|450615766|FG001|Post-switch Period|Other than listed|15|||
125269676|NCT01891396|450615769|FG000|Overall Study|Withdrawal by Subject|4|||
125269677|NCT01891396|450615770|FG001|Overall Study|Withdrawal by Subject|4|||
125269678|NCT01891396|450615771|FG002|Overall Study|Withdrawal by Subject|3|||
125269679|NCT01891396|450615769|FG000|Overall Study|Lost to Follow-up|0|||
125269680|NCT01891396|450615770|FG001|Overall Study|Lost to Follow-up|1|||
125269681|NCT01891396|450615771|FG002|Overall Study|Lost to Follow-up|0|||
125269682|NCT00400517|450615773|FG000|Overall Study|Withdrawal by Subject|1|||
125269683|NCT00400517|450615773|FG000|Overall Study|Physician Decision|1|||
125269684|NCT01881789|450615775|FG000|Overall Study|Withdrawal by Subject|0|||
125269685|NCT01881789|450615776|FG001|Overall Study|Withdrawal by Subject|2|||
125269686|NCT01881789|450615777|FG002|Overall Study|Withdrawal by Subject|1|||
125269687|NCT01881789|450615778|FG003|Overall Study|Withdrawal by Subject|0|||
125269688|NCT01881789|450615779|FG004|Overall Study|Withdrawal by Subject|1|||
125269689|NCT01881789|450615780|FG005|Overall Study|Withdrawal by Subject|1|||
125269690|NCT01881789|450615775|FG000|Overall Study|Study Terminated by Sponsor|0|||
125269691|NCT01881789|450615776|FG001|Overall Study|Study Terminated by Sponsor|0|||
125269692|NCT01881789|450615777|FG002|Overall Study|Study Terminated by Sponsor|0|||
125269693|NCT01881789|450615778|FG003|Overall Study|Study Terminated by Sponsor|0|||
125269694|NCT01881789|450615779|FG004|Overall Study|Study Terminated by Sponsor|0|||
125269695|NCT01881789|450615780|FG005|Overall Study|Study Terminated by Sponsor|1|||
125269696|NCT01881789|450615775|FG000|Overall Study|Other|3|||
125269697|NCT01881789|450615776|FG001|Overall Study|Other|5|||
125269698|NCT01881789|450615777|FG002|Overall Study|Other|2|||
125269699|NCT01881789|450615778|FG003|Overall Study|Other|3|||
125269700|NCT01881789|450615779|FG004|Overall Study|Other|1|||
125447573|NCT03682536|451264846|FG001|Treatment|Other Reasons|7|||
125447574|NCT03682536|451264845|FG000|Treatment|Physician Decision|5|||
125447575|NCT03682536|451264846|FG001|Treatment|Physician Decision|5|||
125447576|NCT03682536|451264845|FG000|Treatment|Protocol Violation|1|||
125447577|NCT03682536|451264846|FG001|Treatment|Protocol Violation|0|||
125447578|NCT03682536|451264845|FG000|Treatment|Study Terminated by Sponsor|1|||
125447579|NCT03682536|451264846|FG001|Treatment|Study Terminated by Sponsor|2|||
125447580|NCT03682536|451264845|FG000|Treatment|Lost to Follow-up|0|||
125447581|NCT03682536|451264846|FG001|Treatment|Lost to Follow-up|1|||
125447582|NCT03682536|451264845|FG000|Treatment|Withdrawal by Subject|16|||
125447583|NCT03682536|451264846|FG001|Treatment|Withdrawal by Subject|18|||
125447584|NCT03682536|451264845|FG000|Treatment|Lack of Efficacy|41|||
125447585|NCT03682536|451264846|FG001|Treatment|Lack of Efficacy|68|||
125447586|NCT03682536|451264845|FG000|Treatment|Disease Progression|9|||
125447587|NCT03682536|451264846|FG001|Treatment|Disease Progression|7|||
125447588|NCT03682536|451264845|FG000|Treatment|Adverse Event|9|||
125447589|NCT03682536|451264846|FG001|Treatment|Adverse Event|5|||
125447590|NCT03682536|451264845|FG000|Treatment|Death|14|||
125447591|NCT03682536|451264846|FG001|Treatment|Death|13|||
125447592|NCT03008122|451264847|FG000|Overall Study|Physician Decision|3|||
125447593|NCT03008122|451264848|FG001|Overall Study|Physician Decision|2|||
125447594|NCT03008122|451264849|FG002|Overall Study|Physician Decision|0|||
125447595|NCT03008122|451264847|FG000|Overall Study|Withdrawal by Subject|1|||
125447596|NCT03008122|451264848|FG001|Overall Study|Withdrawal by Subject|3|||
125447597|NCT03008122|451264849|FG002|Overall Study|Withdrawal by Subject|0|||
125447598|NCT03008122|451264847|FG000|Overall Study|Lost to Follow-up|4|||
125447599|NCT03008122|451264848|FG001|Overall Study|Lost to Follow-up|8|||
125447600|NCT03008122|451264849|FG002|Overall Study|Lost to Follow-up|3|||
125447601|NCT03008122|451264847|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
125447602|NCT03008122|451264848|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
125447603|NCT03008122|451264849|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
125447604|NCT03008122|451264847|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
125447605|NCT03008122|451264848|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
125447606|NCT03008122|451264849|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
125447607|NCT03008122|451264847|FG000|Overall Study|Death|0|||
125447608|NCT03008122|451264848|FG001|Overall Study|Death|0|||
125447609|NCT03008122|451264849|FG002|Overall Study|Death|1|||
125447610|NCT04529538|451264851|FG000|Overall Study|Lost to Follow-up|3|||
125447611|NCT04529538|451264852|FG001|Overall Study|Lost to Follow-up|2|||
125447612|NCT04529538|451264853|FG002|Overall Study|Lost to Follow-up|1|||
125447613|NCT04529538|451264854|FG003|Overall Study|Lost to Follow-up|0|||
125447614|NCT04529538|451264855|FG004|Overall Study|Lost to Follow-up|1|||
125447615|NCT04529538|451264856|FG005|Overall Study|Lost to Follow-up|1|||
125447616|NCT04529538|451264857|FG006|Overall Study|Lost to Follow-up|2|||
125447617|NCT04529538|451264858|FG007|Overall Study|Lost to Follow-up|0|||
125447618|NCT04529538|451264851|FG000|Overall Study|Not eligible at enrollment|0|||
125447619|NCT04529538|451264852|FG001|Overall Study|Not eligible at enrollment|1|||
125447620|NCT04529538|451264853|FG002|Overall Study|Not eligible at enrollment|2|||
125447621|NCT04529538|451264854|FG003|Overall Study|Not eligible at enrollment|1|||
125447622|NCT04529538|451264855|FG004|Overall Study|Not eligible at enrollment|0|||
125447623|NCT04529538|451264856|FG005|Overall Study|Not eligible at enrollment|0|||
125447624|NCT04529538|451264857|FG006|Overall Study|Not eligible at enrollment|0|||
125447625|NCT04529538|451264858|FG007|Overall Study|Not eligible at enrollment|1|||
125269701|NCT01881789|450615780|FG005|Overall Study|Other|1|||
125269702|NCT01964378|450615784|FG000|Overall Study|Disc. due to death before first dosing|0|||
125269703|NCT01964378|450615785|FG001|Overall Study|Disc. due to death before first dosing|1|||
125269704|NCT01964378|450615784|FG000|Overall Study|Disc. due to AE before first dosing|1|||
125269705|NCT01964378|450615785|FG001|Overall Study|Disc. due to AE before first dosing|0|||
125269706|NCT01964378|450615784|FG000|Overall Study|Death|3|||
125269707|NCT01964378|450615785|FG001|Overall Study|Death|2|||
125269708|NCT01964378|450615784|FG000|Overall Study|Adverse Event|12|||
125269709|NCT01964378|450615785|FG001|Overall Study|Adverse Event|5|||
125269710|NCT01964378|450615784|FG000|Overall Study|Lack of Efficacy|0|||
125269711|NCT01964378|450615785|FG001|Overall Study|Lack of Efficacy|1|||
125447626|NCT04529538|451264851|FG000|Overall Study|Withdrawal by Subject|0|||
125447627|NCT04529538|451264852|FG001|Overall Study|Withdrawal by Subject|1|||
125447628|NCT04529538|451264853|FG002|Overall Study|Withdrawal by Subject|1|||
125447629|NCT04529538|451264854|FG003|Overall Study|Withdrawal by Subject|2|||
125269712|NCT01964378|450615784|FG000|Overall Study|Protocol Violation|0|||
125269713|NCT01964378|450615785|FG001|Overall Study|Protocol Violation|1|||
125447630|NCT04529538|451264855|FG004|Overall Study|Withdrawal by Subject|0|||
125447631|NCT04529538|451264856|FG005|Overall Study|Withdrawal by Subject|2|||
125447632|NCT04529538|451264857|FG006|Overall Study|Withdrawal by Subject|3|||
125447633|NCT04529538|451264858|FG007|Overall Study|Withdrawal by Subject|0|||
125269714|NCT01964378|450615784|FG000|Overall Study|Lost to Follow-up|0|||
125269715|NCT01964378|450615785|FG001|Overall Study|Lost to Follow-up|1|||
125269716|NCT01964378|450615784|FG000|Overall Study|Withdrawal by Subject|7|||
125447634|NCT04529538|451264851|FG000|Overall Study|Other|0|||
125447635|NCT04529538|451264852|FG001|Overall Study|Other|1|||
125447636|NCT04529538|451264853|FG002|Overall Study|Other|0|||
125447637|NCT04529538|451264854|FG003|Overall Study|Other|0|||
125447638|NCT04529538|451264855|FG004|Overall Study|Other|0|||
125447639|NCT04529538|451264856|FG005|Overall Study|Other|0|||
125447640|NCT04529538|451264857|FG006|Overall Study|Other|0|||
125269717|NCT01964378|450615785|FG001|Overall Study|Withdrawal by Subject|5|||
125269718|NCT01964378|450615784|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
125269719|NCT01964378|450615785|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
125269720|NCT01964378|450615784|FG000|Overall Study|Other|1|||
125269721|NCT01964378|450615785|FG001|Overall Study|Other|2|||
125269722|NCT03542266|450615786|FG000|Treatment Phase|Withdrawal by Subject|1|||
125269723|NCT03542266|450615786|FG000|Treatment Phase|Adverse Event|1|||
125269724|NCT03542266|450615786|FG000|Treatment Phase|PD|1|||
125269725|NCT01162473|450615791|FG000|Overall Study|Adverse Event|2|||
125269726|NCT01162473|450615792|FG001|Overall Study|Adverse Event|1|||
125269727|NCT01162473|450615791|FG000|Overall Study|Withdrawal by Subject|0|||
125269728|NCT01162473|450615792|FG001|Overall Study|Withdrawal by Subject|4|||
125269729|NCT01392573|450615801|FG000|Overall Study|Adverse Event|1|||
125269730|NCT01392573|450615802|FG001|Overall Study|Adverse Event|3|||
125269731|NCT01392573|450615801|FG000|Overall Study|Lack of Efficacy|1|||
125269732|NCT01392573|450615802|FG001|Overall Study|Lack of Efficacy|2|||
125269733|NCT01392573|450615801|FG000|Overall Study|Protocol Violation|0|||
125269734|NCT01392573|450615802|FG001|Overall Study|Protocol Violation|2|||
125269735|NCT01392573|450615801|FG000|Overall Study|Withdrawal Criteria|13|||
125269736|NCT01392573|450615802|FG001|Overall Study|Withdrawal Criteria|15|||
125269737|NCT01392573|450615801|FG000|Overall Study|Site closure|8|||
125269738|NCT01392573|450615802|FG001|Overall Study|Site closure|7|||
125269739|NCT01392573|450615801|FG000|Overall Study|Unclassified|9|||
125269740|NCT01392573|450615802|FG001|Overall Study|Unclassified|6|||
125269741|NCT03008070|450615803|FG000|Overall Study|Adverse Event|3|||
125269742|NCT03008070|450615804|FG001|Overall Study|Adverse Event|3|||
125269743|NCT03008070|450615805|FG002|Overall Study|Adverse Event|3|||
125269744|NCT03008070|450615803|FG000|Overall Study|Lost to Follow-up|1|||
125269745|NCT03008070|450615804|FG001|Overall Study|Lost to Follow-up|1|||
125269746|NCT03008070|450615805|FG002|Overall Study|Lost to Follow-up|0|||
125269747|NCT03008070|450615803|FG000|Overall Study|Non compliance|0|||
125269748|NCT03008070|450615804|FG001|Overall Study|Non compliance|1|||
125269749|NCT03008070|450615805|FG002|Overall Study|Non compliance|1|||
125269750|NCT03008070|450615803|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
125269751|NCT03008070|450615804|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
125269752|NCT03008070|450615805|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
125269753|NCT03008070|450615803|FG000|Overall Study|Withdrawal by Subject|2|||
125269754|NCT03008070|450615804|FG001|Overall Study|Withdrawal by Subject|0|||
125269755|NCT03008070|450615805|FG002|Overall Study|Withdrawal by Subject|1|||
125269756|NCT03008070|450615803|FG000|Overall Study|Use of prohibited drug|0|||
125269757|NCT03008070|450615804|FG001|Overall Study|Use of prohibited drug|0|||
125269758|NCT03008070|450615805|FG002|Overall Study|Use of prohibited drug|2|||
125269759|NCT04409834|450615808|FG000|Overall Study|Death|55|||
125269760|NCT04409834|450615809|FG001|Overall Study|Death|62|||
125269761|NCT01365455|450615810|FG000|Induction Period|Adverse Event|5|||
125269762|NCT01365455|450615811|FG001|Induction Period|Adverse Event|3|||
125269763|NCT01365455|450615812|FG002|Induction Period|Adverse Event|4|||
125269764|NCT01365455|450615813|FG003|Induction Period|Adverse Event|0|||
125269765|NCT01365455|450615814|FG004|Induction Period|Adverse Event|0|||
125269766|NCT01365455|450615810|FG000|Induction Period|Lack of Efficacy|1|||
125269767|NCT01365455|450615811|FG001|Induction Period|Lack of Efficacy|1|||
125398992|NCT02161718|451093269|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
125398993|NCT02161718|451093270|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
125398994|NCT02161718|451093271|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
125398995|NCT02161718|451093269|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
125398996|NCT02161718|451093270|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
125398997|NCT02161718|451093271|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
125398998|NCT02161718|451093269|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
125398999|NCT02161718|451093270|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
125447641|NCT04529538|451264858|FG007|Overall Study|Other|0|||
125447642|NCT04529538|451264851|FG000|Overall Study|Adverse Event|0|||
125447643|NCT04529538|451264852|FG001|Overall Study|Adverse Event|0|||
125269768|NCT01365455|450615812|FG002|Induction Period|Lack of Efficacy|0|||
125269769|NCT01365455|450615813|FG003|Induction Period|Lack of Efficacy|0|||
125269770|NCT01365455|450615814|FG004|Induction Period|Lack of Efficacy|0|||
125269771|NCT01365455|450615810|FG000|Induction Period|Pregnancy|0|||
125269772|NCT01365455|450615811|FG001|Induction Period|Pregnancy|1|||
125269773|NCT01365455|450615812|FG002|Induction Period|Pregnancy|0|||
125269774|NCT01365455|450615813|FG003|Induction Period|Pregnancy|0|||
125269775|NCT01365455|450615814|FG004|Induction Period|Pregnancy|0|||
125447644|NCT04529538|451264853|FG002|Overall Study|Adverse Event|0|||
125269776|NCT01365455|450615810|FG000|Induction Period|Protocol deviation|0|||
125269777|NCT01365455|450615811|FG001|Induction Period|Protocol deviation|1|||
125269778|NCT01365455|450615812|FG002|Induction Period|Protocol deviation|1|||
125269779|NCT01365455|450615813|FG003|Induction Period|Protocol deviation|0|||
125269780|NCT01365455|450615814|FG004|Induction Period|Protocol deviation|0|||
125269781|NCT01365455|450615810|FG000|Induction Period|Subject/guardian decision|9|||
125269782|NCT01365455|450615811|FG001|Induction Period|Subject/guardian decision|1|||
125269783|NCT01365455|450615812|FG002|Induction Period|Subject/guardian decision|8|||
125269784|NCT01365455|450615813|FG003|Induction Period|Subject/guardian decision|0|||
125269785|NCT01365455|450615814|FG004|Induction Period|Subject/guardian decision|0|||
125269786|NCT01365455|450615810|FG000|Induction Period|Lost to Follow-up|0|||
125269787|NCT01365455|450615811|FG001|Induction Period|Lost to Follow-up|0|||
125269788|NCT01365455|450615812|FG002|Induction Period|Lost to Follow-up|3|||
125269789|NCT01365455|450615813|FG003|Induction Period|Lost to Follow-up|0|||
125269790|NCT01365455|450615814|FG004|Induction Period|Lost to Follow-up|0|||
125269791|NCT01365455|450615810|FG000|Maintenance Period|Adverse Event|12|||
125269792|NCT01365455|450615811|FG001|Maintenance Period|Adverse Event|5|||
125269793|NCT01365455|450615812|FG002|Maintenance Period|Adverse Event|1|||
125269794|NCT01365455|450615813|FG003|Maintenance Period|Adverse Event|2|||
125269795|NCT01365455|450615814|FG004|Maintenance Period|Adverse Event|4|||
125269796|NCT01365455|450615810|FG000|Maintenance Period|Lack of Efficacy|10|||
125269797|NCT01365455|450615811|FG001|Maintenance Period|Lack of Efficacy|2|||
125269798|NCT01365455|450615812|FG002|Maintenance Period|Lack of Efficacy|0|||
125269799|NCT01365455|450615813|FG003|Maintenance Period|Lack of Efficacy|2|||
125269800|NCT01365455|450615814|FG004|Maintenance Period|Lack of Efficacy|2|||
125269801|NCT01365455|450615810|FG000|Maintenance Period|Lost to Follow-up|2|||
125269802|NCT01365455|450615811|FG001|Maintenance Period|Lost to Follow-up|4|||
125269803|NCT01365455|450615812|FG002|Maintenance Period|Lost to Follow-up|0|||
125269804|NCT01365455|450615813|FG003|Maintenance Period|Lost to Follow-up|0|||
125269805|NCT01365455|450615814|FG004|Maintenance Period|Lost to Follow-up|3|||
125269806|NCT01365455|450615810|FG000|Maintenance Period|Non-compliance with study treatment|0|||
125269807|NCT01365455|450615811|FG001|Maintenance Period|Non-compliance with study treatment|0|||
125269808|NCT01365455|450615812|FG002|Maintenance Period|Non-compliance with study treatment|0|||
125269809|NCT01365455|450615813|FG003|Maintenance Period|Non-compliance with study treatment|1|||
125269810|NCT01365455|450615814|FG004|Maintenance Period|Non-compliance with study treatment|0|||
125269811|NCT01365455|450615810|FG000|Maintenance Period|Physician Decision|0|||
125269812|NCT01365455|450615811|FG001|Maintenance Period|Physician Decision|1|||
125269813|NCT01365455|450615812|FG002|Maintenance Period|Physician Decision|0|||
125269814|NCT01365455|450615813|FG003|Maintenance Period|Physician Decision|0|||
125269815|NCT01365455|450615814|FG004|Maintenance Period|Physician Decision|1|||
125269816|NCT01365455|450615810|FG000|Maintenance Period|Pregnancy|0|||
125269817|NCT01365455|450615811|FG001|Maintenance Period|Pregnancy|4|||
125269818|NCT01365455|450615812|FG002|Maintenance Period|Pregnancy|0|||
125269819|NCT01365455|450615813|FG003|Maintenance Period|Pregnancy|0|||
125269820|NCT01365455|450615814|FG004|Maintenance Period|Pregnancy|2|||
125269821|NCT01365455|450615810|FG000|Maintenance Period|Protocol deviation|1|||
125269822|NCT01365455|450615811|FG001|Maintenance Period|Protocol deviation|1|||
125269823|NCT01365455|450615812|FG002|Maintenance Period|Protocol deviation|0|||
125269824|NCT01365455|450615813|FG003|Maintenance Period|Protocol deviation|0|||
125269825|NCT01365455|450615814|FG004|Maintenance Period|Protocol deviation|0|||
125269826|NCT01365455|450615810|FG000|Maintenance Period|Subject/guardian decision|4|||
125269827|NCT01365455|450615811|FG001|Maintenance Period|Subject/guardian decision|6|||
125269828|NCT01365455|450615812|FG002|Maintenance Period|Subject/guardian decision|2|||
125269829|NCT01365455|450615813|FG003|Maintenance Period|Subject/guardian decision|4|||
125269830|NCT01365455|450615814|FG004|Maintenance Period|Subject/guardian decision|1|||
125269831|NCT00928187|450615815|FG000|Overall Study|Death|1|||
125269832|NCT00928187|450615816|FG001|Overall Study|Death|2|||
125269833|NCT00928187|450615817|FG002|Overall Study|Death|3|||
125269834|NCT00928187|450615815|FG000|Overall Study|Lost to Follow-up|1|||
125269835|NCT00928187|450615816|FG001|Overall Study|Lost to Follow-up|2|||
125269836|NCT00928187|450615817|FG002|Overall Study|Lost to Follow-up|1|||
125269837|NCT00928187|450615815|FG000|Overall Study|Withdrawal by Subject|0|||
125269838|NCT00928187|450615816|FG001|Overall Study|Withdrawal by Subject|1|||
125269839|NCT00928187|450615817|FG002|Overall Study|Withdrawal by Subject|1|||
125269840|NCT00928187|450615815|FG000|Overall Study|Protocol Violation|0|||
125269841|NCT00928187|450615816|FG001|Overall Study|Protocol Violation|1|||
125269842|NCT00928187|450615817|FG002|Overall Study|Protocol Violation|0|||
125269843|NCT01273038|450617412|FG000|Second Intervention (14 Days)|Adverse Event|0|||
125269844|NCT01273038|450617413|FG001|Second Intervention (14 Days)|Adverse Event|1|||
125269845|NCT01273038|450617412|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
125269846|NCT01273038|450617413|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
125269847|NCT01976299|450617414|FG000|Overall Study|Withdrawal by Subject|3|||
125269848|NCT01976299|450617415|FG001|Overall Study|Withdrawal by Subject|1|||
125269849|NCT01976299|450617414|FG000|Overall Study|Death|4|||
125399000|NCT02161718|451093271|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
125269850|NCT01976299|450617415|FG001|Overall Study|Death|2|||
125269851|NCT01976299|450617414|FG000|Overall Study|Lost to Follow-up|7|||
125269852|NCT01976299|450617415|FG001|Overall Study|Lost to Follow-up|1|||
125269853|NCT01976299|450617414|FG000|Overall Study|See clarification above in comments|9|||
125269854|NCT01976299|450617415|FG001|Overall Study|See clarification above in comments|2|||
125269855|NCT00540592|450617418|FG000|Overall Study|Adverse Event|0|||
125269856|NCT00540592|450617419|FG001|Overall Study|Adverse Event|1|||
125269857|NCT00540592|450617420|FG002|Overall Study|Adverse Event|0|||
125269858|NCT00540592|450617421|FG003|Overall Study|Adverse Event|0|||
125269859|NCT00540592|450617422|FG004|Overall Study|Adverse Event|1|||
125269860|NCT00540592|450617423|FG005|Overall Study|Adverse Event|0|||
125269861|NCT00540592|450617424|FG006|Overall Study|Adverse Event|0|||
125269862|NCT00540592|450617425|FG007|Overall Study|Adverse Event|1|||
125269863|NCT00540592|450617426|FG008|Overall Study|Adverse Event|1|||
125269864|NCT00540592|450617427|FG009|Overall Study|Adverse Event|2|||
125269865|NCT00540592|450617418|FG000|Overall Study|Lost to Follow-up|2|||
125269866|NCT00540592|450617419|FG001|Overall Study|Lost to Follow-up|0|||
125269867|NCT00540592|450617420|FG002|Overall Study|Lost to Follow-up|0|||
125269868|NCT00540592|450617421|FG003|Overall Study|Lost to Follow-up|0|||
125269869|NCT00540592|450617422|FG004|Overall Study|Lost to Follow-up|0|||
125269870|NCT00540592|450617423|FG005|Overall Study|Lost to Follow-up|0|||
125269871|NCT00540592|450617424|FG006|Overall Study|Lost to Follow-up|0|||
125269872|NCT00540592|450617425|FG007|Overall Study|Lost to Follow-up|0|||
125269873|NCT00540592|450617426|FG008|Overall Study|Lost to Follow-up|0|||
125269874|NCT00540592|450617427|FG009|Overall Study|Lost to Follow-up|0|||
125269875|NCT00540592|450617418|FG000|Overall Study|Withdrawal by Subject|0|||
125269876|NCT00540592|450617419|FG001|Overall Study|Withdrawal by Subject|0|||
125269877|NCT00540592|450617420|FG002|Overall Study|Withdrawal by Subject|1|||
125269878|NCT00540592|450617421|FG003|Overall Study|Withdrawal by Subject|1|||
125269879|NCT00540592|450617422|FG004|Overall Study|Withdrawal by Subject|0|||
125269880|NCT00540592|450617423|FG005|Overall Study|Withdrawal by Subject|0|||
125269881|NCT00540592|450617424|FG006|Overall Study|Withdrawal by Subject|0|||
125269882|NCT00540592|450617425|FG007|Overall Study|Withdrawal by Subject|0|||
125269883|NCT00540592|450617426|FG008|Overall Study|Withdrawal by Subject|0|||
125269884|NCT00540592|450617427|FG009|Overall Study|Withdrawal by Subject|0|||
125269885|NCT01456130|450617428|FG000|Overall Study|Adverse Event|4|||
125269886|NCT01456130|450617428|FG000|Overall Study|Voluntary Withdrawal|1|||
125269887|NCT01456130|450617428|FG000|Overall Study|Lack of Efficacy|4|||
125269888|NCT01456130|450617428|FG000|Overall Study|Other|1|||
125269889|NCT02688192|450617433|FG000|Overall Study|Lost to Follow-up|11|||
125269890|NCT02688192|450617434|FG001|Overall Study|Lost to Follow-up|5|||
125269891|NCT02688192|450617433|FG000|Overall Study|Physician Decision|1|||
125269892|NCT02688192|450617434|FG001|Overall Study|Physician Decision|0|||
125269893|NCT05384834|450617435|FG000|Overall Study|Lost to Follow-up|43|||
125269894|NCT05384834|450617435|FG000|Overall Study|Withdrawal by Subject|5|||
125269895|NCT01282866|450617439|FG000|Overall Study|Adverse Event|1|||
125269896|NCT01299389|450617440|FG000|Double-blind|Adverse Event|45|||
125269897|NCT01299389|450617441|FG001|Double-blind|Adverse Event|27|||
125269898|NCT01299389|450617442|FG002|Double-blind|Adverse Event|0|||
125269899|NCT01299389|450617443|FG003|Double-blind|Adverse Event|0|||
125269900|NCT01299389|450617440|FG000|Double-blind|Lack of Efficacy|45|||
125269901|NCT01299389|450617441|FG001|Double-blind|Lack of Efficacy|21|||
125269902|NCT01299389|450617442|FG002|Double-blind|Lack of Efficacy|0|||
125269903|NCT01299389|450617443|FG003|Double-blind|Lack of Efficacy|0|||
125269904|NCT01299389|450617440|FG000|Double-blind|Lost to Follow-up|2|||
125269905|NCT01299389|450617441|FG001|Double-blind|Lost to Follow-up|1|||
125269906|NCT01299389|450617442|FG002|Double-blind|Lost to Follow-up|0|||
125269907|NCT01299389|450617443|FG003|Double-blind|Lost to Follow-up|0|||
125269908|NCT01299389|450617440|FG000|Double-blind|Withdrawal by Subject|16|||
125269909|NCT01299389|450617441|FG001|Double-blind|Withdrawal by Subject|13|||
125269910|NCT01299389|450617442|FG002|Double-blind|Withdrawal by Subject|0|||
125269911|NCT01299389|450617443|FG003|Double-blind|Withdrawal by Subject|0|||
125269912|NCT01299389|450617440|FG000|Double-blind|Other|1|||
125269913|NCT01299389|450617441|FG001|Double-blind|Other|1|||
125269914|NCT01299389|450617442|FG002|Double-blind|Other|0|||
125269915|NCT01299389|450617443|FG003|Double-blind|Other|0|||
125399001|NCT02161718|451093269|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
125399002|NCT02161718|451093270|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
125399003|NCT02161718|451093271|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
125399004|NCT02161718|451093269|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
125269916|NCT01299389|450617440|FG000|Double-blind|"fail to meet study population criteria"|0|||
125269917|NCT01299389|450617441|FG001|Double-blind|"fail to meet study population criteria"|1|||
125269918|NCT01299389|450617442|FG002|Double-blind|"fail to meet study population criteria"|0|||
125269919|NCT01299389|450617443|FG003|Double-blind|"fail to meet study population criteria"|0|||
125399005|NCT02161718|451093270|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
125269920|NCT01299389|450617440|FG000|Post-observational|Other|0|||
125269921|NCT01299389|450617441|FG001|Post-observational|Other|0|||
125269922|NCT01299389|450617442|FG002|Post-observational|Other|12|||
125269923|NCT01299389|450617443|FG003|Post-observational|Other|6|||
125269924|NCT01151020|450617444|FG000|Overall Study|Death|25|||
125399006|NCT02161718|451093271|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
125399007|NCT02161718|451093269|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
125399008|NCT02161718|451093270|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
125399009|NCT02161718|451093271|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
125399010|NCT02161718|451093269|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
125399011|NCT02161718|451093270|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
125399012|NCT02161718|451093271|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
125399013|NCT02161718|451093269|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
125399014|NCT02161718|451093270|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
125399015|NCT02161718|451093271|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
125399016|NCT02161718|451093269|FG000|Post- Randomization Period|Lost to Follow-up|0|||
125399017|NCT02161718|451093270|FG001|Post- Randomization Period|Lost to Follow-up|9|||
125399018|NCT02161718|451093271|FG002|Post- Randomization Period|Lost to Follow-up|15|||
125399019|NCT02161718|451093269|FG000|Post- Randomization Period|Adverse Event|0|||
125399020|NCT02161718|451093270|FG001|Post- Randomization Period|Adverse Event|9|||
125399021|NCT02161718|451093271|FG002|Post- Randomization Period|Adverse Event|10|||
125399022|NCT02161718|451093269|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
125447645|NCT04529538|451264854|FG003|Overall Study|Adverse Event|1|||
125447646|NCT04529538|451264855|FG004|Overall Study|Adverse Event|0|||
125269925|NCT01151020|450617444|FG000|Overall Study|Conversion to open repair|1|||
125269926|NCT01151020|450617444|FG000|Overall Study|Lost to Follow-up|4|||
125269927|NCT01151020|450617444|FG000|Overall Study|Withdrawal by Subject|22|||
125269928|NCT01151020|450617444|FG000|Overall Study|Patients did not receive the device|2|||
125447647|NCT04529538|451264856|FG005|Overall Study|Adverse Event|0|||
125447648|NCT04529538|451264857|FG006|Overall Study|Adverse Event|0|||
125447649|NCT04529538|451264858|FG007|Overall Study|Adverse Event|0|||
125447650|NCT04529538|451264851|FG000|Overall Study|Protocol Deviation|0|||
125447651|NCT04529538|451264852|FG001|Overall Study|Protocol Deviation|0|||
125447652|NCT04529538|451264853|FG002|Overall Study|Protocol Deviation|0|||
125447653|NCT04529538|451264854|FG003|Overall Study|Protocol Deviation|1|||
125447654|NCT04529538|451264855|FG004|Overall Study|Protocol Deviation|0|||
125447655|NCT04529538|451264856|FG005|Overall Study|Protocol Deviation|0|||
125447656|NCT04529538|451264857|FG006|Overall Study|Protocol Deviation|0|||
125447657|NCT04529538|451264858|FG007|Overall Study|Protocol Deviation|0|||
125447658|NCT04529538|451264851|FG000|Overall Study|Physician Decision|0|||
125447659|NCT04529538|451264852|FG001|Overall Study|Physician Decision|0|||
125447660|NCT04529538|451264853|FG002|Overall Study|Physician Decision|0|||
125447661|NCT04529538|451264854|FG003|Overall Study|Physician Decision|0|||
125269929|NCT01635998|450617445|FG000|Overall Study|Death|1|||
125269930|NCT01635998|450617446|FG001|Overall Study|Death|1|||
125269931|NCT01635998|450617445|FG000|Overall Study|Lost to Follow-up|2|||
125269932|NCT01635998|450617446|FG001|Overall Study|Lost to Follow-up|1|||
125269933|NCT01635998|450617445|FG000|Overall Study|Withdrawal by Subject|1|||
125269934|NCT01635998|450617446|FG001|Overall Study|Withdrawal by Subject|5|||
125269935|NCT01220401|450617457|FG000|Overall Study|Withdrawal by Subject|2|||
125269936|NCT01220401|450617457|FG000|Overall Study|Protocol Violation|1|||
125269937|NCT03386435|450617460|FG000|Overall Study|Protocol Violation|5|||
125269938|NCT03386435|450617461|FG001|Overall Study|Protocol Violation|7|||
125269939|NCT00625586|450617462|FG000|Overall Study|Adverse Event|1|||
125269940|NCT00625586|450617462|FG000|Overall Study|Progressive disease|1|||
125269941|NCT00124072|450617465|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
125269942|NCT00124072|450617466|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
125269943|NCT00124072|450617467|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
125269944|NCT00124072|450617468|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
125269945|NCT00124072|450617465|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
125269946|NCT00124072|450617466|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
125269947|NCT00124072|450617467|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
125269948|NCT00124072|450617468|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
125269949|NCT00124072|450617465|FG000|Overall Study|Death|499|||
125269950|NCT00124072|450617466|FG001|Overall Study|Death|484|||
125269951|NCT00124072|450617467|FG002|Overall Study|Death|471|||
125269952|NCT00124072|450617468|FG003|Overall Study|Death|480|||
125269953|NCT02534883|450617469|FG000|Overall Study|Early Termination|8|||
125269954|NCT02534883|450617470|FG001|Overall Study|Early Termination|3|||
125269955|NCT00886769|450617471|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
125269956|NCT00886769|450617472|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
125269957|NCT03328832|450617473|FG000|Overall Study|Lost to Follow-up|0|||
125269958|NCT03328832|450617474|FG001|Overall Study|Lost to Follow-up|1|||
125269959|NCT00778336|450617477|FG000|Index Procedure-Discharge|Death|6|||
125447662|NCT04529538|451264855|FG004|Overall Study|Physician Decision|0|||
125447663|NCT04529538|451264856|FG005|Overall Study|Physician Decision|1|||
125447664|NCT04529538|451264857|FG006|Overall Study|Physician Decision|0|||
125447665|NCT04529538|451264858|FG007|Overall Study|Physician Decision|1|||
125269960|NCT00778336|450617478|FG001|Index Procedure-Discharge|Death|3|||
125269961|NCT00778336|450617479|FG002|Index Procedure-Discharge|Death|2|||
125269962|NCT00778336|450617480|FG003|Index Procedure-Discharge|Death|0|||
125269963|NCT00778336|450617477|FG000|3 Month Follow Up|Lost to Follow-up|15|||
125269964|NCT00778336|450617478|FG001|3 Month Follow Up|Lost to Follow-up|20|||
125269965|NCT00778336|450617479|FG002|3 Month Follow Up|Lost to Follow-up|3|||
125269966|NCT00778336|450617480|FG003|3 Month Follow Up|Lost to Follow-up|0|||
125269967|NCT00778336|450617477|FG000|3 Month Follow Up|Death|8|||
125269968|NCT00778336|450617478|FG001|3 Month Follow Up|Death|3|||
125269969|NCT00778336|450617479|FG002|3 Month Follow Up|Death|2|||
125269970|NCT00778336|450617480|FG003|3 Month Follow Up|Death|0|||
125269971|NCT00414076|450617481|FG000|Overall Study|Progression|1|||
125269972|NCT00414076|450617482|FG001|Overall Study|Progression|2|||
125269973|NCT00414076|450617481|FG000|Overall Study|Withdrawal by Subject|1|||
125269974|NCT00414076|450617482|FG001|Overall Study|Withdrawal by Subject|3|||
125269975|NCT00414076|450617481|FG000|Overall Study|Adverse Event|1|||
125269976|NCT00414076|450617482|FG001|Overall Study|Adverse Event|0|||
125269977|NCT00049257|450617483|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
125269978|NCT00049257|450617483|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
125269979|NCT00049257|450617483|FG000|Carboplatin, Paclitaxel|Death|2|||
125269980|NCT00049257|450617483|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
125269981|NCT04721158|450617484|FG000|Overall Study|Lost to Follow-up|4|||
125269982|NCT04721158|450617484|FG000|Overall Study|Device did not connect|1|||
125269983|NCT04872569|450617485|FG000|Overall Study|Withdrawal by Subject|2|||
125269984|NCT02382991|450617486|FG000|Overall Study|Adverse Event|1|||
125269985|NCT02382991|450617487|FG001|Overall Study|Adverse Event|2|||
125269986|NCT02382991|450617486|FG000|Overall Study|Lost to Follow-up|1|||
125269987|NCT02382991|450617487|FG001|Overall Study|Lost to Follow-up|0|||
125269988|NCT02382991|450617486|FG000|Overall Study|Withdrawal by Subject|0|||
125269989|NCT02382991|450617487|FG001|Overall Study|Withdrawal by Subject|1|||
125269990|NCT04466384|450617488|FG000|First Phase|Protocol Violation|1|||
125269991|NCT04466384|450617489|FG001|First Phase|Protocol Violation|0|||
125269992|NCT04466384|450617488|FG000|First Phase|Missing data|1|||
125269993|NCT04466384|450617489|FG001|First Phase|Missing data|0|||
125269994|NCT04466384|450617488|FG000|Cross Over Phase|Physician Decision|1|||
125269995|NCT04466384|450617489|FG001|Cross Over Phase|Physician Decision|0|||
125269996|NCT04466384|450617488|FG000|Cross Over Phase|Withdrawal by Subject|0|||
125269997|NCT04466384|450617489|FG001|Cross Over Phase|Withdrawal by Subject|1|||
125269998|NCT03666988|450617490|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
125269999|NCT03666988|450617491|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
125270000|NCT03666988|450617492|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
125270001|NCT03666988|450617493|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
125270002|NCT03666988|450617494|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
125270003|NCT03666988|450617495|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
125270004|NCT03666988|450617490|FG000|Part 1 (Up to 28 Months)|Other|0|||
125270005|NCT03666988|450617491|FG001|Part 1 (Up to 28 Months)|Other|1|||
125270006|NCT03666988|450617492|FG002|Part 1 (Up to 28 Months)|Other|1|||
125270007|NCT03666988|450617493|FG003|Part 1 (Up to 28 Months)|Other|0|||
125270008|NCT03666988|450617494|FG004|Part 1 (Up to 28 Months)|Other|0|||
125270009|NCT03666988|450617495|FG005|Part 1 (Up to 28 Months)|Other|0|||
125270010|NCT03666988|450617490|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
125270011|NCT03666988|450617491|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
125270012|NCT03666988|450617492|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
125270013|NCT03666988|450617493|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
125270014|NCT03666988|450617494|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
125270015|NCT03666988|450617495|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
125270016|NCT03666988|450617490|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
125270017|NCT03666988|450617491|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
125270018|NCT03666988|450617492|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
125270019|NCT03666988|450617493|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
125270020|NCT03666988|450617494|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
125270021|NCT03666988|450617495|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
125270022|NCT03666988|450617490|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
125270023|NCT03666988|450617491|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
125270024|NCT03666988|450617492|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
125270025|NCT03666988|450617493|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
125270026|NCT03666988|450617494|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
125270027|NCT03666988|450617495|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
125270028|NCT03554018|450617498|FG000|Overall Study|Lost to Follow-up|3|||
125270029|NCT03554018|450617499|FG001|Overall Study|Lost to Follow-up|7|||
125270030|NCT02891226|450617502|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
125270031|NCT02891226|450617503|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
125270032|NCT02891226|450617504|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
125270033|NCT02891226|450617505|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270034|NCT02891226|450617506|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270035|NCT02891226|450617507|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270036|NCT02891226|450617508|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270037|NCT02891226|450617509|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270038|NCT02891226|450617510|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270039|NCT02891226|450617511|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270040|NCT02891226|450617512|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270041|NCT02891226|450617513|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270042|NCT02891226|450617514|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270043|NCT02891226|450617515|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270044|NCT02891226|450617516|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270045|NCT02891226|450617517|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
125270046|NCT02891226|450617502|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
125270047|NCT02891226|450617503|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
125270048|NCT02891226|450617504|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270049|NCT02891226|450617505|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270050|NCT02891226|450617506|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125399023|NCT02161718|451093270|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
125399024|NCT02161718|451093271|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
125399025|NCT02161718|451093269|FG000|Post- Randomization Period|Physician Decision|0|||
125399026|NCT02161718|451093270|FG001|Post- Randomization Period|Physician Decision|2|||
125399027|NCT02161718|451093271|FG002|Post- Randomization Period|Physician Decision|4|||
125399028|NCT02161718|451093269|FG000|Post- Randomization Period|Protocol Violation|0|||
125399029|NCT02161718|451093270|FG001|Post- Randomization Period|Protocol Violation|2|||
125399030|NCT02161718|451093271|FG002|Post- Randomization Period|Protocol Violation|3|||
125399031|NCT02161718|451093269|FG000|Post- Randomization Period|Lack of Efficacy|0|||
125399032|NCT02161718|451093270|FG001|Post- Randomization Period|Lack of Efficacy|0|||
125399033|NCT02161718|451093271|FG002|Post- Randomization Period|Lack of Efficacy|1|||
125270051|NCT02891226|450617507|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270052|NCT02891226|450617508|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270053|NCT02891226|450617509|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270054|NCT02891226|450617510|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270055|NCT02891226|450617511|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270056|NCT02891226|450617512|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270057|NCT02891226|450617513|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270058|NCT02891226|450617514|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270059|NCT02891226|450617515|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270060|NCT02891226|450617516|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270061|NCT02891226|450617517|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
125270062|NCT02891226|450617502|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270063|NCT02891226|450617503|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270064|NCT02891226|450617504|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270065|NCT02891226|450617505|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
125270066|NCT02891226|450617506|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270067|NCT02891226|450617507|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270068|NCT02891226|450617508|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270069|NCT02891226|450617509|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270070|NCT02891226|450617510|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270071|NCT02891226|450617511|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270072|NCT02891226|450617512|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270073|NCT02891226|450617513|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270074|NCT02891226|450617514|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270075|NCT02891226|450617515|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270076|NCT02891226|450617516|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270077|NCT02891226|450617517|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
125270078|NCT02891226|450617502|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270079|NCT02891226|450617503|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270080|NCT02891226|450617504|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
125270081|NCT02891226|450617505|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270082|NCT02891226|450617506|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270083|NCT02891226|450617507|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270084|NCT02891226|450617508|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270085|NCT02891226|450617509|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270086|NCT02891226|450617510|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270087|NCT02891226|450617511|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270088|NCT02891226|450617512|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270089|NCT02891226|450617513|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125399034|NCT02161718|451093269|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
125270090|NCT02891226|450617514|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270091|NCT02891226|450617515|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270092|NCT02891226|450617516|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270093|NCT02891226|450617517|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
125270094|NCT02891226|450617502|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270095|NCT02891226|450617503|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270096|NCT02891226|450617504|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125399035|NCT02161718|451093270|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
125399036|NCT02161718|451093271|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
125399037|NCT02161718|451093269|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
125399038|NCT02161718|451093270|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
125399039|NCT02161718|451093271|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
125399040|NCT02161718|451093269|FG000|Post- Randomization Period|Relocation|0|||
125399041|NCT02161718|451093270|FG001|Post- Randomization Period|Relocation|3|||
125399042|NCT02161718|451093271|FG002|Post- Randomization Period|Relocation|0|||
125399043|NCT01857063|451093274|FG000|Period 1 (7 Days)|Adverse Event|0|||
125399044|NCT01857063|451093275|FG001|Period 1 (7 Days)|Adverse Event|1|||
125399045|NCT01857063|451093274|FG000|Period 1 (7 Days)|Physician Decision|1|||
125399046|NCT01857063|451093275|FG001|Period 1 (7 Days)|Physician Decision|0|||
125399047|NCT01857063|451093274|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
125399048|NCT01857063|451093275|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
125447666|NCT02322775|451264863|FG000|Overall Study|Adverse Event|1|||
125447667|NCT02322775|451264864|FG001|Overall Study|Adverse Event|0|||
125447668|NCT02322775|451264863|FG000|Overall Study|Lost to Follow-up|0|||
125270097|NCT02891226|450617505|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
125270098|NCT02891226|450617506|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270099|NCT02891226|450617507|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270100|NCT02891226|450617508|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270101|NCT02891226|450617509|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270102|NCT02891226|450617510|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270103|NCT02891226|450617511|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270104|NCT02891226|450617512|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270105|NCT02891226|450617513|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270106|NCT02891226|450617514|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270107|NCT02891226|450617515|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270108|NCT02891226|450617516|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270109|NCT02891226|450617517|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
125270110|NCT02891226|450617502|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270111|NCT02891226|450617503|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270112|NCT02891226|450617504|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270113|NCT02891226|450617505|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
125270114|NCT02891226|450617506|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270115|NCT02891226|450617507|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270116|NCT02891226|450617508|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270117|NCT02891226|450617509|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270118|NCT02891226|450617510|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270119|NCT02891226|450617511|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270120|NCT02891226|450617512|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270121|NCT02891226|450617513|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270122|NCT02891226|450617514|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270123|NCT02891226|450617515|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270124|NCT02891226|450617516|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270125|NCT02891226|450617517|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
125270126|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270127|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270128|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270129|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270130|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270131|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270132|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
125270133|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
125270134|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
125270135|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
125270136|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270137|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270138|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270139|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270140|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270141|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
125270142|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125399049|NCT01857063|451093274|FG000|Period 2 (7 Days)|Adverse Event|2|||
125399050|NCT01857063|451093275|FG001|Period 2 (7 Days)|Adverse Event|1|||
125270143|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270144|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270145|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270146|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270147|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
125270148|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270149|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270150|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125399051|NCT01857063|451093274|FG000|Period 2 (7 Days)|Physician Decision|1|||
125270151|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
125270152|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270153|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270154|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270155|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270156|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270157|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
125270158|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270159|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270160|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270161|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270162|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270163|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270164|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
125270165|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
125270166|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
125270167|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
125270168|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270169|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270170|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270171|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270172|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270173|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
125270174|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270175|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270176|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270177|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270178|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
125270179|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270180|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270181|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270182|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270183|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270184|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270185|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270186|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270187|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270188|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270189|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
125270190|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270191|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270192|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270193|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270194|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270195|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270196|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
125270197|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270198|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270199|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270200|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270201|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270202|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270203|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270204|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270205|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
125270206|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270207|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270208|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270209|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270210|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270211|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125399052|NCT01857063|451093275|FG001|Period 2 (7 Days)|Physician Decision|1|||
125399053|NCT01857063|451093274|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
125399054|NCT01857063|451093275|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
125399055|NCT04115358|451093278|FG000|Overall Study|exfoliation|0|||
125270212|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270213|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
125270214|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
125270215|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
125270216|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270217|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270218|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270219|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270220|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270221|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
125270222|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270223|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270224|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270225|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270226|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270227|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270228|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270229|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
125270230|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270231|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270232|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270233|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270234|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270235|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270236|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270237|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
125270238|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270239|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270240|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270241|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270242|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270243|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270244|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270245|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270246|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
125270247|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270248|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270249|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270250|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270251|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270252|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270253|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
125270254|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270255|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270256|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270257|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270258|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270259|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270260|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270261|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270262|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270263|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
125270264|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270265|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270266|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270267|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270268|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125270269|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
125399056|NCT04115358|451093279|FG001|Overall Study|exfoliation|0|||
125399057|NCT04115358|451093280|FG002|Overall Study|exfoliation|1|||
125399058|NCT01205165|451093281|FG000|Overall Study|Lost to Follow-up|2|||
125399059|NCT02115282|451093284|FG000|Overall Study|Disease progression during treatment|216|||
125399060|NCT02115282|451093285|FG001|Overall Study|Disease progression during treatment|229|||
125270270|NCT02891226|450617502|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270271|NCT02891226|450617503|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270272|NCT02891226|450617504|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270273|NCT02891226|450617505|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270274|NCT02891226|450617506|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270275|NCT02891226|450617507|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270276|NCT02891226|450617508|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270277|NCT02891226|450617509|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270278|NCT02891226|450617510|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270279|NCT02891226|450617511|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
125270280|NCT02891226|450617512|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270281|NCT02891226|450617513|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270282|NCT02891226|450617514|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270283|NCT02891226|450617515|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270284|NCT02891226|450617516|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270285|NCT02891226|450617517|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
125270286|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270287|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270288|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270289|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270290|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270291|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270292|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270293|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270294|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270295|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270296|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
125270297|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270298|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270299|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270300|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270301|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
125270302|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270303|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270304|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270305|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270306|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270307|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270308|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270309|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270310|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270311|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270312|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
125270313|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270314|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270315|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270316|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270317|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
125270318|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270319|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270320|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270321|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270322|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270323|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270324|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270325|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270326|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270327|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270328|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
125270329|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270330|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270331|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270332|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270333|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
125270334|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270335|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270336|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270337|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270338|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270339|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270340|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270341|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270342|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270343|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270344|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
125270345|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270346|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270347|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270348|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270349|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
125270350|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270351|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270352|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270353|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270354|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270355|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270356|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270357|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270358|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270359|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270360|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
125270361|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270362|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270363|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270364|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270365|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
125270366|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270367|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270368|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270369|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270370|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270371|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270372|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270373|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270374|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270375|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270376|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
125270377|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270378|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270379|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270380|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270381|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
125270382|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270383|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270384|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270385|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270386|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270387|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270388|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270389|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270390|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270391|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270392|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
125270393|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270394|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270395|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270396|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270397|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
125270398|NCT02891226|450617502|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270399|NCT02891226|450617503|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125399061|NCT02115282|451093284|FG000|Overall Study|Adverse Event|49|||
125270400|NCT02891226|450617504|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270401|NCT02891226|450617505|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270402|NCT02891226|450617506|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270403|NCT02891226|450617507|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270404|NCT02891226|450617508|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270405|NCT02891226|450617509|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270406|NCT02891226|450617510|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270407|NCT02891226|450617511|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125399062|NCT02115282|451093285|FG001|Overall Study|Adverse Event|23|||
125399063|NCT02115282|451093284|FG000|Overall Study|Death|1|||
125270408|NCT02891226|450617512|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
125270409|NCT02891226|450617513|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270410|NCT02891226|450617514|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270411|NCT02891226|450617515|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270412|NCT02891226|450617516|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270413|NCT02891226|450617517|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
125270414|NCT02891226|450617502|FG000|Follow-up Period|Withdrawal by Subject|0|||
125270415|NCT02891226|450617503|FG001|Follow-up Period|Withdrawal by Subject|0|||
125270416|NCT02891226|450617504|FG002|Follow-up Period|Withdrawal by Subject|0|||
125270417|NCT02891226|450617505|FG003|Follow-up Period|Withdrawal by Subject|0|||
125270418|NCT02891226|450617506|FG004|Follow-up Period|Withdrawal by Subject|0|||
125270419|NCT02891226|450617507|FG005|Follow-up Period|Withdrawal by Subject|0|||
125270420|NCT02891226|450617508|FG006|Follow-up Period|Withdrawal by Subject|0|||
125270421|NCT02891226|450617509|FG007|Follow-up Period|Withdrawal by Subject|0|||
125270422|NCT02891226|450617510|FG008|Follow-up Period|Withdrawal by Subject|0|||
125270423|NCT02891226|450617511|FG009|Follow-up Period|Withdrawal by Subject|0|||
125270424|NCT02891226|450617512|FG010|Follow-up Period|Withdrawal by Subject|0|||
125270425|NCT02891226|450617513|FG011|Follow-up Period|Withdrawal by Subject|1|||
125270426|NCT02891226|450617514|FG012|Follow-up Period|Withdrawal by Subject|0|||
125270427|NCT02891226|450617515|FG013|Follow-up Period|Withdrawal by Subject|0|||
125270428|NCT02891226|450617516|FG014|Follow-up Period|Withdrawal by Subject|1|||
125270429|NCT02891226|450617517|FG015|Follow-up Period|Withdrawal by Subject|1|||
125270430|NCT01928433|450617518|FG000|Overall Study|Adverse Event|5|||
125270431|NCT01928433|450617519|FG001|Overall Study|Adverse Event|2|||
125270432|NCT01928433|450617520|FG002|Overall Study|Adverse Event|5|||
125270433|NCT01928433|450617518|FG000|Overall Study|Protocol Violation|0|||
125270434|NCT01928433|450617519|FG001|Overall Study|Protocol Violation|0|||
125270435|NCT01928433|450617520|FG002|Overall Study|Protocol Violation|2|||
125270436|NCT01928433|450617518|FG000|Overall Study|Lack of Efficacy|5|||
125270437|NCT01928433|450617519|FG001|Overall Study|Lack of Efficacy|4|||
125270438|NCT01928433|450617520|FG002|Overall Study|Lack of Efficacy|4|||
125270439|NCT01928433|450617518|FG000|Overall Study|Withdrawal by Subject|0|||
125270440|NCT01928433|450617519|FG001|Overall Study|Withdrawal by Subject|4|||
125270441|NCT01928433|450617520|FG002|Overall Study|Withdrawal by Subject|0|||
125270442|NCT01928433|450617518|FG000|Overall Study|Negative screening urine culture|7|||
125270443|NCT01928433|450617519|FG001|Overall Study|Negative screening urine culture|6|||
125270444|NCT01928433|450617520|FG002|Overall Study|Negative screening urine culture|10|||
125270445|NCT01928433|450617518|FG000|Overall Study|Lost to Follow-up|0|||
125270446|NCT01928433|450617519|FG001|Overall Study|Lost to Follow-up|2|||
125270447|NCT01928433|450617520|FG002|Overall Study|Lost to Follow-up|3|||
125270448|NCT01928433|450617518|FG000|Overall Study|Other reasons|3|||
125270449|NCT01928433|450617519|FG001|Overall Study|Other reasons|3|||
125270450|NCT01928433|450617520|FG002|Overall Study|Other reasons|4|||
125270451|NCT00145626|450617521|FG000|Overall Study|Did not have NK infusions|2|||
125399064|NCT02115282|451093285|FG001|Overall Study|Death|3|||
125270452|NCT00145626|450617521|FG000|Overall Study|Turned 2 years old before treatment|1|||
125270453|NCT00145626|450617521|FG000|Overall Study|Death|1|||
125270454|NCT00145626|450617521|FG000|Overall Study|Withdrawal by Subject|1|||
125270455|NCT00436436|450617522|FG000|Overall Study|Progression|4|||
125270456|NCT00436436|450617522|FG000|Overall Study|Adverse Event|2|||
125270457|NCT00436436|450617522|FG000|Overall Study|Death|6|||
125270458|NCT03654274|450617527|FG000|Overall Study|Adverse Event|19|||
125270459|NCT03654274|450617528|FG001|Overall Study|Adverse Event|23|||
125270460|NCT03654274|450617529|FG002|Overall Study|Adverse Event|24|||
125270461|NCT03654274|450617527|FG000|Overall Study|Protocol Deviation|0|||
125270462|NCT03654274|450617528|FG001|Overall Study|Protocol Deviation|2|||
125399065|NCT02115282|451093284|FG000|Overall Study|Alternative therapy|1|||
125270463|NCT03654274|450617529|FG002|Overall Study|Protocol Deviation|0|||
125270464|NCT03654274|450617527|FG000|Overall Study|Lost to Follow-up|8|||
125399066|NCT02115282|451093285|FG001|Overall Study|Alternative therapy|1|||
125270465|NCT03654274|450617528|FG001|Overall Study|Lost to Follow-up|6|||
125270466|NCT03654274|450617529|FG002|Overall Study|Lost to Follow-up|5|||
125270467|NCT03654274|450617527|FG000|Overall Study|Withdrawal by Subject|46|||
125399067|NCT02115282|451093284|FG000|Overall Study|Complicating disease|0|||
125270468|NCT03654274|450617528|FG001|Overall Study|Withdrawal by Subject|25|||
125270469|NCT03654274|450617529|FG002|Overall Study|Withdrawal by Subject|33|||
125270470|NCT03654274|450617527|FG000|Overall Study|Lack of Efficacy|4|||
125270471|NCT03654274|450617528|FG001|Overall Study|Lack of Efficacy|5|||
125270472|NCT03654274|450617529|FG002|Overall Study|Lack of Efficacy|7|||
125270473|NCT03654274|450617527|FG000|Overall Study|Pregnancy|2|||
125270474|NCT03654274|450617528|FG001|Overall Study|Pregnancy|2|||
125270475|NCT03654274|450617529|FG002|Overall Study|Pregnancy|1|||
125270476|NCT03654274|450617527|FG000|Overall Study|Other|27|||
125270477|NCT03654274|450617528|FG001|Overall Study|Other|29|||
125270478|NCT03654274|450617529|FG002|Overall Study|Other|32|||
125270479|NCT03654274|450617527|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
125270480|NCT03654274|450617528|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
125270481|NCT03654274|450617529|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
125270482|NCT05005273|450617532|FG000|Overall Study|Study Terminated|1|||
125270483|NCT05005273|450617533|FG001|Overall Study|Study Terminated|0|||
125270484|NCT02151786|450617534|FG000|Overall Study|Unavailability of Case Report Form|26|||
125270485|NCT02151786|450617534|FG000|Overall Study|Outside the Contract Period|1|||
125270486|NCT02151786|450617534|FG000|Overall Study|Randomized, not Treated|1|||
125270487|NCT02151786|450617534|FG000|Overall Study|Unavailability of Information|8|||
125270488|NCT03533660|450617535|FG000|Overall Study|Withdrawal by Subject|2|||
125270489|NCT03533660|450617536|FG001|Overall Study|Withdrawal by Subject|2|||
125270490|NCT03533660|450617535|FG000|Overall Study|Death|2|||
125270491|NCT03533660|450617536|FG001|Overall Study|Death|4|||
125270492|NCT03533660|450617535|FG000|Overall Study|Adverse Event|0|||
125270493|NCT03533660|450617536|FG001|Overall Study|Adverse Event|2|||
125270494|NCT00996658|450617537|FG000|Overall Study|Adverse Event|2|||
125270495|NCT00996658|450617538|FG001|Overall Study|Adverse Event|5|||
125270496|NCT00996658|450617537|FG000|Overall Study|Protocol Violation|0|||
125270497|NCT00996658|450617538|FG001|Overall Study|Protocol Violation|1|||
125270498|NCT00996658|450617537|FG000|Overall Study|Lost to Follow-up|2|||
125270499|NCT00996658|450617538|FG001|Overall Study|Lost to Follow-up|5|||
125270500|NCT00996658|450617537|FG000|Overall Study|Non-compliance issues|3|||
125270501|NCT00996658|450617538|FG001|Overall Study|Non-compliance issues|3|||
125270502|NCT00996658|450617537|FG000|Overall Study|Other|9|||
125270503|NCT00996658|450617538|FG001|Overall Study|Other|7|||
125270504|NCT03154476|450617547|FG000|Overall Study|Lost to Follow-up|4|||
125270505|NCT03154476|450617548|FG001|Overall Study|Lost to Follow-up|4|||
125270506|NCT02685826|450617549|FG000|Overall Study|Adverse Event|2|||
125270507|NCT02685826|450617550|FG001|Overall Study|Adverse Event|0|||
125270508|NCT02685826|450617551|FG002|Overall Study|Adverse Event|1|||
125270509|NCT02685826|450617549|FG000|Overall Study|Progressive Disease|2|||
125270510|NCT02685826|450617550|FG001|Overall Study|Progressive Disease|1|||
125270511|NCT02685826|450617551|FG002|Overall Study|Progressive Disease|0|||
125270512|NCT02685826|450617549|FG000|Overall Study|Withdrawal by Subject|2|||
125270513|NCT02685826|450617550|FG001|Overall Study|Withdrawal by Subject|0|||
125270514|NCT02685826|450617551|FG002|Overall Study|Withdrawal by Subject|0|||
125270515|NCT02685826|450617549|FG000|Overall Study|Full Clinical Hold by FDA|19|||
125270516|NCT02685826|450617550|FG001|Overall Study|Full Clinical Hold by FDA|9|||
125270517|NCT02685826|450617551|FG002|Overall Study|Full Clinical Hold by FDA|20|||
125270518|NCT00200967|450617554|FG000|First Treatment Period|Withdrawal by Subject|5|||
125270519|NCT00200967|450617555|FG001|First Treatment Period|Withdrawal by Subject|1|||
125270520|NCT00200967|450617554|FG000|First Treatment Period|Pregnancy|1|||
125270521|NCT00200967|450617555|FG001|First Treatment Period|Pregnancy|0|||
125447669|NCT02322775|451264864|FG001|Overall Study|Lost to Follow-up|1|||
125447670|NCT02322775|451264863|FG000|Overall Study|Protocol Violation|1|||
125447671|NCT02322775|451264864|FG001|Overall Study|Protocol Violation|0|||
125447672|NCT02322775|451264863|FG000|Overall Study|Withdrawal by Subject|3|||
125447673|NCT02322775|451264864|FG001|Overall Study|Withdrawal by Subject|4|||
125270522|NCT00200967|450617554|FG000|Wash-out Period|Lost to Follow-up|0|||
125270523|NCT00200967|450617555|FG001|Wash-out Period|Lost to Follow-up|1|||
125270524|NCT00200967|450617554|FG000|Second Treatment Period|Withdrawal by Subject|1|||
125270525|NCT00200967|450617555|FG001|Second Treatment Period|Withdrawal by Subject|2|||
125270526|NCT00200967|450617554|FG000|Run-out Period|Lost to Follow-up|1|||
125270527|NCT00200967|450617555|FG001|Run-out Period|Lost to Follow-up|0|||
125270528|NCT01444430|450617558|FG000|Overall Study|Withdrawal by Subject|53|||
125270529|NCT01444430|450617559|FG001|Overall Study|Withdrawal by Subject|72|||
125270530|NCT01444430|450617558|FG000|Overall Study|Death|6|||
125270531|NCT01444430|450617559|FG001|Overall Study|Death|8|||
125270532|NCT01444430|450617558|FG000|Overall Study|Lost to Follow-up|2|||
125270533|NCT01444430|450617559|FG001|Overall Study|Lost to Follow-up|0|||
125270534|NCT01444430|450617558|FG000|Overall Study|CRF termination module not completed.|0|||
125270535|NCT01444430|450617559|FG001|Overall Study|CRF termination module not completed.|1|||
125270536|NCT00662831|450618973|FG000|Overall Study|Death|4|||
125270537|NCT00662831|450618974|FG001|Overall Study|Death|1|||
125270538|NCT00662831|450618973|FG000|Overall Study|Lack of Efficacy|6|||
125270539|NCT00662831|450618974|FG001|Overall Study|Lack of Efficacy|6|||
125447674|NCT02322775|451264863|FG000|Overall Study|Not willing to perform all FU visits|0|||
125270540|NCT00662831|450618973|FG000|Overall Study|Lost to Follow-up|1|||
125270541|NCT00662831|450618974|FG001|Overall Study|Lost to Follow-up|0|||
125270542|NCT00662831|450618973|FG000|Overall Study|Withdrawal by Subject|2|||
125270543|NCT00662831|450618974|FG001|Overall Study|Withdrawal by Subject|1|||
125270544|NCT00662831|450618973|FG000|Overall Study|Other|62|||
125270545|NCT00662831|450618974|FG001|Overall Study|Other|31|||
125270546|NCT00662831|450618973|FG000|Overall Study|Protocol Violation|8|||
125270547|NCT00662831|450618974|FG001|Overall Study|Protocol Violation|4|||
125270548|NCT00662831|450618973|FG000|Overall Study|Adverse Event|23|||
125270549|NCT00662831|450618974|FG001|Overall Study|Adverse Event|16|||
125270550|NCT01061723|450618976|FG000|Overall Study|Adverse Event|0|||
125270551|NCT01061723|450618977|FG001|Overall Study|Adverse Event|2|||
125270552|NCT01061723|450618978|FG002|Overall Study|Adverse Event|5|||
125270553|NCT01061723|450618979|FG003|Overall Study|Adverse Event|5|||
125270554|NCT01061723|450618980|FG004|Overall Study|Adverse Event|2|||
125270555|NCT01061723|450618981|FG005|Overall Study|Adverse Event|6|||
125270556|NCT01061723|450618976|FG000|Overall Study|Lack of Efficacy|2|||
125270557|NCT01061723|450618977|FG001|Overall Study|Lack of Efficacy|3|||
125270558|NCT01061723|450618978|FG002|Overall Study|Lack of Efficacy|4|||
125270559|NCT01061723|450618979|FG003|Overall Study|Lack of Efficacy|2|||
125270560|NCT01061723|450618980|FG004|Overall Study|Lack of Efficacy|1|||
125270561|NCT01061723|450618981|FG005|Overall Study|Lack of Efficacy|1|||
125270562|NCT01061723|450618976|FG000|Overall Study|Randomized but not treated|0|||
125270563|NCT01061723|450618977|FG001|Overall Study|Randomized but not treated|0|||
125270564|NCT01061723|450618978|FG002|Overall Study|Randomized but not treated|0|||
125270565|NCT01061723|450618979|FG003|Overall Study|Randomized but not treated|0|||
125270566|NCT01061723|450618980|FG004|Overall Study|Randomized but not treated|0|||
125270567|NCT01061723|450618981|FG005|Overall Study|Randomized but not treated|1|||
125270568|NCT01061723|450618976|FG000|Overall Study|Other than specified above|2|||
125270569|NCT01061723|450618977|FG001|Overall Study|Other than specified above|1|||
125270570|NCT01061723|450618978|FG002|Overall Study|Other than specified above|1|||
125270571|NCT01061723|450618979|FG003|Overall Study|Other than specified above|1|||
125270572|NCT01061723|450618980|FG004|Overall Study|Other than specified above|0|||
125270573|NCT01061723|450618981|FG005|Overall Study|Other than specified above|1|||
125270574|NCT04245449|450618985|FG000|Overall Study|COVID shutdown|7|||
125270575|NCT01147393|450618988|FG000|Dose Level 1|Dose limiting Toxicity|2|||
125270576|NCT01147393|450618988|FG000|Dose Level -1|Dose Limited Toxicity|1|||
125270577|NCT01408277|450618992|FG000|Overall Study|Adverse Event|3|||
125270578|NCT01408277|450618993|FG001|Overall Study|Adverse Event|4|||
125270579|NCT01408277|450618992|FG000|Overall Study|Lost to Follow-up|1|||
125270580|NCT01408277|450618993|FG001|Overall Study|Lost to Follow-up|0|||
125270581|NCT01408277|450618992|FG000|Overall Study|Withdrawal by Subject|2|||
125270582|NCT01408277|450618993|FG001|Overall Study|Withdrawal by Subject|0|||
125270583|NCT01408277|450618992|FG000|Overall Study|Protocol Violation|2|||
125270584|NCT01408277|450618993|FG001|Overall Study|Protocol Violation|0|||
125270585|NCT03801928|450618996|FG000|Overall Study|Adverse Event|1|||
125270586|NCT03801928|450618997|FG001|Overall Study|Adverse Event|0|||
125270587|NCT03801928|450618998|FG002|Overall Study|Adverse Event|1|||
125270588|NCT03801928|450618999|FG003|Overall Study|Adverse Event|2|||
125270589|NCT03801928|450619000|FG004|Overall Study|Adverse Event|0|||
125270590|NCT03801928|450619001|FG005|Overall Study|Adverse Event|2|||
125270591|NCT03801928|450618996|FG000|Overall Study|Lack of Efficacy|0|||
125270592|NCT03801928|450618997|FG001|Overall Study|Lack of Efficacy|0|||
125270593|NCT03801928|450618998|FG002|Overall Study|Lack of Efficacy|1|||
125270594|NCT03801928|450618999|FG003|Overall Study|Lack of Efficacy|0|||
125270595|NCT03801928|450619000|FG004|Overall Study|Lack of Efficacy|0|||
125270596|NCT03801928|450619001|FG005|Overall Study|Lack of Efficacy|0|||
125270597|NCT03801928|450618996|FG000|Overall Study|Lost to Follow-up|5|||
125270598|NCT03801928|450618997|FG001|Overall Study|Lost to Follow-up|1|||
125270599|NCT03801928|450618998|FG002|Overall Study|Lost to Follow-up|1|||
125270600|NCT03801928|450618999|FG003|Overall Study|Lost to Follow-up|4|||
125270601|NCT03801928|450619000|FG004|Overall Study|Lost to Follow-up|4|||
125270602|NCT03801928|450619001|FG005|Overall Study|Lost to Follow-up|2|||
125270603|NCT03801928|450618996|FG000|Overall Study|Withdrawal by Subject|0|||
125270604|NCT03801928|450618997|FG001|Overall Study|Withdrawal by Subject|0|||
125270605|NCT03801928|450618998|FG002|Overall Study|Withdrawal by Subject|2|||
125270606|NCT03801928|450618999|FG003|Overall Study|Withdrawal by Subject|1|||
125270607|NCT03801928|450619000|FG004|Overall Study|Withdrawal by Subject|0|||
125270608|NCT03801928|450619001|FG005|Overall Study|Withdrawal by Subject|0|||
125270609|NCT03801928|450618996|FG000|Overall Study|Other|0|||
125270610|NCT03801928|450618997|FG001|Overall Study|Other|2|||
125270611|NCT03801928|450618998|FG002|Overall Study|Other|0|||
125270612|NCT03801928|450618999|FG003|Overall Study|Other|1|||
125270613|NCT03801928|450619000|FG004|Overall Study|Other|0|||
125270614|NCT03801928|450619001|FG005|Overall Study|Other|1|||
125270615|NCT04263766|450619002|FG000|Overall Study|Withdrawal by Subject|6|||
125270616|NCT04263766|450619003|FG001|Overall Study|Withdrawal by Subject|4|||
125270617|NCT04263766|450619002|FG000|Overall Study|Lack of Efficacy|1|||
125270618|NCT04263766|450619003|FG001|Overall Study|Lack of Efficacy|3|||
125270619|NCT03369665|450619005|FG000|Overall Study|Adverse Event|3|||
125270620|NCT03369665|450619005|FG000|Overall Study|Lost to Follow-up|7|||
125270621|NCT03369665|450619005|FG000|Overall Study|Withdrawal by Subject|15|||
125270622|NCT03369665|450619005|FG000|Overall Study|Progression Disease|2|||
125270623|NCT03369665|450619005|FG000|Overall Study|Not classified|3|||
125270624|NCT02553928|450619006|FG000|Overall Study|Adverse Event|2|||
125270625|NCT02553928|450619007|FG001|Overall Study|Adverse Event|1|||
125270626|NCT02553928|450619006|FG000|Overall Study|Lost to Follow-up|0|||
125270627|NCT02553928|450619007|FG001|Overall Study|Lost to Follow-up|1|||
125270628|NCT02553928|450619006|FG000|Overall Study|Administrative reason(s)|0|||
125270629|NCT02553928|450619007|FG001|Overall Study|Administrative reason(s)|1|||
125270630|NCT03230318|450619008|FG000|Overall Study|Radiographic disease progression|72|||
125270631|NCT03230318|450619009|FG001|Overall Study|Radiographic disease progression|19|||
125270632|NCT03230318|450619008|FG000|Overall Study|Clinical progression|17|||
125270633|NCT03230318|450619009|FG001|Overall Study|Clinical progression|7|||
125270634|NCT03230318|450619008|FG000|Overall Study|Adverse Event|5|||
125270635|NCT03230318|450619009|FG001|Overall Study|Adverse Event|3|||
125270636|NCT03230318|450619008|FG000|Overall Study|Physician Decision|2|||
125270637|NCT03230318|450619009|FG001|Overall Study|Physician Decision|3|||
125270638|NCT03230318|450619008|FG000|Overall Study|Death|3|||
125270639|NCT03230318|450619009|FG001|Overall Study|Death|2|||
125270640|NCT03230318|450619008|FG000|Overall Study|Lost to Follow-up|1|||
125399068|NCT02115282|451093285|FG001|Overall Study|Complicating disease|3|||
125399069|NCT02115282|451093284|FG000|Overall Study|Withdrawal by Subject|12|||
125399070|NCT02115282|451093285|FG001|Overall Study|Withdrawal by Subject|10|||
125399071|NCT02115282|451093284|FG000|Overall Study|Symptomatic progression/deterioration|7|||
125399072|NCT02115282|451093285|FG001|Overall Study|Symptomatic progression/deterioration|18|||
125399073|NCT02115282|451093284|FG000|Overall Study|Non-compliance|5|||
125399074|NCT02115282|451093285|FG001|Overall Study|Non-compliance|1|||
125399075|NCT02115282|451093284|FG000|Overall Study|Protocol Violation|2|||
125399076|NCT02115282|451093285|FG001|Overall Study|Protocol Violation|2|||
125399077|NCT02115282|451093284|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
125399078|NCT02115282|451093285|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
125399079|NCT02115282|451093284|FG000|Overall Study|Not start protocol therapy|9|||
125399080|NCT02115282|451093285|FG001|Overall Study|Not start protocol therapy|10|||
125399081|NCT03306264|451093286|FG000|Overall Study|Death|33|||
125399082|NCT03306264|451093287|FG001|Overall Study|Death|25|||
125399083|NCT03306264|451093288|FG002|Overall Study|Death|34|||
125399084|NCT03306264|451093289|FG003|Overall Study|Death|34|||
125399085|NCT03306264|451093286|FG000|Overall Study|Complete Consent Withdrawal|4|||
125399086|NCT03306264|451093287|FG001|Overall Study|Complete Consent Withdrawal|4|||
125399087|NCT03306264|451093288|FG002|Overall Study|Complete Consent Withdrawal|1|||
125399088|NCT03306264|451093289|FG003|Overall Study|Complete Consent Withdrawal|8|||
125399089|NCT03306264|451093286|FG000|Overall Study|Lost to Follow-up|1|||
125399090|NCT03306264|451093287|FG001|Overall Study|Lost to Follow-up|0|||
125399091|NCT03306264|451093288|FG002|Overall Study|Lost to Follow-up|1|||
125399092|NCT03306264|451093289|FG003|Overall Study|Lost to Follow-up|0|||
125399093|NCT03306264|451093286|FG000|Overall Study|Rollover to ASTX727-06|10|||
125399094|NCT03306264|451093287|FG001|Overall Study|Rollover to ASTX727-06|18|||
125399095|NCT03306264|451093288|FG002|Overall Study|Rollover to ASTX727-06|4|||
125399096|NCT03306264|451093289|FG003|Overall Study|Rollover to ASTX727-06|2|||
125399097|NCT03306264|451093286|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
125399098|NCT03306264|451093287|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
125399099|NCT03306264|451093288|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
125399100|NCT03306264|451093289|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
125399101|NCT00458484|451093290|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
125399102|NCT00458484|451093291|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
125399103|NCT00458484|451093292|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
125399104|NCT00458484|451093293|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
125399105|NCT00458484|451093294|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
125399106|NCT00458484|451093295|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
125399107|NCT00458484|451093296|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
125399108|NCT04538664|451093297|FG000|Overall Study|Withdrawal by Subject|5|||
125399109|NCT04538664|451093298|FG001|Overall Study|Withdrawal by Subject|9|||
125399110|NCT04538664|451093297|FG000|Overall Study|Lost to Follow-up|2|||
125270641|NCT03230318|450619009|FG001|Overall Study|Lost to Follow-up|0|||
125270642|NCT03230318|450619008|FG000|Overall Study|Withdrawal by Subject|1|||
125270643|NCT03230318|450619009|FG001|Overall Study|Withdrawal by Subject|3|||
125270644|NCT03230318|450619008|FG000|Overall Study|Other|3|||
125270645|NCT03230318|450619009|FG001|Overall Study|Other|7|||
125270646|NCT00075764|450619016|FG000|Overall Study|Adverse Event|5|||
125270647|NCT00075764|450619017|FG001|Overall Study|Adverse Event|12|||
125399111|NCT04538664|451093298|FG001|Overall Study|Lost to Follow-up|1|||
125399112|NCT04538664|451093297|FG000|Overall Study|Ongoing|106|||
125399113|NCT04538664|451093298|FG001|Overall Study|Ongoing|115|||
125399114|NCT03431350|451093299|FG000|Overall Study|ONGOING|0|||
125399115|NCT03431350|451093300|FG001|Overall Study|ONGOING|0|||
125270648|NCT00075764|450619016|FG000|Overall Study|Death|4|||
125270649|NCT00075764|450619017|FG001|Overall Study|Death|8|||
125270650|NCT00075764|450619016|FG000|Overall Study|Withdrawal by Subject|28|||
125270651|NCT00075764|450619017|FG001|Overall Study|Withdrawal by Subject|18|||
125270652|NCT00075764|450619016|FG000|Overall Study|Progression|269|||
125270653|NCT00075764|450619017|FG001|Overall Study|Progression|274|||
125270654|NCT00075764|450619016|FG000|Overall Study|Still on treatment|8|||
125270655|NCT00075764|450619017|FG001|Overall Study|Still on treatment|15|||
125270656|NCT00075764|450619016|FG000|Overall Study|Delinquent|4|||
125270657|NCT00075764|450619017|FG001|Overall Study|Delinquent|2|||
125270658|NCT00075764|450619016|FG000|Overall Study|Not protocol specified|27|||
125270659|NCT00075764|450619017|FG001|Overall Study|Not protocol specified|19|||
125270660|NCT00075764|450619016|FG000|Overall Study|Under review|0|||
125270661|NCT00075764|450619017|FG001|Overall Study|Under review|1|||
125270662|NCT02817594|450619018|FG000|Overall Study|Withdrawal by Subject|1|||
125270663|NCT02817594|450619018|FG000|Overall Study|Other|1|||
125270664|NCT02817594|450619018|FG000|Overall Study|Did Not Receive Treatment|1|||
125270665|NCT02010593|450619019|FG000|Overall Study|Lost to Follow-up|1|||
125270666|NCT02010593|450619020|FG001|Overall Study|Lost to Follow-up|0|||
125270667|NCT02010593|450619019|FG000|Overall Study|Physician Decision|1|||
125270668|NCT02010593|450619020|FG001|Overall Study|Physician Decision|0|||
125270669|NCT02010593|450619019|FG000|Overall Study|Unable to adhere to visit schedule|0|||
125270670|NCT02010593|450619020|FG001|Overall Study|Unable to adhere to visit schedule|2|||
125270671|NCT01773967|450619021|FG000|Overall Study|Lost to Follow-up|15|||
125270672|NCT01773967|450619022|FG001|Overall Study|Lost to Follow-up|13|||
125270673|NCT01135459|450619023|FG000|Overall Study|Adverse Event|8|||
125270674|NCT01135459|450619024|FG001|Overall Study|Adverse Event|10|||
125270675|NCT01135459|450619023|FG000|Overall Study|Lack of Efficacy|3|||
125270676|NCT01135459|450619024|FG001|Overall Study|Lack of Efficacy|1|||
125270677|NCT01135459|450619023|FG000|Overall Study|Withdrawal by Subject|2|||
125270678|NCT01135459|450619024|FG001|Overall Study|Withdrawal by Subject|3|||
125270679|NCT01135459|450619023|FG000|Overall Study|Protocol Violation|5|||
125270680|NCT01135459|450619024|FG001|Overall Study|Protocol Violation|3|||
125270681|NCT01135459|450619023|FG000|Overall Study|Lost to Follow-up|2|||
125270682|NCT01135459|450619024|FG001|Overall Study|Lost to Follow-up|1|||
125270683|NCT01135459|450619023|FG000|Overall Study|Non-compliance to study procedures|0|||
125270684|NCT01135459|450619024|FG001|Overall Study|Non-compliance to study procedures|1|||
125270685|NCT01135459|450619023|FG000|Overall Study|Other than specified|1|||
125270686|NCT01135459|450619024|FG001|Overall Study|Other than specified|1|||
125270687|NCT01766037|450619025|FG000|Overall Study|Adverse Event|1|||
125270688|NCT01766037|450619026|FG001|Overall Study|Adverse Event|0|||
125270689|NCT01766037|450619025|FG000|Overall Study|Lack of Efficacy|1|||
125270690|NCT01766037|450619026|FG001|Overall Study|Lack of Efficacy|0|||
125270691|NCT01766037|450619025|FG000|Overall Study|Lost to Follow-up|0|||
125270692|NCT01766037|450619026|FG001|Overall Study|Lost to Follow-up|10|||
125270693|NCT01766037|450619025|FG000|Overall Study|Physician Decision|0|||
125270694|NCT01766037|450619026|FG001|Overall Study|Physician Decision|1|||
125270695|NCT01766037|450619025|FG000|Overall Study|Withdrawal by Subject|18|||
125270696|NCT01766037|450619026|FG001|Overall Study|Withdrawal by Subject|16|||
125270697|NCT01766037|450619025|FG000|Overall Study|Moved from area|5|||
125270698|NCT01766037|450619026|FG001|Overall Study|Moved from area|0|||
125270699|NCT01766037|450619025|FG000|Overall Study|medical - unrelated|1|||
125270700|NCT01766037|450619026|FG001|Overall Study|medical - unrelated|2|||
125270701|NCT01766037|450619025|FG000|Overall Study|nausea / discomfort|3|||
125270702|NCT01766037|450619026|FG001|Overall Study|nausea / discomfort|0|||
125270703|NCT02413996|450619027|FG000|Overall Study|not comfortable with the intervention|9|||
125270704|NCT02413996|450619028|FG001|Overall Study|not comfortable with the intervention|2|||
125270705|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
125270706|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
125270707|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
125270708|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
125270709|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
125270710|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
125270711|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
125270712|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
125270713|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
125270714|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
125270715|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
125270716|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
125270717|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
125270718|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
125270719|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
125270720|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
125270721|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
125270722|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
125270723|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
125270724|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
125270725|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
125270726|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
125270727|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
125270728|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
125270729|NCT01672879|450619029|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
125270730|NCT01672879|450619030|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
125270731|NCT01672879|450619031|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
125270732|NCT01672879|450619029|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
125270733|NCT01672879|450619030|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
125270734|NCT01672879|450619031|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
125270735|NCT01672879|450619029|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
125270736|NCT01672879|450619030|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
125270737|NCT01672879|450619031|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
125270738|NCT01672879|450619029|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
125270739|NCT01672879|450619030|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
125270740|NCT01672879|450619031|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
125270741|NCT01672879|450619029|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
125270742|NCT01672879|450619030|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
125270743|NCT01672879|450619031|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
125270744|NCT01871545|450619032|FG000|Overall Study|Death|2|||
125270745|NCT01871545|450619033|FG001|Overall Study|Death|0|||
125270746|NCT01871545|450619032|FG000|Overall Study|Lack of Efficacy|11|||
125270747|NCT01871545|450619033|FG001|Overall Study|Lack of Efficacy|2|||
125270748|NCT01871545|450619032|FG000|Overall Study|Physician Decision|4|||
125270749|NCT01871545|450619033|FG001|Overall Study|Physician Decision|0|||
125270750|NCT01871545|450619032|FG000|Overall Study|Withdrawal by Subject|0|||
125270751|NCT01871545|450619033|FG001|Overall Study|Withdrawal by Subject|1|||
125270752|NCT04834726|450619036|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
125270753|NCT04834726|450619037|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
125270754|NCT04834726|450619038|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
125270755|NCT04834726|450619039|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
125270756|NCT04834726|450619040|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
125270757|NCT04834726|450619041|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
125270758|NCT04834726|450619042|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
125270759|NCT04834726|450619043|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
125270760|NCT04834726|450619044|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
125270761|NCT02948582|450619047|FG000|Washout Period 1|Adverse Event|0|||
125270762|NCT02948582|450619048|FG001|Washout Period 1|Adverse Event|2|||
125270763|NCT02948582|450619049|FG002|Washout Period 1|Adverse Event|0|||
125270764|NCT02948582|450619050|FG003|Washout Period 1|Adverse Event|0|||
125270765|NCT02948582|450619051|FG004|Washout Period 1|Adverse Event|0|||
125270766|NCT02948582|450619052|FG005|Washout Period 1|Adverse Event|0|||
125270767|NCT02948582|450619047|FG000|Washout Period 1|Protocol Violation|0|||
125270768|NCT02948582|450619048|FG001|Washout Period 1|Protocol Violation|0|||
125270769|NCT02948582|450619049|FG002|Washout Period 1|Protocol Violation|0|||
125270770|NCT02948582|450619050|FG003|Washout Period 1|Protocol Violation|0|||
125270771|NCT02948582|450619051|FG004|Washout Period 1|Protocol Violation|0|||
125270772|NCT02948582|450619052|FG005|Washout Period 1|Protocol Violation|1|||
125270773|NCT02948582|450619047|FG000|Washout Period 2|Adverse Event|0|||
125270774|NCT02948582|450619048|FG001|Washout Period 2|Adverse Event|1|||
125270775|NCT02948582|450619049|FG002|Washout Period 2|Adverse Event|0|||
125270776|NCT02948582|450619050|FG003|Washout Period 2|Adverse Event|0|||
125270777|NCT02948582|450619051|FG004|Washout Period 2|Adverse Event|0|||
125270778|NCT02948582|450619052|FG005|Washout Period 2|Adverse Event|0|||
125270779|NCT02948582|450619047|FG000|Washout Period 2|personal reasons|0|||
125270780|NCT02948582|450619048|FG001|Washout Period 2|personal reasons|0|||
125270781|NCT02948582|450619049|FG002|Washout Period 2|personal reasons|0|||
125270782|NCT02948582|450619050|FG003|Washout Period 2|personal reasons|1|||
125270783|NCT02948582|450619051|FG004|Washout Period 2|personal reasons|0|||
125270784|NCT02948582|450619052|FG005|Washout Period 2|personal reasons|0|||
125270785|NCT02948582|450619047|FG000|Washout Period 4|Adverse Event|1|||
125270786|NCT02948582|450619048|FG001|Washout Period 4|Adverse Event|0|||
125270787|NCT02948582|450619049|FG002|Washout Period 4|Adverse Event|1|||
125270788|NCT02948582|450619050|FG003|Washout Period 4|Adverse Event|0|||
125270789|NCT02948582|450619051|FG004|Washout Period 4|Adverse Event|0|||
125270790|NCT02948582|450619052|FG005|Washout Period 4|Adverse Event|0|||
125270791|NCT03810014|450619053|FG000|Overall Study|Pregnancy|2|||
125270792|NCT03810014|450619054|FG001|Overall Study|Pregnancy|2|||
125399116|NCT03431350|451093301|FG002|Overall Study|ONGOING|2|||
125270793|NCT03810014|450619055|FG002|Overall Study|Pregnancy|0|||
125399117|NCT03431350|451093302|FG003|Overall Study|ONGOING|0|||
125270794|NCT03810014|450619056|FG003|Overall Study|Pregnancy|2|||
125270795|NCT01853462|450619060|FG000|Overall Study|Withdrawal by Subject|1|||
125270796|NCT01853462|450619061|FG001|Overall Study|Withdrawal by Subject|1|||
125270797|NCT02148263|450619062|FG000|Overall Study|Withdrawal by Subject|3|||
125270798|NCT02148263|450619063|FG001|Overall Study|Withdrawal by Subject|2|||
125270799|NCT00132301|450619064|FG000|Overall Study|Death|7|||
125270800|NCT00132301|450619065|FG001|Overall Study|Death|6|||
125270801|NCT00132301|450619064|FG000|Overall Study|Withdrawal by Subject|5|||
125270802|NCT00132301|450619065|FG001|Overall Study|Withdrawal by Subject|2|||
125270803|NCT00132301|450619064|FG000|Overall Study|Physician Decision|1|||
125270804|NCT00132301|450619065|FG001|Overall Study|Physician Decision|1|||
125270805|NCT00132301|450619064|FG000|Overall Study|Lost to Follow-up|5|||
125270806|NCT00132301|450619065|FG001|Overall Study|Lost to Follow-up|3|||
125270807|NCT00132301|450619064|FG000|Overall Study|Other|1|||
125270808|NCT00132301|450619065|FG001|Overall Study|Other|1|||
125270809|NCT00132301|450619064|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
125270810|NCT00132301|450619065|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
125270811|NCT02012218|450619066|FG000|Overall Study|Withdrawal by Subject|1|||
125270812|NCT02012218|450619067|FG001|Overall Study|Withdrawal by Subject|0|||
125270813|NCT02012218|450619068|FG002|Overall Study|Withdrawal by Subject|1|||
125270814|NCT02012218|450619069|FG003|Overall Study|Withdrawal by Subject|1|||
125270815|NCT02012218|450619070|FG004|Overall Study|Withdrawal by Subject|1|||
125270816|NCT02012218|450619066|FG000|Overall Study|Adverse Event|1|||
125270817|NCT02012218|450619067|FG001|Overall Study|Adverse Event|0|||
125270818|NCT02012218|450619068|FG002|Overall Study|Adverse Event|0|||
125270819|NCT02012218|450619069|FG003|Overall Study|Adverse Event|1|||
125270820|NCT02012218|450619070|FG004|Overall Study|Adverse Event|0|||
125270821|NCT02012218|450619066|FG000|Overall Study|Lost to Follow-up|0|||
125270822|NCT02012218|450619067|FG001|Overall Study|Lost to Follow-up|1|||
125270823|NCT02012218|450619068|FG002|Overall Study|Lost to Follow-up|1|||
125270824|NCT02012218|450619069|FG003|Overall Study|Lost to Follow-up|0|||
125270825|NCT02012218|450619070|FG004|Overall Study|Lost to Follow-up|0|||
125270826|NCT02012218|450619066|FG000|Overall Study|Protocol Specified|1|||
125270827|NCT02012218|450619067|FG001|Overall Study|Protocol Specified|0|||
125270828|NCT02012218|450619068|FG002|Overall Study|Protocol Specified|0|||
125270829|NCT02012218|450619069|FG003|Overall Study|Protocol Specified|0|||
125270830|NCT02012218|450619070|FG004|Overall Study|Protocol Specified|0|||
125270831|NCT02012218|450619066|FG000|Overall Study|Protocol Deviation|1|||
125270832|NCT02012218|450619067|FG001|Overall Study|Protocol Deviation|0|||
125270833|NCT02012218|450619068|FG002|Overall Study|Protocol Deviation|0|||
125270834|NCT02012218|450619069|FG003|Overall Study|Protocol Deviation|0|||
125270835|NCT02012218|450619070|FG004|Overall Study|Protocol Deviation|0|||
125270836|NCT02720523|450619076|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
125270837|NCT02720523|450619077|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
125270838|NCT02720523|450619078|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
125270839|NCT02720523|450619079|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
125270840|NCT02720523|450619080|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
125270841|NCT02720523|450619081|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
125270842|NCT02720523|450619082|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
125270843|NCT02720523|450619076|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
125270844|NCT02720523|450619077|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125270845|NCT02720523|450619078|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125270846|NCT02720523|450619079|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125270847|NCT02720523|450619080|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125270848|NCT02720523|450619081|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125270849|NCT02720523|450619082|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
125270850|NCT02720523|450619076|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
125270851|NCT02720523|450619077|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
125270852|NCT02720523|450619078|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
125270853|NCT02720523|450619079|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
125270854|NCT02720523|450619080|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
125270855|NCT02720523|450619081|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
125270856|NCT02720523|450619082|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
125270857|NCT02720523|450619076|FG000|Period 1: Placebo-controlled Period|Other|0|||
125270858|NCT02720523|450619077|FG001|Period 1: Placebo-controlled Period|Other|0|||
125270859|NCT02720523|450619078|FG002|Period 1: Placebo-controlled Period|Other|1|||
125270860|NCT02720523|450619079|FG003|Period 1: Placebo-controlled Period|Other|1|||
125270861|NCT02720523|450619080|FG004|Period 1: Placebo-controlled Period|Other|0|||
125270862|NCT02720523|450619081|FG005|Period 1: Placebo-controlled Period|Other|0|||
125270863|NCT02720523|450619082|FG006|Period 1: Placebo-controlled Period|Other|0|||
125270864|NCT02720523|450619076|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
125270865|NCT02720523|450619077|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
125270866|NCT02720523|450619078|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
125399118|NCT03431350|451093303|FG004|Overall Study|ONGOING|1|||
125399119|NCT03431350|451093304|FG005|Overall Study|ONGOING|3|||
125270867|NCT02720523|450619079|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
125270868|NCT02720523|450619080|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
125270869|NCT02720523|450619081|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
125270870|NCT02720523|450619082|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
125270871|NCT02720523|450619076|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
125270872|NCT02720523|450619077|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
125270873|NCT02720523|450619078|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
125270874|NCT02720523|450619079|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
125270875|NCT02720523|450619080|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
125270876|NCT02720523|450619081|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
125270877|NCT02720523|450619082|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
125270878|NCT02720523|450619076|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
125270879|NCT02720523|450619077|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
125270880|NCT02720523|450619078|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
125270881|NCT02720523|450619079|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
125270882|NCT02720523|450619080|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
125270883|NCT02720523|450619081|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
125270884|NCT02720523|450619082|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
125270885|NCT02720523|450619076|FG000|Period 2: Long-term Extension Period|Other|0|||
125270886|NCT02720523|450619077|FG001|Period 2: Long-term Extension Period|Other|0|||
125270887|NCT02720523|450619078|FG002|Period 2: Long-term Extension Period|Other|0|||
125270888|NCT02720523|450619079|FG003|Period 2: Long-term Extension Period|Other|0|||
125270889|NCT02720523|450619080|FG004|Period 2: Long-term Extension Period|Other|2|||
125270890|NCT02720523|450619081|FG005|Period 2: Long-term Extension Period|Other|0|||
125270891|NCT02720523|450619082|FG006|Period 2: Long-term Extension Period|Other|3|||
125270892|NCT03929913|450619086|FG000|Overall Study|Death|4|||
125270893|NCT03929913|450619086|FG000|Overall Study|Lost to Follow-up|1|||
125270894|NCT03929913|450619086|FG000|Overall Study|Failed Procedure|2|||
125270895|NCT01154452|450619087|FG000|Phase Ib|Not Treated|1|||
125270896|NCT01154452|450619088|FG001|Phase Ib|Not Treated|0|||
125270897|NCT01154452|450619089|FG002|Phase Ib|Not Treated|0|||
125270898|NCT01154452|450619090|FG003|Phase Ib|Not Treated|0|||
125270899|NCT01154452|450619087|FG000|Phase Ib|Adverse Event|2|||
125270900|NCT01154452|450619088|FG001|Phase Ib|Adverse Event|1|||
125270901|NCT01154452|450619089|FG002|Phase Ib|Adverse Event|0|||
125270902|NCT01154452|450619090|FG003|Phase Ib|Adverse Event|0|||
125270903|NCT01154452|450619087|FG000|Phase II|Withdrawal by Subject|0|||
125270904|NCT01154452|450619088|FG001|Phase II|Withdrawal by Subject|0|||
125270905|NCT01154452|450619089|FG002|Phase II|Withdrawal by Subject|1|||
125270906|NCT01154452|450619090|FG003|Phase II|Withdrawal by Subject|2|||
125270907|NCT01154452|450619087|FG000|Phase II|Adverse Event|0|||
125270908|NCT01154452|450619088|FG001|Phase II|Adverse Event|0|||
125270909|NCT01154452|450619089|FG002|Phase II|Adverse Event|4|||
125270910|NCT01154452|450619090|FG003|Phase II|Adverse Event|4|||
125270911|NCT03381287|450619091|FG000|Overall Study|Withdrawal by Subject|0|||
125270912|NCT03381287|450619092|FG001|Overall Study|Withdrawal by Subject|1|||
125270913|NCT03381287|450619093|FG002|Overall Study|Withdrawal by Subject|0|||
125270914|NCT03381287|450619094|FG003|Overall Study|Withdrawal by Subject|0|||
125270915|NCT03381287|450619091|FG000|Overall Study|Adverse Event|0|||
125270916|NCT03381287|450619092|FG001|Overall Study|Adverse Event|0|||
125270917|NCT03381287|450619093|FG002|Overall Study|Adverse Event|0|||
125270918|NCT03381287|450619094|FG003|Overall Study|Adverse Event|1|||
125270919|NCT03381287|450619091|FG000|Overall Study|Physician Decision|0|||
125270920|NCT03381287|450619092|FG001|Overall Study|Physician Decision|0|||
125270921|NCT03381287|450619093|FG002|Overall Study|Physician Decision|0|||
125270922|NCT03381287|450619094|FG003|Overall Study|Physician Decision|1|||
125270923|NCT01102491|450619095|FG000|Overall Study|Protocol Violation|11|||
125270924|NCT01102491|450619096|FG001|Overall Study|Protocol Violation|12|||
125270925|NCT01265992|450619097|FG000|Overall Study|Lost to Follow-up|1|||
125270926|NCT01265992|450619097|FG000|Overall Study|Withdrawal by Subject|1|||
125270927|NCT01265992|450619097|FG000|Overall Study|Adverse Event|1|||
125270928|NCT01265992|450619097|FG000|Overall Study|Administrative reasons|2|||
125270929|NCT01265992|450619097|FG000|Overall Study|Stopped treatment|3|||
125270930|NCT01265992|450619097|FG000|Overall Study|Did not receive treatment|1|||
125270931|NCT01837680|450619100|FG000|Overall Study|Lost to Follow-up|2|||
125270932|NCT01837680|450619101|FG001|Overall Study|Lost to Follow-up|2|||
125270933|NCT01837680|450619100|FG000|Overall Study|lack of insurance|0|||
125270934|NCT01837680|450619101|FG001|Overall Study|lack of insurance|2|||
125270935|NCT01837680|450619100|FG000|Overall Study|allergic reaction|6|||
125270936|NCT01837680|450619101|FG001|Overall Study|allergic reaction|0|||
125270937|NCT01837680|450619100|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
125270938|NCT01837680|450619101|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
125270939|NCT02297815|450620447|FG000|Overall Study|Lost to Follow-up|236|||
125270940|NCT02297815|450620448|FG001|Overall Study|Lost to Follow-up|140|||
125270941|NCT00566982|450620449|FG000|Overall Study|Adverse Event|6|||
125270942|NCT00566982|450620450|FG001|Overall Study|Adverse Event|48|||
125270943|NCT00566982|450620449|FG000|Overall Study|Withdrawal by Subject|1|||
125270944|NCT00566982|450620450|FG001|Overall Study|Withdrawal by Subject|14|||
125270945|NCT00566982|450620449|FG000|Overall Study|Protocol Violation|1|||
125270946|NCT00566982|450620450|FG001|Overall Study|Protocol Violation|4|||
125270947|NCT00566982|450620449|FG000|Overall Study|Lost to Follow-up|0|||
125270948|NCT00566982|450620450|FG001|Overall Study|Lost to Follow-up|1|||
125270949|NCT00566982|450620449|FG000|Overall Study|Other-family problems & doctor's request|0|||
125270950|NCT00566982|450620450|FG001|Overall Study|Other-family problems & doctor's request|2|||
125270951|NCT02197572|450620453|FG000|Overall Study|Progressive Disease|28|||
125270952|NCT02197572|450620453|FG000|Overall Study|Withdrawal by Subject|9|||
125270953|NCT02197572|450620453|FG000|Overall Study|Adverse Event|3|||
125270954|NCT02197572|450620453|FG000|Overall Study|Reason Not Specified|4|||
125270955|NCT02840253|450620454|FG000|Overall Study|Unsuccessful block|4|||
125270956|NCT00473889|450620455|FG000|Overall Study|Did not receive study medication|1|||
125270957|NCT00473889|450620456|FG001|Overall Study|Did not receive study medication|4|||
125270958|NCT00473889|450620455|FG000|Overall Study|Adverse Event|30|||
125270959|NCT00473889|450620456|FG001|Overall Study|Adverse Event|17|||
125270960|NCT00473889|450620455|FG000|Overall Study|Protocol Violation|4|||
125270961|NCT00473889|450620456|FG001|Overall Study|Protocol Violation|2|||
125270962|NCT00473889|450620455|FG000|Overall Study|Lack of Efficacy|28|||
125270963|NCT00473889|450620456|FG001|Overall Study|Lack of Efficacy|29|||
125270964|NCT00473889|450620455|FG000|Overall Study|Lost to Follow-up|2|||
125270965|NCT00473889|450620456|FG001|Overall Study|Lost to Follow-up|1|||
125270966|NCT00473889|450620455|FG000|Overall Study|Physician Decision|10|||
125270967|NCT00473889|450620456|FG001|Overall Study|Physician Decision|5|||
125270968|NCT00473889|450620455|FG000|Overall Study|Trial Terminated|3|||
125270969|NCT00473889|450620456|FG001|Overall Study|Trial Terminated|6|||
125270970|NCT00473889|450620455|FG000|Overall Study|Withdrawal by Subject|5|||
125270971|NCT00473889|450620456|FG001|Overall Study|Withdrawal by Subject|0|||
125270972|NCT03783962|450620457|FG000|Overall Study|Lost to Follow-up|3|||
125270973|NCT03783962|450620458|FG001|Overall Study|Lost to Follow-up|6|||
125270974|NCT03783962|450620457|FG000|Overall Study|Protocol Violation|0|||
125270975|NCT03783962|450620458|FG001|Overall Study|Protocol Violation|1|||
125270976|NCT03458325|450620459|FG000|Overall Study|Withdrawal by Subject|1|||
125270977|NCT01724216|450620468|FG000|Overall Study|Scan was not completed|1|||
125270978|NCT00175916|450620469|FG000|Overall Study|Death|19|||
125270979|NCT00175916|450620469|FG000|Overall Study|Adverse Event|81|||
125270980|NCT00175916|450620469|FG000|Overall Study|Lack of Efficacy|354|||
125270981|NCT00175916|450620469|FG000|Overall Study|Lost to Follow-up|17|||
125270982|NCT00175916|450620469|FG000|Overall Study|Subject Choice|98|||
125270983|NCT00175916|450620469|FG000|Overall Study|Lack of compliance|8|||
125270984|NCT00175916|450620469|FG000|Overall Study|Patient cannot record seizures|1|||
125270985|NCT00175916|450620469|FG000|Overall Study|Sponsor decision|17|||
125270986|NCT00175916|450620469|FG000|Overall Study|Vigabatrin intake|1|||
125270987|NCT00175916|450620469|FG000|Overall Study|Suicidal behaviour|1|||
125270988|NCT00175916|450620469|FG000|Overall Study|Withdrawal by Subject|1|||
125270989|NCT00175916|450620469|FG000|Overall Study|Seizure - free|4|||
125270990|NCT00175916|450620469|FG000|Overall Study|Administrative reason|1|||
125270991|NCT00175916|450620469|FG000|Overall Study|Pregnancy|1|||
125270992|NCT00175916|450620469|FG000|Overall Study|Patient's request|2|||
125270993|NCT00175916|450620469|FG000|Overall Study|Treating physiciant's choice|1|||
125270994|NCT00175916|450620469|FG000|Overall Study|Moved overseas|1|||
125270995|NCT00175916|450620469|FG000|Overall Study|Loss of job and economic burden|1|||
125270996|NCT00175916|450620469|FG000|Overall Study|Site was closed|9|||
125270997|NCT00175916|450620469|FG000|Overall Study|Patient went to prison|1|||
125270998|NCT01014767|450620470|FG000|Overall Study|PI left institution, data unavailable|12|||
125270999|NCT01014767|450620471|FG001|Overall Study|PI left institution, data unavailable|1|||
125271000|NCT01014767|450620472|FG002|Overall Study|PI left institution, data unavailable|4|||
125271001|NCT01014767|450620473|FG003|Overall Study|PI left institution, data unavailable|1|||
125271002|NCT00564733|450620474|FG000|Overall Study|Withdrawal by Subject|4|||
125271003|NCT00564733|450620474|FG000|Overall Study|Ineligible|5|||
125271004|NCT00310375|450620479|FG000|Primary Reporting Phase|Adverse Event|28|||
125271005|NCT00310375|450620480|FG001|Primary Reporting Phase|Adverse Event|22|||
125271006|NCT00310375|450620481|FG002|Primary Reporting Phase|Adverse Event|0|||
125271007|NCT00310375|450620479|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
125271008|NCT00310375|450620480|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
125271009|NCT00310375|450620481|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
125271010|NCT00310375|450620479|FG000|Primary Reporting Phase|Pregnancy|2|||
125271011|NCT00310375|450620480|FG001|Primary Reporting Phase|Pregnancy|2|||
125271012|NCT00310375|450620481|FG002|Primary Reporting Phase|Pregnancy|0|||
125271013|NCT00310375|450620479|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
125271014|NCT00310375|450620480|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
125271015|NCT00310375|450620481|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
125271016|NCT00310375|450620479|FG000|Primary Reporting Phase|Protocol Violation|8|||
125271017|NCT00310375|450620480|FG001|Primary Reporting Phase|Protocol Violation|5|||
125271018|NCT00310375|450620481|FG002|Primary Reporting Phase|Protocol Violation|0|||
125271019|NCT00310375|450620479|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
125271020|NCT00310375|450620480|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
125271021|NCT00310375|450620481|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
125271022|NCT00310375|450620479|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
125271023|NCT00310375|450620480|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
125271024|NCT00310375|450620481|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
125271025|NCT00310375|450620479|FG000|Primary Reporting Phase|Physician Decision|5|||
125271026|NCT00310375|450620480|FG001|Primary Reporting Phase|Physician Decision|3|||
125271027|NCT00310375|450620481|FG002|Primary Reporting Phase|Physician Decision|0|||
125271028|NCT00310375|450620479|FG000|Primary Reporting Phase|Request of the sponsor|2|||
125271029|NCT00310375|450620480|FG001|Primary Reporting Phase|Request of the sponsor|2|||
125271030|NCT00310375|450620481|FG002|Primary Reporting Phase|Request of the sponsor|0|||
125271031|NCT00310375|450620479|FG000|Primary Reporting Phase|Failed to return|1|||
125271032|NCT00310375|450620480|FG001|Primary Reporting Phase|Failed to return|3|||
125271033|NCT00310375|450620481|FG002|Primary Reporting Phase|Failed to return|0|||
125271034|NCT00310375|450620479|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
125271035|NCT00310375|450620480|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
125271036|NCT00310375|450620481|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
125271037|NCT00310375|450620479|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
125271038|NCT00310375|450620480|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
125271039|NCT00310375|450620481|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
125271040|NCT00310375|450620479|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
125271041|NCT00310375|450620480|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
125271042|NCT00310375|450620481|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
125271043|NCT00310375|450620479|FG000|Primary Reporting Phase|Site closure|3|||
125271044|NCT00310375|450620480|FG001|Primary Reporting Phase|Site closure|0|||
125271045|NCT00310375|450620481|FG002|Primary Reporting Phase|Site closure|0|||
125271046|NCT00310375|450620479|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
125271047|NCT00310375|450620480|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
125271048|NCT00310375|450620481|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
125271049|NCT00310375|450620479|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
125271050|NCT00310375|450620480|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
125271051|NCT00310375|450620481|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
125271052|NCT00310375|450620479|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
125271053|NCT00310375|450620480|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
125271054|NCT00310375|450620481|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
125271055|NCT00310375|450620479|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
125271056|NCT00310375|450620480|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
125271057|NCT00310375|450620481|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
125271058|NCT00573391|450620482|FG000|Overall Study|study stopped|2|||
125271059|NCT00573391|450620483|FG001|Overall Study|study stopped|2|||
125271060|NCT00573391|450620482|FG000|Overall Study|Death|1|||
125271061|NCT00573391|450620483|FG001|Overall Study|Death|0|||
125271062|NCT00131352|450620484|FG000|Initial Treatment Period|Adverse Event|1|||
125271063|NCT00131352|450620485|FG001|Initial Treatment Period|Adverse Event|3|||
125271064|NCT00131352|450620484|FG000|Initial Treatment Period|Non-compliant|1|||
125271065|NCT00131352|450620485|FG001|Initial Treatment Period|Non-compliant|2|||
125271066|NCT00131352|450620484|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
125271067|NCT00131352|450620485|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
125271068|NCT00131352|450620484|FG000|Initial Treatment Period|Lack of Efficacy|6|||
125271069|NCT00131352|450620485|FG001|Initial Treatment Period|Lack of Efficacy|4|||
125271070|NCT00131352|450620484|FG000|Initial Treatment Period|Other|0|||
125271071|NCT00131352|450620485|FG001|Initial Treatment Period|Other|2|||
125271072|NCT00131352|450620484|FG000|Repeat Treatment Period|Adverse Event|1|||
125271073|NCT00131352|450620485|FG001|Repeat Treatment Period|Adverse Event|0|||
125271074|NCT00131352|450620484|FG000|Repeat Treatment Period|Other|1|||
125271075|NCT00131352|450620485|FG001|Repeat Treatment Period|Other|0|||
125271076|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
125271077|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
125271078|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271079|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271080|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271081|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271082|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271083|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271084|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271085|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
125271086|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
125271087|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
125271088|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271089|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271090|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125399120|NCT03431350|451093305|FG006|Overall Study|ONGOING|0|||
125399121|NCT03431350|451093306|FG007|Overall Study|ONGOING|1|||
125399122|NCT03431350|451093307|FG008|Overall Study|ONGOING|3|||
125399123|NCT03431350|451093308|FG009|Overall Study|ONGOING|4|||
125399124|NCT03431350|451093309|FG010|Overall Study|ONGOING|2|||
125399125|NCT03431350|451093310|FG011|Overall Study|ONGOING|1|||
125399126|NCT03431350|451093299|FG000|Overall Study|Death|6|||
125399127|NCT03431350|451093300|FG001|Overall Study|Death|5|||
125399128|NCT03431350|451093301|FG002|Overall Study|Death|18|||
125399129|NCT03431350|451093302|FG003|Overall Study|Death|7|||
125399130|NCT03431350|451093303|FG004|Overall Study|Death|4|||
125399131|NCT03431350|451093304|FG005|Overall Study|Death|3|||
125399132|NCT03431350|451093305|FG006|Overall Study|Death|2|||
125399133|NCT03431350|451093306|FG007|Overall Study|Death|0|||
125399134|NCT03431350|451093307|FG008|Overall Study|Death|0|||
125399135|NCT03431350|451093308|FG009|Overall Study|Death|0|||
125399136|NCT03431350|451093309|FG010|Overall Study|Death|4|||
125399137|NCT03431350|451093310|FG011|Overall Study|Death|0|||
125399138|NCT03431350|451093299|FG000|Overall Study|Lost to Follow-up|0|||
125399139|NCT03431350|451093300|FG001|Overall Study|Lost to Follow-up|1|||
125399140|NCT03431350|451093301|FG002|Overall Study|Lost to Follow-up|0|||
125399141|NCT03431350|451093302|FG003|Overall Study|Lost to Follow-up|0|||
125399142|NCT03431350|451093303|FG004|Overall Study|Lost to Follow-up|0|||
125399143|NCT03431350|451093304|FG005|Overall Study|Lost to Follow-up|0|||
125399144|NCT03431350|451093305|FG006|Overall Study|Lost to Follow-up|0|||
125399145|NCT03431350|451093306|FG007|Overall Study|Lost to Follow-up|0|||
125399146|NCT03431350|451093307|FG008|Overall Study|Lost to Follow-up|0|||
125399147|NCT03431350|451093308|FG009|Overall Study|Lost to Follow-up|0|||
125399148|NCT03431350|451093309|FG010|Overall Study|Lost to Follow-up|0|||
125271091|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271092|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271093|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271094|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271095|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
125271096|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
125271097|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271098|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271099|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271100|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271101|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271102|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271103|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271104|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271105|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
125271106|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
125271107|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
125271108|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271109|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271110|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271111|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271112|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271113|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271114|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271115|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
125271116|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271117|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
125271118|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271119|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271120|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271121|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271122|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271123|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271124|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271125|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
125271126|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
125399149|NCT03431350|451093310|FG011|Overall Study|Lost to Follow-up|0|||
125399150|NCT03431350|451093299|FG000|Overall Study|Withdrawal by Subject|0|||
125399151|NCT03431350|451093300|FG001|Overall Study|Withdrawal by Subject|0|||
125399152|NCT03431350|451093301|FG002|Overall Study|Withdrawal by Subject|0|||
125399153|NCT03431350|451093302|FG003|Overall Study|Withdrawal by Subject|1|||
125399154|NCT03431350|451093303|FG004|Overall Study|Withdrawal by Subject|1|||
125399155|NCT03431350|451093304|FG005|Overall Study|Withdrawal by Subject|1|||
125399156|NCT03431350|451093305|FG006|Overall Study|Withdrawal by Subject|0|||
125399157|NCT03431350|451093306|FG007|Overall Study|Withdrawal by Subject|0|||
125399158|NCT03431350|451093307|FG008|Overall Study|Withdrawal by Subject|0|||
125399159|NCT03431350|451093308|FG009|Overall Study|Withdrawal by Subject|2|||
125399160|NCT03431350|451093309|FG010|Overall Study|Withdrawal by Subject|0|||
125399161|NCT03431350|451093310|FG011|Overall Study|Withdrawal by Subject|1|||
125271127|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
125271128|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271129|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271130|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271131|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271132|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271133|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271134|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271135|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
125271136|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
125271137|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
125271138|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271139|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271140|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125399162|NCT03431350|451093299|FG000|Overall Study|Other|0|||
125271141|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271142|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271143|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271144|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271145|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
125271146|NCT01194219|450620486|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
125271147|NCT01194219|450620487|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
125271148|NCT01194219|450620488|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271149|NCT01194219|450620489|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271150|NCT01194219|450620490|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271151|NCT01194219|450620491|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271152|NCT01194219|450620492|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271153|NCT01194219|450620493|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271154|NCT01194219|450620494|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271155|NCT01194219|450620495|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
125271156|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271157|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271158|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
125271159|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
125271160|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271161|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271162|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271163|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271164|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271165|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
125271166|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271167|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271168|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
125271169|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
125271170|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271171|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271172|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271173|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271174|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271175|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
125271176|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271177|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271178|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
125271179|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
125271180|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271181|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271182|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271183|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271184|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271185|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
125271186|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125399163|NCT03431350|451093300|FG001|Overall Study|Other|0|||
125399164|NCT03431350|451093301|FG002|Overall Study|Other|1|||
125271187|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271188|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
125271189|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
125271190|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271191|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271192|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271193|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271194|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271195|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
125271196|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271197|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271198|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
125271199|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125399165|NCT03431350|451093302|FG003|Overall Study|Other|3|||
125399166|NCT03431350|451093303|FG004|Overall Study|Other|2|||
125399167|NCT03431350|451093304|FG005|Overall Study|Other|2|||
125399168|NCT03431350|451093305|FG006|Overall Study|Other|4|||
125399169|NCT03431350|451093306|FG007|Overall Study|Other|0|||
125399170|NCT03431350|451093307|FG008|Overall Study|Other|14|||
125399171|NCT03431350|451093308|FG009|Overall Study|Other|11|||
125399172|NCT03431350|451093309|FG010|Overall Study|Other|11|||
125447675|NCT02322775|451264864|FG001|Overall Study|Not willing to perform all FU visits|1|||
125447676|NCT02507219|451264871|FG000|Overall Study|Physician Decision|1|||
125447677|NCT02507219|451264872|FG001|Overall Study|Physician Decision|0|||
125447678|NCT02507219|451264873|FG002|Overall Study|Physician Decision|0|||
125271200|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271201|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271202|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271203|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271204|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271205|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
125271206|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271207|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271208|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271209|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
125271210|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271211|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271212|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271213|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271214|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271215|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
125271216|NCT01194219|450620486|FG000|Maintenance Phase Weeks16-32|Other|0|||
125271217|NCT01194219|450620487|FG001|Maintenance Phase Weeks16-32|Other|0|||
125271218|NCT01194219|450620488|FG002|Maintenance Phase Weeks16-32|Other|2|||
125271219|NCT01194219|450620489|FG003|Maintenance Phase Weeks16-32|Other|1|||
125271220|NCT01194219|450620490|FG004|Maintenance Phase Weeks16-32|Other|0|||
125271221|NCT01194219|450620491|FG005|Maintenance Phase Weeks16-32|Other|0|||
125271222|NCT01194219|450620492|FG006|Maintenance Phase Weeks16-32|Other|0|||
125271223|NCT01194219|450620493|FG007|Maintenance Phase Weeks16-32|Other|0|||
125271224|NCT01194219|450620494|FG008|Maintenance Phase Weeks16-32|Other|0|||
125271225|NCT01194219|450620495|FG009|Maintenance Phase Weeks16-32|Other|0|||
125271226|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271227|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271228|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271229|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271230|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271231|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
125271232|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
125271233|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
125271234|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271235|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
125271236|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
125271237|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
125271238|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
125271239|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
125271240|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
125399173|NCT03431350|451093310|FG011|Overall Study|Other|15|||
125399174|NCT04325828|451093311|FG000|Overall Study|Ongoing|26|||
125399175|NCT04602624|451093316|FG000|Overall Study|Protocol Deviation|1|||
125399176|NCT04602624|451093316|FG000|Overall Study|Withdrawal by Participant|1|||
125399177|NCT04084769|451093317|FG000|Overall Study|Protocol Violation|1|||
125399178|NCT04084769|451093318|FG001|Overall Study|Protocol Violation|3|||
125271241|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
125271242|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
125271243|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
125271244|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
125271245|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
125271246|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271247|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271248|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271249|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271250|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
125271251|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271252|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
125271253|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271254|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271255|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
125271256|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271257|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271258|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271259|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271260|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
125271261|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271262|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
125271263|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
125271264|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271265|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
125271266|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271267|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271268|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271269|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271270|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
125271271|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
125271272|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
125271273|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271274|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271275|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
125271276|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271277|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271278|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271279|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271280|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271281|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271282|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271283|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
125271284|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271285|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
125271286|NCT01194219|450620486|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271287|NCT01194219|450620487|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271288|NCT01194219|450620488|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271289|NCT01194219|450620489|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271290|NCT01194219|450620490|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271291|NCT01194219|450620491|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271292|NCT01194219|450620492|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
125271293|NCT01194219|450620493|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271294|NCT01194219|450620494|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271295|NCT01194219|450620495|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
125271296|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271297|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271298|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271299|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125399179|NCT04084769|451093319|FG002|Overall Study|Protocol Violation|0|||
125271300|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271301|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271302|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271303|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
125271304|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
125271305|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
125271306|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271307|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271308|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271309|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271310|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271311|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271312|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271313|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
125271314|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
125271315|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
125271316|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271317|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271318|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271319|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271320|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271321|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271322|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271323|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
125271324|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
125271325|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
125271326|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271327|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271328|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271329|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271330|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271331|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271332|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271333|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
125271334|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
125271335|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
125271336|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
125271337|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
125271338|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
125271339|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
125271340|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
125271341|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
125271342|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
125271343|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
125271344|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
125271345|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
125271346|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271347|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271348|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271349|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271350|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271351|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271352|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271353|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
125271354|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
125271355|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
125271356|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271357|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271358|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271359|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271360|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271361|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271362|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271363|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271364|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
125271365|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
125271366|NCT01194219|450620486|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271367|NCT01194219|450620487|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271368|NCT01194219|450620488|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271369|NCT01194219|450620489|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271370|NCT01194219|450620490|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271371|NCT01194219|450620491|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271372|NCT01194219|450620492|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271373|NCT01194219|450620493|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
125271374|NCT01194219|450620494|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
125271375|NCT01194219|450620495|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
125271376|NCT00292045|450620498|FG000|Core Study (Through Week 13)|Adverse Event|1|||
125271377|NCT00292045|450620498|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
125271378|NCT04474197|450620499|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
125271379|NCT04474197|450620500|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
125271380|NCT04474197|450620501|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
125271381|NCT04474197|450620502|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
125271382|NCT02443337|450620503|FG000|Overall Study|Adverse Event|0|||
125271383|NCT02443337|450620504|FG001|Overall Study|Adverse Event|1|||
125271384|NCT02443337|450620503|FG000|Overall Study|Clinical Progressive Disease|3|||
125271385|NCT02443337|450620504|FG001|Overall Study|Clinical Progressive Disease|0|||
125271386|NCT02443337|450620503|FG000|Overall Study|Withdrawal by Subject|2|||
125271387|NCT02443337|450620504|FG001|Overall Study|Withdrawal by Subject|1|||
125271388|NCT00635349|450620506|FG000|Overall Study|Other|8|||
125271389|NCT00635349|450620507|FG001|Overall Study|Other|6|||
125271390|NCT00635349|450620506|FG000|Overall Study|Protocol Violation|18|||
125271391|NCT00635349|450620507|FG001|Overall Study|Protocol Violation|22|||
125271392|NCT00635349|450620506|FG000|Overall Study|Withdrawal by Subject|3|||
125271393|NCT00635349|450620507|FG001|Overall Study|Withdrawal by Subject|8|||
125271394|NCT00635349|450620506|FG000|Overall Study|Lost to Follow-up|4|||
125271395|NCT00635349|450620507|FG001|Overall Study|Lost to Follow-up|3|||
125271396|NCT00635349|450620506|FG000|Overall Study|Adverse Event|11|||
125271397|NCT00635349|450620507|FG001|Overall Study|Adverse Event|9|||
125447679|NCT02507219|451264874|FG003|Overall Study|Physician Decision|0|||
125447680|NCT02507219|451264875|FG004|Overall Study|Physician Decision|0|||
125447681|NCT02507219|451264876|FG005|Overall Study|Physician Decision|0|||
125447682|NCT02507219|451264871|FG000|Overall Study|Withdrawal by Subject|0|||
125447683|NCT02507219|451264872|FG001|Overall Study|Withdrawal by Subject|0|||
125447684|NCT02507219|451264873|FG002|Overall Study|Withdrawal by Subject|0|||
125447685|NCT02507219|451264874|FG003|Overall Study|Withdrawal by Subject|0|||
125447686|NCT02507219|451264875|FG004|Overall Study|Withdrawal by Subject|1|||
125447687|NCT02507219|451264876|FG005|Overall Study|Withdrawal by Subject|0|||
125447688|NCT01342887|451264883|FG000|Overall Study|Death|2|||
125447689|NCT00209274|451264884|FG000|Overall Study|Missed visit|3|||
125447690|NCT00209274|451264885|FG001|Overall Study|Missed visit|2|||
125447691|NCT00209274|451264884|FG000|Overall Study|Death|32|||
125447692|NCT00209274|451264885|FG001|Overall Study|Death|15|||
125447693|NCT00209274|451264884|FG000|Overall Study|Withdrawal by Subject|30|||
125447694|NCT00209274|451264885|FG001|Overall Study|Withdrawal by Subject|15|||
125271398|NCT04860869|450620513|FG000|Overall Study|Withdrawal by Subject|1|||
125271399|NCT04860869|450620514|FG001|Overall Study|Withdrawal by Subject|0|||
125271400|NCT03951766|450620515|FG000|Treatment Phase|Lost to Follow-up|1|||
125271401|NCT03951766|450620515|FG000|Follow-up Phase|Lost to Follow-up|10|||
125271402|NCT03606486|450620518|FG000|Overall Study|Unable to collect sample|5|||
125271403|NCT00049322|450620519|FG000|Overall Study|disease burden|0|||
125271404|NCT00049322|450620520|FG001|Overall Study|disease burden|3|||
125271405|NCT00049322|450620519|FG000|Overall Study|Adverse Event|1|||
125271406|NCT00049322|450620520|FG001|Overall Study|Adverse Event|0|||
125271407|NCT00049322|450620519|FG000|Overall Study|refused angio|0|||
125271408|NCT00049322|450620520|FG001|Overall Study|refused angio|3|||
125271409|NCT03943290|450620523|FG000|Overall Study|Sponsor Terminated Study|6|||
125271410|NCT03943290|450620524|FG001|Overall Study|Sponsor Terminated Study|1|||
125271411|NCT03943290|450620525|FG002|Overall Study|Sponsor Terminated Study|11|||
125271412|NCT03943290|450620526|FG003|Overall Study|Sponsor Terminated Study|6|||
125271413|NCT03943290|450620527|FG004|Overall Study|Sponsor Terminated Study|7|||
125271414|NCT03943290|450620528|FG005|Overall Study|Sponsor Terminated Study|6|||
125447695|NCT00209274|451264884|FG000|Overall Study|Randomized not treated (RNT)|6|||
125447696|NCT00209274|451264885|FG001|Overall Study|Randomized not treated (RNT)|15|||
125271415|NCT03943290|450620529|FG006|Overall Study|Sponsor Terminated Study|6|||
125271416|NCT03943290|450620530|FG007|Overall Study|Sponsor Terminated Study|7|||
125271417|NCT03943290|450620531|FG008|Overall Study|Sponsor Terminated Study|8|||
125271418|NCT03943290|450620523|FG000|Overall Study|Lost to Follow-up|1|||
125271419|NCT03943290|450620524|FG001|Overall Study|Lost to Follow-up|0|||
125271420|NCT03943290|450620525|FG002|Overall Study|Lost to Follow-up|1|||
125271421|NCT03943290|450620526|FG003|Overall Study|Lost to Follow-up|0|||
125271422|NCT03943290|450620527|FG004|Overall Study|Lost to Follow-up|0|||
125271423|NCT03943290|450620528|FG005|Overall Study|Lost to Follow-up|0|||
125271424|NCT03943290|450620529|FG006|Overall Study|Lost to Follow-up|0|||
125271425|NCT03943290|450620530|FG007|Overall Study|Lost to Follow-up|1|||
125447697|NCT02753530|451264886|FG000|Overall Study|Adverse Event|7|||
125447698|NCT02753530|451264887|FG001|Overall Study|Adverse Event|1|||
125447699|NCT02753530|451264886|FG000|Overall Study|Death|0|||
125447700|NCT02753530|451264887|FG001|Overall Study|Death|1|||
125271426|NCT03943290|450620531|FG008|Overall Study|Lost to Follow-up|0|||
125271427|NCT03943290|450620523|FG000|Overall Study|Withdrawal by Subject|0|||
125271428|NCT03943290|450620524|FG001|Overall Study|Withdrawal by Subject|0|||
125271429|NCT03943290|450620525|FG002|Overall Study|Withdrawal by Subject|1|||
125271430|NCT03943290|450620526|FG003|Overall Study|Withdrawal by Subject|0|||
125271431|NCT03943290|450620527|FG004|Overall Study|Withdrawal by Subject|0|||
125271432|NCT03943290|450620528|FG005|Overall Study|Withdrawal by Subject|0|||
125271433|NCT03943290|450620529|FG006|Overall Study|Withdrawal by Subject|0|||
125271434|NCT03943290|450620530|FG007|Overall Study|Withdrawal by Subject|0|||
125271435|NCT03943290|450620531|FG008|Overall Study|Withdrawal by Subject|0|||
125271436|NCT00295646|450620538|FG000|Overall Study|Protocol Violation|18|||
125271437|NCT00295646|450620539|FG001|Overall Study|Protocol Violation|20|||
125271438|NCT00295646|450620540|FG002|Overall Study|Protocol Violation|20|||
125271439|NCT00295646|450620541|FG003|Overall Study|Protocol Violation|18|||
125271440|NCT00295646|450620538|FG000|Overall Study|Withdrawal by Subject|8|||
125271441|NCT00295646|450620539|FG001|Overall Study|Withdrawal by Subject|9|||
125271442|NCT00295646|450620540|FG002|Overall Study|Withdrawal by Subject|11|||
125271443|NCT00295646|450620541|FG003|Overall Study|Withdrawal by Subject|14|||
125271444|NCT00295646|450620538|FG000|Overall Study|Lost to Follow-up|0|||
125271445|NCT00295646|450620539|FG001|Overall Study|Lost to Follow-up|5|||
125271446|NCT00295646|450620540|FG002|Overall Study|Lost to Follow-up|1|||
125271447|NCT00295646|450620541|FG003|Overall Study|Lost to Follow-up|5|||
125271448|NCT00295646|450620538|FG000|Overall Study|Death|9|||
125271449|NCT00295646|450620539|FG001|Overall Study|Death|7|||
125271450|NCT00295646|450620540|FG002|Overall Study|Death|18|||
125271451|NCT00295646|450620541|FG003|Overall Study|Death|8|||
125271452|NCT02441101|450620546|FG000|Overall Study|Withdrawal by Subject|1|||
125271453|NCT02441101|450620547|FG001|Overall Study|Withdrawal by Subject|0|||
125271454|NCT02441101|450620546|FG000|Overall Study|Lost to Follow-up|1|||
125271455|NCT02441101|450620547|FG001|Overall Study|Lost to Follow-up|0|||
125271456|NCT02441101|450620546|FG000|Overall Study|PI relocated and study terminated|1|||
125271457|NCT02441101|450620547|FG001|Overall Study|PI relocated and study terminated|0|||
125271458|NCT00955474|450620548|FG000|Overall Study|Physician Decision|7|||
125271459|NCT00955474|450620549|FG001|Overall Study|Physician Decision|5|||
125271460|NCT01737762|450620552|FG000|Overall Study|Adverse Event|2|||
125271461|NCT01737762|450620553|FG001|Overall Study|Adverse Event|2|||
125271462|NCT01737762|450620552|FG000|Overall Study|Lost to Follow-up|1|||
125271463|NCT01737762|450620553|FG001|Overall Study|Lost to Follow-up|0|||
125271464|NCT01737762|450620552|FG000|Overall Study|Withdrawal by Subject|2|||
125271465|NCT01737762|450620553|FG001|Overall Study|Withdrawal by Subject|2|||
125271466|NCT01737762|450620552|FG000|Overall Study|Progressive disease|1|||
125271467|NCT01737762|450620553|FG001|Overall Study|Progressive disease|2|||
125399180|NCT04084769|451093320|FG003|Overall Study|Protocol Violation|1|||
125399181|NCT04084769|451093317|FG000|Overall Study|Withdrawal by Subject|0|||
125399182|NCT04084769|451093318|FG001|Overall Study|Withdrawal by Subject|1|||
125399183|NCT04084769|451093319|FG002|Overall Study|Withdrawal by Subject|0|||
125399184|NCT04084769|451093320|FG003|Overall Study|Withdrawal by Subject|0|||
125399185|NCT04084769|451093317|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125399186|NCT04084769|451093318|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125399187|NCT04084769|451093319|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125399188|NCT04084769|451093320|FG003|Overall Study|Withdrawal by parent/guardian|1|||
125399189|NCT04084769|451093317|FG000|Overall Study|Lost to Follow-up|2|||
125399190|NCT04084769|451093318|FG001|Overall Study|Lost to Follow-up|0|||
125399191|NCT04084769|451093319|FG002|Overall Study|Lost to Follow-up|0|||
125399192|NCT04084769|451093320|FG003|Overall Study|Lost to Follow-up|0|||
125399193|NCT03492177|451093321|FG000|Overall Study|Adverse Event|1|||
125399194|NCT03492177|451093322|FG001|Overall Study|Adverse Event|0|||
125399195|NCT03492177|451093323|FG002|Overall Study|Adverse Event|0|||
125271468|NCT01737762|450620552|FG000|Overall Study|Physician Decision|1|||
125271469|NCT01737762|450620553|FG001|Overall Study|Physician Decision|1|||
125271470|NCT01737762|450620552|FG000|Overall Study|Moved from area|2|||
125271471|NCT01737762|450620553|FG001|Overall Study|Moved from area|1|||
125271472|NCT01737762|450620552|FG000|Overall Study|Trial termination|11|||
125271473|NCT01737762|450620553|FG001|Overall Study|Trial termination|9|||
125271474|NCT03083665|450620555|FG000|Double-Blind Period|Adverse Event|5|||
125271475|NCT03083665|450620556|FG001|Double-Blind Period|Adverse Event|4|||
125271476|NCT03083665|450620557|FG002|Double-Blind Period|Adverse Event|5|||
125271477|NCT03083665|450620558|FG003|Double-Blind Period|Adverse Event|0|||
125271478|NCT03083665|450620559|FG004|Double-Blind Period|Adverse Event|0|||
125271479|NCT03083665|450620560|FG005|Double-Blind Period|Adverse Event|0|||
125271480|NCT03083665|450620555|FG000|Double-Blind Period|Lack of Efficacy|0|||
125399196|NCT03492177|451093321|FG000|Overall Study|Death|3|||
125399197|NCT03492177|451093322|FG001|Overall Study|Death|0|||
125399198|NCT03492177|451093323|FG002|Overall Study|Death|3|||
125399199|NCT03492177|451093321|FG000|Overall Study|Lack of Efficacy|1|||
125399200|NCT03492177|451093322|FG001|Overall Study|Lack of Efficacy|2|||
125399201|NCT03492177|451093323|FG002|Overall Study|Lack of Efficacy|0|||
125399202|NCT03492177|451093321|FG000|Overall Study|Other|1|||
125399203|NCT03492177|451093322|FG001|Overall Study|Other|0|||
125271481|NCT03083665|450620556|FG001|Double-Blind Period|Lack of Efficacy|0|||
125271482|NCT03083665|450620557|FG002|Double-Blind Period|Lack of Efficacy|1|||
125271483|NCT03083665|450620558|FG003|Double-Blind Period|Lack of Efficacy|0|||
125271484|NCT03083665|450620559|FG004|Double-Blind Period|Lack of Efficacy|0|||
125271485|NCT03083665|450620560|FG005|Double-Blind Period|Lack of Efficacy|0|||
125271486|NCT03083665|450620555|FG000|Double-Blind Period|Protocol Violation|1|||
125271487|NCT03083665|450620556|FG001|Double-Blind Period|Protocol Violation|0|||
125271488|NCT03083665|450620557|FG002|Double-Blind Period|Protocol Violation|1|||
125271489|NCT03083665|450620558|FG003|Double-Blind Period|Protocol Violation|0|||
125271490|NCT03083665|450620559|FG004|Double-Blind Period|Protocol Violation|0|||
125271491|NCT03083665|450620560|FG005|Double-Blind Period|Protocol Violation|0|||
125271492|NCT03083665|450620555|FG000|Double-Blind Period|Lost to Follow-up|1|||
125271493|NCT03083665|450620556|FG001|Double-Blind Period|Lost to Follow-up|0|||
125271494|NCT03083665|450620557|FG002|Double-Blind Period|Lost to Follow-up|1|||
125271495|NCT03083665|450620558|FG003|Double-Blind Period|Lost to Follow-up|0|||
125271496|NCT03083665|450620559|FG004|Double-Blind Period|Lost to Follow-up|0|||
125271497|NCT03083665|450620560|FG005|Double-Blind Period|Lost to Follow-up|0|||
125271498|NCT03083665|450620555|FG000|Double-Blind Period|Withdrawal by Subject|3|||
125271499|NCT03083665|450620556|FG001|Double-Blind Period|Withdrawal by Subject|0|||
125271500|NCT03083665|450620557|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125271501|NCT03083665|450620558|FG003|Double-Blind Period|Withdrawal by Subject|0|||
125271502|NCT03083665|450620559|FG004|Double-Blind Period|Withdrawal by Subject|0|||
125271503|NCT03083665|450620560|FG005|Double-Blind Period|Withdrawal by Subject|0|||
125271504|NCT03083665|450620555|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
125271505|NCT03083665|450620556|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
125271506|NCT03083665|450620557|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
125271507|NCT03083665|450620558|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
125271508|NCT03083665|450620559|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
125271509|NCT03083665|450620560|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
125271510|NCT03083665|450620555|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
125271511|NCT03083665|450620556|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
125271512|NCT03083665|450620557|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
125271513|NCT03083665|450620558|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
125271514|NCT03083665|450620559|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
125271515|NCT03083665|450620560|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
125271516|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
125271517|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
125271518|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
125271519|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
125271520|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
125271521|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
125271522|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
125271523|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
125271524|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
125271525|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
125271526|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
125271527|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
125271528|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
125271529|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
125271530|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
125271531|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
125271532|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
125271533|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
125271534|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
125271535|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
125271536|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
125271537|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
125271538|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
125271539|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
125271540|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
125271541|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
125271542|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
125271543|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
125271544|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
125271545|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
125271546|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
125271547|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
125271548|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
125271549|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
125271550|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
125271551|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
125271552|NCT03083665|450620555|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
125271553|NCT03083665|450620556|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
125271554|NCT03083665|450620557|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
125271555|NCT03083665|450620558|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
125271556|NCT03083665|450620559|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
125271557|NCT03083665|450620560|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
125271558|NCT01467466|450620561|FG000|Overall Study|Withdrawal by Subject|15|||
125271559|NCT01467466|450620562|FG001|Overall Study|Withdrawal by Subject|18|||
125271560|NCT01467466|450620563|FG002|Overall Study|Withdrawal by Subject|13|||
125271561|NCT01467466|450620564|FG003|Overall Study|Withdrawal by Subject|11|||
125271562|NCT01467466|450620561|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
125271563|NCT01467466|450620562|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
125271564|NCT01467466|450620563|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
125271565|NCT01467466|450620564|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
125271566|NCT01467466|450620561|FG000|Overall Study|Procedure Cancelled|46|||
125271567|NCT01467466|450620562|FG001|Overall Study|Procedure Cancelled|45|||
125271568|NCT01467466|450620563|FG002|Overall Study|Procedure Cancelled|25|||
125271569|NCT01467466|450620564|FG003|Overall Study|Procedure Cancelled|29|||
125271570|NCT01467466|450620561|FG000|Overall Study|No Endpoint Blood Draw|38|||
125271571|NCT01467466|450620562|FG001|Overall Study|No Endpoint Blood Draw|32|||
125271572|NCT01467466|450620563|FG002|Overall Study|No Endpoint Blood Draw|51|||
125271573|NCT01467466|450620564|FG003|Overall Study|No Endpoint Blood Draw|43|||
125271574|NCT01144416|450620571|FG000|Intervention Period|Adverse Event|5|||
125271575|NCT01144416|450620572|FG001|Intervention Period|Adverse Event|6|||
125271576|NCT01144416|450620571|FG000|Intervention Period|Insufficient ovarian response|11|||
125271577|NCT01144416|450620572|FG001|Intervention Period|Insufficient ovarian response|17|||
125271578|NCT01144416|450620571|FG000|Intervention Period|Risk of OHSS|0|||
125271579|NCT01144416|450620572|FG001|Intervention Period|Risk of OHSS|1|||
125271580|NCT01144416|450620571|FG000|Intervention Period|Too high ovarian response|4|||
125271581|NCT01144416|450620572|FG001|Intervention Period|Too high ovarian response|2|||
125271582|NCT01144416|450620571|FG000|Intervention Period|No/too few/bad oocytes|7|||
125271583|NCT01144416|450620572|FG001|Intervention Period|No/too few/bad oocytes|5|||
125271584|NCT01144416|450620571|FG000|Intervention Period|No or abnormal fertilization|25|||
125271585|NCT01144416|450620572|FG001|Intervention Period|No or abnormal fertilization|10|||
125271586|NCT01144416|450620571|FG000|Intervention Period|No/too few/bad quality embryos|3|||
125271587|NCT01144416|450620572|FG001|Intervention Period|No/too few/bad quality embryos|3|||
125271588|NCT01144416|450620571|FG000|Intervention Period|Other|7|||
125271589|NCT01144416|450620572|FG001|Intervention Period|Other|5|||
125271590|NCT02131662|450620577|FG000|Overall Study|Protocol Violation|1|||
125271591|NCT02131662|450620578|FG001|Overall Study|Protocol Violation|0|||
125271592|NCT02131662|450620579|FG002|Overall Study|Protocol Violation|0|||
125271593|NCT02131662|450620580|FG003|Overall Study|Protocol Violation|0|||
125271594|NCT02131662|450620581|FG004|Overall Study|Protocol Violation|0|||
125271595|NCT02131662|450620577|FG000|Overall Study|Other|2|||
125271596|NCT02131662|450620578|FG001|Overall Study|Other|4|||
125271597|NCT02131662|450620579|FG002|Overall Study|Other|3|||
125271598|NCT02131662|450620580|FG003|Overall Study|Other|3|||
125271599|NCT02131662|450620581|FG004|Overall Study|Other|4|||
125271600|NCT02131662|450620577|FG000|Overall Study|Adverse Event|0|||
125271601|NCT02131662|450620578|FG001|Overall Study|Adverse Event|1|||
125271602|NCT02131662|450620579|FG002|Overall Study|Adverse Event|1|||
125271603|NCT02131662|450620580|FG003|Overall Study|Adverse Event|1|||
125271604|NCT02131662|450620581|FG004|Overall Study|Adverse Event|3|||
125271605|NCT02131662|450620577|FG000|Overall Study|Pregnancy|0|||
125271606|NCT02131662|450620578|FG001|Overall Study|Pregnancy|1|||
125271607|NCT02131662|450620579|FG002|Overall Study|Pregnancy|0|||
125271608|NCT02131662|450620580|FG003|Overall Study|Pregnancy|1|||
125271609|NCT02131662|450620581|FG004|Overall Study|Pregnancy|0|||
125271610|NCT02131662|450620577|FG000|Overall Study|Wish for pregnancy|0|||
125271611|NCT02131662|450620578|FG001|Overall Study|Wish for pregnancy|0|||
125271612|NCT02131662|450620579|FG002|Overall Study|Wish for pregnancy|0|||
125271613|NCT02131662|450620580|FG003|Overall Study|Wish for pregnancy|0|||
125271614|NCT02131662|450620581|FG004|Overall Study|Wish for pregnancy|1|||
125271615|NCT02131662|450620577|FG000|Overall Study|Lack of Efficacy|1|||
125271616|NCT02131662|450620578|FG001|Overall Study|Lack of Efficacy|0|||
125271617|NCT02131662|450620579|FG002|Overall Study|Lack of Efficacy|0|||
125271618|NCT02131662|450620580|FG003|Overall Study|Lack of Efficacy|0|||
125271619|NCT02131662|450620581|FG004|Overall Study|Lack of Efficacy|1|||
125271620|NCT02131662|450620577|FG000|Overall Study|Withdrawal by Subject|1|||
125271621|NCT02131662|450620578|FG001|Overall Study|Withdrawal by Subject|5|||
125271622|NCT02131662|450620579|FG002|Overall Study|Withdrawal by Subject|1|||
125271623|NCT02131662|450620580|FG003|Overall Study|Withdrawal by Subject|5|||
125271624|NCT02131662|450620581|FG004|Overall Study|Withdrawal by Subject|6|||
125271625|NCT02131662|450620577|FG000|Overall Study|Lost to Follow-up|1|||
125271626|NCT02131662|450620578|FG001|Overall Study|Lost to Follow-up|3|||
125271627|NCT02131662|450620579|FG002|Overall Study|Lost to Follow-up|0|||
125271628|NCT02131662|450620580|FG003|Overall Study|Lost to Follow-up|9|||
125271629|NCT02131662|450620581|FG004|Overall Study|Lost to Follow-up|0|||
125271630|NCT02131662|450620577|FG000|Overall Study|Not treated|2|||
125271631|NCT02131662|450620578|FG001|Overall Study|Not treated|0|||
125271632|NCT02131662|450620579|FG002|Overall Study|Not treated|2|||
125271633|NCT02131662|450620580|FG003|Overall Study|Not treated|2|||
125271634|NCT02131662|450620581|FG004|Overall Study|Not treated|3|||
125271635|NCT01402869|450620582|FG000|Overall Study|Required Tooth Extraction|0|||
125271636|NCT01402869|450620583|FG001|Overall Study|Required Tooth Extraction|0|||
125271637|NCT01402869|450620584|FG002|Overall Study|Required Tooth Extraction|1|||
125271638|NCT01740687|450620585|FG000|Overall Study|Lost to Follow-up|11|||
125271639|NCT01740687|450620585|FG000|Overall Study|Withdrawal by Subject|2|||
125271640|NCT01740687|450620585|FG000|Overall Study|other reason|22|||
125271641|NCT01740687|450620585|FG000|Overall Study|treatment not received|2|||
125271642|NCT00104728|450620587|FG000|Overall Study|screen failures|19|||
125271643|NCT01963767|450620588|FG000|Overall Study|Withdrawal by Subject|4|||
125271644|NCT01963767|450620589|FG001|Overall Study|Withdrawal by Subject|2|||
125271645|NCT01963767|450620588|FG000|Overall Study|Adverse Event|2|||
125271646|NCT01963767|450620589|FG001|Overall Study|Adverse Event|0|||
125271647|NCT03960684|450620590|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
125271648|NCT03941483|450620594|FG000|Overall Study|Miscellaneous|2|||
125271649|NCT03941483|450620595|FG001|Overall Study|Miscellaneous|3|||
125271650|NCT03941483|450620596|FG002|Overall Study|Miscellaneous|0|||
125271651|NCT03941483|450620594|FG000|Overall Study|Study Terminated by Sponsor|1|||
125271652|NCT03941483|450620595|FG001|Overall Study|Study Terminated by Sponsor|0|||
125271653|NCT03941483|450620596|FG002|Overall Study|Study Terminated by Sponsor|0|||
125271654|NCT03941483|450620594|FG000|Overall Study|Withdrawal by Subject|1|||
125271655|NCT03941483|450620595|FG001|Overall Study|Withdrawal by Subject|4|||
125271656|NCT03941483|450620596|FG002|Overall Study|Withdrawal by Subject|1|||
125271657|NCT03941483|450620594|FG000|Overall Study|Lost to Follow-up|2|||
125271658|NCT03941483|450620595|FG001|Overall Study|Lost to Follow-up|1|||
125271659|NCT03941483|450620596|FG002|Overall Study|Lost to Follow-up|8|||
125271660|NCT03941483|450620594|FG000|Overall Study|Death|3|||
125271661|NCT03941483|450620595|FG001|Overall Study|Death|2|||
125271662|NCT03941483|450620596|FG002|Overall Study|Death|6|||
125271663|NCT01082081|450620597|FG000|Overall Study|Lost to Follow-up|0|||
125271664|NCT01082081|450620598|FG001|Overall Study|Lost to Follow-up|0|||
125271665|NCT01082081|450620599|FG002|Overall Study|Lost to Follow-up|1|||
125271666|NCT01082081|450620597|FG000|Overall Study|Withdrawal by Subject|0|||
125271667|NCT01082081|450620598|FG001|Overall Study|Withdrawal by Subject|0|||
125271668|NCT01082081|450620599|FG002|Overall Study|Withdrawal by Subject|1|||
125271669|NCT01082081|450620597|FG000|Overall Study|Other Reason|0|||
125271670|NCT01082081|450620598|FG001|Overall Study|Other Reason|1|||
125271671|NCT01082081|450620599|FG002|Overall Study|Other Reason|0|||
125271672|NCT00670930|450620602|FG000|Overall Study|Adminstrative Problem|0|||
125271673|NCT00670930|450620603|FG001|Overall Study|Adminstrative Problem|1|||
125271674|NCT00670930|450620602|FG000|Overall Study|Lost to Follow-up|1|||
125271675|NCT00670930|450620603|FG001|Overall Study|Lost to Follow-up|0|||
125271676|NCT03493451|450622059|FG000|Overall Study|Death|11|||
125271677|NCT03493451|450622060|FG001|Overall Study|Death|26|||
125271678|NCT03493451|450622061|FG002|Overall Study|Death|3|||
125271679|NCT03493451|450622059|FG000|Overall Study|Lost to Follow-up|1|||
125271680|NCT03493451|450622060|FG001|Overall Study|Lost to Follow-up|4|||
125271681|NCT03493451|450622061|FG002|Overall Study|Lost to Follow-up|1|||
125271682|NCT03493451|450622059|FG000|Overall Study|Withdrawal by Subject|1|||
125271683|NCT03493451|450622060|FG001|Overall Study|Withdrawal by Subject|1|||
125271684|NCT03493451|450622061|FG002|Overall Study|Withdrawal by Subject|2|||
125447701|NCT02753530|451264886|FG000|Overall Study|Physician Decision|0|||
125271685|NCT03493451|450622059|FG000|Overall Study|Progressive Disease|1|||
125271686|NCT03493451|450622060|FG001|Overall Study|Progressive Disease|0|||
125271687|NCT03493451|450622061|FG002|Overall Study|Progressive Disease|0|||
125271688|NCT03493451|450622059|FG000|Overall Study|Transferred to long term extension study|8|||
125271689|NCT03493451|450622060|FG001|Overall Study|Transferred to long term extension study|13|||
125271690|NCT03493451|450622061|FG002|Overall Study|Transferred to long term extension study|5|||
125271691|NCT00600106|450622067|FG000|Overall Study|Withdrawal by Subject|1|||
125271692|NCT00600106|450622068|FG001|Overall Study|Withdrawal by Subject|1|||
125271693|NCT03015363|450622071|FG000|Overall Study|Physician Decision|14|||
125271694|NCT03015363|450622071|FG000|Overall Study|Withdrawal by Subject|3|||
125271695|NCT00833469|450622074|FG000|Overall Study|Withdrawal by Subject|1|||
125271696|NCT00833469|450622074|FG000|Overall Study|Lost to Follow-up|1|||
125271697|NCT01665911|450622075|FG000|Overall Study|Protocol Violation|4|||
125271698|NCT01665911|450622075|FG000|Overall Study|Withdrawal by Subject|1|||
125271699|NCT01665911|450622075|FG000|Overall Study|Adverse Event|1|||
125271700|NCT03650413|450622076|FG000|Overall Study|Adverse Event|1|||
125271701|NCT03650413|450622076|FG000|Overall Study|Lack of Efficacy|17|||
125271702|NCT03650413|450622076|FG000|Overall Study|Other|9|||
125271703|NCT03650413|450622076|FG000|Overall Study|Physician Decision|2|||
125271704|NCT03650413|450622076|FG000|Overall Study|Study Terminated By Sponsor|16|||
125271705|NCT03650413|450622076|FG000|Overall Study|Withdrawal by Subject|16|||
125271706|NCT01206140|450622077|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
125271707|NCT01206140|450622078|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
125271708|NCT00211172|450622079|FG000|Overall Study|Died or lost health plan eligibility|39|||
125271709|NCT00211172|450622080|FG001|Overall Study|Died or lost health plan eligibility|32|||
125271710|NCT00770562|450622084|FG000|Overall Study|Did not take treatment|1|||
125271711|NCT00770562|450622085|FG001|Overall Study|Did not take treatment|1|||
125271712|NCT01643408|450622088|FG000|Overall Study|Adverse Event|12|||
125271713|NCT01643408|450622088|FG000|Overall Study|Other|2|||
125271714|NCT02236572|450622089|FG000|Overall Study|Withdrawal by Subject|1|||
125271715|NCT02236572|450622089|FG000|Overall Study|Protocol Violation|1|||
125271716|NCT02236572|450622089|FG000|Overall Study|Lost to Follow-up|1|||
125271717|NCT01057693|450622090|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
125271718|NCT01057693|450622091|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
125271719|NCT01057693|450622092|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
125271720|NCT01057693|450622090|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
125271721|NCT01057693|450622091|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
125271722|NCT01057693|450622092|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
125271723|NCT01057693|450622090|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
125271724|NCT01057693|450622091|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
125271725|NCT01057693|450622092|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
125271726|NCT01057693|450622090|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
125271727|NCT01057693|450622091|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
125271728|NCT01057693|450622092|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
125271729|NCT01057693|450622090|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
125271730|NCT01057693|450622091|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
125271731|NCT01057693|450622092|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
125271732|NCT01057693|450622090|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
125271733|NCT01057693|450622091|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
125271734|NCT01057693|450622092|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
125271735|NCT01057693|450622090|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
125271736|NCT01057693|450622091|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
125271737|NCT01057693|450622092|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
125271738|NCT01057693|450622090|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
125271739|NCT01057693|450622091|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
125271740|NCT01057693|450622092|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
125271741|NCT01057693|450622090|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
125271742|NCT01057693|450622091|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
125271743|NCT01057693|450622092|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
125271744|NCT01057693|450622090|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
125271745|NCT01057693|450622091|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
125271746|NCT01057693|450622092|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
125271747|NCT01057693|450622090|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
125271748|NCT01057693|450622091|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
125271749|NCT01057693|450622092|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
125271750|NCT01057693|450622090|FG000|Between Single-Blind and Double-Blind|Other|6|||
125271751|NCT01057693|450622091|FG001|Between Single-Blind and Double-Blind|Other|0|||
125271752|NCT01057693|450622092|FG002|Between Single-Blind and Double-Blind|Other|0|||
125271753|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
125271754|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
125271755|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
125271756|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
125271757|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
125271758|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
125271759|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
125271760|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
125271761|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
125271762|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
125271763|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
125271764|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
125271765|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
125271766|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
125399204|NCT03492177|451093323|FG002|Overall Study|Other|0|||
125271767|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
125271768|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
125271769|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
125271770|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
125271771|NCT01057693|450622090|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
125271772|NCT01057693|450622091|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
125271773|NCT01057693|450622092|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
125271774|NCT00709319|450622094|FG000|Overall Study|Death|4|||
125271775|NCT00709319|450622094|FG000|Overall Study|Withdrawal by Subject|2|||
125271776|NCT00579553|450622095|FG000|Overall Study|Lost to Follow-up|16|||
125271777|NCT00579553|450622096|FG001|Overall Study|Lost to Follow-up|13|||
125271778|NCT00363142|450622099|FG000|Overall Study|Adverse Event|2|||
125271779|NCT00363142|450622100|FG001|Overall Study|Adverse Event|0|||
125271780|NCT00363142|450622099|FG000|Overall Study|Lack of Efficacy|0|||
125271781|NCT00363142|450622100|FG001|Overall Study|Lack of Efficacy|1|||
125271782|NCT00363142|450622099|FG000|Overall Study|Lost to Follow-up|1|||
125271783|NCT00363142|450622100|FG001|Overall Study|Lost to Follow-up|0|||
125271784|NCT00363142|450622099|FG000|Overall Study|Non-compliance|1|||
125271785|NCT00363142|450622100|FG001|Overall Study|Non-compliance|1|||
125271786|NCT00363142|450622099|FG000|Overall Study|Withdrawal by Subject|3|||
125271787|NCT00363142|450622100|FG001|Overall Study|Withdrawal by Subject|1|||
125271788|NCT01541865|450622101|FG000|Overall Study|Lost to Follow-up|11|||
125271789|NCT01541865|450622101|FG000|Overall Study|Withdrawal by Subject|9|||
125271790|NCT01541865|450622101|FG000|Overall Study|Adverse Event|1|||
125271791|NCT01541865|450622101|FG000|Overall Study|Protocol Violation|1|||
125271792|NCT03072043|450622104|FG000|Overall Study|Death|0|||
125271793|NCT03072043|450622105|FG001|Overall Study|Death|0|||
125271794|NCT03072043|450622106|FG002|Overall Study|Death|3|||
125271795|NCT03072043|450622104|FG000|Overall Study|Adverse Event|0|||
125271796|NCT03072043|450622105|FG001|Overall Study|Adverse Event|0|||
125271797|NCT03072043|450622106|FG002|Overall Study|Adverse Event|2|||
125271798|NCT03072043|450622104|FG000|Overall Study|Withdrawal by Subject|0|||
125271799|NCT03072043|450622105|FG001|Overall Study|Withdrawal by Subject|0|||
125271800|NCT03072043|450622106|FG002|Overall Study|Withdrawal by Subject|4|||
125271801|NCT01340664|450622107|FG000|Overall Study|Adverse Event|0|||
125271802|NCT01340664|450622108|FG001|Overall Study|Adverse Event|1|||
125271803|NCT01340664|450622109|FG002|Overall Study|Adverse Event|7|||
125271804|NCT01340664|450622107|FG000|Overall Study|Lost to Follow-up|2|||
125271805|NCT01340664|450622108|FG001|Overall Study|Lost to Follow-up|0|||
125271806|NCT01340664|450622109|FG002|Overall Study|Lost to Follow-up|2|||
125271807|NCT01340664|450622107|FG000|Overall Study|Withdrawal by Subject|2|||
125271808|NCT01340664|450622108|FG001|Overall Study|Withdrawal by Subject|4|||
125271809|NCT01340664|450622109|FG002|Overall Study|Withdrawal by Subject|0|||
125271810|NCT01340664|450622107|FG000|Overall Study|Glycemic withdrawal criteria|2|||
125271811|NCT01340664|450622108|FG001|Overall Study|Glycemic withdrawal criteria|0|||
125271812|NCT01340664|450622109|FG002|Overall Study|Glycemic withdrawal criteria|0|||
125271813|NCT01340664|450622107|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
125271814|NCT01340664|450622108|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
125271815|NCT01340664|450622109|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
125271816|NCT01340664|450622107|FG000|Overall Study|Other|1|||
125271817|NCT01340664|450622108|FG001|Overall Study|Other|2|||
125271818|NCT01340664|450622109|FG002|Overall Study|Other|2|||
125271819|NCT02997865|450622111|FG000|Overall Study|Death|2|||
125271820|NCT02997865|450622112|FG001|Overall Study|Death|1|||
125271821|NCT02997865|450622111|FG000|Overall Study|Lost to Follow-up|6|||
125271822|NCT02997865|450622112|FG001|Overall Study|Lost to Follow-up|3|||
125271823|NCT02997865|450622111|FG000|Overall Study|Withdrawal by Subject|5|||
125271824|NCT02997865|450622112|FG001|Overall Study|Withdrawal by Subject|0|||
125271825|NCT01926444|450622113|FG000|Overall Study|Colonoscopy not performed|0|||
125271826|NCT01926444|450622114|FG001|Overall Study|Colonoscopy not performed|0|||
125271827|NCT01926444|450622115|FG002|Overall Study|Colonoscopy not performed|4|||
125271828|NCT01926444|450622116|FG003|Overall Study|Colonoscopy not performed|2|||
125447702|NCT02753530|451264887|FG001|Overall Study|Physician Decision|1|||
125271829|NCT02528942|450622117|FG000|Overall Study|Did not meet imaging criteria|9|||
125271830|NCT02528942|450622117|FG000|Overall Study|Lost to Follow-up|25|||
125271831|NCT00881530|450622118|FG000|Overall Study|Adverse Event|5|||
125271832|NCT00881530|450622119|FG001|Overall Study|Adverse Event|1|||
125271833|NCT00881530|450622120|FG002|Overall Study|Adverse Event|1|||
125271834|NCT00881530|450622121|FG003|Overall Study|Adverse Event|4|||
125271835|NCT00881530|450622122|FG004|Overall Study|Adverse Event|10|||
125271836|NCT00881530|450622123|FG005|Overall Study|Adverse Event|2|||
125271837|NCT00881530|450622118|FG000|Overall Study|Lack of Efficacy|1|||
125271838|NCT00881530|450622119|FG001|Overall Study|Lack of Efficacy|0|||
125271839|NCT00881530|450622120|FG002|Overall Study|Lack of Efficacy|0|||
125271840|NCT00881530|450622121|FG003|Overall Study|Lack of Efficacy|0|||
125271841|NCT00881530|450622122|FG004|Overall Study|Lack of Efficacy|1|||
125271842|NCT00881530|450622123|FG005|Overall Study|Lack of Efficacy|1|||
125271843|NCT00881530|450622118|FG000|Overall Study|Not compliant with the protocol|0|||
125271844|NCT00881530|450622119|FG001|Overall Study|Not compliant with the protocol|0|||
125271845|NCT00881530|450622120|FG002|Overall Study|Not compliant with the protocol|0|||
125271846|NCT00881530|450622121|FG003|Overall Study|Not compliant with the protocol|0|||
125271847|NCT00881530|450622122|FG004|Overall Study|Not compliant with the protocol|2|||
125271848|NCT00881530|450622123|FG005|Overall Study|Not compliant with the protocol|0|||
125271849|NCT00881530|450622118|FG000|Overall Study|Lost to Follow-up|0|||
125271850|NCT00881530|450622119|FG001|Overall Study|Lost to Follow-up|1|||
125271851|NCT00881530|450622120|FG002|Overall Study|Lost to Follow-up|1|||
125271852|NCT00881530|450622121|FG003|Overall Study|Lost to Follow-up|3|||
125271853|NCT00881530|450622122|FG004|Overall Study|Lost to Follow-up|1|||
125271854|NCT00881530|450622123|FG005|Overall Study|Lost to Follow-up|0|||
125271855|NCT00881530|450622118|FG000|Overall Study|Refused to continue medication|7|||
125271856|NCT00881530|450622119|FG001|Overall Study|Refused to continue medication|2|||
125271857|NCT00881530|450622120|FG002|Overall Study|Refused to continue medication|1|||
125271858|NCT00881530|450622121|FG003|Overall Study|Refused to continue medication|2|||
125271859|NCT00881530|450622122|FG004|Overall Study|Refused to continue medication|0|||
125271860|NCT00881530|450622123|FG005|Overall Study|Refused to continue medication|0|||
125271861|NCT00881530|450622118|FG000|Overall Study|Other reason not defined above|1|||
125271862|NCT00881530|450622119|FG001|Overall Study|Other reason not defined above|1|||
125271863|NCT00881530|450622120|FG002|Overall Study|Other reason not defined above|2|||
125271864|NCT00881530|450622121|FG003|Overall Study|Other reason not defined above|0|||
125271865|NCT00881530|450622122|FG004|Overall Study|Other reason not defined above|0|||
125271866|NCT00881530|450622123|FG005|Overall Study|Other reason not defined above|2|||
125271867|NCT01509846|450622124|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
125271868|NCT01509846|450622125|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
125271869|NCT01509846|450622126|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
125271870|NCT01509846|450622127|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
125271871|NCT01509846|450622128|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
125271872|NCT01509846|450622124|FG000|Received Vaccination 2|Illness|0|||
125271873|NCT01509846|450622125|FG001|Received Vaccination 2|Illness|0|||
125271874|NCT01509846|450622126|FG002|Received Vaccination 2|Illness|0|||
125271875|NCT01509846|450622127|FG003|Received Vaccination 2|Illness|0|||
125271876|NCT01509846|450622128|FG004|Received Vaccination 2|Illness|1|||
125271877|NCT01509846|450622124|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
125271878|NCT01509846|450622125|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
125271879|NCT01509846|450622126|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
125271880|NCT01509846|450622127|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
125271881|NCT01509846|450622128|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
125271882|NCT01509846|450622124|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
125271883|NCT01509846|450622125|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
125271884|NCT01509846|450622126|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
125271885|NCT01509846|450622127|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
125271886|NCT01509846|450622128|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
125271887|NCT01509846|450622124|FG000|Received Vaccination 3|Pregnancy|0|||
125271888|NCT01509846|450622125|FG001|Received Vaccination 3|Pregnancy|0|||
125271889|NCT01509846|450622126|FG002|Received Vaccination 3|Pregnancy|0|||
125271890|NCT01509846|450622127|FG003|Received Vaccination 3|Pregnancy|1|||
125271891|NCT01509846|450622128|FG004|Received Vaccination 3|Pregnancy|0|||
125271892|NCT01509846|450622124|FG000|Received Vaccination 3|Lost to Follow-up|0|||
125271893|NCT01509846|450622125|FG001|Received Vaccination 3|Lost to Follow-up|0|||
125271894|NCT01509846|450622126|FG002|Received Vaccination 3|Lost to Follow-up|1|||
125271895|NCT01509846|450622127|FG003|Received Vaccination 3|Lost to Follow-up|0|||
125271896|NCT01509846|450622128|FG004|Received Vaccination 3|Lost to Follow-up|0|||
125271897|NCT01637584|450622129|FG000|Overall Study|Withdrawal by Subject|1|||
125271898|NCT01637584|450622130|FG001|Overall Study|Withdrawal by Subject|3|||
125271899|NCT02484443|450622131|FG000|Overall Study|Lack of Efficacy|28|||
125271900|NCT02484443|450622131|FG000|Overall Study|Physician Decision|2|||
125271901|NCT02484443|450622131|FG000|Overall Study|Ineligible|2|||
125271902|NCT02969915|450622132|FG000|Overall Study|Death|104|||
125271903|NCT02969915|450622133|FG001|Overall Study|Death|125|||
125271904|NCT02969915|450622132|FG000|Overall Study|Lost to Follow-up|108|||
125399205|NCT03492177|451093321|FG000|Overall Study|Ongoing|16|||
125271905|NCT02969915|450622133|FG001|Overall Study|Lost to Follow-up|112|||
125271906|NCT02969915|450622132|FG000|Overall Study|Censored due to COVID-19|481|||
125271907|NCT02969915|450622133|FG001|Overall Study|Censored due to COVID-19|471|||
125271908|NCT03799952|450622134|FG000|Overall Study|Program was too easy, discontinued|1|||
125271909|NCT03799952|450622135|FG001|Overall Study|Program was too easy, discontinued|0|||
125271910|NCT03799952|450622134|FG000|Overall Study|Lost to Follow-up|0|||
125271911|NCT03799952|450622135|FG001|Overall Study|Lost to Follow-up|2|||
125271912|NCT01393899|450622136|FG000|Overall Study|Study terminated by sponsor|1|||
125271913|NCT01393899|450622137|FG001|Overall Study|Study terminated by sponsor|0|||
125271914|NCT01393899|450622138|FG002|Overall Study|Study terminated by sponsor|1|||
125271915|NCT01393899|450622136|FG000|Overall Study|Other|1|||
125399206|NCT03492177|451093322|FG001|Overall Study|Ongoing|19|||
125271916|NCT01393899|450622137|FG001|Overall Study|Other|0|||
125271917|NCT01393899|450622138|FG002|Overall Study|Other|0|||
125271918|NCT01393899|450622136|FG000|Overall Study|Withdrawal by Subject|2|||
125271919|NCT01393899|450622137|FG001|Overall Study|Withdrawal by Subject|2|||
125271920|NCT01393899|450622138|FG002|Overall Study|Withdrawal by Subject|1|||
125271921|NCT01393899|450622136|FG000|Overall Study|Lost to Follow-up|0|||
125271922|NCT01393899|450622137|FG001|Overall Study|Lost to Follow-up|0|||
125271923|NCT01393899|450622138|FG002|Overall Study|Lost to Follow-up|1|||
125271924|NCT01393899|450622136|FG000|Overall Study|Does not meet entrance criteria|1|||
125271925|NCT01393899|450622137|FG001|Overall Study|Does not meet entrance criteria|0|||
125271926|NCT01393899|450622138|FG002|Overall Study|Does not meet entrance criteria|1|||
125271927|NCT01393899|450622136|FG000|Overall Study|Lack of Efficacy|26|||
125271928|NCT01393899|450622137|FG001|Overall Study|Lack of Efficacy|21|||
125271929|NCT01393899|450622138|FG002|Overall Study|Lack of Efficacy|16|||
125271930|NCT01393899|450622136|FG000|Overall Study|Adverse Event|1|||
125271931|NCT01393899|450622137|FG001|Overall Study|Adverse Event|5|||
125271932|NCT01393899|450622138|FG002|Overall Study|Adverse Event|3|||
125271933|NCT02503085|450622139|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
125271934|NCT02503085|450622140|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
125271935|NCT02503085|450622141|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
125271936|NCT02503085|450622142|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
125271937|NCT02595866|450622143|FG000|Overall Study|Adverse Event|2|||
125271938|NCT02595866|450622144|FG001|Overall Study|Adverse Event|5|||
125271939|NCT02595866|450622143|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
125271940|NCT02595866|450622144|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
125271941|NCT02595866|450622143|FG000|Overall Study|Death|0|||
125271942|NCT02595866|450622144|FG001|Overall Study|Death|1|||
125271943|NCT02595866|450622143|FG000|Overall Study|Incarceration|1|||
125271944|NCT02595866|450622144|FG001|Overall Study|Incarceration|0|||
125271945|NCT02595866|450622143|FG000|Overall Study|Lack of Efficacy|17|||
125271946|NCT02595866|450622144|FG001|Overall Study|Lack of Efficacy|7|||
125271947|NCT02595866|450622143|FG000|Overall Study|Physician Decision|4|||
125271948|NCT02595866|450622144|FG001|Overall Study|Physician Decision|3|||
125271949|NCT02595866|450622143|FG000|Overall Study|Switched to Alternative Treatment|1|||
125271950|NCT02595866|450622144|FG001|Overall Study|Switched to Alternative Treatment|0|||
125271951|NCT02595866|450622143|FG000|Overall Study|Study Terminated|0|||
125271952|NCT02595866|450622144|FG001|Overall Study|Study Terminated|4|||
125271953|NCT02595866|450622143|FG000|Overall Study|Withdrawal by Subject|6|||
125271954|NCT02595866|450622144|FG001|Overall Study|Withdrawal by Subject|1|||
125271955|NCT02520388|450622145|FG000|Overall Study|Physician Decision|1|||
125271956|NCT02520388|450622146|FG001|Overall Study|Physician Decision|0|||
125271957|NCT02520388|450622145|FG000|Overall Study|Subject or parent/guardian request|0|||
125271958|NCT02520388|450622146|FG001|Overall Study|Subject or parent/guardian request|6|||
125271959|NCT02520388|450622145|FG000|Overall Study|Adverse Event|1|||
125271960|NCT02520388|450622146|FG001|Overall Study|Adverse Event|4|||
125271961|NCT02520388|450622145|FG000|Overall Study|Lost to Follow-up|3|||
125271962|NCT02520388|450622146|FG001|Overall Study|Lost to Follow-up|2|||
125271963|NCT02520388|450622145|FG000|Overall Study|Other (reason not defined)|4|||
125271964|NCT02520388|450622146|FG001|Overall Study|Other (reason not defined)|4|||
125271965|NCT01232127|450622147|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
125271966|NCT01232127|450622148|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
125271967|NCT01232127|450622149|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
125271968|NCT03035864|450622155|FG000|Treatment Period|Adverse Event|1|||
125271969|NCT03035864|450622156|FG001|Treatment Period|Adverse Event|0|||
125271970|NCT03035864|450622155|FG000|Treatment Period|Other|3|||
125271971|NCT03035864|450622156|FG001|Treatment Period|Other|1|||
125271972|NCT03035864|450622155|FG000|Follow-up Period|Adverse Event|1|||
125271973|NCT03035864|450622156|FG001|Follow-up Period|Adverse Event|0|||
125271974|NCT03035864|450622155|FG000|Follow-up Period|Lost to Follow-up|6|||
125271975|NCT03035864|450622156|FG001|Follow-up Period|Lost to Follow-up|2|||
125447703|NCT02753530|451264886|FG000|Overall Study|Protocol Violation|1|||
125271976|NCT03035864|450622155|FG000|Follow-up Period|Physician Decision|1|||
125271977|NCT03035864|450622156|FG001|Follow-up Period|Physician Decision|0|||
125271978|NCT03035864|450622155|FG000|Follow-up Period|Other|3|||
125271979|NCT03035864|450622156|FG001|Follow-up Period|Other|2|||
125271980|NCT02375373|450622161|FG000|Overall Study|Withdrawal by Subject|11|||
125271981|NCT01890265|450622162|FG000|Overall Study|Other (Unspecified reason)|0|||
125271982|NCT01890265|450622163|FG001|Overall Study|Other (Unspecified reason)|1|||
125271983|NCT01890265|450622164|FG002|Overall Study|Other (Unspecified reason)|0|||
125271984|NCT01890265|450622165|FG003|Overall Study|Other (Unspecified reason)|0|||
125271985|NCT01890265|450622166|FG004|Overall Study|Other (Unspecified reason)|0|||
125271986|NCT01890265|450622167|FG005|Overall Study|Other (Unspecified reason)|0|||
125271987|NCT01890265|450622162|FG000|Overall Study|Progressive disease|6|||
125271988|NCT01890265|450622163|FG001|Overall Study|Progressive disease|6|||
125271989|NCT01890265|450622164|FG002|Overall Study|Progressive disease|0|||
125271990|NCT01890265|450622165|FG003|Overall Study|Progressive disease|0|||
125271991|NCT01890265|450622166|FG004|Overall Study|Progressive disease|0|||
125271992|NCT01890265|450622167|FG005|Overall Study|Progressive disease|0|||
125271993|NCT01890265|450622162|FG000|Overall Study|Adverse Event|2|||
125271994|NCT01890265|450622163|FG001|Overall Study|Adverse Event|1|||
125271995|NCT01890265|450622164|FG002|Overall Study|Adverse Event|0|||
125271996|NCT01890265|450622165|FG003|Overall Study|Adverse Event|0|||
125271997|NCT01890265|450622166|FG004|Overall Study|Adverse Event|0|||
125271998|NCT01890265|450622167|FG005|Overall Study|Adverse Event|0|||
125271999|NCT01890265|450622162|FG000|Overall Study|Death|2|||
125272000|NCT01890265|450622163|FG001|Overall Study|Death|3|||
125272001|NCT01890265|450622164|FG002|Overall Study|Death|1|||
125272002|NCT01890265|450622165|FG003|Overall Study|Death|0|||
125272003|NCT01890265|450622166|FG004|Overall Study|Death|0|||
125272004|NCT01890265|450622167|FG005|Overall Study|Death|0|||
125272005|NCT01890265|450622162|FG000|Overall Study|Withdrawal by Subject|0|||
125272006|NCT01890265|450622163|FG001|Overall Study|Withdrawal by Subject|2|||
125272007|NCT01890265|450622164|FG002|Overall Study|Withdrawal by Subject|3|||
125272008|NCT01890265|450622165|FG003|Overall Study|Withdrawal by Subject|0|||
125272009|NCT01890265|450622166|FG004|Overall Study|Withdrawal by Subject|2|||
125272010|NCT01890265|450622167|FG005|Overall Study|Withdrawal by Subject|0|||
125272011|NCT01445613|450622168|FG000|30-day Follow-up|Withdrawal by Subject|6|||
125272012|NCT01445613|450622168|FG000|30-day Follow-up|Physician Decision|3|||
125272013|NCT01445613|450622168|FG000|30-day Follow-up|Missed visit|23|||
125272014|NCT01445613|450622168|FG000|30-day Follow-up|Death|3|||
125272015|NCT01445613|450622168|FG000|1-year Follow-up|Withdrawal by Subject|12|||
125272016|NCT01445613|450622168|FG000|1-year Follow-up|Missed visit|29|||
125272017|NCT01445613|450622168|FG000|1-year Follow-up|Lost to Follow-up|2|||
125272018|NCT01445613|450622168|FG000|1-year Follow-up|Death|30|||
125272019|NCT01445613|450622168|FG000|1-year Follow-up|Physician Decision|2|||
125272020|NCT01445613|450622168|FG000|1-year Follow-up|Received a non-study stent|2|||
125272021|NCT00809926|450622171|FG000|Overall Study|Adverse Event|18|||
125272022|NCT00809926|450622172|FG001|Overall Study|Adverse Event|10|||
125272023|NCT00809926|450622171|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
125272024|NCT00809926|450622172|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125272025|NCT00809926|450622171|FG000|Overall Study|Patient withdrew consent|8|||
125272026|NCT00809926|450622172|FG001|Overall Study|Patient withdrew consent|6|||
125272027|NCT00809926|450622171|FG000|Overall Study|Lost to Follow-up|2|||
125272028|NCT00809926|450622172|FG001|Overall Study|Lost to Follow-up|1|||
125272029|NCT00809926|450622171|FG000|Overall Study|Administrative Problems|0|||
125272030|NCT00809926|450622172|FG001|Overall Study|Administrative Problems|1|||
125272031|NCT00809926|450622171|FG000|Overall Study|Protocol deviation|0|||
125272032|NCT00809926|450622172|FG001|Overall Study|Protocol deviation|2|||
125272033|NCT00642707|450622173|FG000|Overall Study|Adverse Event|0|||
125272034|NCT00642707|450622174|FG001|Overall Study|Adverse Event|0|||
125272035|NCT00642707|450622175|FG002|Overall Study|Adverse Event|0|||
125272036|NCT00642707|450622176|FG003|Overall Study|Adverse Event|2|||
125272037|NCT00642707|450622173|FG000|Overall Study|Withdrawal by Subject|1|||
125272038|NCT00642707|450622174|FG001|Overall Study|Withdrawal by Subject|0|||
125272039|NCT00642707|450622175|FG002|Overall Study|Withdrawal by Subject|0|||
125272040|NCT00642707|450622176|FG003|Overall Study|Withdrawal by Subject|0|||
125272041|NCT00130039|450622177|FG000|Overall Study|Withdrawal by Subject|15|||
125272042|NCT00130039|450622178|FG001|Overall Study|Withdrawal by Subject|11|||
125272043|NCT00130039|450622177|FG000|Overall Study|Lost to Follow-up|3|||
125272044|NCT00130039|450622178|FG001|Overall Study|Lost to Follow-up|1|||
125272045|NCT00130039|450622177|FG000|Overall Study|Adverse Event|4|||
125272046|NCT00130039|450622178|FG001|Overall Study|Adverse Event|2|||
125272047|NCT00130039|450622177|FG000|Overall Study|Physician Decision|3|||
125272048|NCT00130039|450622178|FG001|Overall Study|Physician Decision|0|||
125272049|NCT00130039|450622177|FG000|Overall Study|clinical events without follow up MRI|5|||
125272050|NCT00130039|450622178|FG001|Overall Study|clinical events without follow up MRI|4|||
125272051|NCT00100802|450622186|FG000|Overall Study|Adverse Event|9|||
125272052|NCT00100802|450622186|FG000|Overall Study|Death|1|||
125272053|NCT00100802|450622186|FG000|Overall Study|Lack of Efficacy|47|||
125272054|NCT00100802|450622186|FG000|Overall Study|Physician Decision|5|||
125272055|NCT00100802|450622186|FG000|Overall Study|Protocol Violation|1|||
125272056|NCT00100802|450622186|FG000|Overall Study|Withdrawal by Subject|5|||
125272057|NCT00100802|450622186|FG000|Overall Study|Ineligible|12|||
125272058|NCT02709720|450622187|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
125272059|NCT02709720|450622187|FG000|Overall Study|Protocol Violation|1|||
125272060|NCT02709720|450622187|FG000|Overall Study|Not take study medication|1|||
125272061|NCT01198574|450622188|FG000|Overall Study|Resigned from schools|4|||
125272062|NCT01198574|450622189|FG001|Overall Study|Resigned from schools|1|||
125272063|NCT01198574|450622190|FG002|Overall Study|Resigned from schools|1|||
125272064|NCT01198574|450622191|FG003|Overall Study|Resigned from schools|4|||
125272065|NCT00325130|450622220|FG000|Overall Study|Lost to Follow-up|6|||
125272066|NCT00325130|450622221|FG001|Overall Study|Lost to Follow-up|14|||
125272067|NCT00325130|450622220|FG000|Overall Study|Withdrawal by Subject|12|||
125272068|NCT00325130|450622221|FG001|Overall Study|Withdrawal by Subject|14|||
125272069|NCT00325130|450622220|FG000|Overall Study|Protocol Deviation|0|||
125272070|NCT00325130|450622221|FG001|Overall Study|Protocol Deviation|1|||
125272071|NCT00325130|450622220|FG000|Overall Study|Moved|0|||
125272072|NCT00325130|450622221|FG001|Overall Study|Moved|1|||
125272073|NCT00325130|450622220|FG000|Overall Study|Patient Discontinued for Other|1|||
125272074|NCT00325130|450622221|FG001|Overall Study|Patient Discontinued for Other|0|||
125272075|NCT00326001|450622222|FG000|Overall Study|Adverse Event|4|||
125272076|NCT00326001|450622223|FG001|Overall Study|Adverse Event|5|||
125272077|NCT00326001|450622222|FG000|Overall Study|Physician Decision|3|||
125272078|NCT00326001|450622223|FG001|Overall Study|Physician Decision|3|||
125272079|NCT01042158|450622224|FG000|Overall Study|Physician Decision|1|||
125272080|NCT03640325|450623517|FG000|Overall Study|Withdrawal by Subject|4|||
125272081|NCT03640325|450623518|FG001|Overall Study|Withdrawal by Subject|1|||
125272082|NCT03640325|450623519|FG002|Overall Study|Withdrawal by Subject|0|||
125272083|NCT03640325|450623517|FG000|Overall Study|Lost to Follow-up|4|||
125272084|NCT03640325|450623518|FG001|Overall Study|Lost to Follow-up|5|||
125272085|NCT03640325|450623519|FG002|Overall Study|Lost to Follow-up|21|||
125272086|NCT03640325|450623517|FG000|Overall Study|Death|5|||
125272087|NCT03640325|450623518|FG001|Overall Study|Death|5|||
125272088|NCT03640325|450623519|FG002|Overall Study|Death|0|||
125272089|NCT01133756|450623523|FG000|Overall Study|Adverse Event|1|||
125272090|NCT01133756|450623524|FG001|Overall Study|Adverse Event|2|||
125272091|NCT01133756|450623525|FG002|Overall Study|Adverse Event|1|||
125272092|NCT01133756|450623523|FG000|Overall Study|Investigator Decision|1|||
125272093|NCT01133756|450623524|FG001|Overall Study|Investigator Decision|0|||
125272094|NCT01133756|450623525|FG002|Overall Study|Investigator Decision|0|||
125272095|NCT01133756|450623523|FG000|Overall Study|Withdrawal by Subject|0|||
125272096|NCT01133756|450623524|FG001|Overall Study|Withdrawal by Subject|1|||
125272097|NCT01133756|450623525|FG002|Overall Study|Withdrawal by Subject|0|||
125272098|NCT01133756|450623523|FG000|Overall Study|Progression of Disease|0|||
125272099|NCT01133756|450623524|FG001|Overall Study|Progression of Disease|0|||
125272100|NCT01133756|450623525|FG002|Overall Study|Progression of Disease|1|||
125272101|NCT01566149|450623526|FG000|Overall Study|Adverse Event|0|||
125272102|NCT01566149|450623527|FG001|Overall Study|Adverse Event|1|||
125272103|NCT01566149|450623526|FG000|Overall Study|Non-compliance with study medication|2|||
125272104|NCT01566149|450623527|FG001|Overall Study|Non-compliance with study medication|0|||
125272105|NCT01566149|450623526|FG000|Overall Study|Protocol Violation|0|||
125272106|NCT01566149|450623527|FG001|Overall Study|Protocol Violation|1|||
125272107|NCT01566149|450623526|FG000|Overall Study|Withdrawal by Subject|1|||
125272108|NCT01566149|450623527|FG001|Overall Study|Withdrawal by Subject|0|||
125272109|NCT03276728|450623530|FG000|Overall Study|Lost to Follow-up|0|||
125272110|NCT03276728|450623531|FG001|Overall Study|Lost to Follow-up|0|||
125272111|NCT03276728|450623532|FG002|Overall Study|Lost to Follow-up|2|||
125272112|NCT03276728|450623533|FG003|Overall Study|Lost to Follow-up|2|||
125272113|NCT03276728|450623534|FG004|Overall Study|Lost to Follow-up|0|||
125272114|NCT03276728|450623535|FG005|Overall Study|Lost to Follow-up|0|||
125272115|NCT03276728|450623536|FG006|Overall Study|Lost to Follow-up|0|||
125272116|NCT03276728|450623537|FG007|Overall Study|Lost to Follow-up|0|||
125272117|NCT03276728|450623530|FG000|Overall Study|Withdrawal by Subject|0|||
125272118|NCT03276728|450623531|FG001|Overall Study|Withdrawal by Subject|0|||
125272119|NCT03276728|450623532|FG002|Overall Study|Withdrawal by Subject|0|||
125272120|NCT03276728|450623533|FG003|Overall Study|Withdrawal by Subject|3|||
125272121|NCT03276728|450623534|FG004|Overall Study|Withdrawal by Subject|0|||
125272122|NCT03276728|450623535|FG005|Overall Study|Withdrawal by Subject|0|||
125272123|NCT03276728|450623536|FG006|Overall Study|Withdrawal by Subject|0|||
125272124|NCT03276728|450623537|FG007|Overall Study|Withdrawal by Subject|0|||
125272125|NCT03276728|450623530|FG000|Overall Study|Decision by sponsor|0|||
125272126|NCT03276728|450623531|FG001|Overall Study|Decision by sponsor|0|||
125272127|NCT03276728|450623532|FG002|Overall Study|Decision by sponsor|0|||
125272128|NCT03276728|450623533|FG003|Overall Study|Decision by sponsor|0|||
125272129|NCT03276728|450623534|FG004|Overall Study|Decision by sponsor|1|||
125272130|NCT03276728|450623535|FG005|Overall Study|Decision by sponsor|0|||
125272131|NCT03276728|450623536|FG006|Overall Study|Decision by sponsor|2|||
125272132|NCT03276728|450623537|FG007|Overall Study|Decision by sponsor|1|||
125272133|NCT03941873|450623544|FG000|Overall Study|Death|0|||
125272134|NCT03941873|450623545|FG001|Overall Study|Death|12|||
125272135|NCT03941873|450623546|FG002|Overall Study|Death|2|||
125272136|NCT03941873|450623547|FG003|Overall Study|Death|53|||
125272137|NCT03941873|450623544|FG000|Overall Study|Withdrawal by Subject|1|||
125272138|NCT03941873|450623545|FG001|Overall Study|Withdrawal by Subject|1|||
125272139|NCT03941873|450623546|FG002|Overall Study|Withdrawal by Subject|0|||
125272140|NCT03941873|450623547|FG003|Overall Study|Withdrawal by Subject|5|||
125272141|NCT03941873|450623544|FG000|Overall Study|Lost to Follow-up|1|||
125447704|NCT02753530|451264887|FG001|Overall Study|Protocol Violation|0|||
125447705|NCT02753530|451264886|FG000|Overall Study|Withdrawal by Subject|4|||
125272142|NCT03941873|450623545|FG001|Overall Study|Lost to Follow-up|2|||
125272143|NCT03941873|450623546|FG002|Overall Study|Lost to Follow-up|0|||
125272144|NCT03941873|450623547|FG003|Overall Study|Lost to Follow-up|0|||
125272145|NCT03941873|450623544|FG000|Overall Study|Sponsor Decision|0|||
125272146|NCT03941873|450623545|FG001|Overall Study|Sponsor Decision|6|||
125272147|NCT03941873|450623546|FG002|Overall Study|Sponsor Decision|0|||
125272148|NCT03941873|450623547|FG003|Overall Study|Sponsor Decision|15|||
125272149|NCT01234480|450623548|FG000|Overall Study|Pregnancy|88|||
125272150|NCT01234480|450623548|FG000|Overall Study|>36/Normal History|50|||
125272151|NCT01234480|450623548|FG000|Overall Study|Age|3|||
125272152|NCT01234480|450623548|FG000|Overall Study|HPV Vaccine History|28|||
125272153|NCT01234480|450623548|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
125272154|NCT01234480|450623548|FG000|Overall Study|Hysterectomy|2|||
125272155|NCT01234480|450623548|FG000|Overall Study|Hysterectomy post enrollment|1|||
125272156|NCT01234480|450623548|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
125272157|NCT01234480|450623548|FG000|Overall Study|Informed Consent Form Violation|30|||
125272158|NCT01234480|450623548|FG000|Overall Study|Incorrect Visit|3|||
125272159|NCT01234480|450623548|FG000|Overall Study|No Florida Lab License|20|||
125272160|NCT01234480|450623548|FG000|Overall Study|Out of Window|42|||
125272161|NCT01234480|450623548|FG000|Overall Study|Sample Processing/Storage|92|||
125272162|NCT01234480|450623548|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
125272163|NCT01234480|450623548|FG000|Overall Study|Site/Subject non-compliance|44|||
125272164|NCT01234480|450623548|FG000|Overall Study|Missing Sample|9|||
125272165|NCT02982772|450623549|FG000|Intervention|Lost to Follow-up|19|||
125272166|NCT02982772|450623550|FG001|Intervention|Lost to Follow-up|13|||
125272167|NCT02982772|450623549|FG000|1M Follow-Up|Lost to Follow-up|21|||
125272168|NCT02982772|450623550|FG001|1M Follow-Up|Lost to Follow-up|18|||
125272169|NCT02982772|450623549|FG000|3M Follow-Up|Lost to Follow-up|17|||
125272170|NCT02982772|450623550|FG001|3M Follow-Up|Lost to Follow-up|11|||
125272171|NCT02982772|450623549|FG000|6M Follow-Up|Lost to Follow-up|11|||
125272172|NCT02982772|450623550|FG001|6M Follow-Up|Lost to Follow-up|9|||
125272173|NCT02982772|450623549|FG000|12M Follow-Up|Lost to Follow-up|11|||
125272174|NCT02982772|450623550|FG001|12M Follow-Up|Lost to Follow-up|5|||
125272175|NCT01238991|450623553|FG000|Overall Study|Adverse Event|1|||
125272176|NCT01238991|450623554|FG001|Overall Study|Adverse Event|0|||
125272177|NCT01238991|450623555|FG002|Overall Study|Adverse Event|3|||
125272178|NCT01238991|450623556|FG003|Overall Study|Adverse Event|1|||
125272179|NCT01238991|450623557|FG004|Overall Study|Adverse Event|1|||
125272180|NCT01238991|450623558|FG005|Overall Study|Adverse Event|0|||
125272181|NCT01238991|450623559|FG006|Overall Study|Adverse Event|1|||
125272182|NCT01238991|450623560|FG007|Overall Study|Adverse Event|1|||
125272183|NCT01238991|450623561|FG008|Overall Study|Adverse Event|0|||
125272184|NCT01238991|450623562|FG009|Overall Study|Adverse Event|0|||
125272185|NCT01238991|450623553|FG000|Overall Study|Death|0|||
125272186|NCT01238991|450623554|FG001|Overall Study|Death|0|||
125272187|NCT01238991|450623555|FG002|Overall Study|Death|0|||
125272188|NCT01238991|450623556|FG003|Overall Study|Death|1|||
125272189|NCT01238991|450623557|FG004|Overall Study|Death|0|||
125272190|NCT01238991|450623558|FG005|Overall Study|Death|0|||
125272191|NCT01238991|450623559|FG006|Overall Study|Death|0|||
125272192|NCT01238991|450623560|FG007|Overall Study|Death|0|||
125272193|NCT01238991|450623561|FG008|Overall Study|Death|0|||
125272194|NCT01238991|450623562|FG009|Overall Study|Death|0|||
125272195|NCT01238991|450623553|FG000|Overall Study|Lack of Efficacy|0|||
125272196|NCT01238991|450623554|FG001|Overall Study|Lack of Efficacy|0|||
125272197|NCT01238991|450623555|FG002|Overall Study|Lack of Efficacy|1|||
125272198|NCT01238991|450623556|FG003|Overall Study|Lack of Efficacy|0|||
125272199|NCT01238991|450623557|FG004|Overall Study|Lack of Efficacy|0|||
125272200|NCT01238991|450623558|FG005|Overall Study|Lack of Efficacy|0|||
125272201|NCT01238991|450623559|FG006|Overall Study|Lack of Efficacy|0|||
125272202|NCT01238991|450623560|FG007|Overall Study|Lack of Efficacy|0|||
125272203|NCT01238991|450623561|FG008|Overall Study|Lack of Efficacy|1|||
125447706|NCT02753530|451264887|FG001|Overall Study|Withdrawal by Subject|3|||
125272204|NCT01238991|450623562|FG009|Overall Study|Lack of Efficacy|0|||
125272205|NCT01238991|450623553|FG000|Overall Study|Withdrawal by Subject|0|||
125272206|NCT01238991|450623554|FG001|Overall Study|Withdrawal by Subject|0|||
125272207|NCT01238991|450623555|FG002|Overall Study|Withdrawal by Subject|1|||
125272208|NCT01238991|450623556|FG003|Overall Study|Withdrawal by Subject|0|||
125272209|NCT01238991|450623557|FG004|Overall Study|Withdrawal by Subject|0|||
125447707|NCT01641861|451264888|FG000|Overall Study|Lost to Follow-up|21|||
125447708|NCT01641861|451264889|FG001|Overall Study|Lost to Follow-up|16|||
125272210|NCT01238991|450623558|FG005|Overall Study|Withdrawal by Subject|0|||
125272211|NCT01238991|450623559|FG006|Overall Study|Withdrawal by Subject|0|||
125272212|NCT01238991|450623560|FG007|Overall Study|Withdrawal by Subject|0|||
125272213|NCT01238991|450623561|FG008|Overall Study|Withdrawal by Subject|0|||
125272214|NCT01238991|450623562|FG009|Overall Study|Withdrawal by Subject|0|||
125272215|NCT01238991|450623553|FG000|Overall Study|Study Terminated by Sponsor|0|||
125272216|NCT01238991|450623554|FG001|Overall Study|Study Terminated by Sponsor|0|||
125272217|NCT01238991|450623555|FG002|Overall Study|Study Terminated by Sponsor|0|||
125272218|NCT01238991|450623556|FG003|Overall Study|Study Terminated by Sponsor|0|||
125272219|NCT01238991|450623557|FG004|Overall Study|Study Terminated by Sponsor|1|||
125272220|NCT01238991|450623558|FG005|Overall Study|Study Terminated by Sponsor|0|||
125272221|NCT01238991|450623559|FG006|Overall Study|Study Terminated by Sponsor|7|||
125272222|NCT01238991|450623560|FG007|Overall Study|Study Terminated by Sponsor|4|||
125272223|NCT01238991|450623561|FG008|Overall Study|Study Terminated by Sponsor|2|||
125272224|NCT01238991|450623562|FG009|Overall Study|Study Terminated by Sponsor|2|||
125272225|NCT01238991|450623553|FG000|Overall Study|Caregiver's request|0|||
125272226|NCT01238991|450623554|FG001|Overall Study|Caregiver's request|0|||
125272227|NCT01238991|450623555|FG002|Overall Study|Caregiver's request|0|||
125272228|NCT01238991|450623556|FG003|Overall Study|Caregiver's request|0|||
125272229|NCT01238991|450623557|FG004|Overall Study|Caregiver's request|0|||
125272230|NCT01238991|450623558|FG005|Overall Study|Caregiver's request|0|||
125447709|NCT01641861|451264888|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
125447710|NCT01641861|451264889|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
125447711|NCT01641861|451264888|FG000|Overall Study|Died due to drowning|0|||
125447712|NCT01641861|451264889|FG001|Overall Study|Died due to drowning|1|||
125447713|NCT05567952|451266762|FG000|Overall Study|Lost to Follow-up|3|||
125447714|NCT05567952|451266763|FG001|Overall Study|Lost to Follow-up|2|||
125447715|NCT05567952|451266762|FG000|Overall Study|Withdrawal by Subject|6|||
125447716|NCT05567952|451266763|FG001|Overall Study|Withdrawal by Subject|3|||
125447717|NCT05567952|451266762|FG000|Overall Study|Other|3|||
125447718|NCT05567952|451266763|FG001|Overall Study|Other|1|||
125447719|NCT04213846|451266764|FG000|Overall Study|Withdrawal by Subject|7|||
125447720|NCT04213846|451266765|FG001|Overall Study|Withdrawal by Subject|6|||
125447721|NCT04213846|451266764|FG000|Overall Study|Lost to Follow-up|15|||
125447722|NCT04213846|451266765|FG001|Overall Study|Lost to Follow-up|21|||
125447723|NCT04423393|451266766|FG000|Overall Study|Withdrawal by Subject|0|||
125447724|NCT04423393|451266767|FG001|Overall Study|Withdrawal by Subject|0|||
125447725|NCT04423393|451266768|FG002|Overall Study|Withdrawal by Subject|0|||
125447726|NCT04423393|451266769|FG003|Overall Study|Withdrawal by Subject|0|||
125272231|NCT01238991|450623559|FG006|Overall Study|Caregiver's request|0|||
125272232|NCT01238991|450623560|FG007|Overall Study|Caregiver's request|0|||
125272233|NCT01238991|450623561|FG008|Overall Study|Caregiver's request|1|||
125272234|NCT01238991|450623562|FG009|Overall Study|Caregiver's request|0|||
125272235|NCT01238991|450623553|FG000|Overall Study|Admission to a nursing home|1|||
125272236|NCT01238991|450623554|FG001|Overall Study|Admission to a nursing home|0|||
125447727|NCT04423393|451266770|FG004|Overall Study|Withdrawal by Subject|0|||
125447728|NCT04423393|451266771|FG005|Overall Study|Withdrawal by Subject|1|||
125447729|NCT04423393|451266772|FG006|Overall Study|Withdrawal by Subject|0|||
125447730|NCT04423393|451266773|FG007|Overall Study|Withdrawal by Subject|0|||
125447731|NCT04423393|451266774|FG008|Overall Study|Withdrawal by Subject|0|||
125272237|NCT01238991|450623555|FG002|Overall Study|Admission to a nursing home|1|||
125272238|NCT01238991|450623556|FG003|Overall Study|Admission to a nursing home|0|||
125399207|NCT03492177|451093323|FG002|Overall Study|Ongoing|17|||
125399208|NCT06425458|451093324|FG000|Overall Study|Removed by study team|2|||
125399209|NCT06425458|451093324|FG000|Overall Study|Lost to Follow-up|5|||
125272239|NCT01238991|450623557|FG004|Overall Study|Admission to a nursing home|0|||
125272240|NCT01238991|450623558|FG005|Overall Study|Admission to a nursing home|0|||
125272241|NCT01238991|450623559|FG006|Overall Study|Admission to a nursing home|0|||
125272242|NCT01238991|450623560|FG007|Overall Study|Admission to a nursing home|0|||
125272243|NCT01238991|450623561|FG008|Overall Study|Admission to a nursing home|0|||
125272244|NCT01238991|450623562|FG009|Overall Study|Admission to a nursing home|0|||
125272245|NCT03370419|450623563|FG000|Overall Study|Lost to Follow-up|16|||
125272246|NCT01897727|450623568|FG000|Overall Study|Exclusion: central sleep apnea|0|||
125272247|NCT01897727|450623569|FG001|Overall Study|Exclusion: central sleep apnea|1|||
125399210|NCT03945981|451093325|FG000|Overall Study|Lost to Follow-up|12|||
125399211|NCT03945981|451093325|FG000|Overall Study|Physician Decision|4|||
125399212|NCT03945981|451093325|FG000|Overall Study|Withdrawal by Subject|6|||
125399213|NCT03945981|451093325|FG000|Overall Study|Protocol Violation|1|||
125272248|NCT02013778|450623572|FG000|Overall Study|Death|4|||
125272249|NCT02013778|450623572|FG000|Overall Study|Withdrawal by Subject|1|||
125272250|NCT02013778|450623572|FG000|Overall Study|Physician Decision|1|||
125272251|NCT02013778|450623572|FG000|Overall Study|Adverse Event|1|||
125399214|NCT03665038|451093326|FG000|Overall Study|Lost to Follow-up|0|||
125447732|NCT04423393|451266775|FG009|Overall Study|Withdrawal by Subject|0|||
125272252|NCT00293813|450623573|FG000|Overall Study|Physician Decision|0|||
125272253|NCT00293813|450623574|FG001|Overall Study|Physician Decision|1|||
125272254|NCT00293813|450623575|FG002|Overall Study|Physician Decision|0|||
125272255|NCT00293813|450623573|FG000|Overall Study|Adverse Event|3|||
125272256|NCT00293813|450623574|FG001|Overall Study|Adverse Event|1|||
125447733|NCT04423393|451266776|FG010|Overall Study|Withdrawal by Subject|0|||
125447734|NCT04423393|451266777|FG011|Overall Study|Withdrawal by Subject|0|||
125447735|NCT04423393|451266778|FG012|Overall Study|Withdrawal by Subject|0|||
125447736|NCT04423393|451266779|FG013|Overall Study|Withdrawal by Subject|1|||
125447737|NCT04423393|451266780|FG014|Overall Study|Withdrawal by Subject|0|||
125272257|NCT00293813|450623575|FG002|Overall Study|Adverse Event|1|||
125272258|NCT00293813|450623573|FG000|Overall Study|Withdrawal by Subject|7|||
125272259|NCT00293813|450623574|FG001|Overall Study|Withdrawal by Subject|4|||
125272260|NCT00293813|450623575|FG002|Overall Study|Withdrawal by Subject|4|||
125399215|NCT03665038|451093327|FG001|Overall Study|Lost to Follow-up|0|||
125399216|NCT03665038|451093328|FG002|Overall Study|Lost to Follow-up|1|||
125399217|NCT04466891|451093329|FG000|Overall Study|Death|60|||
125272261|NCT00293813|450623573|FG000|Overall Study|Lost to Follow-up|3|||
125272262|NCT00293813|450623574|FG001|Overall Study|Lost to Follow-up|2|||
125272263|NCT00293813|450623575|FG002|Overall Study|Lost to Follow-up|3|||
125272264|NCT00293813|450623573|FG000|Overall Study|Noncompliance|0|||
125272265|NCT00293813|450623574|FG001|Overall Study|Noncompliance|1|||
125272266|NCT00293813|450623575|FG002|Overall Study|Noncompliance|0|||
125272267|NCT01521923|450623578|FG000|Overall Study|AE, serious fatal|1|||
125272268|NCT01521923|450623579|FG001|Overall Study|AE, serious fatal|0|||
125272269|NCT01521923|450623580|FG002|Overall Study|AE, serious fatal|0|||
125272270|NCT01521923|450623581|FG003|Overall Study|AE, serious fatal|0|||
125272271|NCT01521923|450623578|FG000|Overall Study|SAE, non-fatal|0|||
125272272|NCT01521923|450623579|FG001|Overall Study|SAE, non-fatal|2|||
125272273|NCT01521923|450623580|FG002|Overall Study|SAE, non-fatal|2|||
125272274|NCT01521923|450623581|FG003|Overall Study|SAE, non-fatal|0|||
125272275|NCT01521923|450623578|FG000|Overall Study|AE, non-serious, non-fatal|1|||
125272276|NCT01521923|450623579|FG001|Overall Study|AE, non-serious, non-fatal|3|||
125272277|NCT01521923|450623580|FG002|Overall Study|AE, non-serious, non-fatal|6|||
125272278|NCT01521923|450623581|FG003|Overall Study|AE, non-serious, non-fatal|2|||
125272279|NCT01521923|450623578|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
125272280|NCT01521923|450623579|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
125272281|NCT01521923|450623580|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
125272282|NCT01521923|450623581|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
125272283|NCT01521923|450623578|FG000|Overall Study|Lack of Efficacy|1|||
125272284|NCT01521923|450623579|FG001|Overall Study|Lack of Efficacy|1|||
125272285|NCT01521923|450623580|FG002|Overall Study|Lack of Efficacy|0|||
125272286|NCT01521923|450623581|FG003|Overall Study|Lack of Efficacy|0|||
125272287|NCT01521923|450623578|FG000|Overall Study|Protocol Violation|0|||
125272288|NCT01521923|450623579|FG001|Overall Study|Protocol Violation|0|||
125272289|NCT01521923|450623580|FG002|Overall Study|Protocol Violation|1|||
125272290|NCT01521923|450623581|FG003|Overall Study|Protocol Violation|0|||
125272291|NCT01521923|450623578|FG000|Overall Study|Lost to Follow-up|1|||
125272292|NCT01521923|450623579|FG001|Overall Study|Lost to Follow-up|0|||
125272293|NCT01521923|450623580|FG002|Overall Study|Lost to Follow-up|2|||
125272294|NCT01521923|450623581|FG003|Overall Study|Lost to Follow-up|1|||
125272295|NCT01521923|450623578|FG000|Overall Study|Withdrawal by Subject|1|||
125272296|NCT01521923|450623579|FG001|Overall Study|Withdrawal by Subject|1|||
125272297|NCT01521923|450623580|FG002|Overall Study|Withdrawal by Subject|1|||
125272298|NCT01521923|450623581|FG003|Overall Study|Withdrawal by Subject|2|||
125272299|NCT01521923|450623578|FG000|Overall Study|Other|2|||
125272300|NCT01521923|450623579|FG001|Overall Study|Other|1|||
125272301|NCT01521923|450623580|FG002|Overall Study|Other|3|||
125272302|NCT01521923|450623581|FG003|Overall Study|Other|6|||
125272303|NCT01521923|450623578|FG000|Overall Study|AE, captured in Period 1|0|||
125272304|NCT01521923|450623579|FG001|Overall Study|AE, captured in Period 1|1|||
125272305|NCT01521923|450623580|FG002|Overall Study|AE, captured in Period 1|0|||
125272306|NCT01521923|450623581|FG003|Overall Study|AE, captured in Period 1|1|||
125272307|NCT01465386|450623585|FG000|Overall Study|Lack of Efficacy|3|||
125272308|NCT01465386|450623585|FG000|Overall Study|Adverse Event|1|||
125272309|NCT01279044|450623586|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
125272310|NCT01279044|450623587|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
125272311|NCT01279044|450623588|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
125272312|NCT01279044|450623586|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
125272313|NCT01279044|450623587|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
125272314|NCT01279044|450623588|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
125272315|NCT01279044|450623586|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
125272316|NCT01279044|450623587|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
125272317|NCT01279044|450623588|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
125272318|NCT01582009|450623589|FG000|Overall Study|Withdrawal by Subject|1|||
125272319|NCT01582009|450623589|FG000|Overall Study|Physician Decision|1|||
125272320|NCT01947283|450623594|FG000|Overall Study|Death|1|||
125272321|NCT01947283|450623595|FG001|Overall Study|Death|1|||
125272322|NCT01947283|450623596|FG002|Overall Study|Death|1|||
125272323|NCT01947283|450623597|FG003|Overall Study|Death|0|||
125272324|NCT01947283|450623598|FG004|Overall Study|Death|0|||
125272325|NCT01947283|450623599|FG005|Overall Study|Death|0|||
125272326|NCT01947283|450623600|FG006|Overall Study|Death|0|||
125272327|NCT01947283|450623594|FG000|Overall Study|Lost to Follow-up|4|||
125272328|NCT01947283|450623595|FG001|Overall Study|Lost to Follow-up|6|||
125272329|NCT01947283|450623596|FG002|Overall Study|Lost to Follow-up|5|||
125272330|NCT01947283|450623597|FG003|Overall Study|Lost to Follow-up|5|||
125272331|NCT01947283|450623598|FG004|Overall Study|Lost to Follow-up|0|||
125272332|NCT01947283|450623599|FG005|Overall Study|Lost to Follow-up|2|||
125272333|NCT01947283|450623600|FG006|Overall Study|Lost to Follow-up|5|||
125272334|NCT01947283|450623594|FG000|Overall Study|Withdrawal by Subject|10|||
125272335|NCT01947283|450623595|FG001|Overall Study|Withdrawal by Subject|8|||
125272336|NCT01947283|450623596|FG002|Overall Study|Withdrawal by Subject|4|||
125272337|NCT01947283|450623597|FG003|Overall Study|Withdrawal by Subject|1|||
125272338|NCT01947283|450623598|FG004|Overall Study|Withdrawal by Subject|0|||
125272339|NCT01947283|450623599|FG005|Overall Study|Withdrawal by Subject|0|||
125272340|NCT01947283|450623600|FG006|Overall Study|Withdrawal by Subject|2|||
125272341|NCT01947283|450623594|FG000|Overall Study|No Clinical Recording|12|||
125272342|NCT01947283|450623595|FG001|Overall Study|No Clinical Recording|6|||
125272343|NCT01947283|450623596|FG002|Overall Study|No Clinical Recording|8|||
125272344|NCT01947283|450623597|FG003|Overall Study|No Clinical Recording|10|||
125272345|NCT01947283|450623598|FG004|Overall Study|No Clinical Recording|0|||
125272346|NCT01947283|450623599|FG005|Overall Study|No Clinical Recording|0|||
125272347|NCT01947283|450623600|FG006|Overall Study|No Clinical Recording|0|||
125272348|NCT01947283|450623594|FG000|Overall Study|Non-coding Clinical Recording language|0|||
125272349|NCT01947283|450623595|FG001|Overall Study|Non-coding Clinical Recording language|0|||
125272350|NCT01947283|450623596|FG002|Overall Study|Non-coding Clinical Recording language|0|||
125272351|NCT01947283|450623597|FG003|Overall Study|Non-coding Clinical Recording language|1|||
125272352|NCT01947283|450623598|FG004|Overall Study|Non-coding Clinical Recording language|0|||
125272353|NCT01947283|450623599|FG005|Overall Study|Non-coding Clinical Recording language|0|||
125272354|NCT01947283|450623600|FG006|Overall Study|Non-coding Clinical Recording language|0|||
125272355|NCT01947283|450623594|FG000|Overall Study|Missing Follow-up Assessment|2|||
125272356|NCT01947283|450623595|FG001|Overall Study|Missing Follow-up Assessment|2|||
125272357|NCT01947283|450623596|FG002|Overall Study|Missing Follow-up Assessment|3|||
125272358|NCT01947283|450623597|FG003|Overall Study|Missing Follow-up Assessment|0|||
125272359|NCT01947283|450623598|FG004|Overall Study|Missing Follow-up Assessment|0|||
125272360|NCT01947283|450623599|FG005|Overall Study|Missing Follow-up Assessment|2|||
125272361|NCT01947283|450623600|FG006|Overall Study|Missing Follow-up Assessment|0|||
125272362|NCT01947283|450623594|FG000|Overall Study|No patients were enrolled in study|0|||
125272363|NCT01947283|450623595|FG001|Overall Study|No patients were enrolled in study|0|||
125272364|NCT01947283|450623596|FG002|Overall Study|No patients were enrolled in study|0|||
125272365|NCT01947283|450623597|FG003|Overall Study|No patients were enrolled in study|0|||
125272366|NCT01947283|450623598|FG004|Overall Study|No patients were enrolled in study|0|||
125272367|NCT01947283|450623599|FG005|Overall Study|No patients were enrolled in study|3|||
125272368|NCT01947283|450623600|FG006|Overall Study|No patients were enrolled in study|1|||
125272369|NCT00460655|450623601|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
125272370|NCT00460655|450623602|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
125272371|NCT00460655|450623603|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
125272372|NCT00460655|450623604|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
125272373|NCT00460655|450623601|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
125399218|NCT04466891|451093330|FG001|Overall Study|Death|6|||
125272374|NCT00460655|450623602|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125272375|NCT00460655|450623603|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125272376|NCT00460655|450623604|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125272377|NCT00460655|450623601|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
125272378|NCT00460655|450623602|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
125399219|NCT04466891|451093329|FG000|Overall Study|Withdrawal by Subject|8|||
125399220|NCT04466891|451093330|FG001|Overall Study|Withdrawal by Subject|1|||
125399221|NCT04466891|451093329|FG000|Overall Study|Study terminated by sponsor|5|||
125399222|NCT04466891|451093330|FG001|Overall Study|Study terminated by sponsor|0|||
125399223|NCT04466891|451093329|FG000|Overall Study|Lost to Follow-up|2|||
125399224|NCT04466891|451093330|FG001|Overall Study|Lost to Follow-up|0|||
125399225|NCT04466891|451093329|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
125399226|NCT04466891|451093330|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
125399227|NCT00445328|451093331|FG000|Overall Study|Death|0|||
125399228|NCT00445328|451093332|FG001|Overall Study|Death|1|||
125399229|NCT00445328|451093331|FG000|Overall Study|Adverse Event|0|||
125399230|NCT00445328|451093332|FG001|Overall Study|Adverse Event|3|||
125399231|NCT00445328|451093331|FG000|Overall Study|Other|0|||
125399232|NCT00445328|451093332|FG001|Overall Study|Other|2|||
125399233|NCT00445328|451093331|FG000|Overall Study|Withdrawal by Subject|2|||
125399234|NCT00445328|451093332|FG001|Overall Study|Withdrawal by Subject|0|||
125399235|NCT00445328|451093331|FG000|Overall Study|Protocol Violation|1|||
125399236|NCT00445328|451093332|FG001|Overall Study|Protocol Violation|0|||
125399237|NCT00316199|451093335|FG000|Overall Study|Adverse Event|2|||
125399238|NCT00316199|451093335|FG000|Overall Study|Death|8|||
125399239|NCT00316199|451093335|FG000|Overall Study|Lost to Follow-up|2|||
125399240|NCT00590954|451093336|FG000|Overall Study|Inevaluable|2|||
125399241|NCT03890367|451093337|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125399242|NCT03890367|451093338|FG001|Overall Study|Withdrawal by parent/guardian|3|||
125399243|NCT03890367|451093339|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125399244|NCT03890367|451093337|FG000|Overall Study|Protocol deviation|2|||
125399245|NCT03890367|451093338|FG001|Overall Study|Protocol deviation|2|||
125272379|NCT00460655|450623603|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
125272380|NCT00460655|450623604|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
125272381|NCT00460655|450623601|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
125399246|NCT03890367|451093339|FG002|Overall Study|Protocol deviation|1|||
125272382|NCT00460655|450623602|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
125272383|NCT00460655|450623603|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
125272384|NCT00460655|450623604|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
125272385|NCT00460655|450623601|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
125272386|NCT00460655|450623602|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
125272387|NCT00460655|450623603|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
125272388|NCT00460655|450623604|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
125272389|NCT00460655|450623601|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
125272390|NCT00460655|450623602|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
125272391|NCT00460655|450623603|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
125272392|NCT00460655|450623604|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
125272393|NCT03592771|450623605|FG000|Overall Study|Adverse Event|2|||
125272394|NCT03592771|450623606|FG001|Overall Study|Adverse Event|0|||
125272395|NCT03592771|450623607|FG002|Overall Study|Adverse Event|1|||
125272396|NCT03592771|450623605|FG000|Overall Study|Death|0|||
125272397|NCT03592771|450623606|FG001|Overall Study|Death|1|||
125272398|NCT03592771|450623607|FG002|Overall Study|Death|1|||
125272399|NCT03592771|450623605|FG000|Overall Study|Lost to Follow-up|5|||
125272400|NCT03592771|450623606|FG001|Overall Study|Lost to Follow-up|11|||
125272401|NCT03592771|450623607|FG002|Overall Study|Lost to Follow-up|15|||
125272402|NCT03592771|450623605|FG000|Overall Study|Withdrawal by Subject|0|||
125272403|NCT03592771|450623606|FG001|Overall Study|Withdrawal by Subject|2|||
125272404|NCT03592771|450623607|FG002|Overall Study|Withdrawal by Subject|0|||
125272405|NCT00735553|450623608|FG000|Overall Study|Study prematurely terminated|77|||
125272406|NCT03654040|450623609|FG000|Overall Study|Death|1|||
125272407|NCT03654040|450623610|FG001|Overall Study|Death|0|||
125272408|NCT03654040|450623609|FG000|Overall Study|Withdrawal by Subject|1|||
125272409|NCT03654040|450623610|FG001|Overall Study|Withdrawal by Subject|0|||
125272410|NCT03654040|450623609|FG000|Overall Study|Study terminated by sponsor|8|||
125272411|NCT03654040|450623610|FG001|Overall Study|Study terminated by sponsor|2|||
125272412|NCT03654040|450623609|FG000|Overall Study|Failure to initiate study therapy|2|||
125272413|NCT03654040|450623610|FG001|Overall Study|Failure to initiate study therapy|0|||
125272414|NCT03654040|450623609|FG000|Overall Study|Transplanted at another center|2|||
125272415|NCT03654040|450623610|FG001|Overall Study|Transplanted at another center|0|||
125272416|NCT03654040|450623609|FG000|Overall Study|Failure to meet eligibility criteria|14|||
125272417|NCT03654040|450623610|FG001|Overall Study|Failure to meet eligibility criteria|2|||
125272418|NCT03654040|450623609|FG000|Overall Study|No longer transplant candidate|1|||
125272419|NCT03654040|450623610|FG001|Overall Study|No longer transplant candidate|0|||
125272420|NCT03654040|450623609|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
125272421|NCT03654040|450623610|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
125272422|NCT03654040|450623609|FG000|Overall Study|Recipient ineligible|0|||
125272423|NCT03654040|450623610|FG001|Overall Study|Recipient ineligible|2|||
125272424|NCT03654040|450623609|FG000|Overall Study|Received deceased liver|0|||
125272425|NCT03654040|450623610|FG001|Overall Study|Received deceased liver|1|||
125272426|NCT01484496|450623614|FG000|Period 1|Protocol Violation|3|||
125272427|NCT01484496|450623615|FG001|Period 1|Protocol Violation|4|||
125272428|NCT01484496|450623616|FG002|Period 1|Protocol Violation|0|||
125272429|NCT01484496|450623617|FG003|Period 1|Protocol Violation|0|||
125272430|NCT01484496|450623614|FG000|Period 1|Physician Decision|5|||
125272431|NCT01484496|450623615|FG001|Period 1|Physician Decision|1|||
125272432|NCT01484496|450623616|FG002|Period 1|Physician Decision|0|||
125272433|NCT01484496|450623617|FG003|Period 1|Physician Decision|0|||
125272434|NCT01484496|450623614|FG000|Period 1|Lack of Efficacy|10|||
125272435|NCT01484496|450623615|FG001|Period 1|Lack of Efficacy|15|||
125272436|NCT01484496|450623616|FG002|Period 1|Lack of Efficacy|0|||
125272437|NCT01484496|450623617|FG003|Period 1|Lack of Efficacy|0|||
125272438|NCT01484496|450623614|FG000|Period 1|Adverse Event|25|||
125272439|NCT01484496|450623615|FG001|Period 1|Adverse Event|40|||
125272440|NCT01484496|450623616|FG002|Period 1|Adverse Event|0|||
125272441|NCT01484496|450623617|FG003|Period 1|Adverse Event|0|||
125272442|NCT01484496|450623614|FG000|Period 1|Withdrawal by Subject|15|||
125272443|NCT01484496|450623615|FG001|Period 1|Withdrawal by Subject|12|||
125272444|NCT01484496|450623616|FG002|Period 1|Withdrawal by Subject|0|||
125272445|NCT01484496|450623617|FG003|Period 1|Withdrawal by Subject|0|||
125272446|NCT01484496|450623614|FG000|Period 1|Lost to Follow-up|2|||
125272447|NCT01484496|450623615|FG001|Period 1|Lost to Follow-up|6|||
125272448|NCT01484496|450623616|FG002|Period 1|Lost to Follow-up|0|||
125272449|NCT01484496|450623617|FG003|Period 1|Lost to Follow-up|0|||
125272450|NCT01484496|450623614|FG000|Period 1|Positive Pregnancy|1|||
125272451|NCT01484496|450623615|FG001|Period 1|Positive Pregnancy|6|||
125272452|NCT01484496|450623616|FG002|Period 1|Positive Pregnancy|0|||
125272453|NCT01484496|450623617|FG003|Period 1|Positive Pregnancy|0|||
125272454|NCT01484496|450623614|FG000|Period 1|Treatment Failure|3|||
125272455|NCT01484496|450623615|FG001|Period 1|Treatment Failure|6|||
125272456|NCT01484496|450623616|FG002|Period 1|Treatment Failure|0|||
125272457|NCT01484496|450623617|FG003|Period 1|Treatment Failure|0|||
125272458|NCT01484496|450623614|FG000|Period 1|Lack of Compliance|2|||
125272459|NCT01484496|450623615|FG001|Period 1|Lack of Compliance|1|||
125272460|NCT01484496|450623616|FG002|Period 1|Lack of Compliance|0|||
125272461|NCT01484496|450623617|FG003|Period 1|Lack of Compliance|0|||
125272462|NCT01484496|450623614|FG000|Period 1|Unable to Visit Site|0|||
125272463|NCT01484496|450623615|FG001|Period 1|Unable to Visit Site|2|||
125272464|NCT01484496|450623616|FG002|Period 1|Unable to Visit Site|0|||
125272465|NCT01484496|450623617|FG003|Period 1|Unable to Visit Site|0|||
125272466|NCT01484496|450623614|FG000|Period 2|Lack of Efficacy|0|||
125272467|NCT01484496|450623615|FG001|Period 2|Lack of Efficacy|0|||
125272468|NCT01484496|450623616|FG002|Period 2|Lack of Efficacy|1|||
125272469|NCT01484496|450623617|FG003|Period 2|Lack of Efficacy|3|||
125272470|NCT01484496|450623614|FG000|Period 2|Adverse Event|0|||
125272471|NCT01484496|450623615|FG001|Period 2|Adverse Event|0|||
125272472|NCT01484496|450623616|FG002|Period 2|Adverse Event|5|||
125272473|NCT01484496|450623617|FG003|Period 2|Adverse Event|13|||
125272474|NCT01484496|450623614|FG000|Period 2|Other|0|||
125272475|NCT01484496|450623615|FG001|Period 2|Other|0|||
125272476|NCT01484496|450623616|FG002|Period 2|Other|9|||
125272477|NCT01484496|450623617|FG003|Period 2|Other|6|||
125272478|NCT01645735|450623618|FG000|Overall Study|Physician Decision|2|||
125272479|NCT01645735|450623619|FG001|Overall Study|Physician Decision|0|||
125272480|NCT01645735|450623618|FG000|Overall Study|Withdrawal by Subject|1|||
125272481|NCT01645735|450623619|FG001|Overall Study|Withdrawal by Subject|0|||
125272482|NCT01645735|450623618|FG000|Overall Study|Protocol Violation|1|||
125272483|NCT01645735|450623619|FG001|Overall Study|Protocol Violation|0|||
125272484|NCT01645735|450623618|FG000|Overall Study|Adverse Event|0|||
125272485|NCT01645735|450623619|FG001|Overall Study|Adverse Event|1|||
125272486|NCT04830215|450623620|FG000|Overall Study|Adverse Event|6|||
125272487|NCT04830215|450623620|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
125272488|NCT04830215|450623620|FG000|Overall Study|Withdrawal by Subject|3|||
125272489|NCT04830215|450623620|FG000|Overall Study|Protocol Deviation|1|||
125272490|NCT03782064|450623621|FG000|Overall Study|Lack of Efficacy|2|||
125272491|NCT03782064|450623621|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
125272492|NCT02446769|450623622|FG000|Screening Period|Screen Failure|11|||
125272493|NCT02446769|450623623|FG001|Screening Period|Screen Failure|0|||
125272494|NCT02446769|450623624|FG002|Screening Period|Screen Failure|0|||
125272495|NCT02446769|450623622|FG000|Study Period|Randomized in Error|0|||
125272496|NCT02446769|450623623|FG001|Study Period|Randomized in Error|2|||
125272497|NCT02446769|450623624|FG002|Study Period|Randomized in Error|0|||
125272498|NCT00645840|450623625|FG000|Overall Study|Protocol Violation|3|||
125272499|NCT03994211|450623626|FG000|Core Phase|Adverse Event|0|||
125272500|NCT03994211|450623627|FG001|Core Phase|Adverse Event|1|||
125272501|NCT03994211|450623628|FG002|Core Phase|Adverse Event|0|||
125272502|NCT03994211|450623626|FG000|Extension Phase|Adverse Event|0|||
125272503|NCT03994211|450623627|FG001|Extension Phase|Adverse Event|0|||
125272504|NCT03994211|450623628|FG002|Extension Phase|Adverse Event|1|||
125272505|NCT03994211|450623626|FG000|Extension Phase|Physician Decision|0|||
125272506|NCT03994211|450623627|FG001|Extension Phase|Physician Decision|0|||
125272507|NCT03994211|450623628|FG002|Extension Phase|Physician Decision|1|||
125272508|NCT03994211|450623626|FG000|Extension Phase|Progressive Disease|0|||
125272509|NCT03994211|450623627|FG001|Extension Phase|Progressive Disease|0|||
125272510|NCT03994211|450623628|FG002|Extension Phase|Progressive Disease|20|||
125272511|NCT03994211|450623626|FG000|Extension Phase|Withdrawal by Subject|0|||
125272512|NCT03994211|450623627|FG001|Extension Phase|Withdrawal by Subject|0|||
125272513|NCT03994211|450623628|FG002|Extension Phase|Withdrawal by Subject|2|||
125272514|NCT00271856|450623634|FG000|Overall Study|Withdrawal by Subject|1|||
125272515|NCT00271856|450623635|FG001|Overall Study|Withdrawal by Subject|7|||
125272516|NCT00271856|450623634|FG000|Overall Study|Lost to Follow-up|10|||
125272517|NCT00271856|450623635|FG001|Overall Study|Lost to Follow-up|11|||
125272518|NCT04599803|450623636|FG000|Overall Study|Withdrawal by Subject|5|||
125272519|NCT04599803|450623636|FG000|Overall Study|Lost to Follow-up|26|||
125272520|NCT04677543|450623637|FG000|Overall Study|Withdrawal by Subject|4|||
125272521|NCT04677543|450623638|FG001|Overall Study|Withdrawal by Subject|1|||
125272522|NCT04677543|450623637|FG000|Overall Study|Physician Decision|0|||
125272523|NCT04677543|450623638|FG001|Overall Study|Physician Decision|1|||
125272524|NCT04677543|450623637|FG000|Overall Study|Adverse Event|0|||
125272525|NCT04677543|450623638|FG001|Overall Study|Adverse Event|1|||
125447738|NCT04423393|451266781|FG015|Overall Study|Withdrawal by Subject|0|||
125272526|NCT00995436|450623643|FG000|Overall Study|Withdrawal by Subject|2|||
125272527|NCT00995436|450623644|FG001|Overall Study|Withdrawal by Subject|5|||
125272528|NCT00995436|450623645|FG002|Overall Study|Withdrawal by Subject|0|||
125272529|NCT00771927|450623647|FG000|Overall Study|Adverse Event|100|||
125272530|NCT00771927|450623648|FG001|Overall Study|Adverse Event|105|||
125272531|NCT00771927|450623647|FG000|Overall Study|Lack of Efficacy|70|||
125272532|NCT00771927|450623648|FG001|Overall Study|Lack of Efficacy|42|||
125272533|NCT00771927|450623647|FG000|Overall Study|Lost to Follow-up|46|||
125272534|NCT00771927|450623648|FG001|Overall Study|Lost to Follow-up|46|||
125272535|NCT00771927|450623647|FG000|Overall Study|Withdrawal by Subject|16|||
125272536|NCT00771927|450623648|FG001|Overall Study|Withdrawal by Subject|17|||
125272537|NCT00771927|450623647|FG000|Overall Study|Other reason|23|||
125272538|NCT00771927|450623648|FG001|Overall Study|Other reason|27|||
125272539|NCT03299244|450623652|FG000|Overall Study|Withdrawal by Subject|34|||
125272540|NCT03299244|450623653|FG001|Overall Study|Withdrawal by Subject|29|||
125272541|NCT03299244|450623652|FG000|Overall Study|Decision by Sponsor|4|||
125272542|NCT03299244|450623653|FG001|Overall Study|Decision by Sponsor|5|||
125272543|NCT03299244|450623652|FG000|Overall Study|Death|9|||
125272544|NCT03299244|450623653|FG001|Overall Study|Death|4|||
125272545|NCT02712996|450623655|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
125272546|NCT02712996|450623656|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
125272547|NCT01016132|450623657|FG000|Overall Study|Discomfort|1|||
125272548|NCT01451749|450623660|FG000|Overall Study|Protocol Violation|14|||
125272549|NCT01451749|450623661|FG001|Overall Study|Protocol Violation|7|||
125272550|NCT01451749|450623660|FG000|Overall Study|Lost to Follow-up|15|||
125272551|NCT01451749|450623661|FG001|Overall Study|Lost to Follow-up|5|||
125272552|NCT01451749|450623660|FG000|Overall Study|Meet the exclusion criteria,and|1|||
125272553|NCT01451749|450623661|FG001|Overall Study|Meet the exclusion criteria,and|1|||
125272554|NCT01451749|450623660|FG000|Overall Study|Adverse Event|2|||
125272555|NCT01451749|450623661|FG001|Overall Study|Adverse Event|0|||
125272556|NCT01451749|450623660|FG000|Overall Study|Withdrawal by Subject|0|||
125272557|NCT01451749|450623661|FG001|Overall Study|Withdrawal by Subject|1|||
125272558|NCT02454530|450623668|FG000|Overall Study|Other|8|||
125272559|NCT02454530|450623669|FG001|Overall Study|Other|13|||
125272560|NCT02454530|450623668|FG000|Overall Study|Missing information|56|||
125272561|NCT02454530|450623669|FG001|Overall Study|Missing information|69|||
125272562|NCT02454530|450623668|FG000|Overall Study|Death|2|||
125272563|NCT02454530|450623669|FG001|Overall Study|Death|41|||
125272564|NCT02454530|450623668|FG000|Overall Study|Lost to Follow-up|4|||
125272565|NCT02454530|450623669|FG001|Overall Study|Lost to Follow-up|4|||
125272566|NCT03265145|450623670|FG000|Overall Study|Protocol Violation|2|||
125272567|NCT03265145|450623671|FG001|Overall Study|Protocol Violation|0|||
125272568|NCT03265145|450623670|FG000|Overall Study|Adverse Event|1|||
125272569|NCT03265145|450623671|FG001|Overall Study|Adverse Event|0|||
125272570|NCT03265145|450623670|FG000|Overall Study|Withdrawal by Subject|23|||
125272571|NCT03265145|450623671|FG001|Overall Study|Withdrawal by Subject|19|||
125272572|NCT03265145|450623670|FG000|Overall Study|Death|12|||
125272573|NCT03265145|450623671|FG001|Overall Study|Death|12|||
125272574|NCT03265145|450623670|FG000|Overall Study|Lost to Follow-up|13|||
125272575|NCT03265145|450623671|FG001|Overall Study|Lost to Follow-up|9|||
125272576|NCT03265145|450623670|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
125272577|NCT03265145|450623671|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
125272578|NCT03265145|450623670|FG000|Overall Study|Switched back to previous medication|1|||
125272579|NCT03265145|450623671|FG001|Overall Study|Switched back to previous medication|0|||
125272580|NCT03265145|450623670|FG000|Overall Study|Did not want to take medication|1|||
125272581|NCT03265145|450623671|FG001|Overall Study|Did not want to take medication|0|||
125272582|NCT03265145|450623670|FG000|Overall Study|Subject could not afford medication|0|||
125272583|NCT03265145|450623671|FG001|Overall Study|Subject could not afford medication|1|||
125272584|NCT03265145|450623670|FG000|Overall Study|Site closed|2|||
125272585|NCT03265145|450623671|FG001|Overall Study|Site closed|3|||
125272586|NCT03265145|450623670|FG000|Overall Study|Incorrectly randomized|16|||
125272587|NCT03265145|450623671|FG001|Overall Study|Incorrectly randomized|6|||
125272588|NCT03265145|450623670|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
125272589|NCT03265145|450623671|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
125272590|NCT03265145|450623670|FG000|Overall Study|Physician Decision|0|||
125272591|NCT03265145|450623671|FG001|Overall Study|Physician Decision|3|||
125272592|NCT03265145|450623670|FG000|Overall Study|Subject transferred to another facility|0|||
125272593|NCT03265145|450623671|FG001|Overall Study|Subject transferred to another facility|1|||
125272594|NCT03159468|450623672|FG000|Overall Study|Withdrawal by Subject|0|||
125272595|NCT03159468|450623673|FG001|Overall Study|Withdrawal by Subject|0|||
125272596|NCT03159468|450623674|FG002|Overall Study|Withdrawal by Subject|3|||
125272597|NCT03159468|450623675|FG003|Overall Study|Withdrawal by Subject|0|||
125272598|NCT03159468|450623676|FG004|Overall Study|Withdrawal by Subject|0|||
125272599|NCT03159468|450623677|FG005|Overall Study|Withdrawal by Subject|0|||
125272600|NCT03280303|450625160|FG000|Overall Study|Death|505|||
125272601|NCT03280303|450625160|FG000|Overall Study|Study terminated by sponsor|383|||
125272602|NCT03280303|450625160|FG000|Overall Study|Other|148|||
125272603|NCT03280303|450625160|FG000|Overall Study|No longer willing to participate in study|101|||
125272604|NCT03280303|450625160|FG000|Overall Study|Lost to follow up|39|||
125272605|NCT03280303|450625160|FG000|Overall Study|Adverse Event|20|||
125272606|NCT02974140|450625167|FG000|Overall Study|Adverse Event|2|||
125272607|NCT02974140|450625167|FG000|Overall Study|Lost to Follow-up|1|||
125272608|NCT02974140|450625167|FG000|Overall Study|Study Terminated by Sponsor|36|||
125272609|NCT00617084|450625168|FG000|Overall Study|Withdrawal by Subject|5|||
125272610|NCT00617084|450625169|FG001|Overall Study|Withdrawal by Subject|7|||
125272611|NCT00617084|450625168|FG000|Overall Study|Missed 12 Months visit|16|||
125272612|NCT00617084|450625169|FG001|Overall Study|Missed 12 Months visit|19|||
125272613|NCT02222688|450625173|FG000|Overall Study|Withdrawal by Subject|0|||
125272614|NCT02222688|450625174|FG001|Overall Study|Withdrawal by Subject|0|||
125272615|NCT02222688|450625175|FG002|Overall Study|Withdrawal by Subject|0|||
125272616|NCT02222688|450625176|FG003|Overall Study|Withdrawal by Subject|2|||
125272617|NCT02222688|450625177|FG004|Overall Study|Withdrawal by Subject|1|||
125272618|NCT02222688|450625178|FG005|Overall Study|Withdrawal by Subject|0|||
125272619|NCT02222688|450625179|FG006|Overall Study|Withdrawal by Subject|1|||
125272620|NCT02222688|450625173|FG000|Overall Study|Disease progression|1|||
125272621|NCT02222688|450625174|FG001|Overall Study|Disease progression|0|||
125272622|NCT02222688|450625175|FG002|Overall Study|Disease progression|0|||
125272623|NCT02222688|450625176|FG003|Overall Study|Disease progression|0|||
125272624|NCT02222688|450625177|FG004|Overall Study|Disease progression|0|||
125272625|NCT02222688|450625178|FG005|Overall Study|Disease progression|0|||
125272626|NCT02222688|450625179|FG006|Overall Study|Disease progression|0|||
125272627|NCT02522429|450625188|FG000|Overall Study|Lost to Follow-up|8|||
125272628|NCT02522429|450625188|FG000|Overall Study|Adverse Event|2|||
125272629|NCT02522429|450625188|FG000|Overall Study|Death|1|||
125272630|NCT02522429|450625188|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
125272631|NCT00500357|450625192|FG000|Overall Study|Death|1|||
125272632|NCT00078806|450625193|FG000|Part 1A|Adverse Event|2|||
125272633|NCT00078806|450625194|FG001|Part 1A|Adverse Event|0|||
125272634|NCT00078806|450625195|FG002|Part 1A|Adverse Event|0|||
125272635|NCT00078806|450625196|FG003|Part 1A|Adverse Event|0|||
125272636|NCT00078806|450625193|FG000|Part 1A|Lack of Efficacy|7|||
125272637|NCT00078806|450625194|FG001|Part 1A|Lack of Efficacy|0|||
125272638|NCT00078806|450625195|FG002|Part 1A|Lack of Efficacy|0|||
125272639|NCT00078806|450625196|FG003|Part 1A|Lack of Efficacy|0|||
125272640|NCT00078806|450625193|FG000|Part 1A|Other|1|||
125272641|NCT00078806|450625194|FG001|Part 1A|Other|0|||
125272642|NCT00078806|450625195|FG002|Part 1A|Other|0|||
125272643|NCT00078806|450625196|FG003|Part 1A|Other|0|||
125272644|NCT00078806|450625193|FG000|Part 1B|Adverse Event|1|||
125272645|NCT00078806|450625194|FG001|Part 1B|Adverse Event|0|||
125272646|NCT00078806|450625195|FG002|Part 1B|Adverse Event|0|||
125272647|NCT00078806|450625196|FG003|Part 1B|Adverse Event|0|||
125272648|NCT00078806|450625193|FG000|Part 1B|Lack of Efficacy|7|||
125272649|NCT00078806|450625194|FG001|Part 1B|Lack of Efficacy|0|||
125272650|NCT00078806|450625195|FG002|Part 1B|Lack of Efficacy|0|||
125272651|NCT00078806|450625196|FG003|Part 1B|Lack of Efficacy|0|||
125272652|NCT00078806|450625193|FG000|Part 2|Adverse Event|0|||
125272653|NCT00078806|450625194|FG001|Part 2|Adverse Event|1|||
125272654|NCT00078806|450625195|FG002|Part 2|Adverse Event|0|||
125272655|NCT00078806|450625196|FG003|Part 2|Adverse Event|0|||
125272656|NCT01734785|450625197|FG000|Open-Label Period|Adverse Event|0|||
125272657|NCT01734785|450625198|FG001|Open-Label Period|Adverse Event|0|||
125272658|NCT01734785|450625199|FG002|Open-Label Period|Adverse Event|0|||
125272659|NCT01734785|450625200|FG003|Open-Label Period|Adverse Event|9|||
125272660|NCT01734785|450625197|FG000|Open-Label Period|Lack of Efficacy|0|||
125272661|NCT01734785|450625198|FG001|Open-Label Period|Lack of Efficacy|0|||
125272662|NCT01734785|450625199|FG002|Open-Label Period|Lack of Efficacy|0|||
125272663|NCT01734785|450625200|FG003|Open-Label Period|Lack of Efficacy|1|||
125272664|NCT01734785|450625197|FG000|Open-Label Period|Protocol Violation|0|||
125272665|NCT01734785|450625198|FG001|Open-Label Period|Protocol Violation|0|||
125272666|NCT01734785|450625199|FG002|Open-Label Period|Protocol Violation|0|||
125272667|NCT01734785|450625200|FG003|Open-Label Period|Protocol Violation|13|||
125272668|NCT01734785|450625197|FG000|Open-Label Period|Lost to Follow-up|0|||
125272669|NCT01734785|450625198|FG001|Open-Label Period|Lost to Follow-up|0|||
125272670|NCT01734785|450625199|FG002|Open-Label Period|Lost to Follow-up|0|||
125272671|NCT01734785|450625200|FG003|Open-Label Period|Lost to Follow-up|14|||
125272672|NCT01734785|450625197|FG000|Open-Label Period|Withdrawal by Subject|0|||
125272673|NCT01734785|450625198|FG001|Open-Label Period|Withdrawal by Subject|0|||
125272674|NCT01734785|450625199|FG002|Open-Label Period|Withdrawal by Subject|0|||
125272675|NCT01734785|450625200|FG003|Open-Label Period|Withdrawal by Subject|12|||
125272676|NCT01734785|450625197|FG000|Open-Label Period|Other Reasons|0|||
125272677|NCT01734785|450625198|FG001|Open-Label Period|Other Reasons|0|||
125272678|NCT01734785|450625199|FG002|Open-Label Period|Other Reasons|0|||
125272679|NCT01734785|450625200|FG003|Open-Label Period|Other Reasons|224|||
125272680|NCT01734785|450625197|FG000|Double-Blind Period|Adverse Event|0|||
125272681|NCT01734785|450625198|FG001|Double-Blind Period|Adverse Event|3|||
125272682|NCT01734785|450625199|FG002|Double-Blind Period|Adverse Event|2|||
125272683|NCT01734785|450625200|FG003|Double-Blind Period|Adverse Event|0|||
125272684|NCT01734785|450625197|FG000|Double-Blind Period|Lack of Efficacy|0|||
125272685|NCT01734785|450625198|FG001|Double-Blind Period|Lack of Efficacy|1|||
125272686|NCT01734785|450625199|FG002|Double-Blind Period|Lack of Efficacy|0|||
125272687|NCT01734785|450625200|FG003|Double-Blind Period|Lack of Efficacy|0|||
125272688|NCT01734785|450625197|FG000|Double-Blind Period|Protocol Violation|0|||
125272689|NCT01734785|450625198|FG001|Double-Blind Period|Protocol Violation|1|||
125272690|NCT01734785|450625199|FG002|Double-Blind Period|Protocol Violation|1|||
125272691|NCT01734785|450625200|FG003|Double-Blind Period|Protocol Violation|0|||
125272692|NCT01734785|450625197|FG000|Double-Blind Period|Lost to Follow-up|2|||
125272693|NCT01734785|450625198|FG001|Double-Blind Period|Lost to Follow-up|4|||
125272694|NCT01734785|450625199|FG002|Double-Blind Period|Lost to Follow-up|2|||
125272695|NCT01734785|450625200|FG003|Double-Blind Period|Lost to Follow-up|0|||
125272696|NCT01734785|450625197|FG000|Double-Blind Period|Withdrawal by Subject|2|||
125272697|NCT01734785|450625198|FG001|Double-Blind Period|Withdrawal by Subject|0|||
125272698|NCT01734785|450625199|FG002|Double-Blind Period|Withdrawal by Subject|0|||
125272699|NCT01734785|450625200|FG003|Double-Blind Period|Withdrawal by Subject|0|||
125272700|NCT01734785|450625197|FG000|Double-Blind Period|Not treated|1|||
125272701|NCT01734785|450625198|FG001|Double-Blind Period|Not treated|0|||
125272702|NCT01734785|450625199|FG002|Double-Blind Period|Not treated|0|||
125272703|NCT01734785|450625200|FG003|Double-Blind Period|Not treated|0|||
125272704|NCT00161616|450625201|FG000|Overall Study|Withdrawal by Subject|6|||
125272705|NCT00161616|450625202|FG001|Overall Study|Withdrawal by Subject|5|||
125272706|NCT00161616|450625201|FG000|Overall Study|Physician Decision|1|||
125272707|NCT00161616|450625202|FG001|Overall Study|Physician Decision|0|||
125272708|NCT00161616|450625201|FG000|Overall Study|Death|1|||
125272709|NCT00161616|450625202|FG001|Overall Study|Death|1|||
125272710|NCT00161616|450625201|FG000|Overall Study|Lost to Follow-up|17|||
125272711|NCT00161616|450625202|FG001|Overall Study|Lost to Follow-up|13|||
125272712|NCT00161616|450625201|FG000|Overall Study|Protocol deviation|1|||
125272713|NCT00161616|450625202|FG001|Overall Study|Protocol deviation|0|||
125272714|NCT00854724|450625203|FG000|First Intervention|Withdrawal by Subject|1|||
125272715|NCT00854724|450625204|FG001|First Intervention|Withdrawal by Subject|1|||
125272716|NCT00854724|450625203|FG000|Washout|Protocol Violation|1|||
125272717|NCT00854724|450625204|FG001|Washout|Protocol Violation|0|||
125272718|NCT00854724|450625203|FG000|Washout|Withdrawal by Subject|0|||
125272719|NCT00854724|450625204|FG001|Washout|Withdrawal by Subject|1|||
125272720|NCT00854724|450625203|FG000|Second Intervention|Protocol Violation|1|||
125272721|NCT00854724|450625204|FG001|Second Intervention|Protocol Violation|0|||
125272722|NCT00854724|450625203|FG000|Second Intervention|Physician Decision|0|||
125272723|NCT00854724|450625204|FG001|Second Intervention|Physician Decision|1|||
125272724|NCT00861757|450625206|FG000|Overall Study|Adverse Event|1|||
125272725|NCT00861757|450625207|FG001|Overall Study|Adverse Event|5|||
125272726|NCT00861757|450625208|FG002|Overall Study|Adverse Event|7|||
125272727|NCT00861757|450625209|FG003|Overall Study|Adverse Event|2|||
125272728|NCT00861757|450625206|FG000|Overall Study|Entry Criteria Not Met|1|||
125272729|NCT00861757|450625207|FG001|Overall Study|Entry Criteria Not Met|2|||
125272730|NCT00861757|450625208|FG002|Overall Study|Entry Criteria Not Met|1|||
125272731|NCT00861757|450625209|FG003|Overall Study|Entry Criteria Not Met|1|||
125272732|NCT00861757|450625206|FG000|Overall Study|Lack of Efficacy|3|||
125272733|NCT00861757|450625207|FG001|Overall Study|Lack of Efficacy|1|||
125272734|NCT00861757|450625208|FG002|Overall Study|Lack of Efficacy|0|||
125272735|NCT00861757|450625209|FG003|Overall Study|Lack of Efficacy|1|||
125272736|NCT00861757|450625206|FG000|Overall Study|Lost to Follow-up|1|||
125272737|NCT00861757|450625207|FG001|Overall Study|Lost to Follow-up|0|||
125272738|NCT00861757|450625208|FG002|Overall Study|Lost to Follow-up|1|||
125272739|NCT00861757|450625209|FG003|Overall Study|Lost to Follow-up|1|||
125272740|NCT00861757|450625206|FG000|Overall Study|Physician Decision|0|||
125272741|NCT00861757|450625207|FG001|Overall Study|Physician Decision|0|||
125272742|NCT00861757|450625208|FG002|Overall Study|Physician Decision|0|||
125272743|NCT00861757|450625209|FG003|Overall Study|Physician Decision|1|||
125272744|NCT00861757|450625206|FG000|Overall Study|Protocol Violation|2|||
125272745|NCT00861757|450625207|FG001|Overall Study|Protocol Violation|2|||
125272746|NCT00861757|450625208|FG002|Overall Study|Protocol Violation|4|||
125272747|NCT00861757|450625209|FG003|Overall Study|Protocol Violation|1|||
125272748|NCT00861757|450625206|FG000|Overall Study|Withdrawal by Subject|1|||
125399247|NCT03890367|451093337|FG000|Overall Study|Lost to Follow-up|1|||
125399248|NCT03890367|451093338|FG001|Overall Study|Lost to Follow-up|1|||
125399249|NCT03890367|451093339|FG002|Overall Study|Lost to Follow-up|0|||
125399250|NCT03370341|451094367|FG000|Overall Study|Lost to Follow-up|0|||
125399251|NCT03370341|451094368|FG001|Overall Study|Lost to Follow-up|1|||
125399252|NCT04368429|451094369|FG000|Overall Study|Adverse Event|1|||
125399253|NCT04368429|451094370|FG001|Overall Study|Adverse Event|0|||
125272749|NCT00861757|450625207|FG001|Overall Study|Withdrawal by Subject|5|||
125272750|NCT00861757|450625208|FG002|Overall Study|Withdrawal by Subject|5|||
125272751|NCT00861757|450625209|FG003|Overall Study|Withdrawal by Subject|2|||
125272752|NCT02140970|450625212|FG000|Overall Study|Lost to Follow-up|1|||
125272753|NCT02140970|450625213|FG001|Overall Study|Lost to Follow-up|2|||
125272754|NCT02140970|450625212|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
125272755|NCT02140970|450625213|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
125272756|NCT02140970|450625212|FG000|Overall Study|Did not meet inclusion criteria|0|||
125272757|NCT02140970|450625213|FG001|Overall Study|Did not meet inclusion criteria|1|||
125272758|NCT02705105|450625214|FG000|Treatment|Objective Disease Progression|1|||
125272759|NCT02705105|450625215|FG001|Treatment|Objective Disease Progression|50|||
125272760|NCT02705105|450625214|FG000|Treatment|Withdrawal by Subject|3|||
125272761|NCT02705105|450625215|FG001|Treatment|Withdrawal by Subject|5|||
125272762|NCT02705105|450625214|FG000|Treatment|Adverse Event|0|||
125272763|NCT02705105|450625215|FG001|Treatment|Adverse Event|17|||
125272764|NCT02705105|450625214|FG000|Treatment|Clinical Disease Progression|0|||
125272765|NCT02705105|450625215|FG001|Treatment|Clinical Disease Progression|32|||
125272766|NCT02705105|450625214|FG000|Treatment|Physician Decision|0|||
125272767|NCT02705105|450625215|FG001|Treatment|Physician Decision|3|||
125272768|NCT02705105|450625214|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
125272769|NCT02705105|450625215|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
125272770|NCT02705105|450625214|FG000|Follow-Up|Death|3|||
125272771|NCT02705105|450625215|FG001|Follow-Up|Death|68|||
125272772|NCT02705105|450625214|FG000|Follow-Up|Withdrawal by Subject|1|||
125272773|NCT02705105|450625215|FG001|Follow-Up|Withdrawal by Subject|14|||
125272774|NCT02705105|450625214|FG000|Follow-Up|Study Terminated|0|||
125272775|NCT02705105|450625215|FG001|Follow-Up|Study Terminated|26|||
125272776|NCT02705105|450625214|FG000|Follow-Up|Discontinued per Amendment 3|0|||
125272777|NCT02705105|450625215|FG001|Follow-Up|Discontinued per Amendment 3|2|||
125272778|NCT01709110|450625218|FG000|Overall Study|Adverse Event|56|||
125272779|NCT01709110|450625219|FG001|Overall Study|Adverse Event|48|||
125272780|NCT01709110|450625218|FG000|Overall Study|Death|14|||
125272781|NCT01709110|450625219|FG001|Overall Study|Death|6|||
125272782|NCT01709110|450625218|FG000|Overall Study|Lost to Follow-up|7|||
125272783|NCT01709110|450625219|FG001|Overall Study|Lost to Follow-up|5|||
125272784|NCT01709110|450625218|FG000|Overall Study|Protocol Violation|4|||
125272785|NCT01709110|450625219|FG001|Overall Study|Protocol Violation|6|||
125272786|NCT01709110|450625218|FG000|Overall Study|Withdrawal by Subject|96|||
125272787|NCT01709110|450625219|FG001|Overall Study|Withdrawal by Subject|89|||
125272788|NCT01709110|450625218|FG000|Overall Study|Physician Decision|4|||
125272789|NCT01709110|450625219|FG001|Overall Study|Physician Decision|10|||
125272790|NCT01709110|450625218|FG000|Overall Study|Sponsor Decision|2|||
125272791|NCT01709110|450625219|FG001|Overall Study|Sponsor Decision|2|||
125272792|NCT01709110|450625218|FG000|Overall Study|Lack of Efficacy|1|||
125272793|NCT01709110|450625219|FG001|Overall Study|Lack of Efficacy|1|||
125272794|NCT01709110|450625218|FG000|Overall Study|Caregiver Decision|1|||
125272795|NCT01709110|450625219|FG001|Overall Study|Caregiver Decision|1|||
125272796|NCT03332173|450625220|FG000|Overall Study|Death|7|||
125272797|NCT03332173|450625220|FG000|Overall Study|Withdrawal by Subject|6|||
125272798|NCT03332173|450625220|FG000|Overall Study|Lost to Follow-up|2|||
125272799|NCT03332173|450625220|FG000|Overall Study|Transferred to long-term extension study|29|||
125272800|NCT02168101|450625221|FG000|Overall Study|Death|2|||
125272801|NCT02168101|450625222|FG001|Overall Study|Death|2|||
125272802|NCT02168101|450625223|FG002|Overall Study|Death|1|||
125272803|NCT00910910|450625224|FG000|Overall Study|Adverse Event|63|||
125272804|NCT00910910|450625225|FG001|Overall Study|Adverse Event|35|||
125272805|NCT00910910|450625224|FG000|Overall Study|PD without histologic change|27|||
125272806|NCT00910910|450625225|FG001|Overall Study|PD without histologic change|23|||
125272807|NCT00910910|450625224|FG000|Overall Study|PD with histologic change|0|||
125272808|NCT00910910|450625225|FG001|Overall Study|PD with histologic change|2|||
125272809|NCT00910910|450625224|FG000|Overall Study|Withdrawal by Subject|7|||
125272810|NCT00910910|450625225|FG001|Overall Study|Withdrawal by Subject|5|||
125272811|NCT00910910|450625224|FG000|Overall Study|Lost to Follow-up|2|||
125272812|NCT00910910|450625225|FG001|Overall Study|Lost to Follow-up|2|||
125272813|NCT00910910|450625224|FG000|Overall Study|Death|9|||
125272814|NCT00910910|450625225|FG001|Overall Study|Death|3|||
125272815|NCT00910910|450625224|FG000|Overall Study|Protocol Violation|2|||
125272816|NCT00910910|450625225|FG001|Overall Study|Protocol Violation|2|||
125272817|NCT00910910|450625224|FG000|Overall Study|Completed 13 cycles of treatment|0|||
125272818|NCT00910910|450625225|FG001|Overall Study|Completed 13 cycles of treatment|118|||
125272819|NCT00910910|450625224|FG000|Overall Study|Other|114|||
125272820|NCT00910910|450625225|FG001|Overall Study|Other|32|||
125272821|NCT00910910|450625224|FG000|Overall Study|Untreated before cycle 1|1|||
125272822|NCT00910910|450625225|FG001|Overall Study|Untreated before cycle 1|2|||
125272823|NCT01973231|450625226|FG000|Overall Study|Protocol Violation|1|||
125272824|NCT01973231|450625227|FG001|Overall Study|Protocol Violation|1|||
125272825|NCT01973231|450625226|FG000|Overall Study|Lost to Follow-up|1|||
125272826|NCT01973231|450625227|FG001|Overall Study|Lost to Follow-up|1|||
125272827|NCT01973231|450625226|FG000|Overall Study|unclassified|2|||
125272828|NCT01973231|450625227|FG001|Overall Study|unclassified|1|||
125272829|NCT01973231|450625226|FG000|Overall Study|Withdrawal by Subject|7|||
125272830|NCT01973231|450625227|FG001|Overall Study|Withdrawal by Subject|9|||
125272831|NCT01485796|450625228|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
125399254|NCT00634647|451094372|FG000|Overall Study|death on study|3|||
125399255|NCT00634647|451094372|FG000|Overall Study|refused further treatment|3|||
125272832|NCT01485796|450625228|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
125399256|NCT00634647|451094372|FG000|Overall Study|declined to participate before treatment|1|||
125272833|NCT01485796|450625228|FG000|Period 2: Epoch 2|Adverse Event|3|||
125272834|NCT01485796|450625228|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
125272835|NCT01485796|450625228|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
125272836|NCT01485796|450625228|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
125272837|NCT01485796|450625228|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
125272838|NCT01485796|450625228|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
125272839|NCT01775553|450625233|FG000|Overall Study|Adverse Event|1|||
125272840|NCT01775553|450625233|FG000|Overall Study|Disease Progression|12|||
125272841|NCT00988052|450625234|FG000|Overall Study|Missing|1|||
125399257|NCT02984020|451094373|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
125399258|NCT02984020|451094373|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
125399259|NCT02984020|451094373|FG000|Overall Study|Other significant protocol violation|2|||
125399260|NCT01700179|451094375|FG000|Overall Study|Physician Decision|2|||
125399261|NCT00667342|451094376|FG000|Overall Study|Protocol Violation|1|||
125399262|NCT00667342|451094377|FG001|Overall Study|Protocol Violation|0|||
125399263|NCT00667342|451094378|FG002|Overall Study|Protocol Violation|0|||
125399264|NCT00667342|451094376|FG000|Overall Study|Withdrawal by Subject|1|||
125399265|NCT00667342|451094377|FG001|Overall Study|Withdrawal by Subject|0|||
125399266|NCT00667342|451094378|FG002|Overall Study|Withdrawal by Subject|0|||
125399267|NCT00667342|451094376|FG000|Overall Study|Physician Decision|3|||
125399268|NCT00667342|451094377|FG001|Overall Study|Physician Decision|0|||
125272842|NCT00988052|450625235|FG001|Overall Study|Missing|0|||
125272843|NCT00988052|450625234|FG000|Overall Study|Teva requested subject withdrawal|3|||
125272844|NCT00988052|450625235|FG001|Overall Study|Teva requested subject withdrawal|1|||
125272845|NCT00988052|450625234|FG000|Overall Study|Death|1|||
125272846|NCT00988052|450625235|FG001|Overall Study|Death|3|||
125272847|NCT00988052|450625234|FG000|Overall Study|Protocol Violation|6|||
125272848|NCT00988052|450625235|FG001|Overall Study|Protocol Violation|5|||
125272849|NCT00988052|450625234|FG000|Overall Study|Pregnancy|6|||
125272850|NCT00988052|450625235|FG001|Overall Study|Pregnancy|6|||
125272851|NCT00988052|450625234|FG000|Overall Study|Lack of Efficacy|8|||
125272852|NCT00988052|450625235|FG001|Overall Study|Lack of Efficacy|7|||
125272853|NCT00988052|450625234|FG000|Overall Study|Lost to Follow-up|6|||
125272854|NCT00988052|450625235|FG001|Overall Study|Lost to Follow-up|11|||
125272855|NCT00988052|450625234|FG000|Overall Study|Physician Decision|27|||
125272856|NCT00988052|450625235|FG001|Overall Study|Physician Decision|28|||
125272857|NCT00988052|450625234|FG000|Overall Study|Adverse Event|35|||
125272858|NCT00988052|450625235|FG001|Overall Study|Adverse Event|28|||
125272859|NCT00988052|450625234|FG000|Overall Study|Withdrawal by Subject|90|||
125272860|NCT00988052|450625235|FG001|Overall Study|Withdrawal by Subject|91|||
125272861|NCT00988052|450625234|FG000|Overall Study|Study terminated by sponsor|240|||
125272862|NCT00988052|450625235|FG001|Overall Study|Study terminated by sponsor|236|||
125272863|NCT01523743|450625236|FG000|Period 1|Adverse Event|1|||
125272864|NCT01523743|450625237|FG001|Period 1|Adverse Event|0|||
125272865|NCT01523743|450625236|FG000|Period 1|Withdrawal by Subject|6|||
125272866|NCT01523743|450625237|FG001|Period 1|Withdrawal by Subject|2|||
125272867|NCT01523743|450625236|FG000|Period 1|Lost to Follow-up|1|||
125272868|NCT01523743|450625237|FG001|Period 1|Lost to Follow-up|0|||
125272869|NCT01523743|450625236|FG000|Period 1|Lack of Efficacy|1|||
125272870|NCT01523743|450625237|FG001|Period 1|Lack of Efficacy|0|||
125272871|NCT01523743|450625236|FG000|Period 1|Felt unable to empty bladder|1|||
125272872|NCT01523743|450625237|FG001|Period 1|Felt unable to empty bladder|0|||
125272873|NCT01523743|450625236|FG000|Period 2|Withdrawal by Subject|0|||
125272874|NCT01523743|450625237|FG001|Period 2|Withdrawal by Subject|2|||
125272875|NCT01523743|450625236|FG000|Period 2|Adverse Event|1|||
125272876|NCT01523743|450625237|FG001|Period 2|Adverse Event|0|||
125272877|NCT02569476|450625238|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
125272878|NCT02569476|450625238|FG000|Overall Study|Death|33|||
125272879|NCT02569476|450625238|FG000|Overall Study|Withdrawal by Subject|9|||
125272880|NCT02569476|450625238|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
125272881|NCT02569476|450625238|FG000|Overall Study|Palliative care|1|||
125272882|NCT02569476|450625238|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
125272883|NCT02569476|450625238|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
125272884|NCT01434654|450625239|FG000|Overall Study|Withdrawal by Subject|1|||
125272885|NCT01434654|450625240|FG001|Overall Study|Withdrawal by Subject|0|||
125272886|NCT01434654|450625239|FG000|Overall Study|Lost to Follow-up|1|||
125272887|NCT01434654|450625240|FG001|Overall Study|Lost to Follow-up|0|||
125272888|NCT00703963|450625243|FG000|Overall Study|Withdrawal by Subject|7|||
125272889|NCT00703963|450625244|FG001|Overall Study|Withdrawal by Subject|13|||
125272890|NCT00703963|450625243|FG000|Overall Study|Physician Decision|0|||
125272891|NCT00703963|450625244|FG001|Overall Study|Physician Decision|1|||
125272892|NCT00402324|450625247|FG000|Overall Study|Lost to Follow-up|11|||
125272893|NCT00402324|450625248|FG001|Overall Study|Lost to Follow-up|11|||
125272894|NCT00402324|450625247|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
125272895|NCT00402324|450625248|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
125272896|NCT00402324|450625247|FG000|Overall Study|Protocol Violation|8|||
125272897|NCT00402324|450625248|FG001|Overall Study|Protocol Violation|7|||
125272898|NCT00402324|450625247|FG000|Overall Study|Withdrawal by Subject|5|||
125272899|NCT00402324|450625248|FG001|Overall Study|Withdrawal by Subject|2|||
125272900|NCT00402324|450625247|FG000|Overall Study|Physician Decision|2|||
125272901|NCT00402324|450625248|FG001|Overall Study|Physician Decision|4|||
125272902|NCT00402324|450625247|FG000|Overall Study|Sponsor Decision|4|||
125272903|NCT00402324|450625248|FG001|Overall Study|Sponsor Decision|5|||
125272904|NCT00402324|450625247|FG000|Overall Study|Lack of Efficacy|1|||
125272905|NCT00402324|450625248|FG001|Overall Study|Lack of Efficacy|4|||
125272906|NCT00402324|450625247|FG000|Overall Study|Adverse Event|6|||
125272907|NCT00402324|450625248|FG001|Overall Study|Adverse Event|4|||
125272908|NCT00402324|450625247|FG000|Overall Study|Death|1|||
125272909|NCT00402324|450625248|FG001|Overall Study|Death|0|||
125272910|NCT01277822|450625249|FG000|Overall Study|Adverse Event|2|||
125272911|NCT01277822|450625250|FG001|Overall Study|Adverse Event|1|||
125272912|NCT01277822|450625249|FG000|Overall Study|Withdrawal by Subject|6|||
125272913|NCT01277822|450625250|FG001|Overall Study|Withdrawal by Subject|7|||
125272914|NCT01277822|450625249|FG000|Overall Study|Physician Decision|1|||
125272915|NCT01277822|450625250|FG001|Overall Study|Physician Decision|1|||
125272916|NCT01277822|450625249|FG000|Overall Study|Protocol Violation|1|||
125272917|NCT01277822|450625250|FG001|Overall Study|Protocol Violation|0|||
125272918|NCT01277822|450625249|FG000|Overall Study|Lost to Follow-up|2|||
125272919|NCT01277822|450625250|FG001|Overall Study|Lost to Follow-up|1|||
125272920|NCT01277822|450625249|FG000|Overall Study|Contraindicated medication used|2|||
125272921|NCT01277822|450625250|FG001|Overall Study|Contraindicated medication used|1|||
125272922|NCT01277822|450625249|FG000|Overall Study|Participant moved|1|||
125272923|NCT01277822|450625250|FG001|Overall Study|Participant moved|0|||
125272924|NCT02625220|450625251|FG000|Overall Study|Adverse Event|2|||
125272925|NCT02625220|450625251|FG000|Overall Study|Lost to Follow-up|2|||
125272926|NCT02625220|450625251|FG000|Overall Study|Protocol Violation|1|||
125272927|NCT02625220|450625251|FG000|Overall Study|Study discontinued at site|2|||
125272928|NCT02923531|450625252|FG000|Overall Study|Adverse Event|4|||
125272929|NCT02923531|450625252|FG000|Overall Study|Clinical Deterioration|1|||
125272930|NCT02923531|450625252|FG000|Overall Study|Disease Progression|3|||
125272931|NCT02923531|450625252|FG000|Overall Study|Study Termination|1|||
125272932|NCT00997984|450625253|FG000|Overall Study|Adverse Event|1|||
125272933|NCT00997984|450625254|FG001|Overall Study|Adverse Event|8|||
125272934|NCT00997984|450625255|FG002|Overall Study|Adverse Event|8|||
125272935|NCT00997984|450625253|FG000|Overall Study|Protocol Violation|1|||
125272936|NCT00997984|450625254|FG001|Overall Study|Protocol Violation|3|||
125272937|NCT00997984|450625255|FG002|Overall Study|Protocol Violation|0|||
125272938|NCT00997984|450625253|FG000|Overall Study|Withdrawal by Subject|6|||
125272939|NCT00997984|450625254|FG001|Overall Study|Withdrawal by Subject|9|||
125272940|NCT00997984|450625255|FG002|Overall Study|Withdrawal by Subject|5|||
125272941|NCT00997984|450625253|FG000|Overall Study|Lost to Follow-up|8|||
125272942|NCT00997984|450625254|FG001|Overall Study|Lost to Follow-up|5|||
125272943|NCT00997984|450625255|FG002|Overall Study|Lost to Follow-up|4|||
125272944|NCT00997984|450625253|FG000|Overall Study|Lack of Efficacy|20|||
125272945|NCT00997984|450625254|FG001|Overall Study|Lack of Efficacy|6|||
125272946|NCT00997984|450625255|FG002|Overall Study|Lack of Efficacy|3|||
125272947|NCT00997984|450625253|FG000|Overall Study|Met exclusion criteria|1|||
125272948|NCT00997984|450625254|FG001|Overall Study|Met exclusion criteria|0|||
125272949|NCT00997984|450625255|FG002|Overall Study|Met exclusion criteria|0|||
125272950|NCT00997984|450625253|FG000|Overall Study|non-compliance|0|||
125272951|NCT00997984|450625254|FG001|Overall Study|non-compliance|2|||
125272952|NCT00997984|450625255|FG002|Overall Study|non-compliance|3|||
125272953|NCT00997984|450625253|FG000|Overall Study|Wrong medication dispensed|0|||
125272954|NCT00997984|450625254|FG001|Overall Study|Wrong medication dispensed|1|||
125272955|NCT00997984|450625255|FG002|Overall Study|Wrong medication dispensed|0|||
125272956|NCT00997984|450625253|FG000|Overall Study|Suicidal ideation|0|||
125272957|NCT00997984|450625254|FG001|Overall Study|Suicidal ideation|0|||
125272958|NCT00997984|450625255|FG002|Overall Study|Suicidal ideation|1|||
125272959|NCT00997984|450625253|FG000|Overall Study|Work schedule|0|||
125272960|NCT00997984|450625254|FG001|Overall Study|Work schedule|0|||
125272961|NCT00997984|450625255|FG002|Overall Study|Work schedule|2|||
125272962|NCT01140867|450625256|FG000|Overall Study|Adverse Event|22|||
125272963|NCT01140867|450625256|FG000|Overall Study|Lack of Efficacy|3|||
125272964|NCT01140867|450625256|FG000|Overall Study|Lost to Follow-up|2|||
125272965|NCT01140867|450625256|FG000|Overall Study|Withdrawal by Subject|1|||
125272966|NCT01140867|450625256|FG000|Overall Study|Protocol Violation|1|||
125272967|NCT01140867|450625256|FG000|Overall Study|Uncooperative patient|2|||
125272968|NCT01140867|450625256|FG000|Overall Study|Medication Noncompliance|2|||
125272969|NCT01119066|450625258|FG000|Overall Study|Withdrawal by Subject|4|||
125272970|NCT01119066|450625259|FG001|Overall Study|Withdrawal by Subject|6|||
125272971|NCT01119066|450625260|FG002|Overall Study|Withdrawal by Subject|0|||
125272972|NCT01119066|450625261|FG003|Overall Study|Withdrawal by Subject|0|||
125272973|NCT01119066|450625258|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
125272974|NCT01119066|450625259|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
125272975|NCT01119066|450625260|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
125272976|NCT01119066|450625261|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
125272977|NCT01119066|450625258|FG000|Overall Study|Relapse identified before transplant|1|||
125272978|NCT01119066|450625259|FG001|Overall Study|Relapse identified before transplant|0|||
125272979|NCT01119066|450625260|FG002|Overall Study|Relapse identified before transplant|0|||
125272980|NCT01119066|450625261|FG003|Overall Study|Relapse identified before transplant|0|||
125272981|NCT01119066|450625258|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
125272982|NCT01119066|450625259|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
125272983|NCT01119066|450625260|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
125272984|NCT01119066|450625261|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
125272985|NCT01119066|450625258|FG000|Overall Study|Relapse identified before transplant|0|||
125272986|NCT01119066|450625259|FG001|Overall Study|Relapse identified before transplant|4|||
125272987|NCT01119066|450625260|FG002|Overall Study|Relapse identified before transplant|0|||
125272988|NCT01119066|450625261|FG003|Overall Study|Relapse identified before transplant|0|||
125272989|NCT02366923|450625262|FG000|Overall Study|Withdrawal by Subject|1|||
125272990|NCT02366923|450625262|FG000|Overall Study|Positive Slit Lamp Findings|2|||
125272991|NCT02366923|450625262|FG000|Overall Study|High Astigmatism|3|||
125272992|NCT03902392|450625263|FG000|Overall Study|Lost to Follow-up|7|||
125272993|NCT03902392|450625264|FG001|Overall Study|Lost to Follow-up|7|||
125272994|NCT01437111|450625265|FG000|Overall Study|Adverse Event|2|||
125272995|NCT01437111|450625265|FG000|Overall Study|Withdrawal by Subject|4|||
125272996|NCT01437111|450625265|FG000|Overall Study|Not reported|5|||
125272997|NCT01437111|450625265|FG000|Overall Study|Physician Decision|1|||
125272998|NCT01437111|450625265|FG000|Overall Study|Lost to Follow-up|5|||
125272999|NCT01437111|450625265|FG000|Overall Study|Protocol Violation|1|||
125273000|NCT00577707|450625266|FG000|Overall Study|Withdrawal by Subject|3|||
125273001|NCT00431444|450625267|FG000|Overall Study|Protocol Violation|1|||
125273002|NCT00431444|450625268|FG001|Overall Study|Protocol Violation|4|||
125273003|NCT00431444|450625267|FG000|Overall Study|Adverse Event|2|||
125273004|NCT00431444|450625268|FG001|Overall Study|Adverse Event|1|||
125273005|NCT00431444|450625267|FG000|Overall Study|Withdrawal by Subject|1|||
125273006|NCT00431444|450625268|FG001|Overall Study|Withdrawal by Subject|1|||
125273007|NCT00431444|450625267|FG000|Overall Study|Lost to Follow-up|1|||
125273008|NCT00431444|450625268|FG001|Overall Study|Lost to Follow-up|0|||
125273009|NCT00431444|450625267|FG000|Overall Study|Administrative Problems|0|||
125273010|NCT00431444|450625268|FG001|Overall Study|Administrative Problems|1|||
125273011|NCT01603043|450625269|FG000|Overall Study|Study Futility|7|||
125273012|NCT01603043|450625270|FG001|Overall Study|Study Futility|3|||
125273013|NCT00556439|450625300|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
125273014|NCT00556439|450625301|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
125273015|NCT00556439|450625302|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
125273016|NCT00556439|450625303|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
125273017|NCT00556439|450625300|FG000|Study Entry to Week 12|Physician Decision|1|||
125273018|NCT00556439|450625301|FG001|Study Entry to Week 12|Physician Decision|0|||
125273019|NCT00556439|450625302|FG002|Study Entry to Week 12|Physician Decision|0|||
125273020|NCT00556439|450625303|FG003|Study Entry to Week 12|Physician Decision|0|||
125273021|NCT00556439|450625300|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
125273022|NCT00556439|450625301|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
125273023|NCT00556439|450625302|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
125273024|NCT00556439|450625303|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
125273025|NCT00556439|450625300|FG000|Study Entry to Week 12|Recurrent infection|1|||
125273026|NCT00556439|450625301|FG001|Study Entry to Week 12|Recurrent infection|0|||
125273027|NCT00556439|450625302|FG002|Study Entry to Week 12|Recurrent infection|0|||
125273028|NCT00556439|450625303|FG003|Study Entry to Week 12|Recurrent infection|0|||
125273029|NCT00556439|450625300|FG000|Study Entry to Week 12|Malignancy|0|||
125273030|NCT00556439|450625301|FG001|Study Entry to Week 12|Malignancy|0|||
125273031|NCT00556439|450625302|FG002|Study Entry to Week 12|Malignancy|1|||
125273032|NCT00556439|450625303|FG003|Study Entry to Week 12|Malignancy|0|||
125273033|NCT00556439|450625300|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
125273034|NCT00556439|450625301|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
125273035|NCT00556439|450625302|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
125273036|NCT00556439|450625303|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
125273037|NCT00556439|450625300|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
125273038|NCT00556439|450625301|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
125273039|NCT00556439|450625302|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
125273040|NCT00556439|450625303|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
125273041|NCT00556439|450625300|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
125273042|NCT00556439|450625301|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
125273043|NCT00556439|450625302|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
125273044|NCT00556439|450625303|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
125273045|NCT00556439|450625300|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
125273046|NCT00556439|450625301|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
125273047|NCT00556439|450625302|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
125273048|NCT00556439|450625303|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
125273049|NCT02100423|450625304|FG000|Overall Study|Death|1|||
125273050|NCT02100423|450625304|FG000|Overall Study|Withdrawal by Subject|3|||
125273051|NCT02100423|450625304|FG000|Overall Study|Adverse Event|1|||
125273052|NCT02100423|450625304|FG000|Overall Study|Physician Decision|1|||
125273053|NCT02931838|450625305|FG000|Overall Study|Reason not provided by investigator|1|||
125273054|NCT02931838|450625306|FG001|Overall Study|Reason not provided by investigator|0|||
125273055|NCT02931838|450625307|FG002|Overall Study|Reason not provided by investigator|1|||
125273056|NCT02931838|450625308|FG003|Overall Study|Reason not provided by investigator|0|||
125273057|NCT02931838|450625309|FG004|Overall Study|Reason not provided by investigator|0|||
125273058|NCT02931838|450625310|FG005|Overall Study|Reason not provided by investigator|0|||
125273059|NCT02931838|450625305|FG000|Overall Study|Poor/non-compliance|0|||
125273060|NCT02931838|450625306|FG001|Overall Study|Poor/non-compliance|0|||
125273061|NCT02931838|450625307|FG002|Overall Study|Poor/non-compliance|1|||
125273062|NCT02931838|450625308|FG003|Overall Study|Poor/non-compliance|0|||
125273063|NCT02931838|450625309|FG004|Overall Study|Poor/non-compliance|0|||
125273064|NCT02931838|450625310|FG005|Overall Study|Poor/non-compliance|0|||
125273065|NCT02931838|450625305|FG000|Overall Study|Lack of Efficacy|5|||
125273066|NCT02931838|450625306|FG001|Overall Study|Lack of Efficacy|4|||
125273067|NCT02931838|450625307|FG002|Overall Study|Lack of Efficacy|0|||
125273068|NCT02931838|450625308|FG003|Overall Study|Lack of Efficacy|0|||
125273069|NCT02931838|450625309|FG004|Overall Study|Lack of Efficacy|0|||
125273070|NCT02931838|450625310|FG005|Overall Study|Lack of Efficacy|1|||
125273071|NCT02931838|450625305|FG000|Overall Study|Lost to Follow-up|1|||
125273072|NCT02931838|450625306|FG001|Overall Study|Lost to Follow-up|0|||
125273073|NCT02931838|450625307|FG002|Overall Study|Lost to Follow-up|1|||
125273074|NCT02931838|450625308|FG003|Overall Study|Lost to Follow-up|1|||
125273075|NCT02931838|450625309|FG004|Overall Study|Lost to Follow-up|2|||
125273076|NCT02931838|450625310|FG005|Overall Study|Lost to Follow-up|0|||
125273077|NCT02931838|450625305|FG000|Overall Study|Subject request to discontinue treatment|4|||
125273078|NCT02931838|450625306|FG001|Overall Study|Subject request to discontinue treatment|3|||
125273079|NCT02931838|450625307|FG002|Overall Study|Subject request to discontinue treatment|3|||
125273080|NCT02931838|450625308|FG003|Overall Study|Subject request to discontinue treatment|0|||
125273081|NCT02931838|450625309|FG004|Overall Study|Subject request to discontinue treatment|1|||
125273082|NCT02931838|450625310|FG005|Overall Study|Subject request to discontinue treatment|0|||
125273083|NCT02931838|450625305|FG000|Overall Study|Withdrawal by Subject|1|||
125273084|NCT02931838|450625306|FG001|Overall Study|Withdrawal by Subject|2|||
125273085|NCT02931838|450625307|FG002|Overall Study|Withdrawal by Subject|0|||
125273086|NCT02931838|450625308|FG003|Overall Study|Withdrawal by Subject|1|||
125273087|NCT02931838|450625309|FG004|Overall Study|Withdrawal by Subject|0|||
125273088|NCT02931838|450625310|FG005|Overall Study|Withdrawal by Subject|0|||
125273089|NCT02931838|450625305|FG000|Overall Study|Adverse Event|2|||
125273090|NCT02931838|450625306|FG001|Overall Study|Adverse Event|1|||
125273091|NCT02931838|450625307|FG002|Overall Study|Adverse Event|2|||
125273092|NCT02931838|450625308|FG003|Overall Study|Adverse Event|1|||
125273093|NCT02931838|450625309|FG004|Overall Study|Adverse Event|3|||
125273094|NCT02931838|450625310|FG005|Overall Study|Adverse Event|1|||
125273095|NCT02701764|450625311|FG000|Overall Study|Lost to Follow-up|0|||
125273096|NCT02701764|450625312|FG001|Overall Study|Lost to Follow-up|1|||
125273097|NCT02949024|450625315|FG000|Overall Study|Withdrawal by Subject|0|||
125273098|NCT02949024|450625316|FG001|Overall Study|Withdrawal by Subject|1|||
125273099|NCT01027650|450625317|FG000|Overall Study|Personal Reasons|0|||
125273100|NCT01027650|450625318|FG001|Overall Study|Personal Reasons|0|||
125273101|NCT01027650|450625319|FG002|Overall Study|Personal Reasons|0|||
125273102|NCT01027650|450625320|FG003|Overall Study|Personal Reasons|0|||
125273103|NCT01027650|450625321|FG004|Overall Study|Personal Reasons|2|||
125273104|NCT01027650|450625322|FG005|Overall Study|Personal Reasons|1|||
125273105|NCT01027650|450625323|FG006|Overall Study|Personal Reasons|0|||
125273106|NCT01027650|450625324|FG007|Overall Study|Personal Reasons|0|||
125273107|NCT01027650|450625317|FG000|Overall Study|Lost to Follow-up|0|||
125273108|NCT01027650|450625318|FG001|Overall Study|Lost to Follow-up|0|||
125273109|NCT01027650|450625319|FG002|Overall Study|Lost to Follow-up|0|||
125273110|NCT01027650|450625320|FG003|Overall Study|Lost to Follow-up|0|||
125273111|NCT01027650|450625321|FG004|Overall Study|Lost to Follow-up|0|||
125273112|NCT01027650|450625322|FG005|Overall Study|Lost to Follow-up|0|||
125273113|NCT01027650|450625323|FG006|Overall Study|Lost to Follow-up|1|||
125273114|NCT01027650|450625324|FG007|Overall Study|Lost to Follow-up|0|||
125273115|NCT01027650|450625317|FG000|Overall Study|Lack of Efficacy|0|||
125273116|NCT01027650|450625318|FG001|Overall Study|Lack of Efficacy|0|||
125273117|NCT01027650|450625319|FG002|Overall Study|Lack of Efficacy|0|||
125273118|NCT01027650|450625320|FG003|Overall Study|Lack of Efficacy|0|||
125273119|NCT01027650|450625321|FG004|Overall Study|Lack of Efficacy|0|||
125273120|NCT01027650|450625322|FG005|Overall Study|Lack of Efficacy|1|||
125273121|NCT01027650|450625323|FG006|Overall Study|Lack of Efficacy|0|||
125273122|NCT01027650|450625324|FG007|Overall Study|Lack of Efficacy|0|||
125273123|NCT00912782|450625325|FG000|Overall Study|Death|2|||
125273124|NCT00912782|450625326|FG001|Overall Study|Death|1|||
125273125|NCT00912782|450625325|FG000|Overall Study|Lost to Follow-up|0|||
125273126|NCT00912782|450625326|FG001|Overall Study|Lost to Follow-up|1|||
125273127|NCT00912782|450625325|FG000|Overall Study|Did not receive vascular access type|1|||
125273128|NCT00912782|450625326|FG001|Overall Study|Did not receive vascular access type|2|||
125273129|NCT00912782|450625325|FG000|Overall Study|Relocated before study completion|0|||
125273130|NCT00912782|450625326|FG001|Overall Study|Relocated before study completion|1|||
125273131|NCT03419897|450627203|FG000|Overall Study|Death|180|||
125273132|NCT03419897|450627203|FG000|Overall Study|Lost to Follow-up|1|||
125447739|NCT04423393|451266782|FG016|Overall Study|Withdrawal by Subject|0|||
125273133|NCT03419897|450627203|FG000|Overall Study|Withdrawal by Subject|6|||
125273134|NCT03419897|450627203|FG000|Overall Study|Sponsor Decision|61|||
125273135|NCT03419897|450627203|FG000|Overall Study|Physician Decision|1|||
125273136|NCT00958360|450627205|FG000|Overall Study|Withdrawal by Subject|3|||
125273137|NCT00958360|450627206|FG001|Overall Study|Withdrawal by Subject|1|||
125273138|NCT00958360|450627205|FG000|Overall Study|Death|6|||
125273139|NCT00958360|450627206|FG001|Overall Study|Death|7|||
125273140|NCT00958360|450627205|FG000|Overall Study|Physician Decision|2|||
125273141|NCT00958360|450627206|FG001|Overall Study|Physician Decision|1|||
125273142|NCT00958360|450627205|FG000|Overall Study|Lost to Follow-up|0|||
125273143|NCT00958360|450627206|FG001|Overall Study|Lost to Follow-up|1|||
125273144|NCT02719691|450627207|FG000|Overall Study|Physician Decision|0|||
125273145|NCT02719691|450627208|FG001|Overall Study|Physician Decision|0|||
125273146|NCT02719691|450627209|FG002|Overall Study|Physician Decision|1|||
125273147|NCT02719691|450627210|FG003|Overall Study|Physician Decision|0|||
125273148|NCT02719691|450627211|FG004|Overall Study|Physician Decision|0|||
125273149|NCT02719691|450627212|FG005|Overall Study|Physician Decision|0|||
125273150|NCT02719691|450627213|FG006|Overall Study|Physician Decision|0|||
125273151|NCT02719691|450627207|FG000|Overall Study|Withdrawal by Subject|0|||
125273152|NCT02719691|450627208|FG001|Overall Study|Withdrawal by Subject|0|||
125273153|NCT02719691|450627209|FG002|Overall Study|Withdrawal by Subject|0|||
125273154|NCT02719691|450627210|FG003|Overall Study|Withdrawal by Subject|0|||
125273155|NCT02719691|450627211|FG004|Overall Study|Withdrawal by Subject|0|||
125273156|NCT02719691|450627212|FG005|Overall Study|Withdrawal by Subject|1|||
125273157|NCT02719691|450627213|FG006|Overall Study|Withdrawal by Subject|0|||
125273158|NCT00336284|450627214|FG000|Overall Study|Death|52|||
125273159|NCT00336284|450627215|FG001|Overall Study|Death|26|||
125273160|NCT00336284|450627214|FG000|Overall Study|Lost to Follow-up|82|||
125273161|NCT00336284|450627215|FG001|Overall Study|Lost to Follow-up|61|||
125273162|NCT00336284|450627214|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
125273163|NCT00336284|450627215|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
125273164|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
125273165|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
125273166|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
125273167|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
125273168|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
125273169|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
125273170|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
125273171|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
125273172|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
125273173|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
125273174|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
125273175|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
125273176|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
125273177|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
125273178|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
125273179|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
125273180|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
125273181|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
125273182|NCT03308968|450627220|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
125273183|NCT03308968|450627221|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
125273184|NCT03308968|450627222|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
125273185|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
125273186|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
125273187|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
125273188|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
125273189|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
125273190|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
125273191|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
125273192|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
125273193|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
125273194|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
125273195|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
125273196|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
125273197|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
125273198|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
125273199|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
125273200|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
125273201|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
125273202|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
125447740|NCT04423393|451266783|FG017|Overall Study|Withdrawal by Subject|0|||
125273203|NCT03308968|450627220|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
125273204|NCT03308968|450627221|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
125273205|NCT03308968|450627222|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
125273206|NCT01961297|450627228|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
125273207|NCT01961297|450627229|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
125273208|NCT02141633|450627230|FG000|Overall Study|Physician Decision|1|||
125273209|NCT02141633|450627231|FG001|Overall Study|Physician Decision|0|||
125273210|NCT02482298|450627232|FG000|Overall Study|Withdrawal by Subject|2|||
125273211|NCT02482298|450627233|FG001|Overall Study|Withdrawal by Subject|1|||
125273212|NCT02482298|450627234|FG002|Overall Study|Withdrawal by Subject|2|||
125273213|NCT02482298|450627232|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
125273214|NCT02482298|450627233|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
125273215|NCT02482298|450627234|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
125273216|NCT02482298|450627232|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
125273217|NCT02482298|450627233|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
125273218|NCT02482298|450627234|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
125273219|NCT02482298|450627232|FG000|Overall Study|Lost to Follow-up|0|||
125273220|NCT02482298|450627233|FG001|Overall Study|Lost to Follow-up|1|||
125273221|NCT02482298|450627234|FG002|Overall Study|Lost to Follow-up|0|||
125273222|NCT01188551|450627239|FG000|Overall Study|Pharmacy issues|1|||
125273223|NCT01188551|450627240|FG001|Overall Study|Pharmacy issues|0|||
125273224|NCT01188551|450627241|FG002|Overall Study|Pharmacy issues|0|||
125273225|NCT01188551|450627242|FG003|Overall Study|Pharmacy issues|0|||
125273226|NCT03782259|450627245|FG000|Overall Study|Lost to Follow-up|1|||
125273227|NCT03782259|450627246|FG001|Overall Study|Lost to Follow-up|1|||
125273228|NCT03782259|450627245|FG000|Overall Study|Moved out of state|0|||
125273229|NCT03782259|450627246|FG001|Overall Study|Moved out of state|2|||
125273230|NCT03782259|450627245|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
125273231|NCT03782259|450627246|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
125273232|NCT03782259|450627245|FG000|Overall Study|Subject discontinued intervention|1|||
125273233|NCT03782259|450627246|FG001|Overall Study|Subject discontinued intervention|0|||
125273234|NCT00603941|450627247|FG000|Overall Study|Disease progression|6|||
125273235|NCT00603941|450627248|FG001|Overall Study|Disease progression|7|||
125273236|NCT00603941|450627249|FG002|Overall Study|Disease progression|1|||
125273237|NCT00603941|450627247|FG000|Overall Study|Adverse Event|1|||
125273238|NCT00603941|450627248|FG001|Overall Study|Adverse Event|0|||
125273239|NCT00603941|450627249|FG002|Overall Study|Adverse Event|1|||
125273240|NCT00603941|450627247|FG000|Overall Study|Physician Decision|0|||
125273241|NCT00603941|450627248|FG001|Overall Study|Physician Decision|1|||
125273242|NCT00603941|450627249|FG002|Overall Study|Physician Decision|0|||
125273243|NCT00603941|450627247|FG000|Overall Study|Withdrawal by Subject|0|||
125273244|NCT00603941|450627248|FG001|Overall Study|Withdrawal by Subject|2|||
125273245|NCT00603941|450627249|FG002|Overall Study|Withdrawal by Subject|0|||
125273246|NCT05069597|450627250|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
125273247|NCT05069597|450627251|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
125273248|NCT05507567|450627252|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
125273249|NCT05507567|450627253|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
125273250|NCT05507567|450627254|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
125273251|NCT05507567|450627252|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
125273252|NCT05507567|450627253|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
125273253|NCT05507567|450627254|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
125273254|NCT05507567|450627252|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
125273255|NCT05507567|450627253|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
125273256|NCT05507567|450627254|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
125273257|NCT05507567|450627252|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
125273258|NCT05507567|450627253|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
125273259|NCT05507567|450627254|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
125273260|NCT00375427|450627255|FG000|Overall Study|Adverse Event|21|||
125273261|NCT00375427|450627256|FG001|Overall Study|Adverse Event|27|||
125273262|NCT00375427|450627255|FG000|Overall Study|Abnormal test procedure result(s)|0|||
125273263|NCT00375427|450627256|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125273264|NCT00375427|450627255|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125273265|NCT00375427|450627256|FG001|Overall Study|Abnormal laboratory value(s)|2|||
125273266|NCT00375427|450627255|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125273267|NCT00375427|450627256|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
125273268|NCT00375427|450627255|FG000|Overall Study|Patient no longer requires study drug|3|||
125273269|NCT00375427|450627256|FG001|Overall Study|Patient no longer requires study drug|7|||
125273270|NCT00375427|450627255|FG000|Overall Study|Protocol Violation|10|||
125273271|NCT00375427|450627256|FG001|Overall Study|Protocol Violation|8|||
125273272|NCT00375427|450627255|FG000|Overall Study|Withdrawal by Subject|9|||
125273273|NCT00375427|450627256|FG001|Overall Study|Withdrawal by Subject|13|||
125273274|NCT00375427|450627255|FG000|Overall Study|Lost to Follow-up|1|||
125273275|NCT00375427|450627256|FG001|Overall Study|Lost to Follow-up|1|||
125273276|NCT00375427|450627255|FG000|Overall Study|Administrative reasons|0|||
125273277|NCT00375427|450627256|FG001|Overall Study|Administrative reasons|1|||
125273278|NCT00375427|450627255|FG000|Overall Study|Death|11|||
125273279|NCT00375427|450627256|FG001|Overall Study|Death|10|||
125273280|NCT00606411|450627267|FG000|Overall Study|Adverse Event|1|||
125273281|NCT00606411|450627268|FG001|Overall Study|Adverse Event|2|||
125273282|NCT00606411|450627267|FG000|Overall Study|Lack of Adherence|1|||
125273283|NCT00606411|450627268|FG001|Overall Study|Lack of Adherence|1|||
125273284|NCT00606411|450627267|FG000|Overall Study|Lack of Efficacy|1|||
125273285|NCT00606411|450627268|FG001|Overall Study|Lack of Efficacy|1|||
125273286|NCT00606411|450627267|FG000|Overall Study|Withdrawal by Subject|2|||
125273287|NCT00606411|450627268|FG001|Overall Study|Withdrawal by Subject|0|||
125273288|NCT00606411|450627267|FG000|Overall Study|Lost to Follow-up|1|||
125273289|NCT00606411|450627268|FG001|Overall Study|Lost to Follow-up|2|||
125273290|NCT00606411|450627267|FG000|Overall Study|Move out of state|0|||
125273291|NCT00606411|450627268|FG001|Overall Study|Move out of state|1|||
125273292|NCT03726658|450627269|FG000|Overall Study|Lost to Follow-up|0|||
125273293|NCT03726658|450627270|FG001|Overall Study|Lost to Follow-up|0|||
125273294|NCT03726658|450627271|FG002|Overall Study|Lost to Follow-up|2|||
125273295|NCT03726658|450627272|FG003|Overall Study|Lost to Follow-up|0|||
125273296|NCT03726658|450627273|FG004|Overall Study|Lost to Follow-up|0|||
125273297|NCT03726658|450627274|FG005|Overall Study|Lost to Follow-up|1|||
125273298|NCT03726658|450627275|FG006|Overall Study|Lost to Follow-up|1|||
125273299|NCT03726658|450627269|FG000|Overall Study|Withdrawal by Subject|1|||
125273300|NCT03726658|450627270|FG001|Overall Study|Withdrawal by Subject|0|||
125273301|NCT03726658|450627271|FG002|Overall Study|Withdrawal by Subject|0|||
125273302|NCT03726658|450627272|FG003|Overall Study|Withdrawal by Subject|0|||
125273303|NCT03726658|450627273|FG004|Overall Study|Withdrawal by Subject|6|||
125273304|NCT03726658|450627274|FG005|Overall Study|Withdrawal by Subject|4|||
125273305|NCT03726658|450627275|FG006|Overall Study|Withdrawal by Subject|2|||
125273306|NCT03726658|450627269|FG000|Overall Study|Pregnancy|0|||
125273307|NCT03726658|450627270|FG001|Overall Study|Pregnancy|0|||
125273308|NCT03726658|450627271|FG002|Overall Study|Pregnancy|0|||
125273309|NCT03726658|450627272|FG003|Overall Study|Pregnancy|0|||
125273310|NCT03726658|450627273|FG004|Overall Study|Pregnancy|0|||
125273311|NCT03726658|450627274|FG005|Overall Study|Pregnancy|0|||
125273312|NCT03726658|450627275|FG006|Overall Study|Pregnancy|1|||
125273313|NCT03726658|450627269|FG000|Overall Study|Not Reported|0|||
125273314|NCT03726658|450627270|FG001|Overall Study|Not Reported|0|||
125273315|NCT03726658|450627271|FG002|Overall Study|Not Reported|0|||
125273316|NCT03726658|450627272|FG003|Overall Study|Not Reported|0|||
125273317|NCT03726658|450627273|FG004|Overall Study|Not Reported|0|||
125273318|NCT03726658|450627274|FG005|Overall Study|Not Reported|0|||
125273319|NCT03726658|450627275|FG006|Overall Study|Not Reported|1|||
125273320|NCT00412958|450627276|FG000|Overall Study|Withdrawal by Subject|3|||
125273321|NCT00412958|450627277|FG001|Overall Study|Withdrawal by Subject|0|||
125273322|NCT00412958|450627278|FG002|Overall Study|Withdrawal by Subject|0|||
125273323|NCT00412958|450627279|FG003|Overall Study|Withdrawal by Subject|1|||
125273324|NCT00412958|450627276|FG000|Overall Study|Adverse Event|0|||
125273325|NCT00412958|450627277|FG001|Overall Study|Adverse Event|1|||
125273326|NCT00412958|450627278|FG002|Overall Study|Adverse Event|0|||
125273327|NCT00412958|450627279|FG003|Overall Study|Adverse Event|0|||
125273328|NCT00412958|450627276|FG000|Overall Study|Lost to Follow-up|0|||
125273329|NCT00412958|450627277|FG001|Overall Study|Lost to Follow-up|1|||
125273330|NCT00412958|450627278|FG002|Overall Study|Lost to Follow-up|0|||
125399269|NCT00667342|451094378|FG002|Overall Study|Physician Decision|0|||
125399270|NCT00667342|451094376|FG000|Overall Study|Relapse or tumor progression|9|||
125273331|NCT00412958|450627279|FG003|Overall Study|Lost to Follow-up|0|||
125273332|NCT00412958|450627276|FG000|Overall Study|Death|0|||
125273333|NCT00412958|450627277|FG001|Overall Study|Death|1|||
125273334|NCT00412958|450627278|FG002|Overall Study|Death|0|||
125273335|NCT00412958|450627279|FG003|Overall Study|Death|0|||
125273336|NCT00412958|450627276|FG000|Overall Study|Transport issue|0|||
125273337|NCT00412958|450627277|FG001|Overall Study|Transport issue|1|||
125273338|NCT00412958|450627278|FG002|Overall Study|Transport issue|0|||
125273339|NCT00412958|450627279|FG003|Overall Study|Transport issue|0|||
125273340|NCT00090779|450627280|FG000|Step 1|Withdrawal by Subject|4|||
125273341|NCT00090779|450627281|FG001|Step 1|Withdrawal by Subject|2|||
125273342|NCT00090779|450627280|FG000|Step 1|Lost to Follow-up|3|||
125273343|NCT00090779|450627281|FG001|Step 1|Lost to Follow-up|2|||
125399271|NCT00667342|451094377|FG001|Overall Study|Relapse or tumor progression|0|||
125273344|NCT00090779|450627280|FG000|Step 1|Death|0|||
125273345|NCT00090779|450627281|FG001|Step 1|Death|2|||
125273346|NCT00090779|450627280|FG000|Step 1|Physician Decision|1|||
125273347|NCT00090779|450627281|FG001|Step 1|Physician Decision|0|||
125273348|NCT00090779|450627280|FG000|Step 1|Pregnancy|1|||
125273349|NCT00090779|450627281|FG001|Step 1|Pregnancy|0|||
125273350|NCT00090779|450627280|FG000|Step 1|Non-compliance to study requirements|0|||
125273351|NCT00090779|450627281|FG001|Step 1|Non-compliance to study requirements|1|||
125273352|NCT00090779|450627280|FG000|Step 1|Subject relocated|2|||
125273353|NCT00090779|450627281|FG001|Step 1|Subject relocated|8|||
125273354|NCT00090779|450627280|FG000|Step 2|Off study per study closure|6|||
125273355|NCT00090779|450627281|FG001|Step 2|Off study per study closure|16|||
125273356|NCT00090779|450627280|FG000|Step 2|Subject relocated|0|||
125273357|NCT00090779|450627281|FG001|Step 2|Subject relocated|1|||
125273358|NCT00090779|450627280|FG000|Step 2|Non-compliance to study requirements|0|||
125273359|NCT00090779|450627281|FG001|Step 2|Non-compliance to study requirements|1|||
125273360|NCT00090779|450627280|FG000|Step 3|Initiation of ART and off extended study|3|||
125273361|NCT00090779|450627281|FG001|Step 3|Initiation of ART and off extended study|2|||
125273362|NCT00090779|450627280|FG000|Step 3|Off extended study due to study closure|4|||
125273363|NCT00090779|450627281|FG001|Step 3|Off extended study due to study closure|3|||
125273364|NCT01318135|450627282|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
125273365|NCT01318135|450627283|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273366|NCT01318135|450627284|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273367|NCT01318135|450627285|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273368|NCT01318135|450627286|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273369|NCT01318135|450627287|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273370|NCT01318135|450627288|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273371|NCT01318135|450627289|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125273372|NCT01318135|450627282|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
125273373|NCT01318135|450627283|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273374|NCT01318135|450627284|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273375|NCT01318135|450627285|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273376|NCT01318135|450627286|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273377|NCT01318135|450627287|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273378|NCT01318135|450627288|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273379|NCT01318135|450627289|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
125273380|NCT01318135|450627282|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
125273381|NCT01318135|450627283|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
125273382|NCT01318135|450627284|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
125273383|NCT01318135|450627285|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
125273384|NCT01318135|450627286|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
125273385|NCT01318135|450627287|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
125273386|NCT01318135|450627288|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
125273387|NCT01318135|450627289|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
125273388|NCT01318135|450627282|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
125273389|NCT01318135|450627283|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
125273390|NCT01318135|450627284|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
125273391|NCT01318135|450627285|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
125273392|NCT01318135|450627286|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
125273393|NCT01318135|450627287|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
125273394|NCT01318135|450627288|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
125273395|NCT01318135|450627289|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
125273396|NCT01318135|450627282|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
125273397|NCT01318135|450627283|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
125273398|NCT01318135|450627284|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
125273399|NCT01318135|450627285|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
125273400|NCT01318135|450627286|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
125273401|NCT01318135|450627287|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
125273402|NCT01318135|450627288|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
125273403|NCT01318135|450627289|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
125273404|NCT01318135|450627282|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
125273405|NCT01318135|450627283|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
125273406|NCT01318135|450627284|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
125273407|NCT01318135|450627285|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
125273408|NCT01318135|450627286|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
125273409|NCT01318135|450627287|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
125273410|NCT01318135|450627288|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
125273411|NCT01318135|450627289|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
125273412|NCT01318135|450627282|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273413|NCT01318135|450627283|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273414|NCT01318135|450627284|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273415|NCT01318135|450627285|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273416|NCT01318135|450627286|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273417|NCT01318135|450627287|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273418|NCT01318135|450627288|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
125273419|NCT01318135|450627289|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
125273420|NCT03012828|450627298|FG000|Overall Study|Lost to Follow-up|1|||
125273421|NCT03012828|450627299|FG001|Overall Study|Lost to Follow-up|0|||
125273422|NCT03012828|450627300|FG002|Overall Study|Lost to Follow-up|1|||
125273423|NCT03012828|450627301|FG003|Overall Study|Lost to Follow-up|0|||
125273424|NCT03012828|450627302|FG004|Overall Study|Lost to Follow-up|1|||
125273425|NCT03012828|450627303|FG005|Overall Study|Lost to Follow-up|0|||
125273426|NCT03012828|450627298|FG000|Overall Study|Withdrawal by Subject|0|||
125273427|NCT03012828|450627299|FG001|Overall Study|Withdrawal by Subject|0|||
125273428|NCT03012828|450627300|FG002|Overall Study|Withdrawal by Subject|1|||
125273429|NCT03012828|450627301|FG003|Overall Study|Withdrawal by Subject|0|||
125273430|NCT03012828|450627302|FG004|Overall Study|Withdrawal by Subject|0|||
125273431|NCT03012828|450627303|FG005|Overall Study|Withdrawal by Subject|1|||
125273432|NCT03012828|450627298|FG000|Overall Study|Non-compliance with protocol|0|||
125273433|NCT03012828|450627299|FG001|Overall Study|Non-compliance with protocol|0|||
125273434|NCT03012828|450627300|FG002|Overall Study|Non-compliance with protocol|0|||
125273435|NCT03012828|450627301|FG003|Overall Study|Non-compliance with protocol|0|||
125273436|NCT03012828|450627302|FG004|Overall Study|Non-compliance with protocol|1|||
125273437|NCT03012828|450627303|FG005|Overall Study|Non-compliance with protocol|0|||
125273438|NCT03012828|450627298|FG000|Overall Study|Delay to last visit would delay DBL|0|||
125273439|NCT03012828|450627299|FG001|Overall Study|Delay to last visit would delay DBL|0|||
125273440|NCT03012828|450627300|FG002|Overall Study|Delay to last visit would delay DBL|0|||
125273441|NCT03012828|450627301|FG003|Overall Study|Delay to last visit would delay DBL|0|||
125273442|NCT03012828|450627302|FG004|Overall Study|Delay to last visit would delay DBL|0|||
125273443|NCT03012828|450627303|FG005|Overall Study|Delay to last visit would delay DBL|1|||
125273444|NCT04396795|450627308|FG000|Month 1|Lost to Follow-up|2|||
125273445|NCT04396795|450627309|FG001|Month 1|Lost to Follow-up|3|||
125273446|NCT04396795|450627308|FG000|Month 3|Lost to Follow-up|1|||
125273447|NCT04396795|450627309|FG001|Month 3|Lost to Follow-up|3|||
125273448|NCT04396795|450627308|FG000|Month 6|Lost to Follow-up|3|||
125273449|NCT04396795|450627309|FG001|Month 6|Lost to Follow-up|3|||
125273450|NCT03472495|450627313|FG000|Overall Study|Treatment no longer indicated|1|||
125273451|NCT03472495|450627314|FG001|Overall Study|Treatment no longer indicated|2|||
125273452|NCT03472495|450627313|FG000|Overall Study|Physician Decision|0|||
125273453|NCT03472495|450627314|FG001|Overall Study|Physician Decision|2|||
125273454|NCT01107392|450627316|FG000|Overall Study|Adverse Event|2|||
125273455|NCT01107392|450627317|FG001|Overall Study|Adverse Event|0|||
125273456|NCT01107392|450627316|FG000|Overall Study|Personal Reasons|2|||
125273457|NCT01107392|450627317|FG001|Overall Study|Personal Reasons|3|||
125273458|NCT01107392|450627316|FG000|Overall Study|Administrative decision|1|||
125273459|NCT01107392|450627317|FG001|Overall Study|Administrative decision|0|||
125273460|NCT02998671|450627320|FG000|Period 1|Study Terminated By Sponsor|2|||
125273461|NCT02998671|450627321|FG001|Period 1|Study Terminated By Sponsor|1|||
125273462|NCT02998671|450627322|FG002|Period 1|Study Terminated By Sponsor|0|||
125273463|NCT02998671|450627323|FG003|Period 1|Study Terminated By Sponsor|0|||
125273464|NCT02998671|450627324|FG004|Period 1|Study Terminated By Sponsor|1|||
125273465|NCT02998671|450627320|FG000|Period 1|Withdrawal by Subject|1|||
125273466|NCT02998671|450627321|FG001|Period 1|Withdrawal by Subject|2|||
125273467|NCT02998671|450627322|FG002|Period 1|Withdrawal by Subject|0|||
125273468|NCT02998671|450627323|FG003|Period 1|Withdrawal by Subject|0|||
125273469|NCT02998671|450627324|FG004|Period 1|Withdrawal by Subject|2|||
125273470|NCT02998671|450627320|FG000|Period 1|Pregnancy|1|||
125273471|NCT02998671|450627321|FG001|Period 1|Pregnancy|0|||
125273472|NCT02998671|450627322|FG002|Period 1|Pregnancy|0|||
125273473|NCT02998671|450627323|FG003|Period 1|Pregnancy|0|||
125273474|NCT02998671|450627324|FG004|Period 1|Pregnancy|0|||
125273475|NCT02998671|450627320|FG000|Period 1|Adverse Event|0|||
125273476|NCT02998671|450627321|FG001|Period 1|Adverse Event|0|||
125273477|NCT02998671|450627322|FG002|Period 1|Adverse Event|0|||
125273478|NCT02998671|450627323|FG003|Period 1|Adverse Event|0|||
125273479|NCT02998671|450627324|FG004|Period 1|Adverse Event|1|||
125273480|NCT02998671|450627320|FG000|Period 2|Adverse Event|0|||
125273481|NCT02998671|450627321|FG001|Period 2|Adverse Event|1|||
125273482|NCT02998671|450627322|FG002|Period 2|Adverse Event|0|||
125273483|NCT02998671|450627323|FG003|Period 2|Adverse Event|0|||
125273484|NCT02998671|450627324|FG004|Period 2|Adverse Event|0|||
125273485|NCT02998671|450627320|FG000|Period 2|Study Terminated By Sponsor|3|||
125273486|NCT02998671|450627321|FG001|Period 2|Study Terminated By Sponsor|5|||
125273487|NCT02998671|450627322|FG002|Period 2|Study Terminated By Sponsor|1|||
125273488|NCT02998671|450627323|FG003|Period 2|Study Terminated By Sponsor|3|||
125273489|NCT02998671|450627324|FG004|Period 2|Study Terminated By Sponsor|0|||
125273490|NCT02998671|450627320|FG000|Period 2|Withdrawal by Subject|0|||
125273491|NCT02998671|450627321|FG001|Period 2|Withdrawal by Subject|1|||
125273492|NCT02998671|450627322|FG002|Period 2|Withdrawal by Subject|0|||
125273493|NCT02998671|450627323|FG003|Period 2|Withdrawal by Subject|0|||
125273494|NCT02998671|450627324|FG004|Period 2|Withdrawal by Subject|0|||
125273495|NCT02998671|450627320|FG000|Period 2|Lost to Follow-up|0|||
125273496|NCT02998671|450627321|FG001|Period 2|Lost to Follow-up|0|||
125273497|NCT02998671|450627322|FG002|Period 2|Lost to Follow-up|0|||
125447741|NCT04423393|451266766|FG000|Overall Study|Sponsor Decision|0|||
125447742|NCT04423393|451266767|FG001|Overall Study|Sponsor Decision|0|||
125273498|NCT02998671|450627323|FG003|Period 2|Lost to Follow-up|1|||
125273499|NCT02998671|450627324|FG004|Period 2|Lost to Follow-up|0|||
125273500|NCT02038946|450627326|FG000|Overall Study|Death|5|||
125273501|NCT02038946|450627326|FG000|Overall Study|Withdrawal by Subject|3|||
125273502|NCT02038946|450627326|FG000|Overall Study|Lost to Follow-up|2|||
125399272|NCT00667342|451094378|FG002|Overall Study|Relapse or tumor progression|7|||
125399273|NCT00667342|451094376|FG000|Overall Study|Adverse Event|0|||
125399274|NCT00667342|451094377|FG001|Overall Study|Adverse Event|0|||
125399275|NCT00667342|451094378|FG002|Overall Study|Adverse Event|1|||
125399276|NCT00667342|451094376|FG000|Overall Study|Ineligible|0|||
125399277|NCT00667342|451094377|FG001|Overall Study|Ineligible|0|||
125399278|NCT00667342|451094378|FG002|Overall Study|Ineligible|1|||
125399279|NCT05220397|451094379|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
125399280|NCT05220397|451094380|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
125399281|NCT05220397|451094381|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
125399282|NCT05220397|451094382|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
125399283|NCT05220397|451094383|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
125399284|NCT01110915|451094384|FG000|Overall Study|Death|2|||
125273503|NCT02038946|450627326|FG000|Overall Study|Other reasons|2|||
125273504|NCT02623205|450627327|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
125273505|NCT02623205|450627328|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
125273506|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
125273507|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
125273508|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
125273509|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
125273510|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
125273511|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
125273512|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
125273513|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
125273514|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
125273515|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
125273516|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
125273517|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
125273518|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
125273519|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
125273520|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
125273521|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
125273522|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
125273523|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
125273524|NCT03162796|450627329|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
125273525|NCT03162796|450627330|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
125273526|NCT03162796|450627331|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
125273527|NCT03162796|450627329|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
125273528|NCT03162796|450627330|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
125273529|NCT03162796|450627331|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
125273530|NCT03162796|450627329|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
125273531|NCT03162796|450627330|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
125273532|NCT03162796|450627331|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
125273533|NCT03162796|450627329|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
125273534|NCT03162796|450627330|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
125273535|NCT03162796|450627331|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
125273536|NCT03162796|450627329|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
125273537|NCT03162796|450627330|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
125273538|NCT03162796|450627331|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
125273539|NCT02473471|450627332|FG000|Overall Study|poor oral hygiene|2|||
125273540|NCT02473471|450627332|FG000|Overall Study|Lost to Follow-up|1|||
125273541|NCT02342288|450627335|FG000|Overall Study|no protocol anesthesiologist available|3|||
125273542|NCT02342288|450627336|FG001|Overall Study|no protocol anesthesiologist available|2|||
125273543|NCT02342288|450627335|FG000|Overall Study|anesthesia leak in system|1|||
125273544|NCT02342288|450627336|FG001|Overall Study|anesthesia leak in system|0|||
125399285|NCT01110915|451094385|FG001|Overall Study|Death|1|||
125399286|NCT01110915|451094384|FG000|Overall Study|Lost to Follow-up|1|||
125399287|NCT01110915|451094385|FG001|Overall Study|Lost to Follow-up|0|||
125447743|NCT04423393|451266768|FG002|Overall Study|Sponsor Decision|0|||
125273545|NCT02342288|450627335|FG000|Overall Study|Withdrawal by Subject|1|||
125273546|NCT02342288|450627336|FG001|Overall Study|Withdrawal by Subject|0|||
125273547|NCT02342288|450627335|FG000|Overall Study|coordinator contaminated with blood|0|||
125273548|NCT02342288|450627336|FG001|Overall Study|coordinator contaminated with blood|1|||
125273549|NCT02342288|450627335|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
125273550|NCT02342288|450627336|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
125273551|NCT02342288|450627335|FG000|Overall Study|coordinator not available|0|||
125273552|NCT02342288|450627336|FG001|Overall Study|coordinator not available|2|||
125273553|NCT03082677|450627337|FG000|Overall Study|Not Treated|2|||
125273554|NCT01916824|450627342|FG000|Overall Study|Lost to Follow-up|3|||
125273555|NCT01916824|450627343|FG001|Overall Study|Lost to Follow-up|6|||
125273556|NCT01916824|450627342|FG000|Overall Study|Physician Decision|2|||
125273557|NCT01916824|450627343|FG001|Overall Study|Physician Decision|0|||
125273558|NCT01916824|450627342|FG000|Overall Study|Withdrawal by Subject|2|||
125273559|NCT01916824|450627343|FG001|Overall Study|Withdrawal by Subject|3|||
125273560|NCT02063984|450627346|FG000|Overall Study|Lost to Follow-up|6|||
125273561|NCT02063984|450627347|FG001|Overall Study|Lost to Follow-up|5|||
125273562|NCT02455336|450627351|FG000|Overall Study|Withdrawal by Subject|0|||
125273563|NCT02455336|450627352|FG001|Overall Study|Withdrawal by Subject|2|||
125273564|NCT02455336|450627351|FG000|Overall Study|Adverse Event|3|||
125273565|NCT02455336|450627352|FG001|Overall Study|Adverse Event|0|||
125273566|NCT02455336|450627351|FG000|Overall Study|Non-responder to treatment|2|||
125273567|NCT02455336|450627352|FG001|Overall Study|Non-responder to treatment|0|||
125273568|NCT02467192|450627355|FG000|Overall Study|Death|1|||
125273569|NCT02467192|450627355|FG000|Overall Study|revealed to have pneumonia before|2|||
125273570|NCT02517398|450627357|FG000|Overall Study|Death|2|||
125273571|NCT02517398|450627358|FG001|Overall Study|Death|3|||
125273572|NCT02517398|450627359|FG002|Overall Study|Death|4|||
125273573|NCT02517398|450627360|FG003|Overall Study|Death|2|||
125273574|NCT02517398|450627361|FG004|Overall Study|Death|3|||
125273575|NCT02517398|450627362|FG005|Overall Study|Death|8|||
125273576|NCT02517398|450627363|FG006|Overall Study|Death|3|||
125273577|NCT02517398|450627364|FG007|Overall Study|Death|2|||
125273578|NCT02517398|450627365|FG008|Overall Study|Death|6|||
125273579|NCT02517398|450627366|FG009|Overall Study|Death|24|||
125273580|NCT02517398|450627367|FG010|Overall Study|Death|53|||
125273581|NCT02517398|450627368|FG011|Overall Study|Death|25|||
125273582|NCT02517398|450627369|FG012|Overall Study|Death|73|||
125273583|NCT02517398|450627370|FG013|Overall Study|Death|29|||
125273584|NCT02517398|450627371|FG014|Overall Study|Death|26|||
125273585|NCT02517398|450627372|FG015|Overall Study|Death|23|||
125273586|NCT02517398|450627373|FG016|Overall Study|Death|26|||
125273587|NCT02517398|450627374|FG017|Overall Study|Death|25|||
125273588|NCT02517398|450627375|FG018|Overall Study|Death|22|||
125273589|NCT02517398|450627376|FG019|Overall Study|Death|7|||
125273590|NCT02517398|450627377|FG020|Overall Study|Death|26|||
125273591|NCT02517398|450627378|FG021|Overall Study|Death|30|||
125273592|NCT02517398|450627379|FG022|Overall Study|Death|20|||
125273593|NCT02517398|450627357|FG000|Overall Study|Other|0|||
125273594|NCT02517398|450627358|FG001|Overall Study|Other|0|||
125273595|NCT02517398|450627359|FG002|Overall Study|Other|0|||
125273596|NCT02517398|450627360|FG003|Overall Study|Other|1|||
125273597|NCT02517398|450627361|FG004|Overall Study|Other|0|||
125273598|NCT02517398|450627362|FG005|Overall Study|Other|0|||
125273599|NCT02517398|450627363|FG006|Overall Study|Other|0|||
125273600|NCT02517398|450627364|FG007|Overall Study|Other|0|||
125273601|NCT02517398|450627365|FG008|Overall Study|Other|0|||
125273602|NCT02517398|450627366|FG009|Overall Study|Other|1|||
125273603|NCT02517398|450627367|FG010|Overall Study|Other|0|||
125273604|NCT02517398|450627368|FG011|Overall Study|Other|0|||
125273605|NCT02517398|450627369|FG012|Overall Study|Other|0|||
125273606|NCT02517398|450627370|FG013|Overall Study|Other|1|||
125273607|NCT02517398|450627371|FG014|Overall Study|Other|0|||
125273608|NCT02517398|450627372|FG015|Overall Study|Other|1|||
125273609|NCT02517398|450627373|FG016|Overall Study|Other|1|||
125399288|NCT01110915|451094384|FG000|Overall Study|Withdrawal by Subject|7|||
125273610|NCT02517398|450627374|FG017|Overall Study|Other|0|||
125399289|NCT01110915|451094385|FG001|Overall Study|Withdrawal by Subject|1|||
125399290|NCT00207142|451094386|FG000|Induction Phase|Adverse Event|9|||
125399291|NCT00207142|451094387|FG001|Induction Phase|Adverse Event|0|||
125273611|NCT02517398|450627375|FG018|Overall Study|Other|0|||
125273612|NCT02517398|450627376|FG019|Overall Study|Other|1|||
125273613|NCT02517398|450627377|FG020|Overall Study|Other|0|||
125273614|NCT02517398|450627378|FG021|Overall Study|Other|0|||
125273615|NCT02517398|450627379|FG022|Overall Study|Other|0|||
125399292|NCT00207142|451094388|FG002|Induction Phase|Adverse Event|0|||
125273616|NCT02517398|450627357|FG000|Overall Study|Lost to Follow-up|0|||
125273617|NCT02517398|450627358|FG001|Overall Study|Lost to Follow-up|0|||
125273618|NCT02517398|450627359|FG002|Overall Study|Lost to Follow-up|0|||
125273619|NCT02517398|450627360|FG003|Overall Study|Lost to Follow-up|0|||
125273620|NCT02517398|450627361|FG004|Overall Study|Lost to Follow-up|0|||
125273621|NCT02517398|450627362|FG005|Overall Study|Lost to Follow-up|0|||
125273622|NCT02517398|450627363|FG006|Overall Study|Lost to Follow-up|0|||
125273623|NCT02517398|450627364|FG007|Overall Study|Lost to Follow-up|0|||
125399293|NCT00207142|451094389|FG003|Induction Phase|Adverse Event|0|||
125273624|NCT02517398|450627365|FG008|Overall Study|Lost to Follow-up|0|||
125273625|NCT02517398|450627366|FG009|Overall Study|Lost to Follow-up|1|||
125273626|NCT02517398|450627367|FG010|Overall Study|Lost to Follow-up|0|||
125273627|NCT02517398|450627368|FG011|Overall Study|Lost to Follow-up|2|||
125273628|NCT02517398|450627369|FG012|Overall Study|Lost to Follow-up|2|||
125273629|NCT02517398|450627370|FG013|Overall Study|Lost to Follow-up|0|||
125273630|NCT02517398|450627371|FG014|Overall Study|Lost to Follow-up|1|||
125273631|NCT02517398|450627372|FG015|Overall Study|Lost to Follow-up|1|||
125273632|NCT02517398|450627373|FG016|Overall Study|Lost to Follow-up|0|||
125273633|NCT02517398|450627374|FG017|Overall Study|Lost to Follow-up|3|||
125273634|NCT02517398|450627375|FG018|Overall Study|Lost to Follow-up|1|||
125273635|NCT02517398|450627376|FG019|Overall Study|Lost to Follow-up|0|||
125273636|NCT02517398|450627377|FG020|Overall Study|Lost to Follow-up|1|||
125273637|NCT02517398|450627378|FG021|Overall Study|Lost to Follow-up|0|||
125273638|NCT02517398|450627379|FG022|Overall Study|Lost to Follow-up|2|||
125273639|NCT02517398|450627357|FG000|Overall Study|Withdrew Consent|0|||
125273640|NCT02517398|450627358|FG001|Overall Study|Withdrew Consent|0|||
125273641|NCT02517398|450627359|FG002|Overall Study|Withdrew Consent|0|||
125273642|NCT02517398|450627360|FG003|Overall Study|Withdrew Consent|0|||
125273643|NCT02517398|450627361|FG004|Overall Study|Withdrew Consent|0|||
125273644|NCT02517398|450627362|FG005|Overall Study|Withdrew Consent|0|||
125273645|NCT02517398|450627363|FG006|Overall Study|Withdrew Consent|1|||
125273646|NCT02517398|450627364|FG007|Overall Study|Withdrew Consent|0|||
125273647|NCT02517398|450627365|FG008|Overall Study|Withdrew Consent|0|||
125273648|NCT02517398|450627366|FG009|Overall Study|Withdrew Consent|2|||
125273649|NCT02517398|450627367|FG010|Overall Study|Withdrew Consent|7|||
125273650|NCT02517398|450627368|FG011|Overall Study|Withdrew Consent|1|||
125273651|NCT02517398|450627369|FG012|Overall Study|Withdrew Consent|5|||
125273652|NCT02517398|450627370|FG013|Overall Study|Withdrew Consent|4|||
125273653|NCT02517398|450627371|FG014|Overall Study|Withdrew Consent|2|||
125273654|NCT02517398|450627372|FG015|Overall Study|Withdrew Consent|5|||
125273655|NCT02517398|450627373|FG016|Overall Study|Withdrew Consent|4|||
125273656|NCT02517398|450627374|FG017|Overall Study|Withdrew Consent|2|||
125273657|NCT02517398|450627375|FG018|Overall Study|Withdrew Consent|3|||
125273658|NCT02517398|450627376|FG019|Overall Study|Withdrew Consent|2|||
125273659|NCT02517398|450627377|FG020|Overall Study|Withdrew Consent|9|||
125273660|NCT02517398|450627378|FG021|Overall Study|Withdrew Consent|3|||
125273661|NCT02517398|450627379|FG022|Overall Study|Withdrew Consent|1|||
125273662|NCT00005947|450627383|FG000|Overall Study|Death|54|||
125273663|NCT00005947|450627384|FG001|Overall Study|Death|40|||
125273664|NCT00005947|450627383|FG000|Overall Study|Patient Refused to Continue|2|||
125273665|NCT00005947|450627384|FG001|Overall Study|Patient Refused to Continue|1|||
125273666|NCT00005947|450627383|FG000|Overall Study|Site Closure|1|||
125273667|NCT00005947|450627384|FG001|Overall Study|Site Closure|0|||
125273668|NCT02195700|450627389|FG000|Overall Study|Protocol Violation|0|||
125273669|NCT02195700|450627390|FG001|Overall Study|Protocol Violation|2|||
125273670|NCT02195700|450627389|FG000|Overall Study|Noncompliance|1|||
125273671|NCT02195700|450627390|FG001|Overall Study|Noncompliance|0|||
125273672|NCT02195700|450627389|FG000|Overall Study|Adverse Event|1|||
125273673|NCT02195700|450627390|FG001|Overall Study|Adverse Event|2|||
125273674|NCT02195700|450627389|FG000|Overall Study|Withdrawal by Subject|3|||
125273675|NCT02195700|450627390|FG001|Overall Study|Withdrawal by Subject|2|||
125273676|NCT02195700|450627389|FG000|Overall Study|Lost to Follow-up|1|||
125273677|NCT02195700|450627390|FG001|Overall Study|Lost to Follow-up|1|||
125273678|NCT03110029|450627391|FG000|Overall Study|Withdrawal by Subject|1|||
125273679|NCT03110029|450627392|FG001|Overall Study|Withdrawal by Subject|1|||
125273680|NCT02524145|450627394|FG000|Overall Study|Withdrawal by Subject|2|||
125273681|NCT02524145|450627395|FG001|Overall Study|Withdrawal by Subject|2|||
125273682|NCT02524145|450627396|FG002|Overall Study|Withdrawal by Subject|3|||
125273683|NCT00283803|450629195|FG000|Overall Study|Physician Decision|9|||
125273684|NCT00283803|450629195|FG000|Overall Study|Withdrawal by Subject|4|||
125273685|NCT01127607|450629196|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
125273686|NCT01127607|450629197|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
125273687|NCT01127607|450629196|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
125273688|NCT01127607|450629197|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
125273689|NCT02220855|450629198|FG000|Overall Study|Adverse Event|8|||
125273690|NCT02220855|450629198|FG000|Overall Study|Disease Progression|5|||
125273691|NCT02220855|450629198|FG000|Overall Study|Withdrawal by Subject|1|||
125273692|NCT03107052|450629211|FG000|Overall Study|Adverse Event|6|||
125273693|NCT03107052|450629212|FG001|Overall Study|Adverse Event|1|||
125273694|NCT03107052|450629213|FG002|Overall Study|Adverse Event|2|||
125273695|NCT03107052|450629211|FG000|Overall Study|Withdrawal by Subject|9|||
125273696|NCT03107052|450629212|FG001|Overall Study|Withdrawal by Subject|5|||
125273697|NCT03107052|450629213|FG002|Overall Study|Withdrawal by Subject|8|||
125273698|NCT03107052|450629211|FG000|Overall Study|Protocol Violation|6|||
125273699|NCT03107052|450629212|FG001|Overall Study|Protocol Violation|0|||
125273700|NCT03107052|450629213|FG002|Overall Study|Protocol Violation|3|||
125273701|NCT03107052|450629211|FG000|Overall Study|Lost to Follow-up|4|||
125273702|NCT03107052|450629212|FG001|Overall Study|Lost to Follow-up|0|||
125273703|NCT03107052|450629213|FG002|Overall Study|Lost to Follow-up|1|||
125273704|NCT03107052|450629211|FG000|Overall Study|Lack of Efficacy|23|||
125273705|NCT03107052|450629212|FG001|Overall Study|Lack of Efficacy|7|||
125273706|NCT03107052|450629213|FG002|Overall Study|Lack of Efficacy|4|||
125273707|NCT03107052|450629211|FG000|Overall Study|Other than specified|4|||
125273708|NCT03107052|450629212|FG001|Overall Study|Other than specified|2|||
125273709|NCT03107052|450629213|FG002|Overall Study|Other than specified|0|||
125273710|NCT03107052|450629211|FG000|Overall Study|Study terminated due to futility|67|||
125273711|NCT03107052|450629212|FG001|Overall Study|Study terminated due to futility|31|||
125273712|NCT03107052|450629213|FG002|Overall Study|Study terminated due to futility|23|||
125273713|NCT02263326|450629214|FG000|Overall Study|Lost to Follow-up|1|||
125273714|NCT02263326|450629215|FG001|Overall Study|Lost to Follow-up|1|||
125273715|NCT02397915|450629216|FG000|Period 1|Protocol Violation|0|||
125273716|NCT02397915|450629217|FG001|Period 1|Protocol Violation|1|||
125273717|NCT02397915|450629218|FG002|Period 1|Protocol Violation|0|||
125273718|NCT02397915|450629219|FG003|Period 1|Protocol Violation|0|||
125273719|NCT02397915|450629216|FG000|Period 1|Physician Decision|1|||
125273720|NCT02397915|450629217|FG001|Period 1|Physician Decision|0|||
125273721|NCT02397915|450629218|FG002|Period 1|Physician Decision|0|||
125273722|NCT02397915|450629219|FG003|Period 1|Physician Decision|0|||
125273723|NCT00933608|450629220|FG000|Overall Study|Adverse Event|4|||
125273724|NCT00933608|450629221|FG001|Overall Study|Adverse Event|2|||
125273725|NCT00933608|450629220|FG000|Overall Study|Physician Decision|1|||
125273726|NCT00933608|450629221|FG001|Overall Study|Physician Decision|0|||
125273727|NCT00391053|450629224|FG000|Overall Study|Serious Adverse Events|1|||
125273728|NCT00391053|450629225|FG001|Overall Study|Serious Adverse Events|0|||
125273729|NCT00391053|450629226|FG002|Overall Study|Serious Adverse Events|1|||
125273730|NCT00391053|450629227|FG003|Overall Study|Serious Adverse Events|4|||
125273731|NCT00391053|450629224|FG000|Overall Study|Protocol Violation|2|||
125273732|NCT00391053|450629225|FG001|Overall Study|Protocol Violation|0|||
125273733|NCT00391053|450629226|FG002|Overall Study|Protocol Violation|0|||
125273734|NCT00391053|450629227|FG003|Overall Study|Protocol Violation|0|||
125273735|NCT00391053|450629224|FG000|Overall Study|Lost to Follow-up|1|||
125273736|NCT00391053|450629225|FG001|Overall Study|Lost to Follow-up|0|||
125273737|NCT00391053|450629226|FG002|Overall Study|Lost to Follow-up|0|||
125273738|NCT00391053|450629227|FG003|Overall Study|Lost to Follow-up|5|||
125273739|NCT00391053|450629224|FG000|Overall Study|Withdrawal by Subject|5|||
125273740|NCT00391053|450629225|FG001|Overall Study|Withdrawal by Subject|1|||
125273741|NCT00391053|450629226|FG002|Overall Study|Withdrawal by Subject|1|||
125273742|NCT00391053|450629227|FG003|Overall Study|Withdrawal by Subject|1|||
125273743|NCT04908384|450629228|FG000|Overall Study|Lost to Follow-up|4|||
125273744|NCT04908384|450629229|FG001|Overall Study|Lost to Follow-up|4|||
125273745|NCT04908384|450629230|FG002|Overall Study|Lost to Follow-up|0|||
125273746|NCT04908384|450629231|FG003|Overall Study|Lost to Follow-up|0|||
125273747|NCT05002985|450629232|FG000|Overall Study|Withdrawal by Subject|1|||
125273748|NCT01642901|450629236|FG000|12-month Follow-up|Withdrawal by Subject|1|||
125273749|NCT01642901|450629237|FG001|12-month Follow-up|Withdrawal by Subject|0|||
125273750|NCT02943070|450629239|FG000|Overall Study|Physician Decision|1|||
125273751|NCT02943070|450629239|FG000|Overall Study|Adverse Event|2|||
125273752|NCT02943070|450629239|FG000|Overall Study|Death|2|||
125273753|NCT02943070|450629239|FG000|Overall Study|Withdrawal by Subject|3|||
125273754|NCT02943070|450629239|FG000|Overall Study|Lost to Follow-up|4|||
125273755|NCT02943070|450629239|FG000|Overall Study|Retreatment or TURP|13|||
125273756|NCT02943070|450629239|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
125273757|NCT04123093|450629244|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
125273758|NCT04123093|450629245|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
125273759|NCT04123093|450629244|FG000|Phase 2|Physician Decision|0|||
125273760|NCT04123093|450629245|FG001|Phase 2|Physician Decision|1|||
125273761|NCT04123093|450629244|FG000|Phase 2|Withdrawal by Subject|0|||
125273762|NCT04123093|450629245|FG001|Phase 2|Withdrawal by Subject|1|||
125273763|NCT04556591|450629246|FG000|Overall Study|Lost to Follow-up|1|||
125273764|NCT04556591|450629247|FG001|Overall Study|Lost to Follow-up|0|||
125273765|NCT04556591|450629246|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
125273766|NCT04556591|450629247|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
125273767|NCT04551963|450629248|FG000|Overall Study|Physician Decision|1|||
125273768|NCT04551963|450629249|FG001|Overall Study|Physician Decision|1|||
125447744|NCT04423393|451266769|FG003|Overall Study|Sponsor Decision|0|||
125273769|NCT04551963|450629248|FG000|Overall Study|Death|1|||
125273770|NCT04551963|450629249|FG001|Overall Study|Death|0|||
125273771|NCT03379259|450629250|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
125273772|NCT03379259|450629251|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
125273773|NCT03379259|450629252|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
125273774|NCT03379259|450629253|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
125273775|NCT03379259|450629254|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
125273776|NCT03379259|450629255|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
125273777|NCT03379259|450629250|FG000|Overall Study|Death|0|||
125273778|NCT03379259|450629251|FG001|Overall Study|Death|1|||
125273779|NCT03379259|450629252|FG002|Overall Study|Death|2|||
125273780|NCT03379259|450629253|FG003|Overall Study|Death|1|||
125273781|NCT03379259|450629254|FG004|Overall Study|Death|4|||
125273782|NCT03379259|450629255|FG005|Overall Study|Death|2|||
125273783|NCT03379259|450629250|FG000|Overall Study|Withdrawal by Subject|0|||
125273784|NCT03379259|450629251|FG001|Overall Study|Withdrawal by Subject|0|||
125273785|NCT03379259|450629252|FG002|Overall Study|Withdrawal by Subject|1|||
125273786|NCT03379259|450629253|FG003|Overall Study|Withdrawal by Subject|0|||
125273787|NCT03379259|450629254|FG004|Overall Study|Withdrawal by Subject|2|||
125273788|NCT03379259|450629255|FG005|Overall Study|Withdrawal by Subject|0|||
125273789|NCT03379259|450629250|FG000|Overall Study|Study terminated by sponsor|0|||
125273790|NCT03379259|450629251|FG001|Overall Study|Study terminated by sponsor|0|||
125273791|NCT03379259|450629252|FG002|Overall Study|Study terminated by sponsor|0|||
125273792|NCT03379259|450629253|FG003|Overall Study|Study terminated by sponsor|1|||
125273793|NCT03379259|450629254|FG004|Overall Study|Study terminated by sponsor|1|||
125273794|NCT03379259|450629255|FG005|Overall Study|Study terminated by sponsor|4|||
125273795|NCT03379259|450629250|FG000|Overall Study|Disease progression|0|||
125273796|NCT03379259|450629251|FG001|Overall Study|Disease progression|0|||
125273797|NCT03379259|450629252|FG002|Overall Study|Disease progression|0|||
125273798|NCT03379259|450629253|FG003|Overall Study|Disease progression|1|||
125273799|NCT03379259|450629254|FG004|Overall Study|Disease progression|0|||
125273800|NCT03379259|450629255|FG005|Overall Study|Disease progression|1|||
125273801|NCT03379259|450629250|FG000|Overall Study|Lost to Follow-up|0|||
125273802|NCT03379259|450629251|FG001|Overall Study|Lost to Follow-up|0|||
125273803|NCT03379259|450629252|FG002|Overall Study|Lost to Follow-up|0|||
125273804|NCT03379259|450629253|FG003|Overall Study|Lost to Follow-up|0|||
125273805|NCT03379259|450629254|FG004|Overall Study|Lost to Follow-up|1|||
125273806|NCT03379259|450629255|FG005|Overall Study|Lost to Follow-up|0|||
125273807|NCT03379259|450629250|FG000|Overall Study|Deteriorating condition|0|||
125273808|NCT03379259|450629251|FG001|Overall Study|Deteriorating condition|0|||
125273809|NCT03379259|450629252|FG002|Overall Study|Deteriorating condition|0|||
125273810|NCT03379259|450629253|FG003|Overall Study|Deteriorating condition|0|||
125273811|NCT03379259|450629254|FG004|Overall Study|Deteriorating condition|1|||
125273812|NCT03379259|450629255|FG005|Overall Study|Deteriorating condition|0|||
125273813|NCT00700622|450629257|FG000|Overall Study|Adverse Event|4|||
125273814|NCT00700622|450629258|FG001|Overall Study|Adverse Event|0|||
125273815|NCT00700622|450629257|FG000|Overall Study|Lost to Follow-up|0|||
125273816|NCT00700622|450629258|FG001|Overall Study|Lost to Follow-up|1|||
125273817|NCT00700622|450629257|FG000|Overall Study|Physician Decision|2|||
125273818|NCT00700622|450629258|FG001|Overall Study|Physician Decision|1|||
125273819|NCT00700622|450629257|FG000|Overall Study|Protocol Violation|0|||
125273820|NCT00700622|450629258|FG001|Overall Study|Protocol Violation|1|||
125273821|NCT00700622|450629257|FG000|Overall Study|Withdrawal by Subject|4|||
125273822|NCT00700622|450629258|FG001|Overall Study|Withdrawal by Subject|1|||
125273823|NCT00700622|450629257|FG000|Overall Study|Other|3|||
125273824|NCT00700622|450629258|FG001|Overall Study|Other|1|||
125273825|NCT02526212|450629262|FG000|Overall Study|Incarceration|1|||
125273826|NCT02526212|450629263|FG001|Overall Study|Incarceration|0|||
125273827|NCT02526212|450629262|FG000|Overall Study|Lost to Follow-up|1|||
125273828|NCT02526212|450629263|FG001|Overall Study|Lost to Follow-up|0|||
125273829|NCT02526212|450629262|FG000|Overall Study|Death|0|||
125273830|NCT02526212|450629263|FG001|Overall Study|Death|1|||
125273831|NCT00040742|450629270|FG000|Overall Study|Death|0|||
125273832|NCT00040742|450629271|FG001|Overall Study|Death|0|||
125273833|NCT00040742|450629272|FG002|Overall Study|Death|1|||
125273834|NCT00040742|450629273|FG003|Overall Study|Death|0|||
125273835|NCT00040742|450629270|FG000|Overall Study|Adverse Event|15|||
125273836|NCT00040742|450629271|FG001|Overall Study|Adverse Event|16|||
125273837|NCT00040742|450629272|FG002|Overall Study|Adverse Event|21|||
125273838|NCT00040742|450629273|FG003|Overall Study|Adverse Event|9|||
125273839|NCT00040742|450629270|FG000|Overall Study|Withdrawal by Subject|7|||
125273840|NCT00040742|450629271|FG001|Overall Study|Withdrawal by Subject|15|||
125273841|NCT00040742|450629272|FG002|Overall Study|Withdrawal by Subject|10|||
125273842|NCT00040742|450629273|FG003|Overall Study|Withdrawal by Subject|13|||
125399294|NCT00207142|451094386|FG000|Induction Phase|Death|1|||
125399295|NCT00207142|451094387|FG001|Induction Phase|Death|0|||
125273843|NCT00040742|450629270|FG000|Overall Study|Chemotoxicity|4|||
125273844|NCT00040742|450629271|FG001|Overall Study|Chemotoxicity|3|||
125273845|NCT00040742|450629272|FG002|Overall Study|Chemotoxicity|5|||
125273846|NCT00040742|450629273|FG003|Overall Study|Chemotoxicity|2|||
125399296|NCT00207142|451094388|FG002|Induction Phase|Death|0|||
125273847|NCT00040742|450629270|FG000|Overall Study|Incomplete Forms|6|||
125273848|NCT00040742|450629271|FG001|Overall Study|Incomplete Forms|10|||
125273849|NCT00040742|450629272|FG002|Overall Study|Incomplete Forms|4|||
125273850|NCT00040742|450629273|FG003|Overall Study|Incomplete Forms|5|||
125273851|NCT00040742|450629270|FG000|Overall Study|Other medical|7|||
125273852|NCT00040742|450629271|FG001|Overall Study|Other medical|5|||
125273853|NCT00040742|450629272|FG002|Overall Study|Other medical|5|||
125273854|NCT00040742|450629273|FG003|Overall Study|Other medical|5|||
125273855|NCT03520920|450629276|FG000|Overall Study|Death|13|||
125273856|NCT03520920|450629277|FG001|Overall Study|Death|1|||
125273857|NCT03520920|450629278|FG002|Overall Study|Death|0|||
125273858|NCT03520920|450629276|FG000|Overall Study|Withdrawal by Subject|2|||
125273859|NCT03520920|450629277|FG001|Overall Study|Withdrawal by Subject|1|||
125273860|NCT03520920|450629278|FG002|Overall Study|Withdrawal by Subject|0|||
125273861|NCT03520920|450629276|FG000|Overall Study|Study Terminated by the Sponsor|5|||
125273862|NCT03520920|450629277|FG001|Overall Study|Study Terminated by the Sponsor|14|||
125273863|NCT03520920|450629278|FG002|Overall Study|Study Terminated by the Sponsor|5|||
125273864|NCT00405392|450629279|FG000|Overall Study|Adverse Event|15|||
125273865|NCT00405392|450629280|FG001|Overall Study|Adverse Event|14|||
125273866|NCT00405392|450629279|FG000|Overall Study|Did not meet Eligibility criteria|7|||
125273867|NCT00405392|450629280|FG001|Overall Study|Did not meet Eligibility criteria|2|||
125273868|NCT00405392|450629279|FG000|Overall Study|Withdrawal by Subject|4|||
125273869|NCT00405392|450629280|FG001|Overall Study|Withdrawal by Subject|3|||
125273870|NCT00405392|450629279|FG000|Overall Study|Lost to Follow-up|1|||
125273871|NCT00405392|450629280|FG001|Overall Study|Lost to Follow-up|2|||
125273872|NCT00405392|450629279|FG000|Overall Study|Data missing|2|||
125273873|NCT00405392|450629280|FG001|Overall Study|Data missing|0|||
125273874|NCT00405392|450629279|FG000|Overall Study|Non-compliance|0|||
125273875|NCT00405392|450629280|FG001|Overall Study|Non-compliance|1|||
125273876|NCT00405392|450629279|FG000|Overall Study|Other|1|||
125273877|NCT00405392|450629280|FG001|Overall Study|Other|5|||
125273878|NCT01703091|450629283|FG000|Overall Study|Adverse Event|5|||
125273879|NCT01703091|450629284|FG001|Overall Study|Adverse Event|3|||
125273880|NCT01703091|450629283|FG000|Overall Study|Physician Decision|2|||
125273881|NCT01703091|450629284|FG001|Overall Study|Physician Decision|1|||
125273882|NCT01703091|450629283|FG000|Overall Study|Withdrawal by Subject|1|||
125273883|NCT01703091|450629284|FG001|Overall Study|Withdrawal by Subject|0|||
125273884|NCT01703091|450629283|FG000|Overall Study|Sponsor Decision|1|||
125273885|NCT01703091|450629284|FG001|Overall Study|Sponsor Decision|0|||
125273886|NCT02550288|450629288|FG000|Overall Study|Adverse Event|0|||
125273887|NCT02550288|450629289|FG001|Overall Study|Adverse Event|1|||
125273888|NCT02550288|450629290|FG002|Overall Study|Adverse Event|0|||
125273889|NCT02550288|450629291|FG003|Overall Study|Adverse Event|0|||
125273890|NCT02550288|450629292|FG004|Overall Study|Adverse Event|0|||
125273891|NCT02550288|450629288|FG000|Overall Study|Physician Decision|0|||
125273892|NCT02550288|450629289|FG001|Overall Study|Physician Decision|0|||
125273893|NCT02550288|450629290|FG002|Overall Study|Physician Decision|0|||
125273894|NCT02550288|450629291|FG003|Overall Study|Physician Decision|1|||
125273895|NCT02550288|450629292|FG004|Overall Study|Physician Decision|0|||
125273896|NCT02550288|450629288|FG000|Overall Study|Protocol Violation|2|||
125273897|NCT02550288|450629289|FG001|Overall Study|Protocol Violation|2|||
125273898|NCT02550288|450629290|FG002|Overall Study|Protocol Violation|1|||
125273899|NCT02550288|450629291|FG003|Overall Study|Protocol Violation|0|||
125273900|NCT02550288|450629292|FG004|Overall Study|Protocol Violation|3|||
125273901|NCT02550288|450629288|FG000|Overall Study|Participant moved|0|||
125273902|NCT02550288|450629289|FG001|Overall Study|Participant moved|0|||
125273903|NCT02550288|450629290|FG002|Overall Study|Participant moved|0|||
125273904|NCT02550288|450629291|FG003|Overall Study|Participant moved|1|||
125273905|NCT02550288|450629292|FG004|Overall Study|Participant moved|0|||
125273906|NCT02550288|450629288|FG000|Overall Study|Withdrawal by Subject|0|||
125273907|NCT02550288|450629289|FG001|Overall Study|Withdrawal by Subject|0|||
125273908|NCT02550288|450629290|FG002|Overall Study|Withdrawal by Subject|0|||
125273909|NCT02550288|450629291|FG003|Overall Study|Withdrawal by Subject|1|||
125273910|NCT02550288|450629292|FG004|Overall Study|Withdrawal by Subject|0|||
125273911|NCT02819297|450629293|FG000|Overall Study|Withdrawal by Subject|25|||
125273912|NCT02819297|450629294|FG001|Overall Study|Withdrawal by Subject|13|||
125273913|NCT02819297|450629293|FG000|Overall Study|Lost to Follow-up|12|||
125273914|NCT02819297|450629294|FG001|Overall Study|Lost to Follow-up|14|||
125273915|NCT02819297|450629293|FG000|Overall Study|Adverse Event|12|||
125273916|NCT02819297|450629294|FG001|Overall Study|Adverse Event|10|||
125273917|NCT02819297|450629293|FG000|Overall Study|Physician Decision|5|||
125273918|NCT02819297|450629294|FG001|Overall Study|Physician Decision|5|||
125273919|NCT02819297|450629293|FG000|Overall Study|Lack of Efficacy|5|||
125273920|NCT02819297|450629294|FG001|Overall Study|Lack of Efficacy|8|||
125273921|NCT02819297|450629293|FG000|Overall Study|Protocol Violation|1|||
125273922|NCT02819297|450629294|FG001|Overall Study|Protocol Violation|2|||
125273923|NCT01071252|450629296|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
125273924|NCT01071252|450629297|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
125273925|NCT01071252|450629298|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
125273926|NCT01071252|450629299|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
125273927|NCT01071252|450629300|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
125273928|NCT01071252|450629296|FG000|Overall Study|Withdrawal by Subject|8|||
125273929|NCT01071252|450629297|FG001|Overall Study|Withdrawal by Subject|2|||
125399297|NCT00207142|451094389|FG003|Induction Phase|Death|0|||
125273930|NCT01071252|450629298|FG002|Overall Study|Withdrawal by Subject|1|||
125273931|NCT01071252|450629299|FG003|Overall Study|Withdrawal by Subject|2|||
125273932|NCT01071252|450629300|FG004|Overall Study|Withdrawal by Subject|3|||
125273933|NCT01071252|450629296|FG000|Overall Study|administrative problems|1|||
125273934|NCT01071252|450629297|FG001|Overall Study|administrative problems|1|||
125273935|NCT01071252|450629298|FG002|Overall Study|administrative problems|0|||
125273936|NCT01071252|450629299|FG003|Overall Study|administrative problems|2|||
125273937|NCT01071252|450629300|FG004|Overall Study|administrative problems|1|||
125273938|NCT01071252|450629296|FG000|Overall Study|Lost to Follow-up|1|||
125273939|NCT01071252|450629297|FG001|Overall Study|Lost to Follow-up|0|||
125273940|NCT01071252|450629298|FG002|Overall Study|Lost to Follow-up|1|||
125273941|NCT01071252|450629299|FG003|Overall Study|Lost to Follow-up|2|||
125273942|NCT01071252|450629300|FG004|Overall Study|Lost to Follow-up|0|||
125273943|NCT01071252|450629296|FG000|Overall Study|Adverse Event|1|||
125273944|NCT01071252|450629297|FG001|Overall Study|Adverse Event|1|||
125273945|NCT01071252|450629298|FG002|Overall Study|Adverse Event|0|||
125273946|NCT01071252|450629299|FG003|Overall Study|Adverse Event|1|||
125273947|NCT01071252|450629300|FG004|Overall Study|Adverse Event|0|||
125273948|NCT01071252|450629296|FG000|Overall Study|Death|0|||
125273949|NCT01071252|450629297|FG001|Overall Study|Death|0|||
125273950|NCT01071252|450629298|FG002|Overall Study|Death|0|||
125273951|NCT01071252|450629299|FG003|Overall Study|Death|0|||
125273952|NCT01071252|450629300|FG004|Overall Study|Death|1|||
125273953|NCT01945996|450629301|FG000|Overall Study|Lost to Follow-up|3|||
125273954|NCT01945996|450629302|FG001|Overall Study|Lost to Follow-up|5|||
125273955|NCT03928418|450629303|FG000|Overall Study|Lost to Follow-up|5|||
125273956|NCT03928418|450629304|FG001|Overall Study|Lost to Follow-up|3|||
125273957|NCT03928418|450629305|FG002|Overall Study|Lost to Follow-up|5|||
125273958|NCT03928418|450629303|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
125273959|NCT03928418|450629304|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
125273960|NCT03928418|450629305|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
125273961|NCT00763256|450629306|FG000|Overall Study|Didn't return for appointments|7|||
125273962|NCT00763256|450629307|FG001|Overall Study|Didn't return for appointments|10|||
125273963|NCT02544750|450629308|FG000|Overall Study|Physician Decision|3|||
125273964|NCT02544750|450629309|FG001|Overall Study|Physician Decision|1|||
125273965|NCT02544750|450629308|FG000|Overall Study|Other reasons|69|||
125273966|NCT02544750|450629309|FG001|Overall Study|Other reasons|39|||
125273967|NCT02544750|450629308|FG000|Overall Study|Met withdrawal criteria|2|||
125273968|NCT02544750|450629309|FG001|Overall Study|Met withdrawal criteria|2|||
125273969|NCT02544750|450629308|FG000|Overall Study|Transition To Commercial Product|1|||
125273970|NCT02544750|450629309|FG001|Overall Study|Transition To Commercial Product|0|||
125273971|NCT02544750|450629308|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
125273972|NCT02544750|450629309|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
125273973|NCT02544750|450629308|FG000|Overall Study|Adverse Event|8|||
125273974|NCT02544750|450629309|FG001|Overall Study|Adverse Event|10|||
125273975|NCT02544750|450629308|FG000|Overall Study|Withdrawal by Subject|10|||
125273976|NCT02544750|450629309|FG001|Overall Study|Withdrawal by Subject|4|||
125273977|NCT02544750|450629308|FG000|Overall Study|Lost to Follow-up|1|||
125273978|NCT02544750|450629309|FG001|Overall Study|Lost to Follow-up|0|||
125273979|NCT00244725|450629310|FG000|Overall Study|Lost to Follow-up|3|||
125273980|NCT00244725|450629311|FG001|Overall Study|Lost to Follow-up|4|||
125273981|NCT00244725|450629312|FG002|Overall Study|Lost to Follow-up|9|||
125273982|NCT00244725|450629313|FG003|Overall Study|Lost to Follow-up|2|||
125273983|NCT00244725|450629310|FG000|Overall Study|Withdrawal by Subject|9|||
125273984|NCT00244725|450629311|FG001|Overall Study|Withdrawal by Subject|7|||
125273985|NCT00244725|450629312|FG002|Overall Study|Withdrawal by Subject|7|||
125273986|NCT00244725|450629313|FG003|Overall Study|Withdrawal by Subject|8|||
125273987|NCT00244725|450629310|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
125273988|NCT00244725|450629311|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
125273989|NCT00244725|450629312|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
125273990|NCT00244725|450629313|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
125273991|NCT00244725|450629310|FG000|Overall Study|Physician Decision|3|||
125273992|NCT00244725|450629311|FG001|Overall Study|Physician Decision|0|||
125273993|NCT00244725|450629312|FG002|Overall Study|Physician Decision|1|||
125273994|NCT00244725|450629313|FG003|Overall Study|Physician Decision|2|||
125273995|NCT00244725|450629310|FG000|Overall Study|Adverse Events|3|||
125273996|NCT00244725|450629311|FG001|Overall Study|Adverse Events|1|||
125273997|NCT00244725|450629312|FG002|Overall Study|Adverse Events|4|||
125399298|NCT00207142|451094386|FG000|Induction Phase|Lack of Efficacy|1|||
125273998|NCT00244725|450629313|FG003|Overall Study|Adverse Events|4|||
125399299|NCT00207142|451094387|FG001|Induction Phase|Lack of Efficacy|0|||
125399300|NCT00207142|451094388|FG002|Induction Phase|Lack of Efficacy|0|||
125273999|NCT00244725|450629310|FG000|Overall Study|Withdrwal by participant|1|||
125274000|NCT00244725|450629311|FG001|Overall Study|Withdrwal by participant|0|||
125274001|NCT00244725|450629312|FG002|Overall Study|Withdrwal by participant|0|||
125274002|NCT00244725|450629313|FG003|Overall Study|Withdrwal by participant|1|||
125274003|NCT00244725|450629310|FG000|Overall Study|Liver function test abnormality|2|||
125274004|NCT00244725|450629311|FG001|Overall Study|Liver function test abnormality|0|||
125274005|NCT00244725|450629312|FG002|Overall Study|Liver function test abnormality|0|||
125274006|NCT00244725|450629313|FG003|Overall Study|Liver function test abnormality|1|||
125274007|NCT00244725|450629310|FG000|Overall Study|Sponsor withdrew the participant|1|||
125274008|NCT00244725|450629311|FG001|Overall Study|Sponsor withdrew the participant|0|||
125399301|NCT00207142|451094389|FG003|Induction Phase|Lack of Efficacy|0|||
125274009|NCT00244725|450629312|FG002|Overall Study|Sponsor withdrew the participant|0|||
125274010|NCT00244725|450629313|FG003|Overall Study|Sponsor withdrew the participant|1|||
125274011|NCT00244725|450629310|FG000|Overall Study|Mediciation Error|0|||
125274012|NCT00244725|450629311|FG001|Overall Study|Mediciation Error|1|||
125274013|NCT00244725|450629312|FG002|Overall Study|Mediciation Error|0|||
125274014|NCT00244725|450629313|FG003|Overall Study|Mediciation Error|0|||
125274015|NCT00244725|450629310|FG000|Overall Study|Rehab Refused to allow participantion|0|||
125274016|NCT00244725|450629311|FG001|Overall Study|Rehab Refused to allow participantion|1|||
125274017|NCT00244725|450629312|FG002|Overall Study|Rehab Refused to allow participantion|0|||
125274018|NCT00244725|450629313|FG003|Overall Study|Rehab Refused to allow participantion|0|||
125274019|NCT00244725|450629310|FG000|Overall Study|Headache|0|||
125274020|NCT00244725|450629311|FG001|Overall Study|Headache|1|||
125274021|NCT00244725|450629312|FG002|Overall Study|Headache|0|||
125274022|NCT00244725|450629313|FG003|Overall Study|Headache|0|||
125274023|NCT00244725|450629310|FG000|Overall Study|Received prohibited medication|0|||
125274024|NCT00244725|450629311|FG001|Overall Study|Received prohibited medication|1|||
125274025|NCT00244725|450629312|FG002|Overall Study|Received prohibited medication|0|||
125274026|NCT00244725|450629313|FG003|Overall Study|Received prohibited medication|1|||
125274027|NCT00244725|450629310|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
125274028|NCT00244725|450629311|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
125274029|NCT00244725|450629312|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
125274030|NCT00244725|450629313|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
125274031|NCT00244725|450629310|FG000|Overall Study|Administrative reason|0|||
125274032|NCT00244725|450629311|FG001|Overall Study|Administrative reason|0|||
125274033|NCT00244725|450629312|FG002|Overall Study|Administrative reason|1|||
125274034|NCT00244725|450629313|FG003|Overall Study|Administrative reason|0|||
125274035|NCT00244725|450629310|FG000|Overall Study|Vomit|0|||
125274036|NCT00244725|450629311|FG001|Overall Study|Vomit|0|||
125274037|NCT00244725|450629312|FG002|Overall Study|Vomit|1|||
125274038|NCT00244725|450629313|FG003|Overall Study|Vomit|0|||
125274039|NCT00244725|450629310|FG000|Overall Study|Failed to follow-up|0|||
125274040|NCT00244725|450629311|FG001|Overall Study|Failed to follow-up|0|||
125274041|NCT00244725|450629312|FG002|Overall Study|Failed to follow-up|1|||
125274042|NCT00244725|450629313|FG003|Overall Study|Failed to follow-up|1|||
125274043|NCT02131311|450629314|FG000|Overall Study|Adverse Event|2|||
125274044|NCT02131311|450629314|FG000|Overall Study|Protocol Violation|1|||
125274045|NCT02131311|450629314|FG000|Overall Study|Lost to Follow-up|1|||
125274046|NCT00255723|450629317|FG000|Overall Study|Adverse Event|1|||
125274047|NCT00255723|450629318|FG001|Overall Study|Adverse Event|1|||
125274048|NCT00255723|450629317|FG000|Overall Study|Death|0|||
125274049|NCT00255723|450629318|FG001|Overall Study|Death|1|||
125274050|NCT00255723|450629317|FG000|Overall Study|Response Data Not Available|1|||
125274051|NCT00255723|450629318|FG001|Overall Study|Response Data Not Available|0|||
125274052|NCT03711370|450629322|FG000|Overall Study|Lost to Follow-up|16|||
125274053|NCT03711370|450629323|FG001|Overall Study|Lost to Follow-up|10|||
125274054|NCT03711370|450629322|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
125274055|NCT03711370|450629323|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
125274056|NCT00407602|450629324|FG000|Overall Study|Death - unrelated to device|1|||
125274057|NCT00407602|450629324|FG000|Overall Study|Device explanted|5|||
125274058|NCT00407602|450629324|FG000|Overall Study|Withdrawal by Subject|1|||
125274059|NCT01169701|450629325|FG000|Overall Study|Lost to Follow-up|1|||
125274060|NCT01169701|450629326|FG001|Overall Study|Lost to Follow-up|1|||
125274061|NCT01169701|450629325|FG000|Overall Study|Withdrawal by Subject|1|||
125274062|NCT01169701|450629326|FG001|Overall Study|Withdrawal by Subject|3|||
125274063|NCT01169701|450629325|FG000|Overall Study|Adverse Event|1|||
125274064|NCT01169701|450629326|FG001|Overall Study|Adverse Event|2|||
125274065|NCT01169701|450629325|FG000|Overall Study|Exclusion criteria|2|||
125274066|NCT01169701|450629326|FG001|Overall Study|Exclusion criteria|0|||
125274067|NCT01169701|450629325|FG000|Overall Study|Death|0|||
125274068|NCT01169701|450629326|FG001|Overall Study|Death|1|||
125274069|NCT01169701|450629325|FG000|Overall Study|Administrative problems|0|||
125274070|NCT01169701|450629326|FG001|Overall Study|Administrative problems|1|||
125274071|NCT01169701|450629325|FG000|Overall Study|Serious adverse event|0|||
125274072|NCT01169701|450629326|FG001|Overall Study|Serious adverse event|1|||
125274073|NCT01169701|450629325|FG000|Overall Study|Sponsor decision|0|||
125274074|NCT01169701|450629326|FG001|Overall Study|Sponsor decision|1|||
125274075|NCT00553436|450629327|FG000|Overall Study|Conversion to another procedure|1|||
125274076|NCT01814046|450629328|FG000|Drug Administration|Death due to complications of RSV|1|||
125274077|NCT01814046|450629329|FG001|Drug Administration|Death due to complications of RSV|0|||
125274078|NCT01814046|450629330|FG002|Drug Administration|Death due to complications of RSV|0|||
125274079|NCT03146663|450629333|FG000|Overall Study|Did not receive study treatment|1|||
125274080|NCT03146663|450629334|FG001|Overall Study|Did not receive study treatment|1|||
125274081|NCT03089047|450629335|FG000|Overall Study|Lost to Follow-up|1|||
125274082|NCT03089047|450629336|FG001|Overall Study|Lost to Follow-up|0|||
125274083|NCT03599518|450629337|FG000|Overall Study|Clinical progression|0|||
125274084|NCT03599518|450629338|FG001|Overall Study|Clinical progression|0|||
125399302|NCT00207142|451094386|FG000|Induction Phase|Lost to Follow-up|5|||
125399303|NCT00207142|451094387|FG001|Induction Phase|Lost to Follow-up|0|||
125399304|NCT00207142|451094388|FG002|Induction Phase|Lost to Follow-up|0|||
125399305|NCT00207142|451094389|FG003|Induction Phase|Lost to Follow-up|0|||
125399306|NCT00207142|451094386|FG000|Induction Phase|Physician Decision|2|||
125399307|NCT00207142|451094387|FG001|Induction Phase|Physician Decision|0|||
125399308|NCT00207142|451094388|FG002|Induction Phase|Physician Decision|0|||
125399309|NCT00207142|451094389|FG003|Induction Phase|Physician Decision|0|||
125399310|NCT00207142|451094386|FG000|Induction Phase|Poor/noncompliance|2|||
125399311|NCT00207142|451094387|FG001|Induction Phase|Poor/noncompliance|0|||
125399312|NCT00207142|451094388|FG002|Induction Phase|Poor/noncompliance|0|||
125399313|NCT00207142|451094389|FG003|Induction Phase|Poor/noncompliance|0|||
125399314|NCT00207142|451094386|FG000|Induction Phase|Pregnancy|1|||
125399315|NCT00207142|451094387|FG001|Induction Phase|Pregnancy|0|||
125399316|NCT00207142|451094388|FG002|Induction Phase|Pregnancy|0|||
125399317|NCT00207142|451094389|FG003|Induction Phase|Pregnancy|0|||
125399318|NCT00207142|451094386|FG000|Induction Phase|Subject no longer meets study criteria|3|||
125399319|NCT00207142|451094387|FG001|Induction Phase|Subject no longer meets study criteria|0|||
125399320|NCT00207142|451094388|FG002|Induction Phase|Subject no longer meets study criteria|0|||
125399321|NCT00207142|451094389|FG003|Induction Phase|Subject no longer meets study criteria|0|||
125399322|NCT00207142|451094386|FG000|Induction Phase|Withdrawal by Subject|4|||
125399323|NCT00207142|451094387|FG001|Induction Phase|Withdrawal by Subject|0|||
125447745|NCT04423393|451266770|FG004|Overall Study|Sponsor Decision|0|||
125274085|NCT03599518|450629339|FG002|Overall Study|Clinical progression|0|||
125274086|NCT03599518|450629340|FG003|Overall Study|Clinical progression|0|||
125274087|NCT03599518|450629341|FG004|Overall Study|Clinical progression|1|||
125274088|NCT03599518|450629337|FG000|Overall Study|Adverse Event|0|||
125274089|NCT03599518|450629338|FG001|Overall Study|Adverse Event|0|||
125274090|NCT03599518|450629339|FG002|Overall Study|Adverse Event|0|||
125274091|NCT03599518|450629340|FG003|Overall Study|Adverse Event|0|||
125274092|NCT03599518|450629341|FG004|Overall Study|Adverse Event|1|||
125274093|NCT03599518|450629337|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
125274094|NCT03599518|450629338|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
125274095|NCT03599518|450629339|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
125274096|NCT03599518|450629340|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
125274097|NCT03599518|450629341|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
125274098|NCT03599518|450629337|FG000|Overall Study|Participant withdrawal from study treatment|0|||
125274099|NCT03599518|450629338|FG001|Overall Study|Participant withdrawal from study treatment|0|||
125274100|NCT03599518|450629339|FG002|Overall Study|Participant withdrawal from study treatment|1|||
125274101|NCT03599518|450629340|FG003|Overall Study|Participant withdrawal from study treatment|0|||
125274102|NCT03599518|450629341|FG004|Overall Study|Participant withdrawal from study treatment|0|||
125274103|NCT00429182|450629344|FG000|Overall Study|Not evaluable, Disease Progression|2|||
125274104|NCT00429182|450629344|FG000|Overall Study|Not eligible|5|||
125274105|NCT02311881|450629355|FG000|Overall Study|Did not meet the study criteria|2|||
125274106|NCT02311881|450629356|FG001|Overall Study|Did not meet the study criteria|2|||
125274107|NCT02311881|450629357|FG002|Overall Study|Did not meet the study criteria|0|||
125274108|NCT02311881|450629355|FG000|Overall Study|Adverse Event|7|||
125274109|NCT02311881|450629356|FG001|Overall Study|Adverse Event|15|||
125274110|NCT02311881|450629357|FG002|Overall Study|Adverse Event|8|||
125274111|NCT02311881|450629355|FG000|Overall Study|Lost to Follow-up|3|||
125274112|NCT02311881|450629356|FG001|Overall Study|Lost to Follow-up|3|||
125274113|NCT02311881|450629357|FG002|Overall Study|Lost to Follow-up|2|||
125274114|NCT02311881|450629355|FG000|Overall Study|Protocol Violation|1|||
125274115|NCT02311881|450629356|FG001|Overall Study|Protocol Violation|2|||
125274116|NCT02311881|450629357|FG002|Overall Study|Protocol Violation|3|||
125274117|NCT02311881|450629355|FG000|Overall Study|Withdrawal of consent|14|||
125274118|NCT02311881|450629356|FG001|Overall Study|Withdrawal of consent|16|||
125274119|NCT02311881|450629357|FG002|Overall Study|Withdrawal of consent|17|||
125274120|NCT02311881|450629355|FG000|Overall Study|Other|0|||
125274121|NCT02311881|450629356|FG001|Overall Study|Other|0|||
125274122|NCT02311881|450629357|FG002|Overall Study|Other|1|||
125274123|NCT02311881|450629355|FG000|Overall Study|Lack of Efficacy|1|||
125274124|NCT02311881|450629356|FG001|Overall Study|Lack of Efficacy|2|||
125274125|NCT02311881|450629357|FG002|Overall Study|Lack of Efficacy|0|||
125274126|NCT02311881|450629355|FG000|Overall Study|Subject has border line pregnancy test|1|||
125274127|NCT02311881|450629356|FG001|Overall Study|Subject has border line pregnancy test|0|||
125274128|NCT02311881|450629357|FG002|Overall Study|Subject has border line pregnancy test|0|||
125274129|NCT02311881|450629355|FG000|Overall Study|Withdrawal by Subject|3|||
125274130|NCT02311881|450629356|FG001|Overall Study|Withdrawal by Subject|1|||
125274131|NCT02311881|450629357|FG002|Overall Study|Withdrawal by Subject|4|||
125274132|NCT02311881|450629355|FG000|Overall Study|Sponsor Decision|1|||
125274133|NCT02311881|450629356|FG001|Overall Study|Sponsor Decision|1|||
125274134|NCT02311881|450629357|FG002|Overall Study|Sponsor Decision|1|||
125399324|NCT00207142|451094388|FG002|Induction Phase|Withdrawal by Subject|0|||
125399325|NCT00207142|451094389|FG003|Induction Phase|Withdrawal by Subject|0|||
125447746|NCT04423393|451266771|FG005|Overall Study|Sponsor Decision|0|||
125274135|NCT02311881|450629355|FG000|Overall Study|Protocol Deviation|1|||
125274136|NCT02311881|450629356|FG001|Overall Study|Protocol Deviation|0|||
125274137|NCT02311881|450629357|FG002|Overall Study|Protocol Deviation|0|||
125274138|NCT02311881|450629355|FG000|Overall Study|Non-Compliance|1|||
125274139|NCT02311881|450629356|FG001|Overall Study|Non-Compliance|0|||
125274140|NCT02311881|450629357|FG002|Overall Study|Non-Compliance|2|||
125274141|NCT02311881|450629355|FG000|Overall Study|Physician Decision|0|||
125274142|NCT02311881|450629356|FG001|Overall Study|Physician Decision|0|||
125274143|NCT02311881|450629357|FG002|Overall Study|Physician Decision|1|||
125274144|NCT02311881|450629355|FG000|Overall Study|Medical Monitor Discretion|0|||
125274145|NCT02311881|450629356|FG001|Overall Study|Medical Monitor Discretion|0|||
125274146|NCT02311881|450629357|FG002|Overall Study|Medical Monitor Discretion|1|||
125274147|NCT02311881|450629355|FG000|Overall Study|Participant taking another medication|0|||
125274148|NCT02311881|450629356|FG001|Overall Study|Participant taking another medication|0|||
125274149|NCT02311881|450629357|FG002|Overall Study|Participant taking another medication|1|||
125274150|NCT02311881|450629355|FG000|Overall Study|Serious Adverse Event|0|||
125274151|NCT02311881|450629356|FG001|Overall Study|Serious Adverse Event|1|||
125274152|NCT02311881|450629357|FG002|Overall Study|Serious Adverse Event|0|||
125274153|NCT00819156|450629358|FG000|Overall Study|Adverse Event|1|||
125274154|NCT00819156|450629359|FG001|Overall Study|Adverse Event|4|||
125274155|NCT00819156|450629360|FG002|Overall Study|Adverse Event|2|||
125274156|NCT00819156|450629361|FG003|Overall Study|Adverse Event|1|||
125274157|NCT00819156|450629362|FG004|Overall Study|Adverse Event|2|||
125274158|NCT00819156|450629363|FG005|Overall Study|Adverse Event|3|||
125274159|NCT00819156|450629358|FG000|Overall Study|Withdrawal by Subject|0|||
125274160|NCT00819156|450629359|FG001|Overall Study|Withdrawal by Subject|3|||
125274161|NCT00819156|450629360|FG002|Overall Study|Withdrawal by Subject|2|||
125274162|NCT00819156|450629361|FG003|Overall Study|Withdrawal by Subject|0|||
125274163|NCT00819156|450629362|FG004|Overall Study|Withdrawal by Subject|1|||
125274164|NCT00819156|450629363|FG005|Overall Study|Withdrawal by Subject|0|||
125274165|NCT00819156|450629358|FG000|Overall Study|Protocol Violation|1|||
125274166|NCT00819156|450629359|FG001|Overall Study|Protocol Violation|0|||
125274167|NCT00819156|450629360|FG002|Overall Study|Protocol Violation|1|||
125274168|NCT00819156|450629361|FG003|Overall Study|Protocol Violation|0|||
125274169|NCT00819156|450629362|FG004|Overall Study|Protocol Violation|0|||
125274170|NCT00819156|450629363|FG005|Overall Study|Protocol Violation|1|||
125274171|NCT00819156|450629358|FG000|Overall Study|Lost to Follow-up|0|||
125274172|NCT00819156|450629359|FG001|Overall Study|Lost to Follow-up|1|||
125274173|NCT00819156|450629360|FG002|Overall Study|Lost to Follow-up|0|||
125274174|NCT00819156|450629361|FG003|Overall Study|Lost to Follow-up|0|||
125274175|NCT00819156|450629362|FG004|Overall Study|Lost to Follow-up|0|||
125274176|NCT00819156|450629363|FG005|Overall Study|Lost to Follow-up|2|||
125274177|NCT00819156|450629358|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
125274178|NCT00819156|450629359|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
125274179|NCT00819156|450629360|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
125274180|NCT00819156|450629361|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
125274181|NCT00819156|450629362|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
125274182|NCT00819156|450629363|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
125274183|NCT00819156|450629358|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
125274184|NCT00819156|450629359|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
125274185|NCT00819156|450629360|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
125274186|NCT00819156|450629361|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
125274187|NCT00819156|450629362|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
125274188|NCT00819156|450629363|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
125274189|NCT00819156|450629358|FG000|Overall Study|Prostate-specific antigen progression|0|||
125274190|NCT00819156|450629359|FG001|Overall Study|Prostate-specific antigen progression|0|||
125274191|NCT00819156|450629360|FG002|Overall Study|Prostate-specific antigen progression|0|||
125274192|NCT00819156|450629361|FG003|Overall Study|Prostate-specific antigen progression|0|||
125274193|NCT00819156|450629362|FG004|Overall Study|Prostate-specific antigen progression|1|||
125274194|NCT00819156|450629363|FG005|Overall Study|Prostate-specific antigen progression|0|||
125274195|NCT00790582|450629364|FG000|Overall Study|Death|14|||
125274196|NCT00790582|450629365|FG001|Overall Study|Death|32|||
125274197|NCT00790582|450629364|FG000|Overall Study|Physician Decision|7|||
125274198|NCT00790582|450629365|FG001|Overall Study|Physician Decision|1|||
125447747|NCT04423393|451266772|FG006|Overall Study|Sponsor Decision|0|||
125274199|NCT00790582|450629364|FG000|Overall Study|Lost to Follow-up|3|||
125274200|NCT00790582|450629365|FG001|Overall Study|Lost to Follow-up|3|||
125274201|NCT00790582|450629364|FG000|Overall Study|Withdrawal by Subject|7|||
125274202|NCT00790582|450629365|FG001|Overall Study|Withdrawal by Subject|51|||
125274203|NCT01575808|450629368|FG000|Overall Study|Death|2|||
125274204|NCT01575808|450629369|FG001|Overall Study|Death|0|||
125274205|NCT01575808|450629368|FG000|Overall Study|Withdrawal by Subject|1|||
125274206|NCT01575808|450629369|FG001|Overall Study|Withdrawal by Subject|0|||
125274207|NCT05823974|450631716|FG000|Overall Study|Lost to Follow-up|0|||
125274208|NCT05823974|450631717|FG001|Overall Study|Lost to Follow-up|3|||
125274209|NCT05823974|450631718|FG002|Overall Study|Lost to Follow-up|1|||
125274210|NCT05823974|450631719|FG003|Overall Study|Lost to Follow-up|0|||
125274211|NCT05823974|450631720|FG004|Overall Study|Lost to Follow-up|1|||
125274212|NCT05823974|450631721|FG005|Overall Study|Lost to Follow-up|0|||
125274213|NCT05823974|450631722|FG006|Overall Study|Lost to Follow-up|1|||
125274214|NCT05823974|450631723|FG007|Overall Study|Lost to Follow-up|0|||
125274215|NCT05823974|450631724|FG008|Overall Study|Lost to Follow-up|0|||
125274216|NCT05823974|450631725|FG009|Overall Study|Lost to Follow-up|1|||
125274217|NCT05823974|450631726|FG010|Overall Study|Lost to Follow-up|1|||
125274218|NCT05823974|450631727|FG011|Overall Study|Lost to Follow-up|0|||
125274219|NCT05823974|450631728|FG012|Overall Study|Lost to Follow-up|1|||
125274220|NCT05823974|450631729|FG013|Overall Study|Lost to Follow-up|2|||
125274221|NCT05823974|450631730|FG014|Overall Study|Lost to Follow-up|1|||
125274222|NCT05823974|450631731|FG015|Overall Study|Lost to Follow-up|1|||
125274223|NCT05823974|450631732|FG016|Overall Study|Lost to Follow-up|1|||
125274224|NCT05823974|450631733|FG017|Overall Study|Lost to Follow-up|0|||
125274225|NCT05823974|450631734|FG018|Overall Study|Lost to Follow-up|0|||
125274226|NCT05823974|450631735|FG019|Overall Study|Lost to Follow-up|2|||
125274227|NCT05823974|450631736|FG020|Overall Study|Lost to Follow-up|0|||
125274228|NCT05823974|450631716|FG000|Overall Study|Physician Decision|0|||
125274229|NCT05823974|450631717|FG001|Overall Study|Physician Decision|0|||
125274230|NCT05823974|450631718|FG002|Overall Study|Physician Decision|0|||
125274231|NCT05823974|450631719|FG003|Overall Study|Physician Decision|0|||
125274232|NCT05823974|450631720|FG004|Overall Study|Physician Decision|0|||
125274233|NCT05823974|450631721|FG005|Overall Study|Physician Decision|0|||
125274234|NCT05823974|450631722|FG006|Overall Study|Physician Decision|0|||
125274235|NCT05823974|450631723|FG007|Overall Study|Physician Decision|0|||
125274236|NCT05823974|450631724|FG008|Overall Study|Physician Decision|0|||
125274237|NCT05823974|450631725|FG009|Overall Study|Physician Decision|0|||
125274238|NCT05823974|450631726|FG010|Overall Study|Physician Decision|0|||
125274239|NCT05823974|450631727|FG011|Overall Study|Physician Decision|0|||
125274240|NCT05823974|450631728|FG012|Overall Study|Physician Decision|0|||
125274241|NCT05823974|450631729|FG013|Overall Study|Physician Decision|0|||
125274242|NCT05823974|450631730|FG014|Overall Study|Physician Decision|0|||
125274243|NCT05823974|450631731|FG015|Overall Study|Physician Decision|1|||
125274244|NCT05823974|450631732|FG016|Overall Study|Physician Decision|0|||
125274245|NCT05823974|450631733|FG017|Overall Study|Physician Decision|1|||
125274246|NCT05823974|450631734|FG018|Overall Study|Physician Decision|1|||
125274247|NCT05823974|450631735|FG019|Overall Study|Physician Decision|0|||
125274248|NCT05823974|450631736|FG020|Overall Study|Physician Decision|0|||
125274249|NCT05823974|450631716|FG000|Overall Study|Withdrawal by Subject|1|||
125274250|NCT05823974|450631717|FG001|Overall Study|Withdrawal by Subject|1|||
125274251|NCT05823974|450631718|FG002|Overall Study|Withdrawal by Subject|2|||
125274252|NCT05823974|450631719|FG003|Overall Study|Withdrawal by Subject|0|||
125274253|NCT05823974|450631720|FG004|Overall Study|Withdrawal by Subject|2|||
125274254|NCT05823974|450631721|FG005|Overall Study|Withdrawal by Subject|3|||
125274255|NCT05823974|450631722|FG006|Overall Study|Withdrawal by Subject|1|||
125274256|NCT05823974|450631723|FG007|Overall Study|Withdrawal by Subject|1|||
125274257|NCT05823974|450631724|FG008|Overall Study|Withdrawal by Subject|2|||
125274258|NCT05823974|450631725|FG009|Overall Study|Withdrawal by Subject|1|||
125274259|NCT05823974|450631726|FG010|Overall Study|Withdrawal by Subject|1|||
125274260|NCT05823974|450631727|FG011|Overall Study|Withdrawal by Subject|0|||
125274261|NCT05823974|450631728|FG012|Overall Study|Withdrawal by Subject|0|||
125274262|NCT05823974|450631729|FG013|Overall Study|Withdrawal by Subject|1|||
125274263|NCT05823974|450631730|FG014|Overall Study|Withdrawal by Subject|1|||
125274264|NCT05823974|450631731|FG015|Overall Study|Withdrawal by Subject|3|||
125274265|NCT05823974|450631732|FG016|Overall Study|Withdrawal by Subject|0|||
125274266|NCT05823974|450631733|FG017|Overall Study|Withdrawal by Subject|2|||
125274267|NCT05823974|450631734|FG018|Overall Study|Withdrawal by Subject|2|||
125274268|NCT05823974|450631735|FG019|Overall Study|Withdrawal by Subject|0|||
125274269|NCT05823974|450631736|FG020|Overall Study|Withdrawal by Subject|1|||
125274270|NCT05823974|450631716|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274271|NCT05823974|450631717|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274272|NCT05823974|450631718|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125274273|NCT05823974|450631719|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274274|NCT05823974|450631720|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274275|NCT05823974|450631721|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274276|NCT05823974|450631722|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274277|NCT05823974|450631723|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274278|NCT05823974|450631724|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274279|NCT05823974|450631725|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274280|NCT05823974|450631726|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274281|NCT05823974|450631727|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274282|NCT05823974|450631728|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274283|NCT05823974|450631729|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274284|NCT05823974|450631730|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
125274285|NCT05823974|450631731|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274286|NCT05823974|450631732|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274287|NCT05823974|450631733|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274288|NCT05823974|450631734|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274289|NCT05823974|450631735|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125274290|NCT05823974|450631736|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
125399326|NCT00207142|451094386|FG000|Induction Phase|Incarceration|1|||
125399327|NCT00207142|451094387|FG001|Induction Phase|Incarceration|0|||
125399328|NCT00207142|451094388|FG002|Induction Phase|Incarceration|0|||
125399329|NCT00207142|451094389|FG003|Induction Phase|Incarceration|0|||
125399330|NCT00207142|451094386|FG000|Induction Phase|Missing lab data|1|||
125399331|NCT00207142|451094387|FG001|Induction Phase|Missing lab data|0|||
125399332|NCT00207142|451094388|FG002|Induction Phase|Missing lab data|0|||
125399333|NCT00207142|451094389|FG003|Induction Phase|Missing lab data|0|||
125399334|NCT00207142|451094386|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
125399335|NCT00207142|451094387|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
125399336|NCT00207142|451094388|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
125399337|NCT00207142|451094389|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
125399338|NCT00207142|451094386|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
125399339|NCT00207142|451094387|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
125399340|NCT00207142|451094388|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
125399341|NCT00207142|451094389|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
125399342|NCT00207142|451094386|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
125399343|NCT00207142|451094387|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
125399344|NCT00207142|451094388|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
125399345|NCT00207142|451094389|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
125399346|NCT00207142|451094386|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
125399347|NCT00207142|451094387|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
125399348|NCT00207142|451094388|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
125399349|NCT00207142|451094389|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
125399350|NCT00207142|451094386|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
125399351|NCT00207142|451094387|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
125399352|NCT00207142|451094388|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
125399353|NCT00207142|451094389|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
125399354|NCT00207142|451094386|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
125399355|NCT00207142|451094387|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
125399356|NCT00207142|451094388|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
125399357|NCT00207142|451094389|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
125399358|NCT00207142|451094386|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
125399359|NCT00207142|451094387|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
125399360|NCT00207142|451094388|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
125399361|NCT00207142|451094389|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
125399362|NCT00207142|451094386|FG000|Maintenance Phase/Rescue Phase|Death|0|||
125399363|NCT00207142|451094387|FG001|Maintenance Phase/Rescue Phase|Death|0|||
125399364|NCT00207142|451094388|FG002|Maintenance Phase/Rescue Phase|Death|0|||
125447748|NCT04423393|451266773|FG007|Overall Study|Sponsor Decision|0|||
125447749|NCT04423393|451266774|FG008|Overall Study|Sponsor Decision|0|||
125447750|NCT04423393|451266775|FG009|Overall Study|Sponsor Decision|0|||
125274291|NCT05823974|450631716|FG000|Overall Study|Other|0|||
125274292|NCT05823974|450631717|FG001|Overall Study|Other|1|||
125274293|NCT05823974|450631718|FG002|Overall Study|Other|1|||
125274294|NCT05823974|450631719|FG003|Overall Study|Other|1|||
125274295|NCT05823974|450631720|FG004|Overall Study|Other|0|||
125274296|NCT05823974|450631721|FG005|Overall Study|Other|1|||
125274297|NCT05823974|450631722|FG006|Overall Study|Other|1|||
125274298|NCT05823974|450631723|FG007|Overall Study|Other|1|||
125274299|NCT05823974|450631724|FG008|Overall Study|Other|1|||
125274300|NCT05823974|450631725|FG009|Overall Study|Other|0|||
125274301|NCT05823974|450631726|FG010|Overall Study|Other|0|||
125274302|NCT05823974|450631727|FG011|Overall Study|Other|0|||
125274303|NCT05823974|450631728|FG012|Overall Study|Other|2|||
125274304|NCT05823974|450631729|FG013|Overall Study|Other|1|||
125274305|NCT05823974|450631730|FG014|Overall Study|Other|0|||
125274306|NCT05823974|450631731|FG015|Overall Study|Other|1|||
125274307|NCT05823974|450631732|FG016|Overall Study|Other|0|||
125399365|NCT00207142|451094389|FG003|Maintenance Phase/Rescue Phase|Death|1|||
125447751|NCT04423393|451266776|FG010|Overall Study|Sponsor Decision|0|||
125274308|NCT05823974|450631733|FG017|Overall Study|Other|0|||
125274309|NCT05823974|450631734|FG018|Overall Study|Other|0|||
125274310|NCT05823974|450631735|FG019|Overall Study|Other|0|||
125274311|NCT05823974|450631736|FG020|Overall Study|Other|0|||
125274312|NCT00316706|450631737|FG000|Overall Study|Lost to Follow-up|38|||
125274313|NCT00316706|450631738|FG001|Overall Study|Lost to Follow-up|48|||
125274314|NCT03292874|450631742|FG000|Overall Study|Due to pandemic|5|||
125274315|NCT00485758|450631750|FG000|Overall Study|Adverse Event|102|||
125274316|NCT00485758|450631751|FG001|Overall Study|Adverse Event|31|||
125274317|NCT00485758|450631750|FG000|Overall Study|Death|0|||
125274318|NCT00485758|450631751|FG001|Overall Study|Death|1|||
125274319|NCT00485758|450631750|FG000|Overall Study|Lost to Follow-up|5|||
125274320|NCT00485758|450631751|FG001|Overall Study|Lost to Follow-up|1|||
125274321|NCT00485758|450631750|FG000|Overall Study|Physician Decision|3|||
125274322|NCT00485758|450631751|FG001|Overall Study|Physician Decision|3|||
125274323|NCT00485758|450631750|FG000|Overall Study|Protocol Violation|11|||
125274324|NCT00485758|450631751|FG001|Overall Study|Protocol Violation|2|||
125274325|NCT00485758|450631750|FG000|Overall Study|Withdrawal by Subject|32|||
125274326|NCT00485758|450631751|FG001|Overall Study|Withdrawal by Subject|27|||
125274327|NCT00485758|450631750|FG000|Overall Study|Study Terminated by Sponsor|3|||
125274328|NCT00485758|450631751|FG001|Overall Study|Study Terminated by Sponsor|0|||
125274329|NCT00654745|450631752|FG000|Overall Study|Adverse Event|12|||
125274330|NCT00654745|450631752|FG000|Overall Study|Lost to Follow-up|7|||
125274331|NCT00654745|450631752|FG000|Overall Study|Protocol Violation|11|||
125274332|NCT00654745|450631752|FG000|Overall Study|Withdrawal by Subject|10|||
125274333|NCT00654745|450631752|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
125274334|NCT01995526|450631753|FG000|Overall Study|Physician Decision|1|||
125274335|NCT00383331|450631754|FG000|Overall Study|Protocol Violation|0|||
125274336|NCT00383331|450631755|FG001|Overall Study|Protocol Violation|1|||
125274337|NCT02229825|450631763|FG000|Overall Study|Personal Reasons|0|||
125274338|NCT02229825|450631764|FG001|Overall Study|Personal Reasons|1|||
125274339|NCT02229825|450631763|FG000|Overall Study|Refused continuing medication|7|||
125274340|NCT02229825|450631764|FG001|Overall Study|Refused continuing medication|6|||
125274341|NCT02229825|450631763|FG000|Overall Study|Lost to Follow-up|1|||
125274342|NCT02229825|450631764|FG001|Overall Study|Lost to Follow-up|2|||
125274343|NCT02229825|450631763|FG000|Overall Study|Protocol Violation|1|||
125274344|NCT02229825|450631764|FG001|Overall Study|Protocol Violation|1|||
125274345|NCT02229825|450631763|FG000|Overall Study|Lack of Efficacy|4|||
125274346|NCT02229825|450631764|FG001|Overall Study|Lack of Efficacy|10|||
125274347|NCT02229825|450631763|FG000|Overall Study|Adverse Event|11|||
125274348|NCT02229825|450631764|FG001|Overall Study|Adverse Event|9|||
125274349|NCT02229825|450631763|FG000|Overall Study|Not treated|0|||
125274350|NCT02229825|450631764|FG001|Overall Study|Not treated|1|||
125274351|NCT01532921|450631767|FG000|Overall Study|Death|3|||
125274352|NCT01532921|450631767|FG000|Overall Study|Withdrawal by Subject|2|||
125274353|NCT01532921|450631767|FG000|Overall Study|Lost to Follow-up|3|||
125274354|NCT01532921|450631767|FG000|Overall Study|Physician Decision|7|||
125274355|NCT01532921|450631767|FG000|Overall Study|Device was explanted during procedure|1|||
125274356|NCT00070109|450631768|FG000|Overall Study|Death|1|||
125274357|NCT00070109|450631769|FG001|Overall Study|Death|1|||
125274358|NCT00070109|450631770|FG002|Overall Study|Death|0|||
125274359|NCT00070109|450631771|FG003|Overall Study|Death|0|||
125274360|NCT00070109|450631772|FG004|Overall Study|Death|1|||
125274361|NCT00070109|450631768|FG000|Overall Study|Lack of Efficacy|6|||
125274362|NCT00070109|450631769|FG001|Overall Study|Lack of Efficacy|4|||
125274363|NCT00070109|450631770|FG002|Overall Study|Lack of Efficacy|5|||
125274364|NCT00070109|450631771|FG003|Overall Study|Lack of Efficacy|15|||
125274365|NCT00070109|450631772|FG004|Overall Study|Lack of Efficacy|5|||
125274366|NCT00070109|450631768|FG000|Overall Study|Physician Decision|1|||
125274367|NCT00070109|450631769|FG001|Overall Study|Physician Decision|0|||
125274368|NCT00070109|450631770|FG002|Overall Study|Physician Decision|0|||
125274369|NCT00070109|450631771|FG003|Overall Study|Physician Decision|0|||
125274370|NCT00070109|450631772|FG004|Overall Study|Physician Decision|0|||
125274371|NCT00070109|450631768|FG000|Overall Study|Withdrawal by Subject|0|||
125274372|NCT00070109|450631769|FG001|Overall Study|Withdrawal by Subject|1|||
125274373|NCT00070109|450631770|FG002|Overall Study|Withdrawal by Subject|1|||
125274374|NCT00070109|450631771|FG003|Overall Study|Withdrawal by Subject|0|||
125274375|NCT00070109|450631772|FG004|Overall Study|Withdrawal by Subject|0|||
125274376|NCT00070109|450631768|FG000|Overall Study|Adverse Event|0|||
125399366|NCT00207142|451094386|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
125399367|NCT00207142|451094387|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
125399368|NCT00207142|451094388|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
125274377|NCT00070109|450631769|FG001|Overall Study|Adverse Event|0|||
125274378|NCT00070109|450631770|FG002|Overall Study|Adverse Event|2|||
125274379|NCT00070109|450631771|FG003|Overall Study|Adverse Event|4|||
125274380|NCT00070109|450631772|FG004|Overall Study|Adverse Event|2|||
125274381|NCT00070109|450631768|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
125274382|NCT00070109|450631769|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
125274383|NCT00070109|450631770|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
125274384|NCT00070109|450631771|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
125274385|NCT00070109|450631772|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
125274386|NCT01390298|450631775|FG000|Overall Study|Death|1|||
125274387|NCT01390298|450631775|FG000|Overall Study|long term ICU admission|1|||
125274388|NCT01390298|450631775|FG000|Overall Study|Withdrawal by Subject|14|||
125274389|NCT01390298|450631775|FG000|Overall Study|Lost to Follow-up|7|||
125274390|NCT01390298|450631775|FG000|Overall Study|Surgery cancelled|1|||
125447752|NCT04423393|451266777|FG011|Overall Study|Sponsor Decision|0|||
125274391|NCT00624468|450631779|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
125274392|NCT00624468|450631780|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
125274393|NCT00624468|450631781|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
125274394|NCT00624468|450631782|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
125274395|NCT00624468|450631779|FG000|Double-blind Period|Withdrew Prematurely|1|||
125274396|NCT00624468|450631780|FG001|Double-blind Period|Withdrew Prematurely|1|||
125274397|NCT00624468|450631781|FG002|Double-blind Period|Withdrew Prematurely|0|||
125274398|NCT00624468|450631782|FG003|Double-blind Period|Withdrew Prematurely|0|||
125274399|NCT00624468|450631779|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
125274400|NCT00624468|450631780|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
125274401|NCT00624468|450631781|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
125274402|NCT00624468|450631782|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
125274403|NCT00624468|450631779|FG000|Safety Follow-up (SFU) Period|Other|0|||
125274404|NCT00624468|450631780|FG001|Safety Follow-up (SFU) Period|Other|0|||
125274405|NCT00624468|450631781|FG002|Safety Follow-up (SFU) Period|Other|1|||
125274406|NCT00624468|450631782|FG003|Safety Follow-up (SFU) Period|Other|1|||
125274407|NCT01524224|450631793|FG000|Overall Study|Progressive Disease|1|||
125274408|NCT01524224|450631794|FG001|Overall Study|Progressive Disease|0|||
125274409|NCT01524224|450631795|FG002|Overall Study|Progressive Disease|2|||
125274410|NCT01524224|450631796|FG003|Overall Study|Progressive Disease|1|||
125274411|NCT01524224|450631797|FG004|Overall Study|Progressive Disease|2|||
125274412|NCT01524224|450631798|FG005|Overall Study|Progressive Disease|1|||
125274413|NCT01524224|450631799|FG006|Overall Study|Progressive Disease|1|||
125274414|NCT01524224|450631800|FG007|Overall Study|Progressive Disease|5|||
125274415|NCT01524224|450631793|FG000|Overall Study|Withdrawal by Subject|2|||
125274416|NCT01524224|450631794|FG001|Overall Study|Withdrawal by Subject|0|||
125274417|NCT01524224|450631795|FG002|Overall Study|Withdrawal by Subject|0|||
125274418|NCT01524224|450631796|FG003|Overall Study|Withdrawal by Subject|0|||
125274419|NCT01524224|450631797|FG004|Overall Study|Withdrawal by Subject|0|||
125274420|NCT01524224|450631798|FG005|Overall Study|Withdrawal by Subject|0|||
125274421|NCT01524224|450631799|FG006|Overall Study|Withdrawal by Subject|2|||
125274422|NCT01524224|450631800|FG007|Overall Study|Withdrawal by Subject|0|||
125274423|NCT01524224|450631793|FG000|Overall Study|Adverse Event|0|||
125274424|NCT01524224|450631794|FG001|Overall Study|Adverse Event|1|||
125274425|NCT01524224|450631795|FG002|Overall Study|Adverse Event|0|||
125274426|NCT01524224|450631796|FG003|Overall Study|Adverse Event|0|||
125274427|NCT01524224|450631797|FG004|Overall Study|Adverse Event|0|||
125274428|NCT01524224|450631798|FG005|Overall Study|Adverse Event|1|||
125274429|NCT01524224|450631799|FG006|Overall Study|Adverse Event|0|||
125274430|NCT01524224|450631800|FG007|Overall Study|Adverse Event|0|||
125274431|NCT01524224|450631793|FG000|Overall Study|Physician Decision|0|||
125274432|NCT01524224|450631794|FG001|Overall Study|Physician Decision|0|||
125274433|NCT01524224|450631795|FG002|Overall Study|Physician Decision|0|||
125274434|NCT01524224|450631796|FG003|Overall Study|Physician Decision|1|||
125274435|NCT01524224|450631797|FG004|Overall Study|Physician Decision|1|||
125274436|NCT01524224|450631798|FG005|Overall Study|Physician Decision|0|||
125274437|NCT01524224|450631799|FG006|Overall Study|Physician Decision|0|||
125274438|NCT01524224|450631800|FG007|Overall Study|Physician Decision|1|||
125274439|NCT01524224|450631793|FG000|Overall Study|Sponsor Decision|0|||
125274440|NCT01524224|450631794|FG001|Overall Study|Sponsor Decision|0|||
125274441|NCT01524224|450631795|FG002|Overall Study|Sponsor Decision|0|||
125274442|NCT01524224|450631796|FG003|Overall Study|Sponsor Decision|0|||
125274443|NCT01524224|450631797|FG004|Overall Study|Sponsor Decision|1|||
125274444|NCT01524224|450631798|FG005|Overall Study|Sponsor Decision|0|||
125274445|NCT01524224|450631799|FG006|Overall Study|Sponsor Decision|0|||
125274446|NCT01524224|450631800|FG007|Overall Study|Sponsor Decision|0|||
125274447|NCT00803361|450631802|FG000|Overall Study|Adverse Event|13|||
125274448|NCT00803361|450631803|FG001|Overall Study|Adverse Event|3|||
125274449|NCT00803361|450631802|FG000|Overall Study|Lack of Efficacy|4|||
125274450|NCT00803361|450631803|FG001|Overall Study|Lack of Efficacy|13|||
125274451|NCT00803361|450631802|FG000|Overall Study|Lost to Follow-up|1|||
125274452|NCT00803361|450631803|FG001|Overall Study|Lost to Follow-up|2|||
125274453|NCT00803361|450631802|FG000|Overall Study|Physician Decision|1|||
125274454|NCT00803361|450631803|FG001|Overall Study|Physician Decision|0|||
125274455|NCT00803361|450631802|FG000|Overall Study|Protocol Violation|2|||
125274456|NCT00803361|450631803|FG001|Overall Study|Protocol Violation|4|||
125274457|NCT00803361|450631802|FG000|Overall Study|Withdrawal by Subject|5|||
125274458|NCT00803361|450631803|FG001|Overall Study|Withdrawal by Subject|6|||
125274459|NCT02858440|450631804|FG000|Overall Study|Lost to Follow-up|3|||
125274460|NCT02858440|450631804|FG000|Overall Study|Protocol Violation|2|||
125274461|NCT02858440|450631804|FG000|Overall Study|Consent withdrawal|3|||
125274462|NCT02858440|450631804|FG000|Overall Study|Migrated/moved from study area|4|||
125274463|NCT01670279|450631805|FG000|Overall Study|Adverse Event|0|||
125274464|NCT01670279|450631806|FG001|Overall Study|Adverse Event|1|||
125274465|NCT01670279|450631807|FG002|Overall Study|Adverse Event|0|||
125274466|NCT01670279|450631808|FG003|Overall Study|Adverse Event|0|||
125274467|NCT01670279|450631805|FG000|Overall Study|Physician Decision|0|||
125274468|NCT01670279|450631806|FG001|Overall Study|Physician Decision|1|||
125274469|NCT01670279|450631807|FG002|Overall Study|Physician Decision|0|||
125274470|NCT01670279|450631808|FG003|Overall Study|Physician Decision|0|||
125274471|NCT01670279|450631805|FG000|Overall Study|Participant met withdrawal criteria|0|||
125274472|NCT01670279|450631806|FG001|Overall Study|Participant met withdrawal criteria|0|||
125274473|NCT01670279|450631807|FG002|Overall Study|Participant met withdrawal criteria|0|||
125274474|NCT01670279|450631808|FG003|Overall Study|Participant met withdrawal criteria|1|||
125274475|NCT01901614|450631809|FG000|Overall Study|Adverse Event|0|||
125274476|NCT01901614|450631810|FG001|Overall Study|Adverse Event|1|||
125274477|NCT01901614|450631809|FG000|Overall Study|Lost to Follow-up|1|||
125274478|NCT01901614|450631810|FG001|Overall Study|Lost to Follow-up|0|||
125274479|NCT01901614|450631809|FG000|Overall Study|Screen Fail|1|||
125274480|NCT01901614|450631810|FG001|Overall Study|Screen Fail|0|||
125274481|NCT01823198|450631811|FG000|Overall Study|Physician Decision|0|||
125274482|NCT01823198|450631812|FG001|Overall Study|Physician Decision|1|||
125274483|NCT01823198|450631813|FG002|Overall Study|Physician Decision|0|||
125274484|NCT01823198|450631814|FG003|Overall Study|Physician Decision|0|||
125274485|NCT01823198|450631815|FG004|Overall Study|Physician Decision|0|||
125274486|NCT01823198|450631816|FG005|Overall Study|Physician Decision|3|||
125274487|NCT01823198|450631817|FG006|Overall Study|Physician Decision|3|||
125274488|NCT02674464|450631818|FG000|Overall Study|Death|10|||
125274489|NCT02674464|450631819|FG001|Overall Study|Death|21|||
125274490|NCT02674464|450631818|FG000|Overall Study|Withdrawal by Subject|24|||
125274491|NCT02674464|450631819|FG001|Overall Study|Withdrawal by Subject|44|||
125274492|NCT02674464|450631818|FG000|Overall Study|Lost to Follow-up|97|||
125274493|NCT02674464|450631819|FG001|Overall Study|Lost to Follow-up|92|||
125274494|NCT02674464|450631818|FG000|Overall Study|Outside survey window|6|||
125274495|NCT02674464|450631819|FG001|Overall Study|Outside survey window|3|||
125274496|NCT00783835|450631820|FG000|Overall Study|Adverse Event|3|||
125274497|NCT00783835|450631820|FG000|Overall Study|Medical Criteria|1|||
125274498|NCT00783835|450631820|FG000|Overall Study|Withdrawal by Subject|2|||
125274499|NCT00783835|450631820|FG000|Overall Study|Lost to Follow-up|1|||
125274500|NCT00783835|450631820|FG000|Overall Study|Participant not Adherent|3|||
125274501|NCT01262638|450631821|FG000|Overall Study|Adverse Event|3|||
125274502|NCT01262638|450631822|FG001|Overall Study|Adverse Event|4|||
125274503|NCT01262638|450631823|FG002|Overall Study|Adverse Event|3|||
125274504|NCT01262638|450631824|FG003|Overall Study|Adverse Event|4|||
125274505|NCT01262638|450631821|FG000|Overall Study|Protocol Violation|1|||
125274506|NCT01262638|450631822|FG001|Overall Study|Protocol Violation|0|||
125274507|NCT01262638|450631823|FG002|Overall Study|Protocol Violation|0|||
125274508|NCT01262638|450631824|FG003|Overall Study|Protocol Violation|1|||
125274509|NCT01262638|450631821|FG000|Overall Study|Withdrawal by Subject|2|||
125274510|NCT01262638|450631822|FG001|Overall Study|Withdrawal by Subject|1|||
125274511|NCT01262638|450631823|FG002|Overall Study|Withdrawal by Subject|0|||
125274512|NCT01262638|450631824|FG003|Overall Study|Withdrawal by Subject|1|||
125274513|NCT01262638|450631821|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
125274514|NCT01262638|450631822|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
125274515|NCT01262638|450631823|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
125274516|NCT01262638|450631824|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
125274517|NCT01262638|450631821|FG000|Overall Study|Lost to Follow-up|1|||
125274518|NCT01262638|450631822|FG001|Overall Study|Lost to Follow-up|1|||
125274519|NCT01262638|450631823|FG002|Overall Study|Lost to Follow-up|1|||
125274520|NCT01262638|450631824|FG003|Overall Study|Lost to Follow-up|1|||
125274521|NCT01262638|450631821|FG000|Overall Study|Participant Went Out of Town|0|||
125274522|NCT01262638|450631822|FG001|Overall Study|Participant Went Out of Town|0|||
125274523|NCT01262638|450631823|FG002|Overall Study|Participant Went Out of Town|1|||
125274524|NCT01262638|450631824|FG003|Overall Study|Participant Went Out of Town|0|||
125274525|NCT02243371|450631829|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
125274526|NCT02243371|450631830|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
125274527|NCT02243371|450631829|FG000|Overall Study|Death (unrelated)|2|||
125274528|NCT02243371|450631830|FG001|Overall Study|Death (unrelated)|4|||
125274529|NCT02243371|450631829|FG000|Overall Study|Adverse Event (unrelated)|0|||
125274530|NCT02243371|450631830|FG001|Overall Study|Adverse Event (unrelated)|1|||
125274531|NCT02243371|450631829|FG000|Overall Study|Lack of Clinical Benefit|0|||
125274532|NCT02243371|450631830|FG001|Overall Study|Lack of Clinical Benefit|1|||
125274533|NCT02243371|450631829|FG000|Overall Study|Withdrawal by Subject|0|||
125274534|NCT02243371|450631830|FG001|Overall Study|Withdrawal by Subject|2|||
125274535|NCT01369199|450631831|FG000|Overall Study|Withdrawal by Subject|1|||
125274536|NCT01369199|450631831|FG000|Overall Study|Lost to Follow-up|2|||
125274537|NCT01066104|450631832|FG000|Overall Study|Adverse Event|1|||
125274538|NCT01066104|450631833|FG001|Overall Study|Adverse Event|1|||
125274539|NCT01066104|450631832|FG000|Overall Study|Protocol Violation|1|||
125274540|NCT01066104|450631833|FG001|Overall Study|Protocol Violation|0|||
125274541|NCT02091362|450631841|FG000|Period 1|Protocol Violation|1|||
125274542|NCT02091362|450631842|FG001|Period 1|Protocol Violation|0|||
125274543|NCT02091362|450631841|FG000|Period 1|Withdrawal by Subject|2|||
125399369|NCT00207142|451094389|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
125274544|NCT02091362|450631842|FG001|Period 1|Withdrawal by Subject|3|||
125399370|NCT05091528|451094390|FG000|Overall Study|Study Termination by Sponsor|0|||
125274545|NCT02091362|450631841|FG000|Period 1|Lost to Follow-up|0|||
125274546|NCT02091362|450631842|FG001|Period 1|Lost to Follow-up|1|||
125274547|NCT02091362|450631841|FG000|Period 1|Adverse Event|2|||
125274548|NCT02091362|450631842|FG001|Period 1|Adverse Event|0|||
125274549|NCT02091362|450631841|FG000|Wash-out|Lost to Follow-up|1|||
125274550|NCT02091362|450631842|FG001|Wash-out|Lost to Follow-up|1|||
125274551|NCT02091362|450631841|FG000|Wash-out|Withdrawal by Subject|0|||
125274552|NCT02091362|450631842|FG001|Wash-out|Withdrawal by Subject|2|||
125274553|NCT02091362|450631841|FG000|Period 2|Adverse Event|1|||
125274554|NCT02091362|450631842|FG001|Period 2|Adverse Event|0|||
125274555|NCT02091362|450631841|FG000|Period 2|Lost to Follow-up|0|||
125274556|NCT02091362|450631842|FG001|Period 2|Lost to Follow-up|1|||
125274557|NCT02091362|450631841|FG000|Period 2|Withdrawal by Subject|1|||
125274558|NCT02091362|450631842|FG001|Period 2|Withdrawal by Subject|1|||
125274559|NCT00470262|450631843|FG000|Overall Study|Withdrawal by Subject|2|||
125274560|NCT00470262|450631844|FG001|Overall Study|Withdrawal by Subject|0|||
125274561|NCT03900728|450631845|FG000|Overall Study|No text responses|0|||
125274562|NCT03900728|450631846|FG001|Overall Study|No text responses|0|||
125274563|NCT03900728|450631847|FG002|Overall Study|No text responses|4|||
125274564|NCT03248167|450631858|FG000|Overall Study|Withdrawal by Subject|2|||
125274565|NCT03248167|450631859|FG001|Overall Study|Withdrawal by Subject|2|||
125274566|NCT03248167|450631858|FG000|Overall Study|Physician Decision|0|||
125274567|NCT03248167|450631859|FG001|Overall Study|Physician Decision|1|||
125274568|NCT03248167|450631858|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
125274569|NCT03248167|450631859|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
125274570|NCT03248167|450631858|FG000|Overall Study|Lost to Follow-up|1|||
125274571|NCT03248167|450631859|FG001|Overall Study|Lost to Follow-up|0|||
125274572|NCT02122146|450631860|FG000|Part 1: Dose Escalation|Death|0|||
125274573|NCT02122146|450631861|FG001|Part 1: Dose Escalation|Death|1|||
125274574|NCT02122146|450631862|FG002|Part 1: Dose Escalation|Death|1|||
125274575|NCT02122146|450631863|FG003|Part 1: Dose Escalation|Death|0|||
125274576|NCT02122146|450631864|FG004|Part 1: Dose Escalation|Death|0|||
125274577|NCT02122146|450631865|FG005|Part 1: Dose Escalation|Death|0|||
125274578|NCT02122146|450631866|FG006|Part 1: Dose Escalation|Death|0|||
125274579|NCT02122146|450631867|FG007|Part 1: Dose Escalation|Death|0|||
125274580|NCT02122146|450631860|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
125274581|NCT02122146|450631861|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
125274582|NCT02122146|450631862|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
125274583|NCT02122146|450631863|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
125274584|NCT02122146|450631864|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
125274585|NCT02122146|450631865|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
125274586|NCT02122146|450631866|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
125274587|NCT02122146|450631867|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
125274588|NCT02122146|450631860|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274589|NCT02122146|450631861|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274590|NCT02122146|450631862|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274591|NCT02122146|450631863|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
125274592|NCT02122146|450631864|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274593|NCT02122146|450631865|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274594|NCT02122146|450631866|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274595|NCT02122146|450631867|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125274596|NCT02122146|450631860|FG000|Part 1: Dose Escalation|Other|1|||
125274597|NCT02122146|450631861|FG001|Part 1: Dose Escalation|Other|0|||
125274598|NCT02122146|450631862|FG002|Part 1: Dose Escalation|Other|0|||
125274599|NCT02122146|450631863|FG003|Part 1: Dose Escalation|Other|0|||
125274600|NCT02122146|450631864|FG004|Part 1: Dose Escalation|Other|0|||
125399371|NCT05091528|451094391|FG001|Overall Study|Study Termination by Sponsor|1|||
125399372|NCT05091528|451094392|FG002|Overall Study|Study Termination by Sponsor|0|||
125399373|NCT05091528|451094393|FG003|Overall Study|Study Termination by Sponsor|1|||
125274601|NCT02122146|450631865|FG005|Part 1: Dose Escalation|Other|1|||
125274602|NCT02122146|450631866|FG006|Part 1: Dose Escalation|Other|1|||
125274603|NCT02122146|450631867|FG007|Part 1: Dose Escalation|Other|2|||
125274604|NCT03835481|450631868|FG000|Double-blind Period|Other not stated below|0|||
125399374|NCT04958109|451094394|FG000|Overall Study|Withdrawal by Subject|0|||
125399375|NCT04958109|451094395|FG001|Overall Study|Withdrawal by Subject|1|||
125399376|NCT04958109|451094394|FG000|Overall Study|Lost to Follow-up|0|||
125274605|NCT03835481|450631869|FG001|Double-blind Period|Other not stated below|0|||
125274606|NCT03835481|450631870|FG002|Double-blind Period|Other not stated below|0|||
125274607|NCT03835481|450631871|FG003|Double-blind Period|Other not stated below|1|||
125274608|NCT03835481|450631872|FG004|Double-blind Period|Other not stated below|1|||
125399377|NCT04958109|451094395|FG001|Overall Study|Lost to Follow-up|1|||
125399378|NCT01573624|451094398|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
125274609|NCT03835481|450631868|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
125274610|NCT03835481|450631869|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
125399379|NCT01573624|451094399|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
125399380|NCT01573624|451094400|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
125399381|NCT01573624|451094401|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
125399382|NCT01573624|451094402|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
125399383|NCT01573624|451094403|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
125399384|NCT01573624|451094404|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
125399385|NCT01573624|451094398|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
125399386|NCT01573624|451094399|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
125399387|NCT01573624|451094400|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
125399388|NCT01573624|451094401|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
125399389|NCT01573624|451094402|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
125399390|NCT01573624|451094403|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
125399391|NCT01573624|451094404|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
125399392|NCT01573624|451094398|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
125399393|NCT01573624|451094399|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
125399394|NCT01573624|451094400|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
125399395|NCT01573624|451094401|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
125399396|NCT01573624|451094402|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
125399397|NCT01573624|451094403|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
125399398|NCT01573624|451094404|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
125399399|NCT01573624|451094398|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125399400|NCT01573624|451094399|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125399401|NCT01573624|451094400|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125399402|NCT01573624|451094401|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125399403|NCT01573624|451094402|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125399404|NCT01573624|451094403|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
125399405|NCT01573624|451094404|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125399406|NCT01573624|451094398|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
125399407|NCT01573624|451094399|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
125399408|NCT01573624|451094400|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
125399409|NCT01573624|451094401|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
125399410|NCT01573624|451094402|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
125399411|NCT01573624|451094403|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
125399412|NCT01573624|451094404|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
125399413|NCT01573624|451094398|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
125399414|NCT01573624|451094399|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
125399415|NCT01573624|451094400|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
125399416|NCT01573624|451094401|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
125399417|NCT01573624|451094402|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
125399418|NCT01573624|451094403|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
125399419|NCT01573624|451094404|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
125399420|NCT01573624|451094398|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
125399421|NCT01573624|451094399|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
125399422|NCT01573624|451094400|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
125399423|NCT01573624|451094401|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
125399424|NCT01573624|451094402|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
125399425|NCT01573624|451094403|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
125399426|NCT01573624|451094404|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
125399427|NCT01573624|451094398|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
125447753|NCT04423393|451266778|FG012|Overall Study|Sponsor Decision|0|||
125447754|NCT04423393|451266779|FG013|Overall Study|Sponsor Decision|1|||
125274611|NCT03835481|450631870|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
125274612|NCT03835481|450631871|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
125274613|NCT03835481|450631872|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
125274614|NCT03835481|450631868|FG000|Double-blind Period|Withdrawal by Subject|0|||
125274615|NCT03835481|450631869|FG001|Double-blind Period|Withdrawal by Subject|0|||
125274616|NCT03835481|450631870|FG002|Double-blind Period|Withdrawal by Subject|1|||
125274617|NCT03835481|450631871|FG003|Double-blind Period|Withdrawal by Subject|0|||
125274618|NCT03835481|450631872|FG004|Double-blind Period|Withdrawal by Subject|5|||
125274619|NCT03835481|450631868|FG000|Double-blind Period|Lost to Follow-up|0|||
125274620|NCT03835481|450631869|FG001|Double-blind Period|Lost to Follow-up|0|||
125274621|NCT03835481|450631870|FG002|Double-blind Period|Lost to Follow-up|0|||
125274622|NCT03835481|450631871|FG003|Double-blind Period|Lost to Follow-up|1|||
125274623|NCT03835481|450631872|FG004|Double-blind Period|Lost to Follow-up|0|||
125274624|NCT03835481|450631868|FG000|Double-blind Period|Protocol Violation|0|||
125447755|NCT04423393|451266780|FG014|Overall Study|Sponsor Decision|0|||
125274625|NCT03835481|450631869|FG001|Double-blind Period|Protocol Violation|2|||
125274626|NCT03835481|450631870|FG002|Double-blind Period|Protocol Violation|0|||
125274627|NCT03835481|450631871|FG003|Double-blind Period|Protocol Violation|1|||
125274628|NCT03835481|450631872|FG004|Double-blind Period|Protocol Violation|0|||
125274629|NCT03835481|450631868|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
125274630|NCT03835481|450631869|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
125274631|NCT03835481|450631870|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
125274632|NCT03835481|450631871|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
125274633|NCT03835481|450631872|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
125274634|NCT03835481|450631868|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
125274635|NCT03835481|450631869|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
125274636|NCT03835481|450631870|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
125274637|NCT03835481|450631871|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
125274638|NCT03835481|450631872|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
125274639|NCT03835481|450631868|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
125274640|NCT03835481|450631869|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
125274641|NCT03835481|450631870|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
125274642|NCT03835481|450631871|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
125274643|NCT03835481|450631872|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
125274644|NCT03835481|450631868|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
125274645|NCT03835481|450631869|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
125274646|NCT03835481|450631870|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
125274647|NCT03835481|450631871|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
125274648|NCT03835481|450631872|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
125274649|NCT03835481|450631868|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
125274650|NCT03835481|450631869|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
125274651|NCT03835481|450631870|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
125274652|NCT03835481|450631871|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
125274653|NCT03835481|450631872|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
125274654|NCT03835481|450631868|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
125274655|NCT03835481|450631869|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
125274656|NCT03835481|450631870|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
125274657|NCT03835481|450631871|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
125274658|NCT03835481|450631872|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
125274659|NCT00191945|450631874|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
125274660|NCT00191945|450631875|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
125274661|NCT00191945|450631874|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
125274662|NCT00191945|450631875|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
125274663|NCT00191945|450631874|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
125274664|NCT00191945|450631875|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
125274665|NCT00191945|450631874|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
125274666|NCT00191945|450631875|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
125274667|NCT02725476|450631876|FG000|Overall Study|Physician Decision|2|||
125274668|NCT02725476|450631877|FG001|Overall Study|Physician Decision|0|||
125274669|NCT02725476|450631876|FG000|Overall Study|Adverse Event|1|||
125274670|NCT02725476|450631877|FG001|Overall Study|Adverse Event|1|||
125274671|NCT04188834|450631888|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
125274672|NCT01030952|450631889|FG000|Overall Study|Protocol Violation|0|||
125274673|NCT01030952|450631890|FG001|Overall Study|Protocol Violation|1|||
125274674|NCT01030952|450631889|FG000|Overall Study|Informed consent withdrawal|1|||
125274675|NCT01030952|450631890|FG001|Overall Study|Informed consent withdrawal|0|||
125274676|NCT01030952|450631889|FG000|Overall Study|Lost to Follow-up|0|||
125274677|NCT01030952|450631890|FG001|Overall Study|Lost to Follow-up|1|||
125274678|NCT01030952|450631889|FG000|Overall Study|Unexplained|1|||
125274679|NCT01030952|450631890|FG001|Overall Study|Unexplained|1|||
125274680|NCT00391430|450631891|FG000|Overall Study|Withdrawal by Subject|3|||
125274681|NCT00391430|450631892|FG001|Overall Study|Withdrawal by Subject|0|||
125274682|NCT00391430|450631893|FG002|Overall Study|Withdrawal by Subject|12|||
125274683|NCT02470585|450631902|FG000|Overall Study|Death|224|||
125274684|NCT02470585|450631903|FG001|Overall Study|Death|227|||
125274685|NCT02470585|450631904|FG002|Overall Study|Death|199|||
125274686|NCT02470585|450631902|FG000|Overall Study|Withdrew consent|21|||
125274687|NCT02470585|450631903|FG001|Overall Study|Withdrew consent|22|||
125274688|NCT02470585|450631904|FG002|Overall Study|Withdrew consent|31|||
125274689|NCT02470585|450631902|FG000|Overall Study|Lost to Follow-up|8|||
125274690|NCT02470585|450631903|FG001|Overall Study|Lost to Follow-up|15|||
125274691|NCT02470585|450631904|FG002|Overall Study|Lost to Follow-up|13|||
125274692|NCT02470585|450631902|FG000|Overall Study|Sponsor discontinued study|117|||
125274693|NCT02470585|450631903|FG001|Overall Study|Sponsor discontinued study|110|||
125274694|NCT02470585|450631904|FG002|Overall Study|Sponsor discontinued study|122|||
125399428|NCT01573624|451094399|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125399429|NCT01573624|451094400|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
125399430|NCT01573624|451094401|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
125399431|NCT01573624|451094402|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125399432|NCT01573624|451094403|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125399433|NCT01573624|451094404|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
125399434|NCT01573624|451094398|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
125447756|NCT04423393|451266781|FG015|Overall Study|Sponsor Decision|0|||
125447757|NCT04423393|451266782|FG016|Overall Study|Sponsor Decision|0|||
125447758|NCT04423393|451266783|FG017|Overall Study|Sponsor Decision|0|||
125447759|NCT00432159|451266792|FG000|Overall Study|Death|0|||
125447760|NCT00432159|451266793|FG001|Overall Study|Death|1|||
125447761|NCT00432159|451266794|FG002|Overall Study|Death|0|||
125447762|NCT00432159|451266795|FG003|Overall Study|Death|0|||
125447763|NCT00432159|451266796|FG004|Overall Study|Death|0|||
125447764|NCT00432159|451266792|FG000|Overall Study|Failure|9|||
125447765|NCT00432159|451266793|FG001|Overall Study|Failure|5|||
125447766|NCT00432159|451266794|FG002|Overall Study|Failure|3|||
125447767|NCT00432159|451266795|FG003|Overall Study|Failure|2|||
125447768|NCT00432159|451266796|FG004|Overall Study|Failure|3|||
125274695|NCT02470585|450631902|FG000|Overall Study|Other, not specified|5|||
125274696|NCT02470585|450631903|FG001|Overall Study|Other, not specified|7|||
125274697|NCT02470585|450631904|FG002|Overall Study|Other, not specified|14|||
125274698|NCT02470585|450631902|FG000|Overall Study|Missing due to site non-compliance|0|||
125274699|NCT02470585|450631903|FG001|Overall Study|Missing due to site non-compliance|2|||
125274700|NCT02470585|450631904|FG002|Overall Study|Missing due to site non-compliance|3|||
125274701|NCT03497039|450631905|FG000|Overall Study|Withdrawal by Subject|1|||
125274702|NCT03497039|450631906|FG001|Overall Study|Withdrawal by Subject|0|||
125274703|NCT03497039|450631905|FG000|Overall Study|Protocol Violation|0|||
125274704|NCT03497039|450631906|FG001|Overall Study|Protocol Violation|1|||
125274705|NCT00465972|450631909|FG000|Overall Study|Withdrawal by Subject|2|||
125274706|NCT00465972|450631910|FG001|Overall Study|Withdrawal by Subject|1|||
125274707|NCT03292640|450631911|FG000|Overall Study|Withdrawal by Subject|17|||
125274708|NCT03292640|450631912|FG001|Overall Study|Withdrawal by Subject|16|||
125274709|NCT03292640|450631911|FG000|Overall Study|Adverse Event|20|||
125274710|NCT03292640|450631912|FG001|Overall Study|Adverse Event|2|||
125274711|NCT03292640|450631911|FG000|Overall Study|Lost to Follow-up|24|||
125274712|NCT03292640|450631912|FG001|Overall Study|Lost to Follow-up|24|||
125274713|NCT02218697|450631913|FG000|Overall Study|Adverse Event|0|||
125274714|NCT02218697|450631914|FG001|Overall Study|Adverse Event|2|||
125274715|NCT02218697|450631913|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
125274716|NCT02218697|450631914|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
125274717|NCT02218697|450631913|FG000|Overall Study|Withdrawal by Subject|2|||
125274718|NCT02218697|450631914|FG001|Overall Study|Withdrawal by Subject|3|||
125274719|NCT03306433|450631917|FG000|Overall Study|Lost to Follow-up|3|||
125274720|NCT03306433|450631917|FG000|Overall Study|Patient did not have teeth extracted|1|||
125274721|NCT03306433|450631917|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
125274722|NCT00294671|450633411|FG000|Overall Study|Lack of Efficacy|11|||
125274723|NCT00294671|450633412|FG001|Overall Study|Lack of Efficacy|23|||
125274724|NCT00294671|450633411|FG000|Overall Study|Liver transplant|7|||
125274725|NCT00294671|450633412|FG001|Overall Study|Liver transplant|9|||
125274726|NCT00294671|450633411|FG000|Overall Study|Drug related adverse event (AE)|4|||
125274727|NCT00294671|450633412|FG001|Overall Study|Drug related adverse event (AE)|2|||
125274728|NCT00294671|450633411|FG000|Overall Study|Non-drug related AE|3|||
125274729|NCT00294671|450633412|FG001|Overall Study|Non-drug related AE|2|||
125274730|NCT00294671|450633411|FG000|Overall Study|Lost to Follow-up|1|||
125274731|NCT00294671|450633412|FG001|Overall Study|Lost to Follow-up|3|||
125274732|NCT00294671|450633411|FG000|Overall Study|Non-compliance|1|||
125274733|NCT00294671|450633412|FG001|Overall Study|Non-compliance|0|||
125447769|NCT00432159|451266792|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
125447770|NCT00432159|451266793|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
125274734|NCT00294671|450633411|FG000|Overall Study|Death|0|||
125447771|NCT00432159|451266794|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
125399435|NCT01573624|451094399|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
125399436|NCT01573624|451094400|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
125447772|NCT00432159|451266795|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
125447773|NCT00432159|451266796|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
125447774|NCT01021878|451266803|FG000|Overall Study|Lost to Follow-up|4|||
125447775|NCT01021878|451266804|FG001|Overall Study|Lost to Follow-up|3|||
125274735|NCT00294671|450633412|FG001|Overall Study|Death|1|||
125274736|NCT01893411|450633416|FG000|Overall Study|Protocol Violation|1|||
125274737|NCT01893411|450633417|FG001|Overall Study|Protocol Violation|0|||
125274738|NCT01893411|450633418|FG002|Overall Study|Protocol Violation|0|||
125274739|NCT01893411|450633416|FG000|Overall Study|Physician Decision|1|||
125274740|NCT01893411|450633417|FG001|Overall Study|Physician Decision|1|||
125274741|NCT01893411|450633418|FG002|Overall Study|Physician Decision|2|||
125274742|NCT01893411|450633416|FG000|Overall Study|Lack of Efficacy|2|||
125274743|NCT01893411|450633417|FG001|Overall Study|Lack of Efficacy|1|||
125274744|NCT01893411|450633418|FG002|Overall Study|Lack of Efficacy|0|||
125274745|NCT01893411|450633416|FG000|Overall Study|Other|3|||
125274746|NCT01893411|450633417|FG001|Overall Study|Other|1|||
125274747|NCT01893411|450633418|FG002|Overall Study|Other|3|||
125274748|NCT01893411|450633416|FG000|Overall Study|Adverse Event|1|||
125274749|NCT01893411|450633417|FG001|Overall Study|Adverse Event|0|||
125274750|NCT01893411|450633418|FG002|Overall Study|Adverse Event|0|||
125274751|NCT01893411|450633416|FG000|Overall Study|Withdrawal by Subject|7|||
125274752|NCT01893411|450633417|FG001|Overall Study|Withdrawal by Subject|4|||
125274753|NCT01893411|450633418|FG002|Overall Study|Withdrawal by Subject|3|||
125274754|NCT01893411|450633416|FG000|Overall Study|Lost to Follow-up|2|||
125274755|NCT01893411|450633417|FG001|Overall Study|Lost to Follow-up|0|||
125274756|NCT01893411|450633418|FG002|Overall Study|Lost to Follow-up|1|||
125274757|NCT02403817|450633421|FG000|Overall Study|Withdrawal by Subject|5|||
125274758|NCT02403817|450633422|FG001|Overall Study|Withdrawal by Subject|0|||
125274759|NCT03053440|450633423|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
125274760|NCT03053440|450633424|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
125274761|NCT03053440|450633423|FG000|Overall Study|Death|18|||
125274762|NCT03053440|450633424|FG001|Overall Study|Death|14|||
125274763|NCT03053440|450633423|FG000|Overall Study|Withdrawal by Subject|9|||
125274764|NCT03053440|450633424|FG001|Overall Study|Withdrawal by Subject|8|||
125274765|NCT03053440|450633423|FG000|Overall Study|Lost to Follow-up|1|||
125274766|NCT03053440|450633424|FG001|Overall Study|Lost to Follow-up|0|||
125274767|NCT03053440|450633423|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
125274768|NCT03053440|450633424|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
125274769|NCT03053440|450633423|FG000|Overall Study|Physician Decision|2|||
125274770|NCT03053440|450633424|FG001|Overall Study|Physician Decision|1|||
125274771|NCT03053440|450633423|FG000|Overall Study|Participant Randomized but died before dosing|1|||
125274772|NCT03053440|450633424|FG001|Overall Study|Participant Randomized but died before dosing|0|||
125274773|NCT00430989|450633425|FG000|Overall Study|Lost to Follow-up|2|||
125274774|NCT00430989|450633426|FG001|Overall Study|Lost to Follow-up|3|||
125274775|NCT00430989|450633425|FG000|Overall Study|Withdrawal by Subject|15|||
125274776|NCT00430989|450633426|FG001|Overall Study|Withdrawal by Subject|14|||
125274777|NCT00430989|450633425|FG000|Overall Study|Protocol Violation|30|||
125274778|NCT00430989|450633426|FG001|Overall Study|Protocol Violation|37|||
125274779|NCT00430989|450633425|FG000|Overall Study|Not eligible|13|||
125274780|NCT00430989|450633426|FG001|Overall Study|Not eligible|6|||
125274781|NCT01701362|450633427|FG000|Overall Study|Adverse events not related to study drug|1|||
125274782|NCT01701362|450633428|FG001|Overall Study|Adverse events not related to study drug|6|||
125274783|NCT01701362|450633427|FG000|Overall Study|Adverse events related to study drug|12|||
125274784|NCT01701362|450633428|FG001|Overall Study|Adverse events related to study drug|10|||
125274785|NCT01701362|450633427|FG000|Overall Study|Protocol Violation|5|||
125274786|NCT01701362|450633428|FG001|Overall Study|Protocol Violation|3|||
125274787|NCT01701362|450633427|FG000|Overall Study|No longer willing to participate|8|||
125274788|NCT01701362|450633428|FG001|Overall Study|No longer willing to participate|14|||
125274789|NCT01701362|450633427|FG000|Overall Study|Lost to Follow-up|6|||
125274790|NCT01701362|450633428|FG001|Overall Study|Lost to Follow-up|9|||
125274791|NCT01701362|450633427|FG000|Overall Study|Insufficient clinical response|6|||
125274792|NCT01701362|450633428|FG001|Overall Study|Insufficient clinical response|6|||
125274793|NCT01701362|450633427|FG000|Overall Study|Death|0|||
125274794|NCT01701362|450633428|FG001|Overall Study|Death|1|||
125274795|NCT01701362|450633427|FG000|Overall Study|Randomized but not treated|1|||
125274796|NCT01701362|450633428|FG001|Overall Study|Randomized but not treated|2|||
125274797|NCT01701362|450633427|FG000|Overall Study|Reasons other than those mentioned above|3|||
125274798|NCT01701362|450633428|FG001|Overall Study|Reasons other than those mentioned above|5|||
125274799|NCT00570778|450633429|FG000|Overall Study|Protocol deviation|2|||
125274800|NCT00570778|450633430|FG001|Overall Study|Protocol deviation|1|||
125274801|NCT00570778|450633431|FG002|Overall Study|Protocol deviation|2|||
125274802|NCT00570778|450633432|FG003|Overall Study|Protocol deviation|2|||
125274803|NCT00570778|450633429|FG000|Overall Study|Adverse Event|0|||
125399437|NCT01573624|451094401|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
125399438|NCT01573624|451094402|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
125399439|NCT01573624|451094403|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
125274804|NCT00570778|450633430|FG001|Overall Study|Adverse Event|1|||
125274805|NCT00570778|450633431|FG002|Overall Study|Adverse Event|4|||
125274806|NCT00570778|450633432|FG003|Overall Study|Adverse Event|1|||
125274807|NCT00570778|450633429|FG000|Overall Study|Subject withdrew consent|0|||
125274808|NCT00570778|450633430|FG001|Overall Study|Subject withdrew consent|1|||
125274809|NCT00570778|450633431|FG002|Overall Study|Subject withdrew consent|0|||
125274810|NCT00570778|450633432|FG003|Overall Study|Subject withdrew consent|1|||
125274811|NCT00570778|450633429|FG000|Overall Study|Abnormal test procedure|1|||
125274812|NCT00570778|450633430|FG001|Overall Study|Abnormal test procedure|0|||
125399440|NCT01573624|451094404|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
125274813|NCT00570778|450633431|FG002|Overall Study|Abnormal test procedure|0|||
125274814|NCT00570778|450633432|FG003|Overall Study|Abnormal test procedure|0|||
125274815|NCT00570778|450633429|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125274816|NCT00570778|450633430|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125274817|NCT00570778|450633431|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125274818|NCT00570778|450633432|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
125274819|NCT00570778|450633429|FG000|Overall Study|Lost to Follow-up|0|||
125274820|NCT00570778|450633430|FG001|Overall Study|Lost to Follow-up|0|||
125274821|NCT00570778|450633431|FG002|Overall Study|Lost to Follow-up|1|||
125274822|NCT00570778|450633432|FG003|Overall Study|Lost to Follow-up|0|||
125274823|NCT00570778|450633429|FG000|Overall Study|Subject no longer requires study drug|0|||
125274824|NCT00570778|450633430|FG001|Overall Study|Subject no longer requires study drug|1|||
125274825|NCT00570778|450633431|FG002|Overall Study|Subject no longer requires study drug|0|||
125274826|NCT00570778|450633432|FG003|Overall Study|Subject no longer requires study drug|0|||
125274827|NCT02120781|450633437|FG000|Overall Study|Physician Decision|2|||
125274828|NCT02120781|450633438|FG001|Overall Study|Physician Decision|0|||
125274829|NCT02120781|450633437|FG000|Overall Study|Completion not documented|2|||
125274830|NCT02120781|450633438|FG001|Overall Study|Completion not documented|1|||
125274831|NCT00984165|450633439|FG000|Overall Study|Death on study|2|||
125274832|NCT00984165|450633440|FG001|Overall Study|Death on study|0|||
125274833|NCT00984165|450633441|FG002|Overall Study|Death on study|0|||
125274834|NCT00984165|450633442|FG003|Overall Study|Death on study|0|||
125274835|NCT00984165|450633439|FG000|Overall Study|Disease progression on study|5|||
125274836|NCT00984165|450633440|FG001|Overall Study|Disease progression on study|1|||
125274837|NCT00984165|450633441|FG002|Overall Study|Disease progression on study|0|||
125274838|NCT00984165|450633442|FG003|Overall Study|Disease progression on study|0|||
125274839|NCT00984165|450633439|FG000|Overall Study|Death of recipient|0|||
125274840|NCT00984165|450633440|FG001|Overall Study|Death of recipient|0|||
125274841|NCT00984165|450633441|FG002|Overall Study|Death of recipient|0|||
125274842|NCT00984165|450633442|FG003|Overall Study|Death of recipient|1|||
125274843|NCT00984165|450633439|FG000|Overall Study|New protocol|0|||
125274844|NCT00984165|450633440|FG001|Overall Study|New protocol|0|||
125274845|NCT00984165|450633441|FG002|Overall Study|New protocol|0|||
125274846|NCT00984165|450633442|FG003|Overall Study|New protocol|1|||
125274847|NCT00984165|450633439|FG000|Overall Study|P+/donor pair removed from protocol|0|||
125274848|NCT00984165|450633440|FG001|Overall Study|P+/donor pair removed from protocol|0|||
125274849|NCT00984165|450633441|FG002|Overall Study|P+/donor pair removed from protocol|0|||
125274850|NCT00984165|450633442|FG003|Overall Study|P+/donor pair removed from protocol|1|||
125274851|NCT00984165|450633439|FG000|Overall Study|removed with a pair recipient|0|||
125274852|NCT00984165|450633440|FG001|Overall Study|removed with a pair recipient|0|||
125274853|NCT00984165|450633441|FG002|Overall Study|removed with a pair recipient|0|||
125274854|NCT00984165|450633442|FG003|Overall Study|removed with a pair recipient|1|||
125274855|NCT00466947|450633443|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
125274856|NCT00466947|450633444|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
125274857|NCT00466947|450633443|FG000|Study End Analysis Period|Adverse Event|35|||
125274858|NCT00466947|450633444|FG001|Study End Analysis Period|Adverse Event|43|||
125274859|NCT00466947|450633443|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
125274860|NCT00466947|450633444|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
125274861|NCT00466947|450633443|FG000|Study End Analysis Period|Physician Decision|29|||
125274862|NCT00466947|450633444|FG001|Study End Analysis Period|Physician Decision|29|||
125274863|NCT00466947|450633443|FG000|Study End Analysis Period|Protocol Violation|9|||
125274864|NCT00466947|450633444|FG001|Study End Analysis Period|Protocol Violation|17|||
125274865|NCT00466947|450633443|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
125274866|NCT00466947|450633444|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
125274867|NCT00466947|450633443|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
125274868|NCT00466947|450633444|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
125274869|NCT00466947|450633443|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
125274870|NCT00466947|450633444|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
125274871|NCT00466947|450633443|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
125274872|NCT00466947|450633444|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
125274873|NCT03850093|450633445|FG000|Overall Study|Withdrawal by Subject|1|||
125274874|NCT03850093|450633446|FG001|Overall Study|Withdrawal by Subject|0|||
125274875|NCT03850093|450633447|FG002|Overall Study|Withdrawal by Subject|2|||
125399441|NCT01573624|451094398|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125447776|NCT01021878|451266803|FG000|Overall Study|Death|0|||
125274876|NCT03226249|450633448|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
125274877|NCT03226249|450633448|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
125274878|NCT03226249|450633448|FG000|Survival Follow-up|Patients still in follow-up.|30|||
125274879|NCT02096952|450633451|FG000|Overall Study|Adverse Event|1|||
125274880|NCT00066222|450633452|FG000|Overall Study|No protocol treatment received|1|||
125274881|NCT02684617|450633453|FG000|Overall Study|Adverse Event|1|||
125274882|NCT02684617|450633454|FG001|Overall Study|Adverse Event|0|||
125274883|NCT02684617|450633455|FG002|Overall Study|Adverse Event|1|||
125274884|NCT02684617|450633453|FG000|Overall Study|Death|8|||
125274885|NCT02684617|450633454|FG001|Overall Study|Death|16|||
125274886|NCT02684617|450633455|FG002|Overall Study|Death|28|||
125274887|NCT02684617|450633453|FG000|Overall Study|Withdrawal by Subject|2|||
125274888|NCT02684617|450633454|FG001|Overall Study|Withdrawal by Subject|0|||
125274889|NCT02684617|450633455|FG002|Overall Study|Withdrawal by Subject|4|||
125274890|NCT02684617|450633453|FG000|Overall Study|Screen Failure|1|||
125274891|NCT02684617|450633454|FG001|Overall Study|Screen Failure|0|||
125274892|NCT02684617|450633455|FG002|Overall Study|Screen Failure|2|||
125274893|NCT02684617|450633453|FG000|Overall Study|Study Terminated by Sponsor|6|||
125274894|NCT02684617|450633454|FG001|Overall Study|Study Terminated by Sponsor|1|||
125274895|NCT02684617|450633455|FG002|Overall Study|Study Terminated by Sponsor|5|||
125274896|NCT00615719|450633466|FG000|Overall Study|Physician Decision|5|||
125274897|NCT02201329|450633467|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
125274898|NCT02201329|450633467|FG000|Overall Study|Withdrawal by Subject|2|||
125274899|NCT03629223|450633468|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
125274900|NCT03629223|450633469|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
125274901|NCT03629223|450633470|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
125274902|NCT03629223|450633471|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
125274903|NCT03629223|450633472|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
125274904|NCT03629223|450633473|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
125274905|NCT03629223|450633468|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
125274906|NCT03629223|450633469|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
125274907|NCT03629223|450633470|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
125274908|NCT03629223|450633471|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
125274909|NCT03629223|450633472|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
125274910|NCT03629223|450633473|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
125274911|NCT03629223|450633468|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
125274912|NCT03629223|450633469|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
125274913|NCT03629223|450633470|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
125274914|NCT03629223|450633471|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
125274915|NCT03629223|450633472|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
125274916|NCT03629223|450633473|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
125274917|NCT03629223|450633468|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
125274918|NCT03629223|450633469|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
125274919|NCT03629223|450633470|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
125274920|NCT03629223|450633471|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
125274921|NCT03629223|450633472|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
125274922|NCT03629223|450633473|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
125274923|NCT03629223|450633468|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
125274924|NCT03629223|450633469|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
125274925|NCT03629223|450633470|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
125274926|NCT03629223|450633471|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
125274927|NCT03629223|450633472|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
125274928|NCT03629223|450633473|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
125274929|NCT01534351|450633474|FG000|Overall Study|Study Terminated Early|1|||
125274930|NCT01534351|450633475|FG001|Overall Study|Study Terminated Early|0|||
125274931|NCT01534351|450633476|FG002|Overall Study|Study Terminated Early|0|||
125274932|NCT02702609|450633477|FG000|Overall Study|Lost to Follow-up|8|||
125274933|NCT02702609|450633478|FG001|Overall Study|Lost to Follow-up|4|||
125274934|NCT02702609|450633477|FG000|Overall Study|Physician Decision|1|||
125274935|NCT02702609|450633478|FG001|Overall Study|Physician Decision|0|||
125274936|NCT00690430|450633480|FG000|Core Phase|Abnormal Laboratory value|0|||
125274937|NCT00690430|450633481|FG001|Core Phase|Abnormal Laboratory value|1|||
125274938|NCT00690430|450633482|FG002|Core Phase|Abnormal Laboratory value|0|||
125274939|NCT00690430|450633480|FG000|Core Phase|Adverse Event|5|||
125274940|NCT00690430|450633481|FG001|Core Phase|Adverse Event|1|||
125274941|NCT00690430|450633482|FG002|Core Phase|Adverse Event|0|||
125274942|NCT00690430|450633480|FG000|Core Phase|Death|0|||
125274943|NCT00690430|450633481|FG001|Core Phase|Death|2|||
125274944|NCT00690430|450633482|FG002|Core Phase|Death|0|||
125274945|NCT00690430|450633480|FG000|Core Phase|Protocol Violation|1|||
125274946|NCT00690430|450633481|FG001|Core Phase|Protocol Violation|0|||
125274947|NCT00690430|450633482|FG002|Core Phase|Protocol Violation|0|||
125274948|NCT00690430|450633480|FG000|Core Phase|Withdrawal by Subject|3|||
125274949|NCT00690430|450633481|FG001|Core Phase|Withdrawal by Subject|3|||
125274950|NCT00690430|450633482|FG002|Core Phase|Withdrawal by Subject|0|||
125274951|NCT00690430|450633480|FG000|Core Phase|Subject no longer requires study drug|1|||
125274952|NCT00690430|450633481|FG001|Core Phase|Subject no longer requires study drug|0|||
125274953|NCT00690430|450633482|FG002|Core Phase|Subject no longer requires study drug|0|||
125274954|NCT00690430|450633480|FG000|Core Phase|Lack of Efficacy|8|||
125274955|NCT00690430|450633481|FG001|Core Phase|Lack of Efficacy|10|||
125274956|NCT00690430|450633482|FG002|Core Phase|Lack of Efficacy|0|||
125274957|NCT00690430|450633480|FG000|Core Phase|Administrative Problems|0|||
125274958|NCT00690430|450633481|FG001|Core Phase|Administrative Problems|1|||
125274959|NCT00690430|450633482|FG002|Core Phase|Administrative Problems|0|||
125274960|NCT00690430|450633480|FG000|Core Phase|Early Termination|0|||
125274961|NCT00690430|450633481|FG001|Core Phase|Early Termination|5|||
125274962|NCT00690430|450633482|FG002|Core Phase|Early Termination|0|||
125274963|NCT00690430|450633480|FG000|Extension Phase|Lack of Efficacy|3|||
125274964|NCT00690430|450633481|FG001|Extension Phase|Lack of Efficacy|1|||
125274965|NCT00690430|450633482|FG002|Extension Phase|Lack of Efficacy|4|||
125274966|NCT00690430|450633480|FG000|Extension Phase|Abnormal Lab Values|1|||
125274967|NCT00690430|450633481|FG001|Extension Phase|Abnormal Lab Values|0|||
125274968|NCT00690430|450633482|FG002|Extension Phase|Abnormal Lab Values|0|||
125274969|NCT00690430|450633480|FG000|Extension Phase|Abnormal test procedure results|1|||
125274970|NCT00690430|450633481|FG001|Extension Phase|Abnormal test procedure results|0|||
125274971|NCT00690430|450633482|FG002|Extension Phase|Abnormal test procedure results|0|||
125274972|NCT00690430|450633480|FG000|Extension Phase|Administrative Problems|0|||
125274973|NCT00690430|450633481|FG001|Extension Phase|Administrative Problems|1|||
125274974|NCT00690430|450633482|FG002|Extension Phase|Administrative Problems|1|||
125274975|NCT00690430|450633480|FG000|Extension Phase|Adverse Event|2|||
125274976|NCT00690430|450633481|FG001|Extension Phase|Adverse Event|1|||
125274977|NCT00690430|450633482|FG002|Extension Phase|Adverse Event|2|||
125274978|NCT00690430|450633480|FG000|Extension Phase|Death|1|||
125274979|NCT00690430|450633481|FG001|Extension Phase|Death|1|||
125274980|NCT00690430|450633482|FG002|Extension Phase|Death|1|||
125274981|NCT00690430|450633480|FG000|Extension Phase|Withdrawal by Subject|0|||
125274982|NCT00690430|450633481|FG001|Extension Phase|Withdrawal by Subject|0|||
125274983|NCT00690430|450633482|FG002|Extension Phase|Withdrawal by Subject|2|||
125274984|NCT00690430|450633480|FG000|Extension Phase|Early Termination|10|||
125274985|NCT00690430|450633481|FG001|Extension Phase|Early Termination|1|||
125274986|NCT00690430|450633482|FG002|Extension Phase|Early Termination|3|||
125274987|NCT02125838|450633485|FG000|Overall Study|Lost to Follow-up|4|||
125274988|NCT02125838|450633486|FG001|Overall Study|Lost to Follow-up|4|||
125274989|NCT00787839|450633487|FG000|Overall Study|Failure to have the OGTT was most common|404|||
125274990|NCT00335738|450633490|FG000|Overall Study|Physician Decision|6|||
125274991|NCT00335738|450633491|FG001|Overall Study|Physician Decision|0|||
125399442|NCT01573624|451094399|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125399443|NCT01573624|451094400|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125399444|NCT01573624|451094401|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
125399445|NCT01573624|451094402|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125399446|NCT01573624|451094403|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
125399447|NCT01573624|451094404|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
125399448|NCT01573624|451094398|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
125399449|NCT01573624|451094399|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
125399450|NCT01573624|451094400|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
125399451|NCT01573624|451094401|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
125399452|NCT01573624|451094402|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
125399453|NCT01573624|451094403|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
125399454|NCT01573624|451094404|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
125399455|NCT01573624|451094398|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
125399456|NCT01573624|451094399|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
125399457|NCT01573624|451094400|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
125399458|NCT01573624|451094401|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
125399459|NCT01573624|451094402|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
125399460|NCT01573624|451094403|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
125399461|NCT01573624|451094404|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
125399462|NCT01573624|451094398|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
125399463|NCT01573624|451094399|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
125399464|NCT01573624|451094400|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
125447777|NCT01021878|451266804|FG001|Overall Study|Death|1|||
125447778|NCT01021878|451266803|FG000|Overall Study|Adverse Event|6|||
125274992|NCT00335738|450633490|FG000|Overall Study|Withdrawal by Subject|2|||
125274993|NCT00335738|450633491|FG001|Overall Study|Withdrawal by Subject|0|||
125274994|NCT00335738|450633490|FG000|Overall Study|Ineligible|3|||
125274995|NCT00335738|450633491|FG001|Overall Study|Ineligible|4|||
125274996|NCT01970241|450633498|FG000|Overall Study|Withdrawal by Subject|2|||
125274997|NCT01970241|450633499|FG001|Overall Study|Withdrawal by Subject|0|||
125274998|NCT01970241|450633498|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
125274999|NCT01970241|450633499|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
125275000|NCT00992056|450633502|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
125275001|NCT00992056|450633503|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
125275002|NCT00992056|450633502|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
125275003|NCT00992056|450633503|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
125275004|NCT00958347|450633507|FG000|Overall Study|Death|43|||
125275005|NCT00958347|450633507|FG000|Overall Study|Withdrawal by Subject|23|||
125275006|NCT00958347|450633507|FG000|Overall Study|Lost to Follow-up|15|||
125275007|NCT00958347|450633507|FG000|Overall Study|revision/removal|10|||
125275008|NCT00958347|450633507|FG000|Overall Study|study termination|135|||
125275009|NCT00375505|450633512|FG000|Overall Study|Adverse Event|1|||
125275010|NCT00375505|450633513|FG001|Overall Study|Adverse Event|2|||
125275011|NCT02146131|450633514|FG000|Overall Study|Physician Decision|61|||
125275012|NCT02146131|450633515|FG001|Overall Study|Physician Decision|56|||
125275013|NCT02567799|450633516|FG000|Concurrent Chemoradiotherapy|Death|1|||
125275014|NCT02567799|450633517|FG001|Concurrent Chemoradiotherapy|Death|0|||
125275015|NCT02567799|450633518|FG002|Concurrent Chemoradiotherapy|Death|0|||
125275016|NCT02567799|450633516|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
125275017|NCT02567799|450633517|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
125275018|NCT02567799|450633518|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
125275019|NCT02567799|450633516|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
125275020|NCT02567799|450633517|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
125275021|NCT02567799|450633518|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
125275022|NCT02567799|450633516|FG000|Follow-up|Death|1|||
125275023|NCT02567799|450633517|FG001|Follow-up|Death|0|||
125275024|NCT02567799|450633518|FG002|Follow-up|Death|1|||
125275025|NCT02567799|450633516|FG000|Follow-up|Progressive Disease|1|||
125275026|NCT02567799|450633517|FG001|Follow-up|Progressive Disease|1|||
125275027|NCT02567799|450633518|FG002|Follow-up|Progressive Disease|3|||
125275028|NCT00349349|450633520|FG000|Overall Study|Adverse Event|5|||
125275029|NCT00349349|450633521|FG001|Overall Study|Adverse Event|6|||
125275030|NCT00349349|450633522|FG002|Overall Study|Adverse Event|2|||
125275031|NCT00349349|450633520|FG000|Overall Study|Withdrawal by Subject|5|||
125275032|NCT00349349|450633521|FG001|Overall Study|Withdrawal by Subject|2|||
125275033|NCT00349349|450633522|FG002|Overall Study|Withdrawal by Subject|1|||
125275034|NCT00349349|450633520|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
125275035|NCT00349349|450633521|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
125275036|NCT00349349|450633522|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
125275037|NCT00349349|450633520|FG000|Overall Study|Death|13|||
125275038|NCT00349349|450633521|FG001|Overall Study|Death|10|||
125275039|NCT00349349|450633522|FG002|Overall Study|Death|1|||
125275040|NCT00349349|450633520|FG000|Overall Study|Other Treatment Selected|2|||
125275041|NCT00349349|450633521|FG001|Overall Study|Other Treatment Selected|0|||
125275042|NCT00349349|450633522|FG002|Overall Study|Other Treatment Selected|0|||
125275043|NCT00349349|450633520|FG000|Overall Study|Participant Reduced General Condition|0|||
125275044|NCT00349349|450633521|FG001|Overall Study|Participant Reduced General Condition|1|||
125275045|NCT00349349|450633522|FG002|Overall Study|Participant Reduced General Condition|0|||
125275046|NCT00349349|450633520|FG000|Overall Study|Physician Decision|1|||
125275047|NCT00349349|450633521|FG001|Overall Study|Physician Decision|2|||
125275048|NCT00349349|450633522|FG002|Overall Study|Physician Decision|1|||
125275049|NCT00349349|450633520|FG000|Overall Study|No Response|0|||
125275050|NCT00349349|450633521|FG001|Overall Study|No Response|3|||
125275051|NCT00349349|450633522|FG002|Overall Study|No Response|0|||
125275052|NCT00349349|450633520|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
125275053|NCT00349349|450633521|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
125275054|NCT00349349|450633522|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
125275055|NCT00861692|450633524|FG000|Overall Study|Death|6|||
125275056|NCT05111002|450633527|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
125275057|NCT05111002|450633528|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
125275058|NCT05111002|450633527|FG000|Secondary Outcome|Lost to Follow-up|1|||
125275059|NCT05111002|450633528|FG001|Secondary Outcome|Lost to Follow-up|0|||
125275060|NCT04380753|450633529|FG000|Overall Study|Participants continuing study|4|||
125275061|NCT04380753|450633529|FG000|Overall Study|Death|2|||
125275062|NCT00972517|450633532|FG000|Overall Study|Adverse Event|0|||
125275063|NCT00972517|450633533|FG001|Overall Study|Adverse Event|0|||
125275064|NCT00972517|450633534|FG002|Overall Study|Adverse Event|0|||
125275065|NCT00972517|450633535|FG003|Overall Study|Adverse Event|1|||
125275066|NCT00972517|450633536|FG004|Overall Study|Adverse Event|0|||
125275067|NCT00972517|450633537|FG005|Overall Study|Adverse Event|0|||
125275068|NCT00972517|450633532|FG000|Overall Study|Withdrawal by Subject|0|||
125275069|NCT00972517|450633533|FG001|Overall Study|Withdrawal by Subject|1|||
125275070|NCT00972517|450633534|FG002|Overall Study|Withdrawal by Subject|0|||
125275071|NCT00972517|450633535|FG003|Overall Study|Withdrawal by Subject|2|||
125275072|NCT00972517|450633536|FG004|Overall Study|Withdrawal by Subject|1|||
125275073|NCT00972517|450633537|FG005|Overall Study|Withdrawal by Subject|0|||
125275074|NCT00851890|450633538|FG000|Overall Study|Lost to Follow-up|0|||
125275075|NCT00851890|450633539|FG001|Overall Study|Lost to Follow-up|1|||
125275076|NCT00851890|450633540|FG002|Overall Study|Lost to Follow-up|0|||
125275077|NCT00851890|450633541|FG003|Overall Study|Lost to Follow-up|1|||
125275078|NCT03135431|450633542|FG000|Overall Study|Study Surgeon not available|2|||
125275079|NCT03135431|450633543|FG001|Overall Study|Study Surgeon not available|0|||
125275080|NCT02709577|450633544|FG000|Overall Study|non-accommodating anatomy|0|||
125275081|NCT02709577|450633545|FG001|Overall Study|non-accommodating anatomy|1|||
125275082|NCT02709577|450633546|FG002|Overall Study|non-accommodating anatomy|0|||
125275083|NCT02709577|450633547|FG003|Overall Study|non-accommodating anatomy|0|||
125275084|NCT02709577|450633544|FG000|Overall Study|procedural complication|0|||
125275085|NCT02709577|450633545|FG001|Overall Study|procedural complication|1|||
125275086|NCT02709577|450633546|FG002|Overall Study|procedural complication|0|||
125275087|NCT02709577|450633547|FG003|Overall Study|procedural complication|0|||
125275088|NCT02709577|450633544|FG000|Overall Study|Withdrawal by Subject|2|||
125275089|NCT02709577|450633545|FG001|Overall Study|Withdrawal by Subject|3|||
125275090|NCT02709577|450633546|FG002|Overall Study|Withdrawal by Subject|2|||
125275091|NCT02709577|450633547|FG003|Overall Study|Withdrawal by Subject|0|||
125275092|NCT00375674|450633548|FG000|Overall Study|Other|26|||
125275093|NCT00375674|450633549|FG001|Overall Study|Other|18|||
125275094|NCT00375674|450633548|FG000|Overall Study|Death|67|||
125275095|NCT00375674|450633549|FG001|Overall Study|Death|76|||
125275096|NCT00375674|450633548|FG000|Overall Study|Participants refused further follow-up|31|||
125275097|NCT00375674|450633549|FG001|Overall Study|Participants refused further follow-up|30|||
125275098|NCT00375674|450633548|FG000|Overall Study|Lost to Follow-up|17|||
125275099|NCT00375674|450633549|FG001|Overall Study|Lost to Follow-up|15|||
125275100|NCT00375674|450633548|FG000|Overall Study|Enrolled but not treated|3|||
125275101|NCT00375674|450633549|FG001|Overall Study|Enrolled but not treated|2|||
125275102|NCT03744910|450636030|FG000|Overall Study|Withdrew Consent|1|||
125275103|NCT03744910|450636031|FG001|Overall Study|Withdrew Consent|8|||
125275104|NCT03744910|450636030|FG000|Overall Study|Physician Decision|5|||
125275105|NCT03744910|450636031|FG001|Overall Study|Physician Decision|4|||
125275106|NCT03744910|450636030|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
125275107|NCT03744910|450636031|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
125275108|NCT03744910|450636030|FG000|Overall Study|Lost to Follow-up|0|||
125275109|NCT03744910|450636031|FG001|Overall Study|Lost to Follow-up|1|||
125275110|NCT03744910|450636030|FG000|Overall Study|Other-unspecified|4|||
125275111|NCT03744910|450636031|FG001|Overall Study|Other-unspecified|1|||
125275112|NCT00064259|450636032|FG000|Overall Study|Adverse Event|1|||
125275113|NCT00064259|450636033|FG001|Overall Study|Adverse Event|0|||
125275114|NCT00064259|450636034|FG002|Overall Study|Adverse Event|0|||
125275115|NCT00064259|450636035|FG003|Overall Study|Adverse Event|1|||
125275116|NCT01132651|450636038|FG000|Overall Study|Lost to Follow-up|1|||
125275117|NCT01132651|450636039|FG001|Overall Study|Lost to Follow-up|1|||
125275118|NCT00948857|450636040|FG000|Overall Study|Lost to Follow-up|1|||
125275119|NCT00948857|450636041|FG001|Overall Study|Lost to Follow-up|0|||
125275120|NCT03430843|450636044|FG000|Overall Study|Death|233|||
125275121|NCT03430843|450636045|FG001|Overall Study|Death|233|||
125275122|NCT03430843|450636044|FG000|Overall Study|Sponsor Decision|17|||
125275123|NCT03430843|450636045|FG001|Overall Study|Sponsor Decision|6|||
125275124|NCT03430843|450636044|FG000|Overall Study|Withdrawal by Subject|5|||
125275125|NCT03430843|450636045|FG001|Overall Study|Withdrawal by Subject|14|||
125275126|NCT03430843|450636044|FG000|Overall Study|Lost to Follow-up|1|||
125275127|NCT03430843|450636045|FG001|Overall Study|Lost to Follow-up|3|||
125275128|NCT00590122|450636054|FG000|Overall Study|swallowed oral dissolving dose|1|||
125275129|NCT00590122|450636055|FG001|Overall Study|swallowed oral dissolving dose|0|||
125275130|NCT03050450|450636056|FG000|Overall Study|Physician Decision|1|||
125275131|NCT03050450|450636057|FG001|Overall Study|Physician Decision|0|||
125275132|NCT03050450|450636058|FG002|Overall Study|Physician Decision|0|||
125275133|NCT03050450|450636059|FG003|Overall Study|Physician Decision|0|||
125275134|NCT03050450|450636060|FG004|Overall Study|Physician Decision|0|||
125275135|NCT00711594|450636061|FG000|Overall Study|Progressive disease|2|||
125275136|NCT00711594|450636062|FG001|Overall Study|Progressive disease|2|||
125275137|NCT00711594|450636063|FG002|Overall Study|Progressive disease|6|||
125275138|NCT00711594|450636064|FG003|Overall Study|Progressive disease|44|||
125275139|NCT00711594|450636061|FG000|Overall Study|Other Adverse Event|1|||
125275140|NCT00711594|450636062|FG001|Overall Study|Other Adverse Event|0|||
125275141|NCT00711594|450636063|FG002|Overall Study|Other Adverse Event|0|||
125275142|NCT00711594|450636064|FG003|Overall Study|Other Adverse Event|16|||
125275143|NCT00711594|450636061|FG000|Overall Study|Withdrawal by Subject|0|||
125275144|NCT00711594|450636062|FG001|Overall Study|Withdrawal by Subject|1|||
125275145|NCT00711594|450636063|FG002|Overall Study|Withdrawal by Subject|0|||
125399465|NCT01573624|451094401|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
125399466|NCT01573624|451094402|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
125275146|NCT00711594|450636064|FG003|Overall Study|Withdrawal by Subject|2|||
125275147|NCT00443872|450636065|FG000|Overall Study|Protocol Violation|7|||
125275148|NCT00443872|450636065|FG000|Overall Study|Lost to Follow-up|2|||
125275149|NCT00443872|450636065|FG000|Overall Study|Adverse Event|8|||
125275150|NCT00135330|450636066|FG000|Overall Study|Adverse Event|2|||
125275151|NCT00135330|450636067|FG001|Overall Study|Adverse Event|5|||
125275152|NCT00135330|450636068|FG002|Overall Study|Adverse Event|1|||
125275153|NCT00135330|450636066|FG000|Overall Study|Lost to Follow-up|0|||
125275154|NCT00135330|450636067|FG001|Overall Study|Lost to Follow-up|2|||
125275155|NCT00135330|450636068|FG002|Overall Study|Lost to Follow-up|3|||
125275156|NCT00135330|450636066|FG000|Overall Study|Physician Decision|1|||
125275157|NCT00135330|450636067|FG001|Overall Study|Physician Decision|1|||
125275158|NCT00135330|450636068|FG002|Overall Study|Physician Decision|0|||
125275159|NCT00135330|450636066|FG000|Overall Study|Protocol Violation|4|||
125275160|NCT00135330|450636067|FG001|Overall Study|Protocol Violation|3|||
125275161|NCT00135330|450636068|FG002|Overall Study|Protocol Violation|3|||
125275162|NCT00135330|450636066|FG000|Overall Study|Patient Decision|5|||
125275163|NCT00135330|450636067|FG001|Overall Study|Patient Decision|1|||
125275164|NCT00135330|450636068|FG002|Overall Study|Patient Decision|4|||
125275165|NCT00135330|450636066|FG000|Overall Study|Sponsor Decision|0|||
125275166|NCT00135330|450636067|FG001|Overall Study|Sponsor Decision|1|||
125275167|NCT00135330|450636068|FG002|Overall Study|Sponsor Decision|0|||
125275168|NCT00104416|450636072|FG000|Double-Blind Phase|Adverse Event|2|||
125275169|NCT00104416|450636073|FG001|Double-Blind Phase|Adverse Event|1|||
125275170|NCT00104416|450636074|FG002|Double-Blind Phase|Adverse Event|0|||
125275171|NCT00104416|450636075|FG003|Double-Blind Phase|Adverse Event|0|||
125275172|NCT00104416|450636076|FG004|Double-Blind Phase|Adverse Event|0|||
125275173|NCT00104416|450636072|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125275174|NCT00104416|450636073|FG001|Double-Blind Phase|Lost to Follow-up|1|||
125275175|NCT00104416|450636074|FG002|Double-Blind Phase|Lost to Follow-up|0|||
125275176|NCT00104416|450636075|FG003|Double-Blind Phase|Lost to Follow-up|0|||
125275177|NCT00104416|450636076|FG004|Double-Blind Phase|Lost to Follow-up|0|||
125275178|NCT00104416|450636072|FG000|Double-Blind Phase|Protocol Violation|0|||
125275179|NCT00104416|450636073|FG001|Double-Blind Phase|Protocol Violation|1|||
125275180|NCT00104416|450636074|FG002|Double-Blind Phase|Protocol Violation|0|||
125275181|NCT00104416|450636075|FG003|Double-Blind Phase|Protocol Violation|0|||
125275182|NCT00104416|450636076|FG004|Double-Blind Phase|Protocol Violation|0|||
125275183|NCT00104416|450636072|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
125275184|NCT00104416|450636073|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
125275185|NCT00104416|450636074|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125275186|NCT00104416|450636075|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
125275187|NCT00104416|450636076|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
125275188|NCT00104416|450636072|FG000|Double-Blind Phase|Pregnancy|1|||
125275189|NCT00104416|450636073|FG001|Double-Blind Phase|Pregnancy|0|||
125275190|NCT00104416|450636074|FG002|Double-Blind Phase|Pregnancy|0|||
125275191|NCT00104416|450636075|FG003|Double-Blind Phase|Pregnancy|0|||
125275192|NCT00104416|450636076|FG004|Double-Blind Phase|Pregnancy|0|||
125275193|NCT00104416|450636072|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
125275194|NCT00104416|450636073|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
125275195|NCT00104416|450636074|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
125275196|NCT00104416|450636075|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
125275197|NCT00104416|450636076|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
125275198|NCT00104416|450636072|FG000|Continuation Phase|Adverse Event|0|||
125275199|NCT00104416|450636073|FG001|Continuation Phase|Adverse Event|0|||
125275200|NCT00104416|450636074|FG002|Continuation Phase|Adverse Event|2|||
125275201|NCT00104416|450636075|FG003|Continuation Phase|Adverse Event|0|||
125275202|NCT00104416|450636076|FG004|Continuation Phase|Adverse Event|2|||
125275203|NCT00104416|450636072|FG000|Continuation Phase|Lost to Follow-up|0|||
125275204|NCT00104416|450636073|FG001|Continuation Phase|Lost to Follow-up|0|||
125275205|NCT00104416|450636074|FG002|Continuation Phase|Lost to Follow-up|1|||
125275206|NCT00104416|450636075|FG003|Continuation Phase|Lost to Follow-up|0|||
125275207|NCT00104416|450636076|FG004|Continuation Phase|Lost to Follow-up|1|||
125275208|NCT00104416|450636072|FG000|Continuation Phase|Withdrawal by Subject|0|||
125275209|NCT00104416|450636073|FG001|Continuation Phase|Withdrawal by Subject|0|||
125275210|NCT00104416|450636074|FG002|Continuation Phase|Withdrawal by Subject|2|||
125275211|NCT00104416|450636075|FG003|Continuation Phase|Withdrawal by Subject|1|||
125275212|NCT00104416|450636076|FG004|Continuation Phase|Withdrawal by Subject|1|||
125275213|NCT00104416|450636072|FG000|Continuation Phase|Pregnancy|0|||
125275214|NCT00104416|450636073|FG001|Continuation Phase|Pregnancy|0|||
125275215|NCT00104416|450636074|FG002|Continuation Phase|Pregnancy|1|||
125275216|NCT00104416|450636075|FG003|Continuation Phase|Pregnancy|1|||
125275217|NCT00104416|450636076|FG004|Continuation Phase|Pregnancy|0|||
125275218|NCT00104416|450636072|FG000|Continuation Phase|Non-compliance|0|||
125275219|NCT00104416|450636073|FG001|Continuation Phase|Non-compliance|0|||
125275220|NCT00104416|450636074|FG002|Continuation Phase|Non-compliance|0|||
125275221|NCT00104416|450636075|FG003|Continuation Phase|Non-compliance|0|||
125275222|NCT00104416|450636076|FG004|Continuation Phase|Non-compliance|1|||
125275223|NCT01309997|450636077|FG000|Overall Study|Adverse Event|1|||
125275224|NCT01309997|450636078|FG001|Overall Study|Adverse Event|0|||
125275225|NCT01309997|450636077|FG000|Overall Study|Death|1|||
125275226|NCT01309997|450636078|FG001|Overall Study|Death|3|||
125275227|NCT01309997|450636077|FG000|Overall Study|Lack of Efficacy|2|||
125275228|NCT01309997|450636078|FG001|Overall Study|Lack of Efficacy|2|||
125275229|NCT01309997|450636077|FG000|Overall Study|Withdrawal by Subject|1|||
125275230|NCT01309997|450636078|FG001|Overall Study|Withdrawal by Subject|1|||
125275231|NCT03462641|450636079|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
125275232|NCT03462641|450636080|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
125275233|NCT03462641|450636079|FG000|Visit 2|Withdrawal by Subject|0|||
125275234|NCT03462641|450636080|FG001|Visit 2|Withdrawal by Subject|1|||
125275235|NCT00372619|450636081|FG000|Overall Study|Ineligible|0|||
125275236|NCT00372619|450636082|FG001|Overall Study|Ineligible|0|||
125275237|NCT00372619|450636083|FG002|Overall Study|Ineligible|0|||
125275238|NCT00372619|450636084|FG003|Overall Study|Ineligible|0|||
125275239|NCT00372619|450636085|FG004|Overall Study|Ineligible|0|||
125275240|NCT00372619|450636086|FG005|Overall Study|Ineligible|2|||
125275241|NCT00372619|450636087|FG006|Overall Study|Ineligible|0|||
125275242|NCT00372619|450636081|FG000|Overall Study|Inevaluable|0|||
125275243|NCT00372619|450636082|FG001|Overall Study|Inevaluable|0|||
125275244|NCT00372619|450636083|FG002|Overall Study|Inevaluable|0|||
125275245|NCT00372619|450636084|FG003|Overall Study|Inevaluable|0|||
125275246|NCT00372619|450636085|FG004|Overall Study|Inevaluable|0|||
125275247|NCT00372619|450636086|FG005|Overall Study|Inevaluable|1|||
125275248|NCT00372619|450636087|FG006|Overall Study|Inevaluable|0|||
125275249|NCT03748706|450636092|FG000|Overall Study|Lost to Follow-up|1|||
125275250|NCT03517371|450636095|FG000|Overall Study|Adverse Event|8|||
125275251|NCT03517371|450636096|FG001|Overall Study|Adverse Event|9|||
125275252|NCT03517371|450636095|FG000|Overall Study|Lost to Follow-up|1|||
125275253|NCT03517371|450636096|FG001|Overall Study|Lost to Follow-up|2|||
125275254|NCT03517371|450636095|FG000|Overall Study|Withdrawal by Subject|4|||
125275255|NCT03517371|450636096|FG001|Overall Study|Withdrawal by Subject|4|||
125275256|NCT03517371|450636095|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
125275257|NCT03517371|450636096|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
125275258|NCT03517371|450636095|FG000|Overall Study|COVID restrictions|2|||
125275259|NCT03517371|450636096|FG001|Overall Study|COVID restrictions|0|||
125275260|NCT03517371|450636095|FG000|Overall Study|Receiving DBS Surgery|0|||
125275261|NCT03517371|450636096|FG001|Overall Study|Receiving DBS Surgery|1|||
125275262|NCT05420961|450636097|FG000|Overall Study|Withdrawal by Subject|2|||
125275263|NCT05420961|450636098|FG001|Overall Study|Withdrawal by Subject|1|||
125275264|NCT05420961|450636099|FG002|Overall Study|Withdrawal by Subject|1|||
125275265|NCT05420961|450636100|FG003|Overall Study|Withdrawal by Subject|0|||
125275266|NCT05420961|450636101|FG004|Overall Study|Withdrawal by Subject|0|||
125275267|NCT05420961|450636097|FG000|Overall Study|Lost to Follow-up|0|||
125275268|NCT05420961|450636098|FG001|Overall Study|Lost to Follow-up|0|||
125275269|NCT05420961|450636099|FG002|Overall Study|Lost to Follow-up|1|||
125275270|NCT05420961|450636100|FG003|Overall Study|Lost to Follow-up|0|||
125275271|NCT05420961|450636101|FG004|Overall Study|Lost to Follow-up|0|||
125275272|NCT05420961|450636097|FG000|Overall Study|Randomized by mistake without study treatment|0|||
125275273|NCT05420961|450636098|FG001|Overall Study|Randomized by mistake without study treatment|0|||
125275274|NCT05420961|450636099|FG002|Overall Study|Randomized by mistake without study treatment|1|||
125275275|NCT05420961|450636100|FG003|Overall Study|Randomized by mistake without study treatment|0|||
125275276|NCT05420961|450636101|FG004|Overall Study|Randomized by mistake without study treatment|1|||
125275277|NCT04283656|450636102|FG000|Overall Study|Adverse Event|1|||
125275278|NCT04283656|450636103|FG001|Overall Study|Adverse Event|0|||
125275279|NCT04283656|450636102|FG000|Overall Study|Lost to Follow-up|0|||
125275280|NCT04283656|450636103|FG001|Overall Study|Lost to Follow-up|1|||
125275281|NCT04482439|450636108|FG000|Overall Study|Lost to Follow-up|1|||
125275282|NCT04482439|450636108|FG000|Overall Study|Unrelated illness|1|||
125275283|NCT02318368|450636109|FG000|Overall Study|Withdrawal by Subject|2|||
125275284|NCT02318368|450636110|FG001|Overall Study|Withdrawal by Subject|0|||
125275285|NCT02318368|450636109|FG000|Overall Study|Study terminated by the sponsor|5|||
125275286|NCT02318368|450636110|FG001|Overall Study|Study terminated by the sponsor|2|||
125275287|NCT02318368|450636109|FG000|Overall Study|Death|0|||
125275288|NCT02318368|450636110|FG001|Overall Study|Death|1|||
125275289|NCT01555073|450636111|FG000|Overall Study|Lost to Follow-up|1|||
125275290|NCT01555073|450636112|FG001|Overall Study|Lost to Follow-up|2|||
125275291|NCT01555073|450636113|FG002|Overall Study|Lost to Follow-up|0|||
125275292|NCT01555073|450636114|FG003|Overall Study|Lost to Follow-up|5|||
125275293|NCT04660552|450636115|FG000|Overall Study|Withdrawal by Subject|3|||
125275294|NCT04660552|450636116|FG001|Overall Study|Withdrawal by Subject|1|||
125275295|NCT03490292|450636117|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
125275296|NCT03490292|450636118|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
125275297|NCT03490292|450636117|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
125275298|NCT03490292|450636118|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
125275299|NCT03490292|450636117|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
125275300|NCT03490292|450636118|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
125275301|NCT03490292|450636117|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
125275302|NCT03490292|450636118|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
125275303|NCT03490292|450636117|FG000|1 Year Follow Up Post Last Dose|Death|1|||
125275304|NCT03490292|450636118|FG001|1 Year Follow Up Post Last Dose|Death|1|||
125275305|NCT02565147|450636119|FG000|Overall Study|Withdrawal by Subject|5|||
125275306|NCT02565147|450636120|FG001|Overall Study|Withdrawal by Subject|1|||
125275307|NCT02565147|450636119|FG000|Overall Study|Lost to Follow-up|0|||
125275308|NCT02565147|450636120|FG001|Overall Study|Lost to Follow-up|1|||
125275309|NCT02565147|450636119|FG000|Overall Study|Death|1|||
125275310|NCT02565147|450636120|FG001|Overall Study|Death|1|||
125275311|NCT01001767|450636123|FG000|Overall Study|no baseline study performed|1|||
125275312|NCT01001767|450636124|FG001|Overall Study|no baseline study performed|0|||
125275313|NCT01001767|450636123|FG000|Overall Study|Protocol Violation|1|||
125275314|NCT01001767|450636124|FG001|Overall Study|Protocol Violation|0|||
125399467|NCT01573624|451094403|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
125399468|NCT01573624|451094404|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
125399469|NCT01573624|451094398|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
125399470|NCT01573624|451094399|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
125399471|NCT01573624|451094400|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
125399472|NCT01573624|451094401|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
125399473|NCT01573624|451094402|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
125399474|NCT01573624|451094403|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
125399475|NCT01573624|451094404|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
125399476|NCT01573624|451094398|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125399477|NCT01573624|451094399|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
125399478|NCT01573624|451094400|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
125399479|NCT01573624|451094401|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125399480|NCT01573624|451094402|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125399481|NCT01573624|451094403|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
125399482|NCT01573624|451094404|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
125399483|NCT01573624|451094398|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
125399484|NCT01573624|451094399|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
125399485|NCT01573624|451094400|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
125399486|NCT01573624|451094401|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
125399487|NCT01573624|451094402|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
125399488|NCT01573624|451094403|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
125399489|NCT01573624|451094404|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
125399490|NCT01573624|451094398|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
125399491|NCT01573624|451094399|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
125399492|NCT01573624|451094400|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
125399493|NCT01573624|451094401|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
125399494|NCT01573624|451094402|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
125399495|NCT01573624|451094403|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
125399496|NCT01573624|451094404|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
125399497|NCT01573624|451094398|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
125399498|NCT01573624|451094399|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
125275315|NCT01001767|450636123|FG000|Overall Study|Lost to Follow-up|1|||
125275316|NCT01001767|450636124|FG001|Overall Study|Lost to Follow-up|0|||
125275317|NCT01001767|450636123|FG000|Overall Study|Physician Decision|1|||
125275318|NCT01001767|450636124|FG001|Overall Study|Physician Decision|0|||
125275319|NCT03098433|450636125|FG000|Overall Study|Withdrawal by Subject|10|||
125275320|NCT01667133|450636127|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
125275321|NCT01667133|450636128|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
125275322|NCT01667133|450636129|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
125275323|NCT01667133|450636130|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
125275324|NCT01667133|450636131|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
125275325|NCT01667133|450636132|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
125275326|NCT01667133|450636133|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
125275327|NCT01667133|450636134|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
125275328|NCT01667133|450636135|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
125275329|NCT01667133|450636136|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
125275330|NCT01667133|450636137|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
125275331|NCT01667133|450636138|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
125275332|NCT01667133|450636127|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275333|NCT01667133|450636128|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275334|NCT01667133|450636129|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
125275335|NCT01667133|450636130|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275336|NCT01667133|450636131|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275337|NCT01667133|450636132|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275338|NCT01667133|450636133|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275339|NCT01667133|450636134|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275340|NCT01667133|450636135|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275341|NCT01667133|450636136|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275342|NCT01667133|450636137|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275343|NCT01667133|450636138|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
125275344|NCT01667133|450636127|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
125275345|NCT01667133|450636128|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
125275346|NCT01667133|450636129|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
125275347|NCT01667133|450636130|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
125275348|NCT01667133|450636131|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
125275349|NCT01667133|450636132|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
125275350|NCT01667133|450636133|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
125275351|NCT01667133|450636134|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
125275352|NCT01667133|450636135|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
125275353|NCT01667133|450636136|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
125275354|NCT01667133|450636137|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
125275355|NCT01667133|450636138|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
125275356|NCT01667133|450636127|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275357|NCT01667133|450636128|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275358|NCT01667133|450636129|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275359|NCT01667133|450636130|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
125275360|NCT01667133|450636131|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275361|NCT01667133|450636132|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275362|NCT01667133|450636133|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275363|NCT01667133|450636134|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275364|NCT01667133|450636135|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275365|NCT01667133|450636136|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275366|NCT01667133|450636137|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275367|NCT01667133|450636138|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
125275368|NCT01667133|450636127|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
125275369|NCT01667133|450636128|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
125275370|NCT01667133|450636129|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
125275371|NCT01667133|450636130|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
125275372|NCT01667133|450636131|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
125275373|NCT01667133|450636132|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
125275374|NCT01667133|450636133|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
125275375|NCT01667133|450636134|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
125275376|NCT01667133|450636135|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
125275377|NCT01667133|450636136|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
125275378|NCT01667133|450636137|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
125275379|NCT01667133|450636138|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
125275380|NCT01667133|450636127|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275381|NCT01667133|450636128|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275382|NCT01667133|450636129|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275383|NCT01667133|450636130|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125399499|NCT01573624|451094400|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
125399500|NCT01573624|451094401|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
125399501|NCT01573624|451094402|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
125399502|NCT01573624|451094403|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
125399503|NCT01573624|451094404|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
125399504|NCT01573624|451094398|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
125399505|NCT01573624|451094399|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
125399506|NCT01573624|451094400|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
125399507|NCT01573624|451094401|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
125399508|NCT01573624|451094402|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
125399509|NCT01573624|451094403|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
125399510|NCT01573624|451094404|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
125399511|NCT01573624|451094398|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
125399512|NCT01573624|451094399|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
125399513|NCT01573624|451094400|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
125399514|NCT01573624|451094401|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
125399515|NCT01573624|451094402|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
125399516|NCT01573624|451094403|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
125399517|NCT01573624|451094404|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
125399518|NCT01573624|451094398|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125399519|NCT01573624|451094399|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125275384|NCT01667133|450636131|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275385|NCT01667133|450636132|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275386|NCT01667133|450636133|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275387|NCT01667133|450636134|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275388|NCT01667133|450636135|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275389|NCT01667133|450636136|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
125275390|NCT01667133|450636137|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275391|NCT01667133|450636138|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
125275392|NCT01667133|450636127|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
125275393|NCT01667133|450636128|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
125275394|NCT01667133|450636129|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
125275395|NCT01667133|450636130|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
125275396|NCT01667133|450636131|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
125275397|NCT01667133|450636132|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
125275398|NCT01667133|450636133|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
125275399|NCT01667133|450636134|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
125275400|NCT01667133|450636135|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
125275401|NCT01667133|450636136|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
125275402|NCT01667133|450636137|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
125275403|NCT01667133|450636138|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
125275404|NCT01667133|450636127|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275405|NCT01667133|450636128|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275406|NCT01667133|450636129|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275407|NCT01667133|450636130|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275408|NCT01667133|450636131|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275409|NCT01667133|450636132|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275410|NCT01667133|450636133|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275411|NCT01667133|450636134|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275412|NCT01667133|450636135|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275413|NCT01667133|450636136|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
125275414|NCT01667133|450636137|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275415|NCT01667133|450636138|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
125275416|NCT01667133|450636127|FG000|Phase 2: Dose-expansion|Death|0|||
125275417|NCT01667133|450636128|FG001|Phase 2: Dose-expansion|Death|0|||
125275418|NCT01667133|450636129|FG002|Phase 2: Dose-expansion|Death|0|||
125275419|NCT01667133|450636130|FG003|Phase 2: Dose-expansion|Death|0|||
125275420|NCT01667133|450636131|FG004|Phase 2: Dose-expansion|Death|0|||
125275421|NCT01667133|450636132|FG005|Phase 2: Dose-expansion|Death|0|||
125275422|NCT01667133|450636133|FG006|Phase 2: Dose-expansion|Death|0|||
125275423|NCT01667133|450636134|FG007|Phase 2: Dose-expansion|Death|0|||
125275424|NCT01667133|450636135|FG008|Phase 2: Dose-expansion|Death|0|||
125275425|NCT01667133|450636136|FG009|Phase 2: Dose-expansion|Death|1|||
125275426|NCT01667133|450636137|FG010|Phase 2: Dose-expansion|Death|0|||
125275427|NCT01667133|450636138|FG011|Phase 2: Dose-expansion|Death|0|||
125275428|NCT01667133|450636127|FG000|Phase 2: Dose-expansion|Other|0|||
125275429|NCT01667133|450636128|FG001|Phase 2: Dose-expansion|Other|0|||
125275430|NCT01667133|450636129|FG002|Phase 2: Dose-expansion|Other|0|||
125275431|NCT01667133|450636130|FG003|Phase 2: Dose-expansion|Other|0|||
125275432|NCT01667133|450636131|FG004|Phase 2: Dose-expansion|Other|0|||
125275433|NCT01667133|450636132|FG005|Phase 2: Dose-expansion|Other|0|||
125275434|NCT01667133|450636133|FG006|Phase 2: Dose-expansion|Other|0|||
125275435|NCT01667133|450636134|FG007|Phase 2: Dose-expansion|Other|0|||
125275436|NCT01667133|450636135|FG008|Phase 2: Dose-expansion|Other|0|||
125275437|NCT01667133|450636136|FG009|Phase 2: Dose-expansion|Other|0|||
125275438|NCT01667133|450636137|FG010|Phase 2: Dose-expansion|Other|0|||
125275439|NCT01667133|450636138|FG011|Phase 2: Dose-expansion|Other|1|||
125275440|NCT01104545|450636141|FG000|Overall Study|Adverse Event|0|||
125275441|NCT01104545|450636142|FG001|Overall Study|Adverse Event|1|||
125275442|NCT01104545|450636143|FG002|Overall Study|Adverse Event|2|||
125275443|NCT02676895|450636145|FG000|Overall Study|Administrative reason|1|||
125275444|NCT02676895|450636146|FG001|Overall Study|Administrative reason|0|||
125275445|NCT02676895|450636147|FG002|Overall Study|Administrative reason|0|||
125275446|NCT02676895|450636145|FG000|Overall Study|Protocol Violation|1|||
125399520|NCT01573624|451094400|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125447779|NCT01021878|451266804|FG001|Overall Study|Adverse Event|5|||
125275447|NCT02676895|450636146|FG001|Overall Study|Protocol Violation|0|||
125275448|NCT02676895|450636147|FG002|Overall Study|Protocol Violation|0|||
125275449|NCT02676895|450636145|FG000|Overall Study|Adverse Event|0|||
125275450|NCT02676895|450636146|FG001|Overall Study|Adverse Event|3|||
125275451|NCT02676895|450636147|FG002|Overall Study|Adverse Event|1|||
125275452|NCT02676895|450636145|FG000|Overall Study|Lost to Follow-up|0|||
125275453|NCT02676895|450636146|FG001|Overall Study|Lost to Follow-up|0|||
125275454|NCT02676895|450636147|FG002|Overall Study|Lost to Follow-up|1|||
125275455|NCT02676895|450636145|FG000|Overall Study|Withdrawal by Subject|0|||
125275456|NCT02676895|450636146|FG001|Overall Study|Withdrawal by Subject|0|||
125275457|NCT02676895|450636147|FG002|Overall Study|Withdrawal by Subject|1|||
125275458|NCT00289289|450636148|FG000|Overall Study|Withdrawal by Subject|5|||
125275459|NCT00289289|450636149|FG001|Overall Study|Withdrawal by Subject|3|||
125275460|NCT00289289|450636150|FG002|Overall Study|Withdrawal by Subject|15|||
125275461|NCT00289289|450636148|FG000|Overall Study|Lost to Follow-up|1|||
125275462|NCT00289289|450636149|FG001|Overall Study|Lost to Follow-up|0|||
125275463|NCT00289289|450636150|FG002|Overall Study|Lost to Follow-up|1|||
125275464|NCT00289289|450636148|FG000|Overall Study|Death|4|||
125275465|NCT00289289|450636149|FG001|Overall Study|Death|2|||
125275466|NCT00289289|450636150|FG002|Overall Study|Death|5|||
125275467|NCT00289289|450636148|FG000|Overall Study|No implant attempted|0|||
125275468|NCT00289289|450636149|FG001|Overall Study|No implant attempted|0|||
125275469|NCT00289289|450636150|FG002|Overall Study|No implant attempted|1|||
125275470|NCT00289289|450636148|FG000|Overall Study|Physician Decision|1|||
125275471|NCT00289289|450636149|FG001|Overall Study|Physician Decision|0|||
125275472|NCT00289289|450636150|FG002|Overall Study|Physician Decision|6|||
125275473|NCT00289289|450636148|FG000|Overall Study|Non-study device implanted|2|||
125275474|NCT00289289|450636149|FG001|Overall Study|Non-study device implanted|1|||
125275475|NCT00289289|450636150|FG002|Overall Study|Non-study device implanted|3|||
125275476|NCT00289289|450636148|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
125275477|NCT00289289|450636149|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
125275478|NCT00289289|450636150|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
125275479|NCT00289289|450636148|FG000|Overall Study|Other Exit Reason|6|||
125275480|NCT00289289|450636149|FG001|Overall Study|Other Exit Reason|4|||
125275481|NCT00289289|450636150|FG002|Overall Study|Other Exit Reason|12|||
125275482|NCT03028129|450636158|FG000|Overall Study|Adverse Event|13|||
125275483|NCT03028129|450636159|FG001|Overall Study|Adverse Event|2|||
125275484|NCT03028129|450636158|FG000|Overall Study|Lost to Follow-up|50|||
125275485|NCT03028129|450636159|FG001|Overall Study|Lost to Follow-up|38|||
125275486|NCT03028129|450636158|FG000|Overall Study|Physician Decision|0|||
125275487|NCT03028129|450636159|FG001|Overall Study|Physician Decision|1|||
125275488|NCT03028129|450636158|FG000|Overall Study|Protocol Violation|1|||
125275489|NCT03028129|450636159|FG001|Overall Study|Protocol Violation|1|||
125275490|NCT03028129|450636158|FG000|Overall Study|Withdrawal by Subject|62|||
125275491|NCT03028129|450636159|FG001|Overall Study|Withdrawal by Subject|45|||
125275492|NCT00564902|450636169|FG000|Overall Study|Withdrawal by Subject|0|||
125275493|NCT00564902|450636170|FG001|Overall Study|Withdrawal by Subject|3|||
125275494|NCT00564902|450636171|FG002|Overall Study|Withdrawal by Subject|4|||
125275495|NCT00564902|450636169|FG000|Overall Study|Death|1|||
125275496|NCT00564902|450636170|FG001|Overall Study|Death|1|||
125275497|NCT00564902|450636171|FG002|Overall Study|Death|0|||
125275498|NCT03583359|450636172|FG000|Overall Study|Withdrawal by Subject|15|||
125275499|NCT03583359|450636173|FG001|Overall Study|Withdrawal by Subject|6|||
125275500|NCT03583359|450636172|FG000|Overall Study|Lost to Follow-up|12|||
125275501|NCT03583359|450636173|FG001|Overall Study|Lost to Follow-up|3|||
125275502|NCT03583359|450636172|FG000|Overall Study|Adverse Event|0|||
125275503|NCT03583359|450636173|FG001|Overall Study|Adverse Event|1|||
125275504|NCT03583359|450636172|FG000|Overall Study|Protocol Violation|0|||
125275505|NCT03583359|450636173|FG001|Overall Study|Protocol Violation|1|||
125275506|NCT03583359|450636172|FG000|Overall Study|Other|2|||
125275507|NCT03583359|450636173|FG001|Overall Study|Other|1|||
125275508|NCT01831466|450636174|FG000|Overall Study|Protocol Violation|1|||
125275509|NCT01831466|450636175|FG001|Overall Study|Protocol Violation|1|||
125275510|NCT01831466|450636176|FG002|Overall Study|Protocol Violation|2|||
125275511|NCT01831466|450636177|FG003|Overall Study|Protocol Violation|0|||
125275512|NCT01831466|450636178|FG004|Overall Study|Protocol Violation|0|||
125275513|NCT01831466|450636179|FG005|Overall Study|Protocol Violation|1|||
125275514|NCT01831466|450636180|FG006|Overall Study|Protocol Violation|0|||
125275515|NCT01831466|450636181|FG007|Overall Study|Protocol Violation|0|||
125275516|NCT01831466|450636182|FG008|Overall Study|Protocol Violation|0|||
125275517|NCT01831466|450636183|FG009|Overall Study|Protocol Violation|0|||
125275518|NCT01831466|450636184|FG010|Overall Study|Protocol Violation|0|||
125275519|NCT01831466|450636185|FG011|Overall Study|Protocol Violation|0|||
125275520|NCT01831466|450636174|FG000|Overall Study|Other|2|||
125275521|NCT01831466|450636175|FG001|Overall Study|Other|3|||
125275522|NCT01831466|450636176|FG002|Overall Study|Other|2|||
125275523|NCT01831466|450636177|FG003|Overall Study|Other|2|||
125275524|NCT01831466|450636178|FG004|Overall Study|Other|2|||
125275525|NCT01831466|450636179|FG005|Overall Study|Other|1|||
125275526|NCT01831466|450636180|FG006|Overall Study|Other|0|||
125275527|NCT01831466|450636181|FG007|Overall Study|Other|0|||
125275528|NCT01831466|450636182|FG008|Overall Study|Other|0|||
125275529|NCT01831466|450636183|FG009|Overall Study|Other|0|||
125275530|NCT01831466|450636184|FG010|Overall Study|Other|0|||
125275531|NCT01831466|450636185|FG011|Overall Study|Other|0|||
125275532|NCT01831466|450636174|FG000|Overall Study|Non-compliance with study treatment|2|||
125275533|NCT01831466|450636175|FG001|Overall Study|Non-compliance with study treatment|1|||
125275534|NCT01831466|450636176|FG002|Overall Study|Non-compliance with study treatment|1|||
125275535|NCT01831466|450636177|FG003|Overall Study|Non-compliance with study treatment|0|||
125275536|NCT01831466|450636178|FG004|Overall Study|Non-compliance with study treatment|0|||
125275537|NCT01831466|450636179|FG005|Overall Study|Non-compliance with study treatment|1|||
125275538|NCT01831466|450636180|FG006|Overall Study|Non-compliance with study treatment|0|||
125275539|NCT01831466|450636181|FG007|Overall Study|Non-compliance with study treatment|0|||
125275540|NCT01831466|450636182|FG008|Overall Study|Non-compliance with study treatment|0|||
125275541|NCT01831466|450636183|FG009|Overall Study|Non-compliance with study treatment|0|||
125275542|NCT01831466|450636184|FG010|Overall Study|Non-compliance with study treatment|0|||
125275543|NCT01831466|450636185|FG011|Overall Study|Non-compliance with study treatment|0|||
125275544|NCT01831466|450636174|FG000|Overall Study|Death|0|||
125275545|NCT01831466|450636175|FG001|Overall Study|Death|1|||
125275546|NCT01831466|450636176|FG002|Overall Study|Death|0|||
125275547|NCT01831466|450636177|FG003|Overall Study|Death|0|||
125275548|NCT01831466|450636178|FG004|Overall Study|Death|0|||
125275549|NCT01831466|450636179|FG005|Overall Study|Death|0|||
125275550|NCT01831466|450636180|FG006|Overall Study|Death|0|||
125275551|NCT01831466|450636181|FG007|Overall Study|Death|0|||
125275552|NCT01831466|450636182|FG008|Overall Study|Death|0|||
125275553|NCT01831466|450636183|FG009|Overall Study|Death|0|||
125275554|NCT01831466|450636184|FG010|Overall Study|Death|0|||
125275555|NCT01831466|450636185|FG011|Overall Study|Death|0|||
125275556|NCT01831466|450636174|FG000|Overall Study|Withdrawal by Subject|6|||
125275557|NCT01831466|450636175|FG001|Overall Study|Withdrawal by Subject|3|||
125275558|NCT01831466|450636176|FG002|Overall Study|Withdrawal by Subject|3|||
125275559|NCT01831466|450636177|FG003|Overall Study|Withdrawal by Subject|3|||
125275560|NCT01831466|450636178|FG004|Overall Study|Withdrawal by Subject|3|||
125275561|NCT01831466|450636179|FG005|Overall Study|Withdrawal by Subject|5|||
125275562|NCT01831466|450636180|FG006|Overall Study|Withdrawal by Subject|0|||
125275563|NCT01831466|450636181|FG007|Overall Study|Withdrawal by Subject|0|||
125275564|NCT01831466|450636182|FG008|Overall Study|Withdrawal by Subject|0|||
125275565|NCT01831466|450636183|FG009|Overall Study|Withdrawal by Subject|1|||
125275566|NCT01831466|450636184|FG010|Overall Study|Withdrawal by Subject|0|||
125275567|NCT01831466|450636185|FG011|Overall Study|Withdrawal by Subject|1|||
125275568|NCT01831466|450636174|FG000|Overall Study|Lost to Follow-up|0|||
125275569|NCT01831466|450636175|FG001|Overall Study|Lost to Follow-up|1|||
125275570|NCT01831466|450636176|FG002|Overall Study|Lost to Follow-up|4|||
125275571|NCT01831466|450636177|FG003|Overall Study|Lost to Follow-up|2|||
125275572|NCT01831466|450636178|FG004|Overall Study|Lost to Follow-up|0|||
125275573|NCT01831466|450636179|FG005|Overall Study|Lost to Follow-up|3|||
125275574|NCT01831466|450636180|FG006|Overall Study|Lost to Follow-up|0|||
125275575|NCT01831466|450636181|FG007|Overall Study|Lost to Follow-up|0|||
125275576|NCT01831466|450636182|FG008|Overall Study|Lost to Follow-up|0|||
125275577|NCT01831466|450636183|FG009|Overall Study|Lost to Follow-up|1|||
125275578|NCT01831466|450636184|FG010|Overall Study|Lost to Follow-up|0|||
125275579|NCT01831466|450636185|FG011|Overall Study|Lost to Follow-up|1|||
125275580|NCT01831466|450636174|FG000|Overall Study|Lack of Efficacy|5|||
125275581|NCT01831466|450636175|FG001|Overall Study|Lack of Efficacy|8|||
125275582|NCT01831466|450636176|FG002|Overall Study|Lack of Efficacy|7|||
125275583|NCT01831466|450636177|FG003|Overall Study|Lack of Efficacy|6|||
125275584|NCT01831466|450636178|FG004|Overall Study|Lack of Efficacy|9|||
125275585|NCT01831466|450636179|FG005|Overall Study|Lack of Efficacy|8|||
125275586|NCT01831466|450636180|FG006|Overall Study|Lack of Efficacy|1|||
125275587|NCT01831466|450636181|FG007|Overall Study|Lack of Efficacy|1|||
125275588|NCT01831466|450636182|FG008|Overall Study|Lack of Efficacy|2|||
125275589|NCT01831466|450636183|FG009|Overall Study|Lack of Efficacy|2|||
125275590|NCT01831466|450636184|FG010|Overall Study|Lack of Efficacy|2|||
125275591|NCT01831466|450636185|FG011|Overall Study|Lack of Efficacy|0|||
125275592|NCT01831466|450636174|FG000|Overall Study|Adverse Event|0|||
125275593|NCT01831466|450636175|FG001|Overall Study|Adverse Event|0|||
125275594|NCT01831466|450636176|FG002|Overall Study|Adverse Event|4|||
125275595|NCT01831466|450636177|FG003|Overall Study|Adverse Event|6|||
125275596|NCT01831466|450636178|FG004|Overall Study|Adverse Event|3|||
125275597|NCT01831466|450636179|FG005|Overall Study|Adverse Event|7|||
125275598|NCT01831466|450636180|FG006|Overall Study|Adverse Event|0|||
125275599|NCT01831466|450636181|FG007|Overall Study|Adverse Event|1|||
125275600|NCT01831466|450636182|FG008|Overall Study|Adverse Event|1|||
125275601|NCT01831466|450636183|FG009|Overall Study|Adverse Event|1|||
125275602|NCT01831466|450636184|FG010|Overall Study|Adverse Event|0|||
125275603|NCT01831466|450636185|FG011|Overall Study|Adverse Event|2|||
125275604|NCT04776720|450636188|FG000|Overall Study|COVID Related|4|||
125275605|NCT04776720|450636189|FG001|Overall Study|COVID Related|2|||
125275606|NCT04776720|450636188|FG000|Overall Study|Adverse Event|2|||
125275607|NCT04776720|450636189|FG001|Overall Study|Adverse Event|0|||
125275608|NCT04776720|450636188|FG000|Overall Study|Serious Adverse Event|0|||
125275609|NCT04776720|450636189|FG001|Overall Study|Serious Adverse Event|1|||
125275610|NCT04776720|450636188|FG000|Overall Study|Too Busy|3|||
125275611|NCT04776720|450636189|FG001|Overall Study|Too Busy|1|||
125275612|NCT04776720|450636188|FG000|Overall Study|Lost to Follow-up|1|||
125275613|NCT04776720|450636189|FG001|Overall Study|Lost to Follow-up|2|||
125275614|NCT04776720|450636188|FG000|Overall Study|Family|2|||
125275615|NCT04776720|450636189|FG001|Overall Study|Family|2|||
125275616|NCT04776720|450636188|FG000|Overall Study|No remote technology access|0|||
125275617|NCT04776720|450636189|FG001|Overall Study|No remote technology access|1|||
125275618|NCT04776720|450636188|FG000|Overall Study|Withdrawal by Subject|1|||
125275619|NCT04776720|450636189|FG001|Overall Study|Withdrawal by Subject|0|||
125275620|NCT04776720|450636188|FG000|Overall Study|Cannot tolerate intervention|1|||
125275621|NCT04776720|450636189|FG001|Overall Study|Cannot tolerate intervention|0|||
125275622|NCT04776720|450636188|FG000|Overall Study|Incomplete outcome data|6|||
125275623|NCT04776720|450636189|FG001|Overall Study|Incomplete outcome data|1|||
125275624|NCT05356910|450636190|FG000|Overall Study|Lost to Follow-up|10|||
125275625|NCT05356910|450636191|FG001|Overall Study|Lost to Follow-up|19|||
125275626|NCT05356910|450636192|FG002|Overall Study|Lost to Follow-up|0|||
125275627|NCT05356910|450636193|FG003|Overall Study|Lost to Follow-up|0|||
125275628|NCT05356910|450636190|FG000|Overall Study|Withdrawal by Subject|4|||
125275629|NCT05356910|450636191|FG001|Overall Study|Withdrawal by Subject|2|||
125275630|NCT05356910|450636192|FG002|Overall Study|Withdrawal by Subject|0|||
125275631|NCT05356910|450636193|FG003|Overall Study|Withdrawal by Subject|0|||
125275632|NCT00803595|450636194|FG000|Overall Study|Adverse Event|3|||
125275633|NCT00803595|450636195|FG001|Overall Study|Adverse Event|4|||
125275634|NCT00803595|450636196|FG002|Overall Study|Adverse Event|1|||
125275635|NCT00803595|450636194|FG000|Overall Study|Protocol Violation|7|||
125275636|NCT00803595|450636195|FG001|Overall Study|Protocol Violation|2|||
125275637|NCT00803595|450636196|FG002|Overall Study|Protocol Violation|12|||
125275638|NCT00803595|450636194|FG000|Overall Study|Withdrawal by Subject|5|||
125275639|NCT00803595|450636195|FG001|Overall Study|Withdrawal by Subject|2|||
125275640|NCT00803595|450636196|FG002|Overall Study|Withdrawal by Subject|3|||
125275641|NCT00984594|450636197|FG000|Overall Study|Lost to Follow-up|1|||
125275642|NCT00984594|450636198|FG001|Overall Study|Lost to Follow-up|0|||
125275643|NCT00984594|450636197|FG000|Overall Study|Withdrawal by Subject|0|||
125275644|NCT00984594|450636198|FG001|Overall Study|Withdrawal by Subject|1|||
125275645|NCT03122145|450636199|FG000|Overall Study|Concurrent respiratory disease|3|||
125275646|NCT03122145|450636200|FG001|Overall Study|Concurrent respiratory disease|0|||
125275647|NCT01597908|450636201|FG000|Randomized Phase|Death|217|||
125275648|NCT01597908|450636202|FG001|Randomized Phase|Death|238|||
125275649|NCT01597908|450636203|FG002|Randomized Phase|Death|0|||
125275650|NCT01597908|450636201|FG000|Randomized Phase|Sponsor Decision|93|||
125275651|NCT01597908|450636202|FG001|Randomized Phase|Sponsor Decision|39|||
125275652|NCT01597908|450636203|FG002|Randomized Phase|Sponsor Decision|0|||
125275653|NCT01597908|450636201|FG000|Randomized Phase|Lost to Follow-up|9|||
125275654|NCT01597908|450636202|FG001|Randomized Phase|Lost to Follow-up|16|||
125275655|NCT01597908|450636203|FG002|Randomized Phase|Lost to Follow-up|0|||
125275656|NCT01597908|450636201|FG000|Randomized Phase|Physician Decision|6|||
125275657|NCT01597908|450636202|FG001|Randomized Phase|Physician Decision|3|||
125275658|NCT01597908|450636203|FG002|Randomized Phase|Physician Decision|0|||
125275659|NCT01597908|450636201|FG000|Randomized Phase|Withdrawal by Subject|26|||
125275660|NCT01597908|450636202|FG001|Randomized Phase|Withdrawal by Subject|22|||
125275661|NCT01597908|450636203|FG002|Randomized Phase|Withdrawal by Subject|0|||
125275662|NCT01597908|450636201|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
125275663|NCT01597908|450636202|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
125275664|NCT01597908|450636203|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
125275665|NCT01597908|450636201|FG000|Crossover Phase|Death|0|||
125275666|NCT01597908|450636202|FG001|Crossover Phase|Death|0|||
125275667|NCT01597908|450636203|FG002|Crossover Phase|Death|11|||
125275668|NCT01597908|450636201|FG000|Crossover Phase|Withdrawal by Subject|0|||
125275669|NCT01597908|450636202|FG001|Crossover Phase|Withdrawal by Subject|0|||
125275670|NCT01597908|450636203|FG002|Crossover Phase|Withdrawal by Subject|3|||
125275671|NCT01597908|450636201|FG000|Crossover Phase|Sponsor Decision|0|||
125275672|NCT01597908|450636202|FG001|Crossover Phase|Sponsor Decision|0|||
125275673|NCT01597908|450636203|FG002|Crossover Phase|Sponsor Decision|20|||
125275674|NCT00837161|450636206|FG000|Overall Study|refused hysterectomy|2|||
125275675|NCT01659996|450636209|FG000|Overall Study|Protocol Violation|3|||
125275676|NCT01659996|450636210|FG001|Overall Study|Protocol Violation|3|||
125275677|NCT01659996|450636211|FG002|Overall Study|Protocol Violation|3|||
125275678|NCT01659996|450636209|FG000|Overall Study|Lost to Follow-up|1|||
125275679|NCT01659996|450636210|FG001|Overall Study|Lost to Follow-up|3|||
125275680|NCT01659996|450636211|FG002|Overall Study|Lost to Follow-up|2|||
125275681|NCT01659996|450636209|FG000|Overall Study|Adverse Event|0|||
125399521|NCT01573624|451094401|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125399522|NCT01573624|451094402|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
125399523|NCT01573624|451094403|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
125399524|NCT01573624|451094404|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
125399525|NCT01573624|451094398|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
125399526|NCT01573624|451094399|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
125399527|NCT01573624|451094400|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
125447780|NCT01021878|451266803|FG000|Overall Study|Transplantation|6|||
125447781|NCT01021878|451266804|FG001|Overall Study|Transplantation|1|||
125275682|NCT01659996|450636210|FG001|Overall Study|Adverse Event|0|||
125275683|NCT01659996|450636211|FG002|Overall Study|Adverse Event|1|||
125275684|NCT01659996|450636209|FG000|Overall Study|Withdrawal by Subject|4|||
125275685|NCT01659996|450636210|FG001|Overall Study|Withdrawal by Subject|1|||
125275686|NCT01659996|450636211|FG002|Overall Study|Withdrawal by Subject|5|||
125275687|NCT01059864|450636218|FG000|Open-Label Run-In Phase|Adverse Event|7|||
125275688|NCT01059864|450636219|FG001|Open-Label Run-In Phase|Adverse Event|0|||
125275689|NCT01059864|450636220|FG002|Open-Label Run-In Phase|Adverse Event|0|||
125275690|NCT01059864|450636218|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
125275691|NCT01059864|450636219|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
125275692|NCT01059864|450636220|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
125275693|NCT01059864|450636218|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
125275694|NCT01059864|450636219|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
125275695|NCT01059864|450636220|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
125275696|NCT01059864|450636218|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
125275697|NCT01059864|450636219|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
125275698|NCT01059864|450636220|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
125275699|NCT01059864|450636218|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
125275700|NCT01059864|450636219|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
125275701|NCT01059864|450636220|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
125275702|NCT01059864|450636218|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
125275703|NCT01059864|450636219|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
125275704|NCT01059864|450636220|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
125275705|NCT00451958|450636221|FG000|CS21A (NCT00451958)|Adverse Event|21|||
125275706|NCT00451958|450636222|FG001|CS21A (NCT00451958)|Adverse Event|34|||
125275707|NCT00451958|450636223|FG002|CS21A (NCT00451958)|Adverse Event|14|||
125275708|NCT00451958|450636224|FG003|CS21A (NCT00451958)|Adverse Event|17|||
125275709|NCT00451958|450636225|FG004|CS21A (NCT00451958)|Adverse Event|0|||
125275710|NCT00451958|450636221|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
125275711|NCT00451958|450636222|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
125275712|NCT00451958|450636223|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
125275713|NCT00451958|450636224|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
125275714|NCT00451958|450636225|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
125275715|NCT00451958|450636221|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
125275716|NCT00451958|450636222|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
125275717|NCT00451958|450636223|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
125275718|NCT00451958|450636224|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
125275719|NCT00451958|450636225|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
125275720|NCT00451958|450636221|FG000|CS21A (NCT00451958)|Physician Decision|2|||
125275721|NCT00451958|450636222|FG001|CS21A (NCT00451958)|Physician Decision|4|||
125275722|NCT00451958|450636223|FG002|CS21A (NCT00451958)|Physician Decision|4|||
125275723|NCT00451958|450636224|FG003|CS21A (NCT00451958)|Physician Decision|4|||
125275724|NCT00451958|450636225|FG004|CS21A (NCT00451958)|Physician Decision|0|||
125275725|NCT00451958|450636221|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
125275726|NCT00451958|450636222|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
125275727|NCT00451958|450636223|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
125275728|NCT00451958|450636224|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
125275729|NCT00451958|450636225|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
125275730|NCT00451958|450636221|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
125275731|NCT00451958|450636222|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
125275732|NCT00451958|450636223|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
125275733|NCT00451958|450636224|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
125275734|NCT00451958|450636225|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
125275735|NCT03281629|450636235|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
125275736|NCT03281629|450636236|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
125275737|NCT03281629|450636235|FG000|Overall Study|Death|0|||
125275738|NCT03281629|450636236|FG001|Overall Study|Death|1|||
125275739|NCT03281629|450636235|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
125275740|NCT03281629|450636236|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
125275741|NCT02175277|450636237|FG000|Overall Study|Protocol-specified Criteria|1|||
125275742|NCT01905943|450637906|FG000|Overall Study|Withdrawal of consent|90|||
125275743|NCT01905943|450637906|FG000|Overall Study|Lost to Follow-up|16|||
125275744|NCT01905943|450637906|FG000|Overall Study|Investigator discretion|7|||
125275745|NCT01905943|450637906|FG000|Overall Study|Death|186|||
125275746|NCT01905943|450637906|FG000|Overall Study|Adverse Event|3|||
125275747|NCT01905943|450637906|FG000|Overall Study|Other|12|||
125275748|NCT02574078|450637907|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275749|NCT02574078|450637908|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275750|NCT02574078|450637909|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275751|NCT02574078|450637910|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275752|NCT02574078|450637911|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275753|NCT02574078|450637912|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
125275754|NCT02574078|450637913|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
125275755|NCT02574078|450637914|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275756|NCT02574078|450637915|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
125275757|NCT02574078|450637916|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275758|NCT02574078|450637917|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275759|NCT02574078|450637918|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275760|NCT02574078|450637919|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125275761|NCT02574078|450637907|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
125399528|NCT01573624|451094401|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
125399529|NCT01573624|451094402|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
125399530|NCT01573624|451094403|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
125275762|NCT02574078|450637908|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
125275763|NCT02574078|450637909|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
125275764|NCT02574078|450637910|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
125275765|NCT02574078|450637911|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
125275766|NCT02574078|450637912|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
125275767|NCT02574078|450637913|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
125275768|NCT02574078|450637914|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
125275769|NCT02574078|450637915|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
125275770|NCT02574078|450637916|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
125275771|NCT02574078|450637917|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
125275772|NCT02574078|450637918|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
125275773|NCT02574078|450637919|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
125275774|NCT02574078|450637907|FG000|Pre-Treatment Period|Other reasons|0|||
125275775|NCT02574078|450637908|FG001|Pre-Treatment Period|Other reasons|0|||
125275776|NCT02574078|450637909|FG002|Pre-Treatment Period|Other reasons|0|||
125275777|NCT02574078|450637910|FG003|Pre-Treatment Period|Other reasons|0|||
125275778|NCT02574078|450637911|FG004|Pre-Treatment Period|Other reasons|0|||
125275779|NCT02574078|450637912|FG005|Pre-Treatment Period|Other reasons|0|||
125275780|NCT02574078|450637913|FG006|Pre-Treatment Period|Other reasons|2|||
125275781|NCT02574078|450637914|FG007|Pre-Treatment Period|Other reasons|0|||
125275782|NCT02574078|450637915|FG008|Pre-Treatment Period|Other reasons|0|||
125275783|NCT02574078|450637916|FG009|Pre-Treatment Period|Other reasons|0|||
125275784|NCT02574078|450637917|FG010|Pre-Treatment Period|Other reasons|2|||
125275785|NCT02574078|450637918|FG011|Pre-Treatment Period|Other reasons|0|||
125275786|NCT02574078|450637919|FG012|Pre-Treatment Period|Other reasons|0|||
125275787|NCT02574078|450637907|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
125275788|NCT02574078|450637908|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
125275789|NCT02574078|450637909|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
125275790|NCT02574078|450637910|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
125275791|NCT02574078|450637911|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
125275792|NCT02574078|450637912|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
125275793|NCT02574078|450637913|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
125275794|NCT02574078|450637914|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
125275795|NCT02574078|450637915|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
125275796|NCT02574078|450637916|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
125275797|NCT02574078|450637917|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
125275798|NCT02574078|450637918|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
125275799|NCT02574078|450637919|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
125275800|NCT02574078|450637907|FG000|Treatment Period|Disease progression|6|||
125275801|NCT02574078|450637908|FG001|Treatment Period|Disease progression|4|||
125275802|NCT02574078|450637909|FG002|Treatment Period|Disease progression|7|||
125275803|NCT02574078|450637910|FG003|Treatment Period|Disease progression|18|||
125275804|NCT02574078|450637911|FG004|Treatment Period|Disease progression|16|||
125275805|NCT02574078|450637912|FG005|Treatment Period|Disease progression|26|||
125275806|NCT02574078|450637913|FG006|Treatment Period|Disease progression|5|||
125275807|NCT02574078|450637914|FG007|Treatment Period|Disease progression|9|||
125275808|NCT02574078|450637915|FG008|Treatment Period|Disease progression|8|||
125275809|NCT02574078|450637916|FG009|Treatment Period|Disease progression|5|||
125275810|NCT02574078|450637917|FG010|Treatment Period|Disease progression|20|||
125275811|NCT02574078|450637918|FG011|Treatment Period|Disease progression|29|||
125275812|NCT02574078|450637919|FG012|Treatment Period|Disease progression|2|||
125275813|NCT02574078|450637907|FG000|Treatment Period|Study drug toxicity|1|||
125275814|NCT02574078|450637908|FG001|Treatment Period|Study drug toxicity|1|||
125275815|NCT02574078|450637909|FG002|Treatment Period|Study drug toxicity|0|||
125275816|NCT02574078|450637910|FG003|Treatment Period|Study drug toxicity|5|||
125275817|NCT02574078|450637911|FG004|Treatment Period|Study drug toxicity|3|||
125275818|NCT02574078|450637912|FG005|Treatment Period|Study drug toxicity|1|||
125275819|NCT02574078|450637913|FG006|Treatment Period|Study drug toxicity|2|||
125275820|NCT02574078|450637914|FG007|Treatment Period|Study drug toxicity|0|||
125275821|NCT02574078|450637915|FG008|Treatment Period|Study drug toxicity|2|||
125275822|NCT02574078|450637916|FG009|Treatment Period|Study drug toxicity|1|||
125399531|NCT01573624|451094404|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
125275823|NCT02574078|450637917|FG010|Treatment Period|Study drug toxicity|16|||
125275824|NCT02574078|450637918|FG011|Treatment Period|Study drug toxicity|2|||
125275825|NCT02574078|450637919|FG012|Treatment Period|Study drug toxicity|4|||
125275826|NCT02574078|450637907|FG000|Treatment Period|Death|2|||
125275827|NCT02574078|450637908|FG001|Treatment Period|Death|0|||
125275828|NCT02574078|450637909|FG002|Treatment Period|Death|0|||
125275829|NCT02574078|450637910|FG003|Treatment Period|Death|0|||
125275830|NCT02574078|450637911|FG004|Treatment Period|Death|1|||
125275831|NCT02574078|450637912|FG005|Treatment Period|Death|1|||
125275832|NCT02574078|450637913|FG006|Treatment Period|Death|1|||
125275833|NCT02574078|450637914|FG007|Treatment Period|Death|1|||
125399532|NCT01573624|451094398|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
125275834|NCT02574078|450637915|FG008|Treatment Period|Death|7|||
125275835|NCT02574078|450637916|FG009|Treatment Period|Death|1|||
125399533|NCT01573624|451094399|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125399534|NCT01573624|451094400|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125399535|NCT01573624|451094401|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125399536|NCT01573624|451094402|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
125399537|NCT01573624|451094403|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
125399538|NCT01573624|451094404|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
125399539|NCT01573624|451094398|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
125399540|NCT01573624|451094399|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
125399541|NCT01573624|451094400|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
125399542|NCT01573624|451094401|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
125399543|NCT01573624|451094402|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
125399544|NCT01573624|451094403|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
125399545|NCT01573624|451094404|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
125399546|NCT01573624|451094398|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
125399547|NCT01573624|451094399|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
125399548|NCT01573624|451094400|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
125399549|NCT01573624|451094401|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
125399550|NCT01573624|451094402|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
125399551|NCT01573624|451094403|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
125399552|NCT01573624|451094404|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
125399553|NCT01573624|451094398|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
125399554|NCT01573624|451094399|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
125399555|NCT01573624|451094400|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
125399556|NCT01573624|451094401|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
125399557|NCT01573624|451094402|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
125399558|NCT01573624|451094403|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
125399559|NCT01573624|451094404|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
125399560|NCT01573624|451094398|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
125399561|NCT01573624|451094399|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
125399562|NCT01573624|451094400|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
125399563|NCT01573624|451094401|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
125399564|NCT01573624|451094402|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
125399565|NCT01573624|451094403|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
125399566|NCT01573624|451094404|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
125399567|NCT02257736|451094420|FG000|Overall Study|Progressive disease|365|||
125399568|NCT02257736|451094421|FG001|Overall Study|Progressive disease|327|||
125399569|NCT02257736|451094420|FG000|Overall Study|Adverse Event|45|||
125399570|NCT02257736|451094421|FG001|Overall Study|Adverse Event|56|||
125399571|NCT02257736|451094420|FG000|Overall Study|Withdrawal by Subject|21|||
125399572|NCT02257736|451094421|FG001|Overall Study|Withdrawal by Subject|38|||
125399573|NCT02257736|451094420|FG000|Overall Study|Death|11|||
125399574|NCT02257736|451094421|FG001|Overall Study|Death|6|||
125399575|NCT02257736|451094420|FG000|Overall Study|Physician Decision|5|||
125399576|NCT02257736|451094421|FG001|Overall Study|Physician Decision|9|||
125399577|NCT02257736|451094420|FG000|Overall Study|Non-Compliance with study drug|1|||
125399578|NCT02257736|451094421|FG001|Overall Study|Non-Compliance with study drug|2|||
125399579|NCT02257736|451094420|FG000|Overall Study|Protocol Violation|1|||
125399580|NCT02257736|451094421|FG001|Overall Study|Protocol Violation|0|||
125399581|NCT02257736|451094420|FG000|Overall Study|Other|1|||
125399582|NCT02257736|451094421|FG001|Overall Study|Other|7|||
125399583|NCT02257736|451094420|FG000|Overall Study|Randomized, not treated|1|||
125399584|NCT02257736|451094421|FG001|Overall Study|Randomized, not treated|2|||
125399585|NCT04136912|451094422|FG000|Overall Study|Operational reasons|0|||
125399586|NCT04136912|451094423|FG001|Overall Study|Operational reasons|0|||
125399587|NCT04136912|451094424|FG002|Overall Study|Operational reasons|2|||
125399588|NCT02167256|451094425|FG000|Overall Study|Adverse Event|13|||
125399589|NCT02167256|451094426|FG001|Overall Study|Adverse Event|6|||
125399590|NCT02167256|451094425|FG000|Overall Study|Withdrawal by Subject|4|||
125399591|NCT02167256|451094426|FG001|Overall Study|Withdrawal by Subject|4|||
125399592|NCT02167256|451094425|FG000|Overall Study|non-compliance|3|||
125399593|NCT02167256|451094426|FG001|Overall Study|non-compliance|0|||
125399594|NCT02167256|451094425|FG000|Overall Study|Study partner unable to participate|1|||
125399595|NCT02167256|451094426|FG001|Overall Study|Study partner unable to participate|0|||
125399596|NCT00414388|451094429|FG000|Overall Study|Adverse Event|1|||
125447782|NCT05305040|451266808|FG000|Overall Study|Not Dosed|37|||
125447783|NCT05305040|451266809|FG001|Overall Study|Not Dosed|37|||
125399597|NCT03591575|451094430|FG000|Overall Study|Adverse Event|2|||
125399598|NCT03591575|451094431|FG001|Overall Study|Adverse Event|0|||
125399599|NCT03591575|451094430|FG000|Overall Study|Withdrawal by Subject|4|||
125399600|NCT03591575|451094431|FG001|Overall Study|Withdrawal by Subject|1|||
125399601|NCT01723228|451094432|FG000|Overall Study|Adverse Event|2|||
125399602|NCT01723228|451094433|FG001|Overall Study|Adverse Event|6|||
125399603|NCT01723228|451094432|FG000|Overall Study|Withdrawal by Subject|2|||
125399604|NCT01723228|451094433|FG001|Overall Study|Withdrawal by Subject|1|||
125399605|NCT01723228|451094432|FG000|Overall Study|Protocol Violation|0|||
125399606|NCT01723228|451094433|FG001|Overall Study|Protocol Violation|2|||
125399607|NCT01723228|451094432|FG000|Overall Study|Lost to Follow-up|2|||
125399608|NCT01723228|451094433|FG001|Overall Study|Lost to Follow-up|1|||
125399609|NCT01723228|451094432|FG000|Overall Study|Other|2|||
125399610|NCT01723228|451094433|FG001|Overall Study|Other|1|||
125399611|NCT00218543|451094434|FG000|Overall Study|Lost to Follow-up|8|||
125399612|NCT00218543|451094434|FG000|Overall Study|relocated|1|||
125399613|NCT00218543|451094434|FG000|Overall Study|Withdrawal by Subject|1|||
125399614|NCT00218543|451094434|FG000|Overall Study|Physician Decision|3|||
125399615|NCT00218543|451094434|FG000|Overall Study|Adverse Event|2|||
125399616|NCT01864291|451094435|FG000|Overall Study|need for revision surgery|2|||
125399617|NCT02448875|451094436|FG000|Overall Study|Adverse Event|2|||
125399618|NCT02448875|451094437|FG001|Overall Study|Adverse Event|1|||
125399619|NCT02448875|451094438|FG002|Overall Study|Adverse Event|0|||
125399620|NCT02448875|451094436|FG000|Overall Study|Lost to Follow-up|1|||
125399621|NCT02448875|451094437|FG001|Overall Study|Lost to Follow-up|0|||
125399622|NCT02448875|451094438|FG002|Overall Study|Lost to Follow-up|0|||
125399623|NCT02448875|451094436|FG000|Overall Study|Investigator Decision|3|||
125399624|NCT02448875|451094437|FG001|Overall Study|Investigator Decision|0|||
125399625|NCT02448875|451094438|FG002|Overall Study|Investigator Decision|1|||
125399626|NCT02448875|451094436|FG000|Overall Study|Withdrawal by Subject|1|||
125399627|NCT02448875|451094437|FG001|Overall Study|Withdrawal by Subject|0|||
125399628|NCT02448875|451094438|FG002|Overall Study|Withdrawal by Subject|0|||
125399629|NCT01451424|451094440|FG000|Overall Study|Withdrawal by Subject|1|||
125399630|NCT01451424|451094441|FG001|Overall Study|Withdrawal by Subject|1|||
125399631|NCT01451424|451094442|FG002|Overall Study|Withdrawal by Subject|0|||
125399632|NCT01451424|451094443|FG003|Overall Study|Withdrawal by Subject|2|||
125399633|NCT01451424|451094440|FG000|Overall Study|Lost to Follow-up|0|||
125399634|NCT01451424|451094441|FG001|Overall Study|Lost to Follow-up|1|||
125399635|NCT01451424|451094442|FG002|Overall Study|Lost to Follow-up|0|||
125399636|NCT01451424|451094443|FG003|Overall Study|Lost to Follow-up|1|||
125399637|NCT01451424|451094440|FG000|Overall Study|Physician Decision|0|||
125399638|NCT01451424|451094441|FG001|Overall Study|Physician Decision|0|||
125399639|NCT01451424|451094442|FG002|Overall Study|Physician Decision|1|||
125399640|NCT01451424|451094443|FG003|Overall Study|Physician Decision|1|||
125399641|NCT01451424|451094440|FG000|Overall Study|Adverse Event|0|||
125399642|NCT01451424|451094441|FG001|Overall Study|Adverse Event|0|||
125399643|NCT01451424|451094442|FG002|Overall Study|Adverse Event|0|||
125399644|NCT01451424|451094443|FG003|Overall Study|Adverse Event|1|||
125399645|NCT00689481|451094444|FG000|Overall Study|Adverse Event|7|||
125399646|NCT00689481|451094445|FG001|Overall Study|Adverse Event|1|||
125399647|NCT00689481|451094444|FG000|Overall Study|Lost to Follow-up|4|||
125399648|NCT00689481|451094445|FG001|Overall Study|Lost to Follow-up|3|||
125399649|NCT00689481|451094444|FG000|Overall Study|Lack of Efficacy|4|||
125399650|NCT00689481|451094445|FG001|Overall Study|Lack of Efficacy|3|||
125399651|NCT00689481|451094444|FG000|Overall Study|Non-compliance with study treatment|1|||
125399652|NCT00689481|451094445|FG001|Overall Study|Non-compliance with study treatment|1|||
125399653|NCT00689481|451094444|FG000|Overall Study|Withdrawal by Subject|8|||
125399654|NCT00689481|451094445|FG001|Overall Study|Withdrawal by Subject|4|||
125399655|NCT00689481|451094444|FG000|Overall Study|Excluded medication started during study|0|||
125399656|NCT00689481|451094445|FG001|Overall Study|Excluded medication started during study|1|||
125399657|NCT00689481|451094444|FG000|Overall Study|Subject early term, left on vacation|0|||
125399658|NCT00689481|451094445|FG001|Overall Study|Subject early term, left on vacation|1|||
125399659|NCT03390504|451094446|FG000|Overall Study|Lost to Follow-up|2|||
125399660|NCT03390504|451094447|FG001|Overall Study|Lost to Follow-up|4|||
125399661|NCT03390504|451094448|FG002|Overall Study|Lost to Follow-up|0|||
125399662|NCT03390504|451094449|FG003|Overall Study|Lost to Follow-up|1|||
125399663|NCT03390504|451094446|FG000|Overall Study|Withdrawal by Subject|3|||
125447784|NCT05305040|451266808|FG000|Overall Study|Study Closure|34|||
125447785|NCT05305040|451266809|FG001|Overall Study|Study Closure|46|||
125447786|NCT05305040|451266808|FG000|Overall Study|Death|14|||
125399664|NCT03390504|451094447|FG001|Overall Study|Withdrawal by Subject|15|||
125447787|NCT05305040|451266809|FG001|Overall Study|Death|13|||
125447788|NCT05305040|451266808|FG000|Overall Study|Withdrawal by Subject|15|||
125399665|NCT03390504|451094448|FG002|Overall Study|Withdrawal by Subject|5|||
125399666|NCT03390504|451094449|FG003|Overall Study|Withdrawal by Subject|2|||
125399667|NCT03390504|451094446|FG000|Overall Study|Other|1|||
125399668|NCT03390504|451094447|FG001|Overall Study|Other|2|||
125399669|NCT03390504|451094448|FG002|Overall Study|Other|2|||
125447789|NCT05305040|451266809|FG001|Overall Study|Withdrawal by Subject|10|||
125399670|NCT03390504|451094449|FG003|Overall Study|Other|6|||
125447790|NCT05305040|451266808|FG000|Overall Study|Other|13|||
125399671|NCT03508219|451094450|FG000|Overall Study|Death|2|||
125399672|NCT03508219|451094450|FG000|Overall Study|Withdrawal by Subject|1|||
125399673|NCT03508219|451094450|FG000|Overall Study|Lost to Follow-up|4|||
125399674|NCT03508219|451094450|FG000|Overall Study|Missed visit|2|||
125399675|NCT02254278|451094453|FG000|Overall Study|Protocol Violation|1|||
125399676|NCT02254278|451094454|FG001|Overall Study|Protocol Violation|1|||
125399677|NCT02782949|451094456|FG000|Overall Study|Protocol Violation|1|||
125399678|NCT02782949|451094457|FG001|Overall Study|Protocol Violation|0|||
125399679|NCT02782949|451094456|FG000|Overall Study|Withdrawal by Subject|0|||
125399680|NCT02782949|451094457|FG001|Overall Study|Withdrawal by Subject|1|||
125399681|NCT04745689|451094458|FG000|Overall Study|Death|9|||
125399682|NCT04745689|451094459|FG001|Overall Study|Death|6|||
125399683|NCT04745689|451094458|FG000|Overall Study|Lost to Follow-up|1|||
125399684|NCT04745689|451094459|FG001|Overall Study|Lost to Follow-up|0|||
125399685|NCT04745689|451094458|FG000|Overall Study|Withdrawal by Subject|2|||
125399686|NCT04745689|451094459|FG001|Overall Study|Withdrawal by Subject|0|||
125399687|NCT04745689|451094458|FG000|Overall Study|Study terminated by sponsor|10|||
125399688|NCT04745689|451094459|FG001|Overall Study|Study terminated by sponsor|3|||
125399689|NCT05645432|451094460|FG000|Overall Study|Withdrawal by Subject|1|||
125399690|NCT02472756|451095470|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
125399691|NCT02472756|451095470|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
125399692|NCT02472756|451095470|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
125399693|NCT02472756|451095470|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
125399694|NCT02472756|451095470|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
125399695|NCT00110266|451095474|FG000|Overall Study|Adverse Event|27|||
125399696|NCT00110266|451095474|FG000|Overall Study|Abnormal laboratory value|15|||
125399697|NCT00110266|451095474|FG000|Overall Study|Withdrawal by Subject|16|||
125399698|NCT00110266|451095474|FG000|Overall Study|Death|17|||
125399699|NCT00110266|451095474|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125399700|NCT00110266|451095474|FG000|Overall Study|Participant condition no longer requires study drug|1|||
125399701|NCT02896400|451095475|FG000|1 Month Follow-up|Lost to Follow-up|7|||
125399702|NCT02896400|451095476|FG001|1 Month Follow-up|Lost to Follow-up|7|||
125399703|NCT02896400|451095477|FG002|1 Month Follow-up|Lost to Follow-up|5|||
125399704|NCT02896400|451095478|FG003|1 Month Follow-up|Lost to Follow-up|8|||
125399705|NCT02896400|451095479|FG004|1 Month Follow-up|Lost to Follow-up|9|||
125399706|NCT02896400|451095480|FG005|1 Month Follow-up|Lost to Follow-up|6|||
125399707|NCT02896400|451095481|FG006|1 Month Follow-up|Lost to Follow-up|5|||
125399708|NCT02896400|451095482|FG007|1 Month Follow-up|Lost to Follow-up|6|||
125399709|NCT02896400|451095483|FG008|1 Month Follow-up|Lost to Follow-up|4|||
125399710|NCT02896400|451095484|FG009|1 Month Follow-up|Lost to Follow-up|7|||
125399711|NCT02896400|451095485|FG010|1 Month Follow-up|Lost to Follow-up|5|||
125399712|NCT02896400|451095486|FG011|1 Month Follow-up|Lost to Follow-up|5|||
125399713|NCT02896400|451095487|FG012|1 Month Follow-up|Lost to Follow-up|3|||
125399714|NCT02896400|451095488|FG013|1 Month Follow-up|Lost to Follow-up|4|||
125399715|NCT02896400|451095489|FG014|1 Month Follow-up|Lost to Follow-up|1|||
125399716|NCT02896400|451095490|FG015|1 Month Follow-up|Lost to Follow-up|2|||
125399717|NCT02896400|451095475|FG000|1 Month Follow-up|Death|0|||
125399718|NCT02896400|451095476|FG001|1 Month Follow-up|Death|0|||
125399719|NCT02896400|451095477|FG002|1 Month Follow-up|Death|0|||
125399720|NCT02896400|451095478|FG003|1 Month Follow-up|Death|0|||
125399721|NCT02896400|451095479|FG004|1 Month Follow-up|Death|0|||
125399722|NCT02896400|451095480|FG005|1 Month Follow-up|Death|0|||
125399723|NCT02896400|451095481|FG006|1 Month Follow-up|Death|0|||
125399724|NCT02896400|451095482|FG007|1 Month Follow-up|Death|0|||
125399725|NCT02896400|451095483|FG008|1 Month Follow-up|Death|0|||
125399726|NCT02896400|451095484|FG009|1 Month Follow-up|Death|0|||
125399727|NCT02896400|451095485|FG010|1 Month Follow-up|Death|0|||
125399728|NCT02896400|451095486|FG011|1 Month Follow-up|Death|0|||
125399729|NCT02896400|451095487|FG012|1 Month Follow-up|Death|0|||
125399730|NCT02896400|451095488|FG013|1 Month Follow-up|Death|0|||
125399731|NCT02896400|451095489|FG014|1 Month Follow-up|Death|0|||
125399732|NCT02896400|451095490|FG015|1 Month Follow-up|Death|1|||
125399733|NCT02896400|451095475|FG000|3 Month Follow-up|Lost to Follow-up|6|||
125399734|NCT02896400|451095476|FG001|3 Month Follow-up|Lost to Follow-up|3|||
125399735|NCT02896400|451095477|FG002|3 Month Follow-up|Lost to Follow-up|6|||
125399736|NCT02896400|451095478|FG003|3 Month Follow-up|Lost to Follow-up|11|||
125399737|NCT02896400|451095479|FG004|3 Month Follow-up|Lost to Follow-up|12|||
125399738|NCT02896400|451095480|FG005|3 Month Follow-up|Lost to Follow-up|6|||
125399739|NCT02896400|451095481|FG006|3 Month Follow-up|Lost to Follow-up|4|||
125447791|NCT05305040|451266809|FG001|Overall Study|Other|10|||
125275836|NCT02574078|450637917|FG010|Treatment Period|Death|0|||
125399740|NCT02896400|451095482|FG007|3 Month Follow-up|Lost to Follow-up|3|||
125399741|NCT02896400|451095483|FG008|3 Month Follow-up|Lost to Follow-up|6|||
125399742|NCT02896400|451095484|FG009|3 Month Follow-up|Lost to Follow-up|5|||
125399743|NCT02896400|451095485|FG010|3 Month Follow-up|Lost to Follow-up|6|||
125399744|NCT02896400|451095486|FG011|3 Month Follow-up|Lost to Follow-up|6|||
125399745|NCT02896400|451095487|FG012|3 Month Follow-up|Lost to Follow-up|3|||
125399746|NCT02896400|451095488|FG013|3 Month Follow-up|Lost to Follow-up|5|||
125399747|NCT02896400|451095489|FG014|3 Month Follow-up|Lost to Follow-up|3|||
125399748|NCT02896400|451095490|FG015|3 Month Follow-up|Lost to Follow-up|2|||
125399749|NCT02896400|451095475|FG000|3 Month Follow-up|Death|0|||
125399750|NCT02896400|451095476|FG001|3 Month Follow-up|Death|0|||
125399751|NCT02896400|451095477|FG002|3 Month Follow-up|Death|0|||
125399752|NCT02896400|451095478|FG003|3 Month Follow-up|Death|0|||
125399753|NCT02896400|451095479|FG004|3 Month Follow-up|Death|0|||
125399754|NCT02896400|451095480|FG005|3 Month Follow-up|Death|0|||
125399755|NCT02896400|451095481|FG006|3 Month Follow-up|Death|0|||
125399756|NCT02896400|451095482|FG007|3 Month Follow-up|Death|0|||
125399757|NCT02896400|451095483|FG008|3 Month Follow-up|Death|0|||
125399758|NCT02896400|451095484|FG009|3 Month Follow-up|Death|0|||
125399759|NCT02896400|451095485|FG010|3 Month Follow-up|Death|0|||
125399760|NCT02896400|451095486|FG011|3 Month Follow-up|Death|0|||
125399761|NCT02896400|451095487|FG012|3 Month Follow-up|Death|0|||
125399762|NCT02896400|451095488|FG013|3 Month Follow-up|Death|1|||
125399763|NCT02896400|451095489|FG014|3 Month Follow-up|Death|1|||
125399764|NCT02896400|451095490|FG015|3 Month Follow-up|Death|0|||
125399765|NCT02896400|451095475|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125399766|NCT02896400|451095476|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
125399767|NCT02896400|451095477|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125399768|NCT02896400|451095478|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125399769|NCT02896400|451095479|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
125399770|NCT02896400|451095480|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125399771|NCT02896400|451095481|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
125399772|NCT02896400|451095482|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
125399773|NCT02896400|451095483|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125399774|NCT02896400|451095484|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125399775|NCT02896400|451095485|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
125399776|NCT02896400|451095486|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
125399777|NCT02896400|451095487|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125399778|NCT02896400|451095488|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
125399779|NCT02896400|451095489|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
125399780|NCT02896400|451095490|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
125399781|NCT02896400|451095475|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
125399782|NCT02896400|451095476|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
125399783|NCT02896400|451095477|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
125399784|NCT02896400|451095478|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
125399785|NCT02896400|451095479|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
125399786|NCT02896400|451095480|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
125399787|NCT02896400|451095481|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
125399788|NCT02896400|451095482|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
125399789|NCT02896400|451095483|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
125399790|NCT02896400|451095484|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
125399791|NCT02896400|451095485|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
125399792|NCT02896400|451095486|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
125399793|NCT02896400|451095487|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
125399794|NCT02896400|451095488|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
125399795|NCT02896400|451095489|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
125399796|NCT02896400|451095490|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
125399797|NCT02488629|451095491|FG000|Overall Study|Lack of Efficacy|3|||
125399798|NCT02488629|451095492|FG001|Overall Study|Lack of Efficacy|1|||
125399799|NCT02488629|451095493|FG002|Overall Study|Lack of Efficacy|0|||
125399800|NCT02488629|451095494|FG003|Overall Study|Lack of Efficacy|0|||
125399801|NCT02488629|451095491|FG000|Overall Study|Withdrawal by Subject|0|||
125399802|NCT02488629|451095492|FG001|Overall Study|Withdrawal by Subject|1|||
125399803|NCT02488629|451095493|FG002|Overall Study|Withdrawal by Subject|0|||
125399804|NCT02488629|451095494|FG003|Overall Study|Withdrawal by Subject|0|||
125399805|NCT02940691|451095495|FG000|Overall Study|Lost to Follow-up|5|||
125399806|NCT02940691|451095495|FG000|Overall Study|Incarceration|1|||
125399807|NCT03912233|451095496|FG000|Overall Study|Adverse Event|1|||
125399808|NCT03912233|451095497|FG001|Overall Study|Adverse Event|0|||
125399809|NCT03912233|451095498|FG002|Overall Study|Adverse Event|0|||
125399810|NCT03912233|451095499|FG003|Overall Study|Adverse Event|0|||
125399811|NCT03912233|451095500|FG004|Overall Study|Adverse Event|0|||
125399812|NCT03912233|451095501|FG005|Overall Study|Adverse Event|0|||
125399813|NCT03912233|451095496|FG000|Overall Study|Physician Decision|1|||
125399814|NCT03912233|451095497|FG001|Overall Study|Physician Decision|0|||
125399815|NCT03912233|451095498|FG002|Overall Study|Physician Decision|0|||
125399816|NCT03912233|451095499|FG003|Overall Study|Physician Decision|0|||
125399817|NCT03912233|451095500|FG004|Overall Study|Physician Decision|0|||
125399818|NCT03912233|451095501|FG005|Overall Study|Physician Decision|0|||
125399819|NCT03912233|451095496|FG000|Overall Study|Other|0|||
125275837|NCT02574078|450637918|FG011|Treatment Period|Death|2|||
125275838|NCT02574078|450637919|FG012|Treatment Period|Death|1|||
125399820|NCT03912233|451095497|FG001|Overall Study|Other|0|||
125399821|NCT03912233|451095498|FG002|Overall Study|Other|0|||
125399822|NCT03912233|451095499|FG003|Overall Study|Other|0|||
125399823|NCT03912233|451095500|FG004|Overall Study|Other|7|||
125399824|NCT03912233|451095501|FG005|Overall Study|Other|12|||
125399825|NCT02177266|451095502|FG000|Overall Study|Adverse Event|0|||
125399826|NCT02177266|451095503|FG001|Overall Study|Adverse Event|1|||
125399827|NCT02177266|451095502|FG000|Overall Study|Withdrawal by Subject|1|||
125399828|NCT02177266|451095503|FG001|Overall Study|Withdrawal by Subject|0|||
125399829|NCT00546715|451095505|FG000|Overall Study|Withdrawal by Subject|0|||
125399830|NCT00546715|451095506|FG001|Overall Study|Withdrawal by Subject|1|||
125399831|NCT00546715|451095507|FG002|Overall Study|Withdrawal by Subject|0|||
125399832|NCT00546715|451095508|FG003|Overall Study|Withdrawal by Subject|0|||
125399833|NCT00723606|451095509|FG000|Overall Study|Adverse Event|2|||
125399834|NCT00723606|451095510|FG001|Overall Study|Adverse Event|5|||
125399835|NCT00723606|451095509|FG000|Overall Study|Other|2|||
125399836|NCT00723606|451095510|FG001|Overall Study|Other|0|||
125399837|NCT00723606|451095509|FG000|Overall Study|Withdrawal by Subject|0|||
125399838|NCT00723606|451095510|FG001|Overall Study|Withdrawal by Subject|2|||
125399839|NCT01502644|451095513|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
125399840|NCT01502644|451095514|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
125399841|NCT01502644|451095515|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
125399842|NCT01502644|451095516|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
125399843|NCT01502644|451095513|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
125399844|NCT01502644|451095514|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
125399845|NCT01502644|451095515|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
125399846|NCT01502644|451095516|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
125399847|NCT01502644|451095513|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
125399848|NCT01502644|451095514|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
125399849|NCT01502644|451095515|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
125399850|NCT01502644|451095516|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
125399851|NCT01502644|451095513|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
125399852|NCT01502644|451095514|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
125399853|NCT01502644|451095515|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
125399854|NCT01502644|451095516|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
125399855|NCT01502644|451095513|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
125399856|NCT01502644|451095514|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
125399857|NCT01502644|451095515|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
125399858|NCT01502644|451095516|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
125399859|NCT00637195|451095517|FG000|Overall Study|Lost to Follow-up|1|||
125399860|NCT00637195|451095518|FG001|Overall Study|Lost to Follow-up|0|||
125399861|NCT00637195|451095517|FG000|Overall Study|Other|2|||
125399862|NCT00637195|451095518|FG001|Overall Study|Other|0|||
125399863|NCT00637195|451095517|FG000|Overall Study|Withdrawal by Subject|0|||
125399864|NCT00637195|451095518|FG001|Overall Study|Withdrawal by Subject|1|||
125399865|NCT02388997|451095519|FG000|Overall Study|Adverse Event|1|||
125399866|NCT02388997|451095520|FG001|Overall Study|Adverse Event|2|||
125399867|NCT02388997|451095519|FG000|Overall Study|Withdrawal by Subject|2|||
125399868|NCT02388997|451095520|FG001|Overall Study|Withdrawal by Subject|1|||
125399869|NCT02388997|451095519|FG000|Overall Study|Lung function exclusion criteria|0|||
125399870|NCT02388997|451095520|FG001|Overall Study|Lung function exclusion criteria|2|||
125399871|NCT02388997|451095519|FG000|Overall Study|Tested positive for virus during run-in|0|||
125399872|NCT02388997|451095520|FG001|Overall Study|Tested positive for virus during run-in|1|||
125399873|NCT03025828|451095521|FG000|Overall Study|Lost to Follow-up|1|||
125399874|NCT01020019|451095522|FG000|Overall Study|Lost to Follow-up|21|||
125399875|NCT01020019|451095523|FG001|Overall Study|Lost to Follow-up|18|||
125399876|NCT01020019|451095522|FG000|Overall Study|Adverse Event|1|||
125399877|NCT01020019|451095523|FG001|Overall Study|Adverse Event|5|||
125399878|NCT01020019|451095522|FG000|Overall Study|not interested in treatment|4|||
125399879|NCT01020019|451095523|FG001|Overall Study|not interested in treatment|4|||
125447792|NCT05305040|451266808|FG000|Overall Study|Primary Malignancy Relapse|3|||
125447793|NCT05305040|451266809|FG001|Overall Study|Primary Malignancy Relapse|4|||
125447794|NCT05305040|451266808|FG000|Overall Study|Adverse Event|3|||
125447795|NCT05305040|451266809|FG001|Overall Study|Adverse Event|3|||
125447796|NCT05305040|451266808|FG000|Overall Study|Lost to Follow-up|2|||
125447797|NCT05305040|451266809|FG001|Overall Study|Lost to Follow-up|1|||
125275839|NCT02574078|450637907|FG000|Treatment Period|Adverse event unrelated to drug|0|||
125275840|NCT02574078|450637908|FG001|Treatment Period|Adverse event unrelated to drug|0|||
125399880|NCT01020019|451095522|FG000|Overall Study|moving|0|||
125447798|NCT05305040|451266808|FG000|Overall Study|Graft versus host disease|2|||
125447799|NCT05305040|451266809|FG001|Overall Study|Graft versus host disease|0|||
125447800|NCT05305040|451266808|FG000|Overall Study|Investigator's Decision|1|||
125399881|NCT01020019|451095523|FG001|Overall Study|moving|2|||
125399882|NCT02375672|451095524|FG000|Overall Study|remain on follow up|20|||
125399883|NCT01559311|451095525|FG000|Overall Study|Protocol Violation|0|||
125399884|NCT01559311|451095526|FG001|Overall Study|Protocol Violation|0|||
125399885|NCT01559311|451095527|FG002|Overall Study|Protocol Violation|2|||
125399886|NCT01559311|451095525|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
125399887|NCT01559311|451095526|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
125399888|NCT01559311|451095527|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
125399889|NCT01559311|451095525|FG000|Overall Study|Withdrawal by Subject|2|||
125399890|NCT01559311|451095526|FG001|Overall Study|Withdrawal by Subject|1|||
125399891|NCT01559311|451095527|FG002|Overall Study|Withdrawal by Subject|0|||
125399892|NCT01559311|451095525|FG000|Overall Study|Death|0|||
125399893|NCT01559311|451095526|FG001|Overall Study|Death|2|||
125399894|NCT01559311|451095527|FG002|Overall Study|Death|3|||
125399895|NCT01559311|451095525|FG000|Overall Study|Lost to Follow-up|0|||
125399896|NCT01559311|451095526|FG001|Overall Study|Lost to Follow-up|3|||
125399897|NCT01559311|451095527|FG002|Overall Study|Lost to Follow-up|2|||
125399898|NCT01559311|451095525|FG000|Overall Study|Adverse Event|0|||
125399899|NCT01559311|451095526|FG001|Overall Study|Adverse Event|0|||
125399900|NCT01559311|451095527|FG002|Overall Study|Adverse Event|1|||
125399901|NCT02346240|451095529|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399902|NCT02346240|451095530|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
125399903|NCT02346240|451095531|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
125399904|NCT02346240|451095532|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
125399905|NCT02346240|451095533|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399906|NCT02346240|451095534|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399907|NCT02346240|451095535|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399908|NCT02346240|451095536|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399909|NCT02346240|451095537|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399910|NCT02346240|451095538|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399911|NCT02346240|451095539|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399912|NCT02346240|451095540|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399913|NCT02346240|451095541|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399914|NCT02346240|451095542|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399915|NCT02346240|451095543|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399916|NCT02346240|451095544|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399917|NCT02346240|451095545|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399918|NCT02346240|451095546|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399919|NCT02346240|451095547|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399920|NCT02346240|451095548|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399921|NCT02346240|451095549|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399922|NCT02346240|451095550|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399923|NCT02346240|451095551|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399924|NCT02346240|451095552|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
125399925|NCT02346240|451095529|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399926|NCT02346240|451095530|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
125399927|NCT02346240|451095531|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399928|NCT02346240|451095532|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399929|NCT02346240|451095533|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399930|NCT02346240|451095534|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399931|NCT02346240|451095535|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399932|NCT02346240|451095536|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399933|NCT02346240|451095537|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399934|NCT02346240|451095538|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399935|NCT02346240|451095539|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399936|NCT02346240|451095540|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399937|NCT02346240|451095541|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125447801|NCT05305040|451266809|FG001|Overall Study|Investigator's Decision|1|||
125275841|NCT02574078|450637909|FG002|Treatment Period|Adverse event unrelated to drug|1|||
125275842|NCT02574078|450637910|FG003|Treatment Period|Adverse event unrelated to drug|0|||
125275843|NCT02574078|450637911|FG004|Treatment Period|Adverse event unrelated to drug|2|||
125275844|NCT02574078|450637912|FG005|Treatment Period|Adverse event unrelated to drug|3|||
125275845|NCT02574078|450637913|FG006|Treatment Period|Adverse event unrelated to drug|0|||
125275846|NCT02574078|450637914|FG007|Treatment Period|Adverse event unrelated to drug|0|||
125275847|NCT02574078|450637915|FG008|Treatment Period|Adverse event unrelated to drug|1|||
125275848|NCT02574078|450637916|FG009|Treatment Period|Adverse event unrelated to drug|2|||
125275849|NCT02574078|450637917|FG010|Treatment Period|Adverse event unrelated to drug|4|||
125399938|NCT02346240|451095542|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399939|NCT02346240|451095543|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125447802|NCT05305040|451266808|FG000|Overall Study|COVID-19 Reasons|1|||
125275850|NCT02574078|450637918|FG011|Treatment Period|Adverse event unrelated to drug|1|||
125275851|NCT02574078|450637919|FG012|Treatment Period|Adverse event unrelated to drug|0|||
125275852|NCT02574078|450637907|FG000|Treatment Period|Administrative reason by Sponsor|0|||
125275853|NCT02574078|450637908|FG001|Treatment Period|Administrative reason by Sponsor|1|||
125275854|NCT02574078|450637909|FG002|Treatment Period|Administrative reason by Sponsor|0|||
125275855|NCT02574078|450637910|FG003|Treatment Period|Administrative reason by Sponsor|0|||
125275856|NCT02574078|450637911|FG004|Treatment Period|Administrative reason by Sponsor|0|||
125275857|NCT02574078|450637912|FG005|Treatment Period|Administrative reason by Sponsor|0|||
125275858|NCT02574078|450637913|FG006|Treatment Period|Administrative reason by Sponsor|1|||
125275859|NCT02574078|450637914|FG007|Treatment Period|Administrative reason by Sponsor|0|||
125275860|NCT02574078|450637915|FG008|Treatment Period|Administrative reason by Sponsor|0|||
125275861|NCT02574078|450637916|FG009|Treatment Period|Administrative reason by Sponsor|0|||
125275862|NCT02574078|450637917|FG010|Treatment Period|Administrative reason by Sponsor|0|||
125275863|NCT02574078|450637918|FG011|Treatment Period|Administrative reason by Sponsor|0|||
125275864|NCT02574078|450637919|FG012|Treatment Period|Administrative reason by Sponsor|3|||
125275865|NCT02574078|450637907|FG000|Treatment Period|Other reasons|1|||
125275866|NCT02574078|450637908|FG001|Treatment Period|Other reasons|0|||
125275867|NCT02574078|450637909|FG002|Treatment Period|Other reasons|1|||
125275868|NCT02574078|450637910|FG003|Treatment Period|Other reasons|3|||
125275869|NCT02574078|450637911|FG004|Treatment Period|Other reasons|3|||
125275870|NCT02574078|450637912|FG005|Treatment Period|Other reasons|1|||
125275871|NCT02574078|450637913|FG006|Treatment Period|Other reasons|2|||
125275872|NCT02574078|450637914|FG007|Treatment Period|Other reasons|1|||
125275873|NCT02574078|450637915|FG008|Treatment Period|Other reasons|3|||
125275874|NCT02574078|450637916|FG009|Treatment Period|Other reasons|1|||
125275875|NCT02574078|450637917|FG010|Treatment Period|Other reasons|1|||
125275876|NCT02574078|450637918|FG011|Treatment Period|Other reasons|3|||
125275877|NCT02574078|450637919|FG012|Treatment Period|Other reasons|1|||
125275878|NCT02574078|450637907|FG000|Treatment Period|Participant request to stop drug|0|||
125275879|NCT02574078|450637908|FG001|Treatment Period|Participant request to stop drug|0|||
125275880|NCT02574078|450637909|FG002|Treatment Period|Participant request to stop drug|0|||
125275881|NCT02574078|450637910|FG003|Treatment Period|Participant request to stop drug|2|||
125275882|NCT02574078|450637911|FG004|Treatment Period|Participant request to stop drug|4|||
125275883|NCT02574078|450637912|FG005|Treatment Period|Participant request to stop drug|0|||
125275884|NCT02574078|450637913|FG006|Treatment Period|Participant request to stop drug|1|||
125275885|NCT02574078|450637914|FG007|Treatment Period|Participant request to stop drug|0|||
125275886|NCT02574078|450637915|FG008|Treatment Period|Participant request to stop drug|3|||
125275887|NCT02574078|450637916|FG009|Treatment Period|Participant request to stop drug|2|||
125275888|NCT02574078|450637917|FG010|Treatment Period|Participant request to stop drug|2|||
125275889|NCT02574078|450637918|FG011|Treatment Period|Participant request to stop drug|4|||
125275890|NCT02574078|450637919|FG012|Treatment Period|Participant request to stop drug|1|||
125275891|NCT02574078|450637907|FG000|Treatment Period|Participant withdrew consent|0|||
125275892|NCT02574078|450637908|FG001|Treatment Period|Participant withdrew consent|0|||
125275893|NCT02574078|450637909|FG002|Treatment Period|Participant withdrew consent|0|||
125275894|NCT02574078|450637910|FG003|Treatment Period|Participant withdrew consent|0|||
125275895|NCT02574078|450637911|FG004|Treatment Period|Participant withdrew consent|1|||
125275896|NCT02574078|450637912|FG005|Treatment Period|Participant withdrew consent|1|||
125275897|NCT02574078|450637913|FG006|Treatment Period|Participant withdrew consent|0|||
125275898|NCT02574078|450637914|FG007|Treatment Period|Participant withdrew consent|1|||
125275899|NCT02574078|450637915|FG008|Treatment Period|Participant withdrew consent|0|||
125275900|NCT02574078|450637916|FG009|Treatment Period|Participant withdrew consent|2|||
125275901|NCT02574078|450637917|FG010|Treatment Period|Participant withdrew consent|1|||
125275902|NCT02574078|450637918|FG011|Treatment Period|Participant withdrew consent|4|||
125275903|NCT02574078|450637919|FG012|Treatment Period|Participant withdrew consent|1|||
125275904|NCT02574078|450637907|FG000|Treatment Period|Participant no longer meets criteria|0|||
125275905|NCT02574078|450637908|FG001|Treatment Period|Participant no longer meets criteria|0|||
125275906|NCT02574078|450637909|FG002|Treatment Period|Participant no longer meets criteria|0|||
125275907|NCT02574078|450637910|FG003|Treatment Period|Participant no longer meets criteria|0|||
125275908|NCT02574078|450637911|FG004|Treatment Period|Participant no longer meets criteria|1|||
125275909|NCT02574078|450637912|FG005|Treatment Period|Participant no longer meets criteria|0|||
125275910|NCT02574078|450637913|FG006|Treatment Period|Participant no longer meets criteria|0|||
125275911|NCT02574078|450637914|FG007|Treatment Period|Participant no longer meets criteria|0|||
125275912|NCT02574078|450637915|FG008|Treatment Period|Participant no longer meets criteria|0|||
125275913|NCT02574078|450637916|FG009|Treatment Period|Participant no longer meets criteria|1|||
125275914|NCT02574078|450637917|FG010|Treatment Period|Participant no longer meets criteria|1|||
125275915|NCT02574078|450637918|FG011|Treatment Period|Participant no longer meets criteria|1|||
125275916|NCT02574078|450637919|FG012|Treatment Period|Participant no longer meets criteria|0|||
125275917|NCT02574078|450637907|FG000|Treatment Period|Lost to Follow-up|0|||
125275918|NCT02574078|450637908|FG001|Treatment Period|Lost to Follow-up|0|||
125275919|NCT02574078|450637909|FG002|Treatment Period|Lost to Follow-up|0|||
125275920|NCT02574078|450637910|FG003|Treatment Period|Lost to Follow-up|0|||
125399940|NCT02346240|451095544|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399941|NCT02346240|451095545|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399942|NCT02346240|451095546|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399943|NCT02346240|451095547|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399944|NCT02346240|451095548|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399945|NCT02346240|451095549|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399946|NCT02346240|451095550|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399947|NCT02346240|451095551|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399948|NCT02346240|451095552|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
125399949|NCT02346240|451095529|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399950|NCT02346240|451095530|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
125399951|NCT02346240|451095531|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399952|NCT02346240|451095532|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399953|NCT02346240|451095533|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399954|NCT02346240|451095534|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399955|NCT02346240|451095535|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399956|NCT02346240|451095536|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399957|NCT02346240|451095537|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399958|NCT02346240|451095538|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399959|NCT02346240|451095539|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399960|NCT02346240|451095540|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399961|NCT02346240|451095541|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399962|NCT02346240|451095542|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399963|NCT02346240|451095543|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399964|NCT02346240|451095544|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399965|NCT02346240|451095545|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399966|NCT02346240|451095546|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399967|NCT02346240|451095547|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399968|NCT02346240|451095548|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399969|NCT02346240|451095549|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399970|NCT02346240|451095550|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399971|NCT02346240|451095551|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399972|NCT02346240|451095552|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
125399973|NCT02346240|451095529|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
125399974|NCT02346240|451095530|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
125399975|NCT02346240|451095531|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
125399976|NCT02346240|451095532|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
125399977|NCT02346240|451095533|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399978|NCT02346240|451095534|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399979|NCT02346240|451095535|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399980|NCT02346240|451095536|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399981|NCT02346240|451095537|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399982|NCT02346240|451095538|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399983|NCT02346240|451095539|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399984|NCT02346240|451095540|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399985|NCT02346240|451095541|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399986|NCT02346240|451095542|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399987|NCT02346240|451095543|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399988|NCT02346240|451095544|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399989|NCT02346240|451095545|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399990|NCT02346240|451095546|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399991|NCT02346240|451095547|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399992|NCT02346240|451095548|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399993|NCT02346240|451095549|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399994|NCT02346240|451095550|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399995|NCT02346240|451095551|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125447803|NCT05305040|451266809|FG001|Overall Study|COVID-19 Reasons|0|||
125447804|NCT00465361|451266810|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
125447805|NCT01333943|451266814|FG000|Overall Study|Known neuropathy|1|||
125447806|NCT01333943|451266815|FG001|Overall Study|Known neuropathy|0|||
125447807|NCT00723294|451266824|FG000|Overall Study|Lobular histology|2|||
125447808|NCT00723294|451266824|FG000|Overall Study|>25% intraductal component|1|||
125447809|NCT00723294|451266824|FG000|Overall Study|No MRI tumor enhancement|1|||
125447810|NCT00723294|451266824|FG000|Overall Study|1.0-Tesla MRI|1|||
125275921|NCT02574078|450637911|FG004|Treatment Period|Lost to Follow-up|0|||
125275922|NCT02574078|450637912|FG005|Treatment Period|Lost to Follow-up|0|||
125275923|NCT02574078|450637913|FG006|Treatment Period|Lost to Follow-up|0|||
125399996|NCT02346240|451095552|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
125399997|NCT02346240|451095529|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
125399998|NCT02346240|451095530|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
125399999|NCT02346240|451095531|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
125400000|NCT02346240|451095532|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
125400001|NCT02346240|451095533|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400002|NCT02346240|451095534|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400003|NCT02346240|451095535|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400004|NCT02346240|451095536|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400005|NCT02346240|451095537|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400006|NCT02346240|451095538|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400007|NCT02346240|451095539|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400008|NCT02346240|451095540|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400009|NCT02346240|451095541|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400010|NCT02346240|451095542|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400011|NCT02346240|451095543|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400012|NCT02346240|451095544|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400013|NCT02346240|451095545|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400014|NCT02346240|451095546|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400015|NCT02346240|451095547|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400016|NCT02346240|451095548|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400017|NCT02346240|451095549|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400018|NCT02346240|451095550|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400019|NCT02346240|451095551|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400020|NCT02346240|451095552|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
125400021|NCT02346240|451095529|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400022|NCT02346240|451095530|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
125400023|NCT02346240|451095531|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400024|NCT02346240|451095532|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
125400025|NCT02346240|451095533|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400026|NCT02346240|451095534|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400027|NCT02346240|451095535|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400028|NCT02346240|451095536|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400029|NCT02346240|451095537|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400030|NCT02346240|451095538|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400031|NCT02346240|451095539|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400032|NCT02346240|451095540|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400033|NCT02346240|451095541|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400034|NCT02346240|451095542|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400035|NCT02346240|451095543|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400036|NCT02346240|451095544|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400037|NCT02346240|451095545|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400038|NCT02346240|451095546|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400039|NCT02346240|451095547|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400040|NCT02346240|451095548|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400041|NCT02346240|451095549|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400042|NCT02346240|451095550|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400043|NCT02346240|451095551|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400044|NCT02346240|451095552|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
125400045|NCT02346240|451095529|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400046|NCT02346240|451095530|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400047|NCT02346240|451095531|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
125400048|NCT02346240|451095532|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400049|NCT02346240|451095533|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400050|NCT02346240|451095534|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400051|NCT02346240|451095535|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400052|NCT02346240|451095536|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400053|NCT02346240|451095537|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400054|NCT02346240|451095538|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400055|NCT02346240|451095539|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400056|NCT02346240|451095540|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125447811|NCT00723294|451266824|FG000|Overall Study|No cryoabalation|2|||
125275924|NCT02574078|450637914|FG007|Treatment Period|Lost to Follow-up|0|||
125400057|NCT02346240|451095541|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400058|NCT02346240|451095542|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400059|NCT02346240|451095543|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400060|NCT02346240|451095544|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400061|NCT02346240|451095545|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400062|NCT02346240|451095546|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400063|NCT02346240|451095547|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400064|NCT02346240|451095548|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400065|NCT02346240|451095549|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400066|NCT02346240|451095550|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400067|NCT02346240|451095551|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400068|NCT02346240|451095552|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
125400069|NCT02346240|451095529|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400070|NCT02346240|451095530|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400071|NCT02346240|451095531|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400072|NCT02346240|451095532|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400073|NCT02346240|451095533|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400074|NCT02346240|451095534|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400075|NCT02346240|451095535|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400076|NCT02346240|451095536|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
125400077|NCT02346240|451095537|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
125400078|NCT02346240|451095538|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400079|NCT02346240|451095539|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400080|NCT02346240|451095540|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400081|NCT02346240|451095541|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400082|NCT02346240|451095542|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
125400083|NCT02346240|451095543|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
125400084|NCT02346240|451095544|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
125400085|NCT02346240|451095545|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
125400086|NCT02346240|451095546|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400087|NCT02346240|451095547|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400088|NCT02346240|451095548|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400089|NCT02346240|451095549|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400090|NCT02346240|451095550|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400091|NCT02346240|451095551|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400092|NCT02346240|451095552|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
125400093|NCT02346240|451095529|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400094|NCT02346240|451095530|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400095|NCT02346240|451095531|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400096|NCT02346240|451095532|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400097|NCT02346240|451095533|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400098|NCT02346240|451095534|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400099|NCT02346240|451095535|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400100|NCT02346240|451095536|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400101|NCT02346240|451095537|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400102|NCT02346240|451095538|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400103|NCT02346240|451095539|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400104|NCT02346240|451095540|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400105|NCT02346240|451095541|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400106|NCT02346240|451095542|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
125400107|NCT02346240|451095543|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400108|NCT02346240|451095544|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
125400109|NCT02346240|451095545|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400110|NCT02346240|451095546|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400111|NCT02346240|451095547|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400112|NCT02346240|451095548|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400113|NCT02346240|451095549|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400114|NCT02346240|451095550|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400115|NCT02346240|451095551|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400116|NCT02346240|451095552|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
125400117|NCT02346240|451095529|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400118|NCT02346240|451095530|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125275925|NCT02574078|450637915|FG008|Treatment Period|Lost to Follow-up|0|||
125275926|NCT02574078|450637916|FG009|Treatment Period|Lost to Follow-up|1|||
125275927|NCT02574078|450637917|FG010|Treatment Period|Lost to Follow-up|0|||
125400119|NCT02346240|451095531|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400120|NCT02346240|451095532|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400121|NCT02346240|451095533|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400122|NCT02346240|451095534|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400123|NCT02346240|451095535|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400124|NCT02346240|451095536|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400125|NCT02346240|451095537|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400126|NCT02346240|451095538|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400127|NCT02346240|451095539|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400128|NCT02346240|451095540|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400129|NCT02346240|451095541|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400130|NCT02346240|451095542|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400131|NCT02346240|451095543|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
125400132|NCT02346240|451095544|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400133|NCT02346240|451095545|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400134|NCT02346240|451095546|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400135|NCT02346240|451095547|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400136|NCT02346240|451095548|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400137|NCT02346240|451095549|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400138|NCT02346240|451095550|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400139|NCT02346240|451095551|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400140|NCT02346240|451095552|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
125400141|NCT02346240|451095529|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400142|NCT02346240|451095530|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400143|NCT02346240|451095531|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400144|NCT02346240|451095532|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400145|NCT02346240|451095533|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400146|NCT02346240|451095534|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125400147|NCT02346240|451095535|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125400148|NCT02346240|451095536|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125400149|NCT02346240|451095537|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125400150|NCT02346240|451095538|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400151|NCT02346240|451095539|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125400152|NCT02346240|451095540|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
125400153|NCT02346240|451095541|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400154|NCT02346240|451095542|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
125400155|NCT02346240|451095543|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
125400156|NCT02346240|451095544|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
125400157|NCT02346240|451095545|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
125400158|NCT02346240|451095546|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400159|NCT02346240|451095547|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400160|NCT02346240|451095548|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400161|NCT02346240|451095549|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400162|NCT02346240|451095550|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400163|NCT02346240|451095551|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400164|NCT02346240|451095552|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
125400165|NCT02346240|451095529|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400166|NCT02346240|451095530|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400167|NCT02346240|451095531|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400168|NCT02346240|451095532|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400169|NCT02346240|451095533|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400170|NCT02346240|451095534|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400171|NCT02346240|451095535|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400172|NCT02346240|451095536|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400173|NCT02346240|451095537|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400174|NCT02346240|451095538|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400175|NCT02346240|451095539|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400176|NCT02346240|451095540|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400177|NCT02346240|451095541|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400178|NCT02346240|451095542|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
125400179|NCT02346240|451095543|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
125400180|NCT02346240|451095544|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
125400181|NCT02346240|451095545|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
125400182|NCT02346240|451095546|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400183|NCT02346240|451095547|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400184|NCT02346240|451095548|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400185|NCT02346240|451095549|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400186|NCT02346240|451095550|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400187|NCT02346240|451095551|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400188|NCT02346240|451095552|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
125400189|NCT02346240|451095529|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400190|NCT02346240|451095530|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400191|NCT02346240|451095531|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400192|NCT02346240|451095532|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400193|NCT02346240|451095533|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400194|NCT02346240|451095534|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400195|NCT02346240|451095535|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
125400196|NCT02346240|451095536|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400197|NCT02346240|451095537|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400198|NCT02346240|451095538|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400199|NCT02346240|451095539|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400200|NCT02346240|451095540|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400201|NCT02346240|451095541|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400202|NCT02346240|451095542|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400203|NCT02346240|451095543|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400204|NCT02346240|451095544|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400205|NCT02346240|451095545|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400206|NCT02346240|451095546|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400207|NCT02346240|451095547|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400208|NCT02346240|451095548|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400209|NCT02346240|451095549|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400210|NCT02346240|451095550|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400211|NCT02346240|451095551|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400212|NCT02346240|451095552|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
125400213|NCT02346240|451095529|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400214|NCT02346240|451095530|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400215|NCT02346240|451095531|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400216|NCT02346240|451095532|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400217|NCT02346240|451095533|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400218|NCT02346240|451095534|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400219|NCT02346240|451095535|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400220|NCT02346240|451095536|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400221|NCT02346240|451095537|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
125400222|NCT02346240|451095538|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400223|NCT02346240|451095539|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400224|NCT02346240|451095540|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
125400225|NCT02346240|451095541|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400226|NCT02346240|451095542|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
125400227|NCT02346240|451095543|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
125400228|NCT02346240|451095544|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400229|NCT02346240|451095545|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400230|NCT02346240|451095546|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400231|NCT02346240|451095547|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400232|NCT02346240|451095548|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400233|NCT02346240|451095549|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400234|NCT02346240|451095550|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400235|NCT02346240|451095551|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400236|NCT02346240|451095552|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
125400237|NCT02346240|451095529|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400238|NCT02346240|451095530|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400239|NCT02346240|451095531|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400240|NCT02346240|451095532|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400241|NCT02346240|451095533|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400242|NCT02346240|451095534|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400243|NCT02346240|451095535|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400244|NCT02346240|451095536|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400245|NCT02346240|451095537|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400246|NCT02346240|451095538|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
125400247|NCT02346240|451095539|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400248|NCT02346240|451095540|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400249|NCT02346240|451095541|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400250|NCT02346240|451095542|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400251|NCT02346240|451095543|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400252|NCT02346240|451095544|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400253|NCT02346240|451095545|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400254|NCT02346240|451095546|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400255|NCT02346240|451095547|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400256|NCT02346240|451095548|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400257|NCT02346240|451095549|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400258|NCT02346240|451095550|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400259|NCT02346240|451095551|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400260|NCT02346240|451095552|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
125400261|NCT02346240|451095529|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400262|NCT02346240|451095530|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400263|NCT02346240|451095531|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400264|NCT02346240|451095532|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400265|NCT02346240|451095533|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400266|NCT02346240|451095534|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400267|NCT02346240|451095535|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400268|NCT02346240|451095536|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400269|NCT02346240|451095537|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400270|NCT02346240|451095538|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400271|NCT02346240|451095539|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
125400272|NCT02346240|451095540|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400273|NCT02346240|451095541|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400274|NCT02346240|451095542|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400275|NCT02346240|451095543|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400276|NCT02346240|451095544|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400277|NCT02346240|451095545|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400278|NCT02346240|451095546|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400279|NCT02346240|451095547|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400280|NCT02346240|451095548|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400281|NCT02346240|451095549|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400282|NCT02346240|451095550|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400283|NCT02346240|451095551|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400284|NCT02346240|451095552|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
125400285|NCT02346240|451095529|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400286|NCT02346240|451095530|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400287|NCT02346240|451095531|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400288|NCT02346240|451095532|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400289|NCT02346240|451095533|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400290|NCT02346240|451095534|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400291|NCT02346240|451095535|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400292|NCT02346240|451095536|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400293|NCT02346240|451095537|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400294|NCT02346240|451095538|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400295|NCT02346240|451095539|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400296|NCT02346240|451095540|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400297|NCT02346240|451095541|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400298|NCT02346240|451095542|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400299|NCT02346240|451095543|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
125400300|NCT02346240|451095544|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400301|NCT02346240|451095545|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400302|NCT02346240|451095546|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400303|NCT02346240|451095547|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400304|NCT02346240|451095548|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400305|NCT02346240|451095549|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400306|NCT02346240|451095550|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400307|NCT02346240|451095551|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400308|NCT02346240|451095552|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
125400309|NCT02346240|451095529|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400310|NCT02346240|451095530|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400311|NCT02346240|451095531|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400312|NCT02346240|451095532|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400313|NCT02346240|451095533|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400314|NCT02346240|451095534|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400315|NCT02346240|451095535|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400316|NCT02346240|451095536|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400317|NCT02346240|451095537|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400318|NCT02346240|451095538|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400319|NCT02346240|451095539|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400320|NCT02346240|451095540|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400321|NCT02346240|451095541|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400322|NCT02346240|451095542|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400323|NCT02346240|451095543|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
125400324|NCT02346240|451095544|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400325|NCT02346240|451095545|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400326|NCT02346240|451095546|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400327|NCT02346240|451095547|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400328|NCT02346240|451095548|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400329|NCT02346240|451095549|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400330|NCT02346240|451095550|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400331|NCT02346240|451095551|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400332|NCT02346240|451095552|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
125400333|NCT02346240|451095529|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400334|NCT02346240|451095530|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400335|NCT02346240|451095531|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400336|NCT02346240|451095532|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400337|NCT02346240|451095533|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400338|NCT02346240|451095534|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400339|NCT02346240|451095535|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400340|NCT02346240|451095536|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400341|NCT02346240|451095537|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400342|NCT02346240|451095538|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400343|NCT02346240|451095539|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400344|NCT02346240|451095540|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400345|NCT02346240|451095541|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400346|NCT02346240|451095542|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400347|NCT02346240|451095543|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
125400348|NCT02346240|451095544|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400349|NCT02346240|451095545|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400350|NCT02346240|451095546|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400351|NCT02346240|451095547|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125275928|NCT02574078|450637918|FG011|Treatment Period|Lost to Follow-up|1|||
125275929|NCT02574078|450637919|FG012|Treatment Period|Lost to Follow-up|0|||
125275930|NCT02574078|450637907|FG000|Treatment Period|Maximum clinical benefit|0|||
125400352|NCT02346240|451095548|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400353|NCT02346240|451095549|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400354|NCT02346240|451095550|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400355|NCT02346240|451095551|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400356|NCT02346240|451095552|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
125400357|NCT02346240|451095529|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400358|NCT02346240|451095530|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400359|NCT02346240|451095531|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400360|NCT02346240|451095532|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400361|NCT02346240|451095533|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400362|NCT02346240|451095534|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400363|NCT02346240|451095535|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400364|NCT02346240|451095536|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400365|NCT02346240|451095537|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400366|NCT02346240|451095538|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400367|NCT02346240|451095539|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400368|NCT02346240|451095540|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400369|NCT02346240|451095541|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400370|NCT02346240|451095542|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400371|NCT02346240|451095543|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400372|NCT02346240|451095544|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400373|NCT02346240|451095545|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
125400374|NCT02346240|451095546|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
125400375|NCT02346240|451095547|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
125400376|NCT02346240|451095548|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
125400377|NCT02346240|451095549|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
125400378|NCT02346240|451095550|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
125400379|NCT02346240|451095551|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
125400380|NCT02346240|451095552|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
125400381|NCT02346240|451095529|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400382|NCT02346240|451095530|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400383|NCT02346240|451095531|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400384|NCT02346240|451095532|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400385|NCT02346240|451095533|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400386|NCT02346240|451095534|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400387|NCT02346240|451095535|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400388|NCT02346240|451095536|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400389|NCT02346240|451095537|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400390|NCT02346240|451095538|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400391|NCT02346240|451095539|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400392|NCT02346240|451095540|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400393|NCT02346240|451095541|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400394|NCT02346240|451095542|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400395|NCT02346240|451095543|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400396|NCT02346240|451095544|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400397|NCT02346240|451095545|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400398|NCT02346240|451095546|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400399|NCT02346240|451095547|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
125400400|NCT02346240|451095548|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
125400401|NCT02346240|451095549|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400402|NCT02346240|451095550|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
125400403|NCT02346240|451095551|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400404|NCT02346240|451095552|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
125400405|NCT02346240|451095529|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400406|NCT02346240|451095530|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400407|NCT02346240|451095531|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400408|NCT02346240|451095532|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400409|NCT02346240|451095533|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400410|NCT02346240|451095534|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400411|NCT02346240|451095535|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400412|NCT02346240|451095536|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400413|NCT02346240|451095537|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400414|NCT02346240|451095538|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400415|NCT02346240|451095539|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400416|NCT02346240|451095540|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400417|NCT02346240|451095541|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400418|NCT02346240|451095542|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400419|NCT02346240|451095543|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400420|NCT02346240|451095544|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400421|NCT02346240|451095545|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400422|NCT02346240|451095546|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400423|NCT02346240|451095547|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
125400424|NCT02346240|451095548|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400425|NCT02346240|451095549|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400426|NCT02346240|451095550|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
125400427|NCT02346240|451095551|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400428|NCT02346240|451095552|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
125400429|NCT02346240|451095529|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400430|NCT02346240|451095530|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400431|NCT02346240|451095531|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400432|NCT02346240|451095532|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400433|NCT02346240|451095533|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400434|NCT02346240|451095534|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400435|NCT02346240|451095535|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400436|NCT02346240|451095536|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400437|NCT02346240|451095537|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400438|NCT02346240|451095538|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400439|NCT02346240|451095539|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400440|NCT02346240|451095540|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400441|NCT02346240|451095541|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400442|NCT02346240|451095542|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400443|NCT02346240|451095543|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400444|NCT02346240|451095544|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400445|NCT02346240|451095545|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400446|NCT02346240|451095546|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400447|NCT02346240|451095547|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400448|NCT02346240|451095548|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400449|NCT02346240|451095549|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400450|NCT02346240|451095550|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
125400451|NCT02346240|451095551|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400452|NCT02346240|451095552|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
125400453|NCT02346240|451095529|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400454|NCT02346240|451095530|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400455|NCT02346240|451095531|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400456|NCT02346240|451095532|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400457|NCT02346240|451095533|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400458|NCT02346240|451095534|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400459|NCT02346240|451095535|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400460|NCT02346240|451095536|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400461|NCT02346240|451095537|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400462|NCT02346240|451095538|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400463|NCT02346240|451095539|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400464|NCT02346240|451095540|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400465|NCT02346240|451095541|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400466|NCT02346240|451095542|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400467|NCT02346240|451095543|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400468|NCT02346240|451095544|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400469|NCT02346240|451095545|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400470|NCT02346240|451095546|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
125400471|NCT02346240|451095547|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
125400472|NCT02346240|451095548|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
125400473|NCT02346240|451095549|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
125400474|NCT02346240|451095550|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
125400475|NCT02346240|451095551|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
125400476|NCT02346240|451095552|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
125400477|NCT02346240|451095529|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400478|NCT02346240|451095530|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400479|NCT02346240|451095531|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400480|NCT02346240|451095532|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400481|NCT02346240|451095533|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125275931|NCT02574078|450637908|FG001|Treatment Period|Maximum clinical benefit|0|||
125275932|NCT02574078|450637909|FG002|Treatment Period|Maximum clinical benefit|0|||
125275933|NCT02574078|450637910|FG003|Treatment Period|Maximum clinical benefit|0|||
125275934|NCT02574078|450637911|FG004|Treatment Period|Maximum clinical benefit|0|||
125275935|NCT02574078|450637912|FG005|Treatment Period|Maximum clinical benefit|0|||
125275936|NCT02574078|450637913|FG006|Treatment Period|Maximum clinical benefit|0|||
125275937|NCT02574078|450637914|FG007|Treatment Period|Maximum clinical benefit|0|||
125275938|NCT02574078|450637915|FG008|Treatment Period|Maximum clinical benefit|0|||
125275939|NCT02574078|450637916|FG009|Treatment Period|Maximum clinical benefit|1|||
125275940|NCT02574078|450637917|FG010|Treatment Period|Maximum clinical benefit|0|||
125275941|NCT02574078|450637918|FG011|Treatment Period|Maximum clinical benefit|0|||
125275942|NCT02574078|450637919|FG012|Treatment Period|Maximum clinical benefit|0|||
125275943|NCT00301262|450637923|FG000|Double Blind Phase (DB)|Adverse Event|1|||
125275944|NCT00301262|450637924|FG001|Double Blind Phase (DB)|Adverse Event|0|||
125275945|NCT00301262|450637923|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
125275946|NCT00301262|450637924|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
125275947|NCT00301262|450637923|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
125275948|NCT00301262|450637924|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
125275949|NCT00301262|450637923|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
125275950|NCT00301262|450637924|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
125275951|NCT00301262|450637923|FG000|Double Blind Phase (DB)|Other|1|||
125275952|NCT00301262|450637924|FG001|Double Blind Phase (DB)|Other|4|||
125275953|NCT00301262|450637923|FG000|Open Label Phase (OL)|Adverse Event|1|||
125275954|NCT00301262|450637924|FG001|Open Label Phase (OL)|Adverse Event|0|||
125275955|NCT00301262|450637923|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
125275956|NCT00301262|450637924|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
125275957|NCT00301262|450637923|FG000|Open Label Phase (OL)|Other|2|||
125275958|NCT00301262|450637924|FG001|Open Label Phase (OL)|Other|0|||
125275959|NCT00368745|450637925|FG000|Double-blind Treatment Period|Adverse Event|6|||
125275960|NCT00368745|450637926|FG001|Double-blind Treatment Period|Adverse Event|6|||
125275961|NCT00368745|450637925|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
125275962|NCT00368745|450637926|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
125275963|NCT00368745|450637925|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
125275964|NCT00368745|450637926|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
125275965|NCT00368745|450637925|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
125275966|NCT00368745|450637926|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
125275967|NCT00368745|450637925|FG000|Double-blind Treatment Period|Other|7|||
125275968|NCT00368745|450637926|FG001|Double-blind Treatment Period|Other|6|||
125275969|NCT03037476|450637927|FG000|Overall Study|Lost to Follow-up|63|||
125275970|NCT03037476|450637928|FG001|Overall Study|Lost to Follow-up|46|||
125275971|NCT01498692|450637931|FG000|Overall Study|Death|4|||
125275972|NCT01498692|450637931|FG000|Overall Study|Withdrawal by Subject|1|||
125275973|NCT01498692|450637931|FG000|Overall Study|Missed 12-month visit|3|||
125275974|NCT01208324|450637932|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
125275975|NCT01208324|450637933|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
125275976|NCT01208324|450637934|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
125275977|NCT01208324|450637935|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
125275978|NCT02707965|450637936|FG000|Overall Study|Withdrawal by Subject|0|||
125275979|NCT02707965|450637937|FG001|Overall Study|Withdrawal by Subject|0|||
125275980|NCT02707965|450637938|FG002|Overall Study|Withdrawal by Subject|1|||
125275981|NCT02707965|450637939|FG003|Overall Study|Withdrawal by Subject|0|||
125275982|NCT02707965|450637940|FG004|Overall Study|Withdrawal by Subject|0|||
125275983|NCT02707965|450637941|FG005|Overall Study|Withdrawal by Subject|0|||
125275984|NCT02707965|450637942|FG006|Overall Study|Withdrawal by Subject|0|||
125275985|NCT02707965|450637943|FG007|Overall Study|Withdrawal by Subject|2|||
125275986|NCT02707965|450637944|FG008|Overall Study|Withdrawal by Subject|0|||
125275987|NCT02707965|450637945|FG009|Overall Study|Withdrawal by Subject|0|||
125275988|NCT02707965|450637946|FG010|Overall Study|Withdrawal by Subject|0|||
125275989|NCT02707965|450637947|FG011|Overall Study|Withdrawal by Subject|0|||
125275990|NCT02707965|450637948|FG012|Overall Study|Withdrawal by Subject|0|||
125275991|NCT02707965|450637949|FG013|Overall Study|Withdrawal by Subject|0|||
125275992|NCT02707965|450637950|FG014|Overall Study|Withdrawal by Subject|0|||
125275993|NCT02707965|450637951|FG015|Overall Study|Withdrawal by Subject|0|||
125275994|NCT02707965|450637936|FG000|Overall Study|PI decisions|0|||
125275995|NCT02707965|450637937|FG001|Overall Study|PI decisions|0|||
125275996|NCT02707965|450637938|FG002|Overall Study|PI decisions|0|||
125275997|NCT02707965|450637939|FG003|Overall Study|PI decisions|0|||
125400482|NCT02346240|451095534|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400483|NCT02346240|451095535|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400484|NCT02346240|451095536|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125275998|NCT02707965|450637940|FG004|Overall Study|PI decisions|0|||
125275999|NCT02707965|450637941|FG005|Overall Study|PI decisions|0|||
125276000|NCT02707965|450637942|FG006|Overall Study|PI decisions|0|||
125276001|NCT02707965|450637943|FG007|Overall Study|PI decisions|0|||
125276002|NCT02707965|450637944|FG008|Overall Study|PI decisions|0|||
125400485|NCT02346240|451095537|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400486|NCT02346240|451095538|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400487|NCT02346240|451095539|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400488|NCT02346240|451095540|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400489|NCT02346240|451095541|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400490|NCT02346240|451095542|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400491|NCT02346240|451095543|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400492|NCT02346240|451095544|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400493|NCT02346240|451095545|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400494|NCT02346240|451095546|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400495|NCT02346240|451095547|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
125400496|NCT02346240|451095548|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
125400497|NCT02346240|451095549|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
125400498|NCT02346240|451095550|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
125400499|NCT02346240|451095551|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
125400500|NCT02346240|451095552|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
125400501|NCT02346240|451095529|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400502|NCT02346240|451095530|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400503|NCT02346240|451095531|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400504|NCT02346240|451095532|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400505|NCT02346240|451095533|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400506|NCT02346240|451095534|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400507|NCT02346240|451095535|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400508|NCT02346240|451095536|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400509|NCT02346240|451095537|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400510|NCT02346240|451095538|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400511|NCT02346240|451095539|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400512|NCT02346240|451095540|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400513|NCT02346240|451095541|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400514|NCT02346240|451095542|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400515|NCT02346240|451095543|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400516|NCT02346240|451095544|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400517|NCT02346240|451095545|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400518|NCT02346240|451095546|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400519|NCT02346240|451095547|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
125400520|NCT02346240|451095548|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400521|NCT02346240|451095549|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
125400522|NCT02346240|451095550|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
125400523|NCT02346240|451095551|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
125400524|NCT02346240|451095552|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
125400525|NCT02346240|451095529|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400526|NCT02346240|451095530|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400527|NCT02346240|451095531|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400528|NCT02346240|451095532|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400529|NCT02346240|451095533|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400530|NCT02346240|451095534|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400531|NCT02346240|451095535|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400532|NCT02346240|451095536|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400533|NCT02346240|451095537|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400534|NCT02346240|451095538|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400535|NCT02346240|451095539|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400536|NCT02346240|451095540|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400537|NCT02346240|451095541|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400538|NCT02346240|451095542|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400539|NCT02346240|451095543|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400540|NCT02346240|451095544|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400541|NCT02346240|451095545|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125447812|NCT00723294|451266824|FG000|Overall Study|Did not undergo surgery|1|||
125447813|NCT00723294|451266824|FG000|Overall Study|Treated prior to registration|1|||
125447814|NCT00723294|451266824|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
125276003|NCT02707965|450637945|FG009|Overall Study|PI decisions|0|||
125400542|NCT02346240|451095546|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400543|NCT02346240|451095547|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
125400544|NCT02346240|451095548|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400545|NCT02346240|451095549|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400546|NCT02346240|451095550|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400547|NCT02346240|451095551|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400548|NCT02346240|451095552|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
125400549|NCT03417141|451095553|FG000|Overall Study|Withdrawal by Subject|1|||
125400550|NCT03417141|451095553|FG000|Overall Study|Protocol Violation|3|||
125400551|NCT03706690|451095554|FG000|Overall Study|Withdrawal by Subject|8|||
125400552|NCT03706690|451095555|FG001|Overall Study|Withdrawal by Subject|8|||
125400553|NCT03706690|451095554|FG000|Overall Study|Death|143|||
125400554|NCT03706690|451095555|FG001|Overall Study|Death|75|||
125400555|NCT03706690|451095554|FG000|Overall Study|Ongoing at DCO|121|||
125400556|NCT03706690|451095555|FG001|Overall Study|Ongoing at DCO|52|||
125400557|NCT02143843|451095556|FG000|Overall Study|Adverse Event|8|||
125400558|NCT02143843|451095556|FG000|Overall Study|Lack of Efficacy|2|||
125400559|NCT02143843|451095556|FG000|Overall Study|Withdrawal by Subject|2|||
125400560|NCT00308711|451095557|FG000|Overall Study|Withdrawal by Subject|1|||
125400561|NCT00308711|451095558|FG001|Overall Study|Withdrawal by Subject|0|||
125400562|NCT00308711|451095559|FG002|Overall Study|Withdrawal by Subject|1|||
125400563|NCT00308711|451095557|FG000|Overall Study|Protocol Violation|0|||
125400564|NCT00308711|451095558|FG001|Overall Study|Protocol Violation|1|||
125400565|NCT00308711|451095559|FG002|Overall Study|Protocol Violation|1|||
125400566|NCT00308711|451095557|FG000|Overall Study|Lost to Follow-up|0|||
125400567|NCT00308711|451095558|FG001|Overall Study|Lost to Follow-up|1|||
125400568|NCT00308711|451095559|FG002|Overall Study|Lost to Follow-up|0|||
125400569|NCT00308711|451095557|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
125400570|NCT00308711|451095558|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
125400571|NCT00308711|451095559|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
125400572|NCT00308711|451095557|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
125400573|NCT00308711|451095558|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
125400574|NCT00308711|451095559|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
125400575|NCT01420081|451095560|FG000|Overall Study|Death|1|||
125400576|NCT01420081|451095561|FG001|Overall Study|Death|0|||
125400577|NCT01420081|451095562|FG002|Overall Study|Death|8|||
125400578|NCT01420081|451095563|FG003|Overall Study|Death|0|||
125400579|NCT01420081|451095564|FG004|Overall Study|Death|7|||
125400580|NCT01420081|451095565|FG005|Overall Study|Death|12|||
125400581|NCT01420081|451095566|FG006|Overall Study|Death|0|||
125400582|NCT01420081|451095567|FG007|Overall Study|Death|1|||
125400583|NCT01420081|451095568|FG008|Overall Study|Death|1|||
125400584|NCT01420081|451095560|FG000|Overall Study|Lost to Follow-up|0|||
125400585|NCT01420081|451095561|FG001|Overall Study|Lost to Follow-up|0|||
125400586|NCT01420081|451095562|FG002|Overall Study|Lost to Follow-up|0|||
125400587|NCT01420081|451095563|FG003|Overall Study|Lost to Follow-up|0|||
125400588|NCT01420081|451095564|FG004|Overall Study|Lost to Follow-up|1|||
125400589|NCT01420081|451095565|FG005|Overall Study|Lost to Follow-up|1|||
125400590|NCT01420081|451095566|FG006|Overall Study|Lost to Follow-up|0|||
125400591|NCT01420081|451095567|FG007|Overall Study|Lost to Follow-up|0|||
125400592|NCT01420081|451095568|FG008|Overall Study|Lost to Follow-up|0|||
125400593|NCT01420081|451095560|FG000|Overall Study|Study Terminated by Sponsor|2|||
125400594|NCT01420081|451095561|FG001|Overall Study|Study Terminated by Sponsor|1|||
125400595|NCT01420081|451095562|FG002|Overall Study|Study Terminated by Sponsor|1|||
125400596|NCT01420081|451095563|FG003|Overall Study|Study Terminated by Sponsor|3|||
125400597|NCT01420081|451095564|FG004|Overall Study|Study Terminated by Sponsor|11|||
125400598|NCT01420081|451095565|FG005|Overall Study|Study Terminated by Sponsor|7|||
125400599|NCT01420081|451095566|FG006|Overall Study|Study Terminated by Sponsor|3|||
125400600|NCT01420081|451095567|FG007|Overall Study|Study Terminated by Sponsor|2|||
125400601|NCT01420081|451095568|FG008|Overall Study|Study Terminated by Sponsor|2|||
125400602|NCT01420081|451095560|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
125400603|NCT01420081|451095561|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
125400604|NCT01420081|451095562|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
125400605|NCT01420081|451095563|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
125400606|NCT01420081|451095564|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
125447815|NCT00723294|451266824|FG000|Overall Study|Benign lesion|1|||
125447816|NCT00723294|451266824|FG000|Overall Study|Withdrawal by Subject|1|||
125400607|NCT01420081|451095565|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
125400608|NCT01420081|451095566|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
125400609|NCT01420081|451095567|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
125400610|NCT01420081|451095568|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
125400611|NCT01420081|451095560|FG000|Overall Study|Other Reasons|0|||
125400612|NCT01420081|451095561|FG001|Overall Study|Other Reasons|0|||
125400613|NCT01420081|451095562|FG002|Overall Study|Other Reasons|1|||
125447817|NCT00723294|451266824|FG000|Overall Study|No treatment due to probe failure|1|||
125400614|NCT01420081|451095563|FG003|Overall Study|Other Reasons|0|||
125400615|NCT01420081|451095564|FG004|Overall Study|Other Reasons|0|||
125400616|NCT01420081|451095565|FG005|Overall Study|Other Reasons|0|||
125400617|NCT01420081|451095566|FG006|Overall Study|Other Reasons|0|||
125400618|NCT01420081|451095567|FG007|Overall Study|Other Reasons|0|||
125400619|NCT01420081|451095568|FG008|Overall Study|Other Reasons|0|||
125400620|NCT03467425|451095569|FG000|Overall Study|Adverse Event|9|||
125400621|NCT03467425|451095570|FG001|Overall Study|Adverse Event|9|||
125400622|NCT03467425|451095569|FG000|Overall Study|Lack of Efficacy|3|||
125400623|NCT03467425|451095570|FG001|Overall Study|Lack of Efficacy|1|||
125400624|NCT03467425|451095569|FG000|Overall Study|Protocol Violation|0|||
125400625|NCT03467425|451095570|FG001|Overall Study|Protocol Violation|1|||
125400626|NCT03467425|451095569|FG000|Overall Study|Lost to Follow-up|18|||
125400627|NCT03467425|451095570|FG001|Overall Study|Lost to Follow-up|25|||
125400628|NCT03467425|451095569|FG000|Overall Study|Physician Decision|2|||
125400629|NCT03467425|451095570|FG001|Overall Study|Physician Decision|1|||
125400630|NCT03467425|451095569|FG000|Overall Study|Withdrawal by Subject|15|||
125400631|NCT03467425|451095570|FG001|Overall Study|Withdrawal by Subject|17|||
125400632|NCT02318693|451095572|FG000|Overall Study|Protocol Violation|0|||
125400633|NCT02318693|451095573|FG001|Overall Study|Protocol Violation|1|||
125400634|NCT00025883|451095574|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
125400635|NCT00025883|451095574|FG000|Overall Study|no baseline data|1|||
125400636|NCT00025883|451095574|FG000|Overall Study|Death|1|||
125400637|NCT00025883|451095574|FG000|Overall Study|Adverse Event|1|||
125400638|NCT00025883|451095574|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
125400639|NCT00528528|451095580|FG000|Overall Study|Lost to Follow-up|0|||
125400640|NCT00528528|451095581|FG001|Overall Study|Lost to Follow-up|0|||
125400641|NCT00528528|451095582|FG002|Overall Study|Lost to Follow-up|1|||
125400642|NCT00528528|451095583|FG003|Overall Study|Lost to Follow-up|1|||
125400643|NCT00528528|451095580|FG000|Overall Study|Ineligible to continue the trial|0|||
125400644|NCT00528528|451095581|FG001|Overall Study|Ineligible to continue the trial|0|||
125400645|NCT00528528|451095582|FG002|Overall Study|Ineligible to continue the trial|0|||
125400646|NCT00528528|451095583|FG003|Overall Study|Ineligible to continue the trial|1|||
125400647|NCT00528528|451095580|FG000|Overall Study|Other|0|||
125400648|NCT00528528|451095581|FG001|Overall Study|Other|1|||
125400649|NCT00528528|451095582|FG002|Overall Study|Other|0|||
125400650|NCT00528528|451095583|FG003|Overall Study|Other|0|||
125400651|NCT00528528|451095580|FG000|Overall Study|Withdrawal by Subject|3|||
125400652|NCT00528528|451095581|FG001|Overall Study|Withdrawal by Subject|2|||
125400653|NCT00528528|451095582|FG002|Overall Study|Withdrawal by Subject|1|||
125400654|NCT00528528|451095583|FG003|Overall Study|Withdrawal by Subject|1|||
125400655|NCT00528528|451095580|FG000|Overall Study|Ongoing participant|0|||
125400656|NCT00528528|451095581|FG001|Overall Study|Ongoing participant|0|||
125400657|NCT00528528|451095582|FG002|Overall Study|Ongoing participant|1|||
125400658|NCT00528528|451095583|FG003|Overall Study|Ongoing participant|0|||
125400659|NCT04579679|451095584|FG000|Overall Study|New Antitumor Therapy|6|||
125400660|NCT04579679|451095585|FG001|Overall Study|New Antitumor Therapy|4|||
125400661|NCT04579679|451095586|FG002|Overall Study|New Antitumor Therapy|7|||
125400662|NCT04579679|451095587|FG003|Overall Study|New Antitumor Therapy|0|||
125400663|NCT04579679|451095584|FG000|Overall Study|Withdrawal of Consent|1|||
125400664|NCT04579679|451095585|FG001|Overall Study|Withdrawal of Consent|1|||
125400665|NCT04579679|451095586|FG002|Overall Study|Withdrawal of Consent|2|||
125400666|NCT04579679|451095587|FG003|Overall Study|Withdrawal of Consent|4|||
125400667|NCT04579679|451095584|FG000|Overall Study|Death|2|||
125400668|NCT04579679|451095585|FG001|Overall Study|Death|2|||
125400669|NCT04579679|451095586|FG002|Overall Study|Death|2|||
125400670|NCT04579679|451095587|FG003|Overall Study|Death|0|||
125400671|NCT04579679|451095584|FG000|Overall Study|Adverse Event|0|||
125400672|NCT04579679|451095585|FG001|Overall Study|Adverse Event|4|||
125400673|NCT04579679|451095586|FG002|Overall Study|Adverse Event|0|||
125400674|NCT04579679|451095587|FG003|Overall Study|Adverse Event|0|||
125400675|NCT04579679|451095584|FG000|Overall Study|Disease Progression|9|||
125400676|NCT04579679|451095585|FG001|Overall Study|Disease Progression|13|||
125400677|NCT04579679|451095586|FG002|Overall Study|Disease Progression|7|||
125400678|NCT04579679|451095587|FG003|Overall Study|Disease Progression|0|||
125400679|NCT04579679|451095584|FG000|Overall Study|Physician Decision|0|||
125400680|NCT04579679|451095585|FG001|Overall Study|Physician Decision|0|||
125400681|NCT04579679|451095586|FG002|Overall Study|Physician Decision|1|||
125400682|NCT04579679|451095587|FG003|Overall Study|Physician Decision|0|||
125400683|NCT04579679|451095584|FG000|Overall Study|Study Terminated by Sponsor|2|||
125400684|NCT04579679|451095585|FG001|Overall Study|Study Terminated by Sponsor|7|||
125400685|NCT04579679|451095586|FG002|Overall Study|Study Terminated by Sponsor|1|||
125400686|NCT04579679|451095587|FG003|Overall Study|Study Terminated by Sponsor|0|||
125400687|NCT03091192|451095588|FG000|Overall Study|Study terminated by sponsor|21|||
125400688|NCT03091192|451095589|FG001|Overall Study|Study terminated by sponsor|14|||
125400689|NCT03091192|451095588|FG000|Overall Study|Death|9|||
125400690|NCT03091192|451095589|FG001|Overall Study|Death|13|||
125400691|NCT03091192|451095588|FG000|Overall Study|Withdrawal by Subject|2|||
125400692|NCT03091192|451095589|FG001|Overall Study|Withdrawal by Subject|0|||
125400693|NCT03091192|451095588|FG000|Overall Study|Lost to Follow-up|1|||
125400694|NCT03091192|451095589|FG001|Overall Study|Lost to Follow-up|0|||
125400695|NCT01038778|451095592|FG000|Overall Study|Withdrawal by Subject|0|||
125400696|NCT01038778|451095593|FG001|Overall Study|Withdrawal by Subject|2|||
125400697|NCT01038778|451095594|FG002|Overall Study|Withdrawal by Subject|3|||
125400698|NCT04487080|451095595|FG000|Overall Study|Withdrawal by Subject|19|||
125400699|NCT04487080|451095596|FG001|Overall Study|Withdrawal by Subject|18|||
125400700|NCT04487080|451095597|FG002|Overall Study|Withdrawal by Subject|13|||
125400701|NCT04487080|451095595|FG000|Overall Study|Lost to Follow-up|3|||
125400702|NCT04487080|451095596|FG001|Overall Study|Lost to Follow-up|1|||
125400703|NCT04487080|451095597|FG002|Overall Study|Lost to Follow-up|0|||
125400704|NCT04487080|451095595|FG000|Overall Study|Ongoing|313|||
125400705|NCT04487080|451095596|FG001|Overall Study|Ongoing|297|||
125400706|NCT04487080|451095597|FG002|Overall Study|Ongoing|149|||
125400707|NCT04740034|451095598|FG000|Overall Study|Death|0|||
125400708|NCT04740034|451095599|FG001|Overall Study|Death|1|||
125400709|NCT04740034|451095600|FG002|Overall Study|Death|2|||
125400710|NCT04740034|451095601|FG003|Overall Study|Death|3|||
125400711|NCT04740034|451095602|FG004|Overall Study|Death|4|||
125400712|NCT04740034|451095603|FG005|Overall Study|Death|4|||
125400713|NCT04740034|451095604|FG006|Overall Study|Death|2|||
125400714|NCT04740034|451095605|FG007|Overall Study|Death|2|||
125400715|NCT04740034|451095606|FG008|Overall Study|Death|2|||
125400716|NCT04740034|451095607|FG009|Overall Study|Death|4|||
125400717|NCT04740034|451095608|FG010|Overall Study|Death|0|||
125400718|NCT04740034|451095598|FG000|Overall Study|Lost to Follow-up|0|||
125400719|NCT04740034|451095599|FG001|Overall Study|Lost to Follow-up|0|||
125400720|NCT04740034|451095600|FG002|Overall Study|Lost to Follow-up|0|||
125400721|NCT04740034|451095601|FG003|Overall Study|Lost to Follow-up|1|||
125400722|NCT04740034|451095602|FG004|Overall Study|Lost to Follow-up|2|||
125400723|NCT04740034|451095603|FG005|Overall Study|Lost to Follow-up|2|||
125400724|NCT04740034|451095604|FG006|Overall Study|Lost to Follow-up|0|||
125400725|NCT04740034|451095605|FG007|Overall Study|Lost to Follow-up|0|||
125400726|NCT04740034|451095606|FG008|Overall Study|Lost to Follow-up|0|||
125400727|NCT04740034|451095607|FG009|Overall Study|Lost to Follow-up|1|||
125400728|NCT04740034|451095608|FG010|Overall Study|Lost to Follow-up|0|||
125400729|NCT04740034|451095598|FG000|Overall Study|Withdrawal by Subject|1|||
125400730|NCT04740034|451095599|FG001|Overall Study|Withdrawal by Subject|0|||
125400731|NCT04740034|451095600|FG002|Overall Study|Withdrawal by Subject|0|||
125400732|NCT04740034|451095601|FG003|Overall Study|Withdrawal by Subject|0|||
125400733|NCT04740034|451095602|FG004|Overall Study|Withdrawal by Subject|0|||
125400734|NCT04740034|451095603|FG005|Overall Study|Withdrawal by Subject|0|||
125400735|NCT04740034|451095604|FG006|Overall Study|Withdrawal by Subject|0|||
125400736|NCT04740034|451095605|FG007|Overall Study|Withdrawal by Subject|1|||
125400737|NCT04740034|451095606|FG008|Overall Study|Withdrawal by Subject|0|||
125400738|NCT04740034|451095607|FG009|Overall Study|Withdrawal by Subject|1|||
125400739|NCT04740034|451095608|FG010|Overall Study|Withdrawal by Subject|0|||
125400740|NCT04740034|451095598|FG000|Overall Study|Decision by sponsor|0|||
125400741|NCT04740034|451095599|FG001|Overall Study|Decision by sponsor|0|||
125400742|NCT04740034|451095600|FG002|Overall Study|Decision by sponsor|1|||
125400743|NCT04740034|451095601|FG003|Overall Study|Decision by sponsor|0|||
125400744|NCT04740034|451095602|FG004|Overall Study|Decision by sponsor|0|||
125400745|NCT04740034|451095603|FG005|Overall Study|Decision by sponsor|0|||
125400746|NCT04740034|451095604|FG006|Overall Study|Decision by sponsor|1|||
125400747|NCT04740034|451095605|FG007|Overall Study|Decision by sponsor|2|||
125400748|NCT04740034|451095606|FG008|Overall Study|Decision by sponsor|1|||
125400749|NCT04740034|451095607|FG009|Overall Study|Decision by sponsor|1|||
125400750|NCT04740034|451095608|FG010|Overall Study|Decision by sponsor|2|||
125400751|NCT03195478|451095609|FG000|Overall Study|Disease Progression|5|||
125400752|NCT03195478|451095610|FG001|Overall Study|Disease Progression|4|||
125400753|NCT03195478|451095611|FG002|Overall Study|Disease Progression|6|||
125400754|NCT03195478|451095612|FG003|Overall Study|Disease Progression|1|||
125400755|NCT03195478|451095609|FG000|Overall Study|Study Drug Toxicity|2|||
125400756|NCT03195478|451095610|FG001|Overall Study|Study Drug Toxicity|0|||
125400757|NCT03195478|451095611|FG002|Overall Study|Study Drug Toxicity|0|||
125400758|NCT03195478|451095612|FG003|Overall Study|Study Drug Toxicity|1|||
125400759|NCT03195478|451095609|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
125400760|NCT03195478|451095610|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
125400761|NCT03195478|451095611|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
125400762|NCT03195478|451095612|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
125400763|NCT03195478|451095609|FG000|Overall Study|Participant Withdrew Consent|1|||
125400764|NCT03195478|451095610|FG001|Overall Study|Participant Withdrew Consent|0|||
125400765|NCT03195478|451095611|FG002|Overall Study|Participant Withdrew Consent|0|||
125400766|NCT03195478|451095612|FG003|Overall Study|Participant Withdrew Consent|0|||
125400767|NCT03195478|451095609|FG000|Overall Study|Maximum Clinical benefit|0|||
125400768|NCT03195478|451095610|FG001|Overall Study|Maximum Clinical benefit|0|||
125400769|NCT03195478|451095611|FG002|Overall Study|Maximum Clinical benefit|1|||
125400770|NCT03195478|451095612|FG003|Overall Study|Maximum Clinical benefit|0|||
125400771|NCT03195478|451095609|FG000|Overall Study|Other Reasons|0|||
125400772|NCT03195478|451095610|FG001|Overall Study|Other Reasons|0|||
125400773|NCT03195478|451095611|FG002|Overall Study|Other Reasons|1|||
125400774|NCT03195478|451095612|FG003|Overall Study|Other Reasons|0|||
125400775|NCT01677195|451096643|FG000|Overall Study|Lost to Follow-up|14|||
125400776|NCT01677195|451096644|FG001|Overall Study|Lost to Follow-up|22|||
125400777|NCT01677195|451096645|FG002|Overall Study|Lost to Follow-up|22|||
125400778|NCT01677195|451096643|FG000|Overall Study|Withdrawal by Subject|1|||
125400779|NCT01677195|451096644|FG001|Overall Study|Withdrawal by Subject|0|||
125400780|NCT01677195|451096645|FG002|Overall Study|Withdrawal by Subject|1|||
125400781|NCT01677195|451096643|FG000|Overall Study|Adverse Event|6|||
125400782|NCT01677195|451096644|FG001|Overall Study|Adverse Event|4|||
125400783|NCT01677195|451096645|FG002|Overall Study|Adverse Event|1|||
125400784|NCT01677195|451096643|FG000|Overall Study|Physician Decision|1|||
125400785|NCT01677195|451096644|FG001|Overall Study|Physician Decision|2|||
125400786|NCT01677195|451096645|FG002|Overall Study|Physician Decision|2|||
125400787|NCT01677195|451096643|FG000|Overall Study|Pregnancy|0|||
125400788|NCT01677195|451096644|FG001|Overall Study|Pregnancy|1|||
125400789|NCT01677195|451096645|FG002|Overall Study|Pregnancy|0|||
125400790|NCT01677195|451096643|FG000|Overall Study|Protocol Violation|7|||
125400791|NCT01677195|451096644|FG001|Overall Study|Protocol Violation|3|||
125400792|NCT01677195|451096645|FG002|Overall Study|Protocol Violation|4|||
125400793|NCT01207778|451096646|FG000|Overall Study|Lost to Follow-up|0|||
125400794|NCT01207778|451096647|FG001|Overall Study|Lost to Follow-up|3|||
125400795|NCT01207778|451096648|FG002|Overall Study|Lost to Follow-up|3|||
125400796|NCT00646204|451096649|FG000|Overall Study|Adverse Event|3|||
125400797|NCT00646204|451096650|FG001|Overall Study|Adverse Event|0|||
125400798|NCT00646204|451096649|FG000|Overall Study|Withdrawal by Subject|1|||
125400799|NCT00646204|451096650|FG001|Overall Study|Withdrawal by Subject|0|||
125400800|NCT00298896|451096657|FG000|Overall Study|Death|3|||
125400801|NCT00298896|451096657|FG000|Overall Study|Physician Decision|2|||
125400802|NCT00298896|451096657|FG000|Overall Study|Intercurrent Illness|1|||
125400803|NCT00298896|451096657|FG000|Overall Study|Disease Progression|41|||
125400804|NCT00298896|451096657|FG000|Overall Study|Withdrawal by Subject|2|||
125400805|NCT00298896|451096657|FG000|Overall Study|Assigned to treatment in error|1|||
125400806|NCT02649972|451096660|FG000|Overall Study|Not treated|1|||
125400807|NCT03285646|451096670|FG000|Overall Study|Adverse Event|1|||
125400808|NCT03285646|451096671|FG001|Overall Study|Adverse Event|0|||
125400809|NCT03285646|451096670|FG000|Overall Study|Withdrawal by Subject|10|||
125400810|NCT03285646|451096671|FG001|Overall Study|Withdrawal by Subject|2|||
125400811|NCT03285646|451096670|FG000|Overall Study|Lost to Follow-up|2|||
125400812|NCT03285646|451096671|FG001|Overall Study|Lost to Follow-up|1|||
125400813|NCT03285646|451096670|FG000|Overall Study|Investigator/Sponsor Decision|0|||
125400814|NCT03285646|451096671|FG001|Overall Study|Investigator/Sponsor Decision|1|||
125400815|NCT02610192|451096673|FG000|Overall Study|Received other treatment|8|||
125400816|NCT02610192|451096673|FG000|Overall Study|Physician Decision|1|||
125400817|NCT00503841|451096674|FG000|Overall Study|All screen failures|44|||
125400818|NCT01344057|451096675|FG000|Overall Study|Premature Withdrawal|1|||
125400819|NCT00306592|451096676|FG000|Overall Study|Adverse Event|8|||
125400820|NCT00306592|451096677|FG001|Overall Study|Adverse Event|15|||
125400821|NCT00306592|451096676|FG000|Overall Study|Lost to Follow-up|1|||
125400822|NCT00306592|451096677|FG001|Overall Study|Lost to Follow-up|0|||
125400823|NCT00306592|451096676|FG000|Overall Study|Noncompliance|0|||
125400824|NCT00306592|451096677|FG001|Overall Study|Noncompliance|2|||
125400825|NCT00306592|451096676|FG000|Overall Study|Persistent Antibodies|6|||
125400826|NCT00306592|451096677|FG001|Overall Study|Persistent Antibodies|3|||
125400827|NCT00306592|451096676|FG000|Overall Study|Voluntary|10|||
125400828|NCT00306592|451096677|FG001|Overall Study|Voluntary|6|||
125400829|NCT00306592|451096676|FG000|Overall Study|Other|5|||
125400830|NCT00306592|451096677|FG001|Overall Study|Other|10|||
125400831|NCT00306592|451096676|FG000|Overall Study|Other|1|||
125400832|NCT00306592|451096677|FG001|Overall Study|Other|2|||
125400833|NCT00306592|451096676|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
125400834|NCT00306592|451096677|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
125400835|NCT03354429|451096678|FG000|Overall Study|Withdrawal by Subject|8|||
125400836|NCT03354429|451096679|FG001|Overall Study|Withdrawal by Subject|7|||
125400837|NCT03354429|451096678|FG000|Overall Study|Lost to Follow-up|1|||
125400838|NCT03354429|451096679|FG001|Overall Study|Lost to Follow-up|0|||
125447818|NCT00826280|451266825|FG000|Overall Study|Randomized but drug not received|1|||
125400839|NCT00654628|451096680|FG000|6-week Active Treatment Period|Adverse Event|9|||
125400840|NCT00654628|451096680|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
125447819|NCT00826280|451266826|FG001|Overall Study|Randomized but drug not received|0|||
125276004|NCT02707965|450637946|FG010|Overall Study|PI decisions|0|||
125400841|NCT00654628|451096680|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
125400842|NCT00654628|451096680|FG000|6-week Active Treatment Period|Out of window period|1|||
125400843|NCT00654628|451096680|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
125400844|NCT00654628|451096680|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
125400845|NCT00953329|451096685|FG000|Overall Study|Lack of Efficacy|1|||
125276005|NCT02707965|450637947|FG011|Overall Study|PI decisions|0|||
125276006|NCT02707965|450637948|FG012|Overall Study|PI decisions|0|||
125276007|NCT02707965|450637949|FG013|Overall Study|PI decisions|0|||
125276008|NCT02707965|450637950|FG014|Overall Study|PI decisions|2|||
125276009|NCT02707965|450637951|FG015|Overall Study|PI decisions|0|||
125276010|NCT02707965|450637936|FG000|Overall Study|Protocol deviation|1|||
125276011|NCT02707965|450637937|FG001|Overall Study|Protocol deviation|1|||
125276012|NCT02707965|450637938|FG002|Overall Study|Protocol deviation|0|||
125276013|NCT02707965|450637939|FG003|Overall Study|Protocol deviation|0|||
125276014|NCT02707965|450637940|FG004|Overall Study|Protocol deviation|0|||
125276015|NCT02707965|450637941|FG005|Overall Study|Protocol deviation|0|||
125276016|NCT02707965|450637942|FG006|Overall Study|Protocol deviation|0|||
125276017|NCT02707965|450637943|FG007|Overall Study|Protocol deviation|1|||
125276018|NCT02707965|450637944|FG008|Overall Study|Protocol deviation|0|||
125276019|NCT02707965|450637945|FG009|Overall Study|Protocol deviation|0|||
125276020|NCT02707965|450637946|FG010|Overall Study|Protocol deviation|0|||
125276021|NCT02707965|450637947|FG011|Overall Study|Protocol deviation|0|||
125276022|NCT02707965|450637948|FG012|Overall Study|Protocol deviation|0|||
125276023|NCT02707965|450637949|FG013|Overall Study|Protocol deviation|0|||
125276024|NCT02707965|450637950|FG014|Overall Study|Protocol deviation|0|||
125276025|NCT02707965|450637951|FG015|Overall Study|Protocol deviation|0|||
125276026|NCT00748618|450637953|FG000|Overall Study|Adverse Event|1|||
125276027|NCT00748618|450637954|FG001|Overall Study|Adverse Event|0|||
125276028|NCT02854436|450637955|FG000|Overall Study|Adverse Event|1|||
125276029|NCT02854436|450637955|FG000|Overall Study|Death|208|||
125276030|NCT02854436|450637955|FG000|Overall Study|Lost to Follow-up|5|||
125276031|NCT02854436|450637955|FG000|Overall Study|Withdrawal by Subject|24|||
125276032|NCT02854436|450637955|FG000|Overall Study|Other|45|||
125276033|NCT02854436|450637955|FG000|Overall Study|Physician Decision|6|||
125276034|NCT01977729|450637956|FG000|Overall Study|Study terminated|1|||
125276035|NCT01268046|450637957|FG000|Overall Study|Withdrawal by Subject|1|||
125276036|NCT01268046|450637958|FG001|Overall Study|Withdrawal by Subject|0|||
125276037|NCT01268046|450637959|FG002|Overall Study|Withdrawal by Subject|0|||
125276038|NCT01268046|450637960|FG003|Overall Study|Withdrawal by Subject|1|||
125276039|NCT01268046|450637957|FG000|Overall Study|Lost to Follow-up|0|||
125276040|NCT01268046|450637958|FG001|Overall Study|Lost to Follow-up|0|||
125276041|NCT01268046|450637959|FG002|Overall Study|Lost to Follow-up|1|||
125276042|NCT01268046|450637960|FG003|Overall Study|Lost to Follow-up|0|||
125276043|NCT00224120|450637961|FG000|Overall Study|Adverse Event|10|||
125276044|NCT00224120|450637962|FG001|Overall Study|Adverse Event|4|||
125276045|NCT00224120|450637961|FG000|Overall Study|Protocol Violation|1|||
125276046|NCT00224120|450637962|FG001|Overall Study|Protocol Violation|0|||
125276047|NCT00224120|450637961|FG000|Overall Study|Withdrawal by Subject|5|||
125276048|NCT00224120|450637962|FG001|Overall Study|Withdrawal by Subject|10|||
125276049|NCT00224120|450637961|FG000|Overall Study|Lack of Efficacy|0|||
125276050|NCT00224120|450637962|FG001|Overall Study|Lack of Efficacy|2|||
125276051|NCT00224120|450637961|FG000|Overall Study|Lost to Follow-up|2|||
125276052|NCT00224120|450637962|FG001|Overall Study|Lost to Follow-up|3|||
125276053|NCT00224120|450637961|FG000|Overall Study|Other|4|||
125276054|NCT00224120|450637962|FG001|Overall Study|Other|5|||
125276055|NCT00282087|450637963|FG000|Overall Study|Death|1|||
125276056|NCT00338286|450637971|FG000|Overall Study|Withdrawal by Subject|50|||
125276057|NCT00338286|450637972|FG001|Overall Study|Withdrawal by Subject|54|||
125276058|NCT00338286|450637971|FG000|Overall Study|Lost to Follow-up|80|||
125276059|NCT00338286|450637972|FG001|Overall Study|Lost to Follow-up|66|||
125276060|NCT00338286|450637971|FG000|Overall Study|Other|103|||
125276061|NCT00338286|450637972|FG001|Overall Study|Other|93|||
125276062|NCT03248531|450637973|FG000|Overall Study|Adverse Event|0|||
125276063|NCT03248531|450637974|FG001|Overall Study|Adverse Event|0|||
125276064|NCT03248531|450637975|FG002|Overall Study|Adverse Event|1|||
125276065|NCT03248531|450637973|FG000|Overall Study|Lost to Follow-up|1|||
125276066|NCT03248531|450637974|FG001|Overall Study|Lost to Follow-up|0|||
125276067|NCT03248531|450637975|FG002|Overall Study|Lost to Follow-up|5|||
125276068|NCT03248531|450637973|FG000|Overall Study|Withdrawal by Subject|3|||
125400846|NCT01350128|451096697|FG000|Overall Study|Withdrawal by Subject|3|||
125400847|NCT01350128|451096697|FG000|Overall Study|Protocol discontinuation criteria|8|||
125400848|NCT01350128|451096697|FG000|Overall Study|Physician Decision|1|||
125400849|NCT01350128|451096697|FG000|Overall Study|Lost to Follow-up|2|||
125400850|NCT02644967|451096703|FG000|Overall Study|Death|26|||
125400851|NCT02644967|451096703|FG000|Overall Study|Physician Decision|1|||
125276069|NCT03248531|450637974|FG001|Overall Study|Withdrawal by Subject|3|||
125400852|NCT02644967|451096703|FG000|Overall Study|Withdrawal by Subject|2|||
125276070|NCT03248531|450637975|FG002|Overall Study|Withdrawal by Subject|2|||
125276071|NCT03248531|450637973|FG000|Overall Study|Sponsor Request|0|||
125276072|NCT03248531|450637974|FG001|Overall Study|Sponsor Request|2|||
125276073|NCT03248531|450637975|FG002|Overall Study|Sponsor Request|0|||
125276074|NCT04075513|450637976|FG000|Overall Study|Withdrawal by Subject|2|||
125276075|NCT04075513|450637977|FG001|Overall Study|Withdrawal by Subject|2|||
125276076|NCT04075513|450637976|FG000|Overall Study|Lack of Efficacy|1|||
125276077|NCT04075513|450637977|FG001|Overall Study|Lack of Efficacy|0|||
125400853|NCT02644967|451096703|FG000|Overall Study|Protocol Violation|1|||
125400854|NCT02644967|451096703|FG000|Overall Study|Progressive Disease|1|||
125400855|NCT02644967|451096703|FG000|Overall Study|Study Terminated by Sponsor|4|||
125400856|NCT03323099|451096705|FG000|Overall Study|Withdrawal by Subject|6|||
125400857|NCT03323099|451096706|FG001|Overall Study|Withdrawal by Subject|12|||
125400858|NCT03323099|451096705|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
125400859|NCT03323099|451096706|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
125400860|NCT02098109|451096714|FG000|Overall Study|Protocol Violation|3|||
125400861|NCT02098109|451096715|FG001|Overall Study|Protocol Violation|0|||
125400862|NCT01822132|451096716|FG000|Overall Study|Lost to Follow-up|4|||
125400863|NCT01822132|451096717|FG001|Overall Study|Lost to Follow-up|2|||
125400864|NCT02519712|451096720|FG000|Overall Study|Disease Relapse|1|||
125400865|NCT02519712|451096720|FG000|Overall Study|Disease Progression|1|||
125400866|NCT02519712|451096720|FG000|Overall Study|Accruals are donors|2|||
125400867|NCT03254134|451096723|FG000|Overall Study|Not eligible patients|599|||
125400868|NCT03254134|451096724|FG001|Overall Study|Not eligible patients|3630|||
125400869|NCT01247090|451096725|FG000|Overall Study|Physician Decision|1|||
125400870|NCT01247090|451096726|FG001|Overall Study|Physician Decision|0|||
125400871|NCT01247090|451096727|FG002|Overall Study|Physician Decision|0|||
125400872|NCT01247090|451096725|FG000|Overall Study|Withdrawal by Subject|0|||
125400873|NCT01247090|451096726|FG001|Overall Study|Withdrawal by Subject|1|||
125400874|NCT01247090|451096727|FG002|Overall Study|Withdrawal by Subject|0|||
125400875|NCT00006916|451096729|FG000|Overall Study|Device not inserted|4|||
125400876|NCT00006916|451096729|FG000|Overall Study|Complication of device insertion|1|||
125400877|NCT03385239|451096734|FG000|Overall Study|Voluntary Withdrawal|2|||
125400878|NCT03385239|451096735|FG001|Overall Study|Voluntary Withdrawal|3|||
125400879|NCT03385239|451096736|FG002|Overall Study|Voluntary Withdrawal|2|||
125400880|NCT03385239|451096737|FG003|Overall Study|Voluntary Withdrawal|3|||
125400881|NCT03385239|451096738|FG004|Overall Study|Voluntary Withdrawal|0|||
125400882|NCT03385239|451096734|FG000|Overall Study|Adverse Event|0|||
125400883|NCT03385239|451096735|FG001|Overall Study|Adverse Event|0|||
125400884|NCT03385239|451096736|FG002|Overall Study|Adverse Event|1|||
125400885|NCT03385239|451096737|FG003|Overall Study|Adverse Event|0|||
125400886|NCT03385239|451096738|FG004|Overall Study|Adverse Event|0|||
125400887|NCT03385239|451096734|FG000|Overall Study|Other|0|||
125400888|NCT03385239|451096735|FG001|Overall Study|Other|0|||
125400889|NCT03385239|451096736|FG002|Overall Study|Other|0|||
125447820|NCT00826280|451266827|FG002|Overall Study|Randomized but drug not received|1|||
125400890|NCT03385239|451096737|FG003|Overall Study|Other|1|||
125400891|NCT03385239|451096738|FG004|Overall Study|Other|0|||
125400892|NCT01574703|451096739|FG000|Overall Study|Adverse Event|0|||
125400893|NCT01574703|451096740|FG001|Overall Study|Adverse Event|2|||
125400894|NCT01574703|451096741|FG002|Overall Study|Adverse Event|1|||
125400895|NCT01574703|451096742|FG003|Overall Study|Adverse Event|1|||
125400896|NCT01574703|451096739|FG000|Overall Study|Protocol Violation|0|||
125400897|NCT01574703|451096740|FG001|Overall Study|Protocol Violation|0|||
125400898|NCT01574703|451096741|FG002|Overall Study|Protocol Violation|0|||
125400899|NCT01574703|451096742|FG003|Overall Study|Protocol Violation|1|||
125400900|NCT01574703|451096739|FG000|Overall Study|Unspecified Reason|27|||
125400901|NCT01574703|451096740|FG001|Overall Study|Unspecified Reason|15|||
125400902|NCT01574703|451096741|FG002|Overall Study|Unspecified Reason|20|||
125400903|NCT01574703|451096742|FG003|Overall Study|Unspecified Reason|16|||
125400904|NCT01574703|451096739|FG000|Overall Study|Withdrawal by Subject|53|||
125400905|NCT01574703|451096740|FG001|Overall Study|Withdrawal by Subject|52|||
125400906|NCT01574703|451096741|FG002|Overall Study|Withdrawal by Subject|36|||
125400907|NCT01574703|451096742|FG003|Overall Study|Withdrawal by Subject|61|||
125400908|NCT01574703|451096739|FG000|Overall Study|Met Withdrawal Criteria|0|||
125400909|NCT01574703|451096740|FG001|Overall Study|Met Withdrawal Criteria|1|||
125400910|NCT01574703|451096741|FG002|Overall Study|Met Withdrawal Criteria|1|||
125400911|NCT01574703|451096742|FG003|Overall Study|Met Withdrawal Criteria|0|||
125400912|NCT01574703|451096739|FG000|Overall Study|Lost to Follow-up|43|||
125400913|NCT01574703|451096740|FG001|Overall Study|Lost to Follow-up|41|||
125400914|NCT01574703|451096741|FG002|Overall Study|Lost to Follow-up|46|||
125400915|NCT01574703|451096742|FG003|Overall Study|Lost to Follow-up|35|||
125400916|NCT01574703|451096739|FG000|Overall Study|Death|2|||
125400917|NCT01574703|451096740|FG001|Overall Study|Death|1|||
125400918|NCT01574703|451096741|FG002|Overall Study|Death|1|||
125276078|NCT04075513|450637976|FG000|Overall Study|Lost to Follow-up|4|||
125276079|NCT04075513|450637977|FG001|Overall Study|Lost to Follow-up|2|||
125400919|NCT01574703|451096742|FG003|Overall Study|Death|0|||
125400920|NCT01524770|451096744|FG000|First Intervention|Withdrawal by Subject|1|||
125400921|NCT01524770|451096745|FG001|First Intervention|Withdrawal by Subject|0|||
125400922|NCT01524770|451096744|FG000|First Intervention|Adverse Event|1|||
125400923|NCT01524770|451096745|FG001|First Intervention|Adverse Event|1|||
125400924|NCT01524770|451096744|FG000|First Intervention|Protocol Violation|1|||
125400925|NCT01524770|451096745|FG001|First Intervention|Protocol Violation|0|||
125400926|NCT02751983|451096746|FG000|Treatment|Stopped ACT, but Remained in study|2|||
125400927|NCT02751983|451096747|FG001|Treatment|Stopped ACT, but Remained in study|0|||
125400928|NCT02751983|451096746|FG000|Treatment|Discharged prior to beginning ACT|2|||
125400929|NCT02751983|451096747|FG001|Treatment|Discharged prior to beginning ACT|0|||
125400930|NCT02751983|451096746|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
125400931|NCT02751983|451096747|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
125400932|NCT02751983|451096746|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
125400933|NCT02751983|451096747|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
125400934|NCT02751983|451096746|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
125400935|NCT02751983|451096747|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
125400936|NCT00813358|451096750|FG000|Overall Study|Death|32|||
125400937|NCT00813358|451096750|FG000|Overall Study|Lost to Follow-up|12|||
125400938|NCT00813358|451096750|FG000|Overall Study|other endpoints|5|||
125400939|NCT00813358|451096750|FG000|Overall Study|Withdrawal by Subject|20|||
125400940|NCT01282216|451096751|FG000|Overall Study|Graft failure|0|||
125400941|NCT01282216|451096752|FG001|Overall Study|Graft failure|0|||
125400942|NCT01282216|451096753|FG002|Overall Study|Graft failure|3|||
125400943|NCT01282216|451096754|FG003|Overall Study|Graft failure|2|||
125400944|NCT01282216|451096751|FG000|Overall Study|Physician Decision|0|||
125400945|NCT01282216|451096752|FG001|Overall Study|Physician Decision|0|||
125400946|NCT01282216|451096753|FG002|Overall Study|Physician Decision|11|||
125400947|NCT01282216|451096754|FG003|Overall Study|Physician Decision|0|||
125400948|NCT01282216|451096751|FG000|Overall Study|Relapse|0|||
125400949|NCT01282216|451096752|FG001|Overall Study|Relapse|0|||
125400950|NCT01282216|451096753|FG002|Overall Study|Relapse|17|||
125400951|NCT01282216|451096754|FG003|Overall Study|Relapse|6|||
125400952|NCT01282216|451096751|FG000|Overall Study|Death|0|||
125400953|NCT01282216|451096752|FG001|Overall Study|Death|0|||
125400954|NCT01282216|451096753|FG002|Overall Study|Death|2|||
125400955|NCT01282216|451096754|FG003|Overall Study|Death|0|||
125400956|NCT03851016|451096755|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125400957|NCT03851016|451096756|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
125400958|NCT03080961|451096757|FG000|Overall Study|Withdrawal by Subject|3|||
125400959|NCT00586469|451096759|FG000|Overall Study|Adverse Event|0|||
125400960|NCT00586469|451096760|FG001|Overall Study|Adverse Event|1|||
125400961|NCT04197713|451096763|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
125400962|NCT04197713|451096764|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
125400963|NCT05569954|451096765|FG000|Overall Study|Lost to Follow-up|3|||
125400964|NCT05569954|451096766|FG001|Overall Study|Lost to Follow-up|4|||
125400965|NCT05569954|451096765|FG000|Overall Study|Protocol Violation|1|||
125400966|NCT05569954|451096766|FG001|Overall Study|Protocol Violation|2|||
125400967|NCT05569954|451096765|FG000|Overall Study|Withdrawal by Subject|4|||
125400968|NCT05569954|451096766|FG001|Overall Study|Withdrawal by Subject|2|||
125400969|NCT01660412|451096767|FG000|Overall Study|Protocol Violation|0|||
125400970|NCT01660412|451096768|FG001|Overall Study|Protocol Violation|3|||
125400971|NCT02239536|451096769|FG000|Overall Study|Non-neoplastic polyp|23|||
125400972|NCT02239536|451096770|FG001|Overall Study|Non-neoplastic polyp|17|||
125400973|NCT04346615|451098753|FG000|Overall Study|Lost to Follow-up|0|||
125400974|NCT04346615|451098754|FG001|Overall Study|Lost to Follow-up|2|||
125400975|NCT04346615|451098753|FG000|Overall Study|Withdrawal by Subject|1|||
125400976|NCT04346615|451098754|FG001|Overall Study|Withdrawal by Subject|0|||
125400977|NCT04346615|451098753|FG000|Overall Study|Death|5|||
125400978|NCT04346615|451098754|FG001|Overall Study|Death|1|||
125400979|NCT04346615|451098753|FG000|Overall Study|Other|0|||
125400980|NCT04346615|451098754|FG001|Overall Study|Other|2|||
125400981|NCT04346615|451098753|FG000|Overall Study|Randomized not treated|1|||
125400982|NCT04346615|451098754|FG001|Overall Study|Randomized not treated|0|||
125400983|NCT04524403|451098757|FG000|Overall Study|Withdrawal by Subject|10|||
125400984|NCT04524403|451098758|FG001|Overall Study|Withdrawal by Subject|3|||
125400985|NCT04524403|451098759|FG002|Overall Study|Withdrawal by Subject|8|||
125400986|NCT04524403|451098757|FG000|Overall Study|Lost to Follow-up|3|||
125400987|NCT04524403|451098758|FG001|Overall Study|Lost to Follow-up|4|||
125400988|NCT04524403|451098759|FG002|Overall Study|Lost to Follow-up|3|||
125400989|NCT04524403|451098757|FG000|Overall Study|Adverse Event|3|||
125400990|NCT04524403|451098758|FG001|Overall Study|Adverse Event|1|||
125400991|NCT04524403|451098759|FG002|Overall Study|Adverse Event|4|||
125400992|NCT04524403|451098757|FG000|Overall Study|Non-compliant with study drug|1|||
125400993|NCT04524403|451098758|FG001|Overall Study|Non-compliant with study drug|2|||
125400994|NCT04524403|451098759|FG002|Overall Study|Non-compliant with study drug|3|||
125400995|NCT04524403|451098757|FG000|Overall Study|Moved|0|||
125400996|NCT04524403|451098758|FG001|Overall Study|Moved|1|||
125400997|NCT04524403|451098759|FG002|Overall Study|Moved|0|||
125400998|NCT00533949|451098762|FG000|Overall Study|Protocol Violation|12|||
125400999|NCT00533949|451098763|FG001|Overall Study|Protocol Violation|12|||
125401000|NCT00533949|451098764|FG002|Overall Study|Protocol Violation|9|||
125401001|NCT00533949|451098765|FG003|Overall Study|Protocol Violation|9|||
125401002|NCT00533949|451098762|FG000|Overall Study|Withdrawal by Subject|3|||
125401003|NCT00533949|451098763|FG001|Overall Study|Withdrawal by Subject|2|||
125401004|NCT00533949|451098764|FG002|Overall Study|Withdrawal by Subject|1|||
125276080|NCT04075513|450637976|FG000|Overall Study|Switch to insulin pump|1|||
125276081|NCT04075513|450637977|FG001|Overall Study|Switch to insulin pump|0|||
125276082|NCT01035463|450637978|FG000|Overall Study|Adverse Event|0|||
125276083|NCT01035463|450637979|FG001|Overall Study|Adverse Event|0|||
125276084|NCT01035463|450637980|FG002|Overall Study|Adverse Event|4|||
125276085|NCT01035463|450637981|FG003|Overall Study|Adverse Event|1|||
125276086|NCT01035463|450637982|FG004|Overall Study|Adverse Event|5|||
125276087|NCT01035463|450637983|FG005|Overall Study|Adverse Event|7|||
125276088|NCT01035463|450637978|FG000|Overall Study|Withdrawal by Subject|0|||
125276089|NCT01035463|450637979|FG001|Overall Study|Withdrawal by Subject|2|||
125276090|NCT01035463|450637980|FG002|Overall Study|Withdrawal by Subject|1|||
125276091|NCT01035463|450637981|FG003|Overall Study|Withdrawal by Subject|0|||
125276092|NCT01035463|450637982|FG004|Overall Study|Withdrawal by Subject|1|||
125276093|NCT01035463|450637983|FG005|Overall Study|Withdrawal by Subject|4|||
125276094|NCT01035463|450637978|FG000|Overall Study|Disease progression|0|||
125276095|NCT01035463|450637979|FG001|Overall Study|Disease progression|0|||
125276096|NCT01035463|450637980|FG002|Overall Study|Disease progression|0|||
125276097|NCT01035463|450637981|FG003|Overall Study|Disease progression|0|||
125276098|NCT01035463|450637982|FG004|Overall Study|Disease progression|0|||
125276099|NCT01035463|450637983|FG005|Overall Study|Disease progression|3|||
125276100|NCT01035463|450637978|FG000|Overall Study|Other Malignancy|0|||
125276101|NCT01035463|450637979|FG001|Overall Study|Other Malignancy|0|||
125276102|NCT01035463|450637980|FG002|Overall Study|Other Malignancy|0|||
125276103|NCT01035463|450637981|FG003|Overall Study|Other Malignancy|0|||
125276104|NCT01035463|450637982|FG004|Overall Study|Other Malignancy|0|||
125276105|NCT01035463|450637983|FG005|Overall Study|Other Malignancy|2|||
125276106|NCT01035463|450637978|FG000|Overall Study|Other|0|||
125276107|NCT01035463|450637979|FG001|Overall Study|Other|0|||
125276108|NCT01035463|450637980|FG002|Overall Study|Other|0|||
125276109|NCT01035463|450637981|FG003|Overall Study|Other|1|||
125276110|NCT01035463|450637982|FG004|Overall Study|Other|0|||
125276111|NCT01035463|450637983|FG005|Overall Study|Other|2|||
125276112|NCT00935493|450637993|FG000|Overall Study|Lost to Follow-up|1|||
125276113|NCT00935493|450637994|FG001|Overall Study|Lost to Follow-up|1|||
125276114|NCT00935493|450637995|FG002|Overall Study|Lost to Follow-up|1|||
125276115|NCT00935493|450637993|FG000|Overall Study|Treatment Discontinued|0|||
125276116|NCT00935493|450637994|FG001|Overall Study|Treatment Discontinued|1|||
125276117|NCT00935493|450637995|FG002|Overall Study|Treatment Discontinued|0|||
125276118|NCT04153981|450637996|FG000|Overall Study|Death|1|||
125276119|NCT04153981|450637996|FG000|Overall Study|Withdrawal by Subject|24|||
125276120|NCT04153981|450637996|FG000|Overall Study|Lost to Follow-up|1|||
125276121|NCT04153981|450637996|FG000|Overall Study|Physician Decision|1|||
125276122|NCT04153981|450637996|FG000|Overall Study|Due to Unavailable Glucometer|1|||
125276123|NCT04153981|450637996|FG000|Overall Study|Covid 19|52|||
125276124|NCT04153981|450637996|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
125276125|NCT04153981|450637996|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
125276126|NCT01355679|450637997|FG000|Overall Study|benign tumor types found at biopsy|2|||
125276127|NCT00964002|450638002|FG000|Overall Study|Protocol Violation|8|||
125276128|NCT00904670|450638003|FG000|Open Label Phase|Withdrawal by Subject|2|||
125276129|NCT00904670|450638004|FG001|Open Label Phase|Withdrawal by Subject|0|||
125276130|NCT00904670|450638003|FG000|Open Label Phase|Adverse Event|2|||
125276131|NCT00904670|450638004|FG001|Open Label Phase|Adverse Event|0|||
125276132|NCT00904670|450638003|FG000|Open Label Phase|Lack of Efficacy|1|||
125276133|NCT00904670|450638004|FG001|Open Label Phase|Lack of Efficacy|0|||
125276134|NCT00904670|450638003|FG000|Open Label Phase|Lost to Follow-up|1|||
125276135|NCT00904670|450638004|FG001|Open Label Phase|Lost to Follow-up|0|||
125276136|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
125276137|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
125276138|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
125276139|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
125276140|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Death|58|||
125276141|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Death|65|||
125276142|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Adverse Event|28|||
125276143|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Adverse Event|40|||
125276144|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Disease Progression|22|||
125276145|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Disease Progression|35|||
125276146|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Other|25|||
125276147|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Other|33|||
125276148|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
125276149|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
125276150|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Noncompliance|8|||
125401005|NCT00533949|451098765|FG003|Overall Study|Withdrawal by Subject|1|||
125276151|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Noncompliance|8|||
125401006|NCT00727194|451098766|FG000|Screening Period|Low QMG scores|0|||
125276152|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
125276153|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
125276154|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
125276155|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
125276156|NCT00286091|450638005|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
125276157|NCT00286091|450638006|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
125276158|NCT00286091|450638005|FG000|Open-label Treatment Phase|Physician Decision|24|||
125276159|NCT00286091|450638006|FG001|Open-label Treatment Phase|Physician Decision|21|||
125276160|NCT00286091|450638005|FG000|Open-label Treatment Phase|Adverse Event|5|||
125276161|NCT00286091|450638006|FG001|Open-label Treatment Phase|Adverse Event|16|||
125276162|NCT00286091|450638005|FG000|Open-label Treatment Phase|Other|11|||
125276163|NCT00286091|450638006|FG001|Open-label Treatment Phase|Other|11|||
125276164|NCT00286091|450638005|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
125276165|NCT00286091|450638006|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
125276166|NCT00286091|450638005|FG000|Open-label Treatment Phase|Death|10|||
125276167|NCT00286091|450638006|FG001|Open-label Treatment Phase|Death|7|||
125276168|NCT00286091|450638005|FG000|Open-label Treatment Phase|Disease Progression|9|||
125276169|NCT00286091|450638006|FG001|Open-label Treatment Phase|Disease Progression|3|||
125276170|NCT00286091|450638005|FG000|Open-label Treatment Phase|Noncompliance|3|||
125276171|NCT00286091|450638006|FG001|Open-label Treatment Phase|Noncompliance|1|||
125276172|NCT00286091|450638005|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
125276173|NCT00286091|450638006|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
125276174|NCT00286091|450638005|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
125276175|NCT00286091|450638006|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
125276176|NCT00286091|450638005|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
125276177|NCT00286091|450638006|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
125276178|NCT03423238|450638007|FG000|Overall Study|Lost to Follow-up|1|||
125276179|NCT03423238|450638008|FG001|Overall Study|Lost to Follow-up|0|||
125276180|NCT03423238|450638007|FG000|Overall Study|Withdrawal by Subject|1|||
125276181|NCT03423238|450638008|FG001|Overall Study|Withdrawal by Subject|0|||
125276182|NCT02036580|450638009|FG000|Overall Study|Withdrawal by Subject|0|||
125276183|NCT02036580|450638010|FG001|Overall Study|Withdrawal by Subject|1|||
125276184|NCT02036580|450638011|FG002|Overall Study|Withdrawal by Subject|0|||
125276185|NCT02036580|450638009|FG000|Overall Study|Adverse Event|1|||
125276186|NCT02036580|450638010|FG001|Overall Study|Adverse Event|0|||
125276187|NCT02036580|450638011|FG002|Overall Study|Adverse Event|0|||
125276188|NCT02584452|450638012|FG000|Overall Study|Physician Decision|1|||
125276189|NCT02584452|450638013|FG001|Overall Study|Physician Decision|1|||
125276190|NCT02584452|450638012|FG000|Overall Study|Lost to Follow-up|1|||
125276191|NCT02584452|450638013|FG001|Overall Study|Lost to Follow-up|1|||
125276192|NCT00923351|450638014|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
125276193|NCT00923351|450638015|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
125276194|NCT00923351|450638016|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
125276195|NCT01536561|450638017|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
125276196|NCT01536561|450638017|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
125276197|NCT01536561|450638017|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
125276198|NCT01536561|450638017|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
125276199|NCT01536561|450638017|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
125276200|NCT01536561|450638017|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
125276201|NCT04552288|450638018|FG000|Overall Study|Death|3|||
125276202|NCT04552288|450638018|FG000|Overall Study|Lost to Follow-up|6|||
125276203|NCT04552288|450638018|FG000|Overall Study|Physician Decision|3|||
125276204|NCT04552288|450638018|FG000|Overall Study|Protocol Violation|9|||
125276205|NCT04552288|450638018|FG000|Overall Study|Withdrawal by Subject|6|||
125276206|NCT04552288|450638018|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
125276207|NCT05285644|450638019|FG000|Overall Study|Adverse Event|3|||
125276208|NCT05285644|450638020|FG001|Overall Study|Adverse Event|3|||
125276209|NCT05285644|450638019|FG000|Overall Study|Withdrawal of Consent|2|||
125276210|NCT05285644|450638020|FG001|Overall Study|Withdrawal of Consent|5|||
125276211|NCT05285644|450638019|FG000|Overall Study|Noncompliance|0|||
125276212|NCT05285644|450638020|FG001|Overall Study|Noncompliance|4|||
125276213|NCT05285644|450638019|FG000|Overall Study|Lost to Follow-up|4|||
125276214|NCT05285644|450638020|FG001|Overall Study|Lost to Follow-up|6|||
125276215|NCT05285644|450638019|FG000|Overall Study|Disallowed Concurrent Medication|1|||
125276216|NCT05285644|450638020|FG001|Overall Study|Disallowed Concurrent Medication|1|||
125276217|NCT05285644|450638019|FG000|Overall Study|Investigator Decision|2|||
125276218|NCT05285644|450638020|FG001|Overall Study|Investigator Decision|0|||
125276219|NCT05285644|450638019|FG000|Overall Study|Protocol Deviation|1|||
125276220|NCT05285644|450638020|FG001|Overall Study|Protocol Deviation|0|||
125276221|NCT05285644|450638019|FG000|Overall Study|As specified in the Clinical Study Report|7|||
125276222|NCT05285644|450638020|FG001|Overall Study|As specified in the Clinical Study Report|3|||
125276223|NCT04532294|450638021|FG000|Overall Study|Withdrawal by Subject|0|||
125276224|NCT04532294|450638022|FG001|Overall Study|Withdrawal by Subject|0|||
125276225|NCT04532294|450638023|FG002|Overall Study|Withdrawal by Subject|1|||
125276226|NCT04532294|450638021|FG000|Overall Study|Participants Not Dosed|0|||
125401007|NCT00727194|451098767|FG001|Screening Period|Low QMG scores|0|||
125401008|NCT00727194|451098768|FG002|Screening Period|Low QMG scores|6|||
125401009|NCT00727194|451098766|FG000|Screening Period|Lacked AChR antibodies|0|||
125401010|NCT00727194|451098767|FG001|Screening Period|Lacked AChR antibodies|0|||
125401011|NCT00727194|451098768|FG002|Screening Period|Lacked AChR antibodies|5|||
125401012|NCT00727194|451098766|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
125401013|NCT00727194|451098767|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
125401014|NCT00727194|451098768|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
125401015|NCT00727194|451098766|FG000|Screening Period|Severe infections|0|||
125401016|NCT00727194|451098767|FG001|Screening Period|Severe infections|0|||
125401017|NCT00727194|451098768|FG002|Screening Period|Severe infections|2|||
125401018|NCT00727194|451098766|FG000|Screening Period|History of thymoma|0|||
125401019|NCT00727194|451098767|FG001|Screening Period|History of thymoma|0|||
125401020|NCT00727194|451098768|FG002|Screening Period|History of thymoma|1|||
125401021|NCT00727194|451098766|FG000|Treatment Period 2|Lack of Efficacy|0|||
125401022|NCT00727194|451098767|FG001|Treatment Period 2|Lack of Efficacy|1|||
125401023|NCT00727194|451098768|FG002|Treatment Period 2|Lack of Efficacy|0|||
125401024|NCT04269161|451098774|FG000|Overall Study|Change of modality and no longer eligible|3|||
125401025|NCT04269161|451098775|FG001|Overall Study|Change of modality and no longer eligible|3|||
125401026|NCT04269161|451098774|FG000|Overall Study|Required procedure outside of NICU|1|||
125401027|NCT04269161|451098775|FG001|Overall Study|Required procedure outside of NICU|0|||
125401028|NCT04269161|451098774|FG000|Overall Study|Equipment issue|1|||
125401029|NCT04269161|451098775|FG001|Overall Study|Equipment issue|1|||
125401030|NCT01513317|451098776|FG000|Overall Study|Withdrawal by Subject|15|||
125401031|NCT01513317|451098777|FG001|Overall Study|Withdrawal by Subject|4|||
125401032|NCT01513317|451098776|FG000|Overall Study|Death|1|||
125401033|NCT01513317|451098777|FG001|Overall Study|Death|1|||
125401034|NCT01513317|451098776|FG000|Overall Study|Study terminated by sponsor|18|||
125401035|NCT01513317|451098777|FG001|Overall Study|Study terminated by sponsor|18|||
125401036|NCT01513317|451098776|FG000|Overall Study|Other|0|||
125401037|NCT01513317|451098777|FG001|Overall Study|Other|1|||
125401038|NCT04108130|451098778|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
125401039|NCT04108130|451098779|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
125401040|NCT04108130|451098778|FG000|Overall Study|Consent Withdrawn|9|||
125401041|NCT04108130|451098779|FG001|Overall Study|Consent Withdrawn|6|||
125401042|NCT04108130|451098778|FG000|Overall Study|Surgery Cancelled|4|||
125401043|NCT04108130|451098779|FG001|Overall Study|Surgery Cancelled|4|||
125401044|NCT04108130|451098778|FG000|Overall Study|Found Ineligible for Study|4|||
125401045|NCT04108130|451098779|FG001|Overall Study|Found Ineligible for Study|3|||
125401046|NCT04108130|451098778|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
125401047|NCT04108130|451098779|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
125401048|NCT04108130|451098778|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
125401049|NCT04108130|451098779|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
125401050|NCT00279708|451098782|FG000|Overall Study|Withdrawal by Subject|2|||
125401051|NCT00279708|451098783|FG001|Overall Study|Withdrawal by Subject|3|||
125401052|NCT00279708|451098782|FG000|Overall Study|Adverse Event|1|||
125401053|NCT00279708|451098783|FG001|Overall Study|Adverse Event|1|||
125401054|NCT02477020|451098787|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
125401055|NCT02477020|451098788|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
125401056|NCT02477020|451098787|FG000|Overall Study|Voluntary Withdrawal|7|||
125401057|NCT02477020|451098788|FG001|Overall Study|Voluntary Withdrawal|16|||
125401058|NCT02477020|451098787|FG000|Overall Study|Reason not Specified|3|||
125401059|NCT02477020|451098788|FG001|Overall Study|Reason not Specified|1|||
125401060|NCT02477020|451098787|FG000|Overall Study|Lack of Efficacy|14|||
125401061|NCT02477020|451098788|FG001|Overall Study|Lack of Efficacy|5|||
125401062|NCT01465802|451098789|FG000|Overall Study|Study terminated by sponsor|1|||
125401063|NCT01465802|451098790|FG001|Overall Study|Study terminated by sponsor|0|||
125401064|NCT01465802|451098791|FG002|Overall Study|Study terminated by sponsor|0|||
125401065|NCT01465802|451098792|FG003|Overall Study|Study terminated by sponsor|1|||
125401066|NCT01465802|451098793|FG004|Overall Study|Study terminated by sponsor|7|||
125401067|NCT01465802|451098789|FG000|Overall Study|Withdrawal by Subject|7|||
125401068|NCT01465802|451098790|FG001|Overall Study|Withdrawal by Subject|7|||
125401069|NCT01465802|451098791|FG002|Overall Study|Withdrawal by Subject|0|||
125401070|NCT01465802|451098792|FG003|Overall Study|Withdrawal by Subject|8|||
125401071|NCT01465802|451098793|FG004|Overall Study|Withdrawal by Subject|1|||
125401072|NCT01465802|451098789|FG000|Overall Study|Lost to Follow-up|1|||
125401073|NCT01465802|451098790|FG001|Overall Study|Lost to Follow-up|1|||
125401074|NCT01465802|451098791|FG002|Overall Study|Lost to Follow-up|0|||
125401075|NCT01465802|451098792|FG003|Overall Study|Lost to Follow-up|0|||
125401076|NCT01465802|451098793|FG004|Overall Study|Lost to Follow-up|0|||
125401077|NCT01465802|451098789|FG000|Overall Study|Reason not specified|9|||
125401078|NCT01465802|451098790|FG001|Overall Study|Reason not specified|4|||
125401079|NCT01465802|451098791|FG002|Overall Study|Reason not specified|0|||
125401080|NCT01465802|451098792|FG003|Overall Study|Reason not specified|10|||
125401081|NCT01465802|451098793|FG004|Overall Study|Reason not specified|2|||
125401082|NCT01465802|451098789|FG000|Overall Study|Death|15|||
125276227|NCT04532294|450638022|FG001|Overall Study|Participants Not Dosed|0|||
125276228|NCT04532294|450638023|FG002|Overall Study|Participants Not Dosed|2|||
125276229|NCT04295759|450638024|FG000|Overall Study|Lack of Efficacy|9|||
125276230|NCT04295759|450638024|FG000|Overall Study|Death|1|||
125276231|NCT04295759|450638024|FG000|Overall Study|Withdrawal by Subject|2|||
125276232|NCT04295759|450638024|FG000|Overall Study|Deemed ineligible|1|||
125276233|NCT01696981|450638025|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
125276234|NCT01696981|450638026|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
125276235|NCT01696981|450638025|FG000|Overall Study|Died Before Randomization|3|||
125276236|NCT01696981|450638026|FG001|Overall Study|Died Before Randomization|8|||
125276237|NCT01696981|450638025|FG000|Overall Study|Died Before ASU (Control)|278|||
125276238|NCT01696981|450638026|FG001|Overall Study|Died Before ASU (Control)|0|||
125276239|NCT01696981|450638025|FG000|Overall Study|Refused ASU (Control)|920|||
125276240|NCT01696981|450638026|FG001|Overall Study|Refused ASU (Control)|0|||
125276241|NCT01696981|450638025|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
125276242|NCT01696981|450638026|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
125276243|NCT02798315|450638027|FG000|Overall Study|Failure to return|1|||
125276244|NCT03335150|450638029|FG000|Overall Study|Withdrawal by Subject|10|||
125276245|NCT03335150|450638030|FG001|Overall Study|Withdrawal by Subject|4|||
125276246|NCT03335150|450638029|FG000|Overall Study|Adverse Event|0|||
125276247|NCT03335150|450638030|FG001|Overall Study|Adverse Event|1|||
125276248|NCT02097719|450638031|FG000|Overall Study|Subject Withdrew Consent|1|||
125276249|NCT02097719|450638032|FG001|Overall Study|Subject Withdrew Consent|0|||
125276250|NCT02097719|450638031|FG000|Overall Study|Lost to Follow-up|0|||
125276251|NCT02097719|450638032|FG001|Overall Study|Lost to Follow-up|1|||
125276252|NCT02097719|450638031|FG000|Overall Study|Adverse Event|2|||
125276253|NCT02097719|450638032|FG001|Overall Study|Adverse Event|0|||
125276254|NCT03028415|450638033|FG000|Overall Study|Lost to Follow-up|6|||
125276255|NCT03028415|450638034|FG001|Overall Study|Lost to Follow-up|3|||
125276256|NCT03028415|450638033|FG000|Overall Study|Withdrawal by Subject|1|||
125276257|NCT03028415|450638034|FG001|Overall Study|Withdrawal by Subject|0|||
125276258|NCT03028415|450638033|FG000|Overall Study|Discontinued due to COVID-19|1|||
125276259|NCT03028415|450638034|FG001|Overall Study|Discontinued due to COVID-19|0|||
125276260|NCT02907216|450638035|FG000|Overall Study|No benefit to be obtained by continuing|0|||
125276261|NCT02907216|450638036|FG001|Overall Study|No benefit to be obtained by continuing|1|||
125276262|NCT02907216|450638035|FG000|Overall Study|Withdrawal by Subject|1|||
125276263|NCT02907216|450638036|FG001|Overall Study|Withdrawal by Subject|0|||
125276264|NCT01854775|450638037|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
125276265|NCT01854775|450638038|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
125276266|NCT01854775|450638039|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
125276267|NCT01854775|450638037|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
125276268|NCT01854775|450638038|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
125276269|NCT01854775|450638039|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
125276270|NCT01854775|450638037|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
125276271|NCT01854775|450638038|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
125276272|NCT01854775|450638039|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
125276273|NCT01854775|450638037|FG000|Extension Phase|Pregnancy|3|||
125276274|NCT01854775|450638038|FG001|Extension Phase|Pregnancy|0|||
125276275|NCT01854775|450638039|FG002|Extension Phase|Pregnancy|0|||
125276276|NCT01854775|450638037|FG000|Extension Phase|Investigator's Discretion|1|||
125276277|NCT01854775|450638038|FG001|Extension Phase|Investigator's Discretion|0|||
125276278|NCT01854775|450638039|FG002|Extension Phase|Investigator's Discretion|0|||
125276279|NCT01854775|450638037|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
125276280|NCT01854775|450638038|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
125276281|NCT01854775|450638039|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
125276282|NCT01854775|450638037|FG000|Extension Phase|Lost to Follow-up|2|||
125276283|NCT01854775|450638038|FG001|Extension Phase|Lost to Follow-up|0|||
125276284|NCT01854775|450638039|FG002|Extension Phase|Lost to Follow-up|0|||
125276285|NCT01854775|450638037|FG000|Extension Phase|Still on Study|32|||
125276286|NCT01854775|450638038|FG001|Extension Phase|Still on Study|47|||
125276287|NCT01854775|450638039|FG002|Extension Phase|Still on Study|18|||
125276288|NCT04601532|450638042|FG000|Overall Study|Lost to Follow-up|1|||
125276289|NCT04601532|450638043|FG001|Overall Study|Lost to Follow-up|2|||
125447821|NCT00826280|451266825|FG000|Overall Study|Adverse Event|1|||
125447822|NCT00826280|451266826|FG001|Overall Study|Adverse Event|3|||
125447823|NCT00826280|451266827|FG002|Overall Study|Adverse Event|0|||
125276290|NCT04601532|450638042|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
125276291|NCT04601532|450638043|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
125276292|NCT03108521|450638044|FG000|Overall Study|Lost to Follow-up|3|||
125447824|NCT00826280|451266825|FG000|Overall Study|Lost to Follow-up|0|||
125447825|NCT00826280|451266826|FG001|Overall Study|Lost to Follow-up|1|||
125447826|NCT00826280|451266827|FG002|Overall Study|Lost to Follow-up|0|||
125447827|NCT00826280|451266825|FG000|Overall Study|Sponsor discontinued subject or study|1|||
125447828|NCT00826280|451266826|FG001|Overall Study|Sponsor discontinued subject or study|0|||
125401083|NCT01465802|451098790|FG001|Overall Study|Death|12|||
125401084|NCT01465802|451098791|FG002|Overall Study|Death|0|||
125401085|NCT01465802|451098792|FG003|Overall Study|Death|10|||
125401086|NCT01465802|451098793|FG004|Overall Study|Death|2|||
125401087|NCT01340976|451098794|FG000|Overall Study|Physician Decision|2|||
125401088|NCT01340976|451098795|FG001|Overall Study|Physician Decision|0|||
125401089|NCT01340976|451098796|FG002|Overall Study|Physician Decision|1|||
125401090|NCT01340976|451098797|FG003|Overall Study|Physician Decision|1|||
125401091|NCT01340976|451098798|FG004|Overall Study|Physician Decision|1|||
125401092|NCT01340976|451098799|FG005|Overall Study|Physician Decision|0|||
125401093|NCT01340976|451098794|FG000|Overall Study|Death|0|||
125401094|NCT01340976|451098795|FG001|Overall Study|Death|1|||
125401095|NCT01340976|451098796|FG002|Overall Study|Death|0|||
125401096|NCT01340976|451098797|FG003|Overall Study|Death|0|||
125401097|NCT01340976|451098798|FG004|Overall Study|Death|0|||
125401098|NCT01340976|451098799|FG005|Overall Study|Death|0|||
125401099|NCT01340976|451098794|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
125401100|NCT01340976|451098795|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
125401101|NCT01340976|451098796|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
125401102|NCT01340976|451098797|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
125401103|NCT01340976|451098798|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
125401104|NCT01340976|451098799|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
125401105|NCT01340976|451098794|FG000|Overall Study|Withdrawal by Subject|0|||
125401106|NCT01340976|451098795|FG001|Overall Study|Withdrawal by Subject|0|||
125401107|NCT01340976|451098796|FG002|Overall Study|Withdrawal by Subject|0|||
125401108|NCT01340976|451098797|FG003|Overall Study|Withdrawal by Subject|1|||
125401109|NCT01340976|451098798|FG004|Overall Study|Withdrawal by Subject|1|||
125401110|NCT01340976|451098799|FG005|Overall Study|Withdrawal by Subject|0|||
125401111|NCT01340976|451098794|FG000|Overall Study|Other anemia treatment|1|||
125401112|NCT01340976|451098795|FG001|Overall Study|Other anemia treatment|0|||
125401113|NCT01340976|451098796|FG002|Overall Study|Other anemia treatment|2|||
125401114|NCT01340976|451098797|FG003|Overall Study|Other anemia treatment|1|||
125401115|NCT01340976|451098798|FG004|Overall Study|Other anemia treatment|0|||
125401116|NCT01340976|451098799|FG005|Overall Study|Other anemia treatment|1|||
125401117|NCT01340976|451098794|FG000|Overall Study|Adverse Event|0|||
125401118|NCT01340976|451098795|FG001|Overall Study|Adverse Event|1|||
125401119|NCT01340976|451098796|FG002|Overall Study|Adverse Event|0|||
125401120|NCT01340976|451098797|FG003|Overall Study|Adverse Event|0|||
125401121|NCT01340976|451098798|FG004|Overall Study|Adverse Event|0|||
125401122|NCT01340976|451098799|FG005|Overall Study|Adverse Event|0|||
125401123|NCT02331446|451098800|FG000|Overall Study|Lost to Follow-up|2|||
125401124|NCT02331446|451098801|FG001|Overall Study|Lost to Follow-up|1|||
125401125|NCT02331446|451098802|FG002|Overall Study|Lost to Follow-up|0|||
125401126|NCT02331446|451098803|FG003|Overall Study|Lost to Follow-up|1|||
125401127|NCT02331446|451098800|FG000|Overall Study|Personal Problem|2|||
125401128|NCT02331446|451098801|FG001|Overall Study|Personal Problem|0|||
125401129|NCT02331446|451098802|FG002|Overall Study|Personal Problem|0|||
125401130|NCT02331446|451098803|FG003|Overall Study|Personal Problem|0|||
125401131|NCT02331446|451098800|FG000|Overall Study|Disease|0|||
125401132|NCT02331446|451098801|FG001|Overall Study|Disease|2|||
125401133|NCT02331446|451098802|FG002|Overall Study|Disease|2|||
125401134|NCT02331446|451098803|FG003|Overall Study|Disease|1|||
125401135|NCT02331446|451098800|FG000|Overall Study|Physician Decision|0|||
125401136|NCT02331446|451098801|FG001|Overall Study|Physician Decision|1|||
125401137|NCT02331446|451098802|FG002|Overall Study|Physician Decision|0|||
125401138|NCT02331446|451098803|FG003|Overall Study|Physician Decision|1|||
125401139|NCT02331446|451098800|FG000|Overall Study|Lost before baseline analysis|0|||
125401140|NCT02331446|451098801|FG001|Overall Study|Lost before baseline analysis|1|||
125401141|NCT02331446|451098802|FG002|Overall Study|Lost before baseline analysis|1|||
125401142|NCT02331446|451098803|FG003|Overall Study|Lost before baseline analysis|0|||
125401143|NCT02566759|451098810|FG000|All Parts|Withdrawal by Subject|0|||
125401144|NCT02566759|451098811|FG001|All Parts|Withdrawal by Subject|1|||
125401145|NCT02566759|451098812|FG002|All Parts|Withdrawal by Subject|0|||
125401146|NCT02566759|451098813|FG003|All Parts|Withdrawal by Subject|0|||
125401147|NCT02566759|451098814|FG004|All Parts|Withdrawal by Subject|0|||
125401148|NCT02566759|451098815|FG005|All Parts|Withdrawal by Subject|0|||
125401149|NCT02566759|451098816|FG006|All Parts|Withdrawal by Subject|0|||
125401150|NCT02566759|451098817|FG007|All Parts|Withdrawal by Subject|0|||
125401151|NCT02566759|451098818|FG008|All Parts|Withdrawal by Subject|0|||
125401152|NCT02566759|451098819|FG009|All Parts|Withdrawal by Subject|0|||
125401153|NCT02566759|451098820|FG010|All Parts|Withdrawal by Subject|0|||
125401154|NCT02566759|451098821|FG011|All Parts|Withdrawal by Subject|0|||
125401155|NCT02566759|451098822|FG012|All Parts|Withdrawal by Subject|0|||
125401156|NCT02566759|451098823|FG013|All Parts|Withdrawal by Subject|0|||
125447829|NCT00826280|451266827|FG002|Overall Study|Sponsor discontinued subject or study|0|||
125401157|NCT02566759|451098824|FG014|All Parts|Withdrawal by Subject|0|||
125401158|NCT02566759|451098825|FG015|All Parts|Withdrawal by Subject|0|||
125401159|NCT02566759|451098826|FG016|All Parts|Withdrawal by Subject|0|||
125401160|NCT02566759|451098810|FG000|All Parts|Adverse Event|0|||
125276293|NCT03108521|450638045|FG001|Overall Study|Lost to Follow-up|0|||
125276294|NCT03108521|450638044|FG000|Overall Study|Lack of Efficacy|2|||
125276295|NCT03108521|450638045|FG001|Overall Study|Lack of Efficacy|0|||
125276296|NCT03108521|450638044|FG000|Overall Study|Physician Decision|4|||
125276297|NCT03108521|450638045|FG001|Overall Study|Physician Decision|0|||
125276298|NCT03108521|450638044|FG000|Overall Study|Adverse Event|3|||
125276299|NCT03108521|450638045|FG001|Overall Study|Adverse Event|0|||
125276300|NCT06899737|450638046|FG000|Overall Study|Lost to Follow-up|19|||
125276301|NCT06899737|450638047|FG001|Overall Study|Lost to Follow-up|7|||
125276302|NCT01945216|450639922|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
125276303|NCT01945216|450639922|FG000|Overall Study|Protocol Violation|42|||
125276304|NCT01945216|450639922|FG000|Overall Study|CRF not assured by investigators|5|||
125276305|NCT03062280|450639926|FG000|Overall Study|Adverse Event|1|||
125276306|NCT03062280|450639926|FG000|Overall Study|Death|1|||
125276307|NCT03062280|450639926|FG000|Overall Study|Fertility Treatment|2|||
125276308|NCT03062280|450639926|FG000|Overall Study|Physician Decision|2|||
125276309|NCT03062280|450639926|FG000|Overall Study|Pregnancy|5|||
125276310|NCT03062280|450639926|FG000|Overall Study|Withdrawal by Subject|11|||
125276311|NCT04299308|450639927|FG000|Overall Study|Withdrawal by Subject|1|||
125276312|NCT04299308|450639928|FG001|Overall Study|Withdrawal by Subject|0|||
125276313|NCT04299308|450639927|FG000|Overall Study|issue with PET image (1)|1|||
125276314|NCT04299308|450639928|FG001|Overall Study|issue with PET image (1)|0|||
125276315|NCT05258890|450639929|FG000|Overall Study|Patient withdrawal|6|||
125276316|NCT05258890|450639930|FG001|Overall Study|Patient withdrawal|7|||
125276317|NCT05258890|450639929|FG000|Overall Study|Patient lost to follow-up|10|||
125276318|NCT05258890|450639930|FG001|Overall Study|Patient lost to follow-up|3|||
125276319|NCT05258890|450639929|FG000|Overall Study|Social network member withdrawal|1|||
125276320|NCT05258890|450639930|FG001|Overall Study|Social network member withdrawal|0|||
125276321|NCT05258890|450639929|FG000|Overall Study|Social network member lost to follow-up|5|||
125276322|NCT05258890|450639930|FG001|Overall Study|Social network member lost to follow-up|0|||
125276323|NCT05959447|450639933|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
125276324|NCT05959447|450639934|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
125276325|NCT05959447|450639933|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
125276326|NCT05959447|450639934|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
125276327|NCT05959447|450639933|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
125276328|NCT05959447|450639934|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
125276329|NCT05959447|450639933|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
125276330|NCT05959447|450639934|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
125276331|NCT00249808|450639936|FG000|Overall Study|Other|27|||
125276332|NCT00249808|450639936|FG000|Overall Study|Protocol Violation|3|||
125276333|NCT00249808|450639936|FG000|Overall Study|Lost to Follow-up|8|||
125276334|NCT00249808|450639936|FG000|Overall Study|Adverse Event|81|||
125276335|NCT00249808|450639936|FG000|Overall Study|Lack of Efficacy|52|||
125276336|NCT00249808|450639936|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
125276337|NCT02789345|450639937|FG000|Overall Study|Adverse Event|0|||
125276338|NCT02789345|450639938|FG001|Overall Study|Adverse Event|0|||
125276339|NCT02789345|450639939|FG002|Overall Study|Adverse Event|1|||
125276340|NCT02789345|450639937|FG000|Overall Study|Death|0|||
125276341|NCT02789345|450639938|FG001|Overall Study|Death|0|||
125276342|NCT02789345|450639939|FG002|Overall Study|Death|1|||
125276343|NCT02789345|450639937|FG000|Overall Study|Physician Decision|2|||
125276344|NCT02789345|450639938|FG001|Overall Study|Physician Decision|0|||
125276345|NCT02789345|450639939|FG002|Overall Study|Physician Decision|1|||
125276346|NCT02789345|450639937|FG000|Overall Study|Progressive Disease|1|||
125276347|NCT02789345|450639938|FG001|Overall Study|Progressive Disease|3|||
125276348|NCT02789345|450639939|FG002|Overall Study|Progressive Disease|14|||
125276349|NCT01804049|450639940|FG000|Overall Study|Adverse Event|2|||
125276350|NCT01804049|450639941|FG001|Overall Study|Adverse Event|10|||
125276351|NCT01804049|450639940|FG000|Overall Study|Lost to Follow-up|2|||
125276352|NCT01804049|450639941|FG001|Overall Study|Lost to Follow-up|1|||
125276353|NCT01804049|450639940|FG000|Overall Study|Decreased interest/personal|4|||
125276354|NCT01804049|450639941|FG001|Overall Study|Decreased interest/personal|5|||
125276355|NCT01804049|450639940|FG000|Overall Study|Other health concerns|2|||
125276356|NCT01804049|450639941|FG001|Overall Study|Other health concerns|7|||
125276357|NCT01804049|450639940|FG000|Overall Study|Moved out of area|0|||
125276358|NCT01804049|450639941|FG001|Overall Study|Moved out of area|7|||
125276359|NCT01804049|450639940|FG000|Overall Study|other MD recommended|1|||
125276360|NCT01804049|450639941|FG001|Overall Study|other MD recommended|1|||
125276361|NCT01804049|450639940|FG000|Overall Study|Enrollment in dual studies|0|||
125276362|NCT01804049|450639941|FG001|Overall Study|Enrollment in dual studies|1|||
125276363|NCT01147250|450639942|FG000|Overall Study|Lost to Follow-up|14|||
125276364|NCT01147250|450639943|FG001|Overall Study|Lost to Follow-up|11|||
125401161|NCT02566759|451098811|FG001|All Parts|Adverse Event|0|||
125401162|NCT02566759|451098812|FG002|All Parts|Adverse Event|0|||
125401163|NCT02566759|451098813|FG003|All Parts|Adverse Event|0|||
125276365|NCT01147250|450639942|FG000|Overall Study|Withdrawal by Subject|83|||
125276366|NCT01147250|450639943|FG001|Overall Study|Withdrawal by Subject|88|||
125276367|NCT01147250|450639942|FG000|Overall Study|Site termination by sponsor|13|||
125276368|NCT01147250|450639943|FG001|Overall Study|Site termination by sponsor|5|||
125276369|NCT01147250|450639942|FG000|Overall Study|Other than specified|0|||
125276370|NCT01147250|450639943|FG001|Overall Study|Other than specified|1|||
125276371|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
125276372|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
125276373|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
125276374|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
125276375|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
125276376|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
125276377|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
125276378|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
125276379|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125276380|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125276381|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125276382|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125276383|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
125276384|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
125276385|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125276386|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125276387|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125276388|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125276389|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
125276390|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
125276391|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
125276392|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
125276393|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
125276394|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
125276395|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125276396|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
125276397|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125276398|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125276399|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125276400|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125276401|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
125276402|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
125276403|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
125276404|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
125276405|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
125276406|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
125276407|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
125276408|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
125276409|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
125276410|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
125276411|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
125276412|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
125276413|NCT03985943|450639946|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
125276414|NCT03985943|450639947|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
125276415|NCT03985943|450639948|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
125276416|NCT03985943|450639949|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
125276417|NCT03985943|450639950|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
125276418|NCT03985943|450639951|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
125276419|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125276420|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125276421|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
125276422|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
125276423|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
125276424|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
125276425|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125276426|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125276427|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
125276428|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
125276429|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
125401164|NCT02566759|451098814|FG004|All Parts|Adverse Event|0|||
125401165|NCT02566759|451098815|FG005|All Parts|Adverse Event|0|||
125401166|NCT02566759|451098816|FG006|All Parts|Adverse Event|0|||
125401167|NCT02566759|451098817|FG007|All Parts|Adverse Event|0|||
125401168|NCT02566759|451098818|FG008|All Parts|Adverse Event|0|||
125401169|NCT02566759|451098819|FG009|All Parts|Adverse Event|0|||
125401170|NCT02566759|451098820|FG010|All Parts|Adverse Event|0|||
125401171|NCT02566759|451098821|FG011|All Parts|Adverse Event|0|||
125401172|NCT02566759|451098822|FG012|All Parts|Adverse Event|1|||
125401173|NCT02566759|451098823|FG013|All Parts|Adverse Event|3|||
125401174|NCT02566759|451098824|FG014|All Parts|Adverse Event|0|||
125401175|NCT02566759|451098825|FG015|All Parts|Adverse Event|0|||
125401176|NCT02566759|451098826|FG016|All Parts|Adverse Event|0|||
125401177|NCT02566759|451098810|FG000|All Parts|Other|0|||
125401178|NCT02566759|451098811|FG001|All Parts|Other|0|||
125401179|NCT02566759|451098812|FG002|All Parts|Other|0|||
125401180|NCT02566759|451098813|FG003|All Parts|Other|0|||
125401181|NCT02566759|451098814|FG004|All Parts|Other|0|||
125401182|NCT02566759|451098815|FG005|All Parts|Other|0|||
125401183|NCT02566759|451098816|FG006|All Parts|Other|0|||
125401184|NCT02566759|451098817|FG007|All Parts|Other|0|||
125401185|NCT02566759|451098818|FG008|All Parts|Other|0|||
125401186|NCT02566759|451098819|FG009|All Parts|Other|0|||
125401187|NCT02566759|451098820|FG010|All Parts|Other|0|||
125401188|NCT02566759|451098821|FG011|All Parts|Other|0|||
125401189|NCT02566759|451098822|FG012|All Parts|Other|0|||
125401190|NCT02566759|451098823|FG013|All Parts|Other|2|||
125401191|NCT02566759|451098824|FG014|All Parts|Other|0|||
125401192|NCT02566759|451098825|FG015|All Parts|Other|0|||
125401193|NCT02566759|451098826|FG016|All Parts|Other|0|||
125401194|NCT02566759|451098810|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401195|NCT02566759|451098811|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401196|NCT02566759|451098812|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401197|NCT02566759|451098813|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401198|NCT02566759|451098814|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401199|NCT02566759|451098815|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401200|NCT02566759|451098816|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401201|NCT02566759|451098817|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401202|NCT02566759|451098818|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401203|NCT02566759|451098819|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401204|NCT02566759|451098820|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401205|NCT02566759|451098821|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401206|NCT02566759|451098822|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401207|NCT02566759|451098823|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401208|NCT02566759|451098824|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401209|NCT02566759|451098825|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
125401210|NCT02566759|451098826|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
125401211|NCT01126541|451098827|FG000|Overall Study|Adverse Event|0|||
125401212|NCT01126541|451098828|FG001|Overall Study|Adverse Event|2|||
125401213|NCT01126541|451098829|FG002|Overall Study|Adverse Event|4|||
125401214|NCT01126541|451098827|FG000|Overall Study|Death|0|||
125401215|NCT01126541|451098828|FG001|Overall Study|Death|1|||
125401216|NCT01126541|451098829|FG002|Overall Study|Death|0|||
125401217|NCT01126541|451098827|FG000|Overall Study|Lack of Efficacy|6|||
125401218|NCT01126541|451098828|FG001|Overall Study|Lack of Efficacy|1|||
125401219|NCT01126541|451098829|FG002|Overall Study|Lack of Efficacy|11|||
125401220|NCT01126541|451098827|FG000|Overall Study|Lost to Follow-up|1|||
125401221|NCT01126541|451098828|FG001|Overall Study|Lost to Follow-up|2|||
125401222|NCT01126541|451098829|FG002|Overall Study|Lost to Follow-up|2|||
125401223|NCT01126541|451098827|FG000|Overall Study|Withdrawal by Subject|2|||
125401224|NCT01126541|451098828|FG001|Overall Study|Withdrawal by Subject|5|||
125401225|NCT01126541|451098829|FG002|Overall Study|Withdrawal by Subject|6|||
125401226|NCT01126541|451098827|FG000|Overall Study|Protocol Violation|0|||
125401227|NCT01126541|451098828|FG001|Overall Study|Protocol Violation|0|||
125401228|NCT01126541|451098829|FG002|Overall Study|Protocol Violation|1|||
125401229|NCT01126541|451098827|FG000|Overall Study|Administrative reason or other|1|||
125401230|NCT01126541|451098828|FG001|Overall Study|Administrative reason or other|1|||
125401231|NCT01126541|451098829|FG002|Overall Study|Administrative reason or other|2|||
125401232|NCT00226941|451098830|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
125401233|NCT00226941|451098831|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
125401234|NCT00226941|451098832|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
125401235|NCT00226941|451098833|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
125401236|NCT00226941|451098830|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
125401237|NCT00226941|451098831|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
125401238|NCT00226941|451098832|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
125401239|NCT00226941|451098833|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
125401240|NCT01513291|451098834|FG000|Treatment Period|Adverse Event|8|||
125401241|NCT01513291|451098835|FG001|Treatment Period|Adverse Event|4|||
125401242|NCT01513291|451098836|FG002|Treatment Period|Adverse Event|0|||
125401243|NCT01513291|451098837|FG003|Treatment Period|Adverse Event|0|||
125401244|NCT01513291|451098838|FG004|Treatment Period|Adverse Event|0|||
125401245|NCT01513291|451098834|FG000|Treatment Period|Lack of Efficacy|3|||
125401246|NCT01513291|451098835|FG001|Treatment Period|Lack of Efficacy|0|||
125401247|NCT01513291|451098836|FG002|Treatment Period|Lack of Efficacy|0|||
125401248|NCT01513291|451098837|FG003|Treatment Period|Lack of Efficacy|0|||
125401249|NCT01513291|451098838|FG004|Treatment Period|Lack of Efficacy|0|||
125401250|NCT01513291|451098834|FG000|Treatment Period|Lost to Follow-up|2|||
125401251|NCT01513291|451098835|FG001|Treatment Period|Lost to Follow-up|3|||
125401252|NCT01513291|451098836|FG002|Treatment Period|Lost to Follow-up|0|||
125401253|NCT01513291|451098837|FG003|Treatment Period|Lost to Follow-up|0|||
125401254|NCT01513291|451098838|FG004|Treatment Period|Lost to Follow-up|0|||
125401255|NCT01513291|451098834|FG000|Treatment Period|Physician Decision|1|||
125401256|NCT01513291|451098835|FG001|Treatment Period|Physician Decision|0|||
125401257|NCT01513291|451098836|FG002|Treatment Period|Physician Decision|0|||
125401258|NCT01513291|451098837|FG003|Treatment Period|Physician Decision|0|||
125401259|NCT01513291|451098838|FG004|Treatment Period|Physician Decision|0|||
125401260|NCT01513291|451098834|FG000|Treatment Period|Protocol Violation|1|||
125401261|NCT01513291|451098835|FG001|Treatment Period|Protocol Violation|2|||
125401262|NCT01513291|451098836|FG002|Treatment Period|Protocol Violation|0|||
125401263|NCT01513291|451098837|FG003|Treatment Period|Protocol Violation|0|||
125401264|NCT01513291|451098838|FG004|Treatment Period|Protocol Violation|0|||
125401265|NCT01513291|451098834|FG000|Treatment Period|Withdrawal by Subject|8|||
125401266|NCT01513291|451098835|FG001|Treatment Period|Withdrawal by Subject|5|||
125401267|NCT01513291|451098836|FG002|Treatment Period|Withdrawal by Subject|0|||
125401268|NCT01513291|451098837|FG003|Treatment Period|Withdrawal by Subject|0|||
125401269|NCT01513291|451098838|FG004|Treatment Period|Withdrawal by Subject|0|||
125401270|NCT01513291|451098834|FG000|Treatment Period|Randomized not treated|0|||
125401271|NCT01513291|451098835|FG001|Treatment Period|Randomized not treated|2|||
125401272|NCT01513291|451098836|FG002|Treatment Period|Randomized not treated|0|||
125401273|NCT01513291|451098837|FG003|Treatment Period|Randomized not treated|0|||
125401274|NCT01513291|451098838|FG004|Treatment Period|Randomized not treated|0|||
125401275|NCT01513291|451098834|FG000|Run-out Period|Lost to Follow-up|0|||
125401276|NCT01513291|451098835|FG001|Run-out Period|Lost to Follow-up|0|||
125401277|NCT01513291|451098836|FG002|Run-out Period|Lost to Follow-up|0|||
125401278|NCT01513291|451098837|FG003|Run-out Period|Lost to Follow-up|1|||
125401279|NCT01513291|451098838|FG004|Run-out Period|Lost to Follow-up|0|||
125401280|NCT01513291|451098834|FG000|Run-out Period|Withdrawal by Subject|0|||
125401281|NCT01513291|451098835|FG001|Run-out Period|Withdrawal by Subject|0|||
125401282|NCT01513291|451098836|FG002|Run-out Period|Withdrawal by Subject|0|||
125401283|NCT01513291|451098837|FG003|Run-out Period|Withdrawal by Subject|1|||
125401284|NCT01513291|451098838|FG004|Run-out Period|Withdrawal by Subject|0|||
125401285|NCT03732638|451098839|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
125401286|NCT03732638|451098840|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
125401287|NCT03732638|451098839|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
125401288|NCT03732638|451098840|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
125401289|NCT03732638|451098839|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
125401290|NCT03732638|451098840|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
125401291|NCT03732638|451098839|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
125401292|NCT03732638|451098840|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
125401293|NCT03732638|451098839|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
125401294|NCT03732638|451098840|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
125401295|NCT03732638|451098839|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
125401296|NCT03732638|451098840|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
125401297|NCT03732638|451098839|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
125401298|NCT03732638|451098840|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
125401299|NCT03732638|451098839|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
125401300|NCT03732638|451098840|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
125401301|NCT03732638|451098839|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
125401302|NCT03732638|451098840|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
125401303|NCT03732638|451098839|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
125401304|NCT03732638|451098840|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
125401305|NCT03732638|451098839|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
125401306|NCT03732638|451098840|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
125401307|NCT03732638|451098839|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
125401308|NCT03732638|451098840|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
125401309|NCT03732638|451098839|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
125401310|NCT03732638|451098840|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
125401311|NCT03732638|451098839|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
125401312|NCT03732638|451098840|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
125401313|NCT03732638|451098839|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
125401314|NCT03732638|451098840|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
125401315|NCT03732638|451098839|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
125401316|NCT03732638|451098840|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
125401317|NCT03732638|451098839|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
125401318|NCT03732638|451098840|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
125401319|NCT03732638|451098839|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
125401320|NCT03732638|451098840|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
125401321|NCT03732638|451098839|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
125401322|NCT03732638|451098840|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
125401323|NCT03732638|451098839|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
125401324|NCT03732638|451098840|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
125401325|NCT03732638|451098839|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
125401326|NCT03732638|451098840|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
125401327|NCT03732638|451098839|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
125401328|NCT03732638|451098840|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
125401329|NCT03732638|451098839|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
125401330|NCT03732638|451098840|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
125401331|NCT03732638|451098839|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
125447830|NCT00826280|451266825|FG000|Overall Study|Reversible ischemic defect not present|43|||
125447831|NCT00826280|451266826|FG001|Overall Study|Reversible ischemic defect not present|40|||
125447832|NCT00826280|451266827|FG002|Overall Study|Reversible ischemic defect not present|44|||
125447833|NCT00826280|451266825|FG000|Overall Study|Interpretation Failure|1|||
125447834|NCT00826280|451266826|FG001|Overall Study|Interpretation Failure|0|||
125447835|NCT00826280|451266827|FG002|Overall Study|Interpretation Failure|0|||
125447836|NCT00826280|451266825|FG000|Overall Study|Machine Failure|1|||
125447837|NCT00826280|451266826|FG001|Overall Study|Machine Failure|1|||
125447838|NCT00826280|451266827|FG002|Overall Study|Machine Failure|0|||
125447839|NCT00826280|451266825|FG000|Overall Study|One or more non-interpretable scan|0|||
125447840|NCT00826280|451266826|FG001|Overall Study|One or more non-interpretable scan|1|||
125447841|NCT00826280|451266827|FG002|Overall Study|One or more non-interpretable scan|1|||
125447842|NCT03201757|451266828|FG000|Overall Study|Withdrawal by Subject|133|||
125447843|NCT03201757|451266828|FG000|Overall Study|Adverse Event|44|||
125447844|NCT03201757|451266828|FG000|Overall Study|Lost to Follow-up|37|||
125447845|NCT03201757|451266828|FG000|Overall Study|Pregnancy|2|||
125447846|NCT03201757|451266828|FG000|Overall Study|Lack of Efficacy|1|||
125447847|NCT03201757|451266828|FG000|Overall Study|Protocol Violation|20|||
125447848|NCT03201757|451266828|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
125447849|NCT03201757|451266828|FG000|Overall Study|Not Yet Determined|5|||
125447850|NCT03201757|451266828|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
125447851|NCT03201757|451266828|FG000|Overall Study|Other|20|||
125447852|NCT01254305|451266829|FG000|Overall Study|Adverse Event|6|||
125447853|NCT01254305|451266830|FG001|Overall Study|Adverse Event|3|||
125276430|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
125276431|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
125276432|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
125276433|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
125276434|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
125276435|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
125276436|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
125276437|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125276438|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125276439|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125276440|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
125276441|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
125447854|NCT01254305|451266831|FG002|Overall Study|Adverse Event|2|||
125447855|NCT01254305|451266829|FG000|Overall Study|Lack of Efficacy|1|||
125447856|NCT01254305|451266830|FG001|Overall Study|Lack of Efficacy|0|||
125447857|NCT01254305|451266831|FG002|Overall Study|Lack of Efficacy|1|||
125447858|NCT01254305|451266829|FG000|Overall Study|Protocol Violation|1|||
125447859|NCT01254305|451266830|FG001|Overall Study|Protocol Violation|7|||
125447860|NCT01254305|451266831|FG002|Overall Study|Protocol Violation|3|||
125447861|NCT01254305|451266829|FG000|Overall Study|Withdrawal by Subject|4|||
125447862|NCT01254305|451266830|FG001|Overall Study|Withdrawal by Subject|2|||
125447863|NCT01254305|451266831|FG002|Overall Study|Withdrawal by Subject|4|||
125447864|NCT01254305|451266829|FG000|Overall Study|Lost to Follow-up|10|||
125447865|NCT01254305|451266830|FG001|Overall Study|Lost to Follow-up|6|||
125447866|NCT01254305|451266831|FG002|Overall Study|Lost to Follow-up|5|||
125447867|NCT01254305|451266829|FG000|Overall Study|Other Reasons|0|||
125447868|NCT01254305|451266830|FG001|Overall Study|Other Reasons|0|||
125447869|NCT01254305|451266831|FG002|Overall Study|Other Reasons|2|||
125447870|NCT01511536|451266832|FG000|Phase 1|Other|0|||
125447871|NCT01511536|451266833|FG001|Phase 1|Other|1|||
125447872|NCT01511536|451266834|FG002|Phase 1|Other|0|||
125447873|NCT01511536|451266832|FG000|Phase 2|Other|0|||
125447874|NCT01511536|451266833|FG001|Phase 2|Other|0|||
125447875|NCT01511536|451266834|FG002|Phase 2|Other|9|||
125276442|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
125276443|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
125276444|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
125276445|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
125276446|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
125276447|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
125276448|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
125276449|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
125276450|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
125276451|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
125276452|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
125276453|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
125276454|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
125276455|NCT03985943|450639946|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
125276456|NCT03985943|450639947|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
125276457|NCT03985943|450639948|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
125276458|NCT03985943|450639949|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
125276459|NCT03985943|450639950|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
125276460|NCT03985943|450639951|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
125276461|NCT00022763|450639955|FG000|Overall Study|Adverse Event|1|||
125276462|NCT00022763|450639956|FG001|Overall Study|Adverse Event|2|||
125276463|NCT00022763|450639955|FG000|Overall Study|Injection Site Reactions|0|||
125276464|NCT00022763|450639956|FG001|Overall Study|Injection Site Reactions|2|||
125276465|NCT00022763|450639955|FG000|Overall Study|Death|0|||
125276466|NCT00022763|450639956|FG001|Overall Study|Death|1|||
125276467|NCT00022763|450639955|FG000|Overall Study|Lost to Follow-up|0|||
125276468|NCT00022763|450639956|FG001|Overall Study|Lost to Follow-up|3|||
125276469|NCT00022763|450639955|FG000|Overall Study|Withdrawal by Subject|4|||
125276470|NCT00022763|450639956|FG001|Overall Study|Withdrawal by Subject|7|||
125276471|NCT00022763|450639955|FG000|Overall Study|Insufficient Therapy|1|||
125276472|NCT00022763|450639956|FG001|Overall Study|Insufficient Therapy|0|||
125276473|NCT00022763|450639955|FG000|Overall Study|Admin|3|||
125276474|NCT00022763|450639956|FG001|Overall Study|Admin|2|||
125276475|NCT00716482|450639957|FG000|Overall Study|Lost to Follow-up|6|||
125276476|NCT00716482|450639957|FG000|Overall Study|Inadequate acquisition or analysis|50|||
125276477|NCT00716482|450639957|FG000|Overall Study|no pathology obtained|10|||
125276478|NCT00716482|450639957|FG000|Overall Study|technical/machine error|28|||
125276479|NCT00716482|450639957|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
125276480|NCT01092780|450639958|FG000|Washout Period 1|Adverse Event|0|||
125276481|NCT01092780|450639959|FG001|Washout Period 1|Adverse Event|1|||
125276482|NCT01092780|450639960|FG002|Washout Period 1|Adverse Event|0|||
125276483|NCT01092780|450639961|FG003|Washout Period 1|Adverse Event|0|||
125276484|NCT01092780|450639958|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
125276485|NCT01092780|450639959|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
125276486|NCT01092780|450639960|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
125276487|NCT01092780|450639961|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
125276488|NCT01092780|450639958|FG000|Washout Period 2|Adverse Event|0|||
125276489|NCT01092780|450639959|FG001|Washout Period 2|Adverse Event|1|||
125276490|NCT01092780|450639960|FG002|Washout Period 2|Adverse Event|1|||
125276491|NCT01092780|450639961|FG003|Washout Period 2|Adverse Event|0|||
125276492|NCT01864148|450639962|FG000|Overall Study|Other|2|||
125276493|NCT01864148|450639963|FG001|Overall Study|Other|1|||
125276494|NCT01864148|450639964|FG002|Overall Study|Other|1|||
125276495|NCT01864148|450639965|FG003|Overall Study|Other|3|||
125276496|NCT01864148|450639966|FG004|Overall Study|Other|1|||
125276497|NCT01864148|450639962|FG000|Overall Study|Death|0|||
125276498|NCT01864148|450639963|FG001|Overall Study|Death|0|||
125276499|NCT01864148|450639964|FG002|Overall Study|Death|0|||
125276500|NCT01864148|450639965|FG003|Overall Study|Death|1|||
125276501|NCT01864148|450639966|FG004|Overall Study|Death|0|||
125276502|NCT01864148|450639962|FG000|Overall Study|Investigator Decision|5|||
125276503|NCT01864148|450639963|FG001|Overall Study|Investigator Decision|0|||
125276504|NCT01864148|450639964|FG002|Overall Study|Investigator Decision|0|||
125276505|NCT01864148|450639965|FG003|Overall Study|Investigator Decision|4|||
125276506|NCT01864148|450639966|FG004|Overall Study|Investigator Decision|6|||
125276507|NCT01864148|450639962|FG000|Overall Study|Withdrawal by Subject|9|||
125276508|NCT01864148|450639963|FG001|Overall Study|Withdrawal by Subject|2|||
125276509|NCT01864148|450639964|FG002|Overall Study|Withdrawal by Subject|6|||
125276510|NCT01864148|450639965|FG003|Overall Study|Withdrawal by Subject|8|||
125276511|NCT01864148|450639966|FG004|Overall Study|Withdrawal by Subject|8|||
125276512|NCT01864148|450639962|FG000|Overall Study|Lost to Follow-up|0|||
125276513|NCT01864148|450639963|FG001|Overall Study|Lost to Follow-up|0|||
125276514|NCT01864148|450639964|FG002|Overall Study|Lost to Follow-up|0|||
125276515|NCT01864148|450639965|FG003|Overall Study|Lost to Follow-up|2|||
125276516|NCT01864148|450639966|FG004|Overall Study|Lost to Follow-up|1|||
125276517|NCT01864148|450639962|FG000|Overall Study|Adverse Event|4|||
125401332|NCT03732638|451098840|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
125401333|NCT01358981|451098841|FG000|Period 1|Withdrawal by Subject|0|||
125401334|NCT01358981|451098842|FG001|Period 1|Withdrawal by Subject|0|||
125401335|NCT01358981|451098843|FG002|Period 1|Withdrawal by Subject|0|||
125401336|NCT01358981|451098844|FG003|Period 1|Withdrawal by Subject|1|||
125401337|NCT01358981|451098845|FG004|Period 1|Withdrawal by Subject|0|||
125401338|NCT01358981|451098846|FG005|Period 1|Withdrawal by Subject|0|||
125401339|NCT01358981|451098847|FG006|Period 1|Withdrawal by Subject|0|||
125401340|NCT03728582|451098848|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
125401341|NCT03728582|451098849|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
125401342|NCT03728582|451098848|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
125401343|NCT03728582|451098849|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
125401344|NCT01034397|451098850|FG000|Overall Study|Lack of compliance|0|||
125401345|NCT01034397|451098851|FG001|Overall Study|Lack of compliance|1|||
125401346|NCT01034397|451098850|FG000|Overall Study|Lack of Efficacy|3|||
125401347|NCT01034397|451098851|FG001|Overall Study|Lack of Efficacy|0|||
125401348|NCT01034397|451098850|FG000|Overall Study|Adverse Event|4|||
125401349|NCT01034397|451098851|FG001|Overall Study|Adverse Event|0|||
125401350|NCT01034397|451098850|FG000|Overall Study|Other|0|||
125401351|NCT01034397|451098851|FG001|Overall Study|Other|1|||
125401352|NCT01018264|451098852|FG000|Overall Study|Withdrawal by Subject|1|||
125401353|NCT01018264|451098853|FG001|Overall Study|Withdrawal by Subject|0|||
125401354|NCT01018264|451098852|FG000|Overall Study|Lost to Follow-up|0|||
125401355|NCT01018264|451098853|FG001|Overall Study|Lost to Follow-up|1|||
125401356|NCT01785524|451098854|FG000|Overall Study|Withdrawal by Subject|2|||
125401357|NCT01785524|451098855|FG001|Overall Study|Withdrawal by Subject|2|||
125401358|NCT03217136|451098860|FG000|Overall Study|Lost to Follow-up|2|||
125401359|NCT03217136|451098861|FG001|Overall Study|Lost to Follow-up|1|||
125401360|NCT03217136|451098860|FG000|Overall Study|Site Randomized Participant in Error|0|||
125401361|NCT03217136|451098861|FG001|Overall Study|Site Randomized Participant in Error|1|||
125401362|NCT03217136|451098860|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
125401363|NCT03217136|451098861|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
125401364|NCT03217136|451098860|FG000|Overall Study|Dispensing Error|1|||
125401365|NCT03217136|451098861|FG001|Overall Study|Dispensing Error|0|||
125401366|NCT03217136|451098860|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125401367|NCT03217136|451098861|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125401368|NCT03670810|451098864|FG000|Main Study|Adverse Event|37|||
125401369|NCT03670810|451098865|FG001|Main Study|Adverse Event|38|||
125401370|NCT03670810|451098866|FG002|Main Study|Adverse Event|3|||
125401371|NCT03670810|451098867|FG003|Main Study|Adverse Event|4|||
125276518|NCT01864148|450639963|FG001|Overall Study|Adverse Event|2|||
125276519|NCT01864148|450639964|FG002|Overall Study|Adverse Event|4|||
125276520|NCT01864148|450639965|FG003|Overall Study|Adverse Event|7|||
125276521|NCT01864148|450639966|FG004|Overall Study|Adverse Event|7|||
125276522|NCT01864148|450639962|FG000|Overall Study|Not Dosed|0|||
125276523|NCT01864148|450639963|FG001|Overall Study|Not Dosed|0|||
125276524|NCT01864148|450639964|FG002|Overall Study|Not Dosed|0|||
125276525|NCT01864148|450639965|FG003|Overall Study|Not Dosed|1|||
125276526|NCT01864148|450639966|FG004|Overall Study|Not Dosed|0|||
125276527|NCT02936869|450639975|FG000|Overall Study|Lost to Follow-up|1|||
125276528|NCT02936869|450639976|FG001|Overall Study|Lost to Follow-up|3|||
125276529|NCT02936869|450639975|FG000|Overall Study|Death|0|||
125276530|NCT02936869|450639976|FG001|Overall Study|Death|1|||
125276531|NCT02936869|450639975|FG000|Overall Study|Legal Case|0|||
125276532|NCT02936869|450639976|FG001|Overall Study|Legal Case|1|||
125276533|NCT02936869|450639975|FG000|Overall Study|Protocol Violation|1|||
125276534|NCT02936869|450639976|FG001|Overall Study|Protocol Violation|0|||
125276535|NCT00506454|450639977|FG000|Overall Study|Withdrawal by Subject|1|||
125276536|NCT00506454|450639978|FG001|Overall Study|Withdrawal by Subject|1|||
125276537|NCT00851552|450639979|FG000|Overall Study|Death|2|||
125276538|NCT00851552|450639979|FG000|Overall Study|Adverse Event|1|||
125276539|NCT00851552|450639979|FG000|Overall Study|Disease Progression|4|||
125276540|NCT02689206|450639980|FG000|Overall Study|Adverse Event|0|||
125276541|NCT02689206|450639981|FG001|Overall Study|Adverse Event|0|||
125276542|NCT02689206|450639982|FG002|Overall Study|Adverse Event|1|||
125401372|NCT03670810|451098868|FG004|Main Study|Adverse Event|4|||
125276543|NCT02689206|450639983|FG003|Overall Study|Adverse Event|0|||
125401373|NCT03670810|451098869|FG005|Main Study|Adverse Event|5|||
125276544|NCT02689206|450639984|FG004|Overall Study|Adverse Event|2|||
125276545|NCT02689206|450639980|FG000|Overall Study|Protocol Violation|1|||
125276546|NCT02689206|450639981|FG001|Overall Study|Protocol Violation|0|||
125276547|NCT02689206|450639982|FG002|Overall Study|Protocol Violation|0|||
125276548|NCT02689206|450639983|FG003|Overall Study|Protocol Violation|1|||
125276549|NCT02689206|450639984|FG004|Overall Study|Protocol Violation|2|||
125276550|NCT02689206|450639980|FG000|Overall Study|Other: Reached stopping criteria|0|||
125401374|NCT03670810|451098870|FG006|Main Study|Adverse Event|0|||
125401375|NCT03670810|451098871|FG007|Main Study|Adverse Event|0|||
125401376|NCT03670810|451098872|FG008|Main Study|Adverse Event|0|||
125401377|NCT03670810|451098864|FG000|Main Study|Lack of Efficacy|8|||
125401378|NCT03670810|451098865|FG001|Main Study|Lack of Efficacy|9|||
125447876|NCT02297503|451266838|FG000|Overall Study|Withdrawal by Subject|1|||
125447877|NCT02297503|451266839|FG001|Overall Study|Withdrawal by Subject|1|||
125447878|NCT02297503|451266838|FG000|Overall Study|Protocol Violation|1|||
125447879|NCT02297503|451266839|FG001|Overall Study|Protocol Violation|0|||
125447880|NCT02297503|451266838|FG000|Overall Study|Pregnancy|0|||
125447881|NCT02297503|451266839|FG001|Overall Study|Pregnancy|1|||
125447882|NCT02297503|451266838|FG000|Overall Study|Lost to Follow-up|0|||
125447883|NCT02297503|451266839|FG001|Overall Study|Lost to Follow-up|1|||
125401379|NCT03670810|451098866|FG002|Main Study|Lack of Efficacy|3|||
125401380|NCT03670810|451098867|FG003|Main Study|Lack of Efficacy|4|||
125401381|NCT03670810|451098868|FG004|Main Study|Lack of Efficacy|0|||
125401382|NCT03670810|451098869|FG005|Main Study|Lack of Efficacy|0|||
125401383|NCT03670810|451098870|FG006|Main Study|Lack of Efficacy|0|||
125401384|NCT03670810|451098871|FG007|Main Study|Lack of Efficacy|0|||
125401385|NCT03670810|451098872|FG008|Main Study|Lack of Efficacy|0|||
125401386|NCT03670810|451098864|FG000|Main Study|Lost to Follow-up|9|||
125401387|NCT03670810|451098865|FG001|Main Study|Lost to Follow-up|7|||
125401388|NCT03670810|451098866|FG002|Main Study|Lost to Follow-up|4|||
125401389|NCT03670810|451098867|FG003|Main Study|Lost to Follow-up|6|||
125401390|NCT03670810|451098868|FG004|Main Study|Lost to Follow-up|1|||
125401391|NCT03670810|451098869|FG005|Main Study|Lost to Follow-up|0|||
125401392|NCT03670810|451098870|FG006|Main Study|Lost to Follow-up|0|||
125401393|NCT03670810|451098871|FG007|Main Study|Lost to Follow-up|0|||
125401394|NCT03670810|451098872|FG008|Main Study|Lost to Follow-up|0|||
125401395|NCT03670810|451098864|FG000|Main Study|Non-compliance with Study Drug|0|||
125401396|NCT03670810|451098865|FG001|Main Study|Non-compliance with Study Drug|2|||
125401397|NCT03670810|451098866|FG002|Main Study|Non-compliance with Study Drug|3|||
125401398|NCT03670810|451098867|FG003|Main Study|Non-compliance with Study Drug|0|||
125401399|NCT03670810|451098868|FG004|Main Study|Non-compliance with Study Drug|0|||
125401400|NCT03670810|451098869|FG005|Main Study|Non-compliance with Study Drug|0|||
125401401|NCT03670810|451098870|FG006|Main Study|Non-compliance with Study Drug|0|||
125401402|NCT03670810|451098871|FG007|Main Study|Non-compliance with Study Drug|1|||
125401403|NCT03670810|451098872|FG008|Main Study|Non-compliance with Study Drug|0|||
125401404|NCT03670810|451098864|FG000|Main Study|Physician Decision|3|||
125401405|NCT03670810|451098865|FG001|Main Study|Physician Decision|0|||
125401406|NCT03670810|451098866|FG002|Main Study|Physician Decision|1|||
125401407|NCT03670810|451098867|FG003|Main Study|Physician Decision|0|||
125401408|NCT03670810|451098868|FG004|Main Study|Physician Decision|0|||
125401409|NCT03670810|451098869|FG005|Main Study|Physician Decision|0|||
125401410|NCT03670810|451098870|FG006|Main Study|Physician Decision|1|||
125401411|NCT03670810|451098871|FG007|Main Study|Physician Decision|1|||
125401412|NCT03670810|451098872|FG008|Main Study|Physician Decision|0|||
125401413|NCT03670810|451098864|FG000|Main Study|Pregnancy|1|||
125401414|NCT03670810|451098865|FG001|Main Study|Pregnancy|2|||
125401415|NCT03670810|451098866|FG002|Main Study|Pregnancy|0|||
125401416|NCT03670810|451098867|FG003|Main Study|Pregnancy|0|||
125401417|NCT03670810|451098868|FG004|Main Study|Pregnancy|0|||
125401418|NCT03670810|451098869|FG005|Main Study|Pregnancy|0|||
125401419|NCT03670810|451098870|FG006|Main Study|Pregnancy|0|||
125401420|NCT03670810|451098871|FG007|Main Study|Pregnancy|0|||
125401421|NCT03670810|451098872|FG008|Main Study|Pregnancy|0|||
125401422|NCT03670810|451098864|FG000|Main Study|Protocol Deviation|2|||
125401423|NCT03670810|451098865|FG001|Main Study|Protocol Deviation|12|||
125401424|NCT03670810|451098866|FG002|Main Study|Protocol Deviation|8|||
125401425|NCT03670810|451098867|FG003|Main Study|Protocol Deviation|4|||
125447884|NCT02297503|451266838|FG000|Overall Study|Medical reason|0|||
125447885|NCT02297503|451266839|FG001|Overall Study|Medical reason|1|||
125447886|NCT02703532|451266841|FG000|Overall Study|Withdrawal by Subject|0|||
125401426|NCT03670810|451098868|FG004|Main Study|Protocol Deviation|0|||
125401427|NCT03670810|451098869|FG005|Main Study|Protocol Deviation|0|||
125401428|NCT03670810|451098870|FG006|Main Study|Protocol Deviation|0|||
125401429|NCT03670810|451098871|FG007|Main Study|Protocol Deviation|0|||
125401430|NCT03670810|451098872|FG008|Main Study|Protocol Deviation|0|||
125401431|NCT03670810|451098864|FG000|Main Study|Withdrawal by Subject|21|||
125401432|NCT03670810|451098865|FG001|Main Study|Withdrawal by Subject|21|||
125401433|NCT03670810|451098866|FG002|Main Study|Withdrawal by Subject|8|||
125401434|NCT03670810|451098867|FG003|Main Study|Withdrawal by Subject|9|||
125401435|NCT03670810|451098868|FG004|Main Study|Withdrawal by Subject|5|||
125401436|NCT03670810|451098869|FG005|Main Study|Withdrawal by Subject|2|||
125401437|NCT03670810|451098870|FG006|Main Study|Withdrawal by Subject|1|||
125401438|NCT03670810|451098871|FG007|Main Study|Withdrawal by Subject|1|||
125401439|NCT03670810|451098872|FG008|Main Study|Withdrawal by Subject|0|||
125401440|NCT03670810|451098864|FG000|Main Study|Participant did not want to take the three other treatments|1|||
125401441|NCT03670810|451098865|FG001|Main Study|Participant did not want to take the three other treatments|0|||
125401442|NCT03670810|451098866|FG002|Main Study|Participant did not want to take the three other treatments|0|||
125401443|NCT03670810|451098867|FG003|Main Study|Participant did not want to take the three other treatments|0|||
125401444|NCT03670810|451098868|FG004|Main Study|Participant did not want to take the three other treatments|0|||
125401445|NCT03670810|451098869|FG005|Main Study|Participant did not want to take the three other treatments|0|||
125447887|NCT02703532|451266842|FG001|Overall Study|Withdrawal by Subject|1|||
125401446|NCT03670810|451098870|FG006|Main Study|Participant did not want to take the three other treatments|0|||
125401447|NCT03670810|451098871|FG007|Main Study|Participant did not want to take the three other treatments|0|||
125401448|NCT03670810|451098872|FG008|Main Study|Participant did not want to take the three other treatments|0|||
125401449|NCT03670810|451098864|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125401450|NCT03670810|451098865|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
125401451|NCT03670810|451098866|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125401452|NCT03670810|451098867|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125401453|NCT03670810|451098868|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125401454|NCT03670810|451098869|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125401455|NCT03670810|451098870|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125401456|NCT03670810|451098871|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125401457|NCT03670810|451098872|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
125401458|NCT03670810|451098864|FG000|Main Study|Travel and Coronavirus issues|0|||
125401459|NCT03670810|451098865|FG001|Main Study|Travel and Coronavirus issues|0|||
125401460|NCT03670810|451098866|FG002|Main Study|Travel and Coronavirus issues|0|||
125401461|NCT03670810|451098867|FG003|Main Study|Travel and Coronavirus issues|1|||
125401462|NCT03670810|451098868|FG004|Main Study|Travel and Coronavirus issues|0|||
125401463|NCT03670810|451098869|FG005|Main Study|Travel and Coronavirus issues|0|||
125401464|NCT03670810|451098870|FG006|Main Study|Travel and Coronavirus issues|0|||
125401465|NCT03670810|451098871|FG007|Main Study|Travel and Coronavirus issues|0|||
125401466|NCT03670810|451098872|FG008|Main Study|Travel and Coronavirus issues|0|||
125401467|NCT03670810|451098864|FG000|Open Label Extension|Protocol Deviation|0|||
125401468|NCT03670810|451098865|FG001|Open Label Extension|Protocol Deviation|0|||
125401469|NCT03670810|451098866|FG002|Open Label Extension|Protocol Deviation|0|||
125401470|NCT03670810|451098867|FG003|Open Label Extension|Protocol Deviation|0|||
125401471|NCT03670810|451098868|FG004|Open Label Extension|Protocol Deviation|0|||
125401472|NCT03670810|451098869|FG005|Open Label Extension|Protocol Deviation|0|||
125401473|NCT03670810|451098870|FG006|Open Label Extension|Protocol Deviation|0|||
125401474|NCT03670810|451098871|FG007|Open Label Extension|Protocol Deviation|0|||
125401475|NCT03670810|451098872|FG008|Open Label Extension|Protocol Deviation|5|||
125401476|NCT03670810|451098864|FG000|Open Label Extension|Death|0|||
125401477|NCT03670810|451098865|FG001|Open Label Extension|Death|0|||
125401478|NCT03670810|451098866|FG002|Open Label Extension|Death|0|||
125401479|NCT03670810|451098867|FG003|Open Label Extension|Death|0|||
125401480|NCT03670810|451098868|FG004|Open Label Extension|Death|0|||
125401481|NCT03670810|451098869|FG005|Open Label Extension|Death|0|||
125401482|NCT03670810|451098870|FG006|Open Label Extension|Death|0|||
125401483|NCT03670810|451098871|FG007|Open Label Extension|Death|0|||
125401484|NCT03670810|451098872|FG008|Open Label Extension|Death|1|||
125401485|NCT03670810|451098864|FG000|Open Label Extension|COVID-19|0|||
125401486|NCT03670810|451098865|FG001|Open Label Extension|COVID-19|0|||
125401487|NCT03670810|451098866|FG002|Open Label Extension|COVID-19|0|||
125401488|NCT03670810|451098867|FG003|Open Label Extension|COVID-19|0|||
125401489|NCT03670810|451098868|FG004|Open Label Extension|COVID-19|0|||
125401490|NCT03670810|451098869|FG005|Open Label Extension|COVID-19|0|||
125401491|NCT03670810|451098870|FG006|Open Label Extension|COVID-19|0|||
125401492|NCT03670810|451098871|FG007|Open Label Extension|COVID-19|0|||
125401493|NCT03670810|451098872|FG008|Open Label Extension|COVID-19|1|||
125401494|NCT03670810|451098864|FG000|Open Label Extension|Lack of Efficacy|0|||
125401495|NCT03670810|451098865|FG001|Open Label Extension|Lack of Efficacy|0|||
125401496|NCT03670810|451098866|FG002|Open Label Extension|Lack of Efficacy|0|||
125401497|NCT03670810|451098867|FG003|Open Label Extension|Lack of Efficacy|0|||
125276551|NCT02689206|450639981|FG001|Overall Study|Other: Reached stopping criteria|1|||
125276552|NCT02689206|450639982|FG002|Overall Study|Other: Reached stopping criteria|2|||
125401498|NCT03670810|451098868|FG004|Open Label Extension|Lack of Efficacy|0|||
125401499|NCT03670810|451098869|FG005|Open Label Extension|Lack of Efficacy|0|||
125401500|NCT03670810|451098870|FG006|Open Label Extension|Lack of Efficacy|0|||
125401501|NCT03670810|451098871|FG007|Open Label Extension|Lack of Efficacy|0|||
125401502|NCT03670810|451098872|FG008|Open Label Extension|Lack of Efficacy|39|||
125401503|NCT03670810|451098864|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
125401504|NCT03670810|451098865|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
125401505|NCT03670810|451098866|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
125401506|NCT03670810|451098867|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
125401507|NCT03670810|451098868|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
125401508|NCT03670810|451098869|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
125401509|NCT03670810|451098870|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
125401510|NCT03670810|451098871|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
125401511|NCT03670810|451098872|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
125401512|NCT03670810|451098864|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125401513|NCT03670810|451098865|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125276553|NCT02689206|450639983|FG003|Overall Study|Other: Reached stopping criteria|3|||
125276554|NCT02689206|450639984|FG004|Overall Study|Other: Reached stopping criteria|4|||
125276555|NCT02689206|450639980|FG000|Overall Study|Physician Decision|1|||
125276556|NCT02689206|450639981|FG001|Overall Study|Physician Decision|0|||
125276557|NCT02689206|450639982|FG002|Overall Study|Physician Decision|0|||
125276558|NCT02689206|450639983|FG003|Overall Study|Physician Decision|0|||
125276559|NCT02689206|450639984|FG004|Overall Study|Physician Decision|0|||
125276560|NCT02689206|450639980|FG000|Overall Study|Withdrawal by Subject|1|||
125276561|NCT02689206|450639981|FG001|Overall Study|Withdrawal by Subject|0|||
125276562|NCT02689206|450639982|FG002|Overall Study|Withdrawal by Subject|1|||
125276563|NCT02689206|450639983|FG003|Overall Study|Withdrawal by Subject|0|||
125276564|NCT02689206|450639984|FG004|Overall Study|Withdrawal by Subject|0|||
125276565|NCT01558596|450639985|FG000|Overall Study|Withdrawal by Subject|1|||
125276566|NCT01558596|450639986|FG001|Overall Study|Withdrawal by Subject|0|||
125276567|NCT01558596|450639985|FG000|Overall Study|surgery elsewhere or cancelled|1|||
125276568|NCT01558596|450639986|FG001|Overall Study|surgery elsewhere or cancelled|1|||
125276569|NCT01558596|450639985|FG000|Overall Study|Protocol Violation|1|||
125276570|NCT01558596|450639986|FG001|Overall Study|Protocol Violation|0|||
125276571|NCT01479764|450639990|FG000|Randomized|Adverse Event|1|||
125276572|NCT01479764|450639991|FG001|Randomized|Adverse Event|1|||
125276573|NCT01479764|450639990|FG000|Randomized|Withdrawal by Subject|1|||
125276574|NCT01479764|450639991|FG001|Randomized|Withdrawal by Subject|0|||
125276575|NCT01479764|450639990|FG000|Treated|Lost to Follow-up|0|||
125276576|NCT01479764|450639991|FG001|Treated|Lost to Follow-up|2|||
125276577|NCT00902850|450639993|FG000|Overall Study|Physician Decision|2|||
125276578|NCT00902850|450639994|FG001|Overall Study|Physician Decision|2|||
125276579|NCT00260832|450639995|FG000|Overall Study|Adverse Event|26|||
125276580|NCT00260832|450639996|FG001|Overall Study|Adverse Event|19|||
125276581|NCT00260832|450639995|FG000|Overall Study|Progression|116|||
125276582|NCT00260832|450639996|FG001|Overall Study|Progression|96|||
125276583|NCT00260832|450639995|FG000|Overall Study|Withdrawal by Subject|15|||
125276584|NCT00260832|450639996|FG001|Overall Study|Withdrawal by Subject|17|||
125276585|NCT00260832|450639995|FG000|Overall Study|Physician Decision|15|||
125276586|NCT00260832|450639996|FG001|Overall Study|Physician Decision|9|||
125276587|NCT00260832|450639995|FG000|Overall Study|Death|43|||
125276588|NCT00260832|450639996|FG001|Overall Study|Death|62|||
125276589|NCT00260832|450639995|FG000|Overall Study|Other|10|||
125276590|NCT00260832|450639996|FG001|Overall Study|Other|7|||
125276591|NCT00260832|450639995|FG000|Overall Study|Protocol Violation|3|||
125276592|NCT00260832|450639996|FG001|Overall Study|Protocol Violation|1|||
125276593|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
125276594|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
125276595|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
125276596|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125276597|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125276598|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125276599|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125276600|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
125276601|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125276602|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125276603|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125276604|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125276605|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125276606|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
125276607|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
125276608|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
125276609|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
125276610|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125276611|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125276612|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125401514|NCT03670810|451098866|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125401515|NCT03670810|451098867|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125401516|NCT03670810|451098868|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125401517|NCT03670810|451098869|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125401518|NCT03670810|451098870|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125276613|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125276614|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
125276615|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
125276616|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125276617|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125401519|NCT03670810|451098871|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
125401520|NCT03670810|451098872|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
125401521|NCT03670810|451098864|FG000|Open Label Extension|Withdrawal by Subject|0|||
125401522|NCT03670810|451098865|FG001|Open Label Extension|Withdrawal by Subject|0|||
125401523|NCT03670810|451098866|FG002|Open Label Extension|Withdrawal by Subject|0|||
125401524|NCT03670810|451098867|FG003|Open Label Extension|Withdrawal by Subject|0|||
125401525|NCT03670810|451098868|FG004|Open Label Extension|Withdrawal by Subject|0|||
125401526|NCT03670810|451098869|FG005|Open Label Extension|Withdrawal by Subject|0|||
125401527|NCT03670810|451098870|FG006|Open Label Extension|Withdrawal by Subject|0|||
125401528|NCT03670810|451098871|FG007|Open Label Extension|Withdrawal by Subject|0|||
125401529|NCT03670810|451098872|FG008|Open Label Extension|Withdrawal by Subject|46|||
125401530|NCT03670810|451098864|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125401531|NCT03670810|451098865|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125401532|NCT03670810|451098866|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125401533|NCT03670810|451098867|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125401534|NCT03670810|451098868|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125401535|NCT03670810|451098869|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125401536|NCT03670810|451098870|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125401537|NCT03670810|451098871|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
125401538|NCT03670810|451098872|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
125401539|NCT03670810|451098864|FG000|Open Label Extension|Physician Decision|0|||
125401540|NCT03670810|451098865|FG001|Open Label Extension|Physician Decision|0|||
125401541|NCT03670810|451098866|FG002|Open Label Extension|Physician Decision|0|||
125401542|NCT03670810|451098867|FG003|Open Label Extension|Physician Decision|0|||
125401543|NCT03670810|451098868|FG004|Open Label Extension|Physician Decision|0|||
125401544|NCT03670810|451098869|FG005|Open Label Extension|Physician Decision|0|||
125401545|NCT03670810|451098870|FG006|Open Label Extension|Physician Decision|0|||
125401546|NCT03670810|451098871|FG007|Open Label Extension|Physician Decision|0|||
125401547|NCT03670810|451098872|FG008|Open Label Extension|Physician Decision|2|||
125401548|NCT03670810|451098864|FG000|Open Label Extension|Non-compliance with study drug|0|||
125401549|NCT03670810|451098865|FG001|Open Label Extension|Non-compliance with study drug|0|||
125401550|NCT03670810|451098866|FG002|Open Label Extension|Non-compliance with study drug|0|||
125401551|NCT03670810|451098867|FG003|Open Label Extension|Non-compliance with study drug|0|||
125401552|NCT03670810|451098868|FG004|Open Label Extension|Non-compliance with study drug|0|||
125401553|NCT03670810|451098869|FG005|Open Label Extension|Non-compliance with study drug|0|||
125401554|NCT03670810|451098870|FG006|Open Label Extension|Non-compliance with study drug|0|||
125401555|NCT03670810|451098871|FG007|Open Label Extension|Non-compliance with study drug|0|||
125401556|NCT03670810|451098872|FG008|Open Label Extension|Non-compliance with study drug|5|||
125401557|NCT03670810|451098864|FG000|Open Label Extension|Pregnancy|0|||
125401558|NCT03670810|451098865|FG001|Open Label Extension|Pregnancy|0|||
125401559|NCT03670810|451098866|FG002|Open Label Extension|Pregnancy|0|||
125401560|NCT03670810|451098867|FG003|Open Label Extension|Pregnancy|0|||
125401561|NCT03670810|451098868|FG004|Open Label Extension|Pregnancy|0|||
125401562|NCT03670810|451098869|FG005|Open Label Extension|Pregnancy|0|||
125401563|NCT03670810|451098870|FG006|Open Label Extension|Pregnancy|0|||
125401564|NCT03670810|451098871|FG007|Open Label Extension|Pregnancy|0|||
125401565|NCT03670810|451098872|FG008|Open Label Extension|Pregnancy|3|||
125401566|NCT03670810|451098864|FG000|Open Label Extension|Adverse Event|0|||
125401567|NCT03670810|451098865|FG001|Open Label Extension|Adverse Event|0|||
125401568|NCT03670810|451098866|FG002|Open Label Extension|Adverse Event|0|||
125401569|NCT03670810|451098867|FG003|Open Label Extension|Adverse Event|0|||
125401570|NCT03670810|451098868|FG004|Open Label Extension|Adverse Event|0|||
125401571|NCT03670810|451098869|FG005|Open Label Extension|Adverse Event|0|||
125401572|NCT03670810|451098870|FG006|Open Label Extension|Adverse Event|0|||
125401573|NCT03670810|451098871|FG007|Open Label Extension|Adverse Event|0|||
125401574|NCT03670810|451098872|FG008|Open Label Extension|Adverse Event|24|||
125401575|NCT03670810|451098864|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
125401576|NCT03670810|451098865|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
125401577|NCT03670810|451098866|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
125401578|NCT03670810|451098867|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
125401579|NCT03670810|451098868|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
125401580|NCT03670810|451098869|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
125401581|NCT03670810|451098870|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
125401582|NCT03670810|451098871|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
125401583|NCT03670810|451098872|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
125401584|NCT03670810|451098864|FG000|Open Label Extension|Lost to Follow-up|0|||
125401585|NCT03670810|451098865|FG001|Open Label Extension|Lost to Follow-up|0|||
125401586|NCT03670810|451098866|FG002|Open Label Extension|Lost to Follow-up|0|||
125401587|NCT03670810|451098867|FG003|Open Label Extension|Lost to Follow-up|0|||
125447888|NCT02703532|451266843|FG002|Overall Study|Withdrawal by Subject|0|||
125447889|NCT02703532|451266844|FG003|Overall Study|Withdrawal by Subject|1|||
125276618|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125276619|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125276620|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125276621|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
125276622|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
125276623|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
125276624|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
125276625|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
125276626|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
125276627|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
125276628|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125276629|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
125276630|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125276631|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125276632|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125276633|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125276634|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125276635|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
125276636|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
125276637|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
125276638|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125276639|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125276640|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125276641|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125276642|NCT03745638|450639997|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
125276643|NCT03745638|450639998|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
125276644|NCT03745638|450639999|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
125276645|NCT03745638|450640000|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
125276646|NCT03745638|450640001|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
125276647|NCT03745638|450640002|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
125276648|NCT03745638|450640003|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
125276649|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125276650|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125276651|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125276652|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125276653|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125276654|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
125276655|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
125276656|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125276657|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125276658|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125276659|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
125276660|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125276661|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
125276662|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
125276663|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125276664|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125276665|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125276666|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
125276667|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
125276668|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
125276669|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
125276670|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125276671|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125276672|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125276673|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125276674|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
125276675|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
125276676|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125276677|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125276678|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125276679|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125447890|NCT02703532|451266841|FG000|Overall Study|Lost to Follow-up|2|||
125401588|NCT03670810|451098868|FG004|Open Label Extension|Lost to Follow-up|0|||
125401589|NCT03670810|451098869|FG005|Open Label Extension|Lost to Follow-up|0|||
125401590|NCT03670810|451098870|FG006|Open Label Extension|Lost to Follow-up|0|||
125401591|NCT03670810|451098871|FG007|Open Label Extension|Lost to Follow-up|0|||
125401592|NCT03670810|451098872|FG008|Open Label Extension|Lost to Follow-up|23|||
125401593|NCT03192150|451098873|FG000|Overall Study|Adverse Event|14|||
125401594|NCT03192150|451098874|FG001|Overall Study|Adverse Event|12|||
125401595|NCT03192150|451098873|FG000|Overall Study|Lack of Efficacy|23|||
125401596|NCT03192150|451098874|FG001|Overall Study|Lack of Efficacy|30|||
125401597|NCT03192150|451098873|FG000|Overall Study|Lost to Follow-up|1|||
125401598|NCT03192150|451098874|FG001|Overall Study|Lost to Follow-up|1|||
125401599|NCT03192150|451098873|FG000|Overall Study|Withdrawal by Subject|4|||
125401600|NCT03192150|451098874|FG001|Overall Study|Withdrawal by Subject|2|||
125401601|NCT03192150|451098873|FG000|Overall Study|Protocol Violation|5|||
125401602|NCT03192150|451098874|FG001|Overall Study|Protocol Violation|2|||
125401603|NCT03192150|451098873|FG000|Overall Study|Surgery Canceled|6|||
125401604|NCT03192150|451098874|FG001|Overall Study|Surgery Canceled|2|||
125401605|NCT03192150|451098873|FG000|Overall Study|Other-Various Administrative Reasons|2|||
125401606|NCT03192150|451098874|FG001|Overall Study|Other-Various Administrative Reasons|5|||
125401607|NCT02579616|451098875|FG000|Overall Study|Participants did not receive treatment|3|||
125401608|NCT00482391|451098876|FG000|Overall Study|Withdrawal by Subject|1|||
125401609|NCT00482391|451098876|FG000|Overall Study|Adverse Event|1|||
125401610|NCT00482391|451098876|FG000|Overall Study|Death|1|||
125401611|NCT06640829|451098887|FG000|Overall Study|Withdrawal by Subject|1|||
125401612|NCT06640829|451098887|FG000|Overall Study|Lost to Follow-up|1|||
125401613|NCT00261716|451098888|FG000|Overall Study|Withdrawal by Subject|6|||
125401614|NCT00261716|451098889|FG001|Overall Study|Withdrawal by Subject|8|||
125401615|NCT00261716|451098888|FG000|Overall Study|Lost to Follow-up|0|||
125401616|NCT00261716|451098889|FG001|Overall Study|Lost to Follow-up|2|||
125401617|NCT02075437|451098890|FG000|Overall Study|Withdrawal by Subject|5|||
125401618|NCT02075437|451098890|FG000|Overall Study|Lost to Follow-up|1|||
125401619|NCT04439240|451098891|FG000|Overall Study|Ineligible|2|||
125401620|NCT04439240|451098891|FG000|Overall Study|Never started treatment|2|||
125401621|NCT04439240|451098891|FG000|Overall Study|Adverse Event|12|||
125401622|NCT04439240|451098891|FG000|Overall Study|Death|2|||
125401623|NCT04439240|451098891|FG000|Overall Study|Disease progression|25|||
125401624|NCT04439240|451098891|FG000|Overall Study|Other diseases|2|||
125401625|NCT04439240|451098891|FG000|Overall Study|Withdrawal by Subject|3|||
125401626|NCT04439240|451098891|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
125401627|NCT04439240|451098891|FG000|Overall Study|Symptomatic decline|1|||
125401628|NCT04439240|451098891|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
125401629|NCT04439240|451098891|FG000|Overall Study|Clinical progression|1|||
125401630|NCT00673452|451098892|FG000|Acute Double-Blind Phase|Adverse Event|41|||
125401631|NCT00673452|451098893|FG001|Acute Double-Blind Phase|Adverse Event|24|||
125401632|NCT00673452|451098892|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
125401633|NCT00673452|451098893|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
125401634|NCT00673452|451098892|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
125401635|NCT00673452|451098893|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
125401636|NCT00673452|451098892|FG000|Acute Double-Blind Phase|Physician Decision|0|||
125401637|NCT00673452|451098893|FG001|Acute Double-Blind Phase|Physician Decision|6|||
125401638|NCT00673452|451098892|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
125447891|NCT02703532|451266842|FG001|Overall Study|Lost to Follow-up|0|||
125447892|NCT02703532|451266843|FG002|Overall Study|Lost to Follow-up|2|||
125447893|NCT02703532|451266844|FG003|Overall Study|Lost to Follow-up|0|||
125447894|NCT00751790|451266849|FG000|Overall Study|Lost to Follow-up|1|||
125447895|NCT00751790|451266849|FG000|Overall Study|Death|3|||
125447896|NCT00751790|451266849|FG000|Overall Study|Withdrawal by Subject|1|||
125447897|NCT04337489|451266852|FG000|Overall Study|Withdrawal by Subject|1|||
125447898|NCT00972543|451266853|FG000|Overall Study|Adverse Event|1|||
125401639|NCT00673452|451098893|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
125401640|NCT00673452|451098892|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
125401641|NCT00673452|451098893|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
125401642|NCT00673452|451098892|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
125401643|NCT00673452|451098893|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
125401644|NCT00673452|451098892|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
125401645|NCT00673452|451098893|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
125401646|NCT00673452|451098892|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
125401647|NCT00673452|451098893|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
125401648|NCT00673452|451098892|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
125401649|NCT00673452|451098893|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
125401650|NCT00673452|451098892|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
125401651|NCT00673452|451098893|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
125401652|NCT00673452|451098892|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
125401653|NCT00673452|451098893|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
125401654|NCT00673452|451098892|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
125401655|NCT00673452|451098893|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
125401656|NCT00673452|451098892|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
125401657|NCT00673452|451098893|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
125401658|NCT00673452|451098892|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
125401659|NCT00673452|451098893|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
125401660|NCT00813124|451098894|FG000|Overall Study|Death|2|||
125401661|NCT00813124|451098894|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
125401662|NCT00813124|451098894|FG000|Overall Study|Withdrawal by Subject|1|||
125401663|NCT00767676|451098895|FG000|Overall Study|Investigator error|54|||
125401664|NCT02075320|451098896|FG000|Overall Study|Withdrawal by Subject|2|||
125401665|NCT01147653|451098898|FG000|Year 2|Withdrawal by Subject|2|||
125401666|NCT01147653|451098899|FG001|Year 2|Withdrawal by Subject|3|||
125401667|NCT00353366|451098900|FG000|Overall Study|Adverse Event|8|||
125401668|NCT00353366|451098900|FG000|Overall Study|Protocol Violation|12|||
125401669|NCT00353366|451098900|FG000|Overall Study|Withdrawal by Subject|12|||
125401670|NCT00353366|451098900|FG000|Overall Study|Lost to Follow-up|92|||
125401671|NCT00353366|451098900|FG000|Overall Study|Other|19|||
125401672|NCT00259857|451098901|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
125401673|NCT00259857|451098902|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
125401674|NCT00259857|451098901|FG000|24 Months Treatment|Lost to Follow-up|0|||
125401675|NCT00259857|451098902|FG001|24 Months Treatment|Lost to Follow-up|3|||
125401676|NCT02214121|451098905|FG000|Part A|Patient decision|2|||
125401677|NCT02214121|451098906|FG001|Part A|Patient decision|0|||
125401678|NCT02214121|451098907|FG002|Part A|Patient decision|0|||
125401679|NCT02214121|451098905|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
125401680|NCT02214121|451098906|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
125401681|NCT02214121|451098907|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
125401682|NCT02214121|451098905|FG000|Part A|Other|1|||
125401683|NCT02214121|451098906|FG001|Part A|Other|0|||
125401684|NCT02214121|451098907|FG002|Part A|Other|0|||
125401685|NCT02214121|451098905|FG000|Part B|Patient decision|0|||
125401686|NCT02214121|451098906|FG001|Part B|Patient decision|1|||
125401687|NCT02214121|451098907|FG002|Part B|Patient decision|0|||
125401688|NCT02214121|451098905|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
125401689|NCT02214121|451098906|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
125401690|NCT02214121|451098907|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
125401691|NCT02214121|451098905|FG000|Part B|Lost to Follow-up|0|||
125401692|NCT02214121|451098906|FG001|Part B|Lost to Follow-up|0|||
125401693|NCT02214121|451098907|FG002|Part B|Lost to Follow-up|1|||
125401694|NCT00715793|451098908|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
125401695|NCT00715793|451098909|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
125401696|NCT00715793|451098908|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
125401697|NCT00715793|451098909|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
125401698|NCT01849588|451098910|FG000|Overall Study|Lack of Efficacy|3|||
125401699|NCT01365273|451098913|FG000|Overall Study|Lost to Follow-up|1|||
125401700|NCT01365273|451098914|FG001|Overall Study|Lost to Follow-up|0|||
125401701|NCT01365273|451098913|FG000|Overall Study|Protocol Violation|0|||
125401702|NCT01365273|451098914|FG001|Overall Study|Protocol Violation|1|||
125401703|NCT01365273|451098913|FG000|Overall Study|Physician Decision|1|||
125401704|NCT01365273|451098914|FG001|Overall Study|Physician Decision|0|||
125401705|NCT01339390|451098915|FG000|Overall Study|Death|32|||
125401706|NCT01339390|451098916|FG001|Overall Study|Death|29|||
125447899|NCT00972543|451266854|FG001|Overall Study|Adverse Event|0|||
125447900|NCT00972543|451266853|FG000|Overall Study|Early study termination by sponsor|4|||
125447901|NCT00972543|451266854|FG001|Overall Study|Early study termination by sponsor|1|||
125401707|NCT01339390|451098915|FG000|Overall Study|Lost to Follow-up|125|||
125401708|NCT01339390|451098916|FG001|Overall Study|Lost to Follow-up|127|||
125401709|NCT02563028|451098918|FG000|Overall Study|Lack of equipment|1|||
125401710|NCT02563028|451098918|FG000|Overall Study|Unable to elicit VEP post induction|1|||
125401711|NCT01462357|451098919|FG000|Overall Study|Death|0|||
125401712|NCT01462357|451098920|FG001|Overall Study|Death|0|||
125401713|NCT01462357|451098921|FG002|Overall Study|Death|1|||
125401714|NCT01462357|451098919|FG000|Overall Study|Withdrawal by Subject|3|||
125401715|NCT01462357|451098920|FG001|Overall Study|Withdrawal by Subject|11|||
125401716|NCT01462357|451098921|FG002|Overall Study|Withdrawal by Subject|3|||
125401717|NCT01462357|451098919|FG000|Overall Study|Migrated/moved from study area|2|||
125401718|NCT01462357|451098920|FG001|Overall Study|Migrated/moved from study area|3|||
125401719|NCT01462357|451098921|FG002|Overall Study|Migrated/moved from study area|1|||
125401720|NCT01462357|451098919|FG000|Overall Study|Lost to Follow-up|3|||
125401721|NCT01462357|451098920|FG001|Overall Study|Lost to Follow-up|5|||
125401722|NCT01462357|451098921|FG002|Overall Study|Lost to Follow-up|7|||
125401723|NCT00806546|451098922|FG000|Overall Study|Enrolled, not treated|35|||
125401724|NCT00806546|451098922|FG000|Overall Study|Lost to Follow-up|32|||
125401725|NCT00806546|451098922|FG000|Overall Study|Adverse Event|74|||
125401726|NCT00806546|451098922|FG000|Overall Study|Withdrawal by Subject|75|||
125401727|NCT00806546|451098922|FG000|Overall Study|Protocol Violation|49|||
125401728|NCT00806546|451098922|FG000|Overall Study|Various|42|||
125276680|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125276681|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125276682|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
125276683|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125276684|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125276685|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125276686|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125276687|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
125276688|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
125276689|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
125276690|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
125276691|NCT03745638|450639997|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
125276692|NCT03745638|450639998|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
125276693|NCT03745638|450639999|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
125276694|NCT03745638|450640000|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
125276695|NCT03745638|450640001|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
125276696|NCT03745638|450640002|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
125276697|NCT03745638|450640003|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
125276698|NCT04470050|450640006|FG000|Double-blind Treatment Phase|Adverse Event|0|||
125276699|NCT04470050|450640007|FG001|Double-blind Treatment Phase|Adverse Event|0|||
125276700|NCT04470050|450640008|FG002|Double-blind Treatment Phase|Adverse Event|0|||
125276701|NCT04470050|450640009|FG003|Double-blind Treatment Phase|Adverse Event|1|||
125276702|NCT04470050|450640010|FG004|Double-blind Treatment Phase|Adverse Event|0|||
125276703|NCT04470050|450640011|FG005|Double-blind Treatment Phase|Adverse Event|0|||
125276704|NCT04470050|450640012|FG006|Double-blind Treatment Phase|Adverse Event|0|||
125276705|NCT04470050|450640006|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
125276706|NCT04470050|450640007|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
125276707|NCT04470050|450640008|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
125276708|NCT04470050|450640009|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
125276709|NCT04470050|450640010|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
125276710|NCT04470050|450640011|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
125276711|NCT04470050|450640012|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
125276712|NCT04470050|450640006|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
125276713|NCT04470050|450640007|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
125276714|NCT04470050|450640008|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
125276715|NCT04470050|450640009|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
125276716|NCT04470050|450640010|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
125276717|NCT04470050|450640011|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
125276718|NCT04470050|450640012|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
125276719|NCT03585764|450640015|FG000|Overall Study|Death|3|||
125276720|NCT03585764|450640016|FG001|Overall Study|Death|2|||
125276721|NCT03585764|450640017|FG002|Overall Study|Death|3|||
125276722|NCT03585764|450640018|FG003|Overall Study|Death|0|||
125276723|NCT03585764|450640015|FG000|Overall Study|Lost to Follow-up|0|||
125276724|NCT03585764|450640016|FG001|Overall Study|Lost to Follow-up|1|||
125276725|NCT03585764|450640017|FG002|Overall Study|Lost to Follow-up|0|||
125276726|NCT03585764|450640018|FG003|Overall Study|Lost to Follow-up|0|||
125276727|NCT03585764|450640015|FG000|Overall Study|Physician Decision|0|||
125276728|NCT03585764|450640016|FG001|Overall Study|Physician Decision|0|||
125276729|NCT03585764|450640017|FG002|Overall Study|Physician Decision|2|||
125276730|NCT03585764|450640018|FG003|Overall Study|Physician Decision|0|||
125276731|NCT03640507|450640019|FG000|Overall Study|Withdrawal by Subject|0|||
125276732|NCT03640507|450640020|FG001|Overall Study|Withdrawal by Subject|0|||
125276733|NCT03640507|450640021|FG002|Overall Study|Withdrawal by Subject|1|||
125276734|NCT03604172|450640022|FG000|Overall Study|Lost to Follow-up|1|||
125276735|NCT03604172|450640023|FG001|Overall Study|Lost to Follow-up|2|||
125276736|NCT01270880|450640027|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
125276737|NCT00976716|450640028|FG000|Overall Study|Adverse Event|1|||
125401729|NCT00096044|451098923|FG000|Overall Study|Withdrawal by Subject|9|||
125276738|NCT04222699|450640029|FG000|Overall Study|Lost to Follow-up|2|||
125276739|NCT01606176|450640030|FG000|Overall Study|Adverse Event|2|||
125276740|NCT01606176|450640031|FG001|Overall Study|Adverse Event|3|||
125276741|NCT01606176|450640030|FG000|Overall Study|Disease progression|1|||
125276742|NCT01606176|450640031|FG001|Overall Study|Disease progression|0|||
125276743|NCT01606176|450640030|FG000|Overall Study|Withdrawal by Subject|1|||
125276744|NCT01606176|450640031|FG001|Overall Study|Withdrawal by Subject|0|||
125276745|NCT01832493|450640032|FG000|Overall Study|Physician Decision|2|||
125276746|NCT01832493|450640032|FG000|Overall Study|Protocol Violation|4|||
125276747|NCT01832493|450640032|FG000|Overall Study|Unable to place LV lead|2|||
125401730|NCT00096044|451098923|FG000|Overall Study|Adverse Event|21|||
125276748|NCT02993822|450640033|FG000|Overall Study|Lack of Efficacy|1|||
125276749|NCT02993822|450640034|FG001|Overall Study|Lack of Efficacy|1|||
125276750|NCT02993822|450640035|FG002|Overall Study|Lack of Efficacy|0|||
125276751|NCT02993822|450640036|FG003|Overall Study|Lack of Efficacy|0|||
125276752|NCT02993822|450640033|FG000|Overall Study|Protocol Violation|1|||
125276753|NCT02993822|450640034|FG001|Overall Study|Protocol Violation|0|||
125276754|NCT02993822|450640035|FG002|Overall Study|Protocol Violation|0|||
125276755|NCT02993822|450640036|FG003|Overall Study|Protocol Violation|0|||
125276756|NCT02993822|450640033|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
125276757|NCT02993822|450640034|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
125276758|NCT02993822|450640035|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
125276759|NCT02993822|450640036|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
125276760|NCT02993822|450640033|FG000|Overall Study|Adverse Event|3|||
125276761|NCT02993822|450640034|FG001|Overall Study|Adverse Event|1|||
125276762|NCT02993822|450640035|FG002|Overall Study|Adverse Event|7|||
125276763|NCT02993822|450640036|FG003|Overall Study|Adverse Event|0|||
125276764|NCT02993822|450640033|FG000|Overall Study|Withdrawal by Subject|4|||
125276765|NCT02993822|450640034|FG001|Overall Study|Withdrawal by Subject|2|||
125276766|NCT02993822|450640035|FG002|Overall Study|Withdrawal by Subject|2|||
125276767|NCT02993822|450640036|FG003|Overall Study|Withdrawal by Subject|3|||
125276768|NCT02993822|450640033|FG000|Overall Study|Lost to Follow-up|1|||
125276769|NCT02993822|450640034|FG001|Overall Study|Lost to Follow-up|0|||
125276770|NCT02993822|450640035|FG002|Overall Study|Lost to Follow-up|1|||
125276771|NCT02993822|450640036|FG003|Overall Study|Lost to Follow-up|0|||
125276772|NCT01732510|450640037|FG000|Overall Study|Adverse Event|0|||
125276773|NCT01732510|450640038|FG001|Overall Study|Adverse Event|1|||
125276774|NCT01732510|450640039|FG002|Overall Study|Adverse Event|1|||
125276775|NCT01732510|450640040|FG003|Overall Study|Adverse Event|0|||
125276776|NCT01732510|450640041|FG004|Overall Study|Adverse Event|0|||
125276777|NCT01732510|450640042|FG005|Overall Study|Adverse Event|0|||
125276778|NCT01732510|450640043|FG006|Overall Study|Adverse Event|1|||
125276779|NCT01732510|450640037|FG000|Overall Study|Protocol Violation|0|||
125276780|NCT01732510|450640038|FG001|Overall Study|Protocol Violation|0|||
125276781|NCT01732510|450640039|FG002|Overall Study|Protocol Violation|0|||
125276782|NCT01732510|450640040|FG003|Overall Study|Protocol Violation|1|||
125276783|NCT01732510|450640041|FG004|Overall Study|Protocol Violation|0|||
125276784|NCT01732510|450640042|FG005|Overall Study|Protocol Violation|0|||
125276785|NCT01732510|450640043|FG006|Overall Study|Protocol Violation|0|||
125276786|NCT01732510|450640037|FG000|Overall Study|Withdrawal by Subject|1|||
125276787|NCT01732510|450640038|FG001|Overall Study|Withdrawal by Subject|3|||
125276788|NCT01732510|450640039|FG002|Overall Study|Withdrawal by Subject|2|||
125276789|NCT01732510|450640040|FG003|Overall Study|Withdrawal by Subject|1|||
125276790|NCT01732510|450640041|FG004|Overall Study|Withdrawal by Subject|5|||
125276791|NCT01732510|450640042|FG005|Overall Study|Withdrawal by Subject|0|||
125276792|NCT01732510|450640043|FG006|Overall Study|Withdrawal by Subject|1|||
125276793|NCT01732510|450640037|FG000|Overall Study|Lost to Follow-up|0|||
125276794|NCT01732510|450640038|FG001|Overall Study|Lost to Follow-up|0|||
125276795|NCT01732510|450640039|FG002|Overall Study|Lost to Follow-up|1|||
125276796|NCT01732510|450640040|FG003|Overall Study|Lost to Follow-up|1|||
125276797|NCT01732510|450640041|FG004|Overall Study|Lost to Follow-up|0|||
125276798|NCT01732510|450640042|FG005|Overall Study|Lost to Follow-up|1|||
125276799|NCT01732510|450640043|FG006|Overall Study|Lost to Follow-up|0|||
125276800|NCT01732510|450640037|FG000|Overall Study|Physician Decision|0|||
125276801|NCT01732510|450640038|FG001|Overall Study|Physician Decision|1|||
125276802|NCT01732510|450640039|FG002|Overall Study|Physician Decision|0|||
125276803|NCT01732510|450640040|FG003|Overall Study|Physician Decision|0|||
125276804|NCT01732510|450640041|FG004|Overall Study|Physician Decision|0|||
125276805|NCT01732510|450640042|FG005|Overall Study|Physician Decision|0|||
125276806|NCT01732510|450640043|FG006|Overall Study|Physician Decision|0|||
125276807|NCT01732510|450640037|FG000|Overall Study|Pregnancy|0|||
125276808|NCT01732510|450640038|FG001|Overall Study|Pregnancy|0|||
125276809|NCT01732510|450640039|FG002|Overall Study|Pregnancy|0|||
125276810|NCT01732510|450640040|FG003|Overall Study|Pregnancy|1|||
125276811|NCT01732510|450640041|FG004|Overall Study|Pregnancy|0|||
125276812|NCT01732510|450640042|FG005|Overall Study|Pregnancy|0|||
125276813|NCT01732510|450640043|FG006|Overall Study|Pregnancy|0|||
125276814|NCT01732510|450640037|FG000|Overall Study|Study Terminated By Sponsor|0|||
125276815|NCT01732510|450640038|FG001|Overall Study|Study Terminated By Sponsor|0|||
125276816|NCT01732510|450640039|FG002|Overall Study|Study Terminated By Sponsor|0|||
125276817|NCT01732510|450640040|FG003|Overall Study|Study Terminated By Sponsor|1|||
125276818|NCT01732510|450640041|FG004|Overall Study|Study Terminated By Sponsor|0|||
125276819|NCT01732510|450640042|FG005|Overall Study|Study Terminated By Sponsor|12|||
125276820|NCT01732510|450640043|FG006|Overall Study|Study Terminated By Sponsor|6|||
125276821|NCT00313144|450640044|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
125276822|NCT00313144|450640044|FG000|Overall Study|Death|7|||
125276823|NCT00313144|450640044|FG000|Overall Study|Lost to Follow-up|5|||
125276824|NCT00313144|450640044|FG000|Overall Study|Withdrawal by Subject|4|||
125276825|NCT00313144|450640044|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
125276826|NCT00313144|450640044|FG000|Overall Study|Physician Decision|4|||
125276827|NCT00313144|450640044|FG000|Overall Study|Adverse event - transient|5|||
125276828|NCT00313144|450640044|FG000|Overall Study|Liver transplant|1|||
125276829|NCT00313144|450640044|FG000|Overall Study|Insurance (homecare provider) change|1|||
125276830|NCT00313144|450640044|FG000|Overall Study|Change to different product|1|||
125276831|NCT00313144|450640044|FG000|Overall Study|Due to termination of the study|66|||
125276832|NCT01221753|450640045|FG000|Overall Study|Adverse Event|1|||
125276833|NCT01262560|450640051|FG000|Overall Study|Protocol Violation|0|||
125276834|NCT01262560|450640052|FG001|Overall Study|Protocol Violation|1|||
125276835|NCT01262560|450640053|FG002|Overall Study|Protocol Violation|2|||
125276836|NCT03213938|450640054|FG000|Overall Study|Lost to Follow-up|4|||
125276837|NCT03213938|450640055|FG001|Overall Study|Lost to Follow-up|3|||
125276838|NCT03213938|450640054|FG000|Overall Study|Lack of Efficacy|1|||
125276839|NCT03213938|450640055|FG001|Overall Study|Lack of Efficacy|0|||
125276840|NCT03213938|450640054|FG000|Overall Study|Decline to participate|5|||
125276841|NCT03213938|450640055|FG001|Overall Study|Decline to participate|4|||
125276842|NCT03213938|450640054|FG000|Overall Study|Without reason|4|||
125276843|NCT03213938|450640055|FG001|Overall Study|Without reason|5|||
125276844|NCT04238481|450640056|FG000|Overall Study|Miscellaneous|0|||
125276845|NCT04238481|450640057|FG001|Overall Study|Miscellaneous|1|||
125276846|NCT04238481|450640058|FG002|Overall Study|Miscellaneous|0|||
125276847|NCT04238481|450640059|FG003|Overall Study|Miscellaneous|0|||
125276848|NCT00673231|450640060|FG000|Overall Study|Withdrawal by Subject|14|||
125276849|NCT00673231|450640061|FG001|Overall Study|Withdrawal by Subject|10|||
125276850|NCT00673231|450640062|FG002|Overall Study|Withdrawal by Subject|8|||
125276851|NCT00673231|450640063|FG003|Overall Study|Withdrawal by Subject|6|||
125276852|NCT00673231|450640060|FG000|Overall Study|Adverse Event|6|||
125276853|NCT00673231|450640061|FG001|Overall Study|Adverse Event|5|||
125276854|NCT00673231|450640062|FG002|Overall Study|Adverse Event|9|||
125276855|NCT00673231|450640063|FG003|Overall Study|Adverse Event|6|||
125276856|NCT00673231|450640060|FG000|Overall Study|Lost to Follow-up|1|||
125276857|NCT00673231|450640061|FG001|Overall Study|Lost to Follow-up|2|||
125276858|NCT00673231|450640062|FG002|Overall Study|Lost to Follow-up|1|||
125276859|NCT00673231|450640063|FG003|Overall Study|Lost to Follow-up|2|||
125276860|NCT00673231|450640060|FG000|Overall Study|Death|0|||
125276861|NCT00673231|450640061|FG001|Overall Study|Death|0|||
125276862|NCT00673231|450640062|FG002|Overall Study|Death|1|||
125276863|NCT00673231|450640063|FG003|Overall Study|Death|0|||
125276864|NCT00673231|450640060|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
125276865|NCT00673231|450640061|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
125276866|NCT00673231|450640062|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
125276867|NCT00673231|450640063|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
125276868|NCT03594747|450640064|FG000|Overall Study|Death|78|||
125276869|NCT03594747|450640065|FG001|Overall Study|Death|86|||
125276870|NCT03594747|450640066|FG002|Overall Study|Death|87|||
125276871|NCT03594747|450640064|FG000|Overall Study|Withdrawal by Subject|5|||
125276872|NCT03594747|450640065|FG001|Overall Study|Withdrawal by Subject|2|||
125276873|NCT03594747|450640066|FG002|Overall Study|Withdrawal by Subject|11|||
125276874|NCT03594747|450640064|FG000|Overall Study|Lost to Follow-up|4|||
125276875|NCT03594747|450640065|FG001|Overall Study|Lost to Follow-up|1|||
125276876|NCT03594747|450640066|FG002|Overall Study|Lost to Follow-up|1|||
125276877|NCT03594747|450640064|FG000|Overall Study|Physician Decision|0|||
125276878|NCT03594747|450640065|FG001|Overall Study|Physician Decision|1|||
125276879|NCT03594747|450640066|FG002|Overall Study|Physician Decision|0|||
125276880|NCT03594747|450640064|FG000|Overall Study|Sponsor decision|23|||
125276881|NCT03594747|450640065|FG001|Overall Study|Sponsor decision|17|||
125276882|NCT03594747|450640066|FG002|Overall Study|Sponsor decision|16|||
125276883|NCT03594747|450640064|FG000|Overall Study|Did not meet inclusion criteria|0|||
125276884|NCT03594747|450640065|FG001|Overall Study|Did not meet inclusion criteria|0|||
125276885|NCT03594747|450640066|FG002|Overall Study|Did not meet inclusion criteria|1|||
125276886|NCT03594747|450640064|FG000|Overall Study|Transfer to long term extension study|10|||
125276887|NCT03594747|450640065|FG001|Overall Study|Transfer to long term extension study|12|||
125276888|NCT03594747|450640066|FG002|Overall Study|Transfer to long term extension study|5|||
125276889|NCT01063062|450640069|FG000|Overall Study|Patient withdrew consent|0|||
125276890|NCT01063062|450640070|FG001|Overall Study|Patient withdrew consent|1|||
125276891|NCT01063062|450640069|FG000|Overall Study|Adverse Event|2|||
125276892|NCT01063062|450640070|FG001|Overall Study|Adverse Event|4|||
125276893|NCT01063062|450640069|FG000|Overall Study|Protocol Violation|5|||
125276894|NCT01063062|450640070|FG001|Overall Study|Protocol Violation|4|||
125276895|NCT01063062|450640069|FG000|Overall Study|Investigator's request|1|||
125276896|NCT01063062|450640070|FG001|Overall Study|Investigator's request|0|||
125276897|NCT01063062|450640069|FG000|Overall Study|Lost to Follow-up|0|||
125276898|NCT01063062|450640070|FG001|Overall Study|Lost to Follow-up|2|||
125276899|NCT01063062|450640069|FG000|Overall Study|Miscellaneous reason|0|||
125276900|NCT01063062|450640070|FG001|Overall Study|Miscellaneous reason|1|||
125276901|NCT02015481|450640075|FG000|Overall Study|Death|1|||
125276902|NCT02485639|450640076|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
125276903|NCT02485639|450640076|FG000|Overall Study|Early termination|4|||
125276904|NCT02485639|450640076|FG000|Overall Study|Withdrawal by Subject|4|||
125401731|NCT00096044|451098923|FG000|Overall Study|Disease Progression|4|||
125401732|NCT00004031|451098924|FG000|Overall Study|Adverse Event|5|||
125401733|NCT00004031|451098925|FG001|Overall Study|Adverse Event|0|||
125401734|NCT00004031|451098924|FG000|Overall Study|Refusal unrelated to adverse events|2|||
125401735|NCT00004031|451098925|FG001|Overall Study|Refusal unrelated to adverse events|11|||
125401736|NCT00004031|451098924|FG000|Overall Study|Progression/relapse|9|||
125401737|NCT00004031|451098925|FG001|Overall Study|Progression/relapse|4|||
125401738|NCT00004031|451098924|FG000|Overall Study|Death|3|||
125401739|NCT00004031|451098925|FG001|Overall Study|Death|1|||
125401740|NCT00004031|451098924|FG000|Overall Study|Other- not protocol specified|3|||
125401741|NCT00004031|451098925|FG001|Overall Study|Other- not protocol specified|3|||
125401742|NCT00004031|451098924|FG000|Overall Study|Reason under review|3|||
125401743|NCT00004031|451098925|FG001|Overall Study|Reason under review|2|||
125401744|NCT01387607|451098926|FG000|Overall Study|Adverse Event|23|||
125401745|NCT01387607|451098927|FG001|Overall Study|Adverse Event|11|||
125401746|NCT01387607|451098926|FG000|Overall Study|Lack of Efficacy|8|||
125401747|NCT01387607|451098927|FG001|Overall Study|Lack of Efficacy|6|||
125401748|NCT01387607|451098926|FG000|Overall Study|Lost to Follow-up|2|||
125401749|NCT01387607|451098927|FG001|Overall Study|Lost to Follow-up|1|||
125401750|NCT01387607|451098926|FG000|Overall Study|No longer meets eligibility criteria|0|||
125401751|NCT01387607|451098927|FG001|Overall Study|No longer meets eligibility criteria|1|||
125401752|NCT01387607|451098926|FG000|Overall Study|Protocol Violation|1|||
125401753|NCT01387607|451098927|FG001|Overall Study|Protocol Violation|5|||
125401754|NCT01387607|451098926|FG000|Overall Study|Withdrawal by Subject|13|||
125401755|NCT01387607|451098927|FG001|Overall Study|Withdrawal by Subject|14|||
125401756|NCT01387607|451098926|FG000|Overall Study|Other|1|||
125401757|NCT01387607|451098927|FG001|Overall Study|Other|1|||
125401758|NCT01387607|451098926|FG000|Overall Study|Randomized, not treated|3|||
125401759|NCT01387607|451098927|FG001|Overall Study|Randomized, not treated|6|||
125401760|NCT03878134|451098928|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
125401761|NCT02908529|451098929|FG000|Overall Study|Lost to Follow-up|0|||
125401762|NCT02908529|451098930|FG001|Overall Study|Lost to Follow-up|2|||
125401763|NCT03337724|451098933|FG000|Overall Study|Reason not Specified|12|||
125401764|NCT03337724|451098934|FG001|Overall Study|Reason not Specified|21|||
125401765|NCT03337724|451098935|FG002|Overall Study|Reason not Specified|9|||
125401766|NCT03337724|451098936|FG003|Overall Study|Reason not Specified|9|||
125401767|NCT03337724|451098937|FG004|Overall Study|Reason not Specified|29|||
125401768|NCT03337724|451098933|FG000|Overall Study|Withdrawal by Subject|13|||
125401769|NCT03337724|451098934|FG001|Overall Study|Withdrawal by Subject|15|||
125401770|NCT03337724|451098935|FG002|Overall Study|Withdrawal by Subject|4|||
125401771|NCT03337724|451098936|FG003|Overall Study|Withdrawal by Subject|15|||
125401772|NCT03337724|451098937|FG004|Overall Study|Withdrawal by Subject|6|||
125401773|NCT03337724|451098933|FG000|Overall Study|Protocol Deviation|0|||
125401774|NCT03337724|451098934|FG001|Overall Study|Protocol Deviation|1|||
125401775|NCT03337724|451098935|FG002|Overall Study|Protocol Deviation|1|||
125401776|NCT03337724|451098936|FG003|Overall Study|Protocol Deviation|1|||
125401777|NCT03337724|451098937|FG004|Overall Study|Protocol Deviation|0|||
125401778|NCT03337724|451098933|FG000|Overall Study|Adverse Event|1|||
125401779|NCT03337724|451098934|FG001|Overall Study|Adverse Event|1|||
125401780|NCT03337724|451098935|FG002|Overall Study|Adverse Event|0|||
125401781|NCT03337724|451098936|FG003|Overall Study|Adverse Event|1|||
125401782|NCT03337724|451098937|FG004|Overall Study|Adverse Event|0|||
125401783|NCT03337724|451098933|FG000|Overall Study|Death|40|||
125401784|NCT03337724|451098934|FG001|Overall Study|Death|89|||
125401785|NCT03337724|451098935|FG002|Overall Study|Death|43|||
125401786|NCT03337724|451098936|FG003|Overall Study|Death|76|||
125401787|NCT03337724|451098937|FG004|Overall Study|Death|50|||
125401788|NCT03337724|451098933|FG000|Overall Study|Lost to Follow-up|5|||
125401789|NCT03337724|451098934|FG001|Overall Study|Lost to Follow-up|5|||
125401790|NCT03337724|451098935|FG002|Overall Study|Lost to Follow-up|4|||
125401791|NCT03337724|451098936|FG003|Overall Study|Lost to Follow-up|7|||
125401792|NCT03337724|451098937|FG004|Overall Study|Lost to Follow-up|4|||
125401793|NCT03337724|451098933|FG000|Overall Study|Physician Decision|16|||
125401794|NCT03337724|451098934|FG001|Overall Study|Physician Decision|34|||
125401795|NCT03337724|451098935|FG002|Overall Study|Physician Decision|14|||
125401796|NCT03337724|451098936|FG003|Overall Study|Physician Decision|34|||
125401797|NCT03337724|451098937|FG004|Overall Study|Physician Decision|13|||
125401798|NCT03337724|451098933|FG000|Overall Study|Progressive Disease|0|||
125401799|NCT03337724|451098934|FG001|Overall Study|Progressive Disease|2|||
125401800|NCT03337724|451098935|FG002|Overall Study|Progressive Disease|1|||
125401801|NCT03337724|451098936|FG003|Overall Study|Progressive Disease|2|||
125401802|NCT03337724|451098937|FG004|Overall Study|Progressive Disease|0|||
125401803|NCT03337724|451098933|FG000|Overall Study|Symptomatic Deterioration|0|||
125401804|NCT03337724|451098934|FG001|Overall Study|Symptomatic Deterioration|0|||
125401805|NCT03337724|451098935|FG002|Overall Study|Symptomatic Deterioration|0|||
125401806|NCT03337724|451098936|FG003|Overall Study|Symptomatic Deterioration|1|||
125401807|NCT03337724|451098937|FG004|Overall Study|Symptomatic Deterioration|0|||
125401808|NCT03551210|451098939|FG000|Overall Study|Adverse Event|5|||
125401809|NCT03551210|451098940|FG001|Overall Study|Adverse Event|6|||
125276905|NCT02597452|450640077|FG000|Overall Study|testing incomplete|30|||
125276906|NCT02566785|450640084|FG000|Overall Study|Lost to Follow-up|0|||
125276907|NCT02566785|450640085|FG001|Overall Study|Lost to Follow-up|2|||
125276908|NCT02566785|450640084|FG000|Overall Study|Worsening condition|1|||
125276909|NCT02566785|450640085|FG001|Overall Study|Worsening condition|1|||
125276910|NCT00281099|450640086|FG000|Overall Study|Death|46|||
125276911|NCT00281099|450640087|FG001|Overall Study|Death|57|||
125276912|NCT00281099|450640086|FG000|Overall Study|Lost to Follow-up|10|||
125276913|NCT00281099|450640087|FG001|Overall Study|Lost to Follow-up|19|||
125276914|NCT00281099|450640086|FG000|Overall Study|Withdrawal by Subject|65|||
125276915|NCT00281099|450640087|FG001|Overall Study|Withdrawal by Subject|70|||
125276916|NCT00281099|450640086|FG000|Overall Study|Physician Decision|79|||
125276917|NCT00281099|450640087|FG001|Overall Study|Physician Decision|72|||
125276918|NCT00281099|450640086|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
125276919|NCT00281099|450640087|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
125276920|NCT04621240|450640088|FG000|Overall Study|Withdrawal by Subject|36|||
125276921|NCT02147197|450640089|FG000|Overall Study|Adverse Event|1|||
125276922|NCT02147197|450640090|FG001|Overall Study|Adverse Event|0|||
125276923|NCT02147197|450640091|FG002|Overall Study|Adverse Event|0|||
125276924|NCT02147197|450640089|FG000|Overall Study|Withdrawal of Consent|4|||
125276925|NCT02147197|450640090|FG001|Overall Study|Withdrawal of Consent|3|||
125276926|NCT02147197|450640091|FG002|Overall Study|Withdrawal of Consent|2|||
125276927|NCT02147197|450640089|FG000|Overall Study|Lost to Follow-up|2|||
125276928|NCT02147197|450640090|FG001|Overall Study|Lost to Follow-up|3|||
125276929|NCT02147197|450640091|FG002|Overall Study|Lost to Follow-up|1|||
125276930|NCT02147197|450640089|FG000|Overall Study|Protocol Violation|1|||
125276931|NCT02147197|450640090|FG001|Overall Study|Protocol Violation|0|||
125276932|NCT02147197|450640091|FG002|Overall Study|Protocol Violation|3|||
125276933|NCT02147197|450640089|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125276934|NCT02147197|450640090|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125276935|NCT02147197|450640091|FG002|Overall Study|Other Miscellaneous Reasons|3|||
125276936|NCT02744612|450642103|FG000|Overall Study|Withdrawal by Subject|0|||
125276937|NCT02744612|450642104|FG001|Overall Study|Withdrawal by Subject|2|||
125276938|NCT02712983|450642106|FG000|Treatment Phase|Adverse Event|3|||
125276939|NCT02712983|450642107|FG001|Treatment Phase|Adverse Event|1|||
125276940|NCT02712983|450642108|FG002|Treatment Phase|Adverse Event|1|||
125276941|NCT02712983|450642109|FG003|Treatment Phase|Adverse Event|4|||
125276942|NCT02712983|450642110|FG004|Treatment Phase|Adverse Event|3|||
125276943|NCT02712983|450642111|FG005|Treatment Phase|Adverse Event|0|||
125276944|NCT02712983|450642112|FG006|Treatment Phase|Adverse Event|6|||
125276945|NCT02712983|450642113|FG007|Treatment Phase|Adverse Event|6|||
125276946|NCT02712983|450642114|FG008|Treatment Phase|Adverse Event|1|||
125276947|NCT02712983|450642106|FG000|Treatment Phase|Protocol Deviation|0|||
125276948|NCT02712983|450642107|FG001|Treatment Phase|Protocol Deviation|0|||
125276949|NCT02712983|450642108|FG002|Treatment Phase|Protocol Deviation|0|||
125276950|NCT02712983|450642109|FG003|Treatment Phase|Protocol Deviation|2|||
125276951|NCT02712983|450642110|FG004|Treatment Phase|Protocol Deviation|0|||
125276952|NCT02712983|450642111|FG005|Treatment Phase|Protocol Deviation|0|||
125276953|NCT02712983|450642112|FG006|Treatment Phase|Protocol Deviation|1|||
125276954|NCT02712983|450642113|FG007|Treatment Phase|Protocol Deviation|0|||
125276955|NCT02712983|450642114|FG008|Treatment Phase|Protocol Deviation|0|||
125276956|NCT02712983|450642106|FG000|Treatment Phase|Technical Problems|0|||
125276957|NCT02712983|450642107|FG001|Treatment Phase|Technical Problems|0|||
125276958|NCT02712983|450642108|FG002|Treatment Phase|Technical Problems|0|||
125276959|NCT02712983|450642109|FG003|Treatment Phase|Technical Problems|0|||
125276960|NCT02712983|450642110|FG004|Treatment Phase|Technical Problems|0|||
125276961|NCT02712983|450642111|FG005|Treatment Phase|Technical Problems|0|||
125276962|NCT02712983|450642112|FG006|Treatment Phase|Technical Problems|1|||
125276963|NCT02712983|450642113|FG007|Treatment Phase|Technical Problems|0|||
125276964|NCT02712983|450642114|FG008|Treatment Phase|Technical Problems|0|||
125276965|NCT02712983|450642106|FG000|Treatment Phase|Physician Decision|0|||
125276966|NCT02712983|450642107|FG001|Treatment Phase|Physician Decision|0|||
125276967|NCT02712983|450642108|FG002|Treatment Phase|Physician Decision|0|||
125276968|NCT02712983|450642109|FG003|Treatment Phase|Physician Decision|0|||
125276969|NCT02712983|450642110|FG004|Treatment Phase|Physician Decision|0|||
125276970|NCT02712983|450642111|FG005|Treatment Phase|Physician Decision|0|||
125276971|NCT02712983|450642112|FG006|Treatment Phase|Physician Decision|0|||
125276972|NCT02712983|450642113|FG007|Treatment Phase|Physician Decision|1|||
125276973|NCT02712983|450642114|FG008|Treatment Phase|Physician Decision|1|||
125276974|NCT02712983|450642106|FG000|Treatment Phase|Subject Decision|2|||
125276975|NCT02712983|450642107|FG001|Treatment Phase|Subject Decision|0|||
125276976|NCT02712983|450642108|FG002|Treatment Phase|Subject Decision|0|||
125276977|NCT02712983|450642109|FG003|Treatment Phase|Subject Decision|2|||
125276978|NCT02712983|450642110|FG004|Treatment Phase|Subject Decision|1|||
125276979|NCT02712983|450642111|FG005|Treatment Phase|Subject Decision|0|||
125276980|NCT02712983|450642112|FG006|Treatment Phase|Subject Decision|1|||
125276981|NCT02712983|450642113|FG007|Treatment Phase|Subject Decision|2|||
125276982|NCT02712983|450642114|FG008|Treatment Phase|Subject Decision|0|||
125401810|NCT03551210|451098939|FG000|Overall Study|Withdrawal by Subject|1|||
125401811|NCT03551210|451098940|FG001|Overall Study|Withdrawal by Subject|7|||
125401812|NCT03551210|451098939|FG000|Overall Study|Needed in other antibiotic treatment|2|||
125401813|NCT03551210|451098940|FG001|Overall Study|Needed in other antibiotic treatment|5|||
125401814|NCT03551210|451098939|FG000|Overall Study|Lost to Follow-up|1|||
125401815|NCT03551210|451098940|FG001|Overall Study|Lost to Follow-up|1|||
125401816|NCT03551210|451098939|FG000|Overall Study|Absence of visit 4 and 5|1|||
125401817|NCT03551210|451098940|FG001|Overall Study|Absence of visit 4 and 5|0|||
125401818|NCT03551210|451098939|FG000|Overall Study|No drug for dispensing|0|||
125401819|NCT03551210|451098940|FG001|Overall Study|No drug for dispensing|1|||
125401820|NCT03265119|451098941|FG000|Overall Study|Adverse Event|2|||
125401821|NCT03265119|451098942|FG001|Overall Study|Adverse Event|1|||
125401822|NCT03265119|451098941|FG000|Overall Study|Lack of Efficacy|3|||
125401823|NCT03265119|451098942|FG001|Overall Study|Lack of Efficacy|0|||
125401824|NCT03265119|451098941|FG000|Overall Study|Protocol Violation|1|||
125401825|NCT03265119|451098942|FG001|Overall Study|Protocol Violation|2|||
125401826|NCT03265119|451098941|FG000|Overall Study|Withdrawal by Subject|2|||
125401827|NCT03265119|451098942|FG001|Overall Study|Withdrawal by Subject|4|||
125401828|NCT03265119|451098941|FG000|Overall Study|Lost to Follow-up|1|||
125401829|NCT03265119|451098942|FG001|Overall Study|Lost to Follow-up|0|||
125401830|NCT03265119|451098941|FG000|Overall Study|Lack of Compliance|1|||
125401831|NCT03265119|451098942|FG001|Overall Study|Lack of Compliance|0|||
125401832|NCT03238911|451098945|FG000|Overall Study|Withdrawal by Subject|1|||
125401833|NCT03238911|451098946|FG001|Overall Study|Withdrawal by Subject|2|||
125401834|NCT03238911|451098945|FG000|Overall Study|Lost to Follow-up|2|||
125401835|NCT03238911|451098946|FG001|Overall Study|Lost to Follow-up|1|||
125401836|NCT03655236|451098947|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
125401837|NCT03655236|451098948|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
125401838|NCT03655236|451098949|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
125401839|NCT03655236|451098947|FG000|Subject Disposition in Part 1 Period|Death|1|||
125401840|NCT03655236|451098948|FG001|Subject Disposition in Part 1 Period|Death|0|||
125401841|NCT03655236|451098949|FG002|Subject Disposition in Part 1 Period|Death|0|||
125401842|NCT03655236|451098947|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
125401843|NCT03655236|451098948|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
125401844|NCT03655236|451098949|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
125401845|NCT03655236|451098947|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
125401846|NCT03655236|451098948|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
125276983|NCT02712983|450642106|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125276984|NCT02712983|450642107|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
125276985|NCT02712983|450642108|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125276986|NCT02712983|450642109|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125276987|NCT02712983|450642110|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125276988|NCT02712983|450642111|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125276989|NCT02712983|450642112|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
125276990|NCT02712983|450642113|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
125276991|NCT02712983|450642114|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
125276992|NCT02712983|450642106|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125276993|NCT02712983|450642107|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125276994|NCT02712983|450642108|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125276995|NCT02712983|450642109|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
125276996|NCT02712983|450642110|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125276997|NCT02712983|450642111|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125276998|NCT02712983|450642112|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125276999|NCT02712983|450642113|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125277000|NCT02712983|450642114|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
125277001|NCT02712983|450642106|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
125277002|NCT02712983|450642107|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
125277003|NCT02712983|450642108|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
125277004|NCT02712983|450642109|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
125277005|NCT02712983|450642110|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
125277006|NCT02712983|450642111|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
125277007|NCT02712983|450642112|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
125277008|NCT02712983|450642113|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
125401847|NCT03655236|451098949|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
125401848|NCT03655236|451098947|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
125401849|NCT03655236|451098948|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
125401850|NCT03655236|451098949|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
125401851|NCT03655236|451098947|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
125401852|NCT03655236|451098948|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
125401853|NCT03655236|451098949|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
125401854|NCT03655236|451098947|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
125401855|NCT03655236|451098948|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
125401856|NCT03655236|451098949|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
125401857|NCT03655236|451098947|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
125401858|NCT03655236|451098948|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
125401859|NCT03655236|451098949|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
125401860|NCT03655236|451098947|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
125401861|NCT03655236|451098948|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
125401862|NCT03655236|451098949|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
125401863|NCT03655236|451098947|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
125401864|NCT03655236|451098948|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
125401865|NCT03655236|451098949|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
125401866|NCT03655236|451098947|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
125401867|NCT03655236|451098948|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
125401868|NCT03655236|451098949|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
125401869|NCT03655236|451098947|FG000|Subject Disposition in Part 1 Period|Other|0|||
125401870|NCT03655236|451098948|FG001|Subject Disposition in Part 1 Period|Other|2|||
125401871|NCT03655236|451098949|FG002|Subject Disposition in Part 1 Period|Other|2|||
125401872|NCT03655236|451098947|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
125401873|NCT03655236|451098948|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
125401874|NCT03655236|451098949|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
125401875|NCT03655236|451098947|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
125401876|NCT03655236|451098948|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
125401877|NCT03655236|451098949|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
125401878|NCT03655236|451098947|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
125401879|NCT03655236|451098948|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
125401880|NCT03655236|451098949|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
125401881|NCT03655236|451098947|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
125401882|NCT03655236|451098948|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
125401883|NCT03655236|451098949|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
125401884|NCT03655236|451098947|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
125401885|NCT03655236|451098948|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
125401886|NCT03655236|451098949|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
125401887|NCT03655236|451098947|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
125401888|NCT03655236|451098948|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
125401889|NCT03655236|451098949|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
125401890|NCT03655236|451098947|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
125401891|NCT03655236|451098948|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
125401892|NCT03655236|451098949|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
125401893|NCT03655236|451098947|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
125401894|NCT03655236|451098948|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
125401895|NCT03655236|451098949|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
125401896|NCT03655236|451098947|FG000|Subject Disposition in Part 2 Period|Other|1|||
125401897|NCT03655236|451098948|FG001|Subject Disposition in Part 2 Period|Other|0|||
125401898|NCT03655236|451098949|FG002|Subject Disposition in Part 2 Period|Other|0|||
125401899|NCT03085927|451100647|FG000|Overall Study|Withdrawal by Subject|1|||
125401900|NCT03085927|451100648|FG001|Overall Study|Withdrawal by Subject|4|||
125401901|NCT03085927|451100647|FG000|Overall Study|Lost to Follow-up|3|||
125401902|NCT03085927|451100648|FG001|Overall Study|Lost to Follow-up|1|||
125401903|NCT03085927|451100647|FG000|Overall Study|Death|1|||
125401904|NCT03085927|451100648|FG001|Overall Study|Death|0|||
125401905|NCT03085927|451100647|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
125401906|NCT03085927|451100648|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
125401907|NCT03085927|451100647|FG000|Overall Study|Dyad Became Ineligible|0|||
125401908|NCT03085927|451100648|FG001|Overall Study|Dyad Became Ineligible|1|||
125401909|NCT02349711|451100650|FG000|Overall Study|Withdrawal by Subject|2|||
125401910|NCT02349711|451100651|FG001|Overall Study|Withdrawal by Subject|1|||
125401911|NCT02349711|451100650|FG000|Overall Study|Lost to Follow-up|1|||
125401912|NCT02349711|451100651|FG001|Overall Study|Lost to Follow-up|1|||
125401913|NCT00194012|451100652|FG000|Randomized Phase|Lack of Efficacy|8|||
125401914|NCT00194012|451100653|FG001|Randomized Phase|Lack of Efficacy|18|||
125401915|NCT00194012|451100652|FG000|Randomized Phase|Study nonadherence|2|||
125401916|NCT00194012|451100653|FG001|Randomized Phase|Study nonadherence|1|||
125401917|NCT00194012|451100652|FG000|Randomized Phase|Withdrawal by Subject|3|||
125401918|NCT00194012|451100653|FG001|Randomized Phase|Withdrawal by Subject|3|||
125401919|NCT00194012|451100652|FG000|Randomized Phase|Adverse Event|2|||
125401920|NCT00194012|451100653|FG001|Randomized Phase|Adverse Event|1|||
125401921|NCT00194012|451100652|FG000|Randomized Phase|Participant reported having a rash|1|||
125401922|NCT00194012|451100653|FG001|Randomized Phase|Participant reported having a rash|0|||
125401923|NCT00194012|451100652|FG000|Randomized Phase|Emesis and enuresis|0|||
125401924|NCT00194012|451100653|FG001|Randomized Phase|Emesis and enuresis|1|||
125401925|NCT00194012|451100652|FG000|Randomized Phase|Oral/nasal twitching|0|||
125401926|NCT00194012|451100653|FG001|Randomized Phase|Oral/nasal twitching|1|||
125401927|NCT00194012|451100652|FG000|Open Label Extension (OLE)|Weight Gain|1|||
125401928|NCT00194012|451100653|FG001|Open Label Extension (OLE)|Weight Gain|0|||
125401929|NCT00194012|451100652|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
125401930|NCT00194012|451100653|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
125401931|NCT00194012|451100652|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
125401932|NCT00194012|451100653|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
125401933|NCT00194012|451100652|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
125401934|NCT00194012|451100653|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
125401935|NCT02564198|451100659|FG000|Overall Study|Withdrawal by Subject|2|||
125401936|NCT02564198|451100660|FG001|Overall Study|Withdrawal by Subject|4|||
125401937|NCT02564198|451100661|FG002|Overall Study|Withdrawal by Subject|0|||
125401938|NCT02564198|451100659|FG000|Overall Study|Adverse Event|0|||
125401939|NCT02564198|451100660|FG001|Overall Study|Adverse Event|1|||
125401940|NCT02564198|451100661|FG002|Overall Study|Adverse Event|0|||
125401941|NCT02200042|451100662|FG000|Overall Study|Withdrawal by Subject|0|||
125401942|NCT02200042|451100663|FG001|Overall Study|Withdrawal by Subject|1|||
125401943|NCT02097134|451100664|FG000|Overall Study|Physician Decision|4|||
125401944|NCT02097134|451100664|FG000|Overall Study|Non-Protocol Therapy|1|||
125401945|NCT02097134|451100664|FG000|Overall Study|Progressive Disease|3|||
125401946|NCT02097134|451100664|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
125401947|NCT01440322|451100669|FG000|Overall Study|Discomfort|2|||
125401948|NCT01440322|451100670|FG001|Overall Study|Discomfort|0|||
125401949|NCT01440322|451100669|FG000|Overall Study|Biomicroscopy|1|||
125401950|NCT01440322|451100670|FG001|Overall Study|Biomicroscopy|0|||
125401951|NCT01440322|451100669|FG000|Overall Study|Symptoms and Problems|1|||
125401952|NCT01440322|451100670|FG001|Overall Study|Symptoms and Problems|0|||
125401953|NCT01440322|451100669|FG000|Overall Study|Unacceptable Subjective Vision|1|||
125401954|NCT01440322|451100670|FG001|Overall Study|Unacceptable Subjective Vision|0|||
125401955|NCT01440322|451100669|FG000|Overall Study|Other Product Related|1|||
125401956|NCT01440322|451100670|FG001|Overall Study|Other Product Related|0|||
125401957|NCT01440322|451100669|FG000|Overall Study|Unrelated Medical Problem|0|||
125401958|NCT01440322|451100670|FG001|Overall Study|Unrelated Medical Problem|1|||
125401959|NCT01440322|451100669|FG000|Overall Study|Other Non-Product Related|1|||
125401960|NCT01440322|451100670|FG001|Overall Study|Other Non-Product Related|0|||
125401961|NCT03394391|451100672|FG000|Overall Study|Lost to Follow-up|1|||
125401962|NCT03394391|451100673|FG001|Overall Study|Lost to Follow-up|2|||
125401963|NCT05044234|451100674|FG000|Overall Study|Lost to Follow-up|2|||
125401964|NCT05044234|451100675|FG001|Overall Study|Lost to Follow-up|1|||
125401965|NCT05044234|451100676|FG002|Overall Study|Lost to Follow-up|1|||
125401966|NCT05044234|451100677|FG003|Overall Study|Lost to Follow-up|2|||
125401967|NCT05044234|451100674|FG000|Overall Study|Withdrawal by Subject|6|||
125401968|NCT05044234|451100675|FG001|Overall Study|Withdrawal by Subject|4|||
125401969|NCT05044234|451100676|FG002|Overall Study|Withdrawal by Subject|5|||
125401970|NCT05044234|451100677|FG003|Overall Study|Withdrawal by Subject|8|||
125401971|NCT05044234|451100674|FG000|Overall Study|Study terminated by Sponsor|21|||
125401972|NCT05044234|451100675|FG001|Overall Study|Study terminated by Sponsor|21|||
125401973|NCT05044234|451100676|FG002|Overall Study|Study terminated by Sponsor|20|||
125401974|NCT05044234|451100677|FG003|Overall Study|Study terminated by Sponsor|14|||
125401975|NCT05044234|451100674|FG000|Overall Study|Other, not specified|0|||
125401976|NCT05044234|451100675|FG001|Overall Study|Other, not specified|0|||
125401977|NCT05044234|451100676|FG002|Overall Study|Other, not specified|1|||
125401978|NCT05044234|451100677|FG003|Overall Study|Other, not specified|2|||
125401979|NCT05044234|451100674|FG000|Overall Study|Delayed data entry|0|||
125401980|NCT05044234|451100675|FG001|Overall Study|Delayed data entry|0|||
125401981|NCT05044234|451100676|FG002|Overall Study|Delayed data entry|0|||
125401982|NCT05044234|451100677|FG003|Overall Study|Delayed data entry|1|||
125401983|NCT02896127|451100678|FG000|COMPLETED WEEK 52|Adverse Event|9|||
125401984|NCT02896127|451100679|FG001|COMPLETED WEEK 52|Adverse Event|2|||
125401985|NCT02896127|451100678|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
125401986|NCT02896127|451100679|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
125401987|NCT02896127|451100678|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
125401988|NCT02896127|451100679|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
125401989|NCT02896127|451100678|FG000|COMPLETED WEEK 52|Physician Decision|1|||
125401990|NCT02896127|451100679|FG001|COMPLETED WEEK 52|Physician Decision|1|||
125401991|NCT02896127|451100678|FG000|COMPLETED WEEK 52|Pregnancy|2|||
125401992|NCT02896127|451100679|FG001|COMPLETED WEEK 52|Pregnancy|0|||
125401993|NCT02896127|451100678|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
125401994|NCT02896127|451100679|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
125401995|NCT02896127|451100678|FG000|COMPLETED WEEK 52|Technical problems|1|||
125401996|NCT02896127|451100679|FG001|COMPLETED WEEK 52|Technical problems|0|||
125401997|NCT02896127|451100678|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
125401998|NCT02896127|451100679|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
125401999|NCT02896127|451100678|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
125402000|NCT02896127|451100679|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
125402001|NCT02896127|451100678|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
125402002|NCT02896127|451100679|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
125402003|NCT02896127|451100678|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
125402004|NCT02896127|451100679|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
125402005|NCT02896127|451100678|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
125277009|NCT02712983|450642114|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
125277010|NCT05360966|450642115|FG000|Overall Study|Adverse Event|5|||
125277011|NCT05360966|450642116|FG001|Overall Study|Adverse Event|5|||
125277012|NCT05360966|450642115|FG000|Overall Study|Withdrawal of Consent|5|||
125277013|NCT05360966|450642116|FG001|Overall Study|Withdrawal of Consent|3|||
125277014|NCT05360966|450642115|FG000|Overall Study|Noncompliance|2|||
125277015|NCT05360966|450642116|FG001|Overall Study|Noncompliance|1|||
125277016|NCT05360966|450642115|FG000|Overall Study|Lost to Follow-up|2|||
125277017|NCT05360966|450642116|FG001|Overall Study|Lost to Follow-up|3|||
125277018|NCT05360966|450642115|FG000|Overall Study|Protocol Deviation|2|||
125277019|NCT05360966|450642116|FG001|Overall Study|Protocol Deviation|1|||
125277020|NCT05360966|450642115|FG000|Overall Study|As specified in the Clinical Study Report|1|||
125277021|NCT05360966|450642116|FG001|Overall Study|As specified in the Clinical Study Report|3|||
125277022|NCT03522246|450642117|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
125277023|NCT03522246|450642118|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
125277024|NCT03522246|450642119|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
125277025|NCT03522246|450642120|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
125277026|NCT03522246|450642121|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
125277027|NCT04683029|450642122|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
125277028|NCT04683029|450642123|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
125277029|NCT04683029|450642124|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
125277030|NCT04683029|450642125|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
125277031|NCT04683029|450642122|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
125277032|NCT04683029|450642123|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
125277033|NCT04683029|450642124|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
125277034|NCT04683029|450642125|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
125277035|NCT04683029|450642122|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
125277036|NCT04683029|450642123|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
125277037|NCT04683029|450642124|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
125277038|NCT04683029|450642125|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
125277039|NCT04493424|450642126|FG000|Overall Study|Termination of the trial by the sponsor|89|||
125277040|NCT04493424|450642126|FG000|Overall Study|Withdrawal by Subject|9|||
125277041|NCT04493424|450642126|FG000|Overall Study|Lost to Follow-up|2|||
125277042|NCT04493424|450642126|FG000|Overall Study|Lack of Efficacy|3|||
125277043|NCT04493424|450642126|FG000|Overall Study|Adverse Event|5|||
125277044|NCT00814580|450642127|FG000|Overall Study|Adverse Event|6|||
125277045|NCT00814580|450642128|FG001|Overall Study|Adverse Event|15|||
125277046|NCT00814580|450642127|FG000|Overall Study|Lack of Efficacy|18|||
125277047|NCT00814580|450642128|FG001|Overall Study|Lack of Efficacy|25|||
125277048|NCT00814580|450642127|FG000|Overall Study|Protocol Violation|2|||
125277049|NCT00814580|450642128|FG001|Overall Study|Protocol Violation|0|||
125277050|NCT00814580|450642127|FG000|Overall Study|Withdrawal by Subject|2|||
125277051|NCT00814580|450642128|FG001|Overall Study|Withdrawal by Subject|2|||
125277052|NCT00814580|450642127|FG000|Overall Study|Other|1|||
125277053|NCT00814580|450642128|FG001|Overall Study|Other|3|||
125277054|NCT00814580|450642127|FG000|Overall Study|Did Not Take Drug|2|||
125277055|NCT00814580|450642128|FG001|Overall Study|Did Not Take Drug|2|||
125277056|NCT02482428|450642129|FG000|Overall Study|Lost to Follow-up|4|||
125277057|NCT02482428|450642130|FG001|Overall Study|Lost to Follow-up|9|||
125277058|NCT02482428|450642131|FG002|Overall Study|Lost to Follow-up|1|||
125277059|NCT02482428|450642132|FG003|Overall Study|Lost to Follow-up|2|||
125277060|NCT02482428|450642133|FG004|Overall Study|Lost to Follow-up|4|||
125277061|NCT02482428|450642129|FG000|Overall Study|Physician Decision|0|||
125402006|NCT02896127|451100679|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
125402007|NCT01434823|451100682|FG000|Overall Study|Incomplete data in medical record|4|||
125277062|NCT02482428|450642130|FG001|Overall Study|Physician Decision|0|||
125277063|NCT02482428|450642131|FG002|Overall Study|Physician Decision|0|||
125277064|NCT02482428|450642132|FG003|Overall Study|Physician Decision|0|||
125277065|NCT02482428|450642133|FG004|Overall Study|Physician Decision|1|||
125277066|NCT02482428|450642129|FG000|Overall Study|protocol deviation|1|||
125277067|NCT02482428|450642130|FG001|Overall Study|protocol deviation|1|||
125277068|NCT02482428|450642131|FG002|Overall Study|protocol deviation|0|||
125277069|NCT02482428|450642132|FG003|Overall Study|protocol deviation|0|||
125402008|NCT01434823|451100683|FG001|Overall Study|Incomplete data in medical record|7|||
125402009|NCT00519649|451100684|FG000|Overall Study|Withdrawal by Subject|1|||
125402010|NCT04879745|451100685|FG000|Overall Study|Lost to Follow-up|4|||
125402011|NCT04879745|451100686|FG001|Overall Study|Lost to Follow-up|1|||
125402012|NCT00120042|451100687|FG000|Overall Study|all completed protocl|0|||
125402013|NCT00120042|451100688|FG001|Overall Study|all completed protocl|0|||
125402014|NCT00120042|451100689|FG002|Overall Study|all completed protocl|0|||
125402015|NCT01263873|451100692|FG000|Overall Study|One provider unable to complete numbers|1|||
125402016|NCT01263873|451100693|FG001|Overall Study|One provider unable to complete numbers|1|||
125402017|NCT01859715|451100694|FG000|Overall Study|No 2nd VAS|16|||
125402018|NCT01859715|451100695|FG001|Overall Study|No 2nd VAS|8|||
125402019|NCT01859715|451100696|FG002|Overall Study|No 2nd VAS|23|||
125402020|NCT01252290|451100697|FG000|Overall Study|Withdrawal by Subject|1|||
125402021|NCT00086580|451100698|FG000|Treatment Period|Disease progression|9|||
125402022|NCT00086580|451100699|FG001|Treatment Period|Disease progression|8|||
125402023|NCT00086580|451100698|FG000|Treatment Period|Unable to comply with protocol|3|||
125402024|NCT00086580|451100699|FG001|Treatment Period|Unable to comply with protocol|1|||
125402025|NCT00086580|451100698|FG000|Treatment Period|Withdrawal by Subject|7|||
125402026|NCT00086580|451100699|FG001|Treatment Period|Withdrawal by Subject|8|||
125402027|NCT00086580|451100698|FG000|Treatment Period|Physician Decision|13|||
125402028|NCT00086580|451100699|FG001|Treatment Period|Physician Decision|7|||
125402029|NCT00086580|451100698|FG000|Treatment Period|AE - not treatment related|7|||
125402030|NCT00086580|451100699|FG001|Treatment Period|AE - not treatment related|7|||
125402031|NCT00086580|451100698|FG000|Treatment Period|Toxicity - treatment related|15|||
125402032|NCT00086580|451100699|FG001|Treatment Period|Toxicity - treatment related|15|||
125402033|NCT00086580|451100698|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
125402034|NCT00086580|451100699|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
125402035|NCT00086580|451100698|FG000|Treatment Period|Death|5|||
125402036|NCT00086580|451100699|FG001|Treatment Period|Death|7|||
125402037|NCT00086580|451100698|FG000|Treatment Period|Other|5|||
125402038|NCT00086580|451100699|FG001|Treatment Period|Other|3|||
125402039|NCT00086580|451100698|FG000|Follow-up Period|Disease progression|72|||
125402040|NCT00086580|451100699|FG001|Follow-up Period|Disease progression|99|||
125402041|NCT00086580|451100698|FG000|Follow-up Period|Unable to comply with protocol|5|||
125402042|NCT00086580|451100699|FG001|Follow-up Period|Unable to comply with protocol|0|||
125402043|NCT00086580|451100698|FG000|Follow-up Period|Withdrawal by Subject|6|||
125402044|NCT00086580|451100699|FG001|Follow-up Period|Withdrawal by Subject|6|||
125402045|NCT00086580|451100698|FG000|Follow-up Period|Physician Decision|0|||
125402046|NCT00086580|451100699|FG001|Follow-up Period|Physician Decision|1|||
125402047|NCT00086580|451100698|FG000|Follow-up Period|AE - not related|1|||
125402048|NCT00086580|451100699|FG001|Follow-up Period|AE - not related|0|||
125402049|NCT00086580|451100698|FG000|Follow-up Period|Death|13|||
125402050|NCT00086580|451100699|FG001|Follow-up Period|Death|7|||
125402051|NCT00086580|451100698|FG000|Follow-up Period|Other|7|||
125402052|NCT00086580|451100699|FG001|Follow-up Period|Other|6|||
125402053|NCT00086580|451100698|FG000|Observation Period|Unable to comply with protocol|1|||
125402054|NCT00086580|451100699|FG001|Observation Period|Unable to comply with protocol|1|||
125402055|NCT00086580|451100698|FG000|Observation Period|Withdrawal by Subject|4|||
125402056|NCT00086580|451100699|FG001|Observation Period|Withdrawal by Subject|2|||
125402057|NCT00086580|451100698|FG000|Observation Period|Death|33|||
125402058|NCT00086580|451100699|FG001|Observation Period|Death|55|||
125402059|NCT00086580|451100698|FG000|Observation Period|Other|8|||
125402060|NCT00086580|451100699|FG001|Observation Period|Other|7|||
125402061|NCT00079274|451100700|FG000|Overall Study|Withdrawal by Subject|111|||
125402062|NCT00079274|451100701|FG001|Overall Study|Withdrawal by Subject|10|||
125402063|NCT00079274|451100702|FG002|Overall Study|Withdrawal by Subject|12|||
125402064|NCT00079274|451100703|FG003|Overall Study|Withdrawal by Subject|163|||
125402065|NCT00079274|451100704|FG004|Overall Study|Withdrawal by Subject|7|||
125402066|NCT00079274|451100705|FG005|Overall Study|Withdrawal by Subject|8|||
125402067|NCT00079274|451100706|FG006|Overall Study|Withdrawal by Subject|0|||
125402068|NCT00079274|451100700|FG000|Overall Study|Adverse Event|130|||
125402069|NCT00079274|451100701|FG001|Overall Study|Adverse Event|8|||
125402070|NCT00079274|451100702|FG002|Overall Study|Adverse Event|8|||
125402071|NCT00079274|451100703|FG003|Overall Study|Adverse Event|184|||
125402072|NCT00079274|451100704|FG004|Overall Study|Adverse Event|7|||
125402073|NCT00079274|451100705|FG005|Overall Study|Adverse Event|8|||
125402074|NCT00079274|451100706|FG006|Overall Study|Adverse Event|0|||
125402075|NCT00079274|451100700|FG000|Overall Study|Recurrence|21|||
125402076|NCT00079274|451100701|FG001|Overall Study|Recurrence|0|||
125402077|NCT00079274|451100702|FG002|Overall Study|Recurrence|1|||
125402078|NCT00079274|451100703|FG003|Overall Study|Recurrence|15|||
125402079|NCT00079274|451100704|FG004|Overall Study|Recurrence|0|||
125402080|NCT00079274|451100705|FG005|Overall Study|Recurrence|2|||
125402081|NCT00079274|451100706|FG006|Overall Study|Recurrence|0|||
125402082|NCT00079274|451100700|FG000|Overall Study|Alternate Treatment|6|||
125402083|NCT00079274|451100701|FG001|Overall Study|Alternate Treatment|1|||
125402084|NCT00079274|451100702|FG002|Overall Study|Alternate Treatment|0|||
125402085|NCT00079274|451100703|FG003|Overall Study|Alternate Treatment|3|||
125402086|NCT00079274|451100704|FG004|Overall Study|Alternate Treatment|0|||
125402087|NCT00079274|451100705|FG005|Overall Study|Alternate Treatment|0|||
125402088|NCT00079274|451100706|FG006|Overall Study|Alternate Treatment|0|||
125402089|NCT00079274|451100700|FG000|Overall Study|Other Medical Problems|6|||
125402090|NCT00079274|451100701|FG001|Overall Study|Other Medical Problems|1|||
125402091|NCT00079274|451100702|FG002|Overall Study|Other Medical Problems|0|||
125402092|NCT00079274|451100703|FG003|Overall Study|Other Medical Problems|7|||
125402093|NCT00079274|451100704|FG004|Overall Study|Other Medical Problems|0|||
125402094|NCT00079274|451100705|FG005|Overall Study|Other Medical Problems|0|||
125402095|NCT00079274|451100706|FG006|Overall Study|Other Medical Problems|0|||
125402096|NCT00079274|451100700|FG000|Overall Study|Death|4|||
125402097|NCT00079274|451100701|FG001|Overall Study|Death|0|||
125402098|NCT00079274|451100702|FG002|Overall Study|Death|1|||
125402099|NCT00079274|451100703|FG003|Overall Study|Death|15|||
125402100|NCT00079274|451100704|FG004|Overall Study|Death|0|||
125402101|NCT00079274|451100705|FG005|Overall Study|Death|0|||
125402102|NCT00079274|451100706|FG006|Overall Study|Death|0|||
125402103|NCT00079274|451100700|FG000|Overall Study|Cytogenetic resistance|0|||
125402104|NCT00079274|451100701|FG001|Overall Study|Cytogenetic resistance|0|||
125277070|NCT02482428|450642133|FG004|Overall Study|protocol deviation|0|||
125277071|NCT02482428|450642129|FG000|Overall Study|subject/guardian decision|4|||
125277072|NCT02482428|450642130|FG001|Overall Study|subject/guardian decision|2|||
125277073|NCT02482428|450642131|FG002|Overall Study|subject/guardian decision|0|||
125277074|NCT02482428|450642132|FG003|Overall Study|subject/guardian decision|0|||
125277075|NCT02482428|450642133|FG004|Overall Study|subject/guardian decision|2|||
125277076|NCT05924165|450642137|FG000|Overall Study|Physician Decision|2|||
125277077|NCT05924165|450642138|FG001|Overall Study|Physician Decision|3|||
125277078|NCT04075292|450642139|FG000|Overall Study|Withdrawal by Subject|1|||
125277079|NCT04075292|450642140|FG001|Overall Study|Withdrawal by Subject|9|||
125277080|NCT04075292|450642139|FG000|Overall Study|Death|2|||
125277081|NCT04075292|450642140|FG001|Overall Study|Death|5|||
125277082|NCT04075292|450642139|FG000|Overall Study|Remained on study at time of DCO|74|||
125277083|NCT04075292|450642140|FG001|Overall Study|Remained on study at time of DCO|64|||
125277084|NCT04308239|450642141|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
125277085|NCT04308239|450642142|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
125277086|NCT04308239|450642141|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
125277087|NCT04308239|450642142|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
125277088|NCT04308239|450642141|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
125277089|NCT04308239|450642142|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
125277090|NCT04308239|450642141|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
125277091|NCT04308239|450642142|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
125277092|NCT00459875|450642145|FG000|Overall Study|Ineligible participant|1|||
125277093|NCT00459875|450642145|FG000|Overall Study|Adverse Event|2|||
125277094|NCT01436656|450642150|FG000|Dose Escalation|Death|1|||
125277095|NCT01436656|450642151|FG001|Dose Escalation|Death|3|||
125277096|NCT01436656|450642152|FG002|Dose Escalation|Death|1|||
125277097|NCT01436656|450642153|FG003|Dose Escalation|Death|0|||
125277098|NCT01436656|450642154|FG004|Dose Escalation|Death|2|||
125277099|NCT01436656|450642155|FG005|Dose Escalation|Death|1|||
125277100|NCT01436656|450642156|FG006|Dose Escalation|Death|1|||
125277101|NCT01436656|450642157|FG007|Dose Escalation|Death|1|||
125277102|NCT01436656|450642158|FG008|Dose Escalation|Death|1|||
125277103|NCT01436656|450642159|FG009|Dose Escalation|Death|0|||
125277104|NCT01436656|450642160|FG010|Dose Escalation|Death|0|||
125277105|NCT01436656|450642161|FG011|Dose Escalation|Death|0|||
125277106|NCT01436656|450642162|FG012|Dose Escalation|Death|0|||
125277107|NCT01436656|450642163|FG013|Dose Escalation|Death|0|||
125277108|NCT01436656|450642164|FG014|Dose Escalation|Death|0|||
125402105|NCT00079274|451100702|FG002|Overall Study|Cytogenetic resistance|0|||
125402106|NCT00079274|451100703|FG003|Overall Study|Cytogenetic resistance|2|||
125402107|NCT00079274|451100704|FG004|Overall Study|Cytogenetic resistance|0|||
125402108|NCT00079274|451100705|FG005|Overall Study|Cytogenetic resistance|0|||
125277109|NCT01436656|450642165|FG015|Dose Escalation|Death|0|||
125277110|NCT01436656|450642166|FG016|Dose Escalation|Death|0|||
125277111|NCT01436656|450642167|FG017|Dose Escalation|Death|0|||
125277112|NCT01436656|450642150|FG000|Dose Escalation|Protocol Violation|0|||
125277113|NCT01436656|450642151|FG001|Dose Escalation|Protocol Violation|0|||
125277114|NCT01436656|450642152|FG002|Dose Escalation|Protocol Violation|0|||
125277115|NCT01436656|450642153|FG003|Dose Escalation|Protocol Violation|0|||
125277116|NCT01436656|450642154|FG004|Dose Escalation|Protocol Violation|0|||
125277117|NCT01436656|450642155|FG005|Dose Escalation|Protocol Violation|1|||
125402109|NCT00079274|451100706|FG006|Overall Study|Cytogenetic resistance|0|||
125402110|NCT00079274|451100700|FG000|Overall Study|Other|43|||
125402111|NCT00079274|451100701|FG001|Overall Study|Other|7|||
125402112|NCT00079274|451100702|FG002|Overall Study|Other|5|||
125402113|NCT00079274|451100703|FG003|Overall Study|Other|55|||
125402114|NCT00079274|451100704|FG004|Overall Study|Other|1|||
125402115|NCT00079274|451100705|FG005|Overall Study|Other|2|||
125402116|NCT00079274|451100706|FG006|Overall Study|Other|0|||
125402117|NCT00617240|451100707|FG000|Overall Study|Lack of Efficacy|1|||
125402118|NCT00617240|451100708|FG001|Overall Study|Lack of Efficacy|0|||
125402119|NCT01611259|451100709|FG000|Overall Study|Physician Decision|1|||
125402120|NCT01611259|451100709|FG000|Overall Study|Lack of Efficacy|2|||
125402121|NCT01611259|451100709|FG000|Overall Study|Adverse Event|4|||
125402122|NCT01611259|451100709|FG000|Overall Study|Withdrawal by Subject|7|||
125402123|NCT04936685|451100710|FG000|Overall Study|Protocol Violation|1|||
125402124|NCT04936685|451100711|FG001|Overall Study|Protocol Violation|0|||
125402125|NCT03969212|451100714|FG000|Overall Study|Adverse Event|1|||
125402126|NCT03969212|451100715|FG001|Overall Study|Adverse Event|0|||
125402127|NCT03969212|451100716|FG002|Overall Study|Adverse Event|0|||
125402128|NCT03969212|451100717|FG003|Overall Study|Adverse Event|0|||
125402129|NCT03969212|451100714|FG000|Overall Study|Lost to Follow-up|2|||
125402130|NCT03969212|451100715|FG001|Overall Study|Lost to Follow-up|2|||
125402131|NCT03969212|451100716|FG002|Overall Study|Lost to Follow-up|2|||
125402132|NCT03969212|451100717|FG003|Overall Study|Lost to Follow-up|2|||
125402133|NCT03969212|451100714|FG000|Overall Study|Protocol Violation|0|||
125402134|NCT03969212|451100715|FG001|Overall Study|Protocol Violation|0|||
125402135|NCT03969212|451100716|FG002|Overall Study|Protocol Violation|0|||
125402136|NCT03969212|451100717|FG003|Overall Study|Protocol Violation|1|||
125402137|NCT03969212|451100714|FG000|Overall Study|Withdrawal by Subject|7|||
125402138|NCT03969212|451100715|FG001|Overall Study|Withdrawal by Subject|13|||
125402139|NCT03969212|451100716|FG002|Overall Study|Withdrawal by Subject|5|||
125402140|NCT03969212|451100717|FG003|Overall Study|Withdrawal by Subject|11|||
125402141|NCT03969212|451100714|FG000|Overall Study|Physician Decision|0|||
125402142|NCT03969212|451100715|FG001|Overall Study|Physician Decision|0|||
125402143|NCT03969212|451100716|FG002|Overall Study|Physician Decision|1|||
125402144|NCT03969212|451100717|FG003|Overall Study|Physician Decision|0|||
125402145|NCT03969212|451100714|FG000|Overall Study|Reason not Specified|22|||
125402146|NCT03969212|451100715|FG001|Overall Study|Reason not Specified|23|||
125402147|NCT03969212|451100716|FG002|Overall Study|Reason not Specified|28|||
125402148|NCT03969212|451100717|FG003|Overall Study|Reason not Specified|26|||
125402149|NCT03773757|451100718|FG000|Overall Study|Withdrawal by Subject|2|||
125402150|NCT03773757|451100719|FG001|Overall Study|Withdrawal by Subject|4|||
125402151|NCT01109316|451100720|FG000|Study Period 1|Adverse Event|0|||
125402152|NCT01109316|451100721|FG001|Study Period 1|Adverse Event|0|||
125402153|NCT01109316|451100722|FG002|Study Period 1|Adverse Event|1|||
125402154|NCT01109316|451100723|FG003|Study Period 1|Adverse Event|0|||
125402155|NCT01109316|451100724|FG004|Study Period 1|Adverse Event|0|||
125402156|NCT01109316|451100725|FG005|Study Period 1|Adverse Event|0|||
125402157|NCT01109316|451100720|FG000|Study Period 1|Lost to Follow-up|0|||
125402158|NCT01109316|451100721|FG001|Study Period 1|Lost to Follow-up|0|||
125402159|NCT01109316|451100722|FG002|Study Period 1|Lost to Follow-up|1|||
125402160|NCT01109316|451100723|FG003|Study Period 1|Lost to Follow-up|1|||
125402161|NCT01109316|451100724|FG004|Study Period 1|Lost to Follow-up|0|||
125402162|NCT01109316|451100725|FG005|Study Period 1|Lost to Follow-up|0|||
125402163|NCT01109316|451100720|FG000|Study Period 1|Withdrawal by Subject|0|||
125402164|NCT01109316|451100721|FG001|Study Period 1|Withdrawal by Subject|0|||
125402165|NCT01109316|451100722|FG002|Study Period 1|Withdrawal by Subject|1|||
125402166|NCT01109316|451100723|FG003|Study Period 1|Withdrawal by Subject|0|||
125402167|NCT01109316|451100724|FG004|Study Period 1|Withdrawal by Subject|2|||
125402168|NCT01109316|451100725|FG005|Study Period 1|Withdrawal by Subject|0|||
125402169|NCT01109316|451100720|FG000|Study Period 1|Sponsor Decision|0|||
125402170|NCT01109316|451100721|FG001|Study Period 1|Sponsor Decision|0|||
125402171|NCT01109316|451100722|FG002|Study Period 1|Sponsor Decision|0|||
125402172|NCT01109316|451100723|FG003|Study Period 1|Sponsor Decision|0|||
125402173|NCT01109316|451100724|FG004|Study Period 1|Sponsor Decision|0|||
125402174|NCT01109316|451100725|FG005|Study Period 1|Sponsor Decision|2|||
125402175|NCT01109316|451100720|FG000|Study Period 2|Entry Criteria Not Met|0|||
125402176|NCT01109316|451100721|FG001|Study Period 2|Entry Criteria Not Met|1|||
125402177|NCT01109316|451100722|FG002|Study Period 2|Entry Criteria Not Met|0|||
125402178|NCT01109316|451100723|FG003|Study Period 2|Entry Criteria Not Met|0|||
125402179|NCT01109316|451100724|FG004|Study Period 2|Entry Criteria Not Met|0|||
125447902|NCT02478359|451266862|FG000|Overall Study|Disenrolled from health plan|106|||
125402180|NCT01109316|451100725|FG005|Study Period 2|Entry Criteria Not Met|0|||
125402181|NCT01109316|451100720|FG000|Study Period 2|Physician Decision|0|||
125402182|NCT01109316|451100721|FG001|Study Period 2|Physician Decision|0|||
125447903|NCT02478359|451266863|FG001|Overall Study|Disenrolled from health plan|65|||
125402183|NCT01109316|451100722|FG002|Study Period 2|Physician Decision|0|||
125402184|NCT01109316|451100723|FG003|Study Period 2|Physician Decision|1|||
125277118|NCT01436656|450642156|FG006|Dose Escalation|Protocol Violation|0|||
125402185|NCT01109316|451100724|FG004|Study Period 2|Physician Decision|0|||
125402186|NCT01109316|451100725|FG005|Study Period 2|Physician Decision|0|||
125402187|NCT01109316|451100720|FG000|Study Period 2|Protocol Violation|1|||
125402188|NCT01109316|451100721|FG001|Study Period 2|Protocol Violation|0|||
125402189|NCT01109316|451100722|FG002|Study Period 2|Protocol Violation|0|||
125402190|NCT01109316|451100723|FG003|Study Period 2|Protocol Violation|0|||
125402191|NCT01109316|451100724|FG004|Study Period 2|Protocol Violation|0|||
125402192|NCT01109316|451100725|FG005|Study Period 2|Protocol Violation|0|||
125402193|NCT01109316|451100720|FG000|Study Period 2|Withdrawal by Subject|0|||
125402194|NCT01109316|451100721|FG001|Study Period 2|Withdrawal by Subject|0|||
125402195|NCT01109316|451100722|FG002|Study Period 2|Withdrawal by Subject|1|||
125402196|NCT01109316|451100723|FG003|Study Period 2|Withdrawal by Subject|0|||
125402197|NCT01109316|451100724|FG004|Study Period 2|Withdrawal by Subject|0|||
125402198|NCT01109316|451100725|FG005|Study Period 2|Withdrawal by Subject|1|||
125402199|NCT01109316|451100720|FG000|Study Period 3|Lost to Follow-up|0|||
125402200|NCT01109316|451100721|FG001|Study Period 3|Lost to Follow-up|0|||
125402201|NCT01109316|451100722|FG002|Study Period 3|Lost to Follow-up|0|||
125402202|NCT01109316|451100723|FG003|Study Period 3|Lost to Follow-up|0|||
125402203|NCT01109316|451100724|FG004|Study Period 3|Lost to Follow-up|1|||
125402204|NCT01109316|451100725|FG005|Study Period 3|Lost to Follow-up|0|||
125402205|NCT01109316|451100720|FG000|Study Period 3|Withdrawal by Subject|1|||
125402206|NCT01109316|451100721|FG001|Study Period 3|Withdrawal by Subject|0|||
125402207|NCT01109316|451100722|FG002|Study Period 3|Withdrawal by Subject|0|||
125402208|NCT01109316|451100723|FG003|Study Period 3|Withdrawal by Subject|0|||
125402209|NCT01109316|451100724|FG004|Study Period 3|Withdrawal by Subject|1|||
125402210|NCT01109316|451100725|FG005|Study Period 3|Withdrawal by Subject|0|||
125402211|NCT01302392|451100728|FG000|Overall Study|Lost to Follow-up|1|||
125402212|NCT01302392|451100729|FG001|Overall Study|Lost to Follow-up|0|||
125402213|NCT01302392|451100728|FG000|Overall Study|Withdrawal by Subject|6|||
125402214|NCT01302392|451100729|FG001|Overall Study|Withdrawal by Subject|1|||
125402215|NCT00670228|451100730|FG000|Overall Study|Adverse Event|1|||
125402216|NCT00670228|451100731|FG001|Overall Study|Adverse Event|0|||
125402217|NCT00670228|451100730|FG000|Overall Study|Death or MACE|0|||
125402218|NCT00670228|451100731|FG001|Overall Study|Death or MACE|1|||
125402219|NCT00670228|451100730|FG000|Overall Study|Not treated|2|||
125402220|NCT00670228|451100731|FG001|Overall Study|Not treated|2|||
125402221|NCT00670228|451100730|FG000|Overall Study|Not meeting the selection criteria|2|||
125277119|NCT01436656|450642157|FG007|Dose Escalation|Protocol Violation|0|||
125277120|NCT01436656|450642158|FG008|Dose Escalation|Protocol Violation|0|||
125277121|NCT01436656|450642159|FG009|Dose Escalation|Protocol Violation|0|||
125277122|NCT01436656|450642160|FG010|Dose Escalation|Protocol Violation|0|||
125277123|NCT01436656|450642161|FG011|Dose Escalation|Protocol Violation|0|||
125277124|NCT01436656|450642162|FG012|Dose Escalation|Protocol Violation|0|||
125277125|NCT01436656|450642163|FG013|Dose Escalation|Protocol Violation|0|||
125277126|NCT01436656|450642164|FG014|Dose Escalation|Protocol Violation|0|||
125277127|NCT01436656|450642165|FG015|Dose Escalation|Protocol Violation|0|||
125277128|NCT01436656|450642166|FG016|Dose Escalation|Protocol Violation|0|||
125277129|NCT01436656|450642167|FG017|Dose Escalation|Protocol Violation|0|||
125277130|NCT01436656|450642150|FG000|Dose Escalation|Withdrawal by Subject|0|||
125277131|NCT01436656|450642151|FG001|Dose Escalation|Withdrawal by Subject|0|||
125277132|NCT01436656|450642152|FG002|Dose Escalation|Withdrawal by Subject|0|||
125277133|NCT01436656|450642153|FG003|Dose Escalation|Withdrawal by Subject|0|||
125277134|NCT01436656|450642154|FG004|Dose Escalation|Withdrawal by Subject|1|||
125277135|NCT01436656|450642155|FG005|Dose Escalation|Withdrawal by Subject|0|||
125277136|NCT01436656|450642156|FG006|Dose Escalation|Withdrawal by Subject|0|||
125277137|NCT01436656|450642157|FG007|Dose Escalation|Withdrawal by Subject|2|||
125277138|NCT01436656|450642158|FG008|Dose Escalation|Withdrawal by Subject|0|||
125277139|NCT01436656|450642159|FG009|Dose Escalation|Withdrawal by Subject|1|||
125277140|NCT01436656|450642160|FG010|Dose Escalation|Withdrawal by Subject|1|||
125277141|NCT01436656|450642161|FG011|Dose Escalation|Withdrawal by Subject|0|||
125277142|NCT01436656|450642162|FG012|Dose Escalation|Withdrawal by Subject|0|||
125277143|NCT01436656|450642163|FG013|Dose Escalation|Withdrawal by Subject|0|||
125277144|NCT01436656|450642164|FG014|Dose Escalation|Withdrawal by Subject|0|||
125277145|NCT01436656|450642165|FG015|Dose Escalation|Withdrawal by Subject|0|||
125277146|NCT01436656|450642166|FG016|Dose Escalation|Withdrawal by Subject|0|||
125277147|NCT01436656|450642167|FG017|Dose Escalation|Withdrawal by Subject|0|||
125277148|NCT01436656|450642150|FG000|Dose Escalation|Administrative problems|0|||
125277149|NCT01436656|450642151|FG001|Dose Escalation|Administrative problems|1|||
125277150|NCT01436656|450642152|FG002|Dose Escalation|Administrative problems|0|||
125277151|NCT01436656|450642153|FG003|Dose Escalation|Administrative problems|0|||
125277152|NCT01436656|450642154|FG004|Dose Escalation|Administrative problems|0|||
125277153|NCT01436656|450642155|FG005|Dose Escalation|Administrative problems|0|||
125277154|NCT01436656|450642156|FG006|Dose Escalation|Administrative problems|0|||
125277155|NCT01436656|450642157|FG007|Dose Escalation|Administrative problems|0|||
125277156|NCT01436656|450642158|FG008|Dose Escalation|Administrative problems|0|||
125277157|NCT01436656|450642159|FG009|Dose Escalation|Administrative problems|0|||
125277158|NCT01436656|450642160|FG010|Dose Escalation|Administrative problems|0|||
125277159|NCT01436656|450642161|FG011|Dose Escalation|Administrative problems|0|||
125277160|NCT01436656|450642162|FG012|Dose Escalation|Administrative problems|0|||
125402222|NCT00670228|451100731|FG001|Overall Study|Not meeting the selection criteria|0|||
125402223|NCT03049813|451100740|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
125402224|NCT03049813|451100741|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
125402225|NCT03049813|451100742|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
125402226|NCT03049813|451100743|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
125402227|NCT03049813|451100740|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
125402228|NCT03049813|451100741|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
125402229|NCT03049813|451100742|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
125402230|NCT03049813|451100743|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
125402231|NCT03049813|451100740|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
125402232|NCT03049813|451100741|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
125402233|NCT03049813|451100742|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
125402234|NCT03049813|451100743|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
125402235|NCT03049813|451100740|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
125402236|NCT03049813|451100741|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
125277161|NCT01436656|450642163|FG013|Dose Escalation|Administrative problems|0|||
125277162|NCT01436656|450642164|FG014|Dose Escalation|Administrative problems|0|||
125277163|NCT01436656|450642165|FG015|Dose Escalation|Administrative problems|0|||
125277164|NCT01436656|450642166|FG016|Dose Escalation|Administrative problems|0|||
125277165|NCT01436656|450642167|FG017|Dose Escalation|Administrative problems|0|||
125277166|NCT01436656|450642150|FG000|Dose Escalation|Lost to Follow-up|1|||
125277167|NCT01436656|450642151|FG001|Dose Escalation|Lost to Follow-up|0|||
125277168|NCT01436656|450642152|FG002|Dose Escalation|Lost to Follow-up|0|||
125277169|NCT01436656|450642153|FG003|Dose Escalation|Lost to Follow-up|0|||
125277170|NCT01436656|450642154|FG004|Dose Escalation|Lost to Follow-up|1|||
125277171|NCT01436656|450642155|FG005|Dose Escalation|Lost to Follow-up|0|||
125277172|NCT01436656|450642156|FG006|Dose Escalation|Lost to Follow-up|0|||
125277173|NCT01436656|450642157|FG007|Dose Escalation|Lost to Follow-up|0|||
125277174|NCT01436656|450642158|FG008|Dose Escalation|Lost to Follow-up|0|||
125277175|NCT01436656|450642159|FG009|Dose Escalation|Lost to Follow-up|0|||
125277176|NCT01436656|450642160|FG010|Dose Escalation|Lost to Follow-up|0|||
125277177|NCT01436656|450642161|FG011|Dose Escalation|Lost to Follow-up|0|||
125277178|NCT01436656|450642162|FG012|Dose Escalation|Lost to Follow-up|0|||
125277179|NCT01436656|450642163|FG013|Dose Escalation|Lost to Follow-up|0|||
125277180|NCT01436656|450642164|FG014|Dose Escalation|Lost to Follow-up|0|||
125277181|NCT01436656|450642165|FG015|Dose Escalation|Lost to Follow-up|0|||
125277182|NCT01436656|450642166|FG016|Dose Escalation|Lost to Follow-up|0|||
125277183|NCT01436656|450642167|FG017|Dose Escalation|Lost to Follow-up|0|||
125277184|NCT01436656|450642150|FG000|Dose Escalation|New anti-cancer therapy|1|||
125277185|NCT01436656|450642151|FG001|Dose Escalation|New anti-cancer therapy|0|||
125277186|NCT01436656|450642152|FG002|Dose Escalation|New anti-cancer therapy|0|||
125277187|NCT01436656|450642153|FG003|Dose Escalation|New anti-cancer therapy|0|||
125277188|NCT01436656|450642154|FG004|Dose Escalation|New anti-cancer therapy|0|||
125277189|NCT01436656|450642155|FG005|Dose Escalation|New anti-cancer therapy|0|||
125277190|NCT01436656|450642156|FG006|Dose Escalation|New anti-cancer therapy|0|||
125277191|NCT01436656|450642157|FG007|Dose Escalation|New anti-cancer therapy|0|||
125277192|NCT01436656|450642158|FG008|Dose Escalation|New anti-cancer therapy|1|||
125277193|NCT01436656|450642159|FG009|Dose Escalation|New anti-cancer therapy|1|||
125277194|NCT01436656|450642160|FG010|Dose Escalation|New anti-cancer therapy|0|||
125277195|NCT01436656|450642161|FG011|Dose Escalation|New anti-cancer therapy|0|||
125277196|NCT01436656|450642162|FG012|Dose Escalation|New anti-cancer therapy|0|||
125277197|NCT01436656|450642163|FG013|Dose Escalation|New anti-cancer therapy|0|||
125277198|NCT01436656|450642164|FG014|Dose Escalation|New anti-cancer therapy|0|||
125277199|NCT01436656|450642165|FG015|Dose Escalation|New anti-cancer therapy|0|||
125277200|NCT01436656|450642166|FG016|Dose Escalation|New anti-cancer therapy|0|||
125277201|NCT01436656|450642167|FG017|Dose Escalation|New anti-cancer therapy|0|||
125277202|NCT01436656|450642150|FG000|Dose Expansion|Adverse Event|0|||
125277203|NCT01436656|450642151|FG001|Dose Expansion|Adverse Event|0|||
125277204|NCT01436656|450642152|FG002|Dose Expansion|Adverse Event|0|||
125277205|NCT01436656|450642153|FG003|Dose Expansion|Adverse Event|0|||
125277206|NCT01436656|450642154|FG004|Dose Expansion|Adverse Event|0|||
125277207|NCT01436656|450642155|FG005|Dose Expansion|Adverse Event|0|||
125277208|NCT01436656|450642156|FG006|Dose Expansion|Adverse Event|0|||
125277209|NCT01436656|450642157|FG007|Dose Expansion|Adverse Event|0|||
125277210|NCT01436656|450642158|FG008|Dose Expansion|Adverse Event|0|||
125277211|NCT01436656|450642159|FG009|Dose Expansion|Adverse Event|0|||
125277212|NCT01436656|450642160|FG010|Dose Expansion|Adverse Event|0|||
125277213|NCT01436656|450642161|FG011|Dose Expansion|Adverse Event|1|||
125277214|NCT01436656|450642162|FG012|Dose Expansion|Adverse Event|0|||
125277215|NCT01436656|450642163|FG013|Dose Expansion|Adverse Event|0|||
125277216|NCT01436656|450642164|FG014|Dose Expansion|Adverse Event|0|||
125277217|NCT01436656|450642165|FG015|Dose Expansion|Adverse Event|0|||
125277218|NCT01436656|450642166|FG016|Dose Expansion|Adverse Event|0|||
125277219|NCT01436656|450642167|FG017|Dose Expansion|Adverse Event|0|||
125277220|NCT01436656|450642150|FG000|Dose Expansion|Withdrawal by Subject|0|||
125277221|NCT01436656|450642151|FG001|Dose Expansion|Withdrawal by Subject|0|||
125277222|NCT01436656|450642152|FG002|Dose Expansion|Withdrawal by Subject|0|||
125277223|NCT01436656|450642153|FG003|Dose Expansion|Withdrawal by Subject|0|||
125277224|NCT01436656|450642154|FG004|Dose Expansion|Withdrawal by Subject|0|||
125402237|NCT03049813|451100742|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
125402238|NCT03049813|451100743|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
125402239|NCT00179413|451100744|FG000|Overall Study|Adverse Event|38|||
125402240|NCT00179413|451100745|FG001|Overall Study|Adverse Event|20|||
125402241|NCT00179413|451100744|FG000|Overall Study|Withdrawal by Subject|87|||
125402242|NCT00179413|451100745|FG001|Overall Study|Withdrawal by Subject|95|||
125402243|NCT00550836|451100746|FG000|Overall Study|Withdrawal by Subject|3|||
125402244|NCT00550836|451100747|FG001|Overall Study|Withdrawal by Subject|9|||
125402245|NCT03075644|451100750|FG000|Overall Study|Withdrawal by Subject|1|||
125402246|NCT03075644|451100751|FG001|Overall Study|Withdrawal by Subject|1|||
125402247|NCT01813019|451100752|FG000|Overall Study|Adverse Event|0|||
125402248|NCT01813019|451100753|FG001|Overall Study|Adverse Event|3|||
125402249|NCT01813019|451100752|FG000|Overall Study|Withdrawal by Subject|3|||
125402250|NCT01813019|451100753|FG001|Overall Study|Withdrawal by Subject|2|||
125402251|NCT01813019|451100752|FG000|Overall Study|administrative problems|2|||
125402252|NCT01813019|451100753|FG001|Overall Study|administrative problems|0|||
125402253|NCT01813019|451100752|FG000|Overall Study|Protocol Deviation|2|||
125402254|NCT01813019|451100753|FG001|Overall Study|Protocol Deviation|1|||
125402255|NCT01458171|451100757|FG000|Overall Study|Adverse Event|1|||
125402256|NCT00094653|451100767|FG000|Overall Study|Death|306|||
125402257|NCT00094653|451100768|FG001|Overall Study|Death|100|||
125402258|NCT00094653|451100769|FG002|Overall Study|Death|119|||
125402259|NCT00094653|451100767|FG000|Overall Study|Subject Withdrew Consent|10|||
125402260|NCT00094653|451100768|FG001|Overall Study|Subject Withdrew Consent|2|||
125402261|NCT00094653|451100769|FG002|Overall Study|Subject Withdrew Consent|3|||
125402262|NCT00094653|451100767|FG000|Overall Study|Other|2|||
125402263|NCT00094653|451100768|FG001|Overall Study|Other|2|||
125402264|NCT00094653|451100769|FG002|Overall Study|Other|2|||
125402265|NCT00094653|451100767|FG000|Overall Study|Lost to Follow-up|3|||
125402266|NCT00094653|451100768|FG001|Overall Study|Lost to Follow-up|2|||
125402267|NCT00094653|451100769|FG002|Overall Study|Lost to Follow-up|1|||
125402268|NCT00094653|451100767|FG000|Overall Study|Protocol Violation|0|||
125402269|NCT00094653|451100768|FG001|Overall Study|Protocol Violation|0|||
125402270|NCT00094653|451100769|FG002|Overall Study|Protocol Violation|1|||
125402271|NCT03921411|451100770|FG000|Overall Study|Withdrawal by Subject|1|||
125402272|NCT03921411|451100770|FG000|Overall Study|Protocol Deviation|2|||
125402273|NCT03921411|451100770|FG000|Overall Study|Enrolled, but never treated|2|||
125402274|NCT03120013|451100772|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
125402275|NCT03120013|451100773|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
125402276|NCT01541826|451100774|FG000|Overall Study|Lost to Follow-up|2|||
125402277|NCT01541826|451100775|FG001|Overall Study|Lost to Follow-up|3|||
125402278|NCT01541826|451100776|FG002|Overall Study|Lost to Follow-up|0|||
125402279|NCT01541826|451100774|FG000|Overall Study|Withdrawal by Subject|2|||
125402280|NCT01541826|451100775|FG001|Overall Study|Withdrawal by Subject|0|||
125402281|NCT01541826|451100776|FG002|Overall Study|Withdrawal by Subject|0|||
125402282|NCT04847674|451100781|FG000|Overall Study|Withdrawal by Subject|0|||
125402283|NCT04847674|451100782|FG001|Overall Study|Withdrawal by Subject|1|||
125402284|NCT04847674|451100783|FG002|Overall Study|Withdrawal by Subject|0|||
125402285|NCT04847674|451100781|FG000|Overall Study|Lost to Follow-up|0|||
125402286|NCT04847674|451100782|FG001|Overall Study|Lost to Follow-up|0|||
125402287|NCT04847674|451100783|FG002|Overall Study|Lost to Follow-up|2|||
125402288|NCT04847674|451100781|FG000|Overall Study|Other than specified|21|||
125402289|NCT04847674|451100782|FG001|Overall Study|Other than specified|20|||
125402290|NCT04847674|451100783|FG002|Overall Study|Other than specified|20|||
125402291|NCT01009099|451100784|FG000|Overall Study|Lost to Follow-up|1|||
125402292|NCT01009099|451100785|FG001|Overall Study|Lost to Follow-up|0|||
125402293|NCT01009099|451100784|FG000|Overall Study|Physician Decision|3|||
125402294|NCT01009099|451100785|FG001|Overall Study|Physician Decision|2|||
125402295|NCT01009099|451100784|FG000|Overall Study|Withdrawal by Subject|1|||
125402296|NCT01009099|451100785|FG001|Overall Study|Withdrawal by Subject|1|||
125402297|NCT01009099|451100784|FG000|Overall Study|Death|0|||
125402298|NCT01009099|451100785|FG001|Overall Study|Death|1|||
125402299|NCT02702401|451100786|FG000|Overall Study|Death|242|||
125447904|NCT00562965|451266864|FG000|Overall Study|Withdrawal by Subject|0|||
125447905|NCT00562965|451266865|FG001|Overall Study|Withdrawal by Subject|1|||
125402300|NCT02702401|451100787|FG001|Overall Study|Death|125|||
125402301|NCT02702401|451100786|FG000|Overall Study|Withdrawal by Subject|15|||
125402302|NCT02702401|451100787|FG001|Overall Study|Withdrawal by Subject|5|||
125402303|NCT02702401|451100786|FG000|Overall Study|Sponsor Decision|19|||
125447906|NCT00562965|451266864|FG000|Overall Study|Death|2|||
125402304|NCT02702401|451100787|FG001|Overall Study|Sponsor Decision|3|||
125402305|NCT02702401|451100786|FG000|Overall Study|Physician Decision|1|||
125447907|NCT00562965|451266865|FG001|Overall Study|Death|4|||
125402306|NCT02702401|451100787|FG001|Overall Study|Physician Decision|2|||
125402307|NCT02702401|451100786|FG000|Overall Study|Lost to Follow-up|1|||
125402308|NCT02702401|451100787|FG001|Overall Study|Lost to Follow-up|0|||
125402309|NCT04292730|451100798|FG000|Overall Study|Lost to Follow-up|8|||
125402310|NCT04292730|451100799|FG001|Overall Study|Lost to Follow-up|12|||
125447908|NCT00562965|451266864|FG000|Overall Study|Lost to Follow-up|1|||
125402311|NCT04292730|451100800|FG002|Overall Study|Lost to Follow-up|12|||
125402312|NCT04292730|451100801|FG003|Overall Study|Lost to Follow-up|48|||
125402313|NCT04292730|451100798|FG000|Overall Study|Death|2|||
125402314|NCT04292730|451100799|FG001|Overall Study|Death|2|||
125402315|NCT04292730|451100800|FG002|Overall Study|Death|4|||
125402316|NCT04292730|451100801|FG003|Overall Study|Death|12|||
125402317|NCT04292730|451100798|FG000|Overall Study|Withdrew Consent|2|||
125402318|NCT04292730|451100799|FG001|Overall Study|Withdrew Consent|2|||
125402319|NCT04292730|451100800|FG002|Overall Study|Withdrew Consent|5|||
125402320|NCT04292730|451100801|FG003|Overall Study|Withdrew Consent|6|||
125402321|NCT04292730|451100798|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125277225|NCT01436656|450642155|FG005|Dose Expansion|Withdrawal by Subject|0|||
125277226|NCT01436656|450642156|FG006|Dose Expansion|Withdrawal by Subject|0|||
125277227|NCT01436656|450642157|FG007|Dose Expansion|Withdrawal by Subject|0|||
125277228|NCT01436656|450642158|FG008|Dose Expansion|Withdrawal by Subject|0|||
125277229|NCT01436656|450642159|FG009|Dose Expansion|Withdrawal by Subject|0|||
125277230|NCT01436656|450642160|FG010|Dose Expansion|Withdrawal by Subject|0|||
125277231|NCT01436656|450642161|FG011|Dose Expansion|Withdrawal by Subject|1|||
125277232|NCT01436656|450642162|FG012|Dose Expansion|Withdrawal by Subject|3|||
125277233|NCT01436656|450642163|FG013|Dose Expansion|Withdrawal by Subject|1|||
125277234|NCT01436656|450642164|FG014|Dose Expansion|Withdrawal by Subject|2|||
125277235|NCT01436656|450642165|FG015|Dose Expansion|Withdrawal by Subject|0|||
125277236|NCT01436656|450642166|FG016|Dose Expansion|Withdrawal by Subject|1|||
125277237|NCT01436656|450642167|FG017|Dose Expansion|Withdrawal by Subject|1|||
125277238|NCT01436656|450642150|FG000|Dose Expansion|Death|0|||
125277239|NCT01436656|450642151|FG001|Dose Expansion|Death|0|||
125277240|NCT01436656|450642152|FG002|Dose Expansion|Death|0|||
125277241|NCT01436656|450642153|FG003|Dose Expansion|Death|0|||
125277242|NCT01436656|450642154|FG004|Dose Expansion|Death|0|||
125277243|NCT01436656|450642155|FG005|Dose Expansion|Death|0|||
125277244|NCT01436656|450642156|FG006|Dose Expansion|Death|0|||
125277245|NCT01436656|450642157|FG007|Dose Expansion|Death|0|||
125277246|NCT01436656|450642158|FG008|Dose Expansion|Death|0|||
125277247|NCT01436656|450642159|FG009|Dose Expansion|Death|0|||
125277248|NCT01436656|450642160|FG010|Dose Expansion|Death|0|||
125277249|NCT01436656|450642161|FG011|Dose Expansion|Death|0|||
125277250|NCT01436656|450642162|FG012|Dose Expansion|Death|1|||
125277251|NCT01436656|450642163|FG013|Dose Expansion|Death|0|||
125277252|NCT01436656|450642164|FG014|Dose Expansion|Death|3|||
125277253|NCT01436656|450642165|FG015|Dose Expansion|Death|0|||
125277254|NCT01436656|450642166|FG016|Dose Expansion|Death|3|||
125277255|NCT01436656|450642167|FG017|Dose Expansion|Death|3|||
125277256|NCT01436656|450642150|FG000|Dose Expansion|Lost to Follow-up|0|||
125277257|NCT01436656|450642151|FG001|Dose Expansion|Lost to Follow-up|0|||
125277258|NCT01436656|450642152|FG002|Dose Expansion|Lost to Follow-up|0|||
125277259|NCT01436656|450642153|FG003|Dose Expansion|Lost to Follow-up|0|||
125277260|NCT01436656|450642154|FG004|Dose Expansion|Lost to Follow-up|0|||
125277261|NCT01436656|450642155|FG005|Dose Expansion|Lost to Follow-up|0|||
125277262|NCT01436656|450642156|FG006|Dose Expansion|Lost to Follow-up|0|||
125277263|NCT01436656|450642157|FG007|Dose Expansion|Lost to Follow-up|0|||
125277264|NCT01436656|450642158|FG008|Dose Expansion|Lost to Follow-up|0|||
125277265|NCT01436656|450642159|FG009|Dose Expansion|Lost to Follow-up|0|||
125277266|NCT01436656|450642160|FG010|Dose Expansion|Lost to Follow-up|0|||
125277267|NCT01436656|450642161|FG011|Dose Expansion|Lost to Follow-up|0|||
125277268|NCT01436656|450642162|FG012|Dose Expansion|Lost to Follow-up|0|||
125277269|NCT01436656|450642163|FG013|Dose Expansion|Lost to Follow-up|0|||
125277270|NCT01436656|450642164|FG014|Dose Expansion|Lost to Follow-up|0|||
125277271|NCT01436656|450642165|FG015|Dose Expansion|Lost to Follow-up|0|||
125277272|NCT01436656|450642166|FG016|Dose Expansion|Lost to Follow-up|0|||
125277273|NCT01436656|450642167|FG017|Dose Expansion|Lost to Follow-up|3|||
125277274|NCT01436656|450642150|FG000|Dose Expansion|Disease progression|0|||
125277275|NCT01436656|450642151|FG001|Dose Expansion|Disease progression|0|||
125402322|NCT04292730|451100799|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125447909|NCT00562965|451266865|FG001|Overall Study|Lost to Follow-up|0|||
125277276|NCT01436656|450642152|FG002|Dose Expansion|Disease progression|0|||
125277277|NCT01436656|450642153|FG003|Dose Expansion|Disease progression|0|||
125277278|NCT01436656|450642154|FG004|Dose Expansion|Disease progression|0|||
125277279|NCT01436656|450642155|FG005|Dose Expansion|Disease progression|0|||
125277280|NCT01436656|450642156|FG006|Dose Expansion|Disease progression|0|||
125277281|NCT01436656|450642157|FG007|Dose Expansion|Disease progression|0|||
125277282|NCT01436656|450642158|FG008|Dose Expansion|Disease progression|0|||
125277283|NCT01436656|450642159|FG009|Dose Expansion|Disease progression|0|||
125277284|NCT01436656|450642160|FG010|Dose Expansion|Disease progression|0|||
125277285|NCT01436656|450642161|FG011|Dose Expansion|Disease progression|3|||
125277286|NCT01436656|450642162|FG012|Dose Expansion|Disease progression|1|||
125402323|NCT04292730|451100800|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125402324|NCT04292730|451100801|FG003|Overall Study|Non-Compliance with Study Drug|0|||
125277287|NCT01436656|450642163|FG013|Dose Expansion|Disease progression|0|||
125277288|NCT01436656|450642164|FG014|Dose Expansion|Disease progression|1|||
125402325|NCT04292730|451100798|FG000|Overall Study|Protocol Violation|0|||
125277289|NCT01436656|450642165|FG015|Dose Expansion|Disease progression|0|||
125277290|NCT01436656|450642166|FG016|Dose Expansion|Disease progression|0|||
125277291|NCT01436656|450642167|FG017|Dose Expansion|Disease progression|1|||
125277292|NCT01436656|450642150|FG000|Dose Expansion|New cancer therapy|0|||
125277293|NCT01436656|450642151|FG001|Dose Expansion|New cancer therapy|0|||
125277294|NCT01436656|450642152|FG002|Dose Expansion|New cancer therapy|0|||
125277295|NCT01436656|450642153|FG003|Dose Expansion|New cancer therapy|0|||
125277296|NCT01436656|450642154|FG004|Dose Expansion|New cancer therapy|0|||
125277297|NCT01436656|450642155|FG005|Dose Expansion|New cancer therapy|0|||
125277298|NCT01436656|450642156|FG006|Dose Expansion|New cancer therapy|0|||
125277299|NCT01436656|450642157|FG007|Dose Expansion|New cancer therapy|0|||
125277300|NCT01436656|450642158|FG008|Dose Expansion|New cancer therapy|0|||
125277301|NCT01436656|450642159|FG009|Dose Expansion|New cancer therapy|0|||
125277302|NCT01436656|450642160|FG010|Dose Expansion|New cancer therapy|0|||
125277303|NCT01436656|450642161|FG011|Dose Expansion|New cancer therapy|1|||
125277304|NCT01436656|450642162|FG012|Dose Expansion|New cancer therapy|1|||
125277305|NCT01436656|450642163|FG013|Dose Expansion|New cancer therapy|0|||
125277306|NCT01436656|450642164|FG014|Dose Expansion|New cancer therapy|2|||
125277307|NCT01436656|450642165|FG015|Dose Expansion|New cancer therapy|0|||
125277308|NCT01436656|450642166|FG016|Dose Expansion|New cancer therapy|0|||
125277309|NCT01436656|450642167|FG017|Dose Expansion|New cancer therapy|0|||
125277310|NCT04729972|450642168|FG000|Overall Study|Adverse Event|1|||
125277311|NCT00576628|450642170|FG000|Overall Study|Adverse Event|11|||
125277312|NCT00576628|450642170|FG000|Overall Study|Death|2|||
125277313|NCT00576628|450642170|FG000|Overall Study|Failure to return|1|||
125277314|NCT00576628|450642170|FG000|Overall Study|Refused Treatment|8|||
125277315|NCT00576628|450642170|FG000|Overall Study|Pregnancy|1|||
125277316|NCT00576628|450642170|FG000|Overall Study|RBC transfusion|1|||
125277317|NCT00576628|450642170|FG000|Overall Study|Progression of Kidney Disease|1|||
125277318|NCT00576628|450642170|FG000|Overall Study|Progression of Renal Failure|1|||
125277319|NCT00576628|450642170|FG000|Overall Study|The patient move into other town|1|||
125277320|NCT00576628|450642170|FG000|Overall Study|Transplantation|1|||
125277321|NCT00576628|450642170|FG000|Overall Study|Dialysis|15|||
125277322|NCT03206970|450642171|FG000|Overall Study|Death|21|||
125277323|NCT03206970|450642171|FG000|Overall Study|Withdrawal by Subject|13|||
125277324|NCT03206970|450642171|FG000|Overall Study|Lost to Follow-up|3|||
125277325|NCT03206970|450642171|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
125277326|NCT02516982|450642172|FG000|Overall Study|Called in to antenatal appointment|32|||
125277327|NCT02516982|450642173|FG001|Overall Study|Called in to antenatal appointment|35|||
125277328|NCT02516982|450642174|FG002|Overall Study|Called in to antenatal appointment|0|||
125277329|NCT02516982|450642175|FG003|Overall Study|Called in to antenatal appointment|0|||
125277330|NCT02516982|450642172|FG000|Overall Study|Withdrawal by Subject|0|||
125277331|NCT02516982|450642173|FG001|Overall Study|Withdrawal by Subject|0|||
125277332|NCT02516982|450642174|FG002|Overall Study|Withdrawal by Subject|1|||
125277333|NCT02516982|450642175|FG003|Overall Study|Withdrawal by Subject|2|||
125277334|NCT02516982|450642172|FG000|Overall Study|Protocol Violation|0|||
125277335|NCT02516982|450642173|FG001|Overall Study|Protocol Violation|0|||
125277336|NCT02516982|450642174|FG002|Overall Study|Protocol Violation|1|||
125277337|NCT02516982|450642175|FG003|Overall Study|Protocol Violation|1|||
125277338|NCT02516982|450642172|FG000|Overall Study|Did not install the app|0|||
125277339|NCT02516982|450642173|FG001|Overall Study|Did not install the app|0|||
125277340|NCT02516982|450642174|FG002|Overall Study|Did not install the app|46|||
125277341|NCT02516982|450642175|FG003|Overall Study|Did not install the app|47|||
125277342|NCT00962741|450642181|FG000|Overall Study|Failed to return|3|||
125277343|NCT00962741|450642181|FG000|Overall Study|Lost to Follow-up|2|||
125277344|NCT00962741|450642181|FG000|Overall Study|Withdrawal by Subject|1|||
125277345|NCT00962741|450642181|FG000|Overall Study|Lack of Efficacy|1|||
125277346|NCT00962741|450642181|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
125277347|NCT01814878|450642182|FG000|Overall Study|Adverse Event|16|||
125277348|NCT01814878|450642183|FG001|Overall Study|Adverse Event|5|||
125277349|NCT01814878|450642182|FG000|Overall Study|Withdrawal by Subject|20|||
125277350|NCT01814878|450642183|FG001|Overall Study|Withdrawal by Subject|16|||
125277351|NCT01814878|450642182|FG000|Overall Study|Protocol Violation|5|||
125277352|NCT01814878|450642183|FG001|Overall Study|Protocol Violation|5|||
125277353|NCT01814878|450642182|FG000|Overall Study|Physician Decision|3|||
125277354|NCT01814878|450642183|FG001|Overall Study|Physician Decision|1|||
125277355|NCT01814878|450642182|FG000|Overall Study|Screening failure (drop-out)|0|||
125277356|NCT01814878|450642183|FG001|Overall Study|Screening failure (drop-out)|3|||
125277357|NCT01814878|450642182|FG000|Overall Study|Other|2|||
125277358|NCT01814878|450642183|FG001|Overall Study|Other|0|||
125277359|NCT03645421|450642184|FG000|Overall Study|Adverse Event|0|||
125277360|NCT03645421|450642185|FG001|Overall Study|Adverse Event|0|||
125277361|NCT03645421|450642186|FG002|Overall Study|Adverse Event|4|||
125277362|NCT03645421|450642187|FG003|Overall Study|Adverse Event|1|||
125277363|NCT03645421|450642184|FG000|Overall Study|Withdrawal by patient|0|||
125277364|NCT03645421|450642185|FG001|Overall Study|Withdrawal by patient|0|||
125277365|NCT03645421|450642186|FG002|Overall Study|Withdrawal by patient|0|||
125277366|NCT03645421|450642187|FG003|Overall Study|Withdrawal by patient|3|||
125277367|NCT03645421|450642184|FG000|Overall Study|Study specific withdrawal criteria|0|||
125277368|NCT03645421|450642185|FG001|Overall Study|Study specific withdrawal criteria|0|||
125277369|NCT03645421|450642186|FG002|Overall Study|Study specific withdrawal criteria|1|||
125277370|NCT03645421|450642187|FG003|Overall Study|Study specific withdrawal criteria|0|||
125277371|NCT02253433|450642191|FG000|Overall Study|Unable to Contact|9|||
125277372|NCT02253433|450642192|FG001|Overall Study|Unable to Contact|16|||
125277373|NCT02253433|450642191|FG000|Overall Study|Death|1|||
125277374|NCT02253433|450642192|FG001|Overall Study|Death|1|||
125277375|NCT02253433|450642191|FG000|Overall Study|No Longer Interested|3|||
125277376|NCT02253433|450642192|FG001|Overall Study|No Longer Interested|15|||
125277377|NCT02253433|450642191|FG000|Overall Study|Out of Study Area|2|||
125277378|NCT02253433|450642192|FG001|Overall Study|Out of Study Area|7|||
125277379|NCT02253433|450642191|FG000|Overall Study|Uncomfortable with home visitors|0|||
125277380|NCT02253433|450642192|FG001|Overall Study|Uncomfortable with home visitors|3|||
125277381|NCT02253433|450642191|FG000|Overall Study|Unstable Housing/Homeless|0|||
125277382|NCT02253433|450642192|FG001|Overall Study|Unstable Housing/Homeless|7|||
125277383|NCT02253433|450642191|FG000|Overall Study|Too Busy|0|||
125277384|NCT02253433|450642192|FG001|Overall Study|Too Busy|4|||
125277385|NCT02253433|450642191|FG000|Overall Study|Medical or Other Concerns|1|||
125277386|NCT02253433|450642192|FG001|Overall Study|Medical or Other Concerns|2|||
125277387|NCT00759876|450642200|FG000|Overall Study|Sponsor terminated study early|36|||
125402326|NCT04292730|451100799|FG001|Overall Study|Protocol Violation|0|||
125402327|NCT04292730|451100800|FG002|Overall Study|Protocol Violation|1|||
125402328|NCT04292730|451100801|FG003|Overall Study|Protocol Violation|0|||
125402329|NCT04292730|451100798|FG000|Overall Study|Randomized but not Treated|8|||
125402330|NCT04292730|451100799|FG001|Overall Study|Randomized but not Treated|4|||
125402331|NCT04292730|451100800|FG002|Overall Study|Randomized but not Treated|0|||
125402332|NCT04292730|451100801|FG003|Overall Study|Randomized but not Treated|14|||
125402333|NCT01527292|451100803|FG000|Overall Study|Physician Decision|0|||
125402334|NCT01527292|451100804|FG001|Overall Study|Physician Decision|3|||
125402335|NCT01482767|451100805|FG000|Overall Study|Death|1|||
125402336|NCT01482767|451100806|FG001|Overall Study|Death|1|||
125402337|NCT01482767|451100805|FG000|Overall Study|Withdrawal by Subject|7|||
125402338|NCT01482767|451100806|FG001|Overall Study|Withdrawal by Subject|5|||
125402339|NCT01482767|451100805|FG000|Overall Study|Lost to Follow-up|12|||
125402340|NCT01482767|451100806|FG001|Overall Study|Lost to Follow-up|6|||
125402341|NCT01482767|451100805|FG000|Overall Study|Adverse Event|0|||
125402342|NCT01482767|451100806|FG001|Overall Study|Adverse Event|3|||
125402343|NCT01482767|451100805|FG000|Overall Study|Site closure|22|||
125402344|NCT01482767|451100806|FG001|Overall Study|Site closure|14|||
125402345|NCT01482767|451100805|FG000|Overall Study|Non-adherence to study requirements|4|||
125402346|NCT01482767|451100806|FG001|Overall Study|Non-adherence to study requirements|7|||
125402347|NCT01482767|451100805|FG000|Overall Study|Alternate HCV treatment|7|||
125402348|NCT01482767|451100806|FG001|Overall Study|Alternate HCV treatment|8|||
125402349|NCT01482767|451100805|FG000|Overall Study|Ineligible|0|||
125402350|NCT01482767|451100806|FG001|Overall Study|Ineligible|5|||
125402351|NCT01482767|451100805|FG000|Overall Study|Nurse error|1|||
125402352|NCT01482767|451100806|FG001|Overall Study|Nurse error|0|||
125402353|NCT01856543|451100807|FG000|Overall Study|Treatment discontinued|6|||
125402354|NCT01856543|451100808|FG001|Overall Study|Treatment discontinued|3|||
125402355|NCT01856543|451100807|FG000|Overall Study|Withdrawn before start|7|||
125402356|NCT01856543|451100808|FG001|Overall Study|Withdrawn before start|3|||
125402357|NCT02920983|451100811|FG000|Dispense 1|Unacceptable Lens Fit|0|||
125402358|NCT02920983|451100812|FG001|Dispense 1|Unacceptable Lens Fit|0|||
125402359|NCT02920983|451100813|FG002|Dispense 1|Unacceptable Lens Fit|0|||
125402360|NCT02920983|451100814|FG003|Dispense 1|Unacceptable Lens Fit|0|||
125402361|NCT02920983|451100815|FG004|Dispense 1|Unacceptable Lens Fit|1|||
125402362|NCT02920983|451100816|FG005|Dispense 1|Unacceptable Lens Fit|0|||
125402363|NCT02920983|451100811|FG000|Dispense 2|Unscceptable lens fit|1|||
125402364|NCT02920983|451100812|FG001|Dispense 2|Unscceptable lens fit|0|||
125402365|NCT02920983|451100813|FG002|Dispense 2|Unscceptable lens fit|0|||
125402366|NCT02920983|451100814|FG003|Dispense 2|Unscceptable lens fit|0|||
125402367|NCT02920983|451100815|FG004|Dispense 2|Unscceptable lens fit|1|||
125402368|NCT02920983|451100816|FG005|Dispense 2|Unscceptable lens fit|0|||
125277388|NCT02836717|450642201|FG000|Test Phase|Lack of Efficacy|14|||
125277389|NCT02836717|450642202|FG001|Test Phase|Lack of Efficacy|8|||
125277390|NCT02836717|450642203|FG002|Test Phase|Lack of Efficacy|0|||
125402369|NCT02920983|451100811|FG000|Dispense 3|Unacceptable Lens Fit|1|||
125402370|NCT02920983|451100812|FG001|Dispense 3|Unacceptable Lens Fit|1|||
125402371|NCT02920983|451100813|FG002|Dispense 3|Unacceptable Lens Fit|0|||
125402372|NCT02920983|451100814|FG003|Dispense 3|Unacceptable Lens Fit|0|||
125402373|NCT02920983|451100815|FG004|Dispense 3|Unacceptable Lens Fit|1|||
125277391|NCT02836717|450642201|FG000|Study Phase|Adverse Event|2|||
125277392|NCT02836717|450642202|FG001|Study Phase|Adverse Event|0|||
125402374|NCT02920983|451100816|FG005|Dispense 3|Unacceptable Lens Fit|0|||
125402375|NCT02553421|451100821|FG000|Overall Study|Lost to Follow-up|21|||
125402376|NCT02553421|451100822|FG001|Overall Study|Lost to Follow-up|1|||
125277393|NCT02836717|450642203|FG002|Study Phase|Adverse Event|0|||
125402377|NCT02553421|451100821|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
125402378|NCT02553421|451100822|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
125402379|NCT02553421|451100821|FG000|Overall Study|Improper Device Placement|3|||
125402380|NCT02553421|451100822|FG001|Overall Study|Improper Device Placement|0|||
125402381|NCT03013491|451100823|FG000|Main Study|Death|2|||
125402382|NCT03013491|451100824|FG001|Main Study|Death|2|||
125402383|NCT03013491|451100825|FG002|Main Study|Death|5|||
125402384|NCT03013491|451100826|FG003|Main Study|Death|3|||
125402385|NCT03013491|451100827|FG004|Main Study|Death|9|||
125402386|NCT03013491|451100828|FG005|Main Study|Death|12|||
125402387|NCT03013491|451100829|FG006|Main Study|Death|3|||
125402388|NCT03013491|451100830|FG007|Main Study|Death|5|||
125402389|NCT03013491|451100831|FG008|Main Study|Death|1|||
125402390|NCT03013491|451100832|FG009|Main Study|Death|2|||
125402391|NCT03013491|451100833|FG010|Main Study|Death|4|||
125402392|NCT03013491|451100834|FG011|Main Study|Death|1|||
125402393|NCT03013491|451100835|FG012|Main Study|Death|1|||
125402394|NCT03013491|451100836|FG013|Main Study|Death|4|||
125402395|NCT03013491|451100837|FG014|Main Study|Death|0|||
125402396|NCT03013491|451100838|FG015|Main Study|Death|3|||
125402397|NCT03013491|451100839|FG016|Main Study|Death|5|||
125402398|NCT03013491|451100840|FG017|Main Study|Death|1|||
125402399|NCT03013491|451100841|FG018|Main Study|Death|47|||
125402400|NCT03013491|451100823|FG000|Main Study|Lost to Follow-up|0|||
125402401|NCT03013491|451100824|FG001|Main Study|Lost to Follow-up|0|||
125402402|NCT03013491|451100825|FG002|Main Study|Lost to Follow-up|1|||
125402403|NCT03013491|451100826|FG003|Main Study|Lost to Follow-up|0|||
125402404|NCT03013491|451100827|FG004|Main Study|Lost to Follow-up|1|||
125402405|NCT03013491|451100828|FG005|Main Study|Lost to Follow-up|0|||
125402406|NCT03013491|451100829|FG006|Main Study|Lost to Follow-up|0|||
125402407|NCT03013491|451100830|FG007|Main Study|Lost to Follow-up|0|||
125402408|NCT03013491|451100831|FG008|Main Study|Lost to Follow-up|0|||
125402409|NCT03013491|451100832|FG009|Main Study|Lost to Follow-up|0|||
125402410|NCT03013491|451100833|FG010|Main Study|Lost to Follow-up|0|||
125402411|NCT03013491|451100834|FG011|Main Study|Lost to Follow-up|0|||
125402412|NCT03013491|451100835|FG012|Main Study|Lost to Follow-up|0|||
125402413|NCT03013491|451100836|FG013|Main Study|Lost to Follow-up|0|||
125402414|NCT03013491|451100837|FG014|Main Study|Lost to Follow-up|0|||
125402415|NCT03013491|451100838|FG015|Main Study|Lost to Follow-up|0|||
125402416|NCT03013491|451100839|FG016|Main Study|Lost to Follow-up|0|||
125402417|NCT03013491|451100840|FG017|Main Study|Lost to Follow-up|0|||
125402418|NCT03013491|451100841|FG018|Main Study|Lost to Follow-up|3|||
125402419|NCT03013491|451100823|FG000|Main Study|Termination of the study by Sponsor|0|||
125402420|NCT03013491|451100824|FG001|Main Study|Termination of the study by Sponsor|0|||
125402421|NCT03013491|451100825|FG002|Main Study|Termination of the study by Sponsor|2|||
125402422|NCT03013491|451100826|FG003|Main Study|Termination of the study by Sponsor|0|||
125402423|NCT03013491|451100827|FG004|Main Study|Termination of the study by Sponsor|1|||
125402424|NCT03013491|451100828|FG005|Main Study|Termination of the study by Sponsor|2|||
125402425|NCT03013491|451100829|FG006|Main Study|Termination of the study by Sponsor|0|||
125402426|NCT03013491|451100830|FG007|Main Study|Termination of the study by Sponsor|0|||
125402427|NCT03013491|451100831|FG008|Main Study|Termination of the study by Sponsor|1|||
125402428|NCT03013491|451100832|FG009|Main Study|Termination of the study by Sponsor|1|||
125402429|NCT03013491|451100833|FG010|Main Study|Termination of the study by Sponsor|1|||
125402430|NCT03013491|451100834|FG011|Main Study|Termination of the study by Sponsor|2|||
125402431|NCT03013491|451100835|FG012|Main Study|Termination of the study by Sponsor|0|||
125402432|NCT03013491|451100836|FG013|Main Study|Termination of the study by Sponsor|0|||
125402433|NCT03013491|451100837|FG014|Main Study|Termination of the study by Sponsor|0|||
125402434|NCT03013491|451100838|FG015|Main Study|Termination of the study by Sponsor|0|||
125402435|NCT03013491|451100839|FG016|Main Study|Termination of the study by Sponsor|0|||
125402436|NCT03013491|451100840|FG017|Main Study|Termination of the study by Sponsor|1|||
125402437|NCT03013491|451100841|FG018|Main Study|Termination of the study by Sponsor|13|||
125402438|NCT03013491|451100823|FG000|Main Study|Withdrawal by Subject|0|||
125402439|NCT03013491|451100824|FG001|Main Study|Withdrawal by Subject|0|||
125277394|NCT02836717|450642201|FG000|Study Phase|Lack of Efficacy|8|||
125447910|NCT00562965|451266864|FG000|Overall Study|Other|0|||
125447911|NCT00562965|451266865|FG001|Overall Study|Other|1|||
125402440|NCT03013491|451100825|FG002|Main Study|Withdrawal by Subject|0|||
125402441|NCT03013491|451100826|FG003|Main Study|Withdrawal by Subject|4|||
125402442|NCT03013491|451100827|FG004|Main Study|Withdrawal by Subject|2|||
125402443|NCT03013491|451100828|FG005|Main Study|Withdrawal by Subject|1|||
125402444|NCT03013491|451100829|FG006|Main Study|Withdrawal by Subject|0|||
125402445|NCT03013491|451100830|FG007|Main Study|Withdrawal by Subject|0|||
125402446|NCT03013491|451100831|FG008|Main Study|Withdrawal by Subject|0|||
125402447|NCT03013491|451100832|FG009|Main Study|Withdrawal by Subject|0|||
125402448|NCT03013491|451100833|FG010|Main Study|Withdrawal by Subject|1|||
125402449|NCT03013491|451100834|FG011|Main Study|Withdrawal by Subject|2|||
125402450|NCT03013491|451100835|FG012|Main Study|Withdrawal by Subject|0|||
125402451|NCT03013491|451100836|FG013|Main Study|Withdrawal by Subject|2|||
125402452|NCT03013491|451100837|FG014|Main Study|Withdrawal by Subject|0|||
125402453|NCT03013491|451100838|FG015|Main Study|Withdrawal by Subject|0|||
125402454|NCT03013491|451100839|FG016|Main Study|Withdrawal by Subject|0|||
125447912|NCT00965484|451266869|FG000|Overall Study|Protocol Violation|1|||
125402455|NCT03013491|451100840|FG017|Main Study|Withdrawal by Subject|0|||
125402456|NCT03013491|451100841|FG018|Main Study|Withdrawal by Subject|18|||
125402457|NCT03013491|451100823|FG000|Main Study|Disease progression|0|||
125402458|NCT03013491|451100824|FG001|Main Study|Disease progression|0|||
125402459|NCT03013491|451100825|FG002|Main Study|Disease progression|0|||
125402460|NCT03013491|451100826|FG003|Main Study|Disease progression|1|||
125402461|NCT03013491|451100827|FG004|Main Study|Disease progression|0|||
125402462|NCT03013491|451100828|FG005|Main Study|Disease progression|0|||
125402463|NCT03013491|451100829|FG006|Main Study|Disease progression|0|||
125402464|NCT03013491|451100830|FG007|Main Study|Disease progression|0|||
125402465|NCT03013491|451100831|FG008|Main Study|Disease progression|1|||
125402466|NCT03013491|451100832|FG009|Main Study|Disease progression|0|||
125402467|NCT03013491|451100833|FG010|Main Study|Disease progression|1|||
125402468|NCT03013491|451100834|FG011|Main Study|Disease progression|0|||
125402469|NCT03013491|451100835|FG012|Main Study|Disease progression|0|||
125402470|NCT03013491|451100836|FG013|Main Study|Disease progression|0|||
125402471|NCT03013491|451100837|FG014|Main Study|Disease progression|0|||
125402472|NCT03013491|451100838|FG015|Main Study|Disease progression|0|||
125402473|NCT03013491|451100839|FG016|Main Study|Disease progression|0|||
125402474|NCT03013491|451100840|FG017|Main Study|Disease progression|0|||
125402475|NCT03013491|451100841|FG018|Main Study|Disease progression|4|||
125402476|NCT03013491|451100823|FG000|Main Study|Symptomatic deterioration|0|||
125402477|NCT03013491|451100824|FG001|Main Study|Symptomatic deterioration|0|||
125402478|NCT03013491|451100825|FG002|Main Study|Symptomatic deterioration|0|||
125402479|NCT03013491|451100826|FG003|Main Study|Symptomatic deterioration|0|||
125402480|NCT03013491|451100827|FG004|Main Study|Symptomatic deterioration|0|||
125402481|NCT03013491|451100828|FG005|Main Study|Symptomatic deterioration|1|||
125402482|NCT03013491|451100829|FG006|Main Study|Symptomatic deterioration|0|||
125402483|NCT03013491|451100830|FG007|Main Study|Symptomatic deterioration|0|||
125402484|NCT03013491|451100831|FG008|Main Study|Symptomatic deterioration|0|||
125402485|NCT03013491|451100832|FG009|Main Study|Symptomatic deterioration|0|||
125402486|NCT03013491|451100833|FG010|Main Study|Symptomatic deterioration|0|||
125402487|NCT03013491|451100834|FG011|Main Study|Symptomatic deterioration|0|||
125402488|NCT03013491|451100835|FG012|Main Study|Symptomatic deterioration|0|||
125402489|NCT03013491|451100836|FG013|Main Study|Symptomatic deterioration|0|||
125402490|NCT03013491|451100837|FG014|Main Study|Symptomatic deterioration|0|||
125402491|NCT03013491|451100838|FG015|Main Study|Symptomatic deterioration|0|||
125402492|NCT03013491|451100839|FG016|Main Study|Symptomatic deterioration|0|||
125402493|NCT03013491|451100840|FG017|Main Study|Symptomatic deterioration|0|||
125402494|NCT03013491|451100841|FG018|Main Study|Symptomatic deterioration|0|||
125402495|NCT03013491|451100823|FG000|Main Study|Protocol version 8.0 approval|0|||
125402496|NCT03013491|451100824|FG001|Main Study|Protocol version 8.0 approval|0|||
125402497|NCT03013491|451100825|FG002|Main Study|Protocol version 8.0 approval|0|||
125402498|NCT03013491|451100826|FG003|Main Study|Protocol version 8.0 approval|0|||
125402499|NCT03013491|451100827|FG004|Main Study|Protocol version 8.0 approval|0|||
125402500|NCT03013491|451100828|FG005|Main Study|Protocol version 8.0 approval|0|||
125402501|NCT03013491|451100829|FG006|Main Study|Protocol version 8.0 approval|0|||
125402502|NCT03013491|451100830|FG007|Main Study|Protocol version 8.0 approval|0|||
125402503|NCT03013491|451100831|FG008|Main Study|Protocol version 8.0 approval|0|||
125402504|NCT03013491|451100832|FG009|Main Study|Protocol version 8.0 approval|0|||
125402505|NCT03013491|451100833|FG010|Main Study|Protocol version 8.0 approval|1|||
125402506|NCT03013491|451100834|FG011|Main Study|Protocol version 8.0 approval|0|||
125402507|NCT03013491|451100835|FG012|Main Study|Protocol version 8.0 approval|0|||
125402508|NCT03013491|451100836|FG013|Main Study|Protocol version 8.0 approval|0|||
125402509|NCT03013491|451100837|FG014|Main Study|Protocol version 8.0 approval|0|||
125402510|NCT03013491|451100838|FG015|Main Study|Protocol version 8.0 approval|0|||
125402511|NCT03013491|451100839|FG016|Main Study|Protocol version 8.0 approval|0|||
125402512|NCT03013491|451100840|FG017|Main Study|Protocol version 8.0 approval|0|||
125402513|NCT03013491|451100841|FG018|Main Study|Protocol version 8.0 approval|0|||
125402514|NCT03013491|451100823|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
125402515|NCT03013491|451100824|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
125402516|NCT03013491|451100825|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
125402517|NCT03013491|451100826|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
125402518|NCT03013491|451100827|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
125402519|NCT03013491|451100828|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
125402520|NCT03013491|451100829|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
125402521|NCT03013491|451100830|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
125402522|NCT03013491|451100831|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
125402523|NCT03013491|451100832|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
125402524|NCT03013491|451100833|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
125402525|NCT03013491|451100834|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
125402526|NCT03013491|451100835|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
125402527|NCT03013491|451100836|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
125402528|NCT03013491|451100837|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
125402529|NCT03013491|451100838|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
125402530|NCT03013491|451100839|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
125402531|NCT03013491|451100840|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
125402532|NCT03013491|451100841|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
125402533|NCT03013491|451100823|FG000|Main Study|Start of new anticancer therapy|0|||
125402534|NCT03013491|451100824|FG001|Main Study|Start of new anticancer therapy|0|||
125402535|NCT03013491|451100825|FG002|Main Study|Start of new anticancer therapy|0|||
125402536|NCT03013491|451100826|FG003|Main Study|Start of new anticancer therapy|0|||
125402537|NCT03013491|451100827|FG004|Main Study|Start of new anticancer therapy|0|||
125402538|NCT03013491|451100828|FG005|Main Study|Start of new anticancer therapy|0|||
125402539|NCT03013491|451100829|FG006|Main Study|Start of new anticancer therapy|0|||
125402540|NCT03013491|451100830|FG007|Main Study|Start of new anticancer therapy|0|||
125402541|NCT03013491|451100831|FG008|Main Study|Start of new anticancer therapy|0|||
125402542|NCT03013491|451100832|FG009|Main Study|Start of new anticancer therapy|0|||
125402543|NCT03013491|451100833|FG010|Main Study|Start of new anticancer therapy|0|||
125402544|NCT03013491|451100834|FG011|Main Study|Start of new anticancer therapy|0|||
125402545|NCT03013491|451100835|FG012|Main Study|Start of new anticancer therapy|0|||
125402546|NCT03013491|451100836|FG013|Main Study|Start of new anticancer therapy|0|||
125402547|NCT03013491|451100837|FG014|Main Study|Start of new anticancer therapy|0|||
125402548|NCT03013491|451100838|FG015|Main Study|Start of new anticancer therapy|0|||
125402549|NCT03013491|451100839|FG016|Main Study|Start of new anticancer therapy|0|||
125402550|NCT03013491|451100840|FG017|Main Study|Start of new anticancer therapy|0|||
125402551|NCT03013491|451100841|FG018|Main Study|Start of new anticancer therapy|2|||
125402552|NCT03013491|451100823|FG000|Long-term Extension|Disease progression|0|||
125402553|NCT03013491|451100824|FG001|Long-term Extension|Disease progression|0|||
125402554|NCT03013491|451100825|FG002|Long-term Extension|Disease progression|0|||
125402555|NCT03013491|451100826|FG003|Long-term Extension|Disease progression|1|||
125402556|NCT03013491|451100827|FG004|Long-term Extension|Disease progression|0|||
125402557|NCT03013491|451100828|FG005|Long-term Extension|Disease progression|0|||
125402558|NCT03013491|451100829|FG006|Long-term Extension|Disease progression|0|||
125402559|NCT03013491|451100830|FG007|Long-term Extension|Disease progression|0|||
125402560|NCT03013491|451100831|FG008|Long-term Extension|Disease progression|0|||
125402561|NCT03013491|451100832|FG009|Long-term Extension|Disease progression|0|||
125402562|NCT03013491|451100833|FG010|Long-term Extension|Disease progression|0|||
125402563|NCT03013491|451100834|FG011|Long-term Extension|Disease progression|0|||
125402564|NCT03013491|451100835|FG012|Long-term Extension|Disease progression|0|||
125402565|NCT03013491|451100836|FG013|Long-term Extension|Disease progression|0|||
125402566|NCT03013491|451100837|FG014|Long-term Extension|Disease progression|0|||
125402567|NCT03013491|451100838|FG015|Long-term Extension|Disease progression|0|||
125402568|NCT03013491|451100839|FG016|Long-term Extension|Disease progression|0|||
125402569|NCT03013491|451100840|FG017|Long-term Extension|Disease progression|0|||
125402570|NCT03013491|451100841|FG018|Long-term Extension|Disease progression|1|||
125402571|NCT03013491|451100823|FG000|Long-term Extension|Withdrawal by Subject|0|||
125402572|NCT03013491|451100824|FG001|Long-term Extension|Withdrawal by Subject|0|||
125402573|NCT03013491|451100825|FG002|Long-term Extension|Withdrawal by Subject|0|||
125402574|NCT03013491|451100826|FG003|Long-term Extension|Withdrawal by Subject|0|||
125402575|NCT03013491|451100827|FG004|Long-term Extension|Withdrawal by Subject|0|||
125402576|NCT03013491|451100828|FG005|Long-term Extension|Withdrawal by Subject|0|||
125402577|NCT03013491|451100829|FG006|Long-term Extension|Withdrawal by Subject|0|||
125402578|NCT03013491|451100830|FG007|Long-term Extension|Withdrawal by Subject|1|||
125402579|NCT03013491|451100831|FG008|Long-term Extension|Withdrawal by Subject|0|||
125402580|NCT03013491|451100832|FG009|Long-term Extension|Withdrawal by Subject|0|||
125402581|NCT03013491|451100833|FG010|Long-term Extension|Withdrawal by Subject|0|||
125402582|NCT03013491|451100834|FG011|Long-term Extension|Withdrawal by Subject|0|||
125402583|NCT03013491|451100835|FG012|Long-term Extension|Withdrawal by Subject|0|||
125402584|NCT03013491|451100836|FG013|Long-term Extension|Withdrawal by Subject|0|||
125402585|NCT03013491|451100837|FG014|Long-term Extension|Withdrawal by Subject|0|||
125402586|NCT03013491|451100838|FG015|Long-term Extension|Withdrawal by Subject|0|||
125402587|NCT03013491|451100839|FG016|Long-term Extension|Withdrawal by Subject|0|||
125402588|NCT03013491|451100840|FG017|Long-term Extension|Withdrawal by Subject|0|||
125402589|NCT03013491|451100841|FG018|Long-term Extension|Withdrawal by Subject|0|||
125402590|NCT03013491|451100823|FG000|Long-term Extension|Adverse Event|0|||
125402591|NCT03013491|451100824|FG001|Long-term Extension|Adverse Event|0|||
125402592|NCT03013491|451100825|FG002|Long-term Extension|Adverse Event|0|||
125402593|NCT03013491|451100826|FG003|Long-term Extension|Adverse Event|0|||
125402594|NCT03013491|451100827|FG004|Long-term Extension|Adverse Event|0|||
125402595|NCT03013491|451100828|FG005|Long-term Extension|Adverse Event|0|||
125402596|NCT03013491|451100829|FG006|Long-term Extension|Adverse Event|0|||
125402597|NCT03013491|451100830|FG007|Long-term Extension|Adverse Event|0|||
125402598|NCT03013491|451100831|FG008|Long-term Extension|Adverse Event|0|||
125402599|NCT03013491|451100832|FG009|Long-term Extension|Adverse Event|0|||
125402600|NCT03013491|451100833|FG010|Long-term Extension|Adverse Event|0|||
125402601|NCT03013491|451100834|FG011|Long-term Extension|Adverse Event|0|||
125402602|NCT03013491|451100835|FG012|Long-term Extension|Adverse Event|0|||
125402603|NCT03013491|451100836|FG013|Long-term Extension|Adverse Event|0|||
125402604|NCT03013491|451100837|FG014|Long-term Extension|Adverse Event|0|||
125402605|NCT03013491|451100838|FG015|Long-term Extension|Adverse Event|0|||
125402606|NCT03013491|451100839|FG016|Long-term Extension|Adverse Event|0|||
125402607|NCT03013491|451100840|FG017|Long-term Extension|Adverse Event|0|||
125402608|NCT03013491|451100841|FG018|Long-term Extension|Adverse Event|1|||
125402609|NCT03013491|451100823|FG000|Long-term Extension|Death|0|||
125402610|NCT03013491|451100824|FG001|Long-term Extension|Death|0|||
125402611|NCT03013491|451100825|FG002|Long-term Extension|Death|0|||
125402612|NCT03013491|451100826|FG003|Long-term Extension|Death|0|||
125402613|NCT03013491|451100827|FG004|Long-term Extension|Death|0|||
125402614|NCT03013491|451100828|FG005|Long-term Extension|Death|0|||
125402615|NCT03013491|451100829|FG006|Long-term Extension|Death|0|||
125402616|NCT03013491|451100830|FG007|Long-term Extension|Death|0|||
125402617|NCT03013491|451100831|FG008|Long-term Extension|Death|0|||
125402618|NCT03013491|451100832|FG009|Long-term Extension|Death|0|||
125402619|NCT03013491|451100833|FG010|Long-term Extension|Death|0|||
125402620|NCT03013491|451100834|FG011|Long-term Extension|Death|0|||
125402621|NCT03013491|451100835|FG012|Long-term Extension|Death|0|||
125402622|NCT03013491|451100836|FG013|Long-term Extension|Death|0|||
125402623|NCT03013491|451100837|FG014|Long-term Extension|Death|0|||
125402624|NCT03013491|451100838|FG015|Long-term Extension|Death|0|||
125402625|NCT03013491|451100839|FG016|Long-term Extension|Death|0|||
125402626|NCT03013491|451100840|FG017|Long-term Extension|Death|0|||
125402627|NCT03013491|451100841|FG018|Long-term Extension|Death|1|||
125402628|NCT00991302|451102448|FG000|Overall Study|Death|0|||
125402629|NCT00991302|451102449|FG001|Overall Study|Death|1|||
125402630|NCT00991302|451102448|FG000|Overall Study|Lost to Follow-up|14|||
125402631|NCT00991302|451102449|FG001|Overall Study|Lost to Follow-up|12|||
125402632|NCT01709318|451102450|FG000|Overall Study|Adverse Event|3|||
125402633|NCT01709318|451102451|FG001|Overall Study|Adverse Event|4|||
125402634|NCT01709318|451102452|FG002|Overall Study|Adverse Event|2|||
125402635|NCT01709318|451102453|FG003|Overall Study|Adverse Event|2|||
125402636|NCT01709318|451102454|FG004|Overall Study|Adverse Event|0|||
125402637|NCT01709318|451102455|FG005|Overall Study|Adverse Event|1|||
125402638|NCT01709318|451102456|FG006|Overall Study|Adverse Event|2|||
125402639|NCT01709318|451102450|FG000|Overall Study|Lost to Follow-up|2|||
125402640|NCT01709318|451102451|FG001|Overall Study|Lost to Follow-up|0|||
125402641|NCT01709318|451102452|FG002|Overall Study|Lost to Follow-up|0|||
125402642|NCT01709318|451102453|FG003|Overall Study|Lost to Follow-up|0|||
125402643|NCT01709318|451102454|FG004|Overall Study|Lost to Follow-up|1|||
125402644|NCT01709318|451102455|FG005|Overall Study|Lost to Follow-up|1|||
125402645|NCT01709318|451102456|FG006|Overall Study|Lost to Follow-up|1|||
125402646|NCT01709318|451102450|FG000|Overall Study|Non-compliance with Study Drug|0|||
125402647|NCT01709318|451102451|FG001|Overall Study|Non-compliance with Study Drug|2|||
125402648|NCT01709318|451102452|FG002|Overall Study|Non-compliance with Study Drug|1|||
125402649|NCT01709318|451102453|FG003|Overall Study|Non-compliance with Study Drug|1|||
125402650|NCT01709318|451102454|FG004|Overall Study|Non-compliance with Study Drug|0|||
125402651|NCT01709318|451102455|FG005|Overall Study|Non-compliance with Study Drug|0|||
125402652|NCT01709318|451102456|FG006|Overall Study|Non-compliance with Study Drug|2|||
125402653|NCT01709318|451102450|FG000|Overall Study|Physician Decision|0|||
125402654|NCT01709318|451102451|FG001|Overall Study|Physician Decision|0|||
125402655|NCT01709318|451102452|FG002|Overall Study|Physician Decision|0|||
125402656|NCT01709318|451102453|FG003|Overall Study|Physician Decision|0|||
125447913|NCT00965484|451266869|FG000|Overall Study|Withdrawal by Subject|1|||
125447914|NCT00848211|451266870|FG000|Overall Study|Protocol Violation|0|||
125447915|NCT00848211|451266871|FG001|Overall Study|Protocol Violation|1|||
125447916|NCT00848211|451266872|FG002|Overall Study|Protocol Violation|1|||
125447917|NCT00848211|451266873|FG003|Overall Study|Protocol Violation|0|||
125447918|NCT00848211|451266870|FG000|Overall Study|Adverse Event|0|||
125402657|NCT01709318|451102454|FG004|Overall Study|Physician Decision|0|||
125402658|NCT01709318|451102455|FG005|Overall Study|Physician Decision|0|||
125402659|NCT01709318|451102456|FG006|Overall Study|Physician Decision|1|||
125402660|NCT01709318|451102450|FG000|Overall Study|Pregnancy|0|||
125402661|NCT01709318|451102451|FG001|Overall Study|Pregnancy|0|||
125402662|NCT01709318|451102452|FG002|Overall Study|Pregnancy|0|||
125402663|NCT01709318|451102453|FG003|Overall Study|Pregnancy|0|||
125402664|NCT01709318|451102454|FG004|Overall Study|Pregnancy|1|||
125402665|NCT01709318|451102455|FG005|Overall Study|Pregnancy|0|||
125402666|NCT01709318|451102456|FG006|Overall Study|Pregnancy|0|||
125447919|NCT00848211|451266871|FG001|Overall Study|Adverse Event|0|||
125402667|NCT01709318|451102450|FG000|Overall Study|Protocol Violation|0|||
125402668|NCT01709318|451102451|FG001|Overall Study|Protocol Violation|0|||
125402669|NCT01709318|451102452|FG002|Overall Study|Protocol Violation|0|||
125402670|NCT01709318|451102453|FG003|Overall Study|Protocol Violation|0|||
125402671|NCT01709318|451102454|FG004|Overall Study|Protocol Violation|2|||
125402672|NCT01709318|451102455|FG005|Overall Study|Protocol Violation|0|||
125402673|NCT01709318|451102456|FG006|Overall Study|Protocol Violation|1|||
125402674|NCT01709318|451102450|FG000|Overall Study|Technical Problems|1|||
125402675|NCT01709318|451102451|FG001|Overall Study|Technical Problems|0|||
125447920|NCT00848211|451266872|FG002|Overall Study|Adverse Event|0|||
125402676|NCT01709318|451102452|FG002|Overall Study|Technical Problems|0|||
125402677|NCT01709318|451102453|FG003|Overall Study|Technical Problems|0|||
125402678|NCT01709318|451102454|FG004|Overall Study|Technical Problems|0|||
125402679|NCT01709318|451102455|FG005|Overall Study|Technical Problems|0|||
125402680|NCT01709318|451102456|FG006|Overall Study|Technical Problems|0|||
125402681|NCT01709318|451102450|FG000|Overall Study|Withdrawal by Subject|3|||
125402682|NCT01709318|451102451|FG001|Overall Study|Withdrawal by Subject|0|||
125402683|NCT01709318|451102452|FG002|Overall Study|Withdrawal by Subject|3|||
125402684|NCT01709318|451102453|FG003|Overall Study|Withdrawal by Subject|3|||
125402685|NCT01709318|451102454|FG004|Overall Study|Withdrawal by Subject|0|||
125402686|NCT01709318|451102455|FG005|Overall Study|Withdrawal by Subject|2|||
125402687|NCT01709318|451102456|FG006|Overall Study|Withdrawal by Subject|4|||
125402688|NCT01709318|451102450|FG000|Overall Study|Other Protocol Specified Criteria|0|||
125402689|NCT01709318|451102451|FG001|Overall Study|Other Protocol Specified Criteria|1|||
125402690|NCT01709318|451102452|FG002|Overall Study|Other Protocol Specified Criteria|0|||
125402691|NCT01709318|451102453|FG003|Overall Study|Other Protocol Specified Criteria|0|||
125402692|NCT01709318|451102454|FG004|Overall Study|Other Protocol Specified Criteria|0|||
125402693|NCT01709318|451102455|FG005|Overall Study|Other Protocol Specified Criteria|0|||
125402694|NCT01709318|451102456|FG006|Overall Study|Other Protocol Specified Criteria|0|||
125402695|NCT03042312|451102457|FG000|Overall Study|Administrative Reason|1|||
125402696|NCT03042312|451102458|FG001|Overall Study|Administrative Reason|1|||
125402697|NCT03042312|451102457|FG000|Overall Study|Adverse Event|0|||
125402698|NCT03042312|451102458|FG001|Overall Study|Adverse Event|1|||
125402699|NCT03042312|451102457|FG000|Overall Study|Lost to Follow-up|1|||
125402700|NCT03042312|451102458|FG001|Overall Study|Lost to Follow-up|3|||
125402701|NCT03042312|451102457|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
125402702|NCT03042312|451102458|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
125402703|NCT03042312|451102457|FG000|Overall Study|Withdrawal by Subject|4|||
125402704|NCT03042312|451102458|FG001|Overall Study|Withdrawal by Subject|5|||
125402705|NCT02383758|451102459|FG000|Overall Study|Withdrawal by Subject|0|||
125402706|NCT02383758|451102460|FG001|Overall Study|Withdrawal by Subject|2|||
125402707|NCT00646958|451102465|FG000|Overall Study|Lack of Efficacy|1|||
125402708|NCT00646958|451102466|FG001|Overall Study|Lack of Efficacy|0|||
125402709|NCT00646958|451102467|FG002|Overall Study|Lack of Efficacy|0|||
125402710|NCT00646958|451102465|FG000|Overall Study|Adverse Event|4|||
125402711|NCT00646958|451102466|FG001|Overall Study|Adverse Event|0|||
125402712|NCT00646958|451102467|FG002|Overall Study|Adverse Event|0|||
125402713|NCT00646958|451102465|FG000|Overall Study|Lost to Follow-up|1|||
125402714|NCT00646958|451102466|FG001|Overall Study|Lost to Follow-up|5|||
125402715|NCT00646958|451102467|FG002|Overall Study|Lost to Follow-up|7|||
125402716|NCT00646958|451102465|FG000|Overall Study|Protocol Violation|1|||
125402717|NCT00646958|451102466|FG001|Overall Study|Protocol Violation|1|||
125402718|NCT00646958|451102467|FG002|Overall Study|Protocol Violation|0|||
125402719|NCT00646958|451102465|FG000|Overall Study|Abnormal screening lab tests|1|||
125402720|NCT00646958|451102466|FG001|Overall Study|Abnormal screening lab tests|1|||
125402721|NCT00646958|451102467|FG002|Overall Study|Abnormal screening lab tests|0|||
125402722|NCT00646958|451102465|FG000|Overall Study|Withdrawal by Subject|1|||
125402723|NCT00646958|451102466|FG001|Overall Study|Withdrawal by Subject|2|||
125402724|NCT00646958|451102467|FG002|Overall Study|Withdrawal by Subject|0|||
125402725|NCT00646958|451102465|FG000|Overall Study|Did not receive study drug|2|||
125402726|NCT00646958|451102466|FG001|Overall Study|Did not receive study drug|0|||
125402727|NCT00646958|451102467|FG002|Overall Study|Did not receive study drug|2|||
125402728|NCT02453594|451102469|FG000|Overall Study|Protocol Violation|0|||
125402729|NCT02453594|451102470|FG001|Overall Study|Protocol Violation|0|||
125402730|NCT02453594|451102471|FG002|Overall Study|Protocol Violation|1|||
125402731|NCT02453594|451102469|FG000|Overall Study|Cohort Was Closed|17|||
125402732|NCT02453594|451102470|FG001|Overall Study|Cohort Was Closed|21|||
125402733|NCT02453594|451102471|FG002|Overall Study|Cohort Was Closed|14|||
125402734|NCT02453594|451102469|FG000|Overall Study|Death|20|||
125402735|NCT02453594|451102470|FG001|Overall Study|Death|24|||
125402736|NCT02453594|451102471|FG002|Overall Study|Death|16|||
125402737|NCT02453594|451102469|FG000|Overall Study|Lost to Follow-up|6|||
125402738|NCT02453594|451102470|FG001|Overall Study|Lost to Follow-up|14|||
125402739|NCT02453594|451102471|FG002|Overall Study|Lost to Follow-up|2|||
125402740|NCT02453594|451102469|FG000|Overall Study|Physician Decision|2|||
125402741|NCT02453594|451102470|FG001|Overall Study|Physician Decision|4|||
125402742|NCT02453594|451102471|FG002|Overall Study|Physician Decision|0|||
125402743|NCT02453594|451102469|FG000|Overall Study|Site Terminated by Sponsor|1|||
125402744|NCT02453594|451102470|FG001|Overall Study|Site Terminated by Sponsor|0|||
125447921|NCT00848211|451266873|FG003|Overall Study|Adverse Event|0|||
125447922|NCT01124617|451266874|FG000|Overall Study|Adverse Event|5|||
125277395|NCT02836717|450642202|FG001|Study Phase|Lack of Efficacy|6|||
125402745|NCT02453594|451102471|FG002|Overall Study|Site Terminated by Sponsor|1|||
125402746|NCT02453594|451102469|FG000|Overall Study|Transitioned to Extension Study|16|||
125402747|NCT02453594|451102470|FG001|Overall Study|Transitioned to Extension Study|9|||
125402748|NCT02453594|451102471|FG002|Overall Study|Transitioned to Extension Study|16|||
125402749|NCT02453594|451102469|FG000|Overall Study|Withdrawal by Subject|7|||
125402750|NCT02453594|451102470|FG001|Overall Study|Withdrawal by Subject|9|||
125402751|NCT02453594|451102471|FG002|Overall Study|Withdrawal by Subject|11|||
125402752|NCT04101526|451102475|FG000|Overall Study|Did not complete all sleep diary entries|0|||
125402753|NCT04101526|451102476|FG001|Overall Study|Did not complete all sleep diary entries|1|||
125402754|NCT02167035|451102477|FG000|Overall Study|Adverse Event|2|||
125402755|NCT02167035|451102478|FG001|Overall Study|Adverse Event|2|||
125402756|NCT02167035|451102477|FG000|Overall Study|Lost to Follow-up|3|||
125402757|NCT02167035|451102478|FG001|Overall Study|Lost to Follow-up|3|||
125402758|NCT02167035|451102477|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
125402759|NCT02167035|451102478|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
125402760|NCT02148003|451102479|FG000|Overall Study|Failed inclusion criteria|1|||
125402761|NCT02148003|451102480|FG001|Overall Study|Failed inclusion criteria|0|||
125402762|NCT02148003|451102479|FG000|Overall Study|Met exclusion criteria|0|||
125402763|NCT02148003|451102480|FG001|Overall Study|Met exclusion criteria|1|||
125402764|NCT02148003|451102479|FG000|Overall Study|Withdrawal by Subject|0|||
125402765|NCT02148003|451102480|FG001|Overall Study|Withdrawal by Subject|1|||
125402766|NCT02489981|451102481|FG000|Overall Study|Adverse Event|21|||
125402767|NCT02489981|451102481|FG000|Overall Study|Insufficient effectiveness|16|||
125402768|NCT02489981|451102481|FG000|Overall Study|Improved|31|||
125402769|NCT02489981|451102481|FG000|Overall Study|Lost to Follow-up|31|||
125402770|NCT02489981|451102481|FG000|Overall Study|Other than listed|28|||
125402771|NCT03852316|451102486|FG000|Overall Study|Protocol Violation|1|||
125402772|NCT03852316|451102486|FG000|Overall Study|Withdrawal by Subject|2|||
125402773|NCT03852316|451102486|FG000|Overall Study|Enrolled but Device not Utilized|1|||
125402774|NCT03592641|451102487|FG000|Overall Study|Withdrawal by Subject|1|||
125402775|NCT00436280|451102488|FG000|Period 1: Induction|Adverse Event|8|||
125402776|NCT00436280|451102488|FG000|Period 1: Induction|Progressive Disease|12|||
125402777|NCT00436280|451102488|FG000|Period 1: Induction|Stable Disease|6|||
125402778|NCT00436280|451102488|FG000|Period 1: Induction|Withdrawal by Subject|1|||
125402779|NCT00436280|451102488|FG000|Period 1: Induction|Death|1|||
125402780|NCT00436280|451102488|FG000|Period 2: Consolidation|Adverse Event|1|||
125402781|NCT00436280|451102488|FG000|Period 2: Consolidation|Progressive Disease|10|||
125402782|NCT00436280|451102488|FG000|Period 2: Consolidation|Stable Disease|1|||
125402783|NCT00436280|451102488|FG000|Period 2: Consolidation|Physician Decision|2|||
125402784|NCT00436280|451102488|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
125402785|NCT00436280|451102488|FG000|Period 2: Consolidation|Death|1|||
125402786|NCT00436280|451102488|FG000|Period 3: Maintenance|Adverse Event|6|||
125402787|NCT00436280|451102488|FG000|Period 3: Maintenance|Progressive Disease|12|||
125402788|NCT01049919|451102492|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
125402789|NCT01049919|451102493|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
125402790|NCT01049919|451102492|FG000|Overall Study|Withdrawal by Subject|5|||
125402791|NCT01049919|451102493|FG001|Overall Study|Withdrawal by Subject|0|||
125402792|NCT01049919|451102492|FG000|Overall Study|Lost to Follow-up|6|||
125402793|NCT01049919|451102493|FG001|Overall Study|Lost to Follow-up|1|||
125402794|NCT01049919|451102492|FG000|Overall Study|Physician Decision|2|||
125402795|NCT01049919|451102493|FG001|Overall Study|Physician Decision|0|||
125402796|NCT01049919|451102492|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
125402797|NCT01049919|451102493|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
125402798|NCT01049919|451102492|FG000|Overall Study|Early study termination by sponsor.|2|||
125402799|NCT01049919|451102493|FG001|Overall Study|Early study termination by sponsor.|0|||
125402800|NCT01532687|451102498|FG000|Overall Study|Death|2|||
125402801|NCT01532687|451102499|FG001|Overall Study|Death|0|||
125402802|NCT01532687|451102498|FG000|Overall Study|Adverse Event|6|||
125402803|NCT01532687|451102499|FG001|Overall Study|Adverse Event|1|||
125402804|NCT01532687|451102498|FG000|Overall Study|Withdrawal by Subject|1|||
125402805|NCT01532687|451102499|FG001|Overall Study|Withdrawal by Subject|0|||
125402806|NCT01532687|451102498|FG000|Overall Study|Physician Decision|2|||
125402807|NCT01532687|451102499|FG001|Overall Study|Physician Decision|1|||
125402808|NCT01532687|451102498|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
125402809|NCT01532687|451102499|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
125402810|NCT03160703|451102500|FG000|Overall Study|Withdrawal by Subject|0|||
125402811|NCT03160703|451102501|FG001|Overall Study|Withdrawal by Subject|0|||
125402812|NCT03160703|451102502|FG002|Overall Study|Withdrawal by Subject|0|||
125402813|NCT03160703|451102503|FG003|Overall Study|Withdrawal by Subject|1|||
125447923|NCT01124617|451266875|FG001|Overall Study|Adverse Event|2|||
125402814|NCT02984995|451102504|FG000|Overall Study|Required stem cell transplant|13|||
125402815|NCT02984995|451102505|FG001|Overall Study|Required stem cell transplant|2|||
125402816|NCT02984995|451102504|FG000|Overall Study|Progressive disease|11|||
125402817|NCT02984995|451102505|FG001|Overall Study|Progressive disease|1|||
125402818|NCT02984995|451102504|FG000|Overall Study|Adverse Event|1|||
125402819|NCT02984995|451102505|FG001|Overall Study|Adverse Event|0|||
125402820|NCT00047463|451102506|FG000|Overall Study|Withdrawal by Subject|0|||
125402821|NCT00047463|451102507|FG001|Overall Study|Withdrawal by Subject|3|||
125402822|NCT01401530|451102509|FG000|Overall Study|Disease Progression|1|||
125402823|NCT01401530|451102510|FG001|Overall Study|Disease Progression|2|||
125402824|NCT01401530|451102511|FG002|Overall Study|Disease Progression|1|||
125402825|NCT01401530|451102509|FG000|Overall Study|Adverse Event|1|||
125402826|NCT01401530|451102510|FG001|Overall Study|Adverse Event|1|||
125402827|NCT01401530|451102511|FG002|Overall Study|Adverse Event|1|||
125402828|NCT01401530|451102509|FG000|Overall Study|Participant Choice|1|||
125402829|NCT01401530|451102510|FG001|Overall Study|Participant Choice|2|||
125402830|NCT01401530|451102511|FG002|Overall Study|Participant Choice|1|||
125402831|NCT01401530|451102509|FG000|Overall Study|Physician Decision|0|||
125402832|NCT01401530|451102510|FG001|Overall Study|Physician Decision|1|||
125402833|NCT01401530|451102511|FG002|Overall Study|Physician Decision|0|||
125402834|NCT01448850|451102512|FG000|Overall Study|Death|3|||
125402835|NCT01448850|451102513|FG001|Overall Study|Death|6|||
125402836|NCT01448850|451102512|FG000|Overall Study|Withdrawal by Subject|13|||
125402837|NCT01448850|451102513|FG001|Overall Study|Withdrawal by Subject|21|||
125402838|NCT01448850|451102512|FG000|Overall Study|Lost to Follow-up|3|||
125402839|NCT01448850|451102513|FG001|Overall Study|Lost to Follow-up|1|||
125402840|NCT01448850|451102512|FG000|Overall Study|Other|15|||
125402841|NCT01448850|451102513|FG001|Overall Study|Other|12|||
125402842|NCT02939404|451102514|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
125402843|NCT02939404|451102515|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
125402844|NCT02939404|451102514|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
125402845|NCT02939404|451102515|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
125402846|NCT02047110|451102522|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
125402847|NCT02047110|451102523|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
125402848|NCT02047110|451102524|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
125402849|NCT02047110|451102525|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
125402850|NCT02047110|451102522|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
125402851|NCT02047110|451102523|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
125402852|NCT02047110|451102524|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
125402853|NCT02047110|451102525|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
125402854|NCT02047110|451102522|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
125402855|NCT02047110|451102523|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
125402856|NCT02047110|451102524|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
125402857|NCT02047110|451102525|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
125402858|NCT02047110|451102522|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
125402859|NCT02047110|451102523|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
125402860|NCT02047110|451102524|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
125402861|NCT02047110|451102525|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
125402862|NCT02047110|451102522|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
125402863|NCT02047110|451102523|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
125402864|NCT02047110|451102524|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
125402865|NCT02047110|451102525|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
125402866|NCT02047110|451102522|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
125402867|NCT02047110|451102523|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
125402868|NCT02047110|451102524|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
125402869|NCT02047110|451102525|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
125402870|NCT02047110|451102522|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
125402871|NCT02047110|451102523|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
125402872|NCT02047110|451102524|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
125402873|NCT02047110|451102525|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
125402874|NCT02047110|451102522|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
125402875|NCT02047110|451102523|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
125402876|NCT02047110|451102524|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
125402877|NCT02047110|451102525|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
125402878|NCT02047110|451102522|FG000|Escape Treatment Period|Adverse Event|1|||
125402879|NCT02047110|451102523|FG001|Escape Treatment Period|Adverse Event|2|||
125402880|NCT02047110|451102524|FG002|Escape Treatment Period|Adverse Event|2|||
125402881|NCT02047110|451102525|FG003|Escape Treatment Period|Adverse Event|0|||
125402882|NCT02047110|451102522|FG000|Escape Treatment Period|Other than specified|1|||
125402883|NCT02047110|451102523|FG001|Escape Treatment Period|Other than specified|2|||
125402884|NCT02047110|451102524|FG002|Escape Treatment Period|Other than specified|0|||
125402885|NCT02047110|451102525|FG003|Escape Treatment Period|Other than specified|1|||
125402886|NCT02047110|451102522|FG000|OLE Treatment Period|Other than specified|0|||
125402887|NCT02047110|451102523|FG001|OLE Treatment Period|Other than specified|0|||
125402888|NCT02047110|451102524|FG002|OLE Treatment Period|Other than specified|1|||
125402889|NCT02047110|451102525|FG003|OLE Treatment Period|Other than specified|0|||
125402890|NCT02247349|451102526|FG000|Overall Study|Disease Progression|7|||
125402891|NCT02247349|451102527|FG001|Overall Study|Disease Progression|4|||
125402892|NCT02247349|451102528|FG002|Overall Study|Disease Progression|26|||
125447924|NCT01124617|451266874|FG000|Overall Study|Lack of Efficacy|2|||
125447925|NCT01124617|451266875|FG001|Overall Study|Lack of Efficacy|1|||
125447926|NCT01124617|451266874|FG000|Overall Study|Protocol Violation|1|||
125277396|NCT02836717|450642203|FG002|Study Phase|Lack of Efficacy|1|||
125277397|NCT02836717|450642201|FG000|Study Phase|Withdrawal by Subject|1|||
125277398|NCT02836717|450642202|FG001|Study Phase|Withdrawal by Subject|0|||
125277399|NCT02836717|450642203|FG002|Study Phase|Withdrawal by Subject|0|||
125277400|NCT02836717|450642201|FG000|Study Phase|Death|1|||
125277401|NCT02836717|450642202|FG001|Study Phase|Death|0|||
125277402|NCT02836717|450642203|FG002|Study Phase|Death|0|||
125277403|NCT02836717|450642201|FG000|Study Phase|abdominal surgeries|2|||
125277404|NCT02836717|450642202|FG001|Study Phase|abdominal surgeries|1|||
125277405|NCT02836717|450642203|FG002|Study Phase|abdominal surgeries|0|||
125277406|NCT03636893|450642204|FG000|Overall Study|Death|0|||
125277407|NCT03636893|450642205|FG001|Overall Study|Death|1|||
125277408|NCT03636893|450642204|FG000|Overall Study|Protocol Violation|0|||
125277409|NCT03636893|450642205|FG001|Overall Study|Protocol Violation|3|||
125277410|NCT03636893|450642204|FG000|Overall Study|Withdrawal by Subject|1|||
125277411|NCT03636893|450642205|FG001|Overall Study|Withdrawal by Subject|2|||
125277412|NCT03636893|450642204|FG000|Overall Study|Refusal to surgery|4|||
125277413|NCT03636893|450642205|FG001|Overall Study|Refusal to surgery|3|||
125277414|NCT03636893|450642204|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
125277415|NCT03636893|450642205|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
125277416|NCT03636893|450642204|FG000|Overall Study|Adverse Event|1|||
125277417|NCT03636893|450642205|FG001|Overall Study|Adverse Event|1|||
125277418|NCT00438360|450642206|FG000|Overall Study|Adverse Event|6|||
125277419|NCT00438360|450642207|FG001|Overall Study|Adverse Event|1|||
125277420|NCT00438360|450642206|FG000|Overall Study|Lack of Efficacy|42|||
125277421|NCT00438360|450642207|FG001|Overall Study|Lack of Efficacy|27|||
125277422|NCT00438360|450642206|FG000|Overall Study|Other|24|||
125277423|NCT00438360|450642207|FG001|Overall Study|Other|15|||
125277424|NCT04560816|450642209|FG000|Overall Study|Withdrawal by Subject|1|||
125277425|NCT04560816|450642210|FG001|Overall Study|Withdrawal by Subject|1|||
125277426|NCT04560816|450642211|FG002|Overall Study|Withdrawal by Subject|1|||
125277427|NCT04560816|450642212|FG003|Overall Study|Withdrawal by Subject|0|||
125277428|NCT04560816|450642213|FG004|Overall Study|Withdrawal by Subject|3|||
125277429|NCT04560816|450642214|FG005|Overall Study|Withdrawal by Subject|0|||
125277430|NCT04560816|450642209|FG000|Overall Study|Lost to Follow-up|1|||
125277431|NCT04560816|450642210|FG001|Overall Study|Lost to Follow-up|0|||
125277432|NCT04560816|450642211|FG002|Overall Study|Lost to Follow-up|0|||
125277433|NCT04560816|450642212|FG003|Overall Study|Lost to Follow-up|0|||
125277434|NCT04560816|450642213|FG004|Overall Study|Lost to Follow-up|0|||
125277435|NCT04560816|450642214|FG005|Overall Study|Lost to Follow-up|0|||
125277436|NCT04560816|450642209|FG000|Overall Study|Protocol Violation|1|||
125277437|NCT04560816|450642210|FG001|Overall Study|Protocol Violation|0|||
125277438|NCT04560816|450642211|FG002|Overall Study|Protocol Violation|0|||
125277439|NCT04560816|450642212|FG003|Overall Study|Protocol Violation|0|||
125277440|NCT04560816|450642213|FG004|Overall Study|Protocol Violation|0|||
125277441|NCT04560816|450642214|FG005|Overall Study|Protocol Violation|0|||
125277442|NCT02277691|450642215|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
125277443|NCT02277691|450642215|FG000|Overall Study|Voluntary Withdrawal|7|||
125277444|NCT02277691|450642215|FG000|Overall Study|Lack of Efficacy|5|||
125277445|NCT02277691|450642215|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
125277446|NCT03818607|450642216|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
125277447|NCT03818607|450642217|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
125277448|NCT03818607|450642216|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
125277449|NCT03818607|450642217|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
125277450|NCT03818607|450642216|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
125277451|NCT03818607|450642217|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
125277452|NCT05059301|450642219|FG000|Overall Study|Adverse Event|0|||
125277453|NCT05059301|450642220|FG001|Overall Study|Adverse Event|2|||
125277454|NCT05059301|450642221|FG002|Overall Study|Adverse Event|2|||
125277455|NCT05059301|450642219|FG000|Overall Study|Lost to Follow-up|2|||
125277456|NCT05059301|450642220|FG001|Overall Study|Lost to Follow-up|3|||
125277457|NCT05059301|450642221|FG002|Overall Study|Lost to Follow-up|3|||
125277458|NCT01164891|450642222|FG000|Overall Study|Disease Progression|5|||
125277459|NCT01164891|450642222|FG000|Overall Study|Adverse Event|1|||
125277460|NCT00441142|450642223|FG000|Overall Study|Adverse Event|2|||
125277461|NCT00441142|450642224|FG001|Overall Study|Adverse Event|3|||
125277462|NCT00441142|450642225|FG002|Overall Study|Adverse Event|3|||
125277463|NCT00441142|450642226|FG003|Overall Study|Adverse Event|22|||
125277464|NCT00441142|450642223|FG000|Overall Study|Lack of Efficacy|3|||
125277465|NCT00441142|450642224|FG001|Overall Study|Lack of Efficacy|3|||
125277466|NCT00441142|450642225|FG002|Overall Study|Lack of Efficacy|17|||
125277467|NCT00441142|450642226|FG003|Overall Study|Lack of Efficacy|32|||
125277468|NCT00441142|450642223|FG000|Overall Study|Withdrawal by Subject|0|||
125277469|NCT00441142|450642224|FG001|Overall Study|Withdrawal by Subject|0|||
125277470|NCT00441142|450642225|FG002|Overall Study|Withdrawal by Subject|2|||
125277471|NCT00441142|450642226|FG003|Overall Study|Withdrawal by Subject|10|||
125277472|NCT00441142|450642223|FG000|Overall Study|Patient still receiving active study tx|1|||
125402893|NCT02247349|451102529|FG003|Overall Study|Disease Progression|31|||
125402894|NCT02247349|451102530|FG004|Overall Study|Disease Progression|16|||
125402895|NCT02247349|451102531|FG005|Overall Study|Disease Progression|6|||
125402896|NCT02247349|451102526|FG000|Overall Study|Study drug toxicity|0|||
125402897|NCT02247349|451102527|FG001|Overall Study|Study drug toxicity|1|||
125402898|NCT02247349|451102528|FG002|Overall Study|Study drug toxicity|1|||
125402899|NCT02247349|451102529|FG003|Overall Study|Study drug toxicity|1|||
125402900|NCT02247349|451102530|FG004|Overall Study|Study drug toxicity|2|||
125402901|NCT02247349|451102531|FG005|Overall Study|Study drug toxicity|2|||
125402902|NCT02247349|451102526|FG000|Overall Study|Death|0|||
125402903|NCT02247349|451102527|FG001|Overall Study|Death|0|||
125402904|NCT02247349|451102528|FG002|Overall Study|Death|0|||
125402905|NCT02247349|451102529|FG003|Overall Study|Death|1|||
125402906|NCT02247349|451102530|FG004|Overall Study|Death|0|||
125402907|NCT02247349|451102531|FG005|Overall Study|Death|0|||
125402908|NCT02247349|451102526|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
125402909|NCT02247349|451102527|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
125402910|NCT02247349|451102528|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
125402911|NCT02247349|451102529|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
125402912|NCT02247349|451102530|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
125402913|NCT02247349|451102531|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
125402914|NCT02247349|451102526|FG000|Overall Study|Participant request to discontinue study treatment|0|||
125402915|NCT02247349|451102527|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125402916|NCT02247349|451102528|FG002|Overall Study|Participant request to discontinue study treatment|1|||
125402917|NCT02247349|451102529|FG003|Overall Study|Participant request to discontinue study treatment|2|||
125402918|NCT02247349|451102530|FG004|Overall Study|Participant request to discontinue study treatment|1|||
125402919|NCT02247349|451102531|FG005|Overall Study|Participant request to discontinue study treatment|0|||
125402920|NCT02247349|451102526|FG000|Overall Study|Withdrawal by Subject|0|||
125402921|NCT02247349|451102527|FG001|Overall Study|Withdrawal by Subject|1|||
125402922|NCT02247349|451102528|FG002|Overall Study|Withdrawal by Subject|0|||
125402923|NCT02247349|451102529|FG003|Overall Study|Withdrawal by Subject|0|||
125402924|NCT02247349|451102530|FG004|Overall Study|Withdrawal by Subject|0|||
125402925|NCT02247349|451102531|FG005|Overall Study|Withdrawal by Subject|0|||
125402926|NCT02247349|451102526|FG000|Overall Study|Administrative reason by sponsor|0|||
125402927|NCT02247349|451102527|FG001|Overall Study|Administrative reason by sponsor|0|||
125402928|NCT02247349|451102528|FG002|Overall Study|Administrative reason by sponsor|0|||
125402929|NCT02247349|451102529|FG003|Overall Study|Administrative reason by sponsor|0|||
125402930|NCT02247349|451102530|FG004|Overall Study|Administrative reason by sponsor|1|||
125402931|NCT02247349|451102531|FG005|Overall Study|Administrative reason by sponsor|0|||
125402932|NCT02247349|451102526|FG000|Overall Study|Other reasons|0|||
125402933|NCT02247349|451102527|FG001|Overall Study|Other reasons|0|||
125402934|NCT02247349|451102528|FG002|Overall Study|Other reasons|1|||
125402935|NCT02247349|451102529|FG003|Overall Study|Other reasons|0|||
125402936|NCT02247349|451102530|FG004|Overall Study|Other reasons|0|||
125402937|NCT02247349|451102531|FG005|Overall Study|Other reasons|0|||
125402938|NCT01959581|451102536|FG000|Overall Study|Lost to Follow-up|5|||
125402939|NCT00280566|451102539|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
125402940|NCT00280566|451102540|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
125402941|NCT00280566|451102541|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
125402942|NCT00280566|451102539|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
125402943|NCT00280566|451102540|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
125402944|NCT00280566|451102541|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
125402945|NCT00280566|451102539|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
125402946|NCT00280566|451102540|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
125402947|NCT00280566|451102541|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
125402948|NCT00280566|451102539|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
125402949|NCT00280566|451102540|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
125402950|NCT00280566|451102541|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
125402951|NCT00280566|451102539|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
125402952|NCT00280566|451102540|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
125402953|NCT00280566|451102541|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
125402954|NCT00280566|451102539|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
125402955|NCT00280566|451102540|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
125402956|NCT00280566|451102541|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
125402957|NCT00280566|451102539|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
125402958|NCT00280566|451102540|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
125447927|NCT01124617|451266875|FG001|Overall Study|Protocol Violation|1|||
125447928|NCT01124617|451266874|FG000|Overall Study|Withdrawal by Subject|9|||
125402959|NCT00280566|451102541|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
125402960|NCT00280566|451102539|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
125402961|NCT00280566|451102540|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
125402962|NCT00280566|451102541|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
125402963|NCT00280566|451102539|FG000|Period 2 Double Blind|Adverse Event|0|||
125447929|NCT01124617|451266875|FG001|Overall Study|Withdrawal by Subject|1|||
125447930|NCT01124617|451266874|FG000|Overall Study|Other|2|||
125402964|NCT00280566|451102540|FG001|Period 2 Double Blind|Adverse Event|11|||
125402965|NCT00280566|451102541|FG002|Period 2 Double Blind|Adverse Event|15|||
125402966|NCT00280566|451102539|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
125402967|NCT00280566|451102540|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
125402968|NCT00280566|451102541|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
125402969|NCT00280566|451102539|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
125402970|NCT00280566|451102540|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
125402971|NCT00280566|451102541|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
125402972|NCT00280566|451102539|FG000|Period 2 Double Blind|miscellaneous|0|||
125402973|NCT00280566|451102540|FG001|Period 2 Double Blind|miscellaneous|10|||
125402974|NCT00280566|451102541|FG002|Period 2 Double Blind|miscellaneous|5|||
125402975|NCT01696032|451102542|FG000|Overall Study|Withdrawal by Subject|0|||
125402976|NCT01696032|451102543|FG001|Overall Study|Withdrawal by Subject|0|||
125402977|NCT01696032|451102544|FG002|Overall Study|Withdrawal by Subject|1|||
125402978|NCT01696032|451102545|FG003|Overall Study|Withdrawal by Subject|2|||
125402979|NCT01696032|451102542|FG000|Overall Study|Death|14|||
125402980|NCT01696032|451102543|FG001|Overall Study|Death|4|||
125402981|NCT01696032|451102544|FG002|Overall Study|Death|43|||
125402982|NCT01696032|451102545|FG003|Overall Study|Death|18|||
125402983|NCT01696032|451102542|FG000|Overall Study|Lost to Follow-up|0|||
125402984|NCT01696032|451102543|FG001|Overall Study|Lost to Follow-up|1|||
125402985|NCT01696032|451102544|FG002|Overall Study|Lost to Follow-up|0|||
125402986|NCT01696032|451102545|FG003|Overall Study|Lost to Follow-up|0|||
125402987|NCT01696032|451102542|FG000|Overall Study|Database lock|0|||
125402988|NCT01696032|451102543|FG001|Overall Study|Database lock|1|||
125402989|NCT01696032|451102544|FG002|Overall Study|Database lock|7|||
125402990|NCT01696032|451102545|FG003|Overall Study|Database lock|2|||
125402991|NCT01192152|451102548|FG000|Period 1|left prematurely (while on treatment B)|0|||
125402992|NCT01192152|451102549|FG001|Period 1|left prematurely (while on treatment B)|1|||
125402993|NCT01192152|451102548|FG000|Period 3|family emergency|1|||
125402994|NCT01192152|451102549|FG001|Period 3|family emergency|0|||
125402995|NCT05013905|451102550|FG000|Overall Study|Adverse Event|1|||
125402996|NCT05013905|451102550|FG000|Overall Study|Lack of Efficacy|1|||
125402997|NCT04666259|451102552|FG000|Treatment Phase|Physician Decision|9|||
125402998|NCT04666259|451102553|FG001|Treatment Phase|Physician Decision|3|||
125402999|NCT04666259|451102554|FG002|Treatment Phase|Physician Decision|3|||
125403000|NCT04666259|451102552|FG000|Treatment Phase|Adverse Event|3|||
125403001|NCT04666259|451102553|FG001|Treatment Phase|Adverse Event|1|||
125403002|NCT04666259|451102554|FG002|Treatment Phase|Adverse Event|0|||
125403003|NCT04666259|451102552|FG000|Treatment Phase|Subject decision|1|||
125403004|NCT04666259|451102553|FG001|Treatment Phase|Subject decision|2|||
125403005|NCT04666259|451102554|FG002|Treatment Phase|Subject decision|0|||
125403006|NCT04666259|451102552|FG000|Treatment Phase|Progressive disease|0|||
125403007|NCT04666259|451102553|FG001|Treatment Phase|Progressive disease|1|||
125403008|NCT04666259|451102554|FG002|Treatment Phase|Progressive disease|0|||
125403009|NCT04666259|451102552|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
125403010|NCT04666259|451102553|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
125403011|NCT04666259|451102554|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
125403012|NCT04666259|451102552|FG000|Safety Follow-up Phase|Physician Decision|2|||
125403013|NCT04666259|451102553|FG001|Safety Follow-up Phase|Physician Decision|0|||
125403014|NCT04666259|451102554|FG002|Safety Follow-up Phase|Physician Decision|0|||
125403015|NCT04666259|451102552|FG000|Safety Follow-up Phase|Subject decision|1|||
125403016|NCT04666259|451102553|FG001|Safety Follow-up Phase|Subject decision|0|||
125403017|NCT04666259|451102554|FG002|Safety Follow-up Phase|Subject decision|0|||
125403018|NCT04666259|451102552|FG000|Safety Follow-up Phase|Death|0|||
125403019|NCT04666259|451102553|FG001|Safety Follow-up Phase|Death|1|||
125403020|NCT04666259|451102554|FG002|Safety Follow-up Phase|Death|0|||
125403021|NCT00854581|451102555|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
125403022|NCT00854581|451102555|FG000|Induction (Up to Day 21)|Death|1|||
125403023|NCT00854581|451102555|FG000|Induction (Up to Day 21)|Physician Decision|1|||
125403024|NCT00854581|451102555|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
125403025|NCT00378703|451102558|FG000|Overall Study|Disease progression|59|||
125403026|NCT00378703|451102559|FG001|Overall Study|Disease progression|43|||
125403027|NCT00378703|451102560|FG002|Overall Study|Disease progression|48|||
125403028|NCT00378703|451102561|FG003|Overall Study|Disease progression|49|||
125403029|NCT00378703|451102558|FG000|Overall Study|Adverse Event|11|||
125403030|NCT00378703|451102559|FG001|Overall Study|Adverse Event|17|||
125403031|NCT00378703|451102560|FG002|Overall Study|Adverse Event|20|||
125403032|NCT00378703|451102561|FG003|Overall Study|Adverse Event|18|||
125403033|NCT00378703|451102558|FG000|Overall Study|Death|2|||
125403034|NCT00378703|451102559|FG001|Overall Study|Death|2|||
125403035|NCT00378703|451102560|FG002|Overall Study|Death|4|||
125447931|NCT01124617|451266875|FG001|Overall Study|Other|1|||
125403036|NCT00378703|451102561|FG003|Overall Study|Death|3|||
125403037|NCT00378703|451102558|FG000|Overall Study|Withdrawal by Subject|4|||
125403038|NCT00378703|451102559|FG001|Overall Study|Withdrawal by Subject|8|||
125403039|NCT00378703|451102560|FG002|Overall Study|Withdrawal by Subject|5|||
125403040|NCT00378703|451102561|FG003|Overall Study|Withdrawal by Subject|7|||
125403041|NCT00378703|451102558|FG000|Overall Study|Physician Decision|1|||
125403042|NCT00378703|451102559|FG001|Overall Study|Physician Decision|4|||
125403043|NCT00378703|451102560|FG002|Overall Study|Physician Decision|1|||
125403044|NCT00378703|451102561|FG003|Overall Study|Physician Decision|0|||
125403045|NCT00378703|451102558|FG000|Overall Study|Alternative therapy|4|||
125403046|NCT00378703|451102559|FG001|Overall Study|Alternative therapy|2|||
125403047|NCT00378703|451102560|FG002|Overall Study|Alternative therapy|0|||
125403048|NCT00378703|451102561|FG003|Overall Study|Alternative therapy|0|||
125403049|NCT00378703|451102558|FG000|Overall Study|Other complicated disease|0|||
125403050|NCT00378703|451102559|FG001|Overall Study|Other complicated disease|2|||
125403051|NCT00378703|451102560|FG002|Overall Study|Other complicated disease|2|||
125403052|NCT00378703|451102561|FG003|Overall Study|Other complicated disease|0|||
125403053|NCT00378703|451102558|FG000|Overall Study|Symptomatic deterioration|0|||
125403054|NCT00378703|451102559|FG001|Overall Study|Symptomatic deterioration|1|||
125403055|NCT00378703|451102560|FG002|Overall Study|Symptomatic deterioration|0|||
125403056|NCT00378703|451102561|FG003|Overall Study|Symptomatic deterioration|2|||
125403057|NCT00378703|451102558|FG000|Overall Study|Surgery|1|||
125403058|NCT00378703|451102559|FG001|Overall Study|Surgery|0|||
125403059|NCT00378703|451102560|FG002|Overall Study|Surgery|0|||
125403060|NCT00378703|451102561|FG003|Overall Study|Surgery|1|||
125403061|NCT00378703|451102558|FG000|Overall Study|Joint decision of physician and patient|1|||
125403062|NCT00378703|451102559|FG001|Overall Study|Joint decision of physician and patient|0|||
125403063|NCT00378703|451102560|FG002|Overall Study|Joint decision of physician and patient|0|||
125403064|NCT00378703|451102561|FG003|Overall Study|Joint decision of physician and patient|0|||
125403065|NCT00378703|451102558|FG000|Overall Study|Adverse events and progressive disease|0|||
125403066|NCT00378703|451102559|FG001|Overall Study|Adverse events and progressive disease|0|||
125403067|NCT00378703|451102560|FG002|Overall Study|Adverse events and progressive disease|0|||
125403068|NCT00378703|451102561|FG003|Overall Study|Adverse events and progressive disease|1|||
125403069|NCT00378703|451102558|FG000|Overall Study|Relocation|0|||
125403070|NCT00378703|451102559|FG001|Overall Study|Relocation|0|||
125403071|NCT00378703|451102560|FG002|Overall Study|Relocation|1|||
125403072|NCT00378703|451102561|FG003|Overall Study|Relocation|0|||
125403073|NCT00378703|451102558|FG000|Overall Study|Ineligible|4|||
125403074|NCT00378703|451102559|FG001|Overall Study|Ineligible|7|||
125403075|NCT00378703|451102560|FG002|Overall Study|Ineligible|7|||
125403076|NCT00378703|451102561|FG003|Overall Study|Ineligible|7|||
125403077|NCT00378703|451102558|FG000|Overall Study|Never started treatment|1|||
125403078|NCT00378703|451102559|FG001|Overall Study|Never started treatment|4|||
125403079|NCT00378703|451102560|FG002|Overall Study|Never started treatment|0|||
125403080|NCT00378703|451102561|FG003|Overall Study|Never started treatment|0|||
125403081|NCT00378703|451102558|FG000|Overall Study|Other|1|||
125403082|NCT00378703|451102559|FG001|Overall Study|Other|1|||
125403083|NCT00378703|451102560|FG002|Overall Study|Other|2|||
125403084|NCT00378703|451102561|FG003|Overall Study|Other|3|||
125403085|NCT02705820|451102562|FG000|Overall Study|Death|2|||
125403086|NCT02705820|451102562|FG000|Overall Study|Disease Progression|34|||
125403087|NCT02705820|451102562|FG000|Overall Study|Clinical Deterioration|3|||
125403088|NCT05402995|451102563|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
125403089|NCT05402995|451102564|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
125403090|NCT05402995|451102565|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
125403091|NCT05402995|451102566|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
125403092|NCT01541930|451102567|FG000|Overall Study|Withdrawal by Subject|1|||
125403093|NCT02501096|451102568|FG000|Overall Study|Lost to Follow-up|0|||
125403094|NCT02501096|451102569|FG001|Overall Study|Lost to Follow-up|0|||
125403095|NCT02501096|451102570|FG002|Overall Study|Lost to Follow-up|0|||
125403096|NCT02501096|451102571|FG003|Overall Study|Lost to Follow-up|0|||
125403097|NCT02501096|451102572|FG004|Overall Study|Lost to Follow-up|1|||
125403098|NCT02501096|451102573|FG005|Overall Study|Lost to Follow-up|1|||
125403099|NCT02501096|451102574|FG006|Overall Study|Lost to Follow-up|3|||
125403100|NCT02501096|451102575|FG007|Overall Study|Lost to Follow-up|0|||
125403101|NCT02501096|451102576|FG008|Overall Study|Lost to Follow-up|0|||
125403102|NCT02501096|451102568|FG000|Overall Study|Withdrawal by Subject|1|||
125403103|NCT02501096|451102569|FG001|Overall Study|Withdrawal by Subject|0|||
125403104|NCT02501096|451102570|FG002|Overall Study|Withdrawal by Subject|7|||
125403105|NCT02501096|451102571|FG003|Overall Study|Withdrawal by Subject|13|||
125403106|NCT02501096|451102572|FG004|Overall Study|Withdrawal by Subject|2|||
125403107|NCT02501096|451102573|FG005|Overall Study|Withdrawal by Subject|2|||
125403108|NCT02501096|451102574|FG006|Overall Study|Withdrawal by Subject|2|||
125403109|NCT02501096|451102575|FG007|Overall Study|Withdrawal by Subject|3|||
125403110|NCT02501096|451102576|FG008|Overall Study|Withdrawal by Subject|0|||
125403111|NCT02501096|451102568|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
125403112|NCT02501096|451102569|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
125403113|NCT02501096|451102570|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
125403114|NCT02501096|451102571|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
125403115|NCT02501096|451102572|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
125403116|NCT02501096|451102573|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
125403117|NCT02501096|451102574|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
125403118|NCT02501096|451102575|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
125403119|NCT02501096|451102576|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
125403120|NCT02501096|451102568|FG000|Overall Study|Death|1|||
125403121|NCT02501096|451102569|FG001|Overall Study|Death|1|||
125403122|NCT02501096|451102570|FG002|Overall Study|Death|88|||
125403123|NCT02501096|451102571|FG003|Overall Study|Death|74|||
125403124|NCT02501096|451102572|FG004|Overall Study|Death|15|||
125403125|NCT02501096|451102573|FG005|Overall Study|Death|16|||
125403126|NCT02501096|451102574|FG006|Overall Study|Death|15|||
125403127|NCT02501096|451102575|FG007|Overall Study|Death|16|||
125403128|NCT02501096|451102576|FG008|Overall Study|Death|1|||
125403129|NCT04187196|451102577|FG000|Overall Study|Screen Failure|2|||
125403130|NCT04187196|451102578|FG001|Overall Study|Screen Failure|0|||
125403131|NCT03139916|451102581|FG000|Overall Study|Withdrawal by Subject|2|||
125403132|NCT03139916|451102581|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
125403133|NCT01957475|451102582|FG000|Test Period 1|Withdrawal by Subject|1|||
125403134|NCT01957475|451102583|FG001|Test Period 1|Withdrawal by Subject|0|||
125403135|NCT01957475|451102582|FG000|Test Period 1|Other|1|||
125403136|NCT01957475|451102583|FG001|Test Period 1|Other|0|||
125403137|NCT01957475|451102582|FG000|Test Period 1|Lack of Efficacy|0|||
125403138|NCT01957475|451102583|FG001|Test Period 1|Lack of Efficacy|1|||
125403139|NCT01957475|451102582|FG000|Test Period 2|Adverse Event|1|||
125403140|NCT01957475|451102583|FG001|Test Period 2|Adverse Event|0|||
125403141|NCT04587193|451102584|FG000|Overall Study|Screen failure after consent|3|||
125403142|NCT04587193|451102585|FG001|Overall Study|Screen failure after consent|0|||
125403143|NCT04587193|451102584|FG000|Overall Study|Device broke during study|3|||
125403144|NCT04587193|451102585|FG001|Overall Study|Device broke during study|2|||
125403145|NCT01552772|451102586|FG000|Overall Study|Lost to Follow-up|2|||
125403146|NCT01552772|451102586|FG000|Overall Study|Adverse Event|1|||
125403147|NCT01552772|451102586|FG000|Overall Study|Protocol Deviation|1|||
125403148|NCT02707640|451102592|FG000|Overall Study|Adverse Event|4|||
125403149|NCT02707640|451102593|FG001|Overall Study|Adverse Event|2|||
125403150|NCT02707640|451102592|FG000|Overall Study|Death|1|||
125403151|NCT02707640|451102593|FG001|Overall Study|Death|2|||
125403152|NCT02707640|451102592|FG000|Overall Study|Physician Decision|2|||
125403153|NCT02707640|451102593|FG001|Overall Study|Physician Decision|0|||
125403154|NCT02707640|451102592|FG000|Overall Study|Withdrawal by Subject|0|||
125403155|NCT02707640|451102593|FG001|Overall Study|Withdrawal by Subject|1|||
125403156|NCT02707640|451102592|FG000|Overall Study|Participant's Personal Decision|1|||
125403157|NCT02707640|451102593|FG001|Overall Study|Participant's Personal Decision|2|||
125403158|NCT02707640|451102592|FG000|Overall Study|Sponsor Discretion|1|||
125403159|NCT02707640|451102593|FG001|Overall Study|Sponsor Discretion|0|||
125403160|NCT02517905|451102594|FG000|Overall Study|Lost to Follow-up|4|||
125403161|NCT02517905|451102595|FG001|Overall Study|Lost to Follow-up|0|||
125403162|NCT02517905|451102594|FG000|Overall Study|Withdrawal by Subject|4|||
125403163|NCT02517905|451102595|FG001|Overall Study|Withdrawal by Subject|0|||
125403164|NCT02517905|451102594|FG000|Overall Study|Screen failure|2|||
125403165|NCT02517905|451102595|FG001|Overall Study|Screen failure|2|||
125403166|NCT02742103|451103897|FG000|Overall Study|Protocol Violation|1|||
125403167|NCT02742103|451103898|FG001|Overall Study|Protocol Violation|0|||
125403168|NCT02742103|451103897|FG000|Overall Study|Death|2|||
125403169|NCT02742103|451103898|FG001|Overall Study|Death|2|||
125403170|NCT02742103|451103897|FG000|Overall Study|Adverse Event|1|||
125403171|NCT02742103|451103898|FG001|Overall Study|Adverse Event|0|||
125403172|NCT02742103|451103897|FG000|Overall Study|Moved to another town|0|||
125403173|NCT02742103|451103898|FG001|Overall Study|Moved to another town|1|||
125403174|NCT02742103|451103897|FG000|Overall Study|Withdrawal by Subject|5|||
125403175|NCT02742103|451103898|FG001|Overall Study|Withdrawal by Subject|2|||
125403176|NCT00600821|451103899|FG000|Overall Study|Death|45|||
125403177|NCT00600821|451103900|FG001|Overall Study|Death|46|||
125403178|NCT00600821|451103899|FG000|Overall Study|Lost to Follow-up|2|||
125403179|NCT00600821|451103900|FG001|Overall Study|Lost to Follow-up|2|||
125403180|NCT00600821|451103899|FG000|Overall Study|Withdrawal by Subject|1|||
125403181|NCT00600821|451103900|FG001|Overall Study|Withdrawal by Subject|1|||
125403182|NCT00600821|451103899|FG000|Overall Study|Terminated by sponsor|8|||
125403183|NCT00600821|451103900|FG001|Overall Study|Terminated by sponsor|6|||
125403184|NCT00600821|451103899|FG000|Overall Study|Objective progression or relapse|0|||
125403185|NCT00600821|451103900|FG001|Overall Study|Objective progression or relapse|1|||
125403186|NCT00600821|451103899|FG000|Overall Study|Randomized but not treated|0|||
125403187|NCT00600821|451103900|FG001|Overall Study|Randomized but not treated|1|||
125403188|NCT00600821|451103899|FG000|Overall Study|Other|2|||
125403189|NCT00600821|451103900|FG001|Overall Study|Other|3|||
125403190|NCT00659646|451103906|FG000|Overall Study|Protocol Violation|12|||
125403191|NCT00659646|451103907|FG001|Overall Study|Protocol Violation|8|||
125403192|NCT00659646|451103906|FG000|Overall Study|Adverse Event|1|||
125403193|NCT00659646|451103907|FG001|Overall Study|Adverse Event|0|||
125403194|NCT00659646|451103906|FG000|Overall Study|Lost to Follow-up|1|||
125403195|NCT00659646|451103907|FG001|Overall Study|Lost to Follow-up|0|||
125277473|NCT00441142|450642224|FG001|Overall Study|Patient still receiving active study tx|0|||
125277474|NCT00441142|450642225|FG002|Overall Study|Patient still receiving active study tx|0|||
125277475|NCT00441142|450642226|FG003|Overall Study|Patient still receiving active study tx|2|||
125277476|NCT00441142|450642223|FG000|Overall Study|Physician Decision|0|||
125277477|NCT00441142|450642224|FG001|Overall Study|Physician Decision|1|||
125277478|NCT00441142|450642225|FG002|Overall Study|Physician Decision|0|||
125277479|NCT00441142|450642226|FG003|Overall Study|Physician Decision|1|||
125277480|NCT00441142|450642223|FG000|Overall Study|Death|0|||
125277481|NCT00441142|450642224|FG001|Overall Study|Death|0|||
125277482|NCT00441142|450642225|FG002|Overall Study|Death|0|||
125277483|NCT00441142|450642226|FG003|Overall Study|Death|1|||
125277484|NCT04952597|450642227|FG000|Overall Study|Death|12|||
125277485|NCT04952597|450642228|FG001|Overall Study|Death|13|||
125277486|NCT04952597|450642229|FG002|Overall Study|Death|14|||
125277487|NCT04952597|450642227|FG000|Overall Study|Withdrawal by Subject|1|||
125277488|NCT04952597|450642228|FG001|Overall Study|Withdrawal by Subject|0|||
125277489|NCT04952597|450642229|FG002|Overall Study|Withdrawal by Subject|3|||
125277490|NCT04952597|450642227|FG000|Overall Study|Lost to Follow-up|0|||
125277491|NCT04952597|450642228|FG001|Overall Study|Lost to Follow-up|1|||
125277492|NCT04952597|450642229|FG002|Overall Study|Lost to Follow-up|1|||
125277493|NCT05730335|450642230|FG000|Overall Study|Lost to Follow-up|8|||
125277494|NCT05730335|450642230|FG000|Overall Study|Withdrawal by Subject|6|||
125277495|NCT05286658|450642237|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
125277496|NCT05286658|450642237|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
125277497|NCT05411822|450642238|FG000|Overall Study|Withdrawal by Subject|2|||
125277498|NCT05411822|450642239|FG001|Overall Study|Withdrawal by Subject|1|||
125277499|NCT04004221|450642241|FG000|Overall Study|Death|89|||
125277500|NCT04004221|450642241|FG000|Overall Study|Withdrawal by Subject|5|||
125277501|NCT04004221|450642241|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
125277502|NCT04004221|450642241|FG000|Overall Study|Sponsor Decision|9|||
125277503|NCT04004221|450642241|FG000|Overall Study|Participant refused to enter LTE|1|||
125277504|NCT01814397|450642243|FG000|Overall Study|Adverse Event|7|||
125277505|NCT01814397|450642243|FG000|Overall Study|Withdrawal by Subject|7|||
125277506|NCT01939977|450642245|FG000|Overall Study|Adverse Event|4|||
125277507|NCT01939977|450642246|FG001|Overall Study|Adverse Event|3|||
125277508|NCT01939977|450642245|FG000|Overall Study|Lack of Efficacy|3|||
125277509|NCT01939977|450642246|FG001|Overall Study|Lack of Efficacy|0|||
125277510|NCT01939977|450642245|FG000|Overall Study|Physician Decision|1|||
125277511|NCT01939977|450642246|FG001|Overall Study|Physician Decision|1|||
125277512|NCT01939977|450642245|FG000|Overall Study|Withdrawal by Subject|0|||
125277513|NCT01939977|450642246|FG001|Overall Study|Withdrawal by Subject|2|||
125277514|NCT01939977|450642245|FG000|Overall Study|Did not meet inclusion criteria|1|||
125277515|NCT01939977|450642246|FG001|Overall Study|Did not meet inclusion criteria|0|||
125277516|NCT01939977|450642245|FG000|Overall Study|Did not receive study medication|0|||
125277517|NCT01939977|450642246|FG001|Overall Study|Did not receive study medication|1|||
125277518|NCT02952313|450642256|FG000|Primary Endpoint|Lost to Follow-up|4|||
125277519|NCT02952313|450642256|FG000|Primary Endpoint|Withdrawal by Subject|1|||
125277520|NCT02952313|450642256|FG000|Primary Endpoint|Lack of Efficacy|1|||
125277521|NCT02952313|450642256|FG000|Primary Endpoint|Missed visit|1|||
125277522|NCT02952313|450642256|FG000|Long-term Follow-up|Lost to Follow-up|12|||
125277523|NCT02952313|450642256|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
125277524|NCT02952313|450642256|FG000|Long-term Follow-up|Lack of Efficacy|6|||
125277525|NCT02952313|450642256|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
125277526|NCT02952313|450642256|FG000|Long-term Follow-up|Physician Decision|1|||
125277527|NCT02952313|450642256|FG000|Long-term Follow-up|Death|1|||
125277528|NCT02095873|450642263|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
125277529|NCT02095873|450642264|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
125277530|NCT02095873|450642263|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
125277531|NCT02095873|450642264|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
125277532|NCT02095873|450642263|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
125277533|NCT02095873|450642264|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
125277534|NCT00792740|450642267|FG000|Overall Study|Disease Worsening|3|||
125277535|NCT00792740|450642268|FG001|Overall Study|Disease Worsening|2|||
125277536|NCT00792740|450642267|FG000|Overall Study|Personal Reason|1|||
125277537|NCT00792740|450642268|FG001|Overall Study|Personal Reason|0|||
125277538|NCT00792740|450642267|FG000|Overall Study|Adverse Event|1|||
125277539|NCT00792740|450642268|FG001|Overall Study|Adverse Event|3|||
125277540|NCT00792740|450642267|FG000|Overall Study|Patient's withdrawal of consent|0|||
125277541|NCT00792740|450642268|FG001|Overall Study|Patient's withdrawal of consent|1|||
125277542|NCT00792740|450642267|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
125277543|NCT00792740|450642268|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
125277544|NCT00792740|450642267|FG000|Overall Study|Other reasons|0|||
125277545|NCT00792740|450642268|FG001|Overall Study|Other reasons|1|||
125277546|NCT03206918|450642271|FG000|Overall Study|Death|11|||
125277547|NCT03206918|450642271|FG000|Overall Study|Withdrawal by Subject|5|||
125403196|NCT00659646|451103906|FG000|Overall Study|protocol noncompliance after randomized|1|||
125403197|NCT00659646|451103907|FG001|Overall Study|protocol noncompliance after randomized|0|||
125403198|NCT00023673|451103908|FG000|Overall Study|Ineligible / no protocol treatment|0|||
125403199|NCT00023673|451103909|FG001|Overall Study|Ineligible / no protocol treatment|0|||
125403200|NCT00023673|451103910|FG002|Overall Study|Ineligible / no protocol treatment|0|||
125403201|NCT00023673|451103911|FG003|Overall Study|Ineligible / no protocol treatment|1|||
125403202|NCT00023673|451103908|FG000|Overall Study|Patient withdrew consent|0|||
125403203|NCT00023673|451103909|FG001|Overall Study|Patient withdrew consent|0|||
125403204|NCT00023673|451103910|FG002|Overall Study|Patient withdrew consent|0|||
125403205|NCT00023673|451103911|FG003|Overall Study|Patient withdrew consent|1|||
125403206|NCT00424372|451103921|FG000|Overall Study|Death|1|||
125403207|NCT00424372|451103921|FG000|Overall Study|Adverse Event|18|||
125403208|NCT00424372|451103921|FG000|Overall Study|Lack of Efficacy|6|||
125403209|NCT00424372|451103921|FG000|Overall Study|Withdrawal by Subject|4|||
125403210|NCT00424372|451103921|FG000|Overall Study|Protocol Violation|1|||
125403211|NCT00424372|451103921|FG000|Overall Study|Health deterioration|1|||
125403212|NCT02932891|451103922|FG000|Overall Study|Lost to Follow-up|2|||
125403213|NCT02932891|451103922|FG000|Overall Study|HPA Suppress|2|||
125403214|NCT04622254|451103923|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
125403215|NCT04622254|451103924|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
125403216|NCT04622254|451103925|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
125403217|NCT04622254|451103926|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
125403218|NCT04622254|451103927|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
125403219|NCT04622254|451103928|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
125403220|NCT04622254|451103923|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
125403221|NCT04622254|451103924|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
125403222|NCT04622254|451103925|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
125403223|NCT04622254|451103926|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
125403224|NCT04622254|451103927|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
125403225|NCT04622254|451103928|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
125403226|NCT04622254|451103923|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
125403227|NCT04622254|451103924|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
125403228|NCT04622254|451103925|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
125403229|NCT04622254|451103926|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
125403230|NCT04622254|451103927|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
125403231|NCT04622254|451103928|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
125403232|NCT04622254|451103923|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125403233|NCT04622254|451103924|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
125403234|NCT04622254|451103925|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
125403235|NCT04622254|451103926|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125403236|NCT04622254|451103927|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125403237|NCT04622254|451103928|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
125403238|NCT04622254|451103923|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125403239|NCT04622254|451103924|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125403240|NCT04622254|451103925|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125403241|NCT04622254|451103926|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
125403242|NCT04622254|451103927|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125403243|NCT04622254|451103928|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
125403244|NCT04622254|451103923|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
125403245|NCT04622254|451103924|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
125403246|NCT04622254|451103925|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
125403247|NCT04622254|451103926|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
125403248|NCT04622254|451103927|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
125403249|NCT04622254|451103928|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
125403250|NCT04622254|451103923|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125403251|NCT04622254|451103924|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125403252|NCT04622254|451103925|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125403253|NCT04622254|451103926|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
125403254|NCT04622254|451103927|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125403255|NCT04622254|451103928|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
125403256|NCT04622254|451103923|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125403257|NCT04622254|451103924|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125403258|NCT04622254|451103925|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125403259|NCT04622254|451103926|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
125447932|NCT00945477|451266876|FG000|Overall Study|Adverse Event|3|||
125447933|NCT00945477|451266876|FG000|Overall Study|Lack of Efficacy|2|||
125447934|NCT00945477|451266876|FG000|Overall Study|Withdrawal by Subject|1|||
125447935|NCT00619151|451266877|FG000|Overall Study|Study terminated prior to followup|1|||
125447936|NCT00619151|451266878|FG001|Overall Study|Study terminated prior to followup|0|||
125447937|NCT02825043|451266879|FG000|Overall Study|Lost to Follow-up|4|||
125447938|NCT03582137|451266885|FG000|Overall Study|Adverse Event|1|||
125403260|NCT04622254|451103927|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125403261|NCT04622254|451103928|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
125403262|NCT04622254|451103923|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
125403263|NCT04622254|451103924|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
125403264|NCT04622254|451103925|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
125403265|NCT04622254|451103926|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
125403266|NCT04622254|451103927|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
125403267|NCT04622254|451103928|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
125403268|NCT04622254|451103923|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
125403269|NCT04622254|451103924|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
125403270|NCT04622254|451103925|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
125403271|NCT04622254|451103926|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
125403272|NCT04622254|451103927|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
125403273|NCT04622254|451103928|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
125403274|NCT04622254|451103923|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
125403275|NCT04622254|451103924|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
125403276|NCT04622254|451103925|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
125403277|NCT04622254|451103926|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
125403278|NCT04622254|451103927|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
125403279|NCT04622254|451103928|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
125403280|NCT02652624|451103929|FG000|Randomized Phase|Pregnancy|3|||
125403281|NCT02652624|451103930|FG001|Randomized Phase|Pregnancy|1|||
125403282|NCT02652624|451103929|FG000|Randomized Phase|Investigator's Discretion|0|||
125403283|NCT02652624|451103930|FG001|Randomized Phase|Investigator's Discretion|2|||
125403284|NCT02652624|451103929|FG000|Randomized Phase|Death|0|||
125403285|NCT02652624|451103930|FG001|Randomized Phase|Death|1|||
125403286|NCT02652624|451103929|FG000|Randomized Phase|Lost to Follow-up|0|||
125403287|NCT02652624|451103930|FG001|Randomized Phase|Lost to Follow-up|1|||
125403288|NCT02652624|451103929|FG000|Extension Phase|Lost to Follow-up|3|||
125403289|NCT02652624|451103930|FG001|Extension Phase|Lost to Follow-up|1|||
125403290|NCT02652624|451103929|FG000|Extension Phase|Pregnancy|1|||
125403291|NCT02652624|451103930|FG001|Extension Phase|Pregnancy|1|||
125403292|NCT02652624|451103929|FG000|Extension Phase|Adverse Event|0|||
125403293|NCT02652624|451103930|FG001|Extension Phase|Adverse Event|1|||
125403294|NCT02652624|451103929|FG000|Extension Phase|Withdrew Consent|0|||
125403295|NCT02652624|451103930|FG001|Extension Phase|Withdrew Consent|1|||
125403296|NCT01023659|451103931|FG000|Overall Study|Lost to Follow-up|73|||
125403297|NCT01023659|451103932|FG001|Overall Study|Lost to Follow-up|228|||
125403298|NCT01023659|451103933|FG002|Overall Study|Lost to Follow-up|99|||
125403299|NCT00912405|451103934|FG000|Overall Study|Lost to Follow-up|5|||
125403300|NCT01797536|451103937|FG000|Overall Study|Adverse Event|0|||
125277548|NCT03206918|450642271|FG000|Overall Study|Study terminated by sponsor|12|||
125277549|NCT03206918|450642271|FG000|Overall Study|Lost to Follow-up|3|||
125277550|NCT03206918|450642271|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
125277551|NCT03823287|450642272|FG000|Overall Study|Withdrawal by Subject|25|||
125277552|NCT03823287|450642273|FG001|Overall Study|Withdrawal by Subject|17|||
125277553|NCT03823287|450642272|FG000|Overall Study|Death|13|||
125277554|NCT03823287|450642273|FG001|Overall Study|Death|7|||
125277555|NCT03823287|450642272|FG000|Overall Study|Lost to Follow-up|7|||
125277556|NCT03823287|450642273|FG001|Overall Study|Lost to Follow-up|8|||
125277557|NCT03823287|450642272|FG000|Overall Study|Adverse Event|6|||
125277558|NCT03823287|450642273|FG001|Overall Study|Adverse Event|8|||
125277559|NCT03823287|450642272|FG000|Overall Study|Physician Decision|5|||
125277560|NCT03823287|450642273|FG001|Overall Study|Physician Decision|2|||
125277561|NCT03823287|450642272|FG000|Overall Study|Lack of Efficacy|2|||
125277562|NCT03823287|450642273|FG001|Overall Study|Lack of Efficacy|0|||
125277563|NCT03823287|450642272|FG000|Overall Study|Other|2|||
125277564|NCT03823287|450642273|FG001|Overall Study|Other|4|||
125277565|NCT01170273|450642275|FG000|Overall Study|Lost to Follow-up|6|||
125277566|NCT01170273|450642276|FG001|Overall Study|Lost to Follow-up|8|||
125277567|NCT01170273|450642275|FG000|Overall Study|Protocol Violation|1|||
125403301|NCT01797536|451103938|FG001|Overall Study|Adverse Event|1|||
125403302|NCT01797536|451103939|FG002|Overall Study|Adverse Event|0|||
125403303|NCT01797536|451103940|FG003|Overall Study|Adverse Event|0|||
125403304|NCT00501540|451103941|FG000|Overall Study|Death|5|||
125277568|NCT01170273|450642276|FG001|Overall Study|Protocol Violation|0|||
125277569|NCT01170273|450642275|FG000|Overall Study|Death|1|||
125277570|NCT01170273|450642276|FG001|Overall Study|Death|0|||
125277571|NCT01170273|450642275|FG000|Overall Study|Adverse Event|0|||
125277572|NCT01170273|450642276|FG001|Overall Study|Adverse Event|1|||
125277573|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
125403305|NCT00098839|451103942|FG000|Overall Study|Adverse Event|5|||
125403306|NCT00098839|451103943|FG001|Overall Study|Adverse Event|2|||
125403307|NCT00098839|451103942|FG000|Overall Study|Death|1|||
125277574|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
125277575|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
125403308|NCT00098839|451103943|FG001|Overall Study|Death|2|||
125403309|NCT00098839|451103942|FG000|Overall Study|Physician Decision|4|||
125403310|NCT00098839|451103943|FG001|Overall Study|Physician Decision|14|||
125403311|NCT00098839|451103942|FG000|Overall Study|Withdrawal by Subject|1|||
125403312|NCT00098839|451103943|FG001|Overall Study|Withdrawal by Subject|0|||
125403313|NCT00098839|451103942|FG000|Overall Study|Refusal of further protocol therapy|3|||
125403314|NCT00098839|451103943|FG001|Overall Study|Refusal of further protocol therapy|1|||
125403315|NCT00098839|451103942|FG000|Overall Study|Relapse|6|||
125403316|NCT00098839|451103943|FG001|Overall Study|Relapse|3|||
125403317|NCT00098839|451103942|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
125403318|NCT00098839|451103943|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
125403319|NCT00098839|451103942|FG000|Overall Study|Ineligible|2|||
125403320|NCT00098839|451103943|FG001|Overall Study|Ineligible|0|||
125403321|NCT03228680|451103946|FG000|Overall Study|Adverse Event|13|||
125403322|NCT03228680|451103947|FG001|Overall Study|Adverse Event|18|||
125403323|NCT03228680|451103946|FG000|Overall Study|Randomization failure|0|||
125403324|NCT03228680|451103947|FG001|Overall Study|Randomization failure|1|||
125403325|NCT03228680|451103946|FG000|Overall Study|Withdrawal by Subject|1|||
125403326|NCT03228680|451103947|FG001|Overall Study|Withdrawal by Subject|0|||
125403327|NCT03228680|451103946|FG000|Overall Study|Other|9|||
125403328|NCT03228680|451103947|FG001|Overall Study|Other|16|||
125403329|NCT00796861|451103955|FG000|Overall Study|Withdrawal by Subject|2|||
125403330|NCT00796861|451103955|FG000|Overall Study|Death|2|||
125403331|NCT02370888|451103956|FG000|Overall Study|disease progression|2|||
125403332|NCT02370888|451103956|FG000|Overall Study|did not meet chimerism criteria|6|||
125403333|NCT02104557|451103957|FG000|Overall Study|Adverse Event|24|||
125403334|NCT02104557|451103957|FG000|Overall Study|Lost to Follow-up|34|||
125403335|NCT02104557|451103957|FG000|Overall Study|Violated the usage and dosage|14|||
125403336|NCT02104557|451103957|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
125403337|NCT02104557|451103957|FG000|Overall Study|Administered Sayana prior to the contract|1|||
125403338|NCT02104557|451103957|FG000|Overall Study|Other|17|||
125403339|NCT02104557|451103957|FG000|Overall Study|Change to other contraception methods|5|||
125403340|NCT02104557|451103957|FG000|Overall Study|Discontinuation due to no pain|1|||
125403341|NCT02104557|451103957|FG000|Overall Study|Withdrawal consent|2|||
125403342|NCT02104557|451103957|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
125403343|NCT02104557|451103957|FG000|Overall Study|Discontinuation of contraception|9|||
125403344|NCT02178475|451103959|FG000|Overall Study|Withdrawal by Subject|7|||
125403345|NCT02178475|451103959|FG000|Overall Study|Lost to Follow-up|10|||
125403346|NCT02178475|451103959|FG000|Overall Study|Death|13|||
125403347|NCT02178475|451103959|FG000|Overall Study|Protocol-specified Criteria|99|||
125403348|NCT01430585|451103960|FG000|Overall Study|Death|1|||
125403349|NCT01430585|451103960|FG000|Overall Study|Objective Progression or Relapse|3|||
125403350|NCT01430585|451103960|FG000|Overall Study|Study Terminated by Sponsor|3|||
125403351|NCT01430585|451103960|FG000|Overall Study|Other|7|||
125403352|NCT01412424|451103961|FG000|Core Treatment Period|Treatment Failure|24|||
125403353|NCT01412424|451103961|FG000|Core Treatment Period|Adverse Event|21|||
125403354|NCT01412424|451103961|FG000|Core Treatment Period|Patient Request|5|||
125403355|NCT01412424|451103961|FG000|Core Treatment Period|Lost to Follow-up|2|||
125403356|NCT01412424|451103961|FG000|Core Treatment Period|Sponsor Request|1|||
125403357|NCT01412424|451103961|FG000|Extension Treatment Period|Adverse Event|2|||
125403358|NCT01412424|451103961|FG000|Extension Treatment Period|Treatment Failure|2|||
125403359|NCT01412424|451103961|FG000|Extension Treatment Period|Patient Request|2|||
125403360|NCT04304001|451103964|FG000|Overall Study|Lost to Follow-up|13|||
125403361|NCT04304001|451103965|FG001|Overall Study|Lost to Follow-up|9|||
125403362|NCT02664038|451103971|FG000|13 Week|Lost to Follow-up|7|||
125403363|NCT02664038|451103972|FG001|13 Week|Lost to Follow-up|14|||
125403364|NCT02664038|451103971|FG000|13 Week|Withdrawal by Subject|1|||
125403365|NCT02664038|451103972|FG001|13 Week|Withdrawal by Subject|0|||
125403366|NCT02664038|451103971|FG000|26 Week|Lost to Follow-up|5|||
125403367|NCT02664038|451103972|FG001|26 Week|Lost to Follow-up|4|||
125403368|NCT02606136|451103977|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
125403369|NCT02606136|451103977|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
125403370|NCT02606136|451103977|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
125403371|NCT02606136|451103977|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
125403372|NCT03296696|451103978|FG000|Overall Study|Started Other Antitumor Therapy|1|||
125403373|NCT03296696|451103979|FG001|Overall Study|Started Other Antitumor Therapy|2|||
125403374|NCT03296696|451103980|FG002|Overall Study|Started Other Antitumor Therapy|1|||
125403375|NCT03296696|451103981|FG003|Overall Study|Started Other Antitumor Therapy|2|||
125447939|NCT03582137|451266886|FG001|Overall Study|Adverse Event|0|||
125447940|NCT01982760|451266887|FG000|Overall Study|Physician Decision|1|||
125403376|NCT03296696|451103982|FG004|Overall Study|Started Other Antitumor Therapy|1|||
125403377|NCT03296696|451103983|FG005|Overall Study|Started Other Antitumor Therapy|1|||
125403378|NCT03296696|451103984|FG006|Overall Study|Started Other Antitumor Therapy|2|||
125403379|NCT03296696|451103985|FG007|Overall Study|Started Other Antitumor Therapy|3|||
125403380|NCT03296696|451103986|FG008|Overall Study|Started Other Antitumor Therapy|1|||
125403381|NCT03296696|451103987|FG009|Overall Study|Started Other Antitumor Therapy|0|||
125403382|NCT03296696|451103978|FG000|Overall Study|Death|0|||
125403383|NCT03296696|451103979|FG001|Overall Study|Death|1|||
125403384|NCT03296696|451103980|FG002|Overall Study|Death|1|||
125403385|NCT03296696|451103981|FG003|Overall Study|Death|2|||
125403386|NCT03296696|451103982|FG004|Overall Study|Death|2|||
125403387|NCT03296696|451103983|FG005|Overall Study|Death|3|||
125403388|NCT03296696|451103984|FG006|Overall Study|Death|1|||
125403389|NCT03296696|451103985|FG007|Overall Study|Death|2|||
125403390|NCT03296696|451103986|FG008|Overall Study|Death|0|||
125403391|NCT03296696|451103987|FG009|Overall Study|Death|0|||
125403392|NCT03296696|451103978|FG000|Overall Study|Withdrawal by Subject|0|||
125403393|NCT03296696|451103979|FG001|Overall Study|Withdrawal by Subject|0|||
125403394|NCT03296696|451103980|FG002|Overall Study|Withdrawal by Subject|1|||
125403395|NCT03296696|451103981|FG003|Overall Study|Withdrawal by Subject|0|||
125403396|NCT03296696|451103982|FG004|Overall Study|Withdrawal by Subject|1|||
125403397|NCT03296696|451103983|FG005|Overall Study|Withdrawal by Subject|0|||
125403398|NCT03296696|451103984|FG006|Overall Study|Withdrawal by Subject|0|||
125403399|NCT03296696|451103985|FG007|Overall Study|Withdrawal by Subject|0|||
125403400|NCT03296696|451103986|FG008|Overall Study|Withdrawal by Subject|0|||
125403401|NCT03296696|451103987|FG009|Overall Study|Withdrawal by Subject|1|||
125403402|NCT04694131|451103991|FG000|Overall Study|Withdrawal by Subject|7|||
125403403|NCT04694131|451103991|FG000|Overall Study|Screen Failure|1|||
125403404|NCT04694131|451103991|FG000|Overall Study|High stimulation threshold|3|||
125403405|NCT04456699|451103992|FG000|Overall Study|Death|48|||
125403406|NCT04456699|451103993|FG001|Overall Study|Death|50|||
125403407|NCT04456699|451103994|FG002|Overall Study|Death|52|||
125403408|NCT04456699|451103992|FG000|Overall Study|Physician Decision|0|||
125403409|NCT04456699|451103993|FG001|Overall Study|Physician Decision|0|||
125403410|NCT04456699|451103994|FG002|Overall Study|Physician Decision|2|||
125403411|NCT04456699|451103992|FG000|Overall Study|Sponsor Decision|55|||
125403412|NCT04456699|451103993|FG001|Overall Study|Sponsor Decision|61|||
125403413|NCT04456699|451103994|FG002|Overall Study|Sponsor Decision|50|||
125403414|NCT04456699|451103992|FG000|Overall Study|Withdrawal by Subject|8|||
125403415|NCT04456699|451103993|FG001|Overall Study|Withdrawal by Subject|4|||
125403416|NCT04456699|451103994|FG002|Overall Study|Withdrawal by Subject|5|||
125403417|NCT04112810|451103995|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
125403418|NCT04542070|451104006|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
125403419|NCT04542070|451104007|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
125403420|NCT04542070|451104008|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
125403421|NCT04542070|451104009|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
125403422|NCT04542070|451104006|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
125403423|NCT04542070|451104007|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
125403424|NCT04542070|451104008|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
125403425|NCT04542070|451104009|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
125403426|NCT04542070|451104006|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
125403427|NCT04542070|451104007|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
125403428|NCT04542070|451104008|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
125403429|NCT04542070|451104009|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
125403430|NCT04542070|451104006|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
125403431|NCT04542070|451104007|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
125403432|NCT04542070|451104008|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
125403433|NCT04542070|451104009|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
125403434|NCT04542070|451104006|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
125403435|NCT04542070|451104007|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
125403436|NCT04542070|451104008|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
125403437|NCT04542070|451104009|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
125403438|NCT04542070|451104006|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
125403439|NCT04542070|451104007|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
125403440|NCT04542070|451104008|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
125403441|NCT04542070|451104009|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
125403442|NCT04542070|451104006|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
125403443|NCT04542070|451104007|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
125403444|NCT04542070|451104008|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
125403445|NCT04542070|451104009|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
125403446|NCT04542070|451104006|FG000|Maintenance + Extension Period|Adverse Event|10|||
125403447|NCT04542070|451104007|FG001|Maintenance + Extension Period|Adverse Event|2|||
125403448|NCT04542070|451104008|FG002|Maintenance + Extension Period|Adverse Event|0|||
125403449|NCT04542070|451104009|FG003|Maintenance + Extension Period|Adverse Event|0|||
125403450|NCT04542070|451104006|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
125403451|NCT04542070|451104007|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
125403452|NCT04542070|451104008|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
125403453|NCT04542070|451104009|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
125403454|NCT04542070|451104006|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
125403455|NCT04542070|451104007|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
125403456|NCT04542070|451104008|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
125403457|NCT04542070|451104009|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
125403458|NCT04542070|451104006|FG000|Maintenance + Extension Period|Physician Decision|1|||
125403459|NCT04542070|451104007|FG001|Maintenance + Extension Period|Physician Decision|1|||
125403460|NCT04542070|451104008|FG002|Maintenance + Extension Period|Physician Decision|0|||
125403461|NCT04542070|451104009|FG003|Maintenance + Extension Period|Physician Decision|0|||
125403462|NCT04542070|451104006|FG000|Maintenance + Extension Period|Protocol Violation|2|||
125403463|NCT04542070|451104007|FG001|Maintenance + Extension Period|Protocol Violation|5|||
125403464|NCT04542070|451104008|FG002|Maintenance + Extension Period|Protocol Violation|0|||
125403465|NCT04542070|451104009|FG003|Maintenance + Extension Period|Protocol Violation|0|||
125403466|NCT04542070|451104006|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
125403467|NCT04542070|451104007|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
125403468|NCT04542070|451104008|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
125403469|NCT04542070|451104009|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
125403470|NCT04542070|451104006|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
125403471|NCT04542070|451104007|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
125403472|NCT04542070|451104008|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
125403473|NCT04542070|451104009|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
125403474|NCT04542070|451104006|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
125403475|NCT04542070|451104007|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
125403476|NCT04542070|451104008|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
125403477|NCT04542070|451104009|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
125403478|NCT04542070|451104006|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
125403479|NCT04542070|451104007|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
125403480|NCT04542070|451104008|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
125403481|NCT04542070|451104009|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
125403482|NCT04542070|451104006|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
125403483|NCT04542070|451104007|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
125403484|NCT04542070|451104008|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
125403485|NCT04542070|451104009|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
125403486|NCT04542070|451104006|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
125403487|NCT04542070|451104007|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
125403488|NCT04542070|451104008|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
125403489|NCT04542070|451104009|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
125403490|NCT04542070|451104006|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
125403491|NCT04542070|451104007|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
125403492|NCT04542070|451104008|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
125403493|NCT04542070|451104009|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
125403494|NCT02188485|451104011|FG000|Overall Study|Withdrawal by Subject|2|||
125403495|NCT02188485|451104012|FG001|Overall Study|Withdrawal by Subject|1|||
125403496|NCT02188485|451104011|FG000|Overall Study|PI withdrew, lack of capacity|0|||
125403497|NCT02188485|451104012|FG001|Overall Study|PI withdrew, lack of capacity|2|||
125403498|NCT02457325|451104016|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
125403499|NCT02457325|451104017|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
125403500|NCT00773097|451104018|FG000|Overall Study|Withdrawal by Subject|1|||
125403501|NCT00773097|451104018|FG000|Overall Study|Physician Decision|6|||
125403502|NCT02086591|451105533|FG000|Overall Study|Adverse Event|1|||
125403503|NCT02086591|451105533|FG000|Overall Study|Withdrawal by Subject|1|||
125403504|NCT02086591|451105533|FG000|Overall Study|protocol terminated|3|||
125403505|NCT01774903|451105534|FG000|Overall Study|Adverse Event|7|||
125403506|NCT01774903|451105534|FG000|Overall Study|Withdrawal by Subject|2|||
125403507|NCT01774903|451105534|FG000|Overall Study|Lack of Efficacy|1|||
125403508|NCT01774903|451105534|FG000|Overall Study|Ineligible to continue the trial|1|||
125403509|NCT02212730|451105537|FG000|Overall Study|Tumor not of the required cell histology|1|||
125403510|NCT02212730|451105538|FG001|Overall Study|Tumor not of the required cell histology|0|||
125403511|NCT02212730|451105537|FG000|Overall Study|Withdrawal by Subject|1|||
125403512|NCT02212730|451105538|FG001|Overall Study|Withdrawal by Subject|0|||
125403513|NCT02212730|451105537|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
125403514|NCT02212730|451105538|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
125277576|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
125403515|NCT02880371|451105539|FG000|Phase 1b|Lost to Follow-up|1|||
125403516|NCT02880371|451105540|FG001|Phase 1b|Lost to Follow-up|0|||
125447941|NCT01982760|451266888|FG001|Overall Study|Physician Decision|0|||
125447942|NCT02303574|451266890|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
125447943|NCT02303574|451266891|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
125403517|NCT02880371|451105541|FG002|Phase 1b|Lost to Follow-up|0|||
125403518|NCT02880371|451105542|FG003|Phase 1b|Lost to Follow-up|0|||
125403519|NCT02880371|451105543|FG004|Phase 1b|Lost to Follow-up|0|||
125403520|NCT02880371|451105544|FG005|Phase 1b|Lost to Follow-up|0|||
125403521|NCT02880371|451105545|FG006|Phase 1b|Lost to Follow-up|0|||
125403522|NCT02880371|451105546|FG007|Phase 1b|Lost to Follow-up|0|||
125403523|NCT02880371|451105539|FG000|Phase 1b|Participants terminated by Sponsor|1|||
125403524|NCT02880371|451105540|FG001|Phase 1b|Participants terminated by Sponsor|0|||
125403525|NCT02880371|451105541|FG002|Phase 1b|Participants terminated by Sponsor|0|||
125403526|NCT02880371|451105542|FG003|Phase 1b|Participants terminated by Sponsor|0|||
125403527|NCT02880371|451105543|FG004|Phase 1b|Participants terminated by Sponsor|0|||
125403528|NCT02880371|451105544|FG005|Phase 1b|Participants terminated by Sponsor|0|||
125403529|NCT02880371|451105545|FG006|Phase 1b|Participants terminated by Sponsor|0|||
125403530|NCT02880371|451105546|FG007|Phase 1b|Participants terminated by Sponsor|0|||
125403531|NCT02880371|451105539|FG000|Phase 1b|Withdrawal by Subject|0|||
125403532|NCT02880371|451105540|FG001|Phase 1b|Withdrawal by Subject|0|||
125403533|NCT02880371|451105541|FG002|Phase 1b|Withdrawal by Subject|1|||
125403534|NCT02880371|451105542|FG003|Phase 1b|Withdrawal by Subject|0|||
125403535|NCT02880371|451105543|FG004|Phase 1b|Withdrawal by Subject|0|||
125403536|NCT02880371|451105544|FG005|Phase 1b|Withdrawal by Subject|0|||
125403537|NCT02880371|451105545|FG006|Phase 1b|Withdrawal by Subject|0|||
125403538|NCT02880371|451105546|FG007|Phase 1b|Withdrawal by Subject|0|||
125403539|NCT02880371|451105539|FG000|Phase 1b|Death|4|||
125403540|NCT02880371|451105540|FG001|Phase 1b|Death|6|||
125403541|NCT02880371|451105541|FG002|Phase 1b|Death|5|||
125403542|NCT02880371|451105542|FG003|Phase 1b|Death|1|||
125403543|NCT02880371|451105543|FG004|Phase 1b|Death|0|||
125403544|NCT02880371|451105544|FG005|Phase 1b|Death|0|||
125403545|NCT02880371|451105545|FG006|Phase 1b|Death|0|||
125403546|NCT02880371|451105546|FG007|Phase 1b|Death|0|||
125403547|NCT02880371|451105539|FG000|Phase 1b|Enrolled but not Treated|0|||
125403548|NCT02880371|451105540|FG001|Phase 1b|Enrolled but not Treated|1|||
125403549|NCT02880371|451105541|FG002|Phase 1b|Enrolled but not Treated|0|||
125403550|NCT02880371|451105542|FG003|Phase 1b|Enrolled but not Treated|0|||
125403551|NCT02880371|451105543|FG004|Phase 1b|Enrolled but not Treated|0|||
125403552|NCT02880371|451105544|FG005|Phase 1b|Enrolled but not Treated|0|||
125403553|NCT02880371|451105545|FG006|Phase 1b|Enrolled but not Treated|0|||
125403554|NCT02880371|451105546|FG007|Phase 1b|Enrolled but not Treated|0|||
125403555|NCT02880371|451105539|FG000|Phase 2|Enrolled but not Treated|0|||
125403556|NCT02880371|451105540|FG001|Phase 2|Enrolled but not Treated|0|||
125403557|NCT02880371|451105541|FG002|Phase 2|Enrolled but not Treated|0|||
125403558|NCT02880371|451105542|FG003|Phase 2|Enrolled but not Treated|0|||
125403559|NCT02880371|451105543|FG004|Phase 2|Enrolled but not Treated|0|||
125403560|NCT02880371|451105544|FG005|Phase 2|Enrolled but not Treated|1|||
125403561|NCT02880371|451105545|FG006|Phase 2|Enrolled but not Treated|1|||
125403562|NCT02880371|451105546|FG007|Phase 2|Enrolled but not Treated|0|||
125403563|NCT02880371|451105539|FG000|Phase 2|Other|0|||
125403564|NCT02880371|451105540|FG001|Phase 2|Other|0|||
125403565|NCT02880371|451105541|FG002|Phase 2|Other|0|||
125403566|NCT02880371|451105542|FG003|Phase 2|Other|0|||
125403567|NCT02880371|451105543|FG004|Phase 2|Other|0|||
125403568|NCT02880371|451105544|FG005|Phase 2|Other|1|||
125403569|NCT02880371|451105545|FG006|Phase 2|Other|2|||
125403570|NCT02880371|451105546|FG007|Phase 2|Other|1|||
125403571|NCT02880371|451105539|FG000|Phase 2|Participants terminated by Sponsor|0|||
125403572|NCT02880371|451105540|FG001|Phase 2|Participants terminated by Sponsor|0|||
125403573|NCT02880371|451105541|FG002|Phase 2|Participants terminated by Sponsor|0|||
125403574|NCT02880371|451105542|FG003|Phase 2|Participants terminated by Sponsor|0|||
125403575|NCT02880371|451105543|FG004|Phase 2|Participants terminated by Sponsor|1|||
125403576|NCT02880371|451105544|FG005|Phase 2|Participants terminated by Sponsor|6|||
125403577|NCT02880371|451105545|FG006|Phase 2|Participants terminated by Sponsor|1|||
125403578|NCT02880371|451105546|FG007|Phase 2|Participants terminated by Sponsor|5|||
125403579|NCT02880371|451105539|FG000|Phase 2|Death|0|||
125403580|NCT02880371|451105540|FG001|Phase 2|Death|0|||
125403581|NCT02880371|451105541|FG002|Phase 2|Death|0|||
125403582|NCT02880371|451105542|FG003|Phase 2|Death|0|||
125403583|NCT02880371|451105543|FG004|Phase 2|Death|1|||
125403584|NCT02880371|451105544|FG005|Phase 2|Death|10|||
125403585|NCT02880371|451105545|FG006|Phase 2|Death|20|||
125403586|NCT02880371|451105546|FG007|Phase 2|Death|5|||
125403587|NCT02880371|451105539|FG000|Phase 2|Lost to Follow-up|0|||
125403588|NCT02880371|451105540|FG001|Phase 2|Lost to Follow-up|0|||
125403589|NCT02880371|451105541|FG002|Phase 2|Lost to Follow-up|0|||
125403590|NCT02880371|451105542|FG003|Phase 2|Lost to Follow-up|0|||
125403591|NCT02880371|451105543|FG004|Phase 2|Lost to Follow-up|0|||
125403592|NCT02880371|451105544|FG005|Phase 2|Lost to Follow-up|0|||
125403593|NCT02880371|451105545|FG006|Phase 2|Lost to Follow-up|3|||
125403594|NCT02880371|451105546|FG007|Phase 2|Lost to Follow-up|0|||
125403595|NCT02880371|451105539|FG000|Phase 2|Withdrawal by Subject|0|||
125403596|NCT02880371|451105540|FG001|Phase 2|Withdrawal by Subject|0|||
125403597|NCT02880371|451105541|FG002|Phase 2|Withdrawal by Subject|0|||
125403598|NCT02880371|451105542|FG003|Phase 2|Withdrawal by Subject|0|||
125403599|NCT02880371|451105543|FG004|Phase 2|Withdrawal by Subject|0|||
125403600|NCT02880371|451105544|FG005|Phase 2|Withdrawal by Subject|1|||
125403601|NCT02880371|451105545|FG006|Phase 2|Withdrawal by Subject|1|||
125403602|NCT02880371|451105546|FG007|Phase 2|Withdrawal by Subject|0|||
125403603|NCT02880371|451105539|FG000|Phase 2|End of Study page not completed by error|0|||
125403604|NCT02880371|451105540|FG001|Phase 2|End of Study page not completed by error|0|||
125403605|NCT02880371|451105541|FG002|Phase 2|End of Study page not completed by error|0|||
125403606|NCT02880371|451105542|FG003|Phase 2|End of Study page not completed by error|0|||
125403607|NCT02880371|451105543|FG004|Phase 2|End of Study page not completed by error|0|||
125403608|NCT02880371|451105544|FG005|Phase 2|End of Study page not completed by error|1|||
125403609|NCT02880371|451105545|FG006|Phase 2|End of Study page not completed by error|0|||
125403610|NCT02880371|451105546|FG007|Phase 2|End of Study page not completed by error|0|||
125403611|NCT01777997|451105549|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
125403612|NCT01777997|451105549|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
125403613|NCT01777997|451105549|FG000|Weeks 48 to 72/96 on ART|Death|1|||
125403614|NCT01777997|451105549|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
125403615|NCT02660359|451105550|FG000|Overall Study|Protocol Deviation|0|||
125403616|NCT02660359|451105551|FG001|Overall Study|Protocol Deviation|0|||
125403617|NCT02660359|451105552|FG002|Overall Study|Protocol Deviation|1|||
125403618|NCT02660359|451105550|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
125403619|NCT02660359|451105551|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
125403620|NCT02660359|451105552|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
125403621|NCT02660359|451105550|FG000|Overall Study|Lack of Efficacy|1|||
125403622|NCT02660359|451105551|FG001|Overall Study|Lack of Efficacy|1|||
125403623|NCT02660359|451105552|FG002|Overall Study|Lack of Efficacy|1|||
125403624|NCT02660359|451105550|FG000|Overall Study|Adverse Event|0|||
125403625|NCT02660359|451105551|FG001|Overall Study|Adverse Event|1|||
125403626|NCT02660359|451105552|FG002|Overall Study|Adverse Event|0|||
125403627|NCT02660359|451105550|FG000|Overall Study|Other|2|||
125403628|NCT02660359|451105551|FG001|Overall Study|Other|1|||
125403629|NCT02660359|451105552|FG002|Overall Study|Other|3|||
125403630|NCT02660359|451105550|FG000|Overall Study|Withdrawal by Subject|7|||
125403631|NCT02660359|451105551|FG001|Overall Study|Withdrawal by Subject|5|||
125403632|NCT02660359|451105552|FG002|Overall Study|Withdrawal by Subject|8|||
125403633|NCT02660359|451105550|FG000|Overall Study|Lost to Follow-up|3|||
125403634|NCT02660359|451105551|FG001|Overall Study|Lost to Follow-up|3|||
125403635|NCT02660359|451105552|FG002|Overall Study|Lost to Follow-up|0|||
125403636|NCT00529386|451105553|FG000|Overall Study|Lost to Follow-up|1|||
125403637|NCT04532112|451105554|FG000|Overall Study|Adverse Event|3|||
125403638|NCT04532112|451105555|FG001|Overall Study|Adverse Event|0|||
125403639|NCT03348904|451105556|FG000|Overall Study|Administrative reason by the sponsor|0|||
125403640|NCT03348904|451105557|FG001|Overall Study|Administrative reason by the sponsor|1|||
125403641|NCT03348904|451105558|FG002|Overall Study|Administrative reason by the sponsor|0|||
125403642|NCT02039427|451105564|FG000|Overall Study|Duration of surgery > 3h|1|||
125403643|NCT02039427|451105565|FG001|Overall Study|Duration of surgery > 3h|1|||
125403644|NCT02039427|451105566|FG002|Overall Study|Duration of surgery > 3h|0|||
125403645|NCT02039427|451105567|FG003|Overall Study|Duration of surgery > 3h|0|||
125403646|NCT02039427|451105564|FG000|Overall Study|Withdrawal on concent|0|||
125403647|NCT02039427|451105565|FG001|Overall Study|Withdrawal on concent|0|||
125403648|NCT02039427|451105566|FG002|Overall Study|Withdrawal on concent|0|||
125403649|NCT02039427|451105567|FG003|Overall Study|Withdrawal on concent|1|||
125403650|NCT02039427|451105564|FG000|Overall Study|Cancellation of surgery|0|||
125403651|NCT02039427|451105565|FG001|Overall Study|Cancellation of surgery|0|||
125403652|NCT02039427|451105566|FG002|Overall Study|Cancellation of surgery|1|||
125403653|NCT02039427|451105567|FG003|Overall Study|Cancellation of surgery|0|||
125403654|NCT02039427|451105564|FG000|Overall Study|Loss of follow - up|1|||
125403655|NCT02039427|451105565|FG001|Overall Study|Loss of follow - up|0|||
125403656|NCT02039427|451105566|FG002|Overall Study|Loss of follow - up|2|||
125403657|NCT02039427|451105567|FG003|Overall Study|Loss of follow - up|4|||
125403658|NCT02039427|451105564|FG000|Overall Study|Steroid Use|1|||
125403659|NCT02039427|451105565|FG001|Overall Study|Steroid Use|0|||
125403660|NCT02039427|451105566|FG002|Overall Study|Steroid Use|0|||
125403661|NCT02039427|451105567|FG003|Overall Study|Steroid Use|0|||
125403662|NCT04354831|451105568|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
125403663|NCT04354831|451105569|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
125403664|NCT02732847|451105570|FG000|Overall Study|some filled early|42|||
125403665|NCT02732847|451105571|FG001|Overall Study|some filled early|42|||
125403666|NCT04027686|451105572|FG000|Overall Study|Lost to Follow-up|2|||
125403667|NCT04027686|451105573|FG001|Overall Study|Lost to Follow-up|0|||
125403668|NCT04027686|451105572|FG000|Overall Study|Withdrawal by Subject|0|||
125403669|NCT04027686|451105573|FG001|Overall Study|Withdrawal by Subject|1|||
125403670|NCT00111228|451105574|FG000|Overall Study|Withdrawal by Subject|5|||
125403671|NCT00111228|451105575|FG001|Overall Study|Withdrawal by Subject|1|||
125403672|NCT00111228|451105576|FG002|Overall Study|Withdrawal by Subject|0|||
125403673|NCT00779766|451105577|FG000|Month 24|Serious Adverse Event|2|||
125403674|NCT00779766|451105578|FG001|Month 24|Serious Adverse Event|3|||
125403675|NCT00779766|451105577|FG000|Month 24|Adverse Event|3|||
125403676|NCT00779766|451105578|FG001|Month 24|Adverse Event|3|||
125403677|NCT00779766|451105577|FG000|Month 24|Protocol Violation|3|||
125403678|NCT00779766|451105578|FG001|Month 24|Protocol Violation|1|||
125403679|NCT00779766|451105577|FG000|Month 24|Withdrawal by Subject|159|||
125403680|NCT00779766|451105578|FG001|Month 24|Withdrawal by Subject|127|||
125403681|NCT00779766|451105577|FG000|Month 24|Migrated/moved from study area|138|||
125403682|NCT00779766|451105578|FG001|Month 24|Migrated/moved from study area|162|||
125403683|NCT00779766|451105577|FG000|Month 24|Lost to Follow-up|9|||
125403684|NCT00779766|451105578|FG001|Month 24|Lost to Follow-up|9|||
125403685|NCT00779766|451105577|FG000|Month 24|Other|18|||
125403686|NCT00779766|451105578|FG001|Month 24|Other|27|||
125403687|NCT00779766|451105577|FG000|Month 48|Withdrawal by Subject|68|||
125403688|NCT00779766|451105578|FG001|Month 48|Withdrawal by Subject|63|||
125403689|NCT00779766|451105577|FG000|Month 48|Migrated/moved from study area|76|||
125403690|NCT00779766|451105578|FG001|Month 48|Migrated/moved from study area|75|||
125403691|NCT00779766|451105577|FG000|Month 48|Lost to Follow-up|29|||
125403692|NCT00779766|451105578|FG001|Month 48|Lost to Follow-up|30|||
125403693|NCT00779766|451105577|FG000|Month 48|Other|1|||
125403694|NCT00779766|451105578|FG001|Month 48|Other|0|||
125403695|NCT00779766|451105577|FG000|Month 72|Withdrawal by Subject|55|||
125403696|NCT00779766|451105578|FG001|Month 72|Withdrawal by Subject|71|||
125403697|NCT00779766|451105577|FG000|Month 72|Migrated/moved from study area|124|||
125403698|NCT00779766|451105578|FG001|Month 72|Migrated/moved from study area|109|||
125403699|NCT00779766|451105577|FG000|Month 72|Lost to Follow-up|6|||
125403700|NCT00779766|451105578|FG001|Month 72|Lost to Follow-up|8|||
125403701|NCT00779766|451105577|FG000|Month 72|Other|0|||
125403702|NCT00779766|451105578|FG001|Month 72|Other|1|||
125403703|NCT01274637|451105581|FG000|Overall Study|Withdrawal by Subject|0|||
125403704|NCT01274637|451105582|FG001|Overall Study|Withdrawal by Subject|1|||
125403705|NCT01274637|451105581|FG000|Overall Study|Lost to Follow-up|0|||
125403706|NCT01274637|451105582|FG001|Overall Study|Lost to Follow-up|1|||
125403707|NCT02357576|451105586|FG000|Treatment Period|Withdrawal by Subject|0|||
125403708|NCT02357576|451105587|FG001|Treatment Period|Withdrawal by Subject|1|||
125403709|NCT02357576|451105586|FG000|Treatment Period|Physician Decision|0|||
125403710|NCT02357576|451105587|FG001|Treatment Period|Physician Decision|1|||
125403711|NCT02357576|451105586|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
125403712|NCT02357576|451105587|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
125403713|NCT02357576|451105586|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
125403714|NCT02357576|451105587|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
125403715|NCT02357576|451105586|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
125403716|NCT02357576|451105587|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
125403717|NCT02357576|451105586|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
125403718|NCT02357576|451105587|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
125403719|NCT00699699|451105590|FG000|Overall Study|Adverse Event|36|||
125403720|NCT00699699|451105590|FG000|Overall Study|Individual different reasons|21|||
125403721|NCT01000051|451105593|FG000|Overall Study|Withdrawal by Subject|1|||
125403722|NCT01000051|451105594|FG001|Overall Study|Withdrawal by Subject|1|||
125403723|NCT01000051|451105593|FG000|Overall Study|Disease Progression|1|||
125403724|NCT01000051|451105594|FG001|Overall Study|Disease Progression|0|||
125403725|NCT01000051|451105593|FG000|Overall Study|Serious noncompliance|1|||
125403726|NCT01000051|451105594|FG001|Overall Study|Serious noncompliance|0|||
125403727|NCT00414050|451105595|FG000|Overall Study|Adverse Event|1|||
125403728|NCT00414050|451105596|FG001|Overall Study|Adverse Event|1|||
125403729|NCT00414050|451105597|FG002|Overall Study|Adverse Event|1|||
125403730|NCT00414050|451105598|FG003|Overall Study|Adverse Event|1|||
125403731|NCT00414050|451105595|FG000|Overall Study|Lost to Follow-up|2|||
125403732|NCT00414050|451105596|FG001|Overall Study|Lost to Follow-up|2|||
125403733|NCT00414050|451105597|FG002|Overall Study|Lost to Follow-up|1|||
125403734|NCT00414050|451105598|FG003|Overall Study|Lost to Follow-up|1|||
125403735|NCT00414050|451105595|FG000|Overall Study|Withdrawal by Subject|5|||
125447944|NCT02303574|451266892|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
125403736|NCT00414050|451105596|FG001|Overall Study|Withdrawal by Subject|3|||
125403737|NCT00414050|451105597|FG002|Overall Study|Withdrawal by Subject|2|||
125403738|NCT00414050|451105598|FG003|Overall Study|Withdrawal by Subject|4|||
125403739|NCT00414050|451105595|FG000|Overall Study|Subject discontinued for other reason|1|||
125403740|NCT00414050|451105596|FG001|Overall Study|Subject discontinued for other reason|2|||
125403741|NCT00414050|451105597|FG002|Overall Study|Subject discontinued for other reason|2|||
125403742|NCT00414050|451105598|FG003|Overall Study|Subject discontinued for other reason|1|||
125403743|NCT00414050|451105595|FG000|Overall Study|Subject Moved|0|||
125403744|NCT00414050|451105596|FG001|Overall Study|Subject Moved|0|||
125403745|NCT00414050|451105597|FG002|Overall Study|Subject Moved|0|||
125403746|NCT00414050|451105598|FG003|Overall Study|Subject Moved|1|||
125403747|NCT03495908|451105600|FG000|Overall Study|Withdrawal by Subject|3|||
125403748|NCT03495908|451105601|FG001|Overall Study|Withdrawal by Subject|1|||
125403749|NCT03495908|451105600|FG000|Overall Study|Lost to Follow-up|1|||
125403750|NCT03495908|451105601|FG001|Overall Study|Lost to Follow-up|4|||
125403751|NCT03495908|451105600|FG000|Overall Study|Adverse Event|0|||
125277577|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
125277578|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
125277579|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
125277580|NCT01673854|450642277|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
125277581|NCT01673854|450642277|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
125277582|NCT01673854|450642277|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
125277583|NCT01673854|450642277|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
125277584|NCT01673854|450642277|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
125277585|NCT00334737|450642278|FG000|Hospital Phase|Death|1|||
125277586|NCT00334737|450642279|FG001|Hospital Phase|Death|2|||
125277587|NCT00334737|450642280|FG002|Hospital Phase|Death|3|||
125277588|NCT00334737|450642278|FG000|Hospital Phase|Withdrawal by Subject|0|||
125277589|NCT00334737|450642279|FG001|Hospital Phase|Withdrawal by Subject|0|||
125277590|NCT00334737|450642280|FG002|Hospital Phase|Withdrawal by Subject|1|||
125277591|NCT00334737|450642278|FG000|Hospital Phase|Did not receive study drug|1|||
125277592|NCT00334737|450642279|FG001|Hospital Phase|Did not receive study drug|0|||
125277593|NCT00334737|450642280|FG002|Hospital Phase|Did not receive study drug|0|||
125277594|NCT00334737|450642278|FG000|Follow up Phase|Lost to Follow-up|5|||
125277595|NCT00334737|450642279|FG001|Follow up Phase|Lost to Follow-up|3|||
125277596|NCT00334737|450642280|FG002|Follow up Phase|Lost to Follow-up|6|||
125277597|NCT00583752|450642281|FG000|Overall Study|Lost to Follow-up|5|||
125277598|NCT00583752|450642282|FG001|Overall Study|Lost to Follow-up|5|||
125277599|NCT02316353|450642283|FG000|Overall Study|Pregnancy|1|||
125277600|NCT02316353|450642284|FG001|Overall Study|Pregnancy|3|||
125277601|NCT02316353|450642283|FG000|Overall Study|Adverse Event|1|||
125277602|NCT02316353|450642284|FG001|Overall Study|Adverse Event|3|||
125277603|NCT02316353|450642283|FG000|Overall Study|Withdrawal by Subject|6|||
125277604|NCT02316353|450642284|FG001|Overall Study|Withdrawal by Subject|2|||
125277605|NCT02954406|450643907|FG000|Overall Study|Adverse Event|0|||
125277606|NCT02954406|450643908|FG001|Overall Study|Adverse Event|1|||
125277607|NCT02954406|450643909|FG002|Overall Study|Adverse Event|0|||
125277608|NCT02954406|450643910|FG003|Overall Study|Adverse Event|0|||
125277609|NCT02954406|450643911|FG004|Overall Study|Adverse Event|1|||
125277610|NCT02954406|450643912|FG005|Overall Study|Adverse Event|0|||
125277611|NCT02954406|450643913|FG006|Overall Study|Adverse Event|0|||
125277612|NCT02954406|450643914|FG007|Overall Study|Adverse Event|0|||
125277613|NCT02954406|450643915|FG008|Overall Study|Adverse Event|1|||
125277614|NCT02954406|450643916|FG009|Overall Study|Adverse Event|1|||
125277615|NCT02954406|450643917|FG010|Overall Study|Adverse Event|0|||
125277616|NCT02954406|450643907|FG000|Overall Study|Progressive Disease|3|||
125277617|NCT02954406|450643908|FG001|Overall Study|Progressive Disease|4|||
125277618|NCT02954406|450643909|FG002|Overall Study|Progressive Disease|3|||
125277619|NCT02954406|450643910|FG003|Overall Study|Progressive Disease|4|||
125277620|NCT02954406|450643911|FG004|Overall Study|Progressive Disease|3|||
125277621|NCT02954406|450643912|FG005|Overall Study|Progressive Disease|3|||
125277622|NCT02954406|450643913|FG006|Overall Study|Progressive Disease|2|||
125277623|NCT02954406|450643914|FG007|Overall Study|Progressive Disease|2|||
125277624|NCT02954406|450643915|FG008|Overall Study|Progressive Disease|1|||
125277625|NCT02954406|450643916|FG009|Overall Study|Progressive Disease|1|||
125277626|NCT02954406|450643917|FG010|Overall Study|Progressive Disease|0|||
125277627|NCT02954406|450643907|FG000|Overall Study|Symptomatic Deterioration|0|||
125277628|NCT02954406|450643908|FG001|Overall Study|Symptomatic Deterioration|1|||
125277629|NCT02954406|450643909|FG002|Overall Study|Symptomatic Deterioration|0|||
125277630|NCT02954406|450643910|FG003|Overall Study|Symptomatic Deterioration|0|||
125277631|NCT02954406|450643911|FG004|Overall Study|Symptomatic Deterioration|0|||
125277632|NCT02954406|450643912|FG005|Overall Study|Symptomatic Deterioration|0|||
125277633|NCT02954406|450643913|FG006|Overall Study|Symptomatic Deterioration|0|||
125277634|NCT02954406|450643914|FG007|Overall Study|Symptomatic Deterioration|0|||
125277635|NCT02954406|450643915|FG008|Overall Study|Symptomatic Deterioration|0|||
125277636|NCT02954406|450643916|FG009|Overall Study|Symptomatic Deterioration|0|||
125277637|NCT02954406|450643917|FG010|Overall Study|Symptomatic Deterioration|0|||
125277638|NCT02954406|450643907|FG000|Overall Study|Death|0|||
125277639|NCT02954406|450643908|FG001|Overall Study|Death|0|||
125277640|NCT02954406|450643909|FG002|Overall Study|Death|0|||
125277641|NCT02954406|450643910|FG003|Overall Study|Death|0|||
125277642|NCT02954406|450643911|FG004|Overall Study|Death|1|||
125277643|NCT02954406|450643912|FG005|Overall Study|Death|0|||
125277644|NCT02954406|450643913|FG006|Overall Study|Death|0|||
125277645|NCT02954406|450643914|FG007|Overall Study|Death|0|||
125277646|NCT02954406|450643915|FG008|Overall Study|Death|1|||
125277647|NCT02954406|450643916|FG009|Overall Study|Death|1|||
125277648|NCT02954406|450643917|FG010|Overall Study|Death|0|||
125277649|NCT02954406|450643907|FG000|Overall Study|Reason Not Specified|0|||
125277650|NCT02954406|450643908|FG001|Overall Study|Reason Not Specified|0|||
125277651|NCT02954406|450643909|FG002|Overall Study|Reason Not Specified|3|||
125277652|NCT02954406|450643910|FG003|Overall Study|Reason Not Specified|2|||
125277653|NCT02954406|450643911|FG004|Overall Study|Reason Not Specified|2|||
125277654|NCT02954406|450643912|FG005|Overall Study|Reason Not Specified|0|||
125403752|NCT03495908|451105601|FG001|Overall Study|Adverse Event|2|||
125403753|NCT03495908|451105600|FG000|Overall Study|Death|1|||
125403754|NCT03495908|451105601|FG001|Overall Study|Death|0|||
125403755|NCT03495908|451105600|FG000|Overall Study|Physician Decision|5|||
125403756|NCT03495908|451105601|FG001|Overall Study|Physician Decision|4|||
125403757|NCT03495908|451105600|FG000|Overall Study|No documented reason|0|||
125403758|NCT03495908|451105601|FG001|Overall Study|No documented reason|2|||
125403759|NCT03304379|451105606|FG000|Overall Study|Protocol Violation|8|||
125403760|NCT03304379|451105607|FG001|Overall Study|Protocol Violation|10|||
125403761|NCT03304379|451105608|FG002|Overall Study|Protocol Violation|5|||
125403762|NCT03304379|451105609|FG003|Overall Study|Protocol Violation|0|||
125403763|NCT03304379|451105610|FG004|Overall Study|Protocol Violation|2|||
125403764|NCT03304379|451105606|FG000|Overall Study|Adverse Event|4|||
125403765|NCT03304379|451105607|FG001|Overall Study|Adverse Event|20|||
125403766|NCT03304379|451105608|FG002|Overall Study|Adverse Event|17|||
125403767|NCT03304379|451105609|FG003|Overall Study|Adverse Event|1|||
125403768|NCT03304379|451105610|FG004|Overall Study|Adverse Event|0|||
125403769|NCT03304379|451105606|FG000|Overall Study|Lack of Efficacy|17|||
125403770|NCT03304379|451105607|FG001|Overall Study|Lack of Efficacy|16|||
125403771|NCT03304379|451105608|FG002|Overall Study|Lack of Efficacy|20|||
125403772|NCT03304379|451105609|FG003|Overall Study|Lack of Efficacy|0|||
125403773|NCT03304379|451105610|FG004|Overall Study|Lack of Efficacy|0|||
125403774|NCT03304379|451105606|FG000|Overall Study|Physician Decision|6|||
125403775|NCT03304379|451105607|FG001|Overall Study|Physician Decision|10|||
125403776|NCT03304379|451105608|FG002|Overall Study|Physician Decision|6|||
125403777|NCT03304379|451105609|FG003|Overall Study|Physician Decision|9|||
125403778|NCT03304379|451105610|FG004|Overall Study|Physician Decision|10|||
125403779|NCT03304379|451105606|FG000|Overall Study|Withdrawal by Subject|26|||
125403780|NCT03304379|451105607|FG001|Overall Study|Withdrawal by Subject|58|||
125403781|NCT03304379|451105608|FG002|Overall Study|Withdrawal by Subject|66|||
125403782|NCT03304379|451105609|FG003|Overall Study|Withdrawal by Subject|3|||
125403783|NCT03304379|451105610|FG004|Overall Study|Withdrawal by Subject|5|||
125403784|NCT03304379|451105606|FG000|Overall Study|Lost to Follow-up|8|||
125403785|NCT03304379|451105607|FG001|Overall Study|Lost to Follow-up|24|||
125403786|NCT03304379|451105608|FG002|Overall Study|Lost to Follow-up|35|||
125403787|NCT03304379|451105609|FG003|Overall Study|Lost to Follow-up|4|||
125403788|NCT03304379|451105610|FG004|Overall Study|Lost to Follow-up|0|||
125403789|NCT03304379|451105606|FG000|Overall Study|Death|1|||
125403790|NCT03304379|451105607|FG001|Overall Study|Death|2|||
125403791|NCT03304379|451105608|FG002|Overall Study|Death|0|||
125403792|NCT03304379|451105609|FG003|Overall Study|Death|0|||
125403793|NCT03304379|451105610|FG004|Overall Study|Death|0|||
125403794|NCT03304379|451105606|FG000|Overall Study|Other|0|||
125403795|NCT03304379|451105607|FG001|Overall Study|Other|1|||
125403796|NCT03304379|451105608|FG002|Overall Study|Other|0|||
125403797|NCT03304379|451105609|FG003|Overall Study|Other|0|||
125403798|NCT03304379|451105610|FG004|Overall Study|Other|0|||
125403799|NCT01469065|451105624|FG000|Overall Study|Lack of Efficacy|0|||
125403800|NCT01469065|451105625|FG001|Overall Study|Lack of Efficacy|0|||
125403801|NCT01469065|451105626|FG002|Overall Study|Lack of Efficacy|0|||
125403802|NCT01469065|451105627|FG003|Overall Study|Lack of Efficacy|0|||
125403803|NCT01469065|451105628|FG004|Overall Study|Lack of Efficacy|1|||
125403804|NCT01469065|451105624|FG000|Overall Study|Other|0|||
125403805|NCT01469065|451105625|FG001|Overall Study|Other|1|||
125403806|NCT01469065|451105626|FG002|Overall Study|Other|0|||
125403807|NCT01469065|451105627|FG003|Overall Study|Other|0|||
125403808|NCT01469065|451105628|FG004|Overall Study|Other|0|||
125403809|NCT00578565|451105629|FG000|Overall Study|Adverse Event|3|||
125403810|NCT01752933|451105630|FG000|Treatment|Disease Progression|3|||
125403811|NCT01752933|451105631|FG001|Treatment|Disease Progression|29|||
125403812|NCT01752933|451105630|FG000|Treatment|Withdrawal by Subject|0|||
125403813|NCT01752933|451105631|FG001|Treatment|Withdrawal by Subject|5|||
125403814|NCT01752933|451105630|FG000|Treatment|Adverse Event|1|||
125403815|NCT01752933|451105631|FG001|Treatment|Adverse Event|4|||
125403816|NCT01752933|451105630|FG000|Treatment|Physician Decision|0|||
125403817|NCT01752933|451105631|FG001|Treatment|Physician Decision|3|||
125403818|NCT01752933|451105630|FG000|Treatment|Death|0|||
125403819|NCT01752933|451105631|FG001|Treatment|Death|2|||
125403820|NCT01752933|451105630|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
125403821|NCT01752933|451105631|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
125403822|NCT01752933|451105630|FG000|Treatment|Patient noncompliant|0|||
125403823|NCT01752933|451105631|FG001|Treatment|Patient noncompliant|1|||
125403824|NCT01752933|451105630|FG000|Treatment|Patient unable to travel to appointments|0|||
125403825|NCT01752933|451105631|FG001|Treatment|Patient unable to travel to appointments|1|||
125403826|NCT01752933|451105630|FG000|Overall Study and Follow-up|Death|4|||
125403827|NCT01752933|451105631|FG001|Overall Study and Follow-up|Death|34|||
125403828|NCT01752933|451105630|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
125403829|NCT01752933|451105631|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
125403830|NCT01752933|451105630|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
125403831|NCT01752933|451105631|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
125403832|NCT01752933|451105630|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
125403833|NCT01752933|451105631|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
125403834|NCT02203591|451105632|FG000|Overall Study|Did not meet treatment day baseline|147|||
125403835|NCT02203591|451105633|FG001|Overall Study|Did not meet treatment day baseline|141|||
125403836|NCT02203591|451105634|FG002|Overall Study|Did not meet treatment day baseline|150|||
125403837|NCT02203591|451105635|FG003|Overall Study|Did not meet treatment day baseline|45|||
125403838|NCT02203591|451105636|FG004|Overall Study|Did not meet treatment day baseline|33|||
125403839|NCT02203591|451105637|FG005|Overall Study|Did not meet treatment day baseline|35|||
125403840|NCT02203591|451105638|FG006|Overall Study|Did not meet treatment day baseline|29|||
125403841|NCT02203591|451105639|FG007|Overall Study|Did not meet treatment day baseline|12|||
125403842|NCT02203591|451105632|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
125403843|NCT02203591|451105633|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
125403844|NCT02203591|451105634|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
125403845|NCT02203591|451105635|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
125403846|NCT02203591|451105636|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
125403847|NCT02203591|451105637|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
125403848|NCT02203591|451105638|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
125403849|NCT02203591|451105639|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
125403850|NCT01706250|451105641|FG000|Overall Study|Lost to Follow-up|2|||
125403851|NCT03286140|451105642|FG000|Overall Study|Withdrawal by Subject|10|||
125403852|NCT03286140|451105643|FG001|Overall Study|Withdrawal by Subject|5|||
125403853|NCT03286140|451105642|FG000|Overall Study|Lost to Follow-up|5|||
125403854|NCT03286140|451105643|FG001|Overall Study|Lost to Follow-up|10|||
125403855|NCT03286140|451105642|FG000|Overall Study|Failure to comply|0|||
125403856|NCT03286140|451105643|FG001|Overall Study|Failure to comply|1|||
125403857|NCT01565291|451105647|FG000|Overall Study|Withdrawal by Subject|1|||
125403858|NCT01565291|451105648|FG001|Overall Study|Withdrawal by Subject|0|||
125403859|NCT00515827|451105649|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
125403860|NCT00515827|451105650|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
125403861|NCT00515827|451105649|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
125403862|NCT00515827|451105650|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
125403863|NCT03181542|451105651|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
125403864|NCT03181542|451105652|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
125403865|NCT03149237|451105658|FG000|Overall Study|Withdrawal by Subject|4|||
125403866|NCT03149237|451105659|FG001|Overall Study|Withdrawal by Subject|5|||
125403867|NCT04568122|451105660|FG000|Overall Study|Lost to Follow-up|48|||
125403868|NCT04568122|451105661|FG001|Overall Study|Lost to Follow-up|44|||
125403869|NCT04568122|451105662|FG002|Overall Study|Lost to Follow-up|4|||
125403870|NCT04568122|451105663|FG003|Overall Study|Lost to Follow-up|0|||
125403871|NCT04568122|451105664|FG004|Overall Study|Lost to Follow-up|0|||
125403872|NCT01227512|451105667|FG000|Overall Study|Physician Decision|6|||
125403873|NCT01227512|451105668|FG001|Overall Study|Physician Decision|6|||
125403874|NCT01227512|451105667|FG000|Overall Study|Adverse Event|4|||
125403875|NCT01227512|451105668|FG001|Overall Study|Adverse Event|3|||
125403876|NCT01227512|451105667|FG000|Overall Study|Withdrawal by Subject|3|||
125403877|NCT01227512|451105668|FG001|Overall Study|Withdrawal by Subject|0|||
125403878|NCT01227512|451105667|FG000|Overall Study|Participant met withdrawal criteria|0|||
125403879|NCT01227512|451105668|FG001|Overall Study|Participant met withdrawal criteria|1|||
125403880|NCT04055116|451105675|FG000|First Intervention|Physician Decision|2|||
125403881|NCT04055116|451105676|FG001|First Intervention|Physician Decision|7|||
125403882|NCT02774681|451105677|FG000|Treatment on Study|Progressive Disease|7|||
125403883|NCT02774681|451105677|FG000|Follow-Up for 3 Years|Death|11|||
125403884|NCT02774681|451105677|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
125403885|NCT04497987|451105678|FG000|Overall Study|Adverse Event|1|||
125403886|NCT04497987|451105679|FG001|Overall Study|Adverse Event|0|||
125403887|NCT04497987|451105678|FG000|Overall Study|Death|21|||
125403888|NCT04497987|451105679|FG001|Overall Study|Death|13|||
125403889|NCT04497987|451105678|FG000|Overall Study|Lost to Follow-up|19|||
125403890|NCT04497987|451105679|FG001|Overall Study|Lost to Follow-up|17|||
125403891|NCT04497987|451105678|FG000|Overall Study|Other - as reported by the investigator|22|||
125403892|NCT04497987|451105679|FG001|Overall Study|Other - as reported by the investigator|16|||
125403893|NCT04497987|451105678|FG000|Overall Study|Physician Decision|1|||
125403894|NCT04497987|451105679|FG001|Overall Study|Physician Decision|0|||
125403895|NCT04497987|451105678|FG000|Overall Study|Withdrawal by Subject|35|||
125403896|NCT04497987|451105679|FG001|Overall Study|Withdrawal by Subject|21|||
125403897|NCT00512096|451105680|FG000|Overall Study|Adverse Event|2|||
125403898|NCT00512096|451105680|FG000|Overall Study|Withdrawal by Subject|2|||
125403899|NCT00512096|451105680|FG000|Overall Study|Lack of Efficacy|3|||
125403900|NCT01069289|451105681|FG000|Overall Study|Withdrawal by Subject|15|||
125403901|NCT01069289|451105682|FG001|Overall Study|Withdrawal by Subject|26|||
125403902|NCT01069289|451105681|FG000|Overall Study|Adverse Event|21|||
125403903|NCT01069289|451105682|FG001|Overall Study|Adverse Event|28|||
125447945|NCT02303574|451266893|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
125277655|NCT02954406|450643913|FG006|Overall Study|Reason Not Specified|1|||
125277656|NCT02954406|450643914|FG007|Overall Study|Reason Not Specified|0|||
125277657|NCT02954406|450643915|FG008|Overall Study|Reason Not Specified|1|||
125277658|NCT02954406|450643916|FG009|Overall Study|Reason Not Specified|0|||
125403904|NCT01069289|451105681|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
125403905|NCT01069289|451105682|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125403906|NCT01069289|451105681|FG000|Overall Study|Severe non-compliance to protocol|3|||
125403907|NCT01069289|451105682|FG001|Overall Study|Severe non-compliance to protocol|2|||
125403908|NCT01069289|451105681|FG000|Overall Study|Due to deteriorating health condition|1|||
125403909|NCT01069289|451105682|FG001|Overall Study|Due to deteriorating health condition|0|||
125403910|NCT00298038|451105683|FG000|Overall Study|Lost to Follow-up|0|||
125403911|NCT00298038|451105684|FG001|Overall Study|Lost to Follow-up|1|||
125403912|NCT00298038|451105683|FG000|Overall Study|Liver Transplant|0|||
125403913|NCT00298038|451105684|FG001|Overall Study|Liver Transplant|1|||
125403914|NCT00298038|451105683|FG000|Overall Study|Protocol Violation|1|||
125403915|NCT00298038|451105684|FG001|Overall Study|Protocol Violation|3|||
125403916|NCT00298038|451105683|FG000|Overall Study|Death|6|||
125403917|NCT00298038|451105684|FG001|Overall Study|Death|3|||
125403918|NCT00298038|451105683|FG000|Overall Study|Withdrawal by Subject|6|||
125403919|NCT00298038|451105684|FG001|Overall Study|Withdrawal by Subject|9|||
125403920|NCT00298038|451105683|FG000|Overall Study|Adverse Event|8|||
125403921|NCT00298038|451105684|FG001|Overall Study|Adverse Event|7|||
125403922|NCT00298038|451105683|FG000|Overall Study|Breakthrough overt HE episode|28|||
125403923|NCT00298038|451105684|FG001|Overall Study|Breakthrough overt HE episode|69|||
125403924|NCT00298038|451105683|FG000|Overall Study|Noncompliance|1|||
125403925|NCT00298038|451105684|FG001|Overall Study|Noncompliance|0|||
125403926|NCT00298038|451105683|FG000|Overall Study|Cocaine Abuse|1|||
125403927|NCT00298038|451105684|FG001|Overall Study|Cocaine Abuse|0|||
125403928|NCT00298038|451105683|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
125403929|NCT00298038|451105684|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
125403930|NCT02696096|451105685|FG000|Overall Study|ruled out at screening|1|||
125403931|NCT02696096|451105685|FG000|Overall Study|did not attend second fMRI|1|||
125403932|NCT01755416|451105688|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
125403933|NCT01755416|451105689|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
125403934|NCT02573324|451108159|FG000|Overall Study|Withdrawal by Subject|26|||
125403935|NCT02573324|451108160|FG001|Overall Study|Withdrawal by Subject|23|||
125403936|NCT02573324|451108161|FG002|Overall Study|Withdrawal by Subject|3|||
125403937|NCT02573324|451108159|FG000|Overall Study|Lost to Follow-up|4|||
125403938|NCT02573324|451108160|FG001|Overall Study|Lost to Follow-up|5|||
125403939|NCT02573324|451108161|FG002|Overall Study|Lost to Follow-up|0|||
125403940|NCT02573324|451108159|FG000|Overall Study|Study Terminated by Sponsor|107|||
125403941|NCT02573324|451108160|FG001|Overall Study|Study Terminated by Sponsor|89|||
125403942|NCT02573324|451108161|FG002|Overall Study|Study Terminated by Sponsor|2|||
125403943|NCT02573324|451108159|FG000|Overall Study|Death|182|||
125403944|NCT02573324|451108160|FG001|Overall Study|Death|200|||
125403945|NCT02573324|451108161|FG002|Overall Study|Death|1|||
125403946|NCT02573324|451108159|FG000|Overall Study|Other, Not Specified|20|||
125403947|NCT02573324|451108160|FG001|Overall Study|Other, Not Specified|27|||
125403948|NCT02573324|451108161|FG002|Overall Study|Other, Not Specified|0|||
125403949|NCT02573324|451108159|FG000|Overall Study|Unknown Reason|2|||
125403950|NCT02573324|451108160|FG001|Overall Study|Unknown Reason|0|||
125403951|NCT02573324|451108161|FG002|Overall Study|Unknown Reason|0|||
125403952|NCT01607905|451108162|FG000|Overall Study|Withdrawal by participant|7|||
125403953|NCT01607905|451108163|FG001|Overall Study|Withdrawal by participant|2|||
125403954|NCT01607905|451108164|FG002|Overall Study|Withdrawal by participant|4|||
125403955|NCT01607905|451108165|FG003|Overall Study|Withdrawal by participant|6|||
125403956|NCT01607905|451108166|FG004|Overall Study|Withdrawal by participant|0|||
125403957|NCT01607905|451108167|FG005|Overall Study|Withdrawal by participant|4|||
125403958|NCT01607905|451108168|FG006|Overall Study|Withdrawal by participant|12|||
125403959|NCT01607905|451108162|FG000|Overall Study|Incidence or severity of AEs|5|||
125403960|NCT01607905|451108163|FG001|Overall Study|Incidence or severity of AEs|1|||
125403961|NCT01607905|451108164|FG002|Overall Study|Incidence or severity of AEs|1|||
125403962|NCT01607905|451108165|FG003|Overall Study|Incidence or severity of AEs|3|||
125403963|NCT01607905|451108166|FG004|Overall Study|Incidence or severity of AEs|0|||
125403964|NCT01607905|451108167|FG005|Overall Study|Incidence or severity of AEs|2|||
125403965|NCT01607905|451108168|FG006|Overall Study|Incidence or severity of AEs|8|||
125403966|NCT01607905|451108162|FG000|Overall Study|Disease progression|44|||
125403967|NCT01607905|451108163|FG001|Overall Study|Disease progression|16|||
125403968|NCT01607905|451108164|FG002|Overall Study|Disease progression|15|||
125403969|NCT01607905|451108165|FG003|Overall Study|Disease progression|11|||
125403970|NCT01607905|451108166|FG004|Overall Study|Disease progression|6|||
125277659|NCT02954406|450643917|FG010|Overall Study|Reason Not Specified|0|||
125403971|NCT01607905|451108167|FG005|Overall Study|Disease progression|7|||
125403972|NCT01607905|451108168|FG006|Overall Study|Disease progression|21|||
125403973|NCT01607905|451108162|FG000|Overall Study|Non-compliance with study procedures|0|||
125447946|NCT02303574|451266894|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
125447947|NCT02303574|451266895|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
125447948|NCT02303574|451266896|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
125447949|NCT02303574|451266897|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
125447950|NCT02303574|451266898|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
125447951|NCT02303574|451266899|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
125447952|NCT02303574|451266890|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
125447953|NCT02303574|451266891|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
125447954|NCT02303574|451266892|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
125447955|NCT02303574|451266893|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
125447956|NCT02303574|451266894|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
125447957|NCT02303574|451266895|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
125447958|NCT02303574|451266896|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
125447959|NCT02303574|451266897|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
125447960|NCT02303574|451266898|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
125447961|NCT02303574|451266899|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
125403974|NCT01607905|451108163|FG001|Overall Study|Non-compliance with study procedures|0|||
125403975|NCT01607905|451108164|FG002|Overall Study|Non-compliance with study procedures|0|||
125403976|NCT01607905|451108165|FG003|Overall Study|Non-compliance with study procedures|0|||
125403977|NCT01607905|451108166|FG004|Overall Study|Non-compliance with study procedures|0|||
125403978|NCT01607905|451108167|FG005|Overall Study|Non-compliance with study procedures|0|||
125403979|NCT01607905|451108168|FG006|Overall Study|Non-compliance with study procedures|1|||
125403980|NCT01607905|451108162|FG000|Overall Study|Death|1|||
125403981|NCT01607905|451108163|FG001|Overall Study|Death|1|||
125403982|NCT01607905|451108164|FG002|Overall Study|Death|1|||
125403983|NCT01607905|451108165|FG003|Overall Study|Death|1|||
125403984|NCT01607905|451108166|FG004|Overall Study|Death|0|||
125403985|NCT01607905|451108167|FG005|Overall Study|Death|0|||
125403986|NCT01607905|451108168|FG006|Overall Study|Death|3|||
125403987|NCT01607905|451108162|FG000|Overall Study|Other treatments become available|1|||
125403988|NCT01607905|451108163|FG001|Overall Study|Other treatments become available|0|||
125403989|NCT01607905|451108164|FG002|Overall Study|Other treatments become available|0|||
125403990|NCT01607905|451108165|FG003|Overall Study|Other treatments become available|0|||
125403991|NCT01607905|451108166|FG004|Overall Study|Other treatments become available|0|||
125403992|NCT01607905|451108167|FG005|Overall Study|Other treatments become available|0|||
125403993|NCT01607905|451108168|FG006|Overall Study|Other treatments become available|1|||
125403994|NCT01607905|451108162|FG000|Overall Study|Investigator discretion|0|||
125403995|NCT01607905|451108163|FG001|Overall Study|Investigator discretion|0|||
125403996|NCT01607905|451108164|FG002|Overall Study|Investigator discretion|0|||
125403997|NCT01607905|451108165|FG003|Overall Study|Investigator discretion|0|||
125403998|NCT01607905|451108166|FG004|Overall Study|Investigator discretion|0|||
125403999|NCT01607905|451108167|FG005|Overall Study|Investigator discretion|1|||
125404000|NCT01607905|451108168|FG006|Overall Study|Investigator discretion|0|||
125404001|NCT01607905|451108162|FG000|Overall Study|Other|1|||
125404002|NCT01607905|451108163|FG001|Overall Study|Other|0|||
125404003|NCT01607905|451108164|FG002|Overall Study|Other|0|||
125404004|NCT01607905|451108165|FG003|Overall Study|Other|0|||
125404005|NCT01607905|451108166|FG004|Overall Study|Other|0|||
125404006|NCT01607905|451108167|FG005|Overall Study|Other|0|||
125404007|NCT01607905|451108168|FG006|Overall Study|Other|1|||
125404008|NCT01607905|451108162|FG000|Overall Study|Randomized but not treated|1|||
125404009|NCT01607905|451108163|FG001|Overall Study|Randomized but not treated|0|||
125404010|NCT01607905|451108164|FG002|Overall Study|Randomized but not treated|0|||
125404011|NCT01607905|451108165|FG003|Overall Study|Randomized but not treated|0|||
125404012|NCT01607905|451108166|FG004|Overall Study|Randomized but not treated|1|||
125404013|NCT01607905|451108167|FG005|Overall Study|Randomized but not treated|1|||
125404014|NCT01607905|451108168|FG006|Overall Study|Randomized but not treated|0|||
125447962|NCT00859014|451266900|FG000|Overall Study|Death|4|||
125447963|NCT00859014|451266900|FG000|Overall Study|Lost to Follow-up|1|||
125447964|NCT04796935|451266901|FG000|Overall Study|Withdrawal by Subject|0|||
125447965|NCT04796935|451266902|FG001|Overall Study|Withdrawal by Subject|1|||
125447966|NCT04796935|451266901|FG000|Overall Study|Physician Decision|0|||
125447967|NCT04796935|451266902|FG001|Overall Study|Physician Decision|1|||
125404015|NCT01105533|451108169|FG000|Overall Study|Death|0|||
125404016|NCT01105533|451108170|FG001|Overall Study|Death|0|||
125404017|NCT01105533|451108171|FG002|Overall Study|Death|0|||
125404018|NCT01105533|451108172|FG003|Overall Study|Death|0|||
125404019|NCT01105533|451108173|FG004|Overall Study|Death|1|||
125404020|NCT01105533|451108174|FG005|Overall Study|Death|0|||
125404021|NCT01105533|451108175|FG006|Overall Study|Death|0|||
125447968|NCT04796935|451266901|FG000|Overall Study|Device not available|1|||
125404022|NCT01105533|451108176|FG007|Overall Study|Death|0|||
125404023|NCT01105533|451108177|FG008|Overall Study|Death|0|||
125404024|NCT01105533|451108169|FG000|Overall Study|Lack of Efficacy|1|||
125404025|NCT01105533|451108170|FG001|Overall Study|Lack of Efficacy|1|||
125404026|NCT01105533|451108171|FG002|Overall Study|Lack of Efficacy|3|||
125404027|NCT01105533|451108172|FG003|Overall Study|Lack of Efficacy|3|||
125404028|NCT01105533|451108173|FG004|Overall Study|Lack of Efficacy|4|||
125404029|NCT01105533|451108174|FG005|Overall Study|Lack of Efficacy|5|||
125404030|NCT01105533|451108175|FG006|Overall Study|Lack of Efficacy|3|||
125404031|NCT01105533|451108176|FG007|Overall Study|Lack of Efficacy|2|||
125404032|NCT01105533|451108177|FG008|Overall Study|Lack of Efficacy|9|||
125404033|NCT01105533|451108169|FG000|Overall Study|Adverse Event|0|||
125404034|NCT01105533|451108170|FG001|Overall Study|Adverse Event|0|||
125404035|NCT01105533|451108171|FG002|Overall Study|Adverse Event|0|||
125404036|NCT01105533|451108172|FG003|Overall Study|Adverse Event|0|||
125404037|NCT01105533|451108173|FG004|Overall Study|Adverse Event|1|||
125404038|NCT01105533|451108174|FG005|Overall Study|Adverse Event|2|||
125404039|NCT01105533|451108175|FG006|Overall Study|Adverse Event|2|||
125404040|NCT01105533|451108176|FG007|Overall Study|Adverse Event|0|||
125404041|NCT01105533|451108177|FG008|Overall Study|Adverse Event|1|||
125404042|NCT01105533|451108169|FG000|Overall Study|Other|0|||
125404043|NCT01105533|451108170|FG001|Overall Study|Other|0|||
125404044|NCT01105533|451108171|FG002|Overall Study|Other|0|||
125404045|NCT01105533|451108172|FG003|Overall Study|Other|0|||
125404046|NCT01105533|451108173|FG004|Overall Study|Other|1|||
125404047|NCT01105533|451108174|FG005|Overall Study|Other|0|||
125404048|NCT01105533|451108175|FG006|Overall Study|Other|3|||
125404049|NCT01105533|451108176|FG007|Overall Study|Other|1|||
125404050|NCT01105533|451108177|FG008|Overall Study|Other|2|||
125404051|NCT01105533|451108169|FG000|Overall Study|Physician Decision|0|||
125404052|NCT01105533|451108170|FG001|Overall Study|Physician Decision|0|||
125404053|NCT01105533|451108171|FG002|Overall Study|Physician Decision|0|||
125404054|NCT01105533|451108172|FG003|Overall Study|Physician Decision|0|||
125404055|NCT01105533|451108173|FG004|Overall Study|Physician Decision|0|||
125404056|NCT01105533|451108174|FG005|Overall Study|Physician Decision|0|||
125404057|NCT01105533|451108175|FG006|Overall Study|Physician Decision|0|||
125404058|NCT01105533|451108176|FG007|Overall Study|Physician Decision|1|||
125404059|NCT01105533|451108177|FG008|Overall Study|Physician Decision|0|||
125404060|NCT02096835|451108178|FG000|Overall Study|Withdrawal by Subject|1|||
125404061|NCT02096835|451108179|FG001|Overall Study|Withdrawal by Subject|0|||
125404062|NCT02096835|451108180|FG002|Overall Study|Withdrawal by Subject|0|||
125404063|NCT02096835|451108178|FG000|Overall Study|converted to open procedures|1|||
125404064|NCT02096835|451108179|FG001|Overall Study|converted to open procedures|0|||
125404065|NCT02096835|451108180|FG002|Overall Study|converted to open procedures|0|||
125404066|NCT02096835|451108178|FG000|Overall Study|Lost to Follow-up|1|||
125404067|NCT02096835|451108179|FG001|Overall Study|Lost to Follow-up|0|||
125404068|NCT02096835|451108180|FG002|Overall Study|Lost to Follow-up|1|||
125404069|NCT03892889|451108181|FG000|Overall Study|Adverse Event|17|||
125404070|NCT03892889|451108181|FG000|Overall Study|Lack of Efficacy|1|||
125404071|NCT03892889|451108181|FG000|Overall Study|Lost to Follow-up|46|||
125404072|NCT03892889|451108181|FG000|Overall Study|Non-compliance with study drug|22|||
125404073|NCT03892889|451108181|FG000|Overall Study|Pregnancy|1|||
125404074|NCT03892889|451108181|FG000|Overall Study|Protocol Deviation|3|||
125404075|NCT03892889|451108181|FG000|Overall Study|Withdrawal by Subject|50|||
125404076|NCT03892889|451108181|FG000|Overall Study|Withdrawal by Caregiver|1|||
125404077|NCT03892889|451108181|FG000|Overall Study|Study Terminated by Sponsor|50|||
125404078|NCT03892889|451108181|FG000|Overall Study|Physician Decision|8|||
125404079|NCT03892889|451108181|FG000|Overall Study|Reason not Specified|5|||
125404080|NCT04260191|451108182|FG000|Overall Study|Decision by Sponsor|0|||
125404081|NCT04260191|451108183|FG001|Overall Study|Decision by Sponsor|1|||
125404082|NCT04260191|451108184|FG002|Overall Study|Decision by Sponsor|0|||
125404083|NCT04260191|451108182|FG000|Overall Study|Withdrawal by Subject|1|||
125404084|NCT04260191|451108183|FG001|Overall Study|Withdrawal by Subject|0|||
125404085|NCT04260191|451108184|FG002|Overall Study|Withdrawal by Subject|3|||
125404086|NCT04260191|451108182|FG000|Overall Study|Death|4|||
125404087|NCT04260191|451108183|FG001|Overall Study|Death|3|||
125404088|NCT04260191|451108184|FG002|Overall Study|Death|2|||
125404089|NCT01643473|451108185|FG000|Overall Study|Lost to Follow-up|1|||
125404090|NCT01643473|451108186|FG001|Overall Study|Lost to Follow-up|0|||
125404091|NCT01519518|451108187|FG000|Overall Study|Consent not available|7|||
125404092|NCT01519518|451108188|FG001|Overall Study|Consent not available|10|||
125404093|NCT01312909|451108190|FG000|Overall Study|Randomized but not treated|1|||
125404094|NCT01312909|451108191|FG001|Overall Study|Randomized but not treated|3|||
125404095|NCT01312909|451108192|FG002|Overall Study|Randomized but not treated|1|||
125404096|NCT01312909|451108190|FG000|Overall Study|Adverse Event|1|||
125404097|NCT01312909|451108191|FG001|Overall Study|Adverse Event|0|||
125404098|NCT01312909|451108192|FG002|Overall Study|Adverse Event|3|||
125404099|NCT01312909|451108190|FG000|Overall Study|Protocol Violation|2|||
125404100|NCT01312909|451108191|FG001|Overall Study|Protocol Violation|0|||
125404101|NCT01312909|451108192|FG002|Overall Study|Protocol Violation|2|||
125404102|NCT01312909|451108190|FG000|Overall Study|Other|9|||
125404103|NCT01312909|451108191|FG001|Overall Study|Other|6|||
125404104|NCT01312909|451108192|FG002|Overall Study|Other|11|||
125404105|NCT01312909|451108190|FG000|Overall Study|Withdrawal by Subject|8|||
125404106|NCT01312909|451108191|FG001|Overall Study|Withdrawal by Subject|10|||
125447969|NCT04796935|451266902|FG001|Overall Study|Device not available|0|||
125447970|NCT04796935|451266901|FG000|Overall Study|Trained provider not available|1|||
125447971|NCT04796935|451266902|FG001|Overall Study|Trained provider not available|0|||
125447972|NCT00235495|451266917|FG000|Overall Study|Death|52|||
125447973|NCT00235495|451266918|FG001|Overall Study|Death|42|||
125447974|NCT00235495|451266917|FG000|Overall Study|Withdrawal by Subject|5|||
125447975|NCT00235495|451266918|FG001|Overall Study|Withdrawal by Subject|3|||
125447976|NCT00235495|451266917|FG000|Overall Study|Lost to Follow-up|11|||
125447977|NCT00235495|451266918|FG001|Overall Study|Lost to Follow-up|13|||
125447978|NCT00235495|451266917|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
125447979|NCT00235495|451266918|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
125447980|NCT02234310|451266919|FG000|Overall Study|Physician Decision|1|||
125447981|NCT02234310|451266919|FG000|Overall Study|Adverse Event|1|||
125447982|NCT02234310|451266919|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
125447983|NCT02234310|451266919|FG000|Overall Study|Withdrawal by Subject|2|||
125447984|NCT02192359|451266920|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
125447985|NCT02192359|451266921|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
125447986|NCT02192359|451266922|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
125447987|NCT02192359|451266923|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
125447988|NCT02192359|451266920|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
125447989|NCT02192359|451266921|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
125447990|NCT02192359|451266922|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
125447991|NCT02192359|451266923|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
125447992|NCT02192359|451266920|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
125447993|NCT02192359|451266921|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
125447994|NCT02192359|451266922|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
125447995|NCT02192359|451266923|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
125447996|NCT00114959|451266924|FG000|Overall Study|Lack of Efficacy|6|||
125447997|NCT00114959|451266924|FG000|Overall Study|Physician Decision|1|||
125447998|NCT00114959|451266924|FG000|Overall Study|Death|1|||
125447999|NCT03251378|451266925|FG000|Overall Study|Death|3|||
125448000|NCT03251378|451266926|FG001|Overall Study|Death|2|||
125448001|NCT03251378|451266927|FG002|Overall Study|Death|3|||
125448002|NCT03251378|451266928|FG003|Overall Study|Death|30|||
125448003|NCT03251378|451266929|FG004|Overall Study|Death|24|||
125448004|NCT03251378|451266930|FG005|Overall Study|Death|12|||
125448005|NCT03251378|451266931|FG006|Overall Study|Death|12|||
125448006|NCT03251378|451266925|FG000|Overall Study|Lost to Follow-up|0|||
125448007|NCT03251378|451266926|FG001|Overall Study|Lost to Follow-up|0|||
125448008|NCT03251378|451266927|FG002|Overall Study|Lost to Follow-up|1|||
125448009|NCT03251378|451266928|FG003|Overall Study|Lost to Follow-up|3|||
125448010|NCT03251378|451266929|FG004|Overall Study|Lost to Follow-up|0|||
125448011|NCT03251378|451266930|FG005|Overall Study|Lost to Follow-up|0|||
125448012|NCT03251378|451266931|FG006|Overall Study|Lost to Follow-up|0|||
125277660|NCT05396014|450643918|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
125277661|NCT05396014|450643919|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277662|NCT05396014|450643920|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277663|NCT05396014|450643921|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277664|NCT05396014|450643922|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277665|NCT05396014|450643923|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277666|NCT05396014|450643924|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277667|NCT05396014|450643925|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277668|NCT05396014|450643926|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277669|NCT05396014|450643927|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277670|NCT05396014|450643928|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277671|NCT05396014|450643929|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277672|NCT05396014|450643930|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277673|NCT05396014|450643931|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
125277674|NCT05396014|450643932|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277675|NCT05396014|450643933|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277676|NCT05396014|450643934|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277677|NCT05396014|450643935|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125448013|NCT03251378|451266925|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
125448014|NCT03251378|451266926|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
125448015|NCT03251378|451266927|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
125277678|NCT05396014|450643936|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277679|NCT05396014|450643937|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277680|NCT05396014|450643938|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277681|NCT05396014|450643939|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277682|NCT05396014|450643940|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277683|NCT05396014|450643941|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277684|NCT05396014|450643942|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277685|NCT05396014|450643943|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277686|NCT05396014|450643944|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
125277687|NCT05396014|450643945|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277688|NCT05396014|450643946|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277689|NCT05396014|450643947|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277690|NCT05396014|450643948|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277691|NCT05396014|450643949|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277692|NCT05396014|450643950|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277693|NCT05396014|450643951|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277694|NCT05396014|450643952|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125404107|NCT01312909|451108192|FG002|Overall Study|Withdrawal by Subject|7|||
125404108|NCT01312909|451108190|FG000|Overall Study|Lost to Follow-up|21|||
125404109|NCT01312909|451108191|FG001|Overall Study|Lost to Follow-up|17|||
125404110|NCT01312909|451108192|FG002|Overall Study|Lost to Follow-up|20|||
125404111|NCT01312909|451108190|FG000|Overall Study|Insufficient clinical response|0|||
125404112|NCT01312909|451108191|FG001|Overall Study|Insufficient clinical response|0|||
125404113|NCT01312909|451108192|FG002|Overall Study|Insufficient clinical response|1|||
125404114|NCT01312909|451108190|FG000|Overall Study|Entrance criteria not met|0|||
125404115|NCT01312909|451108191|FG001|Overall Study|Entrance criteria not met|0|||
125404116|NCT01312909|451108192|FG002|Overall Study|Entrance criteria not met|2|||
125404117|NCT00938431|451108194|FG000|Overall Study|Adverse Event|5|||
125404118|NCT00938431|451108195|FG001|Overall Study|Adverse Event|8|||
125404119|NCT00938431|451108196|FG002|Overall Study|Adverse Event|6|||
125404120|NCT00938431|451108194|FG000|Overall Study|Lack of Efficacy|0|||
125404121|NCT00938431|451108195|FG001|Overall Study|Lack of Efficacy|1|||
125404122|NCT00938431|451108196|FG002|Overall Study|Lack of Efficacy|0|||
125404123|NCT00938431|451108194|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
125404124|NCT00938431|451108195|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
125404125|NCT00938431|451108196|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
125404126|NCT00938431|451108194|FG000|Overall Study|Dosing compliance issue|0|||
125404127|NCT00938431|451108195|FG001|Overall Study|Dosing compliance issue|0|||
125404128|NCT00938431|451108196|FG002|Overall Study|Dosing compliance issue|1|||
125404129|NCT00938431|451108194|FG000|Overall Study|Reached maximum dose early|0|||
125404130|NCT00938431|451108195|FG001|Overall Study|Reached maximum dose early|0|||
125404131|NCT00938431|451108196|FG002|Overall Study|Reached maximum dose early|1|||
125404132|NCT02944578|451108202|FG000|Overall Study|Physician Decision|1|||
125404133|NCT02944578|451108203|FG001|Overall Study|Physician Decision|0|||
125404134|NCT02691455|451108204|FG000|Overall Study|Withdrawal by Subject|1|||
125404135|NCT02691455|451108205|FG001|Overall Study|Withdrawal by Subject|2|||
125404136|NCT02691455|451108204|FG000|Overall Study|Lost to Follow-up|15|||
125404137|NCT02691455|451108205|FG001|Overall Study|Lost to Follow-up|15|||
125404138|NCT01257204|451108206|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
125404139|NCT01257204|451108207|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
125404140|NCT01257204|451108208|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
125404141|NCT01257204|451108206|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
125404142|NCT01257204|451108207|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
125404143|NCT01257204|451108208|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
125404144|NCT01257204|451108206|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
125404145|NCT01257204|451108207|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
125404146|NCT01257204|451108208|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
125404147|NCT01257204|451108206|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
125404148|NCT01257204|451108207|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
125404149|NCT01257204|451108208|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
125404150|NCT01257204|451108206|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
125404151|NCT01257204|451108207|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
125404152|NCT01257204|451108208|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
125404153|NCT01257204|451108206|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
125404154|NCT01257204|451108207|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
125404155|NCT01257204|451108208|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
125404156|NCT01257204|451108206|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
125404157|NCT01257204|451108207|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
125404158|NCT01257204|451108208|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
125404159|NCT01257204|451108206|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
125404160|NCT01257204|451108207|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
125277695|NCT05396014|450643953|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125448016|NCT03251378|451266928|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
125277696|NCT05396014|450643954|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277697|NCT05396014|450643955|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277698|NCT05396014|450643956|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277699|NCT05396014|450643957|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
125277700|NCT05396014|450643958|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277701|NCT05396014|450643959|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277702|NCT05396014|450643960|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
125277703|NCT05396014|450643918|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
125277704|NCT05396014|450643919|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277705|NCT05396014|450643920|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277706|NCT05396014|450643921|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277707|NCT05396014|450643922|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277708|NCT05396014|450643923|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277709|NCT05396014|450643924|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277710|NCT05396014|450643925|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277711|NCT05396014|450643926|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277712|NCT05396014|450643927|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277713|NCT05396014|450643928|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277714|NCT05396014|450643929|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277715|NCT05396014|450643930|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277716|NCT05396014|450643931|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
125277717|NCT05396014|450643932|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277718|NCT05396014|450643933|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277719|NCT05396014|450643934|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277720|NCT05396014|450643935|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277721|NCT05396014|450643936|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277722|NCT05396014|450643937|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277723|NCT05396014|450643938|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277724|NCT05396014|450643939|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277725|NCT05396014|450643940|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277726|NCT05396014|450643941|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277727|NCT05396014|450643942|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277728|NCT05396014|450643943|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277729|NCT05396014|450643944|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
125277730|NCT05396014|450643945|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277731|NCT05396014|450643946|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277732|NCT05396014|450643947|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277733|NCT05396014|450643948|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277734|NCT05396014|450643949|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277735|NCT05396014|450643950|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277736|NCT05396014|450643951|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277737|NCT05396014|450643952|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277738|NCT05396014|450643953|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277739|NCT05396014|450643954|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277740|NCT05396014|450643955|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277741|NCT05396014|450643956|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277742|NCT05396014|450643957|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
125277743|NCT05396014|450643958|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277744|NCT05396014|450643959|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277745|NCT05396014|450643960|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
125277746|NCT05396014|450643918|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
125277747|NCT05396014|450643919|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277748|NCT05396014|450643920|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277749|NCT05396014|450643921|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277750|NCT05396014|450643922|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277751|NCT05396014|450643923|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277752|NCT05396014|450643924|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277753|NCT05396014|450643925|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277754|NCT05396014|450643926|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277755|NCT05396014|450643927|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277756|NCT05396014|450643928|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277757|NCT05396014|450643929|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277758|NCT05396014|450643930|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277759|NCT05396014|450643931|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
125277760|NCT05396014|450643932|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277761|NCT05396014|450643933|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277762|NCT05396014|450643934|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277763|NCT05396014|450643935|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277764|NCT05396014|450643936|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277765|NCT05396014|450643937|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277766|NCT05396014|450643938|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277767|NCT05396014|450643939|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277768|NCT05396014|450643940|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277769|NCT05396014|450643941|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277770|NCT05396014|450643942|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277771|NCT05396014|450643943|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277772|NCT05396014|450643944|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
125277773|NCT05396014|450643945|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277774|NCT05396014|450643946|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277775|NCT05396014|450643947|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277776|NCT05396014|450643948|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277777|NCT05396014|450643949|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277778|NCT05396014|450643950|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277779|NCT05396014|450643951|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277780|NCT05396014|450643952|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277781|NCT05396014|450643953|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277782|NCT05396014|450643954|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277783|NCT05396014|450643955|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277784|NCT05396014|450643956|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277785|NCT05396014|450643957|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
125277786|NCT05396014|450643958|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277787|NCT05396014|450643959|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277788|NCT05396014|450643960|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
125277789|NCT05396014|450643918|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277790|NCT05396014|450643919|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277791|NCT05396014|450643920|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277792|NCT05396014|450643921|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277793|NCT05396014|450643922|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277794|NCT05396014|450643923|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277795|NCT05396014|450643924|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277796|NCT05396014|450643925|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277797|NCT05396014|450643926|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277798|NCT05396014|450643927|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277799|NCT05396014|450643928|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277800|NCT05396014|450643929|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277801|NCT05396014|450643930|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277802|NCT05396014|450643931|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277803|NCT05396014|450643932|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277804|NCT05396014|450643933|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277805|NCT05396014|450643934|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277806|NCT05396014|450643935|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277807|NCT05396014|450643936|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277808|NCT05396014|450643937|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277809|NCT05396014|450643938|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277810|NCT05396014|450643939|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277811|NCT05396014|450643940|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277812|NCT05396014|450643941|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277813|NCT05396014|450643942|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277814|NCT05396014|450643943|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277815|NCT05396014|450643944|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
125277816|NCT05396014|450643945|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277817|NCT05396014|450643946|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277818|NCT05396014|450643947|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277819|NCT05396014|450643948|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277820|NCT05396014|450643949|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277821|NCT05396014|450643950|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277822|NCT05396014|450643951|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277823|NCT05396014|450643952|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277824|NCT05396014|450643953|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277825|NCT05396014|450643954|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277826|NCT05396014|450643955|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277827|NCT05396014|450643956|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277828|NCT05396014|450643957|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
125277829|NCT05396014|450643958|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277830|NCT05396014|450643959|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277831|NCT05396014|450643960|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
125277832|NCT05396014|450643918|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277833|NCT05396014|450643919|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277834|NCT05396014|450643920|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277835|NCT05396014|450643921|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277836|NCT05396014|450643922|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277837|NCT05396014|450643923|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277838|NCT05396014|450643924|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277839|NCT05396014|450643925|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277840|NCT05396014|450643926|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277841|NCT05396014|450643927|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277842|NCT05396014|450643928|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277843|NCT05396014|450643929|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277844|NCT05396014|450643930|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277845|NCT05396014|450643931|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277846|NCT05396014|450643932|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277847|NCT05396014|450643933|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277848|NCT05396014|450643934|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277849|NCT05396014|450643935|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277850|NCT05396014|450643936|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277851|NCT05396014|450643937|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277852|NCT05396014|450643938|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277853|NCT05396014|450643939|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277854|NCT05396014|450643940|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277855|NCT05396014|450643941|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277856|NCT05396014|450643942|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277857|NCT05396014|450643943|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277858|NCT05396014|450643944|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
125277859|NCT05396014|450643945|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277860|NCT05396014|450643946|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277861|NCT05396014|450643947|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277862|NCT05396014|450643948|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277863|NCT05396014|450643949|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277864|NCT05396014|450643950|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277865|NCT05396014|450643951|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277866|NCT05396014|450643952|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277867|NCT05396014|450643953|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277868|NCT05396014|450643954|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277869|NCT05396014|450643955|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277870|NCT05396014|450643956|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277871|NCT05396014|450643957|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277872|NCT05396014|450643958|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277873|NCT05396014|450643959|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277874|NCT05396014|450643960|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
125277875|NCT05396014|450643918|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277876|NCT05396014|450643919|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277877|NCT05396014|450643920|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277878|NCT05396014|450643921|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277879|NCT05396014|450643922|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277880|NCT05396014|450643923|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277881|NCT05396014|450643924|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277882|NCT05396014|450643925|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277883|NCT05396014|450643926|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277884|NCT05396014|450643927|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277885|NCT05396014|450643928|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277886|NCT05396014|450643929|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277887|NCT05396014|450643930|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277888|NCT05396014|450643931|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
125277889|NCT05396014|450643932|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277890|NCT05396014|450643933|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125448017|NCT03251378|451266929|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
125277891|NCT05396014|450643934|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277892|NCT05396014|450643935|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277893|NCT05396014|450643936|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277894|NCT05396014|450643937|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277895|NCT05396014|450643938|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277896|NCT05396014|450643939|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277897|NCT05396014|450643940|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277898|NCT05396014|450643941|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277899|NCT05396014|450643942|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277900|NCT05396014|450643943|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277901|NCT05396014|450643944|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277902|NCT05396014|450643945|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277903|NCT05396014|450643946|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277904|NCT05396014|450643947|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277905|NCT05396014|450643948|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277906|NCT05396014|450643949|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277907|NCT05396014|450643950|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277908|NCT05396014|450643951|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277909|NCT05396014|450643952|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277910|NCT05396014|450643953|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277911|NCT05396014|450643954|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277912|NCT05396014|450643955|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125448018|NCT03251378|451266930|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
125448019|NCT03251378|451266931|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
125448020|NCT03251378|451266925|FG000|Overall Study|Progressive disease|2|||
125448021|NCT03251378|451266926|FG001|Overall Study|Progressive disease|0|||
125448022|NCT03251378|451266927|FG002|Overall Study|Progressive disease|0|||
125448023|NCT03251378|451266928|FG003|Overall Study|Progressive disease|1|||
125448024|NCT03251378|451266929|FG004|Overall Study|Progressive disease|0|||
125448025|NCT03251378|451266930|FG005|Overall Study|Progressive disease|0|||
125448026|NCT03251378|451266931|FG006|Overall Study|Progressive disease|0|||
125448027|NCT03251378|451266925|FG000|Overall Study|Physician Decision|0|||
125448028|NCT03251378|451266926|FG001|Overall Study|Physician Decision|2|||
125448029|NCT03251378|451266927|FG002|Overall Study|Physician Decision|0|||
125448030|NCT03251378|451266928|FG003|Overall Study|Physician Decision|0|||
125448031|NCT03251378|451266929|FG004|Overall Study|Physician Decision|0|||
125448032|NCT03251378|451266930|FG005|Overall Study|Physician Decision|0|||
125448033|NCT03251378|451266931|FG006|Overall Study|Physician Decision|0|||
125277913|NCT05396014|450643956|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277914|NCT05396014|450643957|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277915|NCT05396014|450643958|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277916|NCT05396014|450643959|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277917|NCT05396014|450643960|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
125277918|NCT05396014|450643918|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
125404161|NCT01257204|451108208|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
125404162|NCT01257204|451108206|FG000|Follow-up Period (up to Week 48)|Other|0|||
125404163|NCT01257204|451108207|FG001|Follow-up Period (up to Week 48)|Other|0|||
125404164|NCT01257204|451108208|FG002|Follow-up Period (up to Week 48)|Other|5|||
125404165|NCT00451282|451108212|FG000|Overall Study|Lost to Follow-up|6|||
125404166|NCT00451282|451108213|FG001|Overall Study|Lost to Follow-up|5|||
125404167|NCT00577122|451108214|FG000|Overall Study|Adverse Event|0|||
125404168|NCT00577122|451108215|FG001|Overall Study|Adverse Event|2|||
125404169|NCT00577122|451108214|FG000|Overall Study|Progression, relapse during active trt|6|||
125404170|NCT00577122|451108215|FG001|Overall Study|Progression, relapse during active trt|8|||
125404171|NCT00577122|451108214|FG000|Overall Study|Prog, refract disease during active trt|8|||
125404172|NCT00577122|451108215|FG001|Overall Study|Prog, refract disease during active trt|5|||
125404173|NCT00577122|451108214|FG000|Overall Study|Alternative Therapy|0|||
125404174|NCT00577122|451108215|FG001|Overall Study|Alternative Therapy|1|||
125404175|NCT01824303|451108222|FG000|Randomized Study|Withdrawal by Subject|1|||
125404176|NCT01824303|451108223|FG001|Randomized Study|Withdrawal by Subject|1|||
125404177|NCT01824303|451108222|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
125404178|NCT01824303|451108223|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
125448034|NCT03251378|451266925|FG000|Overall Study|Other|2|||
125448035|NCT03251378|451266926|FG001|Overall Study|Other|3|||
125448036|NCT03251378|451266927|FG002|Overall Study|Other|2|||
125448037|NCT03251378|451266928|FG003|Overall Study|Other|0|||
125448038|NCT03251378|451266929|FG004|Overall Study|Other|1|||
125448039|NCT03251378|451266930|FG005|Overall Study|Other|1|||
125448040|NCT03251378|451266931|FG006|Overall Study|Other|1|||
125448041|NCT03251378|451266925|FG000|Overall Study|Other|0|||
125404179|NCT01743092|451108224|FG000|Overall Study|Lost to Follow-up|14|||
125404180|NCT01743092|451108225|FG001|Overall Study|Lost to Follow-up|15|||
125404181|NCT03586869|451108226|FG000|Overall Study|Progressive Disease|3|||
125404182|NCT00403455|451108227|FG000|Overall Study|Withdrawal by Subject|1|||
125404183|NCT02809976|451108234|FG000|Overall Study|Lost to Follow-up|1|||
125404184|NCT02809976|451108234|FG000|Overall Study|Withdrawal by Subject|1|||
125404185|NCT00087568|451108235|FG000|Overall Study|Adverse Event|4|||
125404186|NCT00087568|451108236|FG001|Overall Study|Adverse Event|0|||
125404187|NCT00087568|451108235|FG000|Overall Study|Withdrawal by Subject|1|||
125404188|NCT00087568|451108236|FG001|Overall Study|Withdrawal by Subject|1|||
125404189|NCT00087568|451108235|FG000|Overall Study|Lost to Follow-up|1|||
125404190|NCT00087568|451108236|FG001|Overall Study|Lost to Follow-up|0|||
125404191|NCT00087568|451108235|FG000|Overall Study|Lack of Efficacy|24|||
125404192|NCT00087568|451108236|FG001|Overall Study|Lack of Efficacy|1|||
125404193|NCT04394351|451108237|FG000|Part A (16 Weeks)|Adverse Event|1|||
125404194|NCT04394351|451108238|FG001|Part A (16 Weeks)|Adverse Event|0|||
125404195|NCT04394351|451108239|FG002|Part A (16 Weeks)|Adverse Event|0|||
125404196|NCT04394351|451108240|FG003|Part A (16 Weeks)|Adverse Event|0|||
125404197|NCT04394351|451108241|FG004|Part A (16 Weeks)|Adverse Event|0|||
125404198|NCT04394351|451108242|FG005|Part A (16 Weeks)|Adverse Event|0|||
125404199|NCT04394351|451108243|FG006|Part A (16 Weeks)|Adverse Event|0|||
125404200|NCT04394351|451108244|FG007|Part A (16 Weeks)|Adverse Event|0|||
125404201|NCT04394351|451108237|FG000|Part A (16 Weeks)|Physician Decision|0|||
125404202|NCT04394351|451108238|FG001|Part A (16 Weeks)|Physician Decision|1|||
125404203|NCT04394351|451108239|FG002|Part A (16 Weeks)|Physician Decision|0|||
125404204|NCT04394351|451108240|FG003|Part A (16 Weeks)|Physician Decision|0|||
125404205|NCT04394351|451108241|FG004|Part A (16 Weeks)|Physician Decision|0|||
125448042|NCT03251378|451266926|FG001|Overall Study|Other|0|||
125448043|NCT03251378|451266927|FG002|Overall Study|Other|0|||
125448044|NCT03251378|451266928|FG003|Overall Study|Other|4|||
125448045|NCT03251378|451266929|FG004|Overall Study|Other|13|||
125448046|NCT03251378|451266930|FG005|Overall Study|Other|0|||
125448047|NCT03251378|451266931|FG006|Overall Study|Other|0|||
125448048|NCT04060680|451266934|FG000|Overall Study|Unsuccessful implant|17|||
125448049|NCT04060680|451266935|FG001|Overall Study|Unsuccessful implant|2|||
125448050|NCT04060680|451266934|FG000|Overall Study|Adverse Event|3|||
125448051|NCT04060680|451266935|FG001|Overall Study|Adverse Event|0|||
125448052|NCT04060680|451266934|FG000|Overall Study|Death|2|||
125448053|NCT04060680|451266935|FG001|Overall Study|Death|0|||
125448054|NCT04060680|451266934|FG000|Overall Study|Study product no longer in use|1|||
125448055|NCT04060680|451266935|FG001|Overall Study|Study product no longer in use|0|||
125448056|NCT04060680|451266934|FG000|Overall Study|Withdrawal by Subject|1|||
125448057|NCT04060680|451266935|FG001|Overall Study|Withdrawal by Subject|0|||
125448058|NCT01929993|451268827|FG000|Overall Study|Protocol Violation|4|||
125448059|NCT01929993|451268828|FG001|Overall Study|Protocol Violation|6|||
125448060|NCT01929993|451268827|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
125448061|NCT01929993|451268828|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
125448062|NCT01852162|451268829|FG000|Overall Study|Adverse Event|1|||
125448063|NCT01852162|451268830|FG001|Overall Study|Adverse Event|0|||
125448064|NCT01852162|451268829|FG000|Overall Study|Withdrawal by Subject|3|||
125448065|NCT01852162|451268830|FG001|Overall Study|Withdrawal by Subject|1|||
125448066|NCT01256476|451268831|FG000|Overall Study|Adverse Event|2|||
125448067|NCT01256476|451268832|FG001|Overall Study|Adverse Event|1|||
125448068|NCT01256476|451268831|FG000|Overall Study|Withdrawal by Subject|2|||
125448069|NCT01256476|451268832|FG001|Overall Study|Withdrawal by Subject|1|||
125448070|NCT01256476|451268831|FG000|Overall Study|Lost to Follow-up|1|||
125448071|NCT01256476|451268832|FG001|Overall Study|Lost to Follow-up|2|||
125448072|NCT01256476|451268831|FG000|Overall Study|Persistent ALT or AST elevation|1|||
125448073|NCT01256476|451268832|FG001|Overall Study|Persistent ALT or AST elevation|0|||
125448074|NCT01256476|451268831|FG000|Overall Study|Physician Decision|0|||
125448075|NCT01256476|451268832|FG001|Overall Study|Physician Decision|1|||
125448076|NCT01256476|451268831|FG000|Overall Study|Subject non-compliance|0|||
125448077|NCT01256476|451268832|FG001|Overall Study|Subject non-compliance|1|||
125404206|NCT04394351|451108242|FG005|Part A (16 Weeks)|Physician Decision|0|||
125448078|NCT01256476|451268831|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
125448079|NCT01256476|451268832|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
125404207|NCT04394351|451108243|FG006|Part A (16 Weeks)|Physician Decision|0|||
125404208|NCT04394351|451108244|FG007|Part A (16 Weeks)|Physician Decision|0|||
125404209|NCT04394351|451108237|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
125448080|NCT00163215|451268837|FG000|Overall Study|Lack of Efficacy|3|||
125448081|NCT00163215|451268837|FG000|Overall Study|Withdrawal by Subject|5|||
125448082|NCT00163215|451268837|FG000|Overall Study|Other|7|||
125448083|NCT00231179|451268838|FG000|Overall Study|Lost to Follow-up|21|||
125448084|NCT00231179|451268839|FG001|Overall Study|Lost to Follow-up|21|||
125404210|NCT04394351|451108238|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
125404211|NCT04394351|451108239|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
125404212|NCT04394351|451108240|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
125404213|NCT04394351|451108241|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
125404214|NCT04394351|451108242|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
125404215|NCT04394351|451108243|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
125404216|NCT04394351|451108244|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
125404217|NCT04394351|451108237|FG000|Part B (36 Weeks)|Adverse Event|0|||
125404218|NCT04394351|451108238|FG001|Part B (36 Weeks)|Adverse Event|0|||
125404219|NCT04394351|451108239|FG002|Part B (36 Weeks)|Adverse Event|0|||
125404220|NCT04394351|451108240|FG003|Part B (36 Weeks)|Adverse Event|0|||
125404221|NCT04394351|451108241|FG004|Part B (36 Weeks)|Adverse Event|0|||
125404222|NCT04394351|451108242|FG005|Part B (36 Weeks)|Adverse Event|0|||
125404223|NCT04394351|451108243|FG006|Part B (36 Weeks)|Adverse Event|1|||
125404224|NCT04394351|451108244|FG007|Part B (36 Weeks)|Adverse Event|0|||
125404225|NCT02992899|451108249|FG000|Overall Study|Withdrawal by Subject|1|||
125404226|NCT02992899|451108250|FG001|Overall Study|Withdrawal by Subject|0|||
125404227|NCT02992899|451108249|FG000|Overall Study|Lost to Follow-up|1|||
125404228|NCT02992899|451108250|FG001|Overall Study|Lost to Follow-up|3|||
125404229|NCT02738775|451108251|FG000|Overall Study|Withdrawal by Subject|0|||
125404230|NCT02738775|451108252|FG001|Overall Study|Withdrawal by Subject|1|||
125404231|NCT02738775|451108253|FG002|Overall Study|Withdrawal by Subject|0|||
125404232|NCT02738775|451108254|FG003|Overall Study|Withdrawal by Subject|0|||
125404233|NCT02738775|451108255|FG004|Overall Study|Withdrawal by Subject|0|||
125404234|NCT02738775|451108256|FG005|Overall Study|Withdrawal by Subject|0|||
125404235|NCT02738775|451108251|FG000|Overall Study|Adverse Event|0|||
125404236|NCT02738775|451108252|FG001|Overall Study|Adverse Event|0|||
125404237|NCT02738775|451108253|FG002|Overall Study|Adverse Event|0|||
125404238|NCT02738775|451108254|FG003|Overall Study|Adverse Event|1|||
125404239|NCT02738775|451108255|FG004|Overall Study|Adverse Event|0|||
125404240|NCT02738775|451108256|FG005|Overall Study|Adverse Event|0|||
125404241|NCT02738775|451108251|FG000|Overall Study|Pregnancy|0|||
125404242|NCT02738775|451108252|FG001|Overall Study|Pregnancy|1|||
125404243|NCT02738775|451108253|FG002|Overall Study|Pregnancy|0|||
125404244|NCT02738775|451108254|FG003|Overall Study|Pregnancy|0|||
125404245|NCT02738775|451108255|FG004|Overall Study|Pregnancy|0|||
125404246|NCT02738775|451108256|FG005|Overall Study|Pregnancy|0|||
125404247|NCT02738775|451108251|FG000|Overall Study|Missing|0|||
125404248|NCT02738775|451108252|FG001|Overall Study|Missing|0|||
125404249|NCT02738775|451108253|FG002|Overall Study|Missing|0|||
125404250|NCT02738775|451108254|FG003|Overall Study|Missing|0|||
125404251|NCT02738775|451108255|FG004|Overall Study|Missing|0|||
125404252|NCT02738775|451108256|FG005|Overall Study|Missing|1|||
125404253|NCT04574362|451108257|FG000|Overall Study|Other|0|||
125404254|NCT04574362|451108258|FG001|Overall Study|Other|5|||
125404255|NCT04574362|451108257|FG000|Overall Study|COVID-19|0|||
125404256|NCT04574362|451108258|FG001|Overall Study|COVID-19|1|||
125404257|NCT04574362|451108257|FG000|Overall Study|Adverse Event|1|||
125404258|NCT04574362|451108258|FG001|Overall Study|Adverse Event|1|||
125404259|NCT04574362|451108257|FG000|Overall Study|Withdrawal by Subject|2|||
125404260|NCT04574362|451108258|FG001|Overall Study|Withdrawal by Subject|4|||
125404261|NCT04574362|451108257|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
125404262|NCT04574362|451108258|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
125404263|NCT04574362|451108257|FG000|Overall Study|Participant refused to come to the hospital|1|||
125404264|NCT04574362|451108258|FG001|Overall Study|Participant refused to come to the hospital|0|||
125404265|NCT04574362|451108257|FG000|Overall Study|Participant refused the visit|1|||
125404266|NCT04574362|451108258|FG001|Overall Study|Participant refused the visit|0|||
125404267|NCT04574362|451108257|FG000|Overall Study|Participant quit early because of business trip|1|||
125404268|NCT04574362|451108258|FG001|Overall Study|Participant quit early because of business trip|0|||
125404269|NCT01060384|451108259|FG000|Overall Study|Withdrawal by Subject|0|||
125404270|NCT01060384|451108260|FG001|Overall Study|Withdrawal by Subject|1|||
125404271|NCT01060384|451108261|FG002|Overall Study|Withdrawal by Subject|0|||
125404272|NCT01060384|451108262|FG003|Overall Study|Withdrawal by Subject|0|||
125404273|NCT01060384|451108263|FG004|Overall Study|Withdrawal by Subject|0|||
125404274|NCT01060384|451108259|FG000|Overall Study|Death|0|||
125404275|NCT01060384|451108260|FG001|Overall Study|Death|0|||
125404276|NCT01060384|451108261|FG002|Overall Study|Death|0|||
125404277|NCT01060384|451108262|FG003|Overall Study|Death|0|||
125404278|NCT01060384|451108263|FG004|Overall Study|Death|1|||
125404279|NCT01060384|451108259|FG000|Overall Study|Intercurrent illness|0|||
125404280|NCT01060384|451108260|FG001|Overall Study|Intercurrent illness|0|||
125404281|NCT01060384|451108261|FG002|Overall Study|Intercurrent illness|0|||
125404282|NCT01060384|451108262|FG003|Overall Study|Intercurrent illness|0|||
125404283|NCT01060384|451108263|FG004|Overall Study|Intercurrent illness|1|||
125404284|NCT00812929|451108266|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
125404285|NCT00812929|451108267|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
125404286|NCT00812929|451108268|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
125404287|NCT00812929|451108269|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
125404288|NCT00812929|451108270|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
125404289|NCT00812929|451108271|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
125404290|NCT00812929|451108272|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
125404291|NCT00812929|451108273|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
125404292|NCT00812929|451108274|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
125404293|NCT00812929|451108275|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
125404294|NCT00812929|451108266|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
125404295|NCT00812929|451108267|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
125404296|NCT00812929|451108268|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
125404297|NCT00812929|451108269|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
125404298|NCT00812929|451108270|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
125404299|NCT00812929|451108271|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
125404300|NCT00812929|451108272|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
125404301|NCT00812929|451108273|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
125404302|NCT00812929|451108274|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
125404303|NCT00812929|451108275|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
125404304|NCT00812929|451108266|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
125404305|NCT00812929|451108267|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
125404306|NCT00812929|451108268|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
125404307|NCT00812929|451108269|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
125404308|NCT00812929|451108270|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
125404309|NCT00812929|451108271|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
125404310|NCT00812929|451108272|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
125404311|NCT00812929|451108273|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
125404312|NCT00812929|451108274|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
125404313|NCT00812929|451108275|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
125404314|NCT00211081|451108277|FG000|Overall Study|Withdrawal by Subject|2|||
125404315|NCT01332305|451108278|FG000|Overall Study|Adverse Event|1|||
125404316|NCT01332305|451108279|FG001|Overall Study|Adverse Event|4|||
125404317|NCT01332305|451108280|FG002|Overall Study|Adverse Event|6|||
125404318|NCT01332305|451108281|FG003|Overall Study|Adverse Event|3|||
125404319|NCT01332305|451108282|FG004|Overall Study|Adverse Event|5|||
125404320|NCT01332305|451108278|FG000|Overall Study|Withdrawal by Subject|6|||
125404321|NCT01332305|451108279|FG001|Overall Study|Withdrawal by Subject|5|||
125404322|NCT01332305|451108280|FG002|Overall Study|Withdrawal by Subject|4|||
125404323|NCT01332305|451108281|FG003|Overall Study|Withdrawal by Subject|1|||
125404324|NCT01332305|451108282|FG004|Overall Study|Withdrawal by Subject|0|||
125404325|NCT01332305|451108278|FG000|Overall Study|Lost to Follow-up|0|||
125404326|NCT01332305|451108279|FG001|Overall Study|Lost to Follow-up|2|||
125404327|NCT01332305|451108280|FG002|Overall Study|Lost to Follow-up|3|||
125404328|NCT01332305|451108281|FG003|Overall Study|Lost to Follow-up|2|||
125404329|NCT01332305|451108282|FG004|Overall Study|Lost to Follow-up|3|||
125404330|NCT01332305|451108278|FG000|Overall Study|Protocol Violation|1|||
125404331|NCT01332305|451108279|FG001|Overall Study|Protocol Violation|2|||
125404332|NCT01332305|451108280|FG002|Overall Study|Protocol Violation|1|||
125404333|NCT01332305|451108281|FG003|Overall Study|Protocol Violation|0|||
125404334|NCT01332305|451108282|FG004|Overall Study|Protocol Violation|3|||
125404335|NCT01332305|451108278|FG000|Overall Study|Withdrawal by Sponsor|1|||
125404336|NCT01332305|451108279|FG001|Overall Study|Withdrawal by Sponsor|0|||
125404337|NCT01332305|451108280|FG002|Overall Study|Withdrawal by Sponsor|0|||
125404338|NCT01332305|451108281|FG003|Overall Study|Withdrawal by Sponsor|1|||
125404339|NCT01332305|451108282|FG004|Overall Study|Withdrawal by Sponsor|1|||
125404340|NCT01332305|451108278|FG000|Overall Study|Treatment Failure|1|||
125404341|NCT01332305|451108279|FG001|Overall Study|Treatment Failure|1|||
125404342|NCT01332305|451108280|FG002|Overall Study|Treatment Failure|0|||
125404343|NCT01332305|451108281|FG003|Overall Study|Treatment Failure|0|||
125404344|NCT01332305|451108282|FG004|Overall Study|Treatment Failure|0|||
125404345|NCT01332305|451108278|FG000|Overall Study|Physician Decision|0|||
125404346|NCT01332305|451108279|FG001|Overall Study|Physician Decision|0|||
125404347|NCT01332305|451108280|FG002|Overall Study|Physician Decision|0|||
125404348|NCT01332305|451108281|FG003|Overall Study|Physician Decision|1|||
125404349|NCT01332305|451108282|FG004|Overall Study|Physician Decision|0|||
125404350|NCT02170727|451108283|FG000|Overall Study|Lost to Follow-up|1|||
125404351|NCT02170727|451108284|FG001|Overall Study|Lost to Follow-up|0|||
125404352|NCT02170727|451108283|FG000|Overall Study|Withdrawal by Subject|2|||
125404353|NCT02170727|451108284|FG001|Overall Study|Withdrawal by Subject|0|||
125404354|NCT00720876|451108285|FG000|Overall Study|found to be ineligible after starting tx|2|||
125404355|NCT00684424|451108291|FG000|Overall Study|Adverse Event|1|||
125404356|NCT00684424|451108291|FG000|Overall Study|Lost to Follow-up|2|||
125404357|NCT00684424|451108291|FG000|Overall Study|Other|2|||
125404358|NCT02410811|451108292|FG000|Overall Study|Withdrawal by Subject|0|||
125404359|NCT02410811|451108293|FG001|Overall Study|Withdrawal by Subject|0|||
125404360|NCT02410811|451108294|FG002|Overall Study|Withdrawal by Subject|1|||
125404361|NCT02410811|451108295|FG003|Overall Study|Withdrawal by Subject|0|||
125404362|NCT00057746|451108296|FG000|Overall Study|Withdrawal by Subject|0|||
125404363|NCT00057746|451108297|FG001|Overall Study|Withdrawal by Subject|0|||
125404364|NCT00057746|451108298|FG002|Overall Study|Withdrawal by Subject|1|||
125404365|NCT03511560|451108301|FG000|Overall Study|Death|0|||
125404366|NCT03511560|451108302|FG001|Overall Study|Death|1|||
125277919|NCT05396014|450643919|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277920|NCT05396014|450643920|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277921|NCT05396014|450643921|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277922|NCT05396014|450643922|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277923|NCT05396014|450643923|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277924|NCT05396014|450643924|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277925|NCT05396014|450643925|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277926|NCT05396014|450643926|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277927|NCT05396014|450643927|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277928|NCT05396014|450643928|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277929|NCT05396014|450643929|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277930|NCT05396014|450643930|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277931|NCT05396014|450643931|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
125277932|NCT05396014|450643932|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277933|NCT05396014|450643933|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277934|NCT05396014|450643934|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277935|NCT05396014|450643935|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277936|NCT05396014|450643936|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277937|NCT05396014|450643937|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277938|NCT05396014|450643938|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277939|NCT05396014|450643939|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277940|NCT05396014|450643940|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277941|NCT05396014|450643941|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277942|NCT05396014|450643942|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277943|NCT05396014|450643943|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277944|NCT05396014|450643944|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277945|NCT05396014|450643945|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277946|NCT05396014|450643946|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277947|NCT05396014|450643947|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277948|NCT05396014|450643948|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277949|NCT05396014|450643949|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277950|NCT05396014|450643950|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277951|NCT05396014|450643951|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277952|NCT05396014|450643952|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277953|NCT05396014|450643953|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277954|NCT05396014|450643954|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277955|NCT05396014|450643955|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277956|NCT05396014|450643956|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277957|NCT05396014|450643957|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
125277958|NCT05396014|450643958|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277959|NCT05396014|450643959|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277960|NCT05396014|450643960|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
125277961|NCT05396014|450643918|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
125277962|NCT05396014|450643919|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277963|NCT05396014|450643920|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277964|NCT05396014|450643921|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277965|NCT05396014|450643922|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277966|NCT05396014|450643923|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277967|NCT05396014|450643924|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277968|NCT05396014|450643925|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277969|NCT05396014|450643926|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277970|NCT05396014|450643927|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277971|NCT05396014|450643928|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277972|NCT05396014|450643929|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277973|NCT05396014|450643930|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277974|NCT05396014|450643931|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277975|NCT05396014|450643932|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277976|NCT05396014|450643933|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277977|NCT05396014|450643934|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277978|NCT05396014|450643935|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277979|NCT05396014|450643936|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277980|NCT05396014|450643937|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277981|NCT05396014|450643938|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277982|NCT05396014|450643939|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277983|NCT05396014|450643940|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125404367|NCT03511560|451108301|FG000|Overall Study|Adverse Event|0|||
125404368|NCT03511560|451108302|FG001|Overall Study|Adverse Event|2|||
125404369|NCT03511560|451108301|FG000|Overall Study|Transplant cancelled|0|||
125404370|NCT03511560|451108302|FG001|Overall Study|Transplant cancelled|1|||
125404371|NCT03511560|451108301|FG000|Overall Study|Patient switched to another drug|1|||
125404372|NCT03511560|451108302|FG001|Overall Study|Patient switched to another drug|0|||
125404373|NCT02985736|451108307|FG000|Overall Study|Lost to Follow-up|3|||
125404374|NCT00382733|451108308|FG000|Overall Study|Withdrawal by Subject|0|||
125404375|NCT00382733|451108309|FG001|Overall Study|Withdrawal by Subject|1|||
125404376|NCT00382733|451108310|FG002|Overall Study|Withdrawal by Subject|0|||
125404377|NCT00382733|451108311|FG003|Overall Study|Withdrawal by Subject|0|||
125404378|NCT00382733|451108312|FG004|Overall Study|Withdrawal by Subject|0|||
125404379|NCT00439140|451108313|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
125404380|NCT00439140|451108314|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
125404381|NCT00439140|451108315|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
125404382|NCT00439140|451108313|FG000|Treatment Cycle 1|Personal reasons|0|||
125404383|NCT00439140|451108314|FG001|Treatment Cycle 1|Personal reasons|2|||
125404384|NCT00439140|451108315|FG002|Treatment Cycle 1|Personal reasons|0|||
125404385|NCT00439140|451108313|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
125404386|NCT00439140|451108314|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
125404387|NCT00439140|451108315|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
125404388|NCT00439140|451108313|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
125404389|NCT00439140|451108314|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
125404390|NCT00439140|451108315|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
125404391|NCT00439140|451108313|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
125404392|NCT00439140|451108314|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
125404393|NCT00439140|451108315|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
125404394|NCT04154631|451108322|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
125404395|NCT04154631|451108323|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
125404396|NCT02185768|451108324|FG000|Overall Study|Patients were not treated|2|||
125404397|NCT02550652|451108326|FG000|Overall Study|Death|1|||
125404398|NCT02550652|451108327|FG001|Overall Study|Death|4|||
125404399|NCT02550652|451108326|FG000|Overall Study|Lack of Efficacy|1|||
125404400|NCT02550652|451108327|FG001|Overall Study|Lack of Efficacy|0|||
125404401|NCT02550652|451108326|FG000|Overall Study|Withdrawal by Subject|4|||
125404402|NCT02550652|451108327|FG001|Overall Study|Withdrawal by Subject|7|||
125404403|NCT02550652|451108326|FG000|Overall Study|Post Trial Access|1|||
125404404|NCT02550652|451108327|FG001|Overall Study|Post Trial Access|0|||
125404405|NCT02550652|451108326|FG000|Overall Study|Lost to Follow-up|1|||
125404406|NCT02550652|451108327|FG001|Overall Study|Lost to Follow-up|3|||
125404407|NCT02550652|451108326|FG000|Overall Study|Physician Decision|0|||
125404408|NCT02550652|451108327|FG001|Overall Study|Physician Decision|2|||
125404409|NCT02550652|451108326|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
125404410|NCT02550652|451108327|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
125404411|NCT01466192|451108337|FG000|Overall Study|Physician Decision|1|||
125404412|NCT01466192|451108337|FG000|Overall Study|Withdrawal by Subject|3|||
125404413|NCT00700011|451108340|FG000|Overall Study|Death|0|||
125404414|NCT00700011|451108341|FG001|Overall Study|Death|1|||
125404415|NCT00678561|451108342|FG000|Overall Study|Adverse Event|0|||
125404416|NCT00678561|451108343|FG001|Overall Study|Adverse Event|1|||
125404417|NCT00678561|451108344|FG002|Overall Study|Adverse Event|1|||
125404418|NCT00678561|451108345|FG003|Overall Study|Adverse Event|0|||
125404419|NCT00678561|451108346|FG004|Overall Study|Adverse Event|1|||
125404420|NCT00678561|451108347|FG005|Overall Study|Adverse Event|0|||
125404421|NCT00678561|451108348|FG006|Overall Study|Adverse Event|0|||
125404422|NCT00678561|451108349|FG007|Overall Study|Adverse Event|0|||
125404423|NCT00678561|451108342|FG000|Overall Study|Protocol Violation|0|||
125448085|NCT00231179|451268838|FG000|Overall Study|Withdrawal by Subject|3|||
125404424|NCT00678561|451108343|FG001|Overall Study|Protocol Violation|0|||
125404425|NCT00678561|451108344|FG002|Overall Study|Protocol Violation|0|||
125404426|NCT00678561|451108345|FG003|Overall Study|Protocol Violation|0|||
125404427|NCT00678561|451108346|FG004|Overall Study|Protocol Violation|1|||
125404428|NCT00678561|451108347|FG005|Overall Study|Protocol Violation|1|||
125404429|NCT00678561|451108348|FG006|Overall Study|Protocol Violation|0|||
125404430|NCT00678561|451108349|FG007|Overall Study|Protocol Violation|0|||
125404431|NCT00678561|451108342|FG000|Overall Study|Withdrawal by Subject|0|||
125404432|NCT00678561|451108343|FG001|Overall Study|Withdrawal by Subject|0|||
125404433|NCT00678561|451108344|FG002|Overall Study|Withdrawal by Subject|0|||
125404434|NCT00678561|451108345|FG003|Overall Study|Withdrawal by Subject|0|||
125404435|NCT00678561|451108346|FG004|Overall Study|Withdrawal by Subject|0|||
125404436|NCT00678561|451108347|FG005|Overall Study|Withdrawal by Subject|0|||
125404437|NCT00678561|451108348|FG006|Overall Study|Withdrawal by Subject|0|||
125404438|NCT00678561|451108349|FG007|Overall Study|Withdrawal by Subject|1|||
125404439|NCT00437034|451108350|FG000|Overall Study|Adverse Event|1|||
125448086|NCT00231179|451268839|FG001|Overall Study|Withdrawal by Subject|3|||
125404440|NCT00437034|451108350|FG000|Overall Study|Disease progression during treatment|5|||
125404441|NCT00853658|451108352|FG000|Overall Study|Death|713|||
125404442|NCT00853658|451108353|FG001|Overall Study|Death|768|||
125277984|NCT05396014|450643941|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277985|NCT05396014|450643942|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277986|NCT05396014|450643943|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277987|NCT05396014|450643944|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
125277988|NCT05396014|450643945|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277989|NCT05396014|450643946|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277990|NCT05396014|450643947|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277991|NCT05396014|450643948|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277992|NCT05396014|450643949|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277993|NCT05396014|450643950|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277994|NCT05396014|450643951|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277995|NCT05396014|450643952|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277996|NCT05396014|450643953|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277997|NCT05396014|450643954|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277998|NCT05396014|450643955|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125277999|NCT05396014|450643956|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125278000|NCT05396014|450643957|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125278001|NCT05396014|450643958|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125278002|NCT05396014|450643959|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125278003|NCT05396014|450643960|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
125278004|NCT05396014|450643918|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278005|NCT05396014|450643919|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278006|NCT05396014|450643920|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278007|NCT05396014|450643921|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278008|NCT05396014|450643922|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278009|NCT05396014|450643923|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278010|NCT05396014|450643924|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278011|NCT05396014|450643925|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278012|NCT05396014|450643926|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278013|NCT05396014|450643927|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278014|NCT05396014|450643928|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278015|NCT05396014|450643929|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278016|NCT05396014|450643930|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278017|NCT05396014|450643931|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
125278018|NCT05396014|450643932|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278019|NCT05396014|450643933|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278020|NCT05396014|450643934|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278021|NCT05396014|450643935|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278022|NCT05396014|450643936|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278023|NCT05396014|450643937|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278024|NCT05396014|450643938|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278025|NCT05396014|450643939|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278026|NCT05396014|450643940|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278027|NCT05396014|450643941|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278028|NCT05396014|450643942|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278029|NCT05396014|450643943|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278030|NCT05396014|450643944|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278031|NCT05396014|450643945|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278032|NCT05396014|450643946|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278033|NCT05396014|450643947|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278034|NCT05396014|450643948|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278035|NCT05396014|450643949|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278036|NCT05396014|450643950|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278037|NCT05396014|450643951|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278038|NCT05396014|450643952|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278039|NCT05396014|450643953|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278040|NCT05396014|450643954|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278041|NCT05396014|450643955|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278042|NCT05396014|450643956|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278043|NCT05396014|450643957|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278044|NCT05396014|450643958|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278045|NCT05396014|450643959|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278046|NCT05396014|450643960|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
125278047|NCT05396014|450643918|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278048|NCT05396014|450643919|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125404443|NCT00853658|451108354|FG002|Overall Study|Death|753|||
125448087|NCT02892409|451268840|FG000|Overall Study|Adverse Event|1|||
125448088|NCT02892409|451268841|FG001|Overall Study|Adverse Event|0|||
125448089|NCT02892409|451268840|FG000|Overall Study|Withdrawal by Subject|2|||
125448090|NCT02892409|451268841|FG001|Overall Study|Withdrawal by Subject|1|||
125448091|NCT02123966|451268844|FG000|Overall Study|Intercurrent Illness|1|||
125448092|NCT01460381|451268845|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
125448093|NCT01460381|451268846|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
125448094|NCT02652130|451268852|FG000|Overall Study|Death|1|||
125448095|NCT02028884|451268853|FG000|Double-blind Period|Adverse Event|5|||
125448096|NCT02028884|451268854|FG001|Double-blind Period|Adverse Event|3|||
125448097|NCT02028884|451268855|FG002|Double-blind Period|Adverse Event|0|||
125448098|NCT02028884|451268853|FG000|Double-blind Period|Eligibility Violation|1|||
125448099|NCT02028884|451268854|FG001|Double-blind Period|Eligibility Violation|0|||
125448100|NCT02028884|451268855|FG002|Double-blind Period|Eligibility Violation|0|||
125448101|NCT02028884|451268853|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
125448102|NCT02028884|451268854|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
125448103|NCT02028884|451268855|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
125448104|NCT02028884|451268853|FG000|Double-blind Period|Withdrawal by Subject|2|||
125448105|NCT02028884|451268854|FG001|Double-blind Period|Withdrawal by Subject|0|||
125448106|NCT02028884|451268855|FG002|Double-blind Period|Withdrawal by Subject|0|||
125448107|NCT02028884|451268853|FG000|Open-label Extension Period|Adverse Event|3|||
125448108|NCT02028884|451268854|FG001|Open-label Extension Period|Adverse Event|1|||
125448109|NCT02028884|451268855|FG002|Open-label Extension Period|Adverse Event|0|||
125448110|NCT02028884|451268853|FG000|Open-label Extension Period|Lack of Efficacy|3|||
125278049|NCT05396014|450643920|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278050|NCT05396014|450643921|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
125404444|NCT00853658|451108352|FG000|Overall Study|Lost to Follow-up|11|||
125404445|NCT00853658|451108353|FG001|Overall Study|Lost to Follow-up|6|||
125404446|NCT00853658|451108354|FG002|Overall Study|Lost to Follow-up|11|||
125404447|NCT00853658|451108352|FG000|Overall Study|H.A. Request|26|||
125404448|NCT00853658|451108353|FG001|Overall Study|H.A. Request|23|||
125404449|NCT00853658|451108354|FG002|Overall Study|H.A. Request|19|||
125404450|NCT00853658|451108352|FG000|Overall Study|IRB request|0|||
125404451|NCT00853658|451108353|FG001|Overall Study|IRB request|0|||
125404452|NCT00853658|451108354|FG002|Overall Study|IRB request|2|||
125404453|NCT00853658|451108352|FG000|Overall Study|Vital Status known (alive) at study end|2|||
125404454|NCT00853658|451108353|FG001|Overall Study|Vital Status known (alive) at study end|3|||
125404455|NCT00853658|451108354|FG002|Overall Study|Vital Status known (alive) at study end|3|||
125404456|NCT00853658|451108352|FG000|Overall Study|Vital Status unknown at study end|1|||
125404457|NCT00853658|451108353|FG001|Overall Study|Vital Status unknown at study end|1|||
125404458|NCT00853658|451108354|FG002|Overall Study|Vital Status unknown at study end|0|||
125448111|NCT02028884|451268854|FG001|Open-label Extension Period|Lack of Efficacy|0|||
125278051|NCT05396014|450643922|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278052|NCT05396014|450643923|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278053|NCT05396014|450643924|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278054|NCT05396014|450643925|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278055|NCT05396014|450643926|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
125278056|NCT05396014|450643927|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278057|NCT05396014|450643928|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278058|NCT05396014|450643929|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278059|NCT05396014|450643930|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278060|NCT05396014|450643931|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278061|NCT05396014|450643932|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278062|NCT05396014|450643933|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278063|NCT05396014|450643934|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278064|NCT05396014|450643935|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278065|NCT05396014|450643936|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278066|NCT05396014|450643937|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278067|NCT05396014|450643938|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278068|NCT05396014|450643939|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278069|NCT05396014|450643940|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278070|NCT05396014|450643941|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278071|NCT05396014|450643942|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278072|NCT05396014|450643943|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
125404459|NCT00853658|451108352|FG000|Overall Study|Vital Status at study end N/A|8|||
125404460|NCT00853658|451108353|FG001|Overall Study|Vital Status at study end N/A|10|||
125404461|NCT00853658|451108354|FG002|Overall Study|Vital Status at study end N/A|10|||
125404462|NCT00853658|451108352|FG000|Overall Study|Patient's request|21|||
125404463|NCT00853658|451108353|FG001|Overall Study|Patient's request|17|||
125448112|NCT02028884|451268855|FG002|Open-label Extension Period|Lack of Efficacy|0|||
125448113|NCT02028884|451268853|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
125404464|NCT00853658|451108354|FG002|Overall Study|Patient's request|11|||
125404465|NCT00853658|451108352|FG000|Overall Study|Missing study completion information|5|||
125404466|NCT00853658|451108353|FG001|Overall Study|Missing study completion information|4|||
125404467|NCT00853658|451108354|FG002|Overall Study|Missing study completion information|6|||
125404468|NCT02047604|451108355|FG000|Overall Study|Withdrawal by Subject|0|||
125404469|NCT02047604|451108356|FG001|Overall Study|Withdrawal by Subject|0|||
125404470|NCT02047604|451108357|FG002|Overall Study|Withdrawal by Subject|0|||
125404471|NCT02047604|451108358|FG003|Overall Study|Withdrawal by Subject|0|||
125404472|NCT02047604|451108359|FG004|Overall Study|Withdrawal by Subject|1|||
125404473|NCT02047604|451108360|FG005|Overall Study|Withdrawal by Subject|1|||
125404474|NCT04035486|451108361|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
125404475|NCT04035486|451108362|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
125404476|NCT04035486|451108363|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
125404477|NCT04035486|451108364|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
125404478|NCT04035486|451108361|FG000|Overall Study|Death|6|||
125404479|NCT04035486|451108362|FG001|Overall Study|Death|3|||
125404480|NCT04035486|451108363|FG002|Overall Study|Death|70|||
125404481|NCT04035486|451108364|FG003|Overall Study|Death|77|||
125404482|NCT04035486|451108361|FG000|Overall Study|Screen Failure|0|||
125404483|NCT04035486|451108362|FG001|Overall Study|Screen Failure|0|||
125404484|NCT04035486|451108363|FG002|Overall Study|Screen Failure|1|||
125404485|NCT04035486|451108364|FG003|Overall Study|Screen Failure|1|||
125404486|NCT04035486|451108361|FG000|Overall Study|Withdrawal by Subject|1|||
125404487|NCT04035486|451108362|FG001|Overall Study|Withdrawal by Subject|1|||
125404488|NCT04035486|451108363|FG002|Overall Study|Withdrawal by Subject|11|||
125404489|NCT04035486|451108364|FG003|Overall Study|Withdrawal by Subject|9|||
125404490|NCT01976845|451108367|FG000|Overall Study|Physician Decision|8|||
125404491|NCT01976845|451108368|FG001|Overall Study|Physician Decision|8|||
125404492|NCT01976845|451108369|FG002|Overall Study|Physician Decision|3|||
125404493|NCT06748040|451108370|FG000|Overall Study|Death|3|||
125404494|NCT06748040|451108371|FG001|Overall Study|Death|4|||
125404495|NCT06748040|451108370|FG000|Overall Study|Lost to Follow-up|134|||
125404496|NCT06748040|451108371|FG001|Overall Study|Lost to Follow-up|132|||
125404497|NCT06748040|451108370|FG000|Overall Study|Withdrawal by Subject|3|||
125404498|NCT06748040|451108371|FG001|Overall Study|Withdrawal by Subject|5|||
125404499|NCT02556710|451110563|FG000|Overall Study|Surgical treatment|3|||
125404500|NCT02556710|451110564|FG001|Overall Study|Surgical treatment|0|||
125404501|NCT02556710|451110563|FG000|Overall Study|Required proscribed pain medication|2|||
125404502|NCT02556710|451110564|FG001|Overall Study|Required proscribed pain medication|1|||
125404503|NCT02556710|451110563|FG000|Overall Study|Lack of Efficacy|1|||
125404504|NCT02556710|451110564|FG001|Overall Study|Lack of Efficacy|0|||
125404505|NCT02556710|451110563|FG000|Overall Study|Worsening osteoarthritis|1|||
125404506|NCT02556710|451110564|FG001|Overall Study|Worsening osteoarthritis|0|||
125404507|NCT02556710|451110563|FG000|Overall Study|Moved out of state|1|||
125404508|NCT02556710|451110564|FG001|Overall Study|Moved out of state|0|||
125404509|NCT02556710|451110563|FG000|Overall Study|Missing reason|3|||
125404510|NCT02556710|451110564|FG001|Overall Study|Missing reason|1|||
125404511|NCT02556710|451110563|FG000|Overall Study|Pain as lack of efficacy|0|||
125404512|NCT02556710|451110564|FG001|Overall Study|Pain as lack of efficacy|4|||
125404513|NCT04258839|451110567|FG000|Overall Study|Adverse Event|2|||
125404514|NCT04258839|451110568|FG001|Overall Study|Adverse Event|4|||
125404515|NCT04258839|451110567|FG000|Overall Study|Lack of Efficacy|0|||
125404516|NCT04258839|451110568|FG001|Overall Study|Lack of Efficacy|2|||
125404517|NCT04258839|451110567|FG000|Overall Study|Lost to Follow-up|2|||
125404518|NCT04258839|451110568|FG001|Overall Study|Lost to Follow-up|0|||
125404519|NCT04258839|451110567|FG000|Overall Study|Withdrawal by Subject|1|||
125404520|NCT04258839|451110568|FG001|Overall Study|Withdrawal by Subject|2|||
125404521|NCT04258839|451110567|FG000|Overall Study|Withdrawal by Caregiver|5|||
125404522|NCT04258839|451110568|FG001|Overall Study|Withdrawal by Caregiver|6|||
125404523|NCT04258839|451110567|FG000|Overall Study|Reason not Specified|0|||
125404524|NCT04258839|451110568|FG001|Overall Study|Reason not Specified|1|||
125404525|NCT00612066|451110571|FG000|Overall Study|Adverse Event|1|||
125404526|NCT00630877|451110572|FG000|Overall Study|Adverse Event|11|||
125404527|NCT00630877|451110573|FG001|Overall Study|Adverse Event|8|||
125404528|NCT00630877|451110574|FG002|Overall Study|Adverse Event|7|||
125404529|NCT00630877|451110572|FG000|Overall Study|Withdrawal by Subject|3|||
125404530|NCT00630877|451110573|FG001|Overall Study|Withdrawal by Subject|4|||
125404531|NCT00630877|451110574|FG002|Overall Study|Withdrawal by Subject|0|||
125404532|NCT00630877|451110572|FG000|Overall Study|Lost to Follow-up|2|||
125404533|NCT00630877|451110573|FG001|Overall Study|Lost to Follow-up|0|||
125404534|NCT00630877|451110574|FG002|Overall Study|Lost to Follow-up|0|||
125404535|NCT00630877|451110572|FG000|Overall Study|Noncompliance|2|||
125404536|NCT00630877|451110573|FG001|Overall Study|Noncompliance|3|||
125404537|NCT00630877|451110574|FG002|Overall Study|Noncompliance|1|||
125404538|NCT00630877|451110572|FG000|Overall Study|Protocol violation|1|||
125404539|NCT00630877|451110573|FG001|Overall Study|Protocol violation|0|||
125404540|NCT00630877|451110574|FG002|Overall Study|Protocol violation|1|||
125404541|NCT00630877|451110572|FG000|Overall Study|Personal reasons|0|||
125404542|NCT00630877|451110573|FG001|Overall Study|Personal reasons|0|||
125404543|NCT00630877|451110574|FG002|Overall Study|Personal reasons|1|||
125404544|NCT01529645|451110575|FG000|Overall Study|Lost to Follow-up|0|||
125404545|NCT01529645|451110576|FG001|Overall Study|Lost to Follow-up|1|||
125404546|NCT01529645|451110577|FG002|Overall Study|Lost to Follow-up|1|||
125404547|NCT01529645|451110578|FG003|Overall Study|Lost to Follow-up|1|||
125404548|NCT01529645|451110579|FG004|Overall Study|Lost to Follow-up|1|||
125404549|NCT01529645|451110580|FG005|Overall Study|Lost to Follow-up|0|||
125404550|NCT01529645|451110581|FG006|Overall Study|Lost to Follow-up|2|||
125404551|NCT01529645|451110582|FG007|Overall Study|Lost to Follow-up|0|||
125404552|NCT01529645|451110583|FG008|Overall Study|Lost to Follow-up|1|||
125404553|NCT01529645|451110584|FG009|Overall Study|Lost to Follow-up|0|||
125404554|NCT01529645|451110575|FG000|Overall Study|SAE - Premature contractions|0|||
125404555|NCT01529645|451110576|FG001|Overall Study|SAE - Premature contractions|0|||
125404556|NCT01529645|451110577|FG002|Overall Study|SAE - Premature contractions|1|||
125404557|NCT01529645|451110578|FG003|Overall Study|SAE - Premature contractions|0|||
125404558|NCT01529645|451110579|FG004|Overall Study|SAE - Premature contractions|0|||
125404559|NCT01529645|451110580|FG005|Overall Study|SAE - Premature contractions|0|||
125404560|NCT01529645|451110581|FG006|Overall Study|SAE - Premature contractions|0|||
125404561|NCT01529645|451110582|FG007|Overall Study|SAE - Premature contractions|0|||
125404562|NCT01529645|451110583|FG008|Overall Study|SAE - Premature contractions|0|||
125404563|NCT01529645|451110584|FG009|Overall Study|SAE - Premature contractions|0|||
125404564|NCT01529645|451110575|FG000|Overall Study|Withdrawal by Subject|2|||
125404565|NCT01529645|451110576|FG001|Overall Study|Withdrawal by Subject|0|||
125404566|NCT01529645|451110577|FG002|Overall Study|Withdrawal by Subject|0|||
125404567|NCT01529645|451110578|FG003|Overall Study|Withdrawal by Subject|1|||
125404568|NCT01529645|451110579|FG004|Overall Study|Withdrawal by Subject|1|||
125404569|NCT01529645|451110580|FG005|Overall Study|Withdrawal by Subject|1|||
125404570|NCT01529645|451110581|FG006|Overall Study|Withdrawal by Subject|0|||
125404571|NCT01529645|451110582|FG007|Overall Study|Withdrawal by Subject|0|||
125404572|NCT01529645|451110583|FG008|Overall Study|Withdrawal by Subject|0|||
125404573|NCT01529645|451110584|FG009|Overall Study|Withdrawal by Subject|0|||
125404574|NCT01602315|451110585|FG000|Overall Study|Protocol Violation|0|||
125404575|NCT01602315|451110586|FG001|Overall Study|Protocol Violation|0|||
125404576|NCT01602315|451110587|FG002|Overall Study|Protocol Violation|0|||
125404577|NCT01602315|451110588|FG003|Overall Study|Protocol Violation|0|||
125404578|NCT01602315|451110589|FG004|Overall Study|Protocol Violation|0|||
125404579|NCT01602315|451110590|FG005|Overall Study|Protocol Violation|1|||
125404580|NCT01602315|451110591|FG006|Overall Study|Protocol Violation|0|||
125404581|NCT01602315|451110585|FG000|Overall Study|Physician Decision|2|||
125404582|NCT01602315|451110586|FG001|Overall Study|Physician Decision|0|||
125404583|NCT01602315|451110587|FG002|Overall Study|Physician Decision|0|||
125404584|NCT01602315|451110588|FG003|Overall Study|Physician Decision|0|||
125404585|NCT01602315|451110589|FG004|Overall Study|Physician Decision|2|||
125404586|NCT01602315|451110590|FG005|Overall Study|Physician Decision|1|||
125404587|NCT01602315|451110591|FG006|Overall Study|Physician Decision|1|||
125404588|NCT01602315|451110585|FG000|Overall Study|Disease progression|6|||
125404589|NCT01602315|451110586|FG001|Overall Study|Disease progression|3|||
125404590|NCT01602315|451110587|FG002|Overall Study|Disease progression|10|||
125404591|NCT01602315|451110588|FG003|Overall Study|Disease progression|1|||
125404592|NCT01602315|451110589|FG004|Overall Study|Disease progression|41|||
125404593|NCT01602315|451110590|FG005|Overall Study|Disease progression|12|||
125404594|NCT01602315|451110591|FG006|Overall Study|Disease progression|15|||
125404595|NCT01602315|451110585|FG000|Overall Study|Death|1|||
125404596|NCT01602315|451110586|FG001|Overall Study|Death|1|||
125404597|NCT01602315|451110587|FG002|Overall Study|Death|1|||
125404598|NCT01602315|451110588|FG003|Overall Study|Death|1|||
125404599|NCT01602315|451110589|FG004|Overall Study|Death|7|||
125404600|NCT01602315|451110590|FG005|Overall Study|Death|2|||
125404601|NCT01602315|451110591|FG006|Overall Study|Death|2|||
125404602|NCT01602315|451110585|FG000|Overall Study|Withdrawal by Subject|2|||
125404603|NCT01602315|451110586|FG001|Overall Study|Withdrawal by Subject|0|||
125404604|NCT01602315|451110587|FG002|Overall Study|Withdrawal by Subject|2|||
125404605|NCT01602315|451110588|FG003|Overall Study|Withdrawal by Subject|0|||
125404606|NCT01602315|451110589|FG004|Overall Study|Withdrawal by Subject|6|||
125404607|NCT01602315|451110590|FG005|Overall Study|Withdrawal by Subject|0|||
125404608|NCT01602315|451110591|FG006|Overall Study|Withdrawal by Subject|1|||
125404609|NCT01602315|451110585|FG000|Overall Study|Adverse Event|5|||
125404610|NCT01602315|451110586|FG001|Overall Study|Adverse Event|1|||
125404611|NCT01602315|451110587|FG002|Overall Study|Adverse Event|5|||
125404612|NCT01602315|451110588|FG003|Overall Study|Adverse Event|4|||
125404613|NCT01602315|451110589|FG004|Overall Study|Adverse Event|15|||
125404614|NCT01602315|451110590|FG005|Overall Study|Adverse Event|3|||
125404615|NCT01602315|451110591|FG006|Overall Study|Adverse Event|9|||
125404616|NCT01602315|451110585|FG000|Overall Study|Subject/guardian decision|0|||
125404617|NCT01602315|451110586|FG001|Overall Study|Subject/guardian decision|0|||
125404618|NCT01602315|451110587|FG002|Overall Study|Subject/guardian decision|0|||
125404619|NCT01602315|451110588|FG003|Overall Study|Subject/guardian decision|0|||
125404620|NCT01602315|451110589|FG004|Overall Study|Subject/guardian decision|0|||
125404621|NCT01602315|451110590|FG005|Overall Study|Subject/guardian decision|0|||
125404622|NCT01602315|451110591|FG006|Overall Study|Subject/guardian decision|1|||
125404623|NCT01602315|451110585|FG000|Overall Study|Cross-over patients to combo treatment|0|||
125404624|NCT01602315|451110586|FG001|Overall Study|Cross-over patients to combo treatment|0|||
125404625|NCT01602315|451110587|FG002|Overall Study|Cross-over patients to combo treatment|0|||
125404626|NCT01602315|451110588|FG003|Overall Study|Cross-over patients to combo treatment|0|||
125404627|NCT01602315|451110589|FG004|Overall Study|Cross-over patients to combo treatment|0|||
125404628|NCT01602315|451110590|FG005|Overall Study|Cross-over patients to combo treatment|16|||
125404629|NCT01602315|451110591|FG006|Overall Study|Cross-over patients to combo treatment|0|||
125404630|NCT00440271|451110592|FG000|Overall Study|Protocol Violation|1|||
125404631|NCT00440271|451110593|FG001|Overall Study|Protocol Violation|1|||
125404632|NCT00440271|451110592|FG000|Overall Study|Adverse Event|0|||
125404633|NCT00440271|451110593|FG001|Overall Study|Adverse Event|1|||
125404634|NCT00440271|451110592|FG000|Overall Study|Lost to Follow-up|1|||
125404635|NCT00440271|451110593|FG001|Overall Study|Lost to Follow-up|0|||
125404636|NCT00440271|451110592|FG000|Overall Study|Withdrawal by Subject|0|||
125404637|NCT00440271|451110593|FG001|Overall Study|Withdrawal by Subject|2|||
125404638|NCT00440271|451110592|FG000|Overall Study|Lack of Efficacy|0|||
125404639|NCT00440271|451110593|FG001|Overall Study|Lack of Efficacy|1|||
125404640|NCT00440271|451110592|FG000|Overall Study|Due to closure of trial|8|||
125404641|NCT00440271|451110593|FG001|Overall Study|Due to closure of trial|10|||
125404642|NCT00440271|451110592|FG000|Overall Study|Other|2|||
125404643|NCT00440271|451110593|FG001|Overall Study|Other|0|||
125404644|NCT00723801|451110596|FG000|Overall Study|Lost to Follow-up|1|||
125404645|NCT00723801|451110597|FG001|Overall Study|Lost to Follow-up|2|||
125404646|NCT00723801|451110596|FG000|Overall Study|Protocol Violation|2|||
125404647|NCT00723801|451110597|FG001|Overall Study|Protocol Violation|1|||
125404648|NCT01565993|451110598|FG000|Overall Study|Physician Decision|0|||
125404649|NCT01565993|451110599|FG001|Overall Study|Physician Decision|3|||
125404650|NCT04086472|451110600|FG000|Overall Study|Lost to Follow-up|1|||
125404651|NCT04086472|451110601|FG001|Overall Study|Lost to Follow-up|0|||
125404652|NCT04086472|451110602|FG002|Overall Study|Lost to Follow-up|0|||
125404653|NCT04086472|451110603|FG003|Overall Study|Lost to Follow-up|0|||
125404654|NCT04086472|451110604|FG004|Overall Study|Lost to Follow-up|1|||
125448114|NCT02028884|451268854|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
125278073|NCT05396014|450643944|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278074|NCT05396014|450643945|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278075|NCT05396014|450643946|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278076|NCT05396014|450643947|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278077|NCT05396014|450643948|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278078|NCT05396014|450643949|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278079|NCT05396014|450643950|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278080|NCT05396014|450643951|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278081|NCT05396014|450643952|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278082|NCT05396014|450643953|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278083|NCT05396014|450643954|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278084|NCT05396014|450643955|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278085|NCT05396014|450643956|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278086|NCT05396014|450643957|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
125278087|NCT05396014|450643958|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
125278088|NCT05396014|450643959|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
125278089|NCT05396014|450643960|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
125278090|NCT05396014|450643918|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278091|NCT05396014|450643919|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278092|NCT05396014|450643920|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278093|NCT05396014|450643921|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278094|NCT05396014|450643922|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278095|NCT05396014|450643923|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278096|NCT05396014|450643924|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278097|NCT05396014|450643925|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125404655|NCT04086472|451110600|FG000|Overall Study|Physician Decision|0|||
125404656|NCT04086472|451110601|FG001|Overall Study|Physician Decision|1|||
125404657|NCT04086472|451110602|FG002|Overall Study|Physician Decision|1|||
125404658|NCT04086472|451110603|FG003|Overall Study|Physician Decision|0|||
125448115|NCT02028884|451268855|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
125404659|NCT04086472|451110604|FG004|Overall Study|Physician Decision|0|||
125404660|NCT04086472|451110600|FG000|Overall Study|Withdrawal by Subject|1|||
125448116|NCT02028884|451268853|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
125448117|NCT02028884|451268854|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
125278098|NCT05396014|450643926|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
125278099|NCT05396014|450643927|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278100|NCT05396014|450643928|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278101|NCT05396014|450643929|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278102|NCT05396014|450643930|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278103|NCT05396014|450643931|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278104|NCT05396014|450643932|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278105|NCT05396014|450643933|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278106|NCT05396014|450643934|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278107|NCT05396014|450643935|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278108|NCT05396014|450643936|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278109|NCT05396014|450643937|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278110|NCT05396014|450643938|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278111|NCT05396014|450643939|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278112|NCT05396014|450643940|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
125278113|NCT05396014|450643941|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278114|NCT05396014|450643942|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278115|NCT05396014|450643943|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278116|NCT05396014|450643944|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278117|NCT05396014|450643945|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278118|NCT05396014|450643946|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278119|NCT05396014|450643947|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278120|NCT05396014|450643948|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278121|NCT05396014|450643949|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278122|NCT05396014|450643950|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278123|NCT05396014|450643951|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278124|NCT05396014|450643952|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278125|NCT05396014|450643953|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
125278126|NCT05396014|450643954|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278127|NCT05396014|450643955|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278128|NCT05396014|450643956|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278129|NCT05396014|450643957|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
125278130|NCT05396014|450643958|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278131|NCT05396014|450643959|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
125278132|NCT05396014|450643960|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
125278133|NCT05396014|450643918|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278134|NCT05396014|450643919|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278135|NCT05396014|450643920|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278136|NCT05396014|450643921|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278137|NCT05396014|450643922|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278138|NCT05396014|450643923|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278139|NCT05396014|450643924|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125404661|NCT04086472|451110601|FG001|Overall Study|Withdrawal by Subject|1|||
125404662|NCT04086472|451110602|FG002|Overall Study|Withdrawal by Subject|1|||
125404663|NCT04086472|451110603|FG003|Overall Study|Withdrawal by Subject|0|||
125404664|NCT04086472|451110604|FG004|Overall Study|Withdrawal by Subject|0|||
125404665|NCT04086472|451110600|FG000|Overall Study|Various reasons|2|||
125404666|NCT04086472|451110601|FG001|Overall Study|Various reasons|0|||
125404667|NCT04086472|451110602|FG002|Overall Study|Various reasons|0|||
125278140|NCT05396014|450643925|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278141|NCT05396014|450643926|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278142|NCT05396014|450643927|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278143|NCT05396014|450643928|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278144|NCT05396014|450643929|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278145|NCT05396014|450643930|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278146|NCT05396014|450643931|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
125278147|NCT05396014|450643932|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278148|NCT05396014|450643933|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278149|NCT05396014|450643934|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278150|NCT05396014|450643935|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125404668|NCT04086472|451110603|FG003|Overall Study|Various reasons|3|||
125278151|NCT05396014|450643936|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278152|NCT05396014|450643937|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278153|NCT05396014|450643938|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278154|NCT05396014|450643939|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278155|NCT05396014|450643940|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125404669|NCT04086472|451110604|FG004|Overall Study|Various reasons|1|||
125404670|NCT00048724|451110605|FG000|Overall Study|Adverse Event|53|||
125404671|NCT00048724|451110606|FG001|Overall Study|Adverse Event|12|||
125448118|NCT02028884|451268855|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
125448119|NCT02028884|451268853|FG000|Open-label Extension Period|Switched to another treatment option|3|||
125448120|NCT02028884|451268854|FG001|Open-label Extension Period|Switched to another treatment option|0|||
125448121|NCT02028884|451268855|FG002|Open-label Extension Period|Switched to another treatment option|0|||
125448122|NCT02373813|451268856|FG000|Run-In Period|Other, Not Specified|5|||
125448123|NCT02373813|451268857|FG001|Run-In Period|Other, Not Specified|0|||
125278156|NCT05396014|450643941|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278157|NCT05396014|450643942|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278158|NCT05396014|450643943|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278159|NCT05396014|450643944|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
125278160|NCT05396014|450643945|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278161|NCT05396014|450643946|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278162|NCT05396014|450643947|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278163|NCT05396014|450643948|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278164|NCT05396014|450643949|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278165|NCT05396014|450643950|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278166|NCT05396014|450643951|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278167|NCT05396014|450643952|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
125278168|NCT05396014|450643953|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278169|NCT05396014|450643954|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278170|NCT05396014|450643955|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278171|NCT05396014|450643956|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278172|NCT05396014|450643957|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278173|NCT05396014|450643958|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278174|NCT05396014|450643959|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
125278175|NCT05396014|450643960|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
125278176|NCT05396014|450643918|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278177|NCT05396014|450643919|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278178|NCT05396014|450643920|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278179|NCT05396014|450643921|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278180|NCT05396014|450643922|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278181|NCT05396014|450643923|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278182|NCT05396014|450643924|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278183|NCT05396014|450643925|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278184|NCT05396014|450643926|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278185|NCT05396014|450643927|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278186|NCT05396014|450643928|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278187|NCT05396014|450643929|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278188|NCT05396014|450643930|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278189|NCT05396014|450643931|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278190|NCT05396014|450643932|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278191|NCT05396014|450643933|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278192|NCT05396014|450643934|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278193|NCT05396014|450643935|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278194|NCT05396014|450643936|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278195|NCT05396014|450643937|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278196|NCT05396014|450643938|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278197|NCT05396014|450643939|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278198|NCT05396014|450643940|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278199|NCT05396014|450643941|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278200|NCT05396014|450643942|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278201|NCT05396014|450643943|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278202|NCT05396014|450643944|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
125278203|NCT05396014|450643945|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278204|NCT05396014|450643946|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278205|NCT05396014|450643947|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278206|NCT05396014|450643948|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278207|NCT05396014|450643949|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278208|NCT05396014|450643950|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278209|NCT05396014|450643951|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278210|NCT05396014|450643952|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278211|NCT05396014|450643953|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278212|NCT05396014|450643954|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278213|NCT05396014|450643955|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278214|NCT05396014|450643956|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278215|NCT05396014|450643957|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278216|NCT05396014|450643958|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278217|NCT05396014|450643959|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278218|NCT05396014|450643960|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
125278219|NCT00516893|450643969|FG000|Overall Study|Lost to Follow-up|4|||
125278220|NCT00516893|450643969|FG000|Overall Study|Adverse Event|3|||
125278221|NCT00516893|450643969|FG000|Overall Study|Withdrawal by Subject|2|||
125278222|NCT00516893|450643969|FG000|Overall Study|Noncompliance|2|||
125278223|NCT00516893|450643969|FG000|Overall Study|Death|1|||
125278224|NCT00516893|450643969|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
125278225|NCT00516893|450643969|FG000|Overall Study|Relocated|1|||
125278226|NCT00516893|450643969|FG000|Overall Study|Pregnancy|1|||
125278227|NCT00516893|450643969|FG000|Overall Study|Received Medication From Another Study|1|||
125278228|NCT05935878|450643972|FG000|Overall Study|Death|1|||
125278229|NCT05935878|450643973|FG001|Overall Study|Death|2|||
125278230|NCT05935878|450643972|FG000|Overall Study|Withdrawal by Subject|5|||
125278231|NCT05935878|450643973|FG001|Overall Study|Withdrawal by Subject|5|||
125278232|NCT05935878|450643972|FG000|Overall Study|Revision of implant|1|||
125278233|NCT05935878|450643973|FG001|Overall Study|Revision of implant|1|||
125278234|NCT05935878|450643972|FG000|Overall Study|Mobile bearing dislocation|0|||
125278235|NCT05935878|450643973|FG001|Overall Study|Mobile bearing dislocation|1|||
125278236|NCT01443364|450643980|FG000|Overall Study|Lack of Efficacy|14|||
125278237|NCT01443364|450643980|FG000|Overall Study|Lost to Follow-up|3|||
125278238|NCT01443364|450643980|FG000|Overall Study|Withdrawal by Subject|5|||
125278239|NCT01443364|450643980|FG000|Overall Study|Other Reason|4|||
125278240|NCT01443364|450643980|FG000|Overall Study|SAE, non-fatal|6|||
125278241|NCT01443364|450643980|FG000|Overall Study|AE, non-serious non-fatal|8|||
125278242|NCT01443364|450643980|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
125278243|NCT00559845|450643981|FG000|Overall Study|Withdrew Consent|1|||
125278244|NCT00559845|450643981|FG000|Overall Study|Disease Progression|1|||
125278245|NCT00559845|450643981|FG000|Overall Study|Adverse Event|3|||
125278246|NCT00559845|450643981|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
125278247|NCT00559845|450643981|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
125278248|NCT01406938|450643984|FG000|Induction Period|Subject/guardian decision|6|||
125278249|NCT01406938|450643985|FG001|Induction Period|Subject/guardian decision|8|||
125278250|NCT01406938|450643986|FG002|Induction Period|Subject/guardian decision|0|||
125278251|NCT01406938|450643987|FG003|Induction Period|Subject/guardian decision|0|||
125278252|NCT01406938|450643988|FG004|Induction Period|Subject/guardian decision|0|||
125278253|NCT01406938|450643989|FG005|Induction Period|Subject/guardian decision|0|||
125278254|NCT01406938|450643984|FG000|Induction Period|Protocol deviation|1|||
125278255|NCT01406938|450643985|FG001|Induction Period|Protocol deviation|0|||
125278256|NCT01406938|450643986|FG002|Induction Period|Protocol deviation|0|||
125278257|NCT01406938|450643987|FG003|Induction Period|Protocol deviation|0|||
125278258|NCT01406938|450643988|FG004|Induction Period|Protocol deviation|0|||
125278259|NCT01406938|450643989|FG005|Induction Period|Protocol deviation|0|||
125278260|NCT01406938|450643984|FG000|Induction Period|Adverse Event|8|||
125278261|NCT01406938|450643985|FG001|Induction Period|Adverse Event|9|||
125278262|NCT01406938|450643986|FG002|Induction Period|Adverse Event|0|||
125278263|NCT01406938|450643987|FG003|Induction Period|Adverse Event|0|||
125278264|NCT01406938|450643988|FG004|Induction Period|Adverse Event|0|||
125278265|NCT01406938|450643989|FG005|Induction Period|Adverse Event|0|||
125278266|NCT01406938|450643984|FG000|Induction Period|Lack of Efficacy|1|||
125278267|NCT01406938|450643985|FG001|Induction Period|Lack of Efficacy|0|||
125278268|NCT01406938|450643986|FG002|Induction Period|Lack of Efficacy|0|||
125278269|NCT01406938|450643987|FG003|Induction Period|Lack of Efficacy|0|||
125278270|NCT01406938|450643988|FG004|Induction Period|Lack of Efficacy|0|||
125278271|NCT01406938|450643989|FG005|Induction Period|Lack of Efficacy|0|||
125278272|NCT01406938|450643984|FG000|Induction Period|Lost to Follow-up|2|||
125278273|NCT01406938|450643985|FG001|Induction Period|Lost to Follow-up|3|||
125278274|NCT01406938|450643986|FG002|Induction Period|Lost to Follow-up|0|||
125278275|NCT01406938|450643987|FG003|Induction Period|Lost to Follow-up|0|||
125278276|NCT01406938|450643988|FG004|Induction Period|Lost to Follow-up|0|||
125278277|NCT01406938|450643989|FG005|Induction Period|Lost to Follow-up|0|||
125278278|NCT01406938|450643984|FG000|Maintenance Period|Adverse Event|0|||
125278279|NCT01406938|450643985|FG001|Maintenance Period|Adverse Event|0|||
125278280|NCT01406938|450643986|FG002|Maintenance Period|Adverse Event|2|||
125278281|NCT01406938|450643987|FG003|Maintenance Period|Adverse Event|8|||
125278282|NCT01406938|450643988|FG004|Maintenance Period|Adverse Event|4|||
125278283|NCT01406938|450643989|FG005|Maintenance Period|Adverse Event|2|||
125278284|NCT01406938|450643984|FG000|Maintenance Period|Death|0|||
125278285|NCT01406938|450643985|FG001|Maintenance Period|Death|0|||
125278286|NCT01406938|450643986|FG002|Maintenance Period|Death|0|||
125278287|NCT01406938|450643987|FG003|Maintenance Period|Death|0|||
125278288|NCT01406938|450643988|FG004|Maintenance Period|Death|1|||
125278289|NCT01406938|450643989|FG005|Maintenance Period|Death|0|||
125278290|NCT01406938|450643984|FG000|Maintenance Period|Subject/guardian decision|0|||
125278291|NCT01406938|450643985|FG001|Maintenance Period|Subject/guardian decision|0|||
125278292|NCT01406938|450643986|FG002|Maintenance Period|Subject/guardian decision|11|||
125278293|NCT01406938|450643987|FG003|Maintenance Period|Subject/guardian decision|7|||
125278294|NCT01406938|450643988|FG004|Maintenance Period|Subject/guardian decision|10|||
125278295|NCT01406938|450643989|FG005|Maintenance Period|Subject/guardian decision|7|||
125278296|NCT01406938|450643984|FG000|Maintenance Period|Protocol Violation|0|||
125278297|NCT01406938|450643985|FG001|Maintenance Period|Protocol Violation|0|||
125278298|NCT01406938|450643986|FG002|Maintenance Period|Protocol Violation|2|||
125278299|NCT01406938|450643987|FG003|Maintenance Period|Protocol Violation|2|||
125278300|NCT01406938|450643988|FG004|Maintenance Period|Protocol Violation|2|||
125404672|NCT00048724|451110605|FG000|Overall Study|Withdrawal by Subject|34|||
125404673|NCT00048724|451110606|FG001|Overall Study|Withdrawal by Subject|54|||
125404674|NCT00048724|451110605|FG000|Overall Study|Lost to Follow-up|5|||
125404675|NCT00048724|451110606|FG001|Overall Study|Lost to Follow-up|5|||
125404676|NCT00048724|451110605|FG000|Overall Study|Protocol-defined Clinical Event|17|||
125404677|NCT00048724|451110606|FG001|Overall Study|Protocol-defined Clinical Event|32|||
125404678|NCT00048724|451110605|FG000|Overall Study|Noncompliance With Protocol|4|||
125404679|NCT00048724|451110606|FG001|Overall Study|Noncompliance With Protocol|12|||
125404680|NCT00048724|451110605|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
125404681|NCT00048724|451110606|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
125404682|NCT00048724|451110605|FG000|Overall Study|Administrative|1|||
125404683|NCT00048724|451110606|FG001|Overall Study|Administrative|1|||
125404684|NCT00844545|451110607|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
125404685|NCT00844545|451110607|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
125404686|NCT00844545|451110607|FG000|Extension Treatment Period|Adverse Event|2|||
125404687|NCT00844545|451110607|FG000|Post Treatment Period|Withdrawal by Subject|1|||
125404688|NCT01600040|451110615|FG000|Overall Study|Withdrawal by Subject|1|||
125404689|NCT04713748|451110616|FG000|Overall Study|Not enough kits allocated|35|||
125404690|NCT00113516|451110617|FG000|Part 1|Adverse Event|6|||
125404691|NCT00113516|451110618|FG001|Part 1|Adverse Event|0|||
125404692|NCT00113516|451110617|FG000|Part 1|Death|3|||
125404693|NCT00113516|451110618|FG001|Part 1|Death|0|||
125404694|NCT00113516|451110617|FG000|Part 1|Other|3|||
125404695|NCT00113516|451110618|FG001|Part 1|Other|0|||
125404696|NCT00113516|451110617|FG000|Part 1|Withdrawal by Subject|2|||
125404697|NCT00113516|451110618|FG001|Part 1|Withdrawal by Subject|0|||
125404698|NCT00113516|451110617|FG000|Part 1|Lack of Efficacy|2|||
125404699|NCT00113516|451110618|FG001|Part 1|Lack of Efficacy|0|||
125404700|NCT00113516|451110617|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
125404701|NCT00113516|451110618|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
125404702|NCT00113516|451110617|FG000|Part 1|Laboratory Abnormality|1|||
125404703|NCT00113516|451110618|FG001|Part 1|Laboratory Abnormality|0|||
125404704|NCT00113516|451110617|FG000|Part 1|Ongoing|1|||
125404705|NCT00113516|451110618|FG001|Part 1|Ongoing|0|||
125404706|NCT00113516|451110617|FG000|Part 1|Missing|65|||
125404707|NCT00113516|451110618|FG001|Part 1|Missing|0|||
125404708|NCT00113516|451110617|FG000|Part 2|Adverse Event|0|||
125404709|NCT00113516|451110618|FG001|Part 2|Adverse Event|16|||
125404710|NCT00113516|451110617|FG000|Part 2|Death|0|||
125404711|NCT00113516|451110618|FG001|Part 2|Death|5|||
125404712|NCT00113516|451110617|FG000|Part 2|Lack of Efficacy|0|||
125404713|NCT00113516|451110618|FG001|Part 2|Lack of Efficacy|37|||
125404714|NCT00113516|451110617|FG000|Part 2|Withdrawal by Subject|0|||
125404715|NCT00113516|451110618|FG001|Part 2|Withdrawal by Subject|3|||
125404716|NCT00113516|451110617|FG000|Part 2|Other|0|||
125404717|NCT00113516|451110618|FG001|Part 2|Other|3|||
125404718|NCT00113516|451110617|FG000|Part 2|Laboratory Abnormality|0|||
125404719|NCT00113516|451110618|FG001|Part 2|Laboratory Abnormality|1|||
125404720|NCT00113516|451110617|FG000|Part 2|Ongoing|0|||
125404721|NCT00113516|451110618|FG001|Part 2|Ongoing|1|||
125404722|NCT00642304|451110619|FG000|Overall Study|Adverse Event|1|||
125404723|NCT00642304|451110619|FG000|Overall Study|Death|1|||
125404724|NCT00642304|451110619|FG000|Overall Study|Blood transfusion|2|||
125404725|NCT00642304|451110619|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
125404726|NCT00642304|451110619|FG000|Overall Study|Transplantation|1|||
125404727|NCT00812812|451110629|FG000|Overall Study|Adverse Event|2|||
125404728|NCT00812812|451110630|FG001|Overall Study|Adverse Event|1|||
125404729|NCT00812812|451110629|FG000|Overall Study|Lack of Efficacy|1|||
125404730|NCT00812812|451110630|FG001|Overall Study|Lack of Efficacy|0|||
125404731|NCT00812812|451110629|FG000|Overall Study|Lost to Follow-up|0|||
125404732|NCT00812812|451110630|FG001|Overall Study|Lost to Follow-up|1|||
125404733|NCT00812812|451110629|FG000|Overall Study|Withdrawal by Subject|0|||
125278301|NCT01406938|450643989|FG005|Maintenance Period|Protocol Violation|2|||
125278302|NCT01406938|450643984|FG000|Maintenance Period|Pregnancy|0|||
125404734|NCT00812812|451110630|FG001|Overall Study|Withdrawal by Subject|2|||
125404735|NCT03755765|451110631|FG000|Overall Study|Withdrawal by Subject|2|||
125404736|NCT03755765|451110632|FG001|Overall Study|Withdrawal by Subject|4|||
125404737|NCT03755765|451110633|FG002|Overall Study|Withdrawal by Subject|4|||
125404738|NCT00678691|451110639|FG000|Overall Study|Adverse Event|6|||
125404739|NCT00678691|451110640|FG001|Overall Study|Adverse Event|4|||
125404740|NCT02863354|451110647|FG000|Year 1|Lost to Follow-up|1|||
125404741|NCT02863354|451110648|FG001|Year 1|Lost to Follow-up|1|||
125404742|NCT02863354|451110647|FG000|Year 1|Withdrawal by Subject|3|||
125404743|NCT02863354|451110648|FG001|Year 1|Withdrawal by Subject|0|||
125404744|NCT02863354|451110647|FG000|Year 1|Death|0|||
125404745|NCT02863354|451110648|FG001|Year 1|Death|1|||
125404746|NCT02863354|451110647|FG000|Year 2|Lost to Follow-up|2|||
125404747|NCT02863354|451110648|FG001|Year 2|Lost to Follow-up|2|||
125404748|NCT03235024|451110649|FG000|Overall Study|Adverse Event|2|||
125404749|NCT03235024|451110650|FG001|Overall Study|Adverse Event|2|||
125404750|NCT03235024|451110649|FG000|Overall Study|Death|1|||
125404751|NCT03235024|451110650|FG001|Overall Study|Death|0|||
125404752|NCT03235024|451110649|FG000|Overall Study|Lost to Follow-up|2|||
125404753|NCT03235024|451110650|FG001|Overall Study|Lost to Follow-up|5|||
125404754|NCT03235024|451110649|FG000|Overall Study|Protocol Violation|1|||
125404755|NCT03235024|451110650|FG001|Overall Study|Protocol Violation|0|||
125404756|NCT03235024|451110649|FG000|Overall Study|Withdrawal by Subject|0|||
125404757|NCT03235024|451110650|FG001|Overall Study|Withdrawal by Subject|3|||
125404758|NCT01632800|451110651|FG000|Overall Study|Subject did not fit in apparatus|1|||
125404759|NCT01599650|451110653|FG000|Overall Study|Administrative issue|1|||
125404760|NCT01599650|451110654|FG001|Overall Study|Administrative issue|0|||
125404761|NCT01599650|451110655|FG002|Overall Study|Administrative issue|1|||
125404762|NCT01599650|451110653|FG000|Overall Study|Physician Decision|2|||
125404763|NCT01599650|451110654|FG001|Overall Study|Physician Decision|0|||
125404764|NCT01599650|451110655|FG002|Overall Study|Physician Decision|7|||
125404765|NCT01599650|451110653|FG000|Overall Study|Protocol Violation|0|||
125404766|NCT01599650|451110654|FG001|Overall Study|Protocol Violation|3|||
125404767|NCT01599650|451110655|FG002|Overall Study|Protocol Violation|0|||
125404768|NCT01599650|451110653|FG000|Overall Study|Death|2|||
125404769|NCT01599650|451110654|FG001|Overall Study|Death|1|||
125404770|NCT01599650|451110655|FG002|Overall Study|Death|2|||
125404771|NCT01599650|451110653|FG000|Overall Study|Lost to Follow-up|3|||
125404772|NCT01599650|451110654|FG001|Overall Study|Lost to Follow-up|3|||
125404773|NCT01599650|451110655|FG002|Overall Study|Lost to Follow-up|3|||
125404774|NCT01599650|451110653|FG000|Overall Study|Withdrawal by Subject|11|||
125404775|NCT01599650|451110654|FG001|Overall Study|Withdrawal by Subject|11|||
125404776|NCT01599650|451110655|FG002|Overall Study|Withdrawal by Subject|10|||
125404777|NCT01599650|451110653|FG000|Overall Study|Adverse Event|3|||
125404778|NCT01599650|451110654|FG001|Overall Study|Adverse Event|8|||
125404779|NCT01599650|451110655|FG002|Overall Study|Adverse Event|4|||
125404780|NCT01748994|451110656|FG000|Overall Study|Lost to Follow-up|8|||
125404781|NCT01748994|451110657|FG001|Overall Study|Lost to Follow-up|6|||
125404782|NCT02520531|451110665|FG000|Overall Study|Revision of study device components|2|||
125404783|NCT02520531|451110666|FG001|Overall Study|Revision of study device components|2|||
125404784|NCT02520531|451110665|FG000|Overall Study|Death|1|||
125404785|NCT02520531|451110666|FG001|Overall Study|Death|2|||
125404786|NCT02520531|451110665|FG000|Overall Study|Lost to Follow-up|1|||
125404787|NCT02520531|451110666|FG001|Overall Study|Lost to Follow-up|1|||
125404788|NCT02520531|451110665|FG000|Overall Study|Meet exclusion criterion|0|||
125404789|NCT02520531|451110666|FG001|Overall Study|Meet exclusion criterion|1|||
125404790|NCT02520531|451110665|FG000|Overall Study|Withdrawal by Subject|1|||
125404791|NCT02520531|451110666|FG001|Overall Study|Withdrawal by Subject|0|||
125404792|NCT02520531|451110665|FG000|Overall Study|Not study device|1|||
125404793|NCT02520531|451110666|FG001|Overall Study|Not study device|0|||
125404794|NCT01723904|451110669|FG000|Overall Study|Noncompliant|3|||
125404795|NCT01723904|451110669|FG000|Overall Study|Adverse Event|5|||
125404796|NCT01723904|451110669|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
125404797|NCT00799617|451110674|FG000|Main Testosterone Trial|Randomized in error|1|||
125404798|NCT00799617|451110675|FG001|Main Testosterone Trial|Randomized in error|1|||
125404799|NCT00799617|451110674|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
125404800|NCT00799617|451110675|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
125404801|NCT00799617|451110674|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
125404802|NCT00799617|451110675|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
125404803|NCT00799617|451110674|FG000|Sexual Funtion Trial|No Baseline Data|4|||
125404804|NCT00799617|451110675|FG001|Sexual Funtion Trial|No Baseline Data|7|||
125404805|NCT00799617|451110674|FG000|Physical Function Trial|Lost to Follow-up|6|||
125278303|NCT01406938|450643985|FG001|Maintenance Period|Pregnancy|0|||
125404806|NCT00799617|451110675|FG001|Physical Function Trial|Lost to Follow-up|11|||
125404807|NCT00799617|451110674|FG000|Vitality Trial|Lost to Follow-up|7|||
125404808|NCT00799617|451110675|FG001|Vitality Trial|Lost to Follow-up|22|||
125404809|NCT00799617|451110674|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
125404810|NCT00799617|451110675|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
125404811|NCT00799617|451110674|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
125404812|NCT00799617|451110675|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
125404813|NCT00799617|451110674|FG000|Bone Trial|Month 12 scan not available|6|||
125404814|NCT00799617|451110675|FG001|Bone Trial|Month 12 scan not available|16|||
125404815|NCT00799617|451110674|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
125404816|NCT00799617|451110675|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
125404817|NCT00799617|451110674|FG000|Anemia Trial|Withdrawal by Subject|3|||
125404818|NCT00799617|451110675|FG001|Anemia Trial|Withdrawal by Subject|3|||
125404819|NCT04545515|451110676|FG000|Overall Study|Adverse Event|1|||
125404820|NCT04545515|451110676|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
125404821|NCT04545515|451110676|FG000|Overall Study|Commercial drug is available for participant|7|||
125404822|NCT00958880|451110677|FG000|Overall Study|Lost to Follow-up|2|||
125404823|NCT00958880|451110678|FG001|Overall Study|Lost to Follow-up|2|||
125404824|NCT01848990|451110679|FG000|Overall Study|Adverse Event|6|||
125404825|NCT01848990|451110680|FG001|Overall Study|Adverse Event|2|||
125404826|NCT01848990|451110681|FG002|Overall Study|Adverse Event|0|||
125404827|NCT01848990|451110679|FG000|Overall Study|Lost to Follow-up|6|||
125404828|NCT01848990|451110680|FG001|Overall Study|Lost to Follow-up|2|||
125404829|NCT01848990|451110681|FG002|Overall Study|Lost to Follow-up|2|||
125404830|NCT01848990|451110679|FG000|Overall Study|Protocol Violation|1|||
125404831|NCT01848990|451110680|FG001|Overall Study|Protocol Violation|1|||
125404832|NCT01848990|451110681|FG002|Overall Study|Protocol Violation|0|||
125404833|NCT01848990|451110679|FG000|Overall Study|Withdrawal by Subject|29|||
125404834|NCT01848990|451110680|FG001|Overall Study|Withdrawal by Subject|10|||
125404835|NCT01848990|451110681|FG002|Overall Study|Withdrawal by Subject|11|||
125404836|NCT01848990|451110679|FG000|Overall Study|Physician Decision|1|||
125404837|NCT01848990|451110680|FG001|Overall Study|Physician Decision|1|||
125404838|NCT01848990|451110681|FG002|Overall Study|Physician Decision|0|||
125404839|NCT01848990|451110679|FG000|Overall Study|Non Compliance|1|||
125404840|NCT01848990|451110680|FG001|Overall Study|Non Compliance|0|||
125404841|NCT01848990|451110681|FG002|Overall Study|Non Compliance|0|||
125404842|NCT01848990|451110679|FG000|Overall Study|Death|1|||
125404843|NCT01848990|451110680|FG001|Overall Study|Death|0|||
125404844|NCT01848990|451110681|FG002|Overall Study|Death|1|||
125404845|NCT01848990|451110679|FG000|Overall Study|Other|1|||
125404846|NCT01848990|451110680|FG001|Overall Study|Other|4|||
125404847|NCT01848990|451110681|FG002|Overall Study|Other|2|||
125404848|NCT01712984|451110682|FG000|Overall Study|Adverse Event|0|||
125404849|NCT01712984|451110683|FG001|Overall Study|Adverse Event|0|||
125404850|NCT01712984|451110684|FG002|Overall Study|Adverse Event|1|||
125404851|NCT01712984|451110682|FG000|Overall Study|Protocol Violation|2|||
125404852|NCT01712984|451110683|FG001|Overall Study|Protocol Violation|0|||
125404853|NCT01712984|451110684|FG002|Overall Study|Protocol Violation|1|||
125448124|NCT02373813|451268858|FG002|Run-In Period|Other, Not Specified|0|||
125448125|NCT02373813|451268859|FG003|Run-In Period|Other, Not Specified|0|||
125448126|NCT02373813|451268856|FG000|Run-In Period|Withdrawal by Subject|16|||
125448127|NCT02373813|451268857|FG001|Run-In Period|Withdrawal by Subject|0|||
125448128|NCT02373813|451268858|FG002|Run-In Period|Withdrawal by Subject|0|||
125448129|NCT02373813|451268859|FG003|Run-In Period|Withdrawal by Subject|0|||
125448130|NCT02373813|451268856|FG000|Run-In Period|Decision by Sponsor|11|||
125448131|NCT02373813|451268857|FG001|Run-In Period|Decision by Sponsor|0|||
125448132|NCT02373813|451268858|FG002|Run-In Period|Decision by Sponsor|0|||
125448133|NCT02373813|451268859|FG003|Run-In Period|Decision by Sponsor|0|||
125448134|NCT02373813|451268856|FG000|Run-In Period|Protocol Violation|75|||
125448135|NCT02373813|451268857|FG001|Run-In Period|Protocol Violation|0|||
125448136|NCT02373813|451268858|FG002|Run-In Period|Protocol Violation|0|||
125448137|NCT02373813|451268859|FG003|Run-In Period|Protocol Violation|0|||
125448138|NCT02373813|451268856|FG000|Run-In Period|Lost to Follow-up|2|||
125448139|NCT02373813|451268857|FG001|Run-In Period|Lost to Follow-up|0|||
125448140|NCT02373813|451268858|FG002|Run-In Period|Lost to Follow-up|0|||
125448141|NCT02373813|451268859|FG003|Run-In Period|Lost to Follow-up|0|||
125448142|NCT02373813|451268856|FG000|Run-In Period|Adverse Event|3|||
125448143|NCT02373813|451268857|FG001|Run-In Period|Adverse Event|0|||
125448144|NCT02373813|451268858|FG002|Run-In Period|Adverse Event|0|||
125448145|NCT02373813|451268859|FG003|Run-In Period|Adverse Event|0|||
125448146|NCT02373813|451268856|FG000|Run-In Period|Noncompliance|1|||
125448147|NCT02373813|451268857|FG001|Run-In Period|Noncompliance|0|||
125448148|NCT02373813|451268858|FG002|Run-In Period|Noncompliance|0|||
125448149|NCT02373813|451268859|FG003|Run-In Period|Noncompliance|0|||
125448150|NCT02373813|451268856|FG000|Run-In Period|Ineligibility Determined|3|||
125448151|NCT02373813|451268857|FG001|Run-In Period|Ineligibility Determined|0|||
125448152|NCT02373813|451268858|FG002|Run-In Period|Ineligibility Determined|0|||
125448153|NCT02373813|451268859|FG003|Run-In Period|Ineligibility Determined|0|||
125448154|NCT02373813|451268856|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
125404854|NCT01712984|451110682|FG000|Overall Study|Lost to Follow-up|8|||
125404855|NCT01712984|451110683|FG001|Overall Study|Lost to Follow-up|10|||
125404856|NCT01712984|451110684|FG002|Overall Study|Lost to Follow-up|1|||
125404857|NCT01712984|451110682|FG000|Overall Study|Withdrawal by Subject|6|||
125448155|NCT02373813|451268857|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
125448156|NCT02373813|451268858|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
125448157|NCT02373813|451268859|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
125448158|NCT02373813|451268856|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
125448159|NCT02373813|451268857|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
125404858|NCT01712984|451110683|FG001|Overall Study|Withdrawal by Subject|6|||
125404859|NCT01712984|451110684|FG002|Overall Study|Withdrawal by Subject|7|||
125404860|NCT02755831|451110687|FG000|Overall Study|Lost to Follow-up|3|||
125404861|NCT02755831|451110688|FG001|Overall Study|Lost to Follow-up|3|||
125404862|NCT01720069|451110689|FG000|Overall Study|Could not use e-diary correctly|0|||
125404863|NCT01720069|451110690|FG001|Overall Study|Could not use e-diary correctly|1|||
125404864|NCT01720069|451110691|FG002|Overall Study|Could not use e-diary correctly|1|||
125404865|NCT01720069|451110689|FG000|Overall Study|Randomised without baseline values|0|||
125404866|NCT01720069|451110690|FG001|Overall Study|Randomised without baseline values|0|||
125404867|NCT01720069|451110691|FG002|Overall Study|Randomised without baseline values|1|||
125404868|NCT01720069|451110689|FG000|Overall Study|Adverse Event|0|||
125404869|NCT01720069|451110690|FG001|Overall Study|Adverse Event|0|||
125404870|NCT01720069|451110691|FG002|Overall Study|Adverse Event|1|||
125404871|NCT01720069|451110689|FG000|Overall Study|Lack of Efficacy|0|||
125404872|NCT01720069|451110690|FG001|Overall Study|Lack of Efficacy|4|||
125404873|NCT01720069|451110691|FG002|Overall Study|Lack of Efficacy|0|||
125404874|NCT01720069|451110689|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
125404875|NCT01720069|451110690|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
125404876|NCT01720069|451110691|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
125404877|NCT01720069|451110689|FG000|Overall Study|Withdrawal by Subject|0|||
125404878|NCT01720069|451110690|FG001|Overall Study|Withdrawal by Subject|2|||
125404879|NCT01720069|451110691|FG002|Overall Study|Withdrawal by Subject|1|||
125404880|NCT01720069|451110689|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
125404881|NCT01720069|451110690|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
125404882|NCT01720069|451110691|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
125404883|NCT01720069|451110689|FG000|Overall Study|Non-compliance on using e-diary|0|||
125404884|NCT01720069|451110690|FG001|Overall Study|Non-compliance on using e-diary|0|||
125404885|NCT01720069|451110691|FG002|Overall Study|Non-compliance on using e-diary|1|||
125404886|NCT01720069|451110689|FG000|Overall Study|Lost to Follow-up|0|||
125404887|NCT01720069|451110690|FG001|Overall Study|Lost to Follow-up|0|||
125404888|NCT01720069|451110691|FG002|Overall Study|Lost to Follow-up|1|||
125404889|NCT00508742|451110692|FG000|Period 1: Infant Series|Adverse Event|5|||
125404890|NCT00508742|451110693|FG001|Period 1: Infant Series|Adverse Event|4|||
125404891|NCT00508742|451110692|FG000|Period 1: Infant Series|Protocol Violation|1|||
125404892|NCT00508742|451110693|FG001|Period 1: Infant Series|Protocol Violation|0|||
125404893|NCT00508742|451110692|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
125404894|NCT00508742|451110693|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
125404895|NCT00508742|451110692|FG000|Period 1: Infant Series|Physician Decision|1|||
125404896|NCT00508742|451110693|FG001|Period 1: Infant Series|Physician Decision|0|||
125404897|NCT00508742|451110692|FG000|Period 1: Infant Series|Other|4|||
125404898|NCT00508742|451110693|FG001|Period 1: Infant Series|Other|1|||
125404899|NCT00508742|451110692|FG000|Period 2: After Infant Series|Adverse Event|2|||
125404900|NCT00508742|451110693|FG001|Period 2: After Infant Series|Adverse Event|6|||
125404901|NCT00508742|451110692|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
125404902|NCT00508742|451110693|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
125404903|NCT00508742|451110692|FG000|Period 2: After Infant Series|Protocol Violation|1|||
125404904|NCT00508742|451110693|FG001|Period 2: After Infant Series|Protocol Violation|0|||
125404905|NCT00508742|451110692|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
125404906|NCT00508742|451110693|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
125404907|NCT00508742|451110692|FG000|Period 2: After Infant Series|Failed to Return|1|||
125404908|NCT00508742|451110693|FG001|Period 2: After Infant Series|Failed to Return|0|||
125404909|NCT00508742|451110692|FG000|Period 2: After Infant Series|Other|2|||
125404910|NCT00508742|451110693|FG001|Period 2: After Infant Series|Other|1|||
125278304|NCT01406938|450643986|FG002|Maintenance Period|Pregnancy|0|||
125278305|NCT01406938|450643987|FG003|Maintenance Period|Pregnancy|0|||
125278306|NCT01406938|450643988|FG004|Maintenance Period|Pregnancy|1|||
125278307|NCT01406938|450643989|FG005|Maintenance Period|Pregnancy|0|||
125278308|NCT01406938|450643984|FG000|Maintenance Period|Lost to Follow-up|0|||
125278309|NCT01406938|450643985|FG001|Maintenance Period|Lost to Follow-up|0|||
125278310|NCT01406938|450643986|FG002|Maintenance Period|Lost to Follow-up|0|||
125278311|NCT01406938|450643987|FG003|Maintenance Period|Lost to Follow-up|0|||
125278312|NCT01406938|450643988|FG004|Maintenance Period|Lost to Follow-up|4|||
125278313|NCT01406938|450643989|FG005|Maintenance Period|Lost to Follow-up|0|||
125278314|NCT01406938|450643984|FG000|Maintenance Period|Lack of Efficacy|0|||
125278315|NCT01406938|450643985|FG001|Maintenance Period|Lack of Efficacy|0|||
125278316|NCT01406938|450643986|FG002|Maintenance Period|Lack of Efficacy|2|||
125278317|NCT01406938|450643987|FG003|Maintenance Period|Lack of Efficacy|1|||
125278318|NCT01406938|450643988|FG004|Maintenance Period|Lack of Efficacy|3|||
125278319|NCT01406938|450643989|FG005|Maintenance Period|Lack of Efficacy|5|||
125278320|NCT01406938|450643984|FG000|Follow up|Lack of Efficacy|3|||
125278321|NCT01406938|450643985|FG001|Follow up|Lack of Efficacy|2|||
125278322|NCT01406938|450643986|FG002|Follow up|Lack of Efficacy|1|||
125404911|NCT00508742|451110692|FG000|Period 3: Toddler Dose|Adverse Event|1|||
125404912|NCT00508742|451110693|FG001|Period 3: Toddler Dose|Adverse Event|0|||
125404913|NCT00508742|451110692|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
125404914|NCT00508742|451110693|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
125278323|NCT01406938|450643987|FG003|Follow up|Lack of Efficacy|0|||
125278324|NCT01406938|450643988|FG004|Follow up|Lack of Efficacy|0|||
125278325|NCT01406938|450643989|FG005|Follow up|Lack of Efficacy|0|||
125278326|NCT01406938|450643984|FG000|Follow up|Patient/guardian decision|4|||
125404915|NCT00508742|451110692|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
125404916|NCT00508742|451110693|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
125404917|NCT00508742|451110692|FG000|Period 3: Toddler Dose|Other|5|||
125404918|NCT00508742|451110693|FG001|Period 3: Toddler Dose|Other|4|||
125404919|NCT02460224|451110698|FG000|Overall Study|Adverse Event|0|||
125404920|NCT02460224|451110699|FG001|Overall Study|Adverse Event|0|||
125404921|NCT02460224|451110700|FG002|Overall Study|Adverse Event|0|||
125404922|NCT02460224|451110701|FG003|Overall Study|Adverse Event|0|||
125404923|NCT02460224|451110702|FG004|Overall Study|Adverse Event|0|||
125404924|NCT02460224|451110703|FG005|Overall Study|Adverse Event|0|||
125404925|NCT02460224|451110704|FG006|Overall Study|Adverse Event|1|||
125404926|NCT02460224|451110705|FG007|Overall Study|Adverse Event|0|||
125404927|NCT02460224|451110706|FG008|Overall Study|Adverse Event|0|||
125404928|NCT02460224|451110707|FG009|Overall Study|Adverse Event|0|||
125404929|NCT02460224|451110708|FG010|Overall Study|Adverse Event|0|||
125404930|NCT02460224|451110709|FG011|Overall Study|Adverse Event|0|||
125404931|NCT02460224|451110710|FG012|Overall Study|Adverse Event|1|||
125404932|NCT02460224|451110711|FG013|Overall Study|Adverse Event|0|||
125404933|NCT02460224|451110712|FG014|Overall Study|Adverse Event|0|||
125404934|NCT02460224|451110713|FG015|Overall Study|Adverse Event|0|||
125404935|NCT02460224|451110714|FG016|Overall Study|Adverse Event|1|||
125404936|NCT02460224|451110715|FG017|Overall Study|Adverse Event|0|||
125404937|NCT02460224|451110716|FG018|Overall Study|Adverse Event|1|||
125404938|NCT02460224|451110717|FG019|Overall Study|Adverse Event|0|||
125404939|NCT02460224|451110718|FG020|Overall Study|Adverse Event|1|||
125404940|NCT02460224|451110719|FG021|Overall Study|Adverse Event|1|||
125404941|NCT02460224|451110720|FG022|Overall Study|Adverse Event|1|||
125404942|NCT02460224|451110721|FG023|Overall Study|Adverse Event|0|||
125404943|NCT02460224|451110722|FG024|Overall Study|Adverse Event|0|||
125404944|NCT02460224|451110723|FG025|Overall Study|Adverse Event|0|||
125404945|NCT02460224|451110724|FG026|Overall Study|Adverse Event|11|||
125404946|NCT02460224|451110725|FG027|Overall Study|Adverse Event|1|||
125404947|NCT02460224|451110726|FG028|Overall Study|Adverse Event|6|||
125404948|NCT02460224|451110698|FG000|Overall Study|Death|0|||
125404949|NCT02460224|451110699|FG001|Overall Study|Death|0|||
125404950|NCT02460224|451110700|FG002|Overall Study|Death|0|||
125404951|NCT02460224|451110701|FG003|Overall Study|Death|0|||
125404952|NCT02460224|451110702|FG004|Overall Study|Death|0|||
125404953|NCT02460224|451110703|FG005|Overall Study|Death|2|||
125404954|NCT02460224|451110704|FG006|Overall Study|Death|1|||
125404955|NCT02460224|451110705|FG007|Overall Study|Death|0|||
125404956|NCT02460224|451110706|FG008|Overall Study|Death|0|||
125404957|NCT02460224|451110707|FG009|Overall Study|Death|1|||
125404958|NCT02460224|451110708|FG010|Overall Study|Death|0|||
125404959|NCT02460224|451110709|FG011|Overall Study|Death|0|||
125404960|NCT02460224|451110710|FG012|Overall Study|Death|0|||
125404961|NCT02460224|451110711|FG013|Overall Study|Death|1|||
125404962|NCT02460224|451110712|FG014|Overall Study|Death|0|||
125404963|NCT02460224|451110713|FG015|Overall Study|Death|0|||
125404964|NCT02460224|451110714|FG016|Overall Study|Death|2|||
125404965|NCT02460224|451110715|FG017|Overall Study|Death|1|||
125404966|NCT02460224|451110716|FG018|Overall Study|Death|0|||
125404967|NCT02460224|451110717|FG019|Overall Study|Death|2|||
125404968|NCT02460224|451110718|FG020|Overall Study|Death|0|||
125404969|NCT02460224|451110719|FG021|Overall Study|Death|0|||
125404970|NCT02460224|451110720|FG022|Overall Study|Death|0|||
125404971|NCT02460224|451110721|FG023|Overall Study|Death|0|||
125404972|NCT02460224|451110722|FG024|Overall Study|Death|1|||
125404973|NCT02460224|451110723|FG025|Overall Study|Death|1|||
125404974|NCT02460224|451110724|FG026|Overall Study|Death|5|||
125404975|NCT02460224|451110725|FG027|Overall Study|Death|0|||
125404976|NCT02460224|451110726|FG028|Overall Study|Death|1|||
125404977|NCT02460224|451110698|FG000|Overall Study|Lost to Follow-up|0|||
125404978|NCT02460224|451110699|FG001|Overall Study|Lost to Follow-up|0|||
125404979|NCT02460224|451110700|FG002|Overall Study|Lost to Follow-up|0|||
125404980|NCT02460224|451110701|FG003|Overall Study|Lost to Follow-up|0|||
125404981|NCT02460224|451110702|FG004|Overall Study|Lost to Follow-up|0|||
125404982|NCT02460224|451110703|FG005|Overall Study|Lost to Follow-up|0|||
125404983|NCT02460224|451110704|FG006|Overall Study|Lost to Follow-up|0|||
125404984|NCT02460224|451110705|FG007|Overall Study|Lost to Follow-up|0|||
125404985|NCT02460224|451110706|FG008|Overall Study|Lost to Follow-up|0|||
125404986|NCT02460224|451110707|FG009|Overall Study|Lost to Follow-up|0|||
125404987|NCT02460224|451110708|FG010|Overall Study|Lost to Follow-up|0|||
125404988|NCT02460224|451110709|FG011|Overall Study|Lost to Follow-up|0|||
125404989|NCT02460224|451110710|FG012|Overall Study|Lost to Follow-up|0|||
125404990|NCT02460224|451110711|FG013|Overall Study|Lost to Follow-up|0|||
125404991|NCT02460224|451110712|FG014|Overall Study|Lost to Follow-up|0|||
125404992|NCT02460224|451110713|FG015|Overall Study|Lost to Follow-up|0|||
125404993|NCT02460224|451110714|FG016|Overall Study|Lost to Follow-up|0|||
125404994|NCT02460224|451110715|FG017|Overall Study|Lost to Follow-up|0|||
125404995|NCT02460224|451110716|FG018|Overall Study|Lost to Follow-up|0|||
125404996|NCT02460224|451110717|FG019|Overall Study|Lost to Follow-up|0|||
125404997|NCT02460224|451110718|FG020|Overall Study|Lost to Follow-up|0|||
125404998|NCT02460224|451110719|FG021|Overall Study|Lost to Follow-up|0|||
125404999|NCT02460224|451110720|FG022|Overall Study|Lost to Follow-up|1|||
125405000|NCT02460224|451110721|FG023|Overall Study|Lost to Follow-up|0|||
125405001|NCT02460224|451110722|FG024|Overall Study|Lost to Follow-up|0|||
125405002|NCT02460224|451110723|FG025|Overall Study|Lost to Follow-up|0|||
125405003|NCT02460224|451110724|FG026|Overall Study|Lost to Follow-up|0|||
125405004|NCT02460224|451110725|FG027|Overall Study|Lost to Follow-up|0|||
125405005|NCT02460224|451110726|FG028|Overall Study|Lost to Follow-up|0|||
125405006|NCT02460224|451110698|FG000|Overall Study|Physician Decision|0|||
125405007|NCT02460224|451110699|FG001|Overall Study|Physician Decision|1|||
125405008|NCT02460224|451110700|FG002|Overall Study|Physician Decision|0|||
125405009|NCT02460224|451110701|FG003|Overall Study|Physician Decision|0|||
125405010|NCT02460224|451110702|FG004|Overall Study|Physician Decision|1|||
125405011|NCT02460224|451110703|FG005|Overall Study|Physician Decision|0|||
125405012|NCT02460224|451110704|FG006|Overall Study|Physician Decision|0|||
125405013|NCT02460224|451110705|FG007|Overall Study|Physician Decision|1|||
125405014|NCT02460224|451110706|FG008|Overall Study|Physician Decision|0|||
125405015|NCT02460224|451110707|FG009|Overall Study|Physician Decision|0|||
125405016|NCT02460224|451110708|FG010|Overall Study|Physician Decision|0|||
125405017|NCT02460224|451110709|FG011|Overall Study|Physician Decision|1|||
125405018|NCT02460224|451110710|FG012|Overall Study|Physician Decision|0|||
125405019|NCT02460224|451110711|FG013|Overall Study|Physician Decision|1|||
125405020|NCT02460224|451110712|FG014|Overall Study|Physician Decision|0|||
125405021|NCT02460224|451110713|FG015|Overall Study|Physician Decision|0|||
125405022|NCT02460224|451110714|FG016|Overall Study|Physician Decision|2|||
125405023|NCT02460224|451110715|FG017|Overall Study|Physician Decision|1|||
125405024|NCT02460224|451110716|FG018|Overall Study|Physician Decision|1|||
125405025|NCT02460224|451110717|FG019|Overall Study|Physician Decision|2|||
125405026|NCT02460224|451110718|FG020|Overall Study|Physician Decision|1|||
125405027|NCT02460224|451110719|FG021|Overall Study|Physician Decision|1|||
125405028|NCT02460224|451110720|FG022|Overall Study|Physician Decision|0|||
125405029|NCT02460224|451110721|FG023|Overall Study|Physician Decision|0|||
125405030|NCT02460224|451110722|FG024|Overall Study|Physician Decision|1|||
125405031|NCT02460224|451110723|FG025|Overall Study|Physician Decision|0|||
125405032|NCT02460224|451110724|FG026|Overall Study|Physician Decision|14|||
125405033|NCT02460224|451110725|FG027|Overall Study|Physician Decision|1|||
125405034|NCT02460224|451110726|FG028|Overall Study|Physician Decision|6|||
125405035|NCT02460224|451110698|FG000|Overall Study|Progressive disease|15|||
125405036|NCT02460224|451110699|FG001|Overall Study|Progressive disease|11|||
125405037|NCT02460224|451110700|FG002|Overall Study|Progressive disease|5|||
125405038|NCT02460224|451110701|FG003|Overall Study|Progressive disease|6|||
125405039|NCT02460224|451110702|FG004|Overall Study|Progressive disease|3|||
125405040|NCT02460224|451110703|FG005|Overall Study|Progressive disease|26|||
125405041|NCT02460224|451110704|FG006|Overall Study|Progressive disease|28|||
125405042|NCT02460224|451110705|FG007|Overall Study|Progressive disease|4|||
125405043|NCT02460224|451110706|FG008|Overall Study|Progressive disease|5|||
125405044|NCT02460224|451110707|FG009|Overall Study|Progressive disease|9|||
125405045|NCT02460224|451110708|FG010|Overall Study|Progressive disease|5|||
125405046|NCT02460224|451110709|FG011|Overall Study|Progressive disease|4|||
125405047|NCT02460224|451110710|FG012|Overall Study|Progressive disease|5|||
125405048|NCT02460224|451110711|FG013|Overall Study|Progressive disease|4|||
125405049|NCT02460224|451110712|FG014|Overall Study|Progressive disease|5|||
125405050|NCT02460224|451110713|FG015|Overall Study|Progressive disease|5|||
125405051|NCT02460224|451110714|FG016|Overall Study|Progressive disease|15|||
125405052|NCT02460224|451110715|FG017|Overall Study|Progressive disease|3|||
125405053|NCT02460224|451110716|FG018|Overall Study|Progressive disease|8|||
125405054|NCT02460224|451110717|FG019|Overall Study|Progressive disease|3|||
125405055|NCT02460224|451110718|FG020|Overall Study|Progressive disease|4|||
125405056|NCT02460224|451110719|FG021|Overall Study|Progressive disease|9|||
125405057|NCT02460224|451110720|FG022|Overall Study|Progressive disease|4|||
125405058|NCT02460224|451110721|FG023|Overall Study|Progressive disease|11|||
125448160|NCT02373813|451268858|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
125405059|NCT02460224|451110722|FG024|Overall Study|Progressive disease|4|||
125405060|NCT02460224|451110723|FG025|Overall Study|Progressive disease|5|||
125405061|NCT02460224|451110724|FG026|Overall Study|Progressive disease|85|||
125405062|NCT02460224|451110725|FG027|Overall Study|Progressive disease|17|||
125405063|NCT02460224|451110726|FG028|Overall Study|Progressive disease|77|||
125405064|NCT02460224|451110698|FG000|Overall Study|Subject/guardian decision|2|||
125405065|NCT02460224|451110699|FG001|Overall Study|Subject/guardian decision|0|||
125405066|NCT02460224|451110700|FG002|Overall Study|Subject/guardian decision|1|||
125405067|NCT02460224|451110701|FG003|Overall Study|Subject/guardian decision|0|||
125405068|NCT02460224|451110702|FG004|Overall Study|Subject/guardian decision|2|||
125448161|NCT02373813|451268859|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
125448162|NCT02373813|451268856|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125405069|NCT02460224|451110703|FG005|Overall Study|Subject/guardian decision|2|||
125405070|NCT02460224|451110704|FG006|Overall Study|Subject/guardian decision|0|||
125405071|NCT02460224|451110705|FG007|Overall Study|Subject/guardian decision|0|||
125405072|NCT02460224|451110706|FG008|Overall Study|Subject/guardian decision|1|||
125405073|NCT02460224|451110707|FG009|Overall Study|Subject/guardian decision|1|||
125405074|NCT02460224|451110708|FG010|Overall Study|Subject/guardian decision|0|||
125405075|NCT02460224|451110709|FG011|Overall Study|Subject/guardian decision|1|||
125405076|NCT02460224|451110710|FG012|Overall Study|Subject/guardian decision|0|||
125405077|NCT02460224|451110711|FG013|Overall Study|Subject/guardian decision|0|||
125405078|NCT02460224|451110712|FG014|Overall Study|Subject/guardian decision|0|||
125405079|NCT02460224|451110713|FG015|Overall Study|Subject/guardian decision|1|||
125405080|NCT02460224|451110714|FG016|Overall Study|Subject/guardian decision|0|||
125405081|NCT02460224|451110715|FG017|Overall Study|Subject/guardian decision|1|||
125405082|NCT02460224|451110716|FG018|Overall Study|Subject/guardian decision|2|||
125405083|NCT02460224|451110717|FG019|Overall Study|Subject/guardian decision|0|||
125405084|NCT02460224|451110718|FG020|Overall Study|Subject/guardian decision|0|||
125405085|NCT02460224|451110719|FG021|Overall Study|Subject/guardian decision|1|||
125405086|NCT02460224|451110720|FG022|Overall Study|Subject/guardian decision|0|||
125405087|NCT02460224|451110721|FG023|Overall Study|Subject/guardian decision|0|||
125405088|NCT02460224|451110722|FG024|Overall Study|Subject/guardian decision|0|||
125405089|NCT02460224|451110723|FG025|Overall Study|Subject/guardian decision|0|||
125405090|NCT02460224|451110724|FG026|Overall Study|Subject/guardian decision|6|||
125405091|NCT02460224|451110725|FG027|Overall Study|Subject/guardian decision|2|||
125405092|NCT02460224|451110726|FG028|Overall Study|Subject/guardian decision|3|||
125405093|NCT03146650|451110728|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
125405094|NCT03146650|451110728|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
125405095|NCT03146650|451110728|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
125405096|NCT03146650|451110728|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
125405097|NCT03146650|451110728|FG000|2 Year Follow-up|Death|11|||
125405098|NCT03146650|451110728|FG000|2 Year Follow-up|Still in follow-up|7|||
125405099|NCT03146650|451110728|FG000|2 Year Follow-up|Lost to Follow-up|1|||
125405100|NCT03333486|451110731|FG000|Overall Study|Withdrawal by Subject|1|||
125405101|NCT03333486|451110731|FG000|Overall Study|Lost to Follow-up|1|||
125405102|NCT03246529|451110733|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
125405103|NCT03246529|451110734|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
125405104|NCT03246529|451110735|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
125405105|NCT03246529|451110733|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
125405106|NCT03246529|451110734|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
125405107|NCT03246529|451110735|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
125405108|NCT03246529|451110733|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
125405109|NCT03246529|451110734|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
125405110|NCT03246529|451110735|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
125405111|NCT03246529|451110733|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
125405112|NCT03246529|451110734|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
125405113|NCT03246529|451110735|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
125405114|NCT03246529|451110733|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
125405115|NCT03246529|451110734|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
125405116|NCT03246529|451110735|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
125405117|NCT03246529|451110733|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
125405118|NCT03246529|451110734|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
125405119|NCT03246529|451110735|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
125405120|NCT03246529|451110733|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
125405121|NCT03246529|451110734|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
125405122|NCT03246529|451110735|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
125405123|NCT03246529|451110733|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
125405124|NCT03246529|451110734|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
125405125|NCT03246529|451110735|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
125405126|NCT03246529|451110733|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
125405127|NCT03246529|451110734|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
125405128|NCT03246529|451110735|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
125405129|NCT01209624|451110736|FG000|Overall Study|Death|2|||
125405130|NCT01209624|451110736|FG000|Overall Study|Adverse Event|13|||
125405131|NCT01209624|451110736|FG000|Overall Study|Lack of Efficacy|17|||
125405132|NCT01209624|451110736|FG000|Overall Study|Lost to Follow-up|290|||
125405133|NCT01209624|451110736|FG000|Overall Study|Other|4|||
125405134|NCT00441337|451110741|FG000|Overall Study|Disease Progression|6|||
125405135|NCT00441337|451110742|FG001|Overall Study|Disease Progression|6|||
125405136|NCT00441337|451110743|FG002|Overall Study|Disease Progression|4|||
125405137|NCT00441337|451110744|FG003|Overall Study|Disease Progression|18|||
125405138|NCT00441337|451110741|FG000|Overall Study|Lost to Follow-up|0|||
125405139|NCT00441337|451110742|FG001|Overall Study|Lost to Follow-up|0|||
125405140|NCT00441337|451110743|FG002|Overall Study|Lost to Follow-up|0|||
125405141|NCT00441337|451110744|FG003|Overall Study|Lost to Follow-up|1|||
125405142|NCT00441337|451110741|FG000|Overall Study|Sponsor Decision|0|||
125405143|NCT00441337|451110742|FG001|Overall Study|Sponsor Decision|0|||
125405144|NCT00441337|451110743|FG002|Overall Study|Sponsor Decision|1|||
125405145|NCT00441337|451110744|FG003|Overall Study|Sponsor Decision|2|||
125405146|NCT00441337|451110741|FG000|Overall Study|Did not meet inclusion criteria|0|||
125405147|NCT00441337|451110742|FG001|Overall Study|Did not meet inclusion criteria|0|||
125405148|NCT00441337|451110743|FG002|Overall Study|Did not meet inclusion criteria|1|||
125405149|NCT00441337|451110744|FG003|Overall Study|Did not meet inclusion criteria|0|||
125405150|NCT01818336|451112759|FG000|Overall Study|Declined retest visit|0|||
125405151|NCT01818336|451112760|FG001|Overall Study|Declined retest visit|11|||
125405152|NCT01818336|451112759|FG000|Overall Study|Lost to Follow-up|0|||
125405153|NCT01818336|451112760|FG001|Overall Study|Lost to Follow-up|1|||
125405154|NCT00827372|451112765|FG000|Overall Study|Adverse Event|5|||
125405155|NCT00827372|451112765|FG000|Overall Study|Lack of Efficacy|3|||
125405156|NCT02293005|451112766|FG000|Overall Study|Adverse Event|2|||
125405157|NCT02293005|451112766|FG000|Overall Study|Death|4|||
125405158|NCT02293005|451112766|FG000|Overall Study|Lost to Follow-up|1|||
125405159|NCT02293005|451112766|FG000|Overall Study|Withdrawal by Subject|2|||
125405160|NCT02293005|451112766|FG000|Overall Study|Progression|17|||
125405161|NCT02602288|451112774|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
125405162|NCT02602288|451112775|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
125405163|NCT02602288|451112774|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
125405164|NCT02602288|451112775|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
125405165|NCT02602288|451112774|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
125405166|NCT02602288|451112775|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
125405167|NCT02602288|451112774|FG000|12 Month Follow-up|Lost to Follow-up|0|||
125405168|NCT02602288|451112775|FG001|12 Month Follow-up|Lost to Follow-up|4|||
125405169|NCT02602288|451112774|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
125405170|NCT02602288|451112775|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
125405171|NCT01310413|451112776|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
125405172|NCT01310413|451112777|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
125405173|NCT01310413|451112778|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
125405174|NCT01310413|451112779|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
125405175|NCT01310413|451112780|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
125405176|NCT01310413|451112781|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
125405177|NCT01310413|451112782|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
125405178|NCT01310413|451112776|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
125405179|NCT01310413|451112777|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
125405180|NCT01310413|451112778|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
125405181|NCT01310413|451112779|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
125405182|NCT01310413|451112780|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
125405183|NCT01310413|451112781|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
125405184|NCT01310413|451112782|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
125405185|NCT01310413|451112776|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
125405186|NCT01310413|451112777|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
125405187|NCT01310413|451112778|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
125405188|NCT01310413|451112779|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
125405189|NCT01310413|451112780|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
125405190|NCT01310413|451112781|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
125405191|NCT01310413|451112782|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
125405192|NCT01310413|451112776|FG000|Day 0 to Day 385|Other|1|||
125405193|NCT01310413|451112777|FG001|Day 0 to Day 385|Other|0|||
125405194|NCT01310413|451112778|FG002|Day 0 to Day 385|Other|3|||
125405195|NCT01310413|451112779|FG003|Day 0 to Day 385|Other|0|||
125405196|NCT01310413|451112780|FG004|Day 0 to Day 385|Other|0|||
125405197|NCT01310413|451112781|FG005|Day 0 to Day 385|Other|0|||
125405198|NCT01310413|451112782|FG006|Day 0 to Day 385|Other|0|||
125405199|NCT01310413|451112776|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
125405200|NCT01310413|451112777|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
125405201|NCT01310413|451112778|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
125405202|NCT01310413|451112779|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
125405203|NCT01310413|451112780|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
125405204|NCT01310413|451112781|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
125405205|NCT01310413|451112782|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
125405206|NCT01310413|451112776|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
125405207|NCT01310413|451112777|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
125405208|NCT01310413|451112778|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
125405209|NCT01310413|451112779|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
125405210|NCT01310413|451112780|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
125405211|NCT01310413|451112781|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
125405212|NCT01310413|451112782|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
125405213|NCT00941733|451112783|FG000|Overall Study|Death|24|||
125405214|NCT00941733|451112784|FG001|Overall Study|Death|10|||
125405215|NCT00941733|451112783|FG000|Overall Study|Withdrawal by Subject|14|||
125405216|NCT00941733|451112784|FG001|Overall Study|Withdrawal by Subject|6|||
125405217|NCT00941733|451112783|FG000|Overall Study|Adverse Event|20|||
125405218|NCT00941733|451112784|FG001|Overall Study|Adverse Event|4|||
125405219|NCT00941733|451112783|FG000|Overall Study|Lost to Follow-up|1|||
125405220|NCT00941733|451112784|FG001|Overall Study|Lost to Follow-up|2|||
125405221|NCT00941733|451112783|FG000|Overall Study|Protocol Violation|15|||
125405222|NCT00941733|451112784|FG001|Overall Study|Protocol Violation|6|||
125405223|NCT02391948|451112787|FG000|6-month Assessment|Death|0|||
125405224|NCT02391948|451112788|FG001|6-month Assessment|Death|0|||
125405225|NCT02391948|451112789|FG002|6-month Assessment|Death|0|||
125405226|NCT02391948|451112790|FG003|6-month Assessment|Death|0|||
125405227|NCT02391948|451112791|FG004|6-month Assessment|Death|1|||
125405228|NCT02391948|451112787|FG000|6-month Assessment|Withdrawal by Subject|0|||
125405229|NCT02391948|451112788|FG001|6-month Assessment|Withdrawal by Subject|0|||
125405230|NCT02391948|451112789|FG002|6-month Assessment|Withdrawal by Subject|1|||
125405231|NCT02391948|451112790|FG003|6-month Assessment|Withdrawal by Subject|2|||
125405232|NCT02391948|451112791|FG004|6-month Assessment|Withdrawal by Subject|0|||
125405233|NCT02391948|451112787|FG000|6-month Assessment|Lost to Follow-up|4|||
125405234|NCT02391948|451112788|FG001|6-month Assessment|Lost to Follow-up|5|||
125405235|NCT02391948|451112789|FG002|6-month Assessment|Lost to Follow-up|2|||
125405236|NCT02391948|451112790|FG003|6-month Assessment|Lost to Follow-up|3|||
125405237|NCT02391948|451112791|FG004|6-month Assessment|Lost to Follow-up|1|||
125405238|NCT02391948|451112787|FG000|6-month Assessment|Medical issue/illness|1|||
125405239|NCT02391948|451112788|FG001|6-month Assessment|Medical issue/illness|1|||
125405240|NCT02391948|451112789|FG002|6-month Assessment|Medical issue/illness|0|||
125405241|NCT02391948|451112790|FG003|6-month Assessment|Medical issue/illness|0|||
125405242|NCT02391948|451112791|FG004|6-month Assessment|Medical issue/illness|0|||
125405243|NCT02391948|451112787|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
125405244|NCT02391948|451112788|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
125405245|NCT02391948|451112789|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
125405246|NCT02391948|451112790|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
125405247|NCT02391948|451112791|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
125405248|NCT02391948|451112787|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
125405249|NCT02391948|451112788|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
125405250|NCT02391948|451112789|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
125405251|NCT02391948|451112790|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
125405252|NCT02391948|451112791|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
125405253|NCT02391948|451112787|FG000|12-month Assessment|Death|0|||
125405254|NCT02391948|451112788|FG001|12-month Assessment|Death|0|||
125405255|NCT02391948|451112789|FG002|12-month Assessment|Death|0|||
125405256|NCT02391948|451112790|FG003|12-month Assessment|Death|1|||
125405257|NCT02391948|451112791|FG004|12-month Assessment|Death|0|||
125405258|NCT02391948|451112787|FG000|12-month Assessment|Withdrawal by Subject|1|||
125405259|NCT02391948|451112788|FG001|12-month Assessment|Withdrawal by Subject|0|||
125405260|NCT02391948|451112789|FG002|12-month Assessment|Withdrawal by Subject|0|||
125405261|NCT02391948|451112790|FG003|12-month Assessment|Withdrawal by Subject|1|||
125405262|NCT02391948|451112791|FG004|12-month Assessment|Withdrawal by Subject|0|||
125405263|NCT02391948|451112787|FG000|12-month Assessment|Lost to Follow-up|5|||
125405264|NCT02391948|451112788|FG001|12-month Assessment|Lost to Follow-up|4|||
125405265|NCT02391948|451112789|FG002|12-month Assessment|Lost to Follow-up|4|||
125405266|NCT02391948|451112790|FG003|12-month Assessment|Lost to Follow-up|4|||
125405267|NCT02391948|451112791|FG004|12-month Assessment|Lost to Follow-up|5|||
125405268|NCT02391948|451112787|FG000|12-month Assessment|Medical issue/illness|0|||
125405269|NCT02391948|451112788|FG001|12-month Assessment|Medical issue/illness|1|||
125405270|NCT02391948|451112789|FG002|12-month Assessment|Medical issue/illness|0|||
125405271|NCT02391948|451112790|FG003|12-month Assessment|Medical issue/illness|1|||
125405272|NCT02391948|451112791|FG004|12-month Assessment|Medical issue/illness|0|||
125405273|NCT02391948|451112787|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
125405274|NCT02391948|451112788|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
125405275|NCT02391948|451112789|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
125405276|NCT02391948|451112790|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
125405277|NCT02391948|451112791|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
125405278|NCT02391948|451112787|FG000|18-month Assessment|Death|0|||
125405279|NCT02391948|451112788|FG001|18-month Assessment|Death|0|||
125405280|NCT02391948|451112789|FG002|18-month Assessment|Death|0|||
125405281|NCT02391948|451112790|FG003|18-month Assessment|Death|1|||
125405282|NCT02391948|451112791|FG004|18-month Assessment|Death|1|||
125405283|NCT02391948|451112787|FG000|18-month Assessment|Withdrawal by Subject|1|||
125405284|NCT02391948|451112788|FG001|18-month Assessment|Withdrawal by Subject|0|||
125405285|NCT02391948|451112789|FG002|18-month Assessment|Withdrawal by Subject|0|||
125278327|NCT01406938|450643985|FG001|Follow up|Patient/guardian decision|2|||
125405286|NCT02391948|451112790|FG003|18-month Assessment|Withdrawal by Subject|1|||
125405287|NCT02391948|451112791|FG004|18-month Assessment|Withdrawal by Subject|0|||
125405288|NCT02391948|451112787|FG000|18-month Assessment|Lost to Follow-up|2|||
125405289|NCT02391948|451112788|FG001|18-month Assessment|Lost to Follow-up|6|||
125405290|NCT02391948|451112789|FG002|18-month Assessment|Lost to Follow-up|2|||
125405291|NCT02391948|451112790|FG003|18-month Assessment|Lost to Follow-up|2|||
125405292|NCT02391948|451112791|FG004|18-month Assessment|Lost to Follow-up|3|||
125405293|NCT02391948|451112787|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
125405294|NCT02391948|451112788|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
125405295|NCT02391948|451112789|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
125405296|NCT02391948|451112790|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
125405297|NCT02391948|451112791|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
125405298|NCT02391948|451112787|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
125405299|NCT02391948|451112788|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
125405300|NCT02391948|451112789|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
125405301|NCT02391948|451112790|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
125405302|NCT02391948|451112791|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
125405303|NCT02391948|451112787|FG000|24-month Assessment|Death|0|||
125405304|NCT02391948|451112788|FG001|24-month Assessment|Death|0|||
125405305|NCT02391948|451112789|FG002|24-month Assessment|Death|0|||
125405306|NCT02391948|451112790|FG003|24-month Assessment|Death|0|||
125405307|NCT02391948|451112791|FG004|24-month Assessment|Death|1|||
125405308|NCT02391948|451112787|FG000|24-month Assessment|Withdrawal by Subject|1|||
125405309|NCT02391948|451112788|FG001|24-month Assessment|Withdrawal by Subject|1|||
125405310|NCT02391948|451112789|FG002|24-month Assessment|Withdrawal by Subject|0|||
125405311|NCT02391948|451112790|FG003|24-month Assessment|Withdrawal by Subject|0|||
125405312|NCT02391948|451112791|FG004|24-month Assessment|Withdrawal by Subject|1|||
125405313|NCT02391948|451112787|FG000|24-month Assessment|Lost to Follow-up|5|||
125405314|NCT02391948|451112788|FG001|24-month Assessment|Lost to Follow-up|4|||
125405315|NCT02391948|451112789|FG002|24-month Assessment|Lost to Follow-up|0|||
125405316|NCT02391948|451112790|FG003|24-month Assessment|Lost to Follow-up|0|||
125405317|NCT02391948|451112791|FG004|24-month Assessment|Lost to Follow-up|0|||
125405318|NCT02391948|451112787|FG000|24-month Assessment|Medical issue/illness|0|||
125405319|NCT02391948|451112788|FG001|24-month Assessment|Medical issue/illness|0|||
125405320|NCT02391948|451112789|FG002|24-month Assessment|Medical issue/illness|1|||
125405321|NCT02391948|451112790|FG003|24-month Assessment|Medical issue/illness|0|||
125405322|NCT02391948|451112791|FG004|24-month Assessment|Medical issue/illness|0|||
125405323|NCT02391948|451112787|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
125405324|NCT02391948|451112788|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
125405325|NCT02391948|451112789|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
125405326|NCT02391948|451112790|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
125405327|NCT02391948|451112791|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
125405328|NCT03698773|451112795|FG000|Overall Study|Lost to Follow-up|2|||
125405329|NCT03698773|451112796|FG001|Overall Study|Lost to Follow-up|1|||
125405330|NCT00705575|451112797|FG000|Overall Study|Abnormal laboratory value(s)|0|||
125405331|NCT00705575|451112798|FG001|Overall Study|Abnormal laboratory value(s)|3|||
125405332|NCT00705575|451112797|FG000|Overall Study|Abnormal test procedure result(s)|2|||
125405333|NCT00705575|451112798|FG001|Overall Study|Abnormal test procedure result(s)|12|||
125405334|NCT00705575|451112797|FG000|Overall Study|Adverse Event|11|||
125405335|NCT00705575|451112798|FG001|Overall Study|Adverse Event|15|||
125405336|NCT00705575|451112797|FG000|Overall Study|Lost to Follow-up|3|||
125405337|NCT00705575|451112798|FG001|Overall Study|Lost to Follow-up|4|||
125405338|NCT00705575|451112797|FG000|Overall Study|Protocol Violation|2|||
125405339|NCT00705575|451112798|FG001|Overall Study|Protocol Violation|2|||
125448163|NCT02373813|451268857|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
125448164|NCT02373813|451268858|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
125278328|NCT01406938|450643986|FG002|Follow up|Patient/guardian decision|4|||
125278329|NCT01406938|450643987|FG003|Follow up|Patient/guardian decision|2|||
125278330|NCT01406938|450643988|FG004|Follow up|Patient/guardian decision|4|||
125278331|NCT01406938|450643989|FG005|Follow up|Patient/guardian decision|1|||
125405340|NCT00705575|451112797|FG000|Overall Study|Withdrawal by Subject|5|||
125405341|NCT00705575|451112798|FG001|Overall Study|Withdrawal by Subject|10|||
125405342|NCT02822794|451112799|FG000|Overall Study|Withdrew Consent|1|||
125405343|NCT02822794|451112800|FG001|Overall Study|Withdrew Consent|0|||
125405344|NCT01243944|451112806|FG000|Overall Study|Adverse Event|15|||
125405345|NCT01243944|451112807|FG001|Overall Study|Adverse Event|13|||
125405346|NCT01243944|451112806|FG000|Overall Study|Lost to Follow-up|2|||
125405347|NCT01243944|451112807|FG001|Overall Study|Lost to Follow-up|1|||
125405348|NCT01243944|451112806|FG000|Overall Study|Physician Decision|2|||
125405349|NCT01243944|451112807|FG001|Overall Study|Physician Decision|7|||
125405350|NCT01243944|451112806|FG000|Overall Study|Disease progression|12|||
125405351|NCT01243944|451112807|FG001|Overall Study|Disease progression|11|||
125405352|NCT01243944|451112806|FG000|Overall Study|Protocol deviation|1|||
125405353|NCT01243944|451112807|FG001|Overall Study|Protocol deviation|1|||
125405354|NCT01243944|451112806|FG000|Overall Study|Participant decision|10|||
125405355|NCT01243944|451112807|FG001|Overall Study|Participant decision|15|||
125448165|NCT02373813|451268859|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
125448166|NCT02373813|451268856|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125278332|NCT01406938|450643984|FG000|Follow up|Protocol Violation|0|||
125405356|NCT01243944|451112806|FG000|Overall Study|Death|2|||
125405357|NCT01243944|451112807|FG001|Overall Study|Death|3|||
125405358|NCT01243944|451112806|FG000|Overall Study|Non-compliance with study treatment|1|||
125278333|NCT01406938|450643985|FG001|Follow up|Protocol Violation|0|||
125278334|NCT01406938|450643986|FG002|Follow up|Protocol Violation|1|||
125278335|NCT01406938|450643987|FG003|Follow up|Protocol Violation|0|||
125278336|NCT01406938|450643988|FG004|Follow up|Protocol Violation|0|||
125278337|NCT01406938|450643989|FG005|Follow up|Protocol Violation|0|||
125448167|NCT02373813|451268857|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
125448168|NCT02373813|451268858|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
125448169|NCT02373813|451268859|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
125278338|NCT01406938|450643984|FG000|Follow up|Physician Decision|0|||
125278339|NCT01406938|450643985|FG001|Follow up|Physician Decision|0|||
125278340|NCT01406938|450643986|FG002|Follow up|Physician Decision|2|||
125278341|NCT01406938|450643987|FG003|Follow up|Physician Decision|0|||
125278342|NCT01406938|450643988|FG004|Follow up|Physician Decision|3|||
125278343|NCT01406938|450643989|FG005|Follow up|Physician Decision|1|||
125278344|NCT01406938|450643984|FG000|Follow up|Lost to Follow-up|1|||
125278345|NCT01406938|450643985|FG001|Follow up|Lost to Follow-up|1|||
125278346|NCT01406938|450643986|FG002|Follow up|Lost to Follow-up|0|||
125278347|NCT01406938|450643987|FG003|Follow up|Lost to Follow-up|1|||
125278348|NCT01406938|450643988|FG004|Follow up|Lost to Follow-up|2|||
125278349|NCT01406938|450643989|FG005|Follow up|Lost to Follow-up|1|||
125278350|NCT00878254|450643991|FG000|Overall Study|Physician Decision|1|||
125278351|NCT00878254|450643991|FG000|Overall Study|Death|1|||
125278352|NCT00878254|450643991|FG000|Overall Study|Withdrawal by Subject|1|||
125278353|NCT03367403|450643994|FG000|Overall Study|Adverse Event|20|||
125278354|NCT03367403|450643995|FG001|Overall Study|Adverse Event|6|||
125278355|NCT03367403|450643996|FG002|Overall Study|Adverse Event|2|||
125278356|NCT03367403|450643994|FG000|Overall Study|Withdrawal by Subject|12|||
125278357|NCT03367403|450643995|FG001|Overall Study|Withdrawal by Subject|13|||
125278358|NCT03367403|450643996|FG002|Overall Study|Withdrawal by Subject|1|||
125278359|NCT03367403|450643994|FG000|Overall Study|Death|1|||
125278360|NCT03367403|450643995|FG001|Overall Study|Death|2|||
125278361|NCT03367403|450643996|FG002|Overall Study|Death|0|||
125278362|NCT03367403|450643994|FG000|Overall Study|Physician Decision|0|||
125278363|NCT03367403|450643995|FG001|Overall Study|Physician Decision|1|||
125278364|NCT03367403|450643996|FG002|Overall Study|Physician Decision|0|||
125278365|NCT03367403|450643994|FG000|Overall Study|Protocol Violation|1|||
125278366|NCT03367403|450643995|FG001|Overall Study|Protocol Violation|1|||
125278367|NCT03367403|450643996|FG002|Overall Study|Protocol Violation|0|||
125278368|NCT03367403|450643994|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
125278369|NCT03367403|450643995|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
125278370|NCT03367403|450643996|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
125278371|NCT03367403|450643994|FG000|Overall Study|COVID-19|3|||
125278372|NCT03367403|450643995|FG001|Overall Study|COVID-19|6|||
125278373|NCT03367403|450643996|FG002|Overall Study|COVID-19|0|||
125278374|NCT03367403|450643994|FG000|Overall Study|Abuse of Alcohol Intake|0|||
125278375|NCT03367403|450643995|FG001|Overall Study|Abuse of Alcohol Intake|1|||
125278376|NCT03367403|450643996|FG002|Overall Study|Abuse of Alcohol Intake|0|||
125278377|NCT03367403|450643994|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
125278378|NCT03367403|450643995|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
125278379|NCT03367403|450643996|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
125278380|NCT00194077|450643997|FG000|Overall Study|Lack of Efficacy|22|||
125278381|NCT00194077|450643998|FG001|Overall Study|Lack of Efficacy|29|||
125278382|NCT00194077|450643997|FG000|Overall Study|Study nonadherence|1|||
125278383|NCT00194077|450643998|FG001|Overall Study|Study nonadherence|0|||
125278384|NCT00194077|450643997|FG000|Overall Study|Withdrawal by Subject|1|||
125278385|NCT00194077|450643998|FG001|Overall Study|Withdrawal by Subject|1|||
125278386|NCT03470194|450644001|FG000|Overall Study|Lost to Follow-up|11|||
125278387|NCT03470194|450644002|FG001|Overall Study|Lost to Follow-up|17|||
125278388|NCT03286543|450644003|FG000|Consented|Screen failure before randomization|2|||
125278389|NCT03286543|450644004|FG001|Consented|Screen failure before randomization|0|||
125278390|NCT03286543|450644005|FG002|Consented|Screen failure before randomization|0|||
125278391|NCT03286543|450644003|FG000|Consented|Screen failure before enrollment|4|||
125278392|NCT03286543|450644004|FG001|Consented|Screen failure before enrollment|0|||
125278393|NCT03286543|450644005|FG002|Consented|Screen failure before enrollment|0|||
125278394|NCT03286543|450644003|FG000|Consented|TKA cancelled after enrollment|1|||
125278395|NCT03286543|450644004|FG001|Consented|TKA cancelled after enrollment|0|||
125278396|NCT03286543|450644005|FG002|Consented|TKA cancelled after enrollment|0|||
125278397|NCT03286543|450644003|FG000|Consented|Withdrawn from study|12|||
125278398|NCT03286543|450644004|FG001|Consented|Withdrawn from study|0|||
125278399|NCT03286543|450644005|FG002|Consented|Withdrawn from study|0|||
125278400|NCT03286543|450644003|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
125278401|NCT03286543|450644004|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
125278402|NCT03286543|450644005|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
125278403|NCT03286543|450644003|FG000|Study Enrollment|Withdrawn from study|0|||
125278404|NCT03286543|450644004|FG001|Study Enrollment|Withdrawn from study|6|||
125278405|NCT03286543|450644005|FG002|Study Enrollment|Withdrawn from study|6|||
125278406|NCT00758069|450644006|FG000|Overall Study|Lack of Efficacy|0|||
125278407|NCT00758069|450644007|FG001|Overall Study|Lack of Efficacy|0|||
125278408|NCT00758069|450644008|FG002|Overall Study|Lack of Efficacy|1|||
125278409|NCT00758069|450644006|FG000|Overall Study|Incorrect Study Drug|1|||
125278410|NCT00758069|450644007|FG001|Overall Study|Incorrect Study Drug|0|||
125278411|NCT00758069|450644008|FG002|Overall Study|Incorrect Study Drug|0|||
125278412|NCT00588237|450644009|FG000|Overall Study|Evaluable for toxicity only|3|||
125278413|NCT00588237|450644009|FG000|Overall Study|Patien not treated|1|||
125278414|NCT04908865|450644013|FG000|Overall Study|Adverse Event|2|||
125278415|NCT04908865|450644013|FG000|Overall Study|Lack of Efficacy|5|||
125278416|NCT04908865|450644013|FG000|Overall Study|Lost to Follow-up|1|||
125278417|NCT03249909|450644018|FG000|Overall Study|Withdrawal by Subject|3|||
125278418|NCT03249909|450644019|FG001|Overall Study|Withdrawal by Subject|0|||
125278419|NCT03249909|450644020|FG002|Overall Study|Withdrawal by Subject|0|||
125278420|NCT03249909|450644018|FG000|Overall Study|Adverse Event|3|||
125278421|NCT03249909|450644019|FG001|Overall Study|Adverse Event|0|||
125278422|NCT03249909|450644020|FG002|Overall Study|Adverse Event|0|||
125278423|NCT03249909|450644018|FG000|Overall Study|Lost to Follow-up|0|||
125278424|NCT03249909|450644019|FG001|Overall Study|Lost to Follow-up|1|||
125278425|NCT03249909|450644020|FG002|Overall Study|Lost to Follow-up|0|||
125278426|NCT00606034|450644021|FG000|Overall Study|incarceration|1|||
125278427|NCT02027311|450644023|FG000|Overall Study|Protocol Violation|3|||
125278428|NCT02027311|450644024|FG001|Overall Study|Protocol Violation|2|||
125278429|NCT02466425|450644027|FG000|Overall Study|Adverse Event|3|||
125278430|NCT02466425|450644028|FG001|Overall Study|Adverse Event|11|||
125278431|NCT02466425|450644027|FG000|Overall Study|Lack of Efficacy|4|||
125278432|NCT02466425|450644028|FG001|Overall Study|Lack of Efficacy|1|||
125278433|NCT02466425|450644027|FG000|Overall Study|Lost to Follow-up|3|||
125278434|NCT02466425|450644028|FG001|Overall Study|Lost to Follow-up|0|||
125278435|NCT02466425|450644027|FG000|Overall Study|Protocol Violation|1|||
125278436|NCT02466425|450644028|FG001|Overall Study|Protocol Violation|0|||
125278437|NCT02466425|450644027|FG000|Overall Study|Withdrawal by Subject|0|||
125278438|NCT02466425|450644028|FG001|Overall Study|Withdrawal by Subject|1|||
125278439|NCT02466425|450644027|FG000|Overall Study|Other|1|||
125278440|NCT02466425|450644028|FG001|Overall Study|Other|3|||
125278441|NCT02466425|450644027|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
125278442|NCT02466425|450644028|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125278443|NCT01721486|450644033|FG000|Overall Study|Protocol Violation|1|||
125278444|NCT01721486|450644034|FG001|Overall Study|Protocol Violation|0|||
125278445|NCT01721486|450644033|FG000|Overall Study|Physician Decision|0|||
125278446|NCT01721486|450644034|FG001|Overall Study|Physician Decision|1|||
125278447|NCT00582712|450644035|FG000|Overall Study|Adverse Event|1|||
125278448|NCT00582712|450644035|FG000|Overall Study|Lack of Efficacy|1|||
125278449|NCT00582712|450644035|FG000|Overall Study|Withdrawal by Subject|1|||
125278450|NCT00582712|450644035|FG000|Overall Study|Complicating disease requiring treatment|1|||
125278451|NCT05141175|450644036|FG000|Overall Study|Withdrawal by Subject|1|||
125278452|NCT01901289|450644038|FG000|Overall Study|Death|32|||
125278453|NCT01901289|450644038|FG000|Overall Study|Lost to Follow-up|16|||
125278454|NCT01901289|450644038|FG000|Overall Study|Withdrawal by Subject|35|||
125278455|NCT01901289|450644038|FG000|Overall Study|Other type of endpoint met|2|||
125278456|NCT01813058|450644039|FG000|Overall Study|Withdrawal by Subject|5|||
125278457|NCT01813058|450644040|FG001|Overall Study|Withdrawal by Subject|4|||
125278458|NCT00182078|450644042|FG000|Overall Study|Withdrawal by Subject|1|||
125278459|NCT00182078|450644043|FG001|Overall Study|Withdrawal by Subject|0|||
125278460|NCT00395486|450644044|FG000|Overall Study|Adverse Event|1|||
125278461|NCT00395486|450644045|FG001|Overall Study|Adverse Event|2|||
125278462|NCT00395486|450644044|FG000|Overall Study|Withdrawal by Subject|5|||
125278463|NCT00395486|450644045|FG001|Overall Study|Withdrawal by Subject|2|||
125278464|NCT00395486|450644044|FG000|Overall Study|Lost to Follow-up|0|||
125278465|NCT00395486|450644045|FG001|Overall Study|Lost to Follow-up|1|||
125278466|NCT01076205|450644046|FG000|Overall Study|Adverse Drug Reaction|299|||
125278467|NCT01076205|450644046|FG000|Overall Study|Lack of Effectiveness|1423|||
125278468|NCT01076205|450644046|FG000|Overall Study|Other Reason|1075|||
125278469|NCT01076205|450644046|FG000|Overall Study|Unknown Reason|71|||
125278470|NCT01076205|450644046|FG000|Overall Study|Lost to Follow-up|3151|||
125278471|NCT04731298|450644053|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
125278472|NCT04731298|450644054|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
125278473|NCT02443116|450644060|FG000|Part 1|Adverse Event|2|||
125278474|NCT02443116|450644061|FG001|Part 1|Adverse Event|3|||
125278475|NCT02443116|450644062|FG002|Part 1|Adverse Event|0|||
125278476|NCT02443116|450644063|FG003|Part 1|Adverse Event|0|||
125278477|NCT02443116|450644064|FG004|Part 1|Adverse Event|0|||
125278478|NCT02443116|450644065|FG005|Part 1|Adverse Event|0|||
125278479|NCT02443116|450644066|FG006|Part 1|Adverse Event|0|||
125278480|NCT02443116|450644067|FG007|Part 1|Adverse Event|0|||
125278481|NCT02443116|450644068|FG008|Part 1|Adverse Event|0|||
125278482|NCT02443116|450644060|FG000|Part 1|Withdrew informed consent|0|||
125278483|NCT02443116|450644061|FG001|Part 1|Withdrew informed consent|1|||
125405359|NCT01243944|451112807|FG001|Overall Study|Non-compliance with study treatment|0|||
125405360|NCT01416805|451112808|FG000|Overall Study|Lost to Follow-up|4|||
125405361|NCT01416805|451112809|FG001|Overall Study|Lost to Follow-up|4|||
125405362|NCT02802345|451112810|FG000|Overall Study|Not Treated|0|||
125405363|NCT02802345|451112811|FG001|Overall Study|Not Treated|1|||
125405364|NCT02802345|451112810|FG000|Overall Study|Adverse Event|28|||
125405365|NCT02802345|451112811|FG001|Overall Study|Adverse Event|20|||
125405366|NCT02802345|451112810|FG000|Overall Study|Withdrawal by Subject|3|||
125405367|NCT02802345|451112811|FG001|Overall Study|Withdrawal by Subject|3|||
125405368|NCT02802345|451112810|FG000|Overall Study|Protocol Violation|0|||
125405369|NCT02802345|451112811|FG001|Overall Study|Protocol Violation|1|||
125405370|NCT02802345|451112810|FG000|Overall Study|Other than listed|1|||
125405371|NCT02802345|451112811|FG001|Overall Study|Other than listed|5|||
125405372|NCT04632940|451112812|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
125405373|NCT04632940|451112813|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
125405374|NCT04632940|451112812|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
125405375|NCT04632940|451112813|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
125405376|NCT04632940|451112812|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
125405377|NCT04632940|451112813|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
125405378|NCT04632940|451112812|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
125405379|NCT04632940|451112813|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
125405380|NCT04632940|451112812|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
125405381|NCT04632940|451112813|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
125405382|NCT04632940|451112812|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
125405383|NCT04632940|451112813|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
125405384|NCT04632940|451112812|FG000|OLE Period (52 Weeks)|Other than specified|0|||
125405385|NCT04632940|451112813|FG001|OLE Period (52 Weeks)|Other than specified|1|||
125405386|NCT04632940|451112812|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
125405387|NCT04632940|451112813|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
125405388|NCT05857527|451112816|FG000|Overall Study|Withdrawal by Subject|0|||
125405389|NCT05857527|451112817|FG001|Overall Study|Withdrawal by Subject|1|||
125405390|NCT02799082|451112818|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
125405391|NCT02799082|451112819|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
125405392|NCT02799082|451112818|FG000|Overall Study|Protocol Violation|0|||
125405393|NCT02799082|451112819|FG001|Overall Study|Protocol Violation|1|||
125405394|NCT03251924|451112826|FG000|Overall Study|Disease Progression|6|||
125405395|NCT03251924|451112827|FG001|Overall Study|Disease Progression|6|||
125405396|NCT03251924|451112828|FG002|Overall Study|Disease Progression|7|||
125405397|NCT03251924|451112829|FG003|Overall Study|Disease Progression|8|||
125405398|NCT03251924|451112830|FG004|Overall Study|Disease Progression|8|||
125405399|NCT03251924|451112831|FG005|Overall Study|Disease Progression|7|||
125405400|NCT03251924|451112832|FG006|Overall Study|Disease Progression|6|||
125405401|NCT03251924|451112833|FG007|Overall Study|Disease Progression|10|||
125405402|NCT03251924|451112834|FG008|Overall Study|Disease Progression|6|||
125405403|NCT03251924|451112826|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
125278484|NCT02443116|450644062|FG002|Part 1|Withdrew informed consent|0|||
125278485|NCT02443116|450644063|FG003|Part 1|Withdrew informed consent|0|||
125278486|NCT02443116|450644064|FG004|Part 1|Withdrew informed consent|0|||
125278487|NCT02443116|450644065|FG005|Part 1|Withdrew informed consent|0|||
125278488|NCT02443116|450644066|FG006|Part 1|Withdrew informed consent|0|||
125278489|NCT02443116|450644067|FG007|Part 1|Withdrew informed consent|0|||
125278490|NCT02443116|450644068|FG008|Part 1|Withdrew informed consent|0|||
125278491|NCT02443116|450644060|FG000|Part 1|Lost to Follow-up|0|||
125278492|NCT02443116|450644061|FG001|Part 1|Lost to Follow-up|0|||
125278493|NCT02443116|450644062|FG002|Part 1|Lost to Follow-up|2|||
125278494|NCT02443116|450644063|FG003|Part 1|Lost to Follow-up|0|||
125278495|NCT02443116|450644064|FG004|Part 1|Lost to Follow-up|0|||
125405404|NCT03251924|451112827|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
125405405|NCT03251924|451112828|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
125405406|NCT03251924|451112829|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
125405407|NCT03251924|451112830|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
125405408|NCT03251924|451112831|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
125405409|NCT03251924|451112832|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
125405410|NCT03251924|451112833|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
125405411|NCT03251924|451112834|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
125405412|NCT03251924|451112826|FG000|Overall Study|Death|0|||
125405413|NCT03251924|451112827|FG001|Overall Study|Death|1|||
125405414|NCT03251924|451112828|FG002|Overall Study|Death|0|||
125405415|NCT03251924|451112829|FG003|Overall Study|Death|1|||
125405416|NCT03251924|451112830|FG004|Overall Study|Death|1|||
125405417|NCT03251924|451112831|FG005|Overall Study|Death|1|||
125405418|NCT03251924|451112832|FG006|Overall Study|Death|0|||
125405419|NCT03251924|451112833|FG007|Overall Study|Death|0|||
125278496|NCT02443116|450644065|FG005|Part 1|Lost to Follow-up|0|||
125278497|NCT02443116|450644066|FG006|Part 1|Lost to Follow-up|0|||
125278498|NCT02443116|450644067|FG007|Part 1|Lost to Follow-up|0|||
125278499|NCT02443116|450644068|FG008|Part 1|Lost to Follow-up|0|||
125278500|NCT02443116|450644060|FG000|Part 1|Participant moved out of state|0|||
125278501|NCT02443116|450644061|FG001|Part 1|Participant moved out of state|0|||
125278502|NCT02443116|450644062|FG002|Part 1|Participant moved out of state|1|||
125278503|NCT02443116|450644063|FG003|Part 1|Participant moved out of state|0|||
125278504|NCT02443116|450644064|FG004|Part 1|Participant moved out of state|0|||
125278505|NCT02443116|450644065|FG005|Part 1|Participant moved out of state|0|||
125278506|NCT02443116|450644066|FG006|Part 1|Participant moved out of state|0|||
125278507|NCT02443116|450644067|FG007|Part 1|Participant moved out of state|0|||
125278508|NCT02443116|450644068|FG008|Part 1|Participant moved out of state|0|||
125278509|NCT02443116|450644060|FG000|Part 1|Participant enrolled in another clinical trial|0|||
125278510|NCT02443116|450644061|FG001|Part 1|Participant enrolled in another clinical trial|0|||
125278511|NCT02443116|450644062|FG002|Part 1|Participant enrolled in another clinical trial|1|||
125278512|NCT02443116|450644063|FG003|Part 1|Participant enrolled in another clinical trial|0|||
125278513|NCT02443116|450644064|FG004|Part 1|Participant enrolled in another clinical trial|0|||
125278514|NCT02443116|450644065|FG005|Part 1|Participant enrolled in another clinical trial|0|||
125278515|NCT02443116|450644066|FG006|Part 1|Participant enrolled in another clinical trial|0|||
125278516|NCT02443116|450644067|FG007|Part 1|Participant enrolled in another clinical trial|0|||
125278517|NCT02443116|450644068|FG008|Part 1|Participant enrolled in another clinical trial|0|||
125278518|NCT02443116|450644060|FG000|Part 2|Adverse Event|0|||
125278519|NCT02443116|450644061|FG001|Part 2|Adverse Event|0|||
125405420|NCT03251924|451112834|FG008|Overall Study|Death|0|||
125405421|NCT03251924|451112826|FG000|Overall Study|Study Drug Toxicity|0|||
125405422|NCT03251924|451112827|FG001|Overall Study|Study Drug Toxicity|0|||
125405423|NCT03251924|451112828|FG002|Overall Study|Study Drug Toxicity|0|||
125405424|NCT03251924|451112829|FG003|Overall Study|Study Drug Toxicity|1|||
125405425|NCT03251924|451112830|FG004|Overall Study|Study Drug Toxicity|0|||
125405426|NCT03251924|451112831|FG005|Overall Study|Study Drug Toxicity|0|||
125405427|NCT03251924|451112832|FG006|Overall Study|Study Drug Toxicity|0|||
125405428|NCT03251924|451112833|FG007|Overall Study|Study Drug Toxicity|0|||
125405429|NCT03251924|451112834|FG008|Overall Study|Study Drug Toxicity|1|||
125405430|NCT03251924|451112826|FG000|Overall Study|Other Reasons|0|||
125405431|NCT03251924|451112827|FG001|Overall Study|Other Reasons|0|||
125405432|NCT03251924|451112828|FG002|Overall Study|Other Reasons|0|||
125405433|NCT03251924|451112829|FG003|Overall Study|Other Reasons|0|||
125405434|NCT03251924|451112830|FG004|Overall Study|Other Reasons|0|||
125405435|NCT03251924|451112831|FG005|Overall Study|Other Reasons|0|||
125405436|NCT03251924|451112832|FG006|Overall Study|Other Reasons|0|||
125405437|NCT03251924|451112833|FG007|Overall Study|Other Reasons|0|||
125405438|NCT03251924|451112834|FG008|Overall Study|Other Reasons|1|||
125405439|NCT03251924|451112826|FG000|Overall Study|Participant request to discontinue study treatment|0|||
125405440|NCT03251924|451112827|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125405441|NCT03251924|451112828|FG002|Overall Study|Participant request to discontinue study treatment|0|||
125405442|NCT03251924|451112829|FG003|Overall Study|Participant request to discontinue study treatment|0|||
125405443|NCT03251924|451112830|FG004|Overall Study|Participant request to discontinue study treatment|0|||
125405444|NCT03251924|451112831|FG005|Overall Study|Participant request to discontinue study treatment|0|||
125405445|NCT03251924|451112832|FG006|Overall Study|Participant request to discontinue study treatment|0|||
125405446|NCT03251924|451112833|FG007|Overall Study|Participant request to discontinue study treatment|1|||
125405447|NCT03251924|451112834|FG008|Overall Study|Participant request to discontinue study treatment|0|||
125405448|NCT01193556|451112843|FG000|Overall Study|Study termination|26|||
125405449|NCT01193556|451112844|FG001|Overall Study|Study termination|25|||
125405450|NCT02617589|451112845|FG000|Randomization|Request to Discontinue Study Treatment|1|||
125405451|NCT02617589|451112846|FG001|Randomization|Request to Discontinue Study Treatment|3|||
125405452|NCT02617589|451112845|FG000|Randomization|Participant Withdrew Consent|1|||
125405453|NCT02617589|451112846|FG001|Randomization|Participant Withdrew Consent|2|||
125405454|NCT02617589|451112845|FG000|Treatment|Other Reasons|3|||
125405455|NCT02617589|451112846|FG001|Treatment|Other Reasons|3|||
125405456|NCT02617589|451112845|FG000|Treatment|Poor/Non Compliance|1|||
125405457|NCT02617589|451112846|FG001|Treatment|Poor/Non Compliance|1|||
125405458|NCT02617589|451112845|FG000|Treatment|Maximum Clinical Benefit|0|||
125405459|NCT02617589|451112846|FG001|Treatment|Maximum Clinical Benefit|2|||
125405460|NCT02617589|451112845|FG000|Treatment|Participant Withdrew Consent|2|||
125405461|NCT02617589|451112846|FG001|Treatment|Participant Withdrew Consent|6|||
125448170|NCT00354029|451268860|FG000|Overall Study|Protocol Violation|4|||
125448171|NCT00354029|451268861|FG001|Overall Study|Protocol Violation|2|||
125278520|NCT02443116|450644062|FG002|Part 2|Adverse Event|0|||
125278521|NCT02443116|450644063|FG003|Part 2|Adverse Event|0|||
125278522|NCT02443116|450644064|FG004|Part 2|Adverse Event|1|||
125405462|NCT02617589|451112845|FG000|Treatment|Participant Request to Discontinue|12|||
125405463|NCT02617589|451112846|FG001|Treatment|Participant Request to Discontinue|21|||
125405464|NCT02617589|451112845|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
125405465|NCT02617589|451112846|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
125278523|NCT02443116|450644065|FG005|Part 2|Adverse Event|1|||
125278524|NCT02443116|450644066|FG006|Part 2|Adverse Event|2|||
125278525|NCT02443116|450644067|FG007|Part 2|Adverse Event|0|||
125278526|NCT02443116|450644068|FG008|Part 2|Adverse Event|0|||
125405466|NCT02617589|451112845|FG000|Treatment|Death|1|||
125405467|NCT02617589|451112846|FG001|Treatment|Death|1|||
125405468|NCT02617589|451112845|FG000|Treatment|Study Drug Toxicity|27|||
125405469|NCT02617589|451112846|FG001|Treatment|Study Drug Toxicity|20|||
125405470|NCT02617589|451112845|FG000|Treatment|Disease Progression|216|||
125405471|NCT02617589|451112846|FG001|Treatment|Disease Progression|136|||
125405472|NCT01591681|451112847|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
125405473|NCT01591681|451112847|FG000|Overall Study|Failed to use system during run-in|1|||
125405474|NCT00179647|451112852|FG000|Overall Study|Adverse Event|294|||
125405475|NCT00179647|451112852|FG000|Overall Study|Lack of Efficacy|478|||
125405476|NCT00179647|451112852|FG000|Overall Study|Withdrawal by Subject|83|||
125405477|NCT00179647|451112852|FG000|Overall Study|Lost to Follow-up|4|||
125405478|NCT00179647|451112852|FG000|Overall Study|Death|94|||
125405479|NCT00179647|451112852|FG000|Overall Study|Other|960|||
125405480|NCT00835406|451112853|FG000|Period: First Intervention|Adverse Event|0|||
125405481|NCT00835406|451112854|FG001|Period: First Intervention|Adverse Event|1|||
125405482|NCT00835406|451112853|FG000|Period: First Intervention|Withdrawal by Subject|2|||
125405483|NCT00835406|451112854|FG001|Period: First Intervention|Withdrawal by Subject|0|||
125405484|NCT00835406|451112853|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
125405485|NCT00835406|451112854|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
125405486|NCT02138214|451112857|FG000|Overall Study|Withdrawal by Subject|0|||
125278527|NCT02443116|450644060|FG000|Part 2|Withdrew informed consent|0|||
125278528|NCT02443116|450644061|FG001|Part 2|Withdrew informed consent|0|||
125278529|NCT02443116|450644062|FG002|Part 2|Withdrew informed consent|0|||
125278530|NCT02443116|450644063|FG003|Part 2|Withdrew informed consent|0|||
125278531|NCT02443116|450644064|FG004|Part 2|Withdrew informed consent|0|||
125278532|NCT02443116|450644065|FG005|Part 2|Withdrew informed consent|1|||
125278533|NCT02443116|450644066|FG006|Part 2|Withdrew informed consent|1|||
125278534|NCT02443116|450644067|FG007|Part 2|Withdrew informed consent|0|||
125278535|NCT02443116|450644068|FG008|Part 2|Withdrew informed consent|0|||
125278536|NCT02443116|450644060|FG000|Part 2|Inability to comply with protocol|0|||
125278537|NCT02443116|450644061|FG001|Part 2|Inability to comply with protocol|0|||
125278538|NCT02443116|450644062|FG002|Part 2|Inability to comply with protocol|0|||
125278539|NCT02443116|450644063|FG003|Part 2|Inability to comply with protocol|1|||
125278540|NCT02443116|450644064|FG004|Part 2|Inability to comply with protocol|0|||
125278541|NCT02443116|450644065|FG005|Part 2|Inability to comply with protocol|0|||
125278542|NCT02443116|450644066|FG006|Part 2|Inability to comply with protocol|0|||
125278543|NCT02443116|450644067|FG007|Part 2|Inability to comply with protocol|0|||
125278544|NCT02443116|450644068|FG008|Part 2|Inability to comply with protocol|0|||
125278545|NCT02443116|450644060|FG000|Part 2|Lost to Follow-up|0|||
125278546|NCT02443116|450644061|FG001|Part 2|Lost to Follow-up|0|||
125278547|NCT02443116|450644062|FG002|Part 2|Lost to Follow-up|0|||
125278548|NCT02443116|450644063|FG003|Part 2|Lost to Follow-up|1|||
125278549|NCT02443116|450644064|FG004|Part 2|Lost to Follow-up|0|||
125278550|NCT02443116|450644065|FG005|Part 2|Lost to Follow-up|0|||
125278551|NCT02443116|450644066|FG006|Part 2|Lost to Follow-up|0|||
125278552|NCT02443116|450644067|FG007|Part 2|Lost to Follow-up|0|||
125278553|NCT02443116|450644068|FG008|Part 2|Lost to Follow-up|0|||
125278554|NCT02443116|450644060|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278555|NCT02443116|450644061|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278556|NCT02443116|450644062|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278557|NCT02443116|450644063|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278558|NCT02443116|450644064|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278559|NCT02443116|450644065|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
125278560|NCT02443116|450644066|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278561|NCT02443116|450644067|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278562|NCT02443116|450644068|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
125278563|NCT02443116|450644060|FG000|Part 3|Adverse Event|0|||
125278564|NCT02443116|450644061|FG001|Part 3|Adverse Event|0|||
125278565|NCT02443116|450644062|FG002|Part 3|Adverse Event|0|||
125278566|NCT02443116|450644063|FG003|Part 3|Adverse Event|0|||
125278567|NCT02443116|450644064|FG004|Part 3|Adverse Event|0|||
125278568|NCT02443116|450644065|FG005|Part 3|Adverse Event|0|||
125278569|NCT02443116|450644066|FG006|Part 3|Adverse Event|0|||
125278570|NCT02443116|450644067|FG007|Part 3|Adverse Event|0|||
125278571|NCT02443116|450644068|FG008|Part 3|Adverse Event|1|||
125278572|NCT02443116|450644060|FG000|Part 3|Withdrew informed consent|0|||
125278573|NCT02443116|450644061|FG001|Part 3|Withdrew informed consent|0|||
125278574|NCT02443116|450644062|FG002|Part 3|Withdrew informed consent|0|||
125278575|NCT02443116|450644063|FG003|Part 3|Withdrew informed consent|0|||
125278576|NCT02443116|450644064|FG004|Part 3|Withdrew informed consent|0|||
125278577|NCT02443116|450644065|FG005|Part 3|Withdrew informed consent|0|||
125278578|NCT02443116|450644066|FG006|Part 3|Withdrew informed consent|0|||
125278579|NCT02443116|450644067|FG007|Part 3|Withdrew informed consent|3|||
125278580|NCT02443116|450644068|FG008|Part 3|Withdrew informed consent|2|||
125405487|NCT02138214|451112858|FG001|Overall Study|Withdrawal by Subject|1|||
125405488|NCT02138214|451112859|FG002|Overall Study|Withdrawal by Subject|0|||
125405489|NCT02138214|451112857|FG000|Overall Study|Lost to Follow-up|0|||
125405490|NCT02138214|451112858|FG001|Overall Study|Lost to Follow-up|2|||
125405491|NCT02138214|451112859|FG002|Overall Study|Lost to Follow-up|4|||
125405492|NCT02138214|451112857|FG000|Overall Study|Screen Failure|0|||
125405493|NCT02138214|451112858|FG001|Overall Study|Screen Failure|1|||
125405494|NCT02138214|451112859|FG002|Overall Study|Screen Failure|0|||
125405495|NCT03027466|451112862|FG000|Overall Study|Opting out of the app|1869|||
125405496|NCT03027466|451112863|FG001|Overall Study|Opting out of the app|1819|||
125405497|NCT03027466|451112864|FG002|Overall Study|Opting out of the app|1743|||
125405498|NCT03027466|451112865|FG003|Overall Study|Opting out of the app|1821|||
125405499|NCT02486406|451112866|FG000|Overall Study|Withdrew consent|1|||
125405500|NCT02486406|451112867|FG001|Overall Study|Withdrew consent|0|||
125405501|NCT02486406|451112868|FG002|Overall Study|Withdrew consent|0|||
125405502|NCT02486406|451112869|FG003|Overall Study|Withdrew consent|1|||
125405503|NCT02486406|451112866|FG000|Overall Study|Lost to Follow-up|1|||
125405504|NCT02486406|451112867|FG001|Overall Study|Lost to Follow-up|3|||
125405505|NCT02486406|451112868|FG002|Overall Study|Lost to Follow-up|1|||
125405506|NCT02486406|451112869|FG003|Overall Study|Lost to Follow-up|3|||
125405507|NCT02486406|451112866|FG000|Overall Study|Other, not specified|0|||
125405508|NCT02486406|451112867|FG001|Overall Study|Other, not specified|0|||
125405509|NCT02486406|451112868|FG002|Overall Study|Other, not specified|1|||
125405510|NCT02486406|451112869|FG003|Overall Study|Other, not specified|0|||
125405511|NCT01826825|451112874|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
125405512|NCT01826825|451112875|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
125405513|NCT01858194|451112876|FG000|Overall Study|Total Artificial Heart Implant|0|||
125405514|NCT01858194|451112877|FG001|Overall Study|Total Artificial Heart Implant|1|||
125405515|NCT01858194|451112876|FG000|Overall Study|Lost to Follow-up|0|||
125405516|NCT01858194|451112877|FG001|Overall Study|Lost to Follow-up|1|||
125405517|NCT02158039|451112878|FG000|Overall Study|Withdrawal by Subject|1|||
125405518|NCT02158039|451112878|FG000|Overall Study|Screen Failure|9|||
125405519|NCT03062891|451112890|FG000|Overall Study|Withdrawal by Subject|2|||
125405520|NCT03062891|451112891|FG001|Overall Study|Withdrawal by Subject|0|||
125405521|NCT03062891|451112890|FG000|Overall Study|Lost to Follow-up|50|||
125405522|NCT03062891|451112891|FG001|Overall Study|Lost to Follow-up|38|||
125405523|NCT02127307|451112892|FG000|Overall Study|Protocol Violation|36|||
125405524|NCT02127307|451112892|FG000|Overall Study|Lost to Follow-up|2|||
125405525|NCT02127307|451112892|FG000|Overall Study|Death|101|||
125405526|NCT02127307|451112892|FG000|Overall Study|Other than specified above|169|||
125405527|NCT03509948|451112893|FG000|Overall Study|Protocol Violation|0|||
125405528|NCT03509948|451112894|FG001|Overall Study|Protocol Violation|1|||
125405529|NCT03221257|451112895|FG000|Overall Study|Lost to Follow-up|0|||
125405530|NCT03221257|451112896|FG001|Overall Study|Lost to Follow-up|1|||
125405531|NCT03221257|451112895|FG000|Overall Study|Withdrawal by Subject|1|||
125405532|NCT03221257|451112896|FG001|Overall Study|Withdrawal by Subject|1|||
125405533|NCT01334866|451112900|FG000|Overall Study|Withdrawal by Subject|10|||
125405534|NCT01334866|451112900|FG000|Overall Study|Lost to Follow-up|3|||
125405535|NCT01334866|451112900|FG000|Overall Study|Physician Decision|3|||
125405536|NCT01334866|451112900|FG000|Overall Study|medically necessary prior to procedure|2|||
125405537|NCT01334866|451112900|FG000|Overall Study|medically necessary post-procedure|1|||
125405538|NCT01071512|451112909|FG000|Overall Study|Adverse Event|1|||
125405539|NCT01071512|451112909|FG000|Overall Study|Development of antibodies to drug|2|||
125278581|NCT02443116|450644060|FG000|Part 3|Lost to Follow-up|0|||
125405540|NCT01071512|451112909|FG000|Overall Study|positive anti-JC virus antibody test|2|||
125405541|NCT01687166|451112920|FG000|Overall Study|Attempt subject|2|||
125405542|NCT01687166|451112921|FG001|Overall Study|Attempt subject|3|||
125405543|NCT01687166|451112922|FG002|Overall Study|Attempt subject|2|||
125405544|NCT01687166|451112923|FG003|Overall Study|Attempt subject|0|||
125405545|NCT01687166|451112920|FG000|Overall Study|Did not meet eligibility criteria|4|||
125405546|NCT01687166|451112921|FG001|Overall Study|Did not meet eligibility criteria|6|||
125405547|NCT01687166|451112922|FG002|Overall Study|Did not meet eligibility criteria|1|||
125405548|NCT01687166|451112923|FG003|Overall Study|Did not meet eligibility criteria|1|||
125405549|NCT01687166|451112920|FG000|Overall Study|Adverse Event|2|||
125405550|NCT01687166|451112921|FG001|Overall Study|Adverse Event|1|||
125405551|NCT01687166|451112922|FG002|Overall Study|Adverse Event|0|||
125405552|NCT01687166|451112923|FG003|Overall Study|Adverse Event|0|||
125405553|NCT01687166|451112920|FG000|Overall Study|Physician Decision|3|||
125405554|NCT01687166|451112921|FG001|Overall Study|Physician Decision|2|||
125405555|NCT01687166|451112922|FG002|Overall Study|Physician Decision|1|||
125405556|NCT01687166|451112923|FG003|Overall Study|Physician Decision|0|||
125405557|NCT01687166|451112920|FG000|Overall Study|Withdrawal by Subject|11|||
125405558|NCT01687166|451112921|FG001|Overall Study|Withdrawal by Subject|4|||
125405559|NCT01687166|451112922|FG002|Overall Study|Withdrawal by Subject|3|||
125405560|NCT01687166|451112923|FG003|Overall Study|Withdrawal by Subject|0|||
125405561|NCT01687166|451112920|FG000|Overall Study|Lost to Follow-up|2|||
125405562|NCT01687166|451112921|FG001|Overall Study|Lost to Follow-up|5|||
125405563|NCT01687166|451112922|FG002|Overall Study|Lost to Follow-up|1|||
125405564|NCT01687166|451112923|FG003|Overall Study|Lost to Follow-up|0|||
125405565|NCT01687166|451112920|FG000|Overall Study|Equipment/Device Availability|0|||
125405566|NCT01687166|451112921|FG001|Overall Study|Equipment/Device Availability|1|||
125405567|NCT01687166|451112922|FG002|Overall Study|Equipment/Device Availability|0|||
125405568|NCT01687166|451112923|FG003|Overall Study|Equipment/Device Availability|0|||
125405569|NCT01687166|451112920|FG000|Overall Study|Death|1|||
125405570|NCT01687166|451112921|FG001|Overall Study|Death|1|||
125405571|NCT01687166|451112922|FG002|Overall Study|Death|0|||
125405572|NCT01687166|451112923|FG003|Overall Study|Death|0|||
125405573|NCT01687166|451112920|FG000|Overall Study|Protocol Violation|1|||
125405574|NCT01687166|451112921|FG001|Overall Study|Protocol Violation|1|||
125405575|NCT01687166|451112922|FG002|Overall Study|Protocol Violation|1|||
125405576|NCT01687166|451112923|FG003|Overall Study|Protocol Violation|0|||
125405577|NCT01687166|451112920|FG000|Overall Study|Subject moved out of state|0|||
125405578|NCT01687166|451112921|FG001|Overall Study|Subject moved out of state|1|||
125405579|NCT01687166|451112922|FG002|Overall Study|Subject moved out of state|0|||
125405580|NCT01687166|451112923|FG003|Overall Study|Subject moved out of state|0|||
125405581|NCT01687166|451112920|FG000|Overall Study|Patient unable to be compliant|1|||
125405582|NCT01687166|451112921|FG001|Overall Study|Patient unable to be compliant|0|||
125405583|NCT01687166|451112922|FG002|Overall Study|Patient unable to be compliant|0|||
125405584|NCT01687166|451112923|FG003|Overall Study|Patient unable to be compliant|0|||
125405585|NCT01687166|451112920|FG000|Overall Study|Physician choice to use different device|1|||
125405586|NCT01687166|451112921|FG001|Overall Study|Physician choice to use different device|2|||
125405587|NCT01687166|451112922|FG002|Overall Study|Physician choice to use different device|4|||
125405588|NCT01687166|451112923|FG003|Overall Study|Physician choice to use different device|0|||
125405589|NCT01687166|451112920|FG000|Overall Study|Insurance|0|||
125405590|NCT01687166|451112921|FG001|Overall Study|Insurance|0|||
125405591|NCT01687166|451112922|FG002|Overall Study|Insurance|1|||
125405592|NCT01687166|451112923|FG003|Overall Study|Insurance|1|||
125405593|NCT02296112|451112924|FG000|Overall Study|Disease progression|7|||
125405594|NCT02296112|451112924|FG000|Overall Study|Toxicity|1|||
125405595|NCT02296112|451112924|FG000|Overall Study|Began an alternate therapy|1|||
125405596|NCT02442830|451112925|FG000|Overall Study|Technical Failure|0|||
125405597|NCT02442830|451112926|FG001|Overall Study|Technical Failure|1|||
125405598|NCT01516879|451112927|FG000|Overall Study|Withdrawal by Subject|9|||
125405599|NCT01516879|451112928|FG001|Overall Study|Withdrawal by Subject|11|||
125405600|NCT01516879|451112927|FG000|Overall Study|Death|0|||
125405601|NCT01516879|451112928|FG001|Overall Study|Death|2|||
125405602|NCT01516879|451112927|FG000|Overall Study|Lost to Follow-up|2|||
125405603|NCT01516879|451112928|FG001|Overall Study|Lost to Follow-up|11|||
125405604|NCT01516879|451112927|FG000|Overall Study|Other|5|||
125405605|NCT01516879|451112928|FG001|Overall Study|Other|10|||
125405606|NCT00183872|451112929|FG000|Overall Study|Death|3|||
125405607|NCT00183872|451112929|FG000|Overall Study|Adverse Event|9|||
125405608|NCT00183872|451112929|FG000|Overall Study|Withdrawal by Subject|2|||
125405609|NCT00183872|451112929|FG000|Overall Study|Drug delayed more than 28 days|2|||
125405610|NCT02797262|451112930|FG000|Overall Study|Withdrawal by Subject|5|||
125405611|NCT02797262|451112931|FG001|Overall Study|Withdrawal by Subject|1|||
125405612|NCT02797262|451112930|FG000|Overall Study|Lost to Follow-up|10|||
125405613|NCT02797262|451112931|FG001|Overall Study|Lost to Follow-up|7|||
125405614|NCT02797262|451112930|FG000|Overall Study|Death|1|||
125405615|NCT02797262|451112931|FG001|Overall Study|Death|2|||
125405616|NCT02797262|451112930|FG000|Overall Study|Adverse Event|1|||
125405617|NCT02797262|451112931|FG001|Overall Study|Adverse Event|0|||
125405618|NCT02797262|451112930|FG000|Overall Study|COVID-19|2|||
125405619|NCT02797262|451112931|FG001|Overall Study|COVID-19|1|||
125405620|NCT02797262|451112930|FG000|Overall Study|Out-of-country|1|||
125405621|NCT02797262|451112931|FG001|Overall Study|Out-of-country|0|||
125405622|NCT01600586|451112932|FG000|Overall Study|Physician Decision|3|||
125405623|NCT01600586|451112933|FG001|Overall Study|Physician Decision|3|||
125405624|NCT01898793|451112934|FG000|Overall Study|Death|2|||
125405625|NCT01898793|451112935|FG001|Overall Study|Death|1|||
125405626|NCT01898793|451112936|FG002|Overall Study|Death|4|||
125405627|NCT01898793|451112937|FG003|Overall Study|Death|0|||
125405628|NCT01898793|451112938|FG004|Overall Study|Death|0|||
125405629|NCT01898793|451112939|FG005|Overall Study|Death|0|||
125405630|NCT01898793|451112940|FG006|Overall Study|Death|0|||
125405631|NCT00931307|451112941|FG000|Overall Study|Lack of Efficacy|12|||
125405632|NCT00931307|451112941|FG000|Overall Study|Biomicroscopy|1|||
125405633|NCT00983814|451112942|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
125405634|NCT00983814|451112943|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
125405635|NCT00983814|451112944|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
125405636|NCT00983814|451112942|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
125405637|NCT00983814|451112943|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
125405638|NCT00983814|451112944|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
125405639|NCT00983814|451112942|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
125405640|NCT00983814|451112943|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
125405641|NCT00983814|451112944|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
125405642|NCT00983814|451112942|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
125405643|NCT00983814|451112943|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
125405644|NCT00983814|451112944|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
125405645|NCT00983814|451112942|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
125405646|NCT00983814|451112943|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
125278582|NCT02443116|450644061|FG001|Part 3|Lost to Follow-up|0|||
125278583|NCT02443116|450644062|FG002|Part 3|Lost to Follow-up|0|||
125278584|NCT02443116|450644063|FG003|Part 3|Lost to Follow-up|0|||
125278585|NCT02443116|450644064|FG004|Part 3|Lost to Follow-up|0|||
125278586|NCT02443116|450644065|FG005|Part 3|Lost to Follow-up|0|||
125278587|NCT02443116|450644066|FG006|Part 3|Lost to Follow-up|0|||
125278588|NCT02443116|450644067|FG007|Part 3|Lost to Follow-up|1|||
125278589|NCT02443116|450644068|FG008|Part 3|Lost to Follow-up|2|||
125278590|NCT01932372|450644069|FG000|Overall Study|Not meeting eligibility criteria|33|||
125278591|NCT01932372|450644070|FG001|Overall Study|Not meeting eligibility criteria|179|||
125278592|NCT01917929|450644071|FG000|Overall Study|Death|8|||
125278593|NCT01917929|450644071|FG000|Overall Study|Lost to Follow-up|19|||
125278594|NCT01917929|450644071|FG000|Overall Study|Withdrawal by Subject|33|||
125278595|NCT01917929|450644071|FG000|Overall Study|Adverse Event|6|||
125278596|NCT01917929|450644071|FG000|Overall Study|Investigative Site Terminated|35|||
125278597|NCT01917929|450644071|FG000|Overall Study|Censored because study device not implanted|6|||
125278598|NCT01917929|450644071|FG000|Overall Study|Censored because surgery not performed|3|||
125278599|NCT01917929|450644071|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
125278600|NCT01917929|450644071|FG000|Overall Study|Sponsor terminated study|175|||
125278601|NCT02059499|450644079|FG000|Upto Week 20|Lost to Follow-up|2|||
125278602|NCT02059499|450644080|FG001|Upto Week 20|Lost to Follow-up|6|||
125278603|NCT02059499|450644081|FG002|Upto Week 20|Lost to Follow-up|0|||
125278604|NCT02059499|450644079|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
125278605|NCT02059499|450644080|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
125278606|NCT02059499|450644081|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
125278607|NCT02059499|450644079|FG000|Upto Week 20|Withdrawal by Subject|1|||
125278608|NCT02059499|450644080|FG001|Upto Week 20|Withdrawal by Subject|1|||
125278609|NCT02059499|450644081|FG002|Upto Week 20|Withdrawal by Subject|0|||
125278610|NCT02059499|450644079|FG000|Upto Week 20|No treatment per protocol criteria|0|||
125278611|NCT02059499|450644080|FG001|Upto Week 20|No treatment per protocol criteria|0|||
125278612|NCT02059499|450644081|FG002|Upto Week 20|No treatment per protocol criteria|5|||
125278613|NCT02059499|450644079|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
125278614|NCT02059499|450644080|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
125278615|NCT02059499|450644081|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
125278616|NCT02059499|450644079|FG000|Post-week 20|Lost to Follow-up|0|||
125278617|NCT02059499|450644080|FG001|Post-week 20|Lost to Follow-up|2|||
125278618|NCT02059499|450644081|FG002|Post-week 20|Lost to Follow-up|0|||
125278619|NCT02059499|450644079|FG000|Post-week 20|Withdrawal by Subject|0|||
125278620|NCT02059499|450644080|FG001|Post-week 20|Withdrawal by Subject|1|||
125278621|NCT02059499|450644081|FG002|Post-week 20|Withdrawal by Subject|0|||
125278622|NCT02059499|450644079|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
125278623|NCT02059499|450644080|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
125278624|NCT02059499|450644081|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
125278625|NCT00703846|450644082|FG000|Overall Study|Adverse Event|8|||
125278626|NCT00703846|450644082|FG000|Overall Study|Lost to Follow-up|55|||
125278627|NCT00703846|450644082|FG000|Overall Study|Lack of Efficacy|15|||
125278628|NCT00703846|450644082|FG000|Overall Study|Noncompliance with Study Treatment|2|||
125278629|NCT00703846|450644082|FG000|Overall Study|Withdrawal by Subject|40|||
125278630|NCT00703846|450644082|FG000|Overall Study|Death|1|||
125278631|NCT00703846|450644082|FG000|Overall Study|Other|14|||
125278632|NCT00703846|450644082|FG000|Overall Study|Did Not Receive Study Drug|2|||
125278633|NCT00830375|450644087|FG000|Overall Study|Lost to Follow-up|1|||
125278634|NCT01700959|450644088|FG000|Overall Study|Adverse Event|0|||
125278635|NCT01700959|450644089|FG001|Overall Study|Adverse Event|1|||
125278636|NCT01700959|450644090|FG002|Overall Study|Adverse Event|1|||
125278637|NCT01700959|450644091|FG003|Overall Study|Adverse Event|2|||
125278638|NCT01700959|450644092|FG004|Overall Study|Adverse Event|0|||
125278639|NCT01700959|450644093|FG005|Overall Study|Adverse Event|2|||
125278640|NCT01700959|450644088|FG000|Overall Study|Withdrawal by Subject|15|||
125278641|NCT01700959|450644089|FG001|Overall Study|Withdrawal by Subject|9|||
125278642|NCT01700959|450644090|FG002|Overall Study|Withdrawal by Subject|12|||
125278643|NCT01700959|450644091|FG003|Overall Study|Withdrawal by Subject|11|||
125278644|NCT01700959|450644092|FG004|Overall Study|Withdrawal by Subject|8|||
125278645|NCT01700959|450644093|FG005|Overall Study|Withdrawal by Subject|12|||
125278646|NCT01700959|450644088|FG000|Overall Study|Ineligible|2|||
125278647|NCT01700959|450644089|FG001|Overall Study|Ineligible|1|||
125278648|NCT01700959|450644090|FG002|Overall Study|Ineligible|2|||
125278649|NCT01700959|450644091|FG003|Overall Study|Ineligible|0|||
125278650|NCT01700959|450644092|FG004|Overall Study|Ineligible|0|||
125278651|NCT01700959|450644093|FG005|Overall Study|Ineligible|1|||
125278652|NCT01700959|450644088|FG000|Overall Study|Noncompliant|9|||
125405647|NCT00983814|451112944|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
125405648|NCT00829621|451112945|FG000|Overall Study|Death|1|||
125405649|NCT00829621|451112946|FG001|Overall Study|Death|0|||
125405650|NCT00829621|451112945|FG000|Overall Study|Lost to Follow-up|3|||
125405651|NCT00829621|451112946|FG001|Overall Study|Lost to Follow-up|4|||
125405652|NCT00774995|451112947|FG000|Overall Study|Protocol Violation|0|||
125405653|NCT00774995|451112948|FG001|Overall Study|Protocol Violation|0|||
125405654|NCT00774995|451112949|FG002|Overall Study|Protocol Violation|1|||
125405655|NCT00774995|451112950|FG003|Overall Study|Protocol Violation|0|||
125405656|NCT02139644|451114640|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
125405657|NCT02139644|451114641|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125405658|NCT02139644|451114642|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125405659|NCT02139644|451114643|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125405660|NCT02139644|451114644|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125405661|NCT02139644|451114645|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
125405662|NCT02139644|451114640|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
125405663|NCT02139644|451114641|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125405664|NCT02139644|451114642|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125405665|NCT02139644|451114643|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125405666|NCT02139644|451114644|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125405667|NCT02139644|451114645|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
125405668|NCT02139644|451114640|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
125405669|NCT02139644|451114641|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125405670|NCT02139644|451114642|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125405671|NCT02139644|451114643|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125405672|NCT02139644|451114644|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125405673|NCT02139644|451114645|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
125405674|NCT02139644|451114640|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
125405675|NCT02139644|451114641|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125405676|NCT02139644|451114642|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125405677|NCT02139644|451114643|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125405678|NCT02139644|451114644|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125405679|NCT02139644|451114645|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
125405680|NCT02139644|451114640|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
125405681|NCT02139644|451114641|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125405682|NCT02139644|451114642|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125405683|NCT02139644|451114643|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125405684|NCT02139644|451114644|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125405685|NCT02139644|451114645|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
125405686|NCT02139644|451114640|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
125405687|NCT02139644|451114641|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
125405688|NCT02139644|451114642|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
125405689|NCT02139644|451114643|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
125405690|NCT02139644|451114644|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
125405691|NCT02139644|451114645|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
125405692|NCT02139644|451114640|FG000|Run-In Period (Pre-assignment)|Other|6|||
125405693|NCT02139644|451114641|FG001|Run-In Period (Pre-assignment)|Other|0|||
125405694|NCT02139644|451114642|FG002|Run-In Period (Pre-assignment)|Other|0|||
125405695|NCT02139644|451114643|FG003|Run-In Period (Pre-assignment)|Other|0|||
125405696|NCT02139644|451114644|FG004|Run-In Period (Pre-assignment)|Other|0|||
125405697|NCT02139644|451114645|FG005|Run-In Period (Pre-assignment)|Other|0|||
125405698|NCT02139644|451114640|FG000|Treatment Period|Adverse Event|0|||
125405699|NCT02139644|451114641|FG001|Treatment Period|Adverse Event|0|||
125405700|NCT02139644|451114642|FG002|Treatment Period|Adverse Event|3|||
125405701|NCT02139644|451114643|FG003|Treatment Period|Adverse Event|2|||
125405702|NCT02139644|451114644|FG004|Treatment Period|Adverse Event|1|||
125405703|NCT02139644|451114645|FG005|Treatment Period|Adverse Event|6|||
125405704|NCT02139644|451114640|FG000|Treatment Period|Withdrawal by Subject|0|||
125405705|NCT02139644|451114641|FG001|Treatment Period|Withdrawal by Subject|0|||
125405706|NCT02139644|451114642|FG002|Treatment Period|Withdrawal by Subject|2|||
125405707|NCT02139644|451114643|FG003|Treatment Period|Withdrawal by Subject|2|||
125405708|NCT02139644|451114644|FG004|Treatment Period|Withdrawal by Subject|3|||
125405709|NCT02139644|451114645|FG005|Treatment Period|Withdrawal by Subject|2|||
125405710|NCT02139644|451114640|FG000|Treatment Period|Non-compliance|0|||
125405711|NCT02139644|451114641|FG001|Treatment Period|Non-compliance|0|||
125448172|NCT02403674|451268862|FG000|Base Study|Death|1|||
125405712|NCT02139644|451114642|FG002|Treatment Period|Non-compliance|0|||
125405713|NCT02139644|451114643|FG003|Treatment Period|Non-compliance|1|||
125405714|NCT02139644|451114644|FG004|Treatment Period|Non-compliance|0|||
125405715|NCT02139644|451114645|FG005|Treatment Period|Non-compliance|0|||
125405716|NCT02139644|451114640|FG000|Treatment Period|Protocol Violation|0|||
125448173|NCT02403674|451268863|FG001|Base Study|Death|4|||
125405717|NCT02139644|451114641|FG001|Treatment Period|Protocol Violation|0|||
125405718|NCT02139644|451114642|FG002|Treatment Period|Protocol Violation|0|||
125405719|NCT02139644|451114643|FG003|Treatment Period|Protocol Violation|1|||
125405720|NCT02139644|451114644|FG004|Treatment Period|Protocol Violation|1|||
125405721|NCT02139644|451114645|FG005|Treatment Period|Protocol Violation|1|||
125405722|NCT02139644|451114640|FG000|Treatment Period|Disease progression|0|||
125405723|NCT02139644|451114641|FG001|Treatment Period|Disease progression|0|||
125405724|NCT02139644|451114642|FG002|Treatment Period|Disease progression|0|||
125405725|NCT02139644|451114643|FG003|Treatment Period|Disease progression|1|||
125405726|NCT02139644|451114644|FG004|Treatment Period|Disease progression|1|||
125405727|NCT02139644|451114645|FG005|Treatment Period|Disease progression|2|||
125405728|NCT02139644|451114640|FG000|Treatment Period|Lost to Follow-up|0|||
125405729|NCT02139644|451114641|FG001|Treatment Period|Lost to Follow-up|0|||
125405730|NCT02139644|451114642|FG002|Treatment Period|Lost to Follow-up|1|||
125405731|NCT02139644|451114643|FG003|Treatment Period|Lost to Follow-up|1|||
125405732|NCT02139644|451114644|FG004|Treatment Period|Lost to Follow-up|1|||
125405733|NCT02139644|451114645|FG005|Treatment Period|Lost to Follow-up|1|||
125405734|NCT02139644|451114640|FG000|Treatment Period|Lack of Efficacy|0|||
125405735|NCT02139644|451114641|FG001|Treatment Period|Lack of Efficacy|0|||
125405736|NCT02139644|451114642|FG002|Treatment Period|Lack of Efficacy|1|||
125405737|NCT02139644|451114643|FG003|Treatment Period|Lack of Efficacy|0|||
125405738|NCT02139644|451114644|FG004|Treatment Period|Lack of Efficacy|1|||
125405739|NCT02139644|451114645|FG005|Treatment Period|Lack of Efficacy|4|||
125405740|NCT02139644|451114640|FG000|Treatment Period|Other|0|||
125405741|NCT02139644|451114641|FG001|Treatment Period|Other|3|||
125405742|NCT02139644|451114642|FG002|Treatment Period|Other|1|||
125405743|NCT02139644|451114643|FG003|Treatment Period|Other|1|||
125405744|NCT02139644|451114644|FG004|Treatment Period|Other|0|||
125405745|NCT02139644|451114645|FG005|Treatment Period|Other|1|||
125405746|NCT00608829|451114646|FG000|Overall Study|Death|6|||
125405747|NCT00608829|451114646|FG000|Overall Study|Withdrawal by Subject|4|||
125405748|NCT00608829|451114646|FG000|Overall Study|Subject refuses to follow up or return.|5|||
125405749|NCT02564471|451114647|FG000|Overall Study|Adverse Event|1|||
125405750|NCT02564471|451114648|FG001|Overall Study|Adverse Event|0|||
125405751|NCT02564471|451114649|FG002|Overall Study|Adverse Event|0|||
125405752|NCT02564471|451114650|FG003|Overall Study|Adverse Event|0|||
125405753|NCT02564471|451114647|FG000|Overall Study|Withdrawal by Subject|2|||
125405754|NCT02564471|451114648|FG001|Overall Study|Withdrawal by Subject|1|||
125405755|NCT02564471|451114649|FG002|Overall Study|Withdrawal by Subject|3|||
125405756|NCT02564471|451114650|FG003|Overall Study|Withdrawal by Subject|0|||
125405757|NCT02564471|451114647|FG000|Overall Study|Lost to Follow-up|0|||
125405758|NCT02564471|451114648|FG001|Overall Study|Lost to Follow-up|2|||
125405759|NCT02564471|451114649|FG002|Overall Study|Lost to Follow-up|0|||
125405760|NCT02564471|451114650|FG003|Overall Study|Lost to Follow-up|0|||
125405761|NCT02805257|451114651|FG000|Overall Study|Lost to Follow-up|7|||
125405762|NCT02805257|451114652|FG001|Overall Study|Lost to Follow-up|6|||
125405763|NCT02805257|451114651|FG000|Overall Study|Death|0|||
125405764|NCT02805257|451114652|FG001|Overall Study|Death|1|||
125405765|NCT02033889|451114658|FG000|Overall Study|Adverse Event|3|||
125405766|NCT02033889|451114659|FG001|Overall Study|Adverse Event|1|||
125405767|NCT02033889|451114660|FG002|Overall Study|Adverse Event|3|||
125405768|NCT02033889|451114658|FG000|Overall Study|Death|3|||
125405769|NCT02033889|451114659|FG001|Overall Study|Death|1|||
125405770|NCT02033889|451114660|FG002|Overall Study|Death|2|||
125405771|NCT02033889|451114658|FG000|Overall Study|Excluded Medication|1|||
125405772|NCT02033889|451114659|FG001|Overall Study|Excluded Medication|1|||
125405773|NCT02033889|451114660|FG002|Overall Study|Excluded Medication|0|||
125405774|NCT02033889|451114658|FG000|Overall Study|Lost to Follow-up|8|||
125405775|NCT02033889|451114659|FG001|Overall Study|Lost to Follow-up|5|||
125405776|NCT02033889|451114660|FG002|Overall Study|Lost to Follow-up|6|||
125405777|NCT02033889|451114658|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125405778|NCT02033889|451114659|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125405779|NCT02033889|451114660|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125405780|NCT02033889|451114658|FG000|Overall Study|Physician Decision|0|||
125405781|NCT02033889|451114659|FG001|Overall Study|Physician Decision|1|||
125405782|NCT02033889|451114660|FG002|Overall Study|Physician Decision|1|||
125405783|NCT02033889|451114658|FG000|Overall Study|Participant moved|0|||
125405784|NCT02033889|451114659|FG001|Overall Study|Participant moved|1|||
125405785|NCT02033889|451114660|FG002|Overall Study|Participant moved|0|||
125405786|NCT02033889|451114658|FG000|Overall Study|Withdrawal by Subject|18|||
125405787|NCT02033889|451114659|FG001|Overall Study|Withdrawal by Subject|10|||
125405788|NCT02033889|451114660|FG002|Overall Study|Withdrawal by Subject|13|||
125405789|NCT02343458|451114663|FG000|Overall Study|Adverse Event|15|||
125405790|NCT02343458|451114664|FG001|Overall Study|Adverse Event|14|||
125405791|NCT02343458|451114665|FG002|Overall Study|Adverse Event|15|||
125405792|NCT02343458|451114666|FG003|Overall Study|Adverse Event|3|||
125405793|NCT02343458|451114663|FG000|Overall Study|Lack of Efficacy|3|||
125405794|NCT02343458|451114664|FG001|Overall Study|Lack of Efficacy|8|||
125405795|NCT02343458|451114665|FG002|Overall Study|Lack of Efficacy|4|||
125405796|NCT02343458|451114666|FG003|Overall Study|Lack of Efficacy|8|||
125405797|NCT02343458|451114663|FG000|Overall Study|Withdrawal by Subject|18|||
125405798|NCT02343458|451114664|FG001|Overall Study|Withdrawal by Subject|17|||
125405799|NCT02343458|451114665|FG002|Overall Study|Withdrawal by Subject|23|||
125405800|NCT02343458|451114666|FG003|Overall Study|Withdrawal by Subject|14|||
125405801|NCT02343458|451114663|FG000|Overall Study|Physician Decision|1|||
125405802|NCT02343458|451114664|FG001|Overall Study|Physician Decision|4|||
125405803|NCT02343458|451114665|FG002|Overall Study|Physician Decision|2|||
125405804|NCT02343458|451114666|FG003|Overall Study|Physician Decision|2|||
125405805|NCT02343458|451114663|FG000|Overall Study|Lost to Follow-up|5|||
125405806|NCT02343458|451114664|FG001|Overall Study|Lost to Follow-up|5|||
125405807|NCT02343458|451114665|FG002|Overall Study|Lost to Follow-up|3|||
125405808|NCT02343458|451114666|FG003|Overall Study|Lost to Follow-up|1|||
125405809|NCT02343458|451114663|FG000|Overall Study|Protocol Violation|2|||
125405810|NCT02343458|451114664|FG001|Overall Study|Protocol Violation|5|||
125405811|NCT02343458|451114665|FG002|Overall Study|Protocol Violation|2|||
125405812|NCT02343458|451114666|FG003|Overall Study|Protocol Violation|2|||
125405813|NCT02343458|451114663|FG000|Overall Study|Protocol Specified Criteria|17|||
125405814|NCT02343458|451114664|FG001|Overall Study|Protocol Specified Criteria|13|||
125405815|NCT02343458|451114665|FG002|Overall Study|Protocol Specified Criteria|14|||
125405816|NCT02343458|451114666|FG003|Overall Study|Protocol Specified Criteria|8|||
125405817|NCT02080091|451114667|FG000|Overall Study|Study Terminated|22|||
125405818|NCT02080091|451114667|FG000|Overall Study|Death|1|||
125405819|NCT02080091|451114667|FG000|Overall Study|Withdrawal by Subject|1|||
125405820|NCT02080091|451114667|FG000|Overall Study|Other|1|||
125405821|NCT01913041|451114668|FG000|Overall Study|Protocol Violation|35|||
125405822|NCT01913041|451114668|FG000|Overall Study|Withdrawal by Subject|3|||
125405823|NCT01913041|451114668|FG000|Overall Study|Physician Decision|1|||
125405824|NCT01265953|451114670|FG000|Overall Study|Non compliance|5|||
125405825|NCT01265953|451114671|FG001|Overall Study|Non compliance|3|||
125405826|NCT01610700|451114672|FG000|Overall Study|Adverse Event|3|||
125405827|NCT01610700|451114673|FG001|Overall Study|Adverse Event|1|||
125405828|NCT01610700|451114672|FG000|Overall Study|Withdrawal by Subject|0|||
125405829|NCT01610700|451114673|FG001|Overall Study|Withdrawal by Subject|1|||
125405830|NCT01610700|451114672|FG000|Overall Study|subject took one dose of street cannabis|0|||
125405831|NCT01610700|451114673|FG001|Overall Study|subject took one dose of street cannabis|1|||
125405832|NCT02648698|451114674|FG000|Overall Study|Protocol Violation|1|||
125405833|NCT02648698|451114675|FG001|Overall Study|Protocol Violation|5|||
125405834|NCT01640301|451114676|FG000|Overall Study|Death|0|||
125405835|NCT01640301|451114677|FG001|Overall Study|Death|8|||
125405836|NCT03143829|451114678|FG000|Overall Study|Withdrawal by Subject|2|||
125405837|NCT03143829|451114679|FG001|Overall Study|Withdrawal by Subject|5|||
125405838|NCT03143829|451114678|FG000|Overall Study|Lost to Follow-up|0|||
125405839|NCT03143829|451114679|FG001|Overall Study|Lost to Follow-up|2|||
125405840|NCT03143829|451114678|FG000|Overall Study|Death|1|||
125405841|NCT03143829|451114679|FG001|Overall Study|Death|1|||
125405842|NCT03143829|451114678|FG000|Overall Study|changed treatment, no longer eligible|2|||
125405843|NCT03143829|451114679|FG001|Overall Study|changed treatment, no longer eligible|2|||
125405844|NCT00672477|451114682|FG000|Overall Study|Adverse Event|10|||
125405845|NCT00672477|451114683|FG001|Overall Study|Adverse Event|7|||
125405846|NCT00672477|451114682|FG000|Overall Study|Death|7|||
125405847|NCT00672477|451114683|FG001|Overall Study|Death|11|||
125405848|NCT00672477|451114682|FG000|Overall Study|Physician Decision|2|||
125405849|NCT00672477|451114683|FG001|Overall Study|Physician Decision|0|||
125405850|NCT00672477|451114682|FG000|Overall Study|Protocol Violation|1|||
125405851|NCT00672477|451114683|FG001|Overall Study|Protocol Violation|1|||
125405852|NCT00672477|451114682|FG000|Overall Study|Withdrawal by Subject|5|||
125405853|NCT00672477|451114683|FG001|Overall Study|Withdrawal by Subject|3|||
125405854|NCT00672477|451114682|FG000|Overall Study|Lack of Efficacy|1|||
125405855|NCT00672477|451114683|FG001|Overall Study|Lack of Efficacy|1|||
125405856|NCT00672477|451114682|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
125405857|NCT00672477|451114683|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
125405858|NCT02886572|451114687|FG000|Overall Study|Death|8|||
125405859|NCT00274716|451114692|FG000|Phase A|Other non-reported reason|4|||
125405860|NCT00274716|451114693|FG001|Phase A|Other non-reported reason|2|||
125278653|NCT01700959|450644089|FG001|Overall Study|Noncompliant|9|||
125405861|NCT00274716|451114694|FG002|Phase A|Other non-reported reason|1|||
125405862|NCT00274716|451114695|FG003|Phase A|Other non-reported reason|2|||
125405863|NCT00274716|451114696|FG004|Phase A|Other non-reported reason|0|||
125405864|NCT00274716|451114697|FG005|Phase A|Other non-reported reason|1|||
125405865|NCT00274716|451114692|FG000|Phase A|Participant moved|0|||
125405866|NCT00274716|451114693|FG001|Phase A|Participant moved|0|||
125405867|NCT00274716|451114694|FG002|Phase A|Participant moved|1|||
125405868|NCT00274716|451114695|FG003|Phase A|Participant moved|0|||
125405869|NCT00274716|451114696|FG004|Phase A|Participant moved|0|||
125405870|NCT00274716|451114697|FG005|Phase A|Participant moved|1|||
125405871|NCT00274716|451114692|FG000|Phase A|Site Terminated|0|||
125405872|NCT00274716|451114693|FG001|Phase A|Site Terminated|0|||
125278654|NCT01700959|450644090|FG002|Overall Study|Noncompliant|17|||
125405873|NCT00274716|451114694|FG002|Phase A|Site Terminated|0|||
125278655|NCT01700959|450644091|FG003|Overall Study|Noncompliant|18|||
125278656|NCT01700959|450644092|FG004|Overall Study|Noncompliant|15|||
125405874|NCT00274716|451114695|FG003|Phase A|Site Terminated|1|||
125405875|NCT00274716|451114696|FG004|Phase A|Site Terminated|0|||
125405876|NCT00274716|451114697|FG005|Phase A|Site Terminated|0|||
125405877|NCT00274716|451114692|FG000|Phase A|Protocol Violation|1|||
125405878|NCT00274716|451114693|FG001|Phase A|Protocol Violation|0|||
125405879|NCT00274716|451114694|FG002|Phase A|Protocol Violation|0|||
125405880|NCT00274716|451114695|FG003|Phase A|Protocol Violation|1|||
125405881|NCT00274716|451114696|FG004|Phase A|Protocol Violation|0|||
125405882|NCT00274716|451114697|FG005|Phase A|Protocol Violation|0|||
125405883|NCT00274716|451114692|FG000|Phase A|Met criteria for discontinuation|1|||
125405884|NCT00274716|451114693|FG001|Phase A|Met criteria for discontinuation|1|||
125405885|NCT00274716|451114694|FG002|Phase A|Met criteria for discontinuation|0|||
125405886|NCT00274716|451114695|FG003|Phase A|Met criteria for discontinuation|0|||
125405887|NCT00274716|451114696|FG004|Phase A|Met criteria for discontinuation|0|||
125405888|NCT00274716|451114697|FG005|Phase A|Met criteria for discontinuation|0|||
125405889|NCT00274716|451114692|FG000|Phase A|Withdrawal by Subject|2|||
125405890|NCT00274716|451114693|FG001|Phase A|Withdrawal by Subject|2|||
125405891|NCT00274716|451114694|FG002|Phase A|Withdrawal by Subject|1|||
125405892|NCT00274716|451114695|FG003|Phase A|Withdrawal by Subject|3|||
125405893|NCT00274716|451114696|FG004|Phase A|Withdrawal by Subject|0|||
125405894|NCT00274716|451114697|FG005|Phase A|Withdrawal by Subject|1|||
125405895|NCT00274716|451114692|FG000|Phase A|Adverse Event|2|||
125405896|NCT00274716|451114693|FG001|Phase A|Adverse Event|3|||
125405897|NCT00274716|451114694|FG002|Phase A|Adverse Event|3|||
125405898|NCT00274716|451114695|FG003|Phase A|Adverse Event|0|||
125405899|NCT00274716|451114696|FG004|Phase A|Adverse Event|2|||
125405900|NCT00274716|451114697|FG005|Phase A|Adverse Event|0|||
125405901|NCT00274716|451114692|FG000|Phase A|Completed but did not enter Phase B|1|||
125405902|NCT00274716|451114693|FG001|Phase A|Completed but did not enter Phase B|2|||
125405903|NCT00274716|451114694|FG002|Phase A|Completed but did not enter Phase B|2|||
125405904|NCT00274716|451114695|FG003|Phase A|Completed but did not enter Phase B|2|||
125405905|NCT00274716|451114696|FG004|Phase A|Completed but did not enter Phase B|1|||
125278657|NCT01700959|450644093|FG005|Overall Study|Noncompliant|9|||
125278658|NCT01700959|450644088|FG000|Overall Study|Side effects|1|||
125405906|NCT00274716|451114697|FG005|Phase A|Completed but did not enter Phase B|1|||
125405907|NCT00274716|451114692|FG000|Phase B|Adverse Event|0|||
125405908|NCT00274716|451114693|FG001|Phase B|Adverse Event|0|||
125405909|NCT00274716|451114694|FG002|Phase B|Adverse Event|2|||
125405910|NCT00274716|451114695|FG003|Phase B|Adverse Event|0|||
125405911|NCT00274716|451114696|FG004|Phase B|Adverse Event|0|||
125405912|NCT00274716|451114697|FG005|Phase B|Adverse Event|1|||
125405913|NCT00274716|451114692|FG000|Phase B|Protocol Violation|0|||
125405914|NCT00274716|451114693|FG001|Phase B|Protocol Violation|2|||
125405915|NCT00274716|451114694|FG002|Phase B|Protocol Violation|0|||
125405916|NCT00274716|451114695|FG003|Phase B|Protocol Violation|0|||
125405917|NCT00274716|451114696|FG004|Phase B|Protocol Violation|0|||
125405918|NCT00274716|451114697|FG005|Phase B|Protocol Violation|0|||
125405919|NCT00274716|451114692|FG000|Phase B|Withdrawal by Subject|0|||
125405920|NCT00274716|451114693|FG001|Phase B|Withdrawal by Subject|1|||
125405921|NCT00274716|451114694|FG002|Phase B|Withdrawal by Subject|0|||
125405922|NCT00274716|451114695|FG003|Phase B|Withdrawal by Subject|0|||
125405923|NCT00274716|451114696|FG004|Phase B|Withdrawal by Subject|0|||
125405924|NCT00274716|451114697|FG005|Phase B|Withdrawal by Subject|0|||
125405925|NCT00274716|451114692|FG000|Phase B|Participant moved|1|||
125405926|NCT00274716|451114693|FG001|Phase B|Participant moved|0|||
125405927|NCT00274716|451114694|FG002|Phase B|Participant moved|0|||
125405928|NCT00274716|451114695|FG003|Phase B|Participant moved|0|||
125405929|NCT00274716|451114696|FG004|Phase B|Participant moved|0|||
125405930|NCT00274716|451114697|FG005|Phase B|Participant moved|0|||
125405931|NCT00274716|451114692|FG000|Phase B|Other non-reported reason|0|||
125278659|NCT01700959|450644089|FG001|Overall Study|Side effects|4|||
125405932|NCT00274716|451114693|FG001|Phase B|Other non-reported reason|0|||
125405933|NCT00274716|451114694|FG002|Phase B|Other non-reported reason|1|||
125405934|NCT00274716|451114695|FG003|Phase B|Other non-reported reason|1|||
125405935|NCT00274716|451114696|FG004|Phase B|Other non-reported reason|0|||
125448174|NCT02403674|451268862|FG000|Base Study|Adverse Event|11|||
125278660|NCT01700959|450644090|FG002|Overall Study|Side effects|8|||
125278661|NCT01700959|450644091|FG003|Overall Study|Side effects|4|||
125405936|NCT00274716|451114697|FG005|Phase B|Other non-reported reason|0|||
125405937|NCT00274716|451114692|FG000|Phase B|Lost to Follow-up|0|||
125278662|NCT01700959|450644092|FG004|Overall Study|Side effects|4|||
125278663|NCT01700959|450644093|FG005|Overall Study|Side effects|1|||
125405938|NCT00274716|451114693|FG001|Phase B|Lost to Follow-up|1|||
125405939|NCT00274716|451114694|FG002|Phase B|Lost to Follow-up|0|||
125405940|NCT00274716|451114695|FG003|Phase B|Lost to Follow-up|0|||
125405941|NCT00274716|451114696|FG004|Phase B|Lost to Follow-up|0|||
125405942|NCT00274716|451114697|FG005|Phase B|Lost to Follow-up|0|||
125405943|NCT00982319|451114700|FG000|Overall Study|Surgery date change|1|||
125405944|NCT00982319|451114701|FG001|Overall Study|Surgery date change|0|||
125405945|NCT00982319|451114700|FG000|Overall Study|Preop values out of acceptable range|1|||
125405946|NCT00982319|451114701|FG001|Overall Study|Preop values out of acceptable range|1|||
125405947|NCT00982319|451114700|FG000|Overall Study|Pregnancy|0|||
125405948|NCT00982319|451114701|FG001|Overall Study|Pregnancy|1|||
125405949|NCT00975975|451114702|FG000|Overall Study|Death|6|||
125405950|NCT00961259|451114703|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
125405951|NCT00961259|451114704|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
125405952|NCT00961259|451114705|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
125405953|NCT01252251|451114708|FG000|Overall Study|Withdrawal by Subject|1|||
125405954|NCT01324024|451114709|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
125405955|NCT01324024|451114710|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125405956|NCT01923181|451114711|FG000|Overall Study|Protocol Violation|2|||
125405957|NCT01923181|451114712|FG001|Overall Study|Protocol Violation|2|||
125405958|NCT01923181|451114713|FG002|Overall Study|Protocol Violation|0|||
125405959|NCT01923181|451114714|FG003|Overall Study|Protocol Violation|2|||
125405960|NCT01923181|451114715|FG004|Overall Study|Protocol Violation|2|||
125405961|NCT01923181|451114716|FG005|Overall Study|Protocol Violation|1|||
125405962|NCT01923181|451114717|FG006|Overall Study|Protocol Violation|1|||
125405963|NCT01923181|451114718|FG007|Overall Study|Protocol Violation|2|||
125405964|NCT01923181|451114719|FG008|Overall Study|Protocol Violation|1|||
125405965|NCT01923181|451114711|FG000|Overall Study|Withdrawal by Subject|0|||
125405966|NCT01923181|451114712|FG001|Overall Study|Withdrawal by Subject|1|||
125405967|NCT01923181|451114713|FG002|Overall Study|Withdrawal by Subject|0|||
125405968|NCT01923181|451114714|FG003|Overall Study|Withdrawal by Subject|1|||
125405969|NCT01923181|451114715|FG004|Overall Study|Withdrawal by Subject|4|||
125405970|NCT01923181|451114716|FG005|Overall Study|Withdrawal by Subject|2|||
125405971|NCT01923181|451114717|FG006|Overall Study|Withdrawal by Subject|4|||
125405972|NCT01923181|451114718|FG007|Overall Study|Withdrawal by Subject|3|||
125405973|NCT01923181|451114719|FG008|Overall Study|Withdrawal by Subject|1|||
125405974|NCT01923181|451114711|FG000|Overall Study|Other|1|||
125405975|NCT01923181|451114712|FG001|Overall Study|Other|0|||
125405976|NCT01923181|451114713|FG002|Overall Study|Other|0|||
125405977|NCT01923181|451114714|FG003|Overall Study|Other|1|||
125405978|NCT01923181|451114715|FG004|Overall Study|Other|0|||
125405979|NCT01923181|451114716|FG005|Overall Study|Other|0|||
125405980|NCT01923181|451114717|FG006|Overall Study|Other|0|||
125405981|NCT01923181|451114718|FG007|Overall Study|Other|0|||
125405982|NCT01923181|451114719|FG008|Overall Study|Other|0|||
125405983|NCT01923181|451114711|FG000|Overall Study|Lost to Follow-up|0|||
125405984|NCT01923181|451114712|FG001|Overall Study|Lost to Follow-up|3|||
125405985|NCT01923181|451114713|FG002|Overall Study|Lost to Follow-up|2|||
125405986|NCT01923181|451114714|FG003|Overall Study|Lost to Follow-up|1|||
125405987|NCT01923181|451114715|FG004|Overall Study|Lost to Follow-up|2|||
125405988|NCT01923181|451114716|FG005|Overall Study|Lost to Follow-up|1|||
125405989|NCT01923181|451114717|FG006|Overall Study|Lost to Follow-up|3|||
125405990|NCT01923181|451114718|FG007|Overall Study|Lost to Follow-up|3|||
125405991|NCT01923181|451114719|FG008|Overall Study|Lost to Follow-up|1|||
125405992|NCT02057757|451114725|FG000|Overall Study|Withdrawal by Subject|3|||
125405993|NCT02057757|451114726|FG001|Overall Study|Withdrawal by Subject|5|||
125405994|NCT02057757|451114725|FG000|Overall Study|Death|2|||
125405995|NCT02057757|451114726|FG001|Overall Study|Death|0|||
125405996|NCT02057757|451114725|FG000|Overall Study|Lost to Follow-up|8|||
125405997|NCT02057757|451114726|FG001|Overall Study|Lost to Follow-up|3|||
125405998|NCT02057757|451114725|FG000|Overall Study|Non-compliance|1|||
125405999|NCT02057757|451114726|FG001|Overall Study|Non-compliance|0|||
125406000|NCT03614793|451114727|FG000|Overall Study|Lost to Follow-up|1|||
125406001|NCT03614793|451114728|FG001|Overall Study|Lost to Follow-up|2|||
125406002|NCT03614793|451114727|FG000|Overall Study|Lack of Efficacy|0|||
125406003|NCT03614793|451114728|FG001|Overall Study|Lack of Efficacy|5|||
125406004|NCT03614793|451114727|FG000|Overall Study|Withdrawal by Subject|0|||
125406005|NCT03614793|451114728|FG001|Overall Study|Withdrawal by Subject|1|||
125406006|NCT03614793|451114727|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
125406007|NCT03614793|451114728|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
125406008|NCT02082522|451114729|FG000|Overall Study|Sponsor termination|5|||
125406009|NCT02082522|451114730|FG001|Overall Study|Sponsor termination|3|||
125406010|NCT02082522|451114729|FG000|Overall Study|Withdrawal by Subject|2|||
125406011|NCT02082522|451114730|FG001|Overall Study|Withdrawal by Subject|4|||
125406012|NCT02082522|451114729|FG000|Overall Study|Death|1|||
125406013|NCT02082522|451114730|FG001|Overall Study|Death|0|||
125406014|NCT02082522|451114729|FG000|Overall Study|Lost to Follow-up|1|||
125406015|NCT02082522|451114730|FG001|Overall Study|Lost to Follow-up|0|||
125406016|NCT02082522|451114729|FG000|Overall Study|Physician Decision|3|||
125406017|NCT02082522|451114730|FG001|Overall Study|Physician Decision|1|||
125406018|NCT02082522|451114729|FG000|Overall Study|Disease progression|2|||
125406019|NCT02082522|451114730|FG001|Overall Study|Disease progression|2|||
125406020|NCT02082522|451114729|FG000|Overall Study|Chemotherapy change|1|||
125406021|NCT02082522|451114730|FG001|Overall Study|Chemotherapy change|3|||
125406022|NCT00456092|451114731|FG000|Extension Phase|Grade 2 or Greater AE|2|||
125406023|NCT00456092|451114732|FG001|Extension Phase|Grade 2 or Greater AE|2|||
125406024|NCT00456092|451114733|FG002|Extension Phase|Grade 2 or Greater AE|0|||
125406025|NCT00456092|451114734|FG003|Extension Phase|Grade 2 or Greater AE|0|||
125406026|NCT00456092|451114735|FG004|Extension Phase|Grade 2 or Greater AE|2|||
125406027|NCT00456092|451114731|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
125406028|NCT00456092|451114732|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
125406029|NCT00456092|451114733|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
125406030|NCT00456092|451114734|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
125406031|NCT00456092|451114735|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
125406032|NCT00456092|451114731|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
125406033|NCT00456092|451114732|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
125406034|NCT00456092|451114733|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
125406035|NCT00456092|451114734|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
125406036|NCT00456092|451114735|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
125406037|NCT00456092|451114731|FG000|Extension Phase|Withdrew Consent|2|||
125406038|NCT00456092|451114732|FG001|Extension Phase|Withdrew Consent|0|||
125406039|NCT00456092|451114733|FG002|Extension Phase|Withdrew Consent|0|||
125406040|NCT00456092|451114734|FG003|Extension Phase|Withdrew Consent|0|||
125406041|NCT00456092|451114735|FG004|Extension Phase|Withdrew Consent|0|||
125406042|NCT00456092|451114731|FG000|Extension Phase|Lost to Follow-up|1|||
125406043|NCT00456092|451114732|FG001|Extension Phase|Lost to Follow-up|1|||
125406044|NCT00456092|451114733|FG002|Extension Phase|Lost to Follow-up|0|||
125406045|NCT00456092|451114734|FG003|Extension Phase|Lost to Follow-up|0|||
125406046|NCT00456092|451114735|FG004|Extension Phase|Lost to Follow-up|1|||
125406047|NCT00456092|451114731|FG000|Extension Phase|Other|2|||
125406048|NCT00456092|451114732|FG001|Extension Phase|Other|0|||
125406049|NCT00456092|451114733|FG002|Extension Phase|Other|0|||
125406050|NCT00456092|451114734|FG003|Extension Phase|Other|1|||
125406051|NCT00456092|451114735|FG004|Extension Phase|Other|1|||
125406052|NCT00456092|451114731|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
125406053|NCT00456092|451114732|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
125406054|NCT00456092|451114733|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
125406055|NCT00456092|451114734|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
125406056|NCT00456092|451114735|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
125406057|NCT00456092|451114731|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
125406058|NCT00456092|451114732|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
125406059|NCT00456092|451114733|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
125406060|NCT00456092|451114734|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
125406061|NCT00456092|451114735|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
125406062|NCT00456092|451114731|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
125406063|NCT00456092|451114732|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
125406064|NCT00456092|451114733|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
125406065|NCT00456092|451114734|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
125406066|NCT00456092|451114735|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
125406067|NCT00456092|451114731|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
125406068|NCT00456092|451114732|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
125406069|NCT00456092|451114733|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
125406070|NCT00456092|451114734|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
125406071|NCT00456092|451114735|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
125406072|NCT00456092|451114731|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
125406073|NCT00456092|451114732|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
125406074|NCT00456092|451114733|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
125406075|NCT00456092|451114734|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
125406076|NCT00456092|451114735|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
125406077|NCT00456092|451114731|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
125406078|NCT00456092|451114732|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
125406079|NCT00456092|451114733|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
125406080|NCT00456092|451114734|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
125406081|NCT00456092|451114735|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
125406082|NCT00456092|451114731|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
125406083|NCT00456092|451114732|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
125406084|NCT00456092|451114733|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
125406085|NCT00456092|451114734|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
125278664|NCT00782171|450645773|FG000|Overall Study|Lost to Follow-up|2|||
125406086|NCT00456092|451114735|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
125406087|NCT00456092|451114731|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
125406088|NCT00456092|451114732|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
125406089|NCT00456092|451114733|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
125406090|NCT00456092|451114734|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
125406091|NCT00456092|451114735|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
125406092|NCT00456092|451114731|FG000|Treatment Phase (12 Weeks)|Other|1|||
125406093|NCT00456092|451114732|FG001|Treatment Phase (12 Weeks)|Other|0|||
125406094|NCT00456092|451114733|FG002|Treatment Phase (12 Weeks)|Other|1|||
125406095|NCT00456092|451114734|FG003|Treatment Phase (12 Weeks)|Other|0|||
125406096|NCT00456092|451114735|FG004|Treatment Phase (12 Weeks)|Other|0|||
125406097|NCT01863446|451114736|FG000|Overall Study|Withdrawal by Subject|1|||
125406098|NCT01863446|451114737|FG001|Overall Study|Withdrawal by Subject|0|||
125406099|NCT01863446|451114738|FG002|Overall Study|Withdrawal by Subject|1|||
125406100|NCT01863446|451114739|FG003|Overall Study|Withdrawal by Subject|2|||
125406101|NCT01863446|451114736|FG000|Overall Study|Physician Decision|0|||
125406102|NCT01863446|451114737|FG001|Overall Study|Physician Decision|0|||
125406103|NCT01863446|451114738|FG002|Overall Study|Physician Decision|1|||
125406104|NCT01863446|451114739|FG003|Overall Study|Physician Decision|0|||
125406105|NCT03603964|451114744|FG000|Overall Study|Death|9|||
125406106|NCT03603964|451114744|FG000|Overall Study|Withdrawal by participant|7|||
125406107|NCT03603964|451114744|FG000|Overall Study|Study terminated by Sponsor|19|||
125406108|NCT04317586|451114745|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
125406109|NCT04317586|451114745|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
125406110|NCT00563797|451114746|FG000|Overall Study|Lost to Follow-up|7|||
125406111|NCT00563797|451114747|FG001|Overall Study|Lost to Follow-up|2|||
125406112|NCT00807092|451114748|FG000|Overall Study|Adverse Event|0|||
125406113|NCT00807092|451114749|FG001|Overall Study|Adverse Event|1|||
125406114|NCT00807092|451114748|FG000|Overall Study|Protocol Violation|0|||
125406115|NCT00807092|451114749|FG001|Overall Study|Protocol Violation|2|||
125406116|NCT00807092|451114748|FG000|Overall Study|Withdrawal by Subject|1|||
125406117|NCT00807092|451114749|FG001|Overall Study|Withdrawal by Subject|0|||
125406118|NCT00807092|451114748|FG000|Overall Study|CGMS data collection failed|0|||
125406119|NCT00807092|451114749|FG001|Overall Study|CGMS data collection failed|1|||
125406120|NCT04116229|451114750|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
125406121|NCT04116229|451114751|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
125406122|NCT04116229|451114750|FG000|Overall Study|Scheduling not possible.|0|||
125406123|NCT04116229|451114751|FG001|Overall Study|Scheduling not possible.|1|||
125406124|NCT01794949|451114752|FG000|Overall Study|Lost to Follow-up|1|||
125406125|NCT01794949|451114753|FG001|Overall Study|Lost to Follow-up|0|||
125406126|NCT03003676|451114754|FG000|Overall Study|Lack of Efficacy|5|||
125406127|NCT03003676|451114755|FG001|Overall Study|Lack of Efficacy|7|||
125406128|NCT03003676|451114754|FG000|Overall Study|Withdrawal by Subject|0|||
125406129|NCT03003676|451114755|FG001|Overall Study|Withdrawal by Subject|1|||
125406130|NCT03003676|451114754|FG000|Overall Study|Hepatitis B infection|1|||
125406131|NCT03003676|451114755|FG001|Overall Study|Hepatitis B infection|0|||
125406132|NCT02443298|451114762|FG000|Overall Study|Adverse Event|3|||
125406133|NCT02443298|451114763|FG001|Overall Study|Adverse Event|3|||
125406134|NCT02443298|451114762|FG000|Overall Study|Withdrawal by Subject|1|||
125406135|NCT02443298|451114763|FG001|Overall Study|Withdrawal by Subject|2|||
125406136|NCT00908960|451114765|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
125406137|NCT00908960|451114766|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
125406138|NCT00908960|451114767|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
125406139|NCT05074433|451114768|FG000|Overall Study|Adverse Event|0|||
125406140|NCT05074433|451114769|FG001|Overall Study|Adverse Event|2|||
125406141|NCT05074433|451114770|FG002|Overall Study|Adverse Event|0|||
125406142|NCT05074433|451114771|FG003|Overall Study|Adverse Event|1|||
125406143|NCT05074433|451114768|FG000|Overall Study|Sponsor Request|0|||
125406144|NCT05074433|451114769|FG001|Overall Study|Sponsor Request|1|||
125406145|NCT05074433|451114770|FG002|Overall Study|Sponsor Request|1|||
125406146|NCT05074433|451114771|FG003|Overall Study|Sponsor Request|0|||
125406147|NCT05074433|451114768|FG000|Overall Study|Death|1|||
125406148|NCT05074433|451114769|FG001|Overall Study|Death|0|||
125406149|NCT05074433|451114770|FG002|Overall Study|Death|0|||
125406150|NCT05074433|451114771|FG003|Overall Study|Death|0|||
125406151|NCT05074433|451114768|FG000|Overall Study|Lost to Follow-up|0|||
125406152|NCT05074433|451114769|FG001|Overall Study|Lost to Follow-up|0|||
125406153|NCT05074433|451114770|FG002|Overall Study|Lost to Follow-up|2|||
125406154|NCT05074433|451114771|FG003|Overall Study|Lost to Follow-up|0|||
125406155|NCT05074433|451114768|FG000|Overall Study|Subject Decision|8|||
125406156|NCT05074433|451114769|FG001|Overall Study|Subject Decision|6|||
125406157|NCT05074433|451114770|FG002|Overall Study|Subject Decision|4|||
125406158|NCT05074433|451114771|FG003|Overall Study|Subject Decision|5|||
125406159|NCT01158924|451114773|FG000|Overall Study|Withdrawal by Subject|1|||
125406160|NCT01158924|451114774|FG001|Overall Study|Withdrawal by Subject|2|||
125406161|NCT01158924|451114773|FG000|Overall Study|Lost to Follow-up|0|||
125406162|NCT01158924|451114774|FG001|Overall Study|Lost to Follow-up|1|||
125406163|NCT03795922|451114775|FG000|Overall Study|Adverse Event|2|||
125448175|NCT02403674|451268863|FG001|Base Study|Adverse Event|26|||
125448176|NCT02403674|451268862|FG000|Base Study|Lack of Efficacy|31|||
125406164|NCT03795922|451114776|FG001|Overall Study|Adverse Event|1|||
125406165|NCT03795922|451114775|FG000|Overall Study|Withdrawal by Subject|5|||
125406166|NCT03795922|451114776|FG001|Overall Study|Withdrawal by Subject|13|||
125406167|NCT03795922|451114775|FG000|Overall Study|Lost to Follow-up|2|||
125448177|NCT02403674|451268863|FG001|Base Study|Lack of Efficacy|23|||
125406168|NCT03795922|451114776|FG001|Overall Study|Lost to Follow-up|3|||
125406169|NCT03795922|451114775|FG000|Overall Study|Pregnancy|0|||
125406170|NCT03795922|451114776|FG001|Overall Study|Pregnancy|1|||
125406171|NCT03795922|451114775|FG000|Overall Study|Physician Decision|1|||
125406172|NCT03795922|451114776|FG001|Overall Study|Physician Decision|2|||
125406173|NCT03795922|451114775|FG000|Overall Study|Protocol Violation|0|||
125406174|NCT03795922|451114776|FG001|Overall Study|Protocol Violation|1|||
125406175|NCT03795922|451114775|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
125406176|NCT03795922|451114776|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
125406177|NCT00733824|451114779|FG000|Phase I|Withdrawal by Subject|1|||
125406178|NCT00733824|451114780|FG001|Phase I|Withdrawal by Subject|0|||
125406179|NCT00733824|451114781|FG002|Phase I|Withdrawal by Subject|0|||
125406180|NCT00733824|451114782|FG003|Phase I|Withdrawal by Subject|0|||
125406181|NCT00733824|451114783|FG004|Phase I|Withdrawal by Subject|0|||
125406182|NCT02480621|451114784|FG000|Randomization|Withdrawal by Subject|1|||
125406183|NCT02480621|451114785|FG001|Randomization|Withdrawal by Subject|0|||
125406184|NCT02480621|451114784|FG000|Randomization|Surgeon did not give intervention|0|||
125406185|NCT02480621|451114785|FG001|Randomization|Surgeon did not give intervention|1|||
125406186|NCT02480621|451114784|FG000|Follow Up|Lost to Follow-up|4|||
125406187|NCT02480621|451114785|FG001|Follow Up|Lost to Follow-up|2|||
125406188|NCT03056690|451114786|FG000|Overall Study|Adverse Event|3|||
125406189|NCT03056690|451114787|FG001|Overall Study|Adverse Event|2|||
125406190|NCT03056690|451114786|FG000|Overall Study|Lack of Efficacy|1|||
125406191|NCT03056690|451114787|FG001|Overall Study|Lack of Efficacy|2|||
125406192|NCT03056690|451114786|FG000|Overall Study|Lost to Follow-up|3|||
125406193|NCT03056690|451114787|FG001|Overall Study|Lost to Follow-up|2|||
125406194|NCT03056690|451114786|FG000|Overall Study|Protocol Violation|2|||
125406195|NCT03056690|451114787|FG001|Overall Study|Protocol Violation|2|||
125406196|NCT03056690|451114786|FG000|Overall Study|Withdrawal by Subject|3|||
125406197|NCT03056690|451114787|FG001|Overall Study|Withdrawal by Subject|6|||
125406198|NCT03056690|451114786|FG000|Overall Study|Non-compliance with Study Drug|1|||
125406199|NCT03056690|451114787|FG001|Overall Study|Non-compliance with Study Drug|0|||
125406200|NCT03056690|451114786|FG000|Overall Study|Miscellaneous|1|||
125406201|NCT03056690|451114787|FG001|Overall Study|Miscellaneous|2|||
125406202|NCT01440946|451114792|FG000|Overall Study|Lost to Follow-up|1|||
125406203|NCT01440946|451114793|FG001|Overall Study|Lost to Follow-up|1|||
125406204|NCT01440946|451114792|FG000|Overall Study|Physician Decision|1|||
125406205|NCT01440946|451114793|FG001|Overall Study|Physician Decision|0|||
125406206|NCT00235989|451114794|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
125406207|NCT00235989|451114795|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
125406208|NCT00235989|451114796|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
125406209|NCT00235989|451114797|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
125406210|NCT00235989|451114798|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
125406211|NCT00235989|451114799|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
125406212|NCT00235989|451114794|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
125406213|NCT00235989|451114795|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
125406214|NCT00235989|451114796|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
125406215|NCT00235989|451114797|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
125406216|NCT00235989|451114798|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
125406217|NCT00235989|451114799|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
125406218|NCT00235989|451114794|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
125406219|NCT00235989|451114795|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
125406220|NCT00235989|451114796|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
125406221|NCT00235989|451114797|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
125406222|NCT00235989|451114798|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
125406223|NCT00235989|451114799|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
125406224|NCT00235989|451114794|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
125406225|NCT00235989|451114795|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
125406226|NCT00235989|451114796|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
125406227|NCT00235989|451114797|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
125406228|NCT00235989|451114798|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
125406229|NCT00235989|451114799|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
125406230|NCT00235989|451114794|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
125406231|NCT00235989|451114795|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
125406232|NCT00235989|451114796|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
125448178|NCT02403674|451268862|FG000|Base Study|Lost to Follow-up|6|||
125278665|NCT00782171|450645774|FG001|Overall Study|Lost to Follow-up|2|||
125406233|NCT00235989|451114797|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
125406234|NCT00235989|451114798|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
125406235|NCT00235989|451114799|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
125406236|NCT00983580|451114800|FG000|Overall Study|Cancel Prior to treatment|1|||
125406237|NCT00983580|451114801|FG001|Overall Study|Cancel Prior to treatment|3|||
125448179|NCT02403674|451268863|FG001|Base Study|Lost to Follow-up|8|||
125448180|NCT02403674|451268862|FG000|Base Study|Withdrawal by Subject|10|||
125448181|NCT02403674|451268863|FG001|Base Study|Withdrawal by Subject|17|||
125448182|NCT02403674|451268862|FG000|Base Study|Physician Decision|2|||
125448183|NCT02403674|451268863|FG001|Base Study|Physician Decision|2|||
125448184|NCT02403674|451268862|FG000|Base Study|Pregnancy|2|||
125448185|NCT02403674|451268863|FG001|Base Study|Pregnancy|2|||
125448186|NCT02403674|451268862|FG000|Base Study|Protocol Violation|8|||
125448187|NCT02403674|451268863|FG001|Base Study|Protocol Violation|4|||
125448188|NCT02403674|451268862|FG000|Base Study|Non-Compliance with study drug|1|||
125448189|NCT02403674|451268863|FG001|Base Study|Non-Compliance with study drug|4|||
125448190|NCT02403674|451268862|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
125448191|NCT02403674|451268863|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
125448192|NCT02403674|451268862|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
125448193|NCT02403674|451268863|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
125448194|NCT02403674|451268862|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
125448195|NCT02403674|451268863|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
125448196|NCT02403674|451268862|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
125448197|NCT02403674|451268863|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
125448198|NCT02403674|451268862|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
125278666|NCT00782171|450645773|FG000|Overall Study|Withdrawal by Subject|2|||
125278667|NCT00782171|450645774|FG001|Overall Study|Withdrawal by Subject|1|||
125278668|NCT00782171|450645773|FG000|Overall Study|complications|3|||
125278669|NCT00782171|450645774|FG001|Overall Study|complications|1|||
125278670|NCT00782171|450645773|FG000|Overall Study|others|7|||
125278671|NCT00782171|450645774|FG001|Overall Study|others|9|||
125278672|NCT00782171|450645773|FG000|Overall Study|not eligible|8|||
125278673|NCT00782171|450645774|FG001|Overall Study|not eligible|6|||
125278674|NCT02582814|450645782|FG000|Overall Study|Study-specific withdrawal criteria|1|||
125278675|NCT02582814|450645783|FG001|Overall Study|Study-specific withdrawal criteria|0|||
125278676|NCT02582814|450645782|FG000|Overall Study|Withdrawal by Subject|4|||
125278677|NCT02582814|450645783|FG001|Overall Study|Withdrawal by Subject|3|||
125278678|NCT02582814|450645782|FG000|Overall Study|Adverse Event|4|||
125278679|NCT02582814|450645783|FG001|Overall Study|Adverse Event|4|||
125278680|NCT03530995|450645784|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
125278681|NCT03530995|450645785|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
125278682|NCT03530995|450645784|FG000|Part 1 Period 3|Protocol Violation|1|||
125278683|NCT03530995|450645785|FG001|Part 1 Period 3|Protocol Violation|0|||
125278684|NCT03530995|450645784|FG000|Part 1 Period 4|Physician Decision|1|||
125278685|NCT03530995|450645785|FG001|Part 1 Period 4|Physician Decision|0|||
125278686|NCT03530995|450645784|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
125278687|NCT03530995|450645785|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
125278688|NCT01986231|450645789|FG000|Overall Study|Adverse Event|1|||
125278689|NCT01558115|450645790|FG000|Overall Study|Withdrawal by Subject|3|||
125278690|NCT01558115|450645790|FG000|Overall Study|Study closed due to poor enrollment|4|||
125278691|NCT01696994|450645791|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
125278692|NCT01696994|450645792|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
125278693|NCT01696994|450645791|FG000|Overall Study|Died Before Randomization|1|||
125278694|NCT01696994|450645792|FG001|Overall Study|Died Before Randomization|2|||
125278695|NCT01696994|450645791|FG000|Overall Study|Died Before ASU (Control)|73|||
125278696|NCT01696994|450645792|FG001|Overall Study|Died Before ASU (Control)|0|||
125278697|NCT01696994|450645791|FG000|Overall Study|No Ovaries at Baseline|4807|||
125278698|NCT01696994|450645792|FG001|Overall Study|No Ovaries at Baseline|4851|||
125278699|NCT01696994|450645791|FG000|Overall Study|Refused ASU (Control)|311|||
125278700|NCT01696994|450645792|FG001|Overall Study|Refused ASU (Control)|0|||
125278701|NCT01696994|450645791|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
125278702|NCT01696994|450645792|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
125278703|NCT04644276|450645793|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
125278704|NCT04644276|450645794|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
125278705|NCT04644276|450645795|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
125278706|NCT00705250|450645796|FG000|Overall Study|Withdrawal by Subject|1|||
125278707|NCT00705250|450645796|FG000|Overall Study|Patient died in car accident|1|||
125278708|NCT01576146|450645797|FG000|Extension Period 1|Adverse Event|2|||
125278709|NCT01576146|450645797|FG000|Extension Period 1|Death|2|||
125278710|NCT01576146|450645797|FG000|Extension Period 1|Physician Decision|2|||
125448199|NCT02403674|451268863|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
125278711|NCT01576146|450645797|FG000|Extension Period 1|Withdrawal by Subject|1|||
125278712|NCT01576146|450645797|FG000|Extension Period 1|Lost to Follow-up|1|||
125278713|NCT01576146|450645797|FG000|Extension Period 1|Parathyroidectomy|1|||
125278714|NCT01576146|450645797|FG000|Extension Period 1|Renal Transplant|1|||
125278715|NCT01576146|450645797|FG000|Extension Period 2|Sponsor Decision|13|||
125278716|NCT01576146|450645797|FG000|Extension Period 2|Death|1|||
125278717|NCT01576146|450645797|FG000|Extension Period 2|Adverse Event|1|||
125448200|NCT02403674|451268862|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
125448201|NCT02403674|451268863|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
125406238|NCT00983580|451114800|FG000|Overall Study|Protocol Violation|1|||
125406239|NCT00983580|451114801|FG001|Overall Study|Protocol Violation|1|||
125406240|NCT00983580|451114800|FG000|Overall Study|Ineligible|3|||
125406241|NCT00983580|451114801|FG001|Overall Study|Ineligible|0|||
125406242|NCT03568461|451114804|FG000|Overall Study|Death|7|||
125406243|NCT03568461|451114804|FG000|Overall Study|Physician Decision|5|||
125406244|NCT03568461|451114804|FG000|Overall Study|Subject decision|5|||
125406245|NCT03568461|451114804|FG000|Overall Study|Lost to Follow-up|1|||
125406246|NCT03964454|451114805|FG000|Overall Study|Lost to Follow-up|13|||
125406247|NCT03964454|451114806|FG001|Overall Study|Lost to Follow-up|7|||
125406248|NCT03964454|451114805|FG000|Overall Study|Withdrawal by Subject|4|||
125406249|NCT03964454|451114806|FG001|Overall Study|Withdrawal by Subject|11|||
125406250|NCT03328897|451116141|FG000|Randomized-treatment Epoch|Adverse Event|4|||
125406251|NCT03328897|451116142|FG001|Randomized-treatment Epoch|Adverse Event|1|||
125406252|NCT03328897|451116143|FG002|Randomized-treatment Epoch|Adverse Event|1|||
125406253|NCT03328897|451116141|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
125406254|NCT03328897|451116142|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
125406255|NCT03328897|451116143|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
125406256|NCT03328897|451116141|FG000|Randomized-treatment Epoch|Pregnancy|3|||
125406257|NCT03328897|451116142|FG001|Randomized-treatment Epoch|Pregnancy|0|||
125406258|NCT03328897|451116143|FG002|Randomized-treatment Epoch|Pregnancy|0|||
125406259|NCT03328897|451116141|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
125406260|NCT03328897|451116142|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
125406261|NCT03328897|451116143|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
125406262|NCT03328897|451116141|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
125406263|NCT03328897|451116142|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
125406264|NCT03328897|451116143|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
125406265|NCT03328897|451116141|FG000|Follow-up Epoch|Adverse Event|4|||
125406266|NCT03328897|451116142|FG001|Follow-up Epoch|Adverse Event|0|||
125406267|NCT03328897|451116143|FG002|Follow-up Epoch|Adverse Event|1|||
125406268|NCT03328897|451116141|FG000|Follow-up Epoch|Lack of Efficacy|1|||
125406269|NCT03328897|451116142|FG001|Follow-up Epoch|Lack of Efficacy|1|||
125406270|NCT03328897|451116143|FG002|Follow-up Epoch|Lack of Efficacy|1|||
125406271|NCT03328897|451116141|FG000|Follow-up Epoch|Lost to Follow-up|0|||
125406272|NCT03328897|451116142|FG001|Follow-up Epoch|Lost to Follow-up|1|||
125406273|NCT03328897|451116143|FG002|Follow-up Epoch|Lost to Follow-up|0|||
125406274|NCT03328897|451116141|FG000|Follow-up Epoch|Pregnancy|1|||
125406275|NCT03328897|451116142|FG001|Follow-up Epoch|Pregnancy|0|||
125406276|NCT03328897|451116143|FG002|Follow-up Epoch|Pregnancy|0|||
125406277|NCT03328897|451116141|FG000|Follow-up Epoch|Patient/guardian decision|2|||
125406278|NCT03328897|451116142|FG001|Follow-up Epoch|Patient/guardian decision|1|||
125406279|NCT03328897|451116143|FG002|Follow-up Epoch|Patient/guardian decision|0|||
125406280|NCT02766608|451116146|FG000|Overall Study|Adverse Event|27|||
125406281|NCT02766608|451116147|FG001|Overall Study|Adverse Event|22|||
125406282|NCT02766608|451116148|FG002|Overall Study|Adverse Event|17|||
125406283|NCT02766608|451116149|FG003|Overall Study|Adverse Event|13|||
125406284|NCT02766608|451116150|FG004|Overall Study|Adverse Event|12|||
125406285|NCT02766608|451116146|FG000|Overall Study|Withdrawal by Subject|21|||
125406286|NCT02766608|451116147|FG001|Overall Study|Withdrawal by Subject|20|||
125406287|NCT02766608|451116148|FG002|Overall Study|Withdrawal by Subject|24|||
125406288|NCT02766608|451116149|FG003|Overall Study|Withdrawal by Subject|13|||
125406289|NCT02766608|451116150|FG004|Overall Study|Withdrawal by Subject|10|||
125406290|NCT02766608|451116146|FG000|Overall Study|Lack of Efficacy|16|||
125406291|NCT02766608|451116147|FG001|Overall Study|Lack of Efficacy|15|||
125406292|NCT02766608|451116148|FG002|Overall Study|Lack of Efficacy|32|||
125406293|NCT02766608|451116149|FG003|Overall Study|Lack of Efficacy|8|||
125406294|NCT02766608|451116150|FG004|Overall Study|Lack of Efficacy|2|||
125406295|NCT02766608|451116146|FG000|Overall Study|Lost to Follow-up|6|||
125406296|NCT02766608|451116147|FG001|Overall Study|Lost to Follow-up|3|||
125406297|NCT02766608|451116148|FG002|Overall Study|Lost to Follow-up|5|||
125448202|NCT02403674|451268862|FG000|Study Extension 1 (Open-Label)|Death|1|||
125278718|NCT01576146|450645797|FG000|Extension Period 2|Renal Transplant|1|||
125278719|NCT01576146|450645797|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
125406298|NCT02766608|451116149|FG003|Overall Study|Lost to Follow-up|2|||
125406299|NCT02766608|451116150|FG004|Overall Study|Lost to Follow-up|2|||
125406300|NCT02766608|451116146|FG000|Overall Study|Physician Decision|3|||
125406301|NCT02766608|451116147|FG001|Overall Study|Physician Decision|2|||
125406302|NCT02766608|451116148|FG002|Overall Study|Physician Decision|3|||
125406303|NCT02766608|451116149|FG003|Overall Study|Physician Decision|1|||
125406304|NCT02766608|451116150|FG004|Overall Study|Physician Decision|2|||
125406305|NCT02766608|451116146|FG000|Overall Study|Protocol disc criteria|3|||
125406306|NCT02766608|451116147|FG001|Overall Study|Protocol disc criteria|3|||
125406307|NCT02766608|451116148|FG002|Overall Study|Protocol disc criteria|4|||
125406308|NCT02766608|451116149|FG003|Overall Study|Protocol disc criteria|0|||
125406309|NCT02766608|451116150|FG004|Overall Study|Protocol disc criteria|0|||
125406310|NCT02766608|451116146|FG000|Overall Study|Protocol Violation|0|||
125406311|NCT02766608|451116147|FG001|Overall Study|Protocol Violation|4|||
125406312|NCT02766608|451116148|FG002|Overall Study|Protocol Violation|4|||
125278720|NCT01951586|450645804|FG000|Overall Study|Death|61|||
125278721|NCT01951586|450645805|FG001|Overall Study|Death|120|||
125278722|NCT01951586|450645804|FG000|Overall Study|Withdrawal by Subject|8|||
125278723|NCT01951586|450645805|FG001|Overall Study|Withdrawal by Subject|17|||
125278724|NCT01951586|450645804|FG000|Overall Study|Lost to Follow-up|0|||
125278725|NCT01951586|450645805|FG001|Overall Study|Lost to Follow-up|1|||
125278726|NCT01951586|450645804|FG000|Overall Study|Sponsor Decision|9|||
125278727|NCT01951586|450645805|FG001|Overall Study|Sponsor Decision|10|||
125278728|NCT04995419|450645808|FG000|Overall Study|Withdrawal by Subject|3|||
125278729|NCT04995419|450645808|FG000|Overall Study|Progressive Disease|19|||
125278730|NCT04995419|450645808|FG000|Overall Study|Adverse Event|2|||
125278731|NCT04995419|450645808|FG000|Overall Study|Ongoing|16|||
125278732|NCT01822899|450645809|FG000|Overall Study|Adverse Event|6|||
125278733|NCT01822899|450645810|FG001|Overall Study|Adverse Event|5|||
125278734|NCT01822899|450645809|FG000|Overall Study|Lack of Efficacy|6|||
125278735|NCT01822899|450645810|FG001|Overall Study|Lack of Efficacy|3|||
125278736|NCT01822899|450645809|FG000|Overall Study|Protocol Violation|6|||
125278737|NCT01822899|450645810|FG001|Overall Study|Protocol Violation|3|||
125278738|NCT01822899|450645809|FG000|Overall Study|Lost to Follow-up|1|||
125278739|NCT01822899|450645810|FG001|Overall Study|Lost to Follow-up|0|||
125278740|NCT01822899|450645809|FG000|Overall Study|Withdrawal by Subject|5|||
125278741|NCT01822899|450645810|FG001|Overall Study|Withdrawal by Subject|7|||
125278742|NCT05332392|450645811|FG000|Overall Study|Did not meet inclusion criteria|25|||
125278743|NCT05332392|450645811|FG000|Overall Study|Principal Investigator's decision|17|||
125278744|NCT05332392|450645811|FG000|Overall Study|Adverse Event|1|||
125278745|NCT05332392|450645811|FG000|Overall Study|Subject's decision|1|||
125278746|NCT02752633|450645813|FG000|Overall Study|Withdrawal by Subject|1|||
125278747|NCT02846389|450645814|FG000|Overall Study|Withdrawal by Subject|1|||
125278748|NCT02846389|450645815|FG001|Overall Study|Withdrawal by Subject|1|||
125278749|NCT00853242|450645817|FG000|Overall Study|Adverse Event|0|||
125278750|NCT00853242|450645818|FG001|Overall Study|Adverse Event|1|||
125278751|NCT00853242|450645819|FG002|Overall Study|Adverse Event|1|||
125278752|NCT00853242|450645820|FG003|Overall Study|Adverse Event|0|||
125278753|NCT00853242|450645821|FG004|Overall Study|Adverse Event|3|||
125278754|NCT00853242|450645822|FG005|Overall Study|Adverse Event|1|||
125278755|NCT00853242|450645823|FG006|Overall Study|Adverse Event|1|||
125278756|NCT00853242|450645817|FG000|Overall Study|Noncompliant|0|||
125278757|NCT00853242|450645818|FG001|Overall Study|Noncompliant|0|||
125278758|NCT00853242|450645819|FG002|Overall Study|Noncompliant|0|||
125278759|NCT00853242|450645820|FG003|Overall Study|Noncompliant|0|||
125278760|NCT00853242|450645821|FG004|Overall Study|Noncompliant|1|||
125278761|NCT00853242|450645822|FG005|Overall Study|Noncompliant|0|||
125278762|NCT00853242|450645823|FG006|Overall Study|Noncompliant|0|||
125278763|NCT00853242|450645817|FG000|Overall Study|Withdrawal by Subject|1|||
125278764|NCT00853242|450645818|FG001|Overall Study|Withdrawal by Subject|2|||
125278765|NCT00853242|450645819|FG002|Overall Study|Withdrawal by Subject|0|||
125278766|NCT00853242|450645820|FG003|Overall Study|Withdrawal by Subject|4|||
125278767|NCT00853242|450645821|FG004|Overall Study|Withdrawal by Subject|0|||
125278768|NCT00853242|450645822|FG005|Overall Study|Withdrawal by Subject|0|||
125278769|NCT00853242|450645823|FG006|Overall Study|Withdrawal by Subject|2|||
125278770|NCT00853242|450645817|FG000|Overall Study|Other|2|||
125278771|NCT00853242|450645818|FG001|Overall Study|Other|0|||
125278772|NCT00853242|450645819|FG002|Overall Study|Other|2|||
125278773|NCT00853242|450645820|FG003|Overall Study|Other|0|||
125278774|NCT00853242|450645821|FG004|Overall Study|Other|0|||
125278775|NCT00853242|450645822|FG005|Overall Study|Other|1|||
125278776|NCT00853242|450645823|FG006|Overall Study|Other|2|||
125278777|NCT01265563|450645824|FG000|Overall Study|Withdrawal by Subject|0|||
125278778|NCT01265563|450645825|FG001|Overall Study|Withdrawal by Subject|1|||
125278779|NCT01265563|450645826|FG002|Overall Study|Withdrawal by Subject|1|||
125278780|NCT01265563|450645827|FG003|Overall Study|Withdrawal by Subject|0|||
125278781|NCT01265563|450645828|FG004|Overall Study|Withdrawal by Subject|2|||
125278782|NCT02141399|450645833|FG000|Overall Study|Adverse Event|158|||
125278783|NCT02141399|450645833|FG000|Overall Study|Lack of Efficacy|62|||
125278784|NCT02141399|450645833|FG000|Overall Study|Lost to Follow-up|151|||
125278785|NCT02141399|450645833|FG000|Overall Study|Non-compliance with study drug|18|||
125278786|NCT02141399|450645833|FG000|Overall Study|Other|45|||
125278787|NCT02141399|450645833|FG000|Overall Study|Physician Decision|17|||
125278788|NCT02141399|450645833|FG000|Overall Study|Pregnancy|3|||
125278789|NCT02141399|450645833|FG000|Overall Study|Protocol Violation|38|||
125278790|NCT02141399|450645833|FG000|Overall Study|Withdrawal by Subject|238|||
125278791|NCT02141399|450645833|FG000|Overall Study|Failure to meet eligibility criteria|14|||
125278792|NCT01296711|450645834|FG000|Overall Study|Adverse Event|3|||
125278793|NCT01296711|450645835|FG001|Overall Study|Adverse Event|1|||
125278794|NCT01296711|450645836|FG002|Overall Study|Adverse Event|4|||
125278795|NCT01296711|450645837|FG003|Overall Study|Adverse Event|3|||
125278796|NCT01296711|450645838|FG004|Overall Study|Adverse Event|1|||
125278797|NCT01296711|450645839|FG005|Overall Study|Adverse Event|6|||
125278798|NCT01296711|450645840|FG006|Overall Study|Adverse Event|11|||
125278799|NCT01296711|450645841|FG007|Overall Study|Adverse Event|3|||
125406313|NCT02766608|451116149|FG003|Overall Study|Protocol Violation|0|||
125406314|NCT02766608|451116150|FG004|Overall Study|Protocol Violation|1|||
125406315|NCT02766608|451116146|FG000|Overall Study|Administrative Reasons|3|||
125406316|NCT02766608|451116147|FG001|Overall Study|Administrative Reasons|1|||
125406317|NCT02766608|451116148|FG002|Overall Study|Administrative Reasons|1|||
125406318|NCT02766608|451116149|FG003|Overall Study|Administrative Reasons|0|||
125406319|NCT02766608|451116150|FG004|Overall Study|Administrative Reasons|0|||
125406320|NCT02066298|451116151|FG000|Overall Study|Lost to Follow-up|3|||
125406321|NCT02066298|451116152|FG001|Overall Study|Lost to Follow-up|2|||
125406322|NCT02066298|451116153|FG002|Overall Study|Lost to Follow-up|3|||
125406323|NCT02066298|451116154|FG003|Overall Study|Lost to Follow-up|2|||
125406324|NCT02066298|451116155|FG004|Overall Study|Lost to Follow-up|3|||
125406325|NCT02066298|451116156|FG005|Overall Study|Lost to Follow-up|4|||
125406326|NCT02066298|451116151|FG000|Overall Study|Withdrawal by Subject|6|||
125406327|NCT02066298|451116152|FG001|Overall Study|Withdrawal by Subject|6|||
125406328|NCT02066298|451116153|FG002|Overall Study|Withdrawal by Subject|6|||
125406329|NCT02066298|451116154|FG003|Overall Study|Withdrawal by Subject|4|||
125406330|NCT02066298|451116155|FG004|Overall Study|Withdrawal by Subject|5|||
125406331|NCT02066298|451116156|FG005|Overall Study|Withdrawal by Subject|8|||
125406332|NCT02066298|451116151|FG000|Overall Study|Physician Decision|0|||
125406333|NCT02066298|451116152|FG001|Overall Study|Physician Decision|0|||
125406334|NCT02066298|451116153|FG002|Overall Study|Physician Decision|1|||
125448203|NCT02403674|451268863|FG001|Study Extension 1 (Open-Label)|Death|0|||
125448204|NCT02403674|451268862|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
125448205|NCT02403674|451268863|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
125448206|NCT02403674|451268862|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
125448207|NCT02403674|451268863|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
125448208|NCT02403674|451268862|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
125448209|NCT02403674|451268863|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
125448210|NCT02403674|451268862|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
125448211|NCT02403674|451268863|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
125278800|NCT01296711|450645834|FG000|Overall Study|Lack of Efficacy|1|||
125278801|NCT01296711|450645835|FG001|Overall Study|Lack of Efficacy|4|||
125448212|NCT02403674|451268862|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
125448213|NCT02403674|451268863|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
125448214|NCT02403674|451268862|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
125448215|NCT02403674|451268863|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
125448216|NCT02403674|451268862|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
125448217|NCT02403674|451268863|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
125448218|NCT02403674|451268862|FG000|Study Extension 2 (Open-Label)|Death|2|||
125448219|NCT02403674|451268863|FG001|Study Extension 2 (Open-Label)|Death|2|||
125448220|NCT02403674|451268862|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
125448221|NCT02403674|451268863|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
125448222|NCT02403674|451268862|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
125448223|NCT02403674|451268863|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
125448224|NCT02403674|451268862|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
125278802|NCT01296711|450645836|FG002|Overall Study|Lack of Efficacy|1|||
125278803|NCT01296711|450645837|FG003|Overall Study|Lack of Efficacy|1|||
125278804|NCT01296711|450645838|FG004|Overall Study|Lack of Efficacy|1|||
125278805|NCT01296711|450645839|FG005|Overall Study|Lack of Efficacy|0|||
125278806|NCT01296711|450645840|FG006|Overall Study|Lack of Efficacy|2|||
125278807|NCT01296711|450645841|FG007|Overall Study|Lack of Efficacy|3|||
125278808|NCT01296711|450645834|FG000|Overall Study|Lost to Follow-up|0|||
125278809|NCT01296711|450645835|FG001|Overall Study|Lost to Follow-up|0|||
125278810|NCT01296711|450645836|FG002|Overall Study|Lost to Follow-up|1|||
125278811|NCT01296711|450645837|FG003|Overall Study|Lost to Follow-up|1|||
125278812|NCT01296711|450645838|FG004|Overall Study|Lost to Follow-up|2|||
125278813|NCT01296711|450645839|FG005|Overall Study|Lost to Follow-up|0|||
125278814|NCT01296711|450645840|FG006|Overall Study|Lost to Follow-up|4|||
125278815|NCT01296711|450645841|FG007|Overall Study|Lost to Follow-up|2|||
125278816|NCT01296711|450645834|FG000|Overall Study|Protocol Violation|0|||
125278817|NCT01296711|450645835|FG001|Overall Study|Protocol Violation|0|||
125406335|NCT02066298|451116154|FG003|Overall Study|Physician Decision|0|||
125406336|NCT02066298|451116155|FG004|Overall Study|Physician Decision|1|||
125406337|NCT02066298|451116156|FG005|Overall Study|Physician Decision|0|||
125406338|NCT02348489|451116158|FG000|Overall Study|Death|336|||
125406339|NCT02348489|451116159|FG001|Overall Study|Death|335|||
125406340|NCT02348489|451116158|FG000|Overall Study|Withdrawal by Subject|14|||
125406341|NCT02348489|451116159|FG001|Overall Study|Withdrawal by Subject|27|||
125448225|NCT02403674|451268863|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
125278818|NCT01296711|450645836|FG002|Overall Study|Protocol Violation|0|||
125278819|NCT01296711|450645837|FG003|Overall Study|Protocol Violation|1|||
125278820|NCT01296711|450645838|FG004|Overall Study|Protocol Violation|1|||
125278821|NCT01296711|450645839|FG005|Overall Study|Protocol Violation|0|||
125278822|NCT01296711|450645840|FG006|Overall Study|Protocol Violation|0|||
125278823|NCT01296711|450645841|FG007|Overall Study|Protocol Violation|0|||
125278824|NCT01296711|450645834|FG000|Overall Study|Withdrawal by Subject|4|||
125278825|NCT01296711|450645835|FG001|Overall Study|Withdrawal by Subject|2|||
125278826|NCT01296711|450645836|FG002|Overall Study|Withdrawal by Subject|2|||
125278827|NCT01296711|450645837|FG003|Overall Study|Withdrawal by Subject|1|||
125278828|NCT01296711|450645838|FG004|Overall Study|Withdrawal by Subject|1|||
125278829|NCT01296711|450645839|FG005|Overall Study|Withdrawal by Subject|1|||
125278830|NCT01296711|450645840|FG006|Overall Study|Withdrawal by Subject|2|||
125278831|NCT01296711|450645841|FG007|Overall Study|Withdrawal by Subject|1|||
125448226|NCT02403674|451268862|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
125448227|NCT02403674|451268863|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
125448228|NCT02403674|451268862|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
125448229|NCT02403674|451268863|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
125448230|NCT02403674|451268862|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
125448231|NCT02403674|451268863|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
125448232|NCT02403674|451268862|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
125448233|NCT02403674|451268863|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
125448234|NCT03738241|451268865|FG000|Overall Study|Withdrawal by Subject|0|||
125278832|NCT01296711|450645834|FG000|Overall Study|Study termination|8|||
125278833|NCT01296711|450645835|FG001|Overall Study|Study termination|1|||
125278834|NCT01296711|450645836|FG002|Overall Study|Study termination|5|||
125278835|NCT01296711|450645837|FG003|Overall Study|Study termination|4|||
125278836|NCT01296711|450645838|FG004|Overall Study|Study termination|4|||
125278837|NCT01296711|450645839|FG005|Overall Study|Study termination|4|||
125278838|NCT01296711|450645840|FG006|Overall Study|Study termination|8|||
125278839|NCT01296711|450645841|FG007|Overall Study|Study termination|10|||
125278840|NCT01296711|450645834|FG000|Overall Study|Continued elevated liver enzymes|0|||
125278841|NCT01296711|450645835|FG001|Overall Study|Continued elevated liver enzymes|0|||
125278842|NCT01296711|450645836|FG002|Overall Study|Continued elevated liver enzymes|0|||
125278843|NCT01296711|450645837|FG003|Overall Study|Continued elevated liver enzymes|1|||
125278844|NCT01296711|450645838|FG004|Overall Study|Continued elevated liver enzymes|0|||
125278845|NCT01296711|450645839|FG005|Overall Study|Continued elevated liver enzymes|0|||
125278846|NCT01296711|450645840|FG006|Overall Study|Continued elevated liver enzymes|0|||
125278847|NCT01296711|450645841|FG007|Overall Study|Continued elevated liver enzymes|0|||
125278848|NCT01296711|450645834|FG000|Overall Study|Methotrexate discontinued|0|||
125278849|NCT01296711|450645835|FG001|Overall Study|Methotrexate discontinued|0|||
125278850|NCT01296711|450645836|FG002|Overall Study|Methotrexate discontinued|0|||
125278851|NCT01296711|450645837|FG003|Overall Study|Methotrexate discontinued|1|||
125278852|NCT01296711|450645838|FG004|Overall Study|Methotrexate discontinued|0|||
125278853|NCT01296711|450645839|FG005|Overall Study|Methotrexate discontinued|0|||
125278854|NCT01296711|450645840|FG006|Overall Study|Methotrexate discontinued|0|||
125278855|NCT01296711|450645841|FG007|Overall Study|Methotrexate discontinued|0|||
125278856|NCT01296711|450645834|FG000|Overall Study|Investigator discretion|0|||
125278857|NCT01296711|450645835|FG001|Overall Study|Investigator discretion|0|||
125278858|NCT01296711|450645836|FG002|Overall Study|Investigator discretion|0|||
125406342|NCT02348489|451116158|FG000|Overall Study|Lost to Follow-up|3|||
125406343|NCT02348489|451116159|FG001|Overall Study|Lost to Follow-up|5|||
125406344|NCT01639001|451116160|FG000|Overall Study|Refused further follow-up|9|||
125406345|NCT01639001|451116161|FG001|Overall Study|Refused further follow-up|12|||
125406346|NCT01639001|451116160|FG000|Overall Study|Lost to Follow-up|3|||
125406347|NCT01639001|451116161|FG001|Overall Study|Lost to Follow-up|0|||
125406348|NCT01639001|451116160|FG000|Overall Study|Death|62|||
125278859|NCT01296711|450645837|FG003|Overall Study|Investigator discretion|0|||
125278860|NCT01296711|450645838|FG004|Overall Study|Investigator discretion|0|||
125278861|NCT01296711|450645839|FG005|Overall Study|Investigator discretion|0|||
125278862|NCT01296711|450645840|FG006|Overall Study|Investigator discretion|1|||
125278863|NCT01296711|450645841|FG007|Overall Study|Investigator discretion|0|||
125278864|NCT01296711|450645834|FG000|Overall Study|Other|0|||
125406349|NCT01639001|451116161|FG001|Overall Study|Death|61|||
125448235|NCT03738241|451268866|FG001|Overall Study|Withdrawal by Subject|0|||
125278865|NCT01296711|450645835|FG001|Overall Study|Other|0|||
125278866|NCT01296711|450645836|FG002|Overall Study|Other|0|||
125278867|NCT01296711|450645837|FG003|Overall Study|Other|0|||
125278868|NCT01296711|450645838|FG004|Overall Study|Other|0|||
125278869|NCT01296711|450645839|FG005|Overall Study|Other|0|||
125278870|NCT01296711|450645840|FG006|Overall Study|Other|1|||
125278871|NCT01296711|450645841|FG007|Overall Study|Other|0|||
125278872|NCT01296711|450645834|FG000|Overall Study|Required restricted steroid injections|0|||
125278873|NCT01296711|450645835|FG001|Overall Study|Required restricted steroid injections|0|||
125406350|NCT01639001|451116160|FG000|Overall Study|Randomized but not treated|0|||
125406351|NCT01639001|451116161|FG001|Overall Study|Randomized but not treated|2|||
125448236|NCT03738241|451268867|FG002|Overall Study|Withdrawal by Subject|0|||
125448237|NCT03738241|451268868|FG003|Overall Study|Withdrawal by Subject|0|||
125278874|NCT01296711|450645836|FG002|Overall Study|Required restricted steroid injections|0|||
125278875|NCT01296711|450645837|FG003|Overall Study|Required restricted steroid injections|0|||
125278876|NCT01296711|450645838|FG004|Overall Study|Required restricted steroid injections|0|||
125406352|NCT01639001|451116160|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
125406353|NCT01639001|451116161|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
125406354|NCT02866682|451116162|FG000|Overall Study|Death|0|||
125406355|NCT02866682|451116163|FG001|Overall Study|Death|1|||
125406356|NCT02866682|451116162|FG000|Overall Study|Lost to Follow-up|0|||
125406357|NCT02866682|451116163|FG001|Overall Study|Lost to Follow-up|4|||
125406358|NCT02866682|451116162|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
125406359|NCT02866682|451116163|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
125406360|NCT02866682|451116162|FG000|Overall Study|Other|0|||
125406361|NCT02866682|451116163|FG001|Overall Study|Other|1|||
125406362|NCT00201006|451116164|FG000|Overall Study|Withdrawal by Subject|7|||
125406363|NCT00201006|451116165|FG001|Overall Study|Withdrawal by Subject|2|||
125406364|NCT00201006|451116166|FG002|Overall Study|Withdrawal by Subject|3|||
125406365|NCT00201006|451116164|FG000|Overall Study|Adverse Event|1|||
125406366|NCT00201006|451116165|FG001|Overall Study|Adverse Event|0|||
125406367|NCT00201006|451116166|FG002|Overall Study|Adverse Event|1|||
125406368|NCT01750268|451116167|FG000|Overall Study|Lost to Follow-up|0|||
125406369|NCT01750268|451116168|FG001|Overall Study|Lost to Follow-up|2|||
125406370|NCT01750268|451116167|FG000|Overall Study|Physician Decision|0|||
125406371|NCT01750268|451116168|FG001|Overall Study|Physician Decision|3|||
125406372|NCT01750268|451116167|FG000|Overall Study|Withdrawal by Subject|2|||
125406373|NCT01750268|451116168|FG001|Overall Study|Withdrawal by Subject|0|||
125406374|NCT01969838|451116172|FG000|Double-blind Phase|Adverse Event|10|||
125406375|NCT01969838|451116173|FG001|Double-blind Phase|Adverse Event|4|||
125406376|NCT01969838|451116174|FG002|Double-blind Phase|Adverse Event|0|||
125406377|NCT01969838|451116175|FG003|Double-blind Phase|Adverse Event|0|||
125406378|NCT01969838|451116172|FG000|Double-blind Phase|Death|5|||
125406379|NCT01969838|451116173|FG001|Double-blind Phase|Death|2|||
125406380|NCT01969838|451116174|FG002|Double-blind Phase|Death|0|||
125406381|NCT01969838|451116175|FG003|Double-blind Phase|Death|0|||
125406382|NCT01969838|451116172|FG000|Double-blind Phase|Physician Decision|5|||
125406383|NCT01969838|451116173|FG001|Double-blind Phase|Physician Decision|1|||
125406384|NCT01969838|451116174|FG002|Double-blind Phase|Physician Decision|0|||
125406385|NCT01969838|451116175|FG003|Double-blind Phase|Physician Decision|0|||
125406386|NCT01969838|451116172|FG000|Double-blind Phase|Subject Decision|4|||
125406387|NCT01969838|451116173|FG001|Double-blind Phase|Subject Decision|2|||
125406388|NCT01969838|451116174|FG002|Double-blind Phase|Subject Decision|0|||
125406389|NCT01969838|451116175|FG003|Double-blind Phase|Subject Decision|0|||
125406390|NCT01969838|451116172|FG000|Double-blind Phase|Disease Progression|2|||
125406391|NCT01969838|451116173|FG001|Double-blind Phase|Disease Progression|0|||
125406392|NCT01969838|451116174|FG002|Double-blind Phase|Disease Progression|0|||
125406393|NCT01969838|451116175|FG003|Double-blind Phase|Disease Progression|0|||
125406394|NCT01969838|451116172|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
125406395|NCT01969838|451116173|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
125406396|NCT01969838|451116174|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
125406397|NCT01969838|451116175|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
125406398|NCT01969838|451116172|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
125406399|NCT01969838|451116173|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
125406400|NCT01969838|451116174|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
125406401|NCT01969838|451116175|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
125406402|NCT01969838|451116172|FG000|Open-label Phase|Adverse Event|0|||
125406403|NCT01969838|451116173|FG001|Open-label Phase|Adverse Event|0|||
125406404|NCT01969838|451116174|FG002|Open-label Phase|Adverse Event|37|||
125406405|NCT01969838|451116175|FG003|Open-label Phase|Adverse Event|49|||
125406406|NCT01969838|451116172|FG000|Open-label Phase|Disease Progression|0|||
125406407|NCT01969838|451116173|FG001|Open-label Phase|Disease Progression|0|||
125406408|NCT01969838|451116174|FG002|Open-label Phase|Disease Progression|26|||
125406409|NCT01969838|451116175|FG003|Open-label Phase|Disease Progression|27|||
125406410|NCT01969838|451116172|FG000|Open-label Phase|Lack of Efficacy|0|||
125406411|NCT01969838|451116173|FG001|Open-label Phase|Lack of Efficacy|0|||
125406412|NCT01969838|451116174|FG002|Open-label Phase|Lack of Efficacy|17|||
125406413|NCT01969838|451116175|FG003|Open-label Phase|Lack of Efficacy|19|||
125406414|NCT01969838|451116172|FG000|Open-label Phase|Subject Decision|0|||
125406415|NCT01969838|451116173|FG001|Open-label Phase|Subject Decision|0|||
125406416|NCT01969838|451116174|FG002|Open-label Phase|Subject Decision|14|||
125406417|NCT01969838|451116175|FG003|Open-label Phase|Subject Decision|15|||
125406418|NCT01969838|451116172|FG000|Open-label Phase|Death|0|||
125406419|NCT01969838|451116173|FG001|Open-label Phase|Death|0|||
125406420|NCT01969838|451116174|FG002|Open-label Phase|Death|13|||
125406421|NCT01969838|451116175|FG003|Open-label Phase|Death|11|||
125406422|NCT01969838|451116172|FG000|Open-label Phase|Physician Decision|0|||
125406423|NCT01969838|451116173|FG001|Open-label Phase|Physician Decision|0|||
125406424|NCT01969838|451116174|FG002|Open-label Phase|Physician Decision|9|||
125406425|NCT01969838|451116175|FG003|Open-label Phase|Physician Decision|14|||
125406426|NCT01969838|451116172|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
125406427|NCT01969838|451116173|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
125278877|NCT01296711|450645839|FG005|Overall Study|Required restricted steroid injections|0|||
125278878|NCT01296711|450645840|FG006|Overall Study|Required restricted steroid injections|1|||
125278879|NCT01296711|450645841|FG007|Overall Study|Required restricted steroid injections|0|||
125278880|NCT01296711|450645834|FG000|Overall Study|Ongoing missed appointments|0|||
125278881|NCT01296711|450645835|FG001|Overall Study|Ongoing missed appointments|0|||
125278882|NCT01296711|450645836|FG002|Overall Study|Ongoing missed appointments|0|||
125278883|NCT01296711|450645837|FG003|Overall Study|Ongoing missed appointments|0|||
125278884|NCT01296711|450645838|FG004|Overall Study|Ongoing missed appointments|0|||
125278885|NCT01296711|450645839|FG005|Overall Study|Ongoing missed appointments|0|||
125278886|NCT01296711|450645840|FG006|Overall Study|Ongoing missed appointments|1|||
125278887|NCT01296711|450645841|FG007|Overall Study|Ongoing missed appointments|0|||
125278888|NCT01296711|450645834|FG000|Overall Study|Failure to comply with visits|0|||
125278889|NCT01296711|450645835|FG001|Overall Study|Failure to comply with visits|0|||
125278890|NCT01296711|450645836|FG002|Overall Study|Failure to comply with visits|0|||
125278891|NCT01296711|450645837|FG003|Overall Study|Failure to comply with visits|0|||
125278892|NCT01296711|450645838|FG004|Overall Study|Failure to comply with visits|0|||
125278893|NCT01296711|450645839|FG005|Overall Study|Failure to comply with visits|0|||
125278894|NCT01296711|450645840|FG006|Overall Study|Failure to comply with visits|0|||
125278895|NCT01296711|450645841|FG007|Overall Study|Failure to comply with visits|1|||
125278896|NCT01296711|450645834|FG000|Overall Study|Patient decision due to transport|0|||
125278897|NCT01296711|450645835|FG001|Overall Study|Patient decision due to transport|0|||
125278898|NCT01296711|450645836|FG002|Overall Study|Patient decision due to transport|0|||
125278899|NCT01296711|450645837|FG003|Overall Study|Patient decision due to transport|0|||
125278900|NCT01296711|450645838|FG004|Overall Study|Patient decision due to transport|0|||
125278901|NCT01296711|450645839|FG005|Overall Study|Patient decision due to transport|0|||
125278902|NCT01296711|450645840|FG006|Overall Study|Patient decision due to transport|0|||
125278903|NCT01296711|450645841|FG007|Overall Study|Patient decision due to transport|1|||
125278904|NCT01126268|450645842|FG000|Overall Study|Adverse Event|1|||
125278905|NCT04026009|450645843|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125278906|NCT04026009|450645844|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
125278907|NCT04026009|450645845|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
125278908|NCT04026009|450645846|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
125278909|NCT04026009|450645847|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
125278910|NCT04026009|450645843|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
125278911|NCT04026009|450645844|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
125278912|NCT04026009|450645845|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
125278913|NCT04026009|450645846|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
125278914|NCT04026009|450645847|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
125278915|NCT00842153|450645850|FG000|Overall Study|Adverse Event|0|||
125278916|NCT00842153|450645851|FG001|Overall Study|Adverse Event|1|||
125278917|NCT00842153|450645850|FG000|Overall Study|Lost to Follow-up|1|||
125278918|NCT00842153|450645851|FG001|Overall Study|Lost to Follow-up|2|||
125278919|NCT00002540|450645852|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
125278920|NCT00002540|450645853|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
125278921|NCT00002540|450645852|FG000|Overall Study|Died Before Randomization|2|||
125278922|NCT00002540|450645853|FG001|Overall Study|Died Before Randomization|6|||
125278923|NCT00002540|450645852|FG000|Overall Study|Died Before ASU (Control)|202|||
125278924|NCT00002540|450645853|FG001|Overall Study|Died Before ASU (Control)|0|||
125278925|NCT00002540|450645852|FG000|Overall Study|Refused ASU (Control)|597|||
125278926|NCT00002540|450645853|FG001|Overall Study|Refused ASU (Control)|0|||
125278927|NCT00002540|450645852|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
125278928|NCT00002540|450645853|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
125278929|NCT01345929|450645854|FG000|Overall Study|Withdrawal by Subject|9|||
125278930|NCT01345929|450645855|FG001|Overall Study|Withdrawal by Subject|8|||
125278931|NCT01345929|450645854|FG000|Overall Study|Lost to Follow-up|9|||
125278932|NCT01345929|450645855|FG001|Overall Study|Lost to Follow-up|9|||
125278933|NCT01345929|450645854|FG000|Overall Study|Adverse Event|0|||
125406428|NCT01969838|451116174|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
125406429|NCT01969838|451116175|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
125406430|NCT03087591|451116176|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
125406431|NCT03087591|451116176|FG000|Overall Study|Withdrawal by Subject|1|||
125406432|NCT00408993|451116177|FG000|Overall Study|Adverse Event|15|||
125406433|NCT00408993|451116178|FG001|Overall Study|Adverse Event|4|||
125406434|NCT00408993|451116177|FG000|Overall Study|Protocol Violation|1|||
125406435|NCT00408993|451116178|FG001|Overall Study|Protocol Violation|6|||
125406436|NCT00408993|451116177|FG000|Overall Study|Lack of Efficacy|1|||
125406437|NCT00408993|451116178|FG001|Overall Study|Lack of Efficacy|4|||
125278934|NCT01345929|450645855|FG001|Overall Study|Adverse Event|1|||
125278935|NCT01345929|450645854|FG000|Overall Study|Didn't meet eligibility criteria|2|||
125278936|NCT01345929|450645855|FG001|Overall Study|Didn't meet eligibility criteria|0|||
125278937|NCT01345929|450645854|FG000|Overall Study|40,000 CFU/ML|1|||
125278938|NCT01345929|450645855|FG001|Overall Study|40,000 CFU/ML|0|||
125406438|NCT00408993|451116177|FG000|Overall Study|Withdrawal by Subject|2|||
125406439|NCT00408993|451116178|FG001|Overall Study|Withdrawal by Subject|3|||
125406440|NCT03738865|451116179|FG000|Overall Study|Withdrawal by Subject|3|||
125406441|NCT03738865|451116180|FG001|Overall Study|Withdrawal by Subject|3|||
125406442|NCT03738865|451116179|FG000|Overall Study|Adverse Event|2|||
125406443|NCT03738865|451116180|FG001|Overall Study|Adverse Event|0|||
125406444|NCT03738865|451116179|FG000|Overall Study|Physician Decision|0|||
125406445|NCT03738865|451116180|FG001|Overall Study|Physician Decision|1|||
125406446|NCT02621606|451116181|FG000|Overall Study|Withdrawal by Subject|0|||
125406447|NCT02621606|451116182|FG001|Overall Study|Withdrawal by Subject|1|||
125406448|NCT02621606|451116183|FG002|Overall Study|Withdrawal by Subject|0|||
125406449|NCT01694706|451116184|FG000|Overall Study|Adverse Event|0|||
125406450|NCT01694706|451116185|FG001|Overall Study|Adverse Event|1|||
125406451|NCT01694706|451116186|FG002|Overall Study|Adverse Event|0|||
125406452|NCT01694706|451116184|FG000|Overall Study|other reason not defined above|1|||
125406453|NCT01694706|451116185|FG001|Overall Study|other reason not defined above|0|||
125406454|NCT01694706|451116186|FG002|Overall Study|other reason not defined above|0|||
125406455|NCT02840877|451116187|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
125406456|NCT02840877|451116187|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
125278939|NCT01345929|450645854|FG000|Overall Study|Patient withdrawal|0|||
125406457|NCT02840877|451116187|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
125406458|NCT02840877|451116187|FG000|Baseline to 12 Weeks|Death|1|||
125406459|NCT02840877|451116187|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
125406460|NCT02840877|451116187|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
125406461|NCT02840877|451116187|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
125406462|NCT02840877|451116187|FG000|12 Weeks to 6 Months|Treatment failure|1|||
125406463|NCT02840877|451116187|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
125406464|NCT02840877|451116187|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
125406465|NCT02840877|451116187|FG000|12 Weeks to 6 Months|Death|1|||
125406466|NCT02840877|451116187|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
125406467|NCT02840877|451116187|FG000|6 Months to 18 Months|Treatment failure|7|||
125406468|NCT02840877|451116187|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
125406469|NCT02840877|451116187|FG000|6 Months to 18 Months|Moved/transferred out|6|||
125406470|NCT02840877|451116187|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
125406471|NCT02840877|451116187|FG000|6 Months to 18 Months|Death|4|||
125406472|NCT02840877|451116187|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
125406473|NCT02840877|451116187|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
125406474|NCT02840877|451116187|FG000|6 Months to 18 Months|Still in study.|14|||
125406475|NCT02252081|451116190|FG000|Overall Study|Withdrawal by Subject|2|||
125406476|NCT02252081|451116191|FG001|Overall Study|Withdrawal by Subject|1|||
125406477|NCT02252081|451116190|FG000|Overall Study|Adverse Event|4|||
125406478|NCT02252081|451116191|FG001|Overall Study|Adverse Event|1|||
125406479|NCT02252081|451116190|FG000|Overall Study|non compliance & others|0|||
125406480|NCT02252081|451116191|FG001|Overall Study|non compliance & others|2|||
125406481|NCT01168999|451116192|FG000|Overall Study|Lost to Follow-up|2|||
125406482|NCT01168999|451116193|FG001|Overall Study|Lost to Follow-up|1|||
125406483|NCT01168999|451116194|FG002|Overall Study|Lost to Follow-up|0|||
125406484|NCT01168999|451116195|FG003|Overall Study|Lost to Follow-up|0|||
125406485|NCT01276327|451116198|FG000|Overall Study|Adverse Event|1|||
125406486|NCT01276327|451116199|FG001|Overall Study|Adverse Event|3|||
125406487|NCT01276327|451116198|FG000|Overall Study|Withdrawal by Subject|1|||
125406488|NCT01276327|451116199|FG001|Overall Study|Withdrawal by Subject|0|||
125406489|NCT03766646|451116202|FG000|Overall Study|Withdrawal by Subject|1|||
125406490|NCT03766646|451116203|FG001|Overall Study|Withdrawal by Subject|0|||
125406491|NCT03766646|451116202|FG000|Overall Study|Protocol Violation|0|||
125406492|NCT03766646|451116203|FG001|Overall Study|Protocol Violation|3|||
125406493|NCT00659269|451116221|FG000|Overall Study|Physician Decision|1|||
125406494|NCT00659269|451116222|FG001|Overall Study|Physician Decision|1|||
125406495|NCT01158222|451116223|FG000|Overall Study|Not eligible for intermediate phase|17|||
125406496|NCT01490060|451116228|FG000|Cycle 1|Change of Treatment|0|||
125406497|NCT01490060|451116229|FG001|Cycle 1|Change of Treatment|1|||
125406498|NCT01490060|451116230|FG002|Cycle 1|Change of Treatment|1|||
125406499|NCT01490060|451116231|FG003|Cycle 1|Change of Treatment|1|||
125406500|NCT01490060|451116228|FG000|Cycle 1|Insurance Denied|0|||
125406501|NCT01490060|451116229|FG001|Cycle 1|Insurance Denied|0|||
125406502|NCT01490060|451116230|FG002|Cycle 1|Insurance Denied|2|||
125406503|NCT01490060|451116231|FG003|Cycle 1|Insurance Denied|0|||
125406504|NCT01490060|451116228|FG000|Cycle 1|Withdrawal by Subject|0|||
125406505|NCT01490060|451116229|FG001|Cycle 1|Withdrawal by Subject|0|||
125406506|NCT01490060|451116230|FG002|Cycle 1|Withdrawal by Subject|0|||
125406507|NCT01490060|451116231|FG003|Cycle 1|Withdrawal by Subject|1|||
125448238|NCT03738241|451268869|FG004|Overall Study|Withdrawal by Subject|0|||
125448239|NCT03738241|451268870|FG005|Overall Study|Withdrawal by Subject|0|||
125448240|NCT03738241|451268871|FG006|Overall Study|Withdrawal by Subject|0|||
125406508|NCT01490060|451116228|FG000|Cycle 1|Treatment at Another Facility|0|||
125406509|NCT01490060|451116229|FG001|Cycle 1|Treatment at Another Facility|0|||
125278940|NCT01345929|450645855|FG001|Overall Study|Patient withdrawal|1|||
125278941|NCT02151903|450645856|FG000|Overall Study|Withdrawal by Subject|1|||
125278942|NCT02151903|450645857|FG001|Overall Study|Withdrawal by Subject|0|||
125278943|NCT02151903|450645856|FG000|Overall Study|Progressive disease|2|||
125278944|NCT02151903|450645857|FG001|Overall Study|Progressive disease|1|||
125278945|NCT01500252|450645860|FG000|Overall Study|Death|4|||
125278946|NCT01500252|450645861|FG001|Overall Study|Death|2|||
125278947|NCT01500252|450645860|FG000|Overall Study|Lost to Follow-up|5|||
125278948|NCT01500252|450645861|FG001|Overall Study|Lost to Follow-up|4|||
125278949|NCT05319600|450645862|FG000|Overall Study|Withdrawal by Subject|1|||
125278950|NCT05319600|450645863|FG001|Overall Study|Withdrawal by Subject|0|||
125278951|NCT05319600|450645862|FG000|Overall Study|Lost to Follow-up|0|||
125278952|NCT05319600|450645863|FG001|Overall Study|Lost to Follow-up|4|||
125278953|NCT03768089|450645867|FG000|Part A|Lost to Follow-up|0|||
125278954|NCT03768089|450645868|FG001|Part A|Lost to Follow-up|0|||
125278955|NCT03768089|450645869|FG002|Part A|Lost to Follow-up|0|||
125278956|NCT03768089|450645870|FG003|Part A|Lost to Follow-up|0|||
125278957|NCT03768089|450645871|FG004|Part A|Lost to Follow-up|1|||
125278958|NCT03768089|450645872|FG005|Part A|Lost to Follow-up|0|||
125278959|NCT03768089|450645873|FG006|Part A|Lost to Follow-up|0|||
125278960|NCT03768089|450645874|FG007|Part A|Lost to Follow-up|0|||
125278961|NCT03768089|450645875|FG008|Part A|Lost to Follow-up|0|||
125278962|NCT03768089|450645876|FG009|Part A|Lost to Follow-up|0|||
125278963|NCT03768089|450645877|FG010|Part A|Lost to Follow-up|0|||
125278964|NCT03768089|450645878|FG011|Part A|Lost to Follow-up|0|||
125278965|NCT03768089|450645879|FG012|Part A|Lost to Follow-up|0|||
125278966|NCT03768089|450645880|FG013|Part A|Lost to Follow-up|0|||
125278967|NCT03768089|450645881|FG014|Part A|Lost to Follow-up|0|||
125278968|NCT03768089|450645882|FG015|Part A|Lost to Follow-up|0|||
125278969|NCT03768089|450645883|FG016|Part A|Lost to Follow-up|0|||
125278970|NCT03768089|450645884|FG017|Part A|Lost to Follow-up|0|||
125278971|NCT03768089|450645867|FG000|Part C|Randomized, Never Dosed|0|||
125278972|NCT03768089|450645868|FG001|Part C|Randomized, Never Dosed|0|||
125278973|NCT03768089|450645869|FG002|Part C|Randomized, Never Dosed|0|||
125278974|NCT03768089|450645870|FG003|Part C|Randomized, Never Dosed|0|||
125278975|NCT03768089|450645871|FG004|Part C|Randomized, Never Dosed|0|||
125278976|NCT03768089|450645872|FG005|Part C|Randomized, Never Dosed|0|||
125278977|NCT03768089|450645873|FG006|Part C|Randomized, Never Dosed|0|||
125278978|NCT03768089|450645874|FG007|Part C|Randomized, Never Dosed|0|||
125278979|NCT03768089|450645875|FG008|Part C|Randomized, Never Dosed|0|||
125278980|NCT03768089|450645876|FG009|Part C|Randomized, Never Dosed|0|||
125278981|NCT03768089|450645877|FG010|Part C|Randomized, Never Dosed|0|||
125278982|NCT03768089|450645878|FG011|Part C|Randomized, Never Dosed|0|||
125278983|NCT03768089|450645879|FG012|Part C|Randomized, Never Dosed|0|||
125278984|NCT03768089|450645880|FG013|Part C|Randomized, Never Dosed|0|||
125278985|NCT03768089|450645881|FG014|Part C|Randomized, Never Dosed|1|||
125278986|NCT03768089|450645882|FG015|Part C|Randomized, Never Dosed|0|||
125278987|NCT03768089|450645883|FG016|Part C|Randomized, Never Dosed|0|||
125278988|NCT03768089|450645884|FG017|Part C|Randomized, Never Dosed|0|||
125278989|NCT02120300|450645887|FG000|Overall Study|Enrolled but Never Treated|2|||
125278990|NCT02120300|450645888|FG001|Overall Study|Enrolled but Never Treated|0|||
125278991|NCT02120300|450645889|FG002|Overall Study|Enrolled but Never Treated|0|||
125278992|NCT02120300|450645890|FG003|Overall Study|Enrolled but Never Treated|0|||
125278993|NCT02120300|450645887|FG000|Overall Study|Lack of Efficacy|0|||
125278994|NCT02120300|450645888|FG001|Overall Study|Lack of Efficacy|0|||
125278995|NCT02120300|450645889|FG002|Overall Study|Lack of Efficacy|0|||
125278996|NCT02120300|450645890|FG003|Overall Study|Lack of Efficacy|1|||
125278997|NCT02120300|450645887|FG000|Overall Study|Lost to Follow-up|1|||
125278998|NCT02120300|450645888|FG001|Overall Study|Lost to Follow-up|0|||
125278999|NCT02120300|450645889|FG002|Overall Study|Lost to Follow-up|0|||
125279000|NCT02120300|450645890|FG003|Overall Study|Lost to Follow-up|0|||
125279001|NCT00361231|450645894|FG000|Overall Study|Physician Decision|3|||
125279002|NCT00361231|450645894|FG000|Overall Study|Symptomatic deterioration|5|||
125279003|NCT00361231|450645894|FG000|Overall Study|Radiographic disease progression|16|||
125279004|NCT00361231|450645894|FG000|Overall Study|Withdrawal by Subject|4|||
125279005|NCT00361231|450645894|FG000|Overall Study|Adverse Event|6|||
125279006|NCT01208961|450645897|FG000|High-Fat Period III|Protocol Violation|1|||
125448241|NCT03738241|451268872|FG007|Overall Study|Withdrawal by Subject|0|||
125279007|NCT01208961|450645898|FG001|High-Fat Period III|Protocol Violation|0|||
125279008|NCT02241733|450645901|FG000|Overall Study|Lost to Follow-up|9|||
125279009|NCT02241733|450645902|FG001|Overall Study|Lost to Follow-up|4|||
125279010|NCT02241733|450645901|FG000|Overall Study|Physician Decision|6|||
125279011|NCT02241733|450645902|FG001|Overall Study|Physician Decision|2|||
125279012|NCT02241733|450645901|FG000|Overall Study|Withdrawal by Subject|0|||
125448242|NCT03738241|451268873|FG008|Overall Study|Withdrawal by Subject|0|||
125279013|NCT02241733|450645902|FG001|Overall Study|Withdrawal by Subject|2|||
125279014|NCT02241733|450645901|FG000|Overall Study|Death|0|||
125279015|NCT02241733|450645902|FG001|Overall Study|Death|2|||
125279016|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
125279017|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
125279018|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
125406510|NCT01490060|451116230|FG002|Cycle 1|Treatment at Another Facility|0|||
125406511|NCT01490060|451116231|FG003|Cycle 1|Treatment at Another Facility|1|||
125406512|NCT01490060|451116228|FG000|Cycle 2|Change of Treatment|1|||
125406513|NCT01490060|451116229|FG001|Cycle 2|Change of Treatment|1|||
125406514|NCT01490060|451116230|FG002|Cycle 2|Change of Treatment|0|||
125406515|NCT01490060|451116231|FG003|Cycle 2|Change of Treatment|0|||
125406516|NCT01490060|451116228|FG000|Cycle 2|Non-Compliance|0|||
125406517|NCT01490060|451116229|FG001|Cycle 2|Non-Compliance|0|||
125406518|NCT01490060|451116230|FG002|Cycle 2|Non-Compliance|1|||
125406519|NCT01490060|451116231|FG003|Cycle 2|Non-Compliance|0|||
125406520|NCT01490060|451116228|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
125406521|NCT01490060|451116229|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
125406522|NCT01490060|451116230|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
125406523|NCT01490060|451116231|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
125406524|NCT01877421|451116232|FG000|Phase 2|Lost to Follow-up|0|||
125406525|NCT01877421|451116233|FG001|Phase 2|Lost to Follow-up|0|||
125406526|NCT01877421|451116234|FG002|Phase 2|Lost to Follow-up|0|||
125406527|NCT01877421|451116235|FG003|Phase 2|Lost to Follow-up|0|||
125406528|NCT01877421|451116236|FG004|Phase 2|Lost to Follow-up|0|||
125406529|NCT01877421|451116237|FG005|Phase 2|Lost to Follow-up|0|||
125406530|NCT01877421|451116238|FG006|Phase 2|Lost to Follow-up|1|||
125406531|NCT01877421|451116239|FG007|Phase 2|Lost to Follow-up|0|||
125406532|NCT01877421|451116240|FG008|Phase 2|Lost to Follow-up|0|||
125406533|NCT01877421|451116241|FG009|Phase 2|Lost to Follow-up|0|||
125406534|NCT01877421|451116242|FG010|Phase 2|Lost to Follow-up|0|||
125406535|NCT01877421|451116243|FG011|Phase 2|Lost to Follow-up|0|||
125406536|NCT01877421|451116244|FG012|Phase 2|Lost to Follow-up|0|||
125406537|NCT01877421|451116245|FG013|Phase 2|Lost to Follow-up|0|||
125406538|NCT01877421|451116246|FG014|Phase 2|Lost to Follow-up|0|||
125406539|NCT01877421|451116247|FG015|Phase 2|Lost to Follow-up|0|||
125406540|NCT01877421|451116248|FG016|Phase 2|Lost to Follow-up|0|||
125406541|NCT01877421|451116249|FG017|Phase 2|Lost to Follow-up|0|||
125406542|NCT01877421|451116232|FG000|Phase 2|Withdrawal by Subject|0|||
125406543|NCT01877421|451116233|FG001|Phase 2|Withdrawal by Subject|0|||
125406544|NCT01877421|451116234|FG002|Phase 2|Withdrawal by Subject|0|||
125406545|NCT01877421|451116235|FG003|Phase 2|Withdrawal by Subject|0|||
125406546|NCT01877421|451116236|FG004|Phase 2|Withdrawal by Subject|0|||
125406547|NCT01877421|451116237|FG005|Phase 2|Withdrawal by Subject|0|||
125406548|NCT01877421|451116238|FG006|Phase 2|Withdrawal by Subject|0|||
125406549|NCT01877421|451116239|FG007|Phase 2|Withdrawal by Subject|0|||
125406550|NCT01877421|451116240|FG008|Phase 2|Withdrawal by Subject|1|||
125406551|NCT01877421|451116241|FG009|Phase 2|Withdrawal by Subject|0|||
125406552|NCT01877421|451116242|FG010|Phase 2|Withdrawal by Subject|1|||
125406553|NCT01877421|451116243|FG011|Phase 2|Withdrawal by Subject|0|||
125406554|NCT01877421|451116244|FG012|Phase 2|Withdrawal by Subject|1|||
125406555|NCT01877421|451116245|FG013|Phase 2|Withdrawal by Subject|0|||
125406556|NCT01877421|451116246|FG014|Phase 2|Withdrawal by Subject|0|||
125406557|NCT01877421|451116247|FG015|Phase 2|Withdrawal by Subject|1|||
125406558|NCT01877421|451116248|FG016|Phase 2|Withdrawal by Subject|0|||
125406559|NCT01877421|451116249|FG017|Phase 2|Withdrawal by Subject|0|||
125406560|NCT01877421|451116232|FG000|Phase 2|Protocol Violation|0|||
125406561|NCT01877421|451116233|FG001|Phase 2|Protocol Violation|0|||
125406562|NCT01877421|451116234|FG002|Phase 2|Protocol Violation|0|||
125406563|NCT01877421|451116235|FG003|Phase 2|Protocol Violation|0|||
125406564|NCT01877421|451116236|FG004|Phase 2|Protocol Violation|0|||
125406565|NCT01877421|451116237|FG005|Phase 2|Protocol Violation|0|||
125406566|NCT01877421|451116238|FG006|Phase 2|Protocol Violation|0|||
125406567|NCT01877421|451116239|FG007|Phase 2|Protocol Violation|0|||
125406568|NCT01877421|451116240|FG008|Phase 2|Protocol Violation|0|||
125406569|NCT01877421|451116241|FG009|Phase 2|Protocol Violation|0|||
125406570|NCT01877421|451116242|FG010|Phase 2|Protocol Violation|1|||
125406571|NCT01877421|451116243|FG011|Phase 2|Protocol Violation|0|||
125406572|NCT01877421|451116244|FG012|Phase 2|Protocol Violation|0|||
125406573|NCT01877421|451116245|FG013|Phase 2|Protocol Violation|0|||
125406574|NCT01877421|451116246|FG014|Phase 2|Protocol Violation|0|||
125406575|NCT01877421|451116247|FG015|Phase 2|Protocol Violation|0|||
125406576|NCT01877421|451116248|FG016|Phase 2|Protocol Violation|0|||
125406577|NCT01877421|451116249|FG017|Phase 2|Protocol Violation|0|||
125406578|NCT01047683|451116250|FG000|Overall Study|Adverse Event|3|||
125406579|NCT01047683|451116251|FG001|Overall Study|Adverse Event|1|||
125406580|NCT01047683|451116252|FG002|Overall Study|Adverse Event|0|||
125406581|NCT01047683|451116250|FG000|Overall Study|Withdrew Consent|1|||
125406582|NCT01047683|451116251|FG001|Overall Study|Withdrew Consent|4|||
125406583|NCT01047683|451116252|FG002|Overall Study|Withdrew Consent|2|||
125406584|NCT01047683|451116250|FG000|Overall Study|Lost to Follow-up|0|||
125406585|NCT01047683|451116251|FG001|Overall Study|Lost to Follow-up|1|||
125406586|NCT01047683|451116252|FG002|Overall Study|Lost to Follow-up|0|||
125406587|NCT01047683|451116250|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
125406588|NCT01047683|451116251|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
125406589|NCT01047683|451116252|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
125406590|NCT00724451|451116256|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
125406591|NCT00724451|451116256|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
125406592|NCT00724451|451116256|FG000|Overall Study|Not Eligible for Treatment|431|||
125406593|NCT00724451|451116256|FG000|Overall Study|Participant Refused Treatment|89|||
125406594|NCT00724451|451116256|FG000|Overall Study|Never Started Treatment|89|||
125406595|NCT00724451|451116256|FG000|Overall Study|Unknown; No Data Sources Available|9|||
125406596|NCT00724451|451116256|FG000|Overall Study|Physician Decision|116|||
125406597|NCT00724451|451116256|FG000|Overall Study|Withdrawal by Subject|45|||
125406598|NCT00724451|451116256|FG000|Overall Study|Investigator + Participant Decision|13|||
125406599|NCT01260922|451116258|FG000|First Intervention|Withdrawal by Subject|0|||
125406600|NCT01260922|451116259|FG001|First Intervention|Withdrawal by Subject|1|||
125406601|NCT01260922|451116258|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
125406602|NCT01260922|451116259|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
125406603|NCT01260922|451116258|FG000|Second Intervention|Emesis|0|||
125406604|NCT01260922|451116259|FG001|Second Intervention|Emesis|2|||
125406605|NCT03732248|451116262|FG000|Overall Study|Withdrawal by Subject|1|||
125406606|NCT03732248|451116263|FG001|Overall Study|Withdrawal by Subject|0|||
125406607|NCT03653429|451116265|FG000|Overall Study|Physician Decision|4|||
125406608|NCT03653429|451116266|FG001|Overall Study|Physician Decision|10|||
125406609|NCT01971346|451116280|FG000|Overall Study|Protocol Violation|3|||
125406610|NCT01971346|451116280|FG000|Overall Study|Lost to Follow-up|2|||
125406611|NCT01971346|451116280|FG000|Overall Study|Withdrawal by Subject|2|||
125406612|NCT01971346|451116280|FG000|Overall Study|Physician Decision|1|||
125406613|NCT01652716|451116281|FG000|Overall Study|Loss of glucose control|1|||
125406614|NCT01652716|451116282|FG001|Overall Study|Loss of glucose control|0|||
125406615|NCT01652716|451116281|FG000|Overall Study|Administrative|0|||
125406616|NCT01652716|451116282|FG001|Overall Study|Administrative|2|||
125406617|NCT01652716|451116281|FG000|Overall Study|Investigator decision|1|||
125406618|NCT01652716|451116282|FG001|Overall Study|Investigator decision|4|||
125406619|NCT01652716|451116281|FG000|Overall Study|Lost to Follow-up|12|||
125406620|NCT01652716|451116282|FG001|Overall Study|Lost to Follow-up|11|||
125406621|NCT01652716|451116281|FG000|Overall Study|Protocol Violation|2|||
125406622|NCT01652716|451116282|FG001|Overall Study|Protocol Violation|1|||
125406623|NCT01652716|451116281|FG000|Overall Study|Adverse Event|7|||
125406624|NCT01652716|451116282|FG001|Overall Study|Adverse Event|10|||
125406625|NCT01652716|451116281|FG000|Overall Study|Withdrawal by Subject|33|||
125406626|NCT01652716|451116282|FG001|Overall Study|Withdrawal by Subject|18|||
125406627|NCT00360334|451116285|FG000|Overall Study|Adverse Event|7|||
125406628|NCT00360334|451116286|FG001|Overall Study|Adverse Event|4|||
125406629|NCT00360334|451116285|FG000|Overall Study|Protocol Violation|1|||
125406630|NCT00360334|451116286|FG001|Overall Study|Protocol Violation|1|||
125406631|NCT00360334|451116285|FG000|Overall Study|Physician Decision|2|||
125406632|NCT00360334|451116286|FG001|Overall Study|Physician Decision|3|||
125406633|NCT00360334|451116285|FG000|Overall Study|Lack of Efficacy|0|||
125406634|NCT00360334|451116286|FG001|Overall Study|Lack of Efficacy|1|||
125406635|NCT00360334|451116285|FG000|Overall Study|Entry criterion not met|1|||
125406636|NCT00360334|451116286|FG001|Overall Study|Entry criterion not met|2|||
125406637|NCT00360334|451116285|FG000|Overall Study|Subject decision|8|||
125406638|NCT00360334|451116286|FG001|Overall Study|Subject decision|2|||
125406639|NCT01978184|451116289|FG000|Overall Study|Progressive disease|5|||
125406640|NCT01978184|451116290|FG001|Overall Study|Progressive disease|5|||
125406641|NCT01978184|451116289|FG000|Overall Study|Other than PDA|2|||
125406642|NCT01978184|451116290|FG001|Overall Study|Other than PDA|2|||
125406643|NCT01978184|451116289|FG000|Overall Study|Physician Decision|0|||
125406644|NCT01978184|451116290|FG001|Overall Study|Physician Decision|3|||
125406645|NCT01978184|451116289|FG000|Overall Study|Noncompliance|1|||
125406646|NCT01978184|451116290|FG001|Overall Study|Noncompliance|2|||
125406647|NCT01978184|451116289|FG000|Overall Study|Death|1|||
125406648|NCT01978184|451116290|FG001|Overall Study|Death|0|||
125406649|NCT01978184|451116289|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
125279019|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
125279020|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
125279021|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
125279022|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
125279023|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
125279024|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
125406650|NCT01978184|451116290|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
125406651|NCT02447991|451116306|FG000|Overall Study|Withdrawn by subject - no data|0|||
125406652|NCT02447991|451116307|FG001|Overall Study|Withdrawn by subject - no data|2|||
125406653|NCT02447991|451116306|FG000|Overall Study|Withdrawn by Subject - with data|4|||
125406654|NCT02447991|451116307|FG001|Overall Study|Withdrawn by Subject - with data|4|||
125448243|NCT03738241|451268874|FG009|Overall Study|Withdrawal by Subject|1|||
125406655|NCT02447991|451116306|FG000|Overall Study|Lost to Follow-up - no data|3|||
125448244|NCT03738241|451268865|FG000|Overall Study|Physician Decision|0|||
125279025|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
125448245|NCT03738241|451268866|FG001|Overall Study|Physician Decision|0|||
125448246|NCT03738241|451268867|FG002|Overall Study|Physician Decision|0|||
125406656|NCT02447991|451116307|FG001|Overall Study|Lost to Follow-up - no data|6|||
125406657|NCT02447991|451116306|FG000|Overall Study|Lost to follow-up - with data|0|||
125406658|NCT02447991|451116307|FG001|Overall Study|Lost to follow-up - with data|3|||
125406659|NCT02447991|451116306|FG000|Overall Study|End of study - no treatment results|3|||
125406660|NCT02447991|451116307|FG001|Overall Study|End of study - no treatment results|6|||
125406661|NCT02447991|451116306|FG000|Overall Study|End of study - partial treatment results|0|||
125406662|NCT02447991|451116307|FG001|Overall Study|End of study - partial treatment results|9|||
125406663|NCT00459134|451116308|FG000|Overall Study|Physician Decision|1|||
125406664|NCT00459134|451116309|FG001|Overall Study|Physician Decision|1|||
125406665|NCT00459134|451116308|FG000|Overall Study|Withdrawal by Subject|8|||
125406666|NCT00459134|451116309|FG001|Overall Study|Withdrawal by Subject|7|||
125406667|NCT00459134|451116308|FG000|Overall Study|Lost to Follow-up|6|||
125406668|NCT00459134|451116309|FG001|Overall Study|Lost to Follow-up|7|||
125406669|NCT00459134|451116308|FG000|Overall Study|Surgery|1|||
125406670|NCT00459134|451116309|FG001|Overall Study|Surgery|2|||
125406671|NCT00459134|451116308|FG000|Overall Study|Toxicity|4|||
125406672|NCT00459134|451116309|FG001|Overall Study|Toxicity|5|||
125406673|NCT00459134|451116308|FG000|Overall Study|Progression|1|||
125406674|NCT00459134|451116309|FG001|Overall Study|Progression|0|||
125406675|NCT00459134|451116308|FG000|Overall Study|Multiple Reasons|2|||
125406676|NCT00459134|451116309|FG001|Overall Study|Multiple Reasons|3|||
125406677|NCT03525834|451118213|FG000|Overall Study|Progressive disease|1|||
125406678|NCT03095417|451118214|FG000|Overall Study|missed|1|||
125406679|NCT03095417|451118215|FG001|Overall Study|missed|2|||
125406680|NCT03095417|451118216|FG002|Overall Study|missed|0|||
125406681|NCT03095417|451118217|FG003|Overall Study|missed|1|||
125406682|NCT03095417|451118214|FG000|Overall Study|Lost to Follow-up|2|||
125406683|NCT03095417|451118215|FG001|Overall Study|Lost to Follow-up|2|||
125406684|NCT03095417|451118216|FG002|Overall Study|Lost to Follow-up|1|||
125406685|NCT03095417|451118217|FG003|Overall Study|Lost to Follow-up|0|||
125406686|NCT03095417|451118214|FG000|Overall Study|refusal|0|||
125406687|NCT03095417|451118215|FG001|Overall Study|refusal|1|||
125406688|NCT03095417|451118216|FG002|Overall Study|refusal|0|||
125406689|NCT03095417|451118217|FG003|Overall Study|refusal|1|||
125406690|NCT03095417|451118214|FG000|Overall Study|Withdrawal by Subject|8|||
125406691|NCT03095417|451118215|FG001|Overall Study|Withdrawal by Subject|2|||
125406692|NCT03095417|451118216|FG002|Overall Study|Withdrawal by Subject|5|||
125406693|NCT03095417|451118217|FG003|Overall Study|Withdrawal by Subject|4|||
125406694|NCT03095417|451118214|FG000|Overall Study|Physician Decision|1|||
125406695|NCT03095417|451118215|FG001|Overall Study|Physician Decision|2|||
125406696|NCT03095417|451118216|FG002|Overall Study|Physician Decision|2|||
125406697|NCT03095417|451118217|FG003|Overall Study|Physician Decision|2|||
125406698|NCT03095417|451118214|FG000|Overall Study|Death|1|||
125406699|NCT03095417|451118215|FG001|Overall Study|Death|2|||
125406700|NCT03095417|451118216|FG002|Overall Study|Death|1|||
125406701|NCT03095417|451118217|FG003|Overall Study|Death|3|||
125406702|NCT01410110|451118218|FG000|Overall Study|Withdrawal by Subject|4|||
125406703|NCT01410110|451118219|FG001|Overall Study|Withdrawal by Subject|2|||
125406704|NCT01525082|451118220|FG000|Overall Study|Death|1|||
125406705|NCT02543346|451118223|FG000|Second Priming Visit|Withdrawal by Subject|0|||
125406706|NCT02543346|451118224|FG001|Second Priming Visit|Withdrawal by Subject|2|||
125406707|NCT02543346|451118225|FG002|Second Priming Visit|Withdrawal by Subject|2|||
125406708|NCT02543346|451118226|FG003|Second Priming Visit|Withdrawal by Subject|2|||
125406709|NCT02543346|451118223|FG000|Second Priming Visit|Adverse Event|1|||
125406710|NCT02543346|451118224|FG001|Second Priming Visit|Adverse Event|0|||
125406711|NCT02543346|451118225|FG002|Second Priming Visit|Adverse Event|0|||
125406712|NCT02543346|451118226|FG003|Second Priming Visit|Adverse Event|0|||
125406713|NCT01767116|451118227|FG000|Overall Study|Lost to Follow-up|2|||
125406714|NCT01767116|451118228|FG001|Overall Study|Lost to Follow-up|2|||
125406715|NCT02141516|451118233|FG000|Overall Study|Adverse Event|0|||
125406716|NCT02141516|451118234|FG001|Overall Study|Adverse Event|1|||
125279026|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
125279027|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
125406717|NCT02141516|451118235|FG002|Overall Study|Adverse Event|0|||
125406718|NCT02141516|451118233|FG000|Overall Study|Lost to Follow-up|0|||
125406719|NCT02141516|451118234|FG001|Overall Study|Lost to Follow-up|1|||
125406720|NCT02141516|451118235|FG002|Overall Study|Lost to Follow-up|0|||
125406721|NCT02141516|451118233|FG000|Overall Study|Other|0|||
125406722|NCT02141516|451118234|FG001|Overall Study|Other|3|||
125406723|NCT02141516|451118235|FG002|Overall Study|Other|0|||
125406724|NCT00153101|451118238|FG000|Overall Study|Lost to Follow-up|14|||
125406725|NCT00153101|451118239|FG001|Overall Study|Lost to Follow-up|14|||
125406726|NCT00153101|451118240|FG002|Overall Study|Lost to Follow-up|12|||
125406727|NCT00153101|451118241|FG003|Overall Study|Lost to Follow-up|5|||
125406728|NCT00153101|451118242|FG004|Overall Study|Lost to Follow-up|5|||
125406729|NCT00153101|451118238|FG000|Overall Study|Withdrawal by Subject|3|||
125406730|NCT00153101|451118239|FG001|Overall Study|Withdrawal by Subject|4|||
125406731|NCT00153101|451118240|FG002|Overall Study|Withdrawal by Subject|3|||
125406732|NCT00153101|451118241|FG003|Overall Study|Withdrawal by Subject|3|||
125279028|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
125279029|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
125279030|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
125406733|NCT00153101|451118242|FG004|Overall Study|Withdrawal by Subject|5|||
125406734|NCT02610140|451118243|FG000|Randomization and Treatment Period|Radiological progression|23|||
125406735|NCT02610140|451118244|FG001|Randomization and Treatment Period|Radiological progression|15|||
125406736|NCT02610140|451118243|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
125406737|NCT02610140|451118244|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
125406738|NCT02610140|451118243|FG000|Randomization and Treatment Period|Protocol Violation|1|||
125406739|NCT02610140|451118244|FG001|Randomization and Treatment Period|Protocol Violation|0|||
125406740|NCT02610140|451118243|FG000|Randomization and Treatment Period|Physician Decision|0|||
125406741|NCT02610140|451118244|FG001|Randomization and Treatment Period|Physician Decision|1|||
125406742|NCT02610140|451118243|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
125406743|NCT02610140|451118244|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
125406744|NCT02610140|451118243|FG000|Randomization and Treatment Period|Death|7|||
125406745|NCT02610140|451118244|FG001|Randomization and Treatment Period|Death|1|||
125406746|NCT02610140|451118243|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
125406747|NCT02610140|451118244|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
125406748|NCT02610140|451118243|FG000|Randomization and Treatment Period|Adverse Event|44|||
125406749|NCT02610140|451118244|FG001|Randomization and Treatment Period|Adverse Event|13|||
125406750|NCT02610140|451118243|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
125406751|NCT02610140|451118244|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
125406752|NCT02610140|451118243|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
125406753|NCT02610140|451118244|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
125406754|NCT02610140|451118243|FG000|Randomization and Treatment Period|Not treated|3|||
125406755|NCT02610140|451118244|FG001|Randomization and Treatment Period|Not treated|10|||
125406756|NCT02610140|451118243|FG000|Safety Follow-up|Other|0|||
125406757|NCT02610140|451118244|FG001|Safety Follow-up|Other|2|||
125406758|NCT02610140|451118243|FG000|Safety Follow-up|Lost to Follow-up|1|||
125406759|NCT02610140|451118244|FG001|Safety Follow-up|Lost to Follow-up|0|||
125406760|NCT02610140|451118243|FG000|Safety Follow-up|No follow-up|5|||
125406761|NCT02610140|451118244|FG001|Safety Follow-up|No follow-up|3|||
125406762|NCT02610140|451118243|FG000|Safety Follow-up|Death|12|||
125406763|NCT02610140|451118244|FG001|Safety Follow-up|Death|2|||
125406764|NCT02610140|451118243|FG000|Safety Follow-up|Deterioration of general conditions|15|||
125406765|NCT02610140|451118244|FG001|Safety Follow-up|Deterioration of general conditions|5|||
125406766|NCT02610140|451118243|FG000|Safety Follow-up|Withdrawal by Subject|12|||
125406767|NCT02610140|451118244|FG001|Safety Follow-up|Withdrawal by Subject|12|||
125406768|NCT02610140|451118243|FG000|Active Follow-up|Progressive disease - radiological|30|||
125406769|NCT02610140|451118244|FG001|Active Follow-up|Progressive disease - radiological|22|||
125406770|NCT02610140|451118243|FG000|Active Follow-up|Death|8|||
125406771|NCT02610140|451118244|FG001|Active Follow-up|Death|1|||
125406772|NCT02610140|451118243|FG000|Active Follow-up|Withdrawal by Subject|4|||
125406773|NCT02610140|451118244|FG001|Active Follow-up|Withdrawal by Subject|0|||
125406774|NCT02610140|451118243|FG000|Active Follow-up|Progressive disease - clinical|1|||
125406775|NCT02610140|451118244|FG001|Active Follow-up|Progressive disease - clinical|2|||
125406776|NCT02610140|451118243|FG000|Active Follow-up|Deterioration of general conditions|1|||
125406777|NCT02610140|451118244|FG001|Active Follow-up|Deterioration of general conditions|0|||
125406778|NCT02610140|451118243|FG000|Active Follow-up|Ongoing but not completed|4|||
125406779|NCT02610140|451118244|FG001|Active Follow-up|Ongoing but not completed|1|||
125406780|NCT02610140|451118243|FG000|Long-term Follow-up|Death|86|||
125406781|NCT02610140|451118244|FG001|Long-term Follow-up|Death|44|||
125406782|NCT02610140|451118243|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
125406783|NCT02610140|451118244|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
125406784|NCT02610140|451118243|FG000|Long-term Follow-up|Lost to Follow-up|1|||
125406785|NCT02610140|451118244|FG001|Long-term Follow-up|Lost to Follow-up|2|||
125448247|NCT03738241|451268868|FG003|Overall Study|Physician Decision|0|||
125279031|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
125279032|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
125279033|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
125406786|NCT02610140|451118243|FG000|Long-term Follow-up|Ongoing but not completed|30|||
125406787|NCT02610140|451118244|FG001|Long-term Follow-up|Ongoing but not completed|17|||
125406788|NCT03169153|451118245|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
125406789|NCT03169153|451118246|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
125406790|NCT03169153|451118245|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
125406791|NCT03169153|451118246|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
125406792|NCT03169153|451118245|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
125406793|NCT03169153|451118246|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
125406794|NCT03169153|451118245|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
125406795|NCT03169153|451118246|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
125448248|NCT03738241|451268869|FG004|Overall Study|Physician Decision|0|||
125448249|NCT03738241|451268870|FG005|Overall Study|Physician Decision|0|||
125448250|NCT03738241|451268871|FG006|Overall Study|Physician Decision|0|||
125448251|NCT03738241|451268872|FG007|Overall Study|Physician Decision|0|||
125448252|NCT03738241|451268873|FG008|Overall Study|Physician Decision|1|||
125448253|NCT03738241|451268874|FG009|Overall Study|Physician Decision|0|||
125448254|NCT03738241|451268865|FG000|Overall Study|Adverse Event|1|||
125448255|NCT03738241|451268866|FG001|Overall Study|Adverse Event|0|||
125279034|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
125279035|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
125279036|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
125279037|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
125279038|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
125279039|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
125279040|NCT01866111|450645904|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
125279041|NCT01866111|450645905|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
125279042|NCT01866111|450645906|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
125279043|NCT01866111|450645907|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
125279044|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
125279045|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
125279046|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
125279047|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
125279048|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
125279049|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
125279050|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
125279051|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
125279052|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
125279053|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
125279054|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
125279055|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
125279056|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
125279057|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
125279058|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
125279059|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
125279060|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Death|1|||
125279061|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Death|1|||
125279062|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Death|3|||
125279063|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Death|2|||
125279064|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
125279065|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
125279066|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
125279067|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
125279068|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
125279069|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
125279070|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
125279071|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
125279072|NCT01866111|450645904|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
125279073|NCT01866111|450645905|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
125279074|NCT01866111|450645906|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
125279075|NCT01866111|450645907|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
125279076|NCT04576455|450645909|FG000|Overall Study|Ongoing in the Study|48|||
125279077|NCT04576455|450645910|FG001|Overall Study|Ongoing in the Study|58|||
125279078|NCT04576455|450645909|FG000|Overall Study|Death|83|||
125279079|NCT04576455|450645910|FG001|Overall Study|Death|77|||
125279080|NCT04576455|450645909|FG000|Overall Study|Lost to Follow-up|4|||
125279081|NCT04576455|450645910|FG001|Overall Study|Lost to Follow-up|5|||
125279082|NCT04576455|450645909|FG000|Overall Study|Withdrawal by Subject|16|||
125279083|NCT04576455|450645910|FG001|Overall Study|Withdrawal by Subject|12|||
125279084|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
125279085|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125279086|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125279087|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125279088|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125279089|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
125279090|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
125448256|NCT03738241|451268867|FG002|Overall Study|Adverse Event|0|||
125448257|NCT03738241|451268868|FG003|Overall Study|Adverse Event|0|||
125448258|NCT03738241|451268869|FG004|Overall Study|Adverse Event|0|||
125406796|NCT00887341|451118247|FG000|Overall Study|Refused treatment|1|||
125406797|NCT00887341|451118248|FG001|Overall Study|Refused treatment|0|||
125406798|NCT00887341|451118247|FG000|Overall Study|Withdrawal by Subject|1|||
125406799|NCT00887341|451118248|FG001|Overall Study|Withdrawal by Subject|1|||
125406800|NCT00887341|451118247|FG000|Overall Study|Adverse Event|0|||
125406801|NCT00887341|451118248|FG001|Overall Study|Adverse Event|1|||
125406802|NCT00887341|451118247|FG000|Overall Study|Lost to Follow-up|0|||
125406803|NCT00887341|451118248|FG001|Overall Study|Lost to Follow-up|1|||
125406804|NCT01649856|451118249|FG000|Overall Study|Withdrawal by Subject|14|||
125406805|NCT01649856|451118250|FG001|Overall Study|Withdrawal by Subject|14|||
125406806|NCT01649856|451118249|FG000|Overall Study|Protocol Violation|4|||
125406807|NCT01649856|451118250|FG001|Overall Study|Protocol Violation|4|||
125406808|NCT01649856|451118249|FG000|Overall Study|Treatment Failure|1|||
125406809|NCT01649856|451118250|FG001|Overall Study|Treatment Failure|1|||
125406810|NCT01649856|451118249|FG000|Overall Study|Death|69|||
125406811|NCT01649856|451118250|FG001|Overall Study|Death|34|||
125406812|NCT01649856|451118249|FG000|Overall Study|Stable or Progressed Disease|5|||
125406813|NCT01649856|451118250|FG001|Overall Study|Stable or Progressed Disease|3|||
125406814|NCT01649856|451118249|FG000|Overall Study|Lost to Follow-up|20|||
125406815|NCT01649856|451118250|FG001|Overall Study|Lost to Follow-up|16|||
125406816|NCT01649856|451118249|FG000|Overall Study|Lack of Compliance|6|||
125406817|NCT01649856|451118250|FG001|Overall Study|Lack of Compliance|1|||
125406818|NCT01649856|451118249|FG000|Overall Study|Other|20|||
125406819|NCT01649856|451118250|FG001|Overall Study|Other|5|||
125406820|NCT00622635|451118251|FG000|Treatment Period 1|Adverse Event|0|||
125406821|NCT00622635|451118252|FG001|Treatment Period 1|Adverse Event|0|||
125406822|NCT00622635|451118253|FG002|Treatment Period 1|Adverse Event|1|||
125406823|NCT00622635|451118254|FG003|Treatment Period 1|Adverse Event|0|||
125406824|NCT00622635|451118255|FG004|Treatment Period 1|Adverse Event|0|||
125406825|NCT00622635|451118256|FG005|Treatment Period 1|Adverse Event|0|||
125406826|NCT00622635|451118251|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125406827|NCT00622635|451118252|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125406828|NCT00622635|451118253|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125406829|NCT00622635|451118254|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125406830|NCT00622635|451118255|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125406831|NCT00622635|451118256|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125406832|NCT00622635|451118251|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
125406833|NCT00622635|451118252|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
125406834|NCT00622635|451118253|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
125406835|NCT00622635|451118254|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
125406836|NCT00622635|451118255|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
125406837|NCT00622635|451118256|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
125406838|NCT00622635|451118251|FG000|Treatment Period 2|Adverse Event|1|||
125406839|NCT00622635|451118252|FG001|Treatment Period 2|Adverse Event|0|||
125406840|NCT00622635|451118253|FG002|Treatment Period 2|Adverse Event|0|||
125406841|NCT00622635|451118254|FG003|Treatment Period 2|Adverse Event|0|||
125406842|NCT00622635|451118255|FG004|Treatment Period 2|Adverse Event|0|||
125406843|NCT00622635|451118256|FG005|Treatment Period 2|Adverse Event|0|||
125406844|NCT00622635|451118251|FG000|Treatment Period 3|Adverse Event|0|||
125406845|NCT00622635|451118252|FG001|Treatment Period 3|Adverse Event|0|||
125406846|NCT00622635|451118253|FG002|Treatment Period 3|Adverse Event|0|||
125279091|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
125406847|NCT00622635|451118254|FG003|Treatment Period 3|Adverse Event|2|||
125406848|NCT00622635|451118255|FG004|Treatment Period 3|Adverse Event|0|||
125406849|NCT00622635|451118256|FG005|Treatment Period 3|Adverse Event|0|||
125406850|NCT00622635|451118251|FG000|Treatment Period 3|Withdrawal by Subject|0|||
125406851|NCT00622635|451118252|FG001|Treatment Period 3|Withdrawal by Subject|0|||
125406852|NCT00622635|451118253|FG002|Treatment Period 3|Withdrawal by Subject|0|||
125406853|NCT00622635|451118254|FG003|Treatment Period 3|Withdrawal by Subject|1|||
125406854|NCT00622635|451118255|FG004|Treatment Period 3|Withdrawal by Subject|0|||
125406855|NCT00622635|451118256|FG005|Treatment Period 3|Withdrawal by Subject|0|||
125406856|NCT00281840|451118257|FG000|Overall Study|Adverse Event|12|||
125406857|NCT00281840|451118257|FG000|Overall Study|Physician Decision|6|||
125406858|NCT00281840|451118257|FG000|Overall Study|Withdrawal by Subject|3|||
125406859|NCT00281840|451118257|FG000|Overall Study|Disease Progression|2|||
125406860|NCT00281840|451118257|FG000|Overall Study|exceed maximum delay in treatment|1|||
125406861|NCT00281840|451118257|FG000|Overall Study|Complicating Disease|1|||
125406862|NCT01975389|451118267|FG000|Overall Study|Adverse Event|10|||
125406863|NCT01975389|451118268|FG001|Overall Study|Adverse Event|6|||
125406864|NCT01975389|451118267|FG000|Overall Study|Death|61|||
125406865|NCT01975389|451118268|FG001|Overall Study|Death|54|||
125406866|NCT01975389|451118267|FG000|Overall Study|Lost to Follow-up|81|||
125406867|NCT01975389|451118268|FG001|Overall Study|Lost to Follow-up|86|||
125406868|NCT01975389|451118267|FG000|Overall Study|Withdrawal by Subject|90|||
125406869|NCT01975389|451118268|FG001|Overall Study|Withdrawal by Subject|76|||
125406870|NCT01975389|451118267|FG000|Overall Study|Other|6|||
125406871|NCT01975389|451118268|FG001|Overall Study|Other|9|||
125406872|NCT01975389|451118267|FG000|Overall Study|Randomized, not treated|4|||
125406873|NCT01975389|451118268|FG001|Overall Study|Randomized, not treated|5|||
125406874|NCT01079234|451118271|FG000|Main: Week 0 to 26|Adverse Event|5|||
125406875|NCT01079234|451118272|FG001|Main: Week 0 to 26|Adverse Event|4|||
125406876|NCT01079234|451118273|FG002|Main: Week 0 to 26|Adverse Event|1|||
125406877|NCT01079234|451118274|FG003|Main: Week 0 to 26|Adverse Event|0|||
125406878|NCT01079234|451118271|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
125406879|NCT01079234|451118272|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
125406880|NCT01079234|451118273|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
125406881|NCT01079234|451118274|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
125406882|NCT01079234|451118271|FG000|Main: Week 0 to 26|Protocol Violation|6|||
125406883|NCT01079234|451118272|FG001|Main: Week 0 to 26|Protocol Violation|2|||
125406884|NCT01079234|451118273|FG002|Main: Week 0 to 26|Protocol Violation|4|||
125406885|NCT01079234|451118274|FG003|Main: Week 0 to 26|Protocol Violation|0|||
125406886|NCT01079234|451118271|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
125406887|NCT01079234|451118272|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
125406888|NCT01079234|451118273|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
125406889|NCT01079234|451118274|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
125406890|NCT01079234|451118271|FG000|Main: Week 0 to 26|Unclassified|7|||
125406891|NCT01079234|451118272|FG001|Main: Week 0 to 26|Unclassified|13|||
125406892|NCT01079234|451118273|FG002|Main: Week 0 to 26|Unclassified|4|||
125406893|NCT01079234|451118274|FG003|Main: Week 0 to 26|Unclassified|0|||
125406894|NCT01079234|451118271|FG000|Extension: Week 27 to 52|Adverse Event|0|||
125406895|NCT01079234|451118272|FG001|Extension: Week 27 to 52|Adverse Event|0|||
125406896|NCT01079234|451118273|FG002|Extension: Week 27 to 52|Adverse Event|1|||
125406897|NCT01079234|451118274|FG003|Extension: Week 27 to 52|Adverse Event|0|||
125406898|NCT01079234|451118271|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
125406899|NCT01079234|451118272|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
125406900|NCT01079234|451118273|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
125406901|NCT01079234|451118274|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
125406902|NCT01079234|451118271|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
125406903|NCT01079234|451118272|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
125406904|NCT01079234|451118273|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
125406905|NCT01079234|451118274|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
125406906|NCT01079234|451118271|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
125406907|NCT01079234|451118272|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
125406908|NCT01079234|451118273|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
125406909|NCT01079234|451118274|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
125406910|NCT01079234|451118271|FG000|Extension: Week 27 to 52|Unclassified|0|||
125406911|NCT01079234|451118272|FG001|Extension: Week 27 to 52|Unclassified|0|||
125406912|NCT01079234|451118273|FG002|Extension: Week 27 to 52|Unclassified|4|||
125406913|NCT01079234|451118274|FG003|Extension: Week 27 to 52|Unclassified|7|||
125406914|NCT01312961|451118280|FG000|Overall Study|Adverse Event|3|||
125406915|NCT01312961|451118281|FG001|Overall Study|Adverse Event|3|||
125406916|NCT01312961|451118280|FG000|Overall Study|Lack of Efficacy|11|||
125406917|NCT01312961|451118281|FG001|Overall Study|Lack of Efficacy|1|||
125406918|NCT01312961|451118280|FG000|Overall Study|Poor compliance to protocol|1|||
125406919|NCT01312961|451118281|FG001|Overall Study|Poor compliance to protocol|0|||
125406920|NCT01312961|451118280|FG000|Overall Study|Other than specified above|2|||
125406921|NCT01312961|451118281|FG001|Overall Study|Other than specified above|3|||
125406922|NCT04278417|451118287|FG000|Overall Study|Withdrawal by Subject|20|||
125406923|NCT04278417|451118288|FG001|Overall Study|Withdrawal by Subject|20|||
125406924|NCT04278417|451118287|FG000|Overall Study|Progressive disease|0|||
125406925|NCT04278417|451118288|FG001|Overall Study|Progressive disease|2|||
125406926|NCT04278417|451118287|FG000|Overall Study|Physician Decision|4|||
125406927|NCT04278417|451118288|FG001|Overall Study|Physician Decision|6|||
125406928|NCT04278417|451118287|FG000|Overall Study|Lost to Follow-up|11|||
125406929|NCT04278417|451118288|FG001|Overall Study|Lost to Follow-up|13|||
125406930|NCT04278417|451118287|FG000|Overall Study|Death|8|||
125406931|NCT04278417|451118288|FG001|Overall Study|Death|9|||
125406932|NCT04278417|451118287|FG000|Overall Study|Adverse Event|3|||
125406933|NCT04278417|451118288|FG001|Overall Study|Adverse Event|5|||
125406934|NCT00205712|451118290|FG000|Overall Study|Lost to Follow-up|0|||
125406935|NCT00205712|451118291|FG001|Overall Study|Lost to Follow-up|1|||
125406936|NCT01603875|451118299|FG000|Overall Study|Preexisting rabies antibody|3|||
125406937|NCT01603875|451118300|FG001|Overall Study|Preexisting rabies antibody|4|||
125406938|NCT01603875|451118301|FG002|Overall Study|Preexisting rabies antibody|3|||
125406939|NCT01603875|451118299|FG000|Overall Study|Lost to Follow-up|4|||
125406940|NCT01603875|451118300|FG001|Overall Study|Lost to Follow-up|3|||
125406941|NCT01603875|451118301|FG002|Overall Study|Lost to Follow-up|6|||
125406942|NCT01603875|451118299|FG000|Overall Study|Protocol Violation|0|||
125406943|NCT01603875|451118300|FG001|Overall Study|Protocol Violation|1|||
125406944|NCT01603875|451118301|FG002|Overall Study|Protocol Violation|0|||
125406945|NCT01337297|451118302|FG000|Overall Study|They entered to single anodal tDCS|4|||
125406946|NCT01337297|451118303|FG001|Overall Study|They entered to single anodal tDCS|3|||
125406947|NCT01337297|451118302|FG000|Overall Study|Lost to Follow-up|1|||
125406948|NCT01337297|451118303|FG001|Overall Study|Lost to Follow-up|3|||
125406949|NCT02316717|451118304|FG000|Overall Study|Adverse Event|2|||
125279092|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125279093|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125279094|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125279095|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
125279096|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
125279097|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
125279098|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
125279099|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
125279100|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
125279101|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
125279102|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
125279103|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
125279104|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125448259|NCT03738241|451268870|FG005|Overall Study|Adverse Event|0|||
125448260|NCT03738241|451268871|FG006|Overall Study|Adverse Event|0|||
125279105|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125279106|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125279107|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
125279108|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
125279109|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
125279110|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
125279111|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
125279112|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
125279113|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
125279114|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
125279115|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
125279116|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
125279117|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
125279118|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
125279119|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
125303105|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
125303106|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303107|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303108|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303109|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125448261|NCT03738241|451268872|FG007|Overall Study|Adverse Event|0|||
125448262|NCT03738241|451268873|FG008|Overall Study|Adverse Event|0|||
125448263|NCT03738241|451268874|FG009|Overall Study|Adverse Event|0|||
125448264|NCT03169361|451268875|FG000|Overall Study|Protocol Violation|32|||
125448265|NCT02788656|451268876|FG000|Overall Study|Withdrawal by Subject|1|||
125448266|NCT02788656|451268877|FG001|Overall Study|Withdrawal by Subject|0|||
125448267|NCT02263885|451268878|FG000|Overall Study|Withdrawal by Subject|7|||
125448268|NCT02263885|451268878|FG000|Overall Study|Alternative Treatment|3|||
125448269|NCT00088465|451268879|FG000|Overall Study|Withdrawal by Subject|290|||
125448270|NCT00088465|451268879|FG000|Overall Study|Adverse Event|77|||
125448271|NCT00088465|451268879|FG000|Overall Study|Lost to Follow-up|57|||
125448272|NCT00088465|451268879|FG000|Overall Study|Physician Decision|45|||
125448273|NCT00088465|451268879|FG000|Overall Study|Sponsor Decision|37|||
125448274|NCT00088465|451268879|FG000|Overall Study|Lack of Efficacy|27|||
125303110|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303111|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
125303112|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303113|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
125303114|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303115|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303116|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303117|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303118|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303119|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303120|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303121|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303122|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303123|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303124|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
125303125|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
125303126|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303127|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125406950|NCT02316717|451118305|FG001|Overall Study|Adverse Event|2|||
125406951|NCT02316717|451118306|FG002|Overall Study|Adverse Event|0|||
125406952|NCT02316717|451118304|FG000|Overall Study|Lost to Follow-up|1|||
125406953|NCT02316717|451118305|FG001|Overall Study|Lost to Follow-up|2|||
125406954|NCT02316717|451118306|FG002|Overall Study|Lost to Follow-up|1|||
125406955|NCT02316717|451118304|FG000|Overall Study|Non compliance|3|||
125406956|NCT02316717|451118305|FG001|Overall Study|Non compliance|1|||
125406957|NCT02316717|451118306|FG002|Overall Study|Non compliance|0|||
125406958|NCT02316717|451118304|FG000|Overall Study|Protocol Violation|2|||
125406959|NCT02316717|451118305|FG001|Overall Study|Protocol Violation|0|||
125406960|NCT02316717|451118306|FG002|Overall Study|Protocol Violation|0|||
125406961|NCT02316717|451118304|FG000|Overall Study|Withdrawal by Subject|2|||
125406962|NCT02316717|451118305|FG001|Overall Study|Withdrawal by Subject|1|||
125406963|NCT02316717|451118306|FG002|Overall Study|Withdrawal by Subject|1|||
125406964|NCT02316717|451118304|FG000|Overall Study|Death|0|||
125406965|NCT02316717|451118305|FG001|Overall Study|Death|0|||
125406966|NCT02316717|451118306|FG002|Overall Study|Death|1|||
125406967|NCT02316717|451118304|FG000|Overall Study|Physician Decision|0|||
125406968|NCT02316717|451118305|FG001|Overall Study|Physician Decision|1|||
125406969|NCT02316717|451118306|FG002|Overall Study|Physician Decision|0|||
125406970|NCT02316717|451118304|FG000|Overall Study|TBC|1|||
125406971|NCT02316717|451118305|FG001|Overall Study|TBC|0|||
125406972|NCT02316717|451118306|FG002|Overall Study|TBC|0|||
125406973|NCT02778204|451118307|FG000|Overall Study|Adverse Event|1|||
125406974|NCT02778204|451118308|FG001|Overall Study|Adverse Event|0|||
125406975|NCT02778204|451118309|FG002|Overall Study|Adverse Event|0|||
125406976|NCT02778204|451118310|FG003|Overall Study|Adverse Event|0|||
125406977|NCT02778204|451118307|FG000|Overall Study|Withdrawal by Subject|0|||
125406978|NCT02778204|451118308|FG001|Overall Study|Withdrawal by Subject|0|||
125406979|NCT02778204|451118309|FG002|Overall Study|Withdrawal by Subject|1|||
125406980|NCT02778204|451118310|FG003|Overall Study|Withdrawal by Subject|2|||
125406981|NCT02778204|451118307|FG000|Overall Study|Lost to Follow-up|1|||
125406982|NCT02778204|451118308|FG001|Overall Study|Lost to Follow-up|0|||
125448275|NCT00088465|451268879|FG000|Overall Study|Protocol Violation|17|||
125448276|NCT00088465|451268879|FG000|Overall Study|Death|11|||
125279120|NCT03989349|450645911|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
125279121|NCT03989349|450645912|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
125279122|NCT03989349|450645913|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
125279123|NCT03989349|450645914|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
125279124|NCT03989349|450645915|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
125279125|NCT03989349|450645916|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
125279126|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125279127|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
125279128|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
125279129|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
125279130|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
125279131|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
125279132|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125279133|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
125279134|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
125279135|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
125279136|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
125279137|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
125279138|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
125279139|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
125279140|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
125279141|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
125279142|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
125279143|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
125279144|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125279145|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125406983|NCT02778204|451118309|FG002|Overall Study|Lost to Follow-up|2|||
125406984|NCT02778204|451118310|FG003|Overall Study|Lost to Follow-up|1|||
125406985|NCT02778204|451118307|FG000|Overall Study|Protocol Violation|0|||
125406986|NCT02778204|451118308|FG001|Overall Study|Protocol Violation|0|||
125406987|NCT02778204|451118309|FG002|Overall Study|Protocol Violation|1|||
125406988|NCT02778204|451118310|FG003|Overall Study|Protocol Violation|0|||
125406989|NCT02778204|451118307|FG000|Overall Study|Eligibility Violation|0|||
125406990|NCT02778204|451118308|FG001|Overall Study|Eligibility Violation|0|||
125406991|NCT02778204|451118309|FG002|Overall Study|Eligibility Violation|0|||
125406992|NCT02778204|451118310|FG003|Overall Study|Eligibility Violation|1|||
125406993|NCT04122443|451118311|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
125448277|NCT02688621|451268880|FG000|Overall Study|Pregnancy|1|||
125279146|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
125279147|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125279148|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
125279149|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
125279150|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
125279151|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
125279152|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
125279153|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
125279154|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
125279155|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
125279156|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
125279157|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
125279158|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
125279159|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
125279160|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
125279161|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
125406994|NCT04122443|451118312|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
125406995|NCT04122443|451118313|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
125406996|NCT04122443|451118311|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
125406997|NCT04122443|451118312|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
125406998|NCT04122443|451118313|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
125406999|NCT00298831|451118314|FG000|Overall Study|Adverse Event|1|||
125407000|NCT00298831|451118314|FG000|Overall Study|Lost to Follow-up|3|||
125407001|NCT00298831|451118314|FG000|Overall Study|Withdrawal by Subject|1|||
125407002|NCT00298831|451118314|FG000|Overall Study|Participants did not receive treatment|27|||
125407003|NCT01072201|451118315|FG000|Overall Study|Lost to Follow-up|0|||
125407004|NCT01072201|451118316|FG001|Overall Study|Lost to Follow-up|1|||
125407005|NCT02052466|451118317|FG000|Overall Study|Withdrawal by Subject|1|||
125407006|NCT02052466|451118317|FG000|Overall Study|Acromial fracture|1|||
125407007|NCT00595582|451118318|FG000|Overall Study|Pilot study that PI terminated|2|||
125407008|NCT00595582|451118318|FG000|Overall Study|Lost to Follow-up|1|||
125407009|NCT00595582|451118318|FG000|Overall Study|Adverse Event|2|||
125407010|NCT00595582|451118318|FG000|Overall Study|Physician Decision|5|||
125407011|NCT00965848|451118320|FG000|Overall Study|Protocol Violation|3|||
125407012|NCT00965848|451118321|FG001|Overall Study|Protocol Violation|0|||
125407013|NCT00965848|451118322|FG002|Overall Study|Protocol Violation|1|||
125407014|NCT00965848|451118320|FG000|Overall Study|Death|11|||
125407015|NCT00965848|451118321|FG001|Overall Study|Death|1|||
125407016|NCT00965848|451118322|FG002|Overall Study|Death|5|||
125407017|NCT00965848|451118320|FG000|Overall Study|Lost to Follow-up|0|||
125407018|NCT00965848|451118321|FG001|Overall Study|Lost to Follow-up|0|||
125407019|NCT00965848|451118322|FG002|Overall Study|Lost to Follow-up|1|||
125407020|NCT00965848|451118320|FG000|Overall Study|Withdrawal by Subject|1|||
125407021|NCT00965848|451118321|FG001|Overall Study|Withdrawal by Subject|0|||
125407022|NCT00965848|451118322|FG002|Overall Study|Withdrawal by Subject|0|||
125407023|NCT00965848|451118320|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
125407024|NCT00965848|451118321|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
125407025|NCT00965848|451118322|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
125407026|NCT00965848|451118320|FG000|Overall Study|Not Clinically Evaluable|7|||
125407027|NCT00965848|451118321|FG001|Overall Study|Not Clinically Evaluable|1|||
125407028|NCT00965848|451118322|FG002|Overall Study|Not Clinically Evaluable|1|||
125407029|NCT00965848|451118320|FG000|Overall Study|Other|5|||
125407030|NCT00965848|451118321|FG001|Overall Study|Other|0|||
125407031|NCT00965848|451118322|FG002|Overall Study|Other|1|||
125407032|NCT01306617|451118323|FG000|Overall Study|Adverse Event|1|||
125407033|NCT01306617|451118324|FG001|Overall Study|Adverse Event|0|||
125407034|NCT01306617|451118325|FG002|Overall Study|Adverse Event|0|||
125407035|NCT01306617|451118323|FG000|Overall Study|Virologic Failure|0|||
125407036|NCT01306617|451118324|FG001|Overall Study|Virologic Failure|0|||
125407037|NCT01306617|451118325|FG002|Overall Study|Virologic Failure|5|||
125407038|NCT01306617|451118323|FG000|Overall Study|Non-compliance|0|||
125407039|NCT01306617|451118324|FG001|Overall Study|Non-compliance|1|||
125407040|NCT01306617|451118325|FG002|Overall Study|Non-compliance|0|||
125407041|NCT04028388|451118334|FG000|Overall Study|Evaluations missing|3|||
125407042|NCT04028388|451118335|FG001|Overall Study|Evaluations missing|6|||
125407043|NCT04028388|451118334|FG000|Overall Study|Not started|2|||
125407044|NCT04028388|451118335|FG001|Overall Study|Not started|0|||
125407045|NCT00555438|451118336|FG000|10 Days Post-operative|Death|4|||
125407046|NCT00555438|451118336|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
125407047|NCT01114516|451118337|FG000|Overall Study|Lost to Follow-up|2|||
125407048|NCT01114516|451118338|FG001|Overall Study|Lost to Follow-up|1|||
125448278|NCT02688621|451268881|FG001|Overall Study|Pregnancy|3|||
125448279|NCT02688621|451268880|FG000|Overall Study|Lost to Follow-up|38|||
125407049|NCT00129259|451118340|FG000|Overall Study|Lost to Follow-up|1|||
125407050|NCT00129259|451118341|FG001|Overall Study|Lost to Follow-up|1|||
125407051|NCT00129259|451118340|FG000|Overall Study|Withdrawal by Subject|2|||
125407052|NCT00129259|451118341|FG001|Overall Study|Withdrawal by Subject|1|||
125407053|NCT00129259|451118340|FG000|Overall Study|Only available minimal phone assessments|0|||
125407054|NCT00129259|451118341|FG001|Overall Study|Only available minimal phone assessments|1|||
125407055|NCT01609556|451118345|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125407056|NCT01609556|451118346|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125407057|NCT01609556|451118347|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125407058|NCT01609556|451118348|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125407059|NCT01609556|451118349|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
125407060|NCT01609556|451118350|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125407061|NCT01609556|451118351|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125407062|NCT01609556|451118352|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
125407063|NCT01609556|451118353|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
125407064|NCT01609556|451118354|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125407065|NCT01609556|451118355|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
125407066|NCT01609556|451118356|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
125407067|NCT01609556|451118357|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125407068|NCT01609556|451118358|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125407069|NCT01609556|451118359|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125407070|NCT01609556|451118360|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
125407071|NCT01609556|451118345|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
125407072|NCT01609556|451118346|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
125407073|NCT01609556|451118347|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
125407074|NCT01609556|451118348|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
125407075|NCT01609556|451118349|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
125407076|NCT01609556|451118350|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
125407077|NCT01609556|451118351|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
125407078|NCT01609556|451118352|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
125407079|NCT01609556|451118353|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
125407080|NCT01609556|451118354|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
125407081|NCT01609556|451118355|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
125407082|NCT01609556|451118356|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
125407083|NCT01609556|451118357|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
125407084|NCT01609556|451118358|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
125407085|NCT01609556|451118359|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
125407086|NCT01609556|451118360|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
125407087|NCT01609556|451118345|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125407088|NCT01609556|451118346|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125407089|NCT01609556|451118347|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125407090|NCT01609556|451118348|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125407091|NCT01609556|451118349|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125407092|NCT01609556|451118350|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
125407093|NCT01609556|451118351|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
125407094|NCT01609556|451118352|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125407095|NCT01609556|451118353|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125407096|NCT01609556|451118354|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
125407097|NCT01609556|451118355|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
125407098|NCT01609556|451118356|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
125407099|NCT01609556|451118357|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125407100|NCT01609556|451118358|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125407101|NCT01609556|451118359|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125407102|NCT01609556|451118360|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
125407103|NCT01609556|451118345|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407104|NCT01609556|451118346|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407105|NCT01609556|451118347|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407106|NCT01609556|451118348|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407107|NCT01609556|451118349|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407108|NCT01609556|451118350|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
125407109|NCT01609556|451118351|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407110|NCT01609556|451118352|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407111|NCT01609556|451118353|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407112|NCT01609556|451118354|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407113|NCT01609556|451118355|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407114|NCT01609556|451118356|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
125407115|NCT01609556|451118357|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407116|NCT01609556|451118358|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407117|NCT01609556|451118359|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407118|NCT01609556|451118360|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
125407119|NCT01609556|451118345|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407120|NCT01609556|451118346|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407121|NCT01609556|451118347|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407122|NCT01609556|451118348|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407123|NCT01609556|451118349|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407124|NCT01609556|451118350|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
125407125|NCT01609556|451118351|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407126|NCT01609556|451118352|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407127|NCT01609556|451118353|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407128|NCT01609556|451118354|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407129|NCT01609556|451118355|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407130|NCT01609556|451118356|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407131|NCT01609556|451118357|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407132|NCT01609556|451118358|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407133|NCT01609556|451118359|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407134|NCT01609556|451118360|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
125407135|NCT01609556|451118345|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407136|NCT01609556|451118346|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407137|NCT01609556|451118347|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407138|NCT01609556|451118348|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407139|NCT01609556|451118349|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407140|NCT01609556|451118350|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407141|NCT01609556|451118351|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407142|NCT01609556|451118352|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407143|NCT01609556|451118353|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
125407144|NCT01609556|451118354|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407145|NCT01609556|451118355|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407146|NCT01609556|451118356|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407147|NCT01609556|451118357|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407148|NCT01609556|451118358|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407149|NCT01609556|451118359|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407150|NCT01609556|451118360|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
125407151|NCT01609556|451118345|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
125407152|NCT01609556|451118346|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125407153|NCT01609556|451118347|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125407154|NCT01609556|451118348|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125407155|NCT01609556|451118349|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125407156|NCT01609556|451118350|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
125407157|NCT01609556|451118351|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125407158|NCT01609556|451118352|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125407159|NCT01609556|451118353|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125407160|NCT01609556|451118354|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125407161|NCT01609556|451118355|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
125407162|NCT01609556|451118356|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125407163|NCT01609556|451118357|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125407164|NCT01609556|451118358|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125407165|NCT01609556|451118359|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125407166|NCT01609556|451118360|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
125407167|NCT01609556|451118345|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125407168|NCT01609556|451118346|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125407169|NCT01609556|451118347|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125407170|NCT01609556|451118348|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125407171|NCT01609556|451118349|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125407172|NCT01609556|451118350|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125407173|NCT01609556|451118351|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125407174|NCT01609556|451118352|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125407175|NCT01609556|451118353|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125407176|NCT01609556|451118354|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125407177|NCT01609556|451118355|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125407178|NCT01609556|451118356|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
125407179|NCT01609556|451118357|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
125407180|NCT01609556|451118358|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
125407181|NCT01609556|451118359|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
125407182|NCT01609556|451118360|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
125407183|NCT01609556|451118345|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125407184|NCT01609556|451118346|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125407185|NCT01609556|451118347|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125407186|NCT01609556|451118348|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125407187|NCT01609556|451118349|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125407188|NCT01609556|451118350|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125407189|NCT01609556|451118351|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125407190|NCT01609556|451118352|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125407191|NCT01609556|451118353|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125407192|NCT01609556|451118354|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125407193|NCT01609556|451118355|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125407194|NCT01609556|451118356|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
125407195|NCT01609556|451118357|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
125407196|NCT01609556|451118358|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
125407197|NCT01609556|451118359|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
125407198|NCT01609556|451118360|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
125407199|NCT01609556|451118345|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125407200|NCT01609556|451118346|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125407201|NCT01609556|451118347|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125407202|NCT01609556|451118348|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125407203|NCT01609556|451118349|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125407204|NCT01609556|451118350|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125407205|NCT01609556|451118351|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125407206|NCT01609556|451118352|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125407207|NCT01609556|451118353|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125407208|NCT01609556|451118354|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125407209|NCT01609556|451118355|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125407210|NCT01609556|451118356|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
125407211|NCT01609556|451118357|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
125407212|NCT01609556|451118358|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
125407213|NCT01609556|451118359|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
125407214|NCT01609556|451118360|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
125407215|NCT01609556|451118345|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125407216|NCT01609556|451118346|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125279162|NCT03989349|450645911|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
125279163|NCT03989349|450645912|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
125279164|NCT03989349|450645913|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
125279165|NCT03989349|450645914|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
125279166|NCT03989349|450645915|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
125279167|NCT03989349|450645916|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
125279168|NCT01352221|450645917|FG000|Double-blind Phase|Adverse Event|6|||
125279169|NCT01352221|450645918|FG001|Double-blind Phase|Adverse Event|4|||
125279170|NCT01352221|450645919|FG002|Double-blind Phase|Adverse Event|0|||
125279171|NCT01352221|450645920|FG003|Double-blind Phase|Adverse Event|0|||
125279172|NCT01352221|450645917|FG000|Double-blind Phase|Withdrawal by Subject|3|||
125279173|NCT01352221|450645918|FG001|Double-blind Phase|Withdrawal by Subject|5|||
125279174|NCT01352221|450645919|FG002|Double-blind Phase|Withdrawal by Subject|0|||
125279175|NCT01352221|450645920|FG003|Double-blind Phase|Withdrawal by Subject|0|||
125279176|NCT01352221|450645917|FG000|Double-blind Phase|Lost to Follow-up|0|||
125279177|NCT01352221|450645918|FG001|Double-blind Phase|Lost to Follow-up|1|||
125279178|NCT01352221|450645919|FG002|Double-blind Phase|Lost to Follow-up|0|||
125279179|NCT01352221|450645920|FG003|Double-blind Phase|Lost to Follow-up|0|||
125279180|NCT01352221|450645917|FG000|Double-blind Phase|Protocol Violation|0|||
125407217|NCT01609556|451118347|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125407218|NCT01609556|451118348|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125407219|NCT01609556|451118349|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125407220|NCT01609556|451118350|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125279181|NCT01352221|450645918|FG001|Double-blind Phase|Protocol Violation|1|||
125279182|NCT01352221|450645919|FG002|Double-blind Phase|Protocol Violation|0|||
125279183|NCT01352221|450645920|FG003|Double-blind Phase|Protocol Violation|0|||
125279184|NCT01352221|450645917|FG000|Open-label Phase|Physician Decision|0|||
125279185|NCT01352221|450645918|FG001|Open-label Phase|Physician Decision|0|||
125279186|NCT01352221|450645919|FG002|Open-label Phase|Physician Decision|2|||
125279187|NCT01352221|450645920|FG003|Open-label Phase|Physician Decision|1|||
125279188|NCT01352221|450645917|FG000|Open-label Phase|Pregnancy|0|||
125279189|NCT01352221|450645918|FG001|Open-label Phase|Pregnancy|0|||
125407221|NCT01609556|451118351|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125407222|NCT01609556|451118352|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125407223|NCT01609556|451118353|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125407224|NCT01609556|451118354|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125407225|NCT01609556|451118355|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125407226|NCT01609556|451118356|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125407227|NCT01609556|451118357|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
125407228|NCT01609556|451118358|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125407229|NCT01609556|451118359|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125407230|NCT01609556|451118360|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
125407231|NCT01609556|451118345|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125407232|NCT01609556|451118346|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125407233|NCT01609556|451118347|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125407234|NCT01609556|451118348|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125407235|NCT01609556|451118349|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125407236|NCT01609556|451118350|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125407237|NCT01609556|451118351|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125407238|NCT01609556|451118352|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125407239|NCT01609556|451118353|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125407240|NCT01609556|451118354|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125407241|NCT01609556|451118355|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125407242|NCT01609556|451118356|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
125407243|NCT01609556|451118357|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
125407244|NCT01609556|451118358|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
125407245|NCT01609556|451118359|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
125407246|NCT01609556|451118360|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
125407247|NCT01609556|451118345|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407248|NCT01609556|451118346|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407249|NCT01609556|451118347|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407250|NCT01609556|451118348|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407251|NCT01609556|451118349|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407252|NCT01609556|451118350|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407253|NCT01609556|451118351|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407254|NCT01609556|451118352|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407255|NCT01609556|451118353|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407256|NCT01609556|451118354|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407257|NCT01609556|451118355|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407258|NCT01609556|451118356|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407259|NCT01609556|451118357|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407260|NCT01609556|451118358|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407261|NCT01609556|451118359|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
125407262|NCT01609556|451118360|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
125407263|NCT01609556|451118345|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
125407264|NCT01609556|451118346|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
125407265|NCT01609556|451118347|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
125407266|NCT01609556|451118348|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
125407267|NCT01609556|451118349|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
125407268|NCT01609556|451118350|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
125407269|NCT01609556|451118351|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
125407270|NCT01609556|451118352|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
125407271|NCT01609556|451118353|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
125407272|NCT01609556|451118354|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
125407273|NCT01609556|451118355|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
125407274|NCT01609556|451118356|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
125407275|NCT01609556|451118357|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
125407276|NCT01609556|451118358|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
125407277|NCT01609556|451118359|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
125407278|NCT01609556|451118360|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
125407279|NCT01609556|451118345|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407280|NCT01609556|451118346|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407281|NCT01609556|451118347|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407282|NCT01609556|451118348|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125448280|NCT02688621|451268881|FG001|Overall Study|Lost to Follow-up|15|||
125279190|NCT01352221|450645919|FG002|Open-label Phase|Pregnancy|1|||
125279191|NCT01352221|450645920|FG003|Open-label Phase|Pregnancy|0|||
125279192|NCT01352221|450645917|FG000|Open-label Phase|Adverse Event|0|||
125279193|NCT01352221|450645918|FG001|Open-label Phase|Adverse Event|0|||
125448281|NCT02688621|451268880|FG000|Overall Study|Withdrawal by Subject|1|||
125448282|NCT02688621|451268881|FG001|Overall Study|Withdrawal by Subject|0|||
125448283|NCT03239210|451268882|FG000|Overall Study|Lost to Follow-up|2|||
125448284|NCT03239210|451268883|FG001|Overall Study|Lost to Follow-up|2|||
125448285|NCT03239210|451268882|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
125448286|NCT03239210|451268883|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
125448287|NCT03239210|451268882|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
125448288|NCT03239210|451268883|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
125448289|NCT01403987|451268885|FG000|Overall Study|Residents forgot their secret PIN|18|||
125448290|NCT01403987|451268886|FG001|Overall Study|Residents forgot their secret PIN|17|||
125448291|NCT01403987|451268887|FG002|Overall Study|Residents forgot their secret PIN|18|||
125448292|NCT00180674|451268889|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
125448293|NCT00180674|451268889|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
125448294|NCT03836664|451268890|FG000|Overall Study|Didn't complete forms and lost drug|3|||
125448295|NCT03836664|451268891|FG001|Overall Study|Didn't complete forms and lost drug|3|||
125448296|NCT01427907|451268892|FG000|Overall Study|Withdrawal by Subject|3|||
125448297|NCT01427907|451268893|FG001|Overall Study|Withdrawal by Subject|4|||
125448298|NCT02179918|451268894|FG000|Overall Study|Death|0|||
125448299|NCT02179918|451268895|FG001|Overall Study|Death|0|||
125448300|NCT02179918|451268896|FG002|Overall Study|Death|0|||
125448301|NCT02179918|451268897|FG003|Overall Study|Death|1|||
125448302|NCT02179918|451268898|FG004|Overall Study|Death|0|||
125448303|NCT02179918|451268894|FG000|Overall Study|Lost to Follow-up|0|||
125448304|NCT02179918|451268895|FG001|Overall Study|Lost to Follow-up|0|||
125448305|NCT02179918|451268896|FG002|Overall Study|Lost to Follow-up|1|||
125448306|NCT02179918|451268897|FG003|Overall Study|Lost to Follow-up|0|||
125279194|NCT01352221|450645919|FG002|Open-label Phase|Adverse Event|8|||
125279195|NCT01352221|450645920|FG003|Open-label Phase|Adverse Event|4|||
125279196|NCT01352221|450645917|FG000|Open-label Phase|Withdrawal by Subject|0|||
125279197|NCT01352221|450645918|FG001|Open-label Phase|Withdrawal by Subject|0|||
125407283|NCT01609556|451118349|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407284|NCT01609556|451118350|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407285|NCT01609556|451118351|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407286|NCT01609556|451118352|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407287|NCT01609556|451118353|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407288|NCT01609556|451118354|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407289|NCT01609556|451118355|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407290|NCT01609556|451118356|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407291|NCT01609556|451118357|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
125407292|NCT01609556|451118358|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407293|NCT01609556|451118359|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407294|NCT01609556|451118360|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
125407295|NCT02758236|451118361|FG000|Overall Study|Investigator discretion|43|||
125407296|NCT04452344|451118362|FG000|Overall Study|Withdrawal by Subject|3|||
125407297|NCT04452344|451118363|FG001|Overall Study|Withdrawal by Subject|6|||
125407298|NCT04452344|451118362|FG000|Overall Study|Adverse Event|1|||
125407299|NCT04452344|451118363|FG001|Overall Study|Adverse Event|2|||
125407300|NCT04452344|451118362|FG000|Overall Study|Lost to Follow-up|2|||
125407301|NCT04452344|451118363|FG001|Overall Study|Lost to Follow-up|2|||
125407302|NCT04452344|451118362|FG000|Overall Study|No Post-Op Visit|6|||
125407303|NCT04452344|451118363|FG001|Overall Study|No Post-Op Visit|7|||
125407304|NCT05789875|451118364|FG000|Overall Study|Lost to Follow-up|6|||
125407305|NCT01994395|451118365|FG000|Overall Study|Withdrawal by Subject|1|||
125407306|NCT01994395|451118366|FG001|Overall Study|Withdrawal by Subject|2|||
125407307|NCT01940705|451118368|FG000|Overall Study|Lost to Follow-up|1|||
125407308|NCT01940705|451118369|FG001|Overall Study|Lost to Follow-up|3|||
125407309|NCT01940705|451118370|FG002|Overall Study|Lost to Follow-up|2|||
125407310|NCT01940705|451118371|FG003|Overall Study|Lost to Follow-up|2|||
125407311|NCT01940705|451118368|FG000|Overall Study|Withdrawal by Subject|2|||
125407312|NCT01940705|451118369|FG001|Overall Study|Withdrawal by Subject|2|||
125279198|NCT01352221|450645919|FG002|Open-label Phase|Withdrawal by Subject|1|||
125407313|NCT01940705|451118370|FG002|Overall Study|Withdrawal by Subject|3|||
125407314|NCT01940705|451118371|FG003|Overall Study|Withdrawal by Subject|2|||
125448307|NCT02179918|451268898|FG004|Overall Study|Lost to Follow-up|0|||
125448308|NCT02179918|451268894|FG000|Overall Study|Progressive Disease|4|||
125279199|NCT01352221|450645920|FG003|Open-label Phase|Withdrawal by Subject|6|||
125407315|NCT01940705|451118368|FG000|Overall Study|Intervention not given|0|||
125279200|NCT01352221|450645917|FG000|Open-label Phase|Worsening of IBD|0|||
125448309|NCT02179918|451268895|FG001|Overall Study|Progressive Disease|1|||
125448310|NCT02179918|451268896|FG002|Overall Study|Progressive Disease|1|||
125407316|NCT01940705|451118369|FG001|Overall Study|Intervention not given|3|||
125407317|NCT01940705|451118370|FG002|Overall Study|Intervention not given|3|||
125448311|NCT02179918|451268897|FG003|Overall Study|Progressive Disease|2|||
125279201|NCT01352221|450645918|FG001|Open-label Phase|Worsening of IBD|0|||
125407318|NCT01940705|451118371|FG003|Overall Study|Intervention not given|0|||
125407319|NCT01940705|451118368|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
125407320|NCT01940705|451118369|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
125407321|NCT01940705|451118370|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
125407322|NCT01940705|451118371|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
125407323|NCT03779841|451118374|FG000|Randomized Population|Did Not Receive Treatment|3|||
125407324|NCT03779841|451118375|FG001|Randomized Population|Did Not Receive Treatment|1|||
125407325|NCT03779841|451118376|FG002|Randomized Population|Did Not Receive Treatment|0|||
125407326|NCT03779841|451118374|FG000|Treated (Safety) Population|Adverse Event|1|||
125407327|NCT03779841|451118375|FG001|Treated (Safety) Population|Adverse Event|1|||
125407328|NCT03779841|451118376|FG002|Treated (Safety) Population|Adverse Event|0|||
125407329|NCT03779841|451118374|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
125407330|NCT03779841|451118375|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
125407331|NCT03779841|451118376|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
125407332|NCT03779841|451118374|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
125407333|NCT03779841|451118375|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
125407334|NCT03779841|451118376|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
125407335|NCT03779841|451118374|FG000|Treated (Safety) Population|Death|1|||
125407336|NCT03779841|451118375|FG001|Treated (Safety) Population|Death|0|||
125407337|NCT03779841|451118376|FG002|Treated (Safety) Population|Death|2|||
125407338|NCT01632579|451118377|FG000|Washout Period|Adverse Event|1|||
125407339|NCT01632579|451118378|FG001|Washout Period|Adverse Event|0|||
125407340|NCT01632579|451118379|FG002|Washout Period|Adverse Event|0|||
125407341|NCT01632579|451118380|FG003|Washout Period|Adverse Event|0|||
125407342|NCT01632579|451118381|FG004|Washout Period|Adverse Event|0|||
125407343|NCT01632579|451118382|FG005|Washout Period|Adverse Event|0|||
125407344|NCT01632579|451118383|FG006|Washout Period|Adverse Event|0|||
125407345|NCT01632579|451118384|FG007|Washout Period|Adverse Event|0|||
125407346|NCT01632579|451118385|FG008|Washout Period|Adverse Event|0|||
125407347|NCT01632579|451118377|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
125407348|NCT01632579|451118378|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
125407349|NCT01632579|451118379|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
125407350|NCT01632579|451118380|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
125407351|NCT01632579|451118381|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
125407352|NCT01632579|451118382|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
125407353|NCT01632579|451118383|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
125407354|NCT01632579|451118384|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
125407355|NCT01632579|451118385|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
125407356|NCT00162136|451118386|FG000|Overall Study|Adverse Event|1|||
125407357|NCT00162136|451118386|FG000|Overall Study|Death|1|||
125407358|NCT00162136|451118386|FG000|Overall Study|Disease Progression/Relapse|23|||
125407359|NCT00162136|451118386|FG000|Overall Study|Investigator Request|5|||
125407360|NCT00162136|451118386|FG000|Overall Study|Study Drug Toxicity|4|||
125407361|NCT00162136|451118386|FG000|Overall Study|Withdrawal by Subject|1|||
125407362|NCT02788175|451118387|FG000|Overall Study|Protocol Violation|3|||
125407363|NCT02788175|451118387|FG000|Overall Study|Withdrawal by Subject|4|||
125407364|NCT02788175|451118387|FG000|Overall Study|Ineligible prior to study agent|6|||
125407365|NCT03930745|451118388|FG000|Overall Study|Lost to Follow-up|10|||
125407366|NCT03930745|451118389|FG001|Overall Study|Lost to Follow-up|5|||
125407367|NCT03930745|451118388|FG000|Overall Study|Withdrawal by Subject|1|||
125407368|NCT03930745|451118389|FG001|Overall Study|Withdrawal by Subject|2|||
125407369|NCT03930745|451118388|FG000|Overall Study|Protocol Violation|2|||
125407370|NCT03930745|451118389|FG001|Overall Study|Protocol Violation|2|||
125407371|NCT03930745|451118388|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
125407372|NCT03930745|451118389|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
125407373|NCT03930745|451118388|FG000|Overall Study|Adverse Event|0|||
125407374|NCT03930745|451118389|FG001|Overall Study|Adverse Event|1|||
125407375|NCT03930745|451118388|FG000|Overall Study|Pregnancy|0|||
125407376|NCT03930745|451118389|FG001|Overall Study|Pregnancy|1|||
125407377|NCT00818441|451118394|FG000|Overall Study|Death|69|||
125407378|NCT00818441|451118395|FG001|Overall Study|Death|26|||
125407379|NCT00818441|451118394|FG000|Overall Study|Other|5|||
125407380|NCT00818441|451118395|FG001|Overall Study|Other|0|||
125407381|NCT00818441|451118394|FG000|Overall Study|Lost to Follow-up|2|||
125407382|NCT00818441|451118395|FG001|Overall Study|Lost to Follow-up|1|||
125407383|NCT00818441|451118394|FG000|Overall Study|Withdrawal by Subject|2|||
125407384|NCT00818441|451118395|FG001|Overall Study|Withdrawal by Subject|0|||
125407385|NCT00818441|451118394|FG000|Overall Study|Adverse Event|0|||
125279202|NCT01352221|450645919|FG002|Open-label Phase|Worsening of IBD|1|||
125279203|NCT01352221|450645920|FG003|Open-label Phase|Worsening of IBD|0|||
125407386|NCT00818441|451118395|FG001|Overall Study|Adverse Event|1|||
125407387|NCT00818441|451118394|FG000|Overall Study|Study terminated by sponsor|11|||
125407388|NCT00818441|451118395|FG001|Overall Study|Study terminated by sponsor|2|||
125407389|NCT04095858|451118396|FG000|Overall Study|Death|1|||
125407390|NCT04095858|451118397|FG001|Overall Study|Death|0|||
125407391|NCT04095858|451118396|FG000|Overall Study|Study terminated by Sponsor|2|||
125407392|NCT04095858|451118397|FG001|Overall Study|Study terminated by Sponsor|4|||
125407393|NCT00612313|451118399|FG000|Overall Study|Withdrawal by Subject|6|||
125407394|NCT00612313|451118400|FG001|Overall Study|Withdrawal by Subject|9|||
125407395|NCT00612313|451118399|FG000|Overall Study|Lost to Follow-up|11|||
125407396|NCT00612313|451118400|FG001|Overall Study|Lost to Follow-up|4|||
125407397|NCT01043874|451120373|FG000|Overall Study|Adverse Event|3|||
125407398|NCT01043874|451120373|FG000|Overall Study|Withdrawal by Subject|1|||
125407399|NCT01043874|451120373|FG000|Overall Study|Lack of Efficacy|1|||
125407400|NCT01043874|451120373|FG000|Overall Study|Administrative Problems|1|||
125407401|NCT00182689|451120379|FG000|Overall Study|Adverse Event|8|||
125407402|NCT00182689|451120380|FG001|Overall Study|Adverse Event|11|||
125407403|NCT00182689|451120379|FG000|Overall Study|Withdrawal by Subject|2|||
125407404|NCT00182689|451120380|FG001|Overall Study|Withdrawal by Subject|2|||
125407405|NCT00182689|451120379|FG000|Overall Study|Progression|27|||
125407406|NCT00182689|451120380|FG001|Overall Study|Progression|29|||
125407407|NCT00182689|451120379|FG000|Overall Study|Death|1|||
125407408|NCT00182689|451120380|FG001|Overall Study|Death|0|||
125407409|NCT00182689|451120379|FG000|Overall Study|not protocol specified|0|||
125407410|NCT00182689|451120380|FG001|Overall Study|not protocol specified|3|||
125407411|NCT00182689|451120379|FG000|Overall Study|Ineligible|1|||
125407412|NCT00182689|451120380|FG001|Overall Study|Ineligible|4|||
125407413|NCT00182689|451120379|FG000|Overall Study|Never received treatment|1|||
125407414|NCT00182689|451120380|FG001|Overall Study|Never received treatment|0|||
125407415|NCT03422003|451120381|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
125407416|NCT03422003|451120382|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
125407417|NCT03422003|451120381|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
125407418|NCT03422003|451120382|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
125407419|NCT01337089|451120383|FG000|Overall Study|Adverse Event|237|||
125407420|NCT01337089|451120383|FG000|Overall Study|Withdrawal by Subject|129|||
125407421|NCT01337089|451120383|FG000|Overall Study|Withdrawal by Investigator|33|||
125407422|NCT01337089|451120383|FG000|Overall Study|Met Withdrawal Criteria|3|||
125407423|NCT01337089|451120383|FG000|Overall Study|Lost to Follow-up|2|||
125407424|NCT01040871|451120388|FG000|Overall Study|Adverse Event|6|||
125407425|NCT01040871|451120389|FG001|Overall Study|Adverse Event|2|||
125407426|NCT01040871|451120388|FG000|Overall Study|Withdrawal by Subject|2|||
125407427|NCT01040871|451120389|FG001|Overall Study|Withdrawal by Subject|0|||
125407428|NCT01040871|451120388|FG000|Overall Study|Death|1|||
125407429|NCT01040871|451120389|FG001|Overall Study|Death|3|||
125407430|NCT01040871|451120388|FG000|Overall Study|Lack of Efficacy|1|||
125407431|NCT01040871|451120389|FG001|Overall Study|Lack of Efficacy|1|||
125407432|NCT01040871|451120388|FG000|Overall Study|drug supply issue|1|||
125407433|NCT01040871|451120389|FG001|Overall Study|drug supply issue|0|||
125407434|NCT01040871|451120388|FG000|Overall Study|Randomized and Not Treated|2|||
125407435|NCT01040871|451120389|FG001|Overall Study|Randomized and Not Treated|1|||
125407436|NCT00673049|451120394|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
125407437|NCT00673049|451120395|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
125407438|NCT00673049|451120396|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
125407439|NCT00673049|451120397|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
125407440|NCT00673049|451120394|FG000|Before Progression on Erlotinib|Death|235|||
125407441|NCT00673049|451120395|FG001|Before Progression on Erlotinib|Death|167|||
125407442|NCT00673049|451120396|FG002|Before Progression on Erlotinib|Death|1|||
125407443|NCT00673049|451120397|FG003|Before Progression on Erlotinib|Death|0|||
125407444|NCT00673049|451120394|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
125407445|NCT00673049|451120395|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
125407446|NCT00673049|451120396|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
125407447|NCT00673049|451120397|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
125407448|NCT00673049|451120394|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
125407449|NCT00673049|451120395|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
125407450|NCT00673049|451120396|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
125407451|NCT00673049|451120397|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
125407452|NCT00673049|451120394|FG000|Before Progression on Erlotinib|Other|1|||
125407453|NCT00673049|451120395|FG001|Before Progression on Erlotinib|Other|2|||
125407454|NCT00673049|451120396|FG002|Before Progression on Erlotinib|Other|0|||
125448312|NCT02179918|451268898|FG004|Overall Study|Progressive Disease|6|||
125448313|NCT02179918|451268894|FG000|Overall Study|Other|0|||
125279204|NCT02016716|450645921|FG000|Overall Study|Withdrawal by Subject|5|||
125407455|NCT00673049|451120397|FG003|Before Progression on Erlotinib|Other|0|||
125407456|NCT00673049|451120394|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
125407457|NCT00673049|451120395|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
125407458|NCT00673049|451120396|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
125407459|NCT00673049|451120397|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
125407460|NCT00673049|451120394|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
125407461|NCT00673049|451120395|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
125407462|NCT00673049|451120396|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
125407463|NCT00673049|451120397|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
125407464|NCT00673049|451120394|FG000|After Progression on Erlotinib|Death|0|||
125407465|NCT00673049|451120395|FG001|After Progression on Erlotinib|Death|0|||
125407466|NCT00673049|451120396|FG002|After Progression on Erlotinib|Death|0|||
125407467|NCT00673049|451120397|FG003|After Progression on Erlotinib|Death|71|||
125407468|NCT00673049|451120394|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
125407469|NCT00673049|451120395|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
125407470|NCT00673049|451120396|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
125407471|NCT00673049|451120397|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
125407472|NCT00673049|451120394|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
125407473|NCT00673049|451120395|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
125407474|NCT00673049|451120396|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
125407475|NCT00673049|451120397|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
125407476|NCT00673049|451120394|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
125407477|NCT00673049|451120395|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
125407478|NCT00673049|451120396|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
125407479|NCT00673049|451120397|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
125407480|NCT01175824|451120398|FG000|Overall Study|Adverse Event|2|||
125407481|NCT01175824|451120399|FG001|Overall Study|Adverse Event|1|||
125407482|NCT01175824|451120398|FG000|Overall Study|Lack of Efficacy|2|||
125407483|NCT01175824|451120399|FG001|Overall Study|Lack of Efficacy|0|||
125407484|NCT01175824|451120398|FG000|Overall Study|Lost to Follow-up|0|||
125407485|NCT01175824|451120399|FG001|Overall Study|Lost to Follow-up|1|||
125407486|NCT01175824|451120398|FG000|Overall Study|Physician Decision|0|||
125407487|NCT01175824|451120399|FG001|Overall Study|Physician Decision|4|||
125407488|NCT01175824|451120398|FG000|Overall Study|Protocol Violation|2|||
125407489|NCT01175824|451120399|FG001|Overall Study|Protocol Violation|5|||
125407490|NCT01175824|451120398|FG000|Overall Study|Withdrawal by Subject|3|||
125407491|NCT01175824|451120399|FG001|Overall Study|Withdrawal by Subject|7|||
125407492|NCT01175824|451120398|FG000|Overall Study|Sponsor Decision|1|||
125407493|NCT01175824|451120399|FG001|Overall Study|Sponsor Decision|0|||
125407494|NCT01175824|451120398|FG000|Overall Study|Entry Criteria Not Met|6|||
125407495|NCT01175824|451120399|FG001|Overall Study|Entry Criteria Not Met|4|||
125407496|NCT00924950|451120400|FG000|Overall Study|Lost to Follow-up|2|||
125407497|NCT02979535|451120401|FG000|Overall Study|Non compliance with the protocol|78|||
125407498|NCT02979535|451120402|FG001|Overall Study|Non compliance with the protocol|82|||
125407499|NCT02979535|451120401|FG000|Overall Study|Consent withdrawn by participant|11|||
125407500|NCT02979535|451120402|FG001|Overall Study|Consent withdrawn by participant|18|||
125407501|NCT02979535|451120401|FG000|Overall Study|Lost to Follow-up|6|||
125407502|NCT02979535|451120402|FG001|Overall Study|Lost to Follow-up|1|||
125407503|NCT02530619|451120406|FG000|Registered for Study|Withdrawal by Subject|2|||
125407504|NCT02530619|451120406|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
125407505|NCT02530619|451120406|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
125407506|NCT02530619|451120406|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
125407507|NCT02530619|451120406|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
125407508|NCT02530619|451120406|FG000|Follow-up Period (6 Months)|Death|4|||
125407509|NCT02530619|451120406|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
125407510|NCT02530619|451120406|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
125407511|NCT00009737|451120408|FG000|Overall Study|Adverse Event|112|||
125407512|NCT00009737|451120409|FG001|Overall Study|Adverse Event|75|||
125407513|NCT00009737|451120408|FG000|Overall Study|Death|4|||
125407514|NCT00009737|451120409|FG001|Overall Study|Death|6|||
125407515|NCT00009737|451120408|FG000|Overall Study|Lack of Efficacy|17|||
125407516|NCT00009737|451120409|FG001|Overall Study|Lack of Efficacy|15|||
125407517|NCT00009737|451120408|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
125407518|NCT00009737|451120409|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
125407519|NCT00009737|451120408|FG000|Overall Study|Other Protocol Violation|1|||
125407520|NCT00009737|451120409|FG001|Overall Study|Other Protocol Violation|0|||
125407521|NCT00009737|451120408|FG000|Overall Study|Refused Treatment|15|||
125407522|NCT00009737|451120409|FG001|Overall Study|Refused Treatment|16|||
125407523|NCT00009737|451120408|FG000|Overall Study|Lost to Follow-up|1|||
125407524|NCT00009737|451120409|FG001|Overall Study|Lost to Follow-up|1|||
125407525|NCT00009737|451120408|FG000|Overall Study|Administrative/Other Reasons|7|||
125279205|NCT02016716|450645922|FG001|Overall Study|Withdrawal by Subject|5|||
125407526|NCT00009737|451120409|FG001|Overall Study|Administrative/Other Reasons|1|||
125407527|NCT01163682|451120413|FG000|Overall Study|Lost to Follow-up|6|||
125279206|NCT02016716|450645923|FG002|Overall Study|Withdrawal by Subject|5|||
125279207|NCT02016716|450645921|FG000|Overall Study|Protocol-specified Criteria|0|||
125407528|NCT01163682|451120414|FG001|Overall Study|Lost to Follow-up|9|||
125407529|NCT00359762|451120420|FG000|Period II|Adverse Event|17|||
125407530|NCT00359762|451120421|FG001|Period II|Adverse Event|0|||
125407531|NCT00359762|451120422|FG002|Period II|Adverse Event|0|||
125407532|NCT00359762|451120423|FG003|Period II|Adverse Event|0|||
125407533|NCT00359762|451120424|FG004|Period II|Adverse Event|49|||
125407534|NCT00359762|451120420|FG000|Period II|Protocol Violation|18|||
125407535|NCT00359762|451120421|FG001|Period II|Protocol Violation|0|||
125407536|NCT00359762|451120422|FG002|Period II|Protocol Violation|0|||
125407537|NCT00359762|451120423|FG003|Period II|Protocol Violation|0|||
125407538|NCT00359762|451120424|FG004|Period II|Protocol Violation|11|||
125407539|NCT00359762|451120420|FG000|Period II|Physician Decision|17|||
125407540|NCT00359762|451120421|FG001|Period II|Physician Decision|0|||
125407541|NCT00359762|451120422|FG002|Period II|Physician Decision|0|||
125407542|NCT00359762|451120423|FG003|Period II|Physician Decision|0|||
125407543|NCT00359762|451120424|FG004|Period II|Physician Decision|23|||
125407544|NCT00359762|451120420|FG000|Period II|Death|2|||
125407545|NCT00359762|451120421|FG001|Period II|Death|0|||
125407546|NCT00359762|451120422|FG002|Period II|Death|0|||
125407547|NCT00359762|451120423|FG003|Period II|Death|0|||
125407548|NCT00359762|451120424|FG004|Period II|Death|4|||
125407549|NCT00359762|451120420|FG000|Period II|Lack of Efficacy|11|||
125407550|NCT00359762|451120421|FG001|Period II|Lack of Efficacy|0|||
125407551|NCT00359762|451120422|FG002|Period II|Lack of Efficacy|0|||
125407552|NCT00359762|451120423|FG003|Period II|Lack of Efficacy|0|||
125407553|NCT00359762|451120424|FG004|Period II|Lack of Efficacy|8|||
125407554|NCT00359762|451120420|FG000|Period II|Lost to follow up|5|||
125407555|NCT00359762|451120421|FG001|Period II|Lost to follow up|0|||
125407556|NCT00359762|451120422|FG002|Period II|Lost to follow up|0|||
125407557|NCT00359762|451120423|FG003|Period II|Lost to follow up|0|||
125407558|NCT00359762|451120424|FG004|Period II|Lost to follow up|5|||
125407559|NCT00359762|451120420|FG000|Period II|Entry Criteria Not Met|8|||
125407560|NCT00359762|451120421|FG001|Period II|Entry Criteria Not Met|0|||
125407561|NCT00359762|451120422|FG002|Period II|Entry Criteria Not Met|0|||
125407562|NCT00359762|451120423|FG003|Period II|Entry Criteria Not Met|0|||
125407563|NCT00359762|451120424|FG004|Period II|Entry Criteria Not Met|4|||
125407564|NCT00359762|451120420|FG000|Period II|Subject Decision|50|||
125407565|NCT00359762|451120421|FG001|Period II|Subject Decision|0|||
125407566|NCT00359762|451120422|FG002|Period II|Subject Decision|0|||
125407567|NCT00359762|451120423|FG003|Period II|Subject Decision|0|||
125407568|NCT00359762|451120424|FG004|Period II|Subject Decision|70|||
125407569|NCT00359762|451120420|FG000|Period III|Protocol Violation|0|||
125407570|NCT00359762|451120421|FG001|Period III|Protocol Violation|5|||
125407571|NCT00359762|451120422|FG002|Period III|Protocol Violation|3|||
125407572|NCT00359762|451120423|FG003|Period III|Protocol Violation|8|||
125407573|NCT00359762|451120424|FG004|Period III|Protocol Violation|0|||
125407574|NCT00359762|451120420|FG000|Period III|Adverse Event|0|||
125407575|NCT00359762|451120421|FG001|Period III|Adverse Event|3|||
125407576|NCT00359762|451120422|FG002|Period III|Adverse Event|4|||
125407577|NCT00359762|451120423|FG003|Period III|Adverse Event|10|||
125407578|NCT00359762|451120424|FG004|Period III|Adverse Event|0|||
125407579|NCT00359762|451120420|FG000|Period III|Physician Decision|0|||
125407580|NCT00359762|451120421|FG001|Period III|Physician Decision|5|||
125407581|NCT00359762|451120422|FG002|Period III|Physician Decision|9|||
125407582|NCT00359762|451120423|FG003|Period III|Physician Decision|15|||
125407583|NCT00359762|451120424|FG004|Period III|Physician Decision|0|||
125407584|NCT00359762|451120420|FG000|Period III|Lack of Efficacy|0|||
125407585|NCT00359762|451120421|FG001|Period III|Lack of Efficacy|7|||
125407586|NCT00359762|451120422|FG002|Period III|Lack of Efficacy|5|||
125407587|NCT00359762|451120423|FG003|Period III|Lack of Efficacy|9|||
125407588|NCT00359762|451120424|FG004|Period III|Lack of Efficacy|0|||
125407589|NCT00359762|451120420|FG000|Period III|Lost to follow up|0|||
125407590|NCT00359762|451120421|FG001|Period III|Lost to follow up|1|||
125407591|NCT00359762|451120422|FG002|Period III|Lost to follow up|1|||
125407592|NCT00359762|451120423|FG003|Period III|Lost to follow up|2|||
125407593|NCT00359762|451120424|FG004|Period III|Lost to follow up|0|||
125407594|NCT00359762|451120420|FG000|Period III|Entry Criteria Not Met|0|||
125407595|NCT00359762|451120421|FG001|Period III|Entry Criteria Not Met|1|||
125407596|NCT00359762|451120422|FG002|Period III|Entry Criteria Not Met|0|||
125407597|NCT00359762|451120423|FG003|Period III|Entry Criteria Not Met|1|||
125407598|NCT00359762|451120424|FG004|Period III|Entry Criteria Not Met|0|||
125407599|NCT00359762|451120420|FG000|Period III|Subject Decision|0|||
125279208|NCT02016716|450645922|FG001|Overall Study|Protocol-specified Criteria|1|||
125279209|NCT02016716|450645923|FG002|Overall Study|Protocol-specified Criteria|0|||
125279210|NCT02016716|450645921|FG000|Overall Study|Lost to Follow-up|1|||
125279211|NCT02016716|450645922|FG001|Overall Study|Lost to Follow-up|2|||
125407600|NCT00359762|451120421|FG001|Period III|Subject Decision|7|||
125407601|NCT00359762|451120422|FG002|Period III|Subject Decision|8|||
125407602|NCT00359762|451120423|FG003|Period III|Subject Decision|20|||
125407603|NCT00359762|451120424|FG004|Period III|Subject Decision|0|||
125407604|NCT00530023|451120425|FG000|Overall Study|Withdrawal by Subject|0|||
125407605|NCT00530023|451120426|FG001|Overall Study|Withdrawal by Subject|1|||
125407606|NCT01172938|451120430|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
125279212|NCT02016716|450645923|FG002|Overall Study|Lost to Follow-up|1|||
125407607|NCT01172938|451120431|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
125407608|NCT01172938|451120432|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
125407609|NCT01172938|451120433|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125407610|NCT01172938|451120434|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125407611|NCT01172938|451120435|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125407612|NCT01172938|451120436|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125407613|NCT01172938|451120437|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125407614|NCT01172938|451120438|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
125407615|NCT01172938|451120430|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
125407616|NCT01172938|451120431|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
125407617|NCT01172938|451120432|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
125407618|NCT01172938|451120433|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125407619|NCT01172938|451120434|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125407620|NCT01172938|451120435|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125407621|NCT01172938|451120436|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125407622|NCT01172938|451120437|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125407623|NCT01172938|451120438|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
125407624|NCT01172938|451120430|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125407625|NCT01172938|451120431|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
125407626|NCT01172938|451120432|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
125407627|NCT01172938|451120433|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125407628|NCT01172938|451120434|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125407629|NCT01172938|451120435|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125407630|NCT01172938|451120436|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125407631|NCT01172938|451120437|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125407632|NCT01172938|451120438|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
125407633|NCT01172938|451120430|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
125407634|NCT01172938|451120431|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
125407635|NCT01172938|451120432|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
125407636|NCT01172938|451120433|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125407637|NCT01172938|451120434|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125407638|NCT01172938|451120435|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125407639|NCT01172938|451120436|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125407640|NCT01172938|451120437|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125407641|NCT01172938|451120438|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
125407642|NCT01172938|451120430|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
125407643|NCT01172938|451120431|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
125407644|NCT01172938|451120432|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
125407645|NCT01172938|451120433|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
125407646|NCT01172938|451120434|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
125407647|NCT01172938|451120435|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
125407648|NCT01172938|451120436|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
125407649|NCT01172938|451120437|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
125407650|NCT01172938|451120438|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
125407651|NCT01172938|451120430|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
125407652|NCT01172938|451120431|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125407653|NCT01172938|451120432|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125407654|NCT01172938|451120433|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125407655|NCT01172938|451120434|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125407656|NCT01172938|451120435|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125407657|NCT01172938|451120436|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125407658|NCT01172938|451120437|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125407659|NCT01172938|451120438|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
125407660|NCT01172938|451120430|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
125407661|NCT01172938|451120431|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
125407662|NCT01172938|451120432|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
125407663|NCT01172938|451120433|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
125407664|NCT01172938|451120434|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
125407665|NCT01172938|451120435|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
125279213|NCT02248649|450645924|FG000|Overall Study|Death|7|||
125279214|NCT02248649|450645925|FG001|Overall Study|Death|11|||
125407666|NCT01172938|451120436|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
125407667|NCT01172938|451120437|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
125407668|NCT01172938|451120438|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
125407669|NCT01172938|451120430|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
125448314|NCT02179918|451268895|FG001|Overall Study|Other|1|||
125279215|NCT02248649|450645924|FG000|Overall Study|Lost to Follow-up|14|||
125279216|NCT02248649|450645925|FG001|Overall Study|Lost to Follow-up|10|||
125407670|NCT01172938|451120431|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
125407671|NCT01172938|451120432|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
125407672|NCT01172938|451120433|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
125407673|NCT01172938|451120434|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
125407674|NCT01172938|451120435|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
125407675|NCT01172938|451120436|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
125407676|NCT01172938|451120437|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
125407677|NCT01172938|451120438|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
125407678|NCT01172938|451120430|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
125407679|NCT01172938|451120431|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
125407680|NCT01172938|451120432|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
125407681|NCT01172938|451120433|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
125407682|NCT01172938|451120434|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
125407683|NCT01172938|451120435|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
125407684|NCT01172938|451120436|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
125407685|NCT01172938|451120437|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
125407686|NCT01172938|451120438|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
125407687|NCT01172938|451120430|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125407688|NCT01172938|451120431|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125407689|NCT01172938|451120432|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
125407690|NCT01172938|451120433|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125407691|NCT01172938|451120434|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125407692|NCT01172938|451120435|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125407693|NCT01172938|451120436|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125407694|NCT01172938|451120437|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125279217|NCT01439971|450645926|FG000|Overall Study|Required number in cohort dosed|0|||
125279218|NCT01439971|450645927|FG001|Overall Study|Required number in cohort dosed|1|||
125279219|NCT01439971|450645928|FG002|Overall Study|Required number in cohort dosed|2|||
125279220|NCT01439971|450645929|FG003|Overall Study|Required number in cohort dosed|0|||
125279221|NCT01439971|450645930|FG004|Overall Study|Required number in cohort dosed|1|||
125279222|NCT02628600|450645934|FG000|Overall Study|Death|2|||
125279223|NCT02628600|450645935|FG001|Overall Study|Death|1|||
125279224|NCT02628600|450645934|FG000|Overall Study|Adverse Event|3|||
125279225|NCT02628600|450645935|FG001|Overall Study|Adverse Event|20|||
125279226|NCT02628600|450645934|FG000|Overall Study|Protocol Violation|0|||
125279227|NCT02628600|450645935|FG001|Overall Study|Protocol Violation|1|||
125279228|NCT02628600|450645934|FG000|Overall Study|Lack of Efficacy|2|||
125279229|NCT02628600|450645935|FG001|Overall Study|Lack of Efficacy|0|||
125279230|NCT02628600|450645934|FG000|Overall Study|Withdrawal by Subject|13|||
125279231|NCT02628600|450645935|FG001|Overall Study|Withdrawal by Subject|8|||
125279232|NCT02628600|450645934|FG000|Overall Study|Lost to Follow-up|1|||
125279233|NCT02628600|450645935|FG001|Overall Study|Lost to Follow-up|0|||
125279234|NCT02628600|450645934|FG000|Overall Study|Physician Decision|2|||
125279235|NCT02628600|450645935|FG001|Overall Study|Physician Decision|2|||
125279236|NCT02628600|450645934|FG000|Overall Study|Other not specified|1|||
125279237|NCT02628600|450645935|FG001|Overall Study|Other not specified|0|||
125279238|NCT01221623|450645940|FG000|Overall Study|Withdrawal by Subject|19|||
125279239|NCT01221623|450645941|FG001|Overall Study|Withdrawal by Subject|8|||
125279240|NCT01221623|450645940|FG000|Overall Study|Lost to Follow-up|7|||
125279241|NCT01221623|450645941|FG001|Overall Study|Lost to Follow-up|1|||
125279242|NCT01221623|450645940|FG000|Overall Study|Adverse Event|6|||
125279243|NCT01221623|450645941|FG001|Overall Study|Adverse Event|3|||
125279244|NCT01221623|450645940|FG000|Overall Study|Death|1|||
125279245|NCT01221623|450645941|FG001|Overall Study|Death|0|||
125279246|NCT01221623|450645940|FG000|Overall Study|Other|5|||
125279247|NCT01221623|450645941|FG001|Overall Study|Other|2|||
125279248|NCT00875485|450648953|FG000|Challenge Dose Epoch|Pregnancy|1|||
125279249|NCT00875485|450648954|FG001|Challenge Dose Epoch|Pregnancy|0|||
125279250|NCT01271010|450648955|FG000|Overall Study|Reason not specified|11|||
125279251|NCT01271010|450648955|FG000|Overall Study|Start of new CLL therapy|1|||
125279252|NCT01271010|450648955|FG000|Overall Study|Protocol Violation|1|||
125279253|NCT01271010|450648955|FG000|Overall Study|Death|2|||
125279254|NCT01271010|450648955|FG000|Overall Study|Progression and relapse of disease|1|||
125279255|NCT01271010|450648955|FG000|Overall Study|Withdrawal by Subject|18|||
125279256|NCT01271010|450648955|FG000|Overall Study|Disease progression|27|||
125279257|NCT01631747|450648956|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
125279258|NCT01631747|450648957|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
125279259|NCT01631747|450648956|FG000|Live Birth|Pregnancy Termination|1|||
125279260|NCT01631747|450648957|FG001|Live Birth|Pregnancy Termination|0|||
125279261|NCT01631747|450648956|FG000|Live Birth|MIscarriage|2|||
125279262|NCT01631747|450648957|FG001|Live Birth|MIscarriage|0|||
125279263|NCT01631747|450648956|FG000|Live Birth|Stillbirth|1|||
125279264|NCT01631747|450648957|FG001|Live Birth|Stillbirth|1|||
125407695|NCT01172938|451120438|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
125407696|NCT01172938|451120430|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
125407697|NCT01172938|451120431|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
125407698|NCT01172938|451120432|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
125407699|NCT01172938|451120433|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
125407700|NCT01172938|451120434|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
125407701|NCT01172938|451120435|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
125407702|NCT01172938|451120436|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
125407703|NCT01172938|451120437|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
125407704|NCT01172938|451120438|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
125407705|NCT01172938|451120430|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
125407706|NCT01172938|451120431|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
125407707|NCT01172938|451120432|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
125407708|NCT01172938|451120433|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
125407709|NCT01172938|451120434|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
125407710|NCT01172938|451120435|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
125407711|NCT01172938|451120436|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
125407712|NCT01172938|451120437|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
125407713|NCT01172938|451120438|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
125407714|NCT01172938|451120430|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
125407715|NCT01172938|451120431|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
125407716|NCT01172938|451120432|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
125407717|NCT01172938|451120433|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
125407718|NCT01172938|451120434|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
125407719|NCT01172938|451120435|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
125407720|NCT01172938|451120436|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
125407721|NCT01172938|451120437|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
125407722|NCT01172938|451120438|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
125407723|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
125407724|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
125407725|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
125407726|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
125407727|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
125407728|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
125407729|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
125407730|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
125407731|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
125407732|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
125407733|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
125407734|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
125407735|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
125407736|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
125407737|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
125407738|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
125407739|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
125407740|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
125407741|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125407742|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125407743|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
125407744|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125407745|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125407746|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125407747|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125407748|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125407749|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
125407750|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
125407751|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
125407752|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
125407753|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
125407754|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
125407755|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
125407756|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
125407757|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
125407758|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
125407759|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125407760|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125407761|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
125407762|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125407763|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125407764|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125407765|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125407766|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125407767|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
125407768|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
125407769|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
125407770|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
125407771|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
125407772|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
125407773|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
125407774|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
125407775|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
125407776|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
125407777|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125407778|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
125407779|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125407780|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125407781|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125407782|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125407783|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125407784|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
125407785|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
125407786|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125407787|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
125407788|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125407789|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125407790|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125407791|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125407792|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125407793|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125407794|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
125407795|NCT01172938|451120430|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125407796|NCT01172938|451120431|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125407797|NCT01172938|451120432|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125407798|NCT01172938|451120433|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125407799|NCT01172938|451120434|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125407800|NCT01172938|451120435|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125407801|NCT01172938|451120436|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125407802|NCT01172938|451120437|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
125407803|NCT01172938|451120438|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
125407804|NCT01172938|451120430|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
125407805|NCT01172938|451120431|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
125407806|NCT01172938|451120432|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
125407807|NCT01172938|451120433|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
125407808|NCT01172938|451120434|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
125407809|NCT01172938|451120435|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
125407810|NCT01172938|451120436|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
125407811|NCT01172938|451120437|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
125407812|NCT01172938|451120438|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
125407813|NCT01172938|451120430|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
125407814|NCT01172938|451120431|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
125407815|NCT01172938|451120432|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
125407816|NCT01172938|451120433|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
125407817|NCT01172938|451120434|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
125407818|NCT01172938|451120435|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
125407819|NCT01172938|451120436|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
125407820|NCT01172938|451120437|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
125407821|NCT01172938|451120438|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
125407822|NCT01172938|451120430|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
125407823|NCT01172938|451120431|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
125448315|NCT02179918|451268896|FG002|Overall Study|Other|0|||
125448316|NCT02179918|451268897|FG003|Overall Study|Other|0|||
125279265|NCT01631747|450648956|FG000|One Year Infant Outcomes|Patient Refused|13|||
125279266|NCT01631747|450648957|FG001|One Year Infant Outcomes|Patient Refused|9|||
125279267|NCT02908685|450648958|FG000|Part 1 OLE|Withdrawal by Subject|0|||
125279268|NCT02908685|450648959|FG001|Part 1 OLE|Withdrawal by Subject|0|||
125279269|NCT02908685|450648960|FG002|Part 1 OLE|Withdrawal by Subject|0|||
125279270|NCT02908685|450648961|FG003|Part 1 OLE|Withdrawal by Subject|0|||
125279271|NCT02908685|450648962|FG004|Part 1 OLE|Withdrawal by Subject|0|||
125279272|NCT02908685|450648963|FG005|Part 1 OLE|Withdrawal by Subject|0|||
125279273|NCT02908685|450648964|FG006|Part 1 OLE|Withdrawal by Subject|0|||
125279274|NCT02908685|450648965|FG007|Part 1 OLE|Withdrawal by Subject|0|||
125279275|NCT02908685|450648966|FG008|Part 1 OLE|Withdrawal by Subject|0|||
125407824|NCT01172938|451120432|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
125407825|NCT01172938|451120433|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
125407826|NCT01172938|451120434|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
125279276|NCT02908685|450648967|FG009|Part 1 OLE|Withdrawal by Subject|0|||
125279277|NCT02908685|450648968|FG010|Part 1 OLE|Withdrawal by Subject|2|||
125279278|NCT02908685|450648969|FG011|Part 1 OLE|Withdrawal by Subject|1|||
125279279|NCT02908685|450648970|FG012|Part 1 OLE|Withdrawal by Subject|0|||
125279280|NCT02908685|450648971|FG013|Part 1 OLE|Withdrawal by Subject|0|||
125279281|NCT02908685|450648958|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279282|NCT02908685|450648959|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279283|NCT02908685|450648960|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279284|NCT02908685|450648961|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279285|NCT02908685|450648962|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279286|NCT02908685|450648963|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279287|NCT02908685|450648964|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279288|NCT02908685|450648965|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279289|NCT02908685|450648966|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279290|NCT02908685|450648967|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279291|NCT02908685|450648968|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125407827|NCT01172938|451120435|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
125407828|NCT01172938|451120436|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
125407829|NCT01172938|451120437|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
125407830|NCT01172938|451120438|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
125407831|NCT01172938|451120430|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125407832|NCT01172938|451120431|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
125407833|NCT01172938|451120432|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125407834|NCT01172938|451120433|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125407835|NCT01172938|451120434|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125407836|NCT01172938|451120435|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125407837|NCT01172938|451120436|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125407838|NCT01172938|451120437|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125407839|NCT01172938|451120438|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
125407840|NCT01172938|451120430|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125407841|NCT01172938|451120431|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125407842|NCT01172938|451120432|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
125407843|NCT01172938|451120433|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125407844|NCT01172938|451120434|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125407845|NCT01172938|451120435|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125407846|NCT01172938|451120436|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125407847|NCT01172938|451120437|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125407848|NCT01172938|451120438|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
125407849|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
125407850|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
125407851|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
125407852|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
125407853|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
125407854|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
125407855|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
125407856|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
125407857|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
125407858|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
125407859|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
125279292|NCT02908685|450648969|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
125279293|NCT02908685|450648970|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
125279294|NCT02908685|450648971|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
125279295|NCT02908685|450648958|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279296|NCT02908685|450648959|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279297|NCT02908685|450648960|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125407860|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
125407861|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
125407862|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
125407863|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
125407864|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
125407865|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
125407866|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
125407867|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
125407868|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
125407869|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
125407870|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
125407871|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
125407872|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
125407873|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
125407874|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
125407875|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
125407876|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125407877|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125407878|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
125407879|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125407880|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125407881|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125407882|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125407883|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
125407884|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
125407885|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125407886|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125407887|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125407888|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125407889|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125407890|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125407891|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125407892|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
125407893|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
125407894|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
125407895|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
125407896|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
125407897|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
125407898|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
125407899|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
125407900|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
125407901|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
125407902|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
125407903|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125407904|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125407905|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
125407906|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125407907|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125407908|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125407909|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125407910|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125407911|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
125407912|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125407913|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
125407914|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125407915|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125407916|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125407917|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125407918|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125407919|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
125407920|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
125407921|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
125407922|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
125448317|NCT02179918|451268898|FG004|Overall Study|Other|1|||
125279298|NCT02908685|450648961|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279299|NCT02908685|450648962|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279300|NCT02908685|450648963|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279301|NCT02908685|450648964|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279302|NCT02908685|450648965|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279303|NCT02908685|450648966|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279304|NCT02908685|450648967|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279305|NCT02908685|450648968|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279306|NCT02908685|450648969|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279307|NCT02908685|450648970|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
125279308|NCT02908685|450648971|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
125279309|NCT02908685|450648958|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279310|NCT02908685|450648959|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279311|NCT02908685|450648960|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279312|NCT02908685|450648961|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279313|NCT02908685|450648962|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279314|NCT02908685|450648963|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279315|NCT02908685|450648964|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279316|NCT02908685|450648965|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279317|NCT02908685|450648966|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279318|NCT02908685|450648967|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279319|NCT02908685|450648968|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279320|NCT02908685|450648969|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279321|NCT02908685|450648970|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
125279322|NCT02908685|450648971|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
125279323|NCT02908685|450648958|FG000|Part 2 OLE: > Month 24|Death|0|||
125279324|NCT02908685|450648959|FG001|Part 2 OLE: > Month 24|Death|0|||
125279325|NCT02908685|450648960|FG002|Part 2 OLE: > Month 24|Death|0|||
125279326|NCT02908685|450648961|FG003|Part 2 OLE: > Month 24|Death|0|||
125279327|NCT02908685|450648962|FG004|Part 2 OLE: > Month 24|Death|0|||
125279328|NCT02908685|450648963|FG005|Part 2 OLE: > Month 24|Death|0|||
125279329|NCT02908685|450648964|FG006|Part 2 OLE: > Month 24|Death|0|||
125279330|NCT02908685|450648965|FG007|Part 2 OLE: > Month 24|Death|0|||
125279331|NCT02908685|450648966|FG008|Part 2 OLE: > Month 24|Death|0|||
125279332|NCT02908685|450648967|FG009|Part 2 OLE: > Month 24|Death|0|||
125279333|NCT02908685|450648968|FG010|Part 2 OLE: > Month 24|Death|0|||
125279334|NCT02908685|450648969|FG011|Part 2 OLE: > Month 24|Death|0|||
125279335|NCT02908685|450648970|FG012|Part 2 OLE: > Month 24|Death|1|||
125279336|NCT02908685|450648971|FG013|Part 2 OLE: > Month 24|Death|0|||
125279337|NCT02908685|450648958|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
125279338|NCT02908685|450648959|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
125279339|NCT02908685|450648960|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
125279340|NCT02908685|450648961|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
125279341|NCT02908685|450648962|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
125279342|NCT02908685|450648963|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
125279343|NCT02908685|450648964|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
125279344|NCT02908685|450648965|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
125279345|NCT02908685|450648966|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
125279346|NCT02908685|450648967|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
125279347|NCT02908685|450648968|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
125279348|NCT02908685|450648969|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
125279349|NCT02908685|450648970|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
125279350|NCT02908685|450648971|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
125279351|NCT02908685|450648958|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279352|NCT02908685|450648959|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279353|NCT02908685|450648960|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279354|NCT02908685|450648961|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279355|NCT02908685|450648962|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279356|NCT02908685|450648963|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279357|NCT02908685|450648964|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279358|NCT02908685|450648965|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279359|NCT02908685|450648966|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279360|NCT02908685|450648967|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279361|NCT02908685|450648968|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279362|NCT02908685|450648969|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
125279363|NCT02908685|450648970|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
125279364|NCT02908685|450648971|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
125279365|NCT01691014|450648974|FG000|Overall Study|Premature Termination|1|||
125279366|NCT01691014|450648975|FG001|Overall Study|Premature Termination|6|||
125279367|NCT01691014|450648976|FG002|Overall Study|Premature Termination|0|||
125279368|NCT01691014|450648977|FG003|Overall Study|Premature Termination|3|||
125407923|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
125407924|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
125407925|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
125407926|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
125407927|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
125407928|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
125407929|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
125407930|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125407931|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125407932|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
125407933|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125407934|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125407935|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125407936|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125407937|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125407938|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
125407939|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125407940|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125407941|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
125407942|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125407943|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125407944|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125407945|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125407946|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125407947|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
125407948|NCT01172938|451120430|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125407949|NCT01172938|451120431|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125407950|NCT01172938|451120432|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125407951|NCT01172938|451120433|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125407952|NCT01172938|451120434|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125407953|NCT01172938|451120435|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125407954|NCT01172938|451120436|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125407955|NCT01172938|451120437|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
125407956|NCT01172938|451120438|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
125407957|NCT00003498|451120439|FG000|Overall Study|Not evaluable.|4|||
125407958|NCT05282004|451120443|FG000|Overall Study|Adverse Event|2|||
125407959|NCT04808609|451120444|FG000|Overall Study|Lost to Follow-up|0|||
125407960|NCT04808609|451120445|FG001|Overall Study|Lost to Follow-up|2|||
125407961|NCT04808609|451120444|FG000|Overall Study|Administrative Withdrawal|0|||
125407962|NCT04808609|451120445|FG001|Overall Study|Administrative Withdrawal|1|||
125407963|NCT01993719|451120449|FG000|First Drug Administration|Not treated|1|||
125407964|NCT01993719|451120450|FG001|First Drug Administration|Not treated|0|||
125407965|NCT01993719|451120451|FG002|First Drug Administration|Not treated|0|||
125407966|NCT01993719|451120452|FG003|First Drug Administration|Not treated|0|||
125407967|NCT01993719|451120453|FG004|First Drug Administration|Not treated|0|||
125407968|NCT04382326|451120457|FG000|Overall Study|Adverse Event, not serious|1|||
125407969|NCT04382326|451120458|FG001|Overall Study|Adverse Event, not serious|2|||
125407970|NCT04382326|451120457|FG000|Overall Study|Other|1|||
125407971|NCT04382326|451120458|FG001|Overall Study|Other|0|||
125407972|NCT04382326|451120457|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
125407973|NCT04382326|451120458|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
125407974|NCT04382326|451120457|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
125407975|NCT04382326|451120458|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
125407976|NCT04382326|451120457|FG000|Overall Study|Protocol Violation|29|||
125407977|NCT04382326|451120458|FG001|Overall Study|Protocol Violation|23|||
125407978|NCT04382326|451120457|FG000|Overall Study|Physician Decision|0|||
125407979|NCT04382326|451120458|FG001|Overall Study|Physician Decision|1|||
125407980|NCT04382326|451120457|FG000|Overall Study|Lost to Follow-up|48|||
125407981|NCT04382326|451120458|FG001|Overall Study|Lost to Follow-up|63|||
125407982|NCT04382326|451120457|FG000|Overall Study|Adverse Event, non-fatal|1|||
125407983|NCT04382326|451120458|FG001|Overall Study|Adverse Event, non-fatal|1|||
125407984|NCT03224468|451120468|FG000|Overall Study|Did not obtain MM card|53|||
125407985|NCT03224468|451120469|FG001|Overall Study|Did not obtain MM card|0|||
125407986|NCT03224468|451120468|FG000|Overall Study|Lost to Follow-up|4|||
125407987|NCT03224468|451120469|FG001|Overall Study|Lost to Follow-up|11|||
125407988|NCT03224468|451120468|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
125279369|NCT01691014|450648974|FG000|Overall Study|Other|0|||
125279370|NCT01691014|450648975|FG001|Overall Study|Other|0|||
125407989|NCT03224468|451120469|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
125407990|NCT02461589|451120470|FG000|Overall Study|Withdrawal by Subject|5|||
125407991|NCT02461589|451120471|FG001|Overall Study|Withdrawal by Subject|1|||
125407992|NCT02461589|451120472|FG002|Overall Study|Withdrawal by Subject|3|||
125407993|NCT02461589|451120473|FG003|Overall Study|Withdrawal by Subject|2|||
125407994|NCT02461589|451120474|FG004|Overall Study|Withdrawal by Subject|1|||
125407995|NCT02461589|451120475|FG005|Overall Study|Withdrawal by Subject|2|||
125407996|NCT02461589|451120476|FG006|Overall Study|Withdrawal by Subject|1|||
125407997|NCT02461589|451120477|FG007|Overall Study|Withdrawal by Subject|3|||
125407998|NCT02461589|451120478|FG008|Overall Study|Withdrawal by Subject|3|||
125407999|NCT02461589|451120479|FG009|Overall Study|Withdrawal by Subject|1|||
125408000|NCT02461589|451120470|FG000|Overall Study|Lost to Follow-up|0|||
125408001|NCT02461589|451120471|FG001|Overall Study|Lost to Follow-up|0|||
125408002|NCT02461589|451120472|FG002|Overall Study|Lost to Follow-up|2|||
125408003|NCT02461589|451120473|FG003|Overall Study|Lost to Follow-up|3|||
125408004|NCT02461589|451120474|FG004|Overall Study|Lost to Follow-up|1|||
125408005|NCT02461589|451120475|FG005|Overall Study|Lost to Follow-up|1|||
125408006|NCT02461589|451120476|FG006|Overall Study|Lost to Follow-up|3|||
125279371|NCT01691014|450648976|FG002|Overall Study|Other|2|||
125279372|NCT01691014|450648977|FG003|Overall Study|Other|0|||
125279373|NCT01691014|450648974|FG000|Overall Study|Withdrawal by Subject|0|||
125279374|NCT01691014|450648975|FG001|Overall Study|Withdrawal by Subject|1|||
125279375|NCT01691014|450648976|FG002|Overall Study|Withdrawal by Subject|1|||
125279376|NCT01691014|450648977|FG003|Overall Study|Withdrawal by Subject|1|||
125279377|NCT01691014|450648974|FG000|Overall Study|Adverse Event|0|||
125279378|NCT01691014|450648975|FG001|Overall Study|Adverse Event|5|||
125279379|NCT01691014|450648976|FG002|Overall Study|Adverse Event|1|||
125279380|NCT01691014|450648977|FG003|Overall Study|Adverse Event|1|||
125279381|NCT01691014|450648974|FG000|Overall Study|Lack of Efficacy|2|||
125279382|NCT01691014|450648975|FG001|Overall Study|Lack of Efficacy|3|||
125279383|NCT01691014|450648976|FG002|Overall Study|Lack of Efficacy|7|||
125279384|NCT01691014|450648977|FG003|Overall Study|Lack of Efficacy|0|||
125279385|NCT02370537|450648978|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
125279386|NCT02370537|450648979|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
125279387|NCT02370537|450648980|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
125279388|NCT02370537|450648978|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
125279389|NCT02370537|450648979|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
125279390|NCT02370537|450648980|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
125279391|NCT02370537|450648978|FG000|Part B|Not randomised to receive treatment|1|||
125279392|NCT02370537|450648979|FG001|Part B|Not randomised to receive treatment|2|||
125279393|NCT02370537|450648980|FG002|Part B|Not randomised to receive treatment|259|||
125279394|NCT02370537|450648978|FG000|Part B|Withdrawal by Subject|0|||
125279395|NCT02370537|450648979|FG001|Part B|Withdrawal by Subject|1|||
125279396|NCT02370537|450648980|FG002|Part B|Withdrawal by Subject|0|||
125279397|NCT03100539|450648987|FG000|Overall Study|Lost to Follow-up|60|||
125279398|NCT03100539|450648988|FG001|Overall Study|Lost to Follow-up|54|||
125279399|NCT03100539|450648989|FG002|Overall Study|Lost to Follow-up|17|||
125279400|NCT03100539|450648987|FG000|Overall Study|Uncollected|8|||
125279401|NCT03100539|450648988|FG001|Overall Study|Uncollected|8|||
125279402|NCT03100539|450648989|FG002|Overall Study|Uncollected|0|||
125279403|NCT03100539|450648987|FG000|Overall Study|Ally Health|0|||
125279404|NCT03100539|450648988|FG001|Overall Study|Ally Health|0|||
125279405|NCT03100539|450648989|FG002|Overall Study|Ally Health|3|||
125279406|NCT03100539|450648987|FG000|Overall Study|Disinterest|0|||
125279407|NCT03100539|450648988|FG001|Overall Study|Disinterest|0|||
125279408|NCT03100539|450648989|FG002|Overall Study|Disinterest|22|||
125279409|NCT03100539|450648987|FG000|Overall Study|Veteran Health|0|||
125279410|NCT03100539|450648988|FG001|Overall Study|Veteran Health|0|||
125279411|NCT03100539|450648989|FG002|Overall Study|Veteran Health|8|||
125279412|NCT03100539|450648987|FG000|Overall Study|Moved|0|||
125279413|NCT03100539|450648988|FG001|Overall Study|Moved|0|||
125279414|NCT03100539|450648989|FG002|Overall Study|Moved|1|||
125279415|NCT03100539|450648987|FG000|Overall Study|Scheduling Conflicts|0|||
125279416|NCT03100539|450648988|FG001|Overall Study|Scheduling Conflicts|0|||
125279417|NCT03100539|450648989|FG002|Overall Study|Scheduling Conflicts|12|||
125279418|NCT05897242|450648990|FG000|Overall Study|Lost to Follow-up|6|||
125279419|NCT05897242|450648991|FG001|Overall Study|Lost to Follow-up|1|||
125279420|NCT05897242|450648990|FG000|Overall Study|Incomplete|1|||
125279421|NCT05897242|450648991|FG001|Overall Study|Incomplete|0|||
125279422|NCT05897242|450648990|FG000|Overall Study|Withdrawal by Subject|1|||
125279423|NCT05897242|450648991|FG001|Overall Study|Withdrawal by Subject|0|||
125408007|NCT02461589|451120477|FG007|Overall Study|Lost to Follow-up|1|||
125408008|NCT02461589|451120478|FG008|Overall Study|Lost to Follow-up|3|||
125408009|NCT02461589|451120479|FG009|Overall Study|Lost to Follow-up|1|||
125279424|NCT00809835|450648992|FG000|Overall Study|Lost to Follow-up|7|||
125279425|NCT00809835|450648993|FG001|Overall Study|Lost to Follow-up|6|||
125279426|NCT00809835|450648994|FG002|Overall Study|Lost to Follow-up|10|||
125279427|NCT00809835|450648995|FG003|Overall Study|Lost to Follow-up|2|||
125279428|NCT00809835|450648992|FG000|Overall Study|Withdrawal by Subject|1|||
125279429|NCT00809835|450648993|FG001|Overall Study|Withdrawal by Subject|1|||
125279430|NCT00809835|450648994|FG002|Overall Study|Withdrawal by Subject|1|||
125408010|NCT02461589|451120470|FG000|Overall Study|Death|0|||
125408011|NCT02461589|451120471|FG001|Overall Study|Death|0|||
125408012|NCT02461589|451120472|FG002|Overall Study|Death|0|||
125408013|NCT02461589|451120473|FG003|Overall Study|Death|0|||
125408014|NCT02461589|451120474|FG004|Overall Study|Death|0|||
125408015|NCT02461589|451120475|FG005|Overall Study|Death|0|||
125408016|NCT02461589|451120476|FG006|Overall Study|Death|0|||
125408017|NCT02461589|451120477|FG007|Overall Study|Death|1|||
125408018|NCT02461589|451120478|FG008|Overall Study|Death|0|||
125408019|NCT02461589|451120479|FG009|Overall Study|Death|0|||
125408020|NCT02461589|451120470|FG000|Overall Study|Unclassified|0|||
125408021|NCT02461589|451120471|FG001|Overall Study|Unclassified|0|||
125408022|NCT02461589|451120472|FG002|Overall Study|Unclassified|0|||
125408023|NCT02461589|451120473|FG003|Overall Study|Unclassified|0|||
125408024|NCT02461589|451120474|FG004|Overall Study|Unclassified|0|||
125408025|NCT02461589|451120475|FG005|Overall Study|Unclassified|0|||
125408026|NCT02461589|451120476|FG006|Overall Study|Unclassified|1|||
125408027|NCT02461589|451120477|FG007|Overall Study|Unclassified|0|||
125408028|NCT02461589|451120478|FG008|Overall Study|Unclassified|0|||
125408029|NCT02461589|451120479|FG009|Overall Study|Unclassified|2|||
125408030|NCT02461589|451120470|FG000|Overall Study|Missing follow-up information|1|||
125408031|NCT02461589|451120471|FG001|Overall Study|Missing follow-up information|1|||
125408032|NCT02461589|451120472|FG002|Overall Study|Missing follow-up information|0|||
125408033|NCT02461589|451120473|FG003|Overall Study|Missing follow-up information|0|||
125408034|NCT02461589|451120474|FG004|Overall Study|Missing follow-up information|0|||
125408035|NCT02461589|451120475|FG005|Overall Study|Missing follow-up information|0|||
125408036|NCT02461589|451120476|FG006|Overall Study|Missing follow-up information|1|||
125408037|NCT02461589|451120477|FG007|Overall Study|Missing follow-up information|0|||
125408038|NCT02461589|451120478|FG008|Overall Study|Missing follow-up information|0|||
125408039|NCT02461589|451120479|FG009|Overall Study|Missing follow-up information|0|||
125408040|NCT02461589|451120470|FG000|Overall Study|Withdrawal from trial before exposure|0|||
125408041|NCT02461589|451120471|FG001|Overall Study|Withdrawal from trial before exposure|0|||
125408042|NCT02461589|451120472|FG002|Overall Study|Withdrawal from trial before exposure|0|||
125408043|NCT02461589|451120473|FG003|Overall Study|Withdrawal from trial before exposure|0|||
125408044|NCT02461589|451120474|FG004|Overall Study|Withdrawal from trial before exposure|0|||
125408045|NCT02461589|451120475|FG005|Overall Study|Withdrawal from trial before exposure|0|||
125408046|NCT02461589|451120476|FG006|Overall Study|Withdrawal from trial before exposure|0|||
125408047|NCT02461589|451120477|FG007|Overall Study|Withdrawal from trial before exposure|0|||
125408048|NCT02461589|451120478|FG008|Overall Study|Withdrawal from trial before exposure|0|||
125408049|NCT02461589|451120479|FG009|Overall Study|Withdrawal from trial before exposure|1|||
125408050|NCT04067141|451120480|FG000|First Intervention|Withdrawal by Subject|0|||
125408051|NCT04067141|451120481|FG001|First Intervention|Withdrawal by Subject|1|||
125408052|NCT04067141|451120480|FG000|Second Intervention|Adverse Event|0|||
125408053|NCT04067141|451120481|FG001|Second Intervention|Adverse Event|2|||
125408054|NCT01038921|451120482|FG000|Overall Study|Withdrawal by Subject|1|||
125408055|NCT01038921|451120483|FG001|Overall Study|Withdrawal by Subject|0|||
125408056|NCT01038921|451120482|FG000|Overall Study|Physician Decision|1|||
125408057|NCT01038921|451120483|FG001|Overall Study|Physician Decision|0|||
125408058|NCT01978119|451120484|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
125408059|NCT01978119|451120485|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
125408060|NCT01978119|451120484|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
125408061|NCT01978119|451120485|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125408062|NCT01978119|451120484|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125408063|NCT01978119|451120485|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
125408064|NCT02352493|451120486|FG000|Overall Study|Pregnancy|0|||
125408065|NCT02352493|451120487|FG001|Overall Study|Pregnancy|0|||
125408066|NCT02352493|451120488|FG002|Overall Study|Pregnancy|0|||
125408067|NCT02352493|451120489|FG003|Overall Study|Pregnancy|0|||
125408068|NCT02352493|451120490|FG004|Overall Study|Pregnancy|0|||
125408069|NCT02352493|451120491|FG005|Overall Study|Pregnancy|0|||
125408070|NCT02352493|451120492|FG006|Overall Study|Pregnancy|1|||
125408071|NCT02352493|451120493|FG007|Overall Study|Pregnancy|0|||
125408072|NCT02352493|451120494|FG008|Overall Study|Pregnancy|1|||
125408073|NCT02352493|451120495|FG009|Overall Study|Pregnancy|0|||
125408074|NCT02352493|451120496|FG010|Overall Study|Pregnancy|0|||
125408075|NCT02352493|451120497|FG011|Overall Study|Pregnancy|0|||
125408076|NCT02352493|451120498|FG012|Overall Study|Pregnancy|0|||
125408077|NCT02352493|451120499|FG013|Overall Study|Pregnancy|0|||
125408078|NCT02352493|451120500|FG014|Overall Study|Pregnancy|0|||
125408079|NCT02352493|451120501|FG015|Overall Study|Pregnancy|0|||
125279431|NCT00809835|450648995|FG003|Overall Study|Withdrawal by Subject|0|||
125408080|NCT02352493|451120502|FG016|Overall Study|Pregnancy|0|||
125408081|NCT02352493|451120503|FG017|Overall Study|Pregnancy|0|||
125408082|NCT02352493|451120486|FG000|Overall Study|Withdrawal by Subject|0|||
125408083|NCT02352493|451120487|FG001|Overall Study|Withdrawal by Subject|0|||
125408084|NCT02352493|451120488|FG002|Overall Study|Withdrawal by Subject|0|||
125408085|NCT02352493|451120489|FG003|Overall Study|Withdrawal by Subject|0|||
125408086|NCT02352493|451120490|FG004|Overall Study|Withdrawal by Subject|0|||
125408087|NCT02352493|451120491|FG005|Overall Study|Withdrawal by Subject|0|||
125408088|NCT02352493|451120492|FG006|Overall Study|Withdrawal by Subject|0|||
125408089|NCT02352493|451120493|FG007|Overall Study|Withdrawal by Subject|0|||
125408090|NCT02352493|451120494|FG008|Overall Study|Withdrawal by Subject|1|||
125408091|NCT02352493|451120495|FG009|Overall Study|Withdrawal by Subject|0|||
125408092|NCT02352493|451120496|FG010|Overall Study|Withdrawal by Subject|0|||
125408093|NCT02352493|451120497|FG011|Overall Study|Withdrawal by Subject|0|||
125408094|NCT02352493|451120498|FG012|Overall Study|Withdrawal by Subject|0|||
125408095|NCT02352493|451120499|FG013|Overall Study|Withdrawal by Subject|0|||
125408096|NCT02352493|451120500|FG014|Overall Study|Withdrawal by Subject|1|||
125408097|NCT02352493|451120501|FG015|Overall Study|Withdrawal by Subject|0|||
125408098|NCT02352493|451120502|FG016|Overall Study|Withdrawal by Subject|0|||
125408099|NCT02352493|451120503|FG017|Overall Study|Withdrawal by Subject|0|||
125408100|NCT02352493|451120486|FG000|Overall Study|Lost to Follow-up|0|||
125408101|NCT02352493|451120487|FG001|Overall Study|Lost to Follow-up|0|||
125408102|NCT02352493|451120488|FG002|Overall Study|Lost to Follow-up|0|||
125408103|NCT02352493|451120489|FG003|Overall Study|Lost to Follow-up|0|||
125408104|NCT02352493|451120490|FG004|Overall Study|Lost to Follow-up|0|||
125408105|NCT02352493|451120491|FG005|Overall Study|Lost to Follow-up|0|||
125408106|NCT02352493|451120492|FG006|Overall Study|Lost to Follow-up|0|||
125408107|NCT02352493|451120493|FG007|Overall Study|Lost to Follow-up|0|||
125408108|NCT02352493|451120494|FG008|Overall Study|Lost to Follow-up|0|||
125408109|NCT02352493|451120495|FG009|Overall Study|Lost to Follow-up|1|||
125408110|NCT02352493|451120496|FG010|Overall Study|Lost to Follow-up|0|||
125408111|NCT02352493|451120497|FG011|Overall Study|Lost to Follow-up|0|||
125408112|NCT02352493|451120498|FG012|Overall Study|Lost to Follow-up|1|||
125408113|NCT02352493|451120499|FG013|Overall Study|Lost to Follow-up|2|||
125408114|NCT02352493|451120500|FG014|Overall Study|Lost to Follow-up|0|||
125408115|NCT02352493|451120501|FG015|Overall Study|Lost to Follow-up|0|||
125408116|NCT02352493|451120502|FG016|Overall Study|Lost to Follow-up|0|||
125408117|NCT02352493|451120503|FG017|Overall Study|Lost to Follow-up|0|||
125408118|NCT03295201|451120504|FG000|Overall Study|Lost to Follow-up|1|||
125408119|NCT03295201|451120505|FG001|Overall Study|Lost to Follow-up|1|||
125408120|NCT03295201|451120504|FG000|Overall Study|Hospital admission|0|||
125408121|NCT03295201|451120505|FG001|Overall Study|Hospital admission|1|||
125408122|NCT01465334|451120506|FG000|Overall Study|Disease Progression|1|||
125408123|NCT01465334|451120507|FG001|Overall Study|Disease Progression|0|||
125408124|NCT01465334|451120506|FG000|Overall Study|Adverse Event|1|||
125408125|NCT01465334|451120507|FG001|Overall Study|Adverse Event|0|||
125408126|NCT01465334|451120506|FG000|Overall Study|Richter's transformation|0|||
125408127|NCT01465334|451120507|FG001|Overall Study|Richter's transformation|3|||
125408128|NCT01465334|451120506|FG000|Overall Study|Refractory Disease|0|||
125408129|NCT01465334|451120507|FG001|Overall Study|Refractory Disease|3|||
125408130|NCT00572572|451120508|FG000|Overall Study|Withdrawal by Subject|3|||
125408131|NCT00572572|451120509|FG001|Overall Study|Withdrawal by Subject|6|||
125408132|NCT01831089|451120510|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
125408133|NCT01831089|451120511|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
125408134|NCT01831089|451120512|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
125408135|NCT01831089|451120513|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
125408136|NCT01831089|451120514|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
125408137|NCT01831089|451120515|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
125408138|NCT01831089|451120510|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
125408139|NCT01831089|451120511|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
125408140|NCT01831089|451120512|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
125408141|NCT01831089|451120513|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
125408142|NCT01831089|451120514|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
125408143|NCT01831089|451120515|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
125408144|NCT01831089|451120510|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
125408145|NCT01831089|451120511|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
125408146|NCT01831089|451120512|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
125408147|NCT01831089|451120513|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
125408148|NCT01831089|451120514|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
125408149|NCT01831089|451120515|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
125408150|NCT01831089|451120510|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
125408151|NCT01831089|451120511|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
125408152|NCT01831089|451120512|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
125408153|NCT01831089|451120513|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
125408154|NCT01831089|451120514|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
125408155|NCT01831089|451120515|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
125408156|NCT01831089|451120510|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
125408157|NCT01831089|451120511|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
125408158|NCT01831089|451120512|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
125408159|NCT01831089|451120513|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
125408160|NCT01831089|451120514|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
125408161|NCT01831089|451120515|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
125408162|NCT01831089|451120510|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
125408163|NCT01831089|451120511|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
125408164|NCT01831089|451120512|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
125408165|NCT01831089|451120513|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
125408166|NCT01831089|451120514|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
125408167|NCT01831089|451120515|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
125408168|NCT01831089|451120510|FG000|Cohort III: Dose Level 3|Global end of study|0|||
125408169|NCT01831089|451120511|FG001|Cohort III: Dose Level 3|Global end of study|0|||
125408170|NCT01831089|451120512|FG002|Cohort III: Dose Level 3|Global end of study|1|||
125408171|NCT01831089|451120513|FG003|Cohort III: Dose Level 3|Global end of study|0|||
125408172|NCT01831089|451120514|FG004|Cohort III: Dose Level 3|Global end of study|0|||
125408173|NCT01831089|451120515|FG005|Cohort III: Dose Level 3|Global end of study|0|||
125408174|NCT01831089|451120510|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
125408175|NCT01831089|451120511|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
125408176|NCT01831089|451120512|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
125408177|NCT01831089|451120513|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
125408178|NCT01831089|451120514|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
125408179|NCT01831089|451120515|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
125408180|NCT01831089|451120510|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
125408181|NCT01831089|451120511|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
125408182|NCT01831089|451120512|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
125408183|NCT01831089|451120513|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
125408184|NCT01831089|451120514|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
125408185|NCT01831089|451120515|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
125408186|NCT01831089|451120510|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
125408187|NCT01831089|451120511|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
125408188|NCT01831089|451120512|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
125408189|NCT01831089|451120513|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
125408190|NCT01831089|451120514|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
125408191|NCT01831089|451120515|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
125408192|NCT01831089|451120510|FG000|Cohort V: Dose Level 5|Death|0|||
125408193|NCT01831089|451120511|FG001|Cohort V: Dose Level 5|Death|0|||
125408194|NCT01831089|451120512|FG002|Cohort V: Dose Level 5|Death|0|||
125408195|NCT01831089|451120513|FG003|Cohort V: Dose Level 5|Death|0|||
125408196|NCT01831089|451120514|FG004|Cohort V: Dose Level 5|Death|1|||
125408197|NCT01831089|451120515|FG005|Cohort V: Dose Level 5|Death|0|||
125408198|NCT01831089|451120510|FG000|Cohort V: Dose Level 5|Global end of study|0|||
125408199|NCT01831089|451120511|FG001|Cohort V: Dose Level 5|Global end of study|0|||
125408200|NCT01831089|451120512|FG002|Cohort V: Dose Level 5|Global end of study|0|||
125408201|NCT01831089|451120513|FG003|Cohort V: Dose Level 5|Global end of study|0|||
125408202|NCT01831089|451120514|FG004|Cohort V: Dose Level 5|Global end of study|2|||
125408203|NCT01831089|451120515|FG005|Cohort V: Dose Level 5|Global end of study|0|||
125408204|NCT01831089|451120510|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
125408205|NCT01831089|451120511|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
125408206|NCT01831089|451120512|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
125408207|NCT01831089|451120513|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
125408208|NCT01831089|451120514|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
125279432|NCT00066703|450648996|FG000|Overall Study|Adverse Event|80|||
125279433|NCT00066703|450648997|FG001|Overall Study|Adverse Event|111|||
125408209|NCT01831089|451120515|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
125408210|NCT01831089|451120510|FG000|Cohort B: Arm B|Progressive disease|0|||
125408211|NCT01831089|451120511|FG001|Cohort B: Arm B|Progressive disease|0|||
125408212|NCT01831089|451120512|FG002|Cohort B: Arm B|Progressive disease|0|||
125408213|NCT01831089|451120513|FG003|Cohort B: Arm B|Progressive disease|0|||
125408214|NCT01831089|451120514|FG004|Cohort B: Arm B|Progressive disease|0|||
125408215|NCT01831089|451120515|FG005|Cohort B: Arm B|Progressive disease|8|||
125408216|NCT01831089|451120510|FG000|Cohort B: Arm B|Physician Decision|0|||
125408217|NCT01831089|451120511|FG001|Cohort B: Arm B|Physician Decision|0|||
125408218|NCT01831089|451120512|FG002|Cohort B: Arm B|Physician Decision|0|||
125408219|NCT01831089|451120513|FG003|Cohort B: Arm B|Physician Decision|0|||
125408220|NCT01831089|451120514|FG004|Cohort B: Arm B|Physician Decision|0|||
125408221|NCT01831089|451120515|FG005|Cohort B: Arm B|Physician Decision|2|||
125408222|NCT01831089|451120510|FG000|Cohort B: Arm B|Never treated|0|||
125408223|NCT01831089|451120511|FG001|Cohort B: Arm B|Never treated|0|||
125408224|NCT01831089|451120512|FG002|Cohort B: Arm B|Never treated|0|||
125408225|NCT01831089|451120513|FG003|Cohort B: Arm B|Never treated|0|||
125408226|NCT01831089|451120514|FG004|Cohort B: Arm B|Never treated|0|||
125408227|NCT01831089|451120515|FG005|Cohort B: Arm B|Never treated|2|||
125408228|NCT01831089|451120510|FG000|Cohort B: Arm B|Adverse Event|0|||
125408229|NCT01831089|451120511|FG001|Cohort B: Arm B|Adverse Event|0|||
125408230|NCT01831089|451120512|FG002|Cohort B: Arm B|Adverse Event|0|||
125408231|NCT01831089|451120513|FG003|Cohort B: Arm B|Adverse Event|0|||
125408232|NCT01831089|451120514|FG004|Cohort B: Arm B|Adverse Event|0|||
125408233|NCT01831089|451120515|FG005|Cohort B: Arm B|Adverse Event|1|||
125279434|NCT00066703|450648996|FG000|Overall Study|Death|3|||
125279435|NCT00066703|450648997|FG001|Overall Study|Death|0|||
125279436|NCT00066703|450648996|FG000|Overall Study|Lack of Efficacy|114|||
125279437|NCT00066703|450648997|FG001|Overall Study|Lack of Efficacy|69|||
125279438|NCT00066703|450648996|FG000|Overall Study|Lost to Follow-up|31|||
125279439|NCT00066703|450648997|FG001|Overall Study|Lost to Follow-up|28|||
125279440|NCT00066703|450648996|FG000|Overall Study|Withdrawal by Subject|38|||
125279441|NCT00066703|450648997|FG001|Overall Study|Withdrawal by Subject|63|||
125279442|NCT00066703|450648996|FG000|Overall Study|Treatment ongoing|346|||
125279443|NCT00066703|450648997|FG001|Overall Study|Treatment ongoing|311|||
125279444|NCT01696968|450648998|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
125279445|NCT01696968|450648999|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
125279446|NCT01696968|450648998|FG000|Overall Study|Died Before Randomization|3|||
125279447|NCT01696968|450648999|FG001|Overall Study|Died Before Randomization|8|||
125279448|NCT01696968|450648998|FG000|Overall Study|Died Before ASU (Control)|278|||
125279449|NCT01696968|450648999|FG001|Overall Study|Died Before ASU (Control)|0|||
125279450|NCT01696968|450648998|FG000|Overall Study|Refused ASU (Control)|920|||
125279451|NCT01696968|450648999|FG001|Overall Study|Refused ASU (Control)|0|||
125279452|NCT01696968|450648998|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
125279453|NCT01696968|450648999|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
125279454|NCT05659719|450649000|FG000|Overall Study|At sponsor's request|0|||
125279455|NCT05659719|450649001|FG001|Overall Study|At sponsor's request|0|||
125279456|NCT05659719|450649002|FG002|Overall Study|At sponsor's request|0|||
125279457|NCT05659719|450649003|FG003|Overall Study|At sponsor's request|95|||
125279458|NCT05659719|450649000|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
125279459|NCT05659719|450649001|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
125279460|NCT05659719|450649002|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
125279461|NCT05659719|450649003|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
125279462|NCT05659719|450649000|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
125279463|NCT05659719|450649001|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
125279464|NCT05659719|450649002|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
125279465|NCT05659719|450649003|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
125279466|NCT05659719|450649000|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
125279467|NCT05659719|450649001|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
125279468|NCT05659719|450649002|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
125279469|NCT05659719|450649003|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
125279470|NCT05659719|450649000|FG000|Overall Study|Lost to Follow-up|0|||
125279471|NCT05659719|450649001|FG001|Overall Study|Lost to Follow-up|0|||
125279472|NCT05659719|450649002|FG002|Overall Study|Lost to Follow-up|0|||
125279473|NCT05659719|450649003|FG003|Overall Study|Lost to Follow-up|2|||
125279474|NCT05659719|450649000|FG000|Overall Study|Moved to another observational study|0|||
125279475|NCT05659719|450649001|FG001|Overall Study|Moved to another observational study|0|||
125279476|NCT05659719|450649002|FG002|Overall Study|Moved to another observational study|0|||
125279477|NCT05659719|450649003|FG003|Overall Study|Moved to another observational study|1|||
125279478|NCT05659719|450649000|FG000|Overall Study|The child was enrolled in an interventional study|0|||
125279479|NCT05659719|450649001|FG001|Overall Study|The child was enrolled in an interventional study|0|||
125279480|NCT05659719|450649002|FG002|Overall Study|The child was enrolled in an interventional study|0|||
125279481|NCT05659719|450649003|FG003|Overall Study|The child was enrolled in an interventional study|55|||
125279482|NCT05659719|450649000|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
125279483|NCT05659719|450649001|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
125279484|NCT05659719|450649002|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
125279485|NCT05659719|450649003|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
125279486|NCT05659719|450649000|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
125279487|NCT05659719|450649001|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
125279488|NCT05659719|450649002|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
125279489|NCT05659719|450649003|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
125279490|NCT01681186|450649004|FG000|Washout Period From Second Intervention|Adverse Event|0|||
125279491|NCT01681186|450649005|FG001|Washout Period From Second Intervention|Adverse Event|0|||
125279492|NCT01681186|450649006|FG002|Washout Period From Second Intervention|Adverse Event|0|||
125279493|NCT01681186|450649007|FG003|Washout Period From Second Intervention|Adverse Event|0|||
125279494|NCT01681186|450649008|FG004|Washout Period From Second Intervention|Adverse Event|0|||
125279495|NCT01681186|450649009|FG005|Washout Period From Second Intervention|Adverse Event|0|||
125279496|NCT01681186|450649010|FG006|Washout Period From Second Intervention|Adverse Event|1|||
125279497|NCT01681186|450649011|FG007|Washout Period From Second Intervention|Adverse Event|0|||
125408234|NCT01831089|451120510|FG000|Cohort B: Arm B|Global end of study|0|||
125408235|NCT01831089|451120511|FG001|Cohort B: Arm B|Global end of study|0|||
125408236|NCT01831089|451120512|FG002|Cohort B: Arm B|Global end of study|0|||
125408237|NCT01831089|451120513|FG003|Cohort B: Arm B|Global end of study|0|||
125408238|NCT01831089|451120514|FG004|Cohort B: Arm B|Global end of study|0|||
125408239|NCT01831089|451120515|FG005|Cohort B: Arm B|Global end of study|1|||
125408240|NCT00889421|451120516|FG000|Overall Study|Lack of Efficacy|3|||
125408241|NCT01958918|451120517|FG000|Overall Study|Death|1|||
125408242|NCT01958918|451120518|FG001|Overall Study|Death|3|||
125408243|NCT01958918|451120517|FG000|Overall Study|Lost to Follow-up|4|||
125408244|NCT01958918|451120518|FG001|Overall Study|Lost to Follow-up|7|||
125408245|NCT01958918|451120517|FG000|Overall Study|Withdrawal by Subject|13|||
125408246|NCT01958918|451120518|FG001|Overall Study|Withdrawal by Subject|8|||
125408247|NCT01958918|451120517|FG000|Overall Study|Lack of Efficacy|13|||
125408248|NCT01958918|451120518|FG001|Overall Study|Lack of Efficacy|10|||
125408249|NCT01958918|451120517|FG000|Overall Study|Adverse Event|12|||
125408250|NCT01958918|451120518|FG001|Overall Study|Adverse Event|12|||
125408251|NCT01958918|451120517|FG000|Overall Study|administrative problems|0|||
125408252|NCT01958918|451120518|FG001|Overall Study|administrative problems|2|||
125408253|NCT01925183|451120519|FG000|Overall Study|Adverse Event|1|||
125408254|NCT01925183|451120520|FG001|Overall Study|Adverse Event|0|||
125408255|NCT02114892|451120521|FG000|Overall Study|Lost to Follow-up|1|||
125408256|NCT02114892|451120522|FG001|Overall Study|Lost to Follow-up|2|||
125408257|NCT04327934|451120525|FG000|Overall Study|Did not qualify|7|||
125408258|NCT04327934|451120526|FG001|Overall Study|Did not qualify|4|||
125408259|NCT04327934|451120525|FG000|Overall Study|Physician Decision|0|||
125408260|NCT04327934|451120526|FG001|Overall Study|Physician Decision|1|||
125408261|NCT03783923|451120533|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
125408262|NCT03783923|451120534|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
125408263|NCT03783923|451120533|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
125408264|NCT03783923|451120534|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
125408265|NCT03783923|451120533|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
125408266|NCT03783923|451120534|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
125408267|NCT03783923|451120533|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
125408268|NCT03783923|451120534|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
125408269|NCT03783923|451120533|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
125408270|NCT03783923|451120534|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
125408271|NCT00061048|451120536|FG000|Overall Study|Adverse Event|2|||
125408272|NCT00061048|451120536|FG000|Overall Study|disease progression|20|||
125408273|NCT01431508|451120537|FG000|Overall Study|Lack of Efficacy|1|||
125408274|NCT01431508|451120537|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
125408275|NCT00023452|451120538|FG000|Overall Study|Ineligible for Study|163|||
125408276|NCT00023452|451120539|FG001|Overall Study|Ineligible for Study|159|||
125408277|NCT00023452|451120538|FG000|Overall Study|Out of Window|129|||
125408278|NCT00023452|451120539|FG001|Overall Study|Out of Window|69|||
125408279|NCT00023452|451120538|FG000|Overall Study|Death|2|||
125408280|NCT00023452|451120539|FG001|Overall Study|Death|0|||
125408281|NCT00023452|451120538|FG000|Overall Study|Withdrawal by Subject|66|||
125408282|NCT00023452|451120539|FG001|Overall Study|Withdrawal by Subject|54|||
125408283|NCT00023452|451120538|FG000|Overall Study|Adverse Event|139|||
125408284|NCT00023452|451120539|FG001|Overall Study|Adverse Event|196|||
125408285|NCT00023452|451120538|FG000|Overall Study|Lost to Follow-up|293|||
125408286|NCT00023452|451120539|FG001|Overall Study|Lost to Follow-up|60|||
125408287|NCT00023452|451120538|FG000|Overall Study|Physician Decision|49|||
125408288|NCT00023452|451120539|FG001|Overall Study|Physician Decision|21|||
125408289|NCT00023452|451120538|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
125408290|NCT00023452|451120539|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
125408291|NCT00023452|451120538|FG000|Overall Study|Pregnant|53|||
125408292|NCT00023452|451120539|FG001|Overall Study|Pregnant|20|||
125408293|NCT00023452|451120538|FG000|Overall Study|Other|204|||
125408294|NCT00023452|451120539|FG001|Overall Study|Other|69|||
125408295|NCT03483623|451120540|FG000|Overall Study|43 complete sets achieved|1|||
125408296|NCT02770391|451120541|FG000|Overall Study|Lost to Follow-up|2|||
125408297|NCT02770391|451120541|FG000|Overall Study|Withdrawal by Subject|1|||
125408298|NCT02770391|451120541|FG000|Overall Study|Surgery delayed unevaluable|2|||
125408299|NCT02770391|451120541|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
125408300|NCT02199691|451120542|FG000|Overall Study|Protocol Violation|3|||
125408301|NCT02199691|451120543|FG001|Overall Study|Protocol Violation|3|||
125408302|NCT02199691|451120544|FG002|Overall Study|Protocol Violation|6|||
125408303|NCT02199691|451120545|FG003|Overall Study|Protocol Violation|7|||
125408304|NCT02199691|451120542|FG000|Overall Study|Withdrawal by Subject|5|||
125408305|NCT02199691|451120543|FG001|Overall Study|Withdrawal by Subject|3|||
125408306|NCT02199691|451120544|FG002|Overall Study|Withdrawal by Subject|12|||
125408307|NCT02199691|451120545|FG003|Overall Study|Withdrawal by Subject|13|||
125408308|NCT02199691|451120542|FG000|Overall Study|Lost to Follow-up|2|||
125408309|NCT02199691|451120543|FG001|Overall Study|Lost to Follow-up|1|||
125408310|NCT02199691|451120544|FG002|Overall Study|Lost to Follow-up|9|||
125408311|NCT02199691|451120545|FG003|Overall Study|Lost to Follow-up|10|||
125408312|NCT00836875|451120551|FG000|Overall Study|Death|3|||
125408313|NCT00836875|451120552|FG001|Overall Study|Death|2|||
125408314|NCT00836875|451120551|FG000|Overall Study|Withdrawal by Subject|0|||
125408315|NCT00836875|451120552|FG001|Overall Study|Withdrawal by Subject|1|||
125408316|NCT03403634|451120555|FG000|Overall Study|Disease progression|3|||
125408317|NCT03403634|451120555|FG000|Overall Study|Did not meet eligibility criteria|4|||
125408318|NCT00428610|451120556|FG000|Overall Study|Death Due to Adverse Event|3|||
125408319|NCT00428610|451120557|FG001|Overall Study|Death Due to Adverse Event|0|||
125408320|NCT00428610|451120558|FG002|Overall Study|Death Due to Adverse Event|5|||
125408321|NCT00428610|451120556|FG000|Overall Study|Death Due to Progressive Disease|0|||
125408322|NCT00428610|451120557|FG001|Overall Study|Death Due to Progressive Disease|0|||
125408323|NCT00428610|451120558|FG002|Overall Study|Death Due to Progressive Disease|2|||
125408324|NCT00428610|451120556|FG000|Overall Study|Adverse Event|2|||
125408325|NCT00428610|451120557|FG001|Overall Study|Adverse Event|3|||
125408326|NCT00428610|451120558|FG002|Overall Study|Adverse Event|2|||
125408327|NCT00428610|451120556|FG000|Overall Study|Investigator Decision|2|||
125408328|NCT00428610|451120557|FG001|Overall Study|Investigator Decision|1|||
125408329|NCT00428610|451120558|FG002|Overall Study|Investigator Decision|1|||
125408330|NCT00428610|451120556|FG000|Overall Study|Progressive Disease|42|||
125408331|NCT00428610|451120557|FG001|Overall Study|Progressive Disease|14|||
125408332|NCT00428610|451120558|FG002|Overall Study|Progressive Disease|22|||
125408333|NCT00428610|451120556|FG000|Overall Study|Withdrawal by Subject|4|||
125408334|NCT00428610|451120557|FG001|Overall Study|Withdrawal by Subject|0|||
125408335|NCT00428610|451120558|FG002|Overall Study|Withdrawal by Subject|0|||
125408336|NCT04820673|451122550|FG000|Overall Study|Adverse Event|6|||
125408337|NCT04820673|451122550|FG000|Overall Study|Due to Lack of Effectiveness|1|||
125408338|NCT04820673|451122550|FG000|Overall Study|Pregnancy|1|||
125408339|NCT04820673|451122550|FG000|Overall Study|Voluntary Withdrawal|20|||
125408340|NCT04820673|451122550|FG000|Overall Study|Lost to Follow-up|10|||
125408341|NCT00587587|451122553|FG000|Overall Study|Lost to Follow-up|6|||
125408342|NCT00587587|451122554|FG001|Overall Study|Lost to Follow-up|1|||
125408343|NCT01075321|451122562|FG000|Overall Study|Withdrawal by Subject|0|||
125408344|NCT01075321|451122563|FG001|Overall Study|Withdrawal by Subject|0|||
125408345|NCT01075321|451122564|FG002|Overall Study|Withdrawal by Subject|1|||
125408346|NCT01075321|451122565|FG003|Overall Study|Withdrawal by Subject|1|||
125408347|NCT01075321|451122562|FG000|Overall Study|Protocol Violation|0|||
125408348|NCT01075321|451122563|FG001|Overall Study|Protocol Violation|0|||
125408349|NCT01075321|451122564|FG002|Overall Study|Protocol Violation|1|||
125408350|NCT01075321|451122565|FG003|Overall Study|Protocol Violation|0|||
125408351|NCT01075321|451122562|FG000|Overall Study|Treatment Incomplete due to progression|1|||
125408352|NCT01075321|451122563|FG001|Overall Study|Treatment Incomplete due to progression|0|||
125408353|NCT01075321|451122564|FG002|Overall Study|Treatment Incomplete due to progression|0|||
125408354|NCT01075321|451122565|FG003|Overall Study|Treatment Incomplete due to progression|0|||
125408355|NCT01075321|451122562|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
125408356|NCT01075321|451122563|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
125408357|NCT01075321|451122564|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
125408358|NCT01075321|451122565|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
125408359|NCT00633984|451122569|FG000|Overall Study|Lost to Follow-up|0|||
125408360|NCT00633984|451122570|FG001|Overall Study|Lost to Follow-up|6|||
125408361|NCT00633984|451122569|FG000|Overall Study|Withdrawal by Subject|8|||
125408362|NCT00633984|451122570|FG001|Overall Study|Withdrawal by Subject|7|||
125408363|NCT00633984|451122569|FG000|Overall Study|Hospitalized|1|||
125408364|NCT00633984|451122570|FG001|Overall Study|Hospitalized|0|||
125408365|NCT00097591|451122571|FG000|Overall Study|Withdrawal of consent|342|||
125408366|NCT00097591|451122572|FG001|Overall Study|Withdrawal of consent|323|||
125408367|NCT00097591|451122571|FG000|Overall Study|Less than 6 months on study drug|9|||
125408368|NCT00097591|451122572|FG001|Overall Study|Less than 6 months on study drug|7|||
125408369|NCT00097591|451122571|FG000|Overall Study|Unable to attend termination visit|53|||
125408370|NCT00097591|451122572|FG001|Overall Study|Unable to attend termination visit|51|||
125408371|NCT00097591|451122571|FG000|Overall Study|Lost to follow up|6|||
125408372|NCT00097591|451122572|FG001|Overall Study|Lost to follow up|10|||
125408373|NCT00097591|451122571|FG000|Overall Study|Other|0|||
125408374|NCT00097591|451122572|FG001|Overall Study|Other|3|||
125408375|NCT01557946|451122575|FG000|Overall Study|Adverse Event|3|||
125408376|NCT01557946|451122576|FG001|Overall Study|Adverse Event|0|||
125408377|NCT03586999|451122583|FG000|Overall Study|Lack of Efficacy|2|||
125408378|NCT04096560|451122584|FG000|Overall Study|Reason not Specified|1|||
125408379|NCT04096560|451122585|FG001|Overall Study|Reason not Specified|0|||
125408380|NCT04096560|451122586|FG002|Overall Study|Reason not Specified|0|||
125408381|NCT04096560|451122587|FG003|Overall Study|Reason not Specified|0|||
125408382|NCT04096560|451122588|FG004|Overall Study|Reason not Specified|1|||
125408383|NCT04096560|451122589|FG005|Overall Study|Reason not Specified|1|||
125408384|NCT04096560|451122590|FG006|Overall Study|Reason not Specified|1|||
125408385|NCT04096560|451122591|FG007|Overall Study|Reason not Specified|0|||
125408386|NCT04096560|451122584|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
125279498|NCT01681186|450649004|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
125279499|NCT01681186|450649005|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
125279500|NCT01681186|450649006|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
125279501|NCT01681186|450649007|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
125279502|NCT01681186|450649008|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
125279503|NCT01681186|450649009|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
125279504|NCT01681186|450649010|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
125279505|NCT01681186|450649011|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
125279506|NCT01681186|450649004|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279507|NCT01681186|450649005|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279508|NCT01681186|450649006|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279509|NCT01681186|450649007|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279510|NCT01681186|450649008|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279511|NCT01681186|450649009|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279512|NCT01681186|450649010|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
125279513|NCT01681186|450649011|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
125279514|NCT01681186|450649004|FG000|Fourth Intervention|Protocol Violation|0|||
125279515|NCT01681186|450649005|FG001|Fourth Intervention|Protocol Violation|0|||
125279516|NCT01681186|450649006|FG002|Fourth Intervention|Protocol Violation|0|||
125279517|NCT01681186|450649007|FG003|Fourth Intervention|Protocol Violation|0|||
125279518|NCT01681186|450649008|FG004|Fourth Intervention|Protocol Violation|0|||
125279519|NCT01681186|450649009|FG005|Fourth Intervention|Protocol Violation|0|||
125279520|NCT01681186|450649010|FG006|Fourth Intervention|Protocol Violation|0|||
125448318|NCT02179918|451268894|FG000|Overall Study|Subject refused further follow-up|0|||
125448319|NCT02179918|451268895|FG001|Overall Study|Subject refused further follow-up|1|||
125448320|NCT02179918|451268896|FG002|Overall Study|Subject refused further follow-up|0|||
125448321|NCT02179918|451268897|FG003|Overall Study|Subject refused further follow-up|0|||
125448322|NCT02179918|451268898|FG004|Overall Study|Subject refused further follow-up|1|||
125408387|NCT04096560|451122585|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
125408388|NCT04096560|451122586|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
125408389|NCT04096560|451122587|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
125408390|NCT04096560|451122588|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
125408391|NCT04096560|451122589|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
125408392|NCT04096560|451122590|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
125408393|NCT04096560|451122591|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
125408394|NCT04096560|451122584|FG000|Overall Study|Study Terminated by Sponsor|0|||
125408395|NCT04096560|451122585|FG001|Overall Study|Study Terminated by Sponsor|0|||
125408396|NCT04096560|451122586|FG002|Overall Study|Study Terminated by Sponsor|0|||
125408397|NCT04096560|451122587|FG003|Overall Study|Study Terminated by Sponsor|5|||
125408398|NCT04096560|451122588|FG004|Overall Study|Study Terminated by Sponsor|6|||
125408399|NCT04096560|451122589|FG005|Overall Study|Study Terminated by Sponsor|4|||
125408400|NCT04096560|451122590|FG006|Overall Study|Study Terminated by Sponsor|6|||
125408401|NCT04096560|451122591|FG007|Overall Study|Study Terminated by Sponsor|1|||
125408402|NCT04096560|451122584|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125408403|NCT04096560|451122585|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125408404|NCT04096560|451122586|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125408405|NCT04096560|451122587|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125408406|NCT04096560|451122588|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125408407|NCT04096560|451122589|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125408408|NCT04096560|451122590|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
125408409|NCT04096560|451122591|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
125408410|NCT02464969|451122592|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
125448323|NCT04537949|451268903|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
125448324|NCT04537949|451268904|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
125279521|NCT01681186|450649011|FG007|Fourth Intervention|Protocol Violation|1|||
125279522|NCT05160415|450649012|FG000|Overall Study|Withdrawal by Subject|3|||
125279523|NCT04848220|450649013|FG000|Overall Study|Unable to proceed to study procedure|0|||
125279524|NCT04848220|450649014|FG001|Overall Study|Unable to proceed to study procedure|1|||
125408411|NCT02464969|451122593|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
125408412|NCT02464969|451122592|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
125408413|NCT02464969|451122593|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
125408414|NCT02464969|451122592|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
125408415|NCT02464969|451122593|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
125408416|NCT02464969|451122592|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
125408417|NCT02464969|451122593|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
125448325|NCT04537949|451268905|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
125408418|NCT02464969|451122592|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
125408419|NCT02464969|451122593|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
125408420|NCT02464969|451122592|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
125408421|NCT02464969|451122593|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
125408422|NCT02464969|451122592|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
125408423|NCT02464969|451122593|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
125408424|NCT02464969|451122592|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
125408425|NCT02464969|451122593|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
125408426|NCT02464969|451122592|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
125279525|NCT04848220|450649015|FG002|Overall Study|Unable to proceed to study procedure|0|||
125279526|NCT04848220|450649013|FG000|Overall Study|Fractional flow not significant|0|||
125408427|NCT02464969|451122593|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
125408428|NCT02464969|451122592|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
125408429|NCT02464969|451122593|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
125408430|NCT02464969|451122592|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
125408431|NCT02464969|451122593|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
125408432|NCT00534352|451122594|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
125408433|NCT00534352|451122594|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
125408434|NCT00534352|451122594|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
125408435|NCT00534352|451122594|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
125408436|NCT00534352|451122594|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
125279527|NCT04848220|450649014|FG001|Overall Study|Fractional flow not significant|1|||
125279528|NCT04848220|450649015|FG002|Overall Study|Fractional flow not significant|0|||
125279529|NCT02923830|450649016|FG000|Overall Study|Physician Decision|13|||
125279530|NCT02923830|450649017|FG001|Overall Study|Physician Decision|15|||
125279531|NCT01751906|450649018|FG000|Overall Study|Lost to Follow-up|151|||
125279532|NCT01751906|450649019|FG001|Overall Study|Lost to Follow-up|68|||
125279533|NCT01751906|450649018|FG000|Overall Study|Withdrawal by Subject|22|||
125279534|NCT01751906|450649019|FG001|Overall Study|Withdrawal by Subject|18|||
125279535|NCT01751906|450649018|FG000|Overall Study|Physician Decision|5|||
125279536|NCT01751906|450649019|FG001|Overall Study|Physician Decision|2|||
125279537|NCT01751906|450649018|FG000|Overall Study|Death|84|||
125279538|NCT01751906|450649019|FG001|Overall Study|Death|43|||
125279539|NCT01751906|450649018|FG000|Overall Study|Denied on premises for follow-up by law|1|||
125279540|NCT01751906|450649019|FG001|Overall Study|Denied on premises for follow-up by law|0|||
125279541|NCT01110330|450649020|FG000|Overall Study|Adverse Event|0|||
125279542|NCT01110330|450649021|FG001|Overall Study|Adverse Event|4|||
125279543|NCT01110330|450649022|FG002|Overall Study|Adverse Event|3|||
125279544|NCT01110330|450649020|FG000|Overall Study|Lack of Efficacy|3|||
125279545|NCT01110330|450649021|FG001|Overall Study|Lack of Efficacy|1|||
125279546|NCT01110330|450649022|FG002|Overall Study|Lack of Efficacy|1|||
125279547|NCT01110330|450649020|FG000|Overall Study|Lost to Follow-up|9|||
125279548|NCT01110330|450649021|FG001|Overall Study|Lost to Follow-up|10|||
125279549|NCT01110330|450649022|FG002|Overall Study|Lost to Follow-up|15|||
125279550|NCT01110330|450649020|FG000|Overall Study|Physician Decision|0|||
125279551|NCT01110330|450649021|FG001|Overall Study|Physician Decision|1|||
125279552|NCT01110330|450649022|FG002|Overall Study|Physician Decision|0|||
125279553|NCT01110330|450649020|FG000|Overall Study|Protocol Violation|2|||
125279554|NCT01110330|450649021|FG001|Overall Study|Protocol Violation|0|||
125279555|NCT01110330|450649022|FG002|Overall Study|Protocol Violation|4|||
125279556|NCT01110330|450649020|FG000|Overall Study|Withdrawal by Subject|0|||
125279557|NCT01110330|450649021|FG001|Overall Study|Withdrawal by Subject|6|||
125279558|NCT01110330|450649022|FG002|Overall Study|Withdrawal by Subject|2|||
125279559|NCT01110330|450649020|FG000|Overall Study|Other|1|||
125279560|NCT01110330|450649021|FG001|Overall Study|Other|1|||
125279561|NCT01110330|450649022|FG002|Overall Study|Other|1|||
125279562|NCT02557100|450649031|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
125279563|NCT02557100|450649032|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
125279564|NCT02557100|450649033|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
125279565|NCT02557100|450649031|FG000|Single Blind Treatment Period|Death|0|||
125279566|NCT02557100|450649032|FG001|Single Blind Treatment Period|Death|1|||
125279567|NCT02557100|450649033|FG002|Single Blind Treatment Period|Death|0|||
125279568|NCT02557100|450649031|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
125279569|NCT02557100|450649032|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
125279570|NCT02557100|450649033|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
125279571|NCT02557100|450649031|FG000|Single Blind Treatment Period|Adverse Event|0|||
125408437|NCT00534352|451122594|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
125408438|NCT02399085|451122599|FG000|Overall Study|Adverse Event|16|||
125408439|NCT02399085|451122599|FG000|Overall Study|Death|2|||
125408440|NCT02399085|451122599|FG000|Overall Study|Withdrawal by Subject|8|||
125408441|NCT02399085|451122599|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
125279572|NCT02557100|450649032|FG001|Single Blind Treatment Period|Adverse Event|1|||
125408442|NCT02399085|451122599|FG000|Overall Study|Physician Decision|5|||
125408443|NCT00833924|451122600|FG000|Overall Study|Death|21|||
125408444|NCT00833924|451122600|FG000|Overall Study|Conversion|2|||
125408445|NCT00833924|451122600|FG000|Overall Study|Lost to Follow-up|2|||
125408446|NCT00833924|451122600|FG000|Overall Study|Withdrawal by Subject|13|||
125408447|NCT00833924|451122600|FG000|Overall Study|In study follow-up|71|||
125408448|NCT01485861|451122601|FG000|Phase Ib|Death|1|||
125408449|NCT01485861|451122602|FG001|Phase Ib|Death|0|||
125408450|NCT01485861|451122603|FG002|Phase Ib|Death|0|||
125408451|NCT01485861|451122604|FG003|Phase Ib|Death|0|||
125408452|NCT01485861|451122605|FG004|Phase Ib|Death|0|||
125408453|NCT01485861|451122606|FG005|Phase Ib|Death|0|||
125408454|NCT01485861|451122601|FG000|Phase Ib|Physician Decision|1|||
125408455|NCT01485861|451122602|FG001|Phase Ib|Physician Decision|1|||
125408456|NCT01485861|451122603|FG002|Phase Ib|Physician Decision|0|||
125408457|NCT01485861|451122604|FG003|Phase Ib|Physician Decision|0|||
125408458|NCT01485861|451122605|FG004|Phase Ib|Physician Decision|0|||
125408459|NCT01485861|451122606|FG005|Phase Ib|Physician Decision|0|||
125408460|NCT01485861|451122601|FG000|Phase Ib|Adverse Event|0|||
125408461|NCT01485861|451122602|FG001|Phase Ib|Adverse Event|4|||
125408462|NCT01485861|451122603|FG002|Phase Ib|Adverse Event|0|||
125408463|NCT01485861|451122604|FG003|Phase Ib|Adverse Event|0|||
125408464|NCT01485861|451122605|FG004|Phase Ib|Adverse Event|0|||
125408465|NCT01485861|451122606|FG005|Phase Ib|Adverse Event|0|||
125408466|NCT01485861|451122601|FG000|Phase Ib|Progression of disease|5|||
125408467|NCT01485861|451122602|FG001|Phase Ib|Progression of disease|0|||
125408468|NCT01485861|451122603|FG002|Phase Ib|Progression of disease|0|||
125408469|NCT01485861|451122604|FG003|Phase Ib|Progression of disease|0|||
125408470|NCT01485861|451122605|FG004|Phase Ib|Progression of disease|0|||
125408471|NCT01485861|451122606|FG005|Phase Ib|Progression of disease|0|||
125408472|NCT01485861|451122601|FG000|Phase Ib|Other|3|||
125408473|NCT01485861|451122602|FG001|Phase Ib|Other|0|||
125408474|NCT01485861|451122603|FG002|Phase Ib|Other|0|||
125408475|NCT01485861|451122604|FG003|Phase Ib|Other|0|||
125408476|NCT01485861|451122605|FG004|Phase Ib|Other|0|||
125408477|NCT01485861|451122606|FG005|Phase Ib|Other|0|||
125408478|NCT01485861|451122601|FG000|Phase Ib|Withdrawal by Subject|4|||
125408479|NCT01485861|451122602|FG001|Phase Ib|Withdrawal by Subject|1|||
125408480|NCT01485861|451122603|FG002|Phase Ib|Withdrawal by Subject|0|||
125408481|NCT01485861|451122604|FG003|Phase Ib|Withdrawal by Subject|0|||
125408482|NCT01485861|451122605|FG004|Phase Ib|Withdrawal by Subject|0|||
125408483|NCT01485861|451122606|FG005|Phase Ib|Withdrawal by Subject|0|||
125408484|NCT01485861|451122601|FG000|Phase II|Death|0|||
125408485|NCT01485861|451122602|FG001|Phase II|Death|0|||
125408486|NCT01485861|451122603|FG002|Phase II|Death|67|||
125408487|NCT01485861|451122604|FG003|Phase II|Death|71|||
125408488|NCT01485861|451122605|FG004|Phase II|Death|68|||
125408489|NCT01485861|451122606|FG005|Phase II|Death|0|||
125408490|NCT01485861|451122601|FG000|Phase II|Progression of Disease|0|||
125408491|NCT01485861|451122602|FG001|Phase II|Progression of Disease|0|||
125408492|NCT01485861|451122603|FG002|Phase II|Progression of Disease|1|||
125408493|NCT01485861|451122604|FG003|Phase II|Progression of Disease|0|||
125408494|NCT01485861|451122605|FG004|Phase II|Progression of Disease|0|||
125408495|NCT01485861|451122606|FG005|Phase II|Progression of Disease|0|||
125408496|NCT01485861|451122601|FG000|Phase II|Other|0|||
125408497|NCT01485861|451122602|FG001|Phase II|Other|0|||
125408498|NCT01485861|451122603|FG002|Phase II|Other|0|||
125408499|NCT01485861|451122604|FG003|Phase II|Other|1|||
125408500|NCT01485861|451122605|FG004|Phase II|Other|0|||
125408501|NCT01485861|451122606|FG005|Phase II|Other|0|||
125408502|NCT01485861|451122601|FG000|Phase II|Withdrawal by Subject|0|||
125408503|NCT01485861|451122602|FG001|Phase II|Withdrawal by Subject|0|||
125408504|NCT01485861|451122603|FG002|Phase II|Withdrawal by Subject|6|||
125408505|NCT01485861|451122604|FG003|Phase II|Withdrawal by Subject|3|||
125408506|NCT01485861|451122605|FG004|Phase II|Withdrawal by Subject|4|||
125408507|NCT01485861|451122606|FG005|Phase II|Withdrawal by Subject|0|||
125408508|NCT01485861|451122601|FG000|Phase II|Lost to Follow-up|0|||
125408509|NCT01485861|451122602|FG001|Phase II|Lost to Follow-up|0|||
125279573|NCT02557100|450649033|FG002|Single Blind Treatment Period|Adverse Event|0|||
125279574|NCT02557100|450649031|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
125408510|NCT01485861|451122603|FG002|Phase II|Lost to Follow-up|2|||
125408511|NCT01485861|451122604|FG003|Phase II|Lost to Follow-up|3|||
125408512|NCT01485861|451122605|FG004|Phase II|Lost to Follow-up|5|||
125408513|NCT01485861|451122606|FG005|Phase II|Lost to Follow-up|0|||
125408514|NCT01485861|451122601|FG000|Phase II|Study Ended|0|||
125408515|NCT01485861|451122602|FG001|Phase II|Study Ended|0|||
125408516|NCT01485861|451122603|FG002|Phase II|Study Ended|7|||
125408517|NCT01485861|451122604|FG003|Phase II|Study Ended|8|||
125408518|NCT01485861|451122605|FG004|Phase II|Study Ended|6|||
125408519|NCT01485861|451122606|FG005|Phase II|Study Ended|0|||
125408520|NCT01485861|451122601|FG000|Safety Phase|Death|0|||
125408521|NCT01485861|451122602|FG001|Safety Phase|Death|0|||
125408522|NCT01485861|451122603|FG002|Safety Phase|Death|0|||
125408523|NCT01485861|451122604|FG003|Safety Phase|Death|0|||
125408524|NCT01485861|451122605|FG004|Safety Phase|Death|0|||
125408525|NCT01485861|451122606|FG005|Safety Phase|Death|2|||
125408526|NCT01485861|451122601|FG000|Safety Phase|Adverse Event|0|||
125408527|NCT01485861|451122602|FG001|Safety Phase|Adverse Event|0|||
125408528|NCT01485861|451122603|FG002|Safety Phase|Adverse Event|0|||
125408529|NCT01485861|451122604|FG003|Safety Phase|Adverse Event|0|||
125408530|NCT01485861|451122605|FG004|Safety Phase|Adverse Event|0|||
125408531|NCT01485861|451122606|FG005|Safety Phase|Adverse Event|1|||
125408532|NCT01485861|451122601|FG000|Safety Phase|Other|0|||
125408533|NCT01485861|451122602|FG001|Safety Phase|Other|0|||
125408534|NCT01485861|451122603|FG002|Safety Phase|Other|0|||
125408535|NCT01485861|451122604|FG003|Safety Phase|Other|0|||
125408536|NCT01485861|451122605|FG004|Safety Phase|Other|0|||
125408537|NCT01485861|451122606|FG005|Safety Phase|Other|5|||
125408538|NCT01485861|451122601|FG000|Safety Phase|Progression of Disease|0|||
125408539|NCT01485861|451122602|FG001|Safety Phase|Progression of Disease|0|||
125408540|NCT01485861|451122603|FG002|Safety Phase|Progression of Disease|0|||
125408541|NCT01485861|451122604|FG003|Safety Phase|Progression of Disease|0|||
125408542|NCT01485861|451122605|FG004|Safety Phase|Progression of Disease|0|||
125408543|NCT01485861|451122606|FG005|Safety Phase|Progression of Disease|9|||
125408544|NCT01485861|451122601|FG000|Safety Phase|Withdrawal by Subject|0|||
125408545|NCT01485861|451122602|FG001|Safety Phase|Withdrawal by Subject|0|||
125408546|NCT01485861|451122603|FG002|Safety Phase|Withdrawal by Subject|0|||
125408547|NCT01485861|451122604|FG003|Safety Phase|Withdrawal by Subject|0|||
125408548|NCT01485861|451122605|FG004|Safety Phase|Withdrawal by Subject|0|||
125408549|NCT01485861|451122606|FG005|Safety Phase|Withdrawal by Subject|6|||
125408550|NCT01485861|451122601|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
125408551|NCT01485861|451122602|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
125408552|NCT01485861|451122603|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
125408553|NCT01485861|451122604|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
125408554|NCT01485861|451122605|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
125408555|NCT01485861|451122606|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
125408556|NCT04796610|451122611|FG000|Overall Study|Withdrawal by Subject|1|||
125408557|NCT04796610|451122612|FG001|Overall Study|Withdrawal by Subject|0|||
125408558|NCT04796610|451122613|FG002|Overall Study|Withdrawal by Subject|0|||
125408559|NCT04796610|451122614|FG003|Overall Study|Withdrawal by Subject|0|||
125408560|NCT04796610|451122611|FG000|Overall Study|Lost to Follow-up|2|||
125408561|NCT04796610|451122612|FG001|Overall Study|Lost to Follow-up|0|||
125408562|NCT04796610|451122613|FG002|Overall Study|Lost to Follow-up|1|||
125408563|NCT04796610|451122614|FG003|Overall Study|Lost to Follow-up|1|||
125408564|NCT02059148|451122615|FG000|Treatment 1|Protocol Violation|0|||
125408565|NCT02059148|451122616|FG001|Treatment 1|Protocol Violation|0|||
125408566|NCT02059148|451122617|FG002|Treatment 1|Protocol Violation|0|||
125408567|NCT02059148|451122618|FG003|Treatment 1|Protocol Violation|0|||
125408568|NCT02059148|451122619|FG004|Treatment 1|Protocol Violation|0|||
125408569|NCT02059148|451122620|FG005|Treatment 1|Protocol Violation|1|||
125408570|NCT00403546|451122626|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
125408571|NCT00403546|451122627|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
125408572|NCT00403546|451122628|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
125408573|NCT00403546|451122626|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
125408574|NCT00403546|451122627|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
125408575|NCT00403546|451122628|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
125408576|NCT00403546|451122626|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
125408577|NCT00403546|451122627|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
125408578|NCT00403546|451122628|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
125408579|NCT00403546|451122626|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
125408580|NCT00403546|451122627|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
125408581|NCT00403546|451122628|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
125408582|NCT00403546|451122626|FG000|Screening Phase|Screening Failure|22|||
125408583|NCT00403546|451122627|FG001|Screening Phase|Screening Failure|0|||
125408584|NCT00403546|451122628|FG002|Screening Phase|Screening Failure|0|||
125408585|NCT00403546|451122626|FG000|Screening Phase|Adverse Event|1|||
125408586|NCT00403546|451122627|FG001|Screening Phase|Adverse Event|0|||
125408587|NCT00403546|451122628|FG002|Screening Phase|Adverse Event|0|||
125408588|NCT00403546|451122626|FG000|Screening Phase|Terminated Prior to Randomization|5|||
125408589|NCT00403546|451122627|FG001|Screening Phase|Terminated Prior to Randomization|0|||
125408590|NCT00403546|451122628|FG002|Screening Phase|Terminated Prior to Randomization|0|||
125408591|NCT00403546|451122626|FG000|Randomized Trial|Early Terminations|0|||
125408592|NCT00403546|451122627|FG001|Randomized Trial|Early Terminations|17|||
125408593|NCT00403546|451122628|FG002|Randomized Trial|Early Terminations|16|||
125408594|NCT02673697|451122629|FG000|Overall Study|Adverse Event|2|||
125408595|NCT02673697|451122630|FG001|Overall Study|Adverse Event|0|||
125408596|NCT02673697|451122629|FG000|Overall Study|Death|32|||
125408597|NCT02673697|451122630|FG001|Overall Study|Death|24|||
125408598|NCT02673697|451122629|FG000|Overall Study|Lost to Follow-up|5|||
125408599|NCT02673697|451122630|FG001|Overall Study|Lost to Follow-up|2|||
125408600|NCT02673697|451122629|FG000|Overall Study|Physician Decision|2|||
125408601|NCT02673697|451122630|FG001|Overall Study|Physician Decision|1|||
125408602|NCT02673697|451122629|FG000|Overall Study|Withdrawal by Subject|10|||
125408603|NCT02673697|451122630|FG001|Overall Study|Withdrawal by Subject|7|||
125408604|NCT02673697|451122629|FG000|Overall Study|Change subj medical status|1|||
125408605|NCT02673697|451122630|FG001|Overall Study|Change subj medical status|2|||
125408606|NCT02673697|451122629|FG000|Overall Study|Explant|10|||
125408607|NCT02673697|451122630|FG001|Overall Study|Explant|5|||
125408608|NCT02673697|451122629|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
125408609|NCT02673697|451122630|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
125408610|NCT00437489|451122631|FG000|Overall Study|Study terminated by sponsor|23|||
125408611|NCT00437489|451122632|FG001|Overall Study|Study terminated by sponsor|21|||
125408612|NCT00437489|451122631|FG000|Overall Study|Lost to Follow-up|0|||
125408613|NCT00437489|451122632|FG001|Overall Study|Lost to Follow-up|1|||
125408614|NCT03893448|451122638|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
125408615|NCT03893448|451122639|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
125408616|NCT03893448|451122638|FG000|Overall Study|Physician Decision|8|||
125408617|NCT03893448|451122639|FG001|Overall Study|Physician Decision|14|||
125408618|NCT03893448|451122638|FG000|Overall Study|Lost to Follow-up|34|||
125408619|NCT03893448|451122639|FG001|Overall Study|Lost to Follow-up|27|||
125408620|NCT03893448|451122638|FG000|Overall Study|Death|1|||
125408621|NCT03893448|451122639|FG001|Overall Study|Death|0|||
125408622|NCT05061446|451122647|FG000|Overall Study|Adverse Event|2|||
125408623|NCT05061446|451122648|FG001|Overall Study|Adverse Event|0|||
125408624|NCT05061446|451122649|FG002|Overall Study|Adverse Event|0|||
125408625|NCT05061446|451122647|FG000|Overall Study|Participant no longer available due to personal reason|0|||
125408626|NCT05061446|451122648|FG001|Overall Study|Participant no longer available due to personal reason|1|||
125408627|NCT05061446|451122649|FG002|Overall Study|Participant no longer available due to personal reason|0|||
125408628|NCT03880578|451122650|FG000|Overall Study|Withdrawal by Subject|0|||
125408629|NCT03880578|451122651|FG001|Overall Study|Withdrawal by Subject|3|||
125408630|NCT03880578|451122652|FG002|Overall Study|Withdrawal by Subject|1|||
125408631|NCT03880578|451122650|FG000|Overall Study|Death|0|||
125408632|NCT03880578|451122651|FG001|Overall Study|Death|1|||
125408633|NCT03880578|451122652|FG002|Overall Study|Death|0|||
125408634|NCT04934670|451122653|FG000|Overall Study|Death|4|||
125408635|NCT04934670|451122654|FG001|Overall Study|Death|0|||
125408636|NCT04934670|451122653|FG000|Overall Study|Lost to Follow-up|1|||
125408637|NCT04934670|451122654|FG001|Overall Study|Lost to Follow-up|4|||
125408638|NCT02041429|451122659|FG000|Overall Study|Progressive Disease|2|||
125408639|NCT02041429|451122660|FG001|Overall Study|Progressive Disease|2|||
125408640|NCT02041429|451122661|FG002|Overall Study|Progressive Disease|3|||
125408641|NCT02041429|451122662|FG003|Overall Study|Progressive Disease|2|||
125408642|NCT02041429|451122659|FG000|Overall Study|Toxicity|0|||
125408643|NCT02041429|451122660|FG001|Overall Study|Toxicity|1|||
125408644|NCT02041429|451122661|FG002|Overall Study|Toxicity|4|||
125408645|NCT02041429|451122662|FG003|Overall Study|Toxicity|2|||
125408646|NCT02041429|451122659|FG000|Overall Study|Withdrawal by Subject|0|||
125408647|NCT02041429|451122660|FG001|Overall Study|Withdrawal by Subject|1|||
125408648|NCT02041429|451122661|FG002|Overall Study|Withdrawal by Subject|0|||
125408649|NCT02041429|451122662|FG003|Overall Study|Withdrawal by Subject|0|||
125408650|NCT02041429|451122659|FG000|Overall Study|On Maintenance Therapy|1|||
125408651|NCT02041429|451122660|FG001|Overall Study|On Maintenance Therapy|0|||
125408652|NCT02041429|451122661|FG002|Overall Study|On Maintenance Therapy|0|||
125408653|NCT02041429|451122662|FG003|Overall Study|On Maintenance Therapy|2|||
125408654|NCT00861341|451122663|FG000|Overall Study|Withdrawal by Subject|2|||
125408655|NCT03299192|451122664|FG000|Overall Study|Fell before classes started|1|||
125448326|NCT04537949|451268906|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
125408656|NCT03299192|451122665|FG001|Overall Study|Fell before classes started|0|||
125408657|NCT03299192|451122666|FG002|Overall Study|Fell before classes started|0|||
125408658|NCT03299192|451122664|FG000|Overall Study|Other|0|||
125408659|NCT03299192|451122665|FG001|Overall Study|Other|2|||
125408660|NCT03299192|451122666|FG002|Overall Study|Other|1|||
125408661|NCT01418209|451122667|FG000|Overall Study|Withdrawal by Subject|1|||
125408662|NCT01418209|451122668|FG001|Overall Study|Withdrawal by Subject|0|||
125448327|NCT04537949|451268907|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
125408663|NCT01418209|451122669|FG002|Overall Study|Withdrawal by Subject|1|||
125408664|NCT01418209|451122667|FG000|Overall Study|Did not provide hot flash diary data|1|||
125408665|NCT01418209|451122668|FG001|Overall Study|Did not provide hot flash diary data|3|||
125408666|NCT01418209|451122669|FG002|Overall Study|Did not provide hot flash diary data|3|||
125408667|NCT01916304|451122674|FG000|Overall Study|Screening failure|17|||
125408668|NCT02460198|451122676|FG000|Overall Study|Adverse Event|1|||
125408669|NCT02460198|451122677|FG001|Overall Study|Adverse Event|3|||
125408670|NCT02460198|451122676|FG000|Overall Study|Death|36|||
125408671|NCT02460198|451122677|FG001|Overall Study|Death|28|||
125408672|NCT02460198|451122676|FG000|Overall Study|Lost to Follow-up|1|||
125408673|NCT02460198|451122677|FG001|Overall Study|Lost to Follow-up|1|||
125408674|NCT02460198|451122676|FG000|Overall Study|Transferred to Extension Study|15|||
125408675|NCT02460198|451122677|FG001|Overall Study|Transferred to Extension Study|15|||
125408676|NCT02460198|451122676|FG000|Overall Study|Withdrawal by Subject|2|||
125408677|NCT02460198|451122677|FG001|Overall Study|Withdrawal by Subject|4|||
125408678|NCT02460198|451122676|FG000|Overall Study|Site Terminated By Sponsor|0|||
125408679|NCT02460198|451122677|FG001|Overall Study|Site Terminated By Sponsor|1|||
125408680|NCT02460198|451122676|FG000|Overall Study|Did Not Continue on Extension Study|6|||
125408681|NCT02460198|451122677|FG001|Overall Study|Did Not Continue on Extension Study|11|||
125408682|NCT04382612|451122678|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
125408683|NCT04666441|451122679|FG000|Overall Study|Lost to Follow-up|1|||
125408684|NCT04666441|451122680|FG001|Overall Study|Lost to Follow-up|4|||
125408685|NCT04666441|451122681|FG002|Overall Study|Lost to Follow-up|1|||
125408686|NCT04666441|451122682|FG003|Overall Study|Lost to Follow-up|3|||
125408687|NCT04666441|451122683|FG004|Overall Study|Lost to Follow-up|0|||
125408688|NCT04666441|451122684|FG005|Overall Study|Lost to Follow-up|2|||
125408689|NCT04666441|451122685|FG006|Overall Study|Lost to Follow-up|2|||
125408690|NCT04666441|451122686|FG007|Overall Study|Lost to Follow-up|2|||
125408691|NCT04666441|451122679|FG000|Overall Study|Subject Decision|1|||
125408692|NCT04666441|451122680|FG001|Overall Study|Subject Decision|1|||
125408693|NCT04666441|451122681|FG002|Overall Study|Subject Decision|3|||
125408694|NCT04666441|451122682|FG003|Overall Study|Subject Decision|1|||
125408695|NCT04666441|451122683|FG004|Overall Study|Subject Decision|0|||
125408696|NCT04666441|451122684|FG005|Overall Study|Subject Decision|1|||
125408697|NCT04666441|451122685|FG006|Overall Study|Subject Decision|3|||
125408698|NCT04666441|451122686|FG007|Overall Study|Subject Decision|2|||
125408699|NCT03149328|451122687|FG000|Overall Study|Withdrawal by Subject|30|||
125408700|NCT03149328|451122688|FG001|Overall Study|Withdrawal by Subject|26|||
125408701|NCT03149328|451122687|FG000|Overall Study|Changed Dialysis Modality|18|||
125408702|NCT03149328|451122688|FG001|Overall Study|Changed Dialysis Modality|1|||
125408703|NCT03149328|451122687|FG000|Overall Study|Transplant|9|||
125408704|NCT03149328|451122688|FG001|Overall Study|Transplant|1|||
125408705|NCT03149328|451122687|FG000|Overall Study|Lost to Follow-up|25|||
125408706|NCT03149328|451122688|FG001|Overall Study|Lost to Follow-up|16|||
125408707|NCT03149328|451122687|FG000|Overall Study|Left Study Site|1|||
125408708|NCT03149328|451122688|FG001|Overall Study|Left Study Site|2|||
125408709|NCT03149328|451122687|FG000|Overall Study|Language Barrier|1|||
125408710|NCT03149328|451122688|FG001|Overall Study|Language Barrier|0|||
125408711|NCT00813761|451122689|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
125408712|NCT00813761|451122690|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
125408713|NCT00813761|451122691|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
125408714|NCT00813761|451122692|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
125408715|NCT00813761|451122689|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
125408716|NCT00813761|451122690|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
125408717|NCT00813761|451122691|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
125408718|NCT00813761|451122692|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
125408719|NCT00813761|451122689|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
125408720|NCT00813761|451122690|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
125408721|NCT00813761|451122691|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
125408722|NCT00813761|451122692|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
125408723|NCT00813761|451122689|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
125408724|NCT00813761|451122690|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
125408725|NCT00813761|451122691|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
125408726|NCT00813761|451122692|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
125408727|NCT00813761|451122689|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
125408728|NCT00813761|451122690|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
125408729|NCT00813761|451122691|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
125408730|NCT00813761|451122692|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
125408731|NCT00813761|451122689|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
125408732|NCT00813761|451122690|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
125408733|NCT00813761|451122691|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
125408734|NCT00813761|451122692|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
125408735|NCT00813761|451122689|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
125408736|NCT00813761|451122690|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
125408737|NCT00813761|451122691|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
125448328|NCT04537949|451268908|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
125279575|NCT02557100|450649032|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
125448329|NCT04537949|451268909|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
125408738|NCT00813761|451122692|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
125408739|NCT00813761|451122689|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
125408740|NCT00813761|451122690|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
125408741|NCT00813761|451122691|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
125408742|NCT00813761|451122692|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
125408743|NCT00813761|451122689|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
125408744|NCT00813761|451122690|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
125408745|NCT00813761|451122691|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
125408746|NCT00813761|451122692|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
125408747|NCT00813761|451122689|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
125408748|NCT00813761|451122690|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
125408749|NCT00813761|451122691|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
125408750|NCT00813761|451122692|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
125408751|NCT00813761|451122689|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
125408752|NCT00813761|451122690|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
125408753|NCT00813761|451122691|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
125408754|NCT00813761|451122692|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
125408755|NCT00813761|451122689|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
125408756|NCT00813761|451122690|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
125408757|NCT00813761|451122691|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
125408758|NCT00813761|451122692|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
125408759|NCT01328002|451122693|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
125408760|NCT01328002|451122694|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
125408761|NCT01328002|451122693|FG000|Open-Label Period|Adverse Event|8|||
125408762|NCT01328002|451122694|FG001|Open-Label Period|Adverse Event|0|||
125408763|NCT01328002|451122693|FG000|Open-Label Period|Lack of Efficacy|3|||
125408764|NCT01328002|451122694|FG001|Open-Label Period|Lack of Efficacy|0|||
125408765|NCT01328002|451122693|FG000|Open-Label Period|Protocol Violation|2|||
125408766|NCT01328002|451122694|FG001|Open-Label Period|Protocol Violation|0|||
125408767|NCT01328002|451122693|FG000|Open-Label Period|Withdrawal by Subject|9|||
125408768|NCT01328002|451122694|FG001|Open-Label Period|Withdrawal by Subject|0|||
125408769|NCT01328002|451122693|FG000|Open-Label Period|Lost to Follow-up|6|||
125408770|NCT01328002|451122694|FG001|Open-Label Period|Lost to Follow-up|0|||
125408771|NCT01328002|451122693|FG000|Open-Label Period|Other Reason|2|||
125408772|NCT01328002|451122694|FG001|Open-Label Period|Other Reason|0|||
125408773|NCT01328002|451122693|FG000|Double-Blind Period|Adverse Event|1|||
125408774|NCT01328002|451122694|FG001|Double-Blind Period|Adverse Event|0|||
125408775|NCT01328002|451122693|FG000|Double-Blind Period|Lack of Efficacy|1|||
125279576|NCT02557100|450649033|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
125279577|NCT02557100|450649031|FG000|Cumulative Abatacept Period|Other Reasons|0|||
125279578|NCT02557100|450649032|FG001|Cumulative Abatacept Period|Other Reasons|0|||
125279579|NCT02557100|450649033|FG002|Cumulative Abatacept Period|Other Reasons|1|||
125279580|NCT02557100|450649031|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
125279581|NCT02557100|450649032|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
125279582|NCT02557100|450649033|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
125279583|NCT02557100|450649031|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
125279584|NCT02557100|450649032|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
125279585|NCT02557100|450649033|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
125279586|NCT00510718|450649036|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
125279587|NCT00510718|450649037|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
125279588|NCT00510718|450649036|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
125279589|NCT00510718|450649037|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
125279590|NCT00510718|450649036|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
125279591|NCT00510718|450649037|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
125279592|NCT00510718|450649036|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
125279593|NCT00510718|450649037|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
125279594|NCT00510718|450649036|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
125279595|NCT00510718|450649037|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
125279596|NCT00510718|450649036|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
125279597|NCT00510718|450649037|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
125279598|NCT02150057|450649047|FG000|Overall Study|Lost to Follow-up|6|||
125279599|NCT02150057|450649048|FG001|Overall Study|Lost to Follow-up|4|||
125279600|NCT00489424|450649049|FG000|Overall Study|Adverse Event|3|||
125279601|NCT00489424|450649050|FG001|Overall Study|Adverse Event|3|||
125279602|NCT00489424|450649051|FG002|Overall Study|Adverse Event|4|||
125279603|NCT00489424|450649049|FG000|Overall Study|Lack of Efficacy|1|||
125279604|NCT00489424|450649050|FG001|Overall Study|Lack of Efficacy|0|||
125279605|NCT00489424|450649051|FG002|Overall Study|Lack of Efficacy|0|||
125279606|NCT00489424|450649049|FG000|Overall Study|Administrative problems|0|||
125279607|NCT00489424|450649050|FG001|Overall Study|Administrative problems|2|||
125279608|NCT00489424|450649051|FG002|Overall Study|Administrative problems|1|||
125279609|NCT00394251|450649052|FG000|Overall Study|Adverse Event|7|||
125279610|NCT00394251|450649053|FG001|Overall Study|Adverse Event|5|||
125279611|NCT00394251|450649052|FG000|Overall Study|Unacceptable Toxicity|20|||
125279612|NCT00394251|450649053|FG001|Overall Study|Unacceptable Toxicity|18|||
125279613|NCT00394251|450649052|FG000|Overall Study|Physician Decision|1|||
125279614|NCT00394251|450649053|FG001|Overall Study|Physician Decision|1|||
125279615|NCT00394251|450649052|FG000|Overall Study|Protocol Violation|0|||
125279616|NCT00394251|450649053|FG001|Overall Study|Protocol Violation|1|||
125279617|NCT00394251|450649052|FG000|Overall Study|Withdrawal by Subject|7|||
125279618|NCT00394251|450649053|FG001|Overall Study|Withdrawal by Subject|11|||
125279619|NCT00394251|450649052|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
125408776|NCT01328002|451122694|FG001|Double-Blind Period|Lack of Efficacy|0|||
125408777|NCT00691210|451122695|FG000|Overall Study|Progression of Disease|0|||
125408778|NCT00691210|451122696|FG001|Overall Study|Progression of Disease|0|||
125408779|NCT00691210|451122697|FG002|Overall Study|Progression of Disease|0|||
125408780|NCT00691210|451122698|FG003|Overall Study|Progression of Disease|2|||
125408781|NCT00691210|451122699|FG004|Overall Study|Progression of Disease|0|||
125408782|NCT00691210|451122700|FG005|Overall Study|Progression of Disease|0|||
125408783|NCT00691210|451122701|FG006|Overall Study|Progression of Disease|0|||
125408784|NCT00691210|451122702|FG007|Overall Study|Progression of Disease|0|||
125408785|NCT00691210|451122695|FG000|Overall Study|Lack of Efficacy|0|||
125408786|NCT00691210|451122696|FG001|Overall Study|Lack of Efficacy|0|||
125408787|NCT00691210|451122697|FG002|Overall Study|Lack of Efficacy|0|||
125408788|NCT00691210|451122698|FG003|Overall Study|Lack of Efficacy|1|||
125408789|NCT00691210|451122699|FG004|Overall Study|Lack of Efficacy|0|||
125408790|NCT00691210|451122700|FG005|Overall Study|Lack of Efficacy|1|||
125408791|NCT00691210|451122701|FG006|Overall Study|Lack of Efficacy|0|||
125408792|NCT00691210|451122702|FG007|Overall Study|Lack of Efficacy|0|||
125408793|NCT01208233|451122703|FG000|Overall Study|Adverse Event|0|||
125408794|NCT01208233|451122704|FG001|Overall Study|Adverse Event|1|||
125408795|NCT01208233|451122705|FG002|Overall Study|Adverse Event|2|||
125408796|NCT01208233|451122706|FG003|Overall Study|Adverse Event|0|||
125408797|NCT01208233|451122707|FG004|Overall Study|Adverse Event|3|||
125408798|NCT01208233|451122708|FG005|Overall Study|Adverse Event|5|||
125408799|NCT01208233|451122703|FG000|Overall Study|Death|0|||
125408800|NCT01208233|451122704|FG001|Overall Study|Death|0|||
125408801|NCT01208233|451122705|FG002|Overall Study|Death|0|||
125408802|NCT01208233|451122706|FG003|Overall Study|Death|0|||
125408803|NCT01208233|451122707|FG004|Overall Study|Death|3|||
125408804|NCT01208233|451122708|FG005|Overall Study|Death|5|||
125408805|NCT01208233|451122703|FG000|Overall Study|Did not meet entrance criteria|2|||
125408806|NCT01208233|451122704|FG001|Overall Study|Did not meet entrance criteria|1|||
125408807|NCT01208233|451122705|FG002|Overall Study|Did not meet entrance criteria|1|||
125408808|NCT01208233|451122706|FG003|Overall Study|Did not meet entrance criteria|0|||
125408809|NCT01208233|451122707|FG004|Overall Study|Did not meet entrance criteria|1|||
125408810|NCT01208233|451122708|FG005|Overall Study|Did not meet entrance criteria|0|||
125408811|NCT01208233|451122703|FG000|Overall Study|Medication error without adverse event|0|||
125408812|NCT01208233|451122704|FG001|Overall Study|Medication error without adverse event|0|||
125408813|NCT01208233|451122705|FG002|Overall Study|Medication error without adverse event|0|||
125408814|NCT01208233|451122706|FG003|Overall Study|Medication error without adverse event|0|||
125408815|NCT01208233|451122707|FG004|Overall Study|Medication error without adverse event|0|||
125408816|NCT01208233|451122708|FG005|Overall Study|Medication error without adverse event|1|||
125408817|NCT01208233|451122703|FG000|Overall Study|Study terminated by sponsor|0|||
125408818|NCT01208233|451122704|FG001|Overall Study|Study terminated by sponsor|0|||
125408819|NCT01208233|451122705|FG002|Overall Study|Study terminated by sponsor|0|||
125408820|NCT01208233|451122706|FG003|Overall Study|Study terminated by sponsor|0|||
125408821|NCT01208233|451122707|FG004|Overall Study|Study terminated by sponsor|10|||
125408822|NCT01208233|451122708|FG005|Overall Study|Study terminated by sponsor|7|||
125408823|NCT01208233|451122703|FG000|Overall Study|Protocol Violation|0|||
125408824|NCT01208233|451122704|FG001|Overall Study|Protocol Violation|0|||
125408825|NCT01208233|451122705|FG002|Overall Study|Protocol Violation|0|||
125408826|NCT01208233|451122706|FG003|Overall Study|Protocol Violation|0|||
125408827|NCT01208233|451122707|FG004|Overall Study|Protocol Violation|3|||
125408828|NCT01208233|451122708|FG005|Overall Study|Protocol Violation|0|||
125408829|NCT01208233|451122703|FG000|Overall Study|Other|2|||
125408830|NCT01208233|451122704|FG001|Overall Study|Other|1|||
125408831|NCT01208233|451122705|FG002|Overall Study|Other|0|||
125408832|NCT01208233|451122706|FG003|Overall Study|Other|0|||
125408833|NCT01208233|451122707|FG004|Overall Study|Other|0|||
125408834|NCT01208233|451122708|FG005|Overall Study|Other|1|||
125408835|NCT01208233|451122703|FG000|Overall Study|Withdrawal by Subject|1|||
125408836|NCT01208233|451122704|FG001|Overall Study|Withdrawal by Subject|0|||
125408837|NCT01208233|451122705|FG002|Overall Study|Withdrawal by Subject|1|||
125408838|NCT01208233|451122706|FG003|Overall Study|Withdrawal by Subject|1|||
125408839|NCT01208233|451122707|FG004|Overall Study|Withdrawal by Subject|4|||
125408840|NCT01208233|451122708|FG005|Overall Study|Withdrawal by Subject|2|||
125408841|NCT01181895|451122710|FG000|Overall Study|Adverse Event|3|||
125408842|NCT01181895|451122711|FG001|Overall Study|Adverse Event|1|||
125408843|NCT01181895|451122712|FG002|Overall Study|Adverse Event|1|||
125408844|NCT01181895|451122710|FG000|Overall Study|Lack of Efficacy|8|||
125408845|NCT01181895|451122711|FG001|Overall Study|Lack of Efficacy|9|||
125408846|NCT01181895|451122712|FG002|Overall Study|Lack of Efficacy|9|||
125408847|NCT01181895|451122710|FG000|Overall Study|Protocol Violation|2|||
125448330|NCT04537949|451268910|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
125408848|NCT01181895|451122711|FG001|Overall Study|Protocol Violation|1|||
125408849|NCT01181895|451122712|FG002|Overall Study|Protocol Violation|0|||
125408850|NCT01181895|451122710|FG000|Overall Study|Lost to Follow-up|0|||
125408851|NCT01181895|451122711|FG001|Overall Study|Lost to Follow-up|1|||
125408852|NCT01181895|451122712|FG002|Overall Study|Lost to Follow-up|2|||
125408853|NCT01181895|451122710|FG000|Overall Study|Investigator Discretion|1|||
125408854|NCT01181895|451122711|FG001|Overall Study|Investigator Discretion|2|||
125408855|NCT01181895|451122712|FG002|Overall Study|Investigator Discretion|1|||
125408856|NCT01181895|451122710|FG000|Overall Study|Withdrawal by Subject|3|||
125408857|NCT01181895|451122711|FG001|Overall Study|Withdrawal by Subject|0|||
125408858|NCT01181895|451122712|FG002|Overall Study|Withdrawal by Subject|5|||
125408859|NCT00766415|451122717|FG000|Overall Study|Withdrawal by Subject|0|||
125408860|NCT00766415|451122718|FG001|Overall Study|Withdrawal by Subject|1|||
125408861|NCT02752048|451122721|FG000|Overall Study|Withdrawal by Subject|0|||
125408862|NCT02752048|451122722|FG001|Overall Study|Withdrawal by Subject|0|||
125408863|NCT02752048|451122723|FG002|Overall Study|Withdrawal by Subject|3|||
125408864|NCT01312467|451122724|FG000|Overall Study|Adverse Event|4|||
125408865|NCT01312467|451122724|FG000|Overall Study|Lost to Follow-up|1|||
125408866|NCT01312467|451122724|FG000|Overall Study|Withdrawal by Subject|2|||
125408867|NCT01312467|451122724|FG000|Overall Study|Deported to country of origin|1|||
125408868|NCT01312467|451122724|FG000|Overall Study|Another medical condition|1|||
125408869|NCT01312467|451122724|FG000|Overall Study|Ineligible|4|||
125408870|NCT00132769|451122725|FG000|Overall Study|Withdrawal by Subject|1|||
125408871|NCT00132769|451122726|FG001|Overall Study|Withdrawal by Subject|3|||
125408872|NCT00132769|451122725|FG000|Overall Study|Lack of Efficacy|7|||
125408873|NCT00132769|451122726|FG001|Overall Study|Lack of Efficacy|6|||
125408874|NCT00132769|451122725|FG000|Overall Study|Adverse Event|2|||
125408875|NCT00132769|451122726|FG001|Overall Study|Adverse Event|1|||
125408876|NCT00132769|451122725|FG000|Overall Study|Protocol Violation|1|||
125408877|NCT00132769|451122726|FG001|Overall Study|Protocol Violation|1|||
125408878|NCT00560833|451122742|FG000|Overall Study|Adverse Event|16|||
125408879|NCT00560833|451122743|FG001|Overall Study|Adverse Event|10|||
125408880|NCT00560833|451122744|FG002|Overall Study|Adverse Event|25|||
125408881|NCT00560833|451122745|FG003|Overall Study|Adverse Event|23|||
125408882|NCT00560833|451122746|FG004|Overall Study|Adverse Event|35|||
125408883|NCT00560833|451122742|FG000|Overall Study|Lost to Follow-up|0|||
125408884|NCT00560833|451122743|FG001|Overall Study|Lost to Follow-up|0|||
125408885|NCT00560833|451122744|FG002|Overall Study|Lost to Follow-up|1|||
125408886|NCT00560833|451122745|FG003|Overall Study|Lost to Follow-up|0|||
125408887|NCT00560833|451122746|FG004|Overall Study|Lost to Follow-up|0|||
125408888|NCT00560833|451122742|FG000|Overall Study|Lack of Efficacy|22|||
125408889|NCT00560833|451122743|FG001|Overall Study|Lack of Efficacy|9|||
125408890|NCT00560833|451122744|FG002|Overall Study|Lack of Efficacy|6|||
125408891|NCT00560833|451122745|FG003|Overall Study|Lack of Efficacy|4|||
125408892|NCT00560833|451122746|FG004|Overall Study|Lack of Efficacy|4|||
125408893|NCT00560833|451122742|FG000|Overall Study|Participant uncooperative|5|||
125408894|NCT00560833|451122743|FG001|Overall Study|Participant uncooperative|5|||
125408895|NCT00560833|451122744|FG002|Overall Study|Participant uncooperative|4|||
125408896|NCT00560833|451122745|FG003|Overall Study|Participant uncooperative|4|||
125408897|NCT00560833|451122746|FG004|Overall Study|Participant uncooperative|2|||
125408898|NCT00560833|451122742|FG000|Overall Study|Other|1|||
125408899|NCT00560833|451122743|FG001|Overall Study|Other|1|||
125408900|NCT00560833|451122744|FG002|Overall Study|Other|3|||
125408901|NCT00560833|451122745|FG003|Overall Study|Other|0|||
125408902|NCT00560833|451122746|FG004|Overall Study|Other|0|||
125408903|NCT00560833|451122742|FG000|Overall Study|Never received drug|0|||
125408904|NCT00560833|451122743|FG001|Overall Study|Never received drug|1|||
125408905|NCT00560833|451122744|FG002|Overall Study|Never received drug|0|||
125408906|NCT00560833|451122745|FG003|Overall Study|Never received drug|0|||
125408907|NCT00560833|451122746|FG004|Overall Study|Never received drug|1|||
125408908|NCT00898677|451122751|FG000|Overall Study|Adverse Event|0|||
125408909|NCT00898677|451122752|FG001|Overall Study|Adverse Event|0|||
125408910|NCT00898677|451122753|FG002|Overall Study|Adverse Event|1|||
125408911|NCT00898677|451122754|FG003|Overall Study|Adverse Event|0|||
125408912|NCT00898677|451122751|FG000|Overall Study|Lost to Follow-up|0|||
125408913|NCT00898677|451122752|FG001|Overall Study|Lost to Follow-up|0|||
125408914|NCT00898677|451122753|FG002|Overall Study|Lost to Follow-up|2|||
125408915|NCT00898677|451122754|FG003|Overall Study|Lost to Follow-up|0|||
125408916|NCT00898677|451122751|FG000|Overall Study|Protocol Violation|1|||
125408917|NCT00898677|451122752|FG001|Overall Study|Protocol Violation|1|||
125408918|NCT00898677|451122753|FG002|Overall Study|Protocol Violation|2|||
125448331|NCT04537949|451268903|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
125279620|NCT00394251|450649053|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
125408919|NCT00898677|451122754|FG003|Overall Study|Protocol Violation|0|||
125408920|NCT00898677|451122751|FG000|Overall Study|Withdrawal by Subject|0|||
125408921|NCT00898677|451122752|FG001|Overall Study|Withdrawal by Subject|0|||
125408922|NCT00898677|451122753|FG002|Overall Study|Withdrawal by Subject|0|||
125408923|NCT00898677|451122754|FG003|Overall Study|Withdrawal by Subject|1|||
125408924|NCT00898677|451122751|FG000|Overall Study|Not Treated: Adverse Event|0|||
125408925|NCT00898677|451122752|FG001|Overall Study|Not Treated: Adverse Event|2|||
125408926|NCT00898677|451122753|FG002|Overall Study|Not Treated: Adverse Event|1|||
125408927|NCT00898677|451122754|FG003|Overall Study|Not Treated: Adverse Event|0|||
125408928|NCT00898677|451122751|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
125408929|NCT00898677|451122752|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
125408930|NCT00898677|451122753|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
125279621|NCT05791565|450649054|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
125279622|NCT05791565|450649055|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
125279623|NCT02388165|450649056|FG000|Overall Study|Study terminated by sponsor|5|||
125279624|NCT02388165|450649057|FG001|Overall Study|Study terminated by sponsor|5|||
125279625|NCT02388165|450649056|FG000|Overall Study|Other|11|||
125279626|NCT02388165|450649057|FG001|Overall Study|Other|13|||
125279627|NCT02388165|450649056|FG000|Overall Study|No longer meet eligibility criteria|40|||
125279628|NCT02388165|450649057|FG001|Overall Study|No longer meet eligibility criteria|43|||
125279629|NCT02388165|450649056|FG000|Overall Study|Withdrawal of consent|31|||
125279630|NCT02388165|450649057|FG001|Overall Study|Withdrawal of consent|32|||
125279631|NCT02388165|450649056|FG000|Overall Study|Lost to Follow-up|19|||
125279632|NCT02388165|450649057|FG001|Overall Study|Lost to Follow-up|20|||
125279633|NCT02388165|450649056|FG000|Overall Study|Death|13|||
125279634|NCT02388165|450649057|FG001|Overall Study|Death|10|||
125279635|NCT02388165|450649056|FG000|Overall Study|Adverse Event|3|||
125279636|NCT02388165|450649057|FG001|Overall Study|Adverse Event|5|||
125279637|NCT02388165|450649056|FG000|Overall Study|Did not meet entrance criteria|5|||
125279638|NCT02388165|450649057|FG001|Overall Study|Did not meet entrance criteria|2|||
125279639|NCT00880269|450649058|FG000|Overall Study|Protocol Violation|1|||
125279640|NCT00880269|450649059|FG001|Overall Study|Protocol Violation|0|||
125279641|NCT00880269|450649058|FG000|Overall Study|Disease Progression|13|||
125279642|NCT00880269|450649059|FG001|Overall Study|Disease Progression|11|||
125279643|NCT00880269|450649058|FG000|Overall Study|New Cancer Therapy|1|||
125279644|NCT00880269|450649059|FG001|Overall Study|New Cancer Therapy|0|||
125279645|NCT00880269|450649058|FG000|Overall Study|Death|4|||
125279646|NCT00880269|450649059|FG001|Overall Study|Death|2|||
125279647|NCT00880269|450649058|FG000|Overall Study|Lost to Follow-up|0|||
125279648|NCT00880269|450649059|FG001|Overall Study|Lost to Follow-up|1|||
125279649|NCT00880269|450649058|FG000|Overall Study|Withdrawal by Subject|3|||
125279650|NCT00880269|450649059|FG001|Overall Study|Withdrawal by Subject|4|||
125279651|NCT00880269|450649058|FG000|Overall Study|Adverse Event|10|||
125279652|NCT00880269|450649059|FG001|Overall Study|Adverse Event|9|||
125279653|NCT01667224|450649066|FG000|Overall Study|Withdrawal by Subject|3|||
125279654|NCT01667224|450649067|FG001|Overall Study|Withdrawal by Subject|1|||
125279655|NCT01667224|450649066|FG000|Overall Study|Protocol Violation|1|||
125279656|NCT01667224|450649067|FG001|Overall Study|Protocol Violation|1|||
125279657|NCT00316225|450649070|FG000|Overall Study|Adverse Event|2|||
125279658|NCT00316225|450649070|FG000|Overall Study|Physician Decision|3|||
125279659|NCT00316225|450649070|FG000|Overall Study|Progressive Disease|15|||
125279660|NCT00316225|450649070|FG000|Overall Study|Withdrawal by Subject|3|||
125279661|NCT00316225|450649070|FG000|Overall Study|Death|2|||
125279662|NCT06004895|450649080|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
125279663|NCT06004895|450649080|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
125279664|NCT02314156|450649082|FG000|Overall Study|Adverse Event|1|||
125279665|NCT02314156|450649083|FG001|Overall Study|Adverse Event|0|||
125279666|NCT02314156|450649082|FG000|Overall Study|Withdrawal by Subject|1|||
125279667|NCT02314156|450649083|FG001|Overall Study|Withdrawal by Subject|0|||
125279668|NCT03497975|450649087|FG000|Overall Study|Withdrew Consent|34|||
125279669|NCT03497975|450649088|FG001|Overall Study|Withdrew Consent|35|||
125279670|NCT03497975|450649087|FG000|Overall Study|Lost to Follow-up|7|||
125279671|NCT03497975|450649088|FG001|Overall Study|Lost to Follow-up|7|||
125279672|NCT03497975|450649087|FG000|Overall Study|Physician Decision|4|||
125279673|NCT03497975|450649088|FG001|Overall Study|Physician Decision|5|||
125279674|NCT03497975|450649087|FG000|Overall Study|Discontinued|42|||
125279675|NCT03497975|450649088|FG001|Overall Study|Discontinued|39|||
125279676|NCT03497975|450649087|FG000|Overall Study|Reason Not Specified|15|||
125279677|NCT03497975|450649088|FG001|Overall Study|Reason Not Specified|14|||
125279678|NCT01257230|450649089|FG000|Overall Study|Not Treated|0|||
125279679|NCT01257230|450649090|FG001|Overall Study|Not Treated|0|||
125279680|NCT01257230|450649091|FG002|Overall Study|Not Treated|1|||
125279681|NCT01257230|450649089|FG000|Overall Study|Adverse Event|2|||
125279682|NCT01257230|450649090|FG001|Overall Study|Adverse Event|0|||
125279683|NCT01257230|450649091|FG002|Overall Study|Adverse Event|0|||
125279684|NCT01257230|450649089|FG000|Overall Study|Lack of Efficacy|0|||
125279685|NCT01257230|450649090|FG001|Overall Study|Lack of Efficacy|1|||
125279686|NCT01257230|450649091|FG002|Overall Study|Lack of Efficacy|0|||
125279687|NCT01257230|450649089|FG000|Overall Study|Protocol Violation|3|||
125279688|NCT01257230|450649090|FG001|Overall Study|Protocol Violation|0|||
125279689|NCT01257230|450649091|FG002|Overall Study|Protocol Violation|1|||
125279690|NCT01257230|450649089|FG000|Overall Study|Withdrawal by Subject|0|||
125279691|NCT01257230|450649090|FG001|Overall Study|Withdrawal by Subject|4|||
125279692|NCT01257230|450649091|FG002|Overall Study|Withdrawal by Subject|1|||
125279693|NCT01257230|450649089|FG000|Overall Study|Other reason not defined above|1|||
125279694|NCT01257230|450649090|FG001|Overall Study|Other reason not defined above|5|||
125279695|NCT01257230|450649091|FG002|Overall Study|Other reason not defined above|3|||
125279696|NCT01205061|450649094|FG000|Overall Study|Adverse Event|4|||
125279697|NCT01205061|450649094|FG000|Overall Study|Withdrawal by Subject|11|||
125279698|NCT01205061|450649094|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
125408931|NCT00898677|451122754|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
125408932|NCT00898677|451122751|FG000|Overall Study|Not Treated: Pregnancy|0|||
125408933|NCT00898677|451122752|FG001|Overall Study|Not Treated: Pregnancy|0|||
125408934|NCT00898677|451122753|FG002|Overall Study|Not Treated: Pregnancy|1|||
125408935|NCT00898677|451122754|FG003|Overall Study|Not Treated: Pregnancy|0|||
125408936|NCT00898677|451122751|FG000|Overall Study|Not Treated: Protocol Violation|2|||
125408937|NCT00898677|451122752|FG001|Overall Study|Not Treated: Protocol Violation|0|||
125408938|NCT00898677|451122753|FG002|Overall Study|Not Treated: Protocol Violation|2|||
125408939|NCT00898677|451122754|FG003|Overall Study|Not Treated: Protocol Violation|0|||
125408940|NCT00898677|451122751|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
125408941|NCT00898677|451122752|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
125408942|NCT00898677|451122753|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
125408943|NCT00898677|451122754|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
125408944|NCT00898677|451122751|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
125408945|NCT00898677|451122752|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
125408946|NCT00898677|451122753|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
125408947|NCT00898677|451122754|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
125408948|NCT00898677|451122751|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
125408949|NCT00898677|451122752|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
125408950|NCT00898677|451122753|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
125408951|NCT00898677|451122754|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
125408952|NCT00898677|451122751|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
125408953|NCT00898677|451122752|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
125408954|NCT00898677|451122753|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
125408955|NCT00898677|451122754|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
125408956|NCT00898677|451122751|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
125408957|NCT00898677|451122752|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
125408958|NCT00898677|451122753|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
125408959|NCT00898677|451122754|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
125408960|NCT00898677|451122751|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
125408961|NCT00898677|451122752|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
125408962|NCT00898677|451122753|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
125408963|NCT00898677|451122754|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
125408964|NCT00898677|451122751|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
125408965|NCT00898677|451122752|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
125408966|NCT00898677|451122753|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
125408967|NCT00898677|451122754|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
125408968|NCT05350449|451122755|FG000|Overall Study|Withdrawal by Subject|4|||
125408969|NCT05350449|451122756|FG001|Overall Study|Withdrawal by Subject|8|||
125408970|NCT01076400|451124351|FG000|Overall Study|Adverse Event|2|||
125408971|NCT01076400|451124352|FG001|Overall Study|Adverse Event|0|||
125408972|NCT01076400|451124353|FG002|Overall Study|Adverse Event|0|||
125408973|NCT01076400|451124351|FG000|Overall Study|Progressive Disease|5|||
125408974|NCT01076400|451124352|FG001|Overall Study|Progressive Disease|0|||
125408975|NCT01076400|451124353|FG002|Overall Study|Progressive Disease|0|||
125408976|NCT00796718|451124356|FG000|Overall Study|Adverse Event|2|||
125408977|NCT00796718|451124356|FG000|Overall Study|Exclusion Criteria|1|||
125408978|NCT00796718|451124356|FG000|Overall Study|Lost to Follow-up|5|||
125408979|NCT00796718|451124356|FG000|Overall Study|Withdrawal by Informed Consent|1|||
125408980|NCT02696850|451124357|FG000|Overall Study|Withdrawal by Subject|3|||
125408981|NCT02696850|451124358|FG001|Overall Study|Withdrawal by Subject|3|||
125408982|NCT02696850|451124357|FG000|Overall Study|Lost to Follow-up|8|||
125408983|NCT02696850|451124358|FG001|Overall Study|Lost to Follow-up|5|||
125408984|NCT02044510|451124359|FG000|Overall Study|Adverse Event|1|||
125408985|NCT02044510|451124360|FG001|Overall Study|Adverse Event|2|||
125408986|NCT03455855|451124361|FG000|Overall Study|Lost to Follow-up|4|||
125408987|NCT03455855|451124362|FG001|Overall Study|Lost to Follow-up|2|||
125408988|NCT04193202|451124363|FG000|Overall Study|Adverse Event|2|||
125408989|NCT04193202|451124364|FG001|Overall Study|Adverse Event|1|||
125408990|NCT04193202|451124363|FG000|Overall Study|Death|0|||
125408991|NCT04193202|451124364|FG001|Overall Study|Death|1|||
125408992|NCT04193202|451124363|FG000|Overall Study|Physician Decision|1|||
125408993|NCT04193202|451124364|FG001|Overall Study|Physician Decision|1|||
125279699|NCT01205061|450649094|FG000|Overall Study|Lost to Follow-up|9|||
125408994|NCT04193202|451124363|FG000|Overall Study|Protocol Violation|2|||
125408995|NCT04193202|451124364|FG001|Overall Study|Protocol Violation|2|||
125408996|NCT04193202|451124363|FG000|Overall Study|Withdrawal by Subject|11|||
125408997|NCT04193202|451124364|FG001|Overall Study|Withdrawal by Subject|5|||
125408998|NCT00581945|451124367|FG000|Overall Study|Adverse Event|4|||
125408999|NCT00581945|451124368|FG001|Overall Study|Adverse Event|4|||
125409000|NCT00581945|451124367|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125409001|NCT00581945|451124368|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125279700|NCT01205061|450649094|FG000|Overall Study|Other|1|||
125279701|NCT00765037|450649095|FG000|Overall Study|Lost to Follow-up|5|||
125409002|NCT00581945|451124367|FG000|Overall Study|Withdrawal by Subject|2|||
125409003|NCT00581945|451124368|FG001|Overall Study|Withdrawal by Subject|6|||
125409004|NCT00581945|451124367|FG000|Overall Study|Death|1|||
125409005|NCT00581945|451124368|FG001|Overall Study|Death|0|||
125409006|NCT01933334|451124372|FG000|Overall Study|Adverse Event|5|||
125409007|NCT01933334|451124373|FG001|Overall Study|Adverse Event|1|||
125409008|NCT01933334|451124372|FG000|Overall Study|Withdrawal by Subject|0|||
125409009|NCT01933334|451124373|FG001|Overall Study|Withdrawal by Subject|1|||
125409010|NCT00767000|451124374|FG000|54-week Study|Adverse Event|4|||
125409011|NCT00767000|451124375|FG001|54-week Study|Adverse Event|6|||
125409012|NCT00767000|451124376|FG002|54-week Study|Adverse Event|6|||
125409013|NCT00767000|451124377|FG003|54-week Study|Adverse Event|8|||
125409014|NCT00767000|451124378|FG004|54-week Study|Adverse Event|4|||
125409015|NCT00767000|451124374|FG000|54-week Study|Creaninine/creatinine clearance|2|||
125409016|NCT00767000|451124375|FG001|54-week Study|Creaninine/creatinine clearance|1|||
125409017|NCT00767000|451124376|FG002|54-week Study|Creaninine/creatinine clearance|2|||
125409018|NCT00767000|451124377|FG003|54-week Study|Creaninine/creatinine clearance|2|||
125409019|NCT00767000|451124378|FG004|54-week Study|Creaninine/creatinine clearance|4|||
125409020|NCT00767000|451124374|FG000|54-week Study|Hyperglycemia|0|||
125409021|NCT00767000|451124375|FG001|54-week Study|Hyperglycemia|0|||
125409022|NCT00767000|451124376|FG002|54-week Study|Hyperglycemia|1|||
125409023|NCT00767000|451124377|FG003|54-week Study|Hyperglycemia|0|||
125409024|NCT00767000|451124378|FG004|54-week Study|Hyperglycemia|1|||
125409025|NCT00767000|451124374|FG000|54-week Study|Hypoglycemia|0|||
125409026|NCT00767000|451124375|FG001|54-week Study|Hypoglycemia|1|||
125409027|NCT00767000|451124376|FG002|54-week Study|Hypoglycemia|0|||
125409028|NCT00767000|451124377|FG003|54-week Study|Hypoglycemia|0|||
125409029|NCT00767000|451124378|FG004|54-week Study|Hypoglycemia|0|||
125409030|NCT00767000|451124374|FG000|54-week Study|Interruption of study medication|0|||
125409031|NCT00767000|451124375|FG001|54-week Study|Interruption of study medication|0|||
125409032|NCT00767000|451124376|FG002|54-week Study|Interruption of study medication|1|||
125409033|NCT00767000|451124377|FG003|54-week Study|Interruption of study medication|0|||
125409034|NCT00767000|451124378|FG004|54-week Study|Interruption of study medication|0|||
125409035|NCT00767000|451124374|FG000|54-week Study|Lack of Efficacy|2|||
125409036|NCT00767000|451124375|FG001|54-week Study|Lack of Efficacy|0|||
125409037|NCT00767000|451124376|FG002|54-week Study|Lack of Efficacy|1|||
125409038|NCT00767000|451124377|FG003|54-week Study|Lack of Efficacy|0|||
125409039|NCT00767000|451124378|FG004|54-week Study|Lack of Efficacy|5|||
125409040|NCT00767000|451124374|FG000|54-week Study|Lost to Follow-up|4|||
125409041|NCT00767000|451124375|FG001|54-week Study|Lost to Follow-up|0|||
125409042|NCT00767000|451124376|FG002|54-week Study|Lost to Follow-up|1|||
125409043|NCT00767000|451124377|FG003|54-week Study|Lost to Follow-up|4|||
125409044|NCT00767000|451124378|FG004|54-week Study|Lost to Follow-up|2|||
125409045|NCT00767000|451124374|FG000|54-week Study|Physician Decision|4|||
125409046|NCT00767000|451124375|FG001|54-week Study|Physician Decision|0|||
125409047|NCT00767000|451124376|FG002|54-week Study|Physician Decision|1|||
125409048|NCT00767000|451124377|FG003|54-week Study|Physician Decision|1|||
125409049|NCT00767000|451124378|FG004|54-week Study|Physician Decision|1|||
125409050|NCT00767000|451124374|FG000|54-week Study|Progressive disease|0|||
125409051|NCT00767000|451124375|FG001|54-week Study|Progressive disease|0|||
125409052|NCT00767000|451124376|FG002|54-week Study|Progressive disease|1|||
125409053|NCT00767000|451124377|FG003|54-week Study|Progressive disease|0|||
125409054|NCT00767000|451124378|FG004|54-week Study|Progressive disease|0|||
125409055|NCT00767000|451124374|FG000|54-week Study|Protocol Violation|0|||
125409056|NCT00767000|451124375|FG001|54-week Study|Protocol Violation|0|||
125409057|NCT00767000|451124376|FG002|54-week Study|Protocol Violation|1|||
125409058|NCT00767000|451124377|FG003|54-week Study|Protocol Violation|2|||
125409059|NCT00767000|451124378|FG004|54-week Study|Protocol Violation|0|||
125409060|NCT00767000|451124374|FG000|54-week Study|Withdrawal by Subject|2|||
125409061|NCT00767000|451124375|FG001|54-week Study|Withdrawal by Subject|3|||
125409062|NCT00767000|451124376|FG002|54-week Study|Withdrawal by Subject|5|||
125409063|NCT00767000|451124377|FG003|54-week Study|Withdrawal by Subject|11|||
125409064|NCT00767000|451124378|FG004|54-week Study|Withdrawal by Subject|13|||
125409065|NCT00767000|451124374|FG000|54-week Study|Study terminated by sponsor|90|||
125409066|NCT00767000|451124375|FG001|54-week Study|Study terminated by sponsor|102|||
125409067|NCT00767000|451124376|FG002|54-week Study|Study terminated by sponsor|89|||
125409068|NCT00767000|451124377|FG003|54-week Study|Study terminated by sponsor|196|||
125409069|NCT00767000|451124378|FG004|54-week Study|Study terminated by sponsor|194|||
125409070|NCT00767000|451124374|FG000|54-week Study|Reason not reported|0|||
125409071|NCT00767000|451124375|FG001|54-week Study|Reason not reported|0|||
125409072|NCT00767000|451124376|FG002|54-week Study|Reason not reported|0|||
125409073|NCT00767000|451124377|FG003|54-week Study|Reason not reported|1|||
125409074|NCT00767000|451124378|FG004|54-week Study|Reason not reported|0|||
125409075|NCT00767000|451124374|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
125409076|NCT00767000|451124375|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
125409077|NCT00767000|451124376|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
125409078|NCT00767000|451124377|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
125409079|NCT00767000|451124378|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
125409080|NCT02039505|451124379|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
125409081|NCT02039505|451124380|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
125409082|NCT02039505|451124381|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
125409083|NCT02039505|451124382|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
125409084|NCT02039505|451124383|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
125409085|NCT02039505|451124384|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
125409086|NCT02039505|451124385|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
125409087|NCT02039505|451124379|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
125409088|NCT02039505|451124380|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
125409089|NCT02039505|451124381|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
125409090|NCT02039505|451124382|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
125409091|NCT02039505|451124383|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
125409092|NCT02039505|451124384|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
125409093|NCT02039505|451124385|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
125409094|NCT02039505|451124379|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
125409095|NCT02039505|451124380|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
125409096|NCT02039505|451124381|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
125409097|NCT02039505|451124382|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
125409098|NCT02039505|451124383|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
125409099|NCT02039505|451124384|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
125409100|NCT02039505|451124385|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
125409101|NCT02039505|451124379|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
125409102|NCT02039505|451124380|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
125409103|NCT02039505|451124381|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
125409104|NCT02039505|451124382|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
125409105|NCT02039505|451124383|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
125409106|NCT02039505|451124384|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
125409107|NCT02039505|451124385|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
125409108|NCT02039505|451124379|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
125409109|NCT02039505|451124380|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
125409110|NCT02039505|451124381|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
125409111|NCT02039505|451124382|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
125409112|NCT02039505|451124383|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
125409113|NCT02039505|451124384|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
125409114|NCT02039505|451124385|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
125409115|NCT02039505|451124379|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
125409116|NCT02039505|451124380|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
125409117|NCT02039505|451124381|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
125409118|NCT02039505|451124382|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
125409119|NCT02039505|451124383|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
125409120|NCT02039505|451124384|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
125409121|NCT02039505|451124385|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
125409122|NCT02039505|451124379|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
125409123|NCT02039505|451124380|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
125409124|NCT02039505|451124381|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
125409125|NCT02039505|451124382|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
125409126|NCT02039505|451124383|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
125409127|NCT02039505|451124384|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
125409128|NCT02039505|451124385|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
125409129|NCT02039505|451124379|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
125409130|NCT02039505|451124380|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
125409131|NCT02039505|451124381|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
125409132|NCT02039505|451124382|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
125409133|NCT02039505|451124383|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
125409134|NCT02039505|451124384|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
125409135|NCT02039505|451124385|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
125409136|NCT02039505|451124379|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
125409137|NCT02039505|451124380|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
125409138|NCT02039505|451124381|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
125409139|NCT02039505|451124382|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
125409140|NCT02039505|451124383|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
125409141|NCT02039505|451124384|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
125409142|NCT02039505|451124385|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
125409143|NCT02039505|451124379|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
125409144|NCT02039505|451124380|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
125409145|NCT02039505|451124381|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
125409146|NCT02039505|451124382|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
125409147|NCT02039505|451124383|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
125409148|NCT02039505|451124384|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
125409149|NCT02039505|451124385|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
125409150|NCT02039505|451124379|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
125409151|NCT02039505|451124380|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
125409152|NCT02039505|451124381|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
125409153|NCT02039505|451124382|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
125409154|NCT02039505|451124383|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
125409155|NCT02039505|451124384|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
125409156|NCT02039505|451124385|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
125409157|NCT00003457|451124386|FG000|Overall Study|Not evaluable|9|||
125409158|NCT02246998|451124390|FG000|Overall Study|Adverse Event|0|||
125409159|NCT02246998|451124391|FG001|Overall Study|Adverse Event|1|||
125409160|NCT02246998|451124392|FG002|Overall Study|Adverse Event|1|||
125409161|NCT02246998|451124393|FG003|Overall Study|Adverse Event|0|||
125409162|NCT02246998|451124390|FG000|Overall Study|Lost to Follow-up|1|||
125409163|NCT02246998|451124391|FG001|Overall Study|Lost to Follow-up|0|||
125409164|NCT02246998|451124392|FG002|Overall Study|Lost to Follow-up|0|||
125409165|NCT02246998|451124393|FG003|Overall Study|Lost to Follow-up|1|||
125409166|NCT02246998|451124390|FG000|Overall Study|Randomized but Never Dosed|1|||
125409167|NCT02246998|451124391|FG001|Overall Study|Randomized but Never Dosed|2|||
125409168|NCT02246998|451124392|FG002|Overall Study|Randomized but Never Dosed|2|||
125409169|NCT02246998|451124393|FG003|Overall Study|Randomized but Never Dosed|1|||
125409170|NCT02525133|451124396|FG000|Overall Study|Adverse Event|0|||
125409171|NCT02525133|451124397|FG001|Overall Study|Adverse Event|1|||
125409172|NCT02525133|451124396|FG000|Overall Study|Death|0|||
125409173|NCT02525133|451124397|FG001|Overall Study|Death|1|||
125409174|NCT02525133|451124396|FG000|Overall Study|did not meet randomization criteria|1|||
125409175|NCT02525133|451124397|FG001|Overall Study|did not meet randomization criteria|0|||
125409176|NCT02525133|451124396|FG000|Overall Study|Lost to Follow-up|5|||
125409177|NCT02525133|451124397|FG001|Overall Study|Lost to Follow-up|1|||
125409178|NCT02525133|451124396|FG000|Overall Study|randomized not enrolled|3|||
125409179|NCT02525133|451124397|FG001|Overall Study|randomized not enrolled|0|||
125409180|NCT02525133|451124396|FG000|Overall Study|Withdrawal by Subject|1|||
125409181|NCT02525133|451124397|FG001|Overall Study|Withdrawal by Subject|0|||
125409182|NCT01343082|451124398|FG000|The run-in Period|Not meeting criteria|3|||
125409183|NCT01343082|451124399|FG001|The run-in Period|Not meeting criteria|4|||
125409184|NCT01343082|451124400|FG002|The run-in Period|Not meeting criteria|5|||
125409185|NCT01343082|451124398|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
125409186|NCT01343082|451124399|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
125409187|NCT01343082|451124400|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
125409188|NCT01343082|451124398|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
125409189|NCT01343082|451124399|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
125409190|NCT01343082|451124400|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
125409191|NCT01343082|451124398|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
125409192|NCT01343082|451124399|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
125409193|NCT01343082|451124400|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
125409194|NCT01343082|451124398|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
125409195|NCT01343082|451124399|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
125409196|NCT01343082|451124400|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
125409197|NCT01075074|451124401|FG000|Overall Study|Surgeon changed to open incisional case|1|||
125409198|NCT01075074|451124402|FG001|Overall Study|Surgeon changed to open incisional case|2|||
125409199|NCT01075074|451124403|FG002|Overall Study|Surgeon changed to open incisional case|2|||
125409200|NCT04265755|451124404|FG000|Overall Study|Withdrawal by Subject|39|||
125409201|NCT04265755|451124404|FG000|Overall Study|Decision by sponsor|2|||
125409202|NCT04265755|451124404|FG000|Overall Study|Lost to Follow-up|11|||
125409203|NCT04265755|451124404|FG000|Overall Study|Death|1|||
125409204|NCT01575561|451124405|FG000|Overall Study|Adverse Event|9|||
125409205|NCT01575561|451124405|FG000|Overall Study|Lack of Efficacy|8|||
125409206|NCT01575561|451124405|FG000|Overall Study|Lost to Follow-up|6|||
125409207|NCT01575561|451124405|FG000|Overall Study|Protocol Violation|4|||
125409208|NCT01575561|451124405|FG000|Overall Study|Withdrawal by Subject|11|||
125409209|NCT01575561|451124405|FG000|Overall Study|administration|1|||
125409210|NCT02496884|451124406|FG000|Overall Study|Counted twice as enrolled|2|||
125409211|NCT02496884|451124407|FG001|Overall Study|Counted twice as enrolled|0|||
125279702|NCT00765037|450649095|FG000|Overall Study|Adverse Event|1|||
125279703|NCT01988662|450649100|FG000|Overall Study|Subject/guardian decision|1|||
125409212|NCT02496884|451124408|FG002|Overall Study|Counted twice as enrolled|0|||
125409213|NCT02496884|451124409|FG003|Overall Study|Counted twice as enrolled|0|||
125409214|NCT02496884|451124406|FG000|Overall Study|Withdrawal by Subject|0|||
125409215|NCT02496884|451124407|FG001|Overall Study|Withdrawal by Subject|3|||
125409216|NCT02496884|451124408|FG002|Overall Study|Withdrawal by Subject|0|||
125409217|NCT02496884|451124409|FG003|Overall Study|Withdrawal by Subject|0|||
125409218|NCT01114646|451124410|FG000|Overall Study|Withdrawal by Subject|3|||
125409219|NCT01114646|451124411|FG001|Overall Study|Withdrawal by Subject|2|||
125409220|NCT01046110|451124412|FG000|Overall Study|Adverse Event|9|||
125409221|NCT01046110|451124413|FG001|Overall Study|Adverse Event|2|||
125409222|NCT01046110|451124412|FG000|Overall Study|Lack of Efficacy|0|||
125409223|NCT01046110|451124413|FG001|Overall Study|Lack of Efficacy|1|||
125409224|NCT01046110|451124412|FG000|Overall Study|Protocol Violation|7|||
125409225|NCT01046110|451124413|FG001|Overall Study|Protocol Violation|12|||
125409226|NCT01046110|451124412|FG000|Overall Study|Withdrawal Criteria|3|||
125409227|NCT01046110|451124413|FG001|Overall Study|Withdrawal Criteria|5|||
125409228|NCT01046110|451124412|FG000|Overall Study|Unclassified|36|||
125409229|NCT01046110|451124413|FG001|Overall Study|Unclassified|35|||
125409230|NCT02013765|451124423|FG000|Overall Study|Trial was terminated by sponsor|1|||
125409231|NCT00718042|451124428|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
125409232|NCT00718042|451124429|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
125409233|NCT00718042|451124430|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
125409234|NCT00718042|451124431|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
125409235|NCT00718042|451124432|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
125409236|NCT00718042|451124433|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
125409237|NCT00718042|451124428|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
125409238|NCT00718042|451124429|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
125409239|NCT00718042|451124430|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
125409240|NCT00718042|451124431|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
125409241|NCT00718042|451124432|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
125409242|NCT00718042|451124433|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
125409243|NCT00718042|451124428|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
125409244|NCT00718042|451124429|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
125409245|NCT00718042|451124430|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
125409246|NCT00718042|451124431|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
125409247|NCT00718042|451124432|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
125409248|NCT00718042|451124433|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
125409249|NCT00718042|451124428|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
125409250|NCT00718042|451124429|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
125409251|NCT00718042|451124430|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
125279704|NCT01988662|450649101|FG001|Overall Study|Subject/guardian decision|1|||
125279705|NCT01988662|450649100|FG000|Overall Study|Adverse Event|3|||
125279706|NCT01988662|450649101|FG001|Overall Study|Adverse Event|1|||
125279707|NCT03070171|450649103|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
125279708|NCT03070171|450649104|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
125279709|NCT03070171|450649103|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
125279710|NCT03070171|450649104|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
125279711|NCT01471028|450649108|FG000|VTI-208|Adverse Event|39|||
125279712|NCT01471028|450649109|FG001|VTI-208|Adverse Event|41|||
125279713|NCT01471028|450649108|FG000|VTI-208|Withdrawal by Subject|0|||
125409252|NCT00718042|451124431|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
125409253|NCT00718042|451124432|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
125409254|NCT00718042|451124433|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
125409255|NCT00718042|451124428|FG000|Donor Follow-up|Lost to Follow-up|13|||
125409256|NCT00718042|451124429|FG001|Donor Follow-up|Lost to Follow-up|0|||
125279714|NCT01471028|450649109|FG001|VTI-208|Withdrawal by Subject|2|||
125279715|NCT01471028|450649108|FG000|VTI-208|Lost to Follow-up|1|||
125279716|NCT01471028|450649109|FG001|VTI-208|Lost to Follow-up|1|||
125409257|NCT00718042|451124430|FG002|Donor Follow-up|Lost to Follow-up|0|||
125409258|NCT00718042|451124431|FG003|Donor Follow-up|Lost to Follow-up|0|||
125409259|NCT00718042|451124432|FG004|Donor Follow-up|Lost to Follow-up|19|||
125279717|NCT01471028|450649108|FG000|VTI-208E|Death|7|||
125279718|NCT01471028|450649109|FG001|VTI-208E|Death|10|||
125409260|NCT00718042|451124433|FG005|Donor Follow-up|Lost to Follow-up|0|||
125409261|NCT00575588|451124434|FG000|Overall Study|Adverse Event|11|||
125409262|NCT00575588|451124435|FG001|Overall Study|Adverse Event|13|||
125448332|NCT04537949|451268904|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
125409263|NCT00575588|451124434|FG000|Overall Study|Withdrawal by Subject|27|||
125279719|NCT01471028|450649108|FG000|VTI-208E|Withdrawal by Subject|1|||
125279720|NCT01471028|450649109|FG001|VTI-208E|Withdrawal by Subject|0|||
125279721|NCT01471028|450649108|FG000|VTI-208E|Lost to Follow-up|0|||
125279722|NCT01471028|450649109|FG001|VTI-208E|Lost to Follow-up|2|||
125279723|NCT00610857|450649111|FG000|Overall Study|Not evaluable for response|2|||
125409264|NCT00575588|451124435|FG001|Overall Study|Withdrawal by Subject|31|||
125409265|NCT00575588|451124434|FG000|Overall Study|Lost to Follow-up|1|||
125409266|NCT00575588|451124435|FG001|Overall Study|Lost to Follow-up|3|||
125409267|NCT00575588|451124434|FG000|Overall Study|Death|4|||
125409268|NCT00575588|451124435|FG001|Overall Study|Death|2|||
125409269|NCT00575588|451124434|FG000|Overall Study|Incorrect enrollment|8|||
125409270|NCT00575588|451124435|FG001|Overall Study|Incorrect enrollment|4|||
125409271|NCT00575588|451124434|FG000|Overall Study|Study specific discontinuation criteria|203|||
125409272|NCT00575588|451124435|FG001|Overall Study|Study specific discontinuation criteria|218|||
125409273|NCT00575588|451124434|FG000|Overall Study|Severe non-compliance to protocol|5|||
125409274|NCT00575588|451124435|FG001|Overall Study|Severe non-compliance to protocol|7|||
125409275|NCT00575588|451124434|FG000|Overall Study|Safety reasons|2|||
125409276|NCT00575588|451124435|FG001|Overall Study|Safety reasons|1|||
125409277|NCT00575588|451124434|FG000|Overall Study|Elevated triglyceride|1|||
125409278|NCT00575588|451124435|FG001|Overall Study|Elevated triglyceride|0|||
125409279|NCT00575588|451124434|FG000|Overall Study|Patient moved|1|||
125409280|NCT00575588|451124435|FG001|Overall Study|Patient moved|3|||
125409281|NCT00575588|451124434|FG000|Overall Study|Impossible to determine HbA1c|0|||
125409282|NCT00575588|451124435|FG001|Overall Study|Impossible to determine HbA1c|1|||
125409283|NCT00614939|451124436|FG000|Overall Study|Withdrawal by Subject|10|||
125409284|NCT00614939|451124437|FG001|Overall Study|Withdrawal by Subject|17|||
125409285|NCT00614939|451124436|FG000|Overall Study|Study specific discontinuation criteris|13|||
125409286|NCT00614939|451124437|FG001|Overall Study|Study specific discontinuation criteris|16|||
125409287|NCT00614939|451124436|FG000|Overall Study|Adverse Event|2|||
125409288|NCT00614939|451124437|FG001|Overall Study|Adverse Event|5|||
125409289|NCT00614939|451124436|FG000|Overall Study|Incorrect enrollment|1|||
125409290|NCT00614939|451124437|FG001|Overall Study|Incorrect enrollment|2|||
125409291|NCT00614939|451124436|FG000|Overall Study|Death|4|||
125409292|NCT00614939|451124437|FG001|Overall Study|Death|3|||
125409293|NCT00614939|451124436|FG000|Overall Study|Poor/non-compliance|4|||
125409294|NCT00614939|451124437|FG001|Overall Study|Poor/non-compliance|0|||
125409295|NCT00614939|451124436|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
125409296|NCT00614939|451124437|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
125409297|NCT00840970|451124438|FG000|Overall Study|Adverse Event|0|||
125409298|NCT00840970|451124439|FG001|Overall Study|Adverse Event|0|||
125409299|NCT00840970|451124440|FG002|Overall Study|Adverse Event|1|||
125409300|NCT00504829|451124441|FG000|Overall Study|Protocol Violation|6|||
125409301|NCT00504829|451124442|FG001|Overall Study|Protocol Violation|4|||
125409302|NCT00504829|451124443|FG002|Overall Study|Protocol Violation|10|||
125409303|NCT01854827|451124444|FG000|Overall Study|Death|1|||
125409304|NCT02571452|451124445|FG000|Overall Study Treatment|Protocol Violation|0|||
125409305|NCT02571452|451124446|FG001|Overall Study Treatment|Protocol Violation|1|||
125409306|NCT02571452|451124445|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
125409307|NCT02571452|451124446|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
125409308|NCT02571452|451124445|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
125409309|NCT02571452|451124446|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
125409310|NCT01751568|451124459|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
125409311|NCT01751568|451124460|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
125409312|NCT01751568|451124461|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
125409313|NCT02660944|451124462|FG000|Overall Study|Adverse Event|3|||
125409314|NCT02660944|451124463|FG001|Overall Study|Adverse Event|4|||
125409315|NCT02660944|451124462|FG000|Overall Study|Physician Decision|3|||
125409316|NCT02660944|451124463|FG001|Overall Study|Physician Decision|1|||
125409317|NCT02660944|451124462|FG000|Overall Study|Withdrawal by Subject|5|||
125409318|NCT02660944|451124463|FG001|Overall Study|Withdrawal by Subject|3|||
125409319|NCT02660944|451124462|FG000|Overall Study|Lost to Follow-up|4|||
125409320|NCT02660944|451124463|FG001|Overall Study|Lost to Follow-up|1|||
125409321|NCT02660944|451124462|FG000|Overall Study|Subject schedule|0|||
125409322|NCT02660944|451124463|FG001|Overall Study|Subject schedule|1|||
125409323|NCT02660944|451124462|FG000|Overall Study|Exclusion criteria met|2|||
125409324|NCT02660944|451124463|FG001|Overall Study|Exclusion criteria met|0|||
125409325|NCT04079933|451124467|FG000|Overall Study|Withdrawal by Subject|3|||
125409326|NCT04079933|451124468|FG001|Overall Study|Withdrawal by Subject|4|||
125409327|NCT04079933|451124467|FG000|Overall Study|Lost to Follow-up|0|||
125409328|NCT04079933|451124468|FG001|Overall Study|Lost to Follow-up|1|||
125409329|NCT01229436|451124469|FG000|Overall Study|Withdrawal by Subject|2|||
125409330|NCT01229436|451124469|FG000|Overall Study|Lost to Follow-up|3|||
125409331|NCT00345579|451124473|FG000|Overall Study|Adverse Event|9|||
125409332|NCT00345579|451124474|FG001|Overall Study|Adverse Event|6|||
125409333|NCT00345579|451124473|FG000|Overall Study|Protocol Violation|14|||
125409334|NCT00345579|451124474|FG001|Overall Study|Protocol Violation|5|||
125409335|NCT00345579|451124473|FG000|Overall Study|Withdrawal by Subject|50|||
125409336|NCT00345579|451124474|FG001|Overall Study|Withdrawal by Subject|17|||
125448333|NCT04537949|451268905|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
125409337|NCT00345579|451124473|FG000|Overall Study|Lost to Follow-up|82|||
125409338|NCT00345579|451124474|FG001|Overall Study|Lost to Follow-up|36|||
125409339|NCT00345579|451124473|FG000|Overall Study|Other|9|||
125409340|NCT00345579|451124474|FG001|Overall Study|Other|1|||
125409341|NCT01731171|451124475|FG000|Overall Study|Withdrawal by Subject|4|||
125409342|NCT01731171|451124476|FG001|Overall Study|Withdrawal by Subject|1|||
125409343|NCT01731171|451124475|FG000|Overall Study|Lost to Follow-up|3|||
125409344|NCT01731171|451124476|FG001|Overall Study|Lost to Follow-up|2|||
125409345|NCT01731171|451124475|FG000|Overall Study|Moved out of Area|0|||
125409346|NCT01731171|451124476|FG001|Overall Study|Moved out of Area|2|||
125409347|NCT01731171|451124475|FG000|Overall Study|Terminated for Lack of Adherence|0|||
125409348|NCT01731171|451124476|FG001|Overall Study|Terminated for Lack of Adherence|1|||
125409349|NCT01731171|451124475|FG000|Overall Study|Terminated for Safety Reasons|0|||
125409350|NCT01731171|451124476|FG001|Overall Study|Terminated for Safety Reasons|1|||
125409351|NCT00413413|451124477|FG000|Single-Blind|Adverse Event|0|||
125409352|NCT00413413|451124478|FG001|Single-Blind|Adverse Event|9|||
125409353|NCT00413413|451124479|FG002|Single-Blind|Adverse Event|0|||
125409354|NCT00413413|451124477|FG000|Single-Blind|Lack of Efficacy|0|||
125409355|NCT00413413|451124478|FG001|Single-Blind|Lack of Efficacy|5|||
125409356|NCT00413413|451124479|FG002|Single-Blind|Lack of Efficacy|0|||
125409357|NCT00413413|451124477|FG000|Single-Blind|Subject no longer requires study drug|0|||
125409358|NCT00413413|451124478|FG001|Single-Blind|Subject no longer requires study drug|151|||
125409359|NCT00413413|451124479|FG002|Single-Blind|Subject no longer requires study drug|0|||
125409360|NCT00413413|451124477|FG000|Single-Blind|Protocol Violation|0|||
125409361|NCT00413413|451124478|FG001|Single-Blind|Protocol Violation|16|||
125409362|NCT00413413|451124479|FG002|Single-Blind|Protocol Violation|0|||
125409363|NCT00413413|451124477|FG000|Single-Blind|Withdrawal by Subject|0|||
125409364|NCT00413413|451124478|FG001|Single-Blind|Withdrawal by Subject|27|||
125409365|NCT00413413|451124479|FG002|Single-Blind|Withdrawal by Subject|0|||
125409366|NCT00413413|451124477|FG000|Single-Blind|Lost to Follow-up|0|||
125409367|NCT00413413|451124478|FG001|Single-Blind|Lost to Follow-up|8|||
125409368|NCT00413413|451124479|FG002|Single-Blind|Lost to Follow-up|0|||
125409369|NCT00413413|451124477|FG000|Double-Blind|Adverse Event|6|||
125409370|NCT00413413|451124478|FG001|Double-Blind|Adverse Event|0|||
125409371|NCT00413413|451124479|FG002|Double-Blind|Adverse Event|5|||
125409372|NCT00413413|451124477|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
125409373|NCT00413413|451124478|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
125409374|NCT00413413|451124479|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
125409375|NCT00413413|451124477|FG000|Double-Blind|Protocol deviation|1|||
125409376|NCT00413413|451124478|FG001|Double-Blind|Protocol deviation|2|||
125409377|NCT00413413|451124479|FG002|Double-Blind|Protocol deviation|1|||
125409378|NCT00413413|451124477|FG000|Double-Blind|Subject withdrew consent|4|||
125409379|NCT00413413|451124478|FG001|Double-Blind|Subject withdrew consent|6|||
125279724|NCT04826094|450649112|FG000|Overall Study|Lost to Follow-up|2|||
125279725|NCT04826094|450649113|FG001|Overall Study|Lost to Follow-up|1|||
125279726|NCT04826094|450649114|FG002|Overall Study|Lost to Follow-up|0|||
125279727|NCT04826094|450649115|FG003|Overall Study|Lost to Follow-up|0|||
125409380|NCT00413413|451124479|FG002|Double-Blind|Subject withdrew consent|9|||
125409381|NCT00413413|451124477|FG000|Double-Blind|Lost to Follow-up|3|||
125409382|NCT00413413|451124478|FG001|Double-Blind|Lost to Follow-up|4|||
125409383|NCT00413413|451124479|FG002|Double-Blind|Lost to Follow-up|2|||
125409384|NCT02604589|451124486|FG000|Overall Study|catheter dislodgement|0|||
125409385|NCT02604589|451124487|FG001|Overall Study|catheter dislodgement|0|||
125409386|NCT02604589|451124488|FG002|Overall Study|catheter dislodgement|1|||
125409387|NCT03321981|451124494|FG000|Overall Study|Progressive Disease (PD)|15|||
125409388|NCT03321981|451124495|FG001|Overall Study|Progressive Disease (PD)|30|||
125409389|NCT03321981|451124496|FG002|Overall Study|Progressive Disease (PD)|47|||
125409390|NCT03321981|451124494|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
125409391|NCT03321981|451124495|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
125409392|NCT03321981|451124496|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
125409393|NCT03321981|451124494|FG000|Overall Study|Adverse Event|0|||
125409394|NCT03321981|451124495|FG001|Overall Study|Adverse Event|0|||
125409395|NCT03321981|451124496|FG002|Overall Study|Adverse Event|2|||
125409396|NCT03321981|451124494|FG000|Overall Study|symptomatic deterioration|0|||
125448334|NCT04537949|451268906|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
125448335|NCT04537949|451268907|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
125279728|NCT04826094|450649116|FG004|Overall Study|Lost to Follow-up|1|||
125409397|NCT03321981|451124495|FG001|Overall Study|symptomatic deterioration|1|||
125409398|NCT03321981|451124496|FG002|Overall Study|symptomatic deterioration|1|||
125409399|NCT03321981|451124494|FG000|Overall Study|Lack of compliance|0|||
125409400|NCT03321981|451124495|FG001|Overall Study|Lack of compliance|1|||
125409401|NCT03321981|451124496|FG002|Overall Study|Lack of compliance|0|||
125409402|NCT03321981|451124494|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
125409403|NCT03321981|451124495|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
125409404|NCT03321981|451124496|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
125409405|NCT03321981|451124494|FG000|Overall Study|Death|0|||
125409406|NCT03321981|451124495|FG001|Overall Study|Death|1|||
125409407|NCT03321981|451124496|FG002|Overall Study|Death|0|||
125409408|NCT03321981|451124494|FG000|Overall Study|Subject withdrawal of investigational product|0|||
125409409|NCT03321981|451124495|FG001|Overall Study|Subject withdrawal of investigational product|1|||
125409410|NCT03321981|451124496|FG002|Overall Study|Subject withdrawal of investigational product|0|||
125409411|NCT03321981|451124494|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
125409412|NCT03321981|451124495|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
125409413|NCT03321981|451124496|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
125409414|NCT03321981|451124494|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
125409415|NCT03321981|451124495|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
125409416|NCT03321981|451124496|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
125409417|NCT00817089|451124505|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
125409418|NCT00817089|451124506|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
125409419|NCT00817089|451124507|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
125409420|NCT00817089|451124508|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
125409421|NCT00817089|451124505|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
125409422|NCT00817089|451124506|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
125409423|NCT00817089|451124507|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
125409424|NCT00817089|451124508|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
125409425|NCT03067441|451124509|FG000|Overall Study|Withdrawal by Subject|16|||
125409426|NCT03067441|451124510|FG001|Overall Study|Withdrawal by Subject|34|||
125409427|NCT03067441|451124509|FG000|Overall Study|Lost to Follow-up|7|||
125409428|NCT03067441|451124510|FG001|Overall Study|Lost to Follow-up|5|||
125409429|NCT03067441|451124509|FG000|Overall Study|Adverse Event|7|||
125409430|NCT03067441|451124510|FG001|Overall Study|Adverse Event|14|||
125409431|NCT03067441|451124509|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
125409432|NCT03067441|451124510|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
125409433|NCT03067441|451124509|FG000|Overall Study|Physician Decision|1|||
125409434|NCT03067441|451124510|FG001|Overall Study|Physician Decision|3|||
125409435|NCT03067441|451124509|FG000|Overall Study|Other|1|||
125409436|NCT03067441|451124510|FG001|Overall Study|Other|1|||
125409437|NCT01592708|451124514|FG000|Overall Study|Protocol Violation|3|||
125409438|NCT01592708|451124515|FG001|Overall Study|Protocol Violation|0|||
125279729|NCT04826094|450649117|FG005|Overall Study|Lost to Follow-up|3|||
125279730|NCT04826094|450649118|FG006|Overall Study|Lost to Follow-up|1|||
125448336|NCT04537949|451268908|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
125448337|NCT04537949|451268909|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
125448338|NCT04537949|451268910|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
125448339|NCT04537949|451268903|FG000|Follow-up Phase|Lost to Follow-up|0|||
125448340|NCT04537949|451268904|FG001|Follow-up Phase|Lost to Follow-up|3|||
125448341|NCT04537949|451268905|FG002|Follow-up Phase|Lost to Follow-up|0|||
125448342|NCT04537949|451268906|FG003|Follow-up Phase|Lost to Follow-up|0|||
125448343|NCT04537949|451268907|FG004|Follow-up Phase|Lost to Follow-up|0|||
125448344|NCT04537949|451268908|FG005|Follow-up Phase|Lost to Follow-up|0|||
125448345|NCT04537949|451268909|FG006|Follow-up Phase|Lost to Follow-up|0|||
125448346|NCT04537949|451268910|FG007|Follow-up Phase|Lost to Follow-up|0|||
125448347|NCT04537949|451268903|FG000|Follow-up Phase|personal reasons|0|||
125279731|NCT04826094|450649119|FG007|Overall Study|Lost to Follow-up|1|||
125279732|NCT04826094|450649112|FG000|Overall Study|Participant withdrew consent|1|||
125279733|NCT04826094|450649113|FG001|Overall Study|Participant withdrew consent|0|||
125279734|NCT04826094|450649114|FG002|Overall Study|Participant withdrew consent|0|||
125279735|NCT04826094|450649115|FG003|Overall Study|Participant withdrew consent|1|||
125279736|NCT04826094|450649116|FG004|Overall Study|Participant withdrew consent|1|||
125279737|NCT04826094|450649117|FG005|Overall Study|Participant withdrew consent|1|||
125279738|NCT04826094|450649118|FG006|Overall Study|Participant withdrew consent|0|||
125279739|NCT04826094|450649119|FG007|Overall Study|Participant withdrew consent|1|||
125279740|NCT04826094|450649112|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
125279741|NCT04826094|450649113|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
125279742|NCT04826094|450649114|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
125279743|NCT04826094|450649115|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
125279744|NCT04826094|450649116|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
125279745|NCT04826094|450649117|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
125279746|NCT04826094|450649118|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
125409439|NCT01785602|451124516|FG000|Overall Study|Withdrawal by Subject|2|||
125448348|NCT04537949|451268904|FG001|Follow-up Phase|personal reasons|0|||
125448349|NCT04537949|451268905|FG002|Follow-up Phase|personal reasons|0|||
125279747|NCT04826094|450649119|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
125409440|NCT01785602|451124517|FG001|Overall Study|Withdrawal by Subject|0|||
125409441|NCT01785602|451124516|FG000|Overall Study|Lost to Follow-up|1|||
125409442|NCT01785602|451124517|FG001|Overall Study|Lost to Follow-up|1|||
125448350|NCT04537949|451268906|FG003|Follow-up Phase|personal reasons|1|||
125409443|NCT01785602|451124516|FG000|Overall Study|Adverse Event|3|||
125409444|NCT01785602|451124517|FG001|Overall Study|Adverse Event|5|||
125409445|NCT01785602|451124516|FG000|Overall Study|Administrative problems|7|||
125409446|NCT01785602|451124517|FG001|Overall Study|Administrative problems|3|||
125409447|NCT04177108|451124518|FG000|Overall Study|Withdrawal by Subject|4|||
125409448|NCT04177108|451124519|FG001|Overall Study|Withdrawal by Subject|8|||
125409449|NCT04177108|451124520|FG002|Overall Study|Withdrawal by Subject|9|||
125409450|NCT04177108|451124521|FG003|Overall Study|Withdrawal by Subject|11|||
125409451|NCT04177108|451124522|FG004|Overall Study|Withdrawal by Subject|13|||
125409452|NCT04177108|451124518|FG000|Overall Study|Physician Decision|23|||
125409453|NCT04177108|451124519|FG001|Overall Study|Physician Decision|15|||
125409454|NCT04177108|451124520|FG002|Overall Study|Physician Decision|18|||
125409455|NCT04177108|451124521|FG003|Overall Study|Physician Decision|29|||
125409456|NCT04177108|451124522|FG004|Overall Study|Physician Decision|23|||
125409457|NCT04177108|451124518|FG000|Overall Study|Reason Not Specified|0|||
125409458|NCT04177108|451124519|FG001|Overall Study|Reason Not Specified|1|||
125409459|NCT04177108|451124520|FG002|Overall Study|Reason Not Specified|0|||
125409460|NCT04177108|451124521|FG003|Overall Study|Reason Not Specified|0|||
125409461|NCT04177108|451124522|FG004|Overall Study|Reason Not Specified|2|||
125409462|NCT04177108|451124518|FG000|Overall Study|Lost to Follow-up|0|||
125409463|NCT04177108|451124519|FG001|Overall Study|Lost to Follow-up|0|||
125409464|NCT04177108|451124520|FG002|Overall Study|Lost to Follow-up|1|||
125409465|NCT04177108|451124521|FG003|Overall Study|Lost to Follow-up|1|||
125409466|NCT04177108|451124522|FG004|Overall Study|Lost to Follow-up|1|||
125409467|NCT04177108|451124518|FG000|Overall Study|Death|16|||
125409468|NCT04177108|451124519|FG001|Overall Study|Death|19|||
125409469|NCT04177108|451124520|FG002|Overall Study|Death|13|||
125409470|NCT04177108|451124521|FG003|Overall Study|Death|17|||
125409471|NCT04177108|451124522|FG004|Overall Study|Death|18|||
125409472|NCT01827904|451124526|FG000|Main Study|Withdrawal by Subject|1|||
125409473|NCT01827904|451124527|FG001|Main Study|Withdrawal by Subject|0|||
125409474|NCT01827904|451124528|FG002|Main Study|Withdrawal by Subject|0|||
125409475|NCT01827904|451124526|FG000|Main Study|Adverse Event|1|||
125409476|NCT01827904|451124527|FG001|Main Study|Adverse Event|0|||
125409477|NCT01827904|451124528|FG002|Main Study|Adverse Event|0|||
125279748|NCT04826094|450649112|FG000|Overall Study|Withdrawn by Investigator|0|||
125279749|NCT04826094|450649113|FG001|Overall Study|Withdrawn by Investigator|0|||
125279750|NCT04826094|450649114|FG002|Overall Study|Withdrawn by Investigator|0|||
125279751|NCT04826094|450649115|FG003|Overall Study|Withdrawn by Investigator|0|||
125279752|NCT04826094|450649116|FG004|Overall Study|Withdrawn by Investigator|0|||
125279753|NCT04826094|450649117|FG005|Overall Study|Withdrawn by Investigator|1|||
125279754|NCT04826094|450649118|FG006|Overall Study|Withdrawn by Investigator|0|||
125279755|NCT04826094|450649119|FG007|Overall Study|Withdrawn by Investigator|1|||
125409478|NCT01827904|451124526|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
125409479|NCT01827904|451124527|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
125409480|NCT01827904|451124528|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
125409481|NCT01827904|451124526|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
125409482|NCT01827904|451124527|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
125409483|NCT01827904|451124528|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
125409484|NCT01827904|451124526|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
125409485|NCT01827904|451124527|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
125409486|NCT01827904|451124528|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
125409487|NCT01827904|451124526|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
125409488|NCT01827904|451124527|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
125409489|NCT01827904|451124528|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
125409490|NCT01827904|451124526|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
125409491|NCT01827904|451124527|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
125409492|NCT01827904|451124528|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
125409493|NCT01827904|451124526|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
125409494|NCT01827904|451124527|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
125409495|NCT01827904|451124528|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
125409496|NCT01827904|451124526|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
125279756|NCT04826094|450649112|FG000|Overall Study|Other: Moved from area|1|||
125409497|NCT01827904|451124527|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
125409498|NCT01827904|451124528|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
125279757|NCT04826094|450649113|FG001|Overall Study|Other: Moved from area|1|||
125279758|NCT04826094|450649114|FG002|Overall Study|Other: Moved from area|1|||
125409499|NCT01827904|451124526|FG000|Long-term Annual Follow-up|Physician Decision|1|||
125409500|NCT01827904|451124527|FG001|Long-term Annual Follow-up|Physician Decision|0|||
125409501|NCT01827904|451124528|FG002|Long-term Annual Follow-up|Physician Decision|0|||
125409502|NCT01827904|451124526|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
125409503|NCT01827904|451124527|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
125409504|NCT01827904|451124528|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
125409505|NCT01827904|451124526|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
125409506|NCT01827904|451124527|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
125409507|NCT01827904|451124528|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
125409508|NCT00101101|451124529|FG000|Overall Study|never received vaccine|20|||
125409509|NCT01800903|451124530|FG000|Second Test Period|unable to catheterise|1|||
125409510|NCT01800903|451124531|FG001|Second Test Period|unable to catheterise|0|||
125409511|NCT01800903|451124532|FG002|Second Test Period|unable to catheterise|0|||
125409512|NCT01800903|451124533|FG003|Second Test Period|unable to catheterise|0|||
125409513|NCT01800903|451124534|FG004|Second Test Period|unable to catheterise|0|||
125409514|NCT01800903|451124535|FG005|Second Test Period|unable to catheterise|0|||
125409515|NCT01850004|451124540|FG000|Overall Study|Poor/Non-compliance|1|||
125409516|NCT01850004|451124540|FG000|Overall Study|Participant Withdrew Consent|9|||
125409517|NCT01850004|451124540|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
125409518|NCT01850004|451124540|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
125409519|NCT01850004|451124540|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
125409520|NCT01850004|451124540|FG000|Overall Study|Other Reasons|2|||
125409521|NCT01850004|451124540|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
125409522|NCT01850004|451124540|FG000|Overall Study|Maximum Clinical Benefit|4|||
125409523|NCT03136068|451126510|FG000|Overall Study|Lost to Follow-up|1|||
125409524|NCT03136068|451126511|FG001|Overall Study|Lost to Follow-up|1|||
125409525|NCT03136068|451126510|FG000|Overall Study|Protocol Violation|1|||
125409526|NCT03136068|451126511|FG001|Overall Study|Protocol Violation|0|||
125409527|NCT00432380|451126517|FG000|Overall Study|Migrated/moved from study area|3|||
125409528|NCT00432380|451126518|FG001|Overall Study|Migrated/moved from study area|4|||
125409529|NCT00432380|451126519|FG002|Overall Study|Migrated/moved from study area|1|||
125409530|NCT00432380|451126517|FG000|Overall Study|Adverse Event|1|||
125409531|NCT00432380|451126518|FG001|Overall Study|Adverse Event|0|||
125409532|NCT00432380|451126519|FG002|Overall Study|Adverse Event|0|||
125409533|NCT01071395|451126527|FG000|Overall Study|Withdrawal by Subject|2|||
125409534|NCT01071395|451126528|FG001|Overall Study|Withdrawal by Subject|1|||
125409535|NCT01071395|451126527|FG000|Overall Study|Adverse Event|3|||
125409536|NCT01071395|451126528|FG001|Overall Study|Adverse Event|1|||
125409537|NCT01539291|451126529|FG000|Study GS-US-312-0116|Adverse Event|9|||
125409538|NCT01539291|451126530|FG001|Study GS-US-312-0116|Adverse Event|0|||
125409539|NCT01539291|451126531|FG002|Study GS-US-312-0116|Adverse Event|0|||
125409540|NCT01539291|451126532|FG003|Study GS-US-312-0116|Adverse Event|0|||
125409541|NCT01539291|451126529|FG000|Study GS-US-312-0116|Physician Decision|1|||
125409542|NCT01539291|451126530|FG001|Study GS-US-312-0116|Physician Decision|0|||
125409543|NCT01539291|451126531|FG002|Study GS-US-312-0116|Physician Decision|0|||
125409544|NCT01539291|451126532|FG003|Study GS-US-312-0116|Physician Decision|0|||
125409545|NCT01539291|451126529|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
125409546|NCT01539291|451126530|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
125409547|NCT01539291|451126531|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
125409548|NCT01539291|451126532|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
125409549|NCT01539291|451126529|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
125409550|NCT01539291|451126530|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
125409551|NCT01539291|451126531|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
125409552|NCT01539291|451126532|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
125409553|NCT01539291|451126529|FG000|Study GS-US-312-0116|Other|1|||
125409554|NCT01539291|451126530|FG001|Study GS-US-312-0116|Other|0|||
125409555|NCT01539291|451126531|FG002|Study GS-US-312-0116|Other|0|||
125409556|NCT01539291|451126532|FG003|Study GS-US-312-0116|Other|0|||
125409557|NCT01539291|451126529|FG000|Study GS-US-312-0117|Adverse Event|22|||
125409558|NCT01539291|451126530|FG001|Study GS-US-312-0117|Adverse Event|1|||
125409559|NCT01539291|451126531|FG002|Study GS-US-312-0117|Adverse Event|9|||
125409560|NCT01539291|451126532|FG003|Study GS-US-312-0117|Adverse Event|12|||
125409561|NCT01539291|451126529|FG000|Study GS-US-312-0117|Physician Decision|9|||
125409562|NCT01539291|451126530|FG001|Study GS-US-312-0117|Physician Decision|0|||
125409563|NCT01539291|451126531|FG002|Study GS-US-312-0117|Physician Decision|6|||
125409564|NCT01539291|451126532|FG003|Study GS-US-312-0117|Physician Decision|4|||
125409565|NCT01539291|451126529|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
125409566|NCT01539291|451126530|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
125409567|NCT01539291|451126531|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
125409568|NCT01539291|451126532|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
125409569|NCT01539291|451126529|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
125409570|NCT01539291|451126530|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
125409571|NCT01539291|451126531|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
125409572|NCT01539291|451126532|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
125409573|NCT01539291|451126529|FG000|Study GS-US-312-0117|Other|2|||
125409574|NCT01539291|451126530|FG001|Study GS-US-312-0117|Other|1|||
125409575|NCT01539291|451126531|FG002|Study GS-US-312-0117|Other|1|||
125409576|NCT01539291|451126532|FG003|Study GS-US-312-0117|Other|1|||
125409577|NCT02239510|451126535|FG000|Overall Study|Lost to Follow-up|2|||
125409578|NCT02239510|451126536|FG001|Overall Study|Lost to Follow-up|1|||
125409579|NCT03019536|451126540|FG000|Overall Study|Withdrawal by Subject|1|||
125448351|NCT04537949|451268907|FG004|Follow-up Phase|personal reasons|1|||
125279759|NCT04826094|450649115|FG003|Overall Study|Other: Moved from area|0|||
125409580|NCT03019536|451126541|FG001|Overall Study|Withdrawal by Subject|1|||
125409581|NCT03019536|451126542|FG002|Overall Study|Withdrawal by Subject|0|||
125409582|NCT03019536|451126540|FG000|Overall Study|Adverse Event|0|||
125409583|NCT03019536|451126541|FG001|Overall Study|Adverse Event|0|||
125409584|NCT03019536|451126542|FG002|Overall Study|Adverse Event|2|||
125409585|NCT01782131|451126545|FG000|Overall Study|Death|93|||
125409586|NCT01782131|451126546|FG001|Overall Study|Death|96|||
125409587|NCT01782131|451126545|FG000|Overall Study|Lost to Follow-up|1|||
125409588|NCT01782131|451126546|FG001|Overall Study|Lost to Follow-up|3|||
125409589|NCT01782131|451126545|FG000|Overall Study|Withdrawal by Subject|10|||
125409590|NCT01782131|451126546|FG001|Overall Study|Withdrawal by Subject|10|||
125409591|NCT01782131|451126545|FG000|Overall Study|Randomized but not treated|5|||
125409592|NCT01782131|451126546|FG001|Overall Study|Randomized but not treated|5|||
125409593|NCT01782131|451126545|FG000|Overall Study|Reason not provided|0|||
125409594|NCT01782131|451126546|FG001|Overall Study|Reason not provided|1|||
125409595|NCT01627249|451126547|FG000|Overall Study|Death|3|||
125409596|NCT01627249|451126548|FG001|Overall Study|Death|5|||
125409597|NCT01627249|451126549|FG002|Overall Study|Death|3|||
125409598|NCT01627249|451126547|FG000|Overall Study|Withdrawal by Subject|12|||
125409599|NCT01627249|451126548|FG001|Overall Study|Withdrawal by Subject|6|||
125409600|NCT01627249|451126549|FG002|Overall Study|Withdrawal by Subject|9|||
125409601|NCT01627249|451126547|FG000|Overall Study|Missed Visit|1|||
125409602|NCT01627249|451126548|FG001|Overall Study|Missed Visit|1|||
125409603|NCT01627249|451126549|FG002|Overall Study|Missed Visit|0|||
125409604|NCT03266588|451126550|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
125409605|NCT03266588|451126551|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
125409606|NCT03266588|451126552|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
125409607|NCT03266588|451126550|FG000|Observational Period|Withdrawal by Subject|44|||
125409608|NCT03266588|451126551|FG001|Observational Period|Withdrawal by Subject|22|||
125409609|NCT03266588|451126552|FG002|Observational Period|Withdrawal by Subject|13|||
125409610|NCT03266588|451126550|FG000|Observational Period|Non-compliance|18|||
125409611|NCT03266588|451126551|FG001|Observational Period|Non-compliance|12|||
125409612|NCT03266588|451126552|FG002|Observational Period|Non-compliance|10|||
125409613|NCT03266588|451126550|FG000|Observational Period|Lost to Follow-up|8|||
125409614|NCT03266588|451126551|FG001|Observational Period|Lost to Follow-up|12|||
125409615|NCT03266588|451126552|FG002|Observational Period|Lost to Follow-up|4|||
125409616|NCT03266588|451126550|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
125409617|NCT03266588|451126551|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
125409618|NCT03266588|451126552|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
125409619|NCT03266588|451126550|FG000|Observational Period|Protocol Deviation|1|||
125409620|NCT03266588|451126551|FG001|Observational Period|Protocol Deviation|0|||
125409621|NCT03266588|451126552|FG002|Observational Period|Protocol Deviation|0|||
125409622|NCT03266588|451126550|FG000|Observational Period|Other Reasons|3|||
125409623|NCT03266588|451126551|FG001|Observational Period|Other Reasons|0|||
125409624|NCT03266588|451126552|FG002|Observational Period|Other Reasons|1|||
125409625|NCT03266588|451126550|FG000|Long-term Treatment Period|Adverse Event|33|||
125409626|NCT03266588|451126551|FG001|Long-term Treatment Period|Adverse Event|17|||
125409627|NCT03266588|451126552|FG002|Long-term Treatment Period|Adverse Event|8|||
125409628|NCT03266588|451126550|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
125409629|NCT03266588|451126551|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
125409630|NCT03266588|451126552|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
125409631|NCT03266588|451126550|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
125409632|NCT03266588|451126551|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
125409633|NCT03266588|451126552|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
125409634|NCT03266588|451126550|FG000|Long-term Treatment Period|Non-Compliance|126|||
125409635|NCT03266588|451126551|FG001|Long-term Treatment Period|Non-Compliance|57|||
125409636|NCT03266588|451126552|FG002|Long-term Treatment Period|Non-Compliance|7|||
125409637|NCT03266588|451126550|FG000|Long-term Treatment Period|Pregnancy|11|||
125409638|NCT03266588|451126551|FG001|Long-term Treatment Period|Pregnancy|5|||
125409639|NCT03266588|451126552|FG002|Long-term Treatment Period|Pregnancy|0|||
125409640|NCT03266588|451126550|FG000|Long-term Treatment Period|Protocol Deviation|17|||
125409641|NCT03266588|451126551|FG001|Long-term Treatment Period|Protocol Deviation|10|||
125409642|NCT03266588|451126552|FG002|Long-term Treatment Period|Protocol Deviation|4|||
125279760|NCT04826094|450649116|FG004|Overall Study|Other: Moved from area|0|||
125279761|NCT04826094|450649117|FG005|Overall Study|Other: Moved from area|0|||
125279762|NCT04826094|450649118|FG006|Overall Study|Other: Moved from area|0|||
125409643|NCT03266588|451126550|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
125409644|NCT03266588|451126551|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
125409645|NCT03266588|451126552|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
125409646|NCT03266588|451126550|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
125279763|NCT04826094|450649119|FG007|Overall Study|Other: Moved from area|0|||
125409647|NCT03266588|451126551|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
125409648|NCT03266588|451126552|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
125409649|NCT03266588|451126550|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
125409650|NCT03266588|451126551|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
125409651|NCT03266588|451126552|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
125409652|NCT03266588|451126550|FG000|Long-term Treatment Period|Other Reasons|5|||
125409653|NCT03266588|451126551|FG001|Long-term Treatment Period|Other Reasons|0|||
125409654|NCT03266588|451126552|FG002|Long-term Treatment Period|Other Reasons|0|||
125409655|NCT03266588|451126550|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
125409656|NCT03266588|451126551|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
125409657|NCT03266588|451126552|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
125409658|NCT02627677|451126554|FG000|Overall Study|Adverse event (not progressive disease)|1|||
125409659|NCT02627677|451126555|FG001|Overall Study|Adverse event (not progressive disease)|4|||
125409660|NCT02627677|451126556|FG002|Overall Study|Adverse event (not progressive disease)|1|||
125409661|NCT02627677|451126554|FG000|Overall Study|Progressive disease|1|||
125409662|NCT02627677|451126555|FG001|Overall Study|Progressive disease|3|||
125409663|NCT02627677|451126556|FG002|Overall Study|Progressive disease|0|||
125409664|NCT02627677|451126554|FG000|Overall Study|Lack of Efficacy|1|||
125409665|NCT02627677|451126555|FG001|Overall Study|Lack of Efficacy|2|||
125409666|NCT02627677|451126556|FG002|Overall Study|Lack of Efficacy|0|||
125409667|NCT02627677|451126554|FG000|Overall Study|Lost to Follow-up|0|||
125409668|NCT02627677|451126555|FG001|Overall Study|Lost to Follow-up|0|||
125409669|NCT02627677|451126556|FG002|Overall Study|Lost to Follow-up|1|||
125409670|NCT02627677|451126554|FG000|Overall Study|Pregnancy|0|||
125409671|NCT02627677|451126555|FG001|Overall Study|Pregnancy|1|||
125409672|NCT02627677|451126556|FG002|Overall Study|Pregnancy|0|||
125409673|NCT02627677|451126554|FG000|Overall Study|Study Terminated by Sponsor|5|||
125409674|NCT02627677|451126555|FG001|Overall Study|Study Terminated by Sponsor|10|||
125409675|NCT02627677|451126556|FG002|Overall Study|Study Terminated by Sponsor|6|||
125409676|NCT02627677|451126554|FG000|Overall Study|Physician Decision|0|||
125409677|NCT02627677|451126555|FG001|Overall Study|Physician Decision|0|||
125409678|NCT02627677|451126556|FG002|Overall Study|Physician Decision|2|||
125409679|NCT02627677|451126554|FG000|Overall Study|Withdrawal by Subject|2|||
125409680|NCT02627677|451126555|FG001|Overall Study|Withdrawal by Subject|1|||
125409681|NCT02627677|451126556|FG002|Overall Study|Withdrawal by Subject|1|||
125409682|NCT02627677|451126554|FG000|Overall Study|Reason not Specified|0|||
125409683|NCT02627677|451126555|FG001|Overall Study|Reason not Specified|0|||
125409684|NCT02627677|451126556|FG002|Overall Study|Reason not Specified|1|||
125409685|NCT02627677|451126554|FG000|Overall Study|Randomized but not Treated|1|||
125409686|NCT02627677|451126555|FG001|Overall Study|Randomized but not Treated|0|||
125409687|NCT02627677|451126556|FG002|Overall Study|Randomized but not Treated|0|||
125409688|NCT00966940|451126557|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
125409689|NCT00966940|451126558|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
125409690|NCT00966940|451126557|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
125409691|NCT00966940|451126558|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
125409692|NCT01073618|451126559|FG000|Overall Study|Death|208|||
125409693|NCT01073618|451126559|FG000|Overall Study|Adverse Event|19|||
125409694|NCT01073618|451126559|FG000|Overall Study|Other|80|||
125409695|NCT02032901|451126562|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
125409696|NCT02032901|451126563|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
125409697|NCT02032901|451126562|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
125409698|NCT02032901|451126563|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
125409699|NCT00982020|451126564|FG000|Overall Study|Adverse Event|19|||
125409700|NCT00982020|451126565|FG001|Overall Study|Adverse Event|15|||
125409701|NCT00982020|451126564|FG000|Overall Study|Withdrawal by Subject|11|||
125409702|NCT00982020|451126565|FG001|Overall Study|Withdrawal by Subject|14|||
125409703|NCT00982020|451126564|FG000|Overall Study|Lost to Follow-up|5|||
125409704|NCT00982020|451126565|FG001|Overall Study|Lost to Follow-up|11|||
125409705|NCT00982020|451126564|FG000|Overall Study|Lack of Efficacy|10|||
125409706|NCT00982020|451126565|FG001|Overall Study|Lack of Efficacy|4|||
125409707|NCT00982020|451126564|FG000|Overall Study|Parent/Caregiver Decision|5|||
125409708|NCT00982020|451126565|FG001|Overall Study|Parent/Caregiver Decision|5|||
125409709|NCT00982020|451126564|FG000|Overall Study|Treatment Non-compliance|3|||
125409710|NCT00982020|451126565|FG001|Overall Study|Treatment Non-compliance|6|||
125448352|NCT04537949|451268908|FG005|Follow-up Phase|personal reasons|0|||
125409711|NCT00982020|451126564|FG000|Overall Study|Physician Decision|2|||
125409712|NCT00982020|451126565|FG001|Overall Study|Physician Decision|5|||
125409713|NCT00982020|451126564|FG000|Overall Study|Entry Criteria Not Met|2|||
125409714|NCT00982020|451126565|FG001|Overall Study|Entry Criteria Not Met|1|||
125409715|NCT00982020|451126564|FG000|Overall Study|Protocol Violation|0|||
125409716|NCT00982020|451126565|FG001|Overall Study|Protocol Violation|2|||
125409717|NCT00982020|451126564|FG000|Overall Study|Clinical Relapse|0|||
125409718|NCT00982020|451126565|FG001|Overall Study|Clinical Relapse|1|||
125409719|NCT01722331|451126566|FG000|Part 1|Adverse Event|5|||
125409720|NCT01722331|451126567|FG001|Part 1|Adverse Event|0|||
125409721|NCT01722331|451126568|FG002|Part 1|Adverse Event|0|||
125409722|NCT01722331|451126569|FG003|Part 1|Adverse Event|0|||
125409723|NCT01722331|451126570|FG004|Part 1|Adverse Event|0|||
125409724|NCT01722331|451126571|FG005|Part 1|Adverse Event|0|||
125409725|NCT01722331|451126572|FG006|Part 1|Adverse Event|0|||
125409726|NCT01722331|451126566|FG000|Part 1|Lack of Efficacy|0|||
125409727|NCT01722331|451126567|FG001|Part 1|Lack of Efficacy|0|||
125409728|NCT01722331|451126568|FG002|Part 1|Lack of Efficacy|1|||
125409729|NCT01722331|451126569|FG003|Part 1|Lack of Efficacy|0|||
125409730|NCT01722331|451126570|FG004|Part 1|Lack of Efficacy|2|||
125409731|NCT01722331|451126571|FG005|Part 1|Lack of Efficacy|0|||
125409732|NCT01722331|451126572|FG006|Part 1|Lack of Efficacy|0|||
125409733|NCT01722331|451126566|FG000|Part 1|Lost to Follow-up|1|||
125409734|NCT01722331|451126567|FG001|Part 1|Lost to Follow-up|0|||
125409735|NCT01722331|451126568|FG002|Part 1|Lost to Follow-up|2|||
125409736|NCT01722331|451126569|FG003|Part 1|Lost to Follow-up|0|||
125279764|NCT04826094|450649112|FG000|Overall Study|Other: Declined|0|||
125279765|NCT04826094|450649113|FG001|Overall Study|Other: Declined|0|||
125279766|NCT04826094|450649114|FG002|Overall Study|Other: Declined|0|||
125279767|NCT04826094|450649115|FG003|Overall Study|Other: Declined|0|||
125279768|NCT04826094|450649116|FG004|Overall Study|Other: Declined|1|||
125279769|NCT04826094|450649117|FG005|Overall Study|Other: Declined|0|||
125279770|NCT04826094|450649118|FG006|Overall Study|Other: Declined|0|||
125279771|NCT04826094|450649119|FG007|Overall Study|Other: Declined|0|||
125279772|NCT04826094|450649112|FG000|Overall Study|Other: Vaccine not administered|0|||
125279773|NCT04826094|450649113|FG001|Overall Study|Other: Vaccine not administered|0|||
125279774|NCT04826094|450649114|FG002|Overall Study|Other: Vaccine not administered|1|||
125279775|NCT04826094|450649115|FG003|Overall Study|Other: Vaccine not administered|0|||
125279776|NCT04826094|450649116|FG004|Overall Study|Other: Vaccine not administered|0|||
125279777|NCT04826094|450649117|FG005|Overall Study|Other: Vaccine not administered|1|||
125279778|NCT04826094|450649118|FG006|Overall Study|Other: Vaccine not administered|1|||
125279779|NCT04826094|450649119|FG007|Overall Study|Other: Vaccine not administered|3|||
125279780|NCT05312697|450649120|FG000|Overall Study|Sponsor Terminated Trial|2|||
125279781|NCT04445519|450649121|FG000|Overall Study|Due to adaptive design|3|||
125279782|NCT04445519|450649122|FG001|Overall Study|Due to adaptive design|0|||
125279783|NCT04445519|450649123|FG002|Overall Study|Due to adaptive design|0|||
125279784|NCT04445519|450649121|FG000|Overall Study|Lost to Follow-up|0|||
125279785|NCT04445519|450649122|FG001|Overall Study|Lost to Follow-up|1|||
125279786|NCT04445519|450649123|FG002|Overall Study|Lost to Follow-up|4|||
125279787|NCT04445519|450649121|FG000|Overall Study|Sponsor or IRB Decision|0|||
125279788|NCT04445519|450649122|FG001|Overall Study|Sponsor or IRB Decision|1|||
125279789|NCT04445519|450649123|FG002|Overall Study|Sponsor or IRB Decision|2|||
125279790|NCT04445519|450649121|FG000|Overall Study|Withdrawal by Subject|0|||
125279791|NCT04445519|450649122|FG001|Overall Study|Withdrawal by Subject|3|||
125279792|NCT04445519|450649123|FG002|Overall Study|Withdrawal by Subject|3|||
125409737|NCT01722331|451126570|FG004|Part 1|Lost to Follow-up|1|||
125409738|NCT01722331|451126571|FG005|Part 1|Lost to Follow-up|0|||
125409739|NCT01722331|451126572|FG006|Part 1|Lost to Follow-up|0|||
125409740|NCT01722331|451126566|FG000|Part 1|Physician Decision|0|||
125409741|NCT01722331|451126567|FG001|Part 1|Physician Decision|0|||
125409742|NCT01722331|451126568|FG002|Part 1|Physician Decision|3|||
125409743|NCT01722331|451126569|FG003|Part 1|Physician Decision|0|||
125409744|NCT01722331|451126570|FG004|Part 1|Physician Decision|1|||
125409745|NCT01722331|451126571|FG005|Part 1|Physician Decision|0|||
125409746|NCT01722331|451126572|FG006|Part 1|Physician Decision|0|||
125409747|NCT01722331|451126566|FG000|Part 1|Pregnancy|1|||
125409748|NCT01722331|451126567|FG001|Part 1|Pregnancy|0|||
125409749|NCT01722331|451126568|FG002|Part 1|Pregnancy|0|||
125409750|NCT01722331|451126569|FG003|Part 1|Pregnancy|0|||
125409751|NCT01722331|451126570|FG004|Part 1|Pregnancy|0|||
125409752|NCT01722331|451126571|FG005|Part 1|Pregnancy|0|||
125409753|NCT01722331|451126572|FG006|Part 1|Pregnancy|0|||
125409754|NCT01722331|451126566|FG000|Part 1|Progressive Disease|0|||
125409755|NCT01722331|451126567|FG001|Part 1|Progressive Disease|0|||
125409756|NCT01722331|451126568|FG002|Part 1|Progressive Disease|0|||
125409757|NCT01722331|451126569|FG003|Part 1|Progressive Disease|0|||
125409758|NCT01722331|451126570|FG004|Part 1|Progressive Disease|1|||
125409759|NCT01722331|451126571|FG005|Part 1|Progressive Disease|0|||
125409760|NCT01722331|451126572|FG006|Part 1|Progressive Disease|0|||
125409761|NCT01722331|451126566|FG000|Part 1|Protocol Violation|1|||
125279793|NCT04445519|450649121|FG000|Overall Study|Adverse Event|0|||
125279794|NCT04445519|450649122|FG001|Overall Study|Adverse Event|8|||
125279795|NCT04445519|450649123|FG002|Overall Study|Adverse Event|6|||
125409762|NCT01722331|451126567|FG001|Part 1|Protocol Violation|0|||
125409763|NCT01722331|451126568|FG002|Part 1|Protocol Violation|0|||
125409764|NCT01722331|451126569|FG003|Part 1|Protocol Violation|0|||
125409765|NCT01722331|451126570|FG004|Part 1|Protocol Violation|1|||
125409766|NCT01722331|451126571|FG005|Part 1|Protocol Violation|0|||
125409767|NCT01722331|451126572|FG006|Part 1|Protocol Violation|0|||
125409768|NCT01722331|451126566|FG000|Part 1|Withdrawal by Subject|2|||
125409769|NCT01722331|451126567|FG001|Part 1|Withdrawal by Subject|0|||
125409770|NCT01722331|451126568|FG002|Part 1|Withdrawal by Subject|3|||
125409771|NCT01722331|451126569|FG003|Part 1|Withdrawal by Subject|0|||
125409772|NCT01722331|451126570|FG004|Part 1|Withdrawal by Subject|3|||
125409773|NCT01722331|451126571|FG005|Part 1|Withdrawal by Subject|0|||
125409774|NCT01722331|451126572|FG006|Part 1|Withdrawal by Subject|0|||
125409775|NCT01722331|451126566|FG000|Part 2|Adverse Event|3|||
125409776|NCT01722331|451126567|FG001|Part 2|Adverse Event|0|||
125409777|NCT01722331|451126568|FG002|Part 2|Adverse Event|0|||
125409778|NCT01722331|451126569|FG003|Part 2|Adverse Event|0|||
125409779|NCT01722331|451126570|FG004|Part 2|Adverse Event|0|||
125409780|NCT01722331|451126571|FG005|Part 2|Adverse Event|1|||
125409781|NCT01722331|451126572|FG006|Part 2|Adverse Event|0|||
125409782|NCT01722331|451126566|FG000|Part 2|Lack of Efficacy|3|||
125409783|NCT01722331|451126567|FG001|Part 2|Lack of Efficacy|0|||
125409784|NCT01722331|451126568|FG002|Part 2|Lack of Efficacy|11|||
125409785|NCT01722331|451126569|FG003|Part 2|Lack of Efficacy|0|||
125409786|NCT01722331|451126570|FG004|Part 2|Lack of Efficacy|0|||
125409787|NCT01722331|451126571|FG005|Part 2|Lack of Efficacy|3|||
125409788|NCT01722331|451126572|FG006|Part 2|Lack of Efficacy|3|||
125409789|NCT01722331|451126566|FG000|Part 2|Lost to Follow-up|0|||
125409790|NCT01722331|451126567|FG001|Part 2|Lost to Follow-up|0|||
125409791|NCT01722331|451126568|FG002|Part 2|Lost to Follow-up|3|||
125409792|NCT01722331|451126569|FG003|Part 2|Lost to Follow-up|0|||
125409793|NCT01722331|451126570|FG004|Part 2|Lost to Follow-up|0|||
125409794|NCT01722331|451126571|FG005|Part 2|Lost to Follow-up|1|||
125409795|NCT01722331|451126572|FG006|Part 2|Lost to Follow-up|1|||
125409796|NCT01722331|451126566|FG000|Part 2|Non-Compliance with Study Drug|1|||
125409797|NCT01722331|451126567|FG001|Part 2|Non-Compliance with Study Drug|0|||
125409798|NCT01722331|451126568|FG002|Part 2|Non-Compliance with Study Drug|1|||
125409799|NCT01722331|451126569|FG003|Part 2|Non-Compliance with Study Drug|0|||
125409800|NCT01722331|451126570|FG004|Part 2|Non-Compliance with Study Drug|0|||
125409801|NCT01722331|451126571|FG005|Part 2|Non-Compliance with Study Drug|0|||
125409802|NCT01722331|451126572|FG006|Part 2|Non-Compliance with Study Drug|0|||
125409803|NCT01722331|451126566|FG000|Part 2|Physician Decision|0|||
125409804|NCT01722331|451126567|FG001|Part 2|Physician Decision|0|||
125409805|NCT01722331|451126568|FG002|Part 2|Physician Decision|2|||
125409806|NCT01722331|451126569|FG003|Part 2|Physician Decision|0|||
125409807|NCT01722331|451126570|FG004|Part 2|Physician Decision|0|||
125409808|NCT01722331|451126571|FG005|Part 2|Physician Decision|0|||
125409809|NCT01722331|451126572|FG006|Part 2|Physician Decision|0|||
125409810|NCT01722331|451126566|FG000|Part 2|Pregnancy|0|||
125409811|NCT01722331|451126567|FG001|Part 2|Pregnancy|0|||
125409812|NCT01722331|451126568|FG002|Part 2|Pregnancy|0|||
125409813|NCT01722331|451126569|FG003|Part 2|Pregnancy|0|||
125409814|NCT01722331|451126570|FG004|Part 2|Pregnancy|0|||
125409815|NCT01722331|451126571|FG005|Part 2|Pregnancy|1|||
125409816|NCT01722331|451126572|FG006|Part 2|Pregnancy|0|||
125409817|NCT01722331|451126566|FG000|Part 2|Progressive Disease|0|||
125409818|NCT01722331|451126567|FG001|Part 2|Progressive Disease|0|||
125409819|NCT01722331|451126568|FG002|Part 2|Progressive Disease|1|||
125409820|NCT01722331|451126569|FG003|Part 2|Progressive Disease|0|||
125409821|NCT01722331|451126570|FG004|Part 2|Progressive Disease|0|||
125409822|NCT01722331|451126571|FG005|Part 2|Progressive Disease|0|||
125409823|NCT01722331|451126572|FG006|Part 2|Progressive Disease|0|||
125409824|NCT01722331|451126566|FG000|Part 2|Protocol Violation|1|||
125409825|NCT01722331|451126567|FG001|Part 2|Protocol Violation|0|||
125409826|NCT01722331|451126568|FG002|Part 2|Protocol Violation|0|||
125409827|NCT01722331|451126569|FG003|Part 2|Protocol Violation|0|||
125409828|NCT01722331|451126570|FG004|Part 2|Protocol Violation|0|||
125409829|NCT01722331|451126571|FG005|Part 2|Protocol Violation|0|||
125409830|NCT01722331|451126572|FG006|Part 2|Protocol Violation|0|||
125409831|NCT01722331|451126566|FG000|Part 2|Withdrawal by Subject|5|||
125409832|NCT01722331|451126567|FG001|Part 2|Withdrawal by Subject|0|||
125409833|NCT01722331|451126568|FG002|Part 2|Withdrawal by Subject|3|||
125409834|NCT01722331|451126569|FG003|Part 2|Withdrawal by Subject|0|||
125409835|NCT01722331|451126570|FG004|Part 2|Withdrawal by Subject|0|||
125409836|NCT01722331|451126571|FG005|Part 2|Withdrawal by Subject|2|||
125409837|NCT01722331|451126572|FG006|Part 2|Withdrawal by Subject|2|||
125409838|NCT01722331|451126566|FG000|Part 2|Other Protocol Specified Criteria|6|||
125409839|NCT01722331|451126567|FG001|Part 2|Other Protocol Specified Criteria|0|||
125409840|NCT01722331|451126568|FG002|Part 2|Other Protocol Specified Criteria|10|||
125409841|NCT01722331|451126569|FG003|Part 2|Other Protocol Specified Criteria|0|||
125409842|NCT01722331|451126570|FG004|Part 2|Other Protocol Specified Criteria|0|||
125409843|NCT01722331|451126571|FG005|Part 2|Other Protocol Specified Criteria|2|||
125409844|NCT01722331|451126572|FG006|Part 2|Other Protocol Specified Criteria|1|||
125409845|NCT01722331|451126566|FG000|Part 3|Adverse Event|2|||
125409846|NCT01722331|451126567|FG001|Part 3|Adverse Event|2|||
125409847|NCT01722331|451126568|FG002|Part 3|Adverse Event|0|||
125409848|NCT01722331|451126569|FG003|Part 3|Adverse Event|1|||
125409849|NCT01722331|451126570|FG004|Part 3|Adverse Event|0|||
125409850|NCT01722331|451126571|FG005|Part 3|Adverse Event|0|||
125409851|NCT01722331|451126572|FG006|Part 3|Adverse Event|0|||
125409852|NCT01722331|451126566|FG000|Part 3|Death|1|||
125409853|NCT01722331|451126567|FG001|Part 3|Death|0|||
125409854|NCT01722331|451126568|FG002|Part 3|Death|0|||
125409855|NCT01722331|451126569|FG003|Part 3|Death|0|||
125409856|NCT01722331|451126570|FG004|Part 3|Death|0|||
125409857|NCT01722331|451126571|FG005|Part 3|Death|0|||
125409858|NCT01722331|451126572|FG006|Part 3|Death|0|||
125409859|NCT01722331|451126566|FG000|Part 3|Lack of Efficacy|1|||
125409860|NCT01722331|451126567|FG001|Part 3|Lack of Efficacy|0|||
125409861|NCT01722331|451126568|FG002|Part 3|Lack of Efficacy|0|||
125409862|NCT01722331|451126569|FG003|Part 3|Lack of Efficacy|0|||
125409863|NCT01722331|451126570|FG004|Part 3|Lack of Efficacy|0|||
125409864|NCT01722331|451126571|FG005|Part 3|Lack of Efficacy|0|||
125409865|NCT01722331|451126572|FG006|Part 3|Lack of Efficacy|0|||
125409866|NCT01722331|451126566|FG000|Part 3|Lost to Follow-up|3|||
125409867|NCT01722331|451126567|FG001|Part 3|Lost to Follow-up|4|||
125409868|NCT01722331|451126568|FG002|Part 3|Lost to Follow-up|0|||
125409869|NCT01722331|451126569|FG003|Part 3|Lost to Follow-up|0|||
125409870|NCT01722331|451126570|FG004|Part 3|Lost to Follow-up|0|||
125409871|NCT01722331|451126571|FG005|Part 3|Lost to Follow-up|1|||
125409872|NCT01722331|451126572|FG006|Part 3|Lost to Follow-up|0|||
125409873|NCT01722331|451126566|FG000|Part 3|Non-Compliance with Study Drug|0|||
125409874|NCT01722331|451126567|FG001|Part 3|Non-Compliance with Study Drug|1|||
125409875|NCT01722331|451126568|FG002|Part 3|Non-Compliance with Study Drug|0|||
125409876|NCT01722331|451126569|FG003|Part 3|Non-Compliance with Study Drug|0|||
125409877|NCT01722331|451126570|FG004|Part 3|Non-Compliance with Study Drug|0|||
125409878|NCT01722331|451126571|FG005|Part 3|Non-Compliance with Study Drug|0|||
125409879|NCT01722331|451126572|FG006|Part 3|Non-Compliance with Study Drug|0|||
125409880|NCT01722331|451126566|FG000|Part 3|Physician Decision|1|||
125409881|NCT01722331|451126567|FG001|Part 3|Physician Decision|1|||
125409882|NCT01722331|451126568|FG002|Part 3|Physician Decision|0|||
125409883|NCT01722331|451126569|FG003|Part 3|Physician Decision|0|||
125409884|NCT01722331|451126570|FG004|Part 3|Physician Decision|0|||
125409885|NCT01722331|451126571|FG005|Part 3|Physician Decision|0|||
125409886|NCT01722331|451126572|FG006|Part 3|Physician Decision|1|||
125409887|NCT01722331|451126566|FG000|Part 3|Protocol Violation|2|||
125409888|NCT01722331|451126567|FG001|Part 3|Protocol Violation|1|||
125409889|NCT01722331|451126568|FG002|Part 3|Protocol Violation|0|||
125409890|NCT01722331|451126569|FG003|Part 3|Protocol Violation|0|||
125409891|NCT01722331|451126570|FG004|Part 3|Protocol Violation|0|||
125409892|NCT01722331|451126571|FG005|Part 3|Protocol Violation|0|||
125409893|NCT01722331|451126572|FG006|Part 3|Protocol Violation|0|||
125409894|NCT01722331|451126566|FG000|Part 3|Withdrawal by Subject|4|||
125409895|NCT01722331|451126567|FG001|Part 3|Withdrawal by Subject|7|||
125409896|NCT01722331|451126568|FG002|Part 3|Withdrawal by Subject|0|||
125409897|NCT01722331|451126569|FG003|Part 3|Withdrawal by Subject|0|||
125409898|NCT01722331|451126570|FG004|Part 3|Withdrawal by Subject|0|||
125409899|NCT01722331|451126571|FG005|Part 3|Withdrawal by Subject|2|||
125409900|NCT01722331|451126572|FG006|Part 3|Withdrawal by Subject|1|||
125409901|NCT01722331|451126566|FG000|Part 3|Other Protocol Specified Criteria|1|||
125409902|NCT01722331|451126567|FG001|Part 3|Other Protocol Specified Criteria|1|||
125409903|NCT01722331|451126568|FG002|Part 3|Other Protocol Specified Criteria|0|||
125409904|NCT01722331|451126569|FG003|Part 3|Other Protocol Specified Criteria|0|||
125409905|NCT01722331|451126570|FG004|Part 3|Other Protocol Specified Criteria|0|||
125409906|NCT01722331|451126571|FG005|Part 3|Other Protocol Specified Criteria|0|||
125409907|NCT01722331|451126572|FG006|Part 3|Other Protocol Specified Criteria|0|||
125409908|NCT00262834|451126573|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
125409909|NCT00262834|451126574|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
125409910|NCT00466193|451126575|FG000|Overall Study|Adverse Event|0|||
125409911|NCT00466193|451126576|FG001|Overall Study|Adverse Event|1|||
125409912|NCT00466193|451126575|FG000|Overall Study|Lost to Follow-up|2|||
125409913|NCT00466193|451126576|FG001|Overall Study|Lost to Follow-up|4|||
125409914|NCT00466193|451126575|FG000|Overall Study|Physician Decision|1|||
125409915|NCT00466193|451126576|FG001|Overall Study|Physician Decision|0|||
125409916|NCT00466193|451126575|FG000|Overall Study|Protocol Violation|1|||
125409917|NCT00466193|451126576|FG001|Overall Study|Protocol Violation|1|||
125409918|NCT00466193|451126575|FG000|Overall Study|Withdrawal by Subject|7|||
125409919|NCT00466193|451126576|FG001|Overall Study|Withdrawal by Subject|2|||
125409920|NCT00466193|451126575|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
125409921|NCT00466193|451126576|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
125409922|NCT01054729|451126577|FG000|Overall Study|Randomized but Not Treated|0|||
125409923|NCT01054729|451126578|FG001|Overall Study|Randomized but Not Treated|1|||
125409924|NCT01054729|451126579|FG002|Overall Study|Randomized but Not Treated|0|||
125409925|NCT01054729|451126580|FG003|Overall Study|Randomized but Not Treated|0|||
125409926|NCT01054729|451126577|FG000|Overall Study|Adverse Event|1|||
125279796|NCT04445519|450649121|FG000|Overall Study|Other Reason|0|||
125409927|NCT01054729|451126578|FG001|Overall Study|Adverse Event|1|||
125409928|NCT01054729|451126579|FG002|Overall Study|Adverse Event|2|||
125409929|NCT01054729|451126580|FG003|Overall Study|Adverse Event|1|||
125409930|NCT01054729|451126577|FG000|Overall Study|Withdrawal by Subject|1|||
125409931|NCT01054729|451126578|FG001|Overall Study|Withdrawal by Subject|0|||
125409932|NCT01054729|451126579|FG002|Overall Study|Withdrawal by Subject|1|||
125409933|NCT01054729|451126580|FG003|Overall Study|Withdrawal by Subject|0|||
125409934|NCT01054729|451126577|FG000|Overall Study|Lost to Follow-up|0|||
125409935|NCT01054729|451126578|FG001|Overall Study|Lost to Follow-up|1|||
125409936|NCT01054729|451126579|FG002|Overall Study|Lost to Follow-up|0|||
125409937|NCT01054729|451126580|FG003|Overall Study|Lost to Follow-up|0|||
125409938|NCT01054729|451126577|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
125409939|NCT01054729|451126578|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
125409940|NCT01054729|451126579|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
125409941|NCT01054729|451126580|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
125409942|NCT01054729|451126577|FG000|Overall Study|Non-responder|1|||
125409943|NCT01054729|451126578|FG001|Overall Study|Non-responder|0|||
125409944|NCT01054729|451126579|FG002|Overall Study|Non-responder|1|||
125409945|NCT01054729|451126580|FG003|Overall Study|Non-responder|1|||
125409946|NCT01054729|451126577|FG000|Overall Study|PEG/RBV Non-responder|1|||
125409947|NCT01054729|451126578|FG001|Overall Study|PEG/RBV Non-responder|0|||
125409948|NCT01054729|451126579|FG002|Overall Study|PEG/RBV Non-responder|1|||
125409949|NCT01054729|451126580|FG003|Overall Study|PEG/RBV Non-responder|0|||
125409950|NCT01054729|451126577|FG000|Overall Study|Personal/Obligations|0|||
125409951|NCT01054729|451126578|FG001|Overall Study|Personal/Obligations|1|||
125409952|NCT01054729|451126579|FG002|Overall Study|Personal/Obligations|0|||
125409953|NCT01054729|451126580|FG003|Overall Study|Personal/Obligations|0|||
125409954|NCT01054729|451126577|FG000|Overall Study|Subject moved|0|||
125409955|NCT01054729|451126578|FG001|Overall Study|Subject moved|0|||
125409956|NCT01054729|451126579|FG002|Overall Study|Subject moved|1|||
125409957|NCT01054729|451126580|FG003|Overall Study|Subject moved|0|||
125409958|NCT01054729|451126577|FG000|Overall Study|Lack of Efficacy|0|||
125409959|NCT01054729|451126578|FG001|Overall Study|Lack of Efficacy|0|||
125409960|NCT01054729|451126579|FG002|Overall Study|Lack of Efficacy|0|||
125409961|NCT01054729|451126580|FG003|Overall Study|Lack of Efficacy|1|||
125409962|NCT01033747|451126581|FG000|Overall Study|Adverse Event|9|||
125409963|NCT01033747|451126582|FG001|Overall Study|Adverse Event|4|||
125409964|NCT01033747|451126581|FG000|Overall Study|Abnormal Laboratory Value|1|||
125409965|NCT01033747|451126582|FG001|Overall Study|Abnormal Laboratory Value|0|||
125409966|NCT01033747|451126581|FG000|Overall Study|Abnormal test procedure|0|||
125409967|NCT01033747|451126582|FG001|Overall Study|Abnormal test procedure|1|||
125409968|NCT01033747|451126581|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
125409969|NCT01033747|451126582|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
125409970|NCT01033747|451126581|FG000|Overall Study|Protocol Violation|1|||
125409971|NCT01033747|451126582|FG001|Overall Study|Protocol Violation|0|||
125409972|NCT01033747|451126581|FG000|Overall Study|Withdrawal by Subject|9|||
125409973|NCT01033747|451126582|FG001|Overall Study|Withdrawal by Subject|6|||
125409974|NCT01033747|451126581|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
125409975|NCT01033747|451126582|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
125409976|NCT01033747|451126581|FG000|Overall Study|Stopped at end of Extension 1|2|||
125409977|NCT01033747|451126582|FG001|Overall Study|Stopped at end of Extension 1|0|||
125409978|NCT02956629|451126583|FG000|Overall Study|Adverse Event|0|||
125409979|NCT02956629|451126584|FG001|Overall Study|Adverse Event|0|||
125409980|NCT02956629|451126585|FG002|Overall Study|Adverse Event|1|||
125409981|NCT02956629|451126586|FG003|Overall Study|Adverse Event|0|||
125409982|NCT02956629|451126587|FG004|Overall Study|Adverse Event|0|||
125409983|NCT02956629|451126588|FG005|Overall Study|Adverse Event|0|||
125409984|NCT02956629|451126583|FG000|Overall Study|Lost to Follow-up|2|||
125409985|NCT02956629|451126584|FG001|Overall Study|Lost to Follow-up|5|||
125409986|NCT02956629|451126585|FG002|Overall Study|Lost to Follow-up|3|||
125409987|NCT02956629|451126586|FG003|Overall Study|Lost to Follow-up|1|||
125409988|NCT02956629|451126587|FG004|Overall Study|Lost to Follow-up|0|||
125409989|NCT02956629|451126588|FG005|Overall Study|Lost to Follow-up|1|||
125409990|NCT02956629|451126583|FG000|Overall Study|Withdrawal by Subject|3|||
125409991|NCT02956629|451126584|FG001|Overall Study|Withdrawal by Subject|1|||
125409992|NCT02956629|451126585|FG002|Overall Study|Withdrawal by Subject|0|||
125409993|NCT02956629|451126586|FG003|Overall Study|Withdrawal by Subject|0|||
125409994|NCT02956629|451126587|FG004|Overall Study|Withdrawal by Subject|0|||
125409995|NCT02956629|451126588|FG005|Overall Study|Withdrawal by Subject|0|||
125409996|NCT00844194|451126589|FG000|Overall Study|Adverse Event|17|||
125409997|NCT00844194|451126590|FG001|Overall Study|Adverse Event|5|||
125409998|NCT00844194|451126589|FG000|Overall Study|Protocol Violation|1|||
125409999|NCT00844194|451126590|FG001|Overall Study|Protocol Violation|1|||
125410000|NCT00844194|451126589|FG000|Overall Study|Lost to Follow-up|1|||
125410001|NCT00844194|451126590|FG001|Overall Study|Lost to Follow-up|1|||
125410002|NCT00844194|451126589|FG000|Overall Study|Withdrawal by Subject|2|||
125410003|NCT00844194|451126590|FG001|Overall Study|Withdrawal by Subject|1|||
125410004|NCT00844194|451126589|FG000|Overall Study|Lack of Efficacy|3|||
125410005|NCT00844194|451126590|FG001|Overall Study|Lack of Efficacy|0|||
125410006|NCT00844194|451126589|FG000|Overall Study|Other reason (not specified)|1|||
125410007|NCT00844194|451126590|FG001|Overall Study|Other reason (not specified)|0|||
125410008|NCT02647658|451126595|FG000|Overall Study|Consent refusal|15|||
125410009|NCT02647658|451126596|FG001|Overall Study|Consent refusal|24|||
125410010|NCT00803023|451126597|FG000|Overall Study|Adverse Event|5|||
125410011|NCT00803023|451126598|FG001|Overall Study|Adverse Event|4|||
125410012|NCT00803023|451126599|FG002|Overall Study|Adverse Event|8|||
125410013|NCT00803023|451126600|FG003|Overall Study|Adverse Event|6|||
125410014|NCT00803023|451126597|FG000|Overall Study|Withdrawal by Subject|0|||
125410015|NCT00803023|451126598|FG001|Overall Study|Withdrawal by Subject|2|||
125410016|NCT00803023|451126599|FG002|Overall Study|Withdrawal by Subject|0|||
125410017|NCT00803023|451126600|FG003|Overall Study|Withdrawal by Subject|0|||
125279797|NCT04445519|450649122|FG001|Overall Study|Other Reason|1|||
125279798|NCT04445519|450649123|FG002|Overall Study|Other Reason|1|||
125279799|NCT04445519|450649121|FG000|Overall Study|Protocol Violation|0|||
125410018|NCT00803023|451126597|FG000|Overall Study|Lost to Follow-up|0|||
125410019|NCT00803023|451126598|FG001|Overall Study|Lost to Follow-up|1|||
125410020|NCT00803023|451126599|FG002|Overall Study|Lost to Follow-up|2|||
125410021|NCT00803023|451126600|FG003|Overall Study|Lost to Follow-up|1|||
125410022|NCT00803023|451126597|FG000|Overall Study|Lack of Efficacy|0|||
125410023|NCT00803023|451126598|FG001|Overall Study|Lack of Efficacy|1|||
125410024|NCT00803023|451126599|FG002|Overall Study|Lack of Efficacy|1|||
125410025|NCT00803023|451126600|FG003|Overall Study|Lack of Efficacy|1|||
125410026|NCT01542528|451126601|FG000|Overall Study|Lost to Follow-up|2|||
125410027|NCT01542528|451126602|FG001|Overall Study|Lost to Follow-up|1|||
125410028|NCT01542528|451126601|FG000|Overall Study|Physician Decision|1|||
125410029|NCT01542528|451126602|FG001|Overall Study|Physician Decision|0|||
125410030|NCT01542528|451126601|FG000|Overall Study|Withdrawal by Subject|9|||
125410031|NCT01542528|451126602|FG001|Overall Study|Withdrawal by Subject|6|||
125410032|NCT01931839|451126605|FG000|Overall Study|Death|0|||
125410033|NCT01931839|451126606|FG001|Overall Study|Death|1|||
125410034|NCT01931839|451126607|FG002|Overall Study|Death|2|||
125410035|NCT01931839|451126608|FG003|Overall Study|Death|0|||
125410036|NCT01931839|451126609|FG004|Overall Study|Death|0|||
125410037|NCT01931839|451126610|FG005|Overall Study|Death|0|||
125410038|NCT01931839|451126611|FG006|Overall Study|Death|0|||
125410039|NCT01931839|451126605|FG000|Overall Study|Physician Decision|1|||
125410040|NCT01931839|451126606|FG001|Overall Study|Physician Decision|0|||
125410041|NCT01931839|451126607|FG002|Overall Study|Physician Decision|1|||
125410042|NCT01931839|451126608|FG003|Overall Study|Physician Decision|0|||
125410043|NCT01931839|451126609|FG004|Overall Study|Physician Decision|0|||
125410044|NCT01931839|451126610|FG005|Overall Study|Physician Decision|0|||
125410045|NCT01931839|451126611|FG006|Overall Study|Physician Decision|1|||
125410046|NCT01931839|451126605|FG000|Overall Study|Withdrawal of consent|0|||
125410047|NCT01931839|451126606|FG001|Overall Study|Withdrawal of consent|0|||
125410048|NCT01931839|451126607|FG002|Overall Study|Withdrawal of consent|0|||
125410049|NCT01931839|451126608|FG003|Overall Study|Withdrawal of consent|0|||
125410050|NCT01931839|451126609|FG004|Overall Study|Withdrawal of consent|1|||
125410051|NCT01931839|451126610|FG005|Overall Study|Withdrawal of consent|0|||
125410052|NCT01931839|451126611|FG006|Overall Study|Withdrawal of consent|0|||
125410053|NCT01931839|451126605|FG000|Overall Study|Adverse Event|9|||
125410054|NCT01931839|451126606|FG001|Overall Study|Adverse Event|4|||
125410055|NCT01931839|451126607|FG002|Overall Study|Adverse Event|1|||
125410056|NCT01931839|451126608|FG003|Overall Study|Adverse Event|3|||
125410057|NCT01931839|451126609|FG004|Overall Study|Adverse Event|0|||
125410058|NCT01931839|451126610|FG005|Overall Study|Adverse Event|0|||
125410059|NCT01931839|451126611|FG006|Overall Study|Adverse Event|1|||
125410060|NCT01931839|451126605|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
125410061|NCT01931839|451126606|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
125410062|NCT01931839|451126607|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
125410063|NCT01931839|451126608|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
125410064|NCT01931839|451126609|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
125410065|NCT01931839|451126610|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
125410066|NCT01931839|451126611|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
125410067|NCT01931839|451126605|FG000|Overall Study|Other non-compliance|15|||
125410068|NCT01931839|451126606|FG001|Overall Study|Other non-compliance|9|||
125410069|NCT01931839|451126607|FG002|Overall Study|Other non-compliance|12|||
125410070|NCT01931839|451126608|FG003|Overall Study|Other non-compliance|3|||
125410071|NCT01931839|451126609|FG004|Overall Study|Other non-compliance|0|||
125410072|NCT01931839|451126610|FG005|Overall Study|Other non-compliance|3|||
125410073|NCT01931839|451126611|FG006|Overall Study|Other non-compliance|0|||
125279800|NCT04445519|450649122|FG001|Overall Study|Protocol Violation|0|||
125448353|NCT04537949|451268909|FG006|Follow-up Phase|personal reasons|0|||
125448354|NCT04537949|451268910|FG007|Follow-up Phase|personal reasons|0|||
125448355|NCT04537949|451268903|FG000|Follow-up Phase|Withdrawal by Subject|0|||
125448356|NCT04537949|451268904|FG001|Follow-up Phase|Withdrawal by Subject|0|||
125410074|NCT01931839|451126605|FG000|Overall Study|Lost to Follow-up|1|||
125410075|NCT01931839|451126606|FG001|Overall Study|Lost to Follow-up|2|||
125410076|NCT01931839|451126607|FG002|Overall Study|Lost to Follow-up|4|||
125410077|NCT01931839|451126608|FG003|Overall Study|Lost to Follow-up|5|||
125410078|NCT01931839|451126609|FG004|Overall Study|Lost to Follow-up|0|||
125410079|NCT01931839|451126610|FG005|Overall Study|Lost to Follow-up|0|||
125410080|NCT01931839|451126611|FG006|Overall Study|Lost to Follow-up|0|||
125410081|NCT01931839|451126605|FG000|Overall Study|Other|4|||
125410082|NCT01931839|451126606|FG001|Overall Study|Other|2|||
125410083|NCT01931839|451126607|FG002|Overall Study|Other|6|||
125410084|NCT01931839|451126608|FG003|Overall Study|Other|0|||
125410085|NCT01931839|451126609|FG004|Overall Study|Other|0|||
125410086|NCT01931839|451126610|FG005|Overall Study|Other|0|||
125410087|NCT01931839|451126611|FG006|Overall Study|Other|0|||
125410088|NCT01762761|451126614|FG000|Overall Study|Adverse Event|15|||
125410089|NCT01762761|451126615|FG001|Overall Study|Adverse Event|17|||
125410090|NCT01762761|451126614|FG000|Overall Study|Lack of Efficacy|9|||
125410091|NCT01762761|451126615|FG001|Overall Study|Lack of Efficacy|25|||
125410092|NCT01762761|451126614|FG000|Overall Study|Protocol Violation|1|||
125410093|NCT01762761|451126615|FG001|Overall Study|Protocol Violation|1|||
125410094|NCT01762761|451126614|FG000|Overall Study|Study closed/terminated|0|||
125410095|NCT01762761|451126615|FG001|Overall Study|Study closed/terminated|2|||
125410096|NCT01762761|451126614|FG000|Overall Study|Lost to Follow-up|3|||
125410097|NCT01762761|451126615|FG001|Overall Study|Lost to Follow-up|6|||
125410098|NCT01762761|451126614|FG000|Overall Study|Physician Decision|4|||
125410099|NCT01762761|451126615|FG001|Overall Study|Physician Decision|6|||
125410100|NCT01762761|451126614|FG000|Overall Study|Withdrawal by Subject|7|||
125410101|NCT01762761|451126615|FG001|Overall Study|Withdrawal by Subject|8|||
125410102|NCT00795600|451126622|FG000|Overall Study|Adverse Event|1|||
125410103|NCT00795600|451126623|FG001|Overall Study|Adverse Event|1|||
125410104|NCT00795600|451126622|FG000|Overall Study|Protocol Violation|1|||
125410105|NCT00795600|451126623|FG001|Overall Study|Protocol Violation|2|||
125410106|NCT00795600|451126622|FG000|Overall Study|Withdrawal by Subject|1|||
125410107|NCT00795600|451126623|FG001|Overall Study|Withdrawal by Subject|0|||
125410108|NCT00795600|451126622|FG000|Overall Study|Unclassified|1|||
125410109|NCT00795600|451126623|FG001|Overall Study|Unclassified|1|||
125410110|NCT03936244|451126624|FG000|Overall Study|Lost to Follow-up|5|||
125410111|NCT03936244|451126625|FG001|Overall Study|Lost to Follow-up|1|||
125410112|NCT03936244|451126624|FG000|Overall Study|Physician Decision|7|||
125410113|NCT03936244|451126625|FG001|Overall Study|Physician Decision|3|||
125410114|NCT01430130|451126632|FG000|Overall Study|Lost to Follow-up|1|||
125410115|NCT01430130|451126632|FG000|Overall Study|Infection on Control Side of Incision|1|||
125410116|NCT04788147|451126634|FG000|Overall Study|Screen Failure|3|||
125410117|NCT04788147|451126635|FG001|Overall Study|Screen Failure|10|||
125410118|NCT04788147|451126634|FG000|Overall Study|Incomplete RMRS image session|2|||
125410119|NCT04788147|451126635|FG001|Overall Study|Incomplete RMRS image session|0|||
125410120|NCT00781326|451126636|FG000|Phase I|Adverse Event|1|||
125410121|NCT00781326|451126636|FG000|Phase I|Withdrawal by Subject|1|||
125410122|NCT00781326|451126636|FG000|Phase I|Physician Decision|2|||
125410123|NCT05101252|451126637|FG000|Overall Study|Unsatisfactory Test Article|1|||
125410124|NCT05101252|451126638|FG001|Overall Study|Unsatisfactory Test Article|0|||
125410125|NCT05101252|451126637|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
125410126|NCT05101252|451126638|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
125410127|NCT05101252|451126637|FG000|Overall Study|Withdrew Consent during study|0|||
125410128|NCT05101252|451126638|FG001|Overall Study|Withdrew Consent during study|1|||
125410129|NCT05101252|451126637|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
125410130|NCT05101252|451126638|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
125410131|NCT02266381|451126639|FG000|Overall Study|Physician Decision|3|||
125410132|NCT02266381|451126640|FG001|Overall Study|Physician Decision|5|||
125410133|NCT02266381|451126641|FG002|Overall Study|Physician Decision|4|||
125410134|NCT02401672|451126642|FG000|Overall Study|Withdrawal by Subject|1|||
125410135|NCT02401672|451126643|FG001|Overall Study|Withdrawal by Subject|3|||
125410136|NCT01459796|451126644|FG000|Overall Study|Non compliance with protocol|2|||
125410137|NCT01459796|451126645|FG001|Overall Study|Non compliance with protocol|4|||
125410138|NCT01459796|451126644|FG000|Overall Study|Adverse Event|5|||
125410139|NCT01459796|451126645|FG001|Overall Study|Adverse Event|5|||
125410140|NCT01459796|451126644|FG000|Overall Study|Withdrawal by Subject|6|||
125410141|NCT01459796|451126645|FG001|Overall Study|Withdrawal by Subject|3|||
125410142|NCT01459796|451126644|FG000|Overall Study|Lost to Follow-up|5|||
125410143|NCT01459796|451126645|FG001|Overall Study|Lost to Follow-up|4|||
125410144|NCT01459796|451126644|FG000|Overall Study|Reason unspecified|1|||
125410145|NCT01459796|451126645|FG001|Overall Study|Reason unspecified|2|||
125410146|NCT01459796|451126644|FG000|Overall Study|Decision by the sponsor|75|||
125279801|NCT04445519|450649123|FG002|Overall Study|Protocol Violation|1|||
125410147|NCT01459796|451126645|FG001|Overall Study|Decision by the sponsor|108|||
125410148|NCT00701051|451126646|FG000|Screening|Failed Screening|40|||
125410149|NCT00701051|451126647|FG001|Screening|Failed Screening|0|||
125410150|NCT00701051|451126648|FG002|Screening|Failed Screening|0|||
125410151|NCT00701051|451126646|FG000|Screening|Time conflicts|19|||
125279802|NCT00177294|450649129|FG000|Overall Study|Withdrawal by Subject|7|||
125410152|NCT00701051|451126647|FG001|Screening|Time conflicts|0|||
125410153|NCT00701051|451126648|FG002|Screening|Time conflicts|0|||
125410154|NCT00701051|451126646|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
125410155|NCT00701051|451126647|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
125279803|NCT00177294|450649130|FG001|Overall Study|Withdrawal by Subject|5|||
125410156|NCT00701051|451126648|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
125410157|NCT03207750|451126659|FG000|Overall Study|Adverse Event|3|||
125410158|NCT03207750|451126660|FG001|Overall Study|Adverse Event|2|||
125410159|NCT03207750|451126659|FG000|Overall Study|Lost to Follow-up|21|||
125410160|NCT03207750|451126660|FG001|Overall Study|Lost to Follow-up|29|||
125410161|NCT03207750|451126659|FG000|Overall Study|Protocol Violation|0|||
125410162|NCT03207750|451126660|FG001|Overall Study|Protocol Violation|1|||
125279804|NCT04154605|450649131|FG000|Overall Study|Procedure Canceled|1|||
125279805|NCT04154605|450649132|FG001|Overall Study|Procedure Canceled|1|||
125279806|NCT04154605|450649131|FG000|Overall Study|Missed follow up|1|||
125279807|NCT04154605|450649132|FG001|Overall Study|Missed follow up|1|||
125279808|NCT04154605|450649131|FG000|Overall Study|Withdrawal by Subject|1|||
125279809|NCT04154605|450649132|FG001|Overall Study|Withdrawal by Subject|0|||
125279810|NCT06359028|450649137|FG000|Overall Study|Adverse Event|1|||
125279811|NCT06359028|450649138|FG001|Overall Study|Adverse Event|0|||
125279812|NCT06359028|450649137|FG000|Overall Study|Withdrawal by Subject|1|||
125279813|NCT06359028|450649138|FG001|Overall Study|Withdrawal by Subject|0|||
125279814|NCT00661726|450649140|FG000|Overall Study|Adverse Event|1|||
125279815|NCT02109432|450651075|FG000|Overall Study|Withdrawal by Subject|1|||
125279816|NCT02920528|450651076|FG000|Overall Study|Incomplete Data|1|||
125279817|NCT02920528|450651077|FG001|Overall Study|Incomplete Data|1|||
125279818|NCT02920528|450651078|FG002|Overall Study|Incomplete Data|1|||
125279819|NCT02920528|450651076|FG000|Overall Study|Adverse Event|0|||
125279820|NCT02920528|450651077|FG001|Overall Study|Adverse Event|0|||
125279821|NCT02920528|450651078|FG002|Overall Study|Adverse Event|3|||
125279822|NCT02920528|450651076|FG000|Overall Study|Did not meet inclusion criteria|2|||
125279823|NCT02920528|450651077|FG001|Overall Study|Did not meet inclusion criteria|0|||
125279824|NCT02920528|450651078|FG002|Overall Study|Did not meet inclusion criteria|1|||
125279825|NCT00623233|450651090|FG000|Overall Study|Adverse Event|10|||
125279826|NCT00623233|450651090|FG000|Overall Study|Physician Decision|10|||
125279827|NCT00623233|450651090|FG000|Overall Study|Lost to Follow-up|1|||
125279828|NCT00623233|450651090|FG000|Overall Study|Withdrawal by Subject|3|||
125279829|NCT01811485|450651091|FG000|Overall Study|Adverse Event|1|||
125279830|NCT01811485|450651092|FG001|Overall Study|Adverse Event|3|||
125279831|NCT01811485|450651093|FG002|Overall Study|Adverse Event|2|||
125279832|NCT01811485|450651091|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125279833|NCT01811485|450651092|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125279834|NCT01811485|450651093|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
125279835|NCT01811485|450651091|FG000|Overall Study|Administrative problems|1|||
125279836|NCT01811485|450651092|FG001|Overall Study|Administrative problems|0|||
125279837|NCT01811485|450651093|FG002|Overall Study|Administrative problems|0|||
125279838|NCT01811485|450651091|FG000|Overall Study|Protocol Deviation|0|||
125279839|NCT01811485|450651092|FG001|Overall Study|Protocol Deviation|1|||
125279840|NCT01811485|450651093|FG002|Overall Study|Protocol Deviation|0|||
125279841|NCT01545934|450651094|FG000|Overall Study|Withdrawal by Subject|4|||
125279842|NCT01545934|450651095|FG001|Overall Study|Withdrawal by Subject|3|||
125279843|NCT01545934|450651094|FG000|Overall Study|Lost to Follow-up|1|||
125279844|NCT01545934|450651095|FG001|Overall Study|Lost to Follow-up|0|||
125279845|NCT03654404|450651096|FG000|Overall Study|Death|1|||
125279846|NCT03654404|450651096|FG000|Overall Study|Lost to Follow-up|2|||
125279847|NCT03654404|450651096|FG000|Overall Study|Withdrawal by Subject|5|||
125279848|NCT02003638|450651097|FG000|Overall Study|Withdrawal by Subject|1|||
125279849|NCT02003638|450651098|FG001|Overall Study|Withdrawal by Subject|0|||
125279850|NCT03215758|450651099|FG000|Overall Study|Technical Problems|1|||
125279851|NCT03215758|450651100|FG001|Overall Study|Technical Problems|0|||
125279852|NCT03215758|450651099|FG000|Overall Study|Protocol deviation|0|||
125279853|NCT03215758|450651100|FG001|Overall Study|Protocol deviation|1|||
125279854|NCT03215758|450651099|FG000|Overall Study|Physician Decision|0|||
125279855|NCT03215758|450651100|FG001|Overall Study|Physician Decision|1|||
125279856|NCT03215758|450651099|FG000|Overall Study|Death|0|||
125279857|NCT03215758|450651100|FG001|Overall Study|Death|1|||
125279858|NCT03215758|450651099|FG000|Overall Study|Adverse Event|1|||
125279859|NCT03215758|450651100|FG001|Overall Study|Adverse Event|2|||
125279860|NCT03215758|450651099|FG000|Overall Study|Subject/Guardian Decision|3|||
125279861|NCT03215758|450651100|FG001|Overall Study|Subject/Guardian Decision|3|||
125279862|NCT04115748|450651101|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
125279863|NCT04115748|450651102|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
125279864|NCT04115748|450651103|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
125279865|NCT04115748|450651104|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
125279866|NCT04115748|450651105|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
125279867|NCT04115748|450651106|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
125279868|NCT04115748|450651107|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
125279869|NCT04115748|450651108|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
125279870|NCT04115748|450651109|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
125279871|NCT04115748|450651110|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
125279872|NCT04115748|450651101|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279873|NCT04115748|450651102|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279874|NCT04115748|450651103|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279875|NCT04115748|450651104|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
125279876|NCT04115748|450651105|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279877|NCT04115748|450651106|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279878|NCT04115748|450651107|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279879|NCT04115748|450651108|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125410163|NCT03207750|451126659|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
125410164|NCT03207750|451126660|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
125410165|NCT03207750|451126659|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
125410166|NCT03207750|451126660|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
125410167|NCT03207750|451126659|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
125410168|NCT03207750|451126660|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
125410169|NCT03207750|451126659|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
125410170|NCT03207750|451126660|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
125410171|NCT03207750|451126659|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
125410172|NCT03207750|451126660|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
125410173|NCT00793910|451126661|FG000|Overall Study|discarded study pills|0|||
125410174|NCT00793910|451126662|FG001|Overall Study|discarded study pills|1|||
125410175|NCT00793910|451126661|FG000|Overall Study|did not pick up medications|1|||
125410176|NCT00793910|451126662|FG001|Overall Study|did not pick up medications|1|||
125410177|NCT00793910|451126661|FG000|Overall Study|ineligible based on entry criteria|2|||
125410178|NCT00793910|451126662|FG001|Overall Study|ineligible based on entry criteria|3|||
125410179|NCT00793910|451126661|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
125410180|NCT00793910|451126662|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
125410181|NCT00793910|451126661|FG000|Overall Study|Withdrawal by Subject|0|||
125410182|NCT00793910|451126662|FG001|Overall Study|Withdrawal by Subject|1|||
125410183|NCT01700946|451126663|FG000|Overall Study|Lost to Follow-up|1|||
125410184|NCT01700946|451126664|FG001|Overall Study|Lost to Follow-up|0|||
125410185|NCT01700946|451126663|FG000|Overall Study|Physician Decision|7|||
125410186|NCT01700946|451126664|FG001|Overall Study|Physician Decision|12|||
125410187|NCT01700946|451126663|FG000|Overall Study|Withdrawal by Subject|0|||
125410188|NCT01700946|451126664|FG001|Overall Study|Withdrawal by Subject|2|||
125410189|NCT01700946|451126663|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
125410190|NCT01700946|451126664|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
125410191|NCT01700946|451126663|FG000|Overall Study|Relapse|2|||
125410192|NCT01700946|451126664|FG001|Overall Study|Relapse|1|||
125410193|NCT01700946|451126663|FG000|Overall Study|Unacceptable toxicity|1|||
125410194|NCT01700946|451126664|FG001|Overall Study|Unacceptable toxicity|0|||
125410195|NCT03634579|451126667|FG000|Overall Study|study termination|9|||
125410196|NCT04111497|451126668|FG000|Overall Study|relapse of primary disease|1|||
125410197|NCT04111497|451126668|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
125410198|NCT01024387|451126675|FG000|Overall Study|Radiographic Progression|29|||
125410199|NCT01024387|451126675|FG000|Overall Study|Symptomatic Progression|10|||
125410200|NCT01024387|451126675|FG000|Overall Study|Physician Decision|5|||
125410201|NCT01024387|451126675|FG000|Overall Study|Withdrawal by Subject|5|||
125410202|NCT01024387|451126675|FG000|Overall Study|Death|2|||
125410203|NCT01024387|451126675|FG000|Overall Study|Prolonged Treatment Delay|1|||
125410204|NCT01024387|451126675|FG000|Overall Study|Adverse Event|3|||
125410205|NCT01024387|451126675|FG000|Overall Study|Other|5|||
125410206|NCT03864900|451126676|FG000|Overall Study|Withdrawal by Subject|1|||
125410207|NCT03864900|451126677|FG001|Overall Study|Withdrawal by Subject|1|||
125410208|NCT03864900|451126676|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
125410209|NCT03864900|451126677|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
125410210|NCT03191903|451126678|FG000|Overall Study|Withdrawal by Subject|6|||
125410211|NCT03191903|451126679|FG001|Overall Study|Withdrawal by Subject|5|||
125410212|NCT03191903|451126680|FG002|Overall Study|Withdrawal by Subject|4|||
125410213|NCT03191903|451126678|FG000|Overall Study|Adverse Event|1|||
125410214|NCT03191903|451126679|FG001|Overall Study|Adverse Event|0|||
125410215|NCT03191903|451126680|FG002|Overall Study|Adverse Event|0|||
125410216|NCT01578551|451126683|FG000|Overall Study|Adverse Event|1|||
125410217|NCT01578551|451126684|FG001|Overall Study|Adverse Event|0|||
125410218|NCT04369469|451126691|FG000|Overall Study|Lost to Follow-up|2|||
125410219|NCT04369469|451126692|FG001|Overall Study|Lost to Follow-up|4|||
125410220|NCT04369469|451126691|FG000|Overall Study|Physician Decision|2|||
125410221|NCT04369469|451126692|FG001|Overall Study|Physician Decision|1|||
125410222|NCT04369469|451126691|FG000|Overall Study|Withdrawal by Subject|2|||
125410223|NCT04369469|451126692|FG001|Overall Study|Withdrawal by Subject|3|||
125410224|NCT04369469|451126691|FG000|Overall Study|Adverse Event|1|||
125410225|NCT04369469|451126692|FG001|Overall Study|Adverse Event|0|||
125410226|NCT04369469|451126691|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
125410227|NCT04369469|451126692|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
125410228|NCT04369469|451126691|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
125410229|NCT04369469|451126692|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
125410230|NCT04369469|451126691|FG000|Overall Study|Unable to Provide Consent|0|||
125410231|NCT04369469|451126692|FG001|Overall Study|Unable to Provide Consent|1|||
125410232|NCT03859323|451129006|FG000|Overall Study|Lost to Follow-up|0|||
125410233|NCT03859323|451129007|FG001|Overall Study|Lost to Follow-up|0|||
125410234|NCT03859323|451129008|FG002|Overall Study|Lost to Follow-up|0|||
125410235|NCT03859323|451129009|FG003|Overall Study|Lost to Follow-up|0|||
125410236|NCT03859323|451129010|FG004|Overall Study|Lost to Follow-up|0|||
125410237|NCT03859323|451129011|FG005|Overall Study|Lost to Follow-up|0|||
125410238|NCT03859323|451129012|FG006|Overall Study|Lost to Follow-up|1|||
125410239|NCT03859323|451129013|FG007|Overall Study|Lost to Follow-up|0|||
125410240|NCT03859323|451129014|FG008|Overall Study|Lost to Follow-up|0|||
125410241|NCT03859323|451129015|FG009|Overall Study|Lost to Follow-up|0|||
125410242|NCT03859323|451129016|FG010|Overall Study|Lost to Follow-up|0|||
125410243|NCT03859323|451129017|FG011|Overall Study|Lost to Follow-up|0|||
125410244|NCT03859323|451129018|FG012|Overall Study|Lost to Follow-up|0|||
125410245|NCT03859323|451129006|FG000|Overall Study|Withdrawal by Subject|0|||
125410246|NCT03859323|451129007|FG001|Overall Study|Withdrawal by Subject|0|||
125410247|NCT03859323|451129008|FG002|Overall Study|Withdrawal by Subject|1|||
125410248|NCT03859323|451129009|FG003|Overall Study|Withdrawal by Subject|0|||
125410249|NCT03859323|451129010|FG004|Overall Study|Withdrawal by Subject|0|||
125410250|NCT03859323|451129011|FG005|Overall Study|Withdrawal by Subject|1|||
125410251|NCT03859323|451129012|FG006|Overall Study|Withdrawal by Subject|0|||
125410252|NCT03859323|451129013|FG007|Overall Study|Withdrawal by Subject|0|||
125410253|NCT03859323|451129014|FG008|Overall Study|Withdrawal by Subject|0|||
125410254|NCT03859323|451129015|FG009|Overall Study|Withdrawal by Subject|1|||
125410255|NCT03859323|451129016|FG010|Overall Study|Withdrawal by Subject|1|||
125410256|NCT03859323|451129017|FG011|Overall Study|Withdrawal by Subject|2|||
125410257|NCT03859323|451129018|FG012|Overall Study|Withdrawal by Subject|1|||
125410258|NCT03859323|451129006|FG000|Overall Study|Pregnancy|0|||
125410259|NCT03859323|451129007|FG001|Overall Study|Pregnancy|0|||
125410260|NCT03859323|451129008|FG002|Overall Study|Pregnancy|0|||
125410261|NCT03859323|451129009|FG003|Overall Study|Pregnancy|0|||
125410262|NCT03859323|451129010|FG004|Overall Study|Pregnancy|0|||
125410263|NCT03859323|451129011|FG005|Overall Study|Pregnancy|0|||
125410264|NCT03859323|451129012|FG006|Overall Study|Pregnancy|0|||
125410265|NCT03859323|451129013|FG007|Overall Study|Pregnancy|0|||
125410266|NCT03859323|451129014|FG008|Overall Study|Pregnancy|0|||
125410267|NCT03859323|451129015|FG009|Overall Study|Pregnancy|1|||
125410268|NCT03859323|451129016|FG010|Overall Study|Pregnancy|0|||
125410269|NCT03859323|451129017|FG011|Overall Study|Pregnancy|0|||
125410270|NCT03859323|451129018|FG012|Overall Study|Pregnancy|0|||
125410271|NCT03320070|451129019|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
125410272|NCT03320070|451129020|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
125410273|NCT03320070|451129019|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
125410274|NCT03320070|451129020|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
125410275|NCT03320070|451129019|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
125410276|NCT03320070|451129020|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
125410277|NCT03320070|451129019|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
125410278|NCT03320070|451129020|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
125410279|NCT03320070|451129019|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
125410280|NCT03320070|451129020|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
125410281|NCT03320070|451129019|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
125410282|NCT03320070|451129020|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
125410283|NCT00996996|451129021|FG000|Overall Study|Progressive Disease|10|||
125410284|NCT00996996|451129021|FG000|Overall Study|Non-compliance|8|||
125410285|NCT00996996|451129021|FG000|Overall Study|Lost to Follow-up|9|||
125410286|NCT00996996|451129021|FG000|Overall Study|Death|5|||
125410287|NCT00996996|451129021|FG000|Overall Study|Did Not Receive Study Medications|1|||
125410288|NCT01375049|451129022|FG000|Overall Study|Adverse Event|2|||
125410289|NCT01375049|451129022|FG000|Overall Study|Lost to Follow-up|1|||
125410290|NCT01375049|451129022|FG000|Overall Study|Withdrawal by Subject|2|||
125410291|NCT01375049|451129022|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
125410292|NCT01175382|451129025|FG000|Overall Study|Lost to Follow-up|4|||
125410293|NCT01175382|451129026|FG001|Overall Study|Lost to Follow-up|3|||
125410294|NCT01175382|451129027|FG002|Overall Study|Lost to Follow-up|1|||
125410295|NCT01175382|451129025|FG000|Overall Study|Physician Decision|0|||
125410296|NCT01175382|451129026|FG001|Overall Study|Physician Decision|1|||
125410297|NCT01175382|451129027|FG002|Overall Study|Physician Decision|0|||
125410298|NCT01175382|451129025|FG000|Overall Study|Withdrawal by Subject|0|||
125410299|NCT01175382|451129026|FG001|Overall Study|Withdrawal by Subject|0|||
125410300|NCT01175382|451129027|FG002|Overall Study|Withdrawal by Subject|1|||
125410301|NCT01175382|451129025|FG000|Overall Study|No longer having problem|1|||
125410302|NCT01175382|451129026|FG001|Overall Study|No longer having problem|0|||
125410303|NCT01175382|451129027|FG002|Overall Study|No longer having problem|1|||
125410304|NCT01175382|451129025|FG000|Overall Study|Unable/unwilling to attend visits|3|||
125410305|NCT01175382|451129026|FG001|Overall Study|Unable/unwilling to attend visits|1|||
125410306|NCT01175382|451129027|FG002|Overall Study|Unable/unwilling to attend visits|2|||
125410307|NCT01175382|451129025|FG000|Overall Study|Unwilling to follow protocol|0|||
125410308|NCT01175382|451129026|FG001|Overall Study|Unwilling to follow protocol|1|||
125410309|NCT01175382|451129027|FG002|Overall Study|Unwilling to follow protocol|0|||
125410310|NCT01175382|451129025|FG000|Overall Study|Unable to tolerate study meds|0|||
125410311|NCT01175382|451129026|FG001|Overall Study|Unable to tolerate study meds|1|||
125410312|NCT01175382|451129027|FG002|Overall Study|Unable to tolerate study meds|1|||
125410313|NCT00774787|451129028|FG000|Overall Study|Lost to Follow-up|1|||
125410314|NCT02554773|451129029|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
125410315|NCT02554773|451129030|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
125410316|NCT02554773|451129029|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
125410317|NCT02554773|451129030|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
125410318|NCT02554773|451129029|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
125410319|NCT02554773|451129030|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
125410320|NCT02554773|451129029|FG000|Original Dose Regimen (SAS 1)|Death|1|||
125410321|NCT02554773|451129030|FG001|Original Dose Regimen (SAS 1)|Death|0|||
125410322|NCT02554773|451129029|FG000|Original Dose Regimen (SAS 1)|Other|4|||
125410323|NCT02554773|451129030|FG001|Original Dose Regimen (SAS 1)|Other|0|||
125410324|NCT02554773|451129029|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
125410325|NCT02554773|451129030|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
125410326|NCT02554773|451129029|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
125410327|NCT02554773|451129030|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
125410328|NCT02554773|451129029|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
125410329|NCT02554773|451129030|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
125410330|NCT02554773|451129029|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
125410331|NCT02554773|451129030|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
125410332|NCT02031276|451129033|FG000|Period 1 Double-blind IV|Adverse Event|6|||
125410333|NCT02031276|451129034|FG001|Period 1 Double-blind IV|Adverse Event|5|||
125410334|NCT02031276|451129035|FG002|Period 1 Double-blind IV|Adverse Event|1|||
125410335|NCT02031276|451129033|FG000|Period 1 Double-blind IV|Other|0|||
125410336|NCT02031276|451129034|FG001|Period 1 Double-blind IV|Other|1|||
125410337|NCT02031276|451129035|FG002|Period 1 Double-blind IV|Other|0|||
125410338|NCT02031276|451129033|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
125410339|NCT02031276|451129034|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
125410340|NCT02031276|451129035|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
125410341|NCT02031276|451129033|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
125410342|NCT02031276|451129034|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
125410343|NCT02031276|451129035|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
125410344|NCT02031276|451129033|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
125410345|NCT02031276|451129034|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
125410346|NCT02031276|451129035|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
125410347|NCT02031276|451129033|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
125410348|NCT02031276|451129034|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
125410349|NCT02031276|451129035|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
125410350|NCT02031276|451129033|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
125410351|NCT02031276|451129034|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
125410352|NCT02031276|451129035|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
125410353|NCT02031276|451129033|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
125410354|NCT02031276|451129034|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
125410355|NCT02031276|451129035|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
125410356|NCT02031276|451129033|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
125410357|NCT02031276|451129034|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
125410358|NCT02031276|451129035|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
125410359|NCT01148810|451129036|FG000|Overall Study|Adverse Event|0|||
125410360|NCT01148810|451129037|FG001|Overall Study|Adverse Event|2|||
125410361|NCT01148810|451129036|FG000|Overall Study|Lack of Efficacy|0|||
125410362|NCT01148810|451129037|FG001|Overall Study|Lack of Efficacy|1|||
125410363|NCT01148810|451129036|FG000|Overall Study|Withdrawal by Subject|0|||
125410364|NCT01148810|451129037|FG001|Overall Study|Withdrawal by Subject|2|||
125410365|NCT01148810|451129036|FG000|Overall Study|Protocol Violation|1|||
125410366|NCT01148810|451129037|FG001|Overall Study|Protocol Violation|0|||
125410367|NCT01854554|451129038|FG000|Overall Study|Denial of Insurance Coverage|12|||
125279880|NCT04115748|450651109|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279881|NCT04115748|450651110|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
125279882|NCT04115748|450651101|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
125279883|NCT04115748|450651102|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
125279884|NCT04115748|450651103|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
125279885|NCT04115748|450651104|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
125279886|NCT04115748|450651105|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
125279887|NCT04115748|450651106|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
125279888|NCT04115748|450651107|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
125410368|NCT01854554|451129039|FG001|Overall Study|Denial of Insurance Coverage|0|||
125410369|NCT01854554|451129038|FG000|Overall Study|Decided to get treatment locally|1|||
125410370|NCT01854554|451129039|FG001|Overall Study|Decided to get treatment locally|5|||
125410371|NCT01854554|451129038|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
125410372|NCT01854554|451129039|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
125410373|NCT01854554|451129038|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
125410374|NCT01854554|451129039|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
125410375|NCT01854554|451129038|FG000|Overall Study|Progression|0|||
125410376|NCT01854554|451129039|FG001|Overall Study|Progression|1|||
125410377|NCT01854554|451129038|FG000|Overall Study|Lost to Follow-up|0|||
125410378|NCT01854554|451129039|FG001|Overall Study|Lost to Follow-up|1|||
125410379|NCT02819726|451129044|FG000|Part A (All Participants)|Lost to Follow-up|0|||
125410380|NCT02819726|451129045|FG001|Part A (All Participants)|Lost to Follow-up|1|||
125410381|NCT02819726|451129046|FG002|Part A (All Participants)|Lost to Follow-up|0|||
125410382|NCT02819726|451129047|FG003|Part A (All Participants)|Lost to Follow-up|0|||
125410383|NCT02819726|451129044|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
125410384|NCT02819726|451129045|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
125410385|NCT02819726|451129046|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
125410386|NCT02819726|451129047|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
125410387|NCT02819726|451129044|FG000|Part A (All Participants)|Protocol non-compliance|3|||
125410388|NCT02819726|451129045|FG001|Part A (All Participants)|Protocol non-compliance|4|||
125410389|NCT02819726|451129046|FG002|Part A (All Participants)|Protocol non-compliance|5|||
125410390|NCT02819726|451129047|FG003|Part A (All Participants)|Protocol non-compliance|0|||
125410391|NCT02819726|451129044|FG000|Part B (All Participants)|Lost to Follow-up|1|||
125410392|NCT02819726|451129045|FG001|Part B (All Participants)|Lost to Follow-up|1|||
125410393|NCT02819726|451129046|FG002|Part B (All Participants)|Lost to Follow-up|2|||
125410394|NCT02819726|451129047|FG003|Part B (All Participants)|Lost to Follow-up|2|||
125410395|NCT02819726|451129044|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
125410396|NCT02819726|451129045|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
125410397|NCT02819726|451129046|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
125410398|NCT02819726|451129047|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
125410399|NCT02819726|451129044|FG000|Part B (All Participants)|Protocol non-compliance|0|||
125410400|NCT02819726|451129045|FG001|Part B (All Participants)|Protocol non-compliance|0|||
125410401|NCT02819726|451129046|FG002|Part B (All Participants)|Protocol non-compliance|1|||
125410402|NCT02819726|451129047|FG003|Part B (All Participants)|Protocol non-compliance|0|||
125410403|NCT02613481|451129048|FG000|Overall Study|Lost to Follow-up|7|||
125410404|NCT02613481|451129048|FG000|Overall Study|Withdrawal by Subject|2|||
125410405|NCT01992536|451129050|FG000|Overall Study|Administrative Reason|0|||
125410406|NCT01992536|451129051|FG001|Overall Study|Administrative Reason|0|||
125410407|NCT01992536|451129052|FG002|Overall Study|Administrative Reason|0|||
125410408|NCT01992536|451129053|FG003|Overall Study|Administrative Reason|0|||
125410409|NCT01992536|451129054|FG004|Overall Study|Administrative Reason|0|||
125410410|NCT01992536|451129055|FG005|Overall Study|Administrative Reason|0|||
125410411|NCT01992536|451129056|FG006|Overall Study|Administrative Reason|7|||
125410412|NCT01992536|451129057|FG007|Overall Study|Administrative Reason|0|||
125410413|NCT01992536|451129058|FG008|Overall Study|Administrative Reason|0|||
125410414|NCT01992536|451129059|FG009|Overall Study|Administrative Reason|0|||
125410415|NCT01992536|451129050|FG000|Overall Study|Lost to Follow-up|4|||
125410416|NCT01992536|451129051|FG001|Overall Study|Lost to Follow-up|2|||
125410417|NCT01992536|451129052|FG002|Overall Study|Lost to Follow-up|1|||
125410418|NCT01992536|451129053|FG003|Overall Study|Lost to Follow-up|0|||
125410419|NCT01992536|451129054|FG004|Overall Study|Lost to Follow-up|0|||
125410420|NCT01992536|451129055|FG005|Overall Study|Lost to Follow-up|1|||
125410421|NCT01992536|451129056|FG006|Overall Study|Lost to Follow-up|0|||
125410422|NCT01992536|451129057|FG007|Overall Study|Lost to Follow-up|0|||
125410423|NCT01992536|451129058|FG008|Overall Study|Lost to Follow-up|1|||
125410424|NCT01992536|451129059|FG009|Overall Study|Lost to Follow-up|1|||
125410425|NCT01992536|451129050|FG000|Overall Study|Withdrawal by Subject|0|||
125410426|NCT01992536|451129051|FG001|Overall Study|Withdrawal by Subject|1|||
125410427|NCT01992536|451129052|FG002|Overall Study|Withdrawal by Subject|0|||
125410428|NCT01992536|451129053|FG003|Overall Study|Withdrawal by Subject|2|||
125410429|NCT01992536|451129054|FG004|Overall Study|Withdrawal by Subject|0|||
125410430|NCT01992536|451129055|FG005|Overall Study|Withdrawal by Subject|0|||
125410431|NCT01992536|451129056|FG006|Overall Study|Withdrawal by Subject|0|||
125279889|NCT04115748|450651108|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
125279890|NCT04115748|450651109|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
125279891|NCT04115748|450651110|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
125279892|NCT04115748|450651101|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279893|NCT04115748|450651102|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125410432|NCT01992536|451129057|FG007|Overall Study|Withdrawal by Subject|0|||
125410433|NCT01992536|451129058|FG008|Overall Study|Withdrawal by Subject|0|||
125410434|NCT01992536|451129059|FG009|Overall Study|Withdrawal by Subject|0|||
125410435|NCT00406029|451129063|FG000|Overall Study|Adverse Event|12|||
125410436|NCT00406029|451129064|FG001|Overall Study|Adverse Event|2|||
125410437|NCT00406029|451129065|FG002|Overall Study|Adverse Event|5|||
125410438|NCT00406029|451129066|FG003|Overall Study|Adverse Event|10|||
125410439|NCT00406029|451129067|FG004|Overall Study|Adverse Event|7|||
125410440|NCT00406029|451129063|FG000|Overall Study|Withdrawal by Subject|3|||
125410441|NCT00406029|451129064|FG001|Overall Study|Withdrawal by Subject|4|||
125410442|NCT00406029|451129065|FG002|Overall Study|Withdrawal by Subject|2|||
125410443|NCT00406029|451129066|FG003|Overall Study|Withdrawal by Subject|2|||
125410444|NCT00406029|451129067|FG004|Overall Study|Withdrawal by Subject|0|||
125410445|NCT00406029|451129063|FG000|Overall Study|Protocol Violation|1|||
125410446|NCT00406029|451129064|FG001|Overall Study|Protocol Violation|2|||
125410447|NCT00406029|451129065|FG002|Overall Study|Protocol Violation|0|||
125410448|NCT00406029|451129066|FG003|Overall Study|Protocol Violation|2|||
125410449|NCT00406029|451129067|FG004|Overall Study|Protocol Violation|0|||
125410450|NCT00406029|451129063|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
125410451|NCT00406029|451129064|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
125410452|NCT00406029|451129065|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
125410453|NCT00406029|451129066|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
125410454|NCT00406029|451129067|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
125410455|NCT00406029|451129063|FG000|Overall Study|Randomized in Error|0|||
125410456|NCT00406029|451129064|FG001|Overall Study|Randomized in Error|0|||
125410457|NCT00406029|451129065|FG002|Overall Study|Randomized in Error|2|||
125410458|NCT00406029|451129066|FG003|Overall Study|Randomized in Error|3|||
125410459|NCT00406029|451129067|FG004|Overall Study|Randomized in Error|1|||
125410460|NCT01709227|451129068|FG000|Overall Study|Physician Decision|1|||
125410461|NCT01709227|451129069|FG001|Overall Study|Physician Decision|0|||
125410462|NCT01709227|451129068|FG000|Overall Study|Pleural Peritoneal communication|0|||
125410463|NCT01709227|451129069|FG001|Overall Study|Pleural Peritoneal communication|9|||
125410464|NCT03669081|451129071|FG000|Overall Study|Data could not be validated|1|||
125410465|NCT03669081|451129072|FG001|Overall Study|Data could not be validated|1|||
125410466|NCT00389324|451129073|FG000|Run-In Phase|Adverse Event|1|||
125410467|NCT00389324|451129073|FG000|Run-In Phase|Lost to Follow-up|1|||
125410468|NCT00389324|451129073|FG000|Run-In Phase|Withdrawal by Subject|1|||
125410469|NCT00389324|451129073|FG000|Subcutaneous Phase|Adverse Event|2|||
125410470|NCT00389324|451129073|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
125410471|NCT00389324|451129073|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
125410472|NCT00389324|451129073|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
125410473|NCT02317575|451129074|FG000|Period 1|Difficulty with venous cannulation|0|||
125410474|NCT02317575|451129075|FG001|Period 1|Difficulty with venous cannulation|1|||
125410475|NCT02317575|451129076|FG002|Period 1|Difficulty with venous cannulation|0|||
125410476|NCT02317575|451129077|FG003|Period 1|Difficulty with venous cannulation|0|||
125410477|NCT02317575|451129078|FG004|Period 1|Difficulty with venous cannulation|0|||
125410478|NCT02317575|451129074|FG000|Period 1|Withdrawal by Subject|1|||
125410479|NCT02317575|451129075|FG001|Period 1|Withdrawal by Subject|0|||
125410480|NCT02317575|451129076|FG002|Period 1|Withdrawal by Subject|0|||
125410481|NCT02317575|451129077|FG003|Period 1|Withdrawal by Subject|0|||
125410482|NCT02317575|451129078|FG004|Period 1|Withdrawal by Subject|0|||
125410483|NCT01921348|451129079|FG000|Overall Study|Withdrawal by Subject|1|||
125410484|NCT01921348|451129080|FG001|Overall Study|Withdrawal by Subject|0|||
125410485|NCT01921348|451129079|FG000|Overall Study|Lost to Follow-up|0|||
125410486|NCT01921348|451129080|FG001|Overall Study|Lost to Follow-up|2|||
125410487|NCT03321019|451129090|FG000|Overall Study|Withdrawal by Subject|0|||
125410488|NCT03321019|451129091|FG001|Overall Study|Withdrawal by Subject|6|||
125410489|NCT03321019|451129090|FG000|Overall Study|Lost to Follow-up|0|||
125410490|NCT03321019|451129091|FG001|Overall Study|Lost to Follow-up|22|||
125410491|NCT03433456|451129095|FG000|Overall Study|Death|1|||
125410492|NCT03433456|451129096|FG001|Overall Study|Death|1|||
125410493|NCT03433456|451129095|FG000|Overall Study|Lost to Follow-up|14|||
125410494|NCT03433456|451129096|FG001|Overall Study|Lost to Follow-up|11|||
125410495|NCT03433456|451129095|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
125410496|NCT03433456|451129096|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
125410497|NCT03694548|451129097|FG000|Part A Survey|Protocol Violation|3|||
125410498|NCT03694548|451129098|FG001|Part A Survey|Protocol Violation|3|||
125410499|NCT03694548|451129099|FG002|Part A Survey|Protocol Violation|0|||
125410500|NCT03694548|451129097|FG000|Part B Yoga Program|Protocol Violation|0|||
125410501|NCT03694548|451129098|FG001|Part B Yoga Program|Protocol Violation|0|||
125410502|NCT03694548|451129099|FG002|Part B Yoga Program|Protocol Violation|3|||
125410503|NCT03694548|451129097|FG000|Part B Yoga Program|Did not attend intervention|0|||
125410504|NCT03694548|451129098|FG001|Part B Yoga Program|Did not attend intervention|0|||
125410505|NCT03694548|451129099|FG002|Part B Yoga Program|Did not attend intervention|8|||
125410506|NCT04496258|451129100|FG000|Overall Study|Withdrawal by Subject|2|||
125410507|NCT04496258|451129101|FG001|Overall Study|Withdrawal by Subject|1|||
125410508|NCT04102501|451129102|FG000|Overall Study|Withdrawal by Subject|7|||
125410509|NCT04102501|451129103|FG001|Overall Study|Withdrawal by Subject|9|||
125410510|NCT04102501|451129102|FG000|Overall Study|Adverse Event|1|||
125410511|NCT04102501|451129103|FG001|Overall Study|Adverse Event|3|||
125410512|NCT01427712|451129104|FG000|Overall Study|Transfer to a different hospital|2|||
125410513|NCT01427712|451129104|FG000|Overall Study|Lost to Follow-up|1|||
125410514|NCT01427712|451129104|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
125410515|NCT01427712|451129104|FG000|Overall Study|Failure to visit|1|||
125410516|NCT00968617|451129106|FG000|Overall Study|Study terminated by sponsor|6|||
125410517|NCT00439777|451129107|FG000|Treatment Period|Death|29|||
125410518|NCT00439777|451129108|FG001|Treatment Period|Death|21|||
125410519|NCT00439777|451129107|FG000|Treatment Period|Study terminated by sponsor|125|||
125410520|NCT00439777|451129108|FG001|Treatment Period|Study terminated by sponsor|132|||
125410521|NCT00439777|451129107|FG000|Treatment Period|Site closed by investigator|0|||
125410522|NCT00439777|451129108|FG001|Treatment Period|Site closed by investigator|1|||
125410523|NCT00439777|451129107|FG000|Treatment Period|Did not take study treatment|7|||
125410524|NCT00439777|451129108|FG001|Treatment Period|Did not take study treatment|8|||
125410525|NCT00439777|451129107|FG000|Treatment Period|Adverse Event|111|||
125410526|NCT00439777|451129108|FG001|Treatment Period|Adverse Event|92|||
125410527|NCT00439777|451129107|FG000|Treatment Period|Protocol Violation|23|||
125410528|NCT00439777|451129108|FG001|Treatment Period|Protocol Violation|30|||
125410529|NCT00439777|451129107|FG000|Treatment Period|Withdrawal by Subject|66|||
125410530|NCT00439777|451129108|FG001|Treatment Period|Withdrawal by Subject|118|||
125410531|NCT00439777|451129107|FG000|Treatment Period|Lack of Efficacy|1|||
125410532|NCT00439777|451129108|FG001|Treatment Period|Lack of Efficacy|4|||
125410533|NCT00439777|451129107|FG000|Treatment Period|Lost to Follow-up|8|||
125410534|NCT00439777|451129108|FG001|Treatment Period|Lost to Follow-up|10|||
125410535|NCT00439777|451129107|FG000|Treatment Period|Protocol driven decision point|1|||
125410536|NCT00439777|451129108|FG001|Treatment Period|Protocol driven decision point|3|||
125410537|NCT00439777|451129107|FG000|Treatment Period|Physician Decision|7|||
125410538|NCT00439777|451129108|FG001|Treatment Period|Physician Decision|18|||
125410539|NCT00439777|451129107|FG000|Treatment Period|Clinical endpoint reached|26|||
125410540|NCT00439777|451129108|FG001|Treatment Period|Clinical endpoint reached|13|||
125410541|NCT00439777|451129107|FG000|Treatment Period|Technical problems|3|||
125410542|NCT00439777|451129108|FG001|Treatment Period|Technical problems|1|||
125410543|NCT00439777|451129107|FG000|Treatment Period|Participant convenience|12|||
125410544|NCT00439777|451129108|FG001|Treatment Period|Participant convenience|8|||
125410545|NCT00439777|451129107|FG000|Observational Period|Protocol Violation|0|||
125410546|NCT00439777|451129108|FG001|Observational Period|Protocol Violation|2|||
125410547|NCT00439777|451129107|FG000|Observational Period|Withdrawal by Subject|9|||
125410548|NCT00439777|451129108|FG001|Observational Period|Withdrawal by Subject|5|||
125410549|NCT00439777|451129107|FG000|Observational Period|Lost to Follow-up|1|||
125410550|NCT00439777|451129108|FG001|Observational Period|Lost to Follow-up|11|||
125410551|NCT00439777|451129107|FG000|Observational Period|Death|27|||
125410552|NCT00439777|451129108|FG001|Observational Period|Death|20|||
125410553|NCT00439777|451129107|FG000|Observational Period|Study terminated by sponsor|3|||
125410554|NCT00439777|451129108|FG001|Observational Period|Study terminated by sponsor|1|||
125410555|NCT00439777|451129107|FG000|Observational Period|Protocol driven decision point|0|||
125410556|NCT00439777|451129108|FG001|Observational Period|Protocol driven decision point|1|||
125410557|NCT00439777|451129107|FG000|Observational Period|Lack of Efficacy|1|||
125410558|NCT00439777|451129108|FG001|Observational Period|Lack of Efficacy|0|||
125410559|NCT00439777|451129107|FG000|Observational Period|Technical problems|0|||
125410560|NCT00439777|451129108|FG001|Observational Period|Technical problems|1|||
125410561|NCT00661492|451129109|FG000|Overall Study|Adverse Event|16|||
125410562|NCT00661492|451129110|FG001|Overall Study|Adverse Event|13|||
125410563|NCT00661492|451129109|FG000|Overall Study|Disease Progression|44|||
125410564|NCT00661492|451129110|FG001|Overall Study|Disease Progression|14|||
125410565|NCT00661492|451129109|FG000|Overall Study|Patient Request|6|||
125410566|NCT00661492|451129110|FG001|Overall Study|Patient Request|1|||
125410567|NCT00661492|451129109|FG000|Overall Study|Investigator Request|1|||
125410568|NCT00661492|451129110|FG001|Overall Study|Investigator Request|0|||
125410569|NCT00661492|451129109|FG000|Overall Study|Lost to Follow-up|0|||
125410570|NCT00661492|451129110|FG001|Overall Study|Lost to Follow-up|1|||
125410571|NCT00661492|451129109|FG000|Overall Study|Other|1|||
125410572|NCT00661492|451129110|FG001|Overall Study|Other|0|||
125279894|NCT04115748|450651103|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279895|NCT04115748|450651104|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279896|NCT04115748|450651105|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279897|NCT04115748|450651106|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279898|NCT04115748|450651107|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279899|NCT04115748|450651108|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125410573|NCT03855189|451129111|FG000|Overall Study|Adverse Event|5|||
125410574|NCT03855189|451129112|FG001|Overall Study|Adverse Event|2|||
125410575|NCT03855189|451129113|FG002|Overall Study|Adverse Event|4|||
125410576|NCT03855189|451129111|FG000|Overall Study|Treatment Failure|1|||
125410577|NCT03855189|451129112|FG001|Overall Study|Treatment Failure|1|||
125410578|NCT03855189|451129113|FG002|Overall Study|Treatment Failure|2|||
125410579|NCT03855189|451129111|FG000|Overall Study|Noncompliance with Protocol|0|||
125410580|NCT03855189|451129112|FG001|Overall Study|Noncompliance with Protocol|1|||
125410581|NCT03855189|451129113|FG002|Overall Study|Noncompliance with Protocol|0|||
125410582|NCT03855189|451129111|FG000|Overall Study|Did Not Return|4|||
125410583|NCT03855189|451129112|FG001|Overall Study|Did Not Return|3|||
125410584|NCT03855189|451129113|FG002|Overall Study|Did Not Return|0|||
125410585|NCT01143259|451129114|FG000|Overall Study|Withdrawal by Subject|3|||
125410586|NCT01143259|451129115|FG001|Overall Study|Withdrawal by Subject|2|||
125410587|NCT01143259|451129114|FG000|Overall Study|Protocol Violation|13|||
125410588|NCT01143259|451129115|FG001|Overall Study|Protocol Violation|9|||
125279900|NCT04115748|450651109|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
125279901|NCT04115748|450651110|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
125279902|NCT00713349|450651111|FG000|Overall Study|Protocol Violation|1|||
125279903|NCT03764631|450651112|FG000|Overall Study|Personal Reasons|3|||
125279904|NCT03764631|450651113|FG001|Overall Study|Personal Reasons|2|||
125279905|NCT03764631|450651112|FG000|Overall Study|Switching Therapy|3|||
125279906|NCT03764631|450651113|FG001|Overall Study|Switching Therapy|3|||
125279907|NCT03764631|450651112|FG000|Overall Study|Adverse Event|0|||
125279908|NCT03764631|450651113|FG001|Overall Study|Adverse Event|1|||
125279909|NCT03764631|450651112|FG000|Overall Study|Lost to Follow-up|33|||
125279910|NCT03764631|450651113|FG001|Overall Study|Lost to Follow-up|41|||
125279911|NCT03764631|450651112|FG000|Overall Study|No data as study site was closed|2|||
125279912|NCT03764631|450651113|FG001|Overall Study|No data as study site was closed|6|||
125279913|NCT01200407|450651114|FG000|Overall Study|Lost to Follow-up|56|||
125410589|NCT01143259|451129114|FG000|Overall Study|Screen Failure|7|||
125410590|NCT01143259|451129115|FG001|Overall Study|Screen Failure|9|||
125410591|NCT00099983|451129116|FG000|Overall Study|Lost to Follow-up|2|||
125410592|NCT00099983|451129117|FG001|Overall Study|Lost to Follow-up|3|||
125410593|NCT00099983|451129116|FG000|Overall Study|Missing Source Documents|14|||
125410594|NCT00099983|451129117|FG001|Overall Study|Missing Source Documents|15|||
125410595|NCT00099983|451129116|FG000|Overall Study|Withdrawal by Subject|3|||
125410596|NCT00099983|451129117|FG001|Overall Study|Withdrawal by Subject|2|||
125410597|NCT00099983|451129116|FG000|Overall Study|Adverse Event|1|||
125410598|NCT00099983|451129117|FG001|Overall Study|Adverse Event|1|||
125410599|NCT00099983|451129116|FG000|Overall Study|Lack of Efficacy|0|||
125410600|NCT00099983|451129117|FG001|Overall Study|Lack of Efficacy|1|||
125410601|NCT00099983|451129116|FG000|Overall Study|Unable to return for appointments|1|||
125410602|NCT00099983|451129117|FG001|Overall Study|Unable to return for appointments|1|||
125410603|NCT00099983|451129116|FG000|Overall Study|Moved|1|||
125410604|NCT00099983|451129117|FG001|Overall Study|Moved|0|||
125410605|NCT00099983|451129116|FG000|Overall Study|Other psychiatric problem|1|||
125410606|NCT00099983|451129117|FG001|Overall Study|Other psychiatric problem|0|||
125410607|NCT00099983|451129116|FG000|Overall Study|Incarcerated|0|||
125410608|NCT00099983|451129117|FG001|Overall Study|Incarcerated|1|||
125410609|NCT00099983|451129116|FG000|Overall Study|Intolerant of burden of visits|0|||
125410610|NCT00099983|451129117|FG001|Overall Study|Intolerant of burden of visits|1|||
125410611|NCT00099983|451129116|FG000|Overall Study|Other issue|1|||
125410612|NCT00099983|451129117|FG001|Overall Study|Other issue|0|||
125410613|NCT02641080|451129118|FG000|Overall Study|Physician Decision|2|||
125410614|NCT02641080|451129119|FG001|Overall Study|Physician Decision|0|||
125410615|NCT02641080|451129118|FG000|Overall Study|Withdrawal by Subject|0|||
125410616|NCT02641080|451129119|FG001|Overall Study|Withdrawal by Subject|1|||
125410617|NCT02641080|451129118|FG000|Overall Study|Rehab Center denied use of pumps|0|||
125410618|NCT02641080|451129119|FG001|Overall Study|Rehab Center denied use of pumps|3|||
125410619|NCT02641080|451129118|FG000|Overall Study|Lost to Follow-up|0|||
125410620|NCT02641080|451129119|FG001|Overall Study|Lost to Follow-up|3|||
125410621|NCT00803634|451129120|FG000|Overall Study|Withdrew Consent|1|||
125410622|NCT00803634|451129121|FG001|Overall Study|Withdrew Consent|0|||
125410623|NCT00803634|451129120|FG000|Overall Study|Lost to Follow-up|2|||
125410624|NCT00803634|451129121|FG001|Overall Study|Lost to Follow-up|3|||
125410625|NCT00803634|451129120|FG000|Overall Study|Death|3|||
125410626|NCT00803634|451129121|FG001|Overall Study|Death|2|||
125279914|NCT01200407|450651114|FG000|Overall Study|Adverse Event|3|||
125279915|NCT01200407|450651114|FG000|Overall Study|Withdrawal by Subject|4|||
125279916|NCT01200407|450651114|FG000|Overall Study|Other|19|||
125279917|NCT03299881|450651115|FG000|Overall Study|Study Termination|17|||
125279918|NCT03299881|450651116|FG001|Overall Study|Study Termination|13|||
125279919|NCT01549886|450651117|FG000|Overall Study|Sponsor's decision|2|||
125279920|NCT01549886|450651118|FG001|Overall Study|Sponsor's decision|3|||
125279921|NCT00473668|450651121|FG000|Overall Study|Withdrawal by Subject|0|||
125279922|NCT00473668|450651122|FG001|Overall Study|Withdrawal by Subject|2|||
125279923|NCT00473668|450651123|FG002|Overall Study|Withdrawal by Subject|0|||
125410627|NCT04307186|451129124|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
125410628|NCT04307186|451129124|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
125410629|NCT04307186|451129124|FG000|Washout 3-14 Days|Progressive disease|1|||
125410630|NCT04307186|451129124|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
125410631|NCT04307186|451129124|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
125410632|NCT00759109|451129128|FG000|Overall Study|Adverse Event|17|||
125410633|NCT00759109|451129129|FG001|Overall Study|Adverse Event|12|||
125410634|NCT00759109|451129128|FG000|Overall Study|Inability to comply|1|||
125410635|NCT00759109|451129129|FG001|Overall Study|Inability to comply|1|||
125410636|NCT00759109|451129128|FG000|Overall Study|Withdrawal by Subject|9|||
125410637|NCT00759109|451129129|FG001|Overall Study|Withdrawal by Subject|5|||
125410638|NCT00759109|451129128|FG000|Overall Study|Death|4|||
125410639|NCT00759109|451129129|FG001|Overall Study|Death|3|||
125410640|NCT00759109|451129128|FG000|Overall Study|Lost to Follow-up|4|||
125410641|NCT00759109|451129129|FG001|Overall Study|Lost to Follow-up|6|||
125410642|NCT00759109|451129128|FG000|Overall Study|Started new therapy|2|||
125279924|NCT00473668|450651121|FG000|Overall Study|Migrated/moved from study area|3|||
125279925|NCT00473668|450651122|FG001|Overall Study|Migrated/moved from study area|2|||
125279926|NCT00473668|450651123|FG002|Overall Study|Migrated/moved from study area|0|||
125279927|NCT00473668|450651121|FG000|Overall Study|Lost to Follow-up|0|||
125279928|NCT00473668|450651122|FG001|Overall Study|Lost to Follow-up|4|||
125279929|NCT00473668|450651123|FG002|Overall Study|Lost to Follow-up|6|||
125279930|NCT00473668|450651121|FG000|Overall Study|Other|2|||
125279931|NCT00473668|450651122|FG001|Overall Study|Other|3|||
125279932|NCT00473668|450651123|FG002|Overall Study|Other|4|||
125279933|NCT03195660|450651124|FG000|Overall Study|The study was terminated|2|||
125279934|NCT05260073|450651126|FG000|Overall Study|Physician Decision|1|||
125279935|NCT05260073|450651126|FG000|Overall Study|Withdrawal by Subject|6|||
125279936|NCT05260073|450651126|FG000|Overall Study|Lost to Follow-up|14|||
125279937|NCT03458910|450651127|FG000|Overall Study|Withdrawal by Subject|7|||
125279938|NCT03458910|450651128|FG001|Overall Study|Withdrawal by Subject|8|||
125448357|NCT04537949|451268905|FG002|Follow-up Phase|Withdrawal by Subject|0|||
125448358|NCT04537949|451268906|FG003|Follow-up Phase|Withdrawal by Subject|0|||
125448359|NCT04537949|451268907|FG004|Follow-up Phase|Withdrawal by Subject|1|||
125448360|NCT04537949|451268908|FG005|Follow-up Phase|Withdrawal by Subject|0|||
125448361|NCT04537949|451268909|FG006|Follow-up Phase|Withdrawal by Subject|0|||
125279939|NCT03458910|450651129|FG002|Overall Study|Withdrawal by Subject|6|||
125279940|NCT03458910|450651130|FG003|Overall Study|Withdrawal by Subject|4|||
125279941|NCT03458910|450651127|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
125279942|NCT03458910|450651128|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
125279943|NCT03458910|450651129|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
125279944|NCT03458910|450651130|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
125279945|NCT04484649|450651131|FG000|Overall Study|Lost to Follow-up|2|||
125279946|NCT04484649|450651132|FG001|Overall Study|Lost to Follow-up|1|||
125279947|NCT04484649|450651131|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
125279948|NCT04484649|450651132|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
125279949|NCT01450696|450651133|FG000|Overall Study|Never Treated|1|||
125279950|NCT01450696|450651134|FG001|Overall Study|Never Treated|1|||
125279951|NCT01450696|450651133|FG000|Overall Study|Death|77|||
125279952|NCT01450696|450651134|FG001|Overall Study|Death|84|||
125279953|NCT01450696|450651133|FG000|Overall Study|Lost to Follow-up|3|||
125279954|NCT01450696|450651134|FG001|Overall Study|Lost to Follow-up|3|||
125279955|NCT01450696|450651133|FG000|Overall Study|Non-Compliance|1|||
125279956|NCT01450696|450651134|FG001|Overall Study|Non-Compliance|0|||
125279957|NCT01450696|450651133|FG000|Overall Study|Withdrawal by Subject|13|||
125279958|NCT01450696|450651134|FG001|Overall Study|Withdrawal by Subject|2|||
125279959|NCT01450696|450651133|FG000|Overall Study|Study Terminated by Sponsor|53|||
125279960|NCT01450696|450651134|FG001|Overall Study|Study Terminated by Sponsor|58|||
125279961|NCT02249091|450651137|FG000|Overall Study|Lack of Efficacy|8|||
125279962|NCT02249091|450651138|FG001|Overall Study|Lack of Efficacy|3|||
125279963|NCT02249091|450651137|FG000|Overall Study|Physician Decision|4|||
125279964|NCT02249091|450651138|FG001|Overall Study|Physician Decision|1|||
125279965|NCT02249091|450651137|FG000|Overall Study|Withdrawal by Subject|2|||
125279966|NCT02249091|450651138|FG001|Overall Study|Withdrawal by Subject|2|||
125279967|NCT02249091|450651137|FG000|Overall Study|Death|3|||
125279968|NCT02249091|450651138|FG001|Overall Study|Death|4|||
125279969|NCT02249091|450651137|FG000|Overall Study|Adverse Event|1|||
125279970|NCT02249091|450651138|FG001|Overall Study|Adverse Event|0|||
125279971|NCT02249091|450651137|FG000|Overall Study|Stable disease with following SCT|0|||
125279972|NCT02249091|450651138|FG001|Overall Study|Stable disease with following SCT|1|||
125279973|NCT02249091|450651137|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
125279974|NCT02249091|450651138|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
125279975|NCT02249091|450651137|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
125279976|NCT02249091|450651138|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
125279977|NCT02249091|450651137|FG000|Overall Study|Refractory AML|1|||
125279978|NCT02249091|450651138|FG001|Overall Study|Refractory AML|1|||
125279979|NCT00433966|450651139|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
125279980|NCT00433966|450651140|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
125279981|NCT00433966|450651141|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
125279982|NCT00433966|450651142|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
125279983|NCT00433966|450651139|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
125279984|NCT00433966|450651140|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
125448362|NCT04537949|451268910|FG007|Follow-up Phase|Withdrawal by Subject|0|||
125448363|NCT04003974|451268911|FG000|Overall Study|Missing|1|||
125279985|NCT00433966|450651141|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
125279986|NCT00433966|450651142|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
125279987|NCT00433966|450651139|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
125279988|NCT00433966|450651140|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
125279989|NCT00433966|450651141|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
125410643|NCT00759109|451129129|FG001|Overall Study|Started new therapy|6|||
125410644|NCT00759109|451129128|FG000|Overall Study|HCV RNA negative|1|||
125410645|NCT00759109|451129129|FG001|Overall Study|HCV RNA negative|0|||
125410646|NCT00759109|451129128|FG000|Overall Study|Participant moved to a different city|0|||
125410647|NCT00759109|451129129|FG001|Overall Study|Participant moved to a different city|1|||
125410648|NCT00759109|451129128|FG000|Overall Study|Participant had a liver transplant|0|||
125410649|NCT00759109|451129129|FG001|Overall Study|Participant had a liver transplant|1|||
125410650|NCT00759109|451129128|FG000|Overall Study|Lost during study|1|||
125410651|NCT00759109|451129129|FG001|Overall Study|Lost during study|0|||
125410652|NCT03165045|451129130|FG000|Visit 1|No registration after visit 1|9|||
125410653|NCT03165045|451129130|FG000|Visit 1|No treatment documented|10|||
125410654|NCT03165045|451129130|FG000|Visit 1|No visit 1|10|||
125410655|NCT03165045|451129130|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
125410656|NCT03165045|451129130|FG000|Visit 2|No available total CCQ score at all|29|||
125410657|NCT03165045|451129130|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
125410658|NCT03238001|451129131|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
125410659|NCT03238001|451129131|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
125410660|NCT03238001|451129131|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
125410661|NCT03238001|451129131|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
125410662|NCT03238001|451129131|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
125410663|NCT03238001|451129131|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
125410664|NCT03238001|451129131|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
125410665|NCT03238001|451129131|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
125410666|NCT01866709|451129135|FG000|Overall Study|Adverse Event|1|||
125410667|NCT01866709|451129136|FG001|Overall Study|Adverse Event|0|||
125410668|NCT03791398|451129137|FG000|Overall Study|Progression of Disease Under Study|2|||
125410669|NCT03791398|451129138|FG001|Overall Study|Progression of Disease Under Study|0|||
125410670|NCT03791398|451129139|FG002|Overall Study|Progression of Disease Under Study|0|||
125410671|NCT02207829|451129140|FG000|Overall Study|Adverse Event|10|||
125410672|NCT02207829|451129141|FG001|Overall Study|Adverse Event|9|||
125410673|NCT02207829|451129140|FG000|Overall Study|Lack of Efficacy|7|||
125410674|NCT02207829|451129141|FG001|Overall Study|Lack of Efficacy|5|||
125410675|NCT02207829|451129140|FG000|Overall Study|Lost to Follow-up|2|||
125410676|NCT02207829|451129141|FG001|Overall Study|Lost to Follow-up|2|||
125279990|NCT00433966|450651142|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
125279991|NCT00433966|450651139|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
125279992|NCT00433966|450651140|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
125279993|NCT00433966|450651141|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
125279994|NCT00433966|450651142|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
125279995|NCT00433966|450651139|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
125279996|NCT00433966|450651140|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
125279997|NCT00433966|450651141|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
125279998|NCT00433966|450651142|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
125279999|NCT02570152|450651143|FG000|Overall Study|Protocol Violation|2|||
125280000|NCT02570152|450651143|FG000|Overall Study|Migrated/moved from study area|13|||
125280001|NCT02957747|450651144|FG000|Overall Study|Withdrawal by Subject|0|||
125280002|NCT02957747|450651145|FG001|Overall Study|Withdrawal by Subject|3|||
125280003|NCT02957747|450651144|FG000|Overall Study|Lost to Follow-up|10|||
125280004|NCT02957747|450651145|FG001|Overall Study|Lost to Follow-up|5|||
125280005|NCT00632827|450651146|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
125280006|NCT00632827|450651146|FG000|Overall Study|Death|2|||
125280007|NCT00632827|450651146|FG000|Overall Study|Adverse Event|5|||
125280008|NCT00632827|450651146|FG000|Overall Study|Lost to Follow-up|1|||
125280009|NCT01177553|450651147|FG000|Overall Study|babies not yet 6 months of age|1|||
125280010|NCT01177553|450651148|FG001|Overall Study|babies not yet 6 months of age|0|||
125280011|NCT03931382|450651151|FG000|Overall Study|Equipment malfunction|2|||
125280012|NCT03931382|450651152|FG001|Overall Study|Equipment malfunction|0|||
125280013|NCT03931382|450651153|FG002|Overall Study|Equipment malfunction|2|||
125280014|NCT03931382|450651151|FG000|Overall Study|Withdrawal by Subject|0|||
125280015|NCT03931382|450651152|FG001|Overall Study|Withdrawal by Subject|1|||
125280016|NCT03931382|450651153|FG002|Overall Study|Withdrawal by Subject|0|||
125280017|NCT00778375|450651160|FG000|Overall Study|Ineligible|3|||
125280018|NCT04590404|450651163|FG000|Overall Study|Death|16|||
125280019|NCT04590404|450651164|FG001|Overall Study|Death|17|||
125280020|NCT04590404|450651163|FG000|Overall Study|Withdrawal by Subject|7|||
125410677|NCT02207829|451129140|FG000|Overall Study|Protocol deviation|5|||
125410678|NCT02207829|451129141|FG001|Overall Study|Protocol deviation|4|||
125410679|NCT02207829|451129140|FG000|Overall Study|Withdrew consent|18|||
125280021|NCT04590404|450651164|FG001|Overall Study|Withdrawal by Subject|2|||
125280022|NCT01581021|450651169|FG000|Overall Study|Lost to Follow-up|4|||
125280023|NCT01581021|450651170|FG001|Overall Study|Lost to Follow-up|6|||
125280024|NCT01581021|450651169|FG000|Overall Study|More than 2 hooks in thoracic|3|||
125410680|NCT02207829|451129141|FG001|Overall Study|Withdrew consent|14|||
125410681|NCT00766376|451129142|FG000|Overall Study|Withdrawal by Subject|27|||
125410682|NCT00927927|451129146|FG000|Overall Study|Withdrawal by Subject|0|||
125410683|NCT00927927|451129147|FG001|Overall Study|Withdrawal by Subject|0|||
125280025|NCT01581021|450651170|FG001|Overall Study|More than 2 hooks in thoracic|0|||
125280026|NCT01581021|450651169|FG000|Overall Study|Neuromuscular|2|||
125280027|NCT01581021|450651170|FG001|Overall Study|Neuromuscular|1|||
125280028|NCT01581021|450651169|FG000|Overall Study|Not Randomized|1|||
125280029|NCT01581021|450651170|FG001|Overall Study|Not Randomized|2|||
125280030|NCT01581021|450651169|FG000|Overall Study|Lenke 6 Classification|0|||
125410684|NCT00927927|451129148|FG002|Overall Study|Withdrawal by Subject|0|||
125410685|NCT00927927|451129149|FG003|Overall Study|Withdrawal by Subject|0|||
125410686|NCT00927927|451129150|FG004|Overall Study|Withdrawal by Subject|0|||
125410687|NCT00927927|451129151|FG005|Overall Study|Withdrawal by Subject|0|||
125410688|NCT00927927|451129152|FG006|Overall Study|Withdrawal by Subject|0|||
125410689|NCT00927927|451129153|FG007|Overall Study|Withdrawal by Subject|2|||
125410690|NCT00927927|451129154|FG008|Overall Study|Withdrawal by Subject|0|||
125410691|NCT00927927|451129155|FG009|Overall Study|Withdrawal by Subject|0|||
125410692|NCT00927927|451129156|FG010|Overall Study|Withdrawal by Subject|0|||
125410693|NCT00927927|451129157|FG011|Overall Study|Withdrawal by Subject|2|||
125410694|NCT00927927|451129158|FG012|Overall Study|Withdrawal by Subject|0|||
125410695|NCT00927927|451129159|FG013|Overall Study|Withdrawal by Subject|0|||
125410696|NCT00927927|451129160|FG014|Overall Study|Withdrawal by Subject|0|||
125410697|NCT01110239|451129167|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
125410698|NCT01110239|451129168|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
125410699|NCT01110239|451129169|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
125410700|NCT01110239|451129170|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
125410701|NCT01110239|451129167|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
125410702|NCT01110239|451129168|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
125410703|NCT01110239|451129169|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
125410704|NCT01110239|451129170|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
125410705|NCT00080223|451129173|FG000|Overall Study|Adverse Event|23|||
125410706|NCT00080223|451129173|FG000|Overall Study|Death|21|||
125410707|NCT00080223|451129173|FG000|Overall Study|Withdrawal by Subject|13|||
125410708|NCT00080223|451129173|FG000|Overall Study|Lung Transplantation|9|||
125410709|NCT00080223|451129173|FG000|Overall Study|Non-compliance With Study Treatment|7|||
125410710|NCT00080223|451129173|FG000|Overall Study|Participant unwilling to continue|2|||
125410711|NCT00080223|451129173|FG000|Overall Study|Physician Decision|1|||
125410712|NCT05204134|451129176|FG000|Overall Study|Withdrawal by Subject|3|||
125410713|NCT05204134|451129176|FG000|Overall Study|Physician Decision|1|||
125410714|NCT03135522|451129179|FG000|Overall Study|Adverse Event|1|||
125410715|NCT03135522|451129180|FG001|Overall Study|Adverse Event|0|||
125410716|NCT03099382|451129181|FG000|Overall Study|Protocol Violation|2|||
125410717|NCT03099382|451129182|FG001|Overall Study|Protocol Violation|3|||
125410718|NCT00499369|451129183|FG000|Overall Study|Adverse Event|2|||
125410719|NCT00499369|451129184|FG001|Overall Study|Adverse Event|2|||
125410720|NCT00499369|451129185|FG002|Overall Study|Adverse Event|3|||
125410721|NCT00499369|451129186|FG003|Overall Study|Adverse Event|1|||
125410722|NCT00499369|451129187|FG004|Overall Study|Adverse Event|2|||
125410723|NCT00499369|451129183|FG000|Overall Study|Withdrawal by Subject|0|||
125410724|NCT00499369|451129184|FG001|Overall Study|Withdrawal by Subject|1|||
125410725|NCT00499369|451129185|FG002|Overall Study|Withdrawal by Subject|1|||
125410726|NCT00499369|451129186|FG003|Overall Study|Withdrawal by Subject|0|||
125410727|NCT00499369|451129187|FG004|Overall Study|Withdrawal by Subject|0|||
125410728|NCT00499369|451129183|FG000|Overall Study|Progression|10|||
125410729|NCT00499369|451129184|FG001|Overall Study|Progression|12|||
125410730|NCT00499369|451129185|FG002|Overall Study|Progression|9|||
125410731|NCT00499369|451129186|FG003|Overall Study|Progression|6|||
125410732|NCT00499369|451129187|FG004|Overall Study|Progression|10|||
125410733|NCT00499369|451129183|FG000|Overall Study|Death|0|||
125410734|NCT00499369|451129184|FG001|Overall Study|Death|1|||
125410735|NCT00499369|451129185|FG002|Overall Study|Death|0|||
125410736|NCT00499369|451129186|FG003|Overall Study|Death|0|||
125410737|NCT00499369|451129187|FG004|Overall Study|Death|0|||
125410738|NCT00499369|451129183|FG000|Overall Study|Not protocol specified|2|||
125410739|NCT00499369|451129184|FG001|Overall Study|Not protocol specified|0|||
125280031|NCT01581021|450651170|FG001|Overall Study|Lenke 6 Classification|1|||
125280032|NCT01581021|450651169|FG000|Overall Study|Lack of Efficacy|0|||
125280033|NCT01581021|450651170|FG001|Overall Study|Lack of Efficacy|1|||
125410740|NCT00499369|451129185|FG002|Overall Study|Not protocol specified|3|||
125410741|NCT00499369|451129186|FG003|Overall Study|Not protocol specified|1|||
125410742|NCT00499369|451129187|FG004|Overall Study|Not protocol specified|0|||
125410743|NCT00499369|451129183|FG000|Overall Study|Ineligible|2|||
125410744|NCT00499369|451129184|FG001|Overall Study|Ineligible|2|||
125280034|NCT00675441|450651171|FG000|Overall Study|Withdrawal by Subject|2|||
125410745|NCT00499369|451129185|FG002|Overall Study|Ineligible|1|||
125410746|NCT00499369|451129186|FG003|Overall Study|Ineligible|1|||
125410747|NCT00499369|451129187|FG004|Overall Study|Ineligible|0|||
125410748|NCT01802411|451129188|FG000|Overall Study|Death|2|||
125410749|NCT01802411|451129189|FG001|Overall Study|Death|1|||
125410750|NCT01802411|451129188|FG000|Overall Study|Adverse Event|2|||
125448364|NCT04003974|451268912|FG001|Overall Study|Missing|0|||
125448365|NCT04003974|451268911|FG000|Overall Study|Withdrawal by Subject|0|||
125448366|NCT04003974|451268912|FG001|Overall Study|Withdrawal by Subject|2|||
125448367|NCT04296942|451268913|FG000|Overall Study|Study closure by sponsor|1|||
125280035|NCT00675441|450651171|FG000|Overall Study|Death|1|||
125280036|NCT00054327|450651177|FG000|Overall Study|Engraftment failure|1|||
125280037|NCT00054327|450651178|FG001|Overall Study|Engraftment failure|0|||
125280038|NCT00054327|450651179|FG002|Overall Study|Engraftment failure|0|||
125280039|NCT00054327|450651180|FG003|Overall Study|Engraftment failure|0|||
125280040|NCT00054327|450651181|FG004|Overall Study|Engraftment failure|0|||
125280041|NCT00054327|450651182|FG005|Overall Study|Engraftment failure|0|||
125280042|NCT00700882|450651183|FG000|Overall Study|Never received treatment|6|||
125280043|NCT00700882|450651183|FG000|Overall Study|Ineligible|2|||
125280044|NCT00700882|450651183|FG000|Overall Study|No KIT mutation|51|||
125280045|NCT04154293|450651193|FG000|Overall Study|Withdrawal by Subject|2|||
125280046|NCT04154293|450651194|FG001|Overall Study|Withdrawal by Subject|3|||
125280047|NCT04154293|450651195|FG002|Overall Study|Withdrawal by Subject|1|||
125280048|NCT04154293|450651193|FG000|Overall Study|Physician Decision|0|||
125280049|NCT04154293|450651194|FG001|Overall Study|Physician Decision|0|||
125280050|NCT04154293|450651195|FG002|Overall Study|Physician Decision|1|||
125280051|NCT02152371|450651196|FG000|Overall Study|Adverse Event|6|||
125280052|NCT02152371|450651197|FG001|Overall Study|Adverse Event|2|||
125280053|NCT02152371|450651196|FG000|Overall Study|Withdrawal by Subject|3|||
125280054|NCT02152371|450651197|FG001|Overall Study|Withdrawal by Subject|7|||
125280055|NCT02152371|450651196|FG000|Overall Study|Protocol Violation|2|||
125280056|NCT02152371|450651197|FG001|Overall Study|Protocol Violation|3|||
125280057|NCT02152371|450651196|FG000|Overall Study|Lost to Follow-up|1|||
125280058|NCT02152371|450651197|FG001|Overall Study|Lost to Follow-up|0|||
125280059|NCT02152371|450651196|FG000|Overall Study|Lack of Efficacy|0|||
125280060|NCT02152371|450651197|FG001|Overall Study|Lack of Efficacy|1|||
125280061|NCT02152371|450651196|FG000|Overall Study|Physician Decision|0|||
125280062|NCT02152371|450651197|FG001|Overall Study|Physician Decision|2|||
125280063|NCT02152371|450651196|FG000|Overall Study|Reason Not Given|0|||
125280064|NCT02152371|450651197|FG001|Overall Study|Reason Not Given|1|||
125280065|NCT04382586|450651199|FG000|Overall Study|Death|3|||
125280066|NCT04382586|450651200|FG001|Overall Study|Death|4|||
125280067|NCT04382586|450651199|FG000|Overall Study|Lost to Follow-up|11|||
125280068|NCT04382586|450651200|FG001|Overall Study|Lost to Follow-up|8|||
125280069|NCT04382586|450651199|FG000|Overall Study|Withdrawal by Subject|3|||
125280070|NCT04382586|450651200|FG001|Overall Study|Withdrawal by Subject|1|||
125280071|NCT04382586|450651199|FG000|Overall Study|Physician Decision|0|||
125280072|NCT04382586|450651200|FG001|Overall Study|Physician Decision|3|||
125280073|NCT05596734|450651202|FG000|Substudy A|Withdrawal by Subject|1|||
125280074|NCT05596734|450651203|FG001|Substudy A|Withdrawal by Subject|0|||
125280075|NCT05596734|450651204|FG002|Substudy A|Withdrawal by Subject|0|||
125280076|NCT05596734|450651205|FG003|Substudy A|Withdrawal by Subject|0|||
125280077|NCT05596734|450651206|FG004|Substudy A|Withdrawal by Subject|0|||
125280078|NCT05596734|450651207|FG005|Substudy A|Withdrawal by Subject|0|||
125280079|NCT05596734|450651208|FG006|Substudy A|Withdrawal by Subject|1|||
125280080|NCT05596734|450651209|FG007|Substudy A|Withdrawal by Subject|0|||
125280081|NCT05596734|450651210|FG008|Substudy A|Withdrawal by Subject|0|||
125280082|NCT05596734|450651211|FG009|Substudy A|Withdrawal by Subject|0|||
125280083|NCT05596734|450651212|FG010|Substudy A|Withdrawal by Subject|0|||
125280084|NCT05596734|450651213|FG011|Substudy A|Withdrawal by Subject|0|||
125280085|NCT05596734|450651214|FG012|Substudy A|Withdrawal by Subject|0|||
125280086|NCT05596734|450651215|FG013|Substudy A|Withdrawal by Subject|0|||
125280087|NCT05596734|450651216|FG014|Substudy A|Withdrawal by Subject|0|||
125280088|NCT05596734|450651217|FG015|Substudy A|Withdrawal by Subject|0|||
125280089|NCT05596734|450651218|FG016|Substudy A|Withdrawal by Subject|0|||
125280090|NCT05596734|450651219|FG017|Substudy A|Withdrawal by Subject|0|||
125280091|NCT05596734|450651220|FG018|Substudy A|Withdrawal by Subject|0|||
125280092|NCT05596734|450651221|FG019|Substudy A|Withdrawal by Subject|0|||
125280093|NCT05596734|450651222|FG020|Substudy A|Withdrawal by Subject|0|||
125280094|NCT05596734|450651223|FG021|Substudy A|Withdrawal by Subject|0|||
125448368|NCT04296942|451268914|FG001|Overall Study|Study closure by sponsor|0|||
125448369|NCT04296942|451268915|FG002|Overall Study|Study closure by sponsor|0|||
125448370|NCT00335153|451268916|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
125280095|NCT05596734|450651224|FG022|Substudy A|Withdrawal by Subject|0|||
125280096|NCT05596734|450651225|FG023|Substudy A|Withdrawal by Subject|0|||
125280097|NCT05596734|450651202|FG000|Substudy A|Lost to Follow-up|1|||
125280098|NCT05596734|450651203|FG001|Substudy A|Lost to Follow-up|0|||
125280099|NCT05596734|450651204|FG002|Substudy A|Lost to Follow-up|1|||
125280100|NCT05596734|450651205|FG003|Substudy A|Lost to Follow-up|0|||
125280101|NCT05596734|450651206|FG004|Substudy A|Lost to Follow-up|0|||
125280102|NCT05596734|450651207|FG005|Substudy A|Lost to Follow-up|0|||
125280103|NCT05596734|450651208|FG006|Substudy A|Lost to Follow-up|0|||
125280104|NCT05596734|450651209|FG007|Substudy A|Lost to Follow-up|0|||
125280105|NCT05596734|450651210|FG008|Substudy A|Lost to Follow-up|0|||
125280106|NCT05596734|450651211|FG009|Substudy A|Lost to Follow-up|0|||
125280107|NCT05596734|450651212|FG010|Substudy A|Lost to Follow-up|0|||
125410751|NCT01802411|451129189|FG001|Overall Study|Adverse Event|7|||
125410752|NCT01802411|451129188|FG000|Overall Study|Lack of Efficacy|8|||
125410753|NCT01802411|451129189|FG001|Overall Study|Lack of Efficacy|10|||
125410754|NCT01802411|451129188|FG000|Overall Study|Withdrawal by Subject|0|||
125410755|NCT01802411|451129189|FG001|Overall Study|Withdrawal by Subject|2|||
125410756|NCT01802411|451129188|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
125410757|NCT01802411|451129189|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
125410758|NCT01802411|451129188|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
125410759|NCT01802411|451129189|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
125410760|NCT01802411|451129188|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
125410761|NCT01802411|451129189|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
125410762|NCT01344460|451129192|FG000|Overall Study|Withdrawal by Subject|1|||
125410763|NCT01344460|451129192|FG000|Overall Study|Lost to Follow-up|2|||
125410764|NCT03285477|451129193|FG000|Treatment and Response Assessment Period|Death|1|||
125410765|NCT03285477|451129194|FG001|Treatment and Response Assessment Period|Death|0|||
125410766|NCT03285477|451129193|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
125410767|NCT03285477|451129194|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
125410768|NCT03285477|451129193|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
125410769|NCT03285477|451129194|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
125410770|NCT03285477|451129193|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
125410771|NCT03285477|451129194|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
125410772|NCT03285477|451129193|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
125410773|NCT03285477|451129194|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
125410774|NCT03283670|451129197|FG000|Placebo Gas|Withdrawal by Subject|2|||
125410775|NCT03283670|451129197|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
125410776|NCT03283670|451129197|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
125410777|NCT00852397|451129200|FG000|Overall Study|Adverse Event|4|||
125410778|NCT00852397|451129201|FG001|Overall Study|Adverse Event|6|||
125410779|NCT00852397|451129202|FG002|Overall Study|Adverse Event|4|||
125410780|NCT00852397|451129200|FG000|Overall Study|Death|0|||
125410781|NCT00852397|451129201|FG001|Overall Study|Death|0|||
125410782|NCT00852397|451129202|FG002|Overall Study|Death|1|||
125410783|NCT00852397|451129200|FG000|Overall Study|Withdrawal by Subject|4|||
125410784|NCT00852397|451129201|FG001|Overall Study|Withdrawal by Subject|1|||
125410785|NCT00852397|451129202|FG002|Overall Study|Withdrawal by Subject|2|||
125410786|NCT00852397|451129200|FG000|Overall Study|Study terminated by sponsor|2|||
125410787|NCT00852397|451129201|FG001|Overall Study|Study terminated by sponsor|1|||
125410788|NCT00852397|451129202|FG002|Overall Study|Study terminated by sponsor|6|||
125410789|NCT00852397|451129200|FG000|Overall Study|Difficulty in study site visit|1|||
125410790|NCT00852397|451129201|FG001|Overall Study|Difficulty in study site visit|0|||
125410791|NCT00852397|451129202|FG002|Overall Study|Difficulty in study site visit|0|||
125410792|NCT00852397|451129200|FG000|Overall Study|Protocol Violation|0|||
125410793|NCT00852397|451129201|FG001|Overall Study|Protocol Violation|0|||
125410794|NCT00852397|451129202|FG002|Overall Study|Protocol Violation|1|||
125410795|NCT03823651|451129207|FG000|Overall Study|Death|5|||
125410796|NCT03823651|451129208|FG001|Overall Study|Death|0|||
125410797|NCT03823651|451129207|FG000|Overall Study|Physician Decision|1|||
125410798|NCT03823651|451129208|FG001|Overall Study|Physician Decision|0|||
125410799|NCT03823651|451129207|FG000|Overall Study|Caregiver to patient who died|0|||
125410800|NCT03823651|451129208|FG001|Overall Study|Caregiver to patient who died|5|||
125410801|NCT03823651|451129207|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
125410802|NCT03823651|451129208|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
125410803|NCT03864614|451129209|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
125410804|NCT03864614|451129210|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
125410805|NCT03864614|451129211|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
125410806|NCT03864614|451129212|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
125410807|NCT03864614|451129209|FG000|Overall Study|Withdrawal by Subject|72|||
125410808|NCT03864614|451129210|FG001|Overall Study|Withdrawal by Subject|100|||
125410809|NCT03864614|451129211|FG002|Overall Study|Withdrawal by Subject|1|||
125410810|NCT03864614|451129212|FG003|Overall Study|Withdrawal by Subject|21|||
125410811|NCT03864614|451129209|FG000|Overall Study|Lost to Follow-up|45|||
125410812|NCT03864614|451129210|FG001|Overall Study|Lost to Follow-up|54|||
125410813|NCT03864614|451129211|FG002|Overall Study|Lost to Follow-up|0|||
125410814|NCT03864614|451129212|FG003|Overall Study|Lost to Follow-up|9|||
125280108|NCT05596734|450651213|FG011|Substudy A|Lost to Follow-up|0|||
125410815|NCT03864614|451129209|FG000|Overall Study|Adverse Event|42|||
125410816|NCT03864614|451129210|FG001|Overall Study|Adverse Event|30|||
125410817|NCT03864614|451129211|FG002|Overall Study|Adverse Event|1|||
125410818|NCT03864614|451129212|FG003|Overall Study|Adverse Event|9|||
125410819|NCT03864614|451129209|FG000|Overall Study|Protocol Deviation|6|||
125410820|NCT03864614|451129210|FG001|Overall Study|Protocol Deviation|26|||
125410821|NCT03864614|451129211|FG002|Overall Study|Protocol Deviation|0|||
125410822|NCT03864614|451129212|FG003|Overall Study|Protocol Deviation|1|||
125410823|NCT03864614|451129209|FG000|Overall Study|Physician Decision|7|||
125410824|NCT03864614|451129210|FG001|Overall Study|Physician Decision|10|||
125410825|NCT03864614|451129211|FG002|Overall Study|Physician Decision|1|||
125410826|NCT03864614|451129212|FG003|Overall Study|Physician Decision|5|||
125410827|NCT03864614|451129209|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
125410828|NCT03864614|451129210|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
125410829|NCT03864614|451129211|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
125410830|NCT03864614|451129212|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
125410831|NCT03864614|451129209|FG000|Overall Study|Sponsor Decision|1|||
125410832|NCT03864614|451129210|FG001|Overall Study|Sponsor Decision|2|||
125410833|NCT03864614|451129211|FG002|Overall Study|Sponsor Decision|0|||
125410834|NCT03864614|451129212|FG003|Overall Study|Sponsor Decision|0|||
125410835|NCT03864614|451129209|FG000|Overall Study|Pregnancy|0|||
125410836|NCT03864614|451129210|FG001|Overall Study|Pregnancy|1|||
125410837|NCT03864614|451129211|FG002|Overall Study|Pregnancy|0|||
125410838|NCT03864614|451129212|FG003|Overall Study|Pregnancy|0|||
125410839|NCT03864614|451129209|FG000|Overall Study|Other|7|||
125410840|NCT03864614|451129210|FG001|Overall Study|Other|9|||
125410841|NCT03864614|451129211|FG002|Overall Study|Other|1|||
125410842|NCT03864614|451129212|FG003|Overall Study|Other|4|||
125410843|NCT03864614|451129209|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
125410844|NCT03864614|451129210|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
125410845|NCT03864614|451129211|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
125410846|NCT03864614|451129212|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
125410847|NCT01404312|451130926|FG000|Overall Study|Death|21|||
125410848|NCT01404312|451130927|FG001|Overall Study|Death|27|||
125410849|NCT01404312|451130926|FG000|Overall Study|Withdrawal by Subject|15|||
125410850|NCT01404312|451130927|FG001|Overall Study|Withdrawal by Subject|18|||
125410851|NCT01404312|451130926|FG000|Overall Study|Participant Unable to get to clinic|93|||
125410852|NCT01404312|451130927|FG001|Overall Study|Participant Unable to get to clinic|103|||
125410853|NCT01404312|451130926|FG000|Overall Study|Lost to Follow-up|115|||
125410854|NCT01404312|451130927|FG001|Overall Study|Lost to Follow-up|111|||
125410855|NCT01404312|451130926|FG000|Overall Study|Site closed|22|||
125410856|NCT01404312|451130927|FG001|Overall Study|Site closed|21|||
125410857|NCT01404312|451130926|FG000|Overall Study|Participant not willing to adhere to req|31|||
125410858|NCT01404312|451130927|FG001|Overall Study|Participant not willing to adhere to req|29|||
125410859|NCT01404312|451130926|FG000|Overall Study|Severe debilitation, unable to continue|1|||
125410860|NCT01404312|451130927|FG001|Overall Study|Severe debilitation, unable to continue|2|||
125410861|NCT04419493|451130928|FG000|Wash-out After Period 1|Adverse Event|1|||
125410862|NCT04419493|451130929|FG001|Wash-out After Period 1|Adverse Event|2|||
125410863|NCT04419493|451130930|FG002|Wash-out After Period 1|Adverse Event|1|||
125410864|NCT04419493|451130931|FG003|Wash-out After Period 1|Adverse Event|0|||
125410865|NCT00524134|451130932|FG000|Overall Study|Withdrawal by Subject|1|||
125410866|NCT00524134|451130932|FG000|Overall Study|Physician Decision|1|||
125410867|NCT00129987|451130933|FG000|1st Educational Session|Withdrawal by Subject|141|||
125410868|NCT00129987|451130934|FG001|1st Educational Session|Withdrawal by Subject|109|||
125410869|NCT00129987|451130933|FG000|1 Year|Withdrawal by Subject|32|||
125410870|NCT00129987|451130934|FG001|1 Year|Withdrawal by Subject|21|||
125410871|NCT00116805|451130938|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
125410872|NCT00116805|451130939|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
125410873|NCT00116805|451130938|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
125410874|NCT00116805|451130939|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
125410875|NCT00116805|451130938|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
125410876|NCT00116805|451130939|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
125410877|NCT00116805|451130938|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
125410878|NCT00116805|451130939|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
125410879|NCT00116805|451130938|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
125410880|NCT00116805|451130939|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
125410881|NCT00116805|451130938|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
125410882|NCT00116805|451130939|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
125410883|NCT00116805|451130938|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
125410884|NCT00116805|451130939|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
125410885|NCT00116805|451130938|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
125410886|NCT00116805|451130939|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
125410887|NCT00116805|451130938|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
125410888|NCT00116805|451130939|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
125410889|NCT00116805|451130938|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
125410890|NCT00116805|451130939|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
125410891|NCT00116805|451130938|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
125410892|NCT00116805|451130939|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
125410893|NCT00116805|451130938|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
125410894|NCT00116805|451130939|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
125410895|NCT00116805|451130938|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
125410896|NCT00116805|451130939|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
125410897|NCT00116805|451130938|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
125410898|NCT00116805|451130939|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
125410899|NCT00116805|451130938|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
125410900|NCT00116805|451130939|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
125410901|NCT00116805|451130938|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
125410902|NCT00116805|451130939|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
125410903|NCT00116805|451130938|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
125410904|NCT00116805|451130939|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
125410905|NCT00116805|451130938|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
125410906|NCT00116805|451130939|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
125410907|NCT00116805|451130938|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
125410908|NCT00116805|451130939|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
125410909|NCT00116805|451130938|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
125410910|NCT00116805|451130939|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
125410911|NCT00116805|451130938|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
125410912|NCT00116805|451130939|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
125410913|NCT00116805|451130938|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
125410914|NCT00116805|451130939|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
125410915|NCT00116805|451130938|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
125410916|NCT00116805|451130939|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
125410917|NCT00116805|451130938|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
125410918|NCT00116805|451130939|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
125410919|NCT00116805|451130938|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
125410920|NCT00116805|451130939|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
125410921|NCT00116805|451130938|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
125410922|NCT00116805|451130939|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
125410923|NCT00116805|451130938|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
125410924|NCT00116805|451130939|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
125410925|NCT00116805|451130938|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
125410926|NCT00116805|451130939|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
125410927|NCT00116805|451130938|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
125410928|NCT00116805|451130939|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
125410929|NCT00116805|451130938|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
125410930|NCT00116805|451130939|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
125410931|NCT00116805|451130938|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
125410932|NCT00116805|451130939|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
125410933|NCT00116805|451130938|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
125410934|NCT00116805|451130939|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
125410935|NCT00116805|451130938|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
125410936|NCT00116805|451130939|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
125410937|NCT00116805|451130938|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
125410938|NCT00116805|451130939|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
125410939|NCT00116805|451130938|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
125410940|NCT00116805|451130939|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
125410941|NCT00116805|451130938|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
125410942|NCT00116805|451130939|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
125410943|NCT00116805|451130938|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
125410944|NCT00116805|451130939|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
125410945|NCT00116805|451130938|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
125410946|NCT00116805|451130939|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
125410947|NCT00116805|451130938|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
125410948|NCT00116805|451130939|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
125410949|NCT00116805|451130938|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
125410950|NCT00116805|451130939|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
125410951|NCT00116805|451130938|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
125410952|NCT00116805|451130939|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
125410953|NCT00116805|451130938|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
125410954|NCT00116805|451130939|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
125410955|NCT00116805|451130938|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
125410956|NCT00116805|451130939|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
125410957|NCT00116805|451130938|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
125410958|NCT00116805|451130939|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
125410959|NCT00116805|451130938|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
125410960|NCT00116805|451130939|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
125410961|NCT01760954|451130940|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
125410962|NCT01760954|451130941|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
125410963|NCT01760954|451130942|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
125410964|NCT01760954|451130943|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
125410965|NCT01760954|451130940|FG000|Treatment Period (6 Months)|Adverse Event|5|||
125410966|NCT01760954|451130941|FG001|Treatment Period (6 Months)|Adverse Event|3|||
125410967|NCT01760954|451130942|FG002|Treatment Period (6 Months)|Adverse Event|4|||
125410968|NCT01760954|451130943|FG003|Treatment Period (6 Months)|Adverse Event|10|||
125410969|NCT01760954|451130940|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
125410970|NCT01760954|451130941|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
125410971|NCT01760954|451130942|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
125410972|NCT01760954|451130943|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
125410973|NCT01760954|451130940|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
125410974|NCT01760954|451130941|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
125410975|NCT01760954|451130942|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
125410976|NCT01760954|451130943|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
125410977|NCT01760954|451130940|FG000|Treatment Period (6 Months)|Pregnancy|5|||
125410978|NCT01760954|451130941|FG001|Treatment Period (6 Months)|Pregnancy|0|||
125410979|NCT01760954|451130942|FG002|Treatment Period (6 Months)|Pregnancy|3|||
125410980|NCT01760954|451130943|FG003|Treatment Period (6 Months)|Pregnancy|2|||
125410981|NCT01760954|451130940|FG000|Treatment Period (6 Months)|Non-compliance|1|||
125410982|NCT01760954|451130941|FG001|Treatment Period (6 Months)|Non-compliance|4|||
125410983|NCT01760954|451130942|FG002|Treatment Period (6 Months)|Non-compliance|0|||
125410984|NCT01760954|451130943|FG003|Treatment Period (6 Months)|Non-compliance|3|||
125410985|NCT01760954|451130940|FG000|Treatment Period (6 Months)|Other|0|||
125410986|NCT01760954|451130941|FG001|Treatment Period (6 Months)|Other|3|||
125410987|NCT01760954|451130942|FG002|Treatment Period (6 Months)|Other|3|||
125410988|NCT01760954|451130943|FG003|Treatment Period (6 Months)|Other|1|||
125410989|NCT01760954|451130940|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
125410990|NCT01760954|451130941|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
125410991|NCT01760954|451130942|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
125410992|NCT01760954|451130943|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
125410993|NCT01760954|451130940|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
125410994|NCT01760954|451130941|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
125410995|NCT01760954|451130942|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
125410996|NCT01760954|451130943|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
125410997|NCT01760954|451130940|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
125410998|NCT01760954|451130941|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
125410999|NCT01760954|451130942|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
125411000|NCT01760954|451130943|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
125411001|NCT01760954|451130940|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
125411002|NCT01760954|451130941|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
125411003|NCT01760954|451130942|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
125411004|NCT01760954|451130943|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
125411005|NCT01760954|451130940|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
125411006|NCT01760954|451130941|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
125411007|NCT01760954|451130942|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
125411008|NCT01760954|451130943|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
125411009|NCT01760954|451130940|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
125411010|NCT01760954|451130941|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
125411011|NCT01760954|451130942|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
125411012|NCT01760954|451130943|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
125411013|NCT01760954|451130940|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
125411014|NCT01760954|451130941|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
125411015|NCT01760954|451130942|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
125411016|NCT01760954|451130943|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
125411017|NCT01760954|451130940|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
125411018|NCT01760954|451130941|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
125411019|NCT01760954|451130942|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
125411020|NCT01760954|451130943|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
125411021|NCT00317772|451130947|FG000|Overall Study|Adverse Event|0|||
125411022|NCT00317772|451130948|FG001|Overall Study|Adverse Event|0|||
125411023|NCT00317772|451130949|FG002|Overall Study|Adverse Event|0|||
125411024|NCT00317772|451130950|FG003|Overall Study|Adverse Event|2|||
125411025|NCT00317772|451130947|FG000|Overall Study|Disease Progression|2|||
125411026|NCT00317772|451130948|FG001|Overall Study|Disease Progression|2|||
125411027|NCT00317772|451130949|FG002|Overall Study|Disease Progression|1|||
125411028|NCT00317772|451130950|FG003|Overall Study|Disease Progression|7|||
125411029|NCT00353704|451130963|FG000|Overall Study|Protocol Violation|3|||
125411030|NCT00353704|451130964|FG001|Overall Study|Protocol Violation|1|||
125411031|NCT04495374|451130965|FG000|Overall Study|Protocol Violation|2|||
125411032|NCT04495374|451130966|FG001|Overall Study|Protocol Violation|1|||
125411033|NCT02473614|451130967|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
125411034|NCT02473614|451130968|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
125411035|NCT01303627|451130969|FG000|Overall Study|the failure while performing URS|0|||
125411036|NCT01303627|451130970|FG001|Overall Study|the failure while performing URS|1|||
125411037|NCT02416791|451130972|FG000|6 Months|Lost to Follow-up|0|||
125411038|NCT02416791|451130973|FG001|6 Months|Lost to Follow-up|0|||
125411039|NCT02416791|451130974|FG002|6 Months|Lost to Follow-up|1|||
125411040|NCT01054820|451130975|FG000|Overall Study|Withdrawal by Subject|2|||
125411041|NCT01154166|451130977|FG000|Overall Study|Adverse Event|14|||
125411042|NCT01154166|451130978|FG001|Overall Study|Adverse Event|9|||
125411043|NCT01154166|451130977|FG000|Overall Study|Lost to Follow-up|1|||
125411044|NCT01154166|451130978|FG001|Overall Study|Lost to Follow-up|1|||
125411045|NCT01154166|451130977|FG000|Overall Study|Protocol Violation|4|||
125411046|NCT01154166|451130978|FG001|Overall Study|Protocol Violation|1|||
125411047|NCT01154166|451130977|FG000|Overall Study|Withdrawal by Subject|10|||
125411048|NCT01154166|451130978|FG001|Overall Study|Withdrawal by Subject|1|||
125411049|NCT01154166|451130977|FG000|Overall Study|Lack of Efficacy|3|||
125411050|NCT01154166|451130978|FG001|Overall Study|Lack of Efficacy|0|||
125411051|NCT01154166|451130977|FG000|Overall Study|Disease Progression|1|||
125411052|NCT01154166|451130978|FG001|Overall Study|Disease Progression|0|||
125411053|NCT01154166|451130977|FG000|Overall Study|Poor Compliance|1|||
125411054|NCT01154166|451130978|FG001|Overall Study|Poor Compliance|0|||
125411055|NCT04121962|451130981|FG000|Overall Study|Lost to Follow-up|42|||
125411056|NCT04121962|451130982|FG001|Overall Study|Lost to Follow-up|39|||
125411057|NCT02019719|451130983|FG000|Overall Study|Adverse Event|1|||
125411058|NCT02019719|451130984|FG001|Overall Study|Adverse Event|0|||
125411059|NCT02019719|451130985|FG002|Overall Study|Adverse Event|0|||
125411060|NCT02019719|451130986|FG003|Overall Study|Adverse Event|1|||
125411061|NCT02019719|451130987|FG004|Overall Study|Adverse Event|1|||
125411062|NCT02019719|451130983|FG000|Overall Study|Protocol Violation|1|||
125411063|NCT02019719|451130984|FG001|Overall Study|Protocol Violation|1|||
125411064|NCT02019719|451130985|FG002|Overall Study|Protocol Violation|0|||
125411065|NCT02019719|451130986|FG003|Overall Study|Protocol Violation|0|||
125411066|NCT02019719|451130987|FG004|Overall Study|Protocol Violation|0|||
125411067|NCT02019719|451130983|FG000|Overall Study|Protocol defined stopping criteria|2|||
125411068|NCT02019719|451130984|FG001|Overall Study|Protocol defined stopping criteria|0|||
125411069|NCT02019719|451130985|FG002|Overall Study|Protocol defined stopping criteria|0|||
125411070|NCT02019719|451130986|FG003|Overall Study|Protocol defined stopping criteria|1|||
125411071|NCT02019719|451130987|FG004|Overall Study|Protocol defined stopping criteria|1|||
125411072|NCT02019719|451130983|FG000|Overall Study|Physician Decision|2|||
125411073|NCT02019719|451130984|FG001|Overall Study|Physician Decision|0|||
125411074|NCT02019719|451130985|FG002|Overall Study|Physician Decision|0|||
125411075|NCT02019719|451130986|FG003|Overall Study|Physician Decision|0|||
125411076|NCT02019719|451130987|FG004|Overall Study|Physician Decision|0|||
125411077|NCT04535037|451130988|FG000|Overall Study|Protocol Violation|1|||
125411078|NCT04535037|451130989|FG001|Overall Study|Protocol Violation|0|||
125411079|NCT04535037|451130988|FG000|Overall Study|Withdrawal by Subject|8|||
125411080|NCT04535037|451130989|FG001|Overall Study|Withdrawal by Subject|9|||
125411081|NCT04535037|451130988|FG000|Overall Study|Migrated / moved from the study area|1|||
125411082|NCT04535037|451130989|FG001|Overall Study|Migrated / moved from the study area|4|||
125411083|NCT04535037|451130988|FG000|Overall Study|Other|2|||
125411084|NCT04535037|451130989|FG001|Overall Study|Other|5|||
125411085|NCT04408469|451130990|FG000|Overall Study|Lost to Follow-up|6|||
125411086|NCT04408469|451130991|FG001|Overall Study|Lost to Follow-up|9|||
125411087|NCT04408469|451130990|FG000|Overall Study|Withdrawal by Subject|6|||
125411088|NCT04408469|451130991|FG001|Overall Study|Withdrawal by Subject|1|||
125411089|NCT04408469|451130990|FG000|Overall Study|Dismissal due to ineligibility|0|||
125411090|NCT04408469|451130991|FG001|Overall Study|Dismissal due to ineligibility|1|||
125411091|NCT04321460|451130994|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
125448371|NCT00335153|451268916|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
125411092|NCT04321460|451130995|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
125411093|NCT02162810|451130998|FG000|Overall Study|Protocol Violation|1|||
125411094|NCT02162810|451130999|FG001|Overall Study|Protocol Violation|0|||
125411095|NCT02162810|451130998|FG000|Overall Study|patients did not report compliance|4|||
125411096|NCT02162810|451130999|FG001|Overall Study|patients did not report compliance|1|||
125411097|NCT02519504|451131004|FG000|Overall Study|Protocol Violation|6|||
125411098|NCT02519504|451131005|FG001|Overall Study|Protocol Violation|5|||
125411099|NCT02519504|451131004|FG000|Overall Study|Ineligible for direct testing|12|||
125411100|NCT02519504|451131005|FG001|Overall Study|Ineligible for direct testing|12|||
125280109|NCT05596734|450651214|FG012|Substudy A|Lost to Follow-up|0|||
125411101|NCT02519504|451131004|FG000|Overall Study|Did not participate in direct testing|95|||
125411102|NCT02519504|451131005|FG001|Overall Study|Did not participate in direct testing|86|||
125411103|NCT01308749|451131006|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
125411104|NCT01308749|451131007|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
125411105|NCT01308749|451131006|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
125411106|NCT01308749|451131007|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
125411107|NCT01308749|451131006|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
125411108|NCT01308749|451131007|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
125411109|NCT04726709|451131008|FG000|Overall Study|Withdrawal by Subject|2|||
125411110|NCT04726709|451131009|FG001|Overall Study|Withdrawal by Subject|2|||
125411111|NCT02223390|451131010|FG000|Overall Study|Lost to Follow-up|9|||
125411112|NCT02223390|451131011|FG001|Overall Study|Lost to Follow-up|4|||
125411113|NCT02843568|451131013|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
125411114|NCT02843568|451131014|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
125411115|NCT02843568|451131013|FG000|Overall Study|Death|3|||
125411116|NCT02843568|451131014|FG001|Overall Study|Death|3|||
125411117|NCT02843568|451131013|FG000|Overall Study|Withdrawal by Subject|1|||
125411118|NCT02843568|451131014|FG001|Overall Study|Withdrawal by Subject|1|||
125411119|NCT02843568|451131013|FG000|Overall Study|Lost to Follow-up|2|||
125411120|NCT02843568|451131014|FG001|Overall Study|Lost to Follow-up|0|||
125411121|NCT01255358|451131015|FG000|Overall Study|Adverse Event|2|||
125411122|NCT01255358|451131015|FG000|Overall Study|Protocol Violation|2|||
125411123|NCT00096941|451131027|FG000|Overall Study|disease progression|3|||
125411124|NCT00022516|451131028|FG000|Overall Study|Adverse Event|0|||
125411125|NCT00022516|451131029|FG001|Overall Study|Adverse Event|59|||
125411126|NCT00022516|451131028|FG000|Overall Study|Lack of Efficacy|0|||
125411127|NCT00022516|451131029|FG001|Overall Study|Lack of Efficacy|27|||
125411128|NCT00022516|451131028|FG000|Overall Study|Physician Decision|0|||
125411129|NCT00022516|451131029|FG001|Overall Study|Physician Decision|1|||
125411130|NCT00022516|451131028|FG000|Overall Study|Protocol Violation|1|||
125411131|NCT00022516|451131029|FG001|Overall Study|Protocol Violation|3|||
125411132|NCT00022516|451131028|FG000|Overall Study|Withdrawal by Subject|2|||
125411133|NCT00022516|451131029|FG001|Overall Study|Withdrawal by Subject|113|||
125411134|NCT00022516|451131028|FG000|Overall Study|Incomplete documentation|0|||
125411135|NCT00022516|451131029|FG001|Overall Study|Incomplete documentation|27|||
125411136|NCT02056301|451131032|FG000|Overall Study|Protocol Violation|1|||
125411137|NCT02056301|451131033|FG001|Overall Study|Protocol Violation|2|||
125411138|NCT02056301|451131032|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
125411139|NCT02056301|451131033|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
125411140|NCT02056301|451131032|FG000|Overall Study|Withdrawal by Subject|0|||
125411141|NCT02056301|451131033|FG001|Overall Study|Withdrawal by Subject|1|||
125411142|NCT02056301|451131032|FG000|Overall Study|Issues with epidural|0|||
125411143|NCT02056301|451131033|FG001|Overall Study|Issues with epidural|3|||
125411144|NCT02209324|451131034|FG000|Overall Study|Adverse Event|2|||
125411145|NCT02209324|451131034|FG000|Overall Study|Lack of Efficacy|1|||
125411146|NCT02209324|451131034|FG000|Overall Study|Lost to Follow-up|1|||
125411147|NCT02209324|451131034|FG000|Overall Study|Physician Decision|3|||
125411148|NCT02209324|451131034|FG000|Overall Study|Protocol Violation|14|||
125411149|NCT02209324|451131034|FG000|Overall Study|Withdrawal by Subject|8|||
125411150|NCT02209324|451131034|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
125411151|NCT02209324|451131034|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
125411152|NCT02209324|451131034|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
125411153|NCT05799495|451131035|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
125411154|NCT05799495|451131036|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
125411155|NCT05799495|451131037|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
125411156|NCT05799495|451131038|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
125411157|NCT05799495|451131035|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
125411158|NCT05799495|451131036|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
125411159|NCT05799495|451131037|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
125411160|NCT05799495|451131038|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
125411161|NCT05799495|451131035|FG000|Treatment (Up to 5 Days)|Other|0|||
125411162|NCT05799495|451131036|FG001|Treatment (Up to 5 Days)|Other|1|||
125411163|NCT05799495|451131037|FG002|Treatment (Up to 5 Days)|Other|0|||
125411164|NCT05799495|451131038|FG003|Treatment (Up to 5 Days)|Other|0|||
125411165|NCT05799495|451131035|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
125280110|NCT05596734|450651215|FG013|Substudy A|Lost to Follow-up|0|||
125280111|NCT05596734|450651216|FG014|Substudy A|Lost to Follow-up|0|||
125280112|NCT05596734|450651217|FG015|Substudy A|Lost to Follow-up|0|||
125448372|NCT00335153|451268916|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
125448373|NCT00335153|451268916|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
125411166|NCT05799495|451131036|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
125411167|NCT05799495|451131037|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
125411168|NCT05799495|451131038|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
125411169|NCT05799495|451131035|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
125411170|NCT05799495|451131036|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
125411171|NCT05799495|451131037|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
125411172|NCT05799495|451131038|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
125411173|NCT05799495|451131035|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125411174|NCT05799495|451131036|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125411175|NCT05799495|451131037|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
125411176|NCT05799495|451131038|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
125411177|NCT03105362|451131039|FG000|Overall Study|Withdrawal by Subject|1|||
125411178|NCT03105362|451131039|FG000|Overall Study|Lost to Follow-up|1|||
125411179|NCT01198600|451131040|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
125411180|NCT01198600|451131041|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
125411181|NCT01198600|451131042|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
125411182|NCT01198600|451131043|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
125411183|NCT01198600|451131040|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
125411184|NCT01198600|451131041|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
125411185|NCT01198600|451131042|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
125411186|NCT01198600|451131043|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
125411187|NCT01198600|451131040|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
125411188|NCT01198600|451131041|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
125411189|NCT01198600|451131042|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
125411190|NCT01198600|451131043|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
125411191|NCT01198600|451131040|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
125411192|NCT01198600|451131041|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
125411193|NCT01198600|451131042|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
125411194|NCT01198600|451131043|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
125411195|NCT01198600|451131040|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
125411196|NCT01198600|451131041|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
125411197|NCT01198600|451131042|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
125411198|NCT01198600|451131043|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
125411199|NCT01198600|451131040|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
125411200|NCT01198600|451131041|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
125411201|NCT01198600|451131042|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
125411202|NCT01198600|451131043|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
125411203|NCT01198600|451131040|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
125411204|NCT01198600|451131041|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
125411205|NCT01198600|451131042|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
125411206|NCT01198600|451131043|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
125411207|NCT04798586|451131045|FG000|Overall Study|Death|2|||
125411208|NCT01669343|451131046|FG000|Part A: All Patients|Withdrawal by Subject|7|||
125411209|NCT01669343|451131046|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
125411210|NCT01669343|451131046|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
125411211|NCT01669343|451131046|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
125411212|NCT01669343|451131046|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
125411213|NCT04433767|451131047|FG000|Overall Study|Adverse Event|1|||
125411214|NCT02371369|451131052|FG000|Part 1|Physician Decision|0|||
125411215|NCT02371369|451131053|FG001|Part 1|Physician Decision|3|||
125411216|NCT02371369|451131052|FG000|Part 1|Adverse Event|8|||
125411217|NCT02371369|451131053|FG001|Part 1|Adverse Event|0|||
125411218|NCT02371369|451131052|FG000|Part 1|Withdrawal by Subject|1|||
125411219|NCT02371369|451131053|FG001|Part 1|Withdrawal by Subject|6|||
125411220|NCT02371369|451131052|FG000|Part 1|Disease progression|0|||
125411221|NCT02371369|451131053|FG001|Part 1|Disease progression|1|||
125411222|NCT02371369|451131052|FG000|Part 1|Protocol Violation|0|||
125411223|NCT02371369|451131053|FG001|Part 1|Protocol Violation|1|||
125411224|NCT02371369|451131052|FG000|Part 2|Adverse Event|6|||
125411225|NCT02371369|451131053|FG001|Part 2|Adverse Event|5|||
125411226|NCT02371369|451131052|FG000|Part 2|Withdrawal by Subject|16|||
125411227|NCT02371369|451131053|FG001|Part 2|Withdrawal by Subject|6|||
125411228|NCT02371369|451131052|FG000|Part 2|Investigator decision|1|||
125411229|NCT02371369|451131053|FG001|Part 2|Investigator decision|2|||
125411230|NCT02371369|451131052|FG000|Part 2|Death|0|||
125411231|NCT02371369|451131053|FG001|Part 2|Death|1|||
125411232|NCT02371369|451131052|FG000|Part 2|Disease progression|1|||
125411233|NCT02371369|451131053|FG001|Part 2|Disease progression|0|||
125411234|NCT02371369|451131052|FG000|Part 2|Subject Noncompliance|1|||
125411235|NCT02371369|451131053|FG001|Part 2|Subject Noncompliance|0|||
125411236|NCT02371369|451131052|FG000|Part 2|Lost to Follow-up|1|||
125411237|NCT02371369|451131053|FG001|Part 2|Lost to Follow-up|1|||
125411238|NCT02371369|451131052|FG000|Part 2|Subject transitioned to commercial supply|6|||
125411239|NCT02371369|451131053|FG001|Part 2|Subject transitioned to commercial supply|4|||
125411240|NCT02371369|451131052|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
125411241|NCT02371369|451131053|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
125280113|NCT05596734|450651218|FG016|Substudy A|Lost to Follow-up|0|||
125280114|NCT05596734|450651219|FG017|Substudy A|Lost to Follow-up|0|||
125280115|NCT05596734|450651220|FG018|Substudy A|Lost to Follow-up|0|||
125280116|NCT05596734|450651221|FG019|Substudy A|Lost to Follow-up|0|||
125280117|NCT05596734|450651222|FG020|Substudy A|Lost to Follow-up|0|||
125280118|NCT05596734|450651223|FG021|Substudy A|Lost to Follow-up|0|||
125280119|NCT05596734|450651224|FG022|Substudy A|Lost to Follow-up|0|||
125411242|NCT02371369|451131052|FG000|Part 2|Surgical resection of tumor|1|||
125411243|NCT02371369|451131053|FG001|Part 2|Surgical resection of tumor|1|||
125411244|NCT02371369|451131052|FG000|Part 2|Other|0|||
125411245|NCT02371369|451131053|FG001|Part 2|Other|1|||
125411246|NCT00503685|451131058|FG000|Overall Study|Adverse Event|0|||
125411247|NCT00503685|451131059|FG001|Overall Study|Adverse Event|0|||
125411248|NCT00503685|451131060|FG002|Overall Study|Adverse Event|2|||
125411249|NCT00503685|451131058|FG000|Overall Study|Withdrawal by Subject|0|||
125411250|NCT00503685|451131059|FG001|Overall Study|Withdrawal by Subject|1|||
125411251|NCT00503685|451131060|FG002|Overall Study|Withdrawal by Subject|0|||
125411252|NCT00503685|451131058|FG000|Overall Study|Protocol Violation|0|||
125411253|NCT00503685|451131059|FG001|Overall Study|Protocol Violation|1|||
125411254|NCT00503685|451131060|FG002|Overall Study|Protocol Violation|0|||
125411255|NCT00503685|451131058|FG000|Overall Study|Eligibility Criteria Not Met|0|||
125411256|NCT00503685|451131059|FG001|Overall Study|Eligibility Criteria Not Met|1|||
125411257|NCT00503685|451131060|FG002|Overall Study|Eligibility Criteria Not Met|0|||
125411258|NCT02838017|451131062|FG000|Overall Study|Lost to Follow-up|14|||
125411259|NCT02838017|451131063|FG001|Overall Study|Lost to Follow-up|11|||
125411260|NCT02120924|451131064|FG000|Overall Study|Lack of Efficacy|1|||
125411261|NCT02120924|451131065|FG001|Overall Study|Lack of Efficacy|2|||
125411262|NCT02120924|451131066|FG002|Overall Study|Lack of Efficacy|3|||
125411263|NCT02120924|451131064|FG000|Overall Study|Adverse Event|0|||
125411264|NCT02120924|451131065|FG001|Overall Study|Adverse Event|1|||
125411265|NCT02120924|451131066|FG002|Overall Study|Adverse Event|3|||
125411266|NCT02120924|451131064|FG000|Overall Study|Withdrawal by Subject|16|||
125411267|NCT02120924|451131065|FG001|Overall Study|Withdrawal by Subject|20|||
125411268|NCT02120924|451131066|FG002|Overall Study|Withdrawal by Subject|8|||
125411269|NCT02120924|451131064|FG000|Overall Study|Lost to Follow-up|14|||
125411270|NCT02120924|451131065|FG001|Overall Study|Lost to Follow-up|14|||
125411271|NCT02120924|451131066|FG002|Overall Study|Lost to Follow-up|11|||
125411272|NCT02120924|451131064|FG000|Overall Study|Pregnancy|2|||
125411273|NCT02120924|451131065|FG001|Overall Study|Pregnancy|0|||
125411274|NCT02120924|451131066|FG002|Overall Study|Pregnancy|0|||
125411275|NCT02120924|451131064|FG000|Overall Study|Protocol Violation|3|||
125280120|NCT05596734|450651225|FG023|Substudy A|Lost to Follow-up|0|||
125280121|NCT05596734|450651202|FG000|Substudy B|Withdrawal by Subject|0|||
125280122|NCT05596734|450651203|FG001|Substudy B|Withdrawal by Subject|0|||
125280123|NCT05596734|450651204|FG002|Substudy B|Withdrawal by Subject|0|||
125280124|NCT05596734|450651205|FG003|Substudy B|Withdrawal by Subject|0|||
125280125|NCT05596734|450651206|FG004|Substudy B|Withdrawal by Subject|0|||
125280126|NCT05596734|450651207|FG005|Substudy B|Withdrawal by Subject|0|||
125280127|NCT05596734|450651208|FG006|Substudy B|Withdrawal by Subject|0|||
125280128|NCT05596734|450651209|FG007|Substudy B|Withdrawal by Subject|0|||
125280129|NCT05596734|450651210|FG008|Substudy B|Withdrawal by Subject|0|||
125280130|NCT05596734|450651211|FG009|Substudy B|Withdrawal by Subject|0|||
125280131|NCT05596734|450651212|FG010|Substudy B|Withdrawal by Subject|0|||
125280132|NCT05596734|450651213|FG011|Substudy B|Withdrawal by Subject|0|||
125280133|NCT05596734|450651214|FG012|Substudy B|Withdrawal by Subject|1|||
125280134|NCT05596734|450651215|FG013|Substudy B|Withdrawal by Subject|0|||
125280135|NCT05596734|450651216|FG014|Substudy B|Withdrawal by Subject|1|||
125280136|NCT05596734|450651217|FG015|Substudy B|Withdrawal by Subject|2|||
125280137|NCT05596734|450651218|FG016|Substudy B|Withdrawal by Subject|2|||
125280138|NCT05596734|450651219|FG017|Substudy B|Withdrawal by Subject|1|||
125280139|NCT05596734|450651220|FG018|Substudy B|Withdrawal by Subject|2|||
125280140|NCT05596734|450651221|FG019|Substudy B|Withdrawal by Subject|0|||
125280141|NCT05596734|450651222|FG020|Substudy B|Withdrawal by Subject|0|||
125280142|NCT05596734|450651223|FG021|Substudy B|Withdrawal by Subject|0|||
125280143|NCT05596734|450651224|FG022|Substudy B|Withdrawal by Subject|0|||
125280144|NCT05596734|450651225|FG023|Substudy B|Withdrawal by Subject|1|||
125280145|NCT05596734|450651202|FG000|Substudy B|Physician Decision|0|||
125280146|NCT05596734|450651203|FG001|Substudy B|Physician Decision|0|||
125280147|NCT05596734|450651204|FG002|Substudy B|Physician Decision|0|||
125411276|NCT02120924|451131065|FG001|Overall Study|Protocol Violation|7|||
125411277|NCT02120924|451131066|FG002|Overall Study|Protocol Violation|2|||
125411278|NCT02120924|451131064|FG000|Overall Study|Physician Decision|0|||
125411279|NCT02120924|451131065|FG001|Overall Study|Physician Decision|1|||
125411280|NCT02120924|451131066|FG002|Overall Study|Physician Decision|1|||
125411281|NCT02120924|451131064|FG000|Overall Study|Death|1|||
125411282|NCT02120924|451131065|FG001|Overall Study|Death|0|||
125280148|NCT05596734|450651205|FG003|Substudy B|Physician Decision|0|||
125280149|NCT05596734|450651206|FG004|Substudy B|Physician Decision|0|||
125280150|NCT05596734|450651207|FG005|Substudy B|Physician Decision|0|||
125411283|NCT02120924|451131066|FG002|Overall Study|Death|0|||
125411284|NCT02120924|451131064|FG000|Overall Study|Compliance with IP|5|||
125411285|NCT02120924|451131065|FG001|Overall Study|Compliance with IP|1|||
125411286|NCT02120924|451131066|FG002|Overall Study|Compliance with IP|1|||
125411287|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
125411288|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
125411289|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
125411290|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
125411291|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
125411292|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
125411293|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
125411294|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
125411295|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
125411296|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
125411297|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
125411298|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
125411299|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
125411300|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
125411301|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
125411302|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
125411303|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
125411304|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
125411305|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
125411306|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
125411307|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
125411308|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
125411309|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
125411310|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
125411311|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
125411312|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
125411313|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
125411314|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
125411315|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
125411316|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
125411317|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
125411318|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
125411319|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
125411320|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
125411321|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
125411322|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
125411323|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
125411324|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
125411325|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
125411326|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
125411327|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
125411328|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
125411329|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
125411330|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
125411331|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
125411332|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
125411333|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
125411334|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
125411335|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
125411336|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
125411337|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
125411338|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
125411339|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
125411340|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
125411341|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
125411342|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
125411343|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
125411344|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
125411345|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
125411346|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
125411347|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
125411348|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
125411349|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
125411350|NCT01884350|451131067|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
125411351|NCT01884350|451131068|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
125411352|NCT01884350|451131069|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
125411353|NCT01059617|451131070|FG000|Overall Study|Other|7|||
125411354|NCT01059617|451131071|FG001|Overall Study|Other|1|||
125411355|NCT01059617|451131072|FG002|Overall Study|Other|8|||
125411356|NCT01059617|451131073|FG003|Overall Study|Other|6|||
125411357|NCT02345512|451131074|FG000|Overall Study|Adverse Event|1|||
125411358|NCT02345512|451131074|FG000|Overall Study|Withdrawal by Subject|1|||
125411359|NCT02663817|451131075|FG000|Overall Study|Screen failure|2|||
125411360|NCT01438541|451131076|FG000|Overall Study|Physician Decision|1|||
125411361|NCT01438541|451131076|FG000|Overall Study|Withdrawal by Subject|1|||
125411362|NCT01438541|451131076|FG000|Overall Study|discharge from the hospital|5|||
125411363|NCT01968434|451131079|FG000|Overall Study|Lost to Follow-up|3|||
125411364|NCT01968434|451131080|FG001|Overall Study|Lost to Follow-up|6|||
125411365|NCT02091167|451131082|FG000|Overall Study|Lost to Follow-up|0|||
125411366|NCT02091167|451131083|FG001|Overall Study|Lost to Follow-up|2|||
125411367|NCT00074282|451132815|FG000|Step 1|Adverse Event|32|||
125411368|NCT00074282|451132816|FG001|Step 1|Adverse Event|0|||
125411369|NCT00074282|451132817|FG002|Step 1|Adverse Event|0|||
125411370|NCT00074282|451132815|FG000|Step 1|Death|6|||
125411371|NCT00074282|451132816|FG001|Step 1|Death|0|||
125411372|NCT00074282|451132817|FG002|Step 1|Death|0|||
125411373|NCT00074282|451132815|FG000|Step 1|Withdrawal by Subject|7|||
125411374|NCT00074282|451132816|FG001|Step 1|Withdrawal by Subject|0|||
125411375|NCT00074282|451132817|FG002|Step 1|Withdrawal by Subject|0|||
125411376|NCT00074282|451132815|FG000|Step 1|Disease progression|2|||
125411377|NCT00074282|451132816|FG001|Step 1|Disease progression|0|||
125411378|NCT00074282|451132817|FG002|Step 1|Disease progression|0|||
125411379|NCT00074282|451132815|FG000|Step 1|Alternative therapy|2|||
125411380|NCT00074282|451132816|FG001|Step 1|Alternative therapy|0|||
125411381|NCT00074282|451132817|FG002|Step 1|Alternative therapy|0|||
125411382|NCT00074282|451132815|FG000|Step 1|Other complicating disease|2|||
125411383|NCT00074282|451132816|FG001|Step 1|Other complicating disease|0|||
125411384|NCT00074282|451132817|FG002|Step 1|Other complicating disease|0|||
125411385|NCT00074282|451132815|FG000|Step 1|Physician Decision|1|||
125411386|NCT00074282|451132816|FG001|Step 1|Physician Decision|0|||
125411387|NCT00074282|451132817|FG002|Step 1|Physician Decision|0|||
125411388|NCT00074282|451132815|FG000|Step 1|Ineligible|4|||
125411389|NCT00074282|451132816|FG001|Step 1|Ineligible|0|||
125411390|NCT00074282|451132817|FG002|Step 1|Ineligible|0|||
125411391|NCT00074282|451132815|FG000|Step 1|Never started treatment|2|||
125411392|NCT00074282|451132816|FG001|Step 1|Never started treatment|0|||
125411393|NCT00074282|451132817|FG002|Step 1|Never started treatment|0|||
125411394|NCT00074282|451132815|FG000|Step 2|Adverse Event|0|||
125411395|NCT00074282|451132816|FG001|Step 2|Adverse Event|2|||
125411396|NCT00074282|451132817|FG002|Step 2|Adverse Event|12|||
125411397|NCT00074282|451132815|FG000|Step 2|Disease progression|0|||
125411398|NCT00074282|451132816|FG001|Step 2|Disease progression|0|||
125411399|NCT00074282|451132817|FG002|Step 2|Disease progression|5|||
125411400|NCT00074282|451132815|FG000|Step 2|Death|0|||
125411401|NCT00074282|451132816|FG001|Step 2|Death|0|||
125411402|NCT00074282|451132817|FG002|Step 2|Death|3|||
125411403|NCT00074282|451132815|FG000|Step 2|Withdrawal by Subject|0|||
125411404|NCT00074282|451132816|FG001|Step 2|Withdrawal by Subject|0|||
125411405|NCT00074282|451132817|FG002|Step 2|Withdrawal by Subject|2|||
125411406|NCT00074282|451132815|FG000|Step 2|Physician Decision|0|||
125411407|NCT00074282|451132816|FG001|Step 2|Physician Decision|0|||
125411408|NCT00074282|451132817|FG002|Step 2|Physician Decision|1|||
125411409|NCT00074282|451132815|FG000|Step 2|Ineligible|0|||
125411410|NCT00074282|451132816|FG001|Step 2|Ineligible|0|||
125411411|NCT00074282|451132817|FG002|Step 2|Ineligible|1|||
125411412|NCT00464542|451132818|FG000|Pre-treatment|Withdrawal by Subject|2|||
125411413|NCT01773226|451132820|FG000|Overall Study|Withdrawal by Subject|1|||
125411414|NCT02055352|451132825|FG000|Overall Study|Adverse Event|0|||
125411415|NCT02055352|451132826|FG001|Overall Study|Adverse Event|1|||
125411416|NCT02055352|451132825|FG000|Overall Study|Non-eligible|0|||
125411417|NCT02055352|451132826|FG001|Overall Study|Non-eligible|1|||
125411418|NCT02055352|451132825|FG000|Overall Study|Poor compliance|1|||
125411419|NCT02055352|451132826|FG001|Overall Study|Poor compliance|1|||
125411420|NCT02055352|451132825|FG000|Overall Study|Death|1|||
125411421|NCT02055352|451132826|FG001|Overall Study|Death|2|||
125411422|NCT02055352|451132825|FG000|Overall Study|Patient decision|1|||
125411423|NCT02055352|451132826|FG001|Overall Study|Patient decision|1|||
125411424|NCT02055352|451132825|FG000|Overall Study|Use of prohibited treatment|0|||
125411425|NCT02055352|451132826|FG001|Overall Study|Use of prohibited treatment|3|||
125411426|NCT02055352|451132825|FG000|Overall Study|AE, study drug would be detrimental|1|||
125411427|NCT02055352|451132826|FG001|Overall Study|AE, study drug would be detrimental|3|||
125411428|NCT02055352|451132825|FG000|Overall Study|Withdrawal of informed consent|1|||
125411429|NCT02055352|451132826|FG001|Overall Study|Withdrawal of informed consent|0|||
125411430|NCT02055352|451132825|FG000|Overall Study|Reason unknown|1|||
125411431|NCT02055352|451132826|FG001|Overall Study|Reason unknown|5|||
125411432|NCT03794089|451132833|FG000|Overall Study|Lost to Follow-up|4|||
125411433|NCT03794089|451132834|FG001|Overall Study|Lost to Follow-up|1|||
125411434|NCT03794089|451132833|FG000|Overall Study|Withdrawal by Subject|2|||
125411435|NCT03794089|451132834|FG001|Overall Study|Withdrawal by Subject|0|||
125411436|NCT03985423|451132835|FG000|Overall Study|Adverse Event|1|||
125411437|NCT03985423|451132835|FG000|Overall Study|Death|2|||
125411438|NCT03985423|451132835|FG000|Overall Study|Physician Decision|1|||
125411439|NCT03985423|451132835|FG000|Overall Study|Withdrawal by Subject|2|||
125411440|NCT03985423|451132835|FG000|Overall Study|Lack of insurance and citizenship|1|||
125411441|NCT01045447|451132846|FG000|Overall Study|Adverse Event|0|||
125411442|NCT01045447|451132847|FG001|Overall Study|Adverse Event|1|||
125411443|NCT01045447|451132846|FG000|Overall Study|Lack of Efficacy|3|||
125411444|NCT01045447|451132847|FG001|Overall Study|Lack of Efficacy|1|||
125411445|NCT01045447|451132846|FG000|Overall Study|Protocol Violation|6|||
125411446|NCT01045447|451132847|FG001|Overall Study|Protocol Violation|3|||
125411447|NCT01045447|451132846|FG000|Overall Study|Withdrawal Criteria|10|||
125411448|NCT01045447|451132847|FG001|Overall Study|Withdrawal Criteria|10|||
125411449|NCT01045447|451132846|FG000|Overall Study|Unclassified|17|||
125411450|NCT01045447|451132847|FG001|Overall Study|Unclassified|13|||
125411451|NCT00489970|451132849|FG000|Persistence Year 9|Lost to Follow-up|2|||
125411452|NCT00489970|451132850|FG001|Persistence Year 9|Lost to Follow-up|2|||
125411453|NCT00489970|451132851|FG002|Persistence Year 9|Lost to Follow-up|3|||
125411454|NCT00489970|451132849|FG000|Persistence Year 9|Other|1|||
125411455|NCT00489970|451132850|FG001|Persistence Year 9|Other|0|||
125411456|NCT00489970|451132851|FG002|Persistence Year 9|Other|2|||
125411457|NCT02707055|451132858|FG000|Phase 1|Withdrawal by Subject|1|||
125411458|NCT02707055|451132859|FG001|Phase 1|Withdrawal by Subject|2|||
125411459|NCT02707055|451132858|FG000|Phase 1|Physician Decision|0|||
125411460|NCT02707055|451132859|FG001|Phase 1|Physician Decision|1|||
125411461|NCT02707055|451132858|FG000|Phase 2|Adverse Event|1|||
125411462|NCT02707055|451132859|FG001|Phase 2|Adverse Event|2|||
125411463|NCT03564496|451132860|FG000|Overall Study|Withdrawal by Subject|1|||
125411464|NCT03564496|451132861|FG001|Overall Study|Withdrawal by Subject|1|||
125411465|NCT03564496|451132862|FG002|Overall Study|Withdrawal by Subject|0|||
125411466|NCT03564496|451132860|FG000|Overall Study|Screen failure|0|||
125411467|NCT03564496|451132861|FG001|Overall Study|Screen failure|3|||
125411468|NCT03564496|451132862|FG002|Overall Study|Screen failure|0|||
125411469|NCT01159938|451132863|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
125411470|NCT01159938|451132864|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
125411471|NCT01159938|451132865|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
125411472|NCT01159938|451132866|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
125411473|NCT01159938|451132867|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
125411474|NCT02318329|451132871|FG000|Overall Study|Progressive Disease|2|||
125411475|NCT02318329|451132872|FG001|Overall Study|Progressive Disease|3|||
125411476|NCT02318329|451132873|FG002|Overall Study|Progressive Disease|2|||
125411477|NCT02318329|451132874|FG003|Overall Study|Progressive Disease|3|||
125411478|NCT02318329|451132875|FG004|Overall Study|Progressive Disease|3|||
125411479|NCT02318329|451132876|FG005|Overall Study|Progressive Disease|3|||
125411480|NCT02318329|451132877|FG006|Overall Study|Progressive Disease|1|||
125411481|NCT02318329|451132878|FG007|Overall Study|Progressive Disease|1|||
125411482|NCT02318329|451132879|FG008|Overall Study|Progressive Disease|5|||
125411483|NCT02318329|451132880|FG009|Overall Study|Progressive Disease|39|||
125280151|NCT05596734|450651208|FG006|Substudy B|Physician Decision|0|||
125280152|NCT05596734|450651209|FG007|Substudy B|Physician Decision|0|||
125448374|NCT00335153|451268916|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
125448375|NCT00335153|451268916|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
125411484|NCT02318329|451132871|FG000|Overall Study|Death|0|||
125411485|NCT02318329|451132872|FG001|Overall Study|Death|0|||
125411486|NCT02318329|451132873|FG002|Overall Study|Death|0|||
125280153|NCT05596734|450651210|FG008|Substudy B|Physician Decision|0|||
125411487|NCT02318329|451132874|FG003|Overall Study|Death|0|||
125411488|NCT02318329|451132875|FG004|Overall Study|Death|0|||
125448376|NCT00335153|451268916|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
125280154|NCT05596734|450651211|FG009|Substudy B|Physician Decision|0|||
125411489|NCT02318329|451132876|FG005|Overall Study|Death|0|||
125411490|NCT02318329|451132877|FG006|Overall Study|Death|0|||
125411491|NCT02318329|451132878|FG007|Overall Study|Death|0|||
125411492|NCT02318329|451132879|FG008|Overall Study|Death|0|||
125411493|NCT02318329|451132880|FG009|Overall Study|Death|5|||
125411494|NCT02318329|451132871|FG000|Overall Study|Lost to Follow-up|0|||
125411495|NCT02318329|451132872|FG001|Overall Study|Lost to Follow-up|0|||
125280155|NCT05596734|450651212|FG010|Substudy B|Physician Decision|0|||
125411496|NCT02318329|451132873|FG002|Overall Study|Lost to Follow-up|0|||
125411497|NCT02318329|451132874|FG003|Overall Study|Lost to Follow-up|0|||
125411498|NCT02318329|451132875|FG004|Overall Study|Lost to Follow-up|0|||
125411499|NCT02318329|451132876|FG005|Overall Study|Lost to Follow-up|0|||
125411500|NCT02318329|451132877|FG006|Overall Study|Lost to Follow-up|0|||
125411501|NCT02318329|451132878|FG007|Overall Study|Lost to Follow-up|0|||
125411502|NCT02318329|451132879|FG008|Overall Study|Lost to Follow-up|0|||
125411503|NCT02318329|451132880|FG009|Overall Study|Lost to Follow-up|1|||
125411504|NCT02318329|451132871|FG000|Overall Study|Withdrawal by Subject|0|||
125411505|NCT02318329|451132872|FG001|Overall Study|Withdrawal by Subject|0|||
125411506|NCT02318329|451132873|FG002|Overall Study|Withdrawal by Subject|0|||
125411507|NCT02318329|451132874|FG003|Overall Study|Withdrawal by Subject|0|||
125411508|NCT02318329|451132875|FG004|Overall Study|Withdrawal by Subject|0|||
125411509|NCT02318329|451132876|FG005|Overall Study|Withdrawal by Subject|0|||
125411510|NCT02318329|451132877|FG006|Overall Study|Withdrawal by Subject|0|||
125411511|NCT02318329|451132878|FG007|Overall Study|Withdrawal by Subject|0|||
125411512|NCT02318329|451132879|FG008|Overall Study|Withdrawal by Subject|0|||
125411513|NCT02318329|451132880|FG009|Overall Study|Withdrawal by Subject|6|||
125411514|NCT02318329|451132871|FG000|Overall Study|Other|1|||
125411515|NCT02318329|451132872|FG001|Overall Study|Other|1|||
125411516|NCT02318329|451132873|FG002|Overall Study|Other|1|||
125411517|NCT02318329|451132874|FG003|Overall Study|Other|0|||
125411518|NCT02318329|451132875|FG004|Overall Study|Other|0|||
125411519|NCT02318329|451132876|FG005|Overall Study|Other|0|||
125411520|NCT02318329|451132877|FG006|Overall Study|Other|0|||
125411521|NCT02318329|451132878|FG007|Overall Study|Other|0|||
125411522|NCT02318329|451132879|FG008|Overall Study|Other|1|||
125411523|NCT02318329|451132880|FG009|Overall Study|Other|1|||
125411524|NCT00086346|451132881|FG000|Randomization|Did not receive test article|4|||
125411525|NCT00086346|451132882|FG001|Randomization|Did not receive test article|4|||
125411526|NCT00086346|451132881|FG000|Patients Dosed With Test Article|Adverse Event|94|||
125411527|NCT00086346|451132882|FG001|Patients Dosed With Test Article|Adverse Event|11|||
125411528|NCT00086346|451132881|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
125411529|NCT00086346|451132882|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
125411530|NCT00086346|451132881|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
125411531|NCT00086346|451132882|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
125411532|NCT00086346|451132881|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
125411533|NCT00086346|451132882|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
125411534|NCT00086346|451132881|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
125411535|NCT00086346|451132882|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
125411536|NCT00086346|451132881|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
125411537|NCT00086346|451132882|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
125411538|NCT03268811|451132883|FG000|Overall Study|Adverse Event|0|||
125411539|NCT03268811|451132884|FG001|Overall Study|Adverse Event|1|||
125411540|NCT02731131|451132892|FG000|Overall Study|Psychiatric Disorder|0|||
125411541|NCT02731131|451132893|FG001|Overall Study|Psychiatric Disorder|1|||
125411542|NCT02731131|451132892|FG000|Overall Study|Refused Therapy|0|||
125411543|NCT02731131|451132893|FG001|Overall Study|Refused Therapy|1|||
125411544|NCT02348216|451132894|FG000|Overall Study|Death|5|||
125411545|NCT02348216|451132895|FG001|Overall Study|Death|53|||
125411546|NCT02348216|451132896|FG002|Overall Study|Death|11|||
125411547|NCT02348216|451132897|FG003|Overall Study|Death|20|||
125411548|NCT02348216|451132898|FG004|Overall Study|Death|16|||
125411549|NCT02348216|451132899|FG005|Overall Study|Death|32|||
125411550|NCT02348216|451132900|FG006|Overall Study|Death|17|||
125411551|NCT02348216|451132894|FG000|Overall Study|Full consent withdrawal|0|||
125411552|NCT02348216|451132895|FG001|Overall Study|Full consent withdrawal|0|||
125411553|NCT02348216|451132896|FG002|Overall Study|Full consent withdrawal|0|||
125411554|NCT02348216|451132897|FG003|Overall Study|Full consent withdrawal|1|||
125411555|NCT02348216|451132898|FG004|Overall Study|Full consent withdrawal|3|||
125411556|NCT02348216|451132899|FG005|Overall Study|Full consent withdrawal|0|||
125411557|NCT02348216|451132900|FG006|Overall Study|Full consent withdrawal|3|||
125411558|NCT02348216|451132894|FG000|Overall Study|Lost to Follow-up|0|||
125411559|NCT02348216|451132895|FG001|Overall Study|Lost to Follow-up|5|||
125411560|NCT02348216|451132896|FG002|Overall Study|Lost to Follow-up|2|||
125411561|NCT02348216|451132897|FG003|Overall Study|Lost to Follow-up|0|||
125411562|NCT02348216|451132898|FG004|Overall Study|Lost to Follow-up|1|||
125411563|NCT02348216|451132899|FG005|Overall Study|Lost to Follow-up|1|||
125411564|NCT02348216|451132900|FG006|Overall Study|Lost to Follow-up|1|||
125411565|NCT02348216|451132894|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
125411566|NCT02348216|451132895|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
125411567|NCT02348216|451132896|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
125411568|NCT02348216|451132897|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
125411569|NCT02348216|451132898|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
125411570|NCT02348216|451132899|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
125411571|NCT02348216|451132900|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
125411572|NCT02348216|451132894|FG000|Overall Study|Reason not specified|2|||
125411573|NCT02348216|451132895|FG001|Overall Study|Reason not specified|19|||
125411574|NCT02348216|451132896|FG002|Overall Study|Reason not specified|11|||
125411575|NCT02348216|451132897|FG003|Overall Study|Reason not specified|17|||
125411576|NCT02348216|451132898|FG004|Overall Study|Reason not specified|21|||
125411577|NCT02348216|451132899|FG005|Overall Study|Reason not specified|17|||
125411578|NCT02348216|451132900|FG006|Overall Study|Reason not specified|19|||
125411579|NCT01055639|451132901|FG000|Overall Study|Adverse Event|0|||
125411580|NCT01055639|451132902|FG001|Overall Study|Adverse Event|1|||
125411581|NCT01055639|451132901|FG000|Overall Study|Lack of Efficacy|0|||
125411582|NCT01055639|451132902|FG001|Overall Study|Lack of Efficacy|1|||
125411583|NCT01055639|451132901|FG000|Overall Study|Lost to Follow-up|8|||
125411584|NCT01055639|451132902|FG001|Overall Study|Lost to Follow-up|11|||
125411585|NCT01055639|451132901|FG000|Overall Study|Protocol Violation|5|||
125411586|NCT01055639|451132902|FG001|Overall Study|Protocol Violation|5|||
125280156|NCT05596734|450651213|FG011|Substudy B|Physician Decision|0|||
125280157|NCT05596734|450651214|FG012|Substudy B|Physician Decision|0|||
125280158|NCT05596734|450651215|FG013|Substudy B|Physician Decision|0|||
125280159|NCT05596734|450651216|FG014|Substudy B|Physician Decision|0|||
125280160|NCT05596734|450651217|FG015|Substudy B|Physician Decision|1|||
125280161|NCT05596734|450651218|FG016|Substudy B|Physician Decision|0|||
125280162|NCT05596734|450651219|FG017|Substudy B|Physician Decision|0|||
125280163|NCT05596734|450651220|FG018|Substudy B|Physician Decision|0|||
125280164|NCT05596734|450651221|FG019|Substudy B|Physician Decision|0|||
125280165|NCT05596734|450651222|FG020|Substudy B|Physician Decision|0|||
125280166|NCT05596734|450651223|FG021|Substudy B|Physician Decision|0|||
125280167|NCT05596734|450651224|FG022|Substudy B|Physician Decision|0|||
125280168|NCT05596734|450651225|FG023|Substudy B|Physician Decision|0|||
125280169|NCT05596734|450651202|FG000|Substudy B|Lost to Follow-up|0|||
125280170|NCT05596734|450651203|FG001|Substudy B|Lost to Follow-up|0|||
125280171|NCT05596734|450651204|FG002|Substudy B|Lost to Follow-up|0|||
125280172|NCT05596734|450651205|FG003|Substudy B|Lost to Follow-up|0|||
125280173|NCT05596734|450651206|FG004|Substudy B|Lost to Follow-up|0|||
125280174|NCT05596734|450651207|FG005|Substudy B|Lost to Follow-up|0|||
125280175|NCT05596734|450651208|FG006|Substudy B|Lost to Follow-up|0|||
125280176|NCT05596734|450651209|FG007|Substudy B|Lost to Follow-up|0|||
125280177|NCT05596734|450651210|FG008|Substudy B|Lost to Follow-up|0|||
125280178|NCT05596734|450651211|FG009|Substudy B|Lost to Follow-up|0|||
125280179|NCT05596734|450651212|FG010|Substudy B|Lost to Follow-up|0|||
125280180|NCT05596734|450651213|FG011|Substudy B|Lost to Follow-up|0|||
125280181|NCT05596734|450651214|FG012|Substudy B|Lost to Follow-up|1|||
125280182|NCT05596734|450651215|FG013|Substudy B|Lost to Follow-up|0|||
125280183|NCT05596734|450651216|FG014|Substudy B|Lost to Follow-up|1|||
125280184|NCT05596734|450651217|FG015|Substudy B|Lost to Follow-up|1|||
125280185|NCT05596734|450651218|FG016|Substudy B|Lost to Follow-up|0|||
125280186|NCT05596734|450651219|FG017|Substudy B|Lost to Follow-up|0|||
125280187|NCT05596734|450651220|FG018|Substudy B|Lost to Follow-up|0|||
125280188|NCT05596734|450651221|FG019|Substudy B|Lost to Follow-up|0|||
125280189|NCT05596734|450651222|FG020|Substudy B|Lost to Follow-up|0|||
125280190|NCT05596734|450651223|FG021|Substudy B|Lost to Follow-up|0|||
125280191|NCT05596734|450651224|FG022|Substudy B|Lost to Follow-up|0|||
125280192|NCT05596734|450651225|FG023|Substudy B|Lost to Follow-up|0|||
125280193|NCT04113018|450651226|FG000|Overall Study|Death|2|||
125280194|NCT04113018|450651226|FG000|Overall Study|Lost to Follow-up|1|||
125280195|NCT04113018|450651226|FG000|Overall Study|Still On Study (on study treatment)|24|||
125280196|NCT04113018|450651226|FG000|Overall Study|Still On Study (in follow up)|12|||
125280197|NCT00079391|450651227|FG000|Overall Study|Withdrawal by Subject|1|||
125280198|NCT02791516|450651232|FG000|Overall Study|Withdrawal by Subject|1|||
125280199|NCT02791516|450651233|FG001|Overall Study|Withdrawal by Subject|1|||
125280200|NCT03479541|450651234|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
125280201|NCT03479541|450651235|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
125280202|NCT03479541|450651236|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
125280203|NCT03479541|450651237|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
125280204|NCT03479541|450651234|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
125280205|NCT03479541|450651235|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
125280206|NCT03479541|450651236|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
125280207|NCT03479541|450651237|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
125280208|NCT03479541|450651234|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
125280209|NCT03479541|450651235|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
125280210|NCT03479541|450651236|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
125280211|NCT03479541|450651237|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
125280212|NCT03479541|450651234|FG000|Home Monitoring|Lost to Follow-up|0|||
125280213|NCT03479541|450651235|FG001|Home Monitoring|Lost to Follow-up|0|||
125411587|NCT01055639|451132901|FG000|Overall Study|Withdrawal by Subject|8|||
125280214|NCT03479541|450651236|FG002|Home Monitoring|Lost to Follow-up|8|||
125280215|NCT03479541|450651237|FG003|Home Monitoring|Lost to Follow-up|12|||
125280216|NCT03479541|450651234|FG000|Home Monitoring|Withdrawal by Subject|0|||
125280217|NCT03479541|450651235|FG001|Home Monitoring|Withdrawal by Subject|0|||
125411588|NCT01055639|451132902|FG001|Overall Study|Withdrawal by Subject|11|||
125411589|NCT00562159|451132903|FG000|Overall Study|Adverse Event|11|||
125411590|NCT00562159|451132904|FG001|Overall Study|Adverse Event|8|||
125411591|NCT00562159|451132903|FG000|Overall Study|Lost to Follow-up|5|||
125411592|NCT00562159|451132904|FG001|Overall Study|Lost to Follow-up|4|||
125411593|NCT00562159|451132903|FG000|Overall Study|Withdrawal by Subject|9|||
125411594|NCT00562159|451132904|FG001|Overall Study|Withdrawal by Subject|8|||
125411595|NCT00562159|451132903|FG000|Overall Study|Protocol Violation|12|||
125411596|NCT00562159|451132904|FG001|Overall Study|Protocol Violation|12|||
125411597|NCT00562159|451132903|FG000|Overall Study|Did not meet protocol eligibility|1|||
125411598|NCT00562159|451132904|FG001|Overall Study|Did not meet protocol eligibility|1|||
125411599|NCT00765245|451132905|FG000|Overall Study|disease progression|3|||
125411600|NCT00765245|451132906|FG001|Overall Study|disease progression|2|||
125411601|NCT00765245|451132905|FG000|Overall Study|Withdrawal by Subject|3|||
125411602|NCT00765245|451132906|FG001|Overall Study|Withdrawal by Subject|0|||
125411603|NCT00765245|451132905|FG000|Overall Study|Adverse Event|5|||
125411604|NCT00765245|451132906|FG001|Overall Study|Adverse Event|0|||
125411605|NCT00765245|451132905|FG000|Overall Study|Physician Decision|1|||
125411606|NCT00765245|451132906|FG001|Overall Study|Physician Decision|0|||
125411607|NCT00765245|451132905|FG000|Overall Study|Death|1|||
125411608|NCT00765245|451132906|FG001|Overall Study|Death|0|||
125280218|NCT03479541|450651236|FG002|Home Monitoring|Withdrawal by Subject|17|||
125280219|NCT03479541|450651237|FG003|Home Monitoring|Withdrawal by Subject|30|||
125280220|NCT03479541|450651234|FG000|Home Monitoring|Early Termination - PI Decision|0|||
125280221|NCT03479541|450651235|FG001|Home Monitoring|Early Termination - PI Decision|0|||
125280222|NCT03479541|450651236|FG002|Home Monitoring|Early Termination - PI Decision|4|||
125280223|NCT03479541|450651237|FG003|Home Monitoring|Early Termination - PI Decision|6|||
125280224|NCT00107900|450651240|FG000|Overall Study|Adverse Event|3|||
125280225|NCT00107900|450651241|FG001|Overall Study|Adverse Event|2|||
125280226|NCT00107900|450651242|FG002|Overall Study|Adverse Event|10|||
125280227|NCT00107900|450651243|FG003|Overall Study|Adverse Event|3|||
125280228|NCT00107900|450651244|FG004|Overall Study|Adverse Event|5|||
125280229|NCT00107900|450651245|FG005|Overall Study|Adverse Event|3|||
125280230|NCT00107900|450651240|FG000|Overall Study|Death|0|||
125280231|NCT00107900|450651241|FG001|Overall Study|Death|0|||
125280232|NCT00107900|450651242|FG002|Overall Study|Death|0|||
125280233|NCT00107900|450651243|FG003|Overall Study|Death|0|||
125280234|NCT00107900|450651244|FG004|Overall Study|Death|1|||
125280235|NCT00107900|450651245|FG005|Overall Study|Death|0|||
125280236|NCT00107900|450651240|FG000|Overall Study|Lost to Follow-up|4|||
125280237|NCT00107900|450651241|FG001|Overall Study|Lost to Follow-up|1|||
125280238|NCT00107900|450651242|FG002|Overall Study|Lost to Follow-up|3|||
125280239|NCT00107900|450651243|FG003|Overall Study|Lost to Follow-up|2|||
125280240|NCT00107900|450651244|FG004|Overall Study|Lost to Follow-up|5|||
125280241|NCT00107900|450651245|FG005|Overall Study|Lost to Follow-up|5|||
125280242|NCT00107900|450651240|FG000|Overall Study|Protocol Violation|1|||
125280243|NCT00107900|450651241|FG001|Overall Study|Protocol Violation|0|||
125280244|NCT00107900|450651242|FG002|Overall Study|Protocol Violation|5|||
125280245|NCT00107900|450651243|FG003|Overall Study|Protocol Violation|5|||
125280246|NCT00107900|450651244|FG004|Overall Study|Protocol Violation|7|||
125280247|NCT00107900|450651245|FG005|Overall Study|Protocol Violation|0|||
125280248|NCT00107900|450651240|FG000|Overall Study|Withdrawal by Subject|1|||
125280249|NCT00107900|450651241|FG001|Overall Study|Withdrawal by Subject|0|||
125280250|NCT00107900|450651242|FG002|Overall Study|Withdrawal by Subject|5|||
125280251|NCT00107900|450651243|FG003|Overall Study|Withdrawal by Subject|0|||
125280252|NCT00107900|450651244|FG004|Overall Study|Withdrawal by Subject|1|||
125280253|NCT00107900|450651245|FG005|Overall Study|Withdrawal by Subject|1|||
125280254|NCT00107900|450651240|FG000|Overall Study|Administrative Reasons|1|||
125280255|NCT00107900|450651241|FG001|Overall Study|Administrative Reasons|0|||
125280256|NCT00107900|450651242|FG002|Overall Study|Administrative Reasons|2|||
125280257|NCT00107900|450651243|FG003|Overall Study|Administrative Reasons|2|||
125280258|NCT00107900|450651244|FG004|Overall Study|Administrative Reasons|2|||
125280259|NCT00107900|450651245|FG005|Overall Study|Administrative Reasons|0|||
125280260|NCT02644096|450651246|FG000|Overall Study|Withdrawal by Subject|28|||
125280261|NCT02644096|450651247|FG001|Overall Study|Withdrawal by Subject|25|||
125280262|NCT02461290|450651248|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
125280263|NCT02461290|450651248|FG000|Overall Study|Lost to Follow-up|3|||
125411609|NCT02417246|451132908|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
125411610|NCT02417246|451132909|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
125411611|NCT02417246|451132908|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
125411612|NCT02417246|451132909|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
125280264|NCT00526656|450651249|FG000|Overall Study|Death|1|||
125280265|NCT00526656|450651249|FG000|Overall Study|Refused surgery|1|||
125280266|NCT01456195|450652800|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
125280267|NCT01456195|450652801|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
125280268|NCT01456195|450652802|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
125280269|NCT01456195|450652800|FG000|Overall Study|Lost to Follow-up|3|||
125280270|NCT01456195|450652801|FG001|Overall Study|Lost to Follow-up|1|||
125280271|NCT01456195|450652802|FG002|Overall Study|Lost to Follow-up|3|||
125280272|NCT01456195|450652800|FG000|Overall Study|Voluntary Withdrawal|5|||
125411613|NCT02417246|451132908|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
125411614|NCT02417246|451132909|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
125411615|NCT02417246|451132908|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
125411616|NCT02417246|451132909|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
125411617|NCT01181921|451132912|FG000|Overall Study|Lost to Follow-up|1|||
125411618|NCT02546544|451132913|FG000|Overall Study|Disease Progression|14|||
125411619|NCT02546544|451132913|FG000|Overall Study|Adverse Event|1|||
125411620|NCT02546544|451132913|FG000|Overall Study|Withdrawal by Subject|1|||
125411621|NCT02548962|451132914|FG000|Overall Study|Withdrawal by Subject|1|||
125411622|NCT02548962|451132915|FG001|Overall Study|Withdrawal by Subject|0|||
125411623|NCT01197950|451132916|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
125411624|NCT01197950|451132917|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
125411625|NCT01197950|451132918|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
125411626|NCT04831736|451132919|FG000|Overall Study|Withdrawal by Subject|0|||
125411627|NCT04831736|451132920|FG001|Overall Study|Withdrawal by Subject|1|||
125411628|NCT01666002|451132926|FG000|Overall Study|Lost to Follow-up|5|||
125411629|NCT01666002|451132927|FG001|Overall Study|Lost to Follow-up|0|||
125411630|NCT01233817|451132928|FG000|Overall Study|Lost to Follow-up|1|||
125411631|NCT01233817|451132928|FG000|Overall Study|Withdrawal by Subject|2|||
125411632|NCT02159482|451132929|FG000|Overall Study|Withdrawal by Subject|2|||
125411633|NCT02159482|451132929|FG000|Overall Study|Physician Decision|3|||
125411634|NCT01248884|451132930|FG000|Overall Study|Withdrawal by Subject|1|||
125411635|NCT01248884|451132931|FG001|Overall Study|Withdrawal by Subject|3|||
125411636|NCT01248884|451132932|FG002|Overall Study|Withdrawal by Subject|1|||
125411637|NCT01248884|451132930|FG000|Overall Study|Adverse Event|1|||
125411638|NCT01248884|451132931|FG001|Overall Study|Adverse Event|0|||
125411639|NCT01248884|451132932|FG002|Overall Study|Adverse Event|0|||
125411640|NCT02511431|451132933|FG000|Treatment|Lost to Follow-up|0|||
125411641|NCT02511431|451132934|FG001|Treatment|Lost to Follow-up|0|||
125411642|NCT02511431|451132935|FG002|Treatment|Lost to Follow-up|1|||
125411643|NCT02511431|451132936|FG003|Treatment|Lost to Follow-up|0|||
125411644|NCT02511431|451132937|FG004|Treatment|Lost to Follow-up|0|||
125411645|NCT02511431|451132938|FG005|Treatment|Lost to Follow-up|1|||
125411646|NCT04479618|451132939|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
125411647|NCT04479618|451132940|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
125411648|NCT04479618|451132941|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
125411649|NCT04479618|451132939|FG000|Overall Study|Lack of Efficacy|1|||
125411650|NCT04479618|451132940|FG001|Overall Study|Lack of Efficacy|0|||
125411651|NCT04479618|451132941|FG002|Overall Study|Lack of Efficacy|0|||
125411652|NCT04479618|451132939|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
125411653|NCT04479618|451132940|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
125411654|NCT04479618|451132941|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
125411655|NCT04479618|451132939|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
125411656|NCT04479618|451132940|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
125411657|NCT04479618|451132941|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
125411658|NCT04479618|451132939|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
125411659|NCT04479618|451132940|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
125411660|NCT04479618|451132941|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
125411661|NCT04479618|451132939|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
125411662|NCT04479618|451132940|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
125411663|NCT04479618|451132941|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
125411664|NCT01202773|451132942|FG000|Overall Study|Adverse Event|4|||
125411665|NCT01202773|451132943|FG001|Overall Study|Adverse Event|5|||
125411666|NCT01202773|451132944|FG002|Overall Study|Adverse Event|5|||
125411667|NCT01202773|451132942|FG000|Overall Study|Lack of Efficacy|5|||
125411668|NCT01202773|451132943|FG001|Overall Study|Lack of Efficacy|4|||
125411669|NCT01202773|451132944|FG002|Overall Study|Lack of Efficacy|9|||
125411670|NCT01202773|451132942|FG000|Overall Study|Entry Criteria Not Met|2|||
125411671|NCT01202773|451132943|FG001|Overall Study|Entry Criteria Not Met|0|||
125411672|NCT01202773|451132944|FG002|Overall Study|Entry Criteria Not Met|1|||
125411673|NCT01202773|451132942|FG000|Overall Study|Lost to Follow-up|1|||
125411674|NCT01202773|451132943|FG001|Overall Study|Lost to Follow-up|2|||
125411675|NCT01202773|451132944|FG002|Overall Study|Lost to Follow-up|2|||
125411676|NCT01202773|451132942|FG000|Overall Study|Withdrawal by Subject|13|||
125411677|NCT01202773|451132943|FG001|Overall Study|Withdrawal by Subject|6|||
125411678|NCT01202773|451132944|FG002|Overall Study|Withdrawal by Subject|5|||
125411679|NCT01202773|451132942|FG000|Overall Study|Physician Decision|2|||
125411680|NCT01202773|451132943|FG001|Overall Study|Physician Decision|0|||
125411681|NCT01202773|451132944|FG002|Overall Study|Physician Decision|0|||
125411682|NCT01202773|451132942|FG000|Overall Study|Protocol Violation|11|||
125411683|NCT01202773|451132943|FG001|Overall Study|Protocol Violation|6|||
125411684|NCT01202773|451132944|FG002|Overall Study|Protocol Violation|10|||
125411685|NCT01202773|451132942|FG000|Overall Study|Sponsor Decision|19|||
125411686|NCT01202773|451132943|FG001|Overall Study|Sponsor Decision|20|||
125411687|NCT01202773|451132944|FG002|Overall Study|Sponsor Decision|23|||
125411688|NCT02828111|451132953|FG000|Overall Study|Withdrawal by Subject|0|||
125280273|NCT01456195|450652801|FG001|Overall Study|Voluntary Withdrawal|3|||
125280274|NCT01456195|450652802|FG002|Overall Study|Voluntary Withdrawal|7|||
125280275|NCT01456195|450652800|FG000|Overall Study|Lack of Efficacy|0|||
125280276|NCT01456195|450652801|FG001|Overall Study|Lack of Efficacy|1|||
125280277|NCT01456195|450652802|FG002|Overall Study|Lack of Efficacy|0|||
125280278|NCT01456195|450652800|FG000|Overall Study|Other Reasons|2|||
125280279|NCT01456195|450652801|FG001|Overall Study|Other Reasons|1|||
125280280|NCT01456195|450652802|FG002|Overall Study|Other Reasons|3|||
125280281|NCT02547038|450652803|FG000|Overall Study|Lost to Follow-up|3|||
125280282|NCT02547038|450652804|FG001|Overall Study|Lost to Follow-up|2|||
125280283|NCT01340625|450652805|FG000|First Intervention|Adverse Event|1|||
125280284|NCT01340625|450652806|FG001|First Intervention|Adverse Event|0|||
125280285|NCT01340625|450652805|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
125280286|NCT01340625|450652806|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
125280287|NCT00734604|450652813|FG000|Overall Study|Adverse Event|0|||
125280288|NCT00734604|450652814|FG001|Overall Study|Adverse Event|2|||
125280289|NCT00734604|450652815|FG002|Overall Study|Adverse Event|0|||
125280290|NCT00734604|450652816|FG003|Overall Study|Adverse Event|2|||
125280291|NCT00734604|450652817|FG004|Overall Study|Adverse Event|1|||
125280292|NCT00734604|450652818|FG005|Overall Study|Adverse Event|1|||
125280293|NCT00734604|450652813|FG000|Overall Study|Serious Adverse Event|1|||
125280294|NCT00734604|450652814|FG001|Overall Study|Serious Adverse Event|0|||
125280295|NCT00734604|450652815|FG002|Overall Study|Serious Adverse Event|1|||
125280296|NCT00734604|450652816|FG003|Overall Study|Serious Adverse Event|2|||
125280297|NCT00734604|450652817|FG004|Overall Study|Serious Adverse Event|0|||
125280298|NCT00734604|450652818|FG005|Overall Study|Serious Adverse Event|1|||
125280299|NCT00734604|450652813|FG000|Overall Study|Lost to Follow-up|1|||
125280300|NCT00734604|450652814|FG001|Overall Study|Lost to Follow-up|2|||
125280301|NCT00734604|450652815|FG002|Overall Study|Lost to Follow-up|2|||
125280302|NCT00734604|450652816|FG003|Overall Study|Lost to Follow-up|4|||
125280303|NCT00734604|450652817|FG004|Overall Study|Lost to Follow-up|2|||
125280304|NCT00734604|450652818|FG005|Overall Study|Lost to Follow-up|3|||
125280305|NCT00734604|450652813|FG000|Overall Study|Physician Decision|0|||
125280306|NCT00734604|450652814|FG001|Overall Study|Physician Decision|1|||
125280307|NCT00734604|450652815|FG002|Overall Study|Physician Decision|1|||
125280308|NCT00734604|450652816|FG003|Overall Study|Physician Decision|0|||
125280309|NCT00734604|450652817|FG004|Overall Study|Physician Decision|0|||
125280310|NCT00734604|450652818|FG005|Overall Study|Physician Decision|0|||
125280311|NCT00734604|450652813|FG000|Overall Study|Protocol Violation|0|||
125280312|NCT00734604|450652814|FG001|Overall Study|Protocol Violation|2|||
125280313|NCT00734604|450652815|FG002|Overall Study|Protocol Violation|0|||
125280314|NCT00734604|450652816|FG003|Overall Study|Protocol Violation|0|||
125280315|NCT00734604|450652817|FG004|Overall Study|Protocol Violation|1|||
125280316|NCT00734604|450652818|FG005|Overall Study|Protocol Violation|0|||
125280317|NCT00734604|450652813|FG000|Overall Study|Sponsor Decision|1|||
125280318|NCT00734604|450652814|FG001|Overall Study|Sponsor Decision|2|||
125280319|NCT00734604|450652815|FG002|Overall Study|Sponsor Decision|1|||
125280320|NCT00734604|450652816|FG003|Overall Study|Sponsor Decision|0|||
125280321|NCT00734604|450652817|FG004|Overall Study|Sponsor Decision|2|||
125280322|NCT00734604|450652818|FG005|Overall Study|Sponsor Decision|0|||
125411689|NCT02828111|451132954|FG001|Overall Study|Withdrawal by Subject|0|||
125448377|NCT00335153|451268916|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
125448378|NCT00335153|451268916|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
125280323|NCT00734604|450652813|FG000|Overall Study|Withdrawal by Subject|0|||
125280324|NCT00734604|450652814|FG001|Overall Study|Withdrawal by Subject|2|||
125280325|NCT00734604|450652815|FG002|Overall Study|Withdrawal by Subject|0|||
125280326|NCT00734604|450652816|FG003|Overall Study|Withdrawal by Subject|1|||
125411690|NCT02828111|451132955|FG002|Overall Study|Withdrawal by Subject|2|||
125411691|NCT02828111|451132956|FG003|Overall Study|Withdrawal by Subject|0|||
125280327|NCT00734604|450652817|FG004|Overall Study|Withdrawal by Subject|2|||
125280328|NCT00734604|450652818|FG005|Overall Study|Withdrawal by Subject|1|||
125280329|NCT00734604|450652813|FG000|Overall Study|Lack of Efficacy|0|||
125280330|NCT00734604|450652814|FG001|Overall Study|Lack of Efficacy|1|||
125280331|NCT00734604|450652815|FG002|Overall Study|Lack of Efficacy|1|||
125280332|NCT00734604|450652816|FG003|Overall Study|Lack of Efficacy|0|||
125280333|NCT00734604|450652817|FG004|Overall Study|Lack of Efficacy|0|||
125280334|NCT00734604|450652818|FG005|Overall Study|Lack of Efficacy|0|||
125280335|NCT02589665|450652819|FG000|Induction Period|Did not receive drug|0|||
125411692|NCT02828111|451132957|FG004|Overall Study|Withdrawal by Subject|0|||
125280336|NCT02589665|450652820|FG001|Induction Period|Did not receive drug|0|||
125280337|NCT02589665|450652821|FG002|Induction Period|Did not receive drug|0|||
125280338|NCT02589665|450652822|FG003|Induction Period|Did not receive drug|1|||
125280339|NCT02589665|450652823|FG004|Induction Period|Did not receive drug|0|||
125280340|NCT02589665|450652824|FG005|Induction Period|Did not receive drug|0|||
125280341|NCT02589665|450652825|FG006|Induction Period|Did not receive drug|0|||
125280342|NCT02589665|450652826|FG007|Induction Period|Did not receive drug|0|||
125280343|NCT02589665|450652827|FG008|Induction Period|Did not receive drug|0|||
125280344|NCT02589665|450652828|FG009|Induction Period|Did not receive drug|0|||
125280345|NCT02589665|450652819|FG000|Induction Period|Adverse Event|3|||
125280346|NCT02589665|450652820|FG001|Induction Period|Adverse Event|0|||
125280347|NCT02589665|450652821|FG002|Induction Period|Adverse Event|2|||
125280348|NCT02589665|450652822|FG003|Induction Period|Adverse Event|2|||
125280349|NCT02589665|450652823|FG004|Induction Period|Adverse Event|0|||
125280350|NCT02589665|450652824|FG005|Induction Period|Adverse Event|0|||
125280351|NCT02589665|450652825|FG006|Induction Period|Adverse Event|0|||
125280352|NCT02589665|450652826|FG007|Induction Period|Adverse Event|0|||
125280353|NCT02589665|450652827|FG008|Induction Period|Adverse Event|0|||
125280354|NCT02589665|450652828|FG009|Induction Period|Adverse Event|0|||
125280355|NCT02589665|450652819|FG000|Induction Period|Withdrawal by Subject|0|||
125280356|NCT02589665|450652820|FG001|Induction Period|Withdrawal by Subject|1|||
125280357|NCT02589665|450652821|FG002|Induction Period|Withdrawal by Subject|0|||
125280358|NCT02589665|450652822|FG003|Induction Period|Withdrawal by Subject|1|||
125280359|NCT02589665|450652823|FG004|Induction Period|Withdrawal by Subject|0|||
125280360|NCT02589665|450652824|FG005|Induction Period|Withdrawal by Subject|0|||
125280361|NCT02589665|450652825|FG006|Induction Period|Withdrawal by Subject|0|||
125411693|NCT02828111|451132953|FG000|Overall Study|Lost to Follow-up|0|||
125411694|NCT02828111|451132954|FG001|Overall Study|Lost to Follow-up|0|||
125411695|NCT02828111|451132955|FG002|Overall Study|Lost to Follow-up|0|||
125411696|NCT02828111|451132956|FG003|Overall Study|Lost to Follow-up|1|||
125411697|NCT02828111|451132957|FG004|Overall Study|Lost to Follow-up|1|||
125411698|NCT03465540|451132960|FG000|Overall Study|Withdrawal by Subject|0|||
125411699|NCT03465540|451132961|FG001|Overall Study|Withdrawal by Subject|0|||
125411700|NCT03465540|451132962|FG002|Overall Study|Withdrawal by Subject|1|||
125411701|NCT03465540|451132963|FG003|Overall Study|Withdrawal by Subject|1|||
125411702|NCT03465540|451132964|FG004|Overall Study|Withdrawal by Subject|1|||
125411703|NCT03465540|451132965|FG005|Overall Study|Withdrawal by Subject|0|||
125411704|NCT03465540|451132960|FG000|Overall Study|Lost to Follow-up|0|||
125411705|NCT03465540|451132961|FG001|Overall Study|Lost to Follow-up|1|||
125411706|NCT03465540|451132962|FG002|Overall Study|Lost to Follow-up|0|||
125411707|NCT03465540|451132963|FG003|Overall Study|Lost to Follow-up|0|||
125411708|NCT03465540|451132964|FG004|Overall Study|Lost to Follow-up|1|||
125411709|NCT03465540|451132965|FG005|Overall Study|Lost to Follow-up|0|||
125411710|NCT03465540|451132960|FG000|Overall Study|Death|1|||
125411711|NCT03465540|451132961|FG001|Overall Study|Death|1|||
125411712|NCT03465540|451132962|FG002|Overall Study|Death|0|||
125411713|NCT03465540|451132963|FG003|Overall Study|Death|2|||
125411714|NCT03465540|451132964|FG004|Overall Study|Death|0|||
125411715|NCT03465540|451132965|FG005|Overall Study|Death|2|||
125411716|NCT03465540|451132960|FG000|Overall Study|Protocol specified criteria|0|||
125411717|NCT03465540|451132961|FG001|Overall Study|Protocol specified criteria|2|||
125411718|NCT03465540|451132962|FG002|Overall Study|Protocol specified criteria|2|||
125411719|NCT03465540|451132963|FG003|Overall Study|Protocol specified criteria|0|||
125411720|NCT03465540|451132964|FG004|Overall Study|Protocol specified criteria|2|||
125411721|NCT03465540|451132965|FG005|Overall Study|Protocol specified criteria|0|||
125411722|NCT02844946|451132966|FG000|Overall Study|Lost to Follow-up|7|||
125411723|NCT02844946|451132967|FG001|Overall Study|Lost to Follow-up|0|||
125411724|NCT00736996|451132968|FG000|Overall Study|Lost to Follow-up|1|||
125411725|NCT00736996|451132969|FG001|Overall Study|Lost to Follow-up|9|||
125411726|NCT00736996|451132970|FG002|Overall Study|Lost to Follow-up|2|||
125411727|NCT00462384|451132971|FG000|Overall Study|Adverse Event|2|||
125280362|NCT02589665|450652826|FG007|Induction Period|Withdrawal by Subject|0|||
125280363|NCT02589665|450652827|FG008|Induction Period|Withdrawal by Subject|0|||
125280364|NCT02589665|450652828|FG009|Induction Period|Withdrawal by Subject|0|||
125280365|NCT02589665|450652819|FG000|Induction Period|Protocol Violation|0|||
125280366|NCT02589665|450652820|FG001|Induction Period|Protocol Violation|1|||
125280367|NCT02589665|450652821|FG002|Induction Period|Protocol Violation|0|||
125411728|NCT00462384|451132971|FG000|Overall Study|Death|2|||
125411729|NCT00462384|451132971|FG000|Overall Study|Withdrawal by Subject|1|||
125411730|NCT00462384|451132971|FG000|Overall Study|Other|4|||
125411731|NCT02806986|451132972|FG000|Treatment Stage 1|Adverse Event|1|||
125411732|NCT02806986|451132972|FG000|Treatment Stage 2|Adverse Event|3|||
125411733|NCT02806986|451132972|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
125411734|NCT02667912|451132973|FG000|Overall Study|Death|3|||
125411735|NCT02667912|451132974|FG001|Overall Study|Death|1|||
125411736|NCT02667912|451132973|FG000|Overall Study|Withdrawal by Subject|1|||
125411737|NCT02667912|451132974|FG001|Overall Study|Withdrawal by Subject|2|||
125411738|NCT02667912|451132973|FG000|Overall Study|Withdrawal by Subject|1|||
125411739|NCT02667912|451132974|FG001|Overall Study|Withdrawal by Subject|0|||
125280368|NCT02589665|450652822|FG003|Induction Period|Protocol Violation|0|||
125280369|NCT02589665|450652823|FG004|Induction Period|Protocol Violation|0|||
125280370|NCT02589665|450652824|FG005|Induction Period|Protocol Violation|0|||
125280371|NCT02589665|450652825|FG006|Induction Period|Protocol Violation|0|||
125280372|NCT02589665|450652826|FG007|Induction Period|Protocol Violation|0|||
125280373|NCT02589665|450652827|FG008|Induction Period|Protocol Violation|0|||
125280374|NCT02589665|450652828|FG009|Induction Period|Protocol Violation|0|||
125280375|NCT02589665|450652819|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280376|NCT02589665|450652820|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280377|NCT02589665|450652821|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280378|NCT02589665|450652822|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280379|NCT02589665|450652823|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
125280380|NCT02589665|450652824|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
125280381|NCT02589665|450652825|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
125280382|NCT02589665|450652826|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280383|NCT02589665|450652827|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280384|NCT02589665|450652828|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280385|NCT02589665|450652819|FG000|Maintenance Period|Withdrawal by Subject|0|||
125280386|NCT02589665|450652820|FG001|Maintenance Period|Withdrawal by Subject|0|||
125280387|NCT02589665|450652821|FG002|Maintenance Period|Withdrawal by Subject|0|||
125280388|NCT02589665|450652822|FG003|Maintenance Period|Withdrawal by Subject|0|||
125280389|NCT02589665|450652823|FG004|Maintenance Period|Withdrawal by Subject|4|||
125280390|NCT02589665|450652824|FG005|Maintenance Period|Withdrawal by Subject|2|||
125280391|NCT02589665|450652825|FG006|Maintenance Period|Withdrawal by Subject|4|||
125280392|NCT02589665|450652826|FG007|Maintenance Period|Withdrawal by Subject|0|||
125280393|NCT02589665|450652827|FG008|Maintenance Period|Withdrawal by Subject|0|||
125280394|NCT02589665|450652828|FG009|Maintenance Period|Withdrawal by Subject|0|||
125280395|NCT02589665|450652819|FG000|Maintenance Period|Lack of Efficacy|0|||
125280396|NCT02589665|450652820|FG001|Maintenance Period|Lack of Efficacy|0|||
125280397|NCT02589665|450652821|FG002|Maintenance Period|Lack of Efficacy|0|||
125280398|NCT02589665|450652822|FG003|Maintenance Period|Lack of Efficacy|0|||
125280399|NCT02589665|450652823|FG004|Maintenance Period|Lack of Efficacy|2|||
125280400|NCT02589665|450652824|FG005|Maintenance Period|Lack of Efficacy|1|||
125280401|NCT02589665|450652825|FG006|Maintenance Period|Lack of Efficacy|0|||
125280402|NCT02589665|450652826|FG007|Maintenance Period|Lack of Efficacy|0|||
125280403|NCT02589665|450652827|FG008|Maintenance Period|Lack of Efficacy|0|||
125280404|NCT02589665|450652828|FG009|Maintenance Period|Lack of Efficacy|0|||
125280405|NCT02589665|450652819|FG000|Maintenance Period|Adverse Event|0|||
125280406|NCT02589665|450652820|FG001|Maintenance Period|Adverse Event|0|||
125280407|NCT02589665|450652821|FG002|Maintenance Period|Adverse Event|0|||
125280408|NCT02589665|450652822|FG003|Maintenance Period|Adverse Event|0|||
125280409|NCT02589665|450652823|FG004|Maintenance Period|Adverse Event|0|||
125280410|NCT02589665|450652824|FG005|Maintenance Period|Adverse Event|0|||
125280411|NCT02589665|450652825|FG006|Maintenance Period|Adverse Event|2|||
125280412|NCT02589665|450652826|FG007|Maintenance Period|Adverse Event|0|||
125280413|NCT02589665|450652827|FG008|Maintenance Period|Adverse Event|0|||
125280414|NCT02589665|450652828|FG009|Maintenance Period|Adverse Event|0|||
125280415|NCT02589665|450652819|FG000|Maintenance Period|Lost to Follow-up|0|||
125280416|NCT02589665|450652820|FG001|Maintenance Period|Lost to Follow-up|0|||
125280417|NCT02589665|450652821|FG002|Maintenance Period|Lost to Follow-up|0|||
125280418|NCT02589665|450652822|FG003|Maintenance Period|Lost to Follow-up|0|||
125280419|NCT02589665|450652823|FG004|Maintenance Period|Lost to Follow-up|0|||
125280420|NCT02589665|450652824|FG005|Maintenance Period|Lost to Follow-up|1|||
125280421|NCT02589665|450652825|FG006|Maintenance Period|Lost to Follow-up|0|||
125280422|NCT02589665|450652826|FG007|Maintenance Period|Lost to Follow-up|0|||
125280423|NCT02589665|450652827|FG008|Maintenance Period|Lost to Follow-up|0|||
125280424|NCT02589665|450652828|FG009|Maintenance Period|Lost to Follow-up|0|||
125280425|NCT02589665|450652819|FG000|Maintenance Period|Physician Decision|0|||
125280426|NCT02589665|450652820|FG001|Maintenance Period|Physician Decision|0|||
125280427|NCT02589665|450652821|FG002|Maintenance Period|Physician Decision|0|||
125280428|NCT02589665|450652822|FG003|Maintenance Period|Physician Decision|0|||
125280429|NCT02589665|450652823|FG004|Maintenance Period|Physician Decision|0|||
125280430|NCT02589665|450652824|FG005|Maintenance Period|Physician Decision|1|||
125280431|NCT02589665|450652825|FG006|Maintenance Period|Physician Decision|0|||
125280432|NCT02589665|450652826|FG007|Maintenance Period|Physician Decision|0|||
125280433|NCT02589665|450652827|FG008|Maintenance Period|Physician Decision|0|||
125280434|NCT02589665|450652828|FG009|Maintenance Period|Physician Decision|0|||
125280435|NCT02589665|450652819|FG000|Maintenance Period|Reason Not Collected|0|||
125280436|NCT02589665|450652820|FG001|Maintenance Period|Reason Not Collected|0|||
125411740|NCT04443218|451132975|FG000|Overall Study|Exited study for other reasons|9|||
125411741|NCT04443218|451132975|FG000|Overall Study|Withdrawal by Subject|1|||
125280437|NCT02589665|450652821|FG002|Maintenance Period|Reason Not Collected|0|||
125411742|NCT04443218|451132975|FG000|Overall Study|Lost to Follow-up|4|||
125411743|NCT04443218|451132975|FG000|Overall Study|Death|19|||
125280438|NCT02589665|450652822|FG003|Maintenance Period|Reason Not Collected|0|||
125280439|NCT02589665|450652823|FG004|Maintenance Period|Reason Not Collected|0|||
125280440|NCT02589665|450652824|FG005|Maintenance Period|Reason Not Collected|1|||
125280441|NCT02589665|450652825|FG006|Maintenance Period|Reason Not Collected|1|||
125280442|NCT02589665|450652826|FG007|Maintenance Period|Reason Not Collected|0|||
125280443|NCT02589665|450652827|FG008|Maintenance Period|Reason Not Collected|0|||
125280444|NCT02589665|450652828|FG009|Maintenance Period|Reason Not Collected|0|||
125280445|NCT02589665|450652819|FG000|Induction Extension Period|Adverse Event|0|||
125280446|NCT02589665|450652820|FG001|Induction Extension Period|Adverse Event|0|||
125280447|NCT02589665|450652821|FG002|Induction Extension Period|Adverse Event|0|||
125280448|NCT02589665|450652822|FG003|Induction Extension Period|Adverse Event|0|||
125280449|NCT02589665|450652823|FG004|Induction Extension Period|Adverse Event|0|||
125280450|NCT02589665|450652824|FG005|Induction Extension Period|Adverse Event|0|||
125280451|NCT02589665|450652825|FG006|Induction Extension Period|Adverse Event|0|||
125280452|NCT02589665|450652826|FG007|Induction Extension Period|Adverse Event|0|||
125280453|NCT02589665|450652827|FG008|Induction Extension Period|Adverse Event|4|||
125280454|NCT02589665|450652828|FG009|Induction Extension Period|Adverse Event|0|||
125280455|NCT02589665|450652819|FG000|Induction Extension Period|Lack of Efficacy|0|||
125280456|NCT02589665|450652820|FG001|Induction Extension Period|Lack of Efficacy|0|||
125280457|NCT02589665|450652821|FG002|Induction Extension Period|Lack of Efficacy|0|||
125280458|NCT02589665|450652822|FG003|Induction Extension Period|Lack of Efficacy|0|||
125280459|NCT02589665|450652823|FG004|Induction Extension Period|Lack of Efficacy|0|||
125280460|NCT02589665|450652824|FG005|Induction Extension Period|Lack of Efficacy|0|||
125280461|NCT02589665|450652825|FG006|Induction Extension Period|Lack of Efficacy|0|||
125280462|NCT02589665|450652826|FG007|Induction Extension Period|Lack of Efficacy|0|||
125280463|NCT02589665|450652827|FG008|Induction Extension Period|Lack of Efficacy|3|||
125280464|NCT02589665|450652828|FG009|Induction Extension Period|Lack of Efficacy|0|||
125280465|NCT02589665|450652819|FG000|Induction Extension Period|Withdrawal by Subject|0|||
125280466|NCT02589665|450652820|FG001|Induction Extension Period|Withdrawal by Subject|0|||
125280467|NCT02589665|450652821|FG002|Induction Extension Period|Withdrawal by Subject|0|||
125280468|NCT02589665|450652822|FG003|Induction Extension Period|Withdrawal by Subject|0|||
125280469|NCT02589665|450652823|FG004|Induction Extension Period|Withdrawal by Subject|0|||
125280470|NCT02589665|450652824|FG005|Induction Extension Period|Withdrawal by Subject|0|||
125280471|NCT02589665|450652825|FG006|Induction Extension Period|Withdrawal by Subject|0|||
125280472|NCT02589665|450652826|FG007|Induction Extension Period|Withdrawal by Subject|2|||
125280473|NCT02589665|450652827|FG008|Induction Extension Period|Withdrawal by Subject|3|||
125280474|NCT02589665|450652828|FG009|Induction Extension Period|Withdrawal by Subject|0|||
125280475|NCT02589665|450652819|FG000|Induction Extension Period|Physician Decision|0|||
125280476|NCT02589665|450652820|FG001|Induction Extension Period|Physician Decision|0|||
125280477|NCT02589665|450652821|FG002|Induction Extension Period|Physician Decision|0|||
125280478|NCT02589665|450652822|FG003|Induction Extension Period|Physician Decision|0|||
125280479|NCT02589665|450652823|FG004|Induction Extension Period|Physician Decision|0|||
125280480|NCT02589665|450652824|FG005|Induction Extension Period|Physician Decision|0|||
125280481|NCT02589665|450652825|FG006|Induction Extension Period|Physician Decision|0|||
125280482|NCT02589665|450652826|FG007|Induction Extension Period|Physician Decision|0|||
125280483|NCT02589665|450652827|FG008|Induction Extension Period|Physician Decision|1|||
125280484|NCT02589665|450652828|FG009|Induction Extension Period|Physician Decision|0|||
125280485|NCT02589665|450652819|FG000|Induction Extension Period|Reason Not Collected|0|||
125280486|NCT02589665|450652820|FG001|Induction Extension Period|Reason Not Collected|0|||
125280487|NCT02589665|450652821|FG002|Induction Extension Period|Reason Not Collected|0|||
125280488|NCT02589665|450652822|FG003|Induction Extension Period|Reason Not Collected|0|||
125280489|NCT02589665|450652823|FG004|Induction Extension Period|Reason Not Collected|0|||
125280490|NCT02589665|450652824|FG005|Induction Extension Period|Reason Not Collected|0|||
125280491|NCT02589665|450652825|FG006|Induction Extension Period|Reason Not Collected|0|||
125280492|NCT02589665|450652826|FG007|Induction Extension Period|Reason Not Collected|0|||
125280493|NCT02589665|450652827|FG008|Induction Extension Period|Reason Not Collected|1|||
125280494|NCT02589665|450652828|FG009|Induction Extension Period|Reason Not Collected|0|||
125280495|NCT02589665|450652819|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280496|NCT02589665|450652820|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280497|NCT02589665|450652821|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280498|NCT02589665|450652822|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280499|NCT02589665|450652823|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280500|NCT02589665|450652824|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280501|NCT02589665|450652825|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280502|NCT02589665|450652826|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125411744|NCT00346034|451132976|FG000|Overall Study|Adverse Event|34|||
125411745|NCT00346034|451132976|FG000|Overall Study|Lack of Efficacy|8|||
125411746|NCT00346034|451132976|FG000|Overall Study|Withdrawal by Subject|13|||
125411747|NCT00346034|451132976|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
125411748|NCT00346034|451132976|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
125280503|NCT02589665|450652827|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
125280504|NCT02589665|450652828|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
125280505|NCT02589665|450652819|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
125280506|NCT02589665|450652820|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
125280507|NCT02589665|450652821|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
125280508|NCT02589665|450652822|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
125280509|NCT02589665|450652823|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
125280510|NCT02589665|450652824|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
125280511|NCT02589665|450652825|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
125280512|NCT02589665|450652826|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
125280513|NCT02589665|450652827|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
125280514|NCT02589665|450652828|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
125280515|NCT02589665|450652819|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
125280516|NCT02589665|450652820|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
125280517|NCT02589665|450652821|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
125280518|NCT02589665|450652822|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
125280519|NCT02589665|450652823|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
125280520|NCT02589665|450652824|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
125280521|NCT02589665|450652825|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
125280522|NCT02589665|450652826|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
125280523|NCT02589665|450652827|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
125280524|NCT02589665|450652828|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
125280525|NCT02589665|450652819|FG000|Maintenance Extension Period|Adverse Event|0|||
125280526|NCT02589665|450652820|FG001|Maintenance Extension Period|Adverse Event|0|||
125280527|NCT02589665|450652821|FG002|Maintenance Extension Period|Adverse Event|0|||
125280528|NCT02589665|450652822|FG003|Maintenance Extension Period|Adverse Event|0|||
125280529|NCT02589665|450652823|FG004|Maintenance Extension Period|Adverse Event|0|||
125280530|NCT02589665|450652824|FG005|Maintenance Extension Period|Adverse Event|0|||
125280531|NCT02589665|450652825|FG006|Maintenance Extension Period|Adverse Event|0|||
125280532|NCT02589665|450652826|FG007|Maintenance Extension Period|Adverse Event|0|||
125280533|NCT02589665|450652827|FG008|Maintenance Extension Period|Adverse Event|0|||
125280534|NCT02589665|450652828|FG009|Maintenance Extension Period|Adverse Event|2|||
125280535|NCT02589665|450652819|FG000|Maintenance Extension Period|Non-responder|0|||
125280536|NCT02589665|450652820|FG001|Maintenance Extension Period|Non-responder|0|||
125280537|NCT02589665|450652821|FG002|Maintenance Extension Period|Non-responder|0|||
125280538|NCT02589665|450652822|FG003|Maintenance Extension Period|Non-responder|0|||
125280539|NCT02589665|450652823|FG004|Maintenance Extension Period|Non-responder|0|||
125280540|NCT02589665|450652824|FG005|Maintenance Extension Period|Non-responder|0|||
125280541|NCT02589665|450652825|FG006|Maintenance Extension Period|Non-responder|0|||
125280542|NCT02589665|450652826|FG007|Maintenance Extension Period|Non-responder|0|||
125280543|NCT02589665|450652827|FG008|Maintenance Extension Period|Non-responder|0|||
125280544|NCT02589665|450652828|FG009|Maintenance Extension Period|Non-responder|1|||
125280545|NCT00978380|450652829|FG000|Overall Study|Protocol Violation|2|||
125280546|NCT00978380|450652829|FG000|Overall Study|Withdrawal criteria|9|||
125280547|NCT00978380|450652829|FG000|Overall Study|Unclassified|8|||
125280548|NCT00327015|450652830|FG000|Overall Study|Lack of Efficacy|18|||
125280549|NCT00327015|450652831|FG001|Overall Study|Lack of Efficacy|18|||
125280550|NCT00327015|450652832|FG002|Overall Study|Lack of Efficacy|35|||
125280551|NCT00327015|450652833|FG003|Overall Study|Lack of Efficacy|29|||
125280552|NCT00327015|450652830|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
125280553|NCT00327015|450652831|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
125280554|NCT00327015|450652832|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
125280555|NCT00327015|450652833|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
125280556|NCT00327015|450652830|FG000|Overall Study|Lost to Follow-up|22|||
125280557|NCT00327015|450652831|FG001|Overall Study|Lost to Follow-up|23|||
125280558|NCT00327015|450652832|FG002|Overall Study|Lost to Follow-up|29|||
125280559|NCT00327015|450652833|FG003|Overall Study|Lost to Follow-up|22|||
125280560|NCT00327015|450652830|FG000|Overall Study|Adverse Event|14|||
125280561|NCT00327015|450652831|FG001|Overall Study|Adverse Event|10|||
125280562|NCT00327015|450652832|FG002|Overall Study|Adverse Event|14|||
125280563|NCT00327015|450652833|FG003|Overall Study|Adverse Event|14|||
125280564|NCT00327015|450652830|FG000|Overall Study|Subject no longer meets study criteria|4|||
125280565|NCT00327015|450652831|FG001|Overall Study|Subject no longer meets study criteria|2|||
125280566|NCT00327015|450652832|FG002|Overall Study|Subject no longer meets study criteria|8|||
125280567|NCT00327015|450652833|FG003|Overall Study|Subject no longer meets study criteria|7|||
125280568|NCT00327015|450652830|FG000|Overall Study|Poor/Noncompliance|11|||
125280569|NCT00327015|450652831|FG001|Overall Study|Poor/Noncompliance|8|||
125280570|NCT00327015|450652832|FG002|Overall Study|Poor/Noncompliance|4|||
125280571|NCT00327015|450652833|FG003|Overall Study|Poor/Noncompliance|5|||
125280572|NCT00327015|450652830|FG000|Overall Study|Physician Decision|0|||
125280573|NCT00327015|450652831|FG001|Overall Study|Physician Decision|1|||
125280574|NCT00327015|450652832|FG002|Overall Study|Physician Decision|3|||
125448379|NCT00335153|451268916|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
125280575|NCT00327015|450652833|FG003|Overall Study|Physician Decision|2|||
125280576|NCT00327015|450652830|FG000|Overall Study|Death|1|||
125280577|NCT00327015|450652831|FG001|Overall Study|Death|2|||
125280578|NCT00327015|450652832|FG002|Overall Study|Death|2|||
125280579|NCT00327015|450652833|FG003|Overall Study|Death|3|||
125280580|NCT00327015|450652830|FG000|Overall Study|Pregnancy|0|||
125280581|NCT00327015|450652831|FG001|Overall Study|Pregnancy|2|||
125280582|NCT00327015|450652832|FG002|Overall Study|Pregnancy|1|||
125280583|NCT00327015|450652833|FG003|Overall Study|Pregnancy|1|||
125280584|NCT00327015|450652830|FG000|Overall Study|Administrative Reason by Sponsor|1|||
125280585|NCT00327015|450652831|FG001|Overall Study|Administrative Reason by Sponsor|2|||
125280586|NCT00327015|450652832|FG002|Overall Study|Administrative Reason by Sponsor|2|||
125280587|NCT00327015|450652833|FG003|Overall Study|Administrative Reason by Sponsor|1|||
125280588|NCT01519791|450652834|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
125280589|NCT01519791|450652835|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
125280590|NCT01519791|450652834|FG000|Overall Study|Protocol Violation|6|||
125280591|NCT01519791|450652835|FG001|Overall Study|Protocol Violation|19|||
125280592|NCT01519791|450652834|FG000|Overall Study|Other Reason|87|||
125280593|NCT01519791|450652835|FG001|Overall Study|Other Reason|222|||
125280594|NCT01519791|450652834|FG000|Overall Study|subjects randomized in error|2|||
125280595|NCT01519791|450652835|FG001|Overall Study|subjects randomized in error|0|||
125280596|NCT01519791|450652834|FG000|Overall Study|Lack of Efficacy|16|||
125280597|NCT01519791|450652835|FG001|Overall Study|Lack of Efficacy|20|||
125280598|NCT01519791|450652834|FG000|Overall Study|SAE, non-fatal|6|||
125280599|NCT01519791|450652835|FG001|Overall Study|SAE, non-fatal|22|||
125280600|NCT01519791|450652834|FG000|Overall Study|AE, serious fatal|0|||
125280601|NCT01519791|450652835|FG001|Overall Study|AE, serious fatal|1|||
125280602|NCT01519791|450652834|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
125280603|NCT01519791|450652835|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
125280604|NCT01519791|450652834|FG000|Overall Study|AE, non-serious non-fatal|12|||
125280605|NCT01519791|450652835|FG001|Overall Study|AE, non-serious non-fatal|31|||
125280606|NCT01519791|450652834|FG000|Overall Study|Withdrawal by Subject|15|||
125280607|NCT01519791|450652835|FG001|Overall Study|Withdrawal by Subject|37|||
125280608|NCT01519791|450652834|FG000|Overall Study|Lost to Follow-up|6|||
125280609|NCT01519791|450652835|FG001|Overall Study|Lost to Follow-up|14|||
125280610|NCT00837265|450652836|FG000|Pilot Phase|Withdrawal by Subject|0|||
125280611|NCT00837265|450652837|FG001|Pilot Phase|Withdrawal by Subject|2|||
125280612|NCT00837265|450652838|FG002|Pilot Phase|Withdrawal by Subject|3|||
125280613|NCT00837265|450652839|FG003|Pilot Phase|Withdrawal by Subject|2|||
125280614|NCT00837265|450652840|FG004|Pilot Phase|Withdrawal by Subject|0|||
125280615|NCT00837265|450652841|FG005|Pilot Phase|Withdrawal by Subject|0|||
125280616|NCT00837265|450652842|FG006|Pilot Phase|Withdrawal by Subject|0|||
125280617|NCT00837265|450652836|FG000|Pilot Phase|Decision of the investigator|2|||
125280618|NCT00837265|450652837|FG001|Pilot Phase|Decision of the investigator|1|||
125280619|NCT00837265|450652838|FG002|Pilot Phase|Decision of the investigator|0|||
125280620|NCT00837265|450652839|FG003|Pilot Phase|Decision of the investigator|0|||
125280621|NCT00837265|450652840|FG004|Pilot Phase|Decision of the investigator|0|||
125280622|NCT00837265|450652841|FG005|Pilot Phase|Decision of the investigator|0|||
125280623|NCT00837265|450652842|FG006|Pilot Phase|Decision of the investigator|0|||
125280624|NCT00837265|450652836|FG000|Pilot Phase|Adverse Event|1|||
125280625|NCT00837265|450652837|FG001|Pilot Phase|Adverse Event|0|||
125280626|NCT00837265|450652838|FG002|Pilot Phase|Adverse Event|0|||
125280627|NCT00837265|450652839|FG003|Pilot Phase|Adverse Event|0|||
125280628|NCT00837265|450652840|FG004|Pilot Phase|Adverse Event|0|||
125280629|NCT00837265|450652841|FG005|Pilot Phase|Adverse Event|0|||
125280630|NCT00837265|450652842|FG006|Pilot Phase|Adverse Event|0|||
125280631|NCT00837265|450652836|FG000|Pilot Phase|Disease progression|0|||
125280632|NCT00837265|450652837|FG001|Pilot Phase|Disease progression|0|||
125280633|NCT00837265|450652838|FG002|Pilot Phase|Disease progression|0|||
125280634|NCT00837265|450652839|FG003|Pilot Phase|Disease progression|1|||
125280635|NCT00837265|450652840|FG004|Pilot Phase|Disease progression|0|||
125448380|NCT00372528|451268917|FG000|Overall Study|Lack of Efficacy|1|||
125448381|NCT00372528|451268917|FG000|Overall Study|Adverse Event|1|||
125280636|NCT00837265|450652841|FG005|Pilot Phase|Disease progression|0|||
125280637|NCT00837265|450652842|FG006|Pilot Phase|Disease progression|0|||
125448382|NCT00372528|451268917|FG000|Overall Study|Study Terminated by Sponsor|18|||
125448383|NCT00372528|451268917|FG000|Overall Study|Other|1|||
125448384|NCT02412761|451268918|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
125280638|NCT00837265|450652836|FG000|Pilot Phase|Participant left the city|0|||
125280639|NCT00837265|450652837|FG001|Pilot Phase|Participant left the city|0|||
125280640|NCT00837265|450652838|FG002|Pilot Phase|Participant left the city|0|||
125280641|NCT00837265|450652839|FG003|Pilot Phase|Participant left the city|1|||
125280642|NCT00837265|450652840|FG004|Pilot Phase|Participant left the city|0|||
125280643|NCT00837265|450652841|FG005|Pilot Phase|Participant left the city|0|||
125280644|NCT00837265|450652842|FG006|Pilot Phase|Participant left the city|0|||
125280645|NCT00837265|450652836|FG000|Main Phase|Withdrawal by Subject|0|||
125280646|NCT00837265|450652837|FG001|Main Phase|Withdrawal by Subject|0|||
125280647|NCT00837265|450652838|FG002|Main Phase|Withdrawal by Subject|0|||
125280648|NCT00837265|450652839|FG003|Main Phase|Withdrawal by Subject|0|||
125280649|NCT00837265|450652840|FG004|Main Phase|Withdrawal by Subject|4|||
125280650|NCT00837265|450652841|FG005|Main Phase|Withdrawal by Subject|2|||
125280651|NCT00837265|450652842|FG006|Main Phase|Withdrawal by Subject|1|||
125280652|NCT00837265|450652836|FG000|Main Phase|Decision of the investigator|0|||
125280653|NCT00837265|450652837|FG001|Main Phase|Decision of the investigator|0|||
125280654|NCT00837265|450652838|FG002|Main Phase|Decision of the investigator|0|||
125280655|NCT00837265|450652839|FG003|Main Phase|Decision of the investigator|0|||
125280656|NCT00837265|450652840|FG004|Main Phase|Decision of the investigator|0|||
125280657|NCT00837265|450652841|FG005|Main Phase|Decision of the investigator|2|||
125280658|NCT00837265|450652842|FG006|Main Phase|Decision of the investigator|1|||
125280659|NCT00837265|450652836|FG000|Main Phase|Adverse Event|0|||
125280660|NCT00837265|450652837|FG001|Main Phase|Adverse Event|0|||
125280661|NCT00837265|450652838|FG002|Main Phase|Adverse Event|0|||
125280662|NCT00837265|450652839|FG003|Main Phase|Adverse Event|0|||
125280663|NCT00837265|450652840|FG004|Main Phase|Adverse Event|0|||
125280664|NCT00837265|450652841|FG005|Main Phase|Adverse Event|1|||
125280665|NCT00837265|450652842|FG006|Main Phase|Adverse Event|0|||
125280666|NCT00837265|450652836|FG000|Main Phase|Death|0|||
125280667|NCT00837265|450652837|FG001|Main Phase|Death|0|||
125280668|NCT00837265|450652838|FG002|Main Phase|Death|0|||
125280669|NCT00837265|450652839|FG003|Main Phase|Death|0|||
125280670|NCT00837265|450652840|FG004|Main Phase|Death|2|||
125280671|NCT00837265|450652841|FG005|Main Phase|Death|0|||
125280672|NCT00837265|450652842|FG006|Main Phase|Death|1|||
125280673|NCT00837265|450652836|FG000|Main Phase|Lost to Follow-up|0|||
125280674|NCT00837265|450652837|FG001|Main Phase|Lost to Follow-up|0|||
125280675|NCT00837265|450652838|FG002|Main Phase|Lost to Follow-up|0|||
125280676|NCT00837265|450652839|FG003|Main Phase|Lost to Follow-up|0|||
125280677|NCT00837265|450652840|FG004|Main Phase|Lost to Follow-up|1|||
125280678|NCT00837265|450652841|FG005|Main Phase|Lost to Follow-up|0|||
125280679|NCT00837265|450652842|FG006|Main Phase|Lost to Follow-up|0|||
125280680|NCT00837265|450652836|FG000|Main Phase|Principal investigator resignation|0|||
125280681|NCT00837265|450652837|FG001|Main Phase|Principal investigator resignation|0|||
125280682|NCT00837265|450652838|FG002|Main Phase|Principal investigator resignation|0|||
125280683|NCT00837265|450652839|FG003|Main Phase|Principal investigator resignation|0|||
125280684|NCT00837265|450652840|FG004|Main Phase|Principal investigator resignation|2|||
125280685|NCT00837265|450652841|FG005|Main Phase|Principal investigator resignation|0|||
125280686|NCT00837265|450652842|FG006|Main Phase|Principal investigator resignation|0|||
125280687|NCT00837265|450652836|FG000|Main Phase|Participant's personal reason|0|||
125411749|NCT04000165|451132977|FG000|Overall Study|Physician Decision|1|||
125411750|NCT04000165|451132977|FG000|Overall Study|Withdrawal by Subject|1|||
125411751|NCT04827212|451134822|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
125411752|NCT04827212|451134823|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
125411753|NCT04827212|451134822|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
125411754|NCT04827212|451134823|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
125411755|NCT00563784|451134824|FG000|Overall Study|Withdrawal by Subject|2|||
125411756|NCT00563784|451134824|FG000|Overall Study|Screen Failures|20|||
125411757|NCT04360824|451134830|FG000|Overall Study|Withdrawal by Subject|2|||
125411758|NCT04360824|451134831|FG001|Overall Study|Withdrawal by Subject|1|||
125411759|NCT04360824|451134830|FG000|Overall Study|Did not receive assigned treatment|1|||
125411760|NCT04360824|451134831|FG001|Overall Study|Did not receive assigned treatment|3|||
125411761|NCT00304070|451134832|FG000|Overall Study|Death|0|||
125411762|NCT00304070|451134833|FG001|Overall Study|Death|0|||
125411763|NCT00304070|451134834|FG002|Overall Study|Death|3|||
125411764|NCT00304070|451134832|FG000|Overall Study|Lost to Follow-up|0|||
125411765|NCT00304070|451134833|FG001|Overall Study|Lost to Follow-up|0|||
125411766|NCT00304070|451134834|FG002|Overall Study|Lost to Follow-up|1|||
125411767|NCT00304070|451134832|FG000|Overall Study|Physician Decision|0|||
125411768|NCT00304070|451134833|FG001|Overall Study|Physician Decision|0|||
125411769|NCT00304070|451134834|FG002|Overall Study|Physician Decision|3|||
125411770|NCT00304070|451134832|FG000|Overall Study|Withdrawal by Subject|0|||
125411771|NCT00304070|451134833|FG001|Overall Study|Withdrawal by Subject|0|||
125411772|NCT00304070|451134834|FG002|Overall Study|Withdrawal by Subject|1|||
125280688|NCT00837265|450652837|FG001|Main Phase|Participant's personal reason|0|||
125280689|NCT00837265|450652838|FG002|Main Phase|Participant's personal reason|0|||
125280690|NCT00837265|450652839|FG003|Main Phase|Participant's personal reason|0|||
125280691|NCT00837265|450652840|FG004|Main Phase|Participant's personal reason|1|||
125280692|NCT00837265|450652841|FG005|Main Phase|Participant's personal reason|0|||
125411773|NCT00304070|451134832|FG000|Overall Study|Progressive Disease|3|||
125411774|NCT00304070|451134833|FG001|Overall Study|Progressive Disease|7|||
125411775|NCT00304070|451134834|FG002|Overall Study|Progressive Disease|4|||
125411776|NCT00320216|451134835|FG000|Overall Study|Adverse Event|0|||
125411777|NCT00320216|451134836|FG001|Overall Study|Adverse Event|6|||
125411778|NCT00320216|451134837|FG002|Overall Study|Adverse Event|0|||
125411779|NCT00320216|451134838|FG003|Overall Study|Adverse Event|2|||
125411780|NCT00320216|451134839|FG004|Overall Study|Adverse Event|2|||
125411781|NCT00320216|451134835|FG000|Overall Study|Lack of Efficacy|6|||
125411782|NCT00320216|451134836|FG001|Overall Study|Lack of Efficacy|2|||
125280693|NCT00837265|450652842|FG006|Main Phase|Participant's personal reason|0|||
125280694|NCT01289353|450652843|FG000|Overall Study|Lost to Follow-up|2|||
125280695|NCT02226562|450652844|FG000|Overall Study|Lost to Follow-up|0|||
125280696|NCT02226562|450652845|FG001|Overall Study|Lost to Follow-up|1|||
125280697|NCT01474772|450652847|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
125280698|NCT01474772|450652848|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
125280699|NCT01474772|450652847|FG000|Period 1|AE not Related to Study Drug|1|||
125280700|NCT01474772|450652848|FG001|Period 1|AE not Related to Study Drug|0|||
125448385|NCT02412761|451268919|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
125280701|NCT01474772|450652847|FG000|Period 1|Withdrawal by Subject|3|||
125280702|NCT01474772|450652848|FG001|Period 1|Withdrawal by Subject|1|||
125280703|NCT01474772|450652847|FG000|Period 1|Lost to Follow-up|1|||
125280704|NCT01474772|450652848|FG001|Period 1|Lost to Follow-up|0|||
125280705|NCT01474772|450652847|FG000|Period 1|Reason not Specified|1|||
125280706|NCT01474772|450652848|FG001|Period 1|Reason not Specified|1|||
125280707|NCT01474772|450652847|FG000|Washout|AE not Related to Study Drug|2|||
125280708|NCT01474772|450652848|FG001|Washout|AE not Related to Study Drug|0|||
125280709|NCT01474772|450652847|FG000|Washout|Withdrawal by Subject|1|||
125280710|NCT01474772|450652848|FG001|Washout|Withdrawal by Subject|0|||
125280711|NCT01474772|450652847|FG000|Washout|Lost to Follow-up|0|||
125280712|NCT01474772|450652848|FG001|Washout|Lost to Follow-up|1|||
125280713|NCT01474772|450652847|FG000|Washout|Reason not Specified|0|||
125280714|NCT01474772|450652848|FG001|Washout|Reason not Specified|1|||
125280715|NCT01474772|450652847|FG000|Period 2|Death|0|||
125280716|NCT01474772|450652848|FG001|Period 2|Death|1|||
125280717|NCT01474772|450652847|FG000|Period 2|AE Related to Study Drug|0|||
125280718|NCT01474772|450652848|FG001|Period 2|AE Related to Study Drug|1|||
125280719|NCT01474772|450652847|FG000|Period 2|AE not Related to Study Drug|4|||
125280720|NCT01474772|450652848|FG001|Period 2|AE not Related to Study Drug|1|||
125280721|NCT01474772|450652847|FG000|Period 2|Lack of Efficacy|1|||
125280722|NCT01474772|450652848|FG001|Period 2|Lack of Efficacy|0|||
125280723|NCT01474772|450652847|FG000|Period 2|Withdrawal by Subject|3|||
125280724|NCT01474772|450652848|FG001|Period 2|Withdrawal by Subject|4|||
125280725|NCT01474772|450652847|FG000|Period 2|Lost to Follow-up|1|||
125280726|NCT01474772|450652848|FG001|Period 2|Lost to Follow-up|1|||
125280727|NCT01474772|450652847|FG000|Period 2|Reason not Specified|0|||
125448386|NCT02412761|451268920|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
125448387|NCT02412761|451268921|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
125448388|NCT02412761|451268922|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
125448389|NCT02412761|451268923|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
125448390|NCT02240680|451268924|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
125448391|NCT02240680|451268925|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
125448392|NCT02240680|451268926|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
125448393|NCT02240680|451268927|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
125448394|NCT02240680|451268924|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
125280728|NCT01474772|450652848|FG001|Period 2|Reason not Specified|2|||
125280729|NCT01474772|450652847|FG000|Follow-up|AE not Related to Study Drug|0|||
125280730|NCT01474772|450652848|FG001|Follow-up|AE not Related to Study Drug|1|||
125280731|NCT00223808|450652849|FG000|Overall Study|<5 hrs therapy before discharge|3|||
125280732|NCT00223808|450652850|FG001|Overall Study|<5 hrs therapy before discharge|5|||
125280733|NCT00223808|450652851|FG002|Overall Study|<5 hrs therapy before discharge|5|||
125280734|NCT00967694|450652854|FG000|Overall Study|Withdrawal by Subject|6|||
125280735|NCT02321319|450652855|FG000|Overall Study|Product discontinued|5|||
125280736|NCT00152477|450652856|FG000|Chemotherapy Period|Adverse Event|9|||
125280737|NCT00152477|450652857|FG001|Chemotherapy Period|Adverse Event|4|||
125280738|NCT00152477|450652858|FG002|Chemotherapy Period|Adverse Event|5|||
125280739|NCT00152477|450652856|FG000|Chemotherapy Period|Death|1|||
125411783|NCT00320216|451134837|FG002|Overall Study|Lack of Efficacy|1|||
125411784|NCT00320216|451134838|FG003|Overall Study|Lack of Efficacy|0|||
125411785|NCT00320216|451134839|FG004|Overall Study|Lack of Efficacy|1|||
125411786|NCT00320216|451134835|FG000|Overall Study|Lost to Follow-up|3|||
125411787|NCT00320216|451134836|FG001|Overall Study|Lost to Follow-up|0|||
125411788|NCT00320216|451134837|FG002|Overall Study|Lost to Follow-up|0|||
125411789|NCT00320216|451134838|FG003|Overall Study|Lost to Follow-up|0|||
125448395|NCT02240680|451268925|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
125280740|NCT00152477|450652857|FG001|Chemotherapy Period|Death|3|||
125448396|NCT02240680|451268926|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
125280741|NCT00152477|450652858|FG002|Chemotherapy Period|Death|3|||
125280742|NCT00152477|450652856|FG000|Chemotherapy Period|Lack of Efficacy|4|||
125280743|NCT00152477|450652857|FG001|Chemotherapy Period|Lack of Efficacy|5|||
125280744|NCT00152477|450652858|FG002|Chemotherapy Period|Lack of Efficacy|6|||
125280745|NCT00152477|450652856|FG000|Chemotherapy Period|Lost to Follow-up|1|||
125280746|NCT00152477|450652857|FG001|Chemotherapy Period|Lost to Follow-up|0|||
125280747|NCT00152477|450652858|FG002|Chemotherapy Period|Lost to Follow-up|1|||
125280748|NCT00152477|450652856|FG000|Chemotherapy Period|Protocol Violation|1|||
125411790|NCT00320216|451134839|FG004|Overall Study|Lost to Follow-up|0|||
125411791|NCT00320216|451134835|FG000|Overall Study|Other|7|||
125411792|NCT00320216|451134836|FG001|Overall Study|Other|2|||
125411793|NCT00320216|451134837|FG002|Overall Study|Other|5|||
125280749|NCT00152477|450652857|FG001|Chemotherapy Period|Protocol Violation|1|||
125280750|NCT00152477|450652858|FG002|Chemotherapy Period|Protocol Violation|0|||
125280751|NCT00152477|450652856|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
125280752|NCT00152477|450652857|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
125280753|NCT00152477|450652858|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
125280754|NCT00152477|450652856|FG000|Chemotherapy Period|Progression of Disease|6|||
125280755|NCT00152477|450652857|FG001|Chemotherapy Period|Progression of Disease|8|||
125280756|NCT00152477|450652858|FG002|Chemotherapy Period|Progression of Disease|4|||
125280757|NCT00152477|450652856|FG000|Chemotherapy Period|Investigator decision|0|||
125280758|NCT00152477|450652857|FG001|Chemotherapy Period|Investigator decision|0|||
125280759|NCT00152477|450652858|FG002|Chemotherapy Period|Investigator decision|1|||
125280760|NCT00152477|450652856|FG000|Chemotherapy Period|Patient condition worsened|1|||
125280761|NCT00152477|450652857|FG001|Chemotherapy Period|Patient condition worsened|0|||
125280762|NCT00152477|450652858|FG002|Chemotherapy Period|Patient condition worsened|0|||
125280763|NCT00152477|450652856|FG000|Monotherapy Period|Adverse Event|1|||
125280764|NCT00152477|450652857|FG001|Monotherapy Period|Adverse Event|0|||
125280765|NCT00152477|450652858|FG002|Monotherapy Period|Adverse Event|5|||
125280766|NCT00152477|450652856|FG000|Monotherapy Period|Death|2|||
125280767|NCT00152477|450652857|FG001|Monotherapy Period|Death|0|||
125280768|NCT00152477|450652858|FG002|Monotherapy Period|Death|1|||
125280769|NCT00152477|450652856|FG000|Monotherapy Period|Lack of Efficacy|7|||
125280770|NCT00152477|450652857|FG001|Monotherapy Period|Lack of Efficacy|16|||
125280771|NCT00152477|450652858|FG002|Monotherapy Period|Lack of Efficacy|10|||
125280772|NCT00152477|450652856|FG000|Monotherapy Period|Protocol Violation|0|||
125280773|NCT00152477|450652857|FG001|Monotherapy Period|Protocol Violation|1|||
125280774|NCT00152477|450652858|FG002|Monotherapy Period|Protocol Violation|0|||
125280775|NCT00152477|450652856|FG000|Monotherapy Period|Withdrawal by Subject|0|||
125280776|NCT00152477|450652857|FG001|Monotherapy Period|Withdrawal by Subject|0|||
125280777|NCT00152477|450652858|FG002|Monotherapy Period|Withdrawal by Subject|4|||
125280778|NCT00152477|450652856|FG000|Monotherapy Period|Progression of Disease|5|||
125280779|NCT00152477|450652857|FG001|Monotherapy Period|Progression of Disease|11|||
125280780|NCT00152477|450652858|FG002|Monotherapy Period|Progression of Disease|12|||
125280781|NCT00152477|450652856|FG000|Monotherapy Period|Patient decision|0|||
125280782|NCT00152477|450652857|FG001|Monotherapy Period|Patient decision|1|||
125280783|NCT00152477|450652858|FG002|Monotherapy Period|Patient decision|1|||
125280784|NCT00152477|450652856|FG000|Monotherapy Period|Study personel decision|0|||
125280785|NCT00152477|450652857|FG001|Monotherapy Period|Study personel decision|0|||
125280786|NCT00152477|450652858|FG002|Monotherapy Period|Study personel decision|1|||
125280787|NCT00960011|450652859|FG000|Overall Study|Death|5|||
125280788|NCT00960011|450652860|FG001|Overall Study|Death|0|||
125280789|NCT00960011|450652859|FG000|Overall Study|Lost to Follow-up|6|||
125280790|NCT00960011|450652860|FG001|Overall Study|Lost to Follow-up|2|||
125280791|NCT01626118|450652866|FG000|Overall Study|Lack of Efficacy|1|||
125280792|NCT01626118|450652867|FG001|Overall Study|Lack of Efficacy|0|||
125280793|NCT01626118|450652868|FG002|Overall Study|Lack of Efficacy|1|||
125280794|NCT01626118|450652869|FG003|Overall Study|Lack of Efficacy|3|||
125280795|NCT01626118|450652866|FG000|Overall Study|Lost to Follow-up|1|||
125280796|NCT01626118|450652867|FG001|Overall Study|Lost to Follow-up|0|||
125280797|NCT01626118|450652868|FG002|Overall Study|Lost to Follow-up|0|||
125280798|NCT01626118|450652869|FG003|Overall Study|Lost to Follow-up|0|||
125280799|NCT01626118|450652866|FG000|Overall Study|Adverse Event|0|||
125280800|NCT01626118|450652867|FG001|Overall Study|Adverse Event|1|||
125280801|NCT01626118|450652868|FG002|Overall Study|Adverse Event|1|||
125280802|NCT01626118|450652869|FG003|Overall Study|Adverse Event|0|||
125280803|NCT01626118|450652866|FG000|Overall Study|Investigator Decision|0|||
125280804|NCT01626118|450652867|FG001|Overall Study|Investigator Decision|1|||
125280805|NCT01626118|450652868|FG002|Overall Study|Investigator Decision|0|||
125280806|NCT01626118|450652869|FG003|Overall Study|Investigator Decision|0|||
125280807|NCT00888329|450652870|FG000|Overall Study|Physician Decision|6|||
125280808|NCT00888329|450652871|FG001|Overall Study|Physician Decision|9|||
125280809|NCT00939029|450652872|FG000|Overall Study|Withdrawal by Subject|3|||
125280810|NCT00939029|450652873|FG001|Overall Study|Withdrawal by Subject|7|||
125280811|NCT00939029|450652872|FG000|Overall Study|Lost to Follow-up|3|||
125280812|NCT00939029|450652873|FG001|Overall Study|Lost to Follow-up|4|||
125280813|NCT00939029|450652872|FG000|Overall Study|Adverse Event|0|||
125280814|NCT00939029|450652873|FG001|Overall Study|Adverse Event|1|||
125280815|NCT06003777|450652874|FG000|Period 1|Adverse Event|0|||
125280816|NCT06003777|450652875|FG001|Period 1|Adverse Event|0|||
125280817|NCT06003777|450652876|FG002|Period 1|Adverse Event|1|||
125280818|NCT06003777|450652877|FG003|Period 1|Adverse Event|0|||
125280819|NCT06003777|450652878|FG004|Period 1|Adverse Event|0|||
125280820|NCT06003777|450652879|FG005|Period 1|Adverse Event|0|||
125280821|NCT06003777|450652880|FG006|Period 1|Adverse Event|0|||
125280822|NCT06003777|450652881|FG007|Period 1|Adverse Event|0|||
125280823|NCT06003777|450652882|FG008|Period 1|Adverse Event|0|||
125280824|NCT06003777|450652883|FG009|Period 1|Adverse Event|0|||
125280825|NCT06003777|450652884|FG010|Period 1|Adverse Event|0|||
125280826|NCT06003777|450652885|FG011|Period 1|Adverse Event|0|||
125280827|NCT06003777|450652874|FG000|Period 1|Withdrawal by Subject|0|||
125280828|NCT06003777|450652875|FG001|Period 1|Withdrawal by Subject|0|||
125280829|NCT06003777|450652876|FG002|Period 1|Withdrawal by Subject|0|||
125280830|NCT06003777|450652877|FG003|Period 1|Withdrawal by Subject|0|||
125280831|NCT06003777|450652878|FG004|Period 1|Withdrawal by Subject|1|||
125280832|NCT06003777|450652879|FG005|Period 1|Withdrawal by Subject|0|||
125280833|NCT06003777|450652880|FG006|Period 1|Withdrawal by Subject|0|||
125280834|NCT06003777|450652881|FG007|Period 1|Withdrawal by Subject|0|||
125280835|NCT06003777|450652882|FG008|Period 1|Withdrawal by Subject|0|||
125280836|NCT06003777|450652883|FG009|Period 1|Withdrawal by Subject|0|||
125280837|NCT06003777|450652884|FG010|Period 1|Withdrawal by Subject|0|||
125280838|NCT06003777|450652885|FG011|Period 1|Withdrawal by Subject|0|||
125280839|NCT06003777|450652874|FG000|Period 2|Withdrawal by Subject|0|||
125280840|NCT06003777|450652875|FG001|Period 2|Withdrawal by Subject|0|||
125280841|NCT06003777|450652876|FG002|Period 2|Withdrawal by Subject|0|||
125280842|NCT06003777|450652877|FG003|Period 2|Withdrawal by Subject|0|||
125280843|NCT06003777|450652878|FG004|Period 2|Withdrawal by Subject|0|||
125280844|NCT06003777|450652879|FG005|Period 2|Withdrawal by Subject|0|||
125280845|NCT06003777|450652880|FG006|Period 2|Withdrawal by Subject|0|||
125280846|NCT06003777|450652881|FG007|Period 2|Withdrawal by Subject|0|||
125280847|NCT06003777|450652882|FG008|Period 2|Withdrawal by Subject|1|||
125280848|NCT06003777|450652883|FG009|Period 2|Withdrawal by Subject|0|||
125280849|NCT06003777|450652884|FG010|Period 2|Withdrawal by Subject|0|||
125280850|NCT06003777|450652885|FG011|Period 2|Withdrawal by Subject|0|||
125280851|NCT06003777|450652874|FG000|Period 3|Adverse Event|0|||
125280852|NCT06003777|450652875|FG001|Period 3|Adverse Event|0|||
125280853|NCT06003777|450652876|FG002|Period 3|Adverse Event|0|||
125280854|NCT06003777|450652877|FG003|Period 3|Adverse Event|0|||
125280855|NCT06003777|450652878|FG004|Period 3|Adverse Event|0|||
125280856|NCT06003777|450652879|FG005|Period 3|Adverse Event|0|||
125280857|NCT06003777|450652880|FG006|Period 3|Adverse Event|1|||
125280858|NCT06003777|450652881|FG007|Period 3|Adverse Event|0|||
125280859|NCT06003777|450652882|FG008|Period 3|Adverse Event|0|||
125280860|NCT06003777|450652883|FG009|Period 3|Adverse Event|0|||
125280861|NCT06003777|450652884|FG010|Period 3|Adverse Event|0|||
125280862|NCT06003777|450652885|FG011|Period 3|Adverse Event|0|||
125280863|NCT06003777|450652874|FG000|Period 4|No longer met eligibility criteria|0|||
125280864|NCT06003777|450652875|FG001|Period 4|No longer met eligibility criteria|0|||
125280865|NCT06003777|450652876|FG002|Period 4|No longer met eligibility criteria|1|||
125280866|NCT06003777|450652877|FG003|Period 4|No longer met eligibility criteria|0|||
125280867|NCT06003777|450652878|FG004|Period 4|No longer met eligibility criteria|0|||
125280868|NCT06003777|450652879|FG005|Period 4|No longer met eligibility criteria|0|||
125280869|NCT06003777|450652880|FG006|Period 4|No longer met eligibility criteria|0|||
125280870|NCT06003777|450652881|FG007|Period 4|No longer met eligibility criteria|0|||
125280871|NCT06003777|450652882|FG008|Period 4|No longer met eligibility criteria|0|||
125280872|NCT06003777|450652883|FG009|Period 4|No longer met eligibility criteria|0|||
125280873|NCT06003777|450652884|FG010|Period 4|No longer met eligibility criteria|0|||
125280874|NCT06003777|450652885|FG011|Period 4|No longer met eligibility criteria|0|||
125280875|NCT06003777|450652874|FG000|Period 4|Withdrawal by Subject|0|||
125280876|NCT06003777|450652875|FG001|Period 4|Withdrawal by Subject|1|||
125280877|NCT06003777|450652876|FG002|Period 4|Withdrawal by Subject|0|||
125280878|NCT06003777|450652877|FG003|Period 4|Withdrawal by Subject|0|||
125280879|NCT06003777|450652878|FG004|Period 4|Withdrawal by Subject|0|||
125280880|NCT06003777|450652879|FG005|Period 4|Withdrawal by Subject|0|||
125280881|NCT06003777|450652880|FG006|Period 4|Withdrawal by Subject|0|||
125280882|NCT06003777|450652881|FG007|Period 4|Withdrawal by Subject|0|||
125280883|NCT06003777|450652882|FG008|Period 4|Withdrawal by Subject|0|||
125280884|NCT06003777|450652883|FG009|Period 4|Withdrawal by Subject|0|||
125280885|NCT06003777|450652884|FG010|Period 4|Withdrawal by Subject|0|||
125280886|NCT06003777|450652885|FG011|Period 4|Withdrawal by Subject|0|||
125280887|NCT01106651|450652886|FG000|Overall Study|Adverse Event|17|||
125280888|NCT01106651|450652887|FG001|Overall Study|Adverse Event|9|||
125280889|NCT01106651|450652888|FG002|Overall Study|Adverse Event|23|||
125280890|NCT01106651|450652886|FG000|Overall Study|Lost to Follow-up|8|||
125280891|NCT01106651|450652887|FG001|Overall Study|Lost to Follow-up|2|||
125280892|NCT01106651|450652888|FG002|Overall Study|Lost to Follow-up|6|||
125280893|NCT01106651|450652886|FG000|Overall Study|Physician Decision|4|||
125280894|NCT01106651|450652887|FG001|Overall Study|Physician Decision|3|||
125280895|NCT01106651|450652888|FG002|Overall Study|Physician Decision|1|||
125280896|NCT01106651|450652886|FG000|Overall Study|Protocol Violation|1|||
125280897|NCT01106651|450652887|FG001|Overall Study|Protocol Violation|2|||
125280898|NCT01106651|450652888|FG002|Overall Study|Protocol Violation|1|||
125280899|NCT01106651|450652886|FG000|Overall Study|Withdrawal by Subject|14|||
125280900|NCT01106651|450652887|FG001|Overall Study|Withdrawal by Subject|7|||
125280901|NCT01106651|450652888|FG002|Overall Study|Withdrawal by Subject|4|||
125280902|NCT01106651|450652886|FG000|Overall Study|Noncompliance with study drug|1|||
125280903|NCT01106651|450652887|FG001|Overall Study|Noncompliance with study drug|0|||
125280904|NCT01106651|450652888|FG002|Overall Study|Noncompliance with study drug|2|||
125280905|NCT01106651|450652886|FG000|Overall Study|Other|34|||
125280906|NCT01106651|450652887|FG001|Overall Study|Other|31|||
125280907|NCT01106651|450652888|FG002|Overall Study|Other|21|||
125280908|NCT01106651|450652886|FG000|Overall Study|Death|0|||
125280909|NCT01106651|450652887|FG001|Overall Study|Death|3|||
125280910|NCT01106651|450652888|FG002|Overall Study|Death|0|||
125280911|NCT00613327|450652892|FG000|Overall Study|Adverse Event|38|||
125280912|NCT00613327|450652892|FG000|Overall Study|Lost to Follow-up|8|||
125280913|NCT00613327|450652892|FG000|Overall Study|Withdrawal by Subject|6|||
125280914|NCT00613327|450652892|FG000|Overall Study|Protocol Violation|2|||
125280915|NCT00613327|450652892|FG000|Overall Study|Other|47|||
125280916|NCT00290771|450652897|FG000|Overall Study|Disease progression|95|||
125280917|NCT00290771|450652898|FG001|Overall Study|Disease progression|73|||
125280918|NCT00290771|450652897|FG000|Overall Study|Death|11|||
125280919|NCT00290771|450652898|FG001|Overall Study|Death|10|||
125280920|NCT00290771|450652897|FG000|Overall Study|Adverse Event|12|||
125280921|NCT00290771|450652898|FG001|Overall Study|Adverse Event|6|||
125280922|NCT00290771|450652897|FG000|Overall Study|Withdrawal by Subject|5|||
125280923|NCT00290771|450652898|FG001|Overall Study|Withdrawal by Subject|6|||
125280924|NCT00290771|450652897|FG000|Overall Study|Administrative problems|2|||
125280925|NCT00290771|450652898|FG001|Overall Study|Administrative problems|1|||
125280926|NCT00290771|450652897|FG000|Overall Study|Protocol Violation|2|||
125280927|NCT00290771|450652898|FG001|Overall Study|Protocol Violation|0|||
125280928|NCT00290771|450652897|FG000|Overall Study|Lost to Follow-up|0|||
125280929|NCT00290771|450652898|FG001|Overall Study|Lost to Follow-up|1|||
125280930|NCT03403361|450652902|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
125280931|NCT02487654|450652904|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
125280932|NCT02487654|450652905|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
125280933|NCT02487654|450652904|FG000|Overall Study|Withdrawal by Subject|3|||
125280934|NCT02487654|450652905|FG001|Overall Study|Withdrawal by Subject|7|||
125280935|NCT02247011|450652906|FG000|Overall Study|Poor quality of radiological results|125|||
125280936|NCT00656058|450652907|FG000|Overall Study|Withdrawal by Subject|2|||
125280937|NCT00656058|450652907|FG000|Overall Study|Withdrawal by Subject|4|||
125280938|NCT03718884|450652908|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
125280939|NCT03718884|450652909|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
125280940|NCT03718884|450652908|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
125280941|NCT03718884|450652909|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
125280942|NCT04700540|450652910|FG000|Overall Study|Withdrawal by Subject|12|||
125280943|NCT04700540|450652911|FG001|Overall Study|Withdrawal by Subject|8|||
125280944|NCT04700540|450652910|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
125280945|NCT04700540|450652911|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
125280946|NCT03515551|450652912|FG000|Overall Study|Death|4|||
125280947|NCT03515551|450652913|FG001|Overall Study|Death|1|||
125280948|NCT03515551|450652914|FG002|Overall Study|Death|2|||
125280949|NCT03515551|450652915|FG003|Overall Study|Death|2|||
125280950|NCT03515551|450652916|FG004|Overall Study|Death|2|||
125280951|NCT03515551|450652917|FG005|Overall Study|Death|4|||
125280952|NCT03515551|450652918|FG006|Overall Study|Death|1|||
125280953|NCT03515551|450652912|FG000|Overall Study|Lost to Follow-up|0|||
125280954|NCT03515551|450652913|FG001|Overall Study|Lost to Follow-up|0|||
125280955|NCT03515551|450652914|FG002|Overall Study|Lost to Follow-up|1|||
125280956|NCT03515551|450652915|FG003|Overall Study|Lost to Follow-up|0|||
125280957|NCT03515551|450652916|FG004|Overall Study|Lost to Follow-up|0|||
125280958|NCT03515551|450652917|FG005|Overall Study|Lost to Follow-up|0|||
125280959|NCT03515551|450652918|FG006|Overall Study|Lost to Follow-up|0|||
125280960|NCT03515551|450652912|FG000|Overall Study|Withdrawal by Subject|0|||
125280961|NCT03515551|450652913|FG001|Overall Study|Withdrawal by Subject|1|||
125280962|NCT03515551|450652914|FG002|Overall Study|Withdrawal by Subject|0|||
125280963|NCT03515551|450652915|FG003|Overall Study|Withdrawal by Subject|0|||
125280964|NCT03515551|450652916|FG004|Overall Study|Withdrawal by Subject|0|||
125280965|NCT03515551|450652917|FG005|Overall Study|Withdrawal by Subject|0|||
125280966|NCT03515551|450652918|FG006|Overall Study|Withdrawal by Subject|1|||
125280967|NCT03515551|450652912|FG000|Overall Study|Study ended by sponsor|0|||
125280968|NCT03515551|450652913|FG001|Overall Study|Study ended by sponsor|0|||
125280969|NCT03515551|450652914|FG002|Overall Study|Study ended by sponsor|2|||
125280970|NCT03515551|450652915|FG003|Overall Study|Study ended by sponsor|1|||
125280971|NCT03515551|450652916|FG004|Overall Study|Study ended by sponsor|3|||
125280972|NCT03515551|450652917|FG005|Overall Study|Study ended by sponsor|0|||
125280973|NCT03515551|450652918|FG006|Overall Study|Study ended by sponsor|3|||
125280974|NCT03515551|450652912|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
125280975|NCT03515551|450652913|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
125280976|NCT03515551|450652914|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
125280977|NCT03515551|450652915|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
125280978|NCT03515551|450652916|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
125280979|NCT03515551|450652917|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
125280980|NCT03515551|450652918|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
125280981|NCT02265536|450652932|FG000|Overall Study|Adverse Event|1|||
125280982|NCT02265536|450652933|FG001|Overall Study|Adverse Event|0|||
125280983|NCT02265536|450652934|FG002|Overall Study|Adverse Event|0|||
125280984|NCT02265536|450652935|FG003|Overall Study|Adverse Event|0|||
125280985|NCT02265536|450652936|FG004|Overall Study|Adverse Event|1|||
125280986|NCT02265536|450652937|FG005|Overall Study|Adverse Event|0|||
125280987|NCT02265536|450652932|FG000|Overall Study|Physician Decision|0|||
125280988|NCT02265536|450652933|FG001|Overall Study|Physician Decision|0|||
125280989|NCT02265536|450652934|FG002|Overall Study|Physician Decision|0|||
125280990|NCT02265536|450652935|FG003|Overall Study|Physician Decision|0|||
125411794|NCT00320216|451134838|FG003|Overall Study|Other|1|||
125411795|NCT00320216|451134839|FG004|Overall Study|Other|3|||
125411796|NCT02265705|451134840|FG000|Treatment Period Week 0-24|Adverse Event|3|||
125411797|NCT02265705|451134841|FG001|Treatment Period Week 0-24|Adverse Event|2|||
125411798|NCT02265705|451134842|FG002|Treatment Period Week 0-24|Adverse Event|0|||
125411799|NCT02265705|451134843|FG003|Treatment Period Week 0-24|Adverse Event|0|||
125411800|NCT02265705|451134844|FG004|Treatment Period Week 0-24|Adverse Event|0|||
125411801|NCT02265705|451134845|FG005|Treatment Period Week 0-24|Adverse Event|0|||
125411802|NCT02265705|451134846|FG006|Treatment Period Week 0-24|Adverse Event|0|||
125411803|NCT02265705|451134840|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
125411804|NCT02265705|451134841|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
125411805|NCT02265705|451134842|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
125411806|NCT02265705|451134843|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
125411807|NCT02265705|451134844|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
125411808|NCT02265705|451134845|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
125411809|NCT02265705|451134846|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
125411810|NCT02265705|451134840|FG000|Treatment Period Week 0-24|Physician Decision|1|||
125411811|NCT02265705|451134841|FG001|Treatment Period Week 0-24|Physician Decision|0|||
125411812|NCT02265705|451134842|FG002|Treatment Period Week 0-24|Physician Decision|0|||
125448397|NCT02240680|451268927|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
125448398|NCT02240680|451268924|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
125280991|NCT02265536|450652936|FG004|Overall Study|Physician Decision|2|||
125280992|NCT02265536|450652937|FG005|Overall Study|Physician Decision|0|||
125280993|NCT02265536|450652932|FG000|Overall Study|Withdrawal by Subject|0|||
125280994|NCT02265536|450652933|FG001|Overall Study|Withdrawal by Subject|3|||
125280995|NCT02265536|450652934|FG002|Overall Study|Withdrawal by Subject|0|||
125280996|NCT02265536|450652935|FG003|Overall Study|Withdrawal by Subject|0|||
125280997|NCT02265536|450652936|FG004|Overall Study|Withdrawal by Subject|0|||
125280998|NCT02265536|450652937|FG005|Overall Study|Withdrawal by Subject|0|||
125280999|NCT03268954|450652938|FG000|Overall Study|Ongoing|23|||
125281000|NCT03268954|450652939|FG001|Overall Study|Ongoing|31|||
125281001|NCT03268954|450652938|FG000|Overall Study|Adverse Event|53|||
125281002|NCT03268954|450652939|FG001|Overall Study|Adverse Event|62|||
125281003|NCT03268954|450652938|FG000|Overall Study|Withdrawal by Subject|25|||
125281004|NCT03268954|450652939|FG001|Overall Study|Withdrawal by Subject|16|||
125281005|NCT03268954|450652938|FG000|Overall Study|Progressive Disease|61|||
125281006|NCT03268954|450652939|FG001|Overall Study|Progressive Disease|48|||
125281007|NCT03268954|450652938|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
125281008|NCT03268954|450652939|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
125281009|NCT03268954|450652938|FG000|Overall Study|Reason not Specified|40|||
125281010|NCT03268954|450652939|FG001|Overall Study|Reason not Specified|40|||
125281011|NCT03802630|450652940|FG000|Overall Study|Study terminated by sponsor|130|||
125281012|NCT03802630|450652941|FG001|Overall Study|Study terminated by sponsor|134|||
125281013|NCT03802630|450652940|FG000|Overall Study|Subject decision|16|||
125281014|NCT03802630|450652941|FG001|Overall Study|Subject decision|9|||
125281015|NCT03802630|450652940|FG000|Overall Study|Adverse Event|3|||
125281016|NCT03802630|450652941|FG001|Overall Study|Adverse Event|1|||
125281017|NCT03802630|450652940|FG000|Overall Study|Lost to Follow-up|2|||
125281018|NCT03802630|450652941|FG001|Overall Study|Lost to Follow-up|2|||
125281019|NCT03802630|450652940|FG000|Overall Study|Physician Decision|2|||
125281020|NCT03802630|450652941|FG001|Overall Study|Physician Decision|0|||
125281021|NCT03802630|450652940|FG000|Overall Study|Death|0|||
125281022|NCT03802630|450652941|FG001|Overall Study|Death|2|||
125411813|NCT02265705|451134843|FG003|Treatment Period Week 0-24|Physician Decision|0|||
125411814|NCT02265705|451134844|FG004|Treatment Period Week 0-24|Physician Decision|0|||
125411815|NCT02265705|451134845|FG005|Treatment Period Week 0-24|Physician Decision|0|||
125411816|NCT02265705|451134846|FG006|Treatment Period Week 0-24|Physician Decision|0|||
125281023|NCT05005013|450652942|FG000|Overall Study|Withdrawal by Subject|5|||
125281024|NCT05005013|450652943|FG001|Overall Study|Withdrawal by Subject|1|||
125281025|NCT05005013|450652942|FG000|Overall Study|Lost to Follow-up|3|||
125281026|NCT05005013|450652943|FG001|Overall Study|Lost to Follow-up|1|||
125281027|NCT05005013|450652942|FG000|Overall Study|Ineligibility|1|||
125281028|NCT05005013|450652943|FG001|Overall Study|Ineligibility|1|||
125281029|NCT06099223|450652944|FG000|Overall Study|Preoperative surveys missed|0|||
125281030|NCT06099223|450652945|FG001|Overall Study|Preoperative surveys missed|1|||
125281031|NCT01802580|450652948|FG000|Overall Study|Physician Decision|1|||
125281032|NCT01802580|450652949|FG001|Overall Study|Physician Decision|0|||
125411817|NCT02265705|451134840|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
125281033|NCT01802580|450652948|FG000|Overall Study|Protocol Violation|2|||
125281034|NCT01802580|450652949|FG001|Overall Study|Protocol Violation|0|||
125281035|NCT01802580|450652948|FG000|Overall Study|Withdrawal by Subject|5|||
125281036|NCT01802580|450652949|FG001|Overall Study|Withdrawal by Subject|6|||
125281037|NCT01802580|450652948|FG000|Overall Study|Other|1|||
125281038|NCT01802580|450652949|FG001|Overall Study|Other|3|||
125281039|NCT01802580|450652948|FG000|Overall Study|Lack of Efficacy|0|||
125281040|NCT01802580|450652949|FG001|Overall Study|Lack of Efficacy|2|||
125281041|NCT00211757|450652950|FG000|Overall Study|Withdrawal by Subject|1|||
125281042|NCT00211757|450652951|FG001|Overall Study|Withdrawal by Subject|1|||
125281043|NCT00211757|450652950|FG000|Overall Study|Lack of Efficacy|0|||
125281044|NCT00211757|450652951|FG001|Overall Study|Lack of Efficacy|1|||
125281045|NCT04091581|450652953|FG000|Overall Study|Lost to Follow-up|0|||
125281046|NCT04091581|450652954|FG001|Overall Study|Lost to Follow-up|1|||
125281047|NCT03724981|450654881|FG000|First Device|Protocol Violation|1|||
125281048|NCT03724981|450654882|FG001|First Device|Protocol Violation|1|||
125281049|NCT04439539|450654886|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
125281050|NCT04439539|450654887|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
125281051|NCT04439539|450654888|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
125281052|NCT04439539|450654886|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
125281053|NCT04439539|450654887|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
125281054|NCT04439539|450654888|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
125281055|NCT04439539|450654886|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
125281056|NCT04439539|450654887|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
125281057|NCT04439539|450654888|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
125281058|NCT03596047|450654889|FG000|Overall Study|Withdrawal by Subject|7|||
125281059|NCT03596047|450654890|FG001|Overall Study|Withdrawal by Subject|4|||
125281060|NCT03596047|450654889|FG000|Overall Study|Lost to Follow-up|0|||
125281061|NCT03596047|450654890|FG001|Overall Study|Lost to Follow-up|2|||
125281062|NCT03727646|450654891|FG000|Overall Study|Adverse Event|1|||
125281063|NCT03727646|450654892|FG001|Overall Study|Adverse Event|0|||
125281064|NCT02290691|450654895|FG000|Overall Study|Noncompliance|0|||
125281065|NCT02290691|450654896|FG001|Overall Study|Noncompliance|1|||
125281066|NCT02290691|450654895|FG000|Overall Study|Withdrawal by Subject|1|||
125281067|NCT02290691|450654896|FG001|Overall Study|Withdrawal by Subject|1|||
125281068|NCT02290691|450654895|FG000|Overall Study|Lost to Follow-up|7|||
125281069|NCT02290691|450654896|FG001|Overall Study|Lost to Follow-up|7|||
125281070|NCT00923975|450654901|FG000|Overall Study|Did not meet inclusion criteria|1|||
125281071|NCT01328535|450654902|FG000|Overall Study|Ineligible|1|||
125281072|NCT01005316|450654903|FG000|Overall Study|Adverse Event|0|||
125281073|NCT01005316|450654904|FG001|Overall Study|Adverse Event|0|||
125281074|NCT01005316|450654905|FG002|Overall Study|Adverse Event|0|||
125281075|NCT01005316|450654906|FG003|Overall Study|Adverse Event|1|||
125281076|NCT01005316|450654903|FG000|Overall Study|Death|20|||
125281077|NCT01005316|450654904|FG001|Overall Study|Death|5|||
125281078|NCT01005316|450654905|FG002|Overall Study|Death|1|||
125281079|NCT01005316|450654906|FG003|Overall Study|Death|15|||
125281080|NCT01005316|450654903|FG000|Overall Study|Study Termination|5|||
125281081|NCT01005316|450654904|FG001|Overall Study|Study Termination|63|||
125281082|NCT01005316|450654905|FG002|Overall Study|Study Termination|9|||
125281083|NCT01005316|450654906|FG003|Overall Study|Study Termination|85|||
125281084|NCT01005316|450654903|FG000|Overall Study|Lost to Follow-up|1|||
125281085|NCT01005316|450654904|FG001|Overall Study|Lost to Follow-up|3|||
125281086|NCT01005316|450654905|FG002|Overall Study|Lost to Follow-up|0|||
125281087|NCT01005316|450654906|FG003|Overall Study|Lost to Follow-up|2|||
125281088|NCT01005316|450654903|FG000|Overall Study|Physician Decision|6|||
125281089|NCT01005316|450654904|FG001|Overall Study|Physician Decision|0|||
125281090|NCT01005316|450654905|FG002|Overall Study|Physician Decision|0|||
125281091|NCT01005316|450654906|FG003|Overall Study|Physician Decision|0|||
125281092|NCT01005316|450654903|FG000|Overall Study|Sponsor Decision|6|||
125281093|NCT01005316|450654904|FG001|Overall Study|Sponsor Decision|3|||
125281094|NCT01005316|450654905|FG002|Overall Study|Sponsor Decision|0|||
125281095|NCT01005316|450654906|FG003|Overall Study|Sponsor Decision|0|||
125281096|NCT01005316|450654903|FG000|Overall Study|Withdrawal by Subject|1|||
125281097|NCT01005316|450654904|FG001|Overall Study|Withdrawal by Subject|1|||
125281098|NCT01005316|450654905|FG002|Overall Study|Withdrawal by Subject|0|||
125281099|NCT01005316|450654906|FG003|Overall Study|Withdrawal by Subject|2|||
125281100|NCT01005316|450654903|FG000|Overall Study|Consented to Another Study|2|||
125281101|NCT01005316|450654904|FG001|Overall Study|Consented to Another Study|0|||
125281102|NCT01005316|450654905|FG002|Overall Study|Consented to Another Study|0|||
125281103|NCT01005316|450654906|FG003|Overall Study|Consented to Another Study|0|||
125281104|NCT01005316|450654903|FG000|Overall Study|Delisted|8|||
125281105|NCT01005316|450654904|FG001|Overall Study|Delisted|0|||
125281106|NCT01005316|450654905|FG002|Overall Study|Delisted|0|||
125281107|NCT01005316|450654906|FG003|Overall Study|Delisted|0|||
125281108|NCT01005316|450654903|FG000|Overall Study|Transferred Care|1|||
125281109|NCT01005316|450654904|FG001|Overall Study|Transferred Care|0|||
125281110|NCT01005316|450654905|FG002|Overall Study|Transferred Care|1|||
125281111|NCT01005316|450654906|FG003|Overall Study|Transferred Care|3|||
125281112|NCT01005316|450654903|FG000|Overall Study|Retransplanted|0|||
125281113|NCT01005316|450654904|FG001|Overall Study|Retransplanted|1|||
125281114|NCT01005316|450654905|FG002|Overall Study|Retransplanted|0|||
125281115|NCT01005316|450654906|FG003|Overall Study|Retransplanted|0|||
125281116|NCT04417218|450654907|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
125281117|NCT04417218|450654908|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
125281118|NCT00873041|450654911|FG000|Core Study|Adverse Event|2|||
125281119|NCT00873041|450654912|FG001|Core Study|Adverse Event|3|||
125281120|NCT00873041|450654913|FG002|Core Study|Adverse Event|1|||
125281121|NCT00873041|450654911|FG000|Core Study|Withdrawal by Subject|1|||
125281122|NCT00873041|450654912|FG001|Core Study|Withdrawal by Subject|2|||
125281123|NCT00873041|450654913|FG002|Core Study|Withdrawal by Subject|2|||
125281124|NCT00873041|450654911|FG000|Core Study|Lost to Follow-up|3|||
125281125|NCT00873041|450654912|FG001|Core Study|Lost to Follow-up|1|||
125281126|NCT00873041|450654913|FG002|Core Study|Lost to Follow-up|0|||
125281127|NCT00873041|450654911|FG000|Core Study|Abnormal laboratory value|0|||
125281128|NCT00873041|450654912|FG001|Core Study|Abnormal laboratory value|0|||
125281129|NCT00873041|450654913|FG002|Core Study|Abnormal laboratory value|1|||
125281130|NCT00873041|450654911|FG000|Core Study|Protocol deviation|1|||
125281131|NCT00873041|450654912|FG001|Core Study|Protocol deviation|0|||
125281132|NCT00873041|450654913|FG002|Core Study|Protocol deviation|1|||
125281133|NCT00873041|450654911|FG000|Extension Study|Adverse Event|1|||
125281134|NCT00873041|450654912|FG001|Extension Study|Adverse Event|0|||
125281135|NCT00873041|450654913|FG002|Extension Study|Adverse Event|1|||
125281136|NCT00873041|450654911|FG000|Extension Study|Administrative reasons|0|||
125281137|NCT00873041|450654912|FG001|Extension Study|Administrative reasons|0|||
125281138|NCT00873041|450654913|FG002|Extension Study|Administrative reasons|1|||
125281139|NCT01734395|450654916|FG000|Overall Study|Other|65|||
125281140|NCT01734395|450654916|FG000|Overall Study|Lost to Follow-up|287|||
125281141|NCT01734395|450654916|FG000|Overall Study|Lack of Efficacy|5|||
125281142|NCT01734395|450654916|FG000|Overall Study|Adverse Event|40|||
125281143|NCT01734395|450654916|FG000|Overall Study|Withdrawal by Subject|10|||
125281144|NCT01734395|450654916|FG000|Overall Study|Missing the reasons for not completed|3|||
125281145|NCT01032291|450654917|FG000|Safety Lead-in|Adverse Event|1|||
125281146|NCT01032291|450654918|FG001|Safety Lead-in|Adverse Event|0|||
125281147|NCT01032291|450654919|FG002|Safety Lead-in|Adverse Event|0|||
125281148|NCT01032291|450654917|FG000|Safety Lead-in|Death|1|||
125281149|NCT01032291|450654918|FG001|Safety Lead-in|Death|0|||
125281150|NCT01032291|450654919|FG002|Safety Lead-in|Death|0|||
125281151|NCT01032291|450654917|FG000|Proof of Concept|Adverse Event|0|||
125281152|NCT01032291|450654918|FG001|Proof of Concept|Adverse Event|5|||
125281153|NCT01032291|450654919|FG002|Proof of Concept|Adverse Event|1|||
125281154|NCT01032291|450654917|FG000|Proof of Concept|Death|0|||
125281155|NCT01032291|450654918|FG001|Proof of Concept|Death|1|||
125281156|NCT01032291|450654919|FG002|Proof of Concept|Death|2|||
125281157|NCT01032291|450654917|FG000|Proof of Concept|Lack of Efficacy|0|||
125281158|NCT01032291|450654918|FG001|Proof of Concept|Lack of Efficacy|1|||
125281159|NCT01032291|450654919|FG002|Proof of Concept|Lack of Efficacy|0|||
125281160|NCT01032291|450654917|FG000|Proof of Concept|Never Received Study Drug|0|||
125281161|NCT01032291|450654918|FG001|Proof of Concept|Never Received Study Drug|1|||
125281162|NCT01032291|450654919|FG002|Proof of Concept|Never Received Study Drug|0|||
125281163|NCT00313313|450654920|FG000|Overall Study|Lack of Efficacy|14|||
125281164|NCT00313313|450654921|FG001|Overall Study|Lack of Efficacy|9|||
125281165|NCT00313313|450654922|FG002|Overall Study|Lack of Efficacy|20|||
125281166|NCT00313313|450654920|FG000|Overall Study|Withdrawal of consent by subject|18|||
125281167|NCT00313313|450654921|FG001|Overall Study|Withdrawal of consent by subject|17|||
125281168|NCT00313313|450654922|FG002|Overall Study|Withdrawal of consent by subject|31|||
125281169|NCT00313313|450654920|FG000|Overall Study|Lost to Follow-up|10|||
125281170|NCT00313313|450654921|FG001|Overall Study|Lost to Follow-up|7|||
125281171|NCT00313313|450654922|FG002|Overall Study|Lost to Follow-up|9|||
125281172|NCT00313313|450654920|FG000|Overall Study|Adverse Event|15|||
125281173|NCT00313313|450654921|FG001|Overall Study|Adverse Event|16|||
125281174|NCT00313313|450654922|FG002|Overall Study|Adverse Event|12|||
125281175|NCT00313313|450654920|FG000|Overall Study|Physician Decision|2|||
125281176|NCT00313313|450654921|FG001|Overall Study|Physician Decision|6|||
125281177|NCT00313313|450654922|FG002|Overall Study|Physician Decision|4|||
125281178|NCT00313313|450654920|FG000|Overall Study|Poor/Noncompliance|3|||
125281179|NCT00313313|450654921|FG001|Overall Study|Poor/Noncompliance|6|||
125281180|NCT00313313|450654922|FG002|Overall Study|Poor/Noncompliance|2|||
125281181|NCT00313313|450654920|FG000|Overall Study|Pregnancy|1|||
125281182|NCT00313313|450654921|FG001|Overall Study|Pregnancy|2|||
125281183|NCT00313313|450654922|FG002|Overall Study|Pregnancy|0|||
125281184|NCT00313313|450654920|FG000|Overall Study|Death|0|||
125281185|NCT00313313|450654921|FG001|Overall Study|Death|0|||
125281186|NCT00313313|450654922|FG002|Overall Study|Death|2|||
125281187|NCT00313313|450654920|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
125281188|NCT00313313|450654921|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
125281189|NCT00313313|450654922|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
125281190|NCT00758264|450654925|FG000|Active Phase|Withdrawal by Subject|0|||
125281191|NCT00758264|450654926|FG001|Active Phase|Withdrawal by Subject|0|||
125281192|NCT00758264|450654927|FG002|Active Phase|Withdrawal by Subject|1|||
125281193|NCT00758264|450654925|FG000|Active Phase|Lost to Follow-up|1|||
125281194|NCT00758264|450654926|FG001|Active Phase|Lost to Follow-up|0|||
125281195|NCT00758264|450654927|FG002|Active Phase|Lost to Follow-up|0|||
125281196|NCT00758264|450654925|FG000|Active Phase|Other|0|||
125281197|NCT00758264|450654926|FG001|Active Phase|Other|0|||
125281198|NCT00758264|450654927|FG002|Active Phase|Other|4|||
125281199|NCT03425006|450654928|FG000|Overall Study|Withdrawal by Subject|1|||
125281200|NCT03425006|450654928|FG000|Overall Study|Physician Decision|1|||
125281201|NCT03425006|450654928|FG000|Overall Study|Death|1|||
125281202|NCT02300558|450654931|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
125281203|NCT02300558|450654931|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
125281204|NCT02300558|450654931|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
125281205|NCT02300558|450654931|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
125281206|NCT00695955|450654932|FG000|Cohort 1|Adverse Event|26|||
125281207|NCT00695955|450654932|FG000|Cohort 1|Protocol Violation|2|||
125281208|NCT00695955|450654932|FG000|Cohort 1|Lost to Follow-up|30|||
125281209|NCT00695955|450654932|FG000|Cohort 1|Withdrawal by Subject|25|||
125281210|NCT00695955|450654932|FG000|Cohort 1|Lack of Efficacy|3|||
125281211|NCT00695955|450654932|FG000|Cohort 1|Other|16|||
125281212|NCT00695955|450654932|FG000|Cohort 2|Adverse Event|24|||
125281213|NCT00695955|450654932|FG000|Cohort 2|Protocol Violation|5|||
125281214|NCT00695955|450654932|FG000|Cohort 2|Lost to Follow-up|38|||
125281215|NCT00695955|450654932|FG000|Cohort 2|Withdrawal by Subject|28|||
125281216|NCT00695955|450654932|FG000|Cohort 2|Lack of Efficacy|4|||
125281217|NCT00695955|450654932|FG000|Cohort 2|Other|5|||
125281218|NCT03888235|450654935|FG000|Overall Study|Lost to Follow-up|1|||
125281219|NCT03888235|450654936|FG001|Overall Study|Lost to Follow-up|1|||
125281220|NCT03888235|450654937|FG002|Overall Study|Lost to Follow-up|0|||
125281221|NCT01054560|450654938|FG000|Overall Study|Death|10|||
125281222|NCT01054560|450654939|FG001|Overall Study|Death|21|||
125281223|NCT01054560|450654938|FG000|Overall Study|Lost to Follow-up|2|||
125281224|NCT01054560|450654939|FG001|Overall Study|Lost to Follow-up|5|||
125281225|NCT01054560|450654938|FG000|Overall Study|Withdrawal by Subject|0|||
125281226|NCT01054560|450654939|FG001|Overall Study|Withdrawal by Subject|2|||
125281227|NCT01054560|450654938|FG000|Overall Study|Physician Decision|1|||
125281228|NCT01054560|450654939|FG001|Overall Study|Physician Decision|0|||
125281229|NCT01421303|450654940|FG000|Overall Study|Lost to Follow-up|13|||
125281230|NCT01421303|450654940|FG000|Overall Study|Non compliance with study procedure|1|||
125281231|NCT01421303|450654940|FG000|Overall Study|Other|7|||
125281232|NCT01421303|450654940|FG000|Overall Study|Withdrawal by Subject|1|||
125281233|NCT00712725|450654942|FG000|Overall Study|Adverse Event|1|||
125281234|NCT00712725|450654943|FG001|Overall Study|Adverse Event|0|||
125281235|NCT00712725|450654944|FG002|Overall Study|Adverse Event|0|||
125281236|NCT00712725|450654945|FG003|Overall Study|Adverse Event|1|||
125281237|NCT00712725|450654946|FG004|Overall Study|Adverse Event|0|||
125281238|NCT00712725|450654947|FG005|Overall Study|Adverse Event|0|||
125281239|NCT00712725|450654948|FG006|Overall Study|Adverse Event|0|||
125281240|NCT00712725|450654949|FG007|Overall Study|Adverse Event|0|||
125281241|NCT00712725|450654942|FG000|Overall Study|Lost to Follow-up|3|||
125281242|NCT00712725|450654943|FG001|Overall Study|Lost to Follow-up|2|||
125281243|NCT00712725|450654944|FG002|Overall Study|Lost to Follow-up|1|||
125281244|NCT00712725|450654945|FG003|Overall Study|Lost to Follow-up|1|||
125281245|NCT00712725|450654946|FG004|Overall Study|Lost to Follow-up|2|||
125281246|NCT00712725|450654947|FG005|Overall Study|Lost to Follow-up|2|||
125281247|NCT00712725|450654948|FG006|Overall Study|Lost to Follow-up|3|||
125281248|NCT00712725|450654949|FG007|Overall Study|Lost to Follow-up|1|||
125281249|NCT00712725|450654942|FG000|Overall Study|Physician Decision|2|||
125281250|NCT00712725|450654943|FG001|Overall Study|Physician Decision|0|||
125411818|NCT02265705|451134841|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
125411819|NCT02265705|451134842|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
125281251|NCT00712725|450654944|FG002|Overall Study|Physician Decision|0|||
125281252|NCT00712725|450654945|FG003|Overall Study|Physician Decision|0|||
125281253|NCT00712725|450654946|FG004|Overall Study|Physician Decision|1|||
125281254|NCT00712725|450654947|FG005|Overall Study|Physician Decision|0|||
125281255|NCT00712725|450654948|FG006|Overall Study|Physician Decision|2|||
125281256|NCT00712725|450654949|FG007|Overall Study|Physician Decision|0|||
125281257|NCT00712725|450654942|FG000|Overall Study|Pregnancy|0|||
125281258|NCT00712725|450654943|FG001|Overall Study|Pregnancy|1|||
125281259|NCT00712725|450654944|FG002|Overall Study|Pregnancy|0|||
125281260|NCT00712725|450654945|FG003|Overall Study|Pregnancy|0|||
125281261|NCT00712725|450654946|FG004|Overall Study|Pregnancy|1|||
125281262|NCT00712725|450654947|FG005|Overall Study|Pregnancy|0|||
125281263|NCT00712725|450654948|FG006|Overall Study|Pregnancy|2|||
125281264|NCT00712725|450654949|FG007|Overall Study|Pregnancy|0|||
125281265|NCT00712725|450654942|FG000|Overall Study|Protocol Violation|2|||
125281266|NCT00712725|450654943|FG001|Overall Study|Protocol Violation|0|||
125281267|NCT00712725|450654944|FG002|Overall Study|Protocol Violation|1|||
125281268|NCT00712725|450654945|FG003|Overall Study|Protocol Violation|3|||
125281269|NCT00712725|450654946|FG004|Overall Study|Protocol Violation|2|||
125281270|NCT00712725|450654947|FG005|Overall Study|Protocol Violation|0|||
125281271|NCT00712725|450654948|FG006|Overall Study|Protocol Violation|1|||
125281272|NCT00712725|450654949|FG007|Overall Study|Protocol Violation|1|||
125281273|NCT00712725|450654942|FG000|Overall Study|Withdrawal by Subject|2|||
125281274|NCT00712725|450654943|FG001|Overall Study|Withdrawal by Subject|1|||
125281275|NCT00712725|450654944|FG002|Overall Study|Withdrawal by Subject|1|||
125281276|NCT00712725|450654945|FG003|Overall Study|Withdrawal by Subject|2|||
125281277|NCT00712725|450654946|FG004|Overall Study|Withdrawal by Subject|1|||
125281278|NCT00712725|450654947|FG005|Overall Study|Withdrawal by Subject|1|||
125281279|NCT00712725|450654948|FG006|Overall Study|Withdrawal by Subject|1|||
125281280|NCT00712725|450654949|FG007|Overall Study|Withdrawal by Subject|2|||
125281281|NCT00712725|450654942|FG000|Overall Study|Lack of Qualifying Event|16|||
125281282|NCT00712725|450654943|FG001|Overall Study|Lack of Qualifying Event|2|||
125281283|NCT00712725|450654944|FG002|Overall Study|Lack of Qualifying Event|6|||
125281284|NCT00712725|450654945|FG003|Overall Study|Lack of Qualifying Event|8|||
125281285|NCT00712725|450654946|FG004|Overall Study|Lack of Qualifying Event|11|||
125281286|NCT00712725|450654947|FG005|Overall Study|Lack of Qualifying Event|13|||
125281287|NCT00712725|450654948|FG006|Overall Study|Lack of Qualifying Event|11|||
125281288|NCT00712725|450654949|FG007|Overall Study|Lack of Qualifying Event|6|||
125281289|NCT00712725|450654942|FG000|Overall Study|Protocol Specified Criteria|3|||
125281290|NCT00712725|450654943|FG001|Overall Study|Protocol Specified Criteria|0|||
125281291|NCT00712725|450654944|FG002|Overall Study|Protocol Specified Criteria|1|||
125281292|NCT00712725|450654945|FG003|Overall Study|Protocol Specified Criteria|2|||
125281293|NCT00712725|450654946|FG004|Overall Study|Protocol Specified Criteria|1|||
125281294|NCT00712725|450654947|FG005|Overall Study|Protocol Specified Criteria|0|||
125281295|NCT00712725|450654948|FG006|Overall Study|Protocol Specified Criteria|2|||
125281296|NCT00712725|450654949|FG007|Overall Study|Protocol Specified Criteria|1|||
125281297|NCT03466099|450654950|FG000|Overall Study|Adverse Event|1|||
125281298|NCT03466099|450654951|FG001|Overall Study|Adverse Event|1|||
125281299|NCT03466099|450654952|FG002|Overall Study|Adverse Event|1|||
125281300|NCT03466099|450654950|FG000|Overall Study|Withdrawal by Subject|2|||
125281301|NCT03466099|450654951|FG001|Overall Study|Withdrawal by Subject|3|||
125281302|NCT03466099|450654952|FG002|Overall Study|Withdrawal by Subject|1|||
125281303|NCT03466099|450654950|FG000|Overall Study|Use of rescue medication|8|||
125281304|NCT03466099|450654951|FG001|Overall Study|Use of rescue medication|9|||
125281305|NCT03466099|450654952|FG002|Overall Study|Use of rescue medication|13|||
125281306|NCT03466099|450654950|FG000|Overall Study|Rescued without meeting criteria|4|||
125281307|NCT03466099|450654951|FG001|Overall Study|Rescued without meeting criteria|1|||
125281308|NCT03466099|450654952|FG002|Overall Study|Rescued without meeting criteria|1|||
125281309|NCT03466099|450654950|FG000|Overall Study|Subject compliance|2|||
125281310|NCT03466099|450654951|FG001|Overall Study|Subject compliance|0|||
125281311|NCT03466099|450654952|FG002|Overall Study|Subject compliance|0|||
125281312|NCT03466099|450654950|FG000|Overall Study|Worsening disease|0|||
125281313|NCT03466099|450654951|FG001|Overall Study|Worsening disease|0|||
125281314|NCT03466099|450654952|FG002|Overall Study|Worsening disease|1|||
125281315|NCT00344318|450654955|FG000|Overall Study|Adverse Event|0|||
125281316|NCT00344318|450654956|FG001|Overall Study|Adverse Event|3|||
125281317|NCT00344318|450654957|FG002|Overall Study|Adverse Event|0|||
125281318|NCT00344318|450654958|FG003|Overall Study|Adverse Event|1|||
125281319|NCT00344318|450654955|FG000|Overall Study|Withdrawal by Subject|2|||
125281320|NCT00344318|450654956|FG001|Overall Study|Withdrawal by Subject|2|||
125281321|NCT00344318|450654957|FG002|Overall Study|Withdrawal by Subject|0|||
125281322|NCT00344318|450654958|FG003|Overall Study|Withdrawal by Subject|2|||
125281323|NCT00344318|450654955|FG000|Overall Study|Lost to Follow-up|2|||
125281324|NCT00344318|450654956|FG001|Overall Study|Lost to Follow-up|0|||
125281325|NCT00344318|450654957|FG002|Overall Study|Lost to Follow-up|1|||
125281326|NCT00344318|450654958|FG003|Overall Study|Lost to Follow-up|0|||
125281327|NCT03832322|450654959|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
125281328|NCT03832322|450654960|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
125281329|NCT01923363|450654961|FG000|Overall Study|Protocol Violation|1|||
125281330|NCT00616018|450654964|FG000|Overall Study|Protocol Violation|3|||
125281331|NCT00404755|450654966|FG000|Phase I (Bupropion)|Adverse Event|3|||
125281332|NCT00404755|450654966|FG000|Phase I (Bupropion)|Other|1|||
125281333|NCT00404755|450654966|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
125281334|NCT00350870|450654967|FG000|Overall Study|Withdrawal by Subject|21|||
125281335|NCT00350870|450654968|FG001|Overall Study|Withdrawal by Subject|17|||
125281336|NCT00350870|450654969|FG002|Overall Study|Withdrawal by Subject|15|||
125281337|NCT00350870|450654970|FG003|Overall Study|Withdrawal by Subject|14|||
125281338|NCT00350870|450654967|FG000|Overall Study|Physician Decision|1|||
125281339|NCT00350870|450654968|FG001|Overall Study|Physician Decision|0|||
125281340|NCT00350870|450654969|FG002|Overall Study|Physician Decision|1|||
125281341|NCT00350870|450654970|FG003|Overall Study|Physician Decision|1|||
125281342|NCT03194568|450654971|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
125281343|NCT05248997|450654972|FG000|Overall Study|Lost to Follow-up|1|||
125281344|NCT05248997|450654973|FG001|Overall Study|Lost to Follow-up|1|||
125281345|NCT05248997|450654972|FG000|Overall Study|Randomized but not treated|32|||
125448399|NCT02240680|451268925|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
125448400|NCT02240680|451268926|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
125448401|NCT02240680|451268927|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
125448402|NCT02240680|451268924|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
125448403|NCT02240680|451268925|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
125448404|NCT02240680|451268926|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
125448405|NCT02240680|451268927|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
125448406|NCT02240680|451268924|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
125448407|NCT02240680|451268925|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
125448408|NCT02240680|451268926|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
125448409|NCT02240680|451268927|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
125448410|NCT02240680|451268924|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
125448411|NCT02240680|451268925|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
125448412|NCT02240680|451268926|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
125448413|NCT02240680|451268927|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
125448414|NCT02240680|451268924|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
125448415|NCT02240680|451268925|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
125448416|NCT02240680|451268926|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
125448417|NCT02240680|451268927|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
125448418|NCT02240680|451268924|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
125448419|NCT02240680|451268925|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
125448420|NCT02240680|451268926|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
125448421|NCT02240680|451268927|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
125448422|NCT01657682|451268928|FG000|Overall Study|Lost to Follow-up|1|||
125281346|NCT05248997|450654973|FG001|Overall Study|Randomized but not treated|25|||
125281347|NCT01453205|450654974|FG000|Overall Study|Lost to Follow-up|3|||
125281348|NCT01453205|450654975|FG001|Overall Study|Lost to Follow-up|0|||
125281349|NCT01453205|450654976|FG002|Overall Study|Lost to Follow-up|1|||
125281350|NCT01453205|450654974|FG000|Overall Study|Withdrawal by Subject|8|||
125281351|NCT01453205|450654975|FG001|Overall Study|Withdrawal by Subject|3|||
125281352|NCT01453205|450654976|FG002|Overall Study|Withdrawal by Subject|0|||
125281353|NCT01453205|450654974|FG000|Overall Study|Death|24|||
125281354|NCT01453205|450654975|FG001|Overall Study|Death|22|||
125281355|NCT01453205|450654976|FG002|Overall Study|Death|18|||
125281356|NCT01453205|450654974|FG000|Overall Study|Other|45|||
125281357|NCT01453205|450654975|FG001|Overall Study|Other|27|||
125281358|NCT01453205|450654976|FG002|Overall Study|Other|35|||
125281359|NCT02602275|450654984|FG000|Day 1|Physician Decision|0|||
125281360|NCT02602275|450654985|FG001|Day 1|Physician Decision|1|||
125281361|NCT04262882|450654986|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
125281362|NCT04262882|450654987|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
125281363|NCT04262882|450654986|FG000|Overall Study|Lost to Follow-up|1|||
125281364|NCT04262882|450654987|FG001|Overall Study|Lost to Follow-up|0|||
125281365|NCT01301066|450654988|FG000|Overall Study|Lost to Follow-up|5|||
125281366|NCT01301066|450654989|FG001|Overall Study|Lost to Follow-up|11|||
125281367|NCT01301066|450654988|FG000|Overall Study|Protocol Violation|8|||
125281368|NCT01301066|450654989|FG001|Overall Study|Protocol Violation|7|||
125281369|NCT01301066|450654988|FG000|Overall Study|Withdrawal by Subject|4|||
125281370|NCT01301066|450654989|FG001|Overall Study|Withdrawal by Subject|9|||
125281371|NCT01301066|450654988|FG000|Overall Study|Adverse Event|6|||
125281372|NCT01301066|450654989|FG001|Overall Study|Adverse Event|6|||
125281373|NCT01301066|450654988|FG000|Overall Study|Sponsor Decision|2|||
125281374|NCT01301066|450654989|FG001|Overall Study|Sponsor Decision|1|||
125281375|NCT01301066|450654988|FG000|Overall Study|Physician Decision|0|||
125281376|NCT01301066|450654989|FG001|Overall Study|Physician Decision|1|||
125281377|NCT01301066|450654988|FG000|Overall Study|Other|2|||
125281378|NCT01301066|450654989|FG001|Overall Study|Other|0|||
125448423|NCT01657682|451268929|FG001|Overall Study|Lost to Follow-up|0|||
125448424|NCT01657682|451268930|FG002|Overall Study|Lost to Follow-up|0|||
125448425|NCT01657682|451268928|FG000|Overall Study|Withdrawal by Subject|0|||
125448426|NCT01657682|451268929|FG001|Overall Study|Withdrawal by Subject|1|||
125448427|NCT01657682|451268930|FG002|Overall Study|Withdrawal by Subject|1|||
125448428|NCT01657682|451268928|FG000|Overall Study|Adverse Event|0|||
125448429|NCT01657682|451268929|FG001|Overall Study|Adverse Event|1|||
125448430|NCT01657682|451268930|FG002|Overall Study|Adverse Event|0|||
125448431|NCT01719861|451268931|FG000|Cycle 1|Death|4|||
125448432|NCT01719861|451268931|FG000|Cycle 2|Death|1|||
125281379|NCT01108731|450654996|FG000|Overall Study|Withdrawal by Subject|1|||
125448433|NCT00783718|451268934|FG000|Induction Phase|Adverse Event|4|||
125281380|NCT01108731|450654997|FG001|Overall Study|Withdrawal by Subject|1|||
125281381|NCT01108731|450654996|FG000|Overall Study|Adverse Event|3|||
125281382|NCT01108731|450654997|FG001|Overall Study|Adverse Event|3|||
125281383|NCT04210245|450654998|FG000|Overall Study|Adverse Event|0|||
125281384|NCT04210245|450654999|FG001|Overall Study|Adverse Event|3|||
125281385|NCT04210245|450655000|FG002|Overall Study|Adverse Event|6|||
125448434|NCT00783718|451268935|FG001|Induction Phase|Adverse Event|0|||
125448435|NCT00783718|451268936|FG002|Induction Phase|Adverse Event|7|||
125448436|NCT00783718|451268937|FG003|Induction Phase|Adverse Event|0|||
125448437|NCT00783718|451268938|FG004|Induction Phase|Adverse Event|0|||
125448438|NCT00783718|451268939|FG005|Induction Phase|Adverse Event|0|||
125448439|NCT00783718|451268940|FG006|Induction Phase|Adverse Event|0|||
125448440|NCT00783718|451268934|FG000|Induction Phase|Protocol Violation|1|||
125448441|NCT00783718|451268935|FG001|Induction Phase|Protocol Violation|1|||
125281386|NCT04210245|450655001|FG003|Overall Study|Adverse Event|0|||
125281387|NCT04210245|450654998|FG000|Overall Study|Withdrawal by Subject|0|||
125281388|NCT04210245|450654999|FG001|Overall Study|Withdrawal by Subject|1|||
125281389|NCT04210245|450655000|FG002|Overall Study|Withdrawal by Subject|4|||
125281390|NCT04210245|450655001|FG003|Overall Study|Withdrawal by Subject|4|||
125281391|NCT04210245|450654998|FG000|Overall Study|Lost to Follow-up|0|||
125281392|NCT04210245|450654999|FG001|Overall Study|Lost to Follow-up|1|||
125281393|NCT04210245|450655000|FG002|Overall Study|Lost to Follow-up|1|||
125281394|NCT04210245|450655001|FG003|Overall Study|Lost to Follow-up|1|||
125281395|NCT04210245|450654998|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
125281396|NCT04210245|450654999|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
125281397|NCT04210245|450655000|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
125281398|NCT04210245|450655001|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
125281399|NCT01892722|450655002|FG000|Overall Study|Protocol deviation|0|||
125281400|NCT01892722|450655003|FG001|Overall Study|Protocol deviation|1|||
125281401|NCT01892722|450655002|FG000|Overall Study|Administrative problems|0|||
125281402|NCT01892722|450655003|FG001|Overall Study|Administrative problems|1|||
125281403|NCT01892722|450655002|FG000|Overall Study|Patient/guardian decision|0|||
125281404|NCT01892722|450655003|FG001|Overall Study|Patient/guardian decision|2|||
125281405|NCT01892722|450655002|FG000|Overall Study|Physician Decision|1|||
125281406|NCT01892722|450655003|FG001|Overall Study|Physician Decision|2|||
125281407|NCT01892722|450655002|FG000|Overall Study|Adverse Event|3|||
125281408|NCT01892722|450655003|FG001|Overall Study|Adverse Event|2|||
125281409|NCT01892722|450655002|FG000|Overall Study|Lack of Efficacy|0|||
125281410|NCT01892722|450655003|FG001|Overall Study|Lack of Efficacy|7|||
125281411|NCT01892722|450655002|FG000|Overall Study|Withdrawal by Subject|3|||
125281412|NCT01892722|450655003|FG001|Overall Study|Withdrawal by Subject|5|||
125281413|NCT01252186|450655004|FG000|Overall Study|Adverse Event|9|||
125281414|NCT01252186|450655005|FG001|Overall Study|Adverse Event|6|||
125281415|NCT01252186|450655006|FG002|Overall Study|Adverse Event|8|||
125281416|NCT01252186|450655004|FG000|Overall Study|Withdrawal by Subject|2|||
125281417|NCT01252186|450655005|FG001|Overall Study|Withdrawal by Subject|5|||
125281418|NCT01252186|450655006|FG002|Overall Study|Withdrawal by Subject|2|||
125281419|NCT01252186|450655004|FG000|Overall Study|Physician Decision|0|||
125281420|NCT01252186|450655005|FG001|Overall Study|Physician Decision|0|||
125281421|NCT01252186|450655006|FG002|Overall Study|Physician Decision|1|||
125281422|NCT01252186|450655004|FG000|Overall Study|Non-compliance|0|||
125281423|NCT01252186|450655005|FG001|Overall Study|Non-compliance|3|||
125281424|NCT01252186|450655006|FG002|Overall Study|Non-compliance|4|||
125281425|NCT01252186|450655004|FG000|Overall Study|Protocol Violation|0|||
125281426|NCT01252186|450655005|FG001|Overall Study|Protocol Violation|0|||
125281427|NCT01252186|450655006|FG002|Overall Study|Protocol Violation|1|||
125281428|NCT01252186|450655004|FG000|Overall Study|Pregnancy|2|||
125281429|NCT01252186|450655005|FG001|Overall Study|Pregnancy|2|||
125281430|NCT01252186|450655006|FG002|Overall Study|Pregnancy|0|||
125281431|NCT01252186|450655004|FG000|Overall Study|Sponsor Request|2|||
125281432|NCT01252186|450655005|FG001|Overall Study|Sponsor Request|1|||
125281433|NCT01252186|450655006|FG002|Overall Study|Sponsor Request|0|||
125281434|NCT01252186|450655004|FG000|Overall Study|Lost to Follow-up|10|||
125281435|NCT01252186|450655005|FG001|Overall Study|Lost to Follow-up|10|||
125281436|NCT01252186|450655006|FG002|Overall Study|Lost to Follow-up|11|||
125281437|NCT01252186|450655004|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
125281438|NCT01252186|450655005|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
125281439|NCT01252186|450655006|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
125448442|NCT00783718|451268936|FG002|Induction Phase|Protocol Violation|6|||
125448443|NCT00783718|451268937|FG003|Induction Phase|Protocol Violation|0|||
125448444|NCT00783718|451268938|FG004|Induction Phase|Protocol Violation|0|||
125448445|NCT00783718|451268939|FG005|Induction Phase|Protocol Violation|0|||
125448446|NCT00783718|451268940|FG006|Induction Phase|Protocol Violation|0|||
125448447|NCT00783718|451268934|FG000|Induction Phase|Lack of Efficacy|5|||
125281440|NCT04283994|450655013|FG000|Overall Study|Death|11|||
125281441|NCT04283994|450655014|FG001|Overall Study|Death|20|||
125281442|NCT04283994|450655015|FG002|Overall Study|Death|11|||
125281443|NCT04283994|450655016|FG003|Overall Study|Death|0|||
125281444|NCT04283994|450655017|FG004|Overall Study|Death|0|||
125281445|NCT04283994|450655018|FG005|Overall Study|Death|0|||
125281446|NCT04283994|450655019|FG006|Overall Study|Death|0|||
125281447|NCT04283994|450655013|FG000|Overall Study|Withdrawal by Subject|16|||
125448448|NCT00783718|451268935|FG001|Induction Phase|Lack of Efficacy|2|||
125281448|NCT04283994|450655014|FG001|Overall Study|Withdrawal by Subject|4|||
125281449|NCT04283994|450655015|FG002|Overall Study|Withdrawal by Subject|6|||
125281450|NCT04283994|450655016|FG003|Overall Study|Withdrawal by Subject|1|||
125281451|NCT04283994|450655017|FG004|Overall Study|Withdrawal by Subject|0|||
125281452|NCT04283994|450655018|FG005|Overall Study|Withdrawal by Subject|1|||
125281453|NCT04283994|450655019|FG006|Overall Study|Withdrawal by Subject|0|||
125281454|NCT03763656|450655020|FG000|Overall Study|Physician Decision|1|||
125281455|NCT03763656|450655020|FG000|Overall Study|Protocol Violation|1|||
125281456|NCT03763656|450655020|FG000|Overall Study|Withdrawal by Subject|7|||
125281457|NCT00487942|450655021|FG000|Overall Study|Adverse Event|1|||
125281458|NCT00487942|450655022|FG001|Overall Study|Adverse Event|1|||
125281459|NCT00487942|450655023|FG002|Overall Study|Adverse Event|1|||
125281460|NCT00487942|450655024|FG003|Overall Study|Adverse Event|1|||
125281461|NCT00487942|450655021|FG000|Overall Study|Lost to Follow-up|1|||
125281462|NCT00487942|450655022|FG001|Overall Study|Lost to Follow-up|0|||
125281463|NCT00487942|450655023|FG002|Overall Study|Lost to Follow-up|0|||
125281464|NCT00487942|450655024|FG003|Overall Study|Lost to Follow-up|1|||
125281465|NCT00487942|450655021|FG000|Overall Study|Protocol Violation|1|||
125281466|NCT00487942|450655022|FG001|Overall Study|Protocol Violation|1|||
125281467|NCT00487942|450655023|FG002|Overall Study|Protocol Violation|0|||
125281468|NCT00487942|450655024|FG003|Overall Study|Protocol Violation|0|||
125281469|NCT00487942|450655021|FG000|Overall Study|Withdrawal by Subject|0|||
125281470|NCT00487942|450655022|FG001|Overall Study|Withdrawal by Subject|1|||
125281471|NCT00487942|450655023|FG002|Overall Study|Withdrawal by Subject|2|||
125281472|NCT00487942|450655024|FG003|Overall Study|Withdrawal by Subject|0|||
125281473|NCT00197145|450656330|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
125281474|NCT00197145|450656331|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
125281475|NCT00197145|450656330|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
125281476|NCT00197145|450656331|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
125281477|NCT00197145|450656330|FG000|Period 1: Randomized Treatment Phase|Other|2|||
125281478|NCT00197145|450656331|FG001|Period 1: Randomized Treatment Phase|Other|2|||
125281479|NCT00197145|450656330|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
125281480|NCT00197145|450656331|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
125281481|NCT00197145|450656330|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
125281482|NCT00197145|450656331|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
125281483|NCT00197145|450656330|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
125281484|NCT00197145|450656331|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
125281485|NCT00197145|450656330|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
125281486|NCT00197145|450656331|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
125281487|NCT00197145|450656330|FG000|Period 2 : Open Label Phase|Other|1|||
125281488|NCT00197145|450656331|FG001|Period 2 : Open Label Phase|Other|0|||
125281489|NCT03372551|450656338|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
125281490|NCT03372551|450656339|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
125281491|NCT03285958|450656344|FG000|Overall Study|Lost to Follow-up|1|||
125281492|NCT03285958|450656345|FG001|Overall Study|Lost to Follow-up|1|||
125281493|NCT03285958|450656344|FG000|Overall Study|Withdrawal by Subject|1|||
125281494|NCT03285958|450656345|FG001|Overall Study|Withdrawal by Subject|0|||
125281495|NCT03285958|450656344|FG000|Overall Study|Not able to attend required orientation|3|||
125281496|NCT03285958|450656345|FG001|Overall Study|Not able to attend required orientation|0|||
125281497|NCT02578680|450656346|FG000|Overall Study|Death|329|||
125281498|NCT02578680|450656347|FG001|Overall Study|Death|181|||
125281499|NCT02578680|450656346|FG000|Overall Study|Lost to Follow-up|3|||
125281500|NCT02578680|450656347|FG001|Overall Study|Lost to Follow-up|1|||
125281501|NCT02578680|450656346|FG000|Overall Study|Physician Decision|0|||
125281502|NCT02578680|450656347|FG001|Overall Study|Physician Decision|1|||
125281503|NCT02578680|450656346|FG000|Overall Study|Protocol Violation|1|||
125281504|NCT02578680|450656347|FG001|Overall Study|Protocol Violation|1|||
125281505|NCT02578680|450656346|FG000|Overall Study|Sponsor Decision|64|||
125281506|NCT02578680|450656347|FG001|Overall Study|Sponsor Decision|13|||
125281507|NCT02578680|450656346|FG000|Overall Study|Withdrawal by Subject|13|||
125281508|NCT02578680|450656347|FG001|Overall Study|Withdrawal by Subject|9|||
125281509|NCT03116828|450656348|FG000|Overall Study|Adverse Event|1|||
125281510|NCT03116828|450656349|FG001|Overall Study|Adverse Event|10|||
125281511|NCT03116828|450656348|FG000|Overall Study|Withdrawal by Subject|4|||
125281512|NCT03116828|450656349|FG001|Overall Study|Withdrawal by Subject|8|||
125281513|NCT03116828|450656348|FG000|Overall Study|OTHER|3|||
125281514|NCT03116828|450656349|FG001|Overall Study|OTHER|3|||
125281515|NCT00176488|450656351|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
125281516|NCT00664560|450656367|FG000|Overall Study|Adverse Event|19|||
125281517|NCT00664560|450656368|FG001|Overall Study|Adverse Event|16|||
125281518|NCT00664560|450656369|FG002|Overall Study|Adverse Event|7|||
125281519|NCT00664560|450656367|FG000|Overall Study|Withdrawal by Subject|9|||
125281520|NCT00664560|450656368|FG001|Overall Study|Withdrawal by Subject|13|||
125281521|NCT00664560|450656369|FG002|Overall Study|Withdrawal by Subject|7|||
125448449|NCT00783718|451268936|FG002|Induction Phase|Lack of Efficacy|14|||
125281522|NCT00664560|450656367|FG000|Overall Study|Lost to Follow-up|0|||
125281523|NCT00664560|450656368|FG001|Overall Study|Lost to Follow-up|2|||
125281524|NCT00664560|450656369|FG002|Overall Study|Lost to Follow-up|0|||
125281525|NCT00664560|450656367|FG000|Overall Study|Other|11|||
125281526|NCT00664560|450656368|FG001|Overall Study|Other|4|||
125281527|NCT00664560|450656369|FG002|Overall Study|Other|5|||
125281528|NCT03350035|450656370|FG000|Overall Study|Lack of Efficacy|2|||
125281529|NCT03350035|450656371|FG001|Overall Study|Lack of Efficacy|0|||
125281530|NCT03350035|450656372|FG002|Overall Study|Lack of Efficacy|0|||
125281531|NCT03350035|450656370|FG000|Overall Study|Subject discharged to hospice|0|||
125281532|NCT03350035|450656371|FG001|Overall Study|Subject discharged to hospice|0|||
125281533|NCT03350035|450656372|FG002|Overall Study|Subject discharged to hospice|1|||
125281534|NCT03576066|450656373|FG000|Overall Study|Noncompliance with study drug|0|||
125281535|NCT03576066|450656374|FG001|Overall Study|Noncompliance with study drug|1|||
125281536|NCT00006164|450656375|FG000|Overall Study|Withdrew or lost to follow-up|70|||
125281537|NCT00006164|450656376|FG001|Overall Study|Withdrew or lost to follow-up|81|||
125281538|NCT00633074|450656379|FG000|Overall Study|Adverse Event|1|||
125281539|NCT00633074|450656380|FG001|Overall Study|Adverse Event|0|||
125281540|NCT00365105|450656381|FG000|Overall Study|Protocol Violation|5|||
125281541|NCT00365105|450656382|FG001|Overall Study|Protocol Violation|8|||
125281542|NCT06422364|450656383|FG000|Overall Study|Withdrawn due to study closure|0|||
125281543|NCT06422364|450656384|FG001|Overall Study|Withdrawn due to study closure|2|||
125281544|NCT01681069|450656385|FG000|Overall Study|Withdrawal by Subject|4|||
125281545|NCT01681069|450656386|FG001|Overall Study|Withdrawal by Subject|5|||
125281546|NCT01681069|450656385|FG000|Overall Study|Protocol Violation|1|||
125281547|NCT01681069|450656386|FG001|Overall Study|Protocol Violation|1|||
125281548|NCT01681069|450656385|FG000|Overall Study|Adverse Event|0|||
125281549|NCT01681069|450656386|FG001|Overall Study|Adverse Event|1|||
125281550|NCT01463696|450656387|FG000|Overall Study|Adverse Event|0|||
125281551|NCT01463696|450656388|FG001|Overall Study|Adverse Event|1|||
125281552|NCT01463696|450656389|FG002|Overall Study|Adverse Event|0|||
125281553|NCT01463696|450656390|FG003|Overall Study|Adverse Event|2|||
125281554|NCT01463696|450656391|FG004|Overall Study|Adverse Event|0|||
125281555|NCT01463696|450656392|FG005|Overall Study|Adverse Event|1|||
125281556|NCT01463696|450656393|FG006|Overall Study|Adverse Event|3|||
125281557|NCT01463696|450656394|FG007|Overall Study|Adverse Event|2|||
125281558|NCT01463696|450656387|FG000|Overall Study|Lost to Follow-up|0|||
125281559|NCT01463696|450656388|FG001|Overall Study|Lost to Follow-up|0|||
125281560|NCT01463696|450656389|FG002|Overall Study|Lost to Follow-up|1|||
125281561|NCT01463696|450656390|FG003|Overall Study|Lost to Follow-up|0|||
125281562|NCT01463696|450656391|FG004|Overall Study|Lost to Follow-up|0|||
125281563|NCT01463696|450656392|FG005|Overall Study|Lost to Follow-up|0|||
125281564|NCT01463696|450656393|FG006|Overall Study|Lost to Follow-up|0|||
125281565|NCT01463696|450656394|FG007|Overall Study|Lost to Follow-up|0|||
125281566|NCT01463696|450656387|FG000|Overall Study|Progressive Disease|0|||
125281567|NCT01463696|450656388|FG001|Overall Study|Progressive Disease|1|||
125281568|NCT01463696|450656389|FG002|Overall Study|Progressive Disease|0|||
125281569|NCT01463696|450656390|FG003|Overall Study|Progressive Disease|1|||
125281570|NCT01463696|450656391|FG004|Overall Study|Progressive Disease|0|||
125281571|NCT01463696|450656392|FG005|Overall Study|Progressive Disease|1|||
125281572|NCT01463696|450656393|FG006|Overall Study|Progressive Disease|4|||
125281573|NCT01463696|450656394|FG007|Overall Study|Progressive Disease|2|||
125281574|NCT01463696|450656387|FG000|Overall Study|Withdrawal by Subject|0|||
125281575|NCT01463696|450656388|FG001|Overall Study|Withdrawal by Subject|0|||
125281576|NCT01463696|450656389|FG002|Overall Study|Withdrawal by Subject|0|||
125281577|NCT01463696|450656390|FG003|Overall Study|Withdrawal by Subject|1|||
125281578|NCT01463696|450656391|FG004|Overall Study|Withdrawal by Subject|1|||
125281579|NCT01463696|450656392|FG005|Overall Study|Withdrawal by Subject|1|||
125281580|NCT01463696|450656393|FG006|Overall Study|Withdrawal by Subject|2|||
125281581|NCT01463696|450656394|FG007|Overall Study|Withdrawal by Subject|0|||
125281582|NCT01463696|450656387|FG000|Overall Study|Not Treated|0|||
125281583|NCT01463696|450656388|FG001|Overall Study|Not Treated|0|||
125281584|NCT01463696|450656389|FG002|Overall Study|Not Treated|0|||
125281585|NCT01463696|450656390|FG003|Overall Study|Not Treated|0|||
125281586|NCT01463696|450656391|FG004|Overall Study|Not Treated|0|||
125281587|NCT01463696|450656392|FG005|Overall Study|Not Treated|0|||
125281588|NCT01463696|450656393|FG006|Overall Study|Not Treated|1|||
125281589|NCT01463696|450656394|FG007|Overall Study|Not Treated|0|||
125281590|NCT03883165|450656396|FG000|Overall Study|Withdrawal by Subject|4|||
125281591|NCT03883165|450656397|FG001|Overall Study|Withdrawal by Subject|3|||
125281592|NCT00245050|450656401|FG000|Overall Study|Adverse Event|3|||
125281593|NCT00245050|450656402|FG001|Overall Study|Adverse Event|2|||
125281594|NCT01843673|450656403|FG000|Overall Study|Lack of Efficacy|2|||
125281595|NCT01843673|450656403|FG000|Overall Study|Withdrawal by Subject|4|||
125281596|NCT00425698|450656404|FG000|Overall Study|Adverse Event|3|||
125281597|NCT00425698|450656405|FG001|Overall Study|Adverse Event|1|||
125281598|NCT00425698|450656404|FG000|Overall Study|Withdrawal by Subject|0|||
125281599|NCT00425698|450656405|FG001|Overall Study|Withdrawal by Subject|1|||
125281600|NCT03275246|450656412|FG000|Overall Study|Protocol Violation|5|||
125281601|NCT03275246|450656412|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
125281602|NCT03905265|450656415|FG000|Overall Study|Withdrawal by Subject|1|||
125281603|NCT03905265|450656416|FG001|Overall Study|Withdrawal by Subject|1|||
125281604|NCT03905265|450656417|FG002|Overall Study|Withdrawal by Subject|0|||
125281605|NCT03905265|450656418|FG003|Overall Study|Withdrawal by Subject|0|||
125281606|NCT02516098|450656419|FG000|Period 1|Protocol Violation|1|||
125281607|NCT02516098|450656420|FG001|Period 1|Protocol Violation|0|||
125281608|NCT02516098|450656419|FG000|Washout After Period 1|Adverse Event|0|||
125281609|NCT02516098|450656420|FG001|Washout After Period 1|Adverse Event|1|||
125281610|NCT02516098|450656419|FG000|Period 2|Withdrawal by Subject|0|||
125281611|NCT02516098|450656420|FG001|Period 2|Withdrawal by Subject|1|||
125281612|NCT01973387|450656421|FG000|Overall Study|Adverse Event|14|||
125281613|NCT01973387|450656422|FG001|Overall Study|Adverse Event|4|||
125281614|NCT01973387|450656421|FG000|Overall Study|Withdrawal by Subject|7|||
125281615|NCT01973387|450656422|FG001|Overall Study|Withdrawal by Subject|4|||
125281616|NCT01973387|450656421|FG000|Overall Study|Study terminated by sponsor|63|||
125281617|NCT01973387|450656422|FG001|Overall Study|Study terminated by sponsor|0|||
125281618|NCT01973387|450656421|FG000|Overall Study|Progressive disease or relapse|16|||
125281619|NCT01973387|450656422|FG001|Overall Study|Progressive disease or relapse|5|||
125281620|NCT01973387|450656421|FG000|Overall Study|Death|4|||
125281621|NCT01973387|450656422|FG001|Overall Study|Death|3|||
125281622|NCT01973387|450656421|FG000|Overall Study|Randomized, not treated|2|||
125281623|NCT01973387|450656422|FG001|Overall Study|Randomized, not treated|2|||
125281624|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
125281625|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
125281626|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
125281627|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
125281628|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
125281629|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
125281630|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
125281631|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
125281632|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
125281633|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
125281634|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
125281635|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
125281636|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
125281637|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
125281638|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
125281639|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
125281640|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
125281641|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281642|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281643|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281644|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281645|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281646|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281647|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281648|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281649|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281650|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281651|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281652|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281653|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125281654|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
125281655|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
125281656|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
125281657|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
125281658|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
125281659|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
125281660|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
125281661|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
125281662|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
125281663|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
125281664|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
125281665|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
125281666|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
125281667|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
125281668|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
125281669|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
125281670|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
125281671|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
125281672|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
125281673|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
125281674|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
125281675|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
125281676|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
125281677|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
125281678|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
125281679|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
125281680|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
125281681|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
125281682|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
125281683|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
125281684|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
125281685|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
125281686|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
125281687|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
125281688|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281689|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281690|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281691|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281692|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281693|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281694|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281695|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281696|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281697|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281698|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125281699|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
125281700|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
125281701|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
125281702|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
125281703|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281704|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281705|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281706|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281707|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281708|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281709|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281710|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281711|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281712|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281713|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
125281714|NCT03831191|450656425|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281715|NCT03831191|450656426|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281716|NCT03831191|450656427|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281717|NCT03831191|450656428|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
125281718|NCT03831191|450656429|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281719|NCT03831191|450656430|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281720|NCT03831191|450656431|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281721|NCT03831191|450656432|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281722|NCT03831191|450656433|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281723|NCT03831191|450656434|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281724|NCT03831191|450656435|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281725|NCT03831191|450656436|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281726|NCT03831191|450656437|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281727|NCT03831191|450656438|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281728|NCT03831191|450656439|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
125281729|NCT03831191|450656425|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
125281730|NCT03831191|450656426|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
125281731|NCT03831191|450656427|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
125281732|NCT03831191|450656428|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
125281733|NCT03831191|450656429|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
125281734|NCT03831191|450656430|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
125281735|NCT03831191|450656431|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
125281736|NCT03831191|450656432|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
125281737|NCT03831191|450656433|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
125281738|NCT03831191|450656434|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
125281739|NCT03831191|450656435|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
125281740|NCT03831191|450656436|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
125281741|NCT03831191|450656437|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
125448450|NCT00783718|451268937|FG003|Induction Phase|Lack of Efficacy|0|||
125281742|NCT03831191|450656438|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
125281743|NCT03831191|450656439|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
125281744|NCT03831191|450656425|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281745|NCT03831191|450656426|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281746|NCT03831191|450656427|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281747|NCT03831191|450656428|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281748|NCT03831191|450656429|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281749|NCT03831191|450656430|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281750|NCT03831191|450656431|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281751|NCT03831191|450656432|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281752|NCT03831191|450656433|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281753|NCT03831191|450656434|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281754|NCT03831191|450656435|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281755|NCT03831191|450656436|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281756|NCT03831191|450656437|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281757|NCT03831191|450656438|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125281758|NCT03831191|450656439|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
125281759|NCT03831191|450656425|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281760|NCT03831191|450656426|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281761|NCT03831191|450656427|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281762|NCT03831191|450656428|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281763|NCT03831191|450656429|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281764|NCT03831191|450656430|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281765|NCT03831191|450656431|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281766|NCT03831191|450656432|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281767|NCT03831191|450656433|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281768|NCT03831191|450656434|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281769|NCT03831191|450656435|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281770|NCT03831191|450656436|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281771|NCT03831191|450656437|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281772|NCT03831191|450656438|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125281773|NCT03831191|450656439|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
125281774|NCT01562314|450656440|FG000|Overall Study|Adverse Event|10|||
125281775|NCT01562314|450656441|FG001|Overall Study|Adverse Event|5|||
125281776|NCT01562314|450656440|FG000|Overall Study|Met Withdrawal Criteria|3|||
125281777|NCT01562314|450656441|FG001|Overall Study|Met Withdrawal Criteria|2|||
125281778|NCT01562314|450656440|FG000|Overall Study|Withdrawal by Subject|0|||
125281779|NCT01562314|450656441|FG001|Overall Study|Withdrawal by Subject|1|||
125281780|NCT03655054|450656442|FG000|Overall Study|Lost to Follow-up|1|||
125281781|NCT02256384|450656453|FG000|Overall Study|Withdrawal by Subject|12|||
125281782|NCT02256384|450656453|FG000|Overall Study|Equipment not capturing data|2|||
125281783|NCT00244933|450656457|FG000|Overall Study|Not response evaluable|2|||
125281784|NCT00349921|450656458|FG000|First Spinal Injection|Physician Decision|1|||
125281785|NCT00349921|450656459|FG001|First Spinal Injection|Physician Decision|0|||
125281786|NCT00349921|450656460|FG002|First Spinal Injection|Physician Decision|0|||
125281787|NCT00349921|450656461|FG003|First Spinal Injection|Physician Decision|0|||
125281788|NCT00349921|450656458|FG000|First Spinal Injection|Adverse Event|0|||
125281789|NCT00349921|450656459|FG001|First Spinal Injection|Adverse Event|0|||
125281790|NCT00349921|450656460|FG002|First Spinal Injection|Adverse Event|1|||
125281791|NCT00349921|450656461|FG003|First Spinal Injection|Adverse Event|0|||
125281792|NCT00920387|450656462|FG000|Stage 1|Adverse Event|1|||
125281793|NCT00920387|450656463|FG001|Stage 1|Adverse Event|0|||
125281794|NCT00920387|450656464|FG002|Stage 1|Adverse Event|0|||
125281795|NCT00157196|450656465|FG000|Overall Study|Ongoing at data cut-off|9|||
125281796|NCT02524275|450656466|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
125281797|NCT00778258|450656467|FG000|Overall Study|Adverse Event|1|||
125281798|NCT00778258|450656468|FG001|Overall Study|Adverse Event|0|||
125281799|NCT00778258|450656469|FG002|Overall Study|Adverse Event|0|||
125281800|NCT00778258|450656470|FG003|Overall Study|Adverse Event|0|||
125281801|NCT00778258|450656471|FG004|Overall Study|Adverse Event|0|||
125281802|NCT00778258|450656472|FG005|Overall Study|Adverse Event|1|||
125281803|NCT00778258|450656473|FG006|Overall Study|Adverse Event|0|||
125281804|NCT00778258|450656474|FG007|Overall Study|Adverse Event|0|||
125281805|NCT00778258|450656475|FG008|Overall Study|Adverse Event|0|||
125281806|NCT00778258|450656467|FG000|Overall Study|Lost to Follow-up|0|||
125281807|NCT00778258|450656468|FG001|Overall Study|Lost to Follow-up|0|||
125281808|NCT00778258|450656469|FG002|Overall Study|Lost to Follow-up|2|||
125281809|NCT00778258|450656470|FG003|Overall Study|Lost to Follow-up|0|||
125281810|NCT00778258|450656471|FG004|Overall Study|Lost to Follow-up|0|||
125281811|NCT00778258|450656472|FG005|Overall Study|Lost to Follow-up|3|||
125281812|NCT00778258|450656473|FG006|Overall Study|Lost to Follow-up|2|||
125281813|NCT00778258|450656474|FG007|Overall Study|Lost to Follow-up|2|||
125281814|NCT00778258|450656475|FG008|Overall Study|Lost to Follow-up|0|||
125281815|NCT00778258|450656467|FG000|Overall Study|Withdrawal by Subject|6|||
125281816|NCT00778258|450656468|FG001|Overall Study|Withdrawal by Subject|2|||
125281817|NCT00778258|450656469|FG002|Overall Study|Withdrawal by Subject|8|||
125281818|NCT00778258|450656470|FG003|Overall Study|Withdrawal by Subject|2|||
125281819|NCT00778258|450656471|FG004|Overall Study|Withdrawal by Subject|0|||
125281820|NCT00778258|450656472|FG005|Overall Study|Withdrawal by Subject|6|||
125281821|NCT00778258|450656473|FG006|Overall Study|Withdrawal by Subject|12|||
125281822|NCT00778258|450656474|FG007|Overall Study|Withdrawal by Subject|12|||
125281823|NCT00778258|450656475|FG008|Overall Study|Withdrawal by Subject|4|||
125281824|NCT00778258|450656467|FG000|Overall Study|New Contraindication|0|||
125281825|NCT00778258|450656468|FG001|Overall Study|New Contraindication|0|||
125281826|NCT00778258|450656469|FG002|Overall Study|New Contraindication|0|||
125281827|NCT00778258|450656470|FG003|Overall Study|New Contraindication|0|||
125281828|NCT00778258|450656471|FG004|Overall Study|New Contraindication|0|||
125281829|NCT00778258|450656472|FG005|Overall Study|New Contraindication|0|||
125281830|NCT00778258|450656473|FG006|Overall Study|New Contraindication|0|||
125281831|NCT00778258|450656474|FG007|Overall Study|New Contraindication|1|||
125281832|NCT00778258|450656475|FG008|Overall Study|New Contraindication|0|||
125281833|NCT00778258|450656467|FG000|Overall Study|Non-compliance|0|||
125281834|NCT00778258|450656468|FG001|Overall Study|Non-compliance|0|||
125281835|NCT00778258|450656469|FG002|Overall Study|Non-compliance|0|||
125281836|NCT00778258|450656470|FG003|Overall Study|Non-compliance|1|||
125281837|NCT00778258|450656471|FG004|Overall Study|Non-compliance|0|||
125281838|NCT00778258|450656472|FG005|Overall Study|Non-compliance|0|||
125281839|NCT00778258|450656473|FG006|Overall Study|Non-compliance|0|||
125281840|NCT00778258|450656474|FG007|Overall Study|Non-compliance|0|||
125281841|NCT00778258|450656475|FG008|Overall Study|Non-compliance|0|||
125281842|NCT00778258|450656467|FG000|Overall Study|Other|0|||
125281843|NCT00778258|450656468|FG001|Overall Study|Other|0|||
125281844|NCT00778258|450656469|FG002|Overall Study|Other|0|||
125281845|NCT00778258|450656470|FG003|Overall Study|Other|0|||
125281846|NCT00778258|450656471|FG004|Overall Study|Other|0|||
125281847|NCT00778258|450656472|FG005|Overall Study|Other|0|||
125281848|NCT00778258|450656473|FG006|Overall Study|Other|1|||
125281849|NCT00778258|450656474|FG007|Overall Study|Other|0|||
125281850|NCT00778258|450656475|FG008|Overall Study|Other|0|||
125281851|NCT00780143|450656484|FG000|Overall Study|Progressive disease|1|||
125281852|NCT00780143|450656484|FG000|Overall Study|Toxicity|1|||
125281853|NCT00780143|450656484|FG000|Overall Study|Adverse Event|1|||
125281854|NCT00082368|450656487|FG000|Overall Study|Not treated-pt had poor IV access|1|||
125281855|NCT00322452|450656488|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125281856|NCT00322452|450656489|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125281857|NCT00322452|450656488|FG000|Overall Study|Lost to Follow-up|5|||
125281858|NCT00322452|450656489|FG001|Overall Study|Lost to Follow-up|2|||
125281859|NCT00322452|450656488|FG000|Overall Study|Withdrawal by Subject|19|||
125281860|NCT00322452|450656489|FG001|Overall Study|Withdrawal by Subject|46|||
125281861|NCT00322452|450656488|FG000|Overall Study|Death|223|||
125281862|NCT00322452|450656489|FG001|Overall Study|Death|227|||
125281863|NCT00882583|450658336|FG000|Overall Study|Physician Decision|1|||
125281864|NCT00882583|450658337|FG001|Overall Study|Physician Decision|0|||
125281865|NCT00882583|450658336|FG000|Overall Study|Adverse Event|0|||
125281866|NCT00882583|450658337|FG001|Overall Study|Adverse Event|1|||
125281867|NCT04753658|450658338|FG000|Overall Study|Progressive disease|7|||
125281868|NCT04753658|450658338|FG000|Overall Study|Other|7|||
125281869|NCT04753658|450658338|FG000|Overall Study|Adverse Event|1|||
125281870|NCT00218634|450658339|FG000|Overall Study|Lost to Follow-up|8|||
125281871|NCT00218634|450658340|FG001|Overall Study|Lost to Follow-up|15|||
125281872|NCT05243745|450658341|FG000|Overall Study|Withdrawal by Subject|0|||
125281873|NCT05243745|450658342|FG001|Overall Study|Withdrawal by Subject|0|||
125281874|NCT05243745|450658343|FG002|Overall Study|Withdrawal by Subject|0|||
125281875|NCT05243745|450658344|FG003|Overall Study|Withdrawal by Subject|1|||
125281876|NCT05243745|450658341|FG000|Overall Study|Unable to Attend Visit 6|0|||
125281877|NCT05243745|450658342|FG001|Overall Study|Unable to Attend Visit 6|0|||
125281878|NCT05243745|450658343|FG002|Overall Study|Unable to Attend Visit 6|1|||
125281879|NCT05243745|450658344|FG003|Overall Study|Unable to Attend Visit 6|0|||
125281880|NCT03842969|450658355|FG000|Overall Study|Participant declined follow-up visit|0|||
125281881|NCT03842969|450658356|FG001|Overall Study|Participant declined follow-up visit|1|||
125281882|NCT03842969|450658357|FG002|Overall Study|Participant declined follow-up visit|0|||
125281883|NCT03842969|450658355|FG000|Overall Study|Sponsor's decision|12|||
125281884|NCT03842969|450658356|FG001|Overall Study|Sponsor's decision|99|||
125281885|NCT03842969|450658357|FG002|Overall Study|Sponsor's decision|61|||
125281886|NCT03842969|450658355|FG000|Overall Study|Pregnancy|0|||
125281887|NCT03842969|450658356|FG001|Overall Study|Pregnancy|0|||
125281888|NCT03842969|450658357|FG002|Overall Study|Pregnancy|1|||
125281889|NCT03842969|450658355|FG000|Overall Study|Death|1|||
125281890|NCT03842969|450658356|FG001|Overall Study|Death|0|||
125281891|NCT03842969|450658357|FG002|Overall Study|Death|1|||
125281892|NCT03842969|450658355|FG000|Overall Study|Withdrawal by Subject|3|||
125281893|NCT03842969|450658356|FG001|Overall Study|Withdrawal by Subject|30|||
125281894|NCT03842969|450658357|FG002|Overall Study|Withdrawal by Subject|18|||
125281895|NCT03842969|450658355|FG000|Overall Study|Protocol Violation|1|||
125281896|NCT03842969|450658356|FG001|Overall Study|Protocol Violation|1|||
125281897|NCT03842969|450658357|FG002|Overall Study|Protocol Violation|0|||
125281898|NCT03842969|450658355|FG000|Overall Study|Physician Decision|0|||
125281899|NCT03842969|450658356|FG001|Overall Study|Physician Decision|3|||
125281900|NCT03842969|450658357|FG002|Overall Study|Physician Decision|0|||
125281901|NCT03842969|450658355|FG000|Overall Study|Lost to Follow-up|0|||
125281902|NCT03842969|450658356|FG001|Overall Study|Lost to Follow-up|2|||
125281903|NCT03842969|450658357|FG002|Overall Study|Lost to Follow-up|0|||
125281904|NCT03842969|450658355|FG000|Overall Study|Adverse Event|0|||
125281905|NCT03842969|450658356|FG001|Overall Study|Adverse Event|2|||
125281906|NCT03842969|450658357|FG002|Overall Study|Adverse Event|0|||
125281907|NCT01044745|450658358|FG000|Overall Study|Ineiligible|2|||
125281908|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Adverse Event|76|||
125281909|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Adverse Event|0|||
125281910|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Adverse Event|0|||
125281911|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Death|3|||
125281912|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Death|0|||
125281913|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Death|0|||
125281914|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
125281915|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
125281916|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
125281917|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Physician Decision|9|||
125281918|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Physician Decision|0|||
125281919|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Physician Decision|0|||
125281920|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
125281921|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
125281922|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
125281923|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Disease progression|45|||
125281924|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Disease progression|0|||
125281925|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Disease progression|0|||
125281926|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
125281927|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
125281928|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
125281929|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
125281930|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
125281931|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
125281932|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
125281933|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
125281934|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
125281935|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
125281936|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
125281937|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
125281938|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
125281939|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
125281940|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
125281941|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
125281942|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
125281943|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
125281944|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
125281945|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
125281946|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
125281947|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
125281948|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
125281949|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
125281950|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
125281951|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
125281952|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
125281953|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Promotor request|1|||
125281954|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Promotor request|0|||
125281955|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Promotor request|0|||
125281956|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
125281957|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
125281958|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
125281959|NCT01461928|450658360|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
125281960|NCT01461928|450658361|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
125281961|NCT01461928|450658362|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
125281962|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Death|3|||
125448451|NCT00783718|451268938|FG004|Induction Phase|Lack of Efficacy|0|||
125448452|NCT00783718|451268939|FG005|Induction Phase|Lack of Efficacy|0|||
125448453|NCT00783718|451268940|FG006|Induction Phase|Lack of Efficacy|0|||
125448454|NCT00783718|451268934|FG000|Induction Phase|Withdrawal by Subject|3|||
125448455|NCT00783718|451268935|FG001|Induction Phase|Withdrawal by Subject|4|||
125448456|NCT00783718|451268936|FG002|Induction Phase|Withdrawal by Subject|8|||
125448457|NCT00783718|451268937|FG003|Induction Phase|Withdrawal by Subject|0|||
125448458|NCT00783718|451268938|FG004|Induction Phase|Withdrawal by Subject|0|||
125448459|NCT00783718|451268939|FG005|Induction Phase|Withdrawal by Subject|0|||
125448460|NCT00783718|451268940|FG006|Induction Phase|Withdrawal by Subject|0|||
125448461|NCT00783718|451268934|FG000|Induction Phase|Lost to Follow-up|1|||
125448462|NCT00783718|451268935|FG001|Induction Phase|Lost to Follow-up|0|||
125281963|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Death|0|||
125281964|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Death|0|||
125281965|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
125281966|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
125281967|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
125281968|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
125448463|NCT00783718|451268936|FG002|Induction Phase|Lost to Follow-up|1|||
125448464|NCT00783718|451268937|FG003|Induction Phase|Lost to Follow-up|0|||
125448465|NCT00783718|451268938|FG004|Induction Phase|Lost to Follow-up|0|||
125448466|NCT00783718|451268939|FG005|Induction Phase|Lost to Follow-up|0|||
125448467|NCT00783718|451268940|FG006|Induction Phase|Lost to Follow-up|0|||
125448468|NCT00783718|451268934|FG000|Maintenance Phase|Adverse Event|12|||
125281969|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
125281970|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
125281971|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Diseases progression|91|||
125281972|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Diseases progression|0|||
125281973|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Diseases progression|0|||
125281974|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Adverse Event|70|||
125281975|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Adverse Event|0|||
125281976|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Adverse Event|0|||
125281977|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Physician Decision|9|||
125281978|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Physician Decision|0|||
125281979|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Physician Decision|0|||
125281980|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
125281981|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
125281982|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
125281983|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
125281984|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
125281985|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
125411820|NCT02265705|451134843|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
125411821|NCT02265705|451134844|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
125411822|NCT02265705|451134845|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
125411823|NCT02265705|451134846|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
125411824|NCT02265705|451134840|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
125411825|NCT02265705|451134841|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
125411826|NCT02265705|451134842|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
125411827|NCT02265705|451134843|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
125411828|NCT02265705|451134844|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
125411829|NCT02265705|451134845|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
125411830|NCT02265705|451134846|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
125411831|NCT02265705|451134840|FG000|Rescue Period|Withdrawal by Subject|0|||
125411832|NCT02265705|451134841|FG001|Rescue Period|Withdrawal by Subject|0|||
125411833|NCT02265705|451134842|FG002|Rescue Period|Withdrawal by Subject|1|||
125411834|NCT02265705|451134843|FG003|Rescue Period|Withdrawal by Subject|0|||
125411835|NCT02265705|451134844|FG004|Rescue Period|Withdrawal by Subject|0|||
125411836|NCT02265705|451134845|FG005|Rescue Period|Withdrawal by Subject|0|||
125411837|NCT02265705|451134846|FG006|Rescue Period|Withdrawal by Subject|0|||
125411838|NCT02265705|451134840|FG000|Rescue Period|Death|0|||
125411839|NCT02265705|451134841|FG001|Rescue Period|Death|0|||
125411840|NCT02265705|451134842|FG002|Rescue Period|Death|1|||
125411841|NCT02265705|451134843|FG003|Rescue Period|Death|0|||
125411842|NCT02265705|451134844|FG004|Rescue Period|Death|0|||
125281986|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
125411843|NCT02265705|451134845|FG005|Rescue Period|Death|0|||
125411844|NCT02265705|451134846|FG006|Rescue Period|Death|0|||
125411845|NCT02265705|451134840|FG000|Rescue Period|Lack of Efficacy|0|||
125411846|NCT02265705|451134841|FG001|Rescue Period|Lack of Efficacy|0|||
125411847|NCT02265705|451134842|FG002|Rescue Period|Lack of Efficacy|1|||
125411848|NCT02265705|451134843|FG003|Rescue Period|Lack of Efficacy|0|||
125411849|NCT02265705|451134844|FG004|Rescue Period|Lack of Efficacy|0|||
125411850|NCT02265705|451134845|FG005|Rescue Period|Lack of Efficacy|0|||
125411851|NCT02265705|451134846|FG006|Rescue Period|Lack of Efficacy|0|||
125281987|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
125281988|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
125281989|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Not compliant|1|||
125281990|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Not compliant|0|||
125281991|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Not compliant|0|||
125281992|NCT01461928|450658360|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
125281993|NCT01461928|450658361|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
125281994|NCT01461928|450658362|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
125281995|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Adverse Event|0|||
125281996|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Adverse Event|2|||
125281997|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Adverse Event|0|||
125281998|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Death|0|||
125281999|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Death|10|||
125282000|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Death|8|||
125282001|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Physician Decision|0|||
125282002|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Physician Decision|0|||
125282003|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Physician Decision|4|||
125282004|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
125282005|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
125282006|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
125282007|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Moved to another town|0|||
125282008|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Moved to another town|1|||
125282009|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Moved to another town|0|||
125282010|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Disease progression|0|||
125282011|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Disease progression|0|||
125282012|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Disease progression|3|||
125282013|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
125282014|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
125282015|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
125282016|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
125282017|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
125282018|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
125282019|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
125282020|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
125282021|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
125282022|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
125282023|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
125282024|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
125282025|NCT01461928|450658360|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
125282026|NCT01461928|450658361|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
125282027|NCT01461928|450658362|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
125282028|NCT01159171|450658365|FG000|Overall Study|Adverse Event|11|||
125282029|NCT01159171|450658365|FG000|Overall Study|Progression of Disease|28|||
125282030|NCT01159171|450658365|FG000|Overall Study|Protocol Violation|1|||
125282031|NCT01159171|450658365|FG000|Overall Study|Need for Surgery|5|||
125282032|NCT01159171|450658365|FG000|Overall Study|Medical Decision|4|||
125282033|NCT01159171|450658365|FG000|Overall Study|Death|1|||
125282034|NCT01892436|450658366|FG000|Overall Study|Withdrawal by Subject|8|||
125282035|NCT01892436|450658367|FG001|Overall Study|Withdrawal by Subject|15|||
125282036|NCT01892436|450658368|FG002|Overall Study|Withdrawal by Subject|4|||
125282037|NCT01892436|450658369|FG003|Overall Study|Withdrawal by Subject|4|||
125282038|NCT01892436|450658366|FG000|Overall Study|Death|1|||
125282039|NCT01892436|450658367|FG001|Overall Study|Death|1|||
125282040|NCT01892436|450658368|FG002|Overall Study|Death|0|||
125282041|NCT01892436|450658369|FG003|Overall Study|Death|0|||
125282042|NCT01892436|450658366|FG000|Overall Study|Physician Decision|2|||
125282043|NCT01892436|450658367|FG001|Overall Study|Physician Decision|1|||
125282044|NCT01892436|450658368|FG002|Overall Study|Physician Decision|0|||
125282045|NCT01892436|450658369|FG003|Overall Study|Physician Decision|1|||
125282046|NCT01892436|450658366|FG000|Overall Study|Pregnancy|0|||
125282047|NCT01892436|450658367|FG001|Overall Study|Pregnancy|2|||
125282048|NCT01892436|450658368|FG002|Overall Study|Pregnancy|1|||
125282049|NCT01892436|450658369|FG003|Overall Study|Pregnancy|0|||
125282050|NCT01892436|450658366|FG000|Overall Study|Technical problems|2|||
125282051|NCT01892436|450658367|FG001|Overall Study|Technical problems|1|||
125282052|NCT01892436|450658368|FG002|Overall Study|Technical problems|1|||
125282053|NCT01892436|450658369|FG003|Overall Study|Technical problems|1|||
125282054|NCT01892436|450658366|FG000|Overall Study|Lack of Efficacy|1|||
125282055|NCT01892436|450658367|FG001|Overall Study|Lack of Efficacy|2|||
125282056|NCT01892436|450658368|FG002|Overall Study|Lack of Efficacy|2|||
125282057|NCT01892436|450658369|FG003|Overall Study|Lack of Efficacy|2|||
125282058|NCT01892436|450658366|FG000|Overall Study|Lost to Follow-up|1|||
125282059|NCT01892436|450658367|FG001|Overall Study|Lost to Follow-up|1|||
125282060|NCT01892436|450658368|FG002|Overall Study|Lost to Follow-up|1|||
125282061|NCT01892436|450658369|FG003|Overall Study|Lost to Follow-up|3|||
125282062|NCT01892436|450658366|FG000|Overall Study|non-compliance with treatment|1|||
125282063|NCT01892436|450658367|FG001|Overall Study|non-compliance with treatment|0|||
125282064|NCT01892436|450658368|FG002|Overall Study|non-compliance with treatment|0|||
125282065|NCT01892436|450658369|FG003|Overall Study|non-compliance with treatment|0|||
125282066|NCT01892436|450658366|FG000|Overall Study|Adverse Event|7|||
125282067|NCT01892436|450658367|FG001|Overall Study|Adverse Event|6|||
125282068|NCT01892436|450658368|FG002|Overall Study|Adverse Event|2|||
125282069|NCT01892436|450658369|FG003|Overall Study|Adverse Event|3|||
125282070|NCT00733291|450658371|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
125282071|NCT00733291|450658372|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
125282072|NCT00733291|450658373|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
125282073|NCT00733291|450658374|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
125282074|NCT02242435|450658385|FG000|Overall Study|Lost to Follow-up|3|||
125282075|NCT02242435|450658386|FG001|Overall Study|Lost to Follow-up|4|||
125282076|NCT02242435|450658385|FG000|Overall Study|Adverse Event|3|||
125282077|NCT02242435|450658386|FG001|Overall Study|Adverse Event|2|||
125282078|NCT02242435|450658385|FG000|Overall Study|Withdrawal by Subject|13|||
125282079|NCT02242435|450658386|FG001|Overall Study|Withdrawal by Subject|8|||
125282080|NCT02242435|450658385|FG000|Overall Study|Death|0|||
125282081|NCT02242435|450658386|FG001|Overall Study|Death|1|||
125282082|NCT02242435|450658385|FG000|Overall Study|Protocol Violation|1|||
125282083|NCT02242435|450658386|FG001|Overall Study|Protocol Violation|0|||
125282084|NCT02242435|450658385|FG000|Overall Study|Physician Decision|0|||
125282085|NCT02242435|450658386|FG001|Overall Study|Physician Decision|1|||
125282086|NCT03895086|450658388|FG000|Overall Study|Early termination study|1|||
125282087|NCT03895086|450658389|FG001|Overall Study|Early termination study|0|||
125282088|NCT01089413|450658393|FG000|Overall Study|Lost to Follow-up|1|||
125282089|NCT01089413|450658393|FG000|Overall Study|Progressive Disease|93|||
125282090|NCT01089413|450658393|FG000|Overall Study|Participant Withdrew Consent|1|||
125282091|NCT01089413|450658393|FG000|Overall Study|Unacceptable Toxicity|12|||
125282092|NCT01089413|450658393|FG000|Overall Study|Death|10|||
125282093|NCT01089413|450658393|FG000|Overall Study|Metastasectomy|13|||
125282094|NCT01089413|450658393|FG000|Overall Study|Other|71|||
125282095|NCT00420004|450658403|FG000|Overall Study|Adverse Event|4|||
125282096|NCT00420004|450658404|FG001|Overall Study|Adverse Event|1|||
125282097|NCT00420004|450658405|FG002|Overall Study|Adverse Event|1|||
125282098|NCT00420004|450658403|FG000|Overall Study|Lack of Efficacy|5|||
125282099|NCT00420004|450658404|FG001|Overall Study|Lack of Efficacy|4|||
125282100|NCT00420004|450658405|FG002|Overall Study|Lack of Efficacy|1|||
125282101|NCT00420004|450658403|FG000|Overall Study|Lost to Follow-up|31|||
125282102|NCT00420004|450658404|FG001|Overall Study|Lost to Follow-up|12|||
125282103|NCT00420004|450658405|FG002|Overall Study|Lost to Follow-up|10|||
125282104|NCT00420004|450658403|FG000|Overall Study|Entry Criteria Not Met|0|||
125282105|NCT00420004|450658404|FG001|Overall Study|Entry Criteria Not Met|1|||
125282106|NCT00420004|450658405|FG002|Overall Study|Entry Criteria Not Met|0|||
125282107|NCT00420004|450658403|FG000|Overall Study|Physician Decision|14|||
125282108|NCT00420004|450658404|FG001|Overall Study|Physician Decision|4|||
125282109|NCT00420004|450658405|FG002|Overall Study|Physician Decision|2|||
125282110|NCT00420004|450658403|FG000|Overall Study|Protocol Violation|5|||
125282111|NCT00420004|450658404|FG001|Overall Study|Protocol Violation|4|||
125282112|NCT00420004|450658405|FG002|Overall Study|Protocol Violation|3|||
125282113|NCT00420004|450658403|FG000|Overall Study|Withdrawal by Subject|67|||
125282114|NCT00420004|450658404|FG001|Overall Study|Withdrawal by Subject|42|||
125282115|NCT00420004|450658405|FG002|Overall Study|Withdrawal by Subject|14|||
125282116|NCT00420004|450658403|FG000|Overall Study|Sponsor Decision|3|||
125282117|NCT00420004|450658404|FG001|Overall Study|Sponsor Decision|3|||
125282118|NCT00420004|450658405|FG002|Overall Study|Sponsor Decision|1|||
125282119|NCT00591149|450658407|FG000|Overall Study|Adverse Event|4|||
125282120|NCT00591149|450658407|FG000|Overall Study|Withdrawal by Subject|1|||
125282121|NCT00470093|450658408|FG000|Overall Study|Adverse Event|2|||
125448469|NCT00783718|451268935|FG001|Maintenance Phase|Adverse Event|0|||
125282122|NCT02456636|450658409|FG000|Overall Study|Death|0|||
125282123|NCT02456636|450658410|FG001|Overall Study|Death|3|||
125282124|NCT02456636|450658411|FG002|Overall Study|Death|0|||
125282125|NCT02456636|450658409|FG000|Overall Study|Pregnancy|1|||
125282126|NCT02456636|450658410|FG001|Overall Study|Pregnancy|3|||
125282127|NCT02456636|450658411|FG002|Overall Study|Pregnancy|5|||
125282128|NCT02456636|450658409|FG000|Overall Study|Physician Decision|4|||
125448470|NCT00783718|451268936|FG002|Maintenance Phase|Adverse Event|0|||
125448471|NCT00783718|451268937|FG003|Maintenance Phase|Adverse Event|15|||
125282129|NCT02456636|450658410|FG001|Overall Study|Physician Decision|5|||
125282130|NCT02456636|450658411|FG002|Overall Study|Physician Decision|4|||
125282131|NCT02456636|450658409|FG000|Overall Study|Withdrawal by Subject|13|||
125282132|NCT02456636|450658410|FG001|Overall Study|Withdrawal by Subject|14|||
125282133|NCT02456636|450658411|FG002|Overall Study|Withdrawal by Subject|16|||
125282134|NCT02456636|450658409|FG000|Overall Study|Lost to Follow-up|50|||
125282135|NCT02456636|450658410|FG001|Overall Study|Lost to Follow-up|44|||
125448472|NCT00783718|451268938|FG004|Maintenance Phase|Adverse Event|7|||
125448473|NCT00783718|451268939|FG005|Maintenance Phase|Adverse Event|6|||
125448474|NCT00783718|451268940|FG006|Maintenance Phase|Adverse Event|16|||
125282136|NCT02456636|450658411|FG002|Overall Study|Lost to Follow-up|50|||
125282137|NCT02379221|450658412|FG000|Overall Study|Lost to Follow-up|1|||
125282138|NCT01610557|450658413|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
125282139|NCT01610557|450658414|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
125282140|NCT01610557|450658415|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
125282141|NCT01610557|450658416|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
125282142|NCT01610557|450658417|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
125282143|NCT01610557|450658413|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
125448475|NCT00783718|451268934|FG000|Maintenance Phase|Protocol Violation|1|||
125448476|NCT00783718|451268935|FG001|Maintenance Phase|Protocol Violation|0|||
125448477|NCT00783718|451268936|FG002|Maintenance Phase|Protocol Violation|0|||
125448478|NCT00783718|451268937|FG003|Maintenance Phase|Protocol Violation|0|||
125448479|NCT00783718|451268938|FG004|Maintenance Phase|Protocol Violation|0|||
125448480|NCT00783718|451268939|FG005|Maintenance Phase|Protocol Violation|0|||
125448481|NCT00783718|451268940|FG006|Maintenance Phase|Protocol Violation|2|||
125448482|NCT00783718|451268934|FG000|Maintenance Phase|Lack of Efficacy|83|||
125448483|NCT00783718|451268935|FG001|Maintenance Phase|Lack of Efficacy|0|||
125448484|NCT00783718|451268936|FG002|Maintenance Phase|Lack of Efficacy|0|||
125282144|NCT01610557|450658414|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
125282145|NCT01610557|450658415|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
125282146|NCT01610557|450658416|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
125282147|NCT01610557|450658417|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
125282148|NCT00519376|450658420|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282149|NCT00519376|450658421|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282150|NCT00519376|450658422|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282151|NCT00519376|450658423|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282152|NCT00519376|450658424|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282153|NCT00519376|450658425|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282154|NCT00519376|450658426|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282155|NCT00519376|450658427|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282156|NCT00519376|450658428|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125448485|NCT00783718|451268937|FG003|Maintenance Phase|Lack of Efficacy|61|||
125448486|NCT00783718|451268938|FG004|Maintenance Phase|Lack of Efficacy|31|||
125448487|NCT00783718|451268939|FG005|Maintenance Phase|Lack of Efficacy|33|||
125448488|NCT00783718|451268940|FG006|Maintenance Phase|Lack of Efficacy|155|||
125448489|NCT00783718|451268934|FG000|Maintenance Phase|Withdrawal by Subject|6|||
125448490|NCT00783718|451268935|FG001|Maintenance Phase|Withdrawal by Subject|0|||
125448491|NCT00783718|451268936|FG002|Maintenance Phase|Withdrawal by Subject|0|||
125448492|NCT00783718|451268937|FG003|Maintenance Phase|Withdrawal by Subject|2|||
125448493|NCT00783718|451268938|FG004|Maintenance Phase|Withdrawal by Subject|5|||
125282157|NCT00519376|450658429|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282158|NCT00519376|450658430|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282159|NCT00519376|450658431|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125448494|NCT00783718|451268939|FG005|Maintenance Phase|Withdrawal by Subject|2|||
125448495|NCT00783718|451268940|FG006|Maintenance Phase|Withdrawal by Subject|20|||
125448496|NCT00783718|451268934|FG000|Maintenance Phase|Lost to Follow-up|3|||
125448497|NCT00783718|451268935|FG001|Maintenance Phase|Lost to Follow-up|0|||
125448498|NCT00783718|451268936|FG002|Maintenance Phase|Lost to Follow-up|0|||
125448499|NCT00783718|451268937|FG003|Maintenance Phase|Lost to Follow-up|0|||
125448500|NCT00783718|451268938|FG004|Maintenance Phase|Lost to Follow-up|2|||
125448501|NCT00783718|451268939|FG005|Maintenance Phase|Lost to Follow-up|0|||
125448502|NCT00783718|451268940|FG006|Maintenance Phase|Lost to Follow-up|2|||
125448503|NCT04159896|451268944|FG000|Overall Study|Lack of Efficacy|7|||
125448504|NCT04159896|451268944|FG000|Overall Study|Withdrawal by Subject|1|||
125448505|NCT04159896|451268944|FG000|Overall Study|Adverse Event|1|||
125448506|NCT04159896|451268944|FG000|Overall Study|A transient ischaemic attack|1|||
125448507|NCT02338609|451268945|FG000|Overall Study|Physician Decision|1|||
125448508|NCT02338609|451268945|FG000|Overall Study|Death|1|||
125448509|NCT02223182|451268946|FG000|Double-Blind Period|Adverse Event|0|||
125448510|NCT02223182|451268947|FG001|Double-Blind Period|Adverse Event|2|||
125448511|NCT02223182|451268948|FG002|Double-Blind Period|Adverse Event|1|||
125448512|NCT02223182|451268949|FG003|Double-Blind Period|Adverse Event|0|||
125448513|NCT02223182|451268946|FG000|Double-Blind Period|Withdrawal by Subject|1|||
125448514|NCT02223182|451268947|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125448515|NCT02223182|451268948|FG002|Double-Blind Period|Withdrawal by Subject|1|||
125448516|NCT02223182|451268949|FG003|Double-Blind Period|Withdrawal by Subject|0|||
125448517|NCT02223182|451268946|FG000|Double-Blind Period|Lost to Follow-up|0|||
125448518|NCT02223182|451268947|FG001|Double-Blind Period|Lost to Follow-up|1|||
125448519|NCT02223182|451268948|FG002|Double-Blind Period|Lost to Follow-up|0|||
125448520|NCT02223182|451268949|FG003|Double-Blind Period|Lost to Follow-up|0|||
125448521|NCT02223182|451268946|FG000|Double-Blind Period|Non Compliance|0|||
125448522|NCT02223182|451268947|FG001|Double-Blind Period|Non Compliance|0|||
125448523|NCT02223182|451268948|FG002|Double-Blind Period|Non Compliance|0|||
125282160|NCT00519376|450658432|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
125282161|NCT00519376|450658433|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282162|NCT00519376|450658434|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282163|NCT00519376|450658435|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
125282164|NCT00519376|450658420|FG000|Treatment Period 4|Lost to Follow-up|0|||
125282165|NCT00519376|450658421|FG001|Treatment Period 4|Lost to Follow-up|0|||
125282166|NCT00519376|450658422|FG002|Treatment Period 4|Lost to Follow-up|1|||
125282167|NCT00519376|450658423|FG003|Treatment Period 4|Lost to Follow-up|0|||
125282168|NCT00519376|450658424|FG004|Treatment Period 4|Lost to Follow-up|0|||
125282169|NCT00519376|450658425|FG005|Treatment Period 4|Lost to Follow-up|0|||
125282170|NCT00519376|450658426|FG006|Treatment Period 4|Lost to Follow-up|0|||
125282171|NCT00519376|450658427|FG007|Treatment Period 4|Lost to Follow-up|0|||
125282172|NCT00519376|450658428|FG008|Treatment Period 4|Lost to Follow-up|0|||
125282173|NCT00519376|450658429|FG009|Treatment Period 4|Lost to Follow-up|0|||
125282174|NCT00519376|450658430|FG010|Treatment Period 4|Lost to Follow-up|0|||
125282175|NCT00519376|450658431|FG011|Treatment Period 4|Lost to Follow-up|0|||
125282176|NCT00519376|450658432|FG012|Treatment Period 4|Lost to Follow-up|0|||
125282177|NCT00519376|450658433|FG013|Treatment Period 4|Lost to Follow-up|0|||
125282178|NCT00519376|450658434|FG014|Treatment Period 4|Lost to Follow-up|0|||
125282179|NCT00519376|450658435|FG015|Treatment Period 4|Lost to Follow-up|0|||
125282180|NCT02039219|450658436|FG000|Treatment|Withdrawal by Subject|1|||
125282181|NCT02039219|450658437|FG001|Treatment|Withdrawal by Subject|0|||
125282182|NCT02039219|450658436|FG000|Treatment|Adverse Event|0|||
125282183|NCT02039219|450658437|FG001|Treatment|Adverse Event|1|||
125282184|NCT02039219|450658436|FG000|Treatment|Physician Decision|1|||
125282185|NCT02039219|450658437|FG001|Treatment|Physician Decision|0|||
125282186|NCT02039219|450658436|FG000|Treatment|Lost to Follow-up|0|||
125282187|NCT02039219|450658437|FG001|Treatment|Lost to Follow-up|1|||
125282188|NCT02039219|450658436|FG000|Treatment|Protocol Violation|1|||
125282189|NCT02039219|450658437|FG001|Treatment|Protocol Violation|0|||
125282190|NCT02039219|450658436|FG000|Treatment|Death|1|||
125282191|NCT02039219|450658437|FG001|Treatment|Death|0|||
125282192|NCT02039219|450658436|FG000|Follow up|Adverse Event|0|||
125282193|NCT02039219|450658437|FG001|Follow up|Adverse Event|1|||
125282194|NCT02974855|450658438|FG000|Overall Study|Adverse Event|0|||
125282195|NCT02974855|450658439|FG001|Overall Study|Adverse Event|1|||
125282196|NCT02974855|450658440|FG002|Overall Study|Adverse Event|0|||
125282197|NCT02974855|450658441|FG003|Overall Study|Adverse Event|1|||
125282198|NCT00129701|450658442|FG000|Overall Study|Withdrawal by Subject|33|||
125282199|NCT02750345|450658443|FG000|Intervention 1|Adverse Event|0|||
125282200|NCT02750345|450658444|FG001|Intervention 1|Adverse Event|0|||
125282201|NCT02750345|450658445|FG002|Intervention 1|Adverse Event|0|||
125282202|NCT02750345|450658446|FG003|Intervention 1|Adverse Event|0|||
125282203|NCT02750345|450658447|FG004|Intervention 1|Adverse Event|1|||
125282204|NCT02750345|450658448|FG005|Intervention 1|Adverse Event|0|||
125282205|NCT02650128|450658449|FG000|Overall Study|Death|2|||
125282206|NCT00608023|450658452|FG000|Overall Study|Withdrawal by Subject|8|||
125282207|NCT00608023|450658453|FG001|Overall Study|Withdrawal by Subject|10|||
125282208|NCT00608023|450658454|FG002|Overall Study|Withdrawal by Subject|7|||
125282209|NCT00608023|450658452|FG000|Overall Study|Adverse Event|1|||
125282210|NCT00608023|450658453|FG001|Overall Study|Adverse Event|4|||
125282211|NCT00608023|450658454|FG002|Overall Study|Adverse Event|5|||
125282212|NCT00608023|450658452|FG000|Overall Study|Lost to Follow-up|2|||
125282213|NCT00608023|450658453|FG001|Overall Study|Lost to Follow-up|2|||
125282214|NCT00608023|450658454|FG002|Overall Study|Lost to Follow-up|1|||
125282215|NCT00608023|450658452|FG000|Overall Study|Protocol Violation|1|||
125282216|NCT00608023|450658453|FG001|Overall Study|Protocol Violation|3|||
125448524|NCT02223182|451268949|FG003|Double-Blind Period|Non Compliance|1|||
125448525|NCT02223182|451268946|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
125282217|NCT00608023|450658454|FG002|Overall Study|Protocol Violation|1|||
125282218|NCT00608023|450658452|FG000|Overall Study|Unknown reason|0|||
125282219|NCT00608023|450658453|FG001|Overall Study|Unknown reason|3|||
125282220|NCT00608023|450658454|FG002|Overall Study|Unknown reason|0|||
125282221|NCT01801436|450658474|FG000|Overall Study|Withdrawal by Subject|3|||
125282222|NCT01801436|450658474|FG000|Overall Study|Adverse Event|2|||
125282223|NCT01801436|450658474|FG000|Overall Study|Progressive disease|4|||
125282224|NCT01126437|450658479|FG000|Overall Study|Not treated|11|||
125282225|NCT01126437|450658480|FG001|Overall Study|Not treated|18|||
125282226|NCT01126437|450658481|FG002|Overall Study|Not treated|19|||
125282227|NCT01126437|450658479|FG000|Overall Study|Sites with data irregularities/fraud|6|||
125282228|NCT01126437|450658480|FG001|Overall Study|Sites with data irregularities/fraud|6|||
125282229|NCT01126437|450658481|FG002|Overall Study|Sites with data irregularities/fraud|7|||
125282230|NCT01126437|450658479|FG000|Overall Study|Adverse Event|602|||
125282231|NCT01126437|450658480|FG001|Overall Study|Adverse Event|606|||
125282232|NCT01126437|450658481|FG002|Overall Study|Adverse Event|635|||
125282233|NCT01126437|450658479|FG000|Overall Study|Lack of Efficacy|65|||
125282234|NCT01126437|450658480|FG001|Overall Study|Lack of Efficacy|60|||
125282235|NCT01126437|450658481|FG002|Overall Study|Lack of Efficacy|59|||
125282236|NCT01126437|450658479|FG000|Overall Study|Protocol Violation|64|||
125282237|NCT01126437|450658480|FG001|Overall Study|Protocol Violation|66|||
125282238|NCT01126437|450658481|FG002|Overall Study|Protocol Violation|41|||
125282239|NCT01126437|450658479|FG000|Overall Study|Lost to Follow-up|52|||
125282240|NCT01126437|450658480|FG001|Overall Study|Lost to Follow-up|63|||
125282241|NCT01126437|450658481|FG002|Overall Study|Lost to Follow-up|55|||
125282242|NCT01126437|450658479|FG000|Overall Study|Withdrawal by Subject|331|||
125282243|NCT01126437|450658480|FG001|Overall Study|Withdrawal by Subject|335|||
125282244|NCT01126437|450658481|FG002|Overall Study|Withdrawal by Subject|319|||
125282245|NCT01126437|450658479|FG000|Overall Study|Other reason not specified|210|||
125282246|NCT01126437|450658480|FG001|Overall Study|Other reason not specified|176|||
125282247|NCT01126437|450658481|FG002|Overall Study|Other reason not specified|178|||
125282248|NCT01846663|450658488|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
125282249|NCT01846663|450658489|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
125282250|NCT01846663|450658488|FG000|Overall Study|Withdrawal by Subject|1|||
125282251|NCT01846663|450658489|FG001|Overall Study|Withdrawal by Subject|0|||
125282252|NCT01846663|450658488|FG000|Overall Study|Adverse Event|1|||
125282253|NCT01846663|450658489|FG001|Overall Study|Adverse Event|2|||
125282254|NCT00813865|450658495|FG000|Overall Study|Failure to Respond|3|||
125282255|NCT00813865|450658495|FG000|Overall Study|Lost to Follow-up|3|||
125282256|NCT00813865|450658495|FG000|Overall Study|Withdrawal by Subject|1|||
125282257|NCT03525600|450658496|FG000|Overall Study|Adverse Event|9|||
125282258|NCT03525600|450658497|FG001|Overall Study|Adverse Event|6|||
125282259|NCT03525600|450658498|FG002|Overall Study|Adverse Event|5|||
125282260|NCT03525600|450658499|FG003|Overall Study|Adverse Event|3|||
125282261|NCT03525600|450658496|FG000|Overall Study|Lost to Follow-up|2|||
125282262|NCT03525600|450658497|FG001|Overall Study|Lost to Follow-up|4|||
125282263|NCT03525600|450658498|FG002|Overall Study|Lost to Follow-up|4|||
125282264|NCT03525600|450658499|FG003|Overall Study|Lost to Follow-up|0|||
125282265|NCT03525600|450658496|FG000|Overall Study|Physician Decision|1|||
125282266|NCT03525600|450658497|FG001|Overall Study|Physician Decision|0|||
125282267|NCT03525600|450658498|FG002|Overall Study|Physician Decision|2|||
125282268|NCT03525600|450658499|FG003|Overall Study|Physician Decision|0|||
125282269|NCT03525600|450658496|FG000|Overall Study|Consent withdrawal|36|||
125282270|NCT03525600|450658497|FG001|Overall Study|Consent withdrawal|20|||
125282271|NCT03525600|450658498|FG002|Overall Study|Consent withdrawal|6|||
125282272|NCT03525600|450658499|FG003|Overall Study|Consent withdrawal|13|||
125282273|NCT03525600|450658496|FG000|Overall Study|Death|7|||
125282274|NCT03525600|450658497|FG001|Overall Study|Death|6|||
125282275|NCT03525600|450658498|FG002|Overall Study|Death|4|||
125282276|NCT03525600|450658499|FG003|Overall Study|Death|3|||
125282277|NCT03525600|450658496|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
125282278|NCT03525600|450658497|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
125282279|NCT03525600|450658498|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
125282280|NCT03525600|450658499|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
125282281|NCT03525600|450658496|FG000|Overall Study|Other|0|||
125282282|NCT03525600|450658497|FG001|Overall Study|Other|1|||
125282283|NCT03525600|450658498|FG002|Overall Study|Other|0|||
125282284|NCT03525600|450658499|FG003|Overall Study|Other|0|||
125282285|NCT03703817|450658507|FG000|Overall Study|Not meeting eligibility criteria|7|||
125282286|NCT03703817|450658508|FG001|Overall Study|Not meeting eligibility criteria|4|||
125411852|NCT02265705|451134840|FG000|Open Label Period|Adverse Event|0|||
125411853|NCT02265705|451134841|FG001|Open Label Period|Adverse Event|0|||
125411854|NCT02265705|451134842|FG002|Open Label Period|Adverse Event|0|||
125411855|NCT02265705|451134843|FG003|Open Label Period|Adverse Event|2|||
125411856|NCT02265705|451134844|FG004|Open Label Period|Adverse Event|2|||
125411857|NCT02265705|451134845|FG005|Open Label Period|Adverse Event|0|||
125411858|NCT02265705|451134846|FG006|Open Label Period|Adverse Event|0|||
125282287|NCT03255967|450658511|FG000|Overall Study|Adverse Event|26|||
125282288|NCT03255967|450658512|FG001|Overall Study|Adverse Event|30|||
125282289|NCT03255967|450658511|FG000|Overall Study|Withdrawal by Subject|6|||
125282290|NCT03255967|450658512|FG001|Overall Study|Withdrawal by Subject|6|||
125282291|NCT03255967|450658511|FG000|Overall Study|Schedule conflict|6|||
125282292|NCT03255967|450658512|FG001|Overall Study|Schedule conflict|4|||
125282293|NCT03255967|450658511|FG000|Overall Study|POA did not sign consent form|2|||
125282294|NCT03255967|450658512|FG001|Overall Study|POA did not sign consent form|0|||
125282295|NCT01202188|450658513|FG000|Overall Study|Protocol deviation|14|||
125282296|NCT01202188|450658514|FG001|Overall Study|Protocol deviation|8|||
125282297|NCT01202188|450658515|FG002|Overall Study|Protocol deviation|12|||
125282298|NCT01202188|450658516|FG003|Overall Study|Protocol deviation|10|||
125411859|NCT02265705|451134840|FG000|Open Label Period|Physician Decision|0|||
125411860|NCT02265705|451134841|FG001|Open Label Period|Physician Decision|0|||
125282299|NCT01202188|450658517|FG004|Overall Study|Protocol deviation|11|||
125282300|NCT01202188|450658513|FG000|Overall Study|Subject withdrew consent|12|||
125282301|NCT01202188|450658514|FG001|Overall Study|Subject withdrew consent|13|||
125282302|NCT01202188|450658515|FG002|Overall Study|Subject withdrew consent|22|||
125282303|NCT01202188|450658516|FG003|Overall Study|Subject withdrew consent|11|||
125282304|NCT01202188|450658517|FG004|Overall Study|Subject withdrew consent|13|||
125448526|NCT02223182|451268947|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
125448527|NCT02223182|451268948|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
125448528|NCT02223182|451268949|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
125448529|NCT02223182|451268946|FG000|Open-Label 500 Period|Adverse Event|1|||
125448530|NCT02223182|451268947|FG001|Open-Label 500 Period|Adverse Event|0|||
125448531|NCT02223182|451268948|FG002|Open-Label 500 Period|Adverse Event|2|||
125448532|NCT02223182|451268949|FG003|Open-Label 500 Period|Adverse Event|1|||
125448533|NCT02223182|451268946|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
125448534|NCT02223182|451268947|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
125448535|NCT02223182|451268948|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
125448536|NCT02223182|451268949|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
125448537|NCT02223182|451268946|FG000|Open-Label 500 Period|Physician Decision|0|||
125448538|NCT02223182|451268947|FG001|Open-Label 500 Period|Physician Decision|0|||
125448539|NCT02223182|451268948|FG002|Open-Label 500 Period|Physician Decision|0|||
125448540|NCT02223182|451268949|FG003|Open-Label 500 Period|Physician Decision|1|||
125448541|NCT02223182|451268946|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
125448542|NCT02223182|451268947|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
125448543|NCT02223182|451268948|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
125448544|NCT02223182|451268949|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
125448545|NCT02223182|451268946|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
125448546|NCT02223182|451268947|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
125448547|NCT02223182|451268948|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
125282305|NCT01202188|450658513|FG000|Overall Study|Adverse Event|5|||
125282306|NCT01202188|450658514|FG001|Overall Study|Adverse Event|23|||
125282307|NCT01202188|450658515|FG002|Overall Study|Adverse Event|13|||
125282308|NCT01202188|450658516|FG003|Overall Study|Adverse Event|10|||
125282309|NCT01202188|450658517|FG004|Overall Study|Adverse Event|10|||
125282310|NCT01202188|450658513|FG000|Overall Study|Administrative problems|3|||
125282311|NCT01202188|450658514|FG001|Overall Study|Administrative problems|2|||
125282312|NCT01202188|450658515|FG002|Overall Study|Administrative problems|1|||
125282313|NCT01202188|450658516|FG003|Overall Study|Administrative problems|1|||
125282314|NCT01202188|450658517|FG004|Overall Study|Administrative problems|2|||
125282315|NCT01202188|450658513|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125282316|NCT01202188|450658514|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
125282317|NCT01202188|450658515|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
125282318|NCT01202188|450658516|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
125282319|NCT01202188|450658517|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
125282320|NCT01202188|450658513|FG000|Overall Study|Lost to Follow-up|1|||
125282321|NCT01202188|450658514|FG001|Overall Study|Lost to Follow-up|1|||
125282322|NCT01202188|450658515|FG002|Overall Study|Lost to Follow-up|0|||
125282323|NCT01202188|450658516|FG003|Overall Study|Lost to Follow-up|4|||
125282324|NCT01202188|450658517|FG004|Overall Study|Lost to Follow-up|1|||
125282325|NCT01202188|450658513|FG000|Overall Study|Death|1|||
125282326|NCT01202188|450658514|FG001|Overall Study|Death|1|||
125282327|NCT01202188|450658515|FG002|Overall Study|Death|1|||
125282328|NCT01202188|450658516|FG003|Overall Study|Death|1|||
125282329|NCT01202188|450658517|FG004|Overall Study|Death|0|||
125282330|NCT01202188|450658513|FG000|Overall Study|Abnormal test procedure result (s)|0|||
125282331|NCT01202188|450658514|FG001|Overall Study|Abnormal test procedure result (s)|0|||
125282332|NCT01202188|450658515|FG002|Overall Study|Abnormal test procedure result (s)|2|||
125282333|NCT01202188|450658516|FG003|Overall Study|Abnormal test procedure result (s)|0|||
125282334|NCT01202188|450658517|FG004|Overall Study|Abnormal test procedure result (s)|0|||
125282335|NCT02438384|450658520|FG000|Overall Study|Lost to Follow-up|8|||
125282336|NCT02438384|450658521|FG001|Overall Study|Lost to Follow-up|6|||
125282337|NCT02438384|450658522|FG002|Overall Study|Lost to Follow-up|4|||
125282338|NCT03319953|450658523|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
125448548|NCT02223182|451268949|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
125448549|NCT02223182|451268946|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
125448550|NCT02223182|451268947|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
125448551|NCT02223182|451268948|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
125448552|NCT02223182|451268949|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
125282339|NCT03319953|450658524|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
125282340|NCT03319953|450658525|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
125282341|NCT03319953|450658526|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
125282342|NCT03319953|450658523|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
125448553|NCT02223182|451268946|FG000|Open-Label 300 Period|Non Compliance|0|||
125282343|NCT03319953|450658524|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
125282344|NCT03319953|450658525|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
125282345|NCT03319953|450658526|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
125282346|NCT03315793|450658527|FG000|Overall Study|Adverse Event|4|||
125282347|NCT03315793|450658528|FG001|Overall Study|Adverse Event|2|||
125282348|NCT03315793|450658527|FG000|Overall Study|Protocol Deviation|1|||
125282349|NCT03315793|450658528|FG001|Overall Study|Protocol Deviation|0|||
125282350|NCT03315793|450658527|FG000|Overall Study|Difficult for regular visit|0|||
125282351|NCT03315793|450658528|FG001|Overall Study|Difficult for regular visit|1|||
125282352|NCT01331837|450658529|FG000|Overall Study|Death|30|||
125282353|NCT01331837|450658530|FG001|Overall Study|Death|34|||
125282354|NCT01331837|450658529|FG000|Overall Study|Lost to Follow-up|3|||
125282355|NCT01331837|450658530|FG001|Overall Study|Lost to Follow-up|1|||
125282356|NCT01331837|450658529|FG000|Overall Study|Info not recorded|10|||
125282357|NCT01331837|450658530|FG001|Overall Study|Info not recorded|16|||
125282358|NCT01331837|450658529|FG000|Overall Study|Withdrawal by Subject|13|||
125282359|NCT01331837|450658530|FG001|Overall Study|Withdrawal by Subject|16|||
125282360|NCT02640625|450660237|FG000|Overall Study|Adverse Event|1|||
125282361|NCT00511433|450660238|FG000|Overall Study|Adverse Event|5|||
125282362|NCT00511433|450660239|FG001|Overall Study|Adverse Event|0|||
125282363|NCT00511433|450660238|FG000|Overall Study|Other Reason|1|||
125282364|NCT00511433|450660239|FG001|Overall Study|Other Reason|1|||
125282365|NCT01740089|450660240|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
125282366|NCT01740089|450660241|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
125282367|NCT01740089|450660242|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
125282368|NCT01740089|450660240|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
125282369|NCT01740089|450660241|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
125282370|NCT01740089|450660242|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
125282371|NCT01740089|450660240|FG000|After 12 Weeks|Lack of Efficacy|3|||
125282372|NCT01740089|450660241|FG001|After 12 Weeks|Lack of Efficacy|1|||
125282373|NCT01740089|450660242|FG002|After 12 Weeks|Lack of Efficacy|4|||
125282374|NCT01740089|450660240|FG000|After 12 Weeks|Adverse Event|2|||
125282375|NCT01740089|450660241|FG001|After 12 Weeks|Adverse Event|0|||
125282376|NCT01740089|450660242|FG002|After 12 Weeks|Adverse Event|5|||
125282377|NCT01740089|450660240|FG000|After 12 Weeks|Protocol Violation|1|||
125282378|NCT01740089|450660241|FG001|After 12 Weeks|Protocol Violation|1|||
125282379|NCT01740089|450660242|FG002|After 12 Weeks|Protocol Violation|1|||
125282380|NCT01740089|450660240|FG000|After 12 Weeks|Withdrawal by Subject|1|||
125282381|NCT01740089|450660241|FG001|After 12 Weeks|Withdrawal by Subject|1|||
125282382|NCT01740089|450660242|FG002|After 12 Weeks|Withdrawal by Subject|1|||
125282383|NCT00790868|450660243|FG000|Overall Study|Withdrawal by Subject|4|||
125282384|NCT00790868|450660244|FG001|Overall Study|Withdrawal by Subject|5|||
125282385|NCT00790868|450660243|FG000|Overall Study|Lost to Follow-up|2|||
125282386|NCT00790868|450660244|FG001|Overall Study|Lost to Follow-up|12|||
125282387|NCT01380535|450660245|FG000|Overall Study|Adverse Event|3|||
125282388|NCT01380535|450660246|FG001|Overall Study|Adverse Event|3|||
125282389|NCT01380535|450660245|FG000|Overall Study|Death|3|||
125282390|NCT01380535|450660246|FG001|Overall Study|Death|0|||
125282391|NCT01380535|450660245|FG000|Overall Study|Study site closed|0|||
125282392|NCT01380535|450660246|FG001|Overall Study|Study site closed|5|||
125282393|NCT01380535|450660245|FG000|Overall Study|Withdrawal by Subject|1|||
125282394|NCT01380535|450660246|FG001|Overall Study|Withdrawal by Subject|2|||
125282395|NCT01380535|450660245|FG000|Overall Study|Protocol Violation|0|||
125282396|NCT01380535|450660246|FG001|Overall Study|Protocol Violation|2|||
125282397|NCT01380535|450660245|FG000|Overall Study|Lack of Efficacy|0|||
125282398|NCT01380535|450660246|FG001|Overall Study|Lack of Efficacy|3|||
125282399|NCT02013206|450660247|FG000|Overall Study|Progressive disease (PD)|14|||
125282400|NCT02013206|450660248|FG001|Overall Study|Progressive disease (PD)|17|||
125282401|NCT02013206|450660247|FG000|Overall Study|Symptomatic deterioration|3|||
125282402|NCT02013206|450660248|FG001|Overall Study|Symptomatic deterioration|1|||
125282403|NCT02013206|450660247|FG000|Overall Study|Adverse Event|1|||
125282404|NCT02013206|450660248|FG001|Overall Study|Adverse Event|0|||
125282405|NCT02013206|450660247|FG000|Overall Study|Patient refusal|2|||
125282406|NCT02013206|450660248|FG001|Overall Study|Patient refusal|0|||
125282407|NCT02013206|450660247|FG000|Overall Study|Patient non-compliance|1|||
125282408|NCT02013206|450660248|FG001|Overall Study|Patient non-compliance|0|||
125282409|NCT02013206|450660247|FG000|Overall Study|Death|1|||
125282410|NCT02013206|450660248|FG001|Overall Study|Death|2|||
125282411|NCT02013206|450660247|FG000|Overall Study|Other reasons off treatment|5|||
125282412|NCT02013206|450660248|FG001|Overall Study|Other reasons off treatment|2|||
125282413|NCT02791191|450660249|FG000|Overall Study|Adverse Event|2|||
125282414|NCT02791191|450660250|FG001|Overall Study|Adverse Event|4|||
125282415|NCT02791191|450660251|FG002|Overall Study|Adverse Event|5|||
125282416|NCT02791191|450660249|FG000|Overall Study|Lack of Efficacy|0|||
125282417|NCT02791191|450660250|FG001|Overall Study|Lack of Efficacy|1|||
125282418|NCT02791191|450660251|FG002|Overall Study|Lack of Efficacy|0|||
125282419|NCT02791191|450660249|FG000|Overall Study|Study Drug Non-Compliance|0|||
125282420|NCT02791191|450660250|FG001|Overall Study|Study Drug Non-Compliance|2|||
125282421|NCT02791191|450660251|FG002|Overall Study|Study Drug Non-Compliance|0|||
125282422|NCT02791191|450660249|FG000|Overall Study|Site Closed by Sponsor|1|||
125282423|NCT02791191|450660250|FG001|Overall Study|Site Closed by Sponsor|1|||
125282424|NCT02791191|450660251|FG002|Overall Study|Site Closed by Sponsor|3|||
125282425|NCT02791191|450660249|FG000|Overall Study|Progressive Disease|1|||
125282426|NCT02791191|450660250|FG001|Overall Study|Progressive Disease|0|||
125282427|NCT02791191|450660251|FG002|Overall Study|Progressive Disease|0|||
125282428|NCT02791191|450660249|FG000|Overall Study|Study Terminated by Sponsor|29|||
125282429|NCT02791191|450660250|FG001|Overall Study|Study Terminated by Sponsor|101|||
125282430|NCT02791191|450660251|FG002|Overall Study|Study Terminated by Sponsor|109|||
125282431|NCT02791191|450660249|FG000|Overall Study|Withdrawal by Subject|3|||
125282432|NCT02791191|450660250|FG001|Overall Study|Withdrawal by Subject|1|||
125282433|NCT02791191|450660251|FG002|Overall Study|Withdrawal by Subject|3|||
125282434|NCT02791191|450660249|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
125282435|NCT02791191|450660250|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
125282436|NCT02791191|450660251|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
125282437|NCT01952665|450660252|FG000|Overall Study|Physician Decision|3|||
125282438|NCT01952665|450660253|FG001|Overall Study|Physician Decision|2|||
125282439|NCT01952665|450660252|FG000|Overall Study|Lost to Follow-up|1|||
125282440|NCT01952665|450660253|FG001|Overall Study|Lost to Follow-up|2|||
125282441|NCT01952665|450660252|FG000|Overall Study|Adverse Event|2|||
125282442|NCT01952665|450660253|FG001|Overall Study|Adverse Event|1|||
125282443|NCT01952665|450660252|FG000|Overall Study|Protocol Violation|0|||
125282444|NCT01952665|450660253|FG001|Overall Study|Protocol Violation|1|||
125282445|NCT01537081|450660254|FG000|Overall Study|Adverse Event|5|||
125282446|NCT01537081|450660255|FG001|Overall Study|Adverse Event|2|||
125282447|NCT01537081|450660256|FG002|Overall Study|Adverse Event|2|||
125282448|NCT01537081|450660254|FG000|Overall Study|Lack of Efficacy|2|||
125282449|NCT01537081|450660255|FG001|Overall Study|Lack of Efficacy|1|||
125282450|NCT01537081|450660256|FG002|Overall Study|Lack of Efficacy|0|||
125282451|NCT01537081|450660254|FG000|Overall Study|Lost to Follow-up|17|||
125282452|NCT01537081|450660255|FG001|Overall Study|Lost to Follow-up|15|||
125282453|NCT01537081|450660256|FG002|Overall Study|Lost to Follow-up|9|||
125282454|NCT01537081|450660254|FG000|Overall Study|Protocol Violation|3|||
125282455|NCT01537081|450660255|FG001|Overall Study|Protocol Violation|2|||
125282456|NCT01537081|450660256|FG002|Overall Study|Protocol Violation|2|||
125282457|NCT01537081|450660254|FG000|Overall Study|Withdrawal by Subject|6|||
125282458|NCT01537081|450660255|FG001|Overall Study|Withdrawal by Subject|11|||
125282459|NCT01537081|450660256|FG002|Overall Study|Withdrawal by Subject|3|||
125282460|NCT01537081|450660254|FG000|Overall Study|Physician Decision|5|||
125282461|NCT01537081|450660255|FG001|Overall Study|Physician Decision|6|||
125282462|NCT01537081|450660256|FG002|Overall Study|Physician Decision|0|||
125282463|NCT01537081|450660254|FG000|Overall Study|Sponsor decision|0|||
125282464|NCT01537081|450660255|FG001|Overall Study|Sponsor decision|1|||
125282465|NCT01537081|450660256|FG002|Overall Study|Sponsor decision|0|||
125282466|NCT01537081|450660254|FG000|Overall Study|Assigned but never dosed|1|||
125282467|NCT01537081|450660255|FG001|Overall Study|Assigned but never dosed|0|||
125282468|NCT01537081|450660256|FG002|Overall Study|Assigned but never dosed|0|||
125282469|NCT01463111|450660259|FG000|Overall Study|Withdrawal by Subject|2|||
125282470|NCT01463111|450660259|FG000|Overall Study|Lost to Follow-up|5|||
125282471|NCT01463111|450660259|FG000|Overall Study|Physician Decision|2|||
125282472|NCT02596958|450660262|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
125282473|NCT02596958|450660262|FG000|Overall Study|Cancer Progression|441|||
125282474|NCT02596958|450660262|FG000|Overall Study|Death From Cancer|112|||
125282475|NCT02596958|450660262|FG000|Overall Study|Death From Other Cause|33|||
125282476|NCT02596958|450660262|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
125282477|NCT02596958|450660262|FG000|Overall Study|Administrative Reasons/Other|231|||
125282478|NCT02596958|450660262|FG000|Overall Study|Lost to Follow-up|33|||
125282479|NCT02596958|450660262|FG000|Overall Study|Missing|32|||
125282480|NCT02596958|450660262|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
125282481|NCT01559259|450660263|FG000|Overall Study|Withdrawal by Subject|0|||
125282482|NCT01559259|450660264|FG001|Overall Study|Withdrawal by Subject|0|||
125282483|NCT01559259|450660265|FG002|Overall Study|Withdrawal by Subject|0|||
125282484|NCT01559259|450660266|FG003|Overall Study|Withdrawal by Subject|1|||
125282485|NCT01559259|450660267|FG004|Overall Study|Withdrawal by Subject|0|||
125282486|NCT01559259|450660263|FG000|Overall Study|Adverse Event|0|||
125282487|NCT01559259|450660264|FG001|Overall Study|Adverse Event|1|||
125282488|NCT01559259|450660265|FG002|Overall Study|Adverse Event|1|||
125282489|NCT01559259|450660266|FG003|Overall Study|Adverse Event|0|||
125282490|NCT01559259|450660267|FG004|Overall Study|Adverse Event|0|||
125411861|NCT02265705|451134842|FG002|Open Label Period|Physician Decision|0|||
125282491|NCT05425732|450660268|FG000|Overall Study|Death|4|||
125282492|NCT05425732|450660269|FG001|Overall Study|Death|2|||
125411862|NCT02265705|451134843|FG003|Open Label Period|Physician Decision|0|||
125282493|NCT05425732|450660270|FG002|Overall Study|Death|0|||
125282494|NCT05425732|450660271|FG003|Overall Study|Death|0|||
125282495|NCT05425732|450660268|FG000|Overall Study|Lost to Follow-up|10|||
125282496|NCT05425732|450660269|FG001|Overall Study|Lost to Follow-up|15|||
125282497|NCT05425732|450660270|FG002|Overall Study|Lost to Follow-up|5|||
125282498|NCT05425732|450660271|FG003|Overall Study|Lost to Follow-up|3|||
125282499|NCT05425732|450660268|FG000|Overall Study|Physician Decision|0|||
125282500|NCT05425732|450660269|FG001|Overall Study|Physician Decision|2|||
125282501|NCT05425732|450660270|FG002|Overall Study|Physician Decision|0|||
125282502|NCT05425732|450660271|FG003|Overall Study|Physician Decision|0|||
125282503|NCT05425732|450660268|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125282504|NCT05425732|450660269|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
125282505|NCT05425732|450660270|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125282506|NCT05425732|450660271|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125282507|NCT05425732|450660268|FG000|Overall Study|Withdrawal by Subject|4|||
125282508|NCT05425732|450660269|FG001|Overall Study|Withdrawal by Subject|8|||
125282509|NCT05425732|450660270|FG002|Overall Study|Withdrawal by Subject|1|||
125282510|NCT05425732|450660271|FG003|Overall Study|Withdrawal by Subject|1|||
125282511|NCT05425732|450660268|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
125282512|NCT05425732|450660269|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
125282513|NCT05425732|450660270|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
125282514|NCT05425732|450660271|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
125282515|NCT00306293|450660273|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
125282516|NCT00306293|450660274|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
125282517|NCT00306293|450660273|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
125282518|NCT00306293|450660274|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
125282519|NCT00306293|450660273|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
125282520|NCT00306293|450660274|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
125282521|NCT00306293|450660273|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
125282522|NCT00306293|450660274|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
125282523|NCT00306293|450660273|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
125282524|NCT00306293|450660274|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
125282525|NCT00306293|450660273|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
125282526|NCT00306293|450660274|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
125282527|NCT00306293|450660273|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
125282528|NCT00306293|450660274|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
125282529|NCT00306293|450660273|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
125282530|NCT00306293|450660274|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
125282531|NCT00185380|450660275|FG000|Overall Study|Adverse Event|41|||
125282532|NCT00185380|450660276|FG001|Overall Study|Adverse Event|43|||
125282533|NCT00185380|450660277|FG002|Overall Study|Adverse Event|48|||
125282534|NCT00185380|450660275|FG000|Overall Study|Lost to Follow-up|0|||
125282535|NCT00185380|450660276|FG001|Overall Study|Lost to Follow-up|4|||
125282536|NCT00185380|450660277|FG002|Overall Study|Lost to Follow-up|3|||
125282537|NCT00185380|450660275|FG000|Overall Study|Pregnancy|1|||
125282538|NCT00185380|450660276|FG001|Overall Study|Pregnancy|4|||
125282539|NCT00185380|450660277|FG002|Overall Study|Pregnancy|0|||
125282540|NCT00185380|450660275|FG000|Overall Study|Protocol Violation|2|||
125282541|NCT00185380|450660276|FG001|Overall Study|Protocol Violation|2|||
125282542|NCT00185380|450660277|FG002|Overall Study|Protocol Violation|1|||
125282543|NCT00185380|450660275|FG000|Overall Study|Withdrawal by Subject|1|||
125282544|NCT00185380|450660276|FG001|Overall Study|Withdrawal by Subject|2|||
125282545|NCT00185380|450660277|FG002|Overall Study|Withdrawal by Subject|0|||
125282546|NCT00185380|450660275|FG000|Overall Study|Failed insertion|1|||
125282547|NCT00185380|450660276|FG001|Overall Study|Failed insertion|1|||
125282548|NCT00185380|450660277|FG002|Overall Study|Failed insertion|2|||
125282549|NCT00185380|450660275|FG000|Overall Study|Planned pregnancy|9|||
125282550|NCT00185380|450660276|FG001|Overall Study|Planned pregnancy|12|||
125282551|NCT00185380|450660277|FG002|Overall Study|Planned pregnancy|12|||
125282552|NCT00185380|450660275|FG000|Overall Study|No need for contraception|3|||
125282553|NCT00185380|450660276|FG001|Overall Study|No need for contraception|3|||
125282554|NCT00185380|450660277|FG002|Overall Study|No need for contraception|3|||
125282555|NCT00185380|450660275|FG000|Overall Study|Could not attend visits|2|||
125282556|NCT00185380|450660276|FG001|Overall Study|Could not attend visits|0|||
125282557|NCT00185380|450660277|FG002|Overall Study|Could not attend visits|4|||
125282558|NCT00185380|450660275|FG000|Overall Study|personal reason|6|||
125282559|NCT00185380|450660276|FG001|Overall Study|personal reason|1|||
125282560|NCT00185380|450660277|FG002|Overall Study|personal reason|1|||
125282561|NCT02199314|450660280|FG000|Overall Study|Withdrawal by Subject|6|||
125282562|NCT02199314|450660280|FG000|Overall Study|Physician Decision|10|||
125282563|NCT04187144|450660281|FG000|Overall Study|Lost to Follow-up|12|||
125282564|NCT04187144|450660282|FG001|Overall Study|Lost to Follow-up|11|||
125282565|NCT04187144|450660281|FG000|Overall Study|Withdrawal by Subject|20|||
125282566|NCT04187144|450660282|FG001|Overall Study|Withdrawal by Subject|18|||
125282567|NCT04187144|450660281|FG000|Overall Study|Adverse Event|19|||
125282568|NCT04187144|450660282|FG001|Overall Study|Adverse Event|4|||
125282569|NCT04187144|450660281|FG000|Overall Study|Physician Decision|5|||
125282570|NCT04187144|450660282|FG001|Overall Study|Physician Decision|3|||
125282571|NCT04187144|450660281|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
125282572|NCT04187144|450660282|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
125282573|NCT04187144|450660281|FG000|Overall Study|Protocol Deviation|1|||
125282574|NCT04187144|450660282|FG001|Overall Study|Protocol Deviation|4|||
125282575|NCT02650804|450660283|FG000|Overall Study|Adverse Event|3|||
125282576|NCT02650804|450660284|FG001|Overall Study|Adverse Event|2|||
125282577|NCT02650804|450660283|FG000|Overall Study|Death|1|||
125282578|NCT02650804|450660284|FG001|Overall Study|Death|2|||
125282579|NCT02650804|450660283|FG000|Overall Study|Progressive Disease|7|||
125282580|NCT02650804|450660284|FG001|Overall Study|Progressive Disease|10|||
125282581|NCT02650804|450660283|FG000|Overall Study|Physician Decision|0|||
125282582|NCT02650804|450660284|FG001|Overall Study|Physician Decision|2|||
125282583|NCT02650804|450660283|FG000|Overall Study|Withdrawal by Subject|1|||
125282584|NCT02650804|450660284|FG001|Overall Study|Withdrawal by Subject|4|||
125282585|NCT02650804|450660283|FG000|Overall Study|Symptomatic deterioration|5|||
125448554|NCT02223182|451268947|FG001|Open-Label 300 Period|Non Compliance|2|||
125448555|NCT02223182|451268948|FG002|Open-Label 300 Period|Non Compliance|1|||
125448556|NCT02223182|451268949|FG003|Open-Label 300 Period|Non Compliance|0|||
125448557|NCT03714022|451268950|FG000|Overall Study|Adverse Event|1|||
125448558|NCT03714022|451268951|FG001|Overall Study|Adverse Event|0|||
125282586|NCT02650804|450660284|FG001|Overall Study|Symptomatic deterioration|7|||
125282587|NCT02650804|450660283|FG000|Overall Study|Protocol Violation|0|||
125282588|NCT02650804|450660284|FG001|Overall Study|Protocol Violation|1|||
125282589|NCT02759107|450660285|FG000|Overall Study|Adverse Event|0|||
125282590|NCT02759107|450660286|FG001|Overall Study|Adverse Event|0|||
125282591|NCT02759107|450660287|FG002|Overall Study|Adverse Event|0|||
125282592|NCT02759107|450660288|FG003|Overall Study|Adverse Event|0|||
125282593|NCT02759107|450660289|FG004|Overall Study|Adverse Event|0|||
125282594|NCT02759107|450660290|FG005|Overall Study|Adverse Event|0|||
125282595|NCT02759107|450660291|FG006|Overall Study|Adverse Event|0|||
125282596|NCT02759107|450660292|FG007|Overall Study|Adverse Event|0|||
125282597|NCT02759107|450660293|FG008|Overall Study|Adverse Event|0|||
125282598|NCT02759107|450660294|FG009|Overall Study|Adverse Event|0|||
125282599|NCT02759107|450660295|FG010|Overall Study|Adverse Event|0|||
125282600|NCT02759107|450660296|FG011|Overall Study|Adverse Event|0|||
125282601|NCT02759107|450660297|FG012|Overall Study|Adverse Event|2|||
125282602|NCT02759107|450660298|FG013|Overall Study|Adverse Event|0|||
125282603|NCT02759107|450660299|FG014|Overall Study|Adverse Event|0|||
125282604|NCT02759107|450660300|FG015|Overall Study|Adverse Event|1|||
125282605|NCT02759107|450660301|FG016|Overall Study|Adverse Event|0|||
125282606|NCT02759107|450660302|FG017|Overall Study|Adverse Event|2|||
125282607|NCT02759107|450660285|FG000|Overall Study|Scheduling Conflict|0|||
125282608|NCT02759107|450660286|FG001|Overall Study|Scheduling Conflict|0|||
125282609|NCT02759107|450660287|FG002|Overall Study|Scheduling Conflict|0|||
125282610|NCT02759107|450660288|FG003|Overall Study|Scheduling Conflict|0|||
125282611|NCT02759107|450660289|FG004|Overall Study|Scheduling Conflict|0|||
125282612|NCT02759107|450660290|FG005|Overall Study|Scheduling Conflict|0|||
125282613|NCT02759107|450660291|FG006|Overall Study|Scheduling Conflict|0|||
125282614|NCT02759107|450660292|FG007|Overall Study|Scheduling Conflict|0|||
125282615|NCT02759107|450660293|FG008|Overall Study|Scheduling Conflict|0|||
125282616|NCT02759107|450660294|FG009|Overall Study|Scheduling Conflict|1|||
125282617|NCT02759107|450660295|FG010|Overall Study|Scheduling Conflict|0|||
125282618|NCT02759107|450660296|FG011|Overall Study|Scheduling Conflict|0|||
125282619|NCT02759107|450660297|FG012|Overall Study|Scheduling Conflict|0|||
125282620|NCT02759107|450660298|FG013|Overall Study|Scheduling Conflict|0|||
125282621|NCT02759107|450660299|FG014|Overall Study|Scheduling Conflict|0|||
125282622|NCT02759107|450660300|FG015|Overall Study|Scheduling Conflict|0|||
125282623|NCT02759107|450660301|FG016|Overall Study|Scheduling Conflict|0|||
125282624|NCT02759107|450660302|FG017|Overall Study|Scheduling Conflict|0|||
125282625|NCT02513485|450660306|FG000|Overall Study|Adverse Event|1|||
125282626|NCT02513485|450660307|FG001|Overall Study|Adverse Event|0|||
125282627|NCT02526524|450660308|FG000|Overall Study|Withdrawal by Subject|3|||
125282628|NCT02526524|450660309|FG001|Overall Study|Withdrawal by Subject|3|||
125282629|NCT02526524|450660310|FG002|Overall Study|Withdrawal by Subject|6|||
125282630|NCT02526524|450660311|FG003|Overall Study|Withdrawal by Subject|1|||
125282631|NCT02526524|450660312|FG004|Overall Study|Withdrawal by Subject|9|||
125282632|NCT02526524|450660313|FG005|Overall Study|Withdrawal by Subject|5|||
125282633|NCT02526524|450660308|FG000|Overall Study|Adverse Event|3|||
125448559|NCT03714022|451268950|FG000|Overall Study|Consent withdrawal|0|||
125282634|NCT02526524|450660309|FG001|Overall Study|Adverse Event|2|||
125282635|NCT02526524|450660310|FG002|Overall Study|Adverse Event|4|||
125282636|NCT02526524|450660311|FG003|Overall Study|Adverse Event|2|||
125282637|NCT02526524|450660312|FG004|Overall Study|Adverse Event|6|||
125448560|NCT03714022|451268951|FG001|Overall Study|Consent withdrawal|1|||
125282638|NCT02526524|450660313|FG005|Overall Study|Adverse Event|8|||
125282639|NCT02526524|450660308|FG000|Overall Study|Lost to Follow-up|2|||
125282640|NCT02526524|450660309|FG001|Overall Study|Lost to Follow-up|3|||
125282641|NCT02526524|450660310|FG002|Overall Study|Lost to Follow-up|8|||
125448561|NCT03714022|451268950|FG000|Overall Study|Lost to Follow-up|3|||
125282642|NCT02526524|450660311|FG003|Overall Study|Lost to Follow-up|1|||
125282643|NCT02526524|450660312|FG004|Overall Study|Lost to Follow-up|2|||
125282644|NCT02526524|450660313|FG005|Overall Study|Lost to Follow-up|5|||
125282645|NCT02526524|450660308|FG000|Overall Study|Protocol Violation|3|||
125282646|NCT02526524|450660309|FG001|Overall Study|Protocol Violation|1|||
125282647|NCT02526524|450660310|FG002|Overall Study|Protocol Violation|5|||
125282648|NCT02526524|450660311|FG003|Overall Study|Protocol Violation|3|||
125282649|NCT02526524|450660312|FG004|Overall Study|Protocol Violation|4|||
125282650|NCT02526524|450660313|FG005|Overall Study|Protocol Violation|3|||
125282651|NCT02526524|450660308|FG000|Overall Study|Loss of Glucose Control|0|||
125282652|NCT02526524|450660309|FG001|Overall Study|Loss of Glucose Control|0|||
125282653|NCT02526524|450660310|FG002|Overall Study|Loss of Glucose Control|3|||
125282654|NCT02526524|450660311|FG003|Overall Study|Loss of Glucose Control|0|||
125282655|NCT02526524|450660312|FG004|Overall Study|Loss of Glucose Control|2|||
125282656|NCT02526524|450660313|FG005|Overall Study|Loss of Glucose Control|0|||
125282657|NCT02526524|450660308|FG000|Overall Study|Physician Decision|0|||
125282658|NCT02526524|450660309|FG001|Overall Study|Physician Decision|0|||
125282659|NCT02526524|450660310|FG002|Overall Study|Physician Decision|0|||
125282660|NCT02526524|450660311|FG003|Overall Study|Physician Decision|0|||
125282661|NCT02526524|450660312|FG004|Overall Study|Physician Decision|1|||
125282662|NCT02526524|450660313|FG005|Overall Study|Physician Decision|0|||
125282663|NCT02526524|450660308|FG000|Overall Study|Sponsor Decision|1|||
125282664|NCT02526524|450660309|FG001|Overall Study|Sponsor Decision|0|||
125282665|NCT02526524|450660310|FG002|Overall Study|Sponsor Decision|0|||
125282666|NCT02526524|450660311|FG003|Overall Study|Sponsor Decision|0|||
125282667|NCT02526524|450660312|FG004|Overall Study|Sponsor Decision|0|||
125282668|NCT02526524|450660313|FG005|Overall Study|Sponsor Decision|0|||
125282669|NCT05312632|450660318|FG000|Overall Study|Adverse Event|12|||
125282670|NCT05312632|450660318|FG000|Overall Study|Withdrawal by Subject|10|||
125282671|NCT05312632|450660318|FG000|Overall Study|Lack of Efficacy|4|||
125282672|NCT05312632|450660318|FG000|Overall Study|Non-compliance with study procedures|9|||
125282673|NCT05312632|450660318|FG000|Overall Study|Other|4|||
125282674|NCT02019108|450660319|FG000|Overall Study|Lost to Follow-up|5|||
125282675|NCT02019108|450660320|FG001|Overall Study|Lost to Follow-up|7|||
125282676|NCT04569136|450660326|FG000|Overall Study|Lost to Follow-up|2|||
125282677|NCT04569136|450660327|FG001|Overall Study|Lost to Follow-up|0|||
125282678|NCT04569136|450660328|FG002|Overall Study|Lost to Follow-up|1|||
125282679|NCT01466660|450660333|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
125282680|NCT01466660|450660334|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
125282681|NCT01466660|450660333|FG000|Overall Study|Worsening of underlying cancer disease|5|||
125282682|NCT01466660|450660334|FG001|Overall Study|Worsening of underlying cancer disease|2|||
125282683|NCT01466660|450660333|FG000|Overall Study|Other adverse event|19|||
125282684|NCT01466660|450660334|FG001|Overall Study|Other adverse event|18|||
125282685|NCT01466660|450660333|FG000|Overall Study|Protocol Violation|2|||
125282686|NCT01466660|450660334|FG001|Overall Study|Protocol Violation|1|||
125282687|NCT01466660|450660333|FG000|Overall Study|Refused continuation of trial medication|4|||
125282688|NCT01466660|450660334|FG001|Overall Study|Refused continuation of trial medication|3|||
125282689|NCT01466660|450660333|FG000|Overall Study|Other reason not defined above|10|||
125282690|NCT01466660|450660334|FG001|Overall Study|Other reason not defined above|8|||
125282691|NCT00191724|450660335|FG000|Overall Study|Adverse Event|0|||
125282692|NCT00191724|450660336|FG001|Overall Study|Adverse Event|0|||
125282693|NCT00191724|450660337|FG002|Overall Study|Adverse Event|1|||
125282694|NCT00191724|450660338|FG003|Overall Study|Adverse Event|0|||
125282695|NCT00191724|450660339|FG004|Overall Study|Adverse Event|0|||
125282696|NCT00191724|450660335|FG000|Overall Study|Lost to Follow-up|1|||
125282697|NCT00191724|450660336|FG001|Overall Study|Lost to Follow-up|1|||
125282698|NCT00191724|450660337|FG002|Overall Study|Lost to Follow-up|0|||
125282699|NCT00191724|450660338|FG003|Overall Study|Lost to Follow-up|2|||
125282700|NCT00191724|450660339|FG004|Overall Study|Lost to Follow-up|3|||
125282701|NCT00191724|450660335|FG000|Overall Study|Withdrawal by Subject|0|||
125282702|NCT00191724|450660336|FG001|Overall Study|Withdrawal by Subject|0|||
125282703|NCT00191724|450660337|FG002|Overall Study|Withdrawal by Subject|0|||
125282704|NCT00191724|450660338|FG003|Overall Study|Withdrawal by Subject|1|||
125282705|NCT00191724|450660339|FG004|Overall Study|Withdrawal by Subject|0|||
125282706|NCT02301546|450660340|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
125282707|NCT02301546|450660341|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
125282708|NCT02301546|450660340|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
125282709|NCT02301546|450660341|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
125282710|NCT02301546|450660340|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
125282711|NCT02301546|450660341|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
125282712|NCT02301546|450660340|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
125282713|NCT02301546|450660341|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
125282714|NCT02301546|450660340|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
125282715|NCT02301546|450660341|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
125282716|NCT02301546|450660340|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
125282717|NCT02301546|450660341|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
125282718|NCT02301546|450660340|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
125282719|NCT02301546|450660341|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
125282720|NCT02447250|450660344|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
125282721|NCT02447250|450660344|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
125282722|NCT02447250|450660344|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
125282723|NCT01885208|450660345|FG000|Overall Study|Unclassified|32|||
125282724|NCT01885208|450660346|FG001|Overall Study|Unclassified|38|||
125282725|NCT01498575|450660349|FG000|Overall Sample|Withdrawal by Subject|60|||
125282726|NCT01498575|450660350|FG001|Overall Sample|Withdrawal by Subject|14|||
125282727|NCT01498575|450660349|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
125282728|NCT01498575|450660350|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
125282729|NCT01498575|450660349|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
125282730|NCT01498575|450660350|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
125282731|NCT01972308|450660352|FG000|Overall Study|Withdrawal by Subject|0|||
125282732|NCT01972308|450660353|FG001|Overall Study|Withdrawal by Subject|1|||
125282733|NCT01972308|450660352|FG000|Overall Study|Lost to Follow-up|4|||
125448562|NCT03714022|451268951|FG001|Overall Study|Lost to Follow-up|2|||
125448563|NCT04739423|451268958|FG000|Overall Study|Protocol Violation|0|||
125448564|NCT04739423|451268959|FG001|Overall Study|Protocol Violation|1|||
125448565|NCT04739423|451268960|FG002|Overall Study|Protocol Violation|0|||
125282734|NCT01972308|450660353|FG001|Overall Study|Lost to Follow-up|6|||
125282735|NCT01972308|450660352|FG000|Overall Study|Death|4|||
125282736|NCT01972308|450660353|FG001|Overall Study|Death|1|||
125282737|NCT02851797|450660358|FG000|Overall Study|Withdrawal by Subject|4|||
125282738|NCT02851797|450660359|FG001|Overall Study|Withdrawal by Subject|2|||
125282739|NCT02851797|450660358|FG000|Overall Study|Adverse Event|3|||
125282740|NCT02851797|450660359|FG001|Overall Study|Adverse Event|0|||
125282741|NCT00543803|450660369|FG000|Overall Study|Adverse Event|14|||
125282742|NCT00543803|450660369|FG000|Overall Study|Lack of Efficacy|22|||
125282743|NCT00543803|450660369|FG000|Overall Study|Lost to Follow-up|20|||
125282744|NCT00543803|450660369|FG000|Overall Study|Other|86|||
125282745|NCT04295681|450660370|FG000|Overall Study|Eligibility error|1|||
125282746|NCT04295681|450660371|FG001|Overall Study|Eligibility error|3|||
125282747|NCT02135029|450660380|FG000|Overall Study|Adverse Event|2|||
125282748|NCT02135029|450660381|FG001|Overall Study|Adverse Event|2|||
125282749|NCT02135029|450660382|FG002|Overall Study|Adverse Event|2|||
125282750|NCT02135029|450660380|FG000|Overall Study|Lost to Follow-up|0|||
125282751|NCT02135029|450660381|FG001|Overall Study|Lost to Follow-up|1|||
125282752|NCT02135029|450660382|FG002|Overall Study|Lost to Follow-up|0|||
125282753|NCT02135029|450660380|FG000|Overall Study|Withdrawal by Subject|2|||
125282754|NCT02135029|450660381|FG001|Overall Study|Withdrawal by Subject|0|||
125282755|NCT02135029|450660382|FG002|Overall Study|Withdrawal by Subject|1|||
125282756|NCT02135029|450660380|FG000|Overall Study|Other|0|||
125282757|NCT02135029|450660381|FG001|Overall Study|Other|1|||
125282758|NCT02135029|450660382|FG002|Overall Study|Other|0|||
125282759|NCT02135029|450660380|FG000|Overall Study|Death|0|||
125282760|NCT02135029|450660381|FG001|Overall Study|Death|1|||
125282761|NCT02135029|450660382|FG002|Overall Study|Death|0|||
125282762|NCT05129449|450660387|FG000|Overall Study|Protocol Violation|1|||
125282763|NCT02839720|450660390|FG000|Overall Study|Adverse Event|2|||
125282764|NCT02839720|450660390|FG000|Overall Study|Non-compliance|2|||
125282765|NCT02839720|450660390|FG000|Overall Study|Intercurrent Illness|1|||
125282766|NCT02839720|450660390|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
125282767|NCT00516906|450660391|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
125282768|NCT00516906|450660392|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
125282769|NCT01974206|450660393|FG000|Overall Study|Did Not Take Study Drug|0|||
125282770|NCT01974206|450660394|FG001|Overall Study|Did Not Take Study Drug|1|||
125282771|NCT01974206|450660393|FG000|Overall Study|Physician Decision|1|||
125282772|NCT01974206|450660394|FG001|Overall Study|Physician Decision|0|||
125282773|NCT01974206|450660393|FG000|Overall Study|Withdrawal by Subject|3|||
125282774|NCT01974206|450660394|FG001|Overall Study|Withdrawal by Subject|0|||
125282775|NCT01974206|450660393|FG000|Overall Study|Lost to Follow-up|1|||
125282776|NCT01974206|450660394|FG001|Overall Study|Lost to Follow-up|0|||
125282777|NCT01974206|450660393|FG000|Overall Study|Death|1|||
125282778|NCT01974206|450660394|FG001|Overall Study|Death|0|||
125282779|NCT05463744|450660407|FG000|Treatment Period|Withdrawal by Subject|19|||
125282780|NCT05463744|450660408|FG001|Treatment Period|Withdrawal by Subject|16|||
125282781|NCT05463744|450660407|FG000|Treatment Period|Adverse Event|4|||
125282782|NCT05463744|450660408|FG001|Treatment Period|Adverse Event|4|||
125282783|NCT05463744|450660407|FG000|Treatment Period|Pregnancy|0|||
125282784|NCT05463744|450660408|FG001|Treatment Period|Pregnancy|3|||
125282785|NCT05463744|450660407|FG000|Treatment Period|Lost to Follow-up|1|||
125282786|NCT05463744|450660408|FG001|Treatment Period|Lost to Follow-up|3|||
125282787|NCT05463744|450660407|FG000|Treatment Period|Inadvertent enrollment|2|||
125282788|NCT05463744|450660408|FG001|Treatment Period|Inadvertent enrollment|1|||
125448566|NCT04739423|451268961|FG003|Overall Study|Protocol Violation|0|||
125282789|NCT05463744|450660407|FG000|Treatment Period|Death|0|||
125282790|NCT05463744|450660408|FG001|Treatment Period|Death|1|||
125282791|NCT05463744|450660407|FG000|Treatment Period|Non-compliance with Study Drug|1|||
125282792|NCT05463744|450660408|FG001|Treatment Period|Non-compliance with Study Drug|0|||
125282793|NCT05463744|450660407|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
125282794|NCT05463744|450660408|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
125282795|NCT05463744|450660407|FG000|Treatment Period|Physician Decision|0|||
125282796|NCT05463744|450660408|FG001|Treatment Period|Physician Decision|1|||
125282797|NCT05463744|450660407|FG000|Follow-Up Period|Withdrawal by Subject|3|||
125282798|NCT05463744|450660408|FG001|Follow-Up Period|Withdrawal by Subject|1|||
125282799|NCT05463744|450660407|FG000|Follow-Up Period|Lost to Follow-up|1|||
125282800|NCT05463744|450660408|FG001|Follow-Up Period|Lost to Follow-up|1|||
125282801|NCT01795495|450660409|FG000|Overall Study|Protocol Violation|1|||
125282802|NCT01795495|450660410|FG001|Overall Study|Protocol Violation|0|||
125282803|NCT01795495|450660411|FG002|Overall Study|Protocol Violation|1|||
125282804|NCT01795495|450660409|FG000|Overall Study|Physician Decision|0|||
125282805|NCT01795495|450660410|FG001|Overall Study|Physician Decision|0|||
125282806|NCT01795495|450660411|FG002|Overall Study|Physician Decision|1|||
125282807|NCT01579565|450662465|FG000|Randomized|Adverse Event|1|||
125282808|NCT01579565|450662466|FG001|Randomized|Adverse Event|3|||
125282809|NCT01579565|450662465|FG000|Randomized|Withdrawal by Subject|3|||
125282810|NCT01579565|450662466|FG001|Randomized|Withdrawal by Subject|0|||
125282811|NCT01579565|450662465|FG000|Randomized|inadequate preoperative pupil dilation|0|||
125282812|NCT01579565|450662466|FG001|Randomized|inadequate preoperative pupil dilation|1|||
125282813|NCT01579565|450662465|FG000|Randomized|prohibited preoperative eating|1|||
125282814|NCT01579565|450662466|FG001|Randomized|prohibited preoperative eating|0|||
125282815|NCT01579565|450662465|FG000|Randomized|prohibited preoperative medication|0|||
125282816|NCT01579565|450662466|FG001|Randomized|prohibited preoperative medication|1|||
125282817|NCT01579565|450662465|FG000|Treated|Physician Decision|0|||
125282818|NCT01579565|450662466|FG001|Treated|Physician Decision|1|||
125282819|NCT01579565|450662465|FG000|Treated|Lost to Follow-up|2|||
125282820|NCT01579565|450662466|FG001|Treated|Lost to Follow-up|1|||
125282821|NCT01579565|450662465|FG000|Treated|declined to return for final visit|0|||
125282822|NCT01579565|450662466|FG001|Treated|declined to return for final visit|1|||
125282823|NCT02867813|450662467|FG000|Overall Study|Withdrawal by Subject|57|||
125282824|NCT02867813|450662468|FG001|Overall Study|Withdrawal by Subject|56|||
125282825|NCT02867813|450662467|FG000|Overall Study|Decision by Sponsor|7|||
125282826|NCT02867813|450662468|FG001|Overall Study|Decision by Sponsor|7|||
125282827|NCT02867813|450662467|FG000|Overall Study|Lost to Follow-up|91|||
125282828|NCT02867813|450662468|FG001|Overall Study|Lost to Follow-up|78|||
125282829|NCT02867813|450662467|FG000|Overall Study|Missing|2|||
125282830|NCT02867813|450662468|FG001|Overall Study|Missing|1|||
125282831|NCT02867813|450662467|FG000|Overall Study|Death|294|||
125282832|NCT02867813|450662468|FG001|Overall Study|Death|268|||
125282833|NCT01448824|450662469|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282834|NCT01448824|450662470|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282835|NCT01448824|450662471|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282836|NCT01448824|450662472|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282837|NCT01448824|450662473|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282838|NCT01448824|450662474|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282839|NCT01448824|450662475|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
125282840|NCT01448824|450662476|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
125282841|NCT01448824|450662469|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
125282842|NCT01448824|450662470|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
125282843|NCT01448824|450662471|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
125282844|NCT01448824|450662472|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
125282845|NCT01448824|450662473|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
125282846|NCT01448824|450662474|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
125282847|NCT01448824|450662475|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
125282848|NCT01448824|450662476|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
125282849|NCT01448824|450662469|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
125282850|NCT01448824|450662470|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
125282851|NCT01448824|450662471|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
125282852|NCT01448824|450662472|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
125282853|NCT01448824|450662473|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
125282854|NCT01448824|450662474|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
125282855|NCT01448824|450662475|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
125282856|NCT01448824|450662476|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
125448567|NCT04739423|451268962|FG004|Overall Study|Protocol Violation|0|||
125448568|NCT04739423|451268963|FG005|Overall Study|Protocol Violation|0|||
125448569|NCT04739423|451268958|FG000|Overall Study|Adverse Event|0|||
125282857|NCT01448824|450662469|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
125282858|NCT01448824|450662470|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
125282859|NCT01448824|450662471|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
125282860|NCT01448824|450662472|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
125448570|NCT04739423|451268959|FG001|Overall Study|Adverse Event|0|||
125448571|NCT04739423|451268960|FG002|Overall Study|Adverse Event|1|||
125448572|NCT04739423|451268961|FG003|Overall Study|Adverse Event|0|||
125448573|NCT04739423|451268962|FG004|Overall Study|Adverse Event|1|||
125448574|NCT04739423|451268963|FG005|Overall Study|Adverse Event|0|||
125282861|NCT01448824|450662473|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
125282862|NCT01448824|450662474|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
125282863|NCT01448824|450662475|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
125448575|NCT04739423|451268958|FG000|Overall Study|Withdrawal by Subject|0|||
125448576|NCT04739423|451268959|FG001|Overall Study|Withdrawal by Subject|0|||
125448577|NCT04739423|451268960|FG002|Overall Study|Withdrawal by Subject|0|||
125448578|NCT04739423|451268961|FG003|Overall Study|Withdrawal by Subject|0|||
125448579|NCT04739423|451268962|FG004|Overall Study|Withdrawal by Subject|0|||
125448580|NCT04739423|451268963|FG005|Overall Study|Withdrawal by Subject|1|||
125448581|NCT01007552|451268964|FG000|Overall Study|Withdrawal by Subject|1|||
125448582|NCT04482855|451268965|FG000|Overall Study|Lost to Follow-up|1|||
125448583|NCT04482855|451268966|FG001|Overall Study|Lost to Follow-up|0|||
125448584|NCT04482855|451268965|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
125448585|NCT04482855|451268966|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
125448586|NCT04482855|451268965|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
125448587|NCT04482855|451268966|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
125448588|NCT03212365|451268968|FG000|Overall Study|Discharged prior to Xa level|12|||
125282864|NCT01448824|450662476|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
125282865|NCT01448824|450662469|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282866|NCT01448824|450662470|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282867|NCT01448824|450662471|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282868|NCT01448824|450662472|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282869|NCT01448824|450662473|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282870|NCT01448824|450662474|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282871|NCT01448824|450662475|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
125282872|NCT01448824|450662476|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
125282873|NCT01448824|450662469|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282874|NCT01448824|450662470|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282875|NCT01448824|450662471|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282876|NCT01448824|450662472|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282877|NCT01448824|450662473|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282878|NCT01448824|450662474|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282879|NCT01448824|450662475|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
125282880|NCT01448824|450662476|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
125282881|NCT01448824|450662469|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282882|NCT01448824|450662470|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282883|NCT01448824|450662471|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282884|NCT01448824|450662472|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282885|NCT01448824|450662473|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282886|NCT01448824|450662474|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282887|NCT01448824|450662475|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
125282888|NCT01448824|450662476|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
125282889|NCT01448824|450662469|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282890|NCT01448824|450662470|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282891|NCT01448824|450662471|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282892|NCT01448824|450662472|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282893|NCT01448824|450662473|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282894|NCT01448824|450662474|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282895|NCT01448824|450662475|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
125282896|NCT01448824|450662476|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
125282897|NCT01995669|450662488|FG000|Overall Study|Progression|2|||
125282898|NCT01995669|450662489|FG001|Overall Study|Progression|1|||
125282899|NCT01995669|450662490|FG002|Overall Study|Progression|1|||
125282900|NCT01995669|450662491|FG003|Overall Study|Progression|13|||
125282901|NCT01995669|450662488|FG000|Overall Study|Adverse Event|0|||
125448589|NCT03212365|451268969|FG001|Overall Study|Discharged prior to Xa level|8|||
125448590|NCT03212365|451268968|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
125448591|NCT03212365|451268969|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
125448592|NCT03212365|451268968|FG000|Overall Study|Refused study medication|3|||
125448593|NCT03212365|451268969|FG001|Overall Study|Refused study medication|0|||
125282902|NCT01995669|450662489|FG001|Overall Study|Adverse Event|0|||
125282903|NCT01995669|450662490|FG002|Overall Study|Adverse Event|0|||
125282904|NCT01995669|450662491|FG003|Overall Study|Adverse Event|3|||
125282905|NCT01995669|450662488|FG000|Overall Study|Death|0|||
125282906|NCT01995669|450662489|FG001|Overall Study|Death|0|||
125448594|NCT03212365|451268968|FG000|Overall Study|Initiated heparin infusion on floor|1|||
125282907|NCT01995669|450662490|FG002|Overall Study|Death|0|||
125282908|NCT01995669|450662491|FG003|Overall Study|Death|6|||
125282909|NCT01995669|450662488|FG000|Overall Study|Withdrawal by Subject|0|||
125282910|NCT01995669|450662489|FG001|Overall Study|Withdrawal by Subject|0|||
125282911|NCT01995669|450662490|FG002|Overall Study|Withdrawal by Subject|0|||
125282912|NCT01995669|450662491|FG003|Overall Study|Withdrawal by Subject|6|||
125282913|NCT01995669|450662488|FG000|Overall Study|Insurance Expired|0|||
125282914|NCT01995669|450662489|FG001|Overall Study|Insurance Expired|0|||
125282915|NCT01995669|450662490|FG002|Overall Study|Insurance Expired|0|||
125282916|NCT01995669|450662491|FG003|Overall Study|Insurance Expired|1|||
125282917|NCT02998203|450662492|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
125282918|NCT02998203|450662493|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
125282919|NCT02998203|450662492|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
125282920|NCT02998203|450662493|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
125282921|NCT03389555|450662494|FG000|Overall Study|Protocol Violation|1|||
125282922|NCT03389555|450662495|FG001|Overall Study|Protocol Violation|3|||
125282923|NCT03389555|450662494|FG000|Overall Study|Death|1|||
125282924|NCT03389555|450662495|FG001|Overall Study|Death|0|||
125282925|NCT00920218|450662498|FG000|Overall Study|Serious Adverse Event|2|||
125282926|NCT00920218|450662499|FG001|Overall Study|Serious Adverse Event|0|||
125282927|NCT00920218|450662500|FG002|Overall Study|Serious Adverse Event|2|||
125282928|NCT00920218|450662501|FG003|Overall Study|Serious Adverse Event|1|||
125282929|NCT00920218|450662498|FG000|Overall Study|Withdrawal by Subject|0|||
125282930|NCT00920218|450662499|FG001|Overall Study|Withdrawal by Subject|3|||
125282931|NCT00920218|450662500|FG002|Overall Study|Withdrawal by Subject|2|||
125282932|NCT00920218|450662501|FG003|Overall Study|Withdrawal by Subject|0|||
125282933|NCT00920218|450662498|FG000|Overall Study|Migrated/moved from study area|0|||
125282934|NCT00920218|450662499|FG001|Overall Study|Migrated/moved from study area|0|||
125282935|NCT00920218|450662500|FG002|Overall Study|Migrated/moved from study area|1|||
125282936|NCT00920218|450662501|FG003|Overall Study|Migrated/moved from study area|0|||
125282937|NCT00920218|450662498|FG000|Overall Study|Lost to Follow-up|0|||
125282938|NCT00920218|450662499|FG001|Overall Study|Lost to Follow-up|1|||
125282939|NCT00920218|450662500|FG002|Overall Study|Lost to Follow-up|0|||
125282940|NCT00920218|450662501|FG003|Overall Study|Lost to Follow-up|3|||
125282941|NCT00920218|450662498|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
125282942|NCT00920218|450662499|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
125282943|NCT00920218|450662500|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
125282944|NCT00920218|450662501|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
125282945|NCT00920218|450662498|FG000|Overall Study|Other|0|||
125282946|NCT00920218|450662499|FG001|Overall Study|Other|0|||
125282947|NCT00920218|450662500|FG002|Overall Study|Other|1|||
125282948|NCT00920218|450662501|FG003|Overall Study|Other|0|||
125282949|NCT03224507|450662505|FG000|Overall Study|Death|3|||
125282950|NCT03224507|450662506|FG001|Overall Study|Death|0|||
125282951|NCT03224507|450662505|FG000|Overall Study|Lack of Efficacy|6|||
125282952|NCT03224507|450662506|FG001|Overall Study|Lack of Efficacy|0|||
125282953|NCT03224507|450662505|FG000|Overall Study|Withdrawal by Subject|6|||
125282954|NCT03224507|450662506|FG001|Overall Study|Withdrawal by Subject|0|||
125282955|NCT01007435|450662507|FG000|Overall Study|Adverse Event|16|||
125282956|NCT01007435|450662508|FG001|Overall Study|Adverse Event|25|||
125282957|NCT01007435|450662509|FG002|Overall Study|Adverse Event|47|||
125282958|NCT01007435|450662510|FG003|Overall Study|Adverse Event|31|||
125282959|NCT01007435|450662507|FG000|Overall Study|Death|2|||
125282960|NCT01007435|450662508|FG001|Overall Study|Death|4|||
125282961|NCT01007435|450662509|FG002|Overall Study|Death|2|||
125282962|NCT01007435|450662510|FG003|Overall Study|Death|1|||
125282963|NCT01007435|450662507|FG000|Overall Study|Insufficient Therapeutic Response|21|||
125282964|NCT01007435|450662508|FG001|Overall Study|Insufficient Therapeutic Response|7|||
125282965|NCT01007435|450662509|FG002|Overall Study|Insufficient Therapeutic Response|2|||
125282966|NCT01007435|450662510|FG003|Overall Study|Insufficient Therapeutic Response|9|||
125282967|NCT01007435|450662507|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
125282968|NCT01007435|450662508|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
125282969|NCT01007435|450662509|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
125282970|NCT01007435|450662510|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
125282971|NCT01007435|450662507|FG000|Overall Study|Other Protocol Violation|2|||
125282972|NCT01007435|450662508|FG001|Overall Study|Other Protocol Violation|0|||
125282973|NCT01007435|450662509|FG002|Overall Study|Other Protocol Violation|1|||
125282974|NCT01007435|450662510|FG003|Overall Study|Other Protocol Violation|0|||
125282975|NCT01007435|450662507|FG000|Overall Study|Refused Treatment|13|||
125282976|NCT01007435|450662508|FG001|Overall Study|Refused Treatment|13|||
125282977|NCT01007435|450662509|FG002|Overall Study|Refused Treatment|5|||
125282978|NCT01007435|450662510|FG003|Overall Study|Refused Treatment|8|||
125282979|NCT01007435|450662507|FG000|Overall Study|Failure to Return|5|||
125282980|NCT01007435|450662508|FG001|Overall Study|Failure to Return|4|||
125282981|NCT01007435|450662509|FG002|Overall Study|Failure to Return|3|||
125282982|NCT01007435|450662510|FG003|Overall Study|Failure to Return|6|||
125282983|NCT01007435|450662507|FG000|Overall Study|Reason not Specified|1|||
125282984|NCT01007435|450662508|FG001|Overall Study|Reason not Specified|1|||
125282985|NCT01007435|450662509|FG002|Overall Study|Reason not Specified|2|||
125282986|NCT01007435|450662510|FG003|Overall Study|Reason not Specified|1|||
125282987|NCT01345591|450662513|FG000|Overall Study|Lost to Follow-up|1|||
125282988|NCT00847665|450662520|FG000|Overall Study|Withdrawal by Subject|1|||
125282989|NCT00847665|450662521|FG001|Overall Study|Withdrawal by Subject|0|||
125282990|NCT00624585|450662522|FG000|Overall Study|Death|3|||
125282991|NCT00624585|450662522|FG000|Overall Study|Disease Progression|6|||
125282992|NCT00624585|450662522|FG000|Overall Study|Adverse Event|3|||
125282993|NCT00676520|450662524|FG000|Overall Study|Withdrawal by Subject|163|||
125282994|NCT00676520|450662524|FG000|Overall Study|Lost to Follow-up|162|||
125282995|NCT00676520|450662524|FG000|Overall Study|Death|159|||
125282996|NCT00676520|450662524|FG000|Overall Study|Physician Decision|20|||
125282997|NCT00676520|450662524|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
125282998|NCT00676520|450662524|FG000|Overall Study|Other Reason|18|||
125282999|NCT01425359|450662525|FG000|Overall Study|Randomized but Not Treated|2|||
125283000|NCT01425359|450662526|FG001|Overall Study|Randomized but Not Treated|3|||
125283001|NCT01425359|450662525|FG000|Overall Study|Adverse Event|9|||
125283002|NCT01425359|450662526|FG001|Overall Study|Adverse Event|8|||
125283003|NCT01425359|450662525|FG000|Overall Study|Revascularization|0|||
125283004|NCT01425359|450662526|FG001|Overall Study|Revascularization|1|||
125283005|NCT01425359|450662525|FG000|Overall Study|Death|0|||
125283006|NCT01425359|450662526|FG001|Overall Study|Death|1|||
125283007|NCT01425359|450662525|FG000|Overall Study|Unsatisfactory Response|1|||
125283008|NCT01425359|450662526|FG001|Overall Study|Unsatisfactory Response|0|||
125283009|NCT01425359|450662525|FG000|Overall Study|Protocol Violation|1|||
125283010|NCT01425359|450662526|FG001|Overall Study|Protocol Violation|2|||
125283011|NCT01425359|450662525|FG000|Overall Study|Subject Withdrew Consent|1|||
125283012|NCT01425359|450662526|FG001|Overall Study|Subject Withdrew Consent|2|||
125283013|NCT01425359|450662525|FG000|Overall Study|Investigator's Discretion|2|||
125283014|NCT01425359|450662526|FG001|Overall Study|Investigator's Discretion|0|||
125283015|NCT01425359|450662525|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
125283016|NCT01425359|450662526|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
125283017|NCT03172325|450662527|FG000|Overall Study|Adverse Event|2|||
125283018|NCT03172325|450662528|FG001|Overall Study|Adverse Event|3|||
125283019|NCT03172325|450662527|FG000|Overall Study|Positive PPD|1|||
125283020|NCT03172325|450662528|FG001|Overall Study|Positive PPD|0|||
125283021|NCT03172325|450662527|FG000|Overall Study|Poor Compliance|1|||
125283022|NCT03172325|450662528|FG001|Overall Study|Poor Compliance|1|||
125283023|NCT03305419|450662533|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283024|NCT03305419|450662534|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
125283025|NCT03305419|450662535|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283026|NCT03305419|450662536|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283027|NCT03305419|450662537|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283028|NCT03305419|450662538|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283029|NCT03305419|450662539|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283030|NCT03305419|450662540|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
125283031|NCT03305419|450662533|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
125283032|NCT03305419|450662534|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
125283033|NCT03305419|450662535|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
125283034|NCT03305419|450662536|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
125283035|NCT03305419|450662537|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
125283036|NCT03305419|450662538|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
125448595|NCT03212365|451268969|FG001|Overall Study|Initiated heparin infusion on floor|1|||
125283037|NCT03305419|450662539|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
125283038|NCT03305419|450662540|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
125283039|NCT03305419|450662533|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
125283040|NCT03305419|450662534|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283041|NCT03305419|450662535|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283042|NCT03305419|450662536|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283043|NCT03305419|450662537|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283044|NCT03305419|450662538|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283045|NCT03305419|450662539|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283046|NCT03305419|450662540|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
125283047|NCT03305419|450662533|FG000|Part B (14 Days)|Adverse Event|0|||
125283048|NCT03305419|450662534|FG001|Part B (14 Days)|Adverse Event|0|||
125283049|NCT03305419|450662535|FG002|Part B (14 Days)|Adverse Event|0|||
125283050|NCT03305419|450662536|FG003|Part B (14 Days)|Adverse Event|0|||
125283051|NCT03305419|450662537|FG004|Part B (14 Days)|Adverse Event|1|||
125283052|NCT03305419|450662538|FG005|Part B (14 Days)|Adverse Event|2|||
125283053|NCT03305419|450662539|FG006|Part B (14 Days)|Adverse Event|4|||
125283054|NCT03305419|450662540|FG007|Part B (14 Days)|Adverse Event|0|||
125283055|NCT03305419|450662533|FG000|Part B (14 Days)|Physician Decision|0|||
125283056|NCT03305419|450662534|FG001|Part B (14 Days)|Physician Decision|0|||
125283057|NCT03305419|450662535|FG002|Part B (14 Days)|Physician Decision|0|||
125283058|NCT03305419|450662536|FG003|Part B (14 Days)|Physician Decision|0|||
125283059|NCT03305419|450662537|FG004|Part B (14 Days)|Physician Decision|2|||
125283060|NCT03305419|450662538|FG005|Part B (14 Days)|Physician Decision|8|||
125283061|NCT03305419|450662539|FG006|Part B (14 Days)|Physician Decision|1|||
125283062|NCT03305419|450662540|FG007|Part B (14 Days)|Physician Decision|0|||
125283063|NCT00075946|450662541|FG000|Overall Study|Path ineligible: undetermined histology|0|||
125283064|NCT00075946|450662542|FG001|Overall Study|Path ineligible: undetermined histology|0|||
125283065|NCT00075946|450662543|FG002|Overall Study|Path ineligible: undetermined histology|0|||
125283066|NCT00075946|450662544|FG003|Overall Study|Path ineligible: undetermined histology|0|||
125283067|NCT00075946|450662545|FG004|Overall Study|Path ineligible: undetermined histology|6|||
125283068|NCT00075946|450662541|FG000|Overall Study|Did not achieve response after induction|0|||
125283069|NCT00075946|450662542|FG001|Overall Study|Did not achieve response after induction|0|||
125283070|NCT00075946|450662543|FG002|Overall Study|Did not achieve response after induction|0|||
125283071|NCT00075946|450662544|FG003|Overall Study|Did not achieve response after induction|0|||
125283072|NCT00075946|450662545|FG004|Overall Study|Did not achieve response after induction|182|||
125283073|NCT00075946|450662541|FG000|Overall Study|Incorrectly randomized (no response)|5|||
125283074|NCT00075946|450662542|FG001|Overall Study|Incorrectly randomized (no response)|5|||
125283075|NCT00075946|450662543|FG002|Overall Study|Incorrectly randomized (no response)|5|||
125283076|NCT00075946|450662544|FG003|Overall Study|Incorrectly randomized (no response)|1|||
125283077|NCT00075946|450662545|FG004|Overall Study|Incorrectly randomized (no response)|0|||
125283078|NCT00075946|450662541|FG000|Overall Study|Adverse Event|2|||
125283079|NCT00075946|450662542|FG001|Overall Study|Adverse Event|10|||
125283080|NCT00075946|450662543|FG002|Overall Study|Adverse Event|0|||
125283081|NCT00075946|450662544|FG003|Overall Study|Adverse Event|2|||
125283082|NCT00075946|450662545|FG004|Overall Study|Adverse Event|0|||
125283083|NCT00075946|450662541|FG000|Overall Study|Death|0|||
125283084|NCT00075946|450662542|FG001|Overall Study|Death|1|||
125283085|NCT00075946|450662543|FG002|Overall Study|Death|0|||
125283086|NCT00075946|450662544|FG003|Overall Study|Death|0|||
125283087|NCT00075946|450662545|FG004|Overall Study|Death|0|||
125283088|NCT00075946|450662541|FG000|Overall Study|Withdrawal by Subject|23|||
125283089|NCT00075946|450662542|FG001|Overall Study|Withdrawal by Subject|58|||
125283090|NCT00075946|450662543|FG002|Overall Study|Withdrawal by Subject|4|||
125283091|NCT00075946|450662544|FG003|Overall Study|Withdrawal by Subject|9|||
125283092|NCT00075946|450662545|FG004|Overall Study|Withdrawal by Subject|0|||
125283093|NCT00075946|450662541|FG000|Overall Study|Alternative therapy|16|||
125283094|NCT00075946|450662542|FG001|Overall Study|Alternative therapy|2|||
125283095|NCT00075946|450662543|FG002|Overall Study|Alternative therapy|5|||
125283096|NCT00075946|450662544|FG003|Overall Study|Alternative therapy|0|||
125283097|NCT00075946|450662545|FG004|Overall Study|Alternative therapy|0|||
125283098|NCT00075946|450662541|FG000|Overall Study|Other complicating disease|7|||
125283099|NCT00075946|450662542|FG001|Overall Study|Other complicating disease|13|||
125283100|NCT00075946|450662543|FG002|Overall Study|Other complicating disease|1|||
125283101|NCT00075946|450662544|FG003|Overall Study|Other complicating disease|4|||
125283102|NCT00075946|450662545|FG004|Overall Study|Other complicating disease|0|||
125283103|NCT00075946|450662541|FG000|Overall Study|No response to retreatment|23|||
125283104|NCT00075946|450662542|FG001|Overall Study|No response to retreatment|0|||
125283105|NCT00075946|450662543|FG002|Overall Study|No response to retreatment|2|||
125283106|NCT00075946|450662544|FG003|Overall Study|No response to retreatment|0|||
125283107|NCT00075946|450662545|FG004|Overall Study|No response to retreatment|0|||
125283108|NCT00075946|450662541|FG000|Overall Study|Time to progression less than 6 months|15|||
125283109|NCT00075946|450662542|FG001|Overall Study|Time to progression less than 6 months|30|||
125283110|NCT00075946|450662543|FG002|Overall Study|Time to progression less than 6 months|8|||
125283111|NCT00075946|450662544|FG003|Overall Study|Time to progression less than 6 months|3|||
125283112|NCT00075946|450662545|FG004|Overall Study|Time to progression less than 6 months|0|||
125283113|NCT00075946|450662541|FG000|Overall Study|Other|57|||
125283114|NCT00075946|450662542|FG001|Overall Study|Other|32|||
125283115|NCT00075946|450662543|FG002|Overall Study|Other|3|||
125283116|NCT00075946|450662544|FG003|Overall Study|Other|11|||
125283117|NCT00075946|450662545|FG004|Overall Study|Other|0|||
125283118|NCT00889603|450662548|FG000|Overall Study|Adverse Event|7|||
125283119|NCT00889603|450662548|FG000|Overall Study|Death|3|||
125448596|NCT03212365|451268968|FG000|Overall Study|Unexpected return to OR|1|||
125283120|NCT00889603|450662548|FG000|Overall Study|Lost to Follow-up|19|||
125283121|NCT00889603|450662548|FG000|Overall Study|No longer willing to participant in stud|4|||
125283122|NCT00889603|450662548|FG000|Overall Study|Other|4|||
125283123|NCT01229254|450662549|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
125283124|NCT01229254|450662550|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
125283125|NCT01229254|450662551|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
125283126|NCT01229254|450662549|FG000|Overall Study|Adverse Event|4|||
125283127|NCT01229254|450662550|FG001|Overall Study|Adverse Event|5|||
125448597|NCT03212365|451268969|FG001|Overall Study|Unexpected return to OR|1|||
125448598|NCT03212365|451268968|FG000|Overall Study|Medication distribution error|1|||
125448599|NCT03212365|451268969|FG001|Overall Study|Medication distribution error|0|||
125448600|NCT03212365|451268968|FG000|Overall Study|Required epidural placement|1|||
125448601|NCT03212365|451268969|FG001|Overall Study|Required epidural placement|0|||
125448602|NCT03212365|451268968|FG000|Overall Study|Withdrawal by Subject|0|||
125448603|NCT03212365|451268969|FG001|Overall Study|Withdrawal by Subject|1|||
125448604|NCT03212365|451268968|FG000|Overall Study|developed acute renal failure|0|||
125448605|NCT03212365|451268969|FG001|Overall Study|developed acute renal failure|1|||
125448606|NCT00429793|451268981|FG000|Overall Study|Improper pre-protocol treatment|3|||
125448607|NCT00429793|451268981|FG000|Overall Study|Required test not done|1|||
125448608|NCT00429793|451268981|FG000|Overall Study|Never treated|1|||
125448609|NCT00429793|451268981|FG000|Overall Study|Non-measurable|1|||
125448610|NCT00097370|451268982|FG000|Stage 1|Adverse Event|3|||
125448611|NCT00097370|451268982|FG000|Stage 1|Withdrawal by Subject|1|||
125448612|NCT00097370|451268982|FG000|Stage 1|Lack of Efficacy|2|||
125448613|NCT00097370|451268982|FG000|Stage 2|Adverse Event|5|||
125448614|NCT00097370|451268982|FG000|Stage 2|Withdrawal by Subject|1|||
125448615|NCT00097370|451268982|FG000|Stage 2|Lack of Efficacy|3|||
125448616|NCT00097370|451268982|FG000|Stage 2|Pregnancy|1|||
125448617|NCT00097370|451268982|FG000|Stage 2|Sponsor Terminated Study|2|||
125448618|NCT00097370|451268982|FG000|Stage 2|Lost to Follow-up|1|||
125448619|NCT00097370|451268982|FG000|Stage 3|Adverse Event|2|||
125448620|NCT00097370|451268982|FG000|Stage 3|Withdrawal by Subject|3|||
125448621|NCT00097370|451268982|FG000|Stage 3|Lack of Efficacy|1|||
125448622|NCT00097370|451268982|FG000|Stage 3|Sponsor Terminated Study|52|||
125448623|NCT00097370|451268982|FG000|Stage 3|Lost to Follow-up|1|||
125448624|NCT02419755|451268983|FG000|Overall Study|Death|1|||
125448625|NCT02419755|451268984|FG001|Overall Study|Death|3|||
125448626|NCT02419755|451268983|FG000|Overall Study|Relapse|0|||
125448627|NCT02419755|451268984|FG001|Overall Study|Relapse|1|||
125448628|NCT02419755|451268983|FG000|Overall Study|Ineligible|1|||
125448629|NCT02419755|451268984|FG001|Overall Study|Ineligible|0|||
125448630|NCT02419755|451268983|FG000|Overall Study|Withdrawal by Subject|1|||
125448631|NCT02419755|451268984|FG001|Overall Study|Withdrawal by Subject|0|||
125448632|NCT02337361|451268986|FG000|3-month Follow-up|Lost to Follow-up|19|||
125448633|NCT02337361|451268987|FG001|3-month Follow-up|Lost to Follow-up|14|||
125448634|NCT02337361|451268986|FG000|6-month Follow-up|Lost to Follow-up|2|||
125448635|NCT02337361|451268987|FG001|6-month Follow-up|Lost to Follow-up|4|||
125448636|NCT02427646|451268988|FG000|Overall Study|Lack of Efficacy|2|||
125448637|NCT02427646|451268989|FG001|Overall Study|Lack of Efficacy|3|||
125448638|NCT02427646|451268988|FG000|Overall Study|Physician Decision|1|||
125448639|NCT02427646|451268989|FG001|Overall Study|Physician Decision|4|||
125448640|NCT02427646|451268988|FG000|Overall Study|Protocol Violation|3|||
125448641|NCT02427646|451268989|FG001|Overall Study|Protocol Violation|3|||
125448642|NCT02427646|451268988|FG000|Overall Study|Bothersome hand weakness|2|||
125448643|NCT02427646|451268989|FG001|Overall Study|Bothersome hand weakness|4|||
125448644|NCT01101542|451268990|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
125448645|NCT01101542|451268990|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
125448646|NCT01101542|451268990|FG000|Year 4 Surveillance Period|Other|287|||
125448647|NCT01101542|451268990|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
125448648|NCT01101542|451268990|FG000|Year 5 Surveillance Period|Pregnancy|1|||
125448649|NCT01101542|451268990|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
125448650|NCT01101542|451268990|FG000|Year 6 Surveillance Period|Pregnancy|1|||
125448651|NCT01101542|451268990|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
125448652|NCT00901485|451268991|FG000|Overall Study|Lack of Efficacy|0|||
125448653|NCT00901485|451268992|FG001|Overall Study|Lack of Efficacy|2|||
125448654|NCT00901485|451268991|FG000|Overall Study|Withdrawal by Subject|1|||
125448655|NCT00901485|451268992|FG001|Overall Study|Withdrawal by Subject|2|||
125448656|NCT02268396|451270839|FG000|Overall Study|Adverse Event|3|||
125448657|NCT02268396|451270839|FG000|Overall Study|Administrative|2|||
125448658|NCT02268396|451270839|FG000|Overall Study|Withdrawal by Subject|1|||
125448659|NCT02268396|451270839|FG000|Overall Study|Lost to Follow-up|2|||
125448660|NCT02268396|451270839|FG000|Overall Study|Protocol-Specified Criteria|2|||
125448661|NCT02268396|451270839|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
125448662|NCT03660943|451270840|FG000|Overall Study|Adverse Event|5|||
125448663|NCT03660943|451270841|FG001|Overall Study|Adverse Event|3|||
125448664|NCT03660943|451270840|FG000|Overall Study|Death|0|||
125448665|NCT03660943|451270841|FG001|Overall Study|Death|2|||
125448666|NCT03660943|451270840|FG000|Overall Study|Lost to Follow-up|7|||
125448667|NCT03660943|451270841|FG001|Overall Study|Lost to Follow-up|3|||
125448668|NCT03660943|451270840|FG000|Overall Study|Protocol Violation|3|||
125448669|NCT03660943|451270841|FG001|Overall Study|Protocol Violation|5|||
125283128|NCT01229254|450662551|FG002|Overall Study|Adverse Event|3|||
125448670|NCT03660943|451270840|FG000|Overall Study|Withdrawal by Subject|8|||
125448671|NCT03660943|451270841|FG001|Overall Study|Withdrawal by Subject|15|||
125448672|NCT03660943|451270840|FG000|Overall Study|Lack of Efficacy|9|||
125448673|NCT03660943|451270841|FG001|Overall Study|Lack of Efficacy|12|||
125448674|NCT03660943|451270840|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
125283129|NCT01229254|450662549|FG000|Overall Study|Lost to Follow-up|3|||
125283130|NCT01229254|450662550|FG001|Overall Study|Lost to Follow-up|0|||
125283131|NCT01229254|450662551|FG002|Overall Study|Lost to Follow-up|1|||
125283132|NCT01229254|450662549|FG000|Overall Study|Physician Decision|0|||
125283133|NCT01229254|450662550|FG001|Overall Study|Physician Decision|3|||
125283134|NCT01229254|450662551|FG002|Overall Study|Physician Decision|0|||
125283135|NCT01229254|450662549|FG000|Overall Study|Protocol Violation|4|||
125283136|NCT01229254|450662550|FG001|Overall Study|Protocol Violation|6|||
125283137|NCT01229254|450662551|FG002|Overall Study|Protocol Violation|5|||
125283138|NCT01229254|450662549|FG000|Overall Study|Withdrawal by Subject|1|||
125283139|NCT01229254|450662550|FG001|Overall Study|Withdrawal by Subject|0|||
125283140|NCT01229254|450662551|FG002|Overall Study|Withdrawal by Subject|1|||
125283141|NCT01229254|450662549|FG000|Overall Study|Non-compliance with Study Drug|0|||
125283142|NCT01229254|450662550|FG001|Overall Study|Non-compliance with Study Drug|1|||
125283143|NCT01229254|450662551|FG002|Overall Study|Non-compliance with Study Drug|1|||
125283144|NCT02231892|450662552|FG000|Overall Study|Lost to Follow-up|1|||
125283145|NCT02231892|450662553|FG001|Overall Study|Lost to Follow-up|0|||
125283146|NCT02231892|450662554|FG002|Overall Study|Lost to Follow-up|3|||
125283147|NCT02231892|450662552|FG000|Overall Study|Withdrawal by Subject|4|||
125283148|NCT02231892|450662553|FG001|Overall Study|Withdrawal by Subject|3|||
125283149|NCT02231892|450662554|FG002|Overall Study|Withdrawal by Subject|15|||
125283150|NCT02231892|450662552|FG000|Overall Study|Physician Decision|0|||
125283151|NCT02231892|450662553|FG001|Overall Study|Physician Decision|2|||
125283152|NCT02231892|450662554|FG002|Overall Study|Physician Decision|4|||
125283153|NCT02231892|450662552|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
125283154|NCT02231892|450662553|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
125283155|NCT02231892|450662554|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
125283156|NCT02231892|450662552|FG000|Overall Study|Participant motor threshold was >83%|0|||
125283157|NCT02231892|450662553|FG001|Overall Study|Participant motor threshold was >83%|0|||
125283158|NCT02231892|450662554|FG002|Overall Study|Participant motor threshold was >83%|9|||
125283159|NCT02231892|450662552|FG000|Overall Study|Could not find motor threshold|2|||
125411863|NCT02265705|451134844|FG004|Open Label Period|Physician Decision|1|||
125411864|NCT02265705|451134845|FG005|Open Label Period|Physician Decision|0|||
125411865|NCT02265705|451134846|FG006|Open Label Period|Physician Decision|0|||
125411866|NCT02265705|451134840|FG000|Open Label Period|Withdrawal by Subject|0|||
125411867|NCT02265705|451134841|FG001|Open Label Period|Withdrawal by Subject|0|||
125411868|NCT02265705|451134842|FG002|Open Label Period|Withdrawal by Subject|0|||
125411869|NCT02265705|451134843|FG003|Open Label Period|Withdrawal by Subject|0|||
125411870|NCT02265705|451134844|FG004|Open Label Period|Withdrawal by Subject|2|||
125411871|NCT02265705|451134845|FG005|Open Label Period|Withdrawal by Subject|0|||
125411872|NCT02265705|451134846|FG006|Open Label Period|Withdrawal by Subject|0|||
125411873|NCT02265705|451134840|FG000|Follow-up Period|Sponsor Decision|0|||
125411874|NCT02265705|451134841|FG001|Follow-up Period|Sponsor Decision|0|||
125411875|NCT02265705|451134842|FG002|Follow-up Period|Sponsor Decision|0|||
125411876|NCT02265705|451134843|FG003|Follow-up Period|Sponsor Decision|0|||
125411877|NCT02265705|451134844|FG004|Follow-up Period|Sponsor Decision|0|||
125411878|NCT02265705|451134845|FG005|Follow-up Period|Sponsor Decision|1|||
125411879|NCT02265705|451134846|FG006|Follow-up Period|Sponsor Decision|6|||
125411880|NCT02265705|451134840|FG000|Follow-up Period|Adverse Event|0|||
125411881|NCT02265705|451134841|FG001|Follow-up Period|Adverse Event|0|||
125411882|NCT02265705|451134842|FG002|Follow-up Period|Adverse Event|0|||
125411883|NCT02265705|451134843|FG003|Follow-up Period|Adverse Event|0|||
125411884|NCT02265705|451134844|FG004|Follow-up Period|Adverse Event|0|||
125411885|NCT02265705|451134845|FG005|Follow-up Period|Adverse Event|0|||
125411886|NCT02265705|451134846|FG006|Follow-up Period|Adverse Event|3|||
125411887|NCT02265705|451134840|FG000|Follow-up Period|Physician Decision|0|||
125411888|NCT02265705|451134841|FG001|Follow-up Period|Physician Decision|0|||
125411889|NCT02265705|451134842|FG002|Follow-up Period|Physician Decision|0|||
125411890|NCT02265705|451134843|FG003|Follow-up Period|Physician Decision|0|||
125411891|NCT02265705|451134844|FG004|Follow-up Period|Physician Decision|0|||
125411892|NCT02265705|451134845|FG005|Follow-up Period|Physician Decision|0|||
125411893|NCT02265705|451134846|FG006|Follow-up Period|Physician Decision|1|||
125411894|NCT02265705|451134840|FG000|Follow-up Period|Withdrawal by Subject|0|||
125283160|NCT02231892|450662553|FG001|Overall Study|Could not find motor threshold|0|||
125283161|NCT02231892|450662554|FG002|Overall Study|Could not find motor threshold|1|||
125411895|NCT02265705|451134841|FG001|Follow-up Period|Withdrawal by Subject|0|||
125411896|NCT02265705|451134842|FG002|Follow-up Period|Withdrawal by Subject|0|||
125411897|NCT02265705|451134843|FG003|Follow-up Period|Withdrawal by Subject|0|||
125411898|NCT02265705|451134844|FG004|Follow-up Period|Withdrawal by Subject|0|||
125283162|NCT02231892|450662552|FG000|Overall Study|Could not find reliable motor hotspot|0|||
125283163|NCT02231892|450662553|FG001|Overall Study|Could not find reliable motor hotspot|0|||
125411899|NCT02265705|451134845|FG005|Follow-up Period|Withdrawal by Subject|0|||
125411900|NCT02265705|451134846|FG006|Follow-up Period|Withdrawal by Subject|1|||
125411901|NCT00377676|451134848|FG000|Overall Study|Adverse Event|498|||
125411902|NCT00377676|451134849|FG001|Overall Study|Adverse Event|107|||
125411903|NCT00377676|451134848|FG000|Overall Study|Protocol Violation|33|||
125448675|NCT03660943|451270841|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
125448676|NCT02491411|451270844|FG000|Overall Study|Physician Decision|4|||
125448677|NCT04034238|451270845|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
125448678|NCT04034238|451270846|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
125448679|NCT04034238|451270847|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
125448680|NCT04034238|451270848|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
125448681|NCT04034238|451270845|FG000|Dose Escalation Phase|Screen failures|0|||
125448682|NCT04034238|451270846|FG001|Dose Escalation Phase|Screen failures|0|||
125448683|NCT04034238|451270847|FG002|Dose Escalation Phase|Screen failures|0|||
125448684|NCT04034238|451270848|FG003|Dose Escalation Phase|Screen failures|2|||
125448685|NCT04034238|451270845|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
125448686|NCT04034238|451270846|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
125448687|NCT04034238|451270847|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
125283164|NCT02231892|450662554|FG002|Overall Study|Could not find reliable motor hotspot|1|||
125283165|NCT01694121|450662557|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
125283166|NCT01694121|450662558|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
125283167|NCT02680041|450662559|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
125283168|NCT02680041|450662559|FG000|Overall Study|Lost to Follow-up|2|||
125283169|NCT00521599|450662560|FG000|Overall Study|Adverse Event|5|||
125283170|NCT00521599|450662561|FG001|Overall Study|Adverse Event|7|||
125283171|NCT00521599|450662562|FG002|Overall Study|Adverse Event|6|||
125283172|NCT00521599|450662560|FG000|Overall Study|Treatment Failure|8|||
125283173|NCT00521599|450662561|FG001|Overall Study|Treatment Failure|9|||
125283174|NCT00521599|450662562|FG002|Overall Study|Treatment Failure|22|||
125283175|NCT00521599|450662560|FG000|Overall Study|Lost to Follow-up|2|||
125283176|NCT00521599|450662561|FG001|Overall Study|Lost to Follow-up|1|||
125283177|NCT00521599|450662562|FG002|Overall Study|Lost to Follow-up|2|||
125283178|NCT00521599|450662560|FG000|Overall Study|Withdrawal by Subject|3|||
125283179|NCT00521599|450662561|FG001|Overall Study|Withdrawal by Subject|5|||
125283180|NCT00521599|450662562|FG002|Overall Study|Withdrawal by Subject|1|||
125283181|NCT00521599|450662560|FG000|Overall Study|Withdrawal by subject treatment related|3|||
125283182|NCT00521599|450662561|FG001|Overall Study|Withdrawal by subject treatment related|1|||
125283183|NCT00521599|450662562|FG002|Overall Study|Withdrawal by subject treatment related|2|||
125283184|NCT00521599|450662560|FG000|Overall Study|Protocol Violation|2|||
125283185|NCT00521599|450662561|FG001|Overall Study|Protocol Violation|4|||
125283186|NCT00521599|450662562|FG002|Overall Study|Protocol Violation|2|||
125283187|NCT00521599|450662560|FG000|Overall Study|Did not meet protocol eligibility|2|||
125283188|NCT00521599|450662561|FG001|Overall Study|Did not meet protocol eligibility|2|||
125283189|NCT00521599|450662562|FG002|Overall Study|Did not meet protocol eligibility|1|||
125283190|NCT02186652|450662563|FG000|Overall Study|Lost to Follow-up|2|||
125283191|NCT02186652|450662564|FG001|Overall Study|Lost to Follow-up|0|||
125283192|NCT00744978|450662565|FG000|Period 1|Lost to Follow-up|1|||
125283193|NCT00744978|450662566|FG001|Period 1|Lost to Follow-up|0|||
125283194|NCT00744978|450662565|FG000|Period 1|Withdrawal by Subject|0|||
125283195|NCT00744978|450662566|FG001|Period 1|Withdrawal by Subject|2|||
125283196|NCT00744978|450662565|FG000|Period 1|Other|0|||
125283197|NCT00744978|450662566|FG001|Period 1|Other|2|||
125283198|NCT00744978|450662565|FG000|Period 1|Adverse Event|4|||
125283199|NCT00744978|450662566|FG001|Period 1|Adverse Event|0|||
125283200|NCT00744978|450662565|FG000|Period 1|Randomized but not Treated|1|||
125283201|NCT00744978|450662566|FG001|Period 1|Randomized but not Treated|1|||
125283202|NCT00744978|450662565|FG000|Period 2|Adverse Event|0|||
125283203|NCT00744978|450662566|FG001|Period 2|Adverse Event|1|||
125283204|NCT00866047|450662570|FG000|Treatment Period|Progressive disease|13|||
125283205|NCT00866047|450662570|FG000|Treatment Period|Adverse Event|16|||
125283206|NCT00866047|450662570|FG000|Treatment Period|Physician Decision|14|||
125283207|NCT00866047|450662570|FG000|Treatment Period|Withdrawal by Subject|5|||
125283208|NCT00866047|450662570|FG000|Follow-up Period|Lost to Follow-up|5|||
125283209|NCT02928029|450662571|FG000|Overall Study|Withdrawal by Subject|0|||
125283210|NCT02928029|450662572|FG001|Overall Study|Withdrawal by Subject|1|||
125283211|NCT02928029|450662571|FG000|Overall Study|Radiological progression|1|||
125448688|NCT04034238|451270848|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
125448689|NCT04034238|451270845|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
125283212|NCT02928029|450662572|FG001|Overall Study|Radiological progression|0|||
125448690|NCT04034238|451270846|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
125448691|NCT04034238|451270847|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
125283213|NCT02928029|450662571|FG000|Overall Study|Clinical progression|1|||
125283214|NCT02928029|450662572|FG001|Overall Study|Clinical progression|2|||
125283215|NCT02928029|450662571|FG000|Overall Study|AE not related to clinical progression|1|||
125283216|NCT02928029|450662572|FG001|Overall Study|AE not related to clinical progression|1|||
125283217|NCT00515294|450662573|FG000|Overall Study|Lost to Follow-up|3|||
125283218|NCT00515294|450662574|FG001|Overall Study|Lost to Follow-up|2|||
125283219|NCT00515294|450662575|FG002|Overall Study|Lost to Follow-up|3|||
125283220|NCT00515294|450662576|FG003|Overall Study|Lost to Follow-up|1|||
125283221|NCT00515294|450662573|FG000|Overall Study|Driver simulator problems|1|||
125283222|NCT00515294|450662574|FG001|Overall Study|Driver simulator problems|1|||
125283223|NCT00515294|450662575|FG002|Overall Study|Driver simulator problems|1|||
125283224|NCT00515294|450662576|FG003|Overall Study|Driver simulator problems|3|||
125283225|NCT00515294|450662573|FG000|Overall Study|Caffeine amount inaccurate|5|||
125283226|NCT00515294|450662574|FG001|Overall Study|Caffeine amount inaccurate|0|||
125283227|NCT00515294|450662575|FG002|Overall Study|Caffeine amount inaccurate|7|||
125283228|NCT00515294|450662576|FG003|Overall Study|Caffeine amount inaccurate|0|||
125283229|NCT02778555|450662577|FG000|Overall Study|Withdrawal by Subject|55|||
125283230|NCT02778555|450662578|FG001|Overall Study|Withdrawal by Subject|32|||
125283231|NCT02778555|450662579|FG002|Overall Study|Withdrawal by Subject|107|||
125283232|NCT04659174|450662584|FG000|Overall Study|Sponsor decision to discontinue study|0|||
125283233|NCT04659174|450662585|FG001|Overall Study|Sponsor decision to discontinue study|2|||
125283234|NCT04659174|450662584|FG000|Overall Study|Lost to Follow-up|9|||
125283235|NCT04659174|450662585|FG001|Overall Study|Lost to Follow-up|11|||
125283236|NCT04659174|450662584|FG000|Overall Study|Adverse Event|8|||
125283237|NCT04659174|450662585|FG001|Overall Study|Adverse Event|5|||
125283238|NCT04659174|450662584|FG000|Overall Study|Withdrawal by Subject|17|||
125283239|NCT04659174|450662585|FG001|Overall Study|Withdrawal by Subject|33|||
125283240|NCT04659174|450662584|FG000|Overall Study|Progressive disease|0|||
125283241|NCT04659174|450662585|FG001|Overall Study|Progressive disease|2|||
125283242|NCT04659174|450662584|FG000|Overall Study|Other reasons|0|||
125411904|NCT00377676|451134849|FG001|Overall Study|Protocol Violation|27|||
125411905|NCT00377676|451134848|FG000|Overall Study|Death|5|||
125411906|NCT00377676|451134849|FG001|Overall Study|Death|2|||
125411907|NCT00377676|451134848|FG000|Overall Study|Withdrawal by Subject|187|||
125411908|NCT00377676|451134849|FG001|Overall Study|Withdrawal by Subject|72|||
125411909|NCT00377676|451134848|FG000|Overall Study|Lost to Follow-up|120|||
125411910|NCT00377676|451134849|FG001|Overall Study|Lost to Follow-up|56|||
125411911|NCT00377676|451134848|FG000|Overall Study|Other|118|||
125411912|NCT00377676|451134849|FG001|Overall Study|Other|58|||
125411913|NCT00779246|451134854|FG000|Overall Study|Missing sufficient data for analysis|33|||
125411914|NCT00779246|451134855|FG001|Overall Study|Missing sufficient data for analysis|53|||
125411915|NCT03579459|451134858|FG000|Overall Study|Adverse Event|7|||
125411916|NCT03579459|451134859|FG001|Overall Study|Adverse Event|6|||
125411917|NCT03579459|451134860|FG002|Overall Study|Adverse Event|2|||
125411918|NCT03579459|451134861|FG003|Overall Study|Adverse Event|6|||
125411919|NCT03579459|451134858|FG000|Overall Study|Death|1|||
125411920|NCT03579459|451134859|FG001|Overall Study|Death|0|||
125411921|NCT03579459|451134860|FG002|Overall Study|Death|1|||
125411922|NCT03579459|451134861|FG003|Overall Study|Death|2|||
125411923|NCT03579459|451134858|FG000|Overall Study|Lost to Follow-up|6|||
125411924|NCT03579459|451134859|FG001|Overall Study|Lost to Follow-up|2|||
125411925|NCT03579459|451134860|FG002|Overall Study|Lost to Follow-up|4|||
125411926|NCT03579459|451134861|FG003|Overall Study|Lost to Follow-up|1|||
125411927|NCT03579459|451134858|FG000|Overall Study|Physician Decision|0|||
125411928|NCT03579459|451134859|FG001|Overall Study|Physician Decision|1|||
125411929|NCT03579459|451134860|FG002|Overall Study|Physician Decision|0|||
125411930|NCT03579459|451134861|FG003|Overall Study|Physician Decision|1|||
125411931|NCT03579459|451134858|FG000|Overall Study|Protocol Violation|1|||
125411932|NCT03579459|451134859|FG001|Overall Study|Protocol Violation|2|||
125411933|NCT03579459|451134860|FG002|Overall Study|Protocol Violation|3|||
125411934|NCT03579459|451134861|FG003|Overall Study|Protocol Violation|5|||
125411935|NCT03579459|451134858|FG000|Overall Study|Withdrawal by Subject|12|||
125411936|NCT03579459|451134859|FG001|Overall Study|Withdrawal by Subject|8|||
125411937|NCT03579459|451134860|FG002|Overall Study|Withdrawal by Subject|11|||
125411938|NCT03579459|451134861|FG003|Overall Study|Withdrawal by Subject|8|||
125411939|NCT03579459|451134858|FG000|Overall Study|Medication error without associated adverse event|2|||
125411940|NCT03579459|451134859|FG001|Overall Study|Medication error without associated adverse event|1|||
125411941|NCT03579459|451134860|FG002|Overall Study|Medication error without associated adverse event|1|||
125411942|NCT03579459|451134861|FG003|Overall Study|Medication error without associated adverse event|0|||
125411943|NCT03579459|451134858|FG000|Overall Study|Other|0|||
125411944|NCT03579459|451134859|FG001|Overall Study|Other|1|||
125411945|NCT03579459|451134860|FG002|Overall Study|Other|1|||
125411946|NCT03579459|451134861|FG003|Overall Study|Other|0|||
125283243|NCT04659174|450662585|FG001|Overall Study|Other reasons|2|||
125283244|NCT04659174|450662584|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
125411947|NCT03579459|451134858|FG000|Overall Study|Randomized not vaccinated|0|||
125411948|NCT03579459|451134859|FG001|Overall Study|Randomized not vaccinated|2|||
125411949|NCT03579459|451134860|FG002|Overall Study|Randomized not vaccinated|0|||
125411950|NCT03579459|451134861|FG003|Overall Study|Randomized not vaccinated|1|||
125411951|NCT02528214|451134868|FG000|Overall Study|Protocol Violation|0|||
125411952|NCT02528214|451134869|FG001|Overall Study|Protocol Violation|1|||
125411953|NCT02528214|451134868|FG000|Overall Study|Adverse Event|0|||
125411954|NCT02528214|451134869|FG001|Overall Study|Adverse Event|1|||
125411955|NCT02528214|451134868|FG000|Overall Study|Other than specified above|0|||
125411956|NCT02528214|451134869|FG001|Overall Study|Other than specified above|1|||
125411957|NCT00941603|451134873|FG000|Overall Study|Adverse Event|10|||
125283245|NCT04659174|450662585|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
125283246|NCT04659174|450662584|FG000|Overall Study|Alcohol or illegal drug use|0|||
125283247|NCT04659174|450662585|FG001|Overall Study|Alcohol or illegal drug use|3|||
125411958|NCT00941603|451134874|FG001|Overall Study|Adverse Event|15|||
125411959|NCT00941603|451134875|FG002|Overall Study|Adverse Event|5|||
125411960|NCT00941603|451134876|FG003|Overall Study|Adverse Event|1|||
125411961|NCT00941603|451134877|FG004|Overall Study|Adverse Event|4|||
125283248|NCT04659174|450662584|FG000|Overall Study|Violation of entry criteria|1|||
125283249|NCT04659174|450662585|FG001|Overall Study|Violation of entry criteria|0|||
125283250|NCT04659174|450662584|FG000|Overall Study|Death|0|||
125283251|NCT04659174|450662585|FG001|Overall Study|Death|1|||
125283252|NCT01639339|450662590|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
125283253|NCT01639339|450662591|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
125283254|NCT01639339|450662590|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
125283255|NCT01639339|450662591|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
125283256|NCT01639339|450662590|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
125283257|NCT01639339|450662591|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
125283258|NCT01639339|450662590|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
125283259|NCT01639339|450662591|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
125283260|NCT01639339|450662590|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
125283261|NCT01639339|450662591|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
125283262|NCT01639339|450662590|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
125283263|NCT01639339|450662591|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
125283264|NCT01639339|450662590|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
125283265|NCT01639339|450662591|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
125283266|NCT01639339|450662590|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
125283267|NCT01639339|450662591|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
125283268|NCT01639339|450662590|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
125283269|NCT01639339|450662591|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
125283270|NCT01639339|450662590|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
125283271|NCT01639339|450662591|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
125283272|NCT03022097|450662592|FG000|Overall Study|Adverse Event|3|||
125283273|NCT03022097|450662593|FG001|Overall Study|Adverse Event|4|||
125283274|NCT03022097|450662594|FG002|Overall Study|Adverse Event|1|||
125283275|NCT03022097|450662595|FG003|Overall Study|Adverse Event|3|||
125283276|NCT03022097|450662592|FG000|Overall Study|Progressive Disease|2|||
125283277|NCT03022097|450662593|FG001|Overall Study|Progressive Disease|0|||
125283278|NCT03022097|450662594|FG002|Overall Study|Progressive Disease|5|||
125283279|NCT03022097|450662595|FG003|Overall Study|Progressive Disease|2|||
125283280|NCT03022097|450662592|FG000|Overall Study|Lack of Efficacy|0|||
125283281|NCT03022097|450662593|FG001|Overall Study|Lack of Efficacy|0|||
125283282|NCT03022097|450662594|FG002|Overall Study|Lack of Efficacy|3|||
125283283|NCT03022097|450662595|FG003|Overall Study|Lack of Efficacy|3|||
125283284|NCT03022097|450662592|FG000|Overall Study|Protocol Violation|1|||
125283285|NCT03022097|450662593|FG001|Overall Study|Protocol Violation|0|||
125283286|NCT03022097|450662594|FG002|Overall Study|Protocol Violation|1|||
125283287|NCT03022097|450662595|FG003|Overall Study|Protocol Violation|0|||
125283288|NCT03022097|450662592|FG000|Overall Study|Withdrawal by Subject|11|||
125283289|NCT03022097|450662593|FG001|Overall Study|Withdrawal by Subject|13|||
125283290|NCT03022097|450662594|FG002|Overall Study|Withdrawal by Subject|15|||
125283291|NCT03022097|450662595|FG003|Overall Study|Withdrawal by Subject|21|||
125283292|NCT03022097|450662592|FG000|Overall Study|Lost to Follow-up|0|||
125283293|NCT03022097|450662593|FG001|Overall Study|Lost to Follow-up|0|||
125283294|NCT03022097|450662594|FG002|Overall Study|Lost to Follow-up|1|||
125283295|NCT03022097|450662595|FG003|Overall Study|Lost to Follow-up|1|||
125283296|NCT03022097|450662592|FG000|Overall Study|Other|4|||
125283297|NCT03022097|450662593|FG001|Overall Study|Other|1|||
125283298|NCT03022097|450662594|FG002|Overall Study|Other|6|||
125283299|NCT03022097|450662595|FG003|Overall Study|Other|4|||
125283300|NCT03022097|450662592|FG000|Overall Study|Due to COVID-19 pandemic|0|||
125283301|NCT03022097|450662593|FG001|Overall Study|Due to COVID-19 pandemic|1|||
125411962|NCT00941603|451134878|FG005|Overall Study|Adverse Event|0|||
125411963|NCT00941603|451134873|FG000|Overall Study|Lost to Follow-up|0|||
125283302|NCT03022097|450662594|FG002|Overall Study|Due to COVID-19 pandemic|0|||
125283303|NCT03022097|450662595|FG003|Overall Study|Due to COVID-19 pandemic|0|||
125283304|NCT01451931|450662598|FG000|Overall Study|Lost to Follow-up|17|||
125283305|NCT01451931|450662599|FG001|Overall Study|Lost to Follow-up|36|||
125283306|NCT01451931|450662600|FG002|Overall Study|Lost to Follow-up|21|||
125283307|NCT01451931|450662598|FG000|Overall Study|Withdrawal by Subject|16|||
125283308|NCT01451931|450662599|FG001|Overall Study|Withdrawal by Subject|22|||
125283309|NCT01451931|450662600|FG002|Overall Study|Withdrawal by Subject|22|||
125283310|NCT00503581|450662601|FG000|Overall Study|Study closed|3|||
125283311|NCT00503581|450662602|FG001|Overall Study|Study closed|4|||
125411964|NCT00941603|451134874|FG001|Overall Study|Lost to Follow-up|0|||
125411965|NCT00941603|451134875|FG002|Overall Study|Lost to Follow-up|0|||
125283312|NCT00503581|450662603|FG002|Overall Study|Study closed|2|||
125283313|NCT04470908|450662604|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
125283314|NCT06107803|450662610|FG000|Overall Study|Adverse Event|1|||
125283315|NCT06107803|450662610|FG000|Overall Study|Withdrawal by Subject|2|||
125283316|NCT06107803|450662610|FG000|Overall Study|Protocol Violation|1|||
125283317|NCT02378298|450662612|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
125283318|NCT02378298|450662613|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
125283319|NCT02378298|450662614|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
125283320|NCT02378298|450662612|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
125283321|NCT02378298|450662613|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
125283322|NCT02378298|450662614|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
125283323|NCT02378298|450662612|FG000|Surveillance (19-68 Weeks)|Death|1|||
125283324|NCT02378298|450662613|FG001|Surveillance (19-68 Weeks)|Death|0|||
125283325|NCT02378298|450662614|FG002|Surveillance (19-68 Weeks)|Death|0|||
125283326|NCT04730635|450662615|FG000|Overall Study|Lost to Follow-up|1|||
125283327|NCT04730635|450662616|FG001|Overall Study|Lost to Follow-up|0|||
125283328|NCT04730635|450662615|FG000|Overall Study|Withdrawal by Subject|0|||
125283329|NCT04730635|450662616|FG001|Overall Study|Withdrawal by Subject|1|||
125283330|NCT04934800|450662617|FG000|Overall Study|Other|1|||
125283331|NCT04934800|450662617|FG000|Overall Study|Withdrawal by Subject|5|||
125283332|NCT04934800|450662617|FG000|Overall Study|Lack of Efficacy|1|||
125283333|NCT04934800|450662617|FG000|Overall Study|Adverse Event|9|||
125283334|NCT04934800|450662617|FG000|Overall Study|Lost to Follow-up|5|||
125283335|NCT04934800|450662617|FG000|Overall Study|Enrolled but not treated|1|||
125283336|NCT02118766|450662620|FG000|Overall Study|Adverse Event|7|||
125283337|NCT02118766|450662621|FG001|Overall Study|Adverse Event|2|||
125283338|NCT02118766|450662620|FG000|Overall Study|Withdrawal by Subject|3|||
125283339|NCT02118766|450662621|FG001|Overall Study|Withdrawal by Subject|6|||
125283340|NCT02118766|450662620|FG000|Overall Study|Lost to Follow-up|5|||
125283341|NCT02118766|450662621|FG001|Overall Study|Lost to Follow-up|4|||
125283342|NCT02118766|450662620|FG000|Overall Study|Withdrawal by parent/guardian|12|||
125283343|NCT02118766|450662621|FG001|Overall Study|Withdrawal by parent/guardian|18|||
125283344|NCT02118766|450662620|FG000|Overall Study|Other|3|||
125283345|NCT02118766|450662621|FG001|Overall Study|Other|1|||
125283346|NCT03219034|450662623|FG000|Overall Study|Lost to Follow-up|9|||
125283347|NCT03219034|450662624|FG001|Overall Study|Lost to Follow-up|13|||
125283348|NCT03219034|450662623|FG000|Overall Study|Additional dental work needed|1|||
125283349|NCT03219034|450662624|FG001|Overall Study|Additional dental work needed|0|||
125283350|NCT03219034|450662623|FG000|Overall Study|UPPP Surgery|1|||
125283351|NCT03219034|450662624|FG001|Overall Study|UPPP Surgery|0|||
125283352|NCT03219034|450662623|FG000|Overall Study|Dental sensitivity|0|||
125283353|NCT03219034|450662624|FG001|Overall Study|Dental sensitivity|1|||
125283354|NCT03219034|450662623|FG000|Overall Study|Death in family|0|||
125283355|NCT03219034|450662624|FG001|Overall Study|Death in family|1|||
125283356|NCT02438683|450662625|FG000|Overall Study|Adverse Event|1|||
125283357|NCT02438683|450662626|FG001|Overall Study|Adverse Event|0|||
125283358|NCT02438683|450662627|FG002|Overall Study|Adverse Event|0|||
125283359|NCT02438683|450662628|FG003|Overall Study|Adverse Event|0|||
125283360|NCT02438683|450662629|FG004|Overall Study|Adverse Event|0|||
125283361|NCT02438683|450662630|FG005|Overall Study|Adverse Event|0|||
125283362|NCT04669262|450662633|FG000|Overall Study|Withdrawal by Subject|0|||
125283363|NCT04669262|450662634|FG001|Overall Study|Withdrawal by Subject|0|||
125283364|NCT04669262|450662635|FG002|Overall Study|Withdrawal by Subject|0|||
125283365|NCT04669262|450662636|FG003|Overall Study|Withdrawal by Subject|1|||
125283366|NCT04669262|450662633|FG000|Overall Study|Randomized but Not Treated|0|||
125283367|NCT04669262|450662634|FG001|Overall Study|Randomized but Not Treated|1|||
125283368|NCT04669262|450662635|FG002|Overall Study|Randomized but Not Treated|0|||
125283369|NCT04669262|450662636|FG003|Overall Study|Randomized but Not Treated|0|||
125283370|NCT01638013|450662637|FG000|Overall Study|Adverse Event|36|||
125283371|NCT01638013|450662638|FG001|Overall Study|Adverse Event|29|||
125283372|NCT01638013|450662639|FG002|Overall Study|Adverse Event|48|||
125283373|NCT01638013|450662637|FG000|Overall Study|Lack of Efficacy|39|||
125283374|NCT01638013|450662638|FG001|Overall Study|Lack of Efficacy|11|||
125283375|NCT01638013|450662639|FG002|Overall Study|Lack of Efficacy|14|||
125283376|NCT01638013|450662637|FG000|Overall Study|Protocol Violation|10|||
125283377|NCT01638013|450662638|FG001|Overall Study|Protocol Violation|7|||
125283378|NCT01638013|450662639|FG002|Overall Study|Protocol Violation|11|||
125283379|NCT01638013|450662637|FG000|Overall Study|Met discontinuation criteria|4|||
125283380|NCT01638013|450662638|FG001|Overall Study|Met discontinuation criteria|0|||
125283381|NCT01638013|450662639|FG002|Overall Study|Met discontinuation criteria|7|||
125283382|NCT01638013|450662637|FG000|Overall Study|Subject Lost to Follow up|1|||
125283383|NCT01638013|450662638|FG001|Overall Study|Subject Lost to Follow up|0|||
125283384|NCT01638013|450662639|FG002|Overall Study|Subject Lost to Follow up|1|||
125283385|NCT01638013|450662637|FG000|Overall Study|Miscellaneous|25|||
125283386|NCT01638013|450662638|FG001|Overall Study|Miscellaneous|19|||
125283387|NCT01638013|450662639|FG002|Overall Study|Miscellaneous|23|||
125283388|NCT01638013|450662637|FG000|Overall Study|Withdrawal of Consent|16|||
125283389|NCT01638013|450662638|FG001|Overall Study|Withdrawal of Consent|12|||
125283390|NCT01638013|450662639|FG002|Overall Study|Withdrawal of Consent|16|||
125283391|NCT01638013|450662637|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
125283392|NCT01638013|450662638|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
125283393|NCT01638013|450662639|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
125283394|NCT01846299|450662640|FG000|Overall Study|Physician Decision|4|||
125283395|NCT01846299|450662641|FG001|Overall Study|Physician Decision|2|||
125283396|NCT01846299|450662640|FG000|Overall Study|Protocol deviation|1|||
125283397|NCT01846299|450662641|FG001|Overall Study|Protocol deviation|0|||
125283398|NCT01846299|450662640|FG000|Overall Study|Death|1|||
125283399|NCT01846299|450662641|FG001|Overall Study|Death|2|||
125283400|NCT01846299|450662640|FG000|Overall Study|Lost to Follow-up|3|||
125283401|NCT01846299|450662641|FG001|Overall Study|Lost to Follow-up|0|||
125283402|NCT01846299|450662640|FG000|Overall Study|Withdrawal by Subject|1|||
125283403|NCT01846299|450662641|FG001|Overall Study|Withdrawal by Subject|6|||
125283404|NCT01846299|450662640|FG000|Overall Study|Adverse Event|2|||
125283405|NCT01846299|450662641|FG001|Overall Study|Adverse Event|0|||
125303128|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303129|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303130|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303131|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303132|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303133|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303134|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303135|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303136|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303137|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
125303138|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303139|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303140|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303141|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303142|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303143|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303144|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
125303145|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303146|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303147|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303148|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303149|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303150|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
125303151|NCT03100058|450736661|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303152|NCT03100058|450736662|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303153|NCT03100058|450736663|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303154|NCT03100058|450736664|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303155|NCT03100058|450736665|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303156|NCT03100058|450736666|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303157|NCT03100058|450736667|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303158|NCT03100058|450736668|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303159|NCT03100058|450736669|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303160|NCT03100058|450736670|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
125303161|NCT03100058|450736671|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
125303162|NCT03100058|450736672|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
125303163|NCT03100058|450736673|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
125303164|NCT03100058|450736661|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303165|NCT03100058|450736662|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303166|NCT03100058|450736663|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303167|NCT03100058|450736664|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303168|NCT03100058|450736665|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303169|NCT03100058|450736666|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303170|NCT03100058|450736667|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303171|NCT03100058|450736668|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303172|NCT03100058|450736669|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303173|NCT03100058|450736670|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125303174|NCT03100058|450736671|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
125303175|NCT03100058|450736672|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
125411966|NCT00941603|451134876|FG003|Overall Study|Lost to Follow-up|1|||
125411967|NCT00941603|451134877|FG004|Overall Study|Lost to Follow-up|0|||
125411968|NCT00941603|451134878|FG005|Overall Study|Lost to Follow-up|2|||
125283406|NCT00496483|450664840|FG000|Overall Study|Not dosed|9|||
125283407|NCT00496483|450664840|FG000|Overall Study|Adverse Event|2|||
125283408|NCT00496483|450664840|FG000|Overall Study|Lack of Efficacy|1|||
125283409|NCT03095027|450664843|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
125283410|NCT03095027|450664844|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
125283411|NCT04021524|450664845|FG000|Overall Study|Change in surgical intervention|0|||
125283412|NCT04021524|450664846|FG001|Overall Study|Change in surgical intervention|1|||
125283413|NCT05275010|450664847|FG000|Overall Study|Reason Not Specified|4|||
125283414|NCT05275010|450664848|FG001|Overall Study|Reason Not Specified|1|||
125283415|NCT05275010|450664847|FG000|Overall Study|Withdrawal by Subject|1|||
125283416|NCT05275010|450664848|FG001|Overall Study|Withdrawal by Subject|0|||
125283417|NCT05275010|450664847|FG000|Overall Study|Lost to Follow-up|0|||
125283418|NCT05275010|450664848|FG001|Overall Study|Lost to Follow-up|1|||
125283419|NCT00730041|450664849|FG000|Overall Study|Lost to Follow-up|0|||
125283420|NCT00730041|450664850|FG001|Overall Study|Lost to Follow-up|2|||
125283421|NCT05526781|450664851|FG000|Overall Study|Lost to Follow-up|1|||
125283422|NCT04085458|450664852|FG000|Overall Study|Other|1|||
125283423|NCT04085458|450664852|FG000|Overall Study|Withdrawal by Subject|2|||
125283424|NCT04085458|450664852|FG000|Overall Study|Adverse Event|2|||
125283425|NCT03632993|450664853|FG000|Overall Study|Withdrawal by Subject|1|||
125283426|NCT03632993|450664854|FG001|Overall Study|Withdrawal by Subject|0|||
125283427|NCT03632993|450664855|FG002|Overall Study|Withdrawal by Subject|0|||
125283428|NCT03632993|450664856|FG003|Overall Study|Withdrawal by Subject|0|||
125283429|NCT03632993|450664857|FG004|Overall Study|Withdrawal by Subject|0|||
125283430|NCT03632993|450664858|FG005|Overall Study|Withdrawal by Subject|0|||
125283431|NCT03632993|450664859|FG006|Overall Study|Withdrawal by Subject|0|||
125283432|NCT03632993|450664860|FG007|Overall Study|Withdrawal by Subject|0|||
125283433|NCT03632993|450664861|FG008|Overall Study|Withdrawal by Subject|0|||
125283434|NCT03632993|450664862|FG009|Overall Study|Withdrawal by Subject|1|||
125283435|NCT03632993|450664853|FG000|Overall Study|Protocol Non-compliance|0|||
125283436|NCT03632993|450664854|FG001|Overall Study|Protocol Non-compliance|1|||
125283437|NCT03632993|450664855|FG002|Overall Study|Protocol Non-compliance|0|||
125283438|NCT03632993|450664856|FG003|Overall Study|Protocol Non-compliance|0|||
125283439|NCT03632993|450664857|FG004|Overall Study|Protocol Non-compliance|0|||
125283440|NCT03632993|450664858|FG005|Overall Study|Protocol Non-compliance|0|||
125283441|NCT03632993|450664859|FG006|Overall Study|Protocol Non-compliance|0|||
125283442|NCT03632993|450664860|FG007|Overall Study|Protocol Non-compliance|0|||
125283443|NCT03632993|450664861|FG008|Overall Study|Protocol Non-compliance|0|||
125283444|NCT03632993|450664862|FG009|Overall Study|Protocol Non-compliance|0|||
125283445|NCT03632993|450664853|FG000|Overall Study|Lost to Follow-up|0|||
125283446|NCT03632993|450664854|FG001|Overall Study|Lost to Follow-up|0|||
125283447|NCT03632993|450664855|FG002|Overall Study|Lost to Follow-up|0|||
125283448|NCT03632993|450664856|FG003|Overall Study|Lost to Follow-up|0|||
125283449|NCT03632993|450664857|FG004|Overall Study|Lost to Follow-up|0|||
125283450|NCT03632993|450664858|FG005|Overall Study|Lost to Follow-up|1|||
125283451|NCT03632993|450664859|FG006|Overall Study|Lost to Follow-up|0|||
125283452|NCT03632993|450664860|FG007|Overall Study|Lost to Follow-up|1|||
125283453|NCT03632993|450664861|FG008|Overall Study|Lost to Follow-up|0|||
125283454|NCT03632993|450664862|FG009|Overall Study|Lost to Follow-up|0|||
125283455|NCT03632993|450664853|FG000|Overall Study|Adverse Event|0|||
125283456|NCT03632993|450664854|FG001|Overall Study|Adverse Event|0|||
125283457|NCT03632993|450664855|FG002|Overall Study|Adverse Event|0|||
125283458|NCT03632993|450664856|FG003|Overall Study|Adverse Event|0|||
125283459|NCT03632993|450664857|FG004|Overall Study|Adverse Event|0|||
125283460|NCT03632993|450664858|FG005|Overall Study|Adverse Event|1|||
125283461|NCT03632993|450664859|FG006|Overall Study|Adverse Event|0|||
125283462|NCT03632993|450664860|FG007|Overall Study|Adverse Event|1|||
125283463|NCT03632993|450664861|FG008|Overall Study|Adverse Event|0|||
125283464|NCT03632993|450664862|FG009|Overall Study|Adverse Event|0|||
125283465|NCT02743949|450664863|FG000|Overall Study|Adverse Event|0|||
125283466|NCT02743949|450664864|FG001|Overall Study|Adverse Event|0|||
125283467|NCT02743949|450664865|FG002|Overall Study|Adverse Event|2|||
125283468|NCT02743949|450664863|FG000|Overall Study|Significant Protocol Deviation|2|||
125283469|NCT02743949|450664864|FG001|Overall Study|Significant Protocol Deviation|0|||
125283470|NCT02743949|450664865|FG002|Overall Study|Significant Protocol Deviation|1|||
125283471|NCT02743949|450664863|FG000|Overall Study|Voluntary Withdrawal|2|||
125283472|NCT02743949|450664864|FG001|Overall Study|Voluntary Withdrawal|1|||
125283473|NCT02743949|450664865|FG002|Overall Study|Voluntary Withdrawal|0|||
125283474|NCT03327220|450664866|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
125283475|NCT03327220|450664867|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
125283476|NCT03327220|450664866|FG000|Overall Study|Investigator Decision|2|||
125283477|NCT03327220|450664867|FG001|Overall Study|Investigator Decision|0|||
125283478|NCT03327220|450664866|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
125283479|NCT03327220|450664867|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
125283480|NCT03327220|450664866|FG000|Overall Study|Fungal infection|1|||
125283481|NCT03327220|450664867|FG001|Overall Study|Fungal infection|0|||
125283482|NCT03327220|450664866|FG000|Overall Study|Discharged to Rehabilitation|0|||
125283483|NCT03327220|450664867|FG001|Overall Study|Discharged to Rehabilitation|1|||
125283484|NCT03327220|450664866|FG000|Overall Study|Missing|1|||
125283485|NCT03327220|450664867|FG001|Overall Study|Missing|0|||
125283486|NCT00523705|450664870|FG000|Overall Study|No time for study.|0|||
125283487|NCT00523705|450664871|FG001|Overall Study|No time for study.|1|||
125283488|NCT00368836|450664872|FG000|Phase II|Screen Failure|1|||
125283489|NCT00368836|450664872|FG000|Phase II|Withdrawal by Subject|1|||
125283490|NCT00368836|450664872|FG000|Phase II|unable to collect blood and/or breath|17|||
125283491|NCT00368836|450664872|FG000|Phase II|Protocol Violation|2|||
125283492|NCT02442310|450664873|FG000|Overall Study|Adverse Event|2|||
125283493|NCT02442310|450664873|FG000|Overall Study|Withdrawal by Subject|1|||
125283494|NCT04154345|450664876|FG000|Overall Study|Covid-19 pandemic|4|||
125283495|NCT03622112|450664889|FG000|Overall Study|Withdrawal by Subject|6|||
125283496|NCT03622112|450664890|FG001|Overall Study|Withdrawal by Subject|2|||
125283497|NCT03622112|450664891|FG002|Overall Study|Withdrawal by Subject|4|||
125283498|NCT03622112|450664892|FG003|Overall Study|Withdrawal by Subject|2|||
125283499|NCT03622112|450664893|FG004|Overall Study|Withdrawal by Subject|1|||
125283500|NCT03622112|450664894|FG005|Overall Study|Withdrawal by Subject|2|||
125283501|NCT03622112|450664895|FG006|Overall Study|Withdrawal by Subject|2|||
125283502|NCT03622112|450664889|FG000|Overall Study|Death|0|||
125283503|NCT03622112|450664890|FG001|Overall Study|Death|0|||
125283504|NCT03622112|450664891|FG002|Overall Study|Death|0|||
125283505|NCT03622112|450664892|FG003|Overall Study|Death|1|||
125283506|NCT03622112|450664893|FG004|Overall Study|Death|0|||
125283507|NCT03622112|450664894|FG005|Overall Study|Death|0|||
125283508|NCT03622112|450664895|FG006|Overall Study|Death|0|||
125283509|NCT03622112|450664889|FG000|Overall Study|Lost to Follow-up|1|||
125283510|NCT03622112|450664890|FG001|Overall Study|Lost to Follow-up|1|||
125283511|NCT03622112|450664891|FG002|Overall Study|Lost to Follow-up|0|||
125283512|NCT03622112|450664892|FG003|Overall Study|Lost to Follow-up|0|||
125283513|NCT03622112|450664893|FG004|Overall Study|Lost to Follow-up|0|||
125283514|NCT03622112|450664894|FG005|Overall Study|Lost to Follow-up|0|||
125283515|NCT03622112|450664895|FG006|Overall Study|Lost to Follow-up|0|||
125283516|NCT03622112|450664889|FG000|Overall Study|Study-specific withdrawal criteria|10|||
125283517|NCT03622112|450664890|FG001|Overall Study|Study-specific withdrawal criteria|8|||
125283518|NCT03622112|450664891|FG002|Overall Study|Study-specific withdrawal criteria|7|||
125283519|NCT03622112|450664892|FG003|Overall Study|Study-specific withdrawal criteria|6|||
125283520|NCT03622112|450664893|FG004|Overall Study|Study-specific withdrawal criteria|4|||
125283521|NCT03622112|450664894|FG005|Overall Study|Study-specific withdrawal criteria|18|||
125283522|NCT03622112|450664895|FG006|Overall Study|Study-specific withdrawal criteria|4|||
125283523|NCT03622112|450664889|FG000|Overall Study|Protocol Violation|2|||
125283524|NCT03622112|450664890|FG001|Overall Study|Protocol Violation|0|||
125283525|NCT03622112|450664891|FG002|Overall Study|Protocol Violation|1|||
125283526|NCT03622112|450664892|FG003|Overall Study|Protocol Violation|1|||
125283527|NCT03622112|450664893|FG004|Overall Study|Protocol Violation|0|||
125283528|NCT03622112|450664894|FG005|Overall Study|Protocol Violation|0|||
125283529|NCT03622112|450664895|FG006|Overall Study|Protocol Violation|0|||
125283530|NCT03622112|450664889|FG000|Overall Study|Adverse Event|6|||
125283531|NCT03622112|450664890|FG001|Overall Study|Adverse Event|8|||
125283532|NCT03622112|450664891|FG002|Overall Study|Adverse Event|4|||
125283533|NCT03622112|450664892|FG003|Overall Study|Adverse Event|11|||
125283534|NCT03622112|450664893|FG004|Overall Study|Adverse Event|4|||
125283535|NCT03622112|450664894|FG005|Overall Study|Adverse Event|20|||
125283536|NCT03622112|450664895|FG006|Overall Study|Adverse Event|2|||
125283537|NCT03622112|450664889|FG000|Overall Study|Reason not specified|0|||
125283538|NCT03622112|450664890|FG001|Overall Study|Reason not specified|1|||
125283539|NCT03622112|450664891|FG002|Overall Study|Reason not specified|0|||
125283540|NCT03622112|450664892|FG003|Overall Study|Reason not specified|1|||
125283541|NCT03622112|450664893|FG004|Overall Study|Reason not specified|1|||
125283542|NCT03622112|450664894|FG005|Overall Study|Reason not specified|2|||
125283543|NCT03622112|450664895|FG006|Overall Study|Reason not specified|1|||
125283544|NCT03773133|450664896|FG000|Overall Study|Screen Failure|8|||
125283545|NCT01610713|450664897|FG000|Overall Study|Adverse Event|3|||
125283546|NCT01610713|450664898|FG001|Overall Study|Adverse Event|0|||
125283547|NCT01610713|450664897|FG000|Overall Study|Lack of Efficacy|1|||
125283548|NCT01610713|450664898|FG001|Overall Study|Lack of Efficacy|0|||
125283549|NCT01610713|450664897|FG000|Overall Study|low mood and poor motivation|1|||
125283550|NCT01610713|450664898|FG001|Overall Study|low mood and poor motivation|0|||
125283551|NCT01610713|450664897|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
125283552|NCT01610713|450664898|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
125283553|NCT01610713|450664897|FG000|Overall Study|Lost to Follow-up|0|||
125283554|NCT01610713|450664898|FG001|Overall Study|Lost to Follow-up|1|||
125283555|NCT03943550|450664902|FG000|Overall Study|Adverse Event|0|||
125283556|NCT03943550|450664903|FG001|Overall Study|Adverse Event|0|||
125283557|NCT03943550|450664904|FG002|Overall Study|Adverse Event|1|||
125283558|NCT03943550|450664902|FG000|Overall Study|Lost to Follow-up|0|||
125283559|NCT03943550|450664903|FG001|Overall Study|Lost to Follow-up|0|||
125283560|NCT03943550|450664904|FG002|Overall Study|Lost to Follow-up|1|||
125283561|NCT03943550|450664902|FG000|Overall Study|Progressive Disease|0|||
125283562|NCT03943550|450664903|FG001|Overall Study|Progressive Disease|0|||
125283563|NCT03943550|450664904|FG002|Overall Study|Progressive Disease|2|||
125283564|NCT03943550|450664902|FG000|Overall Study|Participant Moved Out of the Country|0|||
125283565|NCT03943550|450664903|FG001|Overall Study|Participant Moved Out of the Country|1|||
125283566|NCT03943550|450664904|FG002|Overall Study|Participant Moved Out of the Country|0|||
125283567|NCT03359785|450664905|FG000|Overall Study|Protocol Violation|0|||
125283568|NCT03359785|450664906|FG001|Overall Study|Protocol Violation|1|||
125283569|NCT03359785|450664907|FG002|Overall Study|Protocol Violation|0|||
125283570|NCT03359785|450664908|FG003|Overall Study|Protocol Violation|0|||
125283571|NCT03359785|450664905|FG000|Overall Study|Early study termination due to study pause|0|||
125283572|NCT03359785|450664906|FG001|Overall Study|Early study termination due to study pause|0|||
125283573|NCT03359785|450664907|FG002|Overall Study|Early study termination due to study pause|2|||
125283574|NCT03359785|450664908|FG003|Overall Study|Early study termination due to study pause|0|||
125283575|NCT03359785|450664905|FG000|Overall Study|Withdrawal by Subject|2|||
125283576|NCT03359785|450664906|FG001|Overall Study|Withdrawal by Subject|2|||
125283577|NCT03359785|450664907|FG002|Overall Study|Withdrawal by Subject|0|||
125283578|NCT03359785|450664908|FG003|Overall Study|Withdrawal by Subject|0|||
125283579|NCT03650803|450664912|FG000|Overall Study|Lost to Follow-up|6|||
125283580|NCT02901054|450664916|FG000|Overall Study|Physician Decision|1|||
125283581|NCT02901054|450664916|FG000|Overall Study|Withdrawal by Subject|3|||
125283582|NCT01534260|450664918|FG000|Overall Study|Adverse Event|1|||
125283583|NCT01534260|450664919|FG001|Overall Study|Adverse Event|8|||
125283584|NCT01534260|450664918|FG000|Overall Study|Death|2|||
125283585|NCT01534260|450664919|FG001|Overall Study|Death|0|||
125283586|NCT01534260|450664918|FG000|Overall Study|Lack of Efficacy|1|||
125283587|NCT01534260|450664919|FG001|Overall Study|Lack of Efficacy|1|||
125283588|NCT01534260|450664918|FG000|Overall Study|Withdrawal by Subject|1|||
125283589|NCT01534260|450664919|FG001|Overall Study|Withdrawal by Subject|3|||
125283590|NCT01534260|450664918|FG000|Overall Study|Disease Progression|8|||
125283591|NCT01534260|450664919|FG001|Overall Study|Disease Progression|6|||
125283592|NCT01534260|450664918|FG000|Overall Study|Physician Decision|3|||
125283593|NCT01534260|450664919|FG001|Overall Study|Physician Decision|1|||
125283594|NCT01534260|450664918|FG000|Overall Study|No treatment, per protocol|0|||
125283595|NCT01534260|450664919|FG001|Overall Study|No treatment, per protocol|1|||
125283596|NCT01818258|450664922|FG000|Overall Study|Death|3|||
125283597|NCT01818258|450664923|FG001|Overall Study|Death|0|||
125283598|NCT01818258|450664922|FG000|Overall Study|Withdrawal by Subject|0|||
125283599|NCT01818258|450664923|FG001|Overall Study|Withdrawal by Subject|1|||
125283600|NCT01818258|450664922|FG000|Overall Study|Lost to Follow-up|0|||
125283601|NCT01818258|450664923|FG001|Overall Study|Lost to Follow-up|1|||
125283602|NCT01818258|450664922|FG000|Overall Study|Unable to Travel to Clinic|0|||
125283603|NCT01818258|450664923|FG001|Overall Study|Unable to Travel to Clinic|1|||
125283604|NCT02649218|450664928|FG000|Overall Study|Adverse Event|8|||
125283605|NCT02649218|450664928|FG000|Overall Study|Lack of Efficacy|8|||
125283606|NCT02649218|450664928|FG000|Overall Study|Pregnancy|3|||
125283607|NCT02649218|450664928|FG000|Overall Study|Protocol Violation|3|||
125283608|NCT02649218|450664928|FG000|Overall Study|Physician Decision|1|||
125283609|NCT02649218|450664928|FG000|Overall Study|Withdrawal by Subject|2|||
125283610|NCT05145322|450664932|FG000|Overall Study|Lost to Follow-up|4|||
125283611|NCT05145322|450664933|FG001|Overall Study|Lost to Follow-up|5|||
125283612|NCT01349322|450664934|FG000|Overall Study|Protocol Violation|45|||
125283613|NCT01349322|450664935|FG001|Overall Study|Protocol Violation|47|||
125283614|NCT04376684|450664940|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
125283615|NCT04376684|450664941|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
125283616|NCT04376684|450664942|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
125283617|NCT04376684|450664943|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
125283618|NCT04376684|450664940|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
125283619|NCT04376684|450664941|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
125283620|NCT04376684|450664942|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
125283621|NCT04376684|450664943|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
125283622|NCT04376684|450664940|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
125283623|NCT04376684|450664941|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
125283624|NCT04376684|450664942|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
125283625|NCT04376684|450664943|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
125283626|NCT04376684|450664940|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
125283627|NCT04376684|450664941|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
125283628|NCT04376684|450664942|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
125283629|NCT04376684|450664943|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
125283630|NCT04376684|450664940|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
125283631|NCT04376684|450664941|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
125283632|NCT04376684|450664942|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
125283633|NCT04376684|450664943|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
125283634|NCT04376684|450664940|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
125283635|NCT04376684|450664941|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
125283636|NCT04376684|450664942|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
125283637|NCT04376684|450664943|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
125283638|NCT04376684|450664940|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
125283639|NCT04376684|450664941|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
125283640|NCT04376684|450664942|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
125283641|NCT04376684|450664943|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
125283642|NCT03099174|450664947|FG000|Overall Study|Withdrawal by Subject|0|||
125283643|NCT03099174|450664948|FG001|Overall Study|Withdrawal by Subject|0|||
125283644|NCT03099174|450664949|FG002|Overall Study|Withdrawal by Subject|1|||
125283645|NCT03099174|450664950|FG003|Overall Study|Withdrawal by Subject|0|||
125283646|NCT03099174|450664951|FG004|Overall Study|Withdrawal by Subject|2|||
125283647|NCT03099174|450664952|FG005|Overall Study|Withdrawal by Subject|2|||
125283648|NCT03099174|450664953|FG006|Overall Study|Withdrawal by Subject|1|||
125283649|NCT03099174|450664954|FG007|Overall Study|Withdrawal by Subject|4|||
125283650|NCT03099174|450664947|FG000|Overall Study|Adverse Event|0|||
125283651|NCT03099174|450664948|FG001|Overall Study|Adverse Event|1|||
125283652|NCT03099174|450664949|FG002|Overall Study|Adverse Event|1|||
125283653|NCT03099174|450664950|FG003|Overall Study|Adverse Event|2|||
125283654|NCT03099174|450664951|FG004|Overall Study|Adverse Event|5|||
125283655|NCT03099174|450664952|FG005|Overall Study|Adverse Event|3|||
125283656|NCT03099174|450664953|FG006|Overall Study|Adverse Event|6|||
125283657|NCT03099174|450664954|FG007|Overall Study|Adverse Event|4|||
125283658|NCT03099174|450664947|FG000|Overall Study|Other than listed|6|||
125283659|NCT03099174|450664948|FG001|Overall Study|Other than listed|6|||
125283660|NCT03099174|450664949|FG002|Overall Study|Other than listed|5|||
125283661|NCT03099174|450664950|FG003|Overall Study|Other than listed|6|||
125283662|NCT03099174|450664951|FG004|Overall Study|Other than listed|19|||
125283663|NCT03099174|450664952|FG005|Overall Study|Other than listed|10|||
125283664|NCT03099174|450664953|FG006|Overall Study|Other than listed|26|||
125283665|NCT03099174|450664954|FG007|Overall Study|Other than listed|23|||
125283666|NCT04173260|450664955|FG000|Overall Study|Early termination|4|||
125283667|NCT02308163|450664956|FG000|Overall Study|Not fulfill eligible criteria|1|||
125283668|NCT02308163|450664957|FG001|Overall Study|Not fulfill eligible criteria|2|||
125283669|NCT02308163|450664958|FG002|Overall Study|Not fulfill eligible criteria|0|||
125283670|NCT02308163|450664959|FG003|Overall Study|Not fulfill eligible criteria|1|||
125283671|NCT02308163|450664960|FG004|Overall Study|Not fulfill eligible criteria|1|||
125283672|NCT02308163|450664956|FG000|Overall Study|Adverse Event|9|||
125283673|NCT02308163|450664957|FG001|Overall Study|Adverse Event|5|||
125283674|NCT02308163|450664958|FG002|Overall Study|Adverse Event|2|||
125283675|NCT02308163|450664959|FG003|Overall Study|Adverse Event|2|||
125283676|NCT02308163|450664960|FG004|Overall Study|Adverse Event|11|||
125283677|NCT02308163|450664956|FG000|Overall Study|Lack of Efficacy|11|||
125283678|NCT02308163|450664957|FG001|Overall Study|Lack of Efficacy|3|||
125283679|NCT02308163|450664958|FG002|Overall Study|Lack of Efficacy|8|||
125283680|NCT02308163|450664959|FG003|Overall Study|Lack of Efficacy|4|||
125283681|NCT02308163|450664960|FG004|Overall Study|Lack of Efficacy|6|||
125283682|NCT02308163|450664956|FG000|Overall Study|Withdrawal of consent|2|||
125283683|NCT02308163|450664957|FG001|Overall Study|Withdrawal of consent|3|||
125283684|NCT02308163|450664958|FG002|Overall Study|Withdrawal of consent|0|||
125283685|NCT02308163|450664959|FG003|Overall Study|Withdrawal of consent|2|||
125283686|NCT02308163|450664960|FG004|Overall Study|Withdrawal of consent|6|||
125283687|NCT02308163|450664956|FG000|Overall Study|Protocol Violation|3|||
125283688|NCT02308163|450664957|FG001|Overall Study|Protocol Violation|3|||
125283689|NCT02308163|450664958|FG002|Overall Study|Protocol Violation|3|||
125283690|NCT02308163|450664959|FG003|Overall Study|Protocol Violation|2|||
125283691|NCT02308163|450664960|FG004|Overall Study|Protocol Violation|5|||
125283692|NCT02308163|450664956|FG000|Overall Study|Lab data met discontinuation criteria|3|||
125283693|NCT02308163|450664957|FG001|Overall Study|Lab data met discontinuation criteria|0|||
125283694|NCT02308163|450664958|FG002|Overall Study|Lab data met discontinuation criteria|0|||
125283695|NCT02308163|450664959|FG003|Overall Study|Lab data met discontinuation criteria|2|||
125283696|NCT02308163|450664960|FG004|Overall Study|Lab data met discontinuation criteria|0|||
125283697|NCT02308163|450664956|FG000|Overall Study|Miscellaneous|2|||
125283698|NCT02308163|450664957|FG001|Overall Study|Miscellaneous|2|||
125283699|NCT02308163|450664958|FG002|Overall Study|Miscellaneous|1|||
125283700|NCT02308163|450664959|FG003|Overall Study|Miscellaneous|0|||
125283701|NCT02308163|450664960|FG004|Overall Study|Miscellaneous|5|||
125283702|NCT03941964|450664963|FG000|Overall Study|Adverse Event|1|||
125283703|NCT03941964|450664964|FG001|Overall Study|Adverse Event|8|||
125283704|NCT03941964|450664963|FG000|Overall Study|Progressive disease|7|||
125283705|NCT03941964|450664964|FG001|Overall Study|Progressive disease|3|||
125283706|NCT03941964|450664963|FG000|Overall Study|Lack of Efficacy|0|||
125283707|NCT03941964|450664964|FG001|Overall Study|Lack of Efficacy|1|||
125283708|NCT03941964|450664963|FG000|Overall Study|Death|3|||
125283709|NCT03941964|450664964|FG001|Overall Study|Death|1|||
125283710|NCT03941964|450664963|FG000|Overall Study|Withdrew consent|1|||
125283711|NCT03941964|450664964|FG001|Overall Study|Withdrew consent|3|||
125283712|NCT03941964|450664963|FG000|Overall Study|Physician Decision|9|||
125283713|NCT03941964|450664964|FG001|Overall Study|Physician Decision|2|||
125283714|NCT03941964|450664963|FG000|Overall Study|Other, not specified|2|||
125283715|NCT03941964|450664964|FG001|Overall Study|Other, not specified|1|||
125283716|NCT02136680|450664969|FG000|Overall Study|No Longer Interested|1|||
125283717|NCT02136680|450664970|FG001|Overall Study|No Longer Interested|1|||
125283718|NCT02136680|450664969|FG000|Overall Study|No longer receiving care at clinic|3|||
125283719|NCT02136680|450664970|FG001|Overall Study|No longer receiving care at clinic|5|||
125283720|NCT02136680|450664969|FG000|Overall Study|Moved away|5|||
125283721|NCT02136680|450664970|FG001|Overall Study|Moved away|4|||
125283722|NCT02136680|450664969|FG000|Overall Study|Unable to schedule|17|||
125283723|NCT02136680|450664970|FG001|Overall Study|Unable to schedule|16|||
125283724|NCT02136680|450664969|FG000|Overall Study|Study ended before interview due|6|||
125283725|NCT02136680|450664970|FG001|Overall Study|Study ended before interview due|3|||
125283726|NCT05151445|450664971|FG000|Overall Study|Withdrawal by Subject|3|||
125283727|NCT02298179|450664972|FG000|Overall Study|Lost to Follow-up|0|||
125283728|NCT02298179|450664973|FG001|Overall Study|Lost to Follow-up|0|||
125283729|NCT02298179|450664974|FG002|Overall Study|Lost to Follow-up|1|||
125283730|NCT02298179|450664975|FG003|Overall Study|Lost to Follow-up|0|||
125283731|NCT02298179|450664976|FG004|Overall Study|Lost to Follow-up|0|||
125283732|NCT02298179|450664977|FG005|Overall Study|Lost to Follow-up|0|||
125283733|NCT02298179|450664978|FG006|Overall Study|Lost to Follow-up|0|||
125283734|NCT02298179|450664979|FG007|Overall Study|Lost to Follow-up|1|||
125283735|NCT02298179|450664980|FG008|Overall Study|Lost to Follow-up|0|||
125283736|NCT02298179|450664981|FG009|Overall Study|Lost to Follow-up|0|||
125283737|NCT02298179|450664982|FG010|Overall Study|Lost to Follow-up|0|||
125283738|NCT02298179|450664983|FG011|Overall Study|Lost to Follow-up|0|||
125283739|NCT03559517|450664986|FG000|Overall Study|Withdrawal by Subject|1|||
125283740|NCT03559517|450664987|FG001|Overall Study|Withdrawal by Subject|0|||
125283741|NCT03559517|450664988|FG002|Overall Study|Withdrawal by Subject|0|||
125283742|NCT01457014|450664989|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
125283743|NCT01457014|450664990|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
125283744|NCT01457014|450664991|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
125283745|NCT01457014|450664992|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
125283746|NCT01457014|450664989|FG000|First Night|Withdrawal by Subject|3|||
125283747|NCT01457014|450664990|FG001|First Night|Withdrawal by Subject|0|||
125283748|NCT01457014|450664991|FG002|First Night|Withdrawal by Subject|0|||
125283749|NCT01457014|450664992|FG003|First Night|Withdrawal by Subject|0|||
125283750|NCT01357161|450664993|FG000|Part 1 (Open Label Run-in)|Death|5|||
125283751|NCT01357161|450664994|FG001|Part 1 (Open Label Run-in)|Death|0|||
125283752|NCT01357161|450664995|FG002|Part 1 (Open Label Run-in)|Death|0|||
125283753|NCT01357161|450664993|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
125283754|NCT01357161|450664994|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
125283755|NCT01357161|450664995|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
125283756|NCT01357161|450664993|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
125283757|NCT01357161|450664994|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
125283758|NCT01357161|450664995|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
125283759|NCT01357161|450664993|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
125283760|NCT01357161|450664994|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
125283761|NCT01357161|450664995|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
125283762|NCT01357161|450664993|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
125283763|NCT01357161|450664994|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
125283764|NCT01357161|450664995|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
125283765|NCT01357161|450664993|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
125283766|NCT01357161|450664994|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
125283767|NCT01357161|450664995|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
125283768|NCT01357161|450664993|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
125283769|NCT01357161|450664994|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
125283770|NCT01357161|450664995|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
125283771|NCT01357161|450664993|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
125283772|NCT01357161|450664994|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
125283773|NCT01357161|450664995|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
125283774|NCT01357161|450664993|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
125283775|NCT01357161|450664994|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
125283776|NCT01357161|450664995|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
125283777|NCT01357161|450664993|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
125283778|NCT01357161|450664994|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
125448692|NCT04034238|451270848|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
125283779|NCT01357161|450664995|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
125283780|NCT01357161|450664993|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
125283781|NCT01357161|450664994|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
125283782|NCT01357161|450664995|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
125283783|NCT02825420|450664997|FG000|Overall Study|Death|30|||
125283784|NCT02825420|450664998|FG001|Overall Study|Death|12|||
125283785|NCT02825420|450664997|FG000|Overall Study|Progressive disease|6|||
125283786|NCT02825420|450664998|FG001|Overall Study|Progressive disease|1|||
125448693|NCT01939158|451270849|FG000|Overall Study|Adverse Event|1|||
125283787|NCT02825420|450664997|FG000|Overall Study|Lost to Follow-up|2|||
125283788|NCT02825420|450664998|FG001|Overall Study|Lost to Follow-up|2|||
125283789|NCT02825420|450664997|FG000|Overall Study|Withdrawal by Subject|1|||
125283790|NCT02825420|450664998|FG001|Overall Study|Withdrawal by Subject|1|||
125283791|NCT02825420|450664997|FG000|Overall Study|Protocol amendment not signed|1|||
125283792|NCT02825420|450664998|FG001|Overall Study|Protocol amendment not signed|1|||
125283793|NCT02825420|450664997|FG000|Overall Study|Physician Decision|1|||
125283794|NCT02825420|450664998|FG001|Overall Study|Physician Decision|0|||
125283795|NCT02825420|450664997|FG000|Overall Study|Did not receive PLD|2|||
125283796|NCT02825420|450664998|FG001|Overall Study|Did not receive PLD|0|||
125283797|NCT04027049|450664999|FG000|Overall Study|Withdrawn by family|1|||
125283798|NCT04027049|450665000|FG001|Overall Study|Withdrawn by family|0|||
125283799|NCT04027049|450664999|FG000|Overall Study|Participant safety|1|||
125283800|NCT04027049|450665000|FG001|Overall Study|Participant safety|0|||
125283801|NCT01730339|450666444|FG000|Overall Study|Withdrawal by Subject|3|||
125283802|NCT01730339|450666445|FG001|Overall Study|Withdrawal by Subject|2|||
125283803|NCT01730339|450666444|FG000|Overall Study|Lost to Follow-up|1|||
125283804|NCT01730339|450666445|FG001|Overall Study|Lost to Follow-up|1|||
125283805|NCT01730339|450666444|FG000|Overall Study|Un-specified|1|||
125283806|NCT01730339|450666445|FG001|Overall Study|Un-specified|0|||
125283807|NCT01145352|450666446|FG000|Overall Study|Found to have been registered twice|6|||
125283808|NCT01145352|450666446|FG000|Overall Study|Treated before marketing approval|4|||
125283809|NCT01145352|450666446|FG000|Overall Study|Syringe formulation was used|1|||
125283810|NCT04143217|450666447|FG000|Overall Study|Withdrawal by Subject|42|||
125283811|NCT04143217|450666447|FG000|Overall Study|Adverse Event|29|||
125283812|NCT04143217|450666447|FG000|Overall Study|Lost to Follow-up|29|||
125283813|NCT04143217|450666447|FG000|Overall Study|Lack of Efficacy|15|||
125283814|NCT04143217|450666447|FG000|Overall Study|Physician Decision|1|||
125283815|NCT04143217|450666447|FG000|Overall Study|Non-Compliance With Study Drug|6|||
125283816|NCT04143217|450666447|FG000|Overall Study|Other, Multiple Categories|11|||
125283817|NCT02264665|450666448|FG000|Overall Study|Other|0|||
125283818|NCT02264665|450666449|FG001|Overall Study|Other|0|||
125283819|NCT02264665|450666450|FG002|Overall Study|Other|3|||
125283820|NCT02264665|450666451|FG003|Overall Study|Other|0|||
125283821|NCT02264665|450666452|FG004|Overall Study|Other|0|||
125283822|NCT02264665|450666453|FG005|Overall Study|Other|0|||
125283823|NCT02264665|450666454|FG006|Overall Study|Other|0|||
125283824|NCT02264665|450666448|FG000|Overall Study|Death|9|||
125283825|NCT02264665|450666449|FG001|Overall Study|Death|8|||
125283826|NCT02264665|450666450|FG002|Overall Study|Death|13|||
125283827|NCT02264665|450666451|FG003|Overall Study|Death|5|||
125283828|NCT02264665|450666452|FG004|Overall Study|Death|0|||
125283829|NCT02264665|450666453|FG005|Overall Study|Death|0|||
125283830|NCT02264665|450666454|FG006|Overall Study|Death|1|||
125283831|NCT02264665|450666448|FG000|Overall Study|Lost to Follow-up|1|||
125283832|NCT02264665|450666449|FG001|Overall Study|Lost to Follow-up|0|||
125283833|NCT02264665|450666450|FG002|Overall Study|Lost to Follow-up|2|||
125283834|NCT02264665|450666451|FG003|Overall Study|Lost to Follow-up|1|||
125283835|NCT02264665|450666452|FG004|Overall Study|Lost to Follow-up|0|||
125283836|NCT02264665|450666453|FG005|Overall Study|Lost to Follow-up|0|||
125283837|NCT02264665|450666454|FG006|Overall Study|Lost to Follow-up|0|||
125283838|NCT02264665|450666448|FG000|Overall Study|Participant decision|0|||
125283839|NCT02264665|450666449|FG001|Overall Study|Participant decision|0|||
125283840|NCT02264665|450666450|FG002|Overall Study|Participant decision|0|||
125283841|NCT02264665|450666451|FG003|Overall Study|Participant decision|1|||
125283842|NCT02264665|450666452|FG004|Overall Study|Participant decision|0|||
125283843|NCT02264665|450666453|FG005|Overall Study|Participant decision|0|||
125411969|NCT00941603|451134873|FG000|Overall Study|Withdrawal by Subject|0|||
125411970|NCT00941603|451134874|FG001|Overall Study|Withdrawal by Subject|0|||
125411971|NCT00941603|451134875|FG002|Overall Study|Withdrawal by Subject|0|||
125411972|NCT00941603|451134876|FG003|Overall Study|Withdrawal by Subject|2|||
125411973|NCT00941603|451134877|FG004|Overall Study|Withdrawal by Subject|0|||
125411974|NCT00941603|451134878|FG005|Overall Study|Withdrawal by Subject|1|||
125283844|NCT02264665|450666454|FG006|Overall Study|Participant decision|0|||
125283845|NCT02264665|450666448|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
125283846|NCT02264665|450666449|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
125283847|NCT02264665|450666450|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
125283848|NCT02264665|450666451|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
125283849|NCT02264665|450666452|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
125283850|NCT02264665|450666453|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
125283851|NCT02264665|450666454|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
125283852|NCT02264665|450666448|FG000|Overall Study|Data Missing|0|||
125283853|NCT02264665|450666449|FG001|Overall Study|Data Missing|0|||
125411975|NCT00941603|451134873|FG000|Overall Study|Protocol Violation|0|||
125411976|NCT00941603|451134874|FG001|Overall Study|Protocol Violation|1|||
125411977|NCT00941603|451134875|FG002|Overall Study|Protocol Violation|0|||
125283854|NCT02264665|450666450|FG002|Overall Study|Data Missing|1|||
125283855|NCT02264665|450666451|FG003|Overall Study|Data Missing|0|||
125283856|NCT02264665|450666452|FG004|Overall Study|Data Missing|0|||
125283857|NCT02264665|450666453|FG005|Overall Study|Data Missing|0|||
125283858|NCT02264665|450666454|FG006|Overall Study|Data Missing|0|||
125283859|NCT01962987|450666455|FG000|Overall Study|Adverse Event|4|||
125283860|NCT01962987|450666456|FG001|Overall Study|Adverse Event|4|||
125283861|NCT01962987|450666457|FG002|Overall Study|Adverse Event|0|||
125283862|NCT01962987|450666455|FG000|Overall Study|Lost to Follow-up|0|||
125283863|NCT01962987|450666456|FG001|Overall Study|Lost to Follow-up|0|||
125283864|NCT01962987|450666457|FG002|Overall Study|Lost to Follow-up|1|||
125283865|NCT01962987|450666455|FG000|Overall Study|Non compliance with dosing requirements|4|||
125283866|NCT01962987|450666456|FG001|Overall Study|Non compliance with dosing requirements|2|||
125283867|NCT01962987|450666457|FG002|Overall Study|Non compliance with dosing requirements|0|||
125283868|NCT01962987|450666455|FG000|Overall Study|Miscellaneous|1|||
125283869|NCT01962987|450666456|FG001|Overall Study|Miscellaneous|9|||
125283870|NCT01962987|450666457|FG002|Overall Study|Miscellaneous|2|||
125283871|NCT01962987|450666455|FG000|Overall Study|Restricted medication|5|||
125283872|NCT01962987|450666456|FG001|Overall Study|Restricted medication|1|||
125283873|NCT01962987|450666457|FG002|Overall Study|Restricted medication|1|||
125283874|NCT01962987|450666455|FG000|Overall Study|Serious Adverse Event|1|||
125283875|NCT01962987|450666456|FG001|Overall Study|Serious Adverse Event|0|||
125283876|NCT01962987|450666457|FG002|Overall Study|Serious Adverse Event|0|||
125283877|NCT01962987|450666455|FG000|Overall Study|Withdrawal by Subject|11|||
125283878|NCT01962987|450666456|FG001|Overall Study|Withdrawal by Subject|10|||
125283879|NCT01962987|450666457|FG002|Overall Study|Withdrawal by Subject|6|||
125283880|NCT01962987|450666455|FG000|Overall Study|Randomized in Error|4|||
125283881|NCT01962987|450666456|FG001|Overall Study|Randomized in Error|2|||
125283882|NCT01962987|450666457|FG002|Overall Study|Randomized in Error|2|||
125283883|NCT02688088|450666466|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
125283884|NCT02688088|450666467|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
125283885|NCT02688088|450666468|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
125283886|NCT02688088|450666469|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
125283887|NCT02688088|450666470|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
125283888|NCT02688088|450666466|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
125283889|NCT02688088|450666467|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
125283890|NCT02688088|450666468|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
125283891|NCT02688088|450666469|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
125283892|NCT02688088|450666470|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
125283893|NCT02688088|450666466|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
125283894|NCT02688088|450666467|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
125283895|NCT02688088|450666468|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
125283896|NCT02688088|450666469|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
125283897|NCT02688088|450666470|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
125283898|NCT02688088|450666466|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
125283899|NCT02688088|450666467|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
125283900|NCT02688088|450666468|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
125283901|NCT02688088|450666469|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
125283902|NCT02688088|450666470|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
125283903|NCT02688088|450666466|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
125283904|NCT02688088|450666467|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
125283905|NCT02688088|450666468|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
125283906|NCT02688088|450666469|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
125283907|NCT02688088|450666470|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
125283908|NCT02688088|450666466|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
125283909|NCT02688088|450666467|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
125283910|NCT02688088|450666468|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
125283911|NCT02688088|450666469|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
125283912|NCT02688088|450666470|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
125283913|NCT02688088|450666466|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
125283914|NCT02688088|450666467|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
125283915|NCT02688088|450666468|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
125283916|NCT02688088|450666469|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
125283917|NCT02688088|450666470|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
125283918|NCT02688088|450666466|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
125283919|NCT02688088|450666467|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
125283920|NCT02688088|450666468|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
125283921|NCT02688088|450666469|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
125283922|NCT02688088|450666470|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
125411978|NCT00941603|451134876|FG003|Overall Study|Protocol Violation|0|||
125411979|NCT00941603|451134877|FG004|Overall Study|Protocol Violation|0|||
125411980|NCT00941603|451134878|FG005|Overall Study|Protocol Violation|0|||
125283923|NCT02688088|450666466|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
125283924|NCT02688088|450666467|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
125283925|NCT02688088|450666468|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
125283926|NCT02688088|450666469|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
125283927|NCT02688088|450666470|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
125283928|NCT01921218|450666473|FG000|Overall Study|Death|2|||
125283929|NCT01921218|450666474|FG001|Overall Study|Death|1|||
125283930|NCT01921218|450666473|FG000|Overall Study|Withdrawal by Subject|0|||
125283931|NCT01921218|450666474|FG001|Overall Study|Withdrawal by Subject|2|||
125283932|NCT01921218|450666473|FG000|Overall Study|Kidney transplant|1|||
125283933|NCT01921218|450666474|FG001|Overall Study|Kidney transplant|1|||
125283934|NCT02449889|450666475|FG000|Overall Study|Adverse Event|1|||
125283935|NCT02449889|450666476|FG001|Overall Study|Adverse Event|2|||
125283936|NCT02449889|450666477|FG002|Overall Study|Adverse Event|0|||
125283937|NCT02449889|450666475|FG000|Overall Study|Protocol Violation|0|||
125283938|NCT02449889|450666476|FG001|Overall Study|Protocol Violation|4|||
125283939|NCT02449889|450666477|FG002|Overall Study|Protocol Violation|1|||
125283940|NCT00090142|450666479|FG000|Treatment Period I|Lost to Follow-up|1|||
125283941|NCT00090142|450666480|FG001|Treatment Period I|Lost to Follow-up|2|||
125283942|NCT00090142|450666479|FG000|Treatment Period I|Protocol Violation|2|||
125283943|NCT00090142|450666480|FG001|Treatment Period I|Protocol Violation|0|||
125283944|NCT00090142|450666479|FG000|Treatment Period I|Withdrawal by Subject|2|||
125283945|NCT00090142|450666480|FG001|Treatment Period I|Withdrawal by Subject|0|||
125283946|NCT00090142|450666479|FG000|Treatment Period I|Other|0|||
125283947|NCT00090142|450666480|FG001|Treatment Period I|Other|1|||
125283948|NCT00090142|450666479|FG000|Treatment Period II|Other|1|||
125283949|NCT00090142|450666480|FG001|Treatment Period II|Other|0|||
125283950|NCT00688324|450666481|FG000|Overall Study|Withdrawal by Subject|2|||
125283951|NCT00688324|450666481|FG000|Overall Study|Physician Decision|5|||
125283952|NCT00688324|450666481|FG000|Overall Study|Lost to Follow-up|1|||
125283953|NCT00006046|450666482|FG000|Overall Study|Adverse Event|3|||
125283954|NCT00006046|450666483|FG001|Overall Study|Adverse Event|0|||
125283955|NCT00006046|450666484|FG002|Overall Study|Adverse Event|0|||
125283956|NCT00006046|450666485|FG003|Overall Study|Adverse Event|0|||
125283957|NCT00006046|450666486|FG004|Overall Study|Adverse Event|0|||
125283958|NCT00006046|450666482|FG000|Overall Study|Disease Progression|2|||
125283959|NCT00006046|450666483|FG001|Overall Study|Disease Progression|0|||
125283960|NCT00006046|450666484|FG002|Overall Study|Disease Progression|0|||
125283961|NCT00006046|450666485|FG003|Overall Study|Disease Progression|0|||
125283962|NCT00006046|450666486|FG004|Overall Study|Disease Progression|0|||
125283963|NCT03176472|450666487|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
125283964|NCT03176472|450666488|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
125283965|NCT03176472|450666487|FG000|Double Blind Treatment Period|Adverse Event|0|||
125283966|NCT03176472|450666488|FG001|Double Blind Treatment Period|Adverse Event|5|||
125283967|NCT03176472|450666487|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
125283968|NCT03176472|450666488|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
125283969|NCT03176472|450666487|FG000|Double Blind Treatment Period|Physician Decision|0|||
125283970|NCT03176472|450666488|FG001|Double Blind Treatment Period|Physician Decision|1|||
125283971|NCT03176472|450666487|FG000|Double Blind Treatment Period|Protocol Violation|1|||
125283972|NCT03176472|450666488|FG001|Double Blind Treatment Period|Protocol Violation|0|||
125283973|NCT03176472|450666487|FG000|Double Blind Treatment Period|Not Provided|1|||
125283974|NCT03176472|450666488|FG001|Double Blind Treatment Period|Not Provided|0|||
125283975|NCT03176472|450666487|FG000|Open Label Extension|Withdrawal by Subject|3|||
125283976|NCT03176472|450666488|FG001|Open Label Extension|Withdrawal by Subject|4|||
125283977|NCT03176472|450666487|FG000|Open Label Extension|Adverse Event|2|||
125283978|NCT03176472|450666488|FG001|Open Label Extension|Adverse Event|4|||
125283979|NCT03176472|450666487|FG000|Open Label Extension|Lost to Follow-up|1|||
125283980|NCT03176472|450666488|FG001|Open Label Extension|Lost to Follow-up|2|||
125283981|NCT03176472|450666487|FG000|Open Label Extension|Protocol Violation|0|||
125283982|NCT03176472|450666488|FG001|Open Label Extension|Protocol Violation|1|||
125283983|NCT03176472|450666487|FG000|Open Label Extension|Not Provided|2|||
125283984|NCT03176472|450666488|FG001|Open Label Extension|Not Provided|1|||
125283985|NCT00596154|450666489|FG000|Overall Study|Not Evaluable|2|||
125283986|NCT00642369|450666490|FG000|Overall Study|Adverse Event|2|||
125283987|NCT00642369|450666491|FG001|Overall Study|Adverse Event|3|||
125283988|NCT00642369|450666490|FG000|Overall Study|Withdrawal by Subject|1|||
125283989|NCT00642369|450666491|FG001|Overall Study|Withdrawal by Subject|0|||
125283990|NCT00642369|450666490|FG000|Overall Study|misdiagnosis|0|||
125283991|NCT00642369|450666491|FG001|Overall Study|misdiagnosis|1|||
125283992|NCT00642369|450666490|FG000|Overall Study|Lack of Efficacy|2|||
125283993|NCT00642369|450666491|FG001|Overall Study|Lack of Efficacy|2|||
125283994|NCT00585546|450666498|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
125283995|NCT00585546|450666498|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
125283996|NCT03077438|450666499|FG000|Overall Study|Protocol Violation|3|||
125283997|NCT03077438|450666500|FG001|Overall Study|Protocol Violation|5|||
125283998|NCT03077438|450666499|FG000|Overall Study|Withdrawal by Subject|3|||
125283999|NCT03077438|450666500|FG001|Overall Study|Withdrawal by Subject|6|||
125284000|NCT03077438|450666499|FG000|Overall Study|Lost to Follow-up|6|||
125284001|NCT03077438|450666500|FG001|Overall Study|Lost to Follow-up|3|||
125284002|NCT01190475|450666501|FG000|Overall Study|Withdrawal by Subject|0|||
125284003|NCT01190475|450666502|FG001|Overall Study|Withdrawal by Subject|0|||
125284004|NCT01190475|450666503|FG002|Overall Study|Withdrawal by Subject|1|||
125284005|NCT01535599|450666504|FG000|Overall Study|Adverse Event|6|||
125284006|NCT01535599|450666505|FG001|Overall Study|Adverse Event|15|||
125284007|NCT01535599|450666504|FG000|Overall Study|Lost to Follow-up|3|||
125284008|NCT01535599|450666505|FG001|Overall Study|Lost to Follow-up|4|||
125284009|NCT01535599|450666504|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
125284010|NCT01535599|450666505|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
125284011|NCT01535599|450666504|FG000|Overall Study|Treatment Failure|33|||
125284012|NCT01535599|450666505|FG001|Overall Study|Treatment Failure|66|||
125284013|NCT01535599|450666504|FG000|Overall Study|BL Culture + for Group A Strep|0|||
125284014|NCT01535599|450666505|FG001|Overall Study|BL Culture + for Group A Strep|1|||
125284015|NCT01535599|450666504|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
125284016|NCT01535599|450666505|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
125284017|NCT01535599|450666504|FG000|Overall Study|Randomized in Error|2|||
125284018|NCT01535599|450666505|FG001|Overall Study|Randomized in Error|4|||
125284019|NCT01535599|450666504|FG000|Overall Study|Did not use product|1|||
125284020|NCT01535599|450666505|FG001|Overall Study|Did not use product|0|||
125284021|NCT01535599|450666504|FG000|Overall Study|Other|1|||
125284022|NCT01535599|450666505|FG001|Overall Study|Other|0|||
125284023|NCT01535599|450666504|FG000|Overall Study|Stopped medication|0|||
125284024|NCT01535599|450666505|FG001|Overall Study|Stopped medication|1|||
125284025|NCT01535599|450666504|FG000|Overall Study|Noncompliance|0|||
125284026|NCT01535599|450666505|FG001|Overall Study|Noncompliance|1|||
125284027|NCT01165320|450666506|FG000|Overall Study|Clinical adverse experience|2|||
125284028|NCT01165320|450666507|FG001|Overall Study|Clinical adverse experience|1|||
125284029|NCT01165320|450666508|FG002|Overall Study|Clinical adverse experience|0|||
125284030|NCT01165320|450666506|FG000|Overall Study|Laboratory adverse experience|1|||
125284031|NCT01165320|450666507|FG001|Overall Study|Laboratory adverse experience|0|||
125284032|NCT01165320|450666508|FG002|Overall Study|Laboratory adverse experience|0|||
125284033|NCT01165320|450666506|FG000|Overall Study|Lack of Efficacy|0|||
125284034|NCT01165320|450666507|FG001|Overall Study|Lack of Efficacy|2|||
125284035|NCT01165320|450666508|FG002|Overall Study|Lack of Efficacy|0|||
125284036|NCT01165320|450666506|FG000|Overall Study|Reason unknown|0|||
125284037|NCT01165320|450666507|FG001|Overall Study|Reason unknown|1|||
125284038|NCT01165320|450666508|FG002|Overall Study|Reason unknown|0|||
125284039|NCT00385944|450666512|FG000|1st Maintenance Dose Period|Physician Decision|1|||
125284040|NCT00385944|450666513|FG001|1st Maintenance Dose Period|Physician Decision|0|||
125284041|NCT00385944|450666514|FG002|1st Maintenance Dose Period|Physician Decision|0|||
125284042|NCT00385944|450666512|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
125284043|NCT00385944|450666513|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
125284044|NCT00385944|450666514|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
125284045|NCT00385944|450666512|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
125284046|NCT00385944|450666513|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
125284047|NCT00385944|450666514|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
125284048|NCT00385944|450666512|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
125284049|NCT00385944|450666513|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
125284050|NCT00385944|450666514|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
125284051|NCT00590824|450666515|FG000|Overall Study|Disease could not be resected|0|||
125284052|NCT00590824|450666516|FG001|Overall Study|Disease could not be resected|2|||
125284053|NCT00590824|450666517|FG002|Overall Study|Disease could not be resected|1|||
125284054|NCT00590824|450666518|FG003|Overall Study|Disease could not be resected|0|||
125284055|NCT00590824|450666515|FG000|Overall Study|Adverse Event|0|||
125284056|NCT00590824|450666516|FG001|Overall Study|Adverse Event|0|||
125284057|NCT00590824|450666517|FG002|Overall Study|Adverse Event|0|||
125284058|NCT00590824|450666518|FG003|Overall Study|Adverse Event|1|||
125284059|NCT00791479|450666524|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
125284060|NCT00791479|450666525|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
125284061|NCT00791479|450666526|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
125284062|NCT00791479|450666527|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
125284063|NCT00791479|450666528|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
125284064|NCT00791479|450666529|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
125284065|NCT00791479|450666524|FG000|Overall Study|Adverse Event|0|||
125284066|NCT00791479|450666525|FG001|Overall Study|Adverse Event|1|||
125284067|NCT00791479|450666526|FG002|Overall Study|Adverse Event|0|||
125284068|NCT00791479|450666527|FG003|Overall Study|Adverse Event|2|||
125284069|NCT00791479|450666528|FG004|Overall Study|Adverse Event|0|||
125284070|NCT00791479|450666529|FG005|Overall Study|Adverse Event|1|||
125284071|NCT00791479|450666524|FG000|Overall Study|Lost to Follow-up|0|||
125284072|NCT00791479|450666525|FG001|Overall Study|Lost to Follow-up|1|||
125284073|NCT00791479|450666526|FG002|Overall Study|Lost to Follow-up|0|||
125284074|NCT00791479|450666527|FG003|Overall Study|Lost to Follow-up|0|||
125284075|NCT00791479|450666528|FG004|Overall Study|Lost to Follow-up|0|||
125284076|NCT00791479|450666529|FG005|Overall Study|Lost to Follow-up|1|||
125284077|NCT00791479|450666524|FG000|Overall Study|Protocol Violation|2|||
125284078|NCT00791479|450666525|FG001|Overall Study|Protocol Violation|1|||
125284079|NCT00791479|450666526|FG002|Overall Study|Protocol Violation|0|||
125284080|NCT00791479|450666527|FG003|Overall Study|Protocol Violation|1|||
125284081|NCT00791479|450666528|FG004|Overall Study|Protocol Violation|0|||
125284082|NCT00791479|450666529|FG005|Overall Study|Protocol Violation|0|||
125284083|NCT00791479|450666524|FG000|Overall Study|Withdrawal by Subject|0|||
125284084|NCT00791479|450666525|FG001|Overall Study|Withdrawal by Subject|0|||
125284085|NCT00791479|450666526|FG002|Overall Study|Withdrawal by Subject|0|||
125284086|NCT00791479|450666527|FG003|Overall Study|Withdrawal by Subject|1|||
125284087|NCT00791479|450666528|FG004|Overall Study|Withdrawal by Subject|0|||
125284088|NCT00791479|450666529|FG005|Overall Study|Withdrawal by Subject|1|||
125284089|NCT01778049|450666530|FG000|Open Label Treatment Period|Adverse Event|5|||
125284090|NCT01778049|450666531|FG001|Open Label Treatment Period|Adverse Event|15|||
125284091|NCT01778049|450666532|FG002|Open Label Treatment Period|Adverse Event|0|||
125284092|NCT01778049|450666533|FG003|Open Label Treatment Period|Adverse Event|0|||
125284093|NCT01778049|450666534|FG004|Open Label Treatment Period|Adverse Event|0|||
125284094|NCT01778049|450666535|FG005|Open Label Treatment Period|Adverse Event|0|||
125284095|NCT01778049|450666530|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
125284096|NCT01778049|450666531|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
125284097|NCT01778049|450666532|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
125284098|NCT01778049|450666533|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
125284099|NCT01778049|450666534|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
125284100|NCT01778049|450666535|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
125284101|NCT01778049|450666530|FG000|Open Label Treatment Period|Protocol Violation|5|||
125284102|NCT01778049|450666531|FG001|Open Label Treatment Period|Protocol Violation|5|||
125284103|NCT01778049|450666532|FG002|Open Label Treatment Period|Protocol Violation|0|||
125284104|NCT01778049|450666533|FG003|Open Label Treatment Period|Protocol Violation|0|||
125284105|NCT01778049|450666534|FG004|Open Label Treatment Period|Protocol Violation|0|||
125284106|NCT01778049|450666535|FG005|Open Label Treatment Period|Protocol Violation|0|||
125284107|NCT01778049|450666530|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
125284108|NCT01778049|450666531|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
125284109|NCT01778049|450666532|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
125284110|NCT01778049|450666533|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
125284111|NCT01778049|450666534|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
125284112|NCT01778049|450666535|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
125284113|NCT01778049|450666530|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
125284114|NCT01778049|450666531|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
125284115|NCT01778049|450666532|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
125284116|NCT01778049|450666533|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
125284117|NCT01778049|450666534|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
125284118|NCT01778049|450666535|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
125284119|NCT01778049|450666530|FG000|Open Label Treatment Period|Not treated|2|||
125284120|NCT01778049|450666531|FG001|Open Label Treatment Period|Not treated|1|||
125284121|NCT01778049|450666532|FG002|Open Label Treatment Period|Not treated|0|||
125284122|NCT01778049|450666533|FG003|Open Label Treatment Period|Not treated|0|||
125284123|NCT01778049|450666534|FG004|Open Label Treatment Period|Not treated|0|||
125284124|NCT01778049|450666535|FG005|Open Label Treatment Period|Not treated|0|||
125284125|NCT01778049|450666530|FG000|Open Label Treatment Period|Other reason not defined above|77|||
125284126|NCT01778049|450666531|FG001|Open Label Treatment Period|Other reason not defined above|94|||
125284127|NCT01778049|450666532|FG002|Open Label Treatment Period|Other reason not defined above|0|||
125284128|NCT01778049|450666533|FG003|Open Label Treatment Period|Other reason not defined above|0|||
125284129|NCT01778049|450666534|FG004|Open Label Treatment Period|Other reason not defined above|0|||
125284130|NCT01778049|450666535|FG005|Open Label Treatment Period|Other reason not defined above|0|||
125284131|NCT01778049|450666530|FG000|Double Blind Treatment Period|Adverse Event|0|||
125284132|NCT01778049|450666531|FG001|Double Blind Treatment Period|Adverse Event|0|||
125284133|NCT01778049|450666532|FG002|Double Blind Treatment Period|Adverse Event|4|||
125284134|NCT01778049|450666533|FG003|Double Blind Treatment Period|Adverse Event|5|||
125284135|NCT01778049|450666534|FG004|Double Blind Treatment Period|Adverse Event|3|||
125284136|NCT01778049|450666535|FG005|Double Blind Treatment Period|Adverse Event|2|||
125284137|NCT01778049|450666530|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
125284138|NCT01778049|450666531|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
125284139|NCT01778049|450666532|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
125284140|NCT01778049|450666533|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
125284141|NCT01778049|450666534|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
125284142|NCT01778049|450666535|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
125284143|NCT01778049|450666530|FG000|Double Blind Treatment Period|Protocol Violation|0|||
125284144|NCT01778049|450666531|FG001|Double Blind Treatment Period|Protocol Violation|0|||
125284145|NCT01778049|450666532|FG002|Double Blind Treatment Period|Protocol Violation|2|||
125448694|NCT01939158|451270850|FG001|Overall Study|Adverse Event|0|||
125448695|NCT01939158|451270851|FG002|Overall Study|Adverse Event|0|||
125448696|NCT01939158|451270852|FG003|Overall Study|Adverse Event|0|||
125448697|NCT01939158|451270849|FG000|Overall Study|Withdrawal by Subject|22|||
125448698|NCT01939158|451270850|FG001|Overall Study|Withdrawal by Subject|25|||
125448699|NCT01939158|451270851|FG002|Overall Study|Withdrawal by Subject|15|||
125448700|NCT01939158|451270852|FG003|Overall Study|Withdrawal by Subject|17|||
125448701|NCT01939158|451270849|FG000|Overall Study|Migrated/moved from study area|5|||
125448702|NCT01939158|451270850|FG001|Overall Study|Migrated/moved from study area|7|||
125448703|NCT01939158|451270851|FG002|Overall Study|Migrated/moved from study area|3|||
125448704|NCT01939158|451270852|FG003|Overall Study|Migrated/moved from study area|6|||
125448705|NCT01939158|451270849|FG000|Overall Study|Lost to Follow-up|18|||
125448706|NCT01939158|451270850|FG001|Overall Study|Lost to Follow-up|17|||
125448707|NCT01939158|451270851|FG002|Overall Study|Lost to Follow-up|17|||
125448708|NCT01939158|451270852|FG003|Overall Study|Lost to Follow-up|17|||
125448709|NCT01939158|451270849|FG000|Overall Study|Death|0|||
125448710|NCT01939158|451270850|FG001|Overall Study|Death|0|||
125448711|NCT01939158|451270851|FG002|Overall Study|Death|1|||
125448712|NCT01939158|451270852|FG003|Overall Study|Death|1|||
125448713|NCT01939158|451270849|FG000|Overall Study|No longer meets eligibility criteria|0|||
125448714|NCT01939158|451270850|FG001|Overall Study|No longer meets eligibility criteria|0|||
125448715|NCT01939158|451270851|FG002|Overall Study|No longer meets eligibility criteria|1|||
125448716|NCT01939158|451270852|FG003|Overall Study|No longer meets eligibility criteria|0|||
125448717|NCT01939158|451270849|FG000|Overall Study|Other|1|||
125448718|NCT01939158|451270850|FG001|Overall Study|Other|3|||
125448719|NCT01939158|451270851|FG002|Overall Study|Other|4|||
125284146|NCT01778049|450666533|FG003|Double Blind Treatment Period|Protocol Violation|0|||
125284147|NCT01778049|450666534|FG004|Double Blind Treatment Period|Protocol Violation|0|||
125284148|NCT01778049|450666535|FG005|Double Blind Treatment Period|Protocol Violation|0|||
125411981|NCT00941603|451134873|FG000|Overall Study|Did not meet protocol eligibility|1|||
125411982|NCT00941603|451134874|FG001|Overall Study|Did not meet protocol eligibility|0|||
125411983|NCT00941603|451134875|FG002|Overall Study|Did not meet protocol eligibility|0|||
125411984|NCT00941603|451134876|FG003|Overall Study|Did not meet protocol eligibility|0|||
125411985|NCT00941603|451134877|FG004|Overall Study|Did not meet protocol eligibility|0|||
125411986|NCT00941603|451134878|FG005|Overall Study|Did not meet protocol eligibility|0|||
125411987|NCT02014116|451134880|FG000|Overall Study|Progressive Disease|3|||
125411988|NCT02014116|451134881|FG001|Overall Study|Progressive Disease|4|||
125411989|NCT02014116|451134882|FG002|Overall Study|Progressive Disease|2|||
125411990|NCT02014116|451134883|FG003|Overall Study|Progressive Disease|6|||
125411991|NCT02014116|451134884|FG004|Overall Study|Progressive Disease|1|||
125411992|NCT02014116|451134885|FG005|Overall Study|Progressive Disease|13|||
125411993|NCT02014116|451134886|FG006|Overall Study|Progressive Disease|1|||
125411994|NCT02014116|451134887|FG007|Overall Study|Progressive Disease|3|||
125411995|NCT02014116|451134888|FG008|Overall Study|Progressive Disease|7|||
125411996|NCT02014116|451134880|FG000|Overall Study|Adverse Event|0|||
125411997|NCT02014116|451134881|FG001|Overall Study|Adverse Event|0|||
125411998|NCT02014116|451134882|FG002|Overall Study|Adverse Event|0|||
125411999|NCT02014116|451134883|FG003|Overall Study|Adverse Event|0|||
125412000|NCT02014116|451134884|FG004|Overall Study|Adverse Event|1|||
125412001|NCT02014116|451134885|FG005|Overall Study|Adverse Event|0|||
125412002|NCT02014116|451134886|FG006|Overall Study|Adverse Event|0|||
125412003|NCT02014116|451134887|FG007|Overall Study|Adverse Event|1|||
125412004|NCT02014116|451134888|FG008|Overall Study|Adverse Event|0|||
125412005|NCT02014116|451134880|FG000|Overall Study|Lost to Follow-up|0|||
125412006|NCT02014116|451134881|FG001|Overall Study|Lost to Follow-up|0|||
125412007|NCT02014116|451134882|FG002|Overall Study|Lost to Follow-up|0|||
125412008|NCT02014116|451134883|FG003|Overall Study|Lost to Follow-up|0|||
125412009|NCT02014116|451134884|FG004|Overall Study|Lost to Follow-up|0|||
125412010|NCT02014116|451134885|FG005|Overall Study|Lost to Follow-up|1|||
125412011|NCT02014116|451134886|FG006|Overall Study|Lost to Follow-up|0|||
125412012|NCT02014116|451134887|FG007|Overall Study|Lost to Follow-up|0|||
125412013|NCT02014116|451134888|FG008|Overall Study|Lost to Follow-up|1|||
125412014|NCT02014116|451134880|FG000|Overall Study|Death|0|||
125448720|NCT01939158|451270852|FG003|Overall Study|Other|3|||
125448721|NCT02065245|451270853|FG000|Infusion 1|Lost to Follow-up|0|||
125448722|NCT02065245|451270854|FG001|Infusion 1|Lost to Follow-up|0|||
125448723|NCT02065245|451270855|FG002|Infusion 1|Lost to Follow-up|0|||
125448724|NCT02065245|451270856|FG003|Infusion 1|Lost to Follow-up|0|||
125448725|NCT02065245|451270857|FG004|Infusion 1|Lost to Follow-up|0|||
125448726|NCT02065245|451270858|FG005|Infusion 1|Lost to Follow-up|0|||
125284149|NCT01778049|450666530|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
125412015|NCT02014116|451134881|FG001|Overall Study|Death|0|||
125412016|NCT02014116|451134882|FG002|Overall Study|Death|0|||
125412017|NCT02014116|451134883|FG003|Overall Study|Death|0|||
125412018|NCT02014116|451134884|FG004|Overall Study|Death|0|||
125412019|NCT02014116|451134885|FG005|Overall Study|Death|0|||
125412020|NCT02014116|451134886|FG006|Overall Study|Death|0|||
125412021|NCT02014116|451134887|FG007|Overall Study|Death|1|||
125412022|NCT02014116|451134888|FG008|Overall Study|Death|1|||
125412023|NCT02014116|451134880|FG000|Overall Study|Withdrawal by Subject|0|||
125412024|NCT02014116|451134881|FG001|Overall Study|Withdrawal by Subject|0|||
125412025|NCT02014116|451134882|FG002|Overall Study|Withdrawal by Subject|1|||
125412026|NCT02014116|451134883|FG003|Overall Study|Withdrawal by Subject|1|||
125412027|NCT02014116|451134884|FG004|Overall Study|Withdrawal by Subject|0|||
125412028|NCT02014116|451134885|FG005|Overall Study|Withdrawal by Subject|1|||
125412029|NCT02014116|451134886|FG006|Overall Study|Withdrawal by Subject|0|||
125412030|NCT02014116|451134887|FG007|Overall Study|Withdrawal by Subject|0|||
125412031|NCT02014116|451134888|FG008|Overall Study|Withdrawal by Subject|0|||
125412032|NCT02014116|451134880|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
125412033|NCT02014116|451134881|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
125412034|NCT02014116|451134882|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
125412035|NCT02014116|451134883|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
125412036|NCT02014116|451134884|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
125448727|NCT02065245|451270859|FG006|Infusion 1|Lost to Follow-up|1|||
125284150|NCT01778049|450666531|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
125284151|NCT01778049|450666532|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
125284152|NCT01778049|450666533|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
125284153|NCT01778049|450666534|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
125284154|NCT01778049|450666535|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
125284155|NCT01778049|450666530|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
125284156|NCT01778049|450666531|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
125284157|NCT01778049|450666532|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
125284158|NCT01778049|450666533|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
125284159|NCT01778049|450666534|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
125284160|NCT01778049|450666535|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
125284161|NCT01778049|450666530|FG000|Double Blind Treatment Period|Not treated|0|||
125284162|NCT01778049|450666531|FG001|Double Blind Treatment Period|Not treated|0|||
125284163|NCT01778049|450666532|FG002|Double Blind Treatment Period|Not treated|0|||
125284164|NCT01778049|450666533|FG003|Double Blind Treatment Period|Not treated|2|||
125284165|NCT01778049|450666534|FG004|Double Blind Treatment Period|Not treated|2|||
125284166|NCT01778049|450666535|FG005|Double Blind Treatment Period|Not treated|0|||
125284167|NCT01778049|450666530|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
125284168|NCT01778049|450666531|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
125284169|NCT01778049|450666532|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
125284170|NCT01778049|450666533|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
125284171|NCT01778049|450666534|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
125284172|NCT01778049|450666535|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
125284173|NCT03770728|450666536|FG000|Overall Study|Adverse Event|1|||
125284174|NCT03770728|450666537|FG001|Overall Study|Adverse Event|0|||
125284175|NCT03770728|450666538|FG002|Overall Study|Adverse Event|1|||
125284176|NCT03770728|450666539|FG003|Overall Study|Adverse Event|0|||
125284177|NCT03770728|450666536|FG000|Overall Study|Poor compliance to protocol|0|||
125284178|NCT03770728|450666537|FG001|Overall Study|Poor compliance to protocol|0|||
125284179|NCT03770728|450666538|FG002|Overall Study|Poor compliance to protocol|1|||
125284180|NCT03770728|450666539|FG003|Overall Study|Poor compliance to protocol|0|||
125284181|NCT03770728|450666536|FG000|Overall Study|Withdrawal by Subject|13|||
125284182|NCT03770728|450666537|FG001|Overall Study|Withdrawal by Subject|8|||
125284183|NCT03770728|450666538|FG002|Overall Study|Withdrawal by Subject|9|||
125284184|NCT03770728|450666539|FG003|Overall Study|Withdrawal by Subject|13|||
125284185|NCT03770728|450666536|FG000|Overall Study|Other than specified|24|||
125284186|NCT03770728|450666537|FG001|Overall Study|Other than specified|23|||
125284187|NCT03770728|450666538|FG002|Overall Study|Other than specified|21|||
125284188|NCT03770728|450666539|FG003|Overall Study|Other than specified|22|||
125284189|NCT00503776|450666540|FG000|Overall Study|Withdrawal by Subject|1|||
125284190|NCT00503776|450666541|FG001|Overall Study|Withdrawal by Subject|0|||
125284191|NCT00503776|450666542|FG002|Overall Study|Withdrawal by Subject|1|||
125284192|NCT00503776|450666543|FG003|Overall Study|Withdrawal by Subject|1|||
125284193|NCT00503776|450666540|FG000|Overall Study|Physician Decision|0|||
125284194|NCT00503776|450666541|FG001|Overall Study|Physician Decision|0|||
125284195|NCT00503776|450666542|FG002|Overall Study|Physician Decision|1|||
125284196|NCT00503776|450666543|FG003|Overall Study|Physician Decision|1|||
125284197|NCT02379988|450666544|FG000|Overall Study|Not eligible|1|||
125284198|NCT00107315|450666545|FG000|Overall Study|Disease Progression|9|||
125284199|NCT00107315|450666545|FG000|Overall Study|Adverse Event|4|||
125412037|NCT02014116|451134885|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
125448728|NCT02065245|451270853|FG000|Infusion 1|Death|0|||
125448729|NCT02065245|451270854|FG001|Infusion 1|Death|0|||
125448730|NCT02065245|451270855|FG002|Infusion 1|Death|1|||
125284200|NCT00107315|450666545|FG000|Overall Study|Withdrawal by Subject|2|||
125284201|NCT02509039|450666548|FG000|Overall Study|Adverse Event|0|||
125284202|NCT02509039|450666549|FG001|Overall Study|Adverse Event|1|||
125284203|NCT02509039|450666550|FG002|Overall Study|Adverse Event|1|||
125284204|NCT02509039|450666551|FG003|Overall Study|Adverse Event|1|||
125412038|NCT02014116|451134886|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
125412039|NCT02014116|451134887|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
125412040|NCT02014116|451134888|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
125412041|NCT02014116|451134880|FG000|Overall Study|Physician Decision|0|||
125412042|NCT02014116|451134881|FG001|Overall Study|Physician Decision|0|||
125412043|NCT02014116|451134882|FG002|Overall Study|Physician Decision|0|||
125412044|NCT02014116|451134883|FG003|Overall Study|Physician Decision|0|||
125412045|NCT02014116|451134884|FG004|Overall Study|Physician Decision|0|||
125412046|NCT02014116|451134885|FG005|Overall Study|Physician Decision|0|||
125412047|NCT02014116|451134886|FG006|Overall Study|Physician Decision|0|||
125412048|NCT02014116|451134887|FG007|Overall Study|Physician Decision|0|||
125412049|NCT02014116|451134888|FG008|Overall Study|Physician Decision|1|||
125412050|NCT00383435|451134889|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
125412051|NCT00383435|451134890|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
125412052|NCT00383435|451134891|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
125412053|NCT00383435|451134892|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
125412054|NCT00383435|451134893|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
125284205|NCT02509039|450666548|FG000|Overall Study|Withdrawal by Subject|0|||
125284206|NCT02509039|450666549|FG001|Overall Study|Withdrawal by Subject|0|||
125284207|NCT02509039|450666550|FG002|Overall Study|Withdrawal by Subject|1|||
125284208|NCT02509039|450666551|FG003|Overall Study|Withdrawal by Subject|0|||
125284209|NCT02509039|450666548|FG000|Overall Study|Progressive disease|2|||
125284210|NCT02509039|450666549|FG001|Overall Study|Progressive disease|2|||
125284211|NCT02509039|450666550|FG002|Overall Study|Progressive disease|1|||
125284212|NCT02509039|450666551|FG003|Overall Study|Progressive disease|5|||
125284213|NCT02509039|450666548|FG000|Overall Study|Study terminated by Sponsor|1|||
125284214|NCT02509039|450666549|FG001|Overall Study|Study terminated by Sponsor|0|||
125284215|NCT02509039|450666550|FG002|Overall Study|Study terminated by Sponsor|0|||
125284216|NCT02509039|450666551|FG003|Overall Study|Study terminated by Sponsor|0|||
125284217|NCT05427539|450666556|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
125284218|NCT05427539|450666557|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
125284219|NCT05427539|450666556|FG000|Period 1|Withdrawal by Subject|1|||
125284220|NCT05427539|450666557|FG001|Period 1|Withdrawal by Subject|0|||
125284221|NCT01895543|450666558|FG000|Overall Study|Withdrawal by Subject|43|||
125284222|NCT01895543|450666558|FG000|Overall Study|Lost to Follow-up|25|||
125284223|NCT01895543|450666558|FG000|Overall Study|Adverse Event|28|||
125284224|NCT01895543|450666558|FG000|Overall Study|Subject's substantial non-compliance|6|||
125284225|NCT01895543|450666558|FG000|Overall Study|Protocol Violation|1|||
125284226|NCT01895543|450666558|FG000|Overall Study|Physician Decision|2|||
125284227|NCT01895543|450666558|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
125284228|NCT00543296|450666559|FG000|Overall Study|Physician Decision|7|||
125284229|NCT00934947|450666560|FG000|Overall Study|Adverse Event|0|||
125284230|NCT00934947|450666561|FG001|Overall Study|Adverse Event|2|||
125284231|NCT03276026|450666564|FG000|Overall Study|Protocol Violation|1|||
125284232|NCT03276026|450666565|FG001|Overall Study|Protocol Violation|0|||
125284233|NCT04049266|450666566|FG000|Overall Study|Adverse Event|16|||
125284234|NCT04049266|450666567|FG001|Overall Study|Adverse Event|9|||
125284235|NCT04049266|450666566|FG000|Overall Study|Non-compliance with study drug|0|||
125284236|NCT04049266|450666567|FG001|Overall Study|Non-compliance with study drug|3|||
125284237|NCT04049266|450666566|FG000|Overall Study|Withdrawal by Subject|6|||
125284238|NCT04049266|450666567|FG001|Overall Study|Withdrawal by Subject|10|||
125284239|NCT04049266|450666566|FG000|Overall Study|Lost to Follow-up|2|||
125284240|NCT04049266|450666567|FG001|Overall Study|Lost to Follow-up|2|||
125284241|NCT04049266|450666566|FG000|Overall Study|Progressive disease|11|||
125284242|NCT04049266|450666567|FG001|Overall Study|Progressive disease|2|||
125284243|NCT04049266|450666566|FG000|Overall Study|Physician Decision|1|||
125284244|NCT04049266|450666567|FG001|Overall Study|Physician Decision|0|||
125284245|NCT04049266|450666566|FG000|Overall Study|Patient moved out of state|1|||
125284246|NCT04049266|450666567|FG001|Overall Study|Patient moved out of state|0|||
125284247|NCT01703208|450666568|FG000|Overall Study|Death|61|||
125284248|NCT01703208|450666569|FG001|Overall Study|Death|48|||
125284249|NCT01703208|450666568|FG000|Overall Study|Lack of Efficacy|1|||
125284250|NCT01703208|450666569|FG001|Overall Study|Lack of Efficacy|2|||
125284251|NCT01703208|450666568|FG000|Overall Study|Lost to Follow-up|68|||
125284252|NCT01703208|450666569|FG001|Overall Study|Lost to Follow-up|62|||
125284253|NCT01703208|450666568|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125284254|NCT01703208|450666569|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125284255|NCT01703208|450666568|FG000|Overall Study|Excluded Medication|1|||
125284256|NCT01703208|450666569|FG001|Overall Study|Excluded Medication|2|||
125284257|NCT01703208|450666568|FG000|Overall Study|Site Discontinued Study Participation|23|||
125284258|NCT01703208|450666569|FG001|Overall Study|Site Discontinued Study Participation|27|||
125412055|NCT00383435|451134889|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
125412056|NCT00383435|451134890|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
125284259|NCT01703208|450666568|FG000|Overall Study|Physician Decision|11|||
125284260|NCT01703208|450666569|FG001|Overall Study|Physician Decision|13|||
125284261|NCT01703208|450666568|FG000|Overall Study|Progressive disease|2|||
125284262|NCT01703208|450666569|FG001|Overall Study|Progressive disease|2|||
125284263|NCT01703208|450666568|FG000|Overall Study|Protocol Violation|1|||
125284264|NCT01703208|450666569|FG001|Overall Study|Protocol Violation|1|||
125284265|NCT01703208|450666568|FG000|Overall Study|Study Terminated by Sponsor|1710|||
125284266|NCT01703208|450666569|FG001|Overall Study|Study Terminated by Sponsor|1716|||
125284267|NCT01703208|450666568|FG000|Overall Study|Withdrawal by Subject|205|||
125284268|NCT01703208|450666569|FG001|Overall Study|Withdrawal by Subject|209|||
125284269|NCT01703208|450666568|FG000|Overall Study|Adverse Event|14|||
125284270|NCT01703208|450666569|FG001|Overall Study|Adverse Event|19|||
125284271|NCT01703208|450666568|FG000|Overall Study|Technical Problems|0|||
125284272|NCT01703208|450666569|FG001|Overall Study|Technical Problems|1|||
125284273|NCT01703208|450666568|FG000|Overall Study|Protocol Deviation|2|||
125284274|NCT01703208|450666569|FG001|Overall Study|Protocol Deviation|0|||
125284275|NCT02099344|450666570|FG000|Overall Study|Physician Decision|1|||
125284276|NCT02099344|450666571|FG001|Overall Study|Physician Decision|0|||
125284277|NCT05593913|450666578|FG000|Overall Study|Insufficient image quality|39|||
125284278|NCT02979093|450666581|FG000|First Scan Session|Scanning data problems|1|||
125284279|NCT02979093|450666582|FG001|First Scan Session|Scanning data problems|2|||
125284280|NCT02979093|450666583|FG002|First Scan Session|Scanning data problems|2|||
125284281|NCT02979093|450666584|FG003|First Scan Session|Scanning data problems|0|||
125284282|NCT02979093|450666581|FG000|Second Scan Session|Scanning data problems|3|||
125284283|NCT02979093|450666582|FG001|Second Scan Session|Scanning data problems|0|||
125284284|NCT02979093|450666583|FG002|Second Scan Session|Scanning data problems|1|||
125284285|NCT02979093|450666584|FG003|Second Scan Session|Scanning data problems|3|||
125284286|NCT01096368|450666585|FG000|Overall Study|Death|0|||
125284287|NCT01096368|450666586|FG001|Overall Study|Death|1|||
125284288|NCT01096368|450666587|FG002|Overall Study|Death|0|||
125284289|NCT01096368|450666588|FG003|Overall Study|Death|0|||
125284290|NCT01096368|450666589|FG004|Overall Study|Death|0|||
125284291|NCT01096368|450666585|FG000|Overall Study|Physician Decision|0|||
125284292|NCT01096368|450666586|FG001|Overall Study|Physician Decision|13|||
125284293|NCT01096368|450666587|FG002|Overall Study|Physician Decision|2|||
125284294|NCT01096368|450666588|FG003|Overall Study|Physician Decision|4|||
125284295|NCT01096368|450666589|FG004|Overall Study|Physician Decision|6|||
125284296|NCT01096368|450666585|FG000|Overall Study|Withdrawal by Subject|0|||
125284297|NCT01096368|450666586|FG001|Overall Study|Withdrawal by Subject|52|||
125284298|NCT01096368|450666587|FG002|Overall Study|Withdrawal by Subject|0|||
125284299|NCT01096368|450666588|FG003|Overall Study|Withdrawal by Subject|10|||
125284300|NCT01096368|450666589|FG004|Overall Study|Withdrawal by Subject|14|||
125284301|NCT01096368|450666585|FG000|Overall Study|Ineligible|0|||
125284302|NCT01096368|450666586|FG001|Overall Study|Ineligible|3|||
125284303|NCT01096368|450666587|FG002|Overall Study|Ineligible|2|||
125284304|NCT01096368|450666588|FG003|Overall Study|Ineligible|0|||
125284305|NCT01096368|450666589|FG004|Overall Study|Ineligible|25|||
125284306|NCT01096368|450666585|FG000|Overall Study|Did not start treatment|0|||
125284307|NCT01096368|450666586|FG001|Overall Study|Did not start treatment|4|||
125284308|NCT01096368|450666587|FG002|Overall Study|Did not start treatment|4|||
125284309|NCT01096368|450666588|FG003|Overall Study|Did not start treatment|0|||
125284310|NCT01096368|450666589|FG004|Overall Study|Did not start treatment|0|||
125284311|NCT01096368|450666585|FG000|Overall Study|Progressive disease|0|||
125284312|NCT01096368|450666586|FG001|Overall Study|Progressive disease|6|||
125284313|NCT01096368|450666587|FG002|Overall Study|Progressive disease|0|||
125284314|NCT01096368|450666588|FG003|Overall Study|Progressive disease|10|||
125284315|NCT01096368|450666589|FG004|Overall Study|Progressive disease|3|||
125284316|NCT01096368|450666585|FG000|Overall Study|Other|0|||
125284317|NCT01096368|450666586|FG001|Overall Study|Other|0|||
125284318|NCT01096368|450666587|FG002|Overall Study|Other|1|||
125284319|NCT01096368|450666588|FG003|Overall Study|Other|0|||
125284320|NCT01096368|450666589|FG004|Overall Study|Other|0|||
125284321|NCT01096368|450666585|FG000|Overall Study|Treated with institutional review|0|||
125284322|NCT01096368|450666586|FG001|Overall Study|Treated with institutional review|0|||
125284323|NCT01096368|450666587|FG002|Overall Study|Treated with institutional review|0|||
125284324|NCT01096368|450666588|FG003|Overall Study|Treated with institutional review|0|||
125284325|NCT01096368|450666589|FG004|Overall Study|Treated with institutional review|1|||
125284326|NCT03070223|450666590|FG000|Overall Study|Lost to Follow-up|34|||
125284327|NCT03070223|450666591|FG001|Overall Study|Lost to Follow-up|27|||
125284328|NCT03070223|450666590|FG000|Overall Study|Withdrawal by Subject|12|||
125284329|NCT03070223|450666591|FG001|Overall Study|Withdrawal by Subject|22|||
125284330|NCT03070223|450666590|FG000|Overall Study|Protocol Violation|0|||
125284331|NCT03070223|450666591|FG001|Overall Study|Protocol Violation|1|||
125284332|NCT02684058|450666595|FG000|Treatment Period|Progressive disease|4|||
125284333|NCT02684058|450666596|FG001|Treatment Period|Progressive disease|10|||
125284334|NCT02684058|450666597|FG002|Treatment Period|Progressive disease|19|||
125284335|NCT02684058|450666595|FG000|Treatment Period|Adverse Event|3|||
125284336|NCT02684058|450666596|FG001|Treatment Period|Adverse Event|8|||
125284337|NCT02684058|450666597|FG002|Treatment Period|Adverse Event|1|||
125284338|NCT02684058|450666595|FG000|Treatment Period|Physician Decision|5|||
125284339|NCT02684058|450666596|FG001|Treatment Period|Physician Decision|1|||
125284340|NCT02684058|450666597|FG002|Treatment Period|Physician Decision|2|||
125412057|NCT00383435|451134891|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
125412058|NCT00383435|451134892|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
125412059|NCT00383435|451134893|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
125412060|NCT00383435|451134889|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
125412061|NCT00383435|451134890|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
125412062|NCT00383435|451134891|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
125412063|NCT00383435|451134892|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
125412064|NCT00383435|451134893|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
125412065|NCT00383435|451134889|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
125412066|NCT00383435|451134890|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
125412067|NCT00383435|451134891|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
125412068|NCT00383435|451134892|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
125412069|NCT00383435|451134893|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
125412070|NCT00383435|451134889|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
125412071|NCT00383435|451134890|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
125412072|NCT00383435|451134891|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
125412073|NCT00383435|451134892|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
125412074|NCT00383435|451134893|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
125412075|NCT00383435|451134889|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
125412076|NCT00383435|451134890|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
125412077|NCT00383435|451134891|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
125412078|NCT00383435|451134892|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
125412079|NCT00383435|451134893|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
125412080|NCT00383435|451134889|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
125412081|NCT00383435|451134890|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
125412082|NCT00383435|451134891|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
125412083|NCT00383435|451134892|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
125412084|NCT00383435|451134893|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
125412085|NCT00383435|451134889|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
125412086|NCT00383435|451134890|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
125412087|NCT00383435|451134891|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
125412088|NCT00383435|451134892|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
125412089|NCT00383435|451134893|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
125412090|NCT00383435|451134889|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
125412091|NCT00383435|451134890|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
125412092|NCT00383435|451134891|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
125412093|NCT00383435|451134892|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
125412094|NCT00383435|451134893|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
125412095|NCT00383435|451134889|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
125412096|NCT00383435|451134890|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
125412097|NCT00383435|451134891|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
125412098|NCT00383435|451134892|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
125412099|NCT00383435|451134893|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
125412100|NCT00383435|451134889|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
125412101|NCT00383435|451134890|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
125412102|NCT00383435|451134891|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
125412103|NCT00383435|451134892|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
125412104|NCT00383435|451134893|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
125412105|NCT00383435|451134889|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
125412106|NCT00383435|451134890|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
125412107|NCT00383435|451134891|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
125412108|NCT00383435|451134892|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
125412109|NCT00383435|451134893|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
125412110|NCT00383435|451134889|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
125412111|NCT00383435|451134890|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
125412112|NCT00383435|451134891|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
125448731|NCT02065245|451270856|FG003|Infusion 1|Death|0|||
125448732|NCT02065245|451270857|FG004|Infusion 1|Death|1|||
125448733|NCT02065245|451270858|FG005|Infusion 1|Death|0|||
125448734|NCT02065245|451270859|FG006|Infusion 1|Death|0|||
125448735|NCT02065245|451270853|FG000|Infusion 2|Death|0|||
125448736|NCT02065245|451270854|FG001|Infusion 2|Death|0|||
125448737|NCT02065245|451270855|FG002|Infusion 2|Death|0|||
125448738|NCT02065245|451270856|FG003|Infusion 2|Death|0|||
125448739|NCT02065245|451270857|FG004|Infusion 2|Death|0|||
125448740|NCT02065245|451270858|FG005|Infusion 2|Death|0|||
125412113|NCT00383435|451134892|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
125412114|NCT00383435|451134893|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
125412115|NCT00383435|451134889|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
125412116|NCT00383435|451134890|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
125412117|NCT00383435|451134891|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
125412118|NCT00383435|451134892|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
125412119|NCT00383435|451134893|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
125412120|NCT00383435|451134889|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
125412121|NCT00383435|451134890|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
125412122|NCT00383435|451134891|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
125412123|NCT00383435|451134892|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
125412124|NCT00383435|451134893|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
125412125|NCT00383435|451134889|FG000|26-Week Treatment Safety Extension|Administrative|1|||
125412126|NCT00383435|451134890|FG001|26-Week Treatment Safety Extension|Administrative|1|||
125412127|NCT00383435|451134891|FG002|26-Week Treatment Safety Extension|Administrative|0|||
125412128|NCT00383435|451134892|FG003|26-Week Treatment Safety Extension|Administrative|1|||
125412129|NCT00383435|451134893|FG004|26-Week Treatment Safety Extension|Administrative|0|||
125412130|NCT01753193|451134894|FG000|Overall Study|Withdrawal by Subject|23|||
125412131|NCT01753193|451134894|FG000|Overall Study|Lost to Follow-up|6|||
125412132|NCT01753193|451134894|FG000|Overall Study|Death|1|||
125412133|NCT01753193|451134894|FG000|Overall Study|Other|16|||
125412134|NCT00583557|451134895|FG000|Overall Study|Withdrawal by Subject|18|||
125412135|NCT00583557|451134895|FG000|Overall Study|Adverse Event|9|||
125412136|NCT00583557|451134895|FG000|Overall Study|Lack of Efficacy|31|||
125412137|NCT00583557|451134895|FG000|Overall Study|Lack of Compliance|5|||
125412138|NCT00583557|451134895|FG000|Overall Study|Other|5|||
125412139|NCT00583557|451134895|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
125412140|NCT01131312|451134896|FG000|Overall Study|Lost to Follow-up|425|||
125412141|NCT01131312|451134897|FG001|Overall Study|Lost to Follow-up|229|||
125412142|NCT01131312|451134898|FG002|Overall Study|Lost to Follow-up|351|||
125412143|NCT02682264|451134899|FG000|Overall Study|Withdrawal by Subject|56|||
125412144|NCT02682264|451134900|FG001|Overall Study|Withdrawal by Subject|45|||
125412145|NCT02682264|451134899|FG000|Overall Study|Lost to Follow-up|49|||
125412146|NCT02682264|451134900|FG001|Overall Study|Lost to Follow-up|41|||
125412147|NCT02682264|451134899|FG000|Overall Study|Lack of Efficacy|14|||
125412148|NCT02682264|451134900|FG001|Overall Study|Lack of Efficacy|16|||
125412149|NCT02682264|451134899|FG000|Overall Study|Withdrawal by Parent|6|||
125412150|NCT02682264|451134900|FG001|Overall Study|Withdrawal by Parent|7|||
125412151|NCT02682264|451134899|FG000|Overall Study|Adverse Event|9|||
125412152|NCT02682264|451134900|FG001|Overall Study|Adverse Event|0|||
125412153|NCT02682264|451134899|FG000|Overall Study|Noncompliance with study drug|1|||
125412154|NCT02682264|451134900|FG001|Overall Study|Noncompliance with study drug|4|||
125412155|NCT02682264|451134899|FG000|Overall Study|Pregnancy|1|||
125412156|NCT02682264|451134900|FG001|Overall Study|Pregnancy|2|||
125412157|NCT02682264|451134899|FG000|Overall Study|Recovery|1|||
125412158|NCT02682264|451134900|FG001|Overall Study|Recovery|2|||
125412159|NCT02682264|451134899|FG000|Overall Study|Progressive Disease|1|||
125412160|NCT02682264|451134900|FG001|Overall Study|Progressive Disease|0|||
125412161|NCT02682264|451134899|FG000|Overall Study|Technical Problems|0|||
125412162|NCT02682264|451134900|FG001|Overall Study|Technical Problems|1|||
125412163|NCT02682264|451134899|FG000|Overall Study|Moved abroad and unable to continue|0|||
125412164|NCT02682264|451134900|FG001|Overall Study|Moved abroad and unable to continue|3|||
125412165|NCT02682264|451134899|FG000|Overall Study|Stopped test article application|0|||
125412166|NCT02682264|451134900|FG001|Overall Study|Stopped test article application|1|||
125412167|NCT03447769|451134902|FG000|Overall Study|Progressive disease|138|||
125412168|NCT03447769|451134903|FG001|Overall Study|Progressive disease|148|||
125412169|NCT03447769|451134902|FG000|Overall Study|Study terminated by Sponsor|60|||
125412170|NCT03447769|451134903|FG001|Overall Study|Study terminated by Sponsor|44|||
125412171|NCT03447769|451134902|FG000|Overall Study|Adverse Event|34|||
125412172|NCT03447769|451134903|FG001|Overall Study|Adverse Event|31|||
125412173|NCT03447769|451134902|FG000|Overall Study|Patient decision|27|||
125412174|NCT03447769|451134903|FG001|Overall Study|Patient decision|27|||
125412175|NCT03447769|451134902|FG000|Overall Study|Protocol deviation|4|||
125412176|NCT03447769|451134903|FG001|Overall Study|Protocol deviation|6|||
125412177|NCT03447769|451134902|FG000|Overall Study|Death|2|||
125412178|NCT03447769|451134903|FG001|Overall Study|Death|7|||
125412179|NCT03447769|451134902|FG000|Overall Study|Technical problems|1|||
125412180|NCT03447769|451134903|FG001|Overall Study|Technical problems|0|||
125412181|NCT03447769|451134902|FG000|Overall Study|Lost to Follow-up|0|||
125412182|NCT03447769|451134903|FG001|Overall Study|Lost to Follow-up|1|||
125412183|NCT03447769|451134902|FG000|Overall Study|Physician Decision|13|||
125412184|NCT03447769|451134903|FG001|Overall Study|Physician Decision|5|||
125412185|NCT01343407|451134905|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
125412186|NCT01343407|451134906|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
125412187|NCT01343407|451134907|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
125284341|NCT02684058|450666595|FG000|Treatment Period|New therapy for study indication|1|||
125284342|NCT02684058|450666596|FG001|Treatment Period|New therapy for study indication|0|||
125284343|NCT02684058|450666597|FG002|Treatment Period|New therapy for study indication|0|||
125284344|NCT02684058|450666595|FG000|Treatment Period|Protocol deviation|0|||
125284345|NCT02684058|450666596|FG001|Treatment Period|Protocol deviation|1|||
125284346|NCT02684058|450666597|FG002|Treatment Period|Protocol deviation|0|||
125284347|NCT02684058|450666595|FG000|Treatment Period|Subject/guardian decision|4|||
125284348|NCT02684058|450666596|FG001|Treatment Period|Subject/guardian decision|3|||
125284349|NCT02684058|450666597|FG002|Treatment Period|Subject/guardian decision|0|||
125284350|NCT02684058|450666595|FG000|Treatment Period|Death|0|||
125284351|NCT02684058|450666596|FG001|Treatment Period|Death|0|||
125284352|NCT02684058|450666597|FG002|Treatment Period|Death|2|||
125284353|NCT02684058|450666595|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125284354|NCT02684058|450666596|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
125284355|NCT02684058|450666597|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
125284356|NCT02684058|450666595|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
125284357|NCT02684058|450666596|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
125284358|NCT02684058|450666597|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
125284359|NCT02684058|450666595|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
125284360|NCT02684058|450666596|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
125284361|NCT02684058|450666597|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
125284362|NCT02684058|450666595|FG000|Post-treatment Efficacy Follow-up|Death|0|||
125284363|NCT02684058|450666596|FG001|Post-treatment Efficacy Follow-up|Death|0|||
125284364|NCT02684058|450666597|FG002|Post-treatment Efficacy Follow-up|Death|3|||
125284365|NCT02684058|450666595|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
125284366|NCT02684058|450666596|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
125284367|NCT02684058|450666597|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
125284368|NCT02684058|450666595|FG000|Post-treatment Survival Follow-up|Death|0|||
125284369|NCT02684058|450666596|FG001|Post-treatment Survival Follow-up|Death|0|||
125284370|NCT02684058|450666597|FG002|Post-treatment Survival Follow-up|Death|7|||
125284371|NCT02684058|450666595|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
125284372|NCT02684058|450666596|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
125284373|NCT02684058|450666597|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
125284374|NCT02684058|450666595|FG000|Crossover Treatment Period|Progressive disease|0|||
125284375|NCT02684058|450666596|FG001|Crossover Treatment Period|Progressive disease|1|||
125284376|NCT02684058|450666597|FG002|Crossover Treatment Period|Progressive disease|0|||
125284377|NCT00443053|450666601|FG000|Overall Study|Adverse Event|2|||
125284378|NCT00443053|450666602|FG001|Overall Study|Adverse Event|1|||
125284379|NCT00443053|450666601|FG000|Overall Study|Withdrawal by Subject|9|||
125284380|NCT00443053|450666602|FG001|Overall Study|Withdrawal by Subject|18|||
125284381|NCT00443053|450666601|FG000|Overall Study|Lost to Follow-up|4|||
125284382|NCT00443053|450666602|FG001|Overall Study|Lost to Follow-up|5|||
125284383|NCT00443053|450666601|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
125284384|NCT00443053|450666602|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
125284385|NCT00443053|450666601|FG000|Overall Study|Noncompliance|2|||
125284386|NCT00443053|450666602|FG001|Overall Study|Noncompliance|1|||
125284387|NCT00443053|450666601|FG000|Overall Study|Other|3|||
125284388|NCT00443053|450666602|FG001|Overall Study|Other|4|||
125284389|NCT00443053|450666601|FG000|Overall Study|Physician Decision|0|||
125284390|NCT00443053|450666602|FG001|Overall Study|Physician Decision|4|||
125284391|NCT00350272|450666603|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
125284392|NCT00350272|450666604|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
125284393|NCT00350272|450666603|FG000|Blinded 12-Week Treatment|Death|1|||
125284394|NCT00350272|450666604|FG001|Blinded 12-Week Treatment|Death|0|||
125284395|NCT00350272|450666603|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
125284396|NCT00350272|450666604|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
125284397|NCT00350272|450666603|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
125284398|NCT00350272|450666604|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
125284399|NCT00350272|450666603|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
125284400|NCT00350272|450666604|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
125284401|NCT00350272|450666603|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
125284402|NCT00350272|450666604|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
125284403|NCT00350272|450666603|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
125284404|NCT00350272|450666604|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
125284405|NCT00350272|450666603|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
125284406|NCT00350272|450666604|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
125284407|NCT00350272|450666603|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
125284408|NCT00350272|450666604|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
125284409|NCT00350272|450666603|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
125284410|NCT00350272|450666604|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
125284411|NCT00350272|450666603|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
125448741|NCT02065245|451270859|FG006|Infusion 2|Death|1|||
125284412|NCT00350272|450666604|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
125284413|NCT02226198|450667812|FG000|Lead-in Phase|Protocol Violation|1|||
125284414|NCT02226198|450667813|FG001|Lead-in Phase|Protocol Violation|0|||
125284415|NCT02226198|450667814|FG002|Lead-in Phase|Protocol Violation|0|||
125284416|NCT02226198|450667812|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
125284417|NCT02226198|450667813|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
125284418|NCT02226198|450667814|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
125284419|NCT01288612|450667816|FG000|Overall Study|Unable to contact|11|||
125284420|NCT01288612|450667817|FG001|Overall Study|Unable to contact|16|||
125284421|NCT01288612|450667818|FG002|Overall Study|Unable to contact|20|||
125284422|NCT01288612|450667816|FG000|Overall Study|Declined|78|||
125284423|NCT01288612|450667817|FG001|Overall Study|Declined|63|||
125284424|NCT01288612|450667818|FG002|Overall Study|Declined|62|||
125284425|NCT01288612|450667816|FG000|Overall Study|Unable to intubate|0|||
125284426|NCT01288612|450667817|FG001|Overall Study|Unable to intubate|3|||
125284427|NCT01288612|450667818|FG002|Overall Study|Unable to intubate|0|||
125284428|NCT00871923|450667819|FG000|Overall Study|Death|1|||
125284429|NCT00871923|450667819|FG000|Overall Study|Withdrawal by Subject|1|||
125284430|NCT05599451|450667820|FG000|Overall Study|Not randomized|11|||
125284431|NCT05599451|450667821|FG001|Overall Study|Not randomized|0|||
125284432|NCT05599451|450667822|FG002|Overall Study|Not randomized|0|||
125284433|NCT05599451|450667823|FG003|Overall Study|Not randomized|0|||
125284434|NCT05599451|450667824|FG004|Overall Study|Not randomized|0|||
125284435|NCT05599451|450667820|FG000|Overall Study|Physician Decision|0|||
125284436|NCT05599451|450667821|FG001|Overall Study|Physician Decision|0|||
125284437|NCT05599451|450667822|FG002|Overall Study|Physician Decision|0|||
125284438|NCT05599451|450667823|FG003|Overall Study|Physician Decision|1|||
125284439|NCT05599451|450667824|FG004|Overall Study|Physician Decision|0|||
125284440|NCT00789581|450667827|FG000|AC Therapy|Adverse Event|2|||
125284441|NCT00789581|450667828|FG001|AC Therapy|Adverse Event|3|||
125284442|NCT00789581|450667827|FG000|AC Therapy|Withdrawal by Subject|4|||
125284443|NCT00789581|450667828|FG001|AC Therapy|Withdrawal by Subject|7|||
125284444|NCT00789581|450667827|FG000|AC Therapy|Disease recurrence|3|||
125284445|NCT00789581|450667828|FG001|AC Therapy|Disease recurrence|1|||
125284446|NCT00789581|450667827|FG000|AC Therapy|Intercurrent Illness|1|||
125284447|NCT00789581|450667828|FG001|AC Therapy|Intercurrent Illness|0|||
125284448|NCT00789581|450667827|FG000|AC Therapy|Never Treated|1|||
125284449|NCT00789581|450667828|FG001|AC Therapy|Never Treated|4|||
125284450|NCT00789581|450667827|FG000|AC Therapy|Other|0|||
125284451|NCT00789581|450667828|FG001|AC Therapy|Other|2|||
125284452|NCT00789581|450667827|FG000|Adjuvant Therapy|Never treated|2|||
125284453|NCT00789581|450667828|FG001|Adjuvant Therapy|Never treated|2|||
125284454|NCT00789581|450667827|FG000|Adjuvant Therapy|Adverse Event|20|||
125284455|NCT00789581|450667828|FG001|Adjuvant Therapy|Adverse Event|44|||
125284456|NCT00789581|450667827|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
125284457|NCT00789581|450667828|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
125284458|NCT00789581|450667827|FG000|Adjuvant Therapy|Disease recurrence|2|||
125284459|NCT00789581|450667828|FG001|Adjuvant Therapy|Disease recurrence|1|||
125284460|NCT00789581|450667827|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
125284461|NCT00789581|450667828|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
125284462|NCT00789581|450667827|FG000|Adjuvant Therapy|Protocol Violation|1|||
125284463|NCT00789581|450667828|FG001|Adjuvant Therapy|Protocol Violation|1|||
125284464|NCT00789581|450667827|FG000|Adjuvant Therapy|Other|0|||
125284465|NCT00789581|450667828|FG001|Adjuvant Therapy|Other|1|||
125284466|NCT01468207|450667829|FG000|Treatment Period 1|Adverse Event|1|||
125284467|NCT01468207|450667830|FG001|Treatment Period 1|Adverse Event|0|||
125284468|NCT01468207|450667831|FG002|Treatment Period 1|Adverse Event|0|||
125284469|NCT01468207|450667832|FG003|Treatment Period 1|Adverse Event|0|||
125284470|NCT01468207|450667833|FG004|Treatment Period 1|Adverse Event|0|||
125284471|NCT01468207|450667834|FG005|Treatment Period 1|Adverse Event|0|||
125284472|NCT01468207|450667829|FG000|Treatment Period 1|Protocol Violation|1|||
125284473|NCT01468207|450667830|FG001|Treatment Period 1|Protocol Violation|1|||
125412188|NCT01343407|451134908|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
125412189|NCT01343407|451134909|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
125284474|NCT01468207|450667831|FG002|Treatment Period 1|Protocol Violation|0|||
125284475|NCT01468207|450667832|FG003|Treatment Period 1|Protocol Violation|0|||
125284476|NCT01468207|450667833|FG004|Treatment Period 1|Protocol Violation|0|||
125284477|NCT01468207|450667834|FG005|Treatment Period 1|Protocol Violation|0|||
125284478|NCT01468207|450667829|FG000|Treatment Period 1|Withdrawal by Subject|5|||
125284479|NCT01468207|450667830|FG001|Treatment Period 1|Withdrawal by Subject|4|||
125284480|NCT01468207|450667831|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125284481|NCT01468207|450667832|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125284482|NCT01468207|450667833|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125284483|NCT01468207|450667834|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125284484|NCT01468207|450667829|FG000|Treatment Period 1|Lost to Follow-up|2|||
125284485|NCT01468207|450667830|FG001|Treatment Period 1|Lost to Follow-up|1|||
125284486|NCT01468207|450667831|FG002|Treatment Period 1|Lost to Follow-up|0|||
125284487|NCT01468207|450667832|FG003|Treatment Period 1|Lost to Follow-up|0|||
125284488|NCT01468207|450667833|FG004|Treatment Period 1|Lost to Follow-up|0|||
125412190|NCT01343407|451134910|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
125412191|NCT01343407|451134905|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
125412192|NCT01343407|451134906|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
125412193|NCT01343407|451134907|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
125412194|NCT01343407|451134908|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
125412195|NCT01343407|451134909|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
125412196|NCT01343407|451134910|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
125412197|NCT03950739|451134911|FG000|Treatment Phase|Adverse Event|2|||
125412198|NCT03950739|451134911|FG000|Optional Extension Phase|Death|1|||
125412199|NCT03950739|451134911|FG000|Optional Extension Phase|Progressive Disease|5|||
125412200|NCT03950739|451134911|FG000|Optional Extension Phase|Adverse Event|7|||
125412201|NCT03950739|451134911|FG000|Optional Extension Phase|Lost to Follow-up|2|||
125412202|NCT03950739|451134911|FG000|Optional Extension Phase|Site Closure|2|||
125412203|NCT03950739|451134911|FG000|Optional Extension Phase|Pregnancy|1|||
125412204|NCT03264989|451134915|FG000|Overall Study|Lost to Follow-up|1|||
125412205|NCT03264989|451134916|FG001|Overall Study|Lost to Follow-up|0|||
125412206|NCT03264989|451134915|FG000|Overall Study|New Therapy for study Indication|1|||
125412207|NCT03264989|451134916|FG001|Overall Study|New Therapy for study Indication|0|||
125412208|NCT03264989|451134915|FG000|Overall Study|Protocol Violation|0|||
125412209|NCT03264989|451134916|FG001|Overall Study|Protocol Violation|1|||
125412210|NCT03264989|451134915|FG000|Overall Study|Patient decision|13|||
125412211|NCT03264989|451134916|FG001|Overall Study|Patient decision|0|||
125412212|NCT03264989|451134915|FG000|Overall Study|Physician Decision|6|||
125412213|NCT03264989|451134916|FG001|Overall Study|Physician Decision|4|||
125412214|NCT03264989|451134915|FG000|Overall Study|Adverse Event|2|||
125412215|NCT03264989|451134916|FG001|Overall Study|Adverse Event|1|||
125412216|NCT03264989|451134915|FG000|Overall Study|Death|1|||
125412217|NCT03264989|451134916|FG001|Overall Study|Death|1|||
125412218|NCT03264989|451134915|FG000|Overall Study|Pregnancy|2|||
125412219|NCT03264989|451134916|FG001|Overall Study|Pregnancy|0|||
125412220|NCT03264989|451134915|FG000|Overall Study|End of Study|19|||
125412221|NCT03264989|451134916|FG001|Overall Study|End of Study|5|||
125412222|NCT00797667|451134917|FG000|Overall Study|Lack of Efficacy|0|||
125412223|NCT00797667|451134918|FG001|Overall Study|Lack of Efficacy|1|||
125412224|NCT00797667|451134919|FG002|Overall Study|Lack of Efficacy|0|||
125412225|NCT00797667|451134917|FG000|Overall Study|Lost to Follow-up|8|||
125412226|NCT00797667|451134918|FG001|Overall Study|Lost to Follow-up|12|||
125412227|NCT00797667|451134919|FG002|Overall Study|Lost to Follow-up|2|||
125412228|NCT00797667|451134917|FG000|Overall Study|Physician Decision|3|||
125412229|NCT00797667|451134918|FG001|Overall Study|Physician Decision|1|||
125412230|NCT00797667|451134919|FG002|Overall Study|Physician Decision|0|||
125412231|NCT00797667|451134917|FG000|Overall Study|Pregnancy|2|||
125412232|NCT00797667|451134918|FG001|Overall Study|Pregnancy|0|||
125412233|NCT00797667|451134919|FG002|Overall Study|Pregnancy|0|||
125412234|NCT00797667|451134917|FG000|Overall Study|Protocol Violation|2|||
125412235|NCT00797667|451134918|FG001|Overall Study|Protocol Violation|7|||
125412236|NCT00797667|451134919|FG002|Overall Study|Protocol Violation|0|||
125412237|NCT00797667|451134917|FG000|Overall Study|Study Terminated by Sponsor|217|||
125412238|NCT00797667|451134918|FG001|Overall Study|Study Terminated by Sponsor|216|||
125412239|NCT00797667|451134919|FG002|Overall Study|Study Terminated by Sponsor|115|||
125412240|NCT00797667|451134917|FG000|Overall Study|Withdrawal by Subject|9|||
125412241|NCT00797667|451134918|FG001|Overall Study|Withdrawal by Subject|14|||
125412242|NCT00797667|451134919|FG002|Overall Study|Withdrawal by Subject|2|||
125412243|NCT00797667|451134917|FG000|Overall Study|Adverse Event|19|||
125412244|NCT00797667|451134918|FG001|Overall Study|Adverse Event|8|||
125412245|NCT00797667|451134919|FG002|Overall Study|Adverse Event|8|||
125412246|NCT01986829|451134920|FG000|Overall Study|Death|1|||
125412247|NCT02504866|451134921|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
125412248|NCT02504866|451134922|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
125412249|NCT02504866|451134923|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
125412250|NCT01775137|451134926|FG000|Overall Study|Death|1|||
125412251|NCT01775137|451134926|FG000|Overall Study|Protocol deviation|2|||
125412252|NCT01775137|451134926|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125412253|NCT01775137|451134926|FG000|Overall Study|Adverse Event|1|||
125412254|NCT01775137|451134926|FG000|Overall Study|Withdrawal by participants|5|||
125412255|NCT01343056|451134927|FG000|Overall Study|Lost to Follow-up|7|||
125412256|NCT01343056|451134928|FG001|Overall Study|Lost to Follow-up|5|||
125412257|NCT01343056|451134929|FG002|Overall Study|Lost to Follow-up|3|||
125412258|NCT01343056|451134930|FG003|Overall Study|Lost to Follow-up|9|||
125412259|NCT03231371|451134931|FG000|Overall Study|Withdrawal by Subject|1|||
125412260|NCT03231371|451134931|FG000|Overall Study|chose or were ineligible to have MRI|12|||
125412261|NCT03029208|451134935|FG000|Overall Study|Withdrawal by Subject|2|||
125412262|NCT03029208|451134936|FG001|Overall Study|Withdrawal by Subject|3|||
125412263|NCT03029208|451134935|FG000|Overall Study|Lost to Follow-up|0|||
125412264|NCT03029208|451134936|FG001|Overall Study|Lost to Follow-up|1|||
125412265|NCT01732835|451134939|FG000|6-month Primary Endpoint|Did not receive device|19|||
125412266|NCT01732835|451134939|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
125412267|NCT01732835|451134939|FG000|6-month Primary Endpoint|Adverse Event|3|||
125412268|NCT01732835|451134939|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
125412269|NCT01732835|451134939|FG000|2-year Extended Follow-up|Adverse Event|3|||
125412270|NCT01732835|451134939|FG000|2-year Extended Follow-up|Death|1|||
125412271|NCT02334748|451134940|FG000|Overall Study|Adverse Event|1|||
125412272|NCT02334748|451134940|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
125412273|NCT02334748|451134940|FG000|Overall Study|Patient no longer required study drug|2|||
125412274|NCT02334748|451134940|FG000|Overall Study|Lack of Efficacy|4|||
125412275|NCT02493361|451134941|FG000|Overall Study|Withdrawal by Subject|3|||
125412276|NCT01046643|451134942|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
125412277|NCT01046643|451134943|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
125412278|NCT01046643|451134944|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
125412279|NCT01046643|451134945|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
125412280|NCT01310036|451134956|FG000|Overall Study|Administrative/other|10|||
125412281|NCT01310036|451134956|FG000|Overall Study|Withdrew Consent|11|||
125448742|NCT02065245|451270853|FG000|Infusion 3|Lost to Follow-up|1|||
125448743|NCT02065245|451270854|FG001|Infusion 3|Lost to Follow-up|1|||
125284489|NCT01468207|450667834|FG005|Treatment Period 1|Lost to Follow-up|0|||
125284490|NCT01468207|450667829|FG000|Treatment Period 1|Other|0|||
125284491|NCT01468207|450667830|FG001|Treatment Period 1|Other|2|||
125284492|NCT01468207|450667831|FG002|Treatment Period 1|Other|0|||
125284493|NCT01468207|450667832|FG003|Treatment Period 1|Other|0|||
125284494|NCT01468207|450667833|FG004|Treatment Period 1|Other|0|||
125284495|NCT01468207|450667834|FG005|Treatment Period 1|Other|0|||
125284496|NCT01468207|450667829|FG000|Treatment Period 2|Adverse Event|0|||
125284497|NCT01468207|450667830|FG001|Treatment Period 2|Adverse Event|0|||
125284498|NCT01468207|450667831|FG002|Treatment Period 2|Adverse Event|6|||
125284499|NCT01468207|450667832|FG003|Treatment Period 2|Adverse Event|1|||
125284500|NCT01468207|450667833|FG004|Treatment Period 2|Adverse Event|2|||
125284501|NCT01468207|450667834|FG005|Treatment Period 2|Adverse Event|1|||
125284502|NCT01468207|450667829|FG000|Treatment Period 2|Lack of Efficacy|0|||
125284503|NCT01468207|450667830|FG001|Treatment Period 2|Lack of Efficacy|0|||
125284504|NCT01468207|450667831|FG002|Treatment Period 2|Lack of Efficacy|1|||
125284505|NCT01468207|450667832|FG003|Treatment Period 2|Lack of Efficacy|1|||
125284506|NCT01468207|450667833|FG004|Treatment Period 2|Lack of Efficacy|0|||
125284507|NCT01468207|450667834|FG005|Treatment Period 2|Lack of Efficacy|2|||
125284508|NCT01468207|450667829|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125284509|NCT01468207|450667830|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125284510|NCT01468207|450667831|FG002|Treatment Period 2|Withdrawal by Subject|5|||
125284511|NCT01468207|450667832|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125284512|NCT01468207|450667833|FG004|Treatment Period 2|Withdrawal by Subject|0|||
125284513|NCT01468207|450667834|FG005|Treatment Period 2|Withdrawal by Subject|2|||
125284514|NCT01468207|450667829|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
125284515|NCT01468207|450667830|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
125284516|NCT01468207|450667831|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
125284517|NCT01468207|450667832|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
125284518|NCT01468207|450667833|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
125284519|NCT01468207|450667834|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
125284520|NCT01468207|450667829|FG000|Treatment Period 2|Lost to Follow-up|0|||
125284521|NCT01468207|450667830|FG001|Treatment Period 2|Lost to Follow-up|0|||
125284522|NCT01468207|450667831|FG002|Treatment Period 2|Lost to Follow-up|5|||
125284523|NCT01468207|450667832|FG003|Treatment Period 2|Lost to Follow-up|1|||
125284524|NCT01468207|450667833|FG004|Treatment Period 2|Lost to Follow-up|0|||
125284525|NCT01468207|450667834|FG005|Treatment Period 2|Lost to Follow-up|0|||
125284526|NCT01468207|450667829|FG000|Treatment Period 2|Other|0|||
125284527|NCT01468207|450667830|FG001|Treatment Period 2|Other|0|||
125284528|NCT01468207|450667831|FG002|Treatment Period 2|Other|5|||
125284529|NCT01468207|450667832|FG003|Treatment Period 2|Other|1|||
125284530|NCT01468207|450667833|FG004|Treatment Period 2|Other|1|||
125284531|NCT01468207|450667834|FG005|Treatment Period 2|Other|2|||
125284532|NCT01328041|450667837|FG000|Overall Study|Adverse Event|7|||
125284533|NCT01328041|450667837|FG000|Overall Study|Lack of Efficacy|27|||
125284534|NCT01328041|450667837|FG000|Overall Study|Protocol Violation|7|||
125284535|NCT01328041|450667837|FG000|Overall Study|Lost to Follow-up|7|||
125284536|NCT01328041|450667837|FG000|Overall Study|Physician Decision|2|||
125284537|NCT01328041|450667837|FG000|Overall Study|Withdrawal by Subject|7|||
125284538|NCT00908115|450667838|FG000|Overall Study|Other|14|||
125448744|NCT02065245|451270855|FG002|Infusion 3|Lost to Follow-up|0|||
125284539|NCT01728077|450667839|FG000|Overall Study|Lack of Efficacy|3|||
125284540|NCT01728077|450667840|FG001|Overall Study|Lack of Efficacy|1|||
125412282|NCT01310036|451134956|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
125284541|NCT01728077|450667839|FG000|Overall Study|Lost to Follow-up|1|||
125284542|NCT01728077|450667840|FG001|Overall Study|Lost to Follow-up|0|||
125284543|NCT01728077|450667839|FG000|Overall Study|Subject choice|2|||
125284544|NCT01728077|450667840|FG001|Overall Study|Subject choice|3|||
125284545|NCT01728077|450667839|FG000|Overall Study|Death|0|||
125412283|NCT01310036|451134956|FG000|Overall Study|Progression of Disease|164|||
125284546|NCT01728077|450667840|FG001|Overall Study|Death|1|||
125412284|NCT01310036|451134956|FG000|Overall Study|Death|1|||
125412285|NCT01310036|451134956|FG000|Overall Study|Adverse event or intercurrent illness|12|||
125412286|NCT00874029|451134957|FG000|Overall Study|Withdrawal by Subject|10|||
125412287|NCT00874029|451134957|FG000|Overall Study|Pregnancy|4|||
125412288|NCT00874029|451134957|FG000|Overall Study|Physician Decision|1|||
125412289|NCT00874029|451134957|FG000|Overall Study|Adverse Event|1|||
125412290|NCT00874029|451134957|FG000|Overall Study|Lost to Follow-up|5|||
125412291|NCT03359096|451134958|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
125412292|NCT03359096|451134959|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
125412293|NCT03359096|451134958|FG000|First Intervention (4 Weeks)|Death|1|||
125448745|NCT02065245|451270856|FG003|Infusion 3|Lost to Follow-up|0|||
125448746|NCT02065245|451270857|FG004|Infusion 3|Lost to Follow-up|0|||
125448747|NCT02065245|451270858|FG005|Infusion 3|Lost to Follow-up|0|||
125448748|NCT02065245|451270859|FG006|Infusion 3|Lost to Follow-up|0|||
125448749|NCT01304706|451270860|FG000|Overall Study|Adverse Event|2|||
125448750|NCT01304706|451270860|FG000|Overall Study|Lack of Efficacy|1|||
125448751|NCT01304706|451270860|FG000|Overall Study|Death|3|||
125448752|NCT01304706|451270860|FG000|Overall Study|Withdrawal by Subject|3|||
125448753|NCT01304706|451270860|FG000|Overall Study|Lost to Follow-up|7|||
125448754|NCT01304706|451270860|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
125448755|NCT01345292|451270863|FG000|Overall Study|Withdrawal by Subject|2|||
125448756|NCT01345292|451270864|FG001|Overall Study|Withdrawal by Subject|0|||
125448757|NCT01345292|451270865|FG002|Overall Study|Withdrawal by Subject|1|||
125448758|NCT04822298|451270868|FG000|Overall Study|Death|3|||
125448759|NCT01033643|451270869|FG000|Overall Study|Withdrew Consent|0|||
125448760|NCT01033643|451270870|FG001|Overall Study|Withdrew Consent|3|||
125448761|NCT01033643|451270871|FG002|Overall Study|Withdrew Consent|0|||
125448762|NCT01033643|451270872|FG003|Overall Study|Withdrew Consent|0|||
125448763|NCT01033643|451270873|FG004|Overall Study|Withdrew Consent|0|||
125448764|NCT01033643|451270874|FG005|Overall Study|Withdrew Consent|1|||
125448765|NCT00852475|451270879|FG000|Overall Study|Lost to Follow-up|3|||
125448766|NCT00852475|451270880|FG001|Overall Study|Lost to Follow-up|4|||
125448767|NCT00515086|451270881|FG000|Overall Study|Adverse Event|1|||
125448768|NCT00515086|451270882|FG001|Overall Study|Adverse Event|1|||
125448769|NCT00515086|451270883|FG002|Overall Study|Adverse Event|2|||
125448770|NCT00515086|451270884|FG003|Overall Study|Adverse Event|3|||
125448771|NCT00515086|451270881|FG000|Overall Study|Administrative|1|||
125448772|NCT00515086|451270882|FG001|Overall Study|Administrative|1|||
125448773|NCT00515086|451270883|FG002|Overall Study|Administrative|0|||
125448774|NCT00515086|451270884|FG003|Overall Study|Administrative|0|||
125448775|NCT00515086|451270881|FG000|Overall Study|Withdrawal by Subject|1|||
125448776|NCT00515086|451270882|FG001|Overall Study|Withdrawal by Subject|0|||
125448777|NCT00515086|451270883|FG002|Overall Study|Withdrawal by Subject|0|||
125448778|NCT00515086|451270884|FG003|Overall Study|Withdrawal by Subject|1|||
125448779|NCT00515086|451270881|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
125448780|NCT00515086|451270882|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
125448781|NCT00515086|451270883|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
125448782|NCT00515086|451270884|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
125448783|NCT00515086|451270881|FG000|Overall Study|Lost to Follow-up|1|||
125448784|NCT00515086|451270882|FG001|Overall Study|Lost to Follow-up|0|||
125448785|NCT00515086|451270883|FG002|Overall Study|Lost to Follow-up|0|||
125448786|NCT00515086|451270884|FG003|Overall Study|Lost to Follow-up|0|||
125448787|NCT00515086|451270881|FG000|Overall Study|Study drug no longer required|0|||
125448788|NCT00515086|451270882|FG001|Overall Study|Study drug no longer required|1|||
125448789|NCT00515086|451270883|FG002|Overall Study|Study drug no longer required|0|||
125448790|NCT00515086|451270884|FG003|Overall Study|Study drug no longer required|0|||
125448791|NCT00515086|451270881|FG000|Overall Study|Death|2|||
125448792|NCT00515086|451270882|FG001|Overall Study|Death|0|||
125448793|NCT00515086|451270883|FG002|Overall Study|Death|0|||
125448794|NCT00515086|451270884|FG003|Overall Study|Death|0|||
125448795|NCT02271594|451270888|FG000|Overall Study|Study closed; recruiting failure|19|||
125448796|NCT02271594|451270889|FG001|Overall Study|Study closed; recruiting failure|12|||
125448797|NCT00495469|451270894|FG000|Overall Study|Adverse Event|0|||
125284547|NCT01728077|450667839|FG000|Overall Study|Patient moving|1|||
125412294|NCT03359096|451134959|FG001|First Intervention (4 Weeks)|Death|0|||
125448798|NCT00495469|451270895|FG001|Overall Study|Adverse Event|1|||
125448799|NCT00495469|451270896|FG002|Overall Study|Adverse Event|3|||
125448800|NCT00495469|451270897|FG003|Overall Study|Adverse Event|0|||
125448801|NCT00495469|451270898|FG004|Overall Study|Adverse Event|1|||
125448802|NCT00495469|451270899|FG005|Overall Study|Adverse Event|1|||
125448803|NCT00495469|451270900|FG006|Overall Study|Adverse Event|1|||
125412295|NCT03359096|451134958|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
125412296|NCT03359096|451134959|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
125448804|NCT00495469|451270894|FG000|Overall Study|Lost to Follow-up|1|||
125448805|NCT00495469|451270895|FG001|Overall Study|Lost to Follow-up|1|||
125448806|NCT00495469|451270896|FG002|Overall Study|Lost to Follow-up|3|||
125448807|NCT00495469|451270897|FG003|Overall Study|Lost to Follow-up|1|||
125448808|NCT00495469|451270898|FG004|Overall Study|Lost to Follow-up|0|||
125412297|NCT00856583|451134960|FG000|Overall Study|Lack of Efficacy|389|||
125412298|NCT00856583|451134961|FG001|Overall Study|Lack of Efficacy|377|||
125412299|NCT00856583|451134960|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
125412300|NCT00856583|451134961|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
125412301|NCT00856583|451134960|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
125412302|NCT00856583|451134961|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
125412303|NCT00856583|451134960|FG000|Overall Study|Non-compliance|305|||
125412304|NCT00856583|451134961|FG001|Overall Study|Non-compliance|262|||
125412305|NCT00856583|451134960|FG000|Overall Study|Withdrawal by Subject|1092|||
125412306|NCT00856583|451134961|FG001|Overall Study|Withdrawal by Subject|919|||
125412307|NCT00856583|451134960|FG000|Overall Study|Physician Decision|59|||
125412308|NCT00856583|451134961|FG001|Overall Study|Physician Decision|82|||
125412309|NCT00856583|451134960|FG000|Overall Study|Pregnancy|14|||
125412310|NCT00856583|451134961|FG001|Overall Study|Pregnancy|5|||
125412311|NCT00856583|451134960|FG000|Overall Study|Other|92|||
125412312|NCT00856583|451134961|FG001|Overall Study|Other|104|||
125412313|NCT00856583|451134960|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
125412314|NCT00856583|451134961|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
125412315|NCT01944046|451134965|FG000|Randomized to DB|Adverse Event|5|||
125412316|NCT01944046|451134966|FG001|Randomized to DB|Adverse Event|2|||
125412317|NCT01944046|451134965|FG000|Randomized to DB|Clinical Worsening|3|||
125412318|NCT01944046|451134966|FG001|Randomized to DB|Clinical Worsening|2|||
125412319|NCT01944046|451134965|FG000|Randomized to DB|Lost to Follow-up|3|||
125412320|NCT01944046|451134966|FG001|Randomized to DB|Lost to Follow-up|3|||
125412321|NCT01944046|451134965|FG000|Randomized to DB|Withdrawal by Subject|2|||
125412322|NCT01944046|451134966|FG001|Randomized to DB|Withdrawal by Subject|4|||
125412323|NCT01944046|451134965|FG000|Randomized to DB|Physician Decision|1|||
125412324|NCT01944046|451134966|FG001|Randomized to DB|Physician Decision|2|||
125412325|NCT01944046|451134965|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
125412326|NCT01944046|451134966|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
125412327|NCT01944046|451134965|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
125412328|NCT01944046|451134966|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
125412329|NCT01944046|451134965|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
125412330|NCT01944046|451134966|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
125412331|NCT01944046|451134965|FG000|Open Label Eligible and Consented|Adverse Event|6|||
125412332|NCT01944046|451134966|FG001|Open Label Eligible and Consented|Adverse Event|1|||
125412333|NCT01944046|451134965|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
125412334|NCT01944046|451134966|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
125412335|NCT01944046|451134965|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
125412336|NCT01944046|451134966|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
125412337|NCT02328326|451134967|FG000|Overall Study|Withdrawal by Subject|10|||
125412338|NCT02328326|451134968|FG001|Overall Study|Withdrawal by Subject|3|||
125412339|NCT02328326|451134967|FG000|Overall Study|Death|2|||
125412340|NCT02328326|451134968|FG001|Overall Study|Death|1|||
125412341|NCT02328326|451134967|FG000|Overall Study|Lost to Follow-up|10|||
125412342|NCT02328326|451134968|FG001|Overall Study|Lost to Follow-up|4|||
125412343|NCT00305058|451134983|FG000|Overall Study|Participant too young|1|||
125412344|NCT00305058|451134984|FG001|Overall Study|Participant too young|0|||
125412345|NCT00305058|451134983|FG000|Overall Study|Missing data collection instrument|3|||
125412346|NCT00305058|451134984|FG001|Overall Study|Missing data collection instrument|2|||
125412347|NCT00305058|451134983|FG000|Overall Study|Missing outcome data|3|||
125412348|NCT00305058|451134984|FG001|Overall Study|Missing outcome data|2|||
125412349|NCT03965052|451134990|FG000|Overall Study|Protocol Violation|1|||
125412350|NCT03965052|451134991|FG001|Overall Study|Protocol Violation|0|||
125412351|NCT01910519|451134997|FG000|Overall Study|Withdrawal by Subject|2|||
125412352|NCT01910519|451134998|FG001|Overall Study|Withdrawal by Subject|0|||
125412353|NCT01910519|451134997|FG000|Overall Study|Adverse Event|2|||
125412354|NCT01910519|451134998|FG001|Overall Study|Adverse Event|0|||
125412355|NCT04266028|451134999|FG000|Overall Study|Adverse Event|0|||
125412356|NCT04266028|451135000|FG001|Overall Study|Adverse Event|0|||
125412357|NCT04266028|451135001|FG002|Overall Study|Adverse Event|1|||
125412358|NCT04266028|451135002|FG003|Overall Study|Adverse Event|0|||
125412359|NCT04266028|451135003|FG004|Overall Study|Adverse Event|1|||
125412360|NCT04266028|451135004|FG005|Overall Study|Adverse Event|0|||
125412361|NCT04266028|451135005|FG006|Overall Study|Adverse Event|2|||
125412362|NCT04266028|451135006|FG007|Overall Study|Adverse Event|0|||
125412363|NCT04266028|451134999|FG000|Overall Study|temporary halt of the study|0|||
125412364|NCT04266028|451135000|FG001|Overall Study|temporary halt of the study|0|||
125412365|NCT04266028|451135001|FG002|Overall Study|temporary halt of the study|0|||
125412366|NCT04266028|451135002|FG003|Overall Study|temporary halt of the study|0|||
125412367|NCT04266028|451135003|FG004|Overall Study|temporary halt of the study|0|||
125412368|NCT04266028|451135004|FG005|Overall Study|temporary halt of the study|0|||
125412369|NCT04266028|451135005|FG006|Overall Study|temporary halt of the study|2|||
125412370|NCT04266028|451135006|FG007|Overall Study|temporary halt of the study|1|||
125412371|NCT04266028|451134999|FG000|Overall Study|Onset of birch pollen season|0|||
125448809|NCT00495469|451270899|FG005|Overall Study|Lost to Follow-up|0|||
125412372|NCT04266028|451135000|FG001|Overall Study|Onset of birch pollen season|0|||
125412373|NCT04266028|451135001|FG002|Overall Study|Onset of birch pollen season|0|||
125412374|NCT04266028|451135002|FG003|Overall Study|Onset of birch pollen season|0|||
125412375|NCT04266028|451135003|FG004|Overall Study|Onset of birch pollen season|1|||
125412376|NCT04266028|451135004|FG005|Overall Study|Onset of birch pollen season|0|||
125412377|NCT04266028|451135005|FG006|Overall Study|Onset of birch pollen season|0|||
125412378|NCT04266028|451135006|FG007|Overall Study|Onset of birch pollen season|0|||
125412379|NCT02863991|451135007|FG000|Overall Study|Death|0|||
125412380|NCT02863991|451135008|FG001|Overall Study|Death|3|||
125412381|NCT02863991|451135007|FG000|Overall Study|Lack of Efficacy|0|||
125412382|NCT02863991|451135008|FG001|Overall Study|Lack of Efficacy|1|||
125412383|NCT02863991|451135007|FG000|Overall Study|Study Terminated|2|||
125412384|NCT02863991|451135008|FG001|Overall Study|Study Terminated|8|||
125412385|NCT03096782|451135012|FG000|Overall Study|Death|1|||
125412386|NCT03096782|451135012|FG000|Overall Study|Participant Relapsed|1|||
125412387|NCT00993447|451136828|FG000|Overall Study|Withdrawal by Subject|23|||
125412388|NCT00993447|451136829|FG001|Overall Study|Withdrawal by Subject|8|||
125412389|NCT00993447|451136828|FG000|Overall Study|Protocol Violation|12|||
125412390|NCT00993447|451136829|FG001|Overall Study|Protocol Violation|8|||
125412391|NCT00993447|451136828|FG000|Overall Study|Lost to Follow-up|1|||
125412392|NCT00993447|451136829|FG001|Overall Study|Lost to Follow-up|3|||
125412393|NCT00993447|451136828|FG000|Overall Study|Adverse Event|1|||
125412394|NCT00993447|451136829|FG001|Overall Study|Adverse Event|0|||
125412395|NCT00970502|451136832|FG000|Overall Study|Withdrawal by Subject|1|||
125412396|NCT03811912|451136833|FG000|Overall Study|Withdrew Consent|4|||
125412397|NCT03811912|451136834|FG001|Overall Study|Withdrew Consent|2|||
125412398|NCT04401579|451136835|FG000|Overall Study|Death|23|||
125412399|NCT04401579|451136836|FG001|Overall Study|Death|36|||
125412400|NCT04401579|451136835|FG000|Overall Study|Lost to Follow-up|40|||
125412401|NCT04401579|451136836|FG001|Overall Study|Lost to Follow-up|41|||
125412402|NCT04401579|451136835|FG000|Overall Study|Withdrawal by Subject|8|||
125412403|NCT04401579|451136836|FG001|Overall Study|Withdrawal by Subject|16|||
125412404|NCT04401579|451136835|FG000|Overall Study|Physician Decision|1|||
125412405|NCT04401579|451136836|FG001|Overall Study|Physician Decision|2|||
125412406|NCT04401579|451136835|FG000|Overall Study|Became ineligible after enrollment|1|||
125412407|NCT04401579|451136836|FG001|Overall Study|Became ineligible after enrollment|1|||
125412408|NCT04401579|451136835|FG000|Overall Study|Enrolled but treatment not administered|7|||
125412409|NCT04401579|451136836|FG001|Overall Study|Enrolled but treatment not administered|9|||
125412410|NCT04401579|451136835|FG000|Overall Study|Adverse Event|2|||
125412411|NCT04401579|451136836|FG001|Overall Study|Adverse Event|1|||
125412412|NCT04401579|451136835|FG000|Overall Study|Scheduling error|1|||
125412413|NCT04401579|451136836|FG001|Overall Study|Scheduling error|2|||
125412414|NCT04401579|451136835|FG000|Overall Study|Transferred to another hospital|1|||
125412415|NCT04401579|451136836|FG001|Overall Study|Transferred to another hospital|2|||
125412416|NCT01438411|451136837|FG000|Overall Study|Adverse Event|8|||
125412417|NCT01438411|451136837|FG000|Overall Study|Lost to Follow-up|1|||
125412418|NCT01438411|451136837|FG000|Overall Study|Lack of Efficacy|1|||
125412419|NCT01438411|451136837|FG000|Overall Study|Withdrawal by Subject|3|||
125412420|NCT01863680|451136838|FG000|Overall Study|Adverse Event|17|||
125412421|NCT01863680|451136838|FG000|Overall Study|Risk of OHSS|17|||
125412422|NCT01863680|451136838|FG000|Overall Study|Spontaneous pregnancy|2|||
125412423|NCT01863680|451136838|FG000|Overall Study|Withdrawal by Subject|1|||
125412424|NCT01863680|451136838|FG000|Overall Study|Did not undergo IVF/ET|14|||
125412425|NCT01863680|451136838|FG000|Overall Study|Other|6|||
125412426|NCT00618514|451136839|FG000|Overall Study|Lost to Follow-up|11|||
125412427|NCT00618514|451136840|FG001|Overall Study|Lost to Follow-up|12|||
125412428|NCT00618514|451136841|FG002|Overall Study|Lost to Follow-up|4|||
125412429|NCT00566228|451136842|FG000|Overall Study|Withdrawal by Subject|1|||
125412430|NCT00566228|451136843|FG001|Overall Study|Withdrawal by Subject|0|||
125412431|NCT00566228|451136842|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
125412432|NCT00566228|451136843|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
125284548|NCT01728077|450667840|FG001|Overall Study|Patient moving|0|||
125284549|NCT01728077|450667839|FG000|Overall Study|Non compliance|1|||
125284550|NCT01728077|450667840|FG001|Overall Study|Non compliance|0|||
125284551|NCT00347438|450667844|FG000|Overall Study|Withdrawal by Subject|1|||
125284552|NCT00347438|450667844|FG000|Overall Study|Physician Decision|1|||
125284553|NCT00322023|450667845|FG000|Overall Study|various|0|||
125284554|NCT00322023|450667846|FG001|Overall Study|various|2|||
125284555|NCT00322023|450667847|FG002|Overall Study|various|6|||
125284556|NCT00693017|450667848|FG000|Overall Study|Sponsor Decision|2|||
125284557|NCT00693017|450667849|FG001|Overall Study|Sponsor Decision|1|||
125284558|NCT00693017|450667848|FG000|Overall Study|Death|0|||
125284559|NCT00693017|450667849|FG001|Overall Study|Death|1|||
125412433|NCT00566228|451136842|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
125412434|NCT00566228|451136843|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
125412435|NCT00566228|451136842|FG000|Overall Study|progressed before infusion could occur|0|||
125284560|NCT01082874|450667850|FG000|Overall Study|Lost to Follow-up|10|||
125448810|NCT00495469|451270900|FG006|Overall Study|Lost to Follow-up|0|||
125412436|NCT00566228|451136843|FG001|Overall Study|progressed before infusion could occur|1|||
125412437|NCT02053350|451136844|FG000|Overall Study|Withdrawal by Subject|1|||
125412438|NCT02053350|451136844|FG000|Overall Study|Adverse Event|4|||
125412439|NCT03521635|451136845|FG000|Overall Study|Adverse Event|1|||
125412440|NCT03521635|451136846|FG001|Overall Study|Adverse Event|1|||
125412441|NCT03521635|451136845|FG000|Overall Study|Refused to complete study visit|1|||
125412442|NCT03521635|451136846|FG001|Overall Study|Refused to complete study visit|0|||
125412443|NCT03521635|451136845|FG000|Overall Study|Refused to continue trial medication|2|||
125412444|NCT03521635|451136846|FG001|Overall Study|Refused to continue trial medication|2|||
125412445|NCT03521635|451136845|FG000|Overall Study|Lost to Follow-up|0|||
125412446|NCT03521635|451136846|FG001|Overall Study|Lost to Follow-up|1|||
125412447|NCT03521635|451136845|FG000|Overall Study|Meet exclusion criteria|0|||
125412448|NCT03521635|451136846|FG001|Overall Study|Meet exclusion criteria|1|||
125412449|NCT03521635|451136845|FG000|Overall Study|Patient not taken study medicine|0|||
125412450|NCT03521635|451136846|FG001|Overall Study|Patient not taken study medicine|1|||
125412451|NCT02244944|451136847|FG000|Overall Study|Withdrawal by Subject|1|||
125412452|NCT02244944|451136847|FG000|Overall Study|Study Terminated|1|||
125412453|NCT02367911|451136854|FG000|Overall Study|Withdrawal by Subject|3|||
125412454|NCT02367911|451136855|FG001|Overall Study|Withdrawal by Subject|2|||
125412455|NCT02367911|451136854|FG000|Overall Study|Lost to Follow-up|2|||
125412456|NCT02367911|451136855|FG001|Overall Study|Lost to Follow-up|2|||
125412457|NCT00902304|451136856|FG000|Overall Study|Adverse Event|4|||
125412458|NCT00902304|451136857|FG001|Overall Study|Adverse Event|10|||
125412459|NCT00902304|451136858|FG002|Overall Study|Adverse Event|25|||
125412460|NCT00902304|451136856|FG000|Overall Study|Investigator discretion|3|||
125412461|NCT00902304|451136857|FG001|Overall Study|Investigator discretion|5|||
125412462|NCT00902304|451136858|FG002|Overall Study|Investigator discretion|13|||
125412463|NCT00902304|451136856|FG000|Overall Study|Lost to Follow-up|7|||
125412464|NCT00902304|451136857|FG001|Overall Study|Lost to Follow-up|7|||
125412465|NCT00902304|451136858|FG002|Overall Study|Lost to Follow-up|7|||
125412466|NCT00902304|451136856|FG000|Overall Study|Protocol Violation|9|||
125412467|NCT00902304|451136857|FG001|Overall Study|Protocol Violation|18|||
125412468|NCT00902304|451136858|FG002|Overall Study|Protocol Violation|20|||
125412469|NCT00902304|451136856|FG000|Overall Study|Withdrawal by Subject|32|||
125412470|NCT00902304|451136857|FG001|Overall Study|Withdrawal by Subject|22|||
125412471|NCT00902304|451136858|FG002|Overall Study|Withdrawal by Subject|43|||
125412472|NCT00902304|451136856|FG000|Overall Study|includes pregnancy|3|||
125412473|NCT00902304|451136857|FG001|Overall Study|includes pregnancy|9|||
125412474|NCT00902304|451136858|FG002|Overall Study|includes pregnancy|2|||
125412475|NCT01153633|451136859|FG000|Overall Study|Protocol Violation|1|||
125412476|NCT01153633|451136860|FG001|Overall Study|Protocol Violation|1|||
125412477|NCT01153633|451136859|FG000|Overall Study|Therapeutic failure|3|||
125412478|NCT01153633|451136860|FG001|Overall Study|Therapeutic failure|3|||
125412479|NCT00384085|451136861|FG000|Overall Study|Adverse Event|5|||
125412480|NCT00384085|451136862|FG001|Overall Study|Adverse Event|5|||
125412481|NCT00384085|451136863|FG002|Overall Study|Adverse Event|4|||
125412482|NCT00384085|451136861|FG000|Overall Study|Lack of Efficacy|0|||
125412483|NCT00384085|451136862|FG001|Overall Study|Lack of Efficacy|3|||
125412484|NCT00384085|451136863|FG002|Overall Study|Lack of Efficacy|2|||
125412485|NCT00384085|451136861|FG000|Overall Study|No longer Requires Study Treatment|1|||
125412486|NCT00384085|451136862|FG001|Overall Study|No longer Requires Study Treatment|0|||
125412487|NCT00384085|451136863|FG002|Overall Study|No longer Requires Study Treatment|1|||
125412488|NCT00384085|451136861|FG000|Overall Study|Protocol Violation|2|||
125412489|NCT00384085|451136862|FG001|Overall Study|Protocol Violation|2|||
125412490|NCT00384085|451136863|FG002|Overall Study|Protocol Violation|2|||
125412491|NCT00384085|451136861|FG000|Overall Study|Lost to Follow-up|9|||
125412492|NCT00384085|451136862|FG001|Overall Study|Lost to Follow-up|9|||
125412493|NCT00384085|451136863|FG002|Overall Study|Lost to Follow-up|10|||
125412494|NCT00384085|451136861|FG000|Overall Study|Progressive Disease|0|||
125412495|NCT00384085|451136862|FG001|Overall Study|Progressive Disease|1|||
125412496|NCT00384085|451136863|FG002|Overall Study|Progressive Disease|0|||
125412497|NCT00384085|451136861|FG000|Overall Study|Withdrawal by Subject|14|||
125412498|NCT00384085|451136862|FG001|Overall Study|Withdrawal by Subject|19|||
125412499|NCT00384085|451136863|FG002|Overall Study|Withdrawal by Subject|29|||
125412500|NCT00384085|451136861|FG000|Overall Study|Patient non-compliant|4|||
125412501|NCT00384085|451136862|FG001|Overall Study|Patient non-compliant|4|||
125412502|NCT00384085|451136863|FG002|Overall Study|Patient non-compliant|5|||
125412503|NCT00384085|451136861|FG000|Overall Study|Physician Decision|1|||
125412504|NCT00384085|451136862|FG001|Overall Study|Physician Decision|0|||
125412505|NCT00384085|451136863|FG002|Overall Study|Physician Decision|0|||
125412506|NCT00384085|451136861|FG000|Overall Study|Loss of site personnel|1|||
125412507|NCT00384085|451136862|FG001|Overall Study|Loss of site personnel|0|||
125412508|NCT00384085|451136863|FG002|Overall Study|Loss of site personnel|1|||
125412509|NCT00384085|451136861|FG000|Overall Study|Sponsor decision|1|||
125412510|NCT00384085|451136862|FG001|Overall Study|Sponsor decision|2|||
125412511|NCT00384085|451136863|FG002|Overall Study|Sponsor decision|1|||
125412512|NCT00384085|451136861|FG000|Overall Study|Patient moved|1|||
125412513|NCT00384085|451136862|FG001|Overall Study|Patient moved|0|||
125412514|NCT00384085|451136863|FG002|Overall Study|Patient moved|1|||
125412515|NCT00384085|451136861|FG000|Overall Study|Patient required surgery|0|||
125412516|NCT00384085|451136862|FG001|Overall Study|Patient required surgery|1|||
125412517|NCT00384085|451136863|FG002|Overall Study|Patient required surgery|0|||
125412518|NCT00352365|451136866|FG000|Induction Therapy|Adverse Event|7|||
125412519|NCT00352365|451136866|FG000|Induction Therapy|Progression/Relapse|8|||
125412520|NCT00352365|451136866|FG000|Induction Therapy|Death|7|||
125412521|NCT00352365|451136866|FG000|Induction Therapy|Not protocol specified|1|||
125412522|NCT00352365|451136866|FG000|Induction Therapy|Not eligible|3|||
125412523|NCT00352365|451136866|FG000|Induction Therapy|Death before starting protocol therapy|1|||
125412524|NCT00352365|451136866|FG000|Maintenance Therapy|Progression/Relapse|3|||
125412525|NCT00352365|451136866|FG000|Maintenance Therapy|Death|2|||
125412526|NCT00352365|451136866|FG000|Maintenance Therapy|Not protocol specified|3|||
125412527|NCT00352365|451136866|FG000|Maintenance Therapy|Not eligible|4|||
125412528|NCT00987467|451136870|FG000|Overall Study|Lost to Follow-up|2|||
125412529|NCT00512135|451136871|FG000|Overall Study|Not Treated|5|||
125412530|NCT00512135|451136871|FG000|Overall Study|Lack of Efficacy|2|||
125412531|NCT00512135|451136871|FG000|Overall Study|Adverse Event|6|||
125412532|NCT00512135|451136871|FG000|Overall Study|Withdrawal by Subject|22|||
125412533|NCT00512135|451136871|FG000|Overall Study|Lost to Follow-up|27|||
125412534|NCT00512135|451136871|FG000|Overall Study|Other|22|||
125412535|NCT02646423|451136872|FG000|Overall Study|Adverse Event|5|||
125412536|NCT02646423|451136873|FG001|Overall Study|Adverse Event|7|||
125412537|NCT02646423|451136872|FG000|Overall Study|Ineligible|2|||
125412538|NCT02646423|451136873|FG001|Overall Study|Ineligible|1|||
125412539|NCT02807948|451136874|FG000|Overall Study|Physician Decision|1|||
125412540|NCT02807948|451136875|FG001|Overall Study|Physician Decision|0|||
125412541|NCT02624804|451136876|FG000|Overall Study|Screen Failure|5|||
125412542|NCT01227889|451136880|FG000|Randomized Phase (RP)|Adverse Event|13|||
125412543|NCT01227889|451136881|FG001|Randomized Phase (RP)|Adverse Event|0|||
125412544|NCT01227889|451136880|FG000|Randomized Phase (RP)|Physician Decision|13|||
125412545|NCT01227889|451136881|FG001|Randomized Phase (RP)|Physician Decision|5|||
125412546|NCT01227889|451136880|FG000|Randomized Phase (RP)|Progressive Disease|135|||
125412547|NCT01227889|451136881|FG001|Randomized Phase (RP)|Progressive Disease|52|||
125412548|NCT01227889|451136880|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
125412549|NCT01227889|451136881|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
125412550|NCT01227889|451136880|FG000|Randomized Phase (RP)|Missing|1|||
125412551|NCT01227889|451136881|FG001|Randomized Phase (RP)|Missing|3|||
125412552|NCT01227889|451136880|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
125412553|NCT01227889|451136881|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
125412554|NCT01227889|451136880|FG000|Crossover Phase|Adverse Event|0|||
125412555|NCT01227889|451136881|FG001|Crossover Phase|Adverse Event|1|||
125412556|NCT01227889|451136880|FG000|Crossover Phase|Physician Decision|0|||
125412557|NCT01227889|451136881|FG001|Crossover Phase|Physician Decision|3|||
125412558|NCT01227889|451136880|FG000|Crossover Phase|Progressive Disease|0|||
125412559|NCT01227889|451136881|FG001|Crossover Phase|Progressive Disease|31|||
125412560|NCT01227889|451136880|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
125412561|NCT01227889|451136881|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
125412562|NCT01227889|451136880|FG000|Crossover Phase|Withdrawal by Subject|0|||
125412563|NCT01227889|451136881|FG001|Crossover Phase|Withdrawal by Subject|1|||
125412564|NCT03073603|451136884|FG000|Overall Study|Noncompliance|3|||
125412565|NCT03073603|451136885|FG001|Overall Study|Noncompliance|1|||
125412566|NCT03073603|451136884|FG000|Overall Study|Adverse Event|5|||
125412567|NCT03073603|451136885|FG001|Overall Study|Adverse Event|3|||
125412568|NCT03073603|451136884|FG000|Overall Study|Physician Decision|1|||
125412569|NCT03073603|451136885|FG001|Overall Study|Physician Decision|2|||
125412570|NCT03073603|451136884|FG000|Overall Study|Required treatment not allowed by protocol|1|||
125412571|NCT03073603|451136885|FG001|Overall Study|Required treatment not allowed by protocol|0|||
125412572|NCT03073603|451136884|FG000|Overall Study|Financial or insurance-related|8|||
125412573|NCT03073603|451136885|FG001|Overall Study|Financial or insurance-related|0|||
125412574|NCT03073603|451136884|FG000|Overall Study|Withdrawal by Subject|0|||
125412575|NCT03073603|451136885|FG001|Overall Study|Withdrawal by Subject|1|||
125412576|NCT03073603|451136884|FG000|Overall Study|Discontinued DMT|4|||
125412577|NCT03073603|451136885|FG001|Overall Study|Discontinued DMT|0|||
125412578|NCT03073603|451136884|FG000|Overall Study|Restarted DMT|0|||
125412579|NCT03073603|451136885|FG001|Overall Study|Restarted DMT|1|||
125412580|NCT02553330|451136888|FG000|Overall Study|Study Terminated by Sponsor|2|||
125412581|NCT02553330|451136889|FG001|Overall Study|Study Terminated by Sponsor|13|||
125412582|NCT02553330|451136890|FG002|Overall Study|Study Terminated by Sponsor|12|||
125412583|NCT02553330|451136888|FG000|Overall Study|Withdrawal by Subject|3|||
125412584|NCT02553330|451136889|FG001|Overall Study|Withdrawal by Subject|19|||
125412585|NCT02553330|451136890|FG002|Overall Study|Withdrawal by Subject|21|||
125412586|NCT02553330|451136888|FG000|Overall Study|Other|0|||
125412587|NCT02553330|451136889|FG001|Overall Study|Other|1|||
125412588|NCT02553330|451136890|FG002|Overall Study|Other|0|||
125412589|NCT02553330|451136888|FG000|Overall Study|Non compliance to study treatment|0|||
125412590|NCT02553330|451136889|FG001|Overall Study|Non compliance to study treatment|1|||
125412591|NCT02553330|451136890|FG002|Overall Study|Non compliance to study treatment|0|||
125412592|NCT02553330|451136888|FG000|Overall Study|Adverse Event|0|||
125412593|NCT02553330|451136889|FG001|Overall Study|Adverse Event|1|||
125412594|NCT02553330|451136890|FG002|Overall Study|Adverse Event|0|||
125412595|NCT02553330|451136888|FG000|Overall Study|Lost to Follow-up|0|||
125412596|NCT02553330|451136889|FG001|Overall Study|Lost to Follow-up|4|||
125412597|NCT02553330|451136890|FG002|Overall Study|Lost to Follow-up|4|||
125412598|NCT01659021|451136893|FG000|Main Study|Adverse Event|2|||
125412599|NCT01659021|451136894|FG001|Main Study|Adverse Event|3|||
125412600|NCT01659021|451136893|FG000|Main Study|Lost to Follow-up|1|||
125412601|NCT01659021|451136894|FG001|Main Study|Lost to Follow-up|0|||
125412602|NCT01659021|451136893|FG000|Main Study|Unknown Reasons|2|||
125412603|NCT01659021|451136894|FG001|Main Study|Unknown Reasons|1|||
125412604|NCT01659021|451136893|FG000|Main Study|Physician Decision|34|||
125412605|NCT01659021|451136894|FG001|Main Study|Physician Decision|16|||
125412606|NCT01659021|451136893|FG000|Main Study|Withdrawal by Subject|19|||
125412607|NCT01659021|451136894|FG001|Main Study|Withdrawal by Subject|16|||
125412608|NCT01659021|451136893|FG000|Main Study|Study Terminated by Sponsor|16|||
125412609|NCT01659021|451136894|FG001|Main Study|Study Terminated by Sponsor|1|||
125412610|NCT01659021|451136893|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
125412611|NCT01659021|451136894|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
125412612|NCT01659021|451136893|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
125412613|NCT01659021|451136894|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
125412614|NCT03551938|451136895|FG000|3-Month Follow Up|Lost to Follow-up|39|||
125412615|NCT03551938|451136896|FG001|3-Month Follow Up|Lost to Follow-up|38|||
125412616|NCT03551938|451136895|FG000|6-Month Follow Up|Lost to Follow-up|46|||
125412617|NCT03551938|451136896|FG001|6-Month Follow Up|Lost to Follow-up|42|||
125412618|NCT03551938|451136895|FG000|9-Month Follow Up|Lost to Follow-up|44|||
125412619|NCT03551938|451136896|FG001|9-Month Follow Up|Lost to Follow-up|43|||
125412620|NCT01205685|451136897|FG000|Overall Study|Disease Progression|10|||
125412621|NCT01205685|451136897|FG000|Overall Study|Withdrawal by Subject|1|||
125412622|NCT03058679|451136901|FG000|Baseline to Week 6|Lost to Follow-up|3|||
125412623|NCT03058679|451136902|FG001|Baseline to Week 6|Lost to Follow-up|2|||
125412624|NCT03058679|451136901|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
125412625|NCT03058679|451136902|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
125412626|NCT03058679|451136901|FG000|Baseline to Week 6|Adverse Event|6|||
125412627|NCT03058679|451136902|FG001|Baseline to Week 6|Adverse Event|6|||
125412628|NCT03058679|451136901|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
125412629|NCT03058679|451136902|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
125412630|NCT03058679|451136901|FG000|Baseline to Week 6|Difficulty following the diet|0|||
125412631|NCT03058679|451136902|FG001|Baseline to Week 6|Difficulty following the diet|2|||
125412632|NCT03058679|451136901|FG000|Baseline to Week 6|Physician Decision|1|||
125412633|NCT03058679|451136902|FG001|Baseline to Week 6|Physician Decision|0|||
125412634|NCT03058679|451136901|FG000|Week 6 to Week 12|Change in medication|5|||
125412635|NCT03058679|451136902|FG001|Week 6 to Week 12|Change in medication|7|||
125412636|NCT03058679|451136901|FG000|Week 6 to Week 12|Adverse Event|4|||
125412637|NCT03058679|451136902|FG001|Week 6 to Week 12|Adverse Event|3|||
125412638|NCT03058679|451136901|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
125412639|NCT03058679|451136902|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
125412640|NCT03058679|451136901|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
125412641|NCT03058679|451136902|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
125412642|NCT00599326|451136911|FG000|Overall Study|Lost to Follow-up|1|||
125412643|NCT00599326|451136911|FG000|Overall Study|Noncompliant|1|||
125412644|NCT00784810|451136914|FG000|Overall Study|Adverse Event|32|||
125412645|NCT00784810|451136915|FG001|Overall Study|Adverse Event|20|||
125412646|NCT00784810|451136914|FG000|Overall Study|Lack of Efficacy|14|||
125412647|NCT00784810|451136915|FG001|Overall Study|Lack of Efficacy|11|||
125412648|NCT00784810|451136914|FG000|Overall Study|Withdrawal by Subject|11|||
125412649|NCT00784810|451136915|FG001|Overall Study|Withdrawal by Subject|9|||
125412650|NCT00784810|451136914|FG000|Overall Study|Administrative|5|||
125412651|NCT00784810|451136915|FG001|Overall Study|Administrative|8|||
125412652|NCT00784810|451136914|FG000|Overall Study|Lost to Follow-up|1|||
125412653|NCT00784810|451136915|FG001|Overall Study|Lost to Follow-up|1|||
125412654|NCT02862106|451136916|FG000|Overall Study|Adverse Event|4|||
125412655|NCT02862106|451136917|FG001|Overall Study|Adverse Event|0|||
125412656|NCT02862106|451136916|FG000|Overall Study|Protocol Violation|16|||
125412657|NCT02862106|451136917|FG001|Overall Study|Protocol Violation|1|||
125412658|NCT02862106|451136916|FG000|Overall Study|Lost to Follow-up|15|||
125412659|NCT02862106|451136917|FG001|Overall Study|Lost to Follow-up|5|||
125448811|NCT00495469|451270894|FG000|Overall Study|Protocol Violation|0|||
125284561|NCT01082874|450667851|FG001|Overall Study|Lost to Follow-up|10|||
125284562|NCT01082874|450667852|FG002|Overall Study|Lost to Follow-up|6|||
125284563|NCT01082874|450667853|FG003|Overall Study|Lost to Follow-up|10|||
125412660|NCT02862106|451136916|FG000|Overall Study|Withdrawal by Subject|2|||
125412661|NCT02862106|451136917|FG001|Overall Study|Withdrawal by Subject|0|||
125412662|NCT02862106|451136916|FG000|Overall Study|Subjects moved to other city|1|||
125412663|NCT02862106|451136917|FG001|Overall Study|Subjects moved to other city|0|||
125412664|NCT04137380|451136922|FG000|Overall Study|Physician Decision|0|||
125412665|NCT04137380|451136923|FG001|Overall Study|Physician Decision|0|||
125412666|NCT04137380|451136924|FG002|Overall Study|Physician Decision|0|||
125412667|NCT04137380|451136925|FG003|Overall Study|Physician Decision|1|||
125412668|NCT04137380|451136926|FG004|Overall Study|Physician Decision|0|||
125412669|NCT04137380|451136927|FG005|Overall Study|Physician Decision|0|||
125412670|NCT04137380|451136928|FG006|Overall Study|Physician Decision|0|||
125412671|NCT03434119|451136929|FG000|Overall Study|Randomized but not treated|1|||
125412672|NCT03434119|451136930|FG001|Overall Study|Randomized but not treated|0|||
125412673|NCT03434119|451136929|FG000|Overall Study|Adverse Event|1|||
125412674|NCT03434119|451136930|FG001|Overall Study|Adverse Event|0|||
125412675|NCT03434119|451136929|FG000|Overall Study|Poor Compliance to Protocol|0|||
125412676|NCT03434119|451136930|FG001|Overall Study|Poor Compliance to Protocol|1|||
125412677|NCT03434119|451136929|FG000|Overall Study|Study Terminated by Sponsor|91|||
125412678|NCT03434119|451136930|FG001|Overall Study|Study Terminated by Sponsor|102|||
125412679|NCT03434119|451136929|FG000|Overall Study|Withdrawal by Subject|7|||
125412680|NCT03434119|451136930|FG001|Overall Study|Withdrawal by Subject|5|||
125412681|NCT03434119|451136929|FG000|Overall Study|Other than specified|7|||
125412682|NCT03434119|451136930|FG001|Overall Study|Other than specified|5|||
125412683|NCT00148343|451136931|FG000|Overall Study|Withdrawal by Subject|12|||
125412684|NCT00148343|451136932|FG001|Overall Study|Withdrawal by Subject|7|||
125412685|NCT00148343|451136931|FG000|Overall Study|Physician Decision|3|||
125412686|NCT00148343|451136932|FG001|Overall Study|Physician Decision|4|||
125412687|NCT02079805|451136935|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125412688|NCT02079805|451136936|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
125412689|NCT02079805|451136935|FG000|Overall Study|Voluntary Withdrawal|0|||
125412690|NCT02079805|451136936|FG001|Overall Study|Voluntary Withdrawal|1|||
125412691|NCT02347761|451136937|FG000|All Collected|Death|1|||
125412692|NCT02347761|451136938|FG001|All Collected|Death|0|||
125412693|NCT02347761|451136939|FG002|All Collected|Death|0|||
125412694|NCT02347761|451136937|FG000|All Collected|Lost to Follow-up|3|||
125412695|NCT02347761|451136938|FG001|All Collected|Lost to Follow-up|2|||
125412696|NCT02347761|451136939|FG002|All Collected|Lost to Follow-up|3|||
125412697|NCT02347761|451136937|FG000|All Collected|Withdrawal by Subject|11|||
125412698|NCT02347761|451136938|FG001|All Collected|Withdrawal by Subject|11|||
125412699|NCT02347761|451136939|FG002|All Collected|Withdrawal by Subject|22|||
125412700|NCT02347761|451136937|FG000|All Collected|invetigator disretion|2|||
125412701|NCT02347761|451136938|FG001|All Collected|invetigator disretion|0|||
125412702|NCT02347761|451136939|FG002|All Collected|invetigator disretion|0|||
125412703|NCT02347761|451136937|FG000|All Collected|instillation site pain|0|||
125412704|NCT02347761|451136938|FG001|All Collected|instillation site pain|0|||
125412705|NCT02347761|451136939|FG002|All Collected|instillation site pain|1|||
125412706|NCT02347761|451136937|FG000|All Collected|exacerbation of COPD|0|||
125412707|NCT02347761|451136938|FG001|All Collected|exacerbation of COPD|0|||
125412708|NCT02347761|451136939|FG002|All Collected|exacerbation of COPD|1|||
125412709|NCT02347761|451136937|FG000|All Collected|moved/travel|0|||
125412710|NCT02347761|451136938|FG001|All Collected|moved/travel|1|||
125412711|NCT02347761|451136939|FG002|All Collected|moved/travel|0|||
125412712|NCT02347761|451136937|FG000|On Study Treatment|Lack of Efficacy|2|||
125412713|NCT02347761|451136938|FG001|On Study Treatment|Lack of Efficacy|3|||
125412714|NCT02347761|451136939|FG002|On Study Treatment|Lack of Efficacy|4|||
125412715|NCT02347761|451136937|FG000|On Study Treatment|non-compliance with study medication|0|||
125412716|NCT02347761|451136938|FG001|On Study Treatment|non-compliance with study medication|0|||
125412717|NCT02347761|451136939|FG002|On Study Treatment|non-compliance with study medication|2|||
125412718|NCT02347761|451136937|FG000|On Study Treatment|Withdrawal by Subject|7|||
125412719|NCT02347761|451136938|FG001|On Study Treatment|Withdrawal by Subject|3|||
125412720|NCT02347761|451136939|FG002|On Study Treatment|Withdrawal by Subject|5|||
125412721|NCT02347761|451136937|FG000|On Study Treatment|move/travel|2|||
125412722|NCT02347761|451136938|FG001|On Study Treatment|move/travel|6|||
125412723|NCT02347761|451136939|FG002|On Study Treatment|move/travel|5|||
125412724|NCT02347761|451136937|FG000|On Study Treatment|dissastisfaction with device|2|||
125412725|NCT02347761|451136938|FG001|On Study Treatment|dissastisfaction with device|1|||
125284564|NCT01082874|450667850|FG000|Overall Study|Withdrawal by Subject|1|||
125284565|NCT01082874|450667851|FG001|Overall Study|Withdrawal by Subject|2|||
125412726|NCT02347761|451136939|FG002|On Study Treatment|dissastisfaction with device|4|||
125412727|NCT02347761|451136937|FG000|On Study Treatment|Lost to Follow-up|2|||
125412728|NCT02347761|451136938|FG001|On Study Treatment|Lost to Follow-up|1|||
125412729|NCT02347761|451136939|FG002|On Study Treatment|Lost to Follow-up|1|||
125412730|NCT02347761|451136937|FG000|On Study Treatment|investigator discretion|2|||
125412731|NCT02347761|451136938|FG001|On Study Treatment|investigator discretion|0|||
125412732|NCT02347761|451136939|FG002|On Study Treatment|investigator discretion|0|||
125412733|NCT02347761|451136937|FG000|On Study Treatment|durg not working|0|||
125412734|NCT02347761|451136938|FG001|On Study Treatment|durg not working|1|||
125412735|NCT02347761|451136939|FG002|On Study Treatment|durg not working|1|||
125412736|NCT02347761|451136937|FG000|On Study Treatment|Adverse Event|10|||
125412737|NCT02347761|451136938|FG001|On Study Treatment|Adverse Event|8|||
125448812|NCT00495469|451270895|FG001|Overall Study|Protocol Violation|0|||
125284566|NCT01082874|450667852|FG002|Overall Study|Withdrawal by Subject|5|||
125284567|NCT01082874|450667853|FG003|Overall Study|Withdrawal by Subject|3|||
125284568|NCT01685801|450667871|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
125284569|NCT01685801|450667872|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
125284570|NCT01685801|450667873|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
125284571|NCT01685801|450667874|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
125284572|NCT01685801|450667871|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
125284573|NCT01685801|450667872|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
125284574|NCT01685801|450667873|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
125284575|NCT01685801|450667874|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
125284576|NCT00113399|450667875|FG000|Overall Study|Death|1|||
125284577|NCT00113399|450667876|FG001|Overall Study|Death|1|||
125284578|NCT00113399|450667875|FG000|Overall Study|Withdrawal by Subject|1|||
125284579|NCT00113399|450667876|FG001|Overall Study|Withdrawal by Subject|2|||
125284580|NCT00113399|450667875|FG000|Overall Study|Complete Response|0|||
125284581|NCT00113399|450667876|FG001|Overall Study|Complete Response|1|||
125284582|NCT00113399|450667875|FG000|Overall Study|Other|0|||
125284583|NCT00113399|450667876|FG001|Overall Study|Other|1|||
125284584|NCT00396136|450667877|FG000|Overall Study|Death|43|||
125284585|NCT00396136|450667877|FG000|Overall Study|Withdrawal by Subject|59|||
125284586|NCT00396136|450667877|FG000|Overall Study|Lost to Follow-up|15|||
125284587|NCT00396136|450667877|FG000|Overall Study|Study device explanted|8|||
125284588|NCT04686084|450667879|FG000|Overall Study|Lost to Follow-up|1|||
125284589|NCT01779856|450667880|FG000|Overall Study|Withdrawal by Subject|15|||
125284590|NCT01779856|450667880|FG000|Overall Study|Death|3|||
125284591|NCT01779856|450667880|FG000|Overall Study|Physician Decision|1|||
125284592|NCT01779856|450667880|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
125284593|NCT01779856|450667880|FG000|Overall Study|Delays in scheduling implant|1|||
125284594|NCT01779856|450667880|FG000|Overall Study|Subject ineligible for Implant|2|||
125284595|NCT03350256|450667882|FG000|Overall Study|Inclusion/exclusion violation|4|||
125284596|NCT03350256|450667882|FG000|Overall Study|Recommended for other therapies|2|||
125284597|NCT03350256|450667882|FG000|Overall Study|Protocol Violation|3|||
125284598|NCT03350256|450667882|FG000|Overall Study|Non compliance|2|||
125284599|NCT03350256|450667882|FG000|Overall Study|Denial by insurance|1|||
125284600|NCT03350256|450667882|FG000|Overall Study|Adverse Event|2|||
125284601|NCT03350256|450667882|FG000|Overall Study|Trial failure|12|||
125284602|NCT03350256|450667882|FG000|Overall Study|Did not proceed to permanent implant|3|||
125284603|NCT03350256|450667882|FG000|Overall Study|Withdrawal by Subject|3|||
125284604|NCT03350256|450667882|FG000|Overall Study|Subject moving out of state|1|||
125284605|NCT03350256|450667882|FG000|Overall Study|Lost to Follow-up|1|||
125284606|NCT03350256|450667882|FG000|Overall Study|Lack of Efficacy|2|||
125284607|NCT04043234|450667885|FG000|Overall Study|Lost to Follow-up|1|||
125284608|NCT04043234|450667885|FG000|Overall Study|Withdrawal by Subject|1|||
125284609|NCT01155466|450667886|FG000|Overall Study|Adverse Event|13|||
125284610|NCT01155466|450667887|FG001|Overall Study|Adverse Event|15|||
125284611|NCT01155466|450667888|FG002|Overall Study|Adverse Event|6|||
125284612|NCT01155466|450667889|FG003|Overall Study|Adverse Event|17|||
125284613|NCT01155466|450667890|FG004|Overall Study|Adverse Event|18|||
125284614|NCT01155466|450667886|FG000|Overall Study|Lost to Follow-up|0|||
125284615|NCT01155466|450667887|FG001|Overall Study|Lost to Follow-up|0|||
125284616|NCT01155466|450667888|FG002|Overall Study|Lost to Follow-up|0|||
125284617|NCT01155466|450667889|FG003|Overall Study|Lost to Follow-up|0|||
125284618|NCT01155466|450667890|FG004|Overall Study|Lost to Follow-up|2|||
125284619|NCT01155466|450667886|FG000|Overall Study|Withdrawal by Subject|7|||
125284620|NCT01155466|450667887|FG001|Overall Study|Withdrawal by Subject|5|||
125284621|NCT01155466|450667888|FG002|Overall Study|Withdrawal by Subject|9|||
125284622|NCT01155466|450667889|FG003|Overall Study|Withdrawal by Subject|4|||
125284623|NCT01155466|450667890|FG004|Overall Study|Withdrawal by Subject|4|||
125284624|NCT01155466|450667886|FG000|Overall Study|Protocol Violation|0|||
125284625|NCT01155466|450667887|FG001|Overall Study|Protocol Violation|0|||
125284626|NCT01155466|450667888|FG002|Overall Study|Protocol Violation|2|||
125284627|NCT01155466|450667889|FG003|Overall Study|Protocol Violation|0|||
125284628|NCT01155466|450667890|FG004|Overall Study|Protocol Violation|1|||
125284629|NCT01155466|450667886|FG000|Overall Study|Administrative|0|||
125284630|NCT01155466|450667887|FG001|Overall Study|Administrative|3|||
125284631|NCT01155466|450667888|FG002|Overall Study|Administrative|0|||
125284632|NCT01155466|450667889|FG003|Overall Study|Administrative|0|||
125284633|NCT01155466|450667890|FG004|Overall Study|Administrative|0|||
125284634|NCT01155466|450667886|FG000|Overall Study|Randomized not treated|2|||
125284635|NCT01155466|450667887|FG001|Overall Study|Randomized not treated|2|||
125284636|NCT01155466|450667888|FG002|Overall Study|Randomized not treated|3|||
125284637|NCT01155466|450667889|FG003|Overall Study|Randomized not treated|0|||
125284638|NCT01155466|450667890|FG004|Overall Study|Randomized not treated|2|||
125284639|NCT02210689|450667891|FG000|Overall Study|Withdrawal by Subject|7|||
125284640|NCT02210689|450667892|FG001|Overall Study|Withdrawal by Subject|4|||
125284641|NCT02210689|450667893|FG002|Overall Study|Withdrawal by Subject|2|||
125284642|NCT02210689|450667891|FG000|Overall Study|Adverse Event|0|||
125284643|NCT02210689|450667892|FG001|Overall Study|Adverse Event|1|||
125284644|NCT02210689|450667893|FG002|Overall Study|Adverse Event|0|||
125284645|NCT02210689|450667891|FG000|Overall Study|Protocol Violation|1|||
125284646|NCT02210689|450667892|FG001|Overall Study|Protocol Violation|0|||
125284647|NCT02210689|450667893|FG002|Overall Study|Protocol Violation|0|||
125284648|NCT02210689|450667891|FG000|Overall Study|Lost to Follow-up|11|||
125284649|NCT02210689|450667892|FG001|Overall Study|Lost to Follow-up|9|||
125284650|NCT02210689|450667893|FG002|Overall Study|Lost to Follow-up|5|||
125284651|NCT02210689|450667891|FG000|Overall Study|Pregnancy|0|||
125284652|NCT02210689|450667892|FG001|Overall Study|Pregnancy|1|||
125284653|NCT02210689|450667893|FG002|Overall Study|Pregnancy|0|||
125284654|NCT02210689|450667891|FG000|Overall Study|Lack of Efficacy|0|||
125284655|NCT02210689|450667892|FG001|Overall Study|Lack of Efficacy|1|||
125284656|NCT02210689|450667893|FG002|Overall Study|Lack of Efficacy|5|||
125284657|NCT02210689|450667891|FG000|Overall Study|Prohibited medication|2|||
125284658|NCT02210689|450667892|FG001|Overall Study|Prohibited medication|8|||
125284659|NCT02210689|450667893|FG002|Overall Study|Prohibited medication|1|||
125284660|NCT02210689|450667891|FG000|Overall Study|Negative Nugent score at baseline|6|||
125284661|NCT02210689|450667892|FG001|Overall Study|Negative Nugent score at baseline|2|||
125284662|NCT02210689|450667893|FG002|Overall Study|Negative Nugent score at baseline|2|||
125284663|NCT02210689|450667891|FG000|Overall Study|Other|25|||
125284664|NCT02210689|450667892|FG001|Overall Study|Other|21|||
125284665|NCT02210689|450667893|FG002|Overall Study|Other|8|||
125284666|NCT00223977|450667900|FG000|Overall Study|Adverse Event|7|||
125284667|NCT00223977|450667901|FG001|Overall Study|Adverse Event|10|||
125284668|NCT00223977|450667902|FG002|Overall Study|Adverse Event|0|||
125284669|NCT00223977|450667900|FG000|Overall Study|Protocol Violation|0|||
125284670|NCT00223977|450667901|FG001|Overall Study|Protocol Violation|0|||
125284671|NCT00223977|450667902|FG002|Overall Study|Protocol Violation|1|||
125284672|NCT00223977|450667900|FG000|Overall Study|Withdrawal by Subject|1|||
125284673|NCT00223977|450667901|FG001|Overall Study|Withdrawal by Subject|1|||
125284674|NCT00223977|450667902|FG002|Overall Study|Withdrawal by Subject|2|||
125284675|NCT00223977|450667900|FG000|Overall Study|Other|1|||
125284676|NCT00223977|450667901|FG001|Overall Study|Other|0|||
125284677|NCT00223977|450667902|FG002|Overall Study|Other|0|||
125284678|NCT03136497|450667903|FG000|Overall Study|Screen Failure|1|||
125284679|NCT03136497|450667904|FG001|Overall Study|Screen Failure|0|||
125284680|NCT03136497|450667905|FG002|Overall Study|Screen Failure|0|||
125284681|NCT00557310|450667908|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
125284682|NCT00557310|450667908|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
125284683|NCT00557310|450667908|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
125284684|NCT00557310|450667908|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
125284685|NCT00557310|450667908|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
125284686|NCT00557310|450667908|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
125284687|NCT00367744|450667911|FG000|Overall Study|Lost to Follow-up|4|||
125284688|NCT00367744|450667912|FG001|Overall Study|Lost to Follow-up|5|||
125284689|NCT01271712|450667915|FG000|Double Blind Treatment|Death|2|||
125284690|NCT01271712|450667916|FG001|Double Blind Treatment|Death|0|||
125284691|NCT01271712|450667915|FG000|Double Blind Treatment|Lack of Efficacy|1|||
125284692|NCT01271712|450667916|FG001|Double Blind Treatment|Lack of Efficacy|0|||
125284693|NCT01271712|450667915|FG000|Double Blind Treatment|Adverse Event|9|||
125284694|NCT01271712|450667916|FG001|Double Blind Treatment|Adverse Event|4|||
125284695|NCT01271712|450667915|FG000|Double Blind Treatment|Progressive disease|23|||
125284696|NCT01271712|450667916|FG001|Double Blind Treatment|Progressive disease|3|||
125284697|NCT01271712|450667915|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
125284698|NCT01271712|450667916|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
125284699|NCT01271712|450667915|FG000|Double Blind Treatment|Non compliance with study drug|2|||
125284700|NCT01271712|450667916|FG001|Double Blind Treatment|Non compliance with study drug|0|||
125284701|NCT01271712|450667915|FG000|Double Blind Treatment|receive no study drug|1|||
125284702|NCT01271712|450667916|FG001|Double Blind Treatment|receive no study drug|0|||
125284703|NCT01271712|450667915|FG000|Open Label Treatment|Death|6|||
125284704|NCT01271712|450667916|FG001|Open Label Treatment|Death|5|||
125284705|NCT01271712|450667915|FG000|Open Label Treatment|Withdrawal by Subject|6|||
125284706|NCT01271712|450667916|FG001|Open Label Treatment|Withdrawal by Subject|11|||
125284707|NCT01271712|450667915|FG000|Open Label Treatment|Physician Decision|2|||
125284708|NCT01271712|450667916|FG001|Open Label Treatment|Physician Decision|0|||
125284709|NCT01271712|450667915|FG000|Open Label Treatment|Adverse Event|14|||
125284710|NCT01271712|450667916|FG001|Open Label Treatment|Adverse Event|8|||
125284711|NCT01271712|450667915|FG000|Open Label Treatment|Progressive disease|59|||
125284712|NCT01271712|450667916|FG001|Open Label Treatment|Progressive disease|32|||
125284713|NCT01271712|450667915|FG000|Open Label Treatment|transferred to rollover study|1|||
125284714|NCT01271712|450667916|FG001|Open Label Treatment|transferred to rollover study|0|||
125284715|NCT01271712|450667915|FG000|Open Label Treatment|Non-compliance with study drug|1|||
125284716|NCT01271712|450667916|FG001|Open Label Treatment|Non-compliance with study drug|0|||
125284717|NCT01271712|450667915|FG000|Open Label Treatment|Protocol Violation|0|||
125284718|NCT01271712|450667916|FG001|Open Label Treatment|Protocol Violation|1|||
125412738|NCT02347761|451136939|FG002|On Study Treatment|Adverse Event|20|||
125412739|NCT03879798|451136940|FG000|Overall Study|Adverse Event|0|||
125412740|NCT03879798|451136941|FG001|Overall Study|Adverse Event|0|||
125412741|NCT03879798|451136942|FG002|Overall Study|Adverse Event|0|||
125412742|NCT03879798|451136943|FG003|Overall Study|Adverse Event|0|||
125412743|NCT03879798|451136944|FG004|Overall Study|Adverse Event|0|||
125412744|NCT03879798|451136945|FG005|Overall Study|Adverse Event|1|||
125412745|NCT03879798|451136940|FG000|Overall Study|Lack of Efficacy|0|||
125412746|NCT03879798|451136941|FG001|Overall Study|Lack of Efficacy|0|||
125412747|NCT03879798|451136942|FG002|Overall Study|Lack of Efficacy|0|||
125412748|NCT03879798|451136943|FG003|Overall Study|Lack of Efficacy|0|||
125412749|NCT03879798|451136944|FG004|Overall Study|Lack of Efficacy|0|||
125412750|NCT03879798|451136945|FG005|Overall Study|Lack of Efficacy|1|||
125412751|NCT03879798|451136940|FG000|Overall Study|Withdrawal by Subject|0|||
125412752|NCT03879798|451136941|FG001|Overall Study|Withdrawal by Subject|0|||
125412753|NCT03879798|451136942|FG002|Overall Study|Withdrawal by Subject|0|||
125412754|NCT03879798|451136943|FG003|Overall Study|Withdrawal by Subject|0|||
125412755|NCT03879798|451136944|FG004|Overall Study|Withdrawal by Subject|0|||
125412756|NCT03879798|451136945|FG005|Overall Study|Withdrawal by Subject|1|||
125412757|NCT03625570|451136946|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
125412758|NCT03625570|451136947|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
125412759|NCT03625570|451136946|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
125412760|NCT03625570|451136947|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
125412761|NCT03625570|451136946|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
125412762|NCT03625570|451136947|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
125412763|NCT01040130|451136955|FG000|Overall Study|Adverse Event|1|||
125412764|NCT01040130|451136956|FG001|Overall Study|Adverse Event|1|||
125412765|NCT01040130|451136957|FG002|Overall Study|Adverse Event|0|||
125412766|NCT01040130|451136958|FG003|Overall Study|Adverse Event|5|||
125412767|NCT01040130|451136959|FG004|Overall Study|Adverse Event|0|||
125412768|NCT01040130|451136960|FG005|Overall Study|Adverse Event|3|||
125412769|NCT01040130|451136955|FG000|Overall Study|Protocol Violation|0|||
125412770|NCT01040130|451136956|FG001|Overall Study|Protocol Violation|0|||
125412771|NCT01040130|451136957|FG002|Overall Study|Protocol Violation|2|||
125412772|NCT01040130|451136958|FG003|Overall Study|Protocol Violation|0|||
125412773|NCT01040130|451136959|FG004|Overall Study|Protocol Violation|0|||
125412774|NCT01040130|451136960|FG005|Overall Study|Protocol Violation|0|||
125412775|NCT01040130|451136955|FG000|Overall Study|Withdrawal by Subject|0|||
125412776|NCT01040130|451136956|FG001|Overall Study|Withdrawal by Subject|2|||
125412777|NCT01040130|451136957|FG002|Overall Study|Withdrawal by Subject|0|||
125412778|NCT01040130|451136958|FG003|Overall Study|Withdrawal by Subject|0|||
125412779|NCT01040130|451136959|FG004|Overall Study|Withdrawal by Subject|0|||
125412780|NCT01040130|451136960|FG005|Overall Study|Withdrawal by Subject|1|||
125412781|NCT01040130|451136955|FG000|Overall Study|Other reasons not listed above|2|||
125412782|NCT01040130|451136956|FG001|Overall Study|Other reasons not listed above|0|||
125412783|NCT01040130|451136957|FG002|Overall Study|Other reasons not listed above|0|||
125412784|NCT01040130|451136958|FG003|Overall Study|Other reasons not listed above|0|||
125412785|NCT01040130|451136959|FG004|Overall Study|Other reasons not listed above|0|||
125412786|NCT01040130|451136960|FG005|Overall Study|Other reasons not listed above|0|||
125412787|NCT00553267|451136961|FG000|Overall Study|Adverse Event|8|||
125412788|NCT00553267|451136962|FG001|Overall Study|Adverse Event|10|||
125412789|NCT00553267|451136963|FG002|Overall Study|Adverse Event|5|||
125412790|NCT00553267|451136961|FG000|Overall Study|Non compliant with protocol|3|||
125412791|NCT00553267|451136962|FG001|Overall Study|Non compliant with protocol|3|||
125412792|NCT00553267|451136963|FG002|Overall Study|Non compliant with protocol|2|||
125412793|NCT00553267|451136961|FG000|Overall Study|Lost to Follow-up|0|||
125412794|NCT00553267|451136962|FG001|Overall Study|Lost to Follow-up|0|||
125284719|NCT01271712|450667915|FG000|Open Label Treatment|Switching to other therapy|2|||
125412795|NCT00553267|451136963|FG002|Overall Study|Lost to Follow-up|1|||
125412796|NCT00553267|451136961|FG000|Overall Study|Consent withdrawn|2|||
125412797|NCT00553267|451136962|FG001|Overall Study|Consent withdrawn|3|||
125412798|NCT00553267|451136963|FG002|Overall Study|Consent withdrawn|1|||
125412799|NCT00553267|451136961|FG000|Overall Study|Specified category|1|||
125412800|NCT00553267|451136962|FG001|Overall Study|Specified category|2|||
125412801|NCT00553267|451136963|FG002|Overall Study|Specified category|1|||
125284720|NCT01271712|450667916|FG001|Open Label Treatment|Switching to other therapy|1|||
125412802|NCT01175668|451136964|FG000|Overall Study|Withdrawal by Subject|2|||
125412803|NCT01175668|451136965|FG001|Overall Study|Withdrawal by Subject|0|||
125412804|NCT00096135|451136971|FG000|Overall Study|Physician Decision|20|||
125412805|NCT00096135|451136972|FG001|Overall Study|Physician Decision|4|||
125412806|NCT00096135|451136971|FG000|Overall Study|Refusal of further protocol therapy|4|||
125412807|NCT00096135|451136972|FG001|Overall Study|Refusal of further protocol therapy|1|||
125412808|NCT00096135|451136971|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
125412809|NCT00096135|451136972|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
125412810|NCT00096135|451136971|FG000|Overall Study|Other, specify|15|||
125412811|NCT00096135|451136972|FG001|Overall Study|Other, specify|3|||
125412812|NCT00096135|451136971|FG000|Overall Study|Ineligible|2|||
125412813|NCT00096135|451136972|FG001|Overall Study|Ineligible|0|||
125412814|NCT01568047|451136974|FG000|Overall Study|Ineligibility|1|||
125412815|NCT01568047|451136975|FG001|Overall Study|Ineligibility|0|||
125412816|NCT01568047|451136976|FG002|Overall Study|Ineligibility|0|||
125412817|NCT01568047|451136977|FG003|Overall Study|Ineligibility|0|||
125412818|NCT01568047|451136974|FG000|Overall Study|Withdrawal by Subject|0|||
125412819|NCT01568047|451136975|FG001|Overall Study|Withdrawal by Subject|1|||
125412820|NCT01568047|451136976|FG002|Overall Study|Withdrawal by Subject|0|||
125412821|NCT01568047|451136977|FG003|Overall Study|Withdrawal by Subject|0|||
125412822|NCT01568047|451136974|FG000|Overall Study|Adverse Event|0|||
125412823|NCT01568047|451136975|FG001|Overall Study|Adverse Event|0|||
125412824|NCT01568047|451136976|FG002|Overall Study|Adverse Event|1|||
125412825|NCT01568047|451136977|FG003|Overall Study|Adverse Event|1|||
125412826|NCT02937545|451136981|FG000|Overall Study|Withdrawal by Subject|1|||
125412827|NCT02937545|451136982|FG001|Overall Study|Withdrawal by Subject|2|||
125412828|NCT02937545|451136983|FG002|Overall Study|Withdrawal by Subject|6|||
125412829|NCT02937545|451136984|FG003|Overall Study|Withdrawal by Subject|7|||
125412830|NCT02937545|451136981|FG000|Overall Study|Lost to Follow-up|1|||
125412831|NCT02937545|451136982|FG001|Overall Study|Lost to Follow-up|0|||
125412832|NCT02937545|451136983|FG002|Overall Study|Lost to Follow-up|0|||
125412833|NCT02937545|451136984|FG003|Overall Study|Lost to Follow-up|0|||
125412834|NCT02007577|451136985|FG000|Overall Study|Adverse Event|1|||
125412835|NCT02007577|451136986|FG001|Overall Study|Adverse Event|0|||
125412836|NCT02007577|451136985|FG000|Overall Study|Withdrawal by Subject|0|||
125412837|NCT02007577|451136986|FG001|Overall Study|Withdrawal by Subject|1|||
125412838|NCT02504294|451136987|FG000|Overall Study|Adverse Event|15|||
125412839|NCT02504294|451136988|FG001|Overall Study|Adverse Event|12|||
125412840|NCT02504294|451136987|FG000|Overall Study|Withdrawal by Subject|7|||
125412841|NCT02504294|451136988|FG001|Overall Study|Withdrawal by Subject|1|||
125412842|NCT02504294|451136987|FG000|Overall Study|Protocol Violation|27|||
125412843|NCT02504294|451136988|FG001|Overall Study|Protocol Violation|26|||
125412844|NCT02504294|451136987|FG000|Overall Study|Physician Decision|1|||
125412845|NCT02504294|451136988|FG001|Overall Study|Physician Decision|2|||
125412846|NCT02504294|451136987|FG000|Overall Study|Lost to Follow-up|6|||
125412847|NCT02504294|451136988|FG001|Overall Study|Lost to Follow-up|7|||
125412848|NCT06281548|451136989|FG000|Overall Study|Lost to Follow-up|3|||
125412849|NCT01618838|451136990|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
125412850|NCT00288587|451136991|FG000|Overall Study|Death|4|||
125412851|NCT00288587|451136992|FG001|Overall Study|Death|4|||
125412852|NCT00288587|451136991|FG000|Overall Study|Transplant|0|||
125412853|NCT00288587|451136992|FG001|Overall Study|Transplant|3|||
125412854|NCT00288587|451136991|FG000|Overall Study|Adverse Event|0|||
125412855|NCT00288587|451136992|FG001|Overall Study|Adverse Event|1|||
125412856|NCT00288587|451136991|FG000|Overall Study|Physician Decision|0|||
125412857|NCT00288587|451136992|FG001|Overall Study|Physician Decision|2|||
125412858|NCT00288587|451136991|FG000|Overall Study|Severe Aortic Stenosis|1|||
125412859|NCT00288587|451136992|FG001|Overall Study|Severe Aortic Stenosis|0|||
125412860|NCT00136955|451138766|FG000|Overall Study|Adverse Event|8|||
125412861|NCT00136955|451138766|FG000|Overall Study|Lost to Follow-up|1|||
125412862|NCT00136955|451138766|FG000|Overall Study|Withdrawal by Subject|2|||
125412863|NCT00136955|451138766|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
125412864|NCT04579757|451138768|FG000|Overall Study|Adverse Event|0|||
125412865|NCT04579757|451138769|FG001|Overall Study|Adverse Event|0|||
125412866|NCT04579757|451138770|FG002|Overall Study|Adverse Event|0|||
125412867|NCT04579757|451138771|FG003|Overall Study|Adverse Event|2|||
125412868|NCT04579757|451138772|FG004|Overall Study|Adverse Event|1|||
125412869|NCT04579757|451138773|FG005|Overall Study|Adverse Event|1|||
125412870|NCT04579757|451138774|FG006|Overall Study|Adverse Event|0|||
125412871|NCT04579757|451138775|FG007|Overall Study|Adverse Event|0|||
125412872|NCT04579757|451138776|FG008|Overall Study|Adverse Event|0|||
125412873|NCT04579757|451138768|FG000|Overall Study|Death|4|||
125412874|NCT04579757|451138769|FG001|Overall Study|Death|1|||
125284721|NCT01271712|450667915|FG000|Safety Follow-up|Death|11|||
125284722|NCT01271712|450667916|FG001|Safety Follow-up|Death|7|||
125412875|NCT04579757|451138770|FG002|Overall Study|Death|14|||
125412876|NCT04579757|451138771|FG003|Overall Study|Death|3|||
125412877|NCT04579757|451138772|FG004|Overall Study|Death|2|||
125412878|NCT04579757|451138773|FG005|Overall Study|Death|7|||
125412879|NCT04579757|451138774|FG006|Overall Study|Death|0|||
125412880|NCT04579757|451138775|FG007|Overall Study|Death|1|||
125412881|NCT04579757|451138776|FG008|Overall Study|Death|3|||
125412882|NCT04579757|451138768|FG000|Overall Study|Physician Decision|0|||
125412883|NCT04579757|451138769|FG001|Overall Study|Physician Decision|0|||
125412884|NCT04579757|451138770|FG002|Overall Study|Physician Decision|0|||
125412885|NCT04579757|451138771|FG003|Overall Study|Physician Decision|2|||
125412886|NCT04579757|451138772|FG004|Overall Study|Physician Decision|1|||
125412887|NCT04579757|451138773|FG005|Overall Study|Physician Decision|1|||
125412888|NCT04579757|451138774|FG006|Overall Study|Physician Decision|1|||
125412889|NCT04579757|451138775|FG007|Overall Study|Physician Decision|0|||
125412890|NCT04579757|451138776|FG008|Overall Study|Physician Decision|0|||
125412891|NCT04579757|451138768|FG000|Overall Study|Study Terminated By Sponsor|0|||
125412892|NCT04579757|451138769|FG001|Overall Study|Study Terminated By Sponsor|0|||
125412893|NCT04579757|451138770|FG002|Overall Study|Study Terminated By Sponsor|0|||
125412894|NCT04579757|451138771|FG003|Overall Study|Study Terminated By Sponsor|0|||
125412895|NCT04579757|451138772|FG004|Overall Study|Study Terminated By Sponsor|2|||
125412896|NCT04579757|451138773|FG005|Overall Study|Study Terminated By Sponsor|0|||
125412897|NCT04579757|451138774|FG006|Overall Study|Study Terminated By Sponsor|0|||
125412898|NCT04579757|451138775|FG007|Overall Study|Study Terminated By Sponsor|2|||
125412899|NCT04579757|451138776|FG008|Overall Study|Study Terminated By Sponsor|0|||
125412900|NCT04579757|451138768|FG000|Overall Study|Withdrawal by Subject|1|||
125412901|NCT04579757|451138769|FG001|Overall Study|Withdrawal by Subject|1|||
125412902|NCT04579757|451138770|FG002|Overall Study|Withdrawal by Subject|0|||
125412903|NCT04579757|451138771|FG003|Overall Study|Withdrawal by Subject|0|||
125412904|NCT04579757|451138772|FG004|Overall Study|Withdrawal by Subject|2|||
125412905|NCT04579757|451138773|FG005|Overall Study|Withdrawal by Subject|1|||
125412906|NCT04579757|451138774|FG006|Overall Study|Withdrawal by Subject|0|||
125412907|NCT04579757|451138775|FG007|Overall Study|Withdrawal by Subject|3|||
125412908|NCT04579757|451138776|FG008|Overall Study|Withdrawal by Subject|0|||
125412909|NCT04579757|451138768|FG000|Overall Study|Radiological or Clinical PD|1|||
125412910|NCT04579757|451138769|FG001|Overall Study|Radiological or Clinical PD|4|||
125412911|NCT04579757|451138770|FG002|Overall Study|Radiological or Clinical PD|1|||
125412912|NCT04579757|451138771|FG003|Overall Study|Radiological or Clinical PD|3|||
125412913|NCT04579757|451138772|FG004|Overall Study|Radiological or Clinical PD|9|||
125412914|NCT04579757|451138773|FG005|Overall Study|Radiological or Clinical PD|4|||
125412915|NCT04579757|451138774|FG006|Overall Study|Radiological or Clinical PD|2|||
125412916|NCT04579757|451138775|FG007|Overall Study|Radiological or Clinical PD|2|||
125412917|NCT04579757|451138776|FG008|Overall Study|Radiological or Clinical PD|0|||
125412918|NCT04579757|451138768|FG000|Overall Study|Start of New Therapy|0|||
125412919|NCT04579757|451138769|FG001|Overall Study|Start of New Therapy|0|||
125412920|NCT04579757|451138770|FG002|Overall Study|Start of New Therapy|0|||
125412921|NCT04579757|451138771|FG003|Overall Study|Start of New Therapy|0|||
125412922|NCT04579757|451138772|FG004|Overall Study|Start of New Therapy|2|||
125412923|NCT04579757|451138773|FG005|Overall Study|Start of New Therapy|1|||
125412924|NCT04579757|451138774|FG006|Overall Study|Start of New Therapy|0|||
125412925|NCT04579757|451138775|FG007|Overall Study|Start of New Therapy|0|||
125412926|NCT04579757|451138776|FG008|Overall Study|Start of New Therapy|0|||
125412927|NCT00071487|451138777|FG000|52-Week Double-Blind Period|Adverse Event|5|||
125412928|NCT00071487|451138778|FG001|52-Week Double-Blind Period|Adverse Event|8|||
125412929|NCT00071487|451138779|FG002|52-Week Double-Blind Period|Adverse Event|4|||
125412930|NCT00071487|451138780|FG003|52-Week Double-Blind Period|Adverse Event|8|||
125412931|NCT00071487|451138777|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
125412932|NCT00071487|451138778|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
125412933|NCT00071487|451138779|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
125412934|NCT00071487|451138780|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
125412935|NCT00071487|451138777|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
125412936|NCT00071487|451138778|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
125412937|NCT00071487|451138779|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
125412938|NCT00071487|451138780|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
125412939|NCT00071487|451138777|FG000|52-Week Double-Blind Period|Physician Decision|1|||
125412940|NCT00071487|451138778|FG001|52-Week Double-Blind Period|Physician Decision|0|||
125412941|NCT00071487|451138779|FG002|52-Week Double-Blind Period|Physician Decision|0|||
125412942|NCT00071487|451138780|FG003|52-Week Double-Blind Period|Physician Decision|0|||
125412943|NCT00071487|451138777|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
125412944|NCT00071487|451138778|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
125412945|NCT00071487|451138779|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
125412946|NCT00071487|451138780|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
125412947|NCT00071487|451138777|FG000|52-Week Double-Blind Period|Pregnancy|0|||
125412948|NCT00071487|451138778|FG001|52-Week Double-Blind Period|Pregnancy|1|||
125412949|NCT00071487|451138779|FG002|52-Week Double-Blind Period|Pregnancy|0|||
125412950|NCT00071487|451138780|FG003|52-Week Double-Blind Period|Pregnancy|0|||
125412951|NCT00071487|451138777|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
125412952|NCT00071487|451138778|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
125412953|NCT00071487|451138779|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
125412954|NCT00071487|451138780|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
125412955|NCT00071487|451138777|FG000|52-Week Double-Blind Period|Death|0|||
125412956|NCT00071487|451138778|FG001|52-Week Double-Blind Period|Death|1|||
125412957|NCT00071487|451138779|FG002|52-Week Double-Blind Period|Death|0|||
125412958|NCT00071487|451138780|FG003|52-Week Double-Blind Period|Death|0|||
125412959|NCT00071487|451138777|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
125412960|NCT00071487|451138778|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
125284723|NCT01271712|450667915|FG000|Safety Follow-up|Withdrawal by Subject|4|||
125284724|NCT01271712|450667916|FG001|Safety Follow-up|Withdrawal by Subject|2|||
125412961|NCT00071487|451138779|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
125284725|NCT01271712|450667915|FG000|Safety Follow-up|Protocol Violation|1|||
125412962|NCT00071487|451138780|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
125412963|NCT00071487|451138777|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
125412964|NCT00071487|451138778|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
125412965|NCT00071487|451138779|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
125412966|NCT00071487|451138780|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
125412967|NCT00071487|451138777|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
125412968|NCT00071487|451138778|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
125412969|NCT00071487|451138779|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
125412970|NCT00071487|451138780|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
125412971|NCT00071487|451138777|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125412972|NCT00071487|451138778|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125412973|NCT00071487|451138779|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
125412974|NCT00071487|451138780|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
125412975|NCT00071487|451138777|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
125412976|NCT00071487|451138778|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
125412977|NCT00071487|451138779|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
125412978|NCT00071487|451138780|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
125412979|NCT00071487|451138777|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
125412980|NCT00071487|451138778|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
125412981|NCT00071487|451138779|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
125412982|NCT00071487|451138780|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
125412983|NCT00071487|451138777|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
125412984|NCT00071487|451138778|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
125412985|NCT00071487|451138779|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
125412986|NCT00071487|451138780|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
125412987|NCT03725982|451138781|FG000|First Intervention|Withdrawal by Subject|0|||
125412988|NCT03725982|451138782|FG001|First Intervention|Withdrawal by Subject|1|||
125412989|NCT03725982|451138781|FG000|First Intervention|Physician Decision|1|||
125412990|NCT03725982|451138782|FG001|First Intervention|Physician Decision|1|||
125412991|NCT01262651|451138783|FG000|Overall Study|Adverse Event|40|||
125412992|NCT01262651|451138784|FG001|Overall Study|Adverse Event|35|||
125412993|NCT01262651|451138783|FG000|Overall Study|Withdrawal by Subject|15|||
125412994|NCT01262651|451138784|FG001|Overall Study|Withdrawal by Subject|11|||
125412995|NCT01262651|451138783|FG000|Overall Study|Withdrawal by Investigator|2|||
125412996|NCT01262651|451138784|FG001|Overall Study|Withdrawal by Investigator|2|||
125412997|NCT01262651|451138783|FG000|Overall Study|Met Withdrawal Criteria|1|||
125412998|NCT01262651|451138784|FG001|Overall Study|Met Withdrawal Criteria|0|||
125412999|NCT04743908|451138785|FG000|Overall Study|Death|1|||
125413000|NCT04743908|451138786|FG001|Overall Study|Death|0|||
125413001|NCT04743908|451138785|FG000|Overall Study|Lost to Follow-up|181|||
125413002|NCT04743908|451138786|FG001|Overall Study|Lost to Follow-up|180|||
125413003|NCT04743908|451138785|FG000|Overall Study|Withdrawal by Subject|1|||
125413004|NCT04743908|451138786|FG001|Overall Study|Withdrawal by Subject|2|||
125413005|NCT04969783|451138787|FG000|Overall Study|Lost to Follow-up|2|||
125413006|NCT04969783|451138788|FG001|Overall Study|Lost to Follow-up|0|||
125413007|NCT04969783|451138787|FG000|Overall Study|Withdrawal by Subject|4|||
125413008|NCT04969783|451138788|FG001|Overall Study|Withdrawal by Subject|0|||
125413009|NCT04969783|451138787|FG000|Overall Study|Physician Decision|6|||
125413010|NCT04969783|451138788|FG001|Overall Study|Physician Decision|0|||
125413011|NCT04837482|451138789|FG000|Period 2|Withdrawal by Subject|0|||
125413012|NCT04837482|451138790|FG001|Period 2|Withdrawal by Subject|1|||
125413013|NCT06027216|451138793|FG000|Overall Study|Did not qualify|8|||
125413014|NCT05348681|451138794|FG000|Overall Study|Study terminated by Sponsor|8|||
125413015|NCT05348681|451138795|FG001|Overall Study|Study terminated by Sponsor|3|||
125413016|NCT05348681|451138794|FG000|Overall Study|Withdrawal by Subject|1|||
125413017|NCT05348681|451138795|FG001|Overall Study|Withdrawal by Subject|1|||
125413018|NCT05348681|451138794|FG000|Overall Study|Lost to Follow-up|1|||
125413019|NCT05348681|451138795|FG001|Overall Study|Lost to Follow-up|1|||
125413020|NCT05348681|451138794|FG000|Overall Study|Adverse Event|1|||
125413021|NCT05348681|451138795|FG001|Overall Study|Adverse Event|0|||
125413022|NCT05348681|451138794|FG000|Overall Study|Other|2|||
125413023|NCT05348681|451138795|FG001|Overall Study|Other|1|||
125413024|NCT03646513|451138799|FG000|Overall Study|Premature study termination|4|||
125284726|NCT01271712|450667916|FG001|Safety Follow-up|Protocol Violation|1|||
125284727|NCT01271712|450667915|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
125413025|NCT00782340|451138800|FG000|Open Label Titration|Adverse Event|12|||
125413026|NCT00782340|451138801|FG001|Open Label Titration|Adverse Event|0|||
125413027|NCT00782340|451138802|FG002|Open Label Titration|Adverse Event|0|||
125284728|NCT01271712|450667916|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
125284729|NCT01271712|450667915|FG000|Safety Follow-up|No follow-up|1|||
125413028|NCT00782340|451138800|FG000|Open Label Titration|Treatment failure|50|||
125284730|NCT01271712|450667916|FG001|Safety Follow-up|No follow-up|1|||
125284731|NCT01271712|450667915|FG000|Safety Follow-up|Progressive disease|1|||
125284732|NCT01271712|450667916|FG001|Safety Follow-up|Progressive disease|0|||
125284733|NCT01271712|450667915|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
125284734|NCT01271712|450667916|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
125284735|NCT00096226|450667919|FG000|Overall Study|Ineligible|2|||
125284736|NCT00096226|450667919|FG000|Overall Study|Protocol treatment not started|1|||
125284737|NCT01666119|450667920|FG000|Overall Study|Adverse Event|6|||
125284738|NCT01666119|450667920|FG000|Overall Study|Withdrawal by Subject|16|||
125284739|NCT01666119|450667920|FG000|Overall Study|Lost to Follow-up|7|||
125284740|NCT01666119|450667920|FG000|Overall Study|non compliance with study medication, pa|18|||
125284741|NCT01666119|450667920|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
125284742|NCT05479097|450667926|FG000|Overall Study|Withdrawal by Subject|2|||
125284743|NCT04003207|450667929|FG000|Overall Study|Protocol Violation|1|||
125284744|NCT03894969|450667932|FG000|Overall Study|Adverse Event|0|||
125284745|NCT03894969|450667933|FG001|Overall Study|Adverse Event|2|||
125284746|NCT03894969|450667934|FG002|Overall Study|Adverse Event|0|||
125284747|NCT03894969|450667935|FG003|Overall Study|Adverse Event|1|||
125284748|NCT03894969|450667936|FG004|Overall Study|Adverse Event|2|||
125284749|NCT03894969|450667932|FG000|Overall Study|Lost to Follow-up|3|||
125284750|NCT03894969|450667933|FG001|Overall Study|Lost to Follow-up|1|||
125284751|NCT03894969|450667934|FG002|Overall Study|Lost to Follow-up|1|||
125284752|NCT03894969|450667935|FG003|Overall Study|Lost to Follow-up|0|||
125284753|NCT03894969|450667936|FG004|Overall Study|Lost to Follow-up|0|||
125284754|NCT03894969|450667932|FG000|Overall Study|Withdrawal by Subject|2|||
125284755|NCT03894969|450667933|FG001|Overall Study|Withdrawal by Subject|1|||
125284756|NCT03894969|450667934|FG002|Overall Study|Withdrawal by Subject|3|||
125284757|NCT03894969|450667935|FG003|Overall Study|Withdrawal by Subject|4|||
125284758|NCT03894969|450667936|FG004|Overall Study|Withdrawal by Subject|8|||
125284759|NCT03894969|450667932|FG000|Overall Study|Other|0|||
125284760|NCT03894969|450667933|FG001|Overall Study|Other|0|||
125284761|NCT03894969|450667934|FG002|Overall Study|Other|0|||
125284762|NCT03894969|450667935|FG003|Overall Study|Other|0|||
125284763|NCT03894969|450667936|FG004|Overall Study|Other|3|||
125284764|NCT03894969|450667932|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
125284765|NCT03894969|450667933|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
125284766|NCT03894969|450667934|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
125284767|NCT03894969|450667935|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
125284768|NCT03894969|450667936|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
125284769|NCT03894969|450667932|FG000|Overall Study|Solicited Adverse Event|0|||
125284770|NCT03894969|450667933|FG001|Overall Study|Solicited Adverse Event|1|||
125284771|NCT03894969|450667934|FG002|Overall Study|Solicited Adverse Event|0|||
125284772|NCT03894969|450667935|FG003|Overall Study|Solicited Adverse Event|0|||
125284773|NCT03894969|450667936|FG004|Overall Study|Solicited Adverse Event|0|||
125284774|NCT00468676|450667938|FG000|Overall Study|Lost to Follow-up|14|||
125284775|NCT00468676|450667939|FG001|Overall Study|Lost to Follow-up|11|||
125284776|NCT00468676|450667938|FG000|Overall Study|Death|2|||
125284777|NCT00468676|450667939|FG001|Overall Study|Death|1|||
125284778|NCT00118846|450667945|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
125284779|NCT00118846|450667946|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
125284780|NCT00118846|450667945|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
125284781|NCT00118846|450667946|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
125284782|NCT00118846|450667945|FG000|Overall Study|Physician Decision|1|||
125284783|NCT00118846|450667946|FG001|Overall Study|Physician Decision|0|||
125284784|NCT00118846|450667945|FG000|Overall Study|Medical condition|2|||
125284785|NCT00118846|450667946|FG001|Overall Study|Medical condition|2|||
125284786|NCT00118846|450667945|FG000|Overall Study|Lost to Follow-up|0|||
125284787|NCT00118846|450667946|FG001|Overall Study|Lost to Follow-up|2|||
125284788|NCT00118846|450667945|FG000|Overall Study|Personal reason|4|||
125284789|NCT00118846|450667946|FG001|Overall Study|Personal reason|5|||
125284790|NCT01574157|450667947|FG000|Overall Study|Withdrawal by Subject|4|||
125284791|NCT01574157|450667948|FG001|Overall Study|Withdrawal by Subject|5|||
125284792|NCT01574157|450667947|FG000|Overall Study|Lost to Follow-up|0|||
125284793|NCT01574157|450667948|FG001|Overall Study|Lost to Follow-up|3|||
125284794|NCT00721578|450667949|FG000|Overall Study|Death|1|||
125284795|NCT00721578|450667950|FG001|Overall Study|Death|1|||
125284796|NCT00721578|450667949|FG000|Overall Study|Withdrawal by Subject|1|||
125284797|NCT00721578|450667950|FG001|Overall Study|Withdrawal by Subject|1|||
125284798|NCT01330628|450667952|FG000|Overall Study|Death|2|||
125284799|NCT01330628|450667953|FG001|Overall Study|Death|3|||
125284800|NCT01330628|450667952|FG000|Overall Study|Lost to Follow-up|5|||
125284801|NCT01330628|450667953|FG001|Overall Study|Lost to Follow-up|6|||
125284802|NCT01330628|450667952|FG000|Overall Study|Adverse Event|44|||
125284803|NCT01330628|450667953|FG001|Overall Study|Adverse Event|25|||
125284804|NCT01330628|450667952|FG000|Overall Study|Withdrawn|18|||
125284805|NCT01330628|450667953|FG001|Overall Study|Withdrawn|6|||
125284806|NCT01330628|450667952|FG000|Overall Study|Didn't receive study treatment|1|||
125284807|NCT01330628|450667953|FG001|Overall Study|Didn't receive study treatment|0|||
125284808|NCT02910401|450667954|FG000|Overall Study|Study closure Study closure|0|||
125413029|NCT00782340|451138801|FG001|Open Label Titration|Treatment failure|0|||
125413030|NCT00782340|451138802|FG002|Open Label Titration|Treatment failure|0|||
125413031|NCT00782340|451138800|FG000|Open Label Titration|Protocol Violation|5|||
125413032|NCT00782340|451138801|FG001|Open Label Titration|Protocol Violation|0|||
125413033|NCT00782340|451138802|FG002|Open Label Titration|Protocol Violation|0|||
125413034|NCT00782340|451138800|FG000|Open Label Titration|Withdrawal by Subject|5|||
125413035|NCT00782340|451138801|FG001|Open Label Titration|Withdrawal by Subject|0|||
125413036|NCT00782340|451138802|FG002|Open Label Titration|Withdrawal by Subject|0|||
125413037|NCT00782340|451138800|FG000|Open Label Titration|Enrollment capped|16|||
125413038|NCT00782340|451138801|FG001|Open Label Titration|Enrollment capped|0|||
125413039|NCT00782340|451138802|FG002|Open Label Titration|Enrollment capped|0|||
125413040|NCT00782340|451138800|FG000|Open Label Titration|Did not meet responder criteria|2|||
125413041|NCT00782340|451138801|FG001|Open Label Titration|Did not meet responder criteria|0|||
125413042|NCT00782340|451138802|FG002|Open Label Titration|Did not meet responder criteria|0|||
125413043|NCT00782340|451138800|FG000|Open Label Titration|Lost to Follow-up|5|||
125413044|NCT00782340|451138801|FG001|Open Label Titration|Lost to Follow-up|0|||
125413045|NCT00782340|451138802|FG002|Open Label Titration|Lost to Follow-up|0|||
125413046|NCT00782340|451138800|FG000|Open Label Titration|Randomized in error|6|||
125413047|NCT00782340|451138801|FG001|Open Label Titration|Randomized in error|0|||
125413048|NCT00782340|451138802|FG002|Open Label Titration|Randomized in error|0|||
125413049|NCT02219932|451138808|FG000|Overall Study|Other|5|||
125413050|NCT02219932|451138809|FG001|Overall Study|Other|11|||
125413051|NCT02219932|451138808|FG000|Overall Study|Death|1|||
125413052|NCT02219932|451138809|FG001|Overall Study|Death|1|||
125413053|NCT02219932|451138808|FG000|Overall Study|Investigator Decision|0|||
125413054|NCT02219932|451138809|FG001|Overall Study|Investigator Decision|1|||
125413055|NCT02219932|451138808|FG000|Overall Study|Consent Withdrawn|11|||
125413056|NCT02219932|451138809|FG001|Overall Study|Consent Withdrawn|7|||
125413057|NCT02219932|451138808|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
125413058|NCT02219932|451138809|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
125413059|NCT02219932|451138808|FG000|Overall Study|Protocol Violation|10|||
125413060|NCT02219932|451138809|FG001|Overall Study|Protocol Violation|6|||
125413061|NCT02219932|451138808|FG000|Overall Study|Pregnancy|1|||
125413062|NCT02219932|451138809|FG001|Overall Study|Pregnancy|0|||
125284809|NCT02910401|450667955|FG001|Overall Study|Study closure Study closure|0|||
125284810|NCT02910401|450667956|FG002|Overall Study|Study closure Study closure|2|||
125284811|NCT02910401|450667954|FG000|Overall Study|Physician Decision|1|||
125284812|NCT02910401|450667955|FG001|Overall Study|Physician Decision|0|||
125284813|NCT02910401|450667956|FG002|Overall Study|Physician Decision|0|||
125284814|NCT03222973|450667965|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
125284815|NCT03222973|450667966|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
125284816|NCT03222973|450667967|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
125284817|NCT03222973|450667968|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
125284818|NCT03222973|450667965|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
125284819|NCT03222973|450667966|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
125284820|NCT03222973|450667967|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
125284821|NCT03222973|450667968|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
125284822|NCT03222973|450667965|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
125284823|NCT03222973|450667966|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
125284824|NCT03222973|450667967|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
125284825|NCT03222973|450667968|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
125284826|NCT03222973|450667965|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
125284827|NCT03222973|450667966|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
125284828|NCT03222973|450667967|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
125284829|NCT03222973|450667968|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
125284830|NCT03222973|450667965|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
125284831|NCT03222973|450667966|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
125284832|NCT03222973|450667967|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
125284833|NCT03222973|450667968|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
125284834|NCT03222973|450667965|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
125284835|NCT03222973|450667966|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
125284836|NCT03222973|450667967|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
125284837|NCT03222973|450667968|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
125284838|NCT03222973|450667965|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
125284839|NCT03222973|450667966|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
125284840|NCT03222973|450667967|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
125284841|NCT03222973|450667968|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
125284842|NCT03222973|450667965|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
125284843|NCT03222973|450667966|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
125284844|NCT03222973|450667967|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
125413063|NCT02219932|451138808|FG000|Overall Study|Lost to Follow-up|4|||
125413064|NCT02219932|451138809|FG001|Overall Study|Lost to Follow-up|2|||
125413065|NCT02219932|451138808|FG000|Overall Study|Adverse Event|23|||
125413066|NCT02219932|451138809|FG001|Overall Study|Adverse Event|21|||
125413067|NCT00093145|451138810|FG000|Overall Study|Unacceptable Toxicity Only|2|||
125413068|NCT00093145|451138810|FG000|Overall Study|Physician Decision|5|||
125413069|NCT00093145|451138810|FG000|Overall Study|Withdrawal by Subject|9|||
125413070|NCT00093145|451138810|FG000|Overall Study|Other|1|||
125413071|NCT04389840|451138811|FG000|Overall Study|Adverse Event|0|||
125413072|NCT04389840|451138812|FG001|Overall Study|Adverse Event|0|||
125413073|NCT04389840|451138813|FG002|Overall Study|Adverse Event|0|||
125413074|NCT04389840|451138814|FG003|Overall Study|Adverse Event|1|||
125413075|NCT04389840|451138815|FG004|Overall Study|Adverse Event|0|||
125413076|NCT04389840|451138816|FG005|Overall Study|Adverse Event|0|||
125413077|NCT04389840|451138811|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
125413078|NCT04389840|451138812|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
125413079|NCT04389840|451138813|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
125413080|NCT04389840|451138814|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
125413081|NCT04389840|451138815|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
125413082|NCT04389840|451138816|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
125413083|NCT04389840|451138811|FG000|Overall Study|Death|0|||
125413084|NCT04389840|451138812|FG001|Overall Study|Death|1|||
125413085|NCT04389840|451138813|FG002|Overall Study|Death|0|||
125413086|NCT04389840|451138814|FG003|Overall Study|Death|0|||
125413087|NCT04389840|451138815|FG004|Overall Study|Death|0|||
125413088|NCT04389840|451138816|FG005|Overall Study|Death|0|||
125413089|NCT02252211|451138817|FG000|Overall Study|Adverse Event|0|||
125413090|NCT02252211|451138818|FG001|Overall Study|Adverse Event|1|||
125413091|NCT02252211|451138819|FG002|Overall Study|Adverse Event|0|||
125413092|NCT02252211|451138817|FG000|Overall Study|Progressive disease|3|||
125413093|NCT02252211|451138818|FG001|Overall Study|Progressive disease|2|||
125413094|NCT02252211|451138819|FG002|Overall Study|Progressive disease|0|||
125413095|NCT02252211|451138817|FG000|Overall Study|Withdrawal by Subject|1|||
125413096|NCT02252211|451138818|FG001|Overall Study|Withdrawal by Subject|0|||
125413097|NCT02252211|451138819|FG002|Overall Study|Withdrawal by Subject|0|||
125413098|NCT02252211|451138817|FG000|Overall Study|Serious Adverse Event During Screening|1|||
125413099|NCT02252211|451138818|FG001|Overall Study|Serious Adverse Event During Screening|0|||
125413100|NCT02252211|451138819|FG002|Overall Study|Serious Adverse Event During Screening|1|||
125413101|NCT01985126|451138820|FG000|Overall Study|Death|15|||
125413102|NCT01985126|451138821|FG001|Overall Study|Death|69|||
125413103|NCT01985126|451138820|FG000|Overall Study|Lost to Follow-up|0|||
125413104|NCT01985126|451138821|FG001|Overall Study|Lost to Follow-up|8|||
125413105|NCT01985126|451138820|FG000|Overall Study|Study Terminated By Sponsor|1|||
125413106|NCT01985126|451138821|FG001|Overall Study|Study Terminated By Sponsor|22|||
125413107|NCT01985126|451138820|FG000|Overall Study|Withdrawal by Subject|2|||
125413108|NCT01985126|451138821|FG001|Overall Study|Withdrawal by Subject|7|||
125413109|NCT00968669|451138824|FG000|Overall Study|Lost to Follow-up|5|||
125413110|NCT00968669|451138825|FG001|Overall Study|Lost to Follow-up|2|||
125413111|NCT00968669|451138826|FG002|Overall Study|Lost to Follow-up|1|||
125413112|NCT00968669|451138827|FG003|Overall Study|Lost to Follow-up|4|||
125413113|NCT00968669|451138824|FG000|Overall Study|Withdrawal by Subject|9|||
125413114|NCT00968669|451138825|FG001|Overall Study|Withdrawal by Subject|7|||
125413115|NCT00968669|451138826|FG002|Overall Study|Withdrawal by Subject|5|||
125413116|NCT00968669|451138827|FG003|Overall Study|Withdrawal by Subject|3|||
125413117|NCT00968669|451138824|FG000|Overall Study|Pregnancy|0|||
125413118|NCT00968669|451138825|FG001|Overall Study|Pregnancy|0|||
125413119|NCT00968669|451138826|FG002|Overall Study|Pregnancy|2|||
125413120|NCT00968669|451138827|FG003|Overall Study|Pregnancy|0|||
125413121|NCT00968669|451138824|FG000|Overall Study|AE|1|||
125413122|NCT00968669|451138825|FG001|Overall Study|AE|0|||
125413123|NCT00968669|451138826|FG002|Overall Study|AE|0|||
125413124|NCT00968669|451138827|FG003|Overall Study|AE|0|||
125413125|NCT00968669|451138824|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
125413126|NCT00968669|451138825|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
125413127|NCT00968669|451138826|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
125413128|NCT00968669|451138827|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
125413129|NCT00968669|451138824|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
125413130|NCT00968669|451138825|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
125448813|NCT00495469|451270896|FG002|Overall Study|Protocol Violation|0|||
125448814|NCT00495469|451270897|FG003|Overall Study|Protocol Violation|0|||
125284845|NCT03222973|450667968|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
125284846|NCT03222973|450667965|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
125284847|NCT03222973|450667966|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
125284848|NCT03222973|450667967|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
125284849|NCT03222973|450667968|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
125284850|NCT03222973|450667965|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
125284851|NCT03222973|450667966|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
125413131|NCT00968669|451138826|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
125448815|NCT00495469|451270898|FG004|Overall Study|Protocol Violation|1|||
125448816|NCT00495469|451270899|FG005|Overall Study|Protocol Violation|2|||
125448817|NCT00495469|451270900|FG006|Overall Study|Protocol Violation|0|||
125413132|NCT00968669|451138827|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
125413133|NCT00968669|451138824|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
125413134|NCT00968669|451138825|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
125413135|NCT00968669|451138826|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
125413136|NCT00968669|451138827|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
125413137|NCT00968669|451138824|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
125413138|NCT00968669|451138825|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
125413139|NCT00968669|451138826|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
125413140|NCT00968669|451138827|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
125413141|NCT00968669|451138824|FG000|Overall Study|EARLY WITHDRAWAL|0|||
125413142|NCT00968669|451138825|FG001|Overall Study|EARLY WITHDRAWAL|1|||
125413143|NCT00968669|451138826|FG002|Overall Study|EARLY WITHDRAWAL|0|||
125413144|NCT00968669|451138827|FG003|Overall Study|EARLY WITHDRAWAL|0|||
125413145|NCT00968669|451138824|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
125413146|NCT00968669|451138825|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
125413147|NCT00968669|451138826|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
125413148|NCT00968669|451138827|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
125413149|NCT00968669|451138824|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
125413150|NCT00968669|451138825|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
125413151|NCT00968669|451138826|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
125413152|NCT00968669|451138827|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
125413153|NCT00968669|451138824|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
125413154|NCT00968669|451138825|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
125413155|NCT00968669|451138826|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
125413156|NCT00968669|451138827|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
125413157|NCT00968669|451138824|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
125413158|NCT00968669|451138825|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
125413159|NCT00968669|451138826|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
125413160|NCT00968669|451138827|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
125413161|NCT00968669|451138824|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
125413162|NCT00968669|451138825|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
125413163|NCT00968669|451138826|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
125413164|NCT00968669|451138827|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
125413165|NCT00968669|451138824|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
125413166|NCT00968669|451138825|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
125413167|NCT00968669|451138826|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
125413168|NCT00968669|451138827|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
125413169|NCT00968669|451138824|FG000|Overall Study|SPONSOR DECISION|0|||
125413170|NCT00968669|451138825|FG001|Overall Study|SPONSOR DECISION|1|||
125413171|NCT00968669|451138826|FG002|Overall Study|SPONSOR DECISION|0|||
125413172|NCT00968669|451138827|FG003|Overall Study|SPONSOR DECISION|0|||
125413173|NCT00968669|451138824|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
125413174|NCT00968669|451138825|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
125413175|NCT00968669|451138826|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
125413176|NCT00968669|451138827|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
125413177|NCT00968669|451138824|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
125413178|NCT00968669|451138825|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
125413179|NCT00968669|451138826|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
125413180|NCT00968669|451138827|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
125413181|NCT00968669|451138824|FG000|Overall Study|SUBJECT INCARCERATED|0|||
125413182|NCT00968669|451138825|FG001|Overall Study|SUBJECT INCARCERATED|1|||
125413183|NCT00968669|451138826|FG002|Overall Study|SUBJECT INCARCERATED|0|||
125413184|NCT00968669|451138827|FG003|Overall Study|SUBJECT INCARCERATED|0|||
125413185|NCT00968669|451138824|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
125413186|NCT00968669|451138825|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
125413187|NCT00968669|451138826|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
125413188|NCT00968669|451138827|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
125413189|NCT00968669|451138824|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
125413190|NCT00968669|451138825|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
125413191|NCT00968669|451138826|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
125413192|NCT00968669|451138827|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
125413193|NCT01953926|451138830|FG000|Overall Study|Withdrawal by Subject|23|||
125413194|NCT01953926|451138831|FG001|Overall Study|Withdrawal by Subject|3|||
125413195|NCT01953926|451138832|FG002|Overall Study|Withdrawal by Subject|3|||
125413196|NCT01953926|451138833|FG003|Overall Study|Withdrawal by Subject|5|||
125413197|NCT01953926|451138834|FG004|Overall Study|Withdrawal by Subject|6|||
125413198|NCT01953926|451138835|FG005|Overall Study|Withdrawal by Subject|0|||
125413199|NCT01953926|451138836|FG006|Overall Study|Withdrawal by Subject|1|||
125413200|NCT01953926|451138830|FG000|Overall Study|Physician Decision|1|||
125413201|NCT01953926|451138831|FG001|Overall Study|Physician Decision|0|||
125413202|NCT01953926|451138832|FG002|Overall Study|Physician Decision|0|||
125413203|NCT01953926|451138833|FG003|Overall Study|Physician Decision|0|||
125284852|NCT03222973|450667967|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
125284853|NCT03222973|450667968|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
125284854|NCT03222973|450667965|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
125284855|NCT03222973|450667966|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
125284856|NCT03222973|450667967|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
125284857|NCT03222973|450667968|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
125284858|NCT03222973|450667965|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
125284859|NCT03222973|450667966|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
125284860|NCT03222973|450667967|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
125284861|NCT03222973|450667968|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
125284862|NCT02080481|450667969|FG000|Overall Study|Never received a block.|1|||
125284863|NCT02080481|450667970|FG001|Overall Study|Never received a block.|0|||
125284864|NCT01440517|450669935|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
125284865|NCT02723006|450669940|FG000|Overall Study|Withdrawal by Subject|0|||
125284866|NCT02723006|450669941|FG001|Overall Study|Withdrawal by Subject|1|||
125284867|NCT02723006|450669942|FG002|Overall Study|Withdrawal by Subject|1|||
125284868|NCT02723006|450669940|FG000|Overall Study|Study Terminated by Sponsor|1|||
125284869|NCT02723006|450669941|FG001|Overall Study|Study Terminated by Sponsor|6|||
125284870|NCT02723006|450669942|FG002|Overall Study|Study Terminated by Sponsor|6|||
125284871|NCT00983515|450669943|FG000|Ritonavir Alone|liver panel out of range|6|||
125284872|NCT00983515|450669943|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
125284873|NCT01967823|450669946|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
125284874|NCT00316693|450669947|FG000|Overall Study|Adverse Event|6|||
125284875|NCT00316693|450669948|FG001|Overall Study|Adverse Event|1|||
125284876|NCT00316693|450669947|FG000|Overall Study|Protocol Violation|1|||
125284877|NCT00316693|450669948|FG001|Overall Study|Protocol Violation|0|||
125284878|NCT00316693|450669947|FG000|Overall Study|Withdrawal by Subject|6|||
125284879|NCT00316693|450669948|FG001|Overall Study|Withdrawal by Subject|6|||
125284880|NCT00316693|450669947|FG000|Overall Study|Lost to Follow-up|26|||
125284881|NCT00316693|450669948|FG001|Overall Study|Lost to Follow-up|34|||
125284882|NCT00316693|450669947|FG000|Overall Study|Other|38|||
125284883|NCT00316693|450669948|FG001|Overall Study|Other|44|||
125284884|NCT00539513|450669949|FG000|Overall Study|Withdrawal by Subject|2|||
125284885|NCT00539513|450669950|FG001|Overall Study|Withdrawal by Subject|1|||
125284886|NCT00539513|450669949|FG000|Overall Study|Lost to Follow-up|0|||
125284887|NCT00539513|450669950|FG001|Overall Study|Lost to Follow-up|1|||
125284888|NCT03002818|450669951|FG000|Overall Study|Decision of the investigator|1|||
125284889|NCT00711113|450669955|FG000|Overall Study|Lost to Follow-up|9|||
125284890|NCT00711113|450669955|FG000|Overall Study|Implant lost|2|||
125284891|NCT01606787|450669962|FG000|Overall Study|Withdrawal by Subject|4|||
125284892|NCT01606787|450669963|FG001|Overall Study|Withdrawal by Subject|5|||
125284893|NCT01606787|450669962|FG000|Overall Study|Surgery canceled|0|||
125284894|NCT01606787|450669963|FG001|Overall Study|Surgery canceled|2|||
125284895|NCT00413894|450669964|FG000|Overall Study|Withdrawal by Subject|10|||
125284896|NCT00413894|450669964|FG000|Overall Study|Administrative Reasons|1|||
125284897|NCT00413894|450669964|FG000|Overall Study|Hb <10 grams/deciliter|12|||
125284898|NCT00413894|450669964|FG000|Overall Study|Adverse Event|28|||
125284899|NCT00413894|450669964|FG000|Overall Study|Protocol Violation|11|||
125284900|NCT00413894|450669964|FG000|Overall Study|Other|18|||
125284901|NCT04225676|450669965|FG000|Overall Study|Physician Decision|1|||
125284902|NCT04225676|450669965|FG000|Overall Study|Lack of Efficacy|1|||
125284903|NCT04225676|450669965|FG000|Overall Study|Study terminated by sponsor|3|||
125284904|NCT03245736|450669966|FG000|Overall Study|Adverse Event|1|||
125284905|NCT03245736|450669966|FG000|Overall Study|Progressive Disease|4|||
125284906|NCT01942161|450669967|FG000|Overall Study|Adverse Event|1|||
125284907|NCT01942161|450669968|FG001|Overall Study|Adverse Event|2|||
125284908|NCT01942161|450669969|FG002|Overall Study|Adverse Event|5|||
125284909|NCT01942161|450669967|FG000|Overall Study|Physician Decision|3|||
125284910|NCT01942161|450669968|FG001|Overall Study|Physician Decision|1|||
125284911|NCT01942161|450669969|FG002|Overall Study|Physician Decision|0|||
125284912|NCT01942161|450669967|FG000|Overall Study|Protocol Violation|1|||
125284913|NCT01942161|450669968|FG001|Overall Study|Protocol Violation|0|||
125284914|NCT01942161|450669969|FG002|Overall Study|Protocol Violation|0|||
125284915|NCT01942161|450669967|FG000|Overall Study|Withdrawal by Subject|3|||
125284916|NCT01942161|450669968|FG001|Overall Study|Withdrawal by Subject|3|||
125284917|NCT01942161|450669969|FG002|Overall Study|Withdrawal by Subject|1|||
125284918|NCT05289271|450669972|FG000|Overall Study|Mistakenly allocated, untreated|1|||
125284919|NCT05289271|450669973|FG001|Overall Study|Mistakenly allocated, untreated|0|||
125284920|NCT01257568|450669974|FG000|Overall Study|Lost to Follow-up|2|||
125284921|NCT01257568|450669974|FG000|Overall Study|Withdrawal by Subject|6|||
125284922|NCT01257568|450669974|FG000|Overall Study|Terminated|1|||
125284923|NCT01257568|450669974|FG000|Overall Study|Component Revision|24|||
125284924|NCT03392883|450669977|FG000|Overall Study|Lost to Follow-up|122|||
125284925|NCT03392883|450669978|FG001|Overall Study|Lost to Follow-up|13|||
125284926|NCT03392883|450669979|FG002|Overall Study|Lost to Follow-up|9|||
125284927|NCT03392883|450669977|FG000|Overall Study|Death|4|||
125284928|NCT03392883|450669978|FG001|Overall Study|Death|0|||
125413204|NCT01953926|451138834|FG004|Overall Study|Physician Decision|2|||
125413205|NCT01953926|451138835|FG005|Overall Study|Physician Decision|0|||
125413206|NCT01953926|451138836|FG006|Overall Study|Physician Decision|0|||
125413207|NCT01953926|451138830|FG000|Overall Study|Lost to Follow-up|18|||
125413208|NCT01953926|451138831|FG001|Overall Study|Lost to Follow-up|3|||
125413209|NCT01953926|451138832|FG002|Overall Study|Lost to Follow-up|0|||
125413210|NCT01953926|451138833|FG003|Overall Study|Lost to Follow-up|5|||
125413211|NCT01953926|451138834|FG004|Overall Study|Lost to Follow-up|3|||
125413212|NCT01953926|451138835|FG005|Overall Study|Lost to Follow-up|0|||
125413213|NCT01953926|451138836|FG006|Overall Study|Lost to Follow-up|0|||
125413214|NCT01953926|451138830|FG000|Overall Study|Protocol Violation|1|||
125413215|NCT01953926|451138831|FG001|Overall Study|Protocol Violation|0|||
125413216|NCT01953926|451138832|FG002|Overall Study|Protocol Violation|0|||
125413217|NCT01953926|451138833|FG003|Overall Study|Protocol Violation|0|||
125413218|NCT01953926|451138834|FG004|Overall Study|Protocol Violation|0|||
125413219|NCT01953926|451138835|FG005|Overall Study|Protocol Violation|0|||
125413220|NCT01953926|451138836|FG006|Overall Study|Protocol Violation|0|||
125413221|NCT01953926|451138830|FG000|Overall Study|Other, Disease progression|2|||
125413222|NCT01953926|451138831|FG001|Overall Study|Other, Disease progression|1|||
125413223|NCT01953926|451138832|FG002|Overall Study|Other, Disease progression|0|||
125413224|NCT01953926|451138833|FG003|Overall Study|Other, Disease progression|0|||
125413225|NCT01953926|451138834|FG004|Overall Study|Other, Disease progression|1|||
125413226|NCT01953926|451138835|FG005|Overall Study|Other, Disease progression|0|||
125413227|NCT01953926|451138836|FG006|Overall Study|Other, Disease progression|0|||
125413228|NCT01953926|451138830|FG000|Overall Study|Discontinuation of study by sponsor|41|||
125413229|NCT01953926|451138831|FG001|Overall Study|Discontinuation of study by sponsor|7|||
125413230|NCT01953926|451138832|FG002|Overall Study|Discontinuation of study by sponsor|5|||
125413231|NCT01953926|451138833|FG003|Overall Study|Discontinuation of study by sponsor|12|||
125413232|NCT01953926|451138834|FG004|Overall Study|Discontinuation of study by sponsor|46|||
125413233|NCT01953926|451138835|FG005|Overall Study|Discontinuation of study by sponsor|5|||
125413234|NCT01953926|451138836|FG006|Overall Study|Discontinuation of study by sponsor|6|||
125413235|NCT01953926|451138830|FG000|Overall Study|Not Treated|1|||
125413236|NCT01953926|451138831|FG001|Overall Study|Not Treated|0|||
125413237|NCT01953926|451138832|FG002|Overall Study|Not Treated|1|||
125413238|NCT01953926|451138833|FG003|Overall Study|Not Treated|0|||
125413239|NCT01953926|451138834|FG004|Overall Study|Not Treated|0|||
125413240|NCT01953926|451138835|FG005|Overall Study|Not Treated|0|||
125413241|NCT01953926|451138836|FG006|Overall Study|Not Treated|0|||
125413242|NCT00144339|451138838|FG000|Overall Study|Adverse Event|746|||
125413243|NCT00144339|451138839|FG001|Overall Study|Adverse Event|627|||
125413244|NCT00144339|451138838|FG000|Overall Study|Protocol Violation|75|||
125413245|NCT00144339|451138839|FG001|Overall Study|Protocol Violation|48|||
125413246|NCT00144339|451138838|FG000|Overall Study|Withdrawal by Subject|403|||
125413247|NCT00144339|451138839|FG001|Overall Study|Withdrawal by Subject|300|||
125413248|NCT00144339|451138838|FG000|Overall Study|Lost to Follow-up|76|||
125413249|NCT00144339|451138839|FG001|Overall Study|Lost to Follow-up|64|||
125413250|NCT00144339|451138838|FG000|Overall Study|Other|58|||
125413251|NCT00144339|451138839|FG001|Overall Study|Other|60|||
125413252|NCT01109992|451138840|FG000|Overall Study|Withdrawal by Subject|0|||
125413253|NCT01109992|451138841|FG001|Overall Study|Withdrawal by Subject|1|||
125413254|NCT01109992|451138840|FG000|Overall Study|Movement during rest scan.|0|||
125413255|NCT01109992|451138841|FG001|Overall Study|Movement during rest scan.|1|||
125413256|NCT02338362|451138844|FG000|Overall Study|Withdrawal by Subject|1|||
125413257|NCT02338362|451138845|FG001|Overall Study|Withdrawal by Subject|1|||
125413258|NCT00690755|451138846|FG000|Overall Study|Physician Decision|2|||
125413259|NCT00690755|451138847|FG001|Overall Study|Physician Decision|0|||
125413260|NCT00690755|451138848|FG002|Overall Study|Physician Decision|46|||
125413261|NCT00690755|451138849|FG003|Overall Study|Physician Decision|5|||
125413262|NCT00690755|451138850|FG004|Overall Study|Physician Decision|0|||
125413263|NCT00690755|451138851|FG005|Overall Study|Physician Decision|4|||
125413264|NCT00690755|451138852|FG006|Overall Study|Physician Decision|0|||
125413265|NCT00784043|451138853|FG000|Overall Study|Withdrawal by Subject|8|||
125413266|NCT00784043|451138854|FG001|Overall Study|Withdrawal by Subject|5|||
125413267|NCT00784043|451138853|FG000|Overall Study|Protocol Terminated|23|||
125413268|NCT00784043|451138854|FG001|Overall Study|Protocol Terminated|1|||
125413269|NCT03538626|451138855|FG000|Overall Study|Withdrawal by Subject|0|||
125413270|NCT03538626|451138856|FG001|Overall Study|Withdrawal by Subject|1|||
125413271|NCT03538626|451138857|FG002|Overall Study|Withdrawal by Subject|0|||
125413272|NCT03538626|451138858|FG003|Overall Study|Withdrawal by Subject|0|||
125413273|NCT03538626|451138859|FG004|Overall Study|Withdrawal by Subject|0|||
125413274|NCT03538626|451138860|FG005|Overall Study|Withdrawal by Subject|0|||
125413275|NCT03538626|451138861|FG006|Overall Study|Withdrawal by Subject|0|||
125413276|NCT03538626|451138862|FG007|Overall Study|Withdrawal by Subject|0|||
125413277|NCT03538626|451138855|FG000|Overall Study|Lost to Follow-up|0|||
125413278|NCT03538626|451138856|FG001|Overall Study|Lost to Follow-up|0|||
125413279|NCT03538626|451138857|FG002|Overall Study|Lost to Follow-up|0|||
125413280|NCT03538626|451138858|FG003|Overall Study|Lost to Follow-up|0|||
125413281|NCT03538626|451138859|FG004|Overall Study|Lost to Follow-up|0|||
125413282|NCT03538626|451138860|FG005|Overall Study|Lost to Follow-up|0|||
125413283|NCT03538626|451138861|FG006|Overall Study|Lost to Follow-up|1|||
125413284|NCT03538626|451138862|FG007|Overall Study|Lost to Follow-up|0|||
125413285|NCT01434602|451138867|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
125413286|NCT01434602|451138868|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
125413287|NCT01434602|451138869|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
125413288|NCT01434602|451138870|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
125413289|NCT01434602|451138871|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
125413290|NCT01434602|451138867|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
125413291|NCT01434602|451138868|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
125413292|NCT01434602|451138869|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
125413293|NCT01434602|451138870|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
125413294|NCT01434602|451138871|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
125413295|NCT01434602|451138867|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
125413296|NCT01434602|451138868|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
125413297|NCT01434602|451138869|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
125413298|NCT01434602|451138870|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
125413299|NCT01434602|451138871|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
125413300|NCT01434602|451138867|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
125413301|NCT01434602|451138868|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
125413302|NCT01434602|451138869|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
125413303|NCT01434602|451138870|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
125413304|NCT01434602|451138871|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
125413305|NCT01434602|451138867|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
125413306|NCT01434602|451138868|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
125413307|NCT01434602|451138869|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
125413308|NCT01434602|451138870|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
125413309|NCT01434602|451138871|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
125413310|NCT01434602|451138867|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
125413311|NCT01434602|451138868|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
125413312|NCT01434602|451138869|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
125413313|NCT01434602|451138870|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
125413314|NCT01434602|451138871|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
125413315|NCT01434602|451138867|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
125413316|NCT01434602|451138868|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
125413317|NCT01434602|451138869|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
125413318|NCT01434602|451138870|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
125413319|NCT01434602|451138871|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
125413320|NCT01434602|451138867|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
125413321|NCT01434602|451138868|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
125413322|NCT01434602|451138869|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
125413323|NCT01434602|451138870|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
125413324|NCT01434602|451138871|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
125413325|NCT01434602|451138867|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
125413326|NCT01434602|451138868|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
125284929|NCT03392883|450669979|FG002|Overall Study|Death|0|||
125284930|NCT03392883|450669977|FG000|Overall Study|Lack of Efficacy|29|||
125284931|NCT03392883|450669978|FG001|Overall Study|Lack of Efficacy|0|||
125284932|NCT03392883|450669979|FG002|Overall Study|Lack of Efficacy|0|||
125284933|NCT03392883|450669977|FG000|Overall Study|Withdrawal by Subject|180|||
125284934|NCT03392883|450669978|FG001|Overall Study|Withdrawal by Subject|0|||
125284935|NCT03392883|450669979|FG002|Overall Study|Withdrawal by Subject|0|||
125284936|NCT03392883|450669977|FG000|Overall Study|Adverse Event|1|||
125284937|NCT03392883|450669978|FG001|Overall Study|Adverse Event|0|||
125284938|NCT03392883|450669979|FG002|Overall Study|Adverse Event|0|||
125284939|NCT00132691|450669980|FG000|Overall Study|Lost to Follow-up|5|||
125284940|NCT00132691|450669981|FG001|Overall Study|Lost to Follow-up|8|||
125284941|NCT00132691|450669980|FG000|Overall Study|Missed 2-year visit|4|||
125284942|NCT00132691|450669981|FG001|Overall Study|Missed 2-year visit|4|||
125284943|NCT00132691|450669980|FG000|Overall Study|Death|2|||
125284944|NCT00132691|450669981|FG001|Overall Study|Death|0|||
125284945|NCT01739933|450669991|FG000|Overall Study|Death|89|||
125284946|NCT01739933|450669992|FG001|Overall Study|Death|86|||
125413327|NCT01434602|451138869|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
125413328|NCT01434602|451138870|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
125413329|NCT01434602|451138871|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
125413330|NCT01434602|451138867|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
125413331|NCT01434602|451138868|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
125413332|NCT01434602|451138869|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
125413333|NCT01434602|451138870|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
125413334|NCT01434602|451138871|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
125413335|NCT00499889|451138885|FG000|Overall Study|Infection prior to treatment|1|||
125413336|NCT00142909|451138889|FG000|Randomization|Various Reasons|7|||
125413337|NCT00142909|451138890|FG001|Randomization|Various Reasons|10|||
125413338|NCT00142909|451138889|FG000|Medications Begin|Protocol Violation|2|||
125413339|NCT00142909|451138890|FG001|Medications Begin|Protocol Violation|0|||
125413340|NCT00142909|451138889|FG000|Medications Begin|Withdrawal by Subject|5|||
125413341|NCT00142909|451138890|FG001|Medications Begin|Withdrawal by Subject|3|||
125413342|NCT00142909|451138889|FG000|Medications Begin|Withdrawal by Subject|2|||
125413343|NCT00142909|451138890|FG001|Medications Begin|Withdrawal by Subject|0|||
125413344|NCT00345397|451138891|FG000|Overall Study|Death|1|||
125413345|NCT03351049|451138894|FG000|Overall Study|Withdrawal|26|||
125413346|NCT03351049|451138895|FG001|Overall Study|Withdrawal|22|||
125413347|NCT03832192|451138900|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
125413348|NCT03832192|451138901|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
125413349|NCT03738150|451138902|FG000|Base Study|Withdrawal by Subject|1|||
125413350|NCT03738150|451138902|FG000|Extension Study|Withdrawal by Subject|1|||
125413351|NCT01898195|451138907|FG000|Smoking Abstinence|Did not have good measurements|35|||
125413352|NCT01898195|451138908|FG001|Smoking Abstinence|Did not have good measurements|38|||
125413353|NCT01898195|451138909|FG002|Smoking Abstinence|Did not have good measurements|36|||
125413354|NCT02720484|451138911|FG000|Treatment on Study|Adverse Event|1|||
125413355|NCT02720484|451138911|FG000|Treatment on Study|Withdrawal by Subject|1|||
125413356|NCT02720484|451138911|FG000|Treatment on Study|Progressive Disease|4|||
125413357|NCT02720484|451138911|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
125413358|NCT02720484|451138911|FG000|Follow Up for 2 Years|Death|3|||
125413359|NCT02720484|451138911|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
125413360|NCT05070897|451138917|FG000|Overall Study|Protocol Violation|123|||
125413361|NCT05070897|451138918|FG001|Overall Study|Protocol Violation|68|||
125413362|NCT01617629|451138919|FG000|Overall Study|Death|2|||
125413363|NCT01617629|451138919|FG000|Overall Study|Investigator's Clinical Judgement|1|||
125413364|NCT01617629|451138919|FG000|Overall Study|Reason Not Specified|1|||
125413365|NCT01617629|451138919|FG000|Overall Study|Participant Withdrew Consent|2|||
125413366|NCT01337245|451138920|FG000|Overall Study|Lost to Follow-up|1|||
125413367|NCT01663636|451138921|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
125413368|NCT01663636|451138922|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
125413369|NCT03832946|451138923|FG000|Overall Study|Adverse Event|3|||
125413370|NCT03832946|451138924|FG001|Overall Study|Adverse Event|1|||
125413371|NCT03832946|451138923|FG000|Overall Study|Lost to Follow-up|1|||
125413372|NCT03832946|451138924|FG001|Overall Study|Lost to Follow-up|0|||
125413373|NCT03832946|451138923|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
125413374|NCT03832946|451138924|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
125413375|NCT03832946|451138923|FG000|Overall Study|Lack of Efficacy|1|||
125413376|NCT03832946|451138924|FG001|Overall Study|Lack of Efficacy|0|||
125413377|NCT03832946|451138923|FG000|Overall Study|Withdrawal by Subject|12|||
125413378|NCT03832946|451138924|FG001|Overall Study|Withdrawal by Subject|9|||
125413379|NCT01307501|451138925|FG000|Overall Study|Treatment Failure|1|||
125413380|NCT01307501|451138925|FG000|Overall Study|Death|20|||
125413381|NCT01307501|451138925|FG000|Overall Study|Lost to Follow-up|1|||
125413382|NCT01307501|451138925|FG000|Overall Study|Starting Hospice|1|||
125413383|NCT02005471|451138926|FG000|Main Study|Adverse Event|0|||
125413384|NCT02005471|451138927|FG001|Main Study|Adverse Event|1|||
125413385|NCT02005471|451138928|FG002|Main Study|Adverse Event|0|||
125413386|NCT02005471|451138929|FG003|Main Study|Adverse Event|0|||
125413387|NCT02005471|451138926|FG000|Main Study|Death|83|||
125413388|NCT02005471|451138927|FG001|Main Study|Death|52|||
125413389|NCT02005471|451138928|FG002|Main Study|Death|0|||
125413390|NCT02005471|451138929|FG003|Main Study|Death|0|||
125413391|NCT02005471|451138926|FG000|Main Study|Lost to Follow-up|4|||
125413392|NCT02005471|451138927|FG001|Main Study|Lost to Follow-up|5|||
125413393|NCT02005471|451138928|FG002|Main Study|Lost to Follow-up|0|||
125413394|NCT02005471|451138929|FG003|Main Study|Lost to Follow-up|0|||
125413395|NCT02005471|451138926|FG000|Main Study|Physician Decision|3|||
125413396|NCT02005471|451138927|FG001|Main Study|Physician Decision|1|||
125413397|NCT02005471|451138928|FG002|Main Study|Physician Decision|0|||
125413398|NCT02005471|451138929|FG003|Main Study|Physician Decision|0|||
125413399|NCT02005471|451138926|FG000|Main Study|Withdrawal by Subject|26|||
125413400|NCT02005471|451138927|FG001|Main Study|Withdrawal by Subject|11|||
125413401|NCT02005471|451138928|FG002|Main Study|Withdrawal by Subject|0|||
125413402|NCT02005471|451138929|FG003|Main Study|Withdrawal by Subject|0|||
125413403|NCT02005471|451138926|FG000|Main Study|Reason not Specified|0|||
125413404|NCT02005471|451138927|FG001|Main Study|Reason not Specified|6|||
125413405|NCT02005471|451138928|FG002|Main Study|Reason not Specified|0|||
125413406|NCT02005471|451138929|FG003|Main Study|Reason not Specified|0|||
125413407|NCT02005471|451138926|FG000|Main Study|Randomized but not Dosed|8|||
125413408|NCT02005471|451138927|FG001|Main Study|Randomized but not Dosed|0|||
125413409|NCT02005471|451138928|FG002|Main Study|Randomized but not Dosed|0|||
125413410|NCT02005471|451138929|FG003|Main Study|Randomized but not Dosed|0|||
125413411|NCT02005471|451138926|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
125413412|NCT02005471|451138927|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
125413413|NCT02005471|451138928|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
125413414|NCT02005471|451138929|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
125413415|NCT02005471|451138926|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
125413416|NCT02005471|451138927|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
125413417|NCT02005471|451138928|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
125413418|NCT02005471|451138929|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
125413419|NCT02005471|451138926|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
125413420|NCT02005471|451138927|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
125413421|NCT02005471|451138928|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
125413422|NCT02005471|451138929|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
125413423|NCT03478891|451138930|FG000|Overall Study|Enrolled, but product never administered|0|||
125413424|NCT03478891|451138931|FG001|Overall Study|Enrolled, but product never administered|0|||
125413425|NCT03478891|451138932|FG002|Overall Study|Enrolled, but product never administered|1|||
125413426|NCT03478891|451138930|FG000|Overall Study|Moved from area|0|||
125413427|NCT03478891|451138931|FG001|Overall Study|Moved from area|0|||
125413428|NCT03478891|451138932|FG002|Overall Study|Moved from area|1|||
125413429|NCT03478891|451138930|FG000|Overall Study|Lost to Follow-up|1|||
125413430|NCT03478891|451138931|FG001|Overall Study|Lost to Follow-up|0|||
125413431|NCT03478891|451138932|FG002|Overall Study|Lost to Follow-up|1|||
125413432|NCT03662750|451138933|FG000|Overall Study|Withdrawal by Subject|1|||
125413433|NCT00932893|451138934|FG000|Overall Study|Death|115|||
125413434|NCT00932893|451138935|FG001|Overall Study|Death|24|||
125413435|NCT00932893|451138934|FG000|Overall Study|Lost to Follow-up|8|||
125413436|NCT00932893|451138935|FG001|Overall Study|Lost to Follow-up|0|||
125413437|NCT00932893|451138934|FG000|Overall Study|Withdrawal by Subject|5|||
125413438|NCT00932893|451138935|FG001|Overall Study|Withdrawal by Subject|2|||
125413439|NCT00932893|451138934|FG000|Overall Study|Other|5|||
125413440|NCT00932893|451138935|FG001|Overall Study|Other|144|||
125413441|NCT04450264|451140758|FG000|Overall Study|Incomplete survey|13|||
125413442|NCT04450264|451140759|FG001|Overall Study|Incomplete survey|19|||
125413443|NCT04295564|451140760|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
125413444|NCT04295564|451140761|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
125413445|NCT01682460|451140762|FG000|Overall Study|Withdrawal by Subject|2|||
125413446|NCT01682460|451140762|FG000|Overall Study|Did not meet inclusion criteria|2|||
125413447|NCT05349617|451140764|FG000|Overall Study|Death|1|||
125413448|NCT05349617|451140765|FG001|Overall Study|Death|1|||
125413449|NCT05349617|451140764|FG000|Overall Study|Lost to Follow-up|3|||
125413450|NCT05349617|451140765|FG001|Overall Study|Lost to Follow-up|8|||
125413451|NCT05349617|451140764|FG000|Overall Study|Withdrawal by Subject|2|||
125413452|NCT05349617|451140765|FG001|Overall Study|Withdrawal by Subject|10|||
125413453|NCT00724282|451140766|FG000|Overall Study|Withdrawal by Subject|3|||
125413454|NCT00724282|451140766|FG000|Overall Study|Physician Decision|1|||
125413455|NCT01159691|451140767|FG000|Overall Study|Lost to Follow-up|2|||
125413456|NCT01159691|451140767|FG000|Overall Study|Unknown reasons|1|||
125413457|NCT01159691|451140767|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
125413458|NCT01159691|451140767|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
125413459|NCT01159691|451140767|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
125413460|NCT01159691|451140767|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
125413461|NCT01159691|451140767|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
125413462|NCT01159691|451140767|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
125413463|NCT01928719|451140768|FG000|Overall Study|Lost to Follow-up|26|||
125413464|NCT01928719|451140769|FG001|Overall Study|Lost to Follow-up|11|||
125413465|NCT01928719|451140768|FG000|Overall Study|Withdrawal by Subject|22|||
125413466|NCT01928719|451140769|FG001|Overall Study|Withdrawal by Subject|7|||
125413467|NCT01928719|451140768|FG000|Overall Study|Protocol Violation|3|||
125413468|NCT01928719|451140769|FG001|Overall Study|Protocol Violation|1|||
125413469|NCT01928719|451140768|FG000|Overall Study|Adverse Event|1|||
125413470|NCT01928719|451140769|FG001|Overall Study|Adverse Event|0|||
125413471|NCT00773968|451140770|FG000|Overall Study|Adverse Event|2|||
125413472|NCT00773968|451140770|FG000|Overall Study|Death|1|||
125413473|NCT00773968|451140770|FG000|Overall Study|Failure to Return|2|||
125413474|NCT00773968|451140770|FG000|Overall Study|Lack of Efficacy|3|||
125413475|NCT00773968|451140770|FG000|Overall Study|Protocol Violation|1|||
125413476|NCT00773968|451140770|FG000|Overall Study|Withdrawal by Subject|11|||
125413477|NCT00773968|451140770|FG000|Overall Study|Screen Failure|17|||
125413478|NCT00773968|451140770|FG000|Overall Study|Other|8|||
125413479|NCT00328510|451140773|FG000|Overall Study|Gag disorder, could not use frame|4|||
125413480|NCT00328510|451140774|FG001|Overall Study|Gag disorder, could not use frame|0|||
125413481|NCT00328510|451140773|FG000|Overall Study|Dentition problems, could not use frame|1|||
125413482|NCT00328510|451140774|FG001|Overall Study|Dentition problems, could not use frame|0|||
125413483|NCT00328510|451140773|FG000|Overall Study|Withdrawal by Subject|4|||
125413484|NCT00328510|451140774|FG001|Overall Study|Withdrawal by Subject|2|||
125413485|NCT00328510|451140773|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
125413486|NCT00328510|451140774|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
125413487|NCT00328510|451140773|FG000|Overall Study|Treatment changed to a single fraction|1|||
125413488|NCT00328510|451140774|FG001|Overall Study|Treatment changed to a single fraction|1|||
125413489|NCT03701555|451140780|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
125413490|NCT03701555|451140781|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
125413491|NCT03701555|451140782|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
125413492|NCT03701555|451140783|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
125413493|NCT03701555|451140784|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
125413494|NCT03701555|451140785|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
125413495|NCT03701555|451140786|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
125413496|NCT03701555|451140787|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
125413497|NCT03701555|451140788|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
125413498|NCT03701555|451140789|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
125413499|NCT03701555|451140790|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
125413500|NCT03701555|451140791|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
125413501|NCT03701555|451140792|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
125413502|NCT03701555|451140793|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
125413503|NCT03701555|451140794|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
125413504|NCT03701555|451140795|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
125413505|NCT03701555|451140796|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
125413506|NCT03701555|451140797|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
125413507|NCT03701555|451140798|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
125413508|NCT03701555|451140799|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
125413509|NCT03701555|451140800|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
125413510|NCT03701555|451140801|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
125413511|NCT03701555|451140802|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
125413512|NCT03701555|451140803|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
125413513|NCT03701555|451140804|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
125413514|NCT03701555|451140805|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
125413515|NCT03701555|451140806|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
125413516|NCT03701555|451140807|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
125413517|NCT03701555|451140808|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
125413518|NCT03701555|451140809|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
125413519|NCT03701555|451140810|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
125413520|NCT03701555|451140811|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
125413521|NCT03701555|451140812|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
125413522|NCT03701555|451140813|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
125413523|NCT03701555|451140814|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
125413524|NCT03701555|451140815|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
125413525|NCT03701555|451140780|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
125413526|NCT03701555|451140781|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
125413527|NCT03701555|451140782|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
125413528|NCT03701555|451140783|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
125413529|NCT03701555|451140784|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
125413530|NCT03701555|451140785|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
125413531|NCT03701555|451140786|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
125413532|NCT03701555|451140787|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
125413533|NCT03701555|451140788|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
125413534|NCT03701555|451140789|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
125413535|NCT03701555|451140790|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
125413536|NCT03701555|451140791|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
125413537|NCT03701555|451140792|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
125413538|NCT03701555|451140793|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
125413539|NCT03701555|451140794|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
125413540|NCT03701555|451140795|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
125413541|NCT03701555|451140796|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
125413542|NCT03701555|451140797|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
125413543|NCT03701555|451140798|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
125413544|NCT03701555|451140799|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
125413545|NCT03701555|451140800|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
125413546|NCT03701555|451140801|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
125413547|NCT03701555|451140802|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
125413548|NCT03701555|451140803|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
125413549|NCT03701555|451140804|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
125413550|NCT03701555|451140805|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
125413551|NCT03701555|451140806|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
125413552|NCT03701555|451140807|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
125284947|NCT01739933|450669991|FG000|Overall Study|Withdrawal by Subject|10|||
125284948|NCT01739933|450669992|FG001|Overall Study|Withdrawal by Subject|8|||
125284949|NCT01739933|450669991|FG000|Overall Study|Lost to Follow-up|3|||
125284950|NCT01739933|450669992|FG001|Overall Study|Lost to Follow-up|10|||
125284951|NCT01739933|450669991|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
125284952|NCT01739933|450669992|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
125284953|NCT04098367|450669993|FG000|Overall Study|Adverse Event|0|||
125284954|NCT04098367|450669994|FG001|Overall Study|Adverse Event|0|||
125284955|NCT04098367|450669995|FG002|Overall Study|Adverse Event|1|||
125284956|NCT04098367|450669993|FG000|Overall Study|Lost to Follow-up|1|||
125284957|NCT04098367|450669994|FG001|Overall Study|Lost to Follow-up|5|||
125284958|NCT04098367|450669995|FG002|Overall Study|Lost to Follow-up|2|||
125284959|NCT04098367|450669993|FG000|Overall Study|Withdrawal by Subject|0|||
125284960|NCT04098367|450669994|FG001|Overall Study|Withdrawal by Subject|0|||
125284961|NCT04098367|450669995|FG002|Overall Study|Withdrawal by Subject|1|||
125284962|NCT04098367|450669993|FG000|Overall Study|Sick . Could not attend visit|1|||
125284963|NCT04098367|450669994|FG001|Overall Study|Sick . Could not attend visit|0|||
125284964|NCT04098367|450669995|FG002|Overall Study|Sick . Could not attend visit|0|||
125284965|NCT01231321|450670001|FG000|Overall Study|Adverse Event|3|||
125284966|NCT01231321|450670001|FG000|Overall Study|Lack of Efficacy|2|||
125284967|NCT00354107|450670004|FG000|Overall Study|Adverse Event|2|||
125284968|NCT00354107|450670004|FG000|Overall Study|Physician Decision|2|||
125284969|NCT00354107|450670004|FG000|Overall Study|Withdrawal by Subject|1|||
125284970|NCT03575065|450670007|FG000|Overall Study|Death|31|||
125284971|NCT03575065|450670008|FG001|Overall Study|Death|12|||
125284972|NCT03575065|450670007|FG000|Overall Study|Sponsor's Decision|28|||
125284973|NCT03575065|450670008|FG001|Overall Study|Sponsor's Decision|13|||
125284974|NCT03575065|450670007|FG000|Overall Study|Withdrawal by Subject|2|||
125284975|NCT03575065|450670008|FG001|Overall Study|Withdrawal by Subject|1|||
125284976|NCT03575065|450670007|FG000|Overall Study|Lost to Follow-up|1|||
125284977|NCT03575065|450670008|FG001|Overall Study|Lost to Follow-up|0|||
125284978|NCT03960580|450670009|FG000|Overall Study|Adverse Event|2|||
125284979|NCT03960580|450670010|FG001|Overall Study|Adverse Event|1|||
125284980|NCT03960580|450670011|FG002|Overall Study|Adverse Event|1|||
125284981|NCT03960580|450670009|FG000|Overall Study|Lost to Follow-up|1|||
125284982|NCT03960580|450670010|FG001|Overall Study|Lost to Follow-up|0|||
125284983|NCT03960580|450670011|FG002|Overall Study|Lost to Follow-up|0|||
125284984|NCT03960580|450670009|FG000|Overall Study|Lack of Efficacy|2|||
125284985|NCT03960580|450670010|FG001|Overall Study|Lack of Efficacy|1|||
125284986|NCT03960580|450670011|FG002|Overall Study|Lack of Efficacy|0|||
125284987|NCT03960580|450670009|FG000|Overall Study|Protocol Violation|0|||
125284988|NCT03960580|450670010|FG001|Overall Study|Protocol Violation|0|||
125284989|NCT03960580|450670011|FG002|Overall Study|Protocol Violation|1|||
125284990|NCT03960580|450670009|FG000|Overall Study|Withdrawal by Subject|1|||
125284991|NCT03960580|450670010|FG001|Overall Study|Withdrawal by Subject|1|||
125284992|NCT03960580|450670011|FG002|Overall Study|Withdrawal by Subject|1|||
125284993|NCT03960580|450670009|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
125284994|NCT03960580|450670010|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
125284995|NCT03960580|450670011|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
125284996|NCT02359045|450670014|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
125284997|NCT02359045|450670015|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125284998|NCT02359045|450670014|FG000|Overall Study|Lost to Follow-up|1|||
125284999|NCT02359045|450670015|FG001|Overall Study|Lost to Follow-up|1|||
125285000|NCT02359045|450670014|FG000|Overall Study|Adverse Event|0|||
125285001|NCT02359045|450670015|FG001|Overall Study|Adverse Event|1|||
125285002|NCT00541866|450670016|FG000|Overall Study|Adverse Event|3|||
125285003|NCT00541866|450670017|FG001|Overall Study|Adverse Event|0|||
125285004|NCT00541866|450670018|FG002|Overall Study|Adverse Event|0|||
125285005|NCT00541866|450670019|FG003|Overall Study|Adverse Event|0|||
125285006|NCT00541866|450670020|FG004|Overall Study|Adverse Event|0|||
125285007|NCT00541866|450670016|FG000|Overall Study|Death|1|||
125285008|NCT00541866|450670017|FG001|Overall Study|Death|0|||
125285009|NCT00541866|450670018|FG002|Overall Study|Death|0|||
125285010|NCT00541866|450670019|FG003|Overall Study|Death|0|||
125285011|NCT00541866|450670020|FG004|Overall Study|Death|0|||
125285012|NCT00541866|450670016|FG000|Overall Study|Lack of Efficacy|19|||
125285013|NCT00541866|450670017|FG001|Overall Study|Lack of Efficacy|15|||
125285014|NCT00541866|450670018|FG002|Overall Study|Lack of Efficacy|10|||
125285015|NCT00541866|450670019|FG003|Overall Study|Lack of Efficacy|12|||
125285016|NCT00541866|450670020|FG004|Overall Study|Lack of Efficacy|14|||
125285017|NCT00541866|450670016|FG000|Overall Study|Not Reported or Other|11|||
125285018|NCT00541866|450670017|FG001|Overall Study|Not Reported or Other|3|||
125285019|NCT00541866|450670018|FG002|Overall Study|Not Reported or Other|3|||
125285020|NCT00541866|450670019|FG003|Overall Study|Not Reported or Other|3|||
125285021|NCT00541866|450670020|FG004|Overall Study|Not Reported or Other|1|||
125285022|NCT00541866|450670016|FG000|Overall Study|Physician Decision|0|||
125285023|NCT00541866|450670017|FG001|Overall Study|Physician Decision|0|||
125413553|NCT03701555|451140808|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
125413554|NCT03701555|451140809|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
125413555|NCT03701555|451140810|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
125413556|NCT03701555|451140811|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
125413557|NCT03701555|451140812|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
125413558|NCT03701555|451140813|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
125413559|NCT03701555|451140814|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
125413560|NCT03701555|451140815|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
125413561|NCT03701555|451140780|FG000|Part 2 (Day 1)|Other|0|||
125413562|NCT03701555|451140781|FG001|Part 2 (Day 1)|Other|0|||
125413563|NCT03701555|451140782|FG002|Part 2 (Day 1)|Other|0|||
125413564|NCT03701555|451140783|FG003|Part 2 (Day 1)|Other|0|||
125413565|NCT03701555|451140784|FG004|Part 2 (Day 1)|Other|0|||
125413566|NCT03701555|451140785|FG005|Part 2 (Day 1)|Other|0|||
125413567|NCT03701555|451140786|FG006|Part 2 (Day 1)|Other|0|||
125413568|NCT03701555|451140787|FG007|Part 2 (Day 1)|Other|0|||
125413569|NCT03701555|451140788|FG008|Part 2 (Day 1)|Other|0|||
125413570|NCT03701555|451140789|FG009|Part 2 (Day 1)|Other|0|||
125413571|NCT03701555|451140790|FG010|Part 2 (Day 1)|Other|3|||
125413572|NCT03701555|451140791|FG011|Part 2 (Day 1)|Other|1|||
125413573|NCT03701555|451140792|FG012|Part 2 (Day 1)|Other|0|||
125413574|NCT03701555|451140793|FG013|Part 2 (Day 1)|Other|1|||
125413575|NCT03701555|451140794|FG014|Part 2 (Day 1)|Other|0|||
125413576|NCT03701555|451140795|FG015|Part 2 (Day 1)|Other|2|||
125413577|NCT03701555|451140796|FG016|Part 2 (Day 1)|Other|2|||
125413578|NCT03701555|451140797|FG017|Part 2 (Day 1)|Other|0|||
125413579|NCT03701555|451140798|FG018|Part 2 (Day 1)|Other|0|||
125413580|NCT03701555|451140799|FG019|Part 2 (Day 1)|Other|0|||
125413581|NCT03701555|451140800|FG020|Part 2 (Day 1)|Other|0|||
125413582|NCT03701555|451140801|FG021|Part 2 (Day 1)|Other|0|||
125413583|NCT03701555|451140802|FG022|Part 2 (Day 1)|Other|0|||
125413584|NCT03701555|451140803|FG023|Part 2 (Day 1)|Other|0|||
125413585|NCT03701555|451140804|FG024|Part 2 (Day 1)|Other|0|||
125413586|NCT03701555|451140805|FG025|Part 2 (Day 1)|Other|0|||
125413587|NCT03701555|451140806|FG026|Part 2 (Day 1)|Other|0|||
125413588|NCT03701555|451140807|FG027|Part 2 (Day 1)|Other|0|||
125413589|NCT03701555|451140808|FG028|Part 2 (Day 1)|Other|0|||
125413590|NCT03701555|451140809|FG029|Part 2 (Day 1)|Other|0|||
125413591|NCT03701555|451140810|FG030|Part 2 (Day 1)|Other|0|||
125413592|NCT03701555|451140811|FG031|Part 2 (Day 1)|Other|0|||
125413593|NCT03701555|451140812|FG032|Part 2 (Day 1)|Other|0|||
125413594|NCT03701555|451140813|FG033|Part 2 (Day 1)|Other|0|||
125413595|NCT03701555|451140814|FG034|Part 2 (Day 1)|Other|0|||
125413596|NCT03701555|451140815|FG035|Part 2 (Day 1)|Other|0|||
125413597|NCT03701555|451140780|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
125413598|NCT03701555|451140781|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
125413599|NCT03701555|451140782|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
125413600|NCT03701555|451140783|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
125413601|NCT03701555|451140784|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
125413602|NCT03701555|451140785|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
125413603|NCT03701555|451140786|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
125413604|NCT03701555|451140787|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
125413605|NCT03701555|451140788|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
125413606|NCT03701555|451140789|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
125413607|NCT03701555|451140790|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
125413608|NCT03701555|451140791|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
125413609|NCT03701555|451140792|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
125413610|NCT03701555|451140793|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
125413611|NCT03701555|451140794|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
125413612|NCT03701555|451140795|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
125448818|NCT00495469|451270894|FG000|Overall Study|Withdrawal by Subject|5|||
125413613|NCT03701555|451140796|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
125413614|NCT03701555|451140797|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
125413615|NCT03701555|451140798|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
125413616|NCT03701555|451140799|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
125413617|NCT03701555|451140800|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
125413618|NCT03701555|451140801|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
125413619|NCT03701555|451140802|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
125413620|NCT03701555|451140803|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
125413621|NCT03701555|451140804|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
125413622|NCT03701555|451140805|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
125285024|NCT00541866|450670018|FG002|Overall Study|Physician Decision|2|||
125413623|NCT03701555|451140806|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
125413624|NCT03701555|451140807|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
125285025|NCT00541866|450670019|FG003|Overall Study|Physician Decision|1|||
125413625|NCT03701555|451140808|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
125413626|NCT03701555|451140809|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
125413627|NCT03701555|451140810|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
125413628|NCT03701555|451140811|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
125413629|NCT03701555|451140812|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
125448819|NCT00495469|451270895|FG001|Overall Study|Withdrawal by Subject|3|||
125413630|NCT03701555|451140813|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
125413631|NCT03701555|451140814|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
125413632|NCT03701555|451140815|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
125413633|NCT03701555|451140780|FG000|Part 3 (Day 1)|Subject Decision|0|||
125413634|NCT03701555|451140781|FG001|Part 3 (Day 1)|Subject Decision|0|||
125413635|NCT03701555|451140782|FG002|Part 3 (Day 1)|Subject Decision|0|||
125413636|NCT03701555|451140783|FG003|Part 3 (Day 1)|Subject Decision|0|||
125413637|NCT03701555|451140784|FG004|Part 3 (Day 1)|Subject Decision|0|||
125413638|NCT03701555|451140785|FG005|Part 3 (Day 1)|Subject Decision|0|||
125413639|NCT03701555|451140786|FG006|Part 3 (Day 1)|Subject Decision|0|||
125413640|NCT03701555|451140787|FG007|Part 3 (Day 1)|Subject Decision|0|||
125413641|NCT03701555|451140788|FG008|Part 3 (Day 1)|Subject Decision|0|||
125413642|NCT03701555|451140789|FG009|Part 3 (Day 1)|Subject Decision|0|||
125413643|NCT03701555|451140790|FG010|Part 3 (Day 1)|Subject Decision|0|||
125413644|NCT03701555|451140791|FG011|Part 3 (Day 1)|Subject Decision|0|||
125413645|NCT03701555|451140792|FG012|Part 3 (Day 1)|Subject Decision|0|||
125413646|NCT03701555|451140793|FG013|Part 3 (Day 1)|Subject Decision|0|||
125413647|NCT03701555|451140794|FG014|Part 3 (Day 1)|Subject Decision|0|||
125413648|NCT03701555|451140795|FG015|Part 3 (Day 1)|Subject Decision|0|||
125413649|NCT03701555|451140796|FG016|Part 3 (Day 1)|Subject Decision|0|||
125413650|NCT03701555|451140797|FG017|Part 3 (Day 1)|Subject Decision|0|||
125413651|NCT03701555|451140798|FG018|Part 3 (Day 1)|Subject Decision|0|||
125413652|NCT03701555|451140799|FG019|Part 3 (Day 1)|Subject Decision|0|||
125413653|NCT03701555|451140800|FG020|Part 3 (Day 1)|Subject Decision|0|||
125413654|NCT03701555|451140801|FG021|Part 3 (Day 1)|Subject Decision|0|||
125413655|NCT03701555|451140802|FG022|Part 3 (Day 1)|Subject Decision|0|||
125413656|NCT03701555|451140803|FG023|Part 3 (Day 1)|Subject Decision|0|||
125413657|NCT03701555|451140804|FG024|Part 3 (Day 1)|Subject Decision|0|||
125413658|NCT03701555|451140805|FG025|Part 3 (Day 1)|Subject Decision|0|||
125413659|NCT03701555|451140806|FG026|Part 3 (Day 1)|Subject Decision|1|||
125413660|NCT03701555|451140807|FG027|Part 3 (Day 1)|Subject Decision|0|||
125413661|NCT03701555|451140808|FG028|Part 3 (Day 1)|Subject Decision|0|||
125413662|NCT03701555|451140809|FG029|Part 3 (Day 1)|Subject Decision|0|||
125413663|NCT03701555|451140810|FG030|Part 3 (Day 1)|Subject Decision|0|||
125413664|NCT03701555|451140811|FG031|Part 3 (Day 1)|Subject Decision|2|||
125413665|NCT03701555|451140812|FG032|Part 3 (Day 1)|Subject Decision|1|||
125413666|NCT03701555|451140813|FG033|Part 3 (Day 1)|Subject Decision|1|||
125413667|NCT03701555|451140814|FG034|Part 3 (Day 1)|Subject Decision|0|||
125413668|NCT03701555|451140815|FG035|Part 3 (Day 1)|Subject Decision|0|||
125413669|NCT03701555|451140780|FG000|Part 3 (Day 1)|Other|0|||
125413670|NCT03701555|451140781|FG001|Part 3 (Day 1)|Other|0|||
125413671|NCT03701555|451140782|FG002|Part 3 (Day 1)|Other|0|||
125413672|NCT03701555|451140783|FG003|Part 3 (Day 1)|Other|0|||
125413673|NCT03701555|451140784|FG004|Part 3 (Day 1)|Other|0|||
125413674|NCT03701555|451140785|FG005|Part 3 (Day 1)|Other|0|||
125413675|NCT03701555|451140786|FG006|Part 3 (Day 1)|Other|0|||
125413676|NCT03701555|451140787|FG007|Part 3 (Day 1)|Other|0|||
125413677|NCT03701555|451140788|FG008|Part 3 (Day 1)|Other|0|||
125413678|NCT03701555|451140789|FG009|Part 3 (Day 1)|Other|0|||
125413679|NCT03701555|451140790|FG010|Part 3 (Day 1)|Other|0|||
125413680|NCT03701555|451140791|FG011|Part 3 (Day 1)|Other|0|||
125413681|NCT03701555|451140792|FG012|Part 3 (Day 1)|Other|0|||
125413682|NCT03701555|451140793|FG013|Part 3 (Day 1)|Other|0|||
125285026|NCT00541866|450670020|FG004|Overall Study|Physician Decision|0|||
125285027|NCT01327053|450670025|FG000|Overall Study|Adverse Event|23|||
125285028|NCT01327053|450670026|FG001|Overall Study|Adverse Event|57|||
125285029|NCT01327053|450670025|FG000|Overall Study|Patient/guardian decision|11|||
125285030|NCT01327053|450670026|FG001|Overall Study|Patient/guardian decision|35|||
125285031|NCT01327053|450670025|FG000|Overall Study|Physician Decision|10|||
125285032|NCT01327053|450670026|FG001|Overall Study|Physician Decision|14|||
125285033|NCT01327053|450670025|FG000|Overall Study|Death|1|||
125285034|NCT01327053|450670026|FG001|Overall Study|Death|5|||
125285035|NCT01327053|450670025|FG000|Overall Study|Lost to Follow-up|2|||
125285036|NCT01327053|450670026|FG001|Overall Study|Lost to Follow-up|4|||
125285037|NCT01327053|450670025|FG000|Overall Study|Non-compliance with study treatment|0|||
125413683|NCT03701555|451140794|FG014|Part 3 (Day 1)|Other|0|||
125413684|NCT03701555|451140795|FG015|Part 3 (Day 1)|Other|0|||
125413685|NCT03701555|451140796|FG016|Part 3 (Day 1)|Other|0|||
125413686|NCT03701555|451140797|FG017|Part 3 (Day 1)|Other|0|||
125413687|NCT03701555|451140798|FG018|Part 3 (Day 1)|Other|0|||
125285038|NCT01327053|450670026|FG001|Overall Study|Non-compliance with study treatment|5|||
125285039|NCT01327053|450670025|FG000|Overall Study|Study terminated by Sponsor|1|||
125285040|NCT01327053|450670026|FG001|Overall Study|Study terminated by Sponsor|3|||
125413688|NCT03701555|451140799|FG019|Part 3 (Day 1)|Other|0|||
125413689|NCT03701555|451140800|FG020|Part 3 (Day 1)|Other|0|||
125413690|NCT03701555|451140801|FG021|Part 3 (Day 1)|Other|0|||
125413691|NCT03701555|451140802|FG022|Part 3 (Day 1)|Other|0|||
125413692|NCT03701555|451140803|FG023|Part 3 (Day 1)|Other|0|||
125413693|NCT03701555|451140804|FG024|Part 3 (Day 1)|Other|1|||
125413694|NCT03701555|451140805|FG025|Part 3 (Day 1)|Other|1|||
125413695|NCT03701555|451140806|FG026|Part 3 (Day 1)|Other|0|||
125413696|NCT03701555|451140807|FG027|Part 3 (Day 1)|Other|0|||
125413697|NCT03701555|451140808|FG028|Part 3 (Day 1)|Other|0|||
125285041|NCT01327053|450670025|FG000|Overall Study|Progressive disease|31|||
125285042|NCT01327053|450670026|FG001|Overall Study|Progressive disease|26|||
125285043|NCT01327053|450670025|FG000|Overall Study|Protocol Violation|0|||
125413698|NCT03701555|451140809|FG029|Part 3 (Day 1)|Other|1|||
125413699|NCT03701555|451140810|FG030|Part 3 (Day 1)|Other|1|||
125413700|NCT03701555|451140811|FG031|Part 3 (Day 1)|Other|0|||
125413701|NCT03701555|451140812|FG032|Part 3 (Day 1)|Other|1|||
125413702|NCT03701555|451140813|FG033|Part 3 (Day 1)|Other|1|||
125413703|NCT03701555|451140814|FG034|Part 3 (Day 1)|Other|0|||
125413704|NCT03701555|451140815|FG035|Part 3 (Day 1)|Other|0|||
125413705|NCT04757649|451140816|FG000|Overall Study|Withdrawal by Subject|1|||
125413706|NCT04757649|451140816|FG000|Overall Study|Adverse Event|1|||
125413707|NCT01286779|451140817|FG000|Overall Study|Withdrawal by Subject|9|||
125413708|NCT01286779|451140817|FG000|Overall Study|Protocol Violation|5|||
125413709|NCT01286779|451140817|FG000|Overall Study|Physician Decision|2|||
125413710|NCT01286779|451140817|FG000|Overall Study|Participant had scheduled surgery|1|||
125413711|NCT01286779|451140817|FG000|Overall Study|Participant moved to another country|1|||
125413712|NCT01286779|451140817|FG000|Overall Study|Discontinued by sponsor|1|||
125413713|NCT02896855|451140818|FG000|Overall Study|Death|50|||
125413714|NCT02896855|451140819|FG001|Overall Study|Death|40|||
125413715|NCT02896855|451140818|FG000|Overall Study|Lost to Follow-up|15|||
125413716|NCT02896855|451140819|FG001|Overall Study|Lost to Follow-up|9|||
125413717|NCT02896855|451140818|FG000|Overall Study|Withdrawal by Subject|7|||
125413718|NCT02896855|451140819|FG001|Overall Study|Withdrawal by Subject|4|||
125413719|NCT02370602|451140820|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
125413720|NCT02370602|451140821|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
125413721|NCT02370602|451140822|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
125413722|NCT02370602|451140823|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
125413723|NCT02370602|451140824|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
125413724|NCT02370602|451140825|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
125413725|NCT01296568|451140826|FG000|Continued Access Phase|Lost to Follow-up|1|||
125413726|NCT01296568|451140826|FG000|Continued Access Phase|Withdrawal by Subject|1|||
125413727|NCT01296568|451140826|FG000|Continued Access Phase|Disease Progression|1|||
125413728|NCT00237744|451140827|FG000|Overall Study|Withdrawal by Subject|3|||
125413729|NCT00237744|451140828|FG001|Overall Study|Withdrawal by Subject|1|||
125413730|NCT00237744|451140829|FG002|Overall Study|Withdrawal by Subject|0|||
125413731|NCT00574080|451140830|FG000|Overall Study|Death|10|||
125413732|NCT00574080|451140831|FG001|Overall Study|Death|10|||
125413733|NCT00407537|451140832|FG000|Overall Study|Death|5|||
125413734|NCT00407537|451140833|FG001|Overall Study|Death|2|||
125413735|NCT00407537|451140832|FG000|Overall Study|Adverse Event|36|||
125413736|NCT00407537|451140833|FG001|Overall Study|Adverse Event|0|||
125413737|NCT00407537|451140832|FG000|Overall Study|Lost to Follow-up|12|||
125413738|NCT00407537|451140833|FG001|Overall Study|Lost to Follow-up|19|||
125413739|NCT00407537|451140832|FG000|Overall Study|Other|6|||
125413740|NCT00407537|451140833|FG001|Overall Study|Other|7|||
125413741|NCT00407537|451140832|FG000|Overall Study|Withdrawal by Subject|34|||
125413742|NCT00407537|451140833|FG001|Overall Study|Withdrawal by Subject|16|||
125413743|NCT01519206|451140834|FG000|Overall Study|Lost to Follow-up|3|||
125413744|NCT01519206|451140834|FG000|Overall Study|Missed Visit|2|||
125413745|NCT04139317|451140835|FG000|Overall Study|Adverse Event|10|||
125413746|NCT04139317|451140836|FG001|Overall Study|Adverse Event|2|||
125413747|NCT04139317|451140835|FG000|Overall Study|Death|6|||
125413748|NCT04139317|451140836|FG001|Overall Study|Death|4|||
125413749|NCT04139317|451140835|FG000|Overall Study|Lost to Follow-up|1|||
125413750|NCT04139317|451140836|FG001|Overall Study|Lost to Follow-up|0|||
125413751|NCT04139317|451140835|FG000|Overall Study|Physician Decision|3|||
125413752|NCT04139317|451140836|FG001|Overall Study|Physician Decision|1|||
125413753|NCT04139317|451140835|FG000|Overall Study|Progressive Disease|19|||
125413754|NCT04139317|451140836|FG001|Overall Study|Progressive Disease|9|||
125413755|NCT04139317|451140835|FG000|Overall Study|Subject Decision|2|||
125413756|NCT04139317|451140836|FG001|Overall Study|Subject Decision|2|||
125285044|NCT01327053|450670026|FG001|Overall Study|Protocol Violation|1|||
125285045|NCT01327053|450670025|FG000|Overall Study|Untreated|0|||
125413757|NCT01272934|451140839|FG000|Overall Study|Adverse Event|0|||
125413758|NCT01272934|451140840|FG001|Overall Study|Adverse Event|1|||
125413759|NCT01272934|451140839|FG000|Overall Study|Abnormal Laboratory Value|0|||
125413760|NCT01272934|451140840|FG001|Overall Study|Abnormal Laboratory Value|1|||
125285046|NCT01327053|450670026|FG001|Overall Study|Untreated|1|||
125413761|NCT00214136|451140841|FG000|Overall Study|Death|5|||
125413762|NCT04287920|451140842|FG000|Overall Study|Lost to Follow-up|1|||
125413763|NCT04287920|451140843|FG001|Overall Study|Lost to Follow-up|1|||
125413764|NCT04287920|451140842|FG000|Overall Study|Withdrawal by Subject|0|||
125413765|NCT04287920|451140843|FG001|Overall Study|Withdrawal by Subject|3|||
125413766|NCT04313634|451140844|FG000|Overall Study|Adverse Event|2|||
125413767|NCT04313634|451140845|FG001|Overall Study|Adverse Event|2|||
125413768|NCT04313634|451140846|FG002|Overall Study|Adverse Event|0|||
125285047|NCT00957944|450670027|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
125413769|NCT04313634|451140844|FG000|Overall Study|Withdrawal by Subject|1|||
125413770|NCT04313634|451140845|FG001|Overall Study|Withdrawal by Subject|0|||
125413771|NCT04313634|451140846|FG002|Overall Study|Withdrawal by Subject|1|||
125285048|NCT00957944|450670028|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
125285049|NCT00522418|450670029|FG000|Overall Study|Local IRB Consent Violation|5|||
125285050|NCT00522418|450670030|FG001|Overall Study|Local IRB Consent Violation|5|||
125285051|NCT00522418|450670029|FG000|Overall Study|Early Study Termination|46|||
125285052|NCT00522418|450670030|FG001|Overall Study|Early Study Termination|47|||
125285053|NCT00522418|450670029|FG000|Overall Study|Noncompliance|2|||
125285054|NCT00522418|450670030|FG001|Overall Study|Noncompliance|2|||
125285055|NCT00522418|450670029|FG000|Overall Study|Reason Not Specified|3|||
125285056|NCT00522418|450670030|FG001|Overall Study|Reason Not Specified|1|||
125285057|NCT00522418|450670029|FG000|Overall Study|Consent Withdraw|1|||
125285058|NCT00522418|450670030|FG001|Overall Study|Consent Withdraw|2|||
125285059|NCT00522418|450670029|FG000|Overall Study|Lack of Efficacy|0|||
125285060|NCT00522418|450670030|FG001|Overall Study|Lack of Efficacy|1|||
125285061|NCT01482169|450670031|FG000|Overall Study|Physician Decision|2|||
125285062|NCT01944098|450670032|FG000|Overall Study|Physician Decision|1|||
125285063|NCT01944098|450670033|FG001|Overall Study|Physician Decision|0|||
125285064|NCT00951080|450670034|FG000|Overall Study|Adverse Event|3|||
125285065|NCT00951080|450670035|FG001|Overall Study|Adverse Event|3|||
125285066|NCT00951080|450670034|FG000|Overall Study|Lost to Follow-up|0|||
125285067|NCT00951080|450670035|FG001|Overall Study|Lost to Follow-up|1|||
125285068|NCT00951080|450670034|FG000|Overall Study|Physician Decision|4|||
125285069|NCT00951080|450670035|FG001|Overall Study|Physician Decision|1|||
125285070|NCT00951080|450670034|FG000|Overall Study|Other|19|||
125285071|NCT00951080|450670035|FG001|Overall Study|Other|22|||
125285072|NCT01939002|450670039|FG000|Overall Study|Adverse Event|13|||
125285073|NCT01939002|450670040|FG001|Overall Study|Adverse Event|13|||
125285074|NCT01939002|450670039|FG000|Overall Study|Withdrawal by Subject|5|||
125285075|NCT01939002|450670040|FG001|Overall Study|Withdrawal by Subject|3|||
125285076|NCT01939002|450670039|FG000|Overall Study|Other|1|||
125285077|NCT01939002|450670040|FG001|Overall Study|Other|2|||
125285078|NCT03300024|450670043|FG000|Overall Study|Physician Decision|4|||
125285079|NCT03300024|450670044|FG001|Overall Study|Physician Decision|6|||
125285080|NCT00570037|450670047|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
125285081|NCT00570037|450670048|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
125285082|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
125285083|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
125285084|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Death|0|||
125285085|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Death|0|||
125285086|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
125285087|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
125285088|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
125285089|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
125285090|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
125285091|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
125285092|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
125285093|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
125285094|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
125285095|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
125285096|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
125285097|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
125285098|NCT00433160|450670049|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
125285099|NCT00433160|450670050|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
125285100|NCT00433160|450670049|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
125285101|NCT00433160|450670050|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
125285102|NCT00433160|450670049|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
125285103|NCT00433160|450670050|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
125285104|NCT00433160|450670049|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
125285105|NCT00433160|450670050|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
125285106|NCT00433160|450670049|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
125285107|NCT00433160|450670050|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
125285108|NCT00433160|450670049|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
125285109|NCT00433160|450670050|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
125285110|NCT00433160|450670049|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
125285111|NCT00433160|450670050|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
125285112|NCT00433160|450670049|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
125285113|NCT00433160|450670050|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
125413772|NCT04313634|451140844|FG000|Overall Study|Protocol Violation|0|||
125285114|NCT03372460|450670052|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
125285115|NCT03372460|450670053|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
125285116|NCT02499900|450670054|FG000|Core Study Period|Other|1|||
125285117|NCT02499900|450670055|FG001|Core Study Period|Other|4|||
125413773|NCT04313634|451140845|FG001|Overall Study|Protocol Violation|0|||
125413774|NCT04313634|451140846|FG002|Overall Study|Protocol Violation|1|||
125413775|NCT03585244|451140853|FG000|Overall Study|Withdrawal by Subject|15|||
125413776|NCT01764945|451140856|FG000|Overall Study|Adverse Event|0|||
125413777|NCT01764945|451140857|FG001|Overall Study|Adverse Event|1|||
125413778|NCT01764945|451140858|FG002|Overall Study|Adverse Event|0|||
125413779|NCT01764945|451140859|FG003|Overall Study|Adverse Event|0|||
125413780|NCT01764945|451140860|FG004|Overall Study|Adverse Event|0|||
125413781|NCT01764945|451140861|FG005|Overall Study|Adverse Event|0|||
125413782|NCT01764945|451140862|FG006|Overall Study|Adverse Event|1|||
125413783|NCT01764945|451140863|FG007|Overall Study|Adverse Event|0|||
125413784|NCT05077267|451140864|FG000|Treatment Period|Lost to Follow-up|0|||
125413785|NCT05077267|451140865|FG001|Treatment Period|Lost to Follow-up|1|||
125413786|NCT05077267|451140866|FG002|Treatment Period|Lost to Follow-up|0|||
125413787|NCT05077267|451140864|FG000|Treatment Period|Withdrawal by Subject|0|||
125413788|NCT05077267|451140865|FG001|Treatment Period|Withdrawal by Subject|1|||
125413789|NCT05077267|451140866|FG002|Treatment Period|Withdrawal by Subject|0|||
125413790|NCT05077267|451140864|FG000|Follow-up Period|Lost to Follow-up|0|||
125413791|NCT05077267|451140865|FG001|Follow-up Period|Lost to Follow-up|5|||
125413792|NCT05077267|451140866|FG002|Follow-up Period|Lost to Follow-up|7|||
125413793|NCT05077267|451140864|FG000|Follow-up Period|Withdrawal by Subject|0|||
125413794|NCT05077267|451140865|FG001|Follow-up Period|Withdrawal by Subject|2|||
125413795|NCT05077267|451140866|FG002|Follow-up Period|Withdrawal by Subject|5|||
125413796|NCT05077267|451140864|FG000|Follow-up Period|Study terminated by sponsor|0|||
125413797|NCT05077267|451140865|FG001|Follow-up Period|Study terminated by sponsor|27|||
125413798|NCT05077267|451140866|FG002|Follow-up Period|Study terminated by sponsor|23|||
125413799|NCT05077267|451140864|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
125413800|NCT05077267|451140865|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
125413801|NCT05077267|451140866|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
125413802|NCT05077267|451140864|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
125413803|NCT05077267|451140865|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
125413804|NCT05077267|451140866|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
125413805|NCT02911948|451140867|FG000|Overall Study|Protocol Violation|0|||
125413806|NCT02911948|451140868|FG001|Overall Study|Protocol Violation|1|||
125413807|NCT02911948|451140867|FG000|Overall Study|Withdrawal by Subject|0|||
125413808|NCT02911948|451140868|FG001|Overall Study|Withdrawal by Subject|2|||
125413809|NCT02911948|451140867|FG000|Overall Study|Lack of Efficacy|0|||
125413810|NCT02911948|451140868|FG001|Overall Study|Lack of Efficacy|1|||
125413811|NCT02911948|451140867|FG000|Overall Study|Unclassified|0|||
125413812|NCT02911948|451140868|FG001|Overall Study|Unclassified|3|||
125413813|NCT00586105|451140869|FG000|Overall Study|Adverse Event|4|||
125413814|NCT00586105|451140869|FG000|Overall Study|Death|2|||
125413815|NCT00586105|451140869|FG000|Overall Study|Protocol Violation|1|||
125413816|NCT00586105|451140869|FG000|Overall Study|Withdrawal by Subject|3|||
125413817|NCT00586105|451140869|FG000|Overall Study|Disease progression|19|||
125413818|NCT00586105|451140869|FG000|Overall Study|Switched to commercial drug|9|||
125413819|NCT00586105|451140869|FG000|Overall Study|Reason not reported|1|||
125413820|NCT03835533|451140871|FG000|Overall Study|Death|5|||
125413821|NCT03835533|451140872|FG001|Overall Study|Death|10|||
125413822|NCT03835533|451140873|FG002|Overall Study|Death|9|||
125413823|NCT03835533|451140871|FG000|Overall Study|Withdrawal by Subject|2|||
125413824|NCT03835533|451140872|FG001|Overall Study|Withdrawal by Subject|2|||
125413825|NCT03835533|451140873|FG002|Overall Study|Withdrawal by Subject|2|||
125413826|NCT03835533|451140871|FG000|Overall Study|Lost to Follow-up|1|||
125413827|NCT03835533|451140872|FG001|Overall Study|Lost to Follow-up|0|||
125448820|NCT00495469|451270896|FG002|Overall Study|Withdrawal by Subject|1|||
125413828|NCT03835533|451140873|FG002|Overall Study|Lost to Follow-up|0|||
125413829|NCT03867734|451140874|FG000|Overall Study|Lost to Follow-up|2|||
125413830|NCT01136291|451140875|FG000|Overall Study|Lost to Follow-up|1|||
125413831|NCT01136291|451140876|FG001|Overall Study|Lost to Follow-up|1|||
125413832|NCT02308033|451140879|FG000|Overall Study|Normal Gram stain at Baseline|13|||
125413833|NCT02308033|451140880|FG001|Overall Study|Normal Gram stain at Baseline|10|||
125413834|NCT02308033|451140879|FG000|Overall Study|Positive for STD at Baseline|7|||
125413835|NCT02308033|451140880|FG001|Overall Study|Positive for STD at Baseline|4|||
125413836|NCT02308033|451140879|FG000|Overall Study|Lost to Follow-up|6|||
125413837|NCT02308033|451140880|FG001|Overall Study|Lost to Follow-up|5|||
125413838|NCT01870843|451140886|FG000|Overall Study|Adverse Event|10|||
125413839|NCT01870843|451140886|FG000|Overall Study|Lost to Follow-up|24|||
125413840|NCT01870843|451140886|FG000|Overall Study|Death|1|||
125413841|NCT01870843|451140886|FG000|Overall Study|Withdrawal by Subject|18|||
125413842|NCT03021187|451140887|FG000|Overall Study|Death|0|||
125413843|NCT03021187|451140888|FG001|Overall Study|Death|0|||
125413844|NCT03021187|451140889|FG002|Overall Study|Death|3|||
125413845|NCT03021187|451140890|FG003|Overall Study|Death|0|||
125413846|NCT03021187|451140887|FG000|Overall Study|Withdrawal by Subject|0|||
125413847|NCT03021187|451140888|FG001|Overall Study|Withdrawal by Subject|6|||
125448821|NCT00495469|451270897|FG003|Overall Study|Withdrawal by Subject|3|||
125448822|NCT00495469|451270898|FG004|Overall Study|Withdrawal by Subject|3|||
125413848|NCT03021187|451140889|FG002|Overall Study|Withdrawal by Subject|2|||
125413849|NCT03021187|451140890|FG003|Overall Study|Withdrawal by Subject|5|||
125413850|NCT03021187|451140887|FG000|Overall Study|Lost to Follow-up|10|||
125413851|NCT03021187|451140888|FG001|Overall Study|Lost to Follow-up|3|||
125413852|NCT03021187|451140889|FG002|Overall Study|Lost to Follow-up|1|||
125413853|NCT03021187|451140890|FG003|Overall Study|Lost to Follow-up|4|||
125413854|NCT01664078|451140891|FG000|Overall Study|Death|9|||
125413855|NCT01664078|451140891|FG000|Overall Study|Withdrawal by Subject|4|||
125413856|NCT01664078|451140891|FG000|Overall Study|Lost to Follow-up|2|||
125413857|NCT01664078|451140891|FG000|Overall Study|missed 5 year visit|1|||
125413858|NCT01664078|451140891|FG000|Overall Study|Other|53|||
125413859|NCT00363766|451140901|FG000|Overall Study|Progressive Disease|15|||
125413860|NCT00363766|451140902|FG001|Overall Study|Progressive Disease|9|||
125413861|NCT00363766|451140901|FG000|Overall Study|Adverse Event|10|||
125413862|NCT00363766|451140902|FG001|Overall Study|Adverse Event|2|||
125413863|NCT00363766|451140901|FG000|Overall Study|Disease Related Death|1|||
125413864|NCT00363766|451140902|FG001|Overall Study|Disease Related Death|3|||
125413865|NCT00363766|451140901|FG000|Overall Study|Not Disease Related Death|3|||
125413866|NCT00363766|451140902|FG001|Overall Study|Not Disease Related Death|4|||
125413867|NCT00363766|451140901|FG000|Overall Study|Withdrawal by Subject|2|||
125413868|NCT00363766|451140902|FG001|Overall Study|Withdrawal by Subject|0|||
125413869|NCT00363766|451140901|FG000|Overall Study|Physician Decision|1|||
125413870|NCT00363766|451140902|FG001|Overall Study|Physician Decision|2|||
125413871|NCT00558285|451140903|FG000|Overall Study|Adverse Event|1|||
125413872|NCT00558285|451140904|FG001|Overall Study|Adverse Event|1|||
125413873|NCT00558285|451140905|FG002|Overall Study|Adverse Event|4|||
125413874|NCT00558285|451140906|FG003|Overall Study|Adverse Event|1|||
125413875|NCT00558285|451140907|FG004|Overall Study|Adverse Event|2|||
125413876|NCT00558285|451140903|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125413877|NCT00558285|451140904|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125413878|NCT00558285|451140905|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125413879|NCT00558285|451140906|FG003|Overall Study|Abnormal test procedure result(s)|0|||
125413880|NCT00558285|451140907|FG004|Overall Study|Abnormal test procedure result(s)|0|||
125413881|NCT00558285|451140903|FG000|Overall Study|Subject withdrew consent|2|||
125413882|NCT00558285|451140904|FG001|Overall Study|Subject withdrew consent|0|||
125413883|NCT00558285|451140905|FG002|Overall Study|Subject withdrew consent|1|||
125413884|NCT00558285|451140906|FG003|Overall Study|Subject withdrew consent|1|||
125413885|NCT00558285|451140907|FG004|Overall Study|Subject withdrew consent|1|||
125413886|NCT00558285|451140903|FG000|Overall Study|Lost to Follow-up|1|||
125413887|NCT00558285|451140904|FG001|Overall Study|Lost to Follow-up|1|||
125413888|NCT00558285|451140905|FG002|Overall Study|Lost to Follow-up|0|||
125413889|NCT00558285|451140906|FG003|Overall Study|Lost to Follow-up|0|||
125413890|NCT00558285|451140907|FG004|Overall Study|Lost to Follow-up|0|||
125413891|NCT00558285|451140903|FG000|Overall Study|Administrative problems|0|||
125413892|NCT00558285|451140904|FG001|Overall Study|Administrative problems|0|||
125413893|NCT00558285|451140905|FG002|Overall Study|Administrative problems|0|||
125413894|NCT00558285|451140906|FG003|Overall Study|Administrative problems|1|||
125413895|NCT00558285|451140907|FG004|Overall Study|Administrative problems|1|||
125413896|NCT00558285|451140903|FG000|Overall Study|Protocol deviation|1|||
125413897|NCT00558285|451140904|FG001|Overall Study|Protocol deviation|1|||
125413898|NCT00558285|451140905|FG002|Overall Study|Protocol deviation|0|||
125413899|NCT00558285|451140906|FG003|Overall Study|Protocol deviation|1|||
125413900|NCT00558285|451140907|FG004|Overall Study|Protocol deviation|0|||
125413901|NCT02730819|451140908|FG000|Overall Study|Lost to Follow-up|9|||
125413902|NCT01660906|451140909|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
125413903|NCT02121847|451140911|FG000|Overall Study|Administrative Reasons|1|||
125413904|NCT02121847|451140911|FG000|Overall Study|Adverse Event|2|||
125413905|NCT00809757|451140917|FG000|Overall Study|Adverse Event|2|||
125413906|NCT00809757|451140918|FG001|Overall Study|Adverse Event|3|||
125413907|NCT00809757|451140919|FG002|Overall Study|Adverse Event|3|||
125413908|NCT00809757|451140917|FG000|Overall Study|Lost to Follow-up|0|||
125413909|NCT00809757|451140918|FG001|Overall Study|Lost to Follow-up|0|||
125413910|NCT00809757|451140919|FG002|Overall Study|Lost to Follow-up|1|||
125413911|NCT00809757|451140917|FG000|Overall Study|Protocol Violation|1|||
125413912|NCT00809757|451140918|FG001|Overall Study|Protocol Violation|1|||
125413913|NCT00809757|451140919|FG002|Overall Study|Protocol Violation|1|||
125413914|NCT00809757|451140917|FG000|Overall Study|Withdrawal by Subject|2|||
125413915|NCT00809757|451140918|FG001|Overall Study|Withdrawal by Subject|1|||
125413916|NCT00809757|451140919|FG002|Overall Study|Withdrawal by Subject|3|||
125413917|NCT00809757|451140917|FG000|Overall Study|Subject Uncooperative|1|||
125413918|NCT00809757|451140918|FG001|Overall Study|Subject Uncooperative|0|||
125413919|NCT00809757|451140919|FG002|Overall Study|Subject Uncooperative|2|||
125413920|NCT00809757|451140917|FG000|Overall Study|Noncompliance with Medication|0|||
125413921|NCT00809757|451140918|FG001|Overall Study|Noncompliance with Medication|0|||
125413922|NCT00809757|451140919|FG002|Overall Study|Noncompliance with Medication|1|||
125413923|NCT00253864|451140920|FG000|Overall Study|Lost to Follow-up|5|||
125413924|NCT00253864|451140921|FG001|Overall Study|Lost to Follow-up|8|||
125413925|NCT00659334|451140922|FG000|Overall Study|Screen Failure|8|||
125413926|NCT00659334|451140923|FG001|Overall Study|Screen Failure|5|||
125413927|NCT00659334|451140924|FG002|Overall Study|Screen Failure|0|||
125413928|NCT00659334|451140925|FG003|Overall Study|Screen Failure|0|||
125413929|NCT00659334|451140926|FG004|Overall Study|Screen Failure|0|||
125413930|NCT00659334|451140927|FG005|Overall Study|Screen Failure|0|||
125413931|NCT00659334|451140928|FG006|Overall Study|Screen Failure|1|||
125413932|NCT01174342|451140929|FG000|Overall Study|Conversion to cesarean section|4|||
125413933|NCT01410448|451140933|FG000|Overall Study|No conversion to everolimus|0|||
125413934|NCT01410448|451140934|FG001|Overall Study|No conversion to everolimus|24|||
125413935|NCT01410448|451140933|FG000|Overall Study|Graft loss|4|||
125413936|NCT01410448|451140934|FG001|Overall Study|Graft loss|1|||
125413937|NCT01410448|451140933|FG000|Overall Study|Administrative issues|2|||
125413938|NCT01410448|451140934|FG001|Overall Study|Administrative issues|1|||
125413939|NCT01410448|451140933|FG000|Overall Study|Lost to Follow-up|1|||
125413940|NCT01410448|451140934|FG001|Overall Study|Lost to Follow-up|0|||
125413941|NCT01410448|451140933|FG000|Overall Study|Withdrawal by Subject|3|||
125413942|NCT01410448|451140934|FG001|Overall Study|Withdrawal by Subject|2|||
125413943|NCT01410448|451140933|FG000|Overall Study|Protocol Violation|0|||
125413944|NCT01410448|451140934|FG001|Overall Study|Protocol Violation|4|||
125413945|NCT01410448|451140933|FG000|Overall Study|Death|2|||
125413946|NCT01410448|451140934|FG001|Overall Study|Death|3|||
125413947|NCT01308580|451140935|FG000|Overall Study|Lost to Follow-up|12|||
125413948|NCT01308580|451140936|FG001|Overall Study|Lost to Follow-up|7|||
125413949|NCT00360529|451140937|FG000|Overall Study|Adverse Event|10|||
125413950|NCT00360529|451140938|FG001|Overall Study|Adverse Event|23|||
125413951|NCT00360529|451140939|FG002|Overall Study|Adverse Event|33|||
125413952|NCT00360529|451140937|FG000|Overall Study|Protocol Violation|3|||
125413953|NCT00360529|451140938|FG001|Overall Study|Protocol Violation|3|||
125413954|NCT00360529|451140939|FG002|Overall Study|Protocol Violation|11|||
125413955|NCT00360529|451140937|FG000|Overall Study|Lost to Follow-up|14|||
125413956|NCT00360529|451140938|FG001|Overall Study|Lost to Follow-up|10|||
125413957|NCT00360529|451140939|FG002|Overall Study|Lost to Follow-up|13|||
125413958|NCT00360529|451140937|FG000|Overall Study|Withdrawal by Subject|22|||
125413959|NCT00360529|451140938|FG001|Overall Study|Withdrawal by Subject|14|||
125413960|NCT00360529|451140939|FG002|Overall Study|Withdrawal by Subject|18|||
125413961|NCT00360529|451140937|FG000|Overall Study|Lack of Efficacy|8|||
125413962|NCT00360529|451140938|FG001|Overall Study|Lack of Efficacy|6|||
125413963|NCT00360529|451140939|FG002|Overall Study|Lack of Efficacy|5|||
125413964|NCT00360529|451140937|FG000|Overall Study|Reason discontinued not explained above|4|||
125413965|NCT00360529|451140938|FG001|Overall Study|Reason discontinued not explained above|9|||
125413966|NCT00360529|451140939|FG002|Overall Study|Reason discontinued not explained above|11|||
125413967|NCT03712917|451140940|FG000|Overall Study|Pregnancy|0|||
125413968|NCT03712917|451140941|FG001|Overall Study|Pregnancy|0|||
125413969|NCT03712917|451140942|FG002|Overall Study|Pregnancy|1|||
125413970|NCT03712917|451140940|FG000|Overall Study|Adverse Event|0|||
125413971|NCT03712917|451140941|FG001|Overall Study|Adverse Event|4|||
125413972|NCT03712917|451140942|FG002|Overall Study|Adverse Event|3|||
125413973|NCT03712917|451140940|FG000|Overall Study|Lost to Follow-up|9|||
125413974|NCT03712917|451140941|FG001|Overall Study|Lost to Follow-up|4|||
125413975|NCT03712917|451140942|FG002|Overall Study|Lost to Follow-up|5|||
125413976|NCT05706506|451142879|FG000|Overall Study|Adverse Event|1|||
125413977|NCT05706506|451142879|FG000|Overall Study|Withdrawal by Subject|4|||
125413978|NCT05706506|451142879|FG000|Overall Study|Lost to Follow-up|2|||
125413979|NCT05706506|451142879|FG000|Overall Study|Inadvertent Enrolment|12|||
125413980|NCT05706506|451142879|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
125285118|NCT02499900|450670054|FG000|Core Study Period|Lost to Follow-up|1|||
125413981|NCT05706506|451142879|FG000|Overall Study|Participant Moved Out of State|1|||
125413982|NCT05732454|451142880|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
125413983|NCT05732454|451142881|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
125413984|NCT05732454|451142880|FG000|Part 1: DB Period|Adverse Event|1|||
125413985|NCT05732454|451142881|FG001|Part 1: DB Period|Adverse Event|0|||
125413986|NCT05732454|451142880|FG000|Part 1: DB Period|Lost to Follow-up|1|||
125413987|NCT05732454|451142881|FG001|Part 1: DB Period|Lost to Follow-up|0|||
125413988|NCT05732454|451142880|FG000|Part 1: DB Period|Protocol Violation|0|||
125413989|NCT05732454|451142881|FG001|Part 1: DB Period|Protocol Violation|1|||
125413990|NCT05732454|451142880|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
125413991|NCT05732454|451142881|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
125413992|NCT05732454|451142880|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
125413993|NCT05732454|451142881|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
125413994|NCT05732454|451142880|FG000|Part 1: OLE Period|Adverse Event|0|||
125413995|NCT05732454|451142881|FG001|Part 1: OLE Period|Adverse Event|1|||
125413996|NCT05732454|451142880|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
125413997|NCT05732454|451142881|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
125413998|NCT00838110|451142882|FG000|Overall Study|Death|0|||
125413999|NCT00838110|451142883|FG001|Overall Study|Death|0|||
125414000|NCT00838110|451142884|FG002|Overall Study|Death|1|||
125414001|NCT00838110|451142885|FG003|Overall Study|Death|2|||
125414002|NCT00838110|451142882|FG000|Overall Study|Adverse Event|11|||
125414003|NCT00838110|451142883|FG001|Overall Study|Adverse Event|10|||
125414004|NCT00838110|451142884|FG002|Overall Study|Adverse Event|8|||
125414005|NCT00838110|451142885|FG003|Overall Study|Adverse Event|7|||
125414006|NCT00838110|451142882|FG000|Overall Study|Withdrawal by Subject|5|||
125414007|NCT00838110|451142883|FG001|Overall Study|Withdrawal by Subject|6|||
125414008|NCT00838110|451142884|FG002|Overall Study|Withdrawal by Subject|3|||
125414009|NCT00838110|451142885|FG003|Overall Study|Withdrawal by Subject|4|||
125414010|NCT00838110|451142882|FG000|Overall Study|Other|3|||
125414011|NCT00838110|451142883|FG001|Overall Study|Other|3|||
125414012|NCT00838110|451142884|FG002|Overall Study|Other|3|||
125414013|NCT00838110|451142885|FG003|Overall Study|Other|2|||
125414014|NCT00838110|451142882|FG000|Overall Study|Protocol Violation|0|||
125414015|NCT00838110|451142883|FG001|Overall Study|Protocol Violation|2|||
125414016|NCT00838110|451142884|FG002|Overall Study|Protocol Violation|1|||
125414017|NCT00838110|451142885|FG003|Overall Study|Protocol Violation|1|||
125414018|NCT00838110|451142882|FG000|Overall Study|Lost to Follow-up|3|||
125414019|NCT00838110|451142883|FG001|Overall Study|Lost to Follow-up|0|||
125414020|NCT00838110|451142884|FG002|Overall Study|Lost to Follow-up|0|||
125414021|NCT00838110|451142885|FG003|Overall Study|Lost to Follow-up|0|||
125414022|NCT00838110|451142882|FG000|Overall Study|Did not meet eligibility criteria|0|||
125414023|NCT00838110|451142883|FG001|Overall Study|Did not meet eligibility criteria|0|||
125414024|NCT00838110|451142884|FG002|Overall Study|Did not meet eligibility criteria|1|||
125414025|NCT00838110|451142885|FG003|Overall Study|Did not meet eligibility criteria|2|||
125414026|NCT00838110|451142882|FG000|Overall Study|Randomized but not treated|0|||
125414027|NCT00838110|451142883|FG001|Overall Study|Randomized but not treated|1|||
125414028|NCT00838110|451142884|FG002|Overall Study|Randomized but not treated|0|||
125414029|NCT00838110|451142885|FG003|Overall Study|Randomized but not treated|0|||
125414030|NCT03240588|451142888|FG000|Overall Study|Death|3|||
125414031|NCT03240588|451142889|FG001|Overall Study|Death|0|||
125414032|NCT03240588|451142890|FG002|Overall Study|Death|0|||
125414033|NCT03240588|451142888|FG000|Overall Study|Adverse Event|5|||
125414034|NCT03240588|451142889|FG001|Overall Study|Adverse Event|4|||
125414035|NCT03240588|451142890|FG002|Overall Study|Adverse Event|0|||
125414036|NCT03240588|451142888|FG000|Overall Study|Lost to Follow-up|9|||
125414037|NCT03240588|451142889|FG001|Overall Study|Lost to Follow-up|4|||
125414038|NCT03240588|451142890|FG002|Overall Study|Lost to Follow-up|0|||
125414039|NCT03240588|451142888|FG000|Overall Study|Physician Decision|3|||
125414040|NCT03240588|451142889|FG001|Overall Study|Physician Decision|2|||
125414041|NCT03240588|451142890|FG002|Overall Study|Physician Decision|0|||
125414042|NCT03240588|451142888|FG000|Overall Study|Did not meet eligibility criteria|0|||
125414043|NCT03240588|451142889|FG001|Overall Study|Did not meet eligibility criteria|6|||
125414044|NCT03240588|451142890|FG002|Overall Study|Did not meet eligibility criteria|0|||
125414045|NCT03240588|451142888|FG000|Overall Study|No longer meets protocol criteria|12|||
125414046|NCT03240588|451142889|FG001|Overall Study|No longer meets protocol criteria|7|||
125414047|NCT03240588|451142890|FG002|Overall Study|No longer meets protocol criteria|0|||
125414048|NCT03240588|451142888|FG000|Overall Study|Withdrawal by Subject|60|||
125414049|NCT03240588|451142889|FG001|Overall Study|Withdrawal by Subject|52|||
125414050|NCT03240588|451142890|FG002|Overall Study|Withdrawal by Subject|7|||
125414051|NCT03240588|451142888|FG000|Overall Study|Other, additional details not available.|0|||
125414052|NCT03240588|451142889|FG001|Overall Study|Other, additional details not available.|12|||
125414053|NCT03240588|451142890|FG002|Overall Study|Other, additional details not available.|1|||
125414054|NCT03240588|451142888|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
125414055|NCT03240588|451142889|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
125414056|NCT03240588|451142890|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
125414057|NCT03240588|451142888|FG000|Overall Study|Closure of study|55|||
125414058|NCT03240588|451142889|FG001|Overall Study|Closure of study|3|||
125414059|NCT03240588|451142890|FG002|Overall Study|Closure of study|0|||
125414060|NCT03240588|451142888|FG000|Overall Study|Subject non-compliance|23|||
125414061|NCT03240588|451142889|FG001|Overall Study|Subject non-compliance|2|||
125414062|NCT03240588|451142890|FG002|Overall Study|Subject non-compliance|1|||
125448823|NCT00495469|451270899|FG005|Overall Study|Withdrawal by Subject|2|||
125448824|NCT00495469|451270900|FG006|Overall Study|Withdrawal by Subject|3|||
125414063|NCT03240588|451142888|FG000|Overall Study|Device Deficiency|1|||
125414064|NCT03240588|451142889|FG001|Overall Study|Device Deficiency|0|||
125414065|NCT03240588|451142890|FG002|Overall Study|Device Deficiency|0|||
125414066|NCT03240588|451142888|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
125414067|NCT03240588|451142889|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
125414068|NCT03240588|451142890|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
125414069|NCT00377819|451142893|FG000|Overall Study|Adverse Event|2|||
125414070|NCT00377819|451142894|FG001|Overall Study|Adverse Event|3|||
125414071|NCT00377819|451142893|FG000|Overall Study|Withdrawal by Subject|10|||
125414072|NCT00377819|451142894|FG001|Overall Study|Withdrawal by Subject|4|||
125414073|NCT00377819|451142893|FG000|Overall Study|Death|0|||
125414074|NCT00377819|451142894|FG001|Overall Study|Death|1|||
125285119|NCT02499900|450670055|FG001|Core Study Period|Lost to Follow-up|2|||
125285120|NCT02499900|450670054|FG000|Core Study Period|Per sponsor request|0|||
125285121|NCT02499900|450670055|FG001|Core Study Period|Per sponsor request|1|||
125285122|NCT02499900|450670054|FG000|Core Study Period|Pregnancy|1|||
125285123|NCT02499900|450670055|FG001|Core Study Period|Pregnancy|0|||
125285124|NCT02499900|450670054|FG000|Core Study Period|Protocol Violation|3|||
125285125|NCT02499900|450670055|FG001|Core Study Period|Protocol Violation|0|||
125285126|NCT02499900|450670054|FG000|Core Study Period|Withdrawal by Subject|11|||
125285127|NCT02499900|450670055|FG001|Core Study Period|Withdrawal by Subject|10|||
125285128|NCT02499900|450670054|FG000|Core Study Period|Adverse Event|18|||
125285129|NCT02499900|450670055|FG001|Core Study Period|Adverse Event|14|||
125285130|NCT02499900|450670054|FG000|Core Study Period|Death|0|||
125285131|NCT02499900|450670055|FG001|Core Study Period|Death|1|||
125285132|NCT02499900|450670054|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
125285133|NCT02499900|450670055|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
125285134|NCT02499900|450670054|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
125285135|NCT02499900|450670055|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
125285136|NCT02499900|450670054|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
125285137|NCT02499900|450670055|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
125285138|NCT02499900|450670054|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
125285139|NCT02499900|450670055|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
125285140|NCT02499900|450670054|FG000|Extension Study Period|Adverse Event|2|||
125285141|NCT02499900|450670055|FG001|Extension Study Period|Adverse Event|4|||
125285142|NCT02499900|450670054|FG000|Extension Study Period|Withdrawal by Subject|5|||
125285143|NCT02499900|450670055|FG001|Extension Study Period|Withdrawal by Subject|2|||
125285144|NCT02499900|450670054|FG000|Extension Study Period|Physician Decision|2|||
125285145|NCT02499900|450670055|FG001|Extension Study Period|Physician Decision|5|||
125285146|NCT02499900|450670054|FG000|Extension Study Period|Pregnancy|1|||
125285147|NCT02499900|450670055|FG001|Extension Study Period|Pregnancy|2|||
125285148|NCT02499900|450670054|FG000|Extension Study Period|Lost to Follow-up|2|||
125285149|NCT02499900|450670055|FG001|Extension Study Period|Lost to Follow-up|5|||
125285150|NCT02499900|450670054|FG000|Extension Study Period|Other|0|||
125285151|NCT02499900|450670055|FG001|Extension Study Period|Other|2|||
125285152|NCT01170065|450670058|FG000|Overall Study|Adverse Event|17|||
125285153|NCT01170065|450670059|FG001|Overall Study|Adverse Event|50|||
125285154|NCT01170065|450670060|FG002|Overall Study|Adverse Event|10|||
125285155|NCT01170065|450670058|FG000|Overall Study|Lost to Follow-up|1|||
125285156|NCT01170065|450670059|FG001|Overall Study|Lost to Follow-up|4|||
125285157|NCT01170065|450670060|FG002|Overall Study|Lost to Follow-up|1|||
125285158|NCT01170065|450670058|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
125285159|NCT01170065|450670059|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
125285160|NCT01170065|450670060|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
125285161|NCT01170065|450670058|FG000|Overall Study|Reason other than specified|3|||
125285162|NCT01170065|450670059|FG001|Overall Study|Reason other than specified|8|||
125285163|NCT01170065|450670060|FG002|Overall Study|Reason other than specified|3|||
125285164|NCT01170065|450670058|FG000|Overall Study|Ongoing after planned observation time|5|||
125285165|NCT01170065|450670059|FG001|Overall Study|Ongoing after planned observation time|26|||
125285166|NCT01170065|450670060|FG002|Overall Study|Ongoing after planned observation time|10|||
125285167|NCT04258995|450672589|FG000|Overall Study|Lost to Follow-up|1|||
125285168|NCT04258995|450672590|FG001|Overall Study|Lost to Follow-up|1|||
125285169|NCT00642174|450672600|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
125285170|NCT00642174|450672601|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
125285171|NCT00896363|450672602|FG000|Overall Study|Adverse Event|3|||
125285172|NCT00896363|450672603|FG001|Overall Study|Adverse Event|4|||
125285173|NCT00896363|450672604|FG002|Overall Study|Adverse Event|2|||
125285174|NCT00896363|450672602|FG000|Overall Study|Lack of Efficacy|0|||
125285175|NCT00896363|450672603|FG001|Overall Study|Lack of Efficacy|2|||
125285176|NCT00896363|450672604|FG002|Overall Study|Lack of Efficacy|1|||
125285177|NCT00896363|450672602|FG000|Overall Study|Withdrawal by Subject|3|||
125285178|NCT00896363|450672603|FG001|Overall Study|Withdrawal by Subject|5|||
125285179|NCT00896363|450672604|FG002|Overall Study|Withdrawal by Subject|5|||
125285180|NCT02982018|450672605|FG000|Overall Study|Incorrect Lens Dispensed|1|||
125285181|NCT02982018|450672606|FG001|Overall Study|Incorrect Lens Dispensed|0|||
125285182|NCT02982018|450672605|FG000|Overall Study|Protocol Violation|1|||
125285183|NCT02982018|450672606|FG001|Overall Study|Protocol Violation|1|||
125285184|NCT02982018|450672605|FG000|Overall Study|Adverse Event|1|||
125285185|NCT02982018|450672606|FG001|Overall Study|Adverse Event|1|||
125285186|NCT02982018|450672605|FG000|Overall Study|Lens Discomfort|2|||
125285187|NCT02982018|450672606|FG001|Overall Study|Lens Discomfort|0|||
125285188|NCT02982018|450672605|FG000|Overall Study|Withdrawal by Subject|0|||
125285189|NCT02982018|450672606|FG001|Overall Study|Withdrawal by Subject|1|||
125285190|NCT03334851|450672609|FG000|Overall Study|Other|0|||
125285191|NCT03334851|450672610|FG001|Overall Study|Other|0|||
125285192|NCT03334851|450672611|FG002|Overall Study|Other|0|||
125285193|NCT03334851|450672612|FG003|Overall Study|Other|0|||
125414075|NCT00377819|451142893|FG000|Overall Study|Lost to Follow-up|0|||
125414076|NCT00377819|451142894|FG001|Overall Study|Lost to Follow-up|1|||
125414077|NCT00377819|451142893|FG000|Overall Study|Protocol Violation|1|||
125414078|NCT00377819|451142894|FG001|Overall Study|Protocol Violation|1|||
125414079|NCT02091726|451142895|FG000|Overall Study|Lost to Follow-up|6|||
125414080|NCT03727750|451142896|FG000|Overall Study|Death|45|||
125414081|NCT03727750|451142896|FG000|Overall Study|Withdrawal by Subject|2|||
125414082|NCT03727750|451142896|FG000|Overall Study|Lost to Follow-up|1|||
125414083|NCT03727750|451142896|FG000|Overall Study|Other|1|||
125414084|NCT01914926|451142904|FG000|Overall Study|Adverse Event|1|||
125414085|NCT01914926|451142905|FG001|Overall Study|Adverse Event|0|||
125414086|NCT01914926|451142904|FG000|Overall Study|uncooperative, agitated and removed|0|||
125414087|NCT01914926|451142905|FG001|Overall Study|uncooperative, agitated and removed|1|||
125414088|NCT00467870|451142906|FG000|Overall Study|Adverse Event|13|||
125414089|NCT00467870|451142907|FG001|Overall Study|Adverse Event|9|||
125414090|NCT00467870|451142908|FG002|Overall Study|Adverse Event|1|||
125414091|NCT00467870|451142909|FG003|Overall Study|Adverse Event|15|||
125414092|NCT00467870|451142910|FG004|Overall Study|Adverse Event|15|||
125414093|NCT00467870|451142911|FG005|Overall Study|Adverse Event|1|||
125414094|NCT00467870|451142906|FG000|Overall Study|Protocol Violation|2|||
125414095|NCT00467870|451142907|FG001|Overall Study|Protocol Violation|1|||
125414096|NCT00467870|451142908|FG002|Overall Study|Protocol Violation|1|||
125414097|NCT00467870|451142909|FG003|Overall Study|Protocol Violation|2|||
125414098|NCT00467870|451142910|FG004|Overall Study|Protocol Violation|0|||
125414099|NCT00467870|451142911|FG005|Overall Study|Protocol Violation|0|||
125414100|NCT00467870|451142906|FG000|Overall Study|Withdrawal by Subject|14|||
125414101|NCT00467870|451142907|FG001|Overall Study|Withdrawal by Subject|21|||
125414102|NCT00467870|451142908|FG002|Overall Study|Withdrawal by Subject|0|||
125414103|NCT00467870|451142909|FG003|Overall Study|Withdrawal by Subject|9|||
125414104|NCT00467870|451142910|FG004|Overall Study|Withdrawal by Subject|10|||
125414105|NCT00467870|451142911|FG005|Overall Study|Withdrawal by Subject|1|||
125414106|NCT00467870|451142906|FG000|Overall Study|Lost to Follow-up|5|||
125414107|NCT00467870|451142907|FG001|Overall Study|Lost to Follow-up|3|||
125414108|NCT00467870|451142908|FG002|Overall Study|Lost to Follow-up|1|||
125414109|NCT00467870|451142909|FG003|Overall Study|Lost to Follow-up|1|||
125414110|NCT00467870|451142910|FG004|Overall Study|Lost to Follow-up|3|||
125414111|NCT00467870|451142911|FG005|Overall Study|Lost to Follow-up|0|||
125414112|NCT00467870|451142906|FG000|Overall Study|Subject Non-compliance|3|||
125414113|NCT00467870|451142907|FG001|Overall Study|Subject Non-compliance|4|||
125414114|NCT00467870|451142908|FG002|Overall Study|Subject Non-compliance|0|||
125414115|NCT00467870|451142909|FG003|Overall Study|Subject Non-compliance|1|||
125414116|NCT00467870|451142910|FG004|Overall Study|Subject Non-compliance|5|||
125414117|NCT00467870|451142911|FG005|Overall Study|Subject Non-compliance|0|||
125414118|NCT00467870|451142906|FG000|Overall Study|Other/Unknown|8|||
125414119|NCT00467870|451142907|FG001|Overall Study|Other/Unknown|5|||
125414120|NCT00467870|451142908|FG002|Overall Study|Other/Unknown|1|||
125414121|NCT00467870|451142909|FG003|Overall Study|Other/Unknown|5|||
125414122|NCT00467870|451142910|FG004|Overall Study|Other/Unknown|4|||
125414123|NCT00467870|451142911|FG005|Overall Study|Other/Unknown|0|||
125414124|NCT00321919|451142912|FG000|Overall Study|Adverse Event|17|||
125414125|NCT00321919|451142913|FG001|Overall Study|Adverse Event|10|||
125414126|NCT00321919|451142912|FG000|Overall Study|Death|21|||
125414127|NCT00321919|451142913|FG001|Overall Study|Death|17|||
125414128|NCT00321919|451142912|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125414129|NCT00321919|451142913|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125414130|NCT00321919|451142912|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
125414131|NCT00321919|451142913|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
125414132|NCT00321919|451142912|FG000|Overall Study|Refused Treatment|23|||
125414133|NCT00321919|451142913|FG001|Overall Study|Refused Treatment|14|||
125414134|NCT00321919|451142912|FG000|Overall Study|Other Protocol Violation|2|||
125414135|NCT00321919|451142913|FG001|Overall Study|Other Protocol Violation|3|||
125414136|NCT00321919|451142912|FG000|Overall Study|Failure to Return|3|||
125414137|NCT00321919|451142913|FG001|Overall Study|Failure to Return|1|||
125414138|NCT00321919|451142912|FG000|Overall Study|Other withdrawal reason|7|||
125414139|NCT00321919|451142913|FG001|Overall Study|Other withdrawal reason|6|||
125414140|NCT02261363|451142914|FG000|Overall Study|Lost to Follow-up|21|||
125414141|NCT01517802|451142915|FG000|Overall Study|Death|1|||
125414142|NCT02590354|451142916|FG000|Phase 1|Active hepatitis B or C infection|1|||
125414143|NCT02590354|451142916|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
125414144|NCT02590354|451142916|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
125414145|NCT02590354|451142916|FG000|Phase 1|Subject does not want to participate|20|||
125414146|NCT02590354|451142916|FG000|Phase 1|Lost to Follow-up|1|||
125414147|NCT02590354|451142916|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
125414148|NCT00760929|451142917|FG000|Overall Study|Adverse Event|2|||
125414149|NCT00760929|451142918|FG001|Overall Study|Adverse Event|0|||
125414150|NCT00760929|451142919|FG002|Overall Study|Adverse Event|6|||
125414151|NCT00760929|451142920|FG003|Overall Study|Adverse Event|10|||
125414152|NCT00760929|451142917|FG000|Overall Study|Lack of Efficacy|0|||
125414153|NCT00760929|451142918|FG001|Overall Study|Lack of Efficacy|2|||
125414154|NCT00760929|451142919|FG002|Overall Study|Lack of Efficacy|1|||
125414155|NCT00760929|451142920|FG003|Overall Study|Lack of Efficacy|0|||
125414156|NCT00760929|451142917|FG000|Overall Study|Withdrawal by Subject|1|||
125414157|NCT00760929|451142918|FG001|Overall Study|Withdrawal by Subject|0|||
125414158|NCT00760929|451142919|FG002|Overall Study|Withdrawal by Subject|9|||
125414159|NCT00760929|451142920|FG003|Overall Study|Withdrawal by Subject|1|||
125414160|NCT00760929|451142917|FG000|Overall Study|Lost to Follow-up|0|||
125414161|NCT00760929|451142918|FG001|Overall Study|Lost to Follow-up|0|||
125414162|NCT00760929|451142919|FG002|Overall Study|Lost to Follow-up|1|||
125414163|NCT00760929|451142920|FG003|Overall Study|Lost to Follow-up|0|||
125414164|NCT00760929|451142917|FG000|Overall Study|Progression of Disease|21|||
125414165|NCT00760929|451142918|FG001|Overall Study|Progression of Disease|26|||
125414166|NCT00760929|451142919|FG002|Overall Study|Progression of Disease|38|||
125414167|NCT00760929|451142920|FG003|Overall Study|Progression of Disease|42|||
125414168|NCT00760929|451142917|FG000|Overall Study|Other|2|||
125414169|NCT00760929|451142918|FG001|Overall Study|Other|0|||
125414170|NCT00760929|451142919|FG002|Overall Study|Other|2|||
125414171|NCT00760929|451142920|FG003|Overall Study|Other|1|||
125414172|NCT00760929|451142917|FG000|Overall Study|Death|0|||
125414173|NCT00760929|451142918|FG001|Overall Study|Death|0|||
125414174|NCT00760929|451142919|FG002|Overall Study|Death|1|||
125414175|NCT00760929|451142920|FG003|Overall Study|Death|0|||
125414176|NCT00760929|451142917|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
125414177|NCT00760929|451142918|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
125414178|NCT00760929|451142919|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
125414179|NCT00760929|451142920|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
125414180|NCT02099838|451142921|FG000|Overall Study|Death|1|||
125414181|NCT02099838|451142922|FG001|Overall Study|Death|0|||
125414182|NCT02099838|451142921|FG000|Overall Study|Lost to Follow-up|3|||
125414183|NCT02099838|451142922|FG001|Overall Study|Lost to Follow-up|1|||
125414184|NCT02099838|451142921|FG000|Overall Study|Withdrawal by Subject|0|||
125414185|NCT02099838|451142922|FG001|Overall Study|Withdrawal by Subject|1|||
125414186|NCT02301143|451142923|FG000|Induction Period|Enrolled But Not Treated|1|||
125414187|NCT02301143|451142924|FG001|Induction Period|Enrolled But Not Treated|0|||
125414188|NCT02301143|451142923|FG000|Induction Period|Death|1|||
125414189|NCT02301143|451142924|FG001|Induction Period|Death|0|||
125414190|NCT02301143|451142923|FG000|Induction Period|Adverse Event|22|||
125414191|NCT02301143|451142924|FG001|Induction Period|Adverse Event|0|||
125414192|NCT02301143|451142923|FG000|Induction Period|Progressive Disease|8|||
125414193|NCT02301143|451142924|FG001|Induction Period|Progressive Disease|0|||
125414194|NCT02301143|451142923|FG000|Induction Period|Withdrawal by Subject|3|||
125414195|NCT02301143|451142924|FG001|Induction Period|Withdrawal by Subject|0|||
125414196|NCT02301143|451142923|FG000|Induction Period|Noncompliance with Study Drug|1|||
125414197|NCT02301143|451142924|FG001|Induction Period|Noncompliance with Study Drug|0|||
125414198|NCT02301143|451142923|FG000|Induction Period|Physician Decision|4|||
125414199|NCT02301143|451142924|FG001|Induction Period|Physician Decision|0|||
125414200|NCT02301143|451142923|FG000|Induction Period|Symptomatic Deterioration|2|||
125414201|NCT02301143|451142924|FG001|Induction Period|Symptomatic Deterioration|0|||
125414202|NCT02301143|451142923|FG000|Induction Period|Protocol Violation|2|||
125414203|NCT02301143|451142924|FG001|Induction Period|Protocol Violation|0|||
125414204|NCT02301143|451142923|FG000|Induction Period|Other|1|||
125414205|NCT02301143|451142924|FG001|Induction Period|Other|0|||
125414206|NCT02301143|451142923|FG000|Investigator's Choice|Adverse Event|0|||
125414207|NCT02301143|451142924|FG001|Investigator's Choice|Adverse Event|3|||
125414208|NCT02301143|451142923|FG000|Investigator's Choice|Progressive Disease|0|||
125414209|NCT02301143|451142924|FG001|Investigator's Choice|Progressive Disease|3|||
125414210|NCT02301143|451142923|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
125414211|NCT02301143|451142924|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
125414212|NCT02301143|451142923|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
125414213|NCT02301143|451142924|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
125414214|NCT02301143|451142923|FG000|Investigator's Choice|Other|0|||
125414215|NCT02301143|451142924|FG001|Investigator's Choice|Other|1|||
125414216|NCT02301143|451142923|FG000|Investigator's Choice|Unresectable Surgery|0|||
125414217|NCT02301143|451142924|FG001|Investigator's Choice|Unresectable Surgery|1|||
125414218|NCT02536508|451142927|FG000|Overall Study|Withdrawal by Subject|18|||
125414219|NCT02536508|451142928|FG001|Overall Study|Withdrawal by Subject|13|||
125414220|NCT02536508|451142929|FG002|Overall Study|Withdrawal by Subject|7|||
125414221|NCT02536508|451142927|FG000|Overall Study|Adverse Event|14|||
125414222|NCT02536508|451142928|FG001|Overall Study|Adverse Event|13|||
125414223|NCT02536508|451142929|FG002|Overall Study|Adverse Event|6|||
125414224|NCT02536508|451142927|FG000|Overall Study|Lost to Follow-up|12|||
125414225|NCT02536508|451142928|FG001|Overall Study|Lost to Follow-up|4|||
125414226|NCT02536508|451142929|FG002|Overall Study|Lost to Follow-up|0|||
125414227|NCT02536508|451142927|FG000|Overall Study|Lack of Efficacy|3|||
125414228|NCT02536508|451142928|FG001|Overall Study|Lack of Efficacy|5|||
125285194|NCT03334851|450672613|FG004|Overall Study|Other|0|||
125414229|NCT02536508|451142929|FG002|Overall Study|Lack of Efficacy|4|||
125414230|NCT02536508|451142927|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
125414231|NCT02536508|451142928|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
125414232|NCT02536508|451142929|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
125414233|NCT02536508|451142927|FG000|Overall Study|Physician Decision|0|||
125414234|NCT02536508|451142928|FG001|Overall Study|Physician Decision|4|||
125414235|NCT02536508|451142929|FG002|Overall Study|Physician Decision|2|||
125414236|NCT02536508|451142927|FG000|Overall Study|Major Protocol Deviation|2|||
125414237|NCT02536508|451142928|FG001|Overall Study|Major Protocol Deviation|2|||
125414238|NCT02536508|451142929|FG002|Overall Study|Major Protocol Deviation|2|||
125414239|NCT02536508|451142927|FG000|Overall Study|Administrative Reasons|0|||
125414240|NCT02536508|451142928|FG001|Overall Study|Administrative Reasons|1|||
125414241|NCT02536508|451142929|FG002|Overall Study|Administrative Reasons|0|||
125414242|NCT02460991|451142933|FG000|Overall Study|Withdrawal by Subject|0|||
125414243|NCT02460991|451142934|FG001|Overall Study|Withdrawal by Subject|2|||
125414244|NCT00434057|451142935|FG000|Overall Study|Withdrawal by Subject|1|||
125414245|NCT02473952|451142936|FG000|Overall Study|Adverse Event|2|||
125414246|NCT02473952|451142937|FG001|Overall Study|Adverse Event|2|||
125414247|NCT02473952|451142936|FG000|Overall Study|Withdrawal by Subject|0|||
125414248|NCT02473952|451142937|FG001|Overall Study|Withdrawal by Subject|6|||
125414249|NCT00823719|451142938|FG000|Overall Study|Adverse Event|1|||
125414250|NCT00823719|451142939|FG001|Overall Study|Adverse Event|2|||
125414251|NCT00823719|451142938|FG000|Overall Study|Physician Decision|1|||
125414252|NCT00823719|451142939|FG001|Overall Study|Physician Decision|4|||
125414253|NCT00823719|451142938|FG000|Overall Study|Withdrawal by Subject|0|||
125414254|NCT00823719|451142939|FG001|Overall Study|Withdrawal by Subject|1|||
125414255|NCT00823719|451142938|FG000|Overall Study|Disease Progression|4|||
125414256|NCT00823719|451142939|FG001|Overall Study|Disease Progression|4|||
125414257|NCT00455195|451142940|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
125414258|NCT00455195|451142941|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
125414259|NCT00455195|451142940|FG000|Double-blind Study AGLU02704|Death|1|||
125414260|NCT00455195|451142941|FG001|Double-blind Study AGLU02704|Death|0|||
125414261|NCT00455195|451142940|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
125414262|NCT00455195|451142941|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
125414263|NCT00455195|451142940|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
125414264|NCT00455195|451142941|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
125414265|NCT02117570|451142942|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
125414266|NCT02117570|451142943|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
125414267|NCT02117570|451142944|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
125414268|NCT02117570|451142942|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
125414269|NCT02117570|451142943|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
125414270|NCT02117570|451142944|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
125414271|NCT02117570|451142942|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
125414272|NCT02117570|451142943|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
125414273|NCT02117570|451142944|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
125414274|NCT02117570|451142942|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
125414275|NCT02117570|451142943|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
125414276|NCT02117570|451142944|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
125414277|NCT02117570|451142942|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
125414278|NCT02117570|451142943|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
125414279|NCT02117570|451142944|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
125414280|NCT02117570|451142942|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
125414281|NCT02117570|451142943|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
125414282|NCT02117570|451142944|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
125414283|NCT02117570|451142942|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
125414284|NCT02117570|451142943|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
125414285|NCT02117570|451142944|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
125414286|NCT02508311|451142950|FG000|Overall Study|Withdrawal by Subject|1|||
125414287|NCT02508311|451142951|FG001|Overall Study|Withdrawal by Subject|0|||
125414288|NCT02169674|451142952|FG000|Overall Study|Withdrawal by Subject|2|||
125414289|NCT02169674|451142953|FG001|Overall Study|Withdrawal by Subject|1|||
125414290|NCT02169674|451142952|FG000|Overall Study|Seroprotected|30|||
125414291|NCT02169674|451142953|FG001|Overall Study|Seroprotected|76|||
125414292|NCT02169674|451142952|FG000|Overall Study|Lost to Follow-up|0|||
125414293|NCT02169674|451142953|FG001|Overall Study|Lost to Follow-up|1|||
125414294|NCT03349710|451142954|FG000|Treatment Period|Death|0|||
125414295|NCT03349710|451142955|FG001|Treatment Period|Death|0|||
125414296|NCT03349710|451142956|FG002|Treatment Period|Death|1|||
125414297|NCT03349710|451142957|FG003|Treatment Period|Death|0|||
125414298|NCT03349710|451142954|FG000|Treatment Period|Disease Progression|0|||
125414299|NCT03349710|451142955|FG001|Treatment Period|Disease Progression|2|||
125414300|NCT03349710|451142956|FG002|Treatment Period|Disease Progression|0|||
125414301|NCT03349710|451142957|FG003|Treatment Period|Disease Progression|1|||
125414302|NCT03349710|451142954|FG000|Treatment Period|Study Drug Toxicity|1|||
125414303|NCT03349710|451142955|FG001|Treatment Period|Study Drug Toxicity|0|||
125414304|NCT03349710|451142956|FG002|Treatment Period|Study Drug Toxicity|1|||
125414305|NCT03349710|451142957|FG003|Treatment Period|Study Drug Toxicity|1|||
125414306|NCT03349710|451142954|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
125285195|NCT03334851|450672614|FG005|Overall Study|Other|0|||
125285196|NCT03334851|450672615|FG006|Overall Study|Other|0|||
125285197|NCT03334851|450672616|FG007|Overall Study|Other|1|||
125285198|NCT03334851|450672617|FG008|Overall Study|Other|0|||
125285199|NCT03334851|450672618|FG009|Overall Study|Other|0|||
125285200|NCT03334851|450672619|FG010|Overall Study|Other|0|||
125285201|NCT03334851|450672620|FG011|Overall Study|Other|0|||
125285202|NCT03334851|450672621|FG012|Overall Study|Other|0|||
125285203|NCT03334851|450672609|FG000|Overall Study|Adverse Event|0|||
125285204|NCT03334851|450672610|FG001|Overall Study|Adverse Event|0|||
125285205|NCT03334851|450672611|FG002|Overall Study|Adverse Event|0|||
125285206|NCT03334851|450672612|FG003|Overall Study|Adverse Event|0|||
125285207|NCT03334851|450672613|FG004|Overall Study|Adverse Event|0|||
125285208|NCT03334851|450672614|FG005|Overall Study|Adverse Event|0|||
125285209|NCT03334851|450672615|FG006|Overall Study|Adverse Event|0|||
125285210|NCT03334851|450672616|FG007|Overall Study|Adverse Event|1|||
125285211|NCT03334851|450672617|FG008|Overall Study|Adverse Event|0|||
125285212|NCT03334851|450672618|FG009|Overall Study|Adverse Event|0|||
125285213|NCT03334851|450672619|FG010|Overall Study|Adverse Event|0|||
125285214|NCT03334851|450672620|FG011|Overall Study|Adverse Event|0|||
125285215|NCT03334851|450672621|FG012|Overall Study|Adverse Event|0|||
125285216|NCT03334851|450672609|FG000|Overall Study|Withdrawal by Subject|0|||
125285217|NCT03334851|450672610|FG001|Overall Study|Withdrawal by Subject|0|||
125285218|NCT03334851|450672611|FG002|Overall Study|Withdrawal by Subject|0|||
125285219|NCT03334851|450672612|FG003|Overall Study|Withdrawal by Subject|0|||
125285220|NCT03334851|450672613|FG004|Overall Study|Withdrawal by Subject|0|||
125285221|NCT03334851|450672614|FG005|Overall Study|Withdrawal by Subject|0|||
125285222|NCT03334851|450672615|FG006|Overall Study|Withdrawal by Subject|0|||
125285223|NCT03334851|450672616|FG007|Overall Study|Withdrawal by Subject|0|||
125285224|NCT03334851|450672617|FG008|Overall Study|Withdrawal by Subject|0|||
125285225|NCT03334851|450672618|FG009|Overall Study|Withdrawal by Subject|0|||
125285226|NCT03334851|450672619|FG010|Overall Study|Withdrawal by Subject|1|||
125285227|NCT03334851|450672620|FG011|Overall Study|Withdrawal by Subject|0|||
125285228|NCT03334851|450672621|FG012|Overall Study|Withdrawal by Subject|1|||
125285229|NCT03334851|450672609|FG000|Overall Study|Lost to Follow-up|0|||
125285230|NCT03334851|450672610|FG001|Overall Study|Lost to Follow-up|0|||
125285231|NCT03334851|450672611|FG002|Overall Study|Lost to Follow-up|0|||
125285232|NCT03334851|450672612|FG003|Overall Study|Lost to Follow-up|0|||
125285233|NCT03334851|450672613|FG004|Overall Study|Lost to Follow-up|0|||
125285234|NCT03334851|450672614|FG005|Overall Study|Lost to Follow-up|0|||
125285235|NCT03334851|450672615|FG006|Overall Study|Lost to Follow-up|0|||
125285236|NCT03334851|450672616|FG007|Overall Study|Lost to Follow-up|0|||
125285237|NCT03334851|450672617|FG008|Overall Study|Lost to Follow-up|0|||
125285238|NCT03334851|450672618|FG009|Overall Study|Lost to Follow-up|0|||
125285239|NCT03334851|450672619|FG010|Overall Study|Lost to Follow-up|2|||
125285240|NCT03334851|450672620|FG011|Overall Study|Lost to Follow-up|1|||
125285241|NCT03334851|450672621|FG012|Overall Study|Lost to Follow-up|0|||
125285242|NCT01691885|450672622|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
125285243|NCT01691885|450672623|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
125285244|NCT01691885|450672622|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
125285245|NCT01691885|450672623|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
125285246|NCT03555981|450672624|FG000|Overall Study|Lost to Follow-up|0|||
125285247|NCT03555981|450672625|FG001|Overall Study|Lost to Follow-up|2|||
125285248|NCT02754141|450672629|FG000|Overall Study|Disease progression|11|||
125285249|NCT02754141|450672630|FG001|Overall Study|Disease progression|7|||
125285250|NCT02754141|450672631|FG002|Overall Study|Disease progression|8|||
125285251|NCT02754141|450672632|FG003|Overall Study|Disease progression|5|||
125285252|NCT02754141|450672633|FG004|Overall Study|Disease progression|7|||
125285253|NCT02754141|450672634|FG005|Overall Study|Disease progression|7|||
125285254|NCT02754141|450672635|FG006|Overall Study|Disease progression|7|||
125285255|NCT02754141|450672636|FG007|Overall Study|Disease progression|6|||
125414307|NCT03349710|451142955|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
125414308|NCT03349710|451142956|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
125414309|NCT03349710|451142957|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
125285256|NCT02754141|450672637|FG008|Overall Study|Disease progression|11|||
125285257|NCT02754141|450672638|FG009|Overall Study|Disease progression|16|||
125285258|NCT02754141|450672639|FG010|Overall Study|Disease progression|18|||
125285259|NCT02754141|450672640|FG011|Overall Study|Disease progression|13|||
125285260|NCT02754141|450672641|FG012|Overall Study|Disease progression|10|||
125285261|NCT02754141|450672642|FG013|Overall Study|Disease progression|12|||
125285262|NCT02754141|450672643|FG014|Overall Study|Disease progression|12|||
125285263|NCT02754141|450672644|FG015|Overall Study|Disease progression|14|||
125285264|NCT02754141|450672645|FG016|Overall Study|Disease progression|0|||
125414310|NCT03349710|451142954|FG000|Treatment Period|admin reason by sponsor|0|||
125414311|NCT03349710|451142955|FG001|Treatment Period|admin reason by sponsor|7|||
125414312|NCT03349710|451142956|FG002|Treatment Period|admin reason by sponsor|0|||
125414313|NCT03349710|451142957|FG003|Treatment Period|admin reason by sponsor|19|||
125414314|NCT03349710|451142954|FG000|Treatment Period|Other Reason|2|||
125414315|NCT03349710|451142955|FG001|Treatment Period|Other Reason|0|||
125414316|NCT03349710|451142956|FG002|Treatment Period|Other Reason|2|||
125414317|NCT03349710|451142957|FG003|Treatment Period|Other Reason|1|||
125414318|NCT03349710|451142954|FG000|Treatment Period|completed|6|||
125414319|NCT03349710|451142955|FG001|Treatment Period|completed|0|||
125414320|NCT03349710|451142956|FG002|Treatment Period|completed|18|||
125414321|NCT03349710|451142957|FG003|Treatment Period|completed|1|||
125414322|NCT03349710|451142954|FG000|Treatment Period|participant request to discontinue|0|||
125414323|NCT03349710|451142955|FG001|Treatment Period|participant request to discontinue|0|||
125414324|NCT03349710|451142956|FG002|Treatment Period|participant request to discontinue|4|||
125414325|NCT03349710|451142957|FG003|Treatment Period|participant request to discontinue|0|||
125414326|NCT03349710|451142954|FG000|Treatment Period|participant withdrew consent|1|||
125414327|NCT03349710|451142955|FG001|Treatment Period|participant withdrew consent|0|||
125414328|NCT03349710|451142956|FG002|Treatment Period|participant withdrew consent|0|||
125414329|NCT03349710|451142957|FG003|Treatment Period|participant withdrew consent|0|||
125414330|NCT04258020|451142962|FG000|Overall Study|Withdrawal by Subject|1|||
125414331|NCT04258020|451142963|FG001|Overall Study|Withdrawal by Subject|0|||
125414332|NCT01380327|451142964|FG000|Overall Study|Lost to Follow-up|0|||
125414333|NCT01380327|451142965|FG001|Overall Study|Lost to Follow-up|1|||
125414334|NCT01380327|451142966|FG002|Overall Study|Lost to Follow-up|1|||
125414335|NCT01380327|451142964|FG000|Overall Study|Protocol Violation|3|||
125414336|NCT01380327|451142965|FG001|Overall Study|Protocol Violation|2|||
125414337|NCT01380327|451142966|FG002|Overall Study|Protocol Violation|3|||
125414338|NCT01380327|451142964|FG000|Overall Study|Withdrawal by Subject|0|||
125414339|NCT01380327|451142965|FG001|Overall Study|Withdrawal by Subject|0|||
125414340|NCT01380327|451142966|FG002|Overall Study|Withdrawal by Subject|1|||
125414341|NCT01380327|451142964|FG000|Overall Study|Housing situation precluded ability to k|0|||
125414342|NCT01380327|451142965|FG001|Overall Study|Housing situation precluded ability to k|0|||
125414343|NCT01380327|451142966|FG002|Overall Study|Housing situation precluded ability to k|1|||
125414344|NCT01380327|451142964|FG000|Overall Study|Questionable onset of epilepsy|0|||
125414345|NCT01380327|451142965|FG001|Overall Study|Questionable onset of epilepsy|0|||
125414346|NCT01380327|451142966|FG002|Overall Study|Questionable onset of epilepsy|1|||
125414347|NCT00833989|451142968|FG000|Overall Study|Physician Decision|0|||
125414348|NCT00833989|451142969|FG001|Overall Study|Physician Decision|0|||
125414349|NCT00833989|451142970|FG002|Overall Study|Physician Decision|0|||
125414350|NCT00833989|451142971|FG003|Overall Study|Physician Decision|1|||
125414351|NCT00833989|451142968|FG000|Overall Study|Withdrawal by Subject|3|||
125414352|NCT00833989|451142969|FG001|Overall Study|Withdrawal by Subject|0|||
125414353|NCT00833989|451142970|FG002|Overall Study|Withdrawal by Subject|1|||
125414354|NCT00833989|451142971|FG003|Overall Study|Withdrawal by Subject|1|||
125414355|NCT01587651|451142979|FG000|Overall Study|Adverse Event|0|||
125414356|NCT01587651|451142980|FG001|Overall Study|Adverse Event|1|||
125414357|NCT01587651|451142981|FG002|Overall Study|Adverse Event|0|||
125414358|NCT01587651|451142979|FG000|Overall Study|Protocol Violation|0|||
125414359|NCT01587651|451142980|FG001|Overall Study|Protocol Violation|1|||
125414360|NCT01587651|451142981|FG002|Overall Study|Protocol Violation|1|||
125414361|NCT01587651|451142979|FG000|Overall Study|Withdrawal by Subject|0|||
125414362|NCT01587651|451142980|FG001|Overall Study|Withdrawal by Subject|1|||
125414363|NCT01587651|451142981|FG002|Overall Study|Withdrawal by Subject|0|||
125414364|NCT03325712|451142982|FG000|Overall Study|Protocol Violation|0|||
125414365|NCT03325712|451142983|FG001|Overall Study|Protocol Violation|0|||
125414366|NCT03325712|451142984|FG002|Overall Study|Protocol Violation|0|||
125414367|NCT03325712|451142985|FG003|Overall Study|Protocol Violation|0|||
125414368|NCT03325712|451142986|FG004|Overall Study|Protocol Violation|1|||
125414369|NCT03325712|451142987|FG005|Overall Study|Protocol Violation|0|||
125285265|NCT02754141|450672646|FG017|Overall Study|Disease progression|1|||
125285266|NCT02754141|450672629|FG000|Overall Study|Study drug toxicity|1|||
125414370|NCT03325712|451142988|FG006|Overall Study|Protocol Violation|0|||
125414371|NCT03325712|451142989|FG007|Overall Study|Protocol Violation|0|||
125414372|NCT03325712|451142982|FG000|Overall Study|Adverse Event|0|||
125414373|NCT03325712|451142983|FG001|Overall Study|Adverse Event|0|||
125414374|NCT03325712|451142984|FG002|Overall Study|Adverse Event|0|||
125414375|NCT03325712|451142985|FG003|Overall Study|Adverse Event|0|||
125414376|NCT03325712|451142986|FG004|Overall Study|Adverse Event|1|||
125414377|NCT03325712|451142987|FG005|Overall Study|Adverse Event|0|||
125285267|NCT02754141|450672630|FG001|Overall Study|Study drug toxicity|1|||
125414378|NCT03325712|451142988|FG006|Overall Study|Adverse Event|0|||
125414379|NCT03325712|451142989|FG007|Overall Study|Adverse Event|0|||
125414380|NCT00718718|451142991|FG000|Prior to Week 12|Adverse Event|0|||
125414381|NCT00718718|451142992|FG001|Prior to Week 12|Adverse Event|0|||
125285268|NCT02754141|450672631|FG002|Overall Study|Study drug toxicity|0|||
125285269|NCT02754141|450672632|FG003|Overall Study|Study drug toxicity|0|||
125285270|NCT02754141|450672633|FG004|Overall Study|Study drug toxicity|0|||
125285271|NCT02754141|450672634|FG005|Overall Study|Study drug toxicity|0|||
125285272|NCT02754141|450672635|FG006|Overall Study|Study drug toxicity|0|||
125285273|NCT02754141|450672636|FG007|Overall Study|Study drug toxicity|0|||
125285274|NCT02754141|450672637|FG008|Overall Study|Study drug toxicity|0|||
125285275|NCT02754141|450672638|FG009|Overall Study|Study drug toxicity|0|||
125285276|NCT02754141|450672639|FG010|Overall Study|Study drug toxicity|2|||
125285277|NCT02754141|450672640|FG011|Overall Study|Study drug toxicity|1|||
125285278|NCT02754141|450672641|FG012|Overall Study|Study drug toxicity|1|||
125285279|NCT02754141|450672642|FG013|Overall Study|Study drug toxicity|0|||
125285280|NCT02754141|450672643|FG014|Overall Study|Study drug toxicity|0|||
125285281|NCT02754141|450672644|FG015|Overall Study|Study drug toxicity|0|||
125285282|NCT02754141|450672645|FG016|Overall Study|Study drug toxicity|0|||
125285283|NCT02754141|450672646|FG017|Overall Study|Study drug toxicity|0|||
125285284|NCT02754141|450672629|FG000|Overall Study|AE unrelated to study drug|1|||
125285285|NCT02754141|450672630|FG001|Overall Study|AE unrelated to study drug|1|||
125285286|NCT02754141|450672631|FG002|Overall Study|AE unrelated to study drug|0|||
125285287|NCT02754141|450672632|FG003|Overall Study|AE unrelated to study drug|1|||
125285288|NCT02754141|450672633|FG004|Overall Study|AE unrelated to study drug|3|||
125285289|NCT02754141|450672634|FG005|Overall Study|AE unrelated to study drug|2|||
125285290|NCT02754141|450672635|FG006|Overall Study|AE unrelated to study drug|1|||
125285291|NCT02754141|450672636|FG007|Overall Study|AE unrelated to study drug|0|||
125285292|NCT02754141|450672637|FG008|Overall Study|AE unrelated to study drug|0|||
125285293|NCT02754141|450672638|FG009|Overall Study|AE unrelated to study drug|0|||
125285294|NCT02754141|450672639|FG010|Overall Study|AE unrelated to study drug|0|||
125285295|NCT02754141|450672640|FG011|Overall Study|AE unrelated to study drug|0|||
125285296|NCT02754141|450672641|FG012|Overall Study|AE unrelated to study drug|0|||
125285297|NCT02754141|450672642|FG013|Overall Study|AE unrelated to study drug|0|||
125285298|NCT02754141|450672643|FG014|Overall Study|AE unrelated to study drug|0|||
125285299|NCT02754141|450672644|FG015|Overall Study|AE unrelated to study drug|0|||
125285300|NCT02754141|450672645|FG016|Overall Study|AE unrelated to study drug|0|||
125285301|NCT02754141|450672646|FG017|Overall Study|AE unrelated to study drug|0|||
125285302|NCT02754141|450672629|FG000|Overall Study|Request to discontinue|0|||
125285303|NCT02754141|450672630|FG001|Overall Study|Request to discontinue|0|||
125285304|NCT02754141|450672631|FG002|Overall Study|Request to discontinue|0|||
125285305|NCT02754141|450672632|FG003|Overall Study|Request to discontinue|0|||
125285306|NCT02754141|450672633|FG004|Overall Study|Request to discontinue|0|||
125285307|NCT02754141|450672634|FG005|Overall Study|Request to discontinue|0|||
125285308|NCT02754141|450672635|FG006|Overall Study|Request to discontinue|0|||
125285309|NCT02754141|450672636|FG007|Overall Study|Request to discontinue|0|||
125285310|NCT02754141|450672637|FG008|Overall Study|Request to discontinue|1|||
125285311|NCT02754141|450672638|FG009|Overall Study|Request to discontinue|0|||
125285312|NCT02754141|450672639|FG010|Overall Study|Request to discontinue|0|||
125285313|NCT02754141|450672640|FG011|Overall Study|Request to discontinue|0|||
125285314|NCT02754141|450672641|FG012|Overall Study|Request to discontinue|0|||
125285315|NCT02754141|450672642|FG013|Overall Study|Request to discontinue|1|||
125285316|NCT02754141|450672643|FG014|Overall Study|Request to discontinue|1|||
125285317|NCT02754141|450672644|FG015|Overall Study|Request to discontinue|0|||
125285318|NCT02754141|450672645|FG016|Overall Study|Request to discontinue|0|||
125285319|NCT02754141|450672646|FG017|Overall Study|Request to discontinue|0|||
125285320|NCT02754141|450672629|FG000|Overall Study|Withdrew consent|0|||
125285321|NCT02754141|450672630|FG001|Overall Study|Withdrew consent|0|||
125285322|NCT02754141|450672631|FG002|Overall Study|Withdrew consent|0|||
125285323|NCT02754141|450672632|FG003|Overall Study|Withdrew consent|0|||
125285324|NCT02754141|450672633|FG004|Overall Study|Withdrew consent|0|||
125285325|NCT02754141|450672634|FG005|Overall Study|Withdrew consent|0|||
125285326|NCT02754141|450672635|FG006|Overall Study|Withdrew consent|0|||
125285327|NCT02754141|450672636|FG007|Overall Study|Withdrew consent|0|||
125285328|NCT02754141|450672637|FG008|Overall Study|Withdrew consent|0|||
125285329|NCT02754141|450672638|FG009|Overall Study|Withdrew consent|1|||
125285330|NCT02754141|450672639|FG010|Overall Study|Withdrew consent|0|||
125285331|NCT02754141|450672640|FG011|Overall Study|Withdrew consent|0|||
125285332|NCT02754141|450672641|FG012|Overall Study|Withdrew consent|0|||
125285333|NCT02754141|450672642|FG013|Overall Study|Withdrew consent|0|||
125285334|NCT02754141|450672643|FG014|Overall Study|Withdrew consent|0|||
125285335|NCT02754141|450672644|FG015|Overall Study|Withdrew consent|0|||
125285336|NCT02754141|450672645|FG016|Overall Study|Withdrew consent|0|||
125285337|NCT02754141|450672646|FG017|Overall Study|Withdrew consent|0|||
125285338|NCT02754141|450672629|FG000|Overall Study|Maximum clinical benefit|0|||
125285339|NCT02754141|450672630|FG001|Overall Study|Maximum clinical benefit|0|||
125285340|NCT02754141|450672631|FG002|Overall Study|Maximum clinical benefit|0|||
125285341|NCT02754141|450672632|FG003|Overall Study|Maximum clinical benefit|1|||
125285342|NCT02754141|450672633|FG004|Overall Study|Maximum clinical benefit|0|||
125285343|NCT02754141|450672634|FG005|Overall Study|Maximum clinical benefit|0|||
125285344|NCT02754141|450672635|FG006|Overall Study|Maximum clinical benefit|0|||
125285345|NCT02754141|450672636|FG007|Overall Study|Maximum clinical benefit|0|||
125285346|NCT02754141|450672637|FG008|Overall Study|Maximum clinical benefit|0|||
125285347|NCT02754141|450672638|FG009|Overall Study|Maximum clinical benefit|0|||
125414382|NCT00718718|451142993|FG002|Prior to Week 12|Adverse Event|0|||
125414383|NCT00718718|451142994|FG003|Prior to Week 12|Adverse Event|0|||
125414384|NCT00718718|451142995|FG004|Prior to Week 12|Adverse Event|0|||
125414385|NCT00718718|451142996|FG005|Prior to Week 12|Adverse Event|0|||
125414386|NCT00718718|451142997|FG006|Prior to Week 12|Adverse Event|0|||
125414387|NCT00718718|451142998|FG007|Prior to Week 12|Adverse Event|1|||
125414388|NCT00718718|451142999|FG008|Prior to Week 12|Adverse Event|1|||
125414389|NCT00718718|451143000|FG009|Prior to Week 12|Adverse Event|0|||
125414390|NCT00718718|451142991|FG000|Prior to Week 12|Withdrawal by Subject|0|||
125414391|NCT00718718|451142992|FG001|Prior to Week 12|Withdrawal by Subject|0|||
125414392|NCT00718718|451142993|FG002|Prior to Week 12|Withdrawal by Subject|0|||
125414393|NCT00718718|451142994|FG003|Prior to Week 12|Withdrawal by Subject|0|||
125414394|NCT00718718|451142995|FG004|Prior to Week 12|Withdrawal by Subject|3|||
125414395|NCT00718718|451142996|FG005|Prior to Week 12|Withdrawal by Subject|0|||
125414396|NCT00718718|451142997|FG006|Prior to Week 12|Withdrawal by Subject|1|||
125414397|NCT00718718|451142998|FG007|Prior to Week 12|Withdrawal by Subject|1|||
125414398|NCT00718718|451142999|FG008|Prior to Week 12|Withdrawal by Subject|1|||
125414399|NCT00718718|451143000|FG009|Prior to Week 12|Withdrawal by Subject|0|||
125414400|NCT00718718|451142991|FG000|Prior to Week 12|Other|1|||
125414401|NCT00718718|451142992|FG001|Prior to Week 12|Other|0|||
125414402|NCT00718718|451142993|FG002|Prior to Week 12|Other|1|||
125414403|NCT00718718|451142994|FG003|Prior to Week 12|Other|0|||
125414404|NCT00718718|451142995|FG004|Prior to Week 12|Other|0|||
125414405|NCT00718718|451142996|FG005|Prior to Week 12|Other|0|||
125414406|NCT00718718|451142997|FG006|Prior to Week 12|Other|0|||
125414407|NCT00718718|451142998|FG007|Prior to Week 12|Other|0|||
125414408|NCT00718718|451142999|FG008|Prior to Week 12|Other|0|||
125414409|NCT00718718|451143000|FG009|Prior to Week 12|Other|0|||
125414410|NCT00718718|451142991|FG000|Week 12 to End of Study|Adverse Event|0|||
125414411|NCT00718718|451142992|FG001|Week 12 to End of Study|Adverse Event|0|||
125414412|NCT00718718|451142993|FG002|Week 12 to End of Study|Adverse Event|0|||
125414413|NCT00718718|451142994|FG003|Week 12 to End of Study|Adverse Event|0|||
125414414|NCT00718718|451142995|FG004|Week 12 to End of Study|Adverse Event|0|||
125414415|NCT00718718|451142996|FG005|Week 12 to End of Study|Adverse Event|0|||
125414416|NCT00718718|451142997|FG006|Week 12 to End of Study|Adverse Event|0|||
125414417|NCT00718718|451142998|FG007|Week 12 to End of Study|Adverse Event|1|||
125414418|NCT00718718|451142999|FG008|Week 12 to End of Study|Adverse Event|0|||
125414419|NCT00718718|451143000|FG009|Week 12 to End of Study|Adverse Event|0|||
125414420|NCT00718718|451142991|FG000|Week 12 to End of Study|Death|0|||
125414421|NCT00718718|451142992|FG001|Week 12 to End of Study|Death|0|||
125414422|NCT00718718|451142993|FG002|Week 12 to End of Study|Death|0|||
125414423|NCT00718718|451142994|FG003|Week 12 to End of Study|Death|0|||
125414424|NCT00718718|451142995|FG004|Week 12 to End of Study|Death|0|||
125414425|NCT00718718|451142996|FG005|Week 12 to End of Study|Death|1|||
125414426|NCT00718718|451142997|FG006|Week 12 to End of Study|Death|0|||
125414427|NCT00718718|451142998|FG007|Week 12 to End of Study|Death|0|||
125414428|NCT00718718|451142999|FG008|Week 12 to End of Study|Death|0|||
125414429|NCT00718718|451143000|FG009|Week 12 to End of Study|Death|0|||
125414430|NCT00718718|451142991|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
125414431|NCT00718718|451142992|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
125414432|NCT00718718|451142993|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
125414433|NCT00718718|451142994|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
125414434|NCT00718718|451142995|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
125414435|NCT00718718|451142996|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
125414436|NCT00718718|451142997|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
125414437|NCT00718718|451142998|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
125414438|NCT00718718|451142999|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
125414439|NCT00718718|451143000|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
125414440|NCT00718718|451142991|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
125414441|NCT00718718|451142992|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
125414442|NCT00718718|451142993|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
125414443|NCT00718718|451142994|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
125414444|NCT00718718|451142995|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
125414445|NCT00718718|451142996|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
125414446|NCT00718718|451142997|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
125414447|NCT00718718|451142998|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
125414448|NCT00718718|451142999|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
125414449|NCT00718718|451143000|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
125414450|NCT00718718|451142991|FG000|Week 12 to End of Study|Other|0|||
125414451|NCT00718718|451142992|FG001|Week 12 to End of Study|Other|1|||
125414452|NCT00718718|451142993|FG002|Week 12 to End of Study|Other|0|||
125414453|NCT00718718|451142994|FG003|Week 12 to End of Study|Other|1|||
125414454|NCT00718718|451142995|FG004|Week 12 to End of Study|Other|0|||
125414455|NCT00718718|451142996|FG005|Week 12 to End of Study|Other|0|||
125414456|NCT00718718|451142997|FG006|Week 12 to End of Study|Other|1|||
125414457|NCT00718718|451142998|FG007|Week 12 to End of Study|Other|0|||
125414458|NCT00718718|451142999|FG008|Week 12 to End of Study|Other|0|||
125414459|NCT00718718|451143000|FG009|Week 12 to End of Study|Other|0|||
125414460|NCT04558346|451143011|FG000|Overall Study|Withdrawal by Subject|2|||
125414461|NCT04558346|451143012|FG001|Overall Study|Withdrawal by Subject|0|||
125414462|NCT04558346|451143011|FG000|Overall Study|Lost to Follow-up|0|||
125414463|NCT04558346|451143012|FG001|Overall Study|Lost to Follow-up|1|||
125414464|NCT04558346|451143011|FG000|Overall Study|Adverse Event|0|||
125414465|NCT04558346|451143012|FG001|Overall Study|Adverse Event|1|||
125414466|NCT01462344|451143013|FG000|Overall Study|Withdrawal by Subject|245|||
125414467|NCT01462344|451143014|FG001|Overall Study|Withdrawal by Subject|226|||
125414468|NCT01462344|451143013|FG000|Overall Study|Adverse Event|24|||
125414469|NCT01462344|451143014|FG001|Overall Study|Adverse Event|23|||
125414470|NCT01462344|451143013|FG000|Overall Study|Asthma Exacerbation|34|||
125414471|NCT01462344|451143014|FG001|Overall Study|Asthma Exacerbation|35|||
125414472|NCT01462344|451143013|FG000|Overall Study|Lack of Efficacy|5|||
125414473|NCT01462344|451143014|FG001|Overall Study|Lack of Efficacy|6|||
125414474|NCT01462344|451143013|FG000|Overall Study|Protocol Violation|68|||
125414475|NCT01462344|451143014|FG001|Overall Study|Protocol Violation|53|||
125414476|NCT01462344|451143013|FG000|Overall Study|Lost to Follow-up|7|||
125414477|NCT01462344|451143014|FG001|Overall Study|Lost to Follow-up|7|||
125414478|NCT00724971|451143015|FG000|Overall Study|Adverse Event|5|||
125414479|NCT00724971|451143015|FG000|Overall Study|Withdrawal by Subject|1|||
125414480|NCT01003249|451143018|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125414481|NCT01003249|451143019|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125414482|NCT01003249|451143018|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
125414483|NCT01003249|451143019|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
125414484|NCT01003249|451143018|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
125414485|NCT01003249|451143019|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125414486|NCT01003249|451143018|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
125414487|NCT01003249|451143019|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
125414488|NCT01962974|451143020|FG000|Overall Study|Study termination|7|||
125414489|NCT01692197|451143021|FG000|Overall Study|Failed Screening|3|||
125414490|NCT03086447|451143023|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125414491|NCT03086447|451143024|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
125414492|NCT03086447|451143023|FG000|Overall Study|Lost Lens|2|||
125414493|NCT03086447|451143024|FG001|Overall Study|Lost Lens|5|||
125414494|NCT03086447|451143023|FG000|Overall Study|Product quality complaint|0|||
125414495|NCT03086447|451143024|FG001|Overall Study|Product quality complaint|1|||
125414496|NCT03086447|451143023|FG000|Overall Study|Lens Damage|1|||
125414497|NCT03086447|451143024|FG001|Overall Study|Lens Damage|6|||
125414498|NCT03086447|451143023|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
125414499|NCT03086447|451143024|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
125414500|NCT03086447|451143023|FG000|Overall Study|Test Article No Longer Available|1|||
125414501|NCT03086447|451143024|FG001|Overall Study|Test Article No Longer Available|0|||
125414502|NCT03086447|451143023|FG000|Overall Study|Protocol Violation|2|||
125414503|NCT03086447|451143024|FG001|Overall Study|Protocol Violation|4|||
125414504|NCT03086447|451143023|FG000|Overall Study|Lost to Follow-up|0|||
125414505|NCT03086447|451143024|FG001|Overall Study|Lost to Follow-up|1|||
125414506|NCT03086447|451143023|FG000|Overall Study|Adverse Event|3|||
125414507|NCT03086447|451143024|FG001|Overall Study|Adverse Event|0|||
125414508|NCT03086447|451143023|FG000|Overall Study|Lens Discomfort|2|||
125414509|NCT03086447|451143024|FG001|Overall Study|Lens Discomfort|1|||
125414510|NCT02276482|451143036|FG000|Overall Study|Adverse Event|1|||
125414511|NCT02276482|451143037|FG001|Overall Study|Adverse Event|0|||
125414512|NCT02276482|451143036|FG000|Overall Study|Withdrawal by Subject|1|||
125414513|NCT02276482|451143037|FG001|Overall Study|Withdrawal by Subject|0|||
125414514|NCT02276482|451143036|FG000|Overall Study|Gram-negative infection|1|||
125414515|NCT02276482|451143037|FG001|Overall Study|Gram-negative infection|0|||
125414516|NCT02276482|451143036|FG000|Overall Study|Reason not specified|0|||
125414517|NCT02276482|451143037|FG001|Overall Study|Reason not specified|1|||
125414518|NCT01165281|451143040|FG000|Overall Study|Adverse Event|12|||
125448825|NCT00495469|451270894|FG000|Overall Study|Lack of Efficacy|0|||
125285348|NCT02754141|450672639|FG010|Overall Study|Maximum clinical benefit|0|||
125285349|NCT02754141|450672640|FG011|Overall Study|Maximum clinical benefit|0|||
125285350|NCT02754141|450672641|FG012|Overall Study|Maximum clinical benefit|0|||
125414519|NCT01165281|451143041|FG001|Overall Study|Adverse Event|14|||
125414520|NCT01165281|451143040|FG000|Overall Study|Death|3|||
125414521|NCT01165281|451143041|FG001|Overall Study|Death|4|||
125414522|NCT01165281|451143040|FG000|Overall Study|Lack of Efficacy|4|||
125414523|NCT01165281|451143041|FG001|Overall Study|Lack of Efficacy|1|||
125414524|NCT01165281|451143040|FG000|Overall Study|Lost to Follow-up|0|||
125414525|NCT01165281|451143041|FG001|Overall Study|Lost to Follow-up|1|||
125414526|NCT01165281|451143040|FG000|Overall Study|Physician Decision|8|||
125414527|NCT01165281|451143041|FG001|Overall Study|Physician Decision|1|||
125414528|NCT01165281|451143040|FG000|Overall Study|Protocol Violation|6|||
125414529|NCT01165281|451143041|FG001|Overall Study|Protocol Violation|5|||
125414530|NCT01165281|451143040|FG000|Overall Study|Withdrawal by Subject|8|||
125414531|NCT01165281|451143041|FG001|Overall Study|Withdrawal by Subject|7|||
125448826|NCT00495469|451270895|FG001|Overall Study|Lack of Efficacy|0|||
125448827|NCT00495469|451270896|FG002|Overall Study|Lack of Efficacy|0|||
125414532|NCT01165281|451143040|FG000|Overall Study|Noncompliance with Study Drug|1|||
125414533|NCT01165281|451143041|FG001|Overall Study|Noncompliance with Study Drug|4|||
125414534|NCT01165281|451143040|FG000|Overall Study|Progressive Disease|10|||
125414535|NCT01165281|451143041|FG001|Overall Study|Progressive Disease|14|||
125414536|NCT01165281|451143040|FG000|Overall Study|Other|6|||
125414537|NCT01165281|451143041|FG001|Overall Study|Other|0|||
125414538|NCT00364858|451143042|FG000|Overall Study|Adverse Event|1|||
125414539|NCT00364858|451143043|FG001|Overall Study|Adverse Event|5|||
125414540|NCT00364858|451143042|FG000|Overall Study|Withdrawal by Subject|1|||
125414541|NCT00364858|451143043|FG001|Overall Study|Withdrawal by Subject|1|||
125414542|NCT00364858|451143042|FG000|Overall Study|Pregnancy|1|||
125414543|NCT00364858|451143043|FG001|Overall Study|Pregnancy|1|||
125414544|NCT00364858|451143042|FG000|Overall Study|Clinical failure|2|||
125414545|NCT00364858|451143043|FG001|Overall Study|Clinical failure|13|||
125414546|NCT00364858|451143042|FG000|Overall Study|Discontinuation at baseline|1|||
125414547|NCT00364858|451143043|FG001|Overall Study|Discontinuation at baseline|0|||
125414548|NCT00364858|451143042|FG000|Overall Study|Non-compliant|1|||
125414549|NCT00364858|451143043|FG001|Overall Study|Non-compliant|0|||
125414550|NCT00364858|451143042|FG000|Overall Study|Return to Q2 regimen|0|||
125414551|NCT00364858|451143043|FG001|Overall Study|Return to Q2 regimen|1|||
125414552|NCT00364858|451143042|FG000|Overall Study|Clinical baseline issue|0|||
125414553|NCT00364858|451143043|FG001|Overall Study|Clinical baseline issue|1|||
125414554|NCT00627705|451143044|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
125414555|NCT00627705|451143045|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
125414556|NCT00627705|451143044|FG000|Overall Study|Adverse Event|1|||
125414557|NCT00627705|451143045|FG001|Overall Study|Adverse Event|0|||
125414558|NCT00627705|451143044|FG000|Overall Study|Withdrawal by Subject|0|||
125414559|NCT00627705|451143045|FG001|Overall Study|Withdrawal by Subject|2|||
125414560|NCT00627705|451143044|FG000|Overall Study|Lost to Follow-up|0|||
125414561|NCT00627705|451143045|FG001|Overall Study|Lost to Follow-up|1|||
125414562|NCT01218438|451143049|FG000|Epoch 1|Physician Decision|2|||
125414563|NCT01218438|451143049|FG000|Epoch 1|Adverse Event|1|||
125414564|NCT01218438|451143049|FG000|Epoch 3|Withdrawal by Subject|3|||
125414565|NCT01218438|451143049|FG000|Epoch 3|Adverse Event|1|||
125414566|NCT01218438|451143049|FG000|Epoch 4|Physician Decision|1|||
125414567|NCT01218438|451143049|FG000|Epoch 4|Withdrawal by Subject|2|||
125414568|NCT01218646|451143051|FG000|Overall Study|Adverse Event|0|||
125414569|NCT01218646|451143052|FG001|Overall Study|Adverse Event|0|||
125414570|NCT01218646|451143053|FG002|Overall Study|Adverse Event|1|||
125414571|NCT01218646|451143054|FG003|Overall Study|Adverse Event|0|||
125414572|NCT01218646|451143051|FG000|Overall Study|Lost to Follow-up|1|||
125414573|NCT01218646|451143052|FG001|Overall Study|Lost to Follow-up|0|||
125414574|NCT01218646|451143053|FG002|Overall Study|Lost to Follow-up|0|||
125414575|NCT01218646|451143054|FG003|Overall Study|Lost to Follow-up|0|||
125414576|NCT01218646|451143051|FG000|Overall Study|Protocol Violation|0|||
125414577|NCT01218646|451143052|FG001|Overall Study|Protocol Violation|0|||
125414578|NCT01218646|451143053|FG002|Overall Study|Protocol Violation|1|||
125414579|NCT01218646|451143054|FG003|Overall Study|Protocol Violation|1|||
125414580|NCT05437510|451143057|FG000|Overall Study|Adverse Event|1|||
125414581|NCT05437510|451143058|FG001|Overall Study|Adverse Event|1|||
125414582|NCT05437510|451143057|FG000|Overall Study|Protocol Deviation|1|||
125414583|NCT05437510|451143058|FG001|Overall Study|Protocol Deviation|6|||
125414584|NCT05437510|451143057|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
125414585|NCT05437510|451143058|FG001|Overall Study|Withdrawal by Parent/Guardian|22|||
125414586|NCT05437510|451143057|FG000|Overall Study|Lost to Follow-up|219|||
125414587|NCT05437510|451143058|FG001|Overall Study|Lost to Follow-up|289|||
125414588|NCT05437510|451143057|FG000|Overall Study|Ongoing in the Study Extension|1387|||
125414589|NCT05437510|451143058|FG001|Overall Study|Ongoing in the Study Extension|1352|||
125414590|NCT02105116|451144874|FG000|Overall Study|not eligible for step 2 of trial|5|||
125448828|NCT00495469|451270897|FG003|Overall Study|Lack of Efficacy|0|||
125448829|NCT00495469|451270898|FG004|Overall Study|Lack of Efficacy|0|||
125448830|NCT00495469|451270899|FG005|Overall Study|Lack of Efficacy|0|||
125448831|NCT00495469|451270900|FG006|Overall Study|Lack of Efficacy|1|||
125448832|NCT00495469|451270894|FG000|Overall Study|Liver function test abnormality|0|||
125448833|NCT00495469|451270895|FG001|Overall Study|Liver function test abnormality|1|||
125448834|NCT00495469|451270896|FG002|Overall Study|Liver function test abnormality|0|||
125414591|NCT02105116|451144874|FG000|Overall Study|Death|1|||
125414592|NCT00263666|451144875|FG000|Overall Study|Adverse Event|6|||
125414593|NCT00263666|451144876|FG001|Overall Study|Adverse Event|8|||
125414594|NCT00263666|451144875|FG000|Overall Study|Lost to Follow-up|1|||
125414595|NCT00263666|451144876|FG001|Overall Study|Lost to Follow-up|2|||
125414596|NCT00263666|451144875|FG000|Overall Study|Withdrawal by Subject|0|||
125414597|NCT00263666|451144876|FG001|Overall Study|Withdrawal by Subject|1|||
125414598|NCT00896168|451144877|FG000|Overall Study|Adverse Event|4|||
125448835|NCT00495469|451270897|FG003|Overall Study|Liver function test abnormality|0|||
125414599|NCT00896168|451144878|FG001|Overall Study|Adverse Event|7|||
125414600|NCT00896168|451144877|FG000|Overall Study|Treatment failure|8|||
125414601|NCT00896168|451144878|FG001|Overall Study|Treatment failure|10|||
125414602|NCT00896168|451144877|FG000|Overall Study|Lost to Follow-up|1|||
125414603|NCT00896168|451144878|FG001|Overall Study|Lost to Follow-up|1|||
125414604|NCT00896168|451144877|FG000|Overall Study|Other|1|||
125414605|NCT00896168|451144878|FG001|Overall Study|Other|1|||
125414606|NCT02492100|451144879|FG000|Overall Study|Death|1|||
125414607|NCT01003899|451144883|FG000|Overall Study|Other Adverse Event|8|||
125414608|NCT01003899|451144883|FG000|Overall Study|Not entered|4|||
125414609|NCT01003899|451144883|FG000|Overall Study|Not treated|1|||
125414610|NCT01003899|451144883|FG000|Overall Study|Progressive disease|34|||
125414611|NCT02489500|451144887|FG000|Overall Study|Death|1|||
125414612|NCT02489500|451144888|FG001|Overall Study|Death|1|||
125414613|NCT02863926|451144889|FG000|Overall Study|Physician Decision|1|||
125414614|NCT02863926|451144890|FG001|Overall Study|Physician Decision|0|||
125414615|NCT02863926|451144889|FG000|Overall Study|Lost to Follow-up|1|||
125414616|NCT02863926|451144890|FG001|Overall Study|Lost to Follow-up|1|||
125414617|NCT01259713|451144891|FG000|Overall Study|Adverse Event|54|||
125414618|NCT01259713|451144892|FG001|Overall Study|Adverse Event|23|||
125414619|NCT01259713|451144891|FG000|Overall Study|Death Not Related to IFI|8|||
125414620|NCT01259713|451144892|FG001|Overall Study|Death Not Related to IFI|1|||
125414621|NCT01259713|451144891|FG000|Overall Study|Investigators Discretion|14|||
125414622|NCT01259713|451144892|FG001|Overall Study|Investigators Discretion|6|||
125414623|NCT01259713|451144891|FG000|Overall Study|Lack of Efficacy|2|||
125414624|NCT01259713|451144892|FG001|Overall Study|Lack of Efficacy|0|||
125414625|NCT01259713|451144891|FG000|Overall Study|Protocol Violation|5|||
125414626|NCT01259713|451144892|FG001|Overall Study|Protocol Violation|4|||
125414627|NCT01259713|451144891|FG000|Overall Study|Subject Withdrew Consent|12|||
125414628|NCT01259713|451144892|FG001|Overall Study|Subject Withdrew Consent|7|||
125414629|NCT03422250|451144893|FG000|Intervention|Adverse Event|0|||
125414630|NCT03422250|451144894|FG001|Intervention|Adverse Event|1|||
125414631|NCT03422250|451144895|FG002|Intervention|Adverse Event|0|||
125414632|NCT03422250|451144896|FG003|Intervention|Adverse Event|1|||
125414633|NCT03422250|451144893|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
125414634|NCT03422250|451144894|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
125414635|NCT03422250|451144895|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
125414636|NCT03422250|451144896|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
125414637|NCT03422250|451144893|FG000|Follow-up|Withdrawal by Subject|0|||
125414638|NCT03422250|451144894|FG001|Follow-up|Withdrawal by Subject|0|||
125414639|NCT03422250|451144895|FG002|Follow-up|Withdrawal by Subject|0|||
125414640|NCT03422250|451144896|FG003|Follow-up|Withdrawal by Subject|1|||
125414641|NCT03422250|451144893|FG000|Follow-up|Adverse Event|0|||
125414642|NCT03422250|451144894|FG001|Follow-up|Adverse Event|0|||
125414643|NCT03422250|451144895|FG002|Follow-up|Adverse Event|0|||
125414644|NCT03422250|451144896|FG003|Follow-up|Adverse Event|1|||
125414645|NCT01715805|451144904|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
125414646|NCT01715805|451144905|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
125414647|NCT01715805|451144906|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
125414648|NCT01715805|451144907|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
125414649|NCT01715805|451144904|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
125414650|NCT01715805|451144905|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
125414651|NCT01715805|451144906|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
125414652|NCT01715805|451144907|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
125414653|NCT01715805|451144904|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
125414654|NCT01715805|451144905|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
125414655|NCT01715805|451144906|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
125414656|NCT01715805|451144907|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
125414657|NCT01715805|451144904|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
125414658|NCT01715805|451144905|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
125414659|NCT01715805|451144906|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
125414660|NCT01715805|451144907|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
125414661|NCT01715805|451144904|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
125414662|NCT01715805|451144905|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
125414663|NCT01715805|451144906|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
125414664|NCT01715805|451144907|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
125414665|NCT01715805|451144904|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
125414666|NCT01715805|451144905|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
125414667|NCT01715805|451144906|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
125414668|NCT01715805|451144907|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
125414669|NCT01715805|451144904|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
125414670|NCT01715805|451144905|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
125414671|NCT01715805|451144906|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
125414672|NCT01715805|451144907|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
125414673|NCT01715805|451144904|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
125414674|NCT01715805|451144905|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
125414675|NCT01715805|451144906|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
125414676|NCT01715805|451144907|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
125414677|NCT01715805|451144904|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
125414678|NCT01715805|451144905|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
125414679|NCT01715805|451144906|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
125414680|NCT01715805|451144907|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
125414681|NCT01715805|451144904|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
125414682|NCT01715805|451144905|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
125414683|NCT01715805|451144906|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
125414684|NCT01715805|451144907|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
125414685|NCT01715805|451144904|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
125414686|NCT01715805|451144905|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
125414687|NCT01715805|451144906|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
125414688|NCT01715805|451144907|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
125414689|NCT01715805|451144904|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
125414690|NCT01715805|451144905|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
125414691|NCT01715805|451144906|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
125414692|NCT01715805|451144907|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
125414693|NCT01715805|451144904|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
125414694|NCT01715805|451144905|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
125414695|NCT01715805|451144906|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
125414696|NCT01715805|451144907|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
125414697|NCT01715805|451144904|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
125414698|NCT01715805|451144905|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
125414699|NCT01715805|451144906|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
125414700|NCT01715805|451144907|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
125414701|NCT05177770|451144910|FG000|Overall Study|Death|4|||
125414702|NCT05177770|451144910|FG000|Overall Study|Withdrawal by Subject|1|||
125414703|NCT05177770|451144910|FG000|Overall Study|Adverse Event prior to dosing|1|||
125414704|NCT02365467|451144911|FG000|Overall Study|Death|3|||
125414705|NCT00709722|451144912|FG000|Overall Study|Adverse Event|1|||
125414706|NCT02043782|451144913|FG000|Period 1|Adverse Event|0|||
125414707|NCT02043782|451144914|FG001|Period 1|Adverse Event|0|||
125414708|NCT02043782|451144915|FG002|Period 1|Adverse Event|1|||
125414709|NCT02043782|451144916|FG003|Period 1|Adverse Event|0|||
125414710|NCT02043782|451144917|FG004|Period 1|Adverse Event|0|||
125414711|NCT02043782|451144918|FG005|Period 1|Adverse Event|0|||
125414712|NCT04667117|451144919|FG000|Investigational Period|Lost to Follow-up|0|||
125414713|NCT04667117|451144920|FG001|Investigational Period|Lost to Follow-up|0|||
125414714|NCT04667117|451144921|FG002|Investigational Period|Lost to Follow-up|1|||
125414715|NCT04667117|451144919|FG000|Investigational Period|Protocol Deviation|0|||
125414716|NCT04667117|451144920|FG001|Investigational Period|Protocol Deviation|1|||
125414717|NCT04667117|451144921|FG002|Investigational Period|Protocol Deviation|0|||
125414718|NCT04667117|451144919|FG000|Extension Period|Lost to Follow-up|1|||
125414719|NCT04667117|451144920|FG001|Extension Period|Lost to Follow-up|0|||
125414720|NCT04667117|451144921|FG002|Extension Period|Lost to Follow-up|0|||
125414721|NCT01306162|451144924|FG000|Period 1|Adverse Event|0|||
125414722|NCT01306162|451144925|FG001|Period 1|Adverse Event|0|||
125414723|NCT01306162|451144926|FG002|Period 1|Adverse Event|0|||
125414724|NCT01306162|451144927|FG003|Period 1|Adverse Event|1|||
125414725|NCT01306162|451144924|FG000|Washout 1|Non-compliance to protocol|0|||
125414726|NCT01306162|451144925|FG001|Washout 1|Non-compliance to protocol|1|||
125414727|NCT01306162|451144926|FG002|Washout 1|Non-compliance to protocol|0|||
125414728|NCT01306162|451144927|FG003|Washout 1|Non-compliance to protocol|0|||
125414729|NCT02959437|451144931|FG000|Overall Study|Death|33|||
125414730|NCT02959437|451144932|FG001|Overall Study|Death|3|||
125414731|NCT02959437|451144933|FG002|Overall Study|Death|0|||
125414732|NCT02959437|451144934|FG003|Overall Study|Death|0|||
125414733|NCT02959437|451144931|FG000|Overall Study|Lost to Follow-up|3|||
125414734|NCT02959437|451144932|FG001|Overall Study|Lost to Follow-up|1|||
125414735|NCT02959437|451144933|FG002|Overall Study|Lost to Follow-up|0|||
125285351|NCT02754141|450672642|FG013|Overall Study|Maximum clinical benefit|0|||
125414736|NCT02959437|451144934|FG003|Overall Study|Lost to Follow-up|0|||
125414737|NCT02959437|451144931|FG000|Overall Study|Withdrawal by Subject|11|||
125414738|NCT02959437|451144932|FG001|Overall Study|Withdrawal by Subject|3|||
125414739|NCT02959437|451144933|FG002|Overall Study|Withdrawal by Subject|0|||
125414740|NCT02959437|451144934|FG003|Overall Study|Withdrawal by Subject|0|||
125414741|NCT02959437|451144931|FG000|Overall Study|Progressive Disease|9|||
125414742|NCT02959437|451144932|FG001|Overall Study|Progressive Disease|1|||
125414743|NCT02959437|451144933|FG002|Overall Study|Progressive Disease|0|||
125285352|NCT02754141|450672643|FG014|Overall Study|Maximum clinical benefit|0|||
125414744|NCT02959437|451144934|FG003|Overall Study|Progressive Disease|0|||
125414745|NCT02959437|451144931|FG000|Overall Study|Study Terminated by Sponsor|4|||
125414746|NCT02959437|451144932|FG001|Overall Study|Study Terminated by Sponsor|0|||
125414747|NCT02959437|451144933|FG002|Overall Study|Study Terminated by Sponsor|0|||
125414748|NCT02959437|451144934|FG003|Overall Study|Study Terminated by Sponsor|0|||
125414749|NCT02959437|451144931|FG000|Overall Study|Other Unspecified|2|||
125414750|NCT02959437|451144932|FG001|Overall Study|Other Unspecified|0|||
125414751|NCT02959437|451144933|FG002|Overall Study|Other Unspecified|0|||
125414752|NCT02959437|451144934|FG003|Overall Study|Other Unspecified|0|||
125414753|NCT01949480|451144944|FG000|Overall Study|Physician Decision|5|||
125414754|NCT01949480|451144945|FG001|Overall Study|Physician Decision|8|||
125414755|NCT02105948|451144948|FG000|Overall Study|Adverse Event|10|||
125414756|NCT02105948|451144949|FG001|Overall Study|Adverse Event|7|||
125414757|NCT02105948|451144950|FG002|Overall Study|Adverse Event|11|||
125414758|NCT02105948|451144951|FG003|Overall Study|Adverse Event|11|||
125414759|NCT02105948|451144948|FG000|Overall Study|Lack of Efficacy|0|||
125414760|NCT02105948|451144949|FG001|Overall Study|Lack of Efficacy|1|||
125414761|NCT02105948|451144950|FG002|Overall Study|Lack of Efficacy|3|||
125414762|NCT02105948|451144951|FG003|Overall Study|Lack of Efficacy|2|||
125414763|NCT02105948|451144948|FG000|Overall Study|Lost to Follow-up|0|||
125414764|NCT02105948|451144949|FG001|Overall Study|Lost to Follow-up|0|||
125414765|NCT02105948|451144950|FG002|Overall Study|Lost to Follow-up|2|||
125414766|NCT02105948|451144951|FG003|Overall Study|Lost to Follow-up|1|||
125414767|NCT02105948|451144948|FG000|Overall Study|Physician Decision|2|||
125414768|NCT02105948|451144949|FG001|Overall Study|Physician Decision|2|||
125414769|NCT02105948|451144950|FG002|Overall Study|Physician Decision|2|||
125414770|NCT02105948|451144951|FG003|Overall Study|Physician Decision|2|||
125414771|NCT02105948|451144948|FG000|Overall Study|Withdrawal by Subject|15|||
125414772|NCT02105948|451144949|FG001|Overall Study|Withdrawal by Subject|10|||
125414773|NCT02105948|451144950|FG002|Overall Study|Withdrawal by Subject|10|||
125414774|NCT02105948|451144951|FG003|Overall Study|Withdrawal by Subject|11|||
125414775|NCT00355082|451144953|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
125414776|NCT00355082|451144954|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
125414777|NCT00355082|451144955|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
125414778|NCT00355082|451144953|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
125414779|NCT00355082|451144954|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
125414780|NCT00355082|451144955|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
125414781|NCT00355082|451144953|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
125414782|NCT00355082|451144954|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
125414783|NCT00355082|451144955|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
125414784|NCT00355082|451144953|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
125414785|NCT00355082|451144954|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
125414786|NCT00355082|451144955|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
125414787|NCT00355082|451144953|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
125414788|NCT00355082|451144954|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
125414789|NCT00355082|451144955|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
125414790|NCT00355082|451144953|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
125414791|NCT00355082|451144954|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
125414792|NCT00355082|451144955|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
125414793|NCT00355082|451144953|FG000|Continuation Phase|Adverse Event|2|||
125414794|NCT00355082|451144954|FG001|Continuation Phase|Adverse Event|0|||
125414795|NCT00355082|451144955|FG002|Continuation Phase|Adverse Event|1|||
125414796|NCT00355082|451144953|FG000|Continuation Phase|Lost to Follow-up|2|||
125414797|NCT00355082|451144954|FG001|Continuation Phase|Lost to Follow-up|0|||
125414798|NCT00355082|451144955|FG002|Continuation Phase|Lost to Follow-up|1|||
125414799|NCT00355082|451144953|FG000|Continuation Phase|Protocol Violation|1|||
125414800|NCT00355082|451144954|FG001|Continuation Phase|Protocol Violation|0|||
125414801|NCT00355082|451144955|FG002|Continuation Phase|Protocol Violation|1|||
125414802|NCT00355082|451144953|FG000|Continuation Phase|Withdrawal by Subject|4|||
125414803|NCT00355082|451144954|FG001|Continuation Phase|Withdrawal by Subject|0|||
125414804|NCT00355082|451144955|FG002|Continuation Phase|Withdrawal by Subject|0|||
125448836|NCT00495469|451270898|FG004|Overall Study|Liver function test abnormality|0|||
125285353|NCT02754141|450672644|FG015|Overall Study|Maximum clinical benefit|0|||
125414805|NCT00355082|451144953|FG000|Continuation Phase|Lack of Efficacy|5|||
125414806|NCT00355082|451144954|FG001|Continuation Phase|Lack of Efficacy|0|||
125414807|NCT00355082|451144955|FG002|Continuation Phase|Lack of Efficacy|0|||
125414808|NCT00355082|451144953|FG000|Continuation Phase|Site Closed by Sponsor|8|||
125414809|NCT00355082|451144954|FG001|Continuation Phase|Site Closed by Sponsor|0|||
125448837|NCT00495469|451270899|FG005|Overall Study|Liver function test abnormality|0|||
125414810|NCT00355082|451144955|FG002|Continuation Phase|Site Closed by Sponsor|0|||
125414811|NCT00355082|451144953|FG000|Continuation Phase|Scheduling Error|1|||
125414812|NCT00355082|451144954|FG001|Continuation Phase|Scheduling Error|0|||
125414813|NCT00355082|451144955|FG002|Continuation Phase|Scheduling Error|0|||
125414814|NCT00355082|451144953|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
125414815|NCT00355082|451144954|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
125414816|NCT00355082|451144955|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
125414817|NCT04323436|451144956|FG000|Overall Study|Adverse Event|7|||
125414818|NCT04323436|451144957|FG001|Overall Study|Adverse Event|0|||
125414819|NCT04323436|451144958|FG002|Overall Study|Adverse Event|0|||
125414820|NCT04323436|451144956|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
125414821|NCT04323436|451144957|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
125414822|NCT04323436|451144958|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
125414823|NCT04323436|451144956|FG000|Overall Study|Death|1|||
125414824|NCT04323436|451144957|FG001|Overall Study|Death|0|||
125414825|NCT04323436|451144958|FG002|Overall Study|Death|0|||
125414826|NCT04323436|451144956|FG000|Overall Study|Physician Decision|2|||
125414827|NCT04323436|451144957|FG001|Overall Study|Physician Decision|0|||
125414828|NCT04323436|451144958|FG002|Overall Study|Physician Decision|0|||
125414829|NCT04323436|451144956|FG000|Overall Study|Progressive disease|10|||
125414830|NCT04323436|451144957|FG001|Overall Study|Progressive disease|0|||
125414831|NCT04323436|451144958|FG002|Overall Study|Progressive disease|0|||
125414832|NCT04323436|451144956|FG000|Overall Study|Subject decision|3|||
125414833|NCT04323436|451144957|FG001|Overall Study|Subject decision|0|||
125414834|NCT04323436|451144958|FG002|Overall Study|Subject decision|0|||
125414835|NCT01660763|451144962|FG000|Overall Study|Lack of Efficacy|45|||
125414836|NCT01660763|451144963|FG001|Overall Study|Lack of Efficacy|50|||
125414837|NCT01660763|451144962|FG000|Overall Study|Adverse Event|22|||
125414838|NCT01660763|451144963|FG001|Overall Study|Adverse Event|7|||
125414839|NCT01660763|451144962|FG000|Overall Study|Protocol Violation|1|||
125414840|NCT01660763|451144963|FG001|Overall Study|Protocol Violation|0|||
125414841|NCT01660763|451144962|FG000|Overall Study|Withdrawal by Subject|4|||
125414842|NCT01660763|451144963|FG001|Overall Study|Withdrawal by Subject|0|||
125414843|NCT01660763|451144962|FG000|Overall Study|Patient ready for early discharge|28|||
125414844|NCT01660763|451144963|FG001|Overall Study|Patient ready for early discharge|4|||
125414845|NCT02265237|451144964|FG000|As Treated (Overall Study)|Adverse Event|1|||
125414846|NCT02265237|451144965|FG001|As Treated (Overall Study)|Adverse Event|1|||
125414847|NCT02265237|451144966|FG002|As Treated (Overall Study)|Adverse Event|0|||
125414848|NCT02265237|451144967|FG003|As Treated (Overall Study)|Adverse Event|0|||
125414849|NCT02265237|451144964|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
125414850|NCT02265237|451144965|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
125414851|NCT02265237|451144966|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
125414852|NCT02265237|451144967|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
125414853|NCT02265237|451144964|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
125414854|NCT02265237|451144965|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
125414855|NCT02265237|451144966|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
125414856|NCT02265237|451144967|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
125414857|NCT02265237|451144964|FG000|As Treated (Overall Study)|Other|2|||
125414858|NCT02265237|451144965|FG001|As Treated (Overall Study)|Other|0|||
125414859|NCT02265237|451144966|FG002|As Treated (Overall Study)|Other|3|||
125414860|NCT02265237|451144967|FG003|As Treated (Overall Study)|Other|1|||
125414861|NCT01178853|451144969|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
125414862|NCT01178853|451144970|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
125414863|NCT01178853|451144969|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
125414864|NCT01178853|451144970|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
125414865|NCT01178853|451144969|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
125414866|NCT01178853|451144970|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
125414867|NCT01178853|451144969|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
125414868|NCT01178853|451144970|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
125414869|NCT01178853|451144969|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
125414870|NCT01178853|451144970|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
125285354|NCT02754141|450672645|FG016|Overall Study|Maximum clinical benefit|0|||
125414871|NCT03550313|451144971|FG000|Overall Study|Adverse Event|0|||
125448838|NCT00495469|451270900|FG006|Overall Study|Liver function test abnormality|0|||
125285355|NCT02754141|450672646|FG017|Overall Study|Maximum clinical benefit|0|||
125414872|NCT03550313|451144972|FG001|Overall Study|Adverse Event|1|||
125414873|NCT03550313|451144973|FG002|Overall Study|Adverse Event|0|||
125414874|NCT03550313|451144971|FG000|Overall Study|Lost to Follow-up|5|||
125414875|NCT03550313|451144972|FG001|Overall Study|Lost to Follow-up|7|||
125414876|NCT03550313|451144973|FG002|Overall Study|Lost to Follow-up|12|||
125414877|NCT03550313|451144971|FG000|Overall Study|Study terminated by sponsor|44|||
125414878|NCT03550313|451144972|FG001|Overall Study|Study terminated by sponsor|37|||
125414879|NCT03550313|451144973|FG002|Overall Study|Study terminated by sponsor|48|||
125414880|NCT03550313|451144971|FG000|Overall Study|No longer met eligibility criteria|3|||
125448839|NCT00495469|451270894|FG000|Overall Study|ST depression at randomisation in ECG|0|||
125285356|NCT02754141|450672629|FG000|Overall Study|No longer meets study criteria|0|||
125414881|NCT03550313|451144972|FG001|Overall Study|No longer met eligibility criteria|5|||
125414882|NCT03550313|451144973|FG002|Overall Study|No longer met eligibility criteria|6|||
125414883|NCT03550313|451144971|FG000|Overall Study|Withdrawal by parent/guardian|20|||
125414884|NCT03550313|451144972|FG001|Overall Study|Withdrawal by parent/guardian|18|||
125414885|NCT03550313|451144973|FG002|Overall Study|Withdrawal by parent/guardian|26|||
125448840|NCT00495469|451270895|FG001|Overall Study|ST depression at randomisation in ECG|1|||
125285357|NCT02754141|450672630|FG001|Overall Study|No longer meets study criteria|0|||
125414886|NCT03550313|451144971|FG000|Overall Study|Other|4|||
125414887|NCT03550313|451144972|FG001|Overall Study|Other|2|||
125414888|NCT03550313|451144973|FG002|Overall Study|Other|2|||
125414889|NCT03550313|451144971|FG000|Overall Study|Randomized but not vaccinated|3|||
125414890|NCT03550313|451144972|FG001|Overall Study|Randomized but not vaccinated|23|||
125414891|NCT03550313|451144973|FG002|Overall Study|Randomized but not vaccinated|2|||
125414892|NCT03550313|451144971|FG000|Overall Study|Sites terminated due to quality issues|18|||
125414893|NCT03550313|451144972|FG001|Overall Study|Sites terminated due to quality issues|17|||
125414894|NCT03550313|451144973|FG002|Overall Study|Sites terminated due to quality issues|18|||
125414895|NCT00839072|451144974|FG000|First Intervention Period|Withdrawal by Subject|1|||
125414896|NCT00839072|451144975|FG001|First Intervention Period|Withdrawal by Subject|0|||
125414897|NCT00839072|451144974|FG000|First Intervention Period|Adverse Event|1|||
125414898|NCT00839072|451144975|FG001|First Intervention Period|Adverse Event|1|||
125414899|NCT00839072|451144974|FG000|Second Intervention Period|Withdrawal by Subject|1|||
125414900|NCT00839072|451144975|FG001|Second Intervention Period|Withdrawal by Subject|0|||
125414901|NCT00380068|451144977|FG000|Overall Study|Adverse Event|40|||
125414902|NCT00380068|451144977|FG000|Overall Study|Withdrawal by Subject|10|||
125414903|NCT00380068|451144977|FG000|Overall Study|Not compliant|6|||
125414904|NCT00380068|451144977|FG000|Overall Study|Lost to Follow-up|1|||
125414905|NCT00380068|451144977|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
125414906|NCT00380068|451144977|FG000|Overall Study|Lung transplant|3|||
125414907|NCT00380068|451144977|FG000|Overall Study|Physician Decision|2|||
125414908|NCT00380068|451144977|FG000|Overall Study|Partipant moved away|1|||
125414909|NCT00380068|451144977|FG000|Overall Study|Lack of Efficacy|5|||
125414910|NCT01297062|451144978|FG000|Overall Study|Adverse Event|2|||
125414911|NCT01297062|451144979|FG001|Overall Study|Adverse Event|0|||
125285358|NCT02754141|450672631|FG002|Overall Study|No longer meets study criteria|0|||
125285359|NCT02754141|450672632|FG003|Overall Study|No longer meets study criteria|1|||
125285360|NCT02754141|450672633|FG004|Overall Study|No longer meets study criteria|0|||
125285361|NCT02754141|450672634|FG005|Overall Study|No longer meets study criteria|0|||
125285362|NCT02754141|450672635|FG006|Overall Study|No longer meets study criteria|0|||
125414912|NCT01297062|451144980|FG002|Overall Study|Adverse Event|1|||
125414913|NCT01297062|451144981|FG003|Overall Study|Adverse Event|0|||
125414914|NCT01297062|451144982|FG004|Overall Study|Adverse Event|0|||
125414915|NCT01297062|451144983|FG005|Overall Study|Adverse Event|0|||
125414916|NCT01297062|451144984|FG006|Overall Study|Adverse Event|0|||
125414917|NCT01297062|451144978|FG000|Overall Study|Physician Decision|1|||
125414918|NCT01297062|451144979|FG001|Overall Study|Physician Decision|0|||
125414919|NCT01297062|451144980|FG002|Overall Study|Physician Decision|1|||
125414920|NCT01297062|451144981|FG003|Overall Study|Physician Decision|0|||
125414921|NCT01297062|451144982|FG004|Overall Study|Physician Decision|0|||
125414922|NCT01297062|451144983|FG005|Overall Study|Physician Decision|0|||
125414923|NCT01297062|451144984|FG006|Overall Study|Physician Decision|6|||
125285363|NCT02754141|450672636|FG007|Overall Study|No longer meets study criteria|0|||
125285364|NCT02754141|450672637|FG008|Overall Study|No longer meets study criteria|0|||
125285365|NCT02754141|450672638|FG009|Overall Study|No longer meets study criteria|0|||
125285366|NCT02754141|450672639|FG010|Overall Study|No longer meets study criteria|0|||
125285367|NCT02754141|450672640|FG011|Overall Study|No longer meets study criteria|0|||
125285368|NCT02754141|450672641|FG012|Overall Study|No longer meets study criteria|0|||
125285369|NCT02754141|450672642|FG013|Overall Study|No longer meets study criteria|0|||
125285370|NCT02754141|450672643|FG014|Overall Study|No longer meets study criteria|0|||
125285371|NCT02754141|450672644|FG015|Overall Study|No longer meets study criteria|0|||
125285372|NCT02754141|450672645|FG016|Overall Study|No longer meets study criteria|0|||
125285373|NCT02754141|450672646|FG017|Overall Study|No longer meets study criteria|0|||
125414924|NCT01297062|451144978|FG000|Overall Study|Protocol Violation|0|||
125414925|NCT01297062|451144979|FG001|Overall Study|Protocol Violation|0|||
125414926|NCT01297062|451144980|FG002|Overall Study|Protocol Violation|0|||
125414927|NCT01297062|451144981|FG003|Overall Study|Protocol Violation|0|||
125414928|NCT01297062|451144982|FG004|Overall Study|Protocol Violation|1|||
125414929|NCT01297062|451144983|FG005|Overall Study|Protocol Violation|0|||
125414930|NCT01297062|451144984|FG006|Overall Study|Protocol Violation|0|||
125414931|NCT01297062|451144978|FG000|Overall Study|Subject Decision|1|||
125414932|NCT01297062|451144979|FG001|Overall Study|Subject Decision|1|||
125414933|NCT01297062|451144980|FG002|Overall Study|Subject Decision|0|||
125414934|NCT01297062|451144981|FG003|Overall Study|Subject Decision|1|||
125414935|NCT01297062|451144982|FG004|Overall Study|Subject Decision|1|||
125414936|NCT01297062|451144983|FG005|Overall Study|Subject Decision|1|||
125414937|NCT01297062|451144984|FG006|Overall Study|Subject Decision|2|||
125414938|NCT01458574|451144985|FG000|Overall Study|Adverse Event|5|||
125414939|NCT01458574|451144986|FG001|Overall Study|Adverse Event|9|||
125414940|NCT01458574|451144987|FG002|Overall Study|Adverse Event|7|||
125414941|NCT01458574|451144985|FG000|Overall Study|Lack of Efficacy|70|||
125414942|NCT01458574|451144986|FG001|Overall Study|Lack of Efficacy|53|||
125414943|NCT01458574|451144987|FG002|Overall Study|Lack of Efficacy|132|||
125414944|NCT01458574|451144985|FG000|Overall Study|Lost to Follow-up|3|||
125414945|NCT01458574|451144986|FG001|Overall Study|Lost to Follow-up|2|||
125414946|NCT01458574|451144987|FG002|Overall Study|Lost to Follow-up|1|||
125414947|NCT01458574|451144985|FG000|Overall Study|Pregnancy|1|||
125414948|NCT01458574|451144986|FG001|Overall Study|Pregnancy|1|||
125414949|NCT01458574|451144987|FG002|Overall Study|Pregnancy|0|||
125414950|NCT01458574|451144985|FG000|Overall Study|Protocol Violation|0|||
125414951|NCT01458574|451144986|FG001|Overall Study|Protocol Violation|1|||
125414952|NCT01458574|451144987|FG002|Overall Study|Protocol Violation|0|||
125414953|NCT01458574|451144985|FG000|Overall Study|Withdrawal by Subject|6|||
125414954|NCT01458574|451144986|FG001|Overall Study|Withdrawal by Subject|3|||
125414955|NCT01458574|451144987|FG002|Overall Study|Withdrawal by Subject|5|||
125414956|NCT01458574|451144985|FG000|Overall Study|Other|2|||
125414957|NCT01458574|451144986|FG001|Overall Study|Other|1|||
125414958|NCT01458574|451144987|FG002|Overall Study|Other|0|||
125414959|NCT01458574|451144985|FG000|Overall Study|Randomized but not treated|0|||
125414960|NCT01458574|451144986|FG001|Overall Study|Randomized but not treated|1|||
125414961|NCT01458574|451144987|FG002|Overall Study|Randomized but not treated|0|||
125414962|NCT02125786|451144988|FG000|Overall Study|Still in Follow-up|3|||
125414963|NCT02125786|451144988|FG000|Overall Study|Screen Failure|2|||
125285374|NCT02754141|450672629|FG000|Overall Study|Other reasons|0|||
125285375|NCT02754141|450672630|FG001|Overall Study|Other reasons|0|||
125414964|NCT02125786|451144988|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
125414965|NCT02125786|451144988|FG000|Overall Study|Progressive Disease|44|||
125414966|NCT02125786|451144988|FG000|Overall Study|Death|8|||
125414967|NCT04964089|451144989|FG000|Overall Study|Adverse Event|8|||
125414968|NCT04964089|451144990|FG001|Overall Study|Adverse Event|6|||
125414969|NCT04964089|451144989|FG000|Overall Study|Non-compliance with study schedule|1|||
125414970|NCT04964089|451144990|FG001|Overall Study|Non-compliance with study schedule|0|||
125414971|NCT04964089|451144989|FG000|Overall Study|Withdrawal by Subject|6|||
125414972|NCT04964089|451144990|FG001|Overall Study|Withdrawal by Subject|5|||
125414973|NCT04964089|451144989|FG000|Overall Study|Lost to Follow-up|1|||
125414974|NCT04964089|451144990|FG001|Overall Study|Lost to Follow-up|1|||
125414975|NCT04964089|451144989|FG000|Overall Study|Progressive disease|4|||
125414976|NCT04964089|451144990|FG001|Overall Study|Progressive disease|0|||
125414977|NCT04964089|451144989|FG000|Overall Study|Physician Decision|1|||
125414978|NCT04964089|451144990|FG001|Overall Study|Physician Decision|0|||
125414979|NCT04964089|451144989|FG000|Overall Study|Participant did not want to continue study treatment|1|||
125414980|NCT04964089|451144990|FG001|Overall Study|Participant did not want to continue study treatment|0|||
125414981|NCT04964089|451144989|FG000|Overall Study|Participant moved to different state|1|||
125414982|NCT04964089|451144990|FG001|Overall Study|Participant moved to different state|0|||
125414983|NCT04964089|451144989|FG000|Overall Study|Participant decided to discontinue|0|||
125414984|NCT04964089|451144990|FG001|Overall Study|Participant decided to discontinue|1|||
125414985|NCT01682837|451144991|FG000|Baseline|Withdrawal by Subject|5|||
125414986|NCT01196975|451144992|FG000|Overall Study|Adverse Event|2|||
125414987|NCT01196975|451144993|FG001|Overall Study|Adverse Event|2|||
125414988|NCT01196975|451144994|FG002|Overall Study|Adverse Event|0|||
125414989|NCT01196975|451144995|FG003|Overall Study|Adverse Event|0|||
125414990|NCT01196975|451144996|FG004|Overall Study|Adverse Event|2|||
125414991|NCT01196975|451144992|FG000|Overall Study|Withdrawal by Subject|2|||
125414992|NCT01196975|451144993|FG001|Overall Study|Withdrawal by Subject|1|||
125414993|NCT01196975|451144994|FG002|Overall Study|Withdrawal by Subject|0|||
125414994|NCT01196975|451144995|FG003|Overall Study|Withdrawal by Subject|1|||
125414995|NCT01196975|451144996|FG004|Overall Study|Withdrawal by Subject|0|||
125414996|NCT01196975|451144992|FG000|Overall Study|Lost to Follow-up|11|||
125414997|NCT01196975|451144993|FG001|Overall Study|Lost to Follow-up|6|||
125414998|NCT01196975|451144994|FG002|Overall Study|Lost to Follow-up|5|||
125414999|NCT01196975|451144995|FG003|Overall Study|Lost to Follow-up|5|||
125415000|NCT01196975|451144996|FG004|Overall Study|Lost to Follow-up|11|||
125415001|NCT01365494|451144997|FG000|Overall Study|Adverse Event|1|||
125415002|NCT01365494|451144998|FG001|Overall Study|Adverse Event|0|||
125415003|NCT01365494|451144997|FG000|Overall Study|Withdrawal by Subject|0|||
125415004|NCT01365494|451144998|FG001|Overall Study|Withdrawal by Subject|1|||
125415005|NCT01365494|451144997|FG000|Overall Study|Lost to Follow-up|1|||
125415006|NCT01365494|451144998|FG001|Overall Study|Lost to Follow-up|2|||
125415007|NCT03394924|451145001|FG000|Overall Study|Adverse Event|0|||
125285376|NCT02754141|450672631|FG002|Overall Study|Other reasons|0|||
125415008|NCT03394924|451145002|FG001|Overall Study|Adverse Event|5|||
125415009|NCT03394924|451145003|FG002|Overall Study|Adverse Event|0|||
125415010|NCT03394924|451145001|FG000|Overall Study|Withdrawal by Subject|2|||
125415011|NCT03394924|451145002|FG001|Overall Study|Withdrawal by Subject|0|||
125415012|NCT03394924|451145003|FG002|Overall Study|Withdrawal by Subject|0|||
125415013|NCT03394924|451145001|FG000|Overall Study|Lost to Follow-up|0|||
125415014|NCT03394924|451145002|FG001|Overall Study|Lost to Follow-up|1|||
125415015|NCT03394924|451145003|FG002|Overall Study|Lost to Follow-up|0|||
125415016|NCT03394924|451145001|FG000|Overall Study|Did not meet all inclusion criteria|1|||
125415017|NCT03394924|451145002|FG001|Overall Study|Did not meet all inclusion criteria|0|||
125415018|NCT03394924|451145003|FG002|Overall Study|Did not meet all inclusion criteria|0|||
125415019|NCT03588572|451145004|FG000|Visitation 1|Lack of Efficacy|1|||
125415020|NCT03588572|451145005|FG001|Visitation 1|Lack of Efficacy|1|||
125415021|NCT03588572|451145004|FG000|Visitation 2|Lost to Follow-up|1|||
125415022|NCT03588572|451145005|FG001|Visitation 2|Lost to Follow-up|1|||
125415023|NCT03588572|451145004|FG000|Visitation 2|Lack of Efficacy|0|||
125415024|NCT03588572|451145005|FG001|Visitation 2|Lack of Efficacy|1|||
125415025|NCT03588572|451145004|FG000|Visitation 2|Withdrawal by Subject|1|||
125415026|NCT03588572|451145005|FG001|Visitation 2|Withdrawal by Subject|0|||
125415027|NCT03588572|451145004|FG000|Visitation 3|Lost to Follow-up|1|||
125448841|NCT00495469|451270896|FG002|Overall Study|ST depression at randomisation in ECG|0|||
125448842|NCT00495469|451270897|FG003|Overall Study|ST depression at randomisation in ECG|0|||
125448843|NCT00495469|451270898|FG004|Overall Study|ST depression at randomisation in ECG|0|||
125448844|NCT00495469|451270899|FG005|Overall Study|ST depression at randomisation in ECG|0|||
125448845|NCT00495469|451270900|FG006|Overall Study|ST depression at randomisation in ECG|0|||
125448846|NCT00448864|451270903|FG000|Overall Study|Death|1|||
125448847|NCT00448864|451270904|FG001|Overall Study|Death|0|||
125448848|NCT00448864|451270905|FG002|Overall Study|Death|0|||
125448849|NCT00448864|451270903|FG000|Overall Study|Lost to Follow-up|3|||
125448850|NCT00448864|451270904|FG001|Overall Study|Lost to Follow-up|1|||
125448851|NCT00448864|451270905|FG002|Overall Study|Lost to Follow-up|0|||
125448852|NCT00448864|451270903|FG000|Overall Study|Physician Decision|1|||
125448853|NCT00448864|451270904|FG001|Overall Study|Physician Decision|0|||
125448854|NCT00448864|451270905|FG002|Overall Study|Physician Decision|1|||
125448855|NCT00448864|451270903|FG000|Overall Study|Withdrawal by Subject|0|||
125448856|NCT00448864|451270904|FG001|Overall Study|Withdrawal by Subject|2|||
125448857|NCT00448864|451270905|FG002|Overall Study|Withdrawal by Subject|0|||
125448858|NCT00448864|451270903|FG000|Overall Study|Protocol Violation|0|||
125448859|NCT00448864|451270904|FG001|Overall Study|Protocol Violation|2|||
125448860|NCT00448864|451270905|FG002|Overall Study|Protocol Violation|0|||
125448861|NCT01323660|451270906|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
125448862|NCT01323660|451270907|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
125448863|NCT01323660|451270908|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
125448864|NCT01323660|451270909|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
125448865|NCT01323660|451270910|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
125448866|NCT01323660|451270911|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
125448867|NCT01323660|451270906|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
125448868|NCT01323660|451270907|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
125448869|NCT01323660|451270908|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
125448870|NCT01323660|451270909|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
125448871|NCT01323660|451270910|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
125448872|NCT01323660|451270911|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
125448873|NCT01323660|451270906|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
125448874|NCT01323660|451270907|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
125448875|NCT01323660|451270908|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
125448876|NCT01323660|451270909|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
125448877|NCT01323660|451270910|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
125448878|NCT01323660|451270911|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
125448879|NCT01323660|451270906|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
125448880|NCT01323660|451270907|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
125448881|NCT01323660|451270908|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
125448882|NCT01323660|451270909|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
125448883|NCT01323660|451270910|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
125448884|NCT01323660|451270911|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
125448885|NCT01323660|451270906|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125448886|NCT01323660|451270907|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125448887|NCT01323660|451270908|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125448888|NCT01323660|451270909|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125448889|NCT01323660|451270910|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
125448890|NCT01323660|451270911|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125448891|NCT01323660|451270906|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
125448892|NCT01323660|451270907|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125285377|NCT02754141|450672632|FG003|Overall Study|Other reasons|0|||
125285378|NCT02754141|450672633|FG004|Overall Study|Other reasons|0|||
125415028|NCT03588572|451145005|FG001|Visitation 3|Lost to Follow-up|1|||
125415029|NCT03588572|451145004|FG000|Visitation 3|Physician Decision|1|||
125448893|NCT01323660|451270908|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
125448894|NCT01323660|451270909|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
125448895|NCT01323660|451270910|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
125448896|NCT01323660|451270911|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
125448897|NCT01323660|451270906|FG000|Washout Period (14 Days)|Adverse Event|0|||
125448898|NCT01323660|451270907|FG001|Washout Period (14 Days)|Adverse Event|0|||
125448899|NCT01323660|451270908|FG002|Washout Period (14 Days)|Adverse Event|0|||
125415030|NCT03588572|451145005|FG001|Visitation 3|Physician Decision|1|||
125415031|NCT03588572|451145004|FG000|Visitation 3|Withdrawal by Subject|1|||
125415032|NCT03588572|451145005|FG001|Visitation 3|Withdrawal by Subject|0|||
125415033|NCT02535065|451145011|FG000|Overall Study|Death|13|||
125415034|NCT02535065|451145011|FG000|Overall Study|Lost to Follow-up|1|||
125415035|NCT02535065|451145011|FG000|Overall Study|Withdrawal by Subject|6|||
125415036|NCT00110617|451145012|FG000|Overall Study|Adverse Event|2|||
125415037|NCT00110617|451145013|FG001|Overall Study|Adverse Event|4|||
125415038|NCT00110617|451145012|FG000|Overall Study|Abnormal Laboratory Value|4|||
125415039|NCT00110617|451145013|FG001|Overall Study|Abnormal Laboratory Value|2|||
125415040|NCT00110617|451145012|FG000|Overall Study|Lack of Efficacy|1|||
125415041|NCT00110617|451145013|FG001|Overall Study|Lack of Efficacy|0|||
125415042|NCT00110617|451145012|FG000|Overall Study|Patient no longer requires study drug|1|||
125415043|NCT00110617|451145013|FG001|Overall Study|Patient no longer requires study drug|0|||
125415044|NCT00110617|451145012|FG000|Overall Study|Protocol Violation|5|||
125415045|NCT00110617|451145013|FG001|Overall Study|Protocol Violation|0|||
125415046|NCT00110617|451145012|FG000|Overall Study|Withdrawal by Subject|10|||
125415047|NCT00110617|451145013|FG001|Overall Study|Withdrawal by Subject|4|||
125415048|NCT00110617|451145012|FG000|Overall Study|Lost to Follow-up|9|||
125415049|NCT00110617|451145013|FG001|Overall Study|Lost to Follow-up|1|||
125415050|NCT00110617|451145012|FG000|Overall Study|Administrative problems|6|||
125415051|NCT00110617|451145013|FG001|Overall Study|Administrative problems|5|||
125415052|NCT00110617|451145012|FG000|Overall Study|Death|1|||
125415053|NCT00110617|451145013|FG001|Overall Study|Death|1|||
125415054|NCT00110617|451145012|FG000|Overall Study|Did not receive study drug|0|||
125415055|NCT00110617|451145013|FG001|Overall Study|Did not receive study drug|12|||
125415056|NCT01781572|451145014|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
125415057|NCT01781572|451145015|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
125415058|NCT01781572|451145016|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
125415059|NCT01781572|451145014|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
125415060|NCT01781572|451145015|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
125415061|NCT01781572|451145016|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
125415062|NCT01781572|451145014|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
125415063|NCT01781572|451145015|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
125415064|NCT01781572|451145016|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
125415065|NCT01781572|451145014|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
125415066|NCT01781572|451145015|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
125415067|NCT01781572|451145016|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
125415068|NCT01781572|451145014|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
125415069|NCT01781572|451145015|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
125415070|NCT01781572|451145016|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
125415071|NCT01781572|451145014|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
125415072|NCT01781572|451145015|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
125415073|NCT01781572|451145016|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
125415074|NCT01781572|451145014|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
125415075|NCT01781572|451145015|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
125415076|NCT01781572|451145016|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
125415077|NCT01781572|451145014|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
125415078|NCT01781572|451145015|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
125415079|NCT01781572|451145016|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
125415080|NCT01781572|451145014|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
125415081|NCT01781572|451145015|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
125415082|NCT01781572|451145016|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
125415083|NCT01781572|451145014|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
125415084|NCT01781572|451145015|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
125415085|NCT01781572|451145016|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
125415086|NCT01781572|451145014|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
125415087|NCT01781572|451145015|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
125415088|NCT01781572|451145016|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
125415089|NCT01781572|451145014|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
125415090|NCT01781572|451145015|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
125415091|NCT01781572|451145016|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
125415092|NCT01781572|451145014|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
125415093|NCT01781572|451145015|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
125415094|NCT01781572|451145016|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
125415095|NCT01781572|451145014|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
125415096|NCT01781572|451145015|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
125415097|NCT01781572|451145016|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
125415098|NCT01781572|451145014|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
125415099|NCT01781572|451145015|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
125415100|NCT01781572|451145016|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
125415101|NCT01781572|451145014|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
125415102|NCT01781572|451145015|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
125415103|NCT01781572|451145016|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
125415104|NCT01781572|451145014|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
125415105|NCT01781572|451145015|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
125415106|NCT01781572|451145016|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
125415107|NCT01781572|451145014|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
125415108|NCT01781572|451145015|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
125415109|NCT01781572|451145016|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
125415110|NCT00045110|451145017|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
125415111|NCT00045110|451145018|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
125415112|NCT00045110|451145019|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
125415113|NCT00045110|451145017|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
125415114|NCT00045110|451145018|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
125415115|NCT00045110|451145019|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
125415116|NCT00045110|451145017|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
125415117|NCT00045110|451145018|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
125415118|NCT00045110|451145019|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
125415119|NCT00660010|451145020|FG000|Overall Study|Withdrawal by Subject|2|||
125415120|NCT00660010|451145020|FG000|Overall Study|Lost to Follow-up|3|||
125415121|NCT00660010|451145020|FG000|Overall Study|Adverse Event|1|||
125415122|NCT00660010|451145020|FG000|Overall Study|Noncompliance with visit schedule|3|||
125415123|NCT04827576|451147324|FG000|Overall Study|Death|5|||
125415124|NCT04827576|451147325|FG001|Overall Study|Death|17|||
125415125|NCT04827576|451147326|FG002|Overall Study|Death|17|||
125415126|NCT04827576|451147327|FG003|Overall Study|Death|32|||
125415127|NCT04827576|451147324|FG000|Overall Study|Study Terminated by Sponsor|2|||
125415128|NCT04827576|451147325|FG001|Overall Study|Study Terminated by Sponsor|9|||
125415129|NCT04827576|451147326|FG002|Overall Study|Study Terminated by Sponsor|7|||
125415130|NCT04827576|451147327|FG003|Overall Study|Study Terminated by Sponsor|5|||
125415131|NCT04827576|451147324|FG000|Overall Study|Investigator's Discretion|1|||
125415132|NCT04827576|451147325|FG001|Overall Study|Investigator's Discretion|0|||
125415133|NCT04827576|451147326|FG002|Overall Study|Investigator's Discretion|2|||
125415134|NCT04827576|451147327|FG003|Overall Study|Investigator's Discretion|5|||
125415135|NCT04827576|451147324|FG000|Overall Study|Withdrew Consent|0|||
125415136|NCT04827576|451147325|FG001|Overall Study|Withdrew Consent|3|||
125415137|NCT04827576|451147326|FG002|Overall Study|Withdrew Consent|0|||
125415138|NCT04827576|451147327|FG003|Overall Study|Withdrew Consent|0|||
125415139|NCT04827576|451147324|FG000|Overall Study|Lost to Follow-up|1|||
125415140|NCT04827576|451147325|FG001|Overall Study|Lost to Follow-up|0|||
125415141|NCT04827576|451147326|FG002|Overall Study|Lost to Follow-up|0|||
125415142|NCT04827576|451147327|FG003|Overall Study|Lost to Follow-up|0|||
125415143|NCT03069482|451147328|FG000|Overall Study|Lost to Follow-up|0|||
125415144|NCT03069482|451147329|FG001|Overall Study|Lost to Follow-up|1|||
125415145|NCT03069482|451147328|FG000|Overall Study|Physician Decision|1|||
125415146|NCT03069482|451147329|FG001|Overall Study|Physician Decision|0|||
125415147|NCT04537923|451147330|FG000|Overall Study|Adverse Event|2|||
125415148|NCT04537923|451147331|FG001|Overall Study|Adverse Event|1|||
125415149|NCT04537923|451147332|FG002|Overall Study|Adverse Event|2|||
125415150|NCT04537923|451147333|FG003|Overall Study|Adverse Event|4|||
125415151|NCT04537923|451147330|FG000|Overall Study|Death|3|||
125415152|NCT04537923|451147331|FG001|Overall Study|Death|3|||
125415153|NCT04537923|451147332|FG002|Overall Study|Death|1|||
125415154|NCT04537923|451147333|FG003|Overall Study|Death|11|||
125415155|NCT04537923|451147330|FG000|Overall Study|Lost to Follow-up|1|||
125415156|NCT04537923|451147331|FG001|Overall Study|Lost to Follow-up|2|||
125415157|NCT04537923|451147332|FG002|Overall Study|Lost to Follow-up|1|||
125415158|NCT04537923|451147333|FG003|Overall Study|Lost to Follow-up|6|||
125415159|NCT04537923|451147330|FG000|Overall Study|Physician Decision|1|||
125415160|NCT04537923|451147331|FG001|Overall Study|Physician Decision|0|||
125415161|NCT04537923|451147332|FG002|Overall Study|Physician Decision|2|||
125415162|NCT04537923|451147333|FG003|Overall Study|Physician Decision|5|||
125415163|NCT04537923|451147330|FG000|Overall Study|Pregnancy|1|||
125415164|NCT04537923|451147331|FG001|Overall Study|Pregnancy|0|||
125415165|NCT04537923|451147332|FG002|Overall Study|Pregnancy|0|||
125415166|NCT04537923|451147333|FG003|Overall Study|Pregnancy|0|||
125415167|NCT04537923|451147330|FG000|Overall Study|Withdrawal by Subject|4|||
125415168|NCT04537923|451147331|FG001|Overall Study|Withdrawal by Subject|4|||
125415169|NCT04537923|451147332|FG002|Overall Study|Withdrawal by Subject|4|||
125415170|NCT04537923|451147333|FG003|Overall Study|Withdrawal by Subject|58|||
125415171|NCT04537923|451147330|FG000|Overall Study|Missed study visits|2|||
125415172|NCT04537923|451147331|FG001|Overall Study|Missed study visits|0|||
125415173|NCT04537923|451147332|FG002|Overall Study|Missed study visits|0|||
125415174|NCT04537923|451147333|FG003|Overall Study|Missed study visits|3|||
125415175|NCT04537923|451147330|FG000|Overall Study|Sponsor's decision|0|||
125415176|NCT04537923|451147331|FG001|Overall Study|Sponsor's decision|0|||
125415177|NCT04537923|451147332|FG002|Overall Study|Sponsor's decision|1|||
125415178|NCT04537923|451147333|FG003|Overall Study|Sponsor's decision|1|||
125415179|NCT04537923|451147330|FG000|Overall Study|Safety reasons|1|||
125415180|NCT04537923|451147331|FG001|Overall Study|Safety reasons|0|||
125448900|NCT01323660|451270909|FG003|Washout Period (14 Days)|Adverse Event|0|||
125448901|NCT01323660|451270910|FG004|Washout Period (14 Days)|Adverse Event|1|||
125448902|NCT01323660|451270911|FG005|Washout Period (14 Days)|Adverse Event|0|||
125448903|NCT01323660|451270906|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
125448904|NCT01323660|451270907|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
125448905|NCT01323660|451270908|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
125448906|NCT01323660|451270909|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
125448907|NCT01323660|451270910|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
125448908|NCT01323660|451270911|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
125448909|NCT01323660|451270906|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
125448910|NCT01323660|451270907|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
125448911|NCT01323660|451270908|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
125448912|NCT01323660|451270909|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
125448913|NCT01323660|451270910|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
125448914|NCT01323660|451270911|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
125448915|NCT01323660|451270906|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
125448916|NCT01323660|451270907|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
125448917|NCT01323660|451270908|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
125448918|NCT01323660|451270909|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
125448919|NCT01323660|451270910|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
125448920|NCT01323660|451270911|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
125448921|NCT01323660|451270906|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
125448922|NCT01323660|451270907|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
125448923|NCT01323660|451270908|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
125448924|NCT01323660|451270909|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
125448925|NCT01323660|451270910|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
125448926|NCT01323660|451270911|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
125448927|NCT01323660|451270906|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
125448928|NCT01323660|451270907|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
125448929|NCT01323660|451270908|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
125448930|NCT01323660|451270909|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
125448931|NCT01323660|451270910|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
125448932|NCT01323660|451270911|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
125448933|NCT01323660|451270906|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
125448934|NCT01323660|451270907|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
125448935|NCT01323660|451270908|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
125448936|NCT01323660|451270909|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125448937|NCT01323660|451270910|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
125448938|NCT01323660|451270911|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125448939|NCT04531540|451270914|FG000|Overall Study|Adverse Event|1|||
125448940|NCT04531540|451270914|FG000|Overall Study|Protocol Violation|3|||
125448941|NCT04531540|451270914|FG000|Overall Study|Withdrawal by Subject|4|||
125448942|NCT04531540|451270914|FG000|Overall Study|Found to be Ineligible|1|||
125448943|NCT01575860|451270917|FG000|Overall Study|Withdrawal by Subject|1|||
125448944|NCT01575860|451270917|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
125448945|NCT01106976|451270918|FG000|Overall Study|Lost to Follow-up|8|||
125448946|NCT00278564|451270920|FG000|Overall Study|Lack of Efficacy|4|||
125448947|NCT01094743|451270921|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
125448948|NCT02851511|451270922|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
125448949|NCT02851511|451270923|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
125448950|NCT02851511|451270924|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
125415181|NCT04537923|451147332|FG002|Overall Study|Safety reasons|0|||
125415182|NCT04537923|451147333|FG003|Overall Study|Safety reasons|0|||
125415183|NCT01261611|451147334|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
125415184|NCT01261611|451147335|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
125415185|NCT01261611|451147336|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
125415186|NCT01261611|451147334|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
125415187|NCT01261611|451147335|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
125415188|NCT01261611|451147336|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
125415189|NCT01261611|451147334|FG000|Treatment Cycle 1|Adverse Event|0|||
125415190|NCT01261611|451147335|FG001|Treatment Cycle 1|Adverse Event|1|||
125415191|NCT01261611|451147336|FG002|Treatment Cycle 1|Adverse Event|0|||
125448951|NCT02851511|451270925|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
125448952|NCT02851511|451270922|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
125448953|NCT02851511|451270923|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
125415192|NCT01261611|451147334|FG000|Treatment Cycle 1|Protocol Violation|0|||
125448954|NCT02851511|451270924|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
125448955|NCT02851511|451270925|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
125448956|NCT02851511|451270922|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
125415193|NCT01261611|451147335|FG001|Treatment Cycle 1|Protocol Violation|0|||
125415194|NCT01261611|451147336|FG002|Treatment Cycle 1|Protocol Violation|2|||
125415195|NCT01261611|451147334|FG000|Treatment Cycle 2|Completed study|4|||
125415196|NCT01261611|451147335|FG001|Treatment Cycle 2|Completed study|0|||
125415197|NCT01261611|451147336|FG002|Treatment Cycle 2|Completed study|0|||
125415198|NCT01261611|451147334|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
125415199|NCT01261611|451147335|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
125415200|NCT01261611|451147336|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
125415201|NCT01261611|451147334|FG000|Treatment Cycle 2|Adverse Event|1|||
125415202|NCT01261611|451147335|FG001|Treatment Cycle 2|Adverse Event|0|||
125415203|NCT01261611|451147336|FG002|Treatment Cycle 2|Adverse Event|0|||
125415204|NCT01261611|451147334|FG000|Treatment Cycle 2|Protocol Violation|2|||
125415205|NCT01261611|451147335|FG001|Treatment Cycle 2|Protocol Violation|0|||
125415206|NCT01261611|451147336|FG002|Treatment Cycle 2|Protocol Violation|0|||
125415207|NCT01261611|451147334|FG000|Treatment Cycle 2|Not otherwise specified|2|||
125415208|NCT01261611|451147335|FG001|Treatment Cycle 2|Not otherwise specified|0|||
125415209|NCT01261611|451147336|FG002|Treatment Cycle 2|Not otherwise specified|0|||
125415210|NCT01261611|451147334|FG000|Treatment Cycle 3|Completed study|24|||
125415211|NCT01261611|451147335|FG001|Treatment Cycle 3|Completed study|0|||
125415212|NCT01261611|451147336|FG002|Treatment Cycle 3|Completed study|0|||
125415213|NCT01261611|451147334|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
125415214|NCT01261611|451147335|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
125415215|NCT01261611|451147336|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
125415216|NCT01261611|451147334|FG000|Treatment Cycle 3|Adverse Event|1|||
125415217|NCT01261611|451147335|FG001|Treatment Cycle 3|Adverse Event|0|||
125415218|NCT01261611|451147336|FG002|Treatment Cycle 3|Adverse Event|0|||
125415219|NCT01261611|451147334|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
125415220|NCT01261611|451147335|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
125415221|NCT01261611|451147336|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
125415222|NCT01261611|451147334|FG000|Treatment Cycle 4|Completed study|87|||
125415223|NCT01261611|451147335|FG001|Treatment Cycle 4|Completed study|0|||
125415224|NCT01261611|451147336|FG002|Treatment Cycle 4|Completed study|0|||
125415225|NCT01261611|451147334|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
125415226|NCT01261611|451147335|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
125415227|NCT01261611|451147336|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
125415228|NCT01261611|451147334|FG000|Treatment Cycle 4|Adverse Event|1|||
125415229|NCT01261611|451147335|FG001|Treatment Cycle 4|Adverse Event|0|||
125415230|NCT01261611|451147336|FG002|Treatment Cycle 4|Adverse Event|0|||
125415231|NCT01261611|451147334|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
125415232|NCT01261611|451147335|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
125415233|NCT01261611|451147336|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
125415234|NCT01261611|451147334|FG000|Treatment Cycle 4|Not otherwise specified|3|||
125415235|NCT01261611|451147335|FG001|Treatment Cycle 4|Not otherwise specified|0|||
125415236|NCT01261611|451147336|FG002|Treatment Cycle 4|Not otherwise specified|0|||
125415237|NCT01261611|451147334|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
125415238|NCT01261611|451147335|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
125415239|NCT01261611|451147336|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
125415240|NCT01261611|451147334|FG000|Treatment Cycle 5|Adverse Event|1|||
125415241|NCT01261611|451147335|FG001|Treatment Cycle 5|Adverse Event|0|||
125415242|NCT01261611|451147336|FG002|Treatment Cycle 5|Adverse Event|0|||
125415243|NCT01261611|451147334|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
125415244|NCT01261611|451147335|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
125415245|NCT01261611|451147336|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
125415246|NCT02527798|451147337|FG000|Overall Study|Physician Decision|1|||
125415247|NCT02527798|451147338|FG001|Overall Study|Physician Decision|0|||
125415248|NCT02527798|451147339|FG002|Overall Study|Physician Decision|1|||
125415249|NCT02527798|451147340|FG003|Overall Study|Physician Decision|1|||
125415250|NCT02527798|451147341|FG004|Overall Study|Physician Decision|0|||
125415251|NCT02527798|451147342|FG005|Overall Study|Physician Decision|0|||
125415252|NCT02527798|451147337|FG000|Overall Study|Death|0|||
125415253|NCT02527798|451147338|FG001|Overall Study|Death|0|||
125415254|NCT02527798|451147339|FG002|Overall Study|Death|1|||
125415255|NCT02527798|451147340|FG003|Overall Study|Death|0|||
125415256|NCT02527798|451147341|FG004|Overall Study|Death|0|||
125415257|NCT02527798|451147342|FG005|Overall Study|Death|0|||
125415258|NCT02527798|451147337|FG000|Overall Study|Withdrawal by Subject|0|||
125415259|NCT02527798|451147338|FG001|Overall Study|Withdrawal by Subject|1|||
125415260|NCT02527798|451147339|FG002|Overall Study|Withdrawal by Subject|2|||
125415261|NCT02527798|451147340|FG003|Overall Study|Withdrawal by Subject|0|||
125448957|NCT02851511|451270923|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
125448958|NCT02851511|451270924|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
125415262|NCT02527798|451147341|FG004|Overall Study|Withdrawal by Subject|0|||
125415263|NCT02527798|451147342|FG005|Overall Study|Withdrawal by Subject|0|||
125415264|NCT02527798|451147337|FG000|Overall Study|Reason undisclosed|1|||
125415265|NCT02527798|451147338|FG001|Overall Study|Reason undisclosed|0|||
125415266|NCT02527798|451147339|FG002|Overall Study|Reason undisclosed|1|||
125415267|NCT02527798|451147340|FG003|Overall Study|Reason undisclosed|0|||
125415268|NCT02527798|451147341|FG004|Overall Study|Reason undisclosed|0|||
125415269|NCT02527798|451147342|FG005|Overall Study|Reason undisclosed|0|||
125415270|NCT02527798|451147337|FG000|Overall Study|Did not receive intervention|1|||
125415271|NCT02527798|451147338|FG001|Overall Study|Did not receive intervention|1|||
125415272|NCT02527798|451147339|FG002|Overall Study|Did not receive intervention|0|||
125415273|NCT02527798|451147340|FG003|Overall Study|Did not receive intervention|0|||
125415274|NCT02527798|451147341|FG004|Overall Study|Did not receive intervention|0|||
125415275|NCT02527798|451147342|FG005|Overall Study|Did not receive intervention|0|||
125415276|NCT00156065|451147347|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
125415277|NCT00156065|451147348|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
125415278|NCT00156065|451147349|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
125415279|NCT00156065|451147347|FG000|Overall Study|Adverse Event|8|||
125415280|NCT00156065|451147348|FG001|Overall Study|Adverse Event|11|||
125415281|NCT00156065|451147349|FG002|Overall Study|Adverse Event|4|||
125415282|NCT00156065|451147347|FG000|Overall Study|Lack of Efficacy|2|||
125415283|NCT00156065|451147348|FG001|Overall Study|Lack of Efficacy|9|||
125415284|NCT00156065|451147349|FG002|Overall Study|Lack of Efficacy|3|||
125415285|NCT00156065|451147347|FG000|Overall Study|Withdrawal by Subject|13|||
125415286|NCT00156065|451147348|FG001|Overall Study|Withdrawal by Subject|26|||
125415287|NCT00156065|451147349|FG002|Overall Study|Withdrawal by Subject|16|||
125415288|NCT00156065|451147347|FG000|Overall Study|Lost to Follow-up|5|||
125415289|NCT00156065|451147348|FG001|Overall Study|Lost to Follow-up|7|||
125415290|NCT00156065|451147349|FG002|Overall Study|Lost to Follow-up|1|||
125415291|NCT00156065|451147347|FG000|Overall Study|Other|2|||
125415292|NCT00156065|451147348|FG001|Overall Study|Other|9|||
125415293|NCT00156065|451147349|FG002|Overall Study|Other|3|||
125415294|NCT04745169|451147350|FG000|Overall Study|Kidney transplantation|1|||
125415295|NCT04745169|451147350|FG000|Overall Study|Participant health problems|3|||
125415296|NCT04745169|451147350|FG000|Overall Study|Physician Decision|2|||
125415297|NCT00920426|451147351|FG000|ITZ111451|Adverse Event|1|||
125415298|NCT00920426|451147352|FG001|ITZ111451|Adverse Event|0|||
125415299|NCT00920426|451147353|FG002|ITZ111451|Adverse Event|0|||
125415300|NCT00920426|451147354|FG003|ITZ111451|Adverse Event|0|||
125415301|NCT01292603|451147355|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
125415302|NCT01292603|451147356|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
125415303|NCT01292603|451147357|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
125415304|NCT01292603|451147358|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
125415305|NCT01292603|451147359|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
125415306|NCT01292603|451147360|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
125415307|NCT01292603|451147355|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
125415308|NCT01292603|451147356|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
125415309|NCT01292603|451147357|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
125415310|NCT01292603|451147358|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
125415311|NCT01292603|451147359|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
125415312|NCT01292603|451147360|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
125415313|NCT01292603|451147355|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
125415314|NCT01292603|451147356|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
125415315|NCT01292603|451147357|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
125415316|NCT01292603|451147358|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
125415317|NCT01292603|451147359|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
125415318|NCT01292603|451147360|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
125415319|NCT01292603|451147355|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
125415320|NCT01292603|451147356|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
125285379|NCT02754141|450672634|FG005|Overall Study|Other reasons|0|||
125285380|NCT02754141|450672635|FG006|Overall Study|Other reasons|0|||
125285381|NCT02754141|450672636|FG007|Overall Study|Other reasons|1|||
125285382|NCT02754141|450672637|FG008|Overall Study|Other reasons|0|||
125285383|NCT02754141|450672638|FG009|Overall Study|Other reasons|0|||
125285384|NCT02754141|450672639|FG010|Overall Study|Other reasons|0|||
125285385|NCT02754141|450672640|FG011|Overall Study|Other reasons|0|||
125285386|NCT02754141|450672641|FG012|Overall Study|Other reasons|2|||
125285387|NCT02754141|450672642|FG013|Overall Study|Other reasons|0|||
125285388|NCT02754141|450672643|FG014|Overall Study|Other reasons|0|||
125285389|NCT02754141|450672644|FG015|Overall Study|Other reasons|0|||
125285390|NCT02754141|450672645|FG016|Overall Study|Other reasons|0|||
125285391|NCT02754141|450672646|FG017|Overall Study|Other reasons|0|||
125285392|NCT02754141|450672629|FG000|Overall Study|Completed treatment as per protocol|0|||
125285393|NCT02754141|450672630|FG001|Overall Study|Completed treatment as per protocol|1|||
125415321|NCT01292603|451147357|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
125415322|NCT01292603|451147358|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
125415323|NCT01292603|451147359|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
125415324|NCT01292603|451147360|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
125415325|NCT01292603|451147355|FG000|Part 1: Regular Follow-Up Period|Death|3|||
125415326|NCT01292603|451147356|FG001|Part 1: Regular Follow-Up Period|Death|1|||
125415327|NCT01292603|451147357|FG002|Part 1: Regular Follow-Up Period|Death|3|||
125415328|NCT01292603|451147358|FG003|Part 1: Regular Follow-Up Period|Death|1|||
125415329|NCT01292603|451147359|FG004|Part 1: Regular Follow-Up Period|Death|0|||
125415330|NCT01292603|451147360|FG005|Part 1: Regular Follow-Up Period|Death|0|||
125285394|NCT02754141|450672631|FG002|Overall Study|Completed treatment as per protocol|0|||
125285395|NCT02754141|450672632|FG003|Overall Study|Completed treatment as per protocol|0|||
125285396|NCT02754141|450672633|FG004|Overall Study|Completed treatment as per protocol|0|||
125285397|NCT02754141|450672634|FG005|Overall Study|Completed treatment as per protocol|0|||
125285398|NCT02754141|450672635|FG006|Overall Study|Completed treatment as per protocol|0|||
125285399|NCT02754141|450672636|FG007|Overall Study|Completed treatment as per protocol|0|||
125285400|NCT02754141|450672637|FG008|Overall Study|Completed treatment as per protocol|0|||
125285401|NCT02754141|450672638|FG009|Overall Study|Completed treatment as per protocol|0|||
125285402|NCT02754141|450672639|FG010|Overall Study|Completed treatment as per protocol|0|||
125285403|NCT02754141|450672640|FG011|Overall Study|Completed treatment as per protocol|0|||
125285404|NCT02754141|450672641|FG012|Overall Study|Completed treatment as per protocol|1|||
125285405|NCT02754141|450672642|FG013|Overall Study|Completed treatment as per protocol|0|||
125285406|NCT02754141|450672643|FG014|Overall Study|Completed treatment as per protocol|0|||
125285407|NCT02754141|450672644|FG015|Overall Study|Completed treatment as per protocol|0|||
125285408|NCT02754141|450672645|FG016|Overall Study|Completed treatment as per protocol|0|||
125285409|NCT02754141|450672646|FG017|Overall Study|Completed treatment as per protocol|0|||
125285410|NCT02754141|450672629|FG000|Overall Study|Not completing monotherapy|0|||
125285411|NCT02754141|450672630|FG001|Overall Study|Not completing monotherapy|0|||
125285412|NCT02754141|450672631|FG002|Overall Study|Not completing monotherapy|0|||
125415331|NCT01292603|451147355|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
125415332|NCT01292603|451147356|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
125415333|NCT01292603|451147357|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
125415334|NCT01292603|451147358|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
125415335|NCT01292603|451147359|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
125415336|NCT01292603|451147360|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
125415337|NCT01292603|451147355|FG000|Part 2: Dose Confirmation Period|Death|0|||
125415338|NCT01292603|451147356|FG001|Part 2: Dose Confirmation Period|Death|0|||
125415339|NCT01292603|451147357|FG002|Part 2: Dose Confirmation Period|Death|0|||
125415340|NCT01292603|451147358|FG003|Part 2: Dose Confirmation Period|Death|0|||
125415341|NCT01292603|451147359|FG004|Part 2: Dose Confirmation Period|Death|1|||
125415342|NCT01292603|451147360|FG005|Part 2: Dose Confirmation Period|Death|0|||
125415343|NCT01292603|451147355|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
125415344|NCT01292603|451147356|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
125415345|NCT01292603|451147357|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
125415346|NCT01292603|451147358|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
125415347|NCT01292603|451147359|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
125415348|NCT01292603|451147360|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
125415349|NCT01292603|451147355|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
125415350|NCT01292603|451147356|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
125415351|NCT01292603|451147357|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
125415352|NCT01292603|451147358|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
125415353|NCT01292603|451147359|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
125415354|NCT01292603|451147360|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
125415355|NCT01292603|451147355|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
125415356|NCT01292603|451147356|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
125415357|NCT01292603|451147357|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
125415358|NCT01292603|451147358|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
125415359|NCT01292603|451147359|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
125415360|NCT01292603|451147360|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
125415361|NCT01292603|451147355|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
125415362|NCT01292603|451147356|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
125415363|NCT01292603|451147357|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
125415364|NCT01292603|451147358|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
125415365|NCT01292603|451147359|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
125415366|NCT01292603|451147360|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
125415367|NCT01292603|451147355|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
125415368|NCT01292603|451147356|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
125415369|NCT01292603|451147357|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
125415370|NCT01292603|451147358|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
125415371|NCT01292603|451147359|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
125415372|NCT01292603|451147360|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
125415373|NCT01292603|451147355|FG000|Part 2: Regular Follow-Up|Death|0|||
125415374|NCT01292603|451147356|FG001|Part 2: Regular Follow-Up|Death|0|||
125415375|NCT01292603|451147357|FG002|Part 2: Regular Follow-Up|Death|0|||
125415376|NCT01292603|451147358|FG003|Part 2: Regular Follow-Up|Death|0|||
125415377|NCT01292603|451147359|FG004|Part 2: Regular Follow-Up|Death|6|||
125415378|NCT01292603|451147360|FG005|Part 2: Regular Follow-Up|Death|3|||
125415379|NCT01292603|451147355|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
125415380|NCT01292603|451147356|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
125285413|NCT02754141|450672632|FG003|Overall Study|Not completing monotherapy|0|||
125285414|NCT02754141|450672633|FG004|Overall Study|Not completing monotherapy|0|||
125285415|NCT02754141|450672634|FG005|Overall Study|Not completing monotherapy|0|||
125285416|NCT02754141|450672635|FG006|Overall Study|Not completing monotherapy|0|||
125285417|NCT02754141|450672636|FG007|Overall Study|Not completing monotherapy|0|||
125285418|NCT02754141|450672637|FG008|Overall Study|Not completing monotherapy|0|||
125285419|NCT02754141|450672638|FG009|Overall Study|Not completing monotherapy|0|||
125285420|NCT02754141|450672639|FG010|Overall Study|Not completing monotherapy|0|||
125285421|NCT02754141|450672640|FG011|Overall Study|Not completing monotherapy|0|||
125285422|NCT02754141|450672641|FG012|Overall Study|Not completing monotherapy|0|||
125285423|NCT02754141|450672642|FG013|Overall Study|Not completing monotherapy|1|||
125285424|NCT02754141|450672643|FG014|Overall Study|Not completing monotherapy|0|||
125285425|NCT02754141|450672644|FG015|Overall Study|Not completing monotherapy|0|||
125285426|NCT02754141|450672645|FG016|Overall Study|Not completing monotherapy|0|||
125285427|NCT02754141|450672646|FG017|Overall Study|Not completing monotherapy|0|||
125285428|NCT03361189|450672647|FG000|Overall Study|Received heart transplant|1|||
125285429|NCT03361189|450672648|FG001|Overall Study|Received heart transplant|0|||
125285430|NCT03361189|450672647|FG000|Overall Study|Pacemake replacement|0|||
125285431|NCT03361189|450672648|FG001|Overall Study|Pacemake replacement|1|||
125285432|NCT03344549|450672653|FG000|Overall Study|Withdrawal by Subject|3|||
125285433|NCT03344549|450672654|FG001|Overall Study|Withdrawal by Subject|2|||
125285434|NCT03344549|450672653|FG000|Overall Study|Dialysis|2|||
125285435|NCT03344549|450672654|FG001|Overall Study|Dialysis|0|||
125285436|NCT03344549|450672653|FG000|Overall Study|Cancer|1|||
125285437|NCT03344549|450672654|FG001|Overall Study|Cancer|0|||
125285438|NCT03344549|450672653|FG000|Overall Study|Lack of electronic device|1|||
125285439|NCT03344549|450672654|FG001|Overall Study|Lack of electronic device|0|||
125285440|NCT03344549|450672653|FG000|Overall Study|Transportation difficulty|0|||
125285441|NCT03344549|450672654|FG001|Overall Study|Transportation difficulty|13|||
125285442|NCT02323126|450672655|FG000|Overall Study|Patient / guardian decision|0|||
125285443|NCT02323126|450672656|FG001|Overall Study|Patient / guardian decision|1|||
125285444|NCT02323126|450672657|FG002|Overall Study|Patient / guardian decision|2|||
125285445|NCT02323126|450672655|FG000|Overall Study|Progressive disease|14|||
125285446|NCT02323126|450672656|FG001|Overall Study|Progressive disease|8|||
125285447|NCT02323126|450672657|FG002|Overall Study|Progressive disease|14|||
125285448|NCT02323126|450672655|FG000|Overall Study|Physician Decision|0|||
125285449|NCT02323126|450672656|FG001|Overall Study|Physician Decision|1|||
125285450|NCT02323126|450672657|FG002|Overall Study|Physician Decision|3|||
125285451|NCT02323126|450672655|FG000|Overall Study|Death|1|||
125285452|NCT02323126|450672656|FG001|Overall Study|Death|1|||
125285453|NCT02323126|450672657|FG002|Overall Study|Death|4|||
125285454|NCT02323126|450672655|FG000|Overall Study|Adverse Event|3|||
125285455|NCT02323126|450672656|FG001|Overall Study|Adverse Event|5|||
125448959|NCT02851511|451270925|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
125448960|NCT02851511|451270922|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
125448961|NCT02851511|451270923|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
125448962|NCT02851511|451270924|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
125448963|NCT02851511|451270925|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
125448964|NCT02851511|451270922|FG000|Phase I|Physician Decision|0|||
125448965|NCT02851511|451270923|FG001|Phase I|Physician Decision|0|||
125448966|NCT02851511|451270924|FG002|Phase I|Physician Decision|0|||
125448967|NCT02851511|451270925|FG003|Phase I|Physician Decision|1|||
125448968|NCT02851511|451270922|FG000|Phase I|Withdrawal by Subject|2|||
125448969|NCT02851511|451270923|FG001|Phase I|Withdrawal by Subject|1|||
125448970|NCT02851511|451270924|FG002|Phase I|Withdrawal by Subject|0|||
125448971|NCT02851511|451270925|FG003|Phase I|Withdrawal by Subject|3|||
125448972|NCT02851511|451270922|FG000|Phase II|Physician Decision|18|||
125448973|NCT02851511|451270923|FG001|Phase II|Physician Decision|16|||
125448974|NCT02851511|451270924|FG002|Phase II|Physician Decision|0|||
125448975|NCT02851511|451270925|FG003|Phase II|Physician Decision|0|||
125448976|NCT02851511|451270922|FG000|Phase II|Withdrawal by Subject|18|||
125448977|NCT02851511|451270923|FG001|Phase II|Withdrawal by Subject|16|||
125448978|NCT02851511|451270924|FG002|Phase II|Withdrawal by Subject|0|||
125448979|NCT02851511|451270925|FG003|Phase II|Withdrawal by Subject|0|||
125448980|NCT02851511|451270922|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
125285456|NCT02323126|450672657|FG002|Overall Study|Adverse Event|7|||
125285457|NCT03333252|450672658|FG000|Overall Study|Adverse Event|10|||
125448981|NCT02851511|451270923|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
125448982|NCT02851511|451270924|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
125448983|NCT02851511|451270925|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
125448984|NCT02851511|451270922|FG000|Phase II|Lost to Follow-up|0|||
125285458|NCT03333252|450672659|FG001|Overall Study|Adverse Event|6|||
125285459|NCT03333252|450672660|FG002|Overall Study|Adverse Event|5|||
125285460|NCT03333252|450672661|FG003|Overall Study|Adverse Event|2|||
125285461|NCT03333252|450672658|FG000|Overall Study|Death|1|||
125448985|NCT02851511|451270923|FG001|Phase II|Lost to Follow-up|1|||
125285462|NCT03333252|450672659|FG001|Overall Study|Death|3|||
125285463|NCT03333252|450672660|FG002|Overall Study|Death|0|||
125285464|NCT03333252|450672661|FG003|Overall Study|Death|0|||
125285465|NCT03333252|450672658|FG000|Overall Study|Lack of Efficacy|8|||
125285466|NCT03333252|450672659|FG001|Overall Study|Lack of Efficacy|4|||
125285467|NCT03333252|450672660|FG002|Overall Study|Lack of Efficacy|0|||
125285468|NCT03333252|450672661|FG003|Overall Study|Lack of Efficacy|7|||
125285469|NCT03333252|450672658|FG000|Overall Study|Lost to Follow-up|0|||
125285470|NCT03333252|450672659|FG001|Overall Study|Lost to Follow-up|5|||
125285471|NCT03333252|450672660|FG002|Overall Study|Lost to Follow-up|9|||
125285472|NCT03333252|450672661|FG003|Overall Study|Lost to Follow-up|3|||
125285473|NCT03333252|450672658|FG000|Overall Study|Withdrawal by Subject|14|||
125285474|NCT03333252|450672659|FG001|Overall Study|Withdrawal by Subject|24|||
125285475|NCT03333252|450672660|FG002|Overall Study|Withdrawal by Subject|11|||
125285476|NCT03333252|450672661|FG003|Overall Study|Withdrawal by Subject|17|||
125285477|NCT00666588|450672665|FG000|Overall Study|ineligible|2|||
125285478|NCT00666588|450672666|FG001|Overall Study|ineligible|0|||
125285479|NCT00666588|450672667|FG002|Overall Study|ineligible|0|||
125285480|NCT00666588|450672668|FG003|Overall Study|ineligible|2|||
125285481|NCT00666588|450672665|FG000|Overall Study|inevaluable|2|||
125285482|NCT00666588|450672666|FG001|Overall Study|inevaluable|0|||
125285483|NCT00666588|450672667|FG002|Overall Study|inevaluable|0|||
125285484|NCT00666588|450672668|FG003|Overall Study|inevaluable|0|||
125285485|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
125285486|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
125285487|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
125285488|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
125285489|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
125285490|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
125285491|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
125285492|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
125285493|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
125285494|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
125285495|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Other|1|||
125285496|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Other|1|||
125285497|NCT02075047|450672669|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
125285498|NCT02075047|450672670|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
125285499|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
125285500|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
125285501|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
125285502|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
125285503|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
125285504|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
125285505|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
125285506|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
125285507|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
125285508|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
125285509|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Other|1|||
125285510|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Other|2|||
125285511|NCT02075047|450672669|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
125285512|NCT02075047|450672670|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
125285513|NCT04195438|450672678|FG000|Overall Study|Withdrawal by Subject|1|||
125285514|NCT03447314|450672684|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
125285515|NCT03447314|450672685|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
125285516|NCT03447314|450672686|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
125285517|NCT03447314|450672687|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
125285518|NCT03447314|450672688|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
125285519|NCT03447314|450672689|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
125285520|NCT03447314|450672690|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
125285521|NCT03447314|450672691|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285522|NCT03447314|450672692|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285523|NCT03447314|450672693|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285524|NCT03447314|450672694|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
125285525|NCT03447314|450672695|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
125415381|NCT01292603|451147357|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
125415382|NCT01292603|451147358|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
125415383|NCT01292603|451147359|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
125415384|NCT01292603|451147360|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
125415385|NCT01292603|451147355|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
125415386|NCT01292603|451147356|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
125415387|NCT01292603|451147357|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
125415388|NCT01292603|451147358|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
125285526|NCT03447314|450672696|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285527|NCT03447314|450672697|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285528|NCT03447314|450672698|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125415389|NCT01292603|451147359|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
125415390|NCT01292603|451147360|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
125415391|NCT01292603|451147355|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
125415392|NCT01292603|451147356|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
125415393|NCT01292603|451147357|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
125415394|NCT01292603|451147358|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
125415395|NCT01292603|451147359|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
125415396|NCT01292603|451147360|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
125415397|NCT01292603|451147355|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
125415398|NCT01292603|451147356|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
125415399|NCT01292603|451147357|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
125415400|NCT01292603|451147358|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
125415401|NCT01292603|451147359|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
125415402|NCT01292603|451147360|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
125415403|NCT01292603|451147355|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
125415404|NCT01292603|451147356|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
125415405|NCT01292603|451147357|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
125415406|NCT01292603|451147358|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
125415407|NCT01292603|451147359|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
125415408|NCT01292603|451147360|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
125415409|NCT01292603|451147355|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
125415410|NCT01292603|451147356|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
125415411|NCT01292603|451147357|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
125415412|NCT01292603|451147358|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
125415413|NCT01292603|451147359|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
125415414|NCT01292603|451147360|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
125415415|NCT01292603|451147355|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
125415416|NCT01292603|451147356|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
125415417|NCT01292603|451147357|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
125415418|NCT01292603|451147358|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
125415419|NCT01292603|451147359|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
125415420|NCT01292603|451147360|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
125415421|NCT01292603|451147355|FG000|Overall Survival Status|Death|3|||
125415422|NCT01292603|451147356|FG001|Overall Survival Status|Death|1|||
125415423|NCT01292603|451147357|FG002|Overall Survival Status|Death|3|||
125415424|NCT01292603|451147358|FG003|Overall Survival Status|Death|1|||
125415425|NCT01292603|451147359|FG004|Overall Survival Status|Death|16|||
125415426|NCT01292603|451147360|FG005|Overall Survival Status|Death|10|||
125415427|NCT01432366|451147363|FG000|Overall Study|Non-Responder|7|||
125415428|NCT01432366|451147363|FG000|Overall Study|Adverse Event|8|||
125415429|NCT01432366|451147363|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
125415430|NCT01432366|451147363|FG000|Overall Study|Pregnancy|1|||
125415431|NCT01432366|451147363|FG000|Overall Study|Lost to Follow-up|13|||
125415432|NCT01432366|451147363|FG000|Overall Study|Lack of Efficacy|1|||
125415433|NCT01432366|451147363|FG000|Overall Study|Site Closed|20|||
125415434|NCT01432366|451147363|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
125415435|NCT01432366|451147363|FG000|Overall Study|Other|14|||
125415436|NCT01808690|451147364|FG000|Overall Study|Withdrawal by Subject|1|||
125415437|NCT01808690|451147365|FG001|Overall Study|Withdrawal by Subject|2|||
125415438|NCT03870763|451147366|FG000|Overall Study|Study terminated by sponsor|0|||
125415439|NCT03870763|451147367|FG001|Overall Study|Study terminated by sponsor|2|||
125415440|NCT03870763|451147368|FG002|Overall Study|Study terminated by sponsor|0|||
125415441|NCT03870763|451147366|FG000|Overall Study|Withdrawal by Subject|0|||
125415442|NCT03870763|451147367|FG001|Overall Study|Withdrawal by Subject|1|||
125415443|NCT03870763|451147368|FG002|Overall Study|Withdrawal by Subject|0|||
125415444|NCT03870763|451147366|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
125415445|NCT03870763|451147367|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
125415446|NCT03870763|451147368|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
125415447|NCT02891187|451147369|FG000|Overall Study|Lost to Follow-up|1|||
125415448|NCT02891187|451147370|FG001|Overall Study|Lost to Follow-up|2|||
125415449|NCT03586648|451147375|FG000|Period 1|Withdrawal by Subject|0|||
125415450|NCT03586648|451147376|FG001|Period 1|Withdrawal by Subject|1|||
125415451|NCT03586648|451147375|FG000|Period 1|Lost to Follow-up|1|||
125415452|NCT03586648|451147376|FG001|Period 1|Lost to Follow-up|1|||
125415453|NCT03586648|451147375|FG000|Period 1|Adverse Event|1|||
125415454|NCT03586648|451147376|FG001|Period 1|Adverse Event|0|||
125415455|NCT03586648|451147375|FG000|Period 1|Study related symptoms or complaints|2|||
125448986|NCT02851511|451270924|FG002|Phase II|Lost to Follow-up|0|||
125415456|NCT03586648|451147376|FG001|Period 1|Study related symptoms or complaints|1|||
125448987|NCT02851511|451270925|FG003|Phase II|Lost to Follow-up|0|||
125415457|NCT03586648|451147375|FG000|Period 1|Physician Decision|0|||
125415458|NCT03586648|451147376|FG001|Period 1|Physician Decision|1|||
125415459|NCT03586648|451147375|FG000|Period 2|Adverse Event|1|||
125415460|NCT03586648|451147376|FG001|Period 2|Adverse Event|0|||
125415461|NCT02041195|451147377|FG000|Overall Study|Adverse Event|1|||
125285529|NCT03447314|450672699|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285530|NCT03447314|450672700|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285531|NCT03447314|450672701|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
125285532|NCT03447314|450672684|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
125285533|NCT03447314|450672685|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285534|NCT03447314|450672686|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
125285535|NCT03447314|450672687|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285536|NCT03447314|450672688|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285537|NCT03447314|450672689|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
125285538|NCT03447314|450672690|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
125285539|NCT03447314|450672691|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285540|NCT03447314|450672692|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285541|NCT03447314|450672693|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285542|NCT03447314|450672694|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285543|NCT03447314|450672695|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285544|NCT03447314|450672696|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285545|NCT03447314|450672697|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285546|NCT03447314|450672698|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285547|NCT03447314|450672699|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285548|NCT03447314|450672700|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285549|NCT03447314|450672701|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
125285550|NCT03447314|450672684|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285551|NCT03447314|450672685|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285552|NCT03447314|450672686|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
125285553|NCT03447314|450672687|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285554|NCT03447314|450672688|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285555|NCT03447314|450672689|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285556|NCT03447314|450672690|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285557|NCT03447314|450672691|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285558|NCT03447314|450672692|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285559|NCT03447314|450672693|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285560|NCT03447314|450672694|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285561|NCT03447314|450672695|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285562|NCT03447314|450672696|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285563|NCT03447314|450672697|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285564|NCT03447314|450672698|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285565|NCT03447314|450672699|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285566|NCT03447314|450672700|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285567|NCT03447314|450672701|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
125285568|NCT03447314|450672684|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285569|NCT03447314|450672685|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285570|NCT03447314|450672686|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
125285571|NCT03447314|450672687|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285572|NCT03447314|450672688|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285573|NCT03447314|450672689|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285574|NCT03447314|450672690|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285575|NCT03447314|450672691|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285576|NCT03447314|450672692|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285577|NCT03447314|450672693|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285578|NCT03447314|450672694|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285579|NCT03447314|450672695|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285580|NCT03447314|450672696|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285581|NCT03447314|450672697|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285582|NCT03447314|450672698|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285583|NCT03447314|450672699|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285584|NCT03447314|450672700|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285585|NCT03447314|450672701|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
125285586|NCT03447314|450672684|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285587|NCT03447314|450672685|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285588|NCT03447314|450672686|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285589|NCT03447314|450672687|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125448988|NCT03606460|451270926|FG000|Overall Study|Lost to Follow-up|1|||
125448989|NCT03606460|451270927|FG001|Overall Study|Lost to Follow-up|8|||
125415462|NCT02041195|451147378|FG001|Overall Study|Adverse Event|2|||
125415463|NCT02041195|451147379|FG002|Overall Study|Adverse Event|0|||
125415464|NCT02041195|451147380|FG003|Overall Study|Adverse Event|0|||
125415465|NCT02041195|451147381|FG004|Overall Study|Adverse Event|0|||
125415466|NCT02041195|451147382|FG005|Overall Study|Adverse Event|0|||
125415467|NCT02041195|451147383|FG006|Overall Study|Adverse Event|3|||
125415468|NCT02041195|451147384|FG007|Overall Study|Adverse Event|0|||
125415469|NCT02041195|451147377|FG000|Overall Study|Withdrawal by Subject|1|||
125415470|NCT02041195|451147378|FG001|Overall Study|Withdrawal by Subject|0|||
125415471|NCT02041195|451147379|FG002|Overall Study|Withdrawal by Subject|0|||
125415472|NCT02041195|451147380|FG003|Overall Study|Withdrawal by Subject|0|||
125415473|NCT02041195|451147381|FG004|Overall Study|Withdrawal by Subject|0|||
125415474|NCT02041195|451147382|FG005|Overall Study|Withdrawal by Subject|0|||
125415475|NCT02041195|451147383|FG006|Overall Study|Withdrawal by Subject|4|||
125415476|NCT02041195|451147384|FG007|Overall Study|Withdrawal by Subject|3|||
125415477|NCT02041195|451147377|FG000|Overall Study|Unable to comply with study visits|0|||
125415478|NCT02041195|451147378|FG001|Overall Study|Unable to comply with study visits|1|||
125415479|NCT02041195|451147379|FG002|Overall Study|Unable to comply with study visits|0|||
125415480|NCT02041195|451147380|FG003|Overall Study|Unable to comply with study visits|0|||
125415481|NCT02041195|451147381|FG004|Overall Study|Unable to comply with study visits|1|||
125415482|NCT02041195|451147382|FG005|Overall Study|Unable to comply with study visits|0|||
125415483|NCT02041195|451147383|FG006|Overall Study|Unable to comply with study visits|0|||
125415484|NCT02041195|451147384|FG007|Overall Study|Unable to comply with study visits|0|||
125415485|NCT02395120|451147385|FG000|Overall Study|Missed follow-up dental exam|57|||
125415486|NCT02395120|451147386|FG001|Overall Study|Missed follow-up dental exam|62|||
125415487|NCT02395120|451147387|FG002|Overall Study|Missed follow-up dental exam|6|||
125415488|NCT02395120|451147388|FG003|Overall Study|Missed follow-up dental exam|6|||
125415489|NCT02395120|451147389|FG004|Overall Study|Missed follow-up dental exam|51|||
125415490|NCT00674986|451147391|FG000|Overall Study|Adverse Event|2|||
125415491|NCT00674986|451147392|FG001|Overall Study|Adverse Event|1|||
125415492|NCT00674986|451147391|FG000|Overall Study|Subject withdrew consent|12|||
125415493|NCT00674986|451147392|FG001|Overall Study|Subject withdrew consent|19|||
125415494|NCT00674986|451147391|FG000|Overall Study|Lost to Follow-up|25|||
125415495|NCT00674986|451147392|FG001|Overall Study|Lost to Follow-up|53|||
125415496|NCT00674986|451147391|FG000|Overall Study|Other reasons|4|||
125415497|NCT00674986|451147392|FG001|Overall Study|Other reasons|8|||
125415498|NCT02526693|451147394|FG000|Overall Study|Physician Decision|3|||
125415499|NCT02526693|451147395|FG001|Overall Study|Physician Decision|1|||
125415500|NCT01275625|451147396|FG000|Overall Study|Death|1|||
125415501|NCT01275625|451147396|FG000|Overall Study|Lack of Efficacy|2|||
125415502|NCT01275625|451147396|FG000|Overall Study|Lost to Follow-up|1|||
125415503|NCT01275625|451147396|FG000|Overall Study|Withdrawal by Subject|3|||
125415504|NCT01275625|451147396|FG000|Overall Study|Protocol Violation|1|||
125415505|NCT01275625|451147396|FG000|Overall Study|Adverse Event|4|||
125415506|NCT01275625|451147396|FG000|Overall Study|Other|1|||
125415507|NCT01585103|451147398|FG000|Overall Study|Unable to swallow Cytosponge|6|||
125415508|NCT01349569|451147400|FG000|Overall Study|Lack of Efficacy|4|||
125415509|NCT03581305|451147401|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
125415510|NCT03581305|451147402|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
125415511|NCT03581305|451147401|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
125415512|NCT03581305|451147402|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
125415513|NCT03581305|451147401|FG000|Serotonergic Study|Withdrawal by Subject|5|||
125415514|NCT03581305|451147402|FG001|Serotonergic Study|Withdrawal by Subject|1|||
125415515|NCT01798927|451147405|FG000|Overall Study|Withdrawal by Subject|1|||
125415516|NCT03750552|451147406|FG000|Overall Study|Adverse Event|5|||
125415517|NCT03750552|451147407|FG001|Overall Study|Adverse Event|1|||
125415518|NCT03750552|451147406|FG000|Overall Study|Withdrawal by Subject|1|||
125415519|NCT03750552|451147407|FG001|Overall Study|Withdrawal by Subject|1|||
125415520|NCT03750552|451147406|FG000|Overall Study|Other|2|||
125415521|NCT03750552|451147407|FG001|Overall Study|Other|0|||
125415522|NCT00626522|451147408|FG000|Overall Study|Protocol Violation|0|||
125415523|NCT00626522|451147409|FG001|Overall Study|Protocol Violation|0|||
125415524|NCT00626522|451147410|FG002|Overall Study|Protocol Violation|0|||
125415525|NCT00626522|451147411|FG003|Overall Study|Protocol Violation|0|||
125415526|NCT00626522|451147412|FG004|Overall Study|Protocol Violation|1|||
125415527|NCT00626522|451147413|FG005|Overall Study|Protocol Violation|0|||
125415528|NCT00626522|451147408|FG000|Overall Study|Adverse Event|2|||
125415529|NCT00626522|451147409|FG001|Overall Study|Adverse Event|1|||
125415530|NCT00626522|451147410|FG002|Overall Study|Adverse Event|2|||
125415531|NCT00626522|451147411|FG003|Overall Study|Adverse Event|0|||
125415532|NCT00626522|451147412|FG004|Overall Study|Adverse Event|1|||
125415533|NCT00626522|451147413|FG005|Overall Study|Adverse Event|1|||
125415534|NCT00626522|451147408|FG000|Overall Study|Withdrawal by Subject|2|||
125415535|NCT00626522|451147409|FG001|Overall Study|Withdrawal by Subject|5|||
125448990|NCT04170023|451270928|FG000|LTE Period|Withdrawal by Subject|1|||
125415536|NCT00626522|451147410|FG002|Overall Study|Withdrawal by Subject|5|||
125415537|NCT00626522|451147411|FG003|Overall Study|Withdrawal by Subject|0|||
125448991|NCT04170023|451270929|FG001|LTE Period|Withdrawal by Subject|0|||
125448992|NCT04170023|451270930|FG002|LTE Period|Withdrawal by Subject|0|||
125448993|NCT04170023|451270928|FG000|LTE Period|Study Termination|11|||
125448994|NCT04170023|451270929|FG001|LTE Period|Study Termination|11|||
125448995|NCT04170023|451270930|FG002|LTE Period|Study Termination|5|||
125448996|NCT03704298|451270934|FG000|Overall Study|Death|3|||
125448997|NCT03704298|451270935|FG001|Overall Study|Death|1|||
125448998|NCT03704298|451270936|FG002|Overall Study|Death|1|||
125448999|NCT03704298|451270937|FG003|Overall Study|Death|0|||
125449000|NCT03704298|451270934|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
125449001|NCT03704298|451270935|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
125449002|NCT03704298|451270936|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
125449003|NCT03704298|451270937|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
125449004|NCT03704298|451270934|FG000|Overall Study|Withdrawal by Subject|1|||
125449005|NCT03704298|451270935|FG001|Overall Study|Withdrawal by Subject|0|||
125449006|NCT03704298|451270936|FG002|Overall Study|Withdrawal by Subject|0|||
125449007|NCT03704298|451270937|FG003|Overall Study|Withdrawal by Subject|0|||
125449008|NCT03704298|451270934|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
125449009|NCT03704298|451270935|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
125449010|NCT03704298|451270936|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
125449011|NCT03704298|451270937|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
125449012|NCT01027871|451270938|FG000|Overall Study|Physician Decision|1|||
125449013|NCT01027871|451270939|FG001|Overall Study|Physician Decision|5|||
125449014|NCT01027871|451270940|FG002|Overall Study|Physician Decision|0|||
125449015|NCT01027871|451270938|FG000|Overall Study|Protocol Violation|0|||
125449016|NCT01027871|451270939|FG001|Overall Study|Protocol Violation|2|||
125449017|NCT01027871|451270940|FG002|Overall Study|Protocol Violation|2|||
125449018|NCT01027871|451270938|FG000|Overall Study|Withdrawal by Subject|1|||
125449019|NCT01027871|451270939|FG001|Overall Study|Withdrawal by Subject|2|||
125449020|NCT01027871|451270940|FG002|Overall Study|Withdrawal by Subject|2|||
125449021|NCT01027871|451270938|FG000|Overall Study|Adverse Event|0|||
125449022|NCT01027871|451270939|FG001|Overall Study|Adverse Event|2|||
125449023|NCT01027871|451270940|FG002|Overall Study|Adverse Event|2|||
125449024|NCT01027871|451270938|FG000|Overall Study|Sponsor Decision|0|||
125449025|NCT01027871|451270939|FG001|Overall Study|Sponsor Decision|2|||
125449026|NCT01027871|451270940|FG002|Overall Study|Sponsor Decision|0|||
125449027|NCT01027871|451270938|FG000|Overall Study|Discontinued Prior to Treatment|0|||
125449028|NCT01027871|451270939|FG001|Overall Study|Discontinued Prior to Treatment|0|||
125449029|NCT01027871|451270940|FG002|Overall Study|Discontinued Prior to Treatment|1|||
125449030|NCT01414166|451270941|FG000|Overall Study|Adverse Event|10|||
125449031|NCT01414166|451270942|FG001|Overall Study|Adverse Event|2|||
125449032|NCT01414166|451270941|FG000|Overall Study|Lost to Follow-up|4|||
125449033|NCT01414166|451270942|FG001|Overall Study|Lost to Follow-up|1|||
125449034|NCT01414166|451270941|FG000|Overall Study|Non-compliance with study drug|2|||
125449035|NCT01414166|451270942|FG001|Overall Study|Non-compliance with study drug|0|||
125449036|NCT01414166|451270941|FG000|Overall Study|Physician Decision|2|||
125449037|NCT01414166|451270942|FG001|Overall Study|Physician Decision|0|||
125449038|NCT01414166|451270941|FG000|Overall Study|Protocol Violation|2|||
125449039|NCT01414166|451270942|FG001|Overall Study|Protocol Violation|0|||
125449040|NCT01414166|451270941|FG000|Overall Study|Study terminated by Sponsor|68|||
125449041|NCT01414166|451270942|FG001|Overall Study|Study terminated by Sponsor|75|||
125285590|NCT03447314|450672688|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285591|NCT03447314|450672689|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285592|NCT03447314|450672690|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285593|NCT03447314|450672691|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285594|NCT03447314|450672692|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285595|NCT03447314|450672693|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285596|NCT03447314|450672694|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
125285597|NCT03447314|450672695|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285598|NCT03447314|450672696|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285599|NCT03447314|450672697|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285600|NCT03447314|450672698|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285601|NCT03447314|450672699|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285602|NCT03447314|450672700|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125449042|NCT01414166|451270941|FG000|Overall Study|Withdrawal by Subject|3|||
125449043|NCT01414166|451270942|FG001|Overall Study|Withdrawal by Subject|5|||
125449044|NCT03782727|451270943|FG000|Overall Study|Lost to Follow-up|32|||
125449045|NCT02084082|451270946|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
125285603|NCT03447314|450672701|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
125285604|NCT03447314|450672684|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285605|NCT03447314|450672685|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285606|NCT03447314|450672686|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285607|NCT03447314|450672687|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
125285608|NCT03447314|450672688|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285609|NCT03447314|450672689|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
125285610|NCT03447314|450672690|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285611|NCT03447314|450672691|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285612|NCT03447314|450672692|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285613|NCT03447314|450672693|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285614|NCT03447314|450672694|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285615|NCT03447314|450672695|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285616|NCT03447314|450672696|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285617|NCT03447314|450672697|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285618|NCT03447314|450672698|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285619|NCT03447314|450672699|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285620|NCT03447314|450672700|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285621|NCT03447314|450672701|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
125285622|NCT04600076|450672704|FG000|Overall Study|Lost to Follow-up|3|||
125285623|NCT03006458|450672705|FG000|First Intervention|Unsatisfied Vision|0|||
125285624|NCT03006458|450672706|FG001|First Intervention|Unsatisfied Vision|3|||
125285625|NCT00457821|450672707|FG000|Part 2|Withdrawal by Subject|0|||
125285626|NCT00457821|450672708|FG001|Part 2|Withdrawal by Subject|0|||
125285627|NCT00457821|450672709|FG002|Part 2|Withdrawal by Subject|0|||
125285628|NCT00457821|450672710|FG003|Part 2|Withdrawal by Subject|0|||
125285629|NCT00457821|450672711|FG004|Part 2|Withdrawal by Subject|0|||
125285630|NCT00457821|450672712|FG005|Part 2|Withdrawal by Subject|0|||
125285631|NCT00457821|450672713|FG006|Part 2|Withdrawal by Subject|0|||
125285632|NCT00457821|450672714|FG007|Part 2|Withdrawal by Subject|1|||
125285633|NCT00578877|450672717|FG000|Overall Study|Lost to Follow-up|8|||
125285634|NCT00578877|450672718|FG001|Overall Study|Lost to Follow-up|10|||
125285635|NCT00578877|450672717|FG000|Overall Study|early discontinue|61|||
125285636|NCT00578877|450672718|FG001|Overall Study|early discontinue|101|||
125285637|NCT00578877|450672717|FG000|Overall Study|did not provide follow-up data|12|||
125285638|NCT00578877|450672718|FG001|Overall Study|did not provide follow-up data|17|||
125285639|NCT02437409|450672723|FG000|Overall Study|Withdrawal by Subject|3|||
125285640|NCT02437409|450672723|FG000|Overall Study|Screening failure|12|||
125285641|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
125285642|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
125285643|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
125285644|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
125285645|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
125285646|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
125285647|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
125285648|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
125285649|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
125285650|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
125285651|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
125285652|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
125285653|NCT01632241|450672724|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
125285654|NCT01632241|450672725|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
125285655|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
125285656|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
125285657|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
125285658|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
125285659|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
125285660|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
125285661|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
125285662|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
125285663|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
125285664|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
125285665|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
125285666|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
125285667|NCT01632241|450672724|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
125285668|NCT01632241|450672725|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
125285669|NCT05032690|450672734|FG000|Period 1|Adverse Event|0|||
125285670|NCT05032690|450672735|FG001|Period 1|Adverse Event|1|||
125285671|NCT05032690|450672736|FG002|Period 1|Adverse Event|0|||
125415538|NCT00626522|451147412|FG004|Overall Study|Withdrawal by Subject|4|||
125415539|NCT00626522|451147413|FG005|Overall Study|Withdrawal by Subject|1|||
125415540|NCT00626522|451147408|FG000|Overall Study|COPD exacerbation|0|||
125415541|NCT00626522|451147409|FG001|Overall Study|COPD exacerbation|0|||
125415542|NCT00626522|451147410|FG002|Overall Study|COPD exacerbation|0|||
125415543|NCT00626522|451147411|FG003|Overall Study|COPD exacerbation|1|||
125415544|NCT00626522|451147412|FG004|Overall Study|COPD exacerbation|1|||
125415545|NCT00626522|451147413|FG005|Overall Study|COPD exacerbation|0|||
125415546|NCT00626522|451147408|FG000|Overall Study|Lost to Follow-up|0|||
125415547|NCT00626522|451147409|FG001|Overall Study|Lost to Follow-up|1|||
125415548|NCT00626522|451147410|FG002|Overall Study|Lost to Follow-up|0|||
125415549|NCT00626522|451147411|FG003|Overall Study|Lost to Follow-up|0|||
125415550|NCT00626522|451147412|FG004|Overall Study|Lost to Follow-up|0|||
125415551|NCT00626522|451147413|FG005|Overall Study|Lost to Follow-up|0|||
125415552|NCT00626522|451147408|FG000|Overall Study|Inconsistent reason reported|1|||
125415553|NCT00626522|451147409|FG001|Overall Study|Inconsistent reason reported|0|||
125415554|NCT00626522|451147410|FG002|Overall Study|Inconsistent reason reported|0|||
125415555|NCT00626522|451147411|FG003|Overall Study|Inconsistent reason reported|0|||
125415556|NCT00626522|451147412|FG004|Overall Study|Inconsistent reason reported|0|||
125415557|NCT00626522|451147413|FG005|Overall Study|Inconsistent reason reported|0|||
125415558|NCT00626522|451147408|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
125415559|NCT00626522|451147409|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
125415560|NCT00626522|451147410|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
125415561|NCT00626522|451147411|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
125415562|NCT00626522|451147412|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
125415563|NCT00626522|451147413|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
125415564|NCT01490632|451147416|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
125415565|NCT01490632|451147417|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
125415566|NCT01490632|451147418|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
125415567|NCT01490632|451147419|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
125415568|NCT01490632|451147420|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
125415569|NCT01490632|451147421|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
125415570|NCT01490632|451147422|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
125415571|NCT01490632|451147423|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
125415572|NCT01490632|451147424|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
125415573|NCT01490632|451147425|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
125415574|NCT01490632|451147426|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
125415575|NCT01490632|451147427|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
125415576|NCT01490632|451147428|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
125415577|NCT01490632|451147429|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
125415578|NCT01490632|451147430|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
125415579|NCT01490632|451147431|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
125415580|NCT01490632|451147432|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
125415581|NCT01490632|451147433|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
125415582|NCT01490632|451147434|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
125415583|NCT01490632|451147435|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
125415584|NCT01490632|451147416|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
125415585|NCT01490632|451147417|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
125415586|NCT01490632|451147418|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
125415587|NCT01490632|451147419|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
125415588|NCT01490632|451147420|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415589|NCT01490632|451147421|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415590|NCT01490632|451147422|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415591|NCT01490632|451147423|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415592|NCT01490632|451147424|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415593|NCT01490632|451147425|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415594|NCT01490632|451147426|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415595|NCT01490632|451147427|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415596|NCT01490632|451147428|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415597|NCT01490632|451147429|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415598|NCT01490632|451147430|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415599|NCT01490632|451147431|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415600|NCT01490632|451147432|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415601|NCT01490632|451147433|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415602|NCT01490632|451147434|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415603|NCT01490632|451147435|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
125415604|NCT01490632|451147416|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415605|NCT01490632|451147417|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415606|NCT01490632|451147418|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
125415607|NCT01490632|451147419|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
125415608|NCT01490632|451147420|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
125415609|NCT01490632|451147421|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415610|NCT01490632|451147422|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415611|NCT01490632|451147423|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415612|NCT01490632|451147424|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415613|NCT01490632|451147425|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415614|NCT01490632|451147426|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415615|NCT01490632|451147427|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415616|NCT01490632|451147428|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415617|NCT01490632|451147429|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415618|NCT01490632|451147430|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415619|NCT01490632|451147431|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415620|NCT01490632|451147432|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415621|NCT01490632|451147433|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415622|NCT01490632|451147434|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415623|NCT01490632|451147435|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
125415624|NCT01490632|451147416|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
125415625|NCT01490632|451147417|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
125415626|NCT01490632|451147418|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
125415627|NCT01490632|451147419|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
125415628|NCT01490632|451147420|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
125415629|NCT01490632|451147421|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
125415630|NCT01490632|451147422|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
125415631|NCT01490632|451147423|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
125415632|NCT01490632|451147424|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
125415633|NCT01490632|451147425|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
125415634|NCT01490632|451147426|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
125415635|NCT01490632|451147427|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
125415636|NCT01490632|451147428|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
125415637|NCT01490632|451147429|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
125415638|NCT01490632|451147430|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
125415639|NCT01490632|451147431|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
125415640|NCT01490632|451147432|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
125415641|NCT01490632|451147433|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
125415642|NCT01490632|451147434|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
125415643|NCT01490632|451147435|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
125415644|NCT01490632|451147416|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
125415645|NCT01490632|451147417|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415646|NCT01490632|451147418|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415647|NCT01490632|451147419|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415648|NCT01490632|451147420|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415649|NCT01490632|451147421|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415650|NCT01490632|451147422|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415651|NCT01490632|451147423|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415652|NCT01490632|451147424|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415653|NCT01490632|451147425|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415654|NCT01490632|451147426|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415655|NCT01490632|451147427|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415656|NCT01490632|451147428|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415657|NCT01490632|451147429|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415658|NCT01490632|451147430|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415659|NCT01490632|451147431|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415660|NCT01490632|451147432|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415661|NCT01490632|451147433|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415662|NCT01490632|451147434|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415663|NCT01490632|451147435|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
125415664|NCT01490632|451147416|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
125415665|NCT01490632|451147417|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
125415666|NCT01490632|451147418|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415667|NCT01490632|451147419|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
125415668|NCT01490632|451147420|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
125415669|NCT01490632|451147421|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415670|NCT01490632|451147422|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415671|NCT01490632|451147423|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415672|NCT01490632|451147424|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415673|NCT01490632|451147425|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125449046|NCT02084082|451270947|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
125449047|NCT02084082|451270948|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
125415674|NCT01490632|451147426|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415675|NCT01490632|451147427|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415676|NCT01490632|451147428|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415677|NCT01490632|451147429|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415678|NCT01490632|451147430|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415679|NCT01490632|451147431|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415680|NCT01490632|451147432|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415681|NCT01490632|451147433|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415682|NCT01490632|451147434|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415683|NCT01490632|451147435|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
125415684|NCT01490632|451147416|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415685|NCT01490632|451147417|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415686|NCT01490632|451147418|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415687|NCT01490632|451147419|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415688|NCT01490632|451147420|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
125415689|NCT01490632|451147421|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415690|NCT01490632|451147422|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415691|NCT01490632|451147423|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415692|NCT01490632|451147424|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415693|NCT01490632|451147425|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415694|NCT01490632|451147426|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415695|NCT01490632|451147427|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415696|NCT01490632|451147428|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415697|NCT01490632|451147429|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415698|NCT01490632|451147430|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415699|NCT01490632|451147431|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415700|NCT01490632|451147432|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415701|NCT01490632|451147433|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415702|NCT01490632|451147434|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125285672|NCT05032690|450672737|FG003|Period 1|Adverse Event|0|||
125285673|NCT05032690|450672734|FG000|Period 1|Withdrawal by Subject|1|||
125285674|NCT05032690|450672735|FG001|Period 1|Withdrawal by Subject|0|||
125285675|NCT05032690|450672736|FG002|Period 1|Withdrawal by Subject|0|||
125285676|NCT05032690|450672737|FG003|Period 1|Withdrawal by Subject|0|||
125285677|NCT05032690|450672734|FG000|Period 1|No longer meets eligibility criteria|0|||
125285678|NCT05032690|450672735|FG001|Period 1|No longer meets eligibility criteria|1|||
125285679|NCT05032690|450672736|FG002|Period 1|No longer meets eligibility criteria|0|||
125285680|NCT05032690|450672737|FG003|Period 1|No longer meets eligibility criteria|0|||
125285681|NCT05032690|450672734|FG000|Period 2|Adverse Event|1|||
125285682|NCT05032690|450672735|FG001|Period 2|Adverse Event|0|||
125285683|NCT05032690|450672736|FG002|Period 2|Adverse Event|0|||
125285684|NCT05032690|450672737|FG003|Period 2|Adverse Event|0|||
125285685|NCT05032690|450672734|FG000|Period 2|Withdrawal by Subject|0|||
125285686|NCT05032690|450672735|FG001|Period 2|Withdrawal by Subject|1|||
125285687|NCT05032690|450672736|FG002|Period 2|Withdrawal by Subject|0|||
125285688|NCT05032690|450672737|FG003|Period 2|Withdrawal by Subject|0|||
125285689|NCT05032690|450672734|FG000|Period 2|No longer meets eligibility criteria|0|||
125285690|NCT05032690|450672735|FG001|Period 2|No longer meets eligibility criteria|1|||
125285691|NCT05032690|450672736|FG002|Period 2|No longer meets eligibility criteria|0|||
125285692|NCT05032690|450672737|FG003|Period 2|No longer meets eligibility criteria|0|||
125285693|NCT05032690|450672734|FG000|Period 3|Adverse Event|0|||
125285694|NCT05032690|450672735|FG001|Period 3|Adverse Event|1|||
125285695|NCT05032690|450672736|FG002|Period 3|Adverse Event|0|||
125285696|NCT05032690|450672737|FG003|Period 3|Adverse Event|0|||
125285697|NCT00737568|450672740|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
125285698|NCT00737568|450672741|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
125285699|NCT00737568|450672740|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
125285700|NCT00737568|450672741|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
125285701|NCT00737568|450672740|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
125285702|NCT00737568|450672741|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
125285703|NCT00737568|450672740|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
125285704|NCT00737568|450672741|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
125285705|NCT00737568|450672740|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
125285706|NCT00737568|450672741|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
125285707|NCT00737568|450672740|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
125285708|NCT00737568|450672741|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
125415703|NCT01490632|451147435|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
125415704|NCT01490632|451147416|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415705|NCT01490632|451147417|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415706|NCT01490632|451147418|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415707|NCT01490632|451147419|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415708|NCT01490632|451147420|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415709|NCT01490632|451147421|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
125415710|NCT01490632|451147422|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
125415711|NCT01490632|451147423|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415712|NCT01490632|451147424|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415713|NCT01490632|451147425|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
125415714|NCT01490632|451147426|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
125415715|NCT01490632|451147427|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
125415716|NCT01490632|451147428|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415717|NCT01490632|451147429|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415718|NCT01490632|451147430|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415719|NCT01490632|451147431|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415720|NCT01490632|451147432|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415721|NCT01490632|451147433|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415722|NCT01490632|451147434|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415723|NCT01490632|451147435|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
125415724|NCT01490632|451147416|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415725|NCT01490632|451147417|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415726|NCT01490632|451147418|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415727|NCT01490632|451147419|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415728|NCT01490632|451147420|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415729|NCT01490632|451147421|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415730|NCT01490632|451147422|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
125415731|NCT01490632|451147423|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415732|NCT01490632|451147424|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
125415733|NCT01490632|451147425|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
125415734|NCT01490632|451147426|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
125415735|NCT01490632|451147427|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415736|NCT01490632|451147428|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415737|NCT01490632|451147429|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415738|NCT01490632|451147430|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415739|NCT01490632|451147431|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415740|NCT01490632|451147432|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415741|NCT01490632|451147433|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415742|NCT01490632|451147434|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415743|NCT01490632|451147435|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
125415744|NCT01490632|451147416|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415745|NCT01490632|451147417|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415746|NCT01490632|451147418|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415747|NCT01490632|451147419|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415748|NCT01490632|451147420|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415749|NCT01490632|451147421|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415750|NCT01490632|451147422|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
125415751|NCT01490632|451147423|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415752|NCT01490632|451147424|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415753|NCT01490632|451147425|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
125415754|NCT01490632|451147426|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415755|NCT01490632|451147427|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415756|NCT01490632|451147428|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415757|NCT01490632|451147429|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415758|NCT01490632|451147430|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415759|NCT01490632|451147431|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415760|NCT01490632|451147432|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415761|NCT01490632|451147433|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415762|NCT01490632|451147434|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415763|NCT01490632|451147435|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
125415764|NCT01490632|451147416|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415765|NCT01490632|451147417|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415766|NCT01490632|451147418|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415767|NCT01490632|451147419|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
125449048|NCT02084082|451270949|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
125449049|NCT02084082|451270946|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
125449050|NCT02084082|451270947|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
125449051|NCT02084082|451270948|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
125449052|NCT02084082|451270949|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
125449053|NCT05705167|451270950|FG000|Overall Study|Randomised but not Treated|0|||
125449054|NCT05705167|451270951|FG001|Overall Study|Randomised but not Treated|2|||
125449055|NCT05705167|451270952|FG002|Overall Study|Randomised but not Treated|0|||
125449056|NCT05705167|451270953|FG003|Overall Study|Randomised but not Treated|7|||
125449057|NCT05705167|451270954|FG004|Overall Study|Randomised but not Treated|0|||
125449058|NCT05705167|451270955|FG005|Overall Study|Randomised but not Treated|0|||
125449059|NCT05705167|451270956|FG006|Overall Study|Randomised but not Treated|0|||
125449060|NCT05705167|451270950|FG000|Overall Study|Death|0|||
125449061|NCT05705167|451270951|FG001|Overall Study|Death|0|||
125449062|NCT05705167|451270952|FG002|Overall Study|Death|3|||
125449063|NCT05705167|451270953|FG003|Overall Study|Death|0|||
125449064|NCT05705167|451270954|FG004|Overall Study|Death|1|||
125449065|NCT05705167|451270955|FG005|Overall Study|Death|1|||
125449066|NCT05705167|451270956|FG006|Overall Study|Death|1|||
125449067|NCT05705167|451270950|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
125449068|NCT05705167|451270951|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
125449069|NCT05705167|451270952|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
125449070|NCT05705167|451270953|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
125449071|NCT05705167|451270954|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
125449072|NCT05705167|451270955|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
125449073|NCT05705167|451270956|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
125449074|NCT04736056|451270957|FG000|Overall Study|Death|0|||
125449075|NCT04736056|451270958|FG001|Overall Study|Death|0|||
125449076|NCT04736056|451270959|FG002|Overall Study|Death|0|||
125449077|NCT04736056|451270960|FG003|Overall Study|Death|1|||
125449078|NCT04736056|451270957|FG000|Overall Study|Lost to Follow-up|1|||
125449079|NCT04736056|451270958|FG001|Overall Study|Lost to Follow-up|0|||
125449080|NCT04736056|451270959|FG002|Overall Study|Lost to Follow-up|1|||
125449081|NCT04736056|451270960|FG003|Overall Study|Lost to Follow-up|1|||
125449082|NCT04736056|451270957|FG000|Overall Study|Withdrawal by Subject|2|||
125449083|NCT04736056|451270958|FG001|Overall Study|Withdrawal by Subject|0|||
125449084|NCT04736056|451270959|FG002|Overall Study|Withdrawal by Subject|0|||
125449085|NCT04736056|451270960|FG003|Overall Study|Withdrawal by Subject|0|||
125449086|NCT04736056|451270957|FG000|Overall Study|Physician Decision|1|||
125449087|NCT04736056|451270958|FG001|Overall Study|Physician Decision|0|||
125449088|NCT04736056|451270959|FG002|Overall Study|Physician Decision|1|||
125449089|NCT04736056|451270960|FG003|Overall Study|Physician Decision|0|||
125449090|NCT02099539|451270967|FG000|Overall Study|Progressive Disease|3|||
125449091|NCT02099539|451270968|FG001|Overall Study|Progressive Disease|2|||
125449092|NCT02099539|451270969|FG002|Overall Study|Progressive Disease|2|||
125449093|NCT02099539|451270970|FG003|Overall Study|Progressive Disease|1|||
125449094|NCT02099539|451270971|FG004|Overall Study|Progressive Disease|4|||
125449095|NCT02099539|451270972|FG005|Overall Study|Progressive Disease|2|||
125449096|NCT02099539|451270973|FG006|Overall Study|Progressive Disease|0|||
125449097|NCT02099539|451270967|FG000|Overall Study|Adverse Event|0|||
125449098|NCT02099539|451270968|FG001|Overall Study|Adverse Event|0|||
125449099|NCT02099539|451270969|FG002|Overall Study|Adverse Event|1|||
125449100|NCT02099539|451270970|FG003|Overall Study|Adverse Event|1|||
125449101|NCT02099539|451270971|FG004|Overall Study|Adverse Event|0|||
125449102|NCT02099539|451270972|FG005|Overall Study|Adverse Event|0|||
125449103|NCT02099539|451270973|FG006|Overall Study|Adverse Event|0|||
125285709|NCT00737568|450672740|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
125285710|NCT00737568|450672741|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
125285711|NCT00737568|450672740|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
125285712|NCT00737568|450672741|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
125285713|NCT00737568|450672740|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
125449104|NCT02099539|451270967|FG000|Overall Study|Physician Decision|0|||
125449105|NCT02099539|451270968|FG001|Overall Study|Physician Decision|0|||
125449106|NCT02099539|451270969|FG002|Overall Study|Physician Decision|0|||
125449107|NCT02099539|451270970|FG003|Overall Study|Physician Decision|0|||
125449108|NCT02099539|451270971|FG004|Overall Study|Physician Decision|0|||
125449109|NCT02099539|451270972|FG005|Overall Study|Physician Decision|1|||
125449110|NCT02099539|451270973|FG006|Overall Study|Physician Decision|0|||
125449111|NCT02956967|451270975|FG000|Overall Study|Adverse Event|3|||
125449112|NCT02956967|451270975|FG000|Overall Study|Reason non-related to neutropenia|10|||
125449113|NCT02956967|451270975|FG000|Overall Study|Lost to Follow-up|5|||
125285714|NCT00737568|450672741|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
125285715|NCT00855933|450672742|FG000|Overall Study|Withdrawal by Subject|0|||
125285716|NCT00855933|450672743|FG001|Overall Study|Withdrawal by Subject|1|||
125449114|NCT02956967|451270975|FG000|Overall Study|Missing|1|||
125449115|NCT02956967|451270975|FG000|Overall Study|Termination of Nivestim administration|29|||
125449116|NCT00819234|451270980|FG000|Overall Study|Withdrawal by Subject|8|||
125449117|NCT00819234|451270981|FG001|Overall Study|Withdrawal by Subject|13|||
125449118|NCT00819234|451270982|FG002|Overall Study|Withdrawal by Subject|6|||
125415768|NCT01490632|451147420|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415769|NCT01490632|451147421|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415770|NCT01490632|451147422|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
125415771|NCT01490632|451147423|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415772|NCT01490632|451147424|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415773|NCT01490632|451147425|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415774|NCT01490632|451147426|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415775|NCT01490632|451147427|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415776|NCT01490632|451147428|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415777|NCT01490632|451147429|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415778|NCT01490632|451147430|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415779|NCT01490632|451147431|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415780|NCT01490632|451147432|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415781|NCT01490632|451147433|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415782|NCT01490632|451147434|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415783|NCT01490632|451147435|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
125415784|NCT01490632|451147416|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415785|NCT01490632|451147417|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415786|NCT01490632|451147418|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415787|NCT01490632|451147419|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415788|NCT01490632|451147420|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415789|NCT01490632|451147421|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
125415790|NCT01490632|451147422|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415791|NCT01490632|451147423|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415792|NCT01490632|451147424|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415793|NCT01490632|451147425|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415794|NCT01490632|451147426|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415795|NCT01490632|451147427|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415796|NCT01490632|451147428|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415797|NCT01490632|451147429|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415798|NCT01490632|451147430|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415799|NCT01490632|451147431|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415800|NCT01490632|451147432|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415801|NCT01490632|451147433|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415802|NCT01490632|451147434|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415803|NCT01490632|451147435|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
125415804|NCT01490632|451147416|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415805|NCT01490632|451147417|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415806|NCT01490632|451147418|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415807|NCT01490632|451147419|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415808|NCT01490632|451147420|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415809|NCT01490632|451147421|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415810|NCT01490632|451147422|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
125415811|NCT01490632|451147423|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415812|NCT01490632|451147424|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
125415813|NCT01490632|451147425|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415814|NCT01490632|451147426|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
125415815|NCT01490632|451147427|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
125415816|NCT01490632|451147428|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415817|NCT01490632|451147429|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415818|NCT01490632|451147430|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415819|NCT01490632|451147431|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415820|NCT01490632|451147432|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415821|NCT01490632|451147433|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415822|NCT01490632|451147434|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415823|NCT01490632|451147435|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
125415824|NCT01490632|451147416|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125415825|NCT01490632|451147417|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125415826|NCT01490632|451147418|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125415827|NCT01490632|451147419|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125415828|NCT01490632|451147420|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125415829|NCT01490632|451147421|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
125415830|NCT01490632|451147422|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
125415831|NCT01490632|451147423|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
125415832|NCT01490632|451147424|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
125415833|NCT01490632|451147425|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
125415834|NCT01490632|451147426|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
125415835|NCT01490632|451147427|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
125415836|NCT01490632|451147428|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125415837|NCT01490632|451147429|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125415838|NCT01490632|451147430|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125415839|NCT01490632|451147431|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125415840|NCT01490632|451147432|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125415841|NCT01490632|451147433|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125415842|NCT01490632|451147434|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125415843|NCT01490632|451147435|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
125415844|NCT01490632|451147416|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415845|NCT01490632|451147417|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415846|NCT01490632|451147418|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415847|NCT01490632|451147419|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415848|NCT01490632|451147420|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415849|NCT01490632|451147421|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415850|NCT01490632|451147422|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415851|NCT01490632|451147423|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415852|NCT01490632|451147424|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415853|NCT01490632|451147425|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415854|NCT01490632|451147426|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415855|NCT01490632|451147427|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415856|NCT01490632|451147428|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415857|NCT01490632|451147429|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415858|NCT01490632|451147430|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
125415859|NCT01490632|451147431|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
125415860|NCT01490632|451147432|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415861|NCT01490632|451147433|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415862|NCT01490632|451147434|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415863|NCT01490632|451147435|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
125415864|NCT01490632|451147416|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415865|NCT01490632|451147417|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415866|NCT01490632|451147418|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415867|NCT01490632|451147419|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415868|NCT01490632|451147420|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415869|NCT01490632|451147421|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415870|NCT01490632|451147422|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415871|NCT01490632|451147423|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415872|NCT01490632|451147424|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415873|NCT01490632|451147425|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415874|NCT01490632|451147426|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415875|NCT01490632|451147427|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415876|NCT01490632|451147428|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415877|NCT01490632|451147429|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
125415878|NCT01490632|451147430|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415879|NCT01490632|451147431|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415880|NCT01490632|451147432|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415881|NCT01490632|451147433|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415882|NCT01490632|451147434|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415883|NCT01490632|451147435|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
125415884|NCT01490632|451147416|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415885|NCT01490632|451147417|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415886|NCT01490632|451147418|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415887|NCT01490632|451147419|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415888|NCT01490632|451147420|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415889|NCT01490632|451147421|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415890|NCT01490632|451147422|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415891|NCT01490632|451147423|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415892|NCT01490632|451147424|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125449119|NCT00819234|451270983|FG003|Overall Study|Withdrawal by Subject|3|||
125449120|NCT00819234|451270984|FG004|Overall Study|Withdrawal by Subject|0|||
125449121|NCT00819234|451270985|FG005|Overall Study|Withdrawal by Subject|4|||
125449122|NCT00819234|451270986|FG006|Overall Study|Withdrawal by Subject|4|||
125285717|NCT01960998|450672744|FG000|Overall Study|Lost to Follow-up|3|||
125285718|NCT01960998|450672745|FG001|Overall Study|Lost to Follow-up|7|||
125285719|NCT01960998|450672744|FG000|Overall Study|Death|0|||
125285720|NCT01960998|450672745|FG001|Overall Study|Death|1|||
125285721|NCT01960998|450672744|FG000|Overall Study|Withdrawal by Subject|8|||
125285722|NCT01960998|450672745|FG001|Overall Study|Withdrawal by Subject|2|||
125285723|NCT01960998|450672744|FG000|Overall Study|lost computer access|0|||
125285724|NCT01960998|450672745|FG001|Overall Study|lost computer access|1|||
125285725|NCT00759356|450672746|FG000|Overall Study|Adverse Event|0|||
125285726|NCT00759356|450672747|FG001|Overall Study|Adverse Event|1|||
125285727|NCT00759356|450672746|FG000|Overall Study|Withdrawal by Subject|0|||
125285728|NCT00759356|450672747|FG001|Overall Study|Withdrawal by Subject|2|||
125285729|NCT00759356|450672746|FG000|Overall Study|Subject was unable to return|1|||
125285730|NCT00759356|450672747|FG001|Overall Study|Subject was unable to return|0|||
125285731|NCT01713283|450672748|FG000|Overall Study|Lack of Efficacy|10|||
125285732|NCT01713283|450672749|FG001|Overall Study|Lack of Efficacy|2|||
125285733|NCT01713283|450672748|FG000|Overall Study|Lost to Follow-up|1|||
125285734|NCT01713283|450672749|FG001|Overall Study|Lost to Follow-up|1|||
125285735|NCT02403635|450672750|FG000|Overall Study|Not eligible|9|||
125285736|NCT00835640|450672756|FG000|Second Intervention|Protocol Violation|1|||
125285737|NCT00835640|450672757|FG001|Second Intervention|Protocol Violation|0|||
125285738|NCT01904149|450672758|FG000|Overall Study|Adverse Event|3|||
125285739|NCT01904149|450672759|FG001|Overall Study|Adverse Event|4|||
125285740|NCT01904149|450672760|FG002|Overall Study|Adverse Event|0|||
125285741|NCT01904149|450672761|FG003|Overall Study|Adverse Event|1|||
125285742|NCT01904149|450672762|FG004|Overall Study|Adverse Event|1|||
125285743|NCT01904149|450672763|FG005|Overall Study|Adverse Event|2|||
125285744|NCT01904149|450672758|FG000|Overall Study|Lack of Efficacy|0|||
125285745|NCT01904149|450672759|FG001|Overall Study|Lack of Efficacy|3|||
125285746|NCT01904149|450672760|FG002|Overall Study|Lack of Efficacy|1|||
125285747|NCT01904149|450672761|FG003|Overall Study|Lack of Efficacy|3|||
125285748|NCT01904149|450672762|FG004|Overall Study|Lack of Efficacy|3|||
125285749|NCT01904149|450672763|FG005|Overall Study|Lack of Efficacy|1|||
125285750|NCT01904149|450672758|FG000|Overall Study|Withdrawal by Subject|1|||
125285751|NCT01904149|450672759|FG001|Overall Study|Withdrawal by Subject|3|||
125285752|NCT01904149|450672760|FG002|Overall Study|Withdrawal by Subject|1|||
125285753|NCT01904149|450672761|FG003|Overall Study|Withdrawal by Subject|0|||
125285754|NCT01904149|450672762|FG004|Overall Study|Withdrawal by Subject|1|||
125285755|NCT01904149|450672763|FG005|Overall Study|Withdrawal by Subject|0|||
125285756|NCT01904149|450672758|FG000|Overall Study|Protocol Violation|0|||
125285757|NCT01904149|450672759|FG001|Overall Study|Protocol Violation|1|||
125285758|NCT01904149|450672760|FG002|Overall Study|Protocol Violation|0|||
125285759|NCT01904149|450672761|FG003|Overall Study|Protocol Violation|0|||
125285760|NCT01904149|450672762|FG004|Overall Study|Protocol Violation|0|||
125285761|NCT01904149|450672763|FG005|Overall Study|Protocol Violation|0|||
125285762|NCT01904149|450672758|FG000|Overall Study|non compliance with study drug|1|||
125285763|NCT01904149|450672759|FG001|Overall Study|non compliance with study drug|0|||
125285764|NCT01904149|450672760|FG002|Overall Study|non compliance with study drug|0|||
125285765|NCT01904149|450672761|FG003|Overall Study|non compliance with study drug|0|||
125285766|NCT01904149|450672762|FG004|Overall Study|non compliance with study drug|0|||
125285767|NCT01904149|450672763|FG005|Overall Study|non compliance with study drug|0|||
125285768|NCT00068250|450672764|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
125285769|NCT00068250|450672765|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
125285770|NCT00068250|450672766|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
125285771|NCT00068250|450672767|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
125285772|NCT00812006|450672768|FG000|Overall Study|Lost to Follow-up|0|||
125285773|NCT00812006|450672769|FG001|Overall Study|Lost to Follow-up|0|||
125285774|NCT00812006|450672770|FG002|Overall Study|Lost to Follow-up|2|||
125285775|NCT00812006|450672768|FG000|Overall Study|Physician Decision|0|||
125285776|NCT00812006|450672769|FG001|Overall Study|Physician Decision|0|||
125285777|NCT00812006|450672770|FG002|Overall Study|Physician Decision|1|||
125285778|NCT00812006|450672768|FG000|Overall Study|Withdrawal by Subject|2|||
125285779|NCT00812006|450672769|FG001|Overall Study|Withdrawal by Subject|1|||
125285780|NCT00812006|450672770|FG002|Overall Study|Withdrawal by Subject|1|||
125285781|NCT00812006|450672768|FG000|Overall Study|Lack of Qualifying Event|4|||
125285782|NCT00812006|450672769|FG001|Overall Study|Lack of Qualifying Event|2|||
125285783|NCT00812006|450672770|FG002|Overall Study|Lack of Qualifying Event|2|||
125285784|NCT00235391|450672771|FG000|Overall Study|Adverse Event|4|||
125285785|NCT00235391|450672772|FG001|Overall Study|Adverse Event|5|||
125285786|NCT00235391|450672773|FG002|Overall Study|Adverse Event|10|||
125285787|NCT00235391|450672774|FG003|Overall Study|Adverse Event|72|||
125285788|NCT00235391|450672775|FG004|Overall Study|Adverse Event|5|||
125285789|NCT00235391|450672776|FG005|Overall Study|Adverse Event|2|||
125285790|NCT00235391|450672771|FG000|Overall Study|Abnormal laboratory value(s)|3|||
125285791|NCT00235391|450672772|FG001|Overall Study|Abnormal laboratory value(s)|5|||
125285792|NCT00235391|450672773|FG002|Overall Study|Abnormal laboratory value(s)|4|||
125285793|NCT00235391|450672774|FG003|Overall Study|Abnormal laboratory value(s)|27|||
125415893|NCT01490632|451147425|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415894|NCT01490632|451147426|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415895|NCT01490632|451147427|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415896|NCT01490632|451147428|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415897|NCT01490632|451147429|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415898|NCT01490632|451147430|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
125415899|NCT01490632|451147431|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
125415900|NCT01490632|451147432|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415901|NCT01490632|451147433|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415902|NCT01490632|451147434|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415903|NCT01490632|451147435|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
125415904|NCT01490632|451147416|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415905|NCT01490632|451147417|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415906|NCT01490632|451147418|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415907|NCT01490632|451147419|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415908|NCT01490632|451147420|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415909|NCT01490632|451147421|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415910|NCT01490632|451147422|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415911|NCT01490632|451147423|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415912|NCT01490632|451147424|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415913|NCT01490632|451147425|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415914|NCT01490632|451147426|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415915|NCT01490632|451147427|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415916|NCT01490632|451147428|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
125415917|NCT01490632|451147429|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
125415918|NCT01490632|451147430|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
125415919|NCT01490632|451147431|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
125415920|NCT01490632|451147432|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415921|NCT01490632|451147433|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415922|NCT01490632|451147434|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415923|NCT01490632|451147435|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
125415924|NCT01490632|451147416|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
125415925|NCT01490632|451147417|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
125415926|NCT01490632|451147418|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
125415927|NCT01490632|451147419|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
125415928|NCT01490632|451147420|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
125415929|NCT01490632|451147421|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
125415930|NCT01490632|451147422|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
125415931|NCT01490632|451147423|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
125415932|NCT01490632|451147424|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
125415933|NCT01490632|451147425|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
125415934|NCT01490632|451147426|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
125415935|NCT01490632|451147427|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
125415936|NCT01490632|451147428|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
125415937|NCT01490632|451147429|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
125415938|NCT01490632|451147430|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
125415939|NCT01490632|451147431|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
125415940|NCT01490632|451147432|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
125415941|NCT01490632|451147433|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
125415942|NCT01490632|451147434|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
125415943|NCT01490632|451147435|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
125415944|NCT01490632|451147416|FG000|Part D: Re-Treatment Period|Death|0|||
125415945|NCT01490632|451147417|FG001|Part D: Re-Treatment Period|Death|0|||
125415946|NCT01490632|451147418|FG002|Part D: Re-Treatment Period|Death|0|||
125415947|NCT01490632|451147419|FG003|Part D: Re-Treatment Period|Death|0|||
125415948|NCT01490632|451147420|FG004|Part D: Re-Treatment Period|Death|0|||
125415949|NCT01490632|451147421|FG005|Part D: Re-Treatment Period|Death|0|||
125415950|NCT01490632|451147422|FG006|Part D: Re-Treatment Period|Death|0|||
125415951|NCT01490632|451147423|FG007|Part D: Re-Treatment Period|Death|0|||
125415952|NCT01490632|451147424|FG008|Part D: Re-Treatment Period|Death|0|||
125449123|NCT00819234|451270987|FG007|Overall Study|Withdrawal by Subject|8|||
125449124|NCT00819234|451270988|FG008|Overall Study|Withdrawal by Subject|5|||
125449125|NCT00819234|451270989|FG009|Overall Study|Withdrawal by Subject|3|||
125449126|NCT00819234|451270980|FG000|Overall Study|Adverse Event|0|||
125449127|NCT00819234|451270981|FG001|Overall Study|Adverse Event|0|||
125449128|NCT00819234|451270982|FG002|Overall Study|Adverse Event|1|||
125449129|NCT00819234|451270983|FG003|Overall Study|Adverse Event|0|||
125415953|NCT01490632|451147425|FG009|Part D: Re-Treatment Period|Death|0|||
125415954|NCT01490632|451147426|FG010|Part D: Re-Treatment Period|Death|0|||
125415955|NCT01490632|451147427|FG011|Part D: Re-Treatment Period|Death|0|||
125415956|NCT01490632|451147428|FG012|Part D: Re-Treatment Period|Death|0|||
125415957|NCT01490632|451147429|FG013|Part D: Re-Treatment Period|Death|0|||
125415958|NCT01490632|451147430|FG014|Part D: Re-Treatment Period|Death|0|||
125415959|NCT01490632|451147431|FG015|Part D: Re-Treatment Period|Death|0|||
125415960|NCT01490632|451147432|FG016|Part D: Re-Treatment Period|Death|0|||
125415961|NCT01490632|451147433|FG017|Part D: Re-Treatment Period|Death|0|||
125415962|NCT01490632|451147434|FG018|Part D: Re-Treatment Period|Death|1|||
125415963|NCT01490632|451147435|FG019|Part D: Re-Treatment Period|Death|0|||
125415964|NCT01490632|451147416|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415965|NCT01490632|451147417|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415966|NCT01490632|451147418|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415967|NCT01490632|451147419|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415968|NCT01490632|451147420|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415969|NCT01490632|451147421|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415970|NCT01490632|451147422|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415971|NCT01490632|451147423|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415972|NCT01490632|451147424|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415973|NCT01490632|451147425|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415974|NCT01490632|451147426|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415975|NCT01490632|451147427|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415976|NCT01490632|451147428|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415977|NCT01490632|451147429|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415978|NCT01490632|451147430|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415979|NCT01490632|451147431|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125285794|NCT00235391|450672775|FG004|Overall Study|Abnormal laboratory value(s)|1|||
125285795|NCT00235391|450672776|FG005|Overall Study|Abnormal laboratory value(s)|2|||
125285796|NCT00235391|450672771|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125285797|NCT00235391|450672772|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125285798|NCT00235391|450672773|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
125285799|NCT00235391|450672774|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
125285800|NCT00235391|450672775|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
125285801|NCT00235391|450672776|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
125285802|NCT00235391|450672771|FG000|Overall Study|Condition no longer requires treatment|3|||
125285803|NCT00235391|450672772|FG001|Overall Study|Condition no longer requires treatment|0|||
125285804|NCT00235391|450672773|FG002|Overall Study|Condition no longer requires treatment|0|||
125285805|NCT00235391|450672774|FG003|Overall Study|Condition no longer requires treatment|11|||
125415980|NCT01490632|451147432|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
125415981|NCT01490632|451147433|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
125415982|NCT01490632|451147434|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
125415983|NCT01490632|451147435|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
125415984|NCT01490632|451147416|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415985|NCT01490632|451147417|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415986|NCT01490632|451147418|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415987|NCT01490632|451147419|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415988|NCT01490632|451147420|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415989|NCT01490632|451147421|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415990|NCT01490632|451147422|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415991|NCT01490632|451147423|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415992|NCT01490632|451147424|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415993|NCT01490632|451147425|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415994|NCT01490632|451147426|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415995|NCT01490632|451147427|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415996|NCT01490632|451147428|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415997|NCT01490632|451147429|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415998|NCT01490632|451147430|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125415999|NCT01490632|451147431|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125416000|NCT01490632|451147432|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125285806|NCT00235391|450672775|FG004|Overall Study|Condition no longer requires treatment|1|||
125285807|NCT00235391|450672776|FG005|Overall Study|Condition no longer requires treatment|0|||
125285808|NCT00235391|450672771|FG000|Overall Study|Protocol deviation|0|||
125416001|NCT01490632|451147433|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125416002|NCT01490632|451147434|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
125416003|NCT01490632|451147435|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
125416004|NCT01490632|451147416|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
125416005|NCT01490632|451147417|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
125416006|NCT01490632|451147418|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
125416007|NCT01490632|451147419|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
125416008|NCT01490632|451147420|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
125416009|NCT01490632|451147421|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
125416010|NCT01490632|451147422|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
125416011|NCT01490632|451147423|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
125416012|NCT01490632|451147424|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
125416013|NCT01490632|451147425|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
125416014|NCT01490632|451147426|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
125416015|NCT01490632|451147427|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
125416016|NCT01490632|451147428|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
125416017|NCT01490632|451147429|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
125416018|NCT01490632|451147430|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
125416019|NCT01490632|451147431|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
125416020|NCT01490632|451147432|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
125416021|NCT01490632|451147433|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
125416022|NCT01490632|451147434|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
125416023|NCT01490632|451147435|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
125416024|NCT01490632|451147416|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
125416025|NCT01490632|451147417|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
125416026|NCT01490632|451147418|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
125416027|NCT01490632|451147419|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
125416028|NCT01490632|451147420|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
125416029|NCT01490632|451147421|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
125416030|NCT01490632|451147422|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
125416031|NCT01490632|451147423|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
125416032|NCT01490632|451147424|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
125416033|NCT01490632|451147425|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
125416034|NCT01490632|451147426|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
125416035|NCT01490632|451147427|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
125416036|NCT01490632|451147428|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
125416037|NCT01490632|451147429|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
125416038|NCT01490632|451147430|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
125416039|NCT01490632|451147431|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
125416040|NCT01490632|451147432|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
125416041|NCT01490632|451147433|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
125416042|NCT01490632|451147434|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
125416043|NCT01490632|451147435|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
125416044|NCT01490632|451147416|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416045|NCT01490632|451147417|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416046|NCT01490632|451147418|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416047|NCT01490632|451147419|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416048|NCT01490632|451147420|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416049|NCT01490632|451147421|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416050|NCT01490632|451147422|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416051|NCT01490632|451147423|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416052|NCT01490632|451147424|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416053|NCT01490632|451147425|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416054|NCT01490632|451147426|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416055|NCT01490632|451147427|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416056|NCT01490632|451147428|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416057|NCT01490632|451147429|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416058|NCT01490632|451147430|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416059|NCT01490632|451147431|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416060|NCT01490632|451147432|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
125416061|NCT01490632|451147433|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
125416062|NCT01490632|451147434|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
125416063|NCT01490632|451147435|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
125416064|NCT03822533|451147436|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
125416065|NCT03822533|451147437|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
125416066|NCT03822533|451147436|FG000|3 Month Follow-up|Lost to Follow-up|2|||
125416067|NCT03822533|451147437|FG001|3 Month Follow-up|Lost to Follow-up|2|||
125416068|NCT03822533|451147436|FG000|6 Month Follow-up|Lost to Follow-up|3|||
125416069|NCT03822533|451147437|FG001|6 Month Follow-up|Lost to Follow-up|0|||
125416070|NCT03822533|451147436|FG000|12 Month Follow-up|Lost to Follow-up|2|||
125416071|NCT03822533|451147437|FG001|12 Month Follow-up|Lost to Follow-up|3|||
125416072|NCT03822533|451147436|FG000|12 Month Follow-up|Pregnancy|0|||
125416073|NCT03822533|451147437|FG001|12 Month Follow-up|Pregnancy|1|||
125416074|NCT03822533|451147436|FG000|12 Month Follow-up|Surgery|2|||
125416075|NCT03822533|451147437|FG001|12 Month Follow-up|Surgery|0|||
125416076|NCT03822533|451147436|FG000|12 Month Follow-up|Wrong address|1|||
125416077|NCT03822533|451147437|FG001|12 Month Follow-up|Wrong address|0|||
125416078|NCT03822533|451147436|FG000|12 Month Follow-up|No symptoms|1|||
125416079|NCT03822533|451147437|FG001|12 Month Follow-up|No symptoms|0|||
125416080|NCT03822533|451147436|FG000|12 Month Follow-up|Changed primary care center|0|||
125416081|NCT03822533|451147437|FG001|12 Month Follow-up|Changed primary care center|1|||
125416082|NCT06111742|451147441|FG000|Overall Study|Did not receive intervention|1|||
125416083|NCT06111742|451147442|FG001|Overall Study|Did not receive intervention|0|||
125416084|NCT06111742|451147443|FG002|Overall Study|Did not receive intervention|0|||
125416085|NCT06111742|451147441|FG000|Overall Study|Withdrawal by Subject|2|||
125416086|NCT06111742|451147442|FG001|Overall Study|Withdrawal by Subject|0|||
125416087|NCT06111742|451147443|FG002|Overall Study|Withdrawal by Subject|0|||
125416088|NCT01917526|451147444|FG000|Overall Study|Protocol Violation|1|||
125416089|NCT01917526|451147445|FG001|Overall Study|Protocol Violation|1|||
125416090|NCT04717596|451147446|FG000|Overall Study|Withdrawal by Subject|4|||
125416091|NCT02864082|451147447|FG000|Overall Study|Adverse Event|1|||
125416092|NCT02864082|451147448|FG001|Overall Study|Adverse Event|1|||
125416093|NCT02864082|451147447|FG000|Overall Study|Lost to Follow-up|0|||
125416094|NCT02864082|451147448|FG001|Overall Study|Lost to Follow-up|1|||
125416095|NCT02864082|451147447|FG000|Overall Study|Withdrawal by Subject|2|||
125416096|NCT02864082|451147448|FG001|Overall Study|Withdrawal by Subject|2|||
125416097|NCT01127178|451147449|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
125416098|NCT01127178|451147450|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
125416099|NCT01127178|451147449|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
125416100|NCT01127178|451147450|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
125416101|NCT01127178|451147449|FG000|Dose Escalation: Treatment Phase|Other|2|||
125416102|NCT01127178|451147450|FG001|Dose Escalation: Treatment Phase|Other|0|||
125416103|NCT01127178|451147449|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
125416104|NCT01127178|451147450|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
125416105|NCT01127178|451147449|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
125416106|NCT01127178|451147450|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
125416107|NCT01127178|451147449|FG000|Dose Escalation: Extension Phase|Other|1|||
125416108|NCT01127178|451147450|FG001|Dose Escalation: Extension Phase|Other|0|||
125416109|NCT03621696|451147451|FG000|Overall Study|Not eligible|0|||
125416110|NCT03621696|451147452|FG001|Overall Study|Not eligible|0|||
125416111|NCT03621696|451147453|FG002|Overall Study|Not eligible|0|||
125416112|NCT03621696|451147454|FG003|Overall Study|Not eligible|5|||
125416113|NCT03621696|451147451|FG000|Overall Study|Withdrawal by Subject|1|||
125416114|NCT03621696|451147452|FG001|Overall Study|Withdrawal by Subject|1|||
125416115|NCT03621696|451147453|FG002|Overall Study|Withdrawal by Subject|1|||
125416116|NCT03621696|451147454|FG003|Overall Study|Withdrawal by Subject|0|||
125416117|NCT03621696|451147451|FG000|Overall Study|Physician Decision|0|||
125416118|NCT03621696|451147452|FG001|Overall Study|Physician Decision|0|||
125416119|NCT03621696|451147453|FG002|Overall Study|Physician Decision|1|||
125416120|NCT03621696|451147454|FG003|Overall Study|Physician Decision|0|||
125416121|NCT04349553|451147455|FG000|Overall Study|Withdrawal by Subject|1|||
125416122|NCT04349553|451147456|FG001|Overall Study|Withdrawal by Subject|0|||
125416123|NCT04349553|451147457|FG002|Overall Study|Withdrawal by Subject|1|||
125416124|NCT04349553|451147458|FG003|Overall Study|Withdrawal by Subject|0|||
125416125|NCT02063724|451147459|FG000|Overall Study|Disease progression|1|||
125416126|NCT02372396|451147460|FG000|Overall Study|Lost to Follow-up|7|||
125416127|NCT02372396|451147461|FG001|Overall Study|Lost to Follow-up|9|||
125416128|NCT02310750|451147468|FG000|HP Period 1|Lost to Follow-up|0|||
125416129|NCT02310750|451147469|FG001|HP Period 1|Lost to Follow-up|0|||
125416130|NCT02310750|451147470|FG002|HP Period 1|Lost to Follow-up|0|||
125416131|NCT02310750|451147471|FG003|HP Period 1|Lost to Follow-up|0|||
125416132|NCT02310750|451147472|FG004|HP Period 1|Lost to Follow-up|0|||
125416133|NCT02310750|451147473|FG005|HP Period 1|Lost to Follow-up|0|||
125416134|NCT02310750|451147474|FG006|HP Period 1|Lost to Follow-up|1|||
125416135|NCT02310750|451147475|FG007|HP Period 1|Lost to Follow-up|0|||
125416136|NCT02310750|451147476|FG008|HP Period 1|Lost to Follow-up|0|||
125416137|NCT02310750|451147477|FG009|HP Period 1|Lost to Follow-up|0|||
125416138|NCT02310750|451147478|FG010|HP Period 1|Lost to Follow-up|0|||
125449130|NCT00819234|451270984|FG004|Overall Study|Adverse Event|0|||
125449131|NCT00819234|451270985|FG005|Overall Study|Adverse Event|2|||
125449132|NCT00819234|451270986|FG006|Overall Study|Adverse Event|0|||
125449133|NCT00819234|451270987|FG007|Overall Study|Adverse Event|0|||
125449134|NCT00819234|451270988|FG008|Overall Study|Adverse Event|0|||
125416139|NCT02310750|451147479|FG011|HP Period 1|Lost to Follow-up|0|||
125416140|NCT02310750|451147480|FG012|HP Period 1|Lost to Follow-up|0|||
125416141|NCT02310750|451147481|FG013|HP Period 1|Lost to Follow-up|0|||
125416142|NCT02310750|451147482|FG014|HP Period 1|Lost to Follow-up|0|||
125416143|NCT02310750|451147483|FG015|HP Period 1|Lost to Follow-up|0|||
125416144|NCT02310750|451147468|FG000|HP Period 1|Withdrawal by Subject|1|||
125416145|NCT02310750|451147469|FG001|HP Period 1|Withdrawal by Subject|0|||
125416146|NCT02310750|451147470|FG002|HP Period 1|Withdrawal by Subject|0|||
125416147|NCT02310750|451147471|FG003|HP Period 1|Withdrawal by Subject|1|||
125416148|NCT02310750|451147472|FG004|HP Period 1|Withdrawal by Subject|0|||
125449135|NCT00819234|451270989|FG009|Overall Study|Adverse Event|0|||
125416149|NCT02310750|451147473|FG005|HP Period 1|Withdrawal by Subject|0|||
125416150|NCT02310750|451147474|FG006|HP Period 1|Withdrawal by Subject|0|||
125416151|NCT02310750|451147475|FG007|HP Period 1|Withdrawal by Subject|0|||
125449136|NCT00819234|451270980|FG000|Overall Study|Physician Decision|0|||
125449137|NCT00819234|451270981|FG001|Overall Study|Physician Decision|0|||
125449138|NCT00819234|451270982|FG002|Overall Study|Physician Decision|0|||
125449139|NCT00819234|451270983|FG003|Overall Study|Physician Decision|1|||
125449140|NCT00819234|451270984|FG004|Overall Study|Physician Decision|0|||
125449141|NCT00819234|451270985|FG005|Overall Study|Physician Decision|0|||
125449142|NCT00819234|451270986|FG006|Overall Study|Physician Decision|0|||
125449143|NCT00819234|451270987|FG007|Overall Study|Physician Decision|0|||
125449144|NCT00819234|451270988|FG008|Overall Study|Physician Decision|0|||
125449145|NCT00819234|451270989|FG009|Overall Study|Physician Decision|2|||
125449146|NCT00819234|451270980|FG000|Overall Study|Protocol Violation|0|||
125449147|NCT00819234|451270981|FG001|Overall Study|Protocol Violation|0|||
125449148|NCT00819234|451270982|FG002|Overall Study|Protocol Violation|1|||
125449149|NCT00819234|451270983|FG003|Overall Study|Protocol Violation|0|||
125449150|NCT00819234|451270984|FG004|Overall Study|Protocol Violation|0|||
125449151|NCT00819234|451270985|FG005|Overall Study|Protocol Violation|0|||
125449152|NCT00819234|451270986|FG006|Overall Study|Protocol Violation|0|||
125449153|NCT00819234|451270987|FG007|Overall Study|Protocol Violation|0|||
125449154|NCT00819234|451270988|FG008|Overall Study|Protocol Violation|0|||
125449155|NCT00819234|451270989|FG009|Overall Study|Protocol Violation|0|||
125449156|NCT00819234|451270980|FG000|Overall Study|Lost to Follow-up|2|||
125449157|NCT00819234|451270981|FG001|Overall Study|Lost to Follow-up|2|||
125449158|NCT00819234|451270982|FG002|Overall Study|Lost to Follow-up|0|||
125449159|NCT00819234|451270983|FG003|Overall Study|Lost to Follow-up|2|||
125449160|NCT00819234|451270984|FG004|Overall Study|Lost to Follow-up|1|||
125449161|NCT00819234|451270985|FG005|Overall Study|Lost to Follow-up|1|||
125449162|NCT00819234|451270986|FG006|Overall Study|Lost to Follow-up|1|||
125449163|NCT00819234|451270987|FG007|Overall Study|Lost to Follow-up|1|||
125449164|NCT00819234|451270988|FG008|Overall Study|Lost to Follow-up|1|||
125449165|NCT00819234|451270989|FG009|Overall Study|Lost to Follow-up|2|||
125449166|NCT01823341|451270990|FG000|Overall Study|Failed run-in|7|||
125449167|NCT01823341|451270990|FG000|Overall Study|Withdrawal by Subject|7|||
125449168|NCT01823341|451270990|FG000|Overall Study|Adverse Event|1|||
125449169|NCT05174065|451270991|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
125449170|NCT05174065|451270992|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
125449171|NCT05174065|451270993|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
125449172|NCT05174065|451270991|FG000|Placebo-controlled Period|Other|0|||
125449173|NCT05174065|451270992|FG001|Placebo-controlled Period|Other|1|||
125449174|NCT05174065|451270993|FG002|Placebo-controlled Period|Other|0|||
125449175|NCT05174065|451270991|FG000|Placebo-controlled Period|Adverse Event|1|||
125449176|NCT05174065|451270992|FG001|Placebo-controlled Period|Adverse Event|1|||
125449177|NCT05174065|451270993|FG002|Placebo-controlled Period|Adverse Event|0|||
125449178|NCT05174065|451270991|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
125449179|NCT05174065|451270992|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
125449180|NCT05174065|451270993|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
125449181|NCT05174065|451270991|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
125449182|NCT05174065|451270992|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
125449183|NCT05174065|451270993|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
125449184|NCT05174065|451270991|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
125449185|NCT05174065|451270992|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
125449186|NCT05174065|451270993|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
125449187|NCT00924560|451270994|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
125449188|NCT00924560|451270995|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
125449189|NCT00924560|451270996|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
125449190|NCT00924560|451270994|FG000|Overall Study|Non Compliance with the Protocol|20|||
125449191|NCT00924560|451270995|FG001|Overall Study|Non Compliance with the Protocol|15|||
125449192|NCT00924560|451270996|FG002|Overall Study|Non Compliance with the Protocol|4|||
125449193|NCT00924560|451270994|FG000|Overall Study|Physician Decision|2|||
125449194|NCT00924560|451270995|FG001|Overall Study|Physician Decision|3|||
125449195|NCT00924560|451270996|FG002|Overall Study|Physician Decision|4|||
125449196|NCT00924560|451270994|FG000|Overall Study|Withdrawal by Subject|50|||
125449197|NCT00924560|451270995|FG001|Overall Study|Withdrawal by Subject|44|||
125449198|NCT00924560|451270996|FG002|Overall Study|Withdrawal by Subject|18|||
125449199|NCT00924560|451270994|FG000|Overall Study|Adverse Event|39|||
125449200|NCT00924560|451270995|FG001|Overall Study|Adverse Event|33|||
125449201|NCT00924560|451270996|FG002|Overall Study|Adverse Event|0|||
125449202|NCT00924560|451270994|FG000|Overall Study|Pregnancy|5|||
125449203|NCT00924560|451270995|FG001|Overall Study|Pregnancy|7|||
125449204|NCT00924560|451270996|FG002|Overall Study|Pregnancy|1|||
125449205|NCT00924560|451270994|FG000|Overall Study|Lost to Follow-up|78|||
125449206|NCT00924560|451270995|FG001|Overall Study|Lost to Follow-up|94|||
125449207|NCT00924560|451270996|FG002|Overall Study|Lost to Follow-up|45|||
125449208|NCT00924560|451270994|FG000|Overall Study|Miscellaneous Reasons|13|||
125449209|NCT00924560|451270995|FG001|Overall Study|Miscellaneous Reasons|10|||
125449210|NCT00924560|451270996|FG002|Overall Study|Miscellaneous Reasons|10|||
125449211|NCT03590743|451270998|FG000|Overall Study|Withdrawal by Subject|0|||
125449212|NCT03590743|451270999|FG001|Overall Study|Withdrawal by Subject|1|||
125449213|NCT02696226|451271000|FG000|Overall Study|Study terminated - lack of enrollment|1|||
125416152|NCT02310750|451147476|FG008|HP Period 1|Withdrawal by Subject|0|||
125416153|NCT02310750|451147477|FG009|HP Period 1|Withdrawal by Subject|0|||
125416154|NCT02310750|451147478|FG010|HP Period 1|Withdrawal by Subject|0|||
125416155|NCT02310750|451147479|FG011|HP Period 1|Withdrawal by Subject|0|||
125416156|NCT02310750|451147480|FG012|HP Period 1|Withdrawal by Subject|0|||
125416157|NCT02310750|451147481|FG013|HP Period 1|Withdrawal by Subject|0|||
125416158|NCT02310750|451147482|FG014|HP Period 1|Withdrawal by Subject|0|||
125416159|NCT02310750|451147483|FG015|HP Period 1|Withdrawal by Subject|0|||
125416160|NCT02310750|451147468|FG000|HP Washout 1|Lost to Follow-up|0|||
125416161|NCT02310750|451147469|FG001|HP Washout 1|Lost to Follow-up|0|||
125416162|NCT02310750|451147470|FG002|HP Washout 1|Lost to Follow-up|1|||
125416163|NCT02310750|451147471|FG003|HP Washout 1|Lost to Follow-up|1|||
125416164|NCT02310750|451147472|FG004|HP Washout 1|Lost to Follow-up|2|||
125416165|NCT02310750|451147473|FG005|HP Washout 1|Lost to Follow-up|2|||
125416166|NCT02310750|451147474|FG006|HP Washout 1|Lost to Follow-up|3|||
125416167|NCT02310750|451147475|FG007|HP Washout 1|Lost to Follow-up|0|||
125416168|NCT02310750|451147476|FG008|HP Washout 1|Lost to Follow-up|0|||
125416169|NCT02310750|451147477|FG009|HP Washout 1|Lost to Follow-up|0|||
125416170|NCT02310750|451147478|FG010|HP Washout 1|Lost to Follow-up|0|||
125416171|NCT02310750|451147479|FG011|HP Washout 1|Lost to Follow-up|0|||
125416172|NCT02310750|451147480|FG012|HP Washout 1|Lost to Follow-up|0|||
125416173|NCT02310750|451147481|FG013|HP Washout 1|Lost to Follow-up|0|||
125416174|NCT02310750|451147482|FG014|HP Washout 1|Lost to Follow-up|0|||
125416175|NCT02310750|451147483|FG015|HP Washout 1|Lost to Follow-up|0|||
125416176|NCT02310750|451147468|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125416177|NCT02310750|451147469|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125416178|NCT02310750|451147470|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125416179|NCT02310750|451147471|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
125416180|NCT02310750|451147472|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125416181|NCT02310750|451147473|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
125416182|NCT02310750|451147474|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125416183|NCT02310750|451147475|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125416184|NCT02310750|451147476|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
125416185|NCT02310750|451147477|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
125416186|NCT02310750|451147478|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125416187|NCT02310750|451147479|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125416188|NCT02310750|451147480|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125416189|NCT02310750|451147481|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125416190|NCT02310750|451147482|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125416191|NCT02310750|451147483|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
125416192|NCT02310750|451147468|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416193|NCT02310750|451147469|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416194|NCT02310750|451147470|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416195|NCT02310750|451147471|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416196|NCT02310750|451147472|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416197|NCT02310750|451147473|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416198|NCT02310750|451147474|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416199|NCT02310750|451147475|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416200|NCT02310750|451147476|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416201|NCT02310750|451147477|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
125416202|NCT02310750|451147478|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416203|NCT02310750|451147479|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416204|NCT02310750|451147480|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416205|NCT02310750|451147481|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416206|NCT02310750|451147482|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416207|NCT02310750|451147483|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
125416208|NCT02310750|451147468|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125416209|NCT02310750|451147469|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125416210|NCT02310750|451147470|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125416211|NCT02310750|451147471|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125416212|NCT02310750|451147472|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125416213|NCT02310750|451147473|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125416214|NCT02310750|451147474|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125416215|NCT02310750|451147475|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
125416216|NCT02310750|451147476|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
125416217|NCT02310750|451147477|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
125416218|NCT02310750|451147478|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125416219|NCT02310750|451147479|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125416220|NCT02310750|451147480|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125416221|NCT02310750|451147481|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125449214|NCT02696226|451271001|FG001|Overall Study|Study terminated - lack of enrollment|0|||
125416222|NCT02310750|451147482|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125416223|NCT02310750|451147483|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
125416224|NCT02310750|451147468|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416225|NCT02310750|451147469|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416226|NCT02310750|451147470|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416227|NCT02310750|451147471|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416228|NCT02310750|451147472|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416229|NCT02310750|451147473|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416230|NCT02310750|451147474|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416231|NCT02310750|451147475|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
125416232|NCT02310750|451147476|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
125416233|NCT02310750|451147477|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416234|NCT02310750|451147478|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416235|NCT02310750|451147479|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416236|NCT02310750|451147480|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416237|NCT02310750|451147481|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416238|NCT02310750|451147482|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416239|NCT02310750|451147483|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
125416240|NCT02310750|451147468|FG000|HP Washout 2|Lost to Follow-up|0|||
125416241|NCT02310750|451147469|FG001|HP Washout 2|Lost to Follow-up|0|||
125416242|NCT02310750|451147470|FG002|HP Washout 2|Lost to Follow-up|0|||
125416243|NCT02310750|451147471|FG003|HP Washout 2|Lost to Follow-up|0|||
125416244|NCT02310750|451147472|FG004|HP Washout 2|Lost to Follow-up|1|||
125416245|NCT02310750|451147473|FG005|HP Washout 2|Lost to Follow-up|0|||
125416246|NCT02310750|451147474|FG006|HP Washout 2|Lost to Follow-up|7|||
125416247|NCT02310750|451147475|FG007|HP Washout 2|Lost to Follow-up|0|||
125416248|NCT02310750|451147476|FG008|HP Washout 2|Lost to Follow-up|0|||
125416249|NCT02310750|451147477|FG009|HP Washout 2|Lost to Follow-up|0|||
125416250|NCT02310750|451147478|FG010|HP Washout 2|Lost to Follow-up|0|||
125416251|NCT02310750|451147479|FG011|HP Washout 2|Lost to Follow-up|0|||
125416252|NCT02310750|451147480|FG012|HP Washout 2|Lost to Follow-up|0|||
125416253|NCT02310750|451147481|FG013|HP Washout 2|Lost to Follow-up|0|||
125416254|NCT02310750|451147482|FG014|HP Washout 2|Lost to Follow-up|0|||
125416255|NCT02310750|451147483|FG015|HP Washout 2|Lost to Follow-up|0|||
125416256|NCT02952924|451147486|FG000|Overall Study|Protocol Violation|0|||
125416257|NCT02952924|451147487|FG001|Overall Study|Protocol Violation|0|||
125416258|NCT02952924|451147488|FG002|Overall Study|Protocol Violation|0|||
125416259|NCT02952924|451147489|FG003|Overall Study|Protocol Violation|0|||
125416260|NCT02952924|451147490|FG004|Overall Study|Protocol Violation|0|||
125416261|NCT02952924|451147491|FG005|Overall Study|Protocol Violation|0|||
125416262|NCT02952924|451147492|FG006|Overall Study|Protocol Violation|0|||
125416263|NCT02952924|451147493|FG007|Overall Study|Protocol Violation|0|||
125416264|NCT02952924|451147494|FG008|Overall Study|Protocol Violation|0|||
125416265|NCT02952924|451147495|FG009|Overall Study|Protocol Violation|0|||
125416266|NCT02952924|451147496|FG010|Overall Study|Protocol Violation|0|||
125416267|NCT02952924|451147497|FG011|Overall Study|Protocol Violation|0|||
125416268|NCT02952924|451147498|FG012|Overall Study|Protocol Violation|0|||
125416269|NCT02952924|451147499|FG013|Overall Study|Protocol Violation|0|||
125416270|NCT02952924|451147500|FG014|Overall Study|Protocol Violation|0|||
125416271|NCT02952924|451147501|FG015|Overall Study|Protocol Violation|0|||
125416272|NCT02952924|451147502|FG016|Overall Study|Protocol Violation|0|||
125416273|NCT02952924|451147503|FG017|Overall Study|Protocol Violation|0|||
125416274|NCT02952924|451147504|FG018|Overall Study|Protocol Violation|0|||
125416275|NCT02952924|451147505|FG019|Overall Study|Protocol Violation|1|||
125416276|NCT02952924|451147506|FG020|Overall Study|Protocol Violation|0|||
125416277|NCT02952924|451147507|FG021|Overall Study|Protocol Violation|0|||
125416278|NCT02952924|451147486|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
125416279|NCT02952924|451147487|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
125416280|NCT02952924|451147488|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
125416281|NCT02952924|451147489|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
125416282|NCT02952924|451147490|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
125416283|NCT02952924|451147491|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
125416284|NCT02952924|451147492|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
125416285|NCT02952924|451147493|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
125416286|NCT02952924|451147494|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
125416287|NCT02952924|451147495|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
125416288|NCT02952924|451147496|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
125416289|NCT02952924|451147497|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
125416290|NCT02952924|451147498|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
125416291|NCT02952924|451147499|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
125416292|NCT02952924|451147500|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
125416293|NCT02952924|451147501|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
125416294|NCT02952924|451147502|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
125416295|NCT02952924|451147503|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
125416296|NCT02952924|451147504|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
125416297|NCT02952924|451147505|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
125416298|NCT02952924|451147506|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
125416299|NCT02952924|451147507|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
125416300|NCT02952924|451147486|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416301|NCT02952924|451147487|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416302|NCT02952924|451147488|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416303|NCT02952924|451147489|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416304|NCT02952924|451147490|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416305|NCT02952924|451147491|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416306|NCT02952924|451147492|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416307|NCT02952924|451147493|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416308|NCT02952924|451147494|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416309|NCT02952924|451147495|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416310|NCT02952924|451147496|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416311|NCT02952924|451147497|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416312|NCT02952924|451147498|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416313|NCT02952924|451147499|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416314|NCT02952924|451147500|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416315|NCT02952924|451147501|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416316|NCT02952924|451147502|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416317|NCT02952924|451147503|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416318|NCT02952924|451147504|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416319|NCT02952924|451147505|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416320|NCT02952924|451147506|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
125416321|NCT02952924|451147507|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
125416322|NCT02952924|451147486|FG000|Overall Study|Noncompliance with study drug|0|||
125416323|NCT02952924|451147487|FG001|Overall Study|Noncompliance with study drug|0|||
125416324|NCT02952924|451147488|FG002|Overall Study|Noncompliance with study drug|0|||
125416325|NCT02952924|451147489|FG003|Overall Study|Noncompliance with study drug|0|||
125416326|NCT02952924|451147490|FG004|Overall Study|Noncompliance with study drug|0|||
125416327|NCT02952924|451147491|FG005|Overall Study|Noncompliance with study drug|0|||
125416328|NCT02952924|451147492|FG006|Overall Study|Noncompliance with study drug|0|||
125416329|NCT02952924|451147493|FG007|Overall Study|Noncompliance with study drug|0|||
125416330|NCT02952924|451147494|FG008|Overall Study|Noncompliance with study drug|0|||
125416331|NCT02952924|451147495|FG009|Overall Study|Noncompliance with study drug|0|||
125416332|NCT02952924|451147496|FG010|Overall Study|Noncompliance with study drug|0|||
125416333|NCT02952924|451147497|FG011|Overall Study|Noncompliance with study drug|0|||
125416334|NCT02952924|451147498|FG012|Overall Study|Noncompliance with study drug|0|||
125416335|NCT02952924|451147499|FG013|Overall Study|Noncompliance with study drug|0|||
125416336|NCT02952924|451147500|FG014|Overall Study|Noncompliance with study drug|0|||
125416337|NCT02952924|451147501|FG015|Overall Study|Noncompliance with study drug|0|||
125416338|NCT02952924|451147502|FG016|Overall Study|Noncompliance with study drug|0|||
125416339|NCT02952924|451147503|FG017|Overall Study|Noncompliance with study drug|0|||
125416340|NCT02952924|451147504|FG018|Overall Study|Noncompliance with study drug|0|||
125416341|NCT02952924|451147505|FG019|Overall Study|Noncompliance with study drug|0|||
125416342|NCT02952924|451147506|FG020|Overall Study|Noncompliance with study drug|0|||
125416343|NCT02952924|451147507|FG021|Overall Study|Noncompliance with study drug|1|||
125416344|NCT01226745|451147510|FG000|Overall Study|Did not complete schedule of assessments|8|||
125416345|NCT01226745|451147511|FG001|Overall Study|Did not complete schedule of assessments|3|||
125416346|NCT01226745|451147512|FG002|Overall Study|Did not complete schedule of assessments|6|||
125416347|NCT01226745|451147513|FG003|Overall Study|Did not complete schedule of assessments|0|||
125416348|NCT01226745|451147514|FG004|Overall Study|Did not complete schedule of assessments|0|||
125416349|NCT01226745|451147515|FG005|Overall Study|Did not complete schedule of assessments|1|||
125416350|NCT01226745|451147510|FG000|Overall Study|Lost to Follow-up|2|||
125416351|NCT01226745|451147511|FG001|Overall Study|Lost to Follow-up|6|||
125416352|NCT01226745|451147512|FG002|Overall Study|Lost to Follow-up|6|||
125416353|NCT01226745|451147513|FG003|Overall Study|Lost to Follow-up|1|||
125416354|NCT01226745|451147514|FG004|Overall Study|Lost to Follow-up|1|||
125416355|NCT01226745|451147515|FG005|Overall Study|Lost to Follow-up|2|||
125416356|NCT01226745|451147510|FG000|Overall Study|Death|1|||
125416357|NCT01226745|451147511|FG001|Overall Study|Death|0|||
125416358|NCT01226745|451147512|FG002|Overall Study|Death|0|||
125416359|NCT01226745|451147513|FG003|Overall Study|Death|0|||
125285809|NCT00235391|450672772|FG001|Overall Study|Protocol deviation|0|||
125285810|NCT00235391|450672773|FG002|Overall Study|Protocol deviation|1|||
125285811|NCT00235391|450672774|FG003|Overall Study|Protocol deviation|11|||
125285812|NCT00235391|450672775|FG004|Overall Study|Protocol deviation|0|||
125285813|NCT00235391|450672776|FG005|Overall Study|Protocol deviation|0|||
125285814|NCT00235391|450672771|FG000|Overall Study|Withdrawal by Subject|2|||
125285815|NCT00235391|450672772|FG001|Overall Study|Withdrawal by Subject|3|||
125285816|NCT00235391|450672773|FG002|Overall Study|Withdrawal by Subject|3|||
125285817|NCT00235391|450672774|FG003|Overall Study|Withdrawal by Subject|61|||
125285818|NCT00235391|450672775|FG004|Overall Study|Withdrawal by Subject|5|||
125285819|NCT00235391|450672776|FG005|Overall Study|Withdrawal by Subject|0|||
125285820|NCT00235391|450672771|FG000|Overall Study|Lost to Follow-up|0|||
125285821|NCT00235391|450672772|FG001|Overall Study|Lost to Follow-up|3|||
125285822|NCT00235391|450672773|FG002|Overall Study|Lost to Follow-up|3|||
125285823|NCT00235391|450672774|FG003|Overall Study|Lost to Follow-up|16|||
125285824|NCT00235391|450672775|FG004|Overall Study|Lost to Follow-up|0|||
125285825|NCT00235391|450672776|FG005|Overall Study|Lost to Follow-up|0|||
125285826|NCT00235391|450672771|FG000|Overall Study|Administrative problems|0|||
125285827|NCT00235391|450672772|FG001|Overall Study|Administrative problems|0|||
125285828|NCT00235391|450672773|FG002|Overall Study|Administrative problems|0|||
125285829|NCT00235391|450672774|FG003|Overall Study|Administrative problems|1|||
125285830|NCT00235391|450672775|FG004|Overall Study|Administrative problems|0|||
125285831|NCT00235391|450672776|FG005|Overall Study|Administrative problems|0|||
125285832|NCT00235391|450672771|FG000|Overall Study|Death|0|||
125285833|NCT00235391|450672772|FG001|Overall Study|Death|0|||
125285834|NCT00235391|450672773|FG002|Overall Study|Death|1|||
125285835|NCT00235391|450672774|FG003|Overall Study|Death|4|||
125285836|NCT00235391|450672775|FG004|Overall Study|Death|0|||
125285837|NCT00235391|450672776|FG005|Overall Study|Death|0|||
125285838|NCT03349645|450672777|FG000|Overall Study|Sponsor Terminated Study|75|||
125285839|NCT03349645|450672777|FG000|Overall Study|Withdrawal by Subject|4|||
125285840|NCT03349645|450672777|FG000|Overall Study|Protocol Violation|1|||
125285841|NCT03349645|450672777|FG000|Overall Study|Other|2|||
125285842|NCT00580034|450672783|FG000|Overall Study|Toxicity|10|||
125285843|NCT00580034|450672784|FG001|Overall Study|Toxicity|0|||
125285844|NCT00098748|450672787|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
125285845|NCT00098748|450672788|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
125285846|NCT00098748|450672789|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
125285847|NCT00098748|450672787|FG000|Received Study Treatment|Death|2|||
125285848|NCT00098748|450672788|FG001|Received Study Treatment|Death|1|||
125285849|NCT00098748|450672789|FG002|Received Study Treatment|Death|2|||
125285850|NCT00098748|450672787|FG000|Received Study Treatment|Adverse Event|1|||
125285851|NCT00098748|450672788|FG001|Received Study Treatment|Adverse Event|2|||
125285852|NCT00098748|450672789|FG002|Received Study Treatment|Adverse Event|5|||
125285853|NCT00098748|450672787|FG000|Received Study Treatment|Lack of Efficacy|40|||
125285854|NCT00098748|450672788|FG001|Received Study Treatment|Lack of Efficacy|27|||
125285855|NCT00098748|450672789|FG002|Received Study Treatment|Lack of Efficacy|27|||
125285856|NCT00098748|450672787|FG000|Received Study Treatment|Other|2|||
125285857|NCT00098748|450672788|FG001|Received Study Treatment|Other|2|||
125285858|NCT00098748|450672789|FG002|Received Study Treatment|Other|6|||
125285859|NCT00098748|450672787|FG000|Received Study Treatment|Subject defaulted|3|||
125285860|NCT00098748|450672788|FG001|Received Study Treatment|Subject defaulted|4|||
125285861|NCT00098748|450672789|FG002|Received Study Treatment|Subject defaulted|4|||
125285862|NCT00098748|450672787|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
125285863|NCT00098748|450672788|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
125285864|NCT00098748|450672789|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
125285865|NCT00098748|450672787|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
125285866|NCT00098748|450672788|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
125285867|NCT00098748|450672789|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
125285868|NCT00098748|450672787|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
125285869|NCT00098748|450672788|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
125285870|NCT00098748|450672789|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
125285871|NCT00098748|450672787|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
125285872|NCT00098748|450672788|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
125285873|NCT00098748|450672789|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
125285874|NCT00098748|450672787|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
125285875|NCT00098748|450672788|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
125285876|NCT00098748|450672789|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
125285877|NCT02439450|450672793|FG000|Overall Study|Adverse Event|4|||
125285878|NCT02439450|450672794|FG001|Overall Study|Adverse Event|1|||
125285879|NCT02439450|450672795|FG002|Overall Study|Adverse Event|0|||
125285880|NCT02439450|450672796|FG003|Overall Study|Adverse Event|0|||
125285881|NCT02439450|450672793|FG000|Overall Study|Withdrawal by Subject|1|||
125285882|NCT02439450|450672794|FG001|Overall Study|Withdrawal by Subject|2|||
125285883|NCT02439450|450672795|FG002|Overall Study|Withdrawal by Subject|0|||
125449215|NCT02696226|451271002|FG002|Overall Study|Study terminated - lack of enrollment|2|||
125449216|NCT02696226|451271003|FG003|Overall Study|Study terminated - lack of enrollment|0|||
125449217|NCT02909101|451271011|FG000|Overall Study|Lost to Follow-up|1|||
125449218|NCT02909101|451271012|FG001|Overall Study|Lost to Follow-up|1|||
125416360|NCT01226745|451147514|FG004|Overall Study|Death|0|||
125416361|NCT01226745|451147515|FG005|Overall Study|Death|1|||
125416362|NCT01226745|451147510|FG000|Overall Study|Other|6|||
125416363|NCT01226745|451147511|FG001|Overall Study|Other|7|||
125416364|NCT01226745|451147512|FG002|Overall Study|Other|8|||
125416365|NCT01226745|451147513|FG003|Overall Study|Other|4|||
125416366|NCT01226745|451147514|FG004|Overall Study|Other|3|||
125416367|NCT01226745|451147515|FG005|Overall Study|Other|1|||
125416368|NCT01435577|451147516|FG000|Overall Study|Adverse Event|10|||
125416369|NCT01435577|451147517|FG001|Overall Study|Adverse Event|0|||
125416370|NCT01435577|451147516|FG000|Overall Study|Lack of Efficacy|7|||
125416371|NCT01435577|451147517|FG001|Overall Study|Lack of Efficacy|51|||
125416372|NCT01435577|451147516|FG000|Overall Study|Alternative treatment started|0|||
125416373|NCT01435577|451147517|FG001|Overall Study|Alternative treatment started|1|||
125416374|NCT01934218|451147520|FG000|Double-blind Phase|Adverse Event|8|||
125416375|NCT01934218|451147521|FG001|Double-blind Phase|Adverse Event|8|||
125416376|NCT01934218|451147520|FG000|Double-blind Phase|Lack of Efficacy|6|||
125416377|NCT01934218|451147521|FG001|Double-blind Phase|Lack of Efficacy|7|||
125416378|NCT01934218|451147520|FG000|Double-blind Phase|Lost to Follow-up|7|||
125416379|NCT01934218|451147521|FG001|Double-blind Phase|Lost to Follow-up|14|||
125416380|NCT01934218|451147520|FG000|Double-blind Phase|Physician Decision|1|||
125416381|NCT01934218|451147521|FG001|Double-blind Phase|Physician Decision|2|||
125416382|NCT01934218|451147520|FG000|Double-blind Phase|Protocol Violation|4|||
125416383|NCT01934218|451147521|FG001|Double-blind Phase|Protocol Violation|0|||
125416384|NCT01934218|451147520|FG000|Double-blind Phase|Withdrawal by Subject|16|||
125416385|NCT01934218|451147521|FG001|Double-blind Phase|Withdrawal by Subject|13|||
125416386|NCT01934218|451147520|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
125416387|NCT01934218|451147521|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
125416388|NCT01934218|451147520|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
125416389|NCT01934218|451147521|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
125416390|NCT01934218|451147520|FG000|Open-Label Phase|Adverse Event|2|||
125416391|NCT01934218|451147521|FG001|Open-Label Phase|Adverse Event|4|||
125416392|NCT01934218|451147520|FG000|Open-Label Phase|Lack of Efficacy|1|||
125416393|NCT01934218|451147521|FG001|Open-Label Phase|Lack of Efficacy|4|||
125416394|NCT01934218|451147520|FG000|Open-Label Phase|Lost to Follow-up|4|||
125416395|NCT01934218|451147521|FG001|Open-Label Phase|Lost to Follow-up|2|||
125416396|NCT01934218|451147520|FG000|Open-Label Phase|Physician Decision|1|||
125416397|NCT01934218|451147521|FG001|Open-Label Phase|Physician Decision|0|||
125416398|NCT01934218|451147520|FG000|Open-Label Phase|Protocol Violation|1|||
125416399|NCT01934218|451147521|FG001|Open-Label Phase|Protocol Violation|0|||
125416400|NCT01934218|451147520|FG000|Open-Label Phase|Withdrawal by Subject|13|||
125416401|NCT01934218|451147521|FG001|Open-Label Phase|Withdrawal by Subject|11|||
125416402|NCT01934218|451147520|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
125416403|NCT01934218|451147521|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
125416404|NCT01934218|451147520|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
125416405|NCT01934218|451147521|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
125416406|NCT02232893|451147522|FG000|Overall Study|Withdrawal by Subject|4|||
125416407|NCT02232893|451147523|FG001|Overall Study|Withdrawal by Subject|1|||
125416408|NCT02232893|451147522|FG000|Overall Study|Adverse Event|0|||
125416409|NCT02232893|451147523|FG001|Overall Study|Adverse Event|1|||
125416410|NCT02232893|451147522|FG000|Overall Study|Sponsor request early termination|0|||
125416411|NCT02232893|451147523|FG001|Overall Study|Sponsor request early termination|1|||
125416412|NCT02232893|451147522|FG000|Overall Study|Developed exclusion criteria|0|||
125416413|NCT02232893|451147523|FG001|Overall Study|Developed exclusion criteria|1|||
125416414|NCT02232893|451147522|FG000|Overall Study|Other|0|||
125449219|NCT00604786|451271013|FG000|Overall Study|Lost to Follow-up|2|||
125449220|NCT00604786|451271014|FG001|Overall Study|Lost to Follow-up|0|||
125449221|NCT01221181|451271015|FG000|Overall Study|Lost to Follow-up|1|||
125285884|NCT02439450|450672796|FG003|Overall Study|Withdrawal by Subject|0|||
125285885|NCT02439450|450672793|FG000|Overall Study|Death|3|||
125285886|NCT02439450|450672794|FG001|Overall Study|Death|0|||
125449222|NCT02698436|451271016|FG000|Overall Study|Adverse Event|1|||
125285887|NCT02439450|450672795|FG002|Overall Study|Death|0|||
125416415|NCT02232893|451147523|FG001|Overall Study|Other|3|||
125416416|NCT04782323|451147524|FG000|Overall Study|Death|1|||
125416417|NCT04782323|451147525|FG001|Overall Study|Death|0|||
125416418|NCT04782323|451147526|FG002|Overall Study|Death|0|||
125416419|NCT04782323|451147527|FG003|Overall Study|Death|0|||
125416420|NCT04782323|451147528|FG004|Overall Study|Death|1|||
125416421|NCT04782323|451147529|FG005|Overall Study|Death|1|||
125416422|NCT04782323|451147530|FG006|Overall Study|Death|1|||
125416423|NCT04782323|451147531|FG007|Overall Study|Death|0|||
125449223|NCT02698436|451271017|FG001|Overall Study|Adverse Event|0|||
125285888|NCT02439450|450672796|FG003|Overall Study|Death|1|||
125416424|NCT04782323|451147524|FG000|Overall Study|Withdrawal by Subject|0|||
125416425|NCT04782323|451147525|FG001|Overall Study|Withdrawal by Subject|0|||
125416426|NCT04782323|451147526|FG002|Overall Study|Withdrawal by Subject|1|||
125416427|NCT04782323|451147527|FG003|Overall Study|Withdrawal by Subject|0|||
125416428|NCT04782323|451147528|FG004|Overall Study|Withdrawal by Subject|0|||
125416429|NCT04782323|451147529|FG005|Overall Study|Withdrawal by Subject|1|||
125416430|NCT04782323|451147530|FG006|Overall Study|Withdrawal by Subject|0|||
125416431|NCT04782323|451147531|FG007|Overall Study|Withdrawal by Subject|1|||
125416432|NCT04782323|451147524|FG000|Overall Study|Lost to Follow-up|0|||
125416433|NCT04782323|451147525|FG001|Overall Study|Lost to Follow-up|1|||
125416434|NCT04782323|451147526|FG002|Overall Study|Lost to Follow-up|1|||
125416435|NCT04782323|451147527|FG003|Overall Study|Lost to Follow-up|0|||
125416436|NCT04782323|451147528|FG004|Overall Study|Lost to Follow-up|0|||
125416437|NCT04782323|451147529|FG005|Overall Study|Lost to Follow-up|1|||
125416438|NCT04782323|451147530|FG006|Overall Study|Lost to Follow-up|1|||
125416439|NCT04782323|451147531|FG007|Overall Study|Lost to Follow-up|2|||
125416440|NCT04782323|451147524|FG000|Overall Study|randomization in error|1|||
125416441|NCT04782323|451147525|FG001|Overall Study|randomization in error|0|||
125416442|NCT04782323|451147526|FG002|Overall Study|randomization in error|0|||
125416443|NCT04782323|451147527|FG003|Overall Study|randomization in error|0|||
125416444|NCT04782323|451147528|FG004|Overall Study|randomization in error|0|||
125416445|NCT04782323|451147529|FG005|Overall Study|randomization in error|0|||
125416446|NCT04782323|451147530|FG006|Overall Study|randomization in error|0|||
125416447|NCT04782323|451147531|FG007|Overall Study|randomization in error|0|||
125416448|NCT02663128|451147536|FG000|Period 2|Physician Decision|0|||
125416449|NCT02663128|451147537|FG001|Period 2|Physician Decision|0|||
125416450|NCT02663128|451147538|FG002|Period 2|Physician Decision|0|||
125416451|NCT02663128|451147539|FG003|Period 2|Physician Decision|0|||
125416452|NCT02663128|451147540|FG004|Period 2|Physician Decision|1|||
125416453|NCT02663128|451147541|FG005|Period 2|Physician Decision|0|||
125416454|NCT01358526|451147542|FG000|Open-label Titration Period|Adverse Event|95|||
125416455|NCT01358526|451147543|FG001|Open-label Titration Period|Adverse Event|0|||
125416456|NCT01358526|451147544|FG002|Open-label Titration Period|Adverse Event|0|||
125416457|NCT01358526|451147542|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
125416458|NCT01358526|451147543|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
125416459|NCT01358526|451147544|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
125416460|NCT01358526|451147542|FG000|Open-label Titration Period|Lost to Follow-up|25|||
125416461|NCT01358526|451147543|FG001|Open-label Titration Period|Lost to Follow-up|0|||
125416462|NCT01358526|451147544|FG002|Open-label Titration Period|Lost to Follow-up|0|||
125416463|NCT01358526|451147542|FG000|Open-label Titration Period|Lack of Efficacy|107|||
125416464|NCT01358526|451147543|FG001|Open-label Titration Period|Lack of Efficacy|0|||
125416465|NCT01358526|451147544|FG002|Open-label Titration Period|Lack of Efficacy|0|||
125416466|NCT01358526|451147542|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
125416467|NCT01358526|451147543|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
125416468|NCT01358526|451147544|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
125416469|NCT01358526|451147542|FG000|Open-label Titration Period|Administrative|8|||
125416470|NCT01358526|451147543|FG001|Open-label Titration Period|Administrative|0|||
125416471|NCT01358526|451147544|FG002|Open-label Titration Period|Administrative|0|||
125416472|NCT01358526|451147542|FG000|Open-label Titration Period|Did not qualify|178|||
125416473|NCT01358526|451147543|FG001|Open-label Titration Period|Did not qualify|0|||
125416474|NCT01358526|451147544|FG002|Open-label Titration Period|Did not qualify|0|||
125416475|NCT01358526|451147542|FG000|Double-blind Phase|Adverse Event|0|||
125416476|NCT01358526|451147543|FG001|Double-blind Phase|Adverse Event|24|||
125416477|NCT01358526|451147544|FG002|Double-blind Phase|Adverse Event|23|||
125416478|NCT01358526|451147542|FG000|Double-blind Phase|Withdrawal by Subject|0|||
125416479|NCT01358526|451147543|FG001|Double-blind Phase|Withdrawal by Subject|10|||
125416480|NCT01358526|451147544|FG002|Double-blind Phase|Withdrawal by Subject|8|||
125416481|NCT01358526|451147542|FG000|Double-blind Phase|Lost to Follow-up|0|||
125416482|NCT01358526|451147543|FG001|Double-blind Phase|Lost to Follow-up|4|||
125416483|NCT01358526|451147544|FG002|Double-blind Phase|Lost to Follow-up|1|||
125416484|NCT01358526|451147542|FG000|Double-blind Phase|Lack of Efficacy|0|||
125416485|NCT01358526|451147543|FG001|Double-blind Phase|Lack of Efficacy|31|||
125416486|NCT01358526|451147544|FG002|Double-blind Phase|Lack of Efficacy|73|||
125416487|NCT01358526|451147542|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
125416488|NCT01358526|451147543|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
125416489|NCT01358526|451147544|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
125416490|NCT01358526|451147542|FG000|Double-blind Phase|Administrative|0|||
125416491|NCT01358526|451147543|FG001|Double-blind Phase|Administrative|6|||
125416492|NCT01358526|451147544|FG002|Double-blind Phase|Administrative|10|||
125416493|NCT02715765|451147553|FG000|Overall Study|Study Termination|3|||
125416494|NCT02715765|451147554|FG001|Overall Study|Study Termination|0|||
125416495|NCT02715765|451147555|FG002|Overall Study|Study Termination|0|||
125416496|NCT03387852|451147559|FG000|Overall Study|Adverse event (AE)|3|||
125416497|NCT03387852|451147560|FG001|Overall Study|Adverse event (AE)|0|||
125416498|NCT03387852|451147561|FG002|Overall Study|Adverse event (AE)|2|||
125449224|NCT02698436|451271016|FG000|Overall Study|Withdrawal by Subject|3|||
125449225|NCT02698436|451271017|FG001|Overall Study|Withdrawal by Subject|3|||
125449226|NCT02698436|451271016|FG000|Overall Study|Lost to Follow-up|2|||
125449227|NCT02698436|451271017|FG001|Overall Study|Lost to Follow-up|4|||
125449228|NCT02698436|451271016|FG000|Overall Study|Non-compliance with study regimen|1|||
125449229|NCT02698436|451271017|FG001|Overall Study|Non-compliance with study regimen|0|||
125449230|NCT03073005|451271018|FG000|Overall Study|Death|6|||
125449231|NCT03073005|451271019|FG001|Overall Study|Death|0|||
125449232|NCT03073005|451271020|FG002|Overall Study|Death|7|||
125449233|NCT03073005|451271021|FG003|Overall Study|Death|0|||
125449234|NCT03073005|451271018|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
125449235|NCT03073005|451271019|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
125449236|NCT03073005|451271020|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
125449237|NCT03073005|451271021|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
125449238|NCT03073005|451271018|FG000|Overall Study|Lost to Follow-up|2|||
125449239|NCT03073005|451271019|FG001|Overall Study|Lost to Follow-up|2|||
125449240|NCT03073005|451271020|FG002|Overall Study|Lost to Follow-up|1|||
125449241|NCT03073005|451271021|FG003|Overall Study|Lost to Follow-up|2|||
125449242|NCT03073005|451271018|FG000|Overall Study|Withdrawal by Subject|0|||
125449243|NCT03073005|451271019|FG001|Overall Study|Withdrawal by Subject|4|||
125449244|NCT03073005|451271020|FG002|Overall Study|Withdrawal by Subject|4|||
125449245|NCT03073005|451271021|FG003|Overall Study|Withdrawal by Subject|4|||
125449246|NCT01290094|451271022|FG000|Overall Study|Withdrawal by Subject|1|||
125449247|NCT01290094|451271022|FG000|Overall Study|Lost to Follow-up|5|||
125449248|NCT04091672|451272997|FG000|Overall Study|Death|6|||
125449249|NCT04091672|451272998|FG001|Overall Study|Death|6|||
125449250|NCT04091672|451272997|FG000|Overall Study|Lost to Follow-up|7|||
125449251|NCT04091672|451272998|FG001|Overall Study|Lost to Follow-up|7|||
125449252|NCT04091672|451272997|FG000|Overall Study|Withdrawal by Subject|3|||
125449253|NCT04091672|451272998|FG001|Overall Study|Withdrawal by Subject|3|||
125449254|NCT04091672|451272997|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
125449255|NCT04091672|451272998|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
125449256|NCT05296629|451272999|FG000|Overall Study|Withdrawal by Subject|3|||
125449257|NCT05296629|451273000|FG001|Overall Study|Withdrawal by Subject|10|||
125449258|NCT05296629|451273001|FG002|Overall Study|Withdrawal by Subject|4|||
125449259|NCT05296629|451272999|FG000|Overall Study|Lost to Follow-up|2|||
125449260|NCT05296629|451273000|FG001|Overall Study|Lost to Follow-up|7|||
125449261|NCT05296629|451273001|FG002|Overall Study|Lost to Follow-up|1|||
125449262|NCT05296629|451272999|FG000|Overall Study|Adverse Event|0|||
125449263|NCT05296629|451273000|FG001|Overall Study|Adverse Event|4|||
125449264|NCT05296629|451273001|FG002|Overall Study|Adverse Event|2|||
125449265|NCT05296629|451272999|FG000|Overall Study|Protocol Violation|0|||
125449266|NCT05296629|451273000|FG001|Overall Study|Protocol Violation|2|||
125449267|NCT05296629|451273001|FG002|Overall Study|Protocol Violation|0|||
125449268|NCT02401529|451273004|FG000|Overall Study|Lost to Follow-up|2|||
125449269|NCT02401529|451273005|FG001|Overall Study|Lost to Follow-up|1|||
125449270|NCT02401529|451273004|FG000|Overall Study|Physician Decision|2|||
125449271|NCT02401529|451273005|FG001|Overall Study|Physician Decision|6|||
125449272|NCT02401529|451273004|FG000|Overall Study|Protocol Violation|5|||
125449273|NCT02401529|451273005|FG001|Overall Study|Protocol Violation|0|||
125449274|NCT02949271|451273010|FG000|Overall Study|Lack of Efficacy|5|||
125449275|NCT02949271|451273011|FG001|Overall Study|Lack of Efficacy|4|||
125449276|NCT02949271|451273010|FG000|Overall Study|Lost to Follow-up|3|||
125449277|NCT02949271|451273011|FG001|Overall Study|Lost to Follow-up|6|||
125449278|NCT02949271|451273010|FG000|Overall Study|Physician Decision|5|||
125449279|NCT02949271|451273011|FG001|Overall Study|Physician Decision|5|||
125449280|NCT02949271|451273010|FG000|Overall Study|Protocol Violation|6|||
125449281|NCT02949271|451273011|FG001|Overall Study|Protocol Violation|3|||
125285889|NCT02439450|450672793|FG000|Overall Study|Progressive Disease|18|||
125285890|NCT02439450|450672794|FG001|Overall Study|Progressive Disease|41|||
125449282|NCT02949271|451273010|FG000|Overall Study|Withdrawal by Subject|1|||
125449283|NCT02949271|451273011|FG001|Overall Study|Withdrawal by Subject|0|||
125449284|NCT02949271|451273010|FG000|Overall Study|Delivered prior to intervention|7|||
125449285|NCT02949271|451273011|FG001|Overall Study|Delivered prior to intervention|9|||
125449286|NCT02949271|451273010|FG000|Overall Study|Outside the window for cervical dilation|2|||
125449287|NCT02949271|451273011|FG001|Overall Study|Outside the window for cervical dilation|3|||
125449288|NCT03303105|451273012|FG000|Overall Study|Adverse Event|0|||
125449289|NCT03303105|451273013|FG001|Overall Study|Adverse Event|2|||
125449290|NCT03303105|451273012|FG000|Overall Study|Lack of Efficacy|1|||
125449291|NCT03303105|451273013|FG001|Overall Study|Lack of Efficacy|0|||
125449292|NCT03303105|451273012|FG000|Overall Study|Protocol Violation|1|||
125449293|NCT03303105|451273013|FG001|Overall Study|Protocol Violation|0|||
125449294|NCT03303105|451273012|FG000|Overall Study|Withdrawal by Subject|0|||
125449295|NCT03303105|451273013|FG001|Overall Study|Withdrawal by Subject|2|||
125449296|NCT02790606|451273018|FG000|Overall Study|Death|27|||
125449297|NCT02790606|451273018|FG000|Overall Study|Lost to Follow-up|4|||
125449298|NCT02790606|451273018|FG000|Overall Study|Physician Decision|3|||
125449299|NCT02790606|451273018|FG000|Overall Study|Withdrawal by Subject|1|||
125285891|NCT02439450|450672795|FG002|Overall Study|Progressive Disease|2|||
125285892|NCT02439450|450672796|FG003|Overall Study|Progressive Disease|3|||
125285893|NCT01081301|450672799|FG000|Overall Study|Bereaved|3|||
125285894|NCT01081301|450672799|FG000|Overall Study|Too busy|5|||
125285895|NCT01081301|450672799|FG000|Overall Study|Patient too ill|2|||
125285896|NCT01081301|450672799|FG000|Overall Study|Lost to Follow-up|4|||
125285897|NCT03551665|450672802|FG000|Overall Study|Lost to Follow-up|11|||
125285898|NCT03551665|450672803|FG001|Overall Study|Lost to Follow-up|2|||
125285899|NCT00428220|450674397|FG000|Overall Study|Participant died|8|||
125285900|NCT00428220|450674397|FG000|Overall Study|Global deterioration of health status|7|||
125285901|NCT00428220|450674397|FG000|Overall Study|Lost to Follow-up|4|||
125285902|NCT00428220|450674397|FG000|Overall Study|Objective progression or relapse|123|||
125285903|NCT00428220|450674397|FG000|Overall Study|Participant refused continued treatment|7|||
125285904|NCT00428220|450674397|FG000|Overall Study|Adverse Event|51|||
125285905|NCT00428220|450674397|FG000|Overall Study|Other|23|||
125285906|NCT03283098|450674402|FG000|Overall Study|Withdrawal by Subject|0|||
125285907|NCT03283098|450674403|FG001|Overall Study|Withdrawal by Subject|1|||
125285908|NCT03356977|450674406|FG000|Overall Study|Lost to Follow-up|3|||
125285909|NCT03356977|450674406|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125285910|NCT00445939|450674410|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
125285911|NCT00445939|450674411|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
125285912|NCT00445939|450674412|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
125285913|NCT00445939|450674413|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
125285914|NCT00445939|450674410|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
125285915|NCT00445939|450674411|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
125285916|NCT00445939|450674412|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
125285917|NCT00445939|450674413|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
125285918|NCT00798317|450674415|FG000|Overall Study|Physician Decision|0|||
125285919|NCT00798317|450674416|FG001|Overall Study|Physician Decision|1|||
125285920|NCT00798317|450674415|FG000|Overall Study|Withdrawal by Subject|5|||
125285921|NCT00798317|450674416|FG001|Overall Study|Withdrawal by Subject|4|||
125285922|NCT00798317|450674415|FG000|Overall Study|Lost to Follow-up|2|||
125285923|NCT00798317|450674416|FG001|Overall Study|Lost to Follow-up|2|||
125285924|NCT00798317|450674415|FG000|Overall Study|Adverse Event|2|||
125285925|NCT00798317|450674416|FG001|Overall Study|Adverse Event|0|||
125285926|NCT00798317|450674415|FG000|Overall Study|Death|1|||
125285927|NCT00798317|450674416|FG001|Overall Study|Death|0|||
125285928|NCT00378599|450674420|FG000|Overall Study|Adverse Event|38|||
125285929|NCT00378599|450674420|FG000|Overall Study|Protocol Violation|2|||
125285930|NCT00378599|450674420|FG000|Overall Study|Treatment failure|7|||
125285931|NCT00378599|450674420|FG000|Overall Study|Withdrawal by Subject|5|||
125285932|NCT00416715|450674421|FG000|Overall Study|Not evaluable for joint aches|7|||
125285933|NCT00416715|450674421|FG000|Overall Study|Vitamin D levels not evaluable|8|||
125285934|NCT03812185|450674425|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
125285935|NCT02576535|450674440|FG000|Overall Study|Withdrawal by Subject|2|||
125285936|NCT02545517|450674441|FG000|Overall Study|Death|2|||
125285937|NCT02545517|450674442|FG001|Overall Study|Death|2|||
125285938|NCT02545517|450674443|FG002|Overall Study|Death|1|||
125285939|NCT02545517|450674441|FG000|Overall Study|Lost to Follow-up|14|||
125285940|NCT02545517|450674442|FG001|Overall Study|Lost to Follow-up|13|||
125285941|NCT02545517|450674443|FG002|Overall Study|Lost to Follow-up|17|||
125285942|NCT02545517|450674441|FG000|Overall Study|Protocol Violation|0|||
125285943|NCT02545517|450674442|FG001|Overall Study|Protocol Violation|1|||
125285944|NCT02545517|450674443|FG002|Overall Study|Protocol Violation|1|||
125285945|NCT02545517|450674441|FG000|Overall Study|Withdrawal by Subject|5|||
125285946|NCT02545517|450674442|FG001|Overall Study|Withdrawal by Subject|8|||
125285947|NCT02545517|450674443|FG002|Overall Study|Withdrawal by Subject|9|||
125285948|NCT02545517|450674441|FG000|Overall Study|Administrative reason|5|||
125285949|NCT02545517|450674442|FG001|Overall Study|Administrative reason|6|||
125285950|NCT02545517|450674443|FG002|Overall Study|Administrative reason|10|||
125416499|NCT03387852|451147562|FG003|Overall Study|Adverse event (AE)|0|||
125285951|NCT02545517|450674441|FG000|Overall Study|Other|2|||
125285952|NCT02545517|450674442|FG001|Overall Study|Other|4|||
125285953|NCT02545517|450674443|FG002|Overall Study|Other|3|||
125285954|NCT01529515|450674446|FG000|TRANSITION PHASE|Adverse Event|16|||
125416500|NCT03387852|451147559|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
125285955|NCT01529515|450674447|FG001|TRANSITION PHASE|Adverse Event|0|||
125285956|NCT01529515|450674448|FG002|TRANSITION PHASE|Adverse Event|0|||
125285957|NCT01529515|450674449|FG003|TRANSITION PHASE|Adverse Event|0|||
125285958|NCT01529515|450674446|FG000|TRANSITION PHASE|Death|1|||
125285959|NCT01529515|450674447|FG001|TRANSITION PHASE|Death|0|||
125285960|NCT01529515|450674448|FG002|TRANSITION PHASE|Death|0|||
125285961|NCT01529515|450674449|FG003|TRANSITION PHASE|Death|0|||
125285962|NCT01529515|450674446|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
125285963|NCT01529515|450674447|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
125285964|NCT01529515|450674448|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
125285965|NCT01529515|450674449|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
125285966|NCT01529515|450674446|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
125285967|NCT01529515|450674447|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
125416501|NCT03387852|451147560|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
125416502|NCT03387852|451147561|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
125416503|NCT03387852|451147562|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
125416504|NCT03387852|451147559|FG000|Overall Study|Withdrawal by participant|1|||
125416505|NCT03387852|451147560|FG001|Overall Study|Withdrawal by participant|1|||
125416506|NCT03387852|451147561|FG002|Overall Study|Withdrawal by participant|3|||
125416507|NCT03387852|451147562|FG003|Overall Study|Withdrawal by participant|2|||
125416508|NCT03387852|451147559|FG000|Overall Study|Other- Unspecified|1|||
125416509|NCT03387852|451147560|FG001|Overall Study|Other- Unspecified|1|||
125416510|NCT03387852|451147561|FG002|Overall Study|Other- Unspecified|2|||
125416511|NCT03387852|451147562|FG003|Overall Study|Other- Unspecified|1|||
125416512|NCT03387852|451147559|FG000|Overall Study|Poor compliance to protocol|0|||
125416513|NCT03387852|451147560|FG001|Overall Study|Poor compliance to protocol|0|||
125416514|NCT03387852|451147561|FG002|Overall Study|Poor compliance to protocol|0|||
125416515|NCT03387852|451147562|FG003|Overall Study|Poor compliance to protocol|1|||
125416516|NCT03387852|451147559|FG000|Overall Study|Randomized and not treated|0|||
125416517|NCT03387852|451147560|FG001|Overall Study|Randomized and not treated|0|||
125416518|NCT03387852|451147561|FG002|Overall Study|Randomized and not treated|0|||
125416519|NCT03387852|451147562|FG003|Overall Study|Randomized and not treated|1|||
125416520|NCT02062632|451149746|FG000|Overall Study|No treatment data|1|||
125416521|NCT02280044|451149747|FG000|Overall Study|Planned alternate|0|||
125416522|NCT02280044|451149748|FG001|Overall Study|Planned alternate|2|||
125416523|NCT02332720|451149752|FG000|Part A and Part B|Lost to Follow-up|1|||
125416524|NCT02332720|451149753|FG001|Part A and Part B|Lost to Follow-up|0|||
125416525|NCT02332720|451149754|FG002|Part A and Part B|Lost to Follow-up|0|||
125416526|NCT02332720|451149755|FG003|Part A and Part B|Lost to Follow-up|0|||
125416527|NCT02332720|451149756|FG004|Part A and Part B|Lost to Follow-up|0|||
125416528|NCT02332720|451149757|FG005|Part A and Part B|Lost to Follow-up|2|||
125416529|NCT02332720|451149758|FG006|Part A and Part B|Lost to Follow-up|1|||
125416530|NCT02332720|451149759|FG007|Part A and Part B|Lost to Follow-up|1|||
125416531|NCT02332720|451149760|FG008|Part A and Part B|Lost to Follow-up|0|||
125416532|NCT02332720|451149761|FG009|Part A and Part B|Lost to Follow-up|0|||
125416533|NCT02332720|451149762|FG010|Part A and Part B|Lost to Follow-up|0|||
125416534|NCT02332720|451149763|FG011|Part A and Part B|Lost to Follow-up|0|||
125416535|NCT02332720|451149764|FG012|Part A and Part B|Lost to Follow-up|0|||
125416536|NCT02332720|451149765|FG013|Part A and Part B|Lost to Follow-up|0|||
125416537|NCT02332720|451149766|FG014|Part A and Part B|Lost to Follow-up|0|||
125416538|NCT02332720|451149767|FG015|Part A and Part B|Lost to Follow-up|1|||
125416539|NCT02332720|451149768|FG016|Part A and Part B|Lost to Follow-up|0|||
125416540|NCT02332720|451149769|FG017|Part A and Part B|Lost to Follow-up|0|||
125416541|NCT02332720|451149770|FG018|Part A and Part B|Lost to Follow-up|0|||
125416542|NCT02332720|451149771|FG019|Part A and Part B|Lost to Follow-up|0|||
125416543|NCT02332720|451149772|FG020|Part A and Part B|Lost to Follow-up|0|||
125416544|NCT02332720|451149773|FG021|Part A and Part B|Lost to Follow-up|0|||
125416545|NCT02332720|451149774|FG022|Part A and Part B|Lost to Follow-up|0|||
125416546|NCT02332720|451149752|FG000|Part A and Part B|Adverse Event|0|||
125416547|NCT02332720|451149753|FG001|Part A and Part B|Adverse Event|0|||
125416548|NCT02332720|451149754|FG002|Part A and Part B|Adverse Event|0|||
125416549|NCT02332720|451149755|FG003|Part A and Part B|Adverse Event|0|||
125416550|NCT02332720|451149756|FG004|Part A and Part B|Adverse Event|0|||
125416551|NCT02332720|451149757|FG005|Part A and Part B|Adverse Event|0|||
125416552|NCT02332720|451149758|FG006|Part A and Part B|Adverse Event|0|||
125416553|NCT02332720|451149759|FG007|Part A and Part B|Adverse Event|0|||
125416554|NCT02332720|451149760|FG008|Part A and Part B|Adverse Event|0|||
125416555|NCT02332720|451149761|FG009|Part A and Part B|Adverse Event|0|||
125416556|NCT02332720|451149762|FG010|Part A and Part B|Adverse Event|0|||
125416557|NCT02332720|451149763|FG011|Part A and Part B|Adverse Event|0|||
125416558|NCT02332720|451149764|FG012|Part A and Part B|Adverse Event|0|||
125416559|NCT02332720|451149765|FG013|Part A and Part B|Adverse Event|0|||
125416560|NCT02332720|451149766|FG014|Part A and Part B|Adverse Event|0|||
125416561|NCT02332720|451149767|FG015|Part A and Part B|Adverse Event|0|||
125416562|NCT02332720|451149768|FG016|Part A and Part B|Adverse Event|0|||
125416563|NCT02332720|451149769|FG017|Part A and Part B|Adverse Event|1|||
125416564|NCT02332720|451149770|FG018|Part A and Part B|Adverse Event|0|||
125416565|NCT02332720|451149771|FG019|Part A and Part B|Adverse Event|0|||
125416566|NCT02332720|451149772|FG020|Part A and Part B|Adverse Event|0|||
125416567|NCT02332720|451149773|FG021|Part A and Part B|Adverse Event|0|||
125416568|NCT02332720|451149774|FG022|Part A and Part B|Adverse Event|0|||
125416569|NCT02332720|451149752|FG000|Part A and Part B|Physician Decision|0|||
125416570|NCT02332720|451149753|FG001|Part A and Part B|Physician Decision|0|||
125416571|NCT02332720|451149754|FG002|Part A and Part B|Physician Decision|0|||
125416572|NCT02332720|451149755|FG003|Part A and Part B|Physician Decision|0|||
125416573|NCT02332720|451149756|FG004|Part A and Part B|Physician Decision|0|||
125416574|NCT02332720|451149757|FG005|Part A and Part B|Physician Decision|0|||
125416575|NCT02332720|451149758|FG006|Part A and Part B|Physician Decision|0|||
125449300|NCT02735915|451273019|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
125449301|NCT02735915|451273019|FG000|Overall Study|Withdrawal following SAE|2|||
125449302|NCT02735915|451273019|FG000|Overall Study|Withdrawal by Subject|1|||
125449303|NCT01789203|451273020|FG000|Overall Study|Adverse Event|2|||
125449304|NCT01789203|451273021|FG001|Overall Study|Adverse Event|2|||
125449305|NCT01789203|451273020|FG000|Overall Study|Withdrawal by Subject|1|||
125449306|NCT01789203|451273021|FG001|Overall Study|Withdrawal by Subject|0|||
125449307|NCT01789203|451273020|FG000|Overall Study|Death|1|||
125449308|NCT01789203|451273021|FG001|Overall Study|Death|0|||
125449309|NCT01789203|451273020|FG000|Overall Study|Protocol Violation|2|||
125449310|NCT01789203|451273021|FG001|Overall Study|Protocol Violation|1|||
125449311|NCT01789203|451273020|FG000|Overall Study|Other|1|||
125449312|NCT01789203|451273021|FG001|Overall Study|Other|1|||
125449313|NCT01789203|451273020|FG000|Overall Study|patient non-adherent|2|||
125449314|NCT01789203|451273021|FG001|Overall Study|patient non-adherent|0|||
125449315|NCT00051311|451273027|FG000|Overall Study|Starting new study|0|||
125449316|NCT00051311|451273028|FG001|Overall Study|Starting new study|1|||
125449317|NCT00051311|451273027|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
125449318|NCT00051311|451273028|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
125449319|NCT00051311|451273027|FG000|Overall Study|Death of recipient|8|||
125449320|NCT00051311|451273028|FG001|Overall Study|Death of recipient|8|||
125449321|NCT00051311|451273027|FG000|Overall Study|Recipient taken off study|4|||
125449322|NCT00051311|451273028|FG001|Overall Study|Recipient taken off study|4|||
125449323|NCT00372567|451273036|FG000|Phase 3 Study|Adverse Event|5|||
125449324|NCT00372567|451273037|FG001|Phase 3 Study|Adverse Event|1|||
125449325|NCT00372567|451273038|FG002|Phase 3 Study|Adverse Event|1|||
125449326|NCT00372567|451273036|FG000|Phase 3 Study|Death|1|||
125449327|NCT00372567|451273037|FG001|Phase 3 Study|Death|1|||
125449328|NCT00372567|451273038|FG002|Phase 3 Study|Death|0|||
125449329|NCT00372567|451273036|FG000|Phase 3 Study|Protocol Violation|0|||
125449330|NCT00372567|451273037|FG001|Phase 3 Study|Protocol Violation|0|||
125449331|NCT00372567|451273038|FG002|Phase 3 Study|Protocol Violation|1|||
125449332|NCT00372567|451273036|FG000|Phase 3 Study|Objective progression or relapse|10|||
125449333|NCT00372567|451273037|FG001|Phase 3 Study|Objective progression or relapse|13|||
125449334|NCT00372567|451273038|FG002|Phase 3 Study|Objective progression or relapse|4|||
125416576|NCT02332720|451149759|FG007|Part A and Part B|Physician Decision|0|||
125416577|NCT02332720|451149760|FG008|Part A and Part B|Physician Decision|0|||
125416578|NCT02332720|451149761|FG009|Part A and Part B|Physician Decision|0|||
125416579|NCT02332720|451149762|FG010|Part A and Part B|Physician Decision|0|||
125416580|NCT02332720|451149763|FG011|Part A and Part B|Physician Decision|0|||
125416581|NCT02332720|451149764|FG012|Part A and Part B|Physician Decision|0|||
125416582|NCT02332720|451149765|FG013|Part A and Part B|Physician Decision|0|||
125416583|NCT02332720|451149766|FG014|Part A and Part B|Physician Decision|0|||
125416584|NCT02332720|451149767|FG015|Part A and Part B|Physician Decision|0|||
125416585|NCT02332720|451149768|FG016|Part A and Part B|Physician Decision|0|||
125416586|NCT02332720|451149769|FG017|Part A and Part B|Physician Decision|0|||
125416587|NCT02332720|451149770|FG018|Part A and Part B|Physician Decision|1|||
125416588|NCT02332720|451149771|FG019|Part A and Part B|Physician Decision|0|||
125416589|NCT02332720|451149772|FG020|Part A and Part B|Physician Decision|0|||
125416590|NCT02332720|451149773|FG021|Part A and Part B|Physician Decision|0|||
125416591|NCT02332720|451149774|FG022|Part A and Part B|Physician Decision|0|||
125416592|NCT02332720|451149752|FG000|Part A and Part B|Withdrawal by Subject|0|||
125416593|NCT02332720|451149753|FG001|Part A and Part B|Withdrawal by Subject|0|||
125416594|NCT02332720|451149754|FG002|Part A and Part B|Withdrawal by Subject|0|||
125416595|NCT02332720|451149755|FG003|Part A and Part B|Withdrawal by Subject|0|||
125416596|NCT02332720|451149756|FG004|Part A and Part B|Withdrawal by Subject|0|||
125416597|NCT02332720|451149757|FG005|Part A and Part B|Withdrawal by Subject|1|||
125416598|NCT02332720|451149758|FG006|Part A and Part B|Withdrawal by Subject|0|||
125416599|NCT02332720|451149759|FG007|Part A and Part B|Withdrawal by Subject|0|||
125416600|NCT02332720|451149760|FG008|Part A and Part B|Withdrawal by Subject|0|||
125416601|NCT02332720|451149761|FG009|Part A and Part B|Withdrawal by Subject|0|||
125416602|NCT02332720|451149762|FG010|Part A and Part B|Withdrawal by Subject|0|||
125416603|NCT02332720|451149763|FG011|Part A and Part B|Withdrawal by Subject|0|||
125416604|NCT02332720|451149764|FG012|Part A and Part B|Withdrawal by Subject|0|||
125416605|NCT02332720|451149765|FG013|Part A and Part B|Withdrawal by Subject|0|||
125416606|NCT02332720|451149766|FG014|Part A and Part B|Withdrawal by Subject|0|||
125416607|NCT02332720|451149767|FG015|Part A and Part B|Withdrawal by Subject|0|||
125449335|NCT00372567|451273036|FG000|Phase 3 Study|Global deterioration of health status|0|||
125449336|NCT00372567|451273037|FG001|Phase 3 Study|Global deterioration of health status|1|||
125449337|NCT00372567|451273038|FG002|Phase 3 Study|Global deterioration of health status|0|||
125449338|NCT00372567|451273036|FG000|Phase 3 Study|Other|2|||
125449339|NCT00372567|451273037|FG001|Phase 3 Study|Other|2|||
125416608|NCT02332720|451149768|FG016|Part A and Part B|Withdrawal by Subject|0|||
125416609|NCT02332720|451149769|FG017|Part A and Part B|Withdrawal by Subject|0|||
125416610|NCT02332720|451149770|FG018|Part A and Part B|Withdrawal by Subject|0|||
125416611|NCT02332720|451149771|FG019|Part A and Part B|Withdrawal by Subject|1|||
125416612|NCT02332720|451149772|FG020|Part A and Part B|Withdrawal by Subject|0|||
125416613|NCT02332720|451149773|FG021|Part A and Part B|Withdrawal by Subject|0|||
125416614|NCT02332720|451149774|FG022|Part A and Part B|Withdrawal by Subject|0|||
125416615|NCT03832010|451149775|FG000|Overall Study|Withdrawal by Subject|2|||
125416616|NCT03832010|451149776|FG001|Overall Study|Withdrawal by Subject|1|||
125416617|NCT03832010|451149777|FG002|Overall Study|Withdrawal by Subject|0|||
125416618|NCT03832010|451149775|FG000|Overall Study|Lost to Follow-up|2|||
125416619|NCT03832010|451149776|FG001|Overall Study|Lost to Follow-up|1|||
125416620|NCT03832010|451149777|FG002|Overall Study|Lost to Follow-up|1|||
125416621|NCT02349295|451149778|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
125416622|NCT02349295|451149779|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
125416623|NCT02349295|451149780|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
125416624|NCT02349295|451149781|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125416625|NCT02349295|451149782|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125416626|NCT02349295|451149783|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125416627|NCT02349295|451149784|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125416628|NCT02349295|451149785|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125416629|NCT02349295|451149786|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125416630|NCT02349295|451149787|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125416631|NCT02349295|451149788|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125416632|NCT02349295|451149789|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125416633|NCT02349295|451149790|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125416634|NCT02349295|451149791|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
125416635|NCT02349295|451149778|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
125416636|NCT02349295|451149779|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
125416637|NCT02349295|451149780|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
125416638|NCT02349295|451149781|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125416639|NCT02349295|451149782|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125416640|NCT02349295|451149783|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125416641|NCT02349295|451149784|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125416642|NCT02349295|451149785|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125416643|NCT02349295|451149786|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125416644|NCT02349295|451149787|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125416645|NCT02349295|451149788|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125416646|NCT02349295|451149789|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125416647|NCT02349295|451149790|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125416648|NCT02349295|451149791|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
125416649|NCT02349295|451149778|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
125416650|NCT02349295|451149779|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
125416651|NCT02349295|451149780|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
125416652|NCT02349295|451149781|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125416653|NCT02349295|451149782|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125416654|NCT02349295|451149783|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125416655|NCT02349295|451149784|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125416656|NCT02349295|451149785|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125416657|NCT02349295|451149786|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125416658|NCT02349295|451149787|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125416659|NCT02349295|451149788|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125416660|NCT02349295|451149789|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125416661|NCT02349295|451149790|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125416662|NCT02349295|451149791|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
125416663|NCT02349295|451149778|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
125416664|NCT02349295|451149779|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
125416665|NCT02349295|451149780|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
125416666|NCT02349295|451149781|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125416667|NCT02349295|451149782|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125416668|NCT02349295|451149783|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125416669|NCT02349295|451149784|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125416670|NCT02349295|451149785|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125416671|NCT02349295|451149786|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125416672|NCT02349295|451149787|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125449340|NCT00372567|451273038|FG002|Phase 3 Study|Other|1|||
125285968|NCT01529515|450674448|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
125416673|NCT02349295|451149788|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125416674|NCT02349295|451149789|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125416675|NCT02349295|451149790|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125285969|NCT01529515|450674449|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
125416676|NCT02349295|451149791|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
125449341|NCT00372567|451273036|FG000|Phase 3 Study|study terminated by sponsor|13|||
125449342|NCT00372567|451273037|FG001|Phase 3 Study|study terminated by sponsor|8|||
125449343|NCT00372567|451273038|FG002|Phase 3 Study|study terminated by sponsor|5|||
125449344|NCT00303303|451273042|FG000|Overall Study|Withdrawal by Subject|0|||
125449345|NCT00303303|451273043|FG001|Overall Study|Withdrawal by Subject|0|||
125449346|NCT00303303|451273044|FG002|Overall Study|Withdrawal by Subject|1|||
125449347|NCT00582790|451273047|FG000|Overall Study|Rapid progression of disease|1|||
125449348|NCT00480441|451273048|FG000|Screening|Not Eligible|37|||
125449349|NCT00480441|451273049|FG001|Screening|Not Eligible|0|||
125449350|NCT00480441|451273050|FG002|Screening|Not Eligible|0|||
125449351|NCT00480441|451273048|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
125449352|NCT00480441|451273049|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
125449353|NCT00480441|451273050|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
125449354|NCT00480441|451273048|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
125449355|NCT00480441|451273049|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
125449356|NCT00480441|451273050|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
125449357|NCT00480441|451273048|FG000|Baseline Functional MRI|physical contraindication|4|||
125449358|NCT00480441|451273049|FG001|Baseline Functional MRI|physical contraindication|0|||
125449359|NCT00480441|451273050|FG002|Baseline Functional MRI|physical contraindication|0|||
125449360|NCT00480441|451273048|FG000|Randomization|Lost to Follow-up|0|||
125449361|NCT00480441|451273049|FG001|Randomization|Lost to Follow-up|7|||
125449362|NCT00480441|451273050|FG002|Randomization|Lost to Follow-up|2|||
125449363|NCT01004263|451273062|FG000|Overall Study|Adverse Event|15|||
125449364|NCT01004263|451273062|FG000|Overall Study|Withdrawal by Subject|58|||
125449365|NCT01004263|451273062|FG000|Overall Study|Protocol Violation|10|||
125449366|NCT01004263|451273062|FG000|Overall Study|Lost to Follow-up|64|||
125449367|NCT01004263|451273062|FG000|Overall Study|Lack of Efficacy|13|||
125449368|NCT01004263|451273062|FG000|Overall Study|Pregnancy|2|||
125449369|NCT01004263|451273062|FG000|Overall Study|Physician Decision|15|||
125449370|NCT01004263|451273062|FG000|Overall Study|Lack of Qualifying Event|2|||
125449371|NCT00958009|451273064|FG000|Overall Study|Adverse Event|1|||
125449372|NCT00958009|451273064|FG000|Overall Study|Subject found device difficult to use|1|||
125449373|NCT00558753|451273065|FG000|Overall Study|Lost to Follow-up|5|||
125449374|NCT00558753|451273066|FG001|Overall Study|Lost to Follow-up|7|||
125449375|NCT00821236|451273067|FG000|Overall Study|Lost to Follow-up|3|||
125449376|NCT00578227|451273070|FG000|Overall Study|Lost to Follow-up|0|||
125449377|NCT00578227|451273071|FG001|Overall Study|Lost to Follow-up|1|||
125449378|NCT00578227|451273072|FG002|Overall Study|Lost to Follow-up|1|||
125449379|NCT00578227|451273070|FG000|Overall Study|Withdrawal by Subject|5|||
125449380|NCT00578227|451273071|FG001|Overall Study|Withdrawal by Subject|1|||
125449381|NCT00578227|451273072|FG002|Overall Study|Withdrawal by Subject|3|||
125449382|NCT04668144|451273073|FG000|Overall Study|Protocol Violation|0|||
125449383|NCT04668144|451273074|FG001|Overall Study|Protocol Violation|1|||
125449384|NCT04668144|451273075|FG002|Overall Study|Protocol Violation|2|||
125449385|NCT00577629|451273076|FG000|Treatment Period|Death|1|||
125449386|NCT00577629|451273076|FG000|Long Term Follow-Up|Death|15|||
125416677|NCT02349295|451149778|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125416678|NCT02349295|451149779|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
125416679|NCT02349295|451149780|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
125416680|NCT02349295|451149781|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125416681|NCT02349295|451149782|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125416682|NCT02349295|451149783|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125416683|NCT02349295|451149784|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125416684|NCT02349295|451149785|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125416685|NCT02349295|451149786|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125416686|NCT02349295|451149787|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125416687|NCT02349295|451149788|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125416688|NCT02349295|451149789|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125416689|NCT02349295|451149790|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125416690|NCT02349295|451149791|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
125449387|NCT00577629|451273076|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
125449388|NCT00577629|451273076|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
125449389|NCT00577629|451273076|FG000|Long Term Follow-Up|Physician Decision|1|||
125449390|NCT01605136|451273079|FG000|Study Period|Withdrawal by Subject|2|||
125449391|NCT01605136|451273080|FG001|Study Period|Withdrawal by Subject|0|||
125416691|NCT02349295|451149778|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
125416692|NCT02349295|451149779|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
125449392|NCT01605136|451273079|FG000|Study Period|Physician Decision|1|||
125449393|NCT01605136|451273080|FG001|Study Period|Physician Decision|1|||
125449394|NCT01605136|451273079|FG000|Study Period|Lost to Follow-up|0|||
125449395|NCT01605136|451273080|FG001|Study Period|Lost to Follow-up|2|||
125449396|NCT01605136|451273079|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
125449397|NCT01605136|451273080|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
125449398|NCT01072929|451273081|FG000|Overall Study|Adverse Event|8|||
125285970|NCT01529515|450674446|FG000|TRANSITION PHASE|Protocol Violation|4|||
125285971|NCT01529515|450674447|FG001|TRANSITION PHASE|Protocol Violation|0|||
125285972|NCT01529515|450674448|FG002|TRANSITION PHASE|Protocol Violation|0|||
125285973|NCT01529515|450674449|FG003|TRANSITION PHASE|Protocol Violation|0|||
125285974|NCT01529515|450674446|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
125285975|NCT01529515|450674447|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
125285976|NCT01529515|450674448|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
125285977|NCT01529515|450674449|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
125285978|NCT01529515|450674446|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
125285979|NCT01529515|450674447|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
125285980|NCT01529515|450674448|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
125285981|NCT01529515|450674449|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
125285982|NCT01529515|450674446|FG000|TRANSITION PHASE|Other|9|||
125285983|NCT01529515|450674447|FG001|TRANSITION PHASE|Other|0|||
125285984|NCT01529515|450674448|FG002|TRANSITION PHASE|Other|0|||
125285985|NCT01529515|450674449|FG003|TRANSITION PHASE|Other|0|||
125285986|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Adverse Event|0|||
125285987|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Adverse Event|10|||
125285988|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Adverse Event|0|||
125285989|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Adverse Event|0|||
125285990|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
125285991|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
125285992|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
125285993|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
125285994|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
125285995|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
125285996|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
125285997|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
125285998|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
125285999|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
125286000|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
125286001|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
125286002|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
125286003|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
125286004|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
125286005|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
125286006|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
125286007|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
125286008|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
125286009|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
125286010|NCT01529515|450674446|FG000|MAINTENANCE PHASE|Other|0|||
125286011|NCT01529515|450674447|FG001|MAINTENANCE PHASE|Other|10|||
125286012|NCT01529515|450674448|FG002|MAINTENANCE PHASE|Other|0|||
125286013|NCT01529515|450674449|FG003|MAINTENANCE PHASE|Other|0|||
125286014|NCT01529515|450674446|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
125286015|NCT01529515|450674447|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
125286016|NCT01529515|450674448|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
125286017|NCT01529515|450674449|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
125286018|NCT01529515|450674446|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
125286019|NCT01529515|450674447|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
125286020|NCT01529515|450674448|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
125286021|NCT01529515|450674449|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
125286022|NCT01529515|450674446|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
125286023|NCT01529515|450674447|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
125286024|NCT01529515|450674448|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
125286025|NCT01529515|450674449|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
125286026|NCT01529515|450674446|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
125286027|NCT01529515|450674447|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
125286028|NCT01529515|450674448|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
125286029|NCT01529515|450674449|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
125286030|NCT01529515|450674446|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
125286031|NCT01529515|450674447|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
125286032|NCT01529515|450674448|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
125286033|NCT01529515|450674449|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
125286034|NCT01529515|450674446|FG000|DOUBLE BLIND PHASE|Other|0|||
125416693|NCT02349295|451149780|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
125416694|NCT02349295|451149781|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
125286035|NCT01529515|450674447|FG001|DOUBLE BLIND PHASE|Other|0|||
125286036|NCT01529515|450674448|FG002|DOUBLE BLIND PHASE|Other|9|||
125286037|NCT01529515|450674449|FG003|DOUBLE BLIND PHASE|Other|2|||
125416695|NCT02349295|451149782|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
125286038|NCT03920293|450674451|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
125286039|NCT03920293|450674452|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
125286040|NCT03920293|450674451|FG000|Randomized-Controlled Period|Physician Decision|1|||
125286041|NCT03920293|450674452|FG001|Randomized-Controlled Period|Physician Decision|2|||
125286042|NCT03920293|450674451|FG000|Randomized-Controlled Period|Adverse Event|0|||
125416696|NCT02349295|451149783|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
125286043|NCT03920293|450674452|FG001|Randomized-Controlled Period|Adverse Event|2|||
125286044|NCT03920293|450674451|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
125286045|NCT03920293|450674452|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
125286046|NCT03920293|450674451|FG000|Randomized-Controlled Period|Death|2|||
125286047|NCT03920293|450674452|FG001|Randomized-Controlled Period|Death|0|||
125286048|NCT03920293|450674451|FG000|Randomized-Controlled Period|Protocol Violation|1|||
125286049|NCT03920293|450674452|FG001|Randomized-Controlled Period|Protocol Violation|0|||
125286050|NCT03920293|450674451|FG000|Randomized-Controlled Period|Noncompliance|1|||
125286051|NCT03920293|450674452|FG001|Randomized-Controlled Period|Noncompliance|0|||
125286052|NCT03920293|450674451|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
125286053|NCT03920293|450674452|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
125286054|NCT03920293|450674451|FG000|Open- Label Extension Period|Death|3|||
125286055|NCT03920293|450674452|FG001|Open- Label Extension Period|Death|3|||
125286056|NCT03920293|450674451|FG000|Open- Label Extension Period|Physician Decision|5|||
125286057|NCT03920293|450674452|FG001|Open- Label Extension Period|Physician Decision|3|||
125286058|NCT03920293|450674451|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
125286059|NCT03920293|450674452|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
125286060|NCT01069861|450674453|FG000|Overall Study|Death|1|||
125286061|NCT01069861|450674453|FG000|Overall Study|Adverse Event|1|||
125286062|NCT01069861|450674453|FG000|Overall Study|Did not meet entrance criteria|1|||
125286063|NCT03272828|450674455|FG000|Overall Study|Lost to Follow-up|7|||
125286064|NCT03272828|450674456|FG001|Overall Study|Lost to Follow-up|7|||
125286065|NCT03272828|450674455|FG000|Overall Study|Withdrawal by Subject|2|||
125286066|NCT03272828|450674456|FG001|Overall Study|Withdrawal by Subject|0|||
125286067|NCT03272828|450674455|FG000|Overall Study|Deceased|1|||
125286068|NCT03272828|450674456|FG001|Overall Study|Deceased|1|||
125286069|NCT03272828|450674455|FG000|Overall Study|Failed implant|1|||
125286070|NCT03272828|450674456|FG001|Overall Study|Failed implant|2|||
125286071|NCT00996281|450674458|FG000|Overall Study|Adverse Event|75|||
125286072|NCT00996281|450674459|FG001|Overall Study|Adverse Event|37|||
125286073|NCT00996281|450674458|FG000|Overall Study|Major Protocol Deviation|6|||
125286074|NCT00996281|450674459|FG001|Overall Study|Major Protocol Deviation|7|||
125286075|NCT00996281|450674458|FG000|Overall Study|Lost to Follow-up|14|||
125286076|NCT00996281|450674459|FG001|Overall Study|Lost to Follow-up|16|||
125286077|NCT00996281|450674458|FG000|Overall Study|Withdrawal by Subject|31|||
125286078|NCT00996281|450674459|FG001|Overall Study|Withdrawal by Subject|20|||
125286079|NCT00996281|450674458|FG000|Overall Study|Lack of Efficacy|0|||
125286080|NCT00996281|450674459|FG001|Overall Study|Lack of Efficacy|2|||
125286081|NCT00996281|450674458|FG000|Overall Study|Other|5|||
125286082|NCT00996281|450674459|FG001|Overall Study|Other|7|||
125286083|NCT01920568|450674462|FG000|Overall Study|Adverse Event|27|||
125286084|NCT01920568|450674463|FG001|Overall Study|Adverse Event|8|||
125286085|NCT01920568|450674462|FG000|Overall Study|Protocol Violation|5|||
125286086|NCT01920568|450674463|FG001|Overall Study|Protocol Violation|3|||
125286087|NCT01920568|450674462|FG000|Overall Study|Lost to Follow-up|2|||
125286088|NCT01920568|450674463|FG001|Overall Study|Lost to Follow-up|2|||
125286089|NCT01920568|450674462|FG000|Overall Study|Physician Decision|13|||
125286090|NCT01920568|450674463|FG001|Overall Study|Physician Decision|4|||
125286091|NCT01920568|450674462|FG000|Overall Study|Withdrawal by Subject|79|||
125286092|NCT01920568|450674463|FG001|Overall Study|Withdrawal by Subject|55|||
125286093|NCT01920568|450674462|FG000|Overall Study|Death due to disease progression|25|||
125286094|NCT01920568|450674463|FG001|Overall Study|Death due to disease progression|12|||
125286095|NCT02891681|450674467|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
125286096|NCT02891681|450674468|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
125286097|NCT02891681|450674469|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
125286098|NCT02891681|450674467|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
125286099|NCT02891681|450674468|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
125286100|NCT02891681|450674469|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
125286101|NCT02891681|450674467|FG000|Overall Study|Taken off study after first imaging appointment|1|||
125286102|NCT02891681|450674468|FG001|Overall Study|Taken off study after first imaging appointment|0|||
125286103|NCT02891681|450674469|FG002|Overall Study|Taken off study after first imaging appointment|0|||
125286104|NCT00856206|450674471|FG000|Overall Study|Protocol Violation|6|||
125286105|NCT00856206|450674472|FG001|Overall Study|Protocol Violation|18|||
125416697|NCT02349295|451149784|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
125416698|NCT02349295|451149785|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
125416699|NCT02349295|451149786|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
125286106|NCT00856206|450674471|FG000|Overall Study|Adverse Event|10|||
125286107|NCT00856206|450674472|FG001|Overall Study|Adverse Event|46|||
125286108|NCT00856206|450674471|FG000|Overall Study|Lack of Efficacy|1|||
125286109|NCT00856206|450674472|FG001|Overall Study|Lack of Efficacy|2|||
125286110|NCT00856206|450674471|FG000|Overall Study|Withdrawal by Subject|15|||
125416700|NCT02349295|451149787|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
125416701|NCT02349295|451149788|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
125416702|NCT02349295|451149789|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
125416703|NCT02349295|451149790|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
125416704|NCT02349295|451149791|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
125416705|NCT02349295|451149778|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125416706|NCT02349295|451149779|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125416707|NCT02349295|451149780|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125416708|NCT02349295|451149781|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125416709|NCT02349295|451149782|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125416710|NCT02349295|451149783|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125416711|NCT02349295|451149784|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125416712|NCT02349295|451149785|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
125416713|NCT02349295|451149786|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
125416714|NCT02349295|451149787|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
125416715|NCT02349295|451149788|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
125416716|NCT02349295|451149789|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125416717|NCT02349295|451149790|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125416718|NCT02349295|451149791|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
125416719|NCT02349295|451149778|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125416720|NCT02349295|451149779|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125416721|NCT02349295|451149780|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125416722|NCT02349295|451149781|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125416723|NCT02349295|451149782|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125416724|NCT02349295|451149783|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125416725|NCT02349295|451149784|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125416726|NCT02349295|451149785|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
125416727|NCT02349295|451149786|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
125416728|NCT02349295|451149787|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
125416729|NCT02349295|451149788|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
125416730|NCT02349295|451149789|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125416731|NCT02349295|451149790|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125416732|NCT02349295|451149791|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
125416733|NCT02349295|451149778|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125416734|NCT02349295|451149779|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125416735|NCT02349295|451149780|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125416736|NCT02349295|451149781|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125416737|NCT02349295|451149782|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125416738|NCT02349295|451149783|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125416739|NCT02349295|451149784|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125416740|NCT02349295|451149785|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
125416741|NCT02349295|451149786|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125416742|NCT02349295|451149787|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
125416743|NCT02349295|451149788|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125416744|NCT02349295|451149789|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125416745|NCT02349295|451149790|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125416746|NCT02349295|451149791|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
125416747|NCT02349295|451149778|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
125416748|NCT02349295|451149779|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
125416749|NCT02349295|451149780|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
125416750|NCT02349295|451149781|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
125416751|NCT02349295|451149782|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
125416752|NCT02349295|451149783|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
125416753|NCT02349295|451149784|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
125416754|NCT02349295|451149785|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
125416755|NCT02349295|451149786|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
125416756|NCT02349295|451149787|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
125416757|NCT02349295|451149788|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
125416758|NCT02349295|451149789|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
125416759|NCT02349295|451149790|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
125416760|NCT02349295|451149791|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
125416761|NCT02349295|451149778|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125416762|NCT02349295|451149779|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125416763|NCT02349295|451149780|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125416764|NCT02349295|451149781|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125416765|NCT02349295|451149782|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125449399|NCT01072929|451273082|FG001|Overall Study|Adverse Event|11|||
125449400|NCT01072929|451273083|FG002|Overall Study|Adverse Event|2|||
125449401|NCT01072929|451273081|FG000|Overall Study|Lack of Efficacy|7|||
125416766|NCT02349295|451149783|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125416767|NCT02349295|451149784|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125416768|NCT02349295|451149785|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
125416769|NCT02349295|451149786|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
125416770|NCT02349295|451149787|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
125416771|NCT02349295|451149788|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
125416772|NCT02349295|451149789|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125416773|NCT02349295|451149790|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125416774|NCT02349295|451149791|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
125416775|NCT02349295|451149778|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125416776|NCT02349295|451149779|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125416777|NCT02349295|451149780|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125416778|NCT02349295|451149781|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125416779|NCT02349295|451149782|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125416780|NCT02349295|451149783|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125416781|NCT02349295|451149784|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125416782|NCT02349295|451149785|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
125416783|NCT02349295|451149786|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
125416784|NCT02349295|451149787|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125416785|NCT02349295|451149788|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125416786|NCT02349295|451149789|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125416787|NCT02349295|451149790|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125416788|NCT02349295|451149791|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
125416789|NCT02349295|451149778|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125416790|NCT02349295|451149779|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125416791|NCT02349295|451149780|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125416792|NCT02349295|451149781|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125416793|NCT02349295|451149782|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125416794|NCT02349295|451149783|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125416795|NCT02349295|451149784|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125416796|NCT02349295|451149785|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
125416797|NCT02349295|451149786|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
125416798|NCT02349295|451149787|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125416799|NCT02349295|451149788|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125416800|NCT02349295|451149789|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125416801|NCT02349295|451149790|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125416802|NCT02349295|451149791|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
125416803|NCT02349295|451149778|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125416804|NCT02349295|451149779|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125416805|NCT02349295|451149780|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125416806|NCT02349295|451149781|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125416807|NCT02349295|451149782|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125416808|NCT02349295|451149783|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125416809|NCT02349295|451149784|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125416810|NCT02349295|451149785|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125416811|NCT02349295|451149786|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125416812|NCT02349295|451149787|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125416813|NCT02349295|451149788|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
125416814|NCT02349295|451149789|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
125416815|NCT02349295|451149790|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
125416816|NCT02349295|451149791|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
125416817|NCT02349295|451149778|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125416818|NCT02349295|451149779|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125416819|NCT02349295|451149780|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125416820|NCT02349295|451149781|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125416821|NCT02349295|451149782|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125416822|NCT02349295|451149783|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125416823|NCT02349295|451149784|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125416824|NCT02349295|451149785|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125416825|NCT02349295|451149786|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125416826|NCT02349295|451149787|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125416827|NCT02349295|451149788|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125286111|NCT00856206|450674472|FG001|Overall Study|Withdrawal by Subject|36|||
125286112|NCT00856206|450674471|FG000|Overall Study|Lost to Follow-up|13|||
125286113|NCT00856206|450674472|FG001|Overall Study|Lost to Follow-up|39|||
125286114|NCT00856206|450674471|FG000|Overall Study|Death|2|||
125286115|NCT00856206|450674472|FG001|Overall Study|Death|2|||
125286116|NCT00856206|450674471|FG000|Overall Study|Decision by the Sponsor|4|||
125286117|NCT00856206|450674472|FG001|Overall Study|Decision by the Sponsor|8|||
125286118|NCT00856206|450674471|FG000|Overall Study|Other than specified above|3|||
125286119|NCT00856206|450674472|FG001|Overall Study|Other than specified above|10|||
125286120|NCT04584346|450674473|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
125286121|NCT04584346|450674474|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
125286122|NCT02780856|450674481|FG000|Overall Study|Lost to Follow-up|1|||
125286123|NCT03640052|450674482|FG000|Overall Study|Lost to Follow-up|0|||
125286124|NCT03640052|450674483|FG001|Overall Study|Lost to Follow-up|1|||
125286125|NCT03640052|450674484|FG002|Overall Study|Lost to Follow-up|0|||
125286126|NCT03640052|450674485|FG003|Overall Study|Lost to Follow-up|0|||
125286127|NCT03640052|450674486|FG004|Overall Study|Lost to Follow-up|0|||
125286128|NCT04422561|450674487|FG000|Overall Study|Lost to Follow-up|25|||
125286129|NCT04422561|450674488|FG001|Overall Study|Lost to Follow-up|11|||
125286130|NCT04239222|450674491|FG000|Baseline|Withdrawal by Subject|0|||
125286131|NCT04239222|450674492|FG001|Baseline|Withdrawal by Subject|0|||
125286132|NCT04239222|450674493|FG002|Baseline|Withdrawal by Subject|1|||
125286133|NCT04239222|450674494|FG003|Baseline|Withdrawal by Subject|1|||
125286134|NCT04239222|450674491|FG000|First Foot Assignment|Withdrawal by Subject|0|||
125286135|NCT04239222|450674492|FG001|First Foot Assignment|Withdrawal by Subject|0|||
125286136|NCT04239222|450674493|FG002|First Foot Assignment|Withdrawal by Subject|1|||
125286137|NCT04239222|450674494|FG003|First Foot Assignment|Withdrawal by Subject|0|||
125286138|NCT04239222|450674491|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
125286139|NCT04239222|450674492|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
125286140|NCT04239222|450674493|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
125286141|NCT04239222|450674494|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
125286142|NCT01468233|450674499|FG000|Treatment Period 1|Adverse Event|5|||
125286143|NCT01468233|450674500|FG001|Treatment Period 1|Adverse Event|3|||
125286144|NCT01468233|450674501|FG002|Treatment Period 1|Adverse Event|0|||
125286145|NCT01468233|450674502|FG003|Treatment Period 1|Adverse Event|0|||
125286146|NCT01468233|450674503|FG004|Treatment Period 1|Adverse Event|0|||
125286147|NCT01468233|450674504|FG005|Treatment Period 1|Adverse Event|0|||
125286148|NCT01468233|450674499|FG000|Treatment Period 1|Withdrawal by Subject|3|||
125286149|NCT01468233|450674500|FG001|Treatment Period 1|Withdrawal by Subject|4|||
125286150|NCT01468233|450674501|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125286151|NCT01468233|450674502|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125286152|NCT01468233|450674503|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125286153|NCT01468233|450674504|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125286154|NCT01468233|450674499|FG000|Treatment Period 1|Lost to Follow-up|3|||
125286155|NCT01468233|450674500|FG001|Treatment Period 1|Lost to Follow-up|0|||
125286156|NCT01468233|450674501|FG002|Treatment Period 1|Lost to Follow-up|0|||
125286157|NCT01468233|450674502|FG003|Treatment Period 1|Lost to Follow-up|0|||
125286158|NCT01468233|450674503|FG004|Treatment Period 1|Lost to Follow-up|0|||
125286159|NCT01468233|450674504|FG005|Treatment Period 1|Lost to Follow-up|0|||
125286160|NCT01468233|450674499|FG000|Treatment Period 1|Other|1|||
125286161|NCT01468233|450674500|FG001|Treatment Period 1|Other|1|||
125286162|NCT01468233|450674501|FG002|Treatment Period 1|Other|0|||
125286163|NCT01468233|450674502|FG003|Treatment Period 1|Other|0|||
125286164|NCT01468233|450674503|FG004|Treatment Period 1|Other|0|||
125286165|NCT01468233|450674504|FG005|Treatment Period 1|Other|0|||
125286166|NCT01468233|450674499|FG000|Treatment Period 2|Adverse Event|0|||
125286167|NCT01468233|450674500|FG001|Treatment Period 2|Adverse Event|0|||
125286168|NCT01468233|450674501|FG002|Treatment Period 2|Adverse Event|3|||
125286169|NCT01468233|450674502|FG003|Treatment Period 2|Adverse Event|0|||
125286170|NCT01468233|450674503|FG004|Treatment Period 2|Adverse Event|2|||
125286171|NCT01468233|450674504|FG005|Treatment Period 2|Adverse Event|1|||
125286172|NCT01468233|450674499|FG000|Treatment Period 2|Lack of Efficacy|0|||
125286173|NCT01468233|450674500|FG001|Treatment Period 2|Lack of Efficacy|0|||
125286174|NCT01468233|450674501|FG002|Treatment Period 2|Lack of Efficacy|9|||
125416828|NCT02349295|451149789|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
125416829|NCT02349295|451149790|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
125416830|NCT02349295|451149791|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
125449402|NCT01072929|451273082|FG001|Overall Study|Lack of Efficacy|4|||
125286175|NCT01468233|450674502|FG003|Treatment Period 2|Lack of Efficacy|2|||
125286176|NCT01468233|450674503|FG004|Treatment Period 2|Lack of Efficacy|0|||
125286177|NCT01468233|450674504|FG005|Treatment Period 2|Lack of Efficacy|1|||
125286178|NCT01468233|450674499|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125286179|NCT01468233|450674500|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125286180|NCT01468233|450674501|FG002|Treatment Period 2|Withdrawal by Subject|9|||
125286181|NCT01468233|450674502|FG003|Treatment Period 2|Withdrawal by Subject|1|||
125286182|NCT01468233|450674503|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125286183|NCT01468233|450674504|FG005|Treatment Period 2|Withdrawal by Subject|1|||
125286184|NCT01468233|450674499|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
125286185|NCT01468233|450674500|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
125286186|NCT01468233|450674501|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
125286187|NCT01468233|450674502|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
125286188|NCT01468233|450674503|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
125286189|NCT01468233|450674504|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
125286190|NCT01468233|450674499|FG000|Treatment Period 2|Lost to Follow-up|0|||
125286191|NCT01468233|450674500|FG001|Treatment Period 2|Lost to Follow-up|0|||
125286192|NCT01468233|450674501|FG002|Treatment Period 2|Lost to Follow-up|3|||
125286193|NCT01468233|450674502|FG003|Treatment Period 2|Lost to Follow-up|0|||
125286194|NCT01468233|450674503|FG004|Treatment Period 2|Lost to Follow-up|2|||
125286195|NCT01468233|450674504|FG005|Treatment Period 2|Lost to Follow-up|0|||
125286196|NCT01468233|450674499|FG000|Treatment Period 2|Other|0|||
125286197|NCT01468233|450674500|FG001|Treatment Period 2|Other|0|||
125286198|NCT01468233|450674501|FG002|Treatment Period 2|Other|3|||
125286199|NCT01468233|450674502|FG003|Treatment Period 2|Other|0|||
125286200|NCT01468233|450674503|FG004|Treatment Period 2|Other|1|||
125286201|NCT01468233|450674504|FG005|Treatment Period 2|Other|0|||
125286202|NCT00790647|450674512|FG000|Overall Study|Adverse Event|1|||
125286203|NCT04926831|450674514|FG000|Overall Study|Withdrawal by Subject|2|||
125286204|NCT04926831|450674514|FG000|Overall Study|Adverse Event|2|||
125286205|NCT02701777|450674515|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
125286206|NCT02701777|450674516|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
125286207|NCT02701777|450674517|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
125286208|NCT02701777|450674518|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
125286209|NCT02701777|450674515|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
125286210|NCT02701777|450674516|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
125286211|NCT02701777|450674517|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
125286212|NCT02701777|450674518|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
125286213|NCT03549871|450674521|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
125286214|NCT03549871|450674522|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
125286215|NCT03549871|450674521|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
125286216|NCT03549871|450674522|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
125286217|NCT03549871|450674521|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
125286218|NCT03549871|450674522|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
125286219|NCT03549871|450674521|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
125286220|NCT03549871|450674522|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
125286221|NCT03549871|450674521|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
125286222|NCT03549871|450674522|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
125286223|NCT03549871|450674521|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
125286224|NCT03549871|450674522|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
125286225|NCT03549871|450674521|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
125286226|NCT03549871|450674522|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
125286227|NCT03549871|450674521|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
125286228|NCT03549871|450674522|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
125286229|NCT03549871|450674521|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
125286230|NCT03549871|450674522|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
125286231|NCT03549871|450674521|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
125286232|NCT03549871|450674522|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
125286233|NCT03549871|450674521|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
125286234|NCT03549871|450674522|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
125286235|NCT01133626|450674524|FG000|Overall Study|Adverse Event|0|||
125286236|NCT01133626|450674525|FG001|Overall Study|Adverse Event|1|||
125286237|NCT01133626|450674526|FG002|Overall Study|Adverse Event|0|||
125286238|NCT01133626|450674524|FG000|Overall Study|Withdrawal by Subject|1|||
125286239|NCT01133626|450674525|FG001|Overall Study|Withdrawal by Subject|2|||
125286240|NCT01133626|450674526|FG002|Overall Study|Withdrawal by Subject|2|||
125286241|NCT01133626|450674524|FG000|Overall Study|Other|0|||
125286242|NCT01133626|450674525|FG001|Overall Study|Other|2|||
125286243|NCT01133626|450674526|FG002|Overall Study|Other|0|||
125286244|NCT03298984|450674529|FG000|Overall Study|Physician Decision|1|||
125286245|NCT03298984|450674530|FG001|Overall Study|Physician Decision|0|||
125286246|NCT03298984|450674531|FG002|Overall Study|Physician Decision|0|||
125286247|NCT03298984|450674532|FG003|Overall Study|Physician Decision|6|||
125286248|NCT03298984|450674529|FG000|Overall Study|Lack of Efficacy|0|||
125286249|NCT03298984|450674530|FG001|Overall Study|Lack of Efficacy|1|||
125286250|NCT03298984|450674531|FG002|Overall Study|Lack of Efficacy|1|||
125286251|NCT03298984|450674532|FG003|Overall Study|Lack of Efficacy|4|||
125286252|NCT03298984|450674529|FG000|Overall Study|Relapsed disease (following remission)|0|||
125416831|NCT02349295|451149778|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125416832|NCT02349295|451149779|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125286253|NCT03298984|450674530|FG001|Overall Study|Relapsed disease (following remission)|0|||
125286254|NCT03298984|450674531|FG002|Overall Study|Relapsed disease (following remission)|1|||
125286255|NCT03298984|450674532|FG003|Overall Study|Relapsed disease (following remission)|1|||
125286256|NCT03298984|450674529|FG000|Overall Study|Adverse Event|0|||
125286257|NCT03298984|450674530|FG001|Overall Study|Adverse Event|0|||
125286258|NCT03298984|450674531|FG002|Overall Study|Adverse Event|0|||
125286259|NCT03298984|450674532|FG003|Overall Study|Adverse Event|1|||
125286260|NCT03298984|450674529|FG000|Overall Study|Death|0|||
125286261|NCT03298984|450674530|FG001|Overall Study|Death|0|||
125286262|NCT03298984|450674531|FG002|Overall Study|Death|0|||
125286263|NCT03298984|450674532|FG003|Overall Study|Death|2|||
125286264|NCT03298984|450674529|FG000|Overall Study|Insurance Company Decision|0|||
125286265|NCT03298984|450674530|FG001|Overall Study|Insurance Company Decision|0|||
125286266|NCT03298984|450674531|FG002|Overall Study|Insurance Company Decision|0|||
125286267|NCT03298984|450674532|FG003|Overall Study|Insurance Company Decision|1|||
125286268|NCT02851407|450674533|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125286269|NCT02851407|450674534|FG001|Overall Study|Withdrawal by parent/guardian|7|||
125286270|NCT02851407|450674533|FG000|Overall Study|Protocol deviation|0|||
125286271|NCT02851407|450674534|FG001|Overall Study|Protocol deviation|1|||
125286272|NCT02851407|450674533|FG000|Overall Study|Transferred to another hospital to continue|1|||
125286273|NCT02851407|450674534|FG001|Overall Study|Transferred to another hospital to continue|0|||
125286274|NCT02851407|450674533|FG000|Overall Study|Other Death|30|||
125286275|NCT02851407|450674534|FG001|Overall Study|Other Death|20|||
125286276|NCT02851407|450674533|FG000|Overall Study|Adverse event, serious fatal|6|||
125286277|NCT02851407|450674534|FG001|Overall Study|Adverse event, serious fatal|8|||
125286278|NCT02851407|450674533|FG000|Overall Study|Consent withdrawn by participant|5|||
125286279|NCT02851407|450674534|FG001|Overall Study|Consent withdrawn by participant|3|||
125286280|NCT02851407|450674533|FG000|Overall Study|Screen failure|2|||
125286281|NCT02851407|450674534|FG001|Overall Study|Screen failure|1|||
125286282|NCT02851407|450674533|FG000|Overall Study|Disease relapse|9|||
125286283|NCT02851407|450674534|FG001|Overall Study|Disease relapse|6|||
125286284|NCT02851407|450674533|FG000|Overall Study|Physician Decision|7|||
125286285|NCT02851407|450674534|FG001|Overall Study|Physician Decision|6|||
125286286|NCT02851407|450674533|FG000|Overall Study|Transferred to hospital closer to home|0|||
125286287|NCT02851407|450674534|FG001|Overall Study|Transferred to hospital closer to home|1|||
125286288|NCT02851407|450674533|FG000|Overall Study|Enrolled in an investigational study|0|||
125286289|NCT02851407|450674534|FG001|Overall Study|Enrolled in an investigational study|1|||
125286290|NCT02851407|450674533|FG000|Overall Study|Early recovery|1|||
125286291|NCT02851407|450674534|FG001|Overall Study|Early recovery|0|||
125286292|NCT02851407|450674533|FG000|Overall Study|Adverse event, non-fatal|7|||
125286293|NCT02851407|450674534|FG001|Overall Study|Adverse event, non-fatal|5|||
125286294|NCT02851407|450674533|FG000|Overall Study|Lost to Follow-up|0|||
125286295|NCT02851407|450674534|FG001|Overall Study|Lost to Follow-up|2|||
125286296|NCT00294645|450674535|FG000|Overall Study|Death|10|||
125286297|NCT00294645|450674536|FG001|Overall Study|Death|18|||
125286298|NCT00294645|450674535|FG000|Overall Study|Lost to Follow-up|1|||
125286299|NCT00294645|450674536|FG001|Overall Study|Lost to Follow-up|10|||
125286300|NCT00294645|450674535|FG000|Overall Study|Withdrawal by Subject|18|||
125286301|NCT00294645|450674536|FG001|Overall Study|Withdrawal by Subject|34|||
125286302|NCT00294645|450674535|FG000|Overall Study|Physician Decision|15|||
125286303|NCT00294645|450674536|FG001|Overall Study|Physician Decision|20|||
125286304|NCT00294645|450674535|FG000|Overall Study|Other|4|||
125286305|NCT00294645|450674536|FG001|Overall Study|Other|10|||
125286306|NCT00075725|450674537|FG000|Overall Study|Adverse Event|6|||
125286307|NCT00075725|450674538|FG001|Overall Study|Adverse Event|6|||
125286308|NCT00075725|450674539|FG002|Overall Study|Adverse Event|20|||
125286309|NCT00075725|450674540|FG003|Overall Study|Adverse Event|8|||
125286310|NCT00075725|450674541|FG004|Overall Study|Adverse Event|4|||
125286311|NCT00075725|450674542|FG005|Overall Study|Adverse Event|38|||
125416833|NCT02349295|451149780|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125416834|NCT02349295|451149781|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125416835|NCT02349295|451149782|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125286312|NCT00075725|450674543|FG006|Overall Study|Adverse Event|3|||
125286313|NCT00075725|450674544|FG007|Overall Study|Adverse Event|51|||
125286314|NCT00075725|450674545|FG008|Overall Study|Adverse Event|15|||
125286315|NCT00075725|450674546|FG009|Overall Study|Adverse Event|4|||
125286316|NCT00075725|450674547|FG010|Overall Study|Adverse Event|2|||
125286317|NCT00075725|450674548|FG011|Overall Study|Adverse Event|2|||
125286318|NCT00075725|450674537|FG000|Overall Study|Death|3|||
125286319|NCT00075725|450674538|FG001|Overall Study|Death|5|||
125286320|NCT00075725|450674539|FG002|Overall Study|Death|10|||
125286321|NCT00075725|450674540|FG003|Overall Study|Death|2|||
125286322|NCT00075725|450674541|FG004|Overall Study|Death|3|||
125286323|NCT00075725|450674542|FG005|Overall Study|Death|25|||
125286324|NCT00075725|450674543|FG006|Overall Study|Death|4|||
125286325|NCT00075725|450674544|FG007|Overall Study|Death|22|||
125286326|NCT00075725|450674545|FG008|Overall Study|Death|14|||
125286327|NCT00075725|450674546|FG009|Overall Study|Death|4|||
125286328|NCT00075725|450674547|FG010|Overall Study|Death|3|||
125286329|NCT00075725|450674548|FG011|Overall Study|Death|0|||
125286330|NCT00075725|450674537|FG000|Overall Study|Lost to Follow-up|1|||
125286331|NCT00075725|450674538|FG001|Overall Study|Lost to Follow-up|1|||
125286332|NCT00075725|450674539|FG002|Overall Study|Lost to Follow-up|4|||
125286333|NCT00075725|450674540|FG003|Overall Study|Lost to Follow-up|1|||
125286334|NCT00075725|450674541|FG004|Overall Study|Lost to Follow-up|0|||
125286335|NCT00075725|450674542|FG005|Overall Study|Lost to Follow-up|13|||
125286336|NCT00075725|450674543|FG006|Overall Study|Lost to Follow-up|2|||
125286337|NCT00075725|450674544|FG007|Overall Study|Lost to Follow-up|4|||
125286338|NCT00075725|450674545|FG008|Overall Study|Lost to Follow-up|1|||
125286339|NCT00075725|450674546|FG009|Overall Study|Lost to Follow-up|0|||
125286340|NCT00075725|450674547|FG010|Overall Study|Lost to Follow-up|0|||
125286341|NCT00075725|450674548|FG011|Overall Study|Lost to Follow-up|0|||
125286342|NCT00075725|450674537|FG000|Overall Study|Physician Decision|2|||
125286343|NCT00075725|450674538|FG001|Overall Study|Physician Decision|6|||
125286344|NCT00075725|450674539|FG002|Overall Study|Physician Decision|5|||
125286345|NCT00075725|450674540|FG003|Overall Study|Physician Decision|8|||
125286346|NCT00075725|450674541|FG004|Overall Study|Physician Decision|4|||
125286347|NCT00075725|450674542|FG005|Overall Study|Physician Decision|19|||
125286348|NCT00075725|450674543|FG006|Overall Study|Physician Decision|3|||
125286349|NCT00075725|450674544|FG007|Overall Study|Physician Decision|17|||
125286350|NCT00075725|450674545|FG008|Overall Study|Physician Decision|5|||
125286351|NCT00075725|450674546|FG009|Overall Study|Physician Decision|0|||
125286352|NCT00075725|450674547|FG010|Overall Study|Physician Decision|1|||
125286353|NCT00075725|450674548|FG011|Overall Study|Physician Decision|0|||
125286354|NCT00075725|450674537|FG000|Overall Study|Pregnancy|0|||
125286355|NCT00075725|450674538|FG001|Overall Study|Pregnancy|0|||
125286356|NCT00075725|450674539|FG002|Overall Study|Pregnancy|0|||
125286357|NCT00075725|450674540|FG003|Overall Study|Pregnancy|0|||
125286358|NCT00075725|450674541|FG004|Overall Study|Pregnancy|0|||
125286359|NCT00075725|450674542|FG005|Overall Study|Pregnancy|1|||
125286360|NCT00075725|450674543|FG006|Overall Study|Pregnancy|0|||
125286361|NCT00075725|450674544|FG007|Overall Study|Pregnancy|1|||
125286362|NCT00075725|450674545|FG008|Overall Study|Pregnancy|0|||
125286363|NCT00075725|450674546|FG009|Overall Study|Pregnancy|0|||
125286364|NCT00075725|450674547|FG010|Overall Study|Pregnancy|0|||
125416836|NCT02349295|451149783|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125416837|NCT02349295|451149784|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125416838|NCT02349295|451149785|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125416839|NCT02349295|451149786|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125416840|NCT02349295|451149787|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125416841|NCT02349295|451149788|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125416842|NCT02349295|451149789|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
125416843|NCT02349295|451149790|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
125416844|NCT02349295|451149791|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
125416845|NCT02349295|451149778|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125416846|NCT02349295|451149779|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125416847|NCT02349295|451149780|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125416848|NCT02349295|451149781|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125416849|NCT02349295|451149782|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125416850|NCT02349295|451149783|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125416851|NCT02349295|451149784|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125416852|NCT02349295|451149785|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125416853|NCT02349295|451149786|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125416854|NCT02349295|451149787|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125416855|NCT02349295|451149788|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125416856|NCT02349295|451149789|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
125416857|NCT02349295|451149790|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125416858|NCT02349295|451149791|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
125416859|NCT02349295|451149778|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125416860|NCT02349295|451149779|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125416861|NCT02349295|451149780|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125416862|NCT02349295|451149781|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125416863|NCT02349295|451149782|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125416864|NCT02349295|451149783|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125416865|NCT02349295|451149784|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125416866|NCT02349295|451149785|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125416867|NCT02349295|451149786|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125286365|NCT00075725|450674548|FG011|Overall Study|Pregnancy|0|||
125286366|NCT00075725|450674537|FG000|Overall Study|Protocol Violation|1|||
125286367|NCT00075725|450674538|FG001|Overall Study|Protocol Violation|1|||
125286368|NCT00075725|450674539|FG002|Overall Study|Protocol Violation|0|||
125416868|NCT02349295|451149787|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125416869|NCT02349295|451149788|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125416870|NCT02349295|451149789|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
125416871|NCT02349295|451149790|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125416872|NCT02349295|451149791|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
125416873|NCT02148250|451149794|FG000|Screening|Withdrawal by Subject|5|||
125416874|NCT02148250|451149795|FG001|Screening|Withdrawal by Subject|0|||
125416875|NCT00695903|451149800|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
125416876|NCT00695903|451149801|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
125416877|NCT00695903|451149800|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
125416878|NCT00695903|451149801|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
125416879|NCT00695903|451149800|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
125416880|NCT00695903|451149801|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
125416881|NCT00695903|451149800|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
125416882|NCT00695903|451149801|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
125416883|NCT00695903|451149800|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
125416884|NCT00695903|451149801|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
125416885|NCT00695903|451149800|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
125416886|NCT00695903|451149801|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
125416887|NCT00695903|451149800|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
125416888|NCT00695903|451149801|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
125416889|NCT00695903|451149800|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
125416890|NCT00695903|451149801|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
125416891|NCT00695903|451149800|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
125416892|NCT00695903|451149801|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
125416893|NCT04723576|451149802|FG000|Overall Study|Withdrawal by Subject|2133|||
125416894|NCT04723576|451149803|FG001|Overall Study|Withdrawal by Subject|3234|||
125416895|NCT02097472|451149804|FG000|Received Vaccination 2|Adverse Event|0|||
125416896|NCT02097472|451149805|FG001|Received Vaccination 2|Adverse Event|0|||
125416897|NCT02097472|451149806|FG002|Received Vaccination 2|Adverse Event|0|||
125416898|NCT02097472|451149807|FG003|Received Vaccination 2|Adverse Event|0|||
125416899|NCT02097472|451149808|FG004|Received Vaccination 2|Adverse Event|0|||
125416900|NCT02097472|451149809|FG005|Received Vaccination 2|Adverse Event|0|||
125416901|NCT02097472|451149810|FG006|Received Vaccination 2|Adverse Event|1|||
125416902|NCT02097472|451149811|FG007|Received Vaccination 2|Adverse Event|0|||
125416903|NCT03966157|451149812|FG000|Overall Study|Physician Decision|1|||
125416904|NCT03966157|451149813|FG001|Overall Study|Physician Decision|0|||
125416905|NCT03305016|451149814|FG000|Overall Study|Withdrawal by Subject|2|||
125416906|NCT02119416|451149815|FG000|Overall Study|Protocol Violation|1|||
125416907|NCT02119416|451149816|FG001|Overall Study|Protocol Violation|1|||
125416908|NCT02119416|451149817|FG002|Overall Study|Protocol Violation|1|||
125416909|NCT02119416|451149815|FG000|Overall Study|wrong pubertal stage|1|||
125416910|NCT02119416|451149816|FG001|Overall Study|wrong pubertal stage|0|||
125416911|NCT02119416|451149817|FG002|Overall Study|wrong pubertal stage|1|||
125416912|NCT02384759|451149821|FG000|Overall Study|Patients not treated|3|||
125416913|NCT02384759|451149822|FG001|Overall Study|Patients not treated|2|||
125416914|NCT03043664|451149823|FG000|Overall Study|Lost to Follow-up|1|||
125416915|NCT03593655|451149827|FG000|First Product Use Period|Withdrawal by Subject|1|||
125416916|NCT03593655|451149828|FG001|First Product Use Period|Withdrawal by Subject|1|||
125416917|NCT03593655|451149827|FG000|First Product Use Period|Lost to Follow-up|1|||
125416918|NCT03593655|451149828|FG001|First Product Use Period|Lost to Follow-up|3|||
125416919|NCT03593655|451149827|FG000|Second Product Use Period|Withdrawal by Subject|1|||
125416920|NCT03593655|451149828|FG001|Second Product Use Period|Withdrawal by Subject|1|||
125416921|NCT03593655|451149827|FG000|Second Product Use Period|Lost to Follow-up|1|||
125416922|NCT03593655|451149828|FG001|Second Product Use Period|Lost to Follow-up|0|||
125416923|NCT03593655|451149827|FG000|Third Product Use Period|Lost to Follow-up|1|||
125416924|NCT03593655|451149828|FG001|Third Product Use Period|Lost to Follow-up|2|||
125416925|NCT03593655|451149827|FG000|Third Product Use Period|Physician Decision|0|||
125416926|NCT03593655|451149828|FG001|Third Product Use Period|Physician Decision|1|||
125416927|NCT03593655|451149827|FG000|Third Product Use Period|Withdrawal by Subject|0|||
125416928|NCT03593655|451149828|FG001|Third Product Use Period|Withdrawal by Subject|1|||
125416929|NCT03732209|451149831|FG000|Overall Study|Lost to Follow-up|4|||
125416930|NCT03732209|451149832|FG001|Overall Study|Lost to Follow-up|4|||
125416931|NCT03732209|451149831|FG000|Overall Study|Withdrawal by Subject|8|||
125416932|NCT03732209|451149832|FG001|Overall Study|Withdrawal by Subject|9|||
125416933|NCT05046795|451149833|FG000|Overall Study|Adverse Event|13|||
125416934|NCT05046795|451149834|FG001|Overall Study|Adverse Event|15|||
125416935|NCT05046795|451149833|FG000|Overall Study|Withdrawal by Subject|4|||
125416936|NCT05046795|451149834|FG001|Overall Study|Withdrawal by Subject|7|||
125416937|NCT05046795|451149833|FG000|Overall Study|Physician Decision|1|||
125416938|NCT05046795|451149834|FG001|Overall Study|Physician Decision|2|||
125449403|NCT01072929|451273083|FG002|Overall Study|Lack of Efficacy|0|||
125416939|NCT05046795|451149833|FG000|Overall Study|Protocol Violation|1|||
125416940|NCT05046795|451149834|FG001|Overall Study|Protocol Violation|2|||
125416941|NCT05046795|451149833|FG000|Overall Study|Death|1|||
125416942|NCT05046795|451149834|FG001|Overall Study|Death|0|||
125416943|NCT05046795|451149833|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
125416944|NCT05046795|451149834|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
125416945|NCT03759873|451149837|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
125416946|NCT03759873|451149838|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
125416947|NCT03759873|451149839|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
125416948|NCT03759873|451149840|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
125416949|NCT03759873|451149837|FG000|Overall Study|Moved outside eligible area|0|||
125416950|NCT03759873|451149838|FG001|Overall Study|Moved outside eligible area|2|||
125416951|NCT03759873|451149839|FG002|Overall Study|Moved outside eligible area|0|||
125416952|NCT03759873|451149840|FG003|Overall Study|Moved outside eligible area|0|||
125416953|NCT03759873|451149837|FG000|Overall Study|Withdrawal by Subject|0|||
125416954|NCT03759873|451149838|FG001|Overall Study|Withdrawal by Subject|0|||
125416955|NCT03759873|451149839|FG002|Overall Study|Withdrawal by Subject|1|||
125416956|NCT03759873|451149840|FG003|Overall Study|Withdrawal by Subject|0|||
125416957|NCT03579563|451149841|FG000|Overall Study|Lost to Follow-up|0|||
125416958|NCT03579563|451149842|FG001|Overall Study|Lost to Follow-up|0|||
125416959|NCT03579563|451149843|FG002|Overall Study|Lost to Follow-up|0|||
125416960|NCT03579563|451149844|FG003|Overall Study|Lost to Follow-up|0|||
125416961|NCT03579563|451149845|FG004|Overall Study|Lost to Follow-up|1|||
125416962|NCT03579563|451149846|FG005|Overall Study|Lost to Follow-up|0|||
125416963|NCT03579563|451149841|FG000|Overall Study|Lack of Efficacy|1|||
125416964|NCT03579563|451149842|FG001|Overall Study|Lack of Efficacy|1|||
125416965|NCT03579563|451149843|FG002|Overall Study|Lack of Efficacy|4|||
125416966|NCT03579563|451149844|FG003|Overall Study|Lack of Efficacy|1|||
125416967|NCT03579563|451149845|FG004|Overall Study|Lack of Efficacy|2|||
125416968|NCT03579563|451149846|FG005|Overall Study|Lack of Efficacy|3|||
125416969|NCT03579563|451149841|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
125416970|NCT03579563|451149842|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
125416971|NCT03579563|451149843|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
125416972|NCT03579563|451149844|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
125416973|NCT03579563|451149845|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
125416974|NCT03579563|451149846|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
125416975|NCT03579563|451149841|FG000|Overall Study|Time/distance concern|0|||
125416976|NCT03579563|451149842|FG001|Overall Study|Time/distance concern|0|||
125416977|NCT03579563|451149843|FG002|Overall Study|Time/distance concern|1|||
125416978|NCT03579563|451149844|FG003|Overall Study|Time/distance concern|0|||
125416979|NCT03579563|451149845|FG004|Overall Study|Time/distance concern|0|||
125416980|NCT03579563|451149846|FG005|Overall Study|Time/distance concern|1|||
125416981|NCT03579563|451149841|FG000|Overall Study|COVID shutdown|2|||
125416982|NCT03579563|451149842|FG001|Overall Study|COVID shutdown|3|||
125416983|NCT03579563|451149843|FG002|Overall Study|COVID shutdown|4|||
125416984|NCT03579563|451149844|FG003|Overall Study|COVID shutdown|3|||
125416985|NCT03579563|451149845|FG004|Overall Study|COVID shutdown|1|||
125416986|NCT03579563|451149846|FG005|Overall Study|COVID shutdown|2|||
125416987|NCT03579563|451149841|FG000|Overall Study|Protocol administration error|1|||
125416988|NCT03579563|451149842|FG001|Overall Study|Protocol administration error|0|||
125416989|NCT03579563|451149843|FG002|Overall Study|Protocol administration error|1|||
125416990|NCT03579563|451149844|FG003|Overall Study|Protocol administration error|0|||
125416991|NCT03579563|451149845|FG004|Overall Study|Protocol administration error|1|||
125416992|NCT03579563|451149846|FG005|Overall Study|Protocol administration error|5|||
125416993|NCT02647359|451149847|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
125416994|NCT02647359|451149848|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
125416995|NCT02647359|451149847|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
125416996|NCT02647359|451149848|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
125416997|NCT02647359|451149847|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
125416998|NCT02647359|451149848|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
125416999|NCT02647359|451149847|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
125417000|NCT02647359|451149848|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
125417001|NCT02647359|451149847|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
125449404|NCT01072929|451273081|FG000|Overall Study|Withdrawal by Subject|7|||
125449405|NCT01072929|451273082|FG001|Overall Study|Withdrawal by Subject|15|||
125417002|NCT02647359|451149848|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
125417003|NCT02647359|451149847|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
125417004|NCT02647359|451149848|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
125417005|NCT02513563|451149849|FG000|Overall Study|Death|4|||
125417006|NCT02513563|451149849|FG000|Overall Study|Withdrawal by Subject|4|||
125449406|NCT01072929|451273083|FG002|Overall Study|Withdrawal by Subject|3|||
125286369|NCT00075725|450674540|FG003|Overall Study|Protocol Violation|3|||
125417007|NCT02513563|451149849|FG000|Overall Study|Physician Decision|1|||
125417008|NCT01362140|451149853|FG000|Overall Study|Noncompliance|1|||
125417009|NCT01362140|451149854|FG001|Overall Study|Noncompliance|0|||
125417010|NCT01362140|451149853|FG000|Overall Study|Adverse Event|2|||
125417011|NCT01362140|451149854|FG001|Overall Study|Adverse Event|2|||
125417012|NCT01362140|451149853|FG000|Overall Study|Withdrawal by Subject|3|||
125417013|NCT01362140|451149854|FG001|Overall Study|Withdrawal by Subject|3|||
125417014|NCT01362140|451149853|FG000|Overall Study|Administrative Decision|0|||
125417015|NCT01362140|451149854|FG001|Overall Study|Administrative Decision|1|||
125417016|NCT01362140|451149853|FG000|Overall Study|Death|2|||
125417017|NCT01362140|451149854|FG001|Overall Study|Death|1|||
125417018|NCT01362140|451149853|FG000|Overall Study|Other|1|||
125417019|NCT01362140|451149854|FG001|Overall Study|Other|1|||
125417020|NCT01362140|451149853|FG000|Overall Study|Protocol-specified Criteria|1|||
125417021|NCT01362140|451149854|FG001|Overall Study|Protocol-specified Criteria|2|||
125417022|NCT01362140|451149853|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
125417023|NCT01362140|451149854|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
125417024|NCT06476366|451149856|FG000|Overall Study|Lost to Follow-up|1|||
125417025|NCT06476366|451149857|FG001|Overall Study|Lost to Follow-up|3|||
125417026|NCT06476366|451149856|FG000|Overall Study|Adverse Event|1|||
125417027|NCT06476366|451149857|FG001|Overall Study|Adverse Event|0|||
125417028|NCT01939028|451149860|FG000|Overall Study|Withdrawal by Subject|5|||
125417029|NCT01939028|451149860|FG000|Overall Study|Physician Decision|7|||
125417030|NCT00700401|451149867|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
125417031|NCT00700401|451149867|FG000|Overall Study|Adverse Event|5|||
125417032|NCT00700401|451149867|FG000|Overall Study|Refused Treatment|2|||
125417033|NCT00700401|451149867|FG000|Overall Study|Lost to Follow-up|1|||
125417034|NCT00700401|451149867|FG000|Overall Study|Treatment never started|1|||
125417035|NCT00700401|451149867|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
125417036|NCT00700401|451149867|FG000|Overall Study|Withdrawal by Subject|2|||
125417037|NCT01220557|451149869|FG000|Overall Study|Lost to Follow-up|5|||
125417038|NCT01220557|451149870|FG001|Overall Study|Lost to Follow-up|3|||
125417039|NCT01220557|451149869|FG000|Overall Study|attended less than 6 lessons|1|||
125417040|NCT01220557|451149870|FG001|Overall Study|attended less than 6 lessons|2|||
125417041|NCT01650259|451149871|FG000|Overall Study|Improvement|105|||
125417042|NCT01650259|451149872|FG001|Overall Study|Improvement|0|||
125417043|NCT01650259|451149871|FG000|Overall Study|Adverse Event|127|||
125417044|NCT01650259|451149872|FG001|Overall Study|Adverse Event|0|||
125417045|NCT01650259|451149871|FG000|Overall Study|Lack of Efficacy|143|||
125417046|NCT01650259|451149872|FG001|Overall Study|Lack of Efficacy|0|||
125417047|NCT01650259|451149871|FG000|Overall Study|Lost to Follow-up|435|||
125417048|NCT01650259|451149872|FG001|Overall Study|Lost to Follow-up|0|||
125417049|NCT01650259|451149871|FG000|Overall Study|Patients had no visit after entry|70|||
125417050|NCT01650259|451149872|FG001|Overall Study|Patients had no visit after entry|0|||
125417051|NCT01650259|451149871|FG000|Overall Study|CRF not collected|98|||
125417052|NCT01650259|451149872|FG001|Overall Study|CRF not collected|82|||
125417053|NCT01650259|451149871|FG000|Overall Study|Not treated|1|||
125417054|NCT01650259|451149872|FG001|Overall Study|Not treated|7|||
125417055|NCT01650259|451149871|FG000|Overall Study|Other than listed|64|||
125417056|NCT01650259|451149872|FG001|Overall Study|Other than listed|146|||
125417057|NCT00092131|451149873|FG000|Treatment Period I|Adverse Event|1|||
125417058|NCT00092131|451149874|FG001|Treatment Period I|Adverse Event|0|||
125417059|NCT00092131|451149873|FG000|Treatment Period II|Adverse Event|0|||
125449407|NCT01072929|451273081|FG000|Overall Study|Protocol Violation|13|||
125449408|NCT01072929|451273082|FG001|Overall Study|Protocol Violation|11|||
125449409|NCT01072929|451273083|FG002|Overall Study|Protocol Violation|2|||
125449410|NCT01072929|451273081|FG000|Overall Study|Lost to Follow-up|8|||
125449411|NCT01072929|451273082|FG001|Overall Study|Lost to Follow-up|4|||
125449412|NCT01072929|451273083|FG002|Overall Study|Lost to Follow-up|1|||
125417060|NCT00092131|451149874|FG001|Treatment Period II|Adverse Event|1|||
125417061|NCT03346759|451149890|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
125417062|NCT03346759|451149891|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
125417063|NCT03346759|451149890|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
125417064|NCT03346759|451149891|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
125449413|NCT01072929|451273081|FG000|Overall Study|Noncompliance with study medication|0|||
125417065|NCT03346759|451149890|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
125449414|NCT01072929|451273082|FG001|Overall Study|Noncompliance with study medication|3|||
125417066|NCT03346759|451149891|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
125449415|NCT01072929|451273083|FG002|Overall Study|Noncompliance with study medication|0|||
125449416|NCT01072929|451273081|FG000|Overall Study|Noncompliance with study procedures|1|||
125449417|NCT01072929|451273082|FG001|Overall Study|Noncompliance with study procedures|0|||
125417067|NCT03277313|451149892|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
125417068|NCT03277313|451149893|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
125449418|NCT01072929|451273083|FG002|Overall Study|Noncompliance with study procedures|1|||
125417069|NCT03277313|451149892|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
125417070|NCT03277313|451149893|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
125417071|NCT03277313|451149892|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
125286370|NCT00075725|450674541|FG004|Overall Study|Protocol Violation|3|||
125286371|NCT00075725|450674542|FG005|Overall Study|Protocol Violation|2|||
125286372|NCT00075725|450674543|FG006|Overall Study|Protocol Violation|1|||
125286373|NCT00075725|450674544|FG007|Overall Study|Protocol Violation|2|||
125286374|NCT00075725|450674545|FG008|Overall Study|Protocol Violation|3|||
125286375|NCT00075725|450674546|FG009|Overall Study|Protocol Violation|0|||
125286376|NCT00075725|450674547|FG010|Overall Study|Protocol Violation|0|||
125286377|NCT00075725|450674548|FG011|Overall Study|Protocol Violation|1|||
125286378|NCT00075725|450674537|FG000|Overall Study|Withdrawal by Subject|12|||
125286379|NCT00075725|450674538|FG001|Overall Study|Withdrawal by Subject|3|||
125286380|NCT00075725|450674539|FG002|Overall Study|Withdrawal by Subject|6|||
125286381|NCT00075725|450674540|FG003|Overall Study|Withdrawal by Subject|10|||
125286382|NCT00075725|450674541|FG004|Overall Study|Withdrawal by Subject|6|||
125286383|NCT00075725|450674542|FG005|Overall Study|Withdrawal by Subject|27|||
125286384|NCT00075725|450674543|FG006|Overall Study|Withdrawal by Subject|7|||
125286385|NCT00075725|450674544|FG007|Overall Study|Withdrawal by Subject|31|||
125286386|NCT00075725|450674545|FG008|Overall Study|Withdrawal by Subject|10|||
125286387|NCT00075725|450674546|FG009|Overall Study|Withdrawal by Subject|2|||
125286388|NCT00075725|450674547|FG010|Overall Study|Withdrawal by Subject|0|||
125286389|NCT00075725|450674548|FG011|Overall Study|Withdrawal by Subject|0|||
125286390|NCT00075725|450674537|FG000|Overall Study|Disease Progression, all other reasons|17|||
125286391|NCT00075725|450674538|FG001|Overall Study|Disease Progression, all other reasons|5|||
125286392|NCT00075725|450674539|FG002|Overall Study|Disease Progression, all other reasons|33|||
125286393|NCT00075725|450674540|FG003|Overall Study|Disease Progression, all other reasons|6|||
125286394|NCT00075725|450674541|FG004|Overall Study|Disease Progression, all other reasons|21|||
125286395|NCT00075725|450674542|FG005|Overall Study|Disease Progression, all other reasons|59|||
125286396|NCT00075725|450674543|FG006|Overall Study|Disease Progression, all other reasons|20|||
125286397|NCT00075725|450674544|FG007|Overall Study|Disease Progression, all other reasons|46|||
125286398|NCT00075725|450674545|FG008|Overall Study|Disease Progression, all other reasons|21|||
125286399|NCT00075725|450674546|FG009|Overall Study|Disease Progression, all other reasons|4|||
125286400|NCT00075725|450674547|FG010|Overall Study|Disease Progression, all other reasons|0|||
125286401|NCT00075725|450674548|FG011|Overall Study|Disease Progression, all other reasons|5|||
125286402|NCT00075725|450674537|FG000|Overall Study|Patient off treatment|0|||
125286403|NCT00075725|450674538|FG001|Overall Study|Patient off treatment|0|||
125286404|NCT00075725|450674539|FG002|Overall Study|Patient off treatment|1|||
125286405|NCT00075725|450674540|FG003|Overall Study|Patient off treatment|2|||
125286406|NCT00075725|450674541|FG004|Overall Study|Patient off treatment|1|||
125286407|NCT00075725|450674542|FG005|Overall Study|Patient off treatment|0|||
125286408|NCT00075725|450674543|FG006|Overall Study|Patient off treatment|0|||
125286409|NCT00075725|450674544|FG007|Overall Study|Patient off treatment|2|||
125286410|NCT00075725|450674545|FG008|Overall Study|Patient off treatment|1|||
125286411|NCT00075725|450674546|FG009|Overall Study|Patient off treatment|0|||
125286412|NCT00075725|450674547|FG010|Overall Study|Patient off treatment|0|||
125286413|NCT00075725|450674548|FG011|Overall Study|Patient off treatment|0|||
125286414|NCT00075725|450674537|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
125286415|NCT00075725|450674538|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
125286416|NCT00075725|450674539|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
125286417|NCT00075725|450674540|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
125286418|NCT00075725|450674541|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
125286419|NCT00075725|450674542|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
125286420|NCT00075725|450674543|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
125286421|NCT00075725|450674544|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
125286422|NCT00075725|450674545|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
125286423|NCT00075725|450674546|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
125286424|NCT00075725|450674547|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
125286425|NCT00075725|450674548|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
125286426|NCT00075725|450674537|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
125286427|NCT00075725|450674538|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
125286428|NCT00075725|450674539|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
125286429|NCT00075725|450674540|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
125286430|NCT00075725|450674541|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
125286431|NCT00075725|450674542|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
125286432|NCT00075725|450674543|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
125286433|NCT00075725|450674544|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
125417072|NCT03277313|451149893|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
125286434|NCT00075725|450674545|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
125286435|NCT00075725|450674546|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
125286436|NCT00075725|450674547|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
125286437|NCT00075725|450674548|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
125286438|NCT00075725|450674537|FG000|Overall Study|Pt non compliant with therapy|2|||
125417073|NCT03277313|451149892|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
125417074|NCT03277313|451149893|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
125417075|NCT03277313|451149892|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
125417076|NCT03277313|451149893|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
125417077|NCT02132611|451149896|FG000|Overall Study|Death|2|||
125417078|NCT02194621|451149897|FG000|Overall Study|6 withdrew prior to randomization|2|||
125417079|NCT02194621|451149898|FG001|Overall Study|6 withdrew prior to randomization|2|||
125417080|NCT02194621|451149899|FG002|Overall Study|6 withdrew prior to randomization|2|||
125417081|NCT02194621|451149897|FG000|Overall Study|Withdrawal by Subject|4|||
125417082|NCT02194621|451149898|FG001|Overall Study|Withdrawal by Subject|4|||
125417083|NCT02194621|451149899|FG002|Overall Study|Withdrawal by Subject|7|||
125417084|NCT02493127|451149907|FG000|Overall Study|Lost to Follow-up|1|||
125417085|NCT02493127|451149908|FG001|Overall Study|Lost to Follow-up|1|||
125417086|NCT02763384|451149909|FG000|Overall Study|Physician Decision|1|||
125417087|NCT02763384|451149909|FG000|Overall Study|Rapid decline - went on hospice|1|||
125417088|NCT02096900|451149911|FG000|Overall Study|Did not receive medication|3|||
125417089|NCT02096900|451149912|FG001|Overall Study|Did not receive medication|1|||
125417090|NCT02096900|451149911|FG000|Overall Study|Surgery cancelled- medication received|1|||
125417091|NCT02096900|451149912|FG001|Overall Study|Surgery cancelled- medication received|1|||
125417092|NCT03034577|451149913|FG000|Overall Study|Withdrawal by Subject|6|||
125417093|NCT03034577|451149914|FG001|Overall Study|Withdrawal by Subject|9|||
125417094|NCT03034577|451149913|FG000|Overall Study|Lost to Follow-up|25|||
125417095|NCT03034577|451149914|FG001|Overall Study|Lost to Follow-up|26|||
125417096|NCT04177758|451149917|FG000|Overall Study|Lost to Follow-up|19|||
125417097|NCT04177758|451149918|FG001|Overall Study|Lost to Follow-up|11|||
125417098|NCT03156023|451149929|FG000|Overall Study|Withdrawal by Subject|1|||
125417099|NCT03156023|451149930|FG001|Overall Study|Withdrawal by Subject|0|||
125417100|NCT03156023|451149931|FG002|Overall Study|Withdrawal by Subject|2|||
125417101|NCT03156023|451149932|FG003|Overall Study|Withdrawal by Subject|1|||
125417102|NCT03156023|451149933|FG004|Overall Study|Withdrawal by Subject|1|||
125417103|NCT03156023|451149929|FG000|Overall Study|Lost to Follow-up|0|||
125417104|NCT03156023|451149930|FG001|Overall Study|Lost to Follow-up|0|||
125417105|NCT03156023|451149931|FG002|Overall Study|Lost to Follow-up|0|||
125417106|NCT03156023|451149932|FG003|Overall Study|Lost to Follow-up|0|||
125417107|NCT03156023|451149933|FG004|Overall Study|Lost to Follow-up|1|||
125417108|NCT02010060|451149934|FG000|Overall Study|Lost to Follow-up|1|||
125417109|NCT02010060|451149935|FG001|Overall Study|Lost to Follow-up|2|||
125417110|NCT02010060|451149936|FG002|Overall Study|Lost to Follow-up|2|||
125417111|NCT02010060|451149934|FG000|Overall Study|Injury|0|||
125417112|NCT02010060|451149935|FG001|Overall Study|Injury|1|||
125417113|NCT02010060|451149936|FG002|Overall Study|Injury|0|||
125417114|NCT00726752|451149937|FG000|Overall Study|Lack of Efficacy|6|||
125417115|NCT00791765|451152067|FG000|Weeks 1 to 12|Adverse Event|0|||
125417116|NCT00791765|451152068|FG001|Weeks 1 to 12|Adverse Event|1|||
125417117|NCT00791765|451152067|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
125417118|NCT00791765|451152068|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
125417119|NCT00791765|451152067|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
125417120|NCT00791765|451152068|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
125417121|NCT00791765|451152067|FG000|Weeks 1 to 12|Physician Decision|1|||
125417122|NCT00791765|451152068|FG001|Weeks 1 to 12|Physician Decision|0|||
125417123|NCT00791765|451152067|FG000|Weeks 1 to 12|Disease progression|3|||
125417124|NCT00791765|451152068|FG001|Weeks 1 to 12|Disease progression|0|||
125417125|NCT00791765|451152067|FG000|Weeks 1 to 12|Ineligibility determined|0|||
125417126|NCT00791765|451152068|FG001|Weeks 1 to 12|Ineligibility determined|3|||
125417127|NCT00791765|451152067|FG000|Weeks 13 to 24|Protocol deviation|2|||
125417128|NCT00791765|451152068|FG001|Weeks 13 to 24|Protocol deviation|0|||
125417129|NCT00791765|451152067|FG000|Weeks 13 to 24|Adverse Event|0|||
125417130|NCT00791765|451152068|FG001|Weeks 13 to 24|Adverse Event|3|||
125417131|NCT00791765|451152067|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
125417132|NCT00791765|451152068|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
125417133|NCT00791765|451152067|FG000|Weeks 13 to 24|Disease progression|0|||
125417134|NCT00791765|451152068|FG001|Weeks 13 to 24|Disease progression|1|||
125417135|NCT00791765|451152067|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
125417136|NCT00791765|451152068|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
125417137|NCT00791765|451152067|FG000|Weeks 13 to 24|Other|0|||
125417138|NCT00791765|451152068|FG001|Weeks 13 to 24|Other|1|||
125417139|NCT01877408|451152077|FG000|Overall Study|Lost to Follow-up|0|||
125417140|NCT01877408|451152078|FG001|Overall Study|Lost to Follow-up|2|||
125417141|NCT00907153|451152086|FG000|Overall Study|Lost to Follow-up|1|||
125417142|NCT00907153|451152087|FG001|Overall Study|Lost to Follow-up|1|||
125417143|NCT00907153|451152086|FG000|Overall Study|Withdrawal by Subject|1|||
125417144|NCT00907153|451152087|FG001|Overall Study|Withdrawal by Subject|3|||
125417145|NCT04546581|451152088|FG000|Overall Study|Adverse Event|9|||
125417146|NCT04546581|451152089|FG001|Overall Study|Adverse Event|3|||
125449419|NCT01072929|451273081|FG000|Overall Study|Other|0|||
125417147|NCT04546581|451152088|FG000|Overall Study|Physician Decision|0|||
125417148|NCT04546581|451152089|FG001|Overall Study|Physician Decision|1|||
125417149|NCT04546581|451152088|FG000|Overall Study|Protocol Violation|1|||
125417150|NCT04546581|451152089|FG001|Overall Study|Protocol Violation|2|||
125417151|NCT04546581|451152088|FG000|Overall Study|Withdrawal by Subject|3|||
125417152|NCT04546581|451152089|FG001|Overall Study|Withdrawal by Subject|7|||
125417153|NCT01983293|451152090|FG000|Overall Study|Withdrawal by Subject|29|||
125417154|NCT01983293|451152091|FG001|Overall Study|Withdrawal by Subject|15|||
125417155|NCT01983293|451152090|FG000|Overall Study|Missing 12-month visit|3|||
125417156|NCT01983293|451152091|FG001|Overall Study|Missing 12-month visit|3|||
125417157|NCT01983293|451152090|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
125417158|NCT01983293|451152091|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
125417159|NCT01747772|451152092|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
125417160|NCT03147248|451152093|FG000|Overall Study|Adverse Event|0|||
125417161|NCT03147248|451152094|FG001|Overall Study|Adverse Event|2|||
125417162|NCT03147248|451152095|FG002|Overall Study|Adverse Event|2|||
125417163|NCT03147248|451152096|FG003|Overall Study|Adverse Event|2|||
125417164|NCT03147248|451152097|FG004|Overall Study|Adverse Event|6|||
125417165|NCT03147248|451152098|FG005|Overall Study|Adverse Event|11|||
125417166|NCT03147248|451152093|FG000|Overall Study|Disease progression|1|||
125417167|NCT03147248|451152094|FG001|Overall Study|Disease progression|0|||
125417168|NCT03147248|451152095|FG002|Overall Study|Disease progression|0|||
125417169|NCT03147248|451152096|FG003|Overall Study|Disease progression|0|||
125417170|NCT03147248|451152097|FG004|Overall Study|Disease progression|0|||
125417171|NCT03147248|451152098|FG005|Overall Study|Disease progression|2|||
125417172|NCT03147248|451152093|FG000|Overall Study|Withdrawal by Subject|0|||
125417173|NCT03147248|451152094|FG001|Overall Study|Withdrawal by Subject|0|||
125417174|NCT03147248|451152095|FG002|Overall Study|Withdrawal by Subject|0|||
125417175|NCT03147248|451152096|FG003|Overall Study|Withdrawal by Subject|0|||
125417176|NCT03147248|451152097|FG004|Overall Study|Withdrawal by Subject|12|||
125417177|NCT03147248|451152098|FG005|Overall Study|Withdrawal by Subject|9|||
125417178|NCT03147248|451152093|FG000|Overall Study|Protocol Violation|0|||
125417179|NCT03147248|451152094|FG001|Overall Study|Protocol Violation|0|||
125417180|NCT03147248|451152095|FG002|Overall Study|Protocol Violation|0|||
125417181|NCT03147248|451152096|FG003|Overall Study|Protocol Violation|0|||
125417182|NCT03147248|451152097|FG004|Overall Study|Protocol Violation|2|||
125417183|NCT03147248|451152098|FG005|Overall Study|Protocol Violation|0|||
125417184|NCT03147248|451152093|FG000|Overall Study|Lost to Follow-up|0|||
125417185|NCT03147248|451152094|FG001|Overall Study|Lost to Follow-up|0|||
125417186|NCT03147248|451152095|FG002|Overall Study|Lost to Follow-up|0|||
125417187|NCT03147248|451152096|FG003|Overall Study|Lost to Follow-up|0|||
125417188|NCT03147248|451152097|FG004|Overall Study|Lost to Follow-up|2|||
125417189|NCT03147248|451152098|FG005|Overall Study|Lost to Follow-up|0|||
125417190|NCT03147248|451152093|FG000|Overall Study|Pregnancy|0|||
125417191|NCT03147248|451152094|FG001|Overall Study|Pregnancy|0|||
125417192|NCT03147248|451152095|FG002|Overall Study|Pregnancy|0|||
125417193|NCT03147248|451152096|FG003|Overall Study|Pregnancy|0|||
125417194|NCT03147248|451152097|FG004|Overall Study|Pregnancy|1|||
125417195|NCT03147248|451152098|FG005|Overall Study|Pregnancy|0|||
125417196|NCT03147248|451152093|FG000|Overall Study|Death|0|||
125417197|NCT03147248|451152094|FG001|Overall Study|Death|0|||
125417198|NCT03147248|451152095|FG002|Overall Study|Death|0|||
125417199|NCT03147248|451152096|FG003|Overall Study|Death|0|||
125417200|NCT03147248|451152097|FG004|Overall Study|Death|0|||
125417201|NCT03147248|451152098|FG005|Overall Study|Death|4|||
125417202|NCT03147248|451152093|FG000|Overall Study|Physician Decision|0|||
125417203|NCT03147248|451152094|FG001|Overall Study|Physician Decision|0|||
125417204|NCT03147248|451152095|FG002|Overall Study|Physician Decision|0|||
125417205|NCT03147248|451152096|FG003|Overall Study|Physician Decision|0|||
125417206|NCT03147248|451152097|FG004|Overall Study|Physician Decision|2|||
125417207|NCT03147248|451152098|FG005|Overall Study|Physician Decision|4|||
125417208|NCT03147248|451152093|FG000|Overall Study|Prolonged Dosing Interval|0|||
125417209|NCT03147248|451152094|FG001|Overall Study|Prolonged Dosing Interval|0|||
125417210|NCT03147248|451152095|FG002|Overall Study|Prolonged Dosing Interval|0|||
125417211|NCT03147248|451152096|FG003|Overall Study|Prolonged Dosing Interval|0|||
125417212|NCT03147248|451152097|FG004|Overall Study|Prolonged Dosing Interval|1|||
125417213|NCT03147248|451152098|FG005|Overall Study|Prolonged Dosing Interval|1|||
125417214|NCT01944631|451152104|FG000|Overall Study|Adverse Event|1|||
125417215|NCT01944631|451152105|FG001|Overall Study|Adverse Event|0|||
125417216|NCT01944631|451152104|FG000|Overall Study|Lost to Follow-up|3|||
125417217|NCT01944631|451152105|FG001|Overall Study|Lost to Follow-up|1|||
125417218|NCT01944631|451152104|FG000|Overall Study|Withdrawal by Subject|0|||
125417219|NCT01944631|451152105|FG001|Overall Study|Withdrawal by Subject|1|||
125417220|NCT01412944|451152106|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
125417221|NCT01412944|451152107|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
125417222|NCT01412944|451152108|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
125417223|NCT01412944|451152109|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
125417224|NCT01412944|451152110|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
125417225|NCT01412944|451152111|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
125417226|NCT01412944|451152106|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
125417227|NCT01412944|451152107|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
125417228|NCT01412944|451152108|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
125417229|NCT01412944|451152109|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
125417230|NCT01412944|451152110|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
125417231|NCT01412944|451152111|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
125417232|NCT01412944|451152106|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
125417233|NCT01412944|451152107|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
125417234|NCT01412944|451152108|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
125417235|NCT01412944|451152109|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
125417236|NCT01412944|451152110|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
125417237|NCT01412944|451152111|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
125417238|NCT01412944|451152106|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
125417239|NCT01412944|451152107|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
125417240|NCT01412944|451152108|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
125417241|NCT01412944|451152109|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
125417242|NCT01412944|451152110|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
125417243|NCT01412944|451152111|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
125417244|NCT01412944|451152106|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
125417245|NCT01412944|451152107|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
125417246|NCT01412944|451152108|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
125417247|NCT01412944|451152109|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
125417248|NCT01412944|451152110|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
125417249|NCT01412944|451152111|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
125417250|NCT01412944|451152106|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
125417251|NCT01412944|451152107|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
125417252|NCT01412944|451152108|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
125417253|NCT01412944|451152109|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
125417254|NCT01412944|451152110|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
125417255|NCT01412944|451152111|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
125417256|NCT01412944|451152106|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
125417257|NCT01412944|451152107|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
125417258|NCT01412944|451152108|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
125417259|NCT01412944|451152109|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
125417260|NCT01412944|451152110|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
125417261|NCT01412944|451152111|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
125417262|NCT01412944|451152106|FG000|Entire: IV + Maintenance|Adverse Event|0|||
125417263|NCT01412944|451152107|FG001|Entire: IV + Maintenance|Adverse Event|0|||
125417264|NCT01412944|451152108|FG002|Entire: IV + Maintenance|Adverse Event|0|||
125417265|NCT01412944|451152109|FG003|Entire: IV + Maintenance|Adverse Event|0|||
125417266|NCT01412944|451152110|FG004|Entire: IV + Maintenance|Adverse Event|1|||
125417267|NCT01412944|451152111|FG005|Entire: IV + Maintenance|Adverse Event|0|||
125417268|NCT01412944|451152106|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
125417269|NCT01412944|451152107|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
125417270|NCT01412944|451152108|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
125417271|NCT01412944|451152109|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
125417272|NCT01412944|451152110|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
125417273|NCT01412944|451152111|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
125417274|NCT01412944|451152106|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
125417275|NCT01412944|451152107|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
125417276|NCT01412944|451152108|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
125417277|NCT01412944|451152109|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
125417278|NCT01412944|451152110|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
125417279|NCT01412944|451152111|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
125417280|NCT01412944|451152106|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
125417281|NCT01412944|451152107|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
125417282|NCT01412944|451152108|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
125417283|NCT01412944|451152109|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
125417284|NCT01412944|451152110|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
125417285|NCT01412944|451152111|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
125417286|NCT01412944|451152106|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
125417287|NCT01412944|451152107|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
125417288|NCT01412944|451152108|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
125417289|NCT01412944|451152109|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
125417290|NCT01412944|451152110|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
125417291|NCT01412944|451152111|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
125417292|NCT01412944|451152106|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
125417293|NCT01412944|451152107|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
125417294|NCT01412944|451152108|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
125417295|NCT01412944|451152109|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
125417296|NCT01412944|451152110|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
125417297|NCT01412944|451152111|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
125417298|NCT01412944|451152106|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
125417299|NCT01412944|451152107|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
125286439|NCT00075725|450674538|FG001|Overall Study|Pt non compliant with therapy|1|||
125286440|NCT00075725|450674539|FG002|Overall Study|Pt non compliant with therapy|1|||
125286441|NCT00075725|450674540|FG003|Overall Study|Pt non compliant with therapy|0|||
125286442|NCT00075725|450674541|FG004|Overall Study|Pt non compliant with therapy|2|||
125286443|NCT00075725|450674542|FG005|Overall Study|Pt non compliant with therapy|14|||
125286444|NCT00075725|450674543|FG006|Overall Study|Pt non compliant with therapy|2|||
125286445|NCT00075725|450674544|FG007|Overall Study|Pt non compliant with therapy|5|||
125286446|NCT00075725|450674545|FG008|Overall Study|Pt non compliant with therapy|3|||
125286447|NCT00075725|450674546|FG009|Overall Study|Pt non compliant with therapy|0|||
125286448|NCT00075725|450674547|FG010|Overall Study|Pt non compliant with therapy|0|||
125286449|NCT00075725|450674548|FG011|Overall Study|Pt non compliant with therapy|0|||
125286450|NCT00075725|450674537|FG000|Overall Study|Pt age out of range for treatment|0|||
125286451|NCT00075725|450674538|FG001|Overall Study|Pt age out of range for treatment|1|||
125286452|NCT00075725|450674539|FG002|Overall Study|Pt age out of range for treatment|0|||
125286453|NCT00075725|450674540|FG003|Overall Study|Pt age out of range for treatment|0|||
125286454|NCT00075725|450674541|FG004|Overall Study|Pt age out of range for treatment|0|||
125286455|NCT00075725|450674542|FG005|Overall Study|Pt age out of range for treatment|1|||
125286456|NCT00075725|450674543|FG006|Overall Study|Pt age out of range for treatment|0|||
125286457|NCT00075725|450674544|FG007|Overall Study|Pt age out of range for treatment|1|||
125286458|NCT00075725|450674545|FG008|Overall Study|Pt age out of range for treatment|0|||
125286459|NCT00075725|450674546|FG009|Overall Study|Pt age out of range for treatment|0|||
125286460|NCT00075725|450674547|FG010|Overall Study|Pt age out of range for treatment|0|||
125286461|NCT00075725|450674548|FG011|Overall Study|Pt age out of range for treatment|0|||
125286462|NCT00075725|450674537|FG000|Overall Study|Insurance issues|0|||
125286463|NCT00075725|450674538|FG001|Overall Study|Insurance issues|1|||
125286464|NCT00075725|450674539|FG002|Overall Study|Insurance issues|0|||
125286465|NCT00075725|450674540|FG003|Overall Study|Insurance issues|1|||
125286466|NCT00075725|450674541|FG004|Overall Study|Insurance issues|1|||
125286467|NCT00075725|450674542|FG005|Overall Study|Insurance issues|1|||
125286468|NCT00075725|450674543|FG006|Overall Study|Insurance issues|0|||
125286469|NCT00075725|450674544|FG007|Overall Study|Insurance issues|1|||
125286470|NCT00075725|450674545|FG008|Overall Study|Insurance issues|0|||
125286471|NCT00075725|450674546|FG009|Overall Study|Insurance issues|0|||
125286472|NCT00075725|450674547|FG010|Overall Study|Insurance issues|0|||
125286473|NCT00075725|450674548|FG011|Overall Study|Insurance issues|0|||
125286474|NCT00075725|450674537|FG000|Overall Study|MRD positive after extended ind|0|||
125286475|NCT00075725|450674538|FG001|Overall Study|MRD positive after extended ind|1|||
125286476|NCT00075725|450674539|FG002|Overall Study|MRD positive after extended ind|1|||
125286477|NCT00075725|450674540|FG003|Overall Study|MRD positive after extended ind|0|||
125286478|NCT00075725|450674541|FG004|Overall Study|MRD positive after extended ind|1|||
125286479|NCT00075725|450674542|FG005|Overall Study|MRD positive after extended ind|2|||
125286480|NCT00075725|450674543|FG006|Overall Study|MRD positive after extended ind|0|||
125286481|NCT00075725|450674544|FG007|Overall Study|MRD positive after extended ind|1|||
125286482|NCT00075725|450674545|FG008|Overall Study|MRD positive after extended ind|0|||
125286483|NCT00075725|450674546|FG009|Overall Study|MRD positive after extended ind|0|||
125286484|NCT00075725|450674547|FG010|Overall Study|MRD positive after extended ind|0|||
125286485|NCT00075725|450674548|FG011|Overall Study|MRD positive after extended ind|0|||
125286486|NCT00075725|450674537|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
125286487|NCT00075725|450674538|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
125286488|NCT00075725|450674539|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
125286489|NCT00075725|450674540|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
125286490|NCT00075725|450674541|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
125286491|NCT00075725|450674542|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
125286492|NCT00075725|450674543|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
125286493|NCT00075725|450674544|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
125286494|NCT00075725|450674545|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
125286495|NCT00075725|450674546|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
125286496|NCT00075725|450674547|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
125286497|NCT00075725|450674548|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
125286498|NCT00075725|450674537|FG000|Overall Study|Inevaluable|1|||
125286499|NCT00075725|450674538|FG001|Overall Study|Inevaluable|1|||
125286500|NCT00075725|450674539|FG002|Overall Study|Inevaluable|4|||
125286501|NCT00075725|450674540|FG003|Overall Study|Inevaluable|2|||
125286502|NCT00075725|450674541|FG004|Overall Study|Inevaluable|2|||
125286503|NCT00075725|450674542|FG005|Overall Study|Inevaluable|9|||
125286504|NCT00075725|450674543|FG006|Overall Study|Inevaluable|1|||
125286505|NCT00075725|450674544|FG007|Overall Study|Inevaluable|11|||
125286506|NCT00075725|450674545|FG008|Overall Study|Inevaluable|2|||
125286507|NCT00075725|450674546|FG009|Overall Study|Inevaluable|0|||
125286508|NCT00075725|450674547|FG010|Overall Study|Inevaluable|1|||
125286509|NCT00075725|450674548|FG011|Overall Study|Inevaluable|0|||
125286510|NCT00075725|450674537|FG000|Overall Study|Other|4|||
125286511|NCT00075725|450674538|FG001|Overall Study|Other|2|||
125286512|NCT00075725|450674539|FG002|Overall Study|Other|1|||
125417300|NCT01412944|451152108|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
125417301|NCT01412944|451152109|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
125417302|NCT01412944|451152110|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
125417303|NCT01412944|451152111|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
125417304|NCT01412944|451152106|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
125417305|NCT01412944|451152107|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
125417306|NCT01412944|451152108|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
125417307|NCT01412944|451152109|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
125417308|NCT01412944|451152110|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
125417309|NCT01412944|451152111|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
125417310|NCT01412944|451152106|FG000|Entire: IV + Maintenance|Adverse Event|0|||
125417311|NCT01412944|451152107|FG001|Entire: IV + Maintenance|Adverse Event|1|||
125417312|NCT01412944|451152108|FG002|Entire: IV + Maintenance|Adverse Event|0|||
125417313|NCT01412944|451152109|FG003|Entire: IV + Maintenance|Adverse Event|0|||
125417314|NCT01412944|451152110|FG004|Entire: IV + Maintenance|Adverse Event|0|||
125417315|NCT01412944|451152111|FG005|Entire: IV + Maintenance|Adverse Event|0|||
125417316|NCT01990950|451152112|FG000|Overall Study|Death|3|||
125417317|NCT01990950|451152112|FG000|Overall Study|Lost to Follow-up|2|||
125417318|NCT01990950|451152112|FG000|Overall Study|Withdrawal by Subject|6|||
125417319|NCT02388724|451152114|FG000|Overall Study|Reason not Specified|0|||
125417320|NCT02388724|451152115|FG001|Overall Study|Reason not Specified|1|||
125417321|NCT02388724|451152114|FG000|Overall Study|Major Protocol Deviation|3|||
125417322|NCT02388724|451152115|FG001|Overall Study|Major Protocol Deviation|3|||
125417323|NCT02388724|451152114|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
125417324|NCT02388724|451152115|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
125417325|NCT02388724|451152114|FG000|Overall Study|Voluntary Withdrawal|6|||
125417326|NCT02388724|451152115|FG001|Overall Study|Voluntary Withdrawal|5|||
125417327|NCT02388724|451152114|FG000|Overall Study|Randomized but not Treated|0|||
125417328|NCT02388724|451152115|FG001|Overall Study|Randomized but not Treated|2|||
125417329|NCT02605954|451152117|FG000|Overall Study|Adverse Event|5|||
125417330|NCT02605954|451152118|FG001|Overall Study|Adverse Event|1|||
125417331|NCT02605954|451152117|FG000|Overall Study|Investigator's Discretion|1|||
125417332|NCT02605954|451152118|FG001|Overall Study|Investigator's Discretion|0|||
125417333|NCT02605954|451152117|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125417334|NCT02605954|451152118|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125417335|NCT02605954|451152117|FG000|Overall Study|Withdrew Consent|2|||
125417336|NCT02605954|451152118|FG001|Overall Study|Withdrew Consent|2|||
125449420|NCT01072929|451273082|FG001|Overall Study|Other|3|||
125449421|NCT01072929|451273083|FG002|Overall Study|Other|0|||
125449422|NCT02929108|451273086|FG000|Overall Study|Hospice patient death|100|||
125449423|NCT02929108|451273087|FG001|Overall Study|Hospice patient death|64|||
125449424|NCT02929108|451273088|FG002|Overall Study|Hospice patient death|28|||
125449425|NCT02929108|451273089|FG003|Overall Study|Hospice patient death|46|||
125449426|NCT02929108|451273090|FG004|Overall Study|Hospice patient death|55|||
125417337|NCT02605954|451152117|FG000|Overall Study|Lost to Follow-up|3|||
125417338|NCT02605954|451152118|FG001|Overall Study|Lost to Follow-up|0|||
125417339|NCT02605954|451152117|FG000|Overall Study|Randomized but not treated|0|||
125417340|NCT02605954|451152118|FG001|Overall Study|Randomized but not treated|1|||
125417341|NCT00856856|451152122|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
125417342|NCT00856856|451152122|FG000|4-year Clinical Follow-up|Missed visit|1|||
125417343|NCT00922428|451152125|FG000|Overall Study|retrospective/extremely implausible data|2|||
125417344|NCT00922428|451152125|FG000|Overall Study|no medication use or questionable use|13|||
125417345|NCT02696317|451152126|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
125449427|NCT02929108|451273091|FG005|Overall Study|Hospice patient death|28|||
125449428|NCT02929108|451273092|FG006|Overall Study|Hospice patient death|78|||
125449429|NCT00052962|451273093|FG000|Overall Study|Not evaluable|0|||
125417346|NCT02696317|451152127|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
125417347|NCT02696317|451152126|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
125417348|NCT02696317|451152127|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
125417349|NCT01343368|451152128|FG000|Overall Study|Death|1|||
125417350|NCT01343368|451152129|FG001|Overall Study|Death|0|||
125417351|NCT01343368|451152128|FG000|Overall Study|Lost to Follow-up|1|||
125417352|NCT01343368|451152129|FG001|Overall Study|Lost to Follow-up|0|||
125417353|NCT00321854|451152130|FG000|Overall Study|Adverse Event|41|||
125417354|NCT00321854|451152131|FG001|Overall Study|Adverse Event|43|||
125417355|NCT00321854|451152130|FG000|Overall Study|Lack of Efficacy|9|||
125417356|NCT00321854|451152131|FG001|Overall Study|Lack of Efficacy|14|||
125417357|NCT00321854|451152130|FG000|Overall Study|Protocol Violation|6|||
125417358|NCT00321854|451152131|FG001|Overall Study|Protocol Violation|5|||
125449430|NCT00052962|451273094|FG001|Overall Study|Not evaluable|2|||
125417359|NCT00321854|451152130|FG000|Overall Study|Lost to Follow-up|0|||
125417360|NCT00321854|451152131|FG001|Overall Study|Lost to Follow-up|2|||
125417361|NCT00321854|451152130|FG000|Overall Study|Withdrawal by Subject|6|||
125449431|NCT00052962|451273093|FG000|Overall Study|Not randomized/not evaluable|1|||
125449432|NCT00052962|451273094|FG001|Overall Study|Not randomized/not evaluable|0|||
125449433|NCT01723774|451273098|FG000|Neoadjuvant|Ki67 > 10%|4|||
125417362|NCT00321854|451152131|FG001|Overall Study|Withdrawal by Subject|17|||
125417363|NCT00321854|451152130|FG000|Overall Study|Other|1|||
125417364|NCT00321854|451152131|FG001|Overall Study|Other|1|||
125417365|NCT00413153|451152132|FG000|Overall Study|Withdrawal by Subject|1|||
125417366|NCT00413153|451152133|FG001|Overall Study|Withdrawal by Subject|1|||
125417367|NCT00413153|451152132|FG000|Overall Study|Adverse Event|1|||
125417368|NCT00413153|451152133|FG001|Overall Study|Adverse Event|0|||
125417369|NCT03204279|451152134|FG000|Overall Study|Withdrawal by Subject|0|||
125417370|NCT03204279|451152135|FG001|Overall Study|Withdrawal by Subject|1|||
125417371|NCT02277106|451152136|FG000|Stage 2|Adverse Event|0|||
125417372|NCT02277106|451152137|FG001|Stage 2|Adverse Event|0|||
125417373|NCT02277106|451152138|FG002|Stage 2|Adverse Event|1|||
125417374|NCT04818346|451152139|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
125417375|NCT04818346|451152140|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
125417376|NCT04818346|451152141|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
125417377|NCT04818346|451152142|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
125417378|NCT04818346|451152139|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
125417379|NCT04818346|451152140|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
125417380|NCT04818346|451152141|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
125417381|NCT04818346|451152142|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
125417382|NCT04818346|451152139|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
125417383|NCT04818346|451152140|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
125417384|NCT04818346|451152141|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
125417385|NCT04818346|451152142|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
125417386|NCT04818346|451152139|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
125417387|NCT04818346|451152140|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
125417388|NCT04818346|451152141|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
125417389|NCT04818346|451152142|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
125417390|NCT04818346|451152139|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
125417391|NCT04818346|451152140|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
125417392|NCT04818346|451152141|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
125417393|NCT04818346|451152142|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
125417394|NCT04818346|451152139|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
125417395|NCT04818346|451152140|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
125417396|NCT04818346|451152141|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
125417397|NCT04818346|451152142|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
125417398|NCT04818346|451152139|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
125417399|NCT04818346|451152140|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
125417400|NCT04818346|451152141|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
125417401|NCT04818346|451152142|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
125417402|NCT04818346|451152139|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
125417403|NCT04818346|451152140|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
125417404|NCT04818346|451152141|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
125417405|NCT04818346|451152142|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
125417406|NCT04818346|451152139|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
125417407|NCT04818346|451152140|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
125417408|NCT04818346|451152141|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
125417409|NCT04818346|451152142|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
125417410|NCT04818346|451152139|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
125417411|NCT04818346|451152140|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
125417412|NCT04818346|451152141|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
125417413|NCT04818346|451152142|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
125417414|NCT04818346|451152139|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
125417415|NCT04818346|451152140|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
125417416|NCT04818346|451152141|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
125417417|NCT04818346|451152142|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
125417418|NCT04818346|451152139|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
125417419|NCT04818346|451152140|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
125417420|NCT04818346|451152141|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
125417421|NCT04818346|451152142|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
125417422|NCT04818346|451152139|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
125449434|NCT01723774|451273099|FG001|Neoadjuvant|Ki67 > 10%|0|||
125449435|NCT01723774|451273100|FG002|Neoadjuvant|Ki67 > 10%|10|||
125286513|NCT00075725|450674540|FG003|Overall Study|Other|1|||
125417423|NCT04818346|451152140|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
125417424|NCT04818346|451152141|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
125417425|NCT04818346|451152142|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
125417426|NCT04818346|451152139|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
125417427|NCT04818346|451152140|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
125417428|NCT04818346|451152141|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
125417429|NCT04818346|451152142|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
125417430|NCT04818346|451152139|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
125417431|NCT04818346|451152140|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
125417432|NCT04818346|451152141|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
125417433|NCT04818346|451152142|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
125417434|NCT03150056|451152143|FG000|Overall Study|Withdrawal by Subject|0|||
125417435|NCT03150056|451152144|FG001|Overall Study|Withdrawal by Subject|0|||
125417436|NCT03150056|451152145|FG002|Overall Study|Withdrawal by Subject|0|||
125417437|NCT03150056|451152146|FG003|Overall Study|Withdrawal by Subject|0|||
125417438|NCT03150056|451152147|FG004|Overall Study|Withdrawal by Subject|0|||
125417439|NCT03150056|451152148|FG005|Overall Study|Withdrawal by Subject|2|||
125417440|NCT03150056|451152143|FG000|Overall Study|Study terminated by Sponsor|1|||
125417441|NCT03150056|451152144|FG001|Overall Study|Study terminated by Sponsor|3|||
125417442|NCT03150056|451152145|FG002|Overall Study|Study terminated by Sponsor|1|||
125417443|NCT03150056|451152146|FG003|Overall Study|Study terminated by Sponsor|1|||
125417444|NCT03150056|451152147|FG004|Overall Study|Study terminated by Sponsor|5|||
125417445|NCT03150056|451152148|FG005|Overall Study|Study terminated by Sponsor|6|||
125417446|NCT03150056|451152143|FG000|Overall Study|Death|9|||
125417447|NCT03150056|451152144|FG001|Overall Study|Death|2|||
125417448|NCT03150056|451152145|FG002|Overall Study|Death|2|||
125417449|NCT03150056|451152146|FG003|Overall Study|Death|7|||
125417450|NCT03150056|451152147|FG004|Overall Study|Death|8|||
125417451|NCT03150056|451152148|FG005|Overall Study|Death|10|||
125417452|NCT00965523|451152149|FG000|Study 221|Progressive Disease|4|||
125417453|NCT00965523|451152149|FG000|Study 221|Physician Decision|3|||
125417454|NCT00965523|451152149|FG000|Study 224|Progressive Disease|5|||
125417455|NCT00965523|451152149|FG000|Study 224|Physician Decision|1|||
125417456|NCT01581281|451152151|FG000|Overall Study|Early Study Closure|15|||
125417457|NCT01581281|451152152|FG001|Overall Study|Early Study Closure|6|||
125417458|NCT01581281|451152153|FG002|Overall Study|Early Study Closure|12|||
125417459|NCT02187991|451152154|FG000|Overall Study|Adverse Event|13|||
125417460|NCT02187991|451152155|FG001|Overall Study|Adverse Event|14|||
125417461|NCT02187991|451152156|FG002|Overall Study|Adverse Event|3|||
125417462|NCT02187991|451152157|FG003|Overall Study|Adverse Event|2|||
125417463|NCT02187991|451152154|FG000|Overall Study|Withdrawal by Subject|9|||
125417464|NCT02187991|451152155|FG001|Overall Study|Withdrawal by Subject|6|||
125417465|NCT02187991|451152156|FG002|Overall Study|Withdrawal by Subject|3|||
125417466|NCT02187991|451152157|FG003|Overall Study|Withdrawal by Subject|2|||
125417467|NCT02187991|451152154|FG000|Overall Study|Physician Decision|4|||
125417468|NCT02187991|451152155|FG001|Overall Study|Physician Decision|4|||
125417469|NCT02187991|451152156|FG002|Overall Study|Physician Decision|0|||
125417470|NCT02187991|451152157|FG003|Overall Study|Physician Decision|2|||
125417471|NCT02187991|451152154|FG000|Overall Study|Other, unrelated complication|7|||
125417472|NCT02187991|451152155|FG001|Overall Study|Other, unrelated complication|1|||
125417473|NCT02187991|451152156|FG002|Overall Study|Other, unrelated complication|1|||
125417474|NCT02187991|451152157|FG003|Overall Study|Other, unrelated complication|2|||
125417475|NCT02187991|451152154|FG000|Overall Study|Death|1|||
125417476|NCT02187991|451152155|FG001|Overall Study|Death|3|||
125417477|NCT02187991|451152156|FG002|Overall Study|Death|0|||
125417478|NCT02187991|451152157|FG003|Overall Study|Death|0|||
125417479|NCT03273946|451152165|FG000|Overall Study|Withdrawal by Subject|5|||
125417480|NCT03273946|451152165|FG000|Overall Study|Unwillingness of the guardian|1|||
125417481|NCT03273946|451152165|FG000|Overall Study|Participant refused to use the drug|2|||
125417482|NCT03273946|451152165|FG000|Overall Study|Participant relative refused to use drug|1|||
125417483|NCT00522275|451152166|FG000|Overall Study|Adverse Event|35|||
125417484|NCT00522275|451152166|FG000|Overall Study|Lack of Efficacy|80|||
125417485|NCT00522275|451152166|FG000|Overall Study|Subject withdrew consent|16|||
125417486|NCT00522275|451152166|FG000|Overall Study|Protocol deviation|1|||
125417487|NCT00522275|451152166|FG000|Overall Study|Unsatisfactory compliance|11|||
125417488|NCT00522275|451152166|FG000|Overall Study|Lost to Follow-up|8|||
125417489|NCT00522275|451152166|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
125417490|NCT00522275|451152166|FG000|Overall Study|Other: Subject is pregnant|2|||
125417491|NCT00522275|451152166|FG000|Overall Study|Other: Subject relocated|2|||
125417492|NCT00522275|451152166|FG000|Overall Study|Other: Subject arrested|1|||
125417493|NCT00522275|451152166|FG000|Overall Study|Other: Site / clinic closed|4|||
125449436|NCT01723774|451273101|FG003|Neoadjuvant|Ki67 > 10%|0|||
125286514|NCT00075725|450674541|FG004|Overall Study|Other|1|||
125286515|NCT00075725|450674542|FG005|Overall Study|Other|4|||
125286516|NCT00075725|450674543|FG006|Overall Study|Other|2|||
125417494|NCT00522275|451152166|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
125417495|NCT00522275|451152166|FG000|Overall Study|Other: Sponsor request|2|||
125417496|NCT00522275|451152166|FG000|Overall Study|Other: Subject ran out of medication|1|||
125417497|NCT00522275|451152166|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
125417498|NCT02576067|451152167|FG000|Overall Study|Death|0|||
125417499|NCT02576067|451152168|FG001|Overall Study|Death|1|||
125417500|NCT02576067|451152167|FG000|Overall Study|Lack of Efficacy|1|||
125417501|NCT02576067|451152168|FG001|Overall Study|Lack of Efficacy|0|||
125417502|NCT02576067|451152167|FG000|Overall Study|Lost to Follow-up|11|||
125417503|NCT02576067|451152168|FG001|Overall Study|Lost to Follow-up|0|||
125417504|NCT02576067|451152167|FG000|Overall Study|Withdrawal by Subject|11|||
125417505|NCT02576067|451152168|FG001|Overall Study|Withdrawal by Subject|2|||
125417506|NCT02576067|451152167|FG000|Overall Study|study closure of main CIRT trial)|0|||
125417507|NCT02576067|451152168|FG001|Overall Study|study closure of main CIRT trial)|8|||
125417508|NCT02576067|451152167|FG000|Overall Study|not randomized, failed run-in|7|||
125417509|NCT02576067|451152168|FG001|Overall Study|not randomized, failed run-in|0|||
125417510|NCT02576067|451152167|FG000|Overall Study|screen failure/ re-enrolled|0|||
125417511|NCT02576067|451152168|FG001|Overall Study|screen failure/ re-enrolled|25|||
125417512|NCT02576067|451152167|FG000|Overall Study|Physician Decision|4|||
125417513|NCT02576067|451152168|FG001|Overall Study|Physician Decision|0|||
125417514|NCT04773587|451152169|FG000|Overall Study|Lost to Follow-up|11|||
125417515|NCT04773587|451152170|FG001|Overall Study|Lost to Follow-up|3|||
125417516|NCT04773587|451152169|FG000|Overall Study|Adverse Event|6|||
125417517|NCT04773587|451152170|FG001|Overall Study|Adverse Event|3|||
125417518|NCT04773587|451152169|FG000|Overall Study|Lack of Efficacy|5|||
125417519|NCT04773587|451152170|FG001|Overall Study|Lack of Efficacy|2|||
125417520|NCT04773587|451152169|FG000|Overall Study|Withdrawal by Subject|4|||
125417521|NCT04773587|451152170|FG001|Overall Study|Withdrawal by Subject|5|||
125417522|NCT04773587|451152169|FG000|Overall Study|Noncompliance|1|||
125417523|NCT04773587|451152170|FG001|Overall Study|Noncompliance|0|||
125417524|NCT04773587|451152169|FG000|Overall Study|Protocol Violation|1|||
125417525|NCT04773587|451152170|FG001|Overall Study|Protocol Violation|0|||
125417526|NCT04773587|451152169|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
125417527|NCT04773587|451152170|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
125417528|NCT02372409|451152171|FG000|Overall Study|Lost to Follow-up|1|||
125417529|NCT02372409|451152172|FG001|Overall Study|Lost to Follow-up|0|||
125417530|NCT02372409|451152171|FG000|Overall Study|Disease progression|1|||
125417531|NCT02372409|451152172|FG001|Overall Study|Disease progression|1|||
125417532|NCT01808313|451152173|FG000|Overall Study|Adverse Event|5|||
125417533|NCT01808313|451152173|FG000|Overall Study|Protocol Violation|2|||
125417534|NCT01808313|451152173|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125417535|NCT01808313|451152173|FG000|Overall Study|Lost to Follow-up|1|||
125417536|NCT01808313|451152173|FG000|Overall Study|Physician Decision|1|||
125417537|NCT00622167|451152175|FG000|Overall Study|Did not meet angiographic criteria|20|||
125417538|NCT04598152|451152177|FG000|Overall Study|Lost to Follow-up|0|||
125417539|NCT04598152|451152178|FG001|Overall Study|Lost to Follow-up|1|||
125417540|NCT01954017|451152179|FG000|Overall Study|Adverse Event|0|||
125417541|NCT01954017|451152180|FG001|Overall Study|Adverse Event|0|||
125417542|NCT01954017|451152181|FG002|Overall Study|Adverse Event|1|||
125417543|NCT01954017|451152179|FG000|Overall Study|Death|2|||
125417544|NCT01954017|451152180|FG001|Overall Study|Death|1|||
125417545|NCT01954017|451152181|FG002|Overall Study|Death|1|||
125417546|NCT01954017|451152179|FG000|Overall Study|Withdrawal by Subject|0|||
125417547|NCT01954017|451152180|FG001|Overall Study|Withdrawal by Subject|1|||
125417548|NCT01954017|451152181|FG002|Overall Study|Withdrawal by Subject|0|||
125417549|NCT01954017|451152179|FG000|Overall Study|Protocol Violation|0|||
125417550|NCT01954017|451152180|FG001|Overall Study|Protocol Violation|3|||
125417551|NCT01954017|451152181|FG002|Overall Study|Protocol Violation|2|||
125417552|NCT01954017|451152179|FG000|Overall Study|Necrotizing enterocolitis|1|||
125417553|NCT01954017|451152180|FG001|Overall Study|Necrotizing enterocolitis|0|||
125417554|NCT01954017|451152181|FG002|Overall Study|Necrotizing enterocolitis|1|||
125417555|NCT01954017|451152179|FG000|Overall Study|Enteral intake stopped >7 days|0|||
125417556|NCT01954017|451152180|FG001|Overall Study|Enteral intake stopped >7 days|1|||
125417557|NCT01954017|451152181|FG002|Overall Study|Enteral intake stopped >7 days|1|||
125417558|NCT01954017|451152179|FG000|Overall Study|All other reasons|2|||
125417559|NCT01954017|451152180|FG001|Overall Study|All other reasons|2|||
125417560|NCT01954017|451152181|FG002|Overall Study|All other reasons|7|||
125417561|NCT03674177|451152189|FG000|Overall Study|Lost to Follow-up|2|||
125417562|NCT03674177|451152190|FG001|Overall Study|Lost to Follow-up|1|||
125417563|NCT03674177|451152191|FG002|Overall Study|Lost to Follow-up|0|||
125417564|NCT03674177|451152192|FG003|Overall Study|Lost to Follow-up|2|||
125417565|NCT00714168|451152193|FG000|Overall Study|Pregnancy|5|||
125417566|NCT00714168|451152194|FG001|Overall Study|Pregnancy|4|||
125417567|NCT00714168|451152193|FG000|Overall Study|Lost to Follow-up|32|||
125417568|NCT00714168|451152194|FG001|Overall Study|Lost to Follow-up|50|||
125417569|NCT00714168|451152193|FG000|Overall Study|Relocation|4|||
125417570|NCT00714168|451152194|FG001|Overall Study|Relocation|3|||
125449437|NCT01723774|451273098|FG000|Neoadjuvant|Withdrawal by Subject|3|||
125417571|NCT00714168|451152193|FG000|Overall Study|Non-study medical condition|3|||
125417572|NCT00714168|451152194|FG001|Overall Study|Non-study medical condition|2|||
125417573|NCT00722761|451152195|FG000|Overall Study|Lost to Follow-up|1|||
125417574|NCT00722761|451152196|FG001|Overall Study|Lost to Follow-up|4|||
125417575|NCT00722761|451152195|FG000|Overall Study|Withdrawal by Subject|5|||
125417576|NCT00722761|451152196|FG001|Overall Study|Withdrawal by Subject|2|||
125417577|NCT05819749|451152198|FG000|Overall Study|Lost to Follow-up|1|||
125417578|NCT00377234|451153817|FG000|Overall Study|Adverse Event|14|||
125417579|NCT00377234|451153818|FG001|Overall Study|Adverse Event|17|||
125417580|NCT00377234|451153817|FG000|Overall Study|Withdrawal by Subject|11|||
125417581|NCT00377234|451153818|FG001|Overall Study|Withdrawal by Subject|9|||
125417582|NCT00377234|451153817|FG000|Overall Study|Lost to Follow-up|4|||
125417583|NCT00377234|451153818|FG001|Overall Study|Lost to Follow-up|2|||
125417584|NCT00377234|451153817|FG000|Overall Study|Administrative|2|||
125417585|NCT00377234|451153818|FG001|Overall Study|Administrative|1|||
125417586|NCT00377234|451153817|FG000|Overall Study|Not assigned|3|||
125417587|NCT00377234|451153818|FG001|Overall Study|Not assigned|2|||
125417588|NCT01880424|451153819|FG000|Overall Study|Adverse Event|7|||
125417589|NCT01880424|451153820|FG001|Overall Study|Adverse Event|6|||
125417590|NCT01880424|451153819|FG000|Overall Study|Lack of Efficacy|1|||
125417591|NCT01880424|451153820|FG001|Overall Study|Lack of Efficacy|4|||
125417592|NCT01880424|451153819|FG000|Overall Study|Lost to Follow-up|3|||
125417593|NCT01880424|451153820|FG001|Overall Study|Lost to Follow-up|2|||
125417594|NCT01880424|451153819|FG000|Overall Study|Protocol Violation|11|||
125417595|NCT01880424|451153820|FG001|Overall Study|Protocol Violation|13|||
125417596|NCT01880424|451153819|FG000|Overall Study|Withdrawal by Subject|10|||
125417597|NCT01880424|451153820|FG001|Overall Study|Withdrawal by Subject|30|||
125417598|NCT01880424|451153819|FG000|Overall Study|Other|1|||
125417599|NCT01880424|451153820|FG001|Overall Study|Other|0|||
125417600|NCT00448539|451153825|FG000|Overall Study|Medication non-compliance|4|||
125417601|NCT00448539|451153826|FG001|Overall Study|Medication non-compliance|1|||
125417602|NCT00448539|451153825|FG000|Overall Study|Protocol Violation|1|||
125417603|NCT00448539|451153826|FG001|Overall Study|Protocol Violation|0|||
125417604|NCT00448539|451153825|FG000|Overall Study|Request of the investigator or sponsor|67|||
125417605|NCT00448539|451153826|FG001|Overall Study|Request of the investigator or sponsor|54|||
125417606|NCT00448539|451153825|FG000|Overall Study|Withdrawal by Subject|20|||
125417607|NCT00448539|451153826|FG001|Overall Study|Withdrawal by Subject|24|||
125417608|NCT00448539|451153825|FG000|Overall Study|Diary non-compliance|1|||
125417609|NCT00448539|451153826|FG001|Overall Study|Diary non-compliance|0|||
125417610|NCT00448539|451153825|FG000|Overall Study|Adverse Event|9|||
125417611|NCT00448539|451153826|FG001|Overall Study|Adverse Event|26|||
125417612|NCT00448539|451153825|FG000|Overall Study|Lack of Efficacy|27|||
125417613|NCT00448539|451153826|FG001|Overall Study|Lack of Efficacy|40|||
125417614|NCT00448539|451153825|FG000|Overall Study|Miscellaneous|2|||
125417615|NCT00448539|451153826|FG001|Overall Study|Miscellaneous|1|||
125417616|NCT00448539|451153825|FG000|Overall Study|Change of meds|2|||
125417617|NCT00448539|451153826|FG001|Overall Study|Change of meds|3|||
125417618|NCT00448539|451153825|FG000|Overall Study|Lost to Follow-up|1|||
125417619|NCT00448539|451153826|FG001|Overall Study|Lost to Follow-up|3|||
125417620|NCT02103439|451153827|FG000|Overall Study|Adverse Event|0|||
125417621|NCT02103439|451153828|FG001|Overall Study|Adverse Event|2|||
125417622|NCT02103439|451153827|FG000|Overall Study|Withdrawal by Subject|3|||
125417623|NCT02103439|451153828|FG001|Overall Study|Withdrawal by Subject|1|||
125417624|NCT04955639|451153830|FG000|Overall Study|Withdrawal by Subject|2|||
125417625|NCT04955639|451153831|FG001|Overall Study|Withdrawal by Subject|2|||
125417626|NCT04955639|451153830|FG000|Overall Study|Week 26 survey not completed|2|||
125417627|NCT04955639|451153831|FG001|Overall Study|Week 26 survey not completed|2|||
125417628|NCT04447404|451153832|FG000|Overall Study|Death|2|||
125417629|NCT04447404|451153833|FG001|Overall Study|Death|0|||
125417630|NCT01369342|451153834|FG000|Overall Study|Withdrawal by Subject|7|||
125417631|NCT01369342|451153835|FG001|Overall Study|Withdrawal by Subject|7|||
125417632|NCT01369342|451153836|FG002|Overall Study|Withdrawal by Subject|2|||
125417633|NCT01369342|451153834|FG000|Overall Study|Lost to Follow-up|5|||
125417634|NCT01369342|451153835|FG001|Overall Study|Lost to Follow-up|2|||
125417635|NCT01369342|451153836|FG002|Overall Study|Lost to Follow-up|1|||
125417636|NCT01369342|451153834|FG000|Overall Study|Not Treated|1|||
125417637|NCT01369342|451153835|FG001|Overall Study|Not Treated|0|||
125417638|NCT01369342|451153836|FG002|Overall Study|Not Treated|0|||
125417639|NCT01816594|451153837|FG000|Overall Study|Local Progress|0|||
125417640|NCT01816594|451153838|FG001|Overall Study|Local Progress|2|||
125417641|NCT01816594|451153837|FG000|Overall Study|Adverse Event|9|||
125417642|NCT01816594|451153838|FG001|Overall Study|Adverse Event|0|||
125417643|NCT01816594|451153837|FG000|Overall Study|Withdrawal by Subject|1|||
125417644|NCT01816594|451153838|FG001|Overall Study|Withdrawal by Subject|0|||
125417645|NCT01816594|451153837|FG000|Overall Study|Physician Decision|1|||
125417646|NCT01816594|451153838|FG001|Overall Study|Physician Decision|0|||
125417647|NCT03905655|451153839|FG000|Overall Study|Adverse Event|1|||
125417648|NCT03905655|451153840|FG001|Overall Study|Adverse Event|0|||
125417649|NCT03905655|451153841|FG002|Overall Study|Adverse Event|1|||
125286517|NCT00075725|450674544|FG007|Overall Study|Other|9|||
125286518|NCT00075725|450674545|FG008|Overall Study|Other|2|||
125286519|NCT00075725|450674546|FG009|Overall Study|Other|1|||
125286520|NCT00075725|450674547|FG010|Overall Study|Other|0|||
125286521|NCT00075725|450674548|FG011|Overall Study|Other|3|||
125286522|NCT00075725|450674537|FG000|Overall Study|Pt trying to find a BM donor|0|||
125286523|NCT00075725|450674538|FG001|Overall Study|Pt trying to find a BM donor|1|||
125286524|NCT00075725|450674539|FG002|Overall Study|Pt trying to find a BM donor|0|||
125286525|NCT00075725|450674540|FG003|Overall Study|Pt trying to find a BM donor|0|||
125286526|NCT00075725|450674541|FG004|Overall Study|Pt trying to find a BM donor|0|||
125286527|NCT00075725|450674542|FG005|Overall Study|Pt trying to find a BM donor|0|||
125286528|NCT00075725|450674543|FG006|Overall Study|Pt trying to find a BM donor|0|||
125286529|NCT00075725|450674544|FG007|Overall Study|Pt trying to find a BM donor|0|||
125286530|NCT00075725|450674545|FG008|Overall Study|Pt trying to find a BM donor|0|||
125286531|NCT00075725|450674546|FG009|Overall Study|Pt trying to find a BM donor|0|||
125286532|NCT00075725|450674547|FG010|Overall Study|Pt trying to find a BM donor|0|||
125286533|NCT00075725|450674548|FG011|Overall Study|Pt trying to find a BM donor|0|||
125286534|NCT00075725|450674537|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
125286535|NCT00075725|450674538|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
125286536|NCT00075725|450674539|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
125286537|NCT00075725|450674540|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
125286538|NCT00075725|450674541|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
125286539|NCT00075725|450674542|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
125286540|NCT00075725|450674543|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
125286541|NCT00075725|450674544|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
125286542|NCT00075725|450674545|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
125286543|NCT00075725|450674546|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
125286544|NCT00075725|450674547|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
125286545|NCT00075725|450674548|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
125286546|NCT00075725|450674537|FG000|Overall Study|Unsuccessful institutional transfer|0|||
125286547|NCT00075725|450674538|FG001|Overall Study|Unsuccessful institutional transfer|0|||
125286548|NCT00075725|450674539|FG002|Overall Study|Unsuccessful institutional transfer|2|||
125286549|NCT00075725|450674540|FG003|Overall Study|Unsuccessful institutional transfer|0|||
125286550|NCT00075725|450674541|FG004|Overall Study|Unsuccessful institutional transfer|0|||
125286551|NCT00075725|450674542|FG005|Overall Study|Unsuccessful institutional transfer|0|||
125286552|NCT00075725|450674543|FG006|Overall Study|Unsuccessful institutional transfer|0|||
125286553|NCT00075725|450674544|FG007|Overall Study|Unsuccessful institutional transfer|0|||
125286554|NCT00075725|450674545|FG008|Overall Study|Unsuccessful institutional transfer|0|||
125286555|NCT00075725|450674546|FG009|Overall Study|Unsuccessful institutional transfer|1|||
125286556|NCT00075725|450674547|FG010|Overall Study|Unsuccessful institutional transfer|0|||
125286557|NCT00075725|450674548|FG011|Overall Study|Unsuccessful institutional transfer|0|||
125286558|NCT00075725|450674537|FG000|Overall Study|specimen(s) not submitted|0|||
125286559|NCT00075725|450674538|FG001|Overall Study|specimen(s) not submitted|0|||
125286560|NCT00075725|450674539|FG002|Overall Study|specimen(s) not submitted|2|||
125286561|NCT00075725|450674540|FG003|Overall Study|specimen(s) not submitted|0|||
125286562|NCT00075725|450674541|FG004|Overall Study|specimen(s) not submitted|0|||
125286563|NCT00075725|450674542|FG005|Overall Study|specimen(s) not submitted|0|||
125286564|NCT00075725|450674543|FG006|Overall Study|specimen(s) not submitted|0|||
125286565|NCT00075725|450674544|FG007|Overall Study|specimen(s) not submitted|0|||
125286566|NCT00075725|450674545|FG008|Overall Study|specimen(s) not submitted|0|||
125286567|NCT00075725|450674546|FG009|Overall Study|specimen(s) not submitted|0|||
125286568|NCT00075725|450674547|FG010|Overall Study|specimen(s) not submitted|0|||
125286569|NCT00075725|450674548|FG011|Overall Study|specimen(s) not submitted|0|||
125286570|NCT00075725|450674537|FG000|Overall Study|Pt went to transplant|0|||
125286571|NCT00075725|450674538|FG001|Overall Study|Pt went to transplant|0|||
125286572|NCT00075725|450674539|FG002|Overall Study|Pt went to transplant|0|||
125286573|NCT00075725|450674540|FG003|Overall Study|Pt went to transplant|1|||
125286574|NCT00075725|450674541|FG004|Overall Study|Pt went to transplant|0|||
125286575|NCT00075725|450674542|FG005|Overall Study|Pt went to transplant|1|||
125286576|NCT00075725|450674543|FG006|Overall Study|Pt went to transplant|0|||
125286577|NCT00075725|450674544|FG007|Overall Study|Pt went to transplant|0|||
125286578|NCT00075725|450674545|FG008|Overall Study|Pt went to transplant|0|||
125286579|NCT00075725|450674546|FG009|Overall Study|Pt went to transplant|0|||
125286580|NCT00075725|450674547|FG010|Overall Study|Pt went to transplant|0|||
125286581|NCT00075725|450674548|FG011|Overall Study|Pt went to transplant|0|||
125286582|NCT00075725|450674537|FG000|Overall Study|Pt received additional steroids|0|||
125286583|NCT00075725|450674538|FG001|Overall Study|Pt received additional steroids|0|||
125286584|NCT00075725|450674539|FG002|Overall Study|Pt received additional steroids|0|||
125286585|NCT00075725|450674540|FG003|Overall Study|Pt received additional steroids|1|||
125286586|NCT00075725|450674541|FG004|Overall Study|Pt received additional steroids|0|||
125286587|NCT00075725|450674542|FG005|Overall Study|Pt received additional steroids|0|||
125286588|NCT00075725|450674543|FG006|Overall Study|Pt received additional steroids|0|||
125417650|NCT03905655|451153842|FG003|Overall Study|Adverse Event|1|||
125417651|NCT01064739|451153843|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
125417652|NCT01669629|451153847|FG000|Period 1|protocol deviation|1|||
125417653|NCT01669629|451153848|FG001|Period 1|protocol deviation|2|||
125417654|NCT01221597|451153849|FG000|Overall Study|Adverse Event|4|||
125417655|NCT01221597|451153850|FG001|Overall Study|Adverse Event|1|||
125417656|NCT01221597|451153849|FG000|Overall Study|Withdrawal by Subject|20|||
125417657|NCT01221597|451153850|FG001|Overall Study|Withdrawal by Subject|6|||
125417658|NCT01221597|451153849|FG000|Overall Study|Lost to Follow-up|6|||
125417659|NCT01221597|451153850|FG001|Overall Study|Lost to Follow-up|5|||
125417660|NCT01221597|451153849|FG000|Overall Study|Protocol Violation|1|||
125417661|NCT01221597|451153850|FG001|Overall Study|Protocol Violation|0|||
125417662|NCT01221597|451153849|FG000|Overall Study|Other|3|||
125417663|NCT01221597|451153850|FG001|Overall Study|Other|4|||
125417664|NCT01221597|451153849|FG000|Overall Study|Death|2|||
125417665|NCT01221597|451153850|FG001|Overall Study|Death|0|||
125417666|NCT03667053|451153852|FG000|Overall Study|Withdrawal by Subject|1|||
125417667|NCT03667053|451153853|FG001|Overall Study|Withdrawal by Subject|0|||
125417668|NCT03667053|451153854|FG002|Overall Study|Withdrawal by Subject|0|||
125417669|NCT00487162|451153856|FG000|Overall Study|Adverse Event|0|||
125417670|NCT00487162|451153857|FG001|Overall Study|Adverse Event|1|||
125417671|NCT00487162|451153856|FG000|Overall Study|Physician Decision|0|||
125417672|NCT00487162|451153857|FG001|Overall Study|Physician Decision|1|||
125417673|NCT00487162|451153856|FG000|Overall Study|Withdrawal by Subject|2|||
125417674|NCT00487162|451153857|FG001|Overall Study|Withdrawal by Subject|3|||
125417675|NCT02278328|451153858|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
125417676|NCT02278328|451153859|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
125417677|NCT02278328|451153860|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
125417678|NCT02278328|451153858|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
125417679|NCT02278328|451153859|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
125417680|NCT02278328|451153860|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
125417681|NCT02278328|451153858|FG000|Neuropsych Screening|incomplete consent|0|||
125417682|NCT02278328|451153859|FG001|Neuropsych Screening|incomplete consent|0|||
125417683|NCT02278328|451153860|FG002|Neuropsych Screening|incomplete consent|2|||
125417684|NCT03834779|451153866|FG000|Overall Study|Death|1|||
125417685|NCT03834779|451153867|FG001|Overall Study|Death|2|||
125417686|NCT03834779|451153866|FG000|Overall Study|Lost to Follow-up|6|||
125417687|NCT03834779|451153867|FG001|Overall Study|Lost to Follow-up|4|||
125417688|NCT01292928|451153868|FG000|Overall Study|Death|8|||
125417689|NCT01292928|451153868|FG000|Overall Study|Withdrawal by Subject|8|||
125417690|NCT01292928|451153868|FG000|Overall Study|Lost to Follow-up|6|||
125417691|NCT01292928|451153868|FG000|Overall Study|Physician Decision|2|||
125417692|NCT00130533|451153869|FG000|Overall Study|Withdrawal by Subject|33|||
125417693|NCT00130533|451153870|FG001|Overall Study|Withdrawal by Subject|6|||
125417694|NCT00130533|451153869|FG000|Overall Study|Adverse Event|34|||
125417695|NCT00130533|451153870|FG001|Overall Study|Adverse Event|1|||
125417696|NCT00130533|451153869|FG000|Overall Study|Disease relapse|9|||
125417697|NCT00130533|451153870|FG001|Overall Study|Disease relapse|13|||
125417698|NCT00130533|451153869|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
125417699|NCT00130533|451153870|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
125417700|NCT00130533|451153869|FG000|Overall Study|Death|4|||
125417701|NCT00130533|451153870|FG001|Overall Study|Death|2|||
125417702|NCT00130533|451153869|FG000|Overall Study|Protocol Violation|5|||
125417703|NCT00130533|451153870|FG001|Overall Study|Protocol Violation|1|||
125417704|NCT00130533|451153869|FG000|Overall Study|Lost to Follow-up|1|||
125417705|NCT00130533|451153870|FG001|Overall Study|Lost to Follow-up|1|||
125417706|NCT00130533|451153869|FG000|Overall Study|Sponsor´s decision|2|||
125417707|NCT00130533|451153870|FG001|Overall Study|Sponsor´s decision|0|||
125417708|NCT00130533|451153869|FG000|Overall Study|Second Primary Malignancy|0|||
125417709|NCT00130533|451153870|FG001|Overall Study|Second Primary Malignancy|1|||
125417710|NCT00130533|451153869|FG000|Overall Study|Other|12|||
125417711|NCT00130533|451153870|FG001|Overall Study|Other|5|||
125417712|NCT01059565|451153871|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
125417713|NCT01059565|451153872|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
125417714|NCT01059565|451153871|FG000|24-Week Randomized Phase|Adverse Event|5|||
125417715|NCT01059565|451153872|FG001|24-Week Randomized Phase|Adverse Event|0|||
125417716|NCT01059565|451153871|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
125417717|NCT01059565|451153872|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
125417718|NCT01059565|451153871|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
125417719|NCT01059565|451153872|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
125417720|NCT01059565|451153871|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
125417721|NCT01059565|451153872|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
125417722|NCT01059565|451153871|FG000|24-Week Open-Label Phase|Adverse Event|2|||
125417723|NCT01059565|451153872|FG001|24-Week Open-Label Phase|Adverse Event|0|||
125417724|NCT01059565|451153871|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
125417725|NCT01059565|451153872|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
125417726|NCT01059565|451153871|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
125417727|NCT01059565|451153872|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
125417728|NCT01059565|451153871|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
125417729|NCT01059565|451153872|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
125417730|NCT01059565|451153871|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
125417731|NCT01059565|451153872|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
125417732|NCT01059565|451153871|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
125417733|NCT01059565|451153872|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
125417734|NCT03263429|451153873|FG000|Overall Study|Withdrawal by Subject|0|||
125417735|NCT03263429|451153874|FG001|Overall Study|Withdrawal by Subject|1|||
125417736|NCT03263429|451153875|FG002|Overall Study|Withdrawal by Subject|0|||
125417737|NCT03263429|451153873|FG000|Overall Study|Follow-Up Period Completed|0|||
125417738|NCT03263429|451153874|FG001|Overall Study|Follow-Up Period Completed|2|||
125417739|NCT03263429|451153875|FG002|Overall Study|Follow-Up Period Completed|0|||
125417740|NCT03263429|451153873|FG000|Overall Study|Death|3|||
125417741|NCT03263429|451153874|FG001|Overall Study|Death|5|||
125417742|NCT03263429|451153875|FG002|Overall Study|Death|16|||
125417743|NCT03263429|451153873|FG000|Overall Study|Participant unable to return|0|||
125417744|NCT03263429|451153874|FG001|Overall Study|Participant unable to return|0|||
125417745|NCT03263429|451153875|FG002|Overall Study|Participant unable to return|1|||
125417746|NCT03263429|451153873|FG000|Overall Study|Study Closed|0|||
125417747|NCT03263429|451153874|FG001|Overall Study|Study Closed|0|||
125417748|NCT03263429|451153875|FG002|Overall Study|Study Closed|1|||
125417749|NCT01605617|451153876|FG000|First Intervention|Adverse Event|0|||
125417750|NCT01605617|451153877|FG001|First Intervention|Adverse Event|1|||
125417751|NCT01605617|451153876|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
125417752|NCT01605617|451153877|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
125417753|NCT01314118|451153883|FG000|Overall Study|Adverse Event|9|||
125417754|NCT01314118|451153883|FG000|Overall Study|Progressive disease|27|||
125417755|NCT01314118|451153883|FG000|Overall Study|Physician Decision|11|||
125417756|NCT01314118|451153883|FG000|Overall Study|Death|4|||
125417757|NCT01314118|451153883|FG000|Overall Study|Protocol Violation|5|||
125417758|NCT01314118|451153883|FG000|Overall Study|Withdrawal by Subject|11|||
125417759|NCT01314118|451153883|FG000|Overall Study|Other|2|||
125417760|NCT01314118|451153883|FG000|Overall Study|Ongoing|62|||
125417761|NCT05545072|451153889|FG000|Overall Study|Lost to Follow-up|1|||
125417762|NCT05545072|451153890|FG001|Overall Study|Lost to Follow-up|0|||
125417763|NCT05545072|451153889|FG000|Overall Study|Study ended prematurely due to funding|2|||
125417764|NCT05545072|451153890|FG001|Overall Study|Study ended prematurely due to funding|2|||
125417765|NCT03638141|451153891|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
125417766|NCT05585307|451153894|FG000|Overall Study|Lost to Follow-up|0|||
125417767|NCT05585307|451153895|FG001|Overall Study|Lost to Follow-up|0|||
125417768|NCT05585307|451153896|FG002|Overall Study|Lost to Follow-up|0|||
125417769|NCT05585307|451153897|FG003|Overall Study|Lost to Follow-up|0|||
125417770|NCT05585307|451153898|FG004|Overall Study|Lost to Follow-up|0|||
125417771|NCT05585307|451153899|FG005|Overall Study|Lost to Follow-up|0|||
125417772|NCT05585307|451153900|FG006|Overall Study|Lost to Follow-up|1|||
125417773|NCT05585307|451153901|FG007|Overall Study|Lost to Follow-up|0|||
125417774|NCT03526250|451153902|FG000|Overall Study|Adverse Event|4|||
125417775|NCT03526250|451153902|FG000|Overall Study|Progressive Disease|16|||
125417776|NCT03526250|451153902|FG000|Overall Study|No Treatment|3|||
125417777|NCT01618864|451153903|FG000|Overall Study|Withdrawal by Subject|2|||
125417778|NCT01618864|451153903|FG000|Overall Study|Lost to Follow-up|2|||
125417779|NCT01672801|451153909|FG000|Overall Study|Screen Failure|0|||
125286589|NCT00075725|450674544|FG007|Overall Study|Pt received additional steroids|0|||
125417780|NCT01672801|451153910|FG001|Overall Study|Screen Failure|1|||
125417781|NCT02273141|451153913|FG000|Overall Study|Adverse Event|0|||
125417782|NCT02273141|451153914|FG001|Overall Study|Adverse Event|1|||
125417783|NCT02273141|451153913|FG000|Overall Study|Lost to Follow-up|1|||
125417784|NCT02273141|451153914|FG001|Overall Study|Lost to Follow-up|3|||
125417785|NCT02273141|451153913|FG000|Overall Study|Withdrawal by Subject|10|||
125417786|NCT02273141|451153914|FG001|Overall Study|Withdrawal by Subject|15|||
125417787|NCT02273141|451153913|FG000|Overall Study|Various|6|||
125286590|NCT00075725|450674545|FG008|Overall Study|Pt received additional steroids|0|||
125286591|NCT00075725|450674546|FG009|Overall Study|Pt received additional steroids|0|||
125286592|NCT00075725|450674547|FG010|Overall Study|Pt received additional steroids|0|||
125417788|NCT02273141|451153914|FG001|Overall Study|Various|6|||
125417789|NCT00492284|451153915|FG000|Overall Study|Adverse Event|0|||
125417790|NCT00492284|451153916|FG001|Overall Study|Adverse Event|1|||
125417791|NCT00492284|451153917|FG002|Overall Study|Adverse Event|1|||
125417792|NCT00492284|451153918|FG003|Overall Study|Adverse Event|2|||
125417793|NCT00492284|451153915|FG000|Overall Study|Lost to Follow-up|0|||
125417794|NCT00492284|451153916|FG001|Overall Study|Lost to Follow-up|0|||
125417795|NCT00492284|451153917|FG002|Overall Study|Lost to Follow-up|3|||
125417796|NCT00492284|451153918|FG003|Overall Study|Lost to Follow-up|1|||
125417797|NCT00492284|451153915|FG000|Overall Study|Death|0|||
125417798|NCT00492284|451153916|FG001|Overall Study|Death|3|||
125417799|NCT00492284|451153917|FG002|Overall Study|Death|2|||
125417800|NCT00492284|451153918|FG003|Overall Study|Death|5|||
125417801|NCT00492284|451153915|FG000|Overall Study|Withdrawal by Subject|1|||
125417802|NCT00492284|451153916|FG001|Overall Study|Withdrawal by Subject|0|||
125417803|NCT00492284|451153917|FG002|Overall Study|Withdrawal by Subject|0|||
125417804|NCT00492284|451153918|FG003|Overall Study|Withdrawal by Subject|2|||
125417805|NCT01556438|451153919|FG000|Overall Study|Adverse Event|4|||
125417806|NCT01556438|451153920|FG001|Overall Study|Adverse Event|2|||
125417807|NCT01556438|451153919|FG000|Overall Study|Sponsor Decision|0|||
125417808|NCT01556438|451153920|FG001|Overall Study|Sponsor Decision|2|||
125417809|NCT01556438|451153919|FG000|Overall Study|Progressive Disease|0|||
125286593|NCT00075725|450674548|FG011|Overall Study|Pt received additional steroids|0|||
125286594|NCT00075725|450674537|FG000|Overall Study|Pt relocated|0|||
125286595|NCT00075725|450674538|FG001|Overall Study|Pt relocated|0|||
125286596|NCT00075725|450674539|FG002|Overall Study|Pt relocated|0|||
125286597|NCT00075725|450674540|FG003|Overall Study|Pt relocated|2|||
125286598|NCT00075725|450674541|FG004|Overall Study|Pt relocated|0|||
125286599|NCT00075725|450674542|FG005|Overall Study|Pt relocated|1|||
125286600|NCT00075725|450674543|FG006|Overall Study|Pt relocated|1|||
125286601|NCT00075725|450674544|FG007|Overall Study|Pt relocated|2|||
125286602|NCT00075725|450674545|FG008|Overall Study|Pt relocated|1|||
125286603|NCT00075725|450674546|FG009|Overall Study|Pt relocated|0|||
125286604|NCT00075725|450674547|FG010|Overall Study|Pt relocated|0|||
125286605|NCT00075725|450674548|FG011|Overall Study|Pt relocated|0|||
125286606|NCT00075725|450674537|FG000|Overall Study|Institution Terminated|0|||
125286607|NCT00075725|450674538|FG001|Overall Study|Institution Terminated|0|||
125286608|NCT00075725|450674539|FG002|Overall Study|Institution Terminated|0|||
125286609|NCT00075725|450674540|FG003|Overall Study|Institution Terminated|0|||
125286610|NCT00075725|450674541|FG004|Overall Study|Institution Terminated|1|||
125286611|NCT00075725|450674542|FG005|Overall Study|Institution Terminated|0|||
125286612|NCT00075725|450674543|FG006|Overall Study|Institution Terminated|0|||
125286613|NCT00075725|450674544|FG007|Overall Study|Institution Terminated|3|||
125286614|NCT00075725|450674545|FG008|Overall Study|Institution Terminated|0|||
125286615|NCT00075725|450674546|FG009|Overall Study|Institution Terminated|0|||
125286616|NCT00075725|450674547|FG010|Overall Study|Institution Terminated|0|||
125286617|NCT00075725|450674548|FG011|Overall Study|Institution Terminated|0|||
125286618|NCT00075725|450674537|FG000|Overall Study|Study Closure|1|||
125286619|NCT00075725|450674538|FG001|Overall Study|Study Closure|0|||
125286620|NCT00075725|450674539|FG002|Overall Study|Study Closure|0|||
125286621|NCT00075725|450674540|FG003|Overall Study|Study Closure|0|||
125286622|NCT00075725|450674541|FG004|Overall Study|Study Closure|1|||
125286623|NCT00075725|450674542|FG005|Overall Study|Study Closure|3|||
125286624|NCT00075725|450674543|FG006|Overall Study|Study Closure|0|||
125286625|NCT00075725|450674544|FG007|Overall Study|Study Closure|1|||
125286626|NCT00075725|450674545|FG008|Overall Study|Study Closure|0|||
125286627|NCT00075725|450674546|FG009|Overall Study|Study Closure|0|||
125286628|NCT00075725|450674547|FG010|Overall Study|Study Closure|0|||
125286629|NCT00075725|450674548|FG011|Overall Study|Study Closure|0|||
125286630|NCT00075725|450674537|FG000|Overall Study|Other complications|0|||
125286631|NCT00075725|450674538|FG001|Overall Study|Other complications|0|||
125286632|NCT00075725|450674539|FG002|Overall Study|Other complications|0|||
125286633|NCT00075725|450674540|FG003|Overall Study|Other complications|0|||
125286634|NCT00075725|450674541|FG004|Overall Study|Other complications|0|||
125286635|NCT00075725|450674542|FG005|Overall Study|Other complications|1|||
125286636|NCT00075725|450674543|FG006|Overall Study|Other complications|0|||
125286637|NCT00075725|450674544|FG007|Overall Study|Other complications|0|||
125286638|NCT00075725|450674545|FG008|Overall Study|Other complications|0|||
125286639|NCT00075725|450674546|FG009|Overall Study|Other complications|0|||
125286640|NCT00075725|450674547|FG010|Overall Study|Other complications|0|||
125286641|NCT00075725|450674548|FG011|Overall Study|Other complications|0|||
125286642|NCT00075725|450674537|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
125286643|NCT00075725|450674538|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
125286644|NCT00075725|450674539|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
125286645|NCT00075725|450674540|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
125417810|NCT01556438|451153920|FG001|Overall Study|Progressive Disease|6|||
125417811|NCT01556438|451153919|FG000|Overall Study|Death|0|||
125417812|NCT01556438|451153920|FG001|Overall Study|Death|1|||
125417813|NCT00529399|451153921|FG000|Overall Study|Lost to Follow-up|1|||
125286646|NCT00075725|450674541|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
125286647|NCT00075725|450674542|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
125286648|NCT00075725|450674543|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
125286649|NCT00075725|450674544|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
125286650|NCT00075725|450674545|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
125286651|NCT00075725|450674546|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
125286652|NCT00075725|450674547|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
125286653|NCT00075725|450674548|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
125286654|NCT00075725|450674537|FG000|Overall Study|Pt incarcerated|0|||
125417814|NCT00529399|451153922|FG001|Overall Study|Lost to Follow-up|0|||
125417815|NCT00529399|451153923|FG002|Overall Study|Lost to Follow-up|1|||
125417816|NCT00529399|451153921|FG000|Overall Study|Withdrawal by Subject|1|||
125417817|NCT00529399|451153922|FG001|Overall Study|Withdrawal by Subject|0|||
125417818|NCT00529399|451153923|FG002|Overall Study|Withdrawal by Subject|1|||
125417819|NCT00529399|451153921|FG000|Overall Study|Non-compliant|0|||
125417820|NCT00529399|451153922|FG001|Overall Study|Non-compliant|1|||
125417821|NCT00529399|451153923|FG002|Overall Study|Non-compliant|0|||
125417822|NCT02734212|451153924|FG000|Overall Study|Lost to Follow-up|5|||
125417823|NCT02734212|451153925|FG001|Overall Study|Lost to Follow-up|10|||
125417824|NCT04764396|451153933|FG000|Overall Study|Physician Decision|1|||
125417825|NCT04764396|451153934|FG001|Overall Study|Physician Decision|0|||
125417826|NCT02653482|451153936|FG000|Overall Study|Death|1|||
125417827|NCT02653482|451153937|FG001|Overall Study|Death|1|||
125417828|NCT03230916|451153940|FG000|Overall Study|Withdrawal by Subject|0|||
125417829|NCT03230916|451153941|FG001|Overall Study|Withdrawal by Subject|0|||
125417830|NCT03230916|451153942|FG002|Overall Study|Withdrawal by Subject|0|||
125417831|NCT03230916|451153943|FG003|Overall Study|Withdrawal by Subject|0|||
125417832|NCT03230916|451153944|FG004|Overall Study|Withdrawal by Subject|0|||
125417833|NCT03230916|451153945|FG005|Overall Study|Withdrawal by Subject|1|||
125417834|NCT03230916|451153946|FG006|Overall Study|Withdrawal by Subject|0|||
125417835|NCT03230916|451153947|FG007|Overall Study|Withdrawal by Subject|0|||
125417836|NCT03230916|451153948|FG008|Overall Study|Withdrawal by Subject|0|||
125417837|NCT03230916|451153949|FG009|Overall Study|Withdrawal by Subject|0|||
125417838|NCT03230916|451153950|FG010|Overall Study|Withdrawal by Subject|0|||
125417839|NCT01128413|451153952|FG000|Overall Study|Withdrawal by Subject|1|||
125417840|NCT01128413|451153953|FG001|Overall Study|Withdrawal by Subject|0|||
125417841|NCT01128413|451153952|FG000|Overall Study|NICOM Monitor Problems|2|||
125417842|NCT01128413|451153953|FG001|Overall Study|NICOM Monitor Problems|1|||
125417843|NCT01128413|451153952|FG000|Overall Study|Pt made DNR|1|||
125417844|NCT01128413|451153953|FG001|Overall Study|Pt made DNR|0|||
125417845|NCT03077724|451153955|FG000|Overall Study|Lost to Follow-up|5|||
125417846|NCT03077724|451153956|FG001|Overall Study|Lost to Follow-up|1|||
125417847|NCT03077724|451153955|FG000|Overall Study|Withdrawal by Subject|3|||
125417848|NCT03077724|451153956|FG001|Overall Study|Withdrawal by Subject|1|||
125417849|NCT04370054|451153959|FG000|Treatment Phase|Lost to Follow-up|1|||
125417850|NCT04370054|451153959|FG000|Treatment Phase|Withdrawal by Subject|1|||
125417851|NCT04370054|451153959|FG000|Follow-Up Phase|Ongoing|75|||
125417852|NCT02075593|451153961|FG000|Overall Study|Withdrawal by Subject|1|||
125417853|NCT00680407|451153965|FG000|Overall Study|Lost to Follow-up|3|||
125417854|NCT00680407|451153966|FG001|Overall Study|Lost to Follow-up|3|||
125417855|NCT00680407|451153967|FG002|Overall Study|Lost to Follow-up|1|||
125417856|NCT00680407|451153965|FG000|Overall Study|Withdrawal by Subject|5|||
125417857|NCT00680407|451153966|FG001|Overall Study|Withdrawal by Subject|2|||
125417858|NCT00680407|451153967|FG002|Overall Study|Withdrawal by Subject|2|||
125417859|NCT06167031|451153968|FG000|Overall Study|Lost to Follow-up|5|||
125417860|NCT06167031|451153969|FG001|Overall Study|Lost to Follow-up|1|||
125417861|NCT01588184|451155921|FG000|Overall Study|Death|1|||
125417862|NCT01588184|451155922|FG001|Overall Study|Death|0|||
125417863|NCT01588184|451155923|FG002|Overall Study|Death|0|||
125417864|NCT01588184|451155924|FG003|Overall Study|Death|1|||
125417865|NCT01588184|451155925|FG004|Overall Study|Death|1|||
125417866|NCT01588184|451155926|FG005|Overall Study|Death|1|||
125417867|NCT01588184|451155921|FG000|Overall Study|Withdrawal by Subject|2|||
125417868|NCT01588184|451155922|FG001|Overall Study|Withdrawal by Subject|4|||
125417869|NCT01588184|451155923|FG002|Overall Study|Withdrawal by Subject|0|||
125417870|NCT01588184|451155924|FG003|Overall Study|Withdrawal by Subject|1|||
125417871|NCT01588184|451155925|FG004|Overall Study|Withdrawal by Subject|0|||
125417872|NCT01588184|451155926|FG005|Overall Study|Withdrawal by Subject|0|||
125417873|NCT01588184|451155921|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
125417874|NCT01588184|451155922|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
125417875|NCT01588184|451155923|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
125417876|NCT01588184|451155924|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
125417877|NCT01588184|451155925|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
125417878|NCT01588184|451155926|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
125417879|NCT01588184|451155921|FG000|Overall Study|multiple reasons|0|||
125417880|NCT01588184|451155922|FG001|Overall Study|multiple reasons|3|||
125417881|NCT01588184|451155923|FG002|Overall Study|multiple reasons|0|||
125417882|NCT01588184|451155924|FG003|Overall Study|multiple reasons|1|||
125417883|NCT01588184|451155925|FG004|Overall Study|multiple reasons|0|||
125417884|NCT01588184|451155926|FG005|Overall Study|multiple reasons|0|||
125417885|NCT05912400|451155928|FG000|Overall Study|Lost to Follow-up|1|||
125417886|NCT05912400|451155929|FG001|Overall Study|Lost to Follow-up|0|||
125417887|NCT05912400|451155928|FG000|Overall Study|Physician Decision|6|||
125417888|NCT05912400|451155929|FG001|Overall Study|Physician Decision|0|||
125417889|NCT05912400|451155928|FG000|Overall Study|Withdrawal by Subject|1|||
125417890|NCT05912400|451155929|FG001|Overall Study|Withdrawal by Subject|0|||
125417891|NCT02522494|451155932|FG000|Overall Study|Lost to Follow-up|6|||
125449438|NCT01723774|451273099|FG001|Neoadjuvant|Withdrawal by Subject|1|||
125449439|NCT01723774|451273100|FG002|Neoadjuvant|Withdrawal by Subject|0|||
125449440|NCT01723774|451273101|FG003|Neoadjuvant|Withdrawal by Subject|0|||
125449441|NCT01723774|451273098|FG000|Neoadjuvant|Disease progression|0|||
125449442|NCT01723774|451273099|FG001|Neoadjuvant|Disease progression|1|||
125449443|NCT01723774|451273100|FG002|Neoadjuvant|Disease progression|1|||
125449444|NCT01723774|451273101|FG003|Neoadjuvant|Disease progression|0|||
125449445|NCT01723774|451273098|FG000|Neoadjuvant|Adverse Event|0|||
125449446|NCT01723774|451273099|FG001|Neoadjuvant|Adverse Event|1|||
125449447|NCT01723774|451273100|FG002|Neoadjuvant|Adverse Event|2|||
125449448|NCT01723774|451273101|FG003|Neoadjuvant|Adverse Event|0|||
125449449|NCT01723774|451273098|FG000|Neoadjuvant|High estradiol|0|||
125449450|NCT01723774|451273099|FG001|Neoadjuvant|High estradiol|1|||
125449451|NCT01723774|451273100|FG002|Neoadjuvant|High estradiol|0|||
125449452|NCT01723774|451273101|FG003|Neoadjuvant|High estradiol|0|||
125449453|NCT02487446|451273105|FG000|Period 1|Physician Decision|0|||
125449454|NCT02487446|451273106|FG001|Period 1|Physician Decision|1|||
125449455|NCT02487446|451273105|FG000|Period 1|Lack of Efficacy|1|||
125449456|NCT02487446|451273106|FG001|Period 1|Lack of Efficacy|0|||
125449457|NCT02487446|451273105|FG000|Period 1|Protocol deviation|3|||
125449458|NCT02487446|451273106|FG001|Period 1|Protocol deviation|2|||
125449459|NCT02487446|451273105|FG000|Period 1|Lost to Follow-up|2|||
125449460|NCT02487446|451273106|FG001|Period 1|Lost to Follow-up|0|||
125449461|NCT02487446|451273105|FG000|Period 1|Withdrawal by Subject|2|||
125449462|NCT02487446|451273106|FG001|Period 1|Withdrawal by Subject|0|||
125449463|NCT02487446|451273105|FG000|Period 1|Adverse Event|5|||
125449464|NCT02487446|451273106|FG001|Period 1|Adverse Event|5|||
125449465|NCT02487446|451273105|FG000|Washout|Lost to Follow-up|0|||
125449466|NCT02487446|451273106|FG001|Washout|Lost to Follow-up|2|||
125449467|NCT02487446|451273105|FG000|Washout|Withdrawal by Subject|1|||
125449468|NCT02487446|451273106|FG001|Washout|Withdrawal by Subject|4|||
125449469|NCT02487446|451273105|FG000|Washout|Adverse Event|2|||
125449470|NCT02487446|451273106|FG001|Washout|Adverse Event|2|||
125449471|NCT02487446|451273105|FG000|Period 2|Protocol deviation|0|||
125449472|NCT02487446|451273106|FG001|Period 2|Protocol deviation|1|||
125449473|NCT02487446|451273105|FG000|Period 2|Lost to Follow-up|1|||
125449474|NCT02487446|451273106|FG001|Period 2|Lost to Follow-up|1|||
125449475|NCT02487446|451273105|FG000|Period 2|Withdrawal by Subject|1|||
125286655|NCT00075725|450674538|FG001|Overall Study|Pt incarcerated|0|||
125286656|NCT00075725|450674539|FG002|Overall Study|Pt incarcerated|0|||
125286657|NCT00075725|450674540|FG003|Overall Study|Pt incarcerated|0|||
125286658|NCT00075725|450674541|FG004|Overall Study|Pt incarcerated|0|||
125286659|NCT00075725|450674542|FG005|Overall Study|Pt incarcerated|0|||
125286660|NCT00075725|450674543|FG006|Overall Study|Pt incarcerated|0|||
125286661|NCT00075725|450674544|FG007|Overall Study|Pt incarcerated|1|||
125286662|NCT00075725|450674545|FG008|Overall Study|Pt incarcerated|0|||
125286663|NCT00075725|450674546|FG009|Overall Study|Pt incarcerated|0|||
125286664|NCT00075725|450674547|FG010|Overall Study|Pt incarcerated|0|||
125286665|NCT00075725|450674548|FG011|Overall Study|Pt incarcerated|0|||
125286666|NCT01444027|450674551|FG000|Overall Study|Withdrawal by Subject|4|||
125286667|NCT01444027|450674552|FG001|Overall Study|Withdrawal by Subject|10|||
125286668|NCT01444027|450674553|FG002|Overall Study|Withdrawal by Subject|24|||
125286669|NCT01444027|450674551|FG000|Overall Study|Lost to Follow-up|26|||
125286670|NCT01444027|450674552|FG001|Overall Study|Lost to Follow-up|20|||
125286671|NCT01444027|450674553|FG002|Overall Study|Lost to Follow-up|14|||
125286672|NCT00737711|450674555|FG000|Overall Study|Adverse Event|2|||
125286673|NCT00737711|450674555|FG000|Overall Study|Death|8|||
125286674|NCT00737711|450674555|FG000|Overall Study|Failure to return|4|||
125286675|NCT00737711|450674555|FG000|Overall Study|Protocol Violation|1|||
125286676|NCT00737711|450674555|FG000|Overall Study|Withdrawal by Subject|5|||
125286677|NCT00737711|450674555|FG000|Overall Study|Blood transfusion|6|||
125286678|NCT00737711|450674555|FG000|Overall Study|Other|5|||
125286679|NCT00840060|450676415|FG000|Overall Study|Withdrawal by Subject|1|||
125286680|NCT00840060|450676416|FG001|Overall Study|Withdrawal by Subject|0|||
125286681|NCT00840060|450676415|FG000|Overall Study|Change in emotional/behavioral status|0|||
125449476|NCT02487446|451273106|FG001|Period 2|Withdrawal by Subject|1|||
125449477|NCT02487446|451273105|FG000|Period 2|Adverse Event|6|||
125449478|NCT02487446|451273106|FG001|Period 2|Adverse Event|2|||
125449479|NCT04438785|451273111|FG000|Overall Study|change of weight, give up intervention|2|||
125449480|NCT04438785|451273112|FG001|Overall Study|change of weight, give up intervention|10|||
125286682|NCT00840060|450676416|FG001|Overall Study|Change in emotional/behavioral status|1|||
125286683|NCT01263015|450676417|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
125286684|NCT01263015|450676418|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
125286685|NCT01263015|450676417|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
125286686|NCT01263015|450676418|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
125286687|NCT01263015|450676417|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
125286688|NCT01263015|450676418|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
125449481|NCT04011033|451273113|FG000|Overall Study|Physician Decision|2|||
125449482|NCT04011033|451273114|FG001|Overall Study|Physician Decision|3|||
125449483|NCT04011033|451273113|FG000|Overall Study|Withdrawal by Subject|1|||
125417892|NCT02522494|451155933|FG001|Overall Study|Lost to Follow-up|2|||
125417893|NCT02522494|451155932|FG000|Overall Study|Withdrawal by Subject|1|||
125417894|NCT02522494|451155933|FG001|Overall Study|Withdrawal by Subject|0|||
125417895|NCT02522494|451155932|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
125417896|NCT02522494|451155933|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
125417897|NCT02522494|451155932|FG000|Overall Study|Participant did not watch the video|1|||
125417898|NCT02522494|451155933|FG001|Overall Study|Participant did not watch the video|0|||
125417899|NCT02522494|451155932|FG000|Overall Study|Death|0|||
125417900|NCT02522494|451155933|FG001|Overall Study|Death|1|||
125417901|NCT03461003|451155936|FG000|Overall Study|Lost to Follow-up|2|||
125417902|NCT03461003|451155937|FG001|Overall Study|Lost to Follow-up|2|||
125417903|NCT03461003|451155936|FG000|Overall Study|Withdrawal by Subject|3|||
125417904|NCT03461003|451155937|FG001|Overall Study|Withdrawal by Subject|1|||
125417905|NCT03489304|451155938|FG000|Overall Study|Lost to Follow-up|4|||
125417906|NCT02239679|451155939|FG000|Overall Study|Lost to Follow-up|1|||
125417907|NCT02239679|451155940|FG001|Overall Study|Lost to Follow-up|0|||
125417908|NCT02239679|451155941|FG002|Overall Study|Lost to Follow-up|0|||
125417909|NCT02239679|451155939|FG000|Overall Study|Withdrawal by Subject|2|||
125417910|NCT02239679|451155940|FG001|Overall Study|Withdrawal by Subject|3|||
125417911|NCT02239679|451155941|FG002|Overall Study|Withdrawal by Subject|1|||
125417912|NCT02047045|451155945|FG000|Baseline|Withdrawal by Subject|3|||
125417913|NCT02047045|451155946|FG001|Baseline|Withdrawal by Subject|2|||
125417914|NCT02047045|451155945|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
125417915|NCT02047045|451155946|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
125417916|NCT02047045|451155945|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
125417917|NCT02047045|451155946|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
125417918|NCT02047045|451155945|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
125417919|NCT02047045|451155946|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
125417920|NCT02047045|451155945|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
125417921|NCT02047045|451155946|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
125417922|NCT02047045|451155945|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
125417923|NCT02047045|451155946|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
125417924|NCT02047045|451155945|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
125417925|NCT02047045|451155946|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
125417926|NCT02047045|451155945|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
125417927|NCT02047045|451155946|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
125417928|NCT02047045|451155945|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
125417929|NCT02047045|451155946|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
125417930|NCT03214367|451155947|FG000|Lead-in Period|Withdrawal by Subject|50|||
125417931|NCT03214367|451155948|FG001|Lead-in Period|Withdrawal by Subject|0|||
125417932|NCT03214367|451155949|FG002|Lead-in Period|Withdrawal by Subject|0|||
125417933|NCT03214367|451155950|FG003|Lead-in Period|Withdrawal by Subject|0|||
125417934|NCT03214367|451155951|FG004|Lead-in Period|Withdrawal by Subject|2|||
125417935|NCT03214367|451155952|FG005|Lead-in Period|Withdrawal by Subject|0|||
125417936|NCT03214367|451155953|FG006|Lead-in Period|Withdrawal by Subject|0|||
125417937|NCT03214367|451155954|FG007|Lead-in Period|Withdrawal by Subject|0|||
125417938|NCT03214367|451155947|FG000|Lead-in Period|Adverse Event|3|||
125417939|NCT03214367|451155948|FG001|Lead-in Period|Adverse Event|0|||
125417940|NCT03214367|451155949|FG002|Lead-in Period|Adverse Event|0|||
125417941|NCT03214367|451155950|FG003|Lead-in Period|Adverse Event|0|||
125417942|NCT03214367|451155951|FG004|Lead-in Period|Adverse Event|0|||
125417943|NCT03214367|451155952|FG005|Lead-in Period|Adverse Event|0|||
125417944|NCT03214367|451155953|FG006|Lead-in Period|Adverse Event|0|||
125417945|NCT03214367|451155954|FG007|Lead-in Period|Adverse Event|0|||
125417946|NCT03214367|451155947|FG000|Lead-in Period|Lost to Follow-up|12|||
125417947|NCT03214367|451155948|FG001|Lead-in Period|Lost to Follow-up|0|||
125417948|NCT03214367|451155949|FG002|Lead-in Period|Lost to Follow-up|0|||
125417949|NCT03214367|451155950|FG003|Lead-in Period|Lost to Follow-up|0|||
125417950|NCT03214367|451155951|FG004|Lead-in Period|Lost to Follow-up|0|||
125417951|NCT03214367|451155952|FG005|Lead-in Period|Lost to Follow-up|0|||
125417952|NCT03214367|451155953|FG006|Lead-in Period|Lost to Follow-up|0|||
125417953|NCT03214367|451155954|FG007|Lead-in Period|Lost to Follow-up|0|||
125417954|NCT03214367|451155947|FG000|Lead-in Period|Sponsor Decision|11|||
125417955|NCT03214367|451155948|FG001|Lead-in Period|Sponsor Decision|0|||
125417956|NCT03214367|451155949|FG002|Lead-in Period|Sponsor Decision|0|||
125417957|NCT03214367|451155950|FG003|Lead-in Period|Sponsor Decision|0|||
125417958|NCT03214367|451155951|FG004|Lead-in Period|Sponsor Decision|0|||
125417959|NCT03214367|451155952|FG005|Lead-in Period|Sponsor Decision|0|||
125417960|NCT03214367|451155953|FG006|Lead-in Period|Sponsor Decision|0|||
125417961|NCT03214367|451155954|FG007|Lead-in Period|Sponsor Decision|0|||
125417962|NCT03214367|451155947|FG000|Lead-in Period|Physician Decision|12|||
125417963|NCT03214367|451155948|FG001|Lead-in Period|Physician Decision|0|||
125417964|NCT03214367|451155949|FG002|Lead-in Period|Physician Decision|0|||
125417965|NCT03214367|451155950|FG003|Lead-in Period|Physician Decision|0|||
125417966|NCT03214367|451155951|FG004|Lead-in Period|Physician Decision|0|||
125417967|NCT03214367|451155952|FG005|Lead-in Period|Physician Decision|0|||
125417968|NCT03214367|451155953|FG006|Lead-in Period|Physician Decision|0|||
125417969|NCT03214367|451155954|FG007|Lead-in Period|Physician Decision|0|||
125417970|NCT03214367|451155947|FG000|Lead-in Period|Protocol Violation|5|||
125417971|NCT03214367|451155948|FG001|Lead-in Period|Protocol Violation|0|||
125417972|NCT03214367|451155949|FG002|Lead-in Period|Protocol Violation|0|||
125417973|NCT03214367|451155950|FG003|Lead-in Period|Protocol Violation|0|||
125417974|NCT03214367|451155951|FG004|Lead-in Period|Protocol Violation|0|||
125417975|NCT03214367|451155952|FG005|Lead-in Period|Protocol Violation|0|||
125417976|NCT03214367|451155953|FG006|Lead-in Period|Protocol Violation|0|||
125417977|NCT03214367|451155954|FG007|Lead-in Period|Protocol Violation|0|||
125417978|NCT03214367|451155947|FG000|Lead-in Period|Treatment Interruption|1|||
125417979|NCT03214367|451155948|FG001|Lead-in Period|Treatment Interruption|0|||
125417980|NCT03214367|451155949|FG002|Lead-in Period|Treatment Interruption|0|||
125417981|NCT03214367|451155950|FG003|Lead-in Period|Treatment Interruption|0|||
125417982|NCT03214367|451155951|FG004|Lead-in Period|Treatment Interruption|0|||
125417983|NCT03214367|451155952|FG005|Lead-in Period|Treatment Interruption|0|||
125417984|NCT03214367|451155953|FG006|Lead-in Period|Treatment Interruption|0|||
125417985|NCT03214367|451155954|FG007|Lead-in Period|Treatment Interruption|0|||
125417986|NCT03214367|451155947|FG000|Treatment Period|Adverse Event|0|||
125417987|NCT03214367|451155948|FG001|Treatment Period|Adverse Event|1|||
125417988|NCT03214367|451155949|FG002|Treatment Period|Adverse Event|4|||
125417989|NCT03214367|451155950|FG003|Treatment Period|Adverse Event|2|||
125417990|NCT03214367|451155951|FG004|Treatment Period|Adverse Event|0|||
125417991|NCT03214367|451155952|FG005|Treatment Period|Adverse Event|0|||
125417992|NCT03214367|451155953|FG006|Treatment Period|Adverse Event|0|||
125417993|NCT03214367|451155954|FG007|Treatment Period|Adverse Event|0|||
125417994|NCT03214367|451155947|FG000|Treatment Period|Death|0|||
125417995|NCT03214367|451155948|FG001|Treatment Period|Death|1|||
125417996|NCT03214367|451155949|FG002|Treatment Period|Death|1|||
125417997|NCT03214367|451155950|FG003|Treatment Period|Death|1|||
125417998|NCT03214367|451155951|FG004|Treatment Period|Death|0|||
125417999|NCT03214367|451155952|FG005|Treatment Period|Death|0|||
125418000|NCT03214367|451155953|FG006|Treatment Period|Death|0|||
125418001|NCT03214367|451155954|FG007|Treatment Period|Death|0|||
125418002|NCT03214367|451155947|FG000|Treatment Period|Lost to Follow-up|0|||
125418003|NCT03214367|451155948|FG001|Treatment Period|Lost to Follow-up|5|||
125418004|NCT03214367|451155949|FG002|Treatment Period|Lost to Follow-up|3|||
125418005|NCT03214367|451155950|FG003|Treatment Period|Lost to Follow-up|2|||
125418006|NCT03214367|451155951|FG004|Treatment Period|Lost to Follow-up|0|||
125418007|NCT03214367|451155952|FG005|Treatment Period|Lost to Follow-up|2|||
125418008|NCT03214367|451155953|FG006|Treatment Period|Lost to Follow-up|1|||
125418009|NCT03214367|451155954|FG007|Treatment Period|Lost to Follow-up|0|||
125418010|NCT03214367|451155947|FG000|Treatment Period|Sponsor Decision|0|||
125418011|NCT03214367|451155948|FG001|Treatment Period|Sponsor Decision|3|||
125418012|NCT03214367|451155949|FG002|Treatment Period|Sponsor Decision|0|||
125418013|NCT03214367|451155950|FG003|Treatment Period|Sponsor Decision|0|||
125418014|NCT03214367|451155951|FG004|Treatment Period|Sponsor Decision|0|||
125418015|NCT03214367|451155952|FG005|Treatment Period|Sponsor Decision|0|||
125418016|NCT03214367|451155953|FG006|Treatment Period|Sponsor Decision|0|||
125418017|NCT03214367|451155954|FG007|Treatment Period|Sponsor Decision|0|||
125418018|NCT03214367|451155947|FG000|Treatment Period|Physician Decision|0|||
125418019|NCT03214367|451155948|FG001|Treatment Period|Physician Decision|1|||
125418020|NCT03214367|451155949|FG002|Treatment Period|Physician Decision|2|||
125418021|NCT03214367|451155950|FG003|Treatment Period|Physician Decision|0|||
125418022|NCT03214367|451155951|FG004|Treatment Period|Physician Decision|0|||
125418023|NCT03214367|451155952|FG005|Treatment Period|Physician Decision|0|||
125418024|NCT03214367|451155953|FG006|Treatment Period|Physician Decision|0|||
125418025|NCT03214367|451155954|FG007|Treatment Period|Physician Decision|0|||
125418026|NCT03214367|451155947|FG000|Treatment Period|Protocol Violation|0|||
125418027|NCT03214367|451155948|FG001|Treatment Period|Protocol Violation|3|||
125418028|NCT03214367|451155949|FG002|Treatment Period|Protocol Violation|0|||
125418029|NCT03214367|451155950|FG003|Treatment Period|Protocol Violation|0|||
125418030|NCT03214367|451155951|FG004|Treatment Period|Protocol Violation|0|||
125418031|NCT03214367|451155952|FG005|Treatment Period|Protocol Violation|0|||
125418032|NCT03214367|451155953|FG006|Treatment Period|Protocol Violation|0|||
125418033|NCT03214367|451155954|FG007|Treatment Period|Protocol Violation|0|||
125418034|NCT03214367|451155947|FG000|Treatment Period|Withdrawal by Subject|0|||
125418035|NCT03214367|451155948|FG001|Treatment Period|Withdrawal by Subject|20|||
125418036|NCT03214367|451155949|FG002|Treatment Period|Withdrawal by Subject|23|||
125418037|NCT03214367|451155950|FG003|Treatment Period|Withdrawal by Subject|14|||
125418038|NCT03214367|451155951|FG004|Treatment Period|Withdrawal by Subject|0|||
125418039|NCT03214367|451155952|FG005|Treatment Period|Withdrawal by Subject|1|||
125418040|NCT03214367|451155953|FG006|Treatment Period|Withdrawal by Subject|1|||
125418041|NCT03214367|451155954|FG007|Treatment Period|Withdrawal by Subject|1|||
125418042|NCT03508843|451155955|FG000|Overall Study|Withdrawal by Subject|1|||
125418043|NCT03508843|451155955|FG000|Overall Study|technical difficulties|2|||
125418044|NCT00765843|451155956|FG000|Overall Study|Lost to Follow-up|1|||
125418045|NCT00765843|451155957|FG001|Overall Study|Lost to Follow-up|3|||
125418046|NCT00765843|451155958|FG002|Overall Study|Lost to Follow-up|2|||
125449484|NCT04011033|451273114|FG001|Overall Study|Withdrawal by Subject|0|||
125449485|NCT02027935|451273115|FG000|Overall Study|Death|1|||
125449486|NCT02027935|451273115|FG000|Overall Study|Lack of Efficacy|5|||
125449487|NCT02027935|451273115|FG000|Overall Study|Study Closure|1|||
125449488|NCT00689104|451273116|FG000|Overall Study|Eligibility criterion not met|5|||
125449489|NCT00689104|451273117|FG001|Overall Study|Eligibility criterion not met|8|||
125449490|NCT00689104|451273118|FG002|Overall Study|Eligibility criterion not met|0|||
125449491|NCT00689104|451273119|FG003|Overall Study|Eligibility criterion not met|4|||
125449492|NCT00689104|451273116|FG000|Overall Study|Adverse Event|13|||
125449493|NCT00689104|451273117|FG001|Overall Study|Adverse Event|25|||
125449494|NCT00689104|451273118|FG002|Overall Study|Adverse Event|16|||
125449495|NCT00689104|451273119|FG003|Overall Study|Adverse Event|24|||
125449496|NCT00689104|451273116|FG000|Overall Study|Lack of Efficacy|5|||
125449497|NCT00689104|451273117|FG001|Overall Study|Lack of Efficacy|6|||
125449498|NCT00689104|451273118|FG002|Overall Study|Lack of Efficacy|2|||
125449499|NCT00689104|451273119|FG003|Overall Study|Lack of Efficacy|3|||
125449500|NCT00689104|451273116|FG000|Overall Study|Withdrawal by Subject|12|||
125449501|NCT00689104|451273117|FG001|Overall Study|Withdrawal by Subject|11|||
125449502|NCT00689104|451273118|FG002|Overall Study|Withdrawal by Subject|18|||
125449503|NCT00689104|451273119|FG003|Overall Study|Withdrawal by Subject|11|||
125449504|NCT00689104|451273116|FG000|Overall Study|Lost to Follow-up|4|||
125449505|NCT00689104|451273117|FG001|Overall Study|Lost to Follow-up|3|||
125449506|NCT00689104|451273118|FG002|Overall Study|Lost to Follow-up|2|||
125449507|NCT00689104|451273119|FG003|Overall Study|Lost to Follow-up|5|||
125449508|NCT00689104|451273116|FG000|Overall Study|Protocol Violation|2|||
125449509|NCT00689104|451273117|FG001|Overall Study|Protocol Violation|3|||
125449510|NCT00689104|451273118|FG002|Overall Study|Protocol Violation|5|||
125449511|NCT00689104|451273119|FG003|Overall Study|Protocol Violation|3|||
125449512|NCT00689104|451273116|FG000|Overall Study|Randomized but never received study drug|2|||
125449513|NCT00689104|451273117|FG001|Overall Study|Randomized but never received study drug|1|||
125449514|NCT00689104|451273118|FG002|Overall Study|Randomized but never received study drug|1|||
125449515|NCT00689104|451273119|FG003|Overall Study|Randomized but never received study drug|0|||
125449516|NCT00689104|451273116|FG000|Overall Study|Physician Decision|1|||
125449517|NCT00689104|451273117|FG001|Overall Study|Physician Decision|0|||
125449518|NCT00689104|451273118|FG002|Overall Study|Physician Decision|0|||
125449519|NCT00689104|451273119|FG003|Overall Study|Physician Decision|0|||
125449520|NCT00689104|451273116|FG000|Overall Study|Non-compliance with study procedures|0|||
125449521|NCT00689104|451273117|FG001|Overall Study|Non-compliance with study procedures|0|||
125449522|NCT00689104|451273118|FG002|Overall Study|Non-compliance with study procedures|1|||
125449523|NCT00689104|451273119|FG003|Overall Study|Non-compliance with study procedures|0|||
125449524|NCT01394991|451273122|FG000|Overall Study|Adverse Event|0|||
125449525|NCT01394991|451273123|FG001|Overall Study|Adverse Event|4|||
125449526|NCT01394991|451273122|FG000|Overall Study|Lack of Efficacy|5|||
125449527|NCT01394991|451273123|FG001|Overall Study|Lack of Efficacy|7|||
125449528|NCT01394991|451273122|FG000|Overall Study|Lost to Follow-up|6|||
125449529|NCT01394991|451273123|FG001|Overall Study|Lost to Follow-up|8|||
125449530|NCT01394991|451273122|FG000|Overall Study|Physician Decision|1|||
125449531|NCT01394991|451273123|FG001|Overall Study|Physician Decision|3|||
125449532|NCT01394991|451273122|FG000|Overall Study|Protocol Violation|1|||
125449533|NCT01394991|451273123|FG001|Overall Study|Protocol Violation|1|||
125449534|NCT01394991|451273122|FG000|Overall Study|Withdrawal by Subject|20|||
125449535|NCT01394991|451273123|FG001|Overall Study|Withdrawal by Subject|17|||
125449536|NCT01394991|451273122|FG000|Overall Study|Chemotherapy Termination|10|||
125449537|NCT01394991|451273123|FG001|Overall Study|Chemotherapy Termination|15|||
125449538|NCT01394991|451273122|FG000|Overall Study|Disease Progression|7|||
125449539|NCT01394991|451273123|FG001|Overall Study|Disease Progression|7|||
125449540|NCT01394991|451273122|FG000|Overall Study|Prematurely Termination of Trial|9|||
125449541|NCT01394991|451273123|FG001|Overall Study|Prematurely Termination of Trial|10|||
125449542|NCT00725010|451273133|FG000|Overall Study|Toxicity|9|||
125449543|NCT00725010|451273133|FG000|Overall Study|Tumor Progression|7|||
125449544|NCT00725010|451273133|FG000|Overall Study|Withdrawal by Subject|2|||
125449545|NCT00725010|451273133|FG000|Overall Study|Death|1|||
125449546|NCT00725010|451273133|FG000|Overall Study|Lost to Follow-up|1|||
125449547|NCT00725010|451273133|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
125449548|NCT00725010|451273133|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
125449549|NCT00725010|451273133|FG000|Overall Study|No further documentation|1|||
125449550|NCT00725010|451273133|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
125449551|NCT02414828|451273134|FG000|Overall Study|Lost to Follow-up|0|||
125449552|NCT02414828|451273135|FG001|Overall Study|Lost to Follow-up|1|||
125449553|NCT02414828|451273136|FG002|Overall Study|Lost to Follow-up|1|||
125449554|NCT02414828|451273137|FG003|Overall Study|Lost to Follow-up|2|||
125449555|NCT04949399|451273138|FG000|Overall Study|Lost to Follow-up|11|||
125449556|NCT04949399|451273139|FG001|Overall Study|Lost to Follow-up|6|||
125449557|NCT04949399|451273138|FG000|Overall Study|Withdrawal by Subject|2|||
125286689|NCT01263015|450676417|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
125449558|NCT04949399|451273139|FG001|Overall Study|Withdrawal by Subject|3|||
125449559|NCT00814489|451273140|FG000|Overall Study|Other|2|||
125418047|NCT00765843|451155956|FG000|Overall Study|did not return to receive intervention|0|||
125418048|NCT00765843|451155957|FG001|Overall Study|did not return to receive intervention|1|||
125418049|NCT00765843|451155958|FG002|Overall Study|did not return to receive intervention|0|||
125418050|NCT00765843|451155956|FG000|Overall Study|Adverse Event|0|||
125418051|NCT00765843|451155957|FG001|Overall Study|Adverse Event|0|||
125418052|NCT00765843|451155958|FG002|Overall Study|Adverse Event|1|||
125418053|NCT03555396|451155959|FG000|Overall Study|Death|3|||
125418054|NCT03555396|451155960|FG001|Overall Study|Death|1|||
125418055|NCT03555396|451155959|FG000|Overall Study|Lost to Follow-up|0|||
125418056|NCT03555396|451155960|FG001|Overall Study|Lost to Follow-up|2|||
125418057|NCT02566031|451155968|FG000|Overall Study|Patient/guardian decision|14|||
125418058|NCT02566031|451155969|FG001|Overall Study|Patient/guardian decision|7|||
125418059|NCT02566031|451155968|FG000|Overall Study|Protocol deviation|2|||
125418060|NCT02566031|451155969|FG001|Overall Study|Protocol deviation|3|||
125418061|NCT02566031|451155968|FG000|Overall Study|Adverse Event|3|||
125418062|NCT02566031|451155969|FG001|Overall Study|Adverse Event|1|||
125418063|NCT02566031|451155968|FG000|Overall Study|Lost to Follow-up|1|||
125418064|NCT02566031|451155969|FG001|Overall Study|Lost to Follow-up|1|||
125418065|NCT02479412|451155972|FG000|Overall Study|Adverse Event|0|||
125418066|NCT02479412|451155973|FG001|Overall Study|Adverse Event|0|||
125418067|NCT02479412|451155974|FG002|Overall Study|Adverse Event|1|||
125418068|NCT02479412|451155975|FG003|Overall Study|Adverse Event|0|||
125418069|NCT02479412|451155976|FG004|Overall Study|Adverse Event|0|||
125418070|NCT02479412|451155977|FG005|Overall Study|Adverse Event|0|||
125418071|NCT02479412|451155978|FG006|Overall Study|Adverse Event|0|||
125418072|NCT02479412|451155979|FG007|Overall Study|Adverse Event|0|||
125418073|NCT02479412|451155980|FG008|Overall Study|Adverse Event|0|||
125418074|NCT02479412|451155972|FG000|Overall Study|Study-specific withdrawal criteria|0|||
125418075|NCT02479412|451155973|FG001|Overall Study|Study-specific withdrawal criteria|0|||
125418076|NCT02479412|451155974|FG002|Overall Study|Study-specific withdrawal criteria|1|||
125418077|NCT02479412|451155975|FG003|Overall Study|Study-specific withdrawal criteria|1|||
125418078|NCT02479412|451155976|FG004|Overall Study|Study-specific withdrawal criteria|0|||
125418079|NCT02479412|451155977|FG005|Overall Study|Study-specific withdrawal criteria|0|||
125418080|NCT02479412|451155978|FG006|Overall Study|Study-specific withdrawal criteria|0|||
125418081|NCT02479412|451155979|FG007|Overall Study|Study-specific withdrawal criteria|1|||
125418082|NCT02479412|451155980|FG008|Overall Study|Study-specific withdrawal criteria|1|||
125418083|NCT02479412|451155972|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
125418084|NCT02479412|451155973|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
125418085|NCT02479412|451155974|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
125418086|NCT02479412|451155975|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
125418087|NCT02479412|451155976|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
125418088|NCT02479412|451155977|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
125418089|NCT02479412|451155978|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
125418090|NCT02479412|451155979|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
125418091|NCT02479412|451155980|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
125418092|NCT04969250|451155981|FG000|Overall Study|Protocol Violation|0|||
125418093|NCT04969250|451155982|FG001|Overall Study|Protocol Violation|2|||
125418094|NCT04969250|451155983|FG002|Overall Study|Protocol Violation|3|||
125418095|NCT04969250|451155984|FG003|Overall Study|Protocol Violation|8|||
125418096|NCT04969250|451155981|FG000|Overall Study|Withdrawal by Subject|0|||
125418097|NCT04969250|451155982|FG001|Overall Study|Withdrawal by Subject|1|||
125418098|NCT04969250|451155983|FG002|Overall Study|Withdrawal by Subject|0|||
125418099|NCT04969250|451155984|FG003|Overall Study|Withdrawal by Subject|0|||
125418100|NCT04420221|451155995|FG000|Overall Study|Withdrawal by Subject|0|||
125418101|NCT04420221|451155996|FG001|Overall Study|Withdrawal by Subject|0|||
125418102|NCT04420221|451155997|FG002|Overall Study|Withdrawal by Subject|0|||
125418103|NCT04420221|451155998|FG003|Overall Study|Withdrawal by Subject|0|||
125418104|NCT04420221|451155999|FG004|Overall Study|Withdrawal by Subject|0|||
125418105|NCT04420221|451156000|FG005|Overall Study|Withdrawal by Subject|20|||
125418106|NCT04420221|451156001|FG006|Overall Study|Withdrawal by Subject|5|||
125418107|NCT04420221|451155995|FG000|Overall Study|Other|0|||
125418108|NCT04420221|451155996|FG001|Overall Study|Other|0|||
125418109|NCT04420221|451155997|FG002|Overall Study|Other|0|||
125418110|NCT04420221|451155998|FG003|Overall Study|Other|0|||
125449560|NCT00814489|451273141|FG001|Overall Study|Other|0|||
125449561|NCT00814489|451273142|FG002|Overall Study|Other|1|||
125449562|NCT01712685|451273168|FG000|Overall Study|pt declined to participate before trmt|1|||
125418111|NCT04420221|451155999|FG004|Overall Study|Other|0|||
125418112|NCT04420221|451156000|FG005|Overall Study|Other|1|||
125418113|NCT04420221|451156001|FG006|Overall Study|Other|1|||
125418114|NCT04420221|451155995|FG000|Overall Study|Lost to Follow-up|0|||
125418115|NCT04420221|451155996|FG001|Overall Study|Lost to Follow-up|0|||
125418116|NCT04420221|451155997|FG002|Overall Study|Lost to Follow-up|0|||
125418117|NCT04420221|451155998|FG003|Overall Study|Lost to Follow-up|0|||
125418118|NCT04420221|451155999|FG004|Overall Study|Lost to Follow-up|0|||
125418119|NCT04420221|451156000|FG005|Overall Study|Lost to Follow-up|3|||
125286690|NCT01263015|450676418|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
125286691|NCT01263015|450676417|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
125286692|NCT01263015|450676418|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
125286693|NCT01263015|450676417|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
125286694|NCT01263015|450676418|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
125286695|NCT01263015|450676417|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
125286696|NCT01263015|450676418|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
125286697|NCT01263015|450676417|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
125286698|NCT01263015|450676418|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
125286699|NCT01263015|450676417|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
125286700|NCT01263015|450676418|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
125286701|NCT01263015|450676417|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
125286702|NCT01263015|450676418|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
125286703|NCT01263015|450676417|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
125286704|NCT01263015|450676418|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
125286705|NCT01263015|450676417|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
125286706|NCT01263015|450676418|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
125286707|NCT00303446|450676420|FG000|Overall Study|Withdrawal by Subject|2|||
125286708|NCT00303446|450676421|FG001|Overall Study|Withdrawal by Subject|2|||
125286709|NCT00303446|450676420|FG000|Overall Study|Death|0|||
125286710|NCT00303446|450676421|FG001|Overall Study|Death|1|||
125286711|NCT00303446|450676420|FG000|Overall Study|Physician Decision|0|||
125286712|NCT00303446|450676421|FG001|Overall Study|Physician Decision|1|||
125286713|NCT02251717|450676422|FG000|Overall Study|Adverse Event|0|||
125286714|NCT02251717|450676423|FG001|Overall Study|Adverse Event|1|||
125286715|NCT02251717|450676422|FG000|Overall Study|Withdrew Consent|1|||
125286716|NCT02251717|450676423|FG001|Overall Study|Withdrew Consent|0|||
125286717|NCT00489736|450676424|FG000|Overall Study|Lack of Efficacy|53|||
125286718|NCT00489736|450676425|FG001|Overall Study|Lack of Efficacy|14|||
125286719|NCT00489736|450676424|FG000|Overall Study|Adverse Event|32|||
125286720|NCT00489736|450676425|FG001|Overall Study|Adverse Event|45|||
125286721|NCT00489736|450676424|FG000|Overall Study|Poor compliance|6|||
125286722|NCT00489736|450676425|FG001|Overall Study|Poor compliance|2|||
125286723|NCT00489736|450676424|FG000|Overall Study|Not coded/ Not pre-specified|5|||
125286724|NCT00489736|450676425|FG001|Overall Study|Not coded/ Not pre-specified|8|||
125286725|NCT04035564|450676426|FG000|Overall Study|Protocol Violation|1|||
125286726|NCT04035564|450676427|FG001|Overall Study|Protocol Violation|2|||
125286727|NCT04035564|450676426|FG000|Overall Study|No laboratory available|2|||
125286728|NCT04035564|450676427|FG001|Overall Study|No laboratory available|2|||
125286729|NCT04035564|450676426|FG000|Overall Study|Guardian declined consent|1|||
125286730|NCT04035564|450676427|FG001|Overall Study|Guardian declined consent|2|||
125286731|NCT03505788|450676428|FG000|Overall Study|Lost to Follow-up|2|||
125286732|NCT03505788|450676429|FG001|Overall Study|Lost to Follow-up|1|||
125286733|NCT03505788|450676428|FG000|Overall Study|Withdrawal by Subject|1|||
125286734|NCT03505788|450676429|FG001|Overall Study|Withdrawal by Subject|3|||
125286735|NCT03505788|450676428|FG000|Overall Study|Physician Decision|0|||
125286736|NCT03505788|450676429|FG001|Overall Study|Physician Decision|1|||
125286737|NCT02324205|450676430|FG000|Overall Study|Withdrawal by Subject|37|||
125286738|NCT01774097|450676431|FG000|Overall Study|Withdrawal by Subject|1|||
125286739|NCT01774097|450676432|FG001|Overall Study|Withdrawal by Subject|1|||
125286740|NCT01774097|450676431|FG000|Overall Study|Adverse Event|1|||
125286741|NCT01774097|450676432|FG001|Overall Study|Adverse Event|1|||
125286742|NCT03664674|450676434|FG000|Overall Study|Adverse Event|1|||
125286743|NCT03664674|450676435|FG001|Overall Study|Adverse Event|1|||
125286744|NCT03664674|450676434|FG000|Overall Study|Physician Decision|0|||
125286745|NCT03664674|450676435|FG001|Overall Study|Physician Decision|1|||
125286746|NCT03664674|450676434|FG000|Overall Study|Withdrawal by Subject|2|||
125286747|NCT03664674|450676435|FG001|Overall Study|Withdrawal by Subject|0|||
125286748|NCT02174523|450676437|FG000|Overall Study|Withdrawal by Subject|1|||
125418120|NCT04420221|451156001|FG006|Overall Study|Lost to Follow-up|2|||
125418121|NCT04420221|451155995|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
125286749|NCT02174523|450676438|FG001|Overall Study|Withdrawal by Subject|0|||
125286750|NCT00794365|450676439|FG000|Overall Study|Lost to Follow-up|38|||
125286751|NCT00794365|450676439|FG000|Overall Study|Other|17|||
125286752|NCT00794365|450676439|FG000|Overall Study|Poor Compliance|11|||
125286753|NCT00794365|450676439|FG000|Overall Study|Adverse Event|10|||
125286754|NCT00794365|450676439|FG000|Overall Study|Lack of Efficacy|3|||
125286755|NCT00937404|450676440|FG000|Overall Study|Protocol Violation|1|||
125286756|NCT00937404|450676440|FG000|Overall Study|Withdrawal by Subject|1|||
125286757|NCT00230282|450676442|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
125286758|NCT00230282|450676442|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
125286759|NCT00230282|450676442|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
125286760|NCT00230282|450676442|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
125286761|NCT00090233|450676445|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
125418122|NCT04420221|451155996|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
125418123|NCT04420221|451155997|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
125418124|NCT04420221|451155998|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
125418125|NCT04420221|451155999|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
125418126|NCT04420221|451156000|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
125418127|NCT04420221|451156001|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
125418128|NCT04642638|451156002|FG000|Overall Study|Withdrawal by Subject|23|||
125418129|NCT04642638|451156003|FG001|Overall Study|Withdrawal by Subject|29|||
125418130|NCT04642638|451156004|FG002|Overall Study|Withdrawal by Subject|9|||
125418131|NCT04642638|451156005|FG003|Overall Study|Withdrawal by Subject|7|||
125418132|NCT04642638|451156006|FG004|Overall Study|Withdrawal by Subject|61|||
125418133|NCT04642638|451156007|FG005|Overall Study|Withdrawal by Subject|27|||
125418134|NCT04642638|451156002|FG000|Overall Study|Lost to Follow-up|17|||
125418135|NCT04642638|451156003|FG001|Overall Study|Lost to Follow-up|18|||
125418136|NCT04642638|451156004|FG002|Overall Study|Lost to Follow-up|5|||
125418137|NCT04642638|451156005|FG003|Overall Study|Lost to Follow-up|5|||
125418138|NCT04642638|451156006|FG004|Overall Study|Lost to Follow-up|6|||
125418139|NCT04642638|451156007|FG005|Overall Study|Lost to Follow-up|3|||
125418140|NCT04642638|451156002|FG000|Overall Study|Adverse Event|0|||
125418141|NCT04642638|451156003|FG001|Overall Study|Adverse Event|0|||
125418142|NCT04642638|451156004|FG002|Overall Study|Adverse Event|1|||
125418143|NCT04642638|451156005|FG003|Overall Study|Adverse Event|0|||
125418144|NCT04642638|451156006|FG004|Overall Study|Adverse Event|10|||
125418145|NCT04642638|451156007|FG005|Overall Study|Adverse Event|3|||
125418146|NCT04642638|451156002|FG000|Overall Study|Reason Not Specified|1|||
125418147|NCT04642638|451156003|FG001|Overall Study|Reason Not Specified|4|||
125418148|NCT04642638|451156004|FG002|Overall Study|Reason Not Specified|0|||
125418149|NCT04642638|451156005|FG003|Overall Study|Reason Not Specified|0|||
125418150|NCT04642638|451156006|FG004|Overall Study|Reason Not Specified|38|||
125418151|NCT04642638|451156007|FG005|Overall Study|Reason Not Specified|16|||
125418152|NCT04642638|451156002|FG000|Overall Study|Physician Decision|0|||
125418153|NCT04642638|451156003|FG001|Overall Study|Physician Decision|0|||
125418154|NCT04642638|451156004|FG002|Overall Study|Physician Decision|0|||
125418155|NCT04642638|451156005|FG003|Overall Study|Physician Decision|0|||
125418156|NCT04642638|451156006|FG004|Overall Study|Physician Decision|2|||
125418157|NCT04642638|451156007|FG005|Overall Study|Physician Decision|1|||
125418158|NCT04642638|451156002|FG000|Overall Study|Protocol Deviation|0|||
125418159|NCT04642638|451156003|FG001|Overall Study|Protocol Deviation|0|||
125418160|NCT04642638|451156004|FG002|Overall Study|Protocol Deviation|0|||
125418161|NCT04642638|451156005|FG003|Overall Study|Protocol Deviation|0|||
125418162|NCT04642638|451156006|FG004|Overall Study|Protocol Deviation|1|||
125418163|NCT04642638|451156007|FG005|Overall Study|Protocol Deviation|3|||
125418164|NCT04642638|451156002|FG000|Overall Study|Study Terminated|0|||
125418165|NCT04642638|451156003|FG001|Overall Study|Study Terminated|0|||
125418166|NCT04642638|451156004|FG002|Overall Study|Study Terminated|0|||
125418167|NCT04642638|451156005|FG003|Overall Study|Study Terminated|0|||
125418168|NCT04642638|451156006|FG004|Overall Study|Study Terminated|484|||
125418169|NCT04642638|451156007|FG005|Overall Study|Study Terminated|250|||
125418170|NCT04642638|451156002|FG000|Overall Study|Pregnancy|0|||
125418171|NCT04642638|451156003|FG001|Overall Study|Pregnancy|0|||
125418172|NCT04642638|451156004|FG002|Overall Study|Pregnancy|0|||
125418173|NCT04642638|451156005|FG003|Overall Study|Pregnancy|0|||
125418174|NCT04642638|451156006|FG004|Overall Study|Pregnancy|1|||
125418175|NCT04642638|451156007|FG005|Overall Study|Pregnancy|0|||
125418176|NCT00511004|451156008|FG000|Overall Study|Lost to Follow-up|0|||
125418177|NCT00511004|451156009|FG001|Overall Study|Lost to Follow-up|0|||
125418178|NCT00511004|451156010|FG002|Overall Study|Lost to Follow-up|4|||
125418179|NCT02085408|451156014|FG000|Step 1: Induction|Disease Progression|19|||
125418180|NCT02085408|451156015|FG001|Step 1: Induction|Disease Progression|19|||
125418181|NCT02085408|451156014|FG000|Step 1: Induction|Adverse Event|18|||
125418182|NCT02085408|451156015|FG001|Step 1: Induction|Adverse Event|17|||
125418183|NCT02085408|451156014|FG000|Step 1: Induction|Death|33|||
125418184|NCT02085408|451156015|FG001|Step 1: Induction|Death|30|||
125418185|NCT02085408|451156014|FG000|Step 1: Induction|Withdrawal by Subject|16|||
125418186|NCT02085408|451156015|FG001|Step 1: Induction|Withdrawal by Subject|8|||
125418187|NCT02085408|451156014|FG000|Step 1: Induction|Alternative Therapy|15|||
125418188|NCT02085408|451156015|FG001|Step 1: Induction|Alternative Therapy|19|||
125418189|NCT02085408|451156014|FG000|Step 1: Induction|Complicating Disease|2|||
125418190|NCT02085408|451156015|FG001|Step 1: Induction|Complicating Disease|3|||
125418191|NCT02085408|451156014|FG000|Step 1: Induction|Other|27|||
125418192|NCT02085408|451156015|FG001|Step 1: Induction|Other|39|||
125418193|NCT02085408|451156014|FG000|Step 1: Induction|Never started treatment|6|||
125418194|NCT02085408|451156015|FG001|Step 1: Induction|Never started treatment|4|||
125418195|NCT02085408|451156014|FG000|Step 2: Consolidation|Disease Progression|5|||
125418196|NCT02085408|451156015|FG001|Step 2: Consolidation|Disease Progression|20|||
125418197|NCT02085408|451156014|FG000|Step 2: Consolidation|Adverse Event|9|||
125418198|NCT02085408|451156015|FG001|Step 2: Consolidation|Adverse Event|8|||
125418199|NCT02085408|451156014|FG000|Step 2: Consolidation|Death|4|||
125418200|NCT02085408|451156015|FG001|Step 2: Consolidation|Death|3|||
125418201|NCT02085408|451156014|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
125418202|NCT02085408|451156015|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
125418203|NCT02085408|451156014|FG000|Step 2: Consolidation|Alternative Therapy|9|||
125418204|NCT02085408|451156015|FG001|Step 2: Consolidation|Alternative Therapy|3|||
125418205|NCT02085408|451156014|FG000|Step 2: Consolidation|Complicating Disease|0|||
125418206|NCT02085408|451156015|FG001|Step 2: Consolidation|Complicating Disease|2|||
125418207|NCT02085408|451156014|FG000|Step 2: Consolidation|Other|6|||
125418208|NCT02085408|451156015|FG001|Step 2: Consolidation|Other|6|||
125418209|NCT02085408|451156014|FG000|Step 2: Consolidation|Never started treatment|4|||
125418210|NCT02085408|451156015|FG001|Step 2: Consolidation|Never started treatment|3|||
125418211|NCT02085408|451156014|FG000|Step 3: Maintenance|Disease Progression|13|||
125418212|NCT02085408|451156015|FG001|Step 3: Maintenance|Disease Progression|11|||
125418213|NCT02085408|451156014|FG000|Step 3: Maintenance|Adverse Event|2|||
125418214|NCT02085408|451156015|FG001|Step 3: Maintenance|Adverse Event|4|||
125418215|NCT02085408|451156014|FG000|Step 3: Maintenance|Death|1|||
125418216|NCT02085408|451156015|FG001|Step 3: Maintenance|Death|2|||
125418217|NCT02085408|451156014|FG000|Step 3: Maintenance|Alternative Therapy|1|||
125418218|NCT02085408|451156015|FG001|Step 3: Maintenance|Alternative Therapy|1|||
125418219|NCT02085408|451156014|FG000|Step 3: Maintenance|Complicating Disease|0|||
125418220|NCT02085408|451156015|FG001|Step 3: Maintenance|Complicating Disease|1|||
125418221|NCT02085408|451156014|FG000|Step 3: Maintenance|Other|3|||
125418222|NCT02085408|451156015|FG001|Step 3: Maintenance|Other|2|||
125418223|NCT02085408|451156014|FG000|Step 3: Maintenance|Never started treatment|5|||
125418224|NCT02085408|451156015|FG001|Step 3: Maintenance|Never started treatment|1|||
125418225|NCT03695172|451156016|FG000|Overall Study|Withdrawal by Subject|1|||
125418226|NCT03695172|451156017|FG001|Overall Study|Withdrawal by Subject|1|||
125418227|NCT03695172|451156018|FG002|Overall Study|Withdrawal by Subject|0|||
125418228|NCT04313881|451156022|FG000|Overall Study|Death|138|||
125418229|NCT04313881|451156023|FG001|Overall Study|Death|126|||
125418230|NCT04313881|451156022|FG000|Overall Study|Study terminated by sponsor|108|||
125418231|NCT04313881|451156023|FG001|Overall Study|Study terminated by sponsor|129|||
125418232|NCT04313881|451156022|FG000|Overall Study|Consent withdrawn|19|||
125418233|NCT04313881|451156023|FG001|Overall Study|Consent withdrawn|15|||
125418234|NCT04313881|451156022|FG000|Overall Study|Reason not Specified|3|||
125418235|NCT04313881|451156023|FG001|Overall Study|Reason not Specified|1|||
125418236|NCT00688636|451156026|FG000|Overall Study|Adverse Event|2|||
125418237|NCT00688636|451156027|FG001|Overall Study|Adverse Event|1|||
125418238|NCT01572727|451156028|FG000|Overall Study|Adverse Event|43|||
125418239|NCT01572727|451156029|FG001|Overall Study|Adverse Event|15|||
125418240|NCT01572727|451156028|FG000|Overall Study|Lost to Follow-up|1|||
125418241|NCT01572727|451156029|FG001|Overall Study|Lost to Follow-up|1|||
125418242|NCT01572727|451156028|FG000|Overall Study|Physician Decision|23|||
125418243|NCT01572727|451156029|FG001|Overall Study|Physician Decision|9|||
125418244|NCT01572727|451156028|FG000|Overall Study|Progressive disease|59|||
125418245|NCT01572727|451156029|FG001|Overall Study|Progressive disease|82|||
125418246|NCT01572727|451156028|FG000|Overall Study|Protocol Violation|0|||
125418247|NCT01572727|451156029|FG001|Overall Study|Protocol Violation|1|||
125418248|NCT01572727|451156028|FG000|Overall Study|Study terminated by sponsor|61|||
125418249|NCT01572727|451156029|FG001|Overall Study|Study terminated by sponsor|83|||
125418250|NCT01572727|451156028|FG000|Overall Study|Parent/guardian decision|14|||
125418251|NCT01572727|451156029|FG001|Overall Study|Parent/guardian decision|9|||
125418252|NCT01572727|451156028|FG000|Overall Study|Death|2|||
125418253|NCT01572727|451156029|FG001|Overall Study|Death|2|||
125418254|NCT01572727|451156028|FG000|Overall Study|Untreated|4|||
125418255|NCT01572727|451156029|FG001|Overall Study|Untreated|7|||
125418256|NCT04053764|451156030|FG000|Overall Study|Withdrawal by Subject|6|||
125418257|NCT04053764|451156031|FG001|Overall Study|Withdrawal by Subject|2|||
125418258|NCT04053764|451156030|FG000|Overall Study|Physician Decision|2|||
125418259|NCT04053764|451156031|FG001|Overall Study|Physician Decision|1|||
125418260|NCT04053764|451156030|FG000|Overall Study|Adverse Event|1|||
125418261|NCT04053764|451156031|FG001|Overall Study|Adverse Event|0|||
125418262|NCT04053764|451156030|FG000|Overall Study|Pregnancy|1|||
125418263|NCT04053764|451156031|FG001|Overall Study|Pregnancy|0|||
125418264|NCT02384954|451156035|FG000|Phase 1|Progressive Disease|2|||
125418265|NCT02384954|451156036|FG001|Phase 1|Progressive Disease|0|||
125418266|NCT02384954|451156037|FG002|Phase 1|Progressive Disease|1|||
125418267|NCT02384954|451156038|FG003|Phase 1|Progressive Disease|1|||
125418268|NCT02384954|451156039|FG004|Phase 1|Progressive Disease|0|||
125418269|NCT02384954|451156040|FG005|Phase 1|Progressive Disease|0|||
125418270|NCT02384954|451156041|FG006|Phase 1|Progressive Disease|0|||
125418271|NCT02384954|451156042|FG007|Phase 1|Progressive Disease|0|||
125418272|NCT02384954|451156043|FG008|Phase 1|Progressive Disease|0|||
125418273|NCT02384954|451156035|FG000|Phase 1|Adverse Event|0|||
125418274|NCT02384954|451156036|FG001|Phase 1|Adverse Event|0|||
125418275|NCT02384954|451156037|FG002|Phase 1|Adverse Event|1|||
125418276|NCT02384954|451156038|FG003|Phase 1|Adverse Event|0|||
125418277|NCT02384954|451156039|FG004|Phase 1|Adverse Event|0|||
125418278|NCT02384954|451156040|FG005|Phase 1|Adverse Event|0|||
125418279|NCT02384954|451156041|FG006|Phase 1|Adverse Event|0|||
125418280|NCT02384954|451156042|FG007|Phase 1|Adverse Event|0|||
125418281|NCT02384954|451156043|FG008|Phase 1|Adverse Event|0|||
125418282|NCT02384954|451156035|FG000|Phase 2|Progressive Disease|0|||
125418283|NCT02384954|451156036|FG001|Phase 2|Progressive Disease|0|||
125418284|NCT02384954|451156037|FG002|Phase 2|Progressive Disease|0|||
125418285|NCT02384954|451156038|FG003|Phase 2|Progressive Disease|0|||
125418286|NCT02384954|451156039|FG004|Phase 2|Progressive Disease|0|||
125418287|NCT02384954|451156040|FG005|Phase 2|Progressive Disease|0|||
125418288|NCT02384954|451156041|FG006|Phase 2|Progressive Disease|0|||
125418289|NCT02384954|451156042|FG007|Phase 2|Progressive Disease|1|||
125418290|NCT02384954|451156043|FG008|Phase 2|Progressive Disease|2|||
125418291|NCT02384954|451156035|FG000|Phase 2|Adverse Event|0|||
125418292|NCT02384954|451156036|FG001|Phase 2|Adverse Event|0|||
125418293|NCT02384954|451156037|FG002|Phase 2|Adverse Event|0|||
125418294|NCT02384954|451156038|FG003|Phase 2|Adverse Event|0|||
125418295|NCT02384954|451156039|FG004|Phase 2|Adverse Event|0|||
125418296|NCT02384954|451156040|FG005|Phase 2|Adverse Event|0|||
125418297|NCT02384954|451156041|FG006|Phase 2|Adverse Event|0|||
125418298|NCT02384954|451156042|FG007|Phase 2|Adverse Event|1|||
125418299|NCT02384954|451156043|FG008|Phase 2|Adverse Event|1|||
125418300|NCT02384954|451156035|FG000|Phase 2|Failure to meet continuation criteria|0|||
125418301|NCT02384954|451156036|FG001|Phase 2|Failure to meet continuation criteria|0|||
125418302|NCT02384954|451156037|FG002|Phase 2|Failure to meet continuation criteria|0|||
125418303|NCT02384954|451156038|FG003|Phase 2|Failure to meet continuation criteria|0|||
125418304|NCT02384954|451156039|FG004|Phase 2|Failure to meet continuation criteria|0|||
125418305|NCT02384954|451156040|FG005|Phase 2|Failure to meet continuation criteria|0|||
125418306|NCT02384954|451156041|FG006|Phase 2|Failure to meet continuation criteria|0|||
125418307|NCT02384954|451156042|FG007|Phase 2|Failure to meet continuation criteria|1|||
125418308|NCT02384954|451156043|FG008|Phase 2|Failure to meet continuation criteria|0|||
125418309|NCT04732286|451156044|FG000|Overall Study|Progressive Disease|2|||
125418310|NCT04732286|451156044|FG000|Overall Study|Physician Decision|1|||
125418311|NCT04732286|451156044|FG000|Overall Study|Study Terminated by Sponsor|31|||
125418312|NCT04732286|451156044|FG000|Overall Study|Withdrawal by Subject|10|||
125418313|NCT04732286|451156044|FG000|Overall Study|Non-compliance With Study Drug|1|||
125418314|NCT04732286|451156044|FG000|Overall Study|Lost to Follow-up|4|||
125418315|NCT04732286|451156044|FG000|Overall Study|Death|51|||
125418316|NCT01474681|451156048|FG000|Overall Study|Death|0|||
125418317|NCT01474681|451156049|FG001|Overall Study|Death|3|||
125418318|NCT01474681|451156050|FG002|Overall Study|Death|2|||
125418319|NCT01474681|451156051|FG003|Overall Study|Death|6|||
125418320|NCT03998618|451156055|FG000|Overall Study|Death|7|||
125418321|NCT03998618|451156056|FG001|Overall Study|Death|11|||
125418322|NCT03998618|451156055|FG000|Overall Study|hospice enrollment|3|||
125418323|NCT03998618|451156056|FG001|Overall Study|hospice enrollment|3|||
125418324|NCT03998618|451156055|FG000|Overall Study|Not feeling well/health problems|3|||
125418325|NCT03998618|451156056|FG001|Overall Study|Not feeling well/health problems|5|||
125418326|NCT03998618|451156055|FG000|Overall Study|Lost to Follow-up|6|||
125418327|NCT03998618|451156056|FG001|Overall Study|Lost to Follow-up|6|||
125418328|NCT03998618|451156055|FG000|Overall Study|Withdrawal by Subject|0|||
125418329|NCT03998618|451156056|FG001|Overall Study|Withdrawal by Subject|4|||
125418330|NCT01910129|451156058|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
125418331|NCT01910129|451156059|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
125418332|NCT01910129|451156060|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
125418333|NCT01910129|451156058|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
125418334|NCT01910129|451156059|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
125418335|NCT01910129|451156060|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
125418336|NCT00319098|451156061|FG000|Overall Study|Serious adverse event|3|||
125418337|NCT00319098|451156062|FG001|Overall Study|Serious adverse event|0|||
125418338|NCT00319098|451156061|FG000|Overall Study|Adverse Event|20|||
125418339|NCT00319098|451156062|FG001|Overall Study|Adverse Event|1|||
125418340|NCT00319098|451156061|FG000|Overall Study|Withdrawal by Subject|37|||
125418341|NCT00319098|451156062|FG001|Overall Study|Withdrawal by Subject|8|||
125418342|NCT00319098|451156061|FG000|Overall Study|Migrated/moved from study area|2|||
125418343|NCT00319098|451156062|FG001|Overall Study|Migrated/moved from study area|1|||
125418344|NCT00319098|451156061|FG000|Overall Study|Lost to Follow-up|37|||
125418345|NCT00319098|451156062|FG001|Overall Study|Lost to Follow-up|13|||
125418346|NCT00319098|451156061|FG000|Overall Study|Others|33|||
125418347|NCT00319098|451156062|FG001|Overall Study|Others|8|||
125418348|NCT00319098|451156061|FG000|Overall Study|Protocol Violation|3|||
125418349|NCT00319098|451156062|FG001|Overall Study|Protocol Violation|1|||
125418350|NCT03595904|451156065|FG000|Overall Study|Protocol Violation|3|||
125418351|NCT03595904|451156066|FG001|Overall Study|Protocol Violation|1|||
125418352|NCT03595904|451156065|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
125418353|NCT03595904|451156066|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
125418354|NCT03595904|451156065|FG000|Overall Study|Insurance complications|1|||
125418355|NCT03595904|451156066|FG001|Overall Study|Insurance complications|0|||
125418356|NCT03595904|451156065|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
125420836|NCT01260350|451166153|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125418357|NCT03595904|451156066|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
125418358|NCT01392560|451156067|FG000|Overall Study|Adverse Event|2|||
125418359|NCT01392560|451156067|FG000|Overall Study|not entered|8|||
125418360|NCT01392560|451156067|FG000|Overall Study|discontinued during placebo run-in|2|||
125418361|NCT00295750|451156070|FG000|Overall Study|Adverse Event|19|||
125418362|NCT00295750|451156071|FG001|Overall Study|Adverse Event|15|||
125418363|NCT00295750|451156072|FG002|Overall Study|Adverse Event|12|||
125418364|NCT00295750|451156070|FG000|Overall Study|Lack of Efficacy|1|||
125418365|NCT00295750|451156071|FG001|Overall Study|Lack of Efficacy|1|||
125418366|NCT00295750|451156072|FG002|Overall Study|Lack of Efficacy|0|||
125418367|NCT00295750|451156070|FG000|Overall Study|Lost to Follow-up|1|||
125418368|NCT00295750|451156071|FG001|Overall Study|Lost to Follow-up|4|||
125418369|NCT00295750|451156072|FG002|Overall Study|Lost to Follow-up|1|||
125418370|NCT00295750|451156070|FG000|Overall Study|Taking prohibited therapy|2|||
125418371|NCT00295750|451156071|FG001|Overall Study|Taking prohibited therapy|3|||
125418372|NCT00295750|451156072|FG002|Overall Study|Taking prohibited therapy|2|||
125418373|NCT00295750|451156070|FG000|Overall Study|Administrative errors|2|||
125418374|NCT00295750|451156071|FG001|Overall Study|Administrative errors|4|||
125418375|NCT00295750|451156072|FG002|Overall Study|Administrative errors|5|||
125418376|NCT00295750|451156070|FG000|Overall Study|Trial drug errors|1|||
125418377|NCT00295750|451156071|FG001|Overall Study|Trial drug errors|1|||
125418378|NCT00295750|451156072|FG002|Overall Study|Trial drug errors|0|||
125418379|NCT00295750|451156070|FG000|Overall Study|Disease progression|2|||
125418380|NCT00295750|451156071|FG001|Overall Study|Disease progression|1|||
125418381|NCT00295750|451156072|FG002|Overall Study|Disease progression|0|||
125418382|NCT00295750|451156070|FG000|Overall Study|Personal reasons|0|||
125418383|NCT00295750|451156071|FG001|Overall Study|Personal reasons|1|||
125418384|NCT00295750|451156072|FG002|Overall Study|Personal reasons|0|||
125418385|NCT00295750|451156070|FG000|Overall Study|Randomized but never received trial drug|4|||
125418386|NCT00295750|451156071|FG001|Overall Study|Randomized but never received trial drug|3|||
125418387|NCT00295750|451156072|FG002|Overall Study|Randomized but never received trial drug|3|||
125418388|NCT00295750|451156070|FG000|Overall Study|Withdrawal by Subject|9|||
125418389|NCT00295750|451156071|FG001|Overall Study|Withdrawal by Subject|4|||
125418390|NCT00295750|451156072|FG002|Overall Study|Withdrawal by Subject|7|||
125418391|NCT00295750|451156070|FG000|Overall Study|Protocol Violation|2|||
125418392|NCT00295750|451156071|FG001|Overall Study|Protocol Violation|4|||
125418393|NCT00295750|451156072|FG002|Overall Study|Protocol Violation|2|||
125418394|NCT02199028|451156082|FG000|Week 1|Adverse Event|1|||
125418395|NCT02199028|451156083|FG001|Week 1|Adverse Event|0|||
125418396|NCT02199028|451156082|FG000|Week 3|Adverse Event|1|||
125418397|NCT02199028|451156083|FG001|Week 3|Adverse Event|0|||
125418398|NCT01881126|451156084|FG000|Overall Study|Non-compliance|1|||
125418399|NCT01881126|451156085|FG001|Overall Study|Non-compliance|1|||
125418400|NCT01881126|451156084|FG000|Overall Study|Adverse Event|0|||
125418401|NCT01881126|451156085|FG001|Overall Study|Adverse Event|1|||
125418402|NCT02341417|451156086|FG000|Overall Study|Withdrawal by Subject|0|||
125418403|NCT02341417|451156087|FG001|Overall Study|Withdrawal by Subject|2|||
125418404|NCT02341417|451156088|FG002|Overall Study|Withdrawal by Subject|0|||
125418405|NCT02341417|451156086|FG000|Overall Study|Decision by sponsor|2|||
125418406|NCT02341417|451156087|FG001|Overall Study|Decision by sponsor|0|||
125418407|NCT02341417|451156088|FG002|Overall Study|Decision by sponsor|0|||
125418408|NCT02341417|451156086|FG000|Overall Study|Death|0|||
125418409|NCT02341417|451156087|FG001|Overall Study|Death|0|||
125418410|NCT02341417|451156088|FG002|Overall Study|Death|1|||
125418411|NCT04899349|451156094|FG000|Overall Study|Study terminated by Sponsor|2|||
125418412|NCT04899349|451156095|FG001|Overall Study|Study terminated by Sponsor|0|||
125418413|NCT01857531|451156096|FG000|Overall Study|Withdrawal by Subject|4|||
125418414|NCT04656847|451156100|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
125418415|NCT03301051|451156101|FG000|Overall Study|Adverse Event|0|||
125418416|NCT03301051|451156102|FG001|Overall Study|Adverse Event|4|||
125418417|NCT03301051|451156101|FG000|Overall Study|Withdrawal by Subject|59|||
125418418|NCT03301051|451156102|FG001|Overall Study|Withdrawal by Subject|65|||
125418419|NCT03301051|451156101|FG000|Overall Study|Lost to Follow-up|263|||
125418420|NCT03301051|451156102|FG001|Overall Study|Lost to Follow-up|282|||
125418421|NCT03301051|451156101|FG000|Overall Study|Protocol Violation|1|||
125418422|NCT03301051|451156102|FG001|Overall Study|Protocol Violation|3|||
125418423|NCT03301051|451156101|FG000|Overall Study|Physician Decision|1|||
125418424|NCT03301051|451156102|FG001|Overall Study|Physician Decision|3|||
125418425|NCT03301051|451156101|FG000|Overall Study|Death|1|||
125418426|NCT03301051|451156102|FG001|Overall Study|Death|1|||
125418427|NCT03301051|451156101|FG000|Overall Study|Miscellaneous|8|||
125418428|NCT03301051|451156102|FG001|Overall Study|Miscellaneous|4|||
125418429|NCT03301051|451156101|FG000|Overall Study|Randomized, not vaccinated|13|||
125418430|NCT03301051|451156102|FG001|Overall Study|Randomized, not vaccinated|10|||
125418431|NCT00047879|451156103|FG000|Overall Study|Progressive disease|4|||
125418432|NCT00047879|451156104|FG001|Overall Study|Progressive disease|3|||
125418433|NCT04657211|451156110|FG000|Overall Study|Withdrawal by Subject|21|||
125418434|NCT04657211|451156110|FG000|Overall Study|Lost to Follow-up|113|||
125418435|NCT04657211|451156110|FG000|Overall Study|Death|47|||
125418436|NCT04657211|451156110|FG000|Overall Study|Transfer to another institution|21|||
125418437|NCT04657211|451156110|FG000|Overall Study|Other|29|||
125418438|NCT03776136|451156111|FG000|Overall Study|Death|85|||
125418439|NCT03776136|451156111|FG000|Overall Study|Withdrawal by Subject|3|||
125418440|NCT03776136|451156111|FG000|Overall Study|Sponsor Decision|15|||
125418441|NCT00613951|451156112|FG000|Overall Study|Adverse Event|1|||
125418442|NCT00613951|451156113|FG001|Overall Study|Adverse Event|0|||
125418443|NCT00613951|451156114|FG002|Overall Study|Adverse Event|1|||
125418444|NCT00613951|451156112|FG000|Overall Study|Lack of Efficacy|0|||
125418445|NCT00613951|451156113|FG001|Overall Study|Lack of Efficacy|1|||
125418446|NCT00613951|451156114|FG002|Overall Study|Lack of Efficacy|1|||
125418447|NCT00613951|451156112|FG000|Overall Study|Protocol Violation|1|||
125418448|NCT00613951|451156113|FG001|Overall Study|Protocol Violation|1|||
125418449|NCT00613951|451156114|FG002|Overall Study|Protocol Violation|1|||
125418450|NCT00613951|451156112|FG000|Overall Study|Unclassified|5|||
125418451|NCT00613951|451156113|FG001|Overall Study|Unclassified|3|||
125418452|NCT00613951|451156114|FG002|Overall Study|Unclassified|2|||
125418453|NCT01329029|451156119|FG000|Overall Study|Withdrawal by Subject|117|||
125418454|NCT01329029|451156120|FG001|Overall Study|Withdrawal by Subject|87|||
125418455|NCT01329029|451156119|FG000|Overall Study|Adverse Event|82|||
125418456|NCT01329029|451156120|FG001|Overall Study|Adverse Event|29|||
125418457|NCT01329029|451156119|FG000|Overall Study|Death|16|||
125418458|NCT01329029|451156120|FG001|Overall Study|Death|19|||
125418459|NCT01329029|451156119|FG000|Overall Study|Other|14|||
125418460|NCT01329029|451156120|FG001|Overall Study|Other|20|||
125418461|NCT01329029|451156119|FG000|Overall Study|COPD Exacerbation|11|||
125418462|NCT01329029|451156120|FG001|Overall Study|COPD Exacerbation|18|||
125418463|NCT01329029|451156119|FG000|Overall Study|Physician Decision|16|||
125418464|NCT01329029|451156120|FG001|Overall Study|Physician Decision|13|||
125418465|NCT01329029|451156119|FG000|Overall Study|Lost to Follow-up|8|||
125418466|NCT01329029|451156120|FG001|Overall Study|Lost to Follow-up|5|||
125418467|NCT01329029|451156119|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
125418468|NCT01329029|451156120|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
125418469|NCT01266642|451156121|FG000|Overall Study|Protocol Violation|0|||
125418470|NCT01266642|451156122|FG001|Overall Study|Protocol Violation|1|||
125418471|NCT00924287|451158493|FG000|Overall Study|Death|1|||
125418472|NCT01625897|451158494|FG000|Overall Study|Adverse Event|27|||
125418473|NCT01625897|451158495|FG001|Overall Study|Adverse Event|10|||
125418474|NCT01625897|451158494|FG000|Overall Study|Physician Decision|0|||
125418475|NCT01625897|451158495|FG001|Overall Study|Physician Decision|1|||
125418476|NCT01625897|451158494|FG000|Overall Study|Withdrawal by Subject|25|||
125418477|NCT01625897|451158495|FG001|Overall Study|Withdrawal by Subject|3|||
125418478|NCT02621931|451158496|FG000|Overall Study|Death|0|||
125418479|NCT02621931|451158497|FG001|Overall Study|Death|1|||
125418480|NCT02621931|451158498|FG002|Overall Study|Death|0|||
125418481|NCT02621931|451158496|FG000|Overall Study|Adverse Event|8|||
125418482|NCT02621931|451158497|FG001|Overall Study|Adverse Event|5|||
125418483|NCT02621931|451158498|FG002|Overall Study|Adverse Event|7|||
125418484|NCT02621931|451158496|FG000|Overall Study|Withdrawal by Subject|12|||
125418485|NCT02621931|451158497|FG001|Overall Study|Withdrawal by Subject|10|||
125418486|NCT02621931|451158498|FG002|Overall Study|Withdrawal by Subject|11|||
125418487|NCT02621931|451158496|FG000|Overall Study|Protocol Violation|2|||
125418488|NCT02621931|451158497|FG001|Overall Study|Protocol Violation|2|||
125418489|NCT02621931|451158498|FG002|Overall Study|Protocol Violation|2|||
125418490|NCT02621931|451158496|FG000|Overall Study|Pregnancy|2|||
125418491|NCT02621931|451158497|FG001|Overall Study|Pregnancy|0|||
125418492|NCT02621931|451158498|FG002|Overall Study|Pregnancy|0|||
125418493|NCT02621931|451158496|FG000|Overall Study|Noncompliance to study procedures|0|||
125418494|NCT02621931|451158497|FG001|Overall Study|Noncompliance to study procedures|1|||
125418495|NCT02621931|451158498|FG002|Overall Study|Noncompliance to study procedures|2|||
125418496|NCT02621931|451158496|FG000|Overall Study|Lost to Follow-up|8|||
125418497|NCT02621931|451158497|FG001|Overall Study|Lost to Follow-up|7|||
125418498|NCT02621931|451158498|FG002|Overall Study|Lost to Follow-up|10|||
125418499|NCT02621931|451158496|FG000|Overall Study|Lack of Efficacy|0|||
125418500|NCT02621931|451158497|FG001|Overall Study|Lack of Efficacy|0|||
125418501|NCT02621931|451158498|FG002|Overall Study|Lack of Efficacy|1|||
125418502|NCT02621931|451158496|FG000|Overall Study|Other|1|||
125418503|NCT02621931|451158497|FG001|Overall Study|Other|1|||
125418504|NCT02621931|451158498|FG002|Overall Study|Other|3|||
125418505|NCT01912612|451158501|FG000|Overall Study|Adverse Event|4|||
125418506|NCT01912612|451158502|FG001|Overall Study|Adverse Event|0|||
125418507|NCT01912612|451158503|FG002|Overall Study|Adverse Event|0|||
125418508|NCT01912612|451158501|FG000|Overall Study|Withdrew consent|1|||
125418509|NCT01912612|451158502|FG001|Overall Study|Withdrew consent|0|||
125418510|NCT01912612|451158503|FG002|Overall Study|Withdrew consent|0|||
125418511|NCT01912612|451158501|FG000|Overall Study|Study design change|0|||
125418512|NCT01912612|451158502|FG001|Overall Study|Study design change|0|||
125418513|NCT01912612|451158503|FG002|Overall Study|Study design change|3|||
125418514|NCT02008890|451158504|FG000|Period 1|Withdrawal by Subject|7|||
125418515|NCT02008890|451158505|FG001|Period 1|Withdrawal by Subject|7|||
125418516|NCT02008890|451158506|FG002|Period 1|Withdrawal by Subject|5|||
125418517|NCT02008890|451158507|FG003|Period 1|Withdrawal by Subject|0|||
125418518|NCT02008890|451158508|FG004|Period 1|Withdrawal by Subject|0|||
125418519|NCT02008890|451158504|FG000|Period 1|Pregnancy|1|||
125418520|NCT02008890|451158505|FG001|Period 1|Pregnancy|0|||
125418521|NCT02008890|451158506|FG002|Period 1|Pregnancy|0|||
125418522|NCT02008890|451158507|FG003|Period 1|Pregnancy|0|||
125418523|NCT02008890|451158508|FG004|Period 1|Pregnancy|0|||
125418524|NCT02008890|451158504|FG000|Period 1|Physician Decision|1|||
125418525|NCT02008890|451158505|FG001|Period 1|Physician Decision|0|||
125418526|NCT02008890|451158506|FG002|Period 1|Physician Decision|1|||
125418527|NCT02008890|451158507|FG003|Period 1|Physician Decision|0|||
125418528|NCT02008890|451158508|FG004|Period 1|Physician Decision|0|||
125418529|NCT02008890|451158504|FG000|Period 1|Adverse Event|6|||
125418530|NCT02008890|451158505|FG001|Period 1|Adverse Event|8|||
125418531|NCT02008890|451158506|FG002|Period 1|Adverse Event|6|||
125418532|NCT02008890|451158507|FG003|Period 1|Adverse Event|0|||
125418533|NCT02008890|451158508|FG004|Period 1|Adverse Event|0|||
125418534|NCT02008890|451158504|FG000|Period 2|Adverse Event|12|||
125418535|NCT02008890|451158505|FG001|Period 2|Adverse Event|7|||
125418536|NCT02008890|451158506|FG002|Period 2|Adverse Event|0|||
125418537|NCT02008890|451158507|FG003|Period 2|Adverse Event|5|||
125418538|NCT02008890|451158508|FG004|Period 2|Adverse Event|5|||
125418539|NCT02008890|451158504|FG000|Period 2|Withdrawal by Subject|11|||
125418540|NCT02008890|451158505|FG001|Period 2|Withdrawal by Subject|8|||
125418541|NCT02008890|451158506|FG002|Period 2|Withdrawal by Subject|0|||
125418542|NCT02008890|451158507|FG003|Period 2|Withdrawal by Subject|7|||
125418543|NCT02008890|451158508|FG004|Period 2|Withdrawal by Subject|2|||
125418544|NCT02008890|451158504|FG000|Period 2|Physician Decision|4|||
125418545|NCT02008890|451158505|FG001|Period 2|Physician Decision|0|||
125418546|NCT02008890|451158506|FG002|Period 2|Physician Decision|0|||
125418547|NCT02008890|451158507|FG003|Period 2|Physician Decision|2|||
125418548|NCT02008890|451158508|FG004|Period 2|Physician Decision|1|||
125418549|NCT02008890|451158504|FG000|Period 2|Lost to Follow-up|0|||
125418550|NCT02008890|451158505|FG001|Period 2|Lost to Follow-up|0|||
125418551|NCT02008890|451158506|FG002|Period 2|Lost to Follow-up|1|||
125418552|NCT02008890|451158507|FG003|Period 2|Lost to Follow-up|0|||
125418553|NCT02008890|451158508|FG004|Period 2|Lost to Follow-up|0|||
125418554|NCT02008890|451158504|FG000|Extension Period|Withdrawal by Subject|3|||
125418555|NCT02008890|451158505|FG001|Extension Period|Withdrawal by Subject|2|||
125418556|NCT02008890|451158506|FG002|Extension Period|Withdrawal by Subject|0|||
125418557|NCT02008890|451158507|FG003|Extension Period|Withdrawal by Subject|4|||
125418558|NCT02008890|451158508|FG004|Extension Period|Withdrawal by Subject|2|||
125418559|NCT02008890|451158504|FG000|Extension Period|Lost to Follow-up|1|||
125418560|NCT02008890|451158505|FG001|Extension Period|Lost to Follow-up|0|||
125418561|NCT02008890|451158506|FG002|Extension Period|Lost to Follow-up|0|||
125418562|NCT02008890|451158507|FG003|Extension Period|Lost to Follow-up|0|||
125418563|NCT02008890|451158508|FG004|Extension Period|Lost to Follow-up|0|||
125418564|NCT02008890|451158504|FG000|Extension Period|Adverse Event|1|||
125418565|NCT02008890|451158505|FG001|Extension Period|Adverse Event|3|||
125418566|NCT02008890|451158506|FG002|Extension Period|Adverse Event|0|||
125418567|NCT02008890|451158507|FG003|Extension Period|Adverse Event|0|||
125418568|NCT02008890|451158508|FG004|Extension Period|Adverse Event|2|||
125418569|NCT02207816|451158509|FG000|Overall Study|Serious Adverse Event|0|||
125418570|NCT02207816|451158510|FG001|Overall Study|Serious Adverse Event|5|||
125418571|NCT02207816|451158511|FG002|Overall Study|Serious Adverse Event|2|||
125418572|NCT02207816|451158509|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
125449563|NCT00662909|451273172|FG000|Overall Study|Adverse Event|17|||
125286762|NCT00090233|450676446|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
125286763|NCT00090233|450676445|FG000|Overall Study|Adverse Event|214|||
125286764|NCT00090233|450676446|FG001|Overall Study|Adverse Event|198|||
125286765|NCT00090233|450676445|FG000|Overall Study|Lost to Follow-up|68|||
125286766|NCT00090233|450676446|FG001|Overall Study|Lost to Follow-up|95|||
125286767|NCT00090233|450676445|FG000|Overall Study|Protocol Violation|960|||
125418573|NCT02207816|451158510|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
125418574|NCT02207816|451158511|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
125418575|NCT02207816|451158509|FG000|Overall Study|Withdrawal by Subject|4|||
125418576|NCT02207816|451158510|FG001|Overall Study|Withdrawal by Subject|9|||
125418577|NCT02207816|451158511|FG002|Overall Study|Withdrawal by Subject|7|||
125418578|NCT02207816|451158509|FG000|Overall Study|Migrated/Moved From Study Area|41|||
125418579|NCT02207816|451158510|FG001|Overall Study|Migrated/Moved From Study Area|60|||
125418580|NCT02207816|451158511|FG002|Overall Study|Migrated/Moved From Study Area|51|||
125418581|NCT02207816|451158509|FG000|Overall Study|Lost to Follow-up|3|||
125418582|NCT02207816|451158510|FG001|Overall Study|Lost to Follow-up|9|||
125418583|NCT02207816|451158511|FG002|Overall Study|Lost to Follow-up|1|||
125418584|NCT02207816|451158509|FG000|Overall Study|Other|1|||
125418585|NCT02207816|451158510|FG001|Overall Study|Other|2|||
125418586|NCT02207816|451158511|FG002|Overall Study|Other|4|||
125418587|NCT01217073|451158512|FG000|Base Period|Adverse Event|1|||
125418588|NCT01217073|451158513|FG001|Base Period|Adverse Event|0|||
125286768|NCT00090233|450676446|FG001|Overall Study|Protocol Violation|1022|||
125418589|NCT01217073|451158514|FG002|Base Period|Adverse Event|1|||
125418590|NCT01217073|451158515|FG003|Base Period|Adverse Event|0|||
125418591|NCT01217073|451158516|FG004|Base Period|Adverse Event|4|||
125418592|NCT01217073|451158517|FG005|Base Period|Adverse Event|1|||
125418593|NCT01217073|451158518|FG006|Base Period|Adverse Event|0|||
125418594|NCT01217073|451158519|FG007|Base Period|Adverse Event|0|||
125418595|NCT01217073|451158512|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
125418596|NCT01217073|451158513|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125418597|NCT01217073|451158514|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125418598|NCT01217073|451158515|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125418599|NCT01217073|451158516|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125418600|NCT01217073|451158517|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125418601|NCT01217073|451158518|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125418602|NCT01217073|451158519|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
125418603|NCT01217073|451158512|FG000|Base Period|Excluded medication|0|||
125418604|NCT01217073|451158513|FG001|Base Period|Excluded medication|0|||
125418605|NCT01217073|451158514|FG002|Base Period|Excluded medication|0|||
125418606|NCT01217073|451158515|FG003|Base Period|Excluded medication|0|||
125418607|NCT01217073|451158516|FG004|Base Period|Excluded medication|1|||
125418608|NCT01217073|451158517|FG005|Base Period|Excluded medication|0|||
125418609|NCT01217073|451158518|FG006|Base Period|Excluded medication|0|||
125418610|NCT01217073|451158519|FG007|Base Period|Excluded medication|0|||
125418611|NCT01217073|451158512|FG000|Base Period|Lack of Efficacy|0|||
125418612|NCT01217073|451158513|FG001|Base Period|Lack of Efficacy|0|||
125418613|NCT01217073|451158514|FG002|Base Period|Lack of Efficacy|0|||
125418614|NCT01217073|451158515|FG003|Base Period|Lack of Efficacy|0|||
125418615|NCT01217073|451158516|FG004|Base Period|Lack of Efficacy|0|||
125418616|NCT01217073|451158517|FG005|Base Period|Lack of Efficacy|1|||
125418617|NCT01217073|451158518|FG006|Base Period|Lack of Efficacy|0|||
125418618|NCT01217073|451158519|FG007|Base Period|Lack of Efficacy|0|||
125418619|NCT01217073|451158512|FG000|Base Period|Lost to Follow-up|0|||
125418620|NCT01217073|451158513|FG001|Base Period|Lost to Follow-up|0|||
125418621|NCT01217073|451158514|FG002|Base Period|Lost to Follow-up|1|||
125418622|NCT01217073|451158515|FG003|Base Period|Lost to Follow-up|1|||
125418623|NCT01217073|451158516|FG004|Base Period|Lost to Follow-up|3|||
125418624|NCT01217073|451158517|FG005|Base Period|Lost to Follow-up|0|||
125418625|NCT01217073|451158518|FG006|Base Period|Lost to Follow-up|0|||
125418626|NCT01217073|451158519|FG007|Base Period|Lost to Follow-up|0|||
125418627|NCT01217073|451158512|FG000|Base Period|Physician Decision|0|||
125418628|NCT01217073|451158513|FG001|Base Period|Physician Decision|0|||
125418629|NCT01217073|451158514|FG002|Base Period|Physician Decision|0|||
125418630|NCT01217073|451158515|FG003|Base Period|Physician Decision|0|||
125418631|NCT01217073|451158516|FG004|Base Period|Physician Decision|1|||
125418632|NCT01217073|451158517|FG005|Base Period|Physician Decision|0|||
125418633|NCT01217073|451158518|FG006|Base Period|Physician Decision|0|||
125418634|NCT01217073|451158519|FG007|Base Period|Physician Decision|0|||
125418635|NCT01217073|451158512|FG000|Base Period|Protocol Violation|1|||
125418636|NCT01217073|451158513|FG001|Base Period|Protocol Violation|0|||
125418637|NCT01217073|451158514|FG002|Base Period|Protocol Violation|0|||
125418638|NCT01217073|451158515|FG003|Base Period|Protocol Violation|0|||
125418639|NCT01217073|451158516|FG004|Base Period|Protocol Violation|1|||
125418640|NCT01217073|451158517|FG005|Base Period|Protocol Violation|2|||
125418641|NCT01217073|451158518|FG006|Base Period|Protocol Violation|0|||
125418642|NCT01217073|451158519|FG007|Base Period|Protocol Violation|0|||
125418643|NCT01217073|451158512|FG000|Base Period|Withdrawal by Subject|4|||
125418644|NCT01217073|451158513|FG001|Base Period|Withdrawal by Subject|5|||
125418645|NCT01217073|451158514|FG002|Base Period|Withdrawal by Subject|5|||
125418646|NCT01217073|451158515|FG003|Base Period|Withdrawal by Subject|1|||
125418647|NCT01217073|451158516|FG004|Base Period|Withdrawal by Subject|5|||
125418648|NCT01217073|451158517|FG005|Base Period|Withdrawal by Subject|5|||
125418649|NCT01217073|451158518|FG006|Base Period|Withdrawal by Subject|0|||
125418650|NCT01217073|451158519|FG007|Base Period|Withdrawal by Subject|0|||
125418651|NCT01217073|451158512|FG000|Extension Period|Adverse Event|0|||
125418652|NCT01217073|451158513|FG001|Extension Period|Adverse Event|0|||
125418653|NCT01217073|451158514|FG002|Extension Period|Adverse Event|0|||
125418654|NCT01217073|451158515|FG003|Extension Period|Adverse Event|0|||
125418655|NCT01217073|451158516|FG004|Extension Period|Adverse Event|0|||
125418656|NCT01217073|451158517|FG005|Extension Period|Adverse Event|0|||
125418657|NCT01217073|451158518|FG006|Extension Period|Adverse Event|19|||
125418658|NCT01217073|451158519|FG007|Extension Period|Adverse Event|5|||
125418659|NCT01217073|451158512|FG000|Extension Period|ALT/AST|0|||
125418660|NCT01217073|451158513|FG001|Extension Period|ALT/AST|0|||
125418661|NCT01217073|451158514|FG002|Extension Period|ALT/AST|0|||
125418662|NCT01217073|451158515|FG003|Extension Period|ALT/AST|0|||
125418663|NCT01217073|451158516|FG004|Extension Period|ALT/AST|0|||
125418664|NCT01217073|451158517|FG005|Extension Period|ALT/AST|0|||
125418665|NCT01217073|451158518|FG006|Extension Period|ALT/AST|2|||
125418666|NCT01217073|451158519|FG007|Extension Period|ALT/AST|0|||
125418667|NCT01217073|451158512|FG000|Extension Period|Contraindication to study medication|0|||
125418668|NCT01217073|451158513|FG001|Extension Period|Contraindication to study medication|0|||
125418669|NCT01217073|451158514|FG002|Extension Period|Contraindication to study medication|0|||
125418670|NCT01217073|451158515|FG003|Extension Period|Contraindication to study medication|0|||
125418671|NCT01217073|451158516|FG004|Extension Period|Contraindication to study medication|0|||
125418672|NCT01217073|451158517|FG005|Extension Period|Contraindication to study medication|0|||
125418673|NCT01217073|451158518|FG006|Extension Period|Contraindication to study medication|1|||
125418674|NCT01217073|451158519|FG007|Extension Period|Contraindication to study medication|0|||
125418675|NCT01217073|451158512|FG000|Extension Period|Creatinine/eGFR|0|||
125418676|NCT01217073|451158513|FG001|Extension Period|Creatinine/eGFR|0|||
125418677|NCT01217073|451158514|FG002|Extension Period|Creatinine/eGFR|0|||
125418678|NCT01217073|451158515|FG003|Extension Period|Creatinine/eGFR|0|||
125418679|NCT01217073|451158516|FG004|Extension Period|Creatinine/eGFR|0|||
125418680|NCT01217073|451158517|FG005|Extension Period|Creatinine/eGFR|0|||
125418681|NCT01217073|451158518|FG006|Extension Period|Creatinine/eGFR|11|||
125418682|NCT01217073|451158519|FG007|Extension Period|Creatinine/eGFR|1|||
125418683|NCT01217073|451158512|FG000|Extension Period|Death|0|||
125418684|NCT01217073|451158513|FG001|Extension Period|Death|0|||
125418685|NCT01217073|451158514|FG002|Extension Period|Death|0|||
125418686|NCT01217073|451158515|FG003|Extension Period|Death|0|||
125418687|NCT01217073|451158516|FG004|Extension Period|Death|0|||
125418688|NCT01217073|451158517|FG005|Extension Period|Death|0|||
125418689|NCT01217073|451158518|FG006|Extension Period|Death|1|||
125418690|NCT01217073|451158519|FG007|Extension Period|Death|0|||
125418691|NCT01217073|451158512|FG000|Extension Period|Excluded medication|0|||
125418692|NCT01217073|451158513|FG001|Extension Period|Excluded medication|0|||
125418693|NCT01217073|451158514|FG002|Extension Period|Excluded medication|0|||
125418694|NCT01217073|451158515|FG003|Extension Period|Excluded medication|0|||
125418695|NCT01217073|451158516|FG004|Extension Period|Excluded medication|0|||
125418696|NCT01217073|451158517|FG005|Extension Period|Excluded medication|0|||
125418697|NCT01217073|451158518|FG006|Extension Period|Excluded medication|2|||
125418698|NCT01217073|451158519|FG007|Extension Period|Excluded medication|0|||
125418699|NCT01217073|451158512|FG000|Extension Period|Lack of Efficacy|0|||
125418700|NCT01217073|451158513|FG001|Extension Period|Lack of Efficacy|0|||
125418701|NCT01217073|451158514|FG002|Extension Period|Lack of Efficacy|0|||
125418702|NCT01217073|451158515|FG003|Extension Period|Lack of Efficacy|0|||
125418703|NCT01217073|451158516|FG004|Extension Period|Lack of Efficacy|0|||
125418704|NCT01217073|451158517|FG005|Extension Period|Lack of Efficacy|0|||
125418705|NCT01217073|451158518|FG006|Extension Period|Lack of Efficacy|3|||
125418706|NCT01217073|451158519|FG007|Extension Period|Lack of Efficacy|0|||
125418707|NCT01217073|451158512|FG000|Extension Period|Lost to Follow-up|0|||
125418708|NCT01217073|451158513|FG001|Extension Period|Lost to Follow-up|0|||
125418709|NCT01217073|451158514|FG002|Extension Period|Lost to Follow-up|0|||
125418710|NCT01217073|451158515|FG003|Extension Period|Lost to Follow-up|0|||
125418711|NCT01217073|451158516|FG004|Extension Period|Lost to Follow-up|0|||
125418712|NCT01217073|451158517|FG005|Extension Period|Lost to Follow-up|0|||
125418713|NCT01217073|451158518|FG006|Extension Period|Lost to Follow-up|9|||
125418714|NCT01217073|451158519|FG007|Extension Period|Lost to Follow-up|1|||
125418715|NCT01217073|451158512|FG000|Extension Period|Non-compliance with study drug|0|||
125418716|NCT01217073|451158513|FG001|Extension Period|Non-compliance with study drug|0|||
125418717|NCT01217073|451158514|FG002|Extension Period|Non-compliance with study drug|0|||
125418718|NCT01217073|451158515|FG003|Extension Period|Non-compliance with study drug|0|||
125418719|NCT01217073|451158516|FG004|Extension Period|Non-compliance with study drug|0|||
125418720|NCT01217073|451158517|FG005|Extension Period|Non-compliance with study drug|0|||
125418721|NCT01217073|451158518|FG006|Extension Period|Non-compliance with study drug|0|||
125418722|NCT01217073|451158519|FG007|Extension Period|Non-compliance with study drug|1|||
125418723|NCT01217073|451158512|FG000|Extension Period|Physician Decision|0|||
125418724|NCT01217073|451158513|FG001|Extension Period|Physician Decision|0|||
125418725|NCT01217073|451158514|FG002|Extension Period|Physician Decision|0|||
125418726|NCT01217073|451158515|FG003|Extension Period|Physician Decision|0|||
125418727|NCT01217073|451158516|FG004|Extension Period|Physician Decision|0|||
125418728|NCT01217073|451158517|FG005|Extension Period|Physician Decision|0|||
125449564|NCT00662909|451273173|FG001|Overall Study|Adverse Event|18|||
125449565|NCT00662909|451273174|FG002|Overall Study|Adverse Event|19|||
125449566|NCT00662909|451273172|FG000|Overall Study|Lack of Efficacy|9|||
125418729|NCT01217073|451158518|FG006|Extension Period|Physician Decision|4|||
125418730|NCT01217073|451158519|FG007|Extension Period|Physician Decision|1|||
125418731|NCT01217073|451158512|FG000|Extension Period|Protocol Violation|0|||
125418732|NCT01217073|451158513|FG001|Extension Period|Protocol Violation|0|||
125418733|NCT01217073|451158514|FG002|Extension Period|Protocol Violation|0|||
125418734|NCT01217073|451158515|FG003|Extension Period|Protocol Violation|0|||
125418735|NCT01217073|451158516|FG004|Extension Period|Protocol Violation|0|||
125418736|NCT01217073|451158517|FG005|Extension Period|Protocol Violation|0|||
125418737|NCT01217073|451158518|FG006|Extension Period|Protocol Violation|2|||
125418738|NCT01217073|451158519|FG007|Extension Period|Protocol Violation|1|||
125418739|NCT01217073|451158512|FG000|Extension Period|Site discontinued study participation|0|||
125418740|NCT01217073|451158513|FG001|Extension Period|Site discontinued study participation|0|||
125449567|NCT00662909|451273173|FG001|Overall Study|Lack of Efficacy|1|||
125418741|NCT01217073|451158514|FG002|Extension Period|Site discontinued study participation|0|||
125418742|NCT01217073|451158515|FG003|Extension Period|Site discontinued study participation|0|||
125418743|NCT01217073|451158516|FG004|Extension Period|Site discontinued study participation|0|||
125418744|NCT01217073|451158517|FG005|Extension Period|Site discontinued study participation|0|||
125418745|NCT01217073|451158518|FG006|Extension Period|Site discontinued study participation|7|||
125418746|NCT01217073|451158519|FG007|Extension Period|Site discontinued study participation|2|||
125418747|NCT01217073|451158512|FG000|Extension Period|Withdrawal by Subject|0|||
125418748|NCT01217073|451158513|FG001|Extension Period|Withdrawal by Subject|0|||
125418749|NCT01217073|451158514|FG002|Extension Period|Withdrawal by Subject|0|||
125418750|NCT01217073|451158515|FG003|Extension Period|Withdrawal by Subject|0|||
125418751|NCT01217073|451158516|FG004|Extension Period|Withdrawal by Subject|0|||
125418752|NCT01217073|451158517|FG005|Extension Period|Withdrawal by Subject|0|||
125418753|NCT01217073|451158518|FG006|Extension Period|Withdrawal by Subject|30|||
125418754|NCT01217073|451158519|FG007|Extension Period|Withdrawal by Subject|8|||
125418755|NCT02564523|451158520|FG000|Overall Study|Withdrawal by Subject|3|||
125418756|NCT02564523|451158521|FG001|Overall Study|Withdrawal by Subject|0|||
125418757|NCT02564523|451158522|FG002|Overall Study|Withdrawal by Subject|1|||
125418758|NCT02564523|451158523|FG003|Overall Study|Withdrawal by Subject|0|||
125418759|NCT02564523|451158524|FG004|Overall Study|Withdrawal by Subject|1|||
125418760|NCT02564523|451158525|FG005|Overall Study|Withdrawal by Subject|0|||
125418761|NCT02564523|451158526|FG006|Overall Study|Withdrawal by Subject|1|||
125418762|NCT02564523|451158527|FG007|Overall Study|Withdrawal by Subject|0|||
125418763|NCT02564523|451158528|FG008|Overall Study|Withdrawal by Subject|0|||
125418764|NCT02564523|451158529|FG009|Overall Study|Withdrawal by Subject|0|||
125418765|NCT02564523|451158530|FG010|Overall Study|Withdrawal by Subject|1|||
125418766|NCT02564523|451158531|FG011|Overall Study|Withdrawal by Subject|0|||
125418767|NCT02564523|451158532|FG012|Overall Study|Withdrawal by Subject|1|||
125418768|NCT02564523|451158533|FG013|Overall Study|Withdrawal by Subject|0|||
125418769|NCT02564523|451158534|FG014|Overall Study|Withdrawal by Subject|0|||
125418770|NCT02564523|451158535|FG015|Overall Study|Withdrawal by Subject|0|||
125418771|NCT02564523|451158536|FG016|Overall Study|Withdrawal by Subject|0|||
125418772|NCT02564523|451158537|FG017|Overall Study|Withdrawal by Subject|0|||
125418773|NCT02564523|451158520|FG000|Overall Study|Adverse Event|0|||
125418774|NCT02564523|451158521|FG001|Overall Study|Adverse Event|0|||
125418775|NCT02564523|451158522|FG002|Overall Study|Adverse Event|0|||
125418776|NCT02564523|451158523|FG003|Overall Study|Adverse Event|0|||
125418777|NCT02564523|451158524|FG004|Overall Study|Adverse Event|0|||
125418778|NCT02564523|451158525|FG005|Overall Study|Adverse Event|0|||
125418779|NCT02564523|451158526|FG006|Overall Study|Adverse Event|0|||
125418780|NCT02564523|451158527|FG007|Overall Study|Adverse Event|0|||
125418781|NCT02564523|451158528|FG008|Overall Study|Adverse Event|0|||
125418782|NCT02564523|451158529|FG009|Overall Study|Adverse Event|0|||
125418783|NCT02564523|451158530|FG010|Overall Study|Adverse Event|0|||
125418784|NCT02564523|451158531|FG011|Overall Study|Adverse Event|0|||
125418785|NCT02564523|451158532|FG012|Overall Study|Adverse Event|0|||
125418786|NCT02564523|451158533|FG013|Overall Study|Adverse Event|0|||
125418787|NCT02564523|451158534|FG014|Overall Study|Adverse Event|0|||
125418788|NCT02564523|451158535|FG015|Overall Study|Adverse Event|0|||
125418789|NCT02564523|451158536|FG016|Overall Study|Adverse Event|0|||
125418790|NCT02564523|451158537|FG017|Overall Study|Adverse Event|1|||
125418791|NCT02564523|451158520|FG000|Overall Study|Death|0|||
125286769|NCT00090233|450676445|FG000|Overall Study|Withdrawal by Subject|182|||
125286770|NCT00090233|450676446|FG001|Overall Study|Withdrawal by Subject|211|||
125418792|NCT02564523|451158521|FG001|Overall Study|Death|0|||
125418793|NCT02564523|451158522|FG002|Overall Study|Death|0|||
125418794|NCT02564523|451158523|FG003|Overall Study|Death|0|||
125418795|NCT02564523|451158524|FG004|Overall Study|Death|0|||
125418796|NCT02564523|451158525|FG005|Overall Study|Death|0|||
125418797|NCT02564523|451158526|FG006|Overall Study|Death|1|||
125418798|NCT02564523|451158527|FG007|Overall Study|Death|0|||
125418799|NCT02564523|451158528|FG008|Overall Study|Death|0|||
125418800|NCT02564523|451158529|FG009|Overall Study|Death|0|||
125418801|NCT02564523|451158530|FG010|Overall Study|Death|1|||
125418802|NCT02564523|451158531|FG011|Overall Study|Death|0|||
125418803|NCT02564523|451158532|FG012|Overall Study|Death|0|||
125418804|NCT02564523|451158533|FG013|Overall Study|Death|0|||
125418805|NCT02564523|451158534|FG014|Overall Study|Death|0|||
125418806|NCT02564523|451158535|FG015|Overall Study|Death|0|||
125418807|NCT02564523|451158536|FG016|Overall Study|Death|0|||
125418808|NCT02564523|451158537|FG017|Overall Study|Death|0|||
125418809|NCT02564523|451158520|FG000|Overall Study|Lost to Follow-up|2|||
125418810|NCT02564523|451158521|FG001|Overall Study|Lost to Follow-up|1|||
125418811|NCT02564523|451158522|FG002|Overall Study|Lost to Follow-up|4|||
125418812|NCT02564523|451158523|FG003|Overall Study|Lost to Follow-up|0|||
125418813|NCT02564523|451158524|FG004|Overall Study|Lost to Follow-up|1|||
125418814|NCT02564523|451158525|FG005|Overall Study|Lost to Follow-up|0|||
125418815|NCT02564523|451158526|FG006|Overall Study|Lost to Follow-up|1|||
125418816|NCT02564523|451158527|FG007|Overall Study|Lost to Follow-up|0|||
125286771|NCT00090233|450676445|FG000|Overall Study|Moved|203|||
125418817|NCT02564523|451158528|FG008|Overall Study|Lost to Follow-up|0|||
125418818|NCT02564523|451158529|FG009|Overall Study|Lost to Follow-up|0|||
125418819|NCT02564523|451158530|FG010|Overall Study|Lost to Follow-up|0|||
125418820|NCT02564523|451158531|FG011|Overall Study|Lost to Follow-up|1|||
125418821|NCT02564523|451158532|FG012|Overall Study|Lost to Follow-up|1|||
125418822|NCT02564523|451158533|FG013|Overall Study|Lost to Follow-up|0|||
125418823|NCT02564523|451158534|FG014|Overall Study|Lost to Follow-up|0|||
125418824|NCT02564523|451158535|FG015|Overall Study|Lost to Follow-up|0|||
125418825|NCT02564523|451158536|FG016|Overall Study|Lost to Follow-up|0|||
125418826|NCT02564523|451158537|FG017|Overall Study|Lost to Follow-up|0|||
125418827|NCT02564523|451158520|FG000|Overall Study|Physician Decision|0|||
125418828|NCT02564523|451158521|FG001|Overall Study|Physician Decision|0|||
125418829|NCT02564523|451158522|FG002|Overall Study|Physician Decision|0|||
125418830|NCT02564523|451158523|FG003|Overall Study|Physician Decision|0|||
125418831|NCT02564523|451158524|FG004|Overall Study|Physician Decision|1|||
125418832|NCT02564523|451158525|FG005|Overall Study|Physician Decision|0|||
125418833|NCT02564523|451158526|FG006|Overall Study|Physician Decision|0|||
125418834|NCT02564523|451158527|FG007|Overall Study|Physician Decision|0|||
125418835|NCT02564523|451158528|FG008|Overall Study|Physician Decision|0|||
125418836|NCT02564523|451158529|FG009|Overall Study|Physician Decision|0|||
125418837|NCT02564523|451158530|FG010|Overall Study|Physician Decision|1|||
125418838|NCT02564523|451158531|FG011|Overall Study|Physician Decision|0|||
125418839|NCT02564523|451158532|FG012|Overall Study|Physician Decision|0|||
125418840|NCT02564523|451158533|FG013|Overall Study|Physician Decision|0|||
125418841|NCT02564523|451158534|FG014|Overall Study|Physician Decision|0|||
125418842|NCT02564523|451158535|FG015|Overall Study|Physician Decision|0|||
125418843|NCT02564523|451158536|FG016|Overall Study|Physician Decision|0|||
125418844|NCT02564523|451158537|FG017|Overall Study|Physician Decision|0|||
125418845|NCT02564523|451158520|FG000|Overall Study|Protocol Violation|2|||
125418846|NCT02564523|451158521|FG001|Overall Study|Protocol Violation|2|||
125418847|NCT02564523|451158522|FG002|Overall Study|Protocol Violation|5|||
125449568|NCT00662909|451273174|FG002|Overall Study|Lack of Efficacy|5|||
125449569|NCT00662909|451273172|FG000|Overall Study|Withdrawal by Subject|29|||
125449570|NCT00662909|451273173|FG001|Overall Study|Withdrawal by Subject|22|||
125449571|NCT00662909|451273174|FG002|Overall Study|Withdrawal by Subject|16|||
125449572|NCT00662909|451273172|FG000|Overall Study|Lost to Follow-up|2|||
125449573|NCT00662909|451273173|FG001|Overall Study|Lost to Follow-up|9|||
125449574|NCT00662909|451273174|FG002|Overall Study|Lost to Follow-up|3|||
125449575|NCT00662909|451273172|FG000|Overall Study|Protocol Violation|7|||
125449576|NCT00662909|451273173|FG001|Overall Study|Protocol Violation|4|||
125449577|NCT00662909|451273174|FG002|Overall Study|Protocol Violation|5|||
125449578|NCT00662909|451273172|FG000|Overall Study|Randomized- never received study drug|1|||
125449579|NCT00662909|451273173|FG001|Overall Study|Randomized- never received study drug|0|||
125449580|NCT00662909|451273174|FG002|Overall Study|Randomized- never received study drug|0|||
125449581|NCT00662909|451273172|FG000|Overall Study|Non-compliance with study procedures|3|||
125449582|NCT00662909|451273173|FG001|Overall Study|Non-compliance with study procedures|3|||
125449583|NCT00662909|451273174|FG002|Overall Study|Non-compliance with study procedures|2|||
125449584|NCT00662909|451273172|FG000|Overall Study|Physician Decision|1|||
125449585|NCT00662909|451273173|FG001|Overall Study|Physician Decision|1|||
125449586|NCT00662909|451273174|FG002|Overall Study|Physician Decision|2|||
125449587|NCT00662909|451273172|FG000|Overall Study|Eligibility criterion not met|0|||
125449588|NCT00662909|451273173|FG001|Overall Study|Eligibility criterion not met|1|||
125449589|NCT00662909|451273174|FG002|Overall Study|Eligibility criterion not met|1|||
125286772|NCT00090233|450676446|FG001|Overall Study|Moved|189|||
125449590|NCT01518257|451274758|FG000|Overall Study|Lost to Follow-up|1|||
125286773|NCT00090233|450676445|FG000|Overall Study|Other|1211|||
125286774|NCT00090233|450676446|FG001|Overall Study|Other|1160|||
125418848|NCT02564523|451158523|FG003|Overall Study|Protocol Violation|0|||
125418849|NCT02564523|451158524|FG004|Overall Study|Protocol Violation|1|||
125418850|NCT02564523|451158525|FG005|Overall Study|Protocol Violation|0|||
125418851|NCT02564523|451158526|FG006|Overall Study|Protocol Violation|0|||
125418852|NCT02564523|451158527|FG007|Overall Study|Protocol Violation|0|||
125418853|NCT02564523|451158528|FG008|Overall Study|Protocol Violation|0|||
125418854|NCT02564523|451158529|FG009|Overall Study|Protocol Violation|0|||
125418855|NCT02564523|451158530|FG010|Overall Study|Protocol Violation|0|||
125418856|NCT02564523|451158531|FG011|Overall Study|Protocol Violation|0|||
125418857|NCT02564523|451158532|FG012|Overall Study|Protocol Violation|0|||
125418858|NCT02564523|451158533|FG013|Overall Study|Protocol Violation|0|||
125418859|NCT02564523|451158534|FG014|Overall Study|Protocol Violation|0|||
125418860|NCT02564523|451158535|FG015|Overall Study|Protocol Violation|0|||
125418861|NCT02564523|451158536|FG016|Overall Study|Protocol Violation|0|||
125418862|NCT02564523|451158537|FG017|Overall Study|Protocol Violation|0|||
125418863|NCT02564523|451158520|FG000|Overall Study|Other|3|||
125418864|NCT02564523|451158521|FG001|Overall Study|Other|0|||
125286775|NCT00090233|450676445|FG000|Overall Study|Data not available at data cut-off point|1552|||
125418865|NCT02564523|451158522|FG002|Overall Study|Other|0|||
125418866|NCT02564523|451158523|FG003|Overall Study|Other|1|||
125449591|NCT01518257|451274759|FG001|Overall Study|Lost to Follow-up|0|||
125449592|NCT01518257|451274758|FG000|Overall Study|Other Miscellaneous Reason|1|||
125418867|NCT02564523|451158524|FG004|Overall Study|Other|0|||
125418868|NCT02564523|451158525|FG005|Overall Study|Other|0|||
125418869|NCT02564523|451158526|FG006|Overall Study|Other|0|||
125418870|NCT02564523|451158527|FG007|Overall Study|Other|0|||
125418871|NCT02564523|451158528|FG008|Overall Study|Other|0|||
125418872|NCT02564523|451158529|FG009|Overall Study|Other|0|||
125418873|NCT02564523|451158530|FG010|Overall Study|Other|0|||
125418874|NCT02564523|451158531|FG011|Overall Study|Other|0|||
125418875|NCT02564523|451158532|FG012|Overall Study|Other|0|||
125418876|NCT02564523|451158533|FG013|Overall Study|Other|0|||
125418877|NCT02564523|451158534|FG014|Overall Study|Other|0|||
125418878|NCT02564523|451158535|FG015|Overall Study|Other|0|||
125418879|NCT02564523|451158536|FG016|Overall Study|Other|0|||
125418880|NCT02564523|451158537|FG017|Overall Study|Other|0|||
125418881|NCT04862143|451158552|FG000|Overall Study|Adverse Event|1|||
125418882|NCT04862143|451158552|FG000|Overall Study|Study terminated by sponsor|1|||
125418883|NCT03031938|451158553|FG000|Overall Study|Death|1|||
125418884|NCT03031938|451158554|FG001|Overall Study|Death|0|||
125418885|NCT00454051|451158555|FG000|Overall Study|Adverse Event|1|||
125418886|NCT00454051|451158556|FG001|Overall Study|Adverse Event|2|||
125418887|NCT00454051|451158555|FG000|Overall Study|Withdrawal by Subject|1|||
125418888|NCT00454051|451158556|FG001|Overall Study|Withdrawal by Subject|0|||
125418889|NCT00454051|451158555|FG000|Overall Study|Protocol Violation|1|||
125418890|NCT00454051|451158556|FG001|Overall Study|Protocol Violation|1|||
125418891|NCT01571362|451158557|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
125418892|NCT01571362|451158558|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
125418893|NCT01571362|451158559|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
125418894|NCT01571362|451158557|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
125418895|NCT01571362|451158558|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
125418896|NCT01571362|451158559|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
125418897|NCT01571362|451158557|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
125418898|NCT01571362|451158558|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
125418899|NCT01571362|451158559|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
125418900|NCT01571362|451158557|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
125418901|NCT01571362|451158558|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
125418902|NCT01571362|451158559|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
125418903|NCT01571362|451158557|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
125418904|NCT01571362|451158558|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
125418905|NCT01571362|451158559|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
125418906|NCT01571362|451158557|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
125418907|NCT01571362|451158558|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
125418908|NCT01571362|451158559|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
125418909|NCT01571362|451158557|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
125418910|NCT01571362|451158558|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
125418911|NCT01571362|451158559|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
125418912|NCT01571362|451158557|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
125418913|NCT01571362|451158558|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
125418914|NCT01571362|451158559|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
125418915|NCT01571362|451158557|FG000|Double-Blind Treatment Period|Adverse Event|0|||
125418916|NCT01571362|451158558|FG001|Double-Blind Treatment Period|Adverse Event|9|||
125418917|NCT01571362|451158559|FG002|Double-Blind Treatment Period|Adverse Event|14|||
125418918|NCT01571362|451158557|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
125418919|NCT01571362|451158558|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
125418920|NCT01571362|451158559|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
125418921|NCT01571362|451158557|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
125418922|NCT01571362|451158558|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
125418923|NCT01571362|451158559|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
125418924|NCT01571362|451158557|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
125418925|NCT01571362|451158558|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
125449593|NCT01518257|451274759|FG001|Overall Study|Other Miscellaneous Reason|0|||
125449594|NCT00924664|451274760|FG000|Overall Study|Adverse Event|23|||
125418926|NCT01571362|451158559|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
125418927|NCT01491854|451158571|FG000|Overall Study|mainly due to premature termination|93|||
125418928|NCT01491854|451158571|FG000|Overall Study|Death|1|||
125418929|NCT01491854|451158571|FG000|Overall Study|Withdrawal by Subject|3|||
125418930|NCT01491854|451158571|FG000|Overall Study|Lost to Follow-up|33|||
125418931|NCT00121238|451158572|FG000|Overall Study|disease progression before intervention|1|||
125418932|NCT00121238|451158572|FG000|Overall Study|Protocol Violation|2|||
125418933|NCT01026974|451158584|FG000|Overall Study|Withdrawal by Subject|0|||
125418934|NCT01026974|451158585|FG001|Overall Study|Withdrawal by Subject|1|||
125418935|NCT01026974|451158586|FG002|Overall Study|Withdrawal by Subject|7|||
125418936|NCT01026974|451158587|FG003|Overall Study|Withdrawal by Subject|2|||
125418937|NCT01026974|451158584|FG000|Overall Study|Lost to Follow-up|1|||
125418938|NCT01026974|451158585|FG001|Overall Study|Lost to Follow-up|1|||
125418939|NCT01026974|451158586|FG002|Overall Study|Lost to Follow-up|4|||
125418940|NCT01026974|451158587|FG003|Overall Study|Lost to Follow-up|0|||
125418941|NCT01026974|451158584|FG000|Overall Study|Adverse Event|0|||
125418942|NCT01026974|451158585|FG001|Overall Study|Adverse Event|0|||
125418943|NCT01026974|451158586|FG002|Overall Study|Adverse Event|0|||
125418944|NCT01026974|451158587|FG003|Overall Study|Adverse Event|1|||
125418945|NCT01026974|451158584|FG000|Overall Study|Inappropriate enrollment|0|||
125418946|NCT01026974|451158585|FG001|Overall Study|Inappropriate enrollment|0|||
125418947|NCT01026974|451158586|FG002|Overall Study|Inappropriate enrollment|1|||
125418948|NCT01026974|451158587|FG003|Overall Study|Inappropriate enrollment|0|||
125418949|NCT00325468|451158589|FG000|Overall Study|Adverse Event|1|||
125418950|NCT00325468|451158590|FG001|Overall Study|Adverse Event|1|||
125418951|NCT00325468|451158591|FG002|Overall Study|Adverse Event|0|||
125418952|NCT00325468|451158592|FG003|Overall Study|Adverse Event|5|||
125418953|NCT00325468|451158593|FG004|Overall Study|Adverse Event|1|||
125418954|NCT00325468|451158589|FG000|Overall Study|Death|2|||
125418955|NCT00325468|451158590|FG001|Overall Study|Death|0|||
125418956|NCT00325468|451158591|FG002|Overall Study|Death|2|||
125418957|NCT00325468|451158592|FG003|Overall Study|Death|4|||
125418958|NCT00325468|451158593|FG004|Overall Study|Death|0|||
125418959|NCT00325468|451158589|FG000|Overall Study|Lost to Follow-up|0|||
125418960|NCT00325468|451158590|FG001|Overall Study|Lost to Follow-up|0|||
125418961|NCT00325468|451158591|FG002|Overall Study|Lost to Follow-up|1|||
125418962|NCT00325468|451158592|FG003|Overall Study|Lost to Follow-up|2|||
125418963|NCT00325468|451158593|FG004|Overall Study|Lost to Follow-up|2|||
125418964|NCT00325468|451158589|FG000|Overall Study|Physician Decision|1|||
125418965|NCT00325468|451158590|FG001|Overall Study|Physician Decision|1|||
125418966|NCT00325468|451158591|FG002|Overall Study|Physician Decision|0|||
125418967|NCT00325468|451158592|FG003|Overall Study|Physician Decision|1|||
125418968|NCT00325468|451158593|FG004|Overall Study|Physician Decision|0|||
125418969|NCT00325468|451158589|FG000|Overall Study|Withdrawal by Subject|3|||
125418970|NCT00325468|451158590|FG001|Overall Study|Withdrawal by Subject|1|||
125418971|NCT00325468|451158591|FG002|Overall Study|Withdrawal by Subject|0|||
125418972|NCT00325468|451158592|FG003|Overall Study|Withdrawal by Subject|14|||
125418973|NCT00325468|451158593|FG004|Overall Study|Withdrawal by Subject|4|||
125418974|NCT00325468|451158589|FG000|Overall Study|site closure etc|4|||
125418975|NCT00325468|451158590|FG001|Overall Study|site closure etc|2|||
125418976|NCT00325468|451158591|FG002|Overall Study|site closure etc|1|||
125418977|NCT00325468|451158592|FG003|Overall Study|site closure etc|8|||
125418978|NCT00325468|451158593|FG004|Overall Study|site closure etc|1|||
125418979|NCT03280121|451158594|FG000|Overall Study|Physician Decision|1|||
125418980|NCT03280121|451158594|FG000|Overall Study|Lost to Follow-up|1|||
125418981|NCT03280121|451158594|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
125418982|NCT00990652|451158595|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
125418983|NCT00990652|451158595|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
125418984|NCT00727272|451158609|FG000|Washout Period A|Adverse Event|0|||
125418985|NCT00727272|451158610|FG001|Washout Period A|Adverse Event|0|||
125418986|NCT00727272|451158611|FG002|Washout Period A|Adverse Event|1|||
125418987|NCT00727272|451158609|FG000|Washout Period B|Withdrawal by Subject|0|||
125418988|NCT00727272|451158610|FG001|Washout Period B|Withdrawal by Subject|0|||
125418989|NCT00727272|451158611|FG002|Washout Period B|Withdrawal by Subject|1|||
125418990|NCT00651664|451158612|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
125418991|NCT00651664|451158613|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
125418992|NCT00651664|451158614|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
125418993|NCT00651664|451158615|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
125418994|NCT00651664|451158616|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
125418995|NCT00651664|451158617|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
125418996|NCT00651664|451158618|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
125418997|NCT00651664|451158619|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
125418998|NCT00651664|451158620|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
125418999|NCT00651664|451158621|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
125419000|NCT00651664|451158612|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
125419001|NCT00651664|451158613|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
125419002|NCT00651664|451158614|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
125419003|NCT00651664|451158615|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
125419004|NCT00651664|451158616|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
125419005|NCT00651664|451158617|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
125419006|NCT00651664|451158618|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
125419007|NCT00651664|451158619|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
125419008|NCT00651664|451158620|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
125419009|NCT00651664|451158621|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
125419010|NCT00651664|451158612|FG000|Overall Study|Progressive Disease|3|||
125419011|NCT00651664|451158613|FG001|Overall Study|Progressive Disease|3|||
125419012|NCT00651664|451158614|FG002|Overall Study|Progressive Disease|3|||
125419013|NCT00651664|451158615|FG003|Overall Study|Progressive Disease|12|||
125286776|NCT00090233|450676446|FG001|Overall Study|Data not available at data cut-off point|1563|||
125286777|NCT04863248|450676447|FG000|Overall Study|Sponsor Terminated|4|||
125286778|NCT04863248|450676448|FG001|Overall Study|Sponsor Terminated|1|||
125286779|NCT04863248|450676447|FG000|Overall Study|Death|0|||
125286780|NCT04863248|450676448|FG001|Overall Study|Death|1|||
125286781|NCT04863248|450676447|FG000|Overall Study|Withdrawal by Subject|0|||
125286782|NCT04863248|450676448|FG001|Overall Study|Withdrawal by Subject|1|||
125286783|NCT01691105|450676449|FG000|1 Month Follow-up|Lost to Follow-up|41|||
125286784|NCT01691105|450676450|FG001|1 Month Follow-up|Lost to Follow-up|38|||
125286785|NCT01691105|450676449|FG000|1 Month Follow-up|Death|2|||
125286786|NCT01691105|450676450|FG001|1 Month Follow-up|Death|3|||
125286787|NCT01691105|450676449|FG000|6 Month Follow-up|Lost to Follow-up|39|||
125286788|NCT01691105|450676450|FG001|6 Month Follow-up|Lost to Follow-up|58|||
125286789|NCT01691105|450676449|FG000|6 Month Follow-up|Death|13|||
125286790|NCT01691105|450676450|FG001|6 Month Follow-up|Death|13|||
125286791|NCT01691105|450676449|FG000|12 Month Follow-up|Lost to Follow-up|50|||
125286792|NCT01691105|450676450|FG001|12 Month Follow-up|Lost to Follow-up|71|||
125286793|NCT01691105|450676449|FG000|12 Month Follow-up|Death|22|||
125286794|NCT01691105|450676450|FG001|12 Month Follow-up|Death|30|||
125286795|NCT01691105|450676449|FG000|12 Month Biochemical Verification|Death|22|||
125286796|NCT01691105|450676450|FG001|12 Month Biochemical Verification|Death|30|||
125286797|NCT01691105|450676449|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
125286798|NCT01691105|450676450|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
125286799|NCT01691105|450676449|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
125286800|NCT01691105|450676450|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
125286801|NCT03263923|450676451|FG000|Overall Study|Withdrawal by Subject|10|||
125286802|NCT03263923|450676452|FG001|Overall Study|Withdrawal by Subject|8|||
125286803|NCT03263923|450676451|FG000|Overall Study|Lost to Follow-up|15|||
125286804|NCT03263923|450676452|FG001|Overall Study|Lost to Follow-up|13|||
125286805|NCT03362931|450676453|FG000|Overall Study|Adverse Event|1|||
125286806|NCT03362931|450676453|FG000|Overall Study|Death|2|||
125286807|NCT02927925|450676462|FG000|Overall Study|Death|16|||
125286808|NCT02927925|450676462|FG000|Overall Study|Physician Decision|1|||
125286809|NCT02927925|450676462|FG000|Overall Study|Withdrawal by Subject|11|||
125286810|NCT02927925|450676462|FG000|Overall Study|Other|3|||
125286811|NCT02927925|450676462|FG000|Overall Study|Disease progression at clinical cutoff|1|||
125286812|NCT02229214|450676463|FG000|Overall Study|Adverse Event|2|||
125286813|NCT02229214|450676464|FG001|Overall Study|Adverse Event|0|||
125286814|NCT02229214|450676463|FG000|Overall Study|Withdrawal by Subject|4|||
125286815|NCT02229214|450676464|FG001|Overall Study|Withdrawal by Subject|0|||
125286816|NCT00969761|450676471|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
125286817|NCT00969761|450676472|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286818|NCT00969761|450676473|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286819|NCT00969761|450676474|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
125286820|NCT00969761|450676475|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286821|NCT00969761|450676476|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286822|NCT00969761|450676477|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286823|NCT00969761|450676478|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286824|NCT00969761|450676479|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
125286825|NCT00969761|450676480|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
125286826|NCT00969761|450676481|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286827|NCT00969761|450676482|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
125286828|NCT00969761|450676471|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286829|NCT00969761|450676472|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286830|NCT00969761|450676473|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
125286831|NCT00969761|450676474|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286832|NCT00969761|450676475|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286833|NCT00969761|450676476|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286834|NCT00969761|450676477|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286835|NCT00969761|450676478|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286836|NCT00969761|450676479|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286837|NCT00969761|450676480|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286838|NCT00969761|450676481|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286839|NCT00969761|450676482|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
125286840|NCT00969761|450676471|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286841|NCT00969761|450676472|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286842|NCT00969761|450676473|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
125286843|NCT00969761|450676474|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286844|NCT00969761|450676475|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286845|NCT00969761|450676476|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286846|NCT00969761|450676477|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286847|NCT00969761|450676478|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286848|NCT00969761|450676479|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286849|NCT00969761|450676480|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286850|NCT00969761|450676481|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286851|NCT00969761|450676482|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
125286852|NCT00969761|450676471|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286853|NCT00969761|450676472|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125419014|NCT00651664|451158616|FG004|Overall Study|Progressive Disease|4|||
125419015|NCT00651664|451158617|FG005|Overall Study|Progressive Disease|1|||
125419016|NCT00651664|451158618|FG006|Overall Study|Progressive Disease|3|||
125419017|NCT00651664|451158619|FG007|Overall Study|Progressive Disease|6|||
125419018|NCT00651664|451158620|FG008|Overall Study|Progressive Disease|5|||
125419019|NCT00651664|451158621|FG009|Overall Study|Progressive Disease|5|||
125419020|NCT00651664|451158612|FG000|Overall Study|Patient Declined Further Treatment|0|||
125419021|NCT00651664|451158613|FG001|Overall Study|Patient Declined Further Treatment|0|||
125419022|NCT00651664|451158614|FG002|Overall Study|Patient Declined Further Treatment|0|||
125419023|NCT00651664|451158615|FG003|Overall Study|Patient Declined Further Treatment|1|||
125419024|NCT00651664|451158616|FG004|Overall Study|Patient Declined Further Treatment|1|||
125419025|NCT00651664|451158617|FG005|Overall Study|Patient Declined Further Treatment|1|||
125419026|NCT00651664|451158618|FG006|Overall Study|Patient Declined Further Treatment|0|||
125419027|NCT00651664|451158619|FG007|Overall Study|Patient Declined Further Treatment|0|||
125419028|NCT00651664|451158620|FG008|Overall Study|Patient Declined Further Treatment|0|||
125419029|NCT00651664|451158621|FG009|Overall Study|Patient Declined Further Treatment|1|||
125419030|NCT00651664|451158612|FG000|Overall Study|Symptomatic Deterioration|0|||
125419031|NCT00651664|451158613|FG001|Overall Study|Symptomatic Deterioration|0|||
125419032|NCT00651664|451158614|FG002|Overall Study|Symptomatic Deterioration|0|||
125419033|NCT00651664|451158615|FG003|Overall Study|Symptomatic Deterioration|1|||
125419034|NCT00651664|451158616|FG004|Overall Study|Symptomatic Deterioration|0|||
125419035|NCT00651664|451158617|FG005|Overall Study|Symptomatic Deterioration|0|||
125419036|NCT00651664|451158618|FG006|Overall Study|Symptomatic Deterioration|1|||
125419037|NCT00651664|451158619|FG007|Overall Study|Symptomatic Deterioration|0|||
125419038|NCT00651664|451158620|FG008|Overall Study|Symptomatic Deterioration|1|||
125419039|NCT00651664|451158621|FG009|Overall Study|Symptomatic Deterioration|0|||
125419040|NCT00651664|451158612|FG000|Overall Study|Reason not Specified|0|||
125419041|NCT00651664|451158613|FG001|Overall Study|Reason not Specified|0|||
125419042|NCT00651664|451158614|FG002|Overall Study|Reason not Specified|0|||
125419043|NCT00651664|451158615|FG003|Overall Study|Reason not Specified|0|||
125419044|NCT00651664|451158616|FG004|Overall Study|Reason not Specified|0|||
125419045|NCT00651664|451158617|FG005|Overall Study|Reason not Specified|0|||
125419046|NCT00651664|451158618|FG006|Overall Study|Reason not Specified|1|||
125419047|NCT00651664|451158619|FG007|Overall Study|Reason not Specified|0|||
125419048|NCT00651664|451158620|FG008|Overall Study|Reason not Specified|0|||
125419049|NCT00651664|451158621|FG009|Overall Study|Reason not Specified|0|||
125419050|NCT00936858|451158622|FG000|Overall Study|Death|3|||
125419051|NCT00936858|451158622|FG000|Overall Study|Progression|29|||
125419052|NCT00936858|451158622|FG000|Overall Study|Withdrawal by Subject|5|||
125419053|NCT00936858|451158622|FG000|Overall Study|Adverse Event|1|||
125419054|NCT00936858|451158622|FG000|Overall Study|Physician Decision|7|||
125419055|NCT00936858|451158622|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
125419056|NCT00936858|451158622|FG000|Overall Study|Lost to Follow-up|1|||
125419057|NCT00989287|451158629|FG000|Overall Study|Adverse Event|1|||
125419058|NCT00989287|451158630|FG001|Overall Study|Adverse Event|0|||
125419059|NCT00989287|451158629|FG000|Overall Study|Lost to Follow-up|0|||
125419060|NCT00989287|451158630|FG001|Overall Study|Lost to Follow-up|1|||
125419061|NCT04403698|451158632|FG000|Overall Study|Adverse Event|1|||
125419062|NCT04403698|451158633|FG001|Overall Study|Adverse Event|1|||
125449595|NCT00924664|451274761|FG001|Overall Study|Adverse Event|39|||
125449596|NCT00924664|451274760|FG000|Overall Study|Lack of Efficacy|10|||
125286854|NCT00969761|450676473|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286855|NCT00969761|450676474|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286856|NCT00969761|450676475|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286857|NCT00969761|450676476|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125419063|NCT04403698|451158632|FG000|Overall Study|Lost to Follow-up|1|||
125419064|NCT04403698|451158633|FG001|Overall Study|Lost to Follow-up|0|||
125419065|NCT04403698|451158632|FG000|Overall Study|Protocol Violation|0|||
125419066|NCT04403698|451158633|FG001|Overall Study|Protocol Violation|1|||
125419067|NCT03152552|451158634|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
125419068|NCT03152552|451158635|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
125419069|NCT03152552|451158636|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
125449597|NCT00924664|451274761|FG001|Overall Study|Lack of Efficacy|15|||
125449598|NCT00924664|451274760|FG000|Overall Study|Lost to Follow-up|10|||
125449599|NCT00924664|451274761|FG001|Overall Study|Lost to Follow-up|12|||
125449600|NCT00924664|451274760|FG000|Overall Study|Withdrawal by Subject|47|||
125449601|NCT00924664|451274761|FG001|Overall Study|Withdrawal by Subject|71|||
125449602|NCT00924664|451274760|FG000|Overall Study|Protocol Violation|2|||
125449603|NCT00924664|451274761|FG001|Overall Study|Protocol Violation|5|||
125449604|NCT00924664|451274760|FG000|Overall Study|Pregnancy|1|||
125449605|NCT00924664|451274761|FG001|Overall Study|Pregnancy|1|||
125449606|NCT00924664|451274760|FG000|Overall Study|Death|0|||
125449607|NCT00924664|451274761|FG001|Overall Study|Death|2|||
125449608|NCT00924664|451274760|FG000|Overall Study|Study terminated by sponsor|199|||
125449609|NCT00924664|451274761|FG001|Overall Study|Study terminated by sponsor|330|||
125449610|NCT00924664|451274760|FG000|Overall Study|Other|29|||
125449611|NCT00924664|451274761|FG001|Overall Study|Other|52|||
125449612|NCT00924664|451274760|FG000|Overall Study|Randomized but not Treated|1|||
125449613|NCT00924664|451274761|FG001|Overall Study|Randomized but not Treated|0|||
125449614|NCT03158948|451274763|FG000|Overall Study|Death|1|||
125449615|NCT03158948|451274764|FG001|Overall Study|Death|1|||
125449616|NCT03158948|451274765|FG002|Overall Study|Death|3|||
125449617|NCT03158948|451274766|FG003|Overall Study|Death|2|||
125449618|NCT03158948|451274763|FG000|Overall Study|Physician Decision|0|||
125449619|NCT03158948|451274764|FG001|Overall Study|Physician Decision|0|||
125449620|NCT03158948|451274765|FG002|Overall Study|Physician Decision|0|||
125449621|NCT03158948|451274766|FG003|Overall Study|Physician Decision|1|||
125449622|NCT02153788|451274767|FG000|Overall Study|Physician Decision|2|||
125449623|NCT02153788|451274768|FG001|Overall Study|Physician Decision|1|||
125449624|NCT04672460|451274769|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
125449625|NCT04672460|451274770|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
125449626|NCT04672460|451274769|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
125449627|NCT04672460|451274770|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
125449628|NCT04672460|451274769|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
125449629|NCT04672460|451274770|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
125449630|NCT04672460|451274769|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
125449631|NCT04672460|451274770|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
125449632|NCT04672460|451274769|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
125449633|NCT04672460|451274770|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
125449634|NCT04672460|451274769|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
125449635|NCT04672460|451274770|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
125449636|NCT04672460|451274769|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
125449637|NCT04672460|451274770|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
125449638|NCT04672460|451274769|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
125449639|NCT04672460|451274770|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
125449640|NCT04672460|451274769|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
125449641|NCT04672460|451274770|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
125449642|NCT04672460|451274769|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
125449643|NCT04672460|451274770|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
125449644|NCT04672460|451274769|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
125449645|NCT04672460|451274770|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
125449646|NCT04672460|451274769|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
125449647|NCT04672460|451274770|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
125449648|NCT04672460|451274769|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
125449649|NCT04672460|451274770|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
125449650|NCT04672460|451274769|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
125449651|NCT04672460|451274770|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
125449652|NCT04672460|451274769|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
125449653|NCT04672460|451274770|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
125449654|NCT04672460|451274769|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
125449655|NCT04672460|451274770|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
125449656|NCT04672460|451274769|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
125449657|NCT04672460|451274770|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
125449658|NCT01876043|451274774|FG000|Overall Study|Death|1|||
125449659|NCT01876043|451274774|FG000|Overall Study|Withdrawal by Subject|1|||
125449660|NCT00079937|451274775|FG000|Overall Study|Adverse Event|2|||
125449661|NCT00079937|451274776|FG001|Overall Study|Adverse Event|1|||
125449662|NCT00079937|451274775|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125449663|NCT00079937|451274776|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125449664|NCT00079937|451274775|FG000|Overall Study|Subject no longer requires study drug|3|||
125449665|NCT00079937|451274776|FG001|Overall Study|Subject no longer requires study drug|0|||
125449666|NCT00079937|451274775|FG000|Overall Study|Protocol Violation|8|||
125449667|NCT00079937|451274776|FG001|Overall Study|Protocol Violation|6|||
125449668|NCT00079937|451274775|FG000|Overall Study|Withdrawal by Subject|21|||
125449669|NCT00079937|451274776|FG001|Overall Study|Withdrawal by Subject|7|||
125449670|NCT00079937|451274775|FG000|Overall Study|Lost to Follow-up|12|||
125449671|NCT00079937|451274776|FG001|Overall Study|Lost to Follow-up|5|||
125449672|NCT00079937|451274775|FG000|Overall Study|Administrative problems|22|||
125449673|NCT00079937|451274776|FG001|Overall Study|Administrative problems|11|||
125449674|NCT01616563|451274777|FG000|Overall Study|Lost to Follow-up|40|||
125449675|NCT02206685|451274778|FG000|Overall Study|Surgery cancelled/changed|2|||
125449676|NCT02206685|451274779|FG001|Overall Study|Surgery cancelled/changed|3|||
125449677|NCT02206685|451274778|FG000|Overall Study|Withdrawal by Subject|1|||
125449678|NCT02206685|451274779|FG001|Overall Study|Withdrawal by Subject|2|||
125449679|NCT02206685|451274778|FG000|Overall Study|Protocol Violation|2|||
125449680|NCT02206685|451274779|FG001|Overall Study|Protocol Violation|2|||
125449681|NCT00093795|451274783|FG000|Overall Study|No follow up data|20|||
125449682|NCT00093795|451274784|FG001|Overall Study|No follow up data|16|||
125449683|NCT00093795|451274785|FG002|Overall Study|No follow up data|17|||
125449684|NCT01195675|451274786|FG000|Overall Study|Adverse Event|1|||
125449685|NCT01195675|451274786|FG000|Overall Study|Withdrawal by Subject|2|||
125449686|NCT01106287|451274787|FG000|Overall Study|Adverse Event|1|||
125449687|NCT01106287|451274788|FG001|Overall Study|Adverse Event|0|||
125449688|NCT01106287|451274789|FG002|Overall Study|Adverse Event|0|||
125449689|NCT01106287|451274790|FG003|Overall Study|Adverse Event|0|||
125449690|NCT00072475|451274791|FG000|Overall Study|Adverse Event|44|||
125449691|NCT00072475|451274791|FG000|Overall Study|Death|3|||
125419070|NCT03152552|451158637|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
125419071|NCT03152552|451158638|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
125419072|NCT03152552|451158634|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
125419073|NCT03152552|451158635|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
125419074|NCT03152552|451158636|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
125419075|NCT03152552|451158637|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
125419076|NCT03152552|451158638|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
125419077|NCT03152552|451158634|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
125419078|NCT03152552|451158635|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
125419079|NCT03152552|451158636|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
125419080|NCT03152552|451158637|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
125419081|NCT03152552|451158638|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
125419082|NCT03152552|451158634|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125419083|NCT03152552|451158635|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125419084|NCT03152552|451158636|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
125419085|NCT03152552|451158637|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125419086|NCT03152552|451158638|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
125419087|NCT03152552|451158634|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
125419088|NCT03152552|451158635|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
125419089|NCT03152552|451158636|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
125419090|NCT03152552|451158637|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
125419091|NCT03152552|451158638|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
125419092|NCT03152552|451158634|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
125419093|NCT03152552|451158635|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
125419094|NCT03152552|451158636|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
125419095|NCT03152552|451158637|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
125419096|NCT03152552|451158638|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
125419097|NCT03152552|451158634|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
125419098|NCT03152552|451158635|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
125419099|NCT03152552|451158636|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
125419100|NCT03152552|451158637|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
125419101|NCT03152552|451158638|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
125419102|NCT03743038|451158639|FG000|Overall Study|Physician Decision|1|||
125419103|NCT01300546|451158640|FG000|Overall Study|Withdrawal by Subject|1|||
125449692|NCT00072475|451274791|FG000|Overall Study|Withdrawal by Subject|46|||
125449693|NCT00072475|451274791|FG000|Overall Study|Patient/Investigator Decision|4|||
125449694|NCT04730947|451274792|FG000|Overall Study|Withdrawal by Subject|0|||
125449695|NCT04730947|451274793|FG001|Overall Study|Withdrawal by Subject|1|||
125449696|NCT00940017|451274794|FG000|Overall Study|did not meet entrance criteria|3|||
125449697|NCT00940017|451274794|FG000|Overall Study|Adverse Event|1|||
125419104|NCT01300546|451158641|FG001|Overall Study|Withdrawal by Subject|0|||
125419105|NCT01300546|451158640|FG000|Overall Study|Lost to Follow-up|0|||
125419106|NCT01300546|451158641|FG001|Overall Study|Lost to Follow-up|2|||
125419107|NCT01300546|451158640|FG000|Overall Study|Lack of Efficacy|0|||
125449698|NCT01450943|451274797|FG000|Overall Study|Screen failure, loss to follow-up|2|||
125449699|NCT01450943|451274798|FG001|Overall Study|Screen failure, loss to follow-up|7|||
125449700|NCT01450943|451274799|FG002|Overall Study|Screen failure, loss to follow-up|6|||
125449701|NCT01684046|451274800|FG000|Period 1, First 30 Days|Adverse Event|0|||
125449702|NCT01684046|451274801|FG001|Period 1, First 30 Days|Adverse Event|2|||
125449703|NCT01097655|451274802|FG000|Overall Study|Withdrawal by Subject|1|||
125449704|NCT01097655|451274802|FG000|Overall Study|Subject Documented Twice|1|||
125419108|NCT01300546|451158641|FG001|Overall Study|Lack of Efficacy|3|||
125419109|NCT01300546|451158640|FG000|Overall Study|Adverse Event|0|||
125419110|NCT01300546|451158641|FG001|Overall Study|Adverse Event|1|||
125419111|NCT02820623|451158642|FG000|Overall Study|Withdrawal by Subject|1|||
125419112|NCT02820623|451158643|FG001|Overall Study|Withdrawal by Subject|3|||
125419113|NCT02820623|451158644|FG002|Overall Study|Withdrawal by Subject|3|||
125419114|NCT02820623|451158642|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
125419115|NCT02820623|451158643|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
125419116|NCT02820623|451158644|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
125419117|NCT02820623|451158642|FG000|Overall Study|Therapist unable to enroll clients|1|||
125419118|NCT02820623|451158643|FG001|Overall Study|Therapist unable to enroll clients|1|||
125419119|NCT02820623|451158644|FG002|Overall Study|Therapist unable to enroll clients|3|||
125419120|NCT02820623|451158642|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
125419121|NCT02820623|451158643|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
125419122|NCT02820623|451158644|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
125419123|NCT00435370|451158645|FG000|Overall Study|Adverse Event|8|||
125419124|NCT00435370|451158646|FG001|Overall Study|Adverse Event|8|||
125419125|NCT00435370|451158645|FG000|Overall Study|Withdrawal by Subject|10|||
125419126|NCT00435370|451158646|FG001|Overall Study|Withdrawal by Subject|10|||
125419127|NCT00435370|451158645|FG000|Overall Study|Antipsychotic medication changed|4|||
125419128|NCT00435370|451158646|FG001|Overall Study|Antipsychotic medication changed|2|||
125419129|NCT01965834|451158647|FG000|Overall Study|Lack of Efficacy|4|||
125419130|NCT03943095|451158648|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
125419131|NCT03943095|451158649|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
125419132|NCT03943095|451158648|FG000|Overall Study|Withdrawal by Subject|1|||
125419133|NCT03943095|451158649|FG001|Overall Study|Withdrawal by Subject|0|||
125419134|NCT00617344|451158651|FG000|Overall Study|Serious adverse event|1|||
125419135|NCT00617344|451158652|FG001|Overall Study|Serious adverse event|0|||
125419136|NCT00617344|451158653|FG002|Overall Study|Serious adverse event|0|||
125419137|NCT00617344|451158651|FG000|Overall Study|Other Adverse Event|1|||
125419138|NCT00617344|451158652|FG001|Overall Study|Other Adverse Event|1|||
125419139|NCT00617344|451158653|FG002|Overall Study|Other Adverse Event|0|||
125419140|NCT00617344|451158651|FG000|Overall Study|Protocol Violation|10|||
125419141|NCT00617344|451158652|FG001|Overall Study|Protocol Violation|8|||
125419142|NCT00617344|451158653|FG002|Overall Study|Protocol Violation|5|||
125419143|NCT00617344|451158651|FG000|Overall Study|Lost to Follow-up|5|||
125419144|NCT00617344|451158652|FG001|Overall Study|Lost to Follow-up|4|||
125419145|NCT00617344|451158653|FG002|Overall Study|Lost to Follow-up|1|||
125419146|NCT00617344|451158651|FG000|Overall Study|Withdrawal by Subject|8|||
125419147|NCT00617344|451158652|FG001|Overall Study|Withdrawal by Subject|9|||
125419148|NCT00617344|451158653|FG002|Overall Study|Withdrawal by Subject|2|||
125419149|NCT01864564|451158659|FG000|Overall Study|Lost to Follow-up|17|||
125419150|NCT01864564|451158660|FG001|Overall Study|Lost to Follow-up|23|||
125419151|NCT01864564|451158659|FG000|Overall Study|Withdrawal by Subject|20|||
125419152|NCT01864564|451158660|FG001|Overall Study|Withdrawal by Subject|11|||
125419153|NCT01864564|451158659|FG000|Overall Study|Protocol Violation|0|||
125419154|NCT01864564|451158660|FG001|Overall Study|Protocol Violation|27|||
125419155|NCT01864564|451158659|FG000|Overall Study|not reported|0|||
125419156|NCT01864564|451158660|FG001|Overall Study|not reported|34|||
125419157|NCT02269670|451158661|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
125419158|NCT00941330|451158662|FG000|Overall Study|Other|1|||
125419159|NCT00941330|451158663|FG001|Overall Study|Other|0|||
125419160|NCT00941330|451158662|FG000|Overall Study|Physician Decision|0|||
125419161|NCT00941330|451158663|FG001|Overall Study|Physician Decision|2|||
125419162|NCT02693665|451158664|FG000|Overall Study|Death|3|||
125419163|NCT02693665|451158665|FG001|Overall Study|Death|2|||
125419164|NCT02693665|451158664|FG000|Overall Study|Lost to Follow-up|7|||
125419165|NCT02693665|451158665|FG001|Overall Study|Lost to Follow-up|3|||
125419166|NCT02693665|451158664|FG000|Overall Study|Protocol Violation|1|||
125419167|NCT02693665|451158665|FG001|Overall Study|Protocol Violation|0|||
125286858|NCT00969761|450676477|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125419168|NCT02693665|451158664|FG000|Overall Study|Withdrawal by Subject|2|||
125419169|NCT02693665|451158665|FG001|Overall Study|Withdrawal by Subject|0|||
125419170|NCT02693665|451158664|FG000|Overall Study|patient wanted to leave it behind|1|||
125419171|NCT02693665|451158665|FG001|Overall Study|patient wanted to leave it behind|0|||
125419172|NCT02693665|451158664|FG000|Overall Study|anxiety|1|||
125419173|NCT02693665|451158665|FG001|Overall Study|anxiety|0|||
125419174|NCT02693665|451158664|FG000|Overall Study|family issues|1|||
125419175|NCT02693665|451158665|FG001|Overall Study|family issues|0|||
125419176|NCT02693665|451158664|FG000|Overall Study|no reason given|1|||
125419177|NCT02693665|451158665|FG001|Overall Study|no reason given|0|||
125419178|NCT00710424|451158668|FG000|Overall Study|Adverse Event|30|||
125419179|NCT00710424|451158669|FG001|Overall Study|Adverse Event|12|||
125419180|NCT00710424|451158668|FG000|Overall Study|Lack of Efficacy|4|||
125419181|NCT00710424|451158669|FG001|Overall Study|Lack of Efficacy|5|||
125419182|NCT00710424|451158668|FG000|Overall Study|Withdrawal by Subject|5|||
125286859|NCT00969761|450676478|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286860|NCT00969761|450676479|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
125286861|NCT00969761|450676480|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125419183|NCT00710424|451158669|FG001|Overall Study|Withdrawal by Subject|3|||
125419184|NCT00710424|451158668|FG000|Overall Study|Lost to Follow-up|0|||
125419185|NCT00710424|451158669|FG001|Overall Study|Lost to Follow-up|1|||
125419186|NCT00710424|451158668|FG000|Overall Study|Refused medication, no side effects|1|||
125419187|NCT00710424|451158669|FG001|Overall Study|Refused medication, no side effects|0|||
125419188|NCT00710424|451158668|FG000|Overall Study|Non-compliance with stable analgesia|1|||
125419189|NCT00710424|451158669|FG001|Overall Study|Non-compliance with stable analgesia|0|||
125419190|NCT00710424|451158668|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
125419191|NCT00710424|451158669|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
125419192|NCT00710424|451158668|FG000|Overall Study|Subject thought medication changed|1|||
125419193|NCT00710424|451158669|FG001|Overall Study|Subject thought medication changed|0|||
125419194|NCT00710424|451158668|FG000|Overall Study|Ceased treatment due to travel|1|||
125419195|NCT00710424|451158669|FG001|Overall Study|Ceased treatment due to travel|0|||
125419196|NCT00710424|451158668|FG000|Overall Study|Subject preferred paracetamol|0|||
125419197|NCT00710424|451158669|FG001|Overall Study|Subject preferred paracetamol|1|||
125419198|NCT00710424|451158668|FG000|Overall Study|Felt good so stopped treatment|0|||
125419199|NCT00710424|451158669|FG001|Overall Study|Felt good so stopped treatment|1|||
125419200|NCT01962493|451158672|FG000|Overall Study|Adverse Event|1|||
125419201|NCT01962493|451158673|FG001|Overall Study|Adverse Event|2|||
125419202|NCT01962493|451158672|FG000|Overall Study|Protocol Violation|0|||
125419203|NCT01962493|451158673|FG001|Overall Study|Protocol Violation|1|||
125419204|NCT01962493|451158672|FG000|Overall Study|Withdrawal by Subject|4|||
125419205|NCT01962493|451158673|FG001|Overall Study|Withdrawal by Subject|2|||
125419206|NCT06273774|451158674|FG000|Overall Study|Participant was out of state.|0|||
125419207|NCT06273774|451158675|FG001|Overall Study|Participant was out of state.|0|||
125419208|NCT06273774|451158676|FG002|Overall Study|Participant was out of state.|0|||
125419209|NCT06273774|451158677|FG003|Overall Study|Participant was out of state.|0|||
125419210|NCT06273774|451158678|FG004|Overall Study|Participant was out of state.|0|||
125419211|NCT06273774|451158679|FG005|Overall Study|Participant was out of state.|1|||
125419212|NCT06273774|451158674|FG000|Overall Study|Lost to Follow-up|0|||
125419213|NCT06273774|451158675|FG001|Overall Study|Lost to Follow-up|0|||
125419214|NCT06273774|451158676|FG002|Overall Study|Lost to Follow-up|0|||
125419215|NCT06273774|451158677|FG003|Overall Study|Lost to Follow-up|0|||
125419216|NCT06273774|451158678|FG004|Overall Study|Lost to Follow-up|1|||
125419217|NCT06273774|451158679|FG005|Overall Study|Lost to Follow-up|0|||
125419218|NCT04414696|451158685|FG000|3-month Follow up|Withdrawal by Subject|1|||
125419219|NCT04414696|451158686|FG001|3-month Follow up|Withdrawal by Subject|0|||
125419220|NCT04414696|451158685|FG000|3-month Follow up|Lost to Follow-up|22|||
125419221|NCT04414696|451158686|FG001|3-month Follow up|Lost to Follow-up|23|||
125419222|NCT04414696|451158685|FG000|6-month Follow up|Withdrawal by Subject|1|||
125419223|NCT04414696|451158686|FG001|6-month Follow up|Withdrawal by Subject|2|||
125419224|NCT04414696|451158685|FG000|6-month Follow up|Lost to Follow-up|5|||
125419225|NCT04414696|451158686|FG001|6-month Follow up|Lost to Follow-up|2|||
125419226|NCT00655980|451158687|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
125419227|NCT00655980|451158688|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
125419228|NCT00655980|451158689|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
125419229|NCT02985866|451160216|FG000|Overall Study|Poor CGM data|1|||
125419230|NCT02985866|451160217|FG001|Overall Study|Poor CGM data|1|||
125419231|NCT02811861|451160218|FG000|Overall Study|Radiological Disease Progression|123|||
125419232|NCT02811861|451160219|FG001|Overall Study|Radiological Disease Progression|97|||
125419233|NCT02811861|451160220|FG002|Overall Study|Radiological Disease Progression|174|||
125419234|NCT02811861|451160218|FG000|Overall Study|Clinical Disease Progression|20|||
125419235|NCT02811861|451160219|FG001|Overall Study|Clinical Disease Progression|19|||
125419236|NCT02811861|451160220|FG002|Overall Study|Clinical Disease Progression|22|||
125419237|NCT02811861|451160218|FG000|Overall Study|Adverse Event|63|||
125419238|NCT02811861|451160219|FG001|Overall Study|Adverse Event|60|||
125286862|NCT00969761|450676481|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286863|NCT00969761|450676482|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
125286864|NCT00969761|450676471|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
125286865|NCT00969761|450676472|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
125286866|NCT00969761|450676473|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
125286867|NCT00969761|450676474|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
125286868|NCT00969761|450676475|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
125286869|NCT00969761|450676476|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
125286870|NCT00969761|450676477|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
125286871|NCT00969761|450676478|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
125286872|NCT00969761|450676479|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
125286873|NCT00969761|450676480|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
125419239|NCT02811861|451160220|FG002|Overall Study|Adverse Event|41|||
125419240|NCT02811861|451160218|FG000|Overall Study|Lost to Follow-up|0|||
125419241|NCT02811861|451160219|FG001|Overall Study|Lost to Follow-up|0|||
125419242|NCT02811861|451160220|FG002|Overall Study|Lost to Follow-up|1|||
125419243|NCT02811861|451160218|FG000|Overall Study|Subject Choice|29|||
125419244|NCT02811861|451160219|FG001|Overall Study|Subject Choice|17|||
125419245|NCT02811861|451160220|FG002|Overall Study|Subject Choice|23|||
125419246|NCT02811861|451160218|FG000|Overall Study|Withdrawal by Subject|4|||
125419247|NCT02811861|451160219|FG001|Overall Study|Withdrawal by Subject|4|||
125419248|NCT02811861|451160220|FG002|Overall Study|Withdrawal by Subject|9|||
125419249|NCT02811861|451160218|FG000|Overall Study|Other|4|||
125419250|NCT02811861|451160219|FG001|Overall Study|Other|13|||
125419251|NCT02811861|451160220|FG002|Overall Study|Other|3|||
125419252|NCT02811861|451160218|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
125419253|NCT02811861|451160219|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
125419254|NCT02811861|451160220|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
125419255|NCT02811861|451160218|FG000|Overall Study|Randomized but not treated|2|||
125419256|NCT02811861|451160219|FG001|Overall Study|Randomized but not treated|3|||
125419257|NCT02811861|451160220|FG002|Overall Study|Randomized but not treated|17|||
125419258|NCT02925455|451160221|FG000|Overall Study|Withdrawal by Subject|2|||
125419259|NCT02925455|451160222|FG001|Overall Study|Withdrawal by Subject|0|||
125419260|NCT00686166|451160223|FG000|Overall Study|Adverse Event|7|||
125419261|NCT00686166|451160223|FG000|Overall Study|Withdrawal by Subject|1|||
125419262|NCT00686166|451160223|FG000|Overall Study|Progression/Relapse|1|||
125419263|NCT00686166|451160223|FG000|Overall Study|Death|1|||
125419264|NCT00686166|451160223|FG000|Overall Study|Not Protocol Specified|1|||
125419265|NCT00686166|451160223|FG000|Overall Study|Ineligible|5|||
125419266|NCT00686166|451160223|FG000|Overall Study|Did not begin protocol therapy|4|||
125419267|NCT00360308|451160224|FG000|Overall Study|Adverse Event|15|||
125419268|NCT00360308|451160225|FG001|Overall Study|Adverse Event|14|||
125419269|NCT00360308|451160226|FG002|Overall Study|Adverse Event|25|||
125419270|NCT00360308|451160224|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
125419271|NCT00360308|451160225|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
125419272|NCT00360308|451160226|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
125419273|NCT00360308|451160224|FG000|Overall Study|Protocol Violation|2|||
125419274|NCT00360308|451160225|FG001|Overall Study|Protocol Violation|1|||
125419275|NCT00360308|451160226|FG002|Overall Study|Protocol Violation|2|||
125419276|NCT00360308|451160224|FG000|Overall Study|Withdrawal by Subject|11|||
125419277|NCT00360308|451160225|FG001|Overall Study|Withdrawal by Subject|7|||
125419278|NCT00360308|451160226|FG002|Overall Study|Withdrawal by Subject|14|||
125419279|NCT00360308|451160224|FG000|Overall Study|Lack of Efficacy|3|||
125419280|NCT00360308|451160225|FG001|Overall Study|Lack of Efficacy|0|||
125419281|NCT00360308|451160226|FG002|Overall Study|Lack of Efficacy|2|||
125419282|NCT00360308|451160224|FG000|Overall Study|Other|2|||
125419283|NCT00360308|451160225|FG001|Overall Study|Other|1|||
125419284|NCT00360308|451160226|FG002|Overall Study|Other|1|||
125419285|NCT00360308|451160224|FG000|Overall Study|Study termination by sponsor|43|||
125419286|NCT00360308|451160225|FG001|Overall Study|Study termination by sponsor|55|||
125419287|NCT00360308|451160226|FG002|Overall Study|Study termination by sponsor|44|||
125419288|NCT02732938|451160227|FG000|Overall Study|Death|0|||
125419289|NCT02732938|451160228|FG001|Overall Study|Death|11|||
125419290|NCT02732938|451160229|FG002|Overall Study|Death|0|||
125419291|NCT02732938|451160227|FG000|Overall Study|Randomized but did not receive treatment|0|||
125419292|NCT02732938|451160228|FG001|Overall Study|Randomized but did not receive treatment|1|||
125449705|NCT01097655|451274802|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
125449706|NCT05458102|451274804|FG000|Overall Study|Withdrew consent|2|||
125449707|NCT05458102|451274805|FG001|Overall Study|Withdrew consent|0|||
125449708|NCT05458102|451274804|FG000|Overall Study|Adverse Event|1|||
125419293|NCT02732938|451160229|FG002|Overall Study|Randomized but did not receive treatment|0|||
125419294|NCT02732938|451160227|FG000|Overall Study|Refused further follow-up|1|||
125419295|NCT02732938|451160228|FG001|Overall Study|Refused further follow-up|0|||
125419296|NCT02732938|451160229|FG002|Overall Study|Refused further follow-up|0|||
125419297|NCT02732938|451160227|FG000|Overall Study|Study terminated by sponsor|3|||
125419298|NCT02732938|451160228|FG001|Overall Study|Study terminated by sponsor|6|||
125419299|NCT02732938|451160229|FG002|Overall Study|Study terminated by sponsor|0|||
125419300|NCT03927950|451160230|FG000|Overall Study|Adverse Event|9|||
125419301|NCT03647501|451160231|FG000|Overall Study|Lost to Follow-up|1|||
125419302|NCT03647501|451160232|FG001|Overall Study|Lost to Follow-up|1|||
125419303|NCT03647501|451160231|FG000|Overall Study|Withdrawal by Subject|0|||
125419304|NCT03647501|451160232|FG001|Overall Study|Withdrawal by Subject|1|||
125419305|NCT04530448|451160233|FG000|Overall Study|Physician Decision|3|||
125419306|NCT04530448|451160234|FG001|Overall Study|Physician Decision|0|||
125419307|NCT01613248|451160235|FG000|Overall Study|Adverse Event|0|||
125419308|NCT01613248|451160236|FG001|Overall Study|Adverse Event|0|||
125419309|NCT01613248|451160237|FG002|Overall Study|Adverse Event|0|||
125449709|NCT05458102|451274805|FG001|Overall Study|Adverse Event|0|||
125419310|NCT01613248|451160238|FG003|Overall Study|Adverse Event|1|||
125419311|NCT01613248|451160239|FG004|Overall Study|Adverse Event|0|||
125286874|NCT00969761|450676481|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
125286875|NCT00969761|450676482|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
125286876|NCT00969761|450676471|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286877|NCT00969761|450676472|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286878|NCT00969761|450676473|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286879|NCT00969761|450676474|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
125286880|NCT00969761|450676475|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
125286881|NCT00969761|450676476|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286882|NCT00969761|450676477|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286883|NCT00969761|450676478|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286884|NCT00969761|450676479|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
125286885|NCT00969761|450676480|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286886|NCT00969761|450676481|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286887|NCT00969761|450676482|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
125286888|NCT03305081|450676485|FG000|Overall Study|Lost to Follow-up|10|||
125286889|NCT03305081|450676486|FG001|Overall Study|Lost to Follow-up|15|||
125286890|NCT01571284|450676493|FG000|Overall Study|Participant's decision|84|||
125286891|NCT01571284|450676493|FG000|Overall Study|Lost to Follow-up|3|||
125286892|NCT01571284|450676493|FG000|Overall Study|Enrolled but not treated|2|||
125286893|NCT01571284|450676493|FG000|Overall Study|Other than specified above|80|||
125286894|NCT04065074|450676494|FG000|Overall Study|Adverse Event|1|||
125286895|NCT04065074|450676494|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
125286896|NCT00871117|450676495|FG000|Overall Study|Lost to Follow-up|5|||
125286897|NCT00871117|450676496|FG001|Overall Study|Lost to Follow-up|6|||
125286898|NCT00871117|450676495|FG000|Overall Study|Other|0|||
125286899|NCT00871117|450676496|FG001|Overall Study|Other|4|||
125286900|NCT03385265|450676500|FG000|Overall Study|Withdrawal by Subject|5|||
125286901|NCT03385265|450676501|FG001|Overall Study|Withdrawal by Subject|2|||
125286902|NCT03385265|450676502|FG002|Overall Study|Withdrawal by Subject|5|||
125286903|NCT03385265|450676503|FG003|Overall Study|Withdrawal by Subject|2|||
125286904|NCT01560637|450676504|FG000|Overall Study|Adverse Event|63|||
125286905|NCT01560637|450676504|FG000|Overall Study|Death|69|||
125286906|NCT01560637|450676504|FG000|Overall Study|Lost to Follow-up|8|||
125286907|NCT01560637|450676504|FG000|Overall Study|Protocol Violation|8|||
125286908|NCT01560637|450676504|FG000|Overall Study|Withdrawal by Subject|24|||
125286909|NCT01560637|450676504|FG000|Overall Study|Progressive Disease|20|||
125286910|NCT01560637|450676504|FG000|Overall Study|Other Reason Not Specified|6|||
125286911|NCT02323204|450676505|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
125286912|NCT02323204|450676506|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
125286913|NCT02323204|450676507|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
125286914|NCT02323204|450676508|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
125286915|NCT02323204|450676505|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
125286916|NCT02323204|450676506|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
125286917|NCT02323204|450676507|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
125286918|NCT02323204|450676508|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
125286919|NCT02323204|450676505|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
125286920|NCT02323204|450676506|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
125286921|NCT02323204|450676507|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
125286922|NCT02323204|450676508|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
125286923|NCT02323204|450676505|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
125286924|NCT02323204|450676506|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
125286925|NCT02323204|450676507|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
125286926|NCT02323204|450676508|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
125286927|NCT02323204|450676505|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
125286928|NCT02323204|450676506|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
125286929|NCT02323204|450676507|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
125286930|NCT02323204|450676508|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
125286931|NCT02323204|450676505|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
125286932|NCT02323204|450676506|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
125286933|NCT02323204|450676507|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
125286934|NCT02323204|450676508|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
125286935|NCT02323204|450676505|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
125419312|NCT01613248|451160240|FG005|Overall Study|Adverse Event|0|||
125286936|NCT02323204|450676506|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
125286937|NCT02323204|450676507|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
125419313|NCT01613248|451160235|FG000|Overall Study|Withdrawal by Subject|3|||
125286938|NCT02323204|450676508|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
125286939|NCT02323204|450676505|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
125419314|NCT01613248|451160236|FG001|Overall Study|Withdrawal by Subject|2|||
125419315|NCT01613248|451160237|FG002|Overall Study|Withdrawal by Subject|2|||
125286940|NCT02323204|450676506|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
125286941|NCT02323204|450676507|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
125286942|NCT02323204|450676508|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
125286943|NCT02323204|450676505|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
125286944|NCT02323204|450676506|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
125286945|NCT02323204|450676507|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
125286946|NCT02323204|450676508|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
125286947|NCT03831880|450676514|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
125286948|NCT03831880|450676515|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
125286949|NCT03831880|450676514|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
125286950|NCT03831880|450676515|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
125286951|NCT01852825|450676516|FG000|Overall Study|Withdrawal by Subject|2|||
125286952|NCT01852825|450676517|FG001|Overall Study|Withdrawal by Subject|0|||
125286953|NCT01852825|450676518|FG002|Overall Study|Withdrawal by Subject|0|||
125286954|NCT00724854|450676520|FG000|Overall Study|Lack of Efficacy|187|||
125286955|NCT00724854|450676521|FG001|Overall Study|Lack of Efficacy|13|||
125286956|NCT00724854|450676520|FG000|Overall Study|Lost to Follow-up|87|||
125286957|NCT00724854|450676521|FG001|Overall Study|Lost to Follow-up|10|||
125286958|NCT00724854|450676520|FG000|Overall Study|Adverse Event|62|||
125286959|NCT00724854|450676521|FG001|Overall Study|Adverse Event|4|||
125286960|NCT00724854|450676520|FG000|Overall Study|Other|42|||
125286961|NCT00724854|450676521|FG001|Overall Study|Other|3|||
125286962|NCT00724854|450676520|FG000|Overall Study|Death|11|||
125286963|NCT00724854|450676521|FG001|Overall Study|Death|0|||
125286964|NCT00724854|450676520|FG000|Overall Study|Change of treatment|7|||
125286965|NCT00724854|450676521|FG001|Overall Study|Change of treatment|0|||
125286966|NCT00724854|450676520|FG000|Overall Study|Withdrawal by Subject|5|||
125286967|NCT00724854|450676521|FG001|Overall Study|Withdrawal by Subject|0|||
125286968|NCT00724854|450676520|FG000|Overall Study|Adverse event + lack of efficacy|2|||
125286969|NCT00724854|450676521|FG001|Overall Study|Adverse event + lack of efficacy|1|||
125286970|NCT01095653|450676522|FG000|Overall Study|Lack of Efficacy|3|||
125286971|NCT01095653|450676523|FG001|Overall Study|Lack of Efficacy|0|||
125286972|NCT01095653|450676524|FG002|Overall Study|Lack of Efficacy|0|||
125286973|NCT01095653|450676522|FG000|Overall Study|Adverse Event|1|||
125286974|NCT01095653|450676523|FG001|Overall Study|Adverse Event|4|||
125286975|NCT01095653|450676524|FG002|Overall Study|Adverse Event|4|||
125286976|NCT01095653|450676522|FG000|Overall Study|Lost to Follow-up|1|||
125286977|NCT01095653|450676523|FG001|Overall Study|Lost to Follow-up|0|||
125286978|NCT01095653|450676524|FG002|Overall Study|Lost to Follow-up|4|||
125286979|NCT01095653|450676522|FG000|Overall Study|Withdrawal by Subject|4|||
125286980|NCT01095653|450676523|FG001|Overall Study|Withdrawal by Subject|5|||
125286981|NCT01095653|450676524|FG002|Overall Study|Withdrawal by Subject|3|||
125286982|NCT01095653|450676522|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
125286983|NCT01095653|450676523|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
125286984|NCT01095653|450676524|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
125286985|NCT00171925|450676525|FG000|Overall Study|Adverse Event|10|||
125286986|NCT00171925|450676526|FG001|Overall Study|Adverse Event|6|||
125286987|NCT00171925|450676525|FG000|Overall Study|Protocol Violation|1|||
125286988|NCT00171925|450676526|FG001|Overall Study|Protocol Violation|1|||
125286989|NCT00171925|450676525|FG000|Overall Study|Withdrawal by Subject|6|||
125286990|NCT00171925|450676526|FG001|Overall Study|Withdrawal by Subject|9|||
125286991|NCT00171925|450676525|FG000|Overall Study|Lost to Follow-up|2|||
125286992|NCT00171925|450676526|FG001|Overall Study|Lost to Follow-up|2|||
125286993|NCT00171925|450676525|FG000|Overall Study|Administrative problems|10|||
125286994|NCT00171925|450676526|FG001|Overall Study|Administrative problems|11|||
125286995|NCT00171925|450676525|FG000|Overall Study|Death|1|||
125286996|NCT00171925|450676526|FG001|Overall Study|Death|2|||
125286997|NCT02692040|450676527|FG000|Overall Study|Protocol Violation|0|||
125286998|NCT02692040|450676528|FG001|Overall Study|Protocol Violation|0|||
125286999|NCT02692040|450676529|FG002|Overall Study|Protocol Violation|0|||
125287000|NCT02692040|450676530|FG003|Overall Study|Protocol Violation|0|||
125287001|NCT02692040|450676531|FG004|Overall Study|Protocol Violation|0|||
125287002|NCT02692040|450676532|FG005|Overall Study|Protocol Violation|0|||
125287003|NCT02692040|450676533|FG006|Overall Study|Protocol Violation|0|||
125287004|NCT02692040|450676534|FG007|Overall Study|Protocol Violation|0|||
125287005|NCT02692040|450676535|FG008|Overall Study|Protocol Violation|0|||
125287006|NCT02692040|450676536|FG009|Overall Study|Protocol Violation|0|||
125287007|NCT02692040|450676537|FG010|Overall Study|Protocol Violation|0|||
125287008|NCT02692040|450676538|FG011|Overall Study|Protocol Violation|0|||
125287009|NCT02692040|450676539|FG012|Overall Study|Protocol Violation|1|||
125287010|NCT02692040|450676540|FG013|Overall Study|Protocol Violation|0|||
125287011|NCT02692040|450676541|FG014|Overall Study|Protocol Violation|0|||
125287012|NCT02692040|450676542|FG015|Overall Study|Protocol Violation|0|||
125287013|NCT02692040|450676543|FG016|Overall Study|Protocol Violation|0|||
125287014|NCT02692040|450676527|FG000|Overall Study|Adverse Event|0|||
125287015|NCT02692040|450676528|FG001|Overall Study|Adverse Event|0|||
125287016|NCT02692040|450676529|FG002|Overall Study|Adverse Event|0|||
125287017|NCT02692040|450676530|FG003|Overall Study|Adverse Event|0|||
125287018|NCT02692040|450676531|FG004|Overall Study|Adverse Event|0|||
125287019|NCT02692040|450676532|FG005|Overall Study|Adverse Event|0|||
125287020|NCT02692040|450676533|FG006|Overall Study|Adverse Event|0|||
125287021|NCT02692040|450676534|FG007|Overall Study|Adverse Event|0|||
125287022|NCT02692040|450676535|FG008|Overall Study|Adverse Event|0|||
125287023|NCT02692040|450676536|FG009|Overall Study|Adverse Event|0|||
125287024|NCT02692040|450676537|FG010|Overall Study|Adverse Event|0|||
125287025|NCT02692040|450676538|FG011|Overall Study|Adverse Event|0|||
125287026|NCT02692040|450676539|FG012|Overall Study|Adverse Event|0|||
125287027|NCT02692040|450676540|FG013|Overall Study|Adverse Event|3|||
125287028|NCT02692040|450676541|FG014|Overall Study|Adverse Event|1|||
125287029|NCT02692040|450676542|FG015|Overall Study|Adverse Event|1|||
125287030|NCT02692040|450676543|FG016|Overall Study|Adverse Event|0|||
125287031|NCT02752958|450676544|FG000|Overall Study|Adverse Event|3|||
125287032|NCT02752958|450676544|FG000|Overall Study|Lost to Follow-up|1|||
125287033|NCT02752958|450676544|FG000|Overall Study|Protocol Violation|1|||
125287034|NCT02752958|450676544|FG000|Overall Study|Withdrawal by Subject|2|||
125287035|NCT02752958|450676544|FG000|Overall Study|Other (Reason not specified)|2|||
125287036|NCT00853125|450676545|FG000|Overall Study|Study participant's donor was CMV +|1|||
125287037|NCT03746600|450676551|FG000|Overall Study|Withdrawal by Subject|3|||
125287038|NCT03746600|450676552|FG001|Overall Study|Withdrawal by Subject|3|||
125287039|NCT03746600|450676551|FG000|Overall Study|dismissed from study|1|||
125287040|NCT03746600|450676552|FG001|Overall Study|dismissed from study|0|||
125287041|NCT03746600|450676551|FG000|Overall Study|Lost to Follow-up|1|||
125287042|NCT03746600|450676552|FG001|Overall Study|Lost to Follow-up|0|||
125287043|NCT03023826|450676553|FG000|Period 1|Withdrawal by Subject|0|||
125287044|NCT03023826|450676554|FG001|Period 1|Withdrawal by Subject|0|||
125287045|NCT03023826|450676555|FG002|Period 1|Withdrawal by Subject|0|||
125287046|NCT03023826|450676556|FG003|Period 1|Withdrawal by Subject|0|||
125419316|NCT01613248|451160238|FG003|Overall Study|Withdrawal by Subject|5|||
125419317|NCT01613248|451160239|FG004|Overall Study|Withdrawal by Subject|0|||
125419318|NCT01613248|451160240|FG005|Overall Study|Withdrawal by Subject|1|||
125419319|NCT01613248|451160235|FG000|Overall Study|Lost to Follow-up|5|||
125419320|NCT01613248|451160236|FG001|Overall Study|Lost to Follow-up|7|||
125419321|NCT01613248|451160237|FG002|Overall Study|Lost to Follow-up|4|||
125419322|NCT01613248|451160238|FG003|Overall Study|Lost to Follow-up|8|||
125419323|NCT01613248|451160239|FG004|Overall Study|Lost to Follow-up|4|||
125419324|NCT01613248|451160240|FG005|Overall Study|Lost to Follow-up|2|||
125419325|NCT01613248|451160235|FG000|Overall Study|Study Terminated by Sponsor|4|||
125419326|NCT01613248|451160236|FG001|Overall Study|Study Terminated by Sponsor|6|||
125419327|NCT01613248|451160237|FG002|Overall Study|Study Terminated by Sponsor|8|||
125419328|NCT01613248|451160238|FG003|Overall Study|Study Terminated by Sponsor|8|||
125419329|NCT01613248|451160239|FG004|Overall Study|Study Terminated by Sponsor|9|||
125419330|NCT01613248|451160240|FG005|Overall Study|Study Terminated by Sponsor|11|||
125419331|NCT01613248|451160235|FG000|Overall Study|Physician Decision|8|||
125419332|NCT01613248|451160236|FG001|Overall Study|Physician Decision|8|||
125419333|NCT01613248|451160237|FG002|Overall Study|Physician Decision|9|||
125419334|NCT01613248|451160238|FG003|Overall Study|Physician Decision|4|||
125419335|NCT01613248|451160239|FG004|Overall Study|Physician Decision|7|||
125419336|NCT01613248|451160240|FG005|Overall Study|Physician Decision|6|||
125419337|NCT01613248|451160235|FG000|Overall Study|Lack of Qualifying Event|9|||
125419338|NCT01613248|451160236|FG001|Overall Study|Lack of Qualifying Event|11|||
125419339|NCT01613248|451160237|FG002|Overall Study|Lack of Qualifying Event|10|||
125419340|NCT01613248|451160238|FG003|Overall Study|Lack of Qualifying Event|11|||
125419341|NCT01613248|451160239|FG004|Overall Study|Lack of Qualifying Event|15|||
125419342|NCT01613248|451160240|FG005|Overall Study|Lack of Qualifying Event|18|||
125419343|NCT01613248|451160235|FG000|Overall Study|Pregnancy|0|||
125419344|NCT01613248|451160236|FG001|Overall Study|Pregnancy|0|||
125419345|NCT01613248|451160237|FG002|Overall Study|Pregnancy|0|||
125419346|NCT01613248|451160238|FG003|Overall Study|Pregnancy|1|||
125419347|NCT01613248|451160239|FG004|Overall Study|Pregnancy|0|||
125419348|NCT01613248|451160240|FG005|Overall Study|Pregnancy|0|||
125419349|NCT01433354|451160242|FG000|Overall Study|Adverse Event|6|||
125419350|NCT01433354|451160242|FG000|Overall Study|Lost to Follow-up|1|||
125419351|NCT01433354|451160242|FG000|Overall Study|Administrative problems|90|||
125287047|NCT03023826|450676557|FG004|Period 1|Withdrawal by Subject|1|||
125287048|NCT03023826|450676558|FG005|Period 1|Withdrawal by Subject|0|||
125287049|NCT00977938|450676559|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
125419352|NCT01433354|451160242|FG000|Overall Study|Protocol Violation|2|||
125287050|NCT00977938|450676560|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
125287051|NCT00977938|450676561|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
125419353|NCT01433354|451160242|FG000|Overall Study|Lack of Efficacy|17|||
125419354|NCT01433354|451160242|FG000|Overall Study|Subject Withdrew Consent|3|||
125419355|NCT02015676|451160249|FG000|Overall Study|Adverse Event|2|||
125419356|NCT02015676|451160250|FG001|Overall Study|Adverse Event|18|||
125419357|NCT02015676|451160251|FG002|Overall Study|Adverse Event|0|||
125419358|NCT02015676|451160249|FG000|Overall Study|Lack of Efficacy|2|||
125419359|NCT02015676|451160250|FG001|Overall Study|Lack of Efficacy|4|||
125419360|NCT02015676|451160251|FG002|Overall Study|Lack of Efficacy|0|||
125287052|NCT00977938|450676562|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
125287053|NCT00977938|450676559|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
125287054|NCT00977938|450676560|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
125287055|NCT00977938|450676561|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
125287056|NCT00977938|450676562|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
125287057|NCT00977938|450676559|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
125287058|NCT00977938|450676560|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
125287059|NCT00977938|450676561|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
125287060|NCT00977938|450676562|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
125287061|NCT00977938|450676559|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
125287062|NCT00977938|450676560|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
125287063|NCT00977938|450676561|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
125287064|NCT00977938|450676562|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
125287065|NCT00977938|450676559|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
125287066|NCT00977938|450676560|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
125287067|NCT00977938|450676561|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
125287068|NCT00977938|450676562|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
125287069|NCT00977938|450676559|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
125287070|NCT00977938|450676560|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
125287071|NCT00977938|450676561|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
125287072|NCT00977938|450676562|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
125287073|NCT02142283|450676565|FG000|Overall Study|Death|20|||
125287074|NCT02142283|450676566|FG001|Overall Study|Death|18|||
125287075|NCT02142283|450676565|FG000|Overall Study|Withdrawal by Subject|1|||
125287076|NCT02142283|450676566|FG001|Overall Study|Withdrawal by Subject|3|||
125287077|NCT00717522|450676567|FG000|Overall Study|Disease Progression|5|||
125287078|NCT00717522|450676567|FG000|Overall Study|Adverse Event|1|||
125287079|NCT00717522|450676567|FG000|Overall Study|Death|1|||
125287080|NCT02981407|450676572|FG000|Overall Study|Withdrawal by Subject|2|||
125287081|NCT02981407|450676573|FG001|Overall Study|Withdrawal by Subject|0|||
125287082|NCT00355342|450676576|FG000|Overall Study|Adverse Event|13|||
125287083|NCT00355342|450676577|FG001|Overall Study|Adverse Event|15|||
125287084|NCT00355342|450676576|FG000|Overall Study|Lost to Follow-up|4|||
125287085|NCT00355342|450676577|FG001|Overall Study|Lost to Follow-up|2|||
125287086|NCT00355342|450676576|FG000|Overall Study|Withdrawal by Subject|14|||
125287087|NCT00355342|450676577|FG001|Overall Study|Withdrawal by Subject|11|||
125287088|NCT00355342|450676576|FG000|Overall Study|Sponsor terminated study|2|||
125287089|NCT00355342|450676577|FG001|Overall Study|Sponsor terminated study|2|||
125287090|NCT00355342|450676576|FG000|Overall Study|Overcompliant-PI discretion|1|||
125287091|NCT00355342|450676577|FG001|Overall Study|Overcompliant-PI discretion|0|||
125287092|NCT00355342|450676576|FG000|Overall Study|Use of prohibited medication|1|||
125287093|NCT00355342|450676577|FG001|Overall Study|Use of prohibited medication|0|||
125287094|NCT00355342|450676576|FG000|Overall Study|COPD exacerbation|1|||
125287095|NCT00355342|450676577|FG001|Overall Study|COPD exacerbation|1|||
125287096|NCT00355342|450676576|FG000|Overall Study|Dispensed wrong study drug kit|1|||
125287097|NCT00355342|450676577|FG001|Overall Study|Dispensed wrong study drug kit|0|||
125287098|NCT00355342|450676576|FG000|Overall Study|Non-compliance with Dexa scans|1|||
125287099|NCT00355342|450676577|FG001|Overall Study|Non-compliance with Dexa scans|0|||
125287100|NCT00355342|450676576|FG000|Overall Study|Withdrawal by participant and physician|1|||
125287101|NCT00355342|450676577|FG001|Overall Study|Withdrawal by participant and physician|0|||
125287102|NCT00355342|450676576|FG000|Overall Study|Participant relocated|0|||
125287103|NCT00355342|450676577|FG001|Overall Study|Participant relocated|1|||
125287104|NCT00355342|450676576|FG000|Overall Study|Participant discontinued study drug|0|||
125287105|NCT00355342|450676577|FG001|Overall Study|Participant discontinued study drug|1|||
125287106|NCT00355342|450676576|FG000|Overall Study|Study management|0|||
125287107|NCT00355342|450676577|FG001|Overall Study|Study management|1|||
125287108|NCT00355342|450676576|FG000|Overall Study|Protocol Violation|0|||
125287109|NCT00355342|450676577|FG001|Overall Study|Protocol Violation|1|||
125287110|NCT00355342|450676576|FG000|Overall Study|Use of protocol excluded medication|0|||
125287111|NCT00355342|450676577|FG001|Overall Study|Use of protocol excluded medication|1|||
125287112|NCT01416441|450676578|FG000|Overall Study|Lost to Follow-up|5|||
125287113|NCT01416441|450676578|FG000|Overall Study|Adverse Event|6|||
125287114|NCT01416441|450676578|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
125287115|NCT01416441|450676578|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
125449710|NCT05458102|451274804|FG000|Overall Study|Enrolled but never treated|1|||
125287116|NCT01416441|450676578|FG000|Overall Study|Investigator Withdrew Subject|2|||
125287117|NCT01416441|450676578|FG000|Overall Study|Subject Withdrew Consent|12|||
125287118|NCT01416441|450676578|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
125287119|NCT02653495|450676583|FG000|Overall Study|Lost to Follow-up|2|||
125287120|NCT02653495|450676584|FG001|Overall Study|Lost to Follow-up|0|||
125287121|NCT02653495|450676583|FG000|Overall Study|Screening Failure|10|||
125449711|NCT05458102|451274805|FG001|Overall Study|Enrolled but never treated|0|||
125449712|NCT05458102|451274804|FG000|Overall Study|Protocol Violation|1|||
125287122|NCT02653495|450676584|FG001|Overall Study|Screening Failure|0|||
125287123|NCT00953680|450676585|FG000|Period 1|Withdrawal by Subject|0|||
125449713|NCT05458102|451274805|FG001|Overall Study|Protocol Violation|0|||
125449714|NCT05328973|451274812|FG000|Overall Study|Withdrawal by Subject|0|||
125449715|NCT05328973|451274813|FG001|Overall Study|Withdrawal by Subject|1|||
125449716|NCT00946114|451274814|FG000|Overall Study|Death|5|||
125449717|NCT00946114|451274815|FG001|Overall Study|Death|2|||
125449718|NCT00946114|451274814|FG000|Overall Study|Other|1|||
125449719|NCT00946114|451274815|FG001|Overall Study|Other|0|||
125449720|NCT00946114|451274814|FG000|Overall Study|Withdrawal by Subject|2|||
125449721|NCT00946114|451274815|FG001|Overall Study|Withdrawal by Subject|0|||
125449722|NCT01764386|451274819|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
125449723|NCT01764386|451274820|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
125449724|NCT01764386|451274819|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
125449725|NCT01764386|451274820|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
125449726|NCT01764386|451274819|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
125449727|NCT01764386|451274820|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
125449728|NCT01764386|451274819|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
125449729|NCT01764386|451274820|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
125449730|NCT01764386|451274819|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
125449731|NCT01764386|451274820|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
125449732|NCT01764386|451274819|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
125449733|NCT01764386|451274820|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
125449734|NCT01764386|451274819|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
125287124|NCT00953680|450676586|FG001|Period 1|Withdrawal by Subject|1|||
125287125|NCT01360398|450676587|FG000|Overall Study|Withdrawal by Subject|14|||
125287126|NCT01360398|450676587|FG000|Overall Study|Other|7|||
125287127|NCT01360398|450676587|FG000|Overall Study|Migrated/moved from study area|1|||
125287128|NCT00624780|450676591|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
125287129|NCT00624780|450676592|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
125287130|NCT00624780|450676593|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
125287131|NCT00624780|450676594|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
125287132|NCT00624780|450676595|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
125287133|NCT00624780|450676596|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
125287134|NCT00624780|450676591|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
125287135|NCT00624780|450676592|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
125287136|NCT00624780|450676593|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
125287137|NCT00624780|450676594|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
125287138|NCT00624780|450676595|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
125287139|NCT00624780|450676596|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
125287140|NCT00624780|450676591|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
125287141|NCT00624780|450676592|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
125287142|NCT00624780|450676593|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
125287143|NCT00624780|450676594|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
125287144|NCT00624780|450676595|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
125287145|NCT00624780|450676596|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
125287146|NCT00624780|450676591|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
125287147|NCT00624780|450676592|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
125287148|NCT00624780|450676593|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
125287149|NCT00624780|450676594|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
125287150|NCT00624780|450676595|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
125287151|NCT00624780|450676596|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
125287152|NCT00624780|450676591|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
125287153|NCT00624780|450676592|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
125287154|NCT00624780|450676593|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
125287155|NCT00624780|450676594|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
125419361|NCT02015676|451160249|FG000|Overall Study|Protocol Violation|1|||
125419362|NCT02015676|451160250|FG001|Overall Study|Protocol Violation|0|||
125419363|NCT02015676|451160251|FG002|Overall Study|Protocol Violation|0|||
125419364|NCT02015676|451160249|FG000|Overall Study|Withdrawal by Subject|1|||
125419365|NCT02015676|451160250|FG001|Overall Study|Withdrawal by Subject|7|||
125419366|NCT02015676|451160251|FG002|Overall Study|Withdrawal by Subject|1|||
125419367|NCT02015676|451160249|FG000|Overall Study|Administrative reasons|0|||
125419368|NCT02015676|451160250|FG001|Overall Study|Administrative reasons|3|||
125419369|NCT02015676|451160251|FG002|Overall Study|Administrative reasons|1|||
125419370|NCT02015676|451160249|FG000|Overall Study|Death|0|||
125419371|NCT02015676|451160250|FG001|Overall Study|Death|1|||
125419372|NCT02015676|451160251|FG002|Overall Study|Death|0|||
125419373|NCT02015676|451160249|FG000|Overall Study|Disease progression|3|||
125419374|NCT02015676|451160250|FG001|Overall Study|Disease progression|1|||
125287156|NCT00624780|450676595|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
125287157|NCT00624780|450676596|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
125287158|NCT00624780|450676591|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
125287159|NCT00624780|450676592|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
125287160|NCT00624780|450676593|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
125287161|NCT00624780|450676594|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
125287162|NCT00624780|450676595|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
125287163|NCT00624780|450676596|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
125287164|NCT00624780|450676591|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
125287165|NCT00624780|450676592|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
125287166|NCT00624780|450676593|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
125287167|NCT00624780|450676594|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
125287168|NCT00624780|450676595|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
125287169|NCT00624780|450676596|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
125287170|NCT00624780|450676591|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
125287171|NCT00624780|450676592|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
125287172|NCT00624780|450676593|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
125287173|NCT00624780|450676594|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
125287174|NCT00624780|450676595|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
125287175|NCT00624780|450676596|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
125287176|NCT00624780|450676591|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
125287177|NCT00624780|450676592|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
125287178|NCT00624780|450676593|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
125287179|NCT00624780|450676594|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
125287180|NCT00624780|450676595|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
125287181|NCT00624780|450676596|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
125287182|NCT00624780|450676591|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
125287183|NCT00624780|450676592|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
125287184|NCT00624780|450676593|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
125287185|NCT00624780|450676594|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
125287186|NCT00624780|450676595|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
125287187|NCT00624780|450676596|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
125287188|NCT00624780|450676591|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
125287189|NCT00624780|450676592|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
125287190|NCT00624780|450676593|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
125287191|NCT00624780|450676594|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
125287192|NCT00624780|450676595|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
125287193|NCT00624780|450676596|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
125287194|NCT00624780|450676591|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
125287195|NCT00624780|450676592|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
125287196|NCT00624780|450676593|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
125287197|NCT00624780|450676594|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
125287198|NCT00624780|450676595|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
125287199|NCT00624780|450676596|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
125287200|NCT00624780|450676591|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
125287201|NCT00624780|450676592|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
125287202|NCT00624780|450676593|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
125287203|NCT00624780|450676594|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
125287204|NCT00624780|450676595|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
125287205|NCT00624780|450676596|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
125287206|NCT00624780|450676591|FG000|Follow-up (Week 26)|Death|0|||
125287207|NCT00624780|450676592|FG001|Follow-up (Week 26)|Death|0|||
125287208|NCT00624780|450676593|FG002|Follow-up (Week 26)|Death|1|||
125287209|NCT00624780|450676594|FG003|Follow-up (Week 26)|Death|0|||
125287210|NCT00624780|450676595|FG004|Follow-up (Week 26)|Death|0|||
125287211|NCT00624780|450676596|FG005|Follow-up (Week 26)|Death|0|||
125287212|NCT00624780|450676591|FG000|Follow-up (Week 26)|Adverse Event|0|||
125287213|NCT00624780|450676592|FG001|Follow-up (Week 26)|Adverse Event|0|||
125287214|NCT00624780|450676593|FG002|Follow-up (Week 26)|Adverse Event|0|||
125287215|NCT00624780|450676594|FG003|Follow-up (Week 26)|Adverse Event|0|||
125287216|NCT00624780|450676595|FG004|Follow-up (Week 26)|Adverse Event|1|||
125287217|NCT00624780|450676596|FG005|Follow-up (Week 26)|Adverse Event|0|||
125287218|NCT00624780|450676591|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
125287219|NCT00624780|450676592|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
125287220|NCT00624780|450676593|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
125287221|NCT00624780|450676594|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
125287222|NCT00624780|450676595|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
125287223|NCT00624780|450676596|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
125287224|NCT00624780|450676591|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
125287225|NCT00624780|450676592|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
125287226|NCT00624780|450676593|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
125287227|NCT00624780|450676594|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
125287228|NCT00624780|450676595|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
125287229|NCT00624780|450676596|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
125287230|NCT00624780|450676591|FG000|Follow-up (Week 26)|Other|1|||
125287231|NCT00624780|450676592|FG001|Follow-up (Week 26)|Other|1|||
125287232|NCT00624780|450676593|FG002|Follow-up (Week 26)|Other|0|||
125287233|NCT00624780|450676594|FG003|Follow-up (Week 26)|Other|0|||
125287234|NCT00624780|450676595|FG004|Follow-up (Week 26)|Other|0|||
125287235|NCT00624780|450676596|FG005|Follow-up (Week 26)|Other|0|||
125287236|NCT01514240|450678612|FG000|Overall Study|Adverse Event|4|||
125287237|NCT01514240|450678613|FG001|Overall Study|Adverse Event|4|||
125287238|NCT01514240|450678612|FG000|Overall Study|Subject Decision|2|||
125287239|NCT01514240|450678613|FG001|Overall Study|Subject Decision|7|||
125287240|NCT00549900|450678615|FG000|Overall Study|Adverse Event|1|||
125287241|NCT01007123|450678620|FG000|Overall Study|Adverse Event|3|||
125287242|NCT01007123|450678621|FG001|Overall Study|Adverse Event|4|||
125287243|NCT01007123|450678622|FG002|Overall Study|Adverse Event|7|||
125287244|NCT01007123|450678623|FG003|Overall Study|Adverse Event|1|||
125287245|NCT01007123|450678620|FG000|Overall Study|Lack of Efficacy|1|||
125287246|NCT01007123|450678621|FG001|Overall Study|Lack of Efficacy|0|||
125287247|NCT01007123|450678622|FG002|Overall Study|Lack of Efficacy|1|||
125287248|NCT01007123|450678623|FG003|Overall Study|Lack of Efficacy|4|||
125287249|NCT01007123|450678620|FG000|Overall Study|Protocol Violation|1|||
125287250|NCT01007123|450678621|FG001|Overall Study|Protocol Violation|1|||
125287251|NCT01007123|450678622|FG002|Overall Study|Protocol Violation|2|||
125287252|NCT01007123|450678623|FG003|Overall Study|Protocol Violation|1|||
125287253|NCT01007123|450678620|FG000|Overall Study|Withdrawal by Subject|1|||
125287254|NCT01007123|450678621|FG001|Overall Study|Withdrawal by Subject|0|||
125287255|NCT01007123|450678622|FG002|Overall Study|Withdrawal by Subject|1|||
125287256|NCT01007123|450678623|FG003|Overall Study|Withdrawal by Subject|0|||
125287257|NCT01007123|450678620|FG000|Overall Study|Lost to Follow-up|0|||
125287258|NCT01007123|450678621|FG001|Overall Study|Lost to Follow-up|1|||
125287259|NCT01007123|450678622|FG002|Overall Study|Lost to Follow-up|0|||
125287260|NCT01007123|450678623|FG003|Overall Study|Lost to Follow-up|0|||
125287261|NCT00149994|450678624|FG000|Overall Study|Administrative problems:|1|||
125287262|NCT00149994|450678625|FG001|Overall Study|Administrative problems:|0|||
125287263|NCT00149994|450678624|FG000|Overall Study|Protocol Violation|0|||
125287264|NCT00149994|450678625|FG001|Overall Study|Protocol Violation|1|||
125287265|NCT00613925|450678628|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
125287266|NCT00613925|450678629|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
125287267|NCT00252694|450678632|FG000|Overall Study|Withdrawal by Subject|83|||
125287268|NCT00252694|450678633|FG001|Overall Study|Withdrawal by Subject|91|||
125287269|NCT00252694|450678632|FG000|Overall Study|Death|36|||
125287270|NCT00252694|450678633|FG001|Overall Study|Death|34|||
125287271|NCT00252694|450678632|FG000|Overall Study|Mostly Lost to Follow Up|8|||
125287272|NCT00252694|450678633|FG001|Overall Study|Mostly Lost to Follow Up|13|||
125287273|NCT00252694|450678632|FG000|Overall Study|Patient Moving|17|||
125287274|NCT00252694|450678633|FG001|Overall Study|Patient Moving|16|||
125287275|NCT01342965|450678634|FG000|Overall Study|Death|58|||
125287276|NCT01342965|450678635|FG001|Overall Study|Death|57|||
125287277|NCT01342965|450678634|FG000|Overall Study|Lost to Follow-up|5|||
125287278|NCT01342965|450678635|FG001|Overall Study|Lost to Follow-up|3|||
125287279|NCT01342965|450678634|FG000|Overall Study|Other Reasons- Unspecified|44|||
125287280|NCT01342965|450678635|FG001|Overall Study|Other Reasons- Unspecified|38|||
125287281|NCT01342965|450678634|FG000|Overall Study|Withdrawal by Subject|2|||
125287282|NCT01342965|450678635|FG001|Overall Study|Withdrawal by Subject|9|||
125287283|NCT03538444|450678646|FG000|Overall Study|opioid withdrawal|1|||
125419375|NCT02015676|451160251|FG002|Overall Study|Disease progression|1|||
125287284|NCT03538444|450678647|FG001|Overall Study|opioid withdrawal|0|||
125287285|NCT04644237|450678659|FG000|Overall Study|Death|3|||
125287286|NCT04644237|450678660|FG001|Overall Study|Death|2|||
125287287|NCT04644237|450678659|FG000|Overall Study|Adverse Event|15|||
125287288|NCT04644237|450678660|FG001|Overall Study|Adverse Event|12|||
125287289|NCT04644237|450678659|FG000|Overall Study|Progressive Disease|47|||
125287290|NCT04644237|450678660|FG001|Overall Study|Progressive Disease|19|||
125287291|NCT04644237|450678659|FG000|Overall Study|Clinical Progression|4|||
125419376|NCT02013622|451160257|FG000|Overall Study|Lost to Follow-up|10|||
125419377|NCT02013622|451160257|FG000|Overall Study|Adverse Event|3|||
125287292|NCT04644237|450678660|FG001|Overall Study|Clinical Progression|1|||
125287293|NCT04644237|450678659|FG000|Overall Study|Withdrawal by Subject|1|||
125287294|NCT04644237|450678660|FG001|Overall Study|Withdrawal by Subject|2|||
125287295|NCT04644237|450678659|FG000|Overall Study|Physician Decision|3|||
125287296|NCT04644237|450678660|FG001|Overall Study|Physician Decision|0|||
125287297|NCT04644237|450678659|FG000|Overall Study|Other|1|||
125287298|NCT04644237|450678660|FG001|Overall Study|Other|0|||
125287299|NCT04644237|450678659|FG000|Overall Study|Randomized but not Treated|1|||
125287300|NCT04644237|450678660|FG001|Overall Study|Randomized but not Treated|0|||
125287301|NCT01779869|450678661|FG000|Overall Study|Physician Decision|2|||
125419378|NCT02013622|451160257|FG000|Overall Study|Met Withdrawal Criteria|3|||
125287302|NCT02233738|450678663|FG000|Overall Study|Lost to Follow-up|5|||
125287303|NCT02233738|450678664|FG001|Overall Study|Lost to Follow-up|12|||
125287304|NCT02233738|450678663|FG000|Overall Study|Death|0|||
125287305|NCT02233738|450678664|FG001|Overall Study|Death|1|||
125287306|NCT02233738|450678663|FG000|Overall Study|Withdrawal by Subject|0|||
125287307|NCT02233738|450678664|FG001|Overall Study|Withdrawal by Subject|1|||
125419379|NCT02013622|451160257|FG000|Overall Study|Withdrawal by Subject|6|||
125419380|NCT02013622|451160257|FG000|Overall Study|Protocol Deviation|1|||
125419381|NCT02013622|451160257|FG000|Overall Study|Lack of Efficacy|1|||
125287308|NCT02233738|450678663|FG000|Overall Study|Did not return after Baseline|3|||
125287309|NCT02233738|450678664|FG001|Overall Study|Did not return after Baseline|2|||
125287310|NCT00096174|450678665|FG000|Overall Study|Lack of Efficacy|9|||
125287311|NCT00096174|450678665|FG000|Overall Study|Adverse Event|15|||
125287312|NCT00096174|450678665|FG000|Overall Study|Death|6|||
125287313|NCT00096174|450678665|FG000|Overall Study|Withdrawal by Subject|15|||
125287314|NCT00096174|450678665|FG000|Overall Study|Not started protocol therapy|3|||
125287315|NCT00096174|450678665|FG000|Overall Study|Ineligible|6|||
125287316|NCT00096174|450678665|FG000|Overall Study|other reason|8|||
125287317|NCT00027378|450678669|FG000|Overall Study|Physician Decision|0|||
125287318|NCT00027378|450678670|FG001|Overall Study|Physician Decision|3|||
125287319|NCT05605691|450678671|FG000|Overall Study|Lost to Follow-up|1|||
125287320|NCT03199053|450678674|FG000|ST Period|Withdrawal by Subject|2|||
125287321|NCT03199053|450678675|FG001|ST Period|Withdrawal by Subject|4|||
125287322|NCT03199053|450678676|FG002|ST Period|Withdrawal by Subject|6|||
125287323|NCT03199053|450678674|FG000|ST Period|Withdrawal by parent/guardian|1|||
125287324|NCT03199053|450678675|FG001|ST Period|Withdrawal by parent/guardian|1|||
125287325|NCT03199053|450678676|FG002|ST Period|Withdrawal by parent/guardian|1|||
125287326|NCT03199053|450678674|FG000|ST Period|Lost to Follow-up|2|||
125287327|NCT03199053|450678675|FG001|ST Period|Lost to Follow-up|0|||
125287328|NCT03199053|450678676|FG002|ST Period|Lost to Follow-up|1|||
125287329|NCT03199053|450678674|FG000|LT Period|Withdrawal by Subject|1|||
125287330|NCT03199053|450678675|FG001|LT Period|Withdrawal by Subject|3|||
125287331|NCT03199053|450678676|FG002|LT Period|Withdrawal by Subject|3|||
125287332|NCT03199053|450678674|FG000|LT Period|Withdrawal by parent/guardian|0|||
125287333|NCT03199053|450678675|FG001|LT Period|Withdrawal by parent/guardian|0|||
125287334|NCT03199053|450678676|FG002|LT Period|Withdrawal by parent/guardian|1|||
125287335|NCT03199053|450678674|FG000|LT Period|Lost to Follow-up|0|||
125287336|NCT03199053|450678675|FG001|LT Period|Lost to Follow-up|1|||
125287337|NCT03199053|450678676|FG002|LT Period|Lost to Follow-up|1|||
125287338|NCT03199053|450678674|FG000|LT Period|Miscellaneous|0|||
125287339|NCT03199053|450678675|FG001|LT Period|Miscellaneous|0|||
125287340|NCT03199053|450678676|FG002|LT Period|Miscellaneous|2|||
125287341|NCT03199053|450678674|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
125287342|NCT03199053|450678675|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
125287343|NCT03199053|450678676|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
125287344|NCT03199053|450678674|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
125287345|NCT03199053|450678675|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
125287346|NCT03199053|450678676|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
125287347|NCT03199053|450678674|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
125287348|NCT03199053|450678675|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
125287349|NCT03199053|450678676|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
125287350|NCT03199053|450678674|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
125287351|NCT03199053|450678675|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
125287352|NCT03199053|450678676|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
125287353|NCT01824823|450678679|FG000|Overall Study|Lack of Efficacy|1|||
125287354|NCT01824823|450678680|FG001|Overall Study|Lack of Efficacy|1|||
125287355|NCT01824823|450678679|FG000|Overall Study|Off-treatment reason not submitted|1|||
125419382|NCT04307004|451160265|FG000|Randomization 1|Withdrawal by Subject|25|||
125287356|NCT01824823|450678680|FG001|Overall Study|Off-treatment reason not submitted|0|||
125287357|NCT02098369|450678681|FG000|Overall Study|Withdrawal by Subject|1|||
125287358|NCT02098369|450678682|FG001|Overall Study|Withdrawal by Subject|5|||
125287359|NCT02098369|450678683|FG002|Overall Study|Withdrawal by Subject|0|||
125287360|NCT02098369|450678681|FG000|Overall Study|Lost to Follow-up|5|||
125287361|NCT02098369|450678682|FG001|Overall Study|Lost to Follow-up|1|||
125287362|NCT02098369|450678683|FG002|Overall Study|Lost to Follow-up|3|||
125287363|NCT02098369|450678681|FG000|Overall Study|Death|1|||
125287364|NCT02098369|450678682|FG001|Overall Study|Death|1|||
125287365|NCT02098369|450678683|FG002|Overall Study|Death|1|||
125287366|NCT02098369|450678681|FG000|Overall Study|Other|0|||
125287367|NCT02098369|450678682|FG001|Overall Study|Other|2|||
125287368|NCT02098369|450678683|FG002|Overall Study|Other|1|||
125287369|NCT00246025|450678684|FG000|Overall Study|Adverse Event|7|||
125287370|NCT00246025|450678685|FG001|Overall Study|Adverse Event|9|||
125287371|NCT00246025|450678686|FG002|Overall Study|Adverse Event|9|||
125287372|NCT00246025|450678687|FG003|Overall Study|Adverse Event|10|||
125287373|NCT00246025|450678684|FG000|Overall Study|Withdrawal by Subject|3|||
125287374|NCT00246025|450678685|FG001|Overall Study|Withdrawal by Subject|0|||
125287375|NCT00246025|450678686|FG002|Overall Study|Withdrawal by Subject|1|||
125287376|NCT00246025|450678687|FG003|Overall Study|Withdrawal by Subject|2|||
125287377|NCT00246025|450678684|FG000|Overall Study|unsuitable medical history was found|0|||
125287378|NCT00246025|450678685|FG001|Overall Study|unsuitable medical history was found|0|||
125287379|NCT00246025|450678686|FG002|Overall Study|unsuitable medical history was found|0|||
125287380|NCT00246025|450678687|FG003|Overall Study|unsuitable medical history was found|1|||
125287381|NCT03444766|450678692|FG000|Overall Study|Other Reasons|2|||
125287382|NCT03444766|450678692|FG000|Overall Study|Participant Withdrew Consent|5|||
125287383|NCT03444766|450678692|FG000|Overall Study|Lost to Follow-up|2|||
125287384|NCT03444766|450678692|FG000|Overall Study|Death|2|||
125287385|NCT03444766|450678692|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
125287386|NCT03444766|450678692|FG000|Overall Study|Disease Progression|49|||
125287387|NCT02460783|450678696|FG000|Overall Study|Withdrawal by Subject|1|||
125287388|NCT02460783|450678697|FG001|Overall Study|Withdrawal by Subject|3|||
125287389|NCT02460783|450678696|FG000|Overall Study|Lost to Follow-up|1|||
125287390|NCT02460783|450678697|FG001|Overall Study|Lost to Follow-up|1|||
125287391|NCT01646645|450678698|FG000|Overall Study|No Treated|1|||
125287392|NCT01646645|450678698|FG000|Overall Study|Inevaluable Donor|29|||
125287393|NCT02374814|450678707|FG000|Overall Study|Lost to Follow-up|1|||
125287394|NCT02374814|450678708|FG001|Overall Study|Lost to Follow-up|1|||
125287395|NCT02374814|450678709|FG002|Overall Study|Lost to Follow-up|0|||
125287396|NCT02374814|450678710|FG003|Overall Study|Lost to Follow-up|1|||
125287397|NCT02374814|450678711|FG004|Overall Study|Lost to Follow-up|0|||
125287398|NCT02374814|450678712|FG005|Overall Study|Lost to Follow-up|0|||
125287399|NCT02374814|450678707|FG000|Overall Study|Withdrawal by Subject|0|||
125287400|NCT02374814|450678708|FG001|Overall Study|Withdrawal by Subject|0|||
125287401|NCT02374814|450678709|FG002|Overall Study|Withdrawal by Subject|1|||
125287402|NCT02374814|450678710|FG003|Overall Study|Withdrawal by Subject|1|||
125287403|NCT02374814|450678711|FG004|Overall Study|Withdrawal by Subject|0|||
125287404|NCT02374814|450678712|FG005|Overall Study|Withdrawal by Subject|0|||
125287405|NCT00884039|450678713|FG000|Overall Study|Withdrawal by Subject|0|||
125287406|NCT00884039|450678714|FG001|Overall Study|Withdrawal by Subject|1|||
125287407|NCT00884039|450678713|FG000|Overall Study|Lack of Efficacy|2|||
125287408|NCT00884039|450678714|FG001|Overall Study|Lack of Efficacy|0|||
125287409|NCT00072293|450678715|FG000|Overall Study|Lost to Follow-up|1|||
125287410|NCT00072293|450678716|FG001|Overall Study|Lost to Follow-up|1|||
125287411|NCT00072293|450678715|FG000|Overall Study|Withdrawal by Subject|0|||
125287412|NCT00072293|450678716|FG001|Overall Study|Withdrawal by Subject|1|||
125287413|NCT04209114|450678717|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
125287414|NCT04209114|450678718|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
125287415|NCT04209114|450678719|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
125287416|NCT04209114|450678717|FG000|Pre-Treatment Phase|Other reasons|0|||
125287417|NCT04209114|450678718|FG001|Pre-Treatment Phase|Other reasons|0|||
125287418|NCT04209114|450678719|FG002|Pre-Treatment Phase|Other reasons|1|||
125287419|NCT04209114|450678717|FG000|Pre-Treatment Phase|Death|0|||
125287420|NCT04209114|450678718|FG001|Pre-Treatment Phase|Death|0|||
125287421|NCT04209114|450678719|FG002|Pre-Treatment Phase|Death|1|||
125287422|NCT04209114|450678717|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
125287423|NCT04209114|450678718|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
125287424|NCT04209114|450678719|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
125287425|NCT04209114|450678717|FG000|Treatment Phase|Other reasons|5|||
125287426|NCT04209114|450678718|FG001|Treatment Phase|Other reasons|3|||
125287427|NCT04209114|450678719|FG002|Treatment Phase|Other reasons|0|||
125287428|NCT04209114|450678717|FG000|Treatment Phase|Lost to Follow-up|1|||
125287429|NCT04209114|450678718|FG001|Treatment Phase|Lost to Follow-up|0|||
125287430|NCT04209114|450678719|FG002|Treatment Phase|Lost to Follow-up|0|||
125287431|NCT04209114|450678717|FG000|Treatment Phase|Participant withdrew consent|1|||
125287432|NCT04209114|450678718|FG001|Treatment Phase|Participant withdrew consent|0|||
125287433|NCT04209114|450678719|FG002|Treatment Phase|Participant withdrew consent|0|||
125287434|NCT04209114|450678717|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
125287435|NCT04209114|450678718|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
125287436|NCT04209114|450678719|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
125287437|NCT04209114|450678717|FG000|Treatment Phase|Death|4|||
125287438|NCT04209114|450678718|FG001|Treatment Phase|Death|1|||
125287439|NCT04209114|450678719|FG002|Treatment Phase|Death|0|||
125449735|NCT01764386|451274820|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
125287440|NCT04209114|450678717|FG000|Treatment Phase|Study drug toxicity|4|||
125287441|NCT04209114|450678718|FG001|Treatment Phase|Study drug toxicity|6|||
125287442|NCT04209114|450678719|FG002|Treatment Phase|Study drug toxicity|0|||
125287443|NCT04209114|450678717|FG000|Treatment Phase|Disease progression|6|||
125449736|NCT01764386|451274819|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
125287444|NCT04209114|450678718|FG001|Treatment Phase|Disease progression|9|||
125287445|NCT04209114|450678719|FG002|Treatment Phase|Disease progression|0|||
125287446|NCT00624819|450678722|FG000|Follow-up Period: Year 4|Parents decision|0|||
125287447|NCT00624819|450678723|FG001|Follow-up Period: Year 4|Parents decision|0|||
125287448|NCT00624819|450678724|FG002|Follow-up Period: Year 4|Parents decision|1|||
125449737|NCT01764386|451274820|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
125449738|NCT03929302|451274823|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
125449739|NCT03929302|451274824|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
125449740|NCT03929302|451274825|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
125449741|NCT03929302|451274823|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
125449742|NCT03929302|451274824|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
125449743|NCT03929302|451274825|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
125449744|NCT03929302|451274823|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
125449745|NCT03929302|451274824|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
125449746|NCT03929302|451274825|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
125449747|NCT04454567|451274827|FG000|Overall Study|Study Terminated by Sponsor|1|||
125449748|NCT04454567|451274828|FG001|Overall Study|Study Terminated by Sponsor|1|||
125449749|NCT01123161|451274831|FG000|Overall Study|Lost to Follow-up|1|||
125449750|NCT01123161|451274832|FG001|Overall Study|Lost to Follow-up|0|||
125449751|NCT01123161|451274831|FG000|Overall Study|Withdrawal by Subject|1|||
125449752|NCT01123161|451274832|FG001|Overall Study|Withdrawal by Subject|0|||
125449753|NCT02757885|451274833|FG000|Overall Study|Screen Failures|4|||
125449754|NCT01175707|451274834|FG000|Overall Study|Adverse Event|4|||
125449755|NCT01175707|451274835|FG001|Overall Study|Adverse Event|6|||
125449756|NCT00003377|451274838|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
125449757|NCT00003377|451274839|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
125449758|NCT00003377|451274840|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
125449759|NCT00003377|451274841|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
125449760|NCT00003377|451274842|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
125449761|NCT00003377|451274838|FG000|Period II|Ureteral stent complications|0|||
125449762|NCT00003377|451274839|FG001|Period II|Ureteral stent complications|0|||
125449763|NCT00003377|451274840|FG002|Period II|Ureteral stent complications|0|||
125449764|NCT00003377|451274841|FG003|Period II|Ureteral stent complications|0|||
125449765|NCT00003377|451274842|FG004|Period II|Ureteral stent complications|1|||
125449766|NCT05349084|451274845|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
125449767|NCT05124899|451274846|FG000|Overall Study|Lost to Follow-up|3|||
125449768|NCT01417000|451274848|FG000|Overall Study|Death|59|||
125449769|NCT01417000|451274849|FG001|Overall Study|Death|28|||
125449770|NCT01417000|451274848|FG000|Overall Study|Lost to Follow-up|1|||
125449771|NCT01417000|451274849|FG001|Overall Study|Lost to Follow-up|0|||
125449772|NCT01417000|451274848|FG000|Overall Study|Study Terminated by Sponsor|1|||
125449773|NCT01417000|451274849|FG001|Overall Study|Study Terminated by Sponsor|1|||
125449774|NCT00647348|451274856|FG000|Overall Study|Lost to Follow-up|3|||
125449775|NCT00647348|451274857|FG001|Overall Study|Lost to Follow-up|6|||
125449776|NCT00797225|451274858|FG000|Weeks 1 to 12|Adverse Event|0|||
125449777|NCT00797225|451274859|FG001|Weeks 1 to 12|Adverse Event|0|||
125449778|NCT00797225|451274860|FG002|Weeks 1 to 12|Adverse Event|1|||
125287449|NCT00624819|450678725|FG003|Follow-up Period: Year 4|Parents decision|0|||
125287450|NCT00624819|450678722|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
125287451|NCT00624819|450678723|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
125287452|NCT00624819|450678724|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
125287453|NCT00624819|450678725|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
125287454|NCT02826421|450678730|FG000|Overall Study|Adverse Event|1|||
125287455|NCT02826421|450678731|FG001|Overall Study|Adverse Event|0|||
125287456|NCT02826421|450678732|FG002|Overall Study|Adverse Event|0|||
125287457|NCT02826421|450678733|FG003|Overall Study|Adverse Event|1|||
125287458|NCT02826421|450678730|FG000|Overall Study|Withdrawal by Subject|1|||
125287459|NCT02826421|450678731|FG001|Overall Study|Withdrawal by Subject|3|||
125287460|NCT02826421|450678732|FG002|Overall Study|Withdrawal by Subject|1|||
125287461|NCT02826421|450678733|FG003|Overall Study|Withdrawal by Subject|1|||
125287462|NCT02826421|450678730|FG000|Overall Study|Reason not given|1|||
125287463|NCT02826421|450678731|FG001|Overall Study|Reason not given|0|||
125287464|NCT02826421|450678732|FG002|Overall Study|Reason not given|1|||
125287465|NCT02826421|450678733|FG003|Overall Study|Reason not given|0|||
125287466|NCT02210221|450678736|FG000|Overall Study|Lack of Efficacy|7|||
125287467|NCT02210221|450678736|FG000|Overall Study|Withdrawal by Subject|43|||
125287468|NCT02141490|450678737|FG000|Overall Study|Screening failures|4|||
125287469|NCT02141490|450678738|FG001|Overall Study|Screening failures|0|||
125287470|NCT02141490|450678739|FG002|Overall Study|Screening failures|0|||
125287471|NCT00434759|450678740|FG000|Overall Study|Lack of Efficacy|5|||
125287472|NCT00434759|450678741|FG001|Overall Study|Lack of Efficacy|4|||
125287473|NCT00434759|450678740|FG000|Overall Study|Withdrawal by Subject|17|||
125449779|NCT00797225|451274861|FG003|Weeks 1 to 12|Adverse Event|0|||
125449780|NCT00797225|451274862|FG004|Weeks 1 to 12|Adverse Event|0|||
125449781|NCT00797225|451274863|FG005|Weeks 1 to 12|Adverse Event|0|||
125449782|NCT00797225|451274864|FG006|Weeks 1 to 12|Adverse Event|0|||
125287474|NCT00434759|450678741|FG001|Overall Study|Withdrawal by Subject|1|||
125449783|NCT00797225|451274865|FG007|Weeks 1 to 12|Adverse Event|0|||
125449784|NCT00797225|451274858|FG000|Weeks 1 to 12|Non-compliance|0|||
125449785|NCT00797225|451274859|FG001|Weeks 1 to 12|Non-compliance|1|||
125287475|NCT00434759|450678740|FG000|Overall Study|family affairs|2|||
125287476|NCT00434759|450678741|FG001|Overall Study|family affairs|0|||
125287477|NCT02436408|450678743|FG000|Overall Study|Death|1|||
125287478|NCT01300819|450678744|FG000|Overall Study|Adverse Event|9|||
125287479|NCT01300819|450678745|FG001|Overall Study|Adverse Event|27|||
125287480|NCT01300819|450678744|FG000|Overall Study|Lack of Efficacy|2|||
125287481|NCT01300819|450678745|FG001|Overall Study|Lack of Efficacy|1|||
125287482|NCT01300819|450678744|FG000|Overall Study|Withdrawal by Subject|10|||
125287483|NCT01300819|450678745|FG001|Overall Study|Withdrawal by Subject|12|||
125287484|NCT01300819|450678744|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
125287485|NCT01300819|450678745|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
125287486|NCT01300819|450678744|FG000|Overall Study|Refusal to down titrate study drug|0|||
125287487|NCT01300819|450678745|FG001|Overall Study|Refusal to down titrate study drug|1|||
125287488|NCT01300819|450678744|FG000|Overall Study|Administrative reason|0|||
125287489|NCT01300819|450678745|FG001|Overall Study|Administrative reason|1|||
125287490|NCT01300819|450678744|FG000|Overall Study|Safety follow up not done by mistake|0|||
125287491|NCT01300819|450678745|FG001|Overall Study|Safety follow up not done by mistake|1|||
125287492|NCT01300819|450678744|FG000|Overall Study|Follow up call was not done|1|||
125287493|NCT01300819|450678745|FG001|Overall Study|Follow up call was not done|0|||
125287494|NCT02649855|450678746|FG000|Overall Study|Refused further treatment|2|||
125287495|NCT02649855|450678747|FG001|Overall Study|Refused further treatment|1|||
125287496|NCT02649855|450678748|FG002|Overall Study|Refused further treatment|1|||
125287497|NCT02649855|450678746|FG000|Overall Study|Withdrew consent|0|||
125287498|NCT02649855|450678747|FG001|Overall Study|Withdrew consent|1|||
125287499|NCT02649855|450678748|FG002|Overall Study|Withdrew consent|0|||
125287500|NCT02649855|450678746|FG000|Overall Study|Switched to alternative treatment|0|||
125287501|NCT02649855|450678747|FG001|Overall Study|Switched to alternative treatment|1|||
125287502|NCT02649855|450678748|FG002|Overall Study|Switched to alternative treatment|1|||
125287503|NCT02649855|450678746|FG000|Overall Study|Principal investigator discretion|0|||
125287504|NCT02649855|450678747|FG001|Overall Study|Principal investigator discretion|1|||
125287505|NCT02649855|450678748|FG002|Overall Study|Principal investigator discretion|1|||
125287506|NCT02649855|450678746|FG000|Overall Study|No treatment, per protocol|1|||
125287507|NCT02649855|450678747|FG001|Overall Study|No treatment, per protocol|0|||
125287508|NCT02649855|450678748|FG002|Overall Study|No treatment, per protocol|0|||
125287509|NCT02649855|450678746|FG000|Overall Study|Initiate new treatment|1|||
125287510|NCT02649855|450678747|FG001|Overall Study|Initiate new treatment|0|||
125287511|NCT02649855|450678748|FG002|Overall Study|Initiate new treatment|0|||
125287512|NCT01319721|450678752|FG000|Overall Study|Lost to Follow-up|1|||
125287513|NCT01319721|450678753|FG001|Overall Study|Lost to Follow-up|6|||
125287514|NCT00461305|450678754|FG000|Treatment|Adverse Event|26|||
125287515|NCT00461305|450678755|FG001|Treatment|Adverse Event|3|||
125287516|NCT00461305|450678754|FG000|Treatment|Lost to Follow-up|4|||
125287517|NCT00461305|450678755|FG001|Treatment|Lost to Follow-up|2|||
125287518|NCT00461305|450678754|FG000|Treatment|Protocol Violation|13|||
125287519|NCT00461305|450678755|FG001|Treatment|Protocol Violation|2|||
125287520|NCT00461305|450678754|FG000|Treatment|Withdrawal by Subject|48|||
125287521|NCT00461305|450678755|FG001|Treatment|Withdrawal by Subject|2|||
125287522|NCT00461305|450678754|FG000|Treatment|Never dispensed|5|||
125287523|NCT00461305|450678755|FG001|Treatment|Never dispensed|0|||
125287524|NCT00461305|450678754|FG000|Treatment|Study drug not taken|1|||
125287525|NCT00461305|450678755|FG001|Treatment|Study drug not taken|0|||
125287526|NCT00461305|450678754|FG000|Treatment|Partially missing diary|2|||
125287527|NCT00461305|450678755|FG001|Treatment|Partially missing diary|0|||
125287528|NCT00461305|450678754|FG000|Treatment|Other (missing drug etc)|2|||
125287529|NCT00461305|450678755|FG001|Treatment|Other (missing drug etc)|0|||
125287530|NCT00461305|450678754|FG000|Continued Treatment|Adverse Event|26|||
125287531|NCT00461305|450678755|FG001|Continued Treatment|Adverse Event|0|||
125287532|NCT00461305|450678754|FG000|Continued Treatment|Lost to Follow-up|4|||
125287533|NCT00461305|450678755|FG001|Continued Treatment|Lost to Follow-up|0|||
125287534|NCT00461305|450678754|FG000|Continued Treatment|Protocol Violation|13|||
125287535|NCT00461305|450678755|FG001|Continued Treatment|Protocol Violation|0|||
125287536|NCT00461305|450678754|FG000|Continued Treatment|Withdrawal by Subject|48|||
125287537|NCT00461305|450678755|FG001|Continued Treatment|Withdrawal by Subject|0|||
125287538|NCT00461305|450678754|FG000|Continued Treatment|Partially missing diary|2|||
125287539|NCT00461305|450678755|FG001|Continued Treatment|Partially missing diary|0|||
125287540|NCT00461305|450678754|FG000|Continued Treatment|Other (missing drug etc)|2|||
125287541|NCT00461305|450678755|FG001|Continued Treatment|Other (missing drug etc)|0|||
125287542|NCT01103063|450681336|FG000|Overall Study|Adverse Event|3|||
125287543|NCT01103063|450681337|FG001|Overall Study|Adverse Event|1|||
125287544|NCT01103063|450681336|FG000|Overall Study|Lost to Follow-up|68|||
125287545|NCT01103063|450681337|FG001|Overall Study|Lost to Follow-up|51|||
125287546|NCT01103063|450681336|FG000|Overall Study|Withdrawal by Subject|60|||
125287547|NCT01103063|450681337|FG001|Overall Study|Withdrawal by Subject|15|||
125287548|NCT01103063|450681336|FG000|Overall Study|Other|16|||
125287549|NCT01103063|450681337|FG001|Overall Study|Other|11|||
125287550|NCT01103063|450681336|FG000|Overall Study|Protocol Violation|1|||
125287551|NCT01103063|450681337|FG001|Overall Study|Protocol Violation|0|||
125287552|NCT01103063|450681336|FG000|Overall Study|Study terminated by Sponsor|326|||
125287553|NCT01103063|450681337|FG001|Overall Study|Study terminated by Sponsor|342|||
125287554|NCT01103063|450681336|FG000|Overall Study|Death|3|||
125287555|NCT01103063|450681337|FG001|Overall Study|Death|1|||
125287556|NCT01187446|450681340|FG000|Overall Study|Patient started non-protocol therapy|0|||
125287557|NCT01187446|450681341|FG001|Overall Study|Patient started non-protocol therapy|1|||
125287558|NCT00496197|450681342|FG000|Overall Study|Discontinued study due to death|43|||
125287559|NCT00496197|450681342|FG000|Overall Study|Adverse Event|13|||
125287560|NCT00496197|450681342|FG000|Overall Study|Does not meet entrance criteria|5|||
125287561|NCT00496197|450681342|FG000|Overall Study|Insufficient clinical response|3|||
125287562|NCT00496197|450681342|FG000|Overall Study|Insufficient bacteriological response|10|||
125287563|NCT00496197|450681342|FG000|Overall Study|Lost to Follow-up|11|||
125287564|NCT00496197|450681342|FG000|Overall Study|Withdrawal by Subject|11|||
125287565|NCT00496197|450681342|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
125287566|NCT00496197|450681342|FG000|Overall Study|Other|14|||
125287567|NCT00496197|450681342|FG000|Overall Study|Protocol Violation|8|||
125287568|NCT01344538|450681343|FG000|Overall Study|Adverse Event|1|||
125287569|NCT01344538|450681344|FG001|Overall Study|Adverse Event|1|||
125287570|NCT01344538|450681343|FG000|Overall Study|Lost to Follow-up|1|||
125287571|NCT01344538|450681344|FG001|Overall Study|Lost to Follow-up|0|||
125287572|NCT01655381|450681345|FG000|Overall Study|Investigator Decision|1|||
125287573|NCT01655381|450681345|FG000|Overall Study|Moved to Another City|1|||
125287574|NCT01655381|450681345|FG000|Overall Study|Insufficient Treatment Response|1|||
125287575|NCT00320255|450681346|FG000|Overall Study|Lack of Efficacy|1|||
125287576|NCT00320255|450681347|FG001|Overall Study|Lack of Efficacy|0|||
125287577|NCT00320255|450681348|FG002|Overall Study|Lack of Efficacy|0|||
125287578|NCT00320255|450681349|FG003|Overall Study|Lack of Efficacy|0|||
125287579|NCT00320255|450681350|FG004|Overall Study|Lack of Efficacy|0|||
125419383|NCT04307004|451160266|FG001|Randomization 1|Withdrawal by Subject|26|||
125419384|NCT04307004|451160267|FG002|Randomization 1|Withdrawal by Subject|0|||
125419385|NCT04307004|451160268|FG003|Randomization 1|Withdrawal by Subject|0|||
125419386|NCT04307004|451160265|FG000|Randomization 2|Withdrawal by Subject|0|||
125419387|NCT04307004|451160266|FG001|Randomization 2|Withdrawal by Subject|0|||
125419388|NCT04307004|451160267|FG002|Randomization 2|Withdrawal by Subject|28|||
125419389|NCT04307004|451160268|FG003|Randomization 2|Withdrawal by Subject|23|||
125419390|NCT02701985|451160269|FG000|Overall Study|Withdrawal by Subject|1|||
125419391|NCT02701985|451160270|FG001|Overall Study|Withdrawal by Subject|1|||
125419392|NCT02701985|451160269|FG000|Overall Study|Lost to Follow-up|1|||
125419393|NCT02701985|451160270|FG001|Overall Study|Lost to Follow-up|0|||
125419394|NCT02701985|451160269|FG000|Overall Study|Death|1|||
125419395|NCT02701985|451160270|FG001|Overall Study|Death|0|||
125419396|NCT02701985|451160269|FG000|Overall Study|Adverse Event|0|||
125419397|NCT02701985|451160270|FG001|Overall Study|Adverse Event|5|||
125419398|NCT01640808|451160271|FG000|Overall Study|Unable to continue dynamic CT|14|||
125419399|NCT01640808|451160272|FG001|Overall Study|Unable to continue dynamic CT|4|||
125419400|NCT01640808|451160271|FG000|Overall Study|Withdrawal by Subject|12|||
125419401|NCT01640808|451160272|FG001|Overall Study|Withdrawal by Subject|4|||
125419402|NCT01640808|451160271|FG000|Overall Study|Lost to Follow-up|4|||
125419403|NCT01640808|451160272|FG001|Overall Study|Lost to Follow-up|0|||
125419404|NCT01640808|451160271|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
125419405|NCT01640808|451160272|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
125419406|NCT01640808|451160271|FG000|Overall Study|Administration of anticancer drugs|2|||
125419407|NCT01640808|451160272|FG001|Overall Study|Administration of anticancer drugs|1|||
125419408|NCT01640808|451160271|FG000|Overall Study|Physician Decision|19|||
125419409|NCT01640808|451160272|FG001|Overall Study|Physician Decision|5|||
125419410|NCT01640808|451160271|FG000|Overall Study|Randomized but not treated|4|||
125419411|NCT01640808|451160272|FG001|Overall Study|Randomized but not treated|2|||
125419412|NCT04391023|451160273|FG000|Overall Study|Withdrawal by Subject|2|||
125419413|NCT04391023|451160274|FG001|Overall Study|Withdrawal by Subject|2|||
125419414|NCT04009291|451160275|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
125419415|NCT04009291|451160276|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
125419416|NCT04009291|451160277|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
125419417|NCT04009291|451160278|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
125419418|NCT04009291|451160279|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
125287580|NCT00320255|450681351|FG005|Overall Study|Lack of Efficacy|0|||
125287581|NCT00320255|450681346|FG000|Overall Study|Adverse Event|5|||
125287582|NCT00320255|450681347|FG001|Overall Study|Adverse Event|2|||
125287583|NCT00320255|450681348|FG002|Overall Study|Adverse Event|3|||
125287584|NCT00320255|450681349|FG003|Overall Study|Adverse Event|2|||
125419419|NCT04009291|451160275|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
125419420|NCT04009291|451160276|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
125419421|NCT04009291|451160277|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
125419422|NCT04009291|451160278|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
125419423|NCT04009291|451160279|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
125287585|NCT00320255|450681350|FG004|Overall Study|Adverse Event|0|||
125287586|NCT00320255|450681351|FG005|Overall Study|Adverse Event|0|||
125287587|NCT00320255|450681346|FG000|Overall Study|Withdrawal by Subject|1|||
125287588|NCT00320255|450681347|FG001|Overall Study|Withdrawal by Subject|2|||
125287589|NCT00320255|450681348|FG002|Overall Study|Withdrawal by Subject|2|||
125287590|NCT00320255|450681349|FG003|Overall Study|Withdrawal by Subject|4|||
125287591|NCT00320255|450681350|FG004|Overall Study|Withdrawal by Subject|0|||
125287592|NCT00320255|450681351|FG005|Overall Study|Withdrawal by Subject|0|||
125287593|NCT00320255|450681346|FG000|Overall Study|Poor compliance/noncompliance|1|||
125287594|NCT00320255|450681347|FG001|Overall Study|Poor compliance/noncompliance|1|||
125287595|NCT00320255|450681348|FG002|Overall Study|Poor compliance/noncompliance|0|||
125287596|NCT00320255|450681349|FG003|Overall Study|Poor compliance/noncompliance|1|||
125287597|NCT00320255|450681350|FG004|Overall Study|Poor compliance/noncompliance|0|||
125287598|NCT00320255|450681351|FG005|Overall Study|Poor compliance/noncompliance|0|||
125287599|NCT00320255|450681346|FG000|Overall Study|No longer meets study criteria|0|||
125287600|NCT00320255|450681347|FG001|Overall Study|No longer meets study criteria|0|||
125287601|NCT00320255|450681348|FG002|Overall Study|No longer meets study criteria|0|||
125287602|NCT00320255|450681349|FG003|Overall Study|No longer meets study criteria|1|||
125287603|NCT00320255|450681350|FG004|Overall Study|No longer meets study criteria|0|||
125287604|NCT00320255|450681351|FG005|Overall Study|No longer meets study criteria|0|||
125287605|NCT00320255|450681346|FG000|Overall Study|Other|3|||
125287606|NCT00320255|450681347|FG001|Overall Study|Other|2|||
125287607|NCT00320255|450681348|FG002|Overall Study|Other|1|||
125287608|NCT00320255|450681349|FG003|Overall Study|Other|0|||
125287609|NCT00320255|450681350|FG004|Overall Study|Other|0|||
125287610|NCT00320255|450681351|FG005|Overall Study|Other|0|||
125287611|NCT04979897|450681353|FG000|Overall Study|Death|1|||
125287612|NCT04979897|450681354|FG001|Overall Study|Death|8|||
125287613|NCT04979897|450681353|FG000|Overall Study|Lost to Follow-up|111|||
125287614|NCT04979897|450681354|FG001|Overall Study|Lost to Follow-up|56|||
125287615|NCT04979897|450681353|FG000|Overall Study|Withdrawal by Subject|7|||
125287616|NCT04979897|450681354|FG001|Overall Study|Withdrawal by Subject|2|||
125287617|NCT03405935|450681355|FG000|Overall Study|Adverse Event|3|||
125287618|NCT03405935|450681355|FG000|Overall Study|Death|2|||
125287619|NCT03405935|450681355|FG000|Overall Study|Withdrawal by Subject|1|||
125287620|NCT03405935|450681355|FG000|Overall Study|Lost to Follow-up|2|||
125287621|NCT02781792|450681362|FG000|Overall Study|Adverse Event|1|||
125287622|NCT02781792|450681363|FG001|Overall Study|Adverse Event|2|||
125287623|NCT02781792|450681362|FG000|Overall Study|Withdrawal by Subject|3|||
125287624|NCT02781792|450681363|FG001|Overall Study|Withdrawal by Subject|1|||
125287625|NCT02781792|450681362|FG000|Overall Study|Lack of Efficacy|1|||
125287626|NCT02781792|450681363|FG001|Overall Study|Lack of Efficacy|1|||
125287627|NCT02781792|450681362|FG000|Overall Study|Hospice|0|||
125287628|NCT02781792|450681363|FG001|Overall Study|Hospice|1|||
125287629|NCT01703117|450681364|FG000|Overall Study|Adverse Event|4|||
125287630|NCT01703117|450681365|FG001|Overall Study|Adverse Event|3|||
125287631|NCT01703117|450681364|FG000|Overall Study|Withdrawal by Subject|0|||
125287632|NCT01703117|450681365|FG001|Overall Study|Withdrawal by Subject|1|||
125287633|NCT00683917|450681366|FG000|Overall Study|Study prematurely terminated|10|||
125287634|NCT01170598|450681371|FG000|Overall Study|Withdrawal by Subject|1|||
125287635|NCT01170598|450681371|FG000|Overall Study|Death|3|||
125287636|NCT01170598|450681371|FG000|Overall Study|Lost to Follow-up|1|||
125287637|NCT01170598|450681371|FG000|Overall Study|Refused|1|||
125287638|NCT02119156|450681372|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
125287639|NCT02119156|450681373|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
125287640|NCT02119156|450681374|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
125287641|NCT02119156|450681372|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
125287642|NCT02119156|450681373|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
125287643|NCT02119156|450681374|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
125287644|NCT02119156|450681372|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
125287645|NCT02119156|450681373|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
125287646|NCT02119156|450681374|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
125287647|NCT02119156|450681372|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
125287648|NCT02119156|450681373|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
125287649|NCT02119156|450681374|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
125287650|NCT02119156|450681372|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
125287651|NCT02119156|450681373|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
125287652|NCT02119156|450681374|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
125287653|NCT02685748|450681377|FG000|Overall Study|Withdrawal by Subject|3|||
125287654|NCT02685748|450681378|FG001|Overall Study|Withdrawal by Subject|2|||
125287655|NCT02536300|450681382|FG000|Overall Study|Investigator's Discretion|17|||
125287656|NCT02536300|450681383|FG001|Overall Study|Investigator's Discretion|11|||
125287657|NCT02536300|450681384|FG002|Overall Study|Investigator's Discretion|2|||
125287658|NCT02536300|450681382|FG000|Overall Study|Progressive Disease|11|||
125287659|NCT02536300|450681383|FG001|Overall Study|Progressive Disease|7|||
125287660|NCT02536300|450681384|FG002|Overall Study|Progressive Disease|6|||
125287661|NCT02536300|450681382|FG000|Overall Study|Study Terminated by Sponsor|6|||
125287662|NCT02536300|450681383|FG001|Overall Study|Study Terminated by Sponsor|4|||
125287663|NCT02536300|450681384|FG002|Overall Study|Study Terminated by Sponsor|7|||
125287664|NCT02536300|450681382|FG000|Overall Study|Death|7|||
125287665|NCT02536300|450681383|FG001|Overall Study|Death|0|||
125287666|NCT02536300|450681384|FG002|Overall Study|Death|5|||
125287667|NCT02536300|450681382|FG000|Overall Study|Withdrew Consent|4|||
125287668|NCT02536300|450681383|FG001|Overall Study|Withdrew Consent|2|||
125287669|NCT02536300|450681384|FG002|Overall Study|Withdrew Consent|0|||
125287670|NCT02536300|450681382|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
125287671|NCT02536300|450681383|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
125449786|NCT00797225|451274860|FG002|Weeks 1 to 12|Non-compliance|0|||
125449787|NCT00797225|451274861|FG003|Weeks 1 to 12|Non-compliance|0|||
125449788|NCT00797225|451274862|FG004|Weeks 1 to 12|Non-compliance|0|||
125449789|NCT00797225|451274863|FG005|Weeks 1 to 12|Non-compliance|0|||
125449790|NCT00797225|451274864|FG006|Weeks 1 to 12|Non-compliance|0|||
125449791|NCT00797225|451274865|FG007|Weeks 1 to 12|Non-compliance|0|||
125449792|NCT00797225|451274858|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
125449793|NCT00797225|451274859|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
125449794|NCT00797225|451274860|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
125449795|NCT00797225|451274861|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
125449796|NCT00797225|451274862|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
125449797|NCT00797225|451274863|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
125449798|NCT00797225|451274864|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
125449799|NCT00797225|451274865|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
125449800|NCT00797225|451274858|FG000|Weeks 1 to 12|Sponsor Decision|1|||
125449801|NCT00797225|451274859|FG001|Weeks 1 to 12|Sponsor Decision|0|||
125449802|NCT00797225|451274860|FG002|Weeks 1 to 12|Sponsor Decision|0|||
125449803|NCT00797225|451274861|FG003|Weeks 1 to 12|Sponsor Decision|0|||
125449804|NCT00797225|451274862|FG004|Weeks 1 to 12|Sponsor Decision|0|||
125449805|NCT00797225|451274863|FG005|Weeks 1 to 12|Sponsor Decision|0|||
125449806|NCT00797225|451274864|FG006|Weeks 1 to 12|Sponsor Decision|0|||
125449807|NCT00797225|451274865|FG007|Weeks 1 to 12|Sponsor Decision|0|||
125449808|NCT00797225|451274858|FG000|Weeks 13 to 24|Non-compliance|0|||
125449809|NCT00797225|451274859|FG001|Weeks 13 to 24|Non-compliance|2|||
125449810|NCT00797225|451274860|FG002|Weeks 13 to 24|Non-compliance|0|||
125449811|NCT00797225|451274861|FG003|Weeks 13 to 24|Non-compliance|0|||
125449812|NCT00797225|451274862|FG004|Weeks 13 to 24|Non-compliance|0|||
125449813|NCT00797225|451274863|FG005|Weeks 13 to 24|Non-compliance|0|||
125449814|NCT00797225|451274864|FG006|Weeks 13 to 24|Non-compliance|0|||
125449815|NCT00797225|451274865|FG007|Weeks 13 to 24|Non-compliance|0|||
125449816|NCT00797225|451274858|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
125449817|NCT00797225|451274859|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
125449818|NCT00797225|451274860|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
125449819|NCT00797225|451274861|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
125449820|NCT00797225|451274862|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
125449821|NCT00797225|451274863|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
125449822|NCT00797225|451274864|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
125449823|NCT00797225|451274865|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
125449824|NCT00797225|451274858|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
125449825|NCT00797225|451274859|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
125449826|NCT00797225|451274860|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
125449827|NCT00797225|451274861|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
125449828|NCT00797225|451274862|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
125449829|NCT00797225|451274863|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
125449830|NCT00797225|451274864|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
125449831|NCT00797225|451274865|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
125449832|NCT00797225|451274858|FG000|Weeks 13 to 24|Adverse Event|0|||
125449833|NCT00797225|451274859|FG001|Weeks 13 to 24|Adverse Event|1|||
125449834|NCT00797225|451274860|FG002|Weeks 13 to 24|Adverse Event|0|||
125449835|NCT00797225|451274861|FG003|Weeks 13 to 24|Adverse Event|0|||
125449836|NCT00797225|451274862|FG004|Weeks 13 to 24|Adverse Event|0|||
125449837|NCT00797225|451274863|FG005|Weeks 13 to 24|Adverse Event|0|||
125449838|NCT00797225|451274864|FG006|Weeks 13 to 24|Adverse Event|1|||
125287672|NCT02536300|450681384|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
125287673|NCT02536300|450681382|FG000|Overall Study|Enrolled but Never Treated|0|||
125449839|NCT00797225|451274865|FG007|Weeks 13 to 24|Adverse Event|0|||
125449840|NCT00797225|451274858|FG000|Weeks 13 to 24|Sponsor Decision|0|||
125287674|NCT02536300|450681383|FG001|Overall Study|Enrolled but Never Treated|0|||
125287675|NCT02536300|450681384|FG002|Overall Study|Enrolled but Never Treated|1|||
125449841|NCT00797225|451274859|FG001|Weeks 13 to 24|Sponsor Decision|0|||
125449842|NCT00797225|451274860|FG002|Weeks 13 to 24|Sponsor Decision|0|||
125449843|NCT00797225|451274861|FG003|Weeks 13 to 24|Sponsor Decision|0|||
125449844|NCT00797225|451274862|FG004|Weeks 13 to 24|Sponsor Decision|0|||
125449845|NCT00797225|451274863|FG005|Weeks 13 to 24|Sponsor Decision|0|||
125449846|NCT00797225|451274864|FG006|Weeks 13 to 24|Sponsor Decision|1|||
125449847|NCT00797225|451274865|FG007|Weeks 13 to 24|Sponsor Decision|0|||
125287676|NCT02536300|450681382|FG000|Overall Study|Non-compliance With Study Drug|1|||
125449848|NCT02954055|451274866|FG000|Overall Study|Did not initiate therapy|6|||
125449849|NCT02954055|451274867|FG001|Overall Study|Did not initiate therapy|1|||
125287677|NCT02536300|450681383|FG001|Overall Study|Non-compliance With Study Drug|0|||
125287678|NCT02536300|450681384|FG002|Overall Study|Non-compliance With Study Drug|0|||
125287679|NCT02536300|450681382|FG000|Overall Study|Protocol Violation|0|||
125287680|NCT02536300|450681383|FG001|Overall Study|Protocol Violation|1|||
125287681|NCT02536300|450681384|FG002|Overall Study|Protocol Violation|0|||
125287682|NCT04706273|450681385|FG000|Overall Study|Withdrawal by Subject|27|||
125287683|NCT04706273|450681385|FG000|Overall Study|Physician Decision|1|||
125287684|NCT04706273|450681385|FG000|Overall Study|Lost to Follow-up|42|||
125287685|NCT04706273|450681385|FG000|Overall Study|Death|85|||
125287686|NCT04706273|450681385|FG000|Overall Study|Amputation that removes study device|2|||
125287687|NCT04706273|450681385|FG000|Overall Study|Surgical bypass|3|||
125287688|NCT04706273|450681385|FG000|Overall Study|Changing hospital|23|||
125287689|NCT04706273|450681385|FG000|Overall Study|Unable to attend hospital|2|||
125287690|NCT01080768|450681388|FG000|Overall Study|Protocol Deviation|2|||
125287691|NCT01080768|450681389|FG001|Overall Study|Protocol Deviation|1|||
125287692|NCT00931723|450681394|FG000|Overall Study|Withdrawal by Subject|11|||
125287693|NCT00931723|450681395|FG001|Overall Study|Withdrawal by Subject|13|||
125287694|NCT00931723|450681394|FG000|Overall Study|Adverse Event|6|||
125287695|NCT00931723|450681395|FG001|Overall Study|Adverse Event|13|||
125287696|NCT00931723|450681394|FG000|Overall Study|Lithium found in blood|0|||
125287697|NCT00931723|450681395|FG001|Overall Study|Lithium found in blood|1|||
125287698|NCT00931723|450681394|FG000|Overall Study|Condition under investigation worsened|1|||
125287699|NCT00931723|450681395|FG001|Overall Study|Condition under investigation worsened|2|||
125287700|NCT00931723|450681394|FG000|Overall Study|Lost to Follow-up|1|||
125287701|NCT00931723|450681395|FG001|Overall Study|Lost to Follow-up|2|||
125287702|NCT00931723|450681394|FG000|Overall Study|Study-specific discontinuation criteria|1|||
125287703|NCT00931723|450681395|FG001|Overall Study|Study-specific discontinuation criteria|1|||
125287704|NCT00931723|450681394|FG000|Overall Study|Severe non-compliance to protocol|2|||
125287705|NCT00931723|450681395|FG001|Overall Study|Severe non-compliance to protocol|0|||
125287706|NCT00931723|450681394|FG000|Overall Study|Safety reasons|0|||
125287707|NCT00931723|450681395|FG001|Overall Study|Safety reasons|1|||
125287708|NCT00931723|450681394|FG000|Overall Study|Took prohibited concomitant medication|0|||
125287709|NCT00931723|450681395|FG001|Overall Study|Took prohibited concomitant medication|1|||
125287710|NCT00931723|450681394|FG000|Overall Study|Lack or insufficient theraputic response|2|||
125287711|NCT00931723|450681395|FG001|Overall Study|Lack or insufficient theraputic response|5|||
125287712|NCT00931723|450681394|FG000|Overall Study|Sponsor decision|1|||
125287713|NCT00931723|450681395|FG001|Overall Study|Sponsor decision|0|||
125287714|NCT00931723|450681394|FG000|Overall Study|Late hospital discharge|1|||
125287715|NCT00931723|450681395|FG001|Overall Study|Late hospital discharge|0|||
125287716|NCT03054350|450681398|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
125287717|NCT03054350|450681399|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
125287718|NCT03054350|450681400|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
125449850|NCT05489224|451274870|FG000|Treatment Period I|Withdrawal by Subject|6|||
125449851|NCT05489224|451274871|FG001|Treatment Period I|Withdrawal by Subject|5|||
125449852|NCT05489224|451274872|FG002|Treatment Period I|Withdrawal by Subject|0|||
125449853|NCT05489224|451274870|FG000|Treatment Period I|Adverse Event|3|||
125449854|NCT05489224|451274871|FG001|Treatment Period I|Adverse Event|11|||
125449855|NCT05489224|451274872|FG002|Treatment Period I|Adverse Event|0|||
125449856|NCT05489224|451274870|FG000|Treatment Period I|Lost to Follow-up|0|||
125449857|NCT05489224|451274871|FG001|Treatment Period I|Lost to Follow-up|1|||
125449858|NCT05489224|451274872|FG002|Treatment Period I|Lost to Follow-up|0|||
125449859|NCT05489224|451274870|FG000|Treatment Period I|Physician Decision|0|||
125449860|NCT05489224|451274871|FG001|Treatment Period I|Physician Decision|1|||
125287719|NCT03054350|450681401|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
125287720|NCT03054350|450681402|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
125287721|NCT03054350|450681403|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
125287722|NCT03054350|450681398|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
125287723|NCT03054350|450681399|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
125287724|NCT03054350|450681400|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
125287725|NCT03054350|450681401|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
125449861|NCT05489224|451274872|FG002|Treatment Period I|Physician Decision|0|||
125449862|NCT05489224|451274870|FG000|Treatment Period II up to Week 32|Ongoing|222|||
125449863|NCT05489224|451274871|FG001|Treatment Period II up to Week 32|Ongoing|107|||
125449864|NCT05489224|451274872|FG002|Treatment Period II up to Week 32|Ongoing|107|||
125287726|NCT03054350|450681402|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
125287727|NCT03054350|450681403|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
125287728|NCT03054350|450681398|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
125287729|NCT03054350|450681399|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
125449865|NCT05489224|451274870|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
125287730|NCT03054350|450681400|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
125287731|NCT03054350|450681401|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
125287732|NCT03054350|450681402|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
125287733|NCT03054350|450681403|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
125287734|NCT03054350|450681398|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
125287735|NCT03054350|450681399|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
125287736|NCT03054350|450681400|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
125287737|NCT03054350|450681401|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
125287738|NCT03054350|450681402|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
125287739|NCT03054350|450681403|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
125287740|NCT01133405|450681404|FG000|Period 1|Withdrawal by Subject|0|||
125287741|NCT01133405|450681405|FG001|Period 1|Withdrawal by Subject|1|||
125287742|NCT01133405|450681406|FG002|Period 1|Withdrawal by Subject|0|||
125287743|NCT01133405|450681407|FG003|Period 1|Withdrawal by Subject|1|||
125287744|NCT01133405|450681408|FG004|Period 1|Withdrawal by Subject|0|||
125287745|NCT01133405|450681409|FG005|Period 1|Withdrawal by Subject|1|||
125287746|NCT01133405|450681410|FG006|Period 1|Withdrawal by Subject|0|||
125287747|NCT01133405|450681411|FG007|Period 1|Withdrawal by Subject|0|||
125287748|NCT01133405|450681412|FG008|Period 1|Withdrawal by Subject|0|||
125287749|NCT01133405|450681413|FG009|Period 1|Withdrawal by Subject|0|||
125287750|NCT01133405|450681404|FG000|Period 1|Physician Decision|0|||
125287751|NCT01133405|450681405|FG001|Period 1|Physician Decision|0|||
125287752|NCT01133405|450681406|FG002|Period 1|Physician Decision|0|||
125287753|NCT01133405|450681407|FG003|Period 1|Physician Decision|1|||
125287754|NCT01133405|450681408|FG004|Period 1|Physician Decision|0|||
125287755|NCT01133405|450681409|FG005|Period 1|Physician Decision|0|||
125287756|NCT01133405|450681410|FG006|Period 1|Physician Decision|0|||
125287757|NCT01133405|450681411|FG007|Period 1|Physician Decision|0|||
125287758|NCT01133405|450681412|FG008|Period 1|Physician Decision|0|||
125287759|NCT01133405|450681413|FG009|Period 1|Physician Decision|0|||
125287760|NCT01133405|450681404|FG000|Period 1|Discontinued after randomization|1|||
125287761|NCT01133405|450681405|FG001|Period 1|Discontinued after randomization|0|||
125287762|NCT01133405|450681406|FG002|Period 1|Discontinued after randomization|0|||
125287763|NCT01133405|450681407|FG003|Period 1|Discontinued after randomization|0|||
125287764|NCT01133405|450681408|FG004|Period 1|Discontinued after randomization|0|||
125287765|NCT01133405|450681409|FG005|Period 1|Discontinued after randomization|0|||
125287766|NCT01133405|450681410|FG006|Period 1|Discontinued after randomization|1|||
125287767|NCT01133405|450681411|FG007|Period 1|Discontinued after randomization|0|||
125287768|NCT01133405|450681412|FG008|Period 1|Discontinued after randomization|0|||
125287769|NCT01133405|450681413|FG009|Period 1|Discontinued after randomization|0|||
125287770|NCT01133405|450681404|FG000|Period 1|Received drug only in period 2|0|||
125287771|NCT01133405|450681405|FG001|Period 1|Received drug only in period 2|1|||
125287772|NCT01133405|450681406|FG002|Period 1|Received drug only in period 2|0|||
125287773|NCT01133405|450681407|FG003|Period 1|Received drug only in period 2|2|||
125287774|NCT01133405|450681408|FG004|Period 1|Received drug only in period 2|0|||
125287775|NCT01133405|450681409|FG005|Period 1|Received drug only in period 2|1|||
125287776|NCT01133405|450681410|FG006|Period 1|Received drug only in period 2|0|||
125287777|NCT01133405|450681411|FG007|Period 1|Received drug only in period 2|0|||
125287778|NCT01133405|450681412|FG008|Period 1|Received drug only in period 2|0|||
125287779|NCT01133405|450681413|FG009|Period 1|Received drug only in period 2|0|||
125287780|NCT01133405|450681404|FG000|Period 1|Received drug only in period 3|0|||
125287781|NCT01133405|450681405|FG001|Period 1|Received drug only in period 3|1|||
125287782|NCT01133405|450681406|FG002|Period 1|Received drug only in period 3|1|||
125287783|NCT01133405|450681407|FG003|Period 1|Received drug only in period 3|0|||
125287784|NCT01133405|450681408|FG004|Period 1|Received drug only in period 3|0|||
125287785|NCT01133405|450681409|FG005|Period 1|Received drug only in period 3|0|||
125287786|NCT01133405|450681410|FG006|Period 1|Received drug only in period 3|0|||
125287787|NCT01133405|450681411|FG007|Period 1|Received drug only in period 3|0|||
125287788|NCT01133405|450681412|FG008|Period 1|Received drug only in period 3|0|||
125287789|NCT01133405|450681413|FG009|Period 1|Received drug only in period 3|0|||
125287790|NCT01133405|450681404|FG000|Period 2|Adverse Event|0|||
125287791|NCT01133405|450681405|FG001|Period 2|Adverse Event|0|||
125287792|NCT01133405|450681406|FG002|Period 2|Adverse Event|1|||
125287793|NCT01133405|450681407|FG003|Period 2|Adverse Event|0|||
125287794|NCT01133405|450681408|FG004|Period 2|Adverse Event|0|||
125287795|NCT01133405|450681409|FG005|Period 2|Adverse Event|0|||
125449866|NCT05489224|451274871|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
125449867|NCT05489224|451274872|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
125287796|NCT01133405|450681410|FG006|Period 2|Adverse Event|0|||
125287797|NCT01133405|450681411|FG007|Period 2|Adverse Event|0|||
125287798|NCT01133405|450681412|FG008|Period 2|Adverse Event|0|||
125287799|NCT01133405|450681413|FG009|Period 2|Adverse Event|0|||
125287800|NCT01133405|450681404|FG000|Period 2|Withdrawal by Subject|0|||
125287801|NCT01133405|450681405|FG001|Period 2|Withdrawal by Subject|0|||
125287802|NCT01133405|450681406|FG002|Period 2|Withdrawal by Subject|0|||
125287803|NCT01133405|450681407|FG003|Period 2|Withdrawal by Subject|1|||
125287804|NCT01133405|450681408|FG004|Period 2|Withdrawal by Subject|0|||
125287805|NCT01133405|450681409|FG005|Period 2|Withdrawal by Subject|1|||
125287806|NCT01133405|450681410|FG006|Period 2|Withdrawal by Subject|0|||
125287807|NCT01133405|450681411|FG007|Period 2|Withdrawal by Subject|0|||
125287808|NCT01133405|450681412|FG008|Period 2|Withdrawal by Subject|0|||
125287809|NCT01133405|450681413|FG009|Period 2|Withdrawal by Subject|0|||
125287810|NCT01133405|450681404|FG000|Period 2|Entry Criteria Not Met|0|||
125287811|NCT01133405|450681405|FG001|Period 2|Entry Criteria Not Met|1|||
125287812|NCT01133405|450681406|FG002|Period 2|Entry Criteria Not Met|0|||
125287813|NCT01133405|450681407|FG003|Period 2|Entry Criteria Not Met|0|||
125287814|NCT01133405|450681408|FG004|Period 2|Entry Criteria Not Met|0|||
125287815|NCT01133405|450681409|FG005|Period 2|Entry Criteria Not Met|0|||
125287816|NCT01133405|450681410|FG006|Period 2|Entry Criteria Not Met|0|||
125287817|NCT01133405|450681411|FG007|Period 2|Entry Criteria Not Met|0|||
125287818|NCT01133405|450681412|FG008|Period 2|Entry Criteria Not Met|0|||
125287819|NCT01133405|450681413|FG009|Period 2|Entry Criteria Not Met|0|||
125287820|NCT01133405|450681404|FG000|Period 2|Physician Decision|0|||
125287821|NCT01133405|450681405|FG001|Period 2|Physician Decision|0|||
125287822|NCT01133405|450681406|FG002|Period 2|Physician Decision|0|||
125287823|NCT01133405|450681407|FG003|Period 2|Physician Decision|0|||
125287824|NCT01133405|450681408|FG004|Period 2|Physician Decision|0|||
125287825|NCT01133405|450681409|FG005|Period 2|Physician Decision|1|||
125287826|NCT01133405|450681410|FG006|Period 2|Physician Decision|0|||
125287827|NCT01133405|450681411|FG007|Period 2|Physician Decision|0|||
125287828|NCT01133405|450681412|FG008|Period 2|Physician Decision|0|||
125287829|NCT01133405|450681413|FG009|Period 2|Physician Decision|0|||
125287830|NCT01238835|450681416|FG000|Overall Study|Death|124|||
125287831|NCT01238835|450681416|FG000|Overall Study|Withdrawal by Subject|9|||
125287832|NCT01238835|450681416|FG000|Overall Study|Lost to Follow-up|1|||
125287833|NCT01238835|450681416|FG000|Overall Study|Site early discontinuation|2|||
125287834|NCT01774253|450681417|FG000|Overall Study|Lack of Efficacy|4|||
125287835|NCT01774253|450681417|FG000|Overall Study|Physician Decision|2|||
125287836|NCT01774253|450681417|FG000|Overall Study|Withdrawal by Subject|2|||
125287837|NCT01774253|450681417|FG000|Overall Study|Death|1|||
125287838|NCT00772369|450681418|FG000|Overall Study|Did not return record release form|1|||
125287839|NCT00554619|450681419|FG000|Overall Study|Adverse Event|1|||
125287840|NCT00554619|450681419|FG000|Overall Study|Physician Decision|1|||
125287841|NCT00554619|450681419|FG000|Overall Study|Liver Function Test Abnormality|1|||
125287842|NCT02240368|450681423|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
125287843|NCT02240368|450681424|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
125287844|NCT02240368|450681425|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
125287845|NCT02240368|450681423|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
125287846|NCT02240368|450681424|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
125287847|NCT02240368|450681425|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
125287848|NCT00907803|450681426|FG000|Overall Study|Withdrawal of consent - long commute|1|||
125287849|NCT00907803|450681427|FG001|Overall Study|Withdrawal of consent - long commute|0|||
125287850|NCT00907803|450681428|FG002|Overall Study|Withdrawal of consent - long commute|0|||
125287851|NCT00907803|450681426|FG000|Overall Study|Adverse Event|2|||
125287852|NCT00907803|450681427|FG001|Overall Study|Adverse Event|0|||
125287853|NCT00907803|450681428|FG002|Overall Study|Adverse Event|0|||
125287854|NCT00907803|450681426|FG000|Overall Study|Withdrawal by Subject|0|||
125287855|NCT00907803|450681427|FG001|Overall Study|Withdrawal by Subject|1|||
125287856|NCT00907803|450681428|FG002|Overall Study|Withdrawal by Subject|0|||
125287857|NCT00907803|450681426|FG000|Overall Study|Lost to Follow-up|0|||
125287858|NCT00907803|450681427|FG001|Overall Study|Lost to Follow-up|1|||
125287859|NCT00907803|450681428|FG002|Overall Study|Lost to Follow-up|0|||
125287860|NCT00907803|450681426|FG000|Overall Study|Protocol Violation|0|||
125287861|NCT00907803|450681427|FG001|Overall Study|Protocol Violation|1|||
125287862|NCT00907803|450681428|FG002|Overall Study|Protocol Violation|0|||
125287863|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Death|1|||
125287864|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Death|1|||
125287865|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Death|0|||
125287866|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Death|0|||
125287867|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Death|1|||
125287868|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Death|0|||
125287869|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Death|0|||
125287870|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Death|0|||
125287871|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Death|0|||
125287872|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Death|0|||
125287873|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
125287874|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
125287875|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
125287876|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
125287877|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
125287878|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
125287879|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
125419424|NCT02189798|451160280|FG000|Extended Use Phase|Withdrawal by Subject|0|||
125419425|NCT02189798|451160281|FG001|Extended Use Phase|Withdrawal by Subject|4|||
125287880|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
125287881|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
125287882|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
125287883|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287884|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287885|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287886|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287887|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
125287888|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287889|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287890|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287891|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287892|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
125287893|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
125287894|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287895|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287896|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287897|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287898|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287899|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287900|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287901|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287902|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
125287903|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
125287904|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287905|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287906|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
125287907|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
125287908|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287909|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287910|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287911|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287912|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
125287913|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
125287914|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287915|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287916|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
125287917|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287918|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287919|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287920|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287921|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287922|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
125287923|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
125287924|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
125287925|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
125419426|NCT02189798|451160280|FG000|Extended Use Phase|Physician Decision|1|||
125419427|NCT02189798|451160281|FG001|Extended Use Phase|Physician Decision|0|||
125419428|NCT02189798|451160280|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
125419429|NCT02189798|451160281|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
125419430|NCT02189798|451160280|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
125419431|NCT02189798|451160281|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
125419432|NCT02189798|451160280|FG000|Extended Use Phase|Travel Issues|2|||
125419433|NCT02189798|451160281|FG001|Extended Use Phase|Travel Issues|1|||
125419434|NCT02189798|451160280|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
125419435|NCT02189798|451160281|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
125419436|NCT02834780|451160282|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
125419437|NCT02834780|451160283|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
125419438|NCT02834780|451160284|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
125419439|NCT02834780|451160285|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
125419440|NCT02834780|451160286|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
125419441|NCT02834780|451160287|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
125419442|NCT02834780|451160288|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
125419443|NCT02834780|451160289|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
125419444|NCT02834780|451160290|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
125419445|NCT02834780|451160291|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
125419446|NCT02834780|451160292|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
125287926|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
125287927|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
125287928|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
125287929|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
125287930|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
125287931|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
125287932|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
125287933|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
125287934|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
125287935|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
125287936|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125287937|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
125287938|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125287939|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125287940|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125287941|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125287942|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125287943|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
125287944|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287945|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287946|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
125287947|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
125287948|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287949|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287950|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287951|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287952|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
125287953|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125287954|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125287955|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125287956|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125287957|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125287958|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125287959|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125287960|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125287961|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125287962|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125287963|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287964|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287965|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
125287966|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287967|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
125287968|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287969|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287970|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287971|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287972|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
125287973|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
125287974|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
125287975|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
125287976|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
125287977|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
125287978|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
125287979|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
125287980|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
125287981|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
125287982|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
125287983|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287984|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287985|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287986|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
125287987|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
125287988|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287989|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287990|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287991|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287992|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125287993|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
125287994|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125287995|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
125287996|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
125287997|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
125287998|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125287999|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288000|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288001|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288002|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288003|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
125288004|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288005|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288006|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288007|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
125288008|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288009|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288010|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288011|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288012|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
125288013|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288014|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288015|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288016|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288017|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
125288018|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288019|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288020|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288021|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288022|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288023|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288024|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
125288025|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288026|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288027|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
125288028|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288029|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288030|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288031|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288032|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
125288033|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
125288034|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288035|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288036|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288037|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
125288038|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288039|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288040|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288041|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288042|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
125288043|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
125288044|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288045|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
125288046|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288047|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
125288048|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288049|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288050|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288051|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288052|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
125288053|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Other|5|||
125288054|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Other|1|||
125288055|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Other|0|||
125288056|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Other|3|||
125288057|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Other|0|||
125288058|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Other|0|||
125288059|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Other|0|||
125288060|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Other|0|||
125288061|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Other|0|||
125288062|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Other|0|||
125288063|NCT03352557|450681429|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288064|NCT03352557|450681430|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288065|NCT03352557|450681431|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288066|NCT03352557|450681432|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288067|NCT03352557|450681433|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
125288068|NCT03352557|450681434|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288069|NCT03352557|450681435|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288070|NCT03352557|450681436|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288071|NCT03352557|450681437|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288072|NCT03352557|450681438|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
125288073|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Death|0|||
125288074|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Death|0|||
125288075|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Death|0|||
125288076|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Death|0|||
125288077|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Death|0|||
125288078|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Death|1|||
125288079|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Death|0|||
125288080|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Death|1|||
125288081|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Death|1|||
125288082|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Death|1|||
125288083|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288084|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288085|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288086|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288087|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288088|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
125288089|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288090|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288091|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288092|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
125288093|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288094|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288095|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288096|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288097|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288098|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288099|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288100|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288101|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
125288102|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
125288103|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
125288104|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
125288105|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
125288106|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
125288107|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
125288108|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
125288109|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
125288110|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
125288111|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
125288112|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
125288113|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125288114|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125288115|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125288116|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125288117|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125288118|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
125288119|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
125288120|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
125288121|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
125288122|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
125288123|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288124|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288125|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288126|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288127|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288128|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125288129|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288130|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125288131|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
125288132|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
125288133|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
125288134|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
125288135|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
125288136|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
125288137|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
125288138|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
125288139|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
125288140|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
125288141|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
125288142|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
125288143|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288144|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288145|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288146|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288147|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288148|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288149|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288150|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
125288151|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
125288152|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
125288153|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288154|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288155|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288156|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288157|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288158|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288159|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288160|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
125288161|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288162|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
125288163|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288164|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288165|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288166|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288167|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288168|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288169|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288170|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
125288171|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288172|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
125288173|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288174|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288175|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288176|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288177|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288178|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288179|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288180|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
125288181|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
125288182|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
125288183|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288184|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288185|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288186|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288187|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288188|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
125288189|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288190|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288191|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
125288192|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
125288193|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288194|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288195|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288196|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288197|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288198|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288199|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288200|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288201|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
125288202|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
125288203|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288204|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288205|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288206|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288207|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288208|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288209|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288210|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
125288211|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
125288212|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
125288213|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288214|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288215|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288216|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288217|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288218|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288219|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288220|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
125288221|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
125288222|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
125288223|NCT03352557|450681429|FG000|LTE Period: Week 80 to Week 173|Other|0|||
125288224|NCT03352557|450681430|FG001|LTE Period: Week 80 to Week 173|Other|0|||
125288225|NCT03352557|450681431|FG002|LTE Period: Week 80 to Week 173|Other|0|||
125288226|NCT03352557|450681432|FG003|LTE Period: Week 80 to Week 173|Other|0|||
125288227|NCT03352557|450681433|FG004|LTE Period: Week 80 to Week 173|Other|0|||
125288228|NCT03352557|450681434|FG005|LTE Period: Week 80 to Week 173|Other|0|||
125288229|NCT03352557|450681435|FG006|LTE Period: Week 80 to Week 173|Other|0|||
125288230|NCT03352557|450681436|FG007|LTE Period: Week 80 to Week 173|Other|1|||
125288231|NCT03352557|450681437|FG008|LTE Period: Week 80 to Week 173|Other|0|||
125288232|NCT03352557|450681438|FG009|LTE Period: Week 80 to Week 173|Other|0|||
125288233|NCT03510468|450681439|FG000|Overall Study|Lost to Follow-up|1|||
125288234|NCT03510468|450681439|FG000|Overall Study|Adverse Event|5|||
125288235|NCT03510468|450681439|FG000|Overall Study|Physician Decision|1|||
125288236|NCT03510468|450681439|FG000|Overall Study|non-compliant with treatment|2|||
125288237|NCT03510468|450681439|FG000|Overall Study|Missed visit|1|||
125288238|NCT04612842|450681440|FG000|Overall Study|Lost to Follow-up|20|||
125288239|NCT04612842|450681441|FG001|Overall Study|Lost to Follow-up|11|||
125288240|NCT04612842|450681440|FG000|Overall Study|Withdrawal by Subject|26|||
125288241|NCT04612842|450681441|FG001|Overall Study|Withdrawal by Subject|15|||
125288242|NCT04612842|450681440|FG000|Overall Study|Death|2|||
125288243|NCT04612842|450681441|FG001|Overall Study|Death|2|||
125288244|NCT05426031|450681442|FG000|Overall Study|Circulatory Arrest|3|||
125288245|NCT05426031|450681443|FG001|Overall Study|Circulatory Arrest|2|||
125288246|NCT02419131|450681444|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
125288247|NCT02419131|450681445|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
125288248|NCT02419131|450681446|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
125288249|NCT02419131|450681444|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
125288250|NCT02419131|450681445|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
125288251|NCT02419131|450681446|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
125288252|NCT04677660|450681447|FG000|Overall Study|Lost to Follow-up|0|||
125288253|NCT04677660|450681448|FG001|Overall Study|Lost to Follow-up|2|||
125288254|NCT04677660|450681447|FG000|Overall Study|Withdrawal by Subject|0|||
125288255|NCT04677660|450681448|FG001|Overall Study|Withdrawal by Subject|1|||
125288256|NCT04677660|450681447|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
125288257|NCT04677660|450681448|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
125288258|NCT00089986|450681449|FG000|Overall Study|Adverse Event|6|||
125288259|NCT00089986|450681450|FG001|Overall Study|Adverse Event|9|||
125288260|NCT00089986|450681451|FG002|Overall Study|Adverse Event|6|||
125288261|NCT00089986|450681449|FG000|Overall Study|Lost to Follow-up|3|||
125288262|NCT00089986|450681450|FG001|Overall Study|Lost to Follow-up|1|||
125288263|NCT00089986|450681451|FG002|Overall Study|Lost to Follow-up|1|||
125288264|NCT00089986|450681449|FG000|Overall Study|Protocol Violation|0|||
125288265|NCT00089986|450681450|FG001|Overall Study|Protocol Violation|1|||
125419447|NCT02834780|451160293|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
125419448|NCT02834780|451160294|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
125419449|NCT02834780|451160282|FG000|Overall Study|Withdrawal by Subject|0|||
125419450|NCT02834780|451160283|FG001|Overall Study|Withdrawal by Subject|0|||
125419451|NCT02834780|451160284|FG002|Overall Study|Withdrawal by Subject|1|||
125419452|NCT02834780|451160285|FG003|Overall Study|Withdrawal by Subject|0|||
125419453|NCT02834780|451160286|FG004|Overall Study|Withdrawal by Subject|0|||
125419454|NCT02834780|451160287|FG005|Overall Study|Withdrawal by Subject|0|||
125419455|NCT02834780|451160288|FG006|Overall Study|Withdrawal by Subject|0|||
125419456|NCT02834780|451160289|FG007|Overall Study|Withdrawal by Subject|0|||
125419457|NCT02834780|451160290|FG008|Overall Study|Withdrawal by Subject|0|||
125419458|NCT02834780|451160291|FG009|Overall Study|Withdrawal by Subject|0|||
125419459|NCT02834780|451160292|FG010|Overall Study|Withdrawal by Subject|1|||
125419460|NCT02834780|451160293|FG011|Overall Study|Withdrawal by Subject|0|||
125419461|NCT02834780|451160294|FG012|Overall Study|Withdrawal by Subject|0|||
125419462|NCT02834780|451160282|FG000|Overall Study|Adverse Event|0|||
125419463|NCT02834780|451160283|FG001|Overall Study|Adverse Event|0|||
125419464|NCT02834780|451160284|FG002|Overall Study|Adverse Event|0|||
125449868|NCT05489224|451274870|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
125288266|NCT00089986|450681451|FG002|Overall Study|Protocol Violation|0|||
125288267|NCT00089986|450681449|FG000|Overall Study|Patient transferred to another hospital|2|||
125288268|NCT00089986|450681450|FG001|Overall Study|Patient transferred to another hospital|1|||
125419465|NCT02834780|451160285|FG003|Overall Study|Adverse Event|0|||
125288269|NCT00089986|450681451|FG002|Overall Study|Patient transferred to another hospital|0|||
125288270|NCT00089986|450681449|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
125288271|NCT00089986|450681450|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
125288272|NCT00089986|450681451|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
125288273|NCT00089986|450681449|FG000|Overall Study|Hemohlobin stopping rule|0|||
125288274|NCT00089986|450681450|FG001|Overall Study|Hemohlobin stopping rule|1|||
125288275|NCT00089986|450681451|FG002|Overall Study|Hemohlobin stopping rule|0|||
125288276|NCT00089986|450681449|FG000|Overall Study|Investigator decision to withdrew|0|||
125288277|NCT00089986|450681450|FG001|Overall Study|Investigator decision to withdrew|1|||
125288278|NCT00089986|450681451|FG002|Overall Study|Investigator decision to withdrew|0|||
125288279|NCT00089986|450681449|FG000|Overall Study|Enrollment in another study|0|||
125288280|NCT00089986|450681450|FG001|Overall Study|Enrollment in another study|1|||
125288281|NCT00089986|450681451|FG002|Overall Study|Enrollment in another study|0|||
125288282|NCT00089986|450681449|FG000|Overall Study|Family decision|0|||
125288283|NCT00089986|450681450|FG001|Overall Study|Family decision|1|||
125288284|NCT00089986|450681451|FG002|Overall Study|Family decision|0|||
125288285|NCT00089986|450681449|FG000|Overall Study|Do not resuscitate (DNR)|0|||
125288286|NCT00089986|450681450|FG001|Overall Study|Do not resuscitate (DNR)|0|||
125288287|NCT00089986|450681451|FG002|Overall Study|Do not resuscitate (DNR)|1|||
125288288|NCT00089986|450681449|FG000|Overall Study|Withdrawal by Subject|3|||
125288289|NCT00089986|450681450|FG001|Overall Study|Withdrawal by Subject|6|||
125288290|NCT00089986|450681451|FG002|Overall Study|Withdrawal by Subject|2|||
125288291|NCT02334683|450681454|FG000|First 12 Week Period|Lost to Follow-up|1|||
125288292|NCT02334683|450681455|FG001|First 12 Week Period|Lost to Follow-up|0|||
125288293|NCT02334683|450681454|FG000|Second 12 Week Period|Adverse Event|0|||
125288294|NCT02334683|450681455|FG001|Second 12 Week Period|Adverse Event|1|||
125288295|NCT00916058|450681456|FG000|Phase 1|Screen Failure|0|||
125288296|NCT00916058|450681457|FG001|Phase 1|Screen Failure|0|||
125288297|NCT00916058|450681458|FG002|Phase 1|Screen Failure|0|||
125288298|NCT00916058|450681459|FG003|Phase 1|Screen Failure|0|||
125288299|NCT00916058|450681460|FG004|Phase 1|Screen Failure|0|||
125288300|NCT00916058|450681461|FG005|Phase 1|Screen Failure|1|||
125288301|NCT00916058|450681462|FG006|Phase 1|Screen Failure|0|||
125288302|NCT00916058|450681456|FG000|Phase 2|Screen Failure|0|||
125288303|NCT00916058|450681457|FG001|Phase 2|Screen Failure|0|||
125288304|NCT00916058|450681458|FG002|Phase 2|Screen Failure|0|||
125288305|NCT00916058|450681459|FG003|Phase 2|Screen Failure|0|||
125288306|NCT00916058|450681460|FG004|Phase 2|Screen Failure|0|||
125288307|NCT00916058|450681461|FG005|Phase 2|Screen Failure|0|||
125288308|NCT00916058|450681462|FG006|Phase 2|Screen Failure|3|||
125288309|NCT02437305|450681463|FG000|Overall Study|Lost to Follow-up|18|||
125288310|NCT02437305|450681464|FG001|Overall Study|Lost to Follow-up|12|||
125288311|NCT01071200|450681483|FG000|Overall Study|Lack of ovarian response|1|||
125288312|NCT01071200|450681484|FG001|Overall Study|Lack of ovarian response|1|||
125288313|NCT01071200|450681483|FG000|Overall Study|No fertilization|4|||
125288314|NCT01071200|450681484|FG001|Overall Study|No fertilization|0|||
125288315|NCT01071200|450681483|FG000|Overall Study|No oocytes retrieved|1|||
125288316|NCT01071200|450681484|FG001|Overall Study|No oocytes retrieved|1|||
125288317|NCT01071200|450681483|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
125288318|NCT01071200|450681484|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
125288319|NCT01071200|450681483|FG000|Overall Study|No viable embryos|0|||
125288320|NCT01071200|450681484|FG001|Overall Study|No viable embryos|1|||
125288321|NCT04465877|450681488|FG000|Overall Study|Noncompliant with study requirements|0|||
125288322|NCT04465877|450681489|FG001|Overall Study|Noncompliant with study requirements|0|||
125288323|NCT04465877|450681490|FG002|Overall Study|Noncompliant with study requirements|1|||
125288324|NCT04465877|450681491|FG003|Overall Study|Noncompliant with study requirements|0|||
125288325|NCT03762616|450681492|FG000|Overall Study|Protocol Violation|2|||
125288326|NCT04962230|450681493|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
125288327|NCT04962230|450681493|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
125288328|NCT03576755|450681494|FG000|Overall Study|Withdrawal by Subject|1|||
125288329|NCT03576755|450681495|FG001|Overall Study|Withdrawal by Subject|0|||
125288330|NCT03576755|450681496|FG002|Overall Study|Withdrawal by Subject|0|||
125288331|NCT03576755|450681497|FG003|Overall Study|Withdrawal by Subject|0|||
125288332|NCT03958656|450681500|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
125288333|NCT03958656|450681501|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
125288334|NCT03958656|450681502|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
125288335|NCT03958656|450681503|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
125288336|NCT03958656|450681500|FG000|Overall Study|No longer meets eligibility criteria|0|||
125288337|NCT03958656|450681501|FG001|Overall Study|No longer meets eligibility criteria|0|||
125288338|NCT03958656|450681502|FG002|Overall Study|No longer meets eligibility criteria|1|||
125288339|NCT03958656|450681503|FG003|Overall Study|No longer meets eligibility criteria|0|||
125288340|NCT03958656|450681500|FG000|Overall Study|Started anti-cancer treatment|0|||
125288341|NCT03958656|450681501|FG001|Overall Study|Started anti-cancer treatment|0|||
125288342|NCT03958656|450681502|FG002|Overall Study|Started anti-cancer treatment|1|||
125288343|NCT03958656|450681503|FG003|Overall Study|Started anti-cancer treatment|0|||
125288344|NCT01767493|450681504|FG000|Overall Study|screen failures|3|||
125288345|NCT01598753|450681505|FG000|Overall Study|Adverse Event|1|||
125288346|NCT01598753|450681506|FG001|Overall Study|Adverse Event|9|||
125288347|NCT01598753|450681507|FG002|Overall Study|Adverse Event|1|||
125288348|NCT01598753|450681508|FG003|Overall Study|Adverse Event|7|||
125288349|NCT01598753|450681505|FG000|Overall Study|Lost to Follow-up|4|||
125288350|NCT01598753|450681506|FG001|Overall Study|Lost to Follow-up|3|||
125288351|NCT01598753|450681507|FG002|Overall Study|Lost to Follow-up|7|||
125288352|NCT01598753|450681508|FG003|Overall Study|Lost to Follow-up|5|||
125288353|NCT01598753|450681505|FG000|Overall Study|Physician Decision|0|||
125288354|NCT01598753|450681506|FG001|Overall Study|Physician Decision|1|||
125288355|NCT01598753|450681507|FG002|Overall Study|Physician Decision|0|||
125288356|NCT01598753|450681508|FG003|Overall Study|Physician Decision|2|||
125288357|NCT01598753|450681505|FG000|Overall Study|Withdrawal by Subject|7|||
125288358|NCT01598753|450681506|FG001|Overall Study|Withdrawal by Subject|2|||
125288359|NCT01598753|450681507|FG002|Overall Study|Withdrawal by Subject|0|||
125288360|NCT01598753|450681508|FG003|Overall Study|Withdrawal by Subject|1|||
125288361|NCT03158012|450681509|FG000|Overall Study|Withdrawal by Subject|0|||
125288362|NCT03158012|450681510|FG001|Overall Study|Withdrawal by Subject|1|||
125288363|NCT04346108|450681511|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
125288364|NCT04346108|450681512|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
125288365|NCT04346108|450681513|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
125288366|NCT04346108|450681511|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
125288367|NCT04346108|450681512|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
125288368|NCT04346108|450681513|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
125288369|NCT02788201|450681514|FG000|Overall Study|Death|1|||
125288370|NCT02788201|450681515|FG001|Overall Study|Death|1|||
125288371|NCT02788201|450681516|FG002|Overall Study|Death|1|||
125288372|NCT02788201|450681517|FG003|Overall Study|Death|1|||
125288373|NCT02788201|450681518|FG004|Overall Study|Death|0|||
125288374|NCT02788201|450681519|FG005|Overall Study|Death|1|||
125288375|NCT02788201|450681514|FG000|Overall Study|Ineligible|0|||
125288376|NCT02788201|450681515|FG001|Overall Study|Ineligible|0|||
125288377|NCT02788201|450681516|FG002|Overall Study|Ineligible|0|||
125288378|NCT02788201|450681517|FG003|Overall Study|Ineligible|0|||
125288379|NCT02788201|450681518|FG004|Overall Study|Ineligible|0|||
125288380|NCT02788201|450681519|FG005|Overall Study|Ineligible|1|||
125288381|NCT02788201|450681514|FG000|Overall Study|Withdrawal by Subject|0|||
125288382|NCT02788201|450681515|FG001|Overall Study|Withdrawal by Subject|0|||
125288383|NCT02788201|450681516|FG002|Overall Study|Withdrawal by Subject|0|||
125288384|NCT02788201|450681517|FG003|Overall Study|Withdrawal by Subject|0|||
125288385|NCT02788201|450681518|FG004|Overall Study|Withdrawal by Subject|0|||
125288386|NCT02788201|450681519|FG005|Overall Study|Withdrawal by Subject|1|||
125288387|NCT02446418|450681524|FG000|Overall Study|Adverse Event|4|||
125288388|NCT02446418|450681525|FG001|Overall Study|Adverse Event|8|||
125288389|NCT02446418|450681524|FG000|Overall Study|Physician Decision|5|||
125288390|NCT02446418|450681525|FG001|Overall Study|Physician Decision|1|||
125288391|NCT02446418|450681524|FG000|Overall Study|Withdrawal by Subject|3|||
125288392|NCT02446418|450681525|FG001|Overall Study|Withdrawal by Subject|3|||
125288393|NCT02446418|450681524|FG000|Overall Study|Lost to Follow-up|2|||
125288394|NCT02446418|450681525|FG001|Overall Study|Lost to Follow-up|2|||
125288395|NCT02446418|450681524|FG000|Overall Study|Protocol Violation|1|||
125288396|NCT02446418|450681525|FG001|Overall Study|Protocol Violation|2|||
125288397|NCT02446418|450681524|FG000|Overall Study|Lack of Efficacy|2|||
125288398|NCT02446418|450681525|FG001|Overall Study|Lack of Efficacy|0|||
125288399|NCT02446418|450681524|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
125288400|NCT02446418|450681525|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
125288401|NCT04508751|450681526|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
125288402|NCT04508751|450681527|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
125288403|NCT04508751|450681528|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
125288404|NCT02014480|450681529|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
125288405|NCT02014480|450681530|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
125288406|NCT02014480|450681531|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
125288407|NCT02014480|450681532|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
125288408|NCT02014480|450681533|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
125288409|NCT02014480|450681534|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
125288410|NCT02014480|450681529|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125288411|NCT02014480|450681530|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125449869|NCT05489224|451274871|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
125288412|NCT02014480|450681531|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125288413|NCT02014480|450681532|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
125449870|NCT05489224|451274872|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
125288414|NCT02014480|450681533|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125288415|NCT02014480|450681534|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125449871|NCT00832780|451274876|FG000|Overall Study|Death|16|||
125288416|NCT02014480|450681529|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125288417|NCT02014480|450681530|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125288418|NCT02014480|450681531|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
125288419|NCT02014480|450681532|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125288420|NCT02014480|450681533|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125288421|NCT02014480|450681534|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
125288422|NCT02014480|450681529|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
125288423|NCT02014480|450681530|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
125288424|NCT02014480|450681531|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
125288425|NCT02014480|450681532|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
125288426|NCT02014480|450681533|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125288427|NCT02014480|450681534|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
125288428|NCT02014480|450681529|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125288429|NCT02014480|450681530|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
125288430|NCT02014480|450681531|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125288431|NCT02014480|450681532|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125288432|NCT02014480|450681533|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125288433|NCT02014480|450681534|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
125288434|NCT02014480|450681529|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
125288435|NCT02014480|450681530|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
125288436|NCT02014480|450681531|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
125288437|NCT02014480|450681532|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
125288438|NCT02014480|450681533|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
125288439|NCT02014480|450681534|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
125288440|NCT02014480|450681529|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125288441|NCT02014480|450681530|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125288442|NCT02014480|450681531|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125288443|NCT02014480|450681532|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125288444|NCT02014480|450681533|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
125288445|NCT02014480|450681534|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
125288446|NCT01865812|450681537|FG000|Primary Treatment Phase|Adverse Event|2|||
125288447|NCT01865812|450681538|FG001|Primary Treatment Phase|Adverse Event|0|||
125288448|NCT01865812|450681537|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
125288449|NCT01865812|450681538|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
125288450|NCT01865812|450681537|FG000|Long-term Safety Extension Phase|Pruritus|0|||
125288451|NCT01865812|450681538|FG001|Long-term Safety Extension Phase|Pruritus|3|||
125288452|NCT01865812|450681537|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
125288453|NCT01865812|450681538|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
125288454|NCT01865812|450681537|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
125288455|NCT01865812|450681538|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
125288456|NCT01338610|450681539|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
125288457|NCT01338610|450681540|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
125288458|NCT01338610|450681541|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
125288459|NCT01338610|450681539|FG000|Overall Study|Protocol Violation|1|||
125288460|NCT01338610|450681540|FG001|Overall Study|Protocol Violation|0|||
125288461|NCT01338610|450681541|FG002|Overall Study|Protocol Violation|1|||
125288462|NCT01338610|450681539|FG000|Overall Study|Adverse Event|3|||
125449872|NCT00832780|451274876|FG000|Overall Study|Lost to Follow-up|4|||
125449873|NCT00832780|451274876|FG000|Overall Study|no reason given|2|||
125449874|NCT00832780|451274876|FG000|Overall Study|other complicating condition|2|||
125449875|NCT00832780|451274876|FG000|Overall Study|Physician Decision|1|||
125449876|NCT05780047|451274883|FG000|Overall Study|Did not submit baseline urine test kit|226|||
125449877|NCT05780047|451274883|FG000|Overall Study|Lost to Follow-up|34|||
125449878|NCT05780047|451274883|FG000|Overall Study|Did not submit second urine test kit|124|||
125449879|NCT04873817|451274884|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
125449880|NCT04873817|451274884|FG000|Overall Study|Lost to Follow-up|4|||
125449881|NCT04873817|451274884|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
125449882|NCT04873817|451274884|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
125449883|NCT04873817|451274884|FG000|Overall Study|Other Reasons|3|||
125449884|NCT00665561|451274885|FG000|Overall Study|Death recorded on subject summary pages|75|||
125449885|NCT00665561|451274886|FG001|Overall Study|Death recorded on subject summary pages|75|||
125449886|NCT00665561|451274885|FG000|Overall Study|Does not meet entrance criteria|19|||
125449887|NCT00665561|451274886|FG001|Overall Study|Does not meet entrance criteria|21|||
125449888|NCT00665561|451274885|FG000|Overall Study|Lost to Follow-up|203|||
125449889|NCT00665561|451274886|FG001|Overall Study|Lost to Follow-up|264|||
125449890|NCT00665561|451274885|FG000|Overall Study|Withdrawal by Subject|74|||
125449891|NCT00665561|451274886|FG001|Overall Study|Withdrawal by Subject|65|||
125449892|NCT00665561|451274885|FG000|Overall Study|Other|123|||
125449893|NCT00665561|451274886|FG001|Overall Study|Other|108|||
125449894|NCT00665561|451274885|FG000|Overall Study|Site closed|8|||
125288463|NCT01338610|450681540|FG001|Overall Study|Adverse Event|0|||
125288464|NCT01338610|450681541|FG002|Overall Study|Adverse Event|0|||
125288465|NCT01414205|450681542|FG000|Overall Study|Death|5|||
125288466|NCT01414205|450681543|FG001|Overall Study|Death|1|||
125288467|NCT01414205|450681542|FG000|Overall Study|Lost to Follow-up|1|||
125288468|NCT01414205|450681543|FG001|Overall Study|Lost to Follow-up|4|||
125288469|NCT01414205|450681542|FG000|Overall Study|Physician Decision|0|||
125288470|NCT01414205|450681543|FG001|Overall Study|Physician Decision|1|||
125288471|NCT01414205|450681542|FG000|Overall Study|Randomized but not Treated|1|||
125288472|NCT01414205|450681543|FG001|Overall Study|Randomized but not Treated|1|||
125288473|NCT02046226|450681546|FG000|Overall Study|Lost to Follow-up|7|||
125288474|NCT01166373|450681549|FG000|Overall Study|Lost to Follow-up|3|||
125288475|NCT01166373|450681550|FG001|Overall Study|Lost to Follow-up|2|||
125288476|NCT01166373|450681551|FG002|Overall Study|Lost to Follow-up|2|||
125288477|NCT01166373|450681552|FG003|Overall Study|Lost to Follow-up|2|||
125288478|NCT01166373|450681549|FG000|Overall Study|Withdrawal by Subject|1|||
125288479|NCT01166373|450681550|FG001|Overall Study|Withdrawal by Subject|2|||
125288480|NCT01166373|450681551|FG002|Overall Study|Withdrawal by Subject|2|||
125288481|NCT01166373|450681552|FG003|Overall Study|Withdrawal by Subject|3|||
125288482|NCT01166373|450681549|FG000|Overall Study|Physician Decision|1|||
125288483|NCT01166373|450681550|FG001|Overall Study|Physician Decision|0|||
125288484|NCT01166373|450681551|FG002|Overall Study|Physician Decision|0|||
125288485|NCT01166373|450681552|FG003|Overall Study|Physician Decision|0|||
125288486|NCT01819129|450681553|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
125288487|NCT01819129|450681554|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
125288488|NCT01819129|450681553|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
125288489|NCT01819129|450681554|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
125288490|NCT01819129|450681553|FG000|Overall Study|Other, Subject moved out of the country|0|||
125288491|NCT01819129|450681554|FG001|Overall Study|Other, Subject moved out of the country|1|||
125288492|NCT01819129|450681553|FG000|Overall Study|Withdrawal by Subject|15|||
125288493|NCT01819129|450681554|FG001|Overall Study|Withdrawal by Subject|15|||
125288494|NCT01819129|450681553|FG000|Overall Study|Lost to Follow-up|5|||
125288495|NCT01819129|450681554|FG001|Overall Study|Lost to Follow-up|2|||
125288496|NCT01819129|450681553|FG000|Overall Study|Lack of Efficacy|0|||
125288497|NCT01819129|450681554|FG001|Overall Study|Lack of Efficacy|1|||
125288498|NCT01819129|450681553|FG000|Overall Study|Adverse Event|1|||
125288499|NCT01819129|450681554|FG001|Overall Study|Adverse Event|4|||
125288500|NCT01819129|450681553|FG000|Overall Study|Death|1|||
125288501|NCT01819129|450681554|FG001|Overall Study|Death|1|||
125288502|NCT01819129|450681553|FG000|Overall Study|Withdrawal Criteria|20|||
125288503|NCT01819129|450681554|FG001|Overall Study|Withdrawal Criteria|15|||
125288504|NCT02836873|450681555|FG000|Overall Study|Protocol Violation|0|||
125288505|NCT02836873|450681556|FG001|Overall Study|Protocol Violation|1|||
125288506|NCT02836873|450681555|FG000|Overall Study|Adverse Event|1|||
125288507|NCT02836873|450681556|FG001|Overall Study|Adverse Event|4|||
125288508|NCT02836873|450681555|FG000|Overall Study|Withdrawal by Subject|2|||
125288509|NCT02836873|450681556|FG001|Overall Study|Withdrawal by Subject|2|||
125288510|NCT02836873|450681555|FG000|Overall Study|Lost to Follow-up|1|||
125288511|NCT02836873|450681556|FG001|Overall Study|Lost to Follow-up|3|||
125288512|NCT02836873|450681555|FG000|Overall Study|Physician Decision|0|||
125288513|NCT02836873|450681556|FG001|Overall Study|Physician Decision|1|||
125288514|NCT02836873|450681555|FG000|Overall Study|Other|1|||
125288515|NCT02836873|450681556|FG001|Overall Study|Other|0|||
125288516|NCT02914548|450681559|FG000|Overall Study|Adverse Event|15|||
125288517|NCT02914548|450681560|FG001|Overall Study|Adverse Event|7|||
125288518|NCT02914548|450681561|FG002|Overall Study|Adverse Event|15|||
125288519|NCT02914548|450681559|FG000|Overall Study|Physician Decision|2|||
125288520|NCT02914548|450681560|FG001|Overall Study|Physician Decision|2|||
125288521|NCT02914548|450681561|FG002|Overall Study|Physician Decision|0|||
125288522|NCT02914548|450681559|FG000|Overall Study|Protocol Violation|1|||
125288523|NCT02914548|450681560|FG001|Overall Study|Protocol Violation|0|||
125288524|NCT02914548|450681561|FG002|Overall Study|Protocol Violation|0|||
125288525|NCT02914548|450681559|FG000|Overall Study|Withdrawal by Subject|3|||
125288526|NCT02914548|450681560|FG001|Overall Study|Withdrawal by Subject|4|||
125288527|NCT02914548|450681561|FG002|Overall Study|Withdrawal by Subject|4|||
125288528|NCT02914548|450681559|FG000|Overall Study|>40% of body surface area|0|||
125288529|NCT02914548|450681560|FG001|Overall Study|>40% of body surface area|1|||
125288530|NCT02914548|450681561|FG002|Overall Study|>40% of body surface area|1|||
125288531|NCT02214225|450681564|FG000|Overall Study|Lost to Follow-up|46|||
125288532|NCT02214225|450681565|FG001|Overall Study|Lost to Follow-up|18|||
125288533|NCT02214225|450681566|FG002|Overall Study|Lost to Follow-up|18|||
125288534|NCT02214225|450681564|FG000|Overall Study|Withdrawal by Subject|2|||
125288535|NCT02214225|450681565|FG001|Overall Study|Withdrawal by Subject|0|||
125288536|NCT02214225|450681566|FG002|Overall Study|Withdrawal by Subject|2|||
125288537|NCT02214225|450681564|FG000|Overall Study|Death|5|||
125288538|NCT02214225|450681565|FG001|Overall Study|Death|0|||
125288539|NCT02214225|450681566|FG002|Overall Study|Death|1|||
125288540|NCT02214225|450681564|FG000|Overall Study|randomized in error, not vaccinated|2|||
125288541|NCT02214225|450681565|FG001|Overall Study|randomized in error, not vaccinated|1|||
125419466|NCT02834780|451160286|FG004|Overall Study|Adverse Event|1|||
125288542|NCT02214225|450681566|FG002|Overall Study|randomized in error, not vaccinated|1|||
125288543|NCT02182440|450681569|FG000|Overall Study|Adverse Event|0|||
125288544|NCT02182440|450681570|FG001|Overall Study|Adverse Event|1|||
125288545|NCT02182440|450681571|FG002|Overall Study|Adverse Event|0|||
125288546|NCT02182440|450681572|FG003|Overall Study|Adverse Event|0|||
125288547|NCT02182440|450681569|FG000|Overall Study|Death|31|||
125288548|NCT02182440|450681570|FG001|Overall Study|Death|8|||
125288549|NCT02182440|450681571|FG002|Overall Study|Death|5|||
125288550|NCT02182440|450681572|FG003|Overall Study|Death|16|||
125288551|NCT02182440|450681569|FG000|Overall Study|Protocol Violation|0|||
125288552|NCT02182440|450681570|FG001|Overall Study|Protocol Violation|1|||
125288553|NCT02182440|450681571|FG002|Overall Study|Protocol Violation|0|||
125288554|NCT02182440|450681572|FG003|Overall Study|Protocol Violation|0|||
125288555|NCT02182440|450681569|FG000|Overall Study|Physician Decision|1|||
125288556|NCT02182440|450681570|FG001|Overall Study|Physician Decision|0|||
125288557|NCT02182440|450681571|FG002|Overall Study|Physician Decision|0|||
125288558|NCT02182440|450681572|FG003|Overall Study|Physician Decision|0|||
125288559|NCT02182440|450681569|FG000|Overall Study|Withdrawal by Subject|1|||
125288560|NCT02182440|450681570|FG001|Overall Study|Withdrawal by Subject|1|||
125288561|NCT02182440|450681571|FG002|Overall Study|Withdrawal by Subject|3|||
125288562|NCT02182440|450681572|FG003|Overall Study|Withdrawal by Subject|4|||
125288563|NCT02182440|450681569|FG000|Overall Study|different, e.g adm other hospital|12|||
125288564|NCT02182440|450681570|FG001|Overall Study|different, e.g adm other hospital|3|||
125288565|NCT02182440|450681571|FG002|Overall Study|different, e.g adm other hospital|3|||
125288566|NCT02182440|450681572|FG003|Overall Study|different, e.g adm other hospital|10|||
125288567|NCT01166958|450681573|FG000|Overall Study|Withdrawal by Subject|1|||
125288568|NCT01166958|450681574|FG001|Overall Study|Withdrawal by Subject|0|||
125288569|NCT00405964|450681577|FG000|Overall Study|Treatment Failure|17|||
125288570|NCT00405964|450681578|FG001|Overall Study|Treatment Failure|45|||
125288571|NCT00405964|450681577|FG000|Overall Study|Adverse Event|7|||
125288572|NCT00405964|450681578|FG001|Overall Study|Adverse Event|16|||
125288573|NCT00405964|450681577|FG000|Overall Study|Lost to Follow-up|5|||
125288574|NCT00405964|450681578|FG001|Overall Study|Lost to Follow-up|5|||
125288575|NCT00405964|450681577|FG000|Overall Study|Withdrawal by Subject|19|||
125288576|NCT00405964|450681578|FG001|Overall Study|Withdrawal by Subject|23|||
125288577|NCT00405964|450681577|FG000|Overall Study|Protocol Violation|11|||
125288578|NCT00405964|450681578|FG001|Overall Study|Protocol Violation|6|||
125288579|NCT01253265|450681583|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
125288580|NCT01253265|450681584|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
125288581|NCT01253265|450681585|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
125288582|NCT01253265|450681586|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
125288583|NCT01253265|450681587|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
125288584|NCT01253265|450681583|FG000|Overall Study|Withdrawal by Subject|0|||
125288585|NCT01253265|450681584|FG001|Overall Study|Withdrawal by Subject|0|||
125288586|NCT01253265|450681585|FG002|Overall Study|Withdrawal by Subject|0|||
125288587|NCT01253265|450681586|FG003|Overall Study|Withdrawal by Subject|0|||
125288588|NCT01253265|450681587|FG004|Overall Study|Withdrawal by Subject|1|||
125288589|NCT03271047|450681591|FG000|Phase 1b: Dose Finding Period|Death|8|||
125288590|NCT03271047|450681592|FG001|Phase 1b: Dose Finding Period|Death|8|||
125288591|NCT03271047|450681593|FG002|Phase 1b: Dose Finding Period|Death|0|||
125288592|NCT03271047|450681594|FG003|Phase 1b: Dose Finding Period|Death|0|||
125288593|NCT03271047|450681591|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
125288594|NCT03271047|450681592|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
125288595|NCT03271047|450681593|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
125288596|NCT03271047|450681594|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
125288597|NCT03271047|450681591|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
125288598|NCT03271047|450681592|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
125288599|NCT03271047|450681593|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
125288600|NCT03271047|450681594|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
125288601|NCT03271047|450681591|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
125288602|NCT03271047|450681592|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
125288603|NCT03271047|450681593|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
125288604|NCT03271047|450681594|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
125288605|NCT03271047|450681591|FG000|Randomized Phase 2 Period|Other|0|||
125288606|NCT03271047|450681592|FG001|Randomized Phase 2 Period|Other|0|||
125288607|NCT03271047|450681593|FG002|Randomized Phase 2 Period|Other|0|||
125288608|NCT03271047|450681594|FG003|Randomized Phase 2 Period|Other|1|||
125288609|NCT03271047|450681591|FG000|Randomized Phase 2 Period|Death|0|||
125288610|NCT03271047|450681592|FG001|Randomized Phase 2 Period|Death|0|||
125288611|NCT03271047|450681593|FG002|Randomized Phase 2 Period|Death|20|||
125288612|NCT03271047|450681594|FG003|Randomized Phase 2 Period|Death|21|||
125288613|NCT03271047|450681591|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
125288614|NCT03271047|450681592|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
125288615|NCT03271047|450681593|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
125288616|NCT03271047|450681594|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
125288617|NCT03271047|450681591|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
125288618|NCT03271047|450681592|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
125288619|NCT03271047|450681593|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
125288620|NCT03271047|450681594|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
125288621|NCT03271047|450681591|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
125288622|NCT03271047|450681592|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
125288623|NCT03271047|450681593|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
125288624|NCT03271047|450681594|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
125288625|NCT00495521|450681595|FG000|Overall Study|Physician Decision|0|||
125288626|NCT00495521|450681596|FG001|Overall Study|Physician Decision|1|||
125288627|NCT00823212|450683443|FG000|Overall Study|Death|8|||
125288628|NCT00823212|450683444|FG001|Overall Study|Death|10|||
125288629|NCT00823212|450683443|FG000|Overall Study|Withdrawal by Subject|6|||
125288630|NCT00823212|450683444|FG001|Overall Study|Withdrawal by Subject|1|||
125288631|NCT00823212|450683443|FG000|Overall Study|Incarcerated|0|||
125288632|NCT00823212|450683444|FG001|Overall Study|Incarcerated|1|||
125288633|NCT00823212|450683443|FG000|Overall Study|Missed 12-month visit|21|||
125288634|NCT00823212|450683444|FG001|Overall Study|Missed 12-month visit|21|||
125288635|NCT02509052|450683447|FG000|Overall Study|Non compliance|0|||
125288636|NCT02509052|450683448|FG001|Overall Study|Non compliance|0|||
125288637|NCT02509052|450683449|FG002|Overall Study|Non compliance|1|||
125288638|NCT02585830|450683450|FG000|Overall Study|Withdrawal by Subject|3|||
125288639|NCT01323270|450683456|FG000|Overall Study|Withdrawal by Subject|19|||
125288640|NCT01323270|450683457|FG001|Overall Study|Withdrawal by Subject|10|||
125288641|NCT01323270|450683456|FG000|Overall Study|Protocol Violation|9|||
125288642|NCT01323270|450683457|FG001|Overall Study|Protocol Violation|7|||
125288643|NCT01323270|450683456|FG000|Overall Study|Lost to Follow-up|4|||
125288644|NCT01323270|450683457|FG001|Overall Study|Lost to Follow-up|6|||
125288645|NCT01323270|450683456|FG000|Overall Study|Adverse Event|8|||
125288646|NCT01323270|450683457|FG001|Overall Study|Adverse Event|0|||
125288647|NCT01323270|450683456|FG000|Overall Study|Other|0|||
125288648|NCT01323270|450683457|FG001|Overall Study|Other|3|||
125288649|NCT01323270|450683456|FG000|Overall Study|Physician Decision|0|||
125288650|NCT01323270|450683457|FG001|Overall Study|Physician Decision|2|||
125288651|NCT01323270|450683456|FG000|Overall Study|Not eligible|1|||
125288652|NCT01323270|450683457|FG001|Overall Study|Not eligible|1|||
125288653|NCT01323270|450683456|FG000|Overall Study|Death|1|||
125288654|NCT01323270|450683457|FG001|Overall Study|Death|0|||
125288655|NCT01323270|450683456|FG000|Overall Study|Randomized, but not vaccinated|1|||
125288656|NCT01323270|450683457|FG001|Overall Study|Randomized, but not vaccinated|0|||
125288657|NCT03761394|450683461|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
125288658|NCT03761394|450683462|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
125288659|NCT03761394|450683463|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
125288660|NCT03761394|450683464|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
125288661|NCT03761394|450683461|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
125288662|NCT03761394|450683462|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
125288663|NCT03761394|450683463|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
125288664|NCT03761394|450683464|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
125288665|NCT03761394|450683461|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
125288666|NCT03761394|450683462|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
125288667|NCT03761394|450683463|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
125288668|NCT03761394|450683464|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
125288669|NCT03761394|450683461|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
125288670|NCT03761394|450683462|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
125288671|NCT03761394|450683463|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
125288672|NCT03761394|450683464|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
125288673|NCT01643850|450683473|FG000|Overall Study|Withdrawal by Subject|0|||
125288674|NCT01643850|450683474|FG001|Overall Study|Withdrawal by Subject|0|||
125288675|NCT01643850|450683475|FG002|Overall Study|Withdrawal by Subject|0|||
125288676|NCT01643850|450683476|FG003|Overall Study|Withdrawal by Subject|0|||
125288677|NCT01643850|450683477|FG004|Overall Study|Withdrawal by Subject|1|||
125288678|NCT01643850|450683478|FG005|Overall Study|Withdrawal by Subject|0|||
125288679|NCT01643850|450683479|FG006|Overall Study|Withdrawal by Subject|0|||
125288680|NCT01643850|450683480|FG007|Overall Study|Withdrawal by Subject|0|||
125288681|NCT01643850|450683481|FG008|Overall Study|Withdrawal by Subject|0|||
125288682|NCT01643850|450683473|FG000|Overall Study|Lost to Follow-up|0|||
125288683|NCT01643850|450683474|FG001|Overall Study|Lost to Follow-up|0|||
125288684|NCT01643850|450683475|FG002|Overall Study|Lost to Follow-up|0|||
125288685|NCT01643850|450683476|FG003|Overall Study|Lost to Follow-up|0|||
125288686|NCT01643850|450683477|FG004|Overall Study|Lost to Follow-up|0|||
125288687|NCT01643850|450683478|FG005|Overall Study|Lost to Follow-up|0|||
125288688|NCT01643850|450683479|FG006|Overall Study|Lost to Follow-up|1|||
125288689|NCT01643850|450683480|FG007|Overall Study|Lost to Follow-up|0|||
125288690|NCT01643850|450683481|FG008|Overall Study|Lost to Follow-up|1|||
125288691|NCT01643850|450683473|FG000|Overall Study|Adverse Event|0|||
125288692|NCT01643850|450683474|FG001|Overall Study|Adverse Event|0|||
125288693|NCT01643850|450683475|FG002|Overall Study|Adverse Event|0|||
125288694|NCT01643850|450683476|FG003|Overall Study|Adverse Event|0|||
125288695|NCT01643850|450683477|FG004|Overall Study|Adverse Event|1|||
125288696|NCT01643850|450683478|FG005|Overall Study|Adverse Event|0|||
125288697|NCT01643850|450683479|FG006|Overall Study|Adverse Event|0|||
125288698|NCT01643850|450683480|FG007|Overall Study|Adverse Event|0|||
125288699|NCT01643850|450683481|FG008|Overall Study|Adverse Event|0|||
125288700|NCT01643850|450683473|FG000|Overall Study|Administrative Problems|0|||
125288701|NCT01643850|450683474|FG001|Overall Study|Administrative Problems|0|||
125288702|NCT01643850|450683475|FG002|Overall Study|Administrative Problems|1|||
125288703|NCT01643850|450683476|FG003|Overall Study|Administrative Problems|0|||
125288704|NCT01643850|450683477|FG004|Overall Study|Administrative Problems|1|||
125288705|NCT01643850|450683478|FG005|Overall Study|Administrative Problems|0|||
125288706|NCT01643850|450683479|FG006|Overall Study|Administrative Problems|0|||
125288707|NCT01643850|450683480|FG007|Overall Study|Administrative Problems|0|||
125288708|NCT01643850|450683481|FG008|Overall Study|Administrative Problems|0|||
125288709|NCT03242772|450683483|FG000|Overall Study|Lost to Follow-up|2|||
125288710|NCT03242772|450683484|FG001|Overall Study|Lost to Follow-up|0|||
125288711|NCT03242772|450683483|FG000|Overall Study|Physician Decision|0|||
125288712|NCT03242772|450683484|FG001|Overall Study|Physician Decision|1|||
125288713|NCT03242772|450683483|FG000|Overall Study|Withdrawal by Subject|1|||
125288714|NCT03242772|450683484|FG001|Overall Study|Withdrawal by Subject|0|||
125288715|NCT02434354|450683491|FG000|Overall Study|screen fail|3|||
125288716|NCT00413920|450683492|FG000|Overall Study|Adverse Event|9|||
125288717|NCT00413920|450683493|FG001|Overall Study|Adverse Event|11|||
125288718|NCT00413920|450683492|FG000|Overall Study|Lack of Efficacy|11|||
125288719|NCT00413920|450683493|FG001|Overall Study|Lack of Efficacy|9|||
125288720|NCT00413920|450683492|FG000|Overall Study|Death|3|||
125288721|NCT00413920|450683493|FG001|Overall Study|Death|5|||
125288722|NCT00413920|450683492|FG000|Overall Study|Graft Loss|5|||
125288723|NCT00413920|450683493|FG001|Overall Study|Graft Loss|3|||
125288724|NCT03730961|450683494|FG000|Overall Study|Adverse Event|0|||
125288725|NCT03730961|450683495|FG001|Overall Study|Adverse Event|1|||
125288726|NCT01185964|450683499|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
125288727|NCT01185964|450683500|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
125288728|NCT01185964|450683501|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
125288729|NCT01185964|450683502|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
125288730|NCT01185964|450683499|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
125288731|NCT01185964|450683500|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
125288732|NCT01185964|450683501|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
125288733|NCT01185964|450683502|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
125288734|NCT01185964|450683499|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
125288735|NCT01185964|450683500|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
125288736|NCT01185964|450683501|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
125288737|NCT01185964|450683502|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
125288738|NCT01185964|450683499|FG000|Phase 1b and Phase 2|Adverse Event|1|||
125288739|NCT01185964|450683500|FG001|Phase 1b and Phase 2|Adverse Event|0|||
125288740|NCT01185964|450683501|FG002|Phase 1b and Phase 2|Adverse Event|2|||
125288741|NCT01185964|450683502|FG003|Phase 1b and Phase 2|Adverse Event|0|||
125288742|NCT01185964|450683499|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
125288743|NCT01185964|450683500|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
125288744|NCT01185964|450683501|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
125288745|NCT01185964|450683502|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
125288746|NCT01185964|450683499|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
125288747|NCT01185964|450683500|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
125288748|NCT01185964|450683501|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
125288749|NCT01185964|450683502|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
125288750|NCT01185964|450683499|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
125288751|NCT01185964|450683500|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
125449895|NCT00665561|451274886|FG001|Overall Study|Site closed|0|||
125449896|NCT00665561|451274885|FG000|Overall Study|Withdrawn due to pregnancy|0|||
125449897|NCT00665561|451274886|FG001|Overall Study|Withdrawn due to pregnancy|1|||
125449898|NCT01734811|451274889|FG000|Overall Study|Lost to Follow-up|2|||
125449899|NCT01734811|451274890|FG001|Overall Study|Lost to Follow-up|3|||
125288752|NCT01185964|450683501|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
125288753|NCT01185964|450683502|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
125288754|NCT01185964|450683499|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
125288755|NCT01185964|450683500|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
125288756|NCT01185964|450683501|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
125288757|NCT01185964|450683502|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
125288758|NCT01920893|450683503|FG000|Overall Study|Adverse Event|5|||
125288759|NCT01920893|450683504|FG001|Overall Study|Adverse Event|2|||
125288760|NCT01920893|450683503|FG000|Overall Study|Lack of Efficacy|2|||
125288761|NCT01920893|450683504|FG001|Overall Study|Lack of Efficacy|0|||
125288762|NCT03440918|450683508|FG000|Overall Study|Protocol Violation|0|||
125288763|NCT03440918|450683509|FG001|Overall Study|Protocol Violation|16|||
125288764|NCT03754582|450683525|FG000|Treatment Phase|Adverse Event|0|||
125288765|NCT03754582|450683526|FG001|Treatment Phase|Adverse Event|1|||
125288766|NCT03754582|450683527|FG002|Treatment Phase|Adverse Event|0|||
125288767|NCT03754582|450683525|FG000|Follow-up Phase|Other|0|||
125288768|NCT03754582|450683526|FG001|Follow-up Phase|Other|0|||
125288769|NCT03754582|450683527|FG002|Follow-up Phase|Other|1|||
125288770|NCT02680574|450683528|FG000|Overall Study|Death|137|||
125288771|NCT02680574|450683529|FG001|Overall Study|Death|137|||
125288772|NCT02680574|450683528|FG000|Overall Study|Withdrawal by Subject|17|||
125288773|NCT02680574|450683529|FG001|Overall Study|Withdrawal by Subject|9|||
125288774|NCT02680574|450683528|FG000|Overall Study|Lost to Follow-up|4|||
125288775|NCT02680574|450683529|FG001|Overall Study|Lost to Follow-up|6|||
125288776|NCT02847858|450683530|FG000|Overall Study|Lost to Follow-up|401|||
125288777|NCT02847858|450683531|FG001|Overall Study|Lost to Follow-up|269|||
125288778|NCT00066469|450683533|FG000|Overall Study|Death|3|||
125288779|NCT00066469|450683533|FG000|Overall Study|Lack of Efficacy|9|||
125288780|NCT00066469|450683533|FG000|Overall Study|Lost to Follow-up|1|||
125288781|NCT00066469|450683533|FG000|Overall Study|Physician Decision|1|||
125288782|NCT00066469|450683533|FG000|Overall Study|Withdrawal by Subject|1|||
125288783|NCT00066469|450683533|FG000|Overall Study|ineligible|1|||
125288784|NCT00711802|450683534|FG000|Overall Study|Not treated (no further detail)|2|||
125288785|NCT00711802|450683535|FG001|Overall Study|Not treated (no further detail)|1|||
125288786|NCT00711802|450683536|FG002|Overall Study|Not treated (no further detail)|2|||
125288787|NCT00711802|450683537|FG003|Overall Study|Not treated (no further detail)|0|||
125288788|NCT00711802|450683538|FG004|Overall Study|Not treated (no further detail)|2|||
125288789|NCT00711802|450683539|FG005|Overall Study|Not treated (no further detail)|0|||
125288790|NCT00711802|450683540|FG006|Overall Study|Not treated (no further detail)|0|||
125288791|NCT00711802|450683541|FG007|Overall Study|Not treated (no further detail)|0|||
125288792|NCT00711802|450683534|FG000|Overall Study|Adverse Event|0|||
125288793|NCT00711802|450683535|FG001|Overall Study|Adverse Event|0|||
125288794|NCT00711802|450683536|FG002|Overall Study|Adverse Event|0|||
125288795|NCT00711802|450683537|FG003|Overall Study|Adverse Event|0|||
125288796|NCT00711802|450683538|FG004|Overall Study|Adverse Event|1|||
125288797|NCT00711802|450683539|FG005|Overall Study|Adverse Event|1|||
125288798|NCT00711802|450683540|FG006|Overall Study|Adverse Event|0|||
125288799|NCT00711802|450683541|FG007|Overall Study|Adverse Event|0|||
125288800|NCT00711802|450683534|FG000|Overall Study|Microbiological failure|0|||
125288801|NCT00711802|450683535|FG001|Overall Study|Microbiological failure|1|||
125288802|NCT00711802|450683536|FG002|Overall Study|Microbiological failure|0|||
125288803|NCT00711802|450683537|FG003|Overall Study|Microbiological failure|0|||
125288804|NCT00711802|450683538|FG004|Overall Study|Microbiological failure|0|||
125288805|NCT00711802|450683539|FG005|Overall Study|Microbiological failure|1|||
125288806|NCT00711802|450683540|FG006|Overall Study|Microbiological failure|0|||
125288807|NCT00711802|450683541|FG007|Overall Study|Microbiological failure|0|||
125288808|NCT00711802|450683534|FG000|Overall Study|Protocol Violation|0|||
125288809|NCT00711802|450683535|FG001|Overall Study|Protocol Violation|0|||
125288810|NCT00711802|450683536|FG002|Overall Study|Protocol Violation|0|||
125288811|NCT00711802|450683537|FG003|Overall Study|Protocol Violation|1|||
125288812|NCT00711802|450683538|FG004|Overall Study|Protocol Violation|0|||
125288813|NCT00711802|450683539|FG005|Overall Study|Protocol Violation|0|||
125288814|NCT00711802|450683540|FG006|Overall Study|Protocol Violation|0|||
125288815|NCT00711802|450683541|FG007|Overall Study|Protocol Violation|0|||
125288816|NCT00711802|450683534|FG000|Overall Study|Physician Decision|0|||
125288817|NCT00711802|450683535|FG001|Overall Study|Physician Decision|2|||
125288818|NCT00711802|450683536|FG002|Overall Study|Physician Decision|0|||
125288819|NCT00711802|450683537|FG003|Overall Study|Physician Decision|0|||
125288820|NCT00711802|450683538|FG004|Overall Study|Physician Decision|0|||
125288821|NCT00711802|450683539|FG005|Overall Study|Physician Decision|0|||
125288822|NCT00711802|450683540|FG006|Overall Study|Physician Decision|0|||
125288823|NCT00711802|450683541|FG007|Overall Study|Physician Decision|0|||
125288824|NCT00711802|450683534|FG000|Overall Study|Withdrawal by Subject|0|||
125288825|NCT00711802|450683535|FG001|Overall Study|Withdrawal by Subject|1|||
125288826|NCT00711802|450683536|FG002|Overall Study|Withdrawal by Subject|0|||
125288827|NCT00711802|450683537|FG003|Overall Study|Withdrawal by Subject|1|||
125288828|NCT00711802|450683538|FG004|Overall Study|Withdrawal by Subject|0|||
125288829|NCT00711802|450683539|FG005|Overall Study|Withdrawal by Subject|0|||
125288830|NCT00711802|450683540|FG006|Overall Study|Withdrawal by Subject|0|||
125288831|NCT00711802|450683541|FG007|Overall Study|Withdrawal by Subject|0|||
125288832|NCT00711802|450683534|FG000|Overall Study|Lost to Follow-up|0|||
125288833|NCT00711802|450683535|FG001|Overall Study|Lost to Follow-up|0|||
125288834|NCT00711802|450683536|FG002|Overall Study|Lost to Follow-up|3|||
125288835|NCT00711802|450683537|FG003|Overall Study|Lost to Follow-up|1|||
125288836|NCT00711802|450683538|FG004|Overall Study|Lost to Follow-up|10|||
125288837|NCT00711802|450683539|FG005|Overall Study|Lost to Follow-up|6|||
125288838|NCT00711802|450683540|FG006|Overall Study|Lost to Follow-up|4|||
125288839|NCT00711802|450683541|FG007|Overall Study|Lost to Follow-up|2|||
125288840|NCT00711802|450683534|FG000|Overall Study|Reason not reported|0|||
125288841|NCT00711802|450683535|FG001|Overall Study|Reason not reported|1|||
125288842|NCT00711802|450683536|FG002|Overall Study|Reason not reported|1|||
125288843|NCT00711802|450683537|FG003|Overall Study|Reason not reported|0|||
125288844|NCT00711802|450683538|FG004|Overall Study|Reason not reported|1|||
125288845|NCT00711802|450683539|FG005|Overall Study|Reason not reported|0|||
125288846|NCT00711802|450683540|FG006|Overall Study|Reason not reported|1|||
125288847|NCT00711802|450683541|FG007|Overall Study|Reason not reported|0|||
125288848|NCT02305849|450683543|FG000|Overall Study|Adverse Event|10|||
125288849|NCT02305849|450683544|FG001|Overall Study|Adverse Event|12|||
125288850|NCT02305849|450683545|FG002|Overall Study|Adverse Event|7|||
125288851|NCT02305849|450683546|FG003|Overall Study|Adverse Event|3|||
125288852|NCT02305849|450683543|FG000|Overall Study|Lack of Efficacy|10|||
125288853|NCT02305849|450683544|FG001|Overall Study|Lack of Efficacy|6|||
125288854|NCT02305849|450683545|FG002|Overall Study|Lack of Efficacy|3|||
125288855|NCT02305849|450683546|FG003|Overall Study|Lack of Efficacy|9|||
125288856|NCT02305849|450683543|FG000|Overall Study|Withdrawal by Subject|2|||
125288857|NCT02305849|450683544|FG001|Overall Study|Withdrawal by Subject|2|||
125288858|NCT02305849|450683545|FG002|Overall Study|Withdrawal by Subject|1|||
125288859|NCT02305849|450683546|FG003|Overall Study|Withdrawal by Subject|4|||
125288860|NCT02305849|450683543|FG000|Overall Study|Lost to Follow-up|0|||
125288861|NCT02305849|450683544|FG001|Overall Study|Lost to Follow-up|2|||
125288862|NCT02305849|450683545|FG002|Overall Study|Lost to Follow-up|0|||
125288863|NCT02305849|450683546|FG003|Overall Study|Lost to Follow-up|0|||
125288864|NCT02305849|450683543|FG000|Overall Study|Protocol Violation|3|||
125288865|NCT02305849|450683544|FG001|Overall Study|Protocol Violation|2|||
125288866|NCT02305849|450683545|FG002|Overall Study|Protocol Violation|1|||
125288867|NCT02305849|450683546|FG003|Overall Study|Protocol Violation|1|||
125288868|NCT02305849|450683543|FG000|Overall Study|Lab data met discontinuation criteria|0|||
125288869|NCT02305849|450683544|FG001|Overall Study|Lab data met discontinuation criteria|1|||
125288870|NCT02305849|450683545|FG002|Overall Study|Lab data met discontinuation criteria|2|||
125288871|NCT02305849|450683546|FG003|Overall Study|Lab data met discontinuation criteria|1|||
125288872|NCT02305849|450683543|FG000|Overall Study|Miscellaneous|1|||
125288873|NCT02305849|450683544|FG001|Overall Study|Miscellaneous|2|||
125288874|NCT02305849|450683545|FG002|Overall Study|Miscellaneous|4|||
125288875|NCT02305849|450683546|FG003|Overall Study|Miscellaneous|1|||
125288876|NCT02305849|450683543|FG000|Overall Study|Not fulfill eligibility criteria|1|||
125288877|NCT02305849|450683544|FG001|Overall Study|Not fulfill eligibility criteria|1|||
125288878|NCT02305849|450683545|FG002|Overall Study|Not fulfill eligibility criteria|0|||
125288879|NCT02305849|450683546|FG003|Overall Study|Not fulfill eligibility criteria|0|||
125288880|NCT02410824|450683551|FG000|First Intervention (One Week)|Headache|0|||
125288881|NCT02410824|450683552|FG001|First Intervention (One Week)|Headache|1|||
125288882|NCT00392808|450683553|FG000|Overall Study|Lost to Follow-up|3|||
125288883|NCT00392808|450683554|FG001|Overall Study|Lost to Follow-up|2|||
125288884|NCT00392808|450683555|FG002|Overall Study|Lost to Follow-up|1|||
125288885|NCT00392808|450683556|FG003|Overall Study|Lost to Follow-up|2|||
125288886|NCT00392808|450683553|FG000|Overall Study|Unable to withdraw blood|3|||
125288887|NCT00392808|450683554|FG001|Overall Study|Unable to withdraw blood|1|||
125288888|NCT00392808|450683555|FG002|Overall Study|Unable to withdraw blood|1|||
125288889|NCT00392808|450683556|FG003|Overall Study|Unable to withdraw blood|2|||
125288890|NCT02782325|450683557|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
125288891|NCT02782325|450683558|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
125288892|NCT02782325|450683559|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
125288893|NCT02782325|450683557|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
125288894|NCT02782325|450683558|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
125288895|NCT02782325|450683559|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
125288896|NCT02818036|450683560|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
125288897|NCT02818036|450683561|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
125288898|NCT02818036|450683560|FG000|Overall Study|Withdrawal by Subject|1|||
125288899|NCT02818036|450683561|FG001|Overall Study|Withdrawal by Subject|0|||
125288900|NCT01038713|450683564|FG000|Overall Study|Patient to hospice|1|||
125288901|NCT01038713|450683565|FG001|Overall Study|Patient to hospice|1|||
125288902|NCT01038713|450683566|FG002|Overall Study|Patient to hospice|1|||
125288903|NCT01038713|450683564|FG000|Overall Study|Lost to Follow-up|3|||
125288904|NCT01038713|450683565|FG001|Overall Study|Lost to Follow-up|0|||
125288905|NCT01038713|450683566|FG002|Overall Study|Lost to Follow-up|0|||
125288906|NCT01038713|450683564|FG000|Overall Study|Neuroendocrine Tumor|0|||
125288907|NCT01038713|450683565|FG001|Overall Study|Neuroendocrine Tumor|1|||
125449900|NCT01734811|451274889|FG000|Overall Study|Withdrawal by Subject|2|||
125449901|NCT01734811|451274890|FG001|Overall Study|Withdrawal by Subject|0|||
125288908|NCT01038713|450683566|FG002|Overall Study|Neuroendocrine Tumor|0|||
125288909|NCT01038713|450683564|FG000|Overall Study|died from PEP|0|||
125288910|NCT01038713|450683565|FG001|Overall Study|died from PEP|1|||
125288911|NCT01038713|450683566|FG002|Overall Study|died from PEP|0|||
125288912|NCT01038713|450683564|FG000|Overall Study|Autoimmune Pancreatitis|1|||
125449902|NCT00062868|451274891|FG000|Dose Level 1|Death|2|||
125449903|NCT00062868|451274892|FG001|Dose Level 1|Death|0|||
125449904|NCT00062868|451274893|FG002|Dose Level 1|Death|0|||
125449905|NCT00062868|451274894|FG003|Dose Level 1|Death|2|||
125449906|NCT00062868|451274895|FG004|Dose Level 1|Death|0|||
125449907|NCT00062868|451274896|FG005|Dose Level 1|Death|0|||
125449908|NCT00062868|451274897|FG006|Dose Level 1|Death|3|||
125449909|NCT00062868|451274898|FG007|Dose Level 1|Death|0|||
125449910|NCT00062868|451274899|FG008|Dose Level 1|Death|0|||
125449911|NCT00062868|451274900|FG009|Dose Level 1|Death|0|||
125449912|NCT00062868|451274901|FG010|Dose Level 1|Death|0|||
125449913|NCT00062868|451274902|FG011|Dose Level 1|Death|0|||
125449914|NCT00062868|451274903|FG012|Dose Level 1|Death|0|||
125449915|NCT00062868|451274904|FG013|Dose Level 1|Death|0|||
125449916|NCT00062868|451274905|FG014|Dose Level 1|Death|0|||
125449917|NCT00062868|451274906|FG015|Dose Level 1|Death|0|||
125449918|NCT00062868|451274907|FG016|Dose Level 1|Death|0|||
125449919|NCT00062868|451274908|FG017|Dose Level 1|Death|0|||
125449920|NCT00062868|451274909|FG018|Dose Level 1|Death|7|||
125449921|NCT00062868|451274910|FG019|Dose Level 1|Death|0|||
125449922|NCT00062868|451274911|FG020|Dose Level 1|Death|1|||
125449923|NCT00062868|451274891|FG000|Dose Level 1|Lost to Follow-up|0|||
125449924|NCT00062868|451274892|FG001|Dose Level 1|Lost to Follow-up|0|||
125449925|NCT00062868|451274893|FG002|Dose Level 1|Lost to Follow-up|0|||
125449926|NCT00062868|451274894|FG003|Dose Level 1|Lost to Follow-up|0|||
125449927|NCT00062868|451274895|FG004|Dose Level 1|Lost to Follow-up|0|||
125449928|NCT00062868|451274896|FG005|Dose Level 1|Lost to Follow-up|0|||
125449929|NCT00062868|451274897|FG006|Dose Level 1|Lost to Follow-up|0|||
125449930|NCT00062868|451274898|FG007|Dose Level 1|Lost to Follow-up|0|||
125449931|NCT00062868|451274899|FG008|Dose Level 1|Lost to Follow-up|0|||
125449932|NCT00062868|451274900|FG009|Dose Level 1|Lost to Follow-up|0|||
125449933|NCT00062868|451274901|FG010|Dose Level 1|Lost to Follow-up|0|||
125449934|NCT00062868|451274902|FG011|Dose Level 1|Lost to Follow-up|0|||
125449935|NCT00062868|451274903|FG012|Dose Level 1|Lost to Follow-up|1|||
125449936|NCT00062868|451274904|FG013|Dose Level 1|Lost to Follow-up|0|||
125449937|NCT00062868|451274905|FG014|Dose Level 1|Lost to Follow-up|0|||
125449938|NCT00062868|451274906|FG015|Dose Level 1|Lost to Follow-up|0|||
125449939|NCT00062868|451274907|FG016|Dose Level 1|Lost to Follow-up|0|||
125449940|NCT00062868|451274908|FG017|Dose Level 1|Lost to Follow-up|0|||
125449941|NCT00062868|451274909|FG018|Dose Level 1|Lost to Follow-up|2|||
125449942|NCT00062868|451274910|FG019|Dose Level 1|Lost to Follow-up|0|||
125449943|NCT00062868|451274911|FG020|Dose Level 1|Lost to Follow-up|1|||
125449944|NCT00062868|451274891|FG000|Dose Level 2|Death|0|||
125449945|NCT00062868|451274892|FG001|Dose Level 2|Death|3|||
125449946|NCT00062868|451274893|FG002|Dose Level 2|Death|0|||
125449947|NCT00062868|451274894|FG003|Dose Level 2|Death|0|||
125449948|NCT00062868|451274895|FG004|Dose Level 2|Death|2|||
125449949|NCT00062868|451274896|FG005|Dose Level 2|Death|0|||
125449950|NCT00062868|451274897|FG006|Dose Level 2|Death|0|||
125449951|NCT00062868|451274898|FG007|Dose Level 2|Death|0|||
125449952|NCT00062868|451274899|FG008|Dose Level 2|Death|0|||
125449953|NCT00062868|451274900|FG009|Dose Level 2|Death|0|||
125449954|NCT00062868|451274901|FG010|Dose Level 2|Death|1|||
125449955|NCT00062868|451274902|FG011|Dose Level 2|Death|0|||
125449956|NCT00062868|451274903|FG012|Dose Level 2|Death|0|||
125449957|NCT00062868|451274904|FG013|Dose Level 2|Death|0|||
125449958|NCT00062868|451274905|FG014|Dose Level 2|Death|0|||
125449959|NCT00062868|451274906|FG015|Dose Level 2|Death|0|||
125449960|NCT00062868|451274907|FG016|Dose Level 2|Death|2|||
125449961|NCT00062868|451274908|FG017|Dose Level 2|Death|0|||
125449962|NCT00062868|451274909|FG018|Dose Level 2|Death|0|||
125449963|NCT00062868|451274910|FG019|Dose Level 2|Death|0|||
125449964|NCT00062868|451274911|FG020|Dose Level 2|Death|0|||
125449965|NCT00062868|451274891|FG000|Dose Level 2|Lost to Follow-up|0|||
125449966|NCT00062868|451274892|FG001|Dose Level 2|Lost to Follow-up|0|||
125449967|NCT00062868|451274893|FG002|Dose Level 2|Lost to Follow-up|0|||
125449968|NCT00062868|451274894|FG003|Dose Level 2|Lost to Follow-up|0|||
125449969|NCT00062868|451274895|FG004|Dose Level 2|Lost to Follow-up|0|||
125449970|NCT00062868|451274896|FG005|Dose Level 2|Lost to Follow-up|0|||
125449971|NCT00062868|451274897|FG006|Dose Level 2|Lost to Follow-up|0|||
125449972|NCT00062868|451274898|FG007|Dose Level 2|Lost to Follow-up|0|||
125449973|NCT00062868|451274899|FG008|Dose Level 2|Lost to Follow-up|0|||
125449974|NCT00062868|451274900|FG009|Dose Level 2|Lost to Follow-up|0|||
125449975|NCT00062868|451274901|FG010|Dose Level 2|Lost to Follow-up|0|||
125449976|NCT00062868|451274902|FG011|Dose Level 2|Lost to Follow-up|0|||
125449977|NCT00062868|451274903|FG012|Dose Level 2|Lost to Follow-up|0|||
125449978|NCT00062868|451274904|FG013|Dose Level 2|Lost to Follow-up|1|||
125449979|NCT00062868|451274905|FG014|Dose Level 2|Lost to Follow-up|0|||
125449980|NCT00062868|451274906|FG015|Dose Level 2|Lost to Follow-up|0|||
125449981|NCT00062868|451274907|FG016|Dose Level 2|Lost to Follow-up|1|||
125449982|NCT00062868|451274908|FG017|Dose Level 2|Lost to Follow-up|0|||
125449983|NCT00062868|451274909|FG018|Dose Level 2|Lost to Follow-up|0|||
125449984|NCT00062868|451274910|FG019|Dose Level 2|Lost to Follow-up|0|||
125449985|NCT00062868|451274911|FG020|Dose Level 2|Lost to Follow-up|0|||
125449986|NCT00062868|451274891|FG000|Dose Level 3|Death|0|||
125288913|NCT01038713|450683565|FG001|Overall Study|Autoimmune Pancreatitis|0|||
125288914|NCT01038713|450683566|FG002|Overall Study|Autoimmune Pancreatitis|0|||
125288915|NCT01154283|450683567|FG000|0-6 Weeks|Withdrawal by Subject|7|||
125288916|NCT01154283|450683568|FG001|0-6 Weeks|Withdrawal by Subject|2|||
125288917|NCT01154283|450683567|FG000|0-6 Weeks|Death|0|||
125288918|NCT01154283|450683568|FG001|0-6 Weeks|Death|1|||
125288919|NCT01154283|450683567|FG000|7-12 Weeks|Death|1|||
125288920|NCT01154283|450683568|FG001|7-12 Weeks|Death|0|||
125288921|NCT01154283|450683567|FG000|7-12 Weeks|Withdrawal by Subject|0|||
125288922|NCT01154283|450683568|FG001|7-12 Weeks|Withdrawal by Subject|1|||
125288923|NCT03777917|450683569|FG000|Overall Study|Withdrawal by Subject|1|||
125288924|NCT03777917|450683570|FG001|Overall Study|Withdrawal by Subject|0|||
125288925|NCT03777917|450683569|FG000|Overall Study|Physician Decision|1|||
125288926|NCT03777917|450683570|FG001|Overall Study|Physician Decision|0|||
125288927|NCT03777917|450683569|FG000|Overall Study|Lost to Follow-up|6|||
125288928|NCT03777917|450683570|FG001|Overall Study|Lost to Follow-up|2|||
125288929|NCT03777917|450683569|FG000|Overall Study|Other|1|||
125288930|NCT03777917|450683570|FG001|Overall Study|Other|0|||
125288931|NCT00042432|450683571|FG000|Overall Study|Adverse Event|4|||
125288932|NCT00042432|450683572|FG001|Overall Study|Adverse Event|1|||
125288933|NCT00042432|450683571|FG000|Overall Study|Withdrawal by Subject|1|||
125288934|NCT00042432|450683572|FG001|Overall Study|Withdrawal by Subject|3|||
125288935|NCT00042432|450683571|FG000|Overall Study|Death|0|||
125288936|NCT00042432|450683572|FG001|Overall Study|Death|2|||
125288937|NCT00042432|450683571|FG000|Overall Study|Ineligibility determined|1|||
125288938|NCT00042432|450683572|FG001|Overall Study|Ineligibility determined|0|||
125288939|NCT00042432|450683571|FG000|Overall Study|Initiation of maintenance dialysis|1|||
125288940|NCT00042432|450683572|FG001|Overall Study|Initiation of maintenance dialysis|1|||
125288941|NCT00042432|450683571|FG000|Overall Study|Other|2|||
125288942|NCT00042432|450683572|FG001|Overall Study|Other|0|||
125288943|NCT01853072|450683573|FG000|Overall Study|Adverse event prior to treatment|0|||
125288944|NCT01853072|450683574|FG001|Overall Study|Adverse event prior to treatment|1|||
125288945|NCT01853072|450683573|FG000|Overall Study|Adverse Event|0|||
125288946|NCT01853072|450683574|FG001|Overall Study|Adverse Event|3|||
125288947|NCT01853072|450683573|FG000|Overall Study|Death|1|||
125288948|NCT01853072|450683574|FG001|Overall Study|Death|4|||
125288949|NCT01853072|450683573|FG000|Overall Study|Lost to Follow-up|0|||
125288950|NCT01853072|450683574|FG001|Overall Study|Lost to Follow-up|3|||
125288951|NCT01853072|450683573|FG000|Overall Study|Non-compliance with study drug|0|||
125288952|NCT01853072|450683574|FG001|Overall Study|Non-compliance with study drug|1|||
125288953|NCT01853072|450683573|FG000|Overall Study|Physician Decision|1|||
125288954|NCT01853072|450683574|FG001|Overall Study|Physician Decision|1|||
125288955|NCT01853072|450683573|FG000|Overall Study|Withdrawal by Subject|1|||
125288956|NCT01853072|450683574|FG001|Overall Study|Withdrawal by Subject|2|||
125288957|NCT01853072|450683573|FG000|Overall Study|Reason not specified|9|||
125288958|NCT01853072|450683574|FG001|Overall Study|Reason not specified|6|||
125288959|NCT01816906|450683575|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
125288960|NCT01816906|450683576|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
125288961|NCT01816906|450683575|FG000|Six Months|Lost to Follow-up|14|||
125288962|NCT01816906|450683576|FG001|Six Months|Lost to Follow-up|16|||
125288963|NCT01816906|450683575|FG000|12 Months|Adverse Event|2|||
125288964|NCT01816906|450683576|FG001|12 Months|Adverse Event|2|||
125288965|NCT01816906|450683575|FG000|12 Months|Death|0|||
125288966|NCT01816906|450683576|FG001|12 Months|Death|2|||
125288967|NCT01816906|450683575|FG000|12 Months|Lost to Follow-up|2|||
125288968|NCT01816906|450683576|FG001|12 Months|Lost to Follow-up|1|||
125288969|NCT00746733|450683577|FG000|Second Intervention|Adverse Event|1|||
125288970|NCT00746733|450683578|FG001|Second Intervention|Adverse Event|0|||
125288971|NCT00746733|450683577|FG000|Third Intervention|Withdrawal by Subject|1|||
125288972|NCT00746733|450683578|FG001|Third Intervention|Withdrawal by Subject|1|||
125288973|NCT01527383|450683579|FG000|Overall Study|Adverse Event|5|||
125288974|NCT01527383|450683580|FG001|Overall Study|Adverse Event|0|||
125288975|NCT01527383|450683579|FG000|Overall Study|Lost to Follow-up|3|||
125288976|NCT01527383|450683580|FG001|Overall Study|Lost to Follow-up|0|||
125288977|NCT01527383|450683579|FG000|Overall Study|Physician Decision|2|||
125288978|NCT01527383|450683580|FG001|Overall Study|Physician Decision|0|||
125288979|NCT01527383|450683579|FG000|Overall Study|Pregnancy|1|||
125288980|NCT01527383|450683580|FG001|Overall Study|Pregnancy|0|||
125288981|NCT01527383|450683579|FG000|Overall Study|Protocol Violation|1|||
125288982|NCT01527383|450683580|FG001|Overall Study|Protocol Violation|0|||
125288983|NCT01527383|450683579|FG000|Overall Study|Screen failure|1|||
125288984|NCT01527383|450683580|FG001|Overall Study|Screen failure|0|||
125288985|NCT01527383|450683579|FG000|Overall Study|Participant moved|0|||
125288986|NCT01527383|450683580|FG001|Overall Study|Participant moved|1|||
125288987|NCT01527383|450683579|FG000|Overall Study|Withdrawal by Subject|2|||
125288988|NCT01527383|450683580|FG001|Overall Study|Withdrawal by Subject|3|||
125288989|NCT03412604|450683581|FG000|Overall Study|Withdrawal by Subject|1|||
125288990|NCT01287221|450683583|FG000|Overall Study|Lack of Perceived Benefit|1|||
125288991|NCT01287221|450683584|FG001|Overall Study|Lack of Perceived Benefit|1|||
125288992|NCT01287221|450683583|FG000|Overall Study|Adverse Event|3|||
125449987|NCT00062868|451274892|FG001|Dose Level 3|Death|0|||
125449988|NCT00062868|451274893|FG002|Dose Level 3|Death|0|||
125449989|NCT00062868|451274894|FG003|Dose Level 3|Death|0|||
125449990|NCT00062868|451274895|FG004|Dose Level 3|Death|0|||
125449991|NCT00062868|451274896|FG005|Dose Level 3|Death|0|||
125449992|NCT00062868|451274897|FG006|Dose Level 3|Death|0|||
125449993|NCT00062868|451274898|FG007|Dose Level 3|Death|0|||
125449994|NCT00062868|451274899|FG008|Dose Level 3|Death|0|||
125449995|NCT00062868|451274900|FG009|Dose Level 3|Death|0|||
125449996|NCT00062868|451274901|FG010|Dose Level 3|Death|0|||
125449997|NCT00062868|451274902|FG011|Dose Level 3|Death|1|||
125449998|NCT00062868|451274903|FG012|Dose Level 3|Death|0|||
125449999|NCT00062868|451274904|FG013|Dose Level 3|Death|0|||
125450000|NCT00062868|451274905|FG014|Dose Level 3|Death|0|||
125450001|NCT00062868|451274906|FG015|Dose Level 3|Death|0|||
125450002|NCT00062868|451274907|FG016|Dose Level 3|Death|0|||
125450003|NCT00062868|451274908|FG017|Dose Level 3|Death|1|||
125450004|NCT00062868|451274909|FG018|Dose Level 3|Death|0|||
125450005|NCT00062868|451274910|FG019|Dose Level 3|Death|0|||
125450006|NCT00062868|451274911|FG020|Dose Level 3|Death|0|||
125450007|NCT00062868|451274891|FG000|Dose Level 3|Lost to Follow-up|0|||
125450008|NCT00062868|451274892|FG001|Dose Level 3|Lost to Follow-up|0|||
125450009|NCT00062868|451274893|FG002|Dose Level 3|Lost to Follow-up|0|||
125450010|NCT00062868|451274894|FG003|Dose Level 3|Lost to Follow-up|0|||
125450011|NCT00062868|451274895|FG004|Dose Level 3|Lost to Follow-up|0|||
125450012|NCT00062868|451274896|FG005|Dose Level 3|Lost to Follow-up|0|||
125450013|NCT00062868|451274897|FG006|Dose Level 3|Lost to Follow-up|0|||
125450014|NCT00062868|451274898|FG007|Dose Level 3|Lost to Follow-up|0|||
125450015|NCT00062868|451274899|FG008|Dose Level 3|Lost to Follow-up|0|||
125450016|NCT00062868|451274900|FG009|Dose Level 3|Lost to Follow-up|0|||
125450017|NCT00062868|451274901|FG010|Dose Level 3|Lost to Follow-up|0|||
125450018|NCT00062868|451274902|FG011|Dose Level 3|Lost to Follow-up|0|||
125450019|NCT00062868|451274903|FG012|Dose Level 3|Lost to Follow-up|0|||
125450020|NCT00062868|451274904|FG013|Dose Level 3|Lost to Follow-up|0|||
125450021|NCT00062868|451274905|FG014|Dose Level 3|Lost to Follow-up|1|||
125450022|NCT00062868|451274906|FG015|Dose Level 3|Lost to Follow-up|0|||
125450023|NCT00062868|451274907|FG016|Dose Level 3|Lost to Follow-up|0|||
125450024|NCT00062868|451274908|FG017|Dose Level 3|Lost to Follow-up|0|||
125450025|NCT00062868|451274909|FG018|Dose Level 3|Lost to Follow-up|0|||
125450026|NCT00062868|451274910|FG019|Dose Level 3|Lost to Follow-up|0|||
125288993|NCT01287221|450683584|FG001|Overall Study|Adverse Event|3|||
125288994|NCT01287221|450683583|FG000|Overall Study|Withdrawal by Subject|0|||
125288995|NCT01287221|450683584|FG001|Overall Study|Withdrawal by Subject|1|||
125288996|NCT00930969|450683585|FG000|Overall Study|Death|5|||
125288997|NCT00930969|450683585|FG000|Overall Study|Lost to Follow-up|1|||
125288998|NCT00930969|450683585|FG000|Overall Study|Physician Decision|13|||
125288999|NCT00930969|450683585|FG000|Overall Study|Withdrawal by Subject|19|||
125289000|NCT00657150|450683586|FG000|Overall Study|Adverse Event|19|||
125289001|NCT00657150|450683587|FG001|Overall Study|Adverse Event|10|||
125289002|NCT00657150|450683586|FG000|Overall Study|Non-compliant with protocol|5|||
125289003|NCT00657150|450683587|FG001|Overall Study|Non-compliant with protocol|9|||
125289004|NCT00657150|450683586|FG000|Overall Study|Lost to Follow-up|2|||
125289005|NCT00657150|450683587|FG001|Overall Study|Lost to Follow-up|0|||
125289006|NCT00657150|450683586|FG000|Overall Study|Withdrawal by Subject|51|||
125289007|NCT00657150|450683587|FG001|Overall Study|Withdrawal by Subject|36|||
125289008|NCT00657150|450683586|FG000|Overall Study|Other|38|||
125289009|NCT00657150|450683587|FG001|Overall Study|Other|38|||
125289010|NCT00657150|450683586|FG000|Treatment|Adverse Event|60|||
125289011|NCT00657150|450683587|FG001|Treatment|Adverse Event|53|||
125289012|NCT00657150|450683586|FG000|Treatment|Non-compliant with protocol|10|||
125289013|NCT00657150|450683587|FG001|Treatment|Non-compliant with protocol|9|||
125289014|NCT00657150|450683586|FG000|Treatment|Lost to Follow-up|1|||
125289015|NCT00657150|450683587|FG001|Treatment|Lost to Follow-up|0|||
125289016|NCT00657150|450683586|FG000|Treatment|Withdrawal by Subject|23|||
125289017|NCT00657150|450683587|FG001|Treatment|Withdrawal by Subject|20|||
125289018|NCT00657150|450683586|FG000|Treatment|Other|13|||
125289019|NCT00657150|450683587|FG001|Treatment|Other|15|||
125289020|NCT02966795|450683588|FG000|Overall Study|Patient Left the Country|0|||
125289021|NCT02966795|450683589|FG001|Overall Study|Patient Left the Country|1|||
125450027|NCT00062868|451274911|FG020|Dose Level 3|Lost to Follow-up|0|||
125450028|NCT00062868|451274891|FG000|Dose Level 3|Withdrew|0|||
125450029|NCT00062868|451274892|FG001|Dose Level 3|Withdrew|0|||
125450030|NCT00062868|451274893|FG002|Dose Level 3|Withdrew|2|||
125289022|NCT00787137|450683605|FG000|Overall Study|Study Termination|0|||
125450031|NCT00062868|451274894|FG003|Dose Level 3|Withdrew|0|||
125450032|NCT00062868|451274895|FG004|Dose Level 3|Withdrew|0|||
125289023|NCT00787137|450683606|FG001|Overall Study|Study Termination|0|||
125289024|NCT00787137|450683607|FG002|Overall Study|Study Termination|1|||
125450033|NCT00062868|451274896|FG005|Dose Level 3|Withdrew|0|||
125450034|NCT00062868|451274897|FG006|Dose Level 3|Withdrew|0|||
125450035|NCT00062868|451274898|FG007|Dose Level 3|Withdrew|0|||
125450036|NCT00062868|451274899|FG008|Dose Level 3|Withdrew|0|||
125450037|NCT00062868|451274900|FG009|Dose Level 3|Withdrew|0|||
125450038|NCT00062868|451274901|FG010|Dose Level 3|Withdrew|0|||
125289025|NCT00787930|450683613|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
125289026|NCT02395055|450683614|FG000|Overall Study|Withdrawal by Subject|7|||
125289027|NCT02395055|450683615|FG001|Overall Study|Withdrawal by Subject|3|||
125289028|NCT01896271|450683616|FG000|Overall Study|Physician Decision|10|||
125289029|NCT01367704|450683622|FG000|Overall Study|Lost to Follow-up|47|||
125289030|NCT01367704|450683623|FG001|Overall Study|Lost to Follow-up|161|||
125289031|NCT00526110|450683624|FG000|Overall Study|Adverse Event|2|||
125289032|NCT00526110|450683625|FG001|Overall Study|Adverse Event|9|||
125289033|NCT00526110|450683624|FG000|Overall Study|Disease Progression|0|||
125289034|NCT00526110|450683625|FG001|Overall Study|Disease Progression|19|||
125289035|NCT00526110|450683624|FG000|Overall Study|Maximal Response|0|||
125289036|NCT00526110|450683625|FG001|Overall Study|Maximal Response|6|||
125289037|NCT00526110|450683624|FG000|Overall Study|Withdrawal by Subject|0|||
125289038|NCT00526110|450683625|FG001|Overall Study|Withdrawal by Subject|2|||
125289039|NCT00526110|450683624|FG000|Overall Study|Poor Tolerance|0|||
125289040|NCT00526110|450683625|FG001|Overall Study|Poor Tolerance|5|||
125289041|NCT02193087|450683626|FG000|Overall Study|Adverse Event|2|||
125289042|NCT02193087|450683627|FG001|Overall Study|Adverse Event|0|||
125289043|NCT02193087|450683628|FG002|Overall Study|Adverse Event|0|||
125289044|NCT02193087|450683629|FG003|Overall Study|Adverse Event|11|||
125289045|NCT02193087|450683626|FG000|Overall Study|Lost to Follow-up|14|||
125289046|NCT02193087|450683627|FG001|Overall Study|Lost to Follow-up|6|||
125289047|NCT02193087|450683628|FG002|Overall Study|Lost to Follow-up|4|||
125289048|NCT02193087|450683629|FG003|Overall Study|Lost to Follow-up|37|||
125289049|NCT02193087|450683626|FG000|Overall Study|Protocol Violation|2|||
125289050|NCT02193087|450683627|FG001|Overall Study|Protocol Violation|0|||
125289051|NCT02193087|450683628|FG002|Overall Study|Protocol Violation|1|||
125289052|NCT02193087|450683629|FG003|Overall Study|Protocol Violation|2|||
125289053|NCT02193087|450683626|FG000|Overall Study|Withdrawal by Subject|10|||
125289054|NCT02193087|450683627|FG001|Overall Study|Withdrawal by Subject|3|||
125289055|NCT02193087|450683628|FG002|Overall Study|Withdrawal by Subject|1|||
125289056|NCT02193087|450683629|FG003|Overall Study|Withdrawal by Subject|19|||
125289057|NCT02193087|450683626|FG000|Overall Study|Other Reason Not Specified|7|||
125289058|NCT02193087|450683627|FG001|Overall Study|Other Reason Not Specified|2|||
125289059|NCT02193087|450683628|FG002|Overall Study|Other Reason Not Specified|1|||
125289060|NCT02193087|450683629|FG003|Overall Study|Other Reason Not Specified|9|||
125289061|NCT02193087|450683626|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
125289062|NCT02193087|450683627|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
125289063|NCT02193087|450683628|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
125289064|NCT02193087|450683629|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
125289065|NCT04096820|450683630|FG000|Overall Study|Did not return for intervention|2|||
125289066|NCT04096820|450683630|FG000|Overall Study|Death|1|||
125289067|NCT04030247|450685563|FG000|Overall Study|Withdrawal by Subject|4|||
125289068|NCT04030247|450685563|FG000|Overall Study|Lost to Follow-up|13|||
125289069|NCT00509093|450685564|FG000|Overall Study|Adverse Event|10|||
125289070|NCT00509093|450685564|FG000|Overall Study|Disease Progression|9|||
125289071|NCT00509093|450685564|FG000|Overall Study|Transformed into MDS|1|||
125289072|NCT00509093|450685564|FG000|Overall Study|Withdrawal by Subject|3|||
125289073|NCT00509093|450685564|FG000|Overall Study|Physician Decision|1|||
125289074|NCT04431713|450685565|FG000|Overall Study|Withdrawal by Subject|2|||
125289075|NCT04431713|450685566|FG001|Overall Study|Withdrawal by Subject|0|||
125289076|NCT04431713|450685565|FG000|Overall Study|Death|2|||
125289077|NCT04431713|450685566|FG001|Overall Study|Death|2|||
125289078|NCT03383783|450685569|FG000|Overall Study|Withdrawal by Subject|2|||
125450039|NCT00062868|451274902|FG011|Dose Level 3|Withdrew|0|||
125450040|NCT00062868|451274903|FG012|Dose Level 3|Withdrew|0|||
125450041|NCT00062868|451274904|FG013|Dose Level 3|Withdrew|0|||
125450042|NCT00062868|451274905|FG014|Dose Level 3|Withdrew|0|||
125450043|NCT00062868|451274906|FG015|Dose Level 3|Withdrew|0|||
125450044|NCT00062868|451274907|FG016|Dose Level 3|Withdrew|0|||
125450045|NCT00062868|451274908|FG017|Dose Level 3|Withdrew|0|||
125450046|NCT00062868|451274909|FG018|Dose Level 3|Withdrew|0|||
125289087|NCT01224821|450685575|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
125289088|NCT01224821|450685575|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
125289089|NCT01224821|450685575|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
125289090|NCT01224821|450685575|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
125289091|NCT01224821|450685575|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
125289092|NCT01224821|450685575|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
125289093|NCT01224821|450685575|FG000|Long-Term Follow-Up|Death|2|||
125289094|NCT01224821|450685575|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
125289095|NCT01340937|450685576|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
125289096|NCT01340937|450685577|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
125289097|NCT01340937|450685578|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
125289098|NCT01340937|450685579|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
125289099|NCT01340937|450685576|FG000|Period 1: Infant Series|Adverse Event|0|||
125289100|NCT01340937|450685577|FG001|Period 1: Infant Series|Adverse Event|1|||
125289101|NCT01340937|450685578|FG002|Period 1: Infant Series|Adverse Event|4|||
125289102|NCT01340937|450685579|FG003|Period 1: Infant Series|Adverse Event|0|||
125289103|NCT01340937|450685576|FG000|Period 1: Infant Series|Death|2|||
125289104|NCT01340937|450685577|FG001|Period 1: Infant Series|Death|0|||
125289105|NCT01340937|450685578|FG002|Period 1: Infant Series|Death|2|||
125289106|NCT01340937|450685579|FG003|Period 1: Infant Series|Death|0|||
125289107|NCT01340937|450685576|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
125289108|NCT01340937|450685577|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
125289109|NCT01340937|450685578|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
125289110|NCT01340937|450685579|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
125289111|NCT01340937|450685576|FG000|Period 1: Infant Series|Physician Decision|2|||
125289112|NCT01340937|450685577|FG001|Period 1: Infant Series|Physician Decision|3|||
125289113|NCT01340937|450685578|FG002|Period 1: Infant Series|Physician Decision|1|||
125289114|NCT01340937|450685579|FG003|Period 1: Infant Series|Physician Decision|0|||
125289115|NCT01340937|450685576|FG000|Period 1: Infant Series|Protocol Violation|1|||
125289116|NCT01340937|450685577|FG001|Period 1: Infant Series|Protocol Violation|4|||
125289117|NCT01340937|450685578|FG002|Period 1: Infant Series|Protocol Violation|4|||
125289118|NCT01340937|450685579|FG003|Period 1: Infant Series|Protocol Violation|3|||
125289119|NCT01340937|450685576|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
125289120|NCT01340937|450685577|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
125289121|NCT01340937|450685578|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
125289122|NCT01340937|450685579|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
125289123|NCT01340937|450685576|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
125289124|NCT01340937|450685577|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
125289125|NCT01340937|450685578|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
125289126|NCT01340937|450685579|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
125289127|NCT01340937|450685576|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
125289128|NCT01340937|450685577|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
125289129|NCT01340937|450685578|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
125289130|NCT01340937|450685579|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
125289131|NCT01340937|450685576|FG000|Period 2: Interim Period|Adverse Event|1|||
125289132|NCT01340937|450685577|FG001|Period 2: Interim Period|Adverse Event|0|||
125289133|NCT01340937|450685578|FG002|Period 2: Interim Period|Adverse Event|1|||
125289134|NCT01340937|450685579|FG003|Period 2: Interim Period|Adverse Event|0|||
125289135|NCT01340937|450685576|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
125289136|NCT01340937|450685577|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
125289137|NCT01340937|450685578|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
125289138|NCT01340937|450685579|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
125289139|NCT01340937|450685576|FG000|Period 2: Interim Period|Physician Decision|0|||
125289140|NCT01340937|450685577|FG001|Period 2: Interim Period|Physician Decision|1|||
125289141|NCT01340937|450685578|FG002|Period 2: Interim Period|Physician Decision|1|||
125289142|NCT01340937|450685579|FG003|Period 2: Interim Period|Physician Decision|0|||
125289143|NCT01340937|450685576|FG000|Period 2: Interim Period|Protocol Violation|5|||
125289144|NCT01340937|450685577|FG001|Period 2: Interim Period|Protocol Violation|3|||
125289145|NCT01340937|450685578|FG002|Period 2: Interim Period|Protocol Violation|6|||
125289146|NCT01340937|450685579|FG003|Period 2: Interim Period|Protocol Violation|3|||
125289147|NCT01340937|450685576|FG000|Period 2: Interim Period|Technical problems|4|||
125289148|NCT01340937|450685577|FG001|Period 2: Interim Period|Technical problems|4|||
125289149|NCT01340937|450685578|FG002|Period 2: Interim Period|Technical problems|6|||
125289150|NCT01340937|450685579|FG003|Period 2: Interim Period|Technical problems|3|||
125289151|NCT01340937|450685576|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
125289152|NCT01340937|450685577|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
125289153|NCT01340937|450685578|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
125289154|NCT01340937|450685579|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
125289155|NCT01340937|450685576|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
125289156|NCT01340937|450685577|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
125289157|NCT01340937|450685578|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
125289158|NCT01340937|450685579|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
125289159|NCT01340937|450685576|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
125289160|NCT01340937|450685577|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
125289161|NCT01340937|450685578|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
125289162|NCT01340937|450685579|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
125289163|NCT01340937|450685576|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
125289164|NCT01340937|450685577|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
125289165|NCT01340937|450685578|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
125289166|NCT01340937|450685579|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
125289167|NCT02469415|450685583|FG000|Overall Study|Withdrawal by Subject|1|||
125450047|NCT00062868|451274910|FG019|Dose Level 3|Withdrew|0|||
125289168|NCT02469415|450685583|FG000|Overall Study|Investigational agent placed on hold|2|||
125450048|NCT00062868|451274911|FG020|Dose Level 3|Withdrew|0|||
125289169|NCT00350623|450685586|FG000|Overall Study|Lost to Follow-up|8|||
125289170|NCT00350623|450685587|FG001|Overall Study|Lost to Follow-up|3|||
125289171|NCT00350623|450685588|FG002|Overall Study|Lost to Follow-up|4|||
125289172|NCT00350623|450685586|FG000|Overall Study|Withdrawal by Subject|0|||
125289173|NCT00350623|450685587|FG001|Overall Study|Withdrawal by Subject|1|||
125289174|NCT00350623|450685588|FG002|Overall Study|Withdrawal by Subject|1|||
125289175|NCT00350623|450685586|FG000|Overall Study|patient traveling outside the country|0|||
125289176|NCT00350623|450685587|FG001|Overall Study|patient traveling outside the country|0|||
125289177|NCT00350623|450685588|FG002|Overall Study|patient traveling outside the country|1|||
125289178|NCT00623545|450685589|FG000|Overall Study|Adverse Event|6|||
125289179|NCT00623545|450685589|FG000|Overall Study|Withdrawal by Subject|4|||
125289180|NCT04126564|450685590|FG000|Overall Study|Withdrawal by Subject|0|||
125289181|NCT04126564|450685591|FG001|Overall Study|Withdrawal by Subject|2|||
125289182|NCT04126564|450685590|FG000|Overall Study|Lost to Follow-up|0|||
125289183|NCT04126564|450685591|FG001|Overall Study|Lost to Follow-up|1|||
125289184|NCT03500172|450685592|FG000|Period 1: Baseline Randomization|Death|0|||
125289185|NCT03500172|450685593|FG001|Period 1: Baseline Randomization|Death|0|||
125289186|NCT03500172|450685594|FG002|Period 1: Baseline Randomization|Death|0|||
125289187|NCT03500172|450685595|FG003|Period 1: Baseline Randomization|Death|0|||
125289188|NCT03500172|450685596|FG004|Period 1: Baseline Randomization|Death|0|||
125289189|NCT03500172|450685597|FG005|Period 1: Baseline Randomization|Death|0|||
125289190|NCT03500172|450685598|FG006|Period 1: Baseline Randomization|Death|0|||
125289191|NCT03500172|450685599|FG007|Period 1: Baseline Randomization|Death|0|||
125289192|NCT03500172|450685600|FG008|Period 1: Baseline Randomization|Death|0|||
125289193|NCT03500172|450685601|FG009|Period 1: Baseline Randomization|Death|2|||
125289194|NCT03500172|450685602|FG010|Period 1: Baseline Randomization|Death|0|||
125289195|NCT03500172|450685592|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
125289196|NCT03500172|450685593|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
125289197|NCT03500172|450685594|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
125289198|NCT03500172|450685595|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
125289199|NCT03500172|450685596|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
125289200|NCT03500172|450685597|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
125289201|NCT03500172|450685598|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
125289202|NCT03500172|450685599|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
125289203|NCT03500172|450685600|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
125289204|NCT03500172|450685601|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
125289205|NCT03500172|450685602|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
125289206|NCT03500172|450685592|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
125289207|NCT03500172|450685593|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
125289208|NCT03500172|450685594|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
125289209|NCT03500172|450685595|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
125289210|NCT03500172|450685596|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
125289211|NCT03500172|450685597|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
125289212|NCT03500172|450685598|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
125289213|NCT03500172|450685599|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
125289214|NCT03500172|450685600|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
125289215|NCT03500172|450685601|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
125289216|NCT03500172|450685602|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
125289217|NCT03500172|450685592|FG000|Period 2: Re-Randomization|Death|0|||
125289218|NCT03500172|450685593|FG001|Period 2: Re-Randomization|Death|0|||
125289219|NCT03500172|450685594|FG002|Period 2: Re-Randomization|Death|0|||
125289220|NCT03500172|450685595|FG003|Period 2: Re-Randomization|Death|4|||
125289221|NCT03500172|450685596|FG004|Period 2: Re-Randomization|Death|2|||
125289222|NCT03500172|450685597|FG005|Period 2: Re-Randomization|Death|0|||
125289223|NCT03500172|450685598|FG006|Period 2: Re-Randomization|Death|5|||
125289224|NCT03500172|450685599|FG007|Period 2: Re-Randomization|Death|2|||
125289225|NCT03500172|450685600|FG008|Period 2: Re-Randomization|Death|0|||
125289226|NCT03500172|450685601|FG009|Period 2: Re-Randomization|Death|0|||
125289227|NCT03500172|450685602|FG010|Period 2: Re-Randomization|Death|0|||
125289228|NCT01974752|450685609|FG000|Overall Study|Death|33|||
125289229|NCT01974752|450685610|FG001|Overall Study|Death|11|||
125289230|NCT01974752|450685609|FG000|Overall Study|Lost to Follow-up|2|||
125289231|NCT01974752|450685610|FG001|Overall Study|Lost to Follow-up|0|||
125289232|NCT01974752|450685609|FG000|Overall Study|Withdrawal by Subject|2|||
125289233|NCT01974752|450685610|FG001|Overall Study|Withdrawal by Subject|3|||
125289234|NCT01974752|450685609|FG000|Overall Study|Other Eligibility Criteria|0|||
125289235|NCT01974752|450685610|FG001|Overall Study|Other Eligibility Criteria|1|||
125289236|NCT02435680|450685617|FG000|Overall Study|Physician Decision|3|||
125289237|NCT02435680|450685618|FG001|Overall Study|Physician Decision|0|||
125289238|NCT02435680|450685619|FG002|Overall Study|Physician Decision|0|||
125450049|NCT01866917|451274916|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
125450050|NCT01866917|451274917|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
125289239|NCT02435680|450685617|FG000|Overall Study|subject / guardian decision|0|||
125289240|NCT02435680|450685618|FG001|Overall Study|subject / guardian decision|3|||
125450051|NCT03253653|451274918|FG000|Overall Study|Withdrawal by Subject|4|||
125289241|NCT02435680|450685619|FG002|Overall Study|subject / guardian decision|2|||
125289242|NCT02435680|450685617|FG000|Overall Study|Adverse Event|8|||
125289243|NCT02435680|450685618|FG001|Overall Study|Adverse Event|3|||
125289244|NCT02435680|450685619|FG002|Overall Study|Adverse Event|2|||
125289245|NCT02435680|450685617|FG000|Overall Study|progressive disease|10|||
125289246|NCT02435680|450685618|FG001|Overall Study|progressive disease|7|||
125289247|NCT02435680|450685619|FG002|Overall Study|progressive disease|11|||
125289248|NCT02435680|450685617|FG000|Overall Study|not treated|0|||
125289249|NCT02435680|450685618|FG001|Overall Study|not treated|0|||
125289250|NCT02435680|450685619|FG002|Overall Study|not treated|1|||
125289251|NCT00445848|450685620|FG000|Overall Study|Adverse Event|14|||
125289252|NCT00445848|450685620|FG000|Overall Study|Withdrawal by Subject|4|||
125289253|NCT00445848|450685620|FG000|Overall Study|Progression|62|||
125289254|NCT00445848|450685620|FG000|Overall Study|Other-Not protocol specified|5|||
125289255|NCT00330928|450685621|FG000|Overall Study|Lost to Follow-up|6|||
125289256|NCT00330928|450685621|FG000|Overall Study|Physician Decision|9|||
125289257|NCT00330928|450685621|FG000|Overall Study|Death|1|||
125289258|NCT00330928|450685621|FG000|Overall Study|IVUS could not be performed.|1|||
125289259|NCT03028480|450685622|FG000|Overall Study|No revisit after the first prescription date|2|||
125289260|NCT03028480|450685622|FG000|Overall Study|Did not use the drug|1|||
125289261|NCT03028480|450685622|FG000|Overall Study|Violation of the enrollment deadline|10|||
125289262|NCT03028480|450685622|FG000|Overall Study|Case report forms were not collected|21|||
125289263|NCT02279719|450685625|FG000|Overall Study|Patients randomized but never treated|0|||
125289264|NCT02279719|450685626|FG001|Overall Study|Patients randomized but never treated|0|||
125289265|NCT02279719|450685627|FG002|Overall Study|Patients randomized but never treated|0|||
125289266|NCT02279719|450685628|FG003|Overall Study|Patients randomized but never treated|0|||
125289267|NCT02279719|450685629|FG004|Overall Study|Patients randomized but never treated|3|||
125289268|NCT02279719|450685630|FG005|Overall Study|Patients randomized but never treated|0|||
125289269|NCT02279719|450685631|FG006|Overall Study|Patients randomized but never treated|3|||
125289270|NCT03541187|450685632|FG000|Overall Study|Lost to Follow-up|2|||
125289271|NCT03541187|450685633|FG001|Overall Study|Lost to Follow-up|6|||
125289272|NCT03541187|450685632|FG000|Overall Study|Pregnancy|0|||
125289273|NCT03541187|450685633|FG001|Overall Study|Pregnancy|1|||
125289274|NCT03541187|450685632|FG000|Overall Study|Withdrawal by Subject|6|||
125289275|NCT03541187|450685633|FG001|Overall Study|Withdrawal by Subject|2|||
125289276|NCT03541187|450685632|FG000|Overall Study|Moved out of town|1|||
125289277|NCT03541187|450685633|FG001|Overall Study|Moved out of town|0|||
125289278|NCT03541187|450685632|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
125289279|NCT03541187|450685633|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
125289280|NCT03541187|450685632|FG000|Overall Study|Did not meet randomization criteria|1|||
125289281|NCT03541187|450685633|FG001|Overall Study|Did not meet randomization criteria|1|||
125289282|NCT03541187|450685632|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
125289283|NCT03541187|450685633|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
125289284|NCT03541187|450685632|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
125289285|NCT03541187|450685633|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
125289286|NCT01369680|450685639|FG000|Overall Study|Lost to Follow-up|0|||
125289287|NCT01369680|450685640|FG001|Overall Study|Lost to Follow-up|0|||
125289288|NCT01369680|450685641|FG002|Overall Study|Lost to Follow-up|1|||
125289289|NCT01369680|450685642|FG003|Overall Study|Lost to Follow-up|2|||
125289290|NCT01062841|450685646|FG000|Overall Study|Indwelling Device Removed|41|||
125289291|NCT01062841|450685647|FG001|Overall Study|Indwelling Device Removed|48|||
125289292|NCT01062841|450685646|FG000|Overall Study|Death|3|||
125289293|NCT01062841|450685647|FG001|Overall Study|Death|5|||
125289294|NCT01062841|450685646|FG000|Overall Study|Withdrawal by Subject|2|||
125289295|NCT01062841|450685647|FG001|Overall Study|Withdrawal by Subject|0|||
125289296|NCT01062841|450685646|FG000|Overall Study|Withdrawal by Study|3|||
125289297|NCT01062841|450685647|FG001|Overall Study|Withdrawal by Study|0|||
125289298|NCT01218100|450685648|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
125289299|NCT01218100|450685649|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
125289300|NCT01218100|450685650|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
125289301|NCT01218100|450685651|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
125289302|NCT01218100|450685648|FG000|Overall Study|Adverse Event|4|||
125289303|NCT01218100|450685649|FG001|Overall Study|Adverse Event|6|||
125289304|NCT01218100|450685650|FG002|Overall Study|Adverse Event|6|||
125289305|NCT01218100|450685651|FG003|Overall Study|Adverse Event|7|||
125289306|NCT01218100|450685648|FG000|Overall Study|Lack of Efficacy|9|||
125289307|NCT01218100|450685649|FG001|Overall Study|Lack of Efficacy|6|||
125289308|NCT01218100|450685650|FG002|Overall Study|Lack of Efficacy|5|||
125289309|NCT01218100|450685651|FG003|Overall Study|Lack of Efficacy|12|||
125289310|NCT01218100|450685648|FG000|Overall Study|Protocol Violation|0|||
125289311|NCT01218100|450685649|FG001|Overall Study|Protocol Violation|0|||
125289312|NCT01218100|450685650|FG002|Overall Study|Protocol Violation|1|||
125289313|NCT01218100|450685651|FG003|Overall Study|Protocol Violation|1|||
125289314|NCT01218100|450685648|FG000|Overall Study|Withdrawal by Subject|5|||
125289315|NCT01218100|450685649|FG001|Overall Study|Withdrawal by Subject|2|||
125289316|NCT01218100|450685650|FG002|Overall Study|Withdrawal by Subject|6|||
125289317|NCT01218100|450685651|FG003|Overall Study|Withdrawal by Subject|7|||
125289318|NCT01218100|450685648|FG000|Overall Study|Lost to Follow-up|3|||
125289319|NCT01218100|450685649|FG001|Overall Study|Lost to Follow-up|8|||
125289320|NCT01218100|450685650|FG002|Overall Study|Lost to Follow-up|2|||
125289321|NCT01218100|450685651|FG003|Overall Study|Lost to Follow-up|1|||
125289322|NCT01218100|450685648|FG000|Overall Study|Other Reason|2|||
125289323|NCT01218100|450685649|FG001|Overall Study|Other Reason|2|||
125289324|NCT01218100|450685650|FG002|Overall Study|Other Reason|6|||
125289325|NCT01218100|450685651|FG003|Overall Study|Other Reason|4|||
125289326|NCT01118520|450685652|FG000|Overall Study|AAA repair|9|||
125289327|NCT01118520|450685653|FG001|Overall Study|AAA repair|7|||
125289328|NCT01118520|450685654|FG002|Overall Study|AAA repair|9|||
125289329|NCT01118520|450685652|FG000|Overall Study|Adverse Event|3|||
125289330|NCT01118520|450685653|FG001|Overall Study|Adverse Event|3|||
125289331|NCT01118520|450685654|FG002|Overall Study|Adverse Event|3|||
125289332|NCT01118520|450685652|FG000|Overall Study|Withdrawal by Subject|8|||
125289333|NCT01118520|450685653|FG001|Overall Study|Withdrawal by Subject|13|||
125289334|NCT01118520|450685654|FG002|Overall Study|Withdrawal by Subject|8|||
125289335|NCT01089023|450685660|FG000|Overall Study|Lost to Follow-up|3|||
125289336|NCT01089023|450685660|FG000|Overall Study|Adverse Event|1|||
125289337|NCT01089023|450685660|FG000|Overall Study|Withdrawal by Subject|1|||
125289338|NCT01089023|450685660|FG000|Overall Study|Protocol Violation|1|||
125289339|NCT01089023|450685660|FG000|Overall Study|Lack of Efficacy|1|||
125289340|NCT03220581|450685662|FG000|Overall Study|Withdrawal by Subject|0|||
125289341|NCT03220581|450685663|FG001|Overall Study|Withdrawal by Subject|1|||
125289342|NCT03220581|450685662|FG000|Overall Study|Lost to Follow-up|3|||
125289343|NCT03220581|450685663|FG001|Overall Study|Lost to Follow-up|6|||
125289344|NCT01396265|450685664|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
125289345|NCT02275117|450685666|FG000|Overall Study|Adverse Event|0|||
125289346|NCT02275117|450685667|FG001|Overall Study|Adverse Event|0|||
125289347|NCT02275117|450685668|FG002|Overall Study|Adverse Event|0|||
125289348|NCT02275117|450685669|FG003|Overall Study|Adverse Event|0|||
125289349|NCT02275117|450685670|FG004|Overall Study|Adverse Event|1|||
125289350|NCT02275117|450685666|FG000|Overall Study|Lack of Efficacy|6|||
125289351|NCT02275117|450685667|FG001|Overall Study|Lack of Efficacy|7|||
125289352|NCT02275117|450685668|FG002|Overall Study|Lack of Efficacy|5|||
125289353|NCT02275117|450685669|FG003|Overall Study|Lack of Efficacy|2|||
125289354|NCT02275117|450685670|FG004|Overall Study|Lack of Efficacy|10|||
125289355|NCT02275117|450685666|FG000|Overall Study|Lost to Follow-up|11|||
125289356|NCT02275117|450685667|FG001|Overall Study|Lost to Follow-up|16|||
125289357|NCT02275117|450685668|FG002|Overall Study|Lost to Follow-up|15|||
125289358|NCT02275117|450685669|FG003|Overall Study|Lost to Follow-up|16|||
125289359|NCT02275117|450685670|FG004|Overall Study|Lost to Follow-up|8|||
125289360|NCT02275117|450685666|FG000|Overall Study|Physician Decision|0|||
125289361|NCT02275117|450685667|FG001|Overall Study|Physician Decision|1|||
125289362|NCT02275117|450685668|FG002|Overall Study|Physician Decision|1|||
125289363|NCT02275117|450685669|FG003|Overall Study|Physician Decision|0|||
125289364|NCT02275117|450685670|FG004|Overall Study|Physician Decision|1|||
125289365|NCT02275117|450685666|FG000|Overall Study|Protocol Violation|1|||
125289366|NCT02275117|450685667|FG001|Overall Study|Protocol Violation|0|||
125289367|NCT02275117|450685668|FG002|Overall Study|Protocol Violation|1|||
125289368|NCT02275117|450685669|FG003|Overall Study|Protocol Violation|1|||
125289369|NCT02275117|450685670|FG004|Overall Study|Protocol Violation|0|||
125289370|NCT02275117|450685666|FG000|Overall Study|Withdrawal by Subject|6|||
125289371|NCT02275117|450685667|FG001|Overall Study|Withdrawal by Subject|4|||
125289372|NCT02275117|450685668|FG002|Overall Study|Withdrawal by Subject|7|||
125289373|NCT02275117|450685669|FG003|Overall Study|Withdrawal by Subject|3|||
125289374|NCT02275117|450685670|FG004|Overall Study|Withdrawal by Subject|3|||
125289375|NCT02275117|450685666|FG000|Overall Study|Terminated by Sponsor|4|||
125289376|NCT02275117|450685667|FG001|Overall Study|Terminated by Sponsor|4|||
125289377|NCT02275117|450685668|FG002|Overall Study|Terminated by Sponsor|4|||
125450052|NCT03253653|451274919|FG001|Overall Study|Withdrawal by Subject|1|||
125450053|NCT03253653|451274918|FG000|Overall Study|Protocol Violation|0|||
125289378|NCT02275117|450685669|FG003|Overall Study|Terminated by Sponsor|6|||
125289379|NCT02275117|450685670|FG004|Overall Study|Terminated by Sponsor|4|||
125289380|NCT02275117|450685666|FG000|Overall Study|Worsening of Study Indication|0|||
125289381|NCT02275117|450685667|FG001|Overall Study|Worsening of Study Indication|1|||
125289382|NCT02275117|450685668|FG002|Overall Study|Worsening of Study Indication|2|||
125289383|NCT02275117|450685669|FG003|Overall Study|Worsening of Study Indication|0|||
125289384|NCT02275117|450685670|FG004|Overall Study|Worsening of Study Indication|0|||
125289385|NCT02275117|450685666|FG000|Overall Study|Study Burden|5|||
125289386|NCT02275117|450685667|FG001|Overall Study|Study Burden|4|||
125289387|NCT02275117|450685668|FG002|Overall Study|Study Burden|7|||
125289388|NCT02275117|450685669|FG003|Overall Study|Study Burden|5|||
125289389|NCT02275117|450685670|FG004|Overall Study|Study Burden|7|||
125289390|NCT02275117|450685666|FG000|Overall Study|Other|1|||
125289391|NCT02275117|450685667|FG001|Overall Study|Other|0|||
125289392|NCT02275117|450685668|FG002|Overall Study|Other|0|||
125289393|NCT02275117|450685669|FG003|Overall Study|Other|0|||
125289394|NCT02275117|450685670|FG004|Overall Study|Other|2|||
125289395|NCT03421743|450685674|FG000|Overall Study|Lack of Efficacy|1|||
125289396|NCT03421743|450685675|FG001|Overall Study|Lack of Efficacy|0|||
125289397|NCT03421743|450685674|FG000|Overall Study|Adverse Event|2|||
125289398|NCT03421743|450685675|FG001|Overall Study|Adverse Event|1|||
125289399|NCT03421743|450685674|FG000|Overall Study|Withdrawal by Subject|0|||
125289400|NCT03421743|450685675|FG001|Overall Study|Withdrawal by Subject|1|||
125289401|NCT00681564|450685677|FG000|Overall Study|Lost to Follow-up|6|||
125289402|NCT00681564|450685678|FG001|Overall Study|Lost to Follow-up|6|||
125289403|NCT00681564|450685677|FG000|Overall Study|Withdrawal by Subject|0|||
125289404|NCT00681564|450685678|FG001|Overall Study|Withdrawal by Subject|1|||
125289405|NCT00681564|450685677|FG000|Overall Study|Death|0|||
125289406|NCT00681564|450685678|FG001|Overall Study|Death|1|||
125289407|NCT01009346|450685683|FG000|Overall Study|Adverse Event|4|||
125289408|NCT00541099|450685687|FG000|Overall Study|Ineligible|3|||
125289409|NCT00432744|450685688|FG000|Months 0-6|Withdrawal by Subject|4|||
125289410|NCT00432744|450685689|FG001|Months 0-6|Withdrawal by Subject|4|||
125289411|NCT00432744|450685688|FG000|Months 0-6|Too disabled to score|1|||
125289412|NCT00432744|450685689|FG001|Months 0-6|Too disabled to score|0|||
125289413|NCT00432744|450685688|FG000|Months 7 - 12|Withdrawal by Subject|1|||
125289414|NCT00432744|450685689|FG001|Months 7 - 12|Withdrawal by Subject|0|||
125289415|NCT00432744|450685688|FG000|Months 7 - 12|Too disabled to score|0|||
125289416|NCT00432744|450685689|FG001|Months 7 - 12|Too disabled to score|1|||
125289417|NCT02759315|450685693|FG000|Overall Study|Adverse Event|0|||
125289418|NCT02759315|450685694|FG001|Overall Study|Adverse Event|0|||
125289419|NCT02759315|450685695|FG002|Overall Study|Adverse Event|0|||
125289420|NCT02759315|450685696|FG003|Overall Study|Adverse Event|1|||
125289421|NCT02759315|450685697|FG004|Overall Study|Adverse Event|0|||
125289422|NCT02759315|450685693|FG000|Overall Study|Death|0|||
125289423|NCT02759315|450685694|FG001|Overall Study|Death|0|||
125289424|NCT02759315|450685695|FG002|Overall Study|Death|1|||
125289425|NCT02759315|450685696|FG003|Overall Study|Death|0|||
125289426|NCT02759315|450685697|FG004|Overall Study|Death|0|||
125289427|NCT02759315|450685693|FG000|Overall Study|Lost to Follow-up|2|||
125289428|NCT02759315|450685694|FG001|Overall Study|Lost to Follow-up|0|||
125289429|NCT02759315|450685695|FG002|Overall Study|Lost to Follow-up|4|||
125289430|NCT02759315|450685696|FG003|Overall Study|Lost to Follow-up|0|||
125289431|NCT02759315|450685697|FG004|Overall Study|Lost to Follow-up|0|||
125289432|NCT02759315|450685693|FG000|Overall Study|Protocol Violation|0|||
125289433|NCT02759315|450685694|FG001|Overall Study|Protocol Violation|1|||
125289434|NCT02759315|450685695|FG002|Overall Study|Protocol Violation|0|||
125289435|NCT02759315|450685696|FG003|Overall Study|Protocol Violation|0|||
125289436|NCT02759315|450685697|FG004|Overall Study|Protocol Violation|0|||
125289437|NCT02759315|450685693|FG000|Overall Study|Study terminated prior to completion|2|||
125289438|NCT02759315|450685694|FG001|Overall Study|Study terminated prior to completion|0|||
125289439|NCT02759315|450685695|FG002|Overall Study|Study terminated prior to completion|5|||
125289440|NCT02759315|450685696|FG003|Overall Study|Study terminated prior to completion|0|||
125289441|NCT02759315|450685697|FG004|Overall Study|Study terminated prior to completion|1|||
125289442|NCT02761694|450685698|FG000|Overall Study|Lack of Efficacy|0|||
125289443|NCT02761694|450685699|FG001|Overall Study|Lack of Efficacy|0|||
125289444|NCT02761694|450685700|FG002|Overall Study|Lack of Efficacy|0|||
125289445|NCT02761694|450685701|FG003|Overall Study|Lack of Efficacy|0|||
125289446|NCT02761694|450685702|FG004|Overall Study|Lack of Efficacy|0|||
125289447|NCT02761694|450685703|FG005|Overall Study|Lack of Efficacy|0|||
125289448|NCT02761694|450685704|FG006|Overall Study|Lack of Efficacy|6|||
125289449|NCT02761694|450685705|FG007|Overall Study|Lack of Efficacy|0|||
125289450|NCT02761694|450685706|FG008|Overall Study|Lack of Efficacy|0|||
125289451|NCT02761694|450685707|FG009|Overall Study|Lack of Efficacy|1|||
125289452|NCT02761694|450685708|FG010|Overall Study|Lack of Efficacy|1|||
125289453|NCT02761694|450685709|FG011|Overall Study|Lack of Efficacy|4|||
125289454|NCT02761694|450685698|FG000|Overall Study|Death|0|||
125289455|NCT02761694|450685699|FG001|Overall Study|Death|0|||
125289456|NCT02761694|450685700|FG002|Overall Study|Death|0|||
125450054|NCT03253653|451274919|FG001|Overall Study|Protocol Violation|5|||
125450055|NCT04610684|451276554|FG000|Study Treatment|Withdrawal by Subject|1|||
125289457|NCT02761694|450685701|FG003|Overall Study|Death|0|||
125450056|NCT04610684|451276554|FG000|Study Treatment|Disease Progression|2|||
125450057|NCT04610684|451276554|FG000|Follow up|Death|2|||
125450058|NCT04610684|451276554|FG000|Follow up|Withdrawal by Subject|1|||
125289458|NCT02761694|450685702|FG004|Overall Study|Death|0|||
125289459|NCT02761694|450685703|FG005|Overall Study|Death|0|||
125450059|NCT04978363|451276558|FG000|Overall Study|Other medical issues unrelated to the study|0|||
125289460|NCT02761694|450685704|FG006|Overall Study|Death|2|||
125289461|NCT02761694|450685705|FG007|Overall Study|Death|0|||
125289462|NCT02761694|450685706|FG008|Overall Study|Death|2|||
125289463|NCT02761694|450685707|FG009|Overall Study|Death|2|||
125289464|NCT02761694|450685708|FG010|Overall Study|Death|1|||
125289465|NCT02761694|450685709|FG011|Overall Study|Death|0|||
125289466|NCT02761694|450685698|FG000|Overall Study|Physician Decision|0|||
125289467|NCT02761694|450685699|FG001|Overall Study|Physician Decision|0|||
125289468|NCT02761694|450685700|FG002|Overall Study|Physician Decision|0|||
125289469|NCT02761694|450685701|FG003|Overall Study|Physician Decision|0|||
125289470|NCT02761694|450685702|FG004|Overall Study|Physician Decision|0|||
125289471|NCT02761694|450685703|FG005|Overall Study|Physician Decision|0|||
125289472|NCT02761694|450685704|FG006|Overall Study|Physician Decision|1|||
125289473|NCT02761694|450685705|FG007|Overall Study|Physician Decision|0|||
125289474|NCT02761694|450685706|FG008|Overall Study|Physician Decision|0|||
125289475|NCT02761694|450685707|FG009|Overall Study|Physician Decision|0|||
125289476|NCT02761694|450685708|FG010|Overall Study|Physician Decision|0|||
125289477|NCT02761694|450685709|FG011|Overall Study|Physician Decision|0|||
125289478|NCT02761694|450685698|FG000|Overall Study|Withdrawal by Subject|0|||
125289479|NCT02761694|450685699|FG001|Overall Study|Withdrawal by Subject|0|||
125289480|NCT02761694|450685700|FG002|Overall Study|Withdrawal by Subject|0|||
125289481|NCT02761694|450685701|FG003|Overall Study|Withdrawal by Subject|1|||
125289482|NCT02761694|450685702|FG004|Overall Study|Withdrawal by Subject|0|||
125289483|NCT02761694|450685703|FG005|Overall Study|Withdrawal by Subject|0|||
125289484|NCT02761694|450685704|FG006|Overall Study|Withdrawal by Subject|4|||
125289485|NCT02761694|450685705|FG007|Overall Study|Withdrawal by Subject|0|||
125289486|NCT02761694|450685706|FG008|Overall Study|Withdrawal by Subject|2|||
125289487|NCT02761694|450685707|FG009|Overall Study|Withdrawal by Subject|1|||
125289488|NCT02761694|450685708|FG010|Overall Study|Withdrawal by Subject|0|||
125289489|NCT02761694|450685709|FG011|Overall Study|Withdrawal by Subject|0|||
125289490|NCT02761694|450685698|FG000|Overall Study|Lost to Follow-up|0|||
125289491|NCT02761694|450685699|FG001|Overall Study|Lost to Follow-up|0|||
125289492|NCT02761694|450685700|FG002|Overall Study|Lost to Follow-up|0|||
125289493|NCT02761694|450685701|FG003|Overall Study|Lost to Follow-up|0|||
125289494|NCT02761694|450685702|FG004|Overall Study|Lost to Follow-up|0|||
125289495|NCT02761694|450685703|FG005|Overall Study|Lost to Follow-up|0|||
125289496|NCT02761694|450685704|FG006|Overall Study|Lost to Follow-up|1|||
125289497|NCT02761694|450685705|FG007|Overall Study|Lost to Follow-up|0|||
125289498|NCT02761694|450685706|FG008|Overall Study|Lost to Follow-up|0|||
125289499|NCT02761694|450685707|FG009|Overall Study|Lost to Follow-up|0|||
125289500|NCT02761694|450685708|FG010|Overall Study|Lost to Follow-up|0|||
125289501|NCT02761694|450685709|FG011|Overall Study|Lost to Follow-up|1|||
125289502|NCT02761694|450685698|FG000|Overall Study|Adverse Event|0|||
125289503|NCT02761694|450685699|FG001|Overall Study|Adverse Event|0|||
125289504|NCT02761694|450685700|FG002|Overall Study|Adverse Event|0|||
125289505|NCT02761694|450685701|FG003|Overall Study|Adverse Event|0|||
125289506|NCT02761694|450685702|FG004|Overall Study|Adverse Event|0|||
125289507|NCT02761694|450685703|FG005|Overall Study|Adverse Event|0|||
125289508|NCT02761694|450685704|FG006|Overall Study|Adverse Event|1|||
125289509|NCT02761694|450685705|FG007|Overall Study|Adverse Event|0|||
125289510|NCT02761694|450685706|FG008|Overall Study|Adverse Event|1|||
125289511|NCT02761694|450685707|FG009|Overall Study|Adverse Event|0|||
125289512|NCT02761694|450685708|FG010|Overall Study|Adverse Event|0|||
125289513|NCT02761694|450685709|FG011|Overall Study|Adverse Event|1|||
125289514|NCT02761694|450685698|FG000|Overall Study|Other|4|||
125289515|NCT02761694|450685699|FG001|Overall Study|Other|4|||
125289516|NCT02761694|450685700|FG002|Overall Study|Other|1|||
125289517|NCT02761694|450685701|FG003|Overall Study|Other|2|||
125289518|NCT02761694|450685702|FG004|Overall Study|Other|3|||
125289519|NCT02761694|450685703|FG005|Overall Study|Other|3|||
125289520|NCT02761694|450685704|FG006|Overall Study|Other|18|||
125289521|NCT02761694|450685705|FG007|Overall Study|Other|8|||
125289522|NCT02761694|450685706|FG008|Overall Study|Other|0|||
125289523|NCT02761694|450685707|FG009|Overall Study|Other|1|||
125289524|NCT02761694|450685708|FG010|Overall Study|Other|1|||
125289525|NCT02761694|450685709|FG011|Overall Study|Other|0|||
125289526|NCT03464422|450685713|FG000|Overall Study|Lost to Follow-up|2|||
125289527|NCT03464422|450685713|FG000|Overall Study|Withdrawal by Subject|2|||
125289528|NCT01628367|450685719|FG000|Overall Study|Adverse Event|1|||
125289529|NCT01628367|450685720|FG001|Overall Study|Adverse Event|0|||
125289530|NCT02513823|450685723|FG000|Overall Study|Lost to Follow-up|4|||
125289531|NCT02513823|450685723|FG000|Overall Study|Physician Decision|1|||
125289532|NCT03353922|450685724|FG000|Overall Study|Withdrawal by Subject|1|||
125289533|NCT03353922|450685725|FG001|Overall Study|Withdrawal by Subject|0|||
125289534|NCT03353922|450685726|FG002|Overall Study|Withdrawal by Subject|1|||
125289535|NCT03353922|450685727|FG003|Overall Study|Withdrawal by Subject|1|||
125289536|NCT03353922|450685728|FG004|Overall Study|Withdrawal by Subject|0|||
125289537|NCT03353922|450685729|FG005|Overall Study|Withdrawal by Subject|0|||
125289538|NCT03353922|450685724|FG000|Overall Study|Adverse Event|0|||
125289539|NCT03353922|450685725|FG001|Overall Study|Adverse Event|1|||
125289540|NCT03353922|450685726|FG002|Overall Study|Adverse Event|0|||
125289541|NCT03353922|450685727|FG003|Overall Study|Adverse Event|0|||
125289542|NCT03353922|450685728|FG004|Overall Study|Adverse Event|0|||
125289543|NCT03353922|450685729|FG005|Overall Study|Adverse Event|0|||
125289544|NCT00740714|450685730|FG000|Overall Study|Withdrawal by Subject|17|||
125289545|NCT00740714|450685731|FG001|Overall Study|Withdrawal by Subject|19|||
125289546|NCT00740714|450685732|FG002|Overall Study|Withdrawal by Subject|29|||
125450060|NCT04978363|451276559|FG001|Overall Study|Other medical issues unrelated to the study|0|||
125450061|NCT04978363|451276560|FG002|Overall Study|Other medical issues unrelated to the study|0|||
125450062|NCT04978363|451276561|FG003|Overall Study|Other medical issues unrelated to the study|0|||
125289547|NCT03688555|450685733|FG000|Treatment Period|Adverse Event|0|||
125289548|NCT03688555|450685734|FG001|Treatment Period|Adverse Event|0|||
125289549|NCT03688555|450685735|FG002|Treatment Period|Adverse Event|1|||
125289550|NCT00886119|450685741|FG000|Period 1|Did not meet inclusion criteria|1|||
125289551|NCT00886119|450685742|FG001|Period 1|Did not meet inclusion criteria|0|||
125289552|NCT02743780|450685743|FG000|Part 3 (7 Days)|Adverse Event|0|||
125289553|NCT02743780|450685744|FG001|Part 3 (7 Days)|Adverse Event|0|||
125289554|NCT02743780|450685745|FG002|Part 3 (7 Days)|Adverse Event|1|||
125289555|NCT02743780|450685746|FG003|Part 3 (7 Days)|Adverse Event|0|||
125289556|NCT02743780|450685747|FG004|Part 3 (7 Days)|Adverse Event|0|||
125289557|NCT01294462|450685748|FG000|Overall Study|Lost to Follow-up|1|||
125289558|NCT01294462|450685749|FG001|Overall Study|Lost to Follow-up|0|||
125289559|NCT01294462|450685748|FG000|Overall Study|Withdrawal by Subject|65|||
125289560|NCT01294462|450685749|FG001|Overall Study|Withdrawal by Subject|63|||
125289561|NCT01140568|450685750|FG000|Overall Study|disease progression|31|||
125289562|NCT01140568|450685750|FG000|Overall Study|Withdrawal by Subject|1|||
125289563|NCT01140568|450685750|FG000|Overall Study|Screen Fail|4|||
125289564|NCT01400243|450685752|FG000|Overall Study|Protocol Violation|8|||
125289565|NCT01400243|450685753|FG001|Overall Study|Protocol Violation|11|||
125289566|NCT02279498|450685754|FG000|Overall Study|Adverse Event|3|||
125289567|NCT02279498|450685755|FG001|Overall Study|Adverse Event|0|||
125289568|NCT02279498|450685754|FG000|Overall Study|Lack of Efficacy|4|||
125289569|NCT02279498|450685755|FG001|Overall Study|Lack of Efficacy|0|||
125289570|NCT02279498|450685754|FG000|Overall Study|Lost to Follow-up|0|||
125289571|NCT02279498|450685755|FG001|Overall Study|Lost to Follow-up|1|||
125289572|NCT02279498|450685754|FG000|Overall Study|Withdrawal by Subject|9|||
125289573|NCT02279498|450685755|FG001|Overall Study|Withdrawal by Subject|2|||
125289574|NCT02279498|450685754|FG000|Overall Study|Undefined|2|||
125289575|NCT02279498|450685755|FG001|Overall Study|Undefined|1|||
125289576|NCT01048866|450685756|FG000|Overall Study|Adverse Event|1|||
125289577|NCT01048866|450685757|FG001|Overall Study|Adverse Event|0|||
125289578|NCT01048866|450685756|FG000|Overall Study|Protocol Violation|1|||
125289579|NCT01048866|450685757|FG001|Overall Study|Protocol Violation|0|||
125289580|NCT01048866|450685756|FG000|Overall Study|Physician Decision|1|||
125289581|NCT01048866|450685757|FG001|Overall Study|Physician Decision|0|||
125289582|NCT01048866|450685756|FG000|Overall Study|Withdrawal by Subject|0|||
125289583|NCT01048866|450685757|FG001|Overall Study|Withdrawal by Subject|2|||
125289584|NCT01048866|450685756|FG000|Overall Study|Lost to Follow-up|0|||
125289585|NCT01048866|450685757|FG001|Overall Study|Lost to Follow-up|2|||
125289586|NCT01048866|450685756|FG000|Overall Study|Other|1|||
125289587|NCT01048866|450685757|FG001|Overall Study|Other|1|||
125289588|NCT05320393|450687653|FG000|Overall Study|Withdrawal by Subject|1|||
125289589|NCT05320393|450687654|FG001|Overall Study|Withdrawal by Subject|0|||
125289590|NCT05320393|450687655|FG002|Overall Study|Withdrawal by Subject|2|||
125289591|NCT05320393|450687653|FG000|Overall Study|Lost to Follow-up|1|||
125289592|NCT05320393|450687654|FG001|Overall Study|Lost to Follow-up|2|||
125289593|NCT05320393|450687655|FG002|Overall Study|Lost to Follow-up|1|||
125289594|NCT05320393|450687653|FG000|Overall Study|Moved; too much driving|0|||
125289595|NCT05320393|450687654|FG001|Overall Study|Moved; too much driving|0|||
125289596|NCT05320393|450687655|FG002|Overall Study|Moved; too much driving|2|||
125289597|NCT05320393|450687653|FG000|Overall Study|Did not receive treatment|0|||
125289598|NCT05320393|450687654|FG001|Overall Study|Did not receive treatment|0|||
125289599|NCT05320393|450687655|FG002|Overall Study|Did not receive treatment|1|||
125289600|NCT03187834|450687659|FG000|Overall Study|Lost to Follow-up|0|||
125289601|NCT03187834|450687660|FG001|Overall Study|Lost to Follow-up|1|||
125289602|NCT03187834|450687661|FG002|Overall Study|Lost to Follow-up|2|||
125289603|NCT03187834|450687662|FG003|Overall Study|Lost to Follow-up|2|||
125289604|NCT03187834|450687659|FG000|Overall Study|Had invalid anthropometric measurements|5|||
125289605|NCT03187834|450687660|FG001|Overall Study|Had invalid anthropometric measurements|3|||
125289606|NCT03187834|450687661|FG002|Overall Study|Had invalid anthropometric measurements|4|||
125289607|NCT03187834|450687662|FG003|Overall Study|Had invalid anthropometric measurements|2|||
125289608|NCT03559699|450687663|FG000|Overall Study|Withdrawal by Subject|6|||
125289609|NCT03559699|450687663|FG000|Overall Study|Lost to Follow-up|1|||
125289610|NCT05438602|450687670|FG000|Treatment (15 Days)|Adverse Event|2|||
125289611|NCT05438602|450687671|FG001|Treatment (15 Days)|Adverse Event|1|||
125289612|NCT05438602|450687672|FG002|Treatment (15 Days)|Adverse Event|3|||
125289613|NCT05438602|450687670|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
125289614|NCT05438602|450687671|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
125289615|NCT05438602|450687672|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
125289616|NCT05438602|450687670|FG000|Treatment (15 Days)|Other|0|||
125289617|NCT05438602|450687671|FG001|Treatment (15 Days)|Other|0|||
125289618|NCT05438602|450687672|FG002|Treatment (15 Days)|Other|1|||
125289619|NCT05438602|450687670|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
125289620|NCT05438602|450687671|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
125289621|NCT05438602|450687672|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
125289622|NCT05438602|450687670|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
125289623|NCT05438602|450687671|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
125289624|NCT05438602|450687672|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
125289625|NCT05438602|450687670|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
125289626|NCT05438602|450687671|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
125289627|NCT05438602|450687672|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
125289628|NCT05438602|450687670|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
125289629|NCT05438602|450687671|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
125289630|NCT05438602|450687672|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
125289631|NCT05438602|450687670|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
125289632|NCT05438602|450687671|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
125289633|NCT05438602|450687672|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
125289634|NCT05438602|450687670|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
125289635|NCT05438602|450687671|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
125289636|NCT05438602|450687672|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
125289637|NCT05438602|450687670|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
125289638|NCT05438602|450687671|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
125289639|NCT05438602|450687672|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
125289640|NCT01930890|450687673|FG000|Overall Study|Study Termination|14|||
125289641|NCT01930890|450687674|FG001|Overall Study|Study Termination|28|||
125289642|NCT01930890|450687675|FG002|Overall Study|Study Termination|13|||
125289643|NCT01930890|450687676|FG003|Overall Study|Study Termination|25|||
125289644|NCT01930890|450687673|FG000|Overall Study|Death|0|||
125289645|NCT01930890|450687674|FG001|Overall Study|Death|0|||
125289646|NCT01930890|450687675|FG002|Overall Study|Death|0|||
125289647|NCT01930890|450687676|FG003|Overall Study|Death|1|||
125289648|NCT01930890|450687673|FG000|Overall Study|Investigator Decision|0|||
125289649|NCT01930890|450687674|FG001|Overall Study|Investigator Decision|1|||
125289650|NCT01930890|450687675|FG002|Overall Study|Investigator Decision|0|||
125289651|NCT01930890|450687676|FG003|Overall Study|Investigator Decision|0|||
125289652|NCT01930890|450687673|FG000|Overall Study|Consent Withdrawn|0|||
125289653|NCT01930890|450687674|FG001|Overall Study|Consent Withdrawn|3|||
125289654|NCT01930890|450687675|FG002|Overall Study|Consent Withdrawn|0|||
125289655|NCT01930890|450687676|FG003|Overall Study|Consent Withdrawn|1|||
125289656|NCT01930890|450687673|FG000|Overall Study|Adverse Event|0|||
125289657|NCT01930890|450687674|FG001|Overall Study|Adverse Event|1|||
125289658|NCT01930890|450687675|FG002|Overall Study|Adverse Event|0|||
125289659|NCT01930890|450687676|FG003|Overall Study|Adverse Event|0|||
125289660|NCT02091284|450687677|FG000|Overall Study|Withdrawal by Subject|2|||
125289661|NCT02091284|450687678|FG001|Overall Study|Withdrawal by Subject|1|||
125289662|NCT02091284|450687677|FG000|Overall Study|unreliable data|1|||
125289663|NCT02091284|450687678|FG001|Overall Study|unreliable data|0|||
125289664|NCT01278407|450687679|FG000|Confirmatory Phase|Adverse Event|5|||
125289665|NCT01278407|450687680|FG001|Confirmatory Phase|Adverse Event|10|||
125289666|NCT01278407|450687681|FG002|Confirmatory Phase|Adverse Event|1|||
125289667|NCT01278407|450687682|FG003|Confirmatory Phase|Adverse Event|0|||
125289668|NCT01278407|450687683|FG004|Confirmatory Phase|Adverse Event|0|||
125289669|NCT01278407|450687679|FG000|Confirmatory Phase|Participant's Choice|3|||
125289670|NCT01278407|450687680|FG001|Confirmatory Phase|Participant's Choice|5|||
125289671|NCT01278407|450687681|FG002|Confirmatory Phase|Participant's Choice|3|||
125289672|NCT01278407|450687682|FG003|Confirmatory Phase|Participant's Choice|0|||
125289673|NCT01278407|450687683|FG004|Confirmatory Phase|Participant's Choice|0|||
125289674|NCT01278407|450687679|FG000|Confirmatory Phase|Other|1|||
125289675|NCT01278407|450687680|FG001|Confirmatory Phase|Other|1|||
125289676|NCT01278407|450687681|FG002|Confirmatory Phase|Other|2|||
125289677|NCT01278407|450687682|FG003|Confirmatory Phase|Other|0|||
125289678|NCT01278407|450687683|FG004|Confirmatory Phase|Other|0|||
125289679|NCT01278407|450687679|FG000|Extension Phase|Adverse Event|0|||
125289680|NCT01278407|450687680|FG001|Extension Phase|Adverse Event|0|||
125289681|NCT01278407|450687681|FG002|Extension Phase|Adverse Event|0|||
125289682|NCT01278407|450687682|FG003|Extension Phase|Adverse Event|7|||
125289683|NCT01278407|450687683|FG004|Extension Phase|Adverse Event|16|||
125289684|NCT01278407|450687679|FG000|Extension Phase|Participant's Choice|0|||
125289685|NCT01278407|450687680|FG001|Extension Phase|Participant's Choice|0|||
125289686|NCT01278407|450687681|FG002|Extension Phase|Participant's Choice|0|||
125450063|NCT04978363|451276562|FG004|Overall Study|Other medical issues unrelated to the study|1|||
125289687|NCT01278407|450687682|FG003|Extension Phase|Participant's Choice|4|||
125289688|NCT01278407|450687683|FG004|Extension Phase|Participant's Choice|11|||
125289689|NCT01278407|450687679|FG000|Extension Phase|Other|0|||
125450064|NCT04978363|451276563|FG005|Overall Study|Other medical issues unrelated to the study|0|||
125289690|NCT01278407|450687680|FG001|Extension Phase|Other|0|||
125289691|NCT01278407|450687681|FG002|Extension Phase|Other|0|||
125289692|NCT01278407|450687682|FG003|Extension Phase|Other|1|||
125289693|NCT01278407|450687683|FG004|Extension Phase|Other|3|||
125289694|NCT02534935|450687684|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
125289695|NCT02534935|450687685|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
125289696|NCT02534935|450687686|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
125289697|NCT02534935|450687684|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
125289698|NCT02534935|450687685|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
125289699|NCT02534935|450687686|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
125289700|NCT02534935|450687684|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
125289701|NCT02534935|450687685|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
125289702|NCT02534935|450687686|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
125289703|NCT02534935|450687684|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
125289704|NCT02534935|450687685|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
125289705|NCT02534935|450687686|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
125289706|NCT02534935|450687684|FG000|Stage 1: 24 Months|Adverse Event|0|||
125289707|NCT02534935|450687685|FG001|Stage 1: 24 Months|Adverse Event|2|||
125289708|NCT02534935|450687686|FG002|Stage 1: 24 Months|Adverse Event|0|||
125289709|NCT02534935|450687684|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
125289710|NCT02534935|450687685|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
125289711|NCT02534935|450687686|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
125289712|NCT02534935|450687684|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
125289713|NCT02534935|450687685|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
125289714|NCT02534935|450687686|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
125289715|NCT01460719|450687687|FG000|Overall Study|Adverse Event|1|||
125289716|NCT01460719|450687687|FG000|Overall Study|Withdrawal by Subject|1|||
125289717|NCT00076336|450687690|FG000|Overall Study|Death|13|||
125289718|NCT00076336|450687691|FG001|Overall Study|Death|17|||
125289719|NCT00076336|450687690|FG000|Overall Study|Adverse Event|4|||
125289720|NCT00076336|450687691|FG001|Overall Study|Adverse Event|4|||
125289721|NCT00076336|450687690|FG000|Overall Study|Lost to Follow-up|4|||
125289722|NCT00076336|450687691|FG001|Overall Study|Lost to Follow-up|4|||
125289723|NCT00076336|450687690|FG000|Overall Study|Non-Compliance|2|||
125289724|NCT00076336|450687691|FG001|Overall Study|Non-Compliance|0|||
125289725|NCT00076336|450687690|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
125289726|NCT00076336|450687691|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
125289727|NCT00076336|450687690|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
125289728|NCT00076336|450687691|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
125289729|NCT00076336|450687690|FG000|Overall Study|Liver Transplantation|3|||
125289730|NCT00076336|450687691|FG001|Overall Study|Liver Transplantation|3|||
125289731|NCT00076336|450687690|FG000|Overall Study|Virologic Breakthrough|14|||
125289732|NCT00076336|450687691|FG001|Overall Study|Virologic Breakthrough|16|||
125289733|NCT00076336|450687690|FG000|Overall Study|Treatment failure|4|||
125289734|NCT00076336|450687691|FG001|Overall Study|Treatment failure|5|||
125289735|NCT02838901|450687692|FG000|Overall Study|Withdrawal by Subject|1|||
125289736|NCT02838901|450687693|FG001|Overall Study|Withdrawal by Subject|1|||
125289737|NCT02838901|450687692|FG000|Overall Study|Lost to Follow-up|1|||
125289738|NCT02838901|450687693|FG001|Overall Study|Lost to Follow-up|1|||
125289739|NCT02285114|450687694|FG000|Main Phase|Investigator's Discretion|0|||
125289740|NCT02285114|450687695|FG001|Main Phase|Investigator's Discretion|2|||
125289741|NCT02285114|450687696|FG002|Main Phase|Investigator's Discretion|0|||
125289742|NCT02285114|450687697|FG003|Main Phase|Investigator's Discretion|0|||
125289743|NCT02285114|450687698|FG004|Main Phase|Investigator's Discretion|0|||
125289744|NCT02285114|450687699|FG005|Main Phase|Investigator's Discretion|0|||
125289745|NCT02285114|450687694|FG000|Main Phase|Enrolled but Never Treated|1|||
125289746|NCT02285114|450687695|FG001|Main Phase|Enrolled but Never Treated|0|||
125289747|NCT02285114|450687696|FG002|Main Phase|Enrolled but Never Treated|0|||
125289748|NCT02285114|450687697|FG003|Main Phase|Enrolled but Never Treated|0|||
125289749|NCT02285114|450687698|FG004|Main Phase|Enrolled but Never Treated|0|||
125289750|NCT02285114|450687699|FG005|Main Phase|Enrolled but Never Treated|0|||
125289751|NCT02285114|450687694|FG000|Main Phase|Withdrew Consent|0|||
125450065|NCT04978363|451276564|FG006|Overall Study|Other medical issues unrelated to the study|0|||
125450066|NCT04978363|451276565|FG007|Overall Study|Other medical issues unrelated to the study|0|||
125450067|NCT04978363|451276566|FG008|Overall Study|Other medical issues unrelated to the study|0|||
125450068|NCT04978363|451276567|FG009|Overall Study|Other medical issues unrelated to the study|0|||
125450069|NCT04978363|451276568|FG010|Overall Study|Other medical issues unrelated to the study|0|||
125450070|NCT04978363|451276558|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
125289752|NCT02285114|450687695|FG001|Main Phase|Withdrew Consent|0|||
125289753|NCT02285114|450687696|FG002|Main Phase|Withdrew Consent|1|||
125289754|NCT02285114|450687697|FG003|Main Phase|Withdrew Consent|0|||
125289755|NCT02285114|450687698|FG004|Main Phase|Withdrew Consent|0|||
125289756|NCT02285114|450687699|FG005|Main Phase|Withdrew Consent|0|||
125289757|NCT02285114|450687694|FG000|Extension Phase|Investigator's Discretion|0|||
125289758|NCT02285114|450687695|FG001|Extension Phase|Investigator's Discretion|0|||
125289759|NCT02285114|450687696|FG002|Extension Phase|Investigator's Discretion|0|||
125289760|NCT02285114|450687697|FG003|Extension Phase|Investigator's Discretion|14|||
125289761|NCT02285114|450687698|FG004|Extension Phase|Investigator's Discretion|1|||
125289762|NCT02285114|450687699|FG005|Extension Phase|Investigator's Discretion|0|||
125289763|NCT02285114|450687694|FG000|Extension Phase|Lost to Follow-up|0|||
125289764|NCT02285114|450687695|FG001|Extension Phase|Lost to Follow-up|0|||
125289765|NCT02285114|450687696|FG002|Extension Phase|Lost to Follow-up|0|||
125289766|NCT02285114|450687697|FG003|Extension Phase|Lost to Follow-up|1|||
125289767|NCT02285114|450687698|FG004|Extension Phase|Lost to Follow-up|1|||
125289768|NCT02285114|450687699|FG005|Extension Phase|Lost to Follow-up|0|||
125289769|NCT02285114|450687694|FG000|Extension Phase|Non-compliance with Study Drug|0|||
125289770|NCT02285114|450687695|FG001|Extension Phase|Non-compliance with Study Drug|0|||
125289771|NCT02285114|450687696|FG002|Extension Phase|Non-compliance with Study Drug|0|||
125289772|NCT02285114|450687697|FG003|Extension Phase|Non-compliance with Study Drug|2|||
125289773|NCT02285114|450687698|FG004|Extension Phase|Non-compliance with Study Drug|0|||
125289774|NCT02285114|450687699|FG005|Extension Phase|Non-compliance with Study Drug|0|||
125289775|NCT02285114|450687694|FG000|Extension Phase|Pregnancy|0|||
125289776|NCT02285114|450687695|FG001|Extension Phase|Pregnancy|0|||
125289777|NCT02285114|450687696|FG002|Extension Phase|Pregnancy|0|||
125289778|NCT02285114|450687697|FG003|Extension Phase|Pregnancy|1|||
125289779|NCT02285114|450687698|FG004|Extension Phase|Pregnancy|0|||
125289780|NCT02285114|450687699|FG005|Extension Phase|Pregnancy|0|||
125289781|NCT01156389|450687705|FG000|Overall Study|Elevated liver enzymes|4|||
125289782|NCT01156389|450687706|FG001|Overall Study|Elevated liver enzymes|0|||
125289783|NCT01156389|450687705|FG000|Overall Study|Vomiting|0|||
125289784|NCT01156389|450687706|FG001|Overall Study|Vomiting|1|||
125289785|NCT00869050|450687711|FG000|Overall Study|Screen Failure|3|||
125289786|NCT00585221|450687714|FG000|Overall Study|Protocol Violation|8|||
125289787|NCT03276052|450687716|FG000|Overall Study|Withdrawal by Subject|5|||
125289788|NCT03276052|450687716|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
125289789|NCT01145053|450687717|FG000|Overall Study|Adverse Event|22|||
125289790|NCT01145053|450687717|FG000|Overall Study|Lost to Follow-up|28|||
125289791|NCT01145053|450687717|FG000|Overall Study|Withdrawal by Subject|25|||
125289792|NCT01145053|450687717|FG000|Overall Study|Other|18|||
125289793|NCT01994863|450687718|FG000|Period 1|Adverse Event|4|||
125289794|NCT01994863|450687719|FG001|Period 1|Adverse Event|0|||
125289795|NCT01994863|450687718|FG000|Period 1|Withdrawal by Subject|1|||
125289796|NCT01994863|450687719|FG001|Period 1|Withdrawal by Subject|0|||
125289797|NCT01994863|450687718|FG000|Period 1|Trial stopped by sponsor|1|||
125289798|NCT01994863|450687719|FG001|Period 1|Trial stopped by sponsor|3|||
125289799|NCT01994863|450687718|FG000|Period 1|Lack of Efficacy|1|||
125289800|NCT01994863|450687719|FG001|Period 1|Lack of Efficacy|0|||
125289801|NCT01994863|450687718|FG000|Period 2|Adverse Event|0|||
125289802|NCT01994863|450687719|FG001|Period 2|Adverse Event|1|||
125289803|NCT01994863|450687718|FG000|Period 2|Lack of Efficacy|0|||
125289804|NCT01994863|450687719|FG001|Period 2|Lack of Efficacy|2|||
125289805|NCT01994863|450687718|FG000|Period 2|Withdrawal by Subject|1|||
125289806|NCT01994863|450687719|FG001|Period 2|Withdrawal by Subject|1|||
125289807|NCT03060512|450687720|FG000|Overall Study|Adverse Event|4|||
125289808|NCT03060512|450687721|FG001|Overall Study|Adverse Event|6|||
125289809|NCT03060512|450687720|FG000|Overall Study|Lost to Follow-up|1|||
125289810|NCT03060512|450687721|FG001|Overall Study|Lost to Follow-up|1|||
125289811|NCT03060512|450687720|FG000|Overall Study|Withdrawal by Subject|1|||
125289812|NCT03060512|450687721|FG001|Overall Study|Withdrawal by Subject|0|||
125289813|NCT03060512|450687720|FG000|Overall Study|Non-compliance with study medication|1|||
125289814|NCT03060512|450687721|FG001|Overall Study|Non-compliance with study medication|2|||
125289815|NCT03946124|450687722|FG000|Overall Study|Withdrawal by Subject|19|||
125289816|NCT00919867|450687724|FG000|First Intervention|Withdrawal by Subject|0|||
125289817|NCT00919867|450687725|FG001|First Intervention|Withdrawal by Subject|0|||
125289818|NCT00919867|450687726|FG002|First Intervention|Withdrawal by Subject|1|||
125289819|NCT00919867|450687727|FG003|First Intervention|Withdrawal by Subject|0|||
125289820|NCT00919867|450687728|FG004|First Intervention|Withdrawal by Subject|0|||
125289821|NCT00919867|450687729|FG005|First Intervention|Withdrawal by Subject|0|||
125289822|NCT00919867|450687724|FG000|First Intervention|Physician Decision|0|||
125289823|NCT00919867|450687725|FG001|First Intervention|Physician Decision|0|||
125289824|NCT00919867|450687726|FG002|First Intervention|Physician Decision|0|||
125289825|NCT00919867|450687727|FG003|First Intervention|Physician Decision|0|||
125289826|NCT00919867|450687728|FG004|First Intervention|Physician Decision|0|||
125289827|NCT00919867|450687729|FG005|First Intervention|Physician Decision|1|||
125289828|NCT02498067|450687735|FG000|Overall Study|Lost to Follow-up|22|||
125289829|NCT02498067|450687735|FG000|Overall Study|Did not meet inclusion criteria|11|||
125289830|NCT00747344|450687736|FG000|Controlled Period|Adverse Event|3|||
125450071|NCT04978363|451276559|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
125450072|NCT04978363|451276560|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
125289831|NCT00747344|450687737|FG001|Controlled Period|Adverse Event|0|||
125289832|NCT00747344|450687738|FG002|Controlled Period|Adverse Event|0|||
125289833|NCT00747344|450687739|FG003|Controlled Period|Adverse Event|0|||
125289834|NCT00747344|450687736|FG000|Controlled Period|Lack of Efficacy|2|||
125289835|NCT00747344|450687737|FG001|Controlled Period|Lack of Efficacy|1|||
125289836|NCT00747344|450687738|FG002|Controlled Period|Lack of Efficacy|0|||
125289837|NCT00747344|450687739|FG003|Controlled Period|Lack of Efficacy|0|||
125289838|NCT00747344|450687736|FG000|Controlled Period|Other|0|||
125289839|NCT00747344|450687737|FG001|Controlled Period|Other|3|||
125289840|NCT00747344|450687738|FG002|Controlled Period|Other|0|||
125289841|NCT00747344|450687739|FG003|Controlled Period|Other|0|||
125289842|NCT00747344|450687736|FG000|After Controlled Period|Adverse Event|0|||
125289843|NCT00747344|450687737|FG001|After Controlled Period|Adverse Event|0|||
125289844|NCT00747344|450687738|FG002|After Controlled Period|Adverse Event|0|||
125289845|NCT00747344|450687739|FG003|After Controlled Period|Adverse Event|1|||
125289846|NCT01484834|450687740|FG000|Overall Study|Lost to Follow-up|5|||
125289847|NCT01484834|450687741|FG001|Overall Study|Lost to Follow-up|8|||
125289848|NCT01484834|450687742|FG002|Overall Study|Lost to Follow-up|1|||
125289849|NCT01484834|450687743|FG003|Overall Study|Lost to Follow-up|4|||
125289850|NCT00765882|450687744|FG000|Overall Study|Adverse Event|10|||
125289851|NCT00765882|450687745|FG001|Overall Study|Adverse Event|21|||
125289852|NCT00765882|450687746|FG002|Overall Study|Adverse Event|20|||
125289853|NCT00765882|450687744|FG000|Overall Study|Lack of Efficacy|4|||
125289854|NCT00765882|450687745|FG001|Overall Study|Lack of Efficacy|0|||
125289855|NCT00765882|450687746|FG002|Overall Study|Lack of Efficacy|1|||
125289856|NCT00765882|450687744|FG000|Overall Study|Protocol Violation|4|||
125289857|NCT00765882|450687745|FG001|Overall Study|Protocol Violation|3|||
125289858|NCT00765882|450687746|FG002|Overall Study|Protocol Violation|1|||
125289859|NCT00765882|450687744|FG000|Overall Study|Withdrawal by Subject|2|||
125289860|NCT00765882|450687745|FG001|Overall Study|Withdrawal by Subject|6|||
125289861|NCT00765882|450687746|FG002|Overall Study|Withdrawal by Subject|6|||
125289862|NCT00765882|450687744|FG000|Overall Study|Lost to Follow-up|1|||
125289863|NCT00765882|450687745|FG001|Overall Study|Lost to Follow-up|9|||
125289864|NCT00765882|450687746|FG002|Overall Study|Lost to Follow-up|6|||
125289865|NCT00765882|450687744|FG000|Overall Study|Other Reason|3|||
125289866|NCT00765882|450687745|FG001|Overall Study|Other Reason|1|||
125289867|NCT00765882|450687746|FG002|Overall Study|Other Reason|2|||
125289868|NCT02231762|450687750|FG000|Combination Phase|Adverse Event|10|||
125289869|NCT02231762|450687751|FG001|Combination Phase|Adverse Event|0|||
125289870|NCT02231762|450687752|FG002|Combination Phase|Adverse Event|0|||
125289871|NCT02231762|450687753|FG003|Combination Phase|Adverse Event|0|||
125289872|NCT02231762|450687750|FG000|Combination Phase|Withdrawal by Subject|2|||
125289873|NCT02231762|450687751|FG001|Combination Phase|Withdrawal by Subject|0|||
125289874|NCT02231762|450687752|FG002|Combination Phase|Withdrawal by Subject|0|||
125289875|NCT02231762|450687753|FG003|Combination Phase|Withdrawal by Subject|0|||
125289876|NCT02231762|450687750|FG000|Combination Phase|Disease Progression|6|||
125289877|NCT02231762|450687751|FG001|Combination Phase|Disease Progression|0|||
125289878|NCT02231762|450687752|FG002|Combination Phase|Disease Progression|0|||
125289879|NCT02231762|450687753|FG003|Combination Phase|Disease Progression|0|||
125289880|NCT02231762|450687750|FG000|Combination Phase|Did not meet inclusion criteria|1|||
125289881|NCT02231762|450687751|FG001|Combination Phase|Did not meet inclusion criteria|0|||
125289882|NCT02231762|450687752|FG002|Combination Phase|Did not meet inclusion criteria|0|||
125289883|NCT02231762|450687753|FG003|Combination Phase|Did not meet inclusion criteria|0|||
125289884|NCT02231762|450687750|FG000|Combination Phase|Protocol Violation|1|||
125289885|NCT02231762|450687751|FG001|Combination Phase|Protocol Violation|0|||
125289886|NCT02231762|450687752|FG002|Combination Phase|Protocol Violation|0|||
125289887|NCT02231762|450687753|FG003|Combination Phase|Protocol Violation|0|||
125450073|NCT04978363|451276561|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
125450074|NCT04978363|451276562|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
125450075|NCT04978363|451276563|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
125450076|NCT04978363|451276564|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
125450077|NCT04978363|451276565|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
125450078|NCT04978363|451276566|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
125450079|NCT04978363|451276567|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
125450080|NCT04978363|451276568|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
125450081|NCT04978363|451276558|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
125450082|NCT04978363|451276559|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
125450083|NCT04978363|451276560|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
125450084|NCT04978363|451276561|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
125450085|NCT04978363|451276562|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
125450086|NCT04978363|451276563|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
125450087|NCT04978363|451276564|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
125289888|NCT02231762|450687750|FG000|Maintenance Phase|Disease progression|0|||
125289889|NCT02231762|450687751|FG001|Maintenance Phase|Disease progression|3|||
125289890|NCT02231762|450687752|FG002|Maintenance Phase|Disease progression|4|||
125289891|NCT02231762|450687753|FG003|Maintenance Phase|Disease progression|3|||
125289892|NCT02231762|450687750|FG000|Maintenance Phase|Adverse Event|0|||
125289893|NCT02231762|450687751|FG001|Maintenance Phase|Adverse Event|0|||
125289894|NCT02231762|450687752|FG002|Maintenance Phase|Adverse Event|1|||
125289895|NCT02231762|450687753|FG003|Maintenance Phase|Adverse Event|2|||
125289896|NCT01799239|450687758|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
125289897|NCT01799239|450687759|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
125289898|NCT01799239|450687758|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
125289899|NCT01799239|450687759|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
125289900|NCT01799239|450687758|FG000|Period 1 (7 Days)|Protocol Violation|0|||
125289901|NCT01799239|450687759|FG001|Period 1 (7 Days)|Protocol Violation|1|||
125289902|NCT01799239|450687758|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
125289903|NCT01799239|450687759|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
125289904|NCT01799239|450687758|FG000|Period 2 (7 Days)|Protocol Violation|1|||
125289905|NCT01799239|450687759|FG001|Period 2 (7 Days)|Protocol Violation|0|||
125289906|NCT02594098|450687760|FG000|Overall Study|Lack of Efficacy|17|||
125289907|NCT02594098|450687761|FG001|Overall Study|Lack of Efficacy|6|||
125289908|NCT02594098|450687760|FG000|Overall Study|Withdrawal by Subject|1|||
125289909|NCT02594098|450687761|FG001|Overall Study|Withdrawal by Subject|3|||
125289910|NCT02594098|450687760|FG000|Overall Study|Terminated participation|6|||
125289911|NCT02594098|450687761|FG001|Overall Study|Terminated participation|2|||
125289912|NCT02594098|450687760|FG000|Overall Study|Seek alternative treatment|2|||
125289913|NCT02594098|450687761|FG001|Overall Study|Seek alternative treatment|1|||
125289914|NCT02594098|450687760|FG000|Overall Study|Other|0|||
125289915|NCT02594098|450687761|FG001|Overall Study|Other|1|||
125289916|NCT00033540|450687762|FG000|Overall Study|Adverse Event|14|||
125289917|NCT00033540|450687762|FG000|Overall Study|Death|1|||
125289918|NCT00033540|450687762|FG000|Overall Study|Progression|26|||
125289919|NCT00033540|450687762|FG000|Overall Study|Withdrawal by Subject|6|||
125289920|NCT00033540|450687762|FG000|Overall Study|Other|5|||
125289921|NCT00033540|450687762|FG000|Overall Study|Ineligible|3|||
125289922|NCT00033540|450687762|FG000|Overall Study|Never received treatment|2|||
125289923|NCT03366103|450687763|FG000|Overall Study|Disease Progression|3|||
125289924|NCT03366103|450687764|FG001|Overall Study|Disease Progression|1|||
125289925|NCT03366103|450687765|FG002|Overall Study|Disease Progression|0|||
125289926|NCT03366103|450687763|FG000|Overall Study|Adverse Event|0|||
125289927|NCT03366103|450687764|FG001|Overall Study|Adverse Event|1|||
125289928|NCT03366103|450687765|FG002|Overall Study|Adverse Event|0|||
125289929|NCT01036529|450687766|FG000|Overall Study|Adverse Event|0|||
125289930|NCT01036529|450687767|FG001|Overall Study|Adverse Event|1|||
125289931|NCT01036529|450687766|FG000|Overall Study|Lost to Follow-up|0|||
125289932|NCT01036529|450687767|FG001|Overall Study|Lost to Follow-up|1|||
125289933|NCT01036529|450687766|FG000|Overall Study|Physician Decision|1|||
125289934|NCT01036529|450687767|FG001|Overall Study|Physician Decision|0|||
125289935|NCT01036529|450687766|FG000|Overall Study|Withdrawal by Subject|1|||
125289936|NCT01036529|450687767|FG001|Overall Study|Withdrawal by Subject|1|||
125289937|NCT01036529|450687766|FG000|Overall Study|Sponsor study termination|11|||
125289938|NCT01036529|450687767|FG001|Overall Study|Sponsor study termination|12|||
125289939|NCT01945775|450687768|FG000|Overall Study|Death|214|||
125289940|NCT01945775|450687769|FG001|Overall Study|Death|98|||
125289941|NCT01945775|450687768|FG000|Overall Study|Lost to Follow-up|12|||
125289942|NCT01945775|450687769|FG001|Overall Study|Lost to Follow-up|7|||
125289943|NCT01945775|450687768|FG000|Overall Study|Withdrawal by Subject|11|||
125289944|NCT01945775|450687769|FG001|Overall Study|Withdrawal by Subject|21|||
125289945|NCT01945775|450687768|FG000|Overall Study|Other|50|||
125289946|NCT01945775|450687769|FG001|Overall Study|Other|18|||
125289947|NCT02876328|450687770|FG000|Overall Study|Death|2|||
125289948|NCT02876328|450687771|FG001|Overall Study|Death|1|||
125289949|NCT02876328|450687772|FG002|Overall Study|Death|3|||
125289950|NCT02876328|450687773|FG003|Overall Study|Death|0|||
125289951|NCT02876328|450687774|FG004|Overall Study|Death|0|||
125289952|NCT02876328|450687775|FG005|Overall Study|Death|0|||
125289953|NCT02876328|450687776|FG006|Overall Study|Death|1|||
125289954|NCT02876328|450687777|FG007|Overall Study|Death|3|||
125289955|NCT02876328|450687778|FG008|Overall Study|Death|0|||
125289956|NCT02876328|450687779|FG009|Overall Study|Death|1|||
125289957|NCT02876328|450687780|FG010|Overall Study|Death|1|||
125289958|NCT02876328|450687781|FG011|Overall Study|Death|0|||
125289959|NCT02876328|450687782|FG012|Overall Study|Death|0|||
125289960|NCT02876328|450687783|FG013|Overall Study|Death|0|||
125289961|NCT02876328|450687784|FG014|Overall Study|Death|0|||
125289962|NCT02876328|450687785|FG015|Overall Study|Death|0|||
125289963|NCT02876328|450687786|FG016|Overall Study|Death|1|||
125289964|NCT02876328|450687787|FG017|Overall Study|Death|1|||
125289965|NCT02876328|450687788|FG018|Overall Study|Death|0|||
125289966|NCT02876328|450687789|FG019|Overall Study|Death|0|||
125289967|NCT02876328|450687790|FG020|Overall Study|Death|0|||
125289968|NCT02876328|450687791|FG021|Overall Study|Death|1|||
125289969|NCT02876328|450687792|FG022|Overall Study|Death|0|||
125289970|NCT02876328|450687793|FG023|Overall Study|Death|0|||
125289971|NCT02876328|450687770|FG000|Overall Study|Withdrawal by Subject|0|||
125289972|NCT02876328|450687771|FG001|Overall Study|Withdrawal by Subject|2|||
125289973|NCT02876328|450687772|FG002|Overall Study|Withdrawal by Subject|3|||
125289974|NCT02876328|450687773|FG003|Overall Study|Withdrawal by Subject|3|||
125289975|NCT02876328|450687774|FG004|Overall Study|Withdrawal by Subject|0|||
125289976|NCT02876328|450687775|FG005|Overall Study|Withdrawal by Subject|1|||
125289977|NCT02876328|450687776|FG006|Overall Study|Withdrawal by Subject|0|||
125289978|NCT02876328|450687777|FG007|Overall Study|Withdrawal by Subject|1|||
125419467|NCT02834780|451160287|FG005|Overall Study|Adverse Event|0|||
125289979|NCT02876328|450687778|FG008|Overall Study|Withdrawal by Subject|1|||
125289980|NCT02876328|450687779|FG009|Overall Study|Withdrawal by Subject|2|||
125289981|NCT02876328|450687780|FG010|Overall Study|Withdrawal by Subject|0|||
125289982|NCT02876328|450687781|FG011|Overall Study|Withdrawal by Subject|0|||
125289983|NCT02876328|450687782|FG012|Overall Study|Withdrawal by Subject|0|||
125289984|NCT02876328|450687783|FG013|Overall Study|Withdrawal by Subject|0|||
125289985|NCT02876328|450687784|FG014|Overall Study|Withdrawal by Subject|0|||
125289986|NCT02876328|450687785|FG015|Overall Study|Withdrawal by Subject|0|||
125289987|NCT02876328|450687786|FG016|Overall Study|Withdrawal by Subject|1|||
125289988|NCT02876328|450687787|FG017|Overall Study|Withdrawal by Subject|3|||
125289989|NCT02876328|450687788|FG018|Overall Study|Withdrawal by Subject|0|||
125289990|NCT02876328|450687789|FG019|Overall Study|Withdrawal by Subject|0|||
125289991|NCT02876328|450687790|FG020|Overall Study|Withdrawal by Subject|1|||
125289992|NCT02876328|450687791|FG021|Overall Study|Withdrawal by Subject|0|||
125289993|NCT02876328|450687792|FG022|Overall Study|Withdrawal by Subject|0|||
125289994|NCT02876328|450687793|FG023|Overall Study|Withdrawal by Subject|0|||
125289995|NCT02876328|450687770|FG000|Overall Study|Missed 12 Month Visit|15|||
125289996|NCT02876328|450687771|FG001|Overall Study|Missed 12 Month Visit|10|||
125289997|NCT02876328|450687772|FG002|Overall Study|Missed 12 Month Visit|11|||
125289998|NCT02876328|450687773|FG003|Overall Study|Missed 12 Month Visit|6|||
125289999|NCT02876328|450687774|FG004|Overall Study|Missed 12 Month Visit|10|||
125290000|NCT02876328|450687775|FG005|Overall Study|Missed 12 Month Visit|14|||
125290001|NCT02876328|450687776|FG006|Overall Study|Missed 12 Month Visit|3|||
125290002|NCT02876328|450687777|FG007|Overall Study|Missed 12 Month Visit|8|||
125290003|NCT02876328|450687778|FG008|Overall Study|Missed 12 Month Visit|9|||
125290004|NCT02876328|450687779|FG009|Overall Study|Missed 12 Month Visit|5|||
125290005|NCT02876328|450687780|FG010|Overall Study|Missed 12 Month Visit|4|||
125290006|NCT02876328|450687781|FG011|Overall Study|Missed 12 Month Visit|1|||
125290007|NCT02876328|450687782|FG012|Overall Study|Missed 12 Month Visit|5|||
125290008|NCT02876328|450687783|FG013|Overall Study|Missed 12 Month Visit|4|||
125290009|NCT02876328|450687784|FG014|Overall Study|Missed 12 Month Visit|4|||
125290010|NCT02876328|450687785|FG015|Overall Study|Missed 12 Month Visit|4|||
125290011|NCT02876328|450687786|FG016|Overall Study|Missed 12 Month Visit|3|||
125290012|NCT02876328|450687787|FG017|Overall Study|Missed 12 Month Visit|6|||
125290013|NCT02876328|450687788|FG018|Overall Study|Missed 12 Month Visit|2|||
125290014|NCT02876328|450687789|FG019|Overall Study|Missed 12 Month Visit|2|||
125290015|NCT02876328|450687790|FG020|Overall Study|Missed 12 Month Visit|11|||
125290016|NCT02876328|450687791|FG021|Overall Study|Missed 12 Month Visit|7|||
125290017|NCT02876328|450687792|FG022|Overall Study|Missed 12 Month Visit|1|||
125290018|NCT02876328|450687793|FG023|Overall Study|Missed 12 Month Visit|0|||
125290019|NCT03515941|450687795|FG000|Overall Study|Adverse Event|1|||
125290020|NCT03515941|450687796|FG001|Overall Study|Adverse Event|0|||
125290021|NCT00334282|450687799|FG000|Overall Study|Lost to Follow-up|11|||
125290022|NCT00334282|450687800|FG001|Overall Study|Lost to Follow-up|5|||
125290023|NCT00334282|450687799|FG000|Overall Study|Withdrawal by Subject|17|||
125290024|NCT00334282|450687800|FG001|Overall Study|Withdrawal by Subject|3|||
125290025|NCT00334282|450687799|FG000|Overall Study|Death|194|||
125290026|NCT00334282|450687800|FG001|Overall Study|Death|100|||
125290027|NCT00468845|450687801|FG000|Overall Study|Adverse Event|9|||
125290028|NCT00468845|450687802|FG001|Overall Study|Adverse Event|14|||
125290029|NCT00468845|450687803|FG002|Overall Study|Adverse Event|11|||
125290030|NCT00468845|450687801|FG000|Overall Study|Lost to Follow-up|2|||
125290031|NCT00468845|450687802|FG001|Overall Study|Lost to Follow-up|1|||
125290032|NCT00468845|450687803|FG002|Overall Study|Lost to Follow-up|2|||
125290033|NCT00468845|450687801|FG000|Overall Study|Other|4|||
125290034|NCT00468845|450687802|FG001|Overall Study|Other|9|||
125290035|NCT00468845|450687803|FG002|Overall Study|Other|5|||
125290036|NCT00468845|450687801|FG000|Overall Study|No longer willing to participate|5|||
125290037|NCT00468845|450687802|FG001|Overall Study|No longer willing to participate|6|||
125290038|NCT00468845|450687803|FG002|Overall Study|No longer willing to participate|10|||
125290039|NCT00468845|450687801|FG000|Overall Study|Randomized, not treated|1|||
125290040|NCT00468845|450687802|FG001|Overall Study|Randomized, not treated|4|||
125290041|NCT00468845|450687803|FG002|Overall Study|Randomized, not treated|2|||
125290042|NCT04342689|450687816|FG000|Overall Study|Withdrawal by Subject|32|||
125290043|NCT04342689|450687817|FG001|Overall Study|Withdrawal by Subject|33|||
125290044|NCT04342689|450687816|FG000|Overall Study|Lost to Follow-up|10|||
125290045|NCT04342689|450687817|FG001|Overall Study|Lost to Follow-up|12|||
125290046|NCT01460407|450687818|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
125290047|NCT01460407|450687819|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
125290048|NCT00844805|450687824|FG000|Treatment Phase|Adverse Event|5|||
125290049|NCT00844805|450687825|FG001|Treatment Phase|Adverse Event|1|||
125290050|NCT00844805|450687826|FG002|Treatment Phase|Adverse Event|0|||
125290051|NCT00844805|450687827|FG003|Treatment Phase|Adverse Event|0|||
125290052|NCT00844805|450687824|FG000|Treatment Phase|Withdrawal by Subject|3|||
125290053|NCT00844805|450687825|FG001|Treatment Phase|Withdrawal by Subject|4|||
125290054|NCT00844805|450687826|FG002|Treatment Phase|Withdrawal by Subject|0|||
125290055|NCT00844805|450687827|FG003|Treatment Phase|Withdrawal by Subject|0|||
125290056|NCT00844805|450687824|FG000|Treatment Phase|Noncompliance With Protocol|1|||
125290057|NCT00844805|450687825|FG001|Treatment Phase|Noncompliance With Protocol|0|||
125290058|NCT00844805|450687826|FG002|Treatment Phase|Noncompliance With Protocol|0|||
125290059|NCT00844805|450687827|FG003|Treatment Phase|Noncompliance With Protocol|0|||
125290060|NCT00844805|450687824|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
125290061|NCT00844805|450687825|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
125290062|NCT00844805|450687826|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
125290063|NCT00844805|450687827|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
125290064|NCT00844805|450687824|FG000|Follow-Up Phase|Adverse Event|0|||
125290065|NCT00844805|450687825|FG001|Follow-Up Phase|Adverse Event|0|||
125290066|NCT00844805|450687826|FG002|Follow-Up Phase|Adverse Event|1|||
125290067|NCT00844805|450687827|FG003|Follow-Up Phase|Adverse Event|0|||
125290068|NCT00844805|450687824|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
125290069|NCT00844805|450687825|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
125290070|NCT00844805|450687826|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
125290071|NCT00844805|450687827|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
125290072|NCT00844805|450687824|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
125290073|NCT00844805|450687825|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
125290074|NCT00844805|450687826|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
125290075|NCT00844805|450687827|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
125290076|NCT00844805|450687824|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
125290077|NCT00844805|450687825|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
125290078|NCT00844805|450687826|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
125290079|NCT00844805|450687827|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
125290080|NCT00844805|450687824|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
125290081|NCT00844805|450687825|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
125290082|NCT00844805|450687826|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
125290083|NCT00844805|450687827|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
125290084|NCT03618628|450687831|FG000|Overall Study|Death|1|||
125290085|NCT03618628|450687831|FG000|Overall Study|Lost to Follow-up|1|||
125290086|NCT01741532|450687833|FG000|Overall Study|Adverse Event|4|||
125290087|NCT01741532|450687834|FG001|Overall Study|Adverse Event|0|||
125290088|NCT01741532|450687833|FG000|Overall Study|Withdrawal by Subject|1|||
125290089|NCT01741532|450687834|FG001|Overall Study|Withdrawal by Subject|1|||
125290090|NCT01741532|450687833|FG000|Overall Study|Protocol Violation|0|||
125290091|NCT01741532|450687834|FG001|Overall Study|Protocol Violation|1|||
125290092|NCT01741532|450687833|FG000|Overall Study|Worsening of the disease|3|||
125290093|NCT01741532|450687834|FG001|Overall Study|Worsening of the disease|1|||
125290094|NCT01741532|450687833|FG000|Overall Study|Sponsor decision|1|||
125290095|NCT01741532|450687834|FG001|Overall Study|Sponsor decision|0|||
125290096|NCT01741532|450687833|FG000|Overall Study|Medical event|1|||
125290097|NCT01741532|450687834|FG001|Overall Study|Medical event|0|||
125290098|NCT00475865|450687835|FG000|Overall Study|Adverse Event|0|||
125290099|NCT00475865|450687836|FG001|Overall Study|Adverse Event|3|||
125290100|NCT00475865|450687837|FG002|Overall Study|Adverse Event|4|||
125290101|NCT00475865|450687835|FG000|Overall Study|Lack of Efficacy|1|||
125290102|NCT00475865|450687836|FG001|Overall Study|Lack of Efficacy|0|||
125290103|NCT00475865|450687837|FG002|Overall Study|Lack of Efficacy|0|||
125290104|NCT00475865|450687835|FG000|Overall Study|Progressive disease|0|||
125290105|NCT00475865|450687836|FG001|Overall Study|Progressive disease|1|||
125290106|NCT00475865|450687837|FG002|Overall Study|Progressive disease|2|||
125290107|NCT00475865|450687835|FG000|Overall Study|Participant did not wish to continue|1|||
125290108|NCT00475865|450687836|FG001|Overall Study|Participant did not wish to continue|0|||
125290109|NCT00475865|450687837|FG002|Overall Study|Participant did not wish to continue|0|||
125290110|NCT00475865|450687835|FG000|Overall Study|Other than above|0|||
125290111|NCT00475865|450687836|FG001|Overall Study|Other than above|1|||
125290112|NCT00475865|450687837|FG002|Overall Study|Other than above|0|||
125290113|NCT01453946|450687840|FG000|Overall Study|Did not receive drug for the taper phase|1|||
125290114|NCT01453946|450687840|FG000|Overall Study|Protocol Violation|2|||
125290115|NCT01453946|450687840|FG000|Overall Study|Lack of Efficacy|3|||
125290116|NCT01453946|450687840|FG000|Overall Study|Adverse Event|3|||
125290117|NCT03158272|450687843|FG000|Overall Study|Disease progression|3|||
125290118|NCT03158272|450687844|FG001|Overall Study|Disease progression|3|||
125290119|NCT03158272|450687845|FG002|Overall Study|Disease progression|4|||
125290120|NCT03158272|450687846|FG003|Overall Study|Disease progression|6|||
125290121|NCT03158272|450687843|FG000|Overall Study|Death|0|||
125290122|NCT03158272|450687844|FG001|Overall Study|Death|0|||
125290123|NCT03158272|450687845|FG002|Overall Study|Death|1|||
125290124|NCT03158272|450687846|FG003|Overall Study|Death|0|||
125290125|NCT03158272|450687843|FG000|Overall Study|Other reasons|0|||
125290126|NCT03158272|450687844|FG001|Overall Study|Other reasons|0|||
125290127|NCT03158272|450687845|FG002|Overall Study|Other reasons|1|||
125290128|NCT03158272|450687846|FG003|Overall Study|Other reasons|0|||
125290129|NCT03158272|450687843|FG000|Overall Study|Adverse event unrelated to the drug|0|||
125290130|NCT03158272|450687844|FG001|Overall Study|Adverse event unrelated to the drug|1|||
125290131|NCT03158272|450687845|FG002|Overall Study|Adverse event unrelated to the drug|0|||
125419468|NCT02834780|451160288|FG006|Overall Study|Adverse Event|1|||
125290132|NCT03158272|450687846|FG003|Overall Study|Adverse event unrelated to the drug|0|||
125290133|NCT01822535|450687847|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
125290134|NCT01822535|450687848|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
125290135|NCT01822535|450687847|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
125290136|NCT01822535|450687848|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
125290137|NCT01822535|450687847|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
125290138|NCT01822535|450687848|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
125290139|NCT02278614|450687851|FG000|Overall Study|Withdrawal by Subject|3|||
125290140|NCT02278614|450687852|FG001|Overall Study|Withdrawal by Subject|5|||
125290141|NCT02278614|450687851|FG000|Overall Study|Adverse Event|1|||
125290142|NCT02278614|450687852|FG001|Overall Study|Adverse Event|0|||
125290143|NCT02278614|450687851|FG000|Overall Study|left eye was not eligible|1|||
125290144|NCT02278614|450687852|FG001|Overall Study|left eye was not eligible|0|||
125290145|NCT03582813|450687855|FG000|Overall Study|Lost to Follow-up|18|||
125290146|NCT03582813|450687856|FG001|Overall Study|Lost to Follow-up|21|||
125290147|NCT03582813|450687855|FG000|Overall Study|Withdrawal by Subject|1|||
125290148|NCT03582813|450687856|FG001|Overall Study|Withdrawal by Subject|0|||
125290149|NCT02366767|450687859|FG000|Overall Study|left for home after 1 day at camp|1|||
125290150|NCT02366767|450687860|FG001|Overall Study|left for home after 1 day at camp|0|||
125290151|NCT02558400|450687863|FG000|Overall Study|Adverse Event|47|||
125290152|NCT02558400|450687864|FG001|Overall Study|Adverse Event|53|||
125290153|NCT02558400|450687865|FG002|Overall Study|Adverse Event|4|||
125290154|NCT02558400|450687863|FG000|Overall Study|Withdrawal by Subject|13|||
125290155|NCT02558400|450687864|FG001|Overall Study|Withdrawal by Subject|9|||
125290156|NCT02558400|450687865|FG002|Overall Study|Withdrawal by Subject|8|||
125290157|NCT02558400|450687863|FG000|Overall Study|Non-Compliant|0|||
125290158|NCT02558400|450687864|FG001|Overall Study|Non-Compliant|1|||
125290159|NCT02558400|450687865|FG002|Overall Study|Non-Compliant|3|||
125290160|NCT02558400|450687863|FG000|Overall Study|Lost to Follow-up|5|||
125290161|NCT02558400|450687864|FG001|Overall Study|Lost to Follow-up|5|||
125290162|NCT02558400|450687865|FG002|Overall Study|Lost to Follow-up|4|||
125450088|NCT04978363|451276565|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
125450089|NCT04978363|451276566|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
125450090|NCT04978363|451276567|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
125450091|NCT04978363|451276568|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
125450092|NCT01251614|451276569|FG000|Overall Study|Adverse Event|1|||
125450093|NCT01251614|451276570|FG001|Overall Study|Adverse Event|0|||
125450094|NCT01251614|451276571|FG002|Overall Study|Adverse Event|1|||
125450095|NCT01251614|451276569|FG000|Overall Study|Lack of Efficacy|1|||
125450096|NCT01251614|451276570|FG001|Overall Study|Lack of Efficacy|9|||
125450097|NCT01251614|451276571|FG002|Overall Study|Lack of Efficacy|4|||
125450098|NCT01251614|451276569|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
125450099|NCT01251614|451276570|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
125450100|NCT01251614|451276571|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
125450101|NCT01251614|451276569|FG000|Overall Study|Pregnancy|0|||
125450102|NCT01251614|451276570|FG001|Overall Study|Pregnancy|0|||
125450103|NCT01251614|451276571|FG002|Overall Study|Pregnancy|2|||
125450104|NCT01251614|451276569|FG000|Overall Study|Loss of Disease Control|0|||
125450105|NCT01251614|451276570|FG001|Overall Study|Loss of Disease Control|1|||
125450106|NCT01251614|451276571|FG002|Overall Study|Loss of Disease Control|0|||
125450107|NCT01251614|451276569|FG000|Overall Study|Withdrawal by Subject|0|||
125450108|NCT01251614|451276570|FG001|Overall Study|Withdrawal by Subject|2|||
125450109|NCT01251614|451276571|FG002|Overall Study|Withdrawal by Subject|1|||
125450110|NCT01251614|451276569|FG000|Overall Study|Lost to Follow-up|0|||
125450111|NCT01251614|451276570|FG001|Overall Study|Lost to Follow-up|1|||
125450112|NCT01251614|451276571|FG002|Overall Study|Lost to Follow-up|0|||
125450113|NCT00049517|451276572|FG000|Induction|Disease progression|0|||
125450114|NCT00049517|451276573|FG001|Induction|Disease progression|0|||
125450115|NCT00049517|451276574|FG002|Induction|Disease progression|0|||
125450116|NCT00049517|451276575|FG003|Induction|Disease progression|0|||
125450117|NCT00049517|451276576|FG004|Induction|Disease progression|18|||
125450118|NCT00049517|451276577|FG005|Induction|Disease progression|11|||
125450119|NCT00049517|451276572|FG000|Induction|Adverse Event|0|||
125450120|NCT00049517|451276573|FG001|Induction|Adverse Event|0|||
125450121|NCT00049517|451276574|FG002|Induction|Adverse Event|0|||
125450122|NCT00049517|451276575|FG003|Induction|Adverse Event|0|||
125450123|NCT00049517|451276576|FG004|Induction|Adverse Event|5|||
125450124|NCT00049517|451276577|FG005|Induction|Adverse Event|7|||
125450125|NCT00049517|451276572|FG000|Induction|Death|0|||
125450126|NCT00049517|451276573|FG001|Induction|Death|0|||
125290163|NCT02558400|450687863|FG000|Overall Study|Lack of Efficacy|0|||
125290164|NCT02558400|450687864|FG001|Overall Study|Lack of Efficacy|13|||
125290165|NCT02558400|450687865|FG002|Overall Study|Lack of Efficacy|1|||
125450127|NCT00049517|451276574|FG002|Induction|Death|0|||
125450128|NCT00049517|451276575|FG003|Induction|Death|0|||
125450129|NCT00049517|451276576|FG004|Induction|Death|9|||
125450130|NCT00049517|451276577|FG005|Induction|Death|6|||
125450131|NCT00049517|451276572|FG000|Induction|Withdrawal by Subject|0|||
125290166|NCT02558400|450687863|FG000|Overall Study|Disallowed Concurrent Medication|6|||
125290167|NCT02558400|450687864|FG001|Overall Study|Disallowed Concurrent Medication|7|||
125290168|NCT02558400|450687865|FG002|Overall Study|Disallowed Concurrent Medication|5|||
125290169|NCT02558400|450687863|FG000|Overall Study|Physician Decision|2|||
125290170|NCT02558400|450687864|FG001|Overall Study|Physician Decision|2|||
125290171|NCT02558400|450687865|FG002|Overall Study|Physician Decision|0|||
125290172|NCT02558400|450687863|FG000|Overall Study|Protocol Violation|6|||
125290173|NCT02558400|450687864|FG001|Overall Study|Protocol Violation|3|||
125290174|NCT02558400|450687865|FG002|Overall Study|Protocol Violation|8|||
125290175|NCT02558400|450687863|FG000|Overall Study|Death|0|||
125290176|NCT02558400|450687864|FG001|Overall Study|Death|1|||
125290177|NCT02558400|450687865|FG002|Overall Study|Death|0|||
125290178|NCT02558400|450687863|FG000|Overall Study|Ineligible for the study|0|||
125290179|NCT02558400|450687864|FG001|Overall Study|Ineligible for the study|2|||
125290180|NCT02558400|450687865|FG002|Overall Study|Ineligible for the study|0|||
125290181|NCT02230683|450687866|FG000|Overall Study|Adverse Event|1|||
125290182|NCT00260065|450687867|FG000|Overall Study|Progressive Disease|22|||
125290183|NCT00260065|450687867|FG000|Overall Study|Adverse Event|17|||
125290184|NCT00260065|450687867|FG000|Overall Study|Death|13|||
125290185|NCT00260065|450687867|FG000|Overall Study|Withdrawal by Subject|13|||
125290186|NCT00260065|450687867|FG000|Overall Study|Physician Decision|19|||
125290187|NCT00260065|450687867|FG000|Overall Study|Not otherwise specified|8|||
125290188|NCT00260065|450687867|FG000|Overall Study|Medication Noncompliance|1|||
125290189|NCT04068519|450687868|FG000|Dose Verification|Death|15|||
125290190|NCT04068519|450687868|FG000|Dose Verification|Withdrawal by Subject|1|||
125290191|NCT04068519|450687868|FG000|Pharmacokinetic Sub-study|Death|35|||
125290192|NCT04068519|450687868|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
125290193|NCT04068519|450687868|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
125290194|NCT04068519|450687868|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
125290195|NCT04068519|450687868|FG000|Indication Expansion|Death|152|||
125290196|NCT04068519|450687868|FG000|Indication Expansion|Withdrawal by Subject|10|||
125290197|NCT04068519|450687868|FG000|Indication Expansion|Lost to Follow-up|7|||
125290198|NCT00758589|450689731|FG000|Overall Study|Adverse Event|3|||
125290199|NCT00758589|450689732|FG001|Overall Study|Adverse Event|2|||
125290200|NCT00758589|450689733|FG002|Overall Study|Adverse Event|5|||
125290201|NCT00758589|450689734|FG003|Overall Study|Adverse Event|4|||
125290202|NCT00758589|450689731|FG000|Overall Study|Withdrawal by Subject|0|||
125290203|NCT00758589|450689732|FG001|Overall Study|Withdrawal by Subject|1|||
125290204|NCT00758589|450689733|FG002|Overall Study|Withdrawal by Subject|1|||
125290205|NCT00758589|450689734|FG003|Overall Study|Withdrawal by Subject|1|||
125290206|NCT00758589|450689731|FG000|Overall Study|Palm stopped to work|0|||
125290207|NCT00758589|450689732|FG001|Overall Study|Palm stopped to work|0|||
125290208|NCT00758589|450689733|FG002|Overall Study|Palm stopped to work|0|||
125290209|NCT00758589|450689734|FG003|Overall Study|Palm stopped to work|1|||
125290210|NCT04599166|450689735|FG000|Overall Study|Technological failure connecting to study app|80|||
125290211|NCT01777542|450689736|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
125290212|NCT01777542|450689737|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
125290213|NCT00953524|450689738|FG000|Overall Study|Adverse Event|2|||
125290214|NCT00953524|450689739|FG001|Overall Study|Adverse Event|0|||
125290215|NCT00953524|450689740|FG002|Overall Study|Adverse Event|1|||
125290216|NCT00953524|450689741|FG003|Overall Study|Adverse Event|2|||
125290217|NCT00953524|450689738|FG000|Overall Study|Protocol Violation|18|||
125290218|NCT00953524|450689739|FG001|Overall Study|Protocol Violation|10|||
125290219|NCT00953524|450689740|FG002|Overall Study|Protocol Violation|11|||
125290220|NCT00953524|450689741|FG003|Overall Study|Protocol Violation|6|||
125290221|NCT00953524|450689738|FG000|Overall Study|Lost to Follow-up|0|||
125450132|NCT00049517|451276573|FG001|Induction|Withdrawal by Subject|0|||
125450133|NCT00049517|451276574|FG002|Induction|Withdrawal by Subject|0|||
125450134|NCT00049517|451276575|FG003|Induction|Withdrawal by Subject|0|||
125450135|NCT00049517|451276576|FG004|Induction|Withdrawal by Subject|1|||
125450136|NCT00049517|451276577|FG005|Induction|Withdrawal by Subject|3|||
125450137|NCT00049517|451276572|FG000|Induction|Alternative therapy|0|||
125450138|NCT00049517|451276573|FG001|Induction|Alternative therapy|0|||
125450139|NCT00049517|451276574|FG002|Induction|Alternative therapy|0|||
125450140|NCT00049517|451276575|FG003|Induction|Alternative therapy|0|||
125450141|NCT00049517|451276576|FG004|Induction|Alternative therapy|2|||
125450142|NCT00049517|451276577|FG005|Induction|Alternative therapy|2|||
125290222|NCT00953524|450689739|FG001|Overall Study|Lost to Follow-up|1|||
125290223|NCT00953524|450689740|FG002|Overall Study|Lost to Follow-up|1|||
125290224|NCT00953524|450689741|FG003|Overall Study|Lost to Follow-up|0|||
125290225|NCT00953524|450689738|FG000|Overall Study|Withdrawal by Subject|2|||
125290226|NCT00953524|450689739|FG001|Overall Study|Withdrawal by Subject|4|||
125290227|NCT00953524|450689740|FG002|Overall Study|Withdrawal by Subject|1|||
125290228|NCT00953524|450689741|FG003|Overall Study|Withdrawal by Subject|0|||
125290229|NCT03554772|450689748|FG000|Overall Study|Lost to Follow-up|0|||
125290230|NCT03554772|450689749|FG001|Overall Study|Lost to Follow-up|0|||
125290231|NCT03554772|450689750|FG002|Overall Study|Lost to Follow-up|0|||
125450143|NCT00049517|451276572|FG000|Induction|Other complicating disease|0|||
125290232|NCT03554772|450689751|FG003|Overall Study|Lost to Follow-up|2|||
125290233|NCT05136898|450689752|FG000|Overall Study|Adverse Event|2|||
125290234|NCT03784846|450689753|FG000|Pre-COVID Study|Lost to Follow-up|3|||
125290235|NCT03784846|450689754|FG001|Pre-COVID Study|Lost to Follow-up|3|||
125290236|NCT03784846|450689755|FG002|Pre-COVID Study|Lost to Follow-up|2|||
125290237|NCT03784846|450689753|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
125290238|NCT03784846|450689754|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
125290239|NCT03784846|450689755|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
125290240|NCT03784846|450689753|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
125290241|NCT03784846|450689754|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
125290242|NCT03784846|450689755|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
125290243|NCT03784846|450689753|FG000|Post-COVID Study|Lost to Follow-up|3|||
125290244|NCT03784846|450689754|FG001|Post-COVID Study|Lost to Follow-up|5|||
125290245|NCT03784846|450689755|FG002|Post-COVID Study|Lost to Follow-up|1|||
125290246|NCT03784846|450689753|FG000|Post-COVID Study|Withdrawal by Subject|1|||
125290247|NCT03784846|450689754|FG001|Post-COVID Study|Withdrawal by Subject|2|||
125290248|NCT03784846|450689755|FG002|Post-COVID Study|Withdrawal by Subject|0|||
125290249|NCT00867087|450689756|FG000|Overall Study|Other|1|||
125290250|NCT00867087|450689756|FG000|Overall Study|Withdrawal by Subject|4|||
125290251|NCT00867087|450689756|FG000|Overall Study|Death|37|||
125290252|NCT02088073|450689758|FG000|Acute Phase|Withdrawal by Subject|5|||
125290253|NCT02088073|450689759|FG001|Acute Phase|Withdrawal by Subject|0|||
125290254|NCT02088073|450689760|FG002|Acute Phase|Withdrawal by Subject|0|||
125290255|NCT02088073|450689761|FG003|Acute Phase|Withdrawal by Subject|0|||
125290256|NCT02088073|450689762|FG004|Acute Phase|Withdrawal by Subject|0|||
125290257|NCT02088073|450689758|FG000|Acute Phase|Hyperkalemia|2|||
125290258|NCT02088073|450689759|FG001|Acute Phase|Hyperkalemia|0|||
125290259|NCT02088073|450689760|FG002|Acute Phase|Hyperkalemia|0|||
125290260|NCT02088073|450689761|FG003|Acute Phase|Hyperkalemia|0|||
125290261|NCT02088073|450689762|FG004|Acute Phase|Hyperkalemia|0|||
125290262|NCT02088073|450689758|FG000|Maintanance Phase|Withdrawal by Subject|0|||
125290263|NCT02088073|450689759|FG001|Maintanance Phase|Withdrawal by Subject|2|||
125290264|NCT02088073|450689760|FG002|Maintanance Phase|Withdrawal by Subject|0|||
125290265|NCT02088073|450689761|FG003|Maintanance Phase|Withdrawal by Subject|0|||
125290266|NCT02088073|450689762|FG004|Maintanance Phase|Withdrawal by Subject|0|||
125290267|NCT02088073|450689758|FG000|Maintanance Phase|Adverse Event|0|||
125290268|NCT02088073|450689759|FG001|Maintanance Phase|Adverse Event|0|||
125290269|NCT02088073|450689760|FG002|Maintanance Phase|Adverse Event|3|||
125290270|NCT02088073|450689761|FG003|Maintanance Phase|Adverse Event|0|||
125290271|NCT02088073|450689762|FG004|Maintanance Phase|Adverse Event|1|||
125290272|NCT02088073|450689758|FG000|Maintanance Phase|Physician Decision|0|||
125290273|NCT02088073|450689759|FG001|Maintanance Phase|Physician Decision|0|||
125290274|NCT02088073|450689760|FG002|Maintanance Phase|Physician Decision|0|||
125290275|NCT02088073|450689761|FG003|Maintanance Phase|Physician Decision|0|||
125290276|NCT02088073|450689762|FG004|Maintanance Phase|Physician Decision|1|||
125290277|NCT02088073|450689758|FG000|Maintanance Phase|Sponsor's decision|0|||
125290278|NCT02088073|450689759|FG001|Maintanance Phase|Sponsor's decision|2|||
125290279|NCT02088073|450689760|FG002|Maintanance Phase|Sponsor's decision|0|||
125290280|NCT02088073|450689761|FG003|Maintanance Phase|Sponsor's decision|2|||
125290281|NCT02088073|450689762|FG004|Maintanance Phase|Sponsor's decision|1|||
125290282|NCT02088073|450689758|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
125290283|NCT02088073|450689759|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
125290284|NCT02088073|450689760|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
125290285|NCT02088073|450689761|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
125290286|NCT02088073|450689762|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
125290287|NCT02088073|450689758|FG000|Maintanance Phase|Miscellaneous|0|||
125290288|NCT02088073|450689759|FG001|Maintanance Phase|Miscellaneous|2|||
125290289|NCT02088073|450689760|FG002|Maintanance Phase|Miscellaneous|1|||
125290290|NCT02088073|450689761|FG003|Maintanance Phase|Miscellaneous|2|||
125290291|NCT02088073|450689762|FG004|Maintanance Phase|Miscellaneous|1|||
125290292|NCT02088073|450689758|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
125290293|NCT02088073|450689759|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
125290294|NCT02088073|450689760|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
125290295|NCT02088073|450689761|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
125290296|NCT02088073|450689762|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
125290297|NCT02088073|450689758|FG000|Maintanance Phase|Subject compliance|0|||
125290298|NCT02088073|450689759|FG001|Maintanance Phase|Subject compliance|1|||
125290299|NCT02088073|450689760|FG002|Maintanance Phase|Subject compliance|0|||
125290300|NCT02088073|450689761|FG003|Maintanance Phase|Subject compliance|0|||
125290301|NCT02088073|450689762|FG004|Maintanance Phase|Subject compliance|0|||
125290302|NCT00241631|450689763|FG000|Run in (2 Weeks)|Physician Decision|3|||
125290303|NCT00241631|450689764|FG001|Run in (2 Weeks)|Physician Decision|3|||
125290304|NCT00241631|450689763|FG000|Phase 1 (4 Weeks)|sore throat|1|||
125290305|NCT00241631|450689764|FG001|Phase 1 (4 Weeks)|sore throat|0|||
125290306|NCT00241631|450689763|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
125290307|NCT00241631|450689764|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
125290308|NCT00241631|450689763|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
125450144|NCT00049517|451276573|FG001|Induction|Other complicating disease|0|||
125450145|NCT00049517|451276574|FG002|Induction|Other complicating disease|0|||
125450146|NCT00049517|451276575|FG003|Induction|Other complicating disease|0|||
125450147|NCT00049517|451276576|FG004|Induction|Other complicating disease|3|||
125450148|NCT00049517|451276577|FG005|Induction|Other complicating disease|0|||
125450149|NCT00049517|451276572|FG000|Induction|Reasons not reported|0|||
125450150|NCT00049517|451276573|FG001|Induction|Reasons not reported|0|||
125450151|NCT00049517|451276574|FG002|Induction|Reasons not reported|0|||
125450152|NCT00049517|451276575|FG003|Induction|Reasons not reported|0|||
125450153|NCT00049517|451276576|FG004|Induction|Reasons not reported|22|||
125450154|NCT00049517|451276577|FG005|Induction|Reasons not reported|25|||
125450155|NCT00049517|451276572|FG000|Conditioning/Transplant|Disease progression|14|||
125450156|NCT00049517|451276573|FG001|Conditioning/Transplant|Disease progression|6|||
125450157|NCT00049517|451276574|FG002|Conditioning/Transplant|Disease progression|10|||
125450158|NCT00049517|451276575|FG003|Conditioning/Transplant|Disease progression|6|||
125450159|NCT00049517|451276576|FG004|Conditioning/Transplant|Disease progression|0|||
125450160|NCT00049517|451276577|FG005|Conditioning/Transplant|Disease progression|0|||
125450161|NCT00049517|451276572|FG000|Conditioning/Transplant|Adverse Event|2|||
125450162|NCT00049517|451276573|FG001|Conditioning/Transplant|Adverse Event|1|||
125450163|NCT00049517|451276574|FG002|Conditioning/Transplant|Adverse Event|4|||
125450164|NCT00049517|451276575|FG003|Conditioning/Transplant|Adverse Event|8|||
125290309|NCT00241631|450689764|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
125290310|NCT00241631|450689763|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
125290311|NCT00241631|450689764|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
125290312|NCT03883113|450689765|FG000|Overall Study|Physician Decision|4|||
125290313|NCT03883113|450689766|FG001|Overall Study|Physician Decision|2|||
125290314|NCT03883113|450689765|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
125290315|NCT03883113|450689766|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
125290316|NCT03883113|450689765|FG000|Overall Study|Pregnancy|1|||
125290317|NCT03883113|450689766|FG001|Overall Study|Pregnancy|0|||
125290318|NCT03883113|450689765|FG000|Overall Study|Adverse Event|0|||
125290319|NCT03883113|450689766|FG001|Overall Study|Adverse Event|1|||
125290320|NCT03883113|450689765|FG000|Overall Study|Withdrawal by Subject|1|||
125290321|NCT03883113|450689766|FG001|Overall Study|Withdrawal by Subject|2|||
125290322|NCT03883113|450689765|FG000|Overall Study|Lost to Follow-up|1|||
125290323|NCT03883113|450689766|FG001|Overall Study|Lost to Follow-up|0|||
125290324|NCT01457950|450689774|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
125290325|NCT01457950|450689775|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
125290326|NCT01457950|450689776|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
125290327|NCT01457950|450689777|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
125290328|NCT01457950|450689774|FG000|Double-Blind Phase|Protocol Violation|2|||
125290329|NCT01457950|450689775|FG001|Double-Blind Phase|Protocol Violation|1|||
125290330|NCT01457950|450689776|FG002|Double-Blind Phase|Protocol Violation|0|||
125290331|NCT01457950|450689777|FG003|Double-Blind Phase|Protocol Violation|0|||
125290332|NCT01457950|450689774|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
125290333|NCT01457950|450689775|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
125290334|NCT01457950|450689776|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125290335|NCT01457950|450689777|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
125290336|NCT01457950|450689774|FG000|Open-Label Phase|Adverse Event|0|||
125290337|NCT01457950|450689775|FG001|Open-Label Phase|Adverse Event|0|||
125290338|NCT01457950|450689776|FG002|Open-Label Phase|Adverse Event|0|||
125290339|NCT01457950|450689777|FG003|Open-Label Phase|Adverse Event|1|||
125290340|NCT01457950|450689774|FG000|Open-Label Phase|Protocol Violation|0|||
125290341|NCT01457950|450689775|FG001|Open-Label Phase|Protocol Violation|0|||
125290342|NCT01457950|450689776|FG002|Open-Label Phase|Protocol Violation|0|||
125290343|NCT01457950|450689777|FG003|Open-Label Phase|Protocol Violation|1|||
125290344|NCT01457950|450689774|FG000|Open-Label Phase|Withdrawal by Subject|0|||
125290345|NCT01457950|450689775|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125290346|NCT01457950|450689776|FG002|Open-Label Phase|Withdrawal by Subject|2|||
125290347|NCT01457950|450689777|FG003|Open-Label Phase|Withdrawal by Subject|0|||
125290348|NCT00435162|450689778|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
125450165|NCT00049517|451276576|FG004|Conditioning/Transplant|Adverse Event|0|||
125450166|NCT00049517|451276577|FG005|Conditioning/Transplant|Adverse Event|0|||
125450167|NCT00049517|451276572|FG000|Conditioning/Transplant|Death|1|||
125450168|NCT00049517|451276573|FG001|Conditioning/Transplant|Death|0|||
125450169|NCT00049517|451276574|FG002|Conditioning/Transplant|Death|0|||
125290349|NCT00435162|450689779|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
125290350|NCT00435162|450689780|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
125450170|NCT00049517|451276575|FG003|Conditioning/Transplant|Death|2|||
125450171|NCT00049517|451276576|FG004|Conditioning/Transplant|Death|0|||
125450172|NCT00049517|451276577|FG005|Conditioning/Transplant|Death|0|||
125290351|NCT00435162|450689781|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
125290352|NCT00435162|450689782|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
125290353|NCT00435162|450689783|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
125290354|NCT01765426|450689786|FG000|Overall Study|Lost to Follow-up|0|||
125290355|NCT01765426|450689787|FG001|Overall Study|Lost to Follow-up|1|||
125450173|NCT00049517|451276572|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
125450174|NCT00049517|451276573|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
125450175|NCT00049517|451276574|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
125450176|NCT00049517|451276575|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
125450177|NCT00049517|451276576|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
125450178|NCT00049517|451276577|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
125450179|NCT00049517|451276572|FG000|Conditioning/Transplant|Alternative therapy|4|||
125450180|NCT00049517|451276573|FG001|Conditioning/Transplant|Alternative therapy|4|||
125450181|NCT00049517|451276574|FG002|Conditioning/Transplant|Alternative therapy|2|||
125450182|NCT00049517|451276575|FG003|Conditioning/Transplant|Alternative therapy|1|||
125450183|NCT00049517|451276576|FG004|Conditioning/Transplant|Alternative therapy|1|||
125450184|NCT00049517|451276577|FG005|Conditioning/Transplant|Alternative therapy|0|||
125450185|NCT00049517|451276572|FG000|Conditioning/Transplant|Other complicating disease|2|||
125450186|NCT00049517|451276573|FG001|Conditioning/Transplant|Other complicating disease|0|||
125450187|NCT00049517|451276574|FG002|Conditioning/Transplant|Other complicating disease|0|||
125450188|NCT00049517|451276575|FG003|Conditioning/Transplant|Other complicating disease|4|||
125450189|NCT00049517|451276576|FG004|Conditioning/Transplant|Other complicating disease|0|||
125450190|NCT00049517|451276577|FG005|Conditioning/Transplant|Other complicating disease|1|||
125450191|NCT00049517|451276572|FG000|Conditioning/Transplant|Reasons not reported|25|||
125450192|NCT00049517|451276573|FG001|Conditioning/Transplant|Reasons not reported|31|||
125450193|NCT00049517|451276574|FG002|Conditioning/Transplant|Reasons not reported|18|||
125450194|NCT00049517|451276575|FG003|Conditioning/Transplant|Reasons not reported|15|||
125450195|NCT00049517|451276576|FG004|Conditioning/Transplant|Reasons not reported|5|||
125450196|NCT00049517|451276577|FG005|Conditioning/Transplant|Reasons not reported|5|||
125450197|NCT02256969|451276579|FG000|Overall Study|Screenfailed or withdrew|2|||
125450198|NCT02256969|451276580|FG001|Overall Study|Screenfailed or withdrew|1|||
125450199|NCT02256969|451276581|FG002|Overall Study|Screenfailed or withdrew|1|||
125450200|NCT02347943|451276582|FG000|Overall Study|Study was cancelled|140|||
125450201|NCT02347943|451276583|FG001|Overall Study|Study was cancelled|67|||
125450202|NCT02347943|451276584|FG002|Overall Study|Study was cancelled|45|||
125450203|NCT03566680|451276588|FG000|Overall Study|Pregnancy|1|||
125450204|NCT03566680|451276588|FG000|Overall Study|Lost to Follow-up|13|||
125450205|NCT03566680|451276588|FG000|Overall Study|Withdrawal by Subject|3|||
125450206|NCT02374957|451276595|FG000|Overall Study|Patient did not complete forms correctly|1|||
125450207|NCT02374957|451276596|FG001|Overall Study|Patient did not complete forms correctly|0|||
125450208|NCT00748969|451276597|FG000|Overall Study|Withdrawal by Subject|1|||
125450209|NCT00748969|451276598|FG001|Overall Study|Withdrawal by Subject|0|||
125450210|NCT00748969|451276597|FG000|Overall Study|Withdrawal by Subject|0|||
125450211|NCT00748969|451276598|FG001|Overall Study|Withdrawal by Subject|1|||
125450212|NCT02334306|451276599|FG000|Double-blind Period|Adverse Event|0|||
125450213|NCT02334306|451276600|FG001|Double-blind Period|Adverse Event|1|||
125450214|NCT02334306|451276599|FG000|Double-blind Period|Withdrawal by Subject|1|||
125450215|NCT02334306|451276600|FG001|Double-blind Period|Withdrawal by Subject|1|||
125450216|NCT00465985|451276601|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
125450217|NCT00465985|451276602|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
125450218|NCT00465985|451276601|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
125450219|NCT00465985|451276602|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
125450220|NCT00465985|451276601|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
125450221|NCT00465985|451276602|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
125450222|NCT00465985|451276601|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
125450223|NCT00465985|451276602|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
125450224|NCT01687270|451276603|FG000|Overall Study|Lack of Efficacy|11|||
125450225|NCT01687270|451276603|FG000|Overall Study|Lost to Follow-up|1|||
125450226|NCT03532178|451276604|FG000|First Period|Withdrawal by Subject|1|||
125450227|NCT03532178|451276605|FG001|First Period|Withdrawal by Subject|3|||
125450228|NCT03532178|451276604|FG000|First Period|technical issues in data collection Technical issues|0|||
125450229|NCT03532178|451276605|FG001|First Period|technical issues in data collection Technical issues|1|||
125450230|NCT03532178|451276604|FG000|Second Period|Withdrawal by Subject|1|||
125450231|NCT03532178|451276605|FG001|Second Period|Withdrawal by Subject|1|||
125450232|NCT03532178|451276604|FG000|Second Period|Technical issues|0|||
125450233|NCT03532178|451276605|FG001|Second Period|Technical issues|1|||
125450234|NCT03302156|451276606|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
125450235|NCT03302156|451276607|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
125450236|NCT03302156|451276608|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
125290356|NCT01765426|450689788|FG002|Overall Study|Lost to Follow-up|0|||
125290357|NCT01765426|450689789|FG003|Overall Study|Lost to Follow-up|0|||
125450237|NCT02390557|451276609|FG000|Wave 2|Survey non-respondent|72|||
125450238|NCT02390557|451276610|FG001|Wave 2|Survey non-respondent|41|||
125450239|NCT02390557|451276611|FG002|Wave 2|Survey non-respondent|23|||
125450240|NCT03278028|451276615|FG000|Overall Study|Lost to Follow-up|1|||
125450241|NCT03278028|451276616|FG001|Overall Study|Lost to Follow-up|0|||
125450242|NCT03278028|451276615|FG000|Overall Study|Withdrawal by Subject|3|||
125450243|NCT03278028|451276616|FG001|Overall Study|Withdrawal by Subject|1|||
125450244|NCT03278028|451276615|FG000|Overall Study|Pregnancy|0|||
125450245|NCT03278028|451276616|FG001|Overall Study|Pregnancy|1|||
125450246|NCT01360840|451276617|FG000|Overall Study|Ongoing at data cut-off|10|||
125450247|NCT01360840|451276618|FG001|Overall Study|Ongoing at data cut-off|10|||
125450248|NCT01360840|451276619|FG002|Overall Study|Ongoing at data cut-off|9|||
125450249|NCT00463151|451276621|FG000|Overall Study|Adverse Event|0|||
125450250|NCT00463151|451276622|FG001|Overall Study|Adverse Event|0|||
125450251|NCT00463151|451276623|FG002|Overall Study|Adverse Event|1|||
125450252|NCT00463151|451276624|FG003|Overall Study|Adverse Event|0|||
125450253|NCT00463151|451276621|FG000|Overall Study|Lack of Efficacy|2|||
125450254|NCT00463151|451276622|FG001|Overall Study|Lack of Efficacy|5|||
125450255|NCT00463151|451276623|FG002|Overall Study|Lack of Efficacy|2|||
125450256|NCT00463151|451276624|FG003|Overall Study|Lack of Efficacy|5|||
125450257|NCT00463151|451276621|FG000|Overall Study|Protocol Violation|0|||
125450258|NCT00463151|451276622|FG001|Overall Study|Protocol Violation|0|||
125450259|NCT00463151|451276623|FG002|Overall Study|Protocol Violation|0|||
125450260|NCT00463151|451276624|FG003|Overall Study|Protocol Violation|1|||
125450261|NCT00463151|451276621|FG000|Overall Study|Withdrawal by Subject|0|||
125450262|NCT00463151|451276622|FG001|Overall Study|Withdrawal by Subject|0|||
125450263|NCT00463151|451276623|FG002|Overall Study|Withdrawal by Subject|0|||
125450264|NCT00463151|451276624|FG003|Overall Study|Withdrawal by Subject|1|||
125450265|NCT00293462|451276625|FG000|Overall Study|Withdrawal by Subject|4|||
125450266|NCT00293462|451276626|FG001|Overall Study|Withdrawal by Subject|3|||
125450267|NCT00293462|451276627|FG002|Overall Study|Withdrawal by Subject|8|||
125450268|NCT00293462|451276625|FG000|Overall Study|Death|1|||
125450269|NCT00293462|451276626|FG001|Overall Study|Death|0|||
125450270|NCT00293462|451276627|FG002|Overall Study|Death|0|||
125450271|NCT00293462|451276625|FG000|Overall Study|Lost to Follow-up|0|||
125450272|NCT00293462|451276626|FG001|Overall Study|Lost to Follow-up|1|||
125450273|NCT00293462|451276627|FG002|Overall Study|Lost to Follow-up|0|||
125450274|NCT00293462|451276625|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
125450275|NCT00293462|451276626|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
125450276|NCT00293462|451276627|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
125450277|NCT00293462|451276625|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
125450278|NCT00293462|451276626|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
125450279|NCT00293462|451276627|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
125450280|NCT00293462|451276625|FG000|Overall Study|Refuse Radiation Treatment|1|||
125450281|NCT00293462|451276626|FG001|Overall Study|Refuse Radiation Treatment|0|||
125450282|NCT00293462|451276627|FG002|Overall Study|Refuse Radiation Treatment|0|||
125450283|NCT00293462|451276625|FG000|Overall Study|No Show|0|||
125450284|NCT00293462|451276626|FG001|Overall Study|No Show|0|||
125450285|NCT00293462|451276627|FG002|Overall Study|No Show|1|||
125450286|NCT00293462|451276625|FG000|Overall Study|Went back to his home country|0|||
125450287|NCT00293462|451276626|FG001|Overall Study|Went back to his home country|0|||
125450288|NCT00293462|451276627|FG002|Overall Study|Went back to his home country|1|||
125450289|NCT00293462|451276625|FG000|Overall Study|Blood clot after chemotherapy|0|||
125450290|NCT00293462|451276626|FG001|Overall Study|Blood clot after chemotherapy|0|||
125290358|NCT01510184|450689790|FG000|Overall Study|Sponsor discretion|28|||
125290359|NCT01510184|450689791|FG001|Overall Study|Sponsor discretion|28|||
125290360|NCT01510184|450689790|FG000|Overall Study|Death|1|||
125290361|NCT01510184|450689791|FG001|Overall Study|Death|2|||
125290362|NCT01510184|450689790|FG000|Overall Study|Withdrawal by Subject|1|||
125290363|NCT01510184|450689791|FG001|Overall Study|Withdrawal by Subject|4|||
125290364|NCT01510184|450689790|FG000|Overall Study|Other|0|||
125290365|NCT01510184|450689791|FG001|Overall Study|Other|1|||
125290366|NCT00694096|450689800|FG000|Overall Study|Withdrawal by Subject|5|||
125290367|NCT03351114|450689804|FG000|Overall Study|Withdrawal by Subject|1|||
125290368|NCT01665430|450689805|FG000|Overall Study|Adverse Event|1|||
125290369|NCT01665430|450689805|FG000|Overall Study|Withdrawal by Subject|6|||
125290370|NCT01665430|450689805|FG000|Overall Study|Other Unspecified|2|||
125450291|NCT00293462|451276627|FG002|Overall Study|Blood clot after chemotherapy|1|||
125450292|NCT00293462|451276625|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
125450293|NCT00293462|451276626|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
125450294|NCT00293462|451276627|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
125450295|NCT00293462|451276625|FG000|Overall Study|Possible Tracheostomy leakage|0|||
125450296|NCT00293462|451276626|FG001|Overall Study|Possible Tracheostomy leakage|1|||
125450297|NCT00293462|451276627|FG002|Overall Study|Possible Tracheostomy leakage|0|||
125450298|NCT00293462|451276625|FG000|Overall Study|Low radiation dose in oral cavity|0|||
125450299|NCT00293462|451276626|FG001|Overall Study|Low radiation dose in oral cavity|1|||
125450300|NCT00293462|451276627|FG002|Overall Study|Low radiation dose in oral cavity|0|||
125290371|NCT02310230|450689806|FG000|Overall Study|Physician Decision|1|||
125290372|NCT02310230|450689807|FG001|Overall Study|Physician Decision|3|||
125290373|NCT02310230|450689806|FG000|Overall Study|monitor baseline taken after induction|2|||
125290374|NCT02310230|450689807|FG001|Overall Study|monitor baseline taken after induction|7|||
125290375|NCT02310230|450689806|FG000|Overall Study|Poor signal quality|5|||
125290376|NCT02310230|450689807|FG001|Overall Study|Poor signal quality|8|||
125290377|NCT02310230|450689806|FG000|Overall Study|Case cancelled|1|||
125290378|NCT02310230|450689807|FG001|Overall Study|Case cancelled|0|||
125290379|NCT01371643|450689808|FG000|Overall Study|Withdrawal by Subject|3|||
125290380|NCT01371643|450689809|FG001|Overall Study|Withdrawal by Subject|0|||
125290381|NCT03249935|450689810|FG000|Overall Study|Discharged from facility early|36|||
125290382|NCT03249935|450689810|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
125290383|NCT03249935|450689810|FG000|Overall Study|Protocol Violation|5|||
125290384|NCT01669421|450689815|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
125290385|NCT01669421|450689815|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
125290386|NCT01561755|450689820|FG000|Overall Study|Lost to Follow-up|0|||
125290387|NCT01561755|450689821|FG001|Overall Study|Lost to Follow-up|1|||
125290388|NCT01286987|450689824|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
125290389|NCT01286987|450689825|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
125290390|NCT01286987|450689826|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
125290391|NCT01286987|450689827|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
125290392|NCT01286987|450689828|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
125290393|NCT01286987|450689829|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
125290394|NCT01286987|450689830|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
125290395|NCT01286987|450689831|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
125290396|NCT01286987|450689832|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
125290397|NCT01286987|450689833|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
125290398|NCT01286987|450689834|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
125290399|NCT01286987|450689835|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
125290400|NCT01286987|450689836|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
125290401|NCT01286987|450689837|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
125290402|NCT01286987|450689838|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
125290403|NCT01286987|450689824|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
125290404|NCT01286987|450689825|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
125290405|NCT01286987|450689826|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
125290406|NCT01286987|450689827|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
125290407|NCT01286987|450689828|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
125290408|NCT01286987|450689829|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
125290409|NCT01286987|450689830|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
125290410|NCT01286987|450689831|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
125290411|NCT01286987|450689832|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
125290412|NCT01286987|450689833|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
125290413|NCT01286987|450689834|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
125290414|NCT01286987|450689835|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
125290415|NCT01286987|450689836|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
125290416|NCT01286987|450689837|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
125290417|NCT01286987|450689838|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
125290418|NCT01286987|450689824|FG000|Part 1: Dose Escalation|Physician Decision|0|||
125290419|NCT01286987|450689825|FG001|Part 1: Dose Escalation|Physician Decision|0|||
125290420|NCT01286987|450689826|FG002|Part 1: Dose Escalation|Physician Decision|0|||
125290421|NCT01286987|450689827|FG003|Part 1: Dose Escalation|Physician Decision|0|||
125290422|NCT01286987|450689828|FG004|Part 1: Dose Escalation|Physician Decision|1|||
125290423|NCT01286987|450689829|FG005|Part 1: Dose Escalation|Physician Decision|0|||
125290424|NCT01286987|450689830|FG006|Part 1: Dose Escalation|Physician Decision|0|||
125290425|NCT01286987|450689831|FG007|Part 1: Dose Escalation|Physician Decision|0|||
125290426|NCT01286987|450689832|FG008|Part 1: Dose Escalation|Physician Decision|0|||
125290427|NCT01286987|450689833|FG009|Part 1: Dose Escalation|Physician Decision|0|||
125290428|NCT01286987|450689834|FG010|Part 1: Dose Escalation|Physician Decision|0|||
125290429|NCT01286987|450689835|FG011|Part 1: Dose Escalation|Physician Decision|0|||
125290430|NCT01286987|450689836|FG012|Part 1: Dose Escalation|Physician Decision|0|||
125450301|NCT00293462|451276625|FG000|Overall Study|Physician Decision|0|||
125450302|NCT00293462|451276626|FG001|Overall Study|Physician Decision|1|||
125450303|NCT00293462|451276627|FG002|Overall Study|Physician Decision|0|||
125450304|NCT00688688|451276628|FG000|Overall Study|Eligibility criterion not met|7|||
125450305|NCT00688688|451276629|FG001|Overall Study|Eligibility criterion not met|7|||
125450306|NCT00688688|451276630|FG002|Overall Study|Eligibility criterion not met|10|||
125290431|NCT01286987|450689837|FG013|Part 1: Dose Escalation|Physician Decision|0|||
125290432|NCT01286987|450689838|FG014|Part 1: Dose Escalation|Physician Decision|0|||
125290433|NCT01286987|450689824|FG000|Part 2: Dose Expansion|Death|0|||
125290434|NCT01286987|450689825|FG001|Part 2: Dose Expansion|Death|0|||
125290435|NCT01286987|450689826|FG002|Part 2: Dose Expansion|Death|0|||
125290436|NCT01286987|450689827|FG003|Part 2: Dose Expansion|Death|0|||
125290437|NCT01286987|450689828|FG004|Part 2: Dose Expansion|Death|0|||
125290438|NCT01286987|450689829|FG005|Part 2: Dose Expansion|Death|0|||
125290439|NCT01286987|450689830|FG006|Part 2: Dose Expansion|Death|0|||
125290440|NCT01286987|450689831|FG007|Part 2: Dose Expansion|Death|0|||
125450307|NCT00688688|451276628|FG000|Overall Study|Adverse Event|52|||
125290441|NCT01286987|450689832|FG008|Part 2: Dose Expansion|Death|0|||
125290442|NCT01286987|450689833|FG009|Part 2: Dose Expansion|Death|0|||
125290443|NCT01286987|450689834|FG010|Part 2: Dose Expansion|Death|0|||
125290444|NCT01286987|450689835|FG011|Part 2: Dose Expansion|Death|0|||
125290445|NCT01286987|450689836|FG012|Part 2: Dose Expansion|Death|1|||
125290446|NCT01286987|450689837|FG013|Part 2: Dose Expansion|Death|1|||
125290447|NCT01286987|450689838|FG014|Part 2: Dose Expansion|Death|0|||
125290448|NCT01286987|450689824|FG000|Part 2: Dose Expansion|Physician Decision|0|||
125290449|NCT01286987|450689825|FG001|Part 2: Dose Expansion|Physician Decision|0|||
125290450|NCT01286987|450689826|FG002|Part 2: Dose Expansion|Physician Decision|0|||
125290451|NCT01286987|450689827|FG003|Part 2: Dose Expansion|Physician Decision|0|||
125290452|NCT01286987|450689828|FG004|Part 2: Dose Expansion|Physician Decision|0|||
125290453|NCT01286987|450689829|FG005|Part 2: Dose Expansion|Physician Decision|0|||
125290454|NCT01286987|450689830|FG006|Part 2: Dose Expansion|Physician Decision|0|||
125290455|NCT01286987|450689831|FG007|Part 2: Dose Expansion|Physician Decision|0|||
125290456|NCT01286987|450689832|FG008|Part 2: Dose Expansion|Physician Decision|0|||
125290457|NCT01286987|450689833|FG009|Part 2: Dose Expansion|Physician Decision|0|||
125290458|NCT01286987|450689834|FG010|Part 2: Dose Expansion|Physician Decision|1|||
125290459|NCT01286987|450689835|FG011|Part 2: Dose Expansion|Physician Decision|1|||
125290460|NCT01286987|450689836|FG012|Part 2: Dose Expansion|Physician Decision|0|||
125290461|NCT01286987|450689837|FG013|Part 2: Dose Expansion|Physician Decision|1|||
125290462|NCT01286987|450689838|FG014|Part 2: Dose Expansion|Physician Decision|0|||
125290463|NCT01286987|450689824|FG000|Part 2: Dose Expansion|Other|0|||
125290464|NCT01286987|450689825|FG001|Part 2: Dose Expansion|Other|0|||
125290465|NCT01286987|450689826|FG002|Part 2: Dose Expansion|Other|0|||
125290466|NCT01286987|450689827|FG003|Part 2: Dose Expansion|Other|0|||
125290467|NCT01286987|450689828|FG004|Part 2: Dose Expansion|Other|0|||
125290468|NCT01286987|450689829|FG005|Part 2: Dose Expansion|Other|0|||
125290469|NCT01286987|450689830|FG006|Part 2: Dose Expansion|Other|0|||
125290470|NCT01286987|450689831|FG007|Part 2: Dose Expansion|Other|0|||
125290471|NCT01286987|450689832|FG008|Part 2: Dose Expansion|Other|0|||
125290472|NCT01286987|450689833|FG009|Part 2: Dose Expansion|Other|0|||
125290473|NCT01286987|450689834|FG010|Part 2: Dose Expansion|Other|0|||
125290474|NCT01286987|450689835|FG011|Part 2: Dose Expansion|Other|0|||
125290475|NCT01286987|450689836|FG012|Part 2: Dose Expansion|Other|0|||
125290476|NCT01286987|450689837|FG013|Part 2: Dose Expansion|Other|1|||
125290477|NCT01286987|450689838|FG014|Part 2: Dose Expansion|Other|0|||
125290478|NCT01286987|450689824|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
125290479|NCT01286987|450689825|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
125290480|NCT01286987|450689826|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
125290481|NCT01286987|450689827|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
125290482|NCT01286987|450689828|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
125290483|NCT01286987|450689829|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
125290484|NCT01286987|450689830|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
125290485|NCT01286987|450689831|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
125290486|NCT01286987|450689832|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
125290487|NCT01286987|450689833|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
125290488|NCT01286987|450689834|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
125290489|NCT01286987|450689835|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
125290490|NCT01286987|450689836|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
125290491|NCT01286987|450689837|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
125290492|NCT01286987|450689838|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
125290493|NCT01286987|450689824|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
125290494|NCT01286987|450689825|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
125290495|NCT01286987|450689826|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
125290496|NCT01286987|450689827|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
125290497|NCT01286987|450689828|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
125290498|NCT01286987|450689829|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
125290499|NCT01286987|450689830|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
125290500|NCT01286987|450689831|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
125290501|NCT01286987|450689832|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
125290502|NCT01286987|450689833|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
125290503|NCT01286987|450689834|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
125290504|NCT01286987|450689835|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
125290505|NCT01286987|450689836|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
125290506|NCT01286987|450689837|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
125290507|NCT01286987|450689838|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
125290508|NCT01286987|450689824|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290509|NCT01286987|450689825|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290510|NCT01286987|450689826|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290511|NCT01286987|450689827|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290512|NCT01286987|450689828|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290513|NCT01286987|450689829|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290514|NCT01286987|450689830|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125450308|NCT00688688|451276629|FG001|Overall Study|Adverse Event|51|||
125450309|NCT00688688|451276630|FG002|Overall Study|Adverse Event|50|||
125450310|NCT00688688|451276628|FG000|Overall Study|Lack of Efficacy|34|||
125450311|NCT00688688|451276629|FG001|Overall Study|Lack of Efficacy|25|||
125450312|NCT00688688|451276630|FG002|Overall Study|Lack of Efficacy|45|||
125450313|NCT00688688|451276628|FG000|Overall Study|Withdrawal by Subject|66|||
125450314|NCT00688688|451276629|FG001|Overall Study|Withdrawal by Subject|75|||
125450315|NCT00688688|451276630|FG002|Overall Study|Withdrawal by Subject|65|||
125450316|NCT00688688|451276628|FG000|Overall Study|Lost to Follow-up|14|||
125450317|NCT00688688|451276629|FG001|Overall Study|Lost to Follow-up|7|||
125450318|NCT00688688|451276630|FG002|Overall Study|Lost to Follow-up|7|||
125450319|NCT00688688|451276628|FG000|Overall Study|Protocol Violation|6|||
125450320|NCT00688688|451276629|FG001|Overall Study|Protocol Violation|9|||
125450321|NCT00688688|451276630|FG002|Overall Study|Protocol Violation|11|||
125450322|NCT00688688|451276628|FG000|Overall Study|Randomized but never received study drug|1|||
125450323|NCT00688688|451276629|FG001|Overall Study|Randomized but never received study drug|0|||
125450324|NCT00688688|451276630|FG002|Overall Study|Randomized but never received study drug|0|||
125450325|NCT00688688|451276628|FG000|Overall Study|Non-compliance with study procedures|5|||
125450326|NCT00688688|451276629|FG001|Overall Study|Non-compliance with study procedures|3|||
125450327|NCT00688688|451276630|FG002|Overall Study|Non-compliance with study procedures|4|||
125450328|NCT00688688|451276628|FG000|Overall Study|Taking exclusionary medications|1|||
125450329|NCT00688688|451276629|FG001|Overall Study|Taking exclusionary medications|0|||
125450330|NCT00688688|451276630|FG002|Overall Study|Taking exclusionary medications|0|||
125450331|NCT00688688|451276628|FG000|Overall Study|Site closure|0|||
125450332|NCT00688688|451276629|FG001|Overall Study|Site closure|1|||
125450333|NCT00688688|451276630|FG002|Overall Study|Site closure|0|||
125450334|NCT00688688|451276628|FG000|Overall Study|Violation of exclusion criterion|0|||
125450335|NCT00688688|451276629|FG001|Overall Study|Violation of exclusion criterion|1|||
125450336|NCT00688688|451276630|FG002|Overall Study|Violation of exclusion criterion|0|||
125450337|NCT03283553|451276633|FG000|Patient Participant Flow|Death|5|||
125450338|NCT03283553|451276634|FG001|Patient Participant Flow|Death|10|||
125450339|NCT03283553|451276633|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
125450340|NCT03283553|451276634|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
125450341|NCT03283553|451276633|FG000|Patient Participant Flow|Lost to Follow-up|1|||
125450342|NCT03283553|451276634|FG001|Patient Participant Flow|Lost to Follow-up|1|||
125450343|NCT03283553|451276633|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
125450344|NCT03283553|451276634|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
125450345|NCT03283553|451276633|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
125450346|NCT03283553|451276634|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
125450347|NCT03283553|451276633|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
125450348|NCT03283553|451276634|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
125450349|NCT03686683|451276635|FG000|Overall Study|Withdrawal by Subject|52|||
125450350|NCT03686683|451276636|FG001|Overall Study|Withdrawal by Subject|32|||
125450351|NCT03686683|451276635|FG000|Overall Study|Lost to Follow-up|23|||
125450352|NCT03686683|451276636|FG001|Overall Study|Lost to Follow-up|19|||
125450353|NCT03686683|451276635|FG000|Overall Study|Adverse Event|1|||
125450354|NCT03686683|451276636|FG001|Overall Study|Adverse Event|0|||
125450355|NCT03686683|451276635|FG000|Overall Study|Death|10|||
125450356|NCT03686683|451276636|FG001|Overall Study|Death|5|||
125450357|NCT03686683|451276635|FG000|Overall Study|Progressive Disease|1|||
125450358|NCT03686683|451276636|FG001|Overall Study|Progressive Disease|1|||
125450359|NCT03686683|451276635|FG000|Overall Study|Noncompliance|1|||
125450360|NCT03686683|451276636|FG001|Overall Study|Noncompliance|0|||
125450361|NCT03686683|451276635|FG000|Overall Study|Physician Decision|1|||
125450362|NCT03686683|451276636|FG001|Overall Study|Physician Decision|1|||
125450363|NCT03686683|451276635|FG000|Overall Study|Screen fail post-randomization|1|||
125198415|NCT02829723|450348071|FG003|Overall Study|Subject/guardian decision|1|||
125198416|NCT02829723|450348072|FG004|Overall Study|Subject/guardian decision|0|||
125198417|NCT02829723|450348073|FG005|Overall Study|Subject/guardian decision|0|||
125198418|NCT02829723|450348074|FG006|Overall Study|Subject/guardian decision|0|||
125198419|NCT02829723|450348075|FG007|Overall Study|Subject/guardian decision|1|||
125198420|NCT02829723|450348076|FG008|Overall Study|Subject/guardian decision|0|||
125198421|NCT02829723|450348077|FG009|Overall Study|Subject/guardian decision|0|||
125198422|NCT02829723|450348078|FG010|Overall Study|Subject/guardian decision|0|||
125198423|NCT02829723|450348079|FG011|Overall Study|Subject/guardian decision|0|||
125198424|NCT02829723|450348080|FG012|Overall Study|Subject/guardian decision|0|||
125198425|NCT02829723|450348081|FG013|Overall Study|Subject/guardian decision|0|||
125198426|NCT02829723|450348082|FG014|Overall Study|Subject/guardian decision|1|||
125198427|NCT02829723|450348083|FG015|Overall Study|Subject/guardian decision|0|||
125198428|NCT02829723|450348084|FG016|Overall Study|Subject/guardian decision|1|||
125198429|NCT02829723|450348085|FG017|Overall Study|Subject/guardian decision|0|||
125198430|NCT02829723|450348086|FG018|Overall Study|Subject/guardian decision|1|||
125198431|NCT02829723|450348087|FG019|Overall Study|Subject/guardian decision|0|||
125198432|NCT02829723|450348088|FG020|Overall Study|Subject/guardian decision|1|||
125450364|NCT03686683|451276636|FG001|Overall Study|Screen fail post-randomization|0|||
125450365|NCT03686683|451276635|FG000|Overall Study|Protocol Violation|3|||
125450366|NCT03686683|451276636|FG001|Overall Study|Protocol Violation|0|||
125450367|NCT03686683|451276635|FG000|Overall Study|No data available|1|||
125450368|NCT03686683|451276636|FG001|Overall Study|No data available|0|||
125450369|NCT03255941|451276637|FG000|Overall Study|Not eligible or refused injection|37|||
125450370|NCT03255941|451276638|FG001|Overall Study|Not eligible or refused injection|44|||
125450371|NCT03255941|451276639|FG002|Overall Study|Not eligible or refused injection|5|||
125450372|NCT03255941|451276640|FG003|Overall Study|Not eligible or refused injection|6|||
125450373|NCT03255941|451276637|FG000|Overall Study|Did not complete exit interview|1|||
125450374|NCT03255941|451276638|FG001|Overall Study|Did not complete exit interview|2|||
125450375|NCT03255941|451276639|FG002|Overall Study|Did not complete exit interview|0|||
125450376|NCT03255941|451276640|FG003|Overall Study|Did not complete exit interview|0|||
125450377|NCT00372060|451276641|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
125450378|NCT00372060|451276642|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
125450379|NCT00372060|451276641|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
125450380|NCT00372060|451276642|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
125450381|NCT00372060|451276641|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
125450382|NCT00372060|451276642|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
125450383|NCT00372060|451276641|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
125450384|NCT00372060|451276642|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
125450385|NCT00372060|451276641|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
125450386|NCT00372060|451276642|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
125450387|NCT00372060|451276641|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
125450388|NCT00372060|451276642|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
125450389|NCT01579578|451276643|FG000|Overall Study|Death|4|||
125450390|NCT01579578|451276644|FG001|Overall Study|Death|1|||
125198433|NCT02829723|450348089|FG021|Overall Study|Subject/guardian decision|0|||
125198434|NCT02829723|450348090|FG022|Overall Study|Subject/guardian decision|0|||
125198435|NCT02829723|450348091|FG023|Overall Study|Subject/guardian decision|1|||
125198436|NCT02829723|450348092|FG024|Overall Study|Subject/guardian decision|0|||
125198437|NCT02829723|450348093|FG025|Overall Study|Subject/guardian decision|1|||
125198438|NCT02829723|450348094|FG026|Overall Study|Subject/guardian decision|1|||
125198439|NCT02829723|450348068|FG000|Overall Study|Study terminated by sponsor|0|||
125198440|NCT02829723|450348069|FG001|Overall Study|Study terminated by sponsor|0|||
125198441|NCT02829723|450348070|FG002|Overall Study|Study terminated by sponsor|0|||
125198442|NCT02829723|450348071|FG003|Overall Study|Study terminated by sponsor|0|||
125198443|NCT02829723|450348072|FG004|Overall Study|Study terminated by sponsor|0|||
125198444|NCT02829723|450348073|FG005|Overall Study|Study terminated by sponsor|0|||
125198445|NCT02829723|450348074|FG006|Overall Study|Study terminated by sponsor|0|||
125198446|NCT02829723|450348075|FG007|Overall Study|Study terminated by sponsor|0|||
125198447|NCT02829723|450348076|FG008|Overall Study|Study terminated by sponsor|0|||
125198448|NCT02829723|450348077|FG009|Overall Study|Study terminated by sponsor|0|||
125198449|NCT02829723|450348078|FG010|Overall Study|Study terminated by sponsor|0|||
125198450|NCT02829723|450348079|FG011|Overall Study|Study terminated by sponsor|0|||
125198451|NCT02829723|450348080|FG012|Overall Study|Study terminated by sponsor|0|||
125198452|NCT02829723|450348081|FG013|Overall Study|Study terminated by sponsor|0|||
125198453|NCT02829723|450348082|FG014|Overall Study|Study terminated by sponsor|0|||
125198454|NCT02829723|450348083|FG015|Overall Study|Study terminated by sponsor|0|||
125198455|NCT02829723|450348084|FG016|Overall Study|Study terminated by sponsor|0|||
125198456|NCT02829723|450348085|FG017|Overall Study|Study terminated by sponsor|0|||
125198457|NCT02829723|450348086|FG018|Overall Study|Study terminated by sponsor|0|||
125198458|NCT02829723|450348087|FG019|Overall Study|Study terminated by sponsor|0|||
125198459|NCT02829723|450348088|FG020|Overall Study|Study terminated by sponsor|0|||
125198460|NCT02829723|450348089|FG021|Overall Study|Study terminated by sponsor|1|||
125198461|NCT02829723|450348090|FG022|Overall Study|Study terminated by sponsor|0|||
125198462|NCT02829723|450348091|FG023|Overall Study|Study terminated by sponsor|0|||
125198463|NCT02829723|450348092|FG024|Overall Study|Study terminated by sponsor|0|||
125198464|NCT02829723|450348093|FG025|Overall Study|Study terminated by sponsor|0|||
125450391|NCT01579578|451276643|FG000|Overall Study|Lost to Follow-up|1|||
125198465|NCT02829723|450348094|FG026|Overall Study|Study terminated by sponsor|0|||
125198466|NCT02989649|450348095|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
125198467|NCT02989649|450348095|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
125198468|NCT02989649|450348095|FG000|Overall Study|Lost For Observation During Study|3|||
125198469|NCT02989649|450348095|FG000|Overall Study|Reason Not Specified|13|||
125198470|NCT00330343|450348096|FG000|Overall Study|Lost to Follow-up|5|||
125450392|NCT01579578|451276644|FG001|Overall Study|Lost to Follow-up|1|||
125450393|NCT01579578|451276643|FG000|Overall Study|Withdrawal by Subject|2|||
125450394|NCT01579578|451276644|FG001|Overall Study|Withdrawal by Subject|1|||
125198471|NCT00281632|450348097|FG000|Overall Study|Adverse Event|7|||
125198472|NCT00281632|450348097|FG000|Overall Study|Withdrawal by Subject|2|||
125198473|NCT00281632|450348097|FG000|Overall Study|Disease Progression|22|||
125198474|NCT00281632|450348097|FG000|Overall Study|Death|1|||
125198475|NCT00281632|450348097|FG000|Overall Study|Physician Decision|1|||
125198476|NCT00281632|450348097|FG000|Overall Study|Ongoing|3|||
125198477|NCT03614078|450348098|FG000|Overall Study|Withdrawal by Subject|2|||
125198478|NCT03614078|450348099|FG001|Overall Study|Withdrawal by Subject|2|||
125198479|NCT03614078|450348100|FG002|Overall Study|Withdrawal by Subject|3|||
125198480|NCT03614078|450348098|FG000|Overall Study|Participant Did Not Return for Visit|0|||
125198481|NCT03614078|450348099|FG001|Overall Study|Participant Did Not Return for Visit|1|||
125198482|NCT03614078|450348100|FG002|Overall Study|Participant Did Not Return for Visit|0|||
125198483|NCT03614078|450348098|FG000|Overall Study|High Neutrophils|0|||
125198484|NCT03614078|450348099|FG001|Overall Study|High Neutrophils|0|||
125198485|NCT03614078|450348100|FG002|Overall Study|High Neutrophils|2|||
125198486|NCT03614078|450348098|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
125198487|NCT03614078|450348099|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
125198488|NCT03614078|450348100|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
125198489|NCT03614078|450348098|FG000|Overall Study|Exacerbation of Psoriasis|0|||
125198490|NCT03614078|450348099|FG001|Overall Study|Exacerbation of Psoriasis|1|||
125198491|NCT03614078|450348100|FG002|Overall Study|Exacerbation of Psoriasis|0|||
125198492|NCT03614078|450348098|FG000|Overall Study|Adverse Event|0|||
125198493|NCT03614078|450348099|FG001|Overall Study|Adverse Event|2|||
125198494|NCT03614078|450348100|FG002|Overall Study|Adverse Event|0|||
125198495|NCT03614078|450348098|FG000|Overall Study|Dizziness and Rash|0|||
125198496|NCT03614078|450348099|FG001|Overall Study|Dizziness and Rash|1|||
125198497|NCT03614078|450348100|FG002|Overall Study|Dizziness and Rash|0|||
125198498|NCT02691936|450348102|FG000|Overall Study|Withdrawal by Subject|2|||
125198499|NCT02691936|450348103|FG001|Overall Study|Withdrawal by Subject|5|||
125198500|NCT03382834|450348105|FG000|Step 1|Lost to Follow-up|0|||
125198501|NCT03382834|450348106|FG001|Step 1|Lost to Follow-up|1|||
125198502|NCT03382834|450348105|FG000|Step 2|Death|1|||
125198503|NCT03382834|450348106|FG001|Step 2|Death|0|||
125198504|NCT03382834|450348105|FG000|Step 2|Lost to Follow-up|2|||
125198505|NCT03382834|450348106|FG001|Step 2|Lost to Follow-up|2|||
125198506|NCT03382834|450348105|FG000|Step 2|Site Terminated by Sponsor|1|||
125198507|NCT03382834|450348106|FG001|Step 2|Site Terminated by Sponsor|0|||
125198508|NCT02387957|450348107|FG000|Overall Study|The study was discontinued|21|||
125198509|NCT02387957|450348108|FG001|Overall Study|The study was discontinued|21|||
125198510|NCT02387957|450348109|FG002|Overall Study|The study was discontinued|20|||
125198511|NCT00977314|450348116|FG000|Overall Study|Withdrawal by Subject|1|||
125198512|NCT00977314|450348117|FG001|Overall Study|Withdrawal by Subject|0|||
125198513|NCT00977314|450348116|FG000|Overall Study|Physician Decision|1|||
125198514|NCT00977314|450348117|FG001|Overall Study|Physician Decision|0|||
125198515|NCT01343277|450348121|FG000|Overall Study|Other|3|||
125198516|NCT01343277|450348122|FG001|Overall Study|Other|3|||
125198517|NCT01343277|450348121|FG000|Overall Study|Withdrawal by Subject|18|||
125198518|NCT01343277|450348122|FG001|Overall Study|Withdrawal by Subject|13|||
125198519|NCT01343277|450348121|FG000|Overall Study|Physician Decision|1|||
125290515|NCT01286987|450689831|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290516|NCT01286987|450689832|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290517|NCT01286987|450689833|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290518|NCT01286987|450689834|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
125290519|NCT01286987|450689835|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290520|NCT01286987|450689836|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290521|NCT01286987|450689837|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290522|NCT01286987|450689838|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125290523|NCT04662073|450689839|FG000|Overall Study|Withdrawal by Subject|1|||
125290524|NCT04662073|450689840|FG001|Overall Study|Withdrawal by Subject|0|||
125290525|NCT01479595|450689847|FG000|Overall Study|Protocol deviation|0|||
125290526|NCT01479595|450689848|FG001|Overall Study|Protocol deviation|1|||
125290527|NCT01479595|450689847|FG000|Overall Study|Adverse Event|2|||
125290528|NCT01479595|450689848|FG001|Overall Study|Adverse Event|1|||
125290529|NCT02255565|450689850|FG000|Overall Study|Withdrawal by Subject|0|||
125290530|NCT02255565|450689851|FG001|Overall Study|Withdrawal by Subject|1|||
125290531|NCT02255565|450689852|FG002|Overall Study|Withdrawal by Subject|0|||
125290532|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
125290533|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
125290534|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
125290535|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
125290536|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
125290537|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
125290538|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
125290539|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
125290540|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
125290541|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
125290542|NCT03906656|450689856|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
125290543|NCT03906656|450689857|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
125198520|NCT01343277|450348122|FG001|Overall Study|Physician Decision|2|||
125290544|NCT03906656|450689856|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
125290545|NCT03906656|450689857|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
125290546|NCT03906656|450689856|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
125290547|NCT03906656|450689857|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
125290548|NCT03906656|450689856|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
125290549|NCT03906656|450689857|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
125290550|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
125290551|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
125290552|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
125290553|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
125290554|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
125290555|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
125290556|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
125290557|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
125290558|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
125290559|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
125290560|NCT03906656|450689856|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
125290561|NCT03906656|450689857|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
125290562|NCT03906656|450689856|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
125290563|NCT03906656|450689857|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
125290564|NCT03906656|450689856|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
125290565|NCT03906656|450689857|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
125290566|NCT03906656|450689856|FG000|Home Use 2 (3 Months)|Death|2|||
125290567|NCT03906656|450689857|FG001|Home Use 2 (3 Months)|Death|0|||
125290568|NCT03906656|450689856|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
125290569|NCT03906656|450689857|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
125290570|NCT03906656|450689856|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
125290571|NCT03906656|450689857|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
125290572|NCT00343915|450689858|FG000|Primary Study|Withdrawal by Subject|1|||
125290573|NCT00343915|450689859|FG001|Primary Study|Withdrawal by Subject|0|||
125290574|NCT00343915|450689858|FG000|Primary Study|Lost to Follow-up|2|||
125290575|NCT00343915|450689859|FG001|Primary Study|Lost to Follow-up|3|||
125290576|NCT00343915|450689858|FG000|Primary Study|Other|1|||
125290577|NCT00343915|450689859|FG001|Primary Study|Other|0|||
125290578|NCT00882908|450689860|FG000|Overall Study|Adverse Event|0|||
125290579|NCT00882908|450689861|FG001|Overall Study|Adverse Event|0|||
125290580|NCT00882908|450689862|FG002|Overall Study|Adverse Event|1|||
125290581|NCT00882908|450689863|FG003|Overall Study|Adverse Event|0|||
125290582|NCT00882908|450689864|FG004|Overall Study|Adverse Event|1|||
125290583|NCT00882908|450689860|FG000|Overall Study|Lost to Follow-up|3|||
125290584|NCT00882908|450689861|FG001|Overall Study|Lost to Follow-up|5|||
125290585|NCT00882908|450689862|FG002|Overall Study|Lost to Follow-up|3|||
125290586|NCT00882908|450689863|FG003|Overall Study|Lost to Follow-up|1|||
125290587|NCT00882908|450689864|FG004|Overall Study|Lost to Follow-up|2|||
125290588|NCT00882908|450689860|FG000|Overall Study|Protocol Violation|0|||
125290589|NCT00882908|450689861|FG001|Overall Study|Protocol Violation|1|||
125290590|NCT00882908|450689862|FG002|Overall Study|Protocol Violation|0|||
125290591|NCT00882908|450689863|FG003|Overall Study|Protocol Violation|0|||
125290592|NCT00882908|450689864|FG004|Overall Study|Protocol Violation|0|||
125290593|NCT00882908|450689860|FG000|Overall Study|Withdrawal by Subject|0|||
125290594|NCT00882908|450689861|FG001|Overall Study|Withdrawal by Subject|0|||
125290595|NCT00882908|450689862|FG002|Overall Study|Withdrawal by Subject|3|||
125290596|NCT00882908|450689863|FG003|Overall Study|Withdrawal by Subject|5|||
125290597|NCT00882908|450689864|FG004|Overall Study|Withdrawal by Subject|2|||
125290598|NCT00882908|450689860|FG000|Overall Study|Subject reached a virologic endpoint|0|||
125290599|NCT00882908|450689861|FG001|Overall Study|Subject reached a virologic endpoint|0|||
125290600|NCT00882908|450689862|FG002|Overall Study|Subject reached a virologic endpoint|0|||
125290601|NCT00882908|450689863|FG003|Overall Study|Subject reached a virologic endpoint|0|||
125450395|NCT01579578|451276643|FG000|Overall Study|Eligibility criteria|3|||
125450396|NCT01579578|451276644|FG001|Overall Study|Eligibility criteria|9|||
125290602|NCT00882908|450689864|FG004|Overall Study|Subject reached a virologic endpoint|1|||
125290603|NCT00882908|450689860|FG000|Overall Study|Study terminated in error|0|||
125290604|NCT00882908|450689861|FG001|Overall Study|Study terminated in error|0|||
125290605|NCT00882908|450689862|FG002|Overall Study|Study terminated in error|0|||
125198521|NCT01343277|450348121|FG000|Overall Study|Death|10|||
125198522|NCT01343277|450348122|FG001|Overall Study|Death|1|||
125198523|NCT01343277|450348121|FG000|Overall Study|Adverse Event|67|||
125198524|NCT01343277|450348122|FG001|Overall Study|Adverse Event|13|||
125198525|NCT01343277|450348121|FG000|Overall Study|Disease progression|270|||
125198526|NCT01343277|450348122|FG001|Overall Study|Disease progression|138|||
125198527|NCT01343277|450348121|FG000|Overall Study|Randomized not treated|6|||
125198528|NCT01343277|450348122|FG001|Overall Study|Randomized not treated|21|||
125198529|NCT01343277|450348121|FG000|Overall Study|Treatment ongoing|8|||
125198530|NCT01343277|450348122|FG001|Overall Study|Treatment ongoing|2|||
125198531|NCT01343277|450348121|FG000|Overall Study|Subsequent anticancer therapy|1|||
125198532|NCT01343277|450348122|FG001|Overall Study|Subsequent anticancer therapy|0|||
125198533|NCT01582178|450348130|FG000|Overall Study|Physician Decision|6|||
125198534|NCT01582178|450348131|FG001|Overall Study|Physician Decision|5|||
125198535|NCT03852628|450348132|FG000|Overall Study|Lost to Follow-up|7|||
125198536|NCT03852628|450348133|FG001|Overall Study|Lost to Follow-up|6|||
125198537|NCT03852628|450348132|FG000|Overall Study|Lack of Efficacy|6|||
125198538|NCT03852628|450348133|FG001|Overall Study|Lack of Efficacy|6|||
125198539|NCT02964208|450348134|FG000|Overall Study|Death|103|||
125198540|NCT02964208|450348134|FG000|Overall Study|Withdrawal by Subject|6|||
125198541|NCT02964208|450348134|FG000|Overall Study|Lost to Follow-up|6|||
125198542|NCT02964208|450348134|FG000|Overall Study|Unsuccessful Procedure|5|||
125198543|NCT02964208|450348134|FG000|Overall Study|Device Explant|1|||
125198544|NCT02964208|450348134|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
125198545|NCT00556933|450348138|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
125198546|NCT00556933|450348139|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
125198547|NCT00556933|450348140|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
125198548|NCT00556933|450348141|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
125198549|NCT00556933|450348138|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
125198550|NCT00556933|450348139|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
125198551|NCT00556933|450348140|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
125198552|NCT00556933|450348141|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
125198553|NCT00556933|450348138|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
125198554|NCT00556933|450348139|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
125198555|NCT00556933|450348140|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
125198556|NCT00556933|450348141|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
125198557|NCT00556933|450348138|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
125198558|NCT00556933|450348139|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
125198559|NCT00556933|450348140|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
125198560|NCT00556933|450348141|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
125198561|NCT00556933|450348138|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
125198562|NCT00556933|450348139|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
125290606|NCT00882908|450689863|FG003|Overall Study|Study terminated in error|1|||
125290607|NCT00882908|450689864|FG004|Overall Study|Study terminated in error|0|||
125290608|NCT05291936|450689865|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
125290609|NCT05291936|450689866|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
125290610|NCT05291936|450689865|FG000|Period 1|Withdrew Consent during study|1|||
125290611|NCT05291936|450689866|FG001|Period 1|Withdrew Consent during study|0|||
125290612|NCT05291936|450689865|FG000|Period 2|Adverse Event|0|||
125290613|NCT05291936|450689866|FG001|Period 2|Adverse Event|1|||
125290614|NCT05291936|450689865|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
125290615|NCT05291936|450689866|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125290616|NCT02370095|450689867|FG000|Overall Study|Withdrawal by Subject|0|||
125290617|NCT02370095|450689868|FG001|Overall Study|Withdrawal by Subject|1|||
125290618|NCT01667562|450689872|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
125290619|NCT01667562|450689873|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
125290620|NCT01667562|450689872|FG000|Erlotinib Phase|Lost to Follow-up|0|||
125290621|NCT01667562|450689873|FG001|Erlotinib Phase|Lost to Follow-up|1|||
125290622|NCT01667562|450689872|FG000|Erlotinib Phase|Adverse Event|0|||
125290623|NCT01667562|450689873|FG001|Erlotinib Phase|Adverse Event|1|||
125290624|NCT01667562|450689872|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
125290625|NCT01667562|450689873|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
125290626|NCT02130986|450689874|FG000|Overall Study|Withdrawal by Subject|4|||
125290627|NCT02130986|450689875|FG001|Overall Study|Withdrawal by Subject|4|||
125290628|NCT02130986|450689874|FG000|Overall Study|Lost to Follow-up|151|||
125290629|NCT02130986|450689875|FG001|Overall Study|Lost to Follow-up|160|||
125290630|NCT01129882|450689876|FG000|Overall Study|Adverse Event|39|||
125290631|NCT01129882|450689876|FG000|Overall Study|Death|6|||
125198563|NCT00556933|450348140|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
125198564|NCT00556933|450348141|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
125198565|NCT00556933|450348138|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
125198566|NCT00556933|450348139|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
125198567|NCT00556933|450348140|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
125198568|NCT00556933|450348141|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
125198569|NCT00556933|450348138|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
125198570|NCT00556933|450348139|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
125198571|NCT00556933|450348140|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
125198572|NCT00556933|450348141|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
125198573|NCT00556933|450348138|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
125198574|NCT00556933|450348139|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
125198575|NCT00556933|450348140|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
125290632|NCT01129882|450689876|FG000|Overall Study|Lack of Efficacy|5|||
125290633|NCT01129882|450689876|FG000|Overall Study|Lost to Follow-up|13|||
125290634|NCT01129882|450689876|FG000|Overall Study|Physician Decision|27|||
125290635|NCT01129882|450689876|FG000|Overall Study|Protocol Deviation|3|||
125290636|NCT01129882|450689876|FG000|Overall Study|Withdrawal Criteria Met|19|||
125290637|NCT01129882|450689876|FG000|Overall Study|Trial Termination by Sponsor|6|||
125290638|NCT01129882|450689876|FG000|Overall Study|Withdrawal by Subject|160|||
125290639|NCT00993499|450689880|FG000|Run-in Period (8 Days)|Adverse Event|0|||
125290640|NCT00993499|450689881|FG001|Run-in Period (8 Days)|Adverse Event|1|||
125290641|NCT00993499|450689882|FG002|Run-in Period (8 Days)|Adverse Event|0|||
125290642|NCT00993499|450689883|FG003|Run-in Period (8 Days)|Adverse Event|0|||
125290643|NCT00993499|450689884|FG004|Run-in Period (8 Days)|Adverse Event|0|||
125290644|NCT00993499|450689885|FG005|Run-in Period (8 Days)|Adverse Event|0|||
125290645|NCT00993499|450689880|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
125290646|NCT00993499|450689881|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
125290647|NCT00993499|450689882|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
125290648|NCT00993499|450689883|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
125290649|NCT00993499|450689884|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
125290650|NCT00993499|450689885|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
125290651|NCT00993499|450689880|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
125290652|NCT00993499|450689881|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
125290653|NCT00993499|450689882|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
125290654|NCT00993499|450689883|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
125290655|NCT00993499|450689884|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
125290656|NCT00993499|450689885|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
125290657|NCT00993499|450689880|FG000|Run-in Period (8 Days)|Progressive disease|0|||
125290658|NCT00993499|450689881|FG001|Run-in Period (8 Days)|Progressive disease|1|||
125290659|NCT00993499|450689882|FG002|Run-in Period (8 Days)|Progressive disease|1|||
125290660|NCT00993499|450689883|FG003|Run-in Period (8 Days)|Progressive disease|0|||
125290661|NCT00993499|450689884|FG004|Run-in Period (8 Days)|Progressive disease|0|||
125290662|NCT00993499|450689885|FG005|Run-in Period (8 Days)|Progressive disease|0|||
125290663|NCT00993499|450689880|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
125290664|NCT00993499|450689881|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
125290665|NCT00993499|450689882|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
125290666|NCT00993499|450689883|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
125290667|NCT00993499|450689884|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
125290668|NCT00993499|450689885|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
125290669|NCT00993499|450689880|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
125290670|NCT00993499|450689881|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
125290671|NCT00993499|450689882|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
125290672|NCT00993499|450689883|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
125290673|NCT00993499|450689884|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
125198576|NCT00556933|450348141|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
125198577|NCT00556933|450348138|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
125198578|NCT00556933|450348139|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
125198579|NCT00556933|450348140|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
125198580|NCT00556933|450348141|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
125198581|NCT00556933|450348138|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
125198582|NCT00556933|450348139|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
125198583|NCT00556933|450348140|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
125198584|NCT00556933|450348141|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
125198585|NCT00556933|450348138|FG000|CNI Withdrawal vs. Minimization|Death|0|||
125198586|NCT00556933|450348139|FG001|CNI Withdrawal vs. Minimization|Death|0|||
125198587|NCT00556933|450348140|FG002|CNI Withdrawal vs. Minimization|Death|0|||
125198588|NCT00556933|450348141|FG003|CNI Withdrawal vs. Minimization|Death|1|||
125198589|NCT01743560|450348142|FG000|Overall Study|Disease progression|26|||
125198590|NCT01743560|450348142|FG000|Overall Study|Adverse Event|8|||
125198591|NCT01743560|450348142|FG000|Overall Study|Death|3|||
125198592|NCT01743560|450348142|FG000|Overall Study|Withdrawal by Subject|2|||
125198593|NCT01743560|450348142|FG000|Overall Study|Protocol Violation|1|||
125198594|NCT01743560|450348142|FG000|Overall Study|>1 dose of study drug|3|||
125198595|NCT02640677|450348147|FG000|Overall Study|Lost to Follow-up|1|||
125198596|NCT02640677|450348147|FG000|Overall Study|Withdrawal by Subject|1|||
125198597|NCT04553471|450348148|FG000|Overall Study|Did not start treatment on protocol|3|||
125198598|NCT04553471|450348148|FG000|Overall Study|Death|1|||
125198599|NCT00940823|450348149|FG000|Overall Study|Death|8|||
125198600|NCT00940823|450348150|FG001|Overall Study|Death|12|||
125198601|NCT00940823|450348149|FG000|Overall Study|Lost to Follow-up|27|||
125198602|NCT00940823|450348150|FG001|Overall Study|Lost to Follow-up|20|||
125290674|NCT00993499|450689885|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
125290675|NCT00993499|450689880|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
125290676|NCT00993499|450689881|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
125290677|NCT00993499|450689882|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
125290678|NCT00993499|450689883|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
125290679|NCT00993499|450689884|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
125290680|NCT00993499|450689885|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
125290681|NCT00993499|450689880|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
125290682|NCT00993499|450689881|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
125290683|NCT00993499|450689882|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
125290684|NCT00993499|450689883|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
125290685|NCT00993499|450689884|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
125290686|NCT00993499|450689885|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
125290687|NCT00993499|450689880|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
125290688|NCT00993499|450689881|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
125290689|NCT00993499|450689882|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
125290690|NCT00993499|450689883|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
125290691|NCT00993499|450689884|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
125290692|NCT00993499|450689885|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
125290693|NCT00993499|450689880|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
125290694|NCT00993499|450689881|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
125290695|NCT00993499|450689882|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
125290696|NCT00993499|450689883|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
125290697|NCT00993499|450689884|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
125290698|NCT00993499|450689885|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
125290699|NCT00993499|450689880|FG000|Discontinued After Starting Course 3|DLT|1|||
125290700|NCT00993499|450689881|FG001|Discontinued After Starting Course 3|DLT|0|||
125290701|NCT00993499|450689882|FG002|Discontinued After Starting Course 3|DLT|2|||
125290702|NCT00993499|450689883|FG003|Discontinued After Starting Course 3|DLT|1|||
125290703|NCT00993499|450689884|FG004|Discontinued After Starting Course 3|DLT|0|||
125290704|NCT00993499|450689885|FG005|Discontinued After Starting Course 3|DLT|0|||
125290705|NCT00993499|450689880|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
125290706|NCT00993499|450689881|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
125290707|NCT00993499|450689882|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
125290708|NCT00993499|450689883|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
125290709|NCT00993499|450689884|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
125290710|NCT00993499|450689885|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
125290711|NCT01352741|450689886|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
125290712|NCT01352741|450689887|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
125290713|NCT01352741|450689886|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
125290714|NCT01352741|450689887|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
125290715|NCT01352741|450689886|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
125290716|NCT01352741|450689887|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
125290717|NCT01352741|450689886|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
125290718|NCT01352741|450689887|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
125290719|NCT01352741|450689886|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
125290720|NCT01352741|450689887|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
125290721|NCT01352741|450689886|FG000|Open-label Tapentadol Titration Period|Other|4|||
125290722|NCT01352741|450689887|FG001|Open-label Tapentadol Titration Period|Other|0|||
125290723|NCT01352741|450689886|FG000|Double-blind Comparative Period|Protocol Violation|2|||
125290724|NCT01352741|450689887|FG001|Double-blind Comparative Period|Protocol Violation|0|||
125290725|NCT01352741|450689886|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
125290726|NCT01352741|450689887|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
125290727|NCT01352741|450689886|FG000|Double-blind Comparative Period|Adverse Event|16|||
125290728|NCT01352741|450689887|FG001|Double-blind Comparative Period|Adverse Event|17|||
125290729|NCT01352741|450689886|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
125290730|NCT01352741|450689887|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
125290731|NCT01352741|450689886|FG000|Double-blind Comparative Period|Death|0|||
125290732|NCT01352741|450689887|FG001|Double-blind Comparative Period|Death|1|||
125290733|NCT01352741|450689886|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
125290734|NCT01352741|450689887|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
125290735|NCT01352741|450689886|FG000|Double-blind Comparative Period|Other|1|||
125290736|NCT01352741|450689887|FG001|Double-blind Comparative Period|Other|2|||
125290737|NCT01352741|450689886|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
125290738|NCT01352741|450689887|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
125290739|NCT01352741|450689886|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
125290740|NCT01352741|450689887|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
125290741|NCT01352741|450689886|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
125290742|NCT01352741|450689887|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
125290743|NCT01352741|450689886|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
125290744|NCT01352741|450689887|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
125290745|NCT04070326|450689888|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
125290746|NCT04070326|450689889|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
125290747|NCT00645528|450689890|FG000|Overall Study|Did not show up for Visit 2|7|||
125290748|NCT01498185|450689893|FG000|Overall Study|Adverse Event|0|||
125290749|NCT01498185|450689894|FG001|Overall Study|Adverse Event|0|||
125290750|NCT01498185|450689895|FG002|Overall Study|Adverse Event|0|||
125290751|NCT01498185|450689896|FG003|Overall Study|Adverse Event|1|||
125290752|NCT01498185|450689897|FG004|Overall Study|Adverse Event|0|||
125290753|NCT01498185|450689893|FG000|Overall Study|Withdrawal by Subject|1|||
125290754|NCT01498185|450689894|FG001|Overall Study|Withdrawal by Subject|1|||
125290755|NCT01498185|450689895|FG002|Overall Study|Withdrawal by Subject|0|||
125290756|NCT01498185|450689896|FG003|Overall Study|Withdrawal by Subject|2|||
125290757|NCT01498185|450689897|FG004|Overall Study|Withdrawal by Subject|1|||
125290758|NCT01498185|450689893|FG000|Overall Study|No longer met criteria, etc|0|||
125290759|NCT01498185|450689894|FG001|Overall Study|No longer met criteria, etc|0|||
125290760|NCT01498185|450689895|FG002|Overall Study|No longer met criteria, etc|0|||
125290761|NCT01498185|450689896|FG003|Overall Study|No longer met criteria, etc|0|||
125290762|NCT01498185|450689897|FG004|Overall Study|No longer met criteria, etc|2|||
125290763|NCT00946322|450689898|FG000|Pre-treatment|participant failure to follow up|1|||
125290764|NCT00946322|450689898|FG000|Post-treatment|participant failure to follow up|2|||
125290765|NCT02153346|450689899|FG000|Overall Study|Lost to Follow-up|11|||
125290766|NCT00846040|450689900|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
125290767|NCT00846040|450689901|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
125290768|NCT00846040|450689902|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
125290769|NCT00846040|450689900|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
125290770|NCT00846040|450689901|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
125290771|NCT00846040|450689902|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
125290772|NCT02725593|450689904|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
125290773|NCT02725593|450689905|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
125290774|NCT02725593|450689904|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
125290775|NCT02725593|450689905|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
125290776|NCT02725593|450689904|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
125290777|NCT02725593|450689905|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
125290778|NCT02725593|450689904|FG000|Long Term Extension|Withdrawal by Subject|1|||
125290779|NCT02725593|450689905|FG001|Long Term Extension|Withdrawal by Subject|3|||
125290780|NCT03959982|450691258|FG000|Overall Study|Withdrawal by Subject|1|||
125290781|NCT03959982|450691259|FG001|Overall Study|Withdrawal by Subject|0|||
125290782|NCT03959982|450691258|FG000|Overall Study|Physician Decision|2|||
125290783|NCT03959982|450691259|FG001|Overall Study|Physician Decision|0|||
125290784|NCT03959982|450691258|FG000|Overall Study|Lost to Follow-up|1|||
125290785|NCT03959982|450691259|FG001|Overall Study|Lost to Follow-up|0|||
125290786|NCT05275582|450691262|FG000|Overall Study|Lost to Follow-up|1|||
125290787|NCT05275582|450691263|FG001|Overall Study|Lost to Follow-up|0|||
125290788|NCT05275582|450691262|FG000|Overall Study|Withdrawal by Subject|0|||
125290789|NCT05275582|450691263|FG001|Overall Study|Withdrawal by Subject|2|||
125290790|NCT05275582|450691262|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
125290791|NCT05275582|450691263|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
125290792|NCT05275582|450691262|FG000|Overall Study|Death|1|||
125290793|NCT05275582|450691263|FG001|Overall Study|Death|0|||
125290794|NCT05275582|450691262|FG000|Overall Study|Protocol Violation|1|||
125290795|NCT05275582|450691263|FG001|Overall Study|Protocol Violation|0|||
125290796|NCT04411420|450691264|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
125290797|NCT04411420|450691265|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
125290798|NCT04411420|450691264|FG000|Survey Subset|Lost to Follow-up|134|||
125290799|NCT04411420|450691265|FG001|Survey Subset|Lost to Follow-up|120|||
125290800|NCT00524589|450691272|FG000|Overall Study|Withdrawal by Subject|2|||
125290801|NCT00524589|450691272|FG000|Overall Study|Disease Progression|16|||
125290802|NCT01030874|450691276|FG000|Overall Study|Withdrawal by Subject|1|||
125290803|NCT01030874|450691277|FG001|Overall Study|Withdrawal by Subject|0|||
125290804|NCT01030874|450691276|FG000|Overall Study|Discharged in first 2 weeks|17|||
125290805|NCT01030874|450691277|FG001|Overall Study|Discharged in first 2 weeks|16|||
125290806|NCT04639219|450691280|FG000|Overall Study|Withdrawal by Subject|8|||
125290807|NCT04639219|450691280|FG000|Overall Study|Lost to Follow-up|6|||
125290808|NCT04639219|450691280|FG000|Overall Study|Death|55|||
125290809|NCT01998893|450691283|FG000|Overall Study|Adverse Event|2|||
125290810|NCT01998893|450691283|FG000|Overall Study|Death|1|||
125290811|NCT01998893|450691283|FG000|Overall Study|Lost to Follow-up|8|||
125290812|NCT01998893|450691283|FG000|Overall Study|Physician Decision|2|||
125290813|NCT01998893|450691283|FG000|Overall Study|Protocol Violation|2|||
125290814|NCT01998893|450691283|FG000|Overall Study|Withdrawal by Subject|1|||
125290815|NCT01998893|450691283|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
125290816|NCT02046174|450691284|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
125290817|NCT02046174|450691285|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
125290818|NCT02118597|450691286|FG000|Overall Study|Sponsor terminated the study|14|||
125290819|NCT02118597|450691286|FG000|Overall Study|Serious Adverse Event|1|||
125290820|NCT02118597|450691286|FG000|Overall Study|Investigator's decision|1|||
125290821|NCT01891344|450691287|FG000|Overall Study|Ongoing|6|||
125290822|NCT01891344|450691288|FG001|Overall Study|Ongoing|2|||
125290823|NCT01891344|450691289|FG002|Overall Study|Ongoing|0|||
125290824|NCT01891344|450691290|FG003|Overall Study|Ongoing|1|||
125290825|NCT01891344|450691291|FG004|Overall Study|Ongoing|4|||
125290826|NCT01891344|450691292|FG005|Overall Study|Ongoing|1|||
125290827|NCT01891344|450691293|FG006|Overall Study|Ongoing|0|||
125290828|NCT01891344|450691294|FG007|Overall Study|Ongoing|0|||
125290829|NCT02969590|450691295|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
125290830|NCT02969590|450691296|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
125290831|NCT02969590|450691297|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
125290832|NCT03294135|450691298|FG000|Overall Study|Serious Adverse Event|1|||
125290833|NCT03294135|450691299|FG001|Overall Study|Serious Adverse Event|0|||
125290834|NCT03294135|450691300|FG002|Overall Study|Serious Adverse Event|0|||
125290835|NCT03294135|450691298|FG000|Overall Study|Lost to Follow-up|1|||
125290836|NCT03294135|450691299|FG001|Overall Study|Lost to Follow-up|0|||
125290837|NCT03294135|450691300|FG002|Overall Study|Lost to Follow-up|1|||
125290838|NCT03294135|450691298|FG000|Overall Study|Withdrawal by Subject|0|||
125290839|NCT03294135|450691299|FG001|Overall Study|Withdrawal by Subject|0|||
125290840|NCT03294135|450691300|FG002|Overall Study|Withdrawal by Subject|1|||
125290841|NCT03294135|450691298|FG000|Overall Study|Other|2|||
125290842|NCT03294135|450691299|FG001|Overall Study|Other|0|||
125290843|NCT03294135|450691300|FG002|Overall Study|Other|0|||
125290844|NCT00186537|450691301|FG000|Overall Study|Withdrawal by Subject|4|||
125290845|NCT00186537|450691302|FG001|Overall Study|Withdrawal by Subject|0|||
125290846|NCT00186537|450691303|FG002|Overall Study|Withdrawal by Subject|3|||
125290847|NCT00186537|450691301|FG000|Overall Study|ALT > 1.5 x ULN|3|||
125290848|NCT00186537|450691302|FG001|Overall Study|ALT > 1.5 x ULN|0|||
125290849|NCT00186537|450691303|FG002|Overall Study|ALT > 1.5 x ULN|0|||
125290850|NCT02590562|450691304|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
125290851|NCT02763254|450691305|FG000|Overall Study|Adverse Event|1|||
125290852|NCT03684304|450691306|FG000|Overall Study|Lost to Follow-up|19|||
125290853|NCT03684304|450691307|FG001|Overall Study|Lost to Follow-up|17|||
125290854|NCT00054691|450691308|FG000|Overall Study|Unmeasurable Disease|2|||
125290855|NCT00054691|450691308|FG000|Overall Study|Noncompliant|1|||
125290856|NCT03593681|450691311|FG000|Overall Study|Inadequate sample collected|12|||
125290857|NCT03593681|450691311|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
125290858|NCT03593681|450691311|FG000|Overall Study|Protocol Violation|3|||
125290859|NCT03593681|450691311|FG000|Overall Study|Withdrawal by Subject|3|||
125290860|NCT03593681|450691311|FG000|Overall Study|Procedure not attempted|3|||
125290861|NCT03593681|450691311|FG000|Overall Study|Adverse Event|2|||
125290862|NCT03593681|450691311|FG000|Overall Study|Physician Decision|1|||
125290863|NCT03987932|450691315|FG000|Overall Study|Lost to Follow-up|2|||
125290864|NCT03987932|450691316|FG001|Overall Study|Lost to Follow-up|1|||
125290865|NCT03987932|450691317|FG002|Overall Study|Lost to Follow-up|1|||
125290866|NCT03987932|450691315|FG000|Overall Study|Non-study related elective surgery|0|||
125290867|NCT03987932|450691316|FG001|Overall Study|Non-study related elective surgery|0|||
125290868|NCT03987932|450691317|FG002|Overall Study|Non-study related elective surgery|1|||
125290869|NCT02813668|450691320|FG000|Overall Study|Death|4|||
125290870|NCT02813668|450691320|FG000|Overall Study|Lost to Follow-up|509|||
125290871|NCT02813668|450691320|FG000|Overall Study|Withdrawal by Subject|148|||
125290872|NCT02813668|450691320|FG000|Overall Study|No longer at worksite|85|||
125290873|NCT02813668|450691320|FG000|Overall Study|Medical reasons not related to the study|4|||
125290874|NCT02961790|450691321|FG000|Overall Study|Canceled|4|||
125290875|NCT02961790|450691322|FG001|Overall Study|Canceled|5|||
125290876|NCT02961790|450691323|FG002|Overall Study|Canceled|1|||
125450397|NCT01579578|451276643|FG000|Overall Study|Ongoing|3|||
125290877|NCT02961790|450691324|FG003|Overall Study|Canceled|4|||
125290878|NCT02961790|450691321|FG000|Overall Study|without baseline data|4|||
125290879|NCT02961790|450691322|FG001|Overall Study|without baseline data|0|||
125290880|NCT02961790|450691323|FG002|Overall Study|without baseline data|1|||
125290881|NCT02961790|450691324|FG003|Overall Study|without baseline data|0|||
125290882|NCT02961790|450691321|FG000|Overall Study|without post baseline data|7|||
125290883|NCT02961790|450691322|FG001|Overall Study|without post baseline data|6|||
125290884|NCT02961790|450691323|FG002|Overall Study|without post baseline data|4|||
125290885|NCT02961790|450691324|FG003|Overall Study|without post baseline data|1|||
125290886|NCT02078102|450691329|FG000|Overall Study|Adverse Event|1|||
125290887|NCT02078102|450691330|FG001|Overall Study|Adverse Event|0|||
125290888|NCT02078102|450691329|FG000|Overall Study|Withdrawal by Subject|1|||
125290889|NCT02078102|450691330|FG001|Overall Study|Withdrawal by Subject|0|||
125290890|NCT02078102|450691329|FG000|Overall Study|Physician Decision|0|||
125290891|NCT02078102|450691330|FG001|Overall Study|Physician Decision|1|||
125290892|NCT00598078|450691333|FG000|Period 2 (Day 2)|Adverse Event|1|||
125290893|NCT00598078|450691334|FG001|Period 2 (Day 2)|Adverse Event|0|||
125290894|NCT02185014|450691335|FG000|Overall Study|Adverse Event|18|||
125290895|NCT02185014|450691335|FG000|Overall Study|Withdrew Consent|8|||
125290896|NCT02185014|450691335|FG000|Overall Study|Lost to Follow-up|4|||
125290897|NCT02185014|450691335|FG000|Overall Study|Lack of Efficacy|14|||
125290898|NCT02185014|450691335|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
125290899|NCT02185014|450691335|FG000|Overall Study|Subject Noncompliance|1|||
125290900|NCT02185014|450691335|FG000|Overall Study|Other|4|||
125290901|NCT02387164|450691338|FG000|Overall Study|Lost to Follow-up|2|||
125290902|NCT02387164|450691339|FG001|Overall Study|Lost to Follow-up|0|||
125290903|NCT02387164|450691338|FG000|Overall Study|Diagnosed|1|||
125290904|NCT02387164|450691339|FG001|Overall Study|Diagnosed|2|||
125290905|NCT02370641|450691340|FG000|Overall Study|dropped study|4|||
125290906|NCT02370641|450691341|FG001|Overall Study|dropped study|2|||
125290907|NCT02133664|450691342|FG000|Overall Study|Lost to Follow-up|2|||
125290908|NCT02133664|450691343|FG001|Overall Study|Lost to Follow-up|1|||
125290909|NCT02133664|450691342|FG000|Overall Study|Adverse Event|3|||
125290910|NCT02133664|450691343|FG001|Overall Study|Adverse Event|6|||
125290911|NCT02120365|450691350|FG000|Overall Study|Withdrawal by Subject|0|||
125290912|NCT02120365|450691351|FG001|Overall Study|Withdrawal by Subject|0|||
125290913|NCT02120365|450691352|FG002|Overall Study|Withdrawal by Subject|2|||
125290914|NCT02120365|450691353|FG003|Overall Study|Withdrawal by Subject|4|||
125290915|NCT02120365|450691354|FG004|Overall Study|Withdrawal by Subject|0|||
125290916|NCT02120365|450691355|FG005|Overall Study|Withdrawal by Subject|2|||
125290917|NCT01719003|450691358|FG000|Overall Study|Non compliant with protocol|1|||
125290918|NCT01719003|450691359|FG001|Overall Study|Non compliant with protocol|1|||
125290919|NCT01719003|450691360|FG002|Overall Study|Non compliant with protocol|0|||
125290920|NCT01719003|450691361|FG003|Overall Study|Non compliant with protocol|1|||
125290921|NCT01719003|450691362|FG004|Overall Study|Non compliant with protocol|2|||
125290922|NCT01719003|450691363|FG005|Overall Study|Non compliant with protocol|1|||
125290923|NCT01719003|450691364|FG006|Overall Study|Non compliant with protocol|2|||
125290924|NCT01719003|450691365|FG007|Overall Study|Non compliant with protocol|3|||
125290925|NCT01719003|450691366|FG008|Overall Study|Non compliant with protocol|0|||
125290926|NCT01719003|450691358|FG000|Overall Study|Adverse Event|6|||
125290927|NCT01719003|450691359|FG001|Overall Study|Adverse Event|5|||
125290928|NCT01719003|450691360|FG002|Overall Study|Adverse Event|4|||
125290929|NCT01719003|450691361|FG003|Overall Study|Adverse Event|3|||
125290930|NCT01719003|450691362|FG004|Overall Study|Adverse Event|4|||
125290931|NCT01719003|450691363|FG005|Overall Study|Adverse Event|3|||
125290932|NCT01719003|450691364|FG006|Overall Study|Adverse Event|6|||
125290933|NCT01719003|450691365|FG007|Overall Study|Adverse Event|5|||
125290934|NCT01719003|450691366|FG008|Overall Study|Adverse Event|0|||
125290935|NCT01719003|450691358|FG000|Overall Study|Lost to Follow-up|0|||
125290936|NCT01719003|450691359|FG001|Overall Study|Lost to Follow-up|6|||
125290937|NCT01719003|450691360|FG002|Overall Study|Lost to Follow-up|7|||
125290938|NCT01719003|450691361|FG003|Overall Study|Lost to Follow-up|2|||
125290939|NCT01719003|450691362|FG004|Overall Study|Lost to Follow-up|3|||
125290940|NCT01719003|450691363|FG005|Overall Study|Lost to Follow-up|4|||
125290941|NCT01719003|450691364|FG006|Overall Study|Lost to Follow-up|3|||
125290942|NCT01719003|450691365|FG007|Overall Study|Lost to Follow-up|2|||
125290943|NCT01719003|450691366|FG008|Overall Study|Lost to Follow-up|2|||
125290944|NCT01719003|450691358|FG000|Overall Study|Refusal to continue, not due to AE|2|||
125290945|NCT01719003|450691359|FG001|Overall Study|Refusal to continue, not due to AE|5|||
125290946|NCT01719003|450691360|FG002|Overall Study|Refusal to continue, not due to AE|4|||
125290947|NCT01719003|450691361|FG003|Overall Study|Refusal to continue, not due to AE|4|||
125290948|NCT01719003|450691362|FG004|Overall Study|Refusal to continue, not due to AE|4|||
125290949|NCT01719003|450691363|FG005|Overall Study|Refusal to continue, not due to AE|3|||
125290950|NCT01719003|450691364|FG006|Overall Study|Refusal to continue, not due to AE|8|||
125290951|NCT01719003|450691365|FG007|Overall Study|Refusal to continue, not due to AE|7|||
125290952|NCT01719003|450691366|FG008|Overall Study|Refusal to continue, not due to AE|1|||
125450398|NCT01579578|451276644|FG001|Overall Study|Ongoing|0|||
125450399|NCT01528709|451276645|FG000|Overall Study|Death|2|||
125290953|NCT01719003|450691358|FG000|Overall Study|Reason other than those specified|0|||
125290954|NCT01719003|450691359|FG001|Overall Study|Reason other than those specified|0|||
125290955|NCT01719003|450691360|FG002|Overall Study|Reason other than those specified|2|||
125450400|NCT01528709|451276646|FG001|Overall Study|Death|0|||
125450401|NCT01528709|451276645|FG000|Overall Study|Withdrawal by Subject|10|||
125290956|NCT01719003|450691361|FG003|Overall Study|Reason other than those specified|3|||
125290957|NCT01719003|450691362|FG004|Overall Study|Reason other than those specified|4|||
125290958|NCT01719003|450691363|FG005|Overall Study|Reason other than those specified|1|||
125290959|NCT01719003|450691364|FG006|Overall Study|Reason other than those specified|0|||
125290960|NCT01719003|450691365|FG007|Overall Study|Reason other than those specified|3|||
125290961|NCT01719003|450691366|FG008|Overall Study|Reason other than those specified|1|||
125290962|NCT01719003|450691358|FG000|Overall Study|Lack of Efficacy|0|||
125290963|NCT01719003|450691359|FG001|Overall Study|Lack of Efficacy|0|||
125290964|NCT01719003|450691360|FG002|Overall Study|Lack of Efficacy|0|||
125290965|NCT01719003|450691361|FG003|Overall Study|Lack of Efficacy|0|||
125290966|NCT01719003|450691362|FG004|Overall Study|Lack of Efficacy|0|||
125290967|NCT01719003|450691363|FG005|Overall Study|Lack of Efficacy|0|||
125290968|NCT01719003|450691364|FG006|Overall Study|Lack of Efficacy|1|||
125290969|NCT01719003|450691365|FG007|Overall Study|Lack of Efficacy|0|||
125290970|NCT01719003|450691366|FG008|Overall Study|Lack of Efficacy|0|||
125290971|NCT00581828|450691367|FG000|Overall Study|Protocol Violation|1|||
125290972|NCT01406015|450691373|FG000|Overall Study|Withdrawal by Subject|3|||
125290973|NCT01406015|450691374|FG001|Overall Study|Withdrawal by Subject|3|||
125290974|NCT00394901|450691375|FG000|Baseline Phase|Protocol Violation|0|||
125290975|NCT00394901|450691376|FG001|Baseline Phase|Protocol Violation|0|||
125290976|NCT00394901|450691377|FG002|Baseline Phase|Protocol Violation|1|||
125290977|NCT00394901|450691378|FG003|Baseline Phase|Protocol Violation|0|||
125290978|NCT00394901|450691375|FG000|Double-blind Phase|Adverse Event|5|||
125290979|NCT00394901|450691376|FG001|Double-blind Phase|Adverse Event|7|||
125290980|NCT00394901|450691377|FG002|Double-blind Phase|Adverse Event|16|||
125290981|NCT00394901|450691378|FG003|Double-blind Phase|Adverse Event|20|||
125290982|NCT00394901|450691375|FG000|Double-blind Phase|Lack of Efficacy|6|||
125290983|NCT00394901|450691376|FG001|Double-blind Phase|Lack of Efficacy|4|||
125450402|NCT01528709|451276646|FG001|Overall Study|Withdrawal by Subject|15|||
125450403|NCT01528709|451276645|FG000|Overall Study|allergy|1|||
125450404|NCT01528709|451276646|FG001|Overall Study|allergy|0|||
125450405|NCT01813422|451276657|FG000|Overall Study|Withdrawal by Subject|14|||
125450406|NCT01813422|451276658|FG001|Overall Study|Withdrawal by Subject|8|||
125450407|NCT01813422|451276657|FG000|Overall Study|Death|2|||
125450408|NCT01813422|451276658|FG001|Overall Study|Death|3|||
125450409|NCT01813422|451276657|FG000|Overall Study|Sponsor Decision|2|||
125450410|NCT01813422|451276658|FG001|Overall Study|Sponsor Decision|1|||
125450411|NCT01813422|451276657|FG000|Overall Study|Lost to Follow-up|2|||
125450412|NCT01813422|451276658|FG001|Overall Study|Lost to Follow-up|4|||
125450413|NCT01653743|451276659|FG000|Overall Study|Withdrawal by Subject|1|||
125450414|NCT01653743|451276660|FG001|Overall Study|Withdrawal by Subject|0|||
125450415|NCT01653743|451276659|FG000|Overall Study|Investigator discretion|3|||
125450416|NCT01653743|451276660|FG001|Overall Study|Investigator discretion|0|||
125450417|NCT04889118|451276662|FG000|Overall Study|Death|33|||
125450418|NCT04889118|451276663|FG001|Overall Study|Death|37|||
125450419|NCT04889118|451276662|FG000|Overall Study|Ongoing in Study|31|||
125450420|NCT04889118|451276663|FG001|Overall Study|Ongoing in Study|30|||
125450421|NCT02397889|451276664|FG000|Overall Study|Physician Decision|1|||
125450422|NCT02397889|451276665|FG001|Overall Study|Physician Decision|0|||
125450423|NCT01928940|451276667|FG000|Overall Study|Adverse Event|0|||
125450424|NCT01928940|451276668|FG001|Overall Study|Adverse Event|1|||
125450425|NCT01352507|451276671|FG000|Treatment Period 1|Adverse Event|3|||
125450426|NCT01352507|451276672|FG001|Treatment Period 1|Adverse Event|0|||
125450427|NCT01352507|451276671|FG000|Treatment Period 1|Lost to Follow-up|3|||
125450428|NCT01352507|451276672|FG001|Treatment Period 1|Lost to Follow-up|4|||
125450429|NCT01352507|451276671|FG000|Treatment Period 1|Withdrawal by Subject|7|||
125450430|NCT01352507|451276672|FG001|Treatment Period 1|Withdrawal by Subject|5|||
125450431|NCT01352507|451276671|FG000|Treatment Period 1|Physician Decision|1|||
125450432|NCT01352507|451276672|FG001|Treatment Period 1|Physician Decision|0|||
125450433|NCT01352507|451276671|FG000|Washout Period|Withdrawal by Subject|0|||
125450434|NCT01352507|451276672|FG001|Washout Period|Withdrawal by Subject|1|||
125450435|NCT01352507|451276671|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
125450436|NCT01352507|451276672|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
125290984|NCT00394901|450691377|FG002|Double-blind Phase|Lack of Efficacy|1|||
125290985|NCT00394901|450691378|FG003|Double-blind Phase|Lack of Efficacy|3|||
125290986|NCT00394901|450691375|FG000|Double-blind Phase|Withdrawal by Subject|2|||
125290987|NCT00394901|450691376|FG001|Double-blind Phase|Withdrawal by Subject|0|||
125290988|NCT00394901|450691377|FG002|Double-blind Phase|Withdrawal by Subject|0|||
125290989|NCT00394901|450691378|FG003|Double-blind Phase|Withdrawal by Subject|0|||
125290990|NCT00394901|450691375|FG000|Double-blind Phase|Lost to Follow-up|0|||
125290991|NCT00394901|450691376|FG001|Double-blind Phase|Lost to Follow-up|0|||
125290992|NCT00394901|450691377|FG002|Double-blind Phase|Lost to Follow-up|0|||
125290993|NCT00394901|450691378|FG003|Double-blind Phase|Lost to Follow-up|1|||
125290994|NCT00394901|450691375|FG000|Double-blind Phase|Protocol Violation|0|||
125290995|NCT00394901|450691376|FG001|Double-blind Phase|Protocol Violation|0|||
125290996|NCT00394901|450691377|FG002|Double-blind Phase|Protocol Violation|0|||
125290997|NCT00394901|450691378|FG003|Double-blind Phase|Protocol Violation|1|||
125290998|NCT00394901|450691375|FG000|Double-blind Phase|Death|1|||
125450437|NCT01352507|451276671|FG000|Treatment Period 2|Withdrawal by Subject|4|||
125450438|NCT01352507|451276672|FG001|Treatment Period 2|Withdrawal by Subject|3|||
125450439|NCT01352507|451276671|FG000|Treatment Period 2|Lack of Efficacy|1|||
125450440|NCT01352507|451276672|FG001|Treatment Period 2|Lack of Efficacy|0|||
125290999|NCT00394901|450691376|FG001|Double-blind Phase|Death|0|||
125291000|NCT00394901|450691377|FG002|Double-blind Phase|Death|0|||
125291001|NCT00394901|450691378|FG003|Double-blind Phase|Death|0|||
125291002|NCT00394901|450691375|FG000|Double-blind Phase|Subject's Personal Reason|1|||
125291003|NCT00394901|450691376|FG001|Double-blind Phase|Subject's Personal Reason|0|||
125291004|NCT00394901|450691377|FG002|Double-blind Phase|Subject's Personal Reason|0|||
125291005|NCT00394901|450691378|FG003|Double-blind Phase|Subject's Personal Reason|1|||
125291006|NCT00394901|450691375|FG000|Double-blind Phase|Lack of Compliance|0|||
125291007|NCT00394901|450691376|FG001|Double-blind Phase|Lack of Compliance|3|||
125291008|NCT00394901|450691377|FG002|Double-blind Phase|Lack of Compliance|0|||
125291009|NCT00394901|450691378|FG003|Double-blind Phase|Lack of Compliance|0|||
125291010|NCT00394901|450691375|FG000|Double-blind Phase|Entry into another study was found|0|||
125291011|NCT00394901|450691376|FG001|Double-blind Phase|Entry into another study was found|0|||
125291012|NCT00394901|450691377|FG002|Double-blind Phase|Entry into another study was found|1|||
125291013|NCT00394901|450691378|FG003|Double-blind Phase|Entry into another study was found|0|||
125291014|NCT00394901|450691375|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
125291015|NCT00394901|450691376|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
125291016|NCT00394901|450691377|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
125291017|NCT00394901|450691378|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
125291018|NCT01886690|450691379|FG000|Overall Study|Protocol Violation|0|||
125291019|NCT01886690|450691380|FG001|Overall Study|Protocol Violation|1|||
125291020|NCT01886690|450691379|FG000|Overall Study|Personal Reasons|0|||
125291021|NCT01886690|450691380|FG001|Overall Study|Personal Reasons|1|||
125291022|NCT02360293|450691381|FG000|Overall Study|Lost to Follow-up|73|||
125291023|NCT02360293|450691382|FG001|Overall Study|Lost to Follow-up|95|||
125291024|NCT02360293|450691381|FG000|Overall Study|Withdrawal by Subject|2|||
125291025|NCT02360293|450691382|FG001|Overall Study|Withdrawal by Subject|1|||
125291026|NCT02360293|450691381|FG000|Overall Study|Excluded|1|||
125291027|NCT02360293|450691382|FG001|Overall Study|Excluded|0|||
125450441|NCT01511250|451276673|FG000|Overall Study|Withdrawal of Consent|1|||
125450442|NCT01511250|451276674|FG001|Overall Study|Withdrawal of Consent|0|||
125450443|NCT01511250|451276675|FG002|Overall Study|Withdrawal of Consent|0|||
125450444|NCT01511250|451276676|FG003|Overall Study|Withdrawal of Consent|0|||
125450445|NCT01511250|451276677|FG004|Overall Study|Withdrawal of Consent|0|||
125450446|NCT01511250|451276678|FG005|Overall Study|Withdrawal of Consent|0|||
125450447|NCT01511250|451276679|FG006|Overall Study|Withdrawal of Consent|0|||
125450448|NCT01511250|451276680|FG007|Overall Study|Withdrawal of Consent|1|||
125450449|NCT01511250|451276681|FG008|Overall Study|Withdrawal of Consent|1|||
125450450|NCT01511250|451276682|FG009|Overall Study|Withdrawal of Consent|0|||
125450451|NCT01511250|451276673|FG000|Overall Study|Sponsor/Investigator Decision|1|||
125450452|NCT01511250|451276674|FG001|Overall Study|Sponsor/Investigator Decision|0|||
125450453|NCT01511250|451276675|FG002|Overall Study|Sponsor/Investigator Decision|0|||
125450454|NCT01511250|451276676|FG003|Overall Study|Sponsor/Investigator Decision|0|||
125450455|NCT01511250|451276677|FG004|Overall Study|Sponsor/Investigator Decision|0|||
125450456|NCT01511250|451276678|FG005|Overall Study|Sponsor/Investigator Decision|0|||
125450457|NCT01511250|451276679|FG006|Overall Study|Sponsor/Investigator Decision|0|||
125450458|NCT01511250|451276680|FG007|Overall Study|Sponsor/Investigator Decision|0|||
125450459|NCT01511250|451276681|FG008|Overall Study|Sponsor/Investigator Decision|0|||
125450460|NCT01511250|451276682|FG009|Overall Study|Sponsor/Investigator Decision|0|||
125450461|NCT01511250|451276673|FG000|Overall Study|Lost to Follow-up|7|||
125450462|NCT01511250|451276674|FG001|Overall Study|Lost to Follow-up|3|||
125450463|NCT01511250|451276675|FG002|Overall Study|Lost to Follow-up|3|||
125450464|NCT01511250|451276676|FG003|Overall Study|Lost to Follow-up|3|||
125450465|NCT01511250|451276677|FG004|Overall Study|Lost to Follow-up|0|||
125450466|NCT01511250|451276678|FG005|Overall Study|Lost to Follow-up|0|||
125450467|NCT01511250|451276679|FG006|Overall Study|Lost to Follow-up|2|||
125450468|NCT01511250|451276680|FG007|Overall Study|Lost to Follow-up|3|||
125450469|NCT01511250|451276681|FG008|Overall Study|Lost to Follow-up|13|||
125450470|NCT01511250|451276682|FG009|Overall Study|Lost to Follow-up|5|||
125419469|NCT02834780|451160289|FG007|Overall Study|Adverse Event|1|||
125419470|NCT02834780|451160290|FG008|Overall Study|Adverse Event|0|||
125419471|NCT02834780|451160291|FG009|Overall Study|Adverse Event|2|||
125419472|NCT02834780|451160292|FG010|Overall Study|Adverse Event|0|||
125419473|NCT02834780|451160293|FG011|Overall Study|Adverse Event|3|||
125419474|NCT02834780|451160294|FG012|Overall Study|Adverse Event|2|||
125419475|NCT02834780|451160282|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
125419476|NCT02834780|451160283|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
125419477|NCT02834780|451160284|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
125419478|NCT02834780|451160285|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
125291028|NCT04316741|450691383|FG000|Baseline Enrollment|Lost to Follow-up|1|||
125291029|NCT04316741|450691384|FG001|Baseline Enrollment|Lost to Follow-up|1|||
125450471|NCT01511250|451276673|FG000|Overall Study|Protocol Violation|0|||
125450472|NCT01511250|451276674|FG001|Overall Study|Protocol Violation|2|||
125450473|NCT01511250|451276675|FG002|Overall Study|Protocol Violation|1|||
125450474|NCT01511250|451276676|FG003|Overall Study|Protocol Violation|0|||
125450475|NCT01511250|451276677|FG004|Overall Study|Protocol Violation|0|||
125450476|NCT01511250|451276678|FG005|Overall Study|Protocol Violation|0|||
125450477|NCT01511250|451276679|FG006|Overall Study|Protocol Violation|0|||
125450478|NCT01511250|451276680|FG007|Overall Study|Protocol Violation|0|||
125450479|NCT01511250|451276681|FG008|Overall Study|Protocol Violation|0|||
125291030|NCT04316741|450691383|FG000|Immediate Post-Test|Lost to Follow-up|5|||
125291031|NCT04316741|450691384|FG001|Immediate Post-Test|Lost to Follow-up|1|||
125291032|NCT04316741|450691383|FG000|1-month Post-test|Lost to Follow-up|7|||
125291033|NCT04316741|450691384|FG001|1-month Post-test|Lost to Follow-up|2|||
125291034|NCT04316741|450691383|FG000|3-month Follow-up|Lost to Follow-up|10|||
125291035|NCT04316741|450691384|FG001|3-month Follow-up|Lost to Follow-up|2|||
125291036|NCT01510145|450691385|FG000|Overall Study|Adverse Event|6|||
125291037|NCT01510145|450691385|FG000|Overall Study|Lost to Follow-up|5|||
125291038|NCT01510145|450691385|FG000|Overall Study|Withdrawal by Subject|6|||
125291039|NCT01510145|450691385|FG000|Overall Study|Relative reported subject withdrew|1|||
125291040|NCT02312219|450691386|FG000|Overall Study|Withdrawal by Subject|1|||
125291041|NCT02312219|450691387|FG001|Overall Study|Withdrawal by Subject|2|||
125291042|NCT02312219|450691386|FG000|Overall Study|could not schedule imaging in time|0|||
125291043|NCT02312219|450691387|FG001|Overall Study|could not schedule imaging in time|2|||
125291044|NCT02312219|450691386|FG000|Overall Study|Other|0|||
125291045|NCT02312219|450691387|FG001|Overall Study|Other|1|||
125291046|NCT02312219|450691386|FG000|Overall Study|Not randomized. Ineligible|0|||
125291047|NCT02312219|450691387|FG001|Overall Study|Not randomized. Ineligible|1|||
125291048|NCT01827332|450691389|FG000|Overall Study|Lost to Follow-up|2|||
125291049|NCT01827332|450691390|FG001|Overall Study|Lost to Follow-up|1|||
125291050|NCT00546260|450691391|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
125291051|NCT00546260|450691392|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
125291052|NCT03654885|450693209|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
125291053|NCT03654885|450693210|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
125291054|NCT03654885|450693209|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
125291055|NCT03654885|450693210|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
125291056|NCT03654885|450693209|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
125291057|NCT03654885|450693210|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
125291058|NCT03654885|450693209|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
125291059|NCT03654885|450693210|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
125291060|NCT03654885|450693209|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
125291061|NCT03654885|450693210|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
125291062|NCT03654885|450693209|FG000|Overall Study|Adverse Event in Study Eye|3|||
125291063|NCT03654885|450693210|FG001|Overall Study|Adverse Event in Study Eye|0|||
125291064|NCT03654885|450693209|FG000|Overall Study|Consent Withdrawn|1|||
125291065|NCT03654885|450693210|FG001|Overall Study|Consent Withdrawn|0|||
125291066|NCT03654885|450693209|FG000|Overall Study|Death|3|||
125291067|NCT03654885|450693210|FG001|Overall Study|Death|1|||
125291068|NCT03654885|450693209|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
125291069|NCT03654885|450693210|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
125291070|NCT03654885|450693209|FG000|Overall Study|Lost to Follow-up|3|||
125291071|NCT03654885|450693210|FG001|Overall Study|Lost to Follow-up|3|||
125291072|NCT00289198|450693229|FG000|Overall Study|Adverse Event|0|||
125291073|NCT00289198|450693230|FG001|Overall Study|Adverse Event|2|||
125291074|NCT00289198|450693229|FG000|Overall Study|Protocol Violation|2|||
125291075|NCT00289198|450693230|FG001|Overall Study|Protocol Violation|1|||
125291076|NCT00289198|450693229|FG000|Overall Study|Withdrawal by Subject|4|||
125291077|NCT00289198|450693230|FG001|Overall Study|Withdrawal by Subject|1|||
125291078|NCT00289198|450693229|FG000|Overall Study|Lack of Efficacy|2|||
125291079|NCT00289198|450693230|FG001|Overall Study|Lack of Efficacy|0|||
125291080|NCT00289198|450693229|FG000|Overall Study|Other: Low compliance|0|||
125291081|NCT00289198|450693230|FG001|Overall Study|Other: Low compliance|1|||
125291082|NCT00289198|450693229|FG000|Overall Study|Other: Physician's decision|0|||
125291083|NCT00289198|450693230|FG001|Overall Study|Other: Physician's decision|1|||
125291084|NCT00289198|450693229|FG000|Overall Study|Other: Unable to attend on schedule|2|||
125291085|NCT00289198|450693230|FG001|Overall Study|Other: Unable to attend on schedule|1|||
125291086|NCT00289198|450693229|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
125291087|NCT00289198|450693230|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
125291088|NCT00289198|450693229|FG000|Overall Study|Other: Impossible to come on visit|0|||
125291089|NCT00289198|450693230|FG001|Overall Study|Other: Impossible to come on visit|1|||
125291090|NCT01176565|450693231|FG000|Overall Study|Lost to Follow-up|12|||
125291091|NCT01176565|450693232|FG001|Overall Study|Lost to Follow-up|16|||
125291092|NCT01176565|450693231|FG000|Overall Study|Withdrawal by Subject|7|||
125291093|NCT01176565|450693232|FG001|Overall Study|Withdrawal by Subject|1|||
125291094|NCT01176565|450693231|FG000|Overall Study|Not Analyzed (any other reason)|1|||
125291095|NCT01176565|450693232|FG001|Overall Study|Not Analyzed (any other reason)|2|||
125450480|NCT01511250|451276682|FG009|Overall Study|Protocol Violation|0|||
125450481|NCT05487703|451276686|FG000|Overall Study|Other|19|||
125291096|NCT01062061|450693235|FG000|Overall Study|Enrolled more than once|2|||
125291097|NCT01062061|450693235|FG000|Overall Study|Investigated before study start|13|||
125291098|NCT01062061|450693235|FG000|Overall Study|Outside chief indications|10|||
125291099|NCT01062061|450693235|FG000|Overall Study|Failed to meet inclusion criteria|2|||
125291100|NCT01143051|450693242|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
125291101|NCT01143051|450693243|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
125291102|NCT01143051|450693244|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
125291103|NCT01143051|450693245|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
125291104|NCT01143051|450693246|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
125291105|NCT01143051|450693247|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
125291106|NCT01143051|450693242|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
125291107|NCT01143051|450693243|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
125291108|NCT01143051|450693244|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
125291109|NCT01143051|450693245|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
125291110|NCT01143051|450693246|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
125291111|NCT01143051|450693247|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
125291112|NCT01605227|450693248|FG000|Overall Study|Did not receive study treatment|2|||
125291113|NCT01605227|450693249|FG001|Overall Study|Did not receive study treatment|3|||
125291114|NCT01605227|450693248|FG000|Overall Study|Adverse Event|228|||
125291115|NCT01605227|450693249|FG001|Overall Study|Adverse Event|42|||
125291116|NCT01605227|450693248|FG000|Overall Study|Progressive Disease|132|||
125291117|NCT01605227|450693249|FG001|Overall Study|Progressive Disease|128|||
125291118|NCT01605227|450693248|FG000|Overall Study|Clinical Deterioration|227|||
125291119|NCT01605227|450693249|FG001|Overall Study|Clinical Deterioration|133|||
125291120|NCT01605227|450693248|FG000|Overall Study|Lost to Follow-up|1|||
125291121|NCT01605227|450693249|FG001|Overall Study|Lost to Follow-up|0|||
125291122|NCT01605227|450693248|FG000|Overall Study|Protocol Violation|1|||
125291123|NCT01605227|450693249|FG001|Overall Study|Protocol Violation|0|||
125291124|NCT01605227|450693248|FG000|Overall Study|Physician Decision|9|||
125291125|NCT01605227|450693249|FG001|Overall Study|Physician Decision|7|||
125291126|NCT01605227|450693248|FG000|Overall Study|Withdrawal by Subject|18|||
125291127|NCT01605227|450693249|FG001|Overall Study|Withdrawal by Subject|14|||
125291128|NCT01605227|450693248|FG000|Overall Study|Sponsor Decision|2|||
125291129|NCT01605227|450693249|FG001|Overall Study|Sponsor Decision|0|||
125291130|NCT01605227|450693248|FG000|Overall Study|Started New Therapy|1|||
125291131|NCT01605227|450693249|FG001|Overall Study|Started New Therapy|0|||
125291132|NCT01605227|450693248|FG000|Overall Study|Subject Decision|0|||
125291133|NCT01605227|450693249|FG001|Overall Study|Subject Decision|1|||
125291134|NCT01605227|450693248|FG000|Overall Study|Dose Held >6 weeks|0|||
125291135|NCT01605227|450693249|FG001|Overall Study|Dose Held >6 weeks|1|||
125291136|NCT03093974|450693252|FG000|Overall Study|Withdrawal by Subject|32|||
125291137|NCT03093974|450693253|FG001|Overall Study|Withdrawal by Subject|27|||
125291138|NCT03093974|450693252|FG000|Overall Study|Adverse Event|17|||
125291139|NCT03093974|450693253|FG001|Overall Study|Adverse Event|24|||
125291140|NCT03093974|450693252|FG000|Overall Study|Death|0|||
125291141|NCT03093974|450693253|FG001|Overall Study|Death|1|||
125291142|NCT03093974|450693252|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125291143|NCT03093974|450693253|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125291144|NCT03093974|450693252|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
125291145|NCT03093974|450693253|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
125291146|NCT03093974|450693252|FG000|Overall Study|Lost to Follow-up|0|||
125291147|NCT03093974|450693253|FG001|Overall Study|Lost to Follow-up|1|||
125291148|NCT03093974|450693252|FG000|Overall Study|Other|1|||
125291149|NCT03093974|450693253|FG001|Overall Study|Other|2|||
125291150|NCT01866423|450693255|FG000|Overall Study|Lack of Efficacy|3|||
125291151|NCT01866423|450693255|FG000|Overall Study|Sponsor Decision|1|||
125291152|NCT01813721|450693256|FG000|Overall Study|Ineligibility determined|63|||
125291153|NCT01813721|450693256|FG000|Overall Study|Withdrawal by Subject|1|||
125291154|NCT00810901|450693257|FG000|Overall Study|Lost to Follow-up|88|||
125291155|NCT00810901|450693258|FG001|Overall Study|Lost to Follow-up|58|||
125291156|NCT01133275|450693259|FG000|Overall Study|Withdrawal by Subject|1|||
125291157|NCT01133275|450693259|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
125291158|NCT00900146|450693260|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
125450482|NCT05487703|451276686|FG000|Overall Study|Participant not well|5|||
125450483|NCT05487703|451276686|FG000|Overall Study|Insurance Reasons|6|||
125291159|NCT00900146|450693261|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
125291160|NCT00900146|450693262|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
125291161|NCT00900146|450693263|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
125291162|NCT00900146|450693264|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
125291163|NCT00900146|450693260|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
125291164|NCT00900146|450693261|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
125291165|NCT00900146|450693262|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
125291166|NCT00900146|450693263|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
125291167|NCT00900146|450693264|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
125291168|NCT00900146|450693260|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
125291169|NCT00900146|450693261|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
125291170|NCT00900146|450693262|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
125291171|NCT00900146|450693263|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
125291172|NCT00900146|450693264|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
125291173|NCT00900146|450693260|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
125291174|NCT00900146|450693261|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
125291175|NCT00900146|450693262|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
125291176|NCT00900146|450693263|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
125291177|NCT00900146|450693264|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
125291178|NCT00900146|450693260|FG000|Intermediate: Period III|Lost to Follow-up|2|||
125291179|NCT00900146|450693261|FG001|Intermediate: Period III|Lost to Follow-up|0|||
125291180|NCT00900146|450693262|FG002|Intermediate: Period III|Lost to Follow-up|0|||
125291181|NCT00900146|450693263|FG003|Intermediate: Period III|Lost to Follow-up|0|||
125291182|NCT00900146|450693264|FG004|Intermediate: Period III|Lost to Follow-up|1|||
125291183|NCT00900146|450693260|FG000|Intermediate: Period III|Administrative problems|85|||
125291184|NCT00900146|450693261|FG001|Intermediate: Period III|Administrative problems|92|||
125291185|NCT00900146|450693262|FG002|Intermediate: Period III|Administrative problems|84|||
125291186|NCT00900146|450693263|FG003|Intermediate: Period III|Administrative problems|90|||
125291187|NCT00900146|450693264|FG004|Intermediate: Period III|Administrative problems|163|||
125291188|NCT00700102|450693265|FG000|Overall Study|Died|394|||
125291189|NCT00700102|450693266|FG001|Overall Study|Died|385|||
125291190|NCT00700102|450693265|FG000|Overall Study|Lost to Follow-up|8|||
125291191|NCT00700102|450693266|FG001|Overall Study|Lost to Follow-up|10|||
125291192|NCT02525939|450693271|FG000|Overall Study|Lost to Follow-up|27|||
125291193|NCT02525939|450693272|FG001|Overall Study|Lost to Follow-up|24|||
125291194|NCT02525939|450693271|FG000|Overall Study|Physician Decision|0|||
125291195|NCT02525939|450693272|FG001|Overall Study|Physician Decision|1|||
125291196|NCT02525939|450693271|FG000|Overall Study|Withdrawal by Subject|24|||
125291197|NCT02525939|450693272|FG001|Overall Study|Withdrawal by Subject|39|||
125291198|NCT02525939|450693271|FG000|Overall Study|Death|180|||
125291199|NCT02525939|450693272|FG001|Overall Study|Death|179|||
125291200|NCT01028716|450693273|FG000|Overall Study|Physician Decision|1|||
125291201|NCT05590000|450693274|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
125291202|NCT00536874|450693275|FG000|Overall Study|Adverse Event|1|||
125291203|NCT00536874|450693275|FG000|Overall Study|Death|2|||
125291204|NCT00536874|450693275|FG000|Overall Study|Withdrawal by Subject|1|||
125291205|NCT00762996|450693276|FG000|Period One|Protocol Violation|0|||
125291206|NCT00762996|450693277|FG001|Period One|Protocol Violation|0|||
125291207|NCT00762996|450693278|FG002|Period One|Protocol Violation|1|||
125291208|NCT00762996|450693279|FG003|Period One|Protocol Violation|0|||
125291209|NCT00762996|450693276|FG000|Period One|ineligible|0|||
125291210|NCT00762996|450693277|FG001|Period One|ineligible|0|||
125291211|NCT00762996|450693278|FG002|Period One|ineligible|1|||
125291212|NCT00762996|450693279|FG003|Period One|ineligible|1|||
125291213|NCT00762996|450693276|FG000|Period One|Adverse Event|0|||
125291214|NCT00762996|450693277|FG001|Period One|Adverse Event|0|||
125291215|NCT00762996|450693278|FG002|Period One|Adverse Event|1|||
125291216|NCT00762996|450693279|FG003|Period One|Adverse Event|0|||
125291217|NCT00762996|450693276|FG000|Period One|Withdrawal by Subject|0|||
125291218|NCT00762996|450693277|FG001|Period One|Withdrawal by Subject|0|||
125291219|NCT00762996|450693278|FG002|Period One|Withdrawal by Subject|1|||
125291220|NCT00762996|450693279|FG003|Period One|Withdrawal by Subject|0|||
125291221|NCT02689076|450693281|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
125291222|NCT02689076|450693282|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
125291223|NCT02689076|450693283|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
125291224|NCT02689076|450693281|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
125291225|NCT02689076|450693282|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
125291226|NCT02689076|450693283|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
125291227|NCT02689076|450693281|FG000|Overall Study|Did not have an HIE match|2|||
125291228|NCT02689076|450693282|FG001|Overall Study|Did not have an HIE match|0|||
125291229|NCT02689076|450693283|FG002|Overall Study|Did not have an HIE match|0|||
125291230|NCT02689076|450693281|FG000|Overall Study|Death during non-VA encounter|2|||
125291231|NCT02689076|450693282|FG001|Overall Study|Death during non-VA encounter|5|||
125291232|NCT02689076|450693283|FG002|Overall Study|Death during non-VA encounter|0|||
125291233|NCT02689076|450693281|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
125419479|NCT02834780|451160286|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
125419480|NCT02834780|451160287|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
125419481|NCT02834780|451160288|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
125419482|NCT02834780|451160289|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
125419483|NCT02834780|451160290|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
125419484|NCT02834780|451160291|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
125291234|NCT02689076|450693282|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
125291235|NCT02689076|450693283|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
125291236|NCT02689076|450693281|FG000|Overall Study|Participant no longer active in VA system|1|||
125291237|NCT02689076|450693282|FG001|Overall Study|Participant no longer active in VA system|0|||
125291238|NCT02689076|450693283|FG002|Overall Study|Participant no longer active in VA system|0|||
125291239|NCT02689076|450693281|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
125291240|NCT02689076|450693282|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
125291241|NCT02689076|450693283|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
125291242|NCT01143896|450693285|FG000|Overall Study|Did not complete Baseline Interview|5|||
125291243|NCT01143896|450693286|FG001|Overall Study|Did not complete Baseline Interview|4|||
125291244|NCT01143896|450693285|FG000|Overall Study|Lost to Follow-up|18|||
125291245|NCT01143896|450693286|FG001|Overall Study|Lost to Follow-up|13|||
125291246|NCT01143896|450693285|FG000|Overall Study|Withdrawal by Subject|13|||
125291247|NCT01143896|450693286|FG001|Overall Study|Withdrawal by Subject|5|||
125291248|NCT01143896|450693285|FG000|Overall Study|Death|6|||
125291249|NCT01143896|450693286|FG001|Overall Study|Death|3|||
125291250|NCT02084238|450693287|FG000|Overall Study|Lost to Follow-up|2|||
125291251|NCT00320372|450693288|FG000|Overall Study|Physician Decision|4|||
125291252|NCT00320372|450693289|FG001|Overall Study|Physician Decision|7|||
125419485|NCT02834780|451160292|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
125419486|NCT02834780|451160293|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
125419487|NCT02834780|451160294|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
125419488|NCT02834780|451160282|FG000|Overall Study|Other|1|||
125419489|NCT02834780|451160283|FG001|Overall Study|Other|0|||
125419490|NCT02834780|451160284|FG002|Overall Study|Other|1|||
125419491|NCT02834780|451160285|FG003|Overall Study|Other|2|||
125419492|NCT02834780|451160286|FG004|Overall Study|Other|0|||
125419493|NCT02834780|451160287|FG005|Overall Study|Other|0|||
125419494|NCT02834780|451160288|FG006|Overall Study|Other|0|||
125419495|NCT02834780|451160289|FG007|Overall Study|Other|0|||
125419496|NCT02834780|451160290|FG008|Overall Study|Other|0|||
125419497|NCT02834780|451160291|FG009|Overall Study|Other|0|||
125419498|NCT02834780|451160292|FG010|Overall Study|Other|0|||
125419499|NCT02834780|451160293|FG011|Overall Study|Other|0|||
125419500|NCT02834780|451160294|FG012|Overall Study|Other|1|||
125419501|NCT03449030|451160295|FG000|Overall Study|Withdrawal by Subject|0|||
125419502|NCT03449030|451160296|FG001|Overall Study|Withdrawal by Subject|0|||
125419503|NCT03449030|451160297|FG002|Overall Study|Withdrawal by Subject|0|||
125419504|NCT03449030|451160298|FG003|Overall Study|Withdrawal by Subject|1|||
125419505|NCT03449030|451160299|FG004|Overall Study|Withdrawal by Subject|1|||
125419506|NCT03449030|451160300|FG005|Overall Study|Withdrawal by Subject|1|||
125419507|NCT03449030|451160301|FG006|Overall Study|Withdrawal by Subject|1|||
125419508|NCT03449030|451160302|FG007|Overall Study|Withdrawal by Subject|2|||
125419509|NCT03449030|451160303|FG008|Overall Study|Withdrawal by Subject|0|||
125419510|NCT03449030|451160304|FG009|Overall Study|Withdrawal by Subject|0|||
125419511|NCT03449030|451160295|FG000|Overall Study|Symptomatic Deterioration|0|||
125419512|NCT03449030|451160296|FG001|Overall Study|Symptomatic Deterioration|1|||
125419513|NCT03449030|451160297|FG002|Overall Study|Symptomatic Deterioration|0|||
125419514|NCT03449030|451160298|FG003|Overall Study|Symptomatic Deterioration|0|||
125419515|NCT03449030|451160299|FG004|Overall Study|Symptomatic Deterioration|0|||
125419516|NCT03449030|451160300|FG005|Overall Study|Symptomatic Deterioration|1|||
125419517|NCT03449030|451160301|FG006|Overall Study|Symptomatic Deterioration|1|||
125419518|NCT03449030|451160302|FG007|Overall Study|Symptomatic Deterioration|0|||
125419519|NCT03449030|451160303|FG008|Overall Study|Symptomatic Deterioration|2|||
125419520|NCT03449030|451160304|FG009|Overall Study|Symptomatic Deterioration|0|||
125419521|NCT03449030|451160295|FG000|Overall Study|Progressive Disease|1|||
125419522|NCT03449030|451160296|FG001|Overall Study|Progressive Disease|0|||
125419523|NCT03449030|451160297|FG002|Overall Study|Progressive Disease|1|||
125419524|NCT03449030|451160298|FG003|Overall Study|Progressive Disease|4|||
125419525|NCT03449030|451160299|FG004|Overall Study|Progressive Disease|5|||
125419526|NCT03449030|451160300|FG005|Overall Study|Progressive Disease|3|||
125419527|NCT03449030|451160301|FG006|Overall Study|Progressive Disease|0|||
125419528|NCT03449030|451160302|FG007|Overall Study|Progressive Disease|1|||
125419529|NCT03449030|451160303|FG008|Overall Study|Progressive Disease|1|||
125419530|NCT03449030|451160304|FG009|Overall Study|Progressive Disease|1|||
125419531|NCT03449030|451160295|FG000|Overall Study|Adverse Event|0|||
125450484|NCT05487703|451276686|FG000|Overall Study|Physician Decision|19|||
125291253|NCT00320372|450693288|FG000|Overall Study|Death|7|||
125419532|NCT03449030|451160296|FG001|Overall Study|Adverse Event|0|||
125419533|NCT03449030|451160297|FG002|Overall Study|Adverse Event|0|||
125419534|NCT03449030|451160298|FG003|Overall Study|Adverse Event|0|||
125419535|NCT03449030|451160299|FG004|Overall Study|Adverse Event|0|||
125419536|NCT03449030|451160300|FG005|Overall Study|Adverse Event|2|||
125419537|NCT03449030|451160301|FG006|Overall Study|Adverse Event|0|||
125419538|NCT03449030|451160302|FG007|Overall Study|Adverse Event|0|||
125419539|NCT03449030|451160303|FG008|Overall Study|Adverse Event|0|||
125419540|NCT03449030|451160304|FG009|Overall Study|Adverse Event|0|||
125291254|NCT00320372|450693289|FG001|Overall Study|Death|8|||
125291255|NCT00320372|450693288|FG000|Overall Study|Withdrawal by Subject|55|||
125291256|NCT00320372|450693289|FG001|Overall Study|Withdrawal by Subject|37|||
125291257|NCT00320372|450693288|FG000|Overall Study|Non-Compliance|40|||
125291258|NCT00320372|450693289|FG001|Overall Study|Non-Compliance|39|||
125291259|NCT00320372|450693288|FG000|Overall Study|Did not Meet (I/E)|3|||
125291260|NCT00320372|450693289|FG001|Overall Study|Did not Meet (I/E)|1|||
125291261|NCT00320372|450693288|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
125291262|NCT00320372|450693289|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
125291263|NCT00849875|450693290|FG000|Overall Study|Death|28|||
125291264|NCT00849875|450693290|FG000|Overall Study|Ongoing (unknown completion status)|11|||
125291265|NCT00849875|450693290|FG000|Overall Study|Others|6|||
125291266|NCT00849875|450693290|FG000|Overall Study|Lost to Follow-up|2|||
125291267|NCT00086502|450693291|FG000|Overall Study|Adverse Event|11|||
125291268|NCT00086502|450693292|FG001|Overall Study|Adverse Event|2|||
125291269|NCT00086502|450693291|FG000|Overall Study|Lack of Efficacy|0|||
125291270|NCT00086502|450693292|FG001|Overall Study|Lack of Efficacy|2|||
125291271|NCT00086502|450693291|FG000|Overall Study|Lost to Follow-up|3|||
125291272|NCT00086502|450693292|FG001|Overall Study|Lost to Follow-up|1|||
125291273|NCT00086502|450693291|FG000|Overall Study|Physician Decision|1|||
125291274|NCT00086502|450693292|FG001|Overall Study|Physician Decision|1|||
125291275|NCT00086502|450693291|FG000|Overall Study|Pregnancy|0|||
125291276|NCT00086502|450693292|FG001|Overall Study|Pregnancy|1|||
125291277|NCT00086502|450693291|FG000|Overall Study|Protocol Violation|3|||
125291278|NCT00086502|450693292|FG001|Overall Study|Protocol Violation|3|||
125291279|NCT00086502|450693291|FG000|Overall Study|Withdrawal by Subject|5|||
125291280|NCT00086502|450693292|FG001|Overall Study|Withdrawal by Subject|6|||
125291281|NCT00086502|450693291|FG000|Overall Study|Patient Moved|1|||
125291282|NCT00086502|450693292|FG001|Overall Study|Patient Moved|1|||
125291283|NCT00086502|450693291|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
125291284|NCT00086502|450693292|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
125291285|NCT00086502|450693291|FG000|Overall Study|Patient Accidentally Unblinded|1|||
125291286|NCT00086502|450693292|FG001|Overall Study|Patient Accidentally Unblinded|0|||
125291287|NCT01304329|450693293|FG000|Third Intervention (3 Days)|Adverse Event|0|||
125291288|NCT01304329|450693294|FG001|Third Intervention (3 Days)|Adverse Event|1|||
125291289|NCT01304329|450693295|FG002|Third Intervention (3 Days)|Adverse Event|0|||
125291290|NCT01304329|450693296|FG003|Third Intervention (3 Days)|Adverse Event|0|||
125291291|NCT01304329|450693297|FG004|Third Intervention (3 Days)|Adverse Event|0|||
125291292|NCT01304329|450693298|FG005|Third Intervention (3 Days)|Adverse Event|0|||
125291293|NCT02068118|450693306|FG000|18-month Comparative Study Period|Death|90|||
125291294|NCT02068118|450693307|FG001|18-month Comparative Study Period|Death|97|||
125291295|NCT02068118|450693306|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
125291296|NCT02068118|450693307|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
125291297|NCT02068118|450693306|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
125291298|NCT02068118|450693307|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
125291299|NCT02068118|450693306|FG000|18-month Comparative Study Period|Heart transplant|9|||
125291300|NCT02068118|450693307|FG001|18-month Comparative Study Period|Heart transplant|15|||
125291301|NCT02068118|450693306|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
125291302|NCT02068118|450693307|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
125291303|NCT02068118|450693306|FG000|18-month Comparative Study Period|Hemiplegia|0|||
125291304|NCT02068118|450693307|FG001|18-month Comparative Study Period|Hemiplegia|1|||
125291305|NCT02068118|450693306|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
125291306|NCT02068118|450693307|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
125291307|NCT02068118|450693306|FG000|18-month Comparative Study Period|Move|0|||
125291308|NCT02068118|450693307|FG001|18-month Comparative Study Period|Move|1|||
125291309|NCT02068118|450693306|FG000|18-month Comparative Study Period|Hearing loss|0|||
125291310|NCT02068118|450693307|FG001|18-month Comparative Study Period|Hearing loss|1|||
125291311|NCT02068118|450693306|FG000|Extension Period|Death|0|||
125291312|NCT02068118|450693307|FG001|Extension Period|Death|2|||
125291313|NCT02068118|450693306|FG000|Extension Period|Withdrawal by Subject|1|||
125291314|NCT02068118|450693307|FG001|Extension Period|Withdrawal by Subject|0|||
125291315|NCT02068118|450693306|FG000|Extension Period|Heart transplant|1|||
125291316|NCT02068118|450693307|FG001|Extension Period|Heart transplant|0|||
125291317|NCT02068118|450693306|FG000|Extension Period|Wrong device use|0|||
125291318|NCT02068118|450693307|FG001|Extension Period|Wrong device use|1|||
125291319|NCT00283868|450693308|FG000|Overall Study|Lost to Follow-up|7|||
125291320|NCT00283868|450693309|FG001|Overall Study|Lost to Follow-up|8|||
125419541|NCT03449030|451160295|FG000|Overall Study|Death|0|||
125419542|NCT03449030|451160296|FG001|Overall Study|Death|0|||
125291321|NCT01515475|450693310|FG000|Overall Study|Lost to Follow-up|20|||
125291322|NCT01515475|450693311|FG001|Overall Study|Lost to Follow-up|15|||
125419543|NCT03449030|451160297|FG002|Overall Study|Death|0|||
125291323|NCT01515475|450693312|FG002|Overall Study|Lost to Follow-up|12|||
125291324|NCT01515475|450693313|FG003|Overall Study|Lost to Follow-up|12|||
125291325|NCT01420627|450693314|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
125291326|NCT00837876|450693315|FG000|Overall Study|Death|2|||
125291327|NCT00837876|450693315|FG000|Overall Study|Adverse Event|7|||
125291328|NCT00837876|450693315|FG000|Overall Study|Physician Decision|1|||
125291329|NCT00837876|450693315|FG000|Overall Study|Withdrawal by Subject|3|||
125291330|NCT00837876|450693315|FG000|Overall Study|disease progression|24|||
125291331|NCT01996592|450693320|FG000|Overall Study|no response to text/no diary entry|32|||
125291332|NCT01996592|450693320|FG000|Overall Study|change in surgical date|4|||
125291333|NCT01996592|450693320|FG000|Overall Study|Withdrawal by Subject|5|||
125291334|NCT01996592|450693320|FG000|Overall Study|change in mode of delivery|4|||
125291335|NCT02075632|450693323|FG000|Overall Study|Adverse Event|1|||
125291336|NCT02075632|450693324|FG001|Overall Study|Adverse Event|1|||
125291337|NCT02075632|450693323|FG000|Overall Study|Lost to Follow-up|0|||
125291338|NCT02075632|450693324|FG001|Overall Study|Lost to Follow-up|3|||
125291339|NCT02075632|450693323|FG000|Overall Study|Withdrawal by Subject|0|||
125291340|NCT02075632|450693324|FG001|Overall Study|Withdrawal by Subject|1|||
125291341|NCT05028517|450693325|FG000|Overall Study|Lost to Follow-up|13|||
125291342|NCT05028517|450693326|FG001|Overall Study|Lost to Follow-up|20|||
125291343|NCT05028517|450693327|FG002|Overall Study|Lost to Follow-up|12|||
125291344|NCT05028517|450693325|FG000|Overall Study|Withdrawal by Subject|0|||
125291345|NCT05028517|450693326|FG001|Overall Study|Withdrawal by Subject|0|||
125291346|NCT05028517|450693327|FG002|Overall Study|Withdrawal by Subject|1|||
125291347|NCT02256267|450693328|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
125291348|NCT02256267|450693328|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
125291349|NCT00259298|450693336|FG000|Overall Study|Withdrawal by Subject|1|||
125291350|NCT00259298|450693336|FG000|Overall Study|Physician Decision|2|||
125291351|NCT01969500|450693342|FG000|Overall Study|Death|0|||
125291352|NCT01969500|450693343|FG001|Overall Study|Death|1|||
125291353|NCT01969500|450693342|FG000|Overall Study|extended hospitalization|1|||
125291354|NCT01969500|450693343|FG001|Overall Study|extended hospitalization|1|||
125291355|NCT00613080|450693344|FG000|Overall Study|Ineligible / no protocol treatment|11|||
125291356|NCT03757130|450693345|FG000|Overall Study|Lost to Follow-up|0|||
125291357|NCT03757130|450693346|FG001|Overall Study|Lost to Follow-up|0|||
125291358|NCT03757130|450693347|FG002|Overall Study|Lost to Follow-up|0|||
125291359|NCT03757130|450693348|FG003|Overall Study|Lost to Follow-up|1|||
125291360|NCT03757130|450693349|FG004|Overall Study|Lost to Follow-up|0|||
125291361|NCT03757130|450693350|FG005|Overall Study|Lost to Follow-up|0|||
125291362|NCT03757130|450693351|FG006|Overall Study|Lost to Follow-up|0|||
125291363|NCT03757130|450693352|FG007|Overall Study|Lost to Follow-up|1|||
125291364|NCT03757130|450693345|FG000|Overall Study|Withdrawal by Subject|0|||
125291365|NCT03757130|450693346|FG001|Overall Study|Withdrawal by Subject|0|||
125291366|NCT03757130|450693347|FG002|Overall Study|Withdrawal by Subject|0|||
125291367|NCT03757130|450693348|FG003|Overall Study|Withdrawal by Subject|0|||
125291368|NCT03757130|450693349|FG004|Overall Study|Withdrawal by Subject|0|||
125291369|NCT03757130|450693350|FG005|Overall Study|Withdrawal by Subject|0|||
125291370|NCT03757130|450693351|FG006|Overall Study|Withdrawal by Subject|1|||
125291371|NCT03757130|450693352|FG007|Overall Study|Withdrawal by Subject|0|||
125291372|NCT02226549|450693353|FG000|Overall Study|Randomized but Never Treated|1|||
125291373|NCT02226549|450693354|FG001|Overall Study|Randomized but Never Treated|0|||
125291374|NCT02226549|450693353|FG000|Overall Study|Lost to Follow-up|0|||
125291375|NCT02226549|450693354|FG001|Overall Study|Lost to Follow-up|1|||
125291376|NCT02726880|450693355|FG000|Overall Study|Withdrawal by Subject|2|||
125291377|NCT02726880|450693356|FG001|Overall Study|Withdrawal by Subject|0|||
125291378|NCT02726880|450693355|FG000|Overall Study|Lost to Follow-up|1|||
125291379|NCT02726880|450693356|FG001|Overall Study|Lost to Follow-up|3|||
125291380|NCT01269385|450693357|FG000|Overall Study|Adverse Event|1|||
125291381|NCT01269385|450693358|FG001|Overall Study|Adverse Event|1|||
125291382|NCT01269385|450693359|FG002|Overall Study|Adverse Event|0|||
125291383|NCT01269385|450693360|FG003|Overall Study|Adverse Event|0|||
125291384|NCT03553498|450693361|FG000|Overall Study|Missing primary outcome|1|||
125291385|NCT03553498|450693362|FG001|Overall Study|Missing primary outcome|2|||
125291386|NCT04941807|450693363|FG000|Overall Study|Lost to Follow-up|1|||
125291387|NCT04941807|450693364|FG001|Overall Study|Lost to Follow-up|1|||
125291388|NCT02741570|450693365|FG000|Pre-Treatment Period|Other reasons|0|||
125291389|NCT02741570|450693366|FG001|Pre-Treatment Period|Other reasons|3|||
125291390|NCT02741570|450693365|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
125291391|NCT02741570|450693366|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
125291392|NCT02741570|450693365|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
125291393|NCT02741570|450693366|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
125291394|NCT02741570|450693365|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
125291395|NCT02741570|450693366|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
125291396|NCT02741570|450693365|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
125291397|NCT02741570|450693366|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
125291398|NCT02741570|450693365|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
125291399|NCT02741570|450693366|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
125291400|NCT02741570|450693365|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
125291401|NCT02741570|450693366|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
125291402|NCT02741570|450693365|FG000|Pre-Treatment Period|Death|0|||
125450485|NCT05487703|451276686|FG000|Overall Study|Lack of Efficacy|60|||
125450486|NCT04824131|451276687|FG000|CAB LA Oral Phase|Adverse Event|1|||
125450487|NCT04824131|451276687|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
125450488|NCT04824131|451276687|FG000|Step 3|Withdrawal by Subject|2|||
125450489|NCT04640571|451276688|FG000|Overall Study|Withdrawal by Subject|0|||
125450490|NCT04640571|451276689|FG001|Overall Study|Withdrawal by Subject|0|||
125450491|NCT04640571|451276690|FG002|Overall Study|Withdrawal by Subject|0|||
125450492|NCT04640571|451276691|FG003|Overall Study|Withdrawal by Subject|0|||
125450493|NCT04640571|451276692|FG004|Overall Study|Withdrawal by Subject|0|||
125450494|NCT04640571|451276693|FG005|Overall Study|Withdrawal by Subject|2|||
125450495|NCT01767909|451276695|FG000|Overall Study|Withdrawal by Subject|4|||
125450496|NCT01767909|451276696|FG001|Overall Study|Withdrawal by Subject|7|||
125450497|NCT01767909|451276695|FG000|Overall Study|Adverse Event|3|||
125450498|NCT01767909|451276696|FG001|Overall Study|Adverse Event|1|||
125450499|NCT01767909|451276695|FG000|Overall Study|Withdrawal by Study Partner|3|||
125450500|NCT01767909|451276696|FG001|Overall Study|Withdrawal by Study Partner|1|||
125450501|NCT01767909|451276695|FG000|Overall Study|Non-Compliance|2|||
125450502|NCT01767909|451276696|FG001|Overall Study|Non-Compliance|0|||
125450503|NCT01767909|451276695|FG000|Overall Study|Perceived Lack of Efficacy|1|||
125450504|NCT01767909|451276696|FG001|Overall Study|Perceived Lack of Efficacy|0|||
125450505|NCT01767909|451276695|FG000|Overall Study|Investigator Recommendation|0|||
125450506|NCT01767909|451276696|FG001|Overall Study|Investigator Recommendation|1|||
125450507|NCT01767909|451276695|FG000|Overall Study|Lost to Follow-up|0|||
125450508|NCT01767909|451276696|FG001|Overall Study|Lost to Follow-up|1|||
125450509|NCT01767909|451276695|FG000|Overall Study|LP uncessessful|0|||
125450510|NCT01767909|451276696|FG001|Overall Study|LP uncessessful|1|||
125450511|NCT04319094|451276698|FG000|Baseline|Lost to Follow-up|4|||
125450512|NCT04319094|451276699|FG001|Baseline|Lost to Follow-up|5|||
125450513|NCT04319094|451276698|FG000|Baseline|Protocol Violation|0|||
125450514|NCT04319094|451276699|FG001|Baseline|Protocol Violation|3|||
125450515|NCT04319094|451276698|FG000|Baseline|Withdrawal by Subject|2|||
125450516|NCT04319094|451276699|FG001|Baseline|Withdrawal by Subject|1|||
125450517|NCT04319094|451276698|FG000|Post-Intervention|Death|0|||
125450518|NCT04319094|451276699|FG001|Post-Intervention|Death|1|||
125450519|NCT04319094|451276698|FG000|Post-Intervention|Lost to Follow-up|4|||
125450520|NCT04319094|451276699|FG001|Post-Intervention|Lost to Follow-up|4|||
125450521|NCT04319094|451276698|FG000|Post-Intervention|Withdrawal by Subject|8|||
125450522|NCT04319094|451276699|FG001|Post-Intervention|Withdrawal by Subject|5|||
125450523|NCT04319094|451276698|FG000|Post-Intervention|Incomplete Data Collection|1|||
125450524|NCT04319094|451276699|FG001|Post-Intervention|Incomplete Data Collection|3|||
125450525|NCT04319094|451276698|FG000|3-month|Death|1|||
125450526|NCT04319094|451276699|FG001|3-month|Death|0|||
125450527|NCT04319094|451276698|FG000|3-month|Lost to Follow-up|2|||
125450528|NCT04319094|451276699|FG001|3-month|Lost to Follow-up|2|||
125450529|NCT04319094|451276698|FG000|3-month|Withdrawal by Subject|0|||
125450530|NCT04319094|451276699|FG001|3-month|Withdrawal by Subject|3|||
125450531|NCT04319094|451276698|FG000|3-month|Incomplete data collection|9|||
125450532|NCT04319094|451276699|FG001|3-month|Incomplete data collection|7|||
125450533|NCT04319094|451276698|FG000|6-month|Lost to Follow-up|1|||
125450534|NCT04319094|451276699|FG001|6-month|Lost to Follow-up|1|||
125450535|NCT04319094|451276698|FG000|6-month|Withdrawal by Subject|0|||
125450536|NCT04319094|451276699|FG001|6-month|Withdrawal by Subject|3|||
125450537|NCT04319094|451276698|FG000|6-month|Incomplete data collection|14|||
125450538|NCT04319094|451276699|FG001|6-month|Incomplete data collection|9|||
125450539|NCT04319094|451276698|FG000|9-month|Lost to Follow-up|8|||
125450540|NCT04319094|451276699|FG001|9-month|Lost to Follow-up|4|||
125450541|NCT04319094|451276698|FG000|9-month|Withdrawal by Subject|0|||
125450542|NCT04319094|451276699|FG001|9-month|Withdrawal by Subject|1|||
125450543|NCT04319094|451276698|FG000|9-month|Incomplete data collection|8|||
125450544|NCT04319094|451276699|FG001|9-month|Incomplete data collection|5|||
125450545|NCT04319094|451276698|FG000|12-month|Lost to Follow-up|11|||
125450546|NCT04319094|451276699|FG001|12-month|Lost to Follow-up|8|||
125450547|NCT04956692|451276700|FG000|Overall Study|Death|115|||
125450548|NCT04956692|451276701|FG001|Overall Study|Death|47|||
125450549|NCT04956692|451276700|FG000|Overall Study|Lost to Follow-up|0|||
125450550|NCT04956692|451276701|FG001|Overall Study|Lost to Follow-up|1|||
125291403|NCT02741570|450693366|FG001|Pre-Treatment Period|Death|1|||
125291404|NCT02741570|450693365|FG000|Pre-Treatment Period|Disease progression|0|||
125450551|NCT04956692|451276700|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
125450552|NCT04956692|451276701|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125450553|NCT04956692|451276700|FG000|Overall Study|Withdrawal by Subject|5|||
125450554|NCT04956692|451276701|FG001|Overall Study|Withdrawal by Subject|2|||
125450555|NCT04956692|451276700|FG000|Overall Study|Ongoing in Study|236|||
125450556|NCT04956692|451276701|FG001|Overall Study|Ongoing in Study|123|||
125450557|NCT01822821|451276703|FG000|Overall Study|Eligible surgery cancelled|1|||
125450558|NCT01822821|451276704|FG001|Overall Study|Eligible surgery cancelled|1|||
125450559|NCT01822821|451276703|FG000|Overall Study|Other reasons|1|||
125450560|NCT01822821|451276704|FG001|Overall Study|Other reasons|0|||
125450561|NCT03005288|451276707|FG000|Overall Study|Withdrawal by Subject|7|||
125291405|NCT02741570|450693366|FG001|Pre-Treatment Period|Disease progression|1|||
125291406|NCT02741570|450693365|FG000|Treatment Period|Other reasons|47|||
125291407|NCT02741570|450693366|FG001|Treatment Period|Other reasons|12|||
125291408|NCT02741570|450693365|FG000|Treatment Period|Poor/non-compliance|0|||
125291409|NCT02741570|450693366|FG001|Treatment Period|Poor/non-compliance|2|||
125291410|NCT02741570|450693365|FG000|Treatment Period|Maximum clinical benefit|4|||
125291411|NCT02741570|450693366|FG001|Treatment Period|Maximum clinical benefit|6|||
125291412|NCT02741570|450693365|FG000|Treatment Period|Lost to Follow-up|1|||
125291413|NCT02741570|450693366|FG001|Treatment Period|Lost to Follow-up|3|||
125291414|NCT02741570|450693365|FG000|Treatment Period|Participant withdrew consent|9|||
125291415|NCT02741570|450693366|FG001|Treatment Period|Participant withdrew consent|13|||
125291416|NCT02741570|450693365|FG000|Treatment Period|Participant request to discontinue treatment|8|||
125291417|NCT02741570|450693366|FG001|Treatment Period|Participant request to discontinue treatment|23|||
125291418|NCT02741570|450693365|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
125291419|NCT02741570|450693366|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
125291420|NCT02741570|450693365|FG000|Treatment Period|Death|9|||
125291421|NCT02741570|450693366|FG001|Treatment Period|Death|7|||
125291422|NCT02741570|450693365|FG000|Treatment Period|Study drug toxicity|55|||
125291423|NCT02741570|450693366|FG001|Treatment Period|Study drug toxicity|47|||
125291424|NCT02741570|450693365|FG000|Treatment Period|Disease progression|294|||
125291425|NCT02741570|450693366|FG001|Treatment Period|Disease progression|301|||
125291426|NCT02741570|450693365|FG000|Treatment Period|Administrative reason by sponsor|0|||
125291427|NCT02741570|450693366|FG001|Treatment Period|Administrative reason by sponsor|1|||
125291428|NCT01100567|450693367|FG000|Overall Study|Withdrawal by Subject|5|||
125291429|NCT01100567|450693368|FG001|Overall Study|Withdrawal by Subject|8|||
125291430|NCT01100567|450693367|FG000|Overall Study|Early Hospital Discharge|6|||
125291431|NCT01100567|450693368|FG001|Overall Study|Early Hospital Discharge|4|||
125291432|NCT01100567|450693367|FG000|Overall Study|Lost to Follow-up|1|||
125291433|NCT01100567|450693368|FG001|Overall Study|Lost to Follow-up|2|||
125291434|NCT01100567|450693367|FG000|Overall Study|Physician Decision|0|||
125291435|NCT01100567|450693368|FG001|Overall Study|Physician Decision|1|||
125291436|NCT01100567|450693367|FG000|Overall Study|Deemed ineligible after consent|0|||
125291437|NCT01100567|450693368|FG001|Overall Study|Deemed ineligible after consent|1|||
125291438|NCT03697993|450693380|FG000|Overall Study|Became Ineligible after Enrollment|1|||
125291439|NCT03697993|450693381|FG001|Overall Study|Became Ineligible after Enrollment|3|||
125291440|NCT03697993|450693380|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
125291441|NCT03697993|450693381|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
125291442|NCT03697993|450693380|FG000|Overall Study|Lost to Follow-up|3|||
125291443|NCT03697993|450693381|FG001|Overall Study|Lost to Follow-up|0|||
125291444|NCT03697993|450693380|FG000|Overall Study|Physician Decision|4|||
125291445|NCT03697993|450693381|FG001|Overall Study|Physician Decision|0|||
125291446|NCT03697993|450693380|FG000|Overall Study|Initial Urine Culture Negative|0|||
125291447|NCT03697993|450693381|FG001|Overall Study|Initial Urine Culture Negative|1|||
125291448|NCT03759041|450693382|FG000|Overall Study|Withdrawal by Subject|4|||
125291449|NCT03759041|450693383|FG001|Overall Study|Withdrawal by Subject|10|||
125291450|NCT03759041|450693384|FG002|Overall Study|Withdrawal by Subject|10|||
125291451|NCT03759041|450693382|FG000|Overall Study|Adverse Event|1|||
125291452|NCT03759041|450693383|FG001|Overall Study|Adverse Event|3|||
125291453|NCT03759041|450693384|FG002|Overall Study|Adverse Event|4|||
125291454|NCT03759041|450693382|FG000|Overall Study|Lack of Efficacy|0|||
125291455|NCT03759041|450693383|FG001|Overall Study|Lack of Efficacy|0|||
125291456|NCT03759041|450693384|FG002|Overall Study|Lack of Efficacy|1|||
125291457|NCT03759041|450693382|FG000|Overall Study|Study Terminated by Sponsor|15|||
125291458|NCT03759041|450693383|FG001|Overall Study|Study Terminated by Sponsor|16|||
125291459|NCT03759041|450693384|FG002|Overall Study|Study Terminated by Sponsor|10|||
125291460|NCT03759041|450693382|FG000|Overall Study|Other reason for discontinuation|0|||
125291461|NCT03759041|450693383|FG001|Overall Study|Other reason for discontinuation|2|||
125291462|NCT03759041|450693384|FG002|Overall Study|Other reason for discontinuation|1|||
125291463|NCT03759041|450693382|FG000|Overall Study|Lost to Follow-up|7|||
125291464|NCT03759041|450693383|FG001|Overall Study|Lost to Follow-up|2|||
125291465|NCT03759041|450693384|FG002|Overall Study|Lost to Follow-up|2|||
125291466|NCT03759041|450693382|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
125291467|NCT03759041|450693383|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
125291468|NCT03759041|450693384|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
125291469|NCT04384107|450693385|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
125291470|NCT04384107|450693386|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
125291471|NCT04384107|450693385|FG000|Overall Study|Lost to Follow-up|1|||
125291472|NCT04384107|450693386|FG001|Overall Study|Lost to Follow-up|0|||
125291473|NCT00276614|450693387|FG000|Overall Study|Progression of disease under study|3|||
125291474|NCT01522404|450693390|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
125291475|NCT01522404|450693391|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
125291476|NCT01522404|450693390|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
125291477|NCT01522404|450693391|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
125419544|NCT03449030|451160298|FG003|Overall Study|Death|0|||
125450562|NCT03005288|451276708|FG001|Overall Study|Withdrawal by Subject|5|||
125450563|NCT03005288|451276707|FG000|Overall Study|Lost to Follow-up|0|||
125450564|NCT03005288|451276708|FG001|Overall Study|Lost to Follow-up|1|||
125450565|NCT03005288|451276707|FG000|Overall Study|Adverse Event|5|||
125450566|NCT03005288|451276708|FG001|Overall Study|Adverse Event|0|||
125450567|NCT03005288|451276707|FG000|Overall Study|Protocol deviation|0|||
125450568|NCT03005288|451276708|FG001|Overall Study|Protocol deviation|1|||
125450569|NCT03005288|451276707|FG000|Overall Study|Physician Decision|0|||
125450570|NCT03005288|451276708|FG001|Overall Study|Physician Decision|1|||
125450571|NCT00670540|451276711|FG000|Overall Study|ineligible|17|||
125450572|NCT00670540|451276711|FG000|Overall Study|not living in France|348|||
125450573|NCT00670540|451276711|FG000|Overall Study|refused to participate|189|||
125450574|NCT00670540|451276711|FG000|Overall Study|controls randomised for no follow up|2770|||
125450575|NCT00670540|451276711|FG000|Overall Study|missing information inclusion criteria|1|||
125450576|NCT01515319|451276715|FG000|Overall Study|Withdrawal by Subject|0|||
125291478|NCT01522404|450693390|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
125291479|NCT01522404|450693391|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
125291480|NCT02698371|450693392|FG000|All Participants Flow|Lost to Follow-up|3|||
125291481|NCT02698371|450693392|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
125291482|NCT02698371|450693392|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
125291483|NCT02698371|450693392|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
125291484|NCT02698371|450693392|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
125291485|NCT02698371|450693392|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
125291486|NCT02698371|450693392|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
125291487|NCT03734029|450693393|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
125291488|NCT03734029|450693394|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
125291489|NCT03734029|450693393|FG000|Overall Study|Adverse Event|60|||
125291490|NCT03734029|450693394|FG001|Overall Study|Adverse Event|14|||
125450577|NCT01515319|451276716|FG001|Overall Study|Withdrawal by Subject|0|||
125450578|NCT01515319|451276717|FG002|Overall Study|Withdrawal by Subject|0|||
125450579|NCT01515319|451276718|FG003|Overall Study|Withdrawal by Subject|0|||
125450580|NCT01515319|451276719|FG004|Overall Study|Withdrawal by Subject|0|||
125450581|NCT01515319|451276720|FG005|Overall Study|Withdrawal by Subject|0|||
125450582|NCT01515319|451276721|FG006|Overall Study|Withdrawal by Subject|1|||
125450583|NCT01515319|451276722|FG007|Overall Study|Withdrawal by Subject|0|||
125450584|NCT01515319|451276723|FG008|Overall Study|Withdrawal by Subject|0|||
125450585|NCT01515319|451276724|FG009|Overall Study|Withdrawal by Subject|0|||
125450586|NCT01515319|451276715|FG000|Overall Study|Adverse Event|0|||
125450587|NCT01515319|451276716|FG001|Overall Study|Adverse Event|0|||
125450588|NCT01515319|451276717|FG002|Overall Study|Adverse Event|0|||
125450589|NCT01515319|451276718|FG003|Overall Study|Adverse Event|0|||
125450590|NCT01515319|451276719|FG004|Overall Study|Adverse Event|0|||
125450591|NCT01515319|451276720|FG005|Overall Study|Adverse Event|0|||
125450592|NCT01515319|451276721|FG006|Overall Study|Adverse Event|0|||
125450593|NCT01515319|451276722|FG007|Overall Study|Adverse Event|0|||
125450594|NCT01515319|451276723|FG008|Overall Study|Adverse Event|3|||
125450595|NCT01515319|451276724|FG009|Overall Study|Adverse Event|0|||
125450596|NCT01515319|451276715|FG000|Overall Study|Protocol Violation|0|||
125450597|NCT01515319|451276716|FG001|Overall Study|Protocol Violation|0|||
125450598|NCT01515319|451276717|FG002|Overall Study|Protocol Violation|0|||
125450599|NCT01515319|451276718|FG003|Overall Study|Protocol Violation|0|||
125450600|NCT01515319|451276719|FG004|Overall Study|Protocol Violation|0|||
125450601|NCT01515319|451276720|FG005|Overall Study|Protocol Violation|0|||
125450602|NCT01515319|451276721|FG006|Overall Study|Protocol Violation|0|||
125450603|NCT01515319|451276722|FG007|Overall Study|Protocol Violation|0|||
125450604|NCT01515319|451276723|FG008|Overall Study|Protocol Violation|2|||
125450605|NCT01515319|451276724|FG009|Overall Study|Protocol Violation|0|||
125450606|NCT01449929|451276726|FG000|Randomization Phase 96 Week|Adverse Event|5|||
125450607|NCT01449929|451276727|FG001|Randomization Phase 96 Week|Adverse Event|13|||
125450608|NCT01449929|451276728|FG002|Randomization Phase 96 Week|Adverse Event|0|||
125450609|NCT01449929|451276726|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
125450610|NCT01449929|451276727|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
125450611|NCT01449929|451276728|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
125450612|NCT01449929|451276726|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
125450613|NCT01449929|451276727|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
125450614|NCT01449929|451276728|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
125450615|NCT01449929|451276726|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
125450616|NCT01449929|451276727|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
125450617|NCT01449929|451276728|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
125450618|NCT01449929|451276726|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
125450619|NCT01449929|451276727|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
125450620|NCT01449929|451276728|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
125450621|NCT01449929|451276726|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
125450622|NCT01449929|451276727|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
125291491|NCT03734029|450693393|FG000|Overall Study|Withdrawal by Subject|12|||
125291492|NCT03734029|450693394|FG001|Overall Study|Withdrawal by Subject|11|||
125291493|NCT03734029|450693393|FG000|Overall Study|Clinical progression by investigator|10|||
125291494|NCT03734029|450693394|FG001|Overall Study|Clinical progression by investigator|8|||
125291495|NCT03734029|450693393|FG000|Overall Study|Death|5|||
125291496|NCT03734029|450693394|FG001|Overall Study|Death|2|||
125291497|NCT03734029|450693393|FG000|Overall Study|Physician Decision|4|||
125291498|NCT03734029|450693394|FG001|Overall Study|Physician Decision|3|||
125291499|NCT03734029|450693393|FG000|Overall Study|Other|2|||
125291500|NCT03734029|450693394|FG001|Overall Study|Other|0|||
125291501|NCT03734029|450693393|FG000|Overall Study|Lost to Follow-up|0|||
125291502|NCT03734029|450693394|FG001|Overall Study|Lost to Follow-up|1|||
125291503|NCT03734029|450693393|FG000|Overall Study|Randomized, but not treated|2|||
125291504|NCT03734029|450693394|FG001|Overall Study|Randomized, but not treated|12|||
125291505|NCT03081858|450694879|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
125291506|NCT03081858|450694880|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
125291507|NCT03081858|450694881|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
125291508|NCT03081858|450694882|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
125291509|NCT00262847|450694885|FG000|Overall Study|Disease Progression|309|||
125291510|NCT00262847|450694886|FG001|Overall Study|Disease Progression|274|||
125291511|NCT00262847|450694887|FG002|Overall Study|Disease Progression|195|||
125291512|NCT00262847|450694885|FG000|Overall Study|Patient Refusal|41|||
125291513|NCT00262847|450694886|FG001|Overall Study|Patient Refusal|52|||
125291514|NCT00262847|450694887|FG002|Overall Study|Patient Refusal|47|||
125291515|NCT00262847|450694885|FG000|Overall Study|Adverse Event|74|||
125291516|NCT00262847|450694886|FG001|Overall Study|Adverse Event|88|||
125291517|NCT00262847|450694887|FG002|Overall Study|Adverse Event|108|||
125291518|NCT00262847|450694885|FG000|Overall Study|Death|8|||
125291519|NCT00262847|450694886|FG001|Overall Study|Death|8|||
125291520|NCT00262847|450694887|FG002|Overall Study|Death|11|||
125291521|NCT00262847|450694885|FG000|Overall Study|Concomitant disease|3|||
125291522|NCT00262847|450694886|FG001|Overall Study|Concomitant disease|2|||
125291523|NCT00262847|450694887|FG002|Overall Study|Concomitant disease|4|||
125291524|NCT00262847|450694885|FG000|Overall Study|Other Reasons|79|||
125291525|NCT00262847|450694886|FG001|Overall Study|Other Reasons|88|||
125291526|NCT00262847|450694887|FG002|Overall Study|Other Reasons|27|||
125291527|NCT00262847|450694885|FG000|Overall Study|Did not receive study treatment|4|||
125291528|NCT00262847|450694886|FG001|Overall Study|Did not receive study treatment|1|||
125291529|NCT00262847|450694887|FG002|Overall Study|Did not receive study treatment|4|||
125291530|NCT03966885|450694888|FG000|Overall Study|Death|1|||
125291531|NCT03966885|450694889|FG001|Overall Study|Death|0|||
125291532|NCT03966885|450694888|FG000|Overall Study|Lost to Follow-up|1|||
125291533|NCT03966885|450694889|FG001|Overall Study|Lost to Follow-up|2|||
125291534|NCT03966885|450694888|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
125291535|NCT03966885|450694889|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
125291536|NCT03966885|450694888|FG000|Overall Study|Moved from study area.|0|||
125291537|NCT03966885|450694889|FG001|Overall Study|Moved from study area.|2|||
125291538|NCT03899064|450694904|FG000|Overall Study|Lost to Follow-up|1|||
125291539|NCT03899064|450694904|FG000|Overall Study|Protocol Violation|2|||
125291540|NCT03899064|450694904|FG000|Overall Study|Withdrawal by Subject|2|||
125291541|NCT03899064|450694904|FG000|Overall Study|Other|2|||
125291542|NCT00031460|450694907|FG000|Overall Study|Lost to Follow-up|0|||
125291543|NCT00031460|450694908|FG001|Overall Study|Lost to Follow-up|1|||
125291544|NCT00031460|450694907|FG000|Overall Study|Withdrawal by Subject|1|||
125291545|NCT00031460|450694908|FG001|Overall Study|Withdrawal by Subject|1|||
125291546|NCT00031460|450694907|FG000|Overall Study|Non-Compliant|1|||
125291547|NCT00031460|450694908|FG001|Overall Study|Non-Compliant|1|||
125291548|NCT00031460|450694907|FG000|Overall Study|Death|0|||
125291549|NCT00031460|450694908|FG001|Overall Study|Death|1|||
125291550|NCT00031460|450694907|FG000|Overall Study|Reactivation of Disease|5|||
125291551|NCT00031460|450694908|FG001|Overall Study|Reactivation of Disease|9|||
125291552|NCT00031460|450694907|FG000|Overall Study|Disruption of blinded drug supply|2|||
125291553|NCT00031460|450694908|FG001|Overall Study|Disruption of blinded drug supply|0|||
125291554|NCT00031460|450694907|FG000|Overall Study|Confirmed unevaluable|0|||
125291555|NCT00031460|450694908|FG001|Overall Study|Confirmed unevaluable|1|||
125291556|NCT02210832|450694909|FG000|Overall Study|Pregnancy termination .|3|||
125291557|NCT02210832|450694910|FG001|Overall Study|Pregnancy termination .|4|||
125291558|NCT02210832|450694911|FG002|Overall Study|Pregnancy termination .|1|||
125291559|NCT02210832|450694909|FG000|Overall Study|Lost to Follow-up|26|||
125291560|NCT02210832|450694910|FG001|Overall Study|Lost to Follow-up|32|||
125291561|NCT02210832|450694911|FG002|Overall Study|Lost to Follow-up|17|||
125291562|NCT02080260|450694916|FG000|Overall Study|Death|18|||
125291563|NCT02080260|450694916|FG000|Overall Study|Withdrawal by Subject|1|||
125291564|NCT00471887|450694919|FG000|Overall Study|Adverse Event|9|||
125291565|NCT03602885|450694920|FG000|Overall Study|Lost to Follow-up|3|||
125291566|NCT03602885|450694921|FG001|Overall Study|Lost to Follow-up|0|||
125450623|NCT01449929|451276728|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
125450624|NCT01449929|451276726|FG000|Randomization Phase 96 Week|Physician Decision|2|||
125450625|NCT01449929|451276727|FG001|Randomization Phase 96 Week|Physician Decision|3|||
125450626|NCT01449929|451276728|FG002|Randomization Phase 96 Week|Physician Decision|0|||
125450627|NCT01449929|451276726|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
125450628|NCT01449929|451276727|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
125450629|NCT01449929|451276728|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
125450630|NCT01449929|451276726|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
125450631|NCT01449929|451276727|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
125450632|NCT01449929|451276728|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
125450633|NCT01449929|451276726|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
125450634|NCT01449929|451276727|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
125450635|NCT01449929|451276728|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
125450636|NCT01449929|451276726|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
125450637|NCT01449929|451276727|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
125450638|NCT01449929|451276728|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
125450639|NCT01871285|451276729|FG000|First Intervention (1 Day)|Adverse Event|1|||
125450640|NCT01871285|451276730|FG001|First Intervention (1 Day)|Adverse Event|0|||
125450641|NCT01871285|451276731|FG002|First Intervention (1 Day)|Adverse Event|0|||
125450642|NCT01871285|451276732|FG003|First Intervention (1 Day)|Adverse Event|0|||
125450643|NCT01871285|451276729|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
125450644|NCT01871285|451276730|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
125450645|NCT01871285|451276731|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
125450646|NCT01871285|451276732|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
125450647|NCT01959880|451276733|FG000|Overall Study|Withdrawal by Subject|11|||
125450648|NCT01959880|451276734|FG001|Overall Study|Withdrawal by Subject|13|||
125291567|NCT00098722|450694922|FG000|Double Blind Phase|Adverse Event|7|||
125291568|NCT00098722|450694923|FG001|Double Blind Phase|Adverse Event|7|||
125291569|NCT00098722|450694924|FG002|Double Blind Phase|Adverse Event|3|||
125291570|NCT00098722|450694925|FG003|Double Blind Phase|Adverse Event|0|||
125291571|NCT00098722|450694926|FG004|Double Blind Phase|Adverse Event|0|||
125291572|NCT00098722|450694927|FG005|Double Blind Phase|Adverse Event|0|||
125291573|NCT00098722|450694928|FG006|Double Blind Phase|Adverse Event|0|||
125291574|NCT00098722|450694922|FG000|Double Blind Phase|Death|2|||
125291575|NCT00098722|450694923|FG001|Double Blind Phase|Death|5|||
125291576|NCT00098722|450694924|FG002|Double Blind Phase|Death|0|||
125291577|NCT00098722|450694925|FG003|Double Blind Phase|Death|0|||
125291578|NCT00098722|450694926|FG004|Double Blind Phase|Death|0|||
125291579|NCT00098722|450694927|FG005|Double Blind Phase|Death|0|||
125291580|NCT00098722|450694928|FG006|Double Blind Phase|Death|0|||
125291581|NCT00098722|450694922|FG000|Double Blind Phase|Lack of Efficacy|21|||
125291582|NCT00098722|450694923|FG001|Double Blind Phase|Lack of Efficacy|23|||
125291583|NCT00098722|450694924|FG002|Double Blind Phase|Lack of Efficacy|15|||
125291584|NCT00098722|450694925|FG003|Double Blind Phase|Lack of Efficacy|0|||
125291585|NCT00098722|450694926|FG004|Double Blind Phase|Lack of Efficacy|0|||
125291586|NCT00098722|450694927|FG005|Double Blind Phase|Lack of Efficacy|0|||
125291587|NCT00098722|450694928|FG006|Double Blind Phase|Lack of Efficacy|0|||
125291588|NCT00098722|450694922|FG000|Double Blind Phase|Participant defaulted|16|||
125291589|NCT00098722|450694923|FG001|Double Blind Phase|Participant defaulted|11|||
125291590|NCT00098722|450694924|FG002|Double Blind Phase|Participant defaulted|9|||
125291591|NCT00098722|450694925|FG003|Double Blind Phase|Participant defaulted|0|||
125291592|NCT00098722|450694926|FG004|Double Blind Phase|Participant defaulted|0|||
125291593|NCT00098722|450694927|FG005|Double Blind Phase|Participant defaulted|0|||
125291594|NCT00098722|450694928|FG006|Double Blind Phase|Participant defaulted|0|||
125291595|NCT00098722|450694922|FG000|Double Blind Phase|Pregnancy|1|||
125291596|NCT00098722|450694923|FG001|Double Blind Phase|Pregnancy|0|||
125291597|NCT00098722|450694924|FG002|Double Blind Phase|Pregnancy|0|||
125291598|NCT00098722|450694925|FG003|Double Blind Phase|Pregnancy|0|||
125291599|NCT00098722|450694926|FG004|Double Blind Phase|Pregnancy|0|||
125291600|NCT00098722|450694927|FG005|Double Blind Phase|Pregnancy|0|||
125291601|NCT00098722|450694928|FG006|Double Blind Phase|Pregnancy|0|||
125291602|NCT00098722|450694922|FG000|Double Blind Phase|Randomized, not treated|4|||
125291603|NCT00098722|450694923|FG001|Double Blind Phase|Randomized, not treated|3|||
125291604|NCT00098722|450694924|FG002|Double Blind Phase|Randomized, not treated|3|||
125291605|NCT00098722|450694925|FG003|Double Blind Phase|Randomized, not treated|0|||
125291606|NCT00098722|450694926|FG004|Double Blind Phase|Randomized, not treated|0|||
125291607|NCT00098722|450694927|FG005|Double Blind Phase|Randomized, not treated|0|||
125291608|NCT00098722|450694928|FG006|Double Blind Phase|Randomized, not treated|0|||
125291609|NCT00098722|450694922|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
125291610|NCT00098722|450694923|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
125291611|NCT00098722|450694924|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
125291612|NCT00098722|450694925|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
125291613|NCT00098722|450694926|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
125291614|NCT00098722|450694927|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
125291615|NCT00098722|450694928|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
125291616|NCT00098722|450694922|FG000|Double Blind Phase|Other|7|||
125291617|NCT00098722|450694923|FG001|Double Blind Phase|Other|8|||
125291618|NCT00098722|450694924|FG002|Double Blind Phase|Other|7|||
125291619|NCT00098722|450694925|FG003|Double Blind Phase|Other|0|||
125291620|NCT00098722|450694926|FG004|Double Blind Phase|Other|0|||
125291621|NCT00098722|450694927|FG005|Double Blind Phase|Other|0|||
125291622|NCT00098722|450694928|FG006|Double Blind Phase|Other|0|||
125291623|NCT00098722|450694922|FG000|Open Label Phase|Adverse Event|0|||
125291624|NCT00098722|450694923|FG001|Open Label Phase|Adverse Event|0|||
125291625|NCT00098722|450694924|FG002|Open Label Phase|Adverse Event|0|||
125291626|NCT00098722|450694925|FG003|Open Label Phase|Adverse Event|5|||
125291627|NCT00098722|450694926|FG004|Open Label Phase|Adverse Event|0|||
125291628|NCT00098722|450694927|FG005|Open Label Phase|Adverse Event|0|||
125291629|NCT00098722|450694928|FG006|Open Label Phase|Adverse Event|0|||
125291630|NCT00098722|450694922|FG000|Open Label Phase|Death|0|||
125291631|NCT00098722|450694923|FG001|Open Label Phase|Death|0|||
125291632|NCT00098722|450694924|FG002|Open Label Phase|Death|0|||
125291633|NCT00098722|450694925|FG003|Open Label Phase|Death|2|||
125291634|NCT00098722|450694926|FG004|Open Label Phase|Death|0|||
125291635|NCT00098722|450694927|FG005|Open Label Phase|Death|0|||
125291636|NCT00098722|450694928|FG006|Open Label Phase|Death|0|||
125291637|NCT00098722|450694922|FG000|Open Label Phase|Lack of Efficacy|0|||
125291638|NCT00098722|450694923|FG001|Open Label Phase|Lack of Efficacy|0|||
125291639|NCT00098722|450694924|FG002|Open Label Phase|Lack of Efficacy|0|||
125291640|NCT00098722|450694925|FG003|Open Label Phase|Lack of Efficacy|8|||
125291641|NCT00098722|450694926|FG004|Open Label Phase|Lack of Efficacy|0|||
125291642|NCT00098722|450694927|FG005|Open Label Phase|Lack of Efficacy|0|||
125291643|NCT00098722|450694928|FG006|Open Label Phase|Lack of Efficacy|0|||
125291644|NCT00098722|450694922|FG000|Open Label Phase|Pregnancy|0|||
125291645|NCT00098722|450694923|FG001|Open Label Phase|Pregnancy|0|||
125291646|NCT00098722|450694924|FG002|Open Label Phase|Pregnancy|0|||
125291647|NCT00098722|450694925|FG003|Open Label Phase|Pregnancy|1|||
125291648|NCT00098722|450694926|FG004|Open Label Phase|Pregnancy|0|||
125291649|NCT00098722|450694927|FG005|Open Label Phase|Pregnancy|0|||
125291650|NCT00098722|450694928|FG006|Open Label Phase|Pregnancy|0|||
125291651|NCT00098722|450694922|FG000|Open Label Phase|Participant defaulted|0|||
125291652|NCT00098722|450694923|FG001|Open Label Phase|Participant defaulted|0|||
125291653|NCT00098722|450694924|FG002|Open Label Phase|Participant defaulted|0|||
125291654|NCT00098722|450694925|FG003|Open Label Phase|Participant defaulted|18|||
125291655|NCT00098722|450694926|FG004|Open Label Phase|Participant defaulted|0|||
125291656|NCT00098722|450694927|FG005|Open Label Phase|Participant defaulted|0|||
125291657|NCT00098722|450694928|FG006|Open Label Phase|Participant defaulted|0|||
125291658|NCT00098722|450694922|FG000|Open Label Phase|Ongoing at cut-off date|0|||
125291659|NCT00098722|450694923|FG001|Open Label Phase|Ongoing at cut-off date|0|||
125291660|NCT00098722|450694924|FG002|Open Label Phase|Ongoing at cut-off date|0|||
125291661|NCT00098722|450694925|FG003|Open Label Phase|Ongoing at cut-off date|220|||
125291662|NCT00098722|450694926|FG004|Open Label Phase|Ongoing at cut-off date|50|||
125291663|NCT00098722|450694927|FG005|Open Label Phase|Ongoing at cut-off date|0|||
125291664|NCT00098722|450694928|FG006|Open Label Phase|Ongoing at cut-off date|0|||
125291665|NCT00098722|450694922|FG000|Open Label Phase|Other|0|||
125291666|NCT00098722|450694923|FG001|Open Label Phase|Other|0|||
125291667|NCT00098722|450694924|FG002|Open Label Phase|Other|0|||
125291668|NCT00098722|450694925|FG003|Open Label Phase|Other|18|||
125291669|NCT00098722|450694926|FG004|Open Label Phase|Other|0|||
125291670|NCT00098722|450694927|FG005|Open Label Phase|Other|0|||
125291671|NCT00098722|450694928|FG006|Open Label Phase|Other|0|||
125291672|NCT00098722|450694922|FG000|Observation Phase|Death|0|||
125291673|NCT00098722|450694923|FG001|Observation Phase|Death|0|||
125291674|NCT00098722|450694924|FG002|Observation Phase|Death|0|||
125291675|NCT00098722|450694925|FG003|Observation Phase|Death|0|||
125291676|NCT00098722|450694926|FG004|Observation Phase|Death|0|||
125291677|NCT00098722|450694927|FG005|Observation Phase|Death|5|||
125291678|NCT00098722|450694928|FG006|Observation Phase|Death|3|||
125291679|NCT00098722|450694922|FG000|Observation Phase|Lack of Efficacy|0|||
125291680|NCT00098722|450694923|FG001|Observation Phase|Lack of Efficacy|0|||
125291681|NCT00098722|450694924|FG002|Observation Phase|Lack of Efficacy|0|||
125291682|NCT00098722|450694925|FG003|Observation Phase|Lack of Efficacy|0|||
125291683|NCT00098722|450694926|FG004|Observation Phase|Lack of Efficacy|0|||
125291684|NCT00098722|450694927|FG005|Observation Phase|Lack of Efficacy|2|||
125291685|NCT00098722|450694928|FG006|Observation Phase|Lack of Efficacy|0|||
125291686|NCT00098722|450694922|FG000|Observation Phase|Participant defaulted|0|||
125291687|NCT00098722|450694923|FG001|Observation Phase|Participant defaulted|0|||
125291688|NCT00098722|450694924|FG002|Observation Phase|Participant defaulted|0|||
125291689|NCT00098722|450694925|FG003|Observation Phase|Participant defaulted|0|||
125291690|NCT00098722|450694926|FG004|Observation Phase|Participant defaulted|0|||
125291691|NCT00098722|450694927|FG005|Observation Phase|Participant defaulted|17|||
125291692|NCT00098722|450694928|FG006|Observation Phase|Participant defaulted|4|||
125291693|NCT00098722|450694922|FG000|Observation Phase|Other|0|||
125291694|NCT00098722|450694923|FG001|Observation Phase|Other|0|||
125291695|NCT00098722|450694924|FG002|Observation Phase|Other|0|||
125291696|NCT00098722|450694925|FG003|Observation Phase|Other|0|||
125291697|NCT00098722|450694926|FG004|Observation Phase|Other|0|||
125291698|NCT00098722|450694927|FG005|Observation Phase|Other|21|||
125291699|NCT00098722|450694928|FG006|Observation Phase|Other|10|||
125291700|NCT02351349|450694929|FG000|Overall Study|Withdrawal by Subject|2|||
125291701|NCT02351349|450694930|FG001|Overall Study|Withdrawal by Subject|3|||
125291702|NCT00440310|450694931|FG000|Overall Study|Lost to Follow-up|4|||
125291703|NCT00440310|450694932|FG001|Overall Study|Lost to Follow-up|5|||
125291704|NCT00440310|450694931|FG000|Overall Study|Protocol Violation|0|||
125291705|NCT00440310|450694932|FG001|Overall Study|Protocol Violation|1|||
125291706|NCT00440310|450694931|FG000|Overall Study|Withdrawal by Subject|15|||
125291707|NCT00440310|450694932|FG001|Overall Study|Withdrawal by Subject|14|||
125291708|NCT00440310|450694931|FG000|Overall Study|No Reply at EOS|7|||
125291709|NCT00440310|450694932|FG001|Overall Study|No Reply at EOS|7|||
125291710|NCT00440310|450694931|FG000|Overall Study|Other|1|||
125291711|NCT00440310|450694932|FG001|Overall Study|Other|0|||
125291712|NCT00440310|450694931|FG000|Overall Study|Status Unknown|1|||
125291713|NCT00440310|450694932|FG001|Overall Study|Status Unknown|3|||
125291714|NCT01610596|450694939|FG000|Overall Study|Lost to Follow-up|0|||
125291715|NCT01610596|450694940|FG001|Overall Study|Lost to Follow-up|1|||
125291716|NCT01519674|450694941|FG000|Overall Study|Adverse Event|3|||
125291717|NCT01519674|450694942|FG001|Overall Study|Adverse Event|3|||
125291718|NCT01519674|450694943|FG002|Overall Study|Adverse Event|0|||
125291719|NCT01519674|450694941|FG000|Overall Study|Lack of Efficacy|1|||
125291720|NCT01519674|450694942|FG001|Overall Study|Lack of Efficacy|1|||
125291721|NCT01519674|450694943|FG002|Overall Study|Lack of Efficacy|1|||
125291722|NCT01519674|450694941|FG000|Overall Study|Protocol Violation|0|||
125291723|NCT01519674|450694942|FG001|Overall Study|Protocol Violation|3|||
125291724|NCT01519674|450694943|FG002|Overall Study|Protocol Violation|1|||
125291725|NCT01519674|450694941|FG000|Overall Study|Withdrawal Criteria|7|||
125291726|NCT01519674|450694942|FG001|Overall Study|Withdrawal Criteria|2|||
125291727|NCT01519674|450694943|FG002|Overall Study|Withdrawal Criteria|7|||
125291728|NCT01519674|450694941|FG000|Overall Study|Unsclassified|10|||
125291729|NCT01519674|450694942|FG001|Overall Study|Unsclassified|4|||
125291730|NCT01519674|450694943|FG002|Overall Study|Unsclassified|3|||
125291731|NCT00799591|450694944|FG000|Overall Study|De-escalation of doses|20|||
125291732|NCT00799591|450694944|FG000|Overall Study|Death|14|||
125291733|NCT00799591|450694944|FG000|Overall Study|Technical failure|12|||
125291734|NCT00799591|450694944|FG000|Overall Study|Resistant germ|11|||
125291735|NCT00799591|450694944|FG000|Overall Study|New infection|4|||
125291736|NCT00799591|450694944|FG000|Overall Study|Resistance germ and technical failure|2|||
125291737|NCT00799591|450694944|FG000|Overall Study|Persistance of fever undetermined origin|1|||
125291738|NCT00799591|450694944|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
125291739|NCT00799591|450694944|FG000|Overall Study|Infectious origin not probable|1|||
125291740|NCT03106415|450694947|FG000|Phase 1|Withdrawal by Subject|1|||
125291741|NCT03106415|450694948|FG001|Phase 1|Withdrawal by Subject|0|||
125291742|NCT03106415|450694949|FG002|Phase 1|Withdrawal by Subject|0|||
125291743|NCT03106415|450694947|FG000|Phase 1|Adverse Event|1|||
125291744|NCT03106415|450694948|FG001|Phase 1|Adverse Event|1|||
125291745|NCT03106415|450694949|FG002|Phase 1|Adverse Event|0|||
125291746|NCT03106415|450694947|FG000|Phase 1|Protocol Violation|0|||
125291747|NCT03106415|450694948|FG001|Phase 1|Protocol Violation|1|||
125291748|NCT03106415|450694949|FG002|Phase 1|Protocol Violation|0|||
125291749|NCT00293709|450694950|FG000|Overall Study|Other|47|||
125291750|NCT02785458|450694951|FG000|1 Month|Withdrawal by Subject|2|||
125291751|NCT02785458|450694952|FG001|1 Month|Withdrawal by Subject|1|||
125291752|NCT02785458|450694951|FG000|1 Month|Lost to Follow-up|38|||
125291753|NCT02785458|450694952|FG001|1 Month|Lost to Follow-up|31|||
125291754|NCT02785458|450694951|FG000|1 Month|Deemed Ineligible|1|||
125291755|NCT02785458|450694952|FG001|1 Month|Deemed Ineligible|0|||
125291756|NCT02785458|450694951|FG000|1 Month|Completed Evaluation by Baseline|42|||
125291757|NCT02785458|450694952|FG001|1 Month|Completed Evaluation by Baseline|39|||
125291758|NCT02785458|450694951|FG000|1 Month|Partial Interview|0|||
125291759|NCT02785458|450694952|FG001|1 Month|Partial Interview|4|||
125291760|NCT02785458|450694951|FG000|3 Months|Withdrawal by Subject|3|||
125419545|NCT03449030|451160299|FG004|Overall Study|Death|1|||
125291761|NCT02785458|450694952|FG001|3 Months|Withdrawal by Subject|1|||
125291762|NCT02785458|450694951|FG000|3 Months|Lost to Follow-up|25|||
125291763|NCT02785458|450694952|FG001|3 Months|Lost to Follow-up|21|||
125291764|NCT02785458|450694951|FG000|3 Months|Completed Evaluation at 1 Month|100|||
125291765|NCT02785458|450694952|FG001|3 Months|Completed Evaluation at 1 Month|89|||
125291766|NCT01804582|450694953|FG000|Overall Study|Lost to Follow-up|47|||
125291767|NCT01804582|450694954|FG001|Overall Study|Lost to Follow-up|56|||
125291768|NCT01804582|450694953|FG000|Overall Study|Physician Decision|2|||
125291769|NCT01804582|450694954|FG001|Overall Study|Physician Decision|0|||
125291770|NCT00520013|450694955|FG000|Overall Study|Withdrawal by Subject|0|||
125291771|NCT00520013|450694956|FG001|Overall Study|Withdrawal by Subject|0|||
125291772|NCT00520013|450694957|FG002|Overall Study|Withdrawal by Subject|1|||
125291773|NCT00520013|450694955|FG000|Overall Study|Adverse Event|2|||
125291774|NCT00520013|450694956|FG001|Overall Study|Adverse Event|10|||
125419546|NCT03449030|451160300|FG005|Overall Study|Death|0|||
125291775|NCT00520013|450694957|FG002|Overall Study|Adverse Event|7|||
125291776|NCT00520013|450694955|FG000|Overall Study|Progressive Disease|7|||
125291777|NCT00520013|450694956|FG001|Overall Study|Progressive Disease|3|||
125291778|NCT00520013|450694957|FG002|Overall Study|Progressive Disease|0|||
125291779|NCT00520013|450694955|FG000|Overall Study|Clinical Progression|3|||
125291780|NCT00520013|450694956|FG001|Overall Study|Clinical Progression|1|||
125291781|NCT00520013|450694957|FG002|Overall Study|Clinical Progression|0|||
125291782|NCT00520013|450694955|FG000|Overall Study|Death|0|||
125291783|NCT00520013|450694956|FG001|Overall Study|Death|1|||
125291784|NCT00520013|450694957|FG002|Overall Study|Death|0|||
125291785|NCT00520013|450694955|FG000|Overall Study|Physician Decision|0|||
125291786|NCT00520013|450694956|FG001|Overall Study|Physician Decision|0|||
125291787|NCT00520013|450694957|FG002|Overall Study|Physician Decision|3|||
125291788|NCT02677844|450694958|FG000|Period 3|Withdrawal by Subject|0|||
125291789|NCT02677844|450694959|FG001|Period 3|Withdrawal by Subject|0|||
125291790|NCT02677844|450694960|FG002|Period 3|Withdrawal by Subject|0|||
125291791|NCT02677844|450694961|FG003|Period 3|Withdrawal by Subject|1|||
125291792|NCT02677844|450694962|FG004|Period 3|Withdrawal by Subject|0|||
125291793|NCT02677844|450694963|FG005|Period 3|Withdrawal by Subject|0|||
125291794|NCT02677844|450694964|FG006|Period 3|Withdrawal by Subject|0|||
125291795|NCT01697462|450694965|FG000|Overall Study|Disease Progression|1|||
125291796|NCT01697462|450694965|FG000|Overall Study|Adverse Event|6|||
125291797|NCT01697462|450694965|FG000|Overall Study|Lost to Follow-up|21|||
125291798|NCT01697462|450694965|FG000|Overall Study|Withdrawal by Subject|12|||
125291799|NCT01697462|450694965|FG000|Overall Study|Investigator Decision|21|||
125291800|NCT01697462|450694965|FG000|Overall Study|Death|1|||
125291801|NCT01697462|450694965|FG000|Overall Study|Other|10|||
125291802|NCT01697462|450694965|FG000|Overall Study|Missing|5|||
125291803|NCT03630302|450694966|FG000|Surgery|hardware issue prevented LFP recordings|1|||
125291804|NCT03630302|450694966|FG000|3 Month Visit|Adverse Event|2|||
125291805|NCT03630302|450694966|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
125291806|NCT01135914|450694969|FG000|Overall Study|Withdrawal by Subject|1|||
125291807|NCT01135914|450694970|FG001|Overall Study|Withdrawal by Subject|3|||
125291808|NCT01135914|450694971|FG002|Overall Study|Withdrawal by Subject|6|||
125291809|NCT01135914|450694969|FG000|Overall Study|Lost to Follow-up|1|||
125291810|NCT01135914|450694970|FG001|Overall Study|Lost to Follow-up|0|||
125291811|NCT01135914|450694971|FG002|Overall Study|Lost to Follow-up|1|||
125291812|NCT01135914|450694969|FG000|Overall Study|Protocol Violation|0|||
125291813|NCT01135914|450694970|FG001|Overall Study|Protocol Violation|0|||
125291814|NCT01135914|450694971|FG002|Overall Study|Protocol Violation|3|||
125291815|NCT01135914|450694969|FG000|Overall Study|Lack of Efficacy|2|||
125291816|NCT01135914|450694970|FG001|Overall Study|Lack of Efficacy|1|||
125291817|NCT01135914|450694971|FG002|Overall Study|Lack of Efficacy|10|||
125291818|NCT01135914|450694969|FG000|Overall Study|Adverse Event|0|||
125291819|NCT01135914|450694970|FG001|Overall Study|Adverse Event|1|||
125291820|NCT01135914|450694971|FG002|Overall Study|Adverse Event|2|||
125291821|NCT03532932|450694972|FG000|Overall Study|Protocol Deviation|33|||
125291822|NCT03532932|450694973|FG001|Overall Study|Protocol Deviation|31|||
125291823|NCT03532932|450694972|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
125291824|NCT03532932|450694973|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
125291825|NCT03532932|450694972|FG000|Overall Study|Withdrawal by Subject|2|||
125291826|NCT03532932|450694973|FG001|Overall Study|Withdrawal by Subject|0|||
125291827|NCT03532932|450694972|FG000|Overall Study|Lost to Follow-up|15|||
125291828|NCT03532932|450694973|FG001|Overall Study|Lost to Follow-up|9|||
125291829|NCT03532932|450694972|FG000|Overall Study|Adverse Event|4|||
125291830|NCT03532932|450694973|FG001|Overall Study|Adverse Event|3|||
125291831|NCT03532932|450694972|FG000|Overall Study|Death|0|||
125291832|NCT03532932|450694973|FG001|Overall Study|Death|2|||
125291833|NCT03532932|450694972|FG000|Overall Study|Other|11|||
125291834|NCT03532932|450694973|FG001|Overall Study|Other|16|||
125419547|NCT03449030|451160301|FG006|Overall Study|Death|0|||
125291835|NCT02699450|450694974|FG000|Overall Study|Death|2|||
125291836|NCT02699450|450694975|FG001|Overall Study|Death|1|||
125291837|NCT02699450|450694976|FG002|Overall Study|Death|2|||
125291838|NCT02699450|450694974|FG000|Overall Study|Met Criteria for Study Exit|0|||
125291839|NCT02699450|450694975|FG001|Overall Study|Met Criteria for Study Exit|0|||
125291840|NCT02699450|450694976|FG002|Overall Study|Met Criteria for Study Exit|1|||
125291841|NCT02699450|450694974|FG000|Overall Study|Protocol Violation|4|||
125291842|NCT02699450|450694975|FG001|Overall Study|Protocol Violation|3|||
125291843|NCT02699450|450694976|FG002|Overall Study|Protocol Violation|5|||
125291844|NCT02699450|450694974|FG000|Overall Study|Lost to Follow-up|3|||
125291845|NCT02699450|450694975|FG001|Overall Study|Lost to Follow-up|0|||
125291846|NCT02699450|450694976|FG002|Overall Study|Lost to Follow-up|5|||
125291847|NCT02699450|450694974|FG000|Overall Study|Physician Decision|2|||
125291848|NCT02699450|450694975|FG001|Overall Study|Physician Decision|0|||
125291849|NCT02699450|450694976|FG002|Overall Study|Physician Decision|0|||
125291850|NCT02699450|450694974|FG000|Overall Study|Withdrawal by Subject|3|||
125291851|NCT02699450|450694975|FG001|Overall Study|Withdrawal by Subject|1|||
125291852|NCT02699450|450694976|FG002|Overall Study|Withdrawal by Subject|2|||
125291853|NCT02699450|450694974|FG000|Overall Study|Adverse Event|1|||
125291854|NCT02699450|450694975|FG001|Overall Study|Adverse Event|0|||
125291855|NCT02699450|450694976|FG002|Overall Study|Adverse Event|0|||
125291856|NCT01344629|450694977|FG000|Crossover Period 2|Withdrawal by Subject|0|||
125291857|NCT01344629|450694978|FG001|Crossover Period 2|Withdrawal by Subject|1|||
125291858|NCT00693472|450694980|FG000|Part 1|Adverse Event|1|||
125291859|NCT00693472|450694981|FG001|Part 1|Adverse Event|1|||
125291860|NCT00693472|450694982|FG002|Part 1|Adverse Event|0|||
125291861|NCT00693472|450694983|FG003|Part 1|Adverse Event|0|||
125291862|NCT00693472|450694980|FG000|Part 1|Lost to Follow-up|0|||
125291863|NCT00693472|450694981|FG001|Part 1|Lost to Follow-up|1|||
125291864|NCT00693472|450694982|FG002|Part 1|Lost to Follow-up|0|||
125291865|NCT00693472|450694983|FG003|Part 1|Lost to Follow-up|0|||
125291866|NCT00693472|450694980|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
125291867|NCT00693472|450694981|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
125291868|NCT00693472|450694982|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
125291869|NCT00693472|450694983|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
125291870|NCT00693472|450694980|FG000|Part 2|Adverse Event|0|||
125291871|NCT00693472|450694981|FG001|Part 2|Adverse Event|0|||
125291872|NCT00693472|450694982|FG002|Part 2|Adverse Event|1|||
125291873|NCT00693472|450694983|FG003|Part 2|Adverse Event|0|||
125291874|NCT00693472|450694980|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
125291875|NCT00693472|450694981|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
125291876|NCT00693472|450694982|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
125291877|NCT00693472|450694983|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
125291878|NCT04063787|450694986|FG000|Overall Study|Inadequate Doppler data|4|||
125291879|NCT04063787|450694986|FG000|Overall Study|Lost to Follow-up|2|||
125291880|NCT04063787|450694986|FG000|Overall Study|Death|3|||
125291881|NCT05545644|450694987|FG000|Overall Study|Lost to Follow-up|4|||
125291882|NCT05545644|450694988|FG001|Overall Study|Lost to Follow-up|3|||
125291883|NCT00453973|450694991|FG000|Overall Study|Adverse Event|4|||
125291884|NCT00453973|450694992|FG001|Overall Study|Adverse Event|9|||
125291885|NCT00453973|450694991|FG000|Overall Study|Withdrawal by Subject|7|||
125291886|NCT00453973|450694992|FG001|Overall Study|Withdrawal by Subject|6|||
125291887|NCT00453973|450694991|FG000|Overall Study|PI Decision|0|||
125291888|NCT00453973|450694992|FG001|Overall Study|PI Decision|2|||
125291889|NCT00453973|450694991|FG000|Overall Study|Relocation|1|||
125291890|NCT00453973|450694992|FG001|Overall Study|Relocation|0|||
125291891|NCT00453973|450694991|FG000|Overall Study|Renal transplant|1|||
125291892|NCT00453973|450694992|FG001|Overall Study|Renal transplant|1|||
125291893|NCT00453973|450694991|FG000|Overall Study|Site closed by sponsor|3|||
125291894|NCT00453973|450694992|FG001|Overall Study|Site closed by sponsor|0|||
125291895|NCT00453973|450694991|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
125291896|NCT00453973|450694992|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
125291897|NCT00276094|450694993|FG000|Overall Study|Adverse Event|15|||
125291898|NCT00276094|450694994|FG001|Overall Study|Adverse Event|13|||
125291899|NCT00276094|450694995|FG002|Overall Study|Adverse Event|11|||
125291900|NCT00276094|450694993|FG000|Overall Study|Withdrawal by Subject|14|||
125291901|NCT00276094|450694994|FG001|Overall Study|Withdrawal by Subject|14|||
125291902|NCT00276094|450694995|FG002|Overall Study|Withdrawal by Subject|12|||
125291903|NCT00276094|450694993|FG000|Overall Study|Protocol Violation|16|||
125291904|NCT00276094|450694994|FG001|Overall Study|Protocol Violation|7|||
125291905|NCT00276094|450694995|FG002|Overall Study|Protocol Violation|10|||
125291906|NCT00276094|450694993|FG000|Overall Study|Lost to Follow-up|8|||
125291907|NCT00276094|450694994|FG001|Overall Study|Lost to Follow-up|6|||
125291908|NCT00276094|450694995|FG002|Overall Study|Lost to Follow-up|4|||
125450649|NCT01959880|451276735|FG002|Overall Study|Withdrawal by Subject|8|||
125450650|NCT01959880|451276736|FG003|Overall Study|Withdrawal by Subject|7|||
125450651|NCT01959880|451276733|FG000|Overall Study|Death|1|||
125291909|NCT00276094|450694993|FG000|Overall Study|Other-Subject moved out of country|1|||
125450652|NCT01959880|451276734|FG001|Overall Study|Death|10|||
125450653|NCT01959880|451276735|FG002|Overall Study|Death|1|||
125450654|NCT01959880|451276736|FG003|Overall Study|Death|2|||
125291910|NCT00276094|450694994|FG001|Overall Study|Other-Subject moved out of country|0|||
125291911|NCT00276094|450694995|FG002|Overall Study|Other-Subject moved out of country|0|||
125291912|NCT00276094|450694993|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
125291913|NCT00276094|450694994|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
125291914|NCT00276094|450694995|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
125291915|NCT00276094|450694993|FG000|Overall Study|Other-Lack of efficacy|1|||
125291916|NCT00276094|450694994|FG001|Overall Study|Other-Lack of efficacy|0|||
125450655|NCT01959880|451276733|FG000|Overall Study|Lost to Follow-up|95|||
125291917|NCT00276094|450694995|FG002|Overall Study|Other-Lack of efficacy|0|||
125291918|NCT00276094|450694993|FG000|Overall Study|Other-Refused follow-up visit|1|||
125291919|NCT00276094|450694994|FG001|Overall Study|Other-Refused follow-up visit|0|||
125291920|NCT00276094|450694995|FG002|Overall Study|Other-Refused follow-up visit|0|||
125291921|NCT00276094|450694993|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
125291922|NCT00276094|450694994|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
125291923|NCT00276094|450694995|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
125450656|NCT01959880|451276734|FG001|Overall Study|Lost to Follow-up|18|||
125291924|NCT00276094|450694993|FG000|Overall Study|Other-Relocation|0|||
125291925|NCT00276094|450694994|FG001|Overall Study|Other-Relocation|1|||
125291926|NCT00276094|450694995|FG002|Overall Study|Other-Relocation|0|||
125291927|NCT00276094|450694993|FG000|Overall Study|Other-Study medication lost|0|||
125291928|NCT00276094|450694994|FG001|Overall Study|Other-Study medication lost|0|||
125291929|NCT00276094|450694995|FG002|Overall Study|Other-Study medication lost|1|||
125291930|NCT01873729|450694998|FG000|Overall Study|Withdrawal by Subject|1|||
125291931|NCT02463032|450694999|FG000|Overall Study|Lack of Efficacy|61|||
125291932|NCT02463032|450695000|FG001|Overall Study|Lack of Efficacy|50|||
125291933|NCT02463032|450694999|FG000|Overall Study|Death|8|||
125291934|NCT02463032|450695000|FG001|Overall Study|Death|8|||
125291935|NCT02463032|450694999|FG000|Overall Study|Adverse Event|2|||
125291936|NCT02463032|450695000|FG001|Overall Study|Adverse Event|6|||
125291937|NCT00160199|450695004|FG000|Overall Study|Adverse Event|5|||
125291938|NCT00160199|450695005|FG001|Overall Study|Adverse Event|14|||
125291939|NCT00160199|450695004|FG000|Overall Study|Lack of Efficacy|0|||
125291940|NCT00160199|450695005|FG001|Overall Study|Lack of Efficacy|1|||
125291941|NCT00160199|450695004|FG000|Overall Study|Lost to Follow-up|7|||
125291942|NCT00160199|450695005|FG001|Overall Study|Lost to Follow-up|7|||
125291943|NCT00160199|450695004|FG000|Overall Study|Withdrawal by Subject|4|||
125291944|NCT00160199|450695005|FG001|Overall Study|Withdrawal by Subject|6|||
125291945|NCT00160199|450695004|FG000|Overall Study|Administrative|0|||
125291946|NCT00160199|450695005|FG001|Overall Study|Administrative|1|||
125291947|NCT00160199|450695004|FG000|Overall Study|Protocol Violation|8|||
125291948|NCT00160199|450695005|FG001|Overall Study|Protocol Violation|8|||
125291949|NCT03352453|450695006|FG000|Overall Study|Miscellaneous Reasons|1|||
125291950|NCT03352453|450695007|FG001|Overall Study|Miscellaneous Reasons|2|||
125291951|NCT03352453|450695006|FG000|Overall Study|Lack of Efficacy|1|||
125291952|NCT03352453|450695007|FG001|Overall Study|Lack of Efficacy|0|||
125419548|NCT03449030|451160302|FG007|Overall Study|Death|0|||
125419549|NCT03449030|451160303|FG008|Overall Study|Death|0|||
125419550|NCT03449030|451160304|FG009|Overall Study|Death|0|||
125419551|NCT02415400|451160305|FG000|Overall Study|Adverse Event|0|||
125419552|NCT02415400|451160306|FG001|Overall Study|Adverse Event|1|||
125419553|NCT02415400|451160307|FG002|Overall Study|Adverse Event|1|||
125419554|NCT02415400|451160308|FG003|Overall Study|Adverse Event|2|||
125419555|NCT02415400|451160305|FG000|Overall Study|Participant request to stop therapy|4|||
125419556|NCT02415400|451160306|FG001|Overall Study|Participant request to stop therapy|3|||
125419557|NCT02415400|451160307|FG002|Overall Study|Participant request to stop therapy|8|||
125419558|NCT02415400|451160308|FG003|Overall Study|Participant request to stop therapy|6|||
125419559|NCT02415400|451160305|FG000|Overall Study|Participant withdrew consent|14|||
125419560|NCT02415400|451160306|FG001|Overall Study|Participant withdrew consent|12|||
125419561|NCT02415400|451160307|FG002|Overall Study|Participant withdrew consent|30|||
125419562|NCT02415400|451160308|FG003|Overall Study|Participant withdrew consent|21|||
125419563|NCT02415400|451160305|FG000|Overall Study|Death|39|||
125419564|NCT02415400|451160306|FG001|Overall Study|Death|41|||
125419565|NCT02415400|451160307|FG002|Overall Study|Death|35|||
125419566|NCT02415400|451160308|FG003|Overall Study|Death|42|||
125419567|NCT02415400|451160305|FG000|Overall Study|Lost to Follow-up|3|||
125419568|NCT02415400|451160306|FG001|Overall Study|Lost to Follow-up|3|||
125419569|NCT02415400|451160307|FG002|Overall Study|Lost to Follow-up|2|||
125419570|NCT02415400|451160308|FG003|Overall Study|Lost to Follow-up|5|||
125419571|NCT02415400|451160305|FG000|Overall Study|Poor/Non-Compliance|0|||
125419572|NCT02415400|451160306|FG001|Overall Study|Poor/Non-Compliance|1|||
125419573|NCT02415400|451160307|FG002|Overall Study|Poor/Non-Compliance|3|||
125419574|NCT02415400|451160308|FG003|Overall Study|Poor/Non-Compliance|4|||
125419575|NCT02415400|451160305|FG000|Overall Study|Participant no longer meets criteria|2|||
125419576|NCT02415400|451160306|FG001|Overall Study|Participant no longer meets criteria|0|||
125419577|NCT02415400|451160307|FG002|Overall Study|Participant no longer meets criteria|0|||
125419578|NCT02415400|451160308|FG003|Overall Study|Participant no longer meets criteria|1|||
125419579|NCT02415400|451160305|FG000|Overall Study|Participant doesn't answer phone|1|||
125419580|NCT02415400|451160306|FG001|Overall Study|Participant doesn't answer phone|0|||
125419581|NCT02415400|451160307|FG002|Overall Study|Participant doesn't answer phone|0|||
125419582|NCT02415400|451160308|FG003|Overall Study|Participant doesn't answer phone|0|||
125419583|NCT02415400|451160305|FG000|Overall Study|Participant wanted home visits|1|||
125419584|NCT02415400|451160306|FG001|Overall Study|Participant wanted home visits|0|||
125291953|NCT03352453|450695006|FG000|Overall Study|Withdrawal by Subject|8|||
125419585|NCT02415400|451160307|FG002|Overall Study|Participant wanted home visits|0|||
125419586|NCT02415400|451160308|FG003|Overall Study|Participant wanted home visits|0|||
125291954|NCT03352453|450695007|FG001|Overall Study|Withdrawal by Subject|14|||
125291955|NCT03352453|450695006|FG000|Overall Study|Study Terminated by Sponsor|2|||
125291956|NCT03352453|450695007|FG001|Overall Study|Study Terminated by Sponsor|1|||
125291957|NCT03352453|450695006|FG000|Overall Study|Protocol Deviation|1|||
125291958|NCT03352453|450695007|FG001|Overall Study|Protocol Deviation|0|||
125291959|NCT03352453|450695006|FG000|Overall Study|Lost to Follow-up|7|||
125291960|NCT03352453|450695007|FG001|Overall Study|Lost to Follow-up|6|||
125419587|NCT02415400|451160305|FG000|Overall Study|Randomized in error|2|||
125291961|NCT03352453|450695006|FG000|Overall Study|Adverse Event|2|||
125291962|NCT03352453|450695007|FG001|Overall Study|Adverse Event|9|||
125291963|NCT01241760|450695010|FG000|Overall Study|Adverse Event|1|||
125291964|NCT01241760|450695011|FG001|Overall Study|Adverse Event|0|||
125291965|NCT01241760|450695010|FG000|Overall Study|Lost to Follow-up|18|||
125291966|NCT01241760|450695011|FG001|Overall Study|Lost to Follow-up|22|||
125291967|NCT01241760|450695010|FG000|Overall Study|Withdrawal by Subject|13|||
125291968|NCT01241760|450695011|FG001|Overall Study|Withdrawal by Subject|13|||
125291969|NCT01241760|450695010|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
125291970|NCT01241760|450695011|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
125291971|NCT01241760|450695010|FG000|Overall Study|Other|1|||
125291972|NCT01241760|450695011|FG001|Overall Study|Other|1|||
125291973|NCT03689244|450695012|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
125291974|NCT03689244|450695013|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
125291975|NCT03689244|450695014|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
125291976|NCT03689244|450695015|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
125291977|NCT03689244|450695012|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
125291978|NCT03689244|450695013|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
125291979|NCT03689244|450695014|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
125291980|NCT03689244|450695015|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
125291981|NCT03689244|450695012|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
125291982|NCT03689244|450695013|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
125291983|NCT03689244|450695014|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
125291984|NCT03689244|450695015|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
125291985|NCT03689244|450695012|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
125291986|NCT03689244|450695013|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
125291987|NCT03689244|450695014|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
125291988|NCT03689244|450695015|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
125291989|NCT03689244|450695012|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
125291990|NCT03689244|450695013|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
125291991|NCT03689244|450695014|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
125291992|NCT03689244|450695015|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
125291993|NCT03689244|450695012|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
125291994|NCT03689244|450695013|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
125291995|NCT03689244|450695014|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
125291996|NCT03689244|450695015|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
125291997|NCT03689244|450695012|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
125291998|NCT03689244|450695013|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
125291999|NCT03689244|450695014|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
125292000|NCT03689244|450695015|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
125292001|NCT03689244|450695012|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
125292002|NCT03689244|450695013|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
125292003|NCT03689244|450695014|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
125292004|NCT03689244|450695015|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
125292005|NCT01565564|450695016|FG000|Overall Study|Lost to Follow-up|5|||
125292006|NCT01565564|450695017|FG001|Overall Study|Lost to Follow-up|1|||
125292007|NCT01591863|450695019|FG000|Overall Study|Adverse Event|3|||
125292008|NCT01591863|450695019|FG000|Overall Study|Withdrawal by Subject|1|||
125292009|NCT01591863|450695019|FG000|Overall Study|recurrence|9|||
125292010|NCT01591863|450695019|FG000|Overall Study|Lack of Efficacy|1|||
125292011|NCT00969436|450695020|FG000|Overall Study|Protocol Violation|1|||
125292012|NCT00969436|450695021|FG001|Overall Study|Protocol Violation|3|||
125292013|NCT00969436|450695022|FG002|Overall Study|Protocol Violation|0|||
125292014|NCT00969436|450695020|FG000|Overall Study|Migrated/moved from study area|12|||
125292015|NCT00969436|450695021|FG001|Overall Study|Migrated/moved from study area|10|||
125292016|NCT00969436|450695022|FG002|Overall Study|Migrated/moved from study area|2|||
125292017|NCT00969436|450695020|FG000|Overall Study|Father - serious health problem|0|||
125292018|NCT00969436|450695021|FG001|Overall Study|Father - serious health problem|0|||
125292019|NCT00969436|450695022|FG002|Overall Study|Father - serious health problem|1|||
125292020|NCT00969436|450695020|FG000|Overall Study|Parents personal problem|0|||
125292021|NCT00969436|450695021|FG001|Overall Study|Parents personal problem|0|||
125292022|NCT00969436|450695022|FG002|Overall Study|Parents personal problem|1|||
125419588|NCT02415400|451160306|FG001|Overall Study|Randomized in error|0|||
125419589|NCT02415400|451160307|FG002|Overall Study|Randomized in error|0|||
125419590|NCT02415400|451160308|FG003|Overall Study|Randomized in error|0|||
125419591|NCT02415400|451160305|FG000|Overall Study|No study drug on site|0|||
125419592|NCT02415400|451160306|FG001|Overall Study|No study drug on site|1|||
125419593|NCT02415400|451160307|FG002|Overall Study|No study drug on site|0|||
125419594|NCT02415400|451160308|FG003|Overall Study|No study drug on site|0|||
125419595|NCT02415400|451160305|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
125419596|NCT02415400|451160306|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
125419597|NCT02415400|451160307|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
125419598|NCT02415400|451160308|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
125419599|NCT02415400|451160305|FG000|Overall Study|Coagulation values cannot be set|0|||
125419600|NCT02415400|451160306|FG001|Overall Study|Coagulation values cannot be set|0|||
125419601|NCT02415400|451160307|FG002|Overall Study|Coagulation values cannot be set|1|||
125419602|NCT02415400|451160308|FG003|Overall Study|Coagulation values cannot be set|0|||
125419603|NCT02415400|451160305|FG000|Overall Study|State regulations prevent participation|0|||
125419604|NCT02415400|451160306|FG001|Overall Study|State regulations prevent participation|0|||
125419605|NCT02415400|451160307|FG002|Overall Study|State regulations prevent participation|1|||
125419606|NCT02415400|451160308|FG003|Overall Study|State regulations prevent participation|0|||
125419607|NCT02415400|451160305|FG000|Overall Study|Poor treatment monitoring|0|||
125419608|NCT02415400|451160306|FG001|Overall Study|Poor treatment monitoring|0|||
125419609|NCT02415400|451160307|FG002|Overall Study|Poor treatment monitoring|1|||
125419610|NCT02415400|451160308|FG003|Overall Study|Poor treatment monitoring|0|||
125419611|NCT02415400|451160305|FG000|Overall Study|Participant in jail|0|||
125419612|NCT02415400|451160306|FG001|Overall Study|Participant in jail|0|||
125419613|NCT02415400|451160307|FG002|Overall Study|Participant in jail|1|||
125419614|NCT02415400|451160308|FG003|Overall Study|Participant in jail|0|||
125419615|NCT02415400|451160305|FG000|Overall Study|Investigator decision|0|||
125419616|NCT02415400|451160306|FG001|Overall Study|Investigator decision|0|||
125419617|NCT02415400|451160307|FG002|Overall Study|Investigator decision|1|||
125419618|NCT02415400|451160308|FG003|Overall Study|Investigator decision|1|||
125450657|NCT01959880|451276735|FG002|Overall Study|Lost to Follow-up|15|||
125450658|NCT01959880|451276736|FG003|Overall Study|Lost to Follow-up|8|||
125450659|NCT01959880|451276733|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
125450660|NCT01959880|451276734|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
125450661|NCT01959880|451276735|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
125450662|NCT01959880|451276736|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
125450663|NCT01959880|451276733|FG000|Overall Study|Study completed early-FDA approved|1003|||
125450664|NCT01959880|451276734|FG001|Overall Study|Study completed early-FDA approved|311|||
125450665|NCT01959880|451276735|FG002|Overall Study|Study completed early-FDA approved|179|||
125450666|NCT01959880|451276736|FG003|Overall Study|Study completed early-FDA approved|152|||
125450667|NCT01919619|451276737|FG000|Overall Study|Physician Decision|1|||
125450668|NCT01919619|451276738|FG001|Overall Study|Physician Decision|1|||
125485306|NCT03523572|451412495|FG003|Dose Expansion|Clinical Progression|2|||
125485307|NCT03523572|451412496|FG004|Dose Expansion|Clinical Progression|2|||
125485308|NCT03523572|451412497|FG005|Dose Expansion|Clinical Progression|0|||
125485309|NCT03523572|451412492|FG000|Dose Expansion|Adverse Event|0|||
125485310|NCT03523572|451412493|FG001|Dose Expansion|Adverse Event|0|||
125485311|NCT03523572|451412494|FG002|Dose Expansion|Adverse Event|10|||
125485312|NCT03523572|451412495|FG003|Dose Expansion|Adverse Event|1|||
125485313|NCT03523572|451412496|FG004|Dose Expansion|Adverse Event|5|||
125485314|NCT03523572|451412497|FG005|Dose Expansion|Adverse Event|2|||
125485315|NCT03523572|451412492|FG000|Dose Expansion|Withdrawal by Subject|0|||
125485316|NCT03523572|451412493|FG001|Dose Expansion|Withdrawal by Subject|0|||
125485317|NCT03523572|451412494|FG002|Dose Expansion|Withdrawal by Subject|1|||
125485318|NCT03523572|451412495|FG003|Dose Expansion|Withdrawal by Subject|1|||
125485319|NCT03523572|451412496|FG004|Dose Expansion|Withdrawal by Subject|0|||
125485320|NCT03523572|451412497|FG005|Dose Expansion|Withdrawal by Subject|0|||
125485321|NCT03523572|451412492|FG000|Dose Expansion|Physician Decision|0|||
125485322|NCT03523572|451412493|FG001|Dose Expansion|Physician Decision|0|||
125485323|NCT03523572|451412494|FG002|Dose Expansion|Physician Decision|1|||
125485324|NCT03523572|451412495|FG003|Dose Expansion|Physician Decision|0|||
125485325|NCT03523572|451412496|FG004|Dose Expansion|Physician Decision|1|||
125485326|NCT03523572|451412497|FG005|Dose Expansion|Physician Decision|0|||
125485327|NCT03523572|451412492|FG000|Dose Expansion|Miscellaneous|0|||
125485328|NCT03523572|451412493|FG001|Dose Expansion|Miscellaneous|0|||
125485329|NCT03523572|451412494|FG002|Dose Expansion|Miscellaneous|0|||
125485330|NCT03523572|451412495|FG003|Dose Expansion|Miscellaneous|0|||
125485331|NCT03523572|451412496|FG004|Dose Expansion|Miscellaneous|3|||
125485332|NCT03523572|451412497|FG005|Dose Expansion|Miscellaneous|0|||
125485333|NCT05269966|451412498|FG000|Overall Study|Adverse Event|4|||
125485334|NCT05269966|451412498|FG000|Overall Study|Withdrawal by Subject|1|||
125485335|NCT05269966|451412498|FG000|Overall Study|Lost to Follow-up|4|||
125419619|NCT02415400|451160305|FG000|Overall Study|Site closure; participant won't transfer|0|||
125485336|NCT05269966|451412498|FG000|Overall Study|Physician Decision|1|||
125485337|NCT04685135|451412501|FG000|Overall Study|Death|126|||
125485338|NCT04685135|451412502|FG001|Overall Study|Death|53|||
125485339|NCT04685135|451412501|FG000|Overall Study|Withdrawal by Subject|12|||
125485340|NCT04685135|451412502|FG001|Overall Study|Withdrawal by Subject|16|||
125419620|NCT02415400|451160306|FG001|Overall Study|Site closure; participant won't transfer|0|||
125419621|NCT02415400|451160307|FG002|Overall Study|Site closure; participant won't transfer|0|||
125485341|NCT02240238|451412503|FG000|Phase 1|Adverse Event|0|||
125485342|NCT02240238|451412504|FG001|Phase 1|Adverse Event|0|||
125485343|NCT02240238|451412505|FG002|Phase 1|Adverse Event|0|||
125485344|NCT02240238|451412506|FG003|Phase 1|Adverse Event|0|||
125450669|NCT00256308|451277928|FG000|Overall Study|Death|2|||
125450670|NCT01211665|451277931|FG000|Overall Study|Withdrawal by Subject|1|||
125450671|NCT01211665|451277932|FG001|Overall Study|Withdrawal by Subject|0|||
125450672|NCT01211665|451277931|FG000|Overall Study|Death|1|||
125450673|NCT01211665|451277932|FG001|Overall Study|Death|0|||
125450674|NCT00498186|451277935|FG000|Overall Study|Protocol Violation|10|||
125450675|NCT00498186|451277935|FG000|Overall Study|Lack of Efficacy|31|||
125450676|NCT00498186|451277935|FG000|Overall Study|Adverse Event|89|||
125450677|NCT00498186|451277935|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
125450678|NCT00498186|451277935|FG000|Overall Study|Withdrawal by Subject|18|||
125450679|NCT00498186|451277935|FG000|Overall Study|Lost to Follow-up|3|||
125450680|NCT00498186|451277935|FG000|Overall Study|Other|10|||
125450681|NCT01390857|451277936|FG000|Overall Study|Protocol Violation|2|||
125450682|NCT01390857|451277936|FG000|Overall Study|Lost to Follow-up|1|||
125450683|NCT01390857|451277936|FG000|Overall Study|No Visit after the First Visit|7|||
125450684|NCT00886613|451277942|FG000|Overall Study|Protocol deviation (Part B)|1|||
125450685|NCT00886613|451277943|FG001|Overall Study|Protocol deviation (Part B)|0|||
125450686|NCT00886613|451277944|FG002|Overall Study|Protocol deviation (Part B)|0|||
125450687|NCT00886613|451277942|FG000|Overall Study|Lost to follow-up (Part B)|1|||
125450688|NCT00886613|451277943|FG001|Overall Study|Lost to follow-up (Part B)|0|||
125450689|NCT00886613|451277944|FG002|Overall Study|Lost to follow-up (Part B)|1|||
125450690|NCT00886613|451277942|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
125450691|NCT00886613|451277943|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
125450692|NCT00886613|451277944|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
125450693|NCT04541186|451277949|FG000|Main Study|Adverse Event|0|||
125450694|NCT04541186|451277950|FG001|Main Study|Adverse Event|0|||
125450695|NCT04541186|451277951|FG002|Main Study|Adverse Event|4|||
125450696|NCT04541186|451277952|FG003|Main Study|Adverse Event|0|||
125450697|NCT04541186|451277953|FG004|Main Study|Adverse Event|0|||
125450698|NCT04541186|451277949|FG000|Main Study|Investigator Decision|0|||
125450699|NCT04541186|451277950|FG001|Main Study|Investigator Decision|0|||
125450700|NCT04541186|451277951|FG002|Main Study|Investigator Decision|1|||
125450701|NCT04541186|451277952|FG003|Main Study|Investigator Decision|1|||
125450702|NCT04541186|451277953|FG004|Main Study|Investigator Decision|0|||
125450703|NCT04541186|451277949|FG000|Main Study|Withdrawal by Subject|1|||
125450704|NCT04541186|451277950|FG001|Main Study|Withdrawal by Subject|1|||
125450705|NCT04541186|451277951|FG002|Main Study|Withdrawal by Subject|0|||
125292023|NCT00969436|450695020|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
125292024|NCT00969436|450695021|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
125292025|NCT00969436|450695022|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
125292026|NCT00969436|450695020|FG000|Overall Study|Withdrawal by Subject|3|||
125292027|NCT00969436|450695021|FG001|Overall Study|Withdrawal by Subject|0|||
125292028|NCT00969436|450695022|FG002|Overall Study|Withdrawal by Subject|2|||
125292029|NCT00969436|450695020|FG000|Overall Study|Lost to Follow-up|8|||
125292030|NCT00969436|450695021|FG001|Overall Study|Lost to Follow-up|8|||
125292031|NCT00969436|450695022|FG002|Overall Study|Lost to Follow-up|5|||
125292032|NCT00459537|450695033|FG000|Overall Study|Adverse Event|1|||
125292033|NCT00459537|450695034|FG001|Overall Study|Adverse Event|6|||
125292034|NCT00459537|450695033|FG000|Overall Study|Lack of Efficacy|10|||
125292035|NCT00459537|450695034|FG001|Overall Study|Lack of Efficacy|11|||
125292036|NCT00459537|450695033|FG000|Overall Study|Withdrawal by Subject|20|||
125292037|NCT00459537|450695034|FG001|Overall Study|Withdrawal by Subject|26|||
125292038|NCT00459537|450695033|FG000|Overall Study|Lost to Follow-up|27|||
125292039|NCT00459537|450695034|FG001|Overall Study|Lost to Follow-up|30|||
125292040|NCT00459537|450695033|FG000|Overall Study|Administrative problems|3|||
125292041|NCT00459537|450695034|FG001|Overall Study|Administrative problems|0|||
125292042|NCT00459537|450695033|FG000|Overall Study|Protocol Violation|4|||
125292043|NCT00459537|450695034|FG001|Overall Study|Protocol Violation|3|||
125292044|NCT00459537|450695033|FG000|Overall Study|Missing|1|||
125292045|NCT00459537|450695034|FG001|Overall Study|Missing|0|||
125292046|NCT03159104|450695035|FG000|Overall Study|Violation of inclusion criteria|1|||
125292047|NCT03159104|450695036|FG001|Overall Study|Violation of inclusion criteria|2|||
125450706|NCT04541186|451277952|FG003|Main Study|Withdrawal by Subject|0|||
125450707|NCT04541186|451277953|FG004|Main Study|Withdrawal by Subject|0|||
125292048|NCT00456599|450695037|FG000|Overall Study|Non-compliance|1|||
125292049|NCT00456599|450695037|FG000|Overall Study|Withdrawal by Subject|2|||
125292050|NCT01999218|450695038|FG000|Overall Study|Hyperglycemia|18|||
125450708|NCT04541186|451277949|FG000|Main Study|COVID-19-related Dose Interruption|0|||
125450709|NCT04541186|451277950|FG001|Main Study|COVID-19-related Dose Interruption|0|||
125450710|NCT04541186|451277951|FG002|Main Study|COVID-19-related Dose Interruption|0|||
125292051|NCT01999218|450695039|FG001|Overall Study|Hyperglycemia|17|||
125292052|NCT01999218|450695040|FG002|Overall Study|Hyperglycemia|17|||
125292053|NCT01999218|450695038|FG000|Overall Study|Lack of Efficacy|1|||
125292054|NCT01999218|450695039|FG001|Overall Study|Lack of Efficacy|0|||
125292055|NCT01999218|450695040|FG002|Overall Study|Lack of Efficacy|1|||
125450711|NCT04541186|451277952|FG003|Main Study|COVID-19-related Dose Interruption|0|||
125450712|NCT04541186|451277953|FG004|Main Study|COVID-19-related Dose Interruption|1|||
125450713|NCT04541186|451277949|FG000|Main Study|Randomized in Error Not Treated|0|||
125450714|NCT04541186|451277950|FG001|Main Study|Randomized in Error Not Treated|0|||
125450715|NCT04541186|451277951|FG002|Main Study|Randomized in Error Not Treated|1|||
125450716|NCT04541186|451277952|FG003|Main Study|Randomized in Error Not Treated|0|||
125450717|NCT04541186|451277953|FG004|Main Study|Randomized in Error Not Treated|0|||
125450718|NCT04541186|451277949|FG000|Fibrate Expansion Study|Other than Specified|0|||
125450719|NCT04541186|451277950|FG001|Fibrate Expansion Study|Other than Specified|0|||
125450720|NCT04541186|451277951|FG002|Fibrate Expansion Study|Other than Specified|0|||
125450721|NCT04541186|451277952|FG003|Fibrate Expansion Study|Other than Specified|0|||
125450722|NCT04541186|451277953|FG004|Fibrate Expansion Study|Other than Specified|1|||
125450723|NCT00691028|451277954|FG000|Open-label Period|Adverse Event|0|||
125450724|NCT00691028|451277955|FG001|Open-label Period|Adverse Event|0|||
125450725|NCT00691028|451277956|FG002|Open-label Period|Adverse Event|0|||
125450726|NCT00691028|451277957|FG003|Open-label Period|Adverse Event|16|||
125450727|NCT00691028|451277954|FG000|Open-label Period|Withdrawal by Subject|0|||
125450728|NCT00691028|451277955|FG001|Open-label Period|Withdrawal by Subject|0|||
125450729|NCT00691028|451277956|FG002|Open-label Period|Withdrawal by Subject|0|||
125450730|NCT00691028|451277957|FG003|Open-label Period|Withdrawal by Subject|3|||
125450731|NCT00691028|451277954|FG000|Open-label Period|not come to a hospital|0|||
125450732|NCT00691028|451277955|FG001|Open-label Period|not come to a hospital|0|||
125450733|NCT00691028|451277956|FG002|Open-label Period|not come to a hospital|0|||
125450734|NCT00691028|451277957|FG003|Open-label Period|not come to a hospital|1|||
125450735|NCT00691028|451277954|FG000|Double-blind Period|Adverse Event|8|||
125450736|NCT00691028|451277955|FG001|Double-blind Period|Adverse Event|9|||
125450737|NCT00691028|451277956|FG002|Double-blind Period|Adverse Event|6|||
125450738|NCT00691028|451277957|FG003|Double-blind Period|Adverse Event|0|||
125450739|NCT00691028|451277954|FG000|Double-blind Period|Lack of Efficacy|4|||
125450740|NCT00691028|451277955|FG001|Double-blind Period|Lack of Efficacy|3|||
125450741|NCT00691028|451277956|FG002|Double-blind Period|Lack of Efficacy|2|||
125450742|NCT00691028|451277957|FG003|Double-blind Period|Lack of Efficacy|0|||
125450743|NCT00691028|451277954|FG000|Double-blind Period|Withdrawal by Subject|1|||
125450744|NCT00691028|451277955|FG001|Double-blind Period|Withdrawal by Subject|0|||
125450745|NCT00691028|451277956|FG002|Double-blind Period|Withdrawal by Subject|1|||
125450746|NCT00691028|451277957|FG003|Double-blind Period|Withdrawal by Subject|0|||
125450747|NCT00691028|451277954|FG000|Double-blind Period|not come to a hospital.|0|||
125450748|NCT00691028|451277955|FG001|Double-blind Period|not come to a hospital.|1|||
125450749|NCT00691028|451277956|FG002|Double-blind Period|not come to a hospital.|0|||
125450750|NCT00691028|451277957|FG003|Double-blind Period|not come to a hospital.|0|||
125450751|NCT00058058|451277965|FG000|Overall Study|Withdrawal by Subject|4|||
125450752|NCT00058058|451277965|FG000|Overall Study|Ineligible|20|||
125450753|NCT00058058|451277965|FG000|Overall Study|Claustrophobic|5|||
125450754|NCT00058058|451277965|FG000|Overall Study|technical issues|6|||
125450755|NCT00058058|451277965|FG000|Overall Study|Poor positioning, illness,pain|3|||
125450756|NCT03085017|451277966|FG000|Overall Study|Death|0|||
125450757|NCT03085017|451277967|FG001|Overall Study|Death|3|||
125450758|NCT03255018|451277969|FG000|Overall Study|Death on study|0|||
125450759|NCT03255018|451277970|FG001|Overall Study|Death on study|5|||
125450760|NCT03255018|451277969|FG000|Overall Study|Withdrawal by Subject|0|||
125450761|NCT03255018|451277970|FG001|Overall Study|Withdrawal by Subject|2|||
125450762|NCT03681691|451277976|FG000|Overall Study|COVID|1|||
125450763|NCT03681691|451277977|FG001|Overall Study|COVID|0|||
125450764|NCT03681691|451277976|FG000|Overall Study|prolonged bleeding|1|||
125450765|NCT03681691|451277977|FG001|Overall Study|prolonged bleeding|0|||
125450766|NCT03681691|451277976|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
125450767|NCT03681691|451277977|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
125450768|NCT03432533|451277978|FG000|Overall Study|Lost to Follow-up|1|||
125450769|NCT03432533|451277979|FG001|Overall Study|Lost to Follow-up|2|||
125292056|NCT01999218|450695038|FG000|Overall Study|Lost to Follow-up|22|||
125292057|NCT01999218|450695039|FG001|Overall Study|Lost to Follow-up|17|||
125450770|NCT03432533|451277978|FG000|Overall Study|Withdrawal by Subject|14|||
125450771|NCT03432533|451277979|FG001|Overall Study|Withdrawal by Subject|9|||
125450772|NCT01582243|451277988|FG000|Overall Study|Withdrawal by Subject|1|||
125450773|NCT01582243|451277988|FG000|Overall Study|Adverse Event|1|||
125450774|NCT01582243|451277988|FG000|Overall Study|Lost to Follow-up|1|||
125450775|NCT01119703|451277996|FG000|Overall Study|Adverse Event|0|||
125450776|NCT01119703|451277997|FG001|Overall Study|Adverse Event|1|||
125450777|NCT02096003|451277998|FG000|Overall Study|Protocol Violation|0|||
125450778|NCT02096003|451277999|FG001|Overall Study|Protocol Violation|2|||
125450779|NCT02096003|451277998|FG000|Overall Study|additional surgery|2|||
125450780|NCT02096003|451277999|FG001|Overall Study|additional surgery|1|||
125450781|NCT01763047|451278002|FG000|Period 1|Test Article Not Available|4|||
125450782|NCT01763047|451278003|FG001|Period 1|Test Article Not Available|1|||
125450783|NCT01763047|451278002|FG000|Period 1|Protocol Violation|4|||
125450784|NCT01763047|451278003|FG001|Period 1|Protocol Violation|4|||
125450785|NCT01763047|451278002|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
125450786|NCT01763047|451278003|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
125450787|NCT01763047|451278002|FG000|Period 1|Adverse Event|0|||
125450788|NCT01763047|451278003|FG001|Period 1|Adverse Event|1|||
125450789|NCT01763047|451278002|FG000|Period 1|Unsatisfactory Visual Response|0|||
125450790|NCT01763047|451278003|FG001|Period 1|Unsatisfactory Visual Response|3|||
125450791|NCT01763047|451278002|FG000|Period 1|Lens Power Not Available|0|||
125450792|NCT01763047|451278003|FG001|Period 1|Lens Power Not Available|1|||
125450793|NCT01763047|451278002|FG000|Period 1|Study Site office Closed|0|||
125450794|NCT01763047|451278003|FG001|Period 1|Study Site office Closed|1|||
125450795|NCT01763047|451278002|FG000|Period 2|Lens Discomfort|1|||
125450796|NCT01763047|451278003|FG001|Period 2|Lens Discomfort|0|||
125450797|NCT01763047|451278002|FG000|Period 2|No longer meets Eligibility Criteria|1|||
125450798|NCT01763047|451278003|FG001|Period 2|No longer meets Eligibility Criteria|0|||
125450799|NCT01763047|451278002|FG000|Period 2|Study Site office Closed|1|||
125419622|NCT02415400|451160308|FG003|Overall Study|Site closure; participant won't transfer|1|||
125450800|NCT01763047|451278003|FG001|Period 2|Study Site office Closed|1|||
125450801|NCT01763047|451278002|FG000|Period 2|Unsatisfactory Visual Response|1|||
125450802|NCT01763047|451278003|FG001|Period 2|Unsatisfactory Visual Response|1|||
125450803|NCT01763047|451278002|FG000|Period 2|Protocol Violation|0|||
125450804|NCT01763047|451278003|FG001|Period 2|Protocol Violation|2|||
125450805|NCT01763047|451278002|FG000|Period 2|Unsatisfactory lens Fitting|0|||
125450806|NCT01763047|451278003|FG001|Period 2|Unsatisfactory lens Fitting|1|||
125450807|NCT00916006|451278004|FG000|Overall Study|Adverse Event|1|||
125450808|NCT00916006|451278005|FG001|Overall Study|Adverse Event|1|||
125450809|NCT00916006|451278004|FG000|Overall Study|Withdrawal by Subject|2|||
125450810|NCT00916006|451278005|FG001|Overall Study|Withdrawal by Subject|5|||
125450811|NCT00916006|451278004|FG000|Overall Study|Protocol Violation|0|||
125450812|NCT00916006|451278005|FG001|Overall Study|Protocol Violation|1|||
125450813|NCT04887285|451278006|FG000|Overall Study|Lost to Follow-up|0|||
125450814|NCT04887285|451278007|FG001|Overall Study|Lost to Follow-up|2|||
125450815|NCT04887285|451278008|FG002|Overall Study|Lost to Follow-up|3|||
125450816|NCT04939428|451278009|FG000|Overall Study|Death|0|||
125450817|NCT04939428|451278010|FG001|Overall Study|Death|1|||
125450818|NCT04939428|451278011|FG002|Overall Study|Death|0|||
125450819|NCT04939428|451278009|FG000|Overall Study|Lost to Follow-up|0|||
125450820|NCT04939428|451278010|FG001|Overall Study|Lost to Follow-up|5|||
125450821|NCT04939428|451278011|FG002|Overall Study|Lost to Follow-up|0|||
125450822|NCT04939428|451278009|FG000|Overall Study|Physician Decision|1|||
125450823|NCT04939428|451278010|FG001|Overall Study|Physician Decision|0|||
125450824|NCT04939428|451278011|FG002|Overall Study|Physician Decision|0|||
125450825|NCT04939428|451278009|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125450826|NCT04939428|451278010|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125450827|NCT04939428|451278011|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125450828|NCT04939428|451278009|FG000|Overall Study|Withdrawal by Subject|10|||
125450829|NCT04939428|451278010|FG001|Overall Study|Withdrawal by Subject|11|||
125450830|NCT04939428|451278011|FG002|Overall Study|Withdrawal by Subject|0|||
125450831|NCT04939428|451278009|FG000|Overall Study|Unkown|6|||
125450832|NCT04939428|451278010|FG001|Overall Study|Unkown|3|||
125450833|NCT04939428|451278011|FG002|Overall Study|Unkown|0|||
125450834|NCT04939428|451278009|FG000|Overall Study|Discotinued per protocol|0|||
125450835|NCT04939428|451278010|FG001|Overall Study|Discotinued per protocol|0|||
125450836|NCT04939428|451278011|FG002|Overall Study|Discotinued per protocol|902|||
125450837|NCT02696785|451278012|FG000|Blinded Treatment Period|Adverse Event|0|||
125450838|NCT02696785|451278013|FG001|Blinded Treatment Period|Adverse Event|1|||
125450839|NCT02696785|451278014|FG002|Blinded Treatment Period|Adverse Event|3|||
125450840|NCT02696785|451278015|FG003|Blinded Treatment Period|Adverse Event|0|||
125450841|NCT02696785|451278012|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
125450842|NCT02696785|451278013|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
125450843|NCT02696785|451278014|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
125450844|NCT02696785|451278015|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
125419623|NCT02270450|451160309|FG000|Overall Study|Refusal unrelated to adverse event|3|||
125419624|NCT02270450|451160310|FG001|Overall Study|Refusal unrelated to adverse event|1|||
125419625|NCT02270450|451160311|FG002|Overall Study|Refusal unrelated to adverse event|5|||
125419626|NCT02270450|451160312|FG003|Overall Study|Refusal unrelated to adverse event|14|||
125419627|NCT02270450|451160309|FG000|Overall Study|Progression/relapse|1|||
125419628|NCT02270450|451160310|FG001|Overall Study|Progression/relapse|2|||
125419629|NCT02270450|451160311|FG002|Overall Study|Progression/relapse|4|||
125419630|NCT02270450|451160312|FG003|Overall Study|Progression/relapse|9|||
125419631|NCT02270450|451160309|FG000|Overall Study|Death|19|||
125419632|NCT02270450|451160310|FG001|Overall Study|Death|19|||
125419633|NCT02270450|451160311|FG002|Overall Study|Death|31|||
125419634|NCT02270450|451160312|FG003|Overall Study|Death|59|||
125419635|NCT02363738|451160313|FG000|Overall Study|Adverse Event|5|||
125419636|NCT02363738|451160314|FG001|Overall Study|Adverse Event|2|||
125450845|NCT02696785|451278012|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
125450846|NCT02696785|451278013|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
125419637|NCT02363738|451160313|FG000|Overall Study|Lack of Efficacy|1|||
125419638|NCT02363738|451160314|FG001|Overall Study|Lack of Efficacy|2|||
125419639|NCT02363738|451160313|FG000|Overall Study|Lost to Follow-up|2|||
125450847|NCT02696785|451278014|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
125450848|NCT02696785|451278015|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
125450849|NCT02696785|451278012|FG000|Blinded Treatment Period|Screen Failure|1|||
125450850|NCT02696785|451278013|FG001|Blinded Treatment Period|Screen Failure|0|||
125450851|NCT02696785|451278014|FG002|Blinded Treatment Period|Screen Failure|0|||
125450852|NCT02696785|451278015|FG003|Blinded Treatment Period|Screen Failure|0|||
125450853|NCT02696785|451278012|FG000|Washout Period|Withdrawal by Subject|0|||
125450854|NCT02696785|451278013|FG001|Washout Period|Withdrawal by Subject|1|||
125450855|NCT02696785|451278014|FG002|Washout Period|Withdrawal by Subject|0|||
125450856|NCT02696785|451278015|FG003|Washout Period|Withdrawal by Subject|0|||
125292058|NCT01999218|450695040|FG002|Overall Study|Lost to Follow-up|18|||
125292059|NCT01999218|450695038|FG000|Overall Study|Non-Compliance With Study Drug|6|||
125292060|NCT01999218|450695039|FG001|Overall Study|Non-Compliance With Study Drug|4|||
125292061|NCT01999218|450695040|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125292062|NCT01999218|450695038|FG000|Overall Study|Physician Decision|1|||
125292063|NCT01999218|450695039|FG001|Overall Study|Physician Decision|4|||
125292064|NCT01999218|450695040|FG002|Overall Study|Physician Decision|6|||
125292065|NCT01999218|450695038|FG000|Overall Study|Protocol Violation|4|||
125292066|NCT01999218|450695039|FG001|Overall Study|Protocol Violation|5|||
125292067|NCT01999218|450695040|FG002|Overall Study|Protocol Violation|4|||
125292068|NCT01999218|450695038|FG000|Overall Study|Screen failure|0|||
125292069|NCT01999218|450695039|FG001|Overall Study|Screen failure|1|||
125292070|NCT01999218|450695040|FG002|Overall Study|Screen failure|0|||
125292071|NCT01999218|450695038|FG000|Overall Study|Study Terminated By Sponsor|7|||
125292072|NCT01999218|450695039|FG001|Overall Study|Study Terminated By Sponsor|5|||
125292073|NCT01999218|450695040|FG002|Overall Study|Study Terminated By Sponsor|12|||
125292074|NCT01999218|450695038|FG000|Overall Study|Participant moves|2|||
125292075|NCT01999218|450695039|FG001|Overall Study|Participant moves|5|||
125292076|NCT01999218|450695040|FG002|Overall Study|Participant moves|3|||
125292077|NCT01999218|450695038|FG000|Overall Study|Withdrawal by Subject|28|||
125292078|NCT01999218|450695039|FG001|Overall Study|Withdrawal by Subject|29|||
125292079|NCT01999218|450695040|FG002|Overall Study|Withdrawal by Subject|34|||
125292080|NCT01999218|450695038|FG000|Overall Study|Creatinine/eGFR|0|||
125292081|NCT01999218|450695039|FG001|Overall Study|Creatinine/eGFR|0|||
125292082|NCT01999218|450695040|FG002|Overall Study|Creatinine/eGFR|1|||
125292083|NCT01999218|450695038|FG000|Overall Study|Death|7|||
125450857|NCT02696785|451278012|FG000|Washout Period|Lack of Efficacy|0|||
125450858|NCT02696785|451278013|FG001|Washout Period|Lack of Efficacy|1|||
125450859|NCT02696785|451278014|FG002|Washout Period|Lack of Efficacy|0|||
125450860|NCT02696785|451278015|FG003|Washout Period|Lack of Efficacy|0|||
125450861|NCT02696785|451278012|FG000|Extended Treatment Period|Adverse Event|2|||
125450862|NCT02696785|451278013|FG001|Extended Treatment Period|Adverse Event|3|||
125450863|NCT02696785|451278014|FG002|Extended Treatment Period|Adverse Event|2|||
125450864|NCT02696785|451278015|FG003|Extended Treatment Period|Adverse Event|1|||
125450865|NCT02696785|451278012|FG000|Extended Treatment Period|Lack of Efficacy|0|||
125450866|NCT02696785|451278013|FG001|Extended Treatment Period|Lack of Efficacy|1|||
125450867|NCT02696785|451278014|FG002|Extended Treatment Period|Lack of Efficacy|0|||
125450868|NCT02696785|451278015|FG003|Extended Treatment Period|Lack of Efficacy|0|||
125450869|NCT02696785|451278012|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
125450870|NCT02696785|451278013|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
125450871|NCT02696785|451278014|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
125450872|NCT02696785|451278015|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
125450873|NCT02696785|451278012|FG000|Follow-up Period|Adverse Event|0|||
125450874|NCT02696785|451278013|FG001|Follow-up Period|Adverse Event|0|||
125450875|NCT02696785|451278014|FG002|Follow-up Period|Adverse Event|8|||
125450876|NCT02696785|451278015|FG003|Follow-up Period|Adverse Event|2|||
125450877|NCT02696785|451278012|FG000|Follow-up Period|Lost to Follow-up|0|||
125450878|NCT02696785|451278013|FG001|Follow-up Period|Lost to Follow-up|0|||
125450879|NCT02696785|451278014|FG002|Follow-up Period|Lost to Follow-up|0|||
125450880|NCT02696785|451278015|FG003|Follow-up Period|Lost to Follow-up|1|||
125450881|NCT02696785|451278012|FG000|Follow-up Period|Lack of Efficacy|0|||
125450882|NCT02696785|451278013|FG001|Follow-up Period|Lack of Efficacy|0|||
125450883|NCT02696785|451278014|FG002|Follow-up Period|Lack of Efficacy|0|||
125450884|NCT02696785|451278015|FG003|Follow-up Period|Lack of Efficacy|1|||
125450885|NCT02696785|451278012|FG000|Follow-up Period|Withdrawal by Subject|1|||
125450886|NCT02696785|451278013|FG001|Follow-up Period|Withdrawal by Subject|0|||
125450887|NCT02696785|451278014|FG002|Follow-up Period|Withdrawal by Subject|5|||
125450888|NCT02696785|451278015|FG003|Follow-up Period|Withdrawal by Subject|4|||
125450889|NCT04863898|451278016|FG000|Overall Study|Away from study clinic during intervention training period|2|||
125450890|NCT04863898|451278016|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
125450891|NCT04863898|451278016|FG000|Overall Study|Lost to Follow-up|3|||
125450892|NCT04863898|451278016|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
125450893|NCT04863898|451278016|FG000|Overall Study|No longer employed at clinic|3|||
125450894|NCT00770211|451278017|FG000|Overall Study|Lost to Follow-up|1|||
125450895|NCT00770211|451278018|FG001|Overall Study|Lost to Follow-up|0|||
125450896|NCT00770211|451278017|FG000|Overall Study|Withdrawal by Subject|0|||
125292084|NCT01999218|450695039|FG001|Overall Study|Death|1|||
125450897|NCT00770211|451278018|FG001|Overall Study|Withdrawal by Subject|2|||
125450898|NCT00764868|451278021|FG000|Overall Study|Adverse Event|18|||
125450899|NCT00764868|451278021|FG000|Overall Study|Withdrawal by Subject|31|||
125450900|NCT00764868|451278021|FG000|Overall Study|Non-compliance|16|||
125450901|NCT00764868|451278021|FG000|Overall Study|Lost to Follow-up|25|||
125450902|NCT00764868|451278021|FG000|Overall Study|Lack of Efficacy|5|||
125450903|NCT00764868|451278021|FG000|Overall Study|Subject moved|7|||
125450904|NCT00764868|451278021|FG000|Overall Study|Pregnancy|3|||
125450905|NCT00764868|451278021|FG000|Overall Study|Prohibited medication|1|||
125450906|NCT00764868|451278021|FG000|Overall Study|Out of town|1|||
125450907|NCT00764868|451278021|FG000|Overall Study|Misuse and compliance of study drug|1|||
125450908|NCT00764868|451278021|FG000|Overall Study|Subject sent to boarding school|1|||
125450909|NCT00764868|451278021|FG000|Overall Study|Met an exclusion criteria|1|||
125450910|NCT00764868|451278021|FG000|Overall Study|Positive drug screen|2|||
125450911|NCT00764868|451278021|FG000|Overall Study|Sponsor requested withdrawal|1|||
125450912|NCT03824236|451278026|FG000|Overall Study|Lost to Follow-up|0|||
125450913|NCT03824236|451278027|FG001|Overall Study|Lost to Follow-up|0|||
125450914|NCT03824236|451278028|FG002|Overall Study|Lost to Follow-up|1|||
125450915|NCT00701311|451278029|FG000|Overall Study|Lack of Efficacy|3|||
125450916|NCT00701311|451278029|FG000|Overall Study|Adverse Event|3|||
125450917|NCT00701311|451278029|FG000|Overall Study|Withdrawal by Subject|2|||
125450918|NCT01140347|451278030|FG000|Overall Study|Lost to Follow-up|5|||
125450919|NCT01140347|451278031|FG001|Overall Study|Lost to Follow-up|6|||
125450920|NCT01140347|451278030|FG000|Overall Study|Withdrawal by Subject|13|||
125450921|NCT01140347|451278031|FG001|Overall Study|Withdrawal by Subject|8|||
125450922|NCT00828919|451278032|FG000|Overall Study|Death|0|||
125450923|NCT00828919|451278033|FG001|Overall Study|Death|1|||
125450924|NCT00828919|451278034|FG002|Overall Study|Death|2|||
125450925|NCT00828919|451278035|FG003|Overall Study|Death|0|||
125450926|NCT00828919|451278036|FG004|Overall Study|Death|0|||
125450927|NCT00828919|451278032|FG000|Overall Study|Adverse Event|2|||
125450928|NCT00828919|451278033|FG001|Overall Study|Adverse Event|2|||
125450929|NCT00828919|451278034|FG002|Overall Study|Adverse Event|2|||
125450930|NCT00828919|451278035|FG003|Overall Study|Adverse Event|1|||
125450931|NCT00828919|451278036|FG004|Overall Study|Adverse Event|3|||
125450932|NCT00828919|451278032|FG000|Overall Study|Objective progression or relapse|4|||
125450933|NCT00828919|451278033|FG001|Overall Study|Objective progression or relapse|4|||
125450934|NCT00828919|451278034|FG002|Overall Study|Objective progression or relapse|11|||
125450935|NCT00828919|451278035|FG003|Overall Study|Objective progression or relapse|0|||
125450936|NCT00828919|451278036|FG004|Overall Study|Objective progression or relapse|5|||
125450937|NCT00828919|451278032|FG000|Overall Study|No longer willing to participate in study|0|||
125450938|NCT00828919|451278033|FG001|Overall Study|No longer willing to participate in study|0|||
125450939|NCT00828919|451278034|FG002|Overall Study|No longer willing to participate in study|2|||
125450940|NCT00828919|451278035|FG003|Overall Study|No longer willing to participate in study|0|||
125450941|NCT00828919|451278036|FG004|Overall Study|No longer willing to participate in study|0|||
125450942|NCT00828919|451278032|FG000|Overall Study|Insufficient Clinical Response|0|||
125450943|NCT00828919|451278033|FG001|Overall Study|Insufficient Clinical Response|1|||
125450944|NCT00828919|451278034|FG002|Overall Study|Insufficient Clinical Response|2|||
125450945|NCT00828919|451278035|FG003|Overall Study|Insufficient Clinical Response|0|||
125450946|NCT00828919|451278036|FG004|Overall Study|Insufficient Clinical Response|0|||
125450947|NCT00828919|451278032|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
125450948|NCT00828919|451278033|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
125450949|NCT00828919|451278034|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
125450950|NCT00828919|451278035|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
125450951|NCT00828919|451278036|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
125450952|NCT00828919|451278032|FG000|Overall Study|Other|1|||
125450953|NCT00828919|451278033|FG001|Overall Study|Other|0|||
125450954|NCT00828919|451278034|FG002|Overall Study|Other|1|||
125450955|NCT00828919|451278035|FG003|Overall Study|Other|1|||
125450956|NCT00828919|451278036|FG004|Overall Study|Other|0|||
125450957|NCT00828919|451278032|FG000|Overall Study|Lost to Follow-up|0|||
125450958|NCT00828919|451278033|FG001|Overall Study|Lost to Follow-up|1|||
125450959|NCT00828919|451278034|FG002|Overall Study|Lost to Follow-up|0|||
125450960|NCT00828919|451278035|FG003|Overall Study|Lost to Follow-up|0|||
125450961|NCT00828919|451278036|FG004|Overall Study|Lost to Follow-up|0|||
125450962|NCT02501811|451278038|FG000|Overall Study|Death|1|||
125450963|NCT02501811|451278039|FG001|Overall Study|Death|3|||
125450964|NCT02501811|451278040|FG002|Overall Study|Death|2|||
125450965|NCT02501811|451278041|FG003|Overall Study|Death|3|||
125450966|NCT02501811|451278038|FG000|Overall Study|Withdrawal by Subject|3|||
125450967|NCT02501811|451278039|FG001|Overall Study|Withdrawal by Subject|3|||
125450968|NCT02501811|451278040|FG002|Overall Study|Withdrawal by Subject|2|||
125450969|NCT02501811|451278041|FG003|Overall Study|Withdrawal by Subject|3|||
125450970|NCT02501811|451278038|FG000|Overall Study|Lost to Follow-up|0|||
125450971|NCT02501811|451278039|FG001|Overall Study|Lost to Follow-up|0|||
125450972|NCT02501811|451278040|FG002|Overall Study|Lost to Follow-up|2|||
125450973|NCT02501811|451278041|FG003|Overall Study|Lost to Follow-up|1|||
125450974|NCT00359619|451279785|FG000|Overall Study|Adverse Event|0|||
125450975|NCT00359619|451279786|FG001|Overall Study|Adverse Event|0|||
125450976|NCT00359619|451279787|FG002|Overall Study|Adverse Event|1|||
125450977|NCT00359619|451279788|FG003|Overall Study|Adverse Event|0|||
125450978|NCT00359619|451279789|FG004|Overall Study|Adverse Event|0|||
125450979|NCT00359619|451279790|FG005|Overall Study|Adverse Event|0|||
125450980|NCT00359619|451279791|FG006|Overall Study|Adverse Event|1|||
125450981|NCT00359619|451279785|FG000|Overall Study|Withdrawal by Subject|3|||
125450982|NCT00359619|451279786|FG001|Overall Study|Withdrawal by Subject|1|||
125450983|NCT00359619|451279787|FG002|Overall Study|Withdrawal by Subject|4|||
125450984|NCT00359619|451279788|FG003|Overall Study|Withdrawal by Subject|2|||
125450985|NCT00359619|451279789|FG004|Overall Study|Withdrawal by Subject|2|||
125450986|NCT00359619|451279790|FG005|Overall Study|Withdrawal by Subject|0|||
125450987|NCT00359619|451279791|FG006|Overall Study|Withdrawal by Subject|3|||
125450988|NCT00359619|451279785|FG000|Overall Study|Other|1|||
125450989|NCT00359619|451279786|FG001|Overall Study|Other|0|||
125450990|NCT00359619|451279787|FG002|Overall Study|Other|0|||
125450991|NCT00359619|451279788|FG003|Overall Study|Other|0|||
125450992|NCT00359619|451279789|FG004|Overall Study|Other|0|||
125450993|NCT00359619|451279790|FG005|Overall Study|Other|0|||
125450994|NCT00359619|451279791|FG006|Overall Study|Other|0|||
125450995|NCT00359619|451279785|FG000|Overall Study|Lost to Follow-up|4|||
125450996|NCT00359619|451279786|FG001|Overall Study|Lost to Follow-up|4|||
125450997|NCT00359619|451279787|FG002|Overall Study|Lost to Follow-up|2|||
125450998|NCT00359619|451279788|FG003|Overall Study|Lost to Follow-up|1|||
125450999|NCT00359619|451279789|FG004|Overall Study|Lost to Follow-up|1|||
125451000|NCT00359619|451279790|FG005|Overall Study|Lost to Follow-up|5|||
125451001|NCT00359619|451279791|FG006|Overall Study|Lost to Follow-up|0|||
125451002|NCT01419717|451279792|FG000|Overall Study|Protocol-specified Criteria|62|||
125451003|NCT01419717|451279792|FG000|Overall Study|Adverse Event|19|||
125451004|NCT01419717|451279792|FG000|Overall Study|Death|17|||
125451005|NCT01419717|451279792|FG000|Overall Study|Withdrawal by Subject|10|||
125451006|NCT01419717|451279792|FG000|Overall Study|Disease Progression|9|||
125451007|NCT01419717|451279792|FG000|Overall Study|Other|4|||
125451008|NCT01419717|451279792|FG000|Overall Study|Lost to Follow-up|2|||
125451009|NCT01419717|451279792|FG000|Overall Study|Administrative Decision|1|||
125451010|NCT01419717|451279792|FG000|Overall Study|Noncompliance|1|||
125451011|NCT02857283|451279793|FG000|First Exposure|Withdrawal by Subject|1|||
125451012|NCT02857283|451279794|FG001|First Exposure|Withdrawal by Subject|0|||
125451013|NCT05074498|451279797|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
125451014|NCT05074498|451279798|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
125451015|NCT05074498|451279799|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
125451016|NCT05074498|451279800|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
125451017|NCT05074498|451279801|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
125451018|NCT05074498|451279802|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
125451019|NCT05074498|451279797|FG000|Part 1 (Upto Day 104)|Other|1|||
125451020|NCT05074498|451279798|FG001|Part 1 (Upto Day 104)|Other|0|||
125451021|NCT05074498|451279799|FG002|Part 1 (Upto Day 104)|Other|0|||
125451022|NCT05074498|451279800|FG003|Part 1 (Upto Day 104)|Other|0|||
125451023|NCT05074498|451279801|FG004|Part 1 (Upto Day 104)|Other|0|||
125451024|NCT05074498|451279802|FG005|Part 1 (Upto Day 104)|Other|0|||
125451025|NCT05074498|451279797|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
125451026|NCT05074498|451279798|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
125451027|NCT05074498|451279799|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
125451028|NCT05074498|451279800|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
125451029|NCT05074498|451279801|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
125292085|NCT01999218|450695040|FG002|Overall Study|Death|2|||
125292086|NCT01999218|450695038|FG000|Overall Study|Excluded Medication|1|||
125451030|NCT05074498|451279802|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
125451031|NCT05074498|451279797|FG000|Part 2 (Upto Day 104)|Death|0|||
125451032|NCT05074498|451279798|FG001|Part 2 (Upto Day 104)|Death|0|||
125451033|NCT05074498|451279799|FG002|Part 2 (Upto Day 104)|Death|0|||
125451034|NCT05074498|451279800|FG003|Part 2 (Upto Day 104)|Death|0|||
125451035|NCT05074498|451279801|FG004|Part 2 (Upto Day 104)|Death|1|||
125451036|NCT05074498|451279802|FG005|Part 2 (Upto Day 104)|Death|0|||
125451037|NCT05074498|451279797|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
125451038|NCT05074498|451279798|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
125451039|NCT05074498|451279799|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
125451040|NCT05074498|451279800|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
125451041|NCT05074498|451279801|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
125451042|NCT05074498|451279802|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
125451043|NCT05074498|451279797|FG000|Part 2 (Upto Day 104)|Other|0|||
125451044|NCT05074498|451279798|FG001|Part 2 (Upto Day 104)|Other|0|||
125451045|NCT05074498|451279799|FG002|Part 2 (Upto Day 104)|Other|0|||
125292087|NCT01999218|450695039|FG001|Overall Study|Excluded Medication|1|||
125451046|NCT05074498|451279800|FG003|Part 2 (Upto Day 104)|Other|0|||
125451047|NCT05074498|451279801|FG004|Part 2 (Upto Day 104)|Other|1|||
125292088|NCT01999218|450695040|FG002|Overall Study|Excluded Medication|2|||
125292089|NCT01999218|450695038|FG000|Overall Study|Adverse Event|9|||
125292090|NCT01999218|450695039|FG001|Overall Study|Adverse Event|7|||
125292091|NCT01999218|450695040|FG002|Overall Study|Adverse Event|7|||
125292092|NCT01999218|450695038|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
125292093|NCT01999218|450695039|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
125292094|NCT01999218|450695040|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
125292095|NCT00664326|450696496|FG000|Overall Study|Adverse Event|14|||
125292096|NCT00664326|450696496|FG000|Overall Study|Noncompliance with study medication|3|||
125292097|NCT00664326|450696496|FG000|Overall Study|Withdrawal by Subject|1|||
125292098|NCT00664326|450696496|FG000|Overall Study|Physician Decision|1|||
125292099|NCT00664326|450696496|FG000|Overall Study|Other Reasons|3|||
125292100|NCT00664326|450696496|FG000|Overall Study|Death|2|||
125292101|NCT00664326|450696496|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
125292102|NCT00387647|450696497|FG000|Overall Study|Death|18|||
125292103|NCT02032407|450696498|FG000|Overall Study|Lost to Follow-up|2|||
125292104|NCT02032407|450696498|FG000|Overall Study|Pregnancy|1|||
125292105|NCT02032407|450696498|FG000|Overall Study|Other Miscellaneous Reasons|2|||
125292106|NCT02191605|450696499|FG000|Overall Study|Lost to Follow-up|9|||
125292107|NCT02191605|450696500|FG001|Overall Study|Lost to Follow-up|4|||
125292108|NCT02191605|450696501|FG002|Overall Study|Lost to Follow-up|7|||
125292109|NCT02191605|450696502|FG003|Overall Study|Lost to Follow-up|3|||
125292110|NCT02191605|450696503|FG004|Overall Study|Lost to Follow-up|4|||
125292111|NCT01309269|450696506|FG000|Overall Study|Adverse Event|56|||
125292112|NCT01309269|450696506|FG000|Overall Study|Withdrawal by Subject|25|||
125292113|NCT01309269|450696506|FG000|Overall Study|Lack of Acceptance|15|||
125292114|NCT01309269|450696506|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
125292115|NCT01309269|450696506|FG000|Overall Study|Kidney Transplant|25|||
125292116|NCT01309269|450696506|FG000|Overall Study|Administrative Problems|141|||
125292117|NCT01309269|450696506|FG000|Overall Study|Other|256|||
125292118|NCT01309269|450696506|FG000|Overall Study|Other|1|||
125292119|NCT01309269|450696506|FG000|Overall Study|Study Completion Data Not Recorded|95|||
125292120|NCT01309269|450696506|FG000|Overall Study|Enrolled but not Treated|107|||
125292121|NCT03647267|450696510|FG000|Overall Study|Lost to Follow-up|1|||
125292122|NCT03647267|450696511|FG001|Overall Study|Lost to Follow-up|0|||
125292123|NCT01350115|450696512|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
125292124|NCT01350115|450696513|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
125292125|NCT01350115|450696512|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
125292126|NCT01350115|450696513|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
125292127|NCT01350115|450696512|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
125292128|NCT01350115|450696513|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
125292129|NCT05079477|450696514|FG000|Overall Study|Lost to Follow-up|2|||
125292130|NCT05079477|450696515|FG001|Overall Study|Lost to Follow-up|0|||
125292131|NCT05079477|450696514|FG000|Overall Study|Withdrawal by Subject|1|||
125292132|NCT05079477|450696515|FG001|Overall Study|Withdrawal by Subject|0|||
125292133|NCT05079477|450696514|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
125292134|NCT05079477|450696515|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
125292135|NCT05079477|450696514|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
125292136|NCT05079477|450696515|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
125292137|NCT05013424|450696518|FG000|Overall Study|Lost to Follow-up|1|||
125292138|NCT05013424|450696519|FG001|Overall Study|Lost to Follow-up|1|||
125292139|NCT05013424|450696520|FG002|Overall Study|Lost to Follow-up|1|||
125292140|NCT05013424|450696518|FG000|Overall Study|Withdrawal by Subject|0|||
125292141|NCT05013424|450696519|FG001|Overall Study|Withdrawal by Subject|1|||
125292142|NCT05013424|450696520|FG002|Overall Study|Withdrawal by Subject|0|||
125292143|NCT00240110|450696521|FG000|Overall Study|Lost to Follow-up|6|||
125292144|NCT00240110|450696522|FG001|Overall Study|Lost to Follow-up|7|||
125292145|NCT02654236|450696526|FG000|Overall Study|Withdrawal by Subject|0|||
125292146|NCT02654236|450696527|FG001|Overall Study|Withdrawal by Subject|0|||
125292147|NCT02654236|450696528|FG002|Overall Study|Withdrawal by Subject|2|||
125292148|NCT03204890|450696529|FG000|Overall Study|Withdrawal by Subject|1|||
125292149|NCT01549873|450696530|FG000|Overall Study|Physician Decision|0|||
125292150|NCT01549873|450696531|FG001|Overall Study|Physician Decision|1|||
125292151|NCT03769311|450696532|FG000|Overall Study|Withdrawal by Subject|1|||
125292152|NCT01596335|450696533|FG000|Overall Study|exacerbation of primary disease|5|||
125292153|NCT01596335|450696534|FG001|Overall Study|exacerbation of primary disease|9|||
125292154|NCT03627065|450696535|FG000|Overall Study|Study Terminated by sponsor|1|||
125292155|NCT03627065|450696535|FG000|Overall Study|Withdrawal by Subject|2|||
125292156|NCT04524455|450696537|FG000|Overall Study|Death|3|||
125292157|NCT04524455|450696538|FG001|Overall Study|Death|3|||
125292158|NCT04524455|450696537|FG000|Overall Study|Decision by Sponsor|0|||
125292159|NCT04524455|450696538|FG001|Overall Study|Decision by Sponsor|2|||
125292160|NCT04524455|450696537|FG000|Overall Study|Withdrawal of Consent From Study|1|||
125292161|NCT04524455|450696538|FG001|Overall Study|Withdrawal of Consent From Study|0|||
125451048|NCT05074498|451279802|FG005|Part 2 (Upto Day 104)|Other|0|||
125451049|NCT01240356|451279804|FG000|Overall Study|Withdrawal by Subject|2|||
125451050|NCT01240356|451279805|FG001|Overall Study|Withdrawal by Subject|0|||
125451051|NCT01240356|451279804|FG000|Overall Study|MRI contraindication|1|||
125451052|NCT01240356|451279805|FG001|Overall Study|MRI contraindication|0|||
125451053|NCT03613129|451279809|FG000|Pre-treatment Assessment|Protocol Violation|2|||
125451054|NCT03613129|451279810|FG001|Pre-treatment Assessment|Protocol Violation|0|||
125451055|NCT03613129|451279811|FG002|Pre-treatment Assessment|Protocol Violation|0|||
125451056|NCT03613129|451279812|FG003|Pre-treatment Assessment|Protocol Violation|0|||
125451057|NCT03613129|451279813|FG004|Pre-treatment Assessment|Protocol Violation|0|||
125451058|NCT03613129|451279809|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
125451059|NCT03613129|451279810|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
125451060|NCT03613129|451279811|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
125451061|NCT03613129|451279812|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
125451062|NCT03613129|451279813|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
125451063|NCT02950545|451279816|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
125451064|NCT02950545|451279817|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
125451065|NCT02950545|451279818|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
125451066|NCT02950545|451279819|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
125451067|NCT02950545|451279820|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
125451068|NCT02950545|451279821|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
125451069|NCT02950545|451279816|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
125451070|NCT02950545|451279817|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
125451071|NCT02950545|451279818|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
125451072|NCT02950545|451279819|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
125451073|NCT02950545|451279820|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
125451074|NCT02950545|451279821|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
125451075|NCT02950545|451279816|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
125451076|NCT02950545|451279817|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
125451077|NCT02950545|451279818|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
125451078|NCT02950545|451279819|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
125451079|NCT02950545|451279820|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
125451080|NCT02950545|451279821|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
125451081|NCT02950545|451279816|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
125451082|NCT02950545|451279817|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
125451083|NCT02950545|451279818|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
125451084|NCT02950545|451279819|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
125451085|NCT02950545|451279820|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
125451086|NCT02950545|451279821|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
125451087|NCT02950545|451279816|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
125451088|NCT02950545|451279817|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
125451089|NCT02950545|451279818|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
125451090|NCT02950545|451279819|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
125451091|NCT02950545|451279820|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
125451092|NCT02950545|451279821|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
125451093|NCT01648283|451279823|FG000|Overall Study|Withdrawal by Subject|14|||
125451094|NCT01674569|451279831|FG000|Overall Study|Adverse Event|0|||
125451095|NCT01674569|451279832|FG001|Overall Study|Adverse Event|2|||
125451096|NCT01674569|451279833|FG002|Overall Study|Adverse Event|0|||
125451097|NCT01674569|451279834|FG003|Overall Study|Adverse Event|1|||
125451098|NCT01674569|451279835|FG004|Overall Study|Adverse Event|2|||
125451099|NCT01674569|451279836|FG005|Overall Study|Adverse Event|2|||
125451100|NCT01674569|451279831|FG000|Overall Study|Protocol Violation|0|||
125451101|NCT01674569|451279832|FG001|Overall Study|Protocol Violation|1|||
125451102|NCT01674569|451279833|FG002|Overall Study|Protocol Violation|1|||
125451103|NCT01674569|451279834|FG003|Overall Study|Protocol Violation|0|||
125451104|NCT01674569|451279835|FG004|Overall Study|Protocol Violation|0|||
125451105|NCT01674569|451279836|FG005|Overall Study|Protocol Violation|0|||
125451106|NCT01674569|451279831|FG000|Overall Study|Withdrawal by Subject|0|||
125451107|NCT01674569|451279832|FG001|Overall Study|Withdrawal by Subject|0|||
125451108|NCT01674569|451279833|FG002|Overall Study|Withdrawal by Subject|1|||
125451109|NCT01674569|451279834|FG003|Overall Study|Withdrawal by Subject|0|||
125451110|NCT01674569|451279835|FG004|Overall Study|Withdrawal by Subject|0|||
125451111|NCT01674569|451279836|FG005|Overall Study|Withdrawal by Subject|0|||
125451112|NCT03178201|451279842|FG000|Overall Study|Off study|5|||
125451113|NCT02282527|451279848|FG000|Overall Study|Lost to Follow-up|0|||
125451114|NCT02282527|451279849|FG001|Overall Study|Lost to Follow-up|1|||
125451115|NCT02282527|451279848|FG000|Overall Study|Lack of home health aid|1|||
125451116|NCT02282527|451279849|FG001|Overall Study|Lack of home health aid|0|||
125451117|NCT00941031|451279850|FG000|Induction Period|Lack of Efficacy|2|||
125451118|NCT00941031|451279851|FG001|Induction Period|Lack of Efficacy|1|||
125451119|NCT00941031|451279852|FG002|Induction Period|Lack of Efficacy|0|||
125451120|NCT00941031|451279853|FG003|Induction Period|Lack of Efficacy|5|||
125451121|NCT00941031|451279854|FG004|Induction Period|Lack of Efficacy|0|||
125451122|NCT00941031|451279855|FG005|Induction Period|Lack of Efficacy|0|||
125451123|NCT00941031|451279856|FG006|Induction Period|Lack of Efficacy|0|||
125451124|NCT00941031|451279850|FG000|Induction Period|Withdrawal by Subject|1|||
125451125|NCT00941031|451279851|FG001|Induction Period|Withdrawal by Subject|2|||
125451126|NCT00941031|451279852|FG002|Induction Period|Withdrawal by Subject|2|||
125451127|NCT00941031|451279853|FG003|Induction Period|Withdrawal by Subject|2|||
125451128|NCT00941031|451279854|FG004|Induction Period|Withdrawal by Subject|0|||
125451129|NCT00941031|451279855|FG005|Induction Period|Withdrawal by Subject|0|||
125451130|NCT00941031|451279856|FG006|Induction Period|Withdrawal by Subject|0|||
125451131|NCT00941031|451279850|FG000|Induction Period|Adminstative Problems|1|||
125451132|NCT00941031|451279851|FG001|Induction Period|Adminstative Problems|1|||
125451133|NCT00941031|451279852|FG002|Induction Period|Adminstative Problems|1|||
125451134|NCT00941031|451279853|FG003|Induction Period|Adminstative Problems|0|||
125451135|NCT00941031|451279854|FG004|Induction Period|Adminstative Problems|0|||
125451136|NCT00941031|451279855|FG005|Induction Period|Adminstative Problems|0|||
125451137|NCT00941031|451279856|FG006|Induction Period|Adminstative Problems|0|||
125451138|NCT00941031|451279850|FG000|Induction Period|Adverse Event|1|||
125451139|NCT00941031|451279851|FG001|Induction Period|Adverse Event|0|||
125451140|NCT00941031|451279852|FG002|Induction Period|Adverse Event|3|||
125451141|NCT00941031|451279853|FG003|Induction Period|Adverse Event|2|||
125451142|NCT00941031|451279854|FG004|Induction Period|Adverse Event|0|||
125451143|NCT00941031|451279855|FG005|Induction Period|Adverse Event|0|||
125451144|NCT00941031|451279856|FG006|Induction Period|Adverse Event|0|||
125451145|NCT00941031|451279850|FG000|Maintenance Period|Withdrawal by Subject|0|||
125451146|NCT00941031|451279851|FG001|Maintenance Period|Withdrawal by Subject|0|||
125451147|NCT00941031|451279852|FG002|Maintenance Period|Withdrawal by Subject|0|||
125451148|NCT00941031|451279853|FG003|Maintenance Period|Withdrawal by Subject|0|||
125451149|NCT00941031|451279854|FG004|Maintenance Period|Withdrawal by Subject|6|||
125451150|NCT00941031|451279855|FG005|Maintenance Period|Withdrawal by Subject|2|||
125451151|NCT00941031|451279856|FG006|Maintenance Period|Withdrawal by Subject|13|||
125451152|NCT00941031|451279850|FG000|Maintenance Period|Administrative Problems|0|||
125451153|NCT00941031|451279851|FG001|Maintenance Period|Administrative Problems|0|||
125451154|NCT00941031|451279852|FG002|Maintenance Period|Administrative Problems|0|||
125451155|NCT00941031|451279853|FG003|Maintenance Period|Administrative Problems|0|||
125451156|NCT00941031|451279854|FG004|Maintenance Period|Administrative Problems|1|||
125451157|NCT00941031|451279855|FG005|Maintenance Period|Administrative Problems|0|||
125451158|NCT00941031|451279856|FG006|Maintenance Period|Administrative Problems|1|||
125451159|NCT00941031|451279850|FG000|Maintenance Period|Protocol Violation|0|||
125451160|NCT00941031|451279851|FG001|Maintenance Period|Protocol Violation|0|||
125451161|NCT00941031|451279852|FG002|Maintenance Period|Protocol Violation|0|||
125451162|NCT00941031|451279853|FG003|Maintenance Period|Protocol Violation|0|||
125451163|NCT00941031|451279854|FG004|Maintenance Period|Protocol Violation|0|||
125451164|NCT00941031|451279855|FG005|Maintenance Period|Protocol Violation|0|||
125451165|NCT00941031|451279856|FG006|Maintenance Period|Protocol Violation|1|||
125451166|NCT00941031|451279850|FG000|Maintenance Period|Adverse Event|0|||
125451167|NCT00941031|451279851|FG001|Maintenance Period|Adverse Event|0|||
125451168|NCT00941031|451279852|FG002|Maintenance Period|Adverse Event|0|||
125451169|NCT00941031|451279853|FG003|Maintenance Period|Adverse Event|0|||
125451170|NCT00941031|451279854|FG004|Maintenance Period|Adverse Event|0|||
125451171|NCT00941031|451279855|FG005|Maintenance Period|Adverse Event|2|||
125451172|NCT00941031|451279856|FG006|Maintenance Period|Adverse Event|8|||
125451173|NCT00941031|451279850|FG000|Maintenance Period|Lost to Follow-up|0|||
125451174|NCT00941031|451279851|FG001|Maintenance Period|Lost to Follow-up|0|||
125451175|NCT00941031|451279852|FG002|Maintenance Period|Lost to Follow-up|0|||
125451176|NCT00941031|451279853|FG003|Maintenance Period|Lost to Follow-up|0|||
125451177|NCT00941031|451279854|FG004|Maintenance Period|Lost to Follow-up|2|||
125451178|NCT00941031|451279855|FG005|Maintenance Period|Lost to Follow-up|2|||
125451179|NCT00941031|451279856|FG006|Maintenance Period|Lost to Follow-up|7|||
125292162|NCT04524455|450696537|FG000|Overall Study|Lost to Follow-up|0|||
125292163|NCT04524455|450696538|FG001|Overall Study|Lost to Follow-up|1|||
125292164|NCT01688739|450696541|FG000|Overall Study|Administrative Decision|1|||
125292165|NCT01688739|450696542|FG001|Overall Study|Administrative Decision|0|||
125292166|NCT01688739|450696543|FG002|Overall Study|Administrative Decision|0|||
125292167|NCT01688739|450696544|FG003|Overall Study|Administrative Decision|0|||
125292168|NCT01688739|450696545|FG004|Overall Study|Administrative Decision|0|||
125292169|NCT01688739|450696546|FG005|Overall Study|Administrative Decision|0|||
125292170|NCT01688739|450696547|FG006|Overall Study|Administrative Decision|0|||
125451180|NCT00941031|451279850|FG000|Maintenance Period|Lack of Efficacy|0|||
125451181|NCT00941031|451279851|FG001|Maintenance Period|Lack of Efficacy|0|||
125451182|NCT00941031|451279852|FG002|Maintenance Period|Lack of Efficacy|0|||
125451183|NCT00941031|451279853|FG003|Maintenance Period|Lack of Efficacy|0|||
125451184|NCT00941031|451279854|FG004|Maintenance Period|Lack of Efficacy|0|||
125451185|NCT00941031|451279855|FG005|Maintenance Period|Lack of Efficacy|0|||
125451186|NCT00941031|451279856|FG006|Maintenance Period|Lack of Efficacy|13|||
125292171|NCT01688739|450696548|FG007|Overall Study|Administrative Decision|0|||
125451187|NCT03124108|451279857|FG000|Overall Study|Adverse Event|0|||
125292172|NCT01688739|450696549|FG008|Overall Study|Administrative Decision|0|||
125292173|NCT01688739|450696550|FG009|Overall Study|Administrative Decision|0|||
125292174|NCT00996801|450696551|FG000|Overall Study|Adverse Event|6|||
125292175|NCT00996801|450696552|FG001|Overall Study|Adverse Event|4|||
125292176|NCT00996801|450696553|FG002|Overall Study|Adverse Event|12|||
125292177|NCT00996801|450696554|FG003|Overall Study|Adverse Event|17|||
125292178|NCT00996801|450696555|FG004|Overall Study|Adverse Event|31|||
125292179|NCT00996801|450696556|FG005|Overall Study|Adverse Event|3|||
125292180|NCT00996801|450696551|FG000|Overall Study|Lack of Efficacy|3|||
125292181|NCT00996801|450696552|FG001|Overall Study|Lack of Efficacy|0|||
125451188|NCT03124108|451279858|FG001|Overall Study|Adverse Event|1|||
125451189|NCT03124108|451279859|FG002|Overall Study|Adverse Event|0|||
125451190|NCT00631917|451279860|FG000|Overall Study|Adverse Event|34|||
125451191|NCT00631917|451279861|FG001|Overall Study|Adverse Event|45|||
125451192|NCT00631917|451279860|FG000|Overall Study|Abnormal laboratory value(s)|2|||
125451193|NCT00631917|451279861|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125451194|NCT00631917|451279860|FG000|Overall Study|Abnormal test procedure result(s)|3|||
125451195|NCT00631917|451279861|FG001|Overall Study|Abnormal test procedure result(s)|2|||
125451196|NCT00631917|451279860|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
125451197|NCT00631917|451279861|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
125451198|NCT00631917|451279860|FG000|Overall Study|No longer required study drug|0|||
125451199|NCT00631917|451279861|FG001|Overall Study|No longer required study drug|1|||
125451200|NCT00631917|451279860|FG000|Overall Study|Protocol deviation|6|||
125451201|NCT00631917|451279861|FG001|Overall Study|Protocol deviation|5|||
125451202|NCT00631917|451279860|FG000|Overall Study|Subject withdrew consent|25|||
125451203|NCT00631917|451279861|FG001|Overall Study|Subject withdrew consent|33|||
125451204|NCT00631917|451279860|FG000|Overall Study|Lost to Follow-up|7|||
125451205|NCT00631917|451279861|FG001|Overall Study|Lost to Follow-up|7|||
125451206|NCT00631917|451279860|FG000|Overall Study|Administrative problems|2|||
125451207|NCT00631917|451279861|FG001|Overall Study|Administrative problems|0|||
125451208|NCT00631917|451279860|FG000|Overall Study|Death|1|||
125451209|NCT00631917|451279861|FG001|Overall Study|Death|0|||
125451210|NCT05650333|451279864|FG000|Treatment Period (7 Days)|Adverse Event|1|||
125451211|NCT02403323|451279865|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
125451212|NCT02403323|451279866|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
125451213|NCT02403323|451279867|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
125451214|NCT02403323|451279865|FG000|Part 1: Open Label Extension Period|Death|3|||
125451215|NCT02403323|451279866|FG001|Part 1: Open Label Extension Period|Death|0|||
125451216|NCT02403323|451279867|FG002|Part 1: Open Label Extension Period|Death|0|||
125451217|NCT02403323|451279865|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
125451218|NCT02403323|451279866|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
125451219|NCT02403323|451279867|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
125451220|NCT02403323|451279865|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
125451221|NCT02403323|451279866|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
125451222|NCT02403323|451279867|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
125451223|NCT02403323|451279865|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
125451224|NCT02403323|451279866|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
125451225|NCT02403323|451279867|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
125451226|NCT02403323|451279865|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
125451227|NCT02403323|451279866|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
125451228|NCT02403323|451279867|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
125451229|NCT02403323|451279865|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
125451230|NCT02403323|451279866|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
125451231|NCT02403323|451279867|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
125451232|NCT02403323|451279865|FG000|Part 1: Open Label Extension Period|Other|1|||
125451233|NCT02403323|451279866|FG001|Part 1: Open Label Extension Period|Other|0|||
125451234|NCT02403323|451279867|FG002|Part 1: Open Label Extension Period|Other|0|||
125451235|NCT02403323|451279865|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
125451236|NCT02403323|451279866|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
125451237|NCT02403323|451279867|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
125451238|NCT02403323|451279865|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
125451239|NCT02403323|451279866|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
125451240|NCT02403323|451279867|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
125451241|NCT02403323|451279865|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
125451242|NCT02403323|451279866|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
125451243|NCT02403323|451279867|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
125292182|NCT00996801|450696553|FG002|Overall Study|Lack of Efficacy|1|||
125292183|NCT00996801|450696554|FG003|Overall Study|Lack of Efficacy|3|||
125292184|NCT00996801|450696555|FG004|Overall Study|Lack of Efficacy|0|||
125292185|NCT00996801|450696556|FG005|Overall Study|Lack of Efficacy|1|||
125292186|NCT00996801|450696551|FG000|Overall Study|Lost to Follow-up|0|||
125292187|NCT00996801|450696552|FG001|Overall Study|Lost to Follow-up|0|||
125292188|NCT00996801|450696553|FG002|Overall Study|Lost to Follow-up|0|||
125451244|NCT02403323|451279865|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
125451245|NCT02403323|451279866|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
125451246|NCT02403323|451279867|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
125451247|NCT02403323|451279865|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
125451248|NCT02403323|451279866|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
125451249|NCT02403323|451279867|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
125451250|NCT02403323|451279865|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
125451251|NCT02403323|451279866|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
125451252|NCT02403323|451279867|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
125451253|NCT02403323|451279865|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
125451254|NCT02403323|451279866|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
125451255|NCT02403323|451279867|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
125451256|NCT02403323|451279865|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
125451257|NCT02403323|451279866|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
125451258|NCT02403323|451279867|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
125451259|NCT02403323|451279865|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
125451260|NCT02403323|451279866|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
125451261|NCT02403323|451279867|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
125451262|NCT02403323|451279865|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
125451263|NCT02403323|451279866|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
125451264|NCT02403323|451279867|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
125451265|NCT02616263|451279868|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
125451266|NCT02616263|451279869|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
125451267|NCT02616263|451279868|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
125451268|NCT02616263|451279869|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
125451269|NCT02616263|451279868|FG000|6 Month to 1.5 Year|Death|1|||
125451270|NCT02616263|451279869|FG001|6 Month to 1.5 Year|Death|0|||
125451271|NCT02616263|451279868|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
125451272|NCT02616263|451279869|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
125451273|NCT02616263|451279868|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
125451274|NCT02616263|451279869|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
125451275|NCT02616263|451279868|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
125451276|NCT02616263|451279869|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
125451277|NCT03686384|451279870|FG000|Overall Study|Lack of Efficacy|4|||
125451278|NCT03686384|451279871|FG001|Overall Study|Lack of Efficacy|13|||
125451279|NCT03686384|451279870|FG000|Overall Study|Lost to Follow-up|3|||
125451280|NCT03686384|451279871|FG001|Overall Study|Lost to Follow-up|0|||
125451281|NCT03686384|451279870|FG000|Overall Study|Physician Decision|0|||
125451282|NCT03686384|451279871|FG001|Overall Study|Physician Decision|1|||
125451283|NCT03686384|451279870|FG000|Overall Study|Took prohibited medication|0|||
125451284|NCT03686384|451279871|FG001|Overall Study|Took prohibited medication|1|||
125451285|NCT02820051|451279874|FG000|Overall Study|Lost to Follow-up|7|||
125451286|NCT02820051|451279875|FG001|Overall Study|Lost to Follow-up|4|||
125451287|NCT01222247|451279876|FG000|Overall Study|Lost to Follow-up|2|||
125451288|NCT01222247|451279877|FG001|Overall Study|Lost to Follow-up|2|||
125451289|NCT04639947|451279879|FG000|Overall Study|Screen fail|1|||
125451290|NCT00614744|451279885|FG000|Overall Study|Lost to Follow-up|5|||
125451291|NCT00614744|451279886|FG001|Overall Study|Lost to Follow-up|4|||
125451292|NCT00614744|451279885|FG000|Overall Study|Incomplete for Behavior Issues|0|||
125451293|NCT00614744|451279886|FG001|Overall Study|Incomplete for Behavior Issues|2|||
125451294|NCT00877851|451279887|FG000|Overall Study|Lost to Follow-up|5|||
125451295|NCT00877851|451279888|FG001|Overall Study|Lost to Follow-up|5|||
125451296|NCT00877851|451279887|FG000|Overall Study|computer problem|3|||
125451297|NCT00877851|451279888|FG001|Overall Study|computer problem|0|||
125451298|NCT00877851|451279887|FG000|Overall Study|no longer interested in participating|1|||
125451299|NCT00877851|451279888|FG001|Overall Study|no longer interested in participating|0|||
125451300|NCT03424239|451279889|FG000|Overall Study|Withdrawal by Subject|2|||
125451301|NCT02042443|451279897|FG000|Overall Study|Adverse Event|2|||
125451302|NCT02042443|451279898|FG001|Overall Study|Adverse Event|1|||
125451303|NCT02042443|451279897|FG000|Overall Study|Withdrawal by Subject|0|||
125451304|NCT02042443|451279898|FG001|Overall Study|Withdrawal by Subject|1|||
125451305|NCT02042443|451279897|FG000|Overall Study|Progression|21|||
125451306|NCT02042443|451279898|FG001|Overall Study|Progression|17|||
125451307|NCT02042443|451279897|FG000|Overall Study|not protocol specified|1|||
125451308|NCT02042443|451279898|FG001|Overall Study|not protocol specified|1|||
125451309|NCT02042443|451279897|FG000|Overall Study|Not eligible/not analyzable|3|||
125451310|NCT02042443|451279898|FG001|Overall Study|Not eligible/not analyzable|6|||
125451311|NCT02320253|451279899|FG000|Overall Study|Withdrawal by Subject|3|||
125451312|NCT02320253|451279900|FG001|Overall Study|Withdrawal by Subject|0|||
125451313|NCT02320253|451279901|FG002|Overall Study|Withdrawal by Subject|0|||
125451314|NCT02320253|451279899|FG000|Overall Study|Lost to Follow-up|2|||
125451315|NCT02320253|451279900|FG001|Overall Study|Lost to Follow-up|2|||
125451316|NCT02320253|451279901|FG002|Overall Study|Lost to Follow-up|1|||
125451317|NCT02320253|451279899|FG000|Overall Study|Death|1|||
125451318|NCT02320253|451279900|FG001|Overall Study|Death|0|||
125451319|NCT02320253|451279901|FG002|Overall Study|Death|1|||
125451320|NCT04794179|451279902|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
125451321|NCT04794179|451279903|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
125451322|NCT00768066|451279904|FG000|Overall Study|Did not receive study product injection.|3|||
125451323|NCT00768066|451279905|FG001|Overall Study|Did not receive study product injection.|3|||
125451324|NCT00768066|451279906|FG002|Overall Study|Did not receive study product injection.|0|||
125451325|NCT04831775|451279907|FG000|Overall Study|Lost to Follow-up|11|||
125451326|NCT04831775|451279908|FG001|Overall Study|Lost to Follow-up|13|||
125451327|NCT05550337|451279911|FG000|Overall Study|Lack of Efficacy|0|||
125451328|NCT05550337|451279912|FG001|Overall Study|Lack of Efficacy|0|||
125451329|NCT05550337|451279913|FG002|Overall Study|Lack of Efficacy|1|||
125451330|NCT05550337|451279911|FG000|Overall Study|Adverse Event|1|||
125451331|NCT05550337|451279912|FG001|Overall Study|Adverse Event|5|||
125451332|NCT05550337|451279913|FG002|Overall Study|Adverse Event|0|||
125451333|NCT05550337|451279911|FG000|Overall Study|Withdrawal by Subject|8|||
125451334|NCT05550337|451279912|FG001|Overall Study|Withdrawal by Subject|14|||
125451335|NCT05550337|451279913|FG002|Overall Study|Withdrawal by Subject|10|||
125451336|NCT05550337|451279911|FG000|Overall Study|Pregnancy|0|||
125451337|NCT05550337|451279912|FG001|Overall Study|Pregnancy|0|||
125451338|NCT05550337|451279913|FG002|Overall Study|Pregnancy|1|||
125451339|NCT05550337|451279911|FG000|Overall Study|Protocol Violation|1|||
125451340|NCT05550337|451279912|FG001|Overall Study|Protocol Violation|3|||
125451341|NCT05550337|451279913|FG002|Overall Study|Protocol Violation|4|||
125451342|NCT05550337|451279911|FG000|Overall Study|Physician Decision|2|||
125451343|NCT05550337|451279912|FG001|Overall Study|Physician Decision|1|||
125451344|NCT05550337|451279913|FG002|Overall Study|Physician Decision|1|||
125451345|NCT05550337|451279911|FG000|Overall Study|Lost to Follow-up|16|||
125451346|NCT05550337|451279912|FG001|Overall Study|Lost to Follow-up|11|||
125451347|NCT05550337|451279913|FG002|Overall Study|Lost to Follow-up|11|||
125451348|NCT03115346|451279914|FG000|Overall Study|Did not have AAA surgery|28|||
125451349|NCT03115346|451279915|FG001|Overall Study|Did not have AAA surgery|15|||
125451350|NCT03115346|451279914|FG000|Overall Study|Death|3|||
125451351|NCT03115346|451279915|FG001|Overall Study|Death|1|||
125451352|NCT03115346|451279914|FG000|Overall Study|Withdrawal by Subject|0|||
125451353|NCT03115346|451279915|FG001|Overall Study|Withdrawal by Subject|3|||
125451354|NCT03115346|451279914|FG000|Overall Study|Lost to Follow-up|0|||
125451355|NCT03115346|451279915|FG001|Overall Study|Lost to Follow-up|3|||
125451356|NCT01737268|451279916|FG000|Overall Study|Adverse Event|6|||
125451357|NCT01737268|451279916|FG000|Overall Study|Worsening of Target Disease|2|||
125451358|NCT01737268|451279916|FG000|Overall Study|In consideration of the patient's safety|1|||
125451359|NCT01458275|451279917|FG000|Overall Study|Adverse Event|3|||
125451360|NCT01458275|451279918|FG001|Overall Study|Adverse Event|4|||
125451361|NCT01458275|451279919|FG002|Overall Study|Adverse Event|1|||
125451362|NCT01458275|451279917|FG000|Overall Study|Lost to Follow-up|3|||
125451363|NCT01458275|451279918|FG001|Overall Study|Lost to Follow-up|2|||
125451364|NCT01458275|451279919|FG002|Overall Study|Lost to Follow-up|5|||
125451365|NCT01458275|451279917|FG000|Overall Study|Protocol Violation|5|||
125451366|NCT01458275|451279918|FG001|Overall Study|Protocol Violation|5|||
125451367|NCT01458275|451279919|FG002|Overall Study|Protocol Violation|2|||
125451368|NCT01458275|451279917|FG000|Overall Study|Withdrawal by Subject|3|||
125451369|NCT01458275|451279918|FG001|Overall Study|Withdrawal by Subject|2|||
125451370|NCT01458275|451279919|FG002|Overall Study|Withdrawal by Subject|1|||
125451371|NCT03697460|451279920|FG000|Overall Study|Withdrawal by Subject|3|||
125451372|NCT03499600|451279927|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
125451373|NCT03499600|451279928|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
125451374|NCT00445692|451279929|FG000|Overall Study|Adverse Event|11|||
125451375|NCT00445692|451279929|FG000|Overall Study|Lack of Efficacy|5|||
125451376|NCT01137292|451279930|FG000|Overall Study|Death|30|||
125451377|NCT01137292|451279930|FG000|Overall Study|Adverse Event|3|||
125451378|NCT01137292|451279930|FG000|Overall Study|Lack of Efficacy|13|||
125451379|NCT01137292|451279930|FG000|Overall Study|Lost to Follow-up|1|||
125451380|NCT01137292|451279930|FG000|Overall Study|Other|7|||
125451381|NCT03425539|451279931|FG000|Overall Study|Randomized but not treated|0|||
125451382|NCT03425539|451279932|FG001|Overall Study|Randomized but not treated|1|||
125451383|NCT03425539|451279931|FG000|Overall Study|Adverse Event|2|||
125451384|NCT03425539|451279932|FG001|Overall Study|Adverse Event|2|||
125451385|NCT03425539|451279931|FG000|Overall Study|Withdrawal by Subject|3|||
125451386|NCT03425539|451279932|FG001|Overall Study|Withdrawal by Subject|0|||
125451387|NCT03425539|451279931|FG000|Overall Study|Lost to Follow-up|0|||
125451388|NCT03425539|451279932|FG001|Overall Study|Lost to Follow-up|1|||
125451389|NCT02014558|451279933|FG000|Overall Study|Never Received Study Drug|0|||
125451390|NCT02014558|451279934|FG001|Overall Study|Never Received Study Drug|0|||
125451391|NCT02014558|451279935|FG002|Overall Study|Never Received Study Drug|0|||
125451392|NCT02014558|451279936|FG003|Overall Study|Never Received Study Drug|0|||
125451393|NCT02014558|451279937|FG004|Overall Study|Never Received Study Drug|1|||
125451394|NCT02014558|451279938|FG005|Overall Study|Never Received Study Drug|0|||
125451395|NCT02014558|451279939|FG006|Overall Study|Never Received Study Drug|1|||
125451396|NCT02014558|451279940|FG007|Overall Study|Never Received Study Drug|0|||
125451397|NCT02014558|451279941|FG008|Overall Study|Never Received Study Drug|2|||
125451398|NCT02014558|451279942|FG009|Overall Study|Never Received Study Drug|0|||
125451399|NCT02014558|451279943|FG010|Overall Study|Never Received Study Drug|2|||
125451400|NCT02014558|451279944|FG011|Overall Study|Never Received Study Drug|2|||
125451401|NCT02014558|451279945|FG012|Overall Study|Never Received Study Drug|0|||
125451402|NCT02014558|451279933|FG000|Overall Study|Adverse Event|0|||
125451403|NCT02014558|451279934|FG001|Overall Study|Adverse Event|0|||
125451404|NCT02014558|451279935|FG002|Overall Study|Adverse Event|0|||
125451405|NCT02014558|451279936|FG003|Overall Study|Adverse Event|0|||
125451406|NCT02014558|451279937|FG004|Overall Study|Adverse Event|1|||
125451407|NCT02014558|451279938|FG005|Overall Study|Adverse Event|0|||
125451408|NCT02014558|451279939|FG006|Overall Study|Adverse Event|0|||
125451409|NCT02014558|451279940|FG007|Overall Study|Adverse Event|0|||
125451410|NCT02014558|451279941|FG008|Overall Study|Adverse Event|2|||
125451411|NCT02014558|451279942|FG009|Overall Study|Adverse Event|2|||
125451412|NCT02014558|451279943|FG010|Overall Study|Adverse Event|5|||
125451413|NCT02014558|451279944|FG011|Overall Study|Adverse Event|21|||
125451414|NCT02014558|451279945|FG012|Overall Study|Adverse Event|3|||
125451415|NCT02014558|451279933|FG000|Overall Study|Death|1|||
125451416|NCT02014558|451279934|FG001|Overall Study|Death|0|||
125451417|NCT02014558|451279935|FG002|Overall Study|Death|0|||
125451418|NCT02014558|451279936|FG003|Overall Study|Death|0|||
125451419|NCT02014558|451279937|FG004|Overall Study|Death|0|||
125451420|NCT02014558|451279938|FG005|Overall Study|Death|0|||
125451421|NCT02014558|451279939|FG006|Overall Study|Death|1|||
125451422|NCT02014558|451279940|FG007|Overall Study|Death|1|||
125451423|NCT02014558|451279941|FG008|Overall Study|Death|2|||
125451424|NCT02014558|451279942|FG009|Overall Study|Death|5|||
125451425|NCT02014558|451279943|FG010|Overall Study|Death|5|||
125451426|NCT02014558|451279944|FG011|Overall Study|Death|19|||
125451427|NCT02014558|451279945|FG012|Overall Study|Death|2|||
125451428|NCT02014558|451279933|FG000|Overall Study|Lack of Efficacy|1|||
125451429|NCT02014558|451279934|FG001|Overall Study|Lack of Efficacy|2|||
125451430|NCT02014558|451279935|FG002|Overall Study|Lack of Efficacy|1|||
125451431|NCT02014558|451279936|FG003|Overall Study|Lack of Efficacy|1|||
125451432|NCT02014558|451279937|FG004|Overall Study|Lack of Efficacy|0|||
125451433|NCT02014558|451279938|FG005|Overall Study|Lack of Efficacy|0|||
125451434|NCT02014558|451279939|FG006|Overall Study|Lack of Efficacy|1|||
125451435|NCT02014558|451279940|FG007|Overall Study|Lack of Efficacy|3|||
125451436|NCT02014558|451279941|FG008|Overall Study|Lack of Efficacy|3|||
125451437|NCT02014558|451279942|FG009|Overall Study|Lack of Efficacy|3|||
125451438|NCT02014558|451279943|FG010|Overall Study|Lack of Efficacy|16|||
125451439|NCT02014558|451279944|FG011|Overall Study|Lack of Efficacy|8|||
125451440|NCT02014558|451279945|FG012|Overall Study|Lack of Efficacy|5|||
125451441|NCT02014558|451279933|FG000|Overall Study|Lost to Follow-up|0|||
125451442|NCT02014558|451279934|FG001|Overall Study|Lost to Follow-up|0|||
125451443|NCT02014558|451279935|FG002|Overall Study|Lost to Follow-up|0|||
125451444|NCT02014558|451279936|FG003|Overall Study|Lost to Follow-up|0|||
125451445|NCT02014558|451279937|FG004|Overall Study|Lost to Follow-up|0|||
125451446|NCT02014558|451279938|FG005|Overall Study|Lost to Follow-up|0|||
125451447|NCT02014558|451279939|FG006|Overall Study|Lost to Follow-up|0|||
125451448|NCT02014558|451279940|FG007|Overall Study|Lost to Follow-up|0|||
125451449|NCT02014558|451279941|FG008|Overall Study|Lost to Follow-up|0|||
125451450|NCT02014558|451279942|FG009|Overall Study|Lost to Follow-up|0|||
125451451|NCT02014558|451279943|FG010|Overall Study|Lost to Follow-up|1|||
125451452|NCT02014558|451279944|FG011|Overall Study|Lost to Follow-up|0|||
125451453|NCT02014558|451279945|FG012|Overall Study|Lost to Follow-up|0|||
125451454|NCT02014558|451279933|FG000|Overall Study|Progressive Disease|1|||
125451455|NCT02014558|451279934|FG001|Overall Study|Progressive Disease|0|||
125451456|NCT02014558|451279935|FG002|Overall Study|Progressive Disease|1|||
125451457|NCT02014558|451279936|FG003|Overall Study|Progressive Disease|1|||
125451458|NCT02014558|451279937|FG004|Overall Study|Progressive Disease|1|||
125451459|NCT02014558|451279938|FG005|Overall Study|Progressive Disease|2|||
125451460|NCT02014558|451279939|FG006|Overall Study|Progressive Disease|1|||
125451461|NCT02014558|451279940|FG007|Overall Study|Progressive Disease|6|||
125451462|NCT02014558|451279941|FG008|Overall Study|Progressive Disease|5|||
125451463|NCT02014558|451279942|FG009|Overall Study|Progressive Disease|6|||
125451464|NCT02014558|451279943|FG010|Overall Study|Progressive Disease|22|||
125451465|NCT02014558|451279944|FG011|Overall Study|Progressive Disease|31|||
125451466|NCT02014558|451279945|FG012|Overall Study|Progressive Disease|6|||
125451467|NCT02014558|451279933|FG000|Overall Study|Withdrawal by Subject|0|||
125451468|NCT02014558|451279934|FG001|Overall Study|Withdrawal by Subject|0|||
125451469|NCT02014558|451279935|FG002|Overall Study|Withdrawal by Subject|0|||
125451470|NCT02014558|451279936|FG003|Overall Study|Withdrawal by Subject|0|||
125451471|NCT02014558|451279937|FG004|Overall Study|Withdrawal by Subject|1|||
125451472|NCT02014558|451279938|FG005|Overall Study|Withdrawal by Subject|0|||
125451473|NCT02014558|451279939|FG006|Overall Study|Withdrawal by Subject|0|||
125451474|NCT02014558|451279940|FG007|Overall Study|Withdrawal by Subject|0|||
125451475|NCT02014558|451279941|FG008|Overall Study|Withdrawal by Subject|0|||
125451476|NCT02014558|451279942|FG009|Overall Study|Withdrawal by Subject|2|||
125451477|NCT02014558|451279943|FG010|Overall Study|Withdrawal by Subject|6|||
125451478|NCT02014558|451279944|FG011|Overall Study|Withdrawal by Subject|10|||
125451479|NCT02014558|451279945|FG012|Overall Study|Withdrawal by Subject|0|||
125451480|NCT02014558|451279933|FG000|Overall Study|Miscellaneous|2|||
125451481|NCT02014558|451279934|FG001|Overall Study|Miscellaneous|1|||
125451482|NCT02014558|451279935|FG002|Overall Study|Miscellaneous|1|||
125451483|NCT02014558|451279936|FG003|Overall Study|Miscellaneous|1|||
125451484|NCT02014558|451279937|FG004|Overall Study|Miscellaneous|0|||
125451485|NCT02014558|451279938|FG005|Overall Study|Miscellaneous|1|||
125451486|NCT02014558|451279939|FG006|Overall Study|Miscellaneous|0|||
125451487|NCT02014558|451279940|FG007|Overall Study|Miscellaneous|1|||
125451488|NCT02014558|451279941|FG008|Overall Study|Miscellaneous|1|||
125451489|NCT02014558|451279942|FG009|Overall Study|Miscellaneous|3|||
125451490|NCT02014558|451279943|FG010|Overall Study|Miscellaneous|12|||
125451491|NCT02014558|451279944|FG011|Overall Study|Miscellaneous|11|||
125451492|NCT02014558|451279945|FG012|Overall Study|Miscellaneous|1|||
125451493|NCT04580407|451279946|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
125451494|NCT05567159|451279951|FG000|Overall Study|Adverse Event|4|||
125451495|NCT05567159|451279951|FG000|Overall Study|Physician Decision|3|||
125451496|NCT05567159|451279951|FG000|Overall Study|Protocol deviation|1|||
125451497|NCT00672256|451281847|FG000|Overall Study|PI dropped, bad data|44|||
125451498|NCT02072226|451281853|FG000|Overall Study|Lost to Follow-up|11|||
125451499|NCT02072226|451281854|FG001|Overall Study|Lost to Follow-up|7|||
125451500|NCT02072226|451281853|FG000|Overall Study|Patient Non-compliance|2|||
125451501|NCT02072226|451281854|FG001|Overall Study|Patient Non-compliance|3|||
125451502|NCT02072226|451281853|FG000|Overall Study|Death|1|||
125451503|NCT02072226|451281854|FG001|Overall Study|Death|0|||
125451504|NCT02072226|451281853|FG000|Overall Study|Patient Withdrawal of Consent|1|||
125451505|NCT02072226|451281854|FG001|Overall Study|Patient Withdrawal of Consent|0|||
125451506|NCT01124162|451281857|FG000|First Intervention|Adverse Event|2|||
125451507|NCT01124162|451281858|FG001|First Intervention|Adverse Event|0|||
125451508|NCT01124162|451281857|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
125451509|NCT01124162|451281858|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
125451510|NCT02680756|451281859|FG000|Overall Study|Adverse Event|10|||
125451511|NCT02680756|451281860|FG001|Overall Study|Adverse Event|2|||
125451512|NCT02680756|451281859|FG000|Overall Study|Lost to Follow-up|7|||
125451513|NCT02680756|451281860|FG001|Overall Study|Lost to Follow-up|6|||
125451514|NCT02680756|451281859|FG000|Overall Study|Withdrawal by Subject|5|||
125451515|NCT02680756|451281860|FG001|Overall Study|Withdrawal by Subject|5|||
125451516|NCT02680756|451281859|FG000|Overall Study|Physician Decision|4|||
125451517|NCT02680756|451281860|FG001|Overall Study|Physician Decision|1|||
125451518|NCT02680756|451281859|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
125451519|NCT02680756|451281860|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
125451520|NCT02680756|451281859|FG000|Overall Study|Blood transfusion for any reason|0|||
125451521|NCT02680756|451281860|FG001|Overall Study|Blood transfusion for any reason|1|||
125451522|NCT02680756|451281859|FG000|Overall Study|Death|1|||
125451523|NCT02680756|451281860|FG001|Overall Study|Death|0|||
125451524|NCT02680756|451281859|FG000|Overall Study|Protocol Violation|1|||
125451525|NCT02680756|451281860|FG001|Overall Study|Protocol Violation|0|||
125451526|NCT02680756|451281859|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
125451527|NCT02680756|451281860|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
125451528|NCT02680756|451281859|FG000|Overall Study|None of above or not recorded|3|||
125451529|NCT02680756|451281860|FG001|Overall Study|None of above or not recorded|2|||
125451530|NCT00938340|451281861|FG000|Overall Study|Withdrawal by Subject|3|||
125451531|NCT00938340|451281861|FG000|Overall Study|Protocol Violation|1|||
125451532|NCT00938340|451281861|FG000|Overall Study|Adverse Event|1|||
125451533|NCT04353037|451281864|FG000|Overall Study|Lost to Follow-up|0|||
125451534|NCT04353037|451281865|FG001|Overall Study|Lost to Follow-up|1|||
125451535|NCT04353037|451281866|FG002|Overall Study|Lost to Follow-up|2|||
125451536|NCT04353037|451281867|FG003|Overall Study|Lost to Follow-up|3|||
125451537|NCT04353037|451281864|FG000|Overall Study|Withdrawal by Subject|0|||
125451538|NCT04353037|451281865|FG001|Overall Study|Withdrawal by Subject|2|||
125451539|NCT04353037|451281866|FG002|Overall Study|Withdrawal by Subject|3|||
125451540|NCT04353037|451281867|FG003|Overall Study|Withdrawal by Subject|5|||
125451541|NCT04353037|451281864|FG000|Overall Study|Adverse Event|0|||
125451542|NCT04353037|451281865|FG001|Overall Study|Adverse Event|0|||
125451543|NCT04353037|451281866|FG002|Overall Study|Adverse Event|2|||
125292189|NCT00996801|450696554|FG003|Overall Study|Lost to Follow-up|3|||
125451544|NCT04353037|451281867|FG003|Overall Study|Adverse Event|0|||
125451545|NCT04353037|451281864|FG000|Overall Study|Exposure Change|0|||
125451546|NCT04353037|451281865|FG001|Overall Study|Exposure Change|0|||
125451547|NCT04353037|451281866|FG002|Overall Study|Exposure Change|0|||
125451548|NCT04353037|451281867|FG003|Overall Study|Exposure Change|2|||
125292190|NCT00996801|450696555|FG004|Overall Study|Lost to Follow-up|3|||
125451549|NCT03635112|451281868|FG000|Overall Study|Adverse Event|5|||
125451550|NCT03635112|451281869|FG001|Overall Study|Adverse Event|9|||
125451551|NCT03635112|451281870|FG002|Overall Study|Adverse Event|14|||
125451552|NCT03635112|451281868|FG000|Overall Study|Lost to Follow-up|1|||
125451553|NCT03635112|451281869|FG001|Overall Study|Lost to Follow-up|0|||
125451554|NCT03635112|451281870|FG002|Overall Study|Lost to Follow-up|1|||
125451555|NCT03635112|451281868|FG000|Overall Study|Physician Decision|5|||
125451556|NCT03635112|451281869|FG001|Overall Study|Physician Decision|7|||
125451557|NCT03635112|451281870|FG002|Overall Study|Physician Decision|5|||
125451558|NCT03635112|451281868|FG000|Overall Study|Protocol Violation|0|||
125451559|NCT03635112|451281869|FG001|Overall Study|Protocol Violation|0|||
125451560|NCT03635112|451281870|FG002|Overall Study|Protocol Violation|1|||
125451561|NCT03635112|451281868|FG000|Overall Study|Study Terminated by Sponsor|11|||
125451562|NCT03635112|451281869|FG001|Overall Study|Study Terminated by Sponsor|17|||
125451563|NCT03635112|451281870|FG002|Overall Study|Study Terminated by Sponsor|21|||
125451564|NCT03635112|451281868|FG000|Overall Study|Withdrawal by Subject|4|||
125451565|NCT03635112|451281869|FG001|Overall Study|Withdrawal by Subject|9|||
125451566|NCT03635112|451281870|FG002|Overall Study|Withdrawal by Subject|7|||
125451567|NCT03635112|451281868|FG000|Overall Study|Miscellaneous|0|||
125451568|NCT03635112|451281869|FG001|Overall Study|Miscellaneous|0|||
125451569|NCT03635112|451281870|FG002|Overall Study|Miscellaneous|1|||
125451570|NCT03006341|451281872|FG000|Overall Study|Not linked in the EMR|25069|||
125451571|NCT03006341|451281873|FG001|Overall Study|Not linked in the EMR|67505|||
125451572|NCT03006341|451281874|FG002|Overall Study|Not linked in the EMR|30993|||
125451573|NCT03006341|451281875|FG003|Overall Study|Not linked in the EMR|10685|||
125451574|NCT03101592|451281878|FG000|Overall Study|participant files could not be located|111|||
125451575|NCT03101592|451281879|FG001|Overall Study|participant files could not be located|170|||
125451576|NCT03101592|451281880|FG002|Overall Study|participant files could not be located|118|||
125451577|NCT01770860|451281881|FG000|Overall Study|Withdrawal by Subject|4|||
125451578|NCT01770860|451281881|FG000|Overall Study|Lost to Follow-up|1|||
125451579|NCT01770860|451281881|FG000|Overall Study|Administrative decision made by the PI|1|||
125451580|NCT03398356|451281884|FG000|Before Treatment|Lost to Follow-up|1|||
125451581|NCT03398356|451281885|FG001|Before Treatment|Lost to Follow-up|2|||
125451582|NCT03398356|451281886|FG002|Before Treatment|Lost to Follow-up|0|||
125451583|NCT03398356|451281884|FG000|Before Treatment|drug intolerance|2|||
125451584|NCT03398356|451281885|FG001|Before Treatment|drug intolerance|1|||
125451585|NCT03398356|451281886|FG002|Before Treatment|drug intolerance|0|||
125451586|NCT03398356|451281884|FG000|Before Treatment|Withdrawal by Subject|0|||
125451587|NCT03398356|451281885|FG001|Before Treatment|Withdrawal by Subject|5|||
125451588|NCT03398356|451281886|FG002|Before Treatment|Withdrawal by Subject|0|||
125451589|NCT03398356|451281884|FG000|Before Treatment|Physician Decision|0|||
125451590|NCT03398356|451281885|FG001|Before Treatment|Physician Decision|0|||
125451591|NCT03398356|451281886|FG002|Before Treatment|Physician Decision|11|||
125451592|NCT03398356|451281884|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
125451593|NCT03398356|451281885|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
125451594|NCT03398356|451281886|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
125451595|NCT00601640|451281890|FG000|Overall Study|Withdrawal by Subject|3|||
125451596|NCT00601640|451281891|FG001|Overall Study|Withdrawal by Subject|0|||
125451597|NCT00601640|451281892|FG002|Overall Study|Withdrawal by Subject|7|||
125451598|NCT00601640|451281890|FG000|Overall Study|Death|1|||
125451599|NCT00601640|451281891|FG001|Overall Study|Death|0|||
125451600|NCT00601640|451281892|FG002|Overall Study|Death|0|||
125451601|NCT00601640|451281890|FG000|Overall Study|Adverse Event|0|||
125451602|NCT00601640|451281891|FG001|Overall Study|Adverse Event|4|||
125451603|NCT00601640|451281892|FG002|Overall Study|Adverse Event|2|||
125451604|NCT00601640|451281890|FG000|Overall Study|intercurrent illness|1|||
125451605|NCT00601640|451281891|FG001|Overall Study|intercurrent illness|0|||
125451606|NCT00601640|451281892|FG002|Overall Study|intercurrent illness|0|||
125451607|NCT00601640|451281890|FG000|Overall Study|change in eligibility status|0|||
125451608|NCT00601640|451281891|FG001|Overall Study|change in eligibility status|1|||
125451609|NCT00601640|451281892|FG002|Overall Study|change in eligibility status|1|||
125451610|NCT00530777|451281893|FG000|Overall Study|Lost to Follow-up|0|||
125451611|NCT00530777|451281894|FG001|Overall Study|Lost to Follow-up|1|||
125451612|NCT00530777|451281893|FG000|Overall Study|Death|1|||
125451613|NCT00530777|451281894|FG001|Overall Study|Death|2|||
125451614|NCT00530777|451281893|FG000|Overall Study|Physician Decision|1|||
125451615|NCT00530777|451281894|FG001|Overall Study|Physician Decision|0|||
125451616|NCT00530777|451281893|FG000|Overall Study|Withdrawal by Subject|0|||
125451617|NCT00530777|451281894|FG001|Overall Study|Withdrawal by Subject|1|||
125451618|NCT00530777|451281893|FG000|Overall Study|Unable to adhere to visit schedule|5|||
125451619|NCT00530777|451281894|FG001|Overall Study|Unable to adhere to visit schedule|1|||
125451620|NCT03382821|451281900|FG000|Overall Study|Did not receive allocated intervention.|0|||
125451621|NCT03382821|451281901|FG001|Overall Study|Did not receive allocated intervention.|3|||
125451622|NCT00282438|451281903|FG000|Overall Study|Lack of Efficacy|1|||
125451623|NCT00282438|451281904|FG001|Overall Study|Lack of Efficacy|0|||
125451624|NCT00282438|451281903|FG000|Overall Study|Death|0|||
125451625|NCT00282438|451281904|FG001|Overall Study|Death|1|||
125451626|NCT02095158|451281909|FG000|Overall Study|Adverse Event|14|||
125451627|NCT02095158|451281909|FG000|Overall Study|Lack of Efficacy|3|||
125451628|NCT02095158|451281909|FG000|Overall Study|Pregnancy|1|||
125451629|NCT02095158|451281909|FG000|Overall Study|Lost to Follow-up|20|||
125451630|NCT02095158|451281909|FG000|Overall Study|Personal Reasons|35|||
125451631|NCT02095158|451281909|FG000|Overall Study|Protocol Violation|1|||
125451632|NCT02095158|451281909|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125451633|NCT01008748|451281910|FG000|Overall Study|Lost to Follow-up|80|||
125451634|NCT01008748|451281910|FG000|Overall Study|Other|1|||
125451635|NCT02775435|451281911|FG000|Overall Study|Adverse Event|32|||
125451636|NCT02775435|451281912|FG001|Overall Study|Adverse Event|27|||
125451637|NCT02775435|451281911|FG000|Overall Study|Lost to Follow-up|2|||
125451638|NCT02775435|451281912|FG001|Overall Study|Lost to Follow-up|2|||
125451639|NCT02775435|451281911|FG000|Overall Study|Sponsor decision|44|||
125451640|NCT02775435|451281912|FG001|Overall Study|Sponsor decision|19|||
125451641|NCT02775435|451281911|FG000|Overall Study|Withdrawal by Subject|4|||
125451642|NCT02775435|451281912|FG001|Overall Study|Withdrawal by Subject|9|||
125451643|NCT02775435|451281911|FG000|Overall Study|Death|196|||
125451644|NCT02775435|451281912|FG001|Overall Study|Death|224|||
125451645|NCT01872611|451281913|FG000|Overall Study|Adverse Event|3|||
125451646|NCT01872611|451281914|FG001|Overall Study|Adverse Event|1|||
125451647|NCT01872611|451281913|FG000|Overall Study|Adverse Event, prior to treatment|0|||
125451648|NCT01872611|451281914|FG001|Overall Study|Adverse Event, prior to treatment|1|||
125451649|NCT01872611|451281913|FG000|Overall Study|Death|0|||
125451650|NCT01872611|451281914|FG001|Overall Study|Death|1|||
125451651|NCT01872611|451281913|FG000|Overall Study|Death, prior to treatment|0|||
125451652|NCT01872611|451281914|FG001|Overall Study|Death, prior to treatment|1|||
125451653|NCT01872611|451281913|FG000|Overall Study|Lost to Follow-up|8|||
125451654|NCT01872611|451281914|FG001|Overall Study|Lost to Follow-up|1|||
125451655|NCT01872611|451281913|FG000|Overall Study|Physician Decision|1|||
125451656|NCT01872611|451281914|FG001|Overall Study|Physician Decision|0|||
125451657|NCT01872611|451281913|FG000|Overall Study|Withdrawal by Subject|6|||
125451658|NCT01872611|451281914|FG001|Overall Study|Withdrawal by Subject|1|||
125451659|NCT01872611|451281913|FG000|Overall Study|Reason not provided|6|||
125451660|NCT01872611|451281914|FG001|Overall Study|Reason not provided|6|||
125451661|NCT03537651|451281923|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
125451662|NCT03537651|451281923|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
125451663|NCT03537651|451281923|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
125451664|NCT03537651|451281923|FG000|Part A (Up to 96 Weeks)|Other|1|||
125451665|NCT03537651|451281923|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
125451666|NCT03537651|451281923|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
125451667|NCT03537651|451281923|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
125451668|NCT03537651|451281923|FG000|Part B (Up to 192 Weeks)|Other|1|||
125451669|NCT03885596|451281924|FG000|Overall Study|Withdrawal by Subject|2|||
125451670|NCT03885596|451281925|FG001|Overall Study|Withdrawal by Subject|1|||
125451671|NCT03885596|451281926|FG002|Overall Study|Withdrawal by Subject|0|||
125451672|NCT03885596|451281927|FG003|Overall Study|Withdrawal by Subject|0|||
125451673|NCT03852433|451281928|FG000|Overall Study|Withdrawal of consent|5|||
125451674|NCT03852433|451281929|FG001|Overall Study|Withdrawal of consent|8|||
125451675|NCT03852433|451281930|FG002|Overall Study|Withdrawal of consent|1|||
125451676|NCT03852433|451281931|FG003|Overall Study|Withdrawal of consent|1|||
125451677|NCT03852433|451281928|FG000|Overall Study|Adverse Event|1|||
125451678|NCT03852433|451281929|FG001|Overall Study|Adverse Event|1|||
125451679|NCT03852433|451281930|FG002|Overall Study|Adverse Event|1|||
125451680|NCT03852433|451281931|FG003|Overall Study|Adverse Event|1|||
125451681|NCT03852433|451281928|FG000|Overall Study|Lost to Follow-up|0|||
125451682|NCT03852433|451281929|FG001|Overall Study|Lost to Follow-up|1|||
125451683|NCT03852433|451281930|FG002|Overall Study|Lost to Follow-up|0|||
125451684|NCT03852433|451281931|FG003|Overall Study|Lost to Follow-up|1|||
125451685|NCT03852433|451281928|FG000|Overall Study|Pregnancy|0|||
125451686|NCT03852433|451281929|FG001|Overall Study|Pregnancy|1|||
125451687|NCT03852433|451281930|FG002|Overall Study|Pregnancy|1|||
125451688|NCT03852433|451281931|FG003|Overall Study|Pregnancy|0|||
125451689|NCT03852433|451281928|FG000|Overall Study|Protocol Violation|0|||
125451690|NCT03852433|451281929|FG001|Overall Study|Protocol Violation|0|||
125451691|NCT03852433|451281930|FG002|Overall Study|Protocol Violation|1|||
125451692|NCT03852433|451281931|FG003|Overall Study|Protocol Violation|1|||
125292191|NCT00996801|450696556|FG005|Overall Study|Lost to Follow-up|2|||
125292192|NCT00996801|450696551|FG000|Overall Study|Physician Decision|0|||
125451693|NCT03852433|451281928|FG000|Overall Study|Death|0|||
125451694|NCT03852433|451281929|FG001|Overall Study|Death|0|||
125451695|NCT03852433|451281930|FG002|Overall Study|Death|1|||
125451696|NCT03852433|451281931|FG003|Overall Study|Death|0|||
125451697|NCT03852433|451281928|FG000|Overall Study|Lack of Efficacy|0|||
125451698|NCT03852433|451281929|FG001|Overall Study|Lack of Efficacy|1|||
125451699|NCT03852433|451281930|FG002|Overall Study|Lack of Efficacy|0|||
125451700|NCT03852433|451281931|FG003|Overall Study|Lack of Efficacy|0|||
125451701|NCT03852433|451281928|FG000|Overall Study|Non-compliance with study drug|0|||
125451702|NCT03852433|451281929|FG001|Overall Study|Non-compliance with study drug|0|||
125451703|NCT03852433|451281930|FG002|Overall Study|Non-compliance with study drug|0|||
125451704|NCT03852433|451281931|FG003|Overall Study|Non-compliance with study drug|1|||
125451705|NCT03852433|451281928|FG000|Overall Study|Physician Decision|1|||
125451706|NCT03852433|451281929|FG001|Overall Study|Physician Decision|0|||
125451707|NCT03852433|451281930|FG002|Overall Study|Physician Decision|0|||
125451708|NCT03852433|451281931|FG003|Overall Study|Physician Decision|0|||
125451709|NCT03852433|451281928|FG000|Overall Study|Randomized but never treated|1|||
125451710|NCT03852433|451281929|FG001|Overall Study|Randomized but never treated|0|||
125451711|NCT03852433|451281930|FG002|Overall Study|Randomized but never treated|0|||
125451712|NCT03852433|451281931|FG003|Overall Study|Randomized but never treated|0|||
125451713|NCT01076335|451281932|FG000|Overall Study|Withdrawal by Subject|3|||
125451714|NCT01076335|451281932|FG000|Overall Study|Withdrawal without treatment|1|||
125451715|NCT02939183|451281935|FG000|Overall Study|Death|0|||
125451716|NCT02939183|451281936|FG001|Overall Study|Death|0|||
125451717|NCT02939183|451281937|FG002|Overall Study|Death|1|||
125451718|NCT02939183|451281938|FG003|Overall Study|Death|0|||
125451719|NCT02939183|451281939|FG004|Overall Study|Death|0|||
125451720|NCT02939183|451281940|FG005|Overall Study|Death|2|||
125451721|NCT02939183|451281941|FG006|Overall Study|Death|1|||
125451722|NCT02939183|451281942|FG007|Overall Study|Death|0|||
125451723|NCT02939183|451281943|FG008|Overall Study|Death|0|||
125451724|NCT02939183|451281935|FG000|Overall Study|Sponsor decision|0|||
125451725|NCT02939183|451281936|FG001|Overall Study|Sponsor decision|1|||
125451726|NCT02939183|451281937|FG002|Overall Study|Sponsor decision|0|||
125451727|NCT02939183|451281938|FG003|Overall Study|Sponsor decision|1|||
125451728|NCT02939183|451281939|FG004|Overall Study|Sponsor decision|2|||
125451729|NCT02939183|451281940|FG005|Overall Study|Sponsor decision|0|||
125451730|NCT02939183|451281941|FG006|Overall Study|Sponsor decision|3|||
125451731|NCT02939183|451281942|FG007|Overall Study|Sponsor decision|1|||
125451732|NCT02939183|451281943|FG008|Overall Study|Sponsor decision|4|||
125451733|NCT02939183|451281935|FG000|Overall Study|Withdrawal by Subject|0|||
125451734|NCT02939183|451281936|FG001|Overall Study|Withdrawal by Subject|2|||
125451735|NCT02939183|451281937|FG002|Overall Study|Withdrawal by Subject|0|||
125451736|NCT02939183|451281938|FG003|Overall Study|Withdrawal by Subject|1|||
125451737|NCT02939183|451281939|FG004|Overall Study|Withdrawal by Subject|0|||
125451738|NCT02939183|451281940|FG005|Overall Study|Withdrawal by Subject|0|||
125451739|NCT02939183|451281941|FG006|Overall Study|Withdrawal by Subject|2|||
125451740|NCT02939183|451281942|FG007|Overall Study|Withdrawal by Subject|2|||
125451741|NCT02939183|451281943|FG008|Overall Study|Withdrawal by Subject|2|||
125451742|NCT02939183|451281935|FG000|Overall Study|Not treated due to adverse event|0|||
125451743|NCT02939183|451281936|FG001|Overall Study|Not treated due to adverse event|0|||
125451744|NCT02939183|451281937|FG002|Overall Study|Not treated due to adverse event|0|||
125451745|NCT02939183|451281938|FG003|Overall Study|Not treated due to adverse event|1|||
125451746|NCT02939183|451281939|FG004|Overall Study|Not treated due to adverse event|0|||
125451747|NCT02939183|451281940|FG005|Overall Study|Not treated due to adverse event|0|||
125451748|NCT02939183|451281941|FG006|Overall Study|Not treated due to adverse event|1|||
125451749|NCT02939183|451281942|FG007|Overall Study|Not treated due to adverse event|0|||
125451750|NCT02939183|451281943|FG008|Overall Study|Not treated due to adverse event|0|||
125451751|NCT00654238|451281948|FG000|Overall Study|Screen Failures|4|||
125451752|NCT01446003|451281949|FG000|Period 1|Protocol Violation|2|||
125451753|NCT01446003|451281950|FG001|Period 1|Protocol Violation|0|||
125451754|NCT01446003|451281949|FG000|Period 2|Adverse Event|1|||
125451755|NCT01446003|451281950|FG001|Period 2|Adverse Event|0|||
125451756|NCT00318656|451281951|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
125451757|NCT00318656|451281952|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
125451758|NCT00318656|451281951|FG000|Overall Study|Did not receive any treatment|0|||
125451759|NCT00318656|451281952|FG001|Overall Study|Did not receive any treatment|1|||
125451760|NCT03905135|451281953|FG000|Dose Escalation|Adverse Event|1|||
125451761|NCT03905135|451281954|FG001|Dose Escalation|Adverse Event|1|||
125451762|NCT03905135|451281953|FG000|Dose Escalation|Progressive disease|3|||
125451763|NCT03905135|451281954|FG001|Dose Escalation|Progressive disease|1|||
125451764|NCT03905135|451281953|FG000|Dose Escalation|Intercurrent illness|1|||
125451765|NCT03905135|451281954|FG001|Dose Escalation|Intercurrent illness|0|||
125451766|NCT01740557|451281955|FG000|Overall Study|Ineligible|1|||
125451767|NCT01740557|451281955|FG000|Overall Study|Screen failure|1|||
125451768|NCT00490555|451281960|FG000|Overall Study|noncompliant with drug administration|0|||
125451769|NCT00490555|451281961|FG001|Overall Study|noncompliant with drug administration|0|||
125451770|NCT00490555|451281962|FG002|Overall Study|noncompliant with drug administration|2|||
125451771|NCT00490555|451281963|FG003|Overall Study|noncompliant with drug administration|0|||
125451772|NCT01268566|451281966|FG000|Overall Study|Lost to Follow-up|1|||
125451773|NCT01268566|451281966|FG000|Overall Study|Withdrawal by Subject|12|||
125451774|NCT01268566|451281966|FG000|Overall Study|Death|30|||
125451775|NCT01348087|451281974|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
125451776|NCT01348087|451281974|FG000|Overall Study|Administrative problems|79|||
125451777|NCT01348087|451281974|FG000|Overall Study|protocol deviation|1|||
125451778|NCT01348087|451281974|FG000|Overall Study|Lost to Follow-up|1|||
125451779|NCT01348087|451281974|FG000|Overall Study|Subject withdrew consent|7|||
125451780|NCT01348087|451281974|FG000|Overall Study|Adverse Event|25|||
125451781|NCT01007149|451281975|FG000|Overall Study|Administrative problems|0|||
125451782|NCT01007149|451281976|FG001|Overall Study|Administrative problems|1|||
125451783|NCT02784704|451281977|FG000|Overall Study|Adverse Event|4|||
125451784|NCT02784704|451281978|FG001|Overall Study|Adverse Event|2|||
125451785|NCT02784704|451281977|FG000|Overall Study|Lost to Follow-up|6|||
125451786|NCT02784704|451281978|FG001|Overall Study|Lost to Follow-up|4|||
125451787|NCT02784704|451281977|FG000|Overall Study|Withdrawal by Subject|1|||
125451788|NCT02784704|451281978|FG001|Overall Study|Withdrawal by Subject|3|||
125451789|NCT02784704|451281977|FG000|Overall Study|Subject Non Compliance|2|||
125451790|NCT02784704|451281978|FG001|Overall Study|Subject Non Compliance|0|||
125451791|NCT01913340|451281979|FG000|Overall Study|Death|2|||
125451792|NCT01913340|451281980|FG001|Overall Study|Death|5|||
125451793|NCT01913340|451281979|FG000|Overall Study|Lost to Follow-up|1|||
125451794|NCT01913340|451281980|FG001|Overall Study|Lost to Follow-up|1|||
125451795|NCT00603538|451281981|FG000|Overall Study|Adverse Event|0|||
125451796|NCT00603538|451281982|FG001|Overall Study|Adverse Event|4|||
125451797|NCT00603538|451281983|FG002|Overall Study|Adverse Event|2|||
125451798|NCT00603538|451281981|FG000|Overall Study|Objective progression or relapse|3|||
125451799|NCT00603538|451281982|FG001|Overall Study|Objective progression or relapse|0|||
125451800|NCT00603538|451281983|FG002|Overall Study|Objective progression or relapse|0|||
125451801|NCT05750745|451281985|FG000|Overall Study|Adverse Event|1|||
125451802|NCT05750745|451281986|FG001|Overall Study|Adverse Event|0|||
125451803|NCT05750745|451281987|FG002|Overall Study|Adverse Event|0|||
125451804|NCT05750745|451281985|FG000|Overall Study|Protocol Violation|1|||
125451805|NCT05750745|451281986|FG001|Overall Study|Protocol Violation|0|||
125451806|NCT05750745|451281987|FG002|Overall Study|Protocol Violation|0|||
125451807|NCT05750745|451281985|FG000|Overall Study|Withdrawal by Subject|0|||
125451808|NCT05750745|451281986|FG001|Overall Study|Withdrawal by Subject|1|||
125451809|NCT05750745|451281987|FG002|Overall Study|Withdrawal by Subject|0|||
125451810|NCT00783692|451281993|FG000|Induction Phase|Adverse Event|7|||
125451811|NCT00783692|451281994|FG001|Induction Phase|Adverse Event|9|||
125451812|NCT00783692|451281995|FG002|Induction Phase|Adverse Event|24|||
125451813|NCT00783692|451281996|FG003|Induction Phase|Adverse Event|0|||
125451814|NCT00783692|451281997|FG004|Induction Phase|Adverse Event|0|||
125451815|NCT00783692|451281998|FG005|Induction Phase|Adverse Event|0|||
125451816|NCT00783692|451281999|FG006|Induction Phase|Adverse Event|0|||
125451817|NCT00783692|451281993|FG000|Induction Phase|Protocol Violation|0|||
125451818|NCT00783692|451281994|FG001|Induction Phase|Protocol Violation|0|||
125451819|NCT00783692|451281995|FG002|Induction Phase|Protocol Violation|1|||
125451820|NCT00783692|451281996|FG003|Induction Phase|Protocol Violation|0|||
125451821|NCT00783692|451281997|FG004|Induction Phase|Protocol Violation|0|||
125451822|NCT00783692|451281998|FG005|Induction Phase|Protocol Violation|0|||
125451823|NCT00783692|451281999|FG006|Induction Phase|Protocol Violation|0|||
125451824|NCT00783692|451281993|FG000|Induction Phase|Lack of Efficacy|1|||
125451825|NCT00783692|451281994|FG001|Induction Phase|Lack of Efficacy|3|||
125451826|NCT00783692|451281995|FG002|Induction Phase|Lack of Efficacy|28|||
125451827|NCT00783692|451281996|FG003|Induction Phase|Lack of Efficacy|0|||
125451828|NCT00783692|451281997|FG004|Induction Phase|Lack of Efficacy|0|||
125451829|NCT00783692|451281998|FG005|Induction Phase|Lack of Efficacy|0|||
125451830|NCT00783692|451281999|FG006|Induction Phase|Lack of Efficacy|0|||
125451831|NCT00783692|451281993|FG000|Induction Phase|Withdrawal by Subject|3|||
125451832|NCT00783692|451281994|FG001|Induction Phase|Withdrawal by Subject|9|||
125451833|NCT00783692|451281995|FG002|Induction Phase|Withdrawal by Subject|16|||
125451834|NCT00783692|451281996|FG003|Induction Phase|Withdrawal by Subject|0|||
125451835|NCT00783692|451281997|FG004|Induction Phase|Withdrawal by Subject|0|||
125451836|NCT00783692|451281998|FG005|Induction Phase|Withdrawal by Subject|0|||
125451837|NCT00783692|451281999|FG006|Induction Phase|Withdrawal by Subject|0|||
125451838|NCT00783692|451281993|FG000|Induction Phase|Lost to Follow-up|0|||
125451839|NCT00783692|451281994|FG001|Induction Phase|Lost to Follow-up|0|||
125451840|NCT00783692|451281995|FG002|Induction Phase|Lost to Follow-up|3|||
125451841|NCT00783692|451281996|FG003|Induction Phase|Lost to Follow-up|0|||
125451842|NCT00783692|451281997|FG004|Induction Phase|Lost to Follow-up|0|||
125451843|NCT00783692|451281998|FG005|Induction Phase|Lost to Follow-up|0|||
125451844|NCT00783692|451281999|FG006|Induction Phase|Lost to Follow-up|0|||
125451845|NCT00783692|451281993|FG000|Induction Phase|Other|0|||
125451846|NCT00783692|451281994|FG001|Induction Phase|Other|0|||
125451847|NCT00783692|451281995|FG002|Induction Phase|Other|2|||
125451848|NCT00783692|451281996|FG003|Induction Phase|Other|0|||
125451849|NCT00783692|451281997|FG004|Induction Phase|Other|0|||
125451850|NCT00783692|451281998|FG005|Induction Phase|Other|0|||
125451851|NCT00783692|451281999|FG006|Induction Phase|Other|0|||
125451852|NCT00783692|451281993|FG000|Maintenance Phase|Adverse Event|7|||
125451853|NCT00783692|451281994|FG001|Maintenance Phase|Adverse Event|0|||
125451854|NCT00783692|451281995|FG002|Maintenance Phase|Adverse Event|0|||
125451855|NCT00783692|451281996|FG003|Maintenance Phase|Adverse Event|15|||
125451856|NCT00783692|451281997|FG004|Maintenance Phase|Adverse Event|12|||
125451857|NCT00783692|451281998|FG005|Maintenance Phase|Adverse Event|9|||
125451858|NCT00783692|451281999|FG006|Maintenance Phase|Adverse Event|38|||
125451859|NCT00783692|451281993|FG000|Maintenance Phase|Protocol Violation|0|||
125485345|NCT02240238|451412507|FG004|Phase 1|Adverse Event|0|||
125451860|NCT00783692|451281994|FG001|Maintenance Phase|Protocol Violation|0|||
125451861|NCT00783692|451281995|FG002|Maintenance Phase|Protocol Violation|0|||
125451862|NCT00783692|451281996|FG003|Maintenance Phase|Protocol Violation|1|||
125451863|NCT00783692|451281997|FG004|Maintenance Phase|Protocol Violation|2|||
125451864|NCT00783692|451281998|FG005|Maintenance Phase|Protocol Violation|3|||
125451865|NCT00783692|451281999|FG006|Maintenance Phase|Protocol Violation|4|||
125451866|NCT00783692|451281993|FG000|Maintenance Phase|Lack of Efficacy|79|||
125451867|NCT00783692|451281994|FG001|Maintenance Phase|Lack of Efficacy|0|||
125451868|NCT00783692|451281995|FG002|Maintenance Phase|Lack of Efficacy|0|||
125451869|NCT00783692|451281996|FG003|Maintenance Phase|Lack of Efficacy|64|||
125451870|NCT00783692|451281997|FG004|Maintenance Phase|Lack of Efficacy|58|||
125451871|NCT00783692|451281998|FG005|Maintenance Phase|Lack of Efficacy|48|||
125451872|NCT00783692|451281999|FG006|Maintenance Phase|Lack of Efficacy|177|||
125451873|NCT00783692|451281993|FG000|Maintenance Phase|Withdrawal by Subject|7|||
125451874|NCT00783692|451281994|FG001|Maintenance Phase|Withdrawal by Subject|0|||
125451875|NCT00783692|451281995|FG002|Maintenance Phase|Withdrawal by Subject|0|||
125451876|NCT00783692|451281996|FG003|Maintenance Phase|Withdrawal by Subject|7|||
125451877|NCT00783692|451281997|FG004|Maintenance Phase|Withdrawal by Subject|6|||
125451878|NCT00783692|451281998|FG005|Maintenance Phase|Withdrawal by Subject|9|||
125451879|NCT00783692|451281999|FG006|Maintenance Phase|Withdrawal by Subject|24|||
125451880|NCT00783692|451281993|FG000|Maintenance Phase|Lost to Follow-up|2|||
125451881|NCT00783692|451281994|FG001|Maintenance Phase|Lost to Follow-up|0|||
125451882|NCT00783692|451281995|FG002|Maintenance Phase|Lost to Follow-up|0|||
125451883|NCT00783692|451281996|FG003|Maintenance Phase|Lost to Follow-up|1|||
125451884|NCT00783692|451281997|FG004|Maintenance Phase|Lost to Follow-up|3|||
125451885|NCT00783692|451281998|FG005|Maintenance Phase|Lost to Follow-up|2|||
125451886|NCT00783692|451281999|FG006|Maintenance Phase|Lost to Follow-up|5|||
125451887|NCT00783692|451281993|FG000|Maintenance Phase|Other|0|||
125451888|NCT00783692|451281994|FG001|Maintenance Phase|Other|0|||
125451889|NCT00783692|451281995|FG002|Maintenance Phase|Other|0|||
125451890|NCT00783692|451281996|FG003|Maintenance Phase|Other|1|||
125451891|NCT00783692|451281997|FG004|Maintenance Phase|Other|0|||
125451892|NCT00783692|451281998|FG005|Maintenance Phase|Other|1|||
125451893|NCT00783692|451281999|FG006|Maintenance Phase|Other|1|||
125451894|NCT01096056|451282002|FG000|Overall Study|Lost to Follow-up|0|||
125451895|NCT01096056|451282003|FG001|Overall Study|Lost to Follow-up|1|||
125451896|NCT03568162|451282007|FG000|Overall Study|Adverse Event|0|||
125451897|NCT03568162|451282008|FG001|Overall Study|Adverse Event|1|||
125451898|NCT03568162|451282009|FG002|Overall Study|Adverse Event|2|||
125451899|NCT03568162|451282010|FG003|Overall Study|Adverse Event|0|||
125451900|NCT03568162|451282011|FG004|Overall Study|Adverse Event|0|||
125451901|NCT03568162|451282012|FG005|Overall Study|Adverse Event|1|||
125451902|NCT03568162|451282007|FG000|Overall Study|Death|0|||
125451903|NCT03568162|451282008|FG001|Overall Study|Death|0|||
125451904|NCT03568162|451282009|FG002|Overall Study|Death|0|||
125451905|NCT03568162|451282010|FG003|Overall Study|Death|0|||
125451906|NCT03568162|451282011|FG004|Overall Study|Death|1|||
125451907|NCT03568162|451282012|FG005|Overall Study|Death|0|||
125451908|NCT03568162|451282007|FG000|Overall Study|Lost to Follow-up|3|||
125451909|NCT03568162|451282008|FG001|Overall Study|Lost to Follow-up|2|||
125451910|NCT03568162|451282009|FG002|Overall Study|Lost to Follow-up|4|||
125451911|NCT03568162|451282010|FG003|Overall Study|Lost to Follow-up|2|||
125451912|NCT03568162|451282011|FG004|Overall Study|Lost to Follow-up|3|||
125451913|NCT03568162|451282012|FG005|Overall Study|Lost to Follow-up|2|||
125451914|NCT03568162|451282007|FG000|Overall Study|Physician Decision|0|||
125451915|NCT03568162|451282008|FG001|Overall Study|Physician Decision|1|||
125451916|NCT03568162|451282009|FG002|Overall Study|Physician Decision|1|||
125451917|NCT03568162|451282010|FG003|Overall Study|Physician Decision|0|||
125451918|NCT03568162|451282011|FG004|Overall Study|Physician Decision|1|||
125451919|NCT03568162|451282012|FG005|Overall Study|Physician Decision|0|||
125451920|NCT03568162|451282007|FG000|Overall Study|Pregnancy|0|||
125451921|NCT03568162|451282008|FG001|Overall Study|Pregnancy|0|||
125451922|NCT03568162|451282009|FG002|Overall Study|Pregnancy|0|||
125451923|NCT03568162|451282010|FG003|Overall Study|Pregnancy|1|||
125451924|NCT03568162|451282011|FG004|Overall Study|Pregnancy|0|||
125451925|NCT03568162|451282012|FG005|Overall Study|Pregnancy|0|||
125451926|NCT03568162|451282007|FG000|Overall Study|Protocol Violation|1|||
125451927|NCT03568162|451282008|FG001|Overall Study|Protocol Violation|0|||
125451928|NCT03568162|451282009|FG002|Overall Study|Protocol Violation|1|||
125451929|NCT03568162|451282010|FG003|Overall Study|Protocol Violation|1|||
125451930|NCT03568162|451282011|FG004|Overall Study|Protocol Violation|1|||
125451931|NCT03568162|451282012|FG005|Overall Study|Protocol Violation|1|||
125451932|NCT03568162|451282007|FG000|Overall Study|Withdrawal by Subject|15|||
125451933|NCT03568162|451282008|FG001|Overall Study|Withdrawal by Subject|15|||
125451934|NCT03568162|451282009|FG002|Overall Study|Withdrawal by Subject|26|||
125451935|NCT03568162|451282010|FG003|Overall Study|Withdrawal by Subject|22|||
125451936|NCT03568162|451282011|FG004|Overall Study|Withdrawal by Subject|6|||
125451937|NCT03568162|451282012|FG005|Overall Study|Withdrawal by Subject|9|||
125451938|NCT03568162|451282007|FG000|Overall Study|Others|3|||
125451939|NCT03568162|451282008|FG001|Overall Study|Others|4|||
125451940|NCT03568162|451282009|FG002|Overall Study|Others|1|||
125451941|NCT03568162|451282010|FG003|Overall Study|Others|4|||
125451942|NCT03568162|451282011|FG004|Overall Study|Others|2|||
125451943|NCT03568162|451282012|FG005|Overall Study|Others|1|||
125451944|NCT03717194|451282014|FG000|Overall Study|Withdrawal by Subject|2|||
125451945|NCT03717194|451282015|FG001|Overall Study|Withdrawal by Subject|4|||
125451946|NCT03717194|451282014|FG000|Overall Study|Adverse Event|1|||
125451947|NCT03717194|451282015|FG001|Overall Study|Adverse Event|1|||
125451948|NCT01190176|451282019|FG000|Overall Study|Withdrawal by Subject|1|||
125451949|NCT01190176|451282019|FG000|Overall Study|Lost to Follow-up|1|||
125451950|NCT01836458|451282020|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
125451951|NCT01836458|451282021|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125451952|NCT01836458|451282022|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
125451953|NCT01836458|451282023|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
125451954|NCT02081391|451282024|FG000|12-hour Treatment|Withdrawal by Subject|3|||
125451955|NCT02081391|451282025|FG001|12-hour Treatment|Withdrawal by Subject|2|||
125451956|NCT02081391|451282026|FG002|12-hour Treatment|Withdrawal by Subject|0|||
125451957|NCT02081391|451282027|FG003|12-hour Treatment|Withdrawal by Subject|0|||
125451958|NCT02081391|451282024|FG000|12-hour Treatment|Physician Decision|4|||
125451959|NCT02081391|451282025|FG001|12-hour Treatment|Physician Decision|1|||
125451960|NCT02081391|451282026|FG002|12-hour Treatment|Physician Decision|0|||
125451961|NCT02081391|451282027|FG003|12-hour Treatment|Physician Decision|0|||
125451962|NCT02081391|451282024|FG000|12-hour Treatment|Lack of Efficacy|3|||
125451963|NCT02081391|451282025|FG001|12-hour Treatment|Lack of Efficacy|0|||
125451964|NCT02081391|451282026|FG002|12-hour Treatment|Lack of Efficacy|0|||
125451965|NCT02081391|451282027|FG003|12-hour Treatment|Lack of Efficacy|0|||
125451966|NCT02081391|451282024|FG000|12-hour Treatment|Adverse Event|4|||
125451967|NCT02081391|451282025|FG001|12-hour Treatment|Adverse Event|2|||
125451968|NCT02081391|451282026|FG002|12-hour Treatment|Adverse Event|0|||
125451969|NCT02081391|451282027|FG003|12-hour Treatment|Adverse Event|0|||
125451970|NCT02081391|451282024|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
125451971|NCT02081391|451282025|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
125451972|NCT02081391|451282026|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
125451973|NCT02081391|451282027|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
125451974|NCT02081391|451282024|FG000|12-hour Treatment|Further reasons|2|||
125451975|NCT02081391|451282025|FG001|12-hour Treatment|Further reasons|1|||
125451976|NCT02081391|451282026|FG002|12-hour Treatment|Further reasons|0|||
125451977|NCT02081391|451282027|FG003|12-hour Treatment|Further reasons|0|||
125451978|NCT02081391|451282024|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
125451979|NCT02081391|451282025|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
125451980|NCT02081391|451282026|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
125451981|NCT02081391|451282027|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
125451982|NCT02081391|451282024|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
125451983|NCT02081391|451282025|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
125451984|NCT02081391|451282026|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
125451985|NCT02081391|451282027|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
125451986|NCT02081391|451282024|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
125451987|NCT02081391|451282025|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
125451988|NCT02081391|451282026|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
125451989|NCT02081391|451282027|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
125451990|NCT02081391|451282024|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
125451991|NCT02081391|451282025|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
125451992|NCT02081391|451282026|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
125451993|NCT02081391|451282027|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
125451994|NCT02081391|451282024|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
125451995|NCT02081391|451282025|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
125451996|NCT02081391|451282026|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
125451997|NCT02081391|451282027|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
125451998|NCT02081391|451282024|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
125451999|NCT02081391|451282025|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
125452000|NCT02081391|451282026|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
125292193|NCT00996801|450696552|FG001|Overall Study|Physician Decision|0|||
125292194|NCT00996801|450696553|FG002|Overall Study|Physician Decision|0|||
125292195|NCT00996801|450696554|FG003|Overall Study|Physician Decision|1|||
125452001|NCT02081391|451282027|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
125452002|NCT02624778|451284170|FG000|Overall Study|Lost to Follow-up|0|||
125452003|NCT02624778|451284171|FG001|Overall Study|Lost to Follow-up|0|||
125452004|NCT02624778|451284172|FG002|Overall Study|Lost to Follow-up|1|||
125452005|NCT02624778|451284173|FG003|Overall Study|Lost to Follow-up|0|||
125452006|NCT02624778|451284174|FG004|Overall Study|Lost to Follow-up|0|||
125452007|NCT02624778|451284175|FG005|Overall Study|Lost to Follow-up|0|||
125292196|NCT00996801|450696555|FG004|Overall Study|Physician Decision|0|||
125452008|NCT02624778|451284176|FG006|Overall Study|Lost to Follow-up|0|||
125452009|NCT02624778|451284177|FG007|Overall Study|Lost to Follow-up|0|||
125452010|NCT02624778|451284178|FG008|Overall Study|Lost to Follow-up|0|||
125452011|NCT02624778|451284170|FG000|Overall Study|Withdrawal by Subject|0|||
125452012|NCT02624778|451284171|FG001|Overall Study|Withdrawal by Subject|1|||
125452013|NCT02624778|451284172|FG002|Overall Study|Withdrawal by Subject|0|||
125452014|NCT02624778|451284173|FG003|Overall Study|Withdrawal by Subject|0|||
125452015|NCT02624778|451284174|FG004|Overall Study|Withdrawal by Subject|0|||
125452016|NCT02624778|451284175|FG005|Overall Study|Withdrawal by Subject|1|||
125452017|NCT02624778|451284176|FG006|Overall Study|Withdrawal by Subject|1|||
125452018|NCT02624778|451284177|FG007|Overall Study|Withdrawal by Subject|1|||
125452019|NCT02624778|451284178|FG008|Overall Study|Withdrawal by Subject|1|||
125452020|NCT02624778|451284170|FG000|Overall Study|Adverse Event|0|||
125452021|NCT02624778|451284171|FG001|Overall Study|Adverse Event|0|||
125452022|NCT02624778|451284172|FG002|Overall Study|Adverse Event|0|||
125452023|NCT02624778|451284173|FG003|Overall Study|Adverse Event|0|||
125452024|NCT02624778|451284174|FG004|Overall Study|Adverse Event|0|||
125452025|NCT02624778|451284175|FG005|Overall Study|Adverse Event|0|||
125452026|NCT02624778|451284176|FG006|Overall Study|Adverse Event|0|||
125452027|NCT02624778|451284177|FG007|Overall Study|Adverse Event|0|||
125452028|NCT02624778|451284178|FG008|Overall Study|Adverse Event|2|||
125452029|NCT02624778|451284170|FG000|Overall Study|Death|0|||
125452030|NCT02624778|451284171|FG001|Overall Study|Death|0|||
125452031|NCT02624778|451284172|FG002|Overall Study|Death|0|||
125452032|NCT02624778|451284173|FG003|Overall Study|Death|0|||
125452033|NCT02624778|451284174|FG004|Overall Study|Death|0|||
125452034|NCT02624778|451284175|FG005|Overall Study|Death|0|||
125452035|NCT02624778|451284176|FG006|Overall Study|Death|1|||
125452036|NCT02624778|451284177|FG007|Overall Study|Death|0|||
125452037|NCT02624778|451284178|FG008|Overall Study|Death|0|||
125452038|NCT02624778|451284170|FG000|Overall Study|Physician Decision|0|||
125452039|NCT02624778|451284171|FG001|Overall Study|Physician Decision|0|||
125452040|NCT02624778|451284172|FG002|Overall Study|Physician Decision|0|||
125452041|NCT02624778|451284173|FG003|Overall Study|Physician Decision|0|||
125452042|NCT02624778|451284174|FG004|Overall Study|Physician Decision|0|||
125452043|NCT02624778|451284175|FG005|Overall Study|Physician Decision|0|||
125452044|NCT02624778|451284176|FG006|Overall Study|Physician Decision|0|||
125452045|NCT02624778|451284177|FG007|Overall Study|Physician Decision|3|||
125452046|NCT02624778|451284178|FG008|Overall Study|Physician Decision|3|||
125452047|NCT01537133|451284181|FG000|Overall Study|Withdrawal by Subject|2|||
125452048|NCT01537133|451284182|FG001|Overall Study|Withdrawal by Subject|0|||
125452049|NCT01537133|451284183|FG002|Overall Study|Withdrawal by Subject|0|||
125452050|NCT01537133|451284184|FG003|Overall Study|Withdrawal by Subject|0|||
125452051|NCT01537133|451284181|FG000|Overall Study|Lost to Follow-up|1|||
125452052|NCT01537133|451284182|FG001|Overall Study|Lost to Follow-up|0|||
125452053|NCT01537133|451284183|FG002|Overall Study|Lost to Follow-up|0|||
125452054|NCT01537133|451284184|FG003|Overall Study|Lost to Follow-up|0|||
125452055|NCT01244984|451284189|FG000|Overall Study|Adverse Event|2|||
125452056|NCT01244984|451284190|FG001|Overall Study|Adverse Event|11|||
125452057|NCT01244984|451284191|FG002|Overall Study|Adverse Event|2|||
125452058|NCT01244984|451284189|FG000|Overall Study|Protocol Violation|1|||
125452059|NCT01244984|451284190|FG001|Overall Study|Protocol Violation|0|||
125452060|NCT01244984|451284191|FG002|Overall Study|Protocol Violation|0|||
125452061|NCT01244984|451284189|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
125452062|NCT01244984|451284190|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
125452063|NCT01244984|451284191|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
125452064|NCT01244984|451284189|FG000|Overall Study|Withdrawal by Subject|1|||
125452065|NCT01244984|451284190|FG001|Overall Study|Withdrawal by Subject|2|||
125452066|NCT01244984|451284191|FG002|Overall Study|Withdrawal by Subject|2|||
125452067|NCT01168401|451284192|FG000|Overall Study|Lost to Follow-up|1|||
125452068|NCT01168401|451284193|FG001|Overall Study|Lost to Follow-up|1|||
125452069|NCT01168401|451284194|FG002|Overall Study|Lost to Follow-up|2|||
125452070|NCT01168401|451284195|FG003|Overall Study|Lost to Follow-up|1|||
125452071|NCT01168401|451284196|FG004|Overall Study|Lost to Follow-up|0|||
125452072|NCT01168401|451284197|FG005|Overall Study|Lost to Follow-up|0|||
125452073|NCT01168401|451284198|FG006|Overall Study|Lost to Follow-up|0|||
125452074|NCT01168401|451284199|FG007|Overall Study|Lost to Follow-up|0|||
125452075|NCT01168401|451284200|FG008|Overall Study|Lost to Follow-up|0|||
125452076|NCT01168401|451284201|FG009|Overall Study|Lost to Follow-up|0|||
125452077|NCT01168401|451284202|FG010|Overall Study|Lost to Follow-up|0|||
125452078|NCT01168401|451284192|FG000|Overall Study|Withdrawal by Subject|0|||
125452079|NCT01168401|451284193|FG001|Overall Study|Withdrawal by Subject|0|||
125452080|NCT01168401|451284194|FG002|Overall Study|Withdrawal by Subject|0|||
125452081|NCT01168401|451284195|FG003|Overall Study|Withdrawal by Subject|1|||
125452082|NCT01168401|451284196|FG004|Overall Study|Withdrawal by Subject|0|||
125452083|NCT01168401|451284197|FG005|Overall Study|Withdrawal by Subject|0|||
125452084|NCT01168401|451284198|FG006|Overall Study|Withdrawal by Subject|0|||
125452085|NCT01168401|451284199|FG007|Overall Study|Withdrawal by Subject|0|||
125452086|NCT01168401|451284200|FG008|Overall Study|Withdrawal by Subject|0|||
125452087|NCT01168401|451284201|FG009|Overall Study|Withdrawal by Subject|0|||
125452088|NCT01168401|451284202|FG010|Overall Study|Withdrawal by Subject|0|||
125452089|NCT00003656|451284204|FG000|Overall Study|Adverse Event|0|||
125452090|NCT00003656|451284205|FG001|Overall Study|Adverse Event|1|||
125452091|NCT01941316|451284208|FG000|Overall Study|Adverse Event|0|||
125452092|NCT01941316|451284209|FG001|Overall Study|Adverse Event|1|||
125452093|NCT01941316|451284210|FG002|Overall Study|Adverse Event|0|||
125452094|NCT01941316|451284211|FG003|Overall Study|Adverse Event|7|||
125452095|NCT01941316|451284208|FG000|Overall Study|Progressive Disease|3|||
125452096|NCT01941316|451284209|FG001|Overall Study|Progressive Disease|6|||
125452097|NCT01941316|451284210|FG002|Overall Study|Progressive Disease|2|||
125452098|NCT01941316|451284211|FG003|Overall Study|Progressive Disease|29|||
125452099|NCT01941316|451284208|FG000|Overall Study|Withdrawal by Subject|0|||
125452100|NCT01941316|451284209|FG001|Overall Study|Withdrawal by Subject|2|||
125452101|NCT01941316|451284210|FG002|Overall Study|Withdrawal by Subject|1|||
125452102|NCT01941316|451284211|FG003|Overall Study|Withdrawal by Subject|8|||
125452103|NCT01941316|451284208|FG000|Overall Study|Death|0|||
125452104|NCT01941316|451284209|FG001|Overall Study|Death|0|||
125452105|NCT01941316|451284210|FG002|Overall Study|Death|0|||
125452106|NCT01941316|451284211|FG003|Overall Study|Death|3|||
125452107|NCT01941316|451284208|FG000|Overall Study|Physician Decision|0|||
125452108|NCT01941316|451284209|FG001|Overall Study|Physician Decision|0|||
125452109|NCT01941316|451284210|FG002|Overall Study|Physician Decision|0|||
125452110|NCT01941316|451284211|FG003|Overall Study|Physician Decision|3|||
125452111|NCT01941316|451284208|FG000|Overall Study|Protocol Violation|0|||
125452112|NCT01941316|451284209|FG001|Overall Study|Protocol Violation|0|||
125452113|NCT01941316|451284210|FG002|Overall Study|Protocol Violation|0|||
125452114|NCT01941316|451284211|FG003|Overall Study|Protocol Violation|3|||
125452115|NCT01941316|451284208|FG000|Overall Study|Intercurrent illness|0|||
125452116|NCT01941316|451284209|FG001|Overall Study|Intercurrent illness|0|||
125452117|NCT01941316|451284210|FG002|Overall Study|Intercurrent illness|0|||
125452118|NCT01941316|451284211|FG003|Overall Study|Intercurrent illness|1|||
125452119|NCT01941316|451284208|FG000|Overall Study|Other, not specified|0|||
125452120|NCT01941316|451284209|FG001|Overall Study|Other, not specified|0|||
125452121|NCT01941316|451284210|FG002|Overall Study|Other, not specified|0|||
125452122|NCT01941316|451284211|FG003|Overall Study|Other, not specified|1|||
125452123|NCT03601507|451284216|FG000|Overall Study|Adverse Event|1|||
125452124|NCT02107014|451284219|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
125452125|NCT03168438|451284220|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
125452126|NCT03168438|451284221|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
125452127|NCT05015478|451284224|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
125452128|NCT05015478|451284225|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
125452129|NCT05015478|451284226|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
125452130|NCT05015478|451284227|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
125452131|NCT01649427|451284231|FG000|Overall Study|Adverse Event|1|||
125452132|NCT01649427|451284232|FG001|Overall Study|Adverse Event|1|||
125452133|NCT01649427|451284231|FG000|Overall Study|Withdrawal by Subject|8|||
125452134|NCT01649427|451284232|FG001|Overall Study|Withdrawal by Subject|7|||
125452135|NCT01649427|451284231|FG000|Overall Study|Lost to Follow-up|0|||
125452136|NCT01649427|451284232|FG001|Overall Study|Lost to Follow-up|1|||
125452137|NCT01649427|451284231|FG000|Overall Study|Graft loss|0|||
125452138|NCT01649427|451284232|FG001|Overall Study|Graft loss|1|||
125452139|NCT01649427|451284231|FG000|Overall Study|Surgical problems during nephrectomy|2|||
125452140|NCT01649427|451284232|FG001|Overall Study|Surgical problems during nephrectomy|2|||
125452141|NCT02138916|451284233|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
125452142|NCT02138916|451284234|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
125452143|NCT02138916|451284235|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
125452144|NCT02138916|451284233|FG000|Overall Study|Death|14|||
125452145|NCT02138916|451284234|FG001|Overall Study|Death|11|||
125452146|NCT02138916|451284235|FG002|Overall Study|Death|12|||
125452147|NCT02138916|451284233|FG000|Overall Study|Withdrawal by Subject|27|||
125452148|NCT02138916|451284234|FG001|Overall Study|Withdrawal by Subject|31|||
125452149|NCT02138916|451284235|FG002|Overall Study|Withdrawal by Subject|32|||
125452150|NCT02138916|451284233|FG000|Overall Study|Study specific withdrawal criteria|0|||
125452151|NCT02138916|451284234|FG001|Overall Study|Study specific withdrawal criteria|0|||
125452152|NCT02138916|451284235|FG002|Overall Study|Study specific withdrawal criteria|1|||
125452153|NCT02138916|451284233|FG000|Overall Study|incorrect enrolment|1|||
125452154|NCT02138916|451284234|FG001|Overall Study|incorrect enrolment|1|||
125452155|NCT02138916|451284235|FG002|Overall Study|incorrect enrolment|0|||
125452156|NCT02138916|451284233|FG000|Overall Study|Severe non-compliance|1|||
125452157|NCT02138916|451284234|FG001|Overall Study|Severe non-compliance|2|||
125452158|NCT02138916|451284235|FG002|Overall Study|Severe non-compliance|1|||
125452159|NCT02138916|451284233|FG000|Overall Study|Lost to Follow-up|4|||
125452160|NCT02138916|451284234|FG001|Overall Study|Lost to Follow-up|2|||
125452161|NCT02138916|451284235|FG002|Overall Study|Lost to Follow-up|3|||
125292197|NCT00996801|450696556|FG005|Overall Study|Physician Decision|0|||
125452162|NCT02138916|451284233|FG000|Overall Study|Adverse Event|4|||
125452163|NCT02138916|451284234|FG001|Overall Study|Adverse Event|4|||
125452164|NCT02138916|451284235|FG002|Overall Study|Adverse Event|3|||
125452165|NCT00117988|451284240|FG000|Overall Study|Death|3|||
125452166|NCT00117988|451284240|FG000|Overall Study|Adverse Event|1|||
125452167|NCT05196737|451284242|FG000|Non-intervention Week|Lost to Follow-up|2|||
125452168|NCT05196737|451284242|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
125452169|NCT05096884|451284243|FG000|Overall Study|Excluded based on negative tilt table test|4|||
125452170|NCT04927975|451284244|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
125452171|NCT04927975|451284245|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
125452172|NCT04927975|451284246|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
125452173|NCT04927975|451284247|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
125452174|NCT04927975|451284248|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
125452175|NCT04927975|451284249|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
125452176|NCT04927975|451284244|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
125452177|NCT04927975|451284245|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
125452178|NCT04927975|451284246|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
125452179|NCT04927975|451284247|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
125452180|NCT04927975|451284248|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
125452181|NCT04927975|451284249|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
125452182|NCT04927975|451284244|FG000|Period 1 (Baseline-Week 24)|Death|0|||
125452183|NCT04927975|451284245|FG001|Period 1 (Baseline-Week 24)|Death|0|||
125452184|NCT04927975|451284246|FG002|Period 1 (Baseline-Week 24)|Death|0|||
125452185|NCT04927975|451284247|FG003|Period 1 (Baseline-Week 24)|Death|0|||
125452186|NCT04927975|451284248|FG004|Period 1 (Baseline-Week 24)|Death|0|||
125452187|NCT04927975|451284249|FG005|Period 1 (Baseline-Week 24)|Death|1|||
125452188|NCT04927975|451284244|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
125452189|NCT04927975|451284245|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
125452190|NCT04927975|451284246|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
125452191|NCT04927975|451284247|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
125452192|NCT04927975|451284248|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
125452193|NCT04927975|451284249|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
125452194|NCT04927975|451284244|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
125452195|NCT04927975|451284245|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
125452196|NCT04927975|451284246|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
125452197|NCT04927975|451284247|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
125452198|NCT04927975|451284248|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
125452199|NCT04927975|451284249|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
125452200|NCT03781804|451284250|FG000|Overall Study|Adverse Event|2|||
125452201|NCT03781804|451284251|FG001|Overall Study|Adverse Event|2|||
125452202|NCT03781804|451284252|FG002|Overall Study|Adverse Event|3|||
125452203|NCT03781804|451284250|FG000|Overall Study|Lost to Follow-up|1|||
125452204|NCT03781804|451284251|FG001|Overall Study|Lost to Follow-up|1|||
125452205|NCT03781804|451284252|FG002|Overall Study|Lost to Follow-up|2|||
125452206|NCT03781804|451284250|FG000|Overall Study|Lack of Efficacy|4|||
125452207|NCT03781804|451284251|FG001|Overall Study|Lack of Efficacy|2|||
125452208|NCT03781804|451284252|FG002|Overall Study|Lack of Efficacy|9|||
125452209|NCT03781804|451284250|FG000|Overall Study|Protocol Violation|0|||
125452210|NCT03781804|451284251|FG001|Overall Study|Protocol Violation|0|||
125452211|NCT03781804|451284252|FG002|Overall Study|Protocol Violation|1|||
125452212|NCT03781804|451284250|FG000|Overall Study|Withdrawal by Subject|0|||
125452213|NCT03781804|451284251|FG001|Overall Study|Withdrawal by Subject|1|||
125452214|NCT03781804|451284252|FG002|Overall Study|Withdrawal by Subject|1|||
125452215|NCT03781804|451284250|FG000|Overall Study|Reason not provided|2|||
125452216|NCT03781804|451284251|FG001|Overall Study|Reason not provided|2|||
125452217|NCT03781804|451284252|FG002|Overall Study|Reason not provided|0|||
125452218|NCT00337818|451284253|FG000|Overall Study|Lost to Follow-up|289|||
125452219|NCT00337818|451284254|FG001|Overall Study|Lost to Follow-up|91|||
125452220|NCT00337818|451284255|FG002|Overall Study|Lost to Follow-up|107|||
125452221|NCT04678830|451284256|FG000|Overall Study|Lack of Efficacy|2|||
125452222|NCT04678830|451284257|FG001|Overall Study|Lack of Efficacy|0|||
125452223|NCT04678830|451284256|FG000|Overall Study|Withdrawal by Subject|0|||
125452224|NCT04678830|451284257|FG001|Overall Study|Withdrawal by Subject|1|||
125452225|NCT03563053|451284261|FG000|Overall Study|Withdrawal by Subject|17|||
125452226|NCT03563053|451284261|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
125452227|NCT03563053|451284261|FG000|Overall Study|Adverse Event|3|||
125452228|NCT03563053|451284261|FG000|Overall Study|Physician Decision|1|||
125452229|NCT03563053|451284261|FG000|Overall Study|study terminated by sponsor|71|||
125452230|NCT02189863|451284262|FG000|First 2 Weeks|Motion Sickness|4|||
125452231|NCT02189863|451284263|FG001|First 2 Weeks|Motion Sickness|2|||
125452232|NCT03369951|451284265|FG000|Overall Study|Withdrawal by Subject|3|||
125452233|NCT03369951|451284265|FG000|Overall Study|Death|1|||
125452234|NCT03369951|451284265|FG000|Overall Study|Lost to Follow-up|1|||
125452235|NCT03369951|451284265|FG000|Overall Study|Protocol Violation|1|||
125452236|NCT02926937|451284266|FG000|Overall Study|Adverse Event|0|||
125452237|NCT02926937|451284267|FG001|Overall Study|Adverse Event|1|||
125452238|NCT02926937|451284268|FG002|Overall Study|Adverse Event|1|||
125292198|NCT00996801|450696551|FG000|Overall Study|Progressive Disease|0|||
125452239|NCT02926937|451284266|FG000|Overall Study|Poor Compliance to Protocol|1|||
125452240|NCT02926937|451284267|FG001|Overall Study|Poor Compliance to Protocol|0|||
125452241|NCT02926937|451284268|FG002|Overall Study|Poor Compliance to Protocol|0|||
125452242|NCT02926937|451284266|FG000|Overall Study|Lost to Follow-up|4|||
125452243|NCT02926937|451284267|FG001|Overall Study|Lost to Follow-up|5|||
125452244|NCT02926937|451284268|FG002|Overall Study|Lost to Follow-up|0|||
125452245|NCT02926937|451284266|FG000|Overall Study|At the Participant's own Request|11|||
125452246|NCT02926937|451284267|FG001|Overall Study|At the Participant's own Request|5|||
125452247|NCT02926937|451284268|FG002|Overall Study|At the Participant's own Request|8|||
125452248|NCT02926937|451284266|FG000|Overall Study|Reason not Specified|3|||
125452249|NCT02926937|451284267|FG001|Overall Study|Reason not Specified|4|||
125452250|NCT02926937|451284268|FG002|Overall Study|Reason not Specified|2|||
125452251|NCT01559090|451284269|FG000|Stage I|Withdrawal by Subject|2|||
125452252|NCT01559090|451284270|FG001|Stage I|Withdrawal by Subject|2|||
125452253|NCT01559090|451284271|FG002|Stage I|Withdrawal by Subject|3|||
125452254|NCT01559090|451284269|FG000|Stage II|Withdrawal by Subject|1|||
125452255|NCT01559090|451284270|FG001|Stage II|Withdrawal by Subject|0|||
125452256|NCT01559090|451284271|FG002|Stage II|Withdrawal by Subject|0|||
125452257|NCT03677375|451284272|FG000|Overall Study|Incomplete procedure|8|||
125452258|NCT03677375|451284272|FG000|Overall Study|Adverse Event|3|||
125452259|NCT03677375|451284272|FG000|Overall Study|Physician Decision|1|||
125452260|NCT00561574|451284278|FG000|Overall Study|Adverse Event|21|||
125452261|NCT00561574|451284279|FG001|Overall Study|Adverse Event|24|||
125452262|NCT00561574|451284278|FG000|Overall Study|Lack of Efficacy|11|||
125452263|NCT00561574|451284279|FG001|Overall Study|Lack of Efficacy|21|||
125452264|NCT00561574|451284278|FG000|Overall Study|Withdrawal by Subject|4|||
125452265|NCT00561574|451284279|FG001|Overall Study|Withdrawal by Subject|4|||
125452266|NCT00561574|451284278|FG000|Overall Study|Reason Unrelated to Trial|6|||
125452267|NCT00561574|451284279|FG001|Overall Study|Reason Unrelated to Trial|2|||
125452268|NCT00561574|451284278|FG000|Overall Study|Lost to Follow-up|1|||
125452269|NCT00561574|451284279|FG001|Overall Study|Lost to Follow-up|0|||
125452270|NCT00561574|451284278|FG000|Overall Study|Other|5|||
125452271|NCT00561574|451284279|FG001|Overall Study|Other|7|||
125452272|NCT03971357|451284280|FG000|Overall Study|Lack of Efficacy|0|||
125452273|NCT03971357|451284281|FG001|Overall Study|Lack of Efficacy|1|||
125452274|NCT00124982|451284289|FG000|Short-term Period|Death|1|||
125452275|NCT00124982|451284290|FG001|Short-term Period|Death|1|||
125452276|NCT00124982|451284291|FG002|Short-term Period|Death|0|||
125452277|NCT00124982|451284289|FG000|Short-term Period|Adverse Event|17|||
125452278|NCT00124982|451284290|FG001|Short-term Period|Adverse Event|22|||
125452279|NCT00124982|451284291|FG002|Short-term Period|Adverse Event|0|||
125452280|NCT00124982|451284289|FG000|Short-term Period|Lack of Efficacy|32|||
125452281|NCT00124982|451284290|FG001|Short-term Period|Lack of Efficacy|73|||
125452282|NCT00124982|451284291|FG002|Short-term Period|Lack of Efficacy|0|||
125452283|NCT00124982|451284289|FG000|Short-term Period|Lost to Follow-up|8|||
125452284|NCT00124982|451284290|FG001|Short-term Period|Lost to Follow-up|5|||
125452285|NCT00124982|451284291|FG002|Short-term Period|Lost to Follow-up|0|||
125452286|NCT00124982|451284289|FG000|Short-term Period|Withdrawal of Consent|7|||
125452287|NCT00124982|451284290|FG001|Short-term Period|Withdrawal of Consent|9|||
125452288|NCT00124982|451284291|FG002|Short-term Period|Withdrawal of Consent|0|||
125452289|NCT00124982|451284289|FG000|Short-term Period|Poor/Non-compliance|3|||
125452290|NCT00124982|451284290|FG001|Short-term Period|Poor/Non-compliance|1|||
125452291|NCT00124982|451284291|FG002|Short-term Period|Poor/Non-compliance|0|||
125452292|NCT00124982|451284289|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
125452293|NCT00124982|451284290|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
125452294|NCT00124982|451284291|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
125452295|NCT00124982|451284289|FG000|Short-term Period|Participant Decision|1|||
125452296|NCT00124982|451284290|FG001|Short-term Period|Participant Decision|0|||
125452297|NCT00124982|451284291|FG002|Short-term Period|Participant Decision|0|||
125452298|NCT00124982|451284289|FG000|Short-term Period|Participant Chose Own Doctor|0|||
125452299|NCT00124982|451284290|FG001|Short-term Period|Participant Chose Own Doctor|1|||
125452300|NCT00124982|451284291|FG002|Short-term Period|Participant Chose Own Doctor|0|||
125452301|NCT00124982|451284289|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
125452302|NCT00124982|451284290|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
125452303|NCT00124982|451284291|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
125452304|NCT00124982|451284289|FG000|Short-term Period|Participant Had Lymphopenia|1|||
125452305|NCT00124982|451284290|FG001|Short-term Period|Participant Had Lymphopenia|0|||
125452306|NCT00124982|451284291|FG002|Short-term Period|Participant Had Lymphopenia|0|||
125452307|NCT00124982|451284289|FG000|Long-term Period|Death|0|||
125452308|NCT00124982|451284290|FG001|Long-term Period|Death|0|||
125452309|NCT00124982|451284291|FG002|Long-term Period|Death|1|||
125452310|NCT00124982|451284289|FG000|Long-term Period|Adverse Event|0|||
125452311|NCT00124982|451284290|FG001|Long-term Period|Adverse Event|0|||
125452312|NCT00124982|451284291|FG002|Long-term Period|Adverse Event|17|||
125452313|NCT00124982|451284289|FG000|Long-term Period|Lack of Efficacy|0|||
125452314|NCT00124982|451284290|FG001|Long-term Period|Lack of Efficacy|0|||
125452315|NCT00124982|451284291|FG002|Long-term Period|Lack of Efficacy|46|||
125452316|NCT00124982|451284289|FG000|Long-term Period|Lost to Follow-up|0|||
125452317|NCT00124982|451284290|FG001|Long-term Period|Lost to Follow-up|0|||
125452318|NCT00124982|451284291|FG002|Long-term Period|Lost to Follow-up|4|||
125452319|NCT00124982|451284289|FG000|Long-term Period|Withdrawal by Subject|0|||
125452320|NCT00124982|451284290|FG001|Long-term Period|Withdrawal by Subject|0|||
125452321|NCT00124982|451284291|FG002|Long-term Period|Withdrawal by Subject|16|||
125452322|NCT00124982|451284289|FG000|Long-term Period|Pregnancy|0|||
125452323|NCT00124982|451284290|FG001|Long-term Period|Pregnancy|0|||
125452324|NCT00124982|451284291|FG002|Long-term Period|Pregnancy|1|||
125452325|NCT00124982|451284289|FG000|Long-term Period|Poor/Non-compliance|0|||
125452326|NCT00124982|451284290|FG001|Long-term Period|Poor/Non-compliance|0|||
125452327|NCT00124982|451284291|FG002|Long-term Period|Poor/Non-compliance|2|||
125452328|NCT00124982|451284289|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
125452329|NCT00124982|451284290|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
125452330|NCT00124982|451284291|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
125452331|NCT00124982|451284289|FG000|Long-term Period|Neurologist Recommendation|0|||
125452332|NCT00124982|451284290|FG001|Long-term Period|Neurologist Recommendation|0|||
125452333|NCT00124982|451284291|FG002|Long-term Period|Neurologist Recommendation|1|||
125452334|NCT00630864|451284292|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
125452335|NCT00630864|451284292|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
125452336|NCT00430677|451284293|FG000|Short-term Period|Death|1|||
125452337|NCT00430677|451284294|FG001|Short-term Period|Death|1|||
125452338|NCT00430677|451284295|FG002|Short-term Period|Death|5|||
125452339|NCT00430677|451284293|FG000|Short-term Period|Adverse Event|15|||
125452340|NCT00430677|451284294|FG001|Short-term Period|Adverse Event|13|||
125452341|NCT00430677|451284295|FG002|Short-term Period|Adverse Event|9|||
125452342|NCT00430677|451284293|FG000|Short-term Period|Lack of Efficacy|5|||
125452343|NCT00430677|451284294|FG001|Short-term Period|Lack of Efficacy|6|||
125452344|NCT00430677|451284295|FG002|Short-term Period|Lack of Efficacy|4|||
125452345|NCT00430677|451284293|FG000|Short-term Period|Withdrawal by Subject|1|||
125452346|NCT00430677|451284294|FG001|Short-term Period|Withdrawal by Subject|1|||
125452347|NCT00430677|451284295|FG002|Short-term Period|Withdrawal by Subject|2|||
125452348|NCT00430677|451284293|FG000|Short-term Period|Participant no longer met study criteria|1|||
125452349|NCT00430677|451284294|FG001|Short-term Period|Participant no longer met study criteria|1|||
125452350|NCT00430677|451284295|FG002|Short-term Period|Participant no longer met study criteria|2|||
125452351|NCT00430677|451284293|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
125452352|NCT00430677|451284294|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
125452353|NCT00430677|451284295|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
125452354|NCT00430677|451284293|FG000|Short-term Period|Pregnancy|0|||
125452355|NCT00430677|451284294|FG001|Short-term Period|Pregnancy|2|||
125452356|NCT00430677|451284295|FG002|Short-term Period|Pregnancy|0|||
125452357|NCT00430677|451284293|FG000|Long-term Extension Period|Death|1|||
125452358|NCT00430677|451284294|FG001|Long-term Extension Period|Death|0|||
125452359|NCT00430677|451284295|FG002|Long-term Extension Period|Death|0|||
125452360|NCT00430677|451284293|FG000|Long-term Extension Period|Adverse Event|3|||
125452361|NCT00430677|451284294|FG001|Long-term Extension Period|Adverse Event|2|||
125452362|NCT00430677|451284295|FG002|Long-term Extension Period|Adverse Event|5|||
125452363|NCT00430677|451284293|FG000|Long-term Extension Period|Lack of Efficacy|5|||
125452364|NCT00430677|451284294|FG001|Long-term Extension Period|Lack of Efficacy|3|||
125452365|NCT00430677|451284295|FG002|Long-term Extension Period|Lack of Efficacy|8|||
125452366|NCT00430677|451284293|FG000|Long-term Extension Period|Lost to Follow-up|1|||
125452367|NCT00430677|451284294|FG001|Long-term Extension Period|Lost to Follow-up|1|||
125452368|NCT00430677|451284295|FG002|Long-term Extension Period|Lost to Follow-up|1|||
125452369|NCT00430677|451284293|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
125452370|NCT00430677|451284294|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
125452371|NCT00430677|451284295|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
125452372|NCT00430677|451284293|FG000|Long-term Extension Period|Pregnancy|1|||
125452373|NCT00430677|451284294|FG001|Long-term Extension Period|Pregnancy|1|||
125452374|NCT00430677|451284295|FG002|Long-term Extension Period|Pregnancy|0|||
125452375|NCT00430677|451284293|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
125452376|NCT00430677|451284294|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
125452377|NCT00430677|451284295|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
125452378|NCT00430677|451284293|FG000|Long-term Extension Period|Other|2|||
125452379|NCT00430677|451284294|FG001|Long-term Extension Period|Other|1|||
125452380|NCT00430677|451284295|FG002|Long-term Extension Period|Other|1|||
125452381|NCT00430677|451284293|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
125452382|NCT00430677|451284294|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
125452383|NCT00430677|451284295|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
125452384|NCT01555762|451284296|FG000|Overall Study|No information on Bevacizumab intake|11|||
125452385|NCT01555762|451284296|FG000|Overall Study|Missing start date of infusion|8|||
125452386|NCT01555762|451284296|FG000|Overall Study|75 years old or more ticked No|1|||
125452387|NCT01555762|451284296|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
125452388|NCT01555762|451284296|FG000|Overall Study|Death linked to progression of disease|165|||
125452389|NCT01555762|451284296|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
125452390|NCT01555762|451284296|FG000|Overall Study|Investigator's decision|10|||
125452391|NCT01555762|451284296|FG000|Overall Study|Participant not wishing to continue|5|||
125452392|NCT01555762|451284296|FG000|Overall Study|Missing data|1|||
125452393|NCT01555762|451284296|FG000|Overall Study|Death linked to an adverse event|14|||
125452394|NCT01333514|451284297|FG000|Overall Study|Withdrawal by Subject|1|||
125452395|NCT01333514|451284298|FG001|Overall Study|Withdrawal by Subject|0|||
125452396|NCT00836810|451284299|FG000|Overall Study|New diagnosis|1|||
125452397|NCT00836810|451284300|FG001|Overall Study|New diagnosis|0|||
125452398|NCT00389519|451284303|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
125452399|NCT00389519|451284304|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
125452400|NCT00389519|451284305|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
125452401|NCT00389519|451284306|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
125452402|NCT00389519|451284303|FG000|Placebo Run-In|Withdrawal by Subject|19|||
125452403|NCT00389519|451284304|FG001|Placebo Run-In|Withdrawal by Subject|0|||
125452404|NCT00389519|451284305|FG002|Placebo Run-In|Withdrawal by Subject|0|||
125452405|NCT00389519|451284306|FG003|Placebo Run-In|Withdrawal by Subject|0|||
125452406|NCT00389519|451284303|FG000|Placebo Run-In|Reason not specified|40|||
125452407|NCT00389519|451284304|FG001|Placebo Run-In|Reason not specified|0|||
125452408|NCT00389519|451284305|FG002|Placebo Run-In|Reason not specified|0|||
125452409|NCT00389519|451284306|FG003|Placebo Run-In|Reason not specified|0|||
125452410|NCT00389519|451284303|FG000|Randomized|Did not receive study drug|2|||
125452411|NCT00389519|451284304|FG001|Randomized|Did not receive study drug|0|||
125452412|NCT00389519|451284305|FG002|Randomized|Did not receive study drug|0|||
125452413|NCT00389519|451284306|FG003|Randomized|Did not receive study drug|0|||
125452414|NCT00389519|451284303|FG000|Treated|Adverse Event|1|||
125452415|NCT00389519|451284304|FG001|Treated|Adverse Event|0|||
125452416|NCT00389519|451284305|FG002|Treated|Adverse Event|0|||
125452417|NCT00389519|451284306|FG003|Treated|Adverse Event|2|||
125452418|NCT00389519|451284303|FG000|Treated|Reason not specified|1|||
125452419|NCT00389519|451284304|FG001|Treated|Reason not specified|1|||
125452420|NCT00389519|451284305|FG002|Treated|Reason not specified|0|||
125452421|NCT00389519|451284306|FG003|Treated|Reason not specified|2|||
125452422|NCT02040844|451284311|FG000|Overall Study|Adverse Event|0|||
125452423|NCT02040844|451284312|FG001|Overall Study|Adverse Event|0|||
125452424|NCT02040844|451284313|FG002|Overall Study|Adverse Event|1|||
125452425|NCT02040844|451284311|FG000|Overall Study|Withdrawal by Subject|16|||
125452426|NCT02040844|451284312|FG001|Overall Study|Withdrawal by Subject|22|||
125452427|NCT02040844|451284313|FG002|Overall Study|Withdrawal by Subject|25|||
125452428|NCT02040844|451284311|FG000|Overall Study|Lost to Follow-up|12|||
125452429|NCT02040844|451284312|FG001|Overall Study|Lost to Follow-up|9|||
125452430|NCT02040844|451284313|FG002|Overall Study|Lost to Follow-up|13|||
125452431|NCT02040844|451284311|FG000|Overall Study|Missing|13|||
125452432|NCT02040844|451284312|FG001|Overall Study|Missing|3|||
125452433|NCT02040844|451284313|FG002|Overall Study|Missing|2|||
125452434|NCT02040844|451284311|FG000|Overall Study|Non-specified|8|||
125452435|NCT02040844|451284312|FG001|Overall Study|Non-specified|2|||
125452436|NCT02040844|451284313|FG002|Overall Study|Non-specified|5|||
125452437|NCT02040844|451284311|FG000|Overall Study|Concomitant medication|1|||
125452438|NCT02040844|451284312|FG001|Overall Study|Concomitant medication|3|||
125452439|NCT02040844|451284313|FG002|Overall Study|Concomitant medication|1|||
125452440|NCT01560949|451284316|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
125452441|NCT01560949|451284316|FG000|Surgery Phase|Physician Decision|3|||
125452442|NCT02068885|451284321|FG000|Overall Study|Withdrew|3|||
125452443|NCT02068885|451284322|FG001|Overall Study|Withdrew|5|||
125452444|NCT02068885|451284323|FG002|Overall Study|Withdrew|8|||
125452445|NCT00681811|451284324|FG000|Overall Study|Adverse Event|1|||
125452446|NCT00681811|451284325|FG001|Overall Study|Adverse Event|1|||
125292199|NCT00996801|450696552|FG001|Overall Study|Progressive Disease|1|||
125452447|NCT00681811|451284324|FG000|Overall Study|Withdrawal by Subject|2|||
125452448|NCT00681811|451284325|FG001|Overall Study|Withdrawal by Subject|2|||
125452449|NCT00681811|451284324|FG000|Overall Study|Non-compliance|0|||
125452450|NCT00681811|451284325|FG001|Overall Study|Non-compliance|1|||
125292200|NCT00996801|450696553|FG002|Overall Study|Progressive Disease|0|||
125452451|NCT01562743|451284331|FG000|Overall Study|Adverse Event|29|||
125452452|NCT01562743|451284331|FG000|Overall Study|Lack of Efficacy|3|||
125452453|NCT01562743|451284331|FG000|Overall Study|Withdrawal by Subject|13|||
125452454|NCT01562743|451284331|FG000|Overall Study|Protocol Violation|1|||
125452455|NCT01562743|451284331|FG000|Overall Study|Discontinuation criteria|2|||
125452456|NCT01562743|451284331|FG000|Overall Study|Lost to Follow-up|2|||
125452457|NCT01562743|451284331|FG000|Overall Study|Physician Decision|2|||
125452458|NCT04155424|451284332|FG000|Overall Study|Other than specified|3|||
125452459|NCT04155424|451284332|FG000|Overall Study|Withdrawal by Subject|1|||
125452460|NCT04155424|451284332|FG000|Overall Study|Adverse Event|1|||
125452461|NCT03015740|451284333|FG000|Overall Study|Adverse Event|1|||
125452462|NCT03015740|451284334|FG001|Overall Study|Adverse Event|0|||
125452463|NCT03015740|451284335|FG002|Overall Study|Adverse Event|0|||
125452464|NCT03015740|451284333|FG000|Overall Study|Death|3|||
125452465|NCT03015740|451284334|FG001|Overall Study|Death|5|||
125452466|NCT03015740|451284335|FG002|Overall Study|Death|0|||
125452467|NCT03015740|451284333|FG000|Overall Study|Withdrawal by Subject|2|||
125452468|NCT03015740|451284334|FG001|Overall Study|Withdrawal by Subject|0|||
125452469|NCT03015740|451284335|FG002|Overall Study|Withdrawal by Subject|0|||
125452470|NCT04159506|451284336|FG000|Overall Study|Lost to Follow-up|2|||
125452471|NCT04159506|451284337|FG001|Overall Study|Lost to Follow-up|5|||
125452472|NCT02449044|451284338|FG000|Overall Study|Lost to Follow-up|2|||
125452473|NCT02449044|451284338|FG000|Overall Study|Withdrawal by Subject|13|||
125452474|NCT02449044|451284338|FG000|Overall Study|Adverse Event|30|||
125452475|NCT02449044|451284338|FG000|Overall Study|Met Withdrawal Criteria|7|||
125452476|NCT02449044|451284338|FG000|Overall Study|Physician Decision|9|||
125452477|NCT02449044|451284338|FG000|Overall Study|Sponsor Discontinued Trial|3|||
125452478|NCT00587288|451286154|FG000|Overall Study|Adverse Event|0|||
125452479|NCT00587288|451286155|FG001|Overall Study|Adverse Event|1|||
125452480|NCT00587288|451286154|FG000|Overall Study|Lack of Efficacy|2|||
125452481|NCT00587288|451286155|FG001|Overall Study|Lack of Efficacy|8|||
125452482|NCT00587288|451286154|FG000|Overall Study|Protocol Violation|1|||
125452483|NCT00587288|451286155|FG001|Overall Study|Protocol Violation|0|||
125452484|NCT00531479|451286156|FG000|Overall Study|Death|68|||
125452485|NCT00531479|451286157|FG001|Overall Study|Death|71|||
125452486|NCT00531479|451286156|FG000|Overall Study|Lost to Follow-up|0|||
125452487|NCT00531479|451286157|FG001|Overall Study|Lost to Follow-up|2|||
125452488|NCT00531479|451286156|FG000|Overall Study|Other|0|||
125452489|NCT00531479|451286157|FG001|Overall Study|Other|1|||
125452490|NCT00531479|451286156|FG000|Overall Study|Withdrawal by Subject|6|||
125452491|NCT00531479|451286157|FG001|Overall Study|Withdrawal by Subject|6|||
125452492|NCT00531479|451286156|FG000|Overall Study|Did not receive treatment|2|||
125452493|NCT00531479|451286157|FG001|Overall Study|Did not receive treatment|3|||
125452494|NCT00409708|451286158|FG000|Treatment|Abnormal test procedure result(s)|1|||
125452495|NCT00409708|451286159|FG001|Treatment|Abnormal test procedure result(s)|0|||
125452496|NCT00409708|451286158|FG000|Treatment|Lack of Efficacy|0|||
125452497|NCT00409708|451286159|FG001|Treatment|Lack of Efficacy|1|||
125452498|NCT00409708|451286158|FG000|Treatment|Protocol Violation|6|||
125452499|NCT00409708|451286159|FG001|Treatment|Protocol Violation|2|||
125452500|NCT00409708|451286158|FG000|Treatment|Withdrawal by Subject|3|||
125452501|NCT00409708|451286159|FG001|Treatment|Withdrawal by Subject|8|||
125452502|NCT00409708|451286158|FG000|Treatment|Lost to Follow-up|0|||
125452503|NCT00409708|451286159|FG001|Treatment|Lost to Follow-up|6|||
125452504|NCT00409708|451286158|FG000|Treatment|Administrative problems|5|||
125452505|NCT00409708|451286159|FG001|Treatment|Administrative problems|0|||
125452506|NCT00409708|451286158|FG000|Washout|Lack of Efficacy|9|||
125452507|NCT00409708|451286159|FG001|Washout|Lack of Efficacy|1|||
125452508|NCT00409708|451286158|FG000|Washout|Protocol Violation|0|||
125452509|NCT00409708|451286159|FG001|Washout|Protocol Violation|1|||
125452510|NCT00409708|451286158|FG000|Washout|Withdrawal by Subject|11|||
125452511|NCT00409708|451286159|FG001|Washout|Withdrawal by Subject|5|||
125452512|NCT00409708|451286158|FG000|Washout|Lost to Follow-up|1|||
125452513|NCT00409708|451286159|FG001|Washout|Lost to Follow-up|3|||
125452514|NCT00868231|451286160|FG000|Treatment Period 1|Adverse Event|0|||
125452515|NCT00868231|451286161|FG001|Treatment Period 1|Adverse Event|0|||
125452516|NCT00868231|451286162|FG002|Treatment Period 1|Adverse Event|0|||
125452517|NCT00868231|451286163|FG003|Treatment Period 1|Adverse Event|0|||
125452518|NCT00868231|451286164|FG004|Treatment Period 1|Adverse Event|1|||
125452519|NCT00868231|451286165|FG005|Treatment Period 1|Adverse Event|0|||
125452520|NCT00868231|451286160|FG000|Treatment Period 2|Adverse Event|1|||
125452521|NCT00868231|451286161|FG001|Treatment Period 2|Adverse Event|0|||
125452522|NCT00868231|451286162|FG002|Treatment Period 2|Adverse Event|0|||
125452523|NCT00868231|451286163|FG003|Treatment Period 2|Adverse Event|0|||
125452524|NCT00868231|451286164|FG004|Treatment Period 2|Adverse Event|0|||
125452525|NCT00868231|451286165|FG005|Treatment Period 2|Adverse Event|0|||
125452526|NCT00868231|451286160|FG000|Treatment Period 3|Adverse Event|0|||
125452527|NCT00868231|451286161|FG001|Treatment Period 3|Adverse Event|0|||
125452528|NCT00868231|451286162|FG002|Treatment Period 3|Adverse Event|1|||
125452529|NCT00868231|451286163|FG003|Treatment Period 3|Adverse Event|0|||
125452530|NCT00868231|451286164|FG004|Treatment Period 3|Adverse Event|0|||
125452531|NCT00868231|451286165|FG005|Treatment Period 3|Adverse Event|0|||
125452532|NCT00926393|451286168|FG000|Overall Study|Withdrawal by Subject|1|||
125452533|NCT00926393|451286169|FG001|Overall Study|Withdrawal by Subject|2|||
125452534|NCT00926393|451286168|FG000|Overall Study|Adverse Event|1|||
125452535|NCT00926393|451286169|FG001|Overall Study|Adverse Event|1|||
125452536|NCT04577183|451286171|FG000|Overall Study|Death|1|||
125452537|NCT04577183|451286171|FG000|Overall Study|Withdrawal by Subject|3|||
125452538|NCT04577183|451286171|FG000|Overall Study|Early termination|2|||
125452539|NCT01720043|451286177|FG000|Overall Study|Withdrawal by Subject|1|||
125452540|NCT01688973|451286178|FG000|Overall Study|Ineligible|2|||
125452541|NCT01688973|451286179|FG001|Overall Study|Ineligible|3|||
125452542|NCT01516892|451286183|FG000|Overall Study|Adverse Event|25|||
125452543|NCT01516892|451286183|FG000|Overall Study|Lack of Efficacy|35|||
125452544|NCT01516892|451286183|FG000|Overall Study|Pregnancy|5|||
125452545|NCT01516892|451286183|FG000|Overall Study|Lost to Follow-up|82|||
125452546|NCT01516892|451286183|FG000|Overall Study|Subject Withdrew Consent|92|||
125452547|NCT01516892|451286183|FG000|Overall Study|Protocol Violation|60|||
125452548|NCT01516892|451286183|FG000|Overall Study|Other Miscellaneous Reasons|43|||
125452549|NCT01516892|451286183|FG000|Overall Study|Missing|1|||
125452550|NCT02534896|451286189|FG000|Overall Study|Adverse Event|2|||
125452551|NCT02534896|451286190|FG001|Overall Study|Adverse Event|1|||
125452552|NCT02534896|451286191|FG002|Overall Study|Adverse Event|1|||
125452553|NCT02534896|451286189|FG000|Overall Study|Insufficient therapeutic response|2|||
125452554|NCT02534896|451286190|FG001|Overall Study|Insufficient therapeutic response|0|||
125452555|NCT02534896|451286191|FG002|Overall Study|Insufficient therapeutic response|0|||
125452556|NCT01107626|451286192|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
125452557|NCT01107626|451286193|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
125452558|NCT01107626|451286194|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
125452559|NCT01107626|451286195|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
125452560|NCT01107626|451286192|FG000|Step 1: Induction Therapy|Adverse Event|198|||
125452561|NCT01107626|451286193|FG001|Step 1: Induction Therapy|Adverse Event|0|||
125452562|NCT01107626|451286194|FG002|Step 1: Induction Therapy|Adverse Event|0|||
125452563|NCT01107626|451286195|FG003|Step 1: Induction Therapy|Adverse Event|0|||
125452564|NCT01107626|451286192|FG000|Step 1: Induction Therapy|Death|62|||
125452565|NCT01107626|451286193|FG001|Step 1: Induction Therapy|Death|0|||
125452566|NCT01107626|451286194|FG002|Step 1: Induction Therapy|Death|0|||
125452567|NCT01107626|451286195|FG003|Step 1: Induction Therapy|Death|0|||
125452568|NCT01107626|451286192|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
125452569|NCT01107626|451286193|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
125452570|NCT01107626|451286194|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
125452571|NCT01107626|451286195|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
125452572|NCT01107626|451286192|FG000|Step 1: Induction Therapy|Complicating disease|13|||
125452573|NCT01107626|451286193|FG001|Step 1: Induction Therapy|Complicating disease|0|||
125452574|NCT01107626|451286194|FG002|Step 1: Induction Therapy|Complicating disease|0|||
125452575|NCT01107626|451286195|FG003|Step 1: Induction Therapy|Complicating disease|0|||
125452576|NCT01107626|451286192|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
125452577|NCT01107626|451286193|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
125452578|NCT01107626|451286194|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
125452579|NCT01107626|451286195|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
125452580|NCT01107626|451286192|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
125452581|NCT01107626|451286193|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
125452582|NCT01107626|451286194|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
125452583|NCT01107626|451286195|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
125452584|NCT01107626|451286192|FG000|Step 1: Induction Therapy|Non-compliance|4|||
125452585|NCT01107626|451286193|FG001|Step 1: Induction Therapy|Non-compliance|0|||
125452586|NCT01107626|451286194|FG002|Step 1: Induction Therapy|Non-compliance|0|||
125452587|NCT01107626|451286195|FG003|Step 1: Induction Therapy|Non-compliance|0|||
125452588|NCT01107626|451286192|FG000|Step 1: Induction Therapy|Pain|4|||
125452589|NCT01107626|451286193|FG001|Step 1: Induction Therapy|Pain|0|||
125452590|NCT01107626|451286194|FG002|Step 1: Induction Therapy|Pain|0|||
125452591|NCT01107626|451286195|FG003|Step 1: Induction Therapy|Pain|0|||
125452592|NCT01107626|451286192|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
125452593|NCT01107626|451286193|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
125452594|NCT01107626|451286194|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
125452595|NCT01107626|451286195|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
125452596|NCT01107626|451286192|FG000|Step 1: Induction Therapy|Hospice care|1|||
125452597|NCT01107626|451286193|FG001|Step 1: Induction Therapy|Hospice care|0|||
125452598|NCT01107626|451286194|FG002|Step 1: Induction Therapy|Hospice care|0|||
125452599|NCT01107626|451286195|FG003|Step 1: Induction Therapy|Hospice care|0|||
125452600|NCT01107626|451286192|FG000|Step 1: Induction Therapy|Physician Decision|1|||
125452601|NCT01107626|451286193|FG001|Step 1: Induction Therapy|Physician Decision|0|||
125452602|NCT01107626|451286194|FG002|Step 1: Induction Therapy|Physician Decision|0|||
125452603|NCT01107626|451286195|FG003|Step 1: Induction Therapy|Physician Decision|0|||
125452604|NCT01107626|451286192|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
125452605|NCT01107626|451286193|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
125452606|NCT01107626|451286194|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
125452607|NCT01107626|451286195|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
125452608|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
125452609|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
125452610|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
125452611|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
125452612|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
125452613|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
125452614|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
125452615|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
125452616|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Death|0|||
125452617|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Death|8|||
125452618|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Death|2|||
125452619|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Death|13|||
125452620|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
125452621|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
125452622|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
125452623|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
125452624|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
125452625|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
125452626|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
125452627|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
125452628|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
125452629|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
125452630|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
125452631|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
125452632|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
125452633|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
125452634|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
125452635|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
125452636|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
125452637|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
125452638|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
125452639|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
125452640|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
125452641|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
125452642|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
125452643|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
125452644|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
125452645|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
125452646|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
125452647|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
125452648|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
125452649|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
125452650|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
125452651|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
125452652|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
125452653|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
125452654|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
125452655|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
125452656|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
125452657|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
125452658|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
125452659|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
125452660|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Pain|0|||
125452661|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Pain|0|||
125452662|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Pain|0|||
125452663|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Pain|1|||
125452664|NCT01107626|451286192|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
125452665|NCT01107626|451286193|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
125452666|NCT01107626|451286194|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
125452667|NCT01107626|451286195|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
125452668|NCT00711646|451286196|FG000|Overall Study|Adverse Event|6|||
125452669|NCT00711646|451286197|FG001|Overall Study|Adverse Event|1|||
125452670|NCT00711646|451286196|FG000|Overall Study|Withdrawal by Subject|4|||
125452671|NCT00711646|451286197|FG001|Overall Study|Withdrawal by Subject|0|||
125452672|NCT00711646|451286196|FG000|Overall Study|Protocol Violation|0|||
125452673|NCT00711646|451286197|FG001|Overall Study|Protocol Violation|1|||
125452674|NCT00711646|451286196|FG000|Overall Study|Lost to Follow-up|1|||
125452675|NCT00711646|451286197|FG001|Overall Study|Lost to Follow-up|0|||
125452676|NCT00711646|451286196|FG000|Overall Study|administrative decision|0|||
125452677|NCT00711646|451286197|FG001|Overall Study|administrative decision|1|||
125452678|NCT00711646|451286196|FG000|Overall Study|patient non-compliance|1|||
125452679|NCT00711646|451286197|FG001|Overall Study|patient non-compliance|0|||
125452680|NCT04381494|451286198|FG000|Overall Study|Early termination of trial|19|||
125452681|NCT04381494|451286198|FG000|Overall Study|Investigator's discretion|1|||
125452682|NCT04381494|451286198|FG000|Overall Study|Withdrawal by Subject|9|||
125452683|NCT04381494|451286198|FG000|Overall Study|NSCLC disease progression|4|||
125452684|NCT04381494|451286198|FG000|Overall Study|Device-Related Adverse Event|2|||
125452685|NCT04310579|451286199|FG000|Overall Study|Adverse Event|0|||
125452686|NCT04310579|451286200|FG001|Overall Study|Adverse Event|0|||
125292201|NCT00996801|450696554|FG003|Overall Study|Progressive Disease|0|||
125452687|NCT04310579|451286201|FG002|Overall Study|Adverse Event|0|||
125452688|NCT04310579|451286202|FG003|Overall Study|Adverse Event|0|||
125452689|NCT04310579|451286203|FG004|Overall Study|Adverse Event|0|||
125452690|NCT04310579|451286204|FG005|Overall Study|Adverse Event|0|||
125452691|NCT04310579|451286205|FG006|Overall Study|Adverse Event|2|||
125452692|NCT04310579|451286206|FG007|Overall Study|Adverse Event|0|||
125452693|NCT04310579|451286207|FG008|Overall Study|Adverse Event|1|||
125452694|NCT04310579|451286208|FG009|Overall Study|Adverse Event|1|||
125452695|NCT04310579|451286209|FG010|Overall Study|Adverse Event|0|||
125452696|NCT04310579|451286199|FG000|Overall Study|Withdrawal by Subject|0|||
125452697|NCT04310579|451286200|FG001|Overall Study|Withdrawal by Subject|0|||
125452698|NCT04310579|451286201|FG002|Overall Study|Withdrawal by Subject|0|||
125452699|NCT04310579|451286202|FG003|Overall Study|Withdrawal by Subject|0|||
125452700|NCT04310579|451286203|FG004|Overall Study|Withdrawal by Subject|0|||
125452701|NCT04310579|451286204|FG005|Overall Study|Withdrawal by Subject|1|||
125452702|NCT04310579|451286205|FG006|Overall Study|Withdrawal by Subject|0|||
125452703|NCT04310579|451286206|FG007|Overall Study|Withdrawal by Subject|0|||
125452704|NCT04310579|451286207|FG008|Overall Study|Withdrawal by Subject|0|||
125452705|NCT04310579|451286208|FG009|Overall Study|Withdrawal by Subject|0|||
125452706|NCT04310579|451286209|FG010|Overall Study|Withdrawal by Subject|0|||
125452707|NCT04310579|451286199|FG000|Overall Study|Positive COVID-19 test|0|||
125452708|NCT04310579|451286200|FG001|Overall Study|Positive COVID-19 test|0|||
125452709|NCT04310579|451286201|FG002|Overall Study|Positive COVID-19 test|0|||
125452710|NCT04310579|451286202|FG003|Overall Study|Positive COVID-19 test|0|||
125452711|NCT04310579|451286203|FG004|Overall Study|Positive COVID-19 test|0|||
125452712|NCT04310579|451286204|FG005|Overall Study|Positive COVID-19 test|0|||
125452713|NCT04310579|451286205|FG006|Overall Study|Positive COVID-19 test|0|||
125452714|NCT04310579|451286206|FG007|Overall Study|Positive COVID-19 test|0|||
125452715|NCT04310579|451286207|FG008|Overall Study|Positive COVID-19 test|0|||
125452716|NCT04310579|451286208|FG009|Overall Study|Positive COVID-19 test|0|||
125452717|NCT04310579|451286209|FG010|Overall Study|Positive COVID-19 test|1|||
125452718|NCT01149681|451286210|FG000|Overall Study|Withdrawal by Subject|7|||
125452719|NCT01149681|451286210|FG000|Overall Study|Progressive disease|1|||
125452720|NCT01149681|451286210|FG000|Overall Study|Physician Decision|2|||
125452721|NCT01149681|451286210|FG000|Overall Study|adverse events nonrelated study drug|2|||
125452722|NCT03710564|451286211|FG000|Overall Study|Study Terminated by Sponsor|104|||
125452723|NCT03710564|451286212|FG001|Overall Study|Study Terminated by Sponsor|55|||
125452724|NCT03710564|451286211|FG000|Overall Study|Withdrawal by Subject|57|||
125452725|NCT03710564|451286212|FG001|Overall Study|Withdrawal by Subject|25|||
125452726|NCT03710564|451286211|FG000|Overall Study|Death|10|||
125452727|NCT03710564|451286212|FG001|Overall Study|Death|4|||
125452728|NCT03710564|451286211|FG000|Overall Study|Lost to Follow-up|5|||
125452729|NCT03710564|451286212|FG001|Overall Study|Lost to Follow-up|4|||
125452730|NCT03710564|451286211|FG000|Overall Study|Protocol Violation|3|||
125452731|NCT03710564|451286212|FG001|Overall Study|Protocol Violation|2|||
125452732|NCT03710564|451286211|FG000|Overall Study|Adverse Event|3|||
125452733|NCT03710564|451286212|FG001|Overall Study|Adverse Event|0|||
125452734|NCT03710564|451286211|FG000|Overall Study|Physician Decision|2|||
125452735|NCT03710564|451286212|FG001|Overall Study|Physician Decision|3|||
125452736|NCT02993471|451286213|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
125452737|NCT02993471|451286213|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
125452738|NCT00930813|451286214|FG000|Overall Study|Death|4|||
125452739|NCT00930813|451286215|FG001|Overall Study|Death|5|||
125452740|NCT00930813|451286214|FG000|Overall Study|Withdrawal by Subject|2|||
125452741|NCT00930813|451286215|FG001|Overall Study|Withdrawal by Subject|5|||
125452742|NCT00930813|451286214|FG000|Overall Study|Lost to Follow-up|2|||
125452743|NCT00930813|451286215|FG001|Overall Study|Lost to Follow-up|4|||
125452744|NCT03999554|451286222|FG000|Overall Study|Lost to Follow-up|4|||
125452745|NCT03999554|451286223|FG001|Overall Study|Lost to Follow-up|5|||
125452746|NCT03999554|451286224|FG002|Overall Study|Lost to Follow-up|4|||
125452747|NCT03999554|451286225|FG003|Overall Study|Lost to Follow-up|5|||
125452748|NCT03999554|451286226|FG004|Overall Study|Lost to Follow-up|8|||
125452749|NCT03999554|451286222|FG000|Overall Study|Protocol Violation|0|||
125452750|NCT03999554|451286223|FG001|Overall Study|Protocol Violation|0|||
125452751|NCT03999554|451286224|FG002|Overall Study|Protocol Violation|5|||
125452752|NCT03999554|451286225|FG003|Overall Study|Protocol Violation|0|||
125452753|NCT03999554|451286226|FG004|Overall Study|Protocol Violation|0|||
125452754|NCT03999554|451286222|FG000|Overall Study|Pregnancy|0|||
125452755|NCT03999554|451286223|FG001|Overall Study|Pregnancy|0|||
125452756|NCT03999554|451286224|FG002|Overall Study|Pregnancy|1|||
125452757|NCT03999554|451286225|FG003|Overall Study|Pregnancy|0|||
125452758|NCT03999554|451286226|FG004|Overall Study|Pregnancy|0|||
125452759|NCT03999554|451286222|FG000|Overall Study|Withdrawal by Subject|2|||
125452760|NCT03999554|451286223|FG001|Overall Study|Withdrawal by Subject|2|||
125452761|NCT03999554|451286224|FG002|Overall Study|Withdrawal by Subject|2|||
125452762|NCT03999554|451286225|FG003|Overall Study|Withdrawal by Subject|1|||
125452763|NCT03999554|451286226|FG004|Overall Study|Withdrawal by Subject|1|||
125452764|NCT03999554|451286222|FG000|Overall Study|failure to comply with protocol requirements|0|||
125452765|NCT03999554|451286223|FG001|Overall Study|failure to comply with protocol requirements|0|||
125452766|NCT03999554|451286224|FG002|Overall Study|failure to comply with protocol requirements|0|||
125452767|NCT03999554|451286225|FG003|Overall Study|failure to comply with protocol requirements|1|||
125452768|NCT03999554|451286226|FG004|Overall Study|failure to comply with protocol requirements|0|||
125452769|NCT04582877|451286227|FG000|Overall Study|Did not use device measurement|5|||
125452770|NCT04582877|451286227|FG000|Overall Study|No fractional flow reserve test results|2|||
125452771|NCT04582877|451286227|FG000|Overall Study|Protocol Violation|1|||
125452772|NCT03055767|451286228|FG000|Open-Label Period|Lost to Follow-up|0|||
125452773|NCT03055767|451286229|FG001|Open-Label Period|Lost to Follow-up|0|||
125452774|NCT03055767|451286230|FG002|Open-Label Period|Lost to Follow-up|2|||
125452775|NCT03055767|451286231|FG003|Open-Label Period|Lost to Follow-up|0|||
125452776|NCT03055767|451286228|FG000|Open-Label Period|Withdrawal by Subject|0|||
125452777|NCT03055767|451286229|FG001|Open-Label Period|Withdrawal by Subject|0|||
125452778|NCT03055767|451286230|FG002|Open-Label Period|Withdrawal by Subject|0|||
125452779|NCT03055767|451286231|FG003|Open-Label Period|Withdrawal by Subject|1|||
125452780|NCT00763282|451286234|FG000|Overall Study|Withdrawal by Subject|6|||
125452781|NCT00763282|451286235|FG001|Overall Study|Withdrawal by Subject|5|||
125452782|NCT00763282|451286234|FG000|Overall Study|Death|4|||
125452783|NCT00763282|451286235|FG001|Overall Study|Death|3|||
125452784|NCT00763282|451286234|FG000|Overall Study|Lost to Follow-up|22|||
125452785|NCT00763282|451286235|FG001|Overall Study|Lost to Follow-up|26|||
125452786|NCT00742274|451286236|FG000|Overall Study|Death|1|||
125452787|NCT00742274|451286237|FG001|Overall Study|Death|0|||
125452788|NCT00742274|451286236|FG000|Overall Study|Withdrawal by Subject|1|||
125452789|NCT00742274|451286237|FG001|Overall Study|Withdrawal by Subject|2|||
125452790|NCT00742274|451286236|FG000|Overall Study|Removed for medical reasons|1|||
125452791|NCT00742274|451286237|FG001|Overall Study|Removed for medical reasons|1|||
125452792|NCT02365298|451286240|FG000|Period 2|incorrect Rx dispensed|1|||
125452793|NCT02365298|451286241|FG001|Period 2|incorrect Rx dispensed|0|||
125452794|NCT02365298|451286240|FG000|Period 2|Discontinued at request of Sponsor|1|||
125452795|NCT02365298|451286241|FG001|Period 2|Discontinued at request of Sponsor|0|||
125452796|NCT02365298|451286240|FG000|Period 2|Test Article longer available|0|||
125452797|NCT02365298|451286241|FG001|Period 2|Test Article longer available|1|||
125452798|NCT02365298|451286240|FG000|Period 2|Protocol Violation|0|||
125452799|NCT02365298|451286241|FG001|Period 2|Protocol Violation|1|||
125452800|NCT02974010|451286242|FG000|Overall Study|Lost to Follow-up|3|||
125452801|NCT02974010|451286243|FG001|Overall Study|Lost to Follow-up|1|||
125452802|NCT02974010|451286244|FG002|Overall Study|Lost to Follow-up|0|||
125452803|NCT02974010|451286245|FG003|Overall Study|Lost to Follow-up|0|||
125452804|NCT02974010|451286242|FG000|Overall Study|Withdrawal by Subject|2|||
125452805|NCT02974010|451286243|FG001|Overall Study|Withdrawal by Subject|1|||
125452806|NCT02974010|451286244|FG002|Overall Study|Withdrawal by Subject|0|||
125452807|NCT02974010|451286245|FG003|Overall Study|Withdrawal by Subject|0|||
125452808|NCT02974010|451286242|FG000|Overall Study|Adverse Event|0|||
125452809|NCT02974010|451286243|FG001|Overall Study|Adverse Event|1|||
125452810|NCT02974010|451286244|FG002|Overall Study|Adverse Event|0|||
125452811|NCT02974010|451286245|FG003|Overall Study|Adverse Event|0|||
125452812|NCT02974010|451286242|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
125452813|NCT02974010|451286243|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
125452814|NCT02974010|451286244|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
125452815|NCT02974010|451286245|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
125452816|NCT02974010|451286242|FG000|Overall Study|Lack of Efficacy|0|||
125452817|NCT02974010|451286243|FG001|Overall Study|Lack of Efficacy|0|||
125452818|NCT02974010|451286244|FG002|Overall Study|Lack of Efficacy|1|||
125452819|NCT02974010|451286245|FG003|Overall Study|Lack of Efficacy|0|||
125452820|NCT00320489|451286246|FG000|Overall Study|Adverse Event|26|||
125452821|NCT00320489|451286247|FG001|Overall Study|Adverse Event|25|||
125452822|NCT00320489|451286246|FG000|Overall Study|Clinical Relapse|26|||
125452823|NCT00320489|451286247|FG001|Overall Study|Clinical Relapse|20|||
125452824|NCT00320489|451286246|FG000|Overall Study|Death|0|||
125452825|NCT00320489|451286247|FG001|Overall Study|Death|2|||
125452826|NCT00320489|451286246|FG000|Overall Study|Entry Criteria Exclusion|2|||
125452827|NCT00320489|451286247|FG001|Overall Study|Entry Criteria Exclusion|4|||
125452828|NCT00320489|451286246|FG000|Overall Study|Lack of Efficacy|16|||
125452829|NCT00320489|451286247|FG001|Overall Study|Lack of Efficacy|7|||
125452830|NCT00320489|451286246|FG000|Overall Study|Lost to Follow-up|21|||
125452831|NCT00320489|451286247|FG001|Overall Study|Lost to Follow-up|22|||
125452832|NCT00320489|451286246|FG000|Overall Study|Physician Decision|8|||
125452833|NCT00320489|451286247|FG001|Overall Study|Physician Decision|8|||
125452834|NCT00320489|451286246|FG000|Overall Study|Protocol Violation|4|||
125452835|NCT00320489|451286247|FG001|Overall Study|Protocol Violation|4|||
125452836|NCT00320489|451286246|FG000|Overall Study|Sponsor Decision|3|||
125452837|NCT00320489|451286247|FG001|Overall Study|Sponsor Decision|3|||
125452838|NCT00320489|451286246|FG000|Overall Study|Withdrawal by Subject|39|||
125452839|NCT00320489|451286247|FG001|Overall Study|Withdrawal by Subject|41|||
125452840|NCT03441984|451286248|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
125452841|NCT03441984|451286249|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
125452842|NCT03441984|451286250|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
125452843|NCT03441984|451286251|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
125452844|NCT03441984|451286252|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
125452845|NCT03441984|451286253|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
125452846|NCT03441984|451286254|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
125452847|NCT03441984|451286255|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
125452848|NCT03441984|451286256|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
125452849|NCT03441984|451286257|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
125452850|NCT03441984|451286258|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
125452851|NCT03441984|451286259|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
125452852|NCT04555044|451286268|FG000|Overall Study|Adverse Event|0|||
125452853|NCT04555044|451286269|FG001|Overall Study|Adverse Event|1|||
125452854|NCT04088188|451286270|FG000|Overall Study|Withdrawal by Subject|2|||
125452855|NCT04088188|451286271|FG001|Overall Study|Withdrawal by Subject|0|||
125452856|NCT04088188|451286270|FG000|Overall Study|Adverse Event|2|||
125452857|NCT04088188|451286271|FG001|Overall Study|Adverse Event|0|||
125452858|NCT00580801|451286273|FG000|Overall Study|Physician Decision|1|||
125452859|NCT00580801|451286274|FG001|Overall Study|Physician Decision|0|||
125452860|NCT00580801|451286275|FG002|Overall Study|Physician Decision|0|||
125452861|NCT00580801|451286273|FG000|Overall Study|Adverse Event|2|||
125452862|NCT00580801|451286274|FG001|Overall Study|Adverse Event|0|||
125452863|NCT00580801|451286275|FG002|Overall Study|Adverse Event|0|||
125452864|NCT00580801|451286273|FG000|Overall Study|Lost to Follow-up|2|||
125452865|NCT00580801|451286274|FG001|Overall Study|Lost to Follow-up|0|||
125452866|NCT00580801|451286275|FG002|Overall Study|Lost to Follow-up|0|||
125452867|NCT00580801|451286273|FG000|Overall Study|Reached a virologic endpoint|0|||
125452868|NCT00580801|451286274|FG001|Overall Study|Reached a virologic endpoint|1|||
125452869|NCT00580801|451286275|FG002|Overall Study|Reached a virologic endpoint|2|||
125452870|NCT00580801|451286273|FG000|Overall Study|Participant non-compliant|0|||
125452871|NCT00580801|451286274|FG001|Overall Study|Participant non-compliant|0|||
125452872|NCT00580801|451286275|FG002|Overall Study|Participant non-compliant|1|||
125452873|NCT00580801|451286273|FG000|Overall Study|Travel|1|||
125452874|NCT00580801|451286274|FG001|Overall Study|Travel|0|||
125452875|NCT00580801|451286275|FG002|Overall Study|Travel|0|||
125452876|NCT01670019|451286276|FG000|Overall Study|Adverse Event|3|||
125452877|NCT01670019|451286277|FG001|Overall Study|Adverse Event|0|||
125452878|NCT01670019|451286276|FG000|Overall Study|Withdrawal by Subject|6|||
125452879|NCT01670019|451286277|FG001|Overall Study|Withdrawal by Subject|0|||
125452880|NCT01981850|451286280|FG000|Main Phase Stage 1|Death|2|||
125452881|NCT01981850|451286281|FG001|Main Phase Stage 1|Death|0|||
125452882|NCT01981850|451286282|FG002|Main Phase Stage 1|Death|0|||
125452883|NCT01981850|451286283|FG003|Main Phase Stage 1|Death|0|||
125452884|NCT01981850|451286284|FG004|Main Phase Stage 1|Death|0|||
125452885|NCT01981850|451286285|FG005|Main Phase Stage 1|Death|0|||
125452886|NCT01981850|451286286|FG006|Main Phase Stage 1|Death|0|||
125452887|NCT01981850|451286287|FG007|Main Phase Stage 1|Death|0|||
125452888|NCT01981850|451286288|FG008|Main Phase Stage 1|Death|0|||
125452889|NCT01981850|451286289|FG009|Main Phase Stage 1|Death|0|||
125452890|NCT01981850|451286280|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
125452891|NCT01981850|451286281|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
125452892|NCT01981850|451286282|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
125452893|NCT01981850|451286283|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
125452894|NCT01981850|451286284|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
125452895|NCT01981850|451286285|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
125452896|NCT01981850|451286286|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
125452897|NCT01981850|451286287|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
125452898|NCT01981850|451286288|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
125452899|NCT01981850|451286289|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
125452900|NCT01981850|451286280|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
125452901|NCT01981850|451286281|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
125452902|NCT01981850|451286282|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
125452903|NCT01981850|451286283|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
125452904|NCT01981850|451286284|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
125452905|NCT01981850|451286285|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
125452906|NCT01981850|451286286|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
125452907|NCT01981850|451286287|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
125452908|NCT01981850|451286288|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
125452909|NCT01981850|451286289|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
125452910|NCT01981850|451286280|FG000|Main Phase Stage 1|Various reasons|0|||
125452911|NCT01981850|451286281|FG001|Main Phase Stage 1|Various reasons|0|||
125452912|NCT01981850|451286282|FG002|Main Phase Stage 1|Various reasons|2|||
125452913|NCT01981850|451286283|FG003|Main Phase Stage 1|Various reasons|0|||
125452914|NCT01981850|451286284|FG004|Main Phase Stage 1|Various reasons|0|||
125452915|NCT01981850|451286285|FG005|Main Phase Stage 1|Various reasons|0|||
125452916|NCT01981850|451286286|FG006|Main Phase Stage 1|Various reasons|0|||
125452917|NCT01981850|451286287|FG007|Main Phase Stage 1|Various reasons|0|||
125452918|NCT01981850|451286288|FG008|Main Phase Stage 1|Various reasons|0|||
125452919|NCT01981850|451286289|FG009|Main Phase Stage 1|Various reasons|0|||
125452920|NCT01981850|451286280|FG000|Main Phase Stage 2|Adverse Event|0|||
125452921|NCT01981850|451286281|FG001|Main Phase Stage 2|Adverse Event|0|||
125452922|NCT01981850|451286282|FG002|Main Phase Stage 2|Adverse Event|0|||
125452923|NCT01981850|451286283|FG003|Main Phase Stage 2|Adverse Event|0|||
125452924|NCT01981850|451286284|FG004|Main Phase Stage 2|Adverse Event|6|||
125452925|NCT01981850|451286285|FG005|Main Phase Stage 2|Adverse Event|5|||
125452926|NCT01981850|451286286|FG006|Main Phase Stage 2|Adverse Event|7|||
125452927|NCT01981850|451286287|FG007|Main Phase Stage 2|Adverse Event|0|||
125452928|NCT01981850|451286288|FG008|Main Phase Stage 2|Adverse Event|0|||
125452929|NCT01981850|451286289|FG009|Main Phase Stage 2|Adverse Event|0|||
125452930|NCT01981850|451286280|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
125452931|NCT01981850|451286281|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
125452932|NCT01981850|451286282|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
125452933|NCT01981850|451286283|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
125452934|NCT01981850|451286284|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
125452935|NCT01981850|451286285|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
125452936|NCT01981850|451286286|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
125452937|NCT01981850|451286287|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
125452938|NCT01981850|451286288|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
125452939|NCT01981850|451286289|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
125452940|NCT01981850|451286280|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
125452941|NCT01981850|451286281|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
125452942|NCT01981850|451286282|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
125452943|NCT01981850|451286283|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
125452944|NCT01981850|451286284|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
125452945|NCT01981850|451286285|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
125452946|NCT01981850|451286286|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
125452947|NCT01981850|451286287|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
125452948|NCT01981850|451286288|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
125452949|NCT01981850|451286289|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
125452950|NCT01981850|451286280|FG000|Main Phase Stage 2|Various reasons|0|||
125452951|NCT01981850|451286281|FG001|Main Phase Stage 2|Various reasons|0|||
125452952|NCT01981850|451286282|FG002|Main Phase Stage 2|Various reasons|0|||
125452953|NCT01981850|451286283|FG003|Main Phase Stage 2|Various reasons|0|||
125452954|NCT01981850|451286284|FG004|Main Phase Stage 2|Various reasons|2|||
125452955|NCT01981850|451286285|FG005|Main Phase Stage 2|Various reasons|0|||
125452956|NCT01981850|451286286|FG006|Main Phase Stage 2|Various reasons|1|||
125452957|NCT01981850|451286287|FG007|Main Phase Stage 2|Various reasons|0|||
125452958|NCT01981850|451286288|FG008|Main Phase Stage 2|Various reasons|0|||
125452959|NCT01981850|451286289|FG009|Main Phase Stage 2|Various reasons|0|||
125452960|NCT01981850|451286280|FG000|Main Phase Stage 2|Progressive Disease|0|||
125452961|NCT01981850|451286281|FG001|Main Phase Stage 2|Progressive Disease|0|||
125452962|NCT01981850|451286282|FG002|Main Phase Stage 2|Progressive Disease|0|||
125452963|NCT01981850|451286283|FG003|Main Phase Stage 2|Progressive Disease|0|||
125452964|NCT01981850|451286284|FG004|Main Phase Stage 2|Progressive Disease|0|||
125452965|NCT01981850|451286285|FG005|Main Phase Stage 2|Progressive Disease|6|||
125452966|NCT01981850|451286286|FG006|Main Phase Stage 2|Progressive Disease|6|||
125452967|NCT01981850|451286287|FG007|Main Phase Stage 2|Progressive Disease|0|||
125452968|NCT01981850|451286288|FG008|Main Phase Stage 2|Progressive Disease|0|||
125452969|NCT01981850|451286289|FG009|Main Phase Stage 2|Progressive Disease|0|||
125452970|NCT01981850|451286280|FG000|Open Label Extension (OLE)|Adverse Event|0|||
125452971|NCT01981850|451286281|FG001|Open Label Extension (OLE)|Adverse Event|0|||
125452972|NCT01981850|451286282|FG002|Open Label Extension (OLE)|Adverse Event|0|||
125452973|NCT01981850|451286283|FG003|Open Label Extension (OLE)|Adverse Event|0|||
125452974|NCT01981850|451286284|FG004|Open Label Extension (OLE)|Adverse Event|0|||
125452975|NCT01981850|451286285|FG005|Open Label Extension (OLE)|Adverse Event|0|||
125452976|NCT01981850|451286286|FG006|Open Label Extension (OLE)|Adverse Event|0|||
125452977|NCT01981850|451286287|FG007|Open Label Extension (OLE)|Adverse Event|2|||
125452978|NCT01981850|451286288|FG008|Open Label Extension (OLE)|Adverse Event|1|||
125452979|NCT01981850|451286289|FG009|Open Label Extension (OLE)|Adverse Event|8|||
125452980|NCT01981850|451286280|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
125452981|NCT01981850|451286281|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
125452982|NCT01981850|451286282|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
125452983|NCT01981850|451286283|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
125452984|NCT01981850|451286284|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
125452985|NCT01981850|451286285|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
125452986|NCT01981850|451286286|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
125452987|NCT01981850|451286287|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
125452988|NCT01981850|451286288|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
125485346|NCT02240238|451412508|FG005|Phase 1|Adverse Event|0|||
125452989|NCT01981850|451286289|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
125452990|NCT01981850|451286280|FG000|Open Label Extension (OLE)|Various reasons|0|||
125452991|NCT01981850|451286281|FG001|Open Label Extension (OLE)|Various reasons|0|||
125452992|NCT01981850|451286282|FG002|Open Label Extension (OLE)|Various reasons|0|||
125452993|NCT01981850|451286283|FG003|Open Label Extension (OLE)|Various reasons|0|||
125452994|NCT01981850|451286284|FG004|Open Label Extension (OLE)|Various reasons|0|||
125452995|NCT01981850|451286285|FG005|Open Label Extension (OLE)|Various reasons|0|||
125452996|NCT01981850|451286286|FG006|Open Label Extension (OLE)|Various reasons|0|||
125452997|NCT01981850|451286287|FG007|Open Label Extension (OLE)|Various reasons|3|||
125452998|NCT01981850|451286288|FG008|Open Label Extension (OLE)|Various reasons|1|||
125452999|NCT01981850|451286289|FG009|Open Label Extension (OLE)|Various reasons|3|||
125453000|NCT01981850|451286280|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
125453001|NCT01981850|451286281|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
125453002|NCT01981850|451286282|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
125453003|NCT01981850|451286283|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
125453004|NCT01981850|451286284|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
125453005|NCT01981850|451286285|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
125453006|NCT01981850|451286286|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
125453007|NCT01981850|451286287|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
125453008|NCT01981850|451286288|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
125453009|NCT01981850|451286289|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
125453010|NCT01981850|451286280|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
125453011|NCT01981850|451286281|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
125453012|NCT01981850|451286282|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
125453013|NCT01981850|451286283|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
125453014|NCT01981850|451286284|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
125453015|NCT01981850|451286285|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
125453016|NCT01981850|451286286|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
125453017|NCT01981850|451286287|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
125453018|NCT01981850|451286288|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
125453019|NCT01981850|451286289|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
125453020|NCT01981850|451286280|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
125453021|NCT01981850|451286281|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
125453022|NCT01981850|451286282|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
125453023|NCT01981850|451286283|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
125453024|NCT01981850|451286284|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
125453025|NCT01981850|451286285|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
125453026|NCT01981850|451286286|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
125453027|NCT01981850|451286287|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
125453028|NCT01981850|451286288|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
125453029|NCT01981850|451286289|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
125453030|NCT03722446|451286292|FG000|Overall Study|Protocol Violation|15|||
125453031|NCT03722446|451286293|FG001|Overall Study|Protocol Violation|2|||
125453032|NCT00819910|451286294|FG000|Overall Study|Adverse Event|0|||
125453033|NCT00819910|451286295|FG001|Overall Study|Adverse Event|0|||
125453034|NCT00819910|451286296|FG002|Overall Study|Adverse Event|2|||
125453035|NCT00819910|451286297|FG003|Overall Study|Adverse Event|1|||
125453036|NCT00819910|451286294|FG000|Overall Study|Withdrawal by Subject|1|||
125453037|NCT00819910|451286295|FG001|Overall Study|Withdrawal by Subject|1|||
125453038|NCT00819910|451286296|FG002|Overall Study|Withdrawal by Subject|1|||
125453039|NCT00819910|451286297|FG003|Overall Study|Withdrawal by Subject|0|||
125453040|NCT00819910|451286294|FG000|Overall Study|Lost to Follow-up|1|||
125453041|NCT00819910|451286295|FG001|Overall Study|Lost to Follow-up|0|||
125453042|NCT00819910|451286296|FG002|Overall Study|Lost to Follow-up|0|||
125453043|NCT00819910|451286297|FG003|Overall Study|Lost to Follow-up|0|||
125453044|NCT03102242|451286298|FG000|Overall Study|Adverse Event|2|||
125453045|NCT00946192|451286301|FG000|Overall Study|Lost to Follow-up|6|||
125453046|NCT00946192|451286302|FG001|Overall Study|Lost to Follow-up|11|||
125453047|NCT00946192|451286303|FG002|Overall Study|Lost to Follow-up|9|||
125453048|NCT00946192|451286301|FG000|Overall Study|Withdrawal by Subject|10|||
125453049|NCT00946192|451286302|FG001|Overall Study|Withdrawal by Subject|7|||
125453050|NCT00946192|451286303|FG002|Overall Study|Withdrawal by Subject|3|||
125453051|NCT00946192|451286301|FG000|Overall Study|Did not start medication|2|||
125453052|NCT00946192|451286302|FG001|Overall Study|Did not start medication|0|||
125453053|NCT00946192|451286303|FG002|Overall Study|Did not start medication|0|||
125453054|NCT01080131|451286304|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
125453055|NCT01080131|451286305|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
125453056|NCT01080131|451286304|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
125453057|NCT01080131|451286305|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
125453058|NCT01080131|451286304|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
125453059|NCT01080131|451286305|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
125453060|NCT01080131|451286304|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
125453061|NCT01080131|451286305|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
125453062|NCT01080131|451286304|FG000|Core Study (0- 12 Weeks)|Death|1|||
125453063|NCT01080131|451286305|FG001|Core Study (0- 12 Weeks)|Death|0|||
125453064|NCT01080131|451286304|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
125453065|NCT01080131|451286305|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
125453066|NCT01080131|451286304|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
125453067|NCT01080131|451286305|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
125453068|NCT01080131|451286304|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
125453069|NCT01080131|451286305|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
125453070|NCT01080131|451286304|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
125453071|NCT01080131|451286305|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
125453072|NCT01080131|451286304|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
125453073|NCT01080131|451286305|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
125453074|NCT01080131|451286304|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
125453075|NCT01080131|451286305|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
125453076|NCT01080131|451286304|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
125453077|NCT01080131|451286305|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
125453078|NCT01080131|451286304|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
125453079|NCT01080131|451286305|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
125453080|NCT00797862|451288443|FG000|Overall Study|Adverse Event|86|||
125453081|NCT00797862|451288444|FG001|Overall Study|Adverse Event|44|||
125453082|NCT00797862|451288445|FG002|Overall Study|Adverse Event|58|||
125453083|NCT00797862|451288443|FG000|Overall Study|Abnormal Test Procedure Result|0|||
125453084|NCT00797862|451288444|FG001|Overall Study|Abnormal Test Procedure Result|1|||
125453085|NCT00797862|451288445|FG002|Overall Study|Abnormal Test Procedure Result|1|||
125453086|NCT00797862|451288443|FG000|Overall Study|Lack of Efficacy|1|||
125453087|NCT00797862|451288444|FG001|Overall Study|Lack of Efficacy|7|||
125453088|NCT00797862|451288445|FG002|Overall Study|Lack of Efficacy|6|||
125453089|NCT00797862|451288443|FG000|Overall Study|No longer required study medication|1|||
125453090|NCT00797862|451288444|FG001|Overall Study|No longer required study medication|0|||
125453091|NCT00797862|451288445|FG002|Overall Study|No longer required study medication|0|||
125453092|NCT00797862|451288443|FG000|Overall Study|Withdrawal by Subject|14|||
125453093|NCT00797862|451288444|FG001|Overall Study|Withdrawal by Subject|7|||
125453094|NCT00797862|451288445|FG002|Overall Study|Withdrawal by Subject|7|||
125453095|NCT00797862|451288443|FG000|Overall Study|Lost to Follow-up|11|||
125453096|NCT00797862|451288444|FG001|Overall Study|Lost to Follow-up|0|||
125453097|NCT00797862|451288445|FG002|Overall Study|Lost to Follow-up|5|||
125453098|NCT00797862|451288443|FG000|Overall Study|Administrative Problem|4|||
125453099|NCT00797862|451288444|FG001|Overall Study|Administrative Problem|0|||
125453100|NCT00797862|451288445|FG002|Overall Study|Administrative Problem|0|||
125453101|NCT00797862|451288443|FG000|Overall Study|Protocol Violation|4|||
125453102|NCT00797862|451288444|FG001|Overall Study|Protocol Violation|6|||
125453103|NCT00797862|451288445|FG002|Overall Study|Protocol Violation|8|||
125453104|NCT00797862|451288443|FG000|Overall Study|Mis-randomized|3|||
125453105|NCT00797862|451288444|FG001|Overall Study|Mis-randomized|3|||
125453106|NCT00797862|451288445|FG002|Overall Study|Mis-randomized|1|||
125453107|NCT01474538|451288463|FG000|Treatment Period 1|Death|1|||
125453108|NCT01474538|451288464|FG001|Treatment Period 1|Death|0|||
125453109|NCT01474538|451288463|FG000|Treatment Period 1|Physician Decision|1|||
125453110|NCT01474538|451288464|FG001|Treatment Period 1|Physician Decision|0|||
125453111|NCT01474538|451288463|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125453112|NCT01474538|451288464|FG001|Treatment Period 1|Withdrawal by Subject|3|||
125453113|NCT01474538|451288463|FG000|Treatment Period 1|Protocol Violation|0|||
125453114|NCT01474538|451288464|FG001|Treatment Period 1|Protocol Violation|1|||
125453115|NCT01474538|451288463|FG000|Treatment Period 2|Death|1|||
125453116|NCT01474538|451288464|FG001|Treatment Period 2|Death|0|||
125453117|NCT01474538|451288463|FG000|Treatment Period 2|Adverse Event|1|||
125453118|NCT01474538|451288464|FG001|Treatment Period 2|Adverse Event|1|||
125453119|NCT01474538|451288463|FG000|Treatment Period 2|Withdrawal by Subject|2|||
125453120|NCT01474538|451288464|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125453121|NCT01474538|451288463|FG000|Treatment Period 2|Sponsor decision|1|||
125453122|NCT01474538|451288464|FG001|Treatment Period 2|Sponsor decision|0|||
125453123|NCT01474538|451288463|FG000|Treatment Period 2|Physician Decision|0|||
125453124|NCT01474538|451288464|FG001|Treatment Period 2|Physician Decision|1|||
125453125|NCT01474538|451288463|FG000|Treatment Period 2|Protocol Violation|1|||
125453126|NCT01474538|451288464|FG001|Treatment Period 2|Protocol Violation|0|||
125453127|NCT01456780|451288468|FG000|Overall Study|Lost to Follow-up|3|||
125453128|NCT01456780|451288469|FG001|Overall Study|Lost to Follow-up|3|||
125453129|NCT01456780|451288470|FG002|Overall Study|Lost to Follow-up|0|||
125453130|NCT02501629|451288471|FG000|Overall Study|Death|0|||
125453131|NCT02501629|451288472|FG001|Overall Study|Death|1|||
125453132|NCT02501629|451288471|FG000|Overall Study|Withdrawn from study by sponsor|1|||
125453133|NCT02501629|451288472|FG001|Overall Study|Withdrawn from study by sponsor|0|||
125453134|NCT02501629|451288471|FG000|Overall Study|Early termination by sponsor|1|||
125453135|NCT02501629|451288472|FG001|Overall Study|Early termination by sponsor|0|||
125453136|NCT02501629|451288471|FG000|Overall Study|Withdrawal by Subject|3|||
125453137|NCT02501629|451288472|FG001|Overall Study|Withdrawal by Subject|5|||
125453138|NCT02501629|451288471|FG000|Overall Study|Subject did not return to site|0|||
125453139|NCT02501629|451288472|FG001|Overall Study|Subject did not return to site|1|||
125453140|NCT00349908|451288477|FG000|Overall Study|Withdrawal by Subject|0|||
125453141|NCT00349908|451288478|FG001|Overall Study|Withdrawal by Subject|4|||
125453142|NCT04565249|451288479|FG000|Overall Study|Death|0|||
125453143|NCT04565249|451288480|FG001|Overall Study|Death|0|||
125453144|NCT04565249|451288481|FG002|Overall Study|Death|0|||
125453145|NCT04565249|451288482|FG003|Overall Study|Death|1|||
125453146|NCT03120676|451288483|FG000|Overall Study|Not treated|1|||
125453147|NCT02333630|451288484|FG000|Overall Study|Lost to Follow-up|5|||
125453148|NCT02333630|451288485|FG001|Overall Study|Lost to Follow-up|2|||
125453149|NCT05349864|451288486|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
125453150|NCT05349864|451288487|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
125453151|NCT00984282|451288488|FG000|Double Blind Treatment|Adverse Event|40|||
125453152|NCT00984282|451288489|FG001|Double Blind Treatment|Adverse Event|6|||
125453153|NCT00984282|451288488|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
125453154|NCT00984282|451288489|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
125453155|NCT00984282|451288488|FG000|Double Blind Treatment|Physician Decision|1|||
125453156|NCT00984282|451288489|FG001|Double Blind Treatment|Physician Decision|2|||
125453157|NCT00984282|451288488|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
125453158|NCT00984282|451288489|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
125453159|NCT00984282|451288488|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
125453160|NCT00984282|451288489|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
125453161|NCT00984282|451288488|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
125453162|NCT00984282|451288489|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
125453163|NCT00984282|451288488|FG000|Double Blind Treatment|Lost to Follow-up|3|||
125453164|NCT00984282|451288489|FG001|Double Blind Treatment|Lost to Follow-up|0|||
125453165|NCT00984282|451288488|FG000|Double Blind Treatment|Death|8|||
125453166|NCT00984282|451288489|FG001|Double Blind Treatment|Death|4|||
125453167|NCT00984282|451288488|FG000|Double Blind Treatment|Not treated|0|||
125453168|NCT00984282|451288489|FG001|Double Blind Treatment|Not treated|1|||
125453169|NCT00984282|451288488|FG000|Double Blind Treatment|Switched to commercial drug|6|||
125453170|NCT00984282|451288489|FG001|Double Blind Treatment|Switched to commercial drug|1|||
125453171|NCT00984282|451288488|FG000|Double Blind Treatment|protocol driven decision point|1|||
125453172|NCT00984282|451288489|FG001|Double Blind Treatment|protocol driven decision point|1|||
125453173|NCT00984282|451288488|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
125453174|NCT00984282|451288489|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
125453175|NCT00984282|451288488|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
125453176|NCT00984282|451288489|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
125453177|NCT00984282|451288488|FG000|Open-label Treatment|Adverse Event|20|||
125453178|NCT00984282|451288489|FG001|Open-label Treatment|Adverse Event|30|||
125453179|NCT00984282|451288488|FG000|Open-label Treatment|Withdrawal by Subject|6|||
125453180|NCT00984282|451288489|FG001|Open-label Treatment|Withdrawal by Subject|21|||
125453181|NCT00984282|451288488|FG000|Open-label Treatment|Death|7|||
125453182|NCT00984282|451288489|FG001|Open-label Treatment|Death|15|||
125453183|NCT00984282|451288488|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
125453184|NCT00984282|451288489|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
125453185|NCT00984282|451288488|FG000|Open-label Treatment|Lost to Follow-up|1|||
125453186|NCT00984282|451288489|FG001|Open-label Treatment|Lost to Follow-up|1|||
125453187|NCT00984282|451288488|FG000|Open-label Treatment|Patient convenience|1|||
125453188|NCT00984282|451288489|FG001|Open-label Treatment|Patient convenience|0|||
125453189|NCT00984282|451288488|FG000|Open-label Treatment|Non-compliant with study medication|1|||
125453190|NCT00984282|451288489|FG001|Open-label Treatment|Non-compliant with study medication|0|||
125453191|NCT00984282|451288488|FG000|Open-label Treatment|Target lesion removed|0|||
125453192|NCT00984282|451288489|FG001|Open-label Treatment|Target lesion removed|1|||
125453193|NCT00984282|451288488|FG000|Open-label Treatment|Protocol driven decision point|1|||
125453194|NCT00984282|451288489|FG001|Open-label Treatment|Protocol driven decision point|1|||
125453195|NCT00984282|451288488|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
125453196|NCT00984282|451288489|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
125453197|NCT00984282|451288488|FG000|Open-label Treatment|Switched to commercial drug|6|||
125453198|NCT00984282|451288489|FG001|Open-label Treatment|Switched to commercial drug|7|||
125453199|NCT00984282|451288488|FG000|Open-label Treatment|Physician Decision|1|||
125453200|NCT00984282|451288489|FG001|Open-label Treatment|Physician Decision|0|||
125453201|NCT00984282|451288488|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
125453202|NCT00984282|451288489|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
125453203|NCT00984282|451288488|FG000|Long Term Follow-up|Death|27|||
125453204|NCT00984282|451288489|FG001|Long Term Follow-up|Death|68|||
125453205|NCT00984282|451288488|FG000|Long Term Follow-up|Lost to Follow-up|3|||
125453206|NCT00984282|451288489|FG001|Long Term Follow-up|Lost to Follow-up|6|||
125453207|NCT00984282|451288488|FG000|Long Term Follow-up|Protocol driven decision point|25|||
125453208|NCT00984282|451288489|FG001|Long Term Follow-up|Protocol driven decision point|26|||
125453209|NCT00984282|451288488|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
125453210|NCT00984282|451288489|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
125453211|NCT00984282|451288488|FG000|Long Term Follow-up|Switched to commercial drug|4|||
125453212|NCT00984282|451288489|FG001|Long Term Follow-up|Switched to commercial drug|2|||
125453213|NCT00984282|451288488|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
125453214|NCT00984282|451288489|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
125453215|NCT02223793|451288490|FG000|Overall Study|Lost to Follow-up|10|||
125453216|NCT02223793|451288491|FG001|Overall Study|Lost to Follow-up|1|||
125453217|NCT02223793|451288492|FG002|Overall Study|Lost to Follow-up|2|||
125453218|NCT02223793|451288490|FG000|Overall Study|Withdrawal by Subject|3|||
125453219|NCT02223793|451288491|FG001|Overall Study|Withdrawal by Subject|2|||
125453220|NCT02223793|451288492|FG002|Overall Study|Withdrawal by Subject|3|||
125453221|NCT02223793|451288490|FG000|Overall Study|Moved/studycenter unable to participate|4|||
125453222|NCT02223793|451288491|FG001|Overall Study|Moved/studycenter unable to participate|6|||
125453223|NCT02223793|451288492|FG002|Overall Study|Moved/studycenter unable to participate|8|||
125453224|NCT02359435|451288493|FG000|Overall Study|Lost to Follow-up|4|||
125453225|NCT02359435|451288494|FG001|Overall Study|Lost to Follow-up|4|||
125453226|NCT00315055|451288495|FG000|Overall Study|Protocol Violation|2|||
125453227|NCT00315055|451288496|FG001|Overall Study|Protocol Violation|4|||
125453228|NCT00315055|451288495|FG000|Overall Study|Lost to Follow-up|1|||
125453229|NCT00315055|451288496|FG001|Overall Study|Lost to Follow-up|1|||
125453230|NCT01289119|451288501|FG000|Overall Study|Adverse Event|2|||
125453231|NCT01289119|451288502|FG001|Overall Study|Adverse Event|1|||
125453232|NCT01289119|451288503|FG002|Overall Study|Adverse Event|0|||
125453233|NCT01289119|451288504|FG003|Overall Study|Adverse Event|2|||
125453234|NCT01289119|451288505|FG004|Overall Study|Adverse Event|1|||
125453235|NCT01289119|451288506|FG005|Overall Study|Adverse Event|0|||
125453236|NCT01289119|451288501|FG000|Overall Study|Major Protocol Deviation|2|||
125453237|NCT01289119|451288502|FG001|Overall Study|Major Protocol Deviation|1|||
125453238|NCT01289119|451288503|FG002|Overall Study|Major Protocol Deviation|3|||
125453239|NCT01289119|451288504|FG003|Overall Study|Major Protocol Deviation|0|||
125453240|NCT01289119|451288505|FG004|Overall Study|Major Protocol Deviation|2|||
125453241|NCT01289119|451288506|FG005|Overall Study|Major Protocol Deviation|1|||
125453242|NCT01289119|451288501|FG000|Overall Study|Lost to Follow-up|0|||
125453243|NCT01289119|451288502|FG001|Overall Study|Lost to Follow-up|3|||
125453244|NCT01289119|451288503|FG002|Overall Study|Lost to Follow-up|0|||
125453245|NCT01289119|451288504|FG003|Overall Study|Lost to Follow-up|0|||
125453246|NCT01289119|451288505|FG004|Overall Study|Lost to Follow-up|0|||
125453247|NCT01289119|451288506|FG005|Overall Study|Lost to Follow-up|1|||
125453248|NCT01289119|451288501|FG000|Overall Study|Withdrawal by Subject|4|||
125453249|NCT01289119|451288502|FG001|Overall Study|Withdrawal by Subject|2|||
125453250|NCT01289119|451288503|FG002|Overall Study|Withdrawal by Subject|4|||
125453251|NCT01289119|451288504|FG003|Overall Study|Withdrawal by Subject|3|||
125453252|NCT01289119|451288505|FG004|Overall Study|Withdrawal by Subject|1|||
125453253|NCT01289119|451288506|FG005|Overall Study|Withdrawal by Subject|1|||
125453254|NCT01289119|451288501|FG000|Overall Study|Pregnancy|0|||
125453255|NCT01289119|451288502|FG001|Overall Study|Pregnancy|1|||
125453256|NCT01289119|451288503|FG002|Overall Study|Pregnancy|0|||
125453257|NCT01289119|451288504|FG003|Overall Study|Pregnancy|0|||
125453258|NCT01289119|451288505|FG004|Overall Study|Pregnancy|0|||
125453259|NCT01289119|451288506|FG005|Overall Study|Pregnancy|0|||
125453260|NCT01289119|451288501|FG000|Overall Study|Lack of Efficacy|0|||
125453261|NCT01289119|451288502|FG001|Overall Study|Lack of Efficacy|1|||
125453262|NCT01289119|451288503|FG002|Overall Study|Lack of Efficacy|1|||
125453263|NCT01289119|451288504|FG003|Overall Study|Lack of Efficacy|1|||
125453264|NCT01289119|451288505|FG004|Overall Study|Lack of Efficacy|1|||
125453265|NCT01289119|451288506|FG005|Overall Study|Lack of Efficacy|1|||
125453266|NCT01289119|451288501|FG000|Overall Study|Other|1|||
125453267|NCT01289119|451288502|FG001|Overall Study|Other|0|||
125453268|NCT01289119|451288503|FG002|Overall Study|Other|1|||
125453269|NCT01289119|451288504|FG003|Overall Study|Other|0|||
125453270|NCT01289119|451288505|FG004|Overall Study|Other|0|||
125453271|NCT01289119|451288506|FG005|Overall Study|Other|0|||
125453272|NCT01704846|451288507|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125453273|NCT01704846|451288508|FG001|Treatment Period 2|Withdrawal by Subject|1|||
125453274|NCT00530335|451288509|FG000|Overall Study|Adverse Event|3|||
125453275|NCT00530335|451288509|FG000|Overall Study|Protocol Violation|1|||
125453276|NCT00530335|451288509|FG000|Overall Study|Withdrawal by Subject|1|||
125453277|NCT00530335|451288509|FG000|Overall Study|Physician Decision|1|||
125453278|NCT02321540|451288510|FG000|Overall Study|Death|0|||
125453279|NCT02321540|451288511|FG001|Overall Study|Death|1|||
125453280|NCT02321540|451288510|FG000|Overall Study|Progression|3|||
125453281|NCT02321540|451288511|FG001|Overall Study|Progression|9|||
125453282|NCT01649791|451288512|FG000|Overall Study|Disease Progression|2|||
125453283|NCT01649791|451288512|FG000|Overall Study|Adverse Event|1|||
125453284|NCT00991276|451288516|FG000|First Intervention Period|Adverse Event|0|||
125453285|NCT00991276|451288517|FG001|First Intervention Period|Adverse Event|1|||
125453286|NCT00991276|451288518|FG002|First Intervention Period|Adverse Event|0|||
125453287|NCT00991276|451288519|FG003|First Intervention Period|Adverse Event|1|||
125453288|NCT00991276|451288520|FG004|First Intervention Period|Adverse Event|0|||
125453289|NCT00991276|451288521|FG005|First Intervention Period|Adverse Event|0|||
125453290|NCT00991276|451288516|FG000|First Intervention Period|Protocol Violation|0|||
125453291|NCT00991276|451288517|FG001|First Intervention Period|Protocol Violation|0|||
125453292|NCT00991276|451288518|FG002|First Intervention Period|Protocol Violation|0|||
125453293|NCT00991276|451288519|FG003|First Intervention Period|Protocol Violation|0|||
125453294|NCT00991276|451288520|FG004|First Intervention Period|Protocol Violation|2|||
125453295|NCT00991276|451288521|FG005|First Intervention Period|Protocol Violation|0|||
125453296|NCT00991276|451288516|FG000|First Intervention Period|Insufficient clinical response|0|||
125453297|NCT00991276|451288517|FG001|First Intervention Period|Insufficient clinical response|0|||
125453298|NCT00991276|451288518|FG002|First Intervention Period|Insufficient clinical response|0|||
125453299|NCT00991276|451288519|FG003|First Intervention Period|Insufficient clinical response|0|||
125453300|NCT00991276|451288520|FG004|First Intervention Period|Insufficient clinical response|1|||
125453301|NCT00991276|451288521|FG005|First Intervention Period|Insufficient clinical response|0|||
125453302|NCT00991276|451288516|FG000|First Intervention Period|Other|0|||
125453303|NCT00991276|451288517|FG001|First Intervention Period|Other|0|||
125453304|NCT00991276|451288518|FG002|First Intervention Period|Other|0|||
125453305|NCT00991276|451288519|FG003|First Intervention Period|Other|1|||
125453306|NCT00991276|451288520|FG004|First Intervention Period|Other|1|||
125453307|NCT00991276|451288521|FG005|First Intervention Period|Other|0|||
125453308|NCT00991276|451288516|FG000|First Intervention Period|Withdrawal by Subject|0|||
125453309|NCT00991276|451288517|FG001|First Intervention Period|Withdrawal by Subject|1|||
125453310|NCT00991276|451288518|FG002|First Intervention Period|Withdrawal by Subject|0|||
125453311|NCT00991276|451288519|FG003|First Intervention Period|Withdrawal by Subject|1|||
125453312|NCT00991276|451288520|FG004|First Intervention Period|Withdrawal by Subject|0|||
125453313|NCT00991276|451288521|FG005|First Intervention Period|Withdrawal by Subject|1|||
125453314|NCT00991276|451288516|FG000|First Intervention Period|Lost to Follow-up|0|||
125453315|NCT00991276|451288517|FG001|First Intervention Period|Lost to Follow-up|1|||
125453316|NCT00991276|451288518|FG002|First Intervention Period|Lost to Follow-up|0|||
125453317|NCT00991276|451288519|FG003|First Intervention Period|Lost to Follow-up|1|||
125453318|NCT00991276|451288520|FG004|First Intervention Period|Lost to Follow-up|0|||
125453319|NCT00991276|451288521|FG005|First Intervention Period|Lost to Follow-up|0|||
125453320|NCT00991276|451288516|FG000|Second Intervention Period|Adverse Event|0|||
125453321|NCT00991276|451288517|FG001|Second Intervention Period|Adverse Event|2|||
125453322|NCT00991276|451288518|FG002|Second Intervention Period|Adverse Event|0|||
125453323|NCT00991276|451288519|FG003|Second Intervention Period|Adverse Event|1|||
125453324|NCT00991276|451288520|FG004|Second Intervention Period|Adverse Event|1|||
125453325|NCT00991276|451288521|FG005|Second Intervention Period|Adverse Event|0|||
125453326|NCT00991276|451288516|FG000|Second Intervention Period|Protocol Violation|1|||
125453327|NCT00991276|451288517|FG001|Second Intervention Period|Protocol Violation|0|||
125453328|NCT00991276|451288518|FG002|Second Intervention Period|Protocol Violation|0|||
125453329|NCT00991276|451288519|FG003|Second Intervention Period|Protocol Violation|0|||
125453330|NCT00991276|451288520|FG004|Second Intervention Period|Protocol Violation|0|||
125453331|NCT00991276|451288521|FG005|Second Intervention Period|Protocol Violation|0|||
125453332|NCT00991276|451288516|FG000|Second Intervention Period|Other|0|||
125453333|NCT00991276|451288517|FG001|Second Intervention Period|Other|0|||
125453334|NCT00991276|451288518|FG002|Second Intervention Period|Other|0|||
125453335|NCT00991276|451288519|FG003|Second Intervention Period|Other|1|||
125453336|NCT00991276|451288520|FG004|Second Intervention Period|Other|0|||
125453337|NCT00991276|451288521|FG005|Second Intervention Period|Other|1|||
125453338|NCT00991276|451288516|FG000|Third Intervention Period|Protocol Violation|1|||
125453339|NCT00991276|451288517|FG001|Third Intervention Period|Protocol Violation|0|||
125453340|NCT00991276|451288518|FG002|Third Intervention Period|Protocol Violation|0|||
125453341|NCT00991276|451288519|FG003|Third Intervention Period|Protocol Violation|0|||
125453342|NCT00991276|451288520|FG004|Third Intervention Period|Protocol Violation|0|||
125453343|NCT00991276|451288521|FG005|Third Intervention Period|Protocol Violation|0|||
125453344|NCT00991276|451288516|FG000|Third Intervention Period|Other|0|||
125453345|NCT00991276|451288517|FG001|Third Intervention Period|Other|0|||
125453346|NCT00991276|451288518|FG002|Third Intervention Period|Other|0|||
125453347|NCT00991276|451288519|FG003|Third Intervention Period|Other|0|||
125453348|NCT00991276|451288520|FG004|Third Intervention Period|Other|0|||
125453349|NCT00991276|451288521|FG005|Third Intervention Period|Other|1|||
125453350|NCT00991276|451288516|FG000|Third Intervention Period|Adverse Event|0|||
125453351|NCT00991276|451288517|FG001|Third Intervention Period|Adverse Event|0|||
125453352|NCT00991276|451288518|FG002|Third Intervention Period|Adverse Event|1|||
125453353|NCT00991276|451288519|FG003|Third Intervention Period|Adverse Event|0|||
125453354|NCT00991276|451288520|FG004|Third Intervention Period|Adverse Event|0|||
125453355|NCT00991276|451288521|FG005|Third Intervention Period|Adverse Event|0|||
125453356|NCT00991276|451288516|FG000|Third Intervention Period|Withdrawal by Subject|0|||
125453357|NCT00991276|451288517|FG001|Third Intervention Period|Withdrawal by Subject|0|||
125453358|NCT00991276|451288518|FG002|Third Intervention Period|Withdrawal by Subject|0|||
125453359|NCT00991276|451288519|FG003|Third Intervention Period|Withdrawal by Subject|1|||
125453360|NCT00991276|451288520|FG004|Third Intervention Period|Withdrawal by Subject|0|||
125453361|NCT00991276|451288521|FG005|Third Intervention Period|Withdrawal by Subject|0|||
125453362|NCT01268891|451288522|FG000|Overall Study|Adverse Event|3|||
125453363|NCT01268891|451288523|FG001|Overall Study|Adverse Event|7|||
125453364|NCT01268891|451288522|FG000|Overall Study|Lack of Efficacy|1|||
125453365|NCT01268891|451288523|FG001|Overall Study|Lack of Efficacy|0|||
125453366|NCT01268891|451288522|FG000|Overall Study|Withdrawal of Consent|3|||
125453367|NCT01268891|451288523|FG001|Overall Study|Withdrawal of Consent|1|||
125453368|NCT01268891|451288522|FG000|Overall Study|Administrative or other reason(s)|1|||
125453369|NCT01268891|451288523|FG001|Overall Study|Administrative or other reason(s)|0|||
125453370|NCT02759731|451288524|FG000|Overall Study|Did not complete treatment.|8|||
125453371|NCT00335556|451288525|FG000|Overall Study|Death|0|||
125453372|NCT00335556|451288526|FG001|Overall Study|Death|5|||
125453373|NCT00335556|451288527|FG002|Overall Study|Death|0|||
125453374|NCT00335556|451288528|FG003|Overall Study|Death|0|||
125453375|NCT00335556|451288529|FG004|Overall Study|Death|1|||
125453376|NCT00335556|451288530|FG005|Overall Study|Death|0|||
125453377|NCT00335556|451288525|FG000|Overall Study|Lack of Efficacy|0|||
125453378|NCT00335556|451288526|FG001|Overall Study|Lack of Efficacy|19|||
125453379|NCT00335556|451288527|FG002|Overall Study|Lack of Efficacy|3|||
125453380|NCT00335556|451288528|FG003|Overall Study|Lack of Efficacy|3|||
125453381|NCT00335556|451288529|FG004|Overall Study|Lack of Efficacy|0|||
125453382|NCT00335556|451288530|FG005|Overall Study|Lack of Efficacy|1|||
125453383|NCT00335556|451288525|FG000|Overall Study|Physician Decision|0|||
125453384|NCT00335556|451288526|FG001|Overall Study|Physician Decision|6|||
125453385|NCT00335556|451288527|FG002|Overall Study|Physician Decision|2|||
125453386|NCT00335556|451288528|FG003|Overall Study|Physician Decision|1|||
125453387|NCT00335556|451288529|FG004|Overall Study|Physician Decision|0|||
125453388|NCT00335556|451288530|FG005|Overall Study|Physician Decision|0|||
125453389|NCT00335556|451288525|FG000|Overall Study|Ineligible|2|||
125453390|NCT00335556|451288526|FG001|Overall Study|Ineligible|0|||
125453391|NCT00335556|451288527|FG002|Overall Study|Ineligible|0|||
125453392|NCT00335556|451288528|FG003|Overall Study|Ineligible|0|||
125453393|NCT00335556|451288529|FG004|Overall Study|Ineligible|0|||
125453394|NCT00335556|451288530|FG005|Overall Study|Ineligible|0|||
125453395|NCT00335556|451288525|FG000|Overall Study|Refusal of further protocol therapy|0|||
125453396|NCT00335556|451288526|FG001|Overall Study|Refusal of further protocol therapy|4|||
125453397|NCT00335556|451288527|FG002|Overall Study|Refusal of further protocol therapy|0|||
125453398|NCT00335556|451288528|FG003|Overall Study|Refusal of further protocol therapy|1|||
125453399|NCT00335556|451288529|FG004|Overall Study|Refusal of further protocol therapy|0|||
125453400|NCT00335556|451288530|FG005|Overall Study|Refusal of further protocol therapy|0|||
125453401|NCT01878890|451288531|FG000|Overall Study|Protocol Violation|0|||
125453402|NCT01878890|451288532|FG001|Overall Study|Protocol Violation|1|||
125453403|NCT01878890|451288533|FG002|Overall Study|Protocol Violation|0|||
125453404|NCT01878890|451288534|FG003|Overall Study|Protocol Violation|0|||
125453405|NCT00502593|451288539|FG000|Overall Study|Withdrawn unspecified reason|1|||
125453406|NCT00502593|451288540|FG001|Overall Study|Withdrawn unspecified reason|1|||
125453407|NCT00502593|451288541|FG002|Overall Study|Withdrawn unspecified reason|3|||
125453408|NCT00502593|451288542|FG003|Overall Study|Withdrawn unspecified reason|1|||
125453409|NCT00502593|451288543|FG004|Overall Study|Withdrawn unspecified reason|2|||
125453410|NCT00502593|451288544|FG005|Overall Study|Withdrawn unspecified reason|0|||
125453411|NCT00502593|451288545|FG006|Overall Study|Withdrawn unspecified reason|2|||
125453412|NCT00502593|451288546|FG007|Overall Study|Withdrawn unspecified reason|0|||
125453413|NCT00502593|451288547|FG008|Overall Study|Withdrawn unspecified reason|0|||
125453414|NCT00502593|451288548|FG009|Overall Study|Withdrawn unspecified reason|0|||
125453415|NCT00502593|451288549|FG010|Overall Study|Withdrawn unspecified reason|0|||
125453416|NCT00502593|451288550|FG011|Overall Study|Withdrawn unspecified reason|0|||
125453417|NCT00502593|451288539|FG000|Overall Study|Withdrawal by Subject|0|||
125453418|NCT00502593|451288540|FG001|Overall Study|Withdrawal by Subject|0|||
125453419|NCT00502593|451288541|FG002|Overall Study|Withdrawal by Subject|6|||
125453420|NCT00502593|451288542|FG003|Overall Study|Withdrawal by Subject|2|||
125453421|NCT00502593|451288543|FG004|Overall Study|Withdrawal by Subject|2|||
125453422|NCT00502593|451288544|FG005|Overall Study|Withdrawal by Subject|0|||
125453423|NCT00502593|451288545|FG006|Overall Study|Withdrawal by Subject|3|||
125453424|NCT00502593|451288546|FG007|Overall Study|Withdrawal by Subject|0|||
125453425|NCT00502593|451288547|FG008|Overall Study|Withdrawal by Subject|3|||
125453426|NCT00502593|451288548|FG009|Overall Study|Withdrawal by Subject|0|||
125453427|NCT00502593|451288549|FG010|Overall Study|Withdrawal by Subject|1|||
125453428|NCT00502593|451288550|FG011|Overall Study|Withdrawal by Subject|0|||
125453429|NCT00502593|451288539|FG000|Overall Study|Lost to Follow-up|2|||
125453430|NCT00502593|451288540|FG001|Overall Study|Lost to Follow-up|1|||
125453431|NCT00502593|451288541|FG002|Overall Study|Lost to Follow-up|1|||
125453432|NCT00502593|451288542|FG003|Overall Study|Lost to Follow-up|1|||
125453433|NCT00502593|451288543|FG004|Overall Study|Lost to Follow-up|0|||
125453434|NCT00502593|451288544|FG005|Overall Study|Lost to Follow-up|0|||
125453435|NCT00502593|451288545|FG006|Overall Study|Lost to Follow-up|0|||
125453436|NCT00502593|451288546|FG007|Overall Study|Lost to Follow-up|0|||
125453437|NCT00502593|451288547|FG008|Overall Study|Lost to Follow-up|3|||
125453438|NCT00502593|451288548|FG009|Overall Study|Lost to Follow-up|0|||
125453439|NCT00502593|451288549|FG010|Overall Study|Lost to Follow-up|1|||
125453440|NCT00502593|451288550|FG011|Overall Study|Lost to Follow-up|0|||
125453441|NCT01664104|451288551|FG000|Overall Study|Adverse Event|6|||
125453442|NCT01664104|451288551|FG000|Overall Study|Lack of Efficacy|2|||
125453443|NCT01664104|451288551|FG000|Overall Study|Withdrawal by Subject|1|||
125453444|NCT01664104|451288551|FG000|Overall Study|Lost to Follow-up|4|||
125453445|NCT01664104|451288551|FG000|Overall Study|Other|1|||
125453446|NCT01664104|451288551|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
125453447|NCT03761784|451288552|FG000|Overall Study|Adverse Event|4|||
125453448|NCT03761784|451288553|FG001|Overall Study|Adverse Event|0|||
125453449|NCT03761784|451288552|FG000|Overall Study|Lost to Follow-up|10|||
125453450|NCT03761784|451288553|FG001|Overall Study|Lost to Follow-up|7|||
125453451|NCT03761784|451288552|FG000|Overall Study|Pregnancy|1|||
125453452|NCT03761784|451288553|FG001|Overall Study|Pregnancy|0|||
125453453|NCT03761784|451288552|FG000|Overall Study|Protocol Violation|2|||
125453454|NCT03761784|451288553|FG001|Overall Study|Protocol Violation|0|||
125453455|NCT03761784|451288552|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
125453456|NCT03761784|451288553|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
125453457|NCT03761784|451288552|FG000|Overall Study|Withdrawal by Subject|9|||
125453458|NCT03761784|451288553|FG001|Overall Study|Withdrawal by Subject|4|||
125453459|NCT03761784|451288552|FG000|Overall Study|Physician Decision|1|||
125453460|NCT03761784|451288553|FG001|Overall Study|Physician Decision|0|||
125453461|NCT03761784|451288552|FG000|Overall Study|Other Than Specified|1|||
125453462|NCT03761784|451288553|FG001|Overall Study|Other Than Specified|0|||
125453463|NCT00586339|451288554|FG000|Overall Study|Withdrawal by Subject|1|||
125453464|NCT00586339|451288555|FG001|Overall Study|Withdrawal by Subject|3|||
125453465|NCT00586339|451288556|FG002|Overall Study|Withdrawal by Subject|1|||
125453466|NCT00586339|451288554|FG000|Overall Study|Migrated/moved from study area|3|||
125453467|NCT00586339|451288555|FG001|Overall Study|Migrated/moved from study area|2|||
125453468|NCT00586339|451288556|FG002|Overall Study|Migrated/moved from study area|4|||
125453469|NCT00586339|451288554|FG000|Overall Study|Lost to Follow-up|3|||
125453470|NCT00586339|451288555|FG001|Overall Study|Lost to Follow-up|2|||
125453471|NCT00586339|451288556|FG002|Overall Study|Lost to Follow-up|1|||
125453472|NCT00197236|451288560|FG000|Overall Study|Adverse Event|1|||
125453473|NCT00197236|451288561|FG001|Overall Study|Adverse Event|0|||
125453474|NCT00197236|451288562|FG002|Overall Study|Adverse Event|1|||
125453475|NCT00197236|451288560|FG000|Overall Study|Lost to Follow-up|5|||
125453476|NCT00197236|451288561|FG001|Overall Study|Lost to Follow-up|14|||
125453477|NCT00197236|451288562|FG002|Overall Study|Lost to Follow-up|6|||
125453478|NCT00197236|451288560|FG000|Overall Study|Protocol Violation|0|||
125453479|NCT00197236|451288561|FG001|Overall Study|Protocol Violation|0|||
125453480|NCT00197236|451288562|FG002|Overall Study|Protocol Violation|1|||
125453481|NCT00197236|451288560|FG000|Overall Study|Withdrawal by Subject|7|||
125453482|NCT00197236|451288561|FG001|Overall Study|Withdrawal by Subject|3|||
125453483|NCT00197236|451288562|FG002|Overall Study|Withdrawal by Subject|11|||
125453484|NCT00197236|451288560|FG000|Overall Study|Study drug/medication expiration|1|||
125453485|NCT00197236|451288561|FG001|Overall Study|Study drug/medication expiration|0|||
125453486|NCT00197236|451288562|FG002|Overall Study|Study drug/medication expiration|3|||
125453487|NCT00197236|451288560|FG000|Overall Study|Returned out of specified time window|0|||
125453488|NCT00197236|451288561|FG001|Overall Study|Returned out of specified time window|0|||
125453489|NCT00197236|451288562|FG002|Overall Study|Returned out of specified time window|1|||
125453490|NCT00746330|451288563|FG000|Period 1|Abnormal test procedure result|0|||
125453491|NCT00746330|451288564|FG001|Period 1|Abnormal test procedure result|0|||
125453492|NCT00746330|451288565|FG002|Period 1|Abnormal test procedure result|1|||
125453493|NCT00746330|451288566|FG003|Period 1|Abnormal test procedure result|0|||
125453494|NCT02524288|451288567|FG000|Overall Study|Adverse Event|115|||
125453495|NCT02524288|451288567|FG000|Overall Study|Lost to Follow-up|216|||
125453496|NCT02524288|451288567|FG000|Overall Study|Non-Compliance With Protocol|32|||
125453497|NCT02524288|451288567|FG000|Overall Study|Non-Compliance With Study Drug|14|||
125453498|NCT02524288|451288567|FG000|Overall Study|Pregnancy Wish|6|||
125453499|NCT02524288|451288567|FG000|Overall Study|Protocol Violation|6|||
125453500|NCT02524288|451288567|FG000|Overall Study|Screen Failure|2|||
125453501|NCT02524288|451288567|FG000|Overall Study|Site Discontinued Study Participation|1|||
125453502|NCT02524288|451288567|FG000|Overall Study|Study Terminated By Sponsor|1417|||
125453503|NCT02524288|451288567|FG000|Overall Study|Subject Moved|32|||
125453504|NCT02524288|451288567|FG000|Overall Study|Withdrawal by Subject|76|||
125453505|NCT02524288|451288567|FG000|Overall Study|Pregnancy|22|||
125453506|NCT02524288|451288567|FG000|Overall Study|Physician Decision|2|||
125453507|NCT00517933|451288568|FG000|Period 1|Death|2|||
125453508|NCT00517933|451288569|FG001|Period 1|Death|1|||
125453509|NCT00517933|451288568|FG000|Period 1|Adverse Event|4|||
125453510|NCT00517933|451288569|FG001|Period 1|Adverse Event|4|||
125453511|NCT00517933|451288568|FG000|Period 1|Lost to Follow-up|2|||
125453512|NCT00517933|451288569|FG001|Period 1|Lost to Follow-up|0|||
125453513|NCT00517933|451288568|FG000|Period 1|Underwent lung transplant|0|||
125453514|NCT00517933|451288569|FG001|Period 1|Underwent lung transplant|1|||
125453515|NCT00517933|451288568|FG000|Period 2|Death|2|||
125453516|NCT00517933|451288569|FG001|Period 2|Death|4|||
125453517|NCT00517933|451288568|FG000|Period 2|Adverse Event|2|||
125453518|NCT00517933|451288569|FG001|Period 2|Adverse Event|4|||
125453519|NCT00517933|451288568|FG000|Period 2|Physician Decision|1|||
125453520|NCT00517933|451288569|FG001|Period 2|Physician Decision|0|||
125453521|NCT00517933|451288568|FG000|Period 2|Withdrawal by Subject|1|||
125453522|NCT00517933|451288569|FG001|Period 2|Withdrawal by Subject|3|||
125453523|NCT00517933|451288568|FG000|Period 2|Underwent lung transplant|0|||
125453524|NCT00517933|451288569|FG001|Period 2|Underwent lung transplant|2|||
125453525|NCT01835899|451288571|FG000|Overall Study|Adverse Event|0|||
125453526|NCT01835899|451288572|FG001|Overall Study|Adverse Event|0|||
125453527|NCT01835899|451288573|FG002|Overall Study|Adverse Event|1|||
125453528|NCT01835899|451288571|FG000|Overall Study|Other than stated above|0|||
125453529|NCT01835899|451288572|FG001|Overall Study|Other than stated above|1|||
125453530|NCT01835899|451288573|FG002|Overall Study|Other than stated above|0|||
125453531|NCT00121199|451288576|FG000|Overall Study|Adverse Event|11|||
125453532|NCT00121199|451288576|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
125453533|NCT00121199|451288576|FG000|Overall Study|Progression/Relapse|1|||
125453534|NCT00121199|451288576|FG000|Overall Study|Death|3|||
125453535|NCT00121199|451288576|FG000|Overall Study|Other - Not Protocol Specified|3|||
125453536|NCT00121199|451288576|FG000|Overall Study|Ineligible|9|||
125453537|NCT01018511|451288578|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
125453538|NCT01018511|451288579|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
125453539|NCT01018511|451288580|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
125453540|NCT01018511|451288581|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
125453541|NCT01018511|451288578|FG000|Overall Study|Adverse Event|5|||
125453542|NCT01018511|451288579|FG001|Overall Study|Adverse Event|9|||
125453543|NCT01018511|451288580|FG002|Overall Study|Adverse Event|13|||
125453544|NCT01018511|451288581|FG003|Overall Study|Adverse Event|10|||
125453545|NCT01018511|451288578|FG000|Overall Study|Lack of Efficacy|4|||
125453546|NCT01018511|451288579|FG001|Overall Study|Lack of Efficacy|1|||
125453547|NCT01018511|451288580|FG002|Overall Study|Lack of Efficacy|1|||
125453548|NCT01018511|451288581|FG003|Overall Study|Lack of Efficacy|2|||
125453549|NCT01018511|451288578|FG000|Overall Study|Withdrawal by Subject|6|||
125453550|NCT01018511|451288579|FG001|Overall Study|Withdrawal by Subject|5|||
125453551|NCT01018511|451288580|FG002|Overall Study|Withdrawal by Subject|11|||
125453552|NCT01018511|451288581|FG003|Overall Study|Withdrawal by Subject|9|||
125453553|NCT01018511|451288578|FG000|Overall Study|Lost to Follow-up|0|||
125453554|NCT01018511|451288579|FG001|Overall Study|Lost to Follow-up|0|||
125453555|NCT01018511|451288580|FG002|Overall Study|Lost to Follow-up|1|||
125453556|NCT01018511|451288581|FG003|Overall Study|Lost to Follow-up|0|||
125453557|NCT01018511|451288578|FG000|Overall Study|Protocol Violation|5|||
125292202|NCT00996801|450696555|FG004|Overall Study|Progressive Disease|0|||
125292203|NCT00996801|450696556|FG005|Overall Study|Progressive Disease|0|||
125453558|NCT01018511|451288579|FG001|Overall Study|Protocol Violation|8|||
125453559|NCT01018511|451288580|FG002|Overall Study|Protocol Violation|7|||
125453560|NCT01018511|451288581|FG003|Overall Study|Protocol Violation|9|||
125453561|NCT01018511|451288578|FG000|Overall Study|Miscellaneous|0|||
125453562|NCT01018511|451288579|FG001|Overall Study|Miscellaneous|2|||
125453563|NCT01018511|451288580|FG002|Overall Study|Miscellaneous|0|||
125453564|NCT01018511|451288581|FG003|Overall Study|Miscellaneous|0|||
125453565|NCT04305912|451288583|FG000|First Intervention|COVID-19 Suspension|2|||
125453566|NCT04305912|451288584|FG001|First Intervention|COVID-19 Suspension|0|||
125453567|NCT04305912|451288583|FG000|First Intervention|Withdrawal by Subject|0|||
125453568|NCT04305912|451288584|FG001|First Intervention|Withdrawal by Subject|1|||
125453569|NCT04305912|451288583|FG000|Second Intervention|Adverse Event|0|||
125453570|NCT04305912|451288584|FG001|Second Intervention|Adverse Event|1|||
125453571|NCT04550039|451288585|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
125453572|NCT04550039|451288586|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
125453573|NCT04550039|451288585|FG000|Overall Study|patient self-withdrew from study|0|||
125453574|NCT04550039|451288586|FG001|Overall Study|patient self-withdrew from study|1|||
125453575|NCT04888585|451288587|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
125453576|NCT04888585|451288588|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
125453577|NCT04888585|451288589|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
125453578|NCT04888585|451288590|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
125453579|NCT04888585|451288591|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
125292204|NCT00996801|450696551|FG000|Overall Study|Protocol Violation|3|||
125453580|NCT04888585|451288592|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
125453581|NCT04888585|451288593|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
125453582|NCT04888585|451288594|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
125453583|NCT04888585|451288595|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
125453584|NCT04888585|451288596|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
125453585|NCT04888585|451288597|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
125453586|NCT04888585|451288587|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
125292205|NCT00996801|450696552|FG001|Overall Study|Protocol Violation|4|||
125453587|NCT04888585|451288588|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
125453588|NCT04888585|451288589|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
125453589|NCT04888585|451288590|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
125453590|NCT04888585|451288591|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
125453591|NCT04888585|451288592|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
125453592|NCT04888585|451288593|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
125453593|NCT04888585|451288594|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
125453594|NCT04888585|451288595|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
125453595|NCT04888585|451288596|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
125453596|NCT04888585|451288597|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
125453597|NCT04888585|451288587|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
125453598|NCT04888585|451288588|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
125453599|NCT04888585|451288589|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
125453600|NCT04888585|451288590|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
125453601|NCT04888585|451288591|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
125453602|NCT04888585|451288592|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
125453603|NCT04888585|451288593|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
125453604|NCT04888585|451288594|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
125453605|NCT04888585|451288595|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
125453606|NCT04888585|451288596|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
125453607|NCT04888585|451288597|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
125453608|NCT04888585|451288587|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
125453609|NCT04888585|451288588|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
125453610|NCT04888585|451288589|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
125453611|NCT04888585|451288590|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
125453612|NCT04888585|451288591|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
125453613|NCT04888585|451288592|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
125453614|NCT04888585|451288593|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
125453615|NCT04888585|451288594|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
125453616|NCT04888585|451288595|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
125453617|NCT04888585|451288596|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
125453618|NCT04888585|451288597|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
125453619|NCT04888585|451288587|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
125453620|NCT04888585|451288588|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
125453621|NCT04888585|451288589|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
125453622|NCT04888585|451288590|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
125453623|NCT04888585|451288591|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
125453624|NCT04888585|451288592|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
125453625|NCT04888585|451288593|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
125453626|NCT04888585|451288594|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
125453627|NCT04888585|451288595|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
125453628|NCT04888585|451288596|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
125453629|NCT04888585|451288597|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
125453630|NCT04888585|451288587|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
125453631|NCT04888585|451288588|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
125453632|NCT04888585|451288589|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
125453633|NCT04888585|451288590|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
125453634|NCT04888585|451288591|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
125453635|NCT04888585|451288592|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
125453636|NCT04888585|451288593|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
125453637|NCT04888585|451288594|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
125453638|NCT04888585|451288595|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
125453639|NCT04888585|451288596|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
125453640|NCT04888585|451288597|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
125453641|NCT04888585|451288587|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
125453642|NCT04888585|451288588|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
125453643|NCT04888585|451288589|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
125453644|NCT04888585|451288590|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
125453645|NCT04888585|451288591|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
125453646|NCT04888585|451288592|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
125453647|NCT04888585|451288593|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
125453648|NCT04888585|451288594|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
125453649|NCT04888585|451288595|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
125453650|NCT04888585|451288596|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
125453651|NCT04888585|451288597|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
125453652|NCT04888585|451288587|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
125453653|NCT04888585|451288588|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
125453654|NCT04888585|451288589|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
125453655|NCT04888585|451288590|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
125453656|NCT04888585|451288591|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
125453657|NCT04888585|451288592|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
125453658|NCT04888585|451288593|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
125453659|NCT04888585|451288594|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
125453660|NCT04888585|451288595|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
125453661|NCT04888585|451288596|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
125453662|NCT04888585|451288597|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
125453663|NCT02908464|451288599|FG000|Overall Study|Withdrawal by Subject|2|||
125453664|NCT02908464|451288600|FG001|Overall Study|Withdrawal by Subject|1|||
125453665|NCT02908464|451288599|FG000|Overall Study|Found ineligible after randomization|0|||
125453666|NCT02908464|451288600|FG001|Overall Study|Found ineligible after randomization|2|||
125453667|NCT01772719|451288601|FG000|Overall Study|Withdrawal by Subject|3|||
125453668|NCT01772719|451288601|FG000|Overall Study|Adverse Event|2|||
125453669|NCT01772719|451288601|FG000|Overall Study|Protocol Violation|1|||
125453670|NCT01772719|451288601|FG000|Overall Study|Lost to Follow-up|1|||
125453671|NCT01311713|451288602|FG000|Overall Study|Death|0|||
125453672|NCT01311713|451288603|FG001|Overall Study|Death|0|||
125453673|NCT01311713|451288604|FG002|Overall Study|Death|1|||
125453674|NCT01311713|451288605|FG003|Overall Study|Death|1|||
125453675|NCT01311713|451288606|FG004|Overall Study|Death|0|||
125453676|NCT01311713|451288607|FG005|Overall Study|Death|1|||
125453677|NCT01311713|451288608|FG006|Overall Study|Death|0|||
125453678|NCT01311713|451288602|FG000|Overall Study|Adverse Event|0|||
125453679|NCT01311713|451288603|FG001|Overall Study|Adverse Event|1|||
125453680|NCT01311713|451288604|FG002|Overall Study|Adverse Event|0|||
125453681|NCT01311713|451288605|FG003|Overall Study|Adverse Event|2|||
125453682|NCT01311713|451288606|FG004|Overall Study|Adverse Event|0|||
125453683|NCT01311713|451288607|FG005|Overall Study|Adverse Event|0|||
125453684|NCT01311713|451288608|FG006|Overall Study|Adverse Event|2|||
125453685|NCT01311713|451288602|FG000|Overall Study|Withdrawal by Subject|0|||
125453686|NCT01311713|451288603|FG001|Overall Study|Withdrawal by Subject|1|||
125453687|NCT01311713|451288604|FG002|Overall Study|Withdrawal by Subject|1|||
125453688|NCT01311713|451288605|FG003|Overall Study|Withdrawal by Subject|0|||
125453689|NCT01311713|451288606|FG004|Overall Study|Withdrawal by Subject|0|||
125453690|NCT01311713|451288607|FG005|Overall Study|Withdrawal by Subject|1|||
125453691|NCT01311713|451288608|FG006|Overall Study|Withdrawal by Subject|2|||
125453692|NCT01311713|451288602|FG000|Overall Study|Disease progression|3|||
125453693|NCT01311713|451288603|FG001|Overall Study|Disease progression|4|||
125453694|NCT01311713|451288604|FG002|Overall Study|Disease progression|3|||
125453695|NCT01311713|451288605|FG003|Overall Study|Disease progression|2|||
125453696|NCT01311713|451288606|FG004|Overall Study|Disease progression|4|||
125453697|NCT01311713|451288607|FG005|Overall Study|Disease progression|4|||
125453698|NCT01311713|451288608|FG006|Overall Study|Disease progression|5|||
125453699|NCT01311713|451288602|FG000|Overall Study|Lost to Follow-up|0|||
125453700|NCT01311713|451288603|FG001|Overall Study|Lost to Follow-up|0|||
125453701|NCT01311713|451288604|FG002|Overall Study|Lost to Follow-up|1|||
125453702|NCT01311713|451288605|FG003|Overall Study|Lost to Follow-up|0|||
125453703|NCT01311713|451288606|FG004|Overall Study|Lost to Follow-up|0|||
125453704|NCT01311713|451288607|FG005|Overall Study|Lost to Follow-up|0|||
125453705|NCT01311713|451288608|FG006|Overall Study|Lost to Follow-up|0|||
125453706|NCT01311713|451288602|FG000|Overall Study|Stopped taking study medication|0|||
125453707|NCT01311713|451288603|FG001|Overall Study|Stopped taking study medication|0|||
125453708|NCT01311713|451288604|FG002|Overall Study|Stopped taking study medication|0|||
125453709|NCT01311713|451288605|FG003|Overall Study|Stopped taking study medication|1|||
125453710|NCT01311713|451288606|FG004|Overall Study|Stopped taking study medication|1|||
125453711|NCT01311713|451288607|FG005|Overall Study|Stopped taking study medication|0|||
125453712|NCT01311713|451288608|FG006|Overall Study|Stopped taking study medication|0|||
125453713|NCT01311713|451288602|FG000|Overall Study|Enrolled but not treated|0|||
125453714|NCT01311713|451288603|FG001|Overall Study|Enrolled but not treated|0|||
125453715|NCT01311713|451288604|FG002|Overall Study|Enrolled but not treated|1|||
125453716|NCT01311713|451288605|FG003|Overall Study|Enrolled but not treated|0|||
125453717|NCT01311713|451288606|FG004|Overall Study|Enrolled but not treated|0|||
125453718|NCT01311713|451288607|FG005|Overall Study|Enrolled but not treated|0|||
125453719|NCT01311713|451288608|FG006|Overall Study|Enrolled but not treated|0|||
125453720|NCT01311713|451288602|FG000|Overall Study|Other than specified|0|||
125453721|NCT01311713|451288603|FG001|Overall Study|Other than specified|1|||
125453722|NCT01311713|451288604|FG002|Overall Study|Other than specified|2|||
125453723|NCT01311713|451288605|FG003|Overall Study|Other than specified|0|||
125453724|NCT01311713|451288606|FG004|Overall Study|Other than specified|0|||
125453725|NCT01311713|451288607|FG005|Overall Study|Other than specified|0|||
125453726|NCT01311713|451288608|FG006|Overall Study|Other than specified|0|||
125453727|NCT00299702|451288609|FG000|Overall Study|Death|1|||
125453728|NCT00299702|451288610|FG001|Overall Study|Death|0|||
125453729|NCT00299702|451288609|FG000|Overall Study|Adverse Event|0|||
125453730|NCT00299702|451288610|FG001|Overall Study|Adverse Event|4|||
125453731|NCT00299702|451288609|FG000|Overall Study|Lost to Follow-up|18|||
125453732|NCT00299702|451288610|FG001|Overall Study|Lost to Follow-up|10|||
125453733|NCT00299702|451288609|FG000|Overall Study|Withdrawal by Subject|25|||
125453734|NCT00299702|451288610|FG001|Overall Study|Withdrawal by Subject|23|||
125453735|NCT00299702|451288609|FG000|Overall Study|Pregnancy|0|||
125453736|NCT00299702|451288610|FG001|Overall Study|Pregnancy|1|||
125419640|NCT02363738|451160314|FG001|Overall Study|Lost to Follow-up|1|||
125419641|NCT02081846|451160317|FG000|Overall Study|Withdrawal by Subject|1|||
125419642|NCT02081846|451160318|FG001|Overall Study|Withdrawal by Subject|0|||
125419643|NCT02081846|451160317|FG000|Overall Study|invalid consent|1|||
125419644|NCT02081846|451160318|FG001|Overall Study|invalid consent|0|||
125419645|NCT03282227|451160319|FG000|Overall Study|Exposure Goals Achieved|60|||
125419646|NCT03282227|451160319|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
125419647|NCT03282227|451160319|FG000|Overall Study|Adverse Event|15|||
125419648|NCT03282227|451160319|FG000|Overall Study|Lost to Follow-up|21|||
125419649|NCT03282227|451160319|FG000|Overall Study|Withdrawal by Subject|20|||
125419650|NCT03282227|451160319|FG000|Overall Study|Lack of Efficacy|12|||
125419651|NCT03282227|451160319|FG000|Overall Study|Sponsor decision|3|||
125419652|NCT03282227|451160319|FG000|Overall Study|Physician Decision|2|||
125419653|NCT03282227|451160319|FG000|Overall Study|Pregnancy|2|||
125419654|NCT03282227|451160319|FG000|Overall Study|Other|1|||
125419655|NCT02576678|451160320|FG000|Overall Study|Adverse Event|0|||
125419656|NCT02576678|451160321|FG001|Overall Study|Adverse Event|0|||
125419657|NCT02576678|451160322|FG002|Overall Study|Adverse Event|2|||
125419658|NCT02576678|451160320|FG000|Overall Study|Withdrawal by Subject|3|||
125419659|NCT02576678|451160321|FG001|Overall Study|Withdrawal by Subject|1|||
125419660|NCT02576678|451160322|FG002|Overall Study|Withdrawal by Subject|2|||
125419661|NCT02576678|451160320|FG000|Overall Study|Lost to Follow-up|0|||
125419662|NCT02576678|451160321|FG001|Overall Study|Lost to Follow-up|0|||
125419663|NCT02576678|451160322|FG002|Overall Study|Lost to Follow-up|1|||
125419664|NCT02576678|451160320|FG000|Overall Study|Miscellaneous|2|||
125419665|NCT02576678|451160321|FG001|Overall Study|Miscellaneous|0|||
125419666|NCT02576678|451160322|FG002|Overall Study|Miscellaneous|0|||
125419667|NCT02251990|451160326|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
125419668|NCT02251990|451160327|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
125419669|NCT02251990|451160326|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
125419670|NCT02251990|451160327|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
125419671|NCT02251990|451160326|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
125419672|NCT02251990|451160327|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
125419673|NCT02251990|451160326|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
125419674|NCT02251990|451160327|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
125419675|NCT02251990|451160326|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
125419676|NCT02251990|451160327|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
125419677|NCT02251990|451160326|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
125419678|NCT02251990|451160327|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
125419679|NCT03265600|451160328|FG000|Overall Study|Lost to Follow-up|17|||
125419680|NCT03265600|451160329|FG001|Overall Study|Lost to Follow-up|5|||
125419681|NCT03265600|451160328|FG000|Overall Study|Withdrawal by Subject|4|||
125419682|NCT03265600|451160329|FG001|Overall Study|Withdrawal by Subject|2|||
125419683|NCT03265600|451160328|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
125419684|NCT03265600|451160329|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
125419685|NCT04330638|451160330|FG000|Overall Study|Adverse Event|9|||
125419686|NCT04330638|451160331|FG001|Overall Study|Adverse Event|10|||
125419687|NCT04330638|451160332|FG002|Overall Study|Adverse Event|15|||
125419688|NCT04330638|451160333|FG003|Overall Study|Adverse Event|6|||
125419689|NCT04330638|451160334|FG004|Overall Study|Adverse Event|10|||
125419690|NCT04330638|451160335|FG005|Overall Study|Adverse Event|5|||
125419691|NCT04330638|451160330|FG000|Overall Study|Other|2|||
125419692|NCT04330638|451160331|FG001|Overall Study|Other|2|||
125419693|NCT04330638|451160332|FG002|Overall Study|Other|5|||
125419694|NCT04330638|451160333|FG003|Overall Study|Other|1|||
125419695|NCT04330638|451160334|FG004|Overall Study|Other|3|||
125419696|NCT04330638|451160335|FG005|Overall Study|Other|2|||
125453737|NCT00299702|451288609|FG000|Overall Study|Insufficient Response|4|||
125453738|NCT00299702|451288610|FG001|Overall Study|Insufficient Response|3|||
125419697|NCT04330638|451160330|FG000|Overall Study|Withdrawal by Subject|4|||
125419698|NCT04330638|451160331|FG001|Overall Study|Withdrawal by Subject|0|||
125419699|NCT04330638|451160332|FG002|Overall Study|Withdrawal by Subject|0|||
125419700|NCT04330638|451160333|FG003|Overall Study|Withdrawal by Subject|0|||
125419701|NCT04330638|451160334|FG004|Overall Study|Withdrawal by Subject|0|||
125419702|NCT04330638|451160335|FG005|Overall Study|Withdrawal by Subject|0|||
125419703|NCT04330638|451160330|FG000|Overall Study|Lost to Follow-up|3|||
125485347|NCT02240238|451412509|FG006|Phase 1|Adverse Event|3|||
125453739|NCT00299702|451288609|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
125453740|NCT00299702|451288610|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
125453741|NCT00751036|451288611|FG000|Overall Study|Disease Progression|28|||
125453742|NCT00751036|451288612|FG001|Overall Study|Disease Progression|29|||
125453743|NCT00751036|451288611|FG000|Overall Study|Adverse Event|6|||
125453744|NCT00751036|451288612|FG001|Overall Study|Adverse Event|4|||
125453745|NCT00751036|451288611|FG000|Overall Study|Administrative Problems|3|||
125453746|NCT00751036|451288612|FG001|Overall Study|Administrative Problems|4|||
125453747|NCT00751036|451288611|FG000|Overall Study|Withdrawal by Subject|5|||
125453748|NCT00751036|451288612|FG001|Overall Study|Withdrawal by Subject|2|||
125453749|NCT00751036|451288611|FG000|Overall Study|Death|3|||
125453750|NCT00751036|451288612|FG001|Overall Study|Death|3|||
125453751|NCT00751036|451288611|FG000|Overall Study|Lost to Follow-up|0|||
125453752|NCT00751036|451288612|FG001|Overall Study|Lost to Follow-up|1|||
125453753|NCT00751036|451288611|FG000|Overall Study|Protocol Violation|1|||
125453754|NCT00751036|451288612|FG001|Overall Study|Protocol Violation|0|||
125453755|NCT00751036|451288611|FG000|Overall Study|Missing end of Treatment Page|2|||
125453756|NCT00751036|451288612|FG001|Overall Study|Missing end of Treatment Page|3|||
125453757|NCT05460663|451288613|FG000|Overall Study|Withdrawal by Subject|2|||
125453758|NCT05460663|451288614|FG001|Overall Study|Withdrawal by Subject|5|||
125453759|NCT05273801|451288615|FG000|Overall Study|Physician Decision|1|||
125453760|NCT03820986|451288616|FG000|Overall Study|Death|177|||
125453761|NCT03820986|451288617|FG001|Overall Study|Death|156|||
125453762|NCT03820986|451288616|FG000|Overall Study|Lost to Follow-up|0|||
125453763|NCT03820986|451288617|FG001|Overall Study|Lost to Follow-up|1|||
125453764|NCT03820986|451288616|FG000|Overall Study|Withdrawal by Subject|8|||
125453765|NCT03820986|451288617|FG001|Overall Study|Withdrawal by Subject|3|||
125453766|NCT03820986|451288616|FG000|Overall Study|Ongoing|149|||
125453767|NCT03820986|451288617|FG001|Overall Study|Ongoing|180|||
125453768|NCT01729819|451289935|FG000|Overall Study|Adverse Event|2|||
125453769|NCT01729819|451289936|FG001|Overall Study|Adverse Event|4|||
125453770|NCT01729819|451289935|FG000|Overall Study|Lack of Efficacy|1|||
125453771|NCT01729819|451289936|FG001|Overall Study|Lack of Efficacy|0|||
125453772|NCT01729819|451289935|FG000|Overall Study|Lost to Follow-up|2|||
125453773|NCT01729819|451289936|FG001|Overall Study|Lost to Follow-up|0|||
125453774|NCT01729819|451289935|FG000|Overall Study|Other reason|1|||
125453775|NCT01729819|451289936|FG001|Overall Study|Other reason|0|||
125453776|NCT01729819|451289935|FG000|Overall Study|Protocol Violation|0|||
125453777|NCT01729819|451289936|FG001|Overall Study|Protocol Violation|1|||
125453778|NCT01729819|451289935|FG000|Overall Study|Withdrawal by Subject|0|||
125453779|NCT01729819|451289936|FG001|Overall Study|Withdrawal by Subject|2|||
125453780|NCT03646669|451289939|FG000|Overall Study|Withdrawal by Subject|5|||
125453781|NCT03646669|451289940|FG001|Overall Study|Withdrawal by Subject|0|||
125453782|NCT00269399|451289943|FG000|Overall Study|Lack of Efficacy|27|||
125453783|NCT00269399|451289944|FG001|Overall Study|Lack of Efficacy|10|||
125453784|NCT00269399|451289943|FG000|Overall Study|Adverse Event|10|||
125453785|NCT00269399|451289944|FG001|Overall Study|Adverse Event|4|||
125453786|NCT00269399|451289943|FG000|Overall Study|Withdrawal by Subject|2|||
125453787|NCT00269399|451289944|FG001|Overall Study|Withdrawal by Subject|5|||
125453788|NCT00269399|451289943|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
125453789|NCT00269399|451289944|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
125453790|NCT00269399|451289943|FG000|Overall Study|Other|0|||
125453791|NCT00269399|451289944|FG001|Overall Study|Other|4|||
125453792|NCT00269399|451289943|FG000|Overall Study|Development of exclusion criteria|0|||
125453793|NCT00269399|451289944|FG001|Overall Study|Development of exclusion criteria|1|||
125453794|NCT03441360|451289945|FG000|Overall Study|Radiological disease progression|5|||
125453795|NCT03441360|451289946|FG001|Overall Study|Radiological disease progression|6|||
125453796|NCT03441360|451289947|FG002|Overall Study|Radiological disease progression|4|||
125453797|NCT03441360|451289945|FG000|Overall Study|Clinical disease progression|2|||
125453798|NCT03441360|451289946|FG001|Overall Study|Clinical disease progression|2|||
125453799|NCT03441360|451289947|FG002|Overall Study|Clinical disease progression|0|||
125453800|NCT03441360|451289945|FG000|Overall Study|Adverse Event|1|||
125453801|NCT03441360|451289946|FG001|Overall Study|Adverse Event|0|||
125453802|NCT03441360|451289947|FG002|Overall Study|Adverse Event|1|||
125453803|NCT03467724|451289949|FG000|Overall Study|Lost to Follow-up|5|||
125453804|NCT03467724|451289949|FG000|Overall Study|Withdrawal by Subject|1|||
125453805|NCT03467724|451289949|FG000|Overall Study|Protocol Violation|1|||
125453806|NCT03467724|451289949|FG000|Overall Study|Adverse Event|1|||
125453807|NCT02049866|451289953|FG000|Overall Study|Withdrawal by Subject|1|||
125453808|NCT02955069|451289955|FG000|Overall Study|Adverse Event|7|||
125453809|NCT02955069|451289956|FG001|Overall Study|Adverse Event|2|||
125453810|NCT02955069|451289955|FG000|Overall Study|Death|7|||
125453811|NCT02955069|451289956|FG001|Overall Study|Death|3|||
125453812|NCT02955069|451289955|FG000|Overall Study|Physician Decision|10|||
125453813|NCT02955069|451289956|FG001|Overall Study|Physician Decision|2|||
125453814|NCT02955069|451289955|FG000|Overall Study|Progressive disease|64|||
125453815|NCT02955069|451289956|FG001|Overall Study|Progressive disease|13|||
125453816|NCT02955069|451289955|FG000|Overall Study|Study terminated by sponsor|4|||
125453817|NCT02955069|451289956|FG001|Overall Study|Study terminated by sponsor|0|||
125453818|NCT02955069|451289955|FG000|Overall Study|Subject/Guardian decision|3|||
125453819|NCT02955069|451289956|FG001|Overall Study|Subject/Guardian decision|1|||
125453820|NCT04148937|451289958|FG000|Overall Study|Withdrawal by Subject|0|||
125453821|NCT04148937|451289959|FG001|Overall Study|Withdrawal by Subject|0|||
125453822|NCT04148937|451289960|FG002|Overall Study|Withdrawal by Subject|0|||
125453823|NCT04148937|451289961|FG003|Overall Study|Withdrawal by Subject|1|||
125453824|NCT04148937|451289962|FG004|Overall Study|Withdrawal by Subject|0|||
125453825|NCT04148937|451289963|FG005|Overall Study|Withdrawal by Subject|1|||
125453826|NCT04148937|451289964|FG006|Overall Study|Withdrawal by Subject|1|||
125453827|NCT04148937|451289965|FG007|Overall Study|Withdrawal by Subject|0|||
125453828|NCT04148937|451289958|FG000|Overall Study|Lost to Follow-up|0|||
125453829|NCT04148937|451289959|FG001|Overall Study|Lost to Follow-up|0|||
125453830|NCT04148937|451289960|FG002|Overall Study|Lost to Follow-up|1|||
125453831|NCT04148937|451289961|FG003|Overall Study|Lost to Follow-up|0|||
125453832|NCT04148937|451289962|FG004|Overall Study|Lost to Follow-up|0|||
125453833|NCT04148937|451289963|FG005|Overall Study|Lost to Follow-up|2|||
125453834|NCT04148937|451289964|FG006|Overall Study|Lost to Follow-up|0|||
125453835|NCT04148937|451289965|FG007|Overall Study|Lost to Follow-up|0|||
125453836|NCT03107611|451289970|FG000|Overall Study|Adverse Event|1|||
125453837|NCT03107611|451289971|FG001|Overall Study|Adverse Event|0|||
125453838|NCT03107611|451289972|FG002|Overall Study|Adverse Event|2|||
125453839|NCT03107611|451289970|FG000|Overall Study|Lost to Follow-up|3|||
125453840|NCT03107611|451289971|FG001|Overall Study|Lost to Follow-up|3|||
125453841|NCT03107611|451289972|FG002|Overall Study|Lost to Follow-up|3|||
125453842|NCT03107611|451289970|FG000|Overall Study|Protocol Violation|0|||
125453843|NCT03107611|451289971|FG001|Overall Study|Protocol Violation|0|||
125453844|NCT03107611|451289972|FG002|Overall Study|Protocol Violation|1|||
125453845|NCT03107611|451289970|FG000|Overall Study|Withdrawal by Subject|1|||
125453846|NCT03107611|451289971|FG001|Overall Study|Withdrawal by Subject|0|||
125453847|NCT03107611|451289972|FG002|Overall Study|Withdrawal by Subject|1|||
125453848|NCT03107611|451289970|FG000|Overall Study|Worsening signs/symptoms|2|||
125453849|NCT03107611|451289971|FG001|Overall Study|Worsening signs/symptoms|1|||
125453850|NCT03107611|451289972|FG002|Overall Study|Worsening signs/symptoms|2|||
125453851|NCT01020838|451289973|FG000|Overall Study|Death|90|||
125453852|NCT01020838|451289973|FG000|Overall Study|Adverse Event|1|||
125453853|NCT01020838|451289973|FG000|Overall Study|Withdrawal by Subject|9|||
125453854|NCT01020838|451289973|FG000|Overall Study|Lost to Follow-up|6|||
125453855|NCT01020838|451289973|FG000|Overall Study|Most common: Study ended by sponsor|77|||
125453856|NCT04464421|451289975|FG000|Overall Study|Lost to Follow-up|2|||
125453857|NCT04464421|451289976|FG001|Overall Study|Lost to Follow-up|2|||
125453858|NCT01167426|451289977|FG000|Overall Study|Lost to Follow-up|6|||
125453859|NCT01167426|451289977|FG000|Overall Study|Protocol Violation|1|||
125453860|NCT01167426|451289977|FG000|Overall Study|Withdrawal by Subject|2|||
125453861|NCT01167426|451289977|FG000|Overall Study|Sponsor Decision|1|||
125453862|NCT01908634|451289979|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
125453863|NCT01908634|451289979|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
125453864|NCT04176458|451289980|FG000|Overall Study|Covid 19|4|||
125453865|NCT01570751|451289981|FG000|Period A (16 Weeks)|Protocol Violation|1|||
125453866|NCT01570751|451289982|FG001|Period A (16 Weeks)|Protocol Violation|1|||
125453867|NCT01570751|451289981|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
125453868|NCT01570751|451289982|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
125453869|NCT01570751|451289981|FG000|Period A (16 Weeks)|Unclassified|2|||
125453870|NCT01570751|451289982|FG001|Period A (16 Weeks)|Unclassified|3|||
125453871|NCT01570751|451289981|FG000|Period B (16 Weeks)|Adverse Event|1|||
125453872|NCT01570751|451289982|FG001|Period B (16 Weeks)|Adverse Event|0|||
125453873|NCT01570751|451289981|FG000|Period B (16 Weeks)|Protocol Violation|0|||
125453874|NCT01570751|451289982|FG001|Period B (16 Weeks)|Protocol Violation|1|||
125453875|NCT05790408|451289983|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
125453876|NCT02145182|451289985|FG000|Overall Study|Adverse Event|4|||
125453877|NCT02145182|451289986|FG001|Overall Study|Adverse Event|1|||
125453878|NCT02145182|451289985|FG000|Overall Study|Death|7|||
125453879|NCT02145182|451289986|FG001|Overall Study|Death|7|||
125453880|NCT02145182|451289985|FG000|Overall Study|Lost to Follow-up|2|||
125453881|NCT02145182|451289986|FG001|Overall Study|Lost to Follow-up|2|||
125453882|NCT02145182|451289985|FG000|Overall Study|Pre-transplant Withdrawal|0|||
125453883|NCT02145182|451289986|FG001|Overall Study|Pre-transplant Withdrawal|2|||
125292206|NCT00996801|450696553|FG002|Overall Study|Protocol Violation|1|||
125453884|NCT02145182|451289985|FG000|Overall Study|Withdrawal by Subject|5|||
125453885|NCT02145182|451289986|FG001|Overall Study|Withdrawal by Subject|4|||
125453886|NCT00588666|451289988|FG000|Overall Study|Adverse Event|4|||
125453887|NCT02274493|451289991|FG000|Overall Study|Withdrawal by Subject|1|||
125453888|NCT00558363|451289992|FG000|Overall Study|Physician Decision|18|||
125453889|NCT00558363|451289993|FG001|Overall Study|Physician Decision|4|||
125453890|NCT00558363|451289992|FG000|Overall Study|Withdrawal by Subject|11|||
125453891|NCT00558363|451289993|FG001|Overall Study|Withdrawal by Subject|4|||
125453892|NCT00558363|451289992|FG000|Overall Study|Adverse Event|5|||
125453893|NCT00558363|451289993|FG001|Overall Study|Adverse Event|5|||
125419704|NCT04330638|451160331|FG001|Overall Study|Lost to Follow-up|2|||
125419705|NCT04330638|451160332|FG002|Overall Study|Lost to Follow-up|3|||
125419706|NCT04330638|451160333|FG003|Overall Study|Lost to Follow-up|2|||
125419707|NCT04330638|451160334|FG004|Overall Study|Lost to Follow-up|3|||
125419708|NCT04330638|451160335|FG005|Overall Study|Lost to Follow-up|0|||
125419709|NCT02293538|451160336|FG000|Overall Study|Adverse Event|0|||
125419710|NCT02293538|451160337|FG001|Overall Study|Adverse Event|1|||
125419711|NCT02293538|451160336|FG000|Overall Study|Lost to Follow-up|1|||
125419712|NCT02293538|451160337|FG001|Overall Study|Lost to Follow-up|0|||
125419713|NCT02293538|451160336|FG000|Overall Study|Withdrawal by Subject|0|||
125419714|NCT02293538|451160337|FG001|Overall Study|Withdrawal by Subject|1|||
125419715|NCT00322348|451160342|FG000|Overall Study|Adverse Event|0|||
125419716|NCT00322348|451160343|FG001|Overall Study|Adverse Event|1|||
125419717|NCT00322348|451160342|FG000|Overall Study|Withdrawal by Subject|1|||
125419718|NCT00322348|451160343|FG001|Overall Study|Withdrawal by Subject|4|||
125419719|NCT00322348|451160342|FG000|Overall Study|Lost to Follow-up|1|||
125419720|NCT00322348|451160343|FG001|Overall Study|Lost to Follow-up|0|||
125419721|NCT00322348|451160342|FG000|Overall Study|Death|0|||
125419722|NCT00322348|451160343|FG001|Overall Study|Death|2|||
125419723|NCT00322348|451160342|FG000|Overall Study|Disease Progression|30|||
125419724|NCT00322348|451160343|FG001|Overall Study|Disease Progression|25|||
125419725|NCT00322348|451160342|FG000|Overall Study|Reasons not specified|5|||
125419726|NCT00322348|451160343|FG001|Overall Study|Reasons not specified|1|||
125419727|NCT01090453|451160346|FG000|Overall Study|Withdrawal by Subject|1|||
125419728|NCT01090453|451160347|FG001|Overall Study|Withdrawal by Subject|2|||
125419729|NCT01090453|451160346|FG000|Overall Study|Lost to Follow-up|7|||
125419730|NCT01090453|451160347|FG001|Overall Study|Lost to Follow-up|7|||
125419731|NCT01090453|451160346|FG000|Overall Study|Non serious AEs|1|||
125419732|NCT01090453|451160347|FG001|Overall Study|Non serious AEs|0|||
125419733|NCT01090453|451160346|FG000|Overall Study|Protocol Violation|2|||
125419734|NCT01090453|451160347|FG001|Overall Study|Protocol Violation|0|||
125419735|NCT01090453|451160346|FG000|Overall Study|Other|2|||
125419736|NCT01090453|451160347|FG001|Overall Study|Other|4|||
125419737|NCT01090453|451160346|FG000|Overall Study|Eligibility Criteria|0|||
125419738|NCT01090453|451160347|FG001|Overall Study|Eligibility Criteria|1|||
125419739|NCT00729833|451160349|FG000|Overall Study|Death|5|||
125419740|NCT00729833|451160350|FG001|Overall Study|Death|1|||
125419741|NCT00729833|451160351|FG002|Overall Study|Death|3|||
125419742|NCT00729833|451160352|FG003|Overall Study|Death|5|||
125419743|NCT00729833|451160349|FG000|Overall Study|Study Terminated by Sponsor|0|||
125419744|NCT00729833|451160350|FG001|Overall Study|Study Terminated by Sponsor|0|||
125419745|NCT00729833|451160351|FG002|Overall Study|Study Terminated by Sponsor|1|||
125419746|NCT00729833|451160352|FG003|Overall Study|Study Terminated by Sponsor|0|||
125419747|NCT00729833|451160349|FG000|Overall Study|Lost to Follow-up|1|||
125419748|NCT00729833|451160350|FG001|Overall Study|Lost to Follow-up|0|||
125419749|NCT00729833|451160351|FG002|Overall Study|Lost to Follow-up|0|||
125419750|NCT00729833|451160352|FG003|Overall Study|Lost to Follow-up|0|||
125419751|NCT00729833|451160349|FG000|Overall Study|Withdrawal by Subject|3|||
125419752|NCT00729833|451160350|FG001|Overall Study|Withdrawal by Subject|1|||
125419753|NCT00729833|451160351|FG002|Overall Study|Withdrawal by Subject|3|||
125419754|NCT00729833|451160352|FG003|Overall Study|Withdrawal by Subject|0|||
125419755|NCT00729833|451160349|FG000|Overall Study|Unspecified Reasons|11|||
125419756|NCT00729833|451160350|FG001|Overall Study|Unspecified Reasons|5|||
125419757|NCT00729833|451160351|FG002|Overall Study|Unspecified Reasons|5|||
125419758|NCT00729833|451160352|FG003|Overall Study|Unspecified Reasons|1|||
125419759|NCT03570619|451160353|FG000|Overall Study|Adverse Event|2|||
125419760|NCT03570619|451160354|FG001|Overall Study|Adverse Event|0|||
125419761|NCT03570619|451160355|FG002|Overall Study|Adverse Event|1|||
125419762|NCT03570619|451160353|FG000|Overall Study|new diagnosis of new malignancy|1|||
125419763|NCT03570619|451160354|FG001|Overall Study|new diagnosis of new malignancy|0|||
125419764|NCT03570619|451160355|FG002|Overall Study|new diagnosis of new malignancy|0|||
125419765|NCT03570619|451160353|FG000|Overall Study|Physician Decision|1|||
125419766|NCT03570619|451160354|FG001|Overall Study|Physician Decision|1|||
125419767|NCT03570619|451160355|FG002|Overall Study|Physician Decision|0|||
125419768|NCT03570619|451160353|FG000|Overall Study|Withdrawal by Subject|0|||
125419769|NCT03570619|451160354|FG001|Overall Study|Withdrawal by Subject|2|||
125419770|NCT03570619|451160355|FG002|Overall Study|Withdrawal by Subject|0|||
125419771|NCT01022762|451160357|FG000|Overall Study|Adverse Event|3|||
125419772|NCT01022762|451160358|FG001|Overall Study|Adverse Event|1|||
125419773|NCT01022762|451160357|FG000|Overall Study|Lack of Efficacy|0|||
125419774|NCT01022762|451160358|FG001|Overall Study|Lack of Efficacy|1|||
125419775|NCT01022762|451160357|FG000|Overall Study|Protocol Violation|7|||
125419776|NCT01022762|451160358|FG001|Overall Study|Protocol Violation|6|||
125419777|NCT01022762|451160357|FG000|Overall Study|Unclassified|12|||
125419778|NCT01022762|451160358|FG001|Overall Study|Unclassified|20|||
125419779|NCT01302119|451160359|FG000|Overall Study|Withdrawal by Subject|30|||
125419780|NCT01302119|451160360|FG001|Overall Study|Withdrawal by Subject|20|||
125419781|NCT01302119|451160359|FG000|Overall Study|Lost to Follow-up|10|||
125419782|NCT01302119|451160360|FG001|Overall Study|Lost to Follow-up|4|||
125419783|NCT01302119|451160359|FG000|Overall Study|Adverse Event|2|||
125453894|NCT00558363|451289992|FG000|Overall Study|Lack of Efficacy|2|||
125453895|NCT00558363|451289993|FG001|Overall Study|Lack of Efficacy|2|||
125453896|NCT00558363|451289992|FG000|Overall Study|Protocol Violation|2|||
125453897|NCT00558363|451289993|FG001|Overall Study|Protocol Violation|1|||
125453898|NCT00558363|451289992|FG000|Overall Study|Lost to Follow-up|0|||
125453899|NCT00558363|451289993|FG001|Overall Study|Lost to Follow-up|1|||
125453900|NCT00558363|451289992|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
125453901|NCT00558363|451289993|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
125453902|NCT00558363|451289992|FG000|Overall Study|Randomized in Error|1|||
125453903|NCT00558363|451289993|FG001|Overall Study|Randomized in Error|2|||
125453904|NCT00558363|451289992|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
125453905|NCT00558363|451289993|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
125453906|NCT03102710|451289994|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
125453907|NCT03102710|451289995|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
125453908|NCT03102710|451289996|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
125453909|NCT03102710|451289994|FG000|Overall Study|Technical issues during final MRI scan|0|||
125453910|NCT03102710|451289995|FG001|Overall Study|Technical issues during final MRI scan|1|||
125453911|NCT03102710|451289996|FG002|Overall Study|Technical issues during final MRI scan|0|||
125453912|NCT03102710|451289994|FG000|Overall Study|Nausea during MRI scan|0|||
125453913|NCT03102710|451289995|FG001|Overall Study|Nausea during MRI scan|1|||
125453914|NCT03102710|451289996|FG002|Overall Study|Nausea during MRI scan|0|||
125453915|NCT03102710|451289994|FG000|Overall Study|Subject unable to attend final session|0|||
125453916|NCT03102710|451289995|FG001|Overall Study|Subject unable to attend final session|1|||
125453917|NCT03102710|451289996|FG002|Overall Study|Subject unable to attend final session|0|||
125453918|NCT04012853|451289997|FG000|Overall Study|Withdrawal by Subject|1|||
125453919|NCT04012853|451289998|FG001|Overall Study|Withdrawal by Subject|1|||
125453920|NCT04012853|451289997|FG000|Overall Study|Protocol Violation|1|||
125453921|NCT04012853|451289998|FG001|Overall Study|Protocol Violation|0|||
125453922|NCT04012853|451289997|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
125453923|NCT04012853|451289998|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
125453924|NCT01101165|451290001|FG000|Period 1|Adverse Event|1|||
125453925|NCT01101165|451290002|FG001|Period 1|Adverse Event|2|||
125453926|NCT01101165|451290001|FG000|Period 1|Withdrawal by Subject|0|||
125453927|NCT01101165|451290002|FG001|Period 1|Withdrawal by Subject|2|||
125453928|NCT01101165|451290001|FG000|Period 1|Positive Drug Screen|0|||
125453929|NCT01101165|451290002|FG001|Period 1|Positive Drug Screen|1|||
125453930|NCT01101165|451290001|FG000|Period 1|Lost to Follow-up|1|||
125453931|NCT01101165|451290002|FG001|Period 1|Lost to Follow-up|0|||
125453932|NCT01101165|451290001|FG000|Period 2|Withdrawal by Subject|3|||
125453933|NCT01101165|451290002|FG001|Period 2|Withdrawal by Subject|1|||
125453934|NCT01101165|451290001|FG000|Period 2|Adverse Event|1|||
125453935|NCT01101165|451290002|FG001|Period 2|Adverse Event|0|||
125453936|NCT00015457|451290003|FG000|First Intervention|Adverse Event|0|||
125453937|NCT00015457|451290004|FG001|First Intervention|Adverse Event|2|||
125453938|NCT00015457|451290003|FG000|First Intervention|Lack of Efficacy|0|||
125453939|NCT00015457|451290004|FG001|First Intervention|Lack of Efficacy|1|||
125453940|NCT00015457|451290003|FG000|Second Intervention|Withdrawal by Subject|1|||
125453941|NCT00015457|451290004|FG001|Second Intervention|Withdrawal by Subject|0|||
125453942|NCT02219490|451290005|FG000|Overall Study|Adverse Event|24|||
125453943|NCT02219490|451290005|FG000|Overall Study|Withdrew consent|96|||
125453944|NCT02219490|451290005|FG000|Overall Study|Lost to Follow-up|126|||
125453945|NCT02219490|451290005|FG000|Overall Study|COVID-19 infection|2|||
125453946|NCT02219490|451290005|FG000|Overall Study|COVID-19 logistical restrictions|33|||
125453947|NCT02219490|451290005|FG000|Overall Study|Other, not specified|57|||
125453948|NCT03404843|451290009|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
125453949|NCT03404843|451290010|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
125453950|NCT00567164|451290011|FG000|Overall Study|Withdrawal by Subject|171|||
125453951|NCT00567164|451290012|FG001|Overall Study|Withdrawal by Subject|21|||
125453952|NCT00567164|451290013|FG002|Overall Study|Withdrawal by Subject|17|||
125453953|NCT00567164|451290011|FG000|Overall Study|Protocol Violation|23|||
125453954|NCT00567164|451290012|FG001|Overall Study|Protocol Violation|4|||
125453955|NCT00567164|451290013|FG002|Overall Study|Protocol Violation|2|||
125453956|NCT00567164|451290011|FG000|Overall Study|Adverse Event|92|||
125453957|NCT00567164|451290012|FG001|Overall Study|Adverse Event|13|||
125453958|NCT00567164|451290013|FG002|Overall Study|Adverse Event|9|||
125453959|NCT00567164|451290011|FG000|Overall Study|Death|0|||
125453960|NCT00567164|451290012|FG001|Overall Study|Death|0|||
125453961|NCT00567164|451290013|FG002|Overall Study|Death|1|||
125453962|NCT00567164|451290011|FG000|Overall Study|Lost to Follow-up|202|||
125453963|NCT00567164|451290012|FG001|Overall Study|Lost to Follow-up|23|||
125453964|NCT00567164|451290013|FG002|Overall Study|Lost to Follow-up|21|||
125453965|NCT00567164|451290011|FG000|Overall Study|Pregnancy|20|||
125453966|NCT00567164|451290012|FG001|Overall Study|Pregnancy|4|||
125453967|NCT00567164|451290013|FG002|Overall Study|Pregnancy|6|||
125453968|NCT00567164|451290011|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
125453969|NCT00567164|451290012|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
125453970|NCT00567164|451290013|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
125453971|NCT00567164|451290011|FG000|Overall Study|Missing|1|||
125453972|NCT00567164|451290012|FG001|Overall Study|Missing|0|||
125453973|NCT00567164|451290013|FG002|Overall Study|Missing|0|||
125453974|NCT02430532|451290014|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
125453975|NCT02430532|451290015|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
125453976|NCT02430532|451290014|FG000|Overall Study|Consent Withdrawn|0|||
125453977|NCT02430532|451290015|FG001|Overall Study|Consent Withdrawn|2|||
125453978|NCT02430532|451290014|FG000|Overall Study|Adverse Event|0|||
125453979|NCT02430532|451290015|FG001|Overall Study|Adverse Event|1|||
125453980|NCT04109118|451290028|FG000|Overall Study|Lost to Follow-up|3|||
125453981|NCT03235349|451290031|FG000|Overall Study|Adverse Event|1|||
125453982|NCT03235349|451290031|FG000|Overall Study|Other|1|||
125453983|NCT03396913|451290033|FG000|Overall Study|Lost to Follow-up|0|||
125453984|NCT03396913|451290034|FG001|Overall Study|Lost to Follow-up|6|||
125453985|NCT05824351|451290035|FG000|Overall Study|Adverse Event|6|||
125453986|NCT00828945|451290036|FG000|Overall Study|Death|4|||
125453987|NCT00828945|451290036|FG000|Overall Study|Participant was missing|1|||
125453988|NCT00828945|451290036|FG000|Overall Study|Other|36|||
125453989|NCT02482233|451290041|FG000|Overall Study|Lost to Follow-up|1|||
125453990|NCT02482233|451290042|FG001|Overall Study|Lost to Follow-up|1|||
125453991|NCT03822351|451290043|FG000|Overall Study|Death|27|||
125453992|NCT03822351|451290044|FG001|Overall Study|Death|23|||
125453993|NCT03822351|451290045|FG002|Overall Study|Death|24|||
125453994|NCT03822351|451290043|FG000|Overall Study|Lost to Follow-up|6|||
125453995|NCT03822351|451290044|FG001|Overall Study|Lost to Follow-up|2|||
125453996|NCT03822351|451290045|FG002|Overall Study|Lost to Follow-up|1|||
125453997|NCT03822351|451290043|FG000|Overall Study|Withdrawal by Subject|10|||
125453998|NCT03822351|451290044|FG001|Overall Study|Withdrawal by Subject|4|||
125453999|NCT03822351|451290045|FG002|Overall Study|Withdrawal by Subject|6|||
125454000|NCT03822351|451290043|FG000|Overall Study|Progressive Disease|2|||
125454001|NCT03822351|451290044|FG001|Overall Study|Progressive Disease|1|||
125454002|NCT03822351|451290045|FG002|Overall Study|Progressive Disease|0|||
125454003|NCT03822351|451290043|FG000|Overall Study|Not Treated|1|||
125454004|NCT03822351|451290044|FG001|Overall Study|Not Treated|1|||
125454005|NCT03822351|451290045|FG002|Overall Study|Not Treated|1|||
125454006|NCT00813488|451290046|FG000|Titration Period 1|Adverse Event|6|||
125454007|NCT00813488|451290047|FG001|Titration Period 1|Adverse Event|1|||
125454008|NCT00813488|451290046|FG000|Titration Period 1|Lack of Efficacy|9|||
125454009|NCT00813488|451290047|FG001|Titration Period 1|Lack of Efficacy|7|||
125454010|NCT00813488|451290046|FG000|Titration Period 1|Withdrawal by Subject|2|||
125454011|NCT00813488|451290047|FG001|Titration Period 1|Withdrawal by Subject|2|||
125454012|NCT00813488|451290046|FG000|Titration Period 1|Protocol Violation|4|||
125454013|NCT00813488|451290047|FG001|Titration Period 1|Protocol Violation|3|||
125454014|NCT00813488|451290046|FG000|Titration Period 1|Non-compliance to study medication|4|||
125454015|NCT00813488|451290047|FG001|Titration Period 1|Non-compliance to study medication|1|||
125454016|NCT00813488|451290046|FG000|Titration Period 1|Non-compliance to study procedures|2|||
125454017|NCT00813488|451290047|FG001|Titration Period 1|Non-compliance to study procedures|2|||
125454018|NCT00813488|451290046|FG000|Titration Period 1|Technical Difficulties|0|||
125454019|NCT00813488|451290047|FG001|Titration Period 1|Technical Difficulties|1|||
125454020|NCT00813488|451290046|FG000|Titration Period 2|Adverse Event|2|||
125454021|NCT00813488|451290047|FG001|Titration Period 2|Adverse Event|3|||
125454022|NCT00813488|451290046|FG000|Titration Period 2|Lack of Efficacy|8|||
125454023|NCT00813488|451290047|FG001|Titration Period 2|Lack of Efficacy|4|||
125454024|NCT00813488|451290046|FG000|Titration Period 2|Protocol Violation|3|||
125454025|NCT00813488|451290047|FG001|Titration Period 2|Protocol Violation|2|||
125454026|NCT00813488|451290046|FG000|Titration Period 2|Lost to Follow-up|1|||
125454027|NCT00813488|451290047|FG001|Titration Period 2|Lost to Follow-up|0|||
125454028|NCT00813488|451290046|FG000|Titration Period 2|Non-compliance with study procedures|2|||
125454029|NCT00813488|451290047|FG001|Titration Period 2|Non-compliance with study procedures|1|||
125454030|NCT00813488|451290046|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
125454031|NCT00813488|451290047|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
125454032|NCT00813488|451290046|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
125454033|NCT00813488|451290047|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
125454034|NCT00813488|451290046|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
125454035|NCT00813488|451290047|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
125454036|NCT00813488|451290046|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
125454037|NCT00813488|451290047|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
125454038|NCT00813488|451290046|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
125454039|NCT00813488|451290047|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
125454040|NCT00813488|451290046|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
125454041|NCT00813488|451290047|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
125454042|NCT00813488|451290046|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
125454043|NCT00813488|451290047|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
125454044|NCT00813488|451290046|FG000|Double-blind Treatment Period 2|Other|1|||
125454045|NCT00813488|451290047|FG001|Double-blind Treatment Period 2|Other|0|||
125454046|NCT00813488|451290046|FG000|Open-label Extension|Adverse Event|1|||
125454047|NCT00813488|451290047|FG001|Open-label Extension|Adverse Event|2|||
125454048|NCT00813488|451290046|FG000|Open-label Extension|Lack of Efficacy|3|||
125454049|NCT00813488|451290047|FG001|Open-label Extension|Lack of Efficacy|0|||
125454050|NCT00813488|451290046|FG000|Open-label Extension|Withdrawal by Subject|0|||
125454051|NCT00813488|451290047|FG001|Open-label Extension|Withdrawal by Subject|2|||
125454052|NCT00813488|451290046|FG000|Open-label Extension|Protocol Violation|1|||
125454053|NCT00813488|451290047|FG001|Open-label Extension|Protocol Violation|2|||
125454054|NCT00813488|451290046|FG000|Open-label Extension|Non-compliance study medication|4|||
125454055|NCT00813488|451290047|FG001|Open-label Extension|Non-compliance study medication|0|||
125454056|NCT00813488|451290046|FG000|Open-label Extension|Non-compliance study procedures|2|||
125454057|NCT00813488|451290047|FG001|Open-label Extension|Non-compliance study procedures|1|||
125454058|NCT00813488|451290046|FG000|Open-label Extension|Other|1|||
125454059|NCT00813488|451290047|FG001|Open-label Extension|Other|0|||
125454060|NCT01729871|451290048|FG000|Overall Study|Adverse Event|7|||
125454061|NCT01729871|451290049|FG001|Overall Study|Adverse Event|7|||
125454062|NCT01729871|451290048|FG000|Overall Study|Death|0|||
125454063|NCT01729871|451290049|FG001|Overall Study|Death|1|||
125454064|NCT01729871|451290048|FG000|Overall Study|Lack of Efficacy|0|||
125454065|NCT01729871|451290049|FG001|Overall Study|Lack of Efficacy|1|||
125454066|NCT01729871|451290048|FG000|Overall Study|Physician Decision|0|||
125454067|NCT01729871|451290049|FG001|Overall Study|Physician Decision|2|||
125454068|NCT01729871|451290048|FG000|Overall Study|Protocol Violation|1|||
125454069|NCT01729871|451290049|FG001|Overall Study|Protocol Violation|0|||
125454070|NCT01729871|451290048|FG000|Overall Study|Withdrawal by Subject|0|||
125454071|NCT01729871|451290049|FG001|Overall Study|Withdrawal by Subject|3|||
125454072|NCT01729871|451290048|FG000|Overall Study|Other|4|||
125454073|NCT01729871|451290049|FG001|Overall Study|Other|9|||
125454074|NCT01143077|451290050|FG000|Overall Study|Lack of Efficacy|0|||
125454075|NCT01143077|451290051|FG001|Overall Study|Lack of Efficacy|2|||
125454076|NCT01143077|451290052|FG002|Overall Study|Lack of Efficacy|1|||
125454077|NCT01143077|451290050|FG000|Overall Study|Adverse Event|5|||
125454078|NCT01143077|451290051|FG001|Overall Study|Adverse Event|6|||
125454079|NCT01143077|451290052|FG002|Overall Study|Adverse Event|5|||
125454080|NCT01143077|451290050|FG000|Overall Study|Lost to Follow-up|2|||
125454081|NCT01143077|451290051|FG001|Overall Study|Lost to Follow-up|3|||
125454082|NCT01143077|451290052|FG002|Overall Study|Lost to Follow-up|4|||
125454083|NCT01143077|451290050|FG000|Overall Study|Protocol Violation|2|||
125454084|NCT01143077|451290051|FG001|Overall Study|Protocol Violation|0|||
125454085|NCT01143077|451290052|FG002|Overall Study|Protocol Violation|0|||
125454086|NCT01143077|451290050|FG000|Overall Study|Withdrawal by Subject|4|||
125454087|NCT01143077|451290051|FG001|Overall Study|Withdrawal by Subject|3|||
125454088|NCT01143077|451290052|FG002|Overall Study|Withdrawal by Subject|3|||
125454089|NCT01143077|451290050|FG000|Overall Study|Non-compliance with study drug|0|||
125454090|NCT01143077|451290051|FG001|Overall Study|Non-compliance with study drug|1|||
125454091|NCT01143077|451290052|FG002|Overall Study|Non-compliance with study drug|1|||
125454092|NCT01143077|451290050|FG000|Overall Study|Administrative|1|||
125454093|NCT01143077|451290051|FG001|Overall Study|Administrative|0|||
125454094|NCT01143077|451290052|FG002|Overall Study|Administrative|0|||
125454095|NCT01143077|451290050|FG000|Overall Study|Principal Investigator Decision|2|||
125454096|NCT01143077|451290051|FG001|Overall Study|Principal Investigator Decision|0|||
125454097|NCT01143077|451290052|FG002|Overall Study|Principal Investigator Decision|1|||
125454098|NCT00871429|451290057|FG000|Overall Study|Lost to Follow-up|6|||
125454099|NCT00871429|451290057|FG000|Overall Study|Withdrawal by Subject|17|||
125454100|NCT00871429|451290057|FG000|Overall Study|Questionnaire not completed|1|||
125454101|NCT05025449|451291432|FG000|Overall Study|Withdrawal by Subject|1|||
125454102|NCT05025449|451291432|FG000|Overall Study|Patient emergently taken to operating room|1|||
125454103|NCT00613301|451291433|FG000|Overall Study|Adverse Event|49|||
125454104|NCT00613301|451291433|FG000|Overall Study|Lost to Follow-up|88|||
125454105|NCT00613301|451291433|FG000|Overall Study|Withdrawal by Subject|5|||
125454106|NCT00613301|451291433|FG000|Overall Study|Death|6|||
125454107|NCT00613301|451291433|FG000|Overall Study|Lack of Efficacy|13|||
125454108|NCT00613301|451291433|FG000|Overall Study|Physician Decision|2|||
125454109|NCT00613301|451291433|FG000|Overall Study|No data was collected|53|||
125454110|NCT00613301|451291433|FG000|Overall Study|Irregularly enrolled patients|12|||
125454111|NCT00569946|451291434|FG000|Overall Study|Adverse Event|16|||
125454112|NCT00569946|451291434|FG000|Overall Study|Objective Progression or Relapse|42|||
125454113|NCT00569946|451291434|FG000|Overall Study|Global Deterioration of Health Status|1|||
125454114|NCT00470626|451291437|FG000|Overall Study|Lost to Follow-up|10|||
125454115|NCT00470626|451291437|FG000|Overall Study|Withdrawal by Subject|7|||
125454116|NCT03396835|451291443|FG000|Overall Study|Withdrawn prior to completion|1|||
125454117|NCT03396835|451291443|FG000|Overall Study|Did not meet criteria for data analysis|1|||
125454118|NCT03721016|451291450|FG000|Overall Study|Adverse Event|0|||
125454119|NCT03721016|451291451|FG001|Overall Study|Adverse Event|1|||
125454120|NCT03721016|451291452|FG002|Overall Study|Adverse Event|1|||
125454121|NCT03721016|451291450|FG000|Overall Study|Withdrawal by Subject|8|||
125454122|NCT03721016|451291451|FG001|Overall Study|Withdrawal by Subject|16|||
125454123|NCT03721016|451291452|FG002|Overall Study|Withdrawal by Subject|13|||
125454124|NCT03721016|451291450|FG000|Overall Study|Lost to Follow-up|4|||
125454125|NCT03721016|451291451|FG001|Overall Study|Lost to Follow-up|6|||
125454126|NCT03721016|451291452|FG002|Overall Study|Lost to Follow-up|5|||
125454127|NCT03721016|451291450|FG000|Overall Study|Physician Decision|0|||
125454128|NCT03721016|451291451|FG001|Overall Study|Physician Decision|1|||
125454129|NCT03721016|451291452|FG002|Overall Study|Physician Decision|2|||
125454130|NCT03721016|451291450|FG000|Overall Study|Protocol Violation|0|||
125454131|NCT03721016|451291451|FG001|Overall Study|Protocol Violation|1|||
125454132|NCT03721016|451291452|FG002|Overall Study|Protocol Violation|0|||
125454133|NCT03721016|451291450|FG000|Overall Study|Site terminated by sponsor|3|||
125454134|NCT03721016|451291451|FG001|Overall Study|Site terminated by sponsor|7|||
125454135|NCT03721016|451291452|FG002|Overall Study|Site terminated by sponsor|6|||
125454136|NCT03721016|451291450|FG000|Overall Study|Subject exited early due to COVID-19|1|||
125454137|NCT03721016|451291451|FG001|Overall Study|Subject exited early due to COVID-19|0|||
125454138|NCT03721016|451291452|FG002|Overall Study|Subject exited early due to COVID-19|0|||
125454139|NCT02232178|451291453|FG000|Overall Study|Lost to Follow-up|0|||
125454140|NCT02232178|451291454|FG001|Overall Study|Lost to Follow-up|1|||
125454141|NCT02232178|451291455|FG002|Overall Study|Lost to Follow-up|0|||
125454142|NCT02232178|451291453|FG000|Overall Study|ineligibility|0|||
125454143|NCT02232178|451291454|FG001|Overall Study|ineligibility|0|||
125454144|NCT02232178|451291455|FG002|Overall Study|ineligibility|1|||
125454145|NCT02232178|451291453|FG000|Overall Study|surgical complication|1|||
125454146|NCT02232178|451291454|FG001|Overall Study|surgical complication|0|||
125454147|NCT02232178|451291455|FG002|Overall Study|surgical complication|0|||
125454148|NCT00817635|451291456|FG000|Overall Study|Adverse Event|1|||
125454149|NCT00817635|451291457|FG001|Overall Study|Adverse Event|0|||
125454150|NCT00817635|451291458|FG002|Overall Study|Adverse Event|0|||
125454151|NCT00817635|451291459|FG003|Overall Study|Adverse Event|1|||
125454152|NCT00817635|451291460|FG004|Overall Study|Adverse Event|1|||
125454153|NCT00817635|451291456|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
125454154|NCT00817635|451291457|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
125454155|NCT00817635|451291458|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
125454156|NCT00817635|451291459|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
125454157|NCT00817635|451291460|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
125454158|NCT00817635|451291456|FG000|Overall Study|Withdrawal by Subject|2|||
125454159|NCT00817635|451291457|FG001|Overall Study|Withdrawal by Subject|1|||
125454160|NCT00817635|451291458|FG002|Overall Study|Withdrawal by Subject|0|||
125454161|NCT00817635|451291459|FG003|Overall Study|Withdrawal by Subject|1|||
125454162|NCT00817635|451291460|FG004|Overall Study|Withdrawal by Subject|2|||
125454163|NCT00817635|451291456|FG000|Overall Study|Lost to Follow-up|0|||
125454164|NCT00817635|451291457|FG001|Overall Study|Lost to Follow-up|1|||
125454165|NCT00817635|451291458|FG002|Overall Study|Lost to Follow-up|0|||
125454166|NCT00817635|451291459|FG003|Overall Study|Lost to Follow-up|1|||
125454167|NCT00817635|451291460|FG004|Overall Study|Lost to Follow-up|0|||
125454168|NCT00817635|451291456|FG000|Overall Study|Administrative Problems|0|||
125454169|NCT00817635|451291457|FG001|Overall Study|Administrative Problems|0|||
125454170|NCT00817635|451291458|FG002|Overall Study|Administrative Problems|0|||
125454171|NCT00817635|451291459|FG003|Overall Study|Administrative Problems|0|||
125454172|NCT00817635|451291460|FG004|Overall Study|Administrative Problems|1|||
125454173|NCT00817635|451291456|FG000|Overall Study|Protocol Violation|5|||
125454174|NCT00817635|451291457|FG001|Overall Study|Protocol Violation|1|||
125454175|NCT00817635|451291458|FG002|Overall Study|Protocol Violation|3|||
125454176|NCT00817635|451291459|FG003|Overall Study|Protocol Violation|2|||
125454177|NCT00817635|451291460|FG004|Overall Study|Protocol Violation|3|||
125454178|NCT01720446|451291461|FG000|Overall Study|Lost to Follow-up|12|||
125454179|NCT01720446|451291462|FG001|Overall Study|Lost to Follow-up|6|||
125454180|NCT01720446|451291463|FG002|Overall Study|Lost to Follow-up|16|||
125454181|NCT01720446|451291464|FG003|Overall Study|Lost to Follow-up|16|||
125454182|NCT01720446|451291461|FG000|Overall Study|Withdrawal by Subject|2|||
125454183|NCT01720446|451291462|FG001|Overall Study|Withdrawal by Subject|5|||
125454184|NCT01720446|451291463|FG002|Overall Study|Withdrawal by Subject|4|||
125454185|NCT01720446|451291464|FG003|Overall Study|Withdrawal by Subject|4|||
125454186|NCT02317705|451291467|FG000|Overall Study|Withdrawal by Subject|3|||
125454187|NCT02317705|451291467|FG000|Overall Study|Physician Decision|1|||
125454188|NCT02317705|451291467|FG000|Overall Study|Drug not usable|1|||
125454189|NCT01599325|451291468|FG000|Primary Parent Phase|Adverse Event|5|||
125454190|NCT01599325|451291468|FG000|Primary Parent Phase|Disease Progression|7|||
125454191|NCT01599325|451291468|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
125292207|NCT00996801|450696554|FG003|Overall Study|Protocol Violation|2|||
125292208|NCT00996801|450696555|FG004|Overall Study|Protocol Violation|3|||
125454192|NCT01599325|451291468|FG000|Primary Parent Phase|Death|13|||
125454193|NCT01599325|451291468|FG000|Primary Parent Phase|Protocol Violation|1|||
125454194|NCT01599325|451291468|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
125454195|NCT01599325|451291468|FG000|Primary Parent Phase|Other|2|||
125454196|NCT01599325|451291468|FG000|Extension Phase|Study Closure|1|||
125454197|NCT01599325|451291468|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
125454198|NCT01599325|451291468|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
125454199|NCT01599325|451291468|FG000|Extension Phase|Disease Progression|1|||
125454200|NCT01599325|451291468|FG000|Extension Phase|Withdrawal by Subject|8|||
125292209|NCT00996801|450696556|FG005|Overall Study|Protocol Violation|4|||
125292210|NCT00996801|450696551|FG000|Overall Study|Study Terminated by Sponsor|0|||
125292211|NCT00996801|450696552|FG001|Overall Study|Study Terminated by Sponsor|1|||
125292212|NCT00996801|450696553|FG002|Overall Study|Study Terminated by Sponsor|0|||
125292213|NCT00996801|450696554|FG003|Overall Study|Study Terminated by Sponsor|0|||
125292214|NCT00996801|450696555|FG004|Overall Study|Study Terminated by Sponsor|46|||
125292215|NCT00996801|450696556|FG005|Overall Study|Study Terminated by Sponsor|0|||
125292216|NCT00996801|450696551|FG000|Overall Study|Withdrawal by Subject|8|||
125292217|NCT00996801|450696552|FG001|Overall Study|Withdrawal by Subject|6|||
125292218|NCT00996801|450696553|FG002|Overall Study|Withdrawal by Subject|9|||
125292219|NCT00996801|450696554|FG003|Overall Study|Withdrawal by Subject|5|||
125292220|NCT00996801|450696555|FG004|Overall Study|Withdrawal by Subject|5|||
125292221|NCT00996801|450696556|FG005|Overall Study|Withdrawal by Subject|9|||
125292222|NCT02804750|450696557|FG000|Period 1|Adverse Event|0|||
125292223|NCT02804750|450696558|FG001|Period 1|Adverse Event|2|||
125292224|NCT02804750|450696557|FG000|Period 1|Withdrawal by Subject|0|||
125292225|NCT02804750|450696558|FG001|Period 1|Withdrawal by Subject|1|||
125292226|NCT02804750|450696557|FG000|Period 2|Adverse Event|1|||
125292227|NCT02804750|450696558|FG001|Period 2|Adverse Event|0|||
125292228|NCT02804750|450696557|FG000|Period 3|Adverse Event|0|||
125292229|NCT02804750|450696558|FG001|Period 3|Adverse Event|2|||
125292230|NCT02804750|450696557|FG000|Period 4|Adverse Event|0|||
125292231|NCT02804750|450696558|FG001|Period 4|Adverse Event|5|||
125292232|NCT02559414|450696559|FG000|Overall Study|Lost to Follow-up|0|||
125292233|NCT02559414|450696560|FG001|Overall Study|Lost to Follow-up|1|||
125292234|NCT02559414|450696561|FG002|Overall Study|Lost to Follow-up|0|||
125292235|NCT02559414|450696559|FG000|Overall Study|Withdrawal by Subject|1|||
125292236|NCT02559414|450696560|FG001|Overall Study|Withdrawal by Subject|0|||
125292237|NCT02559414|450696561|FG002|Overall Study|Withdrawal by Subject|1|||
125454201|NCT03256344|451291469|FG000|Overall Study|Death|6|||
125454202|NCT03256344|451291470|FG001|Overall Study|Death|22|||
125454203|NCT03256344|451291469|FG000|Overall Study|Withdrawal by Subject|3|||
125454204|NCT03256344|451291470|FG001|Overall Study|Withdrawal by Subject|3|||
125454205|NCT03256344|451291469|FG000|Overall Study|Sponsor Decision|1|||
125454206|NCT03256344|451291470|FG001|Overall Study|Sponsor Decision|0|||
125454207|NCT00544440|451291472|FG000|Overall Study|Other|1|||
125454208|NCT00544440|451291472|FG000|Overall Study|Adverse Event|1|||
125454209|NCT00544440|451291472|FG000|Overall Study|Withdrawal by Subject|2|||
125454210|NCT00544440|451291472|FG000|Overall Study|Subject Non-compliance|1|||
125454211|NCT00544440|451291472|FG000|Overall Study|Progressive Disease|47|||
125454212|NCT00544440|451291472|FG000|Overall Study|Other|5|||
125454213|NCT00591838|451291473|FG000|Overall Study|Withdrawal by Subject|0|||
125454214|NCT00591838|451291474|FG001|Overall Study|Withdrawal by Subject|0|||
125454215|NCT00591838|451291475|FG002|Overall Study|Withdrawal by Subject|0|||
125454216|NCT00591838|451291476|FG003|Overall Study|Withdrawal by Subject|1|||
125454217|NCT00591838|451291477|FG004|Overall Study|Withdrawal by Subject|0|||
125454218|NCT03586167|451291478|FG000|Overall Study|Other|1|||
125454219|NCT03586167|451291479|FG001|Overall Study|Other|0|||
125454220|NCT02512042|451291480|FG000|Overall Study|Adverse Event|0|||
125454221|NCT02512042|451291481|FG001|Overall Study|Adverse Event|4|||
125454222|NCT02512042|451291480|FG000|Overall Study|Withdrawal by Subject|6|||
125454223|NCT02512042|451291481|FG001|Overall Study|Withdrawal by Subject|6|||
125454224|NCT02512042|451291480|FG000|Overall Study|Non-compliance with study drug|1|||
125454225|NCT02512042|451291481|FG001|Overall Study|Non-compliance with study drug|2|||
125454226|NCT02512042|451291480|FG000|Overall Study|Lost to Follow-up|5|||
125454227|NCT02512042|451291481|FG001|Overall Study|Lost to Follow-up|2|||
125454228|NCT02512042|451291480|FG000|Overall Study|Other|11|||
125454229|NCT02512042|451291481|FG001|Overall Study|Other|11|||
125454230|NCT04163458|451291484|FG000|Overall Study|Protocol Deviation|7|||
125454231|NCT04163458|451291485|FG001|Overall Study|Protocol Deviation|13|||
125292238|NCT02559414|450696559|FG000|Overall Study|Other|0|||
125292239|NCT02559414|450696560|FG001|Overall Study|Other|1|||
125292240|NCT02559414|450696561|FG002|Overall Study|Other|1|||
125292241|NCT03369431|450696562|FG000|Overall Study|Lost to Follow-up|1|||
125292242|NCT03369431|450696563|FG001|Overall Study|Lost to Follow-up|3|||
125292243|NCT03369431|450696562|FG000|Overall Study|Withdrawal by Subject|2|||
125292244|NCT03369431|450696563|FG001|Overall Study|Withdrawal by Subject|3|||
125292245|NCT03369431|450696562|FG000|Overall Study|Protocol Violation|1|||
125292246|NCT03369431|450696563|FG001|Overall Study|Protocol Violation|1|||
125292247|NCT00046930|450696568|FG000|Overall Study|Ineligible|12|||
125292248|NCT00046930|450696569|FG001|Overall Study|Ineligible|4|||
125292249|NCT01113580|450696570|FG000|Overall Study|Protocol Violation|1|||
125292250|NCT01113580|450696571|FG001|Overall Study|Protocol Violation|0|||
125454232|NCT04163458|451291484|FG000|Overall Study|Adverse Event|5|||
125454233|NCT04163458|451291485|FG001|Overall Study|Adverse Event|8|||
125454234|NCT04163458|451291484|FG000|Overall Study|Due to COVID-19 pandemic|4|||
125454235|NCT04163458|451291485|FG001|Overall Study|Due to COVID-19 pandemic|2|||
125454236|NCT04163458|451291484|FG000|Overall Study|Participant withdrew consent|2|||
125454237|NCT04163458|451291485|FG001|Overall Study|Participant withdrew consent|3|||
125454238|NCT04163458|451291484|FG000|Overall Study|Randomization failure|2|||
125454239|NCT04163458|451291485|FG001|Overall Study|Randomization failure|2|||
125454240|NCT04163458|451291484|FG000|Overall Study|Other|4|||
125454241|NCT04163458|451291485|FG001|Overall Study|Other|2|||
125454242|NCT01467700|451291488|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
125454243|NCT01467700|451291489|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
125454244|NCT01467700|451291490|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
125454245|NCT01467700|451291491|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
125454246|NCT01467700|451291488|FG000|Overall Study|Major Protocol Deviation|3|||
125454247|NCT01467700|451291489|FG001|Overall Study|Major Protocol Deviation|3|||
125454248|NCT01467700|451291490|FG002|Overall Study|Major Protocol Deviation|2|||
125454249|NCT01467700|451291491|FG003|Overall Study|Major Protocol Deviation|3|||
125454250|NCT01467700|451291488|FG000|Overall Study|Lost to Follow-up|6|||
125454251|NCT01467700|451291489|FG001|Overall Study|Lost to Follow-up|5|||
125454252|NCT01467700|451291490|FG002|Overall Study|Lost to Follow-up|2|||
125454253|NCT01467700|451291491|FG003|Overall Study|Lost to Follow-up|3|||
125454254|NCT01467700|451291488|FG000|Overall Study|Voluntary Withdrawal|5|||
125454255|NCT01467700|451291489|FG001|Overall Study|Voluntary Withdrawal|7|||
125454256|NCT01467700|451291490|FG002|Overall Study|Voluntary Withdrawal|6|||
125454257|NCT01467700|451291491|FG003|Overall Study|Voluntary Withdrawal|2|||
125454258|NCT01467700|451291488|FG000|Overall Study|Study Termination|6|||
125454259|NCT01467700|451291489|FG001|Overall Study|Study Termination|5|||
125454260|NCT01467700|451291490|FG002|Overall Study|Study Termination|10|||
125454261|NCT01467700|451291491|FG003|Overall Study|Study Termination|7|||
125454262|NCT01467700|451291488|FG000|Overall Study|Pregnancy|0|||
125454263|NCT01467700|451291489|FG001|Overall Study|Pregnancy|1|||
125454264|NCT01467700|451291490|FG002|Overall Study|Pregnancy|1|||
125454265|NCT01467700|451291491|FG003|Overall Study|Pregnancy|0|||
125454266|NCT01467700|451291488|FG000|Overall Study|Lack of Efficacy|2|||
125454267|NCT01467700|451291489|FG001|Overall Study|Lack of Efficacy|0|||
125454268|NCT01467700|451291490|FG002|Overall Study|Lack of Efficacy|2|||
125454269|NCT01467700|451291491|FG003|Overall Study|Lack of Efficacy|1|||
125454270|NCT01467700|451291488|FG000|Overall Study|Reason not Specified|1|||
125454271|NCT01467700|451291489|FG001|Overall Study|Reason not Specified|3|||
125454272|NCT01467700|451291490|FG002|Overall Study|Reason not Specified|2|||
125454273|NCT01467700|451291491|FG003|Overall Study|Reason not Specified|8|||
125454274|NCT01253226|451291492|FG000|Overall Study|Adverse Event|0|||
125454275|NCT01253226|451291493|FG001|Overall Study|Adverse Event|0|||
125454276|NCT01253226|451291494|FG002|Overall Study|Adverse Event|1|||
125454277|NCT01253226|451291495|FG003|Overall Study|Adverse Event|0|||
125454278|NCT01253226|451291496|FG004|Overall Study|Adverse Event|0|||
125454279|NCT01253226|451291492|FG000|Overall Study|Death|0|||
125454280|NCT01253226|451291493|FG001|Overall Study|Death|1|||
125454281|NCT01253226|451291494|FG002|Overall Study|Death|0|||
125454282|NCT01253226|451291495|FG003|Overall Study|Death|0|||
125454283|NCT01253226|451291496|FG004|Overall Study|Death|0|||
125454284|NCT01253226|451291492|FG000|Overall Study|Physician Decision|0|||
125454285|NCT01253226|451291493|FG001|Overall Study|Physician Decision|0|||
125454286|NCT01253226|451291494|FG002|Overall Study|Physician Decision|0|||
125454287|NCT01253226|451291495|FG003|Overall Study|Physician Decision|0|||
125454288|NCT01253226|451291496|FG004|Overall Study|Physician Decision|2|||
125454289|NCT01253226|451291492|FG000|Overall Study|Withdrawal by Subject|0|||
125454290|NCT01253226|451291493|FG001|Overall Study|Withdrawal by Subject|0|||
125454291|NCT01253226|451291494|FG002|Overall Study|Withdrawal by Subject|0|||
125454292|NCT01253226|451291495|FG003|Overall Study|Withdrawal by Subject|1|||
125454293|NCT01253226|451291496|FG004|Overall Study|Withdrawal by Subject|0|||
125454294|NCT00988637|451291498|FG000|Overall Study|Lost to Follow-up|2|||
125454295|NCT00988637|451291499|FG001|Overall Study|Lost to Follow-up|1|||
125454296|NCT00988637|451291498|FG000|Overall Study|Withdrawal by Subject|1|||
125454297|NCT00988637|451291499|FG001|Overall Study|Withdrawal by Subject|1|||
125454298|NCT00988637|451291498|FG000|Overall Study|non-compliance with study drug|0|||
125454299|NCT00988637|451291499|FG001|Overall Study|non-compliance with study drug|1|||
125454300|NCT03593070|451291500|FG000|Overall Study|administrative withdrawal|1|||
125454301|NCT03593070|451291501|FG001|Overall Study|administrative withdrawal|1|||
125454302|NCT01582945|451291502|FG000|Overall Study|Intolerable side-effects|1|||
125454303|NCT01582945|451291502|FG000|Overall Study|Scheduling conflicts|1|||
125454304|NCT03310983|451291503|FG000|Overall Study|Lost to Follow-up|15|||
125454305|NCT03310983|451291504|FG001|Overall Study|Lost to Follow-up|17|||
125454306|NCT04523181|451291509|FG000|Overall Study|Withdrawal by Subject|4|||
125454307|NCT04523181|451291510|FG001|Overall Study|Withdrawal by Subject|5|||
125454308|NCT04523181|451291509|FG000|Overall Study|Lost to Follow-up|2|||
125454309|NCT04523181|451291510|FG001|Overall Study|Lost to Follow-up|3|||
125454310|NCT04523181|451291509|FG000|Overall Study|Physician Decision|1|||
125454311|NCT04523181|451291510|FG001|Overall Study|Physician Decision|0|||
125454312|NCT04523181|451291509|FG000|Overall Study|Transferred to external facility.|1|||
125454313|NCT04523181|451291510|FG001|Overall Study|Transferred to external facility.|1|||
125454314|NCT01656304|451291511|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
125454315|NCT04391309|451291512|FG000|Overall Study|Death|1|||
125454316|NCT04391309|451291513|FG001|Overall Study|Death|1|||
125454317|NCT04391309|451291512|FG000|Overall Study|Lost to Follow-up|3|||
125454318|NCT04391309|451291513|FG001|Overall Study|Lost to Follow-up|2|||
125454319|NCT04391309|451291512|FG000|Overall Study|Withdrawal by Subject|2|||
125454320|NCT04391309|451291513|FG001|Overall Study|Withdrawal by Subject|2|||
125454321|NCT01155869|451291519|FG000|Overall Study|Lost to Follow-up|3|||
125454322|NCT01155869|451291520|FG001|Overall Study|Lost to Follow-up|1|||
125454323|NCT00881335|451291524|FG000|Overall Study|Lost to Follow-up|3|||
125454324|NCT00881335|451291525|FG001|Overall Study|Lost to Follow-up|2|||
125454325|NCT00462943|451291526|FG000|Overall Study|Failure to achieve a response|5|||
125454326|NCT00462943|451291527|FG001|Overall Study|Failure to achieve a response|5|||
125454327|NCT00462943|451291528|FG002|Overall Study|Failure to achieve a response|1|||
125454328|NCT00462943|451291526|FG000|Overall Study|Adverse Event|6|||
125454329|NCT00462943|451291527|FG001|Overall Study|Adverse Event|4|||
125454330|NCT00462943|451291528|FG002|Overall Study|Adverse Event|1|||
125454331|NCT00462943|451291526|FG000|Overall Study|Protocol Violation|1|||
125454332|NCT00462943|451291527|FG001|Overall Study|Protocol Violation|0|||
125454333|NCT00462943|451291528|FG002|Overall Study|Protocol Violation|0|||
125454334|NCT00462943|451291526|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
125454335|NCT00462943|451291527|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
125454336|NCT00462943|451291528|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
125454337|NCT00462943|451291526|FG000|Overall Study|Disease Progression|15|||
125454338|NCT00462943|451291527|FG001|Overall Study|Disease Progression|15|||
125454339|NCT00462943|451291528|FG002|Overall Study|Disease Progression|9|||
125454340|NCT00462943|451291526|FG000|Overall Study|Death|5|||
125454341|NCT00462943|451291527|FG001|Overall Study|Death|2|||
125454342|NCT00462943|451291528|FG002|Overall Study|Death|7|||
125454343|NCT00462943|451291526|FG000|Overall Study|Stem Cell Transplant|1|||
125454344|NCT00462943|451291527|FG001|Overall Study|Stem Cell Transplant|1|||
125454345|NCT00462943|451291528|FG002|Overall Study|Stem Cell Transplant|0|||
125454346|NCT00462943|451291526|FG000|Overall Study|Bone Marrow Transplant|1|||
125454347|NCT00462943|451291527|FG001|Overall Study|Bone Marrow Transplant|0|||
125454348|NCT00462943|451291528|FG002|Overall Study|Bone Marrow Transplant|0|||
125454349|NCT00462943|451291526|FG000|Overall Study|Required Lymphocyte Infusion|1|||
125454350|NCT00462943|451291527|FG001|Overall Study|Required Lymphocyte Infusion|0|||
125454351|NCT00462943|451291528|FG002|Overall Study|Required Lymphocyte Infusion|0|||
125454352|NCT00462943|451291526|FG000|Overall Study|Transplant - not specified|1|||
125454353|NCT00462943|451291527|FG001|Overall Study|Transplant - not specified|0|||
125454354|NCT00462943|451291528|FG002|Overall Study|Transplant - not specified|1|||
125454355|NCT00462943|451291526|FG000|Overall Study|Physician Decision|1|||
125454356|NCT00462943|451291527|FG001|Overall Study|Physician Decision|0|||
125454357|NCT00462943|451291528|FG002|Overall Study|Physician Decision|0|||
125454358|NCT00462943|451291526|FG000|Overall Study|Withdrawal by Subject|0|||
125454359|NCT00462943|451291527|FG001|Overall Study|Withdrawal by Subject|1|||
125454360|NCT00462943|451291528|FG002|Overall Study|Withdrawal by Subject|0|||
125454361|NCT00477412|451291535|FG000|Overall Study|Death|0|||
125454362|NCT00477412|451291536|FG001|Overall Study|Death|0|||
125454363|NCT00477412|451291537|FG002|Overall Study|Death|0|||
125454364|NCT00477412|451291538|FG003|Overall Study|Death|4|||
125454365|NCT00477412|451291535|FG000|Overall Study|Lost to Follow-up|0|||
125454366|NCT00477412|451291536|FG001|Overall Study|Lost to Follow-up|0|||
125454367|NCT00477412|451291537|FG002|Overall Study|Lost to Follow-up|0|||
125454368|NCT00477412|451291538|FG003|Overall Study|Lost to Follow-up|1|||
125454369|NCT00477412|451291535|FG000|Overall Study|Withdrawal by Subject|0|||
125454370|NCT00477412|451291536|FG001|Overall Study|Withdrawal by Subject|0|||
125454371|NCT00477412|451291537|FG002|Overall Study|Withdrawal by Subject|0|||
125454372|NCT00477412|451291538|FG003|Overall Study|Withdrawal by Subject|2|||
125454373|NCT00477412|451291535|FG000|Overall Study|Second Malignancy|0|||
125454374|NCT00477412|451291536|FG001|Overall Study|Second Malignancy|0|||
125454375|NCT00477412|451291537|FG002|Overall Study|Second Malignancy|0|||
125454376|NCT00477412|451291538|FG003|Overall Study|Second Malignancy|1|||
125454377|NCT00477412|451291535|FG000|Overall Study|Adverse Event|1|||
125454378|NCT00477412|451291536|FG001|Overall Study|Adverse Event|0|||
125454379|NCT00477412|451291537|FG002|Overall Study|Adverse Event|1|||
125454380|NCT00477412|451291538|FG003|Overall Study|Adverse Event|0|||
125454381|NCT01838200|451291539|FG000|Overall Study|Adverse Event|0|||
125454382|NCT01838200|451291540|FG001|Overall Study|Adverse Event|2|||
125454383|NCT01838200|451291539|FG000|Overall Study|Progressive disease|3|||
125454384|NCT01838200|451291540|FG001|Overall Study|Progressive disease|0|||
125454385|NCT05526911|451292994|FG000|Overall Study|Adverse Event|2|||
125454386|NCT00762463|451292996|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
125454387|NCT00762463|451292997|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
125454388|NCT00762463|451292998|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
125454389|NCT00762463|451292999|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
125454390|NCT00762463|451292996|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
125485348|NCT02240238|451412510|FG007|Phase 1|Adverse Event|1|||
125454391|NCT00762463|451292997|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
125454392|NCT00762463|451292998|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
125454393|NCT00762463|451292999|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
125454394|NCT00762463|451292996|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
125454395|NCT00762463|451292997|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
125454396|NCT00762463|451292998|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
125454397|NCT00762463|451292999|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
125454398|NCT00762463|451292996|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
125454399|NCT00762463|451292997|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
125454400|NCT00762463|451292998|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
125454401|NCT00762463|451292999|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
125454402|NCT00762463|451292996|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
125454403|NCT00762463|451292997|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
125454404|NCT00762463|451292998|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
125454405|NCT00762463|451292999|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
125454406|NCT00762463|451292996|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
125454407|NCT00762463|451292997|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
125454408|NCT00762463|451292998|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
125454409|NCT00762463|451292999|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
125454410|NCT00762463|451292996|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
125454411|NCT00762463|451292997|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
125454412|NCT00762463|451292998|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
125454413|NCT00762463|451292999|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
125454414|NCT00762463|451292996|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
125454415|NCT00762463|451292997|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
125454416|NCT00762463|451292998|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
125454417|NCT00762463|451292999|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
125454418|NCT01306331|451293000|FG000|Overall Study|Adverse Event|28|||
125454419|NCT01306331|451293001|FG001|Overall Study|Adverse Event|25|||
125454420|NCT01306331|451293000|FG000|Overall Study|Lost to Follow-up|321|||
125454421|NCT01306331|451293001|FG001|Overall Study|Lost to Follow-up|323|||
125454422|NCT01306331|451293000|FG000|Overall Study|Physician Decision|26|||
125454423|NCT01306331|451293001|FG001|Overall Study|Physician Decision|22|||
125454424|NCT01306331|451293000|FG000|Overall Study|Pregnancy|136|||
125454425|NCT01306331|451293001|FG001|Overall Study|Pregnancy|151|||
125454426|NCT01306331|451293000|FG000|Overall Study|Protocol Violation|154|||
125454427|NCT01306331|451293001|FG001|Overall Study|Protocol Violation|124|||
125454428|NCT01306331|451293000|FG000|Overall Study|Withdrawal by Subject|163|||
125454429|NCT01306331|451293001|FG001|Overall Study|Withdrawal by Subject|152|||
125454430|NCT01306331|451293000|FG000|Overall Study|Not sexually active|29|||
125454431|NCT01306331|451293001|FG001|Overall Study|Not sexually active|28|||
125454432|NCT01306331|451293000|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
125454433|NCT01306331|451293001|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
125454434|NCT01306331|451293000|FG000|Overall Study|Other|34|||
125454435|NCT01306331|451293001|FG001|Overall Study|Other|32|||
125454436|NCT04048135|451293004|FG000|Overall Study|Withdrawal by Subject|1|||
125454437|NCT04048135|451293005|FG001|Overall Study|Withdrawal by Subject|1|||
125454438|NCT04048135|451293006|FG002|Overall Study|Withdrawal by Subject|1|||
125454439|NCT04048135|451293007|FG003|Overall Study|Withdrawal by Subject|2|||
125454440|NCT04048135|451293008|FG004|Overall Study|Withdrawal by Subject|0|||
125454441|NCT04048135|451293009|FG005|Overall Study|Withdrawal by Subject|0|||
125454442|NCT04048135|451293010|FG006|Overall Study|Withdrawal by Subject|1|||
125454443|NCT04048135|451293011|FG007|Overall Study|Withdrawal by Subject|1|||
125454444|NCT04048135|451293004|FG000|Overall Study|Adverse Event|0|||
125454445|NCT04048135|451293005|FG001|Overall Study|Adverse Event|0|||
125454446|NCT04048135|451293006|FG002|Overall Study|Adverse Event|0|||
125454447|NCT04048135|451293007|FG003|Overall Study|Adverse Event|1|||
125454448|NCT04048135|451293008|FG004|Overall Study|Adverse Event|1|||
125454449|NCT04048135|451293009|FG005|Overall Study|Adverse Event|0|||
125454450|NCT04048135|451293010|FG006|Overall Study|Adverse Event|0|||
125454451|NCT04048135|451293011|FG007|Overall Study|Adverse Event|0|||
125454452|NCT04048135|451293004|FG000|Overall Study|Protocol Violation|0|||
125454453|NCT04048135|451293005|FG001|Overall Study|Protocol Violation|0|||
125454454|NCT04048135|451293006|FG002|Overall Study|Protocol Violation|0|||
125454455|NCT04048135|451293007|FG003|Overall Study|Protocol Violation|0|||
125454456|NCT04048135|451293008|FG004|Overall Study|Protocol Violation|0|||
125454457|NCT04048135|451293009|FG005|Overall Study|Protocol Violation|1|||
125454458|NCT04048135|451293010|FG006|Overall Study|Protocol Violation|0|||
125454459|NCT04048135|451293011|FG007|Overall Study|Protocol Violation|0|||
125454460|NCT00172185|451293012|FG000|Overall Study|Adverse Event|0|||
125454461|NCT00172185|451293013|FG001|Overall Study|Adverse Event|1|||
125454462|NCT00172185|451293014|FG002|Overall Study|Adverse Event|3|||
125454463|NCT00172185|451293015|FG003|Overall Study|Adverse Event|4|||
125419784|NCT01302119|451160360|FG001|Overall Study|Adverse Event|1|||
125419785|NCT01302119|451160359|FG000|Overall Study|Non-compliance|4|||
125419786|NCT01302119|451160360|FG001|Overall Study|Non-compliance|2|||
125419787|NCT01302119|451160359|FG000|Overall Study|Non-specific|4|||
125419788|NCT01302119|451160360|FG001|Overall Study|Non-specific|1|||
125419789|NCT03336619|451160362|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
125419790|NCT03336619|451160363|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
125419791|NCT03336619|451160362|FG000|Overall Study|Withdrawal by Subject|17|||
125419792|NCT03336619|451160363|FG001|Overall Study|Withdrawal by Subject|16|||
125419793|NCT03336619|451160362|FG000|Overall Study|Adverse Event|2|||
125419794|NCT03336619|451160363|FG001|Overall Study|Adverse Event|5|||
125419795|NCT03336619|451160362|FG000|Overall Study|Physician Decision|3|||
125419796|NCT03336619|451160363|FG001|Overall Study|Physician Decision|0|||
125419797|NCT00744653|451160368|FG000|Overall Study|antineoplastic treatment|11|||
125419798|NCT00744653|451160368|FG000|Overall Study|Death|1|||
125419799|NCT00744653|451160368|FG000|Overall Study|Lost to Follow-up|1|||
125419800|NCT00744653|451160368|FG000|Overall Study|Physician Decision|3|||
125419801|NCT03826667|451160371|FG000|Overall Study|Protocol deviation|21|||
125419802|NCT04439110|451160373|FG000|Overall Study|Ineligible|2|||
125419803|NCT04439110|451160373|FG000|Overall Study|Adverse Event|4|||
125419804|NCT04439110|451160373|FG000|Overall Study|Death|2|||
125419805|NCT04439110|451160373|FG000|Overall Study|Disease proression|25|||
125419806|NCT04439110|451160373|FG000|Overall Study|Withdrawal by Subject|1|||
125419807|NCT04439110|451160373|FG000|Overall Study|Alternative therapy|1|||
125419808|NCT04439110|451160373|FG000|Overall Study|Other complicating disease|1|||
125419809|NCT04439110|451160373|FG000|Overall Study|Personal reasons|1|||
125419810|NCT04439110|451160373|FG000|Overall Study|Still on treatment|1|||
125419811|NCT00127608|451160376|FG000|Overall Study|VZV DNA negative|1|||
125419812|NCT05245864|451160377|FG000|Overall Study|Withdrawal by Subject|1|||
125419813|NCT05245864|451160378|FG001|Overall Study|Withdrawal by Subject|1|||
125419814|NCT00506493|451160386|FG000|Overall Study|Death|6|||
125419815|NCT00506493|451160386|FG000|Overall Study|Withdrawal by Subject|5|||
125419816|NCT03912259|451162143|FG000|Overall Study|Adverse Event (AE)|2|||
125419817|NCT03912259|451162144|FG001|Overall Study|Adverse Event (AE)|4|||
125419818|NCT03912259|451162143|FG000|Overall Study|Lack of Efficacy|4|||
125419819|NCT03912259|451162144|FG001|Overall Study|Lack of Efficacy|1|||
125419820|NCT03912259|451162143|FG000|Overall Study|Withdrawal by Subject|11|||
125419821|NCT03912259|451162144|FG001|Overall Study|Withdrawal by Subject|1|||
125419822|NCT01549613|451162145|FG000|Overall Study|Lost to Follow-up|11|||
125419823|NCT01549613|451162146|FG001|Overall Study|Lost to Follow-up|11|||
125419824|NCT02216123|451162147|FG000|Overall Study|Lost to Follow-up|4|||
125419825|NCT02216123|451162148|FG001|Overall Study|Lost to Follow-up|2|||
125419826|NCT02216123|451162147|FG000|Overall Study|Withdrawal by Subject|2|||
125419827|NCT02216123|451162148|FG001|Overall Study|Withdrawal by Subject|0|||
125419828|NCT03162224|451162151|FG000|Overall Study|Death|4|||
125419829|NCT03162224|451162152|FG001|Overall Study|Death|5|||
125419830|NCT03162224|451162153|FG002|Overall Study|Death|8|||
125419831|NCT03162224|451162151|FG000|Overall Study|Withdrawal by Subject|1|||
125419832|NCT03162224|451162152|FG001|Overall Study|Withdrawal by Subject|0|||
125419833|NCT03162224|451162153|FG002|Overall Study|Withdrawal by Subject|1|||
125419834|NCT03162224|451162151|FG000|Overall Study|Lost to Follow-up|0|||
125419835|NCT03162224|451162152|FG001|Overall Study|Lost to Follow-up|1|||
125419836|NCT03162224|451162153|FG002|Overall Study|Lost to Follow-up|0|||
125419837|NCT03162224|451162151|FG000|Overall Study|Other|6|||
125419838|NCT03162224|451162152|FG001|Overall Study|Other|2|||
125419839|NCT03162224|451162153|FG002|Overall Study|Other|1|||
125419840|NCT04066114|451162154|FG000|Overall Study|Adverse Event|1|||
125419841|NCT04066114|451162155|FG001|Overall Study|Adverse Event|0|||
125419842|NCT04066114|451162156|FG002|Overall Study|Adverse Event|0|||
125419843|NCT04066114|451162154|FG000|Overall Study|Withdrawal by Subject|1|||
125419844|NCT04066114|451162155|FG001|Overall Study|Withdrawal by Subject|0|||
125419845|NCT04066114|451162156|FG002|Overall Study|Withdrawal by Subject|0|||
125419846|NCT04066114|451162154|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
125419847|NCT04066114|451162155|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
125419848|NCT04066114|451162156|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
125419849|NCT00254982|451162157|FG000|Overall Study|Other|2|||
125419850|NCT00254982|451162158|FG001|Overall Study|Other|1|||
125419851|NCT00254982|451162157|FG000|Overall Study|Lack of Efficacy|5|||
125419852|NCT00254982|451162158|FG001|Overall Study|Lack of Efficacy|3|||
125419853|NCT00254982|451162157|FG000|Overall Study|Lost to Follow-up|5|||
125419854|NCT00254982|451162158|FG001|Overall Study|Lost to Follow-up|3|||
125419855|NCT00254982|451162157|FG000|Overall Study|Adverse Event|18|||
125419856|NCT00254982|451162158|FG001|Overall Study|Adverse Event|16|||
125419857|NCT00254982|451162157|FG000|Overall Study|Withdrawal by Subject|1|||
125419858|NCT00254982|451162158|FG001|Overall Study|Withdrawal by Subject|1|||
125454464|NCT00172185|451293012|FG000|Overall Study|Physician Decision|0|||
125454465|NCT00172185|451293013|FG001|Overall Study|Physician Decision|0|||
125454466|NCT00172185|451293014|FG002|Overall Study|Physician Decision|1|||
125454467|NCT00172185|451293015|FG003|Overall Study|Physician Decision|0|||
125454468|NCT00172185|451293012|FG000|Overall Study|SPONSOR Decision|0|||
125454469|NCT00172185|451293013|FG001|Overall Study|SPONSOR Decision|1|||
125454470|NCT00172185|451293014|FG002|Overall Study|SPONSOR Decision|0|||
125454471|NCT00172185|451293015|FG003|Overall Study|SPONSOR Decision|0|||
125454472|NCT00172185|451293012|FG000|Overall Study|Withdrawal by Subject|0|||
125454473|NCT00172185|451293013|FG001|Overall Study|Withdrawal by Subject|0|||
125454474|NCT00172185|451293014|FG002|Overall Study|Withdrawal by Subject|1|||
125454475|NCT00172185|451293015|FG003|Overall Study|Withdrawal by Subject|0|||
125454476|NCT01677936|451293016|FG000|Overall Study|Lost to Follow-up|4|||
125454477|NCT01677936|451293017|FG001|Overall Study|Lost to Follow-up|1|||
125454478|NCT01677936|451293016|FG000|Overall Study|Protocol Violation|3|||
125454479|NCT01677936|451293017|FG001|Overall Study|Protocol Violation|0|||
125454480|NCT01677936|451293016|FG000|Overall Study|Adverse Event|1|||
125454481|NCT01677936|451293017|FG001|Overall Study|Adverse Event|0|||
125454482|NCT01677936|451293016|FG000|Overall Study|Lost to Follow-up|1|||
125454483|NCT01677936|451293017|FG001|Overall Study|Lost to Follow-up|0|||
125454484|NCT01677936|451293016|FG000|Overall Study|Protocol Violation|0|||
125454485|NCT01677936|451293017|FG001|Overall Study|Protocol Violation|4|||
125454486|NCT04358549|451293018|FG000|Overall Study|Adverse Event|0|||
125454487|NCT04358549|451293019|FG001|Overall Study|Adverse Event|1|||
125454488|NCT04358549|451293018|FG000|Overall Study|Death|1|||
125454489|NCT04358549|451293019|FG001|Overall Study|Death|0|||
125454490|NCT04358549|451293018|FG000|Overall Study|Lost to Follow-up|2|||
125454491|NCT04358549|451293019|FG001|Overall Study|Lost to Follow-up|1|||
125454492|NCT04358549|451293018|FG000|Overall Study|Withdrawal by Subject|6|||
125454493|NCT04358549|451293019|FG001|Overall Study|Withdrawal by Subject|6|||
125454494|NCT04358549|451293018|FG000|Overall Study|Start remdesivir|1|||
125454495|NCT04358549|451293019|FG001|Overall Study|Start remdesivir|0|||
125454496|NCT04867902|451293020|FG000|Overall Study|Lost to Follow-up|1|||
125454497|NCT04867902|451293020|FG000|Overall Study|Withdrawal by Subject|2|||
125454498|NCT04867902|451293020|FG000|Overall Study|Protocol Violation|1|||
125454499|NCT05355116|451293021|FG000|Overall Study|Withdrawal by Subject|2|||
125454500|NCT02380742|451293026|FG000|Overall Study|Withdrawal by Subject|1|||
125454501|NCT02380742|451293027|FG001|Overall Study|Withdrawal by Subject|0|||
125454502|NCT00151996|451293028|FG000|Overall Study|Adverse Event|3|||
125454503|NCT00151996|451293029|FG001|Overall Study|Adverse Event|2|||
125454504|NCT00151996|451293028|FG000|Overall Study|Withdrawal by Subject|1|||
125454505|NCT00151996|451293029|FG001|Overall Study|Withdrawal by Subject|1|||
125454506|NCT00151996|451293028|FG000|Overall Study|Protocol Violation|1|||
125454507|NCT00151996|451293029|FG001|Overall Study|Protocol Violation|2|||
125454508|NCT00151996|451293028|FG000|Overall Study|Sponsor's decision|0|||
125454509|NCT00151996|451293029|FG001|Overall Study|Sponsor's decision|2|||
125454510|NCT01801930|451293032|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
125454511|NCT01801930|451293033|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
125454512|NCT01801930|451293034|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
125454513|NCT01801930|451293035|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
125454514|NCT01801930|451293032|FG000|Overall Study|DLT occurs|0|||
125454515|NCT01801930|451293033|FG001|Overall Study|DLT occurs|1|||
125454516|NCT01801930|451293034|FG002|Overall Study|DLT occurs|0|||
125454517|NCT01801930|451293035|FG003|Overall Study|DLT occurs|0|||
125454518|NCT03439124|451293036|FG000|Overall Study|Adverse Event|2|||
125454519|NCT03439124|451293037|FG001|Overall Study|Adverse Event|0|||
125454520|NCT03439124|451293036|FG000|Overall Study|Lost to Follow-up|1|||
125454521|NCT03439124|451293037|FG001|Overall Study|Lost to Follow-up|0|||
125454522|NCT03439124|451293036|FG000|Overall Study|Other reasons|1|||
125454523|NCT03439124|451293037|FG001|Overall Study|Other reasons|0|||
125454524|NCT02236559|451293038|FG000|Overall Study|Met Exclusion|3|||
125454525|NCT02236559|451293039|FG001|Overall Study|Met Exclusion|6|||
125454526|NCT02236559|451293038|FG000|Overall Study|Did not Meet Inclusion|3|||
125454527|NCT02236559|451293039|FG001|Overall Study|Did not Meet Inclusion|3|||
125454528|NCT02236559|451293038|FG000|Overall Study|Subject Did Not Consent|4|||
125454529|NCT02236559|451293039|FG001|Overall Study|Subject Did Not Consent|2|||
125454530|NCT02236559|451293038|FG000|Overall Study|Physician Decision|1|||
125454531|NCT02236559|451293039|FG001|Overall Study|Physician Decision|1|||
125454532|NCT02236559|451293038|FG000|Overall Study|Withdrawal by Subject|1|||
125454533|NCT02236559|451293039|FG001|Overall Study|Withdrawal by Subject|0|||
125454534|NCT01117480|451293040|FG000|Overall Study|Protocol Violation|8|||
125454535|NCT01117480|451293040|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
125454536|NCT00943605|451293041|FG000|Overall Study|Study termination|30|||
125454537|NCT00943605|451293042|FG001|Overall Study|Study termination|30|||
125454538|NCT01072357|451293047|FG000|Overall Study|Lost to Follow-up|0|||
125454539|NCT01072357|451293048|FG001|Overall Study|Lost to Follow-up|1|||
125454540|NCT01876511|451293049|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
125454541|NCT01876511|451293050|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
125454542|NCT01876511|451293051|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
125454543|NCT01876511|451293049|FG000|Overall Study|Death (unrelated)|3|||
125454544|NCT01876511|451293050|FG001|Overall Study|Death (unrelated)|0|||
125454545|NCT01876511|451293051|FG002|Overall Study|Death (unrelated)|2|||
125454546|NCT01876511|451293049|FG000|Overall Study|Drug-related Toxicity|5|||
125454547|NCT01876511|451293050|FG001|Overall Study|Drug-related Toxicity|1|||
125454548|NCT01876511|451293051|FG002|Overall Study|Drug-related Toxicity|6|||
125454549|NCT01876511|451293049|FG000|Overall Study|Patient Decision|3|||
125454550|NCT01876511|451293050|FG001|Overall Study|Patient Decision|0|||
125454551|NCT01876511|451293051|FG002|Overall Study|Patient Decision|6|||
125454552|NCT01876511|451293049|FG000|Overall Study|Physician Decision|1|||
125454553|NCT01876511|451293050|FG001|Overall Study|Physician Decision|0|||
125454554|NCT01876511|451293051|FG002|Overall Study|Physician Decision|1|||
125454555|NCT00891618|451293052|FG000|Overall Study|Withdrawal by Subject|1|||
125454556|NCT01693614|451293053|FG000|Overall Study|Adverse Event|7|||
125454557|NCT01693614|451293054|FG001|Overall Study|Adverse Event|11|||
125454558|NCT01693614|451293055|FG002|Overall Study|Adverse Event|5|||
125454559|NCT01693614|451293053|FG000|Overall Study|Disease progression|11|||
125454560|NCT01693614|451293054|FG001|Overall Study|Disease progression|8|||
125454561|NCT01693614|451293055|FG002|Overall Study|Disease progression|7|||
125454562|NCT01693614|451293053|FG000|Overall Study|Protocol Violation|5|||
125454563|NCT01693614|451293054|FG001|Overall Study|Protocol Violation|2|||
125454564|NCT01693614|451293055|FG002|Overall Study|Protocol Violation|1|||
125454565|NCT01693614|451293053|FG000|Overall Study|Death|1|||
125454566|NCT01693614|451293054|FG001|Overall Study|Death|0|||
125454567|NCT01693614|451293055|FG002|Overall Study|Death|0|||
125454568|NCT01693614|451293053|FG000|Overall Study|Physician Decision|1|||
125454569|NCT01693614|451293054|FG001|Overall Study|Physician Decision|1|||
125454570|NCT01693614|451293055|FG002|Overall Study|Physician Decision|4|||
125454571|NCT01693614|451293053|FG000|Overall Study|Withdrawal by subject/guardian|0|||
125454572|NCT01693614|451293054|FG001|Overall Study|Withdrawal by subject/guardian|0|||
125454573|NCT01693614|451293055|FG002|Overall Study|Withdrawal by subject/guardian|2|||
125454574|NCT01693614|451293053|FG000|Overall Study|Withdrawal by Subject|1|||
125454575|NCT01693614|451293054|FG001|Overall Study|Withdrawal by Subject|0|||
125454576|NCT01693614|451293055|FG002|Overall Study|Withdrawal by Subject|5|||
125454577|NCT01048788|451293056|FG000|Overall Study|Adverse Event|5|||
125454578|NCT01048788|451293057|FG001|Overall Study|Adverse Event|1|||
125454579|NCT01048788|451293058|FG002|Overall Study|Adverse Event|1|||
125454580|NCT01048788|451293056|FG000|Overall Study|Lack of Efficacy|0|||
125454581|NCT01048788|451293057|FG001|Overall Study|Lack of Efficacy|0|||
125454582|NCT01048788|451293058|FG002|Overall Study|Lack of Efficacy|1|||
125454583|NCT01048788|451293056|FG000|Overall Study|Withdrawal by Subject|0|||
125454584|NCT01048788|451293057|FG001|Overall Study|Withdrawal by Subject|1|||
125454585|NCT01048788|451293058|FG002|Overall Study|Withdrawal by Subject|0|||
125454586|NCT00420316|451293061|FG000|Overall Study|Withdrawal by Subject|0|||
125454587|NCT00420316|451293062|FG001|Overall Study|Withdrawal by Subject|1|||
125454588|NCT00420316|451293061|FG000|Overall Study|Lost to Follow-up|12|||
125454589|NCT00420316|451293062|FG001|Overall Study|Lost to Follow-up|8|||
125454590|NCT05419557|451293063|FG000|Overall Study|Lost to Follow-up|11|||
125454591|NCT05419557|451293064|FG001|Overall Study|Lost to Follow-up|4|||
125454592|NCT01196988|451293065|FG000|Overall Study|Adverse Event|1|||
125454593|NCT01196988|451293066|FG001|Overall Study|Adverse Event|2|||
125454594|NCT01196988|451293067|FG002|Overall Study|Adverse Event|0|||
125454595|NCT01196988|451293068|FG003|Overall Study|Adverse Event|0|||
125454596|NCT01196988|451293065|FG000|Overall Study|Withdrawal by Subject|5|||
125454597|NCT01196988|451293066|FG001|Overall Study|Withdrawal by Subject|1|||
125454598|NCT01196988|451293067|FG002|Overall Study|Withdrawal by Subject|4|||
125454599|NCT01196988|451293068|FG003|Overall Study|Withdrawal by Subject|0|||
125454600|NCT01196988|451293065|FG000|Overall Study|Lost to Follow-up|16|||
125454601|NCT01196988|451293066|FG001|Overall Study|Lost to Follow-up|29|||
125454602|NCT01196988|451293067|FG002|Overall Study|Lost to Follow-up|21|||
125454603|NCT01196988|451293068|FG003|Overall Study|Lost to Follow-up|1|||
125454604|NCT01196988|451293065|FG000|Overall Study|Other|2|||
125454605|NCT01196988|451293066|FG001|Overall Study|Other|0|||
125454606|NCT01196988|451293067|FG002|Overall Study|Other|0|||
125454607|NCT01196988|451293068|FG003|Overall Study|Other|0|||
125454608|NCT00868192|451293070|FG000|Overall Study|Ineligible|4|||
125454609|NCT04304534|451293071|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
125454610|NCT04304534|451293072|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
125454611|NCT04304534|451293073|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
125454612|NCT04304534|451293074|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
125454613|NCT04304534|451293071|FG000|Overall Study|Non-Compliance with study drug|0|||
125454614|NCT04304534|451293072|FG001|Overall Study|Non-Compliance with study drug|1|||
125454615|NCT04304534|451293073|FG002|Overall Study|Non-Compliance with study drug|1|||
125454616|NCT04304534|451293074|FG003|Overall Study|Non-Compliance with study drug|1|||
125454617|NCT04304534|451293071|FG000|Overall Study|Lost to Follow-up|0|||
125454618|NCT04304534|451293072|FG001|Overall Study|Lost to Follow-up|1|||
125454619|NCT04304534|451293073|FG002|Overall Study|Lost to Follow-up|2|||
125419859|NCT00254982|451162157|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
125419860|NCT00254982|451162158|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
125419861|NCT00254982|451162157|FG000|Overall Study|Protocol deviation|1|||
125419862|NCT00254982|451162158|FG001|Overall Study|Protocol deviation|1|||
125419863|NCT00254982|451162157|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
125419864|NCT00254982|451162158|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
125419865|NCT00254982|451162157|FG000|Overall Study|Malignancy|0|||
125419866|NCT00254982|451162158|FG001|Overall Study|Malignancy|2|||
125419867|NCT00254982|451162157|FG000|Overall Study|Opportunistic infection|1|||
125419868|NCT00254982|451162158|FG001|Overall Study|Opportunistic infection|0|||
125419869|NCT00254982|451162157|FG000|Overall Study|Abnormal liver function tests|2|||
125419870|NCT00254982|451162158|FG001|Overall Study|Abnormal liver function tests|1|||
125419871|NCT03117738|451162161|FG000|Overall Study|Withdrawal by Subject|3|||
125419872|NCT03117738|451162162|FG001|Overall Study|Withdrawal by Subject|1|||
125419873|NCT03117738|451162161|FG000|Overall Study|Lost to Follow-up|1|||
125419874|NCT03117738|451162162|FG001|Overall Study|Lost to Follow-up|4|||
125419875|NCT04004611|451162163|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125419876|NCT04004611|451162164|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125419877|NCT04004611|451162165|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125419878|NCT04004611|451162166|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125419879|NCT04004611|451162167|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125419880|NCT04004611|451162168|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125419881|NCT04004611|451162169|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125419882|NCT04004611|451162170|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
125419883|NCT04004611|451162171|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
125419884|NCT04004611|451162163|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
125419885|NCT04004611|451162164|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
125419886|NCT04004611|451162165|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
125419887|NCT04004611|451162166|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
125419888|NCT04004611|451162167|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
125419889|NCT04004611|451162168|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
125419890|NCT04004611|451162169|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
125419891|NCT04004611|451162170|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
125419892|NCT04004611|451162171|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
125419893|NCT04004611|451162163|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125419894|NCT04004611|451162164|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125419895|NCT04004611|451162165|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125419896|NCT04004611|451162166|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125419897|NCT04004611|451162167|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
125419898|NCT04004611|451162168|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125419899|NCT04004611|451162169|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125419900|NCT04004611|451162170|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125419901|NCT04004611|451162171|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
125419902|NCT04004611|451162163|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
125419903|NCT04004611|451162164|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
125419904|NCT04004611|451162165|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
125419905|NCT04004611|451162166|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
125419906|NCT04004611|451162167|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
125419907|NCT04004611|451162168|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
125419908|NCT04004611|451162169|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
125419909|NCT04004611|451162170|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
125419910|NCT04004611|451162171|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
125419911|NCT04004611|451162163|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
125419912|NCT04004611|451162164|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125419913|NCT04004611|451162165|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
125419914|NCT04004611|451162166|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125419915|NCT04004611|451162167|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125419916|NCT04004611|451162168|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125419917|NCT04004611|451162169|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125419918|NCT04004611|451162170|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125419919|NCT04004611|451162171|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
125419920|NCT04004611|451162163|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125419921|NCT04004611|451162164|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
125419922|NCT04004611|451162165|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125419923|NCT04004611|451162166|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125419924|NCT04004611|451162167|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125419925|NCT04004611|451162168|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125419926|NCT04004611|451162169|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125454620|NCT04304534|451293074|FG003|Overall Study|Lost to Follow-up|3|||
125454621|NCT04304534|451293071|FG000|Overall Study|Unspecific|4|||
125454622|NCT04304534|451293072|FG001|Overall Study|Unspecific|2|||
125454623|NCT04304534|451293073|FG002|Overall Study|Unspecific|2|||
125454624|NCT04304534|451293074|FG003|Overall Study|Unspecific|2|||
125454625|NCT04304534|451293071|FG000|Overall Study|Technical Problems|2|||
125454626|NCT04304534|451293072|FG001|Overall Study|Technical Problems|2|||
125454627|NCT04304534|451293073|FG002|Overall Study|Technical Problems|3|||
125454628|NCT04304534|451293074|FG003|Overall Study|Technical Problems|4|||
125454629|NCT04304534|451293071|FG000|Overall Study|Death|7|||
125454630|NCT04304534|451293072|FG001|Overall Study|Death|2|||
125454631|NCT04304534|451293073|FG002|Overall Study|Death|4|||
125454632|NCT04304534|451293074|FG003|Overall Study|Death|3|||
125454633|NCT04304534|451293071|FG000|Overall Study|Withdrawal by Subject|7|||
125454634|NCT04304534|451293072|FG001|Overall Study|Withdrawal by Subject|2|||
125454635|NCT04304534|451293073|FG002|Overall Study|Withdrawal by Subject|7|||
125454636|NCT04304534|451293074|FG003|Overall Study|Withdrawal by Subject|4|||
125454637|NCT04304534|451293071|FG000|Overall Study|Physician Decision|4|||
125454638|NCT04304534|451293072|FG001|Overall Study|Physician Decision|9|||
125454639|NCT04304534|451293073|FG002|Overall Study|Physician Decision|9|||
125454640|NCT04304534|451293074|FG003|Overall Study|Physician Decision|5|||
125454641|NCT04304534|451293071|FG000|Overall Study|Subject Decision|34|||
125454642|NCT04304534|451293072|FG001|Overall Study|Subject Decision|25|||
125454643|NCT04304534|451293073|FG002|Overall Study|Subject Decision|25|||
125454644|NCT04304534|451293074|FG003|Overall Study|Subject Decision|26|||
125454645|NCT04304534|451293071|FG000|Overall Study|Adverse Event|35|||
125454646|NCT04304534|451293072|FG001|Overall Study|Adverse Event|40|||
125454647|NCT04304534|451293073|FG002|Overall Study|Adverse Event|39|||
125454648|NCT04304534|451293074|FG003|Overall Study|Adverse Event|44|||
125454649|NCT00464672|451293075|FG000|Overall Study|withdrawal of consent|0|||
125454650|NCT00464672|451293076|FG001|Overall Study|withdrawal of consent|0|||
125454651|NCT00464672|451293077|FG002|Overall Study|withdrawal of consent|0|||
125454652|NCT00464672|451293078|FG003|Overall Study|withdrawal of consent|1|||
125454653|NCT00464672|451293079|FG004|Overall Study|withdrawal of consent|9|||
125454654|NCT00464672|451293080|FG005|Overall Study|withdrawal of consent|4|||
125454655|NCT00464672|451293075|FG000|Overall Study|Lost to Follow-up|25|||
125454656|NCT00464672|451293076|FG001|Overall Study|Lost to Follow-up|10|||
125454657|NCT00464672|451293077|FG002|Overall Study|Lost to Follow-up|0|||
125454658|NCT00464672|451293078|FG003|Overall Study|Lost to Follow-up|0|||
125454659|NCT00464672|451293079|FG004|Overall Study|Lost to Follow-up|1|||
125454660|NCT00464672|451293080|FG005|Overall Study|Lost to Follow-up|0|||
125454661|NCT00957229|451293082|FG000|Study Start|Adverse Event|0|||
125454662|NCT00957229|451293083|FG001|Study Start|Adverse Event|3|||
125454663|NCT00957229|451293082|FG000|Study Start|Disease Progression|1|||
125454664|NCT00957229|451293083|FG001|Study Start|Disease Progression|0|||
125454665|NCT00957229|451293082|FG000|Reallocated to or Continued Vismodegib|Death|1|||
125454666|NCT00957229|451293083|FG001|Reallocated to or Continued Vismodegib|Death|1|||
125454667|NCT00957229|451293082|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
125454668|NCT00957229|451293083|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
125454669|NCT00606580|451293084|FG000|Overall Study|Lost to Follow-up|1|||
125454670|NCT00606580|451293085|FG001|Overall Study|Lost to Follow-up|1|||
125454671|NCT00606580|451293086|FG002|Overall Study|Lost to Follow-up|4|||
125454672|NCT00606580|451293084|FG000|Overall Study|Clinical failures|1|||
125454673|NCT00606580|451293085|FG001|Overall Study|Clinical failures|0|||
125454674|NCT00606580|451293086|FG002|Overall Study|Clinical failures|12|||
125454675|NCT00606580|451293084|FG000|Overall Study|Withdrawal by investigator|0|||
125454676|NCT00606580|451293085|FG001|Overall Study|Withdrawal by investigator|1|||
125454677|NCT00606580|451293086|FG002|Overall Study|Withdrawal by investigator|6|||
125454678|NCT00606580|451293084|FG000|Overall Study|Withdrawal by Subject|0|||
125454679|NCT00606580|451293085|FG001|Overall Study|Withdrawal by Subject|1|||
125454680|NCT00606580|451293086|FG002|Overall Study|Withdrawal by Subject|0|||
125454681|NCT01250002|451293091|FG000|Overall Study|Change to open surgical procedure|4|||
125454682|NCT01250002|451293092|FG001|Overall Study|Change to open surgical procedure|3|||
125454683|NCT00843193|451293105|FG000|Overall Study|Adverse Event|2|||
125454684|NCT00843193|451293106|FG001|Overall Study|Adverse Event|4|||
125454685|NCT00843193|451293105|FG000|Overall Study|Lack of Efficacy|1|||
125454686|NCT00843193|451293106|FG001|Overall Study|Lack of Efficacy|1|||
125454687|NCT00843193|451293105|FG000|Overall Study|Protocol Violation|1|||
125454688|NCT00843193|451293106|FG001|Overall Study|Protocol Violation|2|||
125454689|NCT00843193|451293105|FG000|Overall Study|Lost to Follow-up|1|||
125454690|NCT00843193|451293106|FG001|Overall Study|Lost to Follow-up|0|||
125454691|NCT00843193|451293105|FG000|Overall Study|Physician Decision|0|||
125454692|NCT00843193|451293106|FG001|Overall Study|Physician Decision|1|||
125454693|NCT00843193|451293105|FG000|Overall Study|Withdrawal by Subject|3|||
125454694|NCT00843193|451293106|FG001|Overall Study|Withdrawal by Subject|3|||
125454695|NCT04511650|451293107|FG000|Overall Study|Lost to Follow-up|1|||
125454696|NCT04511650|451293108|FG001|Overall Study|Lost to Follow-up|0|||
125454697|NCT04511650|451293109|FG002|Overall Study|Lost to Follow-up|0|||
125454698|NCT04511650|451293107|FG000|Overall Study|Withdrawal by Subject|1|||
125454699|NCT04511650|451293108|FG001|Overall Study|Withdrawal by Subject|0|||
125454700|NCT04511650|451293109|FG002|Overall Study|Withdrawal by Subject|0|||
125454701|NCT04511650|451293107|FG000|Overall Study|reason not provided|0|||
125454702|NCT04511650|451293108|FG001|Overall Study|reason not provided|0|||
125454703|NCT04511650|451293109|FG002|Overall Study|reason not provided|1|||
125454704|NCT04511650|451293107|FG000|Overall Study|Death|1|||
125454705|NCT04511650|451293108|FG001|Overall Study|Death|1|||
125454706|NCT04511650|451293109|FG002|Overall Study|Death|1|||
125454707|NCT01081145|451293121|FG000|Open-Label Phase|Lack of Efficacy|56|||
125454708|NCT01081145|451293122|FG001|Open-Label Phase|Lack of Efficacy|0|||
125454709|NCT01081145|451293121|FG000|Open-Label Phase|Response criteria not met|46|||
125454710|NCT01081145|451293122|FG001|Open-Label Phase|Response criteria not met|0|||
125454711|NCT01081145|451293121|FG000|Open-Label Phase|Adverse Event|42|||
125454712|NCT01081145|451293122|FG001|Open-Label Phase|Adverse Event|0|||
125454713|NCT01081145|451293121|FG000|Open-Label Phase|Withdrawal by Subject|41|||
125454714|NCT01081145|451293122|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125454715|NCT01081145|451293121|FG000|Open-Label Phase|Other|12|||
125454716|NCT01081145|451293122|FG001|Open-Label Phase|Other|0|||
125454717|NCT01081145|451293121|FG000|Open-Label Phase|Lost to Follow-up|11|||
125454718|NCT01081145|451293122|FG001|Open-Label Phase|Lost to Follow-up|0|||
125454719|NCT01081145|451293121|FG000|Open-Label Phase|Protocol Violation|4|||
125454720|NCT01081145|451293122|FG001|Open-Label Phase|Protocol Violation|0|||
125454721|NCT01081145|451293121|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
125454722|NCT01081145|451293122|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
125454723|NCT01081145|451293121|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
125454724|NCT01081145|451293122|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
125454725|NCT01081145|451293121|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
125454726|NCT01081145|451293122|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
125454727|NCT01081145|451293121|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
125454728|NCT01081145|451293122|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
125454729|NCT01081145|451293121|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
125454730|NCT01081145|451293122|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
125454731|NCT01081145|451293121|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
125454732|NCT01081145|451293122|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
125454733|NCT01081145|451293121|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
125454734|NCT01081145|451293122|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
125454735|NCT02197234|451293123|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
125454736|NCT02197234|451293123|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
125454737|NCT02197234|451293123|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
125454738|NCT02197234|451293123|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
125454739|NCT02197234|451293123|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
125454740|NCT02197234|451293123|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
125454741|NCT05826431|451293125|FG000|Overall Study|Withdrawal by Subject|1|||
125454742|NCT04771273|451293126|FG000|Dose Escalation Period|Not treated with trial medication|0|||
125454743|NCT04771273|451293127|FG001|Dose Escalation Period|Not treated with trial medication|1|||
125454744|NCT04771273|451293128|FG002|Dose Escalation Period|Not treated with trial medication|1|||
125454745|NCT04771273|451293129|FG003|Dose Escalation Period|Not treated with trial medication|0|||
125454746|NCT04771273|451293126|FG000|Dose Escalation Period|Other reasons than listed|2|||
125454747|NCT04771273|451293127|FG001|Dose Escalation Period|Other reasons than listed|0|||
125454748|NCT04771273|451293128|FG002|Dose Escalation Period|Other reasons than listed|2|||
125454749|NCT04771273|451293129|FG003|Dose Escalation Period|Other reasons than listed|1|||
125454750|NCT04771273|451293126|FG000|Dose Escalation Period|Protocol Violation|0|||
125454751|NCT04771273|451293127|FG001|Dose Escalation Period|Protocol Violation|0|||
125454752|NCT04771273|451293128|FG002|Dose Escalation Period|Protocol Violation|3|||
125454753|NCT04771273|451293129|FG003|Dose Escalation Period|Protocol Violation|1|||
125454754|NCT04771273|451293126|FG000|Dose Escalation Period|Burden of study procedures|1|||
125454755|NCT04771273|451293127|FG001|Dose Escalation Period|Burden of study procedures|0|||
125454756|NCT04771273|451293128|FG002|Dose Escalation Period|Burden of study procedures|0|||
125454757|NCT04771273|451293129|FG003|Dose Escalation Period|Burden of study procedures|0|||
125454758|NCT04771273|451293126|FG000|Dose Escalation Period|Change of residence|0|||
125454759|NCT04771273|451293127|FG001|Dose Escalation Period|Change of residence|0|||
125454760|NCT04771273|451293128|FG002|Dose Escalation Period|Change of residence|0|||
125454761|NCT04771273|451293129|FG003|Dose Escalation Period|Change of residence|1|||
125454762|NCT04771273|451293126|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
125454763|NCT04771273|451293127|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
125454764|NCT04771273|451293128|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
125454765|NCT04771273|451293129|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
125454766|NCT04771273|451293126|FG000|Dose Escalation Period|Adverse Event|8|||
125454767|NCT04771273|451293127|FG001|Dose Escalation Period|Adverse Event|9|||
125454768|NCT04771273|451293128|FG002|Dose Escalation Period|Adverse Event|12|||
125454769|NCT04771273|451293129|FG003|Dose Escalation Period|Adverse Event|2|||
125454770|NCT04771273|451293126|FG000|Maintenance Period|Other than listed|4|||
125454771|NCT04771273|451293127|FG001|Maintenance Period|Other than listed|2|||
125454772|NCT04771273|451293128|FG002|Maintenance Period|Other than listed|0|||
125454773|NCT04771273|451293129|FG003|Maintenance Period|Other than listed|3|||
125454774|NCT04771273|451293126|FG000|Maintenance Period|Burden of study procedures|1|||
125454775|NCT04771273|451293127|FG001|Maintenance Period|Burden of study procedures|0|||
125454776|NCT04771273|451293128|FG002|Maintenance Period|Burden of study procedures|0|||
125454777|NCT04771273|451293129|FG003|Maintenance Period|Burden of study procedures|0|||
125454778|NCT04771273|451293126|FG000|Maintenance Period|Change of residence|0|||
125454779|NCT04771273|451293127|FG001|Maintenance Period|Change of residence|1|||
125454780|NCT04771273|451293128|FG002|Maintenance Period|Change of residence|3|||
125454781|NCT04771273|451293129|FG003|Maintenance Period|Change of residence|0|||
125454782|NCT04771273|451293126|FG000|Maintenance Period|Perceived lack of efficacy|0|||
125454783|NCT04771273|451293127|FG001|Maintenance Period|Perceived lack of efficacy|0|||
125454784|NCT04771273|451293128|FG002|Maintenance Period|Perceived lack of efficacy|0|||
125454785|NCT04771273|451293129|FG003|Maintenance Period|Perceived lack of efficacy|1|||
125454786|NCT04771273|451293126|FG000|Maintenance Period|Adverse Event|4|||
125454787|NCT04771273|451293127|FG001|Maintenance Period|Adverse Event|5|||
125454788|NCT04771273|451293128|FG002|Maintenance Period|Adverse Event|5|||
125454789|NCT04771273|451293129|FG003|Maintenance Period|Adverse Event|0|||
125454790|NCT01543685|451293130|FG000|Overall Study|Lack of Efficacy|1|||
125454791|NCT01543685|451293131|FG001|Overall Study|Lack of Efficacy|2|||
125454792|NCT01543685|451293132|FG002|Overall Study|Lack of Efficacy|2|||
125454793|NCT01543685|451293133|FG003|Overall Study|Lack of Efficacy|0|||
125454794|NCT01543685|451293134|FG004|Overall Study|Lack of Efficacy|2|||
125454795|NCT01543685|451293130|FG000|Overall Study|Adverse Event|2|||
125454796|NCT01543685|451293131|FG001|Overall Study|Adverse Event|1|||
125454797|NCT01543685|451293132|FG002|Overall Study|Adverse Event|0|||
125454798|NCT01543685|451293133|FG003|Overall Study|Adverse Event|0|||
125454799|NCT01543685|451293134|FG004|Overall Study|Adverse Event|2|||
125454800|NCT02163915|451293135|FG000|Overall Study|Withdrawal by Subject|2|||
125454801|NCT02163915|451293136|FG001|Overall Study|Withdrawal by Subject|0|||
125454802|NCT02163915|451293137|FG002|Overall Study|Withdrawal by Subject|2|||
125454803|NCT02163915|451293138|FG003|Overall Study|Withdrawal by Subject|2|||
125454804|NCT02163915|451293139|FG004|Overall Study|Withdrawal by Subject|2|||
125454805|NCT02163915|451293135|FG000|Overall Study|Study termination|1|||
125454806|NCT02163915|451293136|FG001|Overall Study|Study termination|0|||
125454807|NCT02163915|451293137|FG002|Overall Study|Study termination|0|||
125454808|NCT02163915|451293138|FG003|Overall Study|Study termination|0|||
125454809|NCT02163915|451293139|FG004|Overall Study|Study termination|2|||
125454810|NCT02163915|451293135|FG000|Overall Study|Physician Decision|0|||
125454811|NCT02163915|451293136|FG001|Overall Study|Physician Decision|0|||
125454812|NCT02163915|451293137|FG002|Overall Study|Physician Decision|0|||
125454813|NCT02163915|451293138|FG003|Overall Study|Physician Decision|1|||
125454814|NCT02163915|451293139|FG004|Overall Study|Physician Decision|0|||
125454815|NCT02013037|451293140|FG000|Overall Study|Death|6|||
125454816|NCT02013037|451293140|FG000|Overall Study|Withdrawal by Subject|1|||
125454817|NCT02013037|451293140|FG000|Overall Study|Awaiting Transplantation|7|||
125454818|NCT02013037|451293140|FG000|Overall Study|Transplanted without DSA|2|||
125454819|NCT02465359|451293141|FG000|Overall Study|Lack of Efficacy|1|||
125454820|NCT02465359|451293141|FG000|Overall Study|Withdrawal by Subject|1|||
125454821|NCT02465359|451293141|FG000|Overall Study|Adverse Event|1|||
125454822|NCT01304147|451293142|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
125454823|NCT01304147|451293143|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
125454824|NCT00708097|451293144|FG000|Period 1|Protocol Violation|0|||
125454825|NCT00708097|451293145|FG001|Period 1|Protocol Violation|1|||
125454826|NCT00708097|451293146|FG002|Period 1|Protocol Violation|0|||
125454827|NCT00708097|451293147|FG003|Period 1|Protocol Violation|2|||
125454828|NCT00708097|451293148|FG004|Period 1|Protocol Violation|0|||
125454829|NCT00708097|451293144|FG000|Period 1|Other Reason|0|||
125454830|NCT00708097|451293145|FG001|Period 1|Other Reason|0|||
125454831|NCT00708097|451293146|FG002|Period 1|Other Reason|0|||
125454832|NCT00708097|451293147|FG003|Period 1|Other Reason|0|||
125454833|NCT00708097|451293148|FG004|Period 1|Other Reason|1|||
125454834|NCT00708097|451293144|FG000|Period 2|Protocol Violation|0|||
125454835|NCT00708097|451293145|FG001|Period 2|Protocol Violation|1|||
125454836|NCT00708097|451293146|FG002|Period 2|Protocol Violation|1|||
125454837|NCT00708097|451293147|FG003|Period 2|Protocol Violation|1|||
125454838|NCT00708097|451293148|FG004|Period 2|Protocol Violation|0|||
125454839|NCT01244828|451293149|FG000|Overall Study|Adverse Event|37|||
125292251|NCT02317809|450696576|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
125292252|NCT02317809|450696577|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
125454840|NCT01244828|451293149|FG000|Overall Study|Withdrawal by Subject|31|||
125454841|NCT01244828|451293149|FG000|Overall Study|Lack of Efficacy|7|||
125454842|NCT01244828|451293149|FG000|Overall Study|Lost to Follow-up|2|||
125454843|NCT01244828|451293149|FG000|Overall Study|Other reason (not specified)|1|||
125454844|NCT03895034|451294648|FG000|Overall Study|Lost to Follow-up|2|||
125454845|NCT01118377|451294653|FG000|Overall Study|Did Not Receive Study Medication|1|||
125454846|NCT01118377|451294653|FG000|Overall Study|Death|38|||
125454847|NCT01118377|451294653|FG000|Overall Study|Failure to Return|3|||
125454848|NCT00739102|451294654|FG000|Overall Study|Death|5|||
125454849|NCT00739102|451294654|FG000|Overall Study|Withdrawal by Subject|10|||
125454850|NCT03179787|451294655|FG000|Overall Study|Lost to Follow-up|15|||
125454851|NCT03179787|451294655|FG000|Overall Study|Case report failures|2|||
125454852|NCT03179787|451294655|FG000|Overall Study|Treatment not administered|1|||
125454853|NCT01510912|451294656|FG000|Overall Study|Adverse Event|99|||
125454854|NCT01510912|451294656|FG000|Overall Study|Lack of Efficacy|12|||
125454855|NCT01510912|451294656|FG000|Overall Study|Non-compliance with trial drug|23|||
125454856|NCT01510912|451294656|FG000|Overall Study|Withdrawal by Subject|49|||
125454857|NCT01510912|451294656|FG000|Overall Study|Physician Decision|1|||
125454858|NCT01510912|451294656|FG000|Overall Study|Protocol Violation|27|||
125454859|NCT01510912|451294656|FG000|Overall Study|Lost to Follow-up|26|||
125454860|NCT01510912|451294656|FG000|Overall Study|Other, including joint replacement|5|||
125454861|NCT00157014|451294657|FG000|Overall Study|Death|4|||
125454862|NCT00157014|451294658|FG001|Overall Study|Death|2|||
125454863|NCT00157014|451294659|FG002|Overall Study|Death|1|||
125454864|NCT00157014|451294660|FG003|Overall Study|Death|1|||
125454865|NCT00157014|451294657|FG000|Overall Study|Physician Decision|0|||
125454866|NCT00157014|451294658|FG001|Overall Study|Physician Decision|1|||
125454867|NCT00157014|451294659|FG002|Overall Study|Physician Decision|0|||
125454868|NCT00157014|451294660|FG003|Overall Study|Physician Decision|0|||
125454869|NCT00157014|451294657|FG000|Overall Study|Medications withdrawn on family request|0|||
125454870|NCT00157014|451294658|FG001|Overall Study|Medications withdrawn on family request|1|||
125454871|NCT00157014|451294659|FG002|Overall Study|Medications withdrawn on family request|0|||
125454872|NCT00157014|451294660|FG003|Overall Study|Medications withdrawn on family request|0|||
125454873|NCT00157014|451294657|FG000|Overall Study|Patient withdrawn by investigator|1|||
125454874|NCT00157014|451294658|FG001|Overall Study|Patient withdrawn by investigator|0|||
125454875|NCT00157014|451294659|FG002|Overall Study|Patient withdrawn by investigator|0|||
125454876|NCT00157014|451294660|FG003|Overall Study|Patient withdrawn by investigator|0|||
125454877|NCT00157014|451294657|FG000|Overall Study|Patient unable to return in nursing home|1|||
125454878|NCT00157014|451294658|FG001|Overall Study|Patient unable to return in nursing home|0|||
125454879|NCT00157014|451294659|FG002|Overall Study|Patient unable to return in nursing home|0|||
125292253|NCT02317809|450696576|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
125292254|NCT02317809|450696577|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
125292255|NCT04912895|450696581|FG000|Overall Study|Unable to provide specimen|2|||
125292256|NCT04912895|450696582|FG001|Overall Study|Unable to provide specimen|0|||
125292257|NCT04912895|450696583|FG002|Overall Study|Unable to provide specimen|0|||
125292258|NCT03458702|450696584|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
125292259|NCT03458702|450696585|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
125292260|NCT03458702|450696584|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
125292261|NCT03458702|450696585|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
125292262|NCT01390779|450696586|FG000|Overall Study|Physician Decision|1|||
125292263|NCT00545532|450696587|FG000|Overall Study|Withdrawal by Subject|1|||
125292264|NCT00545532|450696588|FG001|Overall Study|Withdrawal by Subject|3|||
125292265|NCT00545532|450696587|FG000|Overall Study|Lost to Follow-up|5|||
125292266|NCT00545532|450696588|FG001|Overall Study|Lost to Follow-up|6|||
125292267|NCT00545532|450696587|FG000|Overall Study|Death|0|||
125292268|NCT00545532|450696588|FG001|Overall Study|Death|1|||
125292269|NCT01149486|450696591|FG000|First Intervention|Adverse Event|0|||
125292270|NCT01149486|450696592|FG001|First Intervention|Adverse Event|1|||
125292271|NCT00931801|450696601|FG000|Overall Study|Adverse Event|0|||
125292272|NCT00931801|450696602|FG001|Overall Study|Adverse Event|0|||
125292273|NCT00931801|450696603|FG002|Overall Study|Adverse Event|1|||
125454880|NCT00157014|451294660|FG003|Overall Study|Patient unable to return in nursing home|0|||
125454881|NCT00157014|451294657|FG000|Overall Study|Patient would not receive transplant|0|||
125454882|NCT00157014|451294658|FG001|Overall Study|Patient would not receive transplant|1|||
125454883|NCT00157014|451294659|FG002|Overall Study|Patient would not receive transplant|0|||
125454884|NCT00157014|451294660|FG003|Overall Study|Patient would not receive transplant|0|||
125454885|NCT00157014|451294657|FG000|Overall Study|Withdrawal by Subject|1|||
125292274|NCT00931801|450696601|FG000|Overall Study|Lost to Follow-up|0|||
125292275|NCT00931801|450696602|FG001|Overall Study|Lost to Follow-up|1|||
125454886|NCT00157014|451294658|FG001|Overall Study|Withdrawal by Subject|0|||
125454887|NCT00157014|451294659|FG002|Overall Study|Withdrawal by Subject|0|||
125454888|NCT00157014|451294660|FG003|Overall Study|Withdrawal by Subject|0|||
125454889|NCT03181958|451294661|FG000|Overall Study|Lost to Follow-up|17|||
125454890|NCT03181958|451294662|FG001|Overall Study|Lost to Follow-up|21|||
125454891|NCT03181958|451294663|FG002|Overall Study|Lost to Follow-up|15|||
125454892|NCT01257503|451294664|FG000|Overall Study|Lost to Follow-up|7|||
125292276|NCT00931801|450696603|FG002|Overall Study|Lost to Follow-up|0|||
125292277|NCT00931801|450696601|FG000|Overall Study|Withdrawal by Subject|1|||
125292278|NCT00931801|450696602|FG001|Overall Study|Withdrawal by Subject|0|||
125292279|NCT00931801|450696603|FG002|Overall Study|Withdrawal by Subject|0|||
125292280|NCT00931801|450696601|FG000|Overall Study|Confirmed Virologic Failure|0|||
125292281|NCT00931801|450696602|FG001|Overall Study|Confirmed Virologic Failure|0|||
125292282|NCT00931801|450696603|FG002|Overall Study|Confirmed Virologic Failure|3|||
125292283|NCT01635764|450696605|FG000|Overall Study|Adverse Event|46|||
125292284|NCT01635764|450696605|FG000|Overall Study|Lack of Efficacy|76|||
125292285|NCT01635764|450696605|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
125292286|NCT01635764|450696605|FG000|Overall Study|Protocol Deviation|1|||
125292287|NCT01635764|450696605|FG000|Overall Study|Withdrew Consent|67|||
125292288|NCT01635764|450696605|FG000|Overall Study|Lost to Follow-up|53|||
125292289|NCT01635764|450696605|FG000|Overall Study|Other|28|||
125292290|NCT01174004|450696606|FG000|Overall Study|Adverse Event|2|||
125292291|NCT01174004|450696607|FG001|Overall Study|Adverse Event|10|||
125292292|NCT01174004|450696606|FG000|Overall Study|Withdrawal by Subject|2|||
125292293|NCT01174004|450696607|FG001|Overall Study|Withdrawal by Subject|3|||
125292294|NCT01174004|450696606|FG000|Overall Study|At Discretion of Sponsor|2|||
125292295|NCT01174004|450696607|FG001|Overall Study|At Discretion of Sponsor|2|||
125292296|NCT01174004|450696606|FG000|Overall Study|Protocol Violation|0|||
125292297|NCT01174004|450696607|FG001|Overall Study|Protocol Violation|1|||
125292298|NCT01174004|450696606|FG000|Overall Study|Physician Decision|1|||
125292299|NCT01174004|450696607|FG001|Overall Study|Physician Decision|0|||
125292300|NCT00933244|450696608|FG000|Overall Study|Withdrawal by Subject|5|||
125292301|NCT00933244|450696609|FG001|Overall Study|Withdrawal by Subject|1|||
125292302|NCT00933244|450696610|FG002|Overall Study|Withdrawal by Subject|3|||
125292303|NCT04375397|450696617|FG000|Overall Study|Death|1|||
125454893|NCT01257503|451294665|FG001|Overall Study|Lost to Follow-up|10|||
125454894|NCT01257503|451294664|FG000|Overall Study|Over 5 years old at enrollment|0|||
125454895|NCT01257503|451294665|FG001|Overall Study|Over 5 years old at enrollment|1|||
125454896|NCT01257503|451294664|FG000|Overall Study|strep culture positive at enrollment|1|||
125454897|NCT01257503|451294665|FG001|Overall Study|strep culture positive at enrollment|0|||
125454898|NCT01090024|451294666|FG000|Period 1|Met exclusion criteria|0|||
125454899|NCT01090024|451294667|FG001|Period 1|Met exclusion criteria|0|||
125454900|NCT01090024|451294668|FG002|Period 1|Met exclusion criteria|0|||
125454901|NCT01090024|451294669|FG003|Period 1|Met exclusion criteria|0|||
125454902|NCT01090024|451294670|FG004|Period 1|Met exclusion criteria|0|||
125292304|NCT04375397|450696618|FG001|Overall Study|Death|1|||
125292305|NCT04375397|450696617|FG000|Overall Study|Withdrew consent|2|||
125292306|NCT04375397|450696618|FG001|Overall Study|Withdrew consent|0|||
125292307|NCT04375397|450696617|FG000|Overall Study|Lost to Follow-up|6|||
125292308|NCT04375397|450696618|FG001|Overall Study|Lost to Follow-up|4|||
125292309|NCT04375397|450696617|FG000|Overall Study|Other, not specified|0|||
125292310|NCT04375397|450696618|FG001|Overall Study|Other, not specified|1|||
125454903|NCT01090024|451294671|FG005|Period 1|Met exclusion criteria|0|||
125454904|NCT01090024|451294672|FG006|Period 1|Met exclusion criteria|0|||
125292311|NCT00610441|450696620|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
125292312|NCT00610441|450696621|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
125292313|NCT00610441|450696622|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
125292314|NCT00610441|450696623|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
125292315|NCT00610441|450696620|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
125292316|NCT00610441|450696621|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
125292317|NCT00610441|450696622|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
125292318|NCT00610441|450696623|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
125292319|NCT00610441|450696620|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
125292320|NCT00610441|450696621|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
125292321|NCT00610441|450696622|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
125292322|NCT00610441|450696623|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
125292323|NCT00610441|450696620|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
125292324|NCT00610441|450696621|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
125292325|NCT00610441|450696622|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
125292326|NCT00610441|450696623|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
125454905|NCT01090024|451294673|FG007|Period 1|Met exclusion criteria|0|||
125292327|NCT00610441|450696620|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
125292328|NCT00610441|450696621|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
125292329|NCT00610441|450696622|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
125292330|NCT00610441|450696623|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
125292331|NCT00610441|450696620|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
125292332|NCT00610441|450696621|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
125292333|NCT00610441|450696622|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
125292334|NCT00610441|450696623|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
125292335|NCT00610441|450696620|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
125292336|NCT00610441|450696621|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
125292337|NCT00610441|450696622|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
125292338|NCT00610441|450696623|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
125292339|NCT00610441|450696620|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
125454906|NCT01090024|451294674|FG008|Period 1|Met exclusion criteria|0|||
125454907|NCT01090024|451294675|FG009|Period 1|Met exclusion criteria|0|||
125454908|NCT01090024|451294676|FG010|Period 1|Met exclusion criteria|0|||
125292340|NCT00610441|450696621|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
125292341|NCT00610441|450696622|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
125292342|NCT00610441|450696623|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
125292343|NCT00610441|450696620|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
125292344|NCT00610441|450696621|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
125292345|NCT00610441|450696622|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
125292346|NCT00610441|450696623|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
125292347|NCT03002623|450696628|FG000|Overall Study|Lost to Follow-up|1|||
125292348|NCT03002623|450696629|FG001|Overall Study|Lost to Follow-up|0|||
125292349|NCT03002623|450696628|FG000|Overall Study|Physician Decision|1|||
125292350|NCT03002623|450696629|FG001|Overall Study|Physician Decision|1|||
125292351|NCT02639338|450696630|FG000|Overall Study|Lost to Follow-up|2|||
125292352|NCT02639338|450696631|FG001|Overall Study|Lost to Follow-up|2|||
125292353|NCT02639338|450696630|FG000|Overall Study|Withdrew Consent|1|||
125292354|NCT02639338|450696631|FG001|Overall Study|Withdrew Consent|2|||
125292355|NCT02639338|450696630|FG000|Overall Study|Death|1|||
125292356|NCT02639338|450696631|FG001|Overall Study|Death|0|||
125292357|NCT02639338|450696630|FG000|Overall Study|Randomized but Not Treated|0|||
125292358|NCT02639338|450696631|FG001|Overall Study|Randomized but Not Treated|1|||
125292359|NCT00493636|450696632|FG000|Overall Study|Withdrawal by Subject|1|||
125292360|NCT00493636|450696633|FG001|Overall Study|Withdrawal by Subject|0|||
125292361|NCT00493636|450696632|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
125292362|NCT00493636|450696633|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
125292363|NCT00493636|450696632|FG000|Overall Study|Mis-randomization|1|||
125292364|NCT00493636|450696633|FG001|Overall Study|Mis-randomization|1|||
125292365|NCT01066780|450696640|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
125292366|NCT01066780|450696641|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
125292367|NCT03131596|450698660|FG000|Overall Study|Protocol Violation|3|||
125292368|NCT03131596|450698661|FG001|Overall Study|Protocol Violation|3|||
125292369|NCT03131596|450698660|FG000|Overall Study|Lost to Follow-up|3|||
125292370|NCT03131596|450698661|FG001|Overall Study|Lost to Follow-up|0|||
125292371|NCT00734071|450698664|FG000|Overall Study|Adverse Event|4|||
125292372|NCT00734071|450698665|FG001|Overall Study|Adverse Event|3|||
125292373|NCT00734071|450698664|FG000|Overall Study|Lack of Efficacy|3|||
125292374|NCT00734071|450698665|FG001|Overall Study|Lack of Efficacy|1|||
125292375|NCT00734071|450698664|FG000|Overall Study|Noncompliance|2|||
125292376|NCT00734071|450698665|FG001|Overall Study|Noncompliance|2|||
125292377|NCT00734071|450698664|FG000|Overall Study|Protocol Deviations|3|||
125292378|NCT00734071|450698665|FG001|Overall Study|Protocol Deviations|4|||
125292379|NCT00734071|450698664|FG000|Overall Study|Voluntary Withdrawal|9|||
125292380|NCT00734071|450698665|FG001|Overall Study|Voluntary Withdrawal|7|||
125292381|NCT00734071|450698664|FG000|Overall Study|Lost to Follow-up|16|||
125292382|NCT00734071|450698665|FG001|Overall Study|Lost to Follow-up|8|||
125292383|NCT00734071|450698664|FG000|Overall Study|Other|1|||
125292384|NCT00734071|450698665|FG001|Overall Study|Other|2|||
125292385|NCT00151372|450698666|FG000|Overall Study|Death|12|||
125292386|NCT00151372|450698667|FG001|Overall Study|Death|11|||
125292387|NCT00151372|450698666|FG000|Overall Study|Lost to Follow-up|5|||
125292388|NCT00151372|450698667|FG001|Overall Study|Lost to Follow-up|5|||
125292389|NCT00151372|450698666|FG000|Overall Study|Too sick medically to continue|5|||
125292390|NCT00151372|450698667|FG001|Overall Study|Too sick medically to continue|6|||
125292391|NCT00151372|450698666|FG000|Overall Study|Withdrawal by Subject|7|||
125292392|NCT00151372|450698667|FG001|Overall Study|Withdrawal by Subject|7|||
125292393|NCT00541346|450698669|FG000|Follow-up|Adverse Event|1|||
125292394|NCT04732949|450698670|FG000|Overall Study|Withdrawal by Subject|23|||
125292395|NCT04732949|450698671|FG001|Overall Study|Withdrawal by Subject|27|||
125292396|NCT04732949|450698670|FG000|Overall Study|Protocol Violation|0|||
125292397|NCT04732949|450698671|FG001|Overall Study|Protocol Violation|1|||
125292398|NCT04732949|450698670|FG000|Overall Study|Non-compliance|0|||
125292399|NCT04732949|450698671|FG001|Overall Study|Non-compliance|2|||
125292400|NCT04732949|450698670|FG000|Overall Study|Physician Decision|2|||
125454909|NCT01090024|451294677|FG011|Period 1|Met exclusion criteria|0|||
125454910|NCT01090024|451294678|FG012|Period 1|Met exclusion criteria|0|||
125292401|NCT04732949|450698671|FG001|Overall Study|Physician Decision|1|||
125292402|NCT04732949|450698670|FG000|Overall Study|Serious adverse event (Fatal)|16|||
125292403|NCT04732949|450698671|FG001|Overall Study|Serious adverse event (Fatal)|18|||
125292404|NCT04732949|450698670|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
125292405|NCT04732949|450698671|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
125292406|NCT04732949|450698670|FG000|Overall Study|Non-serious adverse event|1|||
125292407|NCT04732949|450698671|FG001|Overall Study|Non-serious adverse event|3|||
125292408|NCT04732949|450698670|FG000|Overall Study|Lost to Follow-up|26|||
125292409|NCT04732949|450698671|FG001|Overall Study|Lost to Follow-up|27|||
125292410|NCT04732949|450698670|FG000|Overall Study|Other|6|||
125292411|NCT04732949|450698671|FG001|Overall Study|Other|3|||
125292412|NCT00583791|450698674|FG000|Overall Study|Other|67|||
125454911|NCT01090024|451294679|FG013|Period 1|Met exclusion criteria|0|||
125292413|NCT00583791|450698674|FG000|Overall Study|Death|6|||
125292414|NCT03323736|450698675|FG000|Overall Study|Screen Failure|14|||
125292415|NCT03323736|450698676|FG001|Overall Study|Screen Failure|9|||
125292416|NCT03323736|450698677|FG002|Overall Study|Screen Failure|1|||
125292417|NCT03323736|450698675|FG000|Overall Study|Withdrawal Before Treatment|3|||
125292418|NCT03323736|450698676|FG001|Overall Study|Withdrawal Before Treatment|1|||
125292419|NCT03323736|450698677|FG002|Overall Study|Withdrawal Before Treatment|1|||
125292420|NCT03323736|450698675|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
125292421|NCT03323736|450698676|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
125292422|NCT03323736|450698677|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
125292423|NCT03710876|450698678|FG000|Overall Study|Death|0|||
125292424|NCT03710876|450698679|FG001|Overall Study|Death|2|||
125292425|NCT03710876|450698678|FG000|Overall Study|Withdrawal by Subject|0|||
125292426|NCT03710876|450698679|FG001|Overall Study|Withdrawal by Subject|2|||
125292427|NCT02853435|450698680|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
125292428|NCT02853435|450698681|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
125292429|NCT02853435|450698682|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
125292430|NCT02853435|450698683|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
125292431|NCT02853435|450698684|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
125292432|NCT02853435|450698685|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
125292433|NCT03747120|450698688|FG000|Overall Study|treatment related toxicity|3|||
125292434|NCT03747120|450698689|FG001|Overall Study|treatment related toxicity|0|||
125292435|NCT03747120|450698690|FG002|Overall Study|treatment related toxicity|0|||
125292436|NCT03747120|450698688|FG000|Overall Study|Withdrawal by Subject|0|||
125292437|NCT03747120|450698689|FG001|Overall Study|Withdrawal by Subject|1|||
125292438|NCT03747120|450698690|FG002|Overall Study|Withdrawal by Subject|2|||
125292439|NCT04191499|450698699|FG000|Overall Study|Adverse Event|1|||
125292440|NCT04191499|450698700|FG001|Overall Study|Adverse Event|0|||
125292441|NCT04191499|450698699|FG000|Overall Study|Death|42|||
125292442|NCT04191499|450698700|FG001|Overall Study|Death|55|||
125292443|NCT04191499|450698699|FG000|Overall Study|Lost to Follow-up|4|||
125292444|NCT04191499|450698700|FG001|Overall Study|Lost to Follow-up|1|||
125292445|NCT04191499|450698699|FG000|Overall Study|Physician Decision|1|||
125292446|NCT04191499|450698700|FG001|Overall Study|Physician Decision|0|||
125292447|NCT04191499|450698699|FG000|Overall Study|Progressive Disease|1|||
125292448|NCT04191499|450698700|FG001|Overall Study|Progressive Disease|0|||
125292449|NCT04191499|450698699|FG000|Overall Study|Symptomatic Deterioration|1|||
125292450|NCT04191499|450698700|FG001|Overall Study|Symptomatic Deterioration|0|||
125292451|NCT04191499|450698699|FG000|Overall Study|Withdrawal by Subject|7|||
125292452|NCT04191499|450698700|FG001|Overall Study|Withdrawal by Subject|11|||
125292453|NCT04191499|450698699|FG000|Overall Study|Ongoing in the study|104|||
125292454|NCT04191499|450698700|FG001|Overall Study|Ongoing in the study|97|||
125292455|NCT01266317|450698701|FG000|Overall Study|Withdrawal by Subject|2|||
125292456|NCT00490776|450698702|FG000|Overall Study|Withdrawal by Subject|1|||
125292457|NCT00490776|450698702|FG000|Overall Study|Administrative Problems|1|||
125292458|NCT00490776|450698702|FG000|Overall Study|Death|1|||
125292459|NCT00490776|450698702|FG000|Overall Study|New Cancer Therapy|1|||
125292460|NCT00490776|450698702|FG000|Overall Study|Disease Progression|5|||
125292461|NCT04271475|450698714|FG000|DB Period: Day 1 up to EODBT|Death|1|||
125292462|NCT04271475|450698715|FG001|DB Period: Day 1 up to EODBT|Death|0|||
125292463|NCT04271475|450698716|FG002|DB Period: Day 1 up to EODBT|Death|0|||
125292464|NCT04271475|450698717|FG003|DB Period: Day 1 up to EODBT|Death|0|||
125292465|NCT04271475|450698714|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
125292466|NCT04271475|450698715|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
125292467|NCT04271475|450698716|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
125292468|NCT04271475|450698717|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
125292469|NCT04271475|450698714|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
125292470|NCT04271475|450698715|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
125292471|NCT04271475|450698716|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
125292472|NCT04271475|450698717|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
125292473|NCT04271475|450698714|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
125292474|NCT04271475|450698715|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
125292475|NCT04271475|450698716|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
125454912|NCT01090024|451294680|FG014|Period 1|Met exclusion criteria|1|||
125454913|NCT01090024|451294681|FG015|Period 1|Met exclusion criteria|0|||
125292476|NCT04271475|450698717|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
125292477|NCT04271475|450698714|FG000|DB Period: Day 1 up to EODBT|Other|8|||
125292478|NCT04271475|450698715|FG001|DB Period: Day 1 up to EODBT|Other|5|||
125292479|NCT04271475|450698716|FG002|DB Period: Day 1 up to EODBT|Other|0|||
125292480|NCT04271475|450698717|FG003|DB Period: Day 1 up to EODBT|Other|0|||
125292481|NCT04271475|450698714|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
125292482|NCT04271475|450698715|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
125292483|NCT04271475|450698716|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
125292484|NCT04271475|450698717|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
125292485|NCT04271475|450698714|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
125292486|NCT04271475|450698715|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
125292487|NCT04271475|450698716|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
125292488|NCT04271475|450698717|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
125292489|NCT00159913|450698719|FG000|Overall Study|Adverse Event|1|||
125292490|NCT00159913|450698720|FG001|Overall Study|Adverse Event|0|||
125292491|NCT00159913|450698721|FG002|Overall Study|Adverse Event|1|||
125292492|NCT00159913|450698722|FG003|Overall Study|Adverse Event|0|||
125292493|NCT00159913|450698719|FG000|Overall Study|Withdrawal by Subject|0|||
125292494|NCT00159913|450698720|FG001|Overall Study|Withdrawal by Subject|0|||
125292495|NCT00159913|450698721|FG002|Overall Study|Withdrawal by Subject|0|||
125292496|NCT00159913|450698722|FG003|Overall Study|Withdrawal by Subject|1|||
125292497|NCT00159913|450698719|FG000|Overall Study|Lost to Follow-up|0|||
125292498|NCT00159913|450698720|FG001|Overall Study|Lost to Follow-up|0|||
125292499|NCT00159913|450698721|FG002|Overall Study|Lost to Follow-up|0|||
125292500|NCT00159913|450698722|FG003|Overall Study|Lost to Follow-up|1|||
125292501|NCT00159913|450698719|FG000|Overall Study|Protocol Violation|1|||
125292502|NCT00159913|450698720|FG001|Overall Study|Protocol Violation|0|||
125292503|NCT00159913|450698721|FG002|Overall Study|Protocol Violation|1|||
125292504|NCT00159913|450698722|FG003|Overall Study|Protocol Violation|0|||
125292505|NCT00824005|450698723|FG000|Overall Study|Death|0|||
125292506|NCT00824005|450698724|FG001|Overall Study|Death|1|||
125292507|NCT00824005|450698723|FG000|Overall Study|Lost to Follow-up|0|||
125292508|NCT00824005|450698724|FG001|Overall Study|Lost to Follow-up|1|||
125292509|NCT01874275|450698725|FG000|Overall Study|Lost to Follow-up|1|||
125292510|NCT01874275|450698726|FG001|Overall Study|Lost to Follow-up|0|||
125292511|NCT00168103|450698729|FG000|Overall Study|Withdrawal by Subject|1|||
125292512|NCT00168103|450698730|FG001|Overall Study|Withdrawal by Subject|2|||
125292513|NCT00168103|450698731|FG002|Overall Study|Withdrawal by Subject|1|||
125292514|NCT00168103|450698732|FG003|Overall Study|Withdrawal by Subject|0|||
125292515|NCT00168103|450698729|FG000|Overall Study|Lost to Follow-up|1|||
125292516|NCT00168103|450698730|FG001|Overall Study|Lost to Follow-up|3|||
125292517|NCT00168103|450698731|FG002|Overall Study|Lost to Follow-up|0|||
125292518|NCT00168103|450698732|FG003|Overall Study|Lost to Follow-up|0|||
125292519|NCT00989235|450698733|FG000|Overall Study|Death|0|||
125292520|NCT00989235|450698734|FG001|Overall Study|Death|1|||
125292521|NCT00989235|450698733|FG000|Overall Study|Adverse Event|0|||
125292522|NCT00989235|450698734|FG001|Overall Study|Adverse Event|1|||
125292523|NCT00989235|450698733|FG000|Overall Study|Lack of Efficacy|1|||
125292524|NCT00989235|450698734|FG001|Overall Study|Lack of Efficacy|0|||
125292525|NCT00989235|450698733|FG000|Overall Study|Withdrawal of Consent|1|||
125292526|NCT00989235|450698734|FG001|Overall Study|Withdrawal of Consent|1|||
125292527|NCT00989235|450698733|FG000|Overall Study|Desire to Become Pregnant|1|||
125292528|NCT00989235|450698734|FG001|Overall Study|Desire to Become Pregnant|0|||
125292529|NCT00989235|450698733|FG000|Overall Study|Randomized by Mistake|0|||
125292530|NCT00989235|450698734|FG001|Overall Study|Randomized by Mistake|2|||
125292531|NCT00989235|450698733|FG000|Overall Study|Lost to Follow-up|0|||
125292532|NCT00989235|450698734|FG001|Overall Study|Lost to Follow-up|1|||
125292533|NCT02266875|450698735|FG000|Overall Study|Withdrawal by Subject|9|||
125292534|NCT02266875|450698736|FG001|Overall Study|Withdrawal by Subject|0|||
125292535|NCT02266875|450698735|FG000|Overall Study|Lost to Follow-up|2|||
125292536|NCT02266875|450698736|FG001|Overall Study|Lost to Follow-up|0|||
125292537|NCT00875056|450698739|FG000|Overall Study|Adverse Event|6|||
125292538|NCT00875056|450698740|FG001|Overall Study|Adverse Event|1|||
125292539|NCT00875056|450698741|FG002|Overall Study|Adverse Event|2|||
125292540|NCT00875056|450698739|FG000|Overall Study|Progressive Disease|14|||
125292541|NCT00875056|450698740|FG001|Overall Study|Progressive Disease|8|||
125292542|NCT00875056|450698741|FG002|Overall Study|Progressive Disease|3|||
125292543|NCT00875056|450698739|FG000|Overall Study|Withdrawal by Subject|3|||
125292544|NCT00875056|450698740|FG001|Overall Study|Withdrawal by Subject|0|||
125292545|NCT00875056|450698741|FG002|Overall Study|Withdrawal by Subject|1|||
125292546|NCT01318070|450698742|FG000|Overall Study|Adverse Event|1|||
125292547|NCT01318070|450698743|FG001|Overall Study|Adverse Event|1|||
125292548|NCT01318070|450698744|FG002|Overall Study|Adverse Event|5|||
125292549|NCT01318070|450698742|FG000|Overall Study|Withdrawal by Subject|0|||
125292550|NCT01318070|450698743|FG001|Overall Study|Withdrawal by Subject|1|||
125292551|NCT01318070|450698744|FG002|Overall Study|Withdrawal by Subject|1|||
125292552|NCT01318070|450698742|FG000|Overall Study|Lack of Efficacy|0|||
125292553|NCT01318070|450698743|FG001|Overall Study|Lack of Efficacy|0|||
125292554|NCT01318070|450698744|FG002|Overall Study|Lack of Efficacy|1|||
125292555|NCT01318070|450698742|FG000|Overall Study|Principal Investigator Discretion|1|||
125292556|NCT01318070|450698743|FG001|Overall Study|Principal Investigator Discretion|0|||
125292557|NCT01318070|450698744|FG002|Overall Study|Principal Investigator Discretion|0|||
125292558|NCT02956850|450698745|FG000|Overall Study|Withdrawal by Subject|0|||
125292559|NCT02956850|450698746|FG001|Overall Study|Withdrawal by Subject|0|||
125292560|NCT02956850|450698747|FG002|Overall Study|Withdrawal by Subject|0|||
125292561|NCT02956850|450698748|FG003|Overall Study|Withdrawal by Subject|0|||
125292562|NCT02956850|450698749|FG004|Overall Study|Withdrawal by Subject|0|||
125292563|NCT02956850|450698750|FG005|Overall Study|Withdrawal by Subject|0|||
125292564|NCT02956850|450698751|FG006|Overall Study|Withdrawal by Subject|0|||
125292565|NCT02956850|450698752|FG007|Overall Study|Withdrawal by Subject|0|||
125292566|NCT02956850|450698753|FG008|Overall Study|Withdrawal by Subject|0|||
125292567|NCT02956850|450698754|FG009|Overall Study|Withdrawal by Subject|0|||
125292568|NCT02956850|450698755|FG010|Overall Study|Withdrawal by Subject|0|||
125292569|NCT02956850|450698756|FG011|Overall Study|Withdrawal by Subject|0|||
125292570|NCT02956850|450698757|FG012|Overall Study|Withdrawal by Subject|0|||
125292571|NCT02956850|450698758|FG013|Overall Study|Withdrawal by Subject|0|||
125292572|NCT02956850|450698759|FG014|Overall Study|Withdrawal by Subject|0|||
125292573|NCT02956850|450698760|FG015|Overall Study|Withdrawal by Subject|0|||
125292574|NCT02956850|450698761|FG016|Overall Study|Withdrawal by Subject|0|||
125292575|NCT02956850|450698762|FG017|Overall Study|Withdrawal by Subject|1|||
125292576|NCT00391391|450698763|FG000|Overall Study|Adverse Event|0|||
125292577|NCT00391391|450698764|FG001|Overall Study|Adverse Event|0|||
125292578|NCT00391391|450698765|FG002|Overall Study|Adverse Event|0|||
125292579|NCT00391391|450698766|FG003|Overall Study|Adverse Event|1|||
125292580|NCT00391391|450698763|FG000|Overall Study|Lost to Follow-up|1|||
125292581|NCT00391391|450698764|FG001|Overall Study|Lost to Follow-up|3|||
125292582|NCT00391391|450698765|FG002|Overall Study|Lost to Follow-up|7|||
125292583|NCT00391391|450698766|FG003|Overall Study|Lost to Follow-up|4|||
125292584|NCT00391391|450698763|FG000|Overall Study|Protocol Violation|2|||
125292585|NCT00391391|450698764|FG001|Overall Study|Protocol Violation|3|||
125292586|NCT00391391|450698765|FG002|Overall Study|Protocol Violation|6|||
125292587|NCT00391391|450698766|FG003|Overall Study|Protocol Violation|7|||
125292588|NCT00391391|450698763|FG000|Overall Study|Withdrawal by Subject|6|||
125292589|NCT00391391|450698764|FG001|Overall Study|Withdrawal by Subject|4|||
125292590|NCT00391391|450698765|FG002|Overall Study|Withdrawal by Subject|10|||
125292591|NCT00391391|450698766|FG003|Overall Study|Withdrawal by Subject|7|||
125292592|NCT01920152|450698769|FG000|Overall Study|Withdrawal by Subject|1|||
125292593|NCT01920152|450698770|FG001|Overall Study|Withdrawal by Subject|2|||
125292594|NCT01995552|450698773|FG000|Overall Study|Protocol Violation|1|||
125292595|NCT01995552|450698773|FG000|Overall Study|Lack of Efficacy|15|||
125292596|NCT01995552|450698773|FG000|Overall Study|Death|1|||
125292597|NCT00353873|450698774|FG000|Overall Study|Protocol Violation|1|||
125292598|NCT00353873|450698775|FG001|Overall Study|Protocol Violation|2|||
125292599|NCT00353873|450698774|FG000|Overall Study|Exacerbation|1|||
125292600|NCT00353873|450698775|FG001|Overall Study|Exacerbation|0|||
125292601|NCT00353873|450698774|FG000|Overall Study|Adverse Event|1|||
125292602|NCT00353873|450698775|FG001|Overall Study|Adverse Event|0|||
125292603|NCT00353873|450698774|FG000|Overall Study|Physician Decision|2|||
125292604|NCT00353873|450698775|FG001|Overall Study|Physician Decision|0|||
125292605|NCT00353873|450698774|FG000|Overall Study|Withdrawal by Subject|1|||
125292606|NCT00353873|450698775|FG001|Overall Study|Withdrawal by Subject|1|||
125292607|NCT00870194|450698778|FG000|Overall Study|Adverse Event|10|||
125292608|NCT00870194|450698779|FG001|Overall Study|Adverse Event|5|||
125292609|NCT00870194|450698778|FG000|Overall Study|Lack of Efficacy|0|||
125292610|NCT00870194|450698779|FG001|Overall Study|Lack of Efficacy|1|||
125292611|NCT00870194|450698778|FG000|Overall Study|Lost to Follow-up|2|||
125292612|NCT00870194|450698779|FG001|Overall Study|Lost to Follow-up|0|||
125292613|NCT00870194|450698778|FG000|Overall Study|Physician Decision|3|||
125292614|NCT00870194|450698779|FG001|Overall Study|Physician Decision|1|||
125292615|NCT00870194|450698778|FG000|Overall Study|Protocol Violation|3|||
125292616|NCT00870194|450698779|FG001|Overall Study|Protocol Violation|3|||
125292617|NCT00870194|450698778|FG000|Overall Study|Entry Criteria Not Met|1|||
125292618|NCT00870194|450698779|FG001|Overall Study|Entry Criteria Not Met|2|||
125292619|NCT00870194|450698778|FG000|Overall Study|Subject Decision|7|||
125292620|NCT00870194|450698779|FG001|Overall Study|Subject Decision|2|||
125454914|NCT01090024|451294682|FG016|Period 1|Met exclusion criteria|0|||
125454915|NCT01090024|451294683|FG017|Period 1|Met exclusion criteria|0|||
125454916|NCT01090024|451294666|FG000|Period 1|Adverse Event|0|||
125454917|NCT01090024|451294667|FG001|Period 1|Adverse Event|0|||
125292621|NCT02717130|450698780|FG000|Overall Study|Withdrawal by Subject|1|||
125292622|NCT02717130|450698780|FG000|Overall Study|Adverse Event|1|||
125292623|NCT02717130|450698780|FG000|Overall Study|Physician Decision|1|||
125292624|NCT02717130|450698780|FG000|Overall Study|Study Closure|4|||
125292625|NCT00554099|450698781|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
125292626|NCT00554099|450698782|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
125454918|NCT01090024|451294668|FG002|Period 1|Adverse Event|0|||
125292627|NCT00554099|450698783|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
125292628|NCT00554099|450698781|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
125292629|NCT00554099|450698782|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
125292630|NCT00554099|450698783|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
125292631|NCT00554099|450698781|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
125292632|NCT00554099|450698782|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
125292633|NCT00554099|450698783|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
125292634|NCT00554099|450698781|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
125292635|NCT00554099|450698782|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
125454919|NCT01090024|451294669|FG003|Period 1|Adverse Event|0|||
125292636|NCT00554099|450698783|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
125292637|NCT00554099|450698781|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
125292638|NCT00554099|450698782|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
125292639|NCT00554099|450698783|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
125292640|NCT00554099|450698781|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
125292641|NCT00554099|450698782|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
125292642|NCT00554099|450698783|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
125292643|NCT00554099|450698781|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
125292644|NCT00554099|450698782|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
125292645|NCT00554099|450698783|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
125292646|NCT00554099|450698781|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
125292647|NCT00554099|450698782|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
125292648|NCT00554099|450698783|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
125292649|NCT00554099|450698781|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
125292650|NCT00554099|450698782|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
125292651|NCT00554099|450698783|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
125292652|NCT01443130|450698784|FG000|Overall Study|Lost to Follow-up|44|||
125292653|NCT01443130|450698785|FG001|Overall Study|Lost to Follow-up|42|||
125292654|NCT01443130|450698786|FG002|Overall Study|Lost to Follow-up|50|||
125292655|NCT01443130|450698787|FG003|Overall Study|Lost to Follow-up|23|||
125292656|NCT01443130|450698788|FG004|Overall Study|Lost to Follow-up|25|||
125292657|NCT01443130|450698789|FG005|Overall Study|Lost to Follow-up|21|||
125292658|NCT01443130|450698784|FG000|Overall Study|Death|0|||
125292659|NCT01443130|450698785|FG001|Overall Study|Death|1|||
125292660|NCT01443130|450698786|FG002|Overall Study|Death|0|||
125292661|NCT01443130|450698787|FG003|Overall Study|Death|7|||
125292662|NCT01443130|450698788|FG004|Overall Study|Death|10|||
125292663|NCT01443130|450698789|FG005|Overall Study|Death|8|||
125292664|NCT01443130|450698784|FG000|Overall Study|Adverse Event|2|||
125292665|NCT01443130|450698785|FG001|Overall Study|Adverse Event|1|||
125292666|NCT01443130|450698786|FG002|Overall Study|Adverse Event|1|||
125292667|NCT01443130|450698787|FG003|Overall Study|Adverse Event|0|||
125292668|NCT01443130|450698788|FG004|Overall Study|Adverse Event|0|||
125292669|NCT01443130|450698789|FG005|Overall Study|Adverse Event|0|||
125292670|NCT01443130|450698784|FG000|Overall Study|Protocol Violation|2|||
125292671|NCT01443130|450698785|FG001|Overall Study|Protocol Violation|1|||
125292672|NCT01443130|450698786|FG002|Overall Study|Protocol Violation|3|||
125292673|NCT01443130|450698787|FG003|Overall Study|Protocol Violation|2|||
125292674|NCT01443130|450698788|FG004|Overall Study|Protocol Violation|2|||
125292675|NCT01443130|450698789|FG005|Overall Study|Protocol Violation|3|||
125292676|NCT01443130|450698784|FG000|Overall Study|Withdrawal by Subject|15|||
125292677|NCT01443130|450698785|FG001|Overall Study|Withdrawal by Subject|14|||
125292678|NCT01443130|450698786|FG002|Overall Study|Withdrawal by Subject|12|||
125292679|NCT01443130|450698787|FG003|Overall Study|Withdrawal by Subject|7|||
125292680|NCT01443130|450698788|FG004|Overall Study|Withdrawal by Subject|7|||
125292681|NCT01443130|450698789|FG005|Overall Study|Withdrawal by Subject|2|||
125292682|NCT01443130|450698784|FG000|Overall Study|Death of Subject's Infant|5|||
125292683|NCT01443130|450698785|FG001|Overall Study|Death of Subject's Infant|10|||
125292684|NCT01443130|450698786|FG002|Overall Study|Death of Subject's Infant|11|||
125292685|NCT01443130|450698787|FG003|Overall Study|Death of Subject's Infant|0|||
125292686|NCT01443130|450698788|FG004|Overall Study|Death of Subject's Infant|0|||
125292687|NCT01443130|450698789|FG005|Overall Study|Death of Subject's Infant|0|||
125292688|NCT01011933|450698792|FG000|Overall Study|Wrong cell type|1|||
125454920|NCT01090024|451294670|FG004|Period 1|Adverse Event|0|||
125454921|NCT01090024|451294671|FG005|Period 1|Adverse Event|0|||
125454922|NCT01090024|451294672|FG006|Period 1|Adverse Event|0|||
125292689|NCT01011933|450698792|FG000|Overall Study|Improper pre-protocol Rx|1|||
125292690|NCT01011933|450698792|FG000|Overall Study|Inadequate pathology|1|||
125292691|NCT01011933|450698792|FG000|Overall Study|Never treated|1|||
125292692|NCT03461406|450698795|FG000|Overall Study|Death|1|||
125292693|NCT03461406|450698796|FG001|Overall Study|Death|2|||
125292694|NCT03461406|450698795|FG000|Overall Study|Consent Withdrawn by Participant|0|||
125292695|NCT03461406|450698796|FG001|Overall Study|Consent Withdrawn by Participant|1|||
125292696|NCT03461406|450698795|FG000|Overall Study|Screen Failure|3|||
125292697|NCT03461406|450698796|FG001|Overall Study|Screen Failure|1|||
125292698|NCT03461406|450698795|FG000|Overall Study|Reason not Specified|1|||
125292699|NCT03461406|450698796|FG001|Overall Study|Reason not Specified|3|||
125292700|NCT03461406|450698795|FG000|Overall Study|Lost to Follow-up|3|||
125454923|NCT01090024|451294673|FG007|Period 1|Adverse Event|0|||
125292701|NCT03461406|450698796|FG001|Overall Study|Lost to Follow-up|0|||
125292702|NCT01439074|450698797|FG000|Overall Study|Lost to Follow-up|3|||
125292703|NCT01439074|450698798|FG001|Overall Study|Lost to Follow-up|4|||
125292704|NCT01439074|450698797|FG000|Overall Study|Subject shedding|1|||
125292705|NCT01439074|450698798|FG001|Overall Study|Subject shedding|0|||
125292706|NCT01439074|450698797|FG000|Overall Study|Withdrawal by Subject|1|||
125292707|NCT01439074|450698798|FG001|Overall Study|Withdrawal by Subject|5|||
125292708|NCT01439074|450698797|FG000|Overall Study|Other|4|||
125454924|NCT01090024|451294674|FG008|Period 1|Adverse Event|0|||
125454925|NCT01090024|451294675|FG009|Period 1|Adverse Event|1|||
125454926|NCT01090024|451294676|FG010|Period 1|Adverse Event|0|||
125454927|NCT01090024|451294677|FG011|Period 1|Adverse Event|1|||
125454928|NCT01090024|451294678|FG012|Period 1|Adverse Event|0|||
125454929|NCT01090024|451294679|FG013|Period 1|Adverse Event|0|||
125454930|NCT01090024|451294680|FG014|Period 1|Adverse Event|0|||
125454931|NCT01090024|451294681|FG015|Period 1|Adverse Event|0|||
125454932|NCT01090024|451294682|FG016|Period 1|Adverse Event|0|||
125454933|NCT01090024|451294683|FG017|Period 1|Adverse Event|1|||
125454934|NCT01090024|451294666|FG000|Period 1|Withdrawal by Subject|0|||
125454935|NCT01090024|451294667|FG001|Period 1|Withdrawal by Subject|0|||
125454936|NCT01090024|451294668|FG002|Period 1|Withdrawal by Subject|0|||
125454937|NCT01090024|451294669|FG003|Period 1|Withdrawal by Subject|1|||
125454938|NCT01090024|451294670|FG004|Period 1|Withdrawal by Subject|0|||
125454939|NCT01090024|451294671|FG005|Period 1|Withdrawal by Subject|0|||
125454940|NCT01090024|451294672|FG006|Period 1|Withdrawal by Subject|0|||
125454941|NCT01090024|451294673|FG007|Period 1|Withdrawal by Subject|0|||
125292709|NCT01439074|450698798|FG001|Overall Study|Other|4|||
125292710|NCT02012686|450698799|FG000|Overall Study|muscle contraction|0|||
125292711|NCT02012686|450698800|FG001|Overall Study|muscle contraction|1|||
125292712|NCT02012686|450698799|FG000|Overall Study|electrocardiography monitoring noise|0|||
125292713|NCT02012686|450698800|FG001|Overall Study|electrocardiography monitoring noise|1|||
125292714|NCT00612508|450698801|FG000|Overall Study|Withdrawal by Subject|3|||
125292715|NCT00612508|450698802|FG001|Overall Study|Withdrawal by Subject|4|||
125292716|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
125292717|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
125292718|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
125292719|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
125292720|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
125292721|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
125292722|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
125292723|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
125292724|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
125292725|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
125292726|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
125292727|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
125292728|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
125292729|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
125292730|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
125292731|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
125292732|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
125292733|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
125292734|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
125292735|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
125292736|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
125292737|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
125292738|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
125292739|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
125292740|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
125292741|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
125292742|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
125292743|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
125292744|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
125292745|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
125292746|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
125292747|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
125292748|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
125292749|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
125292750|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
125292751|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
125292752|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
125292753|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
125292754|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
125292755|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
125454942|NCT01090024|451294674|FG008|Period 1|Withdrawal by Subject|0|||
125454943|NCT01090024|451294675|FG009|Period 1|Withdrawal by Subject|0|||
125454944|NCT01090024|451294676|FG010|Period 1|Withdrawal by Subject|0|||
125292756|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
125292757|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
125292758|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
125292759|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
125292760|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
125292761|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
125292762|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
125292763|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
125292764|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
125292765|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
125292766|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
125292767|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
125292768|NCT02008357|450698803|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
125292769|NCT02008357|450698804|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
125292770|NCT02008357|450698803|FG000|Open-label Extension Period|Adverse Event|8|||
125292771|NCT02008357|450698804|FG001|Open-label Extension Period|Adverse Event|7|||
125292772|NCT02008357|450698803|FG000|Open-label Extension Period|Death|7|||
125292773|NCT02008357|450698804|FG001|Open-label Extension Period|Death|4|||
125292774|NCT02008357|450698803|FG000|Open-label Extension Period|Lack of Efficacy|9|||
125292775|NCT02008357|450698804|FG001|Open-label Extension Period|Lack of Efficacy|5|||
125292776|NCT02008357|450698803|FG000|Open-label Extension Period|Lost to Follow-up|2|||
125292777|NCT02008357|450698804|FG001|Open-label Extension Period|Lost to Follow-up|2|||
125292778|NCT02008357|450698803|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
125292779|NCT02008357|450698804|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
125292780|NCT02008357|450698803|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
125292781|NCT02008357|450698804|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
125292782|NCT02008357|450698803|FG000|Open-label Extension Period|Safety Risk|2|||
125292783|NCT02008357|450698804|FG001|Open-label Extension Period|Safety Risk|1|||
125292784|NCT02008357|450698803|FG000|Open-label Extension Period|Non-Compliance|0|||
125292785|NCT02008357|450698804|FG001|Open-label Extension Period|Non-Compliance|1|||
125292786|NCT02008357|450698803|FG000|Open-label Extension Period|Investigator Recommendation|0|||
125292787|NCT02008357|450698804|FG001|Open-label Extension Period|Investigator Recommendation|1|||
125292788|NCT02008357|450698803|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
125292789|NCT02008357|450698804|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
125292790|NCT02008357|450698803|FG000|Open-label Extension Period|Coordinating Center Request|2|||
125292791|NCT02008357|450698804|FG001|Open-label Extension Period|Coordinating Center Request|4|||
125292792|NCT02008357|450698803|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
125292793|NCT02008357|450698804|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
125292794|NCT02008357|450698803|FG000|Open-label Extension Period|Study Ended|20|||
125292795|NCT02008357|450698804|FG001|Open-label Extension Period|Study Ended|25|||
125292796|NCT02008357|450698803|FG000|Open-label Extension Period|Personal Reasons|0|||
125292797|NCT02008357|450698804|FG001|Open-label Extension Period|Personal Reasons|1|||
125292798|NCT02008357|450698803|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
125292799|NCT02008357|450698804|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
125292800|NCT02008357|450698803|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
125292801|NCT02008357|450698804|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
125292802|NCT02008357|450698803|FG000|Open-label Extension Period|Other|2|||
125292803|NCT02008357|450698804|FG001|Open-label Extension Period|Other|0|||
125292804|NCT00787202|450698805|FG000|Overall Study|Adverse Event|3|||
125292805|NCT00787202|450698806|FG001|Overall Study|Adverse Event|2|||
125292806|NCT00787202|450698807|FG002|Overall Study|Adverse Event|0|||
125292807|NCT00787202|450698808|FG003|Overall Study|Adverse Event|0|||
125292808|NCT00787202|450698809|FG004|Overall Study|Adverse Event|2|||
125292809|NCT00787202|450698805|FG000|Overall Study|Lack of Efficacy|5|||
125292810|NCT00787202|450698806|FG001|Overall Study|Lack of Efficacy|6|||
125454945|NCT01090024|451294677|FG011|Period 1|Withdrawal by Subject|0|||
125454946|NCT01090024|451294678|FG012|Period 1|Withdrawal by Subject|0|||
125292811|NCT00787202|450698807|FG002|Overall Study|Lack of Efficacy|5|||
125292812|NCT00787202|450698808|FG003|Overall Study|Lack of Efficacy|2|||
125292813|NCT00787202|450698809|FG004|Overall Study|Lack of Efficacy|1|||
125292814|NCT00787202|450698805|FG000|Overall Study|Lost to Follow-up|1|||
125292815|NCT00787202|450698806|FG001|Overall Study|Lost to Follow-up|0|||
125292816|NCT00787202|450698807|FG002|Overall Study|Lost to Follow-up|0|||
125292817|NCT00787202|450698808|FG003|Overall Study|Lost to Follow-up|0|||
125292818|NCT00787202|450698809|FG004|Overall Study|Lost to Follow-up|0|||
125292819|NCT00787202|450698805|FG000|Overall Study|Withdrawal by Subject|2|||
125292820|NCT00787202|450698806|FG001|Overall Study|Withdrawal by Subject|2|||
125292821|NCT00787202|450698807|FG002|Overall Study|Withdrawal by Subject|2|||
125292822|NCT00787202|450698808|FG003|Overall Study|Withdrawal by Subject|0|||
125292823|NCT00787202|450698809|FG004|Overall Study|Withdrawal by Subject|0|||
125292824|NCT00787202|450698805|FG000|Overall Study|Protocol Violation|2|||
125292825|NCT00787202|450698806|FG001|Overall Study|Protocol Violation|1|||
125292826|NCT00787202|450698807|FG002|Overall Study|Protocol Violation|0|||
125292827|NCT00787202|450698808|FG003|Overall Study|Protocol Violation|0|||
125292828|NCT00787202|450698809|FG004|Overall Study|Protocol Violation|1|||
125292829|NCT00787202|450698805|FG000|Overall Study|Randomized, not treated|1|||
125292830|NCT00787202|450698806|FG001|Overall Study|Randomized, not treated|0|||
125292831|NCT00787202|450698807|FG002|Overall Study|Randomized, not treated|0|||
125292832|NCT00787202|450698808|FG003|Overall Study|Randomized, not treated|0|||
125292833|NCT00787202|450698809|FG004|Overall Study|Randomized, not treated|0|||
125292834|NCT01442064|450698810|FG000|Overall Study|Adverse Event|2|||
125292835|NCT01442064|450698811|FG001|Overall Study|Adverse Event|2|||
125292836|NCT01442064|450698812|FG002|Overall Study|Adverse Event|2|||
125292837|NCT01442064|450698813|FG003|Overall Study|Adverse Event|1|||
125292838|NCT01442064|450698814|FG004|Overall Study|Adverse Event|2|||
125292839|NCT01442064|450698815|FG005|Overall Study|Adverse Event|0|||
125292840|NCT01442064|450698810|FG000|Overall Study|Death|0|||
125292841|NCT01442064|450698811|FG001|Overall Study|Death|1|||
125292842|NCT01442064|450698812|FG002|Overall Study|Death|3|||
125292843|NCT01442064|450698813|FG003|Overall Study|Death|3|||
125292844|NCT01442064|450698814|FG004|Overall Study|Death|1|||
125292845|NCT01442064|450698815|FG005|Overall Study|Death|3|||
125292846|NCT01442064|450698810|FG000|Overall Study|Lost to Follow-up|5|||
125292847|NCT01442064|450698811|FG001|Overall Study|Lost to Follow-up|5|||
125292848|NCT01442064|450698812|FG002|Overall Study|Lost to Follow-up|1|||
125292849|NCT01442064|450698813|FG003|Overall Study|Lost to Follow-up|1|||
125292850|NCT01442064|450698814|FG004|Overall Study|Lost to Follow-up|3|||
125292851|NCT01442064|450698815|FG005|Overall Study|Lost to Follow-up|3|||
125292852|NCT01442064|450698810|FG000|Overall Study|Physician Decision|1|||
125292853|NCT01442064|450698811|FG001|Overall Study|Physician Decision|1|||
125292854|NCT01442064|450698812|FG002|Overall Study|Physician Decision|2|||
125292855|NCT01442064|450698813|FG003|Overall Study|Physician Decision|3|||
125292856|NCT01442064|450698814|FG004|Overall Study|Physician Decision|3|||
125292857|NCT01442064|450698815|FG005|Overall Study|Physician Decision|1|||
125292858|NCT01442064|450698810|FG000|Overall Study|Withdrawal by Subject|6|||
125292859|NCT01442064|450698811|FG001|Overall Study|Withdrawal by Subject|3|||
125292860|NCT01442064|450698812|FG002|Overall Study|Withdrawal by Subject|2|||
125292861|NCT01442064|450698813|FG003|Overall Study|Withdrawal by Subject|2|||
125292862|NCT01442064|450698814|FG004|Overall Study|Withdrawal by Subject|2|||
125292863|NCT01442064|450698815|FG005|Overall Study|Withdrawal by Subject|1|||
125292864|NCT01442064|450698810|FG000|Overall Study|Sponsor decision|82|||
125292865|NCT01442064|450698811|FG001|Overall Study|Sponsor decision|88|||
125292866|NCT01442064|450698812|FG002|Overall Study|Sponsor decision|92|||
125292867|NCT01442064|450698813|FG003|Overall Study|Sponsor decision|88|||
125292868|NCT01442064|450698814|FG004|Overall Study|Sponsor decision|95|||
125292869|NCT01442064|450698815|FG005|Overall Study|Sponsor decision|87|||
125292870|NCT01442064|450698810|FG000|Overall Study|Subject non-compliance|0|||
125292871|NCT01442064|450698811|FG001|Overall Study|Subject non-compliance|0|||
125292872|NCT01442064|450698812|FG002|Overall Study|Subject non-compliance|0|||
125292873|NCT01442064|450698813|FG003|Overall Study|Subject non-compliance|0|||
125292874|NCT01442064|450698814|FG004|Overall Study|Subject non-compliance|0|||
125292875|NCT01442064|450698815|FG005|Overall Study|Subject non-compliance|2|||
125292876|NCT01442064|450698810|FG000|Overall Study|Condition mandated other intervention|1|||
125292877|NCT01442064|450698811|FG001|Overall Study|Condition mandated other intervention|1|||
125292878|NCT01442064|450698812|FG002|Overall Study|Condition mandated other intervention|2|||
125292879|NCT01442064|450698813|FG003|Overall Study|Condition mandated other intervention|0|||
125292880|NCT01442064|450698814|FG004|Overall Study|Condition mandated other intervention|0|||
125292881|NCT01442064|450698815|FG005|Overall Study|Condition mandated other intervention|2|||
125292882|NCT00966719|450698816|FG000|Overall Study|Lost to Follow-up|6|||
125292883|NCT00966719|450698817|FG001|Overall Study|Lost to Follow-up|11|||
125454947|NCT01090024|451294679|FG013|Period 1|Withdrawal by Subject|0|||
125292884|NCT01703065|450698818|FG000|Overall Study|Lack of Efficacy|1|||
125292885|NCT01703065|450698819|FG001|Overall Study|Lack of Efficacy|0|||
125292886|NCT02635347|450698820|FG000|Overall Study|Failed screening|20|||
125454948|NCT01090024|451294680|FG014|Period 1|Withdrawal by Subject|0|||
125292887|NCT02635347|450698821|FG001|Overall Study|Failed screening|7|||
125292888|NCT00514020|450698823|FG000|Overall Study|Adverse Event|6|||
125292889|NCT00514020|450698823|FG000|Overall Study|Withdrawal by Subject|3|||
125292890|NCT00514020|450698823|FG000|Overall Study|Physician Decision|1|||
125292891|NCT00514020|450698823|FG000|Overall Study|disease progression|9|||
125292892|NCT00514020|450698823|FG000|Overall Study|other complicating disease|2|||
125292893|NCT00514020|450698823|FG000|Overall Study|patient went to radiation treatment|1|||
125292894|NCT00514020|450698823|FG000|Overall Study|"patients moved to the no tx group"|6|||
125454949|NCT01090024|451294681|FG015|Period 1|Withdrawal by Subject|0|||
125292895|NCT01688921|450698824|FG000|Overall Study|Lost to Follow-up|7|||
125292896|NCT01688921|450698825|FG001|Overall Study|Lost to Follow-up|13|||
125292897|NCT01688921|450698824|FG000|Overall Study|Physician Decision|6|||
125292898|NCT01688921|450698825|FG001|Overall Study|Physician Decision|1|||
125292899|NCT01688921|450698824|FG000|Overall Study|Protocol Violation|0|||
125292900|NCT01688921|450698825|FG001|Overall Study|Protocol Violation|1|||
125292901|NCT01688921|450698824|FG000|Overall Study|informed consent|3|||
125292902|NCT01688921|450698825|FG001|Overall Study|informed consent|0|||
125292903|NCT03089944|450698826|FG000|Overall Study|Lost to Follow-up|8|||
125292904|NCT03089944|450698826|FG000|Overall Study|Withdrew Consent|2|||
125292905|NCT03089944|450698826|FG000|Overall Study|Adverse Event|1|||
125292906|NCT03089944|450698826|FG000|Overall Study|Other|1|||
125292907|NCT01636713|450698831|FG000|Overall Study|Adverse Event|16|||
125292908|NCT01636713|450698832|FG001|Overall Study|Adverse Event|16|||
125292909|NCT01636713|450698833|FG002|Overall Study|Adverse Event|7|||
125292910|NCT01636713|450698831|FG000|Overall Study|Lack of Efficacy|6|||
125292911|NCT01636713|450698832|FG001|Overall Study|Lack of Efficacy|6|||
125292912|NCT01636713|450698833|FG002|Overall Study|Lack of Efficacy|2|||
125292913|NCT01636713|450698831|FG000|Overall Study|Protocol Violation|3|||
125292914|NCT01636713|450698832|FG001|Overall Study|Protocol Violation|0|||
125292915|NCT01636713|450698833|FG002|Overall Study|Protocol Violation|1|||
125292916|NCT01636713|450698831|FG000|Overall Study|Lost to Follow-up|0|||
125292917|NCT01636713|450698832|FG001|Overall Study|Lost to Follow-up|0|||
125292918|NCT01636713|450698833|FG002|Overall Study|Lost to Follow-up|1|||
125292919|NCT01636713|450698831|FG000|Overall Study|Withdrawal by Subject|5|||
125292920|NCT01636713|450698832|FG001|Overall Study|Withdrawal by Subject|4|||
125292921|NCT01636713|450698833|FG002|Overall Study|Withdrawal by Subject|8|||
125292922|NCT01636713|450698831|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
125292923|NCT01636713|450698832|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
125292924|NCT01636713|450698833|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
125292925|NCT03780959|450698834|FG000|Part 1|Adverse Event|1|||
125292926|NCT03780959|450698835|FG001|Part 1|Adverse Event|0|||
125292927|NCT03780959|450698836|FG002|Part 1|Adverse Event|0|||
125292928|NCT03780959|450698834|FG000|Part 1|Withdrawal by Subject|1|||
125292929|NCT03780959|450698835|FG001|Part 1|Withdrawal by Subject|0|||
125292930|NCT03780959|450698836|FG002|Part 1|Withdrawal by Subject|0|||
125292931|NCT03780959|450698834|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
125292932|NCT03780959|450698835|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
125292933|NCT03780959|450698836|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
125292934|NCT03780959|450698834|FG000|Part 1|Response Status|2|||
125292935|NCT03780959|450698835|FG001|Part 1|Response Status|0|||
125292936|NCT03780959|450698836|FG002|Part 1|Response Status|0|||
125292937|NCT03780959|450698834|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
125292938|NCT03780959|450698835|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
125292939|NCT03780959|450698836|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
125292940|NCT03780959|450698834|FG000|Part 2|Response Status|0|||
125292941|NCT03780959|450698835|FG001|Part 2|Response Status|18|||
125292942|NCT03780959|450698836|FG002|Part 2|Response Status|6|||
125292943|NCT00831701|450698837|FG000|Overall Study|Withdrawal by Subject|2|||
125292944|NCT00831701|450698838|FG001|Overall Study|Withdrawal by Subject|0|||
125292945|NCT00831701|450698837|FG000|Overall Study|Stone expulsion before first medication|2|||
125292946|NCT00831701|450698838|FG001|Overall Study|Stone expulsion before first medication|2|||
125292947|NCT00831701|450698837|FG000|Overall Study|Lost to Follow-up|1|||
125292948|NCT00831701|450698838|FG001|Overall Study|Lost to Follow-up|3|||
125292949|NCT00940485|450700175|FG000|Overall Study|HBeAb positive at Baseline|3|||
125292950|NCT00940485|450700176|FG001|Overall Study|HBeAb positive at Baseline|2|||
125292951|NCT00940485|450700175|FG000|Overall Study|Lost to Follow-up|2|||
125292952|NCT00940485|450700176|FG001|Overall Study|Lost to Follow-up|3|||
125292953|NCT00940485|450700175|FG000|Overall Study|Adverse Event|8|||
125292954|NCT00940485|450700176|FG001|Overall Study|Adverse Event|0|||
125292955|NCT00940485|450700175|FG000|Overall Study|Withdrawal by Subject|1|||
125292956|NCT00940485|450700176|FG001|Overall Study|Withdrawal by Subject|1|||
125292957|NCT00940485|450700175|FG000|Overall Study|Others|1|||
125292958|NCT00940485|450700176|FG001|Overall Study|Others|1|||
125292959|NCT03921554|450700180|FG000|Overall Study|Adverse Event|2|||
125292960|NCT03921554|450700180|FG000|Overall Study|Withdrawal by Subject|1|||
125292961|NCT03921554|450700180|FG000|Overall Study|Death|3|||
125292962|NCT03283150|450700187|FG000|Overall Study|Withdrawal by Subject|6|||
125292963|NCT03283150|450700188|FG001|Overall Study|Withdrawal by Subject|0|||
125292964|NCT03283150|450700189|FG002|Overall Study|Withdrawal by Subject|0|||
125292965|NCT01299571|450700192|FG000|Overall Study|Protocol Violation|107|||
125292966|NCT00864851|450700193|FG000|Overall Study|Withdrawal by Subject|0|||
125292967|NCT00864851|450700194|FG001|Overall Study|Withdrawal by Subject|1|||
125292968|NCT00864851|450700195|FG002|Overall Study|Withdrawal by Subject|0|||
125292969|NCT00864851|450700193|FG000|Overall Study|Physician Decision|1|||
125292970|NCT00864851|450700194|FG001|Overall Study|Physician Decision|0|||
125292971|NCT00864851|450700195|FG002|Overall Study|Physician Decision|0|||
125292972|NCT00864851|450700193|FG000|Overall Study|Death|1|||
125292973|NCT00864851|450700194|FG001|Overall Study|Death|0|||
125292974|NCT00864851|450700195|FG002|Overall Study|Death|0|||
125292975|NCT00864851|450700193|FG000|Overall Study|Patient uncooperative|1|||
125292976|NCT00864851|450700194|FG001|Overall Study|Patient uncooperative|0|||
125292977|NCT00864851|450700195|FG002|Overall Study|Patient uncooperative|0|||
125292978|NCT01842581|450700199|FG000|Overall Study|Adverse Event|6|||
125292979|NCT01842581|450700200|FG001|Overall Study|Adverse Event|4|||
125292980|NCT01842581|450700199|FG000|Overall Study|HE breakthrough|26|||
125292981|NCT01842581|450700200|FG001|Overall Study|HE breakthrough|13|||
125292982|NCT01842581|450700199|FG000|Overall Study|Liver transplant|2|||
125292983|NCT01842581|450700200|FG001|Overall Study|Liver transplant|0|||
125292984|NCT01842581|450700199|FG000|Overall Study|Lost to Follow-up|2|||
125292985|NCT01842581|450700200|FG001|Overall Study|Lost to Follow-up|5|||
125292986|NCT01842581|450700199|FG000|Overall Study|Withdrawal by Subject|5|||
125292987|NCT01842581|450700200|FG001|Overall Study|Withdrawal by Subject|7|||
125292988|NCT01842581|450700199|FG000|Overall Study|Other than specified|3|||
125292989|NCT01842581|450700200|FG001|Overall Study|Other than specified|1|||
125292990|NCT01287195|450700203|FG000|Overall Study|Withdrawal by Subject|2|||
125292991|NCT02006069|450700206|FG000|Overall Study|MPP other programming|239|||
125292992|NCT02006069|450700207|FG001|Overall Study|MPP other programming|0|||
125292993|NCT02006069|450700206|FG000|Overall Study|RV only pacing|0|||
125292994|NCT02006069|450700207|FG001|Overall Study|RV only pacing|3|||
125292995|NCT00106691|450700208|FG000|Overall Study|Adverse Event|60|||
125292996|NCT00106691|450700209|FG001|Overall Study|Adverse Event|64|||
125292997|NCT00106691|450700208|FG000|Overall Study|Lost to Follow-up|23|||
125292998|NCT00106691|450700209|FG001|Overall Study|Lost to Follow-up|18|||
125292999|NCT00106691|450700208|FG000|Overall Study|Physician Decision|18|||
125293000|NCT00106691|450700209|FG001|Overall Study|Physician Decision|21|||
125293001|NCT00106691|450700208|FG000|Overall Study|Protocol Violation|13|||
125293002|NCT00106691|450700209|FG001|Overall Study|Protocol Violation|18|||
125454950|NCT01090024|451294682|FG016|Period 1|Withdrawal by Subject|0|||
125454951|NCT01090024|451294683|FG017|Period 1|Withdrawal by Subject|0|||
125454952|NCT01090024|451294666|FG000|Period 1|Lost to Follow-up|0|||
125454953|NCT01090024|451294667|FG001|Period 1|Lost to Follow-up|1|||
125454954|NCT01090024|451294668|FG002|Period 1|Lost to Follow-up|0|||
125454955|NCT01090024|451294669|FG003|Period 1|Lost to Follow-up|0|||
125293003|NCT00106691|450700208|FG000|Overall Study|Withdrawal by Subject|75|||
125293004|NCT00106691|450700209|FG001|Overall Study|Withdrawal by Subject|70|||
125293005|NCT00106691|450700208|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
125293006|NCT00106691|450700209|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
125293007|NCT00106691|450700208|FG000|Overall Study|QTc>480|3|||
125293008|NCT00106691|450700209|FG001|Overall Study|QTc>480|1|||
125293009|NCT00106691|450700208|FG000|Overall Study|mililtary deployment|2|||
125293010|NCT00106691|450700209|FG001|Overall Study|mililtary deployment|0|||
125293011|NCT00106691|450700208|FG000|Overall Study|Study Site Closing/PI Moved|1|||
125293012|NCT00106691|450700209|FG001|Overall Study|Study Site Closing/PI Moved|2|||
125293013|NCT00106691|450700208|FG000|Overall Study|Cardiologist recommendation|1|||
125293014|NCT00106691|450700209|FG001|Overall Study|Cardiologist recommendation|0|||
125293015|NCT00106691|450700208|FG000|Overall Study|Pt. moved to another state|1|||
125293016|NCT00106691|450700209|FG001|Overall Study|Pt. moved to another state|0|||
125293017|NCT00106691|450700208|FG000|Overall Study|Taking exclusionary avodart|1|||
125293018|NCT00106691|450700209|FG001|Overall Study|Taking exclusionary avodart|0|||
125293019|NCT00106691|450700208|FG000|Overall Study|Not able to discontinue plavix|0|||
125293020|NCT00106691|450700209|FG001|Overall Study|Not able to discontinue plavix|1|||
125293021|NCT00530920|450700210|FG000|Overall Study|Randomized but not treated|0|||
125293022|NCT00530920|450700211|FG001|Overall Study|Randomized but not treated|2|||
125293023|NCT00530920|450700212|FG002|Overall Study|Randomized but not treated|0|||
125293024|NCT00530920|450700210|FG000|Overall Study|Adverse Event|0|||
125293025|NCT00530920|450700211|FG001|Overall Study|Adverse Event|0|||
125293026|NCT00530920|450700212|FG002|Overall Study|Adverse Event|3|||
125293027|NCT00530920|450700210|FG000|Overall Study|Withdrawal by Subject|0|||
125454956|NCT01090024|451294670|FG004|Period 1|Lost to Follow-up|0|||
125454957|NCT01090024|451294671|FG005|Period 1|Lost to Follow-up|0|||
125454958|NCT01090024|451294672|FG006|Period 1|Lost to Follow-up|0|||
125454959|NCT01090024|451294673|FG007|Period 1|Lost to Follow-up|0|||
125293028|NCT00530920|450700211|FG001|Overall Study|Withdrawal by Subject|0|||
125293029|NCT00530920|450700212|FG002|Overall Study|Withdrawal by Subject|1|||
125293030|NCT04957758|450700214|FG000|Overall Study|Adverse Event|1|||
125293031|NCT04957758|450700215|FG001|Overall Study|Adverse Event|0|||
125293032|NCT04957758|450700214|FG000|Overall Study|Lost to Follow-up|0|||
125293033|NCT04957758|450700215|FG001|Overall Study|Lost to Follow-up|2|||
125293034|NCT04957758|450700214|FG000|Overall Study|Withdrawal by Subject|4|||
125293035|NCT04957758|450700215|FG001|Overall Study|Withdrawal by Subject|2|||
125293036|NCT04957758|450700214|FG000|Overall Study|Protocol Violation|0|||
125293037|NCT04957758|450700215|FG001|Overall Study|Protocol Violation|1|||
125293038|NCT00707746|450700216|FG000|Treatment Period|Adverse Event|2|||
125293039|NCT00707746|450700217|FG001|Treatment Period|Adverse Event|4|||
125293040|NCT00707746|450700216|FG000|Treatment Period|Ineligibility|0|||
125454960|NCT01090024|451294674|FG008|Period 1|Lost to Follow-up|0|||
125454961|NCT01090024|451294675|FG009|Period 1|Lost to Follow-up|0|||
125293041|NCT00707746|450700217|FG001|Treatment Period|Ineligibility|1|||
125454962|NCT01090024|451294676|FG010|Period 1|Lost to Follow-up|0|||
125454963|NCT01090024|451294677|FG011|Period 1|Lost to Follow-up|0|||
125454964|NCT01090024|451294678|FG012|Period 1|Lost to Follow-up|0|||
125454965|NCT01090024|451294679|FG013|Period 1|Lost to Follow-up|0|||
125454966|NCT01090024|451294680|FG014|Period 1|Lost to Follow-up|0|||
125454967|NCT01090024|451294681|FG015|Period 1|Lost to Follow-up|0|||
125454968|NCT01090024|451294682|FG016|Period 1|Lost to Follow-up|0|||
125454969|NCT01090024|451294683|FG017|Period 1|Lost to Follow-up|0|||
125454970|NCT01090024|451294666|FG000|Period 2|Lost to Follow-up|0|||
125454971|NCT01090024|451294667|FG001|Period 2|Lost to Follow-up|0|||
125454972|NCT01090024|451294668|FG002|Period 2|Lost to Follow-up|0|||
125454973|NCT01090024|451294669|FG003|Period 2|Lost to Follow-up|1|||
125454974|NCT01090024|451294670|FG004|Period 2|Lost to Follow-up|0|||
125454975|NCT01090024|451294671|FG005|Period 2|Lost to Follow-up|0|||
125454976|NCT01090024|451294672|FG006|Period 2|Lost to Follow-up|0|||
125454977|NCT01090024|451294673|FG007|Period 2|Lost to Follow-up|0|||
125454978|NCT01090024|451294674|FG008|Period 2|Lost to Follow-up|0|||
125454979|NCT01090024|451294675|FG009|Period 2|Lost to Follow-up|0|||
125454980|NCT01090024|451294676|FG010|Period 2|Lost to Follow-up|0|||
125454981|NCT01090024|451294677|FG011|Period 2|Lost to Follow-up|0|||
125454982|NCT01090024|451294678|FG012|Period 2|Lost to Follow-up|0|||
125454983|NCT01090024|451294679|FG013|Period 2|Lost to Follow-up|0|||
125454984|NCT01090024|451294680|FG014|Period 2|Lost to Follow-up|0|||
125454985|NCT01090024|451294681|FG015|Period 2|Lost to Follow-up|0|||
125454986|NCT01090024|451294682|FG016|Period 2|Lost to Follow-up|0|||
125293042|NCT02322190|450700218|FG000|Overall Study|Death on study|1|||
125293043|NCT02322190|450700219|FG001|Overall Study|Death on study|0|||
125293044|NCT01685983|450700224|FG000|Overall Study|Adverse Event|7|||
125293045|NCT01685983|450700224|FG000|Overall Study|Death|1|||
125293046|NCT01685983|450700224|FG000|Overall Study|Withdrawal by Subject|19|||
125293047|NCT01685983|450700224|FG000|Overall Study|Protocol Violation|2|||
125293048|NCT01685983|450700224|FG000|Overall Study|Physician Decision|13|||
125293049|NCT01685983|450700224|FG000|Overall Study|Other|7|||
125293050|NCT01685983|450700224|FG000|Overall Study|Progressive Disease|32|||
125293051|NCT01685983|450700224|FG000|Overall Study|Noncompliance with Study Drug|1|||
125293052|NCT00685373|450700225|FG000|Overall Study|Adverse Event|3|||
125293053|NCT00685373|450700225|FG000|Overall Study|Withdrawal by Subject|5|||
125293054|NCT00685373|450700225|FG000|Overall Study|Lack of Efficacy|3|||
125454987|NCT01090024|451294683|FG017|Period 2|Lost to Follow-up|0|||
125454988|NCT01090024|451294666|FG000|Period 2|Adverse Event|1|||
125454989|NCT01090024|451294667|FG001|Period 2|Adverse Event|0|||
125454990|NCT01090024|451294668|FG002|Period 2|Adverse Event|0|||
125454991|NCT01090024|451294669|FG003|Period 2|Adverse Event|0|||
125454992|NCT01090024|451294670|FG004|Period 2|Adverse Event|0|||
125454993|NCT01090024|451294671|FG005|Period 2|Adverse Event|0|||
125454994|NCT01090024|451294672|FG006|Period 2|Adverse Event|0|||
125454995|NCT01090024|451294673|FG007|Period 2|Adverse Event|0|||
125454996|NCT01090024|451294674|FG008|Period 2|Adverse Event|0|||
125454997|NCT01090024|451294675|FG009|Period 2|Adverse Event|0|||
125454998|NCT01090024|451294676|FG010|Period 2|Adverse Event|0|||
125454999|NCT01090024|451294677|FG011|Period 2|Adverse Event|0|||
125455000|NCT01090024|451294678|FG012|Period 2|Adverse Event|0|||
125455001|NCT01090024|451294679|FG013|Period 2|Adverse Event|0|||
125455002|NCT01090024|451294680|FG014|Period 2|Adverse Event|0|||
125455003|NCT01090024|451294681|FG015|Period 2|Adverse Event|0|||
125455004|NCT01090024|451294682|FG016|Period 2|Adverse Event|0|||
125455005|NCT01090024|451294683|FG017|Period 2|Adverse Event|0|||
125455006|NCT01090024|451294666|FG000|Period 3|Withdrawal by Subject|0|||
125455007|NCT01090024|451294667|FG001|Period 3|Withdrawal by Subject|0|||
125455008|NCT01090024|451294668|FG002|Period 3|Withdrawal by Subject|0|||
125455009|NCT01090024|451294669|FG003|Period 3|Withdrawal by Subject|0|||
125455010|NCT01090024|451294670|FG004|Period 3|Withdrawal by Subject|0|||
125455011|NCT01090024|451294671|FG005|Period 3|Withdrawal by Subject|0|||
125455012|NCT01090024|451294672|FG006|Period 3|Withdrawal by Subject|0|||
125293055|NCT00685373|450700225|FG000|Overall Study|Condition no longer requires study drug|1|||
125455013|NCT01090024|451294673|FG007|Period 3|Withdrawal by Subject|0|||
125455014|NCT01090024|451294674|FG008|Period 3|Withdrawal by Subject|0|||
125455015|NCT01090024|451294675|FG009|Period 3|Withdrawal by Subject|0|||
125455016|NCT01090024|451294676|FG010|Period 3|Withdrawal by Subject|0|||
125455017|NCT01090024|451294677|FG011|Period 3|Withdrawal by Subject|0|||
125455018|NCT01090024|451294678|FG012|Period 3|Withdrawal by Subject|0|||
125455019|NCT01090024|451294679|FG013|Period 3|Withdrawal by Subject|0|||
125293056|NCT00685373|450700225|FG000|Overall Study|Lost to Follow-up|2|||
125293057|NCT00685373|450700225|FG000|Overall Study|Protocol Violation|1|||
125293058|NCT02642965|450700226|FG000|Overall Study|Lack of Efficacy|4|||
125293059|NCT02642965|450700226|FG000|Overall Study|Physician Decision|9|||
125455020|NCT01090024|451294680|FG014|Period 3|Withdrawal by Subject|0|||
125293060|NCT01167907|450700227|FG000|Overall Study|Protocol Violation|1|||
125455021|NCT01090024|451294681|FG015|Period 3|Withdrawal by Subject|1|||
125455022|NCT01090024|451294682|FG016|Period 3|Withdrawal by Subject|0|||
125455023|NCT01090024|451294683|FG017|Period 3|Withdrawal by Subject|0|||
125455024|NCT01090024|451294666|FG000|Period 3|Protocol Violation|0|||
125455025|NCT01090024|451294667|FG001|Period 3|Protocol Violation|0|||
125455026|NCT01090024|451294668|FG002|Period 3|Protocol Violation|0|||
125455027|NCT01090024|451294669|FG003|Period 3|Protocol Violation|0|||
125455028|NCT01090024|451294670|FG004|Period 3|Protocol Violation|0|||
125455029|NCT01090024|451294671|FG005|Period 3|Protocol Violation|0|||
125455030|NCT01090024|451294672|FG006|Period 3|Protocol Violation|0|||
125455031|NCT01090024|451294673|FG007|Period 3|Protocol Violation|0|||
125293061|NCT01167907|450700228|FG001|Overall Study|Protocol Violation|0|||
125293062|NCT01167907|450700227|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
125293063|NCT01167907|450700228|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
125293064|NCT00857948|450700229|FG000|Overall Study|Withdrawal by Subject|2|||
125293065|NCT00857948|450700230|FG001|Overall Study|Withdrawal by Subject|0|||
125293066|NCT00857948|450700231|FG002|Overall Study|Withdrawal by Subject|0|||
125293067|NCT00857948|450700232|FG003|Overall Study|Withdrawal by Subject|0|||
125293068|NCT00857948|450700229|FG000|Overall Study|Protocol Violation|1|||
125293069|NCT00857948|450700230|FG001|Overall Study|Protocol Violation|0|||
125293070|NCT00857948|450700231|FG002|Overall Study|Protocol Violation|1|||
125293071|NCT00857948|450700232|FG003|Overall Study|Protocol Violation|0|||
125293072|NCT03077698|450700235|FG000|Progestin Monotherapy|Stable Disease|8|||
125293073|NCT03077698|450700236|FG001|Progestin Monotherapy|Stable Disease|0|||
125293074|NCT03077698|450700235|FG000|Progestin Monotherapy|Adverse Event|1|||
125293075|NCT03077698|450700236|FG001|Progestin Monotherapy|Adverse Event|0|||
125293076|NCT03077698|450700235|FG000|Progestin Monotherapy|Death|1|||
125293077|NCT03077698|450700236|FG001|Progestin Monotherapy|Death|0|||
125419927|NCT04004611|451162170|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125419928|NCT04004611|451162171|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
125419929|NCT04420689|451162172|FG000|Overall Study|COVID-19 related hospitalization|0|||
125419930|NCT04420689|451162173|FG001|Overall Study|COVID-19 related hospitalization|0|||
125419931|NCT04420689|451162174|FG002|Overall Study|COVID-19 related hospitalization|0|||
125419932|NCT04420689|451162175|FG003|Overall Study|COVID-19 related hospitalization|0|||
125419933|NCT04420689|451162176|FG004|Overall Study|COVID-19 related hospitalization|1|||
125419934|NCT04420689|451162177|FG005|Overall Study|COVID-19 related hospitalization|0|||
125419935|NCT04420689|451162178|FG006|Overall Study|COVID-19 related hospitalization|0|||
125419936|NCT04420689|451162172|FG000|Overall Study|Physician Decision|0|||
125419937|NCT04420689|451162173|FG001|Overall Study|Physician Decision|0|||
125419938|NCT04420689|451162174|FG002|Overall Study|Physician Decision|0|||
125419939|NCT04420689|451162175|FG003|Overall Study|Physician Decision|0|||
125419940|NCT04420689|451162176|FG004|Overall Study|Physician Decision|0|||
125419941|NCT04420689|451162177|FG005|Overall Study|Physician Decision|1|||
125419942|NCT04420689|451162178|FG006|Overall Study|Physician Decision|0|||
125419943|NCT00515502|451162179|FG000|Treatment Period 1|Adverse Event|0|||
125419944|NCT00515502|451162180|FG001|Treatment Period 1|Adverse Event|0|||
125419945|NCT00515502|451162181|FG002|Treatment Period 1|Adverse Event|0|||
125419946|NCT00515502|451162182|FG003|Treatment Period 1|Adverse Event|0|||
125419947|NCT00515502|451162183|FG004|Treatment Period 1|Adverse Event|0|||
125419948|NCT00515502|451162184|FG005|Treatment Period 1|Adverse Event|0|||
125419949|NCT00515502|451162185|FG006|Treatment Period 1|Adverse Event|1|||
125419950|NCT00515502|451162186|FG007|Treatment Period 1|Adverse Event|0|||
125419951|NCT00515502|451162187|FG008|Treatment Period 1|Adverse Event|1|||
125419952|NCT00515502|451162188|FG009|Treatment Period 1|Adverse Event|0|||
125419953|NCT00515502|451162189|FG010|Treatment Period 1|Adverse Event|0|||
125419954|NCT00515502|451162190|FG011|Treatment Period 1|Adverse Event|1|||
125419955|NCT00515502|451162179|FG000|Treatment Period 2|Adverse Event|0|||
125419956|NCT00515502|451162180|FG001|Treatment Period 2|Adverse Event|1|||
125419957|NCT00515502|451162181|FG002|Treatment Period 2|Adverse Event|0|||
125419958|NCT00515502|451162182|FG003|Treatment Period 2|Adverse Event|0|||
125419959|NCT00515502|451162183|FG004|Treatment Period 2|Adverse Event|0|||
125419960|NCT00515502|451162184|FG005|Treatment Period 2|Adverse Event|0|||
125419961|NCT00515502|451162185|FG006|Treatment Period 2|Adverse Event|0|||
125419962|NCT00515502|451162186|FG007|Treatment Period 2|Adverse Event|0|||
125419963|NCT00515502|451162187|FG008|Treatment Period 2|Adverse Event|0|||
125419964|NCT00515502|451162188|FG009|Treatment Period 2|Adverse Event|0|||
125419965|NCT00515502|451162189|FG010|Treatment Period 2|Adverse Event|0|||
125419966|NCT00515502|451162190|FG011|Treatment Period 2|Adverse Event|0|||
125419967|NCT03644186|451162194|FG000|Overall Study|Withdrawal by Subject|1|||
125419968|NCT03644186|451162195|FG001|Overall Study|Withdrawal by Subject|1|||
125419969|NCT02192502|451162197|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
125419970|NCT02192502|451162198|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
125419971|NCT02192502|451162197|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
125419972|NCT02192502|451162198|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
125419973|NCT02192502|451162197|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
125419974|NCT02192502|451162198|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
125419975|NCT01381692|451162199|FG000|Overall Study|Adverse Event|1|||
125419976|NCT01381692|451162200|FG001|Overall Study|Adverse Event|0|||
125455032|NCT01090024|451294674|FG008|Period 3|Protocol Violation|1|||
125455033|NCT01090024|451294675|FG009|Period 3|Protocol Violation|0|||
125293078|NCT03077698|450700235|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
125293079|NCT03077698|450700236|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
125293080|NCT03077698|450700235|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
125293081|NCT03077698|450700236|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
125293082|NCT03077698|450700235|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
125293083|NCT03077698|450700236|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
125293084|NCT03077698|450700235|FG000|Safety Follow Up|Withdrawal by Subject|2|||
125293085|NCT03077698|450700236|FG001|Safety Follow Up|Withdrawal by Subject|1|||
125293086|NCT03077698|450700235|FG000|Safety Follow Up|Transfer of care to hospice|1|||
125293087|NCT03077698|450700236|FG001|Safety Follow Up|Transfer of care to hospice|0|||
125293088|NCT00973102|450700239|FG000|Overall Study|Protocol Violation|1|||
125293089|NCT00973102|450700240|FG001|Overall Study|Protocol Violation|0|||
125293090|NCT00973102|450700239|FG000|Overall Study|Prisoner|0|||
125293091|NCT00973102|450700240|FG001|Overall Study|Prisoner|1|||
125293092|NCT03099148|450700243|FG000|Wash-out|scheduling conflict|0|||
125293093|NCT03099148|450700244|FG001|Wash-out|scheduling conflict|1|||
125293094|NCT03099148|450700245|FG002|Wash-out|scheduling conflict|0|||
125293095|NCT03099148|450700246|FG003|Wash-out|scheduling conflict|0|||
125293096|NCT03099148|450700243|FG000|Wash-out|Adverse Event|0|||
125293097|NCT03099148|450700244|FG001|Wash-out|Adverse Event|1|||
125293098|NCT03099148|450700245|FG002|Wash-out|Adverse Event|0|||
125293099|NCT03099148|450700246|FG003|Wash-out|Adverse Event|0|||
125293100|NCT01439126|450700247|FG000|Overall Study|Adverse Event|2|||
125293101|NCT01439126|450700248|FG001|Overall Study|Adverse Event|0|||
125293102|NCT01439126|450700247|FG000|Overall Study|Withdrawal by Subject|5|||
125293103|NCT01439126|450700248|FG001|Overall Study|Withdrawal by Subject|21|||
125293104|NCT01439126|450700247|FG000|Overall Study|Protocol Violation|6|||
125293105|NCT01439126|450700248|FG001|Overall Study|Protocol Violation|4|||
125293106|NCT01439126|450700247|FG000|Overall Study|Lost to Follow-up|6|||
125293107|NCT01439126|450700248|FG001|Overall Study|Lost to Follow-up|3|||
125293108|NCT01439126|450700247|FG000|Overall Study|Other-Use of prohibited treatment|0|||
125293109|NCT01439126|450700248|FG001|Overall Study|Other-Use of prohibited treatment|2|||
125293110|NCT01439126|450700247|FG000|Overall Study|Other-Miscellaneous|12|||
125293111|NCT01439126|450700248|FG001|Overall Study|Other-Miscellaneous|12|||
125293112|NCT01710527|450700249|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
125293113|NCT01710527|450700250|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
125293114|NCT02124772|450700251|FG000|Overall Study|Lack of Efficacy|2|||
125293115|NCT02124772|450700252|FG001|Overall Study|Lack of Efficacy|0|||
125293116|NCT02124772|450700253|FG002|Overall Study|Lack of Efficacy|0|||
125293117|NCT02124772|450700254|FG003|Overall Study|Lack of Efficacy|1|||
125293118|NCT02124772|450700255|FG004|Overall Study|Lack of Efficacy|2|||
125293119|NCT02124772|450700256|FG005|Overall Study|Lack of Efficacy|3|||
125293120|NCT02124772|450700257|FG006|Overall Study|Lack of Efficacy|0|||
125293121|NCT02124772|450700258|FG007|Overall Study|Lack of Efficacy|2|||
125293122|NCT02124772|450700259|FG008|Overall Study|Lack of Efficacy|0|||
125293123|NCT02124772|450700260|FG009|Overall Study|Lack of Efficacy|1|||
125293124|NCT02124772|450700261|FG010|Overall Study|Lack of Efficacy|0|||
125293125|NCT02124772|450700262|FG011|Overall Study|Lack of Efficacy|0|||
125293126|NCT02124772|450700263|FG012|Overall Study|Lack of Efficacy|1|||
125293127|NCT02124772|450700251|FG000|Overall Study|Adverse Event|1|||
125293128|NCT02124772|450700252|FG001|Overall Study|Adverse Event|4|||
125293129|NCT02124772|450700253|FG002|Overall Study|Adverse Event|1|||
125293130|NCT02124772|450700254|FG003|Overall Study|Adverse Event|5|||
125293131|NCT02124772|450700255|FG004|Overall Study|Adverse Event|2|||
125293132|NCT02124772|450700256|FG005|Overall Study|Adverse Event|1|||
125293133|NCT02124772|450700257|FG006|Overall Study|Adverse Event|1|||
125293134|NCT02124772|450700258|FG007|Overall Study|Adverse Event|5|||
125293135|NCT02124772|450700259|FG008|Overall Study|Adverse Event|0|||
125293136|NCT02124772|450700260|FG009|Overall Study|Adverse Event|3|||
125293137|NCT02124772|450700261|FG010|Overall Study|Adverse Event|1|||
125293138|NCT02124772|450700262|FG011|Overall Study|Adverse Event|3|||
125293139|NCT02124772|450700263|FG012|Overall Study|Adverse Event|1|||
125293140|NCT02124772|450700251|FG000|Overall Study|Withdrawal consent|0|||
125293141|NCT02124772|450700252|FG001|Overall Study|Withdrawal consent|1|||
125293142|NCT02124772|450700253|FG002|Overall Study|Withdrawal consent|1|||
125293143|NCT02124772|450700254|FG003|Overall Study|Withdrawal consent|1|||
125293144|NCT02124772|450700255|FG004|Overall Study|Withdrawal consent|0|||
125293145|NCT02124772|450700256|FG005|Overall Study|Withdrawal consent|1|||
125293146|NCT02124772|450700257|FG006|Overall Study|Withdrawal consent|1|||
125293147|NCT02124772|450700258|FG007|Overall Study|Withdrawal consent|0|||
125293148|NCT02124772|450700259|FG008|Overall Study|Withdrawal consent|0|||
125293149|NCT02124772|450700260|FG009|Overall Study|Withdrawal consent|1|||
125293150|NCT02124772|450700261|FG010|Overall Study|Withdrawal consent|0|||
125293151|NCT02124772|450700262|FG011|Overall Study|Withdrawal consent|1|||
125293152|NCT02124772|450700263|FG012|Overall Study|Withdrawal consent|0|||
125293153|NCT02124772|450700251|FG000|Overall Study|Investigator discretion|0|||
125293154|NCT02124772|450700252|FG001|Overall Study|Investigator discretion|2|||
125293155|NCT02124772|450700253|FG002|Overall Study|Investigator discretion|2|||
125293156|NCT02124772|450700254|FG003|Overall Study|Investigator discretion|1|||
125293157|NCT02124772|450700255|FG004|Overall Study|Investigator discretion|1|||
125293158|NCT02124772|450700256|FG005|Overall Study|Investigator discretion|0|||
125293159|NCT02124772|450700257|FG006|Overall Study|Investigator discretion|1|||
125293160|NCT02124772|450700258|FG007|Overall Study|Investigator discretion|0|||
125293161|NCT02124772|450700259|FG008|Overall Study|Investigator discretion|0|||
125293162|NCT02124772|450700260|FG009|Overall Study|Investigator discretion|1|||
125293163|NCT02124772|450700261|FG010|Overall Study|Investigator discretion|0|||
125293164|NCT02124772|450700262|FG011|Overall Study|Investigator discretion|1|||
125293165|NCT02124772|450700263|FG012|Overall Study|Investigator discretion|0|||
125293166|NCT02124772|450700251|FG000|Overall Study|Progressive disease|0|||
125293167|NCT02124772|450700252|FG001|Overall Study|Progressive disease|0|||
125293168|NCT02124772|450700253|FG002|Overall Study|Progressive disease|0|||
125293169|NCT02124772|450700254|FG003|Overall Study|Progressive disease|0|||
125293170|NCT02124772|450700255|FG004|Overall Study|Progressive disease|0|||
125293171|NCT02124772|450700256|FG005|Overall Study|Progressive disease|0|||
125293172|NCT02124772|450700257|FG006|Overall Study|Progressive disease|1|||
125293173|NCT02124772|450700258|FG007|Overall Study|Progressive disease|1|||
125293174|NCT02124772|450700259|FG008|Overall Study|Progressive disease|0|||
125293175|NCT02124772|450700260|FG009|Overall Study|Progressive disease|0|||
125293176|NCT02124772|450700261|FG010|Overall Study|Progressive disease|0|||
125293177|NCT02124772|450700262|FG011|Overall Study|Progressive disease|0|||
125293178|NCT02124772|450700263|FG012|Overall Study|Progressive disease|0|||
125293179|NCT02124772|450700251|FG000|Overall Study|Other|0|||
125293180|NCT02124772|450700252|FG001|Overall Study|Other|7|||
125293181|NCT02124772|450700253|FG002|Overall Study|Other|2|||
125293182|NCT02124772|450700254|FG003|Overall Study|Other|5|||
125293183|NCT02124772|450700255|FG004|Overall Study|Other|4|||
125293184|NCT02124772|450700256|FG005|Overall Study|Other|3|||
125293185|NCT02124772|450700257|FG006|Overall Study|Other|4|||
125293186|NCT02124772|450700258|FG007|Overall Study|Other|1|||
125293187|NCT02124772|450700259|FG008|Overall Study|Other|1|||
125293188|NCT02124772|450700260|FG009|Overall Study|Other|1|||
125293189|NCT02124772|450700261|FG010|Overall Study|Other|1|||
125293190|NCT02124772|450700262|FG011|Overall Study|Other|1|||
125293191|NCT02124772|450700263|FG012|Overall Study|Other|0|||
125293192|NCT01617447|450700264|FG000|Overall Study|Adverse Event|0|||
125293193|NCT01617447|450700265|FG001|Overall Study|Adverse Event|1|||
125293194|NCT01617447|450700264|FG000|Overall Study|Physician Decision|0|||
125293195|NCT01617447|450700265|FG001|Overall Study|Physician Decision|2|||
125293196|NCT02713529|450700267|FG000|Overall Study|Withdrawal by Subject|3|||
125293197|NCT02713529|450700268|FG001|Overall Study|Withdrawal by Subject|1|||
125293198|NCT02713529|450700269|FG002|Overall Study|Withdrawal by Subject|4|||
125293199|NCT02713529|450700270|FG003|Overall Study|Withdrawal by Subject|2|||
125293200|NCT02713529|450700271|FG004|Overall Study|Withdrawal by Subject|0|||
125455034|NCT01090024|451294676|FG010|Period 3|Protocol Violation|0|||
125293201|NCT02713529|450700272|FG005|Overall Study|Withdrawal by Subject|1|||
125293202|NCT02713529|450700273|FG006|Overall Study|Withdrawal by Subject|1|||
125293203|NCT02713529|450700267|FG000|Overall Study|Lost to Follow-up|1|||
125293204|NCT02713529|450700268|FG001|Overall Study|Lost to Follow-up|0|||
125293205|NCT02713529|450700269|FG002|Overall Study|Lost to Follow-up|1|||
125293206|NCT02713529|450700270|FG003|Overall Study|Lost to Follow-up|0|||
125293207|NCT02713529|450700271|FG004|Overall Study|Lost to Follow-up|0|||
125293208|NCT02713529|450700272|FG005|Overall Study|Lost to Follow-up|0|||
125455035|NCT01090024|451294677|FG011|Period 3|Protocol Violation|0|||
125455036|NCT01090024|451294678|FG012|Period 3|Protocol Violation|0|||
125455037|NCT01090024|451294679|FG013|Period 3|Protocol Violation|0|||
125293209|NCT02713529|450700273|FG006|Overall Study|Lost to Follow-up|0|||
125293210|NCT02713529|450700267|FG000|Overall Study|Death|3|||
125293211|NCT02713529|450700268|FG001|Overall Study|Death|3|||
125293212|NCT02713529|450700269|FG002|Overall Study|Death|26|||
125293213|NCT02713529|450700270|FG003|Overall Study|Death|27|||
125293214|NCT02713529|450700271|FG004|Overall Study|Death|3|||
125293215|NCT02713529|450700272|FG005|Overall Study|Death|13|||
125293216|NCT02713529|450700273|FG006|Overall Study|Death|3|||
125293217|NCT00780273|450700274|FG000|Overall Study|Death|1|||
125293218|NCT00780273|450700274|FG000|Overall Study|Lost to Follow-up|1|||
125293219|NCT02358044|450700277|FG000|Overall Study|Adverse Event|0|||
125293220|NCT02358044|450700278|FG001|Overall Study|Adverse Event|1|||
125293221|NCT02358044|450700277|FG000|Overall Study|Lost to Follow-up|2|||
125293222|NCT02358044|450700278|FG001|Overall Study|Lost to Follow-up|1|||
125293223|NCT02358044|450700277|FG000|Overall Study|Physician Decision|0|||
125293224|NCT02358044|450700278|FG001|Overall Study|Physician Decision|1|||
125293225|NCT02358044|450700277|FG000|Overall Study|Withdrawal by Subject|0|||
125293226|NCT02358044|450700278|FG001|Overall Study|Withdrawal by Subject|4|||
125293227|NCT01739803|450700279|FG000|Overall Study|Lost to Follow-up|9|||
125293228|NCT01739803|450700280|FG001|Overall Study|Lost to Follow-up|6|||
125293229|NCT02525094|450700288|FG000|Overall Study|Lost to Follow-up|2|||
125293230|NCT02525094|450700289|FG001|Overall Study|Lost to Follow-up|1|||
125293231|NCT02525094|450700288|FG000|Overall Study|Withdrawal by Subject|5|||
125455038|NCT01090024|451294680|FG014|Period 3|Protocol Violation|0|||
125293232|NCT02525094|450700289|FG001|Overall Study|Withdrawal by Subject|6|||
125293233|NCT02525094|450700288|FG000|Overall Study|Not Treated|1|||
125293234|NCT02525094|450700289|FG001|Overall Study|Not Treated|1|||
125293235|NCT02242981|450700291|FG000|Overall Study|Withdrawal by Subject|1|||
125293236|NCT02210091|450700292|FG000|Overall Study|Physician Decision|0|||
125293237|NCT02210091|450700293|FG001|Overall Study|Physician Decision|1|||
125293238|NCT02210091|450700292|FG000|Overall Study|Withdrawal by Sponsor|0|||
125293239|NCT02210091|450700293|FG001|Overall Study|Withdrawal by Sponsor|1|||
125293240|NCT02290938|450700294|FG000|Overall Study|Lost to Follow-up|14|||
125293241|NCT02290938|450700295|FG001|Overall Study|Lost to Follow-up|43|||
125293242|NCT01831817|450700296|FG000|Overall Study|Lost to Follow-up|1|||
125293243|NCT01831817|450700297|FG001|Overall Study|Lost to Follow-up|0|||
125293244|NCT01831817|450700298|FG002|Overall Study|Lost to Follow-up|0|||
125293245|NCT01831817|450700299|FG003|Overall Study|Lost to Follow-up|0|||
125293246|NCT01831817|450700296|FG000|Overall Study|Withdrawl of Consent|3|||
125293247|NCT01831817|450700297|FG001|Overall Study|Withdrawl of Consent|0|||
125293248|NCT01831817|450700298|FG002|Overall Study|Withdrawl of Consent|0|||
125293249|NCT01831817|450700299|FG003|Overall Study|Withdrawl of Consent|0|||
125293250|NCT05065190|450702012|FG000|Overall Study|Other than listed|2|||
125293251|NCT05065190|450702013|FG001|Overall Study|Other than listed|12|||
125293252|NCT05065190|450702012|FG000|Overall Study|Lack of Efficacy|4|||
125293253|NCT05065190|450702013|FG001|Overall Study|Lack of Efficacy|0|||
125293254|NCT05065190|450702012|FG000|Overall Study|Adverse Event|1|||
125293255|NCT05065190|450702013|FG001|Overall Study|Adverse Event|10|||
125293256|NCT04938037|450702014|FG000|Overall Study|Lost to Follow-up|4|||
125293257|NCT04938037|450702015|FG001|Overall Study|Lost to Follow-up|3|||
125293258|NCT03320330|450702018|FG000|Overall Study|Lack of Efficacy|5|||
125293259|NCT03320330|450702019|FG001|Overall Study|Lack of Efficacy|5|||
125293260|NCT03320330|450702020|FG002|Overall Study|Lack of Efficacy|14|||
125293261|NCT03320330|450702018|FG000|Overall Study|Physician Decision|1|||
125293262|NCT03320330|450702019|FG001|Overall Study|Physician Decision|0|||
125293263|NCT03320330|450702020|FG002|Overall Study|Physician Decision|0|||
125293264|NCT00203021|450702021|FG000|Overall Study|Death|4|||
125293265|NCT00203021|450702022|FG001|Overall Study|Death|1|||
125293266|NCT00203021|450702021|FG000|Overall Study|Adverse Event|10|||
125293267|NCT00203021|450702022|FG001|Overall Study|Adverse Event|5|||
125293268|NCT00203021|450702021|FG000|Overall Study|Withdrawal by Subject|45|||
125293269|NCT00203021|450702022|FG001|Overall Study|Withdrawal by Subject|48|||
125293270|NCT00203021|450702021|FG000|Overall Study|Lost to Follow-up|9|||
125293271|NCT00203021|450702022|FG001|Overall Study|Lost to Follow-up|7|||
125293272|NCT00203021|450702021|FG000|Overall Study|Other than specified|11|||
125293273|NCT00203021|450702022|FG001|Overall Study|Other than specified|16|||
125293274|NCT02936284|450702026|FG000|Overall Study|Withdrawal by Subject|3|||
125293275|NCT02936284|450702027|FG001|Overall Study|Withdrawal by Subject|1|||
125293276|NCT02936284|450702026|FG000|Overall Study|Lost to Follow-up|7|||
125293277|NCT02936284|450702027|FG001|Overall Study|Lost to Follow-up|8|||
125293278|NCT04284813|450702028|FG000|Overall Study|Withdrawal by Subject|1|||
125293279|NCT01146652|450702033|FG000|Overall Study|Adverse Event|506|||
125293280|NCT01146652|450702034|FG001|Overall Study|Adverse Event|15|||
125293281|NCT01146652|450702033|FG000|Overall Study|Lack of Efficacy|91|||
125293282|NCT01146652|450702034|FG001|Overall Study|Lack of Efficacy|7|||
125455039|NCT01090024|451294681|FG015|Period 3|Protocol Violation|0|||
125455040|NCT01090024|451294682|FG016|Period 3|Protocol Violation|0|||
125293283|NCT01146652|450702033|FG000|Overall Study|Poor compliance to protocol|38|||
125293284|NCT01146652|450702034|FG001|Overall Study|Poor compliance to protocol|1|||
125293285|NCT01146652|450702033|FG000|Overall Study|Other unspecified reasons|314|||
125293286|NCT01146652|450702034|FG001|Overall Study|Other unspecified reasons|22|||
125293287|NCT01146652|450702033|FG000|Overall Study|Enrolled but not treated|2|||
125293288|NCT01146652|450702034|FG001|Overall Study|Enrolled but not treated|0|||
125293289|NCT01300351|450702038|FG000|Overall Study|Did not receive treatment|2|||
125293290|NCT01300351|450702039|FG001|Overall Study|Did not receive treatment|0|||
125293291|NCT01300351|450702038|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
125293292|NCT01300351|450702039|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
125293293|NCT01300351|450702038|FG000|Overall Study|Lost to Follow-up|0|||
125293294|NCT01300351|450702039|FG001|Overall Study|Lost to Follow-up|1|||
125293295|NCT01300351|450702038|FG000|Overall Study|Adverse Event|0|||
125455041|NCT01090024|451294683|FG017|Period 3|Protocol Violation|0|||
125293296|NCT01300351|450702039|FG001|Overall Study|Adverse Event|4|||
125293297|NCT01300351|450702038|FG000|Overall Study|Withdrawal by Subject|7|||
125293298|NCT01300351|450702039|FG001|Overall Study|Withdrawal by Subject|10|||
125293299|NCT00431951|450702040|FG000|Overall Study|Inability to follow study procedures|1|||
125293300|NCT00431951|450702041|FG001|Overall Study|Inability to follow study procedures|0|||
125293301|NCT00431951|450702042|FG002|Overall Study|Inability to follow study procedures|1|||
125293302|NCT00431951|450702043|FG003|Overall Study|Inability to follow study procedures|2|||
125293303|NCT00431951|450702040|FG000|Overall Study|Lost to Follow-up|0|||
125293304|NCT00431951|450702041|FG001|Overall Study|Lost to Follow-up|1|||
125293305|NCT00431951|450702042|FG002|Overall Study|Lost to Follow-up|0|||
125293306|NCT00431951|450702043|FG003|Overall Study|Lost to Follow-up|0|||
125293307|NCT00431951|450702040|FG000|Overall Study|Withdrawal by Subject|0|||
125293308|NCT00431951|450702041|FG001|Overall Study|Withdrawal by Subject|1|||
125293309|NCT00431951|450702042|FG002|Overall Study|Withdrawal by Subject|0|||
125293310|NCT00431951|450702043|FG003|Overall Study|Withdrawal by Subject|0|||
125293311|NCT00431951|450702040|FG000|Overall Study|Adverse Event|0|||
125293312|NCT00431951|450702041|FG001|Overall Study|Adverse Event|0|||
125293313|NCT00431951|450702042|FG002|Overall Study|Adverse Event|1|||
125293314|NCT00431951|450702043|FG003|Overall Study|Adverse Event|0|||
125293315|NCT00673881|450702046|FG000|Overall Study|Withdrawal by Subject|1|||
125293316|NCT00096018|450702047|FG000|Overall Study|Became Ineligible (not treated)|0|||
125293317|NCT00096018|450702048|FG001|Overall Study|Became Ineligible (not treated)|3|||
125293318|NCT00096018|450702047|FG000|Overall Study|Miscellaneous (not treated)|0|||
125293319|NCT00096018|450702048|FG001|Overall Study|Miscellaneous (not treated)|2|||
125293320|NCT00096018|450702047|FG000|Overall Study|Adverse Event|0|||
125293321|NCT00096018|450702048|FG001|Overall Study|Adverse Event|5|||
125293322|NCT00096018|450702047|FG000|Overall Study|Death|0|||
125293323|NCT00096018|450702048|FG001|Overall Study|Death|1|||
125293324|NCT00096018|450702047|FG000|Overall Study|Withdrawal by Subject|0|||
125293325|NCT00096018|450702048|FG001|Overall Study|Withdrawal by Subject|2|||
125293326|NCT00096018|450702047|FG000|Overall Study|Miscellaneous|2|||
125293327|NCT00096018|450702048|FG001|Overall Study|Miscellaneous|1|||
125293328|NCT00689793|450702049|FG000|Overall Study|Lost to Follow-up|4|||
125293329|NCT00689793|450702050|FG001|Overall Study|Lost to Follow-up|5|||
125293330|NCT01100528|450702051|FG000|Overall Study|Death|1|||
125293331|NCT01100528|450702051|FG000|Overall Study|Withdrawal by Subject|2|||
125293332|NCT03968159|450702052|FG000|Overall Study|Adverse Event|4|||
125293333|NCT03968159|450702053|FG001|Overall Study|Adverse Event|4|||
125293334|NCT03968159|450702052|FG000|Overall Study|Lost to Follow-up|1|||
125293335|NCT03968159|450702053|FG001|Overall Study|Lost to Follow-up|1|||
125293336|NCT03968159|450702052|FG000|Overall Study|Use of prohibited medication|0|||
125293337|NCT03968159|450702053|FG001|Overall Study|Use of prohibited medication|1|||
125293338|NCT03968159|450702052|FG000|Overall Study|Protocol Violation|2|||
125293339|NCT03968159|450702053|FG001|Overall Study|Protocol Violation|2|||
125293340|NCT03968159|450702052|FG000|Overall Study|Withdrawal by Subject|4|||
125293341|NCT03968159|450702053|FG001|Overall Study|Withdrawal by Subject|6|||
125293342|NCT03968159|450702052|FG000|Overall Study|Lack of Efficacy|0|||
125293343|NCT03968159|450702053|FG001|Overall Study|Lack of Efficacy|1|||
125293344|NCT03968159|450702052|FG000|Overall Study|Not further specified|2|||
125293345|NCT03968159|450702053|FG001|Overall Study|Not further specified|0|||
125293346|NCT02827500|450702061|FG000|Overall Study|Death|7|||
125293347|NCT02827500|450702062|FG001|Overall Study|Death|3|||
125293348|NCT02827500|450702061|FG000|Overall Study|Lost to Follow-up|1|||
125293349|NCT02827500|450702062|FG001|Overall Study|Lost to Follow-up|1|||
125293350|NCT02827500|450702061|FG000|Overall Study|Withdrawal by Subject|3|||
125293351|NCT02827500|450702062|FG001|Overall Study|Withdrawal by Subject|1|||
125293352|NCT02827500|450702061|FG000|Overall Study|Missing primary endpoint data|3|||
125293353|NCT02827500|450702062|FG001|Overall Study|Missing primary endpoint data|1|||
125293354|NCT02827500|450702061|FG000|Overall Study|Other|5|||
125293355|NCT02827500|450702062|FG001|Overall Study|Other|1|||
125293356|NCT02308488|450702065|FG000|Overall Study|Withdrawal by Subject|2|||
125293357|NCT01541917|450702066|FG000|Overall Study|Lost to Follow-up|2|||
125293358|NCT01541917|450702067|FG001|Overall Study|Lost to Follow-up|2|||
125293359|NCT01541917|450702066|FG000|Overall Study|Withdrawal by Subject|13|||
125293360|NCT01541917|450702067|FG001|Overall Study|Withdrawal by Subject|7|||
125293361|NCT00094107|450702072|FG000|Overall Study|Lack of Efficacy|23|||
125293362|NCT00094107|450702072|FG000|Overall Study|Death|5|||
125293363|NCT00094107|450702072|FG000|Overall Study|Adverse Event|3|||
125293364|NCT00094107|450702072|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
125293365|NCT00525824|450702073|FG000|Overall Study|Adverse Event|7|||
125293366|NCT00525824|450702074|FG001|Overall Study|Adverse Event|11|||
125293367|NCT00525824|450702075|FG002|Overall Study|Adverse Event|6|||
125293368|NCT00525824|450702076|FG003|Overall Study|Adverse Event|7|||
125293369|NCT00525824|450702073|FG000|Overall Study|Withdrawal by Subject|5|||
125293370|NCT00525824|450702074|FG001|Overall Study|Withdrawal by Subject|9|||
125293371|NCT00525824|450702075|FG002|Overall Study|Withdrawal by Subject|3|||
125293372|NCT00525824|450702076|FG003|Overall Study|Withdrawal by Subject|4|||
125293373|NCT00525824|450702073|FG000|Overall Study|Lost to Follow-up|4|||
125293374|NCT00525824|450702074|FG001|Overall Study|Lost to Follow-up|2|||
125293375|NCT00525824|450702075|FG002|Overall Study|Lost to Follow-up|4|||
125293376|NCT00525824|450702076|FG003|Overall Study|Lost to Follow-up|0|||
125293377|NCT00525824|450702073|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
125293378|NCT00525824|450702074|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
125293379|NCT00525824|450702075|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
125293380|NCT00525824|450702076|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
125293381|NCT00525824|450702073|FG000|Overall Study|Severe non-compliance|0|||
125293382|NCT00525824|450702074|FG001|Overall Study|Severe non-compliance|1|||
125293383|NCT00525824|450702075|FG002|Overall Study|Severe non-compliance|1|||
125293384|NCT00525824|450702076|FG003|Overall Study|Severe non-compliance|1|||
125293385|NCT00525824|450702073|FG000|Overall Study|Safety reasons|1|||
125293386|NCT00525824|450702074|FG001|Overall Study|Safety reasons|0|||
125293387|NCT00525824|450702075|FG002|Overall Study|Safety reasons|1|||
125293388|NCT00525824|450702076|FG003|Overall Study|Safety reasons|0|||
125293389|NCT00525824|450702073|FG000|Overall Study|Other|1|||
125293390|NCT00525824|450702074|FG001|Overall Study|Other|3|||
125293391|NCT00525824|450702075|FG002|Overall Study|Other|3|||
125293392|NCT00525824|450702076|FG003|Overall Study|Other|1|||
125293393|NCT01378429|450702080|FG000|Overall Study|Noncompliance with study drug|1|||
125293394|NCT01378429|450702081|FG001|Overall Study|Noncompliance with study drug|0|||
125293395|NCT01490294|450702084|FG000|Overall Study|Prematurely discontinuation|4|||
125293396|NCT01490294|450702085|FG001|Overall Study|Prematurely discontinuation|0|||
125293397|NCT01490294|450702086|FG002|Overall Study|Prematurely discontinuation|1|||
125293398|NCT01490294|450702087|FG003|Overall Study|Prematurely discontinuation|1|||
125293399|NCT01490294|450702084|FG000|Overall Study|Adverse Event|1|||
125293400|NCT01490294|450702085|FG001|Overall Study|Adverse Event|0|||
125293401|NCT01490294|450702086|FG002|Overall Study|Adverse Event|0|||
125293402|NCT01490294|450702087|FG003|Overall Study|Adverse Event|0|||
125293403|NCT01751776|450702088|FG000|Overall Study|Adverse Event|0|||
125293404|NCT01751776|450702089|FG001|Overall Study|Adverse Event|0|||
125293405|NCT01751776|450702090|FG002|Overall Study|Adverse Event|0|||
125293406|NCT01751776|450702091|FG003|Overall Study|Adverse Event|0|||
125293407|NCT01751776|450702092|FG004|Overall Study|Adverse Event|0|||
125293408|NCT01751776|450702093|FG005|Overall Study|Adverse Event|0|||
125293409|NCT01751776|450702094|FG006|Overall Study|Adverse Event|4|||
125455042|NCT01090024|451294666|FG000|Period 3|Adverse Event|0|||
125455043|NCT01090024|451294667|FG001|Period 3|Adverse Event|0|||
125455044|NCT01090024|451294668|FG002|Period 3|Adverse Event|0|||
125455045|NCT01090024|451294669|FG003|Period 3|Adverse Event|0|||
125293410|NCT01751776|450702095|FG007|Overall Study|Adverse Event|2|||
125293411|NCT01751776|450702088|FG000|Overall Study|Consent withdrawn|0|||
125293412|NCT01751776|450702089|FG001|Overall Study|Consent withdrawn|0|||
125293413|NCT01751776|450702090|FG002|Overall Study|Consent withdrawn|0|||
125293414|NCT01751776|450702091|FG003|Overall Study|Consent withdrawn|0|||
125293415|NCT01751776|450702092|FG004|Overall Study|Consent withdrawn|0|||
125293416|NCT01751776|450702093|FG005|Overall Study|Consent withdrawn|0|||
125293417|NCT01751776|450702094|FG006|Overall Study|Consent withdrawn|0|||
125293418|NCT01751776|450702095|FG007|Overall Study|Consent withdrawn|1|||
125293419|NCT01751776|450702088|FG000|Overall Study|Other reason not specified above|0|||
125293420|NCT01751776|450702089|FG001|Overall Study|Other reason not specified above|0|||
125293421|NCT01751776|450702090|FG002|Overall Study|Other reason not specified above|0|||
125293422|NCT01751776|450702091|FG003|Overall Study|Other reason not specified above|0|||
125293423|NCT01751776|450702092|FG004|Overall Study|Other reason not specified above|0|||
125293424|NCT01751776|450702093|FG005|Overall Study|Other reason not specified above|0|||
125455046|NCT01090024|451294670|FG004|Period 3|Adverse Event|0|||
125293425|NCT01751776|450702094|FG006|Overall Study|Other reason not specified above|0|||
125293426|NCT01751776|450702095|FG007|Overall Study|Other reason not specified above|1|||
125293427|NCT05219669|450702096|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
125293428|NCT05219669|450702097|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
125293429|NCT05219669|450702098|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
125293430|NCT05219669|450702099|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
125293431|NCT05219669|450702100|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
125293432|NCT05219669|450702101|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
125293433|NCT02404649|450702106|FG000|Overall Study|Adverse Event|1|||
125293434|NCT02404649|450702107|FG001|Overall Study|Adverse Event|2|||
125293435|NCT00330668|450702111|FG000|BID Dosing Period|Adverse Event|1|||
125455047|NCT01090024|451294671|FG005|Period 3|Adverse Event|1|||
125455048|NCT01090024|451294672|FG006|Period 3|Adverse Event|0|||
125455049|NCT01090024|451294673|FG007|Period 3|Adverse Event|0|||
125455050|NCT01090024|451294674|FG008|Period 3|Adverse Event|0|||
125455051|NCT01090024|451294675|FG009|Period 3|Adverse Event|0|||
125293436|NCT00330668|450702111|FG000|BID Dosing Period|Lost to Follow-up|7|||
125293437|NCT00330668|450702111|FG000|BID Dosing Period|Non-Compliance|5|||
125293438|NCT00330668|450702111|FG000|BID Dosing Period|Withdrawal by Subject|19|||
125293439|NCT00330668|450702111|FG000|BID Dosing Period|Sponsor's decision|1|||
125455052|NCT01090024|451294676|FG010|Period 3|Adverse Event|0|||
125455053|NCT01090024|451294677|FG011|Period 3|Adverse Event|0|||
125293440|NCT00330668|450702111|FG000|BID Dosing Period|Other|3|||
125293441|NCT00330668|450702111|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
125293442|NCT00330668|450702111|FG000|QD Dosing Period|Other|1|||
125293443|NCT00330668|450702111|FG000|QD Dosing Period|Withdrawal by Subject|1|||
125293444|NCT00330668|450702111|FG000|QD Dosing Period|Lost to Follow-up|2|||
125293445|NCT01839656|450702112|FG000|Overall Study|Withdrawal by Subject|1|||
125293446|NCT01839656|450702113|FG001|Overall Study|Withdrawal by Subject|1|||
125293447|NCT01839656|450702112|FG000|Overall Study|Adverse event, serious fatal|1|||
125293448|NCT01839656|450702113|FG001|Overall Study|Adverse event, serious fatal|4|||
125293449|NCT01839656|450702112|FG000|Overall Study|Early study closure|0|||
125455054|NCT01090024|451294678|FG012|Period 3|Adverse Event|0|||
125455055|NCT01090024|451294679|FG013|Period 3|Adverse Event|0|||
125293450|NCT01839656|450702113|FG001|Overall Study|Early study closure|11|||
125293451|NCT01839656|450702112|FG000|Overall Study|Adverse Event|1|||
125293452|NCT01839656|450702113|FG001|Overall Study|Adverse Event|0|||
125293453|NCT01595581|450702114|FG000|Overall Study|Withdrawal by Subject|1|||
125293454|NCT01595581|450702115|FG001|Overall Study|Withdrawal by Subject|0|||
125293455|NCT02621073|450702116|FG000|Overall Study|Lost to Follow-up|0|||
125293456|NCT02621073|450702117|FG001|Overall Study|Lost to Follow-up|1|||
125293457|NCT02621073|450702116|FG000|Overall Study|Physician Decision|3|||
125293458|NCT02621073|450702117|FG001|Overall Study|Physician Decision|2|||
125293459|NCT01440881|450702127|FG000|Overall Study|Death|0|||
125293460|NCT01440881|450702128|FG001|Overall Study|Death|1|||
125293461|NCT03474081|450702129|FG000|Overall Study|Adverse Event|6|||
125293462|NCT03474081|450702130|FG001|Overall Study|Adverse Event|3|||
125293463|NCT03474081|450702129|FG000|Overall Study|Lost to Follow-up|2|||
125293464|NCT03474081|450702130|FG001|Overall Study|Lost to Follow-up|1|||
125293465|NCT03474081|450702129|FG000|Overall Study|Physician Decision|3|||
125293466|NCT03474081|450702130|FG001|Overall Study|Physician Decision|2|||
125293467|NCT03474081|450702129|FG000|Overall Study|Withdrawal by Subject|5|||
125293468|NCT03474081|450702130|FG001|Overall Study|Withdrawal by Subject|7|||
125293469|NCT03474081|450702129|FG000|Overall Study|Investigator site closed|1|||
125293470|NCT03474081|450702130|FG001|Overall Study|Investigator site closed|0|||
125293471|NCT02920957|450702137|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
125293472|NCT02920957|450702138|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
125293473|NCT02920957|450702137|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
125293474|NCT02920957|450702138|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
125293475|NCT02920957|450702137|FG000|First Intervention : 1 Month|Adverse Event|1|||
125293476|NCT02920957|450702138|FG001|First Intervention : 1 Month|Adverse Event|0|||
125293477|NCT02920957|450702137|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
125293478|NCT02920957|450702138|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
125293479|NCT02644356|450702140|FG000|Overall Study|Withdrawal by Subject|2|||
125293480|NCT02739321|450702147|FG000|Overall Study|Lack of Efficacy|1|||
125293481|NCT02739321|450702148|FG001|Overall Study|Lack of Efficacy|1|||
125293482|NCT02739321|450702147|FG000|Overall Study|Lost to Follow-up|1|||
125293483|NCT02739321|450702148|FG001|Overall Study|Lost to Follow-up|1|||
125293484|NCT02739321|450702147|FG000|Overall Study|Withdrawal by Subject|1|||
125293485|NCT02739321|450702148|FG001|Overall Study|Withdrawal by Subject|2|||
125293486|NCT01711866|450702149|FG000|Overall Study|Noncompliant|3|||
125293487|NCT01711866|450702149|FG000|Overall Study|Withdrawal by Subject|3|||
125293488|NCT01711866|450702149|FG000|Overall Study|Adverse Event|2|||
125293489|NCT01345682|450702150|FG000|Overall Study|Progressive disease per RECIST|226|||
125293490|NCT01345682|450702151|FG001|Overall Study|Progressive disease per RECIST|93|||
125293491|NCT01345682|450702150|FG000|Overall Study|Worsening of underlying cancer disease|23|||
125293492|NCT01345682|450702151|FG001|Overall Study|Worsening of underlying cancer disease|12|||
125293493|NCT01345682|450702150|FG000|Overall Study|Adverse Event|51|||
125293494|NCT01345682|450702151|FG001|Overall Study|Adverse Event|41|||
125293495|NCT01345682|450702150|FG000|Overall Study|Non-compliance with protocol|0|||
125293496|NCT01345682|450702151|FG001|Overall Study|Non-compliance with protocol|1|||
125293497|NCT01345682|450702150|FG000|Overall Study|Lost to Follow-up|0|||
125293498|NCT01345682|450702151|FG001|Overall Study|Lost to Follow-up|1|||
125293499|NCT01345682|450702150|FG000|Overall Study|Refused to continue trial medication|16|||
125293500|NCT01345682|450702151|FG001|Overall Study|Refused to continue trial medication|9|||
125293501|NCT01345682|450702150|FG000|Overall Study|Not treated|2|||
125293502|NCT01345682|450702151|FG001|Overall Study|Not treated|1|||
125293503|NCT01345682|450702150|FG000|Overall Study|Reason other than those specified above|4|||
125293504|NCT01345682|450702151|FG001|Overall Study|Reason other than those specified above|3|||
125293505|NCT00897390|450702154|FG000|Overall Study|Adverse Event|2|||
125293506|NCT00897390|450702154|FG000|Overall Study|No Longer Met Study Criteria|1|||
125293507|NCT00897390|450702154|FG000|Overall Study|Personal Reasons|1|||
125293508|NCT00897390|450702154|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
125293509|NCT00958217|450702158|FG000|Overall Study|Death|2|||
125293510|NCT00958217|450702159|FG001|Overall Study|Death|1|||
125293511|NCT00958217|450702158|FG000|Overall Study|Withdrawal by Subject|4|||
125293512|NCT00958217|450702159|FG001|Overall Study|Withdrawal by Subject|3|||
125293513|NCT00958217|450702158|FG000|Overall Study|Lost to Follow-up|17|||
125293514|NCT00958217|450702159|FG001|Overall Study|Lost to Follow-up|19|||
125293515|NCT00958217|450702158|FG000|Overall Study|Moved out of area|1|||
125293516|NCT00958217|450702159|FG001|Overall Study|Moved out of area|1|||
125293517|NCT00958217|450702158|FG000|Overall Study|Inpatient hospitalization|0|||
125293518|NCT00958217|450702159|FG001|Overall Study|Inpatient hospitalization|1|||
125293519|NCT01075984|450702162|FG000|Treatment Phase|Adverse Event|0|||
125293520|NCT01075984|450702163|FG001|Treatment Phase|Adverse Event|1|||
125293521|NCT01075984|450702164|FG002|Treatment Phase|Adverse Event|3|||
125293522|NCT01075984|450702165|FG003|Treatment Phase|Adverse Event|7|||
125293523|NCT01075984|450702166|FG004|Treatment Phase|Adverse Event|35|||
125293524|NCT01075984|450702162|FG000|Treatment Phase|Protocol Violation|0|||
125293525|NCT01075984|450702163|FG001|Treatment Phase|Protocol Violation|0|||
125419977|NCT01381692|451162201|FG002|Overall Study|Adverse Event|0|||
125293526|NCT01075984|450702164|FG002|Treatment Phase|Protocol Violation|1|||
125293527|NCT01075984|450702165|FG003|Treatment Phase|Protocol Violation|0|||
125293528|NCT01075984|450702166|FG004|Treatment Phase|Protocol Violation|3|||
125293529|NCT01075984|450702162|FG000|Treatment Phase|Withdrawal by Subject|0|||
125293530|NCT01075984|450702163|FG001|Treatment Phase|Withdrawal by Subject|0|||
125293531|NCT01075984|450702164|FG002|Treatment Phase|Withdrawal by Subject|2|||
125293532|NCT01075984|450702165|FG003|Treatment Phase|Withdrawal by Subject|0|||
125293533|NCT01075984|450702166|FG004|Treatment Phase|Withdrawal by Subject|15|||
125293534|NCT01075984|450702162|FG000|Treatment Phase|Treatment Failure|0|||
125293535|NCT01075984|450702163|FG001|Treatment Phase|Treatment Failure|0|||
125293536|NCT01075984|450702164|FG002|Treatment Phase|Treatment Failure|1|||
125293537|NCT01075984|450702165|FG003|Treatment Phase|Treatment Failure|0|||
125293538|NCT01075984|450702166|FG004|Treatment Phase|Treatment Failure|5|||
125293539|NCT01075984|450702162|FG000|Treatment Phase|Progression of disease|0|||
125293540|NCT01075984|450702163|FG001|Treatment Phase|Progression of disease|0|||
125293541|NCT01075984|450702164|FG002|Treatment Phase|Progression of disease|0|||
125293542|NCT01075984|450702165|FG003|Treatment Phase|Progression of disease|0|||
125293543|NCT01075984|450702166|FG004|Treatment Phase|Progression of disease|2|||
125293544|NCT01075984|450702162|FG000|Follow-up Phase|Protocol Violation|0|||
125293545|NCT01075984|450702163|FG001|Follow-up Phase|Protocol Violation|0|||
125293546|NCT01075984|450702164|FG002|Follow-up Phase|Protocol Violation|1|||
125455056|NCT01090024|451294680|FG014|Period 3|Adverse Event|0|||
125455057|NCT01090024|451294681|FG015|Period 3|Adverse Event|0|||
125455058|NCT01090024|451294682|FG016|Period 3|Adverse Event|0|||
125455059|NCT01090024|451294683|FG017|Period 3|Adverse Event|0|||
125455060|NCT00777556|451294686|FG000|Overall Study|Inappropriate self-selection|34|||
125455061|NCT00777556|451294686|FG000|Overall Study|Dispensed but did not use product|12|||
125455062|NCT00777556|451294686|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
125455063|NCT02131324|451294690|FG000|Overall Study|Withdrawal by Subject|1|||
125455064|NCT02131324|451294691|FG001|Overall Study|Withdrawal by Subject|2|||
125455065|NCT02131324|451294690|FG000|Overall Study|Lost to Follow-up|1|||
125455066|NCT02131324|451294691|FG001|Overall Study|Lost to Follow-up|1|||
125455067|NCT00920686|451294692|FG000|Overall Study|Lost to Follow-up|2|||
125455068|NCT00920686|451294693|FG001|Overall Study|Lost to Follow-up|3|||
125455069|NCT00920686|451294694|FG002|Overall Study|Lost to Follow-up|1|||
125455070|NCT00920686|451294692|FG000|Overall Study|Study drug dosing criteria not met|17|||
125455071|NCT00920686|451294693|FG001|Overall Study|Study drug dosing criteria not met|19|||
125455072|NCT00920686|451294694|FG002|Overall Study|Study drug dosing criteria not met|12|||
125455073|NCT01313182|451294695|FG000|Overall Study|Protocol Violation|66|||
125455074|NCT01313182|451294696|FG001|Overall Study|Protocol Violation|92|||
125455075|NCT01695317|451294697|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
125293547|NCT01075984|450702165|FG003|Follow-up Phase|Protocol Violation|0|||
125293548|NCT01075984|450702166|FG004|Follow-up Phase|Protocol Violation|3|||
125293549|NCT01075984|450702162|FG000|Follow-up Phase|Adverse Event|0|||
125293550|NCT01075984|450702163|FG001|Follow-up Phase|Adverse Event|0|||
125293551|NCT01075984|450702164|FG002|Follow-up Phase|Adverse Event|0|||
125293552|NCT01075984|450702165|FG003|Follow-up Phase|Adverse Event|2|||
125293553|NCT01075984|450702166|FG004|Follow-up Phase|Adverse Event|27|||
125293554|NCT01075984|450702162|FG000|Follow-up Phase|Administrative|0|||
125293555|NCT01075984|450702163|FG001|Follow-up Phase|Administrative|0|||
125293556|NCT01075984|450702164|FG002|Follow-up Phase|Administrative|0|||
125455076|NCT01695317|451294698|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
125455077|NCT01695317|451294697|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
125293557|NCT01075984|450702165|FG003|Follow-up Phase|Administrative|0|||
125293558|NCT01075984|450702166|FG004|Follow-up Phase|Administrative|1|||
125293559|NCT01075984|450702162|FG000|Follow-up Phase|Withdrawal by Subject|0|||
125293560|NCT01075984|450702163|FG001|Follow-up Phase|Withdrawal by Subject|0|||
125293561|NCT01075984|450702164|FG002|Follow-up Phase|Withdrawal by Subject|0|||
125293562|NCT01075984|450702165|FG003|Follow-up Phase|Withdrawal by Subject|0|||
125293563|NCT01075984|450702166|FG004|Follow-up Phase|Withdrawal by Subject|10|||
125455078|NCT01695317|451294698|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
125455079|NCT04044664|451294706|FG000|Stage 1|Adverse Event|3|||
125455080|NCT04044664|451294707|FG001|Stage 1|Adverse Event|3|||
125455081|NCT04044664|451294708|FG002|Stage 1|Adverse Event|1|||
125455082|NCT04044664|451294706|FG000|Stage 1|Lost to Follow-up|3|||
125293564|NCT01075984|450702162|FG000|Follow-up Phase|Progression of disease|0|||
125293565|NCT01075984|450702163|FG001|Follow-up Phase|Progression of disease|0|||
125293566|NCT01075984|450702164|FG002|Follow-up Phase|Progression of disease|0|||
125293567|NCT01075984|450702165|FG003|Follow-up Phase|Progression of disease|0|||
125455083|NCT04044664|451294707|FG001|Stage 1|Lost to Follow-up|2|||
125455084|NCT04044664|451294708|FG002|Stage 1|Lost to Follow-up|2|||
125293568|NCT01075984|450702166|FG004|Follow-up Phase|Progression of disease|2|||
125293569|NCT01075984|450702162|FG000|Follow-up Phase|Treatment failure|0|||
125455085|NCT04044664|451294706|FG000|Stage 1|Withdrawal by Subject|9|||
125455086|NCT04044664|451294707|FG001|Stage 1|Withdrawal by Subject|1|||
125293570|NCT01075984|450702163|FG001|Follow-up Phase|Treatment failure|0|||
125293571|NCT01075984|450702164|FG002|Follow-up Phase|Treatment failure|0|||
125455087|NCT04044664|451294708|FG002|Stage 1|Withdrawal by Subject|0|||
125293572|NCT01075984|450702165|FG003|Follow-up Phase|Treatment failure|0|||
125293573|NCT01075984|450702166|FG004|Follow-up Phase|Treatment failure|4|||
125293574|NCT02198235|450702168|FG000|Overall Study|Lost to Follow-up|3|||
125293575|NCT02198235|450702169|FG001|Overall Study|Lost to Follow-up|2|||
125293576|NCT02198235|450702170|FG002|Overall Study|Lost to Follow-up|2|||
125293577|NCT02440789|450702174|FG000|Overall Study|Withdrawal by Subject|3|||
125293578|NCT02440789|450702174|FG000|Overall Study|Not willing to adhere to reqs|1|||
125293579|NCT04573881|450702176|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
125293580|NCT02564978|450702179|FG000|Overall Study|Adverse Event|8|||
125293581|NCT02564978|450702179|FG000|Overall Study|Death|1|||
125293582|NCT02564978|450702179|FG000|Overall Study|Lost to Follow-up|1|||
125293583|NCT02564978|450702179|FG000|Overall Study|Withdrawal by Subject|15|||
125293584|NCT02564978|450702179|FG000|Overall Study|Early Study Closure|2|||
125293585|NCT02564978|450702179|FG000|Overall Study|Other Reason|5|||
125293586|NCT03684694|450702180|FG000|Phase 1|Withdrawal by Subject|1|||
125293587|NCT03684694|450702181|FG001|Phase 1|Withdrawal by Subject|0|||
125293588|NCT03684694|450702182|FG002|Phase 1|Withdrawal by Subject|0|||
125293589|NCT03684694|450702183|FG003|Phase 1|Withdrawal by Subject|0|||
125293590|NCT03684694|450702184|FG004|Phase 1|Withdrawal by Subject|0|||
125293591|NCT03684694|450702185|FG005|Phase 1|Withdrawal by Subject|0|||
125293592|NCT03684694|450702180|FG000|Phase 1|Investigator/Sponsor Decision|12|||
125293593|NCT03684694|450702181|FG001|Phase 1|Investigator/Sponsor Decision|2|||
125293594|NCT03684694|450702182|FG002|Phase 1|Investigator/Sponsor Decision|1|||
125293595|NCT03684694|450702183|FG003|Phase 1|Investigator/Sponsor Decision|0|||
125293596|NCT03684694|450702184|FG004|Phase 1|Investigator/Sponsor Decision|0|||
125293597|NCT03684694|450702185|FG005|Phase 1|Investigator/Sponsor Decision|0|||
125293598|NCT03684694|450702180|FG000|Phase 1|Death|24|||
125293599|NCT03684694|450702181|FG001|Phase 1|Death|0|||
125293600|NCT03684694|450702182|FG002|Phase 1|Death|3|||
125293601|NCT03684694|450702183|FG003|Phase 1|Death|0|||
125293602|NCT03684694|450702184|FG004|Phase 1|Death|0|||
125293603|NCT03684694|450702185|FG005|Phase 1|Death|0|||
125293604|NCT03684694|450702180|FG000|Phase 1|Lost to Follow-up|0|||
125293605|NCT03684694|450702181|FG001|Phase 1|Lost to Follow-up|0|||
125293606|NCT03684694|450702182|FG002|Phase 1|Lost to Follow-up|1|||
125293607|NCT03684694|450702183|FG003|Phase 1|Lost to Follow-up|0|||
125293608|NCT03684694|450702184|FG004|Phase 1|Lost to Follow-up|0|||
125293609|NCT03684694|450702185|FG005|Phase 1|Lost to Follow-up|0|||
125293610|NCT03684694|450702180|FG000|Phase 1|Miscellaneous|0|||
125293611|NCT03684694|450702181|FG001|Phase 1|Miscellaneous|1|||
125293612|NCT03684694|450702182|FG002|Phase 1|Miscellaneous|0|||
125293613|NCT03684694|450702183|FG003|Phase 1|Miscellaneous|0|||
125293614|NCT03684694|450702184|FG004|Phase 1|Miscellaneous|0|||
125293615|NCT03684694|450702185|FG005|Phase 1|Miscellaneous|0|||
125293616|NCT03684694|450702180|FG000|Phase 2|Withdrawal by Subject|0|||
125293617|NCT03684694|450702181|FG001|Phase 2|Withdrawal by Subject|0|||
125293618|NCT03684694|450702182|FG002|Phase 2|Withdrawal by Subject|0|||
125293619|NCT03684694|450702183|FG003|Phase 2|Withdrawal by Subject|0|||
125455088|NCT04044664|451294706|FG000|Stage 1|noncompliance, personal reason|2|||
125455089|NCT04044664|451294707|FG001|Stage 1|noncompliance, personal reason|0|||
125455090|NCT04044664|451294708|FG002|Stage 1|noncompliance, personal reason|0|||
125455091|NCT04044664|451294706|FG000|Stage 1|randomization error|0|||
125455092|NCT04044664|451294707|FG001|Stage 1|randomization error|1|||
125455093|NCT04044664|451294708|FG002|Stage 1|randomization error|0|||
125455094|NCT04044664|451294706|FG000|Stage 2|Adverse Event|2|||
125455095|NCT04044664|451294707|FG001|Stage 2|Adverse Event|0|||
125455096|NCT04044664|451294708|FG002|Stage 2|Adverse Event|0|||
125455097|NCT04044664|451294706|FG000|Stage 2|Lost to Follow-up|3|||
125455098|NCT04044664|451294707|FG001|Stage 2|Lost to Follow-up|2|||
125293620|NCT03684694|450702184|FG004|Phase 2|Withdrawal by Subject|0|||
125293621|NCT03684694|450702185|FG005|Phase 2|Withdrawal by Subject|1|||
125293622|NCT03684694|450702180|FG000|Phase 2|Investigator/Sponsor Decision|0|||
125293623|NCT03684694|450702181|FG001|Phase 2|Investigator/Sponsor Decision|0|||
125293624|NCT03684694|450702182|FG002|Phase 2|Investigator/Sponsor Decision|0|||
125293625|NCT03684694|450702183|FG003|Phase 2|Investigator/Sponsor Decision|17|||
125293626|NCT03684694|450702184|FG004|Phase 2|Investigator/Sponsor Decision|16|||
125293627|NCT03684694|450702185|FG005|Phase 2|Investigator/Sponsor Decision|6|||
125293628|NCT03684694|450702180|FG000|Phase 2|Death|0|||
125455099|NCT04044664|451294708|FG002|Stage 2|Lost to Follow-up|1|||
125455100|NCT04044664|451294706|FG000|Stage 2|Withdrawal by Subject|3|||
125293629|NCT03684694|450702181|FG001|Phase 2|Death|0|||
125293630|NCT03684694|450702182|FG002|Phase 2|Death|0|||
125293631|NCT03684694|450702183|FG003|Phase 2|Death|28|||
125455101|NCT04044664|451294707|FG001|Stage 2|Withdrawal by Subject|0|||
125293632|NCT03684694|450702184|FG004|Phase 2|Death|14|||
125293633|NCT03684694|450702185|FG005|Phase 2|Death|3|||
125293634|NCT03684694|450702180|FG000|Phase 2|Lost to Follow-up|0|||
125293635|NCT03684694|450702181|FG001|Phase 2|Lost to Follow-up|0|||
125293636|NCT03684694|450702182|FG002|Phase 2|Lost to Follow-up|0|||
125293637|NCT03684694|450702183|FG003|Phase 2|Lost to Follow-up|1|||
125293638|NCT03684694|450702184|FG004|Phase 2|Lost to Follow-up|0|||
125293639|NCT03684694|450702185|FG005|Phase 2|Lost to Follow-up|0|||
125293640|NCT03684694|450702180|FG000|Phase 2|Miscellaneous|0|||
125455102|NCT04044664|451294708|FG002|Stage 2|Withdrawal by Subject|0|||
125455103|NCT04044664|451294706|FG000|Stage 2|protocol deviation|1|||
125455104|NCT04044664|451294707|FG001|Stage 2|protocol deviation|0|||
125455105|NCT04044664|451294708|FG002|Stage 2|protocol deviation|0|||
125455106|NCT00001575|451294709|FG000|Overall Study|Screening failures-Ph I portion|22|||
125455107|NCT00001575|451294709|FG000|Overall Study|Withdrawn/deaths|23|||
125455108|NCT03736785|451294711|FG000|Overall Study|Adverse Event|1|||
125455109|NCT03736785|451294712|FG001|Overall Study|Adverse Event|1|||
125455110|NCT03736785|451294713|FG002|Overall Study|Adverse Event|1|||
125455111|NCT03736785|451294711|FG000|Overall Study|Death|1|||
125455112|NCT03736785|451294712|FG001|Overall Study|Death|0|||
125455113|NCT03736785|451294713|FG002|Overall Study|Death|1|||
125455114|NCT03736785|451294711|FG000|Overall Study|Lost to Follow-up|0|||
125455115|NCT03736785|451294712|FG001|Overall Study|Lost to Follow-up|2|||
125455116|NCT03736785|451294713|FG002|Overall Study|Lost to Follow-up|3|||
125455117|NCT03736785|451294711|FG000|Overall Study|Non compliance with study drug|1|||
125455118|NCT03736785|451294712|FG001|Overall Study|Non compliance with study drug|1|||
125455119|NCT03736785|451294713|FG002|Overall Study|Non compliance with study drug|0|||
125455120|NCT03736785|451294711|FG000|Overall Study|Physician Decision|0|||
125455121|NCT03736785|451294712|FG001|Overall Study|Physician Decision|1|||
125455122|NCT03736785|451294713|FG002|Overall Study|Physician Decision|1|||
125455123|NCT03736785|451294711|FG000|Overall Study|Protocol Violation|1|||
125455124|NCT03736785|451294712|FG001|Overall Study|Protocol Violation|4|||
125455125|NCT03736785|451294713|FG002|Overall Study|Protocol Violation|3|||
125455126|NCT03736785|451294711|FG000|Overall Study|Sponsor Decision|1|||
125455127|NCT03736785|451294712|FG001|Overall Study|Sponsor Decision|0|||
125455128|NCT03736785|451294713|FG002|Overall Study|Sponsor Decision|0|||
125455129|NCT03736785|451294711|FG000|Overall Study|Unknown/Missing data|3|||
125455130|NCT03736785|451294712|FG001|Overall Study|Unknown/Missing data|2|||
125455131|NCT03736785|451294713|FG002|Overall Study|Unknown/Missing data|1|||
125455132|NCT03736785|451294711|FG000|Overall Study|Withdrawal by Subject|9|||
125455133|NCT03736785|451294712|FG001|Overall Study|Withdrawal by Subject|6|||
125293641|NCT03684694|450702181|FG001|Phase 2|Miscellaneous|0|||
125293642|NCT03684694|450702182|FG002|Phase 2|Miscellaneous|0|||
125293643|NCT03684694|450702183|FG003|Phase 2|Miscellaneous|3|||
125293644|NCT03684694|450702184|FG004|Phase 2|Miscellaneous|0|||
125293645|NCT03684694|450702185|FG005|Phase 2|Miscellaneous|0|||
125293646|NCT01825941|450703702|FG000|Overall Study|Lost to Follow-up|4|||
125293647|NCT01825941|450703703|FG001|Overall Study|Lost to Follow-up|1|||
125293648|NCT00528996|450703704|FG000|Overall Study|Other reasons than listing|6|||
125293649|NCT00528996|450703705|FG001|Overall Study|Other reasons than listing|7|||
125293650|NCT00528996|450703706|FG002|Overall Study|Other reasons than listing|14|||
125293651|NCT00528996|450703707|FG003|Overall Study|Other reasons than listing|11|||
125293652|NCT00528996|450703708|FG004|Overall Study|Other reasons than listing|5|||
125293653|NCT00528996|450703704|FG000|Overall Study|Refused continue medication|16|||
125293654|NCT00528996|450703705|FG001|Overall Study|Refused continue medication|0|||
125293655|NCT00528996|450703706|FG002|Overall Study|Refused continue medication|3|||
125293656|NCT00528996|450703707|FG003|Overall Study|Refused continue medication|3|||
125293657|NCT00528996|450703708|FG004|Overall Study|Refused continue medication|6|||
125293658|NCT00528996|450703704|FG000|Overall Study|Lost to Follow-up|2|||
125293659|NCT00528996|450703705|FG001|Overall Study|Lost to Follow-up|0|||
125293660|NCT00528996|450703706|FG002|Overall Study|Lost to Follow-up|4|||
125293661|NCT00528996|450703707|FG003|Overall Study|Lost to Follow-up|1|||
125293662|NCT00528996|450703708|FG004|Overall Study|Lost to Follow-up|3|||
125293663|NCT00528996|450703704|FG000|Overall Study|Protocol Violation|1|||
125293664|NCT00528996|450703705|FG001|Overall Study|Protocol Violation|2|||
125293665|NCT00528996|450703706|FG002|Overall Study|Protocol Violation|3|||
125293666|NCT00528996|450703707|FG003|Overall Study|Protocol Violation|3|||
125293667|NCT00528996|450703708|FG004|Overall Study|Protocol Violation|2|||
125455134|NCT03736785|451294713|FG002|Overall Study|Withdrawal by Subject|4|||
125455135|NCT01744691|451294722|FG000|Overall Study|Progressive Disease|18|||
125455136|NCT01744691|451294722|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
125293668|NCT00528996|450703704|FG000|Overall Study|Lack of Efficacy|7|||
125293669|NCT00528996|450703705|FG001|Overall Study|Lack of Efficacy|2|||
125293670|NCT00528996|450703706|FG002|Overall Study|Lack of Efficacy|1|||
125293671|NCT00528996|450703707|FG003|Overall Study|Lack of Efficacy|3|||
125293672|NCT00528996|450703708|FG004|Overall Study|Lack of Efficacy|3|||
125293673|NCT00528996|450703704|FG000|Overall Study|Adverse Event|32|||
125293674|NCT00528996|450703705|FG001|Overall Study|Adverse Event|13|||
125455137|NCT01744691|451294722|FG000|Overall Study|Withdrawal of consent for treatment|3|||
125455138|NCT01744691|451294722|FG000|Overall Study|Physician Decision|4|||
125293675|NCT00528996|450703706|FG002|Overall Study|Adverse Event|18|||
125455139|NCT02701361|451294724|FG000|Overall Study|Lost to Follow-up|5|||
125455140|NCT02701361|451294725|FG001|Overall Study|Lost to Follow-up|2|||
125455141|NCT02701361|451294726|FG002|Overall Study|Lost to Follow-up|1|||
125293676|NCT00528996|450703707|FG003|Overall Study|Adverse Event|29|||
125293677|NCT00528996|450703708|FG004|Overall Study|Adverse Event|18|||
125293678|NCT05565937|450703715|FG000|Overall Study|Adverse Event|0|||
125455142|NCT02701361|451294724|FG000|Overall Study|Withdrawal by Subject|4|||
125485349|NCT02240238|451412511|FG008|Phase 1|Adverse Event|0|||
125293679|NCT05565937|450703716|FG001|Overall Study|Adverse Event|1|||
125293680|NCT05565937|450703715|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
125293681|NCT05565937|450703716|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
125293682|NCT05565937|450703715|FG000|Overall Study|Lost to Follow-up|2|||
125293683|NCT05565937|450703716|FG001|Overall Study|Lost to Follow-up|0|||
125293684|NCT05565937|450703715|FG000|Overall Study|Pregnancy|0|||
125293685|NCT05565937|450703716|FG001|Overall Study|Pregnancy|2|||
125293686|NCT05565937|450703715|FG000|Overall Study|Anisometropia|0|||
125293687|NCT05565937|450703716|FG001|Overall Study|Anisometropia|1|||
125293688|NCT01022424|450703717|FG000|Overall Study|Adverse Event|1|||
125293689|NCT01022424|450703717|FG000|Overall Study|Physician Decision|1|||
125293690|NCT01022424|450703717|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
125293691|NCT01806064|450703722|FG000|Overall Study|Randomized Not Enrolled|0|||
125293692|NCT01806064|450703723|FG001|Overall Study|Randomized Not Enrolled|0|||
125293693|NCT01806064|450703724|FG002|Overall Study|Randomized Not Enrolled|0|||
125293694|NCT01806064|450703725|FG003|Overall Study|Randomized Not Enrolled|1|||
125293695|NCT01806064|450703726|FG004|Overall Study|Randomized Not Enrolled|2|||
125293696|NCT05160766|450703731|FG000|Overall Study|Adverse Event|0|||
125293697|NCT05160766|450703732|FG001|Overall Study|Adverse Event|1|||
125293698|NCT05160766|450703733|FG002|Overall Study|Adverse Event|0|||
125293699|NCT05160766|450703734|FG003|Overall Study|Adverse Event|0|||
125293700|NCT05160766|450703731|FG000|Overall Study|COVID-19 infection|0|||
125293701|NCT05160766|450703732|FG001|Overall Study|COVID-19 infection|1|||
125293702|NCT05160766|450703733|FG002|Overall Study|COVID-19 infection|0|||
125293703|NCT05160766|450703734|FG003|Overall Study|COVID-19 infection|0|||
125293704|NCT05160766|450703731|FG000|Overall Study|travel time|1|||
125293705|NCT05160766|450703732|FG001|Overall Study|travel time|0|||
125455143|NCT02701361|451294725|FG001|Overall Study|Withdrawal by Subject|0|||
125455144|NCT02701361|451294726|FG002|Overall Study|Withdrawal by Subject|0|||
125455145|NCT02701361|451294724|FG000|Overall Study|timed out in rehab center|0|||
125455146|NCT02701361|451294725|FG001|Overall Study|timed out in rehab center|1|||
125455147|NCT02701361|451294726|FG002|Overall Study|timed out in rehab center|0|||
125455148|NCT02701361|451294724|FG000|Overall Study|incarceration|0|||
125455149|NCT02701361|451294725|FG001|Overall Study|incarceration|0|||
125455150|NCT02701361|451294726|FG002|Overall Study|incarceration|1|||
125455151|NCT04588480|451294727|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
125455152|NCT04588480|451294728|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
125455153|NCT04588480|451294729|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
125455154|NCT04588480|451294727|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
125455155|NCT04588480|451294728|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
125293706|NCT05160766|450703733|FG002|Overall Study|travel time|0|||
125293707|NCT05160766|450703734|FG003|Overall Study|travel time|1|||
125293708|NCT05160766|450703731|FG000|Overall Study|Withdrawal by Subject|3|||
125293709|NCT05160766|450703732|FG001|Overall Study|Withdrawal by Subject|5|||
125293710|NCT05160766|450703733|FG002|Overall Study|Withdrawal by Subject|4|||
125293711|NCT05160766|450703734|FG003|Overall Study|Withdrawal by Subject|2|||
125293712|NCT05160766|450703731|FG000|Overall Study|Death|0|||
125293713|NCT05160766|450703732|FG001|Overall Study|Death|0|||
125293714|NCT05160766|450703733|FG002|Overall Study|Death|2|||
125293715|NCT05160766|450703734|FG003|Overall Study|Death|5|||
125293716|NCT05160766|450703731|FG000|Overall Study|Lost to Follow-up|0|||
125293717|NCT05160766|450703732|FG001|Overall Study|Lost to Follow-up|0|||
125293718|NCT05160766|450703733|FG002|Overall Study|Lost to Follow-up|1|||
125293719|NCT05160766|450703734|FG003|Overall Study|Lost to Follow-up|2|||
125293720|NCT05160766|450703731|FG000|Overall Study|No show|0|||
125293721|NCT05160766|450703732|FG001|Overall Study|No show|0|||
125293722|NCT05160766|450703733|FG002|Overall Study|No show|1|||
125293723|NCT05160766|450703734|FG003|Overall Study|No show|1|||
125455156|NCT04588480|451294729|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
125293724|NCT05160766|450703731|FG000|Overall Study|Physician Decision|0|||
125293725|NCT05160766|450703732|FG001|Overall Study|Physician Decision|0|||
125293726|NCT05160766|450703733|FG002|Overall Study|Physician Decision|0|||
125293727|NCT05160766|450703734|FG003|Overall Study|Physician Decision|1|||
125293728|NCT05160766|450703731|FG000|Overall Study|Protocol Violation|0|||
125293729|NCT05160766|450703732|FG001|Overall Study|Protocol Violation|0|||
125293730|NCT05160766|450703733|FG002|Overall Study|Protocol Violation|1|||
125293731|NCT05160766|450703734|FG003|Overall Study|Protocol Violation|0|||
125293732|NCT01282294|450703735|FG000|Overall Study|Lost to Follow-up|14|||
125293733|NCT01282294|450703735|FG000|Overall Study|Screening failure|1|||
125293734|NCT01282294|450703735|FG000|Overall Study|Adverse Event|1|||
125455157|NCT01190150|451294732|FG000|First Treatment|Withdrawal by Subject|1|||
125293735|NCT01282294|450703735|FG000|Overall Study|Patient non-compliance|2|||
125293736|NCT01282294|450703735|FG000|Overall Study|Physician Decision|1|||
125293737|NCT00004445|450703737|FG000|Overall Study|Physician Decision|2|||
125485350|NCT02240238|451412512|FG009|Phase 1|Adverse Event|0|||
125293738|NCT00004445|450703737|FG000|Overall Study|Withdrawal by Subject|1|||
125293739|NCT04692077|450703738|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
125293740|NCT02753127|450703745|FG000|Overall Study|Lost to Follow-up|13|||
125293741|NCT02753127|450703746|FG001|Overall Study|Lost to Follow-up|11|||
125293742|NCT02753127|450703745|FG000|Overall Study|Withdrawal by Subject|37|||
125293743|NCT02753127|450703746|FG001|Overall Study|Withdrawal by Subject|47|||
125293744|NCT02753127|450703745|FG000|Overall Study|Other|3|||
125293745|NCT02753127|450703746|FG001|Overall Study|Other|8|||
125293746|NCT02753127|450703745|FG000|Overall Study|Hospice|0|||
125293747|NCT02753127|450703746|FG001|Overall Study|Hospice|2|||
125293748|NCT03826342|450703747|FG000|Overall Study|Withdrawal by Subject|8|||
125293749|NCT03826342|450703748|FG001|Overall Study|Withdrawal by Subject|1|||
125293750|NCT03826342|450703747|FG000|Overall Study|Lost to Follow-up|7|||
125293751|NCT03826342|450703748|FG001|Overall Study|Lost to Follow-up|7|||
125293752|NCT03826342|450703747|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
125293753|NCT03826342|450703748|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
125293754|NCT01657760|450703751|FG000|Overall Study|Withdrawal by Subject|0|||
125293755|NCT01657760|450703752|FG001|Overall Study|Withdrawal by Subject|0|||
125293756|NCT01657760|450703753|FG002|Overall Study|Withdrawal by Subject|0|||
125293757|NCT01657760|450703754|FG003|Overall Study|Withdrawal by Subject|1|||
125293758|NCT01657760|450703751|FG000|Overall Study|Physician Decision|1|||
125293759|NCT01657760|450703752|FG001|Overall Study|Physician Decision|1|||
125293760|NCT01657760|450703753|FG002|Overall Study|Physician Decision|1|||
125293761|NCT01657760|450703754|FG003|Overall Study|Physician Decision|2|||
125293762|NCT06250738|450703762|FG000|Overall Study|Lost to Follow-up|1|||
125293763|NCT01818284|450703766|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
125293764|NCT01818284|450703767|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
125293765|NCT01818284|450703766|FG000|Overall Study|Death|0|||
125293766|NCT01818284|450703767|FG001|Overall Study|Death|2|||
125293767|NCT03681678|450703768|FG000|Overall Study|Lost to Follow-up|20|||
125293768|NCT01068249|450703769|FG000|Overall Study|Death|1|||
125293769|NCT01068249|450703769|FG000|Overall Study|Withdrawal by Subject|3|||
125293770|NCT04030962|450703771|FG000|Stage 2|Adverse Event|0|||
125293771|NCT04030962|450703772|FG001|Stage 2|Adverse Event|0|||
125293772|NCT04030962|450703773|FG002|Stage 2|Adverse Event|0|||
125293773|NCT04030962|450703774|FG003|Stage 2|Adverse Event|0|||
125293774|NCT04030962|450703775|FG004|Stage 2|Adverse Event|0|||
125293775|NCT04030962|450703776|FG005|Stage 2|Adverse Event|0|||
125293776|NCT04030962|450703777|FG006|Stage 2|Adverse Event|0|||
125293777|NCT04030962|450703778|FG007|Stage 2|Adverse Event|0|||
125293778|NCT04030962|450703779|FG008|Stage 2|Adverse Event|1|||
125293779|NCT04030962|450703780|FG009|Stage 2|Adverse Event|0|||
125293780|NCT04030962|450703781|FG010|Stage 2|Adverse Event|1|||
125293781|NCT04030962|450703782|FG011|Stage 2|Adverse Event|1|||
125293782|NCT04030962|450703783|FG012|Stage 2|Adverse Event|1|||
125293783|NCT04030962|450703771|FG000|Stage 2|Withdrawal by Subject|0|||
125293784|NCT04030962|450703772|FG001|Stage 2|Withdrawal by Subject|0|||
125293785|NCT04030962|450703773|FG002|Stage 2|Withdrawal by Subject|0|||
125293786|NCT04030962|450703774|FG003|Stage 2|Withdrawal by Subject|0|||
125293787|NCT04030962|450703775|FG004|Stage 2|Withdrawal by Subject|0|||
125293788|NCT04030962|450703776|FG005|Stage 2|Withdrawal by Subject|0|||
125293789|NCT04030962|450703777|FG006|Stage 2|Withdrawal by Subject|0|||
125293790|NCT04030962|450703778|FG007|Stage 2|Withdrawal by Subject|0|||
125293791|NCT04030962|450703779|FG008|Stage 2|Withdrawal by Subject|1|||
125293792|NCT04030962|450703780|FG009|Stage 2|Withdrawal by Subject|0|||
125293793|NCT04030962|450703781|FG010|Stage 2|Withdrawal by Subject|0|||
125293794|NCT04030962|450703782|FG011|Stage 2|Withdrawal by Subject|2|||
125293795|NCT04030962|450703783|FG012|Stage 2|Withdrawal by Subject|1|||
125293796|NCT04030962|450703771|FG000|Stage 2|Lost to Follow-up|0|||
125293797|NCT04030962|450703772|FG001|Stage 2|Lost to Follow-up|0|||
125293798|NCT04030962|450703773|FG002|Stage 2|Lost to Follow-up|0|||
125293799|NCT04030962|450703774|FG003|Stage 2|Lost to Follow-up|0|||
125293800|NCT04030962|450703775|FG004|Stage 2|Lost to Follow-up|0|||
125293801|NCT04030962|450703776|FG005|Stage 2|Lost to Follow-up|0|||
125293802|NCT04030962|450703777|FG006|Stage 2|Lost to Follow-up|0|||
125293803|NCT04030962|450703778|FG007|Stage 2|Lost to Follow-up|0|||
125293804|NCT04030962|450703779|FG008|Stage 2|Lost to Follow-up|1|||
125293805|NCT04030962|450703780|FG009|Stage 2|Lost to Follow-up|0|||
125293806|NCT04030962|450703781|FG010|Stage 2|Lost to Follow-up|0|||
125293807|NCT04030962|450703782|FG011|Stage 2|Lost to Follow-up|0|||
125293808|NCT04030962|450703783|FG012|Stage 2|Lost to Follow-up|0|||
125293809|NCT04030962|450703771|FG000|Stage 2|Technical Problems|0|||
125293810|NCT04030962|450703772|FG001|Stage 2|Technical Problems|0|||
125293811|NCT04030962|450703773|FG002|Stage 2|Technical Problems|0|||
125293812|NCT04030962|450703774|FG003|Stage 2|Technical Problems|0|||
125293813|NCT04030962|450703775|FG004|Stage 2|Technical Problems|0|||
125293814|NCT04030962|450703776|FG005|Stage 2|Technical Problems|0|||
125293815|NCT04030962|450703777|FG006|Stage 2|Technical Problems|0|||
125293816|NCT04030962|450703778|FG007|Stage 2|Technical Problems|0|||
125293817|NCT04030962|450703779|FG008|Stage 2|Technical Problems|0|||
125293818|NCT04030962|450703780|FG009|Stage 2|Technical Problems|0|||
125293819|NCT04030962|450703781|FG010|Stage 2|Technical Problems|0|||
125293820|NCT04030962|450703782|FG011|Stage 2|Technical Problems|1|||
125293821|NCT04030962|450703783|FG012|Stage 2|Technical Problems|0|||
125293822|NCT05288166|450703784|FG000|Overall Study|Adverse Event|1|||
125293823|NCT05288166|450703785|FG001|Overall Study|Adverse Event|0|||
125293824|NCT05288166|450703784|FG000|Overall Study|Lost to Follow-up|2|||
125293825|NCT05288166|450703785|FG001|Overall Study|Lost to Follow-up|0|||
125293826|NCT05288166|450703784|FG000|Overall Study|Physician Decision|0|||
125293827|NCT05288166|450703785|FG001|Overall Study|Physician Decision|2|||
125293828|NCT05288166|450703784|FG000|Overall Study|Screen Failure|1|||
125293829|NCT05288166|450703785|FG001|Overall Study|Screen Failure|1|||
125293830|NCT05288166|450703784|FG000|Overall Study|Withdrawal by Subject|4|||
125293831|NCT05288166|450703785|FG001|Overall Study|Withdrawal by Subject|2|||
125293832|NCT05288166|450703784|FG000|Overall Study|On Study Treatment|408|||
125293833|NCT05288166|450703785|FG001|Overall Study|On Study Treatment|418|||
125293834|NCT01114360|450703786|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
125293835|NCT01114360|450703787|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
125293836|NCT03007745|450703788|FG000|Overall Study|Sleep test negative for OSA|53|||
125293837|NCT03007745|450703789|FG001|Overall Study|Sleep test negative for OSA|49|||
125293838|NCT03007745|450703788|FG000|Overall Study|Physician Decision|6|||
125293839|NCT03007745|450703789|FG001|Overall Study|Physician Decision|9|||
125293840|NCT03007745|450703788|FG000|Overall Study|Withdrawal by Subject|38|||
125293841|NCT03007745|450703789|FG001|Overall Study|Withdrawal by Subject|16|||
125293842|NCT03007745|450703788|FG000|Overall Study|Lost to Follow-up|19|||
125293843|NCT03007745|450703789|FG001|Overall Study|Lost to Follow-up|25|||
125293844|NCT03007745|450703788|FG000|Overall Study|Unable to login to website|17|||
125293845|NCT03007745|450703789|FG001|Overall Study|Unable to login to website|4|||
125293846|NCT01146288|450703791|FG000|First Intervention(1 Day)|Adverse Event|0|||
125293847|NCT01146288|450703792|FG001|First Intervention(1 Day)|Adverse Event|1|||
125293848|NCT00385723|450703793|FG000|Overall Study|Lost to Follow-up|1|||
125293849|NCT00385723|450703794|FG001|Overall Study|Lost to Follow-up|1|||
125293850|NCT00385723|450703795|FG002|Overall Study|Lost to Follow-up|0|||
125293851|NCT00385723|450703793|FG000|Overall Study|Withdrawal by Subject|1|||
125293852|NCT00385723|450703794|FG001|Overall Study|Withdrawal by Subject|0|||
125293853|NCT00385723|450703795|FG002|Overall Study|Withdrawal by Subject|2|||
125293854|NCT03455829|450703796|FG000|Overall Study|Death|2|||
125293855|NCT03455829|450703797|FG001|Overall Study|Death|3|||
125293856|NCT03455829|450703798|FG002|Overall Study|Death|2|||
125293857|NCT03455829|450703799|FG003|Overall Study|Death|4|||
125293858|NCT03455829|450703800|FG004|Overall Study|Death|2|||
125293859|NCT03455829|450703796|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
125293860|NCT03455829|450703797|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
125293861|NCT03455829|450703798|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
125293862|NCT03455829|450703799|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
125293863|NCT03455829|450703800|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
125293864|NCT03455829|450703796|FG000|Overall Study|Disease progression|0|||
125293865|NCT03455829|450703797|FG001|Overall Study|Disease progression|0|||
125293866|NCT03455829|450703798|FG002|Overall Study|Disease progression|0|||
125293867|NCT03455829|450703799|FG003|Overall Study|Disease progression|1|||
125293868|NCT03455829|450703800|FG004|Overall Study|Disease progression|1|||
125293869|NCT05824936|450703802|FG000|Overall Study|Lost to Follow-up|1|||
125293870|NCT03689712|450703803|FG000|Overall Study|Adverse Event|1|||
125293871|NCT03689712|450703804|FG001|Overall Study|Adverse Event|0|||
125293872|NCT03689712|450703803|FG000|Overall Study|Death|20|||
125293873|NCT03689712|450703804|FG001|Overall Study|Death|10|||
125293874|NCT03689712|450703803|FG000|Overall Study|Lost to Follow-up|6|||
125293875|NCT03689712|450703804|FG001|Overall Study|Lost to Follow-up|6|||
125293876|NCT03689712|450703803|FG000|Overall Study|Other|1|||
125293877|NCT03689712|450703804|FG001|Overall Study|Other|0|||
125293878|NCT03689712|450703803|FG000|Overall Study|Patient Non-Compliance|0|||
125293879|NCT03689712|450703804|FG001|Overall Study|Patient Non-Compliance|1|||
125293880|NCT03689712|450703803|FG000|Overall Study|Withdrawal by Subject|20|||
125293881|NCT03689712|450703804|FG001|Overall Study|Withdrawal by Subject|4|||
125293882|NCT03689712|450703803|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
125293883|NCT03689712|450703804|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
125293884|NCT03689712|450703803|FG000|Overall Study|Randomized but not Treated|13|||
125293885|NCT03689712|450703804|FG001|Overall Study|Randomized but not Treated|7|||
125293886|NCT03689712|450703803|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
125293887|NCT03689712|450703804|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
125455158|NCT01190150|451294733|FG001|First Treatment|Withdrawal by Subject|0|||
125455159|NCT01190150|451294732|FG000|Washout|Withdrawal by Subject|0|||
125455160|NCT01190150|451294733|FG001|Washout|Withdrawal by Subject|1|||
125293888|NCT01533922|450703808|FG000|Overall Study|Adverse Event|5|||
125293889|NCT01533922|450703809|FG001|Overall Study|Adverse Event|8|||
125455161|NCT01190150|451294732|FG000|Washout|Difficulty in adherence|0|||
125293890|NCT01533922|450703810|FG002|Overall Study|Adverse Event|6|||
125293891|NCT01533922|450703811|FG003|Overall Study|Adverse Event|3|||
125293892|NCT01533922|450703812|FG004|Overall Study|Adverse Event|4|||
125293893|NCT01533922|450703808|FG000|Overall Study|Lack of Efficacy|0|||
125293894|NCT01533922|450703809|FG001|Overall Study|Lack of Efficacy|0|||
125293895|NCT01533922|450703810|FG002|Overall Study|Lack of Efficacy|1|||
125293896|NCT01533922|450703811|FG003|Overall Study|Lack of Efficacy|0|||
125293897|NCT01533922|450703812|FG004|Overall Study|Lack of Efficacy|0|||
125293898|NCT01533922|450703808|FG000|Overall Study|Protocol Violation|0|||
125293899|NCT01533922|450703809|FG001|Overall Study|Protocol Violation|3|||
125293900|NCT01533922|450703810|FG002|Overall Study|Protocol Violation|0|||
125293901|NCT01533922|450703811|FG003|Overall Study|Protocol Violation|0|||
125293902|NCT01533922|450703812|FG004|Overall Study|Protocol Violation|1|||
125293903|NCT01533922|450703808|FG000|Overall Study|Withdrawal by Subject|3|||
125293904|NCT01533922|450703809|FG001|Overall Study|Withdrawal by Subject|1|||
125293905|NCT01533922|450703810|FG002|Overall Study|Withdrawal by Subject|2|||
125293906|NCT01533922|450703811|FG003|Overall Study|Withdrawal by Subject|2|||
125293907|NCT01533922|450703812|FG004|Overall Study|Withdrawal by Subject|1|||
125293908|NCT01533922|450703808|FG000|Overall Study|Other reason not defined above|2|||
125293909|NCT01533922|450703809|FG001|Overall Study|Other reason not defined above|0|||
125293910|NCT01533922|450703810|FG002|Overall Study|Other reason not defined above|1|||
125293911|NCT01533922|450703811|FG003|Overall Study|Other reason not defined above|0|||
125293912|NCT01533922|450703812|FG004|Overall Study|Other reason not defined above|0|||
125293913|NCT02634606|450703813|FG000|Overall Study|unable to obtain the drug at start|13|||
125293914|NCT00286221|450703814|FG000|Overall Study|Protocol Violation|2|||
125293915|NCT00286221|450703815|FG001|Overall Study|Protocol Violation|1|||
125293916|NCT00286221|450703816|FG002|Overall Study|Protocol Violation|6|||
125293917|NCT00286221|450703817|FG003|Overall Study|Protocol Violation|4|||
125293918|NCT00286221|450703814|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
125293919|NCT00286221|450703815|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
125293920|NCT00286221|450703816|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
125293921|NCT00286221|450703817|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
125293922|NCT00286221|450703814|FG000|Overall Study|Inability to trigger PCA|2|||
125293923|NCT00286221|450703815|FG001|Overall Study|Inability to trigger PCA|0|||
125293924|NCT00286221|450703816|FG002|Overall Study|Inability to trigger PCA|0|||
125293925|NCT00286221|450703817|FG003|Overall Study|Inability to trigger PCA|0|||
125293926|NCT00286221|450703814|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
125293927|NCT00286221|450703815|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
125293928|NCT00286221|450703816|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
125293929|NCT00286221|450703817|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
125293930|NCT02276547|450703819|FG000|Overall Study|Death|2|||
125293931|NCT02276547|450703819|FG000|Overall Study|Explant|2|||
125293932|NCT01754194|450703820|FG000|Overall Study|Lost to Follow-up|39|||
125293933|NCT01754194|450703821|FG001|Overall Study|Lost to Follow-up|14|||
125293934|NCT01754194|450703820|FG000|Overall Study|Withdrawal by Subject|4|||
125293935|NCT01754194|450703821|FG001|Overall Study|Withdrawal by Subject|5|||
125293936|NCT01754194|450703820|FG000|Overall Study|Other|9|||
125293937|NCT01754194|450703821|FG001|Overall Study|Other|8|||
125293938|NCT03344640|450703823|FG000|Overall Study|Adverse Event|1|||
125293939|NCT03344640|450703824|FG001|Overall Study|Adverse Event|0|||
125293940|NCT03344640|450703823|FG000|Overall Study|Physician Decision|1|||
125293941|NCT03344640|450703824|FG001|Overall Study|Physician Decision|1|||
125293942|NCT03344640|450703823|FG000|Overall Study|Withdrawal by Subject|1|||
125293943|NCT03344640|450703824|FG001|Overall Study|Withdrawal by Subject|2|||
125293944|NCT03344640|450703823|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
125293945|NCT03344640|450703824|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
125293946|NCT00815191|450703828|FG000|Overall Study|Protocol Violation|1|||
125293947|NCT00815191|450703829|FG001|Overall Study|Protocol Violation|1|||
125293948|NCT02576860|450703830|FG000|Overall Study|Adverse Event|6|||
125293949|NCT02576860|450703831|FG001|Overall Study|Adverse Event|6|||
125293950|NCT02576860|450703830|FG000|Overall Study|Lost to Follow-up|5|||
125293951|NCT02576860|450703831|FG001|Overall Study|Lost to Follow-up|7|||
125293952|NCT02576860|450703830|FG000|Overall Study|Physician Decision|0|||
125293953|NCT02576860|450703831|FG001|Overall Study|Physician Decision|1|||
125293954|NCT02576860|450703830|FG000|Overall Study|Protocol Violation|0|||
125293955|NCT02576860|450703831|FG001|Overall Study|Protocol Violation|2|||
125293956|NCT02576860|450703830|FG000|Overall Study|Withdrawal by Subject|13|||
125293957|NCT02576860|450703831|FG001|Overall Study|Withdrawal by Subject|8|||
125293958|NCT02576860|450703830|FG000|Overall Study|Disallowed medication|1|||
125293959|NCT02576860|450703831|FG001|Overall Study|Disallowed medication|0|||
125293960|NCT02356887|450703862|FG000|Overall Study|poor compliance|2|||
125293961|NCT00199888|450703863|FG000|Overall Study|Lost to Follow-up|1|||
125293962|NCT02544373|450703869|FG000|Overall Study|Lost to Follow-up|5|||
125293963|NCT02544373|450703870|FG001|Overall Study|Lost to Follow-up|3|||
125293964|NCT02544373|450703869|FG000|Overall Study|Withdrawal by Subject|8|||
125293965|NCT02544373|450703870|FG001|Overall Study|Withdrawal by Subject|2|||
125293966|NCT03172130|450705159|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
125293967|NCT03172130|450705160|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
125293968|NCT02783170|450705162|FG000|Overall Study|Randomized but not Vaccinated|1|||
125293969|NCT02783170|450705163|FG001|Overall Study|Randomized but not Vaccinated|0|||
125293970|NCT02943915|450705164|FG000|Overall Study|Withdrawal by Subject|2|||
125293971|NCT02943915|450705165|FG001|Overall Study|Withdrawal by Subject|1|||
125293972|NCT02943915|450705166|FG002|Overall Study|Withdrawal by Subject|0|||
125293973|NCT02943915|450705167|FG003|Overall Study|Withdrawal by Subject|0|||
125293974|NCT02943915|450705164|FG000|Overall Study|Lost to Follow-up|3|||
125293975|NCT02943915|450705165|FG001|Overall Study|Lost to Follow-up|1|||
125293976|NCT02943915|450705166|FG002|Overall Study|Lost to Follow-up|0|||
125293977|NCT02943915|450705167|FG003|Overall Study|Lost to Follow-up|0|||
125293978|NCT02943915|450705164|FG000|Overall Study|excluded|0|||
125455162|NCT01190150|451294733|FG001|Washout|Difficulty in adherence|1|||
125455163|NCT02750709|451294734|FG000|Treatment Period 1|Adverse Event|0|||
125455164|NCT02750709|451294735|FG001|Treatment Period 1|Adverse Event|0|||
125455165|NCT02750709|451294736|FG002|Treatment Period 1|Adverse Event|0|||
125455166|NCT02750709|451294737|FG003|Treatment Period 1|Adverse Event|0|||
125455167|NCT02750709|451294738|FG004|Treatment Period 1|Adverse Event|0|||
125455168|NCT02750709|451294739|FG005|Treatment Period 1|Adverse Event|1|||
125455169|NCT00404079|451294740|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
125455170|NCT00404079|451294741|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
125293979|NCT02943915|450705165|FG001|Overall Study|excluded|1|||
125293980|NCT02943915|450705166|FG002|Overall Study|excluded|0|||
125293981|NCT02943915|450705167|FG003|Overall Study|excluded|0|||
125293982|NCT05601102|450705168|FG000|Overall Study|Death|1|||
125293983|NCT05601102|450705169|FG001|Overall Study|Death|2|||
125293984|NCT05601102|450705168|FG000|Overall Study|Withdrawal by Subject|1|||
125293985|NCT05601102|450705169|FG001|Overall Study|Withdrawal by Subject|1|||
125293986|NCT05601102|450705168|FG000|Overall Study|Lost to Follow-up|0|||
125293987|NCT05601102|450705169|FG001|Overall Study|Lost to Follow-up|2|||
125293988|NCT02981524|450705171|FG000|Overall Study|Progressive Disease|14|||
125293989|NCT02981524|450705171|FG000|Overall Study|Death (unrelated)|1|||
125293990|NCT02981524|450705171|FG000|Overall Study|Treatment Related Toxicity|1|||
125293991|NCT02981524|450705171|FG000|Overall Study|Withdrawal by Subject|1|||
125293992|NCT00483041|450705172|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
125293993|NCT00483041|450705173|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
125293994|NCT00413010|450705176|FG000|Overall Study|Adverse Event|8|||
125293995|NCT00413010|450705177|FG001|Overall Study|Adverse Event|4|||
125293996|NCT00413010|450705176|FG000|Overall Study|Laboratory abnormality|0|||
125293997|NCT00413010|450705177|FG001|Overall Study|Laboratory abnormality|2|||
125293998|NCT00413010|450705176|FG000|Overall Study|Lack of Efficacy|0|||
125293999|NCT00413010|450705177|FG001|Overall Study|Lack of Efficacy|3|||
125294000|NCT00413010|450705176|FG000|Overall Study|Lost to Follow-up|3|||
125294001|NCT00413010|450705177|FG001|Overall Study|Lost to Follow-up|0|||
125294002|NCT00413010|450705176|FG000|Overall Study|Withdrawal by Subject|7|||
125294003|NCT00413010|450705177|FG001|Overall Study|Withdrawal by Subject|2|||
125294004|NCT00413010|450705176|FG000|Overall Study|Due to termination of the study|54|||
125294005|NCT00413010|450705177|FG001|Overall Study|Due to termination of the study|52|||
125294006|NCT00708734|450705180|FG000|Overall Study|scheduling conflict|2|||
125294007|NCT00708734|450705180|FG000|Overall Study|moved|1|||
125294008|NCT00708734|450705180|FG000|Overall Study|leg injury|1|||
125294009|NCT00708734|450705180|FG000|Overall Study|knee replacement|1|||
125294010|NCT00708734|450705180|FG000|Overall Study|vertigo|1|||
125294011|NCT00708734|450705180|FG000|Overall Study|leg fracture|1|||
125294012|NCT00895661|450705182|FG000|Overall Study|Death|1|||
125294013|NCT00895661|450705182|FG000|Overall Study|reason unknown|2|||
125294014|NCT00907296|450705183|FG000|Overall Study|Ineligibility Determined|1|||
125294015|NCT00907296|450705184|FG001|Overall Study|Ineligibility Determined|0|||
125294016|NCT00907296|450705185|FG002|Overall Study|Ineligibility Determined|0|||
125294017|NCT00907296|450705186|FG003|Overall Study|Ineligibility Determined|1|||
125294018|NCT00907296|450705187|FG004|Overall Study|Ineligibility Determined|0|||
125294019|NCT00907296|450705188|FG005|Overall Study|Ineligibility Determined|0|||
125455171|NCT01120275|451294742|FG000|Overall Study|Adverse Event|3|||
125455172|NCT01120275|451294742|FG000|Overall Study|Progression|27|||
125455173|NCT01120275|451294742|FG000|Overall Study|Ineligible|3|||
125455174|NCT01120275|451294742|FG000|Overall Study|Withdrawal by Subject|1|||
125294020|NCT00907296|450705189|FG006|Overall Study|Ineligibility Determined|0|||
125294021|NCT00907296|450705190|FG007|Overall Study|Ineligibility Determined|1|||
125294022|NCT00907296|450705191|FG008|Overall Study|Ineligibility Determined|0|||
125294023|NCT00907296|450705192|FG009|Overall Study|Ineligibility Determined|0|||
125294024|NCT00907296|450705183|FG000|Overall Study|Protocol Deviation|0|||
125294025|NCT00907296|450705184|FG001|Overall Study|Protocol Deviation|1|||
125455175|NCT01120275|451294742|FG000|Overall Study|Refusal|1|||
125294026|NCT00907296|450705185|FG002|Overall Study|Protocol Deviation|0|||
125294027|NCT00907296|450705186|FG003|Overall Study|Protocol Deviation|0|||
125294028|NCT00907296|450705187|FG004|Overall Study|Protocol Deviation|0|||
125294029|NCT00907296|450705188|FG005|Overall Study|Protocol Deviation|0|||
125294030|NCT00907296|450705189|FG006|Overall Study|Protocol Deviation|0|||
125455176|NCT01120275|451294742|FG000|Overall Study|Not specific|1|||
125455177|NCT02595398|451294743|FG000|Overall Study|Non-compliance|1|||
125294031|NCT00907296|450705190|FG007|Overall Study|Protocol Deviation|0|||
125294032|NCT00907296|450705191|FG008|Overall Study|Protocol Deviation|0|||
125294033|NCT00907296|450705192|FG009|Overall Study|Protocol Deviation|0|||
125294034|NCT00907296|450705183|FG000|Overall Study|Noncompliance|1|||
125294035|NCT00907296|450705184|FG001|Overall Study|Noncompliance|1|||
125294036|NCT00907296|450705185|FG002|Overall Study|Noncompliance|1|||
125294037|NCT00907296|450705186|FG003|Overall Study|Noncompliance|0|||
125294038|NCT00907296|450705187|FG004|Overall Study|Noncompliance|0|||
125294039|NCT00907296|450705188|FG005|Overall Study|Noncompliance|1|||
125294040|NCT00907296|450705189|FG006|Overall Study|Noncompliance|0|||
125294041|NCT00907296|450705190|FG007|Overall Study|Noncompliance|2|||
125294042|NCT00907296|450705191|FG008|Overall Study|Noncompliance|0|||
125294043|NCT00907296|450705192|FG009|Overall Study|Noncompliance|0|||
125294044|NCT00907296|450705183|FG000|Overall Study|Adverse Event|2|||
125294045|NCT00907296|450705184|FG001|Overall Study|Adverse Event|0|||
125294046|NCT00907296|450705185|FG002|Overall Study|Adverse Event|0|||
125294047|NCT00907296|450705186|FG003|Overall Study|Adverse Event|0|||
125294048|NCT00907296|450705187|FG004|Overall Study|Adverse Event|0|||
125294049|NCT00907296|450705188|FG005|Overall Study|Adverse Event|0|||
125294050|NCT00907296|450705189|FG006|Overall Study|Adverse Event|1|||
125294051|NCT00907296|450705190|FG007|Overall Study|Adverse Event|0|||
125294052|NCT00907296|450705191|FG008|Overall Study|Adverse Event|0|||
125294053|NCT00907296|450705192|FG009|Overall Study|Adverse Event|1|||
125294054|NCT00907296|450705183|FG000|Overall Study|Withdrawal by Subject|7|||
125294055|NCT00907296|450705184|FG001|Overall Study|Withdrawal by Subject|2|||
125294056|NCT00907296|450705185|FG002|Overall Study|Withdrawal by Subject|1|||
125294057|NCT00907296|450705186|FG003|Overall Study|Withdrawal by Subject|1|||
125294058|NCT00907296|450705187|FG004|Overall Study|Withdrawal by Subject|1|||
125294059|NCT00907296|450705188|FG005|Overall Study|Withdrawal by Subject|5|||
125294060|NCT00907296|450705189|FG006|Overall Study|Withdrawal by Subject|3|||
125294061|NCT00907296|450705190|FG007|Overall Study|Withdrawal by Subject|2|||
125294062|NCT00907296|450705191|FG008|Overall Study|Withdrawal by Subject|4|||
125294063|NCT00907296|450705192|FG009|Overall Study|Withdrawal by Subject|2|||
125294064|NCT00907296|450705183|FG000|Overall Study|Lost to Follow-up|9|||
125294065|NCT00907296|450705184|FG001|Overall Study|Lost to Follow-up|1|||
125294066|NCT00907296|450705185|FG002|Overall Study|Lost to Follow-up|0|||
125294067|NCT00907296|450705186|FG003|Overall Study|Lost to Follow-up|2|||
125294068|NCT00907296|450705187|FG004|Overall Study|Lost to Follow-up|0|||
125294069|NCT00907296|450705188|FG005|Overall Study|Lost to Follow-up|3|||
125294070|NCT00907296|450705189|FG006|Overall Study|Lost to Follow-up|2|||
125294071|NCT00907296|450705190|FG007|Overall Study|Lost to Follow-up|2|||
125294072|NCT00907296|450705191|FG008|Overall Study|Lost to Follow-up|0|||
125294073|NCT00907296|450705192|FG009|Overall Study|Lost to Follow-up|4|||
125294074|NCT02066129|450705193|FG000|Overall Study|Lost to Follow-up|13|||
125294075|NCT02066129|450705194|FG001|Overall Study|Lost to Follow-up|12|||
125294076|NCT02066129|450705193|FG000|Overall Study|Withdrawal by Subject|7|||
125294077|NCT02066129|450705194|FG001|Overall Study|Withdrawal by Subject|10|||
125294078|NCT02066129|450705193|FG000|Overall Study|Lack of Efficacy|8|||
125294079|NCT02066129|450705194|FG001|Overall Study|Lack of Efficacy|10|||
125294080|NCT02066129|450705193|FG000|Overall Study|Physician Decision|1|||
125294081|NCT02066129|450705194|FG001|Overall Study|Physician Decision|1|||
125294082|NCT00357656|450705195|FG000|Overall Study|Other, No surgery performed|0|||
125294083|NCT00357656|450705196|FG001|Overall Study|Other, No surgery performed|3|||
125294084|NCT02573246|450705197|FG000|Overall Study|Lost to Follow-up|2|||
125294085|NCT02573246|450705198|FG001|Overall Study|Lost to Follow-up|0|||
125294086|NCT02573246|450705199|FG002|Overall Study|Lost to Follow-up|0|||
125294087|NCT02573246|450705200|FG003|Overall Study|Lost to Follow-up|0|||
125294088|NCT02573246|450705201|FG004|Overall Study|Lost to Follow-up|1|||
125294089|NCT02573246|450705197|FG000|Overall Study|Withdrawal by Subject|0|||
125294090|NCT02573246|450705198|FG001|Overall Study|Withdrawal by Subject|0|||
125294091|NCT02573246|450705199|FG002|Overall Study|Withdrawal by Subject|0|||
125294092|NCT02573246|450705200|FG003|Overall Study|Withdrawal by Subject|0|||
125294093|NCT02573246|450705201|FG004|Overall Study|Withdrawal by Subject|1|||
125294094|NCT02573246|450705197|FG000|Overall Study|Physician Decision|1|||
125294095|NCT02573246|450705198|FG001|Overall Study|Physician Decision|1|||
125294096|NCT02573246|450705199|FG002|Overall Study|Physician Decision|3|||
125294097|NCT02573246|450705200|FG003|Overall Study|Physician Decision|2|||
125294098|NCT02573246|450705201|FG004|Overall Study|Physician Decision|2|||
125294099|NCT01219933|450705202|FG000|Overall Study|Adverse Event|8|||
125294100|NCT01219933|450705202|FG000|Overall Study|No LDA reached|5|||
125294101|NCT01219933|450705202|FG000|Overall Study|No LDA maintained|7|||
125294102|NCT01219933|450705202|FG000|Overall Study|Lost to Follow-up|3|||
125294103|NCT01219933|450705202|FG000|Overall Study|GC free|1|||
125455178|NCT02595398|451294744|FG001|Overall Study|Non-compliance|0|||
125455179|NCT02595398|451294743|FG000|Overall Study|Withdrawal by Subject|2|||
125455180|NCT02595398|451294744|FG001|Overall Study|Withdrawal by Subject|1|||
125294104|NCT01219933|450705202|FG000|Overall Study|Withdrawal by Subject|5|||
125294105|NCT01219933|450705202|FG000|Overall Study|Protocol Violation|8|||
125294106|NCT01219933|450705202|FG000|Overall Study|Lack of Efficacy|1|||
125294107|NCT01902888|450705203|FG000|Overall Study|Study Terminated|3|||
125294108|NCT00316888|450705204|FG000|Overall Study|Adverse Event|4|||
125294109|NCT00316888|450705205|FG001|Overall Study|Adverse Event|5|||
125294110|NCT00316888|450705204|FG000|Overall Study|Withdrawal by Subject|2|||
125294111|NCT00316888|450705205|FG001|Overall Study|Withdrawal by Subject|2|||
125294112|NCT00316888|450705204|FG000|Overall Study|Not start protocol therapy|0|||
125294113|NCT00316888|450705205|FG001|Overall Study|Not start protocol therapy|1|||
125294114|NCT03149003|450705206|FG000|Overall Study|Randomized but not treated|0|||
125294115|NCT03149003|450705207|FG001|Overall Study|Randomized but not treated|1|||
125294116|NCT03149003|450705208|FG002|Overall Study|Randomized but not treated|18|||
125294117|NCT04135859|450705209|FG000|Overall Study|Withdrawal by Subject|1|||
125294118|NCT04135859|450705210|FG001|Overall Study|Withdrawal by Subject|0|||
125294119|NCT04135859|450705209|FG000|Overall Study|Withdrawal due to screening failure|1|||
125455181|NCT02595398|451294743|FG000|Overall Study|Lost to Follow-up|1|||
125455182|NCT02595398|451294744|FG001|Overall Study|Lost to Follow-up|0|||
125455183|NCT00197015|451294747|FG000|Overall Study|Adverse Event|3|||
125455184|NCT00197015|451294748|FG001|Overall Study|Adverse Event|0|||
125455185|NCT00197015|451294749|FG002|Overall Study|Adverse Event|1|||
125455186|NCT00197015|451294747|FG000|Overall Study|Protocol Violation|0|||
125455187|NCT00197015|451294748|FG001|Overall Study|Protocol Violation|3|||
125455188|NCT00197015|451294749|FG002|Overall Study|Protocol Violation|3|||
125455189|NCT00197015|451294747|FG000|Overall Study|Withdrawal by Subject|17|||
125455190|NCT00197015|451294748|FG001|Overall Study|Withdrawal by Subject|37|||
125455191|NCT00197015|451294749|FG002|Overall Study|Withdrawal by Subject|34|||
125455192|NCT00197015|451294747|FG000|Overall Study|Lost to Follow-up|28|||
125455193|NCT00197015|451294748|FG001|Overall Study|Lost to Follow-up|46|||
125455194|NCT00197015|451294749|FG002|Overall Study|Lost to Follow-up|37|||
125455195|NCT00197015|451294747|FG000|Overall Study|Other|2|||
125455196|NCT00197015|451294748|FG001|Overall Study|Other|3|||
125455197|NCT00197015|451294749|FG002|Overall Study|Other|2|||
125455198|NCT00880906|451294750|FG000|Overall Study|Lost to Follow-up|0|||
125455199|NCT00880906|451294751|FG001|Overall Study|Lost to Follow-up|1|||
125455200|NCT00880906|451294750|FG000|Overall Study|Did not meet criteria following patholog|12|||
125455201|NCT00880906|451294751|FG001|Overall Study|Did not meet criteria following patholog|6|||
125455202|NCT02982213|451294758|FG000|Overall Study|Did not complete follow up questionnaire|5|||
125455203|NCT02982213|451294759|FG001|Overall Study|Did not complete follow up questionnaire|1|||
125455204|NCT01549652|451294760|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
125455205|NCT01549652|451294761|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
125455206|NCT01549652|451294762|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
125455207|NCT01549652|451294763|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
125455208|NCT01549652|451294760|FG000|Overall Study|Study Drug Titration Failure|5|||
125455209|NCT01549652|451294761|FG001|Overall Study|Study Drug Titration Failure|6|||
125455210|NCT01549652|451294762|FG002|Overall Study|Study Drug Titration Failure|0|||
125455211|NCT01549652|451294763|FG003|Overall Study|Study Drug Titration Failure|0|||
125455212|NCT01549652|451294760|FG000|Overall Study|Withdrawal Effect|0|||
125455213|NCT01549652|451294761|FG001|Overall Study|Withdrawal Effect|2|||
125455214|NCT01549652|451294762|FG002|Overall Study|Withdrawal Effect|0|||
125455215|NCT01549652|451294763|FG003|Overall Study|Withdrawal Effect|0|||
125455216|NCT01549652|451294760|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
125455217|NCT01549652|451294761|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
125455218|NCT01549652|451294762|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
125455219|NCT01549652|451294763|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
125455220|NCT01549652|451294760|FG000|Overall Study|Problem with Infusion|1|||
125455221|NCT01549652|451294761|FG001|Overall Study|Problem with Infusion|0|||
125455222|NCT01549652|451294762|FG002|Overall Study|Problem with Infusion|0|||
125455223|NCT01549652|451294763|FG003|Overall Study|Problem with Infusion|0|||
125455224|NCT01549652|451294760|FG000|Overall Study|Titration Non-Compliance|1|||
125455225|NCT01549652|451294761|FG001|Overall Study|Titration Non-Compliance|3|||
125455226|NCT01549652|451294762|FG002|Overall Study|Titration Non-Compliance|4|||
125455227|NCT01549652|451294763|FG003|Overall Study|Titration Non-Compliance|5|||
125455228|NCT01549652|451294760|FG000|Overall Study|Titration Side Effects|0|||
125455229|NCT01549652|451294761|FG001|Overall Study|Titration Side Effects|0|||
125455230|NCT01549652|451294762|FG002|Overall Study|Titration Side Effects|6|||
125455231|NCT01549652|451294763|FG003|Overall Study|Titration Side Effects|3|||
125455232|NCT01549652|451294760|FG000|Overall Study|Withdrawal by Subject|0|||
125455233|NCT01549652|451294761|FG001|Overall Study|Withdrawal by Subject|0|||
125455234|NCT01549652|451294762|FG002|Overall Study|Withdrawal by Subject|5|||
125294120|NCT04135859|450705210|FG001|Overall Study|Withdrawal due to screening failure|2|||
125455235|NCT01549652|451294763|FG003|Overall Study|Withdrawal by Subject|3|||
125455236|NCT01972152|451294764|FG000|First Treatment Visit|Lost to Follow-up|0|||
125455237|NCT01972152|451294765|FG001|First Treatment Visit|Lost to Follow-up|1|||
125455238|NCT01972152|451294766|FG002|First Treatment Visit|Lost to Follow-up|0|||
125455239|NCT01972152|451294767|FG003|First Treatment Visit|Lost to Follow-up|0|||
125455240|NCT01972152|451294768|FG004|First Treatment Visit|Lost to Follow-up|0|||
125294121|NCT04135859|450705209|FG000|Overall Study|Did not complete stress test|3|||
125455241|NCT01972152|451294769|FG005|First Treatment Visit|Lost to Follow-up|0|||
125455242|NCT01972152|451294764|FG000|Second Treatment Visit|Protocol Violation|0|||
125455243|NCT01972152|451294765|FG001|Second Treatment Visit|Protocol Violation|1|||
125455244|NCT01972152|451294766|FG002|Second Treatment Visit|Protocol Violation|0|||
125455245|NCT01972152|451294767|FG003|Second Treatment Visit|Protocol Violation|0|||
125455246|NCT01972152|451294768|FG004|Second Treatment Visit|Protocol Violation|0|||
125455247|NCT01972152|451294769|FG005|Second Treatment Visit|Protocol Violation|0|||
125455248|NCT00559949|451294770|FG000|Overall Study|Progressive Disease during cycle 1|1|||
125455249|NCT00559949|451294770|FG000|Overall Study|Adverse Event|1|||
125455250|NCT00559949|451294770|FG000|Overall Study|Withdrawal by Subject|4|||
125455251|NCT00559949|451294770|FG000|Overall Study|No disease evaluation per protocol|1|||
125455252|NCT00414648|451294773|FG000|Overall Study|Adverse Event|5|||
125455253|NCT00414648|451294774|FG001|Overall Study|Adverse Event|5|||
125455254|NCT00414648|451294773|FG000|Overall Study|Death|0|||
125455255|NCT00414648|451294774|FG001|Overall Study|Death|1|||
125455256|NCT00414648|451294773|FG000|Overall Study|Lack of Efficacy|0|||
125455257|NCT00414648|451294774|FG001|Overall Study|Lack of Efficacy|2|||
125455258|NCT00414648|451294773|FG000|Overall Study|Withdrawal by Subject|0|||
125455259|NCT00414648|451294774|FG001|Overall Study|Withdrawal by Subject|1|||
125455260|NCT01194258|451294775|FG000|Titration Period|Withdrawal by Subject|6|||
125455261|NCT01194258|451294776|FG001|Titration Period|Withdrawal by Subject|0|||
125455262|NCT01194258|451294777|FG002|Titration Period|Withdrawal by Subject|0|||
125455263|NCT01194258|451294778|FG003|Titration Period|Withdrawal by Subject|0|||
125455264|NCT01194258|451294779|FG004|Titration Period|Withdrawal by Subject|0|||
125455265|NCT01194258|451294775|FG000|Titration Period|Lost to Follow-up|2|||
125455266|NCT01194258|451294776|FG001|Titration Period|Lost to Follow-up|0|||
125455267|NCT01194258|451294777|FG002|Titration Period|Lost to Follow-up|0|||
125455268|NCT01194258|451294778|FG003|Titration Period|Lost to Follow-up|0|||
125455269|NCT01194258|451294779|FG004|Titration Period|Lost to Follow-up|0|||
125455270|NCT01194258|451294775|FG000|Titration Period|Titration failure|3|||
125455271|NCT01194258|451294776|FG001|Titration Period|Titration failure|0|||
125455272|NCT01194258|451294777|FG002|Titration Period|Titration failure|0|||
125455273|NCT01194258|451294778|FG003|Titration Period|Titration failure|0|||
125455274|NCT01194258|451294779|FG004|Titration Period|Titration failure|0|||
125455275|NCT01194258|451294775|FG000|Period 1 (12 Weeks)|Death|0|||
125455276|NCT01194258|451294776|FG001|Period 1 (12 Weeks)|Death|0|||
125455277|NCT01194258|451294777|FG002|Period 1 (12 Weeks)|Death|0|||
125455278|NCT01194258|451294778|FG003|Period 1 (12 Weeks)|Death|0|||
125455279|NCT01194258|451294779|FG004|Period 1 (12 Weeks)|Death|1|||
125455280|NCT01194258|451294775|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
125455281|NCT01194258|451294776|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
125455282|NCT01194258|451294777|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
125455283|NCT01194258|451294778|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
125455284|NCT01194258|451294779|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
125455285|NCT01194258|451294775|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
125455286|NCT01194258|451294776|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
125455287|NCT01194258|451294777|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
125455288|NCT01194258|451294778|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
125455289|NCT01194258|451294779|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
125455290|NCT01194258|451294775|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125455291|NCT01194258|451294776|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
125455292|NCT01194258|451294777|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
125455293|NCT01194258|451294778|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125455294|NCT01194258|451294779|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
125455295|NCT03523962|451294780|FG000|Closed Fractures|Death|86|||
125455296|NCT03523962|451294781|FG001|Closed Fractures|Death|71|||
125455297|NCT03523962|451294782|FG002|Closed Fractures|Death|0|||
125455298|NCT03523962|451294783|FG003|Closed Fractures|Death|0|||
125455299|NCT03523962|451294780|FG000|Closed Fractures|Lost to Follow-up|62|||
125455300|NCT03523962|451294781|FG001|Closed Fractures|Lost to Follow-up|36|||
125455301|NCT03523962|451294782|FG002|Closed Fractures|Lost to Follow-up|0|||
125455302|NCT03523962|451294783|FG003|Closed Fractures|Lost to Follow-up|0|||
125455303|NCT03523962|451294780|FG000|Closed Fractures|Withdrawal by Subject|19|||
125455304|NCT03523962|451294781|FG001|Closed Fractures|Withdrawal by Subject|29|||
125455305|NCT03523962|451294782|FG002|Closed Fractures|Withdrawal by Subject|0|||
125455306|NCT03523962|451294783|FG003|Closed Fractures|Withdrawal by Subject|0|||
125455307|NCT03523962|451294780|FG000|Closed Fractures|Incarceration|1|||
125455308|NCT03523962|451294781|FG001|Closed Fractures|Incarceration|4|||
125455309|NCT03523962|451294782|FG002|Closed Fractures|Incarceration|0|||
125455310|NCT03523962|451294783|FG003|Closed Fractures|Incarceration|0|||
125294122|NCT04135859|450705210|FG001|Overall Study|Did not complete stress test|3|||
125294123|NCT04135859|450705209|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
125455311|NCT03523962|451294780|FG000|Open Fractures|Death|0|||
125455312|NCT03523962|451294781|FG001|Open Fractures|Death|0|||
125455313|NCT03523962|451294782|FG002|Open Fractures|Death|11|||
125455314|NCT03523962|451294783|FG003|Open Fractures|Death|6|||
125455315|NCT03523962|451294780|FG000|Open Fractures|Lost to Follow-up|0|||
125455316|NCT03523962|451294781|FG001|Open Fractures|Lost to Follow-up|0|||
125455317|NCT03523962|451294782|FG002|Open Fractures|Lost to Follow-up|15|||
125455318|NCT03523962|451294783|FG003|Open Fractures|Lost to Follow-up|8|||
125455319|NCT03523962|451294780|FG000|Open Fractures|Withdrawal by Subject|0|||
125455320|NCT03523962|451294781|FG001|Open Fractures|Withdrawal by Subject|0|||
125419978|NCT01381692|451162202|FG003|Overall Study|Adverse Event|0|||
125419979|NCT01381692|451162203|FG004|Overall Study|Adverse Event|0|||
125419980|NCT01381692|451162204|FG005|Overall Study|Adverse Event|0|||
125419981|NCT01869491|451162205|FG000|Overall Study|Adverse Event|3|||
125419982|NCT01869491|451162206|FG001|Overall Study|Adverse Event|5|||
125419983|NCT01869491|451162205|FG000|Overall Study|Lack of Efficacy|0|||
125419984|NCT01869491|451162206|FG001|Overall Study|Lack of Efficacy|3|||
125419985|NCT01869491|451162205|FG000|Overall Study|Withdrawal by Subject|6|||
125419986|NCT01869491|451162206|FG001|Overall Study|Withdrawal by Subject|7|||
125419987|NCT01869491|451162205|FG000|Overall Study|Lost to Follow-up|11|||
125419988|NCT01869491|451162206|FG001|Overall Study|Lost to Follow-up|9|||
125419989|NCT01869491|451162205|FG000|Overall Study|No further need of investigational product|1|||
125419990|NCT01869491|451162206|FG001|Overall Study|No further need of investigational product|0|||
125419991|NCT01270347|451162207|FG000|Core Phase|Adverse Event|1|||
125419992|NCT01270347|451162208|FG001|Core Phase|Adverse Event|6|||
125419993|NCT01270347|451162207|FG000|Core Phase|Withdrawal by Subject|1|||
125419994|NCT01270347|451162208|FG001|Core Phase|Withdrawal by Subject|2|||
125419995|NCT01270347|451162207|FG000|Core Phase|Lost to Follow-up|0|||
125419996|NCT01270347|451162208|FG001|Core Phase|Lost to Follow-up|1|||
125419997|NCT01270347|451162207|FG000|Core Phase|Miscellaneous|8|||
125419998|NCT01270347|451162208|FG001|Core Phase|Miscellaneous|14|||
125419999|NCT01270347|451162207|FG000|Extension Phase|Adverse Event|1|||
125420000|NCT01270347|451162208|FG001|Extension Phase|Adverse Event|3|||
125420001|NCT01270347|451162207|FG000|Extension Phase|Withdrawal by Subject|3|||
125420002|NCT01270347|451162208|FG001|Extension Phase|Withdrawal by Subject|4|||
125420003|NCT01270347|451162207|FG000|Extension Phase|Miscellaneous|2|||
125420004|NCT01270347|451162208|FG001|Extension Phase|Miscellaneous|2|||
125420005|NCT02195986|451162213|FG000|Overall Study|Adverse Event|3|||
125420006|NCT02195986|451162214|FG001|Overall Study|Adverse Event|0|||
125420007|NCT02195986|451162215|FG002|Overall Study|Adverse Event|0|||
125420008|NCT02195986|451162213|FG000|Overall Study|Withdrawal by Subject|0|||
125420009|NCT02195986|451162214|FG001|Overall Study|Withdrawal by Subject|3|||
125420010|NCT02195986|451162215|FG002|Overall Study|Withdrawal by Subject|0|||
125420011|NCT02195986|451162213|FG000|Overall Study|Family Emergency|0|||
125420012|NCT02195986|451162214|FG001|Overall Study|Family Emergency|0|||
125420013|NCT02195986|451162215|FG002|Overall Study|Family Emergency|1|||
125420014|NCT02195986|451162213|FG000|Overall Study|Protocol Violation|0|||
125420015|NCT02195986|451162214|FG001|Overall Study|Protocol Violation|1|||
125420016|NCT02195986|451162215|FG002|Overall Study|Protocol Violation|1|||
125420017|NCT02195986|451162213|FG000|Overall Study|Non-compliance|0|||
125420018|NCT02195986|451162214|FG001|Overall Study|Non-compliance|1|||
125420019|NCT02195986|451162215|FG002|Overall Study|Non-compliance|0|||
125420020|NCT02491671|451162228|FG000|Overall Study|Adverse Event|6|||
125420021|NCT02491671|451162229|FG001|Overall Study|Adverse Event|8|||
125420022|NCT02491671|451162228|FG000|Overall Study|Death|0|||
125420023|NCT02491671|451162229|FG001|Overall Study|Death|2|||
125420024|NCT02491671|451162228|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
125420025|NCT02491671|451162229|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
125420026|NCT00535730|451162230|FG000|Overall Study|Adverse Event|1|||
125420027|NCT00535730|451162231|FG001|Overall Study|Adverse Event|1|||
125420028|NCT00535730|451162230|FG000|Overall Study|Lost to Follow-up|0|||
125420029|NCT00535730|451162231|FG001|Overall Study|Lost to Follow-up|1|||
125420030|NCT00535730|451162230|FG000|Overall Study|Physician Decision|0|||
125420031|NCT00535730|451162231|FG001|Overall Study|Physician Decision|1|||
125420032|NCT00535730|451162230|FG000|Overall Study|Protocol Violation|1|||
125420033|NCT00535730|451162231|FG001|Overall Study|Protocol Violation|0|||
125420034|NCT00535730|451162230|FG000|Overall Study|Withdrawal by Subject|0|||
125420035|NCT00535730|451162231|FG001|Overall Study|Withdrawal by Subject|4|||
125420036|NCT04072159|451162240|FG000|Overall Study|Lost to Follow-up|6|||
125420037|NCT04072159|451162241|FG001|Overall Study|Lost to Follow-up|6|||
125420038|NCT04072159|451162240|FG000|Overall Study|Withdrawal by Subject|2|||
125420039|NCT04072159|451162241|FG001|Overall Study|Withdrawal by Subject|0|||
125420040|NCT00695669|451162244|FG000|Overall Study|Adverse Event|0|||
125420041|NCT00695669|451162245|FG001|Overall Study|Adverse Event|0|||
125420042|NCT00695669|451162246|FG002|Overall Study|Adverse Event|2|||
125420043|NCT00695669|451162247|FG003|Overall Study|Adverse Event|0|||
125420044|NCT00695669|451162244|FG000|Overall Study|Lost to Follow-up|4|||
125420045|NCT00695669|451162245|FG001|Overall Study|Lost to Follow-up|4|||
125420046|NCT00695669|451162246|FG002|Overall Study|Lost to Follow-up|1|||
125420047|NCT00695669|451162247|FG003|Overall Study|Lost to Follow-up|4|||
125420048|NCT05045625|451162248|FG000|Overall Study|Lost to Follow-up|3|||
125420049|NCT00417079|451162249|FG000|Overall Study|Disease progression|267|||
125420050|NCT00417079|451162250|FG001|Overall Study|Disease progression|180|||
125420051|NCT00417079|451162249|FG000|Overall Study|Adverse Event|32|||
125420052|NCT00417079|451162250|FG001|Overall Study|Adverse Event|67|||
125420053|NCT00417079|451162249|FG000|Overall Study|Non-compliance to protocol|0|||
125420054|NCT00417079|451162250|FG001|Overall Study|Non-compliance to protocol|1|||
125455321|NCT03523962|451294782|FG002|Open Fractures|Withdrawal by Subject|6|||
125455322|NCT03523962|451294783|FG003|Open Fractures|Withdrawal by Subject|2|||
125455323|NCT03523962|451294780|FG000|Open Fractures|Incarceration|0|||
125455324|NCT03523962|451294781|FG001|Open Fractures|Incarceration|0|||
125455325|NCT03523962|451294782|FG002|Open Fractures|Incarceration|1|||
125455326|NCT03523962|451294783|FG003|Open Fractures|Incarceration|0|||
125455327|NCT03394027|451294786|FG000|Overall Study|Ineligible|3|||
125455328|NCT03394027|451294787|FG001|Overall Study|Ineligible|1|||
125455329|NCT03394027|451294788|FG002|Overall Study|Ineligible|3|||
125455330|NCT03394027|451294786|FG000|Overall Study|Participant declined to participate before treatment started|0|||
125455331|NCT03394027|451294787|FG001|Overall Study|Participant declined to participate before treatment started|0|||
125455332|NCT03394027|451294788|FG002|Overall Study|Participant declined to participate before treatment started|1|||
125455333|NCT04858425|451294789|FG000|Overall Study|Adverse Event|2|||
125455334|NCT04858425|451294790|FG001|Overall Study|Adverse Event|2|||
125455335|NCT04858425|451294789|FG000|Overall Study|Withdrawal by Subject|3|||
125455336|NCT04858425|451294790|FG001|Overall Study|Withdrawal by Subject|1|||
125455337|NCT04858425|451294789|FG000|Overall Study|Lost to Follow-up|4|||
125455338|NCT04858425|451294790|FG001|Overall Study|Lost to Follow-up|2|||
125455339|NCT04858425|451294789|FG000|Overall Study|Lost to Follow-up|1|||
125455340|NCT04858425|451294790|FG001|Overall Study|Lost to Follow-up|0|||
125455341|NCT03368001|451294793|FG000|Allocation|Lost to Pretest|16|||
125455342|NCT03368001|451294794|FG001|Allocation|Lost to Pretest|25|||
125455343|NCT03368001|451294793|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
125455344|NCT03368001|451294794|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
125455345|NCT03368001|451294793|FG000|Posttest|Lost to Posttest|7|||
125455346|NCT03368001|451294794|FG001|Posttest|Lost to Posttest|11|||
125455347|NCT03368001|451294793|FG000|Posttest|Discontinued Intervention|6|||
125455348|NCT03368001|451294794|FG001|Posttest|Discontinued Intervention|19|||
125455349|NCT03368001|451294793|FG000|Follow-up|Lost to Follow-up|6|||
125455350|NCT03368001|451294794|FG001|Follow-up|Lost to Follow-up|3|||
125455351|NCT04776213|451294797|FG000|Overall Study|Other|1|||
125455352|NCT04776213|451294797|FG000|Overall Study|Withdrawal by Subject|7|||
125455353|NCT04776213|451294797|FG000|Overall Study|Protocol Violation|1|||
125455354|NCT04776213|451294797|FG000|Overall Study|Lost to Follow-up|2|||
125455355|NCT02317016|451294798|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
125455356|NCT02317016|451294798|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
125455357|NCT02317016|451294798|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
125455358|NCT02317016|451294798|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
125455359|NCT02317016|451294798|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
125455360|NCT02317016|451294798|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
125455361|NCT02317016|451294798|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
125455362|NCT02931396|451294802|FG000|Overall Study|Lost to Follow-up|3|||
125455363|NCT02931396|451294803|FG001|Overall Study|Lost to Follow-up|0|||
125455364|NCT02931396|451294802|FG000|Overall Study|Withdrawal by Subject|2|||
125455365|NCT02931396|451294803|FG001|Overall Study|Withdrawal by Subject|0|||
125455366|NCT02132702|451294804|FG000|Overall Study|Protocol Violation|2|||
125455367|NCT02132702|451294804|FG000|Overall Study|Adverse Event|3|||
125455368|NCT02132702|451294804|FG000|Overall Study|Withdrawal by Subject|3|||
125455369|NCT01278862|451294808|FG000|Overall Study|Lost to Follow-up|1|||
125455370|NCT01278862|451294809|FG001|Overall Study|Lost to Follow-up|1|||
125455371|NCT02952261|451294811|FG000|Overall Study|Withdrawal by Subject|4|||
125455372|NCT02952261|451294812|FG001|Overall Study|Withdrawal by Subject|5|||
125455373|NCT02952261|451294811|FG000|Overall Study|Protocol Violation|1|||
125455374|NCT02952261|451294812|FG001|Overall Study|Protocol Violation|0|||
125455375|NCT00603447|451294813|FG000|Overall Study|Adverse Event|0|||
125455376|NCT00603447|451294814|FG001|Overall Study|Adverse Event|1|||
125455377|NCT00603447|451294815|FG002|Overall Study|Adverse Event|1|||
125455378|NCT00603447|451294816|FG003|Overall Study|Adverse Event|2|||
125455379|NCT00603447|451294817|FG004|Overall Study|Adverse Event|1|||
125455380|NCT00603447|451294818|FG005|Overall Study|Adverse Event|2|||
125455381|NCT00603447|451294819|FG006|Overall Study|Adverse Event|10|||
125455382|NCT00603447|451294813|FG000|Overall Study|Other|0|||
125455383|NCT00603447|451294814|FG001|Overall Study|Other|0|||
125455384|NCT00603447|451294815|FG002|Overall Study|Other|1|||
125455385|NCT00603447|451294816|FG003|Overall Study|Other|0|||
125455386|NCT00603447|451294817|FG004|Overall Study|Other|3|||
125455387|NCT00603447|451294818|FG005|Overall Study|Other|0|||
125455388|NCT00603447|451294819|FG006|Overall Study|Other|13|||
125455389|NCT00603447|451294813|FG000|Overall Study|Withdrew Consent|0|||
125455390|NCT00603447|451294814|FG001|Overall Study|Withdrew Consent|2|||
125455391|NCT00603447|451294815|FG002|Overall Study|Withdrew Consent|0|||
125455392|NCT00603447|451294816|FG003|Overall Study|Withdrew Consent|0|||
125455393|NCT00603447|451294817|FG004|Overall Study|Withdrew Consent|1|||
125455394|NCT00603447|451294818|FG005|Overall Study|Withdrew Consent|0|||
125455395|NCT00603447|451294819|FG006|Overall Study|Withdrew Consent|1|||
125455396|NCT05233085|451294820|FG000|Overall Study|Adverse Event|1|||
125455397|NCT05233085|451294821|FG001|Overall Study|Adverse Event|0|||
125455398|NCT05233085|451294822|FG002|Overall Study|Adverse Event|0|||
125455399|NCT05233085|451294823|FG003|Overall Study|Adverse Event|0|||
125455400|NCT00798265|451294824|FG000|Overall Study|Lost to Follow-up|1|||
125455401|NCT00798265|451294825|FG001|Overall Study|Lost to Follow-up|10|||
125455402|NCT00798265|451294824|FG000|Overall Study|Study closing|7|||
125455403|NCT00798265|451294825|FG001|Overall Study|Study closing|6|||
125455404|NCT00798265|451294824|FG000|Overall Study|Withdrawal by Subject|0|||
125455405|NCT00798265|451294825|FG001|Overall Study|Withdrawal by Subject|1|||
125455406|NCT00798265|451294824|FG000|Overall Study|Screen failure|0|||
125455407|NCT00798265|451294825|FG001|Overall Study|Screen failure|1|||
125455408|NCT03837028|451296478|FG000|Overall Study|Lost to Follow-up|4|||
125455409|NCT03837028|451296479|FG001|Overall Study|Lost to Follow-up|0|||
125455410|NCT03837028|451296480|FG002|Overall Study|Lost to Follow-up|2|||
125455411|NCT03837028|451296481|FG003|Overall Study|Lost to Follow-up|0|||
125455412|NCT03837028|451296478|FG000|Overall Study|Withdrawal by Subject|12|||
125455413|NCT03837028|451296479|FG001|Overall Study|Withdrawal by Subject|11|||
125455414|NCT03837028|451296480|FG002|Overall Study|Withdrawal by Subject|11|||
125455415|NCT03837028|451296481|FG003|Overall Study|Withdrawal by Subject|7|||
125455416|NCT01091454|451296482|FG000|Overall Study|Ineligible|1|||
125455417|NCT00646451|451296483|FG000|Overall Study|Adverse Event|3|||
125455418|NCT00646451|451296484|FG001|Overall Study|Adverse Event|0|||
125455419|NCT00646451|451296483|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
125455420|NCT00646451|451296484|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
125455421|NCT03784963|451296485|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
125455422|NCT03784963|451296486|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
125455423|NCT03784963|451296487|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
125455424|NCT03784963|451296488|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
125455425|NCT01362491|451296489|FG000|Overall Study|Ineligible|1|||
125455426|NCT01362491|451296490|FG001|Overall Study|Ineligible|0|||
125455427|NCT01362491|451296491|FG002|Overall Study|Ineligible|0|||
125455428|NCT02030028|451296492|FG000|Overall Study|Withdrawal by Subject|4|||
125455429|NCT02030028|451296492|FG000|Overall Study|lack of transportation|1|||
125455430|NCT00567879|451296493|FG000|Overall Study|Adverse Event|2|||
125455431|NCT00567879|451296494|FG001|Overall Study|Adverse Event|0|||
125455432|NCT00567879|451296495|FG002|Overall Study|Adverse Event|1|||
125455433|NCT00567879|451296496|FG003|Overall Study|Adverse Event|0|||
125455434|NCT00567879|451296497|FG004|Overall Study|Adverse Event|1|||
125455435|NCT00567879|451296498|FG005|Overall Study|Adverse Event|0|||
125455436|NCT00567879|451296493|FG000|Overall Study|Abnormal test procedure(s)|0|||
125455437|NCT00567879|451296494|FG001|Overall Study|Abnormal test procedure(s)|0|||
125455438|NCT00567879|451296495|FG002|Overall Study|Abnormal test procedure(s)|1|||
125455439|NCT00567879|451296496|FG003|Overall Study|Abnormal test procedure(s)|0|||
125455440|NCT00567879|451296497|FG004|Overall Study|Abnormal test procedure(s)|0|||
125455441|NCT00567879|451296498|FG005|Overall Study|Abnormal test procedure(s)|0|||
125455442|NCT00567879|451296493|FG000|Overall Study|Withdrawal by Subject|0|||
125455443|NCT00567879|451296494|FG001|Overall Study|Withdrawal by Subject|0|||
125455444|NCT00567879|451296495|FG002|Overall Study|Withdrawal by Subject|3|||
125455445|NCT00567879|451296496|FG003|Overall Study|Withdrawal by Subject|1|||
125455446|NCT00567879|451296497|FG004|Overall Study|Withdrawal by Subject|0|||
125455447|NCT00567879|451296498|FG005|Overall Study|Withdrawal by Subject|0|||
125455448|NCT00567879|451296493|FG000|Overall Study|New cancer therapy|0|||
125455449|NCT00567879|451296494|FG001|Overall Study|New cancer therapy|0|||
125455450|NCT00567879|451296495|FG002|Overall Study|New cancer therapy|1|||
125455451|NCT00567879|451296496|FG003|Overall Study|New cancer therapy|0|||
125455452|NCT00567879|451296497|FG004|Overall Study|New cancer therapy|0|||
125455453|NCT00567879|451296498|FG005|Overall Study|New cancer therapy|0|||
125455454|NCT00567879|451296493|FG000|Overall Study|Disease progression|5|||
125455455|NCT00567879|451296494|FG001|Overall Study|Disease progression|7|||
125455456|NCT00567879|451296495|FG002|Overall Study|Disease progression|15|||
125455457|NCT00567879|451296496|FG003|Overall Study|Disease progression|5|||
125455458|NCT00567879|451296497|FG004|Overall Study|Disease progression|11|||
125455459|NCT00567879|451296498|FG005|Overall Study|Disease progression|3|||
125455460|NCT01249092|451296499|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
125455461|NCT01249092|451296499|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
125455462|NCT02930343|451296503|FG000|Overall Study|Lost to Follow-up|9|||
125455463|NCT02930343|451296504|FG001|Overall Study|Lost to Follow-up|7|||
125455464|NCT02987543|451296507|FG000|Overall Study|Ongoing study at data cut off|49|||
125455465|NCT02987543|451296508|FG001|Overall Study|Ongoing study at data cut off|21|||
125455466|NCT02987543|451296509|FG002|Overall Study|Ongoing study at data cut off|19|||
125455467|NCT02987543|451296510|FG003|Overall Study|Ongoing study at data cut off|12|||
125455468|NCT02987543|451296507|FG000|Overall Study|Death|88|||
125455469|NCT02987543|451296508|FG001|Overall Study|Death|54|||
125455470|NCT02987543|451296509|FG002|Overall Study|Death|67|||
125455471|NCT02987543|451296510|FG003|Overall Study|Death|28|||
125455472|NCT02987543|451296507|FG000|Overall Study|Lost to Follow-up|3|||
125455473|NCT02987543|451296508|FG001|Overall Study|Lost to Follow-up|0|||
125455474|NCT02987543|451296509|FG002|Overall Study|Lost to Follow-up|1|||
125455475|NCT02987543|451296510|FG003|Overall Study|Lost to Follow-up|0|||
125455476|NCT02987543|451296507|FG000|Overall Study|Screen failure|0|||
125455477|NCT02987543|451296508|FG001|Overall Study|Screen failure|0|||
125455478|NCT02987543|451296509|FG002|Overall Study|Screen failure|0|||
125455479|NCT02987543|451296510|FG003|Overall Study|Screen failure|1|||
125455480|NCT02987543|451296507|FG000|Overall Study|Withdrawal by Subject|21|||
125455481|NCT02987543|451296508|FG001|Overall Study|Withdrawal by Subject|7|||
125455482|NCT02987543|451296509|FG002|Overall Study|Withdrawal by Subject|7|||
125455483|NCT02987543|451296510|FG003|Overall Study|Withdrawal by Subject|6|||
125455484|NCT02987543|451296507|FG000|Overall Study|Study terminated by sponsor|1|||
125455485|NCT02987543|451296508|FG001|Overall Study|Study terminated by sponsor|0|||
125455486|NCT02987543|451296509|FG002|Overall Study|Study terminated by sponsor|0|||
125455487|NCT02987543|451296510|FG003|Overall Study|Study terminated by sponsor|0|||
125455488|NCT02987543|451296507|FG000|Overall Study|Investigator decision|0|||
125455489|NCT02987543|451296508|FG001|Overall Study|Investigator decision|1|||
125455490|NCT02987543|451296509|FG002|Overall Study|Investigator decision|0|||
125455491|NCT02987543|451296510|FG003|Overall Study|Investigator decision|0|||
125455492|NCT02987543|451296507|FG000|Overall Study|Disease progression|0|||
125455493|NCT02987543|451296508|FG001|Overall Study|Disease progression|0|||
125455494|NCT02987543|451296509|FG002|Overall Study|Disease progression|0|||
125455495|NCT02987543|451296510|FG003|Overall Study|Disease progression|1|||
125455496|NCT01977612|451296511|FG000|Overall Study|Lost to Follow-up|1|||
125455497|NCT01977612|451296512|FG001|Overall Study|Lost to Follow-up|1|||
125455498|NCT01451814|451296513|FG000|Overall Study|Withdrawal by Subject|1|||
125455499|NCT01451814|451296514|FG001|Overall Study|Withdrawal by Subject|1|||
125455500|NCT01451814|451296513|FG000|Overall Study|Lost to Follow-up|5|||
125455501|NCT01451814|451296514|FG001|Overall Study|Lost to Follow-up|4|||
125455502|NCT01280591|451296515|FG000|Overall Study|Withdrawal by Subject|0|||
125455503|NCT01280591|451296516|FG001|Overall Study|Withdrawal by Subject|0|||
125455504|NCT01280591|451296517|FG002|Overall Study|Withdrawal by Subject|0|||
125455505|NCT01280591|451296518|FG003|Overall Study|Withdrawal by Subject|2|||
125455506|NCT01280591|451296515|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
125455507|NCT01280591|451296516|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
125455508|NCT01280591|451296517|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
125455509|NCT01280591|451296518|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
125455510|NCT01883492|451296520|FG000|Overall Study|Lost to Follow-up|3|||
125455511|NCT01883492|451296521|FG001|Overall Study|Lost to Follow-up|4|||
125455512|NCT01883492|451296520|FG000|Overall Study|Surgery on contra-lateral hip|0|||
125455513|NCT01883492|451296521|FG001|Overall Study|Surgery on contra-lateral hip|1|||
125455514|NCT01883492|451296520|FG000|Overall Study|Poor X-ray quality|7|||
125455515|NCT01883492|451296521|FG001|Overall Study|Poor X-ray quality|4|||
125455516|NCT01883492|451296520|FG000|Overall Study|Withdrawal by Subject|1|||
125455517|NCT01883492|451296521|FG001|Overall Study|Withdrawal by Subject|0|||
125455518|NCT01883492|451296520|FG000|Overall Study|inappropriate implant used|1|||
125455519|NCT01883492|451296521|FG001|Overall Study|inappropriate implant used|1|||
125455520|NCT01883492|451296520|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
125455521|NCT01883492|451296521|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
125455522|NCT03357341|451296522|FG000|Overall Study|Withdrawal by Subject|3|||
125455523|NCT03357341|451296523|FG001|Overall Study|Withdrawal by Subject|6|||
125455524|NCT03357341|451296522|FG000|Overall Study|Lost to Follow-up|4|||
125455525|NCT03357341|451296523|FG001|Overall Study|Lost to Follow-up|5|||
125455526|NCT03357341|451296522|FG000|Overall Study|Death|0|||
125455527|NCT03357341|451296523|FG001|Overall Study|Death|1|||
125455528|NCT01259102|451296524|FG000|Overall Study|Adverse Event|1|||
125455529|NCT01259102|451296525|FG001|Overall Study|Adverse Event|0|||
125455530|NCT01259102|451296526|FG002|Overall Study|Adverse Event|1|||
125455531|NCT01259102|451296527|FG003|Overall Study|Adverse Event|1|||
125455532|NCT01259102|451296528|FG004|Overall Study|Adverse Event|0|||
125455533|NCT01259102|451296524|FG000|Overall Study|Other|0|||
125455534|NCT01259102|451296525|FG001|Overall Study|Other|0|||
125294124|NCT04135859|450705210|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
125455535|NCT01259102|451296526|FG002|Overall Study|Other|1|||
125455536|NCT01259102|451296527|FG003|Overall Study|Other|1|||
125294125|NCT01814670|450705213|FG000|Overall Study|Protocol Violation|12|||
125294126|NCT01565941|450705214|FG000|Overall Study|Withdrawn by parent/guardian|3|||
125455537|NCT01259102|451296528|FG004|Overall Study|Other|1|||
125455538|NCT01956669|451296532|FG000|Overall Study|Disease Progression|12|||
125455539|NCT01956669|451296533|FG001|Overall Study|Disease Progression|7|||
125455540|NCT01956669|451296534|FG002|Overall Study|Disease Progression|7|||
125455541|NCT01956669|451296535|FG003|Overall Study|Disease Progression|8|||
125455542|NCT01956669|451296536|FG004|Overall Study|Disease Progression|4|||
125455543|NCT01956669|451296537|FG005|Overall Study|Disease Progression|3|||
125455544|NCT01956669|451296538|FG006|Overall Study|Disease Progression|5|||
125455545|NCT01956669|451296532|FG000|Overall Study|Adverse Event|0|||
125455546|NCT01956669|451296533|FG001|Overall Study|Adverse Event|2|||
125455547|NCT01956669|451296534|FG002|Overall Study|Adverse Event|2|||
125455548|NCT01956669|451296535|FG003|Overall Study|Adverse Event|1|||
125455549|NCT01956669|451296536|FG004|Overall Study|Adverse Event|0|||
125455550|NCT01956669|451296537|FG005|Overall Study|Adverse Event|0|||
125455551|NCT01956669|451296538|FG006|Overall Study|Adverse Event|0|||
125455552|NCT01956669|451296532|FG000|Overall Study|Physician Decision|0|||
125455553|NCT01956669|451296533|FG001|Overall Study|Physician Decision|2|||
125455554|NCT01956669|451296534|FG002|Overall Study|Physician Decision|0|||
125455555|NCT01956669|451296535|FG003|Overall Study|Physician Decision|0|||
125455556|NCT01956669|451296536|FG004|Overall Study|Physician Decision|0|||
125455557|NCT01956669|451296537|FG005|Overall Study|Physician Decision|1|||
125455558|NCT01956669|451296538|FG006|Overall Study|Physician Decision|0|||
125455559|NCT01956669|451296532|FG000|Overall Study|Withdrawal by Subject|0|||
125455560|NCT01956669|451296533|FG001|Overall Study|Withdrawal by Subject|0|||
125455561|NCT01956669|451296534|FG002|Overall Study|Withdrawal by Subject|1|||
125455562|NCT01956669|451296535|FG003|Overall Study|Withdrawal by Subject|1|||
125455563|NCT01956669|451296536|FG004|Overall Study|Withdrawal by Subject|0|||
125455564|NCT01956669|451296537|FG005|Overall Study|Withdrawal by Subject|0|||
125455565|NCT01956669|451296538|FG006|Overall Study|Withdrawal by Subject|1|||
125455566|NCT01466881|451296539|FG000|Overall Study|Ineligible|5|||
125455567|NCT01466881|451296539|FG000|Overall Study|Adverse Event|6|||
125455568|NCT01466881|451296539|FG000|Overall Study|Progression/relapse|20|||
125455569|NCT01466881|451296539|FG000|Overall Study|Death|4|||
125455570|NCT01466881|451296539|FG000|Overall Study|Other reason not protocol specified|5|||
125455571|NCT04580303|451296542|FG000|Overall Study|Adverse Event|0|||
125455572|NCT04580303|451296543|FG001|Overall Study|Adverse Event|1|||
125455573|NCT04580303|451296544|FG002|Overall Study|Adverse Event|0|||
125455574|NCT04580303|451296545|FG003|Overall Study|Adverse Event|0|||
125455575|NCT04580303|451296542|FG000|Overall Study|Withdrawal by Subject|0|||
125455576|NCT04580303|451296543|FG001|Overall Study|Withdrawal by Subject|0|||
125455577|NCT04580303|451296544|FG002|Overall Study|Withdrawal by Subject|1|||
125455578|NCT04580303|451296545|FG003|Overall Study|Withdrawal by Subject|0|||
125455579|NCT00927823|451296549|FG000|Continuous Dosing Period|Death|0|||
125455580|NCT00927823|451296550|FG001|Continuous Dosing Period|Death|0|||
125455581|NCT00927823|451296551|FG002|Continuous Dosing Period|Death|6|||
125455582|NCT00927823|451296552|FG003|Continuous Dosing Period|Death|0|||
125455583|NCT00927823|451296549|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
125455584|NCT00927823|451296550|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
125455585|NCT00927823|451296551|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
125455586|NCT00927823|451296552|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
125455587|NCT00927823|451296549|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
125455588|NCT00927823|451296550|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
125455589|NCT00927823|451296551|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
125455590|NCT00927823|451296552|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
125455591|NCT00927823|451296549|FG000|Continuous Dosing Period|Other|1|||
125455592|NCT00927823|451296550|FG001|Continuous Dosing Period|Other|2|||
125455593|NCT00927823|451296551|FG002|Continuous Dosing Period|Other|9|||
125455594|NCT00927823|451296552|FG003|Continuous Dosing Period|Other|3|||
125455595|NCT02299635|451296553|FG000|Overall Study|Adverse Event|2|||
125455596|NCT02299635|451296553|FG000|Overall Study|Death|1|||
125455597|NCT02299635|451296553|FG000|Overall Study|Global deterioration of health status|1|||
125455598|NCT02299635|451296553|FG000|Overall Study|Objective progression or relapse|10|||
125455599|NCT02299635|451296553|FG000|Overall Study|Withdrawal by Subject|2|||
125455600|NCT02299635|451296553|FG000|Overall Study|Other|3|||
125455601|NCT00828672|451296554|FG000|Study Treatment|Lost to Follow-up|1|||
125455602|NCT00828672|451296555|FG001|Study Treatment|Lost to Follow-up|0|||
125455603|NCT00828672|451296554|FG000|Study Treatment|Adverse Event|0|||
125455604|NCT00828672|451296555|FG001|Study Treatment|Adverse Event|1|||
125455605|NCT00828672|451296554|FG000|Study Treatment|Complete response, no surgery|1|||
125455606|NCT00828672|451296555|FG001|Study Treatment|Complete response, no surgery|1|||
125455607|NCT00828672|451296554|FG000|Post-surgery (<30 Days)|No central review materials|0|||
125455608|NCT00828672|451296555|FG001|Post-surgery (<30 Days)|No central review materials|1|||
125455609|NCT01710514|451296563|FG000|Overall Study|Adverse Event|6|||
125455610|NCT01710514|451296564|FG001|Overall Study|Adverse Event|7|||
125455611|NCT01710514|451296563|FG000|Overall Study|Withdrawal by Subject|1|||
125455612|NCT01710514|451296564|FG001|Overall Study|Withdrawal by Subject|0|||
125455613|NCT00831792|451296568|FG000|Overall Study|Not Eligible|3|||
125455614|NCT00831792|451296568|FG000|Overall Study|Adverse Event|1|||
125455615|NCT00831792|451296568|FG000|Overall Study|Death|1|||
125455616|NCT00831792|451296568|FG000|Overall Study|Lack of Efficacy|1|||
125455617|NCT00246012|451296572|FG000|Overall Study|Adverse Event|0|||
125455618|NCT00246012|451296573|FG001|Overall Study|Adverse Event|0|||
125455619|NCT00246012|451296574|FG002|Overall Study|Adverse Event|0|||
125455620|NCT00246012|451296575|FG003|Overall Study|Adverse Event|0|||
125455621|NCT00246012|451296576|FG004|Overall Study|Adverse Event|0|||
125455622|NCT00246012|451296577|FG005|Overall Study|Adverse Event|1|||
125455623|NCT00246012|451296578|FG006|Overall Study|Adverse Event|0|||
125455624|NCT00246012|451296579|FG007|Overall Study|Adverse Event|0|||
125455625|NCT00246012|451296580|FG008|Overall Study|Adverse Event|2|||
125455626|NCT00246012|451296572|FG000|Overall Study|Withdrawal by Subject|0|||
125455627|NCT00246012|451296573|FG001|Overall Study|Withdrawal by Subject|0|||
125455628|NCT00246012|451296574|FG002|Overall Study|Withdrawal by Subject|0|||
125455629|NCT00246012|451296575|FG003|Overall Study|Withdrawal by Subject|0|||
125455630|NCT00246012|451296576|FG004|Overall Study|Withdrawal by Subject|0|||
125455631|NCT00246012|451296577|FG005|Overall Study|Withdrawal by Subject|1|||
125455632|NCT00246012|451296578|FG006|Overall Study|Withdrawal by Subject|0|||
125455633|NCT00246012|451296579|FG007|Overall Study|Withdrawal by Subject|0|||
125455634|NCT00246012|451296580|FG008|Overall Study|Withdrawal by Subject|0|||
125455635|NCT00246012|451296572|FG000|Overall Study|Disease progression|3|||
125455636|NCT00246012|451296573|FG001|Overall Study|Disease progression|1|||
125455637|NCT00246012|451296574|FG002|Overall Study|Disease progression|2|||
125455638|NCT00246012|451296575|FG003|Overall Study|Disease progression|3|||
125455639|NCT00246012|451296576|FG004|Overall Study|Disease progression|3|||
125455640|NCT00246012|451296577|FG005|Overall Study|Disease progression|25|||
125455641|NCT00246012|451296578|FG006|Overall Study|Disease progression|30|||
125455642|NCT00246012|451296579|FG007|Overall Study|Disease progression|27|||
125455643|NCT00246012|451296580|FG008|Overall Study|Disease progression|26|||
125455644|NCT00246012|451296572|FG000|Overall Study|Other|0|||
125455645|NCT00246012|451296573|FG001|Overall Study|Other|0|||
125455646|NCT00246012|451296574|FG002|Overall Study|Other|0|||
125455647|NCT00246012|451296575|FG003|Overall Study|Other|0|||
125455648|NCT00246012|451296576|FG004|Overall Study|Other|0|||
125455649|NCT00246012|451296577|FG005|Overall Study|Other|0|||
125455650|NCT00246012|451296578|FG006|Overall Study|Other|0|||
125455651|NCT00246012|451296579|FG007|Overall Study|Other|1|||
125455652|NCT00246012|451296580|FG008|Overall Study|Other|0|||
125455653|NCT00246012|451296572|FG000|Overall Study|Randomly assigned but not treated|0|||
125455654|NCT00246012|451296573|FG001|Overall Study|Randomly assigned but not treated|0|||
125455655|NCT00246012|451296574|FG002|Overall Study|Randomly assigned but not treated|0|||
125455656|NCT00246012|451296575|FG003|Overall Study|Randomly assigned but not treated|0|||
125455657|NCT00246012|451296576|FG004|Overall Study|Randomly assigned but not treated|0|||
125455658|NCT00246012|451296577|FG005|Overall Study|Randomly assigned but not treated|1|||
125455659|NCT00246012|451296578|FG006|Overall Study|Randomly assigned but not treated|1|||
125455660|NCT00246012|451296579|FG007|Overall Study|Randomly assigned but not treated|0|||
125455661|NCT00246012|451296580|FG008|Overall Study|Randomly assigned but not treated|0|||
125455662|NCT01242085|451296581|FG000|Overall Study|Withdrawal by Subject|4|||
125455663|NCT01242085|451296582|FG001|Overall Study|Withdrawal by Subject|2|||
125455664|NCT01242085|451296583|FG002|Overall Study|Withdrawal by Subject|0|||
125455665|NCT01242085|451296581|FG000|Overall Study|medically unable to have surgery|4|||
125455666|NCT01242085|451296582|FG001|Overall Study|medically unable to have surgery|5|||
125455667|NCT01242085|451296583|FG002|Overall Study|medically unable to have surgery|0|||
125455668|NCT01178762|451296584|FG000|Overall Study|Lost to Follow-up|15|||
125455669|NCT01651949|451296591|FG000|Overall Study|Unknown status|4|||
125455670|NCT01651949|451296592|FG001|Overall Study|Unknown status|4|||
125455671|NCT01651949|451296593|FG002|Overall Study|Unknown status|0|||
125455672|NCT01651949|451296591|FG000|Overall Study|Lost to Follow-up|30|||
125455673|NCT01651949|451296592|FG001|Overall Study|Lost to Follow-up|56|||
125455674|NCT01651949|451296593|FG002|Overall Study|Lost to Follow-up|20|||
125455675|NCT01651949|451296591|FG000|Overall Study|Protocol Violation|0|||
125455676|NCT01651949|451296592|FG001|Overall Study|Protocol Violation|2|||
125455677|NCT01651949|451296593|FG002|Overall Study|Protocol Violation|1|||
125455678|NCT01651949|451296591|FG000|Overall Study|Physician Decision|0|||
125455679|NCT01651949|451296592|FG001|Overall Study|Physician Decision|2|||
125455680|NCT01651949|451296593|FG002|Overall Study|Physician Decision|0|||
125455681|NCT01651949|451296591|FG000|Overall Study|Adverse Event|0|||
125455682|NCT01651949|451296592|FG001|Overall Study|Adverse Event|2|||
125455683|NCT01651949|451296593|FG002|Overall Study|Adverse Event|1|||
125455684|NCT01651949|451296591|FG000|Overall Study|Screen failure|2|||
125455685|NCT01651949|451296592|FG001|Overall Study|Screen failure|2|||
125455686|NCT01651949|451296593|FG002|Overall Study|Screen failure|0|||
125455687|NCT01651949|451296591|FG000|Overall Study|Withdrawal by Subject|17|||
125455688|NCT01651949|451296592|FG001|Overall Study|Withdrawal by Subject|18|||
125455689|NCT01651949|451296593|FG002|Overall Study|Withdrawal by Subject|9|||
125455690|NCT01806714|451296594|FG000|Overall Study|No functioning phone number|200|||
125455691|NCT01806714|451296595|FG001|Overall Study|No functioning phone number|170|||
125455692|NCT02469064|451296596|FG000|Overall Study|Request not to receive intervention.|1|||
125455693|NCT02469064|451296597|FG001|Overall Study|Request not to receive intervention.|3|||
125455694|NCT02155829|451296598|FG000|Overall Study|Adverse Event|1|||
125455695|NCT02155829|451296599|FG001|Overall Study|Adverse Event|0|||
125455696|NCT02155829|451296598|FG000|Overall Study|Withdrawal by Subject|3|||
125455697|NCT02155829|451296599|FG001|Overall Study|Withdrawal by Subject|3|||
125455698|NCT02155829|451296598|FG000|Overall Study|Protocol Violation|2|||
125455699|NCT02155829|451296599|FG001|Overall Study|Protocol Violation|0|||
125455700|NCT00678795|451296600|FG000|Overall Study|Adverse Event|7|||
125455701|NCT00678795|451296601|FG001|Overall Study|Adverse Event|3|||
125455702|NCT00678795|451296600|FG000|Overall Study|Withdrawal by Subject|3|||
125455703|NCT00678795|451296601|FG001|Overall Study|Withdrawal by Subject|0|||
125455704|NCT00678795|451296600|FG000|Overall Study|Protocol Violation|0|||
125455705|NCT00678795|451296601|FG001|Overall Study|Protocol Violation|1|||
125455706|NCT00678795|451296600|FG000|Overall Study|Lost to Follow-up|0|||
125455707|NCT00678795|451296601|FG001|Overall Study|Lost to Follow-up|1|||
125455708|NCT00678795|451296600|FG000|Overall Study|Lack of Efficacy|1|||
125455709|NCT00678795|451296601|FG001|Overall Study|Lack of Efficacy|1|||
125455710|NCT00290732|451296606|FG000|Overall Study|Inability to instill drug intraductally.|0|||
125455711|NCT00290732|451296607|FG001|Overall Study|Inability to instill drug intraductally.|1|||
125455712|NCT00290732|451296608|FG002|Overall Study|Inability to instill drug intraductally.|1|||
125455713|NCT00290732|451296609|FG003|Overall Study|Inability to instill drug intraductally.|0|||
125455714|NCT00290732|451296610|FG004|Overall Study|Inability to instill drug intraductally.|0|||
125455715|NCT00542386|451296611|FG000|Overall Study|Adverse Event|1|||
125455716|NCT00542386|451296612|FG001|Overall Study|Adverse Event|7|||
125455717|NCT00542386|451296613|FG002|Overall Study|Adverse Event|7|||
125455718|NCT00542386|451296614|FG003|Overall Study|Adverse Event|8|||
125455719|NCT00542386|451296615|FG004|Overall Study|Adverse Event|13|||
125455720|NCT00542386|451296616|FG005|Overall Study|Adverse Event|4|||
125455721|NCT00542386|451296611|FG000|Overall Study|Death|0|||
125455722|NCT00542386|451296612|FG001|Overall Study|Death|0|||
125455723|NCT00542386|451296613|FG002|Overall Study|Death|1|||
125455724|NCT00542386|451296614|FG003|Overall Study|Death|2|||
125455725|NCT00542386|451296615|FG004|Overall Study|Death|1|||
125455726|NCT00542386|451296616|FG005|Overall Study|Death|2|||
125455727|NCT00542386|451296611|FG000|Overall Study|Lack of Efficacy|32|||
125455728|NCT00542386|451296612|FG001|Overall Study|Lack of Efficacy|12|||
125455729|NCT00542386|451296613|FG002|Overall Study|Lack of Efficacy|10|||
125455730|NCT00542386|451296614|FG003|Overall Study|Lack of Efficacy|13|||
125455731|NCT00542386|451296615|FG004|Overall Study|Lack of Efficacy|7|||
125455732|NCT00542386|451296616|FG005|Overall Study|Lack of Efficacy|31|||
125455733|NCT00542386|451296611|FG000|Overall Study|Physician Decision|1|||
125455734|NCT00542386|451296612|FG001|Overall Study|Physician Decision|0|||
125455735|NCT00542386|451296613|FG002|Overall Study|Physician Decision|0|||
125455736|NCT00542386|451296614|FG003|Overall Study|Physician Decision|1|||
125455737|NCT00542386|451296615|FG004|Overall Study|Physician Decision|0|||
125455738|NCT00542386|451296616|FG005|Overall Study|Physician Decision|0|||
125455739|NCT00542386|451296611|FG000|Overall Study|Protocol Violation|0|||
125455740|NCT00542386|451296612|FG001|Overall Study|Protocol Violation|0|||
125455741|NCT00542386|451296613|FG002|Overall Study|Protocol Violation|1|||
125455742|NCT00542386|451296614|FG003|Overall Study|Protocol Violation|0|||
125455743|NCT00542386|451296615|FG004|Overall Study|Protocol Violation|0|||
125455744|NCT00542386|451296616|FG005|Overall Study|Protocol Violation|4|||
125455745|NCT00542386|451296611|FG000|Overall Study|Withdrawal by Subject|5|||
125455746|NCT00542386|451296612|FG001|Overall Study|Withdrawal by Subject|8|||
125455747|NCT00542386|451296613|FG002|Overall Study|Withdrawal by Subject|10|||
125455748|NCT00542386|451296614|FG003|Overall Study|Withdrawal by Subject|11|||
125455749|NCT00542386|451296615|FG004|Overall Study|Withdrawal by Subject|15|||
125455750|NCT00542386|451296616|FG005|Overall Study|Withdrawal by Subject|7|||
125455751|NCT00542386|451296611|FG000|Overall Study|Other Reasons|4|||
125455752|NCT00542386|451296612|FG001|Overall Study|Other Reasons|1|||
125455753|NCT00542386|451296613|FG002|Overall Study|Other Reasons|4|||
125455754|NCT00542386|451296614|FG003|Overall Study|Other Reasons|3|||
125455755|NCT00542386|451296615|FG004|Overall Study|Other Reasons|4|||
125455756|NCT00542386|451296616|FG005|Overall Study|Other Reasons|2|||
125455757|NCT04173572|451296619|FG000|Overall Study|Withdrawal by Subject|1|||
125455758|NCT04173572|451296620|FG001|Overall Study|Withdrawal by Subject|5|||
125455759|NCT04173572|451296619|FG000|Overall Study|Lost to Follow-up|3|||
125455760|NCT04173572|451296620|FG001|Overall Study|Lost to Follow-up|1|||
125455761|NCT01839877|451296621|FG000|Overall Study|Protocol Violation|1|||
125455762|NCT03098030|451296622|FG000|Overall Study|Death|10|||
125455763|NCT03098030|451296623|FG001|Overall Study|Death|156|||
125455764|NCT03098030|451296624|FG002|Overall Study|Death|156|||
125455765|NCT03098030|451296625|FG003|Overall Study|Death|82|||
125455766|NCT03098030|451296622|FG000|Overall Study|Withdrawal by Subject|0|||
125455767|NCT03098030|451296623|FG001|Overall Study|Withdrawal by Subject|7|||
125455768|NCT03098030|451296624|FG002|Overall Study|Withdrawal by Subject|8|||
125455769|NCT03098030|451296625|FG003|Overall Study|Withdrawal by Subject|2|||
125455770|NCT03098030|451296622|FG000|Overall Study|Lost to Follow-up|0|||
125455771|NCT03098030|451296623|FG001|Overall Study|Lost to Follow-up|0|||
125455772|NCT03098030|451296624|FG002|Overall Study|Lost to Follow-up|2|||
125455773|NCT03098030|451296625|FG003|Overall Study|Lost to Follow-up|1|||
125455774|NCT01726023|451296626|FG000|Overall Study|Death|1|||
125455775|NCT01726023|451296627|FG001|Overall Study|Death|1|||
125455776|NCT01726023|451296626|FG000|Overall Study|Lost to Follow-up|5|||
125455777|NCT01726023|451296627|FG001|Overall Study|Lost to Follow-up|10|||
125455778|NCT01726023|451296626|FG000|Overall Study|Other Eligibility criteria|7|||
125455779|NCT01726023|451296627|FG001|Overall Study|Other Eligibility criteria|7|||
125455780|NCT01726023|451296626|FG000|Overall Study|Withdrawal by Subject|16|||
125455781|NCT01726023|451296627|FG001|Overall Study|Withdrawal by Subject|8|||
125455782|NCT03643211|451296630|FG000|Overall Study|Contract violation/deficiency|12|||
125485351|NCT02240238|451412513|FG010|Phase 1|Adverse Event|0|||
125420055|NCT00417079|451162249|FG000|Overall Study|Lost to Follow-up|2|||
125420056|NCT00417079|451162250|FG001|Overall Study|Lost to Follow-up|0|||
125420057|NCT00417079|451162249|FG000|Overall Study|Withdrawal by Subject|17|||
125420058|NCT00417079|451162250|FG001|Overall Study|Withdrawal by Subject|8|||
125420059|NCT00417079|451162249|FG000|Overall Study|Not treated|6|||
125420060|NCT00417079|451162250|FG001|Overall Study|Not treated|7|||
125420061|NCT00417079|451162249|FG000|Overall Study|Screened failure|2|||
125420062|NCT00417079|451162250|FG001|Overall Study|Screened failure|1|||
125420063|NCT00417079|451162249|FG000|Overall Study|Investigator's decision|1|||
125420064|NCT00417079|451162250|FG001|Overall Study|Investigator's decision|4|||
125420065|NCT00417079|451162249|FG000|Overall Study|Non-confirmed Disease progression|1|||
125420066|NCT00417079|451162250|FG001|Overall Study|Non-confirmed Disease progression|1|||
125420067|NCT00417079|451162249|FG000|Overall Study|Clinical deterioration|1|||
125420068|NCT00417079|451162250|FG001|Overall Study|Clinical deterioration|0|||
125420069|NCT00417079|451162249|FG000|Overall Study|Screening error|2|||
125420070|NCT00417079|451162250|FG001|Overall Study|Screening error|1|||
125420071|NCT00417079|451162249|FG000|Overall Study|Withdrawal by subject's family|0|||
125420072|NCT00417079|451162250|FG001|Overall Study|Withdrawal by subject's family|1|||
125420073|NCT00417079|451162249|FG000|Overall Study|Patient unable to come to the clinic|0|||
125420074|NCT00417079|451162250|FG001|Overall Study|Patient unable to come to the clinic|1|||
125420075|NCT00417079|451162249|FG000|Overall Study|abnormal liver function tests|0|||
125420076|NCT00417079|451162250|FG001|Overall Study|abnormal liver function tests|1|||
125420077|NCT04084314|451162261|FG000|Overall Study|Subject/guardian decision|91|||
125420078|NCT04084314|451162261|FG000|Overall Study|Adverse Event|24|||
125420079|NCT04084314|451162261|FG000|Overall Study|Lost to Follow-up|19|||
125420080|NCT04084314|451162261|FG000|Overall Study|New therapy for study indication|9|||
125420081|NCT04084314|451162261|FG000|Overall Study|Pregnancy|9|||
125420082|NCT04084314|451162261|FG000|Overall Study|Withdrawal of informed consent|8|||
125420083|NCT04084314|451162261|FG000|Overall Study|Physician Decision|4|||
125420084|NCT04084314|451162261|FG000|Overall Study|Protocol Deviation|3|||
125420085|NCT00802074|451162264|FG000|Overall Study|Adverse Event|1|||
125420086|NCT00802074|451162265|FG001|Overall Study|Adverse Event|1|||
125420087|NCT00802074|451162266|FG002|Overall Study|Adverse Event|1|||
125420088|NCT00802074|451162267|FG003|Overall Study|Adverse Event|0|||
125420089|NCT00802074|451162268|FG004|Overall Study|Adverse Event|0|||
125420090|NCT00802074|451162269|FG005|Overall Study|Adverse Event|0|||
125420091|NCT00802074|451162264|FG000|Overall Study|Withdrawal by Subject|1|||
125420092|NCT00802074|451162265|FG001|Overall Study|Withdrawal by Subject|0|||
125420093|NCT00802074|451162266|FG002|Overall Study|Withdrawal by Subject|0|||
125420094|NCT00802074|451162267|FG003|Overall Study|Withdrawal by Subject|0|||
125420095|NCT00802074|451162268|FG004|Overall Study|Withdrawal by Subject|0|||
125420096|NCT00802074|451162269|FG005|Overall Study|Withdrawal by Subject|0|||
125420097|NCT02298192|451162270|FG000|Overall Study|Unclassified|3|||
125420098|NCT02298192|451162271|FG001|Overall Study|Unclassified|2|||
125420099|NCT02298192|451162270|FG000|Overall Study|Withdrawal criteria|2|||
125420100|NCT02298192|451162271|FG001|Overall Study|Withdrawal criteria|0|||
125420101|NCT02298192|451162270|FG000|Overall Study|Withdrawal by Subject|6|||
125420102|NCT02298192|451162271|FG001|Overall Study|Withdrawal by Subject|1|||
125420103|NCT02298192|451162270|FG000|Overall Study|Lost to Follow-up|2|||
125420104|NCT02298192|451162271|FG001|Overall Study|Lost to Follow-up|1|||
125420105|NCT02298192|451162270|FG000|Overall Study|Adverse Event|6|||
125420106|NCT02298192|451162271|FG001|Overall Study|Adverse Event|2|||
125420107|NCT00679939|451162272|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
125420108|NCT00679939|451162273|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
125420109|NCT00679939|451162272|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
125420110|NCT00679939|451162273|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
125420111|NCT00679939|451162272|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
125420112|NCT00679939|451162273|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
125420113|NCT00679939|451162272|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
125420114|NCT00679939|451162273|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
125420115|NCT00679939|451162272|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
125420116|NCT00679939|451162273|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
125420117|NCT00679939|451162272|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
125420118|NCT00679939|451162273|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
125420119|NCT00679939|451162272|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
125420120|NCT00679939|451162273|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
125420121|NCT00679939|451162272|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
125420122|NCT00679939|451162273|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
125420123|NCT00679939|451162272|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
125420124|NCT00679939|451162273|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
125420125|NCT00679939|451162272|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
125420126|NCT00679939|451162273|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
125455783|NCT03643211|451296630|FG000|Overall Study|Invalid registration|3|||
125455784|NCT03643211|451296630|FG000|Overall Study|No treatment information|2|||
125455785|NCT03643211|451296630|FG000|Overall Study|No adverse event information - No revisit|4|||
125455786|NCT04536077|451296632|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
125455787|NCT04536077|451296633|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
125455788|NCT04536077|451296632|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
125455789|NCT04536077|451296633|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
125455790|NCT05484726|451296634|FG000|Overall Study|Protocol Violation|3|||
125455791|NCT05484726|451296635|FG001|Overall Study|Protocol Violation|3|||
125455792|NCT05484726|451296634|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
125455793|NCT05484726|451296635|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
125455794|NCT05484726|451296634|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
125455795|NCT05484726|451296635|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
125455796|NCT05484726|451296634|FG000|Overall Study|continued need of mechanical ventilation|2|||
125455797|NCT05484726|451296635|FG001|Overall Study|continued need of mechanical ventilation|3|||
125455798|NCT05484726|451296634|FG000|Overall Study|Withdrawal by Subject|2|||
125455799|NCT05484726|451296635|FG001|Overall Study|Withdrawal by Subject|3|||
125455800|NCT05484726|451296634|FG000|Overall Study|IVH (G III & IV)|2|||
125455801|NCT05484726|451296635|FG001|Overall Study|IVH (G III & IV)|1|||
125455802|NCT05484726|451296634|FG000|Overall Study|NEC (stage II & III)|2|||
125455803|NCT05484726|451296635|FG001|Overall Study|NEC (stage II & III)|3|||
125455804|NCT02824432|451296636|FG000|Overall Study|Major Protocol Deviation|1|||
125455805|NCT02824432|451296637|FG001|Overall Study|Major Protocol Deviation|0|||
125455806|NCT00554801|451296638|FG000|Overall Study|left area before completion|5|||
125455807|NCT00554801|451296639|FG001|Overall Study|left area before completion|0|||
125455808|NCT00554801|451296638|FG000|Overall Study|Withdrawal by Subject|14|||
125455809|NCT00554801|451296639|FG001|Overall Study|Withdrawal by Subject|0|||
125455810|NCT04436120|451296643|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
125455811|NCT04436120|451296644|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
125455812|NCT04436120|451296645|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
125455813|NCT04436120|451296646|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
125455814|NCT04436120|451296647|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
125455815|NCT04436120|451296648|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
125455816|NCT04436120|451296649|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
125455817|NCT00604721|451296651|FG000|Overall Study|Physician Decision|1|||
125455818|NCT00604721|451296651|FG000|Overall Study|Withdrawal by Subject|1|||
125455819|NCT01838551|451296652|FG000|Overall Study|Adverse Event|16|||
125455820|NCT01838551|451296652|FG000|Overall Study|Death|1|||
125455821|NCT01838551|451296652|FG000|Overall Study|Lack of Efficacy|10|||
125455822|NCT01838551|451296652|FG000|Overall Study|Physician Decision|4|||
125455823|NCT01838551|451296652|FG000|Overall Study|Withdrawal by Subject|10|||
125455824|NCT01838551|451296652|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
125455825|NCT01981356|451296653|FG000|Overall Study|Lost to Follow-up|4|||
125455826|NCT01981356|451296654|FG001|Overall Study|Lost to Follow-up|1|||
125455827|NCT01981356|451296653|FG000|Overall Study|Withdrawal by Subject|1|||
125455828|NCT01981356|451296654|FG001|Overall Study|Withdrawal by Subject|1|||
125455829|NCT01981356|451296653|FG000|Overall Study|Protocol Violation|2|||
125455830|NCT01981356|451296654|FG001|Overall Study|Protocol Violation|0|||
125455831|NCT00536380|451296655|FG000|Overall Study|Adverse Event|0|||
125455832|NCT00536380|451296656|FG001|Overall Study|Adverse Event|2|||
125455833|NCT00536380|451296657|FG002|Overall Study|Adverse Event|2|||
125455834|NCT00536380|451296655|FG000|Overall Study|Lost to Follow-up|0|||
125455835|NCT00536380|451296656|FG001|Overall Study|Lost to Follow-up|0|||
125455836|NCT00536380|451296657|FG002|Overall Study|Lost to Follow-up|1|||
125455837|NCT00536380|451296655|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
125455838|NCT00536380|451296656|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
125455839|NCT00536380|451296657|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
125455840|NCT00536380|451296655|FG000|Overall Study|Withdrawal related to study drug|7|||
125455841|NCT00536380|451296656|FG001|Overall Study|Withdrawal related to study drug|5|||
125455842|NCT00536380|451296657|FG002|Overall Study|Withdrawal related to study drug|2|||
125455843|NCT00536380|451296655|FG000|Overall Study|Noncompliance with protocol|3|||
125455844|NCT00536380|451296656|FG001|Overall Study|Noncompliance with protocol|2|||
125455845|NCT00536380|451296657|FG002|Overall Study|Noncompliance with protocol|2|||
125455846|NCT00536380|451296655|FG000|Overall Study|Did not meet protocol eligibility|0|||
125455847|NCT00536380|451296656|FG001|Overall Study|Did not meet protocol eligibility|0|||
125455848|NCT00536380|451296657|FG002|Overall Study|Did not meet protocol eligibility|1|||
125455849|NCT00536380|451296655|FG000|Overall Study|Administrative|0|||
125455850|NCT00536380|451296656|FG001|Overall Study|Administrative|0|||
125455851|NCT00536380|451296657|FG002|Overall Study|Administrative|1|||
125455852|NCT02486588|451296658|FG000|Overall Study|Randomized in error- ineligible|738|||
125455853|NCT02486588|451296659|FG001|Overall Study|Randomized in error- ineligible|750|||
125455854|NCT02486588|451296660|FG002|Overall Study|Randomized in error- ineligible|755|||
125455855|NCT02486588|451296661|FG003|Overall Study|Randomized in error- ineligible|738|||
125455856|NCT02486588|451296662|FG004|Overall Study|Randomized in error- ineligible|746|||
125455857|NCT02486588|451296663|FG005|Overall Study|Randomized in error- ineligible|746|||
125455858|NCT03354390|451296664|FG000|Level 1|Death|2|||
125455859|NCT03354390|451296665|FG001|Level 1|Death|0|||
125455860|NCT03354390|451296666|FG002|Level 1|Death|0|||
125455861|NCT03354390|451296667|FG003|Level 1|Death|0|||
125455862|NCT03354390|451296664|FG000|Level 1|Physician Decision|1|||
125455863|NCT03354390|451296665|FG001|Level 1|Physician Decision|0|||
125455864|NCT03354390|451296666|FG002|Level 1|Physician Decision|0|||
125455865|NCT03354390|451296667|FG003|Level 1|Physician Decision|0|||
125455866|NCT03354390|451296664|FG000|Level 2|Physician Decision|0|||
125455867|NCT03354390|451296665|FG001|Level 2|Physician Decision|2|||
125455868|NCT03354390|451296666|FG002|Level 2|Physician Decision|0|||
125455869|NCT03354390|451296667|FG003|Level 2|Physician Decision|0|||
125455870|NCT03354390|451296664|FG000|Level 2|Lack of Efficacy|0|||
125455871|NCT03354390|451296665|FG001|Level 2|Lack of Efficacy|1|||
125455872|NCT03354390|451296666|FG002|Level 2|Lack of Efficacy|0|||
125455873|NCT03354390|451296667|FG003|Level 2|Lack of Efficacy|0|||
125455874|NCT03354390|451296664|FG000|Level 2|Lost to Follow-up|0|||
125455875|NCT03354390|451296665|FG001|Level 2|Lost to Follow-up|1|||
125455876|NCT03354390|451296666|FG002|Level 2|Lost to Follow-up|0|||
125455877|NCT03354390|451296667|FG003|Level 2|Lost to Follow-up|0|||
125455878|NCT03354390|451296664|FG000|Level 3|Death|0|||
125455879|NCT03354390|451296665|FG001|Level 3|Death|0|||
125455880|NCT03354390|451296666|FG002|Level 3|Death|1|||
125455881|NCT03354390|451296667|FG003|Level 3|Death|0|||
125455882|NCT03354390|451296664|FG000|Level 3|Physician Decision|0|||
125455883|NCT03354390|451296665|FG001|Level 3|Physician Decision|0|||
125455884|NCT03354390|451296666|FG002|Level 3|Physician Decision|2|||
125455885|NCT03354390|451296667|FG003|Level 3|Physician Decision|0|||
125455886|NCT03354390|451296664|FG000|Level 4|Death|0|||
125455887|NCT03354390|451296665|FG001|Level 4|Death|0|||
125455888|NCT03354390|451296666|FG002|Level 4|Death|0|||
125455889|NCT03354390|451296667|FG003|Level 4|Death|3|||
125455890|NCT02738840|451298601|FG000|Overall Study|MRI Scan not Performed|5|||
125455891|NCT02738840|451298601|FG000|Overall Study|Lost to Follow-up|1|||
125455892|NCT02738840|451298601|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
125455893|NCT02738840|451298601|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
125455894|NCT01311648|451298604|FG000|Main Study|Protocol Violation|0|||
125455895|NCT01311648|451298605|FG001|Main Study|Protocol Violation|1|||
125455896|NCT01311648|451298604|FG000|Main Study|Adverse Event|0|||
125455897|NCT01311648|451298605|FG001|Main Study|Adverse Event|1|||
125455898|NCT01311648|451298604|FG000|Main Study|Inhibitor management|0|||
125455899|NCT01311648|451298605|FG001|Main Study|Inhibitor management|17|||
125455900|NCT01311648|451298604|FG000|Main Study|Withdrawal by Subject|0|||
125455901|NCT01311648|451298605|FG001|Main Study|Withdrawal by Subject|2|||
125455902|NCT01311648|451298604|FG000|Extension Study|Physician Decision|0|||
125455903|NCT01311648|451298605|FG001|Extension Study|Physician Decision|1|||
125455904|NCT01311648|451298604|FG000|Extension Study|ITI therapy with marketed product|0|||
125455905|NCT01311648|451298605|FG001|Extension Study|ITI therapy with marketed product|1|||
125455906|NCT01311648|451298604|FG000|Extension Study|Incorrect visit planning|0|||
125455907|NCT01311648|451298605|FG001|Extension Study|Incorrect visit planning|1|||
125455908|NCT01311648|451298604|FG000|Extension Study|Family's decision|0|||
125455909|NCT01311648|451298605|FG001|Extension Study|Family's decision|1|||
125455910|NCT01311648|451298604|FG000|Extension Study|Failure of ITI therapy|0|||
125455911|NCT01311648|451298605|FG001|Extension Study|Failure of ITI therapy|3|||
125455912|NCT01311648|451298604|FG000|Extension Study|Long travel|0|||
125455913|NCT01311648|451298605|FG001|Extension Study|Long travel|1|||
125455914|NCT01311648|451298604|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
125455915|NCT01311648|451298605|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
125455916|NCT01311648|451298604|FG000|Extension Study|Withdrawal by Subject|0|||
125455917|NCT01311648|451298605|FG001|Extension Study|Withdrawal by Subject|1|||
125455918|NCT01311648|451298604|FG000|Extension Study|Inhibitor management|0|||
125455919|NCT01311648|451298605|FG001|Extension Study|Inhibitor management|2|||
125455920|NCT01645111|451298606|FG000|Overall Study|Did not require Clevidipine|15|||
125455921|NCT01875250|451298608|FG000|Overall Study|Adverse Event|2|||
125455922|NCT01875250|451298609|FG001|Overall Study|Adverse Event|0|||
125455923|NCT04057196|451298612|FG000|Overall Study|Withdrawal by Subject|3|||
125455924|NCT04057196|451298612|FG000|Overall Study|Death|3|||
125455925|NCT03068468|451298613|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
125455926|NCT03068468|451298614|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
125455927|NCT03068468|451298615|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
125455928|NCT03068468|451298616|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
125455929|NCT03068468|451298613|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
125455930|NCT03068468|451298614|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
125455931|NCT03068468|451298615|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
125455932|NCT03068468|451298616|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
125455933|NCT03068468|451298613|FG000|Placebo-Controlled Period|Adverse Event|16|||
125455934|NCT03068468|451298614|FG001|Placebo-Controlled Period|Adverse Event|21|||
125455935|NCT03068468|451298615|FG002|Placebo-Controlled Period|Adverse Event|0|||
125455936|NCT03068468|451298616|FG003|Placebo-Controlled Period|Adverse Event|0|||
125455937|NCT03068468|451298613|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
125455938|NCT03068468|451298614|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
125455939|NCT03068468|451298615|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
125455940|NCT03068468|451298616|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
125455941|NCT03068468|451298613|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
125455942|NCT03068468|451298614|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
125455943|NCT03068468|451298615|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125455944|NCT03068468|451298616|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125455945|NCT03068468|451298613|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
125455946|NCT03068468|451298614|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
125455947|NCT03068468|451298615|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
125455948|NCT03068468|451298616|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
125455949|NCT03068468|451298613|FG000|Placebo-Controlled Period|Death|0|||
125455950|NCT03068468|451298614|FG001|Placebo-Controlled Period|Death|1|||
125455951|NCT03068468|451298615|FG002|Placebo-Controlled Period|Death|0|||
125455952|NCT03068468|451298616|FG003|Placebo-Controlled Period|Death|0|||
125455953|NCT03068468|451298613|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
125455954|NCT03068468|451298614|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
125455955|NCT03068468|451298615|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
125455956|NCT03068468|451298616|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
125455957|NCT03068468|451298613|FG000|Open-Label Extension Period|Adverse Event|0|||
125455958|NCT03068468|451298614|FG001|Open-Label Extension Period|Adverse Event|0|||
125455959|NCT03068468|451298615|FG002|Open-Label Extension Period|Adverse Event|13|||
125455960|NCT03068468|451298616|FG003|Open-Label Extension Period|Adverse Event|17|||
125455961|NCT03068468|451298613|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
125455962|NCT03068468|451298614|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
125455963|NCT03068468|451298615|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
125455964|NCT03068468|451298616|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
125455965|NCT03068468|451298613|FG000|Open-Label Extension Period|Death|0|||
125455966|NCT03068468|451298614|FG001|Open-Label Extension Period|Death|0|||
125455967|NCT03068468|451298615|FG002|Open-Label Extension Period|Death|0|||
125455968|NCT03068468|451298616|FG003|Open-Label Extension Period|Death|1|||
125455969|NCT03068468|451298613|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
125455970|NCT03068468|451298614|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
125455971|NCT03068468|451298615|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
125455972|NCT03068468|451298616|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
125455973|NCT03068468|451298613|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
125455974|NCT03068468|451298614|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
125294127|NCT01565941|450705215|FG001|Overall Study|Withdrawn by parent/guardian|2|||
125294128|NCT01565941|450705214|FG000|Overall Study|Randomized; did not receive intevention|8|||
125294129|NCT01565941|450705215|FG001|Overall Study|Randomized; did not receive intevention|2|||
125294130|NCT04047420|450705216|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
125294131|NCT04047420|450705216|FG000|Washout Period|Refused Participation|2|||
125294132|NCT03242018|450705217|FG000|Overall Study|Adverse Event|7|||
125294133|NCT03242018|450705218|FG001|Overall Study|Adverse Event|7|||
125294134|NCT03242018|450705219|FG002|Overall Study|Adverse Event|6|||
125294135|NCT03242018|450705217|FG000|Overall Study|Lost to Follow-up|2|||
125294136|NCT03242018|450705218|FG001|Overall Study|Lost to Follow-up|2|||
125294137|NCT03242018|450705219|FG002|Overall Study|Lost to Follow-up|2|||
125294138|NCT03242018|450705217|FG000|Overall Study|At the Participant's Own Request|5|||
125294139|NCT03242018|450705218|FG001|Overall Study|At the Participant's Own Request|1|||
125294140|NCT03242018|450705219|FG002|Overall Study|At the Participant's Own Request|4|||
125294141|NCT03242018|450705217|FG000|Overall Study|Reason Not Specified|3|||
125294142|NCT03242018|450705218|FG001|Overall Study|Reason Not Specified|4|||
125294143|NCT03242018|450705219|FG002|Overall Study|Reason Not Specified|1|||
125294144|NCT03242018|450705217|FG000|Overall Study|Study Terminated by Sponsor|1|||
125294145|NCT03242018|450705218|FG001|Overall Study|Study Terminated by Sponsor|0|||
125294146|NCT03242018|450705219|FG002|Overall Study|Study Terminated by Sponsor|1|||
125294147|NCT03262116|450705220|FG000|Overall Study|Physician Decision|0|||
125294148|NCT03262116|450705221|FG001|Overall Study|Physician Decision|2|||
125294149|NCT03262116|450705222|FG002|Overall Study|Physician Decision|1|||
125294150|NCT03262116|450705223|FG003|Overall Study|Physician Decision|1|||
125455975|NCT03068468|451298615|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
125455976|NCT03068468|451298616|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
125455977|NCT03068468|451298613|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
125455978|NCT03068468|451298614|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
125455979|NCT03068468|451298615|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
125455980|NCT03068468|451298616|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
125455981|NCT03068468|451298613|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
125455982|NCT03068468|451298614|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
125455983|NCT03068468|451298615|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
125455984|NCT03068468|451298616|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
125455985|NCT03068468|451298613|FG000|Open-Label Extension Period|Reason not Specified|0|||
125455986|NCT03068468|451298614|FG001|Open-Label Extension Period|Reason not Specified|0|||
125455987|NCT03068468|451298615|FG002|Open-Label Extension Period|Reason not Specified|1|||
125455988|NCT03068468|451298616|FG003|Open-Label Extension Period|Reason not Specified|4|||
125455989|NCT02466516|451298618|FG000|Overall Study|Adverse Event|1|||
125455990|NCT02466516|451298619|FG001|Overall Study|Adverse Event|1|||
125455991|NCT02466516|451298620|FG002|Overall Study|Adverse Event|0|||
125455992|NCT02466516|451298621|FG003|Overall Study|Adverse Event|0|||
125455993|NCT02466516|451298622|FG004|Overall Study|Adverse Event|0|||
125455994|NCT02466516|451298618|FG000|Overall Study|Withdrew Consent|1|||
125455995|NCT02466516|451298619|FG001|Overall Study|Withdrew Consent|0|||
125455996|NCT02466516|451298620|FG002|Overall Study|Withdrew Consent|0|||
125455997|NCT02466516|451298621|FG003|Overall Study|Withdrew Consent|0|||
125455998|NCT02466516|451298622|FG004|Overall Study|Withdrew Consent|0|||
125455999|NCT02466516|451298618|FG000|Overall Study|Lost to Follow-up|2|||
125456000|NCT02466516|451298619|FG001|Overall Study|Lost to Follow-up|0|||
125456001|NCT02466516|451298620|FG002|Overall Study|Lost to Follow-up|1|||
125456002|NCT02466516|451298621|FG003|Overall Study|Lost to Follow-up|0|||
125456003|NCT02466516|451298622|FG004|Overall Study|Lost to Follow-up|0|||
125456004|NCT03712930|451298623|FG000|Overall Study|Death|7|||
125456005|NCT03712930|451298623|FG000|Overall Study|Physician Decision|1|||
125456006|NCT03712930|451298623|FG000|Overall Study|Study Terminated by Sponsor|3|||
125456007|NCT03712930|451298623|FG000|Overall Study|Progressive Disease|2|||
125456008|NCT01062126|451298625|FG000|Overall Study|Death|209|||
125456009|NCT01062126|451298625|FG000|Overall Study|All Withdrawals|324|||
125456010|NCT00954707|451298628|FG000|Overall Study|Death|34|||
125456011|NCT00954707|451298628|FG000|Overall Study|Withdrawal by Subject|100|||
125456012|NCT00954707|451298628|FG000|Overall Study|Lost to Follow-up|33|||
125456013|NCT00486759|451298629|FG000|Treatment|Adverse event/intercurrent illness|86|||
125456014|NCT00486759|451298630|FG001|Treatment|Adverse event/intercurrent illness|39|||
125456015|NCT00486759|451298629|FG000|Treatment|Insufficient therapeutic response|37|||
125456016|NCT00486759|451298630|FG001|Treatment|Insufficient therapeutic response|39|||
125456017|NCT00486759|451298629|FG000|Treatment|Death|17|||
125456018|NCT00486759|451298630|FG001|Treatment|Death|10|||
125456019|NCT00486759|451298629|FG000|Treatment|Withdrew consent|15|||
125456020|NCT00486759|451298630|FG001|Treatment|Withdrew consent|12|||
125456021|NCT00486759|451298629|FG000|Treatment|Administrative/reason not specified|17|||
125456022|NCT00486759|451298630|FG001|Treatment|Administrative/reason not specified|21|||
125456023|NCT00486759|451298629|FG000|Treatment|Refused treatment|10|||
125456024|NCT00486759|451298630|FG001|Treatment|Refused treatment|7|||
125456025|NCT00486759|451298629|FG000|Treatment|Violation of selection criteria at entry|3|||
125456026|NCT00486759|451298630|FG001|Treatment|Violation of selection criteria at entry|3|||
125456027|NCT00486759|451298629|FG000|Treatment|Other protocol violation|1|||
125456028|NCT00486759|451298630|FG001|Treatment|Other protocol violation|5|||
125456029|NCT00486759|451298629|FG000|Treatment|Failure to return|1|||
125456030|NCT00486759|451298630|FG001|Treatment|Failure to return|1|||
125456031|NCT00486759|451298629|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
125456032|NCT00486759|451298630|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
125456033|NCT00486759|451298629|FG000|Safety Follow-up|Death|40|||
125456034|NCT00486759|451298630|FG001|Safety Follow-up|Death|29|||
125456035|NCT00486759|451298629|FG000|Safety Follow-up|Withdrew consent|32|||
125456036|NCT00486759|451298630|FG001|Safety Follow-up|Withdrew consent|23|||
125456037|NCT00486759|451298629|FG000|Safety Follow-up|Failure to return|9|||
125456038|NCT00486759|451298630|FG001|Safety Follow-up|Failure to return|6|||
125456039|NCT00486759|451298629|FG000|Safety Follow-up|Administrative/not specified|8|||
125456040|NCT00486759|451298630|FG001|Safety Follow-up|Administrative/not specified|6|||
125456041|NCT00486759|451298629|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
125456042|NCT00486759|451298630|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
125456043|NCT00486759|451298629|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
125456044|NCT00486759|451298630|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
125456045|NCT02001623|451298633|FG000|Overall Study|Disease Progression|2|||
125456046|NCT02001623|451298634|FG001|Overall Study|Disease Progression|2|||
125456047|NCT02001623|451298635|FG002|Overall Study|Disease Progression|3|||
125456048|NCT02001623|451298636|FG003|Overall Study|Disease Progression|2|||
125456049|NCT02001623|451298637|FG004|Overall Study|Disease Progression|3|||
125456050|NCT02001623|451298638|FG005|Overall Study|Disease Progression|2|||
125456051|NCT02001623|451298639|FG006|Overall Study|Disease Progression|3|||
125456052|NCT02001623|451298640|FG007|Overall Study|Disease Progression|3|||
125456053|NCT02001623|451298641|FG008|Overall Study|Disease Progression|7|||
125456054|NCT02001623|451298642|FG009|Overall Study|Disease Progression|40|||
125456055|NCT02001623|451298643|FG010|Overall Study|Disease Progression|5|||
125456056|NCT02001623|451298644|FG011|Overall Study|Disease Progression|9|||
125456057|NCT02001623|451298645|FG012|Overall Study|Disease Progression|9|||
125456058|NCT02001623|451298646|FG013|Overall Study|Disease Progression|20|||
125456059|NCT02001623|451298647|FG014|Overall Study|Disease Progression|9|||
125456060|NCT02001623|451298633|FG000|Overall Study|Physician Decision|0|||
125456061|NCT02001623|451298634|FG001|Overall Study|Physician Decision|0|||
125456062|NCT02001623|451298635|FG002|Overall Study|Physician Decision|0|||
125456063|NCT02001623|451298636|FG003|Overall Study|Physician Decision|0|||
125456064|NCT02001623|451298637|FG004|Overall Study|Physician Decision|0|||
125456065|NCT02001623|451298638|FG005|Overall Study|Physician Decision|0|||
125456066|NCT02001623|451298639|FG006|Overall Study|Physician Decision|0|||
125456067|NCT02001623|451298640|FG007|Overall Study|Physician Decision|0|||
125456068|NCT02001623|451298641|FG008|Overall Study|Physician Decision|3|||
125456069|NCT02001623|451298642|FG009|Overall Study|Physician Decision|2|||
125456070|NCT02001623|451298643|FG010|Overall Study|Physician Decision|3|||
125456071|NCT02001623|451298644|FG011|Overall Study|Physician Decision|3|||
125456072|NCT02001623|451298645|FG012|Overall Study|Physician Decision|1|||
125456073|NCT02001623|451298646|FG013|Overall Study|Physician Decision|2|||
125456074|NCT02001623|451298647|FG014|Overall Study|Physician Decision|1|||
125456075|NCT02001623|451298633|FG000|Overall Study|Death|0|||
125456076|NCT02001623|451298634|FG001|Overall Study|Death|1|||
125456077|NCT02001623|451298635|FG002|Overall Study|Death|0|||
125456078|NCT02001623|451298636|FG003|Overall Study|Death|0|||
125456079|NCT02001623|451298637|FG004|Overall Study|Death|0|||
125456080|NCT02001623|451298638|FG005|Overall Study|Death|0|||
125456081|NCT02001623|451298639|FG006|Overall Study|Death|0|||
125456082|NCT02001623|451298640|FG007|Overall Study|Death|0|||
125456083|NCT02001623|451298641|FG008|Overall Study|Death|0|||
125456084|NCT02001623|451298642|FG009|Overall Study|Death|0|||
125456085|NCT02001623|451298643|FG010|Overall Study|Death|0|||
125456086|NCT02001623|451298644|FG011|Overall Study|Death|0|||
125456087|NCT02001623|451298645|FG012|Overall Study|Death|0|||
125456088|NCT02001623|451298646|FG013|Overall Study|Death|0|||
125456089|NCT02001623|451298647|FG014|Overall Study|Death|0|||
125456090|NCT02001623|451298633|FG000|Overall Study|Adverse Event|0|||
125456091|NCT02001623|451298634|FG001|Overall Study|Adverse Event|0|||
125456092|NCT02001623|451298635|FG002|Overall Study|Adverse Event|0|||
125456093|NCT02001623|451298636|FG003|Overall Study|Adverse Event|0|||
125456094|NCT02001623|451298637|FG004|Overall Study|Adverse Event|0|||
125456095|NCT02001623|451298638|FG005|Overall Study|Adverse Event|1|||
125456096|NCT02001623|451298639|FG006|Overall Study|Adverse Event|0|||
125456097|NCT02001623|451298640|FG007|Overall Study|Adverse Event|3|||
125456098|NCT02001623|451298641|FG008|Overall Study|Adverse Event|4|||
125456099|NCT02001623|451298642|FG009|Overall Study|Adverse Event|6|||
125456100|NCT02001623|451298643|FG010|Overall Study|Adverse Event|4|||
125456101|NCT02001623|451298644|FG011|Overall Study|Adverse Event|0|||
125456102|NCT02001623|451298645|FG012|Overall Study|Adverse Event|3|||
125456103|NCT02001623|451298646|FG013|Overall Study|Adverse Event|5|||
125456104|NCT02001623|451298647|FG014|Overall Study|Adverse Event|6|||
125456105|NCT02001623|451298633|FG000|Overall Study|Other - Miscellaneous|0|||
125456106|NCT02001623|451298634|FG001|Overall Study|Other - Miscellaneous|0|||
125456107|NCT02001623|451298635|FG002|Overall Study|Other - Miscellaneous|0|||
125456108|NCT02001623|451298636|FG003|Overall Study|Other - Miscellaneous|0|||
125456109|NCT02001623|451298637|FG004|Overall Study|Other - Miscellaneous|0|||
125456110|NCT02001623|451298638|FG005|Overall Study|Other - Miscellaneous|0|||
125456111|NCT02001623|451298639|FG006|Overall Study|Other - Miscellaneous|0|||
125456112|NCT02001623|451298640|FG007|Overall Study|Other - Miscellaneous|0|||
125456113|NCT02001623|451298641|FG008|Overall Study|Other - Miscellaneous|0|||
125456114|NCT02001623|451298642|FG009|Overall Study|Other - Miscellaneous|1|||
125456115|NCT02001623|451298643|FG010|Overall Study|Other - Miscellaneous|0|||
125456116|NCT02001623|451298644|FG011|Overall Study|Other - Miscellaneous|0|||
125456117|NCT02001623|451298645|FG012|Overall Study|Other - Miscellaneous|0|||
125456118|NCT02001623|451298646|FG013|Overall Study|Other - Miscellaneous|1|||
125456119|NCT02001623|451298647|FG014|Overall Study|Other - Miscellaneous|0|||
125456120|NCT02001623|451298633|FG000|Overall Study|Withdrawal by Subject|1|||
125456121|NCT02001623|451298634|FG001|Overall Study|Withdrawal by Subject|0|||
125456122|NCT02001623|451298635|FG002|Overall Study|Withdrawal by Subject|0|||
125456123|NCT02001623|451298636|FG003|Overall Study|Withdrawal by Subject|0|||
125456124|NCT02001623|451298637|FG004|Overall Study|Withdrawal by Subject|0|||
125456125|NCT02001623|451298638|FG005|Overall Study|Withdrawal by Subject|0|||
125456126|NCT02001623|451298639|FG006|Overall Study|Withdrawal by Subject|0|||
125456127|NCT02001623|451298640|FG007|Overall Study|Withdrawal by Subject|0|||
125456128|NCT02001623|451298641|FG008|Overall Study|Withdrawal by Subject|1|||
125456129|NCT02001623|451298642|FG009|Overall Study|Withdrawal by Subject|3|||
125456130|NCT02001623|451298643|FG010|Overall Study|Withdrawal by Subject|2|||
125456131|NCT02001623|451298644|FG011|Overall Study|Withdrawal by Subject|2|||
125456132|NCT02001623|451298645|FG012|Overall Study|Withdrawal by Subject|1|||
125456133|NCT02001623|451298646|FG013|Overall Study|Withdrawal by Subject|5|||
125456134|NCT02001623|451298647|FG014|Overall Study|Withdrawal by Subject|2|||
125456135|NCT02001623|451298633|FG000|Overall Study|Lost to Follow-up|0|||
125456136|NCT02001623|451298634|FG001|Overall Study|Lost to Follow-up|0|||
125456137|NCT02001623|451298635|FG002|Overall Study|Lost to Follow-up|0|||
125456138|NCT02001623|451298636|FG003|Overall Study|Lost to Follow-up|0|||
125456139|NCT02001623|451298637|FG004|Overall Study|Lost to Follow-up|0|||
125456140|NCT02001623|451298638|FG005|Overall Study|Lost to Follow-up|0|||
125456141|NCT02001623|451298639|FG006|Overall Study|Lost to Follow-up|0|||
125456142|NCT02001623|451298640|FG007|Overall Study|Lost to Follow-up|0|||
125456143|NCT02001623|451298641|FG008|Overall Study|Lost to Follow-up|0|||
125456144|NCT02001623|451298642|FG009|Overall Study|Lost to Follow-up|1|||
125456145|NCT02001623|451298643|FG010|Overall Study|Lost to Follow-up|0|||
125456146|NCT02001623|451298644|FG011|Overall Study|Lost to Follow-up|0|||
125456147|NCT02001623|451298645|FG012|Overall Study|Lost to Follow-up|0|||
125456148|NCT02001623|451298646|FG013|Overall Study|Lost to Follow-up|0|||
125456149|NCT02001623|451298647|FG014|Overall Study|Lost to Follow-up|0|||
125456150|NCT02001623|451298633|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
125456151|NCT02001623|451298634|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
125456152|NCT02001623|451298635|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
125456153|NCT02001623|451298636|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
125456154|NCT02001623|451298637|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
125456155|NCT02001623|451298638|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
125456156|NCT02001623|451298639|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
125456157|NCT02001623|451298640|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
125456158|NCT02001623|451298641|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
125456159|NCT02001623|451298642|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
125456160|NCT02001623|451298643|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
125456161|NCT02001623|451298644|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
125456162|NCT02001623|451298645|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
125456163|NCT02001623|451298646|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
125456164|NCT02001623|451298647|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
125456165|NCT02001623|451298633|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
125456166|NCT02001623|451298634|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
125456167|NCT02001623|451298635|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
125456168|NCT02001623|451298636|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
125456169|NCT02001623|451298637|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
125456170|NCT02001623|451298638|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
125456171|NCT02001623|451298639|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
125456172|NCT02001623|451298640|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
125456173|NCT02001623|451298641|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
125456174|NCT02001623|451298642|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
125456175|NCT02001623|451298643|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
125456176|NCT02001623|451298644|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
125456177|NCT02001623|451298645|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
125294151|NCT03262116|450705224|FG004|Overall Study|Physician Decision|1|||
125294152|NCT03262116|450705225|FG005|Overall Study|Physician Decision|2|||
125294153|NCT02365285|450705226|FG000|Overall Study|Physician Decision|0|||
125294154|NCT02365285|450705227|FG001|Overall Study|Physician Decision|1|||
125294155|NCT02365285|450705228|FG002|Overall Study|Physician Decision|1|||
125294156|NCT02365285|450705229|FG003|Overall Study|Physician Decision|0|||
125294157|NCT02365285|450705226|FG000|Overall Study|Adverse Event|0|||
125294158|NCT02365285|450705227|FG001|Overall Study|Adverse Event|0|||
125294159|NCT02365285|450705228|FG002|Overall Study|Adverse Event|0|||
125294160|NCT02365285|450705229|FG003|Overall Study|Adverse Event|2|||
125294161|NCT02636946|450705232|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
125294162|NCT02636946|450705233|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
125294163|NCT02636946|450705232|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
125294164|NCT02636946|450705233|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
125294165|NCT02636946|450705232|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
125294166|NCT02636946|450705233|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
125294167|NCT02636946|450705232|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
125294168|NCT02636946|450705233|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
125294169|NCT02636946|450705232|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
125456178|NCT02001623|451298646|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
125456179|NCT02001623|451298647|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
125456180|NCT00309452|451298648|FG000|Overall Study|Withdrawal by Subject|3|||
125456181|NCT00309452|451298649|FG001|Overall Study|Withdrawal by Subject|0|||
125456182|NCT00686517|451298650|FG000|Treatment|Serious Adverse Event|1|||
125294170|NCT02636946|450705233|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
125294171|NCT02636946|450705232|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
125294172|NCT02636946|450705233|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
125456183|NCT00686517|451298651|FG001|Treatment|Serious Adverse Event|2|||
125456184|NCT00686517|451298652|FG002|Treatment|Serious Adverse Event|1|||
125456185|NCT00686517|451298650|FG000|Treatment|Adverse Event|2|||
125456186|NCT00686517|451298651|FG001|Treatment|Adverse Event|0|||
125294173|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
125456187|NCT00686517|451298652|FG002|Treatment|Adverse Event|0|||
125456188|NCT00686517|451298650|FG000|Treatment|Poor Protocol Compliance|1|||
125456189|NCT00686517|451298651|FG001|Treatment|Poor Protocol Compliance|0|||
125294174|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
125294175|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
125294176|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
125294177|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
125294178|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
125294179|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
125294180|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
125294181|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
125294182|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
125294183|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
125294184|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
125294185|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
125294186|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
125294187|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
125294188|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
125294189|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
125294190|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
125294191|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
125294192|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
125294193|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
125294194|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
125294195|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
125294196|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
125294197|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
125294198|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
125294199|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
125294200|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
125294201|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
125294202|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
125294203|NCT00121641|450705236|FG000|24-week Short-term Treatment Period|Other Reason|1|||
125294204|NCT00121641|450705237|FG001|24-week Short-term Treatment Period|Other Reason|0|||
125294205|NCT00121641|450705238|FG002|24-week Short-term Treatment Period|Other Reason|0|||
125294206|NCT00121641|450705239|FG003|24-week Short-term Treatment Period|Other Reason|0|||
125294207|NCT00121641|450705240|FG004|24-week Short-term Treatment Period|Other Reason|0|||
125294208|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
125294209|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
125294210|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
125294211|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
125294212|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
125294213|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
125294214|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
125294215|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
125294216|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
125294217|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
125294218|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
125294219|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
125294220|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
125294221|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
125294222|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
125294223|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
125294224|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
125294225|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
125294226|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
125294227|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
125294228|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
125294229|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
125294230|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
125294231|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
125294232|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
125294233|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
125485352|NCT02240238|451412514|FG011|Phase 1|Adverse Event|0|||
125294234|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
125294235|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
125303176|NCT03100058|450736673|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
125294236|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
125294237|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
125294238|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
125294239|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
125294240|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
125294241|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
125294242|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
125294243|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
125294244|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
125294245|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
125294246|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
125294247|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
125294248|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Death|0|||
125294249|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Death|0|||
125294250|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Death|0|||
125294251|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Death|1|||
125294252|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Death|0|||
125294253|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Missing|0|||
125294254|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Missing|0|||
125294255|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Missing|1|||
125294256|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Missing|0|||
125294257|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Missing|0|||
125294258|NCT00121641|450705236|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
125294259|NCT00121641|450705237|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
125294260|NCT00121641|450705238|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
125294261|NCT00121641|450705239|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
125294262|NCT00121641|450705240|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
125294263|NCT01792518|450705241|FG000|Overall Study|Adverse Event|3|||
125294264|NCT01792518|450705242|FG001|Overall Study|Adverse Event|4|||
125294265|NCT01792518|450705241|FG000|Overall Study|Protocol Violation|0|||
125294266|NCT01792518|450705242|FG001|Overall Study|Protocol Violation|1|||
125294267|NCT01792518|450705241|FG000|Overall Study|Lost to Follow-up|3|||
125294268|NCT01792518|450705242|FG001|Overall Study|Lost to Follow-up|1|||
125294269|NCT01792518|450705241|FG000|Overall Study|Withdrawal by Subject|2|||
125294270|NCT01792518|450705242|FG001|Overall Study|Withdrawal by Subject|0|||
125294271|NCT01792518|450705241|FG000|Overall Study|Other Reason|0|||
125294272|NCT01792518|450705242|FG001|Overall Study|Other Reason|1|||
125294273|NCT00249613|450705246|FG000|12 Month Follow-up|Death|1|||
125294274|NCT00249613|450705247|FG001|12 Month Follow-up|Death|1|||
125294275|NCT00249613|450705246|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
125294276|NCT00249613|450705247|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
125294277|NCT00249613|450705246|FG000|12 Month Follow-up|Lost to Follow-up|10|||
125294278|NCT00249613|450705247|FG001|12 Month Follow-up|Lost to Follow-up|8|||
125294279|NCT00806442|450705257|FG000|Overall Study|Lost to Follow-up|3|||
125294280|NCT00806442|450705258|FG001|Overall Study|Lost to Follow-up|2|||
125294281|NCT00806442|450705257|FG000|Overall Study|Withdrawal by Subject|1|||
125294282|NCT00806442|450705258|FG001|Overall Study|Withdrawal by Subject|5|||
125294283|NCT00654004|450705266|FG000|Overall Study|Lost to Follow-up|1|||
125294284|NCT00654004|450705267|FG001|Overall Study|Lost to Follow-up|0|||
125294285|NCT01264770|450705268|FG000|Overall Study|Not reported|0|||
125294286|NCT01264770|450705269|FG001|Overall Study|Not reported|0|||
125294287|NCT01264770|450705270|FG002|Overall Study|Not reported|1|||
125294288|NCT01264770|450705271|FG003|Overall Study|Not reported|0|||
125294289|NCT01264770|450705272|FG004|Overall Study|Not reported|0|||
125294290|NCT01264770|450705273|FG005|Overall Study|Not reported|0|||
125294291|NCT01264770|450705268|FG000|Overall Study|e.g., change in circumstances|8|||
125294292|NCT01264770|450705269|FG001|Overall Study|e.g., change in circumstances|3|||
125294293|NCT01264770|450705270|FG002|Overall Study|e.g., change in circumstances|3|||
125294294|NCT01264770|450705271|FG003|Overall Study|e.g., change in circumstances|3|||
125294295|NCT01264770|450705272|FG004|Overall Study|e.g., change in circumstances|4|||
125294296|NCT01264770|450705273|FG005|Overall Study|e.g., change in circumstances|4|||
125294297|NCT01264770|450705268|FG000|Overall Study|Severe non-compliance to protocol|0|||
125294298|NCT01264770|450705269|FG001|Overall Study|Severe non-compliance to protocol|0|||
125294299|NCT01264770|450705270|FG002|Overall Study|Severe non-compliance to protocol|1|||
125294300|NCT01264770|450705271|FG003|Overall Study|Severe non-compliance to protocol|1|||
125294301|NCT01264770|450705272|FG004|Overall Study|Severe non-compliance to protocol|0|||
125294302|NCT01264770|450705273|FG005|Overall Study|Severe non-compliance to protocol|0|||
125294303|NCT01264770|450705268|FG000|Overall Study|Lack of therapeutic response|1|||
125294304|NCT01264770|450705269|FG001|Overall Study|Lack of therapeutic response|0|||
125294305|NCT01264770|450705270|FG002|Overall Study|Lack of therapeutic response|2|||
125294306|NCT01264770|450705271|FG003|Overall Study|Lack of therapeutic response|1|||
125420127|NCT05608629|451162275|FG000|Overall Study|Lost to Follow-up|2|||
125294307|NCT01264770|450705272|FG004|Overall Study|Lack of therapeutic response|1|||
125294308|NCT01264770|450705273|FG005|Overall Study|Lack of therapeutic response|0|||
125294309|NCT01264770|450705268|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
125294310|NCT01264770|450705269|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
125294311|NCT01264770|450705270|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
125294312|NCT01264770|450705271|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
125294313|NCT01264770|450705272|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
125294314|NCT01264770|450705273|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
125294315|NCT01264770|450705268|FG000|Overall Study|Lost to Follow-up|0|||
125294316|NCT01264770|450705269|FG001|Overall Study|Lost to Follow-up|0|||
125294317|NCT01264770|450705270|FG002|Overall Study|Lost to Follow-up|1|||
125294318|NCT01264770|450705271|FG003|Overall Study|Lost to Follow-up|1|||
125294319|NCT01264770|450705272|FG004|Overall Study|Lost to Follow-up|0|||
125294320|NCT01264770|450705273|FG005|Overall Study|Lost to Follow-up|0|||
125294321|NCT01264770|450705268|FG000|Overall Study|Adverse Event|7|||
125294322|NCT01264770|450705269|FG001|Overall Study|Adverse Event|7|||
125294323|NCT01264770|450705270|FG002|Overall Study|Adverse Event|8|||
125294324|NCT01264770|450705271|FG003|Overall Study|Adverse Event|0|||
125294325|NCT01264770|450705272|FG004|Overall Study|Adverse Event|2|||
125294326|NCT01264770|450705273|FG005|Overall Study|Adverse Event|1|||
125294327|NCT00424190|450705275|FG000|Overall Study|Withdrew consent|3|||
125294328|NCT00424190|450705276|FG001|Overall Study|Withdrew consent|4|||
125294329|NCT00424190|450705275|FG000|Overall Study|Death|3|||
125294330|NCT00424190|450705276|FG001|Overall Study|Death|0|||
125294331|NCT00424190|450705275|FG000|Overall Study|Noncompliance|1|||
125294332|NCT00424190|450705276|FG001|Overall Study|Noncompliance|2|||
125294333|NCT00424190|450705275|FG000|Overall Study|Request of sponsor or investigator|0|||
125294334|NCT00424190|450705276|FG001|Overall Study|Request of sponsor or investigator|2|||
125294335|NCT00424190|450705275|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
125294336|NCT00424190|450705276|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
125294337|NCT00424190|450705275|FG000|Overall Study|Other|15|||
125294338|NCT00424190|450705276|FG001|Overall Study|Other|21|||
125294339|NCT00351273|450705277|FG000|Overall Study|Lost to Follow-up|1|||
125294340|NCT00351273|450705278|FG001|Overall Study|Lost to Follow-up|2|||
125294341|NCT00351273|450705279|FG002|Overall Study|Lost to Follow-up|5|||
125294342|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
125294343|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
125294344|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
125294345|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
125294346|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
125294347|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
125294348|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
125294349|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
125294350|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
125294351|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
125294352|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
125294353|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
125294354|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
125294355|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
125294356|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
125294357|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
125294358|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
125294359|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
125294360|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
125294361|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
125294362|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
125294363|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
125294364|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
125294365|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
125294366|NCT01672866|450705280|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
125294367|NCT01672866|450705281|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
125456190|NCT00686517|451298652|FG002|Treatment|Poor Protocol Compliance|0|||
125456191|NCT00686517|451298650|FG000|Treatment|Protocol Violation|2|||
125456192|NCT00686517|451298651|FG001|Treatment|Protocol Violation|1|||
125456193|NCT00686517|451298652|FG002|Treatment|Protocol Violation|0|||
125456194|NCT01233050|451298653|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
125456195|NCT01233050|451298654|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
125456196|NCT02281318|451298656|FG000|Overall Study|Adverse Event|2|||
125456197|NCT02281318|451298657|FG001|Overall Study|Adverse Event|2|||
125294368|NCT01672866|450705282|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
125456198|NCT02281318|451298656|FG000|Overall Study|Lack of Efficacy|2|||
125456199|NCT02281318|451298657|FG001|Overall Study|Lack of Efficacy|0|||
125456200|NCT02281318|451298656|FG000|Overall Study|Lost to Follow-up|2|||
125294369|NCT01672866|450705280|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
125294370|NCT01672866|450705281|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
125294371|NCT01672866|450705282|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
125294372|NCT01672866|450705280|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
125294373|NCT01672866|450705281|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
125294374|NCT01672866|450705282|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
125294375|NCT01672866|450705280|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
125294376|NCT01672866|450705281|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
125294377|NCT01672866|450705282|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
125294378|NCT01672866|450705280|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
125294379|NCT01672866|450705281|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
125294380|NCT01672866|450705282|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
125294381|NCT02241187|450705283|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
125294382|NCT00160654|450705286|FG000|Overall Study|Adverse Event|14|||
125294383|NCT00160654|450705286|FG000|Overall Study|Lack of Efficacy|4|||
125294384|NCT00160654|450705286|FG000|Overall Study|Lost to Follow-up|2|||
125294385|NCT00160654|450705286|FG000|Overall Study|Intake of expired drug|7|||
125294386|NCT00160654|450705286|FG000|Overall Study|Psychological trauma|1|||
125294387|NCT00160654|450705286|FG000|Overall Study|Sponsor decision|1|||
125294388|NCT00160654|450705286|FG000|Overall Study|Patient met exclusion criteria|1|||
125294389|NCT00160654|450705286|FG000|Overall Study|Patient decision|1|||
125294390|NCT00160654|450705286|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
125294391|NCT00160654|450705286|FG000|Overall Study|Met exclusion criteria|1|||
125294392|NCT02383433|450705289|FG000|Overall Study|Disease progression|2|||
125294393|NCT02535416|450705290|FG000|Overall Study|Family bereavement overseas|1|||
125294394|NCT02535416|450705291|FG001|Overall Study|Family bereavement overseas|0|||
125294395|NCT02535416|450705292|FG002|Overall Study|Family bereavement overseas|0|||
125294396|NCT02535416|450705293|FG003|Overall Study|Family bereavement overseas|0|||
125294397|NCT02535416|450705294|FG004|Overall Study|Family bereavement overseas|0|||
125294398|NCT02535416|450705295|FG005|Overall Study|Family bereavement overseas|0|||
125294399|NCT02535416|450705296|FG006|Overall Study|Family bereavement overseas|0|||
125294400|NCT02535416|450705297|FG007|Overall Study|Family bereavement overseas|0|||
125294401|NCT02535416|450705298|FG008|Overall Study|Family bereavement overseas|0|||
125294402|NCT02831933|450706477|FG000|Overall Study|Physician Decision|11|||
125294403|NCT04544683|450706479|FG000|Overall Study|Lost to Follow-up|2|||
125294404|NCT04544683|450706479|FG000|Overall Study|Underwent cervical spine surgery|6|||
125294405|NCT01073930|450706480|FG000|Overall Study|Withdrawal by Subject|3|||
125294406|NCT01073930|450706481|FG001|Overall Study|Withdrawal by Subject|2|||
125294407|NCT01073930|450706480|FG000|Overall Study|Lost to Follow-up|0|||
125294408|NCT01073930|450706481|FG001|Overall Study|Lost to Follow-up|1|||
125294409|NCT01073930|450706480|FG000|Overall Study|Adverse Event|0|||
125294410|NCT01073930|450706481|FG001|Overall Study|Adverse Event|1|||
125294411|NCT01073930|450706480|FG000|Overall Study|Noncompliance with study drug|0|||
125294412|NCT01073930|450706481|FG001|Overall Study|Noncompliance with study drug|1|||
125294413|NCT01073930|450706480|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
125294414|NCT01073930|450706481|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
125294415|NCT02081599|450706482|FG000|Period 1：Double-blind Period|Adverse Event|3|||
125294416|NCT02081599|450706483|FG001|Period 1：Double-blind Period|Adverse Event|0|||
125294417|NCT02081599|450706482|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
125294418|NCT02081599|450706483|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
125294419|NCT02081599|450706482|FG000|Period 1：Double-blind Period|Physician Decision|1|||
125294420|NCT02081599|450706483|FG001|Period 1：Double-blind Period|Physician Decision|0|||
125294421|NCT02081599|450706482|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
125294422|NCT02081599|450706483|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
125456201|NCT02281318|451298657|FG001|Overall Study|Lost to Follow-up|1|||
125456202|NCT02281318|451298656|FG000|Overall Study|Physician Decision|2|||
125456203|NCT02281318|451298657|FG001|Overall Study|Physician Decision|0|||
125456204|NCT02281318|451298656|FG000|Overall Study|Withdrawal by Subject|6|||
125456205|NCT02281318|451298657|FG001|Overall Study|Withdrawal by Subject|2|||
125456206|NCT01064817|451298660|FG000|Study Completion|Physician Decision|1|||
125456207|NCT01064817|451298661|FG001|Study Completion|Physician Decision|0|||
125456208|NCT01064817|451298660|FG000|Study Completion|Withdrawal by Subject|1|||
125456209|NCT01064817|451298661|FG001|Study Completion|Withdrawal by Subject|0|||
125294423|NCT02081599|450706482|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
125294424|NCT02081599|450706483|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
125294425|NCT02081599|450706482|FG000|Period 1：Double-blind Period|stopping criteria|1|||
125294426|NCT02081599|450706483|FG001|Period 1：Double-blind Period|stopping criteria|0|||
125294427|NCT02081599|450706482|FG000|Period 2：Open-label Period|Adverse Event|1|||
125456210|NCT01368406|451298663|FG000|Overall Study|Lost to Follow-up|8|||
125456211|NCT01368406|451298664|FG001|Overall Study|Lost to Follow-up|4|||
125456212|NCT01368406|451298663|FG000|Overall Study|Withdrawal by Subject|8|||
125294428|NCT02081599|450706483|FG001|Period 2：Open-label Period|Adverse Event|0|||
125294429|NCT02081599|450706482|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
125456213|NCT01368406|451298664|FG001|Overall Study|Withdrawal by Subject|4|||
125456214|NCT01368406|451298663|FG000|Overall Study|relapse of the disease|3|||
125456215|NCT01368406|451298664|FG001|Overall Study|relapse of the disease|2|||
125456216|NCT01368406|451298663|FG000|Overall Study|started working|2|||
125456217|NCT01368406|451298664|FG001|Overall Study|started working|3|||
125456218|NCT03670602|451298665|FG000|Overall Study|Lost to Follow-up|1|||
125456219|NCT03670602|451298666|FG001|Overall Study|Lost to Follow-up|0|||
125456220|NCT03670602|451298665|FG000|Overall Study|Withdrawal by Subject|0|||
125456221|NCT03670602|451298666|FG001|Overall Study|Withdrawal by Subject|3|||
125456222|NCT01456936|451298667|FG000|Overall Study|Other reason|41|||
125456223|NCT01456936|451298668|FG001|Overall Study|Other reason|30|||
125456224|NCT01456936|451298669|FG002|Overall Study|Other reason|36|||
125456225|NCT01456936|451298670|FG003|Overall Study|Other reason|33|||
125456226|NCT01456936|451298667|FG000|Overall Study|No longer meets eligibility criteria|4|||
125456227|NCT01456936|451298668|FG001|Overall Study|No longer meets eligibility criteria|8|||
125456228|NCT01456936|451298669|FG002|Overall Study|No longer meets eligibility criteria|6|||
125456229|NCT01456936|451298670|FG003|Overall Study|No longer meets eligibility criteria|5|||
125456230|NCT01456936|451298667|FG000|Overall Study|Protocol Violation|4|||
125456231|NCT01456936|451298668|FG001|Overall Study|Protocol Violation|2|||
125456232|NCT01456936|451298669|FG002|Overall Study|Protocol Violation|5|||
125456233|NCT01456936|451298670|FG003|Overall Study|Protocol Violation|5|||
125456234|NCT01456936|451298667|FG000|Overall Study|Pregnancy|1|||
125456235|NCT01456936|451298668|FG001|Overall Study|Pregnancy|0|||
125456236|NCT01456936|451298669|FG002|Overall Study|Pregnancy|0|||
125456237|NCT01456936|451298670|FG003|Overall Study|Pregnancy|1|||
125456238|NCT01456936|451298667|FG000|Overall Study|Insufficient clinical response|4|||
125456239|NCT01456936|451298668|FG001|Overall Study|Insufficient clinical response|4|||
125456240|NCT01456936|451298669|FG002|Overall Study|Insufficient clinical response|14|||
125456241|NCT01456936|451298670|FG003|Overall Study|Insufficient clinical response|13|||
125294430|NCT02081599|450706483|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
125456242|NCT01456936|451298667|FG000|Overall Study|No longer willing to participate|195|||
125456243|NCT01456936|451298668|FG001|Overall Study|No longer willing to participate|218|||
125294431|NCT02081599|450706482|FG000|Period 2：Open-label Period|Physician Decision|1|||
125294432|NCT02081599|450706483|FG001|Period 2：Open-label Period|Physician Decision|0|||
125294433|NCT02081599|450706482|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
125294434|NCT02081599|450706483|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
125456244|NCT01456936|451298669|FG002|Overall Study|No longer willing to participate|224|||
125456245|NCT01456936|451298670|FG003|Overall Study|No longer willing to participate|248|||
125456246|NCT01456936|451298667|FG000|Overall Study|Lost to Follow-up|135|||
125456247|NCT01456936|451298668|FG001|Overall Study|Lost to Follow-up|126|||
125456248|NCT01456936|451298669|FG002|Overall Study|Lost to Follow-up|144|||
125456249|NCT01456936|451298670|FG003|Overall Study|Lost to Follow-up|127|||
125456250|NCT01456936|451298667|FG000|Overall Study|Medication error|0|||
125456251|NCT01456936|451298668|FG001|Overall Study|Medication error|1|||
125456252|NCT01456936|451298669|FG002|Overall Study|Medication error|0|||
125456253|NCT01456936|451298670|FG003|Overall Study|Medication error|1|||
125456254|NCT01456936|451298667|FG000|Overall Study|Adverse event (study drug)|25|||
125294435|NCT01266590|450706484|FG000|Overall Study|Adverse Event|3|||
125294436|NCT01266590|450706484|FG000|Overall Study|Lost to Follow-up|1|||
125294437|NCT01266590|450706484|FG000|Overall Study|Withdrawal by Subject|1|||
125294438|NCT01266590|450706484|FG000|Overall Study|Physician Decision|1|||
125294439|NCT00720343|450706487|FG000|Overall Study|Lost to Follow-up|1|||
125294440|NCT00720343|450706488|FG001|Overall Study|Lost to Follow-up|0|||
125294441|NCT00720343|450706487|FG000|Overall Study|Protocol Violation|0|||
125294442|NCT00720343|450706488|FG001|Overall Study|Protocol Violation|2|||
125294443|NCT02008773|450706489|FG000|Overall Study|Adverse Event|3|||
125294444|NCT02008773|450706490|FG001|Overall Study|Adverse Event|3|||
125294445|NCT02008773|450706491|FG002|Overall Study|Adverse Event|1|||
125294446|NCT02008773|450706492|FG003|Overall Study|Adverse Event|2|||
125294447|NCT02008773|450706489|FG000|Overall Study|Medication Non-compliance|2|||
125294448|NCT02008773|450706490|FG001|Overall Study|Medication Non-compliance|1|||
125456255|NCT01456936|451298668|FG001|Overall Study|Adverse event (study drug)|21|||
125456256|NCT01456936|451298669|FG002|Overall Study|Adverse event (study drug)|26|||
125456257|NCT01456936|451298670|FG003|Overall Study|Adverse event (study drug)|17|||
125456258|NCT01456936|451298667|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
125456259|NCT01456936|451298668|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
125456260|NCT01456936|451298669|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
125456261|NCT01456936|451298670|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
125456262|NCT01456936|451298667|FG000|Overall Study|Death|0|||
125456263|NCT01456936|451298668|FG001|Overall Study|Death|3|||
125456264|NCT01456936|451298669|FG002|Overall Study|Death|1|||
125456265|NCT01456936|451298670|FG003|Overall Study|Death|3|||
125456266|NCT01456936|451298667|FG000|Overall Study|Randomized but not treated|21|||
125294449|NCT02008773|450706491|FG002|Overall Study|Medication Non-compliance|3|||
125294450|NCT02008773|450706492|FG003|Overall Study|Medication Non-compliance|2|||
125294451|NCT02008773|450706489|FG000|Overall Study|Withdrawal by Subject|8|||
125456267|NCT01456936|451298668|FG001|Overall Study|Randomized but not treated|28|||
125456268|NCT01456936|451298669|FG002|Overall Study|Randomized but not treated|16|||
125456269|NCT01456936|451298670|FG003|Overall Study|Randomized but not treated|21|||
125456270|NCT00543725|451298671|FG000|Overall Study|Adverse Event|18|||
125456271|NCT00543725|451298672|FG001|Overall Study|Adverse Event|27|||
125456272|NCT00543725|451298671|FG000|Overall Study|Sponsor's Decision|0|||
125456273|NCT00543725|451298672|FG001|Overall Study|Sponsor's Decision|1|||
125456274|NCT00543725|451298671|FG000|Overall Study|Subject Non-Compliant|4|||
125456275|NCT00543725|451298672|FG001|Overall Study|Subject Non-Compliant|4|||
125456276|NCT00543725|451298671|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
125456277|NCT00543725|451298672|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
125456278|NCT00543725|451298671|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
125456279|NCT00543725|451298672|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
125456280|NCT00543725|451298671|FG000|Overall Study|Protocol Violation|0|||
125456281|NCT00543725|451298672|FG001|Overall Study|Protocol Violation|1|||
125456282|NCT00543725|451298671|FG000|Overall Study|Withdrawal by Subject|4|||
125456283|NCT00543725|451298672|FG001|Overall Study|Withdrawal by Subject|13|||
125456284|NCT00543725|451298671|FG000|Overall Study|Lost to Follow-up|15|||
125456285|NCT00543725|451298672|FG001|Overall Study|Lost to Follow-up|11|||
125456286|NCT00543725|451298671|FG000|Overall Study|Other|3|||
125456287|NCT00543725|451298672|FG001|Overall Study|Other|3|||
125456288|NCT00906698|451298673|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
125456289|NCT00906698|451298674|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
125456290|NCT00906698|451298675|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
125456291|NCT00906698|451298676|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
125456292|NCT00906698|451298677|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
125456293|NCT00906698|451298678|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
125456294|NCT00906698|451298673|FG000|Overall Study|Adverse Event|0|||
125456295|NCT00906698|451298674|FG001|Overall Study|Adverse Event|0|||
125456296|NCT00906698|451298675|FG002|Overall Study|Adverse Event|2|||
125456297|NCT00906698|451298676|FG003|Overall Study|Adverse Event|0|||
125456298|NCT00906698|451298677|FG004|Overall Study|Adverse Event|4|||
125456299|NCT00906698|451298678|FG005|Overall Study|Adverse Event|1|||
125456300|NCT00906698|451298673|FG000|Overall Study|Disease progression|3|||
125456301|NCT00906698|451298674|FG001|Overall Study|Disease progression|12|||
125456302|NCT00906698|451298675|FG002|Overall Study|Disease progression|4|||
125456303|NCT00906698|451298676|FG003|Overall Study|Disease progression|4|||
125456304|NCT00906698|451298677|FG004|Overall Study|Disease progression|12|||
125456305|NCT00906698|451298678|FG005|Overall Study|Disease progression|4|||
125456306|NCT00906698|451298673|FG000|Overall Study|Withdrawal by Subject|0|||
125456307|NCT00906698|451298674|FG001|Overall Study|Withdrawal by Subject|0|||
125456308|NCT00906698|451298675|FG002|Overall Study|Withdrawal by Subject|0|||
125456309|NCT00906698|451298676|FG003|Overall Study|Withdrawal by Subject|0|||
125456310|NCT00906698|451298677|FG004|Overall Study|Withdrawal by Subject|1|||
125456311|NCT00906698|451298678|FG005|Overall Study|Withdrawal by Subject|0|||
125456312|NCT00906698|451298673|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
125456313|NCT00906698|451298674|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
125456314|NCT00906698|451298675|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
125456315|NCT00906698|451298676|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
125456316|NCT00906698|451298677|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
125456317|NCT00906698|451298678|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
125456318|NCT02846415|451298680|FG000|Overall Study|Lost to Follow-up|2|||
125456319|NCT02846415|451298681|FG001|Overall Study|Lost to Follow-up|0|||
125456320|NCT02846415|451298680|FG000|Overall Study|Withdrawal by Subject|1|||
125456321|NCT02846415|451298681|FG001|Overall Study|Withdrawal by Subject|1|||
125456322|NCT03383887|451298682|FG000|Overall Study|Lost to Follow-up|0|||
125456323|NCT03383887|451298683|FG001|Overall Study|Lost to Follow-up|1|||
125456324|NCT02322216|451298684|FG000|Overall Study|Adverse Event|1|||
125456325|NCT02322216|451298685|FG001|Overall Study|Adverse Event|0|||
125456326|NCT02322216|451298684|FG000|Overall Study|Withdrawal by Subject|1|||
125456327|NCT02322216|451298685|FG001|Overall Study|Withdrawal by Subject|4|||
125456328|NCT01191788|451298691|FG000|Overall Study|Lost to Follow-up|21|||
125456329|NCT01191788|451298692|FG001|Overall Study|Lost to Follow-up|22|||
125456330|NCT02596035|451298693|FG000|Overall Study|Disease Progression|64|||
125456331|NCT02596035|451298694|FG001|Overall Study|Disease Progression|32|||
125456332|NCT02596035|451298695|FG002|Overall Study|Disease Progression|1|||
125456333|NCT02596035|451298693|FG000|Overall Study|study drug toxicity|12|||
125456334|NCT02596035|451298694|FG001|Overall Study|study drug toxicity|3|||
125456335|NCT02596035|451298695|FG002|Overall Study|study drug toxicity|0|||
125456336|NCT02596035|451298693|FG000|Overall Study|AE unrelated to study drug|5|||
125456337|NCT02596035|451298694|FG001|Overall Study|AE unrelated to study drug|2|||
125456338|NCT02596035|451298695|FG002|Overall Study|AE unrelated to study drug|0|||
125456339|NCT02596035|451298693|FG000|Overall Study|participant request to discontinue study treatment|2|||
125456340|NCT02596035|451298694|FG001|Overall Study|participant request to discontinue study treatment|0|||
125456341|NCT02596035|451298695|FG002|Overall Study|participant request to discontinue study treatment|0|||
125456342|NCT02596035|451298693|FG000|Overall Study|participant withdrew consent|2|||
125456343|NCT02596035|451298694|FG001|Overall Study|participant withdrew consent|2|||
125456344|NCT02596035|451298695|FG002|Overall Study|participant withdrew consent|0|||
125456345|NCT02596035|451298693|FG000|Overall Study|Poor/Non Comlpiance|0|||
125456346|NCT02596035|451298694|FG001|Overall Study|Poor/Non Comlpiance|1|||
125456347|NCT02596035|451298695|FG002|Overall Study|Poor/Non Comlpiance|0|||
125456348|NCT02596035|451298693|FG000|Overall Study|participant no longer meets study criteria|1|||
125456349|NCT02596035|451298694|FG001|Overall Study|participant no longer meets study criteria|0|||
125456350|NCT02596035|451298695|FG002|Overall Study|participant no longer meets study criteria|0|||
125456351|NCT02596035|451298693|FG000|Overall Study|other reasons|11|||
125456352|NCT02596035|451298694|FG001|Overall Study|other reasons|4|||
125456353|NCT02596035|451298695|FG002|Overall Study|other reasons|0|||
125456354|NCT01235949|451298696|FG000|Primary Phase|Migrated/moved from study area|1|||
125456355|NCT01235949|451298697|FG001|Primary Phase|Migrated/moved from study area|1|||
125456356|NCT01235949|451298698|FG002|Primary Phase|Migrated/moved from study area|0|||
125456357|NCT01235949|451298699|FG003|Primary Phase|Migrated/moved from study area|0|||
125456358|NCT01235949|451298700|FG004|Primary Phase|Migrated/moved from study area|1|||
125456359|NCT01235949|451298701|FG005|Primary Phase|Migrated/moved from study area|2|||
125456360|NCT01235949|451298702|FG006|Primary Phase|Migrated/moved from study area|0|||
125456361|NCT01235949|451298703|FG007|Primary Phase|Migrated/moved from study area|0|||
125456362|NCT01235949|451298704|FG008|Primary Phase|Migrated/moved from study area|0|||
125456363|NCT01235949|451298705|FG009|Primary Phase|Migrated/moved from study area|0|||
125456364|NCT01235949|451298706|FG010|Primary Phase|Migrated/moved from study area|0|||
125456365|NCT01235949|451298707|FG011|Primary Phase|Migrated/moved from study area|0|||
125456366|NCT01235949|451298708|FG012|Primary Phase|Migrated/moved from study area|0|||
125456367|NCT01235949|451298709|FG013|Primary Phase|Migrated/moved from study area|0|||
125456368|NCT01235949|451298710|FG014|Primary Phase|Migrated/moved from study area|0|||
125456369|NCT01235949|451298711|FG015|Primary Phase|Migrated/moved from study area|0|||
125456370|NCT01235949|451298712|FG016|Primary Phase|Migrated/moved from study area|0|||
125456371|NCT01235949|451298713|FG017|Primary Phase|Migrated/moved from study area|0|||
125456372|NCT01235949|451298696|FG000|Primary Phase|Adverse Event|0|||
125456373|NCT01235949|451298697|FG001|Primary Phase|Adverse Event|0|||
125294452|NCT02008773|450706490|FG001|Overall Study|Withdrawal by Subject|4|||
125294453|NCT02008773|450706491|FG002|Overall Study|Withdrawal by Subject|7|||
125294454|NCT02008773|450706492|FG003|Overall Study|Withdrawal by Subject|6|||
125294455|NCT02008773|450706489|FG000|Overall Study|Lost to Follow-up|0|||
125294456|NCT02008773|450706490|FG001|Overall Study|Lost to Follow-up|1|||
125294457|NCT02008773|450706491|FG002|Overall Study|Lost to Follow-up|3|||
125294458|NCT02008773|450706492|FG003|Overall Study|Lost to Follow-up|2|||
125294459|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
125294460|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
125294461|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
125294462|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
125294463|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
125294464|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
125294465|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
125294466|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
125294467|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
125294468|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
125294469|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
125294470|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
125294471|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
125294472|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
125294473|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
125294474|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
125294475|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
125294476|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
125294477|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
125294478|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
125294479|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
125294480|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
125294481|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
125294482|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
125294483|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
125294484|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
125294485|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
125456374|NCT01235949|451298698|FG002|Primary Phase|Adverse Event|0|||
125456375|NCT01235949|451298699|FG003|Primary Phase|Adverse Event|1|||
125456376|NCT01235949|451298700|FG004|Primary Phase|Adverse Event|0|||
125456377|NCT01235949|451298701|FG005|Primary Phase|Adverse Event|0|||
125456378|NCT01235949|451298702|FG006|Primary Phase|Adverse Event|0|||
125456379|NCT01235949|451298703|FG007|Primary Phase|Adverse Event|0|||
125456380|NCT01235949|451298704|FG008|Primary Phase|Adverse Event|0|||
125456381|NCT01235949|451298705|FG009|Primary Phase|Adverse Event|0|||
125456382|NCT01235949|451298706|FG010|Primary Phase|Adverse Event|0|||
125456383|NCT01235949|451298707|FG011|Primary Phase|Adverse Event|0|||
125456384|NCT01235949|451298708|FG012|Primary Phase|Adverse Event|0|||
125456385|NCT01235949|451298709|FG013|Primary Phase|Adverse Event|0|||
125456386|NCT01235949|451298710|FG014|Primary Phase|Adverse Event|0|||
125456387|NCT01235949|451298711|FG015|Primary Phase|Adverse Event|0|||
125456388|NCT01235949|451298712|FG016|Primary Phase|Adverse Event|0|||
125456389|NCT01235949|451298713|FG017|Primary Phase|Adverse Event|0|||
125456390|NCT01235949|451298696|FG000|Primary Phase|Withdrawal by Subject|3|||
125456391|NCT01235949|451298697|FG001|Primary Phase|Withdrawal by Subject|2|||
125456392|NCT01235949|451298698|FG002|Primary Phase|Withdrawal by Subject|2|||
125456393|NCT01235949|451298699|FG003|Primary Phase|Withdrawal by Subject|0|||
125456394|NCT01235949|451298700|FG004|Primary Phase|Withdrawal by Subject|0|||
125456395|NCT01235949|451298701|FG005|Primary Phase|Withdrawal by Subject|3|||
125456396|NCT01235949|451298702|FG006|Primary Phase|Withdrawal by Subject|0|||
125456397|NCT01235949|451298703|FG007|Primary Phase|Withdrawal by Subject|0|||
125456398|NCT01235949|451298704|FG008|Primary Phase|Withdrawal by Subject|0|||
125456399|NCT01235949|451298705|FG009|Primary Phase|Withdrawal by Subject|0|||
125456400|NCT01235949|451298706|FG010|Primary Phase|Withdrawal by Subject|0|||
125294486|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
125294487|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
125294488|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
125294489|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
125294490|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
125294491|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
125294492|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
125294493|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
125294494|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
125456401|NCT01235949|451298707|FG011|Primary Phase|Withdrawal by Subject|0|||
125456402|NCT01235949|451298708|FG012|Primary Phase|Withdrawal by Subject|0|||
125456403|NCT01235949|451298709|FG013|Primary Phase|Withdrawal by Subject|0|||
125456404|NCT01235949|451298710|FG014|Primary Phase|Withdrawal by Subject|0|||
125456405|NCT01235949|451298711|FG015|Primary Phase|Withdrawal by Subject|0|||
125456406|NCT01235949|451298712|FG016|Primary Phase|Withdrawal by Subject|0|||
125456407|NCT01235949|451298713|FG017|Primary Phase|Withdrawal by Subject|0|||
125456408|NCT01235949|451298696|FG000|Primary Phase|Lost to Follow-up|0|||
125456409|NCT01235949|451298697|FG001|Primary Phase|Lost to Follow-up|0|||
125456410|NCT01235949|451298698|FG002|Primary Phase|Lost to Follow-up|1|||
125456411|NCT01235949|451298699|FG003|Primary Phase|Lost to Follow-up|1|||
125456412|NCT01235949|451298700|FG004|Primary Phase|Lost to Follow-up|0|||
125456413|NCT01235949|451298701|FG005|Primary Phase|Lost to Follow-up|2|||
125456414|NCT01235949|451298702|FG006|Primary Phase|Lost to Follow-up|0|||
125456415|NCT01235949|451298703|FG007|Primary Phase|Lost to Follow-up|0|||
125456416|NCT01235949|451298704|FG008|Primary Phase|Lost to Follow-up|0|||
125456417|NCT01235949|451298705|FG009|Primary Phase|Lost to Follow-up|0|||
125456418|NCT01235949|451298706|FG010|Primary Phase|Lost to Follow-up|0|||
125456419|NCT01235949|451298707|FG011|Primary Phase|Lost to Follow-up|0|||
125456420|NCT01235949|451298708|FG012|Primary Phase|Lost to Follow-up|0|||
125456421|NCT01235949|451298709|FG013|Primary Phase|Lost to Follow-up|0|||
125456422|NCT01235949|451298710|FG014|Primary Phase|Lost to Follow-up|0|||
125456423|NCT01235949|451298711|FG015|Primary Phase|Lost to Follow-up|0|||
125456424|NCT01235949|451298712|FG016|Primary Phase|Lost to Follow-up|0|||
125456425|NCT01235949|451298713|FG017|Primary Phase|Lost to Follow-up|0|||
125456426|NCT01235949|451298696|FG000|Booster Phase|Migrated/moved from study area|0|||
125456427|NCT01235949|451298697|FG001|Booster Phase|Migrated/moved from study area|0|||
125456428|NCT01235949|451298698|FG002|Booster Phase|Migrated/moved from study area|0|||
125294495|NCT02198794|450706493|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
125294496|NCT02198794|450706494|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
125456429|NCT01235949|451298699|FG003|Booster Phase|Migrated/moved from study area|0|||
125456430|NCT01235949|451298700|FG004|Booster Phase|Migrated/moved from study area|0|||
125456431|NCT01235949|451298701|FG005|Booster Phase|Migrated/moved from study area|0|||
125456432|NCT01235949|451298702|FG006|Booster Phase|Migrated/moved from study area|0|||
125456433|NCT01235949|451298703|FG007|Booster Phase|Migrated/moved from study area|0|||
125456434|NCT01235949|451298704|FG008|Booster Phase|Migrated/moved from study area|0|||
125456435|NCT01235949|451298705|FG009|Booster Phase|Migrated/moved from study area|0|||
125456436|NCT01235949|451298706|FG010|Booster Phase|Migrated/moved from study area|0|||
125456437|NCT01235949|451298707|FG011|Booster Phase|Migrated/moved from study area|1|||
125456438|NCT01235949|451298708|FG012|Booster Phase|Migrated/moved from study area|1|||
125456439|NCT01235949|451298709|FG013|Booster Phase|Migrated/moved from study area|0|||
125456440|NCT01235949|451298710|FG014|Booster Phase|Migrated/moved from study area|0|||
125456441|NCT01235949|451298711|FG015|Booster Phase|Migrated/moved from study area|0|||
125456442|NCT01235949|451298712|FG016|Booster Phase|Migrated/moved from study area|0|||
125456443|NCT01235949|451298713|FG017|Booster Phase|Migrated/moved from study area|1|||
125294497|NCT02198794|450706495|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
125294498|NCT02198794|450706496|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
125294499|NCT02198794|450706493|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
125294500|NCT02198794|450706494|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
125294501|NCT02198794|450706495|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
125294502|NCT02198794|450706496|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
125294503|NCT02198794|450706493|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
125294504|NCT02198794|450706494|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
125294505|NCT02198794|450706495|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
125294506|NCT02198794|450706496|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
125294507|NCT02198794|450706493|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
125294508|NCT02198794|450706494|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
125294509|NCT02198794|450706495|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
125294510|NCT02198794|450706496|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
125294511|NCT02198794|450706493|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
125294512|NCT02198794|450706494|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
125294513|NCT02198794|450706495|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
125294514|NCT02198794|450706496|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
125294515|NCT02198794|450706493|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
125456444|NCT01235949|451298696|FG000|Booster Phase|Adverse Event|0|||
125456445|NCT01235949|451298697|FG001|Booster Phase|Adverse Event|0|||
125456446|NCT01235949|451298698|FG002|Booster Phase|Adverse Event|0|||
125456447|NCT01235949|451298699|FG003|Booster Phase|Adverse Event|0|||
125456448|NCT01235949|451298700|FG004|Booster Phase|Adverse Event|0|||
125456449|NCT01235949|451298701|FG005|Booster Phase|Adverse Event|0|||
125456450|NCT01235949|451298702|FG006|Booster Phase|Adverse Event|0|||
125456451|NCT01235949|451298703|FG007|Booster Phase|Adverse Event|0|||
125456452|NCT01235949|451298704|FG008|Booster Phase|Adverse Event|0|||
125456453|NCT01235949|451298705|FG009|Booster Phase|Adverse Event|0|||
125456454|NCT01235949|451298706|FG010|Booster Phase|Adverse Event|0|||
125456455|NCT01235949|451298707|FG011|Booster Phase|Adverse Event|0|||
125456456|NCT01235949|451298708|FG012|Booster Phase|Adverse Event|0|||
125456457|NCT01235949|451298709|FG013|Booster Phase|Adverse Event|0|||
125456458|NCT01235949|451298710|FG014|Booster Phase|Adverse Event|0|||
125456459|NCT01235949|451298711|FG015|Booster Phase|Adverse Event|1|||
125456460|NCT01235949|451298712|FG016|Booster Phase|Adverse Event|0|||
125456461|NCT01235949|451298713|FG017|Booster Phase|Adverse Event|0|||
125456462|NCT01235949|451298696|FG000|Booster Phase|Withdrawal by Subject|0|||
125456463|NCT01235949|451298697|FG001|Booster Phase|Withdrawal by Subject|0|||
125456464|NCT01235949|451298698|FG002|Booster Phase|Withdrawal by Subject|0|||
125456465|NCT01235949|451298699|FG003|Booster Phase|Withdrawal by Subject|0|||
125456466|NCT01235949|451298700|FG004|Booster Phase|Withdrawal by Subject|0|||
125456467|NCT01235949|451298701|FG005|Booster Phase|Withdrawal by Subject|0|||
125456468|NCT01235949|451298702|FG006|Booster Phase|Withdrawal by Subject|0|||
125456469|NCT01235949|451298703|FG007|Booster Phase|Withdrawal by Subject|1|||
125456470|NCT01235949|451298704|FG008|Booster Phase|Withdrawal by Subject|1|||
125456471|NCT01235949|451298705|FG009|Booster Phase|Withdrawal by Subject|0|||
125456472|NCT01235949|451298706|FG010|Booster Phase|Withdrawal by Subject|1|||
125456473|NCT01235949|451298707|FG011|Booster Phase|Withdrawal by Subject|1|||
125456474|NCT01235949|451298708|FG012|Booster Phase|Withdrawal by Subject|2|||
125456475|NCT01235949|451298709|FG013|Booster Phase|Withdrawal by Subject|0|||
125456476|NCT01235949|451298710|FG014|Booster Phase|Withdrawal by Subject|2|||
125456477|NCT01235949|451298711|FG015|Booster Phase|Withdrawal by Subject|0|||
125456478|NCT01235949|451298712|FG016|Booster Phase|Withdrawal by Subject|0|||
125456479|NCT01235949|451298713|FG017|Booster Phase|Withdrawal by Subject|0|||
125456480|NCT01235949|451298696|FG000|Booster Phase|Lost to Follow-up|0|||
125456481|NCT01235949|451298697|FG001|Booster Phase|Lost to Follow-up|0|||
125456482|NCT01235949|451298698|FG002|Booster Phase|Lost to Follow-up|0|||
125456483|NCT01235949|451298699|FG003|Booster Phase|Lost to Follow-up|0|||
125456484|NCT01235949|451298700|FG004|Booster Phase|Lost to Follow-up|0|||
125456485|NCT01235949|451298701|FG005|Booster Phase|Lost to Follow-up|0|||
125456486|NCT01235949|451298702|FG006|Booster Phase|Lost to Follow-up|0|||
125456487|NCT01235949|451298703|FG007|Booster Phase|Lost to Follow-up|0|||
125456488|NCT01235949|451298704|FG008|Booster Phase|Lost to Follow-up|1|||
125456489|NCT01235949|451298705|FG009|Booster Phase|Lost to Follow-up|1|||
125456490|NCT01235949|451298706|FG010|Booster Phase|Lost to Follow-up|1|||
125456491|NCT01235949|451298707|FG011|Booster Phase|Lost to Follow-up|1|||
125456492|NCT01235949|451298708|FG012|Booster Phase|Lost to Follow-up|0|||
125456493|NCT01235949|451298709|FG013|Booster Phase|Lost to Follow-up|0|||
125456494|NCT01235949|451298710|FG014|Booster Phase|Lost to Follow-up|0|||
125456495|NCT01235949|451298711|FG015|Booster Phase|Lost to Follow-up|0|||
125456496|NCT01235949|451298712|FG016|Booster Phase|Lost to Follow-up|0|||
125456497|NCT01235949|451298713|FG017|Booster Phase|Lost to Follow-up|1|||
125456498|NCT00754936|451298714|FG000|Overall Study|Lost to Follow-up|3|||
125456499|NCT00754936|451298714|FG000|Overall Study|Physician Decision|1|||
125456500|NCT00754936|451298714|FG000|Overall Study|Withdrawal by Subject|2|||
125456501|NCT00754936|451298714|FG000|Overall Study|Side Effects|3|||
125456502|NCT00754936|451298714|FG000|Overall Study|Inter-current medical events|3|||
125456503|NCT00835380|451298720|FG000|Overall Study|Withdrawal by Subject|2|||
125456504|NCT03247543|451298721|FG000|Overall Study|Adverse Event|3|||
125456505|NCT03247543|451298722|FG001|Overall Study|Adverse Event|6|||
125456506|NCT03247543|451298723|FG002|Overall Study|Adverse Event|4|||
125456507|NCT03247543|451298721|FG000|Overall Study|Lost to Follow-up|10|||
125456508|NCT03247543|451298722|FG001|Overall Study|Lost to Follow-up|7|||
125294516|NCT02198794|450706494|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
125294517|NCT02198794|450706495|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
125294518|NCT02198794|450706496|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
125294519|NCT00701805|450706497|FG000|Overall Study|Withdrawal by Subject|3|||
125294520|NCT00701805|450706498|FG001|Overall Study|Withdrawal by Subject|1|||
125294521|NCT00701805|450706499|FG002|Overall Study|Withdrawal by Subject|4|||
125294522|NCT00701805|450706500|FG003|Overall Study|Withdrawal by Subject|3|||
125294523|NCT00701805|450706497|FG000|Overall Study|Adverse Event|0|||
125294524|NCT00701805|450706498|FG001|Overall Study|Adverse Event|1|||
125294525|NCT00701805|450706499|FG002|Overall Study|Adverse Event|1|||
125294526|NCT00701805|450706500|FG003|Overall Study|Adverse Event|0|||
125294527|NCT00701805|450706497|FG000|Overall Study|Missed 7 consecutive doses|0|||
125294528|NCT00701805|450706498|FG001|Overall Study|Missed 7 consecutive doses|1|||
125294529|NCT00701805|450706499|FG002|Overall Study|Missed 7 consecutive doses|0|||
125294530|NCT00701805|450706500|FG003|Overall Study|Missed 7 consecutive doses|0|||
125294531|NCT00701805|450706497|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
125294532|NCT00701805|450706498|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
125294533|NCT00701805|450706499|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
125294534|NCT00701805|450706500|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
125294535|NCT00701805|450706497|FG000|Overall Study|Physician decision, change of therapy|0|||
125294536|NCT00701805|450706498|FG001|Overall Study|Physician decision, change of therapy|0|||
125294537|NCT00701805|450706499|FG002|Overall Study|Physician decision, change of therapy|0|||
125294538|NCT00701805|450706500|FG003|Overall Study|Physician decision, change of therapy|1|||
125294539|NCT00701805|450706497|FG000|Overall Study|Difficult to travel to dialysis site|0|||
125294540|NCT00701805|450706498|FG001|Overall Study|Difficult to travel to dialysis site|0|||
125294541|NCT00701805|450706499|FG002|Overall Study|Difficult to travel to dialysis site|1|||
125294542|NCT00701805|450706500|FG003|Overall Study|Difficult to travel to dialysis site|0|||
125294543|NCT00701805|450706497|FG000|Overall Study|Resumption criteria were not met|0|||
125294544|NCT00701805|450706498|FG001|Overall Study|Resumption criteria were not met|1|||
125294545|NCT00701805|450706499|FG002|Overall Study|Resumption criteria were not met|0|||
125294546|NCT00701805|450706500|FG003|Overall Study|Resumption criteria were not met|0|||
125294547|NCT02252965|450706504|FG000|Overall Study|Adverse Event|9|||
125294548|NCT02252965|450706505|FG001|Overall Study|Adverse Event|14|||
125294549|NCT02252965|450706504|FG000|Overall Study|Lost to Follow-up|16|||
125294550|NCT02252965|450706505|FG001|Overall Study|Lost to Follow-up|8|||
125294551|NCT02252965|450706504|FG000|Overall Study|Protocol Violation|4|||
125294552|NCT02252965|450706505|FG001|Overall Study|Protocol Violation|5|||
125294553|NCT02252965|450706504|FG000|Overall Study|Lack of Efficacy|0|||
125294554|NCT02252965|450706505|FG001|Overall Study|Lack of Efficacy|2|||
125294555|NCT02252965|450706504|FG000|Overall Study|Withdrawal by Subject|7|||
125294556|NCT02252965|450706505|FG001|Overall Study|Withdrawal by Subject|9|||
125294557|NCT02252965|450706504|FG000|Overall Study|Other|4|||
125294558|NCT02252965|450706505|FG001|Overall Study|Other|5|||
125294559|NCT04435600|450706513|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294560|NCT04435600|450706514|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294561|NCT04435600|450706515|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
125294562|NCT04435600|450706516|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294563|NCT04435600|450706517|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294564|NCT04435600|450706518|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294565|NCT04435600|450706519|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294566|NCT04435600|450706520|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294567|NCT04435600|450706521|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294568|NCT04435600|450706522|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
125294569|NCT04435600|450706513|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294570|NCT04435600|450706514|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125456509|NCT03247543|451298723|FG002|Overall Study|Lost to Follow-up|8|||
125456510|NCT03247543|451298721|FG000|Overall Study|Consent withdrawn by caregiver|2|||
125456511|NCT03247543|451298722|FG001|Overall Study|Consent withdrawn by caregiver|2|||
125294571|NCT04435600|450706515|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294572|NCT04435600|450706516|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294573|NCT04435600|450706517|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125456512|NCT03247543|451298723|FG002|Overall Study|Consent withdrawn by caregiver|9|||
125456513|NCT03247543|451298721|FG000|Overall Study|Withdrawal by Subject|0|||
125294574|NCT04435600|450706518|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294575|NCT04435600|450706519|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294576|NCT04435600|450706520|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294577|NCT04435600|450706521|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
125294578|NCT04435600|450706522|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
125294579|NCT04435600|450706513|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294580|NCT04435600|450706514|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294581|NCT04435600|450706515|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294582|NCT04435600|450706516|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294583|NCT04435600|450706517|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294584|NCT04435600|450706518|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294585|NCT04435600|450706519|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294586|NCT04435600|450706520|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294587|NCT04435600|450706521|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
125294588|NCT04435600|450706522|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
125294589|NCT04435600|450706513|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294590|NCT04435600|450706514|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294591|NCT04435600|450706515|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294592|NCT04435600|450706516|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294593|NCT04435600|450706517|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294594|NCT04435600|450706518|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294595|NCT04435600|450706519|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294596|NCT04435600|450706520|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294597|NCT04435600|450706521|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
125294598|NCT04435600|450706522|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
125456514|NCT03247543|451298722|FG001|Overall Study|Withdrawal by Subject|0|||
125456515|NCT03247543|451298723|FG002|Overall Study|Withdrawal by Subject|1|||
125456516|NCT03247543|451298721|FG000|Overall Study|Failure to Follow study procedures|1|||
125456517|NCT03247543|451298722|FG001|Overall Study|Failure to Follow study procedures|3|||
125294599|NCT02797184|450706525|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
125294600|NCT02797184|450706526|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
125294601|NCT05149313|450706527|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
125294602|NCT05149313|450706528|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
125294603|NCT05149313|450706529|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
125294604|NCT05149313|450706530|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
125294605|NCT05149313|450706527|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
125294606|NCT05149313|450706528|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
125294607|NCT05149313|450706529|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
125294608|NCT05149313|450706530|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
125294609|NCT05149313|450706527|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
125294610|NCT05149313|450706528|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
125294611|NCT05149313|450706529|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
125294612|NCT05149313|450706530|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
125294613|NCT05149313|450706527|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
125294614|NCT05149313|450706528|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
125294615|NCT05149313|450706529|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
125294616|NCT05149313|450706530|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
125294617|NCT05149313|450706527|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
125294618|NCT05149313|450706528|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
125456518|NCT03247543|451298723|FG002|Overall Study|Failure to Follow study procedures|1|||
125456519|NCT03247543|451298721|FG000|Overall Study|Lack of Efficacy|1|||
125456520|NCT03247543|451298722|FG001|Overall Study|Lack of Efficacy|0|||
125456521|NCT03247543|451298723|FG002|Overall Study|Lack of Efficacy|0|||
125456522|NCT03247543|451298721|FG000|Overall Study|Non-compliance with study visits|0|||
125456523|NCT03247543|451298722|FG001|Overall Study|Non-compliance with study visits|1|||
125456524|NCT03247543|451298723|FG002|Overall Study|Non-compliance with study visits|0|||
125456525|NCT02059980|451298726|FG000|Overall Study|Lost to Follow-up|2|||
125456526|NCT02059980|451298727|FG001|Overall Study|Lost to Follow-up|1|||
125456527|NCT01104415|451298728|FG000|Core Phase|Consent withdrawn by subjects|1|||
125456528|NCT01104415|451298729|FG001|Core Phase|Consent withdrawn by subjects|0|||
125456529|NCT01104415|451298728|FG000|Extension Period|Progressive disease|0|||
125456530|NCT01104415|451298729|FG001|Extension Period|Progressive disease|4|||
125456531|NCT01104415|451298728|FG000|Extension Period|Death|0|||
125456532|NCT01104415|451298729|FG001|Extension Period|Death|1|||
125456533|NCT01104415|451298728|FG000|Extension Period|Physician Decision|0|||
125456534|NCT01104415|451298729|FG001|Extension Period|Physician Decision|1|||
125456535|NCT01104415|451298728|FG000|Extension Period|Transition to Study LX1606.302|0|||
125456536|NCT01104415|451298729|FG001|Extension Period|Transition to Study LX1606.302|4|||
125456537|NCT01104415|451298728|FG000|Extension Period|Heart surgery/feeling miserable|0|||
125456538|NCT01104415|451298729|FG001|Extension Period|Heart surgery/feeling miserable|1|||
125456539|NCT02341625|451298734|FG000|Overall Study|Disease Progression|2|||
125456540|NCT02341625|451298735|FG001|Overall Study|Disease Progression|2|||
125456541|NCT02341625|451298736|FG002|Overall Study|Disease Progression|3|||
125456542|NCT02341625|451298737|FG003|Overall Study|Disease Progression|6|||
125456543|NCT02341625|451298738|FG004|Overall Study|Disease Progression|7|||
125456544|NCT02341625|451298739|FG005|Overall Study|Disease Progression|7|||
125456545|NCT02341625|451298740|FG006|Overall Study|Disease Progression|28|||
125456546|NCT02341625|451298741|FG007|Overall Study|Disease Progression|5|||
125456547|NCT02341625|451298742|FG008|Overall Study|Disease Progression|4|||
125456548|NCT02341625|451298743|FG009|Overall Study|Disease Progression|19|||
125456549|NCT02341625|451298734|FG000|Overall Study|Study Drug Toxicity|0|||
125456550|NCT02341625|451298735|FG001|Overall Study|Study Drug Toxicity|0|||
125456551|NCT02341625|451298736|FG002|Overall Study|Study Drug Toxicity|0|||
125456552|NCT02341625|451298737|FG003|Overall Study|Study Drug Toxicity|1|||
125456553|NCT02341625|451298738|FG004|Overall Study|Study Drug Toxicity|0|||
125456554|NCT02341625|451298739|FG005|Overall Study|Study Drug Toxicity|3|||
125456555|NCT02341625|451298740|FG006|Overall Study|Study Drug Toxicity|10|||
125456556|NCT02341625|451298741|FG007|Overall Study|Study Drug Toxicity|0|||
125456557|NCT02341625|451298742|FG008|Overall Study|Study Drug Toxicity|0|||
125456558|NCT02341625|451298743|FG009|Overall Study|Study Drug Toxicity|3|||
125456559|NCT02341625|451298734|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
125456560|NCT02341625|451298735|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
125456561|NCT02341625|451298736|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
125456562|NCT02341625|451298737|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
125456563|NCT02341625|451298738|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
125456564|NCT02341625|451298739|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
125456565|NCT02341625|451298740|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
125456566|NCT02341625|451298741|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
125456567|NCT02341625|451298742|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
125456568|NCT02341625|451298743|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
125456569|NCT02341625|451298734|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
125456570|NCT02341625|451298735|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
125456571|NCT02341625|451298736|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
125456572|NCT02341625|451298737|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
125456573|NCT02341625|451298738|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
125456574|NCT02341625|451298739|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
125456575|NCT02341625|451298740|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
125456576|NCT02341625|451298741|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
125456577|NCT02341625|451298742|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
125456578|NCT02341625|451298743|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
125456579|NCT02341625|451298734|FG000|Overall Study|Participant Withdrew Consent|0|||
125456580|NCT02341625|451298735|FG001|Overall Study|Participant Withdrew Consent|0|||
125456581|NCT02341625|451298736|FG002|Overall Study|Participant Withdrew Consent|0|||
125456582|NCT02341625|451298737|FG003|Overall Study|Participant Withdrew Consent|1|||
125456583|NCT02341625|451298738|FG004|Overall Study|Participant Withdrew Consent|0|||
125456584|NCT02341625|451298739|FG005|Overall Study|Participant Withdrew Consent|0|||
125456585|NCT02341625|451298740|FG006|Overall Study|Participant Withdrew Consent|0|||
125456586|NCT02341625|451298741|FG007|Overall Study|Participant Withdrew Consent|0|||
125456587|NCT02341625|451298742|FG008|Overall Study|Participant Withdrew Consent|0|||
125456588|NCT02341625|451298743|FG009|Overall Study|Participant Withdrew Consent|0|||
125456589|NCT02341625|451298734|FG000|Overall Study|Completed Treatment as per Protocol|0|||
125456590|NCT02341625|451298735|FG001|Overall Study|Completed Treatment as per Protocol|0|||
125294619|NCT05149313|450706529|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
125456591|NCT02341625|451298736|FG002|Overall Study|Completed Treatment as per Protocol|0|||
125456592|NCT02341625|451298737|FG003|Overall Study|Completed Treatment as per Protocol|0|||
125456593|NCT02341625|451298738|FG004|Overall Study|Completed Treatment as per Protocol|0|||
125456594|NCT02341625|451298739|FG005|Overall Study|Completed Treatment as per Protocol|0|||
125456595|NCT02341625|451298740|FG006|Overall Study|Completed Treatment as per Protocol|0|||
125456596|NCT02341625|451298741|FG007|Overall Study|Completed Treatment as per Protocol|0|||
125456597|NCT02341625|451298742|FG008|Overall Study|Completed Treatment as per Protocol|0|||
125456598|NCT02341625|451298743|FG009|Overall Study|Completed Treatment as per Protocol|1|||
125456599|NCT02341625|451298734|FG000|Overall Study|Other Reasons|0|||
125456600|NCT02341625|451298735|FG001|Overall Study|Other Reasons|0|||
125456601|NCT02341625|451298736|FG002|Overall Study|Other Reasons|0|||
125456602|NCT02341625|451298737|FG003|Overall Study|Other Reasons|0|||
125294620|NCT05149313|450706530|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
125294621|NCT05149313|450706527|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
125456603|NCT02341625|451298738|FG004|Overall Study|Other Reasons|1|||
125456604|NCT02341625|451298739|FG005|Overall Study|Other Reasons|0|||
125456605|NCT02341625|451298740|FG006|Overall Study|Other Reasons|5|||
125456606|NCT02341625|451298741|FG007|Overall Study|Other Reasons|0|||
125294622|NCT05149313|450706528|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
125294623|NCT05149313|450706529|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
125294624|NCT05149313|450706530|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
125294625|NCT05149313|450706527|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
125294626|NCT05149313|450706528|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
125294627|NCT05149313|450706529|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
125294628|NCT05149313|450706530|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
125294629|NCT05149313|450706527|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125294630|NCT05149313|450706528|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125294631|NCT05149313|450706529|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
125294632|NCT05149313|450706530|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
125456607|NCT02341625|451298742|FG008|Overall Study|Other Reasons|0|||
125456608|NCT02341625|451298743|FG009|Overall Study|Other Reasons|2|||
125456609|NCT02341625|451298734|FG000|Overall Study|Not Reported|0|||
125456610|NCT02341625|451298735|FG001|Overall Study|Not Reported|0|||
125456611|NCT02341625|451298736|FG002|Overall Study|Not Reported|0|||
125456612|NCT02341625|451298737|FG003|Overall Study|Not Reported|0|||
125456613|NCT02341625|451298738|FG004|Overall Study|Not Reported|0|||
125456614|NCT02341625|451298739|FG005|Overall Study|Not Reported|0|||
125456615|NCT02341625|451298740|FG006|Overall Study|Not Reported|0|||
125456616|NCT02341625|451298741|FG007|Overall Study|Not Reported|0|||
125456617|NCT02341625|451298742|FG008|Overall Study|Not Reported|0|||
125294633|NCT05149313|450706527|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
125294634|NCT05149313|450706528|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
125294635|NCT05149313|450706529|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
125294636|NCT05149313|450706530|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
125294637|NCT05149313|450706527|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125294638|NCT05149313|450706528|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125294639|NCT05149313|450706529|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
125294640|NCT05149313|450706530|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125294641|NCT05149313|450706527|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
125294642|NCT05149313|450706528|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
125294643|NCT05149313|450706529|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
125294644|NCT05149313|450706530|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
125294645|NCT03199391|450706535|FG000|Overall Study|Death|1|||
125294646|NCT03199391|450706535|FG000|Overall Study|Lost to Follow-up|3|||
125294647|NCT03199391|450706535|FG000|Overall Study|Adverse Event|2|||
125294648|NCT03199391|450706535|FG000|Overall Study|Withdrawal by Subject|10|||
125294649|NCT04736628|450706536|FG000|Overall Study|Not treated|0|||
125294650|NCT04736628|450706537|FG001|Overall Study|Not treated|0|||
125294651|NCT04736628|450706538|FG002|Overall Study|Not treated|0|||
125294652|NCT04736628|450706539|FG003|Overall Study|Not treated|2|||
125294653|NCT04736628|450706536|FG000|Overall Study|Other reason than listed|1|||
125294654|NCT04736628|450706537|FG001|Overall Study|Other reason than listed|2|||
125294655|NCT04736628|450706538|FG002|Overall Study|Other reason than listed|2|||
125294656|NCT04736628|450706539|FG003|Overall Study|Other reason than listed|3|||
125294657|NCT04736628|450706536|FG000|Overall Study|Protocol deviation|0|||
125294658|NCT04736628|450706537|FG001|Overall Study|Protocol deviation|0|||
125294659|NCT04736628|450706538|FG002|Overall Study|Protocol deviation|0|||
125294660|NCT04736628|450706539|FG003|Overall Study|Protocol deviation|1|||
125294661|NCT04736628|450706536|FG000|Overall Study|Burden of study procedures|1|||
125294662|NCT04736628|450706537|FG001|Overall Study|Burden of study procedures|0|||
125294663|NCT04736628|450706538|FG002|Overall Study|Burden of study procedures|0|||
125294664|NCT04736628|450706539|FG003|Overall Study|Burden of study procedures|1|||
125294665|NCT04736628|450706536|FG000|Overall Study|Change of residence|0|||
125456618|NCT02341625|451298743|FG009|Overall Study|Not Reported|3|||
125456619|NCT02357784|451298747|FG000|Overall Study|Withdrawal by Subject|1|||
125456620|NCT02698241|451298752|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
125294666|NCT04736628|450706537|FG001|Overall Study|Change of residence|1|||
125294667|NCT04736628|450706538|FG002|Overall Study|Change of residence|0|||
125294668|NCT04736628|450706539|FG003|Overall Study|Change of residence|0|||
125294669|NCT04736628|450706536|FG000|Overall Study|Perceived lack of efficacy|1|||
125294670|NCT04736628|450706537|FG001|Overall Study|Perceived lack of efficacy|0|||
125456621|NCT02698241|451298752|FG000|Overall Study|Screening not met|7|||
125294671|NCT04736628|450706538|FG002|Overall Study|Perceived lack of efficacy|0|||
125294672|NCT04736628|450706539|FG003|Overall Study|Perceived lack of efficacy|1|||
125294673|NCT04736628|450706536|FG000|Overall Study|Adverse Event|3|||
125294674|NCT04736628|450706537|FG001|Overall Study|Adverse Event|2|||
125294675|NCT04736628|450706538|FG002|Overall Study|Adverse Event|4|||
125456622|NCT02698241|451298752|FG000|Overall Study|Withdrawal by Subject|7|||
125456623|NCT02698241|451298752|FG000|Overall Study|Physician Decision|2|||
125456624|NCT02698241|451298752|FG000|Overall Study|Subject underwent system modification|2|||
125294676|NCT04736628|450706539|FG003|Overall Study|Adverse Event|3|||
125294677|NCT02046070|450706549|FG000|Overall Study|Progressive Disease|18|||
125294678|NCT02046070|450706550|FG001|Overall Study|Progressive Disease|11|||
125294679|NCT02046070|450706551|FG002|Overall Study|Progressive Disease|40|||
125294680|NCT02046070|450706549|FG000|Overall Study|Adverse Event|8|||
125294681|NCT02046070|450706550|FG001|Overall Study|Adverse Event|10|||
125294682|NCT02046070|450706551|FG002|Overall Study|Adverse Event|17|||
125294683|NCT02046070|450706549|FG000|Overall Study|Withdrawal by Subject|1|||
125294684|NCT02046070|450706550|FG001|Overall Study|Withdrawal by Subject|2|||
125294685|NCT02046070|450706551|FG002|Overall Study|Withdrawal by Subject|6|||
125294686|NCT02046070|450706549|FG000|Overall Study|Study Terminated by Sponsor|1|||
125294687|NCT02046070|450706550|FG001|Overall Study|Study Terminated by Sponsor|1|||
125294688|NCT02046070|450706551|FG002|Overall Study|Study Terminated by Sponsor|1|||
125294689|NCT02046070|450706549|FG000|Overall Study|Reason not Specified|4|||
125294690|NCT02046070|450706550|FG001|Overall Study|Reason not Specified|4|||
125294691|NCT02046070|450706551|FG002|Overall Study|Reason not Specified|6|||
125294692|NCT04619004|450706552|FG000|Overall Study|Death|114|||
125294693|NCT04619004|450706553|FG001|Overall Study|Death|28|||
125294694|NCT04619004|450706552|FG000|Overall Study|Lost to Follow-up|1|||
125294695|NCT04619004|450706553|FG001|Overall Study|Lost to Follow-up|1|||
125294696|NCT04619004|450706552|FG000|Overall Study|Withdrawal by Subject|24|||
125294697|NCT04619004|450706553|FG001|Overall Study|Withdrawal by Subject|7|||
125294698|NCT04619004|450706552|FG000|Overall Study|Other - Not specified|0|||
125294699|NCT04619004|450706553|FG001|Overall Study|Other - Not specified|1|||
125294700|NCT02258529|450706557|FG000|Overall Study|Study Terminated by Sponsor|9|||
125294701|NCT02258529|450706557|FG000|Overall Study|Adverse Event|1|||
125294702|NCT05432167|450706563|FG000|Overall Study|Adverse Event|0|||
125294703|NCT05432167|450706564|FG001|Overall Study|Adverse Event|2|||
125294704|NCT05432167|450706565|FG002|Overall Study|Adverse Event|1|||
125294705|NCT05432167|450706563|FG000|Overall Study|Lost to Follow-up|3|||
125456625|NCT02698241|451298752|FG000|Overall Study|Lost to Follow-up|3|||
125456626|NCT02698241|451298752|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
125456627|NCT02698241|451298752|FG000|Overall Study|geographic and licensing issue|1|||
125456628|NCT02698241|451298752|FG000|Overall Study|Death|2|||
125456629|NCT01837641|451298753|FG000|Overall Study|Sponsor decision|1|||
125456630|NCT01837641|451298754|FG001|Overall Study|Sponsor decision|0|||
125456631|NCT01837641|451298755|FG002|Overall Study|Sponsor decision|0|||
125456632|NCT01837641|451298756|FG003|Overall Study|Sponsor decision|0|||
125456633|NCT01837641|451298757|FG004|Overall Study|Sponsor decision|0|||
125456634|NCT01837641|451298758|FG005|Overall Study|Sponsor decision|1|||
125456635|NCT01837641|451298759|FG006|Overall Study|Sponsor decision|0|||
125456636|NCT01837641|451298760|FG007|Overall Study|Sponsor decision|0|||
125456637|NCT01837641|451298753|FG000|Overall Study|Adverse Event|0|||
125456638|NCT01837641|451298754|FG001|Overall Study|Adverse Event|0|||
125456639|NCT01837641|451298755|FG002|Overall Study|Adverse Event|0|||
125456640|NCT01837641|451298756|FG003|Overall Study|Adverse Event|0|||
125456641|NCT01837641|451298757|FG004|Overall Study|Adverse Event|0|||
125420128|NCT00983073|451162276|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
125420129|NCT00983073|451162276|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
125420130|NCT00983073|451162276|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
125420131|NCT00983073|451162276|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
125456642|NCT01837641|451298758|FG005|Overall Study|Adverse Event|1|||
125456643|NCT01837641|451298759|FG006|Overall Study|Adverse Event|0|||
125456644|NCT01837641|451298760|FG007|Overall Study|Adverse Event|0|||
125456645|NCT01837641|451298753|FG000|Overall Study|Withdrawal by Subject|0|||
125456646|NCT01837641|451298754|FG001|Overall Study|Withdrawal by Subject|0|||
125456647|NCT01837641|451298755|FG002|Overall Study|Withdrawal by Subject|0|||
125456648|NCT01837641|451298756|FG003|Overall Study|Withdrawal by Subject|0|||
125456649|NCT01837641|451298757|FG004|Overall Study|Withdrawal by Subject|1|||
125456650|NCT01837641|451298758|FG005|Overall Study|Withdrawal by Subject|0|||
125456651|NCT01837641|451298759|FG006|Overall Study|Withdrawal by Subject|1|||
125456652|NCT01837641|451298760|FG007|Overall Study|Withdrawal by Subject|0|||
125456653|NCT00906282|451298766|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
125456654|NCT00906282|451298766|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
125456655|NCT00906282|451298766|FG000|Preoperative Chemotherapy|Progressive disease|6|||
125456656|NCT00906282|451298766|FG000|Preoperative Chemotherapy|Toxicity|1|||
125294706|NCT05432167|450706564|FG001|Overall Study|Lost to Follow-up|3|||
125294707|NCT05432167|450706565|FG002|Overall Study|Lost to Follow-up|2|||
125294708|NCT05432167|450706563|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
125294709|NCT05432167|450706564|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
125294710|NCT05432167|450706565|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
125420132|NCT00983073|451162276|FG000|Titration and Optimal Dose Period|Other reason|4|||
125420133|NCT00983073|451162276|FG000|Maintenance Period|Adverse Event|5|||
125456657|NCT02289560|451298767|FG000|Overall Study|Lost to Follow-up|6|||
125294711|NCT05432167|450706563|FG000|Overall Study|Physician Decision|1|||
125420134|NCT00983073|451162276|FG000|Maintenance Period|Withdrawal by Subject|2|||
125420135|NCT00983073|451162276|FG000|Maintenance Period|Lack of Efficacy|2|||
125456658|NCT02289560|451298767|FG000|Overall Study|Alternative Treatment|4|||
125456659|NCT02289560|451298767|FG000|Overall Study|Inadequate Treatment|2|||
125456660|NCT02289560|451298767|FG000|Overall Study|Withdrawal by Subject|23|||
125456661|NCT02540213|451298768|FG000|Overall Study|Death/adverse event|18|||
125456662|NCT02540213|451298768|FG000|Overall Study|Administrative reasons|3|||
125456663|NCT02540213|451298768|FG000|Overall Study|Kidney transplant|3|||
125456664|NCT02540213|451298768|FG000|Overall Study|Lack of Efficacy|6|||
125456665|NCT02540213|451298768|FG000|Overall Study|Consent withdrawn|7|||
125456666|NCT02540213|451298768|FG000|Overall Study|Enrolled but not treated|2|||
125456667|NCT00290706|451298773|FG000|Overall Study|Withdrawal by Subject|2|||
125456668|NCT00290706|451298774|FG001|Overall Study|Withdrawal by Subject|0|||
125456669|NCT00290706|451298775|FG002|Overall Study|Withdrawal by Subject|0|||
125456670|NCT00290706|451298776|FG003|Overall Study|Withdrawal by Subject|0|||
125456671|NCT00290706|451298773|FG000|Overall Study|Progressive Disease|3|||
125456672|NCT00290706|451298774|FG001|Overall Study|Progressive Disease|5|||
125456673|NCT00290706|451298775|FG002|Overall Study|Progressive Disease|4|||
125456674|NCT00290706|451298776|FG003|Overall Study|Progressive Disease|10|||
125456675|NCT00290706|451298773|FG000|Overall Study|Adverse Event|0|||
125456676|NCT00290706|451298774|FG001|Overall Study|Adverse Event|1|||
125456677|NCT00290706|451298775|FG002|Overall Study|Adverse Event|2|||
125456678|NCT00290706|451298776|FG003|Overall Study|Adverse Event|0|||
125456679|NCT00290706|451298773|FG000|Overall Study|Receive auto transplant or radiation|0|||
125456680|NCT00290706|451298774|FG001|Overall Study|Receive auto transplant or radiation|0|||
125294712|NCT05432167|450706564|FG001|Overall Study|Physician Decision|0|||
125294713|NCT05432167|450706565|FG002|Overall Study|Physician Decision|0|||
125294714|NCT05432167|450706563|FG000|Overall Study|Withdrawal by Subject|7|||
125294715|NCT05432167|450706564|FG001|Overall Study|Withdrawal by Subject|4|||
125294716|NCT05432167|450706565|FG002|Overall Study|Withdrawal by Subject|11|||
125294717|NCT05432167|450706563|FG000|Overall Study|Other|0|||
125294718|NCT05432167|450706564|FG001|Overall Study|Other|0|||
125294719|NCT05432167|450706565|FG002|Overall Study|Other|1|||
125294720|NCT01267175|450706566|FG000|Overall Study|Withdrawal by Subject|1|||
125294721|NCT01267175|450706566|FG000|Overall Study|Lost to Follow-up|1|||
125294722|NCT02553538|450706571|FG000|Overall Study|Could Not Reach by Telephone|133|||
125294723|NCT02553538|450706572|FG001|Overall Study|Could Not Reach by Telephone|0|||
125294724|NCT02553538|450706571|FG000|Overall Study|Died or Left Network|54|||
125294725|NCT02553538|450706572|FG001|Overall Study|Died or Left Network|56|||
125294726|NCT04094584|450706573|FG000|Overall Study|No interest in study|88|||
125294727|NCT04094584|450706573|FG000|Overall Study|Unwilling to undergo screening tests|36|||
125294728|NCT04094584|450706573|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
125294729|NCT04094584|450706573|FG000|Overall Study|Opioid use|7|||
125294730|NCT04094584|450706573|FG000|Overall Study|Need for major surgery in study period|4|||
125294731|NCT04094584|450706573|FG000|Overall Study|eligible but declined enrollment|4|||
125294732|NCT04094584|450706573|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
125294733|NCT04094584|450706573|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
125294734|NCT04094584|450706573|FG000|Overall Study|Lost to Follow-up|3|||
125294735|NCT04094584|450706573|FG000|Overall Study|Withdrawal by Subject|2|||
125294736|NCT02690649|450706574|FG000|Overall Study|Withdrawal by Subject|1|||
125294737|NCT02690649|450706575|FG001|Overall Study|Withdrawal by Subject|1|||
125294738|NCT02690649|450706574|FG000|Overall Study|Protocol Violation|0|||
125294739|NCT02690649|450706575|FG001|Overall Study|Protocol Violation|3|||
125294740|NCT00791557|450706576|FG000|Overall Study|Adverse Event|1|||
125294741|NCT02616393|450706582|FG000|Overall Study|Death|5|||
125294742|NCT02616393|450706583|FG001|Overall Study|Death|12|||
125294743|NCT02616393|450706584|FG002|Overall Study|Death|1|||
125294744|NCT02616393|450706582|FG000|Overall Study|Termination by Sponsor|4|||
125294745|NCT02616393|450706583|FG001|Overall Study|Termination by Sponsor|5|||
125294746|NCT02616393|450706584|FG002|Overall Study|Termination by Sponsor|2|||
125294747|NCT02616393|450706582|FG000|Overall Study|Other|3|||
125456681|NCT00290706|451298775|FG002|Overall Study|Receive auto transplant or radiation|0|||
125456682|NCT00290706|451298776|FG003|Overall Study|Receive auto transplant or radiation|1|||
125456683|NCT00290706|451298773|FG000|Overall Study|Physician Decision|0|||
125456684|NCT00290706|451298774|FG001|Overall Study|Physician Decision|0|||
125456685|NCT00290706|451298775|FG002|Overall Study|Physician Decision|0|||
125456686|NCT00290706|451298776|FG003|Overall Study|Physician Decision|1|||
125456687|NCT03395353|451298777|FG000|Overall Study|Adverse Event|20|||
125456688|NCT03395353|451298777|FG000|Overall Study|Protocol Violation|1|||
125456689|NCT03395353|451298777|FG000|Overall Study|Lack of Efficacy|3|||
125456690|NCT03395353|451298777|FG000|Overall Study|Withdrawal by Subject|24|||
125294748|NCT02616393|450706583|FG001|Overall Study|Other|0|||
125294749|NCT02616393|450706584|FG002|Overall Study|Other|0|||
125294750|NCT02616393|450706582|FG000|Overall Study|Withdrawal by Subject|1|||
125294751|NCT02616393|450706583|FG001|Overall Study|Withdrawal by Subject|1|||
125294752|NCT02616393|450706584|FG002|Overall Study|Withdrawal by Subject|0|||
125456691|NCT03395353|451298777|FG000|Overall Study|Discontinued visit|1|||
125456692|NCT03395353|451298777|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
125294753|NCT02616393|450706582|FG000|Overall Study|Lost to Follow-up|0|||
125294754|NCT02616393|450706583|FG001|Overall Study|Lost to Follow-up|2|||
125294755|NCT02616393|450706584|FG002|Overall Study|Lost to Follow-up|0|||
125294756|NCT02900170|450706588|FG000|Overall Study|Lost to Follow-up|8|||
125294757|NCT01600053|450706589|FG000|Overall Study|Adverse Event|2|||
125294758|NCT01600053|450706589|FG000|Overall Study|trial will not meet the interim endpoint|9|||
125294759|NCT02855944|450706590|FG000|Period 1: Treatment|Ongoing|14|||
125294760|NCT02855944|450706591|FG001|Period 1: Treatment|Ongoing|0|||
125294761|NCT02855944|450706590|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
125294762|NCT02855944|450706591|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
125294763|NCT02855944|450706590|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
125456693|NCT03395353|451298777|FG000|Overall Study|Physician Decision|4|||
125456694|NCT03395353|451298777|FG000|Overall Study|Early termination of overall study|33|||
125456695|NCT00605033|451298778|FG000|Overall Study|Adverse Event|2|||
125456696|NCT00605033|451298779|FG001|Overall Study|Adverse Event|2|||
125456697|NCT00605033|451298778|FG000|Overall Study|Lost to Follow-up|1|||
125456698|NCT00605033|451298779|FG001|Overall Study|Lost to Follow-up|1|||
125456699|NCT00605033|451298778|FG000|Overall Study|Withdrawal by Subject|3|||
125456700|NCT00605033|451298779|FG001|Overall Study|Withdrawal by Subject|4|||
125456701|NCT00605033|451298778|FG000|Overall Study|Protocol Violation|1|||
125456702|NCT00605033|451298779|FG001|Overall Study|Protocol Violation|1|||
125294764|NCT02855944|450706591|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
125294765|NCT01475162|450706598|FG000|Overall Study|Physician Decision|1|||
125294766|NCT01475162|450706598|FG000|Overall Study|Death|10|||
125294767|NCT01475162|450706598|FG000|Overall Study|Study closed for safety|3|||
125294768|NCT00490022|450706599|FG000|Overall Study|Adverse Event|0|||
125294769|NCT00490022|450706600|FG001|Overall Study|Adverse Event|2|||
125294770|NCT00490022|450706599|FG000|Overall Study|Withdrawal by Subject|1|||
125294771|NCT00490022|450706600|FG001|Overall Study|Withdrawal by Subject|0|||
125294772|NCT00490022|450706599|FG000|Overall Study|Subject failed to disclose concommitant|0|||
125294773|NCT00490022|450706600|FG001|Overall Study|Subject failed to disclose concommitant|1|||
125294774|NCT02608450|450706601|FG000|Overall Study|Lost to Follow-up|39|||
125294775|NCT02608450|450706602|FG001|Overall Study|Lost to Follow-up|32|||
125294776|NCT02608450|450706601|FG000|Overall Study|Withdrawal by Subject|21|||
125294777|NCT02608450|450706602|FG001|Overall Study|Withdrawal by Subject|15|||
125294778|NCT02608450|450706601|FG000|Overall Study|Adverse Event|3|||
125294779|NCT02608450|450706602|FG001|Overall Study|Adverse Event|6|||
125294780|NCT02608450|450706601|FG000|Overall Study|Withdrawal by parent|2|||
125294781|NCT02608450|450706602|FG001|Overall Study|Withdrawal by parent|3|||
125294782|NCT02608450|450706601|FG000|Overall Study|Lack of Efficacy|0|||
125294783|NCT02608450|450706602|FG001|Overall Study|Lack of Efficacy|3|||
125294784|NCT02608450|450706601|FG000|Overall Study|Noncompliance with study drug|0|||
125294785|NCT02608450|450706602|FG001|Overall Study|Noncompliance with study drug|2|||
125294786|NCT02608450|450706601|FG000|Overall Study|Physician Decision|0|||
125294787|NCT02608450|450706602|FG001|Overall Study|Physician Decision|1|||
125294788|NCT02608450|450706601|FG000|Overall Study|Pregnancy|0|||
125294789|NCT02608450|450706602|FG001|Overall Study|Pregnancy|1|||
125294790|NCT02608450|450706601|FG000|Overall Study|Progressive disease|1|||
125294791|NCT02608450|450706602|FG001|Overall Study|Progressive disease|0|||
125294792|NCT02608450|450706601|FG000|Overall Study|Multiple reasons|0|||
125294793|NCT02608450|450706602|FG001|Overall Study|Multiple reasons|2|||
125294794|NCT01283542|450706603|FG000|Main Phase|Acute or progressive vision loss|1|||
125294795|NCT01283542|450706603|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
125294796|NCT01283542|450706603|FG000|Main Phase|abnormal laboratory values|5|||
125294797|NCT01283542|450706603|FG000|Extension Phase|Physician Decision|1|||
125294798|NCT01283542|450706603|FG000|Extension Phase|Adverse Event|1|||
125294799|NCT01283542|450706603|FG000|Extension Phase|Administrative problems|1|||
125294800|NCT03443427|450706605|FG000|Overall Study|Adverse Event|2|||
125294801|NCT03443427|450706606|FG001|Overall Study|Adverse Event|3|||
125294802|NCT03443427|450706605|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
125294803|NCT03443427|450706606|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
125294804|NCT03443427|450706605|FG000|Overall Study|Other|4|||
125294805|NCT03443427|450706606|FG001|Overall Study|Other|6|||
125294806|NCT00477269|450706607|FG000|Core Study|Adverse Event|6|||
125294807|NCT00477269|450706608|FG001|Core Study|Adverse Event|4|||
125294808|NCT00477269|450706609|FG002|Core Study|Adverse Event|0|||
125294809|NCT00477269|450706607|FG000|Core Study|Death|3|||
125294810|NCT00477269|450706608|FG001|Core Study|Death|3|||
125294811|NCT00477269|450706609|FG002|Core Study|Death|0|||
125294812|NCT00477269|450706607|FG000|Core Study|Withdrawn Consent|0|||
125456703|NCT03227757|451300565|FG000|Overall Study|Death|25|||
125456704|NCT03227757|451300565|FG000|Overall Study|Withdrawal|10|||
125294813|NCT00477269|450706608|FG001|Core Study|Withdrawn Consent|1|||
125294814|NCT00477269|450706609|FG002|Core Study|Withdrawn Consent|0|||
125294815|NCT00477269|450706607|FG000|Open Label Extension|Adverse Event|0|||
125294816|NCT00477269|450706608|FG001|Open Label Extension|Adverse Event|0|||
125294817|NCT00477269|450706609|FG002|Open Label Extension|Adverse Event|4|||
125294818|NCT00477269|450706607|FG000|Open Label Extension|Abnormal laboratory values|0|||
125294819|NCT00477269|450706608|FG001|Open Label Extension|Abnormal laboratory values|0|||
125294820|NCT00477269|450706609|FG002|Open Label Extension|Abnormal laboratory values|1|||
125294821|NCT00477269|450706607|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
125294822|NCT00477269|450706608|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
125294823|NCT00477269|450706609|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
125294824|NCT00477269|450706607|FG000|Open Label Extension|Adminiatrative problems|0|||
125294825|NCT00477269|450706608|FG001|Open Label Extension|Adminiatrative problems|0|||
125294826|NCT00477269|450706609|FG002|Open Label Extension|Adminiatrative problems|2|||
125456705|NCT03227757|451300565|FG000|Overall Study|Missed visits|1|||
125456706|NCT03227757|451300565|FG000|Overall Study|Lost to Follow-up|2|||
125456707|NCT01144468|451300567|FG000|Overall Study|Lost to Follow-up|4|||
125456708|NCT01144468|451300568|FG001|Overall Study|Lost to Follow-up|7|||
125456709|NCT01144468|451300567|FG000|Overall Study|Adverse Event|3|||
125456710|NCT01144468|451300568|FG001|Overall Study|Adverse Event|2|||
125294827|NCT00477269|450706607|FG000|Open Label Extension|Death|0|||
125294828|NCT00477269|450706608|FG001|Open Label Extension|Death|0|||
125294829|NCT00477269|450706609|FG002|Open Label Extension|Death|4|||
125294830|NCT03263780|450706610|FG000|Overall Study|Withdrawal by Subject|3|||
125294831|NCT03263780|450706610|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
125294832|NCT03938324|450707756|FG000|Overall Study|Lost to Follow-up|42|||
125294833|NCT03938324|450707757|FG001|Overall Study|Lost to Follow-up|21|||
125294834|NCT03938324|450707756|FG000|Overall Study|Withdrawal by Subject|6|||
125294835|NCT03938324|450707757|FG001|Overall Study|Withdrawal by Subject|1|||
125294836|NCT02769962|450707758|FG000|Overall Study|Physician Decision|0|||
125294837|NCT02769962|450707759|FG001|Overall Study|Physician Decision|0|||
125294838|NCT02769962|450707760|FG002|Overall Study|Physician Decision|0|||
125294839|NCT02769962|450707761|FG003|Overall Study|Physician Decision|0|||
125294840|NCT02769962|450707762|FG004|Overall Study|Physician Decision|0|||
125294841|NCT02769962|450707763|FG005|Overall Study|Physician Decision|1|||
125294842|NCT02769962|450707764|FG006|Overall Study|Physician Decision|0|||
125294843|NCT02769962|450707765|FG007|Overall Study|Physician Decision|1|||
125294844|NCT02769962|450707758|FG000|Overall Study|Refused further treatment|0|||
125294845|NCT02769962|450707759|FG001|Overall Study|Refused further treatment|0|||
125294846|NCT02769962|450707760|FG002|Overall Study|Refused further treatment|0|||
125294847|NCT02769962|450707761|FG003|Overall Study|Refused further treatment|0|||
125294848|NCT02769962|450707762|FG004|Overall Study|Refused further treatment|0|||
125294849|NCT02769962|450707763|FG005|Overall Study|Refused further treatment|1|||
125294850|NCT02769962|450707764|FG006|Overall Study|Refused further treatment|1|||
125294851|NCT02769962|450707765|FG007|Overall Study|Refused further treatment|0|||
125294852|NCT00837759|450707766|FG000|Overall Study|Protocol Violation|3|||
125294853|NCT00837759|450707766|FG000|Overall Study|Lost to Follow-up|1|||
125294854|NCT05063539|450707767|FG000|Overall Study|Adverse Event|1|||
125294855|NCT05063539|450707768|FG001|Overall Study|Adverse Event|2|||
125294856|NCT05063539|450707769|FG002|Overall Study|Adverse Event|1|||
125294857|NCT05063539|450707767|FG000|Overall Study|Death|0|||
125294858|NCT05063539|450707768|FG001|Overall Study|Death|1|||
125294859|NCT05063539|450707769|FG002|Overall Study|Death|1|||
125294860|NCT05063539|450707767|FG000|Overall Study|Lost to Follow-up|0|||
125294861|NCT05063539|450707768|FG001|Overall Study|Lost to Follow-up|1|||
125294862|NCT05063539|450707769|FG002|Overall Study|Lost to Follow-up|0|||
125294863|NCT05063539|450707767|FG000|Overall Study|Physician Decision|4|||
125294864|NCT05063539|450707768|FG001|Overall Study|Physician Decision|3|||
125294865|NCT05063539|450707769|FG002|Overall Study|Physician Decision|1|||
125294866|NCT05063539|450707767|FG000|Overall Study|Progressive Disease|0|||
125294867|NCT05063539|450707768|FG001|Overall Study|Progressive Disease|2|||
125294868|NCT05063539|450707769|FG002|Overall Study|Progressive Disease|0|||
125294869|NCT05063539|450707767|FG000|Overall Study|Withdrawal by Subject|17|||
125294870|NCT05063539|450707768|FG001|Overall Study|Withdrawal by Subject|26|||
125294871|NCT05063539|450707769|FG002|Overall Study|Withdrawal by Subject|14|||
125294872|NCT05063539|450707767|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
125294873|NCT05063539|450707768|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
125294874|NCT05063539|450707769|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
125294875|NCT05063539|450707767|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
125456711|NCT01144468|451300567|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
125456712|NCT01144468|451300568|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
125456713|NCT02960659|451300569|FG000|Overall Study|Withdrawal by Subject|1|||
125456714|NCT02960659|451300570|FG001|Overall Study|Withdrawal by Subject|0|||
125456715|NCT02960659|451300569|FG000|Overall Study|Poor compliance|0|||
125456716|NCT02960659|451300570|FG001|Overall Study|Poor compliance|1|||
125456717|NCT03140176|451300576|FG000|Overall Study|Reason missing|23|||
125456718|NCT03140176|451300576|FG000|Overall Study|Death|33|||
125294876|NCT05063539|450707768|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
125294877|NCT05063539|450707769|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
125294878|NCT05063539|450707767|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
125456719|NCT03140176|451300576|FG000|Overall Study|Disease progression|1|||
125294879|NCT05063539|450707768|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
125294880|NCT05063539|450707769|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
125294881|NCT05063539|450707767|FG000|Overall Study|Discontinued due to Common Close Design|0|||
125294882|NCT05063539|450707768|FG001|Overall Study|Discontinued due to Common Close Design|1|||
125294883|NCT05063539|450707769|FG002|Overall Study|Discontinued due to Common Close Design|0|||
125294884|NCT05063539|450707767|FG000|Overall Study|Participant not co-operative|0|||
125294885|NCT05063539|450707768|FG001|Overall Study|Participant not co-operative|1|||
125294886|NCT05063539|450707769|FG002|Overall Study|Participant not co-operative|0|||
125294887|NCT05063539|450707767|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
125294888|NCT05063539|450707768|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
125294889|NCT05063539|450707769|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
125294890|NCT05063539|450707767|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
125294891|NCT05063539|450707768|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
125294892|NCT05063539|450707769|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
125294893|NCT04256512|450707770|FG000|Overall Study|Withdrawal by Subject|1|||
125294894|NCT00680368|450707776|FG000|Overall Study|not supervised, not eligible|15|||
125294895|NCT00443781|450707781|FG000|Overall Study|Lost to Follow-up|10|||
125294896|NCT00443781|450707781|FG000|Overall Study|Physician Decision|2|||
125294897|NCT00443781|450707781|FG000|Overall Study|Protocol Violation|1|||
125294898|NCT00443781|450707781|FG000|Overall Study|Withdrawal by Subject|6|||
125294899|NCT00443781|450707781|FG000|Overall Study|Unable to comply with study follow up|2|||
125294900|NCT00443781|450707781|FG000|Overall Study|Investigator terminated participation|1|||
125456720|NCT03140176|451300576|FG000|Overall Study|Physician Decision|1|||
125456721|NCT03140176|451300576|FG000|Overall Study|Withdrawal by Subject|1|||
125456722|NCT03140176|451300576|FG000|Overall Study|Lost to Follow-up|15|||
125456723|NCT01331824|451300577|FG000|Overall Study|Adverse Event|2|||
125294901|NCT00443781|450707781|FG000|Overall Study|Insurance not covered|2|||
125294902|NCT00443781|450707781|FG000|Overall Study|PD/FAD not done|1|||
125294903|NCT00582738|450707782|FG000|Overall Study|Administrative Problems|7|||
125294904|NCT00582738|450707783|FG001|Overall Study|Administrative Problems|8|||
125294905|NCT00582738|450707782|FG000|Overall Study|Adverse Event|0|||
125294906|NCT00582738|450707783|FG001|Overall Study|Adverse Event|5|||
125294907|NCT00582738|450707782|FG000|Overall Study|Graft Lost|0|||
125294908|NCT00582738|450707783|FG001|Overall Study|Graft Lost|1|||
125456724|NCT01331824|451300577|FG000|Overall Study|Death|1|||
125456725|NCT01331824|451300577|FG000|Overall Study|Disease Progression|9|||
125456726|NCT01331824|451300577|FG000|Overall Study|Withdrawal by Subject|1|||
125456727|NCT01185522|451300578|FG000|Overall Study|Lack of Efficacy|28|||
125456728|NCT01185522|451300578|FG000|Overall Study|Lost to Follow-up|19|||
125456729|NCT01185522|451300578|FG000|Overall Study|Withdrawal by Subject|10|||
125456730|NCT01185522|451300578|FG000|Overall Study|Poor tolerance|39|||
125456731|NCT01185522|451300578|FG000|Overall Study|Other reasons|12|||
125456732|NCT00918957|451300579|FG000|Overall Study|Adverse Event|2|||
125456733|NCT00918957|451300580|FG001|Overall Study|Adverse Event|0|||
125456734|NCT00918957|451300579|FG000|Overall Study|Withdrawal by Subject|1|||
125456735|NCT00918957|451300580|FG001|Overall Study|Withdrawal by Subject|0|||
125456736|NCT01803646|451300581|FG000|Overall Study|Protocol Violation|1|||
125456737|NCT01803646|451300582|FG001|Overall Study|Protocol Violation|0|||
125456738|NCT01803646|451300581|FG000|Overall Study|Adverse Event|1|||
125456739|NCT01803646|451300582|FG001|Overall Study|Adverse Event|1|||
125294909|NCT00582738|450707782|FG000|Overall Study|Other|1|||
125294910|NCT00582738|450707783|FG001|Overall Study|Other|0|||
125294911|NCT00582738|450707782|FG000|Overall Study|Protocol Violation|1|||
125294912|NCT00582738|450707783|FG001|Overall Study|Protocol Violation|1|||
125456740|NCT01803646|451300581|FG000|Overall Study|Withdrawal by Subject|9|||
125456741|NCT01803646|451300582|FG001|Overall Study|Withdrawal by Subject|6|||
125294913|NCT00582738|450707782|FG000|Overall Study|Withdrawal by Subject|0|||
125294914|NCT00582738|450707783|FG001|Overall Study|Withdrawal by Subject|3|||
125294915|NCT02758301|450707784|FG000|Overall Study|Death|12|||
125294916|NCT02758301|450707785|FG001|Overall Study|Death|0|||
125294917|NCT02758301|450707784|FG000|Overall Study|Physician Decision|10|||
125294918|NCT02758301|450707785|FG001|Overall Study|Physician Decision|1|||
125294919|NCT02758301|450707784|FG000|Overall Study|Withdrawal by Subject|5|||
125294920|NCT02758301|450707785|FG001|Overall Study|Withdrawal by Subject|6|||
125456742|NCT01803646|451300581|FG000|Overall Study|Randomization error|1|||
125456743|NCT01803646|451300582|FG001|Overall Study|Randomization error|2|||
125456744|NCT01803646|451300581|FG000|Overall Study|Lost to Follow-up|5|||
125456745|NCT01803646|451300582|FG001|Overall Study|Lost to Follow-up|1|||
125456746|NCT01131494|451300583|FG000|Overall Study|Withdrawal by Subject|2|||
125456747|NCT02614560|451300584|FG000|Overall Study|Death|6|||
125456748|NCT02614560|451300585|FG001|Overall Study|Death|2|||
125456749|NCT03923491|451300591|FG000|Overall Study|Lost to Follow-up|5|||
125456750|NCT03923491|451300592|FG001|Overall Study|Lost to Follow-up|8|||
125294921|NCT02758301|450707784|FG000|Overall Study|Lost to Follow-up|7|||
125294922|NCT02758301|450707785|FG001|Overall Study|Lost to Follow-up|0|||
125294923|NCT02758301|450707784|FG000|Overall Study|Protocol Violation|0|||
125294924|NCT02758301|450707785|FG001|Overall Study|Protocol Violation|1|||
125294925|NCT00364533|450707786|FG000|Overall Study|Adverse Event|8|||
125294926|NCT00364533|450707787|FG001|Overall Study|Adverse Event|7|||
125294927|NCT00364533|450707788|FG002|Overall Study|Adverse Event|15|||
125294928|NCT00364533|450707789|FG003|Overall Study|Adverse Event|5|||
125294929|NCT00364533|450707790|FG004|Overall Study|Adverse Event|2|||
125294930|NCT00364533|450707786|FG000|Overall Study|Withdrawal by Subject|4|||
125294931|NCT00364533|450707787|FG001|Overall Study|Withdrawal by Subject|8|||
125294932|NCT00364533|450707788|FG002|Overall Study|Withdrawal by Subject|6|||
125294933|NCT00364533|450707789|FG003|Overall Study|Withdrawal by Subject|6|||
125294934|NCT00364533|450707790|FG004|Overall Study|Withdrawal by Subject|6|||
125294935|NCT00364533|450707786|FG000|Overall Study|Lack of Efficacy|22|||
125294936|NCT00364533|450707787|FG001|Overall Study|Lack of Efficacy|22|||
125294937|NCT00364533|450707788|FG002|Overall Study|Lack of Efficacy|21|||
125294938|NCT00364533|450707789|FG003|Overall Study|Lack of Efficacy|17|||
125294939|NCT00364533|450707790|FG004|Overall Study|Lack of Efficacy|42|||
125294940|NCT00364533|450707786|FG000|Overall Study|Subject discharged from hospital|4|||
125294941|NCT00364533|450707787|FG001|Overall Study|Subject discharged from hospital|1|||
125294942|NCT00364533|450707788|FG002|Overall Study|Subject discharged from hospital|2|||
125294943|NCT00364533|450707789|FG003|Overall Study|Subject discharged from hospital|3|||
125294944|NCT00364533|450707790|FG004|Overall Study|Subject discharged from hospital|1|||
125294945|NCT00364533|450707786|FG000|Overall Study|Variations in drug compliance|2|||
125294946|NCT00364533|450707787|FG001|Overall Study|Variations in drug compliance|1|||
125294947|NCT00364533|450707788|FG002|Overall Study|Variations in drug compliance|1|||
125294948|NCT00364533|450707789|FG003|Overall Study|Variations in drug compliance|0|||
125294949|NCT00364533|450707790|FG004|Overall Study|Variations in drug compliance|0|||
125294950|NCT00364533|450707786|FG000|Overall Study|Non-compliance|1|||
125294951|NCT00364533|450707787|FG001|Overall Study|Non-compliance|0|||
125294952|NCT00364533|450707788|FG002|Overall Study|Non-compliance|0|||
125294953|NCT00364533|450707789|FG003|Overall Study|Non-compliance|0|||
125294954|NCT00364533|450707790|FG004|Overall Study|Non-compliance|0|||
125294955|NCT00364533|450707786|FG000|Overall Study|Protocol Violation|1|||
125294956|NCT00364533|450707787|FG001|Overall Study|Protocol Violation|1|||
125294957|NCT00364533|450707788|FG002|Overall Study|Protocol Violation|0|||
125294958|NCT00364533|450707789|FG003|Overall Study|Protocol Violation|0|||
125294959|NCT00364533|450707790|FG004|Overall Study|Protocol Violation|0|||
125294960|NCT00652899|450707791|FG000|Overall Study|Death|1|||
125294961|NCT00652899|450707791|FG000|Overall Study|Treating physician decision|1|||
125294962|NCT00551291|450707792|FG000|Overall Study|Physician Decision|1|||
125294963|NCT01943552|450707793|FG000|Overall Study|Adverse Event|3|||
125294964|NCT01943552|450707794|FG001|Overall Study|Adverse Event|2|||
125294965|NCT01943552|450707793|FG000|Overall Study|Withdrawal by Subject|6|||
125294966|NCT01943552|450707794|FG001|Overall Study|Withdrawal by Subject|6|||
125294967|NCT01943552|450707793|FG000|Overall Study|Other Reasons|16|||
125294968|NCT01943552|450707794|FG001|Overall Study|Other Reasons|17|||
125294969|NCT05059977|450707797|FG000|Overall Study|Withdrawal by Subject|0|||
125294970|NCT05059977|450707798|FG001|Overall Study|Withdrawal by Subject|0|||
125294971|NCT05059977|450707799|FG002|Overall Study|Withdrawal by Subject|1|||
125294972|NCT00576472|450707802|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294973|NCT00576472|450707803|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294974|NCT00576472|450707804|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294975|NCT00576472|450707805|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
125294976|NCT00576472|450707806|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294977|NCT00576472|450707807|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294978|NCT00576472|450707808|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294979|NCT00576472|450707809|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294980|NCT00576472|450707810|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294981|NCT00576472|450707811|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294982|NCT00576472|450707812|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294983|NCT00576472|450707813|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294984|NCT00576472|450707814|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294985|NCT00576472|450707815|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294986|NCT00576472|450707816|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
125294987|NCT00576472|450707802|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
125294988|NCT00576472|450707803|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
125294989|NCT00576472|450707804|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
125294990|NCT00576472|450707805|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
125294991|NCT00576472|450707806|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
125294992|NCT00576472|450707807|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
125485353|NCT02240238|451412503|FG000|Phase 1|Death|0|||
125294993|NCT00576472|450707808|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
125294994|NCT00576472|450707809|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
125294995|NCT00576472|450707810|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
125294996|NCT00576472|450707811|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
125294997|NCT00576472|450707812|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
125294998|NCT00576472|450707813|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
125294999|NCT00576472|450707814|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
125295000|NCT00576472|450707815|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
125295001|NCT00576472|450707816|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
125295002|NCT00576472|450707802|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295003|NCT00576472|450707803|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295004|NCT00576472|450707804|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295005|NCT00576472|450707805|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
125456751|NCT03923491|451300591|FG000|Overall Study|Withdrawal by Subject|4|||
125456752|NCT03923491|451300592|FG001|Overall Study|Withdrawal by Subject|6|||
125295006|NCT00576472|450707806|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295007|NCT00576472|450707807|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295008|NCT00576472|450707808|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295009|NCT00576472|450707809|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295010|NCT00576472|450707810|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295011|NCT00576472|450707811|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295012|NCT00576472|450707812|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295013|NCT00576472|450707813|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295014|NCT00576472|450707814|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295015|NCT00576472|450707815|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295016|NCT00576472|450707816|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
125295017|NCT00576472|450707802|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
125295018|NCT00576472|450707803|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
125295019|NCT00576472|450707804|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
125295020|NCT00576472|450707805|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
125295021|NCT00576472|450707806|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
125295022|NCT00576472|450707807|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
125295023|NCT00576472|450707808|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
125295024|NCT00576472|450707809|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
125295025|NCT00576472|450707810|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
125295026|NCT00576472|450707811|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
125295027|NCT00576472|450707812|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
125295028|NCT00576472|450707813|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
125295029|NCT00576472|450707814|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
125295030|NCT00576472|450707815|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
125295031|NCT00576472|450707816|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
125295032|NCT00576472|450707802|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295033|NCT00576472|450707803|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295034|NCT00576472|450707804|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295035|NCT00576472|450707805|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
125295036|NCT00576472|450707806|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295037|NCT00576472|450707807|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295038|NCT00576472|450707808|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295039|NCT00576472|450707809|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295040|NCT00576472|450707810|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295041|NCT00576472|450707811|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295042|NCT00576472|450707812|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295043|NCT00576472|450707813|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
125295044|NCT00576472|450707814|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
125456753|NCT00241644|451300597|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
125295045|NCT00576472|450707815|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
125456754|NCT00241644|451300598|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
125456755|NCT00241644|451300599|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
125456756|NCT00241644|451300600|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
125295046|NCT00576472|450707816|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
125456757|NCT00241644|451300597|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
125456758|NCT00241644|451300598|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
125456759|NCT00241644|451300599|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
125456760|NCT00241644|451300600|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
125456761|NCT00241644|451300597|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
125485354|NCT02240238|451412504|FG001|Phase 1|Death|0|||
125295047|NCT00576472|450707802|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295048|NCT00576472|450707803|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295049|NCT00576472|450707804|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295050|NCT00576472|450707805|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295051|NCT00576472|450707806|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295052|NCT00576472|450707807|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295053|NCT00576472|450707808|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
125295054|NCT00576472|450707809|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295055|NCT00576472|450707810|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295056|NCT00576472|450707811|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295057|NCT00576472|450707812|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295058|NCT00576472|450707813|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295059|NCT00576472|450707814|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295060|NCT00576472|450707815|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295061|NCT00576472|450707816|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
125295062|NCT00576472|450707802|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
125295063|NCT00576472|450707803|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
125295064|NCT00576472|450707804|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
125295065|NCT00576472|450707805|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
125295066|NCT00576472|450707806|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
125295067|NCT00576472|450707807|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
125295068|NCT00576472|450707808|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
125295069|NCT00576472|450707809|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
125295070|NCT00576472|450707810|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
125295071|NCT00576472|450707811|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
125295072|NCT00576472|450707812|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
125295073|NCT00576472|450707813|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
125295074|NCT00576472|450707814|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
125295075|NCT00576472|450707815|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
125295076|NCT00576472|450707816|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
125295077|NCT00576472|450707802|FG000|MPH Cross Over Phase|Physician Decision|0|||
125295078|NCT00576472|450707803|FG001|MPH Cross Over Phase|Physician Decision|0|||
125295079|NCT00576472|450707804|FG002|MPH Cross Over Phase|Physician Decision|0|||
125295080|NCT00576472|450707805|FG003|MPH Cross Over Phase|Physician Decision|0|||
125295081|NCT00576472|450707806|FG004|MPH Cross Over Phase|Physician Decision|0|||
125295082|NCT00576472|450707807|FG005|MPH Cross Over Phase|Physician Decision|0|||
125295083|NCT00576472|450707808|FG006|MPH Cross Over Phase|Physician Decision|4|||
125295084|NCT00576472|450707809|FG007|MPH Cross Over Phase|Physician Decision|0|||
125295085|NCT00576472|450707810|FG008|MPH Cross Over Phase|Physician Decision|0|||
125295086|NCT00576472|450707811|FG009|MPH Cross Over Phase|Physician Decision|0|||
125295087|NCT00576472|450707812|FG010|MPH Cross Over Phase|Physician Decision|0|||
125295088|NCT00576472|450707813|FG011|MPH Cross Over Phase|Physician Decision|0|||
125295089|NCT00576472|450707814|FG012|MPH Cross Over Phase|Physician Decision|0|||
125295090|NCT00576472|450707815|FG013|MPH Cross Over Phase|Physician Decision|0|||
125295091|NCT00576472|450707816|FG014|MPH Cross Over Phase|Physician Decision|0|||
125295092|NCT00576472|450707802|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295093|NCT00576472|450707803|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295094|NCT00576472|450707804|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295095|NCT00576472|450707805|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295096|NCT00576472|450707806|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295097|NCT00576472|450707807|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295098|NCT00576472|450707808|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295099|NCT00576472|450707809|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295100|NCT00576472|450707810|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
125295101|NCT00576472|450707811|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295102|NCT00576472|450707812|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
125295103|NCT00576472|450707813|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
125295104|NCT00576472|450707814|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295105|NCT00576472|450707815|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295106|NCT00576472|450707816|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
125295107|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295108|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295109|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295110|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295111|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295112|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295113|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295114|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295115|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295116|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295117|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295118|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295119|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295120|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
125295121|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
125295122|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
125295123|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
125295124|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
125295125|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
125295126|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
125295127|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
125295128|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
125295129|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
125295130|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
125295131|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
125295132|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
125295133|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
125295134|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
125295135|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
125295136|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
125295137|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
125295138|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
125295139|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
125295140|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
125295141|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
125295142|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
125295143|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
125295144|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
125295145|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
125295146|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
125295147|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
125295148|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
125295149|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
125295150|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
125295151|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
125295152|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Side effects|0|||
125295153|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Side effects|0|||
125295154|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Side effects|0|||
125295155|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Side effects|0|||
125295156|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Side effects|0|||
125295157|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Side effects|0|||
125295158|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Side effects|0|||
125295159|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Side effects|0|||
125295160|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Side effects|0|||
125295161|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Side effects|0|||
125295162|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Side effects|0|||
125295163|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Side effects|0|||
125295164|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Side effects|0|||
125295165|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Side effects|0|||
125295166|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Side effects|8|||
125295167|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295168|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295169|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295170|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295171|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295172|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295173|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125456762|NCT00241644|451300598|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
125456763|NCT00241644|451300599|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
125456764|NCT00241644|451300600|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
125456765|NCT00241644|451300597|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
125456766|NCT00241644|451300598|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
125456767|NCT00241644|451300599|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
125456768|NCT00241644|451300600|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
125456769|NCT00241644|451300597|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
125456770|NCT00241644|451300598|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
125456771|NCT00241644|451300599|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
125456772|NCT00241644|451300600|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
125295174|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295175|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125456773|NCT00241644|451300597|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
125456774|NCT00241644|451300598|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
125456775|NCT00241644|451300599|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
125456776|NCT00241644|451300600|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
125485355|NCT02240238|451412505|FG002|Phase 1|Death|0|||
125295176|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125456777|NCT00241644|451300597|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
125456778|NCT00241644|451300598|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
125456779|NCT00241644|451300599|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
125456780|NCT00241644|451300600|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
125456781|NCT00241644|451300597|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
125456782|NCT00241644|451300598|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
125456783|NCT00241644|451300599|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
125456784|NCT00241644|451300600|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
125456785|NCT00241644|451300597|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
125456786|NCT00241644|451300598|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
125456787|NCT00241644|451300599|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
125456788|NCT00241644|451300600|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
125456789|NCT00241644|451300597|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
125456790|NCT00241644|451300598|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
125456791|NCT00241644|451300599|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
125456792|NCT00241644|451300600|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
125456793|NCT00241644|451300597|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
125456794|NCT00241644|451300598|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
125456795|NCT00241644|451300599|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
125456796|NCT00241644|451300600|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
125456797|NCT00241644|451300597|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
125456798|NCT00241644|451300598|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
125456799|NCT00241644|451300599|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
125456800|NCT00241644|451300600|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
125456801|NCT00241644|451300597|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
125456802|NCT00241644|451300598|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
125456803|NCT00241644|451300599|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
125456804|NCT00241644|451300600|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
125456805|NCT03095508|451300601|FG000|Overall Study|Adverse Event|0|||
125456806|NCT03095508|451300602|FG001|Overall Study|Adverse Event|1|||
125456807|NCT01027286|451300603|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
125456808|NCT01027286|451300604|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
125456809|NCT01027286|451300603|FG000|Overall Study|Lost to Follow-up|0|||
125456810|NCT01027286|451300604|FG001|Overall Study|Lost to Follow-up|1|||
125456811|NCT03201809|451300605|FG000|Overall Study|Lost to Follow-up|2|||
125456812|NCT03201809|451300606|FG001|Overall Study|Lost to Follow-up|0|||
125456813|NCT00545844|451300607|FG000|Overall Study|Lost to Follow-up|9|||
125456814|NCT00545844|451300607|FG000|Overall Study|Protocol Violation|1|||
125456815|NCT00545844|451300607|FG000|Overall Study|Withdrawal by Subject|2|||
125456816|NCT00975806|451300609|FG000|Overall Study|Adverse Event|2|||
125456817|NCT00975806|451300610|FG001|Overall Study|Adverse Event|1|||
125456818|NCT00975806|451300611|FG002|Overall Study|Adverse Event|2|||
125456819|NCT00975806|451300609|FG000|Overall Study|Disease Progression|1|||
125456820|NCT00975806|451300610|FG001|Overall Study|Disease Progression|5|||
125456821|NCT00975806|451300611|FG002|Overall Study|Disease Progression|1|||
125456822|NCT00975806|451300609|FG000|Overall Study|Withdrawal by Subject|1|||
125456823|NCT00975806|451300610|FG001|Overall Study|Withdrawal by Subject|0|||
125456824|NCT00975806|451300611|FG002|Overall Study|Withdrawal by Subject|0|||
125456825|NCT00975806|451300609|FG000|Overall Study|Death|0|||
125456826|NCT00975806|451300610|FG001|Overall Study|Death|1|||
125456827|NCT00975806|451300611|FG002|Overall Study|Death|0|||
125456828|NCT00975806|451300609|FG000|Overall Study|Physician decision and disease related|1|||
125456829|NCT00975806|451300610|FG001|Overall Study|Physician decision and disease related|0|||
125456830|NCT00975806|451300611|FG002|Overall Study|Physician decision and disease related|1|||
125456831|NCT00094809|451300612|FG000|Overall Study|Protocol deviation|2|||
125456832|NCT00094809|451300613|FG001|Overall Study|Protocol deviation|2|||
125456833|NCT00094809|451300612|FG000|Overall Study|Noncompliance|1|||
125456834|NCT00094809|451300613|FG001|Overall Study|Noncompliance|0|||
125456835|NCT00094809|451300612|FG000|Overall Study|Adverse Event|3|||
125456836|NCT00094809|451300613|FG001|Overall Study|Adverse Event|1|||
125456837|NCT00094809|451300612|FG000|Overall Study|Withdrawal by Subject|8|||
125456838|NCT00094809|451300613|FG001|Overall Study|Withdrawal by Subject|9|||
125456839|NCT00094809|451300612|FG000|Overall Study|Disease progression|3|||
125456840|NCT00094809|451300613|FG001|Overall Study|Disease progression|3|||
125456841|NCT00094809|451300612|FG000|Overall Study|Physician Decision|3|||
125456842|NCT00094809|451300613|FG001|Overall Study|Physician Decision|5|||
125456843|NCT00094809|451300612|FG000|Overall Study|Lost to Follow-up|6|||
125456844|NCT00094809|451300613|FG001|Overall Study|Lost to Follow-up|6|||
125456845|NCT00094809|451300612|FG000|Overall Study|Death|19|||
125456846|NCT00094809|451300613|FG001|Overall Study|Death|25|||
125456847|NCT00094809|451300612|FG000|Overall Study|Protocol-specified criteria|1|||
125456848|NCT00094809|451300613|FG001|Overall Study|Protocol-specified criteria|1|||
125456849|NCT00094809|451300612|FG000|Overall Study|Other|2|||
125456850|NCT00094809|451300613|FG001|Overall Study|Other|4|||
125456851|NCT00094809|451300612|FG000|Overall Study|Informed consent signed after treatment|1|||
125456852|NCT00094809|451300613|FG001|Overall Study|Informed consent signed after treatment|0|||
125456853|NCT00094809|451300612|FG000|Overall Study|Study drug not received|2|||
125456854|NCT00094809|451300613|FG001|Overall Study|Study drug not received|8|||
125456855|NCT00094809|451300612|FG000|Overall Study|Other|1|||
125456856|NCT00094809|451300613|FG001|Overall Study|Other|1|||
125456857|NCT02377362|451300614|FG000|Part A Second Treatment|Protocol Violation|0|||
125456858|NCT02377362|451300615|FG001|Part A Second Treatment|Protocol Violation|0|||
125456859|NCT02377362|451300616|FG002|Part A Second Treatment|Protocol Violation|0|||
125456860|NCT02377362|451300617|FG003|Part A Second Treatment|Protocol Violation|0|||
125456861|NCT02377362|451300618|FG004|Part A Second Treatment|Protocol Violation|1|||
125456862|NCT02377362|451300619|FG005|Part A Second Treatment|Protocol Violation|0|||
125456863|NCT02377362|451300620|FG006|Part A Second Treatment|Protocol Violation|0|||
125456864|NCT02377362|451300621|FG007|Part A Second Treatment|Protocol Violation|0|||
125456865|NCT02377362|451300622|FG008|Part A Second Treatment|Protocol Violation|0|||
125456866|NCT02377362|451300623|FG009|Part A Second Treatment|Protocol Violation|0|||
125456867|NCT02377362|451300624|FG010|Part A Second Treatment|Protocol Violation|0|||
125456868|NCT02377362|451300625|FG011|Part A Second Treatment|Protocol Violation|0|||
125456869|NCT02377362|451300626|FG012|Part A Second Treatment|Protocol Violation|0|||
125456870|NCT02377362|451300614|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
125456871|NCT02377362|451300615|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
125456872|NCT02377362|451300616|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
125456873|NCT02377362|451300617|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
125456874|NCT02377362|451300618|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
125456875|NCT02377362|451300619|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
125456876|NCT02377362|451300620|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
125456877|NCT02377362|451300621|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
125456878|NCT02377362|451300622|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
125456879|NCT02377362|451300623|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
125456880|NCT02377362|451300624|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
125456881|NCT02377362|451300625|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
125456882|NCT02377362|451300626|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
125456883|NCT02377362|451300614|FG000|Part B Overall|Protocol Violation|0|||
125456884|NCT02377362|451300615|FG001|Part B Overall|Protocol Violation|0|||
125456885|NCT02377362|451300616|FG002|Part B Overall|Protocol Violation|0|||
125456886|NCT02377362|451300617|FG003|Part B Overall|Protocol Violation|0|||
125456887|NCT02377362|451300618|FG004|Part B Overall|Protocol Violation|0|||
125456888|NCT02377362|451300619|FG005|Part B Overall|Protocol Violation|0|||
125456889|NCT02377362|451300620|FG006|Part B Overall|Protocol Violation|0|||
125456890|NCT02377362|451300621|FG007|Part B Overall|Protocol Violation|0|||
125456891|NCT02377362|451300622|FG008|Part B Overall|Protocol Violation|0|||
125456892|NCT02377362|451300623|FG009|Part B Overall|Protocol Violation|1|||
125456893|NCT02377362|451300624|FG010|Part B Overall|Protocol Violation|0|||
125456894|NCT02377362|451300625|FG011|Part B Overall|Protocol Violation|0|||
125456895|NCT02377362|451300626|FG012|Part B Overall|Protocol Violation|0|||
125456896|NCT02377362|451300614|FG000|Part B Overall|Adverse Event|0|||
125456897|NCT02377362|451300615|FG001|Part B Overall|Adverse Event|0|||
125456898|NCT02377362|451300616|FG002|Part B Overall|Adverse Event|0|||
125456899|NCT02377362|451300617|FG003|Part B Overall|Adverse Event|0|||
125456900|NCT02377362|451300618|FG004|Part B Overall|Adverse Event|0|||
125456901|NCT02377362|451300619|FG005|Part B Overall|Adverse Event|0|||
125456902|NCT02377362|451300620|FG006|Part B Overall|Adverse Event|1|||
125456903|NCT02377362|451300621|FG007|Part B Overall|Adverse Event|1|||
125456904|NCT02377362|451300622|FG008|Part B Overall|Adverse Event|0|||
125456905|NCT02377362|451300623|FG009|Part B Overall|Adverse Event|0|||
125456906|NCT02377362|451300624|FG010|Part B Overall|Adverse Event|0|||
125456907|NCT02377362|451300625|FG011|Part B Overall|Adverse Event|0|||
125456908|NCT02377362|451300626|FG012|Part B Overall|Adverse Event|0|||
125456909|NCT02377362|451300614|FG000|Part B Overall|Withdrawal by Subject|0|||
125456910|NCT02377362|451300615|FG001|Part B Overall|Withdrawal by Subject|0|||
125456911|NCT02377362|451300616|FG002|Part B Overall|Withdrawal by Subject|0|||
125456912|NCT02377362|451300617|FG003|Part B Overall|Withdrawal by Subject|0|||
125456913|NCT02377362|451300618|FG004|Part B Overall|Withdrawal by Subject|0|||
125456914|NCT02377362|451300619|FG005|Part B Overall|Withdrawal by Subject|0|||
125456915|NCT02377362|451300620|FG006|Part B Overall|Withdrawal by Subject|1|||
125295177|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125456916|NCT02377362|451300621|FG007|Part B Overall|Withdrawal by Subject|0|||
125456917|NCT02377362|451300622|FG008|Part B Overall|Withdrawal by Subject|0|||
125456918|NCT02377362|451300623|FG009|Part B Overall|Withdrawal by Subject|0|||
125456919|NCT02377362|451300624|FG010|Part B Overall|Withdrawal by Subject|0|||
125456920|NCT02377362|451300625|FG011|Part B Overall|Withdrawal by Subject|1|||
125456921|NCT02377362|451300626|FG012|Part B Overall|Withdrawal by Subject|0|||
125456922|NCT01585038|451300627|FG000|Overall Study|Adverse Event|2|||
125456923|NCT01585038|451300628|FG001|Overall Study|Adverse Event|2|||
125456924|NCT01191086|451300640|FG000|Overall Study|Adverse Event|20|||
125456925|NCT01191086|451300640|FG000|Overall Study|Lack of Efficacy|10|||
125456926|NCT01191086|451300640|FG000|Overall Study|Lost to Follow-up|4|||
125456927|NCT01191086|451300640|FG000|Overall Study|Physician Decision|2|||
125456928|NCT01191086|451300640|FG000|Overall Study|Withdrawal by Subject|24|||
125456929|NCT01191086|451300640|FG000|Overall Study|Discontinuation criterion met|1|||
125456930|NCT01191086|451300640|FG000|Overall Study|Other|1|||
125456931|NCT00771849|451300641|FG000|Overall Study|Lost to Follow-up|1|||
125456932|NCT00771849|451300642|FG001|Overall Study|Lost to Follow-up|2|||
125456933|NCT00771849|451300641|FG000|Overall Study|Withdrawal by Subject|1|||
125456934|NCT00771849|451300642|FG001|Overall Study|Withdrawal by Subject|1|||
125456935|NCT00771849|451300641|FG000|Overall Study|Not vaccinated|0|||
125456936|NCT00771849|451300642|FG001|Overall Study|Not vaccinated|1|||
125456937|NCT02046616|451300647|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
125456938|NCT02046616|451300647|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
125456939|NCT02046616|451300647|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
125456940|NCT02046616|451300647|FG000|24-Week Treatment Period|Physician Decision|3|||
125456941|NCT02046616|451300647|FG000|24-Week Treatment Period|Other|1|||
125456942|NCT02046616|451300647|FG000|8-Week FU Period|Lost to Follow-up|1|||
125456943|NCT02736799|451300648|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
125456944|NCT02736799|451300649|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
125456945|NCT02736799|451300650|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
125456946|NCT02736799|451300651|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
125456947|NCT01156116|451300654|FG000|Overall Study|Withdrawal by Subject|3|||
125456948|NCT01156116|451300655|FG001|Overall Study|Withdrawal by Subject|1|||
125456949|NCT01156116|451300654|FG000|Overall Study|CPAP intolerance|2|||
125456950|NCT01156116|451300655|FG001|Overall Study|CPAP intolerance|0|||
125456951|NCT00344019|451300656|FG000|Overall Study|did not meet final inclusion criteria|0|||
125456952|NCT00344019|451300657|FG001|Overall Study|did not meet final inclusion criteria|0|||
125456953|NCT00344019|451300658|FG002|Overall Study|did not meet final inclusion criteria|74|||
125456954|NCT02057718|451300659|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
125456955|NCT02057718|451300660|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
125456956|NCT02057718|451300659|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
125456957|NCT02057718|451300660|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
125456958|NCT02057718|451300659|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
125456959|NCT02057718|451300660|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
125456960|NCT02057718|451300659|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
125456961|NCT02057718|451300660|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
125456962|NCT02057718|451300659|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
125456963|NCT02057718|451300660|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
125456964|NCT02057718|451300659|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
125456965|NCT02057718|451300660|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
125456966|NCT02057718|451300659|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
125456967|NCT02057718|451300660|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
125456968|NCT02057718|451300659|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
125456969|NCT02057718|451300660|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
125456970|NCT02057718|451300659|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
125456971|NCT02057718|451300660|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
125456972|NCT02057718|451300659|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
125456973|NCT02057718|451300660|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
125456974|NCT02057718|451300659|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
125456975|NCT02057718|451300660|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
125456976|NCT02503202|451300661|FG000|Base Study: Up to Month 6|Death|1|||
125456977|NCT02503202|451300662|FG001|Base Study: Up to Month 6|Death|1|||
125456978|NCT02503202|451300663|FG002|Base Study: Up to Month 6|Death|0|||
125456979|NCT02503202|451300664|FG003|Base Study: Up to Month 6|Death|0|||
125456980|NCT02503202|451300665|FG004|Base Study: Up to Month 6|Death|0|||
125456981|NCT02503202|451300661|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
125456982|NCT02503202|451300662|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
125456983|NCT02503202|451300663|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
125456984|NCT02503202|451300664|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
125456985|NCT02503202|451300665|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
125456986|NCT02503202|451300661|FG000|Base Study: Up to Month 6|Physician Decision|0|||
125456987|NCT02503202|451300662|FG001|Base Study: Up to Month 6|Physician Decision|0|||
125456988|NCT02503202|451300663|FG002|Base Study: Up to Month 6|Physician Decision|0|||
125456989|NCT02503202|451300664|FG003|Base Study: Up to Month 6|Physician Decision|0|||
125456990|NCT02503202|451300665|FG004|Base Study: Up to Month 6|Physician Decision|1|||
125456991|NCT02503202|451300661|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
125456992|NCT02503202|451300662|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
125456993|NCT02503202|451300663|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
125456994|NCT02503202|451300664|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
125456995|NCT02503202|451300665|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
125456996|NCT02503202|451300661|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
125456997|NCT02503202|451300662|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
125456998|NCT02503202|451300663|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
125456999|NCT02503202|451300664|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
125457000|NCT02503202|451300665|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
125457001|NCT02503202|451300661|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
125457002|NCT02503202|451300662|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
125457003|NCT02503202|451300663|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
125457004|NCT02503202|451300664|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
125457005|NCT02503202|451300665|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
125457006|NCT02503202|451300661|FG000|Extension: Month 6 to 24|Death|1|||
125457007|NCT02503202|451300662|FG001|Extension: Month 6 to 24|Death|0|||
125457008|NCT02503202|451300663|FG002|Extension: Month 6 to 24|Death|0|||
125457009|NCT02503202|451300664|FG003|Extension: Month 6 to 24|Death|0|||
125457010|NCT02503202|451300665|FG004|Extension: Month 6 to 24|Death|0|||
125457011|NCT02503202|451300661|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
125457012|NCT02503202|451300662|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
125457013|NCT02503202|451300663|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
125457014|NCT02503202|451300664|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
125457015|NCT02503202|451300665|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
125457016|NCT02503202|451300661|FG000|Extension: Month 6 to 24|Physician Decision|1|||
125457017|NCT02503202|451300662|FG001|Extension: Month 6 to 24|Physician Decision|0|||
125457018|NCT02503202|451300663|FG002|Extension: Month 6 to 24|Physician Decision|1|||
125457019|NCT02503202|451300664|FG003|Extension: Month 6 to 24|Physician Decision|3|||
125457020|NCT02503202|451300665|FG004|Extension: Month 6 to 24|Physician Decision|0|||
125457021|NCT02503202|451300661|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
125457022|NCT02503202|451300662|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
125457023|NCT02503202|451300663|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
125457024|NCT02503202|451300664|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
125457025|NCT02503202|451300665|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
125457026|NCT01959412|451300667|FG000|Overall Study|Protocol deviation|1|||
125457027|NCT01959412|451300668|FG001|Overall Study|Protocol deviation|1|||
125457028|NCT01959412|451300669|FG002|Overall Study|Protocol deviation|0|||
125457029|NCT01959412|451300670|FG003|Overall Study|Protocol deviation|1|||
125457030|NCT01959412|451300671|FG004|Overall Study|Protocol deviation|3|||
125457031|NCT01959412|451300672|FG005|Overall Study|Protocol deviation|0|||
125457032|NCT01959412|451300667|FG000|Overall Study|Adverse Event|0|||
125457033|NCT01959412|451300668|FG001|Overall Study|Adverse Event|0|||
125457034|NCT01959412|451300669|FG002|Overall Study|Adverse Event|0|||
125457035|NCT01959412|451300670|FG003|Overall Study|Adverse Event|1|||
125457036|NCT01959412|451300671|FG004|Overall Study|Adverse Event|0|||
125457037|NCT01959412|451300672|FG005|Overall Study|Adverse Event|0|||
125457038|NCT00509769|451300673|FG000|Overall Study|Progressive disease|77|||
125457039|NCT00509769|451300673|FG000|Overall Study|Adverse Event|4|||
125457040|NCT00509769|451300673|FG000|Overall Study|Patient's decision|1|||
125457041|NCT00509769|451300673|FG000|Overall Study|Physician Decision|8|||
125457042|NCT00509769|451300673|FG000|Overall Study|Use of prohibited therapies during study|1|||
125457043|NCT04364269|451300678|FG000|Overall Study|Adverse Event|1|||
125457044|NCT04364269|451300679|FG001|Overall Study|Adverse Event|0|||
125457045|NCT04364269|451300680|FG002|Overall Study|Adverse Event|0|||
125457046|NCT04364269|451300678|FG000|Overall Study|Withdrawal by Subject|0|||
125457047|NCT04364269|451300679|FG001|Overall Study|Withdrawal by Subject|1|||
125457048|NCT04364269|451300680|FG002|Overall Study|Withdrawal by Subject|0|||
125457049|NCT00383188|451300681|FG000|Overall Study|Adverse Event|4|||
125457050|NCT00383188|451300682|FG001|Overall Study|Adverse Event|7|||
125457051|NCT00383188|451300683|FG002|Overall Study|Adverse Event|9|||
125457052|NCT00383188|451300684|FG003|Overall Study|Adverse Event|8|||
125457053|NCT00383188|451300685|FG004|Overall Study|Adverse Event|8|||
125457054|NCT00383188|451300681|FG000|Overall Study|Lack of Efficacy|9|||
125457055|NCT00383188|451300682|FG001|Overall Study|Lack of Efficacy|3|||
125457056|NCT00383188|451300683|FG002|Overall Study|Lack of Efficacy|3|||
125457057|NCT00383188|451300684|FG003|Overall Study|Lack of Efficacy|2|||
125457058|NCT00383188|451300685|FG004|Overall Study|Lack of Efficacy|6|||
125457059|NCT00383188|451300681|FG000|Overall Study|Other|3|||
125457060|NCT00383188|451300682|FG001|Overall Study|Other|1|||
125457061|NCT00383188|451300683|FG002|Overall Study|Other|0|||
125457062|NCT00383188|451300684|FG003|Overall Study|Other|2|||
125457063|NCT00383188|451300685|FG004|Overall Study|Other|6|||
125457064|NCT00383188|451300681|FG000|Overall Study|No longer willing to participate|1|||
125457065|NCT00383188|451300682|FG001|Overall Study|No longer willing to participate|0|||
125457066|NCT00383188|451300683|FG002|Overall Study|No longer willing to participate|1|||
125485356|NCT02240238|451412506|FG003|Phase 1|Death|0|||
125457067|NCT00383188|451300684|FG003|Overall Study|No longer willing to participate|0|||
125457068|NCT00383188|451300685|FG004|Overall Study|No longer willing to participate|2|||
125457069|NCT00383188|451300681|FG000|Overall Study|Lost to Follow-up|0|||
125457070|NCT00383188|451300682|FG001|Overall Study|Lost to Follow-up|0|||
125457071|NCT00383188|451300683|FG002|Overall Study|Lost to Follow-up|0|||
125457072|NCT00383188|451300684|FG003|Overall Study|Lost to Follow-up|0|||
125457073|NCT00383188|451300685|FG004|Overall Study|Lost to Follow-up|1|||
125457074|NCT01227707|451300691|FG000|Overall Study|Adverse Event|10|||
125457075|NCT01227707|451300691|FG000|Overall Study|Progression of disease|3|||
125457076|NCT01227707|451300691|FG000|Overall Study|Withdrawal by Subject|1|||
125457077|NCT01227707|451300691|FG000|Overall Study|Patient non-compliance|3|||
125457078|NCT01227707|451300691|FG000|Overall Study|Medical decision|6|||
125457079|NCT01227707|451300691|FG000|Overall Study|Death|1|||
125457080|NCT01093534|451300694|FG000|Overall Study|Adverse Event|2|||
125457081|NCT01093534|451300695|FG001|Overall Study|Adverse Event|5|||
125457082|NCT01093534|451300696|FG002|Overall Study|Adverse Event|2|||
125457083|NCT01093534|451300694|FG000|Overall Study|Lack of Efficacy|2|||
125457084|NCT01093534|451300695|FG001|Overall Study|Lack of Efficacy|1|||
125457085|NCT01093534|451300696|FG002|Overall Study|Lack of Efficacy|1|||
125457086|NCT01093534|451300694|FG000|Overall Study|Withdrawal by Subject|5|||
125457087|NCT01093534|451300695|FG001|Overall Study|Withdrawal by Subject|7|||
125457088|NCT01093534|451300696|FG002|Overall Study|Withdrawal by Subject|2|||
125457089|NCT01093534|451300694|FG000|Overall Study|Other|1|||
125457090|NCT01093534|451300695|FG001|Overall Study|Other|3|||
125457091|NCT01093534|451300696|FG002|Overall Study|Other|4|||
125457092|NCT01768676|451300713|FG000|Overall Study|Adverse Event|3|||
125457093|NCT01768676|451300714|FG001|Overall Study|Adverse Event|3|||
125457094|NCT01768676|451300713|FG000|Overall Study|Lost to Follow-up|13|||
125457095|NCT01768676|451300714|FG001|Overall Study|Lost to Follow-up|16|||
125457096|NCT01768676|451300713|FG000|Overall Study|Protocol Violation|1|||
125457097|NCT01768676|451300714|FG001|Overall Study|Protocol Violation|1|||
125457098|NCT01768676|451300713|FG000|Overall Study|Physician Decision|4|||
125457099|NCT01768676|451300714|FG001|Overall Study|Physician Decision|1|||
125457100|NCT01768676|451300713|FG000|Overall Study|Withdrawal by Subject|3|||
125457101|NCT01768676|451300714|FG001|Overall Study|Withdrawal by Subject|10|||
125457102|NCT01196429|451300715|FG000|Overall Study|Ineligible - inadequate pathology|1|||
125457103|NCT01196429|451300716|FG001|Overall Study|Ineligible - inadequate pathology|0|||
125457104|NCT01196429|451300715|FG000|Overall Study|Ineligible - wrong cell type|1|||
125457105|NCT01196429|451300716|FG001|Overall Study|Ineligible - wrong cell type|0|||
125457106|NCT01196429|451300715|FG000|Overall Study|Refused - Never Treated|1|||
125457107|NCT01196429|451300716|FG001|Overall Study|Refused - Never Treated|0|||
125457108|NCT04248829|451300717|FG000|Overall Study|Disease progression|44|||
125457109|NCT04248829|451300718|FG001|Overall Study|Disease progression|109|||
125457110|NCT04248829|451300717|FG000|Overall Study|Adverse Event|19|||
125457111|NCT04248829|451300718|FG001|Overall Study|Adverse Event|18|||
125457112|NCT04248829|451300717|FG000|Overall Study|Withdrawal by Subject|11|||
125457113|NCT04248829|451300718|FG001|Overall Study|Withdrawal by Subject|2|||
125457114|NCT04248829|451300717|FG000|Overall Study|Lost to Follow-up|0|||
125457115|NCT04248829|451300718|FG001|Overall Study|Lost to Follow-up|1|||
125457116|NCT04248829|451300717|FG000|Overall Study|Death|12|||
125457117|NCT04248829|451300718|FG001|Overall Study|Death|14|||
125457118|NCT04248829|451300717|FG000|Overall Study|Physician Decision|2|||
125457119|NCT04248829|451300718|FG001|Overall Study|Physician Decision|4|||
125457120|NCT04248829|451300717|FG000|Overall Study|Any reason not specifically recorded|0|||
125457121|NCT04248829|451300718|FG001|Overall Study|Any reason not specifically recorded|2|||
125457122|NCT02685033|451300719|FG000|Overall Study|Withdrawal of Consent|0|||
125457123|NCT02685033|451300720|FG001|Overall Study|Withdrawal of Consent|1|||
125457124|NCT02685033|451300719|FG000|Overall Study|Lost to Follow-up|2|||
125457125|NCT02685033|451300720|FG001|Overall Study|Lost to Follow-up|1|||
125457126|NCT02685033|451300719|FG000|Overall Study|Adverse Event|1|||
125457127|NCT02685033|451300720|FG001|Overall Study|Adverse Event|0|||
125457128|NCT01066923|451300721|FG000|Overall Study|Withdrawal by Subject|3|||
125457129|NCT01066923|451300722|FG001|Overall Study|Withdrawal by Subject|3|||
125457130|NCT01066923|451300723|FG002|Overall Study|Withdrawal by Subject|8|||
125457131|NCT01066923|451300724|FG003|Overall Study|Withdrawal by Subject|8|||
125457132|NCT00149630|451302020|FG000|Overall Study|Incarceration|2|||
125457133|NCT00149630|451302021|FG001|Overall Study|Incarceration|0|||
125457134|NCT00149630|451302020|FG000|Overall Study|Treatment Programs|4|||
125457135|NCT00149630|451302021|FG001|Overall Study|Treatment Programs|5|||
125457136|NCT00149630|451302020|FG000|Overall Study|Adverse Event|2|||
125457137|NCT00149630|451302021|FG001|Overall Study|Adverse Event|0|||
125457138|NCT05298111|451302026|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
125457139|NCT05298111|451302027|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
125457140|NCT02689349|451302028|FG000|Overall Study|Not implanted|4|||
125457141|NCT02689349|451302029|FG001|Overall Study|Not implanted|0|||
125457142|NCT02689349|451302028|FG000|Overall Study|Withdrawal by Subject|9|||
125457143|NCT02689349|451302029|FG001|Overall Study|Withdrawal by Subject|0|||
125457144|NCT03518112|451302030|FG000|Overall Study|Withdrawal by Subject|1|||
125457145|NCT00771667|451302031|FG000|Induction Phase|Adverse Event|5|||
125457146|NCT00771667|451302032|FG001|Induction Phase|Adverse Event|2|||
125457147|NCT00771667|451302033|FG002|Induction Phase|Adverse Event|4|||
125457148|NCT00771667|451302034|FG003|Induction Phase|Adverse Event|1|||
125457149|NCT00771667|451302035|FG004|Induction Phase|Adverse Event|0|||
125457150|NCT00771667|451302036|FG005|Induction Phase|Adverse Event|0|||
125457151|NCT00771667|451302037|FG006|Induction Phase|Adverse Event|0|||
125457152|NCT00771667|451302038|FG007|Induction Phase|Adverse Event|0|||
125457153|NCT00771667|451302039|FG008|Induction Phase|Adverse Event|0|||
125457154|NCT00771667|451302040|FG009|Induction Phase|Adverse Event|0|||
125457155|NCT00771667|451302031|FG000|Induction Phase|Lack of Efficacy|9|||
125457156|NCT00771667|451302032|FG001|Induction Phase|Lack of Efficacy|2|||
125457157|NCT00771667|451302033|FG002|Induction Phase|Lack of Efficacy|4|||
125457158|NCT00771667|451302034|FG003|Induction Phase|Lack of Efficacy|3|||
125457159|NCT00771667|451302035|FG004|Induction Phase|Lack of Efficacy|0|||
125457160|NCT00771667|451302036|FG005|Induction Phase|Lack of Efficacy|0|||
125457161|NCT00771667|451302037|FG006|Induction Phase|Lack of Efficacy|0|||
125457162|NCT00771667|451302038|FG007|Induction Phase|Lack of Efficacy|0|||
125457163|NCT00771667|451302039|FG008|Induction Phase|Lack of Efficacy|0|||
125457164|NCT00771667|451302040|FG009|Induction Phase|Lack of Efficacy|0|||
125457165|NCT00771667|451302031|FG000|Induction Phase|Lost to Follow-up|1|||
125457166|NCT00771667|451302032|FG001|Induction Phase|Lost to Follow-up|0|||
125457167|NCT00771667|451302033|FG002|Induction Phase|Lost to Follow-up|1|||
125457168|NCT00771667|451302034|FG003|Induction Phase|Lost to Follow-up|0|||
125457169|NCT00771667|451302035|FG004|Induction Phase|Lost to Follow-up|0|||
125457170|NCT00771667|451302036|FG005|Induction Phase|Lost to Follow-up|0|||
125457171|NCT00771667|451302037|FG006|Induction Phase|Lost to Follow-up|0|||
125457172|NCT00771667|451302038|FG007|Induction Phase|Lost to Follow-up|0|||
125457173|NCT00771667|451302039|FG008|Induction Phase|Lost to Follow-up|0|||
125457174|NCT00771667|451302040|FG009|Induction Phase|Lost to Follow-up|0|||
125457175|NCT00771667|451302031|FG000|Induction Phase|Other|4|||
125457176|NCT00771667|451302032|FG001|Induction Phase|Other|6|||
125457177|NCT00771667|451302033|FG002|Induction Phase|Other|3|||
125457178|NCT00771667|451302034|FG003|Induction Phase|Other|4|||
125457179|NCT00771667|451302035|FG004|Induction Phase|Other|0|||
125457180|NCT00771667|451302036|FG005|Induction Phase|Other|0|||
125457181|NCT00771667|451302037|FG006|Induction Phase|Other|0|||
125457182|NCT00771667|451302038|FG007|Induction Phase|Other|0|||
125457183|NCT00771667|451302039|FG008|Induction Phase|Other|0|||
125457184|NCT00771667|451302040|FG009|Induction Phase|Other|0|||
125457185|NCT00771667|451302031|FG000|Maintenance Phase|Adverse Event|0|||
125457186|NCT00771667|451302032|FG001|Maintenance Phase|Adverse Event|0|||
125457187|NCT00771667|451302033|FG002|Maintenance Phase|Adverse Event|0|||
125457188|NCT00771667|451302034|FG003|Maintenance Phase|Adverse Event|0|||
125457189|NCT00771667|451302035|FG004|Maintenance Phase|Adverse Event|1|||
125457190|NCT00771667|451302036|FG005|Maintenance Phase|Adverse Event|3|||
125457191|NCT00771667|451302037|FG006|Maintenance Phase|Adverse Event|5|||
125457192|NCT00771667|451302038|FG007|Maintenance Phase|Adverse Event|1|||
125457193|NCT00771667|451302039|FG008|Maintenance Phase|Adverse Event|8|||
125457194|NCT00771667|451302040|FG009|Maintenance Phase|Adverse Event|7|||
125457195|NCT00771667|451302031|FG000|Maintenance Phase|Lack of Efficacy|0|||
125457196|NCT00771667|451302032|FG001|Maintenance Phase|Lack of Efficacy|0|||
125457197|NCT00771667|451302033|FG002|Maintenance Phase|Lack of Efficacy|0|||
125457198|NCT00771667|451302034|FG003|Maintenance Phase|Lack of Efficacy|0|||
125457199|NCT00771667|451302035|FG004|Maintenance Phase|Lack of Efficacy|1|||
125457200|NCT00771667|451302036|FG005|Maintenance Phase|Lack of Efficacy|3|||
125420136|NCT00983073|451162276|FG000|Maintenance Period|Other Reason|7|||
125420137|NCT01453595|451162277|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
125420138|NCT01453595|451162278|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
125420139|NCT01453595|451162279|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
125420140|NCT02962908|451162282|FG000|Overall Study|Lost to Follow-up|0|||
125420141|NCT02962908|451162283|FG001|Overall Study|Lost to Follow-up|3|||
125420142|NCT02962908|451162284|FG002|Overall Study|Lost to Follow-up|0|||
125420143|NCT02962908|451162285|FG003|Overall Study|Lost to Follow-up|1|||
125420144|NCT02962908|451162282|FG000|Overall Study|Withdrawal by Subject|0|||
125420145|NCT02962908|451162283|FG001|Overall Study|Withdrawal by Subject|3|||
125420146|NCT02962908|451162284|FG002|Overall Study|Withdrawal by Subject|0|||
125420147|NCT02962908|451162285|FG003|Overall Study|Withdrawal by Subject|2|||
125420148|NCT02962908|451162282|FG000|Overall Study|Protocol Violation|0|||
125420149|NCT02962908|451162283|FG001|Overall Study|Protocol Violation|1|||
125420150|NCT02962908|451162284|FG002|Overall Study|Protocol Violation|0|||
125420151|NCT02962908|451162285|FG003|Overall Study|Protocol Violation|0|||
125420152|NCT02962908|451162282|FG000|Overall Study|Physician Decision|0|||
125420153|NCT02962908|451162283|FG001|Overall Study|Physician Decision|1|||
125420154|NCT02962908|451162284|FG002|Overall Study|Physician Decision|0|||
125420155|NCT02962908|451162285|FG003|Overall Study|Physician Decision|0|||
125420156|NCT05540522|451162288|FG000|Overall Study|Adverse Event|1|||
125420157|NCT05540522|451162289|FG001|Overall Study|Adverse Event|0|||
125420158|NCT05540522|451162290|FG002|Overall Study|Adverse Event|2|||
125420159|NCT05540522|451162291|FG003|Overall Study|Adverse Event|5|||
125457201|NCT00771667|451302037|FG006|Maintenance Phase|Lack of Efficacy|3|||
125457202|NCT00771667|451302038|FG007|Maintenance Phase|Lack of Efficacy|2|||
125457203|NCT00771667|451302039|FG008|Maintenance Phase|Lack of Efficacy|11|||
125457204|NCT00771667|451302040|FG009|Maintenance Phase|Lack of Efficacy|7|||
125457205|NCT00771667|451302031|FG000|Maintenance Phase|Other|0|||
125457206|NCT00771667|451302032|FG001|Maintenance Phase|Other|0|||
125457207|NCT00771667|451302033|FG002|Maintenance Phase|Other|0|||
125457208|NCT00771667|451302034|FG003|Maintenance Phase|Other|0|||
125457209|NCT00771667|451302035|FG004|Maintenance Phase|Other|0|||
125457210|NCT00771667|451302036|FG005|Maintenance Phase|Other|1|||
125457211|NCT00771667|451302037|FG006|Maintenance Phase|Other|2|||
125457212|NCT00771667|451302038|FG007|Maintenance Phase|Other|2|||
125457213|NCT00771667|451302039|FG008|Maintenance Phase|Other|3|||
125457214|NCT00771667|451302040|FG009|Maintenance Phase|Other|3|||
125457215|NCT00109967|451302041|FG000|Overall Study|Cancel Prior to Treatment|2|||
125457216|NCT00109967|451302042|FG001|Overall Study|Cancel Prior to Treatment|0|||
125457217|NCT00109967|451302041|FG000|Overall Study|Adverse Event|12|||
125457218|NCT00109967|451302042|FG001|Overall Study|Adverse Event|1|||
125457219|NCT00109967|451302041|FG000|Overall Study|Withdrawal by Subject|5|||
125457220|NCT00109967|451302042|FG001|Overall Study|Withdrawal by Subject|0|||
125457221|NCT00109967|451302041|FG000|Overall Study|Physician Decision|1|||
125457222|NCT00109967|451302042|FG001|Overall Study|Physician Decision|3|||
125457223|NCT00109967|451302041|FG000|Overall Study|Death|0|||
125457224|NCT00109967|451302042|FG001|Overall Study|Death|2|||
125457225|NCT00628862|451302049|FG000|Overall Study|Adverse Event|6|||
125457226|NCT00628862|451302050|FG001|Overall Study|Adverse Event|8|||
125457227|NCT00628862|451302051|FG002|Overall Study|Adverse Event|10|||
125457228|NCT00628862|451302049|FG000|Overall Study|Withdrawal by Subject|4|||
125457229|NCT00628862|451302050|FG001|Overall Study|Withdrawal by Subject|6|||
125457230|NCT00628862|451302051|FG002|Overall Study|Withdrawal by Subject|11|||
125457231|NCT00628862|451302049|FG000|Overall Study|Lost to Follow-up|0|||
125295178|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295179|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295180|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
125295181|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
125295182|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
125295183|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
125295184|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
125295185|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
125295186|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
125295187|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
125295188|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
125295189|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
125295190|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
125295191|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
125295192|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
125295193|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
125295194|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
125295195|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
125295196|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
125295197|NCT00576472|450707802|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295198|NCT00576472|450707803|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295199|NCT00576472|450707804|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295200|NCT00576472|450707805|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295201|NCT00576472|450707806|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295202|NCT00576472|450707807|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295203|NCT00576472|450707808|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295204|NCT00576472|450707809|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295205|NCT00576472|450707810|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295206|NCT00576472|450707811|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295207|NCT00576472|450707812|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295208|NCT00576472|450707813|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125457232|NCT00628862|451302050|FG001|Overall Study|Lost to Follow-up|2|||
125457233|NCT00628862|451302051|FG002|Overall Study|Lost to Follow-up|1|||
125457234|NCT00628862|451302049|FG000|Overall Study|Protocol Violation|1|||
125457235|NCT00628862|451302050|FG001|Overall Study|Protocol Violation|0|||
125457236|NCT00628862|451302051|FG002|Overall Study|Protocol Violation|0|||
125457237|NCT00628862|451302049|FG000|Overall Study|COPD Exacerbation|0|||
125295209|NCT00576472|450707814|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295210|NCT00576472|450707815|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
125295211|NCT00576472|450707816|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
125295212|NCT01504204|450707827|FG000|Overall Study|Lost to Follow-up|1|||
125457238|NCT00628862|451302050|FG001|Overall Study|COPD Exacerbation|1|||
125457239|NCT00628862|451302051|FG002|Overall Study|COPD Exacerbation|0|||
125457240|NCT01063036|451302052|FG000|Participants Treated With Study Drug|Adverse Event|1|||
125485357|NCT02240238|451412507|FG004|Phase 1|Death|0|||
125457241|NCT01063036|451302052|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
125457242|NCT01063036|451302052|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
125457243|NCT01063036|451302052|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
125457244|NCT01063036|451302052|FG000|Participants Treated With Study Drug|Pregnancy|1|||
125457245|NCT01063036|451302052|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
125457246|NCT01063036|451302052|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
125457247|NCT01063036|451302052|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
125457248|NCT00703911|451302055|FG000|Overall Study|Death|1|||
125457249|NCT00703911|451302055|FG000|Overall Study|Physician Decision|6|||
125457250|NCT00703911|451302055|FG000|Overall Study|Lost to Follow-up|1|||
125457251|NCT00703911|451302055|FG000|Overall Study|Withdrawal by Subject|2|||
125457252|NCT02174562|451302058|FG000|Overall Study|Withdrawal by Subject|7|||
125457253|NCT02174562|451302059|FG001|Overall Study|Withdrawal by Subject|2|||
125457254|NCT02174562|451302058|FG000|Overall Study|Death|2|||
125457255|NCT02174562|451302059|FG001|Overall Study|Death|0|||
125457256|NCT02174562|451302058|FG000|Overall Study|Lost to Follow-up|0|||
125457257|NCT02174562|451302059|FG001|Overall Study|Lost to Follow-up|3|||
125457258|NCT05193318|451302060|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
125457259|NCT05193318|451302060|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
125457260|NCT00798096|451302061|FG000|Overall Study|Ongoing|2|||
125457261|NCT01833065|451302062|FG000|Overall Study|Adverse Event|6|||
125457262|NCT01833065|451302063|FG001|Overall Study|Adverse Event|1|||
125457263|NCT01833065|451302064|FG002|Overall Study|Adverse Event|0|||
125295213|NCT01504204|450707828|FG001|Overall Study|Lost to Follow-up|1|||
125295214|NCT00903331|450707829|FG000|Overall Study|Death|4|||
125457264|NCT01833065|451302065|FG003|Overall Study|Adverse Event|2|||
125457265|NCT01833065|451302066|FG004|Overall Study|Adverse Event|3|||
125457266|NCT01833065|451302062|FG000|Overall Study|Protocol Violation|1|||
125457267|NCT01833065|451302063|FG001|Overall Study|Protocol Violation|0|||
125457268|NCT01833065|451302064|FG002|Overall Study|Protocol Violation|0|||
125457269|NCT01833065|451302065|FG003|Overall Study|Protocol Violation|0|||
125457270|NCT01833065|451302066|FG004|Overall Study|Protocol Violation|2|||
125457271|NCT01833065|451302062|FG000|Overall Study|Lost to Follow-up|1|||
125457272|NCT01833065|451302063|FG001|Overall Study|Lost to Follow-up|0|||
125457273|NCT01833065|451302064|FG002|Overall Study|Lost to Follow-up|0|||
125457274|NCT01833065|451302065|FG003|Overall Study|Lost to Follow-up|0|||
125457275|NCT01833065|451302066|FG004|Overall Study|Lost to Follow-up|3|||
125457276|NCT01833065|451302062|FG000|Overall Study|Withdrawal by Subject|6|||
125457277|NCT01833065|451302063|FG001|Overall Study|Withdrawal by Subject|2|||
125457278|NCT01833065|451302064|FG002|Overall Study|Withdrawal by Subject|4|||
125457279|NCT01833065|451302065|FG003|Overall Study|Withdrawal by Subject|3|||
125457280|NCT01833065|451302066|FG004|Overall Study|Withdrawal by Subject|11|||
125457281|NCT01833065|451302062|FG000|Overall Study|Subject's substantial non-compliance|0|||
125457282|NCT01833065|451302063|FG001|Overall Study|Subject's substantial non-compliance|1|||
125457283|NCT01833065|451302064|FG002|Overall Study|Subject's substantial non-compliance|0|||
125457284|NCT01833065|451302065|FG003|Overall Study|Subject's substantial non-compliance|0|||
125457285|NCT01833065|451302066|FG004|Overall Study|Subject's substantial non-compliance|0|||
125457286|NCT01833065|451302062|FG000|Overall Study|Trial terminated by sponsor|8|||
125457287|NCT01833065|451302063|FG001|Overall Study|Trial terminated by sponsor|8|||
125457288|NCT01833065|451302064|FG002|Overall Study|Trial terminated by sponsor|7|||
125457289|NCT01833065|451302065|FG003|Overall Study|Trial terminated by sponsor|3|||
125457290|NCT01833065|451302066|FG004|Overall Study|Trial terminated by sponsor|13|||
125457291|NCT01833065|451302062|FG000|Overall Study|Others|2|||
125457292|NCT01833065|451302063|FG001|Overall Study|Others|1|||
125457293|NCT01833065|451302064|FG002|Overall Study|Others|1|||
125457294|NCT01833065|451302065|FG003|Overall Study|Others|1|||
125457295|NCT01833065|451302066|FG004|Overall Study|Others|4|||
125457296|NCT04889664|451302067|FG000|Screen|Lost to Follow-up|1|||
125457297|NCT04889664|451302067|FG000|Screen|Failed to meet screening criteria|1|||
125457298|NCT04889664|451302067|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
125457299|NCT04107805|451302072|FG000|Overall Study|Adverse Event|0|||
125457300|NCT04107805|451302073|FG001|Overall Study|Adverse Event|0|||
125457301|NCT04107805|451302074|FG002|Overall Study|Adverse Event|0|||
125457302|NCT04107805|451302075|FG003|Overall Study|Adverse Event|1|||
125295215|NCT00903331|450707830|FG001|Overall Study|Death|8|||
125457303|NCT04107805|451302076|FG004|Overall Study|Adverse Event|0|||
125457304|NCT04107805|451302077|FG005|Overall Study|Adverse Event|1|||
125457305|NCT04107805|451302078|FG006|Overall Study|Adverse Event|0|||
125295216|NCT00903331|450707829|FG000|Overall Study|Withdrawal of consent|1|||
125457306|NCT04107805|451302079|FG007|Overall Study|Adverse Event|0|||
125457307|NCT04107805|451302080|FG008|Overall Study|Adverse Event|1|||
125457308|NCT00853827|451302081|FG000|Single Blind Period (1 Week)|Other|4|||
125457309|NCT00853827|451302082|FG001|Single Blind Period (1 Week)|Other|0|||
125457310|NCT00853827|451302081|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
125457311|NCT00853827|451302082|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
125457312|NCT00853827|451302081|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
125457313|NCT00853827|451302082|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
125457314|NCT00853827|451302081|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
125457315|NCT00853827|451302082|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
125457316|NCT00853827|451302081|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
125457317|NCT00853827|451302082|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
125457318|NCT00853827|451302081|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
125457319|NCT00853827|451302082|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
125457320|NCT00853827|451302081|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
125457321|NCT00853827|451302082|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
125457322|NCT00853827|451302081|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
125457323|NCT00853827|451302082|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
125457324|NCT00853827|451302081|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
125457325|NCT00853827|451302082|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
125457326|NCT00853827|451302081|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
125457327|NCT00853827|451302082|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
125457328|NCT00853827|451302081|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
125457329|NCT00853827|451302082|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
125457330|NCT00853827|451302081|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
125457331|NCT00853827|451302082|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
125457332|NCT00853827|451302081|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
125457333|NCT00853827|451302082|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
125457334|NCT00853827|451302081|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
125457335|NCT00853827|451302082|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
125457336|NCT00853827|451302081|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
125457337|NCT00853827|451302082|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
125457338|NCT00853827|451302081|FG000|Double Blind Period (103 Weeks)|Death|1|||
125457339|NCT00853827|451302082|FG001|Double Blind Period (103 Weeks)|Death|6|||
125457340|NCT00906035|451302084|FG000|Overall Study|Withdrawal by Subject|2|||
125457341|NCT00906035|451302085|FG001|Overall Study|Withdrawal by Subject|3|||
125457342|NCT00906035|451302086|FG002|Overall Study|Withdrawal by Subject|0|||
125457343|NCT03058991|451302089|FG000|Overall Study|Lost to Follow-up|17|||
125457344|NCT03058991|451302090|FG001|Overall Study|Lost to Follow-up|12|||
125457345|NCT03058991|451302091|FG002|Overall Study|Lost to Follow-up|12|||
125457346|NCT03058991|451302089|FG000|Overall Study|Withdrawal by Subject|1|||
125457347|NCT03058991|451302090|FG001|Overall Study|Withdrawal by Subject|0|||
125457348|NCT03058991|451302091|FG002|Overall Study|Withdrawal by Subject|0|||
125457349|NCT00130637|451302092|FG000|Overall Study|Adverse Event|2|||
125457350|NCT00130637|451302092|FG000|Overall Study|Withdrawal by Subject|1|||
125457351|NCT01460342|451302094|FG000|Overall Study|Adverse Event|5|||
125457352|NCT01460342|451302095|FG001|Overall Study|Adverse Event|4|||
125457353|NCT01460342|451302094|FG000|Overall Study|Lost to Follow-up|1|||
125457354|NCT01460342|451302095|FG001|Overall Study|Lost to Follow-up|2|||
125457355|NCT01460342|451302094|FG000|Overall Study|Protocol Violation|0|||
125457356|NCT01460342|451302095|FG001|Overall Study|Protocol Violation|1|||
125457357|NCT01460342|451302094|FG000|Overall Study|Withdrawal by Subject|3|||
125457358|NCT01460342|451302095|FG001|Overall Study|Withdrawal by Subject|4|||
125457359|NCT01460342|451302094|FG000|Overall Study|Physician Decision|1|||
125457360|NCT01460342|451302095|FG001|Overall Study|Physician Decision|3|||
125457361|NCT01460342|451302094|FG000|Overall Study|Lack of Efficacy|1|||
125457362|NCT01460342|451302095|FG001|Overall Study|Lack of Efficacy|0|||
125457363|NCT01689519|451302096|FG000|Intent to Treat|Death|157|||
125457364|NCT01689519|451302097|FG001|Intent to Treat|Death|167|||
125457365|NCT01689519|451302096|FG000|Intent to Treat|Lost to Follow-up|4|||
125457366|NCT01689519|451302097|FG001|Intent to Treat|Lost to Follow-up|8|||
125457367|NCT01689519|451302096|FG000|Intent to Treat|Other|2|||
125457368|NCT01689519|451302097|FG001|Intent to Treat|Other|4|||
125457369|NCT01689519|451302096|FG000|Intent to Treat|Physician Decision|4|||
125457370|NCT01689519|451302097|FG001|Intent to Treat|Physician Decision|1|||
125457371|NCT01689519|451302096|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
125457372|NCT01689519|451302097|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
125457373|NCT01689519|451302096|FG000|Intent to Treat|Withdrawal by Subject|21|||
125457374|NCT01689519|451302097|FG001|Intent to Treat|Withdrawal by Subject|20|||
125457375|NCT01689519|451302096|FG000|Safety Population|Death|158|||
125457376|NCT01689519|451302097|FG001|Safety Population|Death|165|||
125457377|NCT01689519|451302096|FG000|Safety Population|Lost to Follow-up|4|||
125457378|NCT01689519|451302097|FG001|Safety Population|Lost to Follow-up|8|||
125457379|NCT01689519|451302096|FG000|Safety Population|Other|2|||
125457380|NCT01689519|451302097|FG001|Safety Population|Other|4|||
125457381|NCT01689519|451302096|FG000|Safety Population|Physician Decision|4|||
125457382|NCT01689519|451302097|FG001|Safety Population|Physician Decision|1|||
125457383|NCT01689519|451302096|FG000|Safety Population|Study Terminated By Sponsor|60|||
125457384|NCT01689519|451302097|FG001|Safety Population|Study Terminated By Sponsor|47|||
125457385|NCT01689519|451302096|FG000|Safety Population|Withdrawal by Subject|20|||
125457386|NCT01689519|451302097|FG001|Safety Population|Withdrawal by Subject|20|||
125420160|NCT05540522|451162288|FG000|Overall Study|Lost to Follow-up|487|||
125420161|NCT05540522|451162289|FG001|Overall Study|Lost to Follow-up|427|||
125420162|NCT05540522|451162290|FG002|Overall Study|Lost to Follow-up|146|||
125420163|NCT05540522|451162291|FG003|Overall Study|Lost to Follow-up|166|||
125420164|NCT05540522|451162288|FG000|Overall Study|Physician Decision|11|||
125420165|NCT05540522|451162289|FG001|Overall Study|Physician Decision|19|||
125420166|NCT05540522|451162290|FG002|Overall Study|Physician Decision|8|||
125420167|NCT05540522|451162291|FG003|Overall Study|Physician Decision|13|||
125420168|NCT05540522|451162288|FG000|Overall Study|Pregnancy|1|||
125420169|NCT05540522|451162289|FG001|Overall Study|Pregnancy|0|||
125420170|NCT05540522|451162290|FG002|Overall Study|Pregnancy|0|||
125420171|NCT05540522|451162291|FG003|Overall Study|Pregnancy|0|||
125420172|NCT05540522|451162288|FG000|Overall Study|Protocol Violation|3|||
125420173|NCT05540522|451162289|FG001|Overall Study|Protocol Violation|1|||
125420174|NCT05540522|451162290|FG002|Overall Study|Protocol Violation|9|||
125420175|NCT05540522|451162291|FG003|Overall Study|Protocol Violation|7|||
125420176|NCT05540522|451162288|FG000|Overall Study|Withdrawal by Subject|168|||
125420177|NCT05540522|451162289|FG001|Overall Study|Withdrawal by Subject|134|||
125420178|NCT05540522|451162290|FG002|Overall Study|Withdrawal by Subject|331|||
125420179|NCT05540522|451162291|FG003|Overall Study|Withdrawal by Subject|322|||
125420180|NCT05540522|451162288|FG000|Overall Study|Death|7|||
125420181|NCT05540522|451162289|FG001|Overall Study|Death|9|||
125420182|NCT05540522|451162290|FG002|Overall Study|Death|49|||
125420183|NCT05540522|451162291|FG003|Overall Study|Death|46|||
125420184|NCT05540522|451162288|FG000|Overall Study|Not vaccinated|34|||
125420185|NCT05540522|451162289|FG001|Overall Study|Not vaccinated|53|||
125420186|NCT05540522|451162290|FG002|Overall Study|Not vaccinated|57|||
125420187|NCT05540522|451162291|FG003|Overall Study|Not vaccinated|50|||
125420188|NCT05540522|451162288|FG000|Overall Study|No longer meets eligibility criteria|0|||
125420189|NCT05540522|451162289|FG001|Overall Study|No longer meets eligibility criteria|0|||
125420190|NCT05540522|451162290|FG002|Overall Study|No longer meets eligibility criteria|3|||
125420191|NCT05540522|451162291|FG003|Overall Study|No longer meets eligibility criteria|2|||
125420192|NCT05540522|451162288|FG000|Overall Study|Other (Unspecified)|8|||
125420193|NCT05540522|451162289|FG001|Overall Study|Other (Unspecified)|10|||
125420194|NCT05540522|451162290|FG002|Overall Study|Other (Unspecified)|4|||
125420195|NCT05540522|451162291|FG003|Overall Study|Other (Unspecified)|2|||
125420196|NCT03754803|451162292|FG000|Overall Study|Withdrawal by Subject|2|||
125420197|NCT05239039|451162293|FG000|Overall Study|Withdrawal by Subject|0|||
125420198|NCT05239039|451162294|FG001|Overall Study|Withdrawal by Subject|1|||
125420199|NCT00936390|451162295|FG000|Overall Study|Protocol Violation|21|||
125420200|NCT00936390|451162296|FG001|Overall Study|Protocol Violation|25|||
125420201|NCT04348604|451162297|FG000|Week 8|Withdrawal by Subject|1|||
125420202|NCT04348604|451162298|FG001|Week 8|Withdrawal by Subject|1|||
125420203|NCT04348604|451162297|FG000|Week 8|Lost to Follow-up|1|||
125420204|NCT04348604|451162298|FG001|Week 8|Lost to Follow-up|2|||
125420205|NCT04348604|451162297|FG000|Week 8|Suspended|0|||
125420206|NCT04348604|451162298|FG001|Week 8|Suspended|1|||
125420207|NCT04348604|451162297|FG000|Week 12|Lost to Follow-up|1|||
125420208|NCT04348604|451162298|FG001|Week 12|Lost to Follow-up|2|||
125420209|NCT04348604|451162297|FG000|Week 12|Withdrawal by Subject|1|||
125420210|NCT04348604|451162298|FG001|Week 12|Withdrawal by Subject|0|||
125420211|NCT04348604|451162297|FG000|Week 24|Lost to Follow-up|2|||
125420212|NCT04348604|451162298|FG001|Week 24|Lost to Follow-up|1|||
125420213|NCT02097108|451162299|FG000|Overall Study|Adverse Event|1|||
125420214|NCT02097108|451162299|FG000|Overall Study|patient was abroad for 6 months|1|||
125420215|NCT02119260|451163544|FG000|Overall Study|Adverse Event|1|||
125420216|NCT02119260|451163545|FG001|Overall Study|Adverse Event|0|||
125420217|NCT02119260|451163546|FG002|Overall Study|Adverse Event|0|||
125420218|NCT02119260|451163547|FG003|Overall Study|Adverse Event|0|||
125420219|NCT02119260|451163548|FG004|Overall Study|Adverse Event|0|||
125420220|NCT02119260|451163549|FG005|Overall Study|Adverse Event|0|||
125420221|NCT02119260|451163550|FG006|Overall Study|Adverse Event|0|||
125420222|NCT02119260|451163544|FG000|Overall Study|Withdrew consent|0|||
125420223|NCT02119260|451163545|FG001|Overall Study|Withdrew consent|1|||
125420224|NCT02119260|451163546|FG002|Overall Study|Withdrew consent|1|||
125420225|NCT02119260|451163547|FG003|Overall Study|Withdrew consent|0|||
125420226|NCT02119260|451163548|FG004|Overall Study|Withdrew consent|0|||
125420227|NCT02119260|451163549|FG005|Overall Study|Withdrew consent|0|||
125420228|NCT02119260|451163550|FG006|Overall Study|Withdrew consent|0|||
125420229|NCT00857207|451163551|FG000|Overall Study|Withdrawal by Subject|13|||
125420230|NCT00857207|451163552|FG001|Overall Study|Withdrawal by Subject|0|||
125420231|NCT00857207|451163551|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
125420232|NCT00857207|451163552|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
125420233|NCT00857207|451163551|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
125420234|NCT00857207|451163552|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
125420235|NCT00955357|451163553|FG000|Titration Phase|Adverse Event|9|||
125457387|NCT01050569|451302100|FG000|Overall Study|Lost to Follow-up|20|||
125457388|NCT01050569|451302101|FG001|Overall Study|Lost to Follow-up|14|||
125457389|NCT01050569|451302102|FG002|Overall Study|Lost to Follow-up|16|||
125457390|NCT01050569|451302100|FG000|Overall Study|Withdrawal by Subject|9|||
125457391|NCT01050569|451302101|FG001|Overall Study|Withdrawal by Subject|3|||
125457392|NCT01050569|451302102|FG002|Overall Study|Withdrawal by Subject|11|||
125457393|NCT01050569|451302100|FG000|Overall Study|Lack of Efficacy|5|||
125457394|NCT01050569|451302101|FG001|Overall Study|Lack of Efficacy|4|||
125457395|NCT01050569|451302102|FG002|Overall Study|Lack of Efficacy|3|||
125457396|NCT01050569|451302100|FG000|Overall Study|Adverse Event|1|||
125457397|NCT01050569|451302101|FG001|Overall Study|Adverse Event|0|||
125457398|NCT01050569|451302102|FG002|Overall Study|Adverse Event|0|||
125457399|NCT01050569|451302100|FG000|Overall Study|Physician Decision|3|||
125457400|NCT01050569|451302101|FG001|Overall Study|Physician Decision|3|||
125457401|NCT01050569|451302102|FG002|Overall Study|Physician Decision|3|||
125457402|NCT01713530|451302104|FG000|Overall Study|Adverse Event|0|||
125457403|NCT01713530|451302105|FG001|Overall Study|Adverse Event|5|||
125457404|NCT01713530|451302104|FG000|Overall Study|Withdrawal criteria|21|||
125457405|NCT01713530|451302105|FG001|Overall Study|Withdrawal criteria|12|||
125457406|NCT01713530|451302104|FG000|Overall Study|Unclassified|4|||
125457407|NCT01713530|451302105|FG001|Overall Study|Unclassified|2|||
125457408|NCT03525119|451302106|FG000|Overall Study|Adverse Event|0|||
125457409|NCT03525119|451302107|FG001|Overall Study|Adverse Event|1|||
125457410|NCT03525119|451302108|FG002|Overall Study|Adverse Event|0|||
125457411|NCT03525119|451302106|FG000|Overall Study|Lost to Follow-up|32|||
125457412|NCT03525119|451302107|FG001|Overall Study|Lost to Follow-up|33|||
125457413|NCT03525119|451302108|FG002|Overall Study|Lost to Follow-up|37|||
125457414|NCT03525119|451302106|FG000|Overall Study|Withdrawal by Subject|5|||
125457415|NCT03525119|451302107|FG001|Overall Study|Withdrawal by Subject|4|||
125457416|NCT03525119|451302108|FG002|Overall Study|Withdrawal by Subject|2|||
125457417|NCT03525119|451302106|FG000|Overall Study|Reason not Specified|2|||
125457418|NCT03525119|451302107|FG001|Overall Study|Reason not Specified|1|||
125457419|NCT03525119|451302108|FG002|Overall Study|Reason not Specified|2|||
125457420|NCT03525119|451302106|FG000|Overall Study|Randomized but not Vaccinated|1|||
125457421|NCT03525119|451302107|FG001|Overall Study|Randomized but not Vaccinated|0|||
125457422|NCT03525119|451302108|FG002|Overall Study|Randomized but not Vaccinated|2|||
125457423|NCT00619645|451302109|FG000|Overall Study|Adverse Event|1|||
125457424|NCT00597519|451302110|FG000|Overall Study|Death|1|||
125457425|NCT04246762|451302111|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
125457426|NCT00410124|451302112|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
125457427|NCT00410124|451302113|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
125457428|NCT00410124|451302112|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
125457429|NCT00410124|451302113|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
125457430|NCT00410124|451302112|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
125457431|NCT00410124|451302113|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
125457432|NCT00410124|451302112|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
125457433|NCT00410124|451302113|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
125457434|NCT00410124|451302112|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
125457435|NCT00410124|451302113|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
125457436|NCT00410124|451302112|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
125457437|NCT00410124|451302113|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
125457438|NCT00410124|451302112|FG000|Core Phase Double Blind (15 Months)|Death|7|||
125457439|NCT00410124|451302113|FG001|Core Phase Double Blind (15 Months)|Death|4|||
125457440|NCT00410124|451302112|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
125457441|NCT00410124|451302113|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
125457442|NCT00410124|451302112|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
125457443|NCT00410124|451302113|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
125457444|NCT00410124|451302112|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
125457445|NCT00410124|451302113|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
125457446|NCT00410124|451302112|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
125457447|NCT00410124|451302113|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
125295217|NCT00903331|450707830|FG001|Overall Study|Withdrawal of consent|8|||
125457448|NCT00410124|451302112|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
125457449|NCT00410124|451302113|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
125457450|NCT00410124|451302112|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
125457451|NCT00410124|451302113|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
125457452|NCT00410124|451302112|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
125295218|NCT00903331|450707829|FG000|Overall Study|Lung transplant|0|||
125457453|NCT00410124|451302113|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
125457454|NCT00410124|451302112|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
125457455|NCT00410124|451302113|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
125295219|NCT00903331|450707830|FG001|Overall Study|Lung transplant|2|||
125457456|NCT00410124|451302112|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
125457457|NCT00410124|451302113|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
125457458|NCT00741988|451302117|FG000|Overall Study|Adverse Event|2|||
125457459|NCT00741988|451302118|FG001|Overall Study|Adverse Event|4|||
125457460|NCT00741988|451302117|FG000|Overall Study|Lack of Efficacy|2|||
125457461|NCT00741988|451302118|FG001|Overall Study|Lack of Efficacy|0|||
125457462|NCT00811057|451302119|FG000|Overall Study|Protocol Violation|5|||
125457463|NCT00811057|451302120|FG001|Overall Study|Protocol Violation|10|||
125457464|NCT00811057|451302121|FG002|Overall Study|Protocol Violation|10|||
125457465|NCT00768651|451302126|FG000|Overall Study|Withdrawal by Subject|1|||
125457466|NCT02104765|451302127|FG000|Overall Study|Lost to Follow-up|0|||
125457467|NCT02104765|451302128|FG001|Overall Study|Lost to Follow-up|0|||
125457468|NCT02104765|451302129|FG002|Overall Study|Lost to Follow-up|1|||
125457469|NCT02104765|451302130|FG003|Overall Study|Lost to Follow-up|0|||
125457470|NCT02104765|451302131|FG004|Overall Study|Lost to Follow-up|0|||
125457471|NCT02104765|451302132|FG005|Overall Study|Lost to Follow-up|0|||
125457472|NCT02104765|451302133|FG006|Overall Study|Lost to Follow-up|0|||
125457473|NCT02104765|451302127|FG000|Overall Study|Withdrawal by Subject|0|||
125457474|NCT02104765|451302128|FG001|Overall Study|Withdrawal by Subject|0|||
125457475|NCT02104765|451302129|FG002|Overall Study|Withdrawal by Subject|0|||
125457476|NCT02104765|451302130|FG003|Overall Study|Withdrawal by Subject|1|||
125457477|NCT02104765|451302131|FG004|Overall Study|Withdrawal by Subject|1|||
125457478|NCT02104765|451302132|FG005|Overall Study|Withdrawal by Subject|0|||
125457479|NCT02104765|451302133|FG006|Overall Study|Withdrawal by Subject|1|||
125457480|NCT00995709|451302138|FG000|Overall Study|Adverse Event|4|||
125457481|NCT00995709|451302139|FG001|Overall Study|Adverse Event|2|||
125457482|NCT00995709|451302140|FG002|Overall Study|Adverse Event|0|||
125457483|NCT00995709|451302138|FG000|Overall Study|Lack of Efficacy|0|||
125457484|NCT00995709|451302139|FG001|Overall Study|Lack of Efficacy|1|||
125457485|NCT00995709|451302140|FG002|Overall Study|Lack of Efficacy|4|||
125457486|NCT00995709|451302138|FG000|Overall Study|Withdrawal by Subject|0|||
125457487|NCT00995709|451302139|FG001|Overall Study|Withdrawal by Subject|4|||
125457488|NCT00995709|451302140|FG002|Overall Study|Withdrawal by Subject|1|||
125457489|NCT00995709|451302138|FG000|Overall Study|Lost to Follow-up|1|||
125457490|NCT00995709|451302139|FG001|Overall Study|Lost to Follow-up|0|||
125457491|NCT00995709|451302140|FG002|Overall Study|Lost to Follow-up|0|||
125457492|NCT00995709|451302138|FG000|Overall Study|Death|0|||
125457493|NCT00995709|451302139|FG001|Overall Study|Death|1|||
125457494|NCT00995709|451302140|FG002|Overall Study|Death|0|||
125457495|NCT00995709|451302138|FG000|Overall Study|Protocol Violation|2|||
125457496|NCT00995709|451302139|FG001|Overall Study|Protocol Violation|1|||
125457497|NCT00995709|451302140|FG002|Overall Study|Protocol Violation|0|||
125457498|NCT01697319|451302141|FG000|Primary Phase|Withdrawal by Subject|1|||
125457499|NCT01697319|451302141|FG000|Extension Phase|Terminated by Sponsor|15|||
125457500|NCT04222959|451302142|FG000|Overall Study|Lost to Follow-up|76|||
125457501|NCT04222959|451302143|FG001|Overall Study|Lost to Follow-up|28|||
125457502|NCT01144182|451302144|FG000|Overall Study|Death|5|||
125457503|NCT01144182|451302145|FG001|Overall Study|Death|6|||
125457504|NCT01144182|451302144|FG000|Overall Study|Withdrawal by Subject|3|||
125457505|NCT01144182|451302145|FG001|Overall Study|Withdrawal by Subject|6|||
125457506|NCT01144182|451302144|FG000|Overall Study|Lost to Follow-up|9|||
125457507|NCT01144182|451302145|FG001|Overall Study|Lost to Follow-up|9|||
125457508|NCT03538054|451302150|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
125457509|NCT03538054|451302150|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
125457510|NCT03538054|451302150|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
125457511|NCT03264456|451302151|FG000|Overall Study|Withdrawal by Subject|3|||
125457512|NCT03264456|451302151|FG000|Overall Study|Lost to Follow-up|1|||
125457513|NCT03254394|451302152|FG000|Overall Study|Withdrawal by Subject|0|||
125457514|NCT03254394|451302153|FG001|Overall Study|Withdrawal by Subject|2|||
125457515|NCT02351180|451302156|FG000|Overall Study|Withdrawal by Subject|1|||
125457516|NCT02351180|451302157|FG001|Overall Study|Withdrawal by Subject|0|||
125457517|NCT03418324|451302158|FG000|Overall Study|Death|0|||
125457518|NCT03418324|451302159|FG001|Overall Study|Death|1|||
125457519|NCT03418324|451302158|FG000|Overall Study|Physician Decision|1|||
125457520|NCT03418324|451302159|FG001|Overall Study|Physician Decision|1|||
125457521|NCT01751724|451302160|FG000|Overall Study|extubated bef.start assigned treatment|1|||
125457522|NCT01751724|451302161|FG001|Overall Study|extubated bef.start assigned treatment|0|||
125457523|NCT01751724|451302160|FG000|Overall Study|withdrawn by parent|0|||
125457524|NCT01751724|451302161|FG001|Overall Study|withdrawn by parent|2|||
125457525|NCT03121950|451302163|FG000|Overall Study|Withdrawal by Subject|11|||
125457526|NCT03121950|451302164|FG001|Overall Study|Withdrawal by Subject|2|||
125457527|NCT01867580|451302165|FG000|Overall Study|Withdrawal by Subject|2|||
125457528|NCT01867580|451302166|FG001|Overall Study|Withdrawal by Subject|3|||
125457529|NCT01867580|451302165|FG000|Overall Study|Physician Decision|17|||
125457530|NCT01867580|451302166|FG001|Overall Study|Physician Decision|12|||
125457531|NCT01867580|451302165|FG000|Overall Study|Lost to Follow-up|3|||
125457532|NCT01867580|451302166|FG001|Overall Study|Lost to Follow-up|5|||
125457533|NCT01867580|451302165|FG000|Overall Study|Sponsor terminated study|1|||
125457534|NCT01867580|451302166|FG001|Overall Study|Sponsor terminated study|0|||
125457535|NCT01867580|451302165|FG000|Overall Study|Missed follow-up assessment|2|||
125457536|NCT01867580|451302166|FG001|Overall Study|Missed follow-up assessment|1|||
125457537|NCT01867580|451302165|FG000|Overall Study|Interruption to therapy|3|||
125457538|NCT01867580|451302166|FG001|Overall Study|Interruption to therapy|0|||
125457539|NCT01867580|451302165|FG000|Overall Study|Osteomyelitis|0|||
125457540|NCT01867580|451302166|FG001|Overall Study|Osteomyelitis|1|||
125457541|NCT01867580|451302165|FG000|Overall Study|Continuation of therapy|0|||
125457542|NCT01867580|451302166|FG001|Overall Study|Continuation of therapy|1|||
125457543|NCT01867580|451302165|FG000|Overall Study|Wound recurrence|0|||
125457544|NCT01867580|451302166|FG001|Overall Study|Wound recurrence|1|||
125457545|NCT03425643|451302169|FG000|Overall Study|Withdrawal by Subject|10|||
125457546|NCT03425643|451302170|FG001|Overall Study|Withdrawal by Subject|12|||
125457547|NCT03425643|451302169|FG000|Overall Study|Lost to Follow-up|2|||
125457548|NCT03425643|451302170|FG001|Overall Study|Lost to Follow-up|0|||
125457549|NCT03425643|451302169|FG000|Overall Study|Death|109|||
125457550|NCT03425643|451302170|FG001|Overall Study|Death|141|||
125457551|NCT03425643|451302169|FG000|Overall Study|Ongoing in study|276|||
125457552|NCT03425643|451302170|FG001|Overall Study|Ongoing in study|247|||
125457553|NCT03141788|451302171|FG000|Overall Study|Lost to Follow-up|1|||
125457554|NCT03141788|451302171|FG000|Overall Study|Protocol Violation|3|||
125457555|NCT03141788|451302171|FG000|Overall Study|Withdrawal by Subject|4|||
125457556|NCT01546155|451303611|FG000|Overall Study|could not tolerate long scan duration|3|||
125457557|NCT02715258|451303613|FG000|Overall Study|Withdrawal by Subject|6|||
125457558|NCT02715258|451303614|FG001|Overall Study|Withdrawal by Subject|1|||
125457559|NCT02715258|451303613|FG000|Overall Study|Lost to Follow-up|7|||
125457560|NCT02715258|451303614|FG001|Overall Study|Lost to Follow-up|1|||
125457561|NCT02715258|451303613|FG000|Overall Study|Terminated by Sponsor|0|||
125457562|NCT02715258|451303614|FG001|Overall Study|Terminated by Sponsor|1|||
125457563|NCT02715258|451303613|FG000|Overall Study|Death|0|||
125457564|NCT02715258|451303614|FG001|Overall Study|Death|1|||
125457565|NCT02715258|451303613|FG000|Overall Study|Subject non-compliant|1|||
125457566|NCT02715258|451303614|FG001|Overall Study|Subject non-compliant|1|||
125457567|NCT02715258|451303613|FG000|Overall Study|GCP violation|2|||
125457568|NCT02715258|451303614|FG001|Overall Study|GCP violation|1|||
125457569|NCT02814643|451303615|FG000|Overall Study|Lost to Follow-up|0|||
125457570|NCT02814643|451303616|FG001|Overall Study|Lost to Follow-up|1|||
125457571|NCT02814643|451303615|FG000|Overall Study|Withdrawal by Subject|1|||
125457572|NCT02814643|451303616|FG001|Overall Study|Withdrawal by Subject|2|||
125457573|NCT02263508|451303617|FG000|Overall Study|Withdrawal by Subject|1|||
125457574|NCT02263508|451303618|FG001|Overall Study|Withdrawal by Subject|23|||
125457575|NCT02263508|451303619|FG002|Overall Study|Withdrawal by Subject|17|||
125457576|NCT02263508|451303617|FG000|Overall Study|Sponsor Decision|12|||
125457577|NCT02263508|451303618|FG001|Overall Study|Sponsor Decision|165|||
125457578|NCT02263508|451303619|FG002|Overall Study|Sponsor Decision|182|||
125457579|NCT02263508|451303617|FG000|Overall Study|Lost to Follow-up|2|||
125457580|NCT02263508|451303618|FG001|Overall Study|Lost to Follow-up|7|||
125457581|NCT02263508|451303619|FG002|Overall Study|Lost to Follow-up|7|||
125457582|NCT02263508|451303617|FG000|Overall Study|Death|6|||
125457583|NCT02263508|451303618|FG001|Overall Study|Death|151|||
125457584|NCT02263508|451303619|FG002|Overall Study|Death|140|||
125457585|NCT03265210|451303622|FG000|Overall Study|Withdrawal by Subject|7|||
125457586|NCT03265210|451303623|FG001|Overall Study|Withdrawal by Subject|9|||
125457587|NCT03265210|451303622|FG000|Overall Study|Lost to Follow-up|2|||
125457588|NCT03265210|451303623|FG001|Overall Study|Lost to Follow-up|0|||
125457589|NCT03265210|451303622|FG000|Overall Study|Physician Decision|2|||
125457590|NCT03265210|451303623|FG001|Overall Study|Physician Decision|0|||
125457591|NCT03265210|451303622|FG000|Overall Study|Adverse Event|1|||
125457592|NCT03265210|451303623|FG001|Overall Study|Adverse Event|0|||
125457593|NCT03546907|451303632|FG000|Overall Study|Lack of Efficacy|1|||
125457594|NCT03546907|451303633|FG001|Overall Study|Lack of Efficacy|1|||
125457595|NCT03546907|451303632|FG000|Overall Study|Withdrawal by Subject|8|||
125457596|NCT03546907|451303633|FG001|Overall Study|Withdrawal by Subject|9|||
125457597|NCT03546907|451303632|FG000|Overall Study|Adverse events (AEs)|7|||
125457598|NCT03546907|451303633|FG001|Overall Study|Adverse events (AEs)|10|||
125457599|NCT03546907|451303632|FG000|Overall Study|Other-unspecified|1|||
125457600|NCT03546907|451303633|FG001|Overall Study|Other-unspecified|1|||
125457601|NCT01281813|451303634|FG000|Overall Study|Adverse Event|0|||
125457602|NCT01281813|451303635|FG001|Overall Study|Adverse Event|0|||
125457603|NCT01281813|451303636|FG002|Overall Study|Adverse Event|10|||
125457604|NCT01281813|451303634|FG000|Overall Study|Lost to Follow-up|0|||
125457605|NCT01281813|451303635|FG001|Overall Study|Lost to Follow-up|0|||
125457606|NCT01281813|451303636|FG002|Overall Study|Lost to Follow-up|31|||
125457607|NCT01281813|451303634|FG000|Overall Study|Withdrawal by Subject|0|||
125457608|NCT01281813|451303635|FG001|Overall Study|Withdrawal by Subject|0|||
125457609|NCT01281813|451303636|FG002|Overall Study|Withdrawal by Subject|13|||
125457610|NCT01281813|451303634|FG000|Overall Study|Subject Non-Compliant|0|||
125457611|NCT01281813|451303635|FG001|Overall Study|Subject Non-Compliant|0|||
125457612|NCT01281813|451303636|FG002|Overall Study|Subject Non-Compliant|6|||
125457613|NCT01281813|451303634|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
125457614|NCT01281813|451303635|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
125457615|NCT01281813|451303636|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
125457616|NCT01281813|451303634|FG000|Overall Study|Sponsor's Decision|4|||
125457617|NCT01281813|451303635|FG001|Overall Study|Sponsor's Decision|3|||
125457618|NCT01281813|451303636|FG002|Overall Study|Sponsor's Decision|7|||
125457619|NCT01281813|451303634|FG000|Overall Study|Switched to Commercially Available Medication|0|||
125457620|NCT01281813|451303635|FG001|Overall Study|Switched to Commercially Available Medication|0|||
125457621|NCT01281813|451303636|FG002|Overall Study|Switched to Commercially Available Medication|26|||
125457622|NCT01281813|451303634|FG000|Overall Study|Other|0|||
125457623|NCT01281813|451303635|FG001|Overall Study|Other|1|||
125457624|NCT01281813|451303636|FG002|Overall Study|Other|39|||
125457625|NCT01458210|451303637|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
125457626|NCT01458210|451303637|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
125457627|NCT01458210|451303637|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
125457628|NCT01458210|451303637|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
125457629|NCT01833832|451303640|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
125457630|NCT01988233|451303641|FG000|Overall Study|Lost to Follow-up|64|||
125457631|NCT01988233|451303642|FG001|Overall Study|Lost to Follow-up|51|||
125457632|NCT03621761|451303643|FG000|Overall Study|Lost to Follow-up|1|||
125457633|NCT03621761|451303644|FG001|Overall Study|Lost to Follow-up|1|||
125457634|NCT03621761|451303645|FG002|Overall Study|Lost to Follow-up|2|||
125457635|NCT03621761|451303643|FG000|Overall Study|Withdrawal by Subject|2|||
125457636|NCT03621761|451303644|FG001|Overall Study|Withdrawal by Subject|1|||
125457637|NCT03621761|451303645|FG002|Overall Study|Withdrawal by Subject|1|||
125457638|NCT03621761|451303643|FG000|Overall Study|Became Ineligible|0|||
125457639|NCT03621761|451303644|FG001|Overall Study|Became Ineligible|2|||
125457640|NCT03621761|451303645|FG002|Overall Study|Became Ineligible|0|||
125457641|NCT03939819|451303646|FG000|Overall Study|Death|2|||
125457642|NCT03939819|451303647|FG001|Overall Study|Death|0|||
125457643|NCT05046132|451303648|FG000|Overall Study|Adverse Event|4|||
125457644|NCT05046132|451303649|FG001|Overall Study|Adverse Event|0|||
125457645|NCT05046132|451303650|FG002|Overall Study|Adverse Event|0|||
125457646|NCT05046132|451303648|FG000|Overall Study|Withdrawal by Subject|3|||
125457647|NCT05046132|451303649|FG001|Overall Study|Withdrawal by Subject|0|||
125457648|NCT05046132|451303650|FG002|Overall Study|Withdrawal by Subject|0|||
125457649|NCT05046132|451303648|FG000|Overall Study|Positive Covid19 Result.|0|||
125457650|NCT05046132|451303649|FG001|Overall Study|Positive Covid19 Result.|1|||
125457651|NCT05046132|451303650|FG002|Overall Study|Positive Covid19 Result.|0|||
125457652|NCT01186848|451303651|FG000|Overall Study|Lost to Follow-up|4|||
125457653|NCT01186848|451303651|FG000|Overall Study|Withdrawal by Subject|2|||
125457654|NCT01186848|451303651|FG000|Overall Study|Adverse Event|2|||
125457655|NCT01183780|451303659|FG000|Overall Study|Withdrawal by Subject|25|||
125457656|NCT01183780|451303660|FG001|Overall Study|Withdrawal by Subject|14|||
125457657|NCT01183780|451303659|FG000|Overall Study|Lost to Follow-up|6|||
125457658|NCT01183780|451303660|FG001|Overall Study|Lost to Follow-up|11|||
125457659|NCT04379713|451303663|FG000|Overall Study|Adverse Event|2|||
125457660|NCT04379713|451303664|FG001|Overall Study|Adverse Event|0|||
125457661|NCT04379713|451303663|FG000|Overall Study|Physician Decision|2|||
125457662|NCT04379713|451303664|FG001|Overall Study|Physician Decision|1|||
125457663|NCT04379713|451303663|FG000|Overall Study|Protocol Violation|11|||
125457664|NCT04379713|451303664|FG001|Overall Study|Protocol Violation|6|||
125457665|NCT04379713|451303663|FG000|Overall Study|No longer met eligibility criteria|14|||
125457666|NCT04379713|451303664|FG001|Overall Study|No longer met eligibility criteria|11|||
125457667|NCT04379713|451303663|FG000|Overall Study|Withdrawal by parent/guardian|36|||
125457668|NCT04379713|451303664|FG001|Overall Study|Withdrawal by parent/guardian|15|||
125457669|NCT04379713|451303663|FG000|Overall Study|Lost to Follow-up|31|||
125457670|NCT04379713|451303664|FG001|Overall Study|Lost to Follow-up|21|||
125457671|NCT02148133|451303668|FG000|Overall Study|Investigator discretion|1|||
125457672|NCT02148133|451303668|FG000|Overall Study|Lack of Efficacy|1|||
125457673|NCT02148133|451303668|FG000|Overall Study|Protocol deviation|1|||
125457674|NCT02148133|451303668|FG000|Overall Study|Protocol-defined stopping criteria|2|||
125457675|NCT03808883|451303669|FG000|Overall Study|Withdrawal by Subject|2|||
125457676|NCT03808883|451303670|FG001|Overall Study|Withdrawal by Subject|0|||
125457677|NCT03808883|451303669|FG000|Overall Study|Did not complete pre test or post test survey|4|||
125457678|NCT03808883|451303670|FG001|Overall Study|Did not complete pre test or post test survey|3|||
125457679|NCT04567888|451303671|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
125457680|NCT04567888|451303672|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
125457681|NCT04567888|451303671|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
125457682|NCT04567888|451303672|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
125457683|NCT04567888|451303671|FG000|Overall Study|Reported Unusual Birth Year|2|||
125457684|NCT04567888|451303672|FG001|Overall Study|Reported Unusual Birth Year|3|||
125457685|NCT04567888|451303671|FG000|Overall Study|Duplicate Responses|0|||
125457686|NCT04567888|451303672|FG001|Overall Study|Duplicate Responses|1|||
125457687|NCT02613364|451303673|FG000|Overall Study|Other|19|||
125457688|NCT02613364|451303674|FG001|Overall Study|Other|29|||
125457689|NCT02613364|451303675|FG002|Overall Study|Other|17|||
125457690|NCT02613364|451303673|FG000|Overall Study|Too time consuming|21|||
125457691|NCT02613364|451303674|FG001|Overall Study|Too time consuming|26|||
125457692|NCT02613364|451303675|FG002|Overall Study|Too time consuming|26|||
125457693|NCT02613364|451303673|FG000|Overall Study|Withdrawal by Subject|13|||
125457694|NCT02613364|451303674|FG001|Overall Study|Withdrawal by Subject|18|||
125457695|NCT02613364|451303675|FG002|Overall Study|Withdrawal by Subject|17|||
125457696|NCT02613364|451303673|FG000|Overall Study|Medical|12|||
125457697|NCT02613364|451303674|FG001|Overall Study|Medical|13|||
125457698|NCT02613364|451303675|FG002|Overall Study|Medical|9|||
125457699|NCT02613364|451303673|FG000|Overall Study|Disliked Study Procedure|1|||
125457700|NCT02613364|451303674|FG001|Overall Study|Disliked Study Procedure|1|||
125457701|NCT02613364|451303675|FG002|Overall Study|Disliked Study Procedure|4|||
125457702|NCT02613364|451303673|FG000|Overall Study|Disliked Intervention|0|||
125457703|NCT02613364|451303674|FG001|Overall Study|Disliked Intervention|3|||
125457704|NCT02613364|451303675|FG002|Overall Study|Disliked Intervention|3|||
125457705|NCT00436644|451303676|FG000|Overall Study|Adverse Event|2|||
125457706|NCT00436644|451303676|FG000|Overall Study|Death|1|||
125457707|NCT00371566|451303678|FG000|Treatment Phase|Withdrawal by Subject|0|||
125457708|NCT00371566|451303679|FG001|Treatment Phase|Withdrawal by Subject|1|||
125457709|NCT00371566|451303678|FG000|Treatment Phase|Adverse Event|0|||
125457710|NCT00371566|451303679|FG001|Treatment Phase|Adverse Event|1|||
125457711|NCT00371566|451303678|FG000|Treatment Phase|Protocol Violation|0|||
125457712|NCT00371566|451303679|FG001|Treatment Phase|Protocol Violation|1|||
125457713|NCT00371566|451303678|FG000|Chemoradiation Phase|Physician Decision|2|||
125457714|NCT00371566|451303679|FG001|Chemoradiation Phase|Physician Decision|0|||
125457715|NCT00371566|451303678|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
125457716|NCT00371566|451303679|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
125457717|NCT00371566|451303678|FG000|Chemoradiation Phase|Non compliant|0|||
125457718|NCT00371566|451303679|FG001|Chemoradiation Phase|Non compliant|1|||
125457719|NCT00371566|451303678|FG000|Chemoradiation Phase|Progressive Disease|1|||
125457720|NCT00371566|451303679|FG001|Chemoradiation Phase|Progressive Disease|1|||
125457721|NCT00371566|451303678|FG000|Chemoradiation Phase|Death|2|||
125457722|NCT00371566|451303679|FG001|Chemoradiation Phase|Death|0|||
125457723|NCT00371566|451303678|FG000|Follow Up Phase|Death|0|||
125457724|NCT00371566|451303679|FG001|Follow Up Phase|Death|5|||
125457725|NCT00371566|451303678|FG000|Follow Up Phase|Disease progression|1|||
125457726|NCT00371566|451303679|FG001|Follow Up Phase|Disease progression|0|||
125457727|NCT00371566|451303678|FG000|Follow Up Phase|Withdrawal by Subject|0|||
125457728|NCT00371566|451303679|FG001|Follow Up Phase|Withdrawal by Subject|1|||
125457729|NCT00371566|451303678|FG000|Follow Up Phase|Physician Decision|1|||
125457730|NCT00371566|451303679|FG001|Follow Up Phase|Physician Decision|1|||
125457731|NCT00371566|451303678|FG000|Follow Up Phase|Lost to Follow-up|1|||
125457732|NCT00371566|451303679|FG001|Follow Up Phase|Lost to Follow-up|0|||
125457733|NCT00878722|451303680|FG000|Overall Study|Progressive disease|3|||
125457734|NCT00878722|451303681|FG001|Overall Study|Progressive disease|3|||
125457735|NCT00878722|451303682|FG002|Overall Study|Progressive disease|3|||
125457736|NCT00878722|451303683|FG003|Overall Study|Progressive disease|7|||
125457737|NCT00878722|451303684|FG004|Overall Study|Progressive disease|7|||
125457738|NCT00878722|451303685|FG005|Overall Study|Progressive disease|1|||
125457739|NCT00878722|451303686|FG006|Overall Study|Progressive disease|4|||
125457740|NCT00878722|451303687|FG007|Overall Study|Progressive disease|3|||
125457741|NCT00878722|451303680|FG000|Overall Study|Death|0|||
125457742|NCT00878722|451303681|FG001|Overall Study|Death|0|||
125457743|NCT00878722|451303682|FG002|Overall Study|Death|0|||
125457744|NCT00878722|451303683|FG003|Overall Study|Death|1|||
125457745|NCT00878722|451303684|FG004|Overall Study|Death|0|||
125457746|NCT00878722|451303685|FG005|Overall Study|Death|1|||
125457747|NCT00878722|451303686|FG006|Overall Study|Death|0|||
125457748|NCT00878722|451303687|FG007|Overall Study|Death|2|||
125457749|NCT00878722|451303680|FG000|Overall Study|Adverse Event|0|||
125457750|NCT00878722|451303681|FG001|Overall Study|Adverse Event|0|||
125295220|NCT02723175|450707831|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
125295221|NCT02723175|450707832|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
125295222|NCT02723175|450707831|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
125457751|NCT00878722|451303682|FG002|Overall Study|Adverse Event|0|||
125457752|NCT00878722|451303683|FG003|Overall Study|Adverse Event|0|||
125457753|NCT00878722|451303684|FG004|Overall Study|Adverse Event|0|||
125457754|NCT00878722|451303685|FG005|Overall Study|Adverse Event|0|||
125457755|NCT00878722|451303686|FG006|Overall Study|Adverse Event|2|||
125457756|NCT00878722|451303687|FG007|Overall Study|Adverse Event|0|||
125457757|NCT00878722|451303680|FG000|Overall Study|Withdrawal by Subject|0|||
125457758|NCT00878722|451303681|FG001|Overall Study|Withdrawal by Subject|0|||
125457759|NCT00878722|451303682|FG002|Overall Study|Withdrawal by Subject|0|||
125457760|NCT00878722|451303683|FG003|Overall Study|Withdrawal by Subject|0|||
125457761|NCT00878722|451303684|FG004|Overall Study|Withdrawal by Subject|0|||
125457762|NCT00878722|451303685|FG005|Overall Study|Withdrawal by Subject|0|||
125457763|NCT00878722|451303686|FG006|Overall Study|Withdrawal by Subject|0|||
125457764|NCT00878722|451303687|FG007|Overall Study|Withdrawal by Subject|2|||
125457765|NCT00878722|451303680|FG000|Overall Study|Relapse|0|||
125457766|NCT00878722|451303681|FG001|Overall Study|Relapse|0|||
125457767|NCT00878722|451303682|FG002|Overall Study|Relapse|0|||
125457768|NCT00878722|451303683|FG003|Overall Study|Relapse|1|||
125457769|NCT00878722|451303684|FG004|Overall Study|Relapse|0|||
125457770|NCT00878722|451303685|FG005|Overall Study|Relapse|0|||
125457771|NCT00878722|451303686|FG006|Overall Study|Relapse|0|||
125457772|NCT00878722|451303687|FG007|Overall Study|Relapse|0|||
125457773|NCT00972504|451303688|FG000|Overall Study|Adverse Event|2|||
125457774|NCT00972504|451303688|FG000|Overall Study|Investigator discretion|1|||
125457775|NCT01161498|451303689|FG000|Overall Study|Disease Progression|0|||
125457776|NCT01161498|451303690|FG001|Overall Study|Disease Progression|1|||
125457777|NCT02807493|451303693|FG000|Overall Study|Adverse Event|5|||
125457778|NCT02807493|451303694|FG001|Overall Study|Adverse Event|2|||
125457779|NCT02807493|451303693|FG000|Overall Study|Lost to Follow-up|6|||
125457780|NCT02807493|451303694|FG001|Overall Study|Lost to Follow-up|0|||
125457781|NCT02807493|451303693|FG000|Overall Study|Physician Decision|4|||
125457782|NCT02807493|451303694|FG001|Overall Study|Physician Decision|1|||
125457783|NCT02807493|451303693|FG000|Overall Study|Protocol Violation|7|||
125457784|NCT02807493|451303694|FG001|Overall Study|Protocol Violation|0|||
125457785|NCT02807493|451303693|FG000|Overall Study|Withdrawal by Subject|17|||
125457786|NCT02807493|451303694|FG001|Overall Study|Withdrawal by Subject|10|||
125457787|NCT02807493|451303693|FG000|Overall Study|Other withdrawal|17|||
125457788|NCT02807493|451303694|FG001|Overall Study|Other withdrawal|0|||
125457789|NCT02807493|451303693|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
125457790|NCT02807493|451303694|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
125457791|NCT03008915|451303699|FG000|Treatment 1|Withdrawal by Subject|0|||
125457792|NCT03008915|451303700|FG001|Treatment 1|Withdrawal by Subject|1|||
125457793|NCT00712166|451303703|FG000|Overall Study|Noncompliance|0|||
125457794|NCT00712166|451303704|FG001|Overall Study|Noncompliance|1|||
125457795|NCT01773122|451303705|FG000|Overall Study|Due to amended age eligibility criteria|3|||
125457796|NCT01773122|451303706|FG001|Overall Study|Due to amended age eligibility criteria|1|||
125457797|NCT01773122|451303707|FG002|Overall Study|Due to amended age eligibility criteria|0|||
125457798|NCT01773122|451303708|FG003|Overall Study|Due to amended age eligibility criteria|1|||
125457799|NCT01264718|451303709|FG000|Overall Study|Lost to Follow-up|3|||
125457800|NCT01264718|451303710|FG001|Overall Study|Lost to Follow-up|2|||
125457801|NCT01264718|451303709|FG000|Overall Study|Withdrawal by Subject|9|||
125457802|NCT01264718|451303710|FG001|Overall Study|Withdrawal by Subject|15|||
125457803|NCT01264718|451303709|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
125457804|NCT01264718|451303710|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
125457805|NCT01769391|451303713|FG000|Overall Study|Death|10|||
125457806|NCT01769391|451303714|FG001|Overall Study|Death|1|||
125457807|NCT01769391|451303713|FG000|Overall Study|Adverse Event|0|||
125457808|NCT01769391|451303714|FG001|Overall Study|Adverse Event|3|||
125457809|NCT01769391|451303713|FG000|Overall Study|Progressive Disease|1|||
125457810|NCT01769391|451303714|FG001|Overall Study|Progressive Disease|2|||
125457811|NCT01769391|451303713|FG000|Overall Study|Withdrawal by Subject|4|||
125457812|NCT01769391|451303714|FG001|Overall Study|Withdrawal by Subject|3|||
125457813|NCT01769391|451303713|FG000|Overall Study|Investigator Decision|2|||
125457814|NCT01769391|451303714|FG001|Overall Study|Investigator Decision|0|||
125457815|NCT03386929|451303715|FG000|Overall Study|Death|0|||
125457816|NCT03386929|451303716|FG001|Overall Study|Death|0|||
125457817|NCT03386929|451303717|FG002|Overall Study|Death|1|||
125457818|NCT03386929|451303715|FG000|Overall Study|Withdrawal by Subject|0|||
125457819|NCT03386929|451303716|FG001|Overall Study|Withdrawal by Subject|1|||
125457820|NCT03386929|451303717|FG002|Overall Study|Withdrawal by Subject|0|||
125457821|NCT03386929|451303715|FG000|Overall Study|Physician Decision|0|||
125457822|NCT03386929|451303716|FG001|Overall Study|Physician Decision|0|||
125457823|NCT03386929|451303717|FG002|Overall Study|Physician Decision|1|||
125457824|NCT03386929|451303715|FG000|Overall Study|Progression|4|||
125457825|NCT03386929|451303716|FG001|Overall Study|Progression|4|||
125457826|NCT03386929|451303717|FG002|Overall Study|Progression|0|||
125457827|NCT03386929|451303715|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
125457828|NCT03386929|451303716|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
125457829|NCT03386929|451303717|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
125457830|NCT03386929|451303715|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
125457831|NCT03386929|451303716|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
125457832|NCT03386929|451303717|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
125457833|NCT01123083|451303727|FG000|Overall Study|Investigator recommendation|1|||
125457834|NCT01123083|451303728|FG001|Overall Study|Investigator recommendation|1|||
125457835|NCT01123083|451303727|FG000|Overall Study|Administrative reasons|0|||
125457836|NCT01123083|451303728|FG001|Overall Study|Administrative reasons|4|||
125457837|NCT01123083|451303727|FG000|Overall Study|Lost to Follow-up|2|||
125457838|NCT01123083|451303728|FG001|Overall Study|Lost to Follow-up|6|||
125457839|NCT01123083|451303727|FG000|Overall Study|Adverse Event|1|||
125457840|NCT01123083|451303728|FG001|Overall Study|Adverse Event|0|||
125457841|NCT01123083|451303727|FG000|Overall Study|Withdrew for another reason not covered|0|||
125457842|NCT01123083|451303728|FG001|Overall Study|Withdrew for another reason not covered|1|||
125457843|NCT01123083|451303727|FG000|Overall Study|Participant/legal representative request|7|||
125457844|NCT01123083|451303728|FG001|Overall Study|Participant/legal representative request|3|||
125457845|NCT01025843|451305420|FG000|Washout 4|Withdrawal by Subject|0|||
125457846|NCT01025843|451305421|FG001|Washout 4|Withdrawal by Subject|0|||
125457847|NCT01025843|451305422|FG002|Washout 4|Withdrawal by Subject|1|||
125457848|NCT01025843|451305423|FG003|Washout 4|Withdrawal by Subject|1|||
125457849|NCT01025843|451305424|FG004|Washout 4|Withdrawal by Subject|0|||
125457850|NCT01025843|451305425|FG005|Washout 4|Withdrawal by Subject|0|||
125457851|NCT01025843|451305426|FG006|Washout 4|Withdrawal by Subject|0|||
125457852|NCT01025843|451305427|FG007|Washout 4|Withdrawal by Subject|0|||
125457853|NCT01025843|451305428|FG008|Washout 4|Withdrawal by Subject|0|||
125457854|NCT01025843|451305429|FG009|Washout 4|Withdrawal by Subject|0|||
125457855|NCT00377455|451305432|FG000|Overall Study|Withdrawal by Subject|1|||
125457856|NCT01070888|451305433|FG000|First Intervention (14 Days)|Adverse Event|0|||
125457857|NCT01070888|451305434|FG001|First Intervention (14 Days)|Adverse Event|1|||
125457858|NCT01070888|451305433|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
125457859|NCT01070888|451305434|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
125457860|NCT01070888|451305433|FG000|Washout (14 Days)|Physician Decision|1|||
125457861|NCT01070888|451305434|FG001|Washout (14 Days)|Physician Decision|0|||
125457862|NCT01897233|451305439|FG000|Part B (24 Weeks)|Adverse Event|1|||
125457863|NCT01897233|451305439|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
125457864|NCT01897233|451305439|FG000|Part B (24 Weeks)|Physician Decision|1|||
125457865|NCT02385669|451305441|FG000|Overall Study|Adverse Event|2|||
125457866|NCT02810080|451305442|FG000|Overall Study|Adverse Event|3|||
125457867|NCT02810080|451305443|FG001|Overall Study|Adverse Event|0|||
125457868|NCT02810080|451305442|FG000|Overall Study|Death|0|||
125457869|NCT02810080|451305443|FG001|Overall Study|Death|2|||
125457870|NCT02810080|451305442|FG000|Overall Study|Physician Decision|4|||
125457871|NCT02810080|451305443|FG001|Overall Study|Physician Decision|0|||
125457872|NCT02810080|451305442|FG000|Overall Study|Withdrawal by Subject|0|||
125457873|NCT02810080|451305443|FG001|Overall Study|Withdrawal by Subject|2|||
125457874|NCT04033432|451305449|FG000|Overall Study|Progressive Disease|8|||
125457875|NCT04033432|451305449|FG000|Overall Study|Adverse Event|4|||
125457876|NCT04033432|451305449|FG000|Overall Study|Death|1|||
125457877|NCT02192606|451305450|FG000|Overall Study|surgery type was changed|1|||
125457878|NCT02192606|451305451|FG001|Overall Study|surgery type was changed|1|||
125457879|NCT02192606|451305450|FG000|Overall Study|Physician Decision|1|||
125457880|NCT02192606|451305451|FG001|Overall Study|Physician Decision|2|||
125457881|NCT02192606|451305450|FG000|Overall Study|3D equipment rep unable to join|0|||
125457882|NCT02192606|451305451|FG001|Overall Study|3D equipment rep unable to join|1|||
125457883|NCT02034916|451305455|FG000|Overall Study|Death|39|||
125457884|NCT02034916|451305456|FG001|Overall Study|Death|28|||
125457885|NCT02034916|451305455|FG000|Overall Study|Withdrawal by Subject|2|||
125457886|NCT02034916|451305456|FG001|Overall Study|Withdrawal by Subject|1|||
125457887|NCT02034916|451305455|FG000|Overall Study|Lost to Follow-up|4|||
125457888|NCT02034916|451305456|FG001|Overall Study|Lost to Follow-up|1|||
125457889|NCT02034916|451305455|FG000|Overall Study|Study terminated by sponsor|4|||
125457890|NCT02034916|451305456|FG001|Overall Study|Study terminated by sponsor|5|||
125457891|NCT01616654|451305461|FG000|Overall Study|Lack of Efficacy|1|||
125457892|NCT01616654|451305462|FG001|Overall Study|Lack of Efficacy|0|||
125457893|NCT01616654|451305463|FG002|Overall Study|Lack of Efficacy|0|||
125457894|NCT01616654|451305464|FG003|Overall Study|Lack of Efficacy|0|||
125457895|NCT01616654|451305465|FG004|Overall Study|Lack of Efficacy|1|||
125457896|NCT01616654|451305461|FG000|Overall Study|Adverse Event|0|||
125457897|NCT01616654|451305462|FG001|Overall Study|Adverse Event|1|||
125457898|NCT01616654|451305463|FG002|Overall Study|Adverse Event|2|||
125457899|NCT01616654|451305464|FG003|Overall Study|Adverse Event|1|||
125457900|NCT01616654|451305465|FG004|Overall Study|Adverse Event|0|||
125457901|NCT01616654|451305461|FG000|Overall Study|Withdrawal by Subject|2|||
125457902|NCT01616654|451305462|FG001|Overall Study|Withdrawal by Subject|2|||
125457903|NCT01616654|451305463|FG002|Overall Study|Withdrawal by Subject|3|||
125457904|NCT01616654|451305464|FG003|Overall Study|Withdrawal by Subject|1|||
125457905|NCT01616654|451305465|FG004|Overall Study|Withdrawal by Subject|5|||
125457906|NCT01616654|451305461|FG000|Overall Study|Protocol Violation|0|||
125457907|NCT01616654|451305462|FG001|Overall Study|Protocol Violation|5|||
125457908|NCT01616654|451305463|FG002|Overall Study|Protocol Violation|2|||
125457909|NCT01616654|451305464|FG003|Overall Study|Protocol Violation|4|||
125457910|NCT01616654|451305465|FG004|Overall Study|Protocol Violation|4|||
125457911|NCT01616654|451305461|FG000|Overall Study|Lost to Follow-up|1|||
125457912|NCT01616654|451305462|FG001|Overall Study|Lost to Follow-up|0|||
125457913|NCT01616654|451305463|FG002|Overall Study|Lost to Follow-up|3|||
125457914|NCT01616654|451305464|FG003|Overall Study|Lost to Follow-up|2|||
125457915|NCT01616654|451305465|FG004|Overall Study|Lost to Follow-up|1|||
125457916|NCT01616654|451305461|FG000|Overall Study|Pregnancy|1|||
125457917|NCT01616654|451305462|FG001|Overall Study|Pregnancy|0|||
125457918|NCT01616654|451305463|FG002|Overall Study|Pregnancy|0|||
125457919|NCT01616654|451305464|FG003|Overall Study|Pregnancy|0|||
125457920|NCT01616654|451305465|FG004|Overall Study|Pregnancy|1|||
125457921|NCT02057692|451305469|FG000|Overall Study|Adverse Event|1|||
125457922|NCT02057692|451305470|FG001|Overall Study|Adverse Event|0|||
125457923|NCT02057692|451305471|FG002|Overall Study|Adverse Event|0|||
125457924|NCT02057692|451305472|FG003|Overall Study|Adverse Event|0|||
125457925|NCT02057692|451305469|FG000|Overall Study|Lost to Follow-up|0|||
125457926|NCT02057692|451305470|FG001|Overall Study|Lost to Follow-up|0|||
125457927|NCT02057692|451305471|FG002|Overall Study|Lost to Follow-up|0|||
125457928|NCT02057692|451305472|FG003|Overall Study|Lost to Follow-up|1|||
125457929|NCT00864682|451305473|FG000|Overall Study|Protocol Violation|2|||
125457930|NCT00864682|451305474|FG001|Overall Study|Protocol Violation|1|||
125457931|NCT00864682|451305475|FG002|Overall Study|Protocol Violation|2|||
125457932|NCT00957658|451305476|FG000|Overall Study|Death|1|||
125457933|NCT00957658|451305476|FG000|Overall Study|Lost to Follow-up|4|||
125457934|NCT00957658|451305476|FG000|Overall Study|Withdrawal by Subject|12|||
125457935|NCT00957658|451305476|FG000|Overall Study|Revision|1|||
125457936|NCT00957658|451305476|FG000|Overall Study|Incomplete 2 yr data|28|||
125457937|NCT00957658|451305476|FG000|Overall Study|Site termination|10|||
125457938|NCT00957658|451305476|FG000|Overall Study|unwilling/unable to return|2|||
125457939|NCT00957658|451305476|FG000|Overall Study|surgery cancelled|2|||
125457940|NCT00957658|451305476|FG000|Overall Study|Protocol Violation|5|||
125457941|NCT04842604|451305478|FG000|Overall Study|Death|1|||
125457942|NCT04842604|451305479|FG001|Overall Study|Death|0|||
125457943|NCT04842604|451305478|FG000|Overall Study|Other|4|||
125457944|NCT04842604|451305479|FG001|Overall Study|Other|4|||
125457945|NCT04842604|451305478|FG000|Overall Study|Randomized but not treated|1|||
125457946|NCT04842604|451305479|FG001|Overall Study|Randomized but not treated|0|||
125457947|NCT01193153|451305480|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
125457948|NCT01193153|451305481|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
125457949|NCT01193153|451305480|FG000|Open-label Lead in Period|Pregnancy|1|||
125457950|NCT01193153|451305481|FG001|Open-label Lead in Period|Pregnancy|0|||
125457951|NCT01193153|451305480|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
125457952|NCT01193153|451305481|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
125457953|NCT01193153|451305480|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
125457954|NCT01193153|451305481|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
125457955|NCT01193153|451305480|FG000|Open-label Lead in Period|Other|14|||
125457956|NCT01193153|451305481|FG001|Open-label Lead in Period|Other|0|||
125457957|NCT01193153|451305480|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
125457958|NCT01193153|451305481|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
125457959|NCT01193153|451305480|FG000|Open-label Lead in Period|Adverse Event|41|||
125457960|NCT01193153|451305481|FG001|Open-label Lead in Period|Adverse Event|0|||
125457961|NCT01193153|451305480|FG000|Open-label Lead in Period|Death|1|||
125457962|NCT01193153|451305481|FG001|Open-label Lead in Period|Death|0|||
125457963|NCT01193153|451305480|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
125457964|NCT01193153|451305481|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
125457965|NCT01193153|451305480|FG000|Open-label Stabilization Period|Adverse Event|9|||
125457966|NCT01193153|451305481|FG001|Open-label Stabilization Period|Adverse Event|0|||
125457967|NCT01193153|451305480|FG000|Open-label Stabilization Period|Death|2|||
125457968|NCT01193153|451305481|FG001|Open-label Stabilization Period|Death|0|||
125457969|NCT01193153|451305480|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
125457970|NCT01193153|451305481|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
125457971|NCT01193153|451305480|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
125457972|NCT01193153|451305481|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
125457973|NCT01193153|451305480|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
125457974|NCT01193153|451305481|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
125457975|NCT01193153|451305480|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
125457976|NCT01193153|451305481|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
125457977|NCT01193153|451305480|FG000|Open-label Stabilization Period|Other|8|||
125457978|NCT01193153|451305481|FG001|Open-label Stabilization Period|Other|0|||
125457979|NCT01193153|451305480|FG000|Double Blind Relapse Prevention Period|Other|2|||
125457980|NCT01193153|451305481|FG001|Double Blind Relapse Prevention Period|Other|3|||
125457981|NCT01193153|451305480|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
125457982|NCT01193153|451305481|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
125457983|NCT01193153|451305480|FG000|Double Blind Relapse Prevention Period|Death|2|||
125457984|NCT01193153|451305481|FG001|Double Blind Relapse Prevention Period|Death|0|||
125457985|NCT01193153|451305480|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
125457986|NCT01193153|451305481|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
125457987|NCT01193153|451305480|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
125457988|NCT01193153|451305481|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
125457989|NCT01193153|451305480|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
125457990|NCT01193153|451305481|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
125457991|NCT01193153|451305480|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
125295223|NCT02723175|450707832|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
125295224|NCT00257660|450707835|FG000|Overall Study|Lack of Efficacy|5|||
125295225|NCT00257660|450707836|FG001|Overall Study|Lack of Efficacy|23|||
125295226|NCT00257660|450707835|FG000|Overall Study|Withdrawal by Subject|2|||
125295227|NCT00257660|450707836|FG001|Overall Study|Withdrawal by Subject|0|||
125295228|NCT00257660|450707835|FG000|Overall Study|Lost to Follow-up|1|||
125295229|NCT00257660|450707836|FG001|Overall Study|Lost to Follow-up|0|||
125420236|NCT00955357|451163554|FG001|Titration Phase|Adverse Event|46|||
125420237|NCT00955357|451163553|FG000|Titration Phase|Lack of Efficacy|0|||
125420238|NCT00955357|451163554|FG001|Titration Phase|Lack of Efficacy|2|||
125420239|NCT00955357|451163553|FG000|Titration Phase|Protocol Violation|3|||
125420240|NCT00955357|451163554|FG001|Titration Phase|Protocol Violation|7|||
125420241|NCT00955357|451163553|FG000|Titration Phase|Lost to Follow-up|1|||
125420242|NCT00955357|451163554|FG001|Titration Phase|Lost to Follow-up|3|||
125420243|NCT00955357|451163553|FG000|Titration Phase|Withdrawal by Subject|3|||
125420244|NCT00955357|451163554|FG001|Titration Phase|Withdrawal by Subject|5|||
125420245|NCT00955357|451163553|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
125420246|NCT00955357|451163554|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
125420247|NCT00955357|451163553|FG000|Titration Phase|Study medication not tolerated|0|||
125420248|NCT00955357|451163554|FG001|Titration Phase|Study medication not tolerated|1|||
125420249|NCT00955357|451163553|FG000|Titration Phase|Non compliance to study procedures|0|||
125420250|NCT00955357|451163554|FG001|Titration Phase|Non compliance to study procedures|1|||
125420251|NCT00955357|451163553|FG000|Maintenance Phase|Adverse Event|3|||
125420252|NCT00955357|451163554|FG001|Maintenance Phase|Adverse Event|23|||
125420253|NCT00955357|451163553|FG000|Maintenance Phase|Lack of Efficacy|0|||
125420254|NCT00955357|451163554|FG001|Maintenance Phase|Lack of Efficacy|4|||
125420255|NCT00955357|451163553|FG000|Maintenance Phase|Protocol Violation|2|||
125420256|NCT00955357|451163554|FG001|Maintenance Phase|Protocol Violation|6|||
125420257|NCT00955357|451163553|FG000|Maintenance Phase|Lost to Follow-up|2|||
125420258|NCT00955357|451163554|FG001|Maintenance Phase|Lost to Follow-up|7|||
125420259|NCT00955357|451163553|FG000|Maintenance Phase|Withdrawal by Subject|4|||
125420260|NCT00955357|451163554|FG001|Maintenance Phase|Withdrawal by Subject|4|||
125420261|NCT00955357|451163553|FG000|Maintenance Phase|Patient moving out of area|0|||
125420262|NCT00955357|451163554|FG001|Maintenance Phase|Patient moving out of area|1|||
125420263|NCT00955357|451163553|FG000|Maintenance Phase|Non compliance to study procedures|1|||
125420264|NCT00955357|451163554|FG001|Maintenance Phase|Non compliance to study procedures|0|||
125420265|NCT00440531|451163561|FG000|Overall Study|Adverse Event|1|||
125420266|NCT00440531|451163562|FG001|Overall Study|Adverse Event|0|||
125420267|NCT00440531|451163563|FG002|Overall Study|Adverse Event|2|||
125420268|NCT00440531|451163561|FG000|Overall Study|Withdrawal by Subject|2|||
125420269|NCT00440531|451163562|FG001|Overall Study|Withdrawal by Subject|0|||
125420270|NCT00440531|451163563|FG002|Overall Study|Withdrawal by Subject|0|||
125420271|NCT00440531|451163561|FG000|Overall Study|Protocol Violation|1|||
125420272|NCT00440531|451163562|FG001|Overall Study|Protocol Violation|2|||
125420273|NCT00440531|451163563|FG002|Overall Study|Protocol Violation|0|||
125420274|NCT00440531|451163561|FG000|Overall Study|Lost to Follow-up|4|||
125420275|NCT00440531|451163562|FG001|Overall Study|Lost to Follow-up|3|||
125420276|NCT00440531|451163563|FG002|Overall Study|Lost to Follow-up|5|||
125420277|NCT00440531|451163561|FG000|Overall Study|see pre-assignment details|2|||
125420278|NCT00440531|451163562|FG001|Overall Study|see pre-assignment details|0|||
125420279|NCT00440531|451163563|FG002|Overall Study|see pre-assignment details|0|||
125420280|NCT02181803|451163570|FG000|Overall Study|Withdrawal by Subject|0|||
125420281|NCT02181803|451163571|FG001|Overall Study|Withdrawal by Subject|2|||
125420282|NCT02181803|451163572|FG002|Overall Study|Withdrawal by Subject|0|||
125420283|NCT02181803|451163573|FG003|Overall Study|Withdrawal by Subject|0|||
125420284|NCT02181803|451163574|FG004|Overall Study|Withdrawal by Subject|0|||
125420285|NCT02181803|451163575|FG005|Overall Study|Withdrawal by Subject|0|||
125420286|NCT02181803|451163576|FG006|Overall Study|Withdrawal by Subject|0|||
125420287|NCT02181803|451163577|FG007|Overall Study|Withdrawal by Subject|0|||
125420288|NCT02181803|451163578|FG008|Overall Study|Withdrawal by Subject|0|||
125420289|NCT02181803|451163570|FG000|Overall Study|Physician Decision|0|||
125420290|NCT02181803|451163571|FG001|Overall Study|Physician Decision|0|||
125420291|NCT02181803|451163572|FG002|Overall Study|Physician Decision|0|||
125420292|NCT02181803|451163573|FG003|Overall Study|Physician Decision|1|||
125420293|NCT02181803|451163574|FG004|Overall Study|Physician Decision|0|||
125420294|NCT02181803|451163575|FG005|Overall Study|Physician Decision|0|||
125420295|NCT02181803|451163576|FG006|Overall Study|Physician Decision|0|||
125420296|NCT02181803|451163577|FG007|Overall Study|Physician Decision|1|||
125420297|NCT02181803|451163578|FG008|Overall Study|Physician Decision|0|||
125420298|NCT02181803|451163570|FG000|Overall Study|Adverse Event|0|||
125420299|NCT02181803|451163571|FG001|Overall Study|Adverse Event|2|||
125420300|NCT02181803|451163572|FG002|Overall Study|Adverse Event|0|||
125420301|NCT02181803|451163573|FG003|Overall Study|Adverse Event|1|||
125420302|NCT02181803|451163574|FG004|Overall Study|Adverse Event|0|||
125457992|NCT01193153|451305481|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
125457993|NCT01193153|451305480|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
125457994|NCT01193153|451305481|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
125457995|NCT01648140|451305482|FG000|Overall Study|Physician Decision|1|||
125457996|NCT01648140|451305483|FG001|Overall Study|Physician Decision|0|||
125457997|NCT01648140|451305484|FG002|Overall Study|Physician Decision|0|||
125457998|NCT01648140|451305485|FG003|Overall Study|Physician Decision|0|||
125457999|NCT01648140|451305482|FG000|Overall Study|Lack of Efficacy|4|||
125458000|NCT01648140|451305483|FG001|Overall Study|Lack of Efficacy|7|||
125458001|NCT01648140|451305484|FG002|Overall Study|Lack of Efficacy|1|||
125458002|NCT01648140|451305485|FG003|Overall Study|Lack of Efficacy|0|||
125458003|NCT01648140|451305482|FG000|Overall Study|Adverse Event|3|||
125458004|NCT01648140|451305483|FG001|Overall Study|Adverse Event|1|||
125458005|NCT01648140|451305484|FG002|Overall Study|Adverse Event|2|||
125458006|NCT01648140|451305485|FG003|Overall Study|Adverse Event|0|||
125458007|NCT01648140|451305482|FG000|Overall Study|Withdrawal by Subject|2|||
125458008|NCT01648140|451305483|FG001|Overall Study|Withdrawal by Subject|3|||
125458009|NCT01648140|451305484|FG002|Overall Study|Withdrawal by Subject|3|||
125458010|NCT01648140|451305485|FG003|Overall Study|Withdrawal by Subject|2|||
125458011|NCT01648140|451305482|FG000|Overall Study|Lost to Follow-up|2|||
125458012|NCT01648140|451305483|FG001|Overall Study|Lost to Follow-up|1|||
125458013|NCT01648140|451305484|FG002|Overall Study|Lost to Follow-up|2|||
125458014|NCT01648140|451305485|FG003|Overall Study|Lost to Follow-up|0|||
125458015|NCT00608907|451305488|FG000|Overall Study|Adverse Event|6|||
125458016|NCT00608907|451305489|FG001|Overall Study|Adverse Event|0|||
125458017|NCT00608907|451305490|FG002|Overall Study|Adverse Event|1|||
125458018|NCT00608907|451305488|FG000|Overall Study|Death|1|||
125458019|NCT00608907|451305489|FG001|Overall Study|Death|0|||
125458020|NCT00608907|451305490|FG002|Overall Study|Death|0|||
125458021|NCT00608907|451305488|FG000|Overall Study|Withdrawal by Subject|4|||
125458022|NCT00608907|451305489|FG001|Overall Study|Withdrawal by Subject|0|||
125458023|NCT00608907|451305490|FG002|Overall Study|Withdrawal by Subject|0|||
125458024|NCT00608907|451305488|FG000|Overall Study|Progressive Disease|1|||
125458025|NCT00608907|451305489|FG001|Overall Study|Progressive Disease|0|||
125458026|NCT00608907|451305490|FG002|Overall Study|Progressive Disease|0|||
125458027|NCT00758602|451305498|FG000|Overall Study|Adverse Event|11|||
125458028|NCT00758602|451305499|FG001|Overall Study|Adverse Event|10|||
125458029|NCT00758602|451305498|FG000|Overall Study|Lost to Follow-up|4|||
125458030|NCT00758602|451305499|FG001|Overall Study|Lost to Follow-up|3|||
125458031|NCT00758602|451305498|FG000|Overall Study|Withdrawal by Subject|1|||
125458032|NCT00758602|451305499|FG001|Overall Study|Withdrawal by Subject|3|||
125458033|NCT00758602|451305498|FG000|Overall Study|Protocol Violation|0|||
125458034|NCT00758602|451305499|FG001|Overall Study|Protocol Violation|2|||
125458035|NCT00758602|451305498|FG000|Overall Study|Death|0|||
125458036|NCT00758602|451305499|FG001|Overall Study|Death|1|||
125458037|NCT00758602|451305498|FG000|Overall Study|Reason not specified|3|||
125458038|NCT00758602|451305499|FG001|Overall Study|Reason not specified|3|||
125458039|NCT00158054|451305506|FG000|Overall Study|Refused to continue|3|||
125458040|NCT00158054|451305507|FG001|Overall Study|Refused to continue|0|||
125458041|NCT00158054|451305506|FG000|Overall Study|Unavailable for follow up|7|||
125458042|NCT00158054|451305507|FG001|Overall Study|Unavailable for follow up|3|||
125458043|NCT00079183|451305523|FG000|Overall Study|Withdrawal by Subject|4|||
125458044|NCT00079183|451305523|FG000|Overall Study|Study medication non-compliance|2|||
125458045|NCT00079183|451305523|FG000|Overall Study|Specimen collection non-compliance|1|||
125458046|NCT02371746|451305524|FG000|Overall Study|Consent withdrawn|0|||
125458047|NCT02371746|451305525|FG001|Overall Study|Consent withdrawn|0|||
125458048|NCT02371746|451305526|FG002|Overall Study|Consent withdrawn|0|||
125458049|NCT02371746|451305527|FG003|Overall Study|Consent withdrawn|0|||
125295230|NCT00257660|450707835|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
125295231|NCT00257660|450707836|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
125295232|NCT00257660|450707835|FG000|Overall Study|No longer wanted to do blood draws|1|||
125458050|NCT02371746|451305528|FG004|Overall Study|Consent withdrawn|0|||
125458051|NCT02371746|451305529|FG005|Overall Study|Consent withdrawn|0|||
125458052|NCT02371746|451305530|FG006|Overall Study|Consent withdrawn|1|||
125458053|NCT01490580|451305532|FG000|Overall Study|Parents withdrew consent|0|||
125458054|NCT01490580|451305533|FG001|Overall Study|Parents withdrew consent|2|||
125458055|NCT00949975|451305536|FG000|Overall Study|Voluntary discontinuation|6|||
125458056|NCT00949975|451305537|FG001|Overall Study|Voluntary discontinuation|5|||
125458057|NCT00949975|451305538|FG002|Overall Study|Voluntary discontinuation|3|||
125458058|NCT00949975|451305539|FG003|Overall Study|Voluntary discontinuation|6|||
125458059|NCT00949975|451305536|FG000|Overall Study|Adverse Event|11|||
125458060|NCT00949975|451305537|FG001|Overall Study|Adverse Event|11|||
125458061|NCT00949975|451305538|FG002|Overall Study|Adverse Event|10|||
125458062|NCT00949975|451305539|FG003|Overall Study|Adverse Event|10|||
125458063|NCT00949975|451305536|FG000|Overall Study|Safety reason|0|||
125458064|NCT00949975|451305537|FG001|Overall Study|Safety reason|1|||
125458065|NCT00949975|451305538|FG002|Overall Study|Safety reason|0|||
125295233|NCT00257660|450707836|FG001|Overall Study|No longer wanted to do blood draws|0|||
125458066|NCT00949975|451305539|FG003|Overall Study|Safety reason|0|||
125458067|NCT00949975|451305536|FG000|Overall Study|Study-specific criteria|0|||
125458068|NCT00949975|451305537|FG001|Overall Study|Study-specific criteria|1|||
125458069|NCT00949975|451305538|FG002|Overall Study|Study-specific criteria|1|||
125458070|NCT00949975|451305539|FG003|Overall Study|Study-specific criteria|0|||
125458071|NCT00949975|451305536|FG000|Overall Study|Incorrect enrolment|5|||
125458072|NCT00949975|451305537|FG001|Overall Study|Incorrect enrolment|10|||
125458073|NCT00949975|451305538|FG002|Overall Study|Incorrect enrolment|4|||
125458074|NCT00949975|451305539|FG003|Overall Study|Incorrect enrolment|7|||
125458075|NCT00949975|451305536|FG000|Overall Study|Severe non-compliance|3|||
125458076|NCT00949975|451305537|FG001|Overall Study|Severe non-compliance|1|||
125458077|NCT00949975|451305538|FG002|Overall Study|Severe non-compliance|0|||
125458078|NCT00949975|451305539|FG003|Overall Study|Severe non-compliance|2|||
125458079|NCT00949975|451305536|FG000|Overall Study|Lost to Follow-up|1|||
125458080|NCT00949975|451305537|FG001|Overall Study|Lost to Follow-up|0|||
125458081|NCT00949975|451305538|FG002|Overall Study|Lost to Follow-up|1|||
125458082|NCT00949975|451305539|FG003|Overall Study|Lost to Follow-up|3|||
125458083|NCT00949975|451305536|FG000|Overall Study|Other|1|||
125458084|NCT00949975|451305537|FG001|Overall Study|Other|0|||
125458085|NCT00949975|451305538|FG002|Overall Study|Other|0|||
125458086|NCT00949975|451305539|FG003|Overall Study|Other|0|||
125458087|NCT02873754|451305540|FG000|Overall Study|Lost to Follow-up|5|||
125458088|NCT02873754|451305540|FG000|Overall Study|Couldn't complete study procedures|1|||
125458089|NCT00082810|451305553|FG000|Overall Study|Adverse Event|3|||
125458090|NCT00082810|451305553|FG000|Overall Study|Progressive disease|24|||
125458091|NCT00082810|451305553|FG000|Overall Study|Withdrawal by Subject|4|||
125458092|NCT02950558|451305554|FG000|Overall Study|Lost to Follow-up|2|||
125458093|NCT02950558|451305555|FG001|Overall Study|Lost to Follow-up|0|||
125458094|NCT00319436|451305556|FG000|Overall Study|Withdrawal by Subject|6|||
125458095|NCT00319436|451305557|FG001|Overall Study|Withdrawal by Subject|7|||
125458096|NCT01321606|451305560|FG000|Overall Study|Lost to Follow-up|0|||
125458097|NCT01321606|451305561|FG001|Overall Study|Lost to Follow-up|0|||
125458098|NCT01321606|451305562|FG002|Overall Study|Lost to Follow-up|0|||
125458099|NCT01321606|451305563|FG003|Overall Study|Lost to Follow-up|1|||
125458100|NCT02914522|451305564|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
125458101|NCT02914522|451305565|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
125458102|NCT02914522|451305566|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
125458103|NCT02914522|451305567|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
125458104|NCT02914522|451305568|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
125458105|NCT02914522|451305569|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
125458106|NCT02914522|451305570|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
125458107|NCT02914522|451305571|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
125458108|NCT02914522|451305572|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
125458109|NCT02914522|451305573|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
125458110|NCT02914522|451305574|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
125458111|NCT02914522|451305564|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
125458112|NCT02914522|451305565|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
125458113|NCT02914522|451305566|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
125458114|NCT02914522|451305567|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
125458115|NCT02914522|451305568|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
125458116|NCT02914522|451305569|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
125458117|NCT02914522|451305570|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
125458118|NCT02914522|451305571|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
125458119|NCT02914522|451305572|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
125458120|NCT02914522|451305573|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
125458121|NCT02914522|451305574|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
125458122|NCT02914522|451305564|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
125458123|NCT02914522|451305565|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
125458124|NCT02914522|451305566|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
125458125|NCT02914522|451305567|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
125458126|NCT02914522|451305568|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
125458127|NCT02914522|451305569|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
125458128|NCT02914522|451305570|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
125458129|NCT02914522|451305571|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
125458130|NCT02914522|451305572|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
125458131|NCT02914522|451305573|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
125458132|NCT02914522|451305574|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
125458133|NCT02914522|451305564|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
125458134|NCT02914522|451305565|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
125458135|NCT02914522|451305566|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
125458136|NCT02914522|451305567|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
125458137|NCT02914522|451305568|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
125458138|NCT02914522|451305569|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
125458139|NCT02914522|451305570|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
125458140|NCT02914522|451305571|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
125458141|NCT02914522|451305572|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
125458142|NCT02914522|451305573|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
125458143|NCT02914522|451305574|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
125458144|NCT02914522|451305564|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
125458145|NCT02914522|451305565|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
125458146|NCT02914522|451305566|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
125458147|NCT02914522|451305567|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
125458148|NCT02914522|451305568|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
125458149|NCT02914522|451305569|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
125458150|NCT02914522|451305570|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
125458151|NCT02914522|451305571|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
125458152|NCT02914522|451305572|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
125458153|NCT02914522|451305573|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
125458154|NCT02914522|451305574|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
125458155|NCT02914522|451305564|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
125458156|NCT02914522|451305565|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
125458157|NCT02914522|451305566|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
125458158|NCT02914522|451305567|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
125458159|NCT02914522|451305568|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
125458160|NCT02914522|451305569|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
125458161|NCT02914522|451305570|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
125458162|NCT02914522|451305571|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
125458163|NCT02914522|451305572|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
125458164|NCT02914522|451305573|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
125458165|NCT02914522|451305574|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
125458166|NCT02914522|451305564|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
125458167|NCT02914522|451305565|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
125458168|NCT02914522|451305566|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
125458169|NCT02914522|451305567|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
125458170|NCT02914522|451305568|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
125458171|NCT02914522|451305569|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
125458172|NCT02914522|451305570|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
125458173|NCT02914522|451305571|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
125458174|NCT02914522|451305572|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
125458175|NCT02914522|451305573|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
125458176|NCT02914522|451305574|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
125458177|NCT02914522|451305564|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
125458178|NCT02914522|451305565|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
125458179|NCT02914522|451305566|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
125458180|NCT02914522|451305567|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
125458181|NCT02914522|451305568|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
125458182|NCT02914522|451305569|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
125458183|NCT02914522|451305570|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
125458184|NCT02914522|451305571|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
125458185|NCT02914522|451305572|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
125458186|NCT02914522|451305573|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
125458187|NCT02914522|451305574|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
125458188|NCT02914522|451305564|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
125458189|NCT02914522|451305565|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
125458190|NCT02914522|451305566|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
125458191|NCT02914522|451305567|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
125458192|NCT02914522|451305568|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
125458193|NCT02914522|451305569|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
125458194|NCT02914522|451305570|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
125458195|NCT02914522|451305571|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
125458196|NCT02914522|451305572|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
125458197|NCT02914522|451305573|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
125458198|NCT02914522|451305574|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
125458199|NCT02914522|451305564|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
125458200|NCT02914522|451305565|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
125458201|NCT02914522|451305566|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
125458202|NCT02914522|451305567|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
125458203|NCT02914522|451305568|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
125458204|NCT02914522|451305569|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
125458205|NCT02914522|451305570|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
125458206|NCT02914522|451305571|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
125458207|NCT02914522|451305572|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
125458208|NCT02914522|451305573|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
125458209|NCT02914522|451305574|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
125458210|NCT02914522|451305564|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
125458211|NCT02914522|451305565|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
125458212|NCT02914522|451305566|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
125458213|NCT02914522|451305567|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
125458214|NCT02914522|451305568|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
125458215|NCT02914522|451305569|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
125458216|NCT02914522|451305570|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
125458217|NCT02914522|451305571|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
125458218|NCT02914522|451305572|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
125458219|NCT02914522|451305573|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
125458220|NCT02914522|451305574|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
125458221|NCT02914522|451305564|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
125458222|NCT02914522|451305565|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
125458223|NCT02914522|451305566|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
125458224|NCT02914522|451305567|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
125458225|NCT02914522|451305568|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
125458226|NCT02914522|451305569|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
125458227|NCT02914522|451305570|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
125458228|NCT02914522|451305571|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
125458229|NCT02914522|451305572|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
125458230|NCT02914522|451305573|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
125458231|NCT02914522|451305574|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
125458232|NCT02914522|451305564|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
125458233|NCT02914522|451305565|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
125458234|NCT02914522|451305566|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
125458235|NCT02914522|451305567|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
125458236|NCT02914522|451305568|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
125458237|NCT02914522|451305569|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
125458238|NCT02914522|451305570|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
125458239|NCT02914522|451305571|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
125458240|NCT02914522|451305572|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
125458241|NCT02914522|451305573|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
125458242|NCT02914522|451305574|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
125458243|NCT02914522|451305564|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
125458244|NCT02914522|451305565|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
125458245|NCT02914522|451305566|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
125458246|NCT02914522|451305567|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
125458247|NCT02914522|451305568|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
125458248|NCT02914522|451305569|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
125458249|NCT02914522|451305570|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
125458250|NCT02914522|451305571|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
125458251|NCT02914522|451305572|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
125458252|NCT02914522|451305573|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
125458253|NCT02914522|451305574|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
125458254|NCT02914522|451305564|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
125458255|NCT02914522|451305565|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
125458256|NCT02914522|451305566|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
125458257|NCT02914522|451305567|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
125458258|NCT02914522|451305568|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
125458259|NCT02914522|451305569|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
125458260|NCT02914522|451305570|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
125458261|NCT02914522|451305571|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
125458262|NCT02914522|451305572|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
125295234|NCT04109976|450707837|FG000|Overall Study|Withdrawal by Subject|1|||
125458263|NCT02914522|451305573|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
125458264|NCT02914522|451305574|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
125458265|NCT02914522|451305564|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
125458266|NCT02914522|451305565|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
125458267|NCT02914522|451305566|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
125458268|NCT02914522|451305567|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
125458269|NCT02914522|451305568|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
125458270|NCT02914522|451305569|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
125458271|NCT02914522|451305570|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
125458272|NCT02914522|451305571|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
125458273|NCT02914522|451305572|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
125458274|NCT02914522|451305573|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
125458275|NCT02914522|451305574|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
125458276|NCT00756730|451305575|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
125458277|NCT00756730|451305576|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
125458278|NCT00756730|451305575|FG000|Overall Study|persistent low-level viremmia|0|||
125458279|NCT00756730|451305576|FG001|Overall Study|persistent low-level viremmia|1|||
125458280|NCT00639002|451305577|FG000|Overall Study|Death|1|||
125458281|NCT00639002|451305577|FG000|Overall Study|Adverse Event|1|||
125458282|NCT00639002|451305577|FG000|Overall Study|Protocol Violation|1|||
125458283|NCT00639002|451305577|FG000|Overall Study|Disease progression|3|||
125458284|NCT00639002|451305577|FG000|Overall Study|Physician Decision|6|||
125458285|NCT00639002|451305577|FG000|Overall Study|Lack of Efficacy|1|||
125458286|NCT05382104|451305578|FG000|Period 2 (2 Days)|Adverse Event|0|||
125458287|NCT05382104|451305579|FG001|Period 2 (2 Days)|Adverse Event|1|||
125458288|NCT05382104|451305580|FG002|Period 2 (2 Days)|Adverse Event|0|||
125458289|NCT05382104|451305581|FG003|Period 2 (2 Days)|Adverse Event|0|||
125458290|NCT05382104|451305582|FG004|Period 2 (2 Days)|Adverse Event|0|||
125458291|NCT05382104|451305583|FG005|Period 2 (2 Days)|Adverse Event|0|||
125458292|NCT02781584|451305588|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
125458293|NCT02781584|451305589|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
125458294|NCT02781584|451305590|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
125458295|NCT02781584|451305591|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
125458296|NCT02781584|451305592|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
125458297|NCT02781584|451305593|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
125458298|NCT02781584|451305594|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
125458299|NCT02781584|451305595|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
125458300|NCT02781584|451305596|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
125458301|NCT02781584|451305597|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
125458302|NCT02781584|451305598|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
125458303|NCT02781584|451305599|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
125458304|NCT02781584|451305600|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
125458305|NCT02781584|451305588|FG000|Pre-treatment Phase|Adverse Event|0|||
125458306|NCT02781584|451305589|FG001|Pre-treatment Phase|Adverse Event|0|||
125458307|NCT02781584|451305590|FG002|Pre-treatment Phase|Adverse Event|0|||
125458308|NCT02781584|451305591|FG003|Pre-treatment Phase|Adverse Event|0|||
125458309|NCT02781584|451305592|FG004|Pre-treatment Phase|Adverse Event|0|||
125458310|NCT02781584|451305593|FG005|Pre-treatment Phase|Adverse Event|0|||
125458311|NCT02781584|451305594|FG006|Pre-treatment Phase|Adverse Event|0|||
125458312|NCT02781584|451305595|FG007|Pre-treatment Phase|Adverse Event|0|||
125458313|NCT02781584|451305596|FG008|Pre-treatment Phase|Adverse Event|0|||
125458314|NCT02781584|451305597|FG009|Pre-treatment Phase|Adverse Event|0|||
125458315|NCT02781584|451305598|FG010|Pre-treatment Phase|Adverse Event|0|||
125458316|NCT02781584|451305599|FG011|Pre-treatment Phase|Adverse Event|1|||
125458317|NCT02781584|451305600|FG012|Pre-treatment Phase|Adverse Event|0|||
125458318|NCT02781584|451305588|FG000|Treatment Phase|Withdrew Consent|0|||
125458319|NCT02781584|451305589|FG001|Treatment Phase|Withdrew Consent|0|||
125458320|NCT02781584|451305590|FG002|Treatment Phase|Withdrew Consent|0|||
125458321|NCT02781584|451305591|FG003|Treatment Phase|Withdrew Consent|0|||
125458322|NCT02781584|451305592|FG004|Treatment Phase|Withdrew Consent|0|||
125458323|NCT02781584|451305593|FG005|Treatment Phase|Withdrew Consent|1|||
125458324|NCT02781584|451305594|FG006|Treatment Phase|Withdrew Consent|0|||
125458325|NCT02781584|451305595|FG007|Treatment Phase|Withdrew Consent|0|||
125458326|NCT02781584|451305596|FG008|Treatment Phase|Withdrew Consent|0|||
125458327|NCT02781584|451305597|FG009|Treatment Phase|Withdrew Consent|0|||
125458328|NCT02781584|451305598|FG010|Treatment Phase|Withdrew Consent|1|||
125458329|NCT02781584|451305599|FG011|Treatment Phase|Withdrew Consent|2|||
125458330|NCT02781584|451305600|FG012|Treatment Phase|Withdrew Consent|0|||
125458331|NCT02781584|451305588|FG000|Treatment Phase|Adverse Event|0|||
125458332|NCT02781584|451305589|FG001|Treatment Phase|Adverse Event|0|||
125458333|NCT02781584|451305590|FG002|Treatment Phase|Adverse Event|0|||
125458334|NCT02781584|451305591|FG003|Treatment Phase|Adverse Event|0|||
125458335|NCT02781584|451305592|FG004|Treatment Phase|Adverse Event|0|||
125458336|NCT02781584|451305593|FG005|Treatment Phase|Adverse Event|0|||
125458337|NCT02781584|451305594|FG006|Treatment Phase|Adverse Event|0|||
125458338|NCT02781584|451305595|FG007|Treatment Phase|Adverse Event|1|||
125458339|NCT02781584|451305596|FG008|Treatment Phase|Adverse Event|0|||
125458340|NCT02781584|451305597|FG009|Treatment Phase|Adverse Event|0|||
125458341|NCT02781584|451305598|FG010|Treatment Phase|Adverse Event|0|||
125458342|NCT02781584|451305599|FG011|Treatment Phase|Adverse Event|0|||
125458343|NCT02781584|451305600|FG012|Treatment Phase|Adverse Event|0|||
125458344|NCT05052983|451305602|FG000|Overall Study|Lack of Efficacy|3|||
125458345|NCT05052983|451305603|FG001|Overall Study|Lack of Efficacy|12|||
125458346|NCT05052983|451305602|FG000|Overall Study|Adverse Event|1|||
125458347|NCT05052983|451305603|FG001|Overall Study|Adverse Event|0|||
125458348|NCT04133363|451305604|FG000|Overall Study|Lost to Follow-up|2|||
125458349|NCT04133363|451305605|FG001|Overall Study|Lost to Follow-up|1|||
125458350|NCT04133363|451305606|FG002|Overall Study|Lost to Follow-up|4|||
125458351|NCT00849147|451305610|FG000|Overall Study|Withdrawal by Subject|1|||
125458352|NCT00849147|451305610|FG000|Overall Study|Protocol Violation|2|||
125458353|NCT00849147|451305610|FG000|Overall Study|Disease Relapse/Progression|2|||
125458354|NCT00482729|451307809|FG000|Overall Study|Adverse Event|29|||
125458355|NCT00482729|451307810|FG001|Overall Study|Adverse Event|33|||
125458356|NCT00482729|451307809|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
125458357|NCT00482729|451307810|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
125458358|NCT00482729|451307809|FG000|Overall Study|Hyperglycemia Criteria|7|||
125458359|NCT00482729|451307810|FG001|Overall Study|Hyperglycemia Criteria|5|||
125458360|NCT00482729|451307809|FG000|Overall Study|Lack of Efficacy|4|||
125458361|NCT00482729|451307810|FG001|Overall Study|Lack of Efficacy|16|||
125458362|NCT00482729|451307809|FG000|Overall Study|Lost to Follow-up|86|||
125458363|NCT00482729|451307810|FG001|Overall Study|Lost to Follow-up|66|||
125458364|NCT00482729|451307809|FG000|Overall Study|Physician Decision|10|||
125458365|NCT00482729|451307810|FG001|Overall Study|Physician Decision|7|||
125458366|NCT00482729|451307809|FG000|Overall Study|Pregnancy|4|||
125458367|NCT00482729|451307810|FG001|Overall Study|Pregnancy|2|||
125458368|NCT00482729|451307809|FG000|Overall Study|Protocol Violation|10|||
125458369|NCT00482729|451307810|FG001|Overall Study|Protocol Violation|18|||
125458370|NCT00482729|451307809|FG000|Overall Study|Withdrawal by Subject|67|||
125458371|NCT00482729|451307810|FG001|Overall Study|Withdrawal by Subject|69|||
125458372|NCT02631148|451307814|FG000|Overall Study|8 were ineligible|8|||
125458373|NCT02631148|451307815|FG001|Overall Study|8 were ineligible|0|||
125458374|NCT02631148|451307814|FG000|Overall Study|Withdrawal by Subject|1|||
125458375|NCT02631148|451307815|FG001|Overall Study|Withdrawal by Subject|0|||
125458376|NCT02631148|451307814|FG000|Overall Study|PAH not available to study participant|1|||
125458377|NCT02631148|451307815|FG001|Overall Study|PAH not available to study participant|0|||
125458378|NCT01134562|451307817|FG000|Overall Study|Adverse Event|0|||
125458379|NCT01134562|451307818|FG001|Overall Study|Adverse Event|1|||
125458380|NCT01134562|451307819|FG002|Overall Study|Adverse Event|0|||
125458381|NCT01134562|451307820|FG003|Overall Study|Adverse Event|0|||
125458382|NCT01134562|451307821|FG004|Overall Study|Adverse Event|0|||
125458383|NCT02496702|451307823|FG000|Overall Study|Lost to Follow-up|8|||
125458384|NCT02496702|451307824|FG001|Overall Study|Lost to Follow-up|6|||
125458385|NCT02496702|451307823|FG000|Overall Study|Only partially tested|0|||
125458386|NCT02496702|451307824|FG001|Overall Study|Only partially tested|2|||
125458387|NCT02525796|451307829|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
125458388|NCT02525796|451307830|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
125458389|NCT02525796|451307831|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
125458390|NCT02525796|451307829|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
125458391|NCT02525796|451307830|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
125458392|NCT02525796|451307831|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
125458393|NCT02525796|451307829|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
125458394|NCT02525796|451307830|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
125458395|NCT02525796|451307831|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
125458396|NCT02525796|451307829|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
125458397|NCT02525796|451307830|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
125458398|NCT02525796|451307831|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
125458399|NCT02525796|451307829|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
125458400|NCT02525796|451307830|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
125458401|NCT02525796|451307831|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
125458402|NCT00955825|451307832|FG000|Overall Study|Adverse Event|15|||
125458403|NCT00955825|451307833|FG001|Overall Study|Adverse Event|2|||
125458404|NCT00955825|451307832|FG000|Overall Study|Withdrawal by Subject|4|||
125458405|NCT00955825|451307833|FG001|Overall Study|Withdrawal by Subject|6|||
125458406|NCT00955825|451307832|FG000|Overall Study|Any other reason not above-mentioned|7|||
125458407|NCT00955825|451307833|FG001|Overall Study|Any other reason not above-mentioned|9|||
125458408|NCT02488980|451307834|FG000|Overall Study|Protocol Violation|2|||
125458409|NCT02488980|451307835|FG001|Overall Study|Protocol Violation|2|||
125458410|NCT02488980|451307836|FG002|Overall Study|Protocol Violation|2|||
125458411|NCT00150176|451307837|FG000|Overall Study|Adverse Event|16|||
125458412|NCT00150176|451307838|FG001|Overall Study|Adverse Event|53|||
125458413|NCT00150176|451307837|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
125458414|NCT00150176|451307838|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
125458415|NCT00150176|451307837|FG000|Overall Study|Withdrawal by Subject|19|||
125458416|NCT00150176|451307838|FG001|Overall Study|Withdrawal by Subject|12|||
125458417|NCT00150176|451307837|FG000|Overall Study|Lost to Follow-up|3|||
125458418|NCT00150176|451307838|FG001|Overall Study|Lost to Follow-up|3|||
125458419|NCT00150176|451307837|FG000|Overall Study|OTHER|11|||
125458420|NCT00150176|451307838|FG001|Overall Study|OTHER|13|||
125458421|NCT00970307|451307841|FG000|Overall Study|Serious Adverse Event|1|||
125458422|NCT00970307|451307842|FG001|Overall Study|Serious Adverse Event|0|||
125458423|NCT00970307|451307843|FG002|Overall Study|Serious Adverse Event|0|||
125458424|NCT00970307|451307841|FG000|Overall Study|Withdrawal by Subject|2|||
125458425|NCT00970307|451307842|FG001|Overall Study|Withdrawal by Subject|3|||
125458426|NCT00970307|451307843|FG002|Overall Study|Withdrawal by Subject|2|||
125458427|NCT05257798|451307850|FG000|Follow-up Phase|Lost to Follow-up|1|||
125458428|NCT05257798|451307851|FG001|Follow-up Phase|Lost to Follow-up|0|||
125458429|NCT00393848|451307852|FG000|Overall Study|Surgical schedule|0|||
125458430|NCT00393848|451307853|FG001|Overall Study|Surgical schedule|0|||
125458431|NCT00393848|451307854|FG002|Overall Study|Surgical schedule|0|||
125458432|NCT00393848|451307855|FG003|Overall Study|Surgical schedule|1|||
125458433|NCT00393848|451307852|FG000|Overall Study|Personal reasons|0|||
125458434|NCT00393848|451307853|FG001|Overall Study|Personal reasons|0|||
125458435|NCT00393848|451307854|FG002|Overall Study|Personal reasons|2|||
125458436|NCT00393848|451307855|FG003|Overall Study|Personal reasons|0|||
125458437|NCT02082158|451307859|FG000|Overall Study|Withdrawal by Subject|0|||
125458438|NCT02082158|451307860|FG001|Overall Study|Withdrawal by Subject|0|||
125458439|NCT02082158|451307861|FG002|Overall Study|Withdrawal by Subject|0|||
125458440|NCT02082158|451307862|FG003|Overall Study|Withdrawal by Subject|0|||
125458441|NCT02082158|451307863|FG004|Overall Study|Withdrawal by Subject|1|||
125458442|NCT02082158|451307864|FG005|Overall Study|Withdrawal by Subject|0|||
125458443|NCT02082158|451307859|FG000|Overall Study|Failed Fit-testing|8|||
125458444|NCT02082158|451307860|FG001|Overall Study|Failed Fit-testing|8|||
125458445|NCT02082158|451307861|FG002|Overall Study|Failed Fit-testing|14|||
125458446|NCT02082158|451307862|FG003|Overall Study|Failed Fit-testing|4|||
125458447|NCT02082158|451307863|FG004|Overall Study|Failed Fit-testing|3|||
125458448|NCT02082158|451307864|FG005|Overall Study|Failed Fit-testing|7|||
125458449|NCT00419094|451307867|FG000|Overall Study|Adverse Event|3|||
125458450|NCT00419094|451307868|FG001|Overall Study|Adverse Event|7|||
125458451|NCT00419094|451307867|FG000|Overall Study|Lack of Efficacy|1|||
125458452|NCT00419094|451307868|FG001|Overall Study|Lack of Efficacy|0|||
125458453|NCT00419094|451307867|FG000|Overall Study|Lost to Follow-up|0|||
125458454|NCT00419094|451307868|FG001|Overall Study|Lost to Follow-up|2|||
125458455|NCT00419094|451307867|FG000|Overall Study|Protocol Violation|1|||
125458456|NCT00419094|451307868|FG001|Overall Study|Protocol Violation|14|||
125458457|NCT00419094|451307867|FG000|Overall Study|Withdrawal of consent|1|||
125458458|NCT00419094|451307868|FG001|Overall Study|Withdrawal of consent|5|||
125458459|NCT00419094|451307867|FG000|Overall Study|Other: Error determining exit criteria|1|||
125458460|NCT00419094|451307868|FG001|Overall Study|Other: Error determining exit criteria|0|||
125458461|NCT00419094|451307867|FG000|Overall Study|Other: Patient non-compliant|0|||
125458462|NCT00419094|451307868|FG001|Overall Study|Other: Patient non-compliant|1|||
125458463|NCT00419094|451307867|FG000|Overall Study|Other: No contact for extended period|0|||
125458464|NCT00419094|451307868|FG001|Overall Study|Other: No contact for extended period|1|||
125458465|NCT01329328|451307877|FG000|Overall Study|Withdrawal by Subject|2|||
125458466|NCT01329328|451307878|FG001|Overall Study|Withdrawal by Subject|4|||
125458467|NCT01329328|451307879|FG002|Overall Study|Withdrawal by Subject|3|||
125458468|NCT00964366|451307880|FG000|Overall Study|Did not qualify at Day 1|1|||
125458469|NCT00964366|451307881|FG001|Overall Study|Did not qualify at Day 1|0|||
125458470|NCT00964366|451307880|FG000|Overall Study|Withdrawal by Subject|0|||
125458471|NCT00964366|451307881|FG001|Overall Study|Withdrawal by Subject|1|||
125458472|NCT01370694|451307882|FG000|Overall Study|Switched to rituximab|4|||
125458473|NCT01370694|451307882|FG000|Overall Study|Progressive disease|2|||
125458474|NCT02393716|451307883|FG000|Overall Study|Death|29|||
125458475|NCT02393716|451307883|FG000|Overall Study|Withdrawal by Subject|8|||
125458476|NCT02393716|451307883|FG000|Overall Study|Device Explanted|8|||
125458477|NCT02393716|451307883|FG000|Overall Study|Missed visit|16|||
125458478|NCT02957539|451307884|FG000|Baseline to Week 16|Lost to Follow-up|8|||
125458479|NCT02957539|451307885|FG001|Baseline to Week 16|Lost to Follow-up|10|||
125458480|NCT02957539|451307886|FG002|Baseline to Week 16|Lost to Follow-up|16|||
125458481|NCT02957539|451307884|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
125458482|NCT02957539|451307885|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
125458483|NCT02957539|451307886|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
125458484|NCT02957539|451307884|FG000|Week 16 to 32|Withdrawal by Subject|3|||
125458485|NCT02957539|451307885|FG001|Week 16 to 32|Withdrawal by Subject|3|||
125458486|NCT02957539|451307886|FG002|Week 16 to 32|Withdrawal by Subject|1|||
125458487|NCT02957539|451307884|FG000|Week 16 to 32|Lost to Follow-up|8|||
125458488|NCT02957539|451307885|FG001|Week 16 to 32|Lost to Follow-up|7|||
125458489|NCT02957539|451307886|FG002|Week 16 to 32|Lost to Follow-up|5|||
125458490|NCT02957539|451307884|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
125458491|NCT02957539|451307885|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
125458492|NCT02957539|451307886|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
125458493|NCT02957539|451307884|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
125458494|NCT02957539|451307885|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
125458495|NCT02957539|451307886|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
125458496|NCT01563354|451307890|FG000|Core Phase|Adverse Event|5|||
125458497|NCT01563354|451307891|FG001|Core Phase|Adverse Event|15|||
125458498|NCT01563354|451307892|FG002|Core Phase|Adverse Event|13|||
125458499|NCT01563354|451307890|FG000|Core Phase|Withdrawal by Subject|1|||
125458500|NCT01563354|451307891|FG001|Core Phase|Withdrawal by Subject|0|||
125458501|NCT01563354|451307892|FG002|Core Phase|Withdrawal by Subject|3|||
125458502|NCT01563354|451307890|FG000|Core Phase|Lost to Follow-up|1|||
125458503|NCT01563354|451307891|FG001|Core Phase|Lost to Follow-up|0|||
125458504|NCT01563354|451307892|FG002|Core Phase|Lost to Follow-up|0|||
125458505|NCT01563354|451307890|FG000|Core Phase|Death|1|||
125458506|NCT01563354|451307891|FG001|Core Phase|Death|5|||
125458507|NCT01563354|451307892|FG002|Core Phase|Death|2|||
125458508|NCT01563354|451307890|FG000|Core Phase|Diseasse progression|18|||
125458509|NCT01563354|451307891|FG001|Core Phase|Diseasse progression|7|||
125458510|NCT01563354|451307892|FG002|Core Phase|Diseasse progression|8|||
125458511|NCT01563354|451307890|FG000|Core Phase|Protocol deviation|2|||
125458512|NCT01563354|451307891|FG001|Core Phase|Protocol deviation|0|||
125458513|NCT01563354|451307892|FG002|Core Phase|Protocol deviation|0|||
125458514|NCT01563354|451307890|FG000|Core Phase|PI decision - did not enter extension|0|||
125458515|NCT01563354|451307891|FG001|Core Phase|PI decision - did not enter extension|1|||
125458516|NCT01563354|451307892|FG002|Core Phase|PI decision - did not enter extension|0|||
125458517|NCT01563354|451307890|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
125458518|NCT01563354|451307891|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
125458519|NCT01563354|451307892|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
125458520|NCT01563354|451307890|FG000|Extension Phase|Adverse Event|0|||
125458521|NCT01563354|451307891|FG001|Extension Phase|Adverse Event|3|||
125458522|NCT01563354|451307892|FG002|Extension Phase|Adverse Event|2|||
125458523|NCT01563354|451307890|FG000|Extension Phase|Withdrawal by Subject|0|||
125458524|NCT01563354|451307891|FG001|Extension Phase|Withdrawal by Subject|1|||
125458525|NCT01563354|451307892|FG002|Extension Phase|Withdrawal by Subject|0|||
125458526|NCT01563354|451307890|FG000|Extension Phase|Administration problems|3|||
125458527|NCT01563354|451307891|FG001|Extension Phase|Administration problems|2|||
125458528|NCT01563354|451307892|FG002|Extension Phase|Administration problems|3|||
125458529|NCT01563354|451307890|FG000|Extension Phase|Disease progression|9|||
125458530|NCT01563354|451307891|FG001|Extension Phase|Disease progression|8|||
125458531|NCT01563354|451307892|FG002|Extension Phase|Disease progression|10|||
125458532|NCT01565928|451307893|FG000|Overall Study|Adverse Event|3|||
125458533|NCT01565928|451307893|FG000|Overall Study|Other|3|||
125458534|NCT01565928|451307893|FG000|Overall Study|Progressive Disease|13|||
125458535|NCT01565928|451307893|FG000|Overall Study|Withdrawal by Subject|1|||
125458536|NCT01565928|451307893|FG000|Overall Study|Death|2|||
125458537|NCT01119950|451307894|FG000|Overall Study|Adverse Event|25|||
125458538|NCT01119950|451307894|FG000|Overall Study|Withdrawal by Subject|9|||
125458539|NCT01119950|451307894|FG000|Overall Study|Protocol Violation|5|||
125458540|NCT01119950|451307894|FG000|Overall Study|Lost to Follow-up|4|||
125458541|NCT01119950|451307894|FG000|Overall Study|Administrative|2|||
125458542|NCT01119950|451307894|FG000|Overall Study|Abnormal lab value|1|||
125458543|NCT01119950|451307894|FG000|Overall Study|Death|1|||
125458544|NCT01591616|451307898|FG000|Overall Study|Withdrawal by Subject|1|||
125458545|NCT00855465|451307899|FG000|Treatment Period|Adverse Event|4|||
125458546|NCT00855465|451307900|FG001|Treatment Period|Adverse Event|2|||
125458547|NCT00855465|451307899|FG000|Treatment Period|Death|2|||
125458548|NCT00855465|451307900|FG001|Treatment Period|Death|2|||
125458549|NCT00855465|451307899|FG000|Treatment Period|Lack of Efficacy|2|||
125458550|NCT00855465|451307900|FG001|Treatment Period|Lack of Efficacy|1|||
125458551|NCT00855465|451307899|FG000|Treatment Period|Non-compliance|1|||
125458552|NCT00855465|451307900|FG001|Treatment Period|Non-compliance|0|||
125458553|NCT00855465|451307899|FG000|Treatment Period|Protocol Violation|2|||
125295235|NCT04109976|450707838|FG001|Overall Study|Withdrawal by Subject|0|||
125295236|NCT02449018|450707839|FG000|Overall Study|Abnormal laboratory value|0|||
125295237|NCT02449018|450707840|FG001|Overall Study|Abnormal laboratory value|1|||
125295238|NCT02449018|450707839|FG000|Overall Study|Administrative problems|1|||
125295239|NCT02449018|450707840|FG001|Overall Study|Administrative problems|0|||
125295240|NCT02449018|450707839|FG000|Overall Study|Adverse Event|5|||
125295241|NCT02449018|450707840|FG001|Overall Study|Adverse Event|1|||
125295242|NCT02449018|450707839|FG000|Overall Study|Protocol deviation|4|||
125295243|NCT02449018|450707840|FG001|Overall Study|Protocol deviation|0|||
125295244|NCT02449018|450707839|FG000|Overall Study|Patient decision|2|||
125458554|NCT00855465|451307900|FG001|Treatment Period|Protocol Violation|0|||
125458555|NCT00855465|451307899|FG000|Treatment Period|Withdrawal by Subject|2|||
125458556|NCT00855465|451307900|FG001|Treatment Period|Withdrawal by Subject|0|||
125458557|NCT00855465|451307899|FG000|Treatment Period|Not treated|1|||
125458558|NCT00855465|451307900|FG001|Treatment Period|Not treated|0|||
125458559|NCT00855465|451307899|FG000|Follow-up Period (FUP)|Adverse Event|0|||
125458560|NCT00855465|451307900|FG001|Follow-up Period (FUP)|Adverse Event|1|||
125458561|NCT00855465|451307899|FG000|Follow-up Period (FUP)|Death|0|||
125458562|NCT00855465|451307900|FG001|Follow-up Period (FUP)|Death|1|||
125295245|NCT02449018|450707840|FG001|Overall Study|Patient decision|0|||
125458563|NCT00855465|451307899|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
125458564|NCT00855465|451307900|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
125295246|NCT03831945|450707841|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
125295247|NCT03831945|450707842|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
125295248|NCT03831945|450707841|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
125295249|NCT03831945|450707842|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
125295250|NCT03831945|450707841|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
125295251|NCT03831945|450707842|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
125295252|NCT03426631|450707843|FG000|Overall Study|Lost to Follow-up|0|||
125295253|NCT03426631|450707844|FG001|Overall Study|Lost to Follow-up|1|||
125295254|NCT03691779|450707850|FG000|Part B (24 Weeks)|Adverse Event|0|||
125295255|NCT03691779|450707851|FG001|Part B (24 Weeks)|Adverse Event|1|||
125295256|NCT03691779|450707850|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
125295257|NCT03691779|450707851|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
125295258|NCT00267150|450707852|FG000|Overall Study|Adverse Event|1|||
125295259|NCT00521222|450707854|FG000|Overall Study|Lost to Follow-up|0|||
125295260|NCT00521222|450707855|FG001|Overall Study|Lost to Follow-up|0|||
125295261|NCT00521222|450707856|FG002|Overall Study|Lost to Follow-up|1|||
125295262|NCT00521222|450707857|FG003|Overall Study|Lost to Follow-up|1|||
125458565|NCT00855465|451307899|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
125458566|NCT00855465|451307900|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
125458567|NCT00855465|451307899|FG000|Follow-up Period (FUP)|Missing|1|||
125458568|NCT00855465|451307900|FG001|Follow-up Period (FUP)|Missing|0|||
125458569|NCT01157182|451307905|FG000|Washout of 28 Days|Adverse Event|2|||
125458570|NCT01157182|451307906|FG001|Washout of 28 Days|Adverse Event|0|||
125458571|NCT03743246|451307907|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
125458572|NCT03743246|451307908|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
125458573|NCT03743246|451307909|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
125458574|NCT03743246|451307910|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
125458575|NCT03743246|451307907|FG000|Pre-Treatment Period|Death|0|||
125458576|NCT03743246|451307908|FG001|Pre-Treatment Period|Death|1|||
125458577|NCT03743246|451307909|FG002|Pre-Treatment Period|Death|0|||
125458578|NCT03743246|451307910|FG003|Pre-Treatment Period|Death|1|||
125458579|NCT03743246|451307907|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
125458580|NCT03743246|451307908|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
125458581|NCT03743246|451307909|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
125458582|NCT03743246|451307910|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
125458583|NCT03743246|451307907|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
125458584|NCT03743246|451307908|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
125458585|NCT03743246|451307909|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
125458586|NCT03743246|451307910|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
125458587|NCT03743246|451307907|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
125458588|NCT03743246|451307908|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
125458589|NCT03743246|451307909|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
125458590|NCT03743246|451307910|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
125458591|NCT03743246|451307907|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
125458592|NCT03743246|451307908|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
125458593|NCT03743246|451307909|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
125458594|NCT03743246|451307910|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
125458595|NCT03743246|451307907|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
125458596|NCT03743246|451307908|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
125458597|NCT03743246|451307909|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
125458598|NCT03743246|451307910|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
125458599|NCT03743246|451307907|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
125458600|NCT03743246|451307908|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
125458601|NCT03743246|451307909|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
125458602|NCT03743246|451307910|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
125458603|NCT03743246|451307907|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
125458604|NCT03743246|451307908|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
125458605|NCT03743246|451307909|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
125458606|NCT03743246|451307910|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
125458607|NCT00716144|451307911|FG000|Overall Study|Withdrawal by Subject|4|||
125458608|NCT00716144|451307912|FG001|Overall Study|Withdrawal by Subject|2|||
125458609|NCT00716144|451307913|FG002|Overall Study|Withdrawal by Subject|6|||
125458610|NCT00716144|451307914|FG003|Overall Study|Withdrawal by Subject|6|||
125458611|NCT00716144|451307911|FG000|Overall Study|Lost to Follow-up|2|||
125458612|NCT00716144|451307912|FG001|Overall Study|Lost to Follow-up|2|||
125295263|NCT00521222|450707854|FG000|Overall Study|Withdrawal by Subject|0|||
125458613|NCT00716144|451307913|FG002|Overall Study|Lost to Follow-up|1|||
125458614|NCT00716144|451307914|FG003|Overall Study|Lost to Follow-up|2|||
125458615|NCT00716144|451307911|FG000|Overall Study|Adverse Event|0|||
125458616|NCT00716144|451307912|FG001|Overall Study|Adverse Event|0|||
125458617|NCT00716144|451307913|FG002|Overall Study|Adverse Event|0|||
125458618|NCT00716144|451307914|FG003|Overall Study|Adverse Event|2|||
125458619|NCT00716144|451307911|FG000|Overall Study|Non-compliance|1|||
125458620|NCT00716144|451307912|FG001|Overall Study|Non-compliance|0|||
125458621|NCT00716144|451307913|FG002|Overall Study|Non-compliance|0|||
125458622|NCT00716144|451307914|FG003|Overall Study|Non-compliance|0|||
125458623|NCT00716144|451307911|FG000|Overall Study|Protocol Violation|2|||
125458624|NCT00716144|451307912|FG001|Overall Study|Protocol Violation|0|||
125458625|NCT00716144|451307913|FG002|Overall Study|Protocol Violation|1|||
125458626|NCT00716144|451307914|FG003|Overall Study|Protocol Violation|0|||
125458627|NCT00716144|451307911|FG000|Overall Study|Physician Decision|0|||
125458628|NCT00716144|451307912|FG001|Overall Study|Physician Decision|1|||
125458629|NCT00716144|451307913|FG002|Overall Study|Physician Decision|2|||
125458630|NCT00716144|451307914|FG003|Overall Study|Physician Decision|2|||
125458631|NCT00716144|451307911|FG000|Overall Study|Intercurrent illness|0|||
125458632|NCT00716144|451307912|FG001|Overall Study|Intercurrent illness|0|||
125458633|NCT00716144|451307913|FG002|Overall Study|Intercurrent illness|1|||
125458634|NCT00716144|451307914|FG003|Overall Study|Intercurrent illness|0|||
125458635|NCT00716144|451307911|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
125458636|NCT00716144|451307912|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
125458637|NCT00716144|451307913|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
125458638|NCT00716144|451307914|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
125458639|NCT00716144|451307911|FG000|Overall Study|Adverse event: left foot pain|0|||
125458640|NCT00716144|451307912|FG001|Overall Study|Adverse event: left foot pain|1|||
125458641|NCT00716144|451307913|FG002|Overall Study|Adverse event: left foot pain|0|||
125458642|NCT00716144|451307914|FG003|Overall Study|Adverse event: left foot pain|0|||
125458643|NCT00716144|451307911|FG000|Overall Study|Clinical Depression|0|||
125458644|NCT00716144|451307912|FG001|Overall Study|Clinical Depression|1|||
125458645|NCT00716144|451307913|FG002|Overall Study|Clinical Depression|0|||
125458646|NCT00716144|451307914|FG003|Overall Study|Clinical Depression|0|||
125458647|NCT05641311|451307915|FG000|Dosing Period 1|Adverse Event|1|||
125458648|NCT05641311|451307916|FG001|Dosing Period 1|Adverse Event|0|||
125458649|NCT00909363|451307917|FG000|Overall Study|Withdrawal by Subject|1|||
125458650|NCT00909363|451307918|FG001|Overall Study|Withdrawal by Subject|0|||
125458651|NCT00909363|451307919|FG002|Overall Study|Withdrawal by Subject|0|||
125458652|NCT00909363|451307917|FG000|Overall Study|Lack of Efficacy|1|||
125458653|NCT00909363|451307918|FG001|Overall Study|Lack of Efficacy|0|||
125458654|NCT00909363|451307919|FG002|Overall Study|Lack of Efficacy|0|||
125458655|NCT05686421|451307924|FG000|Overall Study|Screen failure|22|||
125458656|NCT05686421|451307925|FG001|Overall Study|Screen failure|0|||
125458657|NCT05686421|451307926|FG002|Overall Study|Screen failure|0|||
125458658|NCT05686421|451307927|FG003|Overall Study|Screen failure|0|||
125458659|NCT00367055|451307929|FG000|Overall Study|Adverse Event|6|||
125458660|NCT00367055|451307930|FG001|Overall Study|Adverse Event|3|||
125458661|NCT00367055|451307929|FG000|Overall Study|Patient's Willing|3|||
125458662|NCT00367055|451307930|FG001|Overall Study|Patient's Willing|2|||
125458663|NCT00367055|451307929|FG000|Overall Study|Lack of Efficacy|1|||
125458664|NCT00367055|451307930|FG001|Overall Study|Lack of Efficacy|2|||
125458665|NCT00367055|451307929|FG000|Overall Study|Lost to Follow-up|1|||
125458666|NCT00367055|451307930|FG001|Overall Study|Lost to Follow-up|1|||
125458667|NCT00367055|451307929|FG000|Overall Study|Protocol Violation|0|||
125458668|NCT00367055|451307930|FG001|Overall Study|Protocol Violation|1|||
125458669|NCT00367055|451307929|FG000|Overall Study|Stopping Criterion Met|0|||
125458670|NCT00367055|451307930|FG001|Overall Study|Stopping Criterion Met|1|||
125458671|NCT00367055|451307929|FG000|Overall Study|Participant Living too Far from Hospital|0|||
125458672|NCT00367055|451307930|FG001|Overall Study|Participant Living too Far from Hospital|1|||
125458673|NCT02459899|451307931|FG000|Overall Study|Adverse Event|1|||
125458674|NCT02459899|451307932|FG001|Overall Study|Adverse Event|1|||
125458675|NCT02459899|451307933|FG002|Overall Study|Adverse Event|0|||
125458676|NCT02459899|451307934|FG003|Overall Study|Adverse Event|0|||
125458677|NCT02459899|451307931|FG000|Overall Study|Lost to Follow-up|1|||
125458678|NCT02459899|451307932|FG001|Overall Study|Lost to Follow-up|2|||
125458679|NCT02459899|451307933|FG002|Overall Study|Lost to Follow-up|0|||
125458680|NCT02459899|451307934|FG003|Overall Study|Lost to Follow-up|1|||
125458681|NCT02459899|451307931|FG000|Overall Study|Non-compliance with the treatment|0|||
125458682|NCT02459899|451307932|FG001|Overall Study|Non-compliance with the treatment|0|||
125458683|NCT02459899|451307933|FG002|Overall Study|Non-compliance with the treatment|0|||
125458684|NCT02459899|451307934|FG003|Overall Study|Non-compliance with the treatment|1|||
125458685|NCT02459899|451307931|FG000|Overall Study|Withdrawal by Subject|1|||
125458686|NCT02459899|451307932|FG001|Overall Study|Withdrawal by Subject|3|||
125458687|NCT02459899|451307933|FG002|Overall Study|Withdrawal by Subject|0|||
125458688|NCT02459899|451307934|FG003|Overall Study|Withdrawal by Subject|0|||
125458689|NCT00940992|451307937|FG000|Overall Study|Adverse Event|2|||
125458690|NCT00940992|451307938|FG001|Overall Study|Adverse Event|0|||
125458691|NCT00940992|451307939|FG002|Overall Study|Adverse Event|1|||
125420303|NCT02181803|451163575|FG005|Overall Study|Adverse Event|0|||
125420304|NCT02181803|451163576|FG006|Overall Study|Adverse Event|1|||
125420305|NCT02181803|451163577|FG007|Overall Study|Adverse Event|0|||
125420306|NCT02181803|451163578|FG008|Overall Study|Adverse Event|0|||
125420307|NCT04786444|451163579|FG000|Overall Study|Withdrawal by Subject|4|||
125420308|NCT04786444|451163580|FG001|Overall Study|Withdrawal by Subject|7|||
125420309|NCT04786444|451163581|FG002|Overall Study|Withdrawal by Subject|2|||
125420310|NCT04786444|451163579|FG000|Overall Study|Lost to Follow-up|11|||
125420311|NCT04786444|451163580|FG001|Overall Study|Lost to Follow-up|9|||
125420312|NCT04786444|451163581|FG002|Overall Study|Lost to Follow-up|10|||
125420313|NCT04786444|451163579|FG000|Overall Study|Subject would like to become pregnant|0|||
125420314|NCT04786444|451163580|FG001|Overall Study|Subject would like to become pregnant|1|||
125420315|NCT04786444|451163581|FG002|Overall Study|Subject would like to become pregnant|0|||
125420316|NCT02131272|451163582|FG000|Overall Study|Withdrawal by parent|0|||
125420317|NCT02131272|451163583|FG001|Overall Study|Withdrawal by parent|1|||
125420318|NCT02131272|451163582|FG000|Overall Study|Withdrawal by Subject|0|||
125420319|NCT02131272|451163583|FG001|Overall Study|Withdrawal by Subject|1|||
125420320|NCT02131272|451163582|FG000|Overall Study|Withdrawal Criteria|1|||
125420321|NCT02131272|451163583|FG001|Overall Study|Withdrawal Criteria|0|||
125420322|NCT02462876|451163584|FG000|Overall Study|Death|3|||
125420323|NCT02462876|451163584|FG000|Overall Study|Lost to Follow-up|7|||
125420324|NCT02462876|451163584|FG000|Overall Study|Surgical Bypass|9|||
125420325|NCT02462876|451163584|FG000|Overall Study|Amputation Above the Metatarsals|1|||
125420326|NCT02462876|451163584|FG000|Overall Study|36 months follow-up visit missed|1|||
125420327|NCT02462876|451163584|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
125420328|NCT02462876|451163584|FG000|Overall Study|Patient did not come back to the vascular department|1|||
125420329|NCT02462876|451163584|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
125420330|NCT02462876|451163584|FG000|Overall Study|Patient refused to come back|1|||
125420331|NCT02462876|451163584|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
125420332|NCT02462876|451163584|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
125420333|NCT01786512|451163587|FG000|Overall Study|Lost to Follow-up|0|||
125420334|NCT01786512|451163588|FG001|Overall Study|Lost to Follow-up|0|||
125420335|NCT01786512|451163589|FG002|Overall Study|Lost to Follow-up|0|||
125420336|NCT01786512|451163590|FG003|Overall Study|Lost to Follow-up|0|||
125420337|NCT01786512|451163591|FG004|Overall Study|Lost to Follow-up|0|||
125420338|NCT01786512|451163592|FG005|Overall Study|Lost to Follow-up|0|||
125420339|NCT01786512|451163593|FG006|Overall Study|Lost to Follow-up|0|||
125420340|NCT01786512|451163594|FG007|Overall Study|Lost to Follow-up|0|||
125420341|NCT01786512|451163595|FG008|Overall Study|Lost to Follow-up|0|||
125420342|NCT01786512|451163596|FG009|Overall Study|Lost to Follow-up|1|||
125420343|NCT01786512|451163597|FG010|Overall Study|Lost to Follow-up|0|||
125420344|NCT01786512|451163587|FG000|Overall Study|Decision by sponsor|0|||
125420345|NCT01786512|451163588|FG001|Overall Study|Decision by sponsor|0|||
125420346|NCT01786512|451163589|FG002|Overall Study|Decision by sponsor|0|||
125420347|NCT01786512|451163590|FG003|Overall Study|Decision by sponsor|0|||
125420348|NCT01786512|451163591|FG004|Overall Study|Decision by sponsor|0|||
125420349|NCT01786512|451163592|FG005|Overall Study|Decision by sponsor|0|||
125420350|NCT01786512|451163593|FG006|Overall Study|Decision by sponsor|0|||
125420351|NCT01786512|451163594|FG007|Overall Study|Decision by sponsor|0|||
125420352|NCT01786512|451163595|FG008|Overall Study|Decision by sponsor|0|||
125420353|NCT01786512|451163596|FG009|Overall Study|Decision by sponsor|0|||
125420354|NCT01786512|451163597|FG010|Overall Study|Decision by sponsor|2|||
125420355|NCT01786512|451163587|FG000|Overall Study|Withdrawal by Subject|0|||
125420356|NCT01786512|451163588|FG001|Overall Study|Withdrawal by Subject|1|||
125420357|NCT01786512|451163589|FG002|Overall Study|Withdrawal by Subject|0|||
125420358|NCT01786512|451163590|FG003|Overall Study|Withdrawal by Subject|0|||
125420359|NCT01786512|451163591|FG004|Overall Study|Withdrawal by Subject|0|||
125420360|NCT01786512|451163592|FG005|Overall Study|Withdrawal by Subject|0|||
125420361|NCT01786512|451163593|FG006|Overall Study|Withdrawal by Subject|1|||
125420362|NCT01786512|451163594|FG007|Overall Study|Withdrawal by Subject|0|||
125420363|NCT01786512|451163595|FG008|Overall Study|Withdrawal by Subject|0|||
125420364|NCT01786512|451163596|FG009|Overall Study|Withdrawal by Subject|3|||
125420365|NCT01786512|451163597|FG010|Overall Study|Withdrawal by Subject|7|||
125420366|NCT01786512|451163587|FG000|Overall Study|Death|0|||
125420367|NCT01786512|451163588|FG001|Overall Study|Death|0|||
125420368|NCT01786512|451163589|FG002|Overall Study|Death|0|||
125420369|NCT01786512|451163590|FG003|Overall Study|Death|0|||
125420370|NCT01786512|451163591|FG004|Overall Study|Death|0|||
125420371|NCT01786512|451163592|FG005|Overall Study|Death|0|||
125420372|NCT01786512|451163593|FG006|Overall Study|Death|0|||
125420373|NCT01786512|451163594|FG007|Overall Study|Death|0|||
125420374|NCT01786512|451163595|FG008|Overall Study|Death|4|||
125420375|NCT01786512|451163596|FG009|Overall Study|Death|1|||
125420376|NCT01786512|451163597|FG010|Overall Study|Death|3|||
125458692|NCT00940992|451307937|FG000|Overall Study|subject request|2|||
125458693|NCT00940992|451307938|FG001|Overall Study|subject request|1|||
125458694|NCT00940992|451307939|FG002|Overall Study|subject request|0|||
125458695|NCT00940992|451307937|FG000|Overall Study|Lost to Follow-up|0|||
125458696|NCT00940992|451307938|FG001|Overall Study|Lost to Follow-up|1|||
125458697|NCT00940992|451307939|FG002|Overall Study|Lost to Follow-up|1|||
125458698|NCT03612804|451307954|FG000|Overall Study|Death|0|||
125458699|NCT03612804|451307955|FG001|Overall Study|Death|7|||
125458700|NCT03612804|451307956|FG002|Overall Study|Death|0|||
125458701|NCT03612804|451307957|FG003|Overall Study|Death|8|||
125458702|NCT03612804|451307954|FG000|Overall Study|Medication copay coverage issues|0|||
125458703|NCT03612804|451307955|FG001|Overall Study|Medication copay coverage issues|0|||
125458704|NCT03612804|451307956|FG002|Overall Study|Medication copay coverage issues|0|||
125458705|NCT03612804|451307957|FG003|Overall Study|Medication copay coverage issues|17|||
125458706|NCT03612804|451307954|FG000|Overall Study|Not current smoker at time of screening|0|||
125458707|NCT03612804|451307955|FG001|Overall Study|Not current smoker at time of screening|1|||
125458708|NCT03612804|451307956|FG002|Overall Study|Not current smoker at time of screening|0|||
125458709|NCT03612804|451307957|FG003|Overall Study|Not current smoker at time of screening|3|||
125458710|NCT03612804|451307954|FG000|Overall Study|Non-veteran status|0|||
125458711|NCT03612804|451307955|FG001|Overall Study|Non-veteran status|1|||
125458712|NCT03612804|451307956|FG002|Overall Study|Non-veteran status|0|||
125458713|NCT03612804|451307957|FG003|Overall Study|Non-veteran status|0|||
125458714|NCT03612804|451307954|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
125458715|NCT03612804|451307955|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
125458716|NCT03612804|451307956|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
125458717|NCT03612804|451307957|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
125458718|NCT03612804|451307954|FG000|Overall Study|Provider retired from VA|0|||
125458719|NCT03612804|451307955|FG001|Overall Study|Provider retired from VA|0|||
125458720|NCT03612804|451307956|FG002|Overall Study|Provider retired from VA|2|||
125458721|NCT03612804|451307957|FG003|Overall Study|Provider retired from VA|0|||
125458722|NCT03612804|451307954|FG000|Overall Study|Withdrawal by Subject|0|||
125458723|NCT03612804|451307955|FG001|Overall Study|Withdrawal by Subject|0|||
125458724|NCT03612804|451307956|FG002|Overall Study|Withdrawal by Subject|7|||
125458725|NCT03612804|451307957|FG003|Overall Study|Withdrawal by Subject|0|||
125458726|NCT03612804|451307954|FG000|Overall Study|Provider involved with study activities|1|||
125458727|NCT03612804|451307955|FG001|Overall Study|Provider involved with study activities|0|||
125458728|NCT03612804|451307956|FG002|Overall Study|Provider involved with study activities|0|||
125458729|NCT03612804|451307957|FG003|Overall Study|Provider involved with study activities|0|||
125458730|NCT05019729|451307965|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
125458731|NCT05019729|451307966|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
125458732|NCT05019729|451307967|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
125458733|NCT05019729|451307968|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
125458734|NCT05019729|451307969|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
125458735|NCT05019729|451307970|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
125458736|NCT00361283|451307979|FG000|Overall Study|Lost to Follow-up|27|||
125458737|NCT00038103|451307980|FG000|Overall Study|Adverse Event|5|||
125458738|NCT00038103|451307981|FG001|Overall Study|Adverse Event|6|||
125458739|NCT00038103|451307980|FG000|Overall Study|Lack of Efficacy|48|||
125458740|NCT00038103|451307981|FG001|Overall Study|Lack of Efficacy|41|||
125458741|NCT00038103|451307980|FG000|Overall Study|Withdrawal by Subject|0|||
125458742|NCT00038103|451307981|FG001|Overall Study|Withdrawal by Subject|3|||
125458743|NCT00038103|451307980|FG000|Overall Study|Lost to Follow-up|0|||
125458744|NCT00038103|451307981|FG001|Overall Study|Lost to Follow-up|3|||
125458745|NCT00038103|451307980|FG000|Overall Study|Protocol Violation|0|||
125458746|NCT00038103|451307981|FG001|Overall Study|Protocol Violation|2|||
125458747|NCT00038103|451307980|FG000|Overall Study|Sponsor Decision|0|||
125458748|NCT00038103|451307981|FG001|Overall Study|Sponsor Decision|1|||
125458749|NCT00038103|451307980|FG000|Overall Study|Randomized/never treated|2|||
125458750|NCT00038103|451307981|FG001|Overall Study|Randomized/never treated|0|||
125458751|NCT00208767|451307984|FG000|Overall Study|Adverse Event|9|||
125458752|NCT00208767|451307985|FG001|Overall Study|Adverse Event|1|||
125458753|NCT00208767|451307984|FG000|Overall Study|Withdrawal by Subject|14|||
125458754|NCT00208767|451307985|FG001|Overall Study|Withdrawal by Subject|3|||
125458755|NCT00208767|451307984|FG000|Overall Study|Death|1|||
125458756|NCT00208767|451307985|FG001|Overall Study|Death|0|||
125458757|NCT00208767|451307984|FG000|Overall Study|Lost to Follow-up|3|||
125458758|NCT00208767|451307985|FG001|Overall Study|Lost to Follow-up|3|||
125458759|NCT00387465|451307986|FG000|Overall Study|Withdrawal by Subject|0|||
125458760|NCT00387465|451307987|FG001|Overall Study|Withdrawal by Subject|1|||
125458761|NCT00387465|451307988|FG002|Overall Study|Withdrawal by Subject|0|||
125458762|NCT03545984|451307989|FG000|Overall Study|CSF cases not present during rotation|11|||
125458763|NCT03545984|451307990|FG001|Overall Study|CSF cases not present during rotation|9|||
125458764|NCT01212757|451307996|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
125458765|NCT01212757|451307997|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
125458766|NCT01212757|451307998|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
125458767|NCT01212757|451307999|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125458768|NCT01212757|451308000|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125458769|NCT01212757|451308001|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125458770|NCT01212757|451308002|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125458771|NCT01212757|451308003|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125458772|NCT01212757|451308004|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
125458773|NCT01212757|451307996|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
125458774|NCT01212757|451307997|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
125458775|NCT01212757|451307998|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
125458776|NCT01212757|451307999|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125458777|NCT01212757|451308000|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125458778|NCT01212757|451308001|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125458779|NCT01212757|451308002|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125458780|NCT01212757|451308003|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125458781|NCT01212757|451308004|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
125458782|NCT01212757|451307996|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
125458783|NCT01212757|451307997|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
125458784|NCT01212757|451307998|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
125458785|NCT01212757|451307999|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125458786|NCT01212757|451308000|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125458787|NCT01212757|451308001|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125458788|NCT01212757|451308002|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125458789|NCT01212757|451308003|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125458790|NCT01212757|451308004|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
125458791|NCT01212757|451307996|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
125458792|NCT01212757|451307997|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125458793|NCT01212757|451307998|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
125458794|NCT01212757|451307999|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125458795|NCT01212757|451308000|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125458796|NCT01212757|451308001|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125458797|NCT01212757|451308002|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125458798|NCT01212757|451308003|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125458799|NCT01212757|451308004|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
125458800|NCT01212757|451307996|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
125458801|NCT01212757|451307997|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
125458802|NCT01212757|451307998|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
125458803|NCT01212757|451307999|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125458804|NCT01212757|451308000|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125458805|NCT01212757|451308001|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125458806|NCT01212757|451308002|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125458807|NCT01212757|451308003|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125458808|NCT01212757|451308004|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
125458809|NCT01212757|451307996|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125458810|NCT01212757|451307997|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
125458811|NCT01212757|451307998|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
125458812|NCT01212757|451307999|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125458813|NCT01212757|451308000|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125458814|NCT01212757|451308001|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125458815|NCT01212757|451308002|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125458816|NCT01212757|451308003|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125458817|NCT01212757|451308004|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
125458818|NCT01212757|451307996|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
125458819|NCT01212757|451307997|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
125458820|NCT01212757|451307998|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125458821|NCT01212757|451307999|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125458822|NCT01212757|451308000|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125458823|NCT01212757|451308001|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125458824|NCT01212757|451308002|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125458825|NCT01212757|451308003|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125458826|NCT01212757|451308004|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
125458827|NCT01212757|451307996|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
125458828|NCT01212757|451307997|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
125458829|NCT01212757|451307998|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
125458830|NCT01212757|451307999|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
125458831|NCT01212757|451308000|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
125458832|NCT01212757|451308001|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
125458833|NCT01212757|451308002|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
125458834|NCT01212757|451308003|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
125458835|NCT01212757|451308004|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
125458836|NCT01212757|451307996|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
125458837|NCT01212757|451307997|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
125458838|NCT01212757|451307998|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
125458839|NCT01212757|451307999|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
125458840|NCT01212757|451308000|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
125458841|NCT01212757|451308001|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
125458842|NCT01212757|451308002|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
125458843|NCT01212757|451308003|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
125458844|NCT01212757|451308004|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
125458845|NCT01212757|451307996|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
125458846|NCT01212757|451307997|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
125458847|NCT01212757|451307998|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
125458848|NCT01212757|451307999|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
125458849|NCT01212757|451308000|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
125458850|NCT01212757|451308001|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
125458851|NCT01212757|451308002|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
125458852|NCT01212757|451308003|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
125458853|NCT01212757|451308004|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
125458854|NCT01212757|451307996|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
125458855|NCT01212757|451307997|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
125458856|NCT01212757|451307998|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
125458857|NCT01212757|451307999|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
125458858|NCT01212757|451308000|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
125458859|NCT01212757|451308001|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
125458860|NCT01212757|451308002|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
125458861|NCT01212757|451308003|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
125458862|NCT01212757|451308004|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
125458863|NCT01212757|451307996|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125458864|NCT01212757|451307997|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
125458865|NCT01212757|451307998|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125458866|NCT01212757|451307999|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125458867|NCT01212757|451308000|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
125458868|NCT01212757|451308001|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125458869|NCT01212757|451308002|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125458870|NCT01212757|451308003|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125458871|NCT01212757|451308004|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
125458872|NCT01212757|451307996|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
125458873|NCT01212757|451307997|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
125458874|NCT01212757|451307998|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
125458875|NCT01212757|451307999|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
125458876|NCT01212757|451308000|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
125458877|NCT01212757|451308001|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
125458878|NCT01212757|451308002|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
125458879|NCT01212757|451308003|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
125458880|NCT01212757|451308004|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
125458881|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
125458882|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
125458883|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
125458884|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
125458885|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
125458886|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
125458887|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
125458888|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
125458889|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
125458890|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
125295264|NCT00521222|450707855|FG001|Overall Study|Withdrawal by Subject|0|||
125295265|NCT00521222|450707856|FG002|Overall Study|Withdrawal by Subject|2|||
125295266|NCT00521222|450707857|FG003|Overall Study|Withdrawal by Subject|0|||
125458891|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
125458892|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
125458893|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
125458894|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
125458895|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
125458896|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
125458897|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
125458898|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
125458899|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
125458900|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
125458901|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
125295267|NCT00521222|450707854|FG000|Overall Study|Physician Decision|0|||
125295268|NCT00521222|450707855|FG001|Overall Study|Physician Decision|1|||
125295269|NCT00521222|450707856|FG002|Overall Study|Physician Decision|0|||
125295270|NCT00521222|450707857|FG003|Overall Study|Physician Decision|1|||
125295271|NCT03332160|450707860|FG000|Overall Study|Withdrawal by Subject|1|||
125295272|NCT03332160|450707861|FG001|Overall Study|Withdrawal by Subject|1|||
125295273|NCT03332160|450707860|FG000|Overall Study|Adverse Event|0|||
125295274|NCT03332160|450707861|FG001|Overall Study|Adverse Event|1|||
125458902|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
125458903|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
125458904|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
125458905|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
125458906|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
125458907|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
125458908|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125458909|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
125458910|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
125458911|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125458912|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125458913|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125458914|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
125458915|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
125458916|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
125458917|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
125458918|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
125458919|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
125458920|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
125458921|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
125458922|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
125458923|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
125458924|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
125458925|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
125458926|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
125458927|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
125458928|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
125458929|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
125458930|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
125458931|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
125458932|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
125458933|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
125458934|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
125458935|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
125458936|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
125458937|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
125458938|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
125458939|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
125458940|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
125458941|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
125458942|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
125458943|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
125458944|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
125458945|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
125458946|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
125295275|NCT03332160|450707860|FG000|Overall Study|Developed Exclusion Criteria|0|||
125295276|NCT03332160|450707861|FG001|Overall Study|Developed Exclusion Criteria|1|||
125295277|NCT03332160|450707860|FG000|Overall Study|Non-adherence to treatment|0|||
125295278|NCT03332160|450707861|FG001|Overall Study|Non-adherence to treatment|2|||
125295279|NCT01561963|450707862|FG000|Overall Study|Adverse Event|1|||
125295280|NCT04208087|450707865|FG000|Overall Study|Adverse Event|1|||
125458947|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
125458948|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
125458949|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
125458950|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
125458951|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
125458952|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
125458953|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125458954|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
125458955|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
125458956|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125458957|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125458958|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125458959|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
125458960|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
125458961|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
125458962|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
125458963|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
125458964|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
125458965|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
125458966|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
125458967|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
125458968|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
125458969|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
125458970|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
125458971|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
125458972|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
125458973|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
125458974|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
125458975|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
125458976|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
125458977|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
125458978|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
125458979|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
125458980|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
125458981|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
125458982|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
125458983|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
125458984|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
125458985|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
125458986|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
125458987|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
125458988|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
125458989|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
125458990|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
125458991|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
125458992|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
125458993|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
125458994|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
125458995|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
125458996|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
125458997|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
125458998|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
125458999|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
125459000|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
125459001|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
125459002|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
125459003|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
125459004|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
125459005|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
125459006|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
125459007|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
125459008|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
125459009|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
125459010|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
125459011|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
125295281|NCT04208087|450707866|FG001|Overall Study|Adverse Event|0|||
125295282|NCT04208087|450707867|FG002|Overall Study|Adverse Event|0|||
125295283|NCT04208087|450707868|FG003|Overall Study|Adverse Event|0|||
125459012|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
125459013|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
125459014|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
125459015|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
125459016|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125459017|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
125459018|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
125459019|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125459020|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125459021|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125459022|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
125459023|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
125459024|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
125459025|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
125459026|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
125459027|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
125459028|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
125459029|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
125459030|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
125459031|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
125459032|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
125459033|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
125459034|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
125459035|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
125459036|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
125459037|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
125459038|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
125459039|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
125459040|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
125459041|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
125459042|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
125459043|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125459044|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
125459045|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
125459046|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125459047|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125459048|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125459049|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
125459050|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
125459051|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
125459052|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
125459053|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
125459054|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
125459055|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
125459056|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
125459057|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
125459058|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
125459059|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
125459060|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
125459061|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
125459062|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
125459063|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
125459064|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
125459065|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
125459066|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
125459067|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
125459068|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
125459069|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
125459070|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
125459071|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
125459072|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
125459073|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
125485358|NCT02240238|451412508|FG005|Phase 1|Death|1|||
125295284|NCT04208087|450707869|FG004|Overall Study|Adverse Event|0|||
125295285|NCT04208087|450707865|FG000|Overall Study|Withdrawal by Subject|0|||
125295286|NCT04208087|450707866|FG001|Overall Study|Withdrawal by Subject|0|||
125295287|NCT04208087|450707867|FG002|Overall Study|Withdrawal by Subject|1|||
125295288|NCT04208087|450707868|FG003|Overall Study|Withdrawal by Subject|0|||
125295289|NCT04208087|450707869|FG004|Overall Study|Withdrawal by Subject|0|||
125295290|NCT04208087|450707865|FG000|Overall Study|Other|0|||
125459074|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
125459075|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
125459076|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
125459077|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
125459078|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
125459079|NCT01212757|451307996|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
125459080|NCT01212757|451307997|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
125459081|NCT01212757|451307998|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
125459082|NCT01212757|451307999|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
125459083|NCT01212757|451308000|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
125459084|NCT01212757|451308001|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
125459085|NCT01212757|451308002|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
125459086|NCT01212757|451308003|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
125459087|NCT01212757|451308004|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
125459088|NCT04860258|451309275|FG000|Overall Study|Withdrawal by Subject|0|||
125459089|NCT04860258|451309276|FG001|Overall Study|Withdrawal by Subject|0|||
125459090|NCT04860258|451309277|FG002|Overall Study|Withdrawal by Subject|4|||
125459091|NCT04860258|451309278|FG003|Overall Study|Withdrawal by Subject|1|||
125459092|NCT04860258|451309279|FG004|Overall Study|Withdrawal by Subject|4|||
125459093|NCT04860258|451309280|FG005|Overall Study|Withdrawal by Subject|1|||
125459094|NCT04860258|451309281|FG006|Overall Study|Withdrawal by Subject|0|||
125459095|NCT00028769|451309282|FG000|Overall Study|Adverse Event|2|||
125459096|NCT00028769|451309282|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
125459097|NCT00028769|451309282|FG000|Overall Study|Progression or Death|31|||
125459098|NCT00028769|451309282|FG000|Overall Study|Other - Not Protocol Specified|1|||
125459099|NCT00028769|451309282|FG000|Overall Study|Ineligible|5|||
125459100|NCT00028769|451309282|FG000|Overall Study|Not Analyzable|1|||
125459101|NCT00357396|451309283|FG000|Overall Study|Adverse Event|1|||
125459102|NCT00357396|451309284|FG001|Overall Study|Adverse Event|0|||
125459103|NCT00487578|451309285|FG000|Overall Study|Adverse Event|1|||
125459104|NCT00487578|451309286|FG001|Overall Study|Adverse Event|2|||
125459105|NCT00487578|451309285|FG000|Overall Study|Lack of Efficacy|0|||
125459106|NCT00487578|451309286|FG001|Overall Study|Lack of Efficacy|1|||
125459107|NCT00487578|451309285|FG000|Overall Study|Lost to Follow-up|0|||
125459108|NCT00487578|451309286|FG001|Overall Study|Lost to Follow-up|1|||
125459109|NCT00726999|451309289|FG000|Overall Study|Physician Decision|0|||
125459110|NCT00726999|451309290|FG001|Overall Study|Physician Decision|1|||
125459111|NCT00726999|451309289|FG000|Overall Study|Withdrawal by Subject|2|||
125459112|NCT00726999|451309290|FG001|Overall Study|Withdrawal by Subject|0|||
125459113|NCT00726999|451309289|FG000|Overall Study|Protocol Violation|1|||
125459114|NCT00726999|451309290|FG001|Overall Study|Protocol Violation|0|||
125459115|NCT01499134|451309291|FG000|Overall Study|Withdrawal by Subject|0|||
125459116|NCT01499134|451309292|FG001|Overall Study|Withdrawal by Subject|1|||
125459117|NCT01198275|451309293|FG000|Overall Study|Adverse Event|2|||
125459118|NCT01198275|451309294|FG001|Overall Study|Adverse Event|3|||
125459119|NCT01198275|451309293|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
125459120|NCT01198275|451309294|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
125459121|NCT00391846|451309295|FG000|Overall Study|Adverse Event|4|||
125459122|NCT00391846|451309296|FG001|Overall Study|Adverse Event|1|||
125459123|NCT00391846|451309295|FG000|Overall Study|Did not meet the required elig. crit|2|||
125459124|NCT00391846|451309296|FG001|Overall Study|Did not meet the required elig. crit|2|||
125459125|NCT00391846|451309295|FG000|Overall Study|Withdrawal by Subject|2|||
125459126|NCT00391846|451309296|FG001|Overall Study|Withdrawal by Subject|3|||
125459127|NCT00391846|451309295|FG000|Overall Study|Developed study specific DC criteria|0|||
125459128|NCT00391846|451309296|FG001|Overall Study|Developed study specific DC criteria|1|||
125459129|NCT00738699|451309297|FG000|Overall Study|Withdrawal by Subject|5|||
125459130|NCT00738699|451309298|FG001|Overall Study|Withdrawal by Subject|0|||
125459131|NCT00738699|451309297|FG000|Overall Study|Lost to Follow-up|1|||
125459132|NCT00738699|451309298|FG001|Overall Study|Lost to Follow-up|0|||
125459133|NCT00738699|451309297|FG000|Overall Study|Death|144|||
125459134|NCT00738699|451309298|FG001|Overall Study|Death|68|||
125459135|NCT00738699|451309297|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
125459136|NCT00738699|451309298|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
125459137|NCT00738699|451309297|FG000|Overall Study|Other|2|||
125459138|NCT00738699|451309298|FG001|Overall Study|Other|0|||
125459139|NCT01376089|451309299|FG000|Overall Study|Patient received no contrast media|3|||
125459140|NCT01376089|451309300|FG001|Overall Study|Patient received no contrast media|4|||
125459141|NCT00549848|451309303|FG000|Overall Study|Death|1|||
125459142|NCT00549848|451309304|FG001|Overall Study|Death|4|||
125459143|NCT00549848|451309305|FG002|Overall Study|Death|13|||
125459144|NCT00549848|451309303|FG000|Overall Study|Physician Decision|0|||
125459145|NCT00549848|451309304|FG001|Overall Study|Physician Decision|0|||
125459146|NCT00549848|451309305|FG002|Overall Study|Physician Decision|4|||
125459147|NCT00549848|451309303|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
125459148|NCT00549848|451309304|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
125459149|NCT00549848|451309305|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
125459150|NCT00549848|451309303|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
125459151|NCT00549848|451309304|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
125459152|NCT00549848|451309305|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
125459153|NCT00549848|451309303|FG000|Overall Study|Participant/Family Withdraw|2|||
125459154|NCT00549848|451309304|FG001|Overall Study|Participant/Family Withdraw|3|||
125459155|NCT00549848|451309305|FG002|Overall Study|Participant/Family Withdraw|5|||
125459156|NCT00549848|451309303|FG000|Overall Study|Second Malignancy|1|||
125459157|NCT00549848|451309304|FG001|Overall Study|Second Malignancy|0|||
125459158|NCT00549848|451309305|FG002|Overall Study|Second Malignancy|0|||
125459159|NCT00549848|451309303|FG000|Overall Study|Transplant|3|||
125459160|NCT00549848|451309304|FG001|Overall Study|Transplant|3|||
125459161|NCT00549848|451309305|FG002|Overall Study|Transplant|18|||
125459162|NCT00549848|451309303|FG000|Overall Study|Unacceptable Toxicity|1|||
125459163|NCT00549848|451309304|FG001|Overall Study|Unacceptable Toxicity|6|||
125459164|NCT00549848|451309305|FG002|Overall Study|Unacceptable Toxicity|6|||
125459165|NCT03262935|451309306|FG000|Overall Study|Withdrawal by Subject|6|||
125459166|NCT03262935|451309307|FG001|Overall Study|Withdrawal by Subject|7|||
125459167|NCT03262935|451309306|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
125459168|NCT03262935|451309307|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
125459169|NCT03262935|451309306|FG000|Overall Study|Death|181|||
125459170|NCT03262935|451309307|FG001|Overall Study|Death|94|||
125459171|NCT03262935|451309306|FG000|Overall Study|Lost to Follow-up|9|||
125459172|NCT03262935|451309307|FG001|Overall Study|Lost to Follow-up|4|||
125459173|NCT03262935|451309306|FG000|Overall Study|Other reason|5|||
125459174|NCT03262935|451309307|FG001|Overall Study|Other reason|0|||
125459175|NCT01811706|451309308|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
125459176|NCT01811706|451309309|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
125459177|NCT00753012|451309314|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
125459178|NCT00753012|451309315|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
125459179|NCT00753012|451309314|FG000|Overall Study|Adverse Event|2|||
125459180|NCT00753012|451309315|FG001|Overall Study|Adverse Event|0|||
125459181|NCT00753012|451309314|FG000|Overall Study|Withdrawal by Subject|0|||
125459182|NCT00753012|451309315|FG001|Overall Study|Withdrawal by Subject|1|||
125459183|NCT00753012|451309314|FG000|Overall Study|Lost to Follow-up|4|||
125459184|NCT00753012|451309315|FG001|Overall Study|Lost to Follow-up|0|||
125459185|NCT00753012|451309314|FG000|Overall Study|Confounded endpoint data|1|||
125459186|NCT00753012|451309315|FG001|Overall Study|Confounded endpoint data|0|||
125459187|NCT00943735|451309316|FG000|Overall Study|Adverse Event|12|||
125459188|NCT00943735|451309316|FG000|Overall Study|Withdrawal by Subject|8|||
125459189|NCT00943735|451309316|FG000|Overall Study|Death|1|||
125459190|NCT00943735|451309316|FG000|Overall Study|Other|8|||
125459191|NCT00943735|451309316|FG000|Overall Study|Other|3|||
125459192|NCT03804918|451309317|FG000|Overall Study|Participant did not use the app|1|||
125459193|NCT00217672|451309322|FG000|Allocation|Ineligible|2|||
125459194|NCT00217672|451309323|FG001|Allocation|Ineligible|0|||
125459195|NCT00217672|451309322|FG000|Treatment|disease progression|33|||
125459196|NCT00217672|451309323|FG001|Treatment|disease progression|4|||
125459197|NCT00217672|451309322|FG000|Treatment|Adverse Event|18|||
125459198|NCT00217672|451309323|FG001|Treatment|Adverse Event|2|||
125459199|NCT00217672|451309322|FG000|Treatment|reqd treatment not permitted by protocol|6|||
125459200|NCT00217672|451309323|FG001|Treatment|reqd treatment not permitted by protocol|0|||
125459201|NCT00217672|451309322|FG000|Treatment|Physician Decision|6|||
125459202|NCT00217672|451309323|FG001|Treatment|Physician Decision|0|||
125459203|NCT00217672|451309322|FG000|Treatment|insurance issues|1|||
125459204|NCT00217672|451309323|FG001|Treatment|insurance issues|1|||
125459205|NCT00217672|451309322|FG000|Treatment|Death|2|||
125459206|NCT00217672|451309323|FG001|Treatment|Death|0|||
125459207|NCT00217672|451309322|FG000|Treatment|secondary malignancy|1|||
125459208|NCT00217672|451309323|FG001|Treatment|secondary malignancy|0|||
125459209|NCT00217672|451309322|FG000|Follow-up|Withdrawal by Subject|4|||
125459210|NCT00217672|451309323|FG001|Follow-up|Withdrawal by Subject|0|||
125295291|NCT04208087|450707866|FG001|Overall Study|Other|0|||
125295292|NCT04208087|450707867|FG002|Overall Study|Other|0|||
125295293|NCT04208087|450707868|FG003|Overall Study|Other|0|||
125459211|NCT00217672|451309322|FG000|Follow-up|Lost to Follow-up|1|||
125459212|NCT00217672|451309323|FG001|Follow-up|Lost to Follow-up|0|||
125459213|NCT01596504|451309328|FG000|Overall Study|Participant's Private Reason|0|||
125459214|NCT01596504|451309329|FG001|Overall Study|Participant's Private Reason|1|||
125459215|NCT01596504|451309330|FG002|Overall Study|Participant's Private Reason|0|||
125459216|NCT01596504|451309328|FG000|Overall Study|Adverse Event|1|||
125459217|NCT01596504|451309329|FG001|Overall Study|Adverse Event|2|||
125459218|NCT01596504|451309330|FG002|Overall Study|Adverse Event|1|||
125459219|NCT01596504|451309328|FG000|Overall Study|Withdrawal by Subject|1|||
125295294|NCT04208087|450707869|FG004|Overall Study|Other|1|||
125295295|NCT01977690|450707870|FG000|Overall Study|Withdrawal by Subject|0|||
125459220|NCT01596504|451309329|FG001|Overall Study|Withdrawal by Subject|0|||
125459221|NCT01596504|451309330|FG002|Overall Study|Withdrawal by Subject|0|||
125485359|NCT02240238|451412509|FG006|Phase 1|Death|0|||
125459222|NCT01901276|451309331|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
125459223|NCT01901276|451309332|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
125459224|NCT04347954|451309333|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
125459225|NCT04347954|451309334|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
125459226|NCT04347954|451309335|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
125459227|NCT04347954|451309333|FG000|Overall Study|Lost to Follow-up|0|||
125459228|NCT04347954|451309334|FG001|Overall Study|Lost to Follow-up|1|||
125459229|NCT04347954|451309335|FG002|Overall Study|Lost to Follow-up|0|||
125459230|NCT03257813|451309339|FG000|Overall Study|Protocol Violation|6|||
125459231|NCT03257813|451309340|FG001|Overall Study|Protocol Violation|3|||
125459232|NCT02878330|451309341|FG000|Overall Study|Death|3|||
125459233|NCT02878330|451309342|FG001|Overall Study|Death|2|||
125459234|NCT02878330|451309341|FG000|Overall Study|Lost to Follow-up|11|||
125459235|NCT02878330|451309342|FG001|Overall Study|Lost to Follow-up|26|||
125459236|NCT02878330|451309341|FG000|Overall Study|Withdrawal by Subject|11|||
125459237|NCT02878330|451309342|FG001|Overall Study|Withdrawal by Subject|21|||
125459238|NCT02878330|451309341|FG000|Overall Study|Other|4|||
125459239|NCT02878330|451309342|FG001|Overall Study|Other|7|||
125459240|NCT02954848|451309345|FG000|Overall Study|Randomized but Not Treated|0|||
125459241|NCT02954848|451309346|FG001|Overall Study|Randomized but Not Treated|1|||
125459242|NCT02954848|451309345|FG000|Overall Study|Adverse Event|2|||
125459243|NCT02954848|451309346|FG001|Overall Study|Adverse Event|3|||
125459244|NCT02954848|451309345|FG000|Overall Study|Withdrawal by Participant|0|||
125459245|NCT02954848|451309346|FG001|Overall Study|Withdrawal by Participant|1|||
125459246|NCT01069341|451309347|FG000|Overall Study|Lost to Follow-up|1|||
125459247|NCT00922207|451309348|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
125459248|NCT00922207|451309349|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
125459249|NCT00922207|451309350|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
125459250|NCT00922207|451309348|FG000|Overall Study|Insufficient Therapeutic Response|0|||
125459251|NCT00922207|451309349|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125459252|NCT00922207|451309350|FG002|Overall Study|Insufficient Therapeutic Response|1|||
125459253|NCT00922207|451309348|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
125459254|NCT00922207|451309349|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
125459255|NCT00922207|451309350|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
125459256|NCT00922207|451309348|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
125459257|NCT00922207|451309349|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
125459258|NCT00922207|451309350|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
125459259|NCT00922207|451309348|FG000|Overall Study|Withdrew Consent|2|||
125459260|NCT00922207|451309349|FG001|Overall Study|Withdrew Consent|5|||
125459261|NCT00922207|451309350|FG002|Overall Study|Withdrew Consent|2|||
125459262|NCT00922207|451309348|FG000|Overall Study|Abnormality of Laboratory Test|0|||
125459263|NCT00922207|451309349|FG001|Overall Study|Abnormality of Laboratory Test|1|||
125459264|NCT00922207|451309350|FG002|Overall Study|Abnormality of Laboratory Test|1|||
125459265|NCT01802632|451309351|FG000|Overall Study|Death|28|||
125459266|NCT01802632|451309352|FG001|Overall Study|Death|1|||
125459267|NCT01802632|451309353|FG002|Overall Study|Death|38|||
125459268|NCT01802632|451309354|FG003|Overall Study|Death|0|||
125459269|NCT01802632|451309355|FG004|Overall Study|Death|2|||
125459270|NCT01802632|451309356|FG005|Overall Study|Death|0|||
125459271|NCT01802632|451309351|FG000|Overall Study|Withdrawal by Subject|4|||
125459272|NCT01802632|451309352|FG001|Overall Study|Withdrawal by Subject|2|||
125459273|NCT01802632|451309353|FG002|Overall Study|Withdrawal by Subject|7|||
125459274|NCT01802632|451309354|FG003|Overall Study|Withdrawal by Subject|3|||
125459275|NCT01802632|451309355|FG004|Overall Study|Withdrawal by Subject|0|||
125459276|NCT01802632|451309356|FG005|Overall Study|Withdrawal by Subject|1|||
125459277|NCT01802632|451309351|FG000|Overall Study|Objective Disease Progression|1|||
125459278|NCT01802632|451309352|FG001|Overall Study|Objective Disease Progression|12|||
125459279|NCT01802632|451309353|FG002|Overall Study|Objective Disease Progression|104|||
125459280|NCT01802632|451309354|FG003|Overall Study|Objective Disease Progression|6|||
125459281|NCT01802632|451309355|FG004|Overall Study|Objective Disease Progression|4|||
125459282|NCT01802632|451309356|FG005|Overall Study|Objective Disease Progression|4|||
125459283|NCT01802632|451309351|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
125459284|NCT01802632|451309352|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
125459285|NCT01802632|451309353|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
125459286|NCT01802632|451309354|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
125459287|NCT01802632|451309355|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
125459288|NCT01802632|451309356|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
125459289|NCT01802632|451309351|FG000|Overall Study|Other (not specified)|0|||
125459290|NCT01802632|451309352|FG001|Overall Study|Other (not specified)|0|||
125459291|NCT01802632|451309353|FG002|Overall Study|Other (not specified)|7|||
125459292|NCT01802632|451309354|FG003|Overall Study|Other (not specified)|1|||
125459293|NCT01802632|451309355|FG004|Overall Study|Other (not specified)|0|||
125459294|NCT01802632|451309356|FG005|Overall Study|Other (not specified)|1|||
125459295|NCT02880241|451309369|FG000|Overall Study|Lack of Efficacy|1|||
125459296|NCT02880241|451309370|FG001|Overall Study|Lack of Efficacy|0|||
125459297|NCT02880241|451309371|FG002|Overall Study|Lack of Efficacy|0|||
125459298|NCT02880241|451309372|FG003|Overall Study|Lack of Efficacy|0|||
125459299|NCT02880241|451309373|FG004|Overall Study|Lack of Efficacy|0|||
125459300|NCT02880241|451309374|FG005|Overall Study|Lack of Efficacy|0|||
125459301|NCT02705586|451309376|FG000|Overall Study|Health Issues|2|||
125459302|NCT02705586|451309376|FG000|Overall Study|Transportation Difficulties|5|||
125459303|NCT02705586|451309376|FG000|Overall Study|Vacation/Planned Absence|1|||
125459304|NCT03383146|451309381|FG000|Overall Study|Screen Failure|1|||
125459305|NCT03383146|451309382|FG001|Overall Study|Screen Failure|0|||
125459306|NCT03383146|451309381|FG000|Overall Study|Adverse Event|6|||
125459307|NCT03383146|451309382|FG001|Overall Study|Adverse Event|18|||
125459308|NCT03383146|451309381|FG000|Overall Study|Lack of Efficacy|0|||
125459309|NCT03383146|451309382|FG001|Overall Study|Lack of Efficacy|3|||
125459310|NCT03383146|451309381|FG000|Overall Study|Withdrawal by Subject|20|||
125459311|NCT03383146|451309382|FG001|Overall Study|Withdrawal by Subject|36|||
125459312|NCT03383146|451309381|FG000|Overall Study|Lost to Follow-up|5|||
125459313|NCT03383146|451309382|FG001|Overall Study|Lost to Follow-up|15|||
125459314|NCT03383146|451309381|FG000|Overall Study|Death|0|||
125459315|NCT03383146|451309382|FG001|Overall Study|Death|2|||
125459316|NCT03383146|451309381|FG000|Overall Study|Physician Decision|0|||
125459317|NCT03383146|451309382|FG001|Overall Study|Physician Decision|1|||
125459318|NCT03383146|451309381|FG000|Overall Study|Protocol Deviation|1|||
125459319|NCT03383146|451309382|FG001|Overall Study|Protocol Deviation|8|||
125459320|NCT03383146|451309381|FG000|Overall Study|Study Terminated by the Sponsor|48|||
125459321|NCT03383146|451309382|FG001|Overall Study|Study Terminated by the Sponsor|95|||
125459322|NCT03383146|451309381|FG000|Overall Study|Reason not Specified|4|||
125459323|NCT03383146|451309382|FG001|Overall Study|Reason not Specified|6|||
125459324|NCT02739035|451309387|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
125459325|NCT02739035|451309388|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
125459326|NCT02739035|451309387|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
125459327|NCT02739035|451309388|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
125459328|NCT02739035|451309387|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
125295296|NCT01977690|450707871|FG001|Overall Study|Withdrawal by Subject|4|||
125295297|NCT00952614|450707872|FG000|Overall Study|Death|3|||
125295298|NCT00952614|450707872|FG000|Overall Study|Lost to Follow-up|3|||
125295299|NCT00952614|450707872|FG000|Overall Study|other reason|1|||
125295300|NCT04023682|450707873|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
125295301|NCT00637572|450707875|FG000|Overall Study|Adverse Event|1|||
125295302|NCT00637572|450707876|FG001|Overall Study|Adverse Event|2|||
125295303|NCT00637572|450707875|FG000|Overall Study|Death|0|||
125295304|NCT00637572|450707876|FG001|Overall Study|Death|1|||
125295305|NCT00637572|450707875|FG000|Overall Study|Lost to Follow-up|0|||
125295306|NCT00637572|450707876|FG001|Overall Study|Lost to Follow-up|1|||
125295307|NCT00637572|450707875|FG000|Overall Study|Physician Decision|1|||
125295308|NCT00637572|450707876|FG001|Overall Study|Physician Decision|1|||
125295309|NCT00637572|450707875|FG000|Overall Study|Withdrawal by Subject|0|||
125295310|NCT00637572|450707876|FG001|Overall Study|Withdrawal by Subject|2|||
125295311|NCT00637572|450707875|FG000|Overall Study|Illicit Drug Use|1|||
125295312|NCT00637572|450707876|FG001|Overall Study|Illicit Drug Use|0|||
125295313|NCT04268745|450707884|FG000|Overall Study|Lost to Follow-up|2|||
125295314|NCT04268745|450707885|FG001|Overall Study|Lost to Follow-up|3|||
125295315|NCT04268745|450707884|FG000|Overall Study|Withdrawal by Subject|4|||
125295316|NCT04268745|450707885|FG001|Overall Study|Withdrawal by Subject|2|||
125295317|NCT04268745|450707884|FG000|Overall Study|Death in the family|1|||
125295318|NCT04268745|450707885|FG001|Overall Study|Death in the family|0|||
125295319|NCT00447122|450707887|FG000|Overall Study|worsening medical condition -came off|0|||
125295320|NCT00447122|450707888|FG001|Overall Study|worsening medical condition -came off|1|||
125295321|NCT00447122|450707889|FG002|Overall Study|worsening medical condition -came off|0|||
125295322|NCT00447122|450707890|FG003|Overall Study|worsening medical condition -came off|0|||
125295323|NCT02540291|450707891|FG000|Overall Study|Death|7|||
125295324|NCT02540291|450707892|FG001|Overall Study|Death|7|||
125295325|NCT02540291|450707893|FG002|Overall Study|Death|5|||
125295326|NCT02540291|450707894|FG003|Overall Study|Death|7|||
125295327|NCT02540291|450707891|FG000|Overall Study|Lost to Follow-up|0|||
125295328|NCT02540291|450707892|FG001|Overall Study|Lost to Follow-up|0|||
125295329|NCT02540291|450707893|FG002|Overall Study|Lost to Follow-up|1|||
125459329|NCT02739035|451309388|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
125459330|NCT02739035|451309387|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
125459331|NCT02739035|451309388|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
125295330|NCT02540291|450707894|FG003|Overall Study|Lost to Follow-up|0|||
125295331|NCT02540291|450707891|FG000|Overall Study|Withdrawal Of Consent|0|||
125295332|NCT02540291|450707892|FG001|Overall Study|Withdrawal Of Consent|1|||
125459332|NCT03210402|451309389|FG000|Overall Study|Withdrawal by Subject|0|||
125459333|NCT03210402|451309390|FG001|Overall Study|Withdrawal by Subject|1|||
125459334|NCT02517307|451309393|FG000|Overall Study|Withdrawal by Subject|1|||
125459335|NCT02517307|451309394|FG001|Overall Study|Withdrawal by Subject|0|||
125459336|NCT02517307|451309395|FG002|Overall Study|Withdrawal by Subject|1|||
125295333|NCT02540291|450707893|FG002|Overall Study|Withdrawal Of Consent|0|||
125295334|NCT02540291|450707894|FG003|Overall Study|Withdrawal Of Consent|0|||
125295335|NCT02540291|450707891|FG000|Overall Study|Study Terminated By Sponsor|1|||
125295336|NCT02540291|450707892|FG001|Overall Study|Study Terminated By Sponsor|0|||
125295337|NCT02540291|450707893|FG002|Overall Study|Study Terminated By Sponsor|0|||
125295338|NCT02540291|450707894|FG003|Overall Study|Study Terminated By Sponsor|0|||
125295339|NCT02540291|450707891|FG000|Overall Study|Other|0|||
125295340|NCT02540291|450707892|FG001|Overall Study|Other|0|||
125295341|NCT02540291|450707893|FG002|Overall Study|Other|1|||
125295342|NCT02540291|450707894|FG003|Overall Study|Other|0|||
125295343|NCT01174173|450707899|FG000|Overall Study|drug-drug interaction|1|||
125295344|NCT01918332|450709418|FG000|Overall Study|Adverse Event|0|||
125295345|NCT01918332|450709419|FG001|Overall Study|Adverse Event|0|||
125295346|NCT01918332|450709420|FG002|Overall Study|Adverse Event|0|||
125295347|NCT01918332|450709421|FG003|Overall Study|Adverse Event|1|||
125295348|NCT01918332|450709418|FG000|Overall Study|Withdrawal by Subject|2|||
125295349|NCT01918332|450709419|FG001|Overall Study|Withdrawal by Subject|3|||
125295350|NCT01918332|450709420|FG002|Overall Study|Withdrawal by Subject|2|||
125295351|NCT01918332|450709421|FG003|Overall Study|Withdrawal by Subject|3|||
125295352|NCT01918332|450709418|FG000|Overall Study|Protocol Violation|6|||
125295353|NCT01918332|450709419|FG001|Overall Study|Protocol Violation|2|||
125295354|NCT01918332|450709420|FG002|Overall Study|Protocol Violation|6|||
125295355|NCT01918332|450709421|FG003|Overall Study|Protocol Violation|3|||
125295356|NCT01918332|450709418|FG000|Overall Study|lipid result by central lab did not meet|0|||
125295357|NCT01918332|450709419|FG001|Overall Study|lipid result by central lab did not meet|0|||
125295358|NCT01918332|450709420|FG002|Overall Study|lipid result by central lab did not meet|1|||
125295359|NCT01918332|450709421|FG003|Overall Study|lipid result by central lab did not meet|0|||
125295360|NCT02408523|450709422|FG000|Overall Study|Adverse Event|4|||
125295361|NCT02408523|450709423|FG001|Overall Study|Adverse Event|10|||
125295362|NCT02408523|450709422|FG000|Overall Study|Lack of Efficacy|0|||
125295363|NCT02408523|450709423|FG001|Overall Study|Lack of Efficacy|1|||
125295364|NCT02408523|450709422|FG000|Overall Study|Protocol Violation|1|||
125295365|NCT02408523|450709423|FG001|Overall Study|Protocol Violation|2|||
125295366|NCT02408523|450709422|FG000|Overall Study|Lost to Follow-up|2|||
125295367|NCT02408523|450709423|FG001|Overall Study|Lost to Follow-up|3|||
125295368|NCT02408523|450709422|FG000|Overall Study|Withdrawal by Subject|3|||
125295369|NCT02408523|450709423|FG001|Overall Study|Withdrawal by Subject|1|||
125295370|NCT02408523|450709422|FG000|Overall Study|Sponsor request|1|||
125295371|NCT02408523|450709423|FG001|Overall Study|Sponsor request|0|||
125459337|NCT02517307|451309396|FG003|Overall Study|Withdrawal by Subject|0|||
125459338|NCT02517307|451309393|FG000|Overall Study|Protocol Violation|0|||
125459339|NCT02517307|451309394|FG001|Overall Study|Protocol Violation|0|||
125459340|NCT02517307|451309395|FG002|Overall Study|Protocol Violation|1|||
125459341|NCT02517307|451309396|FG003|Overall Study|Protocol Violation|1|||
125459342|NCT00823979|451309397|FG000|Overall Study|Lack of Efficacy|13|||
125459343|NCT00823979|451309398|FG001|Overall Study|Lack of Efficacy|16|||
125459344|NCT00823979|451309399|FG002|Overall Study|Lack of Efficacy|9|||
125459345|NCT00823979|451309397|FG000|Overall Study|Lost to Follow-up|2|||
125459346|NCT00823979|451309398|FG001|Overall Study|Lost to Follow-up|1|||
125459347|NCT00823979|451309399|FG002|Overall Study|Lost to Follow-up|0|||
125459348|NCT00823979|451309397|FG000|Overall Study|Withdrawal by Subject|2|||
125459349|NCT00823979|451309398|FG001|Overall Study|Withdrawal by Subject|3|||
125459350|NCT00823979|451309399|FG002|Overall Study|Withdrawal by Subject|2|||
125459351|NCT00823979|451309397|FG000|Overall Study|Protocol Violation|1|||
125459352|NCT00823979|451309398|FG001|Overall Study|Protocol Violation|1|||
125459353|NCT00823979|451309399|FG002|Overall Study|Protocol Violation|0|||
125459354|NCT00823979|451309397|FG000|Overall Study|Pregnancy|0|||
125459355|NCT00823979|451309398|FG001|Overall Study|Pregnancy|1|||
125459356|NCT00823979|451309399|FG002|Overall Study|Pregnancy|0|||
125295372|NCT02408523|450709422|FG000|Overall Study|Did not satisfy extension conditions|0|||
125295373|NCT02408523|450709423|FG001|Overall Study|Did not satisfy extension conditions|1|||
125295374|NCT01751139|450709424|FG000|Overall Study|Other|135|||
125295375|NCT01751139|450709424|FG000|Overall Study|Sponsor study termination|1609|||
125295376|NCT01751139|450709424|FG000|Overall Study|Lost to Follow-up|240|||
125295377|NCT01751139|450709424|FG000|Overall Study|Withdrawal by Subject|251|||
125295378|NCT01751139|450709424|FG000|Overall Study|Adverse Event|1|||
125295379|NCT01751139|450709424|FG000|Overall Study|Death|31|||
125295380|NCT01867086|450709425|FG000|Overall Study|Disease Progression|1|||
125295381|NCT04279613|450709426|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
125295382|NCT04279613|450709427|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
125295383|NCT04279613|450709428|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
125295384|NCT04279613|450709429|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
125295385|NCT04279613|450709430|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
125295386|NCT04279613|450709426|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
125459357|NCT00823979|451309397|FG000|Overall Study|Adverse Event|0|||
125459358|NCT00823979|451309398|FG001|Overall Study|Adverse Event|2|||
125459359|NCT00823979|451309399|FG002|Overall Study|Adverse Event|4|||
125459360|NCT00823979|451309397|FG000|Overall Study|Other|2|||
125459361|NCT00823979|451309398|FG001|Overall Study|Other|0|||
125459362|NCT00823979|451309399|FG002|Overall Study|Other|1|||
125459363|NCT00823979|451309397|FG000|Overall Study|Randomized but not Treated|4|||
125459364|NCT00823979|451309398|FG001|Overall Study|Randomized but not Treated|3|||
125459365|NCT00823979|451309399|FG002|Overall Study|Randomized but not Treated|1|||
125459366|NCT00823979|451309397|FG000|Overall Study|Study Terminated by Sponsor|5|||
125459367|NCT00823979|451309398|FG001|Overall Study|Study Terminated by Sponsor|5|||
125459368|NCT00823979|451309399|FG002|Overall Study|Study Terminated by Sponsor|7|||
125459369|NCT03586544|451309400|FG000|First Intervention|Adverse Event|0|||
125459370|NCT03586544|451309401|FG001|First Intervention|Adverse Event|1|||
125459371|NCT03586544|451309400|FG000|Second Intervention|Withdrawal by Subject|0|||
125459372|NCT03586544|451309401|FG001|Second Intervention|Withdrawal by Subject|1|||
125459373|NCT03523091|451309402|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
125459374|NCT03523091|451309403|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
125459375|NCT03523091|451309402|FG000|Overall Study|Withdrawal by Subject|0|||
125459376|NCT03523091|451309403|FG001|Overall Study|Withdrawal by Subject|3|||
125459377|NCT03523091|451309402|FG000|Overall Study|Increase Botox dose|0|||
125459378|NCT03523091|451309403|FG001|Overall Study|Increase Botox dose|1|||
125459379|NCT03863834|451309409|FG000|Overall Study|Lost to Follow-up|3|||
125459380|NCT02685488|451309410|FG000|Overall Study|Withdrawal by Subject|0|||
125459381|NCT02685488|451309411|FG001|Overall Study|Withdrawal by Subject|1|||
125459382|NCT00324038|451309412|FG000|Overall Study|Adverse Event|38|||
125459383|NCT00324038|451309413|FG001|Overall Study|Adverse Event|23|||
125459384|NCT00324038|451309412|FG000|Overall Study|Lack of Efficacy|5|||
125459385|NCT00324038|451309413|FG001|Overall Study|Lack of Efficacy|13|||
125459386|NCT00324038|451309412|FG000|Overall Study|Lost to Follow-up|0|||
125459387|NCT00324038|451309413|FG001|Overall Study|Lost to Follow-up|2|||
125459388|NCT00324038|451309412|FG000|Overall Study|Other|6|||
125459389|NCT00324038|451309413|FG001|Overall Study|Other|13|||
125459390|NCT04257058|451311294|FG000|Overall Study|Lost to Follow-up|31|||
125459391|NCT05147233|451311301|FG000|Overall Study|Adverse Event|0|||
125459392|NCT05147233|451311302|FG001|Overall Study|Adverse Event|1|||
125459393|NCT05147233|451311301|FG000|Overall Study|Lost to Follow-up|1|||
125459394|NCT05147233|451311302|FG001|Overall Study|Lost to Follow-up|1|||
125459395|NCT05147233|451311301|FG000|Overall Study|Protocol Violation|0|||
125459396|NCT05147233|451311302|FG001|Overall Study|Protocol Violation|1|||
125459397|NCT05147233|451311301|FG000|Overall Study|Withdrawal by Subject|2|||
125459398|NCT05147233|451311302|FG001|Overall Study|Withdrawal by Subject|1|||
125459399|NCT04199728|451311309|FG000|Overall Study|Adverse Event|1|||
125459400|NCT04199728|451311310|FG001|Overall Study|Adverse Event|0|||
125459401|NCT04199728|451311309|FG000|Overall Study|Withdrawal by Subject|8|||
125459402|NCT04199728|451311310|FG001|Overall Study|Withdrawal by Subject|3|||
125459403|NCT04199728|451311309|FG000|Overall Study|Screen fail after consent|0|||
125459404|NCT04199728|451311310|FG001|Overall Study|Screen fail after consent|1|||
125459405|NCT04199728|451311309|FG000|Overall Study|Early withdraw criteria met|0|||
125459406|NCT04199728|451311310|FG001|Overall Study|Early withdraw criteria met|1|||
125459407|NCT04199728|451311309|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
125459408|NCT04199728|451311310|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
125459409|NCT00726596|451311311|FG000|Overall Study|Adverse Event|2|||
125459410|NCT00726596|451311312|FG001|Overall Study|Adverse Event|1|||
125459411|NCT00726596|451311311|FG000|Overall Study|Withdrawal by Subject|3|||
125459412|NCT00726596|451311312|FG001|Overall Study|Withdrawal by Subject|3|||
125459413|NCT00661778|451311316|FG000|Overall Study|Disease Progression|23|||
125459414|NCT00661778|451311316|FG000|Overall Study|Adverse Event|18|||
125459415|NCT00661778|451311316|FG000|Overall Study|Reason not Specified|6|||
125459416|NCT00661778|451311316|FG000|Overall Study|Protocol Violation|2|||
125459417|NCT00661778|451311316|FG000|Overall Study|Withdrawal of Consent|1|||
125459418|NCT02962674|451311322|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
125459419|NCT00364286|451311323|FG000|Overall Study|Withdrawal by Subject|1|||
125295387|NCT04279613|450709427|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
125295388|NCT04279613|450709428|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
125459420|NCT00364286|451311323|FG000|Overall Study|Adverse Event|2|||
125459421|NCT02577523|451311326|FG000|Overall Study|Adverse Event|1|||
125459422|NCT02577523|451311327|FG001|Overall Study|Adverse Event|1|||
125459423|NCT02577523|451311326|FG000|Overall Study|Lack of Efficacy|1|||
125295389|NCT04279613|450709429|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
125295390|NCT04279613|450709430|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
125295391|NCT04279613|450709426|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
125459424|NCT02577523|451311327|FG001|Overall Study|Lack of Efficacy|1|||
125459425|NCT02577523|451311326|FG000|Overall Study|Withdrawal by Subject|1|||
125459426|NCT02577523|451311327|FG001|Overall Study|Withdrawal by Subject|0|||
125459427|NCT01266265|451311330|FG000|Overall Study|Death|95|||
125459428|NCT01266265|451311331|FG001|Overall Study|Death|73|||
125459429|NCT01266265|451311330|FG000|Overall Study|Lost to Follow-up|23|||
125459430|NCT01266265|451311331|FG001|Overall Study|Lost to Follow-up|28|||
125459431|NCT01266265|451311330|FG000|Overall Study|Withdrawal by Subject|13|||
125459432|NCT01266265|451311331|FG001|Overall Study|Withdrawal by Subject|11|||
125459433|NCT01266265|451311330|FG000|Overall Study|Respiratory-related adverse event|2|||
125459434|NCT01266265|451311331|FG001|Overall Study|Respiratory-related adverse event|1|||
125459435|NCT01266265|451311330|FG000|Overall Study|Transferred care to another provider|22|||
125459436|NCT01266265|451311331|FG001|Overall Study|Transferred care to another provider|28|||
125459437|NCT01266265|451311330|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
125459438|NCT01266265|451311331|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
125459439|NCT01266265|451311330|FG000|Overall Study|Enrolled in another clinical study|15|||
125459440|NCT01266265|451311331|FG001|Overall Study|Enrolled in another clinical study|26|||
125459441|NCT01266265|451311330|FG000|Overall Study|Non-compliance|8|||
125459442|NCT01266265|451311331|FG001|Overall Study|Non-compliance|5|||
125459443|NCT01266265|451311330|FG000|Overall Study|Lung transplant|6|||
125459444|NCT01266265|451311331|FG001|Overall Study|Lung transplant|5|||
125459445|NCT01266265|451311330|FG000|Overall Study|Site closed early|4|||
125459446|NCT01266265|451311331|FG001|Overall Study|Site closed early|3|||
125459447|NCT01266265|451311330|FG000|Overall Study|Clinical worsening|1|||
125459448|NCT01266265|451311331|FG001|Overall Study|Clinical worsening|1|||
125459449|NCT01580293|451311332|FG000|Part A_Main Trial|Adverse Event|0|||
125459450|NCT01580293|451311333|FG001|Part A_Main Trial|Adverse Event|2|||
125459451|NCT01580293|451311334|FG002|Part A_Main Trial|Adverse Event|0|||
125459452|NCT01580293|451311332|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
125459453|NCT01580293|451311333|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
125459454|NCT01580293|451311334|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
125459455|NCT01580293|451311332|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
125459456|NCT01580293|451311333|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
125459457|NCT01580293|451311334|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
125459458|NCT01580293|451311332|FG000|Part A_Extension|Adverse Event|0|||
125459459|NCT01580293|451311333|FG001|Part A_Extension|Adverse Event|2|||
125459460|NCT01580293|451311334|FG002|Part A_Extension|Adverse Event|0|||
125459461|NCT01580293|451311332|FG000|Part A_Extension|Withdrawal by Subject|0|||
125459462|NCT01580293|451311333|FG001|Part A_Extension|Withdrawal by Subject|3|||
125459463|NCT01580293|451311334|FG002|Part A_Extension|Withdrawal by Subject|0|||
125459464|NCT01580293|451311332|FG000|Part A_Extension|Lost to Follow-up|0|||
125459465|NCT01580293|451311333|FG001|Part A_Extension|Lost to Follow-up|1|||
125459466|NCT01580293|451311334|FG002|Part A_Extension|Lost to Follow-up|0|||
125459467|NCT01580293|451311332|FG000|Part A_Extension|Other Reason|0|||
125459468|NCT01580293|451311333|FG001|Part A_Extension|Other Reason|1|||
125459469|NCT01580293|451311334|FG002|Part A_Extension|Other Reason|0|||
125459470|NCT01580293|451311332|FG000|Part A_Extension|Completed Japan only|0|||
125459471|NCT01580293|451311333|FG001|Part A_Extension|Completed Japan only|5|||
125459472|NCT01580293|451311334|FG002|Part A_Extension|Completed Japan only|0|||
125459473|NCT01580293|451311332|FG000|Part B|Withdrawal by Subject|0|||
125459474|NCT01580293|451311333|FG001|Part B|Withdrawal by Subject|0|||
125459475|NCT01580293|451311334|FG002|Part B|Withdrawal by Subject|1|||
125459476|NCT01580293|451311332|FG000|Part B|Other reason|0|||
125459477|NCT01580293|451311333|FG001|Part B|Other reason|0|||
125459478|NCT01580293|451311334|FG002|Part B|Other reason|1|||
125459479|NCT01400776|451311337|FG000|Overall Study|Adverse Event|7|||
125459480|NCT01400776|451311338|FG001|Overall Study|Adverse Event|2|||
125459481|NCT01400776|451311339|FG002|Overall Study|Adverse Event|9|||
125459482|NCT01400776|451311340|FG003|Overall Study|Adverse Event|2|||
125459483|NCT01400776|451311337|FG000|Overall Study|Lost to Follow-up|1|||
125459484|NCT01400776|451311338|FG001|Overall Study|Lost to Follow-up|0|||
125459485|NCT01400776|451311339|FG002|Overall Study|Lost to Follow-up|4|||
125459486|NCT01400776|451311340|FG003|Overall Study|Lost to Follow-up|1|||
125459487|NCT01400776|451311337|FG000|Overall Study|Withdrew Consent|4|||
125459488|NCT01400776|451311338|FG001|Overall Study|Withdrew Consent|2|||
125459489|NCT01400776|451311339|FG002|Overall Study|Withdrew Consent|6|||
125459490|NCT01400776|451311340|FG003|Overall Study|Withdrew Consent|1|||
125459491|NCT01400776|451311337|FG000|Overall Study|Protocol Deviation|6|||
125459492|NCT01400776|451311338|FG001|Overall Study|Protocol Deviation|1|||
125459493|NCT01400776|451311339|FG002|Overall Study|Protocol Deviation|5|||
125459494|NCT01400776|451311340|FG003|Overall Study|Protocol Deviation|2|||
125295392|NCT04279613|450709427|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
125459495|NCT01400776|451311337|FG000|Overall Study|Reason not Specified|3|||
125295393|NCT04279613|450709428|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
125459496|NCT01400776|451311338|FG001|Overall Study|Reason not Specified|0|||
125459497|NCT01400776|451311339|FG002|Overall Study|Reason not Specified|4|||
125459498|NCT01400776|451311340|FG003|Overall Study|Reason not Specified|3|||
125459499|NCT00423098|451311341|FG000|Overall Study|Adverse Event|1|||
125459500|NCT00423098|451311342|FG001|Overall Study|Adverse Event|2|||
125459501|NCT00423098|451311341|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125459502|NCT00423098|451311342|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125459503|NCT00423098|451311341|FG000|Overall Study|Administrative problems|0|||
125459504|NCT00423098|451311342|FG001|Overall Study|Administrative problems|1|||
125459505|NCT00423098|451311341|FG000|Overall Study|Death|2|||
125459506|NCT00423098|451311342|FG001|Overall Study|Death|0|||
125459507|NCT01227278|451311343|FG000|Overall Study|Withdrawal by Subject|4|||
125485360|NCT02240238|451412510|FG007|Phase 1|Death|0|||
125459508|NCT01227278|451311344|FG001|Overall Study|Withdrawal by Subject|4|||
125459509|NCT01227278|451311343|FG000|Overall Study|Death|0|||
125459510|NCT01227278|451311344|FG001|Overall Study|Death|2|||
125459511|NCT01227278|451311343|FG000|Overall Study|Other|1|||
125459512|NCT01227278|451311344|FG001|Overall Study|Other|2|||
125459513|NCT04035668|451311345|FG000|Overall Study|Adverse Event|3|||
125459514|NCT04035668|451311346|FG001|Overall Study|Adverse Event|4|||
125459515|NCT04035668|451311347|FG002|Overall Study|Adverse Event|2|||
125459516|NCT04035668|451311345|FG000|Overall Study|Lost to Follow-up|0|||
125459517|NCT04035668|451311346|FG001|Overall Study|Lost to Follow-up|1|||
125459518|NCT04035668|451311347|FG002|Overall Study|Lost to Follow-up|0|||
125459519|NCT04035668|451311345|FG000|Overall Study|Physician Decision|2|||
125459520|NCT04035668|451311346|FG001|Overall Study|Physician Decision|1|||
125459521|NCT04035668|451311347|FG002|Overall Study|Physician Decision|1|||
125459522|NCT04035668|451311345|FG000|Overall Study|Subject Decision|2|||
125459523|NCT04035668|451311346|FG001|Overall Study|Subject Decision|2|||
125459524|NCT04035668|451311347|FG002|Overall Study|Subject Decision|0|||
125459525|NCT02320123|451311350|FG000|Overall Study|Lost to Follow-up|4|||
125459526|NCT02320123|451311351|FG001|Overall Study|Lost to Follow-up|6|||
125459527|NCT02320123|451311350|FG000|Overall Study|Death|6|||
125459528|NCT02320123|451311351|FG001|Overall Study|Death|5|||
125459529|NCT04480827|451311352|FG000|Overall Study|Adverse Event|0|||
125459530|NCT04480827|451311353|FG001|Overall Study|Adverse Event|0|||
125459531|NCT04480827|451311354|FG002|Overall Study|Adverse Event|0|||
125459532|NCT04480827|451311355|FG003|Overall Study|Adverse Event|0|||
125459533|NCT04480827|451311356|FG004|Overall Study|Adverse Event|0|||
125459534|NCT04480827|451311357|FG005|Overall Study|Adverse Event|1|||
125459535|NCT04480827|451311358|FG006|Overall Study|Adverse Event|0|||
125459536|NCT00465816|451311359|FG000|Overall Study|Lost to Follow-up|0|||
125459537|NCT00465816|451311360|FG001|Overall Study|Lost to Follow-up|0|||
125459538|NCT00465816|451311361|FG002|Overall Study|Lost to Follow-up|2|||
125459539|NCT02983617|451311367|FG000|Overall Study|Adverse Event|0|||
125459540|NCT02983617|451311368|FG001|Overall Study|Adverse Event|7|||
125459541|NCT02983617|451311367|FG000|Overall Study|Death|0|||
125459542|NCT02983617|451311368|FG001|Overall Study|Death|1|||
125459543|NCT02983617|451311367|FG000|Overall Study|Investigator's Discretion|0|||
125459544|NCT02983617|451311368|FG001|Overall Study|Investigator's Discretion|1|||
125459545|NCT03720210|451311371|FG000|Overall Study|Lost to Follow-up|1|||
125459546|NCT02698891|451311376|FG000|Overall Study|Withdrawal by Subject|2|||
125459547|NCT02698891|451311376|FG000|Overall Study|deemed ineligible|1|||
125459548|NCT02698891|451311376|FG000|Overall Study|Adverse Event|9|||
125459549|NCT00516386|451311377|FG000|Overall Study|not interested in the study|4|||
125459550|NCT00516386|451311377|FG000|Overall Study|Lost to Follow-up|2|||
125459551|NCT00114244|451311378|FG000|Overall Study|Adverse Event|2|||
125459552|NCT00114244|451311379|FG001|Overall Study|Adverse Event|5|||
125459553|NCT00114244|451311378|FG000|Overall Study|Withdrawal by Subject|0|||
125459554|NCT00114244|451311379|FG001|Overall Study|Withdrawal by Subject|2|||
125459555|NCT00711958|451311380|FG000|Overall Study|Withdrawal by Subject|6|||
125459556|NCT00711958|451311381|FG001|Overall Study|Withdrawal by Subject|8|||
125459557|NCT00711958|451311380|FG000|Overall Study|Lack of Efficacy|3|||
125459558|NCT00711958|451311381|FG001|Overall Study|Lack of Efficacy|1|||
125459559|NCT00711958|451311380|FG000|Overall Study|Clinical deterioration|1|||
125459560|NCT00711958|451311381|FG001|Overall Study|Clinical deterioration|0|||
125459561|NCT00711958|451311380|FG000|Overall Study|Adverse Event|9|||
125459562|NCT00711958|451311381|FG001|Overall Study|Adverse Event|7|||
125459563|NCT00711958|451311380|FG000|Overall Study|Protocol Violation|1|||
125459564|NCT00711958|451311381|FG001|Overall Study|Protocol Violation|0|||
125459565|NCT00711958|451311380|FG000|Overall Study|Lost to Follow-up|2|||
125459566|NCT00711958|451311381|FG001|Overall Study|Lost to Follow-up|2|||
125459567|NCT00711958|451311380|FG000|Overall Study|Death|10|||
125459568|NCT00711958|451311381|FG001|Overall Study|Death|5|||
125459569|NCT00711958|451311380|FG000|Overall Study|Progression of disease|1|||
125459570|NCT00711958|451311381|FG001|Overall Study|Progression of disease|0|||
125459571|NCT02694978|451311384|FG000|Overall Study|Adverse Event|10|||
125459572|NCT02694978|451311385|FG001|Overall Study|Adverse Event|9|||
125459573|NCT02694978|451311384|FG000|Overall Study|Withdrawal by Subject|22|||
125459574|NCT02694978|451311385|FG001|Overall Study|Withdrawal by Subject|19|||
125459575|NCT02694978|451311384|FG000|Overall Study|Lost to Follow-up|14|||
125459576|NCT02694978|451311385|FG001|Overall Study|Lost to Follow-up|17|||
125459577|NCT02694978|451311384|FG000|Overall Study|Death|4|||
125459578|NCT02694978|451311385|FG001|Overall Study|Death|1|||
125459579|NCT02694978|451311384|FG000|Overall Study|Other-Decision of Participant|6|||
125459580|NCT02694978|451311385|FG001|Overall Study|Other-Decision of Participant|1|||
125459581|NCT02694978|451311384|FG000|Overall Study|Other-Investigator's decision|1|||
125459582|NCT02694978|451311385|FG001|Overall Study|Other-Investigator's decision|0|||
125459583|NCT02694978|451311384|FG000|Overall Study|Other-Unable to be reached|0|||
125459584|NCT02694978|451311385|FG001|Overall Study|Other-Unable to be reached|1|||
125459585|NCT02694978|451311384|FG000|Overall Study|Other-Protocol noncompliant|2|||
125459586|NCT02694978|451311385|FG001|Overall Study|Other-Protocol noncompliant|1|||
125459587|NCT02694978|451311384|FG000|Overall Study|Other-Personal reasons|3|||
125459588|NCT02694978|451311385|FG001|Overall Study|Other-Personal reasons|3|||
125459589|NCT02694978|451311384|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
125459590|NCT02694978|451311385|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
125459591|NCT01613716|451311386|FG000|Overall Study|screen failures|3|||
125459592|NCT01613716|451311386|FG000|Overall Study|Lost to Follow-up|4|||
125459593|NCT00818454|451311387|FG000|Treatment Period 1|Adverse Event|0|||
125459594|NCT00818454|451311388|FG001|Treatment Period 1|Adverse Event|1|||
125459595|NCT00818454|451311389|FG002|Treatment Period 1|Adverse Event|0|||
125459596|NCT00818454|451311390|FG003|Treatment Period 1|Adverse Event|0|||
125459597|NCT00818454|451311387|FG000|Treatment Period 1|Other|3|||
125459598|NCT00818454|451311388|FG001|Treatment Period 1|Other|0|||
125459599|NCT00818454|451311389|FG002|Treatment Period 1|Other|0|||
125459600|NCT00818454|451311390|FG003|Treatment Period 1|Other|0|||
125459601|NCT00818454|451311387|FG000|Washout Period of 1 Week|Adverse Event|1|||
125459602|NCT00818454|451311388|FG001|Washout Period of 1 Week|Adverse Event|1|||
125459603|NCT00818454|451311389|FG002|Washout Period of 1 Week|Adverse Event|0|||
125459604|NCT00818454|451311390|FG003|Washout Period of 1 Week|Adverse Event|0|||
125459605|NCT00818454|451311387|FG000|Washout Period of 1 Week|Protocol Violation|2|||
125459606|NCT00818454|451311388|FG001|Washout Period of 1 Week|Protocol Violation|0|||
125459607|NCT00818454|451311389|FG002|Washout Period of 1 Week|Protocol Violation|0|||
125459608|NCT00818454|451311390|FG003|Washout Period of 1 Week|Protocol Violation|0|||
125459609|NCT00818454|451311387|FG000|Washout Period of 1 Week|Other|1|||
125459610|NCT00818454|451311388|FG001|Washout Period of 1 Week|Other|2|||
125459611|NCT00818454|451311389|FG002|Washout Period of 1 Week|Other|0|||
125459612|NCT00818454|451311390|FG003|Washout Period of 1 Week|Other|0|||
125459613|NCT00818454|451311387|FG000|Treatment Period 2|Other|2|||
125459614|NCT00818454|451311388|FG001|Treatment Period 2|Other|1|||
125459615|NCT00818454|451311389|FG002|Treatment Period 2|Other|0|||
125459616|NCT00818454|451311390|FG003|Treatment Period 2|Other|0|||
125459617|NCT00818454|451311387|FG000|Treatment Period 3|Adverse Event|0|||
125459618|NCT00818454|451311388|FG001|Treatment Period 3|Adverse Event|0|||
125459619|NCT00818454|451311389|FG002|Treatment Period 3|Adverse Event|0|||
125459620|NCT00818454|451311390|FG003|Treatment Period 3|Adverse Event|1|||
125459621|NCT01171625|451311396|FG000|Overall Study|On-Protocol|67|||
125459622|NCT01171625|451311396|FG000|Overall Study|Death|38|||
125459623|NCT01171625|451311396|FG000|Overall Study|Withdrawal by Subject|31|||
125459624|NCT01171625|451311396|FG000|Overall Study|Explanted|10|||
125459625|NCT01171625|451311396|FG000|Overall Study|Lost to Follow-up|5|||
125459626|NCT01171625|451311396|FG000|Overall Study|Patient received valve-in-valve|3|||
125459627|NCT01171625|451311396|FG000|Overall Study|Other|1|||
125459628|NCT01171625|451311396|FG000|Overall Study|Consented but did not receive device|25|||
125459629|NCT02224924|451311397|FG000|Overall Study|Withdrawal by Subject|7|||
125459630|NCT02224924|451311398|FG001|Overall Study|Withdrawal by Subject|6|||
125459631|NCT02224924|451311397|FG000|Overall Study|Biopsy cancelled|20|||
125459632|NCT02224924|451311398|FG001|Overall Study|Biopsy cancelled|14|||
125459633|NCT02224924|451311397|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
125459634|NCT02224924|451311398|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
125459635|NCT02224924|451311397|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
125459636|NCT02224924|451311398|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
125459637|NCT03020745|451311399|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
125459638|NCT03020745|451311400|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
125459639|NCT03020745|451311401|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
125459640|NCT03020745|451311402|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
125459641|NCT03020745|451311403|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
125459642|NCT03020745|451311404|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
125459643|NCT03020745|451311405|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
125459644|NCT03020745|451311406|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
125459645|NCT03020745|451311407|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
125459646|NCT03020745|451311408|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
125459647|NCT03020745|451311399|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
125459648|NCT03020745|451311400|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
125295394|NCT04279613|450709429|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
125295395|NCT04279613|450709430|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
125295396|NCT04279613|450709426|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
125295397|NCT04279613|450709427|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
125459649|NCT03020745|451311401|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
125459650|NCT03020745|451311402|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
125459651|NCT03020745|451311403|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
125459652|NCT03020745|451311404|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
125459653|NCT03020745|451311405|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
125459654|NCT03020745|451311406|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
125459655|NCT03020745|451311407|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
125459656|NCT03020745|451311408|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
125459657|NCT03020745|451311399|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
125459658|NCT03020745|451311400|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
125485361|NCT02240238|451412511|FG008|Phase 1|Death|0|||
125459659|NCT03020745|451311401|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
125459660|NCT03020745|451311402|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
125459661|NCT03020745|451311403|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
125459662|NCT03020745|451311404|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
125459663|NCT03020745|451311405|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
125459664|NCT03020745|451311406|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
125459665|NCT03020745|451311407|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
125459666|NCT03020745|451311408|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
125459667|NCT03020745|451311399|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
125459668|NCT03020745|451311400|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
125459669|NCT03020745|451311401|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
125459670|NCT03020745|451311402|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
125459671|NCT03020745|451311403|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
125459672|NCT03020745|451311404|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
125459673|NCT03020745|451311405|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
125459674|NCT03020745|451311406|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
125459675|NCT03020745|451311407|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
125459676|NCT03020745|451311408|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
125459677|NCT00139737|451311416|FG000|Overall Study|Withdrawal by Subject|190|||
125459678|NCT00139737|451311416|FG000|Overall Study|Adverse Event|58|||
125459679|NCT00139737|451311416|FG000|Overall Study|Lack of Efficacy|40|||
125459680|NCT00139737|451311416|FG000|Overall Study|Lost to Follow-up|8|||
125459681|NCT00139737|451311416|FG000|Overall Study|Death|3|||
125459682|NCT00139737|451311416|FG000|Overall Study|Laboratory Abnormality|2|||
125459683|NCT00139737|451311416|FG000|Overall Study|Protocol Violation|18|||
125459684|NCT00139737|451311416|FG000|Overall Study|Withdrew During Screening Phase|8|||
125459685|NCT00139737|451311416|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
125459686|NCT00139737|451311416|FG000|Overall Study|Screened, Not Treated|13|||
125459687|NCT03781336|451311419|FG000|Overall Study|Withdrawal by Subject|2|||
125459688|NCT03781336|451311420|FG001|Overall Study|Withdrawal by Subject|2|||
125459689|NCT03460756|451311421|FG000|Overall Study|Adverse Event|0|||
125459690|NCT03460756|451311422|FG001|Overall Study|Adverse Event|0|||
125459691|NCT03460756|451311423|FG002|Overall Study|Adverse Event|0|||
125459692|NCT03460756|451311424|FG003|Overall Study|Adverse Event|1|||
125459693|NCT03460756|451311421|FG000|Overall Study|Lack of Efficacy|0|||
125459694|NCT03460756|451311422|FG001|Overall Study|Lack of Efficacy|0|||
125459695|NCT03460756|451311423|FG002|Overall Study|Lack of Efficacy|0|||
125459696|NCT03460756|451311424|FG003|Overall Study|Lack of Efficacy|2|||
125459697|NCT03460756|451311421|FG000|Overall Study|Lost to Follow-up|0|||
125459698|NCT03460756|451311422|FG001|Overall Study|Lost to Follow-up|1|||
125459699|NCT03460756|451311423|FG002|Overall Study|Lost to Follow-up|2|||
125459700|NCT03460756|451311424|FG003|Overall Study|Lost to Follow-up|1|||
125459701|NCT03460756|451311421|FG000|Overall Study|Pregnancy|0|||
125459702|NCT03460756|451311422|FG001|Overall Study|Pregnancy|0|||
125459703|NCT03460756|451311423|FG002|Overall Study|Pregnancy|0|||
125459704|NCT03460756|451311424|FG003|Overall Study|Pregnancy|1|||
125459705|NCT03460756|451311421|FG000|Overall Study|Protocol Violation|0|||
125459706|NCT03460756|451311422|FG001|Overall Study|Protocol Violation|0|||
125459707|NCT03460756|451311423|FG002|Overall Study|Protocol Violation|0|||
125459708|NCT03460756|451311424|FG003|Overall Study|Protocol Violation|1|||
125459709|NCT03460756|451311421|FG000|Overall Study|Withdrawal by Subject|0|||
125459710|NCT03460756|451311422|FG001|Overall Study|Withdrawal by Subject|4|||
125459711|NCT03460756|451311423|FG002|Overall Study|Withdrawal by Subject|7|||
125459712|NCT03460756|451311424|FG003|Overall Study|Withdrawal by Subject|3|||
125459713|NCT03987451|451311425|FG000|Overall Study|Lost to Follow-up|1|||
125459714|NCT03987451|451311426|FG001|Overall Study|Lost to Follow-up|0|||
125459715|NCT03987451|451311425|FG000|Overall Study|Withdrawal by Subject|1|||
125459716|NCT03987451|451311426|FG001|Overall Study|Withdrawal by Subject|1|||
125459717|NCT02441036|451311429|FG000|Overall Study|No tissue resected|0|||
125459718|NCT02441036|451311430|FG001|Overall Study|No tissue resected|1|||
125459719|NCT02441036|451311431|FG002|Overall Study|No tissue resected|0|||
125459720|NCT02441036|451311432|FG003|Overall Study|No tissue resected|1|||
125295398|NCT04279613|450709428|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
125459721|NCT02441036|451311433|FG004|Overall Study|No tissue resected|0|||
125459722|NCT02194933|451311438|FG000|Overall Study|Lost to Follow-up|1|||
125459723|NCT02194933|451311439|FG001|Overall Study|Lost to Follow-up|2|||
125459724|NCT02194933|451311438|FG000|Overall Study|Participant met withdrawal criteria|1|||
125459725|NCT02194933|451311439|FG001|Overall Study|Participant met withdrawal criteria|3|||
125459726|NCT02194933|451311438|FG000|Overall Study|Withdrawal by Subject|0|||
125459727|NCT02194933|451311439|FG001|Overall Study|Withdrawal by Subject|2|||
125459728|NCT02194933|451311438|FG000|Overall Study|Lack of Efficacy|1|||
125459729|NCT02194933|451311439|FG001|Overall Study|Lack of Efficacy|2|||
125459730|NCT02045836|451311443|FG000|Overall Study|Adverse Event|4|||
125459731|NCT02045836|451311444|FG001|Overall Study|Adverse Event|4|||
125295399|NCT04279613|450709429|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
125459732|NCT02045836|451311443|FG000|Overall Study|Withdrawal by Subject|1|||
125459733|NCT02045836|451311444|FG001|Overall Study|Withdrawal by Subject|1|||
125459734|NCT02045836|451311443|FG000|Overall Study|Lost to Follow-up|4|||
125459735|NCT02045836|451311444|FG001|Overall Study|Lost to Follow-up|7|||
125459736|NCT02045836|451311443|FG000|Overall Study|Migrated from study area|0|||
125459737|NCT02045836|451311444|FG001|Overall Study|Migrated from study area|2|||
125459738|NCT03920215|451311448|FG000|Overall Study|Lost to Follow-up|1|||
125459739|NCT03920215|451311449|FG001|Overall Study|Lost to Follow-up|2|||
125459740|NCT03920215|451311450|FG002|Overall Study|Lost to Follow-up|0|||
125459741|NCT03920215|451311451|FG003|Overall Study|Lost to Follow-up|0|||
125459742|NCT03920215|451311448|FG000|Overall Study|Death|0|||
125459743|NCT03920215|451311449|FG001|Overall Study|Death|0|||
125459744|NCT03920215|451311450|FG002|Overall Study|Death|0|||
125459745|NCT03920215|451311451|FG003|Overall Study|Death|1|||
125459746|NCT02000817|451311452|FG000|Overall Study|Withdrawal by Subject|2|||
125459747|NCT02000817|451311453|FG001|Overall Study|Withdrawal by Subject|0|||
125459748|NCT02000817|451311454|FG002|Overall Study|Withdrawal by Subject|0|||
125459749|NCT02000817|451311455|FG003|Overall Study|Withdrawal by Subject|0|||
125459750|NCT02000817|451311452|FG000|Overall Study|Adverse Event|0|||
125459751|NCT02000817|451311453|FG001|Overall Study|Adverse Event|1|||
125459752|NCT02000817|451311454|FG002|Overall Study|Adverse Event|0|||
125459753|NCT02000817|451311455|FG003|Overall Study|Adverse Event|0|||
125459754|NCT02000817|451311452|FG000|Overall Study|Lost to Follow-up|0|||
125459755|NCT02000817|451311453|FG001|Overall Study|Lost to Follow-up|0|||
125459756|NCT02000817|451311454|FG002|Overall Study|Lost to Follow-up|1|||
125459757|NCT02000817|451311455|FG003|Overall Study|Lost to Follow-up|0|||
125459758|NCT00177216|451311458|FG000|Overall Study|Withdrawal by Subject|6|||
125459759|NCT00177216|451311459|FG001|Overall Study|Withdrawal by Subject|3|||
125459760|NCT00177216|451311460|FG002|Overall Study|Withdrawal by Subject|1|||
125459761|NCT02770248|451311461|FG000|Overall Study|Adverse Event|0|||
125459762|NCT02770248|451311462|FG001|Overall Study|Adverse Event|1|||
125459763|NCT02770248|451311461|FG000|Overall Study|Randomized in error, prior to treatment|0|||
125459764|NCT02770248|451311462|FG001|Overall Study|Randomized in error, prior to treatment|1|||
125459765|NCT03768206|451311465|FG000|Overall Study|Lost to Follow-up|2|||
125459766|NCT03768206|451311466|FG001|Overall Study|Lost to Follow-up|1|||
125295400|NCT04279613|450709430|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
125295401|NCT04279613|450709426|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
125459767|NCT03768206|451311465|FG000|Overall Study|Withdrawal by Subject|0|||
125459768|NCT03768206|451311466|FG001|Overall Study|Withdrawal by Subject|1|||
125459769|NCT04493242|451311467|FG000|Overall Study|Death|10|||
125459770|NCT04493242|451311468|FG001|Overall Study|Death|14|||
125459771|NCT04493242|451311469|FG002|Overall Study|Death|16|||
125459772|NCT04493242|451311467|FG000|Overall Study|Lost to Follow-up|1|||
125459773|NCT04493242|451311468|FG001|Overall Study|Lost to Follow-up|1|||
125459774|NCT04493242|451311469|FG002|Overall Study|Lost to Follow-up|0|||
125459775|NCT04493242|451311467|FG000|Overall Study|Withdrawal by Subject|1|||
125459776|NCT04493242|451311468|FG001|Overall Study|Withdrawal by Subject|0|||
125459777|NCT04493242|451311469|FG002|Overall Study|Withdrawal by Subject|0|||
125459778|NCT04493242|451311467|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
125459779|NCT04493242|451311468|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
125459780|NCT04493242|451311469|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
125459781|NCT04493242|451311467|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
125459782|NCT04493242|451311468|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
125459783|NCT04493242|451311469|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
125459784|NCT02812966|451311472|FG000|Overall Study|Death|1|||
125459785|NCT02812966|451311473|FG001|Overall Study|Death|0|||
125459786|NCT04517864|451313455|FG000|Placebo-Controlled Phase|Adverse Event|1|||
125459787|NCT04517864|451313456|FG001|Placebo-Controlled Phase|Adverse Event|0|||
125459788|NCT04517864|451313457|FG002|Placebo-Controlled Phase|Adverse Event|0|||
125459789|NCT04517864|451313455|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
125459790|NCT04517864|451313456|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
125459791|NCT04517864|451313457|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
125295402|NCT04279613|450709427|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
125295403|NCT04279613|450709428|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
125459792|NCT04517864|451313455|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
125459793|NCT04517864|451313456|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
125295404|NCT04279613|450709429|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
125295405|NCT04279613|450709430|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
125295406|NCT04428151|450709431|FG000|Overall Study|Death|100|||
125459794|NCT04517864|451313457|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
125459795|NCT04517864|451313455|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
125459796|NCT04517864|451313456|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
125459797|NCT04517864|451313457|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
125459798|NCT04517864|451313455|FG000|Active Therapy Extension Phase|Adverse Event|1|||
125295407|NCT04428151|450709432|FG001|Overall Study|Death|86|||
125459799|NCT04517864|451313456|FG001|Active Therapy Extension Phase|Adverse Event|0|||
125459800|NCT04517864|451313457|FG002|Active Therapy Extension Phase|Adverse Event|0|||
125459801|NCT04517864|451313455|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
125459802|NCT04517864|451313456|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
125459803|NCT04517864|451313457|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
125459804|NCT04517864|451313455|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
125459805|NCT04517864|451313456|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
125459806|NCT04517864|451313457|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
125459807|NCT04517864|451313455|FG000|Active Therapy Extension Phase|Physician Decision|1|||
125459808|NCT04517864|451313456|FG001|Active Therapy Extension Phase|Physician Decision|0|||
125459809|NCT04517864|451313457|FG002|Active Therapy Extension Phase|Physician Decision|0|||
125459810|NCT04517864|451313455|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
125459811|NCT04517864|451313456|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
125459812|NCT04517864|451313457|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
125459813|NCT04517864|451313455|FG000|Extension Phase|Adverse Event|0|||
125459814|NCT04517864|451313456|FG001|Extension Phase|Adverse Event|0|||
125459815|NCT04517864|451313457|FG002|Extension Phase|Adverse Event|1|||
125459816|NCT04517864|451313455|FG000|Extension Phase|Lack of Efficacy|0|||
125459817|NCT04517864|451313456|FG001|Extension Phase|Lack of Efficacy|0|||
125459818|NCT04517864|451313457|FG002|Extension Phase|Lack of Efficacy|2|||
125459819|NCT04517864|451313455|FG000|Extension Phase|Study Terminated By Sponsor|0|||
125459820|NCT04517864|451313456|FG001|Extension Phase|Study Terminated By Sponsor|0|||
125459821|NCT04517864|451313457|FG002|Extension Phase|Study Terminated By Sponsor|32|||
125459822|NCT04517864|451313455|FG000|Extension Phase|Withdrawal by Subject|0|||
125459823|NCT04517864|451313456|FG001|Extension Phase|Withdrawal by Subject|0|||
125459824|NCT04517864|451313457|FG002|Extension Phase|Withdrawal by Subject|3|||
125459825|NCT04517864|451313455|FG000|Extension Phase|Approved Drug Available for Indication|0|||
125459826|NCT04517864|451313456|FG001|Extension Phase|Approved Drug Available for Indication|0|||
125459827|NCT04517864|451313457|FG002|Extension Phase|Approved Drug Available for Indication|7|||
125459828|NCT04722003|451313458|FG000|Overall Study|Lost to Follow-up|2|||
125459829|NCT04722003|451313459|FG001|Overall Study|Lost to Follow-up|0|||
125459830|NCT04722003|451313458|FG000|Overall Study|Physician Decision|1|||
125459831|NCT04722003|451313459|FG001|Overall Study|Physician Decision|0|||
125459832|NCT01049503|451313460|FG000|Overall Study|Lost to Follow-up|11|||
125459833|NCT01049503|451313461|FG001|Overall Study|Lost to Follow-up|12|||
125459834|NCT01049503|451313462|FG002|Overall Study|Lost to Follow-up|24|||
125459835|NCT01049503|451313463|FG003|Overall Study|Lost to Follow-up|26|||
125459836|NCT01049503|451313464|FG004|Overall Study|Lost to Follow-up|27|||
125459837|NCT01049503|451313465|FG005|Overall Study|Lost to Follow-up|8|||
125459838|NCT02974634|451313466|FG000|Overall Study|Advanced disease|12|||
125459839|NCT02974634|451313467|FG001|Overall Study|Advanced disease|3|||
125459840|NCT02974634|451313466|FG000|Overall Study|Noncompliance|3|||
125459841|NCT02974634|451313467|FG001|Overall Study|Noncompliance|7|||
125459842|NCT02974634|451313466|FG000|Overall Study|intervention technology related issues|5|||
125459843|NCT02974634|451313467|FG001|Overall Study|intervention technology related issues|0|||
125459844|NCT02974634|451313466|FG000|Overall Study|Death|8|||
125459845|NCT02974634|451313467|FG001|Overall Study|Death|11|||
125459846|NCT00768664|451313471|FG000|Overall Study|Death|57|||
125459847|NCT00768664|451313471|FG000|Overall Study|Lost to Follow-up|2|||
125459848|NCT00768664|451313471|FG000|Overall Study|Other|9|||
125459849|NCT00768664|451313471|FG000|Overall Study|Participant refused|1|||
125295408|NCT04428151|450709433|FG002|Overall Study|Death|57|||
125295409|NCT04428151|450709431|FG000|Overall Study|Lost to Follow-up|1|||
125295410|NCT04428151|450709432|FG001|Overall Study|Lost to Follow-up|1|||
125459850|NCT00708032|451313472|FG000|Overall Study|Adverse Event|0|||
125459851|NCT00708032|451313473|FG001|Overall Study|Adverse Event|2|||
125459852|NCT00708032|451313472|FG000|Overall Study|Lost to Follow-up|1|||
125459853|NCT00708032|451313473|FG001|Overall Study|Lost to Follow-up|2|||
125459854|NCT00708032|451313472|FG000|Overall Study|Pregnancy|0|||
125459855|NCT00708032|451313473|FG001|Overall Study|Pregnancy|1|||
125459856|NCT00708032|451313472|FG000|Overall Study|Poor vision|0|||
125459857|NCT00708032|451313473|FG001|Overall Study|Poor vision|6|||
125459858|NCT00708032|451313472|FG000|Overall Study|Visit out of range at month 12|4|||
125459859|NCT00708032|451313473|FG001|Overall Study|Visit out of range at month 12|1|||
125459860|NCT00708032|451313472|FG000|Overall Study|Did not meet protocol criteria|1|||
125459861|NCT00708032|451313473|FG001|Overall Study|Did not meet protocol criteria|2|||
125459862|NCT00708032|451313472|FG000|Overall Study|Protocol Violation|4|||
125459863|NCT00708032|451313473|FG001|Overall Study|Protocol Violation|1|||
125459864|NCT00708032|451313472|FG000|Overall Study|Withdrawal by Subject|0|||
125459865|NCT00708032|451313473|FG001|Overall Study|Withdrawal by Subject|1|||
125459866|NCT00941655|451313476|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
125459867|NCT00941655|451313477|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
125459868|NCT00941655|451313476|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
125459869|NCT00941655|451313477|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
125459870|NCT00941655|451313476|FG000|Overall Study|progressed while on chemo|0|||
125295411|NCT04428151|450709433|FG002|Overall Study|Lost to Follow-up|0|||
125459871|NCT00941655|451313477|FG001|Overall Study|progressed while on chemo|2|||
125459872|NCT00941655|451313476|FG000|Overall Study|refused further treatment|0|||
125459873|NCT00941655|451313477|FG001|Overall Study|refused further treatment|1|||
125459874|NCT00941655|451313476|FG000|Overall Study|withdrew consent|0|||
125459875|NCT00941655|451313477|FG001|Overall Study|withdrew consent|1|||
125459876|NCT00941655|451313476|FG000|Overall Study|non-compliant|0|||
125459877|NCT00941655|451313477|FG001|Overall Study|non-compliant|1|||
125459878|NCT02477670|451313478|FG000|Stage 1|Adverse Event|2|||
125459879|NCT02477670|451313479|FG001|Stage 1|Adverse Event|7|||
125459880|NCT02477670|451313480|FG002|Stage 1|Adverse Event|0|||
125459881|NCT02477670|451313481|FG003|Stage 1|Adverse Event|0|||
125459882|NCT02477670|451313482|FG004|Stage 1|Adverse Event|0|||
125459883|NCT02477670|451313483|FG005|Stage 1|Adverse Event|0|||
125459884|NCT02477670|451313484|FG006|Stage 1|Adverse Event|0|||
125459885|NCT02477670|451313478|FG000|Stage 1|Lost to Follow-up|0|||
125459886|NCT02477670|451313479|FG001|Stage 1|Lost to Follow-up|2|||
125459887|NCT02477670|451313480|FG002|Stage 1|Lost to Follow-up|0|||
125459888|NCT02477670|451313481|FG003|Stage 1|Lost to Follow-up|0|||
125459889|NCT02477670|451313482|FG004|Stage 1|Lost to Follow-up|0|||
125459890|NCT02477670|451313483|FG005|Stage 1|Lost to Follow-up|0|||
125459891|NCT02477670|451313484|FG006|Stage 1|Lost to Follow-up|0|||
125459892|NCT02477670|451313478|FG000|Stage 1|Withdrawal by Subject|1|||
125459893|NCT02477670|451313479|FG001|Stage 1|Withdrawal by Subject|2|||
125459894|NCT02477670|451313480|FG002|Stage 1|Withdrawal by Subject|0|||
125459895|NCT02477670|451313481|FG003|Stage 1|Withdrawal by Subject|0|||
125459896|NCT02477670|451313482|FG004|Stage 1|Withdrawal by Subject|0|||
125459897|NCT02477670|451313483|FG005|Stage 1|Withdrawal by Subject|0|||
125459898|NCT02477670|451313484|FG006|Stage 1|Withdrawal by Subject|0|||
125459899|NCT02477670|451313478|FG000|Stage 1|Non-compliance with Study Drug|1|||
125459900|NCT02477670|451313479|FG001|Stage 1|Non-compliance with Study Drug|2|||
125459901|NCT02477670|451313480|FG002|Stage 1|Non-compliance with Study Drug|0|||
125459902|NCT02477670|451313481|FG003|Stage 1|Non-compliance with Study Drug|0|||
125459903|NCT02477670|451313482|FG004|Stage 1|Non-compliance with Study Drug|0|||
125459904|NCT02477670|451313483|FG005|Stage 1|Non-compliance with Study Drug|0|||
125459905|NCT02477670|451313484|FG006|Stage 1|Non-compliance with Study Drug|0|||
125459906|NCT02477670|451313478|FG000|Stage 2|Adverse Event|0|||
125459907|NCT02477670|451313479|FG001|Stage 2|Adverse Event|0|||
125459908|NCT02477670|451313480|FG002|Stage 2|Adverse Event|1|||
125459909|NCT02477670|451313481|FG003|Stage 2|Adverse Event|0|||
125459910|NCT02477670|451313482|FG004|Stage 2|Adverse Event|0|||
125459911|NCT02477670|451313483|FG005|Stage 2|Adverse Event|0|||
125459912|NCT02477670|451313484|FG006|Stage 2|Adverse Event|0|||
125459913|NCT02477670|451313478|FG000|Stage 2|Antipsychotic Medication Changed|0|||
125459914|NCT02477670|451313479|FG001|Stage 2|Antipsychotic Medication Changed|0|||
125459915|NCT02477670|451313480|FG002|Stage 2|Antipsychotic Medication Changed|1|||
125459916|NCT02477670|451313481|FG003|Stage 2|Antipsychotic Medication Changed|0|||
125459917|NCT02477670|451313482|FG004|Stage 2|Antipsychotic Medication Changed|0|||
125459918|NCT02477670|451313483|FG005|Stage 2|Antipsychotic Medication Changed|0|||
125459919|NCT02477670|451313484|FG006|Stage 2|Antipsychotic Medication Changed|0|||
125459920|NCT02477670|451313478|FG000|Stage 2|Withdrawal by Subject|0|||
125459921|NCT02477670|451313479|FG001|Stage 2|Withdrawal by Subject|0|||
125459922|NCT02477670|451313480|FG002|Stage 2|Withdrawal by Subject|0|||
125459923|NCT02477670|451313481|FG003|Stage 2|Withdrawal by Subject|1|||
125459924|NCT02477670|451313482|FG004|Stage 2|Withdrawal by Subject|0|||
125459925|NCT02477670|451313483|FG005|Stage 2|Withdrawal by Subject|0|||
125459926|NCT02477670|451313484|FG006|Stage 2|Withdrawal by Subject|0|||
125459927|NCT00004124|451313488|FG000|Overall Study|Received no protocol therapy|12|||
125459928|NCT00004124|451313489|FG001|Overall Study|Received no protocol therapy|20|||
125295412|NCT04428151|450709431|FG000|Overall Study|Withdrawal by Subject|2|||
125295413|NCT04428151|450709432|FG001|Overall Study|Withdrawal by Subject|2|||
125295414|NCT04428151|450709433|FG002|Overall Study|Withdrawal by Subject|3|||
125295415|NCT04428151|450709431|FG000|Overall Study|Participant Ongoing in Study|41|||
125459929|NCT00446550|451313490|FG000|Overall Study|Adverse Event|1|||
125459930|NCT00446550|451313491|FG001|Overall Study|Adverse Event|0|||
125459931|NCT02937831|451313492|FG000|Overall Study|Protocol Violation|4|||
125459932|NCT03287622|451313497|FG000|Overall Study|Withdrawal by Subject|1|||
125459933|NCT03287622|451313498|FG001|Overall Study|Withdrawal by Subject|0|||
125459934|NCT03287622|451313497|FG000|Overall Study|Lost to Follow-up|27|||
125459935|NCT03287622|451313498|FG001|Overall Study|Lost to Follow-up|15|||
125459936|NCT03287622|451313497|FG000|Overall Study|No prescripion after surgery|28|||
125459937|NCT03287622|451313498|FG001|Overall Study|No prescripion after surgery|31|||
125459938|NCT03287622|451313497|FG000|Overall Study|prolonged Length of stay|2|||
125459939|NCT03287622|451313498|FG001|Overall Study|prolonged Length of stay|0|||
125459940|NCT03287622|451313497|FG000|Overall Study|surgery related|0|||
125459941|NCT03287622|451313498|FG001|Overall Study|surgery related|2|||
125459942|NCT03823300|451313499|FG000|Overall Study|Withdrawal by Subject|16|||
125459943|NCT03823300|451313500|FG001|Overall Study|Withdrawal by Subject|22|||
125459944|NCT03823300|451313499|FG000|Overall Study|Death|10|||
125459945|NCT03823300|451313500|FG001|Overall Study|Death|14|||
125459946|NCT03823300|451313499|FG000|Overall Study|Adverse Event|3|||
125459947|NCT03823300|451313500|FG001|Overall Study|Adverse Event|5|||
125459948|NCT03823300|451313499|FG000|Overall Study|Physician Decision|1|||
125459949|NCT03823300|451313500|FG001|Overall Study|Physician Decision|7|||
125459950|NCT03823300|451313499|FG000|Overall Study|Lost to Follow-up|1|||
125459951|NCT03823300|451313500|FG001|Overall Study|Lost to Follow-up|3|||
125459952|NCT03823300|451313499|FG000|Overall Study|Protocol Violation|1|||
125459953|NCT03823300|451313500|FG001|Overall Study|Protocol Violation|1|||
125459954|NCT03823300|451313499|FG000|Overall Study|Lack of Efficacy|1|||
125459955|NCT03823300|451313500|FG001|Overall Study|Lack of Efficacy|1|||
125459956|NCT03823300|451313499|FG000|Overall Study|Not Eligible|0|||
125459957|NCT03823300|451313500|FG001|Overall Study|Not Eligible|1|||
125459958|NCT03823300|451313499|FG000|Overall Study|Other|1|||
125459959|NCT03823300|451313500|FG001|Overall Study|Other|0|||
125459960|NCT00507689|451313503|FG000|Pre-Randomization Period|Adverse Event|1|||
125459961|NCT00507689|451313504|FG001|Pre-Randomization Period|Adverse Event|0|||
125459962|NCT00507689|451313503|FG000|Pre-Randomization Period|Physician Decision|1|||
125459963|NCT00507689|451313504|FG001|Pre-Randomization Period|Physician Decision|0|||
125459964|NCT00507689|451313503|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
125459965|NCT00507689|451313504|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
125459966|NCT00507689|451313503|FG000|Randomized Period|Adverse Event|1|||
125459967|NCT00507689|451313504|FG001|Randomized Period|Adverse Event|1|||
125459968|NCT00507689|451313503|FG000|Randomized Period|Withdrawal by Subject|0|||
125459969|NCT00507689|451313504|FG001|Randomized Period|Withdrawal by Subject|1|||
125459970|NCT01786564|451313505|FG000|Overall Study|Lost to Follow-up|47|||
125459971|NCT01786564|451313505|FG000|Overall Study|Ineligible|17|||
125459972|NCT03184558|451313506|FG000|Overall Study|Withdrawal by Subject|2|||
125459973|NCT03184558|451313506|FG000|Overall Study|Death|16|||
125459974|NCT03184558|451313506|FG000|Overall Study|Lost to Follow-up|2|||
125459975|NCT03184558|451313506|FG000|Overall Study|Other|9|||
125459976|NCT02506257|451313507|FG000|Overall Study|Adverse Event|0|||
125459977|NCT02506257|451313508|FG001|Overall Study|Adverse Event|2|||
125459978|NCT02506257|451313509|FG002|Overall Study|Adverse Event|3|||
125459979|NCT02506257|451313510|FG003|Overall Study|Adverse Event|0|||
125459980|NCT02506257|451313507|FG000|Overall Study|Protocol Violation|0|||
125459981|NCT02506257|451313508|FG001|Overall Study|Protocol Violation|0|||
125459982|NCT02506257|451313509|FG002|Overall Study|Protocol Violation|1|||
125459983|NCT02506257|451313510|FG003|Overall Study|Protocol Violation|0|||
125459984|NCT01924767|451313513|FG000|Overall Study|Adverse Event|1|||
125459985|NCT01924767|451313514|FG001|Overall Study|Adverse Event|0|||
125459986|NCT01924767|451313515|FG002|Overall Study|Adverse Event|1|||
125459987|NCT01924767|451313516|FG003|Overall Study|Adverse Event|0|||
125459988|NCT01924767|451313517|FG004|Overall Study|Adverse Event|0|||
125459989|NCT00723450|451313518|FG000|Open-Label Phase|Adverse Event|26|||
125459990|NCT00723450|451313519|FG001|Open-Label Phase|Adverse Event|0|||
125459991|NCT00723450|451313520|FG002|Open-Label Phase|Adverse Event|0|||
125459992|NCT00723450|451313518|FG000|Open-Label Phase|Lack of Efficacy|18|||
125459993|NCT00723450|451313519|FG001|Open-Label Phase|Lack of Efficacy|0|||
125459994|NCT00723450|451313520|FG002|Open-Label Phase|Lack of Efficacy|0|||
125459995|NCT00723450|451313518|FG000|Open-Label Phase|Protocol Violation|35|||
125459996|NCT00723450|451313519|FG001|Open-Label Phase|Protocol Violation|0|||
125459997|NCT00723450|451313520|FG002|Open-Label Phase|Protocol Violation|0|||
125459998|NCT00723450|451313518|FG000|Open-Label Phase|Lost to Follow-up|7|||
125459999|NCT00723450|451313519|FG001|Open-Label Phase|Lost to Follow-up|0|||
125460000|NCT00723450|451313520|FG002|Open-Label Phase|Lost to Follow-up|0|||
125460001|NCT00723450|451313518|FG000|Open-Label Phase|Physician Decision|2|||
125460002|NCT00723450|451313519|FG001|Open-Label Phase|Physician Decision|0|||
125460003|NCT00723450|451313520|FG002|Open-Label Phase|Physician Decision|0|||
125460004|NCT00723450|451313518|FG000|Open-Label Phase|Withdrawal by Subject|37|||
125460005|NCT00723450|451313519|FG001|Open-Label Phase|Withdrawal by Subject|0|||
125460006|NCT00723450|451313520|FG002|Open-Label Phase|Withdrawal by Subject|0|||
125460007|NCT00723450|451313518|FG000|Randomized Phase|Adverse Event|0|||
125460008|NCT00723450|451313519|FG001|Randomized Phase|Adverse Event|26|||
125460009|NCT00723450|451313520|FG002|Randomized Phase|Adverse Event|17|||
125460010|NCT00723450|451313518|FG000|Randomized Phase|Lack of Efficacy|0|||
125460011|NCT00723450|451313519|FG001|Randomized Phase|Lack of Efficacy|11|||
125460012|NCT00723450|451313520|FG002|Randomized Phase|Lack of Efficacy|11|||
125460013|NCT00723450|451313518|FG000|Randomized Phase|Protocol Violation|0|||
125460014|NCT00723450|451313519|FG001|Randomized Phase|Protocol Violation|9|||
125460015|NCT00723450|451313520|FG002|Randomized Phase|Protocol Violation|13|||
125460016|NCT00723450|451313518|FG000|Randomized Phase|Lost to Follow-up|0|||
125460017|NCT00723450|451313519|FG001|Randomized Phase|Lost to Follow-up|2|||
125460018|NCT00723450|451313520|FG002|Randomized Phase|Lost to Follow-up|3|||
125460019|NCT00723450|451313518|FG000|Randomized Phase|Physician Decision|0|||
125460020|NCT00723450|451313519|FG001|Randomized Phase|Physician Decision|3|||
125460021|NCT00723450|451313520|FG002|Randomized Phase|Physician Decision|1|||
125460022|NCT00723450|451313518|FG000|Randomized Phase|Withdrawal by Subject|0|||
125460023|NCT00723450|451313519|FG001|Randomized Phase|Withdrawal by Subject|14|||
125460024|NCT00723450|451313520|FG002|Randomized Phase|Withdrawal by Subject|22|||
125460025|NCT00612586|451313521|FG000|Overall Study|Adverse Event|6|||
125460026|NCT00612586|451313522|FG001|Overall Study|Adverse Event|2|||
125460027|NCT00612586|451313521|FG000|Overall Study|Death|1|||
125460028|NCT00612586|451313522|FG001|Overall Study|Death|0|||
125460029|NCT00612586|451313521|FG000|Overall Study|Entry Criteria Not Met|0|||
125460030|NCT00612586|451313522|FG001|Overall Study|Entry Criteria Not Met|2|||
125460031|NCT00612586|451313521|FG000|Overall Study|Withdrawal by Subject|7|||
125460032|NCT00612586|451313522|FG001|Overall Study|Withdrawal by Subject|9|||
125460033|NCT00612586|451313521|FG000|Overall Study|Physician Decision|1|||
125460034|NCT00612586|451313522|FG001|Overall Study|Physician Decision|2|||
125460035|NCT00612586|451313521|FG000|Overall Study|Sponsor Decision|1|||
125460036|NCT00612586|451313522|FG001|Overall Study|Sponsor Decision|1|||
125460037|NCT00612586|451313521|FG000|Overall Study|Progressive Disease|26|||
125460038|NCT00612586|451313522|FG001|Overall Study|Progressive Disease|24|||
125460039|NCT00612586|451313521|FG000|Overall Study|Randomized and Not Treated|1|||
125460040|NCT00612586|451313522|FG001|Overall Study|Randomized and Not Treated|1|||
125460041|NCT03192046|451313523|FG000|Overall Study|Withdrawal by Subject|1|||
125460042|NCT03192046|451313524|FG001|Overall Study|Withdrawal by Subject|1|||
125460043|NCT00762606|451313525|FG000|Overall Study|Lost to Follow-up|18|||
125460044|NCT00762606|451313526|FG001|Overall Study|Lost to Follow-up|13|||
125460045|NCT01194154|451313527|FG000|Overall Study|Adverse Event|12|||
125460046|NCT01194154|451313528|FG001|Overall Study|Adverse Event|7|||
125460047|NCT01194154|451313527|FG000|Overall Study|Lost to Follow-up|2|||
125460048|NCT01194154|451313528|FG001|Overall Study|Lost to Follow-up|3|||
125460049|NCT01194154|451313527|FG000|Overall Study|Protocol Violation|0|||
125460050|NCT01194154|451313528|FG001|Overall Study|Protocol Violation|1|||
125460051|NCT01194154|451313527|FG000|Overall Study|Withdrawal by Subject|5|||
125460052|NCT01194154|451313528|FG001|Overall Study|Withdrawal by Subject|6|||
125460053|NCT01194154|451313527|FG000|Overall Study|Blood pressure increase|5|||
125460054|NCT01194154|451313528|FG001|Overall Study|Blood pressure increase|3|||
125460055|NCT01194154|451313527|FG000|Overall Study|Hemoglobin decrease|0|||
125460056|NCT01194154|451313528|FG001|Overall Study|Hemoglobin decrease|1|||
125460057|NCT01194154|451313527|FG000|Overall Study|Hemoglobin increase|12|||
125460058|NCT01194154|451313528|FG001|Overall Study|Hemoglobin increase|3|||
125460059|NCT01194154|451313527|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
125460060|NCT01194154|451313528|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
125460061|NCT01194154|451313527|FG000|Overall Study|Treatment with prohibited medication|4|||
125460062|NCT01194154|451313528|FG001|Overall Study|Treatment with prohibited medication|5|||
125460063|NCT01194154|451313527|FG000|Overall Study|Other|4|||
125460064|NCT01194154|451313528|FG001|Overall Study|Other|0|||
125460065|NCT01194154|451313527|FG000|Overall Study|Did not receive study medication|2|||
125460066|NCT01194154|451313528|FG001|Overall Study|Did not receive study medication|4|||
125460067|NCT01909336|451313529|FG000|Overall Study|Lost to Follow-up|4|||
125460068|NCT01909336|451313530|FG001|Overall Study|Lost to Follow-up|2|||
125460069|NCT01909336|451313531|FG002|Overall Study|Lost to Follow-up|2|||
125460070|NCT01909336|451313529|FG000|Overall Study|Physician Decision|0|||
125460071|NCT01909336|451313530|FG001|Overall Study|Physician Decision|1|||
125460072|NCT01909336|451313531|FG002|Overall Study|Physician Decision|1|||
125460073|NCT01505881|451313532|FG000|Overall Study|Adverse Event|0|||
125460074|NCT01505881|451313533|FG001|Overall Study|Adverse Event|1|||
125460075|NCT01505881|451313532|FG000|Overall Study|Lost to Follow-up|2|||
125460076|NCT01505881|451313533|FG001|Overall Study|Lost to Follow-up|0|||
125460077|NCT01505881|451313532|FG000|Overall Study|Withdrawal by Subject|2|||
125460078|NCT01505881|451313533|FG001|Overall Study|Withdrawal by Subject|0|||
125460079|NCT00842257|451313534|FG000|Overall Study|Adverse Event|1|||
125460080|NCT00395018|451313535|FG000|On-Treatment|Death|4|||
125460081|NCT00395018|451313535|FG000|On-Treatment|Other Reason|2|||
125460082|NCT00395018|451313535|FG000|On-Treatment|Poor/non-compliance|2|||
125460083|NCT00395018|451313535|FG000|On-Treatment|Subject no longer meets study criteria|2|||
125460084|NCT00395018|451313535|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
125460085|NCT00395018|451313535|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
125295416|NCT04428151|450709432|FG001|Overall Study|Participant Ongoing in Study|53|||
125295417|NCT04428151|450709433|FG002|Overall Study|Participant Ongoing in Study|28|||
125460086|NCT00395018|451313535|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
125460087|NCT02314117|451313536|FG000|Overall Study|Lost to Follow-up|9|||
125460088|NCT02314117|451313537|FG001|Overall Study|Lost to Follow-up|14|||
125460089|NCT02314117|451313536|FG000|Overall Study|Withdrawal by Subject|3|||
125460090|NCT02314117|451313537|FG001|Overall Study|Withdrawal by Subject|2|||
125460091|NCT02026258|451313538|FG000|Randomized|Did not start treatment|2|||
125460092|NCT02026258|451313539|FG001|Randomized|Did not start treatment|1|||
125460093|NCT02026258|451313538|FG000|Randomized|Change in treatment plan|1|||
125460094|NCT02026258|451313539|FG001|Randomized|Change in treatment plan|0|||
125460095|NCT02026258|451313538|FG000|Randomized|Presence of periodontal disease|1|||
125460096|NCT02026258|451313539|FG001|Randomized|Presence of periodontal disease|1|||
125460097|NCT02026258|451313538|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
125460098|NCT02026258|451313539|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
125460099|NCT02026258|451313538|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
125460100|NCT02026258|451313539|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
125460101|NCT04439799|451313540|FG000|Overall Study|Lost to Follow-up|6|||
125460102|NCT04439799|451313541|FG001|Overall Study|Lost to Follow-up|6|||
125460103|NCT04439799|451313540|FG000|Overall Study|Withdrawal by Subject|2|||
125460104|NCT04439799|451313541|FG001|Overall Study|Withdrawal by Subject|6|||
125460105|NCT04439799|451313540|FG000|Overall Study|Adverse Event|2|||
125460106|NCT04439799|451313541|FG001|Overall Study|Adverse Event|5|||
125460107|NCT00530842|451313547|FG000|Overall Study|Adverse Event|10|||
125460108|NCT00530842|451313548|FG001|Overall Study|Adverse Event|6|||
125460109|NCT00530842|451313547|FG000|Overall Study|Lack of Efficacy|2|||
125460110|NCT00530842|451313548|FG001|Overall Study|Lack of Efficacy|1|||
125460111|NCT00530842|451313547|FG000|Overall Study|Lost to Follow-up|0|||
125460112|NCT00530842|451313548|FG001|Overall Study|Lost to Follow-up|4|||
125460113|NCT00530842|451313547|FG000|Overall Study|Protocol Violation|3|||
125460114|NCT00530842|451313548|FG001|Overall Study|Protocol Violation|2|||
125460115|NCT00530842|451313547|FG000|Overall Study|Withdrawal by Subject|4|||
125460116|NCT00530842|451313548|FG001|Overall Study|Withdrawal by Subject|5|||
125460117|NCT00530842|451313547|FG000|Overall Study|Individual different reasons|4|||
125460118|NCT00530842|451313548|FG001|Overall Study|Individual different reasons|3|||
125460119|NCT00530842|451313547|FG000|Period 1|Adverse Event|7|||
125460120|NCT00530842|451313548|FG001|Period 1|Adverse Event|3|||
125460121|NCT00530842|451313547|FG000|Period 1|Lack of Efficacy|1|||
125460122|NCT00530842|451313548|FG001|Period 1|Lack of Efficacy|1|||
125460123|NCT00530842|451313547|FG000|Period 1|Protocol Violation|2|||
125460124|NCT00530842|451313548|FG001|Period 1|Protocol Violation|1|||
125460125|NCT00530842|451313547|FG000|Period 1|Withdrawal by Subject|2|||
125460126|NCT00530842|451313548|FG001|Period 1|Withdrawal by Subject|3|||
125460127|NCT00530842|451313547|FG000|Period 1|Individual different reasons|2|||
125460128|NCT00530842|451313548|FG001|Period 1|Individual different reasons|3|||
125460129|NCT00530842|451313547|FG000|Period 2|Adverse Event|3|||
125460130|NCT00530842|451313548|FG001|Period 2|Adverse Event|3|||
125460131|NCT00530842|451313547|FG000|Period 2|Lack of Efficacy|1|||
125460132|NCT00530842|451313548|FG001|Period 2|Lack of Efficacy|0|||
125460133|NCT00530842|451313547|FG000|Period 2|Lost to Follow-up|0|||
125460134|NCT00530842|451313548|FG001|Period 2|Lost to Follow-up|4|||
125460135|NCT00530842|451313547|FG000|Period 2|Protocol Violation|1|||
125460136|NCT00530842|451313548|FG001|Period 2|Protocol Violation|0|||
125460137|NCT00530842|451313547|FG000|Period 2|Withdrawal by Subject|1|||
125460138|NCT00530842|451313548|FG001|Period 2|Withdrawal by Subject|2|||
125460139|NCT00530842|451313547|FG000|Period 2|Individual different reasons|2|||
125460140|NCT00530842|451313548|FG001|Period 2|Individual different reasons|0|||
125460141|NCT02534350|451313549|FG000|Overall Study|Randomized But Not Treated|1|||
125460142|NCT02534350|451313550|FG001|Overall Study|Randomized But Not Treated|0|||
125460143|NCT02534350|451313549|FG000|Overall Study|Protocol Violation|1|||
125460144|NCT02534350|451313550|FG001|Overall Study|Protocol Violation|0|||
125460145|NCT02534350|451313549|FG000|Overall Study|Withdrew Consent|2|||
125460146|NCT02534350|451313550|FG001|Overall Study|Withdrew Consent|0|||
125460147|NCT00346151|451313560|FG000|Overall Study|Withdrawal by Subject|3|||
125460148|NCT00790790|451313570|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
125460149|NCT00790790|451313571|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
125460150|NCT00790790|451313572|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
125460151|NCT00790790|451313570|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
125460152|NCT00790790|451313571|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
125460153|NCT00790790|451313572|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
125460154|NCT00790790|451313570|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
125460155|NCT00790790|451313571|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
125460156|NCT00790790|451313572|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
125460157|NCT00790790|451313570|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
125460158|NCT00790790|451313571|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
125460159|NCT00790790|451313572|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
125460160|NCT00790790|451313570|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
125460161|NCT00790790|451313571|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
125460162|NCT00790790|451313572|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
125460163|NCT02570711|451313573|FG000|Overall Study|Death|1|||
125460164|NCT02570711|451313574|FG001|Overall Study|Death|0|||
125460165|NCT02570711|451313573|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
125460166|NCT02570711|451313574|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
125460167|NCT02798835|451313575|FG000|Overall Study|Protocol Violation|0|||
125460168|NCT02798835|451313576|FG001|Overall Study|Protocol Violation|0|||
125460169|NCT02798835|451313577|FG002|Overall Study|Protocol Violation|3|||
125460170|NCT03070483|451313579|FG000|Overall Study|Lost to Follow-up|2|||
125460171|NCT01585558|451313582|FG000|Overall Study|Withdrawal by Subject|4|||
125460172|NCT01585558|451313583|FG001|Overall Study|Withdrawal by Subject|5|||
125460173|NCT01585558|451313584|FG002|Overall Study|Withdrawal by Subject|8|||
125460174|NCT01585558|451313582|FG000|Overall Study|Lost to Follow-up|2|||
125460175|NCT01585558|451313583|FG001|Overall Study|Lost to Follow-up|0|||
125460176|NCT01585558|451313584|FG002|Overall Study|Lost to Follow-up|3|||
125460177|NCT01585558|451313582|FG000|Overall Study|Adverse Event|3|||
125460178|NCT01585558|451313583|FG001|Overall Study|Adverse Event|4|||
125460179|NCT01585558|451313584|FG002|Overall Study|Adverse Event|1|||
125460180|NCT01585558|451313582|FG000|Overall Study|Protocol Violation|4|||
125460181|NCT01585558|451313583|FG001|Overall Study|Protocol Violation|3|||
125460182|NCT01585558|451313584|FG002|Overall Study|Protocol Violation|2|||
125460183|NCT01585558|451313582|FG000|Overall Study|Lack of Efficacy|0|||
125460184|NCT01585558|451313583|FG001|Overall Study|Lack of Efficacy|0|||
125460185|NCT01585558|451313584|FG002|Overall Study|Lack of Efficacy|1|||
125460186|NCT00094575|451313590|FG000|Overall Study|Death|146|||
125460187|NCT00094575|451313591|FG001|Overall Study|Death|146|||
125460188|NCT01390402|451313592|FG000|Overall Study|Death|1|||
125460189|NCT01390402|451313592|FG000|Overall Study|Disease Progression|4|||
125460190|NCT04513522|451316248|FG000|Overall Study|Other reasons|1|||
125460191|NCT04513522|451316248|FG000|Overall Study|Adverse event unrelated to study drug|9|||
125460192|NCT04513522|451316248|FG000|Overall Study|Study drug toxicity|14|||
125460193|NCT04513522|451316248|FG000|Overall Study|Disease progression|39|||
125460194|NCT04513522|451316248|FG000|Overall Study|Participants withdrew consent|2|||
125460195|NCT00589667|451316249|FG000|Overall Study|Adverse Event|2|||
125460196|NCT00589667|451316249|FG000|Overall Study|Withdrawal by Subject|1|||
125460197|NCT03538041|451316252|FG000|12-Week Treatment Period|Adverse Event|1|||
125460198|NCT03538041|451316253|FG001|12-Week Treatment Period|Adverse Event|1|||
125460199|NCT03538041|451316252|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
125460200|NCT03538041|451316253|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
125460201|NCT03538041|451316252|FG000|Treatment Extension Period|Adverse Event|4|||
125460202|NCT03538041|451316253|FG001|Treatment Extension Period|Adverse Event|1|||
125460203|NCT03538041|451316252|FG000|Treatment Extension Period|Physician Decision|1|||
125460204|NCT03538041|451316253|FG001|Treatment Extension Period|Physician Decision|1|||
125460205|NCT03538041|451316252|FG000|Treatment Extension Period|Lack of Efficacy|1|||
125460206|NCT03538041|451316253|FG001|Treatment Extension Period|Lack of Efficacy|4|||
125460207|NCT03538041|451316252|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
125460208|NCT03538041|451316253|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
125460209|NCT03538041|451316252|FG000|Treatment Extension Period|Death|0|||
125460210|NCT03538041|451316253|FG001|Treatment Extension Period|Death|1|||
125460211|NCT02296424|451316256|FG000|Part 1|New therapy for study indication|0|||
125460212|NCT02296424|451316257|FG001|Part 1|New therapy for study indication|1|||
125460213|NCT02296424|451316258|FG002|Part 1|New therapy for study indication|0|||
125460214|NCT02296424|451316259|FG003|Part 1|New therapy for study indication|0|||
125460215|NCT02296424|451316256|FG000|Part 1|Protocol Violation|0|||
125460216|NCT02296424|451316257|FG001|Part 1|Protocol Violation|1|||
125460217|NCT02296424|451316258|FG002|Part 1|Protocol Violation|0|||
125460218|NCT02296424|451316259|FG003|Part 1|Protocol Violation|0|||
125460219|NCT02296424|451316256|FG000|Part 1|Withdrawal by Subject|0|||
125460220|NCT02296424|451316257|FG001|Part 1|Withdrawal by Subject|2|||
125460221|NCT02296424|451316258|FG002|Part 1|Withdrawal by Subject|0|||
125460222|NCT02296424|451316259|FG003|Part 1|Withdrawal by Subject|0|||
125460223|NCT02296424|451316256|FG000|Part 1|Study terminated by sponsor|0|||
125460224|NCT02296424|451316257|FG001|Part 1|Study terminated by sponsor|1|||
125460225|NCT02296424|451316258|FG002|Part 1|Study terminated by sponsor|0|||
125460226|NCT02296424|451316259|FG003|Part 1|Study terminated by sponsor|0|||
125460227|NCT02296424|451316256|FG000|Part 1|Adverse Event|2|||
125460228|NCT02296424|451316257|FG001|Part 1|Adverse Event|11|||
125460229|NCT02296424|451316258|FG002|Part 1|Adverse Event|0|||
125460230|NCT02296424|451316259|FG003|Part 1|Adverse Event|0|||
125460231|NCT02296424|451316256|FG000|Part 1|Lack of Efficacy|5|||
125460232|NCT02296424|451316257|FG001|Part 1|Lack of Efficacy|17|||
125460233|NCT02296424|451316258|FG002|Part 1|Lack of Efficacy|0|||
125460234|NCT02296424|451316259|FG003|Part 1|Lack of Efficacy|0|||
125460235|NCT02296424|451316256|FG000|Part 1|16 directly started part II|16|||
125460236|NCT02296424|451316257|FG001|Part 1|16 directly started part II|0|||
125460237|NCT02296424|451316258|FG002|Part 1|16 directly started part II|0|||
125460238|NCT02296424|451316259|FG003|Part 1|16 directly started part II|0|||
125460239|NCT02296424|451316256|FG000|Part 2|Lack of Efficacy|0|||
125460240|NCT02296424|451316257|FG001|Part 2|Lack of Efficacy|0|||
125460241|NCT02296424|451316258|FG002|Part 2|Lack of Efficacy|1|||
125460242|NCT02296424|451316259|FG003|Part 2|Lack of Efficacy|0|||
125460243|NCT02296424|451316256|FG000|Part 2|Adverse Event|0|||
125460244|NCT02296424|451316257|FG001|Part 2|Adverse Event|0|||
125460245|NCT02296424|451316258|FG002|Part 2|Adverse Event|1|||
125460246|NCT02296424|451316259|FG003|Part 2|Adverse Event|0|||
125460247|NCT02296424|451316256|FG000|Part 2|Lost to Follow-up|0|||
125460248|NCT02296424|451316257|FG001|Part 2|Lost to Follow-up|0|||
125460249|NCT02296424|451316258|FG002|Part 2|Lost to Follow-up|1|||
125460250|NCT02296424|451316259|FG003|Part 2|Lost to Follow-up|0|||
125460251|NCT00807144|451316262|FG000|Overall Study|Lost to Follow-up|0|||
125460252|NCT00807144|451316263|FG001|Overall Study|Lost to Follow-up|1|||
125460253|NCT01307267|451316264|FG000|Overall Study|Death|4|||
125460254|NCT01307267|451316265|FG001|Overall Study|Death|3|||
125460255|NCT01307267|451316266|FG002|Overall Study|Death|5|||
125460256|NCT01307267|451316267|FG003|Overall Study|Death|3|||
125460257|NCT01307267|451316268|FG004|Overall Study|Death|1|||
125460258|NCT01307267|451316269|FG005|Overall Study|Death|26|||
125460259|NCT01307267|451316270|FG006|Overall Study|Death|2|||
125460260|NCT01307267|451316271|FG007|Overall Study|Death|2|||
125460261|NCT01307267|451316272|FG008|Overall Study|Death|21|||
125460262|NCT01307267|451316273|FG009|Overall Study|Death|2|||
125460263|NCT01307267|451316274|FG010|Overall Study|Death|3|||
125460264|NCT01307267|451316275|FG011|Overall Study|Death|9|||
125460265|NCT01307267|451316276|FG012|Overall Study|Death|0|||
125460266|NCT01307267|451316277|FG013|Overall Study|Death|0|||
125460267|NCT01307267|451316278|FG014|Overall Study|Death|0|||
125460268|NCT01307267|451316279|FG015|Overall Study|Death|0|||
125460269|NCT01307267|451316280|FG016|Overall Study|Death|1|||
125460270|NCT01307267|451316281|FG017|Overall Study|Death|1|||
125460271|NCT01307267|451316282|FG018|Overall Study|Death|2|||
125460272|NCT01307267|451316283|FG019|Overall Study|Death|8|||
125460273|NCT01307267|451316284|FG020|Overall Study|Death|1|||
125460274|NCT01307267|451316285|FG021|Overall Study|Death|2|||
125460275|NCT01307267|451316286|FG022|Overall Study|Death|2|||
125460276|NCT01307267|451316264|FG000|Overall Study|Lost to Follow-up|0|||
125460277|NCT01307267|451316265|FG001|Overall Study|Lost to Follow-up|0|||
125460278|NCT01307267|451316266|FG002|Overall Study|Lost to Follow-up|0|||
125460279|NCT01307267|451316267|FG003|Overall Study|Lost to Follow-up|0|||
125460280|NCT01307267|451316268|FG004|Overall Study|Lost to Follow-up|0|||
125460281|NCT01307267|451316269|FG005|Overall Study|Lost to Follow-up|7|||
125460282|NCT01307267|451316270|FG006|Overall Study|Lost to Follow-up|0|||
125460283|NCT01307267|451316271|FG007|Overall Study|Lost to Follow-up|0|||
125460284|NCT01307267|451316272|FG008|Overall Study|Lost to Follow-up|1|||
125460285|NCT01307267|451316273|FG009|Overall Study|Lost to Follow-up|2|||
125460286|NCT01307267|451316274|FG010|Overall Study|Lost to Follow-up|1|||
125460287|NCT01307267|451316275|FG011|Overall Study|Lost to Follow-up|0|||
125460288|NCT01307267|451316276|FG012|Overall Study|Lost to Follow-up|0|||
125460289|NCT01307267|451316277|FG013|Overall Study|Lost to Follow-up|0|||
125460290|NCT01307267|451316278|FG014|Overall Study|Lost to Follow-up|0|||
125460291|NCT01307267|451316279|FG015|Overall Study|Lost to Follow-up|0|||
125460292|NCT01307267|451316280|FG016|Overall Study|Lost to Follow-up|0|||
125460293|NCT01307267|451316281|FG017|Overall Study|Lost to Follow-up|0|||
125460294|NCT01307267|451316282|FG018|Overall Study|Lost to Follow-up|0|||
125460295|NCT01307267|451316283|FG019|Overall Study|Lost to Follow-up|2|||
125460296|NCT01307267|451316284|FG020|Overall Study|Lost to Follow-up|0|||
125460297|NCT01307267|451316285|FG021|Overall Study|Lost to Follow-up|0|||
125460298|NCT01307267|451316286|FG022|Overall Study|Lost to Follow-up|0|||
125460299|NCT01307267|451316264|FG000|Overall Study|Withdrawal by Subject|0|||
125460300|NCT01307267|451316265|FG001|Overall Study|Withdrawal by Subject|0|||
125460301|NCT01307267|451316266|FG002|Overall Study|Withdrawal by Subject|0|||
125460302|NCT01307267|451316267|FG003|Overall Study|Withdrawal by Subject|0|||
125460303|NCT01307267|451316268|FG004|Overall Study|Withdrawal by Subject|0|||
125460304|NCT01307267|451316269|FG005|Overall Study|Withdrawal by Subject|1|||
125460305|NCT01307267|451316270|FG006|Overall Study|Withdrawal by Subject|0|||
125460306|NCT01307267|451316271|FG007|Overall Study|Withdrawal by Subject|1|||
125460307|NCT01307267|451316272|FG008|Overall Study|Withdrawal by Subject|5|||
125460308|NCT01307267|451316273|FG009|Overall Study|Withdrawal by Subject|1|||
125460309|NCT01307267|451316274|FG010|Overall Study|Withdrawal by Subject|1|||
125460310|NCT01307267|451316275|FG011|Overall Study|Withdrawal by Subject|1|||
125460311|NCT01307267|451316276|FG012|Overall Study|Withdrawal by Subject|0|||
125460312|NCT01307267|451316277|FG013|Overall Study|Withdrawal by Subject|0|||
125460313|NCT01307267|451316278|FG014|Overall Study|Withdrawal by Subject|0|||
125460314|NCT01307267|451316279|FG015|Overall Study|Withdrawal by Subject|0|||
125460315|NCT01307267|451316280|FG016|Overall Study|Withdrawal by Subject|0|||
125460316|NCT01307267|451316281|FG017|Overall Study|Withdrawal by Subject|0|||
125295418|NCT02704689|450709434|FG000|Overall Study|Physician Decision|1|||
125295419|NCT02704689|450709434|FG000|Overall Study|Study device not implanted|2|||
125295420|NCT02212678|450709437|FG000|Overall Study|Adverse Event|1|||
125295421|NCT02337634|450709438|FG000|Overall Study|Protocol Violation|3|||
125295422|NCT02337634|450709439|FG001|Overall Study|Protocol Violation|1|||
125460317|NCT01307267|451316282|FG018|Overall Study|Withdrawal by Subject|0|||
125460318|NCT01307267|451316283|FG019|Overall Study|Withdrawal by Subject|3|||
125460319|NCT01307267|451316284|FG020|Overall Study|Withdrawal by Subject|0|||
125460320|NCT01307267|451316285|FG021|Overall Study|Withdrawal by Subject|0|||
125460321|NCT01307267|451316286|FG022|Overall Study|Withdrawal by Subject|0|||
125295423|NCT02337634|450709438|FG000|Overall Study|Lost to Follow-up|1|||
125295424|NCT02337634|450709439|FG001|Overall Study|Lost to Follow-up|0|||
125460322|NCT01307267|451316264|FG000|Overall Study|Other|0|||
125460323|NCT01307267|451316265|FG001|Overall Study|Other|0|||
125460324|NCT01307267|451316266|FG002|Overall Study|Other|0|||
125460325|NCT01307267|451316267|FG003|Overall Study|Other|0|||
125460326|NCT01307267|451316268|FG004|Overall Study|Other|0|||
125460327|NCT01307267|451316269|FG005|Overall Study|Other|7|||
125460328|NCT01307267|451316270|FG006|Overall Study|Other|0|||
125295425|NCT04068610|450709440|FG000|Overall Study|Death|4|||
125295426|NCT04068610|450709441|FG001|Overall Study|Death|8|||
125460329|NCT01307267|451316271|FG007|Overall Study|Other|1|||
125460330|NCT01307267|451316272|FG008|Overall Study|Other|3|||
125460331|NCT01307267|451316273|FG009|Overall Study|Other|0|||
125460332|NCT01307267|451316274|FG010|Overall Study|Other|1|||
125460333|NCT01307267|451316275|FG011|Overall Study|Other|1|||
125460334|NCT01307267|451316276|FG012|Overall Study|Other|1|||
125460335|NCT01307267|451316277|FG013|Overall Study|Other|0|||
125460336|NCT01307267|451316278|FG014|Overall Study|Other|2|||
125460337|NCT01307267|451316279|FG015|Overall Study|Other|1|||
125460338|NCT01307267|451316280|FG016|Overall Study|Other|0|||
125460339|NCT01307267|451316281|FG017|Overall Study|Other|0|||
125460340|NCT01307267|451316282|FG018|Overall Study|Other|0|||
125460341|NCT01307267|451316283|FG019|Overall Study|Other|19|||
125460342|NCT01307267|451316284|FG020|Overall Study|Other|2|||
125460343|NCT01307267|451316285|FG021|Overall Study|Other|3|||
125460344|NCT01307267|451316286|FG022|Overall Study|Other|2|||
125460345|NCT05174013|451316289|FG000|Overall Study|Lost to Follow-up|0|||
125460346|NCT05174013|451316290|FG001|Overall Study|Lost to Follow-up|0|||
125460347|NCT05174013|451316291|FG002|Overall Study|Lost to Follow-up|0|||
125460348|NCT05174013|451316292|FG003|Overall Study|Lost to Follow-up|1|||
125460349|NCT05174013|451316293|FG004|Overall Study|Lost to Follow-up|0|||
125460350|NCT05174013|451316294|FG005|Overall Study|Lost to Follow-up|0|||
125460351|NCT05174013|451316289|FG000|Overall Study|Withdrawal by Subject|0|||
125460352|NCT05174013|451316290|FG001|Overall Study|Withdrawal by Subject|0|||
125460353|NCT05174013|451316291|FG002|Overall Study|Withdrawal by Subject|1|||
125460354|NCT05174013|451316292|FG003|Overall Study|Withdrawal by Subject|0|||
125460355|NCT05174013|451316293|FG004|Overall Study|Withdrawal by Subject|0|||
125460356|NCT05174013|451316294|FG005|Overall Study|Withdrawal by Subject|0|||
125460357|NCT04956575|451316295|FG000|Overall Study|Death|1|||
125460358|NCT04956575|451316296|FG001|Overall Study|Death|0|||
125460359|NCT04956575|451316297|FG002|Overall Study|Death|0|||
125460360|NCT04956575|451316298|FG003|Overall Study|Death|0|||
125460361|NCT04956575|451316299|FG004|Overall Study|Death|0|||
125460362|NCT04956575|451316300|FG005|Overall Study|Death|0|||
125460363|NCT04956575|451316301|FG006|Overall Study|Death|0|||
125460364|NCT04956575|451316302|FG007|Overall Study|Death|1|||
125460365|NCT04956575|451316303|FG008|Overall Study|Death|0|||
125460366|NCT04956575|451316304|FG009|Overall Study|Death|1|||
125460367|NCT04956575|451316305|FG010|Overall Study|Death|0|||
125460368|NCT04956575|451316306|FG011|Overall Study|Death|0|||
125460369|NCT04956575|451316295|FG000|Overall Study|Lost to Follow-up|3|||
125460370|NCT04956575|451316296|FG001|Overall Study|Lost to Follow-up|4|||
125460371|NCT04956575|451316297|FG002|Overall Study|Lost to Follow-up|2|||
125460372|NCT04956575|451316298|FG003|Overall Study|Lost to Follow-up|3|||
125460373|NCT04956575|451316299|FG004|Overall Study|Lost to Follow-up|1|||
125460374|NCT04956575|451316300|FG005|Overall Study|Lost to Follow-up|10|||
125460375|NCT04956575|451316301|FG006|Overall Study|Lost to Follow-up|11|||
125460376|NCT04956575|451316302|FG007|Overall Study|Lost to Follow-up|7|||
125460377|NCT04956575|451316303|FG008|Overall Study|Lost to Follow-up|4|||
125460378|NCT04956575|451316304|FG009|Overall Study|Lost to Follow-up|2|||
125460379|NCT04956575|451316305|FG010|Overall Study|Lost to Follow-up|3|||
125460380|NCT04956575|451316306|FG011|Overall Study|Lost to Follow-up|8|||
125460381|NCT04956575|451316295|FG000|Overall Study|Withdrawal by Subject|1|||
125460382|NCT04956575|451316296|FG001|Overall Study|Withdrawal by Subject|2|||
125295427|NCT04068610|450709442|FG002|Overall Study|Death|13|||
125295428|NCT04068610|450709440|FG000|Overall Study|Lost to Follow-up|0|||
125295429|NCT04068610|450709441|FG001|Overall Study|Lost to Follow-up|2|||
125295430|NCT04068610|450709442|FG002|Overall Study|Lost to Follow-up|0|||
125295431|NCT04068610|450709440|FG000|Overall Study|Withdrawal by Subject|0|||
125460383|NCT04956575|451316297|FG002|Overall Study|Withdrawal by Subject|1|||
125460384|NCT04956575|451316298|FG003|Overall Study|Withdrawal by Subject|4|||
125460385|NCT04956575|451316299|FG004|Overall Study|Withdrawal by Subject|2|||
125460386|NCT04956575|451316300|FG005|Overall Study|Withdrawal by Subject|8|||
125460387|NCT04956575|451316301|FG006|Overall Study|Withdrawal by Subject|5|||
125460388|NCT04956575|451316302|FG007|Overall Study|Withdrawal by Subject|1|||
125460389|NCT04956575|451316303|FG008|Overall Study|Withdrawal by Subject|1|||
125460390|NCT04956575|451316304|FG009|Overall Study|Withdrawal by Subject|0|||
125460391|NCT04956575|451316305|FG010|Overall Study|Withdrawal by Subject|3|||
125460392|NCT04956575|451316306|FG011|Overall Study|Withdrawal by Subject|1|||
125460393|NCT03593876|451316307|FG000|Overall Study|Withdrawal by Subject|1|||
125295432|NCT04068610|450709441|FG001|Overall Study|Withdrawal by Subject|4|||
125295433|NCT04068610|450709442|FG002|Overall Study|Withdrawal by Subject|2|||
125295434|NCT04068610|450709440|FG000|Overall Study|Other|3|||
125460394|NCT03593876|451316307|FG000|Overall Study|Discharged home before intervention completion|2|||
125460395|NCT00854906|451316313|FG000|Overall Study|One person had no ocular history|1|||
125460396|NCT00486330|451316314|FG000|Overall Study|Adverse Event|2|||
125460397|NCT01290224|451316315|FG000|Overall Study|Adverse Event|1|||
125460398|NCT01290224|451316315|FG000|Overall Study|Refused Further Treatment|4|||
125460399|NCT00346333|451316316|FG000|Overall Study|Death|1|||
125460400|NCT00346333|451316317|FG001|Overall Study|Death|0|||
125295435|NCT04068610|450709441|FG001|Overall Study|Other|12|||
125295436|NCT04068610|450709442|FG002|Overall Study|Other|11|||
125460401|NCT00346333|451316316|FG000|Overall Study|unwilling or unable to continue|4|||
125460402|NCT00346333|451316317|FG001|Overall Study|unwilling or unable to continue|8|||
125460403|NCT00770965|451316321|FG000|Safety Set|Withdrawal by Subject|0|||
125460404|NCT00770965|451316322|FG001|Safety Set|Withdrawal by Subject|0|||
125460405|NCT00770965|451316323|FG002|Safety Set|Withdrawal by Subject|0|||
125460406|NCT00770965|451316324|FG003|Safety Set|Withdrawal by Subject|1|||
125460407|NCT00770965|451316321|FG000|Safety Set|Protocol deviation|0|||
125460408|NCT00770965|451316322|FG001|Safety Set|Protocol deviation|0|||
125460409|NCT00770965|451316323|FG002|Safety Set|Protocol deviation|1|||
125460410|NCT00770965|451316324|FG003|Safety Set|Protocol deviation|0|||
125460411|NCT00770965|451316321|FG000|Excluded Set|Administrative problems|14|||
125460412|NCT00770965|451316322|FG001|Excluded Set|Administrative problems|12|||
125460413|NCT00770965|451316323|FG002|Excluded Set|Administrative problems|12|||
125460414|NCT00770965|451316324|FG003|Excluded Set|Administrative problems|10|||
125460415|NCT00770965|451316321|FG000|Excluded Set|Withdrawal by Subject|1|||
125460416|NCT00770965|451316322|FG001|Excluded Set|Withdrawal by Subject|1|||
125460417|NCT00770965|451316323|FG002|Excluded Set|Withdrawal by Subject|2|||
125460418|NCT00770965|451316324|FG003|Excluded Set|Withdrawal by Subject|3|||
125460419|NCT01391130|451316328|FG000|Overall Study|Withdrawal by Subject|3|||
125460420|NCT01391130|451316329|FG001|Overall Study|Withdrawal by Subject|2|||
125460421|NCT01391130|451316328|FG000|Overall Study|Physician Decision|2|||
125460422|NCT01391130|451316329|FG001|Overall Study|Physician Decision|3|||
125460423|NCT01391130|451316328|FG000|Overall Study|Did not Receive Drug|1|||
125460424|NCT01391130|451316329|FG001|Overall Study|Did not Receive Drug|1|||
125460425|NCT03478696|451316330|FG000|Overall Study|Adverse Event|1|||
125460426|NCT03478696|451316331|FG001|Overall Study|Adverse Event|5|||
125460427|NCT03478696|451316330|FG000|Overall Study|Lost to Follow-up|1|||
125460428|NCT03478696|451316331|FG001|Overall Study|Lost to Follow-up|0|||
125460429|NCT03478696|451316330|FG000|Overall Study|Physician Decision|6|||
125460430|NCT03478696|451316331|FG001|Overall Study|Physician Decision|3|||
125460431|NCT03478696|451316330|FG000|Overall Study|Withdrawal by Subject|9|||
125460432|NCT03478696|451316331|FG001|Overall Study|Withdrawal by Subject|4|||
125460433|NCT03615924|451316332|FG000|Overall Study|Withdrawal by Subject|2|||
125460434|NCT03615924|451316333|FG001|Overall Study|Withdrawal by Subject|5|||
125460435|NCT03615924|451316332|FG000|Overall Study|Death|3|||
125460436|NCT03615924|451316333|FG001|Overall Study|Death|1|||
125460437|NCT03615924|451316332|FG000|Overall Study|Lost to Follow-up|1|||
125460438|NCT03615924|451316333|FG001|Overall Study|Lost to Follow-up|0|||
125460439|NCT03615924|451316332|FG000|Overall Study|Randomized in error|1|||
125295437|NCT02428205|450709443|FG000|Overall Study|Lack of Efficacy|1|||
125295438|NCT02428205|450709444|FG001|Overall Study|Lack of Efficacy|0|||
125295439|NCT02428205|450709443|FG000|Overall Study|Lost to Follow-up|1|||
125295440|NCT02428205|450709444|FG001|Overall Study|Lost to Follow-up|1|||
125295441|NCT02428205|450709443|FG000|Overall Study|Worse behavior|0|||
125295442|NCT02428205|450709444|FG001|Overall Study|Worse behavior|1|||
125295443|NCT00527319|450709445|FG000|Overall Study|Withdrawal by Subject|5|||
125295444|NCT00527319|450709446|FG001|Overall Study|Withdrawal by Subject|0|||
125295445|NCT00527319|450709447|FG002|Overall Study|Withdrawal by Subject|1|||
125295446|NCT00527319|450709445|FG000|Overall Study|Lost to Follow-up|1|||
125295447|NCT00527319|450709446|FG001|Overall Study|Lost to Follow-up|0|||
125295448|NCT00527319|450709447|FG002|Overall Study|Lost to Follow-up|0|||
125295449|NCT00527319|450709445|FG000|Overall Study|Death|0|||
125295450|NCT00527319|450709446|FG001|Overall Study|Death|3|||
125295451|NCT00527319|450709447|FG002|Overall Study|Death|1|||
125295452|NCT00527319|450709445|FG000|Overall Study|Intercurrent Medical Illness|0|||
125295453|NCT00527319|450709446|FG001|Overall Study|Intercurrent Medical Illness|1|||
125295454|NCT00527319|450709447|FG002|Overall Study|Intercurrent Medical Illness|3|||
125295455|NCT00527319|450709445|FG000|Overall Study|Adverse Event|0|||
125295456|NCT00527319|450709446|FG001|Overall Study|Adverse Event|0|||
125295457|NCT00527319|450709447|FG002|Overall Study|Adverse Event|1|||
125460440|NCT03615924|451316333|FG001|Overall Study|Randomized in error|0|||
125460441|NCT03615924|451316332|FG000|Overall Study|Study termination by Sponsor|94|||
125295458|NCT01646203|450709448|FG000|Overall Study|Adverse Event|2|||
125295459|NCT01646203|450709449|FG001|Overall Study|Adverse Event|0|||
125295460|NCT01646203|450709450|FG002|Overall Study|Adverse Event|1|||
125295461|NCT01646203|450709448|FG000|Overall Study|Withdrawal by Subject|0|||
125295462|NCT01646203|450709449|FG001|Overall Study|Withdrawal by Subject|1|||
125295463|NCT01646203|450709450|FG002|Overall Study|Withdrawal by Subject|0|||
125295464|NCT01646203|450709448|FG000|Overall Study|Physician's Decision|0|||
125295465|NCT01646203|450709449|FG001|Overall Study|Physician's Decision|1|||
125460442|NCT03615924|451316333|FG001|Overall Study|Study termination by Sponsor|86|||
125460443|NCT00880048|451316335|FG000|Overall Study|Adverse Event|2|||
125460444|NCT00880048|451316336|FG001|Overall Study|Adverse Event|3|||
125295466|NCT01646203|450709450|FG002|Overall Study|Physician's Decision|0|||
125460445|NCT00880048|451316337|FG002|Overall Study|Adverse Event|5|||
125460446|NCT00880048|451316335|FG000|Overall Study|Lack of Efficacy|1|||
125460447|NCT00880048|451316336|FG001|Overall Study|Lack of Efficacy|2|||
125460448|NCT00880048|451316337|FG002|Overall Study|Lack of Efficacy|2|||
125295467|NCT02066415|450709451|FG000|Overall Study|Decision by Sponsor|5|||
125295468|NCT02066415|450709452|FG001|Overall Study|Decision by Sponsor|4|||
125460449|NCT00880048|451316335|FG000|Overall Study|Protocol Violation|4|||
125460450|NCT00880048|451316336|FG001|Overall Study|Protocol Violation|6|||
125460451|NCT00880048|451316337|FG002|Overall Study|Protocol Violation|5|||
125460452|NCT00880048|451316335|FG000|Overall Study|Lost to Follow-up|6|||
125460453|NCT00880048|451316336|FG001|Overall Study|Lost to Follow-up|6|||
125460454|NCT00880048|451316337|FG002|Overall Study|Lost to Follow-up|5|||
125460455|NCT00880048|451316335|FG000|Overall Study|Physician Decision|1|||
125460456|NCT00880048|451316336|FG001|Overall Study|Physician Decision|1|||
125460457|NCT00880048|451316337|FG002|Overall Study|Physician Decision|7|||
125460458|NCT00880048|451316335|FG000|Overall Study|Withdrawal by Subject|5|||
125460459|NCT00880048|451316336|FG001|Overall Study|Withdrawal by Subject|8|||
125460460|NCT00880048|451316337|FG002|Overall Study|Withdrawal by Subject|5|||
125460461|NCT00880048|451316335|FG000|Overall Study|Study closed/terminated|9|||
125460462|NCT00880048|451316336|FG001|Overall Study|Study closed/terminated|7|||
125460463|NCT00880048|451316337|FG002|Overall Study|Study closed/terminated|6|||
125460464|NCT00367991|451316342|FG000|Overall Study|Withdrawal by Subject|1|||
125460465|NCT00367991|451316343|FG001|Overall Study|Withdrawal by Subject|1|||
125460466|NCT00367991|451316342|FG000|Overall Study|Adverse Event|1|||
125460467|NCT00367991|451316343|FG001|Overall Study|Adverse Event|1|||
125460468|NCT01184508|451316344|FG000|Overall Study|Adverse Event|4|||
125460469|NCT01184508|451316345|FG001|Overall Study|Adverse Event|6|||
125460470|NCT01184508|451316344|FG000|Overall Study|Lack of Efficacy|1|||
125460471|NCT01184508|451316345|FG001|Overall Study|Lack of Efficacy|1|||
125460472|NCT01184508|451316344|FG000|Overall Study|Lost to Follow-up|1|||
125460473|NCT01184508|451316345|FG001|Overall Study|Lost to Follow-up|1|||
125460474|NCT01184508|451316344|FG000|Overall Study|Physician Decision|1|||
125460475|NCT01184508|451316345|FG001|Overall Study|Physician Decision|0|||
125460476|NCT01184508|451316344|FG000|Overall Study|Protocol Violation|3|||
125460477|NCT01184508|451316345|FG001|Overall Study|Protocol Violation|1|||
125460478|NCT01184508|451316344|FG000|Overall Study|Sponsor Decision|5|||
125460479|NCT01184508|451316345|FG001|Overall Study|Sponsor Decision|2|||
125460480|NCT01184508|451316344|FG000|Overall Study|Withdrawal by Subject|1|||
125460481|NCT01184508|451316345|FG001|Overall Study|Withdrawal by Subject|3|||
125460482|NCT01184508|451316344|FG000|Overall Study|Randomized, Not Treated|0|||
125460483|NCT01184508|451316345|FG001|Overall Study|Randomized, Not Treated|1|||
125460484|NCT04707313|451316352|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
125460485|NCT04707313|451316353|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
125460486|NCT04707313|451316354|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
125460487|NCT04707313|451316355|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
125460488|NCT04707313|451316356|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
125460489|NCT04707313|451316357|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
125460490|NCT04707313|451316358|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
125460491|NCT04707313|451316359|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
125460492|NCT04707313|451316360|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
125460493|NCT04707313|451316361|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
125460494|NCT04707313|451316362|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
125460495|NCT04707313|451316363|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
125460496|NCT04707313|451316364|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
125460497|NCT04707313|451316352|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
125460498|NCT04707313|451316353|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
125460499|NCT04707313|451316354|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
125460500|NCT04707313|451316355|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
125460501|NCT04707313|451316356|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
125460502|NCT04707313|451316357|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
125460503|NCT04707313|451316358|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
125460504|NCT04707313|451316359|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
125460505|NCT04707313|451316360|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
125460506|NCT04707313|451316361|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
125460507|NCT04707313|451316362|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
125295469|NCT02066415|450709453|FG002|Overall Study|Decision by Sponsor|2|||
125295470|NCT02066415|450709451|FG000|Overall Study|Withdrawal by Subject|9|||
125295471|NCT02066415|450709452|FG001|Overall Study|Withdrawal by Subject|1|||
125295472|NCT02066415|450709453|FG002|Overall Study|Withdrawal by Subject|4|||
125460508|NCT04707313|451316363|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
125460509|NCT04707313|451316364|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
125460510|NCT04707313|451316352|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
125460511|NCT04707313|451316353|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
125460512|NCT04707313|451316354|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
125460513|NCT04707313|451316355|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
125460514|NCT04707313|451316356|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
125460515|NCT04707313|451316357|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
125460516|NCT04707313|451316358|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
125460517|NCT04707313|451316359|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
125460518|NCT04707313|451316360|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
125460519|NCT04707313|451316361|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
125460520|NCT04707313|451316362|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
125460521|NCT04707313|451316363|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
125460522|NCT04707313|451316364|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
125460523|NCT04707313|451316352|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
125460524|NCT04707313|451316353|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
125460525|NCT04707313|451316354|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
125460526|NCT04707313|451316355|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
125460527|NCT04707313|451316356|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
125460528|NCT04707313|451316357|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
125460529|NCT04707313|451316358|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
125460530|NCT04707313|451316359|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
125460531|NCT04707313|451316360|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
125460532|NCT04707313|451316361|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
125460533|NCT04707313|451316362|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
125460534|NCT04707313|451316363|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
125460535|NCT04707313|451316364|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
125460536|NCT04707313|451316352|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
125460537|NCT04707313|451316353|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
125460538|NCT04707313|451316354|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
125460539|NCT04707313|451316355|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
125460540|NCT04707313|451316356|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
125460541|NCT04707313|451316357|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
125460542|NCT04707313|451316358|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
125460543|NCT04707313|451316359|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
125460544|NCT04707313|451316360|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
125460545|NCT04707313|451316361|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
125460546|NCT04707313|451316362|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
125460547|NCT04707313|451316363|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
125460548|NCT04707313|451316364|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
125460549|NCT04707313|451316352|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
125460550|NCT04707313|451316353|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
125460551|NCT04707313|451316354|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
125460552|NCT04707313|451316355|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
125460553|NCT04707313|451316356|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
125460554|NCT04707313|451316357|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
125460555|NCT04707313|451316358|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
125460556|NCT04707313|451316359|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
125460557|NCT04707313|451316360|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
125460558|NCT04707313|451316361|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
125460559|NCT04707313|451316362|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
125460560|NCT04707313|451316363|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
125460561|NCT04707313|451316364|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
125460562|NCT04707313|451316352|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
125460563|NCT04707313|451316353|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
125460564|NCT04707313|451316354|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
125460565|NCT04707313|451316355|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
125460566|NCT04707313|451316356|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
125460567|NCT04707313|451316357|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
125460568|NCT04707313|451316358|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
125460569|NCT04707313|451316359|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
125460570|NCT04707313|451316360|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
125460571|NCT04707313|451316361|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
125460572|NCT04707313|451316362|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
125460573|NCT04707313|451316363|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
125460574|NCT04707313|451316364|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
125460575|NCT04707313|451316352|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
125460576|NCT04707313|451316353|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
125460577|NCT04707313|451316354|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
125460578|NCT04707313|451316355|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
125460579|NCT04707313|451316356|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
125460580|NCT04707313|451316357|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
125460581|NCT04707313|451316358|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
125460582|NCT04707313|451316359|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
125460583|NCT04707313|451316360|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
125460584|NCT04707313|451316361|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
125460585|NCT04707313|451316362|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
125460586|NCT04707313|451316363|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
125460587|NCT04707313|451316364|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
125460588|NCT04707313|451316352|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
125460589|NCT04707313|451316353|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
125460590|NCT04707313|451316354|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
125460591|NCT04707313|451316355|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
125460592|NCT04707313|451316356|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
125460593|NCT04707313|451316357|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
125460594|NCT04707313|451316358|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
125460595|NCT04707313|451316359|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
125460596|NCT04707313|451316360|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
125460597|NCT04707313|451316361|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
125460598|NCT04707313|451316362|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
125460599|NCT04707313|451316363|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
125460600|NCT04707313|451316364|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
125460601|NCT04707313|451316352|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
125460602|NCT04707313|451316353|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
125460603|NCT04707313|451316354|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
125460604|NCT04707313|451316355|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
125460605|NCT04707313|451316356|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
125460606|NCT04707313|451316357|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
125460607|NCT04707313|451316358|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
125460608|NCT04707313|451316359|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
125460609|NCT04707313|451316360|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
125460610|NCT04707313|451316361|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
125460611|NCT04707313|451316362|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
125460612|NCT04707313|451316363|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
125460613|NCT04707313|451316364|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
125460614|NCT04707313|451316352|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
125460615|NCT04707313|451316353|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
125460616|NCT04707313|451316354|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
125460617|NCT04707313|451316355|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
125460618|NCT04707313|451316356|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
125460619|NCT04707313|451316357|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
125460620|NCT04707313|451316358|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
125460621|NCT04707313|451316359|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
125460622|NCT04707313|451316360|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
125460623|NCT04707313|451316361|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
125460624|NCT04707313|451316362|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
125460625|NCT04707313|451316363|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
125460626|NCT04707313|451316364|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
125460627|NCT04707313|451316352|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
125460628|NCT04707313|451316353|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
125460629|NCT04707313|451316354|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
125460630|NCT04707313|451316355|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
125460631|NCT04707313|451316356|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
125460632|NCT04707313|451316357|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
125460633|NCT04707313|451316358|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
125460634|NCT04707313|451316359|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
125460635|NCT04707313|451316360|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
125460636|NCT04707313|451316361|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
125460637|NCT04707313|451316362|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
125460638|NCT04707313|451316363|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
125460639|NCT04707313|451316364|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
125460640|NCT04707313|451316352|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
125460641|NCT04707313|451316353|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
125460642|NCT04707313|451316354|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
125460643|NCT04707313|451316355|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
125460644|NCT04707313|451316356|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
125460645|NCT04707313|451316357|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
125460646|NCT04707313|451316358|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
125460647|NCT04707313|451316359|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
125460648|NCT04707313|451316360|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
125460649|NCT04707313|451316361|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
125460650|NCT04707313|451316362|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
125460651|NCT04707313|451316363|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
125460652|NCT04707313|451316364|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
125460653|NCT04707313|451316352|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
125295473|NCT02066415|450709451|FG000|Overall Study|Lost to Follow-up|7|||
125460654|NCT04707313|451316353|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
125460655|NCT04707313|451316354|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
125460656|NCT04707313|451316355|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
125460657|NCT04707313|451316356|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
125460658|NCT04707313|451316357|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
125460659|NCT04707313|451316358|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
125460660|NCT04707313|451316359|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
125460661|NCT04707313|451316360|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
125460662|NCT04707313|451316361|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
125460663|NCT04707313|451316362|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
125460664|NCT04707313|451316363|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
125460665|NCT04707313|451316364|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
125460666|NCT00834834|451316367|FG000|Overall Study|Withdrawal by Subject|4|||
125460667|NCT00834834|451316368|FG001|Overall Study|Withdrawal by Subject|3|||
125460668|NCT00539292|451316369|FG000|Overall Study|Physician Decision|1|||
125460669|NCT00539292|451316370|FG001|Overall Study|Physician Decision|0|||
125460670|NCT02020616|451316371|FG000|Overall Study|Adverse Event|0|||
125460671|NCT02020616|451316372|FG001|Overall Study|Adverse Event|0|||
125460672|NCT02020616|451316373|FG002|Overall Study|Adverse Event|0|||
125460673|NCT02020616|451316374|FG003|Overall Study|Adverse Event|0|||
125460674|NCT02020616|451316375|FG004|Overall Study|Adverse Event|0|||
125460675|NCT02020616|451316376|FG005|Overall Study|Adverse Event|1|||
125460676|NCT02020616|451316377|FG006|Overall Study|Adverse Event|1|||
125460677|NCT02020616|451316371|FG000|Overall Study|Physician Decision|0|||
125460678|NCT02020616|451316372|FG001|Overall Study|Physician Decision|0|||
125460679|NCT02020616|451316373|FG002|Overall Study|Physician Decision|0|||
125460680|NCT02020616|451316374|FG003|Overall Study|Physician Decision|0|||
125460681|NCT02020616|451316375|FG004|Overall Study|Physician Decision|0|||
125460682|NCT02020616|451316376|FG005|Overall Study|Physician Decision|1|||
125460683|NCT02020616|451316377|FG006|Overall Study|Physician Decision|2|||
125460684|NCT02020616|451316371|FG000|Overall Study|Withdrawal by Subject|0|||
125460685|NCT02020616|451316372|FG001|Overall Study|Withdrawal by Subject|0|||
125460686|NCT02020616|451316373|FG002|Overall Study|Withdrawal by Subject|1|||
125460687|NCT02020616|451316374|FG003|Overall Study|Withdrawal by Subject|0|||
125460688|NCT02020616|451316375|FG004|Overall Study|Withdrawal by Subject|0|||
125460689|NCT02020616|451316376|FG005|Overall Study|Withdrawal by Subject|1|||
125460690|NCT02020616|451316377|FG006|Overall Study|Withdrawal by Subject|1|||
125460691|NCT02020616|451316371|FG000|Overall Study|Lost to Follow-up|0|||
125460692|NCT02020616|451316372|FG001|Overall Study|Lost to Follow-up|1|||
125460693|NCT02020616|451316373|FG002|Overall Study|Lost to Follow-up|0|||
125460694|NCT02020616|451316374|FG003|Overall Study|Lost to Follow-up|1|||
125460695|NCT02020616|451316375|FG004|Overall Study|Lost to Follow-up|1|||
125460696|NCT02020616|451316376|FG005|Overall Study|Lost to Follow-up|1|||
125460697|NCT02020616|451316377|FG006|Overall Study|Lost to Follow-up|0|||
125460698|NCT02020616|451316371|FG000|Overall Study|Early Termination Criteria Met|0|||
125460699|NCT02020616|451316372|FG001|Overall Study|Early Termination Criteria Met|0|||
125460700|NCT02020616|451316373|FG002|Overall Study|Early Termination Criteria Met|1|||
125460701|NCT02020616|451316374|FG003|Overall Study|Early Termination Criteria Met|0|||
125460702|NCT02020616|451316375|FG004|Overall Study|Early Termination Criteria Met|0|||
125460703|NCT02020616|451316376|FG005|Overall Study|Early Termination Criteria Met|1|||
125460704|NCT02020616|451316377|FG006|Overall Study|Early Termination Criteria Met|0|||
125460705|NCT02020616|451316371|FG000|Overall Study|Randomized in Error|0|||
125460706|NCT02020616|451316372|FG001|Overall Study|Randomized in Error|0|||
125460707|NCT02020616|451316373|FG002|Overall Study|Randomized in Error|0|||
125460708|NCT02020616|451316374|FG003|Overall Study|Randomized in Error|1|||
125460709|NCT02020616|451316375|FG004|Overall Study|Randomized in Error|0|||
125460710|NCT02020616|451316376|FG005|Overall Study|Randomized in Error|0|||
125460711|NCT02020616|451316377|FG006|Overall Study|Randomized in Error|0|||
125460712|NCT02020616|451316371|FG000|Overall Study|Lack of Efficacy|0|||
125460713|NCT02020616|451316372|FG001|Overall Study|Lack of Efficacy|0|||
125460714|NCT02020616|451316373|FG002|Overall Study|Lack of Efficacy|0|||
125460715|NCT02020616|451316374|FG003|Overall Study|Lack of Efficacy|0|||
125460716|NCT02020616|451316375|FG004|Overall Study|Lack of Efficacy|1|||
125460717|NCT02020616|451316376|FG005|Overall Study|Lack of Efficacy|0|||
125460718|NCT02020616|451316377|FG006|Overall Study|Lack of Efficacy|0|||
125460719|NCT00961636|451316384|FG000|Overall Study|Adverse Event|35|||
125460720|NCT00961636|451316385|FG001|Overall Study|Adverse Event|54|||
125460721|NCT00961636|451316386|FG002|Overall Study|Adverse Event|13|||
125460722|NCT00961636|451316384|FG000|Overall Study|Flushing Symptoms|29|||
125460723|NCT00961636|451316385|FG001|Overall Study|Flushing Symptoms|46|||
125460724|NCT00961636|451316386|FG002|Overall Study|Flushing Symptoms|3|||
125460725|NCT00961636|451316384|FG000|Overall Study|Lost to Follow-up|2|||
125460726|NCT00961636|451316385|FG001|Overall Study|Lost to Follow-up|3|||
125460727|NCT00961636|451316386|FG002|Overall Study|Lost to Follow-up|1|||
125460728|NCT00961636|451316384|FG000|Overall Study|Physician Decision|3|||
125460729|NCT00961636|451316385|FG001|Overall Study|Physician Decision|1|||
125460730|NCT00961636|451316386|FG002|Overall Study|Physician Decision|1|||
125460731|NCT00961636|451316384|FG000|Overall Study|Protocol Violation|9|||
125460732|NCT00961636|451316385|FG001|Overall Study|Protocol Violation|5|||
125460733|NCT00961636|451316386|FG002|Overall Study|Protocol Violation|1|||
125460734|NCT00961636|451316384|FG000|Overall Study|Withdrawal by Subject|29|||
125460735|NCT00961636|451316385|FG001|Overall Study|Withdrawal by Subject|22|||
125460736|NCT00961636|451316386|FG002|Overall Study|Withdrawal by Subject|13|||
125460737|NCT02551055|451316389|FG000|Overall Study|Death|2|||
125460738|NCT02551055|451316390|FG001|Overall Study|Death|4|||
125460739|NCT02551055|451316391|FG002|Overall Study|Death|2|||
125460740|NCT02551055|451316392|FG003|Overall Study|Death|2|||
125460741|NCT02551055|451316393|FG004|Overall Study|Death|2|||
125460742|NCT02551055|451316394|FG005|Overall Study|Death|1|||
125460743|NCT02551055|451316395|FG006|Overall Study|Death|2|||
125460744|NCT02551055|451316396|FG007|Overall Study|Death|0|||
125460745|NCT02551055|451316389|FG000|Overall Study|Study Terminated by Sponsor|1|||
125460746|NCT02551055|451316390|FG001|Overall Study|Study Terminated by Sponsor|1|||
125460747|NCT02551055|451316391|FG002|Overall Study|Study Terminated by Sponsor|0|||
125460748|NCT02551055|451316392|FG003|Overall Study|Study Terminated by Sponsor|2|||
125460749|NCT02551055|451316393|FG004|Overall Study|Study Terminated by Sponsor|2|||
125460750|NCT02551055|451316394|FG005|Overall Study|Study Terminated by Sponsor|0|||
125460751|NCT02551055|451316395|FG006|Overall Study|Study Terminated by Sponsor|0|||
125460752|NCT02551055|451316396|FG007|Overall Study|Study Terminated by Sponsor|0|||
125460753|NCT02551055|451316389|FG000|Overall Study|Withdrawal by Subject|1|||
125460754|NCT02551055|451316390|FG001|Overall Study|Withdrawal by Subject|1|||
125460755|NCT02551055|451316391|FG002|Overall Study|Withdrawal by Subject|0|||
125460756|NCT02551055|451316392|FG003|Overall Study|Withdrawal by Subject|1|||
125460757|NCT02551055|451316393|FG004|Overall Study|Withdrawal by Subject|2|||
125460758|NCT02551055|451316394|FG005|Overall Study|Withdrawal by Subject|0|||
125460759|NCT02551055|451316395|FG006|Overall Study|Withdrawal by Subject|0|||
125460760|NCT02551055|451316396|FG007|Overall Study|Withdrawal by Subject|0|||
125460761|NCT02551055|451316389|FG000|Overall Study|Reason not specified|0|||
125460762|NCT02551055|451316390|FG001|Overall Study|Reason not specified|0|||
125460763|NCT02551055|451316391|FG002|Overall Study|Reason not specified|0|||
125460764|NCT02551055|451316392|FG003|Overall Study|Reason not specified|0|||
125460765|NCT02551055|451316393|FG004|Overall Study|Reason not specified|1|||
125460766|NCT02551055|451316394|FG005|Overall Study|Reason not specified|0|||
125460767|NCT02551055|451316395|FG006|Overall Study|Reason not specified|1|||
125460768|NCT02551055|451316396|FG007|Overall Study|Reason not specified|0|||
125460769|NCT00430300|451316400|FG000|Overall Study|Adverse Event|0|||
125460770|NCT00430300|451316401|FG001|Overall Study|Adverse Event|2|||
125460771|NCT00430300|451316402|FG002|Overall Study|Adverse Event|1|||
125460772|NCT00430300|451316403|FG003|Overall Study|Adverse Event|1|||
125460773|NCT00430300|451316400|FG000|Overall Study|Withdrawal by Subject|1|||
125460774|NCT00430300|451316401|FG001|Overall Study|Withdrawal by Subject|0|||
125460775|NCT00430300|451316402|FG002|Overall Study|Withdrawal by Subject|5|||
125460776|NCT00430300|451316403|FG003|Overall Study|Withdrawal by Subject|0|||
125460777|NCT00430300|451316400|FG000|Overall Study|Laboratory abnormality|1|||
125460778|NCT00430300|451316401|FG001|Overall Study|Laboratory abnormality|0|||
125460779|NCT00430300|451316402|FG002|Overall Study|Laboratory abnormality|0|||
125460780|NCT00430300|451316403|FG003|Overall Study|Laboratory abnormality|0|||
125460781|NCT00430300|451316400|FG000|Overall Study|Other|0|||
125460782|NCT00430300|451316401|FG001|Overall Study|Other|0|||
125460783|NCT00430300|451316402|FG002|Overall Study|Other|0|||
125460784|NCT00430300|451316403|FG003|Overall Study|Other|1|||
125460785|NCT02754479|451316404|FG000|Overall Study|Lost to Follow-up|1|||
125460786|NCT01063517|451316409|FG000|Overall Study|Consent withdrawal|1|||
125460787|NCT01063517|451316410|FG001|Overall Study|Consent withdrawal|0|||
125460788|NCT01063517|451316409|FG000|Overall Study|Study reached data cut-off|19|||
125460789|NCT01063517|451316410|FG001|Overall Study|Study reached data cut-off|7|||
125460790|NCT01063517|451316409|FG000|Overall Study|Lost to Follow-up|4|||
125460791|NCT01063517|451316410|FG001|Overall Study|Lost to Follow-up|3|||
125460792|NCT01063517|451316409|FG000|Overall Study|Withdrawal by Subject|1|||
125460793|NCT01063517|451316410|FG001|Overall Study|Withdrawal by Subject|2|||
125460794|NCT01063517|451316409|FG000|Overall Study|Death|33|||
125460795|NCT01063517|451316410|FG001|Overall Study|Death|48|||
125460796|NCT02041104|451316411|FG000|Overall Study|Lost to Follow-up|1|||
125460797|NCT02041104|451316412|FG001|Overall Study|Lost to Follow-up|4|||
125460798|NCT02041104|451316411|FG000|Overall Study|discomfort during OGTT|0|||
125460799|NCT02041104|451316412|FG001|Overall Study|discomfort during OGTT|3|||
125295474|NCT02066415|450709452|FG001|Overall Study|Lost to Follow-up|2|||
125460800|NCT00617201|451316415|FG000|Overall Study|Lost to Follow-up|9|||
125460801|NCT00617201|451316416|FG001|Overall Study|Lost to Follow-up|13|||
125460802|NCT00546871|451316417|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
125460803|NCT00546871|451316418|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
125460804|NCT00546871|451316417|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
125460805|NCT00546871|451316418|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
125460806|NCT00546871|451316417|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
125460807|NCT00546871|451316418|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
125460808|NCT00546871|451316417|FG000|Study Extension Period|Protocol Violation|1|||
125460809|NCT00546871|451316418|FG001|Study Extension Period|Protocol Violation|0|||
125460810|NCT00546871|451316417|FG000|Study Extension Period|Withdrawal by Subject|0|||
125460811|NCT00546871|451316418|FG001|Study Extension Period|Withdrawal by Subject|1|||
125460812|NCT01350804|451316419|FG000|Core Study|Withdrawal by Subject|11|||
125460813|NCT01350804|451316420|FG001|Core Study|Withdrawal by Subject|17|||
125460814|NCT01350804|451316421|FG002|Core Study|Withdrawal by Subject|16|||
125460815|NCT01350804|451316422|FG003|Core Study|Withdrawal by Subject|7|||
125460816|NCT01350804|451316419|FG000|Core Study|Study terminated by Sponsor|0|||
125460817|NCT01350804|451316420|FG001|Core Study|Study terminated by Sponsor|0|||
125460818|NCT01350804|451316421|FG002|Core Study|Study terminated by Sponsor|0|||
125460819|NCT01350804|451316422|FG003|Core Study|Study terminated by Sponsor|2|||
125460820|NCT01350804|451316419|FG000|Core Study|Protocol deviation|1|||
125460821|NCT01350804|451316420|FG001|Core Study|Protocol deviation|0|||
125460822|NCT01350804|451316421|FG002|Core Study|Protocol deviation|1|||
125460823|NCT01350804|451316422|FG003|Core Study|Protocol deviation|0|||
125460824|NCT01350804|451316419|FG000|Core Study|Physician Decision|1|||
125460825|NCT01350804|451316420|FG001|Core Study|Physician Decision|0|||
125460826|NCT01350804|451316421|FG002|Core Study|Physician Decision|1|||
125460827|NCT01350804|451316422|FG003|Core Study|Physician Decision|3|||
125460828|NCT01350804|451316419|FG000|Core Study|Lost to Follow-up|3|||
125460829|NCT01350804|451316420|FG001|Core Study|Lost to Follow-up|0|||
125460830|NCT01350804|451316421|FG002|Core Study|Lost to Follow-up|2|||
125460831|NCT01350804|451316422|FG003|Core Study|Lost to Follow-up|1|||
125460832|NCT01350804|451316419|FG000|Core Study|Lack of Efficacy|16|||
125460833|NCT01350804|451316420|FG001|Core Study|Lack of Efficacy|19|||
125460834|NCT01350804|451316421|FG002|Core Study|Lack of Efficacy|18|||
125460835|NCT01350804|451316422|FG003|Core Study|Lack of Efficacy|5|||
125460836|NCT01350804|451316419|FG000|Core Study|Death|1|||
125460837|NCT01350804|451316420|FG001|Core Study|Death|1|||
125460838|NCT01350804|451316421|FG002|Core Study|Death|1|||
125460839|NCT01350804|451316422|FG003|Core Study|Death|0|||
125460840|NCT01350804|451316419|FG000|Core Study|Adverse Event|8|||
125460841|NCT01350804|451316420|FG001|Core Study|Adverse Event|10|||
125460842|NCT01350804|451316421|FG002|Core Study|Adverse Event|8|||
125460843|NCT01350804|451316422|FG003|Core Study|Adverse Event|8|||
125460844|NCT01350804|451316419|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
125460845|NCT01350804|451316420|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
125460846|NCT01350804|451316421|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
125460847|NCT01350804|451316422|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
125460848|NCT01350804|451316419|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
125460849|NCT01350804|451316420|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
125460850|NCT01350804|451316421|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
125460851|NCT01350804|451316422|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
125460852|NCT01350804|451316419|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
125460853|NCT01350804|451316420|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
125460854|NCT01350804|451316421|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
125460855|NCT01350804|451316422|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
125460856|NCT01350804|451316419|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
125460857|NCT01350804|451316420|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
125460858|NCT01350804|451316421|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
125460859|NCT01350804|451316422|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
125460860|NCT01350804|451316419|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
125460861|NCT01350804|451316420|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
125460862|NCT01350804|451316421|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
125460863|NCT01350804|451316422|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
125460864|NCT01350804|451316419|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
125460865|NCT01350804|451316420|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
125460866|NCT01350804|451316421|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
125460867|NCT01350804|451316422|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
125460868|NCT01713946|451316423|FG000|Overall Study|Death|0|||
125460869|NCT01713946|451316424|FG001|Overall Study|Death|2|||
125295475|NCT02066415|450709453|FG002|Overall Study|Lost to Follow-up|2|||
125460870|NCT01713946|451316425|FG002|Overall Study|Death|2|||
125460871|NCT01713946|451316423|FG000|Overall Study|Adverse Event|19|||
125295476|NCT00430937|450709454|FG000|Overall Study|Adverse Event|3|||
125460872|NCT01713946|451316424|FG001|Overall Study|Adverse Event|14|||
125460873|NCT01713946|451316425|FG002|Overall Study|Adverse Event|13|||
125460874|NCT01713946|451316423|FG000|Overall Study|Withdrawal by Subject|12|||
125460875|NCT01713946|451316424|FG001|Overall Study|Withdrawal by Subject|12|||
125460876|NCT01713946|451316425|FG002|Overall Study|Withdrawal by Subject|8|||
125460877|NCT01713946|451316423|FG000|Overall Study|Lack of Efficacy|8|||
125460878|NCT01713946|451316424|FG001|Overall Study|Lack of Efficacy|8|||
125460879|NCT01713946|451316425|FG002|Overall Study|Lack of Efficacy|14|||
125460880|NCT01713946|451316423|FG000|Overall Study|Protocol Violation|2|||
125460881|NCT01713946|451316424|FG001|Overall Study|Protocol Violation|4|||
125460882|NCT01713946|451316425|FG002|Overall Study|Protocol Violation|1|||
125460883|NCT01713946|451316423|FG000|Overall Study|Lost to Follow-up|0|||
125460884|NCT01713946|451316424|FG001|Overall Study|Lost to Follow-up|0|||
125460885|NCT01713946|451316425|FG002|Overall Study|Lost to Follow-up|1|||
125460886|NCT01713946|451316423|FG000|Overall Study|Administrative problems|1|||
125460887|NCT01713946|451316424|FG001|Overall Study|Administrative problems|0|||
125460888|NCT01713946|451316425|FG002|Overall Study|Administrative problems|0|||
125460889|NCT01713946|451316423|FG000|Overall Study|Did not continue in Ext|0|||
125460890|NCT01713946|451316424|FG001|Overall Study|Did not continue in Ext|3|||
125460891|NCT01713946|451316425|FG002|Overall Study|Did not continue in Ext|0|||
125460892|NCT01713946|451316423|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
125460893|NCT01713946|451316424|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
125460894|NCT01713946|451316425|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
125460895|NCT01713946|451316423|FG000|Overall Study|Patients never switched to everolimus|0|||
125460896|NCT01713946|451316424|FG001|Overall Study|Patients never switched to everolimus|0|||
125460897|NCT01713946|451316425|FG002|Overall Study|Patients never switched to everolimus|5|||
125460898|NCT03183518|451316426|FG000|Overall Study|Other (Not specified)|2|||
125460899|NCT03183518|451316426|FG000|Overall Study|Other (Withdrawal of consent)|1|||
125460900|NCT02299336|451316427|FG000|Overall Study|Withdrawal by Subject|11|||
125460901|NCT02299336|451316427|FG000|Overall Study|Adverse Event|1|||
125460902|NCT02299336|451316427|FG000|Overall Study|Death|1|||
125460903|NCT02299336|451316427|FG000|Overall Study|Lost to Follow-up|1|||
125460904|NCT02106442|451316429|FG000|Overall Study|Case Report Forms Uncollected|7|||
125460905|NCT02106442|451316429|FG000|Overall Study|Protocol Deviation|30|||
125460906|NCT00743444|451317788|FG000|First Intervention|Catheter placement problems|0|||
125460907|NCT00743444|451317789|FG001|First Intervention|Catheter placement problems|1|||
125460908|NCT00743444|451317788|FG000|Washout Period|Adverse Event|0|||
125460909|NCT00743444|451317789|FG001|Washout Period|Adverse Event|1|||
125460910|NCT00814346|451317790|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
125460911|NCT00814346|451317791|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
125460912|NCT00814346|451317790|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
125460913|NCT00814346|451317791|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
125460914|NCT00814346|451317790|FG000|Open Phase (17 Months)|Adverse Event|5|||
125460915|NCT00814346|451317791|FG001|Open Phase (17 Months)|Adverse Event|0|||
125460916|NCT00814346|451317790|FG000|Open Phase (17 Months)|Consent|2|||
125460917|NCT00814346|451317791|FG001|Open Phase (17 Months)|Consent|0|||
125460918|NCT00814346|451317790|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
125460919|NCT00814346|451317791|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
125460920|NCT00814346|451317790|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
125460921|NCT00814346|451317791|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
125460922|NCT03622580|451317797|FG000|Overall Study|Death|16|||
125460923|NCT03622580|451317798|FG001|Overall Study|Death|21|||
125460924|NCT03622580|451317799|FG002|Overall Study|Death|13|||
125460925|NCT03622580|451317797|FG000|Overall Study|Adverse Event|6|||
125460926|NCT03622580|451317798|FG001|Overall Study|Adverse Event|6|||
125460927|NCT03622580|451317799|FG002|Overall Study|Adverse Event|5|||
125460928|NCT03622580|451317797|FG000|Overall Study|Withdrawal by Subject|12|||
125460929|NCT03622580|451317798|FG001|Overall Study|Withdrawal by Subject|7|||
125460930|NCT03622580|451317799|FG002|Overall Study|Withdrawal by Subject|19|||
125460931|NCT03622580|451317797|FG000|Overall Study|Lost to Follow-up|12|||
125460932|NCT03622580|451317798|FG001|Overall Study|Lost to Follow-up|9|||
125460933|NCT03622580|451317799|FG002|Overall Study|Lost to Follow-up|9|||
125460934|NCT03622580|451317797|FG000|Overall Study|Protocol Violation|1|||
125460935|NCT03622580|451317798|FG001|Overall Study|Protocol Violation|0|||
125460936|NCT03622580|451317799|FG002|Overall Study|Protocol Violation|1|||
125460937|NCT03622580|451317797|FG000|Overall Study|Physician Decision|3|||
125460938|NCT03622580|451317798|FG001|Overall Study|Physician Decision|0|||
125460939|NCT03622580|451317799|FG002|Overall Study|Physician Decision|1|||
125460940|NCT03622580|451317797|FG000|Overall Study|Pregnancy|0|||
125460941|NCT03622580|451317798|FG001|Overall Study|Pregnancy|1|||
125460942|NCT03622580|451317799|FG002|Overall Study|Pregnancy|0|||
125460943|NCT03622580|451317797|FG000|Overall Study|Lack of Efficacy|0|||
125460944|NCT03622580|451317798|FG001|Overall Study|Lack of Efficacy|0|||
125460945|NCT03622580|451317799|FG002|Overall Study|Lack of Efficacy|1|||
125460946|NCT03622580|451317797|FG000|Overall Study|Other|2|||
125460947|NCT03622580|451317798|FG001|Overall Study|Other|0|||
125460948|NCT03622580|451317799|FG002|Overall Study|Other|3|||
125460949|NCT05136443|451317800|FG000|Overall Study|Lost to Follow-up|2|||
125460950|NCT05136443|451317800|FG000|Overall Study|Adverse Event|2|||
125460951|NCT02613871|451317805|FG000|Overall Study|Death|2|||
125460952|NCT02613871|451317805|FG000|Overall Study|Withdrew Consent|1|||
125460953|NCT01930045|451317806|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
125460954|NCT01930045|451317807|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
125460955|NCT01930045|451317808|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
125460956|NCT01930045|451317809|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
125460957|NCT01930045|451317810|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
125460958|NCT01930045|451317811|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
125460959|NCT01930045|451317806|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
125460960|NCT01930045|451317807|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
125460961|NCT01930045|451317808|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
125460962|NCT01930045|451317809|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
125460963|NCT01930045|451317810|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
125460964|NCT01930045|451317811|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
125460965|NCT00494442|451317812|FG000|Overall Study|Death|1|||
125460966|NCT00494442|451317813|FG001|Overall Study|Death|1|||
125460967|NCT00494442|451317812|FG000|Overall Study|Lack of Efficacy|16|||
125460968|NCT00494442|451317813|FG001|Overall Study|Lack of Efficacy|10|||
125460969|NCT00494442|451317812|FG000|Overall Study|Adverse Event|0|||
125460970|NCT00494442|451317813|FG001|Overall Study|Adverse Event|2|||
125460971|NCT00494442|451317812|FG000|Overall Study|Physician Decision|0|||
125460972|NCT00494442|451317813|FG001|Overall Study|Physician Decision|1|||
125460973|NCT00494442|451317812|FG000|Overall Study|Non-compliance|0|||
125460974|NCT00494442|451317813|FG001|Overall Study|Non-compliance|1|||
125460975|NCT00494442|451317812|FG000|Overall Study|Intercurrent illness|0|||
125460976|NCT00494442|451317813|FG001|Overall Study|Intercurrent illness|1|||
125460977|NCT00831415|451317816|FG000|Overall Study|Adverse Event|14|||
125460978|NCT00831415|451317816|FG000|Overall Study|Failed to return|3|||
125460979|NCT00831415|451317816|FG000|Overall Study|Physician Decision|6|||
125460980|NCT00831415|451317816|FG000|Overall Study|Lost to Follow-up|9|||
125460981|NCT00831415|451317816|FG000|Overall Study|Protocol Violation|3|||
125460982|NCT00831415|451317816|FG000|Overall Study|Withdrawal by Subject|35|||
125460983|NCT00831415|451317816|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
125460984|NCT00831415|451317816|FG000|Overall Study|Death|1|||
125460985|NCT01241292|451317817|FG000|Overall Study|Administrative Reason by Sponsor|1|||
125460986|NCT01241292|451317818|FG001|Overall Study|Administrative Reason by Sponsor|0|||
125460987|NCT01241292|451317817|FG000|Overall Study|Disease Progression|2|||
125460988|NCT01241292|451317818|FG001|Overall Study|Disease Progression|0|||
125460989|NCT01241292|451317817|FG000|Overall Study|Study Drug Toxicity|0|||
125460990|NCT01241292|451317818|FG001|Overall Study|Study Drug Toxicity|1|||
125460991|NCT01241292|451317817|FG000|Overall Study|Participant Discontinued Treatment|0|||
125460992|NCT01241292|451317818|FG001|Overall Study|Participant Discontinued Treatment|2|||
125460993|NCT03034915|451317821|FG000|Overall Study|Adverse Event|29|||
125460994|NCT03034915|451317822|FG001|Overall Study|Adverse Event|32|||
125460995|NCT03034915|451317823|FG002|Overall Study|Adverse Event|22|||
125460996|NCT03034915|451317821|FG000|Overall Study|Lost to Follow-up|5|||
125460997|NCT03034915|451317822|FG001|Overall Study|Lost to Follow-up|13|||
125460998|NCT03034915|451317823|FG002|Overall Study|Lost to Follow-up|3|||
125460999|NCT03034915|451317821|FG000|Overall Study|Withdrawal by Subject|29|||
125461000|NCT03034915|451317822|FG001|Overall Study|Withdrawal by Subject|46|||
125461001|NCT03034915|451317823|FG002|Overall Study|Withdrawal by Subject|41|||
125461002|NCT03034915|451317821|FG000|Overall Study|Protocol Deviation|2|||
125461003|NCT03034915|451317822|FG001|Overall Study|Protocol Deviation|14|||
125461004|NCT03034915|451317823|FG002|Overall Study|Protocol Deviation|7|||
125461005|NCT03034915|451317821|FG000|Overall Study|Lack of Efficacy|8|||
125461006|NCT03034915|451317822|FG001|Overall Study|Lack of Efficacy|16|||
125461007|NCT03034915|451317823|FG002|Overall Study|Lack of Efficacy|18|||
125461008|NCT03034915|451317821|FG000|Overall Study|Site closed|2|||
125461009|NCT03034915|451317822|FG001|Overall Study|Site closed|2|||
125461010|NCT03034915|451317823|FG002|Overall Study|Site closed|4|||
125461011|NCT03034915|451317821|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
125461012|NCT03034915|451317822|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
125461013|NCT03034915|451317823|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
125461014|NCT03034915|451317821|FG000|Overall Study|Physician Decision|1|||
125461015|NCT03034915|451317822|FG001|Overall Study|Physician Decision|5|||
125461016|NCT03034915|451317823|FG002|Overall Study|Physician Decision|2|||
125461017|NCT03861767|451317824|FG000|Overall Study|Withdrawal by Subject|2|||
125461018|NCT03861767|451317825|FG001|Overall Study|Withdrawal by Subject|1|||
125461019|NCT03861767|451317826|FG002|Overall Study|Withdrawal by Subject|0|||
125461020|NCT03861767|451317827|FG003|Overall Study|Withdrawal by Subject|5|||
125461021|NCT03861767|451317828|FG004|Overall Study|Withdrawal by Subject|2|||
125461022|NCT03861767|451317829|FG005|Overall Study|Withdrawal by Subject|1|||
125461023|NCT03861767|451317830|FG006|Overall Study|Withdrawal by Subject|3|||
125461024|NCT03861767|451317831|FG007|Overall Study|Withdrawal by Subject|1|||
125461025|NCT03861767|451317832|FG008|Overall Study|Withdrawal by Subject|0|||
125461026|NCT03861767|451317833|FG009|Overall Study|Withdrawal by Subject|5|||
125461027|NCT00813904|451317834|FG000|Overall Study|Death|1|||
125461028|NCT01087762|451317835|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
125461029|NCT01087762|451317836|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
125461030|NCT01087762|451317837|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
125461031|NCT01087762|451317838|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
125461032|NCT01087762|451317839|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
125461033|NCT01087762|451317835|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
125461034|NCT01087762|451317836|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
125461035|NCT01087762|451317837|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
125461036|NCT01087762|451317838|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
125461037|NCT01087762|451317839|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
125461038|NCT01087762|451317835|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
125461039|NCT01087762|451317836|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
125461040|NCT01087762|451317837|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
125461041|NCT01087762|451317838|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
125461042|NCT01087762|451317839|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
125461043|NCT01087762|451317835|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
125461044|NCT01087762|451317836|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
125461045|NCT01087762|451317837|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
125461046|NCT01087762|451317838|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
125461047|NCT01087762|451317839|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
125461048|NCT01087762|451317835|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
125461049|NCT01087762|451317836|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
125461050|NCT01087762|451317837|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
125461051|NCT01087762|451317838|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
125461052|NCT01087762|451317839|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
125461053|NCT01087762|451317835|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
125461054|NCT01087762|451317836|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
125461055|NCT01087762|451317837|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
125461056|NCT01087762|451317838|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
125461057|NCT01087762|451317839|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
125461058|NCT01087762|451317835|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
125461059|NCT01087762|451317836|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
125461060|NCT01087762|451317837|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
125461061|NCT01087762|451317838|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
125461062|NCT01087762|451317839|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
125461063|NCT01087762|451317835|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
125461064|NCT01087762|451317836|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
125461065|NCT01087762|451317837|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
125461066|NCT01087762|451317838|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
125461067|NCT01087762|451317839|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
125295477|NCT00430937|450709455|FG001|Overall Study|Adverse Event|8|||
125295478|NCT00430937|450709454|FG000|Overall Study|Death|0|||
125295479|NCT00430937|450709455|FG001|Overall Study|Death|1|||
125295480|NCT00430937|450709454|FG000|Overall Study|Lost to Follow-up|6|||
125295481|NCT00430937|450709455|FG001|Overall Study|Lost to Follow-up|6|||
125295482|NCT00430937|450709454|FG000|Overall Study|Withdrawal by Subject|5|||
125295483|NCT00430937|450709455|FG001|Overall Study|Withdrawal by Subject|2|||
125295484|NCT00430937|450709454|FG000|Overall Study|Protocol Violation|3|||
125461068|NCT01087762|451317835|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
125461069|NCT01087762|451317836|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
125461070|NCT01087762|451317837|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
125461071|NCT01087762|451317838|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
125461072|NCT01087762|451317839|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
125461073|NCT01087762|451317835|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
125461074|NCT01087762|451317836|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
125461075|NCT01087762|451317837|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
125461076|NCT01087762|451317838|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
125461077|NCT01087762|451317839|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
125461078|NCT01087762|451317835|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
125461079|NCT01087762|451317836|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
125461080|NCT01087762|451317837|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
125461081|NCT01087762|451317838|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
125461082|NCT01087762|451317839|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
125461083|NCT01087762|451317835|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
125461084|NCT01087762|451317836|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
125461085|NCT01087762|451317837|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
125295485|NCT00430937|450709455|FG001|Overall Study|Protocol Violation|2|||
125295486|NCT00430937|450709454|FG000|Overall Study|Lack of Efficacy|6|||
125295487|NCT00430937|450709455|FG001|Overall Study|Lack of Efficacy|5|||
125295488|NCT00430937|450709454|FG000|Overall Study|Inappropriate enrollment|2|||
125295489|NCT00430937|450709455|FG001|Overall Study|Inappropriate enrollment|1|||
125295490|NCT00430937|450709454|FG000|Overall Study|Administrative reasons|1|||
125295491|NCT00430937|450709455|FG001|Overall Study|Administrative reasons|0|||
125295492|NCT00430937|450709454|FG000|Overall Study|Protocol discontinuation criteria met|1|||
125295493|NCT00430937|450709455|FG001|Overall Study|Protocol discontinuation criteria met|2|||
125295494|NCT00430937|450709454|FG000|Overall Study|Unable to classify|0|||
125295495|NCT00430937|450709455|FG001|Overall Study|Unable to classify|1|||
125461086|NCT01087762|451317838|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
125461087|NCT01087762|451317839|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
125461088|NCT01087762|451317835|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
125461089|NCT01087762|451317836|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
125461090|NCT01087762|451317837|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
125461091|NCT01087762|451317838|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
125461092|NCT01087762|451317839|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
125461093|NCT00424762|451317845|FG000|Overall Study|Withdrawal by Subject|18|||
125461094|NCT00424762|451317846|FG001|Overall Study|Withdrawal by Subject|19|||
125461095|NCT00424762|451317845|FG000|Overall Study|Lost to Follow-up|2|||
125461096|NCT00424762|451317846|FG001|Overall Study|Lost to Follow-up|3|||
125461097|NCT01405924|451317849|FG000|Overall Study|Protocol Violation|8|||
125461098|NCT01405924|451317849|FG000|Overall Study|Missing/Incomplete Data|2|||
125461099|NCT02808338|451317852|FG000|Screening|Screen Failure|10|||
125461100|NCT02808338|451317852|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
125461101|NCT02808338|451317852|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
125461102|NCT00057837|451317853|FG000|Overall Study|Progression/relapse|12|||
125461103|NCT00057837|451317854|FG001|Overall Study|Progression/relapse|14|||
125461104|NCT00057837|451317853|FG000|Overall Study|Adverse Event|2|||
125461105|NCT00057837|451317854|FG001|Overall Study|Adverse Event|12|||
125461106|NCT00057837|451317853|FG000|Overall Study|Death|5|||
125461107|NCT00057837|451317854|FG001|Overall Study|Death|4|||
125461108|NCT00057837|451317853|FG000|Overall Study|Withdrawal by Subject|5|||
125461109|NCT00057837|451317854|FG001|Overall Study|Withdrawal by Subject|3|||
125461110|NCT00057837|451317853|FG000|Overall Study|Alternative therapy|0|||
125461111|NCT00057837|451317854|FG001|Overall Study|Alternative therapy|1|||
125461112|NCT00057837|451317853|FG000|Overall Study|Other complicating disease|2|||
125461113|NCT00057837|451317854|FG001|Overall Study|Other complicating disease|1|||
125461114|NCT00057837|451317853|FG000|Overall Study|Physician Decision|1|||
125461115|NCT00057837|451317854|FG001|Overall Study|Physician Decision|0|||
125461116|NCT00057837|451317853|FG000|Overall Study|Ineligible|3|||
125461117|NCT00057837|451317854|FG001|Overall Study|Ineligible|3|||
125461118|NCT00057837|451317853|FG000|Overall Study|Never started treatment|1|||
125461119|NCT00057837|451317854|FG001|Overall Study|Never started treatment|1|||
125461120|NCT00463788|451317856|FG000|Overall Study|Progressive Disease|86|||
125461121|NCT00463788|451317857|FG001|Overall Study|Progressive Disease|42|||
125461122|NCT00463788|451317856|FG000|Overall Study|Adverse Event|6|||
125461123|NCT00463788|451317857|FG001|Overall Study|Adverse Event|2|||
125461124|NCT00463788|451317856|FG000|Overall Study|Withdrawal by Subject|6|||
125461125|NCT00463788|451317857|FG001|Overall Study|Withdrawal by Subject|2|||
125461126|NCT00463788|451317856|FG000|Overall Study|Death|4|||
125461127|NCT00463788|451317857|FG001|Overall Study|Death|3|||
125461128|NCT00463788|451317856|FG000|Overall Study|Symptomatic Deterioration|2|||
125461129|NCT00463788|451317857|FG001|Overall Study|Symptomatic Deterioration|3|||
125461130|NCT00463788|451317856|FG000|Overall Study|Lost to Follow-up|1|||
125461131|NCT00463788|451317857|FG001|Overall Study|Lost to Follow-up|0|||
125461132|NCT00463788|451317856|FG000|Overall Study|Protocol Violation|0|||
125461133|NCT00463788|451317857|FG001|Overall Study|Protocol Violation|1|||
125461134|NCT00463788|451317856|FG000|Overall Study|Other|3|||
125461135|NCT00463788|451317857|FG001|Overall Study|Other|0|||
125461136|NCT00463788|451317856|FG000|Overall Study|Randomized but not treated|1|||
125461137|NCT00463788|451317857|FG001|Overall Study|Randomized but not treated|1|||
125461138|NCT00360698|451317858|FG000|Run-In|Physician Decision|0|||
125461139|NCT00360698|451317859|FG001|Run-In|Physician Decision|1|||
125461140|NCT00360698|451317858|FG000|Run-In|Withdrawal by Subject|0|||
125461141|NCT00360698|451317859|FG001|Run-In|Withdrawal by Subject|2|||
125461142|NCT00360698|451317858|FG000|Run-In|Non compliance with treatment procedure|0|||
125461143|NCT00360698|451317859|FG001|Run-In|Non compliance with treatment procedure|1|||
125461144|NCT00360698|451317858|FG000|Run-In|Sponsor request|0|||
125461145|NCT00360698|451317859|FG001|Run-In|Sponsor request|2|||
125461146|NCT00360698|451317858|FG000|Run-In|Patient did not meet inclusion criteria|0|||
125461147|NCT00360698|451317859|FG001|Run-In|Patient did not meet inclusion criteria|1|||
125461148|NCT00360698|451317858|FG000|Run-In|Patient personal reasons|0|||
125461149|NCT00360698|451317859|FG001|Run-In|Patient personal reasons|2|||
125295496|NCT03242252|450709457|FG000|Overall Study|At the Participant's own Request|18|||
125295497|NCT03242252|450709458|FG001|Overall Study|At the Participant's own Request|10|||
125295498|NCT03242252|450709459|FG002|Overall Study|At the Participant's own Request|15|||
125461150|NCT00360698|451317858|FG000|Run-In|Need of insulin with meals|0|||
125461151|NCT00360698|451317859|FG001|Run-In|Need of insulin with meals|1|||
125461152|NCT00360698|451317858|FG000|Treatment Period|Non compliance with treatment procedure|1|||
125461153|NCT00360698|451317859|FG001|Treatment Period|Non compliance with treatment procedure|0|||
125461154|NCT00360698|451317858|FG000|Treatment Period|Early termination by error|0|||
125461155|NCT00360698|451317859|FG001|Treatment Period|Early termination by error|1|||
125461156|NCT03024606|451317864|FG000|Overall Study|Withdrawal by Subject|9|||
125461157|NCT03024606|451317865|FG001|Overall Study|Withdrawal by Subject|10|||
125295499|NCT03242252|450709457|FG000|Overall Study|Adverse Event|8|||
125461158|NCT01692938|451317867|FG000|Overall Study|Protocol Deviation|1|||
125461159|NCT01692938|451317868|FG001|Overall Study|Protocol Deviation|1|||
125461160|NCT01692938|451317867|FG000|Overall Study|Study completed prior to site completion|3|||
125461161|NCT01692938|451317868|FG001|Overall Study|Study completed prior to site completion|3|||
125461162|NCT02547922|451317871|FG000|Overall Study|Withdrawal by Subject|9|||
125461163|NCT02547922|451317872|FG001|Overall Study|Withdrawal by Subject|6|||
125461164|NCT02547922|451317873|FG002|Overall Study|Withdrawal by Subject|10|||
125461165|NCT02547922|451317871|FG000|Overall Study|Adverse Event|3|||
125461166|NCT02547922|451317872|FG001|Overall Study|Adverse Event|1|||
125461167|NCT02547922|451317873|FG002|Overall Study|Adverse Event|2|||
125461168|NCT02547922|451317871|FG000|Overall Study|Lost to Follow-up|1|||
125461169|NCT02547922|451317872|FG001|Overall Study|Lost to Follow-up|0|||
125461170|NCT02547922|451317873|FG002|Overall Study|Lost to Follow-up|0|||
125461171|NCT02547922|451317871|FG000|Overall Study|Lack of Efficacy|5|||
125461172|NCT02547922|451317872|FG001|Overall Study|Lack of Efficacy|7|||
125461173|NCT02547922|451317873|FG002|Overall Study|Lack of Efficacy|4|||
125461174|NCT02547922|451317871|FG000|Overall Study|Death|1|||
125461175|NCT02547922|451317872|FG001|Overall Study|Death|0|||
125461176|NCT02547922|451317873|FG002|Overall Study|Death|0|||
125461177|NCT02547922|451317871|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
125461178|NCT02547922|451317872|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
125461179|NCT02547922|451317873|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
125461180|NCT02547922|451317871|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
125461181|NCT02547922|451317872|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
125461182|NCT02547922|451317873|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
125461183|NCT02547922|451317871|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
125461184|NCT02547922|451317872|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
125461185|NCT02547922|451317873|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
125461186|NCT02547922|451317871|FG000|Overall Study|Physician Decision|2|||
125461187|NCT02547922|451317872|FG001|Overall Study|Physician Decision|1|||
125461188|NCT02547922|451317873|FG002|Overall Study|Physician Decision|2|||
125461189|NCT02547922|451317871|FG000|Overall Study|Patients did not receive IP|1|||
125461190|NCT02547922|451317872|FG001|Overall Study|Patients did not receive IP|1|||
125461191|NCT02547922|451317873|FG002|Overall Study|Patients did not receive IP|0|||
125461192|NCT05190419|451317879|FG000|Overall Study|Lack of Efficacy|8|||
125461193|NCT05190419|451317880|FG001|Overall Study|Lack of Efficacy|0|||
125461194|NCT05190419|451317881|FG002|Overall Study|Lack of Efficacy|1|||
125461195|NCT05190419|451317882|FG003|Overall Study|Lack of Efficacy|0|||
125461196|NCT05190419|451317879|FG000|Overall Study|Withdrawal by Subject|7|||
125461197|NCT05190419|451317880|FG001|Overall Study|Withdrawal by Subject|1|||
125461198|NCT05190419|451317881|FG002|Overall Study|Withdrawal by Subject|2|||
125461199|NCT05190419|451317882|FG003|Overall Study|Withdrawal by Subject|2|||
125461200|NCT05190419|451317879|FG000|Overall Study|Adverse Event|2|||
125461201|NCT05190419|451317880|FG001|Overall Study|Adverse Event|10|||
125461202|NCT05190419|451317881|FG002|Overall Study|Adverse Event|11|||
125461203|NCT05190419|451317882|FG003|Overall Study|Adverse Event|21|||
125461204|NCT05190419|451317879|FG000|Overall Study|Lost to Follow-up|1|||
125461205|NCT05190419|451317880|FG001|Overall Study|Lost to Follow-up|2|||
125461206|NCT05190419|451317881|FG002|Overall Study|Lost to Follow-up|3|||
125461207|NCT05190419|451317882|FG003|Overall Study|Lost to Follow-up|1|||
125461208|NCT05190419|451317879|FG000|Overall Study|Other|1|||
125461209|NCT05190419|451317880|FG001|Overall Study|Other|1|||
125461210|NCT05190419|451317881|FG002|Overall Study|Other|0|||
125461211|NCT05190419|451317882|FG003|Overall Study|Other|3|||
125461212|NCT00919763|451317883|FG000|Overall Study|Adverse Event|7|||
125461213|NCT00919763|451317884|FG001|Overall Study|Adverse Event|1|||
125461214|NCT00919763|451317883|FG000|Overall Study|Lost to Follow-up|1|||
125461215|NCT00919763|451317884|FG001|Overall Study|Lost to Follow-up|0|||
125461216|NCT00919763|451317883|FG000|Overall Study|Protocol Violation|1|||
125461217|NCT00919763|451317884|FG001|Overall Study|Protocol Violation|1|||
125461218|NCT00919763|451317883|FG000|Overall Study|Withdrawal by Subject|3|||
125461219|NCT00919763|451317884|FG001|Overall Study|Withdrawal by Subject|1|||
125461220|NCT00919763|451317883|FG000|Overall Study|Non-compliance|0|||
125461221|NCT00919763|451317884|FG001|Overall Study|Non-compliance|1|||
125461222|NCT00256243|451317888|FG000|Overall Study|Lost to Follow-up|2|||
125461223|NCT00256243|451317888|FG000|Overall Study|Death|7|||
125461224|NCT00256243|451317888|FG000|Overall Study|Not treated|1|||
125461225|NCT05061693|451317889|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
125461226|NCT05061693|451317890|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
125461227|NCT05061693|451317891|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
125461228|NCT05061693|451317892|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
125461229|NCT05061693|451317893|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
125461230|NCT05061693|451317894|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
125461231|NCT05061693|451317895|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
125461232|NCT05061693|451317896|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
125461233|NCT05061693|451317897|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
125461234|NCT05061693|451317898|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
125485362|NCT02240238|451412512|FG009|Phase 1|Death|0|||
125461235|NCT05061693|451317899|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
125461236|NCT05061693|451317900|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
125461237|NCT05061693|451317889|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
125461238|NCT05061693|451317890|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
125461239|NCT05061693|451317891|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
125461240|NCT05061693|451317892|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
125461241|NCT05061693|451317893|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
125461242|NCT05061693|451317894|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
125461243|NCT05061693|451317895|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
125461244|NCT05061693|451317896|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
125461245|NCT05061693|451317897|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
125461246|NCT05061693|451317898|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
125461247|NCT05061693|451317899|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
125461248|NCT05061693|451317900|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
125461249|NCT05061693|451317889|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
125461250|NCT05061693|451317890|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
125461251|NCT05061693|451317891|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
125461252|NCT05061693|451317892|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
125461253|NCT05061693|451317893|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
125461254|NCT05061693|451317894|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
125461255|NCT05061693|451317895|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
125461256|NCT05061693|451317896|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
125461257|NCT05061693|451317897|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
125461258|NCT05061693|451317898|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
125461259|NCT05061693|451317899|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
125461260|NCT05061693|451317900|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
125461261|NCT05061693|451317889|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
125461262|NCT05061693|451317890|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
125461263|NCT05061693|451317891|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
125461264|NCT05061693|451317892|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
125461265|NCT05061693|451317893|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
125461266|NCT05061693|451317894|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
125461267|NCT05061693|451317895|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
125461268|NCT05061693|451317896|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
125461269|NCT05061693|451317897|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
125461270|NCT05061693|451317898|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
125461271|NCT05061693|451317899|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
125461272|NCT05061693|451317900|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
125461273|NCT05061693|451317889|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
125461274|NCT05061693|451317890|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
125461275|NCT05061693|451317891|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
125461276|NCT05061693|451317892|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
125461277|NCT05061693|451317893|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
125461278|NCT05061693|451317894|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
125461279|NCT05061693|451317895|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
125461280|NCT05061693|451317896|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
125461281|NCT05061693|451317897|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
125461282|NCT05061693|451317898|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
125461283|NCT05061693|451317899|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
125461284|NCT05061693|451317900|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
125461285|NCT05061693|451317889|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
125461286|NCT05061693|451317890|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
125295500|NCT03242252|450709458|FG001|Overall Study|Adverse Event|6|||
125461287|NCT05061693|451317891|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
125461288|NCT05061693|451317892|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
125461289|NCT05061693|451317893|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
125461290|NCT05061693|451317894|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
125461291|NCT05061693|451317895|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
125461292|NCT05061693|451317896|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
125485363|NCT02240238|451412513|FG010|Phase 1|Death|0|||
125295501|NCT03242252|450709459|FG002|Overall Study|Adverse Event|9|||
125295502|NCT03242252|450709457|FG000|Overall Study|Poor Compliance to Protocol|0|||
125295503|NCT03242252|450709458|FG001|Overall Study|Poor Compliance to Protocol|2|||
125295504|NCT03242252|450709459|FG002|Overall Study|Poor Compliance to Protocol|3|||
125295505|NCT03242252|450709457|FG000|Overall Study|Study Terminated by Sponsor|1|||
125295506|NCT03242252|450709458|FG001|Overall Study|Study Terminated by Sponsor|0|||
125295507|NCT03242252|450709459|FG002|Overall Study|Study Terminated by Sponsor|0|||
125461293|NCT05061693|451317897|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
125461294|NCT05061693|451317898|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
125461295|NCT05061693|451317899|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
125461296|NCT05061693|451317900|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
125461297|NCT05061693|451317889|FG000|24-week Extension Period|Adverse Event|0|||
125461298|NCT05061693|451317890|FG001|24-week Extension Period|Adverse Event|0|||
125461299|NCT05061693|451317891|FG002|24-week Extension Period|Adverse Event|0|||
125461300|NCT05061693|451317892|FG003|24-week Extension Period|Adverse Event|0|||
125461301|NCT05061693|451317893|FG004|24-week Extension Period|Adverse Event|0|||
125461302|NCT05061693|451317894|FG005|24-week Extension Period|Adverse Event|0|||
125461303|NCT05061693|451317895|FG006|24-week Extension Period|Adverse Event|0|||
125461304|NCT05061693|451317896|FG007|24-week Extension Period|Adverse Event|2|||
125461305|NCT05061693|451317897|FG008|24-week Extension Period|Adverse Event|2|||
125461306|NCT05061693|451317898|FG009|24-week Extension Period|Adverse Event|0|||
125461307|NCT05061693|451317899|FG010|24-week Extension Period|Adverse Event|1|||
125461308|NCT05061693|451317900|FG011|24-week Extension Period|Adverse Event|3|||
125461309|NCT05061693|451317889|FG000|24-week Extension Period|Lack of Efficacy|0|||
125461310|NCT05061693|451317890|FG001|24-week Extension Period|Lack of Efficacy|0|||
125461311|NCT05061693|451317891|FG002|24-week Extension Period|Lack of Efficacy|0|||
125461312|NCT05061693|451317892|FG003|24-week Extension Period|Lack of Efficacy|0|||
125461313|NCT05061693|451317893|FG004|24-week Extension Period|Lack of Efficacy|0|||
125461314|NCT05061693|451317894|FG005|24-week Extension Period|Lack of Efficacy|0|||
125461315|NCT05061693|451317895|FG006|24-week Extension Period|Lack of Efficacy|0|||
125461316|NCT05061693|451317896|FG007|24-week Extension Period|Lack of Efficacy|0|||
125461317|NCT05061693|451317897|FG008|24-week Extension Period|Lack of Efficacy|0|||
125461318|NCT05061693|451317898|FG009|24-week Extension Period|Lack of Efficacy|0|||
125461319|NCT05061693|451317899|FG010|24-week Extension Period|Lack of Efficacy|2|||
125461320|NCT05061693|451317900|FG011|24-week Extension Period|Lack of Efficacy|0|||
125461321|NCT05061693|451317889|FG000|24-week Extension Period|Lost to Follow-up|0|||
125461322|NCT05061693|451317890|FG001|24-week Extension Period|Lost to Follow-up|0|||
125461323|NCT05061693|451317891|FG002|24-week Extension Period|Lost to Follow-up|0|||
125461324|NCT05061693|451317892|FG003|24-week Extension Period|Lost to Follow-up|0|||
125461325|NCT05061693|451317893|FG004|24-week Extension Period|Lost to Follow-up|0|||
125461326|NCT05061693|451317894|FG005|24-week Extension Period|Lost to Follow-up|0|||
125461327|NCT05061693|451317895|FG006|24-week Extension Period|Lost to Follow-up|1|||
125461328|NCT05061693|451317896|FG007|24-week Extension Period|Lost to Follow-up|0|||
125461329|NCT05061693|451317897|FG008|24-week Extension Period|Lost to Follow-up|1|||
125461330|NCT05061693|451317898|FG009|24-week Extension Period|Lost to Follow-up|1|||
125461331|NCT05061693|451317899|FG010|24-week Extension Period|Lost to Follow-up|0|||
125461332|NCT05061693|451317900|FG011|24-week Extension Period|Lost to Follow-up|0|||
125461333|NCT05061693|451317889|FG000|24-week Extension Period|Withdrawal by Subject|0|||
125461334|NCT05061693|451317890|FG001|24-week Extension Period|Withdrawal by Subject|0|||
125461335|NCT05061693|451317891|FG002|24-week Extension Period|Withdrawal by Subject|0|||
125461336|NCT05061693|451317892|FG003|24-week Extension Period|Withdrawal by Subject|0|||
125461337|NCT05061693|451317893|FG004|24-week Extension Period|Withdrawal by Subject|0|||
125461338|NCT05061693|451317894|FG005|24-week Extension Period|Withdrawal by Subject|0|||
125461339|NCT05061693|451317895|FG006|24-week Extension Period|Withdrawal by Subject|0|||
125461340|NCT05061693|451317896|FG007|24-week Extension Period|Withdrawal by Subject|0|||
125461341|NCT05061693|451317897|FG008|24-week Extension Period|Withdrawal by Subject|1|||
125461342|NCT05061693|451317898|FG009|24-week Extension Period|Withdrawal by Subject|2|||
125461343|NCT05061693|451317899|FG010|24-week Extension Period|Withdrawal by Subject|2|||
125461344|NCT05061693|451317900|FG011|24-week Extension Period|Withdrawal by Subject|1|||
125461345|NCT05061693|451317889|FG000|24-week Extension Period|Sponsor Decision|0|||
125461346|NCT05061693|451317890|FG001|24-week Extension Period|Sponsor Decision|0|||
125461347|NCT05061693|451317891|FG002|24-week Extension Period|Sponsor Decision|0|||
125461348|NCT05061693|451317892|FG003|24-week Extension Period|Sponsor Decision|0|||
125461349|NCT05061693|451317893|FG004|24-week Extension Period|Sponsor Decision|0|||
125461350|NCT05061693|451317894|FG005|24-week Extension Period|Sponsor Decision|0|||
125461351|NCT05061693|451317895|FG006|24-week Extension Period|Sponsor Decision|0|||
125461352|NCT05061693|451317896|FG007|24-week Extension Period|Sponsor Decision|1|||
125461353|NCT05061693|451317897|FG008|24-week Extension Period|Sponsor Decision|0|||
125461354|NCT05061693|451317898|FG009|24-week Extension Period|Sponsor Decision|0|||
125461355|NCT05061693|451317899|FG010|24-week Extension Period|Sponsor Decision|0|||
125461356|NCT05061693|451317900|FG011|24-week Extension Period|Sponsor Decision|0|||
125461357|NCT05061693|451317889|FG000|24-week Extension Period|Site Closure|0|||
125461358|NCT05061693|451317890|FG001|24-week Extension Period|Site Closure|0|||
125461359|NCT05061693|451317891|FG002|24-week Extension Period|Site Closure|0|||
125461360|NCT05061693|451317892|FG003|24-week Extension Period|Site Closure|0|||
125461361|NCT05061693|451317893|FG004|24-week Extension Period|Site Closure|0|||
125461362|NCT05061693|451317894|FG005|24-week Extension Period|Site Closure|0|||
125461363|NCT05061693|451317895|FG006|24-week Extension Period|Site Closure|0|||
125461364|NCT05061693|451317896|FG007|24-week Extension Period|Site Closure|0|||
125485364|NCT02240238|451412514|FG011|Phase 1|Death|0|||
125461365|NCT05061693|451317897|FG008|24-week Extension Period|Site Closure|1|||
125461366|NCT05061693|451317898|FG009|24-week Extension Period|Site Closure|0|||
125461367|NCT05061693|451317899|FG010|24-week Extension Period|Site Closure|0|||
125461368|NCT05061693|451317900|FG011|24-week Extension Period|Site Closure|1|||
125461369|NCT03823911|451317901|FG000|Overall Study|Lost to Follow-up|1|||
125461370|NCT03823911|451317902|FG001|Overall Study|Lost to Follow-up|5|||
125461371|NCT03823911|451317903|FG002|Overall Study|Lost to Follow-up|2|||
125461372|NCT03823911|451317901|FG000|Overall Study|Did not meet eligibility criteria|13|||
125461373|NCT03823911|451317902|FG001|Overall Study|Did not meet eligibility criteria|7|||
125461374|NCT03823911|451317903|FG002|Overall Study|Did not meet eligibility criteria|4|||
125461375|NCT03823911|451317901|FG000|Overall Study|Death|0|||
125461376|NCT03823911|451317902|FG001|Overall Study|Death|1|||
125461377|NCT03823911|451317903|FG002|Overall Study|Death|0|||
125461378|NCT01152190|451317904|FG000|Overall Study|Adverse Event|2|||
125461379|NCT01152190|451317905|FG001|Overall Study|Adverse Event|4|||
125461380|NCT01152190|451317904|FG000|Overall Study|Death|1|||
125461381|NCT01152190|451317905|FG001|Overall Study|Death|0|||
125461382|NCT01152190|451317904|FG000|Overall Study|Protocol Violation|1|||
125461383|NCT01152190|451317905|FG001|Overall Study|Protocol Violation|1|||
125461384|NCT01152190|451317904|FG000|Overall Study|Withdrawal by Subject|1|||
125461385|NCT01152190|451317905|FG001|Overall Study|Withdrawal by Subject|3|||
125461386|NCT00547118|451317908|FG000|Overall Study|Did not qualify prior to starting drug|1|||
125461387|NCT00547118|451317909|FG001|Overall Study|Did not qualify prior to starting drug|1|||
125461388|NCT00547118|451317908|FG000|Overall Study|Study suspended|7|||
125461389|NCT00547118|451317909|FG001|Overall Study|Study suspended|8|||
125461390|NCT00442117|451317910|FG000|Overall Study|Adverse Event|3|||
125461391|NCT00442117|451317911|FG001|Overall Study|Adverse Event|2|||
125461392|NCT00442117|451317910|FG000|Overall Study|Lack of Efficacy|2|||
125461393|NCT00442117|451317911|FG001|Overall Study|Lack of Efficacy|6|||
125461394|NCT00442117|451317910|FG000|Overall Study|Lost to Follow-up|1|||
125461395|NCT00442117|451317911|FG001|Overall Study|Lost to Follow-up|2|||
125461396|NCT00442117|451317910|FG000|Overall Study|Withdrawal by Subject|2|||
125461397|NCT00442117|451317911|FG001|Overall Study|Withdrawal by Subject|2|||
125461398|NCT00442117|451317910|FG000|Overall Study|Major Deviation|25|||
125461399|NCT00442117|451317911|FG001|Overall Study|Major Deviation|20|||
125461400|NCT00442117|451317910|FG000|Overall Study|Non compliance with protocol|3|||
125461401|NCT00442117|451317911|FG001|Overall Study|Non compliance with protocol|5|||
125461402|NCT00442117|451317910|FG000|Overall Study|Met Withdrawal Criteria|2|||
125461403|NCT00442117|451317911|FG001|Overall Study|Met Withdrawal Criteria|1|||
125461404|NCT00305695|451317917|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
125461405|NCT00305695|451317918|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
125461406|NCT00305695|451317917|FG000|Overall Study|Did not have baseline scan|1|||
125461407|NCT00305695|451317918|FG001|Overall Study|Did not have baseline scan|1|||
125461408|NCT02031471|451317921|FG000|24 Week Treatment Period|Adverse Event|6|||
125461409|NCT02031471|451317921|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
125461410|NCT02031471|451317921|FG000|24 Week Treatment Period|Protocol Violation|1|||
125461411|NCT02031471|451317921|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
125461412|NCT02031471|451317921|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
125461413|NCT02031471|451317921|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
125461414|NCT02031471|451317921|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
125461415|NCT00841035|451317922|FG000|Phase 1 Overall Study|Physician Decision|13|||
125461416|NCT00997386|451317923|FG000|Overall Study|Death|7|||
125461417|NCT05328297|451319492|FG000|Overall Study|Adverse Event|5|||
125461418|NCT05328297|451319493|FG001|Overall Study|Adverse Event|7|||
125461419|NCT05328297|451319492|FG000|Overall Study|Withdrawal by Subject|4|||
125461420|NCT05328297|451319493|FG001|Overall Study|Withdrawal by Subject|3|||
125461421|NCT05328297|451319492|FG000|Overall Study|Lack of Efficacy|1|||
125461422|NCT05328297|451319493|FG001|Overall Study|Lack of Efficacy|0|||
125461423|NCT05328297|451319492|FG000|Overall Study|Lost to Follow-up|1|||
125461424|NCT05328297|451319493|FG001|Overall Study|Lost to Follow-up|0|||
125461425|NCT05328297|451319492|FG000|Overall Study|Protocol Violation|1|||
125461426|NCT05328297|451319493|FG001|Overall Study|Protocol Violation|0|||
125461427|NCT05328297|451319492|FG000|Overall Study|Randomized but not treated|1|||
125461428|NCT05328297|451319493|FG001|Overall Study|Randomized but not treated|1|||
125461429|NCT03544515|451319503|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
125461430|NCT03544515|451319504|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
125461431|NCT03544515|451319503|FG000|Overall Study|Lost to Follow-up|2|||
125461432|NCT03544515|451319504|FG001|Overall Study|Lost to Follow-up|0|||
125461433|NCT03175172|451319505|FG000|Overall Study|Death|3|||
125461434|NCT03175172|451319505|FG000|Overall Study|Withdrawal by Subject|3|||
125461435|NCT03175172|451319505|FG000|Overall Study|Lost to Follow-up|1|||
125461436|NCT03175172|451319505|FG000|Overall Study|Study Terminated by Sponsor|3|||
125461437|NCT03169244|451319506|FG000|Overall Study|Lost to Follow-up|1|||
125461438|NCT03169244|451319507|FG001|Overall Study|Lost to Follow-up|2|||
125461439|NCT03169244|451319506|FG000|Overall Study|Adverse Event|1|||
125461440|NCT03169244|451319507|FG001|Overall Study|Adverse Event|0|||
125461441|NCT03169244|451319506|FG000|Overall Study|Withdrawal by Subject|2|||
125461442|NCT03169244|451319507|FG001|Overall Study|Withdrawal by Subject|2|||
125461443|NCT03169244|451319506|FG000|Overall Study|Physician Decision|1|||
125461444|NCT03169244|451319507|FG001|Overall Study|Physician Decision|0|||
125461445|NCT01662336|451319508|FG000|Overall Study|Adverse Event|1|||
125461446|NCT01662336|451319508|FG000|Overall Study|No longer on LPV/r|30|||
125461447|NCT01662336|451319508|FG000|Overall Study|Other|29|||
125461448|NCT01662336|451319508|FG000|Overall Study|Withdrawal by Subject|6|||
125461449|NCT03622593|451319512|FG000|Overall Study|Withdrawal by Subject|11|||
125461450|NCT03622593|451319513|FG001|Overall Study|Withdrawal by Subject|9|||
125461451|NCT03622593|451319514|FG002|Overall Study|Withdrawal by Subject|13|||
125461452|NCT03622593|451319512|FG000|Overall Study|Death|12|||
125461453|NCT03622593|451319513|FG001|Overall Study|Death|9|||
125461454|NCT03622593|451319514|FG002|Overall Study|Death|10|||
125461455|NCT03622593|451319512|FG000|Overall Study|Lost to Follow-up|11|||
125461456|NCT03622593|451319513|FG001|Overall Study|Lost to Follow-up|5|||
125461457|NCT03622593|451319514|FG002|Overall Study|Lost to Follow-up|8|||
125461458|NCT03622593|451319512|FG000|Overall Study|Adverse Event|4|||
125461459|NCT03622593|451319513|FG001|Overall Study|Adverse Event|5|||
125461460|NCT03622593|451319514|FG002|Overall Study|Adverse Event|6|||
125461461|NCT03622593|451319512|FG000|Overall Study|Physician Decision|2|||
125461462|NCT03622593|451319513|FG001|Overall Study|Physician Decision|1|||
125461463|NCT03622593|451319514|FG002|Overall Study|Physician Decision|6|||
125461464|NCT03622593|451319512|FG000|Overall Study|Other|2|||
125461465|NCT03622593|451319513|FG001|Overall Study|Other|2|||
125461466|NCT03622593|451319514|FG002|Overall Study|Other|3|||
125461467|NCT03622593|451319512|FG000|Overall Study|Protocol Violation|0|||
125461468|NCT03622593|451319513|FG001|Overall Study|Protocol Violation|0|||
125461469|NCT03622593|451319514|FG002|Overall Study|Protocol Violation|1|||
125461470|NCT03622593|451319512|FG000|Overall Study|Pregnancy|0|||
125461471|NCT03622593|451319513|FG001|Overall Study|Pregnancy|0|||
125461472|NCT03622593|451319514|FG002|Overall Study|Pregnancy|1|||
125461473|NCT03762668|451319515|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
125461474|NCT03762668|451319516|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
125461475|NCT00178399|451319517|FG000|Overall Study|Physician Decision|4|||
125461476|NCT00178399|451319517|FG000|Overall Study|Withdrawal by Subject|8|||
125461477|NCT00178399|451319517|FG000|Overall Study|Lost to Follow-up|1|||
125461478|NCT01393119|451319518|FG000|Overall Study|Adverse Event|1|||
125461479|NCT01393119|451319519|FG001|Overall Study|Adverse Event|1|||
125461480|NCT01393119|451319520|FG002|Overall Study|Adverse Event|0|||
125461481|NCT01393119|451319521|FG003|Overall Study|Adverse Event|1|||
125461482|NCT01393119|451319518|FG000|Overall Study|Withdrawal by Subject|0|||
125461483|NCT01393119|451319519|FG001|Overall Study|Withdrawal by Subject|1|||
125461484|NCT01393119|451319520|FG002|Overall Study|Withdrawal by Subject|1|||
125461485|NCT01393119|451319521|FG003|Overall Study|Withdrawal by Subject|0|||
125461486|NCT01393119|451319518|FG000|Overall Study|Lack of Efficacy|1|||
125461487|NCT01393119|451319519|FG001|Overall Study|Lack of Efficacy|0|||
125461488|NCT01393119|451319520|FG002|Overall Study|Lack of Efficacy|2|||
125461489|NCT01393119|451319521|FG003|Overall Study|Lack of Efficacy|1|||
125461490|NCT01393119|451319518|FG000|Overall Study|Protocol Violation|0|||
125461491|NCT01393119|451319519|FG001|Overall Study|Protocol Violation|0|||
125461492|NCT01393119|451319520|FG002|Overall Study|Protocol Violation|1|||
125461493|NCT01393119|451319521|FG003|Overall Study|Protocol Violation|0|||
125461494|NCT01393119|451319518|FG000|Overall Study|Death|0|||
125461495|NCT01393119|451319519|FG001|Overall Study|Death|0|||
125461496|NCT01393119|451319520|FG002|Overall Study|Death|0|||
125461497|NCT01393119|451319521|FG003|Overall Study|Death|1|||
125461498|NCT01393119|451319518|FG000|Overall Study|Randomized but Not treated|1|||
125461499|NCT01393119|451319519|FG001|Overall Study|Randomized but Not treated|0|||
125461500|NCT01393119|451319520|FG002|Overall Study|Randomized but Not treated|1|||
125461501|NCT01393119|451319521|FG003|Overall Study|Randomized but Not treated|1|||
125461502|NCT01393119|451319518|FG000|Overall Study|Sponsor Termination of Study|11|||
125461503|NCT01393119|451319519|FG001|Overall Study|Sponsor Termination of Study|12|||
125461504|NCT01393119|451319520|FG002|Overall Study|Sponsor Termination of Study|9|||
125461505|NCT01393119|451319521|FG003|Overall Study|Sponsor Termination of Study|12|||
125461506|NCT02544152|451319522|FG000|Overall Study|Adverse Event|0|||
125461507|NCT02544152|451319523|FG001|Overall Study|Adverse Event|4|||
125461508|NCT02544152|451319522|FG000|Overall Study|Withdrawal by Subject|0|||
125461509|NCT02544152|451319523|FG001|Overall Study|Withdrawal by Subject|3|||
125461510|NCT02544152|451319522|FG000|Overall Study|Other|1|||
125461511|NCT02544152|451319523|FG001|Overall Study|Other|0|||
125461512|NCT01759264|451319526|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
125461513|NCT01759264|451319526|FG000|Overall Study|Adverse Event|1|||
125461514|NCT01759264|451319526|FG000|Overall Study|Other|2|||
125461515|NCT01759264|451319526|FG000|Overall Study|Lost to Follow-up|2|||
125461516|NCT01759264|451319526|FG000|Overall Study|Withdrawal by Subject|3|||
125461517|NCT01759264|451319526|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
125461518|NCT00516321|451319527|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
125461519|NCT00516321|451319528|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
125461520|NCT00516321|451319529|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
125461521|NCT00516321|451319527|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
125461522|NCT00516321|451319528|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
125461523|NCT00516321|451319529|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
125461524|NCT00516321|451319527|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
125461525|NCT00516321|451319528|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
125461526|NCT00516321|451319529|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
125461527|NCT00516321|451319527|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
125461528|NCT00516321|451319528|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
125461529|NCT00516321|451319529|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
125461530|NCT00516321|451319527|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
125461531|NCT00516321|451319528|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
125461532|NCT00516321|451319529|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
125461533|NCT00516321|451319527|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
125461534|NCT00516321|451319528|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
125461535|NCT00516321|451319529|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
125461536|NCT00516321|451319527|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
125461537|NCT00516321|451319528|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
125461538|NCT00516321|451319529|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
125461539|NCT00516321|451319527|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
125461540|NCT00516321|451319528|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
125461541|NCT00516321|451319529|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
125461542|NCT00516321|451319527|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
125461543|NCT00516321|451319528|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
125461544|NCT00516321|451319529|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
125461545|NCT00516321|451319527|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
125461546|NCT00516321|451319528|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
125461547|NCT00516321|451319529|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
125461548|NCT00516321|451319527|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
125461549|NCT00516321|451319528|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
125461550|NCT00516321|451319529|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
125461551|NCT02027558|451319531|FG000|Overall Study|Death|0|||
125461552|NCT02027558|451319532|FG001|Overall Study|Death|1|||
125461553|NCT02027558|451319531|FG000|Overall Study|Withdrawal by Subject|2|||
125461554|NCT02027558|451319532|FG001|Overall Study|Withdrawal by Subject|0|||
125461555|NCT02027558|451319531|FG000|Overall Study|Lost to Follow-up|4|||
125461556|NCT02027558|451319532|FG001|Overall Study|Lost to Follow-up|1|||
125461557|NCT02027558|451319531|FG000|Overall Study|Refused assessment|3|||
125461558|NCT02027558|451319532|FG001|Overall Study|Refused assessment|0|||
125461559|NCT02139046|451319533|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
125461560|NCT02139046|451319534|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
125461561|NCT02139046|451319535|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
125461562|NCT02139046|451319536|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
125461563|NCT02139046|451319537|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
125461564|NCT02139046|451319533|FG000|Overall Study|Major Protocol Deviation|9|||
125461565|NCT02139046|451319534|FG001|Overall Study|Major Protocol Deviation|10|||
125461566|NCT02139046|451319535|FG002|Overall Study|Major Protocol Deviation|16|||
125461567|NCT02139046|451319536|FG003|Overall Study|Major Protocol Deviation|12|||
125461568|NCT02139046|451319537|FG004|Overall Study|Major Protocol Deviation|6|||
125461569|NCT02139046|451319533|FG000|Overall Study|Lost to Follow-up|13|||
125461570|NCT02139046|451319534|FG001|Overall Study|Lost to Follow-up|16|||
125461571|NCT02139046|451319535|FG002|Overall Study|Lost to Follow-up|16|||
125461572|NCT02139046|451319536|FG003|Overall Study|Lost to Follow-up|18|||
125461573|NCT02139046|451319537|FG004|Overall Study|Lost to Follow-up|13|||
125461574|NCT02139046|451319533|FG000|Overall Study|Voluntary Withdrawal|20|||
125461575|NCT02139046|451319534|FG001|Overall Study|Voluntary Withdrawal|8|||
125461576|NCT02139046|451319535|FG002|Overall Study|Voluntary Withdrawal|10|||
125461577|NCT02139046|451319536|FG003|Overall Study|Voluntary Withdrawal|15|||
125461578|NCT02139046|451319537|FG004|Overall Study|Voluntary Withdrawal|16|||
125461579|NCT02139046|451319533|FG000|Overall Study|Lack of Efficacy|0|||
125461580|NCT02139046|451319534|FG001|Overall Study|Lack of Efficacy|1|||
125461581|NCT02139046|451319535|FG002|Overall Study|Lack of Efficacy|2|||
125461582|NCT02139046|451319536|FG003|Overall Study|Lack of Efficacy|1|||
125461583|NCT02139046|451319537|FG004|Overall Study|Lack of Efficacy|2|||
125461584|NCT02139046|451319533|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
125461585|NCT02139046|451319534|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
125461586|NCT02139046|451319535|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
125461587|NCT02139046|451319536|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
125461588|NCT02139046|451319537|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
125461589|NCT02139046|451319533|FG000|Overall Study|Other Miscellaneous Reasons|10|||
125461590|NCT02139046|451319534|FG001|Overall Study|Other Miscellaneous Reasons|9|||
125461591|NCT02139046|451319535|FG002|Overall Study|Other Miscellaneous Reasons|4|||
125461592|NCT02139046|451319536|FG003|Overall Study|Other Miscellaneous Reasons|9|||
125461593|NCT02139046|451319537|FG004|Overall Study|Other Miscellaneous Reasons|12|||
125461594|NCT02383472|451319538|FG000|Overall Study|Withdrawal by Subject|1|||
125461595|NCT02383472|451319539|FG001|Overall Study|Withdrawal by Subject|1|||
125461596|NCT01111526|451319540|FG000|Overall Study|GVHD Disease Progression|0|||
125461597|NCT01111526|451319541|FG001|Overall Study|GVHD Disease Progression|1|||
125461598|NCT01111526|451319542|FG002|Overall Study|GVHD Disease Progression|2|||
125461599|NCT02013830|451319543|FG000|Overall Study|Adverse Event|3|||
125461600|NCT02013830|451319543|FG000|Overall Study|Death|1|||
125461601|NCT02013830|451319543|FG000|Overall Study|Insufficient therapeutic response|25|||
125461602|NCT02013830|451319543|FG000|Overall Study|Refused treatment|1|||
125461603|NCT02015546|451319544|FG000|Overall Study|Withdrawal by Subject|1|||
125461604|NCT02015546|451319545|FG001|Overall Study|Withdrawal by Subject|1|||
125461605|NCT02015546|451319546|FG002|Overall Study|Withdrawal by Subject|1|||
125461606|NCT02015546|451319544|FG000|Overall Study|Screem Failure|2|||
125461607|NCT02015546|451319545|FG001|Overall Study|Screem Failure|1|||
125461608|NCT02015546|451319546|FG002|Overall Study|Screem Failure|3|||
125461609|NCT04424641|451319547|FG000|Overall Study|Death|1|||
125461610|NCT04424641|451319548|FG001|Overall Study|Death|2|||
125461611|NCT04424641|451319549|FG002|Overall Study|Death|3|||
125461612|NCT04424641|451319550|FG003|Overall Study|Death|0|||
125461613|NCT04424641|451319551|FG004|Overall Study|Death|3|||
125461614|NCT04424641|451319552|FG005|Overall Study|Death|0|||
125461615|NCT04424641|451319553|FG006|Overall Study|Death|1|||
125461616|NCT04424641|451319554|FG007|Overall Study|Death|2|||
125461617|NCT04424641|451319547|FG000|Overall Study|Sponsor decision|0|||
125461618|NCT04424641|451319548|FG001|Overall Study|Sponsor decision|2|||
125461619|NCT04424641|451319549|FG002|Overall Study|Sponsor decision|3|||
125461620|NCT04424641|451319550|FG003|Overall Study|Sponsor decision|7|||
125461621|NCT04424641|451319551|FG004|Overall Study|Sponsor decision|2|||
125461622|NCT04424641|451319552|FG005|Overall Study|Sponsor decision|2|||
125461623|NCT04424641|451319553|FG006|Overall Study|Sponsor decision|3|||
125461624|NCT04424641|451319554|FG007|Overall Study|Sponsor decision|4|||
125461625|NCT04424641|451319547|FG000|Overall Study|Withdrawal by Subject|0|||
125461626|NCT04424641|451319548|FG001|Overall Study|Withdrawal by Subject|0|||
125461627|NCT04424641|451319549|FG002|Overall Study|Withdrawal by Subject|0|||
125461628|NCT04424641|451319550|FG003|Overall Study|Withdrawal by Subject|0|||
125461629|NCT04424641|451319551|FG004|Overall Study|Withdrawal by Subject|1|||
125461630|NCT04424641|451319552|FG005|Overall Study|Withdrawal by Subject|0|||
125461631|NCT04424641|451319553|FG006|Overall Study|Withdrawal by Subject|0|||
125461632|NCT04424641|451319554|FG007|Overall Study|Withdrawal by Subject|0|||
125461633|NCT04424641|451319547|FG000|Overall Study|Other|0|||
125461634|NCT04424641|451319548|FG001|Overall Study|Other|0|||
125461635|NCT04424641|451319549|FG002|Overall Study|Other|1|||
125461636|NCT04424641|451319550|FG003|Overall Study|Other|0|||
125461637|NCT04424641|451319551|FG004|Overall Study|Other|0|||
125461638|NCT04424641|451319552|FG005|Overall Study|Other|0|||
125461639|NCT04424641|451319553|FG006|Overall Study|Other|0|||
125461640|NCT04424641|451319554|FG007|Overall Study|Other|0|||
125295508|NCT03242252|450709457|FG000|Overall Study|Reason not Specified|4|||
125295509|NCT03242252|450709458|FG001|Overall Study|Reason not Specified|4|||
125295510|NCT03242252|450709459|FG002|Overall Study|Reason not Specified|1|||
125295511|NCT03242252|450709457|FG000|Overall Study|Lost to Follow-up|5|||
125295512|NCT03242252|450709458|FG001|Overall Study|Lost to Follow-up|1|||
125295513|NCT03242252|450709459|FG002|Overall Study|Lost to Follow-up|4|||
125295514|NCT01659255|450709460|FG000|Overall Study|Adverse Event|0|||
125295515|NCT01659255|450709461|FG001|Overall Study|Adverse Event|0|||
125295516|NCT01659255|450709462|FG002|Overall Study|Adverse Event|0|||
125295517|NCT01659255|450709463|FG003|Overall Study|Adverse Event|0|||
125295518|NCT01659255|450709464|FG004|Overall Study|Adverse Event|0|||
125295519|NCT01659255|450709465|FG005|Overall Study|Adverse Event|1|||
125461641|NCT01337635|451319561|FG000|Overall Study|Lost to Follow-up|0|||
125461642|NCT01337635|451319562|FG001|Overall Study|Lost to Follow-up|1|||
125295520|NCT01659255|450709466|FG006|Overall Study|Adverse Event|1|||
125295521|NCT01659255|450709467|FG007|Overall Study|Adverse Event|0|||
125295522|NCT01659255|450709468|FG008|Overall Study|Adverse Event|0|||
125295523|NCT01659255|450709469|FG009|Overall Study|Adverse Event|1|||
125461643|NCT01147341|451319569|FG000|Double Blind Period|Lack of Efficacy|1|||
125461644|NCT01147341|451319570|FG001|Double Blind Period|Lack of Efficacy|1|||
125295524|NCT01659255|450709470|FG010|Overall Study|Adverse Event|0|||
125295525|NCT01659255|450709471|FG011|Overall Study|Adverse Event|1|||
125295526|NCT01659255|450709472|FG012|Overall Study|Adverse Event|0|||
125295527|NCT01659255|450709473|FG013|Overall Study|Adverse Event|2|||
125461645|NCT01147341|451319569|FG000|Double Blind Period|Withdrawal by Subject|0|||
125295528|NCT01659255|450709474|FG014|Overall Study|Adverse Event|0|||
125461646|NCT01147341|451319570|FG001|Double Blind Period|Withdrawal by Subject|1|||
125461647|NCT01147341|451319569|FG000|Open Label Period|Lack of Efficacy|3|||
125461648|NCT01147341|451319570|FG001|Open Label Period|Lack of Efficacy|0|||
125295529|NCT01659255|450709475|FG015|Overall Study|Adverse Event|1|||
125295530|NCT01659255|450709476|FG016|Overall Study|Adverse Event|0|||
125295531|NCT01659255|450709460|FG000|Overall Study|Death|0|||
125295532|NCT01659255|450709461|FG001|Overall Study|Death|1|||
125295533|NCT01659255|450709462|FG002|Overall Study|Death|0|||
125295534|NCT01659255|450709463|FG003|Overall Study|Death|0|||
125295535|NCT01659255|450709464|FG004|Overall Study|Death|0|||
125295536|NCT01659255|450709465|FG005|Overall Study|Death|0|||
125295537|NCT01659255|450709466|FG006|Overall Study|Death|0|||
125295538|NCT01659255|450709467|FG007|Overall Study|Death|1|||
125295539|NCT01659255|450709468|FG008|Overall Study|Death|1|||
125295540|NCT01659255|450709469|FG009|Overall Study|Death|0|||
125295541|NCT01659255|450709470|FG010|Overall Study|Death|0|||
125461649|NCT01147341|451319569|FG000|Open Label Period|Subject moved|1|||
125461650|NCT01147341|451319570|FG001|Open Label Period|Subject moved|0|||
125461651|NCT04054635|451319579|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
125461652|NCT04054635|451319580|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
125461653|NCT04054635|451319581|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
125461654|NCT04054635|451319579|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
125461655|NCT04054635|451319580|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
125461656|NCT04054635|451319581|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
125461657|NCT00891930|451319582|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
125461658|NCT00891930|451319582|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
125461659|NCT00891930|451319582|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
125461660|NCT00891930|451319582|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
125461661|NCT00891930|451319582|FG000|Part 2 Panitumumab + AMG479|Death|30|||
125461662|NCT02537522|451319589|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
125295542|NCT01659255|450709471|FG011|Overall Study|Death|0|||
125461663|NCT02537522|451319590|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
125461664|NCT02537522|451319591|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
125461665|NCT02537522|451319592|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
125461666|NCT02537522|451319589|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
125461667|NCT02537522|451319590|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
125461668|NCT02537522|451319591|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
125461669|NCT02537522|451319592|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
125461670|NCT02537522|451319589|FG000|Phase I - Contralateral|incorrect randomization|0|||
125461671|NCT02537522|451319590|FG001|Phase I - Contralateral|incorrect randomization|1|||
125461672|NCT02537522|451319591|FG002|Phase I - Contralateral|incorrect randomization|0|||
125461673|NCT02537522|451319592|FG003|Phase I - Contralateral|incorrect randomization|0|||
125461674|NCT02537522|451319589|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
125461675|NCT02537522|451319590|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
125461676|NCT02537522|451319591|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
125461677|NCT02537522|451319592|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
125461678|NCT02537522|451319589|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
125461679|NCT02537522|451319590|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
125461680|NCT02537522|451319591|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
125461681|NCT02537522|451319592|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
125461682|NCT01317420|451319593|FG000|Overall Study|Progressive disease according to RECIST|2|||
125461683|NCT01317420|451319594|FG001|Overall Study|Progressive disease according to RECIST|3|||
125461684|NCT01317420|451319595|FG002|Overall Study|Progressive disease according to RECIST|3|||
125461685|NCT01317420|451319596|FG003|Overall Study|Progressive disease according to RECIST|3|||
125461686|NCT01317420|451319597|FG004|Overall Study|Progressive disease according to RECIST|3|||
125461687|NCT01317420|451319598|FG005|Overall Study|Progressive disease according to RECIST|3|||
125461688|NCT01317420|451319599|FG006|Overall Study|Progressive disease according to RECIST|3|||
125461689|NCT01317420|451319600|FG007|Overall Study|Progressive disease according to RECIST|3|||
125461690|NCT01317420|451319601|FG008|Overall Study|Progressive disease according to RECIST|3|||
125461691|NCT01317420|451319602|FG009|Overall Study|Progressive disease according to RECIST|2|||
125461692|NCT01317420|451319603|FG010|Overall Study|Progressive disease according to RECIST|3|||
125461693|NCT01317420|451319604|FG011|Overall Study|Progressive disease according to RECIST|11|||
125461694|NCT01317420|451319605|FG012|Overall Study|Progressive disease according to RECIST|16|||
125461695|NCT01317420|451319593|FG000|Overall Study|Other adverse event|1|||
125461696|NCT01317420|451319594|FG001|Overall Study|Other adverse event|0|||
125461697|NCT01317420|451319595|FG002|Overall Study|Other adverse event|0|||
125461698|NCT01317420|451319596|FG003|Overall Study|Other adverse event|0|||
125461699|NCT01317420|451319597|FG004|Overall Study|Other adverse event|0|||
125461700|NCT01317420|451319598|FG005|Overall Study|Other adverse event|0|||
125461701|NCT01317420|451319599|FG006|Overall Study|Other adverse event|0|||
125461702|NCT01317420|451319600|FG007|Overall Study|Other adverse event|0|||
125461703|NCT01317420|451319601|FG008|Overall Study|Other adverse event|0|||
125295543|NCT01659255|450709472|FG012|Overall Study|Death|1|||
125295544|NCT01659255|450709473|FG013|Overall Study|Death|1|||
125295545|NCT01659255|450709474|FG014|Overall Study|Death|2|||
125295546|NCT01659255|450709475|FG015|Overall Study|Death|1|||
125295547|NCT01659255|450709476|FG016|Overall Study|Death|0|||
125461704|NCT01317420|451319602|FG009|Overall Study|Other adverse event|0|||
125461705|NCT01317420|451319603|FG010|Overall Study|Other adverse event|0|||
125461706|NCT01317420|451319604|FG011|Overall Study|Other adverse event|0|||
125461707|NCT01317420|451319605|FG012|Overall Study|Other adverse event|2|||
125461708|NCT01317420|451319593|FG000|Overall Study|Non-compliant with protocol|0|||
125461709|NCT01317420|451319594|FG001|Overall Study|Non-compliant with protocol|0|||
125461710|NCT01317420|451319595|FG002|Overall Study|Non-compliant with protocol|0|||
125461711|NCT01317420|451319596|FG003|Overall Study|Non-compliant with protocol|0|||
125461712|NCT01317420|451319597|FG004|Overall Study|Non-compliant with protocol|0|||
125461713|NCT01317420|451319598|FG005|Overall Study|Non-compliant with protocol|0|||
125461714|NCT01317420|451319599|FG006|Overall Study|Non-compliant with protocol|0|||
125461715|NCT01317420|451319600|FG007|Overall Study|Non-compliant with protocol|0|||
125461716|NCT01317420|451319601|FG008|Overall Study|Non-compliant with protocol|0|||
125461717|NCT01317420|451319602|FG009|Overall Study|Non-compliant with protocol|0|||
125461718|NCT01317420|451319603|FG010|Overall Study|Non-compliant with protocol|0|||
125461719|NCT01317420|451319604|FG011|Overall Study|Non-compliant with protocol|0|||
125461720|NCT01317420|451319605|FG012|Overall Study|Non-compliant with protocol|1|||
125461721|NCT01317420|451319593|FG000|Overall Study|Refused to cont. taking trial medication|0|||
125461722|NCT01317420|451319594|FG001|Overall Study|Refused to cont. taking trial medication|0|||
125461723|NCT01317420|451319595|FG002|Overall Study|Refused to cont. taking trial medication|0|||
125461724|NCT01317420|451319596|FG003|Overall Study|Refused to cont. taking trial medication|0|||
125461725|NCT01317420|451319597|FG004|Overall Study|Refused to cont. taking trial medication|0|||
125461726|NCT01317420|451319598|FG005|Overall Study|Refused to cont. taking trial medication|0|||
125461727|NCT01317420|451319599|FG006|Overall Study|Refused to cont. taking trial medication|0|||
125461728|NCT01317420|451319600|FG007|Overall Study|Refused to cont. taking trial medication|0|||
125461729|NCT01317420|451319601|FG008|Overall Study|Refused to cont. taking trial medication|0|||
125461730|NCT01317420|451319602|FG009|Overall Study|Refused to cont. taking trial medication|0|||
125461731|NCT01317420|451319603|FG010|Overall Study|Refused to cont. taking trial medication|0|||
125461732|NCT01317420|451319604|FG011|Overall Study|Refused to cont. taking trial medication|0|||
125461733|NCT01317420|451319605|FG012|Overall Study|Refused to cont. taking trial medication|1|||
125461734|NCT01317420|451319593|FG000|Overall Study|Reason other than those specified|0|||
125461735|NCT01317420|451319594|FG001|Overall Study|Reason other than those specified|0|||
125461736|NCT01317420|451319595|FG002|Overall Study|Reason other than those specified|0|||
125461737|NCT01317420|451319596|FG003|Overall Study|Reason other than those specified|0|||
125461738|NCT01317420|451319597|FG004|Overall Study|Reason other than those specified|0|||
125461739|NCT01317420|451319598|FG005|Overall Study|Reason other than those specified|0|||
125461740|NCT01317420|451319599|FG006|Overall Study|Reason other than those specified|0|||
125461741|NCT01317420|451319600|FG007|Overall Study|Reason other than those specified|0|||
125461742|NCT01317420|451319601|FG008|Overall Study|Reason other than those specified|0|||
125461743|NCT01317420|451319602|FG009|Overall Study|Reason other than those specified|1|||
125461744|NCT01317420|451319603|FG010|Overall Study|Reason other than those specified|0|||
125461745|NCT01317420|451319604|FG011|Overall Study|Reason other than those specified|0|||
125461746|NCT01317420|451319605|FG012|Overall Study|Reason other than those specified|0|||
125461747|NCT03194958|451319606|FG000|Overall Study|Death|0|||
125461748|NCT03194958|451319607|FG001|Overall Study|Death|1|||
125461749|NCT03194958|451319608|FG002|Overall Study|Death|1|||
125461750|NCT03194958|451319609|FG003|Overall Study|Death|1|||
125461751|NCT03194958|451319606|FG000|Overall Study|Withdrawal by Subject|24|||
125461752|NCT03194958|451319607|FG001|Overall Study|Withdrawal by Subject|27|||
125461753|NCT03194958|451319608|FG002|Overall Study|Withdrawal by Subject|7|||
125461754|NCT03194958|451319609|FG003|Overall Study|Withdrawal by Subject|22|||
125461755|NCT03194958|451319606|FG000|Overall Study|Lost to Follow-up|168|||
125461756|NCT03194958|451319607|FG001|Overall Study|Lost to Follow-up|196|||
125461757|NCT03194958|451319608|FG002|Overall Study|Lost to Follow-up|174|||
125461758|NCT03194958|451319609|FG003|Overall Study|Lost to Follow-up|186|||
125461759|NCT01968226|451319610|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
125461760|NCT04975308|451319618|FG000|Overall Study|Withdrawal by Subject|6|||
125461761|NCT04975308|451319619|FG001|Overall Study|Withdrawal by Subject|16|||
125461762|NCT04975308|451319620|FG002|Overall Study|Withdrawal by Subject|6|||
125461763|NCT04975308|451319618|FG000|Overall Study|Physician Decision|0|||
125461764|NCT04975308|451319619|FG001|Overall Study|Physician Decision|3|||
125461765|NCT04975308|451319620|FG002|Overall Study|Physician Decision|1|||
125461766|NCT04975308|451319618|FG000|Overall Study|Adverse Event|10|||
125461767|NCT04975308|451319619|FG001|Overall Study|Adverse Event|1|||
125461768|NCT04975308|451319620|FG002|Overall Study|Adverse Event|12|||
125461769|NCT04975308|451319618|FG000|Overall Study|On study treatment (Ongoing)|65|||
125461770|NCT04975308|451319619|FG001|Overall Study|On study treatment (Ongoing)|43|||
125461771|NCT04975308|451319620|FG002|Overall Study|On study treatment (Ongoing)|75|||
125461772|NCT04975308|451319618|FG000|Overall Study|Protocol Deviation|4|||
125461773|NCT04975308|451319619|FG001|Overall Study|Protocol Deviation|3|||
125461774|NCT04975308|451319620|FG002|Overall Study|Protocol Deviation|2|||
125461775|NCT02709655|451319621|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
125461776|NCT02709655|451319622|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
125461777|NCT02709655|451319623|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
125461778|NCT02709655|451319624|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
125461779|NCT02709655|451319625|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
125461780|NCT02709655|451319621|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
125461781|NCT02709655|451319622|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
125461782|NCT02709655|451319623|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
125461783|NCT02709655|451319624|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
125461784|NCT02709655|451319625|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
125461785|NCT02709655|451319621|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
125461786|NCT02709655|451319622|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
125461787|NCT02709655|451319623|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
125461788|NCT02709655|451319624|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
125461789|NCT02709655|451319625|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
125461790|NCT02709655|451319621|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
125461791|NCT02709655|451319622|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
125461792|NCT02709655|451319623|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
125461793|NCT02709655|451319624|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
125461794|NCT02709655|451319625|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
125461795|NCT02709655|451319621|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
125461796|NCT02709655|451319622|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
125461797|NCT02709655|451319623|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
125461798|NCT02709655|451319624|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
125461799|NCT02709655|451319625|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
125461800|NCT02709655|451319621|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
125461801|NCT02709655|451319622|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
125461802|NCT02709655|451319623|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
125461803|NCT02709655|451319624|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
125461804|NCT02709655|451319625|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
125461805|NCT02709655|451319621|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
125461806|NCT02709655|451319622|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
125461807|NCT02709655|451319623|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
125461808|NCT02709655|451319624|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
125461809|NCT02709655|451319625|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
125461810|NCT02709655|451319621|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
125461811|NCT02709655|451319622|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
125461812|NCT02709655|451319623|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
125461813|NCT02709655|451319624|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
125461814|NCT02709655|451319625|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
125461815|NCT02709655|451319621|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
125461816|NCT02709655|451319622|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
125461817|NCT02709655|451319623|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
125461818|NCT02709655|451319624|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
125461819|NCT02709655|451319625|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
125461820|NCT02709655|451319621|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
125461821|NCT02709655|451319622|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
125461822|NCT02709655|451319623|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
125461823|NCT02709655|451319624|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
125461824|NCT02709655|451319625|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
125461825|NCT02709655|451319621|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
125461826|NCT02709655|451319622|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
125461827|NCT02709655|451319623|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
125461828|NCT02709655|451319624|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
125461829|NCT02709655|451319625|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
125461830|NCT02709655|451319621|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
125461831|NCT02709655|451319622|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
125461832|NCT02709655|451319623|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
125461833|NCT02709655|451319624|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
125461834|NCT02709655|451319625|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
125461835|NCT02709655|451319621|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
125461836|NCT02709655|451319622|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
125461837|NCT02709655|451319623|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
125461838|NCT02709655|451319624|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
125461839|NCT02709655|451319625|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
125461840|NCT02709655|451319621|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
125461841|NCT02709655|451319622|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
125461842|NCT02709655|451319623|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
125295548|NCT01659255|450709460|FG000|Overall Study|Progressive Disease|2|||
125461843|NCT02709655|451319624|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
125461844|NCT02709655|451319625|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
125461845|NCT02709655|451319621|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
125461846|NCT02709655|451319622|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
125461847|NCT02709655|451319623|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
125461848|NCT02709655|451319624|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
125461849|NCT02709655|451319625|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
125461850|NCT02709655|451319621|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
125461851|NCT02709655|451319622|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
125461852|NCT02709655|451319623|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
125461853|NCT02709655|451319624|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
125461854|NCT02709655|451319625|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
125461855|NCT00102063|451319626|FG000|Overall Study|Lack of Efficacy|5|||
125461856|NCT00102063|451319627|FG001|Overall Study|Lack of Efficacy|1|||
125461857|NCT00102063|451319628|FG002|Overall Study|Lack of Efficacy|1|||
125461858|NCT00102063|451319626|FG000|Overall Study|Adverse Event|7|||
125461859|NCT00102063|451319627|FG001|Overall Study|Adverse Event|4|||
125461860|NCT00102063|451319628|FG002|Overall Study|Adverse Event|2|||
125461861|NCT00102063|451319626|FG000|Overall Study|Withdrawal by Subject|4|||
125461862|NCT00102063|451319627|FG001|Overall Study|Withdrawal by Subject|12|||
125461863|NCT00102063|451319628|FG002|Overall Study|Withdrawal by Subject|5|||
125461864|NCT00102063|451319626|FG000|Overall Study|Lost to Follow-up|0|||
125461865|NCT00102063|451319627|FG001|Overall Study|Lost to Follow-up|0|||
125461866|NCT00102063|451319628|FG002|Overall Study|Lost to Follow-up|1|||
125461867|NCT00102063|451319626|FG000|Overall Study|Protocol Violation|0|||
125461868|NCT00102063|451319627|FG001|Overall Study|Protocol Violation|1|||
125461869|NCT00102063|451319628|FG002|Overall Study|Protocol Violation|1|||
125461870|NCT01493778|451319629|FG000|Overall Study|Withdrawal by Subject|8|||
125461871|NCT05082025|451319630|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
125461872|NCT04210180|451319631|FG000|Overall Study|Withdrawal by Subject|2|||
125461873|NCT01179334|451319632|FG000|Treatment Period|Adverse Event|1|||
125461874|NCT01179334|451319633|FG001|Treatment Period|Adverse Event|0|||
125461875|NCT01179334|451319632|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
125461876|NCT01179334|451319633|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
125461877|NCT01179334|451319632|FG000|Long-term Extension (LTE) Period|Death|3|||
125461878|NCT01179334|451319633|FG001|Long-term Extension (LTE) Period|Death|0|||
125461879|NCT01179334|451319632|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
125461880|NCT01179334|451319633|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
125461881|NCT00857649|451319634|FG000|Overall Study|Adverse Event|15|||
125461882|NCT00857649|451319635|FG001|Overall Study|Adverse Event|10|||
125461883|NCT00857649|451319634|FG000|Overall Study|Non-compliance|1|||
125461884|NCT00857649|451319635|FG001|Overall Study|Non-compliance|1|||
125461885|NCT00857649|451319634|FG000|Overall Study|Protocol Violation|2|||
125461886|NCT00857649|451319635|FG001|Overall Study|Protocol Violation|2|||
125461887|NCT00857649|451319634|FG000|Overall Study|Withdrawal of Consent|10|||
125461888|NCT00857649|451319635|FG001|Overall Study|Withdrawal of Consent|7|||
125461889|NCT00857649|451319634|FG000|Overall Study|Nursing Home Placement|2|||
125461890|NCT00857649|451319635|FG001|Overall Study|Nursing Home Placement|9|||
125461891|NCT00857649|451319634|FG000|Overall Study|Other Reasons|1|||
125461892|NCT00857649|451319635|FG001|Overall Study|Other Reasons|3|||
125461893|NCT00630786|451319638|FG000|Overall Study|Physician Decision|0|||
125461894|NCT00630786|451319639|FG001|Overall Study|Physician Decision|0|||
125461895|NCT00630786|451319640|FG002|Overall Study|Physician Decision|1|||
125461896|NCT00630786|451319638|FG000|Overall Study|Withdrawal by Subject|0|||
125461897|NCT00630786|451319639|FG001|Overall Study|Withdrawal by Subject|1|||
125461898|NCT00630786|451319640|FG002|Overall Study|Withdrawal by Subject|1|||
125461899|NCT00630786|451319638|FG000|Overall Study|Lost to Follow-up|0|||
125461900|NCT00630786|451319639|FG001|Overall Study|Lost to Follow-up|1|||
125461901|NCT00630786|451319640|FG002|Overall Study|Lost to Follow-up|0|||
125461902|NCT00630786|451319638|FG000|Overall Study|Other|1|||
125461903|NCT00630786|451319639|FG001|Overall Study|Other|0|||
125461904|NCT00630786|451319640|FG002|Overall Study|Other|0|||
125461905|NCT04009577|451319641|FG000|Core Study|Adverse Event|1|||
125461906|NCT04009577|451319642|FG001|Core Study|Adverse Event|0|||
125461907|NCT04009577|451319643|FG002|Core Study|Adverse Event|2|||
125461908|NCT04009577|451319644|FG003|Core Study|Adverse Event|4|||
125461909|NCT04009577|451319641|FG000|Core Study|Withdrawal by Subject|0|||
125461910|NCT04009577|451319642|FG001|Core Study|Withdrawal by Subject|0|||
125461911|NCT04009577|451319643|FG002|Core Study|Withdrawal by Subject|2|||
125461912|NCT04009577|451319644|FG003|Core Study|Withdrawal by Subject|0|||
125461913|NCT04009577|451319641|FG000|Core Study|Other|0|||
125461914|NCT04009577|451319642|FG001|Core Study|Other|0|||
125461915|NCT04009577|451319643|FG002|Core Study|Other|0|||
125461916|NCT04009577|451319644|FG003|Core Study|Other|1|||
125461917|NCT04009577|451319641|FG000|Extension Phase|Adverse Event|0|||
125461918|NCT04009577|451319642|FG001|Extension Phase|Adverse Event|0|||
125461919|NCT04009577|451319643|FG002|Extension Phase|Adverse Event|0|||
125461920|NCT04009577|451319644|FG003|Extension Phase|Adverse Event|1|||
125461921|NCT04009577|451319641|FG000|Extension Phase|Inadequate therapeutic effect|0|||
125461922|NCT04009577|451319642|FG001|Extension Phase|Inadequate therapeutic effect|0|||
125461923|NCT04009577|451319643|FG002|Extension Phase|Inadequate therapeutic effect|1|||
125461924|NCT04009577|451319644|FG003|Extension Phase|Inadequate therapeutic effect|0|||
125461925|NCT04009577|451319641|FG000|Extension Phase|Withdrawal by Subject|0|||
125461926|NCT04009577|451319642|FG001|Extension Phase|Withdrawal by Subject|0|||
125461927|NCT04009577|451319643|FG002|Extension Phase|Withdrawal by Subject|1|||
125461928|NCT04009577|451319644|FG003|Extension Phase|Withdrawal by Subject|0|||
125461929|NCT04009577|451319641|FG000|Extension Phase|Not Treated|0|||
125461930|NCT04009577|451319642|FG001|Extension Phase|Not Treated|0|||
125461931|NCT04009577|451319643|FG002|Extension Phase|Not Treated|2|||
125461932|NCT04009577|451319644|FG003|Extension Phase|Not Treated|0|||
125461933|NCT02994654|451319651|FG000|Overall Study|Lost to Follow-up|1|||
125461934|NCT03603717|451319656|FG000|Overall Study|Lost to Follow-up|20|||
125461935|NCT03603717|451319657|FG001|Overall Study|Lost to Follow-up|20|||
125461936|NCT03603717|451319656|FG000|Overall Study|Withdrawal by Subject|16|||
125461937|NCT03603717|451319657|FG001|Overall Study|Withdrawal by Subject|10|||
125461938|NCT01426269|451321039|FG000|Period 1: 12 Weeks|Adverse Event|5|||
125461939|NCT01426269|451321040|FG001|Period 1: 12 Weeks|Adverse Event|0|||
125461940|NCT01426269|451321041|FG002|Period 1: 12 Weeks|Adverse Event|0|||
125461941|NCT01426269|451321039|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
125461942|NCT01426269|451321040|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
125461943|NCT01426269|451321041|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
125461944|NCT01426269|451321039|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
125461945|NCT01426269|451321040|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
125461946|NCT01426269|451321041|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
125461947|NCT01426269|451321039|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
125461948|NCT01426269|451321040|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
125461949|NCT01426269|451321041|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
125461950|NCT01426269|451321039|FG000|Period 1: 12 Weeks|Pregnancy|1|||
125461951|NCT01426269|451321040|FG001|Period 1: 12 Weeks|Pregnancy|0|||
125461952|NCT01426269|451321041|FG002|Period 1: 12 Weeks|Pregnancy|0|||
125461953|NCT01426269|451321039|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
125461954|NCT01426269|451321040|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
125461955|NCT01426269|451321041|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
125461956|NCT01426269|451321039|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
125461957|NCT01426269|451321040|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
125461958|NCT01426269|451321041|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
125461959|NCT01426269|451321039|FG000|Period 2: 40 Weeks|Adverse Event|0|||
125461960|NCT01426269|451321040|FG001|Period 2: 40 Weeks|Adverse Event|1|||
125461961|NCT01426269|451321041|FG002|Period 2: 40 Weeks|Adverse Event|2|||
125461962|NCT01426269|451321039|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
125461963|NCT01426269|451321040|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
125461964|NCT01426269|451321041|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
125461965|NCT01426269|451321039|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
125461966|NCT01426269|451321040|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
125461967|NCT01426269|451321041|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
125461968|NCT01426269|451321039|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
125461969|NCT01426269|451321040|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
125461970|NCT01426269|451321041|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
125461971|NCT01426269|451321039|FG000|Period 2: 40 Weeks|Site closed|0|||
125461972|NCT01426269|451321040|FG001|Period 2: 40 Weeks|Site closed|6|||
125461973|NCT01426269|451321041|FG002|Period 2: 40 Weeks|Site closed|5|||
125461974|NCT01426269|451321039|FG000|Period 2: 40 Weeks|Relapsed|0|||
125461975|NCT01426269|451321040|FG001|Period 2: 40 Weeks|Relapsed|9|||
125461976|NCT01426269|451321041|FG002|Period 2: 40 Weeks|Relapsed|18|||
125461977|NCT00186186|451321045|FG000|Overall Study|Lack of Efficacy|3|||
125461978|NCT00186186|451321045|FG000|Overall Study|Withdrawal by Subject|3|||
125461979|NCT00186186|451321045|FG000|Overall Study|Not reported as to reason|2|||
125461980|NCT01113931|451321048|FG000|Overall Study|Adverse Event|2|||
125461981|NCT01113931|451321049|FG001|Overall Study|Adverse Event|2|||
125461982|NCT01113931|451321048|FG000|Overall Study|Physician Decision|0|||
125461983|NCT01113931|451321049|FG001|Overall Study|Physician Decision|2|||
125461984|NCT01113931|451321048|FG000|Overall Study|Lost to Follow-up|12|||
125461985|NCT01113931|451321049|FG001|Overall Study|Lost to Follow-up|9|||
125461986|NCT01113931|451321048|FG000|Overall Study|Various|2|||
125461987|NCT01113931|451321049|FG001|Overall Study|Various|4|||
125461988|NCT01113931|451321048|FG000|Overall Study|Withdrawal by Subject|3|||
125461989|NCT01113931|451321049|FG001|Overall Study|Withdrawal by Subject|0|||
125461990|NCT02567656|451321050|FG000|Overall Study|Premature discontinuation due to PD|1|||
125461991|NCT02567656|451321051|FG001|Overall Study|Premature discontinuation due to PD|1|||
125461992|NCT02567656|451321052|FG002|Overall Study|Premature discontinuation due to PD|2|||
125461993|NCT02567656|451321053|FG003|Overall Study|Premature discontinuation due to PD|0|||
125461994|NCT02567656|451321054|FG004|Overall Study|Premature discontinuation due to PD|0|||
125461995|NCT02567656|451321055|FG005|Overall Study|Premature discontinuation due to PD|0|||
125461996|NCT01424397|451321056|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
125461997|NCT01424397|451321057|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
125461998|NCT01424397|451321058|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
125461999|NCT01424397|451321059|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
125462000|NCT01424397|451321060|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
125462001|NCT01424397|451321061|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
125462002|NCT01424397|451321062|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
125462003|NCT01424397|451321063|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
125462004|NCT01424397|451321064|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
125462005|NCT01424397|451321065|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
125462006|NCT01424397|451321066|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
125462007|NCT01424397|451321067|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
125462008|NCT03959241|451321073|FG000|Overall Study|Withdrawal by Subject|7|||
125462009|NCT03959241|451321074|FG001|Overall Study|Withdrawal by Subject|8|||
125462010|NCT03959241|451321073|FG000|Overall Study|Lost to Follow-up|1|||
125462011|NCT03959241|451321074|FG001|Overall Study|Lost to Follow-up|0|||
125462012|NCT03959241|451321073|FG000|Overall Study|Move to Hospice Care|1|||
125462013|NCT03959241|451321074|FG001|Overall Study|Move to Hospice Care|0|||
125462014|NCT03959241|451321073|FG000|Overall Study|Screen Failure|1|||
125462015|NCT03959241|451321074|FG001|Overall Study|Screen Failure|0|||
125462016|NCT03959241|451321073|FG000|Overall Study|Disease Relapse|0|||
125462017|NCT03959241|451321074|FG001|Overall Study|Disease Relapse|1|||
125462018|NCT03959241|451321073|FG000|Overall Study|Off Study|1|||
125462019|NCT03959241|451321074|FG001|Overall Study|Off Study|0|||
125462020|NCT01145885|451321075|FG000|Overall Study|Progressive Disease|7|||
125462021|NCT03691428|451321076|FG000|Overall Study|Withdrawal by Subject|6|||
125462022|NCT03691428|451321077|FG001|Overall Study|Withdrawal by Subject|8|||
125462023|NCT02527148|451321078|FG000|Overall Study|Did not receive study intervention|1|||
125462024|NCT02527148|451321079|FG001|Overall Study|Did not receive study intervention|0|||
125462025|NCT01140048|451321080|FG000|Overall Study|Physician Decision|1|||
125462026|NCT01140048|451321080|FG000|Overall Study|Withdrawal by Subject|13|||
125462027|NCT01140048|451321080|FG000|Overall Study|Lost to Follow-up|31|||
125462028|NCT01831791|451321081|FG000|Overall Study|Withdrawal by Subject|10|||
125462029|NCT00494780|451321082|FG000|Overall Study|Adverse Event|1|||
125462030|NCT00494780|451321083|FG001|Overall Study|Adverse Event|0|||
125462031|NCT00494780|451321082|FG000|Overall Study|Withdrew before Dosed|0|||
125295549|NCT01659255|450709461|FG001|Overall Study|Progressive Disease|0|||
125295550|NCT01659255|450709462|FG002|Overall Study|Progressive Disease|0|||
125295551|NCT01659255|450709463|FG003|Overall Study|Progressive Disease|0|||
125295552|NCT01659255|450709464|FG004|Overall Study|Progressive Disease|0|||
125295553|NCT01659255|450709465|FG005|Overall Study|Progressive Disease|0|||
125462032|NCT00494780|451321083|FG001|Overall Study|Withdrew before Dosed|1|||
125462033|NCT00494780|451321082|FG000|Overall Study|Progression of Study Disease|7|||
125462034|NCT00494780|451321083|FG001|Overall Study|Progression of Study Disease|8|||
125462035|NCT00494780|451321082|FG000|Overall Study|New Treatment|2|||
125462036|NCT00494780|451321083|FG001|Overall Study|New Treatment|2|||
125462037|NCT00494780|451321082|FG000|Overall Study|Non-compliance|1|||
125462038|NCT00494780|451321083|FG001|Overall Study|Non-compliance|0|||
125462039|NCT00494780|451321082|FG000|Overall Study|Residual Tumour Mass|0|||
125462040|NCT00494780|451321083|FG001|Overall Study|Residual Tumour Mass|1|||
125462041|NCT00494780|451321082|FG000|Overall Study|Insurance Issues|0|||
125462042|NCT00494780|451321083|FG001|Overall Study|Insurance Issues|1|||
125462043|NCT00980330|451321084|FG000|Overall Study|Adverse Event|0|||
125462044|NCT00980330|451321085|FG001|Overall Study|Adverse Event|0|||
125462045|NCT00980330|451321086|FG002|Overall Study|Adverse Event|0|||
125462046|NCT00980330|451321087|FG003|Overall Study|Adverse Event|1|||
125462047|NCT00980330|451321088|FG004|Overall Study|Adverse Event|0|||
125462048|NCT00980330|451321089|FG005|Overall Study|Adverse Event|0|||
125462049|NCT00980330|451321090|FG006|Overall Study|Adverse Event|0|||
125462050|NCT00980330|451321084|FG000|Overall Study|Lost to Follow-up|1|||
125462051|NCT00980330|451321085|FG001|Overall Study|Lost to Follow-up|1|||
125462052|NCT00980330|451321086|FG002|Overall Study|Lost to Follow-up|4|||
125462053|NCT00980330|451321087|FG003|Overall Study|Lost to Follow-up|2|||
125462054|NCT00980330|451321088|FG004|Overall Study|Lost to Follow-up|1|||
125462055|NCT00980330|451321089|FG005|Overall Study|Lost to Follow-up|1|||
125462056|NCT00980330|451321090|FG006|Overall Study|Lost to Follow-up|2|||
125462057|NCT00980330|451321084|FG000|Overall Study|Withdrawal by Subject|2|||
125462058|NCT00980330|451321085|FG001|Overall Study|Withdrawal by Subject|4|||
125462059|NCT00980330|451321086|FG002|Overall Study|Withdrawal by Subject|4|||
125462060|NCT00980330|451321087|FG003|Overall Study|Withdrawal by Subject|1|||
125462061|NCT00980330|451321088|FG004|Overall Study|Withdrawal by Subject|3|||
125295554|NCT01659255|450709466|FG006|Overall Study|Progressive Disease|0|||
125295555|NCT01659255|450709467|FG007|Overall Study|Progressive Disease|1|||
125295556|NCT01659255|450709468|FG008|Overall Study|Progressive Disease|0|||
125462062|NCT00980330|451321089|FG005|Overall Study|Withdrawal by Subject|2|||
125462063|NCT00980330|451321090|FG006|Overall Study|Withdrawal by Subject|5|||
125462064|NCT00980330|451321084|FG000|Overall Study|(not specified)|2|||
125462065|NCT00980330|451321085|FG001|Overall Study|(not specified)|0|||
125462066|NCT00980330|451321086|FG002|Overall Study|(not specified)|0|||
125462067|NCT00980330|451321087|FG003|Overall Study|(not specified)|1|||
125462068|NCT00980330|451321088|FG004|Overall Study|(not specified)|1|||
125462069|NCT00980330|451321089|FG005|Overall Study|(not specified)|1|||
125462070|NCT00980330|451321090|FG006|Overall Study|(not specified)|0|||
125462071|NCT00666276|451321091|FG000|Overall Study|Protocol Violation|34|||
125462072|NCT03299816|451321092|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
125462073|NCT03299816|451321093|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
125462074|NCT03299816|451321092|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
125462075|NCT03299816|451321093|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
125462076|NCT03299816|451321092|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
125462077|NCT03299816|451321093|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
125462078|NCT03520413|451321096|FG000|Overall Study|Lost to Follow-up|1|||
125462079|NCT03520413|451321097|FG001|Overall Study|Lost to Follow-up|1|||
125462080|NCT03520413|451321096|FG000|Overall Study|Withdrawal by Subject|1|||
125462081|NCT03520413|451321097|FG001|Overall Study|Withdrawal by Subject|2|||
125462082|NCT03520413|451321096|FG000|Overall Study|Death|0|||
125462083|NCT03520413|451321097|FG001|Overall Study|Death|1|||
125462084|NCT03520413|451321096|FG000|Overall Study|Physician Decision|3|||
125462085|NCT03520413|451321097|FG001|Overall Study|Physician Decision|3|||
125462086|NCT03520413|451321096|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
125462087|NCT03520413|451321097|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
125462088|NCT05001945|451321101|FG000|Overall Study|Adverse Event|0|||
125462089|NCT05001945|451321102|FG001|Overall Study|Adverse Event|0|||
125462090|NCT05001945|451321103|FG002|Overall Study|Adverse Event|0|||
125462091|NCT05001945|451321104|FG003|Overall Study|Adverse Event|1|||
125462092|NCT05001945|451321105|FG004|Overall Study|Adverse Event|0|||
125462093|NCT05001945|451321106|FG005|Overall Study|Adverse Event|0|||
125462094|NCT05001945|451321107|FG006|Overall Study|Adverse Event|0|||
125462095|NCT05001945|451321108|FG007|Overall Study|Adverse Event|0|||
125462096|NCT05001945|451321101|FG000|Overall Study|Lost to Follow-up|0|||
125462097|NCT05001945|451321102|FG001|Overall Study|Lost to Follow-up|1|||
125462098|NCT05001945|451321103|FG002|Overall Study|Lost to Follow-up|1|||
125462099|NCT05001945|451321104|FG003|Overall Study|Lost to Follow-up|2|||
125462100|NCT05001945|451321105|FG004|Overall Study|Lost to Follow-up|0|||
125462101|NCT05001945|451321106|FG005|Overall Study|Lost to Follow-up|1|||
125462102|NCT05001945|451321107|FG006|Overall Study|Lost to Follow-up|0|||
125462103|NCT05001945|451321108|FG007|Overall Study|Lost to Follow-up|0|||
125462104|NCT05001945|451321101|FG000|Overall Study|Protocol Violation|1|||
125462105|NCT05001945|451321102|FG001|Overall Study|Protocol Violation|0|||
125462106|NCT05001945|451321103|FG002|Overall Study|Protocol Violation|1|||
125462107|NCT05001945|451321104|FG003|Overall Study|Protocol Violation|1|||
125462108|NCT05001945|451321105|FG004|Overall Study|Protocol Violation|0|||
125462109|NCT05001945|451321106|FG005|Overall Study|Protocol Violation|1|||
125462110|NCT05001945|451321107|FG006|Overall Study|Protocol Violation|0|||
125462111|NCT05001945|451321108|FG007|Overall Study|Protocol Violation|0|||
125462112|NCT05001945|451321101|FG000|Overall Study|Withdrawal by Subject|0|||
125462113|NCT05001945|451321102|FG001|Overall Study|Withdrawal by Subject|0|||
125462114|NCT05001945|451321103|FG002|Overall Study|Withdrawal by Subject|0|||
125462115|NCT05001945|451321104|FG003|Overall Study|Withdrawal by Subject|1|||
125462116|NCT05001945|451321105|FG004|Overall Study|Withdrawal by Subject|1|||
125462117|NCT05001945|451321106|FG005|Overall Study|Withdrawal by Subject|1|||
125462118|NCT05001945|451321107|FG006|Overall Study|Withdrawal by Subject|0|||
125462119|NCT05001945|451321108|FG007|Overall Study|Withdrawal by Subject|1|||
125462120|NCT05001945|451321101|FG000|Overall Study|Not specified by Investigator|0|||
125462121|NCT05001945|451321102|FG001|Overall Study|Not specified by Investigator|3|||
125462122|NCT05001945|451321103|FG002|Overall Study|Not specified by Investigator|0|||
125462123|NCT05001945|451321104|FG003|Overall Study|Not specified by Investigator|0|||
125462124|NCT05001945|451321105|FG004|Overall Study|Not specified by Investigator|1|||
125462125|NCT05001945|451321106|FG005|Overall Study|Not specified by Investigator|0|||
125462126|NCT05001945|451321107|FG006|Overall Study|Not specified by Investigator|0|||
125462127|NCT05001945|451321108|FG007|Overall Study|Not specified by Investigator|0|||
125462128|NCT02448446|451321109|FG000|Overall Study|Withdrawal by Subject|1|||
125462129|NCT02448446|451321110|FG001|Overall Study|Withdrawal by Subject|0|||
125462130|NCT02425111|451321111|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
125462131|NCT02425111|451321111|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
125462132|NCT02425111|451321111|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
125462133|NCT02425111|451321111|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
125462134|NCT02425111|451321111|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
125462135|NCT02425111|451321111|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
125462136|NCT00545077|451321113|FG000|Overall Study|Treatment not received|5|||
125462137|NCT00545077|451321114|FG001|Overall Study|Treatment not received|1|||
125462138|NCT00545077|451321113|FG000|Overall Study|Disease Progression|131|||
125462139|NCT00545077|451321114|FG001|Overall Study|Disease Progression|98|||
125295557|NCT01659255|450709469|FG009|Overall Study|Progressive Disease|2|||
125462140|NCT00545077|451321113|FG000|Overall Study|Withdrawal by Subject|3|||
125462141|NCT00545077|451321114|FG001|Overall Study|Withdrawal by Subject|14|||
125462142|NCT00545077|451321113|FG000|Overall Study|Physician Decision|6|||
125462143|NCT00545077|451321114|FG001|Overall Study|Physician Decision|3|||
125462144|NCT00545077|451321113|FG000|Overall Study|Lost to Follow-up|2|||
125462145|NCT00545077|451321114|FG001|Overall Study|Lost to Follow-up|0|||
125462146|NCT00545077|451321113|FG000|Overall Study|Protocol Violation|1|||
125462147|NCT00545077|451321114|FG001|Overall Study|Protocol Violation|0|||
125462148|NCT00545077|451321113|FG000|Overall Study|Adverse Event|0|||
125462149|NCT00545077|451321114|FG001|Overall Study|Adverse Event|31|||
125462150|NCT00545077|451321113|FG000|Overall Study|Death|0|||
125462151|NCT00545077|451321114|FG001|Overall Study|Death|8|||
125462152|NCT02202499|451321115|FG000|Overall Study|Cancer diagnosis|0|||
125462153|NCT02202499|451321116|FG001|Overall Study|Cancer diagnosis|0|||
125462154|NCT02202499|451321117|FG002|Overall Study|Cancer diagnosis|1|||
125462155|NCT02202499|451321115|FG000|Overall Study|Moved from area|0|||
125462156|NCT02202499|451321116|FG001|Overall Study|Moved from area|0|||
125462157|NCT02202499|451321117|FG002|Overall Study|Moved from area|1|||
125462158|NCT02202499|451321115|FG000|Overall Study|Declined before randomization|1|||
125462159|NCT02202499|451321116|FG001|Overall Study|Declined before randomization|0|||
125462160|NCT02202499|451321117|FG002|Overall Study|Declined before randomization|0|||
125462161|NCT02202499|451321115|FG000|Overall Study|Auto accident|1|||
125462162|NCT02202499|451321116|FG001|Overall Study|Auto accident|0|||
125462163|NCT02202499|451321117|FG002|Overall Study|Auto accident|0|||
125462164|NCT00535145|451321118|FG000|Phase I|Adverse Event|3|||
125462165|NCT00535145|451321118|FG000|Phase I|Lost to Follow-up|7|||
125462166|NCT00535145|451321118|FG000|Phase I|Withdrawal by Subject|6|||
125462167|NCT00535145|451321118|FG000|Phase I|(eligibility)|8|||
125462168|NCT00535145|451321118|FG000|Phase I|(protocol violation)|1|||
125462169|NCT00535145|451321118|FG000|Phase I|(PI decision)|1|||
125462170|NCT00535145|451321118|FG000|Phase I|(diagnosis)|3|||
125462171|NCT00535145|451321118|FG000|Phase II|Adverse Event|2|||
125462172|NCT00535145|451321118|FG000|Phase II|Lack of Efficacy|1|||
125462173|NCT00535145|451321118|FG000|Phase II|Lost to Follow-up|5|||
125462174|NCT00535145|451321118|FG000|Phase II|Withdrawal by Subject|5|||
125462175|NCT00535145|451321118|FG000|Phase II|Subject non-compliance|2|||
125462176|NCT00529789|451321122|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
125462177|NCT00529789|451321122|FG000|Study Period II/III|Adverse Event|3|||
125462178|NCT00529789|451321122|FG000|Study Period II/III|Lack of Efficacy|2|||
125462179|NCT00529789|451321122|FG000|Study Period II/III|Withdrawal by Subject|1|||
125462180|NCT00529789|451321122|FG000|Study Period II/III|Protocol Violation|3|||
125462181|NCT00529789|451321122|FG000|Study Period II/III|Physician Decision|3|||
125462182|NCT00529789|451321122|FG000|Study Period II/III|Lost to Follow-up|3|||
125462183|NCT00529789|451321122|FG000|Study Period IV|Parent/Caregiver Decision|1|||
125462184|NCT00529789|451321122|FG000|Study Period IV|Adverse Event|1|||
125462185|NCT00529789|451321122|FG000|Study Period IV|Lack of Efficacy|1|||
125462186|NCT00529789|451321122|FG000|Study Period IV|Lost to Follow-up|3|||
125462187|NCT00959946|451321123|FG000|Overall Study|Adverse Event|0|||
125462188|NCT00959946|451321124|FG001|Overall Study|Adverse Event|0|||
125462189|NCT00959946|451321125|FG002|Overall Study|Adverse Event|2|||
125462190|NCT00959946|451321126|FG003|Overall Study|Adverse Event|1|||
125462191|NCT00959946|451321127|FG004|Overall Study|Adverse Event|0|||
125462192|NCT00959946|451321128|FG005|Overall Study|Adverse Event|1|||
125462193|NCT00959946|451321129|FG006|Overall Study|Adverse Event|0|||
125462194|NCT00959946|451321130|FG007|Overall Study|Adverse Event|0|||
125462195|NCT00959946|451321123|FG000|Overall Study|Death|0|||
125462196|NCT00959946|451321124|FG001|Overall Study|Death|0|||
125462197|NCT00959946|451321125|FG002|Overall Study|Death|0|||
125462198|NCT00959946|451321126|FG003|Overall Study|Death|0|||
125462199|NCT00959946|451321127|FG004|Overall Study|Death|0|||
125462200|NCT00959946|451321128|FG005|Overall Study|Death|1|||
125462201|NCT00959946|451321129|FG006|Overall Study|Death|0|||
125462202|NCT00959946|451321130|FG007|Overall Study|Death|0|||
125462203|NCT00959946|451321123|FG000|Overall Study|Disease Progression|2|||
125462204|NCT00959946|451321124|FG001|Overall Study|Disease Progression|4|||
125462205|NCT00959946|451321125|FG002|Overall Study|Disease Progression|2|||
125462206|NCT00959946|451321126|FG003|Overall Study|Disease Progression|4|||
125462207|NCT00959946|451321127|FG004|Overall Study|Disease Progression|4|||
125462208|NCT00959946|451321128|FG005|Overall Study|Disease Progression|6|||
125462209|NCT00959946|451321129|FG006|Overall Study|Disease Progression|2|||
125462210|NCT00959946|451321130|FG007|Overall Study|Disease Progression|2|||
125462211|NCT00959946|451321123|FG000|Overall Study|Withdrawal by Subject|0|||
125462212|NCT00959946|451321124|FG001|Overall Study|Withdrawal by Subject|0|||
125462213|NCT00959946|451321125|FG002|Overall Study|Withdrawal by Subject|0|||
125462214|NCT00959946|451321126|FG003|Overall Study|Withdrawal by Subject|0|||
125462215|NCT00959946|451321127|FG004|Overall Study|Withdrawal by Subject|0|||
125462216|NCT00959946|451321128|FG005|Overall Study|Withdrawal by Subject|1|||
125462217|NCT00959946|451321129|FG006|Overall Study|Withdrawal by Subject|0|||
125462218|NCT00959946|451321130|FG007|Overall Study|Withdrawal by Subject|0|||
125462219|NCT01202955|451321133|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
125462220|NCT01202955|451321134|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
125462221|NCT02115139|451321135|FG000|Overall Study|Protocol Violation|1|||
125462222|NCT02115139|451321135|FG000|Overall Study|treatment discontinuation|6|||
125462223|NCT01909778|451321136|FG000|Overall Study|failed screening|1|||
125462224|NCT02471755|451321138|FG000|Overall Study|Withdrawal by Subject|1|||
125462225|NCT02471755|451321139|FG001|Overall Study|Withdrawal by Subject|0|||
125462226|NCT02471755|451321138|FG000|Overall Study|Lost to Follow-up|0|||
125462227|NCT02471755|451321139|FG001|Overall Study|Lost to Follow-up|1|||
125462228|NCT04740164|451321143|FG000|Overall Study|Lack of Efficacy|4|||
125462229|NCT04740164|451321144|FG001|Overall Study|Lack of Efficacy|0|||
125462230|NCT04740164|451321143|FG000|Overall Study|Physician Decision|3|||
125462231|NCT04740164|451321144|FG001|Overall Study|Physician Decision|3|||
125462232|NCT05323734|451321145|FG000|Overall Study|Adverse Event|5|||
125462233|NCT05323734|451321146|FG001|Overall Study|Adverse Event|2|||
125462234|NCT05323734|451321145|FG000|Overall Study|Physician Decision|1|||
125462235|NCT05323734|451321146|FG001|Overall Study|Physician Decision|0|||
125462236|NCT05323734|451321145|FG000|Overall Study|Lack of Efficacy|1|||
125462237|NCT05323734|451321146|FG001|Overall Study|Lack of Efficacy|2|||
125462238|NCT05323734|451321145|FG000|Overall Study|Withdrawal by Subject|2|||
125462239|NCT05323734|451321146|FG001|Overall Study|Withdrawal by Subject|0|||
125462240|NCT05323734|451321145|FG000|Overall Study|Participant Withdrawn Due|0|||
125462241|NCT05323734|451321146|FG001|Overall Study|Participant Withdrawn Due|1|||
125462242|NCT02486718|451321147|FG000|Enrollment Phase|Death|19|||
125462243|NCT02486718|451321148|FG001|Enrollment Phase|Death|0|||
125462244|NCT02486718|451321149|FG002|Enrollment Phase|Death|0|||
125462245|NCT02486718|451321147|FG000|Enrollment Phase|Symptomatic deterioration|1|||
125462246|NCT02486718|451321148|FG001|Enrollment Phase|Symptomatic deterioration|0|||
125462247|NCT02486718|451321149|FG002|Enrollment Phase|Symptomatic deterioration|0|||
125462248|NCT02486718|451321147|FG000|Enrollment Phase|Withdrawal by Subject|86|||
125462249|NCT02486718|451321148|FG001|Enrollment Phase|Withdrawal by Subject|0|||
125462250|NCT02486718|451321149|FG002|Enrollment Phase|Withdrawal by Subject|0|||
125462251|NCT02486718|451321147|FG000|Enrollment Phase|Protocol Violation|18|||
125462252|NCT02486718|451321148|FG001|Enrollment Phase|Protocol Violation|0|||
125462253|NCT02486718|451321149|FG002|Enrollment Phase|Protocol Violation|0|||
125462254|NCT02486718|451321147|FG000|Enrollment Phase|Physician Decision|18|||
125462255|NCT02486718|451321148|FG001|Enrollment Phase|Physician Decision|0|||
125462256|NCT02486718|451321149|FG002|Enrollment Phase|Physician Decision|0|||
125462257|NCT02486718|451321147|FG000|Enrollment Phase|Reason not provided|41|||
125462258|NCT02486718|451321148|FG001|Enrollment Phase|Reason not provided|0|||
125462259|NCT02486718|451321149|FG002|Enrollment Phase|Reason not provided|0|||
125462260|NCT02486718|451321147|FG000|Enrollment Phase|Disease relapse|54|||
125462261|NCT02486718|451321148|FG001|Enrollment Phase|Disease relapse|0|||
125462262|NCT02486718|451321149|FG002|Enrollment Phase|Disease relapse|0|||
125462263|NCT02486718|451321147|FG000|Enrollment Phase|Lost to Follow-up|4|||
125462264|NCT02486718|451321148|FG001|Enrollment Phase|Lost to Follow-up|0|||
125462265|NCT02486718|451321149|FG002|Enrollment Phase|Lost to Follow-up|0|||
125462266|NCT02486718|451321147|FG000|Enrollment Phase|Adverse Event|34|||
125462267|NCT02486718|451321148|FG001|Enrollment Phase|Adverse Event|0|||
125462268|NCT02486718|451321149|FG002|Enrollment Phase|Adverse Event|0|||
125462269|NCT02486718|451321147|FG000|Randomized Phase|Withdrawal by Subject|0|||
125462270|NCT02486718|451321148|FG001|Randomized Phase|Withdrawal by Subject|44|||
125462271|NCT02486718|451321149|FG002|Randomized Phase|Withdrawal by Subject|47|||
125462272|NCT02486718|451321147|FG000|Randomized Phase|Protocol Violation|0|||
125462273|NCT02486718|451321148|FG001|Randomized Phase|Protocol Violation|2|||
125462274|NCT02486718|451321149|FG002|Randomized Phase|Protocol Violation|0|||
125462275|NCT02486718|451321147|FG000|Randomized Phase|Physician Decision|0|||
125462276|NCT02486718|451321148|FG001|Randomized Phase|Physician Decision|0|||
125462277|NCT02486718|451321149|FG002|Randomized Phase|Physician Decision|3|||
125462278|NCT02486718|451321147|FG000|Randomized Phase|Lost to Follow-up|0|||
125462279|NCT02486718|451321148|FG001|Randomized Phase|Lost to Follow-up|5|||
125462280|NCT02486718|451321149|FG002|Randomized Phase|Lost to Follow-up|11|||
125462281|NCT02486718|451321147|FG000|Randomized Phase|Disease Relapse|0|||
125462282|NCT02486718|451321148|FG001|Randomized Phase|Disease Relapse|1|||
125462283|NCT02486718|451321149|FG002|Randomized Phase|Disease Relapse|0|||
125462284|NCT02486718|451321147|FG000|Randomized Phase|Death|0|||
125462285|NCT02486718|451321148|FG001|Randomized Phase|Death|154|||
125462286|NCT02486718|451321149|FG002|Randomized Phase|Death|155|||
125462287|NCT02486718|451321147|FG000|Randomized Phase|Ongoing|0|||
125462288|NCT02486718|451321148|FG001|Randomized Phase|Ongoing|301|||
125462289|NCT02486718|451321149|FG002|Randomized Phase|Ongoing|282|||
125462290|NCT04177394|451321150|FG000|Overall Study|Death|16|||
125462291|NCT04177394|451321150|FG000|Overall Study|Withdrawal by Subject|19|||
125462292|NCT04177394|451321150|FG000|Overall Study|Missed visits|61|||
125462293|NCT04177394|451321150|FG000|Overall Study|Expected Visits|15|||
125462294|NCT00258895|451321151|FG000|Overall Study|Lost to Follow-up|3|||
125462295|NCT00258895|451321152|FG001|Overall Study|Lost to Follow-up|1|||
125462296|NCT00258895|451321151|FG000|Overall Study|Protocol Violation|6|||
125462297|NCT00258895|451321152|FG001|Overall Study|Protocol Violation|2|||
125462298|NCT00258895|451321151|FG000|Overall Study|Withdrawal by Subject|1|||
125462299|NCT00258895|451321152|FG001|Overall Study|Withdrawal by Subject|0|||
125462300|NCT02248480|451321153|FG000|Overall Study|Lack of Efficacy|4|||
125462301|NCT02248480|451321154|FG001|Overall Study|Lack of Efficacy|6|||
125462302|NCT02248480|451321153|FG000|Overall Study|Adverse Event|11|||
125462303|NCT02248480|451321154|FG001|Overall Study|Adverse Event|2|||
125462304|NCT02248480|451321153|FG000|Overall Study|Withdrawal by Subject|2|||
125462305|NCT02248480|451321154|FG001|Overall Study|Withdrawal by Subject|4|||
125462306|NCT02248480|451321153|FG000|Overall Study|Entry Criteria Not Met|0|||
125462307|NCT02248480|451321154|FG001|Overall Study|Entry Criteria Not Met|1|||
125462308|NCT02248480|451321153|FG000|Overall Study|Other:Physician Decision|0|||
125462309|NCT02248480|451321154|FG001|Overall Study|Other:Physician Decision|1|||
125462310|NCT01595321|451321155|FG000|Overall Study|Adverse Event|1|||
125462311|NCT01595321|451321156|FG001|Overall Study|Adverse Event|1|||
125462312|NCT01595321|451321157|FG002|Overall Study|Adverse Event|1|||
125462313|NCT01595321|451321155|FG000|Overall Study|Lack of Efficacy|0|||
125462314|NCT01595321|451321156|FG001|Overall Study|Lack of Efficacy|0|||
125462315|NCT01595321|451321157|FG002|Overall Study|Lack of Efficacy|4|||
125462316|NCT04504916|451321159|FG000|Overall Study|Study terminated|7|||
125462317|NCT04504916|451321160|FG001|Overall Study|Study terminated|8|||
125462318|NCT04504916|451321159|FG000|Overall Study|Death|54|||
125462319|NCT04504916|451321160|FG001|Overall Study|Death|18|||
125462320|NCT04504916|451321159|FG000|Overall Study|Lost to Follow-up|1|||
125462321|NCT04504916|451321160|FG001|Overall Study|Lost to Follow-up|1|||
125462322|NCT04504916|451321159|FG000|Overall Study|Withdrawal by Subject|8|||
125462323|NCT04504916|451321160|FG001|Overall Study|Withdrawal by Subject|4|||
125462324|NCT04504916|451321159|FG000|Overall Study|Did not agree to follow-up|0|||
125462325|NCT04504916|451321160|FG001|Overall Study|Did not agree to follow-up|1|||
125462326|NCT00373529|451321161|FG000|Overall Study|Physician Decision|19|||
125462327|NCT00373529|451321161|FG000|Overall Study|Withdrawal by Subject|7|||
125462328|NCT00373529|451321161|FG000|Overall Study|Adverse Event|7|||
125462329|NCT00373529|451321161|FG000|Overall Study|Treatment failure|36|||
125462330|NCT00373529|451321161|FG000|Overall Study|Disease recurrence|10|||
125462331|NCT00373529|451321161|FG000|Overall Study|Death|16|||
125462332|NCT00373529|451321161|FG000|Overall Study|Need for treatment prohibited by study|1|||
125462333|NCT00373529|451321161|FG000|Overall Study|Other|8|||
125462334|NCT00373529|451321161|FG000|Overall Study|Failed independent confirmation of AML|3|||
125462335|NCT00373529|451321161|FG000|Overall Study|Consent violation|1|||
125462336|NCT01579916|451321164|FG000|Overall Study|Lost to Follow-up|6|||
125462337|NCT01579916|451321165|FG001|Overall Study|Lost to Follow-up|1|||
125462338|NCT01579916|451321164|FG000|Overall Study|Withdrawal by Subject|1|||
125462339|NCT01579916|451321165|FG001|Overall Study|Withdrawal by Subject|1|||
125462340|NCT01579916|451321164|FG000|Overall Study|Death|1|||
125462341|NCT01579916|451321165|FG001|Overall Study|Death|0|||
125462342|NCT00732381|451321171|FG000|Overall Study|Adverse Event|1|||
125462343|NCT00732381|451321172|FG001|Overall Study|Adverse Event|0|||
125462344|NCT00732381|451321171|FG000|Overall Study|Treatment Failure|1|||
125462345|NCT00732381|451321172|FG001|Overall Study|Treatment Failure|1|||
125462346|NCT00493649|451322160|FG000|Overall Study|Adverse Event|44|||
125462347|NCT00493649|451322160|FG000|Overall Study|Patient Request|21|||
125462348|NCT00493649|451322160|FG000|Overall Study|Investigator Request|2|||
125462349|NCT00493649|451322160|FG000|Overall Study|Disease Progression|1|||
125462350|NCT00493649|451322160|FG000|Overall Study|Lost to Follow-up|1|||
125462351|NCT00493649|451322160|FG000|Overall Study|Other|13|||
125462352|NCT05219253|451322161|FG000|Overall Study|Withdrawal by Subject|1|||
125462353|NCT05219253|451322162|FG001|Overall Study|Withdrawal by Subject|2|||
125462354|NCT03086369|451322163|FG000|Overall Study|Lost to Follow-up|1|||
125462355|NCT03086369|451322164|FG001|Overall Study|Lost to Follow-up|0|||
125462356|NCT03086369|451322165|FG002|Overall Study|Lost to Follow-up|0|||
125462357|NCT03086369|451322166|FG003|Overall Study|Lost to Follow-up|2|||
125462358|NCT03086369|451322167|FG004|Overall Study|Lost to Follow-up|1|||
125462359|NCT03086369|451322163|FG000|Overall Study|Physician Decision|0|||
125462360|NCT03086369|451322164|FG001|Overall Study|Physician Decision|0|||
125462361|NCT03086369|451322165|FG002|Overall Study|Physician Decision|0|||
125462362|NCT03086369|451322166|FG003|Overall Study|Physician Decision|1|||
125462363|NCT03086369|451322167|FG004|Overall Study|Physician Decision|2|||
125462364|NCT03086369|451322163|FG000|Overall Study|Withdrawal by Subject|0|||
125462365|NCT03086369|451322164|FG001|Overall Study|Withdrawal by Subject|0|||
125462366|NCT03086369|451322165|FG002|Overall Study|Withdrawal by Subject|0|||
125462367|NCT03086369|451322166|FG003|Overall Study|Withdrawal by Subject|5|||
125462368|NCT03086369|451322167|FG004|Overall Study|Withdrawal by Subject|3|||
125462369|NCT03086369|451322163|FG000|Overall Study|Progressive Disease|0|||
125462370|NCT03086369|451322164|FG001|Overall Study|Progressive Disease|0|||
125462371|NCT03086369|451322165|FG002|Overall Study|Progressive Disease|0|||
125462372|NCT03086369|451322166|FG003|Overall Study|Progressive Disease|1|||
125462373|NCT03086369|451322167|FG004|Overall Study|Progressive Disease|1|||
125462374|NCT04603924|451322170|FG000|Overall Study|Not Dosed|2|||
125462375|NCT04603924|451322171|FG001|Overall Study|Not Dosed|1|||
125462376|NCT04603924|451322170|FG000|Overall Study|Withdrawal by Subject|6|||
125462377|NCT04603924|451322171|FG001|Overall Study|Withdrawal by Subject|6|||
125462378|NCT04603924|451322170|FG000|Overall Study|Adverse Event|2|||
125462379|NCT04603924|451322171|FG001|Overall Study|Adverse Event|2|||
125462380|NCT04668339|451322172|FG000|Overall Study|Physician Decision|1|||
125462381|NCT04668339|451322173|FG001|Overall Study|Physician Decision|0|||
125462382|NCT04668339|451322174|FG002|Overall Study|Physician Decision|1|||
125462383|NCT04668339|451322175|FG003|Overall Study|Physician Decision|1|||
125462384|NCT04668339|451322172|FG000|Overall Study|Lost to Follow-up|14|||
125462385|NCT04668339|451322173|FG001|Overall Study|Lost to Follow-up|12|||
125462386|NCT04668339|451322174|FG002|Overall Study|Lost to Follow-up|8|||
125462387|NCT04668339|451322175|FG003|Overall Study|Lost to Follow-up|5|||
125462388|NCT04668339|451322172|FG000|Overall Study|Adverse Event|0|||
125462389|NCT04668339|451322173|FG001|Overall Study|Adverse Event|0|||
125462390|NCT04668339|451322174|FG002|Overall Study|Adverse Event|1|||
125462391|NCT04668339|451322175|FG003|Overall Study|Adverse Event|0|||
125462392|NCT04668339|451322172|FG000|Overall Study|Other than specified|3|||
125462393|NCT04668339|451322173|FG001|Overall Study|Other than specified|0|||
125462394|NCT04668339|451322174|FG002|Overall Study|Other than specified|1|||
125462395|NCT04668339|451322175|FG003|Overall Study|Other than specified|0|||
125462396|NCT04668339|451322172|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
125462397|NCT04668339|451322173|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
125462398|NCT04668339|451322174|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
125462399|NCT04668339|451322175|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
125462400|NCT04668339|451322172|FG000|Overall Study|Vaccine not Administered|0|||
125462401|NCT04668339|451322173|FG001|Overall Study|Vaccine not Administered|0|||
125462402|NCT04668339|451322174|FG002|Overall Study|Vaccine not Administered|1|||
125462403|NCT04668339|451322175|FG003|Overall Study|Vaccine not Administered|0|||
125462404|NCT04668339|451322172|FG000|Overall Study|Protocol Violation|18|||
125462405|NCT04668339|451322173|FG001|Overall Study|Protocol Violation|23|||
125462406|NCT04668339|451322174|FG002|Overall Study|Protocol Violation|12|||
125462407|NCT04668339|451322175|FG003|Overall Study|Protocol Violation|20|||
125462408|NCT04668339|451322172|FG000|Overall Study|Withdrawal by Subject|45|||
125462409|NCT04668339|451322173|FG001|Overall Study|Withdrawal by Subject|46|||
125462410|NCT04668339|451322174|FG002|Overall Study|Withdrawal by Subject|46|||
125462411|NCT04668339|451322175|FG003|Overall Study|Withdrawal by Subject|27|||
125462412|NCT04668339|451322172|FG000|Overall Study|Study Terminated by Sponsor|59|||
125462413|NCT04668339|451322173|FG001|Overall Study|Study Terminated by Sponsor|59|||
125462414|NCT04668339|451322174|FG002|Overall Study|Study Terminated by Sponsor|71|||
125462415|NCT04668339|451322175|FG003|Overall Study|Study Terminated by Sponsor|1|||
125462416|NCT00002842|451322185|FG000|Overall Study|ineligible for surgical resection|27|||
125462417|NCT03557008|451322187|FG000|Overall Study|Withdrawal by Subject|2|||
125462418|NCT03557008|451322188|FG001|Overall Study|Withdrawal by Subject|2|||
125462419|NCT03557008|451322187|FG000|Overall Study|Early termination from study|3|||
125462420|NCT03557008|451322188|FG001|Overall Study|Early termination from study|1|||
125462421|NCT01765543|451322189|FG000|Overall Study|Death|1|||
125462422|NCT01765543|451322189|FG000|Overall Study|Withdrawal by Subject|2|||
125462423|NCT05876949|451322190|FG000|Overall Study|Withdrawal by Subject|1|||
125462424|NCT05876949|451322191|FG001|Overall Study|Withdrawal by Subject|3|||
125462425|NCT05876949|451322190|FG000|Overall Study|Physician Decision|0|||
125462426|NCT05876949|451322191|FG001|Overall Study|Physician Decision|2|||
125462427|NCT05876949|451322190|FG000|Overall Study|Death|0|||
125462428|NCT05876949|451322191|FG001|Overall Study|Death|1|||
125462429|NCT03644849|451322192|FG000|Overall Study|Lost to Follow-up|1|||
125462430|NCT03644849|451322193|FG001|Overall Study|Lost to Follow-up|3|||
125462431|NCT00665444|451322196|FG000|Overall Study|Physician Decision|1|||
125462432|NCT00665444|451322196|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
125462433|NCT00638963|451322198|FG000|Overall Study|Withdrawal by Subject|1|||
125462434|NCT00638963|451322199|FG001|Overall Study|Withdrawal by Subject|0|||
125462435|NCT03260140|451322201|FG000|Overall Study|Death|4|||
125462436|NCT03260140|451322202|FG001|Overall Study|Death|1|||
125462437|NCT03260140|451322201|FG000|Overall Study|Withdrawal by Subject|1|||
125462438|NCT03260140|451322202|FG001|Overall Study|Withdrawal by Subject|4|||
125462439|NCT02200770|451322203|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
125462440|NCT02200770|451322204|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
125462441|NCT02200770|451322203|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
125462442|NCT02200770|451322204|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
125462443|NCT02200770|451322203|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
125462444|NCT02200770|451322204|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
125462445|NCT02200770|451322203|FG000|Randomized-controlled Period (RCP)|Other|1|||
125462446|NCT02200770|451322204|FG001|Randomized-controlled Period (RCP)|Other|2|||
125462447|NCT02200770|451322203|FG000|Open-label Period (OLP)|Adverse Event|1|||
125462448|NCT02200770|451322204|FG001|Open-label Period (OLP)|Adverse Event|2|||
125462449|NCT02200770|451322203|FG000|Open-label Period (OLP)|Death|1|||
125462450|NCT02200770|451322204|FG001|Open-label Period (OLP)|Death|2|||
125462451|NCT02200770|451322203|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
125462452|NCT02200770|451322204|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
125462453|NCT02200770|451322203|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
125462454|NCT02200770|451322204|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
125462455|NCT02200770|451322203|FG000|Open-label Period (OLP)|Other|6|||
125462456|NCT02200770|451322204|FG001|Open-label Period (OLP)|Other|15|||
125462457|NCT02423291|451322205|FG000|Overall Study|Lack of Efficacy|14|||
125462458|NCT02423291|451322205|FG000|Overall Study|Adverse Event|1|||
125462459|NCT05283395|451322211|FG000|Overall Study|Adverse Event|4|||
125462460|NCT05283395|451322212|FG001|Overall Study|Adverse Event|4|||
125462461|NCT05283395|451322213|FG002|Overall Study|Adverse Event|0|||
125462462|NCT05283395|451322211|FG000|Overall Study|Patient Lost to Follow-Up|0|||
125462463|NCT05283395|451322212|FG001|Overall Study|Patient Lost to Follow-Up|0|||
125462464|NCT05283395|451322213|FG002|Overall Study|Patient Lost to Follow-Up|1|||
125462465|NCT05283395|451322211|FG000|Overall Study|Patient Withdrawal|2|||
125462466|NCT05283395|451322212|FG001|Overall Study|Patient Withdrawal|4|||
125462467|NCT05283395|451322213|FG002|Overall Study|Patient Withdrawal|2|||
125462468|NCT05283395|451322211|FG000|Overall Study|Investigator Decision|1|||
125462469|NCT05283395|451322212|FG001|Overall Study|Investigator Decision|0|||
125462470|NCT05283395|451322213|FG002|Overall Study|Investigator Decision|1|||
125462471|NCT05283395|451322211|FG000|Overall Study|Enrolled in error|0|||
125462472|NCT05283395|451322212|FG001|Overall Study|Enrolled in error|0|||
125462473|NCT05283395|451322213|FG002|Overall Study|Enrolled in error|1|||
125462474|NCT00712335|451322214|FG000|Overall Study|Withdrawal by Subject|0|||
125462475|NCT00712335|451322215|FG001|Overall Study|Withdrawal by Subject|7|||
125462476|NCT00712335|451322216|FG002|Overall Study|Withdrawal by Subject|2|||
125462477|NCT00712335|451322217|FG003|Overall Study|Withdrawal by Subject|3|||
125462478|NCT00712335|451322218|FG004|Overall Study|Withdrawal by Subject|0|||
125462479|NCT00712335|451322214|FG000|Overall Study|Lost to Follow-up|2|||
125462480|NCT00712335|451322215|FG001|Overall Study|Lost to Follow-up|5|||
125462481|NCT00712335|451322216|FG002|Overall Study|Lost to Follow-up|0|||
125462482|NCT00712335|451322217|FG003|Overall Study|Lost to Follow-up|1|||
125462483|NCT00712335|451322218|FG004|Overall Study|Lost to Follow-up|0|||
125462484|NCT00712335|451322214|FG000|Overall Study|Protocol Violation|1|||
125462485|NCT00712335|451322215|FG001|Overall Study|Protocol Violation|2|||
125462486|NCT00712335|451322216|FG002|Overall Study|Protocol Violation|1|||
125462487|NCT00712335|451322217|FG003|Overall Study|Protocol Violation|0|||
125462488|NCT00712335|451322218|FG004|Overall Study|Protocol Violation|0|||
125462489|NCT00712335|451322214|FG000|Overall Study|Lack of Efficacy|0|||
125462490|NCT00712335|451322215|FG001|Overall Study|Lack of Efficacy|0|||
125462491|NCT00712335|451322216|FG002|Overall Study|Lack of Efficacy|1|||
125462492|NCT00712335|451322217|FG003|Overall Study|Lack of Efficacy|1|||
125462493|NCT00712335|451322218|FG004|Overall Study|Lack of Efficacy|0|||
125462494|NCT00712335|451322214|FG000|Overall Study|Other Reason|0|||
125462495|NCT00712335|451322215|FG001|Overall Study|Other Reason|3|||
125462496|NCT00712335|451322216|FG002|Overall Study|Other Reason|1|||
125462497|NCT00712335|451322217|FG003|Overall Study|Other Reason|0|||
125462498|NCT00712335|451322218|FG004|Overall Study|Other Reason|0|||
125462499|NCT03401112|451322220|FG000|Overall Study|Adverse Event|1|||
125462500|NCT03401112|451322221|FG001|Overall Study|Adverse Event|2|||
125462501|NCT03401112|451322222|FG002|Overall Study|Adverse Event|3|||
125462502|NCT03401112|451322223|FG003|Overall Study|Adverse Event|2|||
125462503|NCT03401112|451322224|FG004|Overall Study|Adverse Event|0|||
125462504|NCT03401112|451322220|FG000|Overall Study|Lost to Follow-up|1|||
125462505|NCT03401112|451322221|FG001|Overall Study|Lost to Follow-up|0|||
125462506|NCT03401112|451322222|FG002|Overall Study|Lost to Follow-up|0|||
125462507|NCT03401112|451322223|FG003|Overall Study|Lost to Follow-up|0|||
125462508|NCT03401112|451322224|FG004|Overall Study|Lost to Follow-up|0|||
125462509|NCT03401112|451322220|FG000|Overall Study|Noncompliance|1|||
125462510|NCT03401112|451322221|FG001|Overall Study|Noncompliance|2|||
125462511|NCT03401112|451322222|FG002|Overall Study|Noncompliance|3|||
125462512|NCT03401112|451322223|FG003|Overall Study|Noncompliance|0|||
125462513|NCT03401112|451322224|FG004|Overall Study|Noncompliance|0|||
125462514|NCT03401112|451322220|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
125462515|NCT03401112|451322221|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
125462516|NCT03401112|451322222|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
125462517|NCT03401112|451322223|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
125462518|NCT03401112|451322224|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
125462519|NCT03401112|451322220|FG000|Overall Study|Withdrawal by Subject|0|||
125462520|NCT03401112|451322221|FG001|Overall Study|Withdrawal by Subject|3|||
125462521|NCT03401112|451322222|FG002|Overall Study|Withdrawal by Subject|2|||
125462522|NCT03401112|451322223|FG003|Overall Study|Withdrawal by Subject|1|||
125462523|NCT03401112|451322224|FG004|Overall Study|Withdrawal by Subject|0|||
125462524|NCT03401112|451322220|FG000|Overall Study|Physician Decision|0|||
125462525|NCT03401112|451322221|FG001|Overall Study|Physician Decision|0|||
125462526|NCT03401112|451322222|FG002|Overall Study|Physician Decision|0|||
125462527|NCT03401112|451322223|FG003|Overall Study|Physician Decision|2|||
125462528|NCT03401112|451322224|FG004|Overall Study|Physician Decision|0|||
125462529|NCT03401112|451322220|FG000|Overall Study|Study was Terminated by Sponsor|0|||
125462530|NCT03401112|451322221|FG001|Overall Study|Study was Terminated by Sponsor|0|||
125462531|NCT03401112|451322222|FG002|Overall Study|Study was Terminated by Sponsor|0|||
125462532|NCT03401112|451322223|FG003|Overall Study|Study was Terminated by Sponsor|1|||
125462533|NCT03401112|451322224|FG004|Overall Study|Study was Terminated by Sponsor|0|||
125462534|NCT03401112|451322220|FG000|Overall Study|Day 1 Assessment not Done|1|||
125462535|NCT03401112|451322221|FG001|Overall Study|Day 1 Assessment not Done|0|||
125462536|NCT03401112|451322222|FG002|Overall Study|Day 1 Assessment not Done|0|||
125462537|NCT03401112|451322223|FG003|Overall Study|Day 1 Assessment not Done|0|||
125462538|NCT03401112|451322224|FG004|Overall Study|Day 1 Assessment not Done|0|||
125462539|NCT03401112|451322220|FG000|Overall Study|Not Dosed|0|||
125462540|NCT03401112|451322221|FG001|Overall Study|Not Dosed|0|||
125462541|NCT03401112|451322222|FG002|Overall Study|Not Dosed|1|||
125462542|NCT03401112|451322223|FG003|Overall Study|Not Dosed|0|||
125462543|NCT03401112|451322224|FG004|Overall Study|Not Dosed|0|||
125462544|NCT03401112|451322220|FG000|Overall Study|Missed Clinical Visit|0|||
125462545|NCT03401112|451322221|FG001|Overall Study|Missed Clinical Visit|0|||
125462546|NCT03401112|451322222|FG002|Overall Study|Missed Clinical Visit|1|||
125462547|NCT03401112|451322223|FG003|Overall Study|Missed Clinical Visit|0|||
125462548|NCT03401112|451322224|FG004|Overall Study|Missed Clinical Visit|0|||
125462549|NCT03401112|451322220|FG000|Overall Study|Missed Doses|0|||
125462550|NCT03401112|451322221|FG001|Overall Study|Missed Doses|0|||
125462551|NCT03401112|451322222|FG002|Overall Study|Missed Doses|1|||
125462552|NCT03401112|451322223|FG003|Overall Study|Missed Doses|0|||
125462553|NCT03401112|451322224|FG004|Overall Study|Missed Doses|0|||
125462554|NCT03475316|451322225|FG000|6 Month Intervention|Adverse Event|2|||
125462555|NCT03475316|451322226|FG001|6 Month Intervention|Adverse Event|1|||
125462556|NCT03475316|451322225|FG000|6 Month Intervention|Withdrawal by Subject|2|||
125462557|NCT03475316|451322226|FG001|6 Month Intervention|Withdrawal by Subject|0|||
125462558|NCT03475316|451322225|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
125462559|NCT03475316|451322226|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
125462560|NCT03475316|451322225|FG000|9 Months|Study stopped due to COVID pandemic|3|||
125462561|NCT03475316|451322226|FG001|9 Months|Study stopped due to COVID pandemic|4|||
125462562|NCT00424645|451322227|FG000|Overall Study|Death|1|||
125462563|NCT00424645|451322228|FG001|Overall Study|Death|0|||
125462564|NCT02555215|451322229|FG000|Overall Study|Other|1|||
125462565|NCT02555215|451322229|FG000|Overall Study|Investigator Decision|2|||
125462566|NCT01430611|451322230|FG000|Overall Study|Adverse Event|0|||
125462567|NCT01430611|451322231|FG001|Overall Study|Adverse Event|1|||
125462568|NCT01430611|451322230|FG000|Overall Study|Protocol Violation|1|||
125462569|NCT01430611|451322231|FG001|Overall Study|Protocol Violation|0|||
125462570|NCT01430611|451322230|FG000|Overall Study|Lost to Follow-up|1|||
125462571|NCT01430611|451322231|FG001|Overall Study|Lost to Follow-up|0|||
125462572|NCT01430611|451322230|FG000|Overall Study|Withdrawal by Subject|15|||
125462573|NCT01430611|451322231|FG001|Overall Study|Withdrawal by Subject|14|||
125462574|NCT03144674|451322234|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
125462575|NCT03144674|451322235|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
125462576|NCT03144674|451322236|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
125462577|NCT03144674|451322237|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
125462578|NCT03144674|451322234|FG000|Overall Study|Death|3|||
125462579|NCT03144674|451322235|FG001|Overall Study|Death|2|||
125462580|NCT03144674|451322236|FG002|Overall Study|Death|6|||
125462581|NCT03144674|451322237|FG003|Overall Study|Death|24|||
125462582|NCT03144674|451322234|FG000|Overall Study|Lost to Follow-up|0|||
125462583|NCT03144674|451322235|FG001|Overall Study|Lost to Follow-up|1|||
125462584|NCT03144674|451322236|FG002|Overall Study|Lost to Follow-up|0|||
125462585|NCT03144674|451322237|FG003|Overall Study|Lost to Follow-up|4|||
125462586|NCT03144674|451322234|FG000|Overall Study|Withdrawal by Participant|0|||
125462587|NCT03144674|451322235|FG001|Overall Study|Withdrawal by Participant|0|||
125462588|NCT03144674|451322236|FG002|Overall Study|Withdrawal by Participant|2|||
125462589|NCT03144674|451322237|FG003|Overall Study|Withdrawal by Participant|6|||
125462590|NCT03144674|451322234|FG000|Overall Study|Discharged from the Trust|0|||
125462591|NCT03144674|451322235|FG001|Overall Study|Discharged from the Trust|0|||
125462592|NCT03144674|451322236|FG002|Overall Study|Discharged from the Trust|1|||
125462593|NCT03144674|451322237|FG003|Overall Study|Discharged from the Trust|0|||
125462594|NCT03144674|451322234|FG000|Overall Study|Exclusion Criteria Met|0|||
125462595|NCT03144674|451322235|FG001|Overall Study|Exclusion Criteria Met|0|||
125462596|NCT03144674|451322236|FG002|Overall Study|Exclusion Criteria Met|1|||
125462597|NCT03144674|451322237|FG003|Overall Study|Exclusion Criteria Met|0|||
125462598|NCT03144674|451322234|FG000|Overall Study|Changed Physicians|0|||
125462599|NCT03144674|451322235|FG001|Overall Study|Changed Physicians|0|||
125462600|NCT03144674|451322236|FG002|Overall Study|Changed Physicians|0|||
125462601|NCT03144674|451322237|FG003|Overall Study|Changed Physicians|1|||
125462602|NCT03144674|451322234|FG000|Overall Study|Removed for Safety|0|||
125462603|NCT03144674|451322235|FG001|Overall Study|Removed for Safety|0|||
125462604|NCT03144674|451322236|FG002|Overall Study|Removed for Safety|0|||
125462605|NCT03144674|451322237|FG003|Overall Study|Removed for Safety|1|||
125462606|NCT03144674|451322234|FG000|Overall Study|Site Closed|0|||
125462607|NCT03144674|451322235|FG001|Overall Study|Site Closed|0|||
125462608|NCT03144674|451322236|FG002|Overall Study|Site Closed|0|||
125462609|NCT03144674|451322237|FG003|Overall Study|Site Closed|1|||
125462610|NCT03144674|451322234|FG000|Overall Study|Histological Criteria Not Met|0|||
125462611|NCT03144674|451322235|FG001|Overall Study|Histological Criteria Not Met|0|||
125462612|NCT03144674|451322236|FG002|Overall Study|Histological Criteria Not Met|0|||
125462613|NCT03144674|451322237|FG003|Overall Study|Histological Criteria Not Met|1|||
125462614|NCT03144674|451322234|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
125462615|NCT03144674|451322235|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
125462616|NCT03144674|451322236|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
125462617|NCT03144674|451322237|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
125462618|NCT03144674|451322234|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
125462619|NCT03144674|451322235|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
125462620|NCT03144674|451322236|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
125462621|NCT03144674|451322237|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
125462622|NCT00206375|451322238|FG000|Overall Study|Lost to Follow-up|1|||
125462623|NCT00206375|451322239|FG001|Overall Study|Lost to Follow-up|0|||
125462624|NCT00206375|451322240|FG002|Overall Study|Lost to Follow-up|0|||
125462625|NCT00206375|451322238|FG000|Overall Study|Withdrawal by Subject|2|||
125462626|NCT00206375|451322239|FG001|Overall Study|Withdrawal by Subject|1|||
125462627|NCT00206375|451322240|FG002|Overall Study|Withdrawal by Subject|3|||
125462628|NCT00206375|451322238|FG000|Overall Study|Study terminated due to lack of funds|0|||
125462629|NCT00206375|451322239|FG001|Overall Study|Study terminated due to lack of funds|1|||
125462630|NCT00206375|451322240|FG002|Overall Study|Study terminated due to lack of funds|1|||
125462631|NCT03368664|451322241|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
125462632|NCT03368664|451322241|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
125462633|NCT03368664|451322241|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
125462634|NCT03368664|451322241|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
125462635|NCT00837616|451322242|FG000|Overall Study|Withdrawal by Subject|0|||
125462636|NCT00837616|451322243|FG001|Overall Study|Withdrawal by Subject|1|||
125462637|NCT01810263|451322250|FG000|Overall Study|Lost to Follow-up|8|||
125462638|NCT01810263|451322251|FG001|Overall Study|Lost to Follow-up|7|||
125462639|NCT00457691|451322253|FG000|Overall Study|Adverse Event|4|||
125462640|NCT00457691|451322254|FG001|Overall Study|Adverse Event|1|||
125462641|NCT00457691|451322253|FG000|Overall Study|Death|163|||
125462642|NCT00457691|451322254|FG001|Overall Study|Death|148|||
125462643|NCT00457691|451322253|FG000|Overall Study|Protocol Violation|1|||
125462644|NCT00457691|451322254|FG001|Overall Study|Protocol Violation|3|||
125462645|NCT00457691|451322253|FG000|Overall Study|Lost to Follow-up|23|||
125462646|NCT00457691|451322254|FG001|Overall Study|Lost to Follow-up|14|||
125462647|NCT00457691|451322253|FG000|Overall Study|Study terminated by Sponsor|1|||
125462648|NCT00457691|451322254|FG001|Overall Study|Study terminated by Sponsor|1|||
125462649|NCT00457691|451322253|FG000|Overall Study|Subject refused (reason other than AE)|14|||
125462650|NCT00457691|451322254|FG001|Overall Study|Subject refused (reason other than AE)|19|||
125462651|NCT00457691|451322253|FG000|Overall Study|Disease progression, study terminated|180|||
125462652|NCT00457691|451322254|FG001|Overall Study|Disease progression, study terminated|196|||
125462653|NCT01121549|451322259|FG000|Overall Study|Adverse Event|10|||
125462654|NCT01121549|451322259|FG000|Overall Study|Lack of Efficacy|11|||
125462655|NCT01121549|451322259|FG000|Overall Study|Lost to Follow-up|12|||
125462656|NCT01121549|451322259|FG000|Overall Study|Did not meet entrance criteria|9|||
125462657|NCT01121549|451322259|FG000|Overall Study|Study terminated by sponsor|197|||
125462658|NCT01121549|451322259|FG000|Overall Study|Pregnancy|1|||
125462659|NCT01121549|451322259|FG000|Overall Study|Protocol Violation|33|||
125462660|NCT01121549|451322259|FG000|Overall Study|Withdrawal by Subject|16|||
125462661|NCT01121549|451322259|FG000|Overall Study|Other|58|||
125462662|NCT02999477|451322262|FG000|Overall Study|found ineligible after first dose|0|||
125462663|NCT02999477|451322263|FG001|Overall Study|found ineligible after first dose|1|||
125462664|NCT02999477|451322262|FG000|Overall Study|Withdrawal by Subject|1|||
125462665|NCT02999477|451322263|FG001|Overall Study|Withdrawal by Subject|1|||
125462666|NCT00573833|451322264|FG000|Overall Study|Not Treated|2|||
125462667|NCT03351075|451324085|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
125462668|NCT03351075|451324086|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
125462669|NCT03351075|451324085|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
125462670|NCT03351075|451324086|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
125462671|NCT03351075|451324085|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
125462672|NCT03351075|451324086|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
125462673|NCT03351075|451324085|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
125462674|NCT03351075|451324086|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
125462675|NCT00925899|451324087|FG000|Part 1|Death|1|||
125462676|NCT00925899|451324088|FG001|Part 1|Death|2|||
125462677|NCT00925899|451324087|FG000|Part 1|Withdrawal by Subject|10|||
125462678|NCT00925899|451324088|FG001|Part 1|Withdrawal by Subject|9|||
125462679|NCT02396316|451324089|FG000|Overall Study|Physician Decision|1|||
125462680|NCT02396316|451324090|FG001|Overall Study|Physician Decision|0|||
125462681|NCT02396316|451324089|FG000|Overall Study|Progressive disease|6|||
125462682|NCT02396316|451324090|FG001|Overall Study|Progressive disease|3|||
125462683|NCT02396316|451324089|FG000|Overall Study|Protocol Violation|0|||
125462684|NCT02396316|451324090|FG001|Overall Study|Protocol Violation|1|||
125462685|NCT02396316|451324089|FG000|Overall Study|Treatment unblinded|0|||
125462686|NCT02396316|451324090|FG001|Overall Study|Treatment unblinded|1|||
125462687|NCT00566735|451324091|FG000|Overall Study|Withdrawal by Subject|0|||
125462688|NCT00566735|451324092|FG001|Overall Study|Withdrawal by Subject|1|||
125462689|NCT00566735|451324091|FG000|Overall Study|Refused neuropsychological testing|2|||
125462690|NCT00566735|451324092|FG001|Overall Study|Refused neuropsychological testing|5|||
125462691|NCT00566735|451324091|FG000|Overall Study|Switched into a manic episode|0|||
125462692|NCT00566735|451324092|FG001|Overall Study|Switched into a manic episode|1|||
125462693|NCT00925587|451324094|FG000|Overall Study|Protocol Specified Criteria|6|||
125462694|NCT00925587|451324095|FG001|Overall Study|Protocol Specified Criteria|6|||
125462695|NCT00925587|451324094|FG000|Overall Study|Physician Decision|4|||
125462696|NCT00925587|451324095|FG001|Overall Study|Physician Decision|1|||
125462697|NCT00925587|451324094|FG000|Overall Study|Protocol Violation|6|||
125462698|NCT00925587|451324095|FG001|Overall Study|Protocol Violation|4|||
125462699|NCT00925587|451324094|FG000|Overall Study|Withdrawal by Subject|9|||
125462700|NCT00925587|451324095|FG001|Overall Study|Withdrawal by Subject|6|||
125462701|NCT00925587|451324094|FG000|Overall Study|Death|5|||
125462702|NCT00925587|451324095|FG001|Overall Study|Death|5|||
125462703|NCT00925587|451324094|FG000|Overall Study|Adverse Event|6|||
125462704|NCT00925587|451324095|FG001|Overall Study|Adverse Event|2|||
125462705|NCT00925587|451324094|FG000|Overall Study|Lost to Follow-up|0|||
125462706|NCT00925587|451324095|FG001|Overall Study|Lost to Follow-up|1|||
125462707|NCT00071799|451324098|FG000|Overall Study|Adverse Event|19|||
125462708|NCT00071799|451324099|FG001|Overall Study|Adverse Event|10|||
125462709|NCT00071799|451324098|FG000|Overall Study|Protocol Violation|1|||
125462710|NCT00071799|451324099|FG001|Overall Study|Protocol Violation|7|||
125462711|NCT00071799|451324098|FG000|Overall Study|Lost to Follow-up|1|||
125462712|NCT00071799|451324099|FG001|Overall Study|Lost to Follow-up|1|||
125462713|NCT00071799|451324098|FG000|Overall Study|Withdrawal by Subject|15|||
125462714|NCT00071799|451324099|FG001|Overall Study|Withdrawal by Subject|37|||
125462715|NCT00071799|451324098|FG000|Overall Study|Physician Decision|0|||
125462716|NCT00071799|451324099|FG001|Overall Study|Physician Decision|2|||
125462717|NCT00071799|451324098|FG000|Overall Study|Lack of Efficacy|11|||
125462718|NCT00071799|451324099|FG001|Overall Study|Lack of Efficacy|18|||
125462719|NCT00071799|451324098|FG000|Overall Study|Disease Progression|23|||
125462720|NCT00071799|451324099|FG001|Overall Study|Disease Progression|20|||
125462721|NCT00071799|451324098|FG000|Overall Study|Different Central+Local Pathology Review|0|||
125462722|NCT00071799|451324099|FG001|Overall Study|Different Central+Local Pathology Review|1|||
125462723|NCT00071799|451324098|FG000|Overall Study|Not Documented|0|||
125462724|NCT00071799|451324099|FG001|Overall Study|Not Documented|2|||
125462725|NCT01177670|451324100|FG000|Overall Study|Study Terminated|115|||
125462726|NCT01177670|451324100|FG000|Overall Study|Physician Decision|50|||
125462727|NCT01177670|451324100|FG000|Overall Study|Withdrawal by Subject|4|||
125462728|NCT00979992|451324101|FG000|Overall Study|Ineligible - inadequate pathology|1|||
125462729|NCT00979992|451324101|FG000|Overall Study|Ineligible - wrong cell type|2|||
125462730|NCT00979992|451324101|FG000|Overall Study|Refused - Never Treated|2|||
125462731|NCT03593213|451324104|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
125462732|NCT03593213|451324105|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
125462733|NCT03593213|451324106|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
125462734|NCT03593213|451324107|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
125462735|NCT03593213|451324104|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
125462736|NCT03593213|451324105|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
125462737|NCT03593213|451324106|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
125462738|NCT03593213|451324107|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
125462739|NCT03593213|451324104|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
125462740|NCT03593213|451324105|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
125462741|NCT03593213|451324106|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
125462742|NCT03593213|451324107|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
125462743|NCT03593213|451324104|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
125462744|NCT03593213|451324105|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
125462745|NCT03593213|451324106|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
125462746|NCT03593213|451324107|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
125462747|NCT03593213|451324104|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
125462748|NCT03593213|451324105|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
125462749|NCT03593213|451324106|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
125462750|NCT03593213|451324107|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
125462751|NCT03593213|451324104|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
125462752|NCT03593213|451324105|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
125462753|NCT03593213|451324106|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
125462754|NCT03593213|451324107|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
125462755|NCT03593213|451324104|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
125462756|NCT03593213|451324105|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
125462757|NCT03593213|451324106|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
125462758|NCT03593213|451324107|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
125462759|NCT03593213|451324104|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
125462760|NCT03593213|451324105|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
125462761|NCT03593213|451324106|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
125462762|NCT03593213|451324107|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
125462763|NCT03593213|451324104|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
125462764|NCT03593213|451324105|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
125462765|NCT03593213|451324106|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
125462766|NCT03593213|451324107|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
125462767|NCT03593213|451324104|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
125462768|NCT03593213|451324105|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
125462769|NCT03593213|451324106|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
125462770|NCT03593213|451324107|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
125462771|NCT03593213|451324104|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
125462772|NCT03593213|451324105|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
125462773|NCT03593213|451324106|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
125462774|NCT03593213|451324107|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
125462775|NCT03593213|451324104|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
125462776|NCT03593213|451324105|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
125462777|NCT03593213|451324106|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
125462778|NCT03593213|451324107|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
125462779|NCT03593213|451324104|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
125462780|NCT03593213|451324105|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
125462781|NCT03593213|451324106|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
125462782|NCT03593213|451324107|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
125462783|NCT03593213|451324104|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
125462784|NCT03593213|451324105|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
125462785|NCT03593213|451324106|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
125462786|NCT03593213|451324107|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
125462787|NCT03593213|451324104|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
125462788|NCT03593213|451324105|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
125462789|NCT03593213|451324106|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
125462790|NCT03593213|451324107|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
125462791|NCT03593213|451324104|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
125462792|NCT03593213|451324105|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
125462793|NCT03593213|451324106|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
125462794|NCT03593213|451324107|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
125462795|NCT03593213|451324104|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
125462796|NCT03593213|451324105|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
125462797|NCT03593213|451324106|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
125462798|NCT03593213|451324107|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
125462799|NCT03593213|451324104|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
125462800|NCT03593213|451324105|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
125462801|NCT03593213|451324106|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
125462802|NCT03593213|451324107|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
125462803|NCT03593213|451324104|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
125462804|NCT03593213|451324105|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
125462805|NCT03593213|451324106|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
125462806|NCT03593213|451324107|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
125462807|NCT01254019|451324112|FG000|Overall Study|Adverse Event|0|||
125462808|NCT01254019|451324113|FG001|Overall Study|Adverse Event|2|||
125462809|NCT01254019|451324112|FG000|Overall Study|Protocol Violation|1|||
125462810|NCT01254019|451324113|FG001|Overall Study|Protocol Violation|0|||
125462811|NCT01254019|451324112|FG000|Overall Study|Withdrawal by Subject|0|||
125462812|NCT01254019|451324113|FG001|Overall Study|Withdrawal by Subject|2|||
125462813|NCT03061474|451324114|FG000|Overall Study|Adverse Event|2|||
125462814|NCT03061474|451324115|FG001|Overall Study|Adverse Event|0|||
125462815|NCT03061474|451324114|FG000|Overall Study|Safety Risk|0|||
125462816|NCT03061474|451324115|FG001|Overall Study|Safety Risk|1|||
125462817|NCT03061474|451324114|FG000|Overall Study|Participant unwilling or unable to participate|0|||
125462818|NCT03061474|451324115|FG001|Overall Study|Participant unwilling or unable to participate|2|||
125462819|NCT03061474|451324114|FG000|Overall Study|Lost to Follow-up|0|||
125462820|NCT03061474|451324115|FG001|Overall Study|Lost to Follow-up|1|||
125462821|NCT02888080|451324116|FG000|Overall Study|Subject / Guardian decision|1|||
125462822|NCT02888080|451324117|FG001|Overall Study|Subject / Guardian decision|3|||
125462823|NCT02888080|451324116|FG000|Overall Study|New Therapy for study indication|1|||
125462824|NCT02888080|451324117|FG001|Overall Study|New Therapy for study indication|0|||
125462825|NCT02888080|451324116|FG000|Overall Study|Lack of Efficacy|0|||
125462826|NCT02888080|451324117|FG001|Overall Study|Lack of Efficacy|1|||
125462827|NCT02888080|451324116|FG000|Overall Study|Adverse Event|0|||
125462828|NCT02888080|451324117|FG001|Overall Study|Adverse Event|1|||
125462829|NCT00845832|451324118|FG000|Treatment Period|Adverse Event|0|||
125462830|NCT00845832|451324119|FG001|Treatment Period|Adverse Event|2|||
125462831|NCT00845832|451324120|FG002|Treatment Period|Adverse Event|0|||
125462832|NCT00845832|451324118|FG000|Treatment Period|Protocol Violation|1|||
125462833|NCT00845832|451324119|FG001|Treatment Period|Protocol Violation|1|||
125462834|NCT00845832|451324120|FG002|Treatment Period|Protocol Violation|0|||
125462835|NCT00845832|451324118|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
125462836|NCT00845832|451324119|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
125462837|NCT00845832|451324120|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
125462838|NCT00845832|451324118|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
125462839|NCT00845832|451324119|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
125462840|NCT00845832|451324120|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
125462841|NCT00189202|451324125|FG000|Overall Study|Physician Decision|5|||
125462842|NCT01039688|451324128|FG000|Overall Study|Adverse Event|38|||
125462843|NCT01039688|451324129|FG001|Overall Study|Adverse Event|39|||
125462844|NCT01039688|451324130|FG002|Overall Study|Adverse Event|24|||
125462845|NCT01039688|451324128|FG000|Overall Study|Lack of Efficacy|20|||
125462846|NCT01039688|451324129|FG001|Overall Study|Lack of Efficacy|11|||
125462847|NCT01039688|451324130|FG002|Overall Study|Lack of Efficacy|26|||
125462848|NCT01039688|451324128|FG000|Overall Study|Lost to Follow-up|11|||
125462849|NCT01039688|451324129|FG001|Overall Study|Lost to Follow-up|9|||
125462850|NCT01039688|451324130|FG002|Overall Study|Lost to Follow-up|5|||
125462851|NCT01039688|451324128|FG000|Overall Study|Other|13|||
125462852|NCT01039688|451324129|FG001|Overall Study|Other|25|||
125462853|NCT01039688|451324130|FG002|Overall Study|Other|12|||
125462854|NCT01039688|451324128|FG000|Overall Study|Withdrawal by Subject|23|||
125462855|NCT01039688|451324129|FG001|Overall Study|Withdrawal by Subject|27|||
125462856|NCT01039688|451324130|FG002|Overall Study|Withdrawal by Subject|13|||
125462857|NCT01039688|451324128|FG000|Overall Study|Death|2|||
125462858|NCT01039688|451324129|FG001|Overall Study|Death|0|||
125462859|NCT01039688|451324130|FG002|Overall Study|Death|0|||
125462860|NCT00668863|451324131|FG000|Overall Study|Objective Progression or Relapse|42|||
125462861|NCT00668863|451324131|FG000|Overall Study|Adverse Event|13|||
125462862|NCT00668863|451324131|FG000|Overall Study|Study Terminated by Sponsor|8|||
125462863|NCT00668863|451324131|FG000|Overall Study|Global Deterioration of Health Status|4|||
125462864|NCT00668863|451324131|FG000|Overall Study|Withdrawal by Subject|1|||
125462865|NCT00668863|451324131|FG000|Overall Study|Surgery|1|||
125462866|NCT00668863|451324131|FG000|Overall Study|Subject's work scheduling problem|1|||
125462867|NCT00668863|451324131|FG000|Overall Study|Physician Decision|1|||
125462868|NCT03844269|451324136|FG000|Overall Study|Withdrawal pre-intervention|1|||
125462869|NCT03844269|451324136|FG000|Overall Study|Did not complete the intervention|2|||
125462870|NCT00101010|451324138|FG000|Overall Study|Physician Decision|1|||
125462871|NCT00869323|451324141|FG000|Maintenance Therapy|concurrent illness|1|||
125462872|NCT01135511|451324142|FG000|Overall Study|Adverse Event|0|||
125462873|NCT01135511|451324143|FG001|Overall Study|Adverse Event|1|||
125462874|NCT01135511|451324144|FG002|Overall Study|Adverse Event|2|||
125462875|NCT01135511|451324145|FG003|Overall Study|Adverse Event|0|||
125462876|NCT01135511|451324146|FG004|Overall Study|Adverse Event|0|||
125462877|NCT01135511|451324147|FG005|Overall Study|Adverse Event|1|||
125462878|NCT01135511|451324148|FG006|Overall Study|Adverse Event|0|||
125462879|NCT01135511|451324149|FG007|Overall Study|Adverse Event|1|||
125462880|NCT01135511|451324150|FG008|Overall Study|Adverse Event|0|||
125462881|NCT01135511|451324142|FG000|Overall Study|Lack of Efficacy|0|||
125462882|NCT01135511|451324143|FG001|Overall Study|Lack of Efficacy|1|||
125462883|NCT01135511|451324144|FG002|Overall Study|Lack of Efficacy|1|||
125462884|NCT01135511|451324145|FG003|Overall Study|Lack of Efficacy|2|||
125462885|NCT01135511|451324146|FG004|Overall Study|Lack of Efficacy|0|||
125462886|NCT01135511|451324147|FG005|Overall Study|Lack of Efficacy|0|||
125462887|NCT01135511|451324148|FG006|Overall Study|Lack of Efficacy|0|||
125462888|NCT01135511|451324149|FG007|Overall Study|Lack of Efficacy|0|||
125462889|NCT01135511|451324150|FG008|Overall Study|Lack of Efficacy|0|||
125462890|NCT01135511|451324142|FG000|Overall Study|Protocol Violation|0|||
125462891|NCT01135511|451324143|FG001|Overall Study|Protocol Violation|0|||
125462892|NCT01135511|451324144|FG002|Overall Study|Protocol Violation|3|||
125462893|NCT01135511|451324145|FG003|Overall Study|Protocol Violation|0|||
125462894|NCT01135511|451324146|FG004|Overall Study|Protocol Violation|0|||
125462895|NCT01135511|451324147|FG005|Overall Study|Protocol Violation|0|||
125462896|NCT01135511|451324148|FG006|Overall Study|Protocol Violation|0|||
125462897|NCT01135511|451324149|FG007|Overall Study|Protocol Violation|0|||
125462898|NCT01135511|451324150|FG008|Overall Study|Protocol Violation|0|||
125462899|NCT01135511|451324142|FG000|Overall Study|Pregnancy|0|||
125462900|NCT01135511|451324143|FG001|Overall Study|Pregnancy|0|||
125462901|NCT01135511|451324144|FG002|Overall Study|Pregnancy|0|||
125462902|NCT01135511|451324145|FG003|Overall Study|Pregnancy|1|||
125462903|NCT01135511|451324146|FG004|Overall Study|Pregnancy|0|||
125462904|NCT01135511|451324147|FG005|Overall Study|Pregnancy|0|||
125462905|NCT01135511|451324148|FG006|Overall Study|Pregnancy|0|||
125462906|NCT01135511|451324149|FG007|Overall Study|Pregnancy|0|||
125462907|NCT01135511|451324150|FG008|Overall Study|Pregnancy|0|||
125462908|NCT01135511|451324142|FG000|Overall Study|could not visit the clinic|0|||
125462909|NCT01135511|451324143|FG001|Overall Study|could not visit the clinic|1|||
125462910|NCT01135511|451324144|FG002|Overall Study|could not visit the clinic|2|||
125462911|NCT01135511|451324145|FG003|Overall Study|could not visit the clinic|0|||
125462912|NCT01135511|451324146|FG004|Overall Study|could not visit the clinic|0|||
125462913|NCT01135511|451324147|FG005|Overall Study|could not visit the clinic|0|||
125462914|NCT01135511|451324148|FG006|Overall Study|could not visit the clinic|0|||
125462915|NCT01135511|451324149|FG007|Overall Study|could not visit the clinic|0|||
125462916|NCT01135511|451324150|FG008|Overall Study|could not visit the clinic|0|||
125462917|NCT01135511|451324142|FG000|Overall Study|noncompliance with study drug taken|0|||
125462918|NCT01135511|451324143|FG001|Overall Study|noncompliance with study drug taken|0|||
125462919|NCT01135511|451324144|FG002|Overall Study|noncompliance with study drug taken|0|||
125462920|NCT01135511|451324145|FG003|Overall Study|noncompliance with study drug taken|0|||
125462921|NCT01135511|451324146|FG004|Overall Study|noncompliance with study drug taken|1|||
125462922|NCT01135511|451324147|FG005|Overall Study|noncompliance with study drug taken|0|||
125462923|NCT01135511|451324148|FG006|Overall Study|noncompliance with study drug taken|0|||
125462924|NCT01135511|451324149|FG007|Overall Study|noncompliance with study drug taken|0|||
125462925|NCT01135511|451324150|FG008|Overall Study|noncompliance with study drug taken|0|||
125462926|NCT01135511|451324142|FG000|Overall Study|Withdrawal by Subject|0|||
125462927|NCT01135511|451324143|FG001|Overall Study|Withdrawal by Subject|0|||
125462928|NCT01135511|451324144|FG002|Overall Study|Withdrawal by Subject|0|||
125462929|NCT01135511|451324145|FG003|Overall Study|Withdrawal by Subject|0|||
125462930|NCT01135511|451324146|FG004|Overall Study|Withdrawal by Subject|0|||
125462931|NCT01135511|451324147|FG005|Overall Study|Withdrawal by Subject|0|||
125462932|NCT01135511|451324148|FG006|Overall Study|Withdrawal by Subject|1|||
125462933|NCT01135511|451324149|FG007|Overall Study|Withdrawal by Subject|0|||
125462934|NCT01135511|451324150|FG008|Overall Study|Withdrawal by Subject|1|||
125462935|NCT05082935|451324160|FG000|Overall Study|Lost to Follow-up|549|||
125462936|NCT05082935|451324161|FG001|Overall Study|Lost to Follow-up|631|||
125462937|NCT05082935|451324160|FG000|Overall Study|Withdrawal by Subject|27|||
125462938|NCT05082935|451324161|FG001|Overall Study|Withdrawal by Subject|58|||
125462939|NCT02957136|451324163|FG000|Overall Study|Withdrawal by Subject|2|||
125462940|NCT02957136|451324164|FG001|Overall Study|Withdrawal by Subject|1|||
125462941|NCT01444417|451324165|FG000|Overall Study|Ineligibility Determined|0|||
125462942|NCT01444417|451324166|FG001|Overall Study|Ineligibility Determined|1|||
125462943|NCT01444417|451324165|FG000|Overall Study|Withdrawal by Subject|2|||
125462944|NCT01444417|451324166|FG001|Overall Study|Withdrawal by Subject|0|||
125462945|NCT01595061|451324167|FG000|Overall Study|Never Treated|3|||
125462946|NCT01595061|451324167|FG000|Overall Study|Inadequate Pathology|1|||
125462947|NCT00960141|451324168|FG000|Overall Study|Adverse Event|4|||
125462948|NCT00960141|451324169|FG001|Overall Study|Adverse Event|8|||
125462949|NCT00960141|451324170|FG002|Overall Study|Adverse Event|2|||
125462950|NCT00960141|451324168|FG000|Overall Study|Lack of Efficacy|3|||
125462951|NCT00960141|451324169|FG001|Overall Study|Lack of Efficacy|4|||
125462952|NCT00960141|451324170|FG002|Overall Study|Lack of Efficacy|2|||
125462953|NCT00960141|451324168|FG000|Overall Study|Lost to Follow-up|1|||
125462954|NCT00960141|451324169|FG001|Overall Study|Lost to Follow-up|0|||
125462955|NCT00960141|451324170|FG002|Overall Study|Lost to Follow-up|0|||
125462956|NCT00960141|451324168|FG000|Overall Study|Protocol Violation|1|||
125462957|NCT00960141|451324169|FG001|Overall Study|Protocol Violation|3|||
125462958|NCT00960141|451324170|FG002|Overall Study|Protocol Violation|2|||
125462959|NCT00960141|451324168|FG000|Overall Study|Withdrawal by Subject|1|||
125462960|NCT00960141|451324169|FG001|Overall Study|Withdrawal by Subject|2|||
125462961|NCT00960141|451324170|FG002|Overall Study|Withdrawal by Subject|1|||
125462962|NCT00457743|451324173|FG000|Overall Study|Adverse Event|0|||
125462963|NCT00457743|451324174|FG001|Overall Study|Adverse Event|4|||
125462964|NCT00457743|451324175|FG002|Overall Study|Adverse Event|0|||
125462965|NCT00457743|451324173|FG000|Overall Study|Lack of Efficacy|3|||
125462966|NCT00457743|451324174|FG001|Overall Study|Lack of Efficacy|23|||
125462967|NCT00457743|451324175|FG002|Overall Study|Lack of Efficacy|3|||
125462968|NCT00566527|451324176|FG000|Overall Study|Reason not provided|3|||
125462969|NCT00566527|451324177|FG001|Overall Study|Reason not provided|11|||
125462970|NCT00566527|451324178|FG002|Overall Study|Reason not provided|10|||
125462971|NCT00566527|451324176|FG000|Overall Study|Adverse Event|2|||
125462972|NCT00566527|451324177|FG001|Overall Study|Adverse Event|0|||
125462973|NCT00566527|451324178|FG002|Overall Study|Adverse Event|1|||
125462974|NCT00566527|451324176|FG000|Overall Study|Physician Decision|3|||
125462975|NCT00566527|451324177|FG001|Overall Study|Physician Decision|8|||
125462976|NCT00566527|451324178|FG002|Overall Study|Physician Decision|20|||
125462977|NCT00566527|451324176|FG000|Overall Study|Lost to Follow-up|3|||
125462978|NCT00566527|451324177|FG001|Overall Study|Lost to Follow-up|4|||
125462979|NCT00566527|451324178|FG002|Overall Study|Lost to Follow-up|4|||
125462980|NCT00566527|451324176|FG000|Overall Study|Withdrawal by Subject|6|||
125462981|NCT00566527|451324177|FG001|Overall Study|Withdrawal by Subject|43|||
125462982|NCT00566527|451324178|FG002|Overall Study|Withdrawal by Subject|43|||
125462983|NCT00356265|451324179|FG000|Overall Study|Withdrawal by Subject|0|||
125462984|NCT00356265|451324180|FG001|Overall Study|Withdrawal by Subject|0|||
125462985|NCT00356265|451324181|FG002|Overall Study|Withdrawal by Subject|1|||
125462986|NCT01837966|451324182|FG000|Overall Study|Withdrawal by Subject|2|||
125462987|NCT01837966|451324183|FG001|Overall Study|Withdrawal by Subject|1|||
125462988|NCT01278394|451324189|FG000|Overall Study|Lost to Follow-up|1|||
125462989|NCT01236560|451324190|FG000|Overall Study|Adverse Event|0|||
125462990|NCT01236560|451324191|FG001|Overall Study|Adverse Event|2|||
125462991|NCT01236560|451324192|FG002|Overall Study|Adverse Event|1|||
125462992|NCT01236560|451324193|FG003|Overall Study|Adverse Event|3|||
125462993|NCT01236560|451324194|FG004|Overall Study|Adverse Event|0|||
125462994|NCT01236560|451324195|FG005|Overall Study|Adverse Event|0|||
125462995|NCT01236560|451324190|FG000|Overall Study|Death|0|||
125462996|NCT01236560|451324191|FG001|Overall Study|Death|1|||
125462997|NCT01236560|451324192|FG002|Overall Study|Death|0|||
125462998|NCT01236560|451324193|FG003|Overall Study|Death|1|||
125462999|NCT01236560|451324194|FG004|Overall Study|Death|0|||
125463000|NCT01236560|451324195|FG005|Overall Study|Death|0|||
125463001|NCT01236560|451324190|FG000|Overall Study|Lost to Follow-up|0|||
125463002|NCT01236560|451324191|FG001|Overall Study|Lost to Follow-up|1|||
125463003|NCT01236560|451324192|FG002|Overall Study|Lost to Follow-up|1|||
125463004|NCT01236560|451324193|FG003|Overall Study|Lost to Follow-up|0|||
125463005|NCT01236560|451324194|FG004|Overall Study|Lost to Follow-up|0|||
125463006|NCT01236560|451324195|FG005|Overall Study|Lost to Follow-up|0|||
125463007|NCT01236560|451324190|FG000|Overall Study|Physician Decision|0|||
125463008|NCT01236560|451324191|FG001|Overall Study|Physician Decision|1|||
125463009|NCT01236560|451324192|FG002|Overall Study|Physician Decision|8|||
125463010|NCT01236560|451324193|FG003|Overall Study|Physician Decision|0|||
125463011|NCT01236560|451324194|FG004|Overall Study|Physician Decision|0|||
125463012|NCT01236560|451324195|FG005|Overall Study|Physician Decision|0|||
125463013|NCT01236560|451324190|FG000|Overall Study|Withdrawal by Subject|0|||
125463014|NCT01236560|451324191|FG001|Overall Study|Withdrawal by Subject|0|||
125463015|NCT01236560|451324192|FG002|Overall Study|Withdrawal by Subject|1|||
125463016|NCT01236560|451324193|FG003|Overall Study|Withdrawal by Subject|2|||
125463017|NCT01236560|451324194|FG004|Overall Study|Withdrawal by Subject|0|||
125463018|NCT01236560|451324195|FG005|Overall Study|Withdrawal by Subject|0|||
125463019|NCT01236560|451324190|FG000|Overall Study|Progressive disease|5|||
125463020|NCT01236560|451324191|FG001|Overall Study|Progressive disease|19|||
125463021|NCT01236560|451324192|FG002|Overall Study|Progressive disease|9|||
125463022|NCT01236560|451324193|FG003|Overall Study|Progressive disease|16|||
125463023|NCT01236560|451324194|FG004|Overall Study|Progressive disease|0|||
125463024|NCT01236560|451324195|FG005|Overall Study|Progressive disease|0|||
125463025|NCT00658996|451324199|FG000|First Intervention|Positive slit lamp finding|1|||
125463026|NCT00658996|451324200|FG001|First Intervention|Positive slit lamp finding|0|||
125463027|NCT00658996|451324199|FG000|First Intervention|Lack of lenses|0|||
125463028|NCT00658996|451324200|FG001|First Intervention|Lack of lenses|1|||
125463029|NCT00658996|451324199|FG000|Crossover Period|Physician Decision|1|||
125463030|NCT00658996|451324200|FG001|Crossover Period|Physician Decision|0|||
125463031|NCT00658996|451324199|FG000|Crossover Period|Ineligible|1|||
125463032|NCT00658996|451324200|FG001|Crossover Period|Ineligible|1|||
125463033|NCT00658996|451324199|FG000|Second Intervention|Developed a stye on upper lid|1|||
125463034|NCT00658996|451324200|FG001|Second Intervention|Developed a stye on upper lid|0|||
125463035|NCT00658996|451324199|FG000|Second Intervention|Positive slit lamp finding|0|||
125463036|NCT00658996|451324200|FG001|Second Intervention|Positive slit lamp finding|1|||
125463037|NCT00688519|451324204|FG000|Overall Study|Adverse Event|2|||
125463038|NCT00688519|451324205|FG001|Overall Study|Adverse Event|3|||
125463039|NCT00688519|451324204|FG000|Overall Study|Lost to Follow-up|3|||
125463040|NCT00688519|451324205|FG001|Overall Study|Lost to Follow-up|3|||
125463041|NCT00688519|451324204|FG000|Overall Study|Lack of Efficacy|3|||
125463042|NCT00688519|451324205|FG001|Overall Study|Lack of Efficacy|1|||
125463043|NCT00688519|451324204|FG000|Overall Study|Withdrawal by Subject|7|||
125463044|NCT00688519|451324205|FG001|Overall Study|Withdrawal by Subject|6|||
125463045|NCT00688519|451324204|FG000|Overall Study|Prohibited medication|1|||
125463046|NCT00688519|451324205|FG001|Overall Study|Prohibited medication|0|||
125295558|NCT01659255|450709470|FG010|Overall Study|Progressive Disease|2|||
125295559|NCT01659255|450709471|FG011|Overall Study|Progressive Disease|3|||
125295560|NCT01659255|450709472|FG012|Overall Study|Progressive Disease|5|||
125295561|NCT01659255|450709473|FG013|Overall Study|Progressive Disease|13|||
125463047|NCT00688519|451324204|FG000|Overall Study|Non-compliance|0|||
125463048|NCT00688519|451324205|FG001|Overall Study|Non-compliance|1|||
125463049|NCT00688519|451324204|FG000|Overall Study|Subject moved out of state|1|||
125463050|NCT00688519|451324205|FG001|Overall Study|Subject moved out of state|0|||
125463051|NCT00688519|451324204|FG000|Overall Study|Investigator decision|1|||
125463052|NCT00688519|451324205|FG001|Overall Study|Investigator decision|0|||
125295562|NCT01659255|450709474|FG014|Overall Study|Progressive Disease|6|||
125463053|NCT00688519|451324204|FG000|Overall Study|Subject moved out of area|1|||
125463054|NCT00688519|451324205|FG001|Overall Study|Subject moved out of area|0|||
125463055|NCT00688519|451324204|FG000|Overall Study|Pregnancy|0|||
125463056|NCT00688519|451324205|FG001|Overall Study|Pregnancy|1|||
125463057|NCT01685606|451324206|FG000|Overall Study|Withdrawal by Subject|1|||
125463058|NCT01353963|451324209|FG000|Overall Study|Adverse Event|2|||
125463059|NCT04789408|451324210|FG000|Overall Study|Death|4|||
125463060|NCT04789408|451324211|FG001|Overall Study|Death|3|||
125463061|NCT04789408|451324212|FG002|Overall Study|Death|6|||
125463062|NCT04789408|451324210|FG000|Overall Study|Did not meet eligibility criteria|1|||
125463063|NCT04789408|451324211|FG001|Overall Study|Did not meet eligibility criteria|0|||
125463064|NCT04789408|451324212|FG002|Overall Study|Did not meet eligibility criteria|0|||
125463065|NCT04789408|451324210|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
125463066|NCT04789408|451324211|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
125463067|NCT04789408|451324212|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
125463068|NCT02079844|451324213|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
125463069|NCT02079844|451324214|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
125463070|NCT02079844|451324215|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
125463071|NCT02079844|451324213|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
125463072|NCT02079844|451324214|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
125463073|NCT02079844|451324215|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
125463074|NCT01420549|451324216|FG000|Overall Study|Adverse Event|1|||
125463075|NCT01420549|451324217|FG001|Overall Study|Adverse Event|1|||
125463076|NCT01420549|451324216|FG000|Overall Study|Lost to Follow-up|2|||
125463077|NCT01420549|451324217|FG001|Overall Study|Lost to Follow-up|2|||
125463078|NCT01420549|451324216|FG000|Overall Study|Protocol Violation|0|||
125463079|NCT01420549|451324217|FG001|Overall Study|Protocol Violation|1|||
125463080|NCT01420549|451324216|FG000|Overall Study|Non-adherence to medication|4|||
125463081|NCT01420549|451324217|FG001|Overall Study|Non-adherence to medication|1|||
125463082|NCT00683696|451325662|FG000|Overall Study|Withdrawn due to study closure|337|||
125463083|NCT00683696|451325663|FG001|Overall Study|Withdrawn due to study closure|338|||
125463084|NCT00683696|451325662|FG000|Overall Study|Withdrawn prior to study closure|13|||
125463085|NCT00683696|451325663|FG001|Overall Study|Withdrawn prior to study closure|28|||
125463086|NCT00683696|451325662|FG000|Overall Study|Lost to Follow-up|5|||
125463087|NCT00683696|451325663|FG001|Overall Study|Lost to Follow-up|6|||
125463088|NCT00683696|451325662|FG000|Overall Study|Vital status follow-up only|3|||
125463089|NCT00683696|451325663|FG001|Overall Study|Vital status follow-up only|3|||
125463090|NCT00683696|451325662|FG000|Overall Study|Death|46|||
125463091|NCT00683696|451325663|FG001|Overall Study|Death|30|||
125463092|NCT03454529|451325666|FG000|Overall Study|Did not receive treatment|6|||
125463093|NCT03454529|451325666|FG000|Overall Study|Received < 80% doses|1|||
125463094|NCT01582100|451325667|FG000|Overall Study|Adverse Event|1|||
125463095|NCT01582100|451325667|FG000|Overall Study|Withdrawal by Subject|1|||
125463096|NCT01078116|451325672|FG000|Overall Study|Lost to Follow-up|17|||
125463097|NCT01078116|451325672|FG000|Overall Study|Adverse Event|5|||
125463098|NCT01078116|451325672|FG000|Overall Study|Withdrawal by Subject|8|||
125463099|NCT01078116|451325672|FG000|Overall Study|Lack of effectiveness|15|||
125463100|NCT01078116|451325672|FG000|Overall Study|Case report form not completed|3|||
125463101|NCT02616900|451325673|FG000|Overall Study|Lack of Efficacy|7|||
125463102|NCT02616900|451325673|FG000|Overall Study|Lost to Follow-up|2|||
125463103|NCT02616900|451325673|FG000|Overall Study|Protocol Violation|5|||
125295563|NCT01659255|450709475|FG015|Overall Study|Progressive Disease|2|||
125295564|NCT01659255|450709476|FG016|Overall Study|Progressive Disease|3|||
125295565|NCT01659255|450709460|FG000|Overall Study|Withdrew Consent|0|||
125463104|NCT02616900|451325673|FG000|Overall Study|Withdrawal by Subject|3|||
125463105|NCT02616900|451325673|FG000|Overall Study|Incomplete data|6|||
125463106|NCT02499159|451325674|FG000|Randomization|Protocol Violation|1|||
125463107|NCT02499159|451325675|FG001|Randomization|Protocol Violation|1|||
125463108|NCT02499159|451325674|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
125463109|NCT02499159|451325675|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
125463110|NCT02499159|451325674|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
125463111|NCT02499159|451325675|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
125463112|NCT02499159|451325674|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
125463113|NCT02499159|451325675|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
125463114|NCT02499159|451325674|FG000|30-Day Follow-Up Phone Call|Other|1|||
125463115|NCT02499159|451325675|FG001|30-Day Follow-Up Phone Call|Other|0|||
125463116|NCT02601820|451325676|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
125463117|NCT02601820|451325676|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
125463118|NCT02601820|451325676|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
125463119|NCT02601820|451325676|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
125463120|NCT02564744|451325680|FG000|Overall Study|Investigator decision|0|||
125295566|NCT01659255|450709461|FG001|Overall Study|Withdrew Consent|0|||
125463121|NCT02564744|451325681|FG001|Overall Study|Investigator decision|0|||
125463122|NCT02564744|451325682|FG002|Overall Study|Investigator decision|0|||
125463123|NCT02564744|451325683|FG003|Overall Study|Investigator decision|0|||
125463124|NCT02564744|451325684|FG004|Overall Study|Investigator decision|1|||
125463125|NCT02564744|451325680|FG000|Overall Study|Death|10|||
125463126|NCT02564744|451325681|FG001|Overall Study|Death|5|||
125463127|NCT02564744|451325682|FG002|Overall Study|Death|4|||
125463128|NCT02564744|451325683|FG003|Overall Study|Death|16|||
125463129|NCT02564744|451325684|FG004|Overall Study|Death|16|||
125463130|NCT02564744|451325680|FG000|Overall Study|End of study Page Missing|0|||
125463131|NCT02564744|451325681|FG001|Overall Study|End of study Page Missing|0|||
125463132|NCT02564744|451325682|FG002|Overall Study|End of study Page Missing|3|||
125463133|NCT02564744|451325683|FG003|Overall Study|End of study Page Missing|3|||
125463134|NCT02564744|451325684|FG004|Overall Study|End of study Page Missing|0|||
125463135|NCT02564744|451325680|FG000|Overall Study|Subject Withdrew Consent|1|||
125463136|NCT02564744|451325681|FG001|Overall Study|Subject Withdrew Consent|1|||
125463137|NCT02564744|451325682|FG002|Overall Study|Subject Withdrew Consent|1|||
125463138|NCT02564744|451325683|FG003|Overall Study|Subject Withdrew Consent|0|||
125463139|NCT02564744|451325684|FG004|Overall Study|Subject Withdrew Consent|2|||
125463140|NCT02564744|451325680|FG000|Overall Study|Lost to Follow-up|0|||
125463141|NCT02564744|451325681|FG001|Overall Study|Lost to Follow-up|1|||
125463142|NCT02564744|451325682|FG002|Overall Study|Lost to Follow-up|0|||
125463143|NCT02564744|451325683|FG003|Overall Study|Lost to Follow-up|0|||
125463144|NCT02564744|451325684|FG004|Overall Study|Lost to Follow-up|1|||
125463145|NCT02564744|451325680|FG000|Overall Study|Reason not specified|1|||
125463146|NCT02564744|451325681|FG001|Overall Study|Reason not specified|0|||
125463147|NCT02564744|451325682|FG002|Overall Study|Reason not specified|0|||
125463148|NCT02564744|451325683|FG003|Overall Study|Reason not specified|0|||
125463149|NCT02564744|451325684|FG004|Overall Study|Reason not specified|0|||
125463150|NCT00508924|451325688|FG000|Overall Study|Protocol Violation|0|||
125463151|NCT00508924|451325689|FG001|Overall Study|Protocol Violation|0|||
125463152|NCT00508924|451325690|FG002|Overall Study|Protocol Violation|1|||
125463153|NCT00508924|451325691|FG003|Overall Study|Protocol Violation|1|||
125463154|NCT02755805|451325692|FG000|Overall Study|Lost to Follow-up|1|||
125463155|NCT02755805|451325693|FG001|Overall Study|Lost to Follow-up|2|||
125463156|NCT02755805|451325692|FG000|Overall Study|Refused assessments|1|||
125463157|NCT02755805|451325693|FG001|Overall Study|Refused assessments|0|||
125463158|NCT02755805|451325692|FG000|Overall Study|Withdrawal by Subject|0|||
125463159|NCT02755805|451325693|FG001|Overall Study|Withdrawal by Subject|2|||
125463160|NCT02252042|451325698|FG000|Overall Study|Adverse Event|9|||
125463161|NCT02252042|451325699|FG001|Overall Study|Adverse Event|6|||
125463162|NCT02252042|451325698|FG000|Overall Study|Death|209|||
125463163|NCT02252042|451325699|FG001|Overall Study|Death|217|||
125463164|NCT02252042|451325698|FG000|Overall Study|Physician Decision|0|||
125463165|NCT02252042|451325699|FG001|Overall Study|Physician Decision|2|||
125463166|NCT02252042|451325698|FG000|Overall Study|Transferred to Extension Study|7|||
125463167|NCT02252042|451325699|FG001|Overall Study|Transferred to Extension Study|1|||
125463168|NCT02252042|451325698|FG000|Overall Study|Did Not Continue on Extension Study|7|||
125463169|NCT02252042|451325699|FG001|Overall Study|Did Not Continue on Extension Study|2|||
125463170|NCT02252042|451325698|FG000|Overall Study|Withdrawal by Subject|15|||
125463171|NCT02252042|451325699|FG001|Overall Study|Withdrawal by Subject|20|||
125463172|NCT04532528|451325703|FG000|Overall Study|Adverse Event|12|||
125463173|NCT04532528|451325704|FG001|Overall Study|Adverse Event|17|||
125463174|NCT04532528|451325703|FG000|Overall Study|Withdrawal of consent|16|||
125463175|NCT04532528|451325704|FG001|Overall Study|Withdrawal of consent|17|||
125463176|NCT04532528|451325703|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
125463177|NCT04532528|451325704|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
125463178|NCT04532528|451325703|FG000|Overall Study|Lost to Follow-up|69|||
125463179|NCT04532528|451325704|FG001|Overall Study|Lost to Follow-up|68|||
125463180|NCT04532528|451325703|FG000|Overall Study|Administrative problems|12|||
125463181|NCT04532528|451325704|FG001|Overall Study|Administrative problems|14|||
125463182|NCT04532528|451325703|FG000|Overall Study|Death|3|||
125463183|NCT04532528|451325704|FG001|Overall Study|Death|3|||
125463184|NCT04532528|451325703|FG000|Overall Study|Other|38|||
125463185|NCT04532528|451325704|FG001|Overall Study|Other|46|||
125463186|NCT01460290|451325707|FG000|Overall Study|Adverse Event|3|||
125463187|NCT01460290|451325707|FG000|Overall Study|Elevated liver function|1|||
125463188|NCT00439569|451325714|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
125463189|NCT00439569|451325714|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
125463190|NCT00439569|451325714|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
125463191|NCT02214160|451325715|FG000|Overall Study|Withdrawal by Subject|1|||
125463192|NCT02214160|451325716|FG001|Overall Study|Withdrawal by Subject|0|||
125463193|NCT02214160|451325717|FG002|Overall Study|Withdrawal by Subject|6|||
125463194|NCT02214160|451325715|FG000|Overall Study|Death|2|||
125463195|NCT02214160|451325716|FG001|Overall Study|Death|2|||
125463196|NCT02214160|451325717|FG002|Overall Study|Death|1|||
125463197|NCT02214160|451325715|FG000|Overall Study|Subject Non-Compliance|0|||
125463198|NCT02214160|451325716|FG001|Overall Study|Subject Non-Compliance|3|||
125463199|NCT02214160|451325717|FG002|Overall Study|Subject Non-Compliance|1|||
125463200|NCT02214160|451325715|FG000|Overall Study|Adverse Event|0|||
125463201|NCT02214160|451325716|FG001|Overall Study|Adverse Event|1|||
125463202|NCT02214160|451325717|FG002|Overall Study|Adverse Event|1|||
125463203|NCT02214160|451325715|FG000|Overall Study|Sponsor Decision|0|||
125463204|NCT02214160|451325716|FG001|Overall Study|Sponsor Decision|2|||
125463205|NCT02214160|451325717|FG002|Overall Study|Sponsor Decision|0|||
125463206|NCT02214160|451325715|FG000|Overall Study|Protocol Violation|1|||
125463207|NCT02214160|451325716|FG001|Overall Study|Protocol Violation|0|||
125463208|NCT02214160|451325717|FG002|Overall Study|Protocol Violation|0|||
125463209|NCT02214160|451325715|FG000|Overall Study|Physician Decision|0|||
125463210|NCT02214160|451325716|FG001|Overall Study|Physician Decision|0|||
125463211|NCT02214160|451325717|FG002|Overall Study|Physician Decision|1|||
125463212|NCT02423798|451325718|FG000|Overall Study|Withdrawal by Subject|3|||
125463213|NCT01063972|451325719|FG000|Overall Study|Death|12|||
125463214|NCT01063972|451325720|FG001|Overall Study|Death|11|||
125463215|NCT01063972|451325719|FG000|Overall Study|Incarcerated|2|||
125463216|NCT01063972|451325720|FG001|Overall Study|Incarcerated|1|||
125463217|NCT01510717|451325722|FG000|Overall Study|Adverse Event|1|||
125463218|NCT01510717|451325723|FG001|Overall Study|Adverse Event|2|||
125463219|NCT01510717|451325722|FG000|Overall Study|Death|1|||
125463220|NCT01510717|451325723|FG001|Overall Study|Death|0|||
125463221|NCT01510717|451325722|FG000|Overall Study|Lost to Follow-up|0|||
125463222|NCT01510717|451325723|FG001|Overall Study|Lost to Follow-up|1|||
125463223|NCT01510717|451325722|FG000|Overall Study|Withdrawal by Subject|0|||
125463224|NCT01510717|451325723|FG001|Overall Study|Withdrawal by Subject|2|||
125463225|NCT01264679|451325724|FG000|Overall Study|Participation in Another Clinical Trial|1|||
125463226|NCT01264679|451325724|FG000|Overall Study|Physician Decision|1|||
125463227|NCT01264679|451325724|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
125463228|NCT01264679|451325724|FG000|Overall Study|Withdrawal by Subject|1|||
125463229|NCT00468052|451325729|FG000|Overall Study|Protocol Violation|7|||
125463230|NCT00468052|451325730|FG001|Overall Study|Protocol Violation|8|||
125463231|NCT02204982|451325733|FG000|Overall Study|Patient ineligible-medical monitor|1|||
125463232|NCT02204982|451325734|FG001|Overall Study|Patient ineligible-medical monitor|0|||
125463233|NCT02204982|451325733|FG000|Overall Study|Withdrawal by Subject|1|||
125463234|NCT02204982|451325734|FG001|Overall Study|Withdrawal by Subject|0|||
125463235|NCT02204982|451325733|FG000|Overall Study|Adverse Event|1|||
125463236|NCT02204982|451325734|FG001|Overall Study|Adverse Event|0|||
125463237|NCT02204982|451325733|FG000|Overall Study|Adverse Event and Investigator decision|1|||
125463238|NCT02204982|451325734|FG001|Overall Study|Adverse Event and Investigator decision|0|||
125463239|NCT02204982|451325733|FG000|Overall Study|Physician Decision|0|||
125463240|NCT02204982|451325734|FG001|Overall Study|Physician Decision|2|||
125463241|NCT02204982|451325733|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
125463242|NCT02204982|451325734|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
125463243|NCT02204982|451325733|FG000|Overall Study|Termination of Study bySponsor|0|||
125463244|NCT02204982|451325734|FG001|Overall Study|Termination of Study bySponsor|1|||
125463245|NCT00159783|451325735|FG000|Overall Study|Adverse Event|5|||
125463246|NCT00159783|451325736|FG001|Overall Study|Adverse Event|7|||
125463247|NCT00159783|451325737|FG002|Overall Study|Adverse Event|9|||
125463248|NCT00159783|451325735|FG000|Overall Study|Lack of Efficacy|1|||
125463249|NCT00159783|451325736|FG001|Overall Study|Lack of Efficacy|2|||
125463250|NCT00159783|451325737|FG002|Overall Study|Lack of Efficacy|3|||
125463251|NCT00159783|451325735|FG000|Overall Study|Withdrawal by Subject|7|||
125463252|NCT00159783|451325736|FG001|Overall Study|Withdrawal by Subject|11|||
125463253|NCT00159783|451325737|FG002|Overall Study|Withdrawal by Subject|12|||
125463254|NCT00159783|451325735|FG000|Overall Study|Lost to Follow-up|6|||
125463255|NCT00159783|451325736|FG001|Overall Study|Lost to Follow-up|5|||
125463256|NCT00159783|451325737|FG002|Overall Study|Lost to Follow-up|11|||
125463257|NCT00159783|451325735|FG000|Overall Study|Other|0|||
125463258|NCT00159783|451325736|FG001|Overall Study|Other|2|||
125463259|NCT00159783|451325737|FG002|Overall Study|Other|4|||
125463260|NCT02928224|451325738|FG000|Overall Study|Lost to Follow-up|1|||
125463261|NCT02928224|451325739|FG001|Overall Study|Lost to Follow-up|1|||
125463262|NCT02928224|451325740|FG002|Overall Study|Lost to Follow-up|3|||
125463263|NCT02928224|451325741|FG003|Overall Study|Lost to Follow-up|0|||
125463264|NCT02928224|451325738|FG000|Overall Study|Death|30|||
125463265|NCT02928224|451325739|FG001|Overall Study|Death|209|||
125463266|NCT02928224|451325740|FG002|Overall Study|Death|193|||
125463267|NCT02928224|451325741|FG003|Overall Study|Death|198|||
125463268|NCT02928224|451325738|FG000|Overall Study|Withdrawal by Subject|0|||
125463269|NCT02928224|451325739|FG001|Overall Study|Withdrawal by Subject|3|||
125463270|NCT02928224|451325740|FG002|Overall Study|Withdrawal by Subject|7|||
125463271|NCT02928224|451325741|FG003|Overall Study|Withdrawal by Subject|20|||
125463272|NCT02928224|451325738|FG000|Overall Study|Study participation terminated by sponsor|3|||
125463273|NCT02928224|451325739|FG001|Overall Study|Study participation terminated by sponsor|8|||
125463274|NCT02928224|451325740|FG002|Overall Study|Study participation terminated by sponsor|12|||
125463275|NCT02928224|451325741|FG003|Overall Study|Study participation terminated by sponsor|3|||
125463276|NCT02928224|451325738|FG000|Overall Study|Other|3|||
125463277|NCT02928224|451325739|FG001|Overall Study|Other|3|||
125463278|NCT02928224|451325740|FG002|Overall Study|Other|5|||
125463279|NCT02928224|451325741|FG003|Overall Study|Other|0|||
125463280|NCT00468910|451325742|FG000|Overall Study|Lost to Follow-up|2|||
125463281|NCT00468910|451325743|FG001|Overall Study|Lost to Follow-up|1|||
125463282|NCT00468910|451325742|FG000|Overall Study|Withdrawal by Subject|2|||
125463283|NCT00468910|451325743|FG001|Overall Study|Withdrawal by Subject|1|||
125463284|NCT00468910|451325742|FG000|Overall Study|Medical Contraindication|0|||
125463285|NCT00468910|451325743|FG001|Overall Study|Medical Contraindication|1|||
125463286|NCT01792830|451325746|FG000|Overall Study|Withdrawal by Subject|22|||
125463287|NCT01792830|451325747|FG001|Overall Study|Withdrawal by Subject|0|||
125463288|NCT01792830|451325748|FG002|Overall Study|Withdrawal by Subject|0|||
125463289|NCT01792830|451325749|FG003|Overall Study|Withdrawal by Subject|2|||
125463290|NCT01792830|451325750|FG004|Overall Study|Withdrawal by Subject|1|||
125463291|NCT01792830|451325751|FG005|Overall Study|Withdrawal by Subject|1|||
125463292|NCT01792830|451325752|FG006|Overall Study|Withdrawal by Subject|1|||
125463293|NCT01792830|451325753|FG007|Overall Study|Withdrawal by Subject|1|||
125463294|NCT01792830|451325754|FG008|Overall Study|Withdrawal by Subject|7|||
125463295|NCT01792830|451325755|FG009|Overall Study|Withdrawal by Subject|0|||
125463296|NCT01792830|451325756|FG010|Overall Study|Withdrawal by Subject|2|||
125463297|NCT01792830|451325746|FG000|Overall Study|Death|3|||
125463298|NCT01792830|451325747|FG001|Overall Study|Death|0|||
125463299|NCT01792830|451325748|FG002|Overall Study|Death|0|||
125463300|NCT01792830|451325749|FG003|Overall Study|Death|1|||
125463301|NCT01792830|451325750|FG004|Overall Study|Death|0|||
125463302|NCT01792830|451325751|FG005|Overall Study|Death|0|||
125463303|NCT01792830|451325752|FG006|Overall Study|Death|1|||
125463304|NCT01792830|451325753|FG007|Overall Study|Death|0|||
125463305|NCT01792830|451325754|FG008|Overall Study|Death|1|||
125463306|NCT01792830|451325755|FG009|Overall Study|Death|0|||
125463307|NCT01792830|451325756|FG010|Overall Study|Death|1|||
125463308|NCT01792830|451325746|FG000|Overall Study|Adverse Event|0|||
125463309|NCT01792830|451325747|FG001|Overall Study|Adverse Event|0|||
125463310|NCT01792830|451325748|FG002|Overall Study|Adverse Event|0|||
125463311|NCT01792830|451325749|FG003|Overall Study|Adverse Event|0|||
125463312|NCT01792830|451325750|FG004|Overall Study|Adverse Event|0|||
125463313|NCT01792830|451325751|FG005|Overall Study|Adverse Event|0|||
125463314|NCT01792830|451325752|FG006|Overall Study|Adverse Event|0|||
125463315|NCT01792830|451325753|FG007|Overall Study|Adverse Event|0|||
125463316|NCT01792830|451325754|FG008|Overall Study|Adverse Event|1|||
125463317|NCT01792830|451325755|FG009|Overall Study|Adverse Event|0|||
125463318|NCT01792830|451325756|FG010|Overall Study|Adverse Event|0|||
125463319|NCT01198028|451325774|FG000|Overall Study|Adverse Event|5|||
125463320|NCT01198028|451325774|FG000|Overall Study|Death|3|||
125463321|NCT01198028|451325774|FG000|Overall Study|Physician Decision|2|||
125463322|NCT02674750|451325777|FG000|Overall Study|Death|4|||
125463323|NCT02674750|451325778|FG001|Overall Study|Death|5|||
125463324|NCT02674750|451325779|FG002|Overall Study|Death|8|||
125463325|NCT02674750|451325777|FG000|Overall Study|Lost to Follow-up|0|||
125463326|NCT02674750|451325778|FG001|Overall Study|Lost to Follow-up|8|||
125463327|NCT02674750|451325779|FG002|Overall Study|Lost to Follow-up|0|||
125463328|NCT02674750|451325777|FG000|Overall Study|Lack of Efficacy|1|||
125463329|NCT02674750|451325778|FG001|Overall Study|Lack of Efficacy|17|||
125463330|NCT02674750|451325779|FG002|Overall Study|Lack of Efficacy|3|||
125463331|NCT02674750|451325777|FG000|Overall Study|Withdrawal by Subject|0|||
125295567|NCT01659255|450709462|FG002|Overall Study|Withdrew Consent|0|||
125463332|NCT02674750|451325778|FG001|Overall Study|Withdrawal by Subject|7|||
125463333|NCT02674750|451325779|FG002|Overall Study|Withdrawal by Subject|1|||
125463334|NCT02674750|451325777|FG000|Overall Study|Other|0|||
125463335|NCT02674750|451325778|FG001|Overall Study|Other|8|||
125463336|NCT02674750|451325779|FG002|Overall Study|Other|0|||
125463337|NCT01597258|451325780|FG000|Overall Study|No Drug Administration|1|||
125463338|NCT01415349|451325781|FG000|Treatment Period 1|Adverse Event|0|||
125463339|NCT01415349|451325782|FG001|Treatment Period 1|Adverse Event|1|||
125463340|NCT01415349|451325781|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125463341|NCT01415349|451325782|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125463342|NCT01616459|451325783|FG000|Overall Study|Adverse Event|1|||
125463343|NCT01616459|451325784|FG001|Overall Study|Adverse Event|1|||
125463344|NCT01616459|451325785|FG002|Overall Study|Adverse Event|2|||
125463345|NCT01616459|451325786|FG003|Overall Study|Adverse Event|0|||
125463346|NCT01616459|451325783|FG000|Overall Study|Lost to Follow-up|1|||
125463347|NCT01616459|451325784|FG001|Overall Study|Lost to Follow-up|11|||
125463348|NCT01616459|451325785|FG002|Overall Study|Lost to Follow-up|3|||
125463349|NCT01616459|451325786|FG003|Overall Study|Lost to Follow-up|2|||
125463350|NCT01616459|451325783|FG000|Overall Study|Protocol Violation|0|||
125463351|NCT01616459|451325784|FG001|Overall Study|Protocol Violation|0|||
125463352|NCT01616459|451325785|FG002|Overall Study|Protocol Violation|0|||
125463353|NCT01616459|451325786|FG003|Overall Study|Protocol Violation|2|||
125463354|NCT01616459|451325783|FG000|Overall Study|Withdrawal by Subject|2|||
125463355|NCT01616459|451325784|FG001|Overall Study|Withdrawal by Subject|4|||
125463356|NCT01616459|451325785|FG002|Overall Study|Withdrawal by Subject|4|||
125463357|NCT01616459|451325786|FG003|Overall Study|Withdrawal by Subject|4|||
125463358|NCT01616459|451325783|FG000|Overall Study|Other reason|0|||
125463359|NCT01616459|451325784|FG001|Overall Study|Other reason|1|||
125463360|NCT01616459|451325785|FG002|Overall Study|Other reason|1|||
125463361|NCT01616459|451325786|FG003|Overall Study|Other reason|0|||
125463362|NCT04980755|451325787|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
125463363|NCT04980755|451325787|FG000|Body Reprogramming Courses|Work commitment|2|||
125463364|NCT04980755|451325787|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
125463365|NCT04980755|451325787|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
125463366|NCT00304031|451327208|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
125463367|NCT00304031|451327209|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
125463368|NCT00304031|451327210|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
125463369|NCT00304031|451327208|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
125463370|NCT00304031|451327209|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
125463371|NCT00304031|451327210|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
125463372|NCT00304031|451327208|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
125463373|NCT00304031|451327209|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
125463374|NCT00304031|451327210|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
125463375|NCT00304031|451327208|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
125463376|NCT00304031|451327209|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
125463377|NCT00304031|451327210|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
125463378|NCT00304031|451327208|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
125463379|NCT00304031|451327209|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
125463380|NCT00304031|451327210|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
125463381|NCT00304031|451327208|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
125463382|NCT00304031|451327209|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
125463383|NCT00304031|451327210|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
125463384|NCT00304031|451327208|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
125463385|NCT00304031|451327209|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
125463386|NCT00304031|451327210|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
125463387|NCT00304031|451327208|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
125463388|NCT00304031|451327209|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
125463389|NCT00304031|451327210|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
125463390|NCT00304031|451327208|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
125463391|NCT00304031|451327209|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
125463392|NCT00304031|451327210|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
125463393|NCT01188655|451327211|FG000|Overall Study|Lack of Efficacy|1|||
125463394|NCT01188655|451327211|FG000|Overall Study|Lost to Follow-up|1|||
125463395|NCT01188655|451327211|FG000|Overall Study|Other|11|||
125463396|NCT03648762|451327212|FG000|Overall Study|Lost to Follow-up|1|||
125463397|NCT03648762|451327213|FG001|Overall Study|Lost to Follow-up|2|||
125463398|NCT03648762|451327214|FG002|Overall Study|Lost to Follow-up|0|||
125463399|NCT03648762|451327212|FG000|Overall Study|Withdrawal by Subject|5|||
125463400|NCT03648762|451327213|FG001|Overall Study|Withdrawal by Subject|2|||
125463401|NCT03648762|451327214|FG002|Overall Study|Withdrawal by Subject|1|||
125463402|NCT01875848|451327227|FG000|Overall Study|Withdrawal by Subject|2|||
125463403|NCT01875848|451327228|FG001|Overall Study|Withdrawal by Subject|0|||
125463404|NCT02189252|451327229|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
125463405|NCT02189252|451327230|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
125463406|NCT02189252|451327231|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
125463407|NCT02189252|451327232|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
125463408|NCT02189252|451327229|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
125463409|NCT02189252|451327230|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
125463410|NCT02189252|451327231|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
125463411|NCT02189252|451327232|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
125463412|NCT00840177|451327233|FG000|Overall Study|Adverse Event|5|||
125463413|NCT00840177|451327234|FG001|Overall Study|Adverse Event|1|||
125463414|NCT00840177|451327235|FG002|Overall Study|Adverse Event|1|||
125463415|NCT00840177|451327233|FG000|Overall Study|Refusal unrelated to adverse events|1|||
125463416|NCT00840177|451327234|FG001|Overall Study|Refusal unrelated to adverse events|0|||
125463417|NCT00840177|451327235|FG002|Overall Study|Refusal unrelated to adverse events|1|||
125463418|NCT00840177|451327233|FG000|Overall Study|Progression/relapse|2|||
125463419|NCT00840177|451327234|FG001|Overall Study|Progression/relapse|0|||
125463420|NCT00840177|451327235|FG002|Overall Study|Progression/relapse|0|||
125463421|NCT00840177|451327233|FG000|Overall Study|Death|4|||
125463422|NCT00840177|451327234|FG001|Overall Study|Death|5|||
125463423|NCT00840177|451327235|FG002|Overall Study|Death|5|||
125463424|NCT00840177|451327233|FG000|Overall Study|not protocol specified|6|||
125463425|NCT00840177|451327234|FG001|Overall Study|not protocol specified|3|||
125463426|NCT00840177|451327235|FG002|Overall Study|not protocol specified|0|||
125463427|NCT00840177|451327233|FG000|Overall Study|Ineligible|0|||
125463428|NCT00840177|451327234|FG001|Overall Study|Ineligible|0|||
125463429|NCT00840177|451327235|FG002|Overall Study|Ineligible|3|||
125295568|NCT01659255|450709463|FG003|Overall Study|Withdrew Consent|0|||
125463430|NCT00840177|451327233|FG000|Overall Study|Did not start treatment|0|||
125295569|NCT01659255|450709464|FG004|Overall Study|Withdrew Consent|0|||
125295570|NCT01659255|450709465|FG005|Overall Study|Withdrew Consent|0|||
125463431|NCT00840177|451327234|FG001|Overall Study|Did not start treatment|0|||
125463432|NCT00840177|451327235|FG002|Overall Study|Did not start treatment|1|||
125463433|NCT01391832|451327236|FG000|Overall Study|Withdrawal by Subject|21|||
125463434|NCT01391832|451327237|FG001|Overall Study|Withdrawal by Subject|22|||
125463435|NCT01391832|451327236|FG000|Overall Study|Lost to Follow-up|0|||
125463436|NCT01391832|451327237|FG001|Overall Study|Lost to Follow-up|1|||
125463437|NCT01599104|451327241|FG000|Overall Study|Withdrawal by Subject|1|||
125463438|NCT01599104|451327242|FG001|Overall Study|Withdrawal by Subject|1|||
125463439|NCT01599104|451327243|FG002|Overall Study|Withdrawal by Subject|2|||
125463440|NCT01599104|451327241|FG000|Overall Study|Technical Problems|1|||
125463441|NCT01599104|451327242|FG001|Overall Study|Technical Problems|0|||
125463442|NCT01599104|451327243|FG002|Overall Study|Technical Problems|0|||
125463443|NCT01599104|451327241|FG000|Overall Study|Physician Decision|3|||
125463444|NCT01599104|451327242|FG001|Overall Study|Physician Decision|2|||
125463445|NCT01599104|451327243|FG002|Overall Study|Physician Decision|2|||
125463446|NCT01599104|451327241|FG000|Overall Study|Non-compliance with study treatment|0|||
125463447|NCT01599104|451327242|FG001|Overall Study|Non-compliance with study treatment|1|||
125463448|NCT01599104|451327243|FG002|Overall Study|Non-compliance with study treatment|0|||
125463449|NCT01599104|451327241|FG000|Overall Study|Lack of Efficacy|4|||
125463450|NCT01599104|451327242|FG001|Overall Study|Lack of Efficacy|4|||
125463451|NCT01599104|451327243|FG002|Overall Study|Lack of Efficacy|10|||
125463452|NCT01599104|451327241|FG000|Overall Study|Adverse Event|7|||
125463453|NCT01599104|451327242|FG001|Overall Study|Adverse Event|6|||
125463454|NCT01599104|451327243|FG002|Overall Study|Adverse Event|12|||
125463455|NCT00714714|451327244|FG000|Overall Study|Adverse Event|1|||
125463456|NCT01308567|451327255|FG000|Overall Study|Lost to Follow-up|2|||
125463457|NCT01308567|451327256|FG001|Overall Study|Lost to Follow-up|4|||
125463458|NCT01308567|451327257|FG002|Overall Study|Lost to Follow-up|4|||
125463459|NCT01149369|451327270|FG000|Overall Study|Adverse Event|6|||
125463460|NCT01149369|451327271|FG001|Overall Study|Adverse Event|3|||
125463461|NCT01040689|451327274|FG000|Overall Study|Adverse Event|0|||
125463462|NCT01040689|451327275|FG001|Overall Study|Adverse Event|0|||
125463463|NCT01040689|451327276|FG002|Overall Study|Adverse Event|2|||
125463464|NCT01040689|451327277|FG003|Overall Study|Adverse Event|4|||
125463465|NCT01040689|451327274|FG000|Overall Study|Lack of Efficacy|0|||
125463466|NCT01040689|451327275|FG001|Overall Study|Lack of Efficacy|0|||
125463467|NCT01040689|451327276|FG002|Overall Study|Lack of Efficacy|1|||
125463468|NCT01040689|451327277|FG003|Overall Study|Lack of Efficacy|0|||
125463469|NCT01040689|451327274|FG000|Overall Study|Lost to Follow-up|1|||
125463470|NCT01040689|451327275|FG001|Overall Study|Lost to Follow-up|0|||
125463471|NCT01040689|451327276|FG002|Overall Study|Lost to Follow-up|0|||
125463472|NCT01040689|451327277|FG003|Overall Study|Lost to Follow-up|0|||
125463473|NCT01040689|451327274|FG000|Overall Study|Withdrawal by Subject|2|||
125463474|NCT01040689|451327275|FG001|Overall Study|Withdrawal by Subject|1|||
125463475|NCT01040689|451327276|FG002|Overall Study|Withdrawal by Subject|1|||
125463476|NCT01040689|451327277|FG003|Overall Study|Withdrawal by Subject|0|||
125463477|NCT01040689|451327274|FG000|Overall Study|Other reasons not listed above|0|||
125463478|NCT01040689|451327275|FG001|Overall Study|Other reasons not listed above|1|||
125463479|NCT01040689|451327276|FG002|Overall Study|Other reasons not listed above|0|||
125463480|NCT01040689|451327277|FG003|Overall Study|Other reasons not listed above|0|||
125463481|NCT01185561|451327278|FG000|Overall Study|Lost to Follow-up|0|||
125463482|NCT01185561|451327279|FG001|Overall Study|Lost to Follow-up|4|||
125463483|NCT01185561|451327278|FG000|Overall Study|Withdrawal by Subject|2|||
125463484|NCT01185561|451327279|FG001|Overall Study|Withdrawal by Subject|8|||
125463485|NCT02242487|451327280|FG000|Overall Study|Adverse Event|13|||
125463486|NCT02242487|451327281|FG001|Overall Study|Adverse Event|15|||
125463487|NCT02242487|451327280|FG000|Overall Study|Lack of Efficacy|4|||
125463488|NCT02242487|451327281|FG001|Overall Study|Lack of Efficacy|6|||
125463489|NCT02242487|451327280|FG000|Overall Study|Protocol Violation|2|||
125463490|NCT02242487|451327281|FG001|Overall Study|Protocol Violation|0|||
125463491|NCT02242487|451327280|FG000|Overall Study|Lost to Follow-up|2|||
125463492|NCT02242487|451327281|FG001|Overall Study|Lost to Follow-up|1|||
125463493|NCT02242487|451327280|FG000|Overall Study|Other - Miscellaneous|4|||
125463494|NCT02242487|451327281|FG001|Overall Study|Other - Miscellaneous|6|||
125463495|NCT02242487|451327280|FG000|Overall Study|Withdrawal by Subject|37|||
125463496|NCT02242487|451327281|FG001|Overall Study|Withdrawal by Subject|19|||
125463497|NCT01599793|451327282|FG000|Overall Study|Adverse Event|2|||
125463498|NCT02593149|451327283|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
125295571|NCT01659255|450709466|FG006|Overall Study|Withdrew Consent|0|||
125295572|NCT01659255|450709467|FG007|Overall Study|Withdrew Consent|0|||
125295573|NCT01659255|450709468|FG008|Overall Study|Withdrew Consent|0|||
125295574|NCT01659255|450709469|FG009|Overall Study|Withdrew Consent|0|||
125295575|NCT01659255|450709470|FG010|Overall Study|Withdrew Consent|1|||
125463499|NCT02593149|451327284|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
125463500|NCT02593149|451327283|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
125295576|NCT01659255|450709471|FG011|Overall Study|Withdrew Consent|0|||
125420377|NCT03166618|451163598|FG000|Overall Study|Study was Terminated|0|||
125420378|NCT03166618|451163599|FG001|Overall Study|Study was Terminated|1|||
125420379|NCT01925950|451163600|FG000|Part 2|Withdrawal by Subject|1|||
125420380|NCT01925950|451163601|FG001|Part 2|Withdrawal by Subject|0|||
125420381|NCT00381940|451163604|FG000|Overall Study|Lack of Efficacy|3|||
125420382|NCT00381940|451163604|FG000|Overall Study|Protocol Violation|1|||
125420383|NCT00381940|451163604|FG000|Overall Study|Ineligible|1|||
125420384|NCT03137303|451163606|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
125420385|NCT03137303|451163607|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
125420386|NCT03137303|451163606|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
125295577|NCT01659255|450709472|FG012|Overall Study|Withdrew Consent|0|||
125295578|NCT01659255|450709473|FG013|Overall Study|Withdrew Consent|1|||
125295579|NCT01659255|450709474|FG014|Overall Study|Withdrew Consent|0|||
125295580|NCT01659255|450709475|FG015|Overall Study|Withdrew Consent|0|||
125295581|NCT01659255|450709476|FG016|Overall Study|Withdrew Consent|0|||
125295582|NCT01659255|450709460|FG000|Overall Study|Investigator Decision|0|||
125295583|NCT01659255|450709461|FG001|Overall Study|Investigator Decision|0|||
125295584|NCT01659255|450709462|FG002|Overall Study|Investigator Decision|0|||
125295585|NCT01659255|450709463|FG003|Overall Study|Investigator Decision|0|||
125295586|NCT01659255|450709464|FG004|Overall Study|Investigator Decision|0|||
125295587|NCT01659255|450709465|FG005|Overall Study|Investigator Decision|0|||
125295588|NCT01659255|450709466|FG006|Overall Study|Investigator Decision|0|||
125295589|NCT01659255|450709467|FG007|Overall Study|Investigator Decision|0|||
125295590|NCT01659255|450709468|FG008|Overall Study|Investigator Decision|0|||
125295591|NCT01659255|450709469|FG009|Overall Study|Investigator Decision|0|||
125295592|NCT01659255|450709470|FG010|Overall Study|Investigator Decision|0|||
125295593|NCT01659255|450709471|FG011|Overall Study|Investigator Decision|0|||
125295594|NCT01659255|450709472|FG012|Overall Study|Investigator Decision|1|||
125295595|NCT01659255|450709473|FG013|Overall Study|Investigator Decision|1|||
125295596|NCT01659255|450709474|FG014|Overall Study|Investigator Decision|0|||
125295597|NCT01659255|450709475|FG015|Overall Study|Investigator Decision|0|||
125295598|NCT01659255|450709476|FG016|Overall Study|Investigator Decision|0|||
125295599|NCT01659255|450709460|FG000|Overall Study|Sponsor's Decision|0|||
125295600|NCT01659255|450709461|FG001|Overall Study|Sponsor's Decision|0|||
125295601|NCT01659255|450709462|FG002|Overall Study|Sponsor's Decision|0|||
125295602|NCT01659255|450709463|FG003|Overall Study|Sponsor's Decision|0|||
125295603|NCT01659255|450709464|FG004|Overall Study|Sponsor's Decision|0|||
125295604|NCT01659255|450709465|FG005|Overall Study|Sponsor's Decision|0|||
125295605|NCT01659255|450709466|FG006|Overall Study|Sponsor's Decision|1|||
125295606|NCT01659255|450709467|FG007|Overall Study|Sponsor's Decision|0|||
125295607|NCT01659255|450709468|FG008|Overall Study|Sponsor's Decision|0|||
125295608|NCT01659255|450709469|FG009|Overall Study|Sponsor's Decision|0|||
125295609|NCT01659255|450709470|FG010|Overall Study|Sponsor's Decision|0|||
125295610|NCT01659255|450709471|FG011|Overall Study|Sponsor's Decision|0|||
125295611|NCT01659255|450709472|FG012|Overall Study|Sponsor's Decision|0|||
125295612|NCT01659255|450709473|FG013|Overall Study|Sponsor's Decision|0|||
125295613|NCT01659255|450709474|FG014|Overall Study|Sponsor's Decision|0|||
125295614|NCT01659255|450709475|FG015|Overall Study|Sponsor's Decision|0|||
125295615|NCT01659255|450709476|FG016|Overall Study|Sponsor's Decision|0|||
125295616|NCT01659255|450709460|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295617|NCT01659255|450709461|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295618|NCT01659255|450709462|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295619|NCT01659255|450709463|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295620|NCT01659255|450709464|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295621|NCT01659255|450709465|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295622|NCT01659255|450709466|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295623|NCT01659255|450709467|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295624|NCT01659255|450709468|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295625|NCT01659255|450709469|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125420387|NCT03137303|451163607|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
125420388|NCT03137303|451163606|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
125420389|NCT03137303|451163607|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
125295626|NCT01659255|450709470|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295627|NCT01659255|450709471|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295628|NCT01659255|450709472|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295629|NCT01659255|450709473|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125420390|NCT03137303|451163606|FG000|T3: 9-month Follow-up|Death|1|||
125295630|NCT01659255|450709474|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125295631|NCT01659255|450709475|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
125295632|NCT01659255|450709476|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
125420391|NCT03137303|451163607|FG001|T3: 9-month Follow-up|Death|0|||
125420392|NCT03137303|451163606|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
125463501|NCT02593149|451327284|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
125463502|NCT01636687|451327286|FG000|Induction Period|Withdrawal by Subject|1|||
125463503|NCT01636687|451327287|FG001|Induction Period|Withdrawal by Subject|0|||
125463504|NCT01636687|451327288|FG002|Induction Period|Withdrawal by Subject|0|||
125463505|NCT01636687|451327289|FG003|Induction Period|Withdrawal by Subject|0|||
125463506|NCT01636687|451327290|FG004|Induction Period|Withdrawal by Subject|0|||
125463507|NCT01636687|451327286|FG000|Induction Period|Adverse Event|1|||
125463508|NCT01636687|451327287|FG001|Induction Period|Adverse Event|0|||
125463509|NCT01636687|451327288|FG002|Induction Period|Adverse Event|0|||
125463510|NCT01636687|451327289|FG003|Induction Period|Adverse Event|0|||
125463511|NCT01636687|451327290|FG004|Induction Period|Adverse Event|1|||
125463512|NCT01636687|451327286|FG000|Induction Period|Lack of Efficacy|0|||
125463513|NCT01636687|451327287|FG001|Induction Period|Lack of Efficacy|0|||
125463514|NCT01636687|451327288|FG002|Induction Period|Lack of Efficacy|0|||
125463515|NCT01636687|451327289|FG003|Induction Period|Lack of Efficacy|0|||
125463516|NCT01636687|451327290|FG004|Induction Period|Lack of Efficacy|1|||
125463517|NCT01636687|451327286|FG000|Induction Period|Physician Decision|1|||
125463518|NCT01636687|451327287|FG001|Induction Period|Physician Decision|0|||
125463519|NCT01636687|451327288|FG002|Induction Period|Physician Decision|0|||
125463520|NCT01636687|451327289|FG003|Induction Period|Physician Decision|0|||
125463521|NCT01636687|451327290|FG004|Induction Period|Physician Decision|0|||
125463522|NCT01636687|451327286|FG000|Maintenance Period|Withdrawal by Subject|2|||
125463523|NCT01636687|451327287|FG001|Maintenance Period|Withdrawal by Subject|0|||
125463524|NCT01636687|451327288|FG002|Maintenance Period|Withdrawal by Subject|2|||
125463525|NCT01636687|451327289|FG003|Maintenance Period|Withdrawal by Subject|0|||
125463526|NCT01636687|451327290|FG004|Maintenance Period|Withdrawal by Subject|0|||
125463527|NCT01636687|451327286|FG000|Maintenance Period|Adverse Event|1|||
125463528|NCT01636687|451327287|FG001|Maintenance Period|Adverse Event|0|||
125463529|NCT01636687|451327288|FG002|Maintenance Period|Adverse Event|0|||
125463530|NCT01636687|451327289|FG003|Maintenance Period|Adverse Event|0|||
125463531|NCT01636687|451327290|FG004|Maintenance Period|Adverse Event|0|||
125463532|NCT01636687|451327286|FG000|Maintenance Period|Lack of Efficacy|4|||
125463533|NCT01636687|451327287|FG001|Maintenance Period|Lack of Efficacy|1|||
125463534|NCT01636687|451327288|FG002|Maintenance Period|Lack of Efficacy|0|||
125463535|NCT01636687|451327289|FG003|Maintenance Period|Lack of Efficacy|0|||
125463536|NCT01636687|451327290|FG004|Maintenance Period|Lack of Efficacy|0|||
125463537|NCT01636687|451327286|FG000|Maintenance Period|Lost to Follow-up|1|||
125463538|NCT01636687|451327287|FG001|Maintenance Period|Lost to Follow-up|1|||
125463539|NCT01636687|451327288|FG002|Maintenance Period|Lost to Follow-up|0|||
125463540|NCT01636687|451327289|FG003|Maintenance Period|Lost to Follow-up|0|||
125463541|NCT01636687|451327290|FG004|Maintenance Period|Lost to Follow-up|1|||
125463542|NCT01636687|451327286|FG000|Maintenance Period|Physician Decision|0|||
125463543|NCT01636687|451327287|FG001|Maintenance Period|Physician Decision|0|||
125463544|NCT01636687|451327288|FG002|Maintenance Period|Physician Decision|0|||
125463545|NCT01636687|451327289|FG003|Maintenance Period|Physician Decision|0|||
125463546|NCT01636687|451327290|FG004|Maintenance Period|Physician Decision|1|||
125463547|NCT01636687|451327286|FG000|Extension Period|technical problems|0|||
125463548|NCT01636687|451327287|FG001|Extension Period|technical problems|1|||
125463549|NCT01636687|451327288|FG002|Extension Period|technical problems|2|||
125463550|NCT01636687|451327289|FG003|Extension Period|technical problems|1|||
125463551|NCT01636687|451327290|FG004|Extension Period|technical problems|0|||
125463552|NCT01636687|451327286|FG000|Extension Period|Adverse Event|4|||
125463553|NCT01636687|451327287|FG001|Extension Period|Adverse Event|3|||
125463554|NCT01636687|451327288|FG002|Extension Period|Adverse Event|2|||
125463555|NCT01636687|451327289|FG003|Extension Period|Adverse Event|1|||
125463556|NCT01636687|451327290|FG004|Extension Period|Adverse Event|0|||
125463557|NCT01636687|451327286|FG000|Extension Period|Lack of Efficacy|7|||
125463558|NCT01636687|451327287|FG001|Extension Period|Lack of Efficacy|0|||
125463559|NCT01636687|451327288|FG002|Extension Period|Lack of Efficacy|2|||
125463560|NCT01636687|451327289|FG003|Extension Period|Lack of Efficacy|1|||
125463561|NCT01636687|451327290|FG004|Extension Period|Lack of Efficacy|0|||
125463562|NCT01636687|451327286|FG000|Extension Period|Lost to Follow-up|1|||
125463563|NCT01636687|451327287|FG001|Extension Period|Lost to Follow-up|0|||
125463564|NCT01636687|451327288|FG002|Extension Period|Lost to Follow-up|1|||
125463565|NCT01636687|451327289|FG003|Extension Period|Lost to Follow-up|0|||
125463566|NCT01636687|451327290|FG004|Extension Period|Lost to Follow-up|0|||
125463567|NCT01636687|451327286|FG000|Extension Period|Physician Decision|1|||
125463568|NCT01636687|451327287|FG001|Extension Period|Physician Decision|0|||
125463569|NCT01636687|451327288|FG002|Extension Period|Physician Decision|0|||
125463570|NCT01636687|451327289|FG003|Extension Period|Physician Decision|1|||
125463571|NCT01636687|451327290|FG004|Extension Period|Physician Decision|0|||
125463572|NCT01636687|451327286|FG000|Extension Period|study terminated by sponsor|33|||
125463573|NCT01636687|451327287|FG001|Extension Period|study terminated by sponsor|50|||
125463574|NCT01636687|451327288|FG002|Extension Period|study terminated by sponsor|17|||
125463575|NCT01636687|451327289|FG003|Extension Period|study terminated by sponsor|23|||
125463576|NCT01636687|451327290|FG004|Extension Period|study terminated by sponsor|0|||
125463577|NCT01636687|451327286|FG000|Extension Period|Withdrawal by Subject|1|||
125463578|NCT01636687|451327287|FG001|Extension Period|Withdrawal by Subject|0|||
125463579|NCT01636687|451327288|FG002|Extension Period|Withdrawal by Subject|1|||
125463580|NCT01636687|451327289|FG003|Extension Period|Withdrawal by Subject|1|||
125463581|NCT01636687|451327290|FG004|Extension Period|Withdrawal by Subject|0|||
125463582|NCT01636687|451327286|FG000|Follow-up Period|Withdrawal by Subject|1|||
125463583|NCT01636687|451327287|FG001|Follow-up Period|Withdrawal by Subject|0|||
125463584|NCT01636687|451327288|FG002|Follow-up Period|Withdrawal by Subject|0|||
125463585|NCT01636687|451327289|FG003|Follow-up Period|Withdrawal by Subject|0|||
125463586|NCT01636687|451327290|FG004|Follow-up Period|Withdrawal by Subject|1|||
125463587|NCT01190007|451327300|FG000|Overall Study|Withdrawal by Subject|4|||
125463588|NCT01190007|451327300|FG000|Overall Study|Adverse Event|8|||
125463589|NCT01190007|451327300|FG000|Overall Study|Difficulty of visit for complications|1|||
125463590|NCT01190007|451327300|FG000|Overall Study|Participant was arrested|1|||
125463591|NCT01254188|451327304|FG000|Overall Study|Disease Progression|6|||
125463592|NCT01254188|451327304|FG000|Overall Study|Protocol Violation|6|||
125463593|NCT01254188|451327304|FG000|Overall Study|Pregnancy|2|||
125463594|NCT01254188|451327304|FG000|Overall Study|Death|4|||
125463595|NCT01254188|451327304|FG000|Overall Study|Lost to Follow-up|5|||
125463596|NCT01254188|451327304|FG000|Overall Study|Withdrawal by Subject|7|||
125463597|NCT01254188|451327304|FG000|Overall Study|Adverse Event|43|||
125463598|NCT01254188|451327304|FG000|Overall Study|per investigator discretion|20|||
125463599|NCT02755116|451327306|FG000|Overall Study|surgery converted to open, pt admitted|3|||
125463600|NCT02755116|451327307|FG001|Overall Study|surgery converted to open, pt admitted|1|||
125463601|NCT01124734|451327308|FG000|Overall Study|Disease progression|13|||
125463602|NCT01124734|451327308|FG000|Overall Study|Adverse Event|1|||
125463603|NCT01124734|451327308|FG000|Overall Study|Withdrawal by Subject|1|||
125463604|NCT01124734|451327308|FG000|Overall Study|Elected for alternative treatment|2|||
125463605|NCT03482011|451327309|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
125463606|NCT03482011|451327310|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
125463607|NCT03482011|451327311|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
125463608|NCT03482011|451327312|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
125463609|NCT03482011|451327313|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
125463610|NCT03482011|451327314|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
125463611|NCT03482011|451327315|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
125463612|NCT03482011|451327316|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
125463613|NCT03482011|451327309|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
125463614|NCT03482011|451327310|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
125463615|NCT03482011|451327311|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125463616|NCT03482011|451327312|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125463617|NCT03482011|451327313|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125463618|NCT03482011|451327314|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125463619|NCT03482011|451327315|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125463620|NCT03482011|451327316|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
125463621|NCT03482011|451327309|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
125463622|NCT03482011|451327310|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
125463623|NCT03482011|451327311|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
125463624|NCT03482011|451327312|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
125463625|NCT03482011|451327313|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
125463626|NCT03482011|451327314|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
125463627|NCT03482011|451327315|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
125463628|NCT03482011|451327316|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
125463629|NCT03482011|451327309|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
125463630|NCT03482011|451327310|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
125463631|NCT03482011|451327311|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
125463632|NCT03482011|451327312|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
125463633|NCT03482011|451327313|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
125463634|NCT03482011|451327314|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
125463635|NCT03482011|451327315|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
125463636|NCT03482011|451327316|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
125463637|NCT03482011|451327309|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
125295633|NCT01659255|450709460|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
125295634|NCT01659255|450709461|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
125463638|NCT03482011|451327310|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
125463639|NCT03482011|451327311|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125463640|NCT03482011|451327312|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125463641|NCT03482011|451327313|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125463642|NCT03482011|451327314|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125463643|NCT03482011|451327315|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125463644|NCT03482011|451327316|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
125463645|NCT03482011|451327309|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
125463646|NCT03482011|451327310|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
125463647|NCT03482011|451327311|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
125463648|NCT03482011|451327312|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
125485365|NCT02240238|451412503|FG000|Phase 1|Sponsor termination|0|||
125463649|NCT03482011|451327313|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
125463650|NCT03482011|451327314|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
125463651|NCT03482011|451327315|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
125463652|NCT03482011|451327316|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
125463653|NCT03482011|451327309|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
125463654|NCT03482011|451327310|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
125463655|NCT03482011|451327311|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
125463656|NCT03482011|451327312|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
125463657|NCT03482011|451327313|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
125463658|NCT03482011|451327314|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
125463659|NCT03482011|451327315|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
125463660|NCT03482011|451327316|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
125463661|NCT03482011|451327309|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125463662|NCT03482011|451327310|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125463663|NCT03482011|451327311|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125463664|NCT03482011|451327312|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125463665|NCT03482011|451327313|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
125463666|NCT03482011|451327314|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125463667|NCT03482011|451327315|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
125463668|NCT03482011|451327316|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
125463669|NCT03482011|451327309|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
125463670|NCT03482011|451327310|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
125463671|NCT03482011|451327311|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
125463672|NCT03482011|451327312|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
125463673|NCT03482011|451327313|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
125463674|NCT03482011|451327314|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
125463675|NCT03482011|451327315|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
125463676|NCT03482011|451327316|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
125463677|NCT03482011|451327309|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125463678|NCT03482011|451327310|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125463679|NCT03482011|451327311|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
125463680|NCT03482011|451327312|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
125463681|NCT03482011|451327313|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
125463682|NCT03482011|451327314|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
125463683|NCT03482011|451327315|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
125463684|NCT03482011|451327316|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
125463685|NCT03482011|451327309|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125463686|NCT03482011|451327310|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125295635|NCT01659255|450709462|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
125295636|NCT01659255|450709463|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
125295637|NCT01659255|450709464|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
125295638|NCT01659255|450709465|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
125295639|NCT01659255|450709466|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
125295640|NCT01659255|450709467|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
125295641|NCT01659255|450709468|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
125463687|NCT03482011|451327311|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125463688|NCT03482011|451327312|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
125463689|NCT03482011|451327313|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
125463690|NCT03482011|451327314|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
125463691|NCT03482011|451327315|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
125463692|NCT03482011|451327316|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
125463693|NCT03482011|451327309|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
125463694|NCT03482011|451327310|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
125463695|NCT03482011|451327311|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
125463696|NCT03482011|451327312|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
125295642|NCT01659255|450709469|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
125295643|NCT01659255|450709470|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
125295644|NCT01659255|450709471|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
125295645|NCT01659255|450709472|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
125463697|NCT03482011|451327313|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
125463698|NCT03482011|451327314|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
125463699|NCT03482011|451327315|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
125463700|NCT03482011|451327316|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
125463701|NCT03482011|451327309|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
125463702|NCT03482011|451327310|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
125463703|NCT03482011|451327311|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
125463704|NCT03482011|451327312|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
125463705|NCT03482011|451327313|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
125463706|NCT03482011|451327314|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
125463707|NCT03482011|451327315|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
125463708|NCT03482011|451327316|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
125463709|NCT03482011|451327309|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
125463710|NCT03482011|451327310|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
125463711|NCT03482011|451327311|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
125463712|NCT03482011|451327312|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
125463713|NCT03482011|451327313|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
125463714|NCT03482011|451327314|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
125463715|NCT03482011|451327315|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
125463716|NCT03482011|451327316|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
125463717|NCT03482011|451327309|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
125463718|NCT03482011|451327310|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
125463719|NCT03482011|451327311|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
125463720|NCT03482011|451327312|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
125463721|NCT03482011|451327313|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
125463722|NCT03482011|451327314|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
125463723|NCT03482011|451327315|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
125463724|NCT03482011|451327316|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
125463725|NCT01576484|451327318|FG000|Overall Study|Adverse Event|1|||
125463726|NCT01576484|451327319|FG001|Overall Study|Adverse Event|1|||
125463727|NCT01576484|451327318|FG000|Overall Study|Protocol Violation|0|||
125463728|NCT01576484|451327319|FG001|Overall Study|Protocol Violation|2|||
125463729|NCT01576484|451327318|FG000|Overall Study|Sponsor Decision|2|||
125463730|NCT01576484|451327319|FG001|Overall Study|Sponsor Decision|8|||
125463731|NCT01576484|451327318|FG000|Overall Study|Withdrawal by Subject|0|||
125463732|NCT01576484|451327319|FG001|Overall Study|Withdrawal by Subject|3|||
125463733|NCT01576484|451327318|FG000|Overall Study|Other|2|||
125463734|NCT01576484|451327319|FG001|Overall Study|Other|5|||
125463735|NCT01943799|451327321|FG000|Overall Study|Lost to Follow-up|0|||
125463736|NCT01943799|451327322|FG001|Overall Study|Lost to Follow-up|1|||
125463737|NCT01943799|451327323|FG002|Overall Study|Lost to Follow-up|1|||
125463738|NCT01943799|451327324|FG003|Overall Study|Lost to Follow-up|0|||
125463739|NCT01943799|451327321|FG000|Overall Study|Protocol Violation|1|||
125463740|NCT01943799|451327322|FG001|Overall Study|Protocol Violation|0|||
125463741|NCT01943799|451327323|FG002|Overall Study|Protocol Violation|0|||
125463742|NCT01943799|451327324|FG003|Overall Study|Protocol Violation|0|||
125463743|NCT01943799|451327321|FG000|Overall Study|Withdrawal by Subject|4|||
125463744|NCT01943799|451327322|FG001|Overall Study|Withdrawal by Subject|2|||
125463745|NCT01943799|451327323|FG002|Overall Study|Withdrawal by Subject|1|||
125463746|NCT01943799|451327324|FG003|Overall Study|Withdrawal by Subject|0|||
125463747|NCT04594759|451327325|FG000|Overall Study|Lost to Follow-up|3|||
125463748|NCT03811574|451327326|FG000|Overall Study|Withdrawal by Subject|2|||
125463749|NCT03811574|451327327|FG001|Overall Study|Withdrawal by Subject|4|||
125463750|NCT03811574|451327328|FG002|Overall Study|Withdrawal by Subject|0|||
125463751|NCT01832480|451327329|FG000|Overall Study|Lost to Follow-up|33|||
125463752|NCT01832480|451327330|FG001|Overall Study|Lost to Follow-up|30|||
125463753|NCT01832480|451327329|FG000|Overall Study|Withdrawal by Subject|0|||
125463754|NCT01832480|451327330|FG001|Overall Study|Withdrawal by Subject|2|||
125463755|NCT01832480|451327329|FG000|Overall Study|post randomization ineligible|8|||
125463756|NCT01832480|451327330|FG001|Overall Study|post randomization ineligible|10|||
125463757|NCT00958633|451327331|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
125463758|NCT00958633|451327332|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
125463759|NCT00958633|451327333|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
125463760|NCT00958633|451327331|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
125463761|NCT00958633|451327332|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
125463762|NCT00958633|451327333|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
125463763|NCT00958633|451327331|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
125463764|NCT00958633|451327332|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
125463765|NCT00958633|451327333|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
125463766|NCT00958633|451327331|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
125463767|NCT00958633|451327332|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
125463768|NCT00958633|451327333|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
125463769|NCT00958633|451327331|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
125463770|NCT00958633|451327332|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
125463771|NCT00958633|451327333|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
125463772|NCT00958633|451327331|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
125463773|NCT00958633|451327332|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
125463774|NCT00958633|451327333|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
125463775|NCT00958633|451327331|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
125463776|NCT00958633|451327332|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
125463777|NCT00958633|451327333|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
125463778|NCT00433199|451327343|FG000|Double-Blind Period|Adverse Event|0|||
125463779|NCT00433199|451327344|FG001|Double-Blind Period|Adverse Event|25|||
125463780|NCT00433199|451327343|FG000|Double-Blind Period|Lack of Efficacy|0|||
125463781|NCT00433199|451327344|FG001|Double-Blind Period|Lack of Efficacy|2|||
125463782|NCT00433199|451327343|FG000|Double-Blind Period|Lost to Follow-up|2|||
125463783|NCT00433199|451327344|FG001|Double-Blind Period|Lost to Follow-up|5|||
125463784|NCT00433199|451327343|FG000|Double-Blind Period|Withdrawal by Subject|8|||
125463785|NCT00433199|451327344|FG001|Double-Blind Period|Withdrawal by Subject|19|||
125463786|NCT00433199|451327343|FG000|Double-Blind Period|Protocol Violation|1|||
125463787|NCT00433199|451327344|FG001|Double-Blind Period|Protocol Violation|10|||
125463788|NCT00433199|451327343|FG000|Double-Blind Period|Administrative|1|||
125463789|NCT00433199|451327344|FG001|Double-Blind Period|Administrative|5|||
125463790|NCT00433199|451327343|FG000|Open-Label Period|Adverse Event|0|||
125463791|NCT00433199|451327344|FG001|Open-Label Period|Adverse Event|19|||
125463792|NCT00433199|451327343|FG000|Open-Label Period|Lack of Efficacy|0|||
125463793|NCT00433199|451327344|FG001|Open-Label Period|Lack of Efficacy|2|||
125463794|NCT00433199|451327343|FG000|Open-Label Period|Lost to Follow-up|0|||
125463795|NCT00433199|451327344|FG001|Open-Label Period|Lost to Follow-up|3|||
125463796|NCT00433199|451327343|FG000|Open-Label Period|Withdrawal by Subject|0|||
125463797|NCT00433199|451327344|FG001|Open-Label Period|Withdrawal by Subject|7|||
125463798|NCT00433199|451327343|FG000|Open-Label Period|Protocol Violation|0|||
125463799|NCT00433199|451327344|FG001|Open-Label Period|Protocol Violation|2|||
125463800|NCT00433199|451327343|FG000|Open-Label Period|Administrative|0|||
125463801|NCT00433199|451327344|FG001|Open-Label Period|Administrative|1|||
125463802|NCT01170962|451327346|FG000|Treatment Period|Lack of Efficacy|96|||
125463803|NCT01170962|451327347|FG001|Treatment Period|Lack of Efficacy|91|||
125463804|NCT01170962|451327348|FG002|Treatment Period|Lack of Efficacy|7|||
125463805|NCT01170962|451327346|FG000|Treatment Period|Adverse Event|11|||
125463806|NCT01170962|451327347|FG001|Treatment Period|Adverse Event|12|||
125295646|NCT01659255|450709473|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
125295647|NCT01659255|450709474|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
125295648|NCT01659255|450709475|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
125295649|NCT01659255|450709476|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
125463807|NCT01170962|451327348|FG002|Treatment Period|Adverse Event|3|||
125463808|NCT01170962|451327346|FG000|Treatment Period|Withdrawal by Subject|2|||
125463809|NCT01170962|451327347|FG001|Treatment Period|Withdrawal by Subject|1|||
125463810|NCT01170962|451327348|FG002|Treatment Period|Withdrawal by Subject|0|||
125463811|NCT01170962|451327346|FG000|Treatment Period|Lost to Follow-up|1|||
125463812|NCT01170962|451327347|FG001|Treatment Period|Lost to Follow-up|1|||
125463813|NCT01170962|451327348|FG002|Treatment Period|Lost to Follow-up|1|||
125463814|NCT01170962|451327346|FG000|Treatment Period|Participant no longer meets criteria|0|||
125463815|NCT01170962|451327347|FG001|Treatment Period|Participant no longer meets criteria|1|||
125463816|NCT01170962|451327348|FG002|Treatment Period|Participant no longer meets criteria|0|||
125463817|NCT01170962|451327346|FG000|Treatment Period|Request to discontinue treatment|7|||
125463818|NCT01170962|451327347|FG001|Treatment Period|Request to discontinue treatment|3|||
125463819|NCT01170962|451327348|FG002|Treatment Period|Request to discontinue treatment|1|||
125463820|NCT01170962|451327346|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
125463821|NCT01170962|451327347|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
125463822|NCT01170962|451327348|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
125463823|NCT01170962|451327346|FG000|Follow up Period|Withdrawal by Subject|14|||
125463824|NCT01170962|451327347|FG001|Follow up Period|Withdrawal by Subject|10|||
125463825|NCT01170962|451327348|FG002|Follow up Period|Withdrawal by Subject|2|||
125463826|NCT01170962|451327346|FG000|Follow up Period|Lost to Follow-up|13|||
125463827|NCT01170962|451327347|FG001|Follow up Period|Lost to Follow-up|8|||
125463828|NCT01170962|451327348|FG002|Follow up Period|Lost to Follow-up|1|||
125463829|NCT01170962|451327346|FG000|Follow up Period|Death|2|||
125463830|NCT01170962|451327347|FG001|Follow up Period|Death|2|||
125463831|NCT01170962|451327348|FG002|Follow up Period|Death|0|||
125463832|NCT01170962|451327346|FG000|Follow up Period|Others|10|||
125463833|NCT01170962|451327347|FG001|Follow up Period|Others|7|||
125463834|NCT01170962|451327348|FG002|Follow up Period|Others|3|||
125463835|NCT02407249|451328859|FG000|Overall Study|Did not complete 12-month follow-up|13|||
125463836|NCT02407249|451328859|FG000|Overall Study|Not treated|13|||
125463837|NCT03345901|451328862|FG000|Overall Study|The study was terminated|18|||
125463838|NCT00722046|451328863|FG000|Overall Study|Adverse Event|0|||
125463839|NCT00722046|451328864|FG001|Overall Study|Adverse Event|1|||
125295650|NCT01116427|450709479|FG000|Core Phase|Adverse Event|0|||
125295651|NCT01116427|450709480|FG001|Core Phase|Adverse Event|1|||
125295652|NCT01116427|450709479|FG000|Core Phase|Lost to Follow-up|1|||
125463840|NCT00722046|451328865|FG002|Overall Study|Adverse Event|2|||
125463841|NCT00722046|451328866|FG003|Overall Study|Adverse Event|1|||
125463842|NCT00722046|451328867|FG004|Overall Study|Adverse Event|2|||
125463843|NCT00722046|451328868|FG005|Overall Study|Adverse Event|1|||
125463844|NCT00722046|451328869|FG006|Overall Study|Adverse Event|0|||
125463845|NCT00722046|451328863|FG000|Overall Study|Death|0|||
125463846|NCT00722046|451328864|FG001|Overall Study|Death|1|||
125463847|NCT00722046|451328865|FG002|Overall Study|Death|0|||
125463848|NCT00722046|451328866|FG003|Overall Study|Death|0|||
125463849|NCT00722046|451328867|FG004|Overall Study|Death|0|||
125463850|NCT00722046|451328868|FG005|Overall Study|Death|0|||
125463851|NCT00722046|451328869|FG006|Overall Study|Death|2|||
125463852|NCT00722046|451328863|FG000|Overall Study|Protocol Violation|1|||
125463853|NCT00722046|451328864|FG001|Overall Study|Protocol Violation|0|||
125463854|NCT00722046|451328865|FG002|Overall Study|Protocol Violation|0|||
125463855|NCT00722046|451328866|FG003|Overall Study|Protocol Violation|0|||
125463856|NCT00722046|451328867|FG004|Overall Study|Protocol Violation|0|||
125463857|NCT00722046|451328868|FG005|Overall Study|Protocol Violation|1|||
125463858|NCT00722046|451328869|FG006|Overall Study|Protocol Violation|0|||
125463859|NCT00722046|451328863|FG000|Overall Study|Withdrawal by Subject|3|||
125463860|NCT00722046|451328864|FG001|Overall Study|Withdrawal by Subject|3|||
125463861|NCT00722046|451328865|FG002|Overall Study|Withdrawal by Subject|4|||
125463862|NCT00722046|451328866|FG003|Overall Study|Withdrawal by Subject|4|||
125463863|NCT00722046|451328867|FG004|Overall Study|Withdrawal by Subject|4|||
125463864|NCT00722046|451328868|FG005|Overall Study|Withdrawal by Subject|7|||
125463865|NCT00722046|451328869|FG006|Overall Study|Withdrawal by Subject|3|||
125463866|NCT00722046|451328863|FG000|Overall Study|Randomized, but not treated|1|||
125463867|NCT00722046|451328864|FG001|Overall Study|Randomized, but not treated|1|||
125463868|NCT00722046|451328865|FG002|Overall Study|Randomized, but not treated|0|||
125463869|NCT00722046|451328866|FG003|Overall Study|Randomized, but not treated|2|||
125463870|NCT00722046|451328867|FG004|Overall Study|Randomized, but not treated|0|||
125463871|NCT00722046|451328868|FG005|Overall Study|Randomized, but not treated|0|||
125463872|NCT00722046|451328869|FG006|Overall Study|Randomized, but not treated|0|||
125463873|NCT00722046|451328863|FG000|Overall Study|Other|0|||
125463874|NCT00722046|451328864|FG001|Overall Study|Other|0|||
125463875|NCT00722046|451328865|FG002|Overall Study|Other|1|||
125463876|NCT00722046|451328866|FG003|Overall Study|Other|1|||
125463877|NCT00722046|451328867|FG004|Overall Study|Other|3|||
125463878|NCT00722046|451328868|FG005|Overall Study|Other|2|||
125463879|NCT00722046|451328869|FG006|Overall Study|Other|1|||
125463880|NCT00686855|451328873|FG000|Overall Study|Lost to Follow-up|1|||
125463881|NCT00686855|451328874|FG001|Overall Study|Lost to Follow-up|0|||
125463882|NCT00686855|451328873|FG000|Overall Study|Progressive GVHD|0|||
125463883|NCT00686855|451328874|FG001|Overall Study|Progressive GVHD|1|||
125463884|NCT02731755|451328880|FG000|First Intervention|Withdrawal by Subject|0|||
125463885|NCT02731755|451328881|FG001|First Intervention|Withdrawal by Subject|2|||
125463886|NCT01460446|451328882|FG000|Overall Study|Non-compliance|2|||
125463887|NCT01460446|451328883|FG001|Overall Study|Non-compliance|9|||
125463888|NCT01460446|451328882|FG000|Overall Study|Consent Withdrawn|0|||
125463889|NCT01460446|451328883|FG001|Overall Study|Consent Withdrawn|4|||
125463890|NCT01460446|451328882|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
125463891|NCT01460446|451328883|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
125463892|NCT01460446|451328882|FG000|Overall Study|Surgery/Illness|1|||
125463893|NCT01460446|451328883|FG001|Overall Study|Surgery/Illness|1|||
125463894|NCT01460446|451328882|FG000|Overall Study|Pregnancy|1|||
125463895|NCT01460446|451328883|FG001|Overall Study|Pregnancy|0|||
125463896|NCT01460446|451328882|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
125463897|NCT01460446|451328883|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
125463898|NCT00414544|451328886|FG000|Overall Study|Lost to Follow-up|14|||
125463899|NCT00799396|451328888|FG000|Clopidogrel Treatment|Adverse Event|6|||
125463900|NCT00799396|451328888|FG000|Clopidogrel Treatment|Physician Decision|5|||
125463901|NCT00799396|451328888|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
125463902|NCT00799396|451328888|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
125463903|NCT00799396|451328888|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
125463904|NCT01318382|451328891|FG000|Overall Study|Physician Decision|2|||
125463905|NCT01318382|451328891|FG000|Overall Study|Device Malfunction|10|||
125463906|NCT01318382|451328891|FG000|Overall Study|Protocol Violation|1|||
125463907|NCT01867216|451328892|FG000|Overall Study|Withdrawal by Subject|2|||
125463908|NCT01867216|451328893|FG001|Overall Study|Withdrawal by Subject|0|||
125463909|NCT01867216|451328894|FG002|Overall Study|Withdrawal by Subject|0|||
125463910|NCT01867216|451328895|FG003|Overall Study|Withdrawal by Subject|0|||
125463911|NCT01867216|451328896|FG004|Overall Study|Withdrawal by Subject|1|||
125463912|NCT01867216|451328897|FG005|Overall Study|Withdrawal by Subject|0|||
125463913|NCT01867216|451328898|FG006|Overall Study|Withdrawal by Subject|1|||
125295653|NCT01116427|450709480|FG001|Core Phase|Lost to Follow-up|0|||
125463914|NCT01867216|451328892|FG000|Overall Study|Physician Decision|1|||
125463915|NCT01867216|451328893|FG001|Overall Study|Physician Decision|0|||
125463916|NCT01867216|451328894|FG002|Overall Study|Physician Decision|0|||
125463917|NCT01867216|451328895|FG003|Overall Study|Physician Decision|0|||
125463918|NCT01867216|451328896|FG004|Overall Study|Physician Decision|0|||
125463919|NCT01867216|451328897|FG005|Overall Study|Physician Decision|0|||
125463920|NCT01867216|451328898|FG006|Overall Study|Physician Decision|0|||
125463921|NCT01867216|451328892|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
125463922|NCT01867216|451328893|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
125463923|NCT01867216|451328894|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
125463924|NCT01867216|451328895|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
125463925|NCT01867216|451328896|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
125295654|NCT01116427|450709479|FG000|Core Phase|Withdrawal by Subject|3|||
125463926|NCT01867216|451328897|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
125463927|NCT01867216|451328898|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
125463928|NCT00542789|451328899|FG000|Overall Study|Adverse Event|18|||
125463929|NCT00542789|451328900|FG001|Overall Study|Adverse Event|17|||
125463930|NCT00542789|451328899|FG000|Overall Study|Withdrawal by Subject|7|||
125463931|NCT00542789|451328900|FG001|Overall Study|Withdrawal by Subject|3|||
125463932|NCT00542789|451328899|FG000|Overall Study|Protocol Violation|8|||
125463933|NCT00542789|451328900|FG001|Overall Study|Protocol Violation|1|||
125463934|NCT00542789|451328899|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
125463935|NCT00542789|451328900|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
125463936|NCT00636207|451328903|FG000|Overall Study|Adverse Event|1|||
125463937|NCT00636207|451328904|FG001|Overall Study|Adverse Event|0|||
125463938|NCT00636207|451328905|FG002|Overall Study|Adverse Event|0|||
125463939|NCT00636207|451328906|FG003|Overall Study|Adverse Event|0|||
125463940|NCT00636207|451328907|FG004|Overall Study|Adverse Event|0|||
125463941|NCT00636207|451328908|FG005|Overall Study|Adverse Event|0|||
125463942|NCT00636207|451328909|FG006|Overall Study|Adverse Event|0|||
125463943|NCT00636207|451328903|FG000|Overall Study|Withdrawal by Subject|0|||
125463944|NCT00636207|451328904|FG001|Overall Study|Withdrawal by Subject|1|||
125463945|NCT00636207|451328905|FG002|Overall Study|Withdrawal by Subject|0|||
125463946|NCT00636207|451328906|FG003|Overall Study|Withdrawal by Subject|0|||
125463947|NCT00636207|451328907|FG004|Overall Study|Withdrawal by Subject|1|||
125463948|NCT00636207|451328908|FG005|Overall Study|Withdrawal by Subject|0|||
125463949|NCT00636207|451328909|FG006|Overall Study|Withdrawal by Subject|0|||
125463950|NCT02594735|451328912|FG000|Overall Study|Adverse Event|1|||
125463951|NCT02529995|451328913|FG000|Part A|Ongoing Study at Data Cut-off|14|||
125463952|NCT02529995|451328914|FG001|Part A|Ongoing Study at Data Cut-off|16|||
125463953|NCT02529995|451328913|FG000|Part A|Discontinued Study|1|||
125463954|NCT02529995|451328914|FG001|Part A|Discontinued Study|0|||
125463955|NCT02529995|451328913|FG000|Part B|Ongoing Study at Data Cut-off|0|||
125463956|NCT02529995|451328914|FG001|Part B|Ongoing Study at Data Cut-off|7|||
125463957|NCT02529995|451328913|FG000|Part B|Discontinued Study|6|||
125463958|NCT02529995|451328914|FG001|Part B|Discontinued Study|5|||
125463959|NCT01075217|451328918|FG000|Overall Study|Adverse Event|1|||
125463960|NCT01075217|451328919|FG001|Overall Study|Adverse Event|1|||
125463961|NCT01075217|451328918|FG000|Overall Study|Physician Decision|1|||
125463962|NCT01075217|451328919|FG001|Overall Study|Physician Decision|0|||
125463963|NCT02969863|451328920|FG000|Overall Study|Physician Decision|1|||
125463964|NCT02969863|451328921|FG001|Overall Study|Physician Decision|0|||
125463965|NCT02969863|451328922|FG002|Overall Study|Physician Decision|0|||
125463966|NCT02969863|451328923|FG003|Overall Study|Physician Decision|0|||
125463967|NCT02969863|451328924|FG004|Overall Study|Physician Decision|0|||
125463968|NCT02969863|451328925|FG005|Overall Study|Physician Decision|0|||
125463969|NCT03737240|451328926|FG000|Overall Study|Lost to Follow-up|16|||
125463970|NCT03737240|451328927|FG001|Overall Study|Lost to Follow-up|15|||
125463971|NCT01068743|451328928|FG000|Period 3|Adverse Event|0|||
125463972|NCT01068743|451328929|FG001|Period 3|Adverse Event|1|||
125463973|NCT01068743|451328930|FG002|Period 3|Adverse Event|0|||
125463974|NCT01068743|451328931|FG003|Period 3|Adverse Event|0|||
125463975|NCT00364013|451328932|FG000|Overall Study|Ineligibility determined|4|||
125463976|NCT00364013|451328933|FG001|Overall Study|Ineligibility determined|2|||
125463977|NCT00364013|451328932|FG000|Overall Study|Adverse Event|4|||
125463978|NCT00364013|451328933|FG001|Overall Study|Adverse Event|3|||
125463979|NCT00364013|451328932|FG000|Overall Study|Withdrawal by Subject|13|||
125463980|NCT00364013|451328933|FG001|Overall Study|Withdrawal by Subject|18|||
125463981|NCT00364013|451328932|FG000|Overall Study|Physician Decision|3|||
125463982|NCT00364013|451328933|FG001|Overall Study|Physician Decision|3|||
125463983|NCT00364013|451328932|FG000|Overall Study|Lost to Follow-up|10|||
125463984|NCT00364013|451328933|FG001|Overall Study|Lost to Follow-up|3|||
125463985|NCT00364013|451328932|FG000|Overall Study|Protocol-specified criteria|6|||
125463986|NCT00364013|451328933|FG001|Overall Study|Protocol-specified criteria|6|||
125463987|NCT00364013|451328932|FG000|Overall Study|Other|41|||
125463988|NCT00364013|451328933|FG001|Overall Study|Other|47|||
125463989|NCT00364013|451328932|FG000|Overall Study|Ongoing|20|||
125295655|NCT01116427|450709480|FG001|Core Phase|Withdrawal by Subject|0|||
125463990|NCT00364013|451328933|FG001|Overall Study|Ongoing|13|||
125463991|NCT00585533|451328935|FG000|Overall Study|objective or symptomatic progression|9|||
125463992|NCT01369498|451328937|FG000|Overall Study|Lack of Efficacy|9|||
125295656|NCT01116427|450709479|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
125463993|NCT01369498|451328938|FG001|Overall Study|Lack of Efficacy|9|||
125463994|NCT01369498|451328939|FG002|Overall Study|Lack of Efficacy|1|||
125463995|NCT01369498|451328940|FG003|Overall Study|Lack of Efficacy|3|||
125463996|NCT01369498|451328937|FG000|Overall Study|Adverse Event|1|||
125463997|NCT01369498|451328938|FG001|Overall Study|Adverse Event|2|||
125295657|NCT01116427|450709480|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
125463998|NCT01369498|451328939|FG002|Overall Study|Adverse Event|0|||
125463999|NCT01369498|451328940|FG003|Overall Study|Adverse Event|1|||
125464000|NCT01369498|451328937|FG000|Overall Study|Withdrawal of Consent|0|||
125464001|NCT01369498|451328938|FG001|Overall Study|Withdrawal of Consent|1|||
125464002|NCT01369498|451328939|FG002|Overall Study|Withdrawal of Consent|1|||
125464003|NCT01369498|451328940|FG003|Overall Study|Withdrawal of Consent|1|||
125464004|NCT01369498|451328937|FG000|Overall Study|Death|0|||
125464005|NCT01369498|451328938|FG001|Overall Study|Death|0|||
125464006|NCT01369498|451328939|FG002|Overall Study|Death|1|||
125464007|NCT01369498|451328940|FG003|Overall Study|Death|0|||
125464008|NCT01369498|451328937|FG000|Overall Study|Investigator's Discretion|1|||
125464009|NCT01369498|451328938|FG001|Overall Study|Investigator's Discretion|0|||
125464010|NCT01369498|451328939|FG002|Overall Study|Investigator's Discretion|1|||
125464011|NCT01369498|451328940|FG003|Overall Study|Investigator's Discretion|3|||
125464012|NCT01369498|451328937|FG000|Overall Study|Unknown Reason|1|||
125464013|NCT01369498|451328938|FG001|Overall Study|Unknown Reason|0|||
125464014|NCT01369498|451328939|FG002|Overall Study|Unknown Reason|11|||
125464015|NCT01369498|451328940|FG003|Overall Study|Unknown Reason|6|||
125464016|NCT01369498|451328937|FG000|Overall Study|Disease Progression|0|||
125464017|NCT01369498|451328938|FG001|Overall Study|Disease Progression|0|||
125464018|NCT01369498|451328939|FG002|Overall Study|Disease Progression|0|||
125464019|NCT01369498|451328940|FG003|Overall Study|Disease Progression|1|||
125464020|NCT02538107|451328949|FG000|Overall Study|Did not receive any Mircera dose|11|||
125464021|NCT02538107|451328949|FG000|Overall Study|Missing|5|||
125464022|NCT02538107|451328949|FG000|Overall Study|Necessity of dialysis|20|||
125464023|NCT02538107|451328949|FG000|Overall Study|Administration of other ESA|11|||
125464024|NCT02538107|451328949|FG000|Overall Study|No further treatment necessary|18|||
125464025|NCT02538107|451328949|FG000|Overall Study|Withdrawal by Subject|17|||
125464026|NCT02538107|451328949|FG000|Overall Study|Death|4|||
125464027|NCT02538107|451328949|FG000|Overall Study|Administrative reason|5|||
125464028|NCT02538107|451328949|FG000|Overall Study|Adverse Event|4|||
125464029|NCT02538107|451328949|FG000|Overall Study|Surgery|1|||
125464030|NCT02538107|451328949|FG000|Overall Study|Other|7|||
125464031|NCT02538107|451328949|FG000|Overall Study|Not recorded|7|||
125464032|NCT01943916|451328950|FG000|Overall Study|Technically invalid images|10|||
125464033|NCT01943916|451328950|FG000|Overall Study|Enrollment Failure|23|||
125464034|NCT01943916|451328950|FG000|Overall Study|Pilot Phase exclusion|100|||
125464035|NCT01943916|451328950|FG000|Overall Study|Quality Assurance Reader Fail|130|||
125464036|NCT01943916|451328950|FG000|Overall Study|Technical Failure|39|||
125464037|NCT01943916|451328950|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
125464038|NCT01943916|451328950|FG000|Overall Study|No Truth Panel Review|38|||
125464039|NCT01943916|451328950|FG000|Overall Study|Protocol Deviation|1|||
125464040|NCT05782231|451328951|FG000|Overall Study|Withdrawal by Subject|1|||
125464041|NCT05274217|451328952|FG000|Overall Study|Study terminated.|11|||
125464042|NCT05274217|451328953|FG001|Overall Study|Study terminated.|0|||
125464043|NCT05609032|451328956|FG000|Overall Study|Lost to Follow-up|3|||
125464044|NCT05609032|451328957|FG001|Overall Study|Lost to Follow-up|1|||
125464045|NCT05609032|451328956|FG000|Overall Study|Withdrawal by Subject|1|||
125464046|NCT05609032|451328957|FG001|Overall Study|Withdrawal by Subject|0|||
125464047|NCT02261467|451328958|FG000|Overall Study|Enrolled in Error|1|||
125464048|NCT02261467|451328959|FG001|Overall Study|Enrolled in Error|0|||
125464049|NCT02261467|451328958|FG000|Overall Study|Protocol Violation|0|||
125464050|NCT02261467|451328959|FG001|Overall Study|Protocol Violation|1|||
125464051|NCT02261467|451328958|FG000|Overall Study|Personal Reasons|17|||
125464052|NCT02261467|451328959|FG001|Overall Study|Personal Reasons|22|||
125464053|NCT02261467|451328958|FG000|Overall Study|Lost to Follow-up|2|||
125464054|NCT02261467|451328959|FG001|Overall Study|Lost to Follow-up|13|||
125464055|NCT02261467|451328958|FG000|Overall Study|Adverse Event|1|||
125464056|NCT02261467|451328959|FG001|Overall Study|Adverse Event|1|||
125464057|NCT01373346|451328964|FG000|Overall Study|Death|1|||
125464058|NCT01395758|451328965|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
125464059|NCT01395758|451328966|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
125464060|NCT01395758|451328967|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
125464061|NCT00357097|451328968|FG000|Overall Study|Did not meet inclusion criteria|5|||
125464062|NCT00357097|451328969|FG001|Overall Study|Did not meet inclusion criteria|3|||
125464063|NCT00357097|451328968|FG000|Overall Study|Adverse Event|34|||
125464064|NCT00357097|451328969|FG001|Overall Study|Adverse Event|6|||
125464065|NCT00357097|451328968|FG000|Overall Study|Withdrawal by Subject|8|||
125464066|NCT00357097|451328969|FG001|Overall Study|Withdrawal by Subject|7|||
125464067|NCT00357097|451328968|FG000|Overall Study|Non-compliance|1|||
125464068|NCT00357097|451328969|FG001|Overall Study|Non-compliance|2|||
125464069|NCT00357097|451328968|FG000|Overall Study|Lack of Efficacy|2|||
125464070|NCT00357097|451328969|FG001|Overall Study|Lack of Efficacy|8|||
125464071|NCT00357097|451328968|FG000|Overall Study|Met Exclusion Criteria|3|||
125464072|NCT00357097|451328969|FG001|Overall Study|Met Exclusion Criteria|1|||
125464073|NCT00357097|451328968|FG000|Overall Study|Other|1|||
125464074|NCT00357097|451328969|FG001|Overall Study|Other|1|||
125464075|NCT00357097|451328968|FG000|Overall Study|Increase of RLS Symptoms|0|||
125464076|NCT00357097|451328969|FG001|Overall Study|Increase of RLS Symptoms|1|||
125464077|NCT00794118|451328970|FG000|Overall Study|Lost to Follow-up|16|||
125464078|NCT00794118|451328970|FG000|Overall Study|Withdrawal by Subject|9|||
125464079|NCT00794118|451328970|FG000|Overall Study|Changed hospital center|2|||
125464080|NCT04305405|451328971|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125464081|NCT04305405|451328972|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125464082|NCT00529659|451328973|FG000|Overall Study|Adverse Event|8|||
125464083|NCT00529659|451328974|FG001|Overall Study|Adverse Event|7|||
125464084|NCT00529659|451328973|FG000|Overall Study|Lost to Follow-up|0|||
125464085|NCT00529659|451328974|FG001|Overall Study|Lost to Follow-up|2|||
125464086|NCT00529659|451328973|FG000|Overall Study|Physician Decision|0|||
125464087|NCT00529659|451328974|FG001|Overall Study|Physician Decision|2|||
125464088|NCT00529659|451328973|FG000|Overall Study|Protocol Violation|2|||
125464089|NCT00529659|451328974|FG001|Overall Study|Protocol Violation|6|||
125464090|NCT00529659|451328973|FG000|Overall Study|Withdrawal by Subject|1|||
125464091|NCT00529659|451328974|FG001|Overall Study|Withdrawal by Subject|6|||
125464092|NCT03887650|451328975|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
125464093|NCT03887650|451328976|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
125464094|NCT03887650|451328975|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
125464095|NCT03887650|451328976|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
125464096|NCT03887650|451328975|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
125464097|NCT03887650|451328976|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
125464098|NCT03512756|451328981|FG000|Part 1|Death|23|||
125464099|NCT03512756|451328982|FG001|Part 1|Death|18|||
125464100|NCT03512756|451328983|FG002|Part 1|Death|0|||
125464101|NCT03512756|451328984|FG003|Part 1|Death|0|||
125464102|NCT03512756|451328981|FG000|Part 1|Lost to Follow-up|0|||
125464103|NCT03512756|451328982|FG001|Part 1|Lost to Follow-up|3|||
125464104|NCT03512756|451328983|FG002|Part 1|Lost to Follow-up|0|||
125464105|NCT03512756|451328984|FG003|Part 1|Lost to Follow-up|0|||
125464106|NCT03512756|451328981|FG000|Part 1|Physician Decision|0|||
125464107|NCT03512756|451328982|FG001|Part 1|Physician Decision|1|||
125464108|NCT03512756|451328983|FG002|Part 1|Physician Decision|0|||
125464109|NCT03512756|451328984|FG003|Part 1|Physician Decision|0|||
125464110|NCT03512756|451328981|FG000|Part 1|Withdrawal by Subject|2|||
125464111|NCT03512756|451328982|FG001|Part 1|Withdrawal by Subject|2|||
125464112|NCT03512756|451328983|FG002|Part 1|Withdrawal by Subject|0|||
125464113|NCT03512756|451328984|FG003|Part 1|Withdrawal by Subject|0|||
125464114|NCT03512756|451328981|FG000|Part 2|Death|0|||
125464115|NCT03512756|451328982|FG001|Part 2|Death|0|||
125464116|NCT03512756|451328983|FG002|Part 2|Death|32|||
125464117|NCT03512756|451328984|FG003|Part 2|Death|21|||
125464118|NCT03512756|451328981|FG000|Part 2|Lost to Follow-up|0|||
125464119|NCT03512756|451328982|FG001|Part 2|Lost to Follow-up|0|||
125464120|NCT03512756|451328983|FG002|Part 2|Lost to Follow-up|1|||
125464121|NCT03512756|451328984|FG003|Part 2|Lost to Follow-up|0|||
125464122|NCT03512756|451328981|FG000|Part 2|Physician Decision|0|||
125464123|NCT03512756|451328982|FG001|Part 2|Physician Decision|0|||
125464124|NCT03512756|451328983|FG002|Part 2|Physician Decision|2|||
125464125|NCT03512756|451328984|FG003|Part 2|Physician Decision|4|||
125464126|NCT03512756|451328981|FG000|Part 2|Study Terminated by Sponsor|0|||
125464127|NCT03512756|451328982|FG001|Part 2|Study Terminated by Sponsor|0|||
125464128|NCT03512756|451328983|FG002|Part 2|Study Terminated by Sponsor|2|||
125464129|NCT03512756|451328984|FG003|Part 2|Study Terminated by Sponsor|6|||
125464130|NCT03512756|451328981|FG000|Part 2|Protocol Violation|0|||
125464131|NCT03512756|451328982|FG001|Part 2|Protocol Violation|0|||
125464132|NCT03512756|451328983|FG002|Part 2|Protocol Violation|1|||
125464133|NCT03512756|451328984|FG003|Part 2|Protocol Violation|0|||
125464134|NCT03512756|451328981|FG000|Part 2|Withdrawal by Subject|0|||
125464135|NCT03512756|451328982|FG001|Part 2|Withdrawal by Subject|0|||
125464136|NCT03512756|451328983|FG002|Part 2|Withdrawal by Subject|3|||
125464137|NCT03512756|451328984|FG003|Part 2|Withdrawal by Subject|9|||
125464138|NCT00736853|451328985|FG000|Open-Label Period|Physician Decision|2|||
125464139|NCT00736853|451328986|FG001|Open-Label Period|Physician Decision|0|||
125464140|NCT00736853|451328987|FG002|Open-Label Period|Physician Decision|0|||
125464141|NCT00736853|451328985|FG000|Open-Label Period|Adverse Event|31|||
125464142|NCT00736853|451328986|FG001|Open-Label Period|Adverse Event|0|||
125464143|NCT00736853|451328987|FG002|Open-Label Period|Adverse Event|0|||
125464144|NCT00736853|451328985|FG000|Open-Label Period|Withdrawal by Subject|16|||
125464145|NCT00736853|451328986|FG001|Open-Label Period|Withdrawal by Subject|0|||
125464146|NCT00736853|451328987|FG002|Open-Label Period|Withdrawal by Subject|0|||
125464147|NCT00736853|451328985|FG000|Open-Label Period|Started but not treated|42|||
125464148|NCT00736853|451328986|FG001|Open-Label Period|Started but not treated|0|||
125464149|NCT00736853|451328987|FG002|Open-Label Period|Started but not treated|0|||
125464150|NCT00736853|451328985|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
125464151|NCT00736853|451328986|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
125464152|NCT00736853|451328987|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
125464153|NCT00736853|451328985|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
125464154|NCT00736853|451328986|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
125464155|NCT00736853|451328987|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
125464156|NCT00736853|451328985|FG000|Double-Blind Period|Lack of Efficacy|0|||
125464157|NCT00736853|451328986|FG001|Double-Blind Period|Lack of Efficacy|19|||
125464158|NCT00736853|451328987|FG002|Double-Blind Period|Lack of Efficacy|42|||
125464159|NCT00736853|451328985|FG000|Double-Blind Period|Adverse Event|0|||
125464160|NCT00736853|451328986|FG001|Double-Blind Period|Adverse Event|3|||
125464161|NCT00736853|451328987|FG002|Double-Blind Period|Adverse Event|2|||
125464162|NCT00736853|451328985|FG000|Double-Blind Period|Withdrawal by Subject|0|||
125464163|NCT00736853|451328986|FG001|Double-Blind Period|Withdrawal by Subject|1|||
125464164|NCT00736853|451328987|FG002|Double-Blind Period|Withdrawal by Subject|4|||
125464165|NCT00736853|451328985|FG000|Double-Blind Period|Ineligible to participate the study|0|||
125464166|NCT00736853|451328986|FG001|Double-Blind Period|Ineligible to participate the study|1|||
125464167|NCT00736853|451328987|FG002|Double-Blind Period|Ineligible to participate the study|0|||
125464168|NCT01199705|451328988|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
125464169|NCT03215927|451330850|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
125464170|NCT03215927|451330851|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
125464171|NCT03215927|451330850|FG000|Open Label Extension|Adverse Event|1|||
125464172|NCT03215927|451330851|FG001|Open Label Extension|Adverse Event|0|||
125464173|NCT03215927|451330850|FG000|Open Label Extension|Lack of Efficacy|1|||
125464174|NCT03215927|451330851|FG001|Open Label Extension|Lack of Efficacy|0|||
125464175|NCT03215927|451330850|FG000|Open Label Extension|Death|0|||
125464176|NCT03215927|451330851|FG001|Open Label Extension|Death|1|||
125464177|NCT03889925|451330854|FG000|Overall Study|Lost to Follow-up|11|||
125464178|NCT03889925|451330855|FG001|Overall Study|Lost to Follow-up|10|||
125464179|NCT03073941|451330856|FG000|Overall Study|Received non-study device intraoperatively|0|||
125464180|NCT03073941|451330857|FG001|Overall Study|Received non-study device intraoperatively|2|||
125464181|NCT03073941|451330856|FG000|Overall Study|Death|1|||
125464182|NCT03073941|451330857|FG001|Overall Study|Death|0|||
125464183|NCT03073941|451330856|FG000|Overall Study|Withdrawal by Subject|1|||
125464184|NCT03073941|451330857|FG001|Overall Study|Withdrawal by Subject|3|||
125464185|NCT03073941|451330856|FG000|Overall Study|Lost to Follow-up|5|||
125464186|NCT03073941|451330857|FG001|Overall Study|Lost to Follow-up|4|||
125464187|NCT03073941|451330856|FG000|Overall Study|Adverse Event|4|||
125464188|NCT03073941|451330857|FG001|Overall Study|Adverse Event|2|||
125464189|NCT03073941|451330856|FG000|Overall Study|Met an exclusion criterion|0|||
125464190|NCT03073941|451330857|FG001|Overall Study|Met an exclusion criterion|1|||
125464191|NCT04250883|451330858|FG000|Overall Study|Lost to Follow-up|1|||
125464192|NCT04250883|451330859|FG001|Overall Study|Lost to Follow-up|0|||
125464193|NCT01823536|451330860|FG000|Overall Study|Lost to Follow-up|1|||
125464194|NCT01823536|451330861|FG001|Overall Study|Lost to Follow-up|0|||
125464195|NCT01823536|451330862|FG002|Overall Study|Lost to Follow-up|0|||
125464196|NCT01823536|451330863|FG003|Overall Study|Lost to Follow-up|1|||
125464197|NCT01823536|451330864|FG004|Overall Study|Lost to Follow-up|1|||
125464198|NCT01823536|451330865|FG005|Overall Study|Lost to Follow-up|0|||
125464199|NCT01823536|451330860|FG000|Overall Study|Protocol Violation|0|||
125464200|NCT01823536|451330861|FG001|Overall Study|Protocol Violation|1|||
125464201|NCT01823536|451330862|FG002|Overall Study|Protocol Violation|0|||
125464202|NCT01823536|451330863|FG003|Overall Study|Protocol Violation|0|||
125464203|NCT01823536|451330864|FG004|Overall Study|Protocol Violation|0|||
125464204|NCT01823536|451330865|FG005|Overall Study|Protocol Violation|0|||
125464205|NCT01823536|451330860|FG000|Overall Study|Withdrawal by Subject|1|||
125295658|NCT01116427|450709479|FG000|Extension Phase|Adverse Event|1|||
125295659|NCT01116427|450709480|FG001|Extension Phase|Adverse Event|1|||
125464206|NCT01823536|451330861|FG001|Overall Study|Withdrawal by Subject|1|||
125464207|NCT01823536|451330862|FG002|Overall Study|Withdrawal by Subject|0|||
125464208|NCT01823536|451330863|FG003|Overall Study|Withdrawal by Subject|0|||
125464209|NCT01823536|451330864|FG004|Overall Study|Withdrawal by Subject|0|||
125464210|NCT01823536|451330865|FG005|Overall Study|Withdrawal by Subject|0|||
125464211|NCT01823536|451330860|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
125464212|NCT01823536|451330861|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
125464213|NCT01823536|451330862|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
125464214|NCT01823536|451330863|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
125464215|NCT01823536|451330864|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
125464216|NCT01823536|451330865|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
125464217|NCT01823536|451330860|FG000|Overall Study|Met exclusion criterion No 6|0|||
125464218|NCT01823536|451330861|FG001|Overall Study|Met exclusion criterion No 6|0|||
125464219|NCT01823536|451330862|FG002|Overall Study|Met exclusion criterion No 6|0|||
125464220|NCT01823536|451330863|FG003|Overall Study|Met exclusion criterion No 6|1|||
125464221|NCT01823536|451330864|FG004|Overall Study|Met exclusion criterion No 6|0|||
125295660|NCT01116427|450709479|FG000|Extension Phase|Lost to Follow-up|2|||
125295661|NCT01116427|450709480|FG001|Extension Phase|Lost to Follow-up|0|||
125295662|NCT01116427|450709479|FG000|Extension Phase|Withdrawal by Subject|5|||
125295663|NCT01116427|450709480|FG001|Extension Phase|Withdrawal by Subject|1|||
125464222|NCT01823536|451330865|FG005|Overall Study|Met exclusion criterion No 6|0|||
125295664|NCT01116427|450709479|FG000|Extension Phase|Not using appropriate birth control|1|||
125295665|NCT01116427|450709480|FG001|Extension Phase|Not using appropriate birth control|0|||
125295666|NCT02989805|450709481|FG000|Overall Study|invalid consent|6|||
125295667|NCT02989805|450709482|FG001|Overall Study|invalid consent|4|||
125295668|NCT02211313|450709483|FG000|Overall Study|Treatment Failure|5|||
125295669|NCT02211313|450709484|FG001|Overall Study|Treatment Failure|2|||
125295670|NCT02211313|450709483|FG000|Overall Study|No Follow up Questionnaires|1|||
125464223|NCT01823536|451330860|FG000|Overall Study|Subject moved out of the state|0|||
125464224|NCT01823536|451330861|FG001|Overall Study|Subject moved out of the state|0|||
125464225|NCT01823536|451330862|FG002|Overall Study|Subject moved out of the state|0|||
125464226|NCT01823536|451330863|FG003|Overall Study|Subject moved out of the state|0|||
125464227|NCT01823536|451330864|FG004|Overall Study|Subject moved out of the state|1|||
125464228|NCT01823536|451330865|FG005|Overall Study|Subject moved out of the state|0|||
125464229|NCT04425629|451330866|FG000|Overall Study|Adverse Event|0|||
125464230|NCT04425629|451330867|FG001|Overall Study|Adverse Event|0|||
125464231|NCT04425629|451330868|FG002|Overall Study|Adverse Event|0|||
125464232|NCT04425629|451330869|FG003|Overall Study|Adverse Event|0|||
125464233|NCT04425629|451330870|FG004|Overall Study|Adverse Event|1|||
125464234|NCT04425629|451330871|FG005|Overall Study|Adverse Event|0|||
125464235|NCT04425629|451330872|FG006|Overall Study|Adverse Event|0|||
125464236|NCT04425629|451330873|FG007|Overall Study|Adverse Event|0|||
125464237|NCT04425629|451330874|FG008|Overall Study|Adverse Event|0|||
125464238|NCT04425629|451330875|FG009|Overall Study|Adverse Event|3|||
125464239|NCT04425629|451330876|FG010|Overall Study|Adverse Event|2|||
125464240|NCT04425629|451330877|FG011|Overall Study|Adverse Event|1|||
125464241|NCT04425629|451330878|FG012|Overall Study|Adverse Event|1|||
125464242|NCT04425629|451330879|FG013|Overall Study|Adverse Event|0|||
125464243|NCT04425629|451330880|FG014|Overall Study|Adverse Event|0|||
125464244|NCT04425629|451330881|FG015|Overall Study|Adverse Event|0|||
125464245|NCT04425629|451330882|FG016|Overall Study|Adverse Event|0|||
125464246|NCT04425629|451330883|FG017|Overall Study|Adverse Event|0|||
125464247|NCT04425629|451330884|FG018|Overall Study|Adverse Event|0|||
125464248|NCT04425629|451330866|FG000|Overall Study|Lost to Follow-up|1|||
125464249|NCT04425629|451330867|FG001|Overall Study|Lost to Follow-up|3|||
125464250|NCT04425629|451330868|FG002|Overall Study|Lost to Follow-up|1|||
125464251|NCT04425629|451330869|FG003|Overall Study|Lost to Follow-up|7|||
125464252|NCT04425629|451330870|FG004|Overall Study|Lost to Follow-up|1|||
125464253|NCT04425629|451330871|FG005|Overall Study|Lost to Follow-up|2|||
125464254|NCT04425629|451330872|FG006|Overall Study|Lost to Follow-up|1|||
125464255|NCT04425629|451330873|FG007|Overall Study|Lost to Follow-up|0|||
125464256|NCT04425629|451330874|FG008|Overall Study|Lost to Follow-up|1|||
125464257|NCT04425629|451330875|FG009|Overall Study|Lost to Follow-up|64|||
125464258|NCT04425629|451330876|FG010|Overall Study|Lost to Follow-up|70|||
125464259|NCT04425629|451330877|FG011|Overall Study|Lost to Follow-up|98|||
125464260|NCT04425629|451330878|FG012|Overall Study|Lost to Follow-up|30|||
125464261|NCT04425629|451330879|FG013|Overall Study|Lost to Follow-up|0|||
125464262|NCT04425629|451330880|FG014|Overall Study|Lost to Follow-up|5|||
125464263|NCT04425629|451330881|FG015|Overall Study|Lost to Follow-up|4|||
125464264|NCT04425629|451330882|FG016|Overall Study|Lost to Follow-up|0|||
125464265|NCT04425629|451330883|FG017|Overall Study|Lost to Follow-up|3|||
125464266|NCT04425629|451330884|FG018|Overall Study|Lost to Follow-up|1|||
125464267|NCT04425629|451330866|FG000|Overall Study|Subject Decision|0|||
125464268|NCT04425629|451330867|FG001|Overall Study|Subject Decision|2|||
125464269|NCT04425629|451330868|FG002|Overall Study|Subject Decision|1|||
125464270|NCT04425629|451330869|FG003|Overall Study|Subject Decision|3|||
125464271|NCT04425629|451330870|FG004|Overall Study|Subject Decision|6|||
125464272|NCT04425629|451330871|FG005|Overall Study|Subject Decision|6|||
125464273|NCT04425629|451330872|FG006|Overall Study|Subject Decision|3|||
125464274|NCT04425629|451330873|FG007|Overall Study|Subject Decision|3|||
125464275|NCT04425629|451330874|FG008|Overall Study|Subject Decision|1|||
125464276|NCT04425629|451330875|FG009|Overall Study|Subject Decision|70|||
125464277|NCT04425629|451330876|FG010|Overall Study|Subject Decision|95|||
125464278|NCT04425629|451330877|FG011|Overall Study|Subject Decision|124|||
125464279|NCT04425629|451330878|FG012|Overall Study|Subject Decision|25|||
125464280|NCT04425629|451330879|FG013|Overall Study|Subject Decision|0|||
125464281|NCT04425629|451330880|FG014|Overall Study|Subject Decision|1|||
125464282|NCT04425629|451330881|FG015|Overall Study|Subject Decision|4|||
125464283|NCT04425629|451330882|FG016|Overall Study|Subject Decision|1|||
125464284|NCT04425629|451330883|FG017|Overall Study|Subject Decision|0|||
125464285|NCT04425629|451330884|FG018|Overall Study|Subject Decision|2|||
125464286|NCT04425629|451330866|FG000|Overall Study|Death|0|||
125464287|NCT04425629|451330867|FG001|Overall Study|Death|0|||
125464288|NCT04425629|451330868|FG002|Overall Study|Death|0|||
125464289|NCT04425629|451330869|FG003|Overall Study|Death|0|||
125464290|NCT04425629|451330870|FG004|Overall Study|Death|0|||
125464291|NCT04425629|451330871|FG005|Overall Study|Death|0|||
125464292|NCT04425629|451330872|FG006|Overall Study|Death|0|||
125464293|NCT04425629|451330873|FG007|Overall Study|Death|0|||
125464294|NCT04425629|451330874|FG008|Overall Study|Death|0|||
125464295|NCT04425629|451330875|FG009|Overall Study|Death|11|||
125464296|NCT04425629|451330876|FG010|Overall Study|Death|2|||
125464297|NCT04425629|451330877|FG011|Overall Study|Death|4|||
125464298|NCT04425629|451330878|FG012|Overall Study|Death|0|||
125464299|NCT04425629|451330879|FG013|Overall Study|Death|0|||
125464300|NCT04425629|451330880|FG014|Overall Study|Death|0|||
125464301|NCT04425629|451330881|FG015|Overall Study|Death|0|||
125464302|NCT04425629|451330882|FG016|Overall Study|Death|0|||
125464303|NCT04425629|451330883|FG017|Overall Study|Death|0|||
125464304|NCT04425629|451330884|FG018|Overall Study|Death|0|||
125295671|NCT02211313|450709484|FG001|Overall Study|No Follow up Questionnaires|1|||
125295672|NCT02648217|450709487|FG000|Overall Study|Adverse Event|0|||
125295673|NCT02648217|450709488|FG001|Overall Study|Adverse Event|1|||
125295674|NCT02648217|450709487|FG000|Overall Study|Lost to Follow-up|1|||
125295675|NCT02648217|450709488|FG001|Overall Study|Lost to Follow-up|1|||
125295676|NCT02648217|450709487|FG000|Overall Study|Withdrawal by Subject|4|||
125295677|NCT02648217|450709488|FG001|Overall Study|Withdrawal by Subject|3|||
125464305|NCT04425629|451330866|FG000|Overall Study|Sponsor Request|0|||
125464306|NCT04425629|451330867|FG001|Overall Study|Sponsor Request|0|||
125464307|NCT04425629|451330868|FG002|Overall Study|Sponsor Request|0|||
125464308|NCT04425629|451330869|FG003|Overall Study|Sponsor Request|2|||
125464309|NCT04425629|451330870|FG004|Overall Study|Sponsor Request|2|||
125295678|NCT02648217|450709487|FG000|Overall Study|Unclassified|5|||
125295679|NCT02648217|450709488|FG001|Overall Study|Unclassified|0|||
125295680|NCT03316950|450709489|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
125295681|NCT03316950|450709490|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
125295682|NCT03316950|450709491|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
125295683|NCT03316950|450709492|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
125295684|NCT03316950|450709489|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
125295685|NCT03316950|450709490|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
125295686|NCT03316950|450709491|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
125295687|NCT03316950|450709492|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
125295688|NCT03316950|450709489|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
125295689|NCT03316950|450709490|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
125295690|NCT03316950|450709491|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
125295691|NCT03316950|450709492|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
125295692|NCT02392403|450709493|FG000|Overall Study|Adverse Event|1|||
125295693|NCT02392403|450709493|FG000|Overall Study|Death|1|||
125295694|NCT02392403|450709493|FG000|Overall Study|Withdrawal by Subject|1|||
125295695|NCT02335424|450709497|FG000|Overall Study|Withdrawal by Subject|19|||
125295696|NCT02335424|450709497|FG000|Overall Study|Adverse Event|25|||
125295697|NCT02335424|450709497|FG000|Overall Study|Death|273|||
125295698|NCT02335424|450709497|FG000|Overall Study|Lost to Follow-up|3|||
125295699|NCT02335424|450709497|FG000|Overall Study|Physician Decision|13|||
125295700|NCT02335424|450709497|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
125295701|NCT02335424|450709497|FG000|Overall Study|Protocol Violation|1|||
125464310|NCT04425629|451330871|FG005|Overall Study|Sponsor Request|2|||
125464311|NCT04425629|451330872|FG006|Overall Study|Sponsor Request|1|||
125464312|NCT04425629|451330873|FG007|Overall Study|Sponsor Request|0|||
125464313|NCT04425629|451330874|FG008|Overall Study|Sponsor Request|0|||
125464314|NCT04425629|451330875|FG009|Overall Study|Sponsor Request|9|||
125464315|NCT04425629|451330876|FG010|Overall Study|Sponsor Request|9|||
125464316|NCT04425629|451330877|FG011|Overall Study|Sponsor Request|10|||
125464317|NCT04425629|451330878|FG012|Overall Study|Sponsor Request|8|||
125464318|NCT04425629|451330879|FG013|Overall Study|Sponsor Request|0|||
125464319|NCT04425629|451330880|FG014|Overall Study|Sponsor Request|0|||
125464320|NCT04425629|451330881|FG015|Overall Study|Sponsor Request|1|||
125464321|NCT04425629|451330882|FG016|Overall Study|Sponsor Request|0|||
125464322|NCT04425629|451330883|FG017|Overall Study|Sponsor Request|0|||
125464323|NCT04425629|451330884|FG018|Overall Study|Sponsor Request|0|||
125464324|NCT04425629|451330866|FG000|Overall Study|Physician Decision|0|||
125464325|NCT04425629|451330867|FG001|Overall Study|Physician Decision|0|||
125464326|NCT04425629|451330868|FG002|Overall Study|Physician Decision|0|||
125464327|NCT04425629|451330869|FG003|Overall Study|Physician Decision|0|||
125464328|NCT04425629|451330870|FG004|Overall Study|Physician Decision|0|||
125464329|NCT04425629|451330871|FG005|Overall Study|Physician Decision|0|||
125295702|NCT02335424|450709497|FG000|Overall Study|Screen failure|1|||
125295703|NCT02776033|450709500|FG000|Overall Study|Withdrawal by Subject|0|||
125295704|NCT02776033|450709501|FG001|Overall Study|Withdrawal by Subject|0|||
125295705|NCT02776033|450709502|FG002|Overall Study|Withdrawal by Subject|2|||
125295706|NCT02776033|450709500|FG000|Overall Study|Physician Decision|2|||
125295707|NCT02776033|450709501|FG001|Overall Study|Physician Decision|0|||
125295708|NCT02776033|450709502|FG002|Overall Study|Physician Decision|0|||
125295709|NCT02776033|450709500|FG000|Overall Study|Lost to Follow-up|1|||
125295710|NCT02776033|450709501|FG001|Overall Study|Lost to Follow-up|0|||
125295711|NCT02776033|450709502|FG002|Overall Study|Lost to Follow-up|0|||
125295712|NCT02776033|450709500|FG000|Overall Study|Adverse Event|1|||
125295713|NCT02776033|450709501|FG001|Overall Study|Adverse Event|2|||
125295714|NCT02776033|450709502|FG002|Overall Study|Adverse Event|0|||
125295715|NCT00657371|450709503|FG000|Overall Study|Poor bowel preparation|15|||
125464330|NCT04425629|451330872|FG006|Overall Study|Physician Decision|0|||
125464331|NCT04425629|451330873|FG007|Overall Study|Physician Decision|0|||
125464332|NCT04425629|451330874|FG008|Overall Study|Physician Decision|0|||
125464333|NCT04425629|451330875|FG009|Overall Study|Physician Decision|4|||
125464334|NCT04425629|451330876|FG010|Overall Study|Physician Decision|3|||
125464335|NCT04425629|451330877|FG011|Overall Study|Physician Decision|5|||
125464336|NCT04425629|451330878|FG012|Overall Study|Physician Decision|1|||
125295716|NCT00657371|450709503|FG000|Overall Study|Unable to intubate the cecum|5|||
125295717|NCT00657371|450709503|FG000|Overall Study|Protocol Violation|2|||
125295718|NCT00657371|450709503|FG000|Overall Study|Device- related reasons|13|||
125464337|NCT04425629|451330879|FG013|Overall Study|Physician Decision|0|||
125464338|NCT04425629|451330880|FG014|Overall Study|Physician Decision|0|||
125464339|NCT04425629|451330881|FG015|Overall Study|Physician Decision|1|||
125464340|NCT04425629|451330882|FG016|Overall Study|Physician Decision|0|||
125464341|NCT04425629|451330883|FG017|Overall Study|Physician Decision|0|||
125464342|NCT04425629|451330884|FG018|Overall Study|Physician Decision|0|||
125464343|NCT04425629|451330866|FG000|Overall Study|Lack of Efficacy|0|||
125464344|NCT04425629|451330867|FG001|Overall Study|Lack of Efficacy|0|||
125464345|NCT04425629|451330868|FG002|Overall Study|Lack of Efficacy|0|||
125464346|NCT04425629|451330869|FG003|Overall Study|Lack of Efficacy|0|||
125464347|NCT04425629|451330870|FG004|Overall Study|Lack of Efficacy|0|||
125464348|NCT04425629|451330871|FG005|Overall Study|Lack of Efficacy|0|||
125464349|NCT04425629|451330872|FG006|Overall Study|Lack of Efficacy|0|||
125464350|NCT04425629|451330873|FG007|Overall Study|Lack of Efficacy|0|||
125464351|NCT04425629|451330874|FG008|Overall Study|Lack of Efficacy|0|||
125464352|NCT04425629|451330875|FG009|Overall Study|Lack of Efficacy|0|||
125464353|NCT04425629|451330876|FG010|Overall Study|Lack of Efficacy|1|||
125464354|NCT04425629|451330877|FG011|Overall Study|Lack of Efficacy|0|||
125464355|NCT04425629|451330878|FG012|Overall Study|Lack of Efficacy|0|||
125464356|NCT04425629|451330879|FG013|Overall Study|Lack of Efficacy|0|||
125464357|NCT04425629|451330880|FG014|Overall Study|Lack of Efficacy|0|||
125464358|NCT04425629|451330881|FG015|Overall Study|Lack of Efficacy|0|||
125464359|NCT04425629|451330882|FG016|Overall Study|Lack of Efficacy|0|||
125464360|NCT04425629|451330883|FG017|Overall Study|Lack of Efficacy|0|||
125464361|NCT04425629|451330884|FG018|Overall Study|Lack of Efficacy|0|||
125464362|NCT04218110|451330885|FG000|Overall Study|Withdrawal by Subject|0|||
125464363|NCT04218110|451330886|FG001|Overall Study|Withdrawal by Subject|0|||
125464364|NCT04218110|451330887|FG002|Overall Study|Withdrawal by Subject|0|||
125464365|NCT04218110|451330888|FG003|Overall Study|Withdrawal by Subject|1|||
125464366|NCT02271854|451330889|FG000|Overall Study|Withdrawal by Subject|2|||
125464367|NCT02271854|451330889|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
125464368|NCT02271854|451330889|FG000|Overall Study|Lost to Follow-up|1|||
125464369|NCT00446459|451330891|FG000|8 Months|Protocol Violation|12|||
125464370|NCT00446459|451330891|FG000|12 Months|Protocol Violation|4|||
125464371|NCT00446459|451330891|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
125464372|NCT02918279|451330892|FG000|Overall Study|Lost to Follow-up|3|||
125464373|NCT02918279|451330893|FG001|Overall Study|Lost to Follow-up|6|||
125464374|NCT02918279|451330892|FG000|Overall Study|Withdrawal by Subject|5|||
125464375|NCT02918279|451330893|FG001|Overall Study|Withdrawal by Subject|15|||
125464376|NCT02918279|451330892|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125464377|NCT02918279|451330893|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125464378|NCT02918279|451330892|FG000|Overall Study|Other|3|||
125464379|NCT02918279|451330893|FG001|Overall Study|Other|1|||
125464380|NCT00309907|451330894|FG000|Overall Study|Death|4|||
125464381|NCT00309907|451330894|FG000|Overall Study|Physician Decision|1|||
125464382|NCT00309907|451330894|FG000|Overall Study|Ineligible|11|||
125464383|NCT00309907|451330894|FG000|Overall Study|Major infectious event|4|||
125464384|NCT00244855|451330895|FG000|Overall Study|Withdrawal by Subject|0|||
125464385|NCT00244855|451330896|FG001|Overall Study|Withdrawal by Subject|1|||
125464386|NCT01641198|451330897|FG000|After 12 Months of Function|Lost to Follow-up|3|||
125464387|NCT01641198|451330898|FG001|After 12 Months of Function|Lost to Follow-up|2|||
125464388|NCT01641198|451330899|FG002|After 12 Months of Function|Lost to Follow-up|2|||
125464389|NCT01641198|451330897|FG000|After 12 Months of Function|Protocol Violation|1|||
125464390|NCT01641198|451330898|FG001|After 12 Months of Function|Protocol Violation|0|||
125464391|NCT01641198|451330899|FG002|After 12 Months of Function|Protocol Violation|0|||
125464392|NCT01641198|451330897|FG000|After 12 Months of Function|Adverse Event|0|||
125464393|NCT01641198|451330898|FG001|After 12 Months of Function|Adverse Event|1|||
125464394|NCT01641198|451330899|FG002|After 12 Months of Function|Adverse Event|0|||
125464395|NCT01641198|451330897|FG000|After 24 Months of Function|Lost to Follow-up|4|||
125464396|NCT01641198|451330898|FG001|After 24 Months of Function|Lost to Follow-up|9|||
125464397|NCT01641198|451330899|FG002|After 24 Months of Function|Lost to Follow-up|6|||
125464398|NCT01641198|451330897|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
125464399|NCT01641198|451330898|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
125464400|NCT01641198|451330899|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
125464401|NCT01641198|451330897|FG000|At 15-20 Years of Function|Death|1|||
125464402|NCT01641198|451330898|FG001|At 15-20 Years of Function|Death|0|||
125464403|NCT01641198|451330899|FG002|At 15-20 Years of Function|Death|1|||
125464404|NCT01236001|451330901|FG000|Overall Study|Adverse Event|5|||
125464405|NCT01236001|451330902|FG001|Overall Study|Adverse Event|14|||
125464406|NCT01236001|451330901|FG000|Overall Study|Lack of Efficacy|6|||
125464407|NCT01236001|451330902|FG001|Overall Study|Lack of Efficacy|6|||
125464408|NCT01236001|451330901|FG000|Overall Study|Lost to Follow-up|6|||
125464409|NCT01236001|451330902|FG001|Overall Study|Lost to Follow-up|1|||
125464410|NCT01236001|451330901|FG000|Overall Study|Incompliance|1|||
125464411|NCT01236001|451330902|FG001|Overall Study|Incompliance|0|||
125464412|NCT01236001|451330901|FG000|Overall Study|Planned Visit After End of Study|0|||
125464413|NCT01236001|451330902|FG001|Overall Study|Planned Visit After End of Study|1|||
125464414|NCT02528188|451330905|FG000|Overall Study|Adverse Event|23|||
125464415|NCT02528188|451330906|FG001|Overall Study|Adverse Event|22|||
125464416|NCT02528188|451330907|FG002|Overall Study|Adverse Event|8|||
125464417|NCT02528188|451330905|FG000|Overall Study|Protocol Violation|4|||
125464418|NCT02528188|451330906|FG001|Overall Study|Protocol Violation|6|||
125464419|NCT02528188|451330907|FG002|Overall Study|Protocol Violation|4|||
125464420|NCT02528188|451330905|FG000|Overall Study|Lack of Efficacy|19|||
125464421|NCT02528188|451330906|FG001|Overall Study|Lack of Efficacy|21|||
125464422|NCT02528188|451330907|FG002|Overall Study|Lack of Efficacy|22|||
125464423|NCT02528188|451330905|FG000|Overall Study|Withdrawal by Subject|97|||
125464424|NCT02528188|451330906|FG001|Overall Study|Withdrawal by Subject|104|||
125464425|NCT02528188|451330907|FG002|Overall Study|Withdrawal by Subject|100|||
125464426|NCT02528188|451330905|FG000|Overall Study|Lost to Follow-up|25|||
125464427|NCT02528188|451330906|FG001|Overall Study|Lost to Follow-up|21|||
125464428|NCT02528188|451330907|FG002|Overall Study|Lost to Follow-up|31|||
125464429|NCT02528188|451330905|FG000|Overall Study|Death|4|||
125464430|NCT02528188|451330906|FG001|Overall Study|Death|4|||
125464431|NCT02528188|451330907|FG002|Overall Study|Death|0|||
125464432|NCT02528188|451330905|FG000|Overall Study|Other|89|||
125464433|NCT02528188|451330906|FG001|Overall Study|Other|91|||
125464434|NCT02528188|451330907|FG002|Overall Study|Other|74|||
125464435|NCT02528188|451330905|FG000|Overall Study|Randomized but not treated|6|||
125464436|NCT02528188|451330906|FG001|Overall Study|Randomized but not treated|7|||
125464437|NCT02528188|451330907|FG002|Overall Study|Randomized but not treated|12|||
125464438|NCT01692730|451330913|FG000|Overall Study|Lost to Follow-up|225|||
125464439|NCT01692730|451330914|FG001|Overall Study|Lost to Follow-up|227|||
125464440|NCT00933400|451330915|FG000|Overall Study|Withdrawal by Subject|21|||
125464441|NCT00933400|451330916|FG001|Overall Study|Withdrawal by Subject|1|||
125464442|NCT01041417|451330919|FG000|Overall Study|Adverse Event|5|||
125464443|NCT01041417|451330920|FG001|Overall Study|Adverse Event|2|||
125464444|NCT01041417|451330919|FG000|Overall Study|Lost to Follow-up|1|||
125464445|NCT01041417|451330920|FG001|Overall Study|Lost to Follow-up|1|||
125464446|NCT01041417|451330919|FG000|Overall Study|Death|1|||
125464447|NCT01041417|451330920|FG001|Overall Study|Death|0|||
125464448|NCT02299375|451330921|FG000|Overall Study|Adverse Event, serious fatal|1|||
125464449|NCT02299375|451330922|FG001|Overall Study|Adverse Event, serious fatal|3|||
125464450|NCT02299375|451330921|FG000|Overall Study|Adverse Event, non-fatal|8|||
125464451|NCT02299375|451330922|FG001|Overall Study|Adverse Event, non-fatal|9|||
125464452|NCT02299375|451330921|FG000|Overall Study|Lack of Efficacy|1|||
125464453|NCT02299375|451330922|FG001|Overall Study|Lack of Efficacy|3|||
125464454|NCT02299375|451330921|FG000|Overall Study|Protocol Violation|1|||
125295719|NCT00657371|450709503|FG000|Overall Study|Pre-existing medical condition|4|||
125295720|NCT02712424|450709504|FG000|Overall Study|Lost to Follow-up|34|||
125295721|NCT02712424|450709505|FG001|Overall Study|Lost to Follow-up|32|||
125295722|NCT02713867|450709511|FG000|Randomization|Other Reason|2|||
125295723|NCT02713867|450709512|FG001|Randomization|Other Reason|1|||
125295724|NCT02713867|450709511|FG000|Randomization|Participant Withdrew consent|0|||
125295725|NCT02713867|450709512|FG001|Randomization|Participant Withdrew consent|2|||
125295726|NCT02713867|450709511|FG000|Treatment Period|Other Reasons|22|||
125295727|NCT02713867|450709512|FG001|Treatment Period|Other Reasons|28|||
125295728|NCT02713867|450709511|FG000|Treatment Period|Administrative reason by sponsor|21|||
125295729|NCT02713867|450709512|FG001|Treatment Period|Administrative reason by sponsor|16|||
125295730|NCT02713867|450709511|FG000|Treatment Period|No longer meets study criteria|2|||
125295731|NCT02713867|450709512|FG001|Treatment Period|No longer meets study criteria|1|||
125295732|NCT02713867|450709511|FG000|Treatment Period|Poor/Non Compliance|1|||
125295733|NCT02713867|450709512|FG001|Treatment Period|Poor/Non Compliance|0|||
125295734|NCT02713867|450709511|FG000|Treatment Period|Maximum Clinical Benefit|5|||
125295735|NCT02713867|450709512|FG001|Treatment Period|Maximum Clinical Benefit|6|||
125295736|NCT02713867|450709511|FG000|Treatment Period|Withdrew consent|3|||
125295737|NCT02713867|450709512|FG001|Treatment Period|Withdrew consent|6|||
125295738|NCT02713867|450709511|FG000|Treatment Period|Requested to Discontinue|8|||
125295739|NCT02713867|450709512|FG001|Treatment Period|Requested to Discontinue|8|||
125295740|NCT02713867|450709511|FG000|Treatment Period|AE unrelated to Study Drug|11|||
125295741|NCT02713867|450709512|FG001|Treatment Period|AE unrelated to Study Drug|10|||
125295742|NCT02713867|450709511|FG000|Treatment Period|Death|7|||
125295743|NCT02713867|450709512|FG001|Treatment Period|Death|3|||
125295744|NCT02713867|450709511|FG000|Treatment Period|Study Drug Toxicity|16|||
125295745|NCT02713867|450709512|FG001|Treatment Period|Study Drug Toxicity|19|||
125295746|NCT02713867|450709511|FG000|Treatment Period|Disease Progression|82|||
125295747|NCT02713867|450709512|FG001|Treatment Period|Disease Progression|83|||
125464455|NCT02299375|451330922|FG001|Overall Study|Protocol Violation|3|||
125464456|NCT02299375|451330921|FG000|Overall Study|Other: Met stopping criteria|1|||
125464457|NCT02299375|451330922|FG001|Overall Study|Other: Met stopping criteria|0|||
125464458|NCT02299375|451330921|FG000|Overall Study|Other: Study closed/terminated|66|||
125464459|NCT02299375|451330922|FG001|Overall Study|Other: Study closed/terminated|55|||
125464460|NCT02299375|451330921|FG000|Overall Study|Lost to Follow-up|0|||
125464461|NCT02299375|451330922|FG001|Overall Study|Lost to Follow-up|2|||
125464462|NCT02299375|451330921|FG000|Overall Study|Physician Decision|1|||
125464463|NCT02299375|451330922|FG001|Overall Study|Physician Decision|1|||
125464464|NCT02299375|451330921|FG000|Overall Study|Withdrawal by Subject|1|||
125464465|NCT02299375|451330922|FG001|Overall Study|Withdrawal by Subject|4|||
125464466|NCT00704184|451330923|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
125464467|NCT00704184|451330924|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
125464468|NCT00704184|451330925|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
125464469|NCT00704184|451330926|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
125464470|NCT00704184|451330927|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
125464471|NCT00704184|451330923|FG000|Open-Label Treatment|Adverse Event|0|||
125464472|NCT00704184|451330924|FG001|Open-Label Treatment|Adverse Event|0|||
125464473|NCT00704184|451330925|FG002|Open-Label Treatment|Adverse Event|2|||
125295748|NCT02715726|450709516|FG000|Overall Study|Adverse Event|2|||
125295749|NCT02715726|450709517|FG001|Overall Study|Adverse Event|6|||
125295750|NCT02715726|450709516|FG000|Overall Study|Protocol Violation|1|||
125295751|NCT02715726|450709517|FG001|Overall Study|Protocol Violation|0|||
125295752|NCT02715726|450709516|FG000|Overall Study|Death|2|||
125295753|NCT02715726|450709517|FG001|Overall Study|Death|1|||
125295754|NCT02715726|450709516|FG000|Overall Study|Participant moved|1|||
125295755|NCT02715726|450709517|FG001|Overall Study|Participant moved|3|||
125295756|NCT02715726|450709516|FG000|Overall Study|Other than specified above|11|||
125295757|NCT02715726|450709517|FG001|Overall Study|Other than specified above|15|||
125295758|NCT02715726|450709516|FG000|Overall Study|Randomized but not treated|1|||
125295759|NCT02715726|450709517|FG001|Overall Study|Randomized but not treated|2|||
125295760|NCT02445573|450709518|FG000|Overall Study|Withdrawal by Subject|1|||
125295761|NCT02445573|450709519|FG001|Overall Study|Withdrawal by Subject|1|||
125464474|NCT00704184|451330926|FG003|Open-Label Treatment|Adverse Event|0|||
125464475|NCT00704184|451330927|FG004|Open-Label Treatment|Adverse Event|1|||
125464476|NCT00704184|451330923|FG000|Open-Label Treatment|Lack of Efficacy|0|||
125464477|NCT00704184|451330924|FG001|Open-Label Treatment|Lack of Efficacy|2|||
125464478|NCT00704184|451330925|FG002|Open-Label Treatment|Lack of Efficacy|2|||
125464479|NCT00704184|451330926|FG003|Open-Label Treatment|Lack of Efficacy|2|||
125464480|NCT00704184|451330927|FG004|Open-Label Treatment|Lack of Efficacy|1|||
125464481|NCT00704184|451330923|FG000|Open-Label Treatment|Physician Decision|0|||
125464482|NCT00704184|451330924|FG001|Open-Label Treatment|Physician Decision|0|||
125464483|NCT00704184|451330925|FG002|Open-Label Treatment|Physician Decision|0|||
125464484|NCT00704184|451330926|FG003|Open-Label Treatment|Physician Decision|0|||
125464485|NCT00704184|451330927|FG004|Open-Label Treatment|Physician Decision|1|||
125464486|NCT00704184|451330923|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
125464487|NCT00704184|451330924|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
125464488|NCT00704184|451330925|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
125464489|NCT00704184|451330926|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
125464490|NCT00704184|451330927|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
125464491|NCT01764464|451330928|FG000|First Intervention|Withdrawal by Subject|1|||
125464492|NCT01764464|451330929|FG001|First Intervention|Withdrawal by Subject|0|||
125464493|NCT01764464|451330928|FG000|First Intervention|Lost to Follow-up|1|||
125464494|NCT01764464|451330929|FG001|First Intervention|Lost to Follow-up|0|||
125464495|NCT01764464|451330928|FG000|First Intervention|Adverse Event|0|||
125464496|NCT01764464|451330929|FG001|First Intervention|Adverse Event|2|||
125464497|NCT01764464|451330928|FG000|First Intervention|did not receive study drug|0|||
125464498|NCT01764464|451330929|FG001|First Intervention|did not receive study drug|1|||
125464499|NCT01764464|451330928|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
125464500|NCT01764464|451330929|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
125464501|NCT03473340|451330939|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
125464502|NCT03473340|451330940|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
125464503|NCT03473340|451330939|FG000|Overall Study|Withdrawal by Subject|1|||
125464504|NCT03473340|451330940|FG001|Overall Study|Withdrawal by Subject|0|||
125464505|NCT03473340|451330939|FG000|Overall Study|Lost to Follow-up|1|||
125464506|NCT03473340|451330940|FG001|Overall Study|Lost to Follow-up|2|||
125464507|NCT03394885|451330942|FG000|Overall Study|Adverse Event|4|||
125464508|NCT03394885|451330942|FG000|Overall Study|Lack of Efficacy|1|||
125464509|NCT03394885|451330942|FG000|Overall Study|Physician Decision|1|||
125295762|NCT02445573|450709518|FG000|Overall Study|Lost to Follow-up|0|||
125295763|NCT02445573|450709519|FG001|Overall Study|Lost to Follow-up|1|||
125295764|NCT03230292|450709520|FG000|Overall Study|Adverse Event|1|||
125295765|NCT03230292|450709520|FG000|Overall Study|Protocol Violation|1|||
125295766|NCT03230292|450709520|FG000|Overall Study|Lost to Follow-up|1|||
125295767|NCT03230292|450709520|FG000|Overall Study|Withdrawal by Subject|3|||
125295768|NCT01639755|450709521|FG000|Overall Study|Study Ongoing|15|||
125295769|NCT01639755|450709521|FG000|Overall Study|Patient had device explantation|4|||
125464510|NCT03394885|451330942|FG000|Overall Study|Withdrawal by Subject|8|||
125464511|NCT03394885|451330942|FG000|Overall Study|Alternative Therapy|1|||
125464512|NCT01212991|451330946|FG000|Double-blind|Lost to Follow-up|8|||
125464513|NCT01212991|451330947|FG001|Double-blind|Lost to Follow-up|4|||
125464514|NCT01212991|451330948|FG002|Double-blind|Lost to Follow-up|0|||
125464515|NCT01212991|451330946|FG000|Double-blind|Death|699|||
125464516|NCT01212991|451330947|FG001|Double-blind|Death|550|||
125464517|NCT01212991|451330948|FG002|Double-blind|Death|0|||
125464518|NCT01212991|451330946|FG000|Double-blind|Withdrawal by Subject|16|||
125464519|NCT01212991|451330947|FG001|Double-blind|Withdrawal by Subject|19|||
125464520|NCT01212991|451330948|FG002|Double-blind|Withdrawal by Subject|0|||
125464521|NCT01212991|451330946|FG000|Double-blind|Other|7|||
125464522|NCT01212991|451330947|FG001|Double-blind|Other|0|||
125464523|NCT01212991|451330948|FG002|Double-blind|Other|0|||
125464524|NCT01212991|451330946|FG000|Double-blind|Sponsor decision|142|||
125464525|NCT01212991|451330947|FG001|Double-blind|Sponsor decision|38|||
125464526|NCT01212991|451330948|FG002|Double-blind|Sponsor decision|0|||
125464527|NCT01212991|451330946|FG000|Open-label|Death|0|||
125464528|NCT01212991|451330947|FG001|Open-label|Death|0|||
125464529|NCT01212991|451330948|FG002|Open-label|Death|166|||
125464530|NCT01212991|451330946|FG000|Open-label|Lost to Follow-up|0|||
125464531|NCT01212991|451330947|FG001|Open-label|Lost to Follow-up|0|||
125464532|NCT01212991|451330948|FG002|Open-label|Lost to Follow-up|5|||
125464533|NCT01212991|451330946|FG000|Open-label|Withdrawal by Subject|0|||
125464534|NCT01212991|451330947|FG001|Open-label|Withdrawal by Subject|0|||
125464535|NCT01212991|451330948|FG002|Open-label|Withdrawal by Subject|7|||
125464536|NCT01212991|451330946|FG000|Open-label|Sponsor decision|0|||
125464537|NCT01212991|451330947|FG001|Open-label|Sponsor decision|0|||
125464538|NCT01212991|451330948|FG002|Open-label|Sponsor decision|53|||
125464539|NCT01212991|451330946|FG000|Open-label|Other|0|||
125464540|NCT01212991|451330947|FG001|Open-label|Other|0|||
125464541|NCT01212991|451330948|FG002|Open-label|Other|3|||
125464542|NCT00801983|451330955|FG000|Period 1|Lost to Follow-up|2|||
125464543|NCT00801983|451330956|FG001|Period 1|Lost to Follow-up|0|||
125464544|NCT00801983|451330955|FG000|Period 1|Withdrawal by Subject|2|||
125464545|NCT00801983|451330956|FG001|Period 1|Withdrawal by Subject|8|||
125464546|NCT00801983|451330955|FG000|Period 2|Withdrawal by Subject|2|||
125464547|NCT00801983|451330956|FG001|Period 2|Withdrawal by Subject|1|||
125464548|NCT01251354|451330959|FG000|Overall Study|Adverse Event|1|||
125464549|NCT01251354|451330959|FG000|Overall Study|Investigator's Decision|1|||
125464550|NCT01251354|451330959|FG000|Overall Study|Disease Progression|4|||
125464551|NCT03807778|451330965|FG000|Overall Study|Adverse Event|0|||
125464552|NCT03807778|451330966|FG001|Overall Study|Adverse Event|0|||
125464553|NCT03807778|451330967|FG002|Overall Study|Adverse Event|3|||
125464554|NCT03807778|451330968|FG003|Overall Study|Adverse Event|5|||
125464555|NCT03807778|451330965|FG000|Overall Study|Progressive Disease|4|||
125464556|NCT03807778|451330966|FG001|Overall Study|Progressive Disease|2|||
125464557|NCT03807778|451330967|FG002|Overall Study|Progressive Disease|8|||
125464558|NCT03807778|451330968|FG003|Overall Study|Progressive Disease|15|||
125464559|NCT03807778|451330965|FG000|Overall Study|Symptomatic Deterioration|0|||
125464560|NCT03807778|451330966|FG001|Overall Study|Symptomatic Deterioration|1|||
125464561|NCT03807778|451330967|FG002|Overall Study|Symptomatic Deterioration|0|||
125464562|NCT03807778|451330968|FG003|Overall Study|Symptomatic Deterioration|1|||
125464563|NCT03807778|451330965|FG000|Overall Study|Withdrawal by Subject|0|||
125464564|NCT03807778|451330966|FG001|Overall Study|Withdrawal by Subject|1|||
125464565|NCT03807778|451330967|FG002|Overall Study|Withdrawal by Subject|0|||
125464566|NCT03807778|451330968|FG003|Overall Study|Withdrawal by Subject|1|||
125464567|NCT03807778|451330965|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
125464568|NCT03807778|451330966|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
125464569|NCT03807778|451330967|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
125464570|NCT03807778|451330968|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
125464571|NCT05135000|451330969|FG000|Overall Study|Adverse Event|2|||
125464572|NCT05135000|451330970|FG001|Overall Study|Adverse Event|0|||
125464573|NCT05135000|451330969|FG000|Overall Study|Lost to Follow-up|1|||
125464574|NCT05135000|451330970|FG001|Overall Study|Lost to Follow-up|0|||
125464575|NCT05135000|451330969|FG000|Overall Study|Study Terminated by Sponsor|6|||
125464576|NCT05135000|451330970|FG001|Overall Study|Study Terminated by Sponsor|3|||
125464577|NCT05094141|451330978|FG000|Overall Study|Death|0|||
125464578|NCT05094141|451330979|FG001|Overall Study|Death|0|||
125464579|NCT05094141|451330980|FG002|Overall Study|Death|1|||
125464580|NCT05094141|451330978|FG000|Overall Study|Withdrawal by Subject|0|||
125464581|NCT05094141|451330979|FG001|Overall Study|Withdrawal by Subject|0|||
125464582|NCT05094141|451330980|FG002|Overall Study|Withdrawal by Subject|1|||
125295770|NCT03995355|450709527|FG000|Overall Study|Adverse Event|1|||
125464583|NCT05094141|451330978|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
125464584|NCT05094141|451330979|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
125464585|NCT05094141|451330980|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
125464586|NCT05094141|451330978|FG000|Overall Study|Did not participate in randomization|0|||
125464587|NCT05094141|451330979|FG001|Overall Study|Did not participate in randomization|0|||
125464588|NCT05094141|451330980|FG002|Overall Study|Did not participate in randomization|33|||
125295771|NCT03995355|450709528|FG001|Overall Study|Adverse Event|0|||
125464589|NCT01170026|451332425|FG000|Overall Study|Lost to Follow-up|4|||
125464590|NCT01170026|451332426|FG001|Overall Study|Lost to Follow-up|2|||
125485366|NCT02240238|451412504|FG001|Phase 1|Sponsor termination|0|||
125464591|NCT03785782|451332427|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
125464592|NCT03785782|451332428|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
125464593|NCT03785782|451332427|FG000|Overall Study|Withdrawal by Subject|1|||
125464594|NCT03785782|451332428|FG001|Overall Study|Withdrawal by Subject|1|||
125464595|NCT03785782|451332427|FG000|Overall Study|insufficient image quality.|3|||
125464596|NCT03785782|451332428|FG001|Overall Study|insufficient image quality.|0|||
125464597|NCT05777785|451332429|FG000|Overall Study|Withdrawal by Subject|5|||
125464598|NCT05777785|451332429|FG000|Overall Study|Lost to Follow-up|1|||
125464599|NCT02763319|451332434|FG000|Overall Study|Adverse Event|12|||
125464600|NCT02763319|451332435|FG001|Overall Study|Adverse Event|3|||
125464601|NCT02763319|451332434|FG000|Overall Study|Death|123|||
125464602|NCT02763319|451332435|FG001|Overall Study|Death|123|||
125464603|NCT02763319|451332434|FG000|Overall Study|Lost to Follow-up|6|||
125464604|NCT02763319|451332435|FG001|Overall Study|Lost to Follow-up|7|||
125464605|NCT02763319|451332434|FG000|Overall Study|Noncompliance with Study Drug|2|||
125464606|NCT02763319|451332435|FG001|Overall Study|Noncompliance with Study Drug|0|||
125464607|NCT02763319|451332434|FG000|Overall Study|"Captured as Other in Database"|29|||
125464608|NCT02763319|451332435|FG001|Overall Study|"Captured as Other in Database"|34|||
125464609|NCT02763319|451332434|FG000|Overall Study|Physician Decision|1|||
125464610|NCT02763319|451332435|FG001|Overall Study|Physician Decision|7|||
125464611|NCT02763319|451332434|FG000|Overall Study|Progressive Disease|24|||
125464612|NCT02763319|451332435|FG001|Overall Study|Progressive Disease|27|||
125464613|NCT02763319|451332434|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
125464614|NCT02763319|451332435|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
125464615|NCT02763319|451332434|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
125464616|NCT02763319|451332435|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
125464617|NCT02763319|451332434|FG000|Overall Study|Withdrawal by Subject|26|||
125464618|NCT02763319|451332435|FG001|Overall Study|Withdrawal by Subject|25|||
125464619|NCT00089544|451332436|FG000|Overall Study|Ineligible|1|||
125464620|NCT00089544|451332437|FG001|Overall Study|Ineligible|0|||
125464621|NCT01622868|451332443|FG000|Overall Study|Protocol Violation|7|||
125464622|NCT01622868|451332444|FG001|Overall Study|Protocol Violation|0|||
125464623|NCT00610649|451332446|FG000|Overall Study|Adverse Event|1|||
125464624|NCT00610649|451332447|FG001|Overall Study|Adverse Event|0|||
125464625|NCT00610649|451332448|FG002|Overall Study|Adverse Event|0|||
125464626|NCT00610649|451332449|FG003|Overall Study|Adverse Event|0|||
125464627|NCT00610649|451332450|FG004|Overall Study|Adverse Event|0|||
125464628|NCT00610649|451332451|FG005|Overall Study|Adverse Event|0|||
125464629|NCT00610649|451332452|FG006|Overall Study|Adverse Event|0|||
125464630|NCT00610649|451332453|FG007|Overall Study|Adverse Event|0|||
125464631|NCT00610649|451332454|FG008|Overall Study|Adverse Event|0|||
125464632|NCT00610649|451332455|FG009|Overall Study|Adverse Event|0|||
125464633|NCT00610649|451332456|FG010|Overall Study|Adverse Event|1|||
125464634|NCT00610649|451332446|FG000|Overall Study|Family Emergency|0|||
125464635|NCT00610649|451332447|FG001|Overall Study|Family Emergency|1|||
125464636|NCT00610649|451332448|FG002|Overall Study|Family Emergency|0|||
125464637|NCT00610649|451332449|FG003|Overall Study|Family Emergency|0|||
125464638|NCT00610649|451332450|FG004|Overall Study|Family Emergency|0|||
125464639|NCT00610649|451332451|FG005|Overall Study|Family Emergency|0|||
125464640|NCT00610649|451332452|FG006|Overall Study|Family Emergency|0|||
125464641|NCT00610649|451332453|FG007|Overall Study|Family Emergency|0|||
125464642|NCT00610649|451332454|FG008|Overall Study|Family Emergency|0|||
125464643|NCT00610649|451332455|FG009|Overall Study|Family Emergency|0|||
125464644|NCT00610649|451332456|FG010|Overall Study|Family Emergency|0|||
125464645|NCT00610649|451332446|FG000|Overall Study|Withdrawal by Subject|0|||
125464646|NCT00610649|451332447|FG001|Overall Study|Withdrawal by Subject|0|||
125464647|NCT00610649|451332448|FG002|Overall Study|Withdrawal by Subject|0|||
125464648|NCT00610649|451332449|FG003|Overall Study|Withdrawal by Subject|0|||
125464649|NCT00610649|451332450|FG004|Overall Study|Withdrawal by Subject|0|||
125464650|NCT00610649|451332451|FG005|Overall Study|Withdrawal by Subject|0|||
125464651|NCT00610649|451332452|FG006|Overall Study|Withdrawal by Subject|0|||
125464652|NCT00610649|451332453|FG007|Overall Study|Withdrawal by Subject|0|||
125464653|NCT00610649|451332454|FG008|Overall Study|Withdrawal by Subject|0|||
125464654|NCT00610649|451332455|FG009|Overall Study|Withdrawal by Subject|1|||
125464655|NCT00610649|451332456|FG010|Overall Study|Withdrawal by Subject|0|||
125464656|NCT04252586|451332457|FG000|Overall Study|Withdrawal by parent/guardian|3|||
125464657|NCT04252586|451332457|FG000|Overall Study|Adverse Event|1|||
125464658|NCT04252586|451332457|FG000|Overall Study|Death|2|||
125464659|NCT04252586|451332457|FG000|Overall Study|Study terminated by sponsor|4|||
125464660|NCT04252586|451332457|FG000|Overall Study|Sponsor request|10|||
125464661|NCT04252586|451332457|FG000|Overall Study|Did not complete treatment period|1|||
125464662|NCT00232180|451332458|FG000|Double-blind (DB) Phase|Death|186|||
125464663|NCT00232180|451332459|FG001|Double-blind (DB) Phase|Death|222|||
125464664|NCT00232180|451332460|FG002|Double-blind (DB) Phase|Death|0|||
125464665|NCT00232180|451332458|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
125464666|NCT00232180|451332459|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
125464667|NCT00232180|451332460|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
125464668|NCT00232180|451332458|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
125464669|NCT00232180|451332459|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
125464670|NCT00232180|451332460|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
125464671|NCT00232180|451332458|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
125464672|NCT00232180|451332459|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
125464673|NCT00232180|451332460|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
125464674|NCT00232180|451332458|FG000|Double-blind (DB) Phase|Adverse Event|83|||
125464675|NCT00232180|451332459|FG001|Double-blind (DB) Phase|Adverse Event|100|||
125464676|NCT00232180|451332460|FG002|Double-blind (DB) Phase|Adverse Event|0|||
125464677|NCT00232180|451332458|FG000|Double-blind (DB) Phase|Other|70|||
125464678|NCT00232180|451332459|FG001|Double-blind (DB) Phase|Other|75|||
125464679|NCT00232180|451332460|FG002|Double-blind (DB) Phase|Other|0|||
125464680|NCT00232180|451332458|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
125464681|NCT00232180|451332459|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
125464682|NCT00232180|451332460|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
125464683|NCT00232180|451332458|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
125464684|NCT00232180|451332459|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
125464685|NCT00232180|451332460|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
125464686|NCT00232180|451332458|FG000|Open Label Phase|Death|0|||
125464687|NCT00232180|451332459|FG001|Open Label Phase|Death|0|||
125464688|NCT00232180|451332460|FG002|Open Label Phase|Death|48|||
125464689|NCT00232180|451332458|FG000|Open Label Phase|Lost to Follow-up|0|||
125464690|NCT00232180|451332459|FG001|Open Label Phase|Lost to Follow-up|0|||
125464691|NCT00232180|451332460|FG002|Open Label Phase|Lost to Follow-up|5|||
125464692|NCT00232180|451332458|FG000|Open Label Phase|Protocol Violation|0|||
125464693|NCT00232180|451332459|FG001|Open Label Phase|Protocol Violation|0|||
125464694|NCT00232180|451332460|FG002|Open Label Phase|Protocol Violation|3|||
125464695|NCT00232180|451332458|FG000|Open Label Phase|Study terminated by sponsor|0|||
125464696|NCT00232180|451332459|FG001|Open Label Phase|Study terminated by sponsor|0|||
125464697|NCT00232180|451332460|FG002|Open Label Phase|Study terminated by sponsor|3|||
125464698|NCT00232180|451332458|FG000|Open Label Phase|Withdrawal by Subject|0|||
125464699|NCT00232180|451332459|FG001|Open Label Phase|Withdrawal by Subject|0|||
125464700|NCT00232180|451332460|FG002|Open Label Phase|Withdrawal by Subject|37|||
125464701|NCT00232180|451332458|FG000|Open Label Phase|Other|0|||
125464702|NCT00232180|451332459|FG001|Open Label Phase|Other|0|||
125464703|NCT00232180|451332460|FG002|Open Label Phase|Other|16|||
125464704|NCT00232180|451332458|FG000|Open Label Phase|Adverse Event|0|||
125464705|NCT00232180|451332459|FG001|Open Label Phase|Adverse Event|0|||
125464706|NCT00232180|451332460|FG002|Open Label Phase|Adverse Event|25|||
125464707|NCT00232180|451332458|FG000|Open Label Phase|Laboratory abnormality|0|||
125464708|NCT00232180|451332459|FG001|Open Label Phase|Laboratory abnormality|0|||
125464709|NCT00232180|451332460|FG002|Open Label Phase|Laboratory abnormality|10|||
125464710|NCT00232180|451332458|FG000|Open Label Phase|Randomized but not treated|0|||
125464711|NCT00232180|451332459|FG001|Open Label Phase|Randomized but not treated|0|||
125464712|NCT00232180|451332460|FG002|Open Label Phase|Randomized but not treated|1|||
125464713|NCT03452189|451332461|FG000|First Intervention (3 Months)|Adverse Event|1|||
125464714|NCT03452189|451332462|FG001|First Intervention (3 Months)|Adverse Event|0|||
125464715|NCT03452189|451332461|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
125464716|NCT03452189|451332462|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
125464717|NCT01571596|451332471|FG000|Overall Study|Adverse Event|2|||
125464718|NCT01571596|451332472|FG001|Overall Study|Adverse Event|0|||
125464719|NCT01571596|451332473|FG002|Overall Study|Adverse Event|0|||
125464720|NCT01571596|451332471|FG000|Overall Study|Study Terminated by the Sponsor|0|||
125464721|NCT01571596|451332472|FG001|Overall Study|Study Terminated by the Sponsor|1|||
125464722|NCT01571596|451332473|FG002|Overall Study|Study Terminated by the Sponsor|1|||
125464723|NCT02767765|451332477|FG000|Overall Study|Adverse Event|4|||
125464724|NCT02767765|451332477|FG000|Overall Study|Death|1|||
125464725|NCT02767765|451332477|FG000|Overall Study|Insufficient response|1|||
125464726|NCT02767765|451332477|FG000|Overall Study|Lost to Follow-up|2|||
125464727|NCT02767765|451332477|FG000|Overall Study|Investigator decision|1|||
125464728|NCT02767765|451332477|FG000|Overall Study|Non-Compliance|1|||
125295772|NCT03995355|450709527|FG000|Overall Study|Withdrawal by Subject|1|||
125464729|NCT02767765|451332477|FG000|Overall Study|Withdrawal by Subject|1|||
125464730|NCT01951170|451332479|FG000|Overall Study|Investigator decision|1|||
125464731|NCT04512482|451332484|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
125464732|NCT04512482|451332485|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
125464733|NCT00774397|451332488|FG000|Overall Study|Adverse Event|1|||
125464734|NCT00774397|451332489|FG001|Overall Study|Adverse Event|3|||
125464735|NCT00774397|451332490|FG002|Overall Study|Adverse Event|16|||
125464736|NCT00774397|451332491|FG003|Overall Study|Adverse Event|8|||
125464737|NCT00774397|451332492|FG004|Overall Study|Adverse Event|8|||
125464738|NCT00774397|451332493|FG005|Overall Study|Adverse Event|3|||
125464739|NCT00774397|451332494|FG006|Overall Study|Adverse Event|16|||
125464740|NCT00774397|451332488|FG000|Overall Study|Lack of Efficacy|11|||
125464741|NCT00774397|451332489|FG001|Overall Study|Lack of Efficacy|4|||
125464742|NCT00774397|451332490|FG002|Overall Study|Lack of Efficacy|5|||
125464743|NCT00774397|451332491|FG003|Overall Study|Lack of Efficacy|3|||
125464744|NCT00774397|451332492|FG004|Overall Study|Lack of Efficacy|27|||
125464745|NCT00774397|451332493|FG005|Overall Study|Lack of Efficacy|15|||
125464746|NCT00774397|451332494|FG006|Overall Study|Lack of Efficacy|9|||
125464747|NCT00774397|451332488|FG000|Overall Study|Protocol Violation|0|||
125464748|NCT00774397|451332489|FG001|Overall Study|Protocol Violation|1|||
125464749|NCT00774397|451332490|FG002|Overall Study|Protocol Violation|3|||
125464750|NCT00774397|451332491|FG003|Overall Study|Protocol Violation|1|||
125464751|NCT00774397|451332492|FG004|Overall Study|Protocol Violation|2|||
125464752|NCT00774397|451332493|FG005|Overall Study|Protocol Violation|1|||
125464753|NCT00774397|451332494|FG006|Overall Study|Protocol Violation|0|||
125464754|NCT00774397|451332488|FG000|Overall Study|Lost to Follow-up|0|||
125464755|NCT00774397|451332489|FG001|Overall Study|Lost to Follow-up|1|||
125464756|NCT00774397|451332490|FG002|Overall Study|Lost to Follow-up|1|||
125464757|NCT00774397|451332491|FG003|Overall Study|Lost to Follow-up|1|||
125464758|NCT00774397|451332492|FG004|Overall Study|Lost to Follow-up|0|||
125464759|NCT00774397|451332493|FG005|Overall Study|Lost to Follow-up|1|||
125464760|NCT00774397|451332494|FG006|Overall Study|Lost to Follow-up|0|||
125464761|NCT00774397|451332488|FG000|Overall Study|Refused to continue trial medication|1|||
125464762|NCT00774397|451332489|FG001|Overall Study|Refused to continue trial medication|3|||
125464763|NCT00774397|451332490|FG002|Overall Study|Refused to continue trial medication|2|||
125464764|NCT00774397|451332491|FG003|Overall Study|Refused to continue trial medication|2|||
125464765|NCT00774397|451332492|FG004|Overall Study|Refused to continue trial medication|6|||
125464766|NCT00774397|451332493|FG005|Overall Study|Refused to continue trial medication|2|||
125464767|NCT00774397|451332494|FG006|Overall Study|Refused to continue trial medication|3|||
125464768|NCT00774397|451332488|FG000|Overall Study|Not treated|0|||
125464769|NCT00774397|451332489|FG001|Overall Study|Not treated|0|||
125464770|NCT00774397|451332490|FG002|Overall Study|Not treated|0|||
125464771|NCT00774397|451332491|FG003|Overall Study|Not treated|0|||
125464772|NCT00774397|451332492|FG004|Overall Study|Not treated|1|||
125464773|NCT00774397|451332493|FG005|Overall Study|Not treated|0|||
125464774|NCT00774397|451332494|FG006|Overall Study|Not treated|1|||
125464775|NCT00774397|451332488|FG000|Overall Study|Other than those stated above|1|||
125464776|NCT00774397|451332489|FG001|Overall Study|Other than those stated above|1|||
125464777|NCT00774397|451332490|FG002|Overall Study|Other than those stated above|3|||
125464778|NCT00774397|451332491|FG003|Overall Study|Other than those stated above|2|||
125464779|NCT00774397|451332492|FG004|Overall Study|Other than those stated above|2|||
125464780|NCT00774397|451332493|FG005|Overall Study|Other than those stated above|0|||
125464781|NCT00774397|451332494|FG006|Overall Study|Other than those stated above|1|||
125464782|NCT00077675|451332495|FG000|Overall Study|Adverse Event|1|||
125464783|NCT00077675|451332496|FG001|Overall Study|Adverse Event|2|||
125464784|NCT00077675|451332495|FG000|Overall Study|Lost to Follow-up|6|||
125464785|NCT00077675|451332496|FG001|Overall Study|Lost to Follow-up|3|||
125464786|NCT00077675|451332495|FG000|Overall Study|Withdrawal by Subject|1|||
125464787|NCT00077675|451332496|FG001|Overall Study|Withdrawal by Subject|0|||
125464788|NCT00077675|451332495|FG000|Overall Study|Other|0|||
125464789|NCT00077675|451332496|FG001|Overall Study|Other|1|||
125464790|NCT00077675|451332495|FG000|Overall Study|Never received study treatment|3|||
125464791|NCT00077675|451332496|FG001|Overall Study|Never received study treatment|3|||
125464792|NCT00391898|451332509|FG000|Overall Study|Adverse Event|3|||
125464793|NCT00391898|451332510|FG001|Overall Study|Adverse Event|0|||
125464794|NCT00391898|451332509|FG000|Overall Study|Other|8|||
125464795|NCT00391898|451332510|FG001|Overall Study|Other|10|||
125464796|NCT00869258|451332513|FG000|Overall Study|Physician Decision|1|||
125464797|NCT02706717|451332514|FG000|Overall Study|Withdrawal by Subject|1|||
125464798|NCT02706717|451332515|FG001|Overall Study|Withdrawal by Subject|8|||
125464799|NCT02706717|451332514|FG000|Overall Study|Lost to Follow-up|0|||
125464800|NCT02706717|451332515|FG001|Overall Study|Lost to Follow-up|1|||
125464801|NCT02706717|451332514|FG000|Overall Study|Physician Decision|0|||
125464802|NCT02706717|451332515|FG001|Overall Study|Physician Decision|1|||
125464803|NCT02706717|451332514|FG000|Overall Study|Death|0|||
125464804|NCT02706717|451332515|FG001|Overall Study|Death|1|||
125464805|NCT02512965|451332519|FG000|Overall Study|Withdrawal by Subject|0|||
125464806|NCT02512965|451332520|FG001|Overall Study|Withdrawal by Subject|4|||
125295773|NCT03995355|450709528|FG001|Overall Study|Withdrawal by Subject|0|||
125295774|NCT03995355|450709527|FG000|Overall Study|Scheduling Issues|0|||
125464807|NCT00835770|451332521|FG000|Overall Study|MS Relapse|17|||
125464808|NCT00835770|451332522|FG001|Overall Study|MS Relapse|23|||
125464809|NCT00835770|451332521|FG000|Overall Study|MS Progression|14|||
125464810|NCT00835770|451332522|FG001|Overall Study|MS Progression|9|||
125464811|NCT00835770|451332521|FG000|Overall Study|Adverse Event|113|||
125464812|NCT00835770|451332522|FG001|Overall Study|Adverse Event|124|||
125464813|NCT00835770|451332521|FG000|Overall Study|Lost to Follow-up|22|||
125464814|NCT00835770|451332522|FG001|Overall Study|Lost to Follow-up|19|||
125464815|NCT00835770|451332521|FG000|Overall Study|Consent Withdrawn|144|||
125464816|NCT00835770|451332522|FG001|Overall Study|Consent Withdrawn|156|||
125464817|NCT00835770|451332521|FG000|Overall Study|Investigator Decision|42|||
125464818|NCT00835770|451332522|FG001|Overall Study|Investigator Decision|42|||
125464819|NCT00835770|451332521|FG000|Overall Study|Participant Non-Compliance|11|||
125464820|NCT00835770|451332522|FG001|Overall Study|Participant Non-Compliance|9|||
125464821|NCT00835770|451332521|FG000|Overall Study|Death|4|||
125464822|NCT00835770|451332522|FG001|Overall Study|Death|6|||
125464823|NCT00835770|451332521|FG000|Overall Study|Other|115|||
125464824|NCT00835770|451332522|FG001|Overall Study|Other|104|||
125464825|NCT00835770|451332521|FG000|Overall Study|Other|2|||
125464826|NCT00835770|451332522|FG001|Overall Study|Other|1|||
125464827|NCT01185782|451332526|FG000|Overall Study|Adverse Event|0|||
125464828|NCT01185782|451332527|FG001|Overall Study|Adverse Event|1|||
125464829|NCT01185782|451332526|FG000|Overall Study|Protocol Violation|1|||
125464830|NCT01185782|451332527|FG001|Overall Study|Protocol Violation|0|||
125464831|NCT01185782|451332526|FG000|Overall Study|Poor Response to Treatment|3|||
125464832|NCT01185782|451332527|FG001|Overall Study|Poor Response to Treatment|1|||
125464833|NCT01185782|451332526|FG000|Overall Study|Other|2|||
125464834|NCT01185782|451332527|FG001|Overall Study|Other|5|||
125464835|NCT01185782|451332526|FG000|Overall Study|Randomized but not treated|0|||
125464836|NCT01185782|451332527|FG001|Overall Study|Randomized but not treated|4|||
125464837|NCT02507752|451332528|FG000|Overall Study|Adverse Event|1|||
125464838|NCT02507752|451332528|FG000|Overall Study|Protocol Violation|6|||
125464839|NCT02507752|451332528|FG000|Overall Study|Lost to Follow-up|7|||
125464840|NCT02507752|451332528|FG000|Overall Study|Infusion reaction at first infusion|1|||
125464841|NCT02507752|451332528|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
125464842|NCT02507752|451332528|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
125464843|NCT03740009|451332533|FG000|Overall Study|Physician Decision|9|||
125464844|NCT03740009|451332533|FG000|Overall Study|Lost to Follow-up|1|||
125464845|NCT01061151|451332534|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
125464846|NCT01061151|451332535|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
125464847|NCT01061151|451332536|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
125464848|NCT01061151|451332537|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
125464849|NCT01061151|451332534|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
125464850|NCT01061151|451332535|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
125464851|NCT01061151|451332536|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
125464852|NCT01061151|451332537|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
125464853|NCT01061151|451332534|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
125464854|NCT01061151|451332535|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
125464855|NCT01061151|451332536|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
125464856|NCT01061151|451332537|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
125464857|NCT01061151|451332534|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
125464858|NCT01061151|451332535|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
125464859|NCT01061151|451332536|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
125464860|NCT01061151|451332537|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
125464861|NCT01061151|451332534|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
125464862|NCT01061151|451332535|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
125464863|NCT01061151|451332536|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
125464864|NCT01061151|451332537|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
125464865|NCT01061151|451332534|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
125464866|NCT01061151|451332535|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
125464867|NCT01061151|451332536|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
125464868|NCT01061151|451332537|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
125464869|NCT01061151|451332534|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
125464870|NCT01061151|451332535|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
125464871|NCT01061151|451332536|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
125464872|NCT01061151|451332537|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
125464873|NCT01061151|451332534|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
125464874|NCT01061151|451332535|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
125464875|NCT01061151|451332536|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
125464876|NCT01061151|451332537|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
125464877|NCT01061151|451332534|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
125464878|NCT01061151|451332535|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
125464879|NCT01061151|451332536|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
125464880|NCT01061151|451332537|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
125464881|NCT01061151|451332534|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
125464882|NCT01061151|451332535|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
125464883|NCT01061151|451332536|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
125464884|NCT01061151|451332537|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
125464885|NCT01061151|451332534|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
125464886|NCT01061151|451332535|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
125464887|NCT01061151|451332536|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
125464888|NCT01061151|451332537|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
125464889|NCT01061151|451332534|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
125464890|NCT01061151|451332535|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
125464891|NCT01061151|451332536|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
125464892|NCT01061151|451332537|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
125464893|NCT01061151|451332534|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
125464894|NCT01061151|451332535|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
125464895|NCT01061151|451332536|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
125464896|NCT01061151|451332537|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
125464897|NCT01061151|451332534|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
125464898|NCT01061151|451332535|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
125464899|NCT01061151|451332536|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
125464900|NCT01061151|451332537|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
125464901|NCT01061151|451332534|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
125464902|NCT01061151|451332535|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
125464903|NCT01061151|451332536|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
125464904|NCT01061151|451332537|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
125464905|NCT04530747|451332548|FG000|Overall Study|Withdrawal by Subject|1|||
125464906|NCT04530747|451332549|FG001|Overall Study|Withdrawal by Subject|0|||
125464907|NCT00529516|451332550|FG000|Overall Study|Adverse Event|2|||
125464908|NCT00529516|451332551|FG001|Overall Study|Adverse Event|1|||
125464909|NCT00529516|451332552|FG002|Overall Study|Adverse Event|0|||
125464910|NCT00529516|451332550|FG000|Overall Study|Withdrawal by Subject|1|||
125464911|NCT00529516|451332551|FG001|Overall Study|Withdrawal by Subject|1|||
125464912|NCT00529516|451332552|FG002|Overall Study|Withdrawal by Subject|0|||
125464913|NCT00529516|451332550|FG000|Overall Study|Lost to Follow-up|0|||
125464914|NCT00529516|451332551|FG001|Overall Study|Lost to Follow-up|0|||
125464915|NCT00529516|451332552|FG002|Overall Study|Lost to Follow-up|1|||
125464916|NCT03752151|451332553|FG000|Overall Study|Withdrawal by Subject|1|||
125464917|NCT03752151|451332553|FG000|Overall Study|Protocol Violation|1|||
125464918|NCT01787760|451332562|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
125464919|NCT01787760|451332563|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
125464920|NCT01787760|451332564|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
125464921|NCT01787760|451332562|FG000|Overall Study|Decompensated on left exotropia|0|||
125464922|NCT01787760|451332563|FG001|Overall Study|Decompensated on left exotropia|0|||
125464923|NCT01787760|451332564|FG002|Overall Study|Decompensated on left exotropia|1|||
125464924|NCT01787760|451332562|FG000|Overall Study|Dryness|0|||
125464925|NCT01787760|451332563|FG001|Overall Study|Dryness|1|||
125464926|NCT01787760|451332564|FG002|Overall Study|Dryness|0|||
125464927|NCT01787760|451332562|FG000|Overall Study|Relocation|1|||
125464928|NCT01787760|451332563|FG001|Overall Study|Relocation|1|||
125464929|NCT01787760|451332564|FG002|Overall Study|Relocation|0|||
125464930|NCT01787760|451332562|FG000|Overall Study|Lens discomfort|3|||
125464931|NCT01787760|451332563|FG001|Overall Study|Lens discomfort|0|||
125464932|NCT01787760|451332564|FG002|Overall Study|Lens discomfort|0|||
125464933|NCT01787760|451332562|FG000|Overall Study|Lens handling difficulty|1|||
125464934|NCT01787760|451332563|FG001|Overall Study|Lens handling difficulty|2|||
125464935|NCT01787760|451332564|FG002|Overall Study|Lens handling difficulty|0|||
125464936|NCT01787760|451332562|FG000|Overall Study|Protocol Violation|6|||
125464937|NCT01787760|451332563|FG001|Overall Study|Protocol Violation|0|||
125464938|NCT01787760|451332564|FG002|Overall Study|Protocol Violation|1|||
125464939|NCT01787760|451332562|FG000|Overall Study|Withdrawal by Subject|5|||
125464940|NCT01787760|451332563|FG001|Overall Study|Withdrawal by Subject|1|||
125464941|NCT01787760|451332564|FG002|Overall Study|Withdrawal by Subject|2|||
125464942|NCT01787760|451332562|FG000|Overall Study|Lost to Follow-up|1|||
125464943|NCT01787760|451332563|FG001|Overall Study|Lost to Follow-up|0|||
125464944|NCT01787760|451332564|FG002|Overall Study|Lost to Follow-up|1|||
125464945|NCT01787760|451332562|FG000|Overall Study|Stroke|1|||
125464946|NCT01787760|451332563|FG001|Overall Study|Stroke|0|||
125464947|NCT01787760|451332564|FG002|Overall Study|Stroke|0|||
125464948|NCT01787760|451332562|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
125464949|NCT01787760|451332563|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
125464950|NCT01787760|451332564|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
125464951|NCT01787760|451332562|FG000|Overall Study|Unsatisfactory physiological response|2|||
125464952|NCT01787760|451332563|FG001|Overall Study|Unsatisfactory physiological response|4|||
125464953|NCT01787760|451332564|FG002|Overall Study|Unsatisfactory physiological response|0|||
125464954|NCT01787760|451332562|FG000|Overall Study|Unsatisfactory visual response|1|||
125464955|NCT01787760|451332563|FG001|Overall Study|Unsatisfactory visual response|1|||
125464956|NCT01787760|451332564|FG002|Overall Study|Unsatisfactory visual response|0|||
125464957|NCT01787760|451332562|FG000|Overall Study|Near vision blur|1|||
125464958|NCT01787760|451332563|FG001|Overall Study|Near vision blur|0|||
125464959|NCT01787760|451332564|FG002|Overall Study|Near vision blur|0|||
125464960|NCT04411056|451333999|FG000|Overall Study|surgery cancelled|1|||
125464961|NCT04411056|451334000|FG001|Overall Study|surgery cancelled|0|||
125464962|NCT04411056|451333999|FG000|Overall Study|Equipment problem during intubation|0|||
125464963|NCT04411056|451334000|FG001|Overall Study|Equipment problem during intubation|1|||
125464964|NCT04623008|451334003|FG000|Baseline to T2|Withdrawal by Subject|4|||
125464965|NCT04623008|451334004|FG001|Baseline to T2|Withdrawal by Subject|2|||
125464966|NCT04623008|451334003|FG000|Baseline to T3|Withdrawal by Subject|4|||
125464967|NCT04623008|451334004|FG001|Baseline to T3|Withdrawal by Subject|2|||
125295775|NCT03995355|450709528|FG001|Overall Study|Scheduling Issues|1|||
125295776|NCT00710385|450709536|FG000|Overall Study|Did not qualify|1|||
125295777|NCT00710385|450709536|FG000|Overall Study|Withdrawal by Subject|1|||
125295778|NCT00710385|450709536|FG000|Overall Study|Undisclosed back pain|1|||
125295779|NCT00710385|450709536|FG000|Overall Study|Physician Decision|1|||
125295780|NCT00710385|450709536|FG000|Overall Study|Undisclosed excessive methadone use|1|||
125295781|NCT01459913|450709543|FG000|Overall Study|Adverse Event|0|||
125295782|NCT01459913|450709544|FG001|Overall Study|Adverse Event|0|||
125295783|NCT01459913|450709545|FG002|Overall Study|Adverse Event|0|||
125295784|NCT01459913|450709546|FG003|Overall Study|Adverse Event|3|||
125295785|NCT01459913|450709543|FG000|Overall Study|Withdrawal by Subject|4|||
125295786|NCT01459913|450709544|FG001|Overall Study|Withdrawal by Subject|0|||
125295787|NCT01459913|450709545|FG002|Overall Study|Withdrawal by Subject|0|||
125464968|NCT03779048|451334014|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
125464969|NCT03779048|451334015|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
125464970|NCT03779048|451334016|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
125464971|NCT03779048|451334014|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
125464972|NCT03779048|451334015|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
125464973|NCT03779048|451334016|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
125464974|NCT03779048|451334014|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
125464975|NCT03779048|451334015|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
125464976|NCT03779048|451334016|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
125464977|NCT04588259|451334017|FG000|Run-in Period|Run-in failure|0|||
125464978|NCT04588259|451334018|FG001|Run-in Period|Run-in failure|23|||
125464979|NCT04588259|451334017|FG000|Run-in Period|Withdrawn before randomisation|0|||
125464980|NCT04588259|451334018|FG001|Run-in Period|Withdrawn before randomisation|8|||
125464981|NCT04588259|451334017|FG000|Treatment Period|Withdrawal by Subject|6|||
125464982|NCT04588259|451334018|FG001|Treatment Period|Withdrawal by Subject|6|||
125464983|NCT00293293|451334025|FG000|Overall Study|Withdrawal by Subject|1|||
125464984|NCT00293293|451334026|FG001|Overall Study|Withdrawal by Subject|1|||
125464985|NCT00293293|451334025|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
125464986|NCT00293293|451334026|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
125464987|NCT00293293|451334025|FG000|Overall Study|Patient discontinued chemotherapy|0|||
125464988|NCT00293293|451334026|FG001|Overall Study|Patient discontinued chemotherapy|1|||
125464989|NCT02988817|451334027|FG000|Overall Study|Withdrawal by Subject|1|||
125464990|NCT02988817|451334028|FG001|Overall Study|Withdrawal by Subject|0|||
125464991|NCT02988817|451334029|FG002|Overall Study|Withdrawal by Subject|0|||
125464992|NCT02988817|451334030|FG003|Overall Study|Withdrawal by Subject|1|||
125464993|NCT02988817|451334031|FG004|Overall Study|Withdrawal by Subject|3|||
125295788|NCT01459913|450709546|FG003|Overall Study|Withdrawal by Subject|5|||
125295789|NCT01459913|450709543|FG000|Overall Study|Lost to Follow-up|7|||
125295790|NCT01459913|450709544|FG001|Overall Study|Lost to Follow-up|4|||
125295791|NCT01459913|450709545|FG002|Overall Study|Lost to Follow-up|1|||
125295792|NCT01459913|450709546|FG003|Overall Study|Lost to Follow-up|8|||
125295793|NCT01459913|450709543|FG000|Overall Study|Death|0|||
125295794|NCT01459913|450709544|FG001|Overall Study|Death|0|||
125295795|NCT01459913|450709545|FG002|Overall Study|Death|0|||
125295796|NCT01459913|450709546|FG003|Overall Study|Death|1|||
125295797|NCT01459913|450709543|FG000|Overall Study|Non- Compliance|0|||
125295798|NCT01459913|450709544|FG001|Overall Study|Non- Compliance|0|||
125295799|NCT01459913|450709545|FG002|Overall Study|Non- Compliance|0|||
125295800|NCT01459913|450709546|FG003|Overall Study|Non- Compliance|3|||
125295801|NCT01459913|450709543|FG000|Overall Study|Physician Decision|0|||
125295802|NCT01459913|450709544|FG001|Overall Study|Physician Decision|1|||
125295803|NCT01459913|450709545|FG002|Overall Study|Physician Decision|0|||
125295804|NCT01459913|450709546|FG003|Overall Study|Physician Decision|0|||
125295805|NCT01459913|450709543|FG000|Overall Study|Study Terminated by Sponsor|30|||
125295806|NCT01459913|450709544|FG001|Overall Study|Study Terminated by Sponsor|15|||
125295807|NCT01459913|450709545|FG002|Overall Study|Study Terminated by Sponsor|9|||
125295808|NCT01459913|450709546|FG003|Overall Study|Study Terminated by Sponsor|11|||
125295809|NCT01459913|450709543|FG000|Overall Study|Other|0|||
125295810|NCT01459913|450709544|FG001|Overall Study|Other|0|||
125295811|NCT01459913|450709545|FG002|Overall Study|Other|3|||
125295812|NCT01459913|450709546|FG003|Overall Study|Other|1|||
125295813|NCT01459913|450709543|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
125295814|NCT01459913|450709544|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
125295815|NCT01459913|450709545|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
125295816|NCT01459913|450709546|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
125295817|NCT01064687|450709549|FG000|Overall Study|Adverse Event|9|||
125295818|NCT01064687|450709550|FG001|Overall Study|Adverse Event|4|||
125295819|NCT01064687|450709551|FG002|Overall Study|Adverse Event|10|||
125295820|NCT01064687|450709552|FG003|Overall Study|Adverse Event|3|||
125295821|NCT01064687|450709549|FG000|Overall Study|Death|1|||
125295822|NCT01064687|450709550|FG001|Overall Study|Death|1|||
125295823|NCT01064687|450709551|FG002|Overall Study|Death|0|||
125295824|NCT01064687|450709552|FG003|Overall Study|Death|0|||
125295825|NCT01064687|450709549|FG000|Overall Study|Entry Criteria Not Met|3|||
125295826|NCT01064687|450709550|FG001|Overall Study|Entry Criteria Not Met|0|||
125295827|NCT01064687|450709551|FG002|Overall Study|Entry Criteria Not Met|0|||
125295828|NCT01064687|450709552|FG003|Overall Study|Entry Criteria Not Met|0|||
125295829|NCT01064687|450709549|FG000|Overall Study|Lack of Efficacy|1|||
125295830|NCT01064687|450709550|FG001|Overall Study|Lack of Efficacy|0|||
125295831|NCT01064687|450709551|FG002|Overall Study|Lack of Efficacy|2|||
125295832|NCT01064687|450709552|FG003|Overall Study|Lack of Efficacy|3|||
125464994|NCT02988817|451334032|FG005|Overall Study|Withdrawal by Subject|1|||
125464995|NCT02988817|451334033|FG006|Overall Study|Withdrawal by Subject|2|||
125464996|NCT02988817|451334034|FG007|Overall Study|Withdrawal by Subject|1|||
125464997|NCT02988817|451334035|FG008|Overall Study|Withdrawal by Subject|1|||
125464998|NCT02988817|451334036|FG009|Overall Study|Withdrawal by Subject|1|||
125464999|NCT02988817|451334037|FG010|Overall Study|Withdrawal by Subject|1|||
125465000|NCT02988817|451334038|FG011|Overall Study|Withdrawal by Subject|12|||
125465001|NCT02988817|451334039|FG012|Overall Study|Withdrawal by Subject|6|||
125465002|NCT02988817|451334040|FG013|Overall Study|Withdrawal by Subject|6|||
125465003|NCT02988817|451334041|FG014|Overall Study|Withdrawal by Subject|4|||
125465004|NCT02988817|451334042|FG015|Overall Study|Withdrawal by Subject|5|||
125465005|NCT02988817|451334043|FG016|Overall Study|Withdrawal by Subject|4|||
125465006|NCT02988817|451334044|FG017|Overall Study|Withdrawal by Subject|11|||
125465007|NCT02988817|451334045|FG018|Overall Study|Withdrawal by Subject|4|||
125465008|NCT02988817|451334046|FG019|Overall Study|Withdrawal by Subject|2|||
125465009|NCT02988817|451334027|FG000|Overall Study|Death|0|||
125465010|NCT02988817|451334028|FG001|Overall Study|Death|1|||
125465011|NCT02988817|451334029|FG002|Overall Study|Death|3|||
125465012|NCT02988817|451334030|FG003|Overall Study|Death|1|||
125465013|NCT02988817|451334031|FG004|Overall Study|Death|6|||
125465014|NCT02988817|451334032|FG005|Overall Study|Death|10|||
125465015|NCT02988817|451334033|FG006|Overall Study|Death|1|||
125465016|NCT02988817|451334034|FG007|Overall Study|Death|2|||
125465017|NCT02988817|451334035|FG008|Overall Study|Death|1|||
125465018|NCT02988817|451334036|FG009|Overall Study|Death|5|||
125465019|NCT02988817|451334037|FG010|Overall Study|Death|1|||
125465020|NCT02988817|451334038|FG011|Overall Study|Death|8|||
125465021|NCT02988817|451334039|FG012|Overall Study|Death|9|||
125465022|NCT02988817|451334040|FG013|Overall Study|Death|17|||
125465023|NCT02988817|451334041|FG014|Overall Study|Death|18|||
125465024|NCT02988817|451334042|FG015|Overall Study|Death|30|||
125465025|NCT02988817|451334043|FG016|Overall Study|Death|17|||
125465026|NCT02988817|451334044|FG017|Overall Study|Death|38|||
125465027|NCT02988817|451334045|FG018|Overall Study|Death|14|||
125465028|NCT02988817|451334046|FG019|Overall Study|Death|16|||
125465029|NCT02988817|451334027|FG000|Overall Study|Other|0|||
125465030|NCT02988817|451334028|FG001|Overall Study|Other|0|||
125465031|NCT02988817|451334029|FG002|Overall Study|Other|0|||
125465032|NCT02988817|451334030|FG003|Overall Study|Other|1|||
125465033|NCT02988817|451334031|FG004|Overall Study|Other|1|||
125465034|NCT02988817|451334032|FG005|Overall Study|Other|0|||
125465035|NCT02988817|451334033|FG006|Overall Study|Other|0|||
125465036|NCT02988817|451334034|FG007|Overall Study|Other|0|||
125465037|NCT02988817|451334035|FG008|Overall Study|Other|0|||
125465038|NCT02988817|451334036|FG009|Overall Study|Other|0|||
125465039|NCT02988817|451334037|FG010|Overall Study|Other|0|||
125465040|NCT02988817|451334038|FG011|Overall Study|Other|0|||
125295833|NCT01064687|450709549|FG000|Overall Study|Lost to Follow-up|7|||
125295834|NCT01064687|450709550|FG001|Overall Study|Lost to Follow-up|10|||
125295835|NCT01064687|450709551|FG002|Overall Study|Lost to Follow-up|13|||
125295836|NCT01064687|450709552|FG003|Overall Study|Lost to Follow-up|5|||
125295837|NCT01064687|450709549|FG000|Overall Study|Physician Decision|2|||
125295838|NCT01064687|450709550|FG001|Overall Study|Physician Decision|2|||
125295839|NCT01064687|450709551|FG002|Overall Study|Physician Decision|0|||
125295840|NCT01064687|450709552|FG003|Overall Study|Physician Decision|0|||
125295841|NCT01064687|450709549|FG000|Overall Study|Protocol Violation|1|||
125465041|NCT02988817|451334039|FG012|Overall Study|Other|0|||
125465042|NCT02988817|451334040|FG013|Overall Study|Other|0|||
125465043|NCT02988817|451334041|FG014|Overall Study|Other|0|||
125465044|NCT02988817|451334042|FG015|Overall Study|Other|1|||
125465045|NCT02988817|451334043|FG016|Overall Study|Other|0|||
125465046|NCT02988817|451334044|FG017|Overall Study|Other|0|||
125465047|NCT02988817|451334045|FG018|Overall Study|Other|0|||
125465048|NCT02988817|451334046|FG019|Overall Study|Other|0|||
125465049|NCT02988817|451334027|FG000|Overall Study|Lost to Follow-up|0|||
125465050|NCT02988817|451334028|FG001|Overall Study|Lost to Follow-up|0|||
125465051|NCT02988817|451334029|FG002|Overall Study|Lost to Follow-up|0|||
125295842|NCT01064687|450709550|FG001|Overall Study|Protocol Violation|1|||
125295843|NCT01064687|450709551|FG002|Overall Study|Protocol Violation|0|||
125295844|NCT01064687|450709552|FG003|Overall Study|Protocol Violation|1|||
125295845|NCT01064687|450709549|FG000|Overall Study|Sponsor Decision|0|||
125295846|NCT01064687|450709550|FG001|Overall Study|Sponsor Decision|0|||
125295847|NCT01064687|450709551|FG002|Overall Study|Sponsor Decision|3|||
125295848|NCT01064687|450709552|FG003|Overall Study|Sponsor Decision|0|||
125295849|NCT01064687|450709549|FG000|Overall Study|Withdrawal by Subject|9|||
125295850|NCT01064687|450709550|FG001|Overall Study|Withdrawal by Subject|7|||
125295851|NCT01064687|450709551|FG002|Overall Study|Withdrawal by Subject|12|||
125295852|NCT01064687|450709552|FG003|Overall Study|Withdrawal by Subject|5|||
125295853|NCT01064687|450709549|FG000|Overall Study|Treatment Noncompliance|1|||
125295854|NCT01064687|450709550|FG001|Overall Study|Treatment Noncompliance|1|||
125295855|NCT01064687|450709551|FG002|Overall Study|Treatment Noncompliance|1|||
125295856|NCT01064687|450709552|FG003|Overall Study|Treatment Noncompliance|0|||
125295857|NCT02299076|450709553|FG000|Overall Study|Fraudulent Entries|20|||
125295858|NCT02299076|450709554|FG001|Overall Study|Fraudulent Entries|14|||
125295859|NCT01969721|450709555|FG000|Overall Study|Adverse Event|3|||
125295860|NCT01969721|450709556|FG001|Overall Study|Adverse Event|8|||
125295861|NCT01969721|450709557|FG002|Overall Study|Adverse Event|3|||
125295862|NCT01969721|450709558|FG003|Overall Study|Adverse Event|2|||
125295863|NCT01969721|450709555|FG000|Overall Study|Lack of Efficacy|0|||
125295864|NCT01969721|450709556|FG001|Overall Study|Lack of Efficacy|0|||
125295865|NCT01969721|450709557|FG002|Overall Study|Lack of Efficacy|1|||
125295866|NCT01969721|450709558|FG003|Overall Study|Lack of Efficacy|0|||
125295867|NCT01969721|450709555|FG000|Overall Study|Non compliant with protocol|1|||
125295868|NCT01969721|450709556|FG001|Overall Study|Non compliant with protocol|1|||
125295869|NCT01969721|450709557|FG002|Overall Study|Non compliant with protocol|0|||
125295870|NCT01969721|450709558|FG003|Overall Study|Non compliant with protocol|2|||
125295871|NCT01969721|450709555|FG000|Overall Study|Other not defined above|0|||
125295872|NCT01969721|450709556|FG001|Overall Study|Other not defined above|2|||
125295873|NCT01969721|450709557|FG002|Overall Study|Other not defined above|0|||
125295874|NCT01969721|450709558|FG003|Overall Study|Other not defined above|0|||
125295875|NCT01969721|450709555|FG000|Overall Study|Discontinued during washout periods.|0|||
125295876|NCT01969721|450709556|FG001|Overall Study|Discontinued during washout periods.|1|||
125295877|NCT01969721|450709557|FG002|Overall Study|Discontinued during washout periods.|1|||
125295878|NCT01969721|450709558|FG003|Overall Study|Discontinued during washout periods.|2|||
125295879|NCT01012323|450709559|FG000|Overall Study|Investigator Judgment|1|||
125295880|NCT02117349|450709560|FG000|Overall Study|Withdrawal by Subject|1|||
125295881|NCT02117349|450709561|FG001|Overall Study|Withdrawal by Subject|0|||
125295882|NCT02117349|450709560|FG000|Overall Study|Lost to Follow-up|1|||
125295883|NCT02117349|450709561|FG001|Overall Study|Lost to Follow-up|1|||
125295884|NCT02117349|450709560|FG000|Overall Study|Death|1|||
125295885|NCT02117349|450709561|FG001|Overall Study|Death|0|||
125295886|NCT00495755|450709562|FG000|Overall Study|Adverse Event|3|||
125295887|NCT02265796|450709563|FG000|Overall Study|Death|1|||
125295888|NCT02265796|450709564|FG001|Overall Study|Death|0|||
125295889|NCT02265796|450709563|FG000|Overall Study|started on excluded medication|1|||
125295890|NCT02265796|450709564|FG001|Overall Study|started on excluded medication|0|||
125295891|NCT02265796|450709563|FG000|Overall Study|Withdrawal by Subject|1|||
125295892|NCT02265796|450709564|FG001|Overall Study|Withdrawal by Subject|1|||
125295893|NCT02477553|450709565|FG000|Overall Study|Screening up-to-date|12|||
125295894|NCT02477553|450709566|FG001|Overall Study|Screening up-to-date|13|||
125295895|NCT02477553|450709565|FG000|Overall Study|No MD visit|1|||
125295896|NCT02477553|450709566|FG001|Overall Study|No MD visit|1|||
125465052|NCT02988817|451334030|FG003|Overall Study|Lost to Follow-up|0|||
125465053|NCT02988817|451334031|FG004|Overall Study|Lost to Follow-up|0|||
125465054|NCT02988817|451334032|FG005|Overall Study|Lost to Follow-up|0|||
125465055|NCT02988817|451334033|FG006|Overall Study|Lost to Follow-up|0|||
125465056|NCT02988817|451334034|FG007|Overall Study|Lost to Follow-up|0|||
125465057|NCT02988817|451334035|FG008|Overall Study|Lost to Follow-up|1|||
125465058|NCT02988817|451334036|FG009|Overall Study|Lost to Follow-up|0|||
125465059|NCT02988817|451334037|FG010|Overall Study|Lost to Follow-up|1|||
125465060|NCT02988817|451334038|FG011|Overall Study|Lost to Follow-up|1|||
125465061|NCT02988817|451334039|FG012|Overall Study|Lost to Follow-up|0|||
125465062|NCT02988817|451334040|FG013|Overall Study|Lost to Follow-up|0|||
125465063|NCT02988817|451334041|FG014|Overall Study|Lost to Follow-up|1|||
125295897|NCT02477553|450709565|FG000|Overall Study|Workup consistent w/CRC|1|||
125295898|NCT02477553|450709566|FG001|Overall Study|Workup consistent w/CRC|1|||
125295899|NCT02477553|450709565|FG000|Overall Study|Technical issues with intervention|2|||
125465064|NCT02988817|451334042|FG015|Overall Study|Lost to Follow-up|1|||
125295900|NCT02477553|450709566|FG001|Overall Study|Technical issues with intervention|0|||
125295901|NCT02477553|450709565|FG000|Overall Study|Elevated risk for CRC|2|||
125295902|NCT02477553|450709566|FG001|Overall Study|Elevated risk for CRC|2|||
125295903|NCT02477553|450709565|FG000|Overall Study|MD advised against screening|1|||
125465065|NCT02988817|451334043|FG016|Overall Study|Lost to Follow-up|2|||
125465066|NCT02988817|451334044|FG017|Overall Study|Lost to Follow-up|3|||
125465067|NCT02988817|451334045|FG018|Overall Study|Lost to Follow-up|0|||
125465068|NCT02988817|451334046|FG019|Overall Study|Lost to Follow-up|0|||
125465069|NCT02988817|451334027|FG000|Overall Study|Sponsor decision|0|||
125465070|NCT02988817|451334028|FG001|Overall Study|Sponsor decision|0|||
125465071|NCT02988817|451334029|FG002|Overall Study|Sponsor decision|0|||
125295904|NCT02477553|450709566|FG001|Overall Study|MD advised against screening|3|||
125295905|NCT02477553|450709565|FG000|Overall Study|patient deceased|1|||
125295906|NCT02477553|450709566|FG001|Overall Study|patient deceased|0|||
125295907|NCT02963701|450709567|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
125295908|NCT02963701|450709568|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
125295909|NCT00896649|450709571|FG000|Overall Study|Physician Decision|1|||
125295910|NCT00896649|450709571|FG000|Overall Study|Pregnancy|1|||
125295911|NCT00896649|450709571|FG000|Overall Study|missing documentation|1|||
125295912|NCT00896649|450709571|FG000|Overall Study|technical difficulties|2|||
125295913|NCT03652675|450709572|FG000|Overall Study|Lost to Follow-up|4|||
125295914|NCT03652675|450709573|FG001|Overall Study|Lost to Follow-up|4|||
125295915|NCT03442296|450709574|FG000|3 Month Follow-up|Death|3|||
125295916|NCT03442296|450709575|FG001|3 Month Follow-up|Death|1|||
125295917|NCT03442296|450709574|FG000|3 Month Follow-up|Lost to Follow-up|1|||
125465072|NCT02988817|451334030|FG003|Overall Study|Sponsor decision|0|||
125465073|NCT02988817|451334031|FG004|Overall Study|Sponsor decision|0|||
125465074|NCT02988817|451334032|FG005|Overall Study|Sponsor decision|0|||
125465075|NCT02988817|451334033|FG006|Overall Study|Sponsor decision|0|||
125465076|NCT02988817|451334034|FG007|Overall Study|Sponsor decision|0|||
125465077|NCT02988817|451334035|FG008|Overall Study|Sponsor decision|0|||
125465078|NCT02988817|451334036|FG009|Overall Study|Sponsor decision|0|||
125465079|NCT02988817|451334037|FG010|Overall Study|Sponsor decision|0|||
125465080|NCT02988817|451334038|FG011|Overall Study|Sponsor decision|1|||
125465081|NCT02988817|451334039|FG012|Overall Study|Sponsor decision|1|||
125465082|NCT02988817|451334040|FG013|Overall Study|Sponsor decision|2|||
125465083|NCT02988817|451334041|FG014|Overall Study|Sponsor decision|2|||
125465084|NCT02988817|451334042|FG015|Overall Study|Sponsor decision|6|||
125465085|NCT02988817|451334043|FG016|Overall Study|Sponsor decision|2|||
125465086|NCT02988817|451334044|FG017|Overall Study|Sponsor decision|3|||
125465087|NCT02988817|451334045|FG018|Overall Study|Sponsor decision|2|||
125465088|NCT02988817|451334046|FG019|Overall Study|Sponsor decision|7|||
125465089|NCT02988817|451334027|FG000|Overall Study|Physician Decision|0|||
125465090|NCT02988817|451334028|FG001|Overall Study|Physician Decision|0|||
125465091|NCT02988817|451334029|FG002|Overall Study|Physician Decision|0|||
125465092|NCT02988817|451334030|FG003|Overall Study|Physician Decision|0|||
125465093|NCT02988817|451334031|FG004|Overall Study|Physician Decision|0|||
125465094|NCT02988817|451334032|FG005|Overall Study|Physician Decision|0|||
125465095|NCT02988817|451334033|FG006|Overall Study|Physician Decision|0|||
125465096|NCT02988817|451334034|FG007|Overall Study|Physician Decision|0|||
125465097|NCT02988817|451334035|FG008|Overall Study|Physician Decision|0|||
125465098|NCT02988817|451334036|FG009|Overall Study|Physician Decision|0|||
125465099|NCT02988817|451334037|FG010|Overall Study|Physician Decision|0|||
125465100|NCT02988817|451334038|FG011|Overall Study|Physician Decision|0|||
125465101|NCT02988817|451334039|FG012|Overall Study|Physician Decision|0|||
125465102|NCT02988817|451334040|FG013|Overall Study|Physician Decision|0|||
125465103|NCT02988817|451334041|FG014|Overall Study|Physician Decision|0|||
125465104|NCT02988817|451334042|FG015|Overall Study|Physician Decision|1|||
125465105|NCT02988817|451334043|FG016|Overall Study|Physician Decision|0|||
125465106|NCT02988817|451334044|FG017|Overall Study|Physician Decision|0|||
125465107|NCT02988817|451334045|FG018|Overall Study|Physician Decision|1|||
125465108|NCT02988817|451334046|FG019|Overall Study|Physician Decision|1|||
125465109|NCT03292913|451334047|FG000|Overall Study|Death|9|||
125465110|NCT03292913|451334048|FG001|Overall Study|Death|3|||
125465111|NCT03292913|451334047|FG000|Overall Study|Lost to Follow-up|49|||
125465112|NCT03292913|451334048|FG001|Overall Study|Lost to Follow-up|49|||
125465113|NCT03292913|451334047|FG000|Overall Study|Withdrawal by Subject|2|||
125465114|NCT03292913|451334048|FG001|Overall Study|Withdrawal by Subject|0|||
125465115|NCT03292913|451334047|FG000|Overall Study|Clinic closed due to COVID|22|||
125465116|NCT03292913|451334048|FG001|Overall Study|Clinic closed due to COVID|36|||
125465117|NCT03950622|451334049|FG000|Overall Study|Withdrawal by Subject|1|||
125465118|NCT03950622|451334050|FG001|Overall Study|Withdrawal by Subject|0|||
125465119|NCT03950622|451334049|FG000|Overall Study|Protocol Deviation|0|||
125465120|NCT03950622|451334050|FG001|Overall Study|Protocol Deviation|1|||
125295918|NCT03442296|450709575|FG001|3 Month Follow-up|Lost to Follow-up|1|||
125295919|NCT03442296|450709574|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
125465121|NCT03950622|451334049|FG000|Overall Study|Physician Decision|1|||
125465122|NCT03950622|451334050|FG001|Overall Study|Physician Decision|0|||
125465123|NCT03950622|451334049|FG000|Overall Study|Lost to Follow-up|5|||
125465124|NCT03950622|451334050|FG001|Overall Study|Lost to Follow-up|5|||
125295920|NCT03442296|450709575|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
125295921|NCT03442296|450709574|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
125295922|NCT03442296|450709575|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
125465125|NCT03950622|451334049|FG000|Overall Study|Death|1|||
125465126|NCT03950622|451334050|FG001|Overall Study|Death|1|||
125465127|NCT03051165|451334053|FG000|Overall Study|Withdrawal by Subject|1|||
125465128|NCT03051165|451334053|FG000|Overall Study|Early termination of study|12|||
125465129|NCT02092116|451334054|FG000|Overall Study|Withdrawal by Subject|0|||
125465130|NCT02092116|451334055|FG001|Overall Study|Withdrawal by Subject|3|||
125465131|NCT02092116|451334054|FG000|Overall Study|Adverse Event|0|||
125465132|NCT02092116|451334055|FG001|Overall Study|Adverse Event|1|||
125465133|NCT03074331|451334056|FG000|Overall Study|Enrolled but Not Treated|1|||
125465134|NCT03074331|451334056|FG000|Overall Study|Lost to Follow-up|5|||
125465135|NCT03074331|451334056|FG000|Overall Study|Withdrew Consent|1|||
125465136|NCT01546753|451334057|FG000|Overall Study|anxiety|1|||
125465137|NCT01546753|451334058|FG001|Overall Study|anxiety|1|||
125465138|NCT01546753|451334057|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
125465139|NCT01546753|451334058|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
125465140|NCT00939510|451334059|FG000|Overall Study|Withdrawal by Subject|1|||
125465141|NCT00546754|451334067|FG000|Overall Study|Serious Adverse Event|1|||
125465142|NCT00546754|451334068|FG001|Overall Study|Serious Adverse Event|1|||
125465143|NCT00546754|451334067|FG000|Overall Study|Adverse Event|11|||
125465144|NCT00546754|451334068|FG001|Overall Study|Adverse Event|16|||
125465145|NCT00546754|451334067|FG000|Overall Study|Lack of Efficacy|1|||
125465146|NCT00546754|451334068|FG001|Overall Study|Lack of Efficacy|1|||
125465147|NCT00546754|451334067|FG000|Overall Study|Lost to Follow-up|9|||
125465148|NCT00546754|451334068|FG001|Overall Study|Lost to Follow-up|15|||
125465149|NCT00546754|451334067|FG000|Overall Study|Protocol Violation|3|||
125465150|NCT00546754|451334068|FG001|Overall Study|Protocol Violation|0|||
125465151|NCT00546754|451334067|FG000|Overall Study|Withdrawal by Subject|6|||
125465152|NCT00546754|451334068|FG001|Overall Study|Withdrawal by Subject|7|||
125465153|NCT00546754|451334067|FG000|Overall Study|Dyspnea|1|||
125465154|NCT00546754|451334068|FG001|Overall Study|Dyspnea|0|||
125465155|NCT00546754|451334067|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
125465156|NCT00546754|451334068|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
125465157|NCT00546754|451334067|FG000|Overall Study|Hip Replacement|1|||
125465158|NCT00546754|451334068|FG001|Overall Study|Hip Replacement|0|||
125465159|NCT00546754|451334067|FG000|Overall Study|Suicide|1|||
125465160|NCT00546754|451334068|FG001|Overall Study|Suicide|0|||
125465161|NCT00546754|451334067|FG000|Overall Study|Missing Cooperation|1|||
125465162|NCT00546754|451334068|FG001|Overall Study|Missing Cooperation|0|||
125465163|NCT00546754|451334067|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
125465164|NCT00546754|451334068|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
125465165|NCT00546754|451334067|FG000|Overall Study|Patient's Decision|0|||
125465166|NCT00546754|451334068|FG001|Overall Study|Patient's Decision|1|||
125465167|NCT00546754|451334067|FG000|Overall Study|Missing|14|||
125465168|NCT00546754|451334068|FG001|Overall Study|Missing|7|||
125465169|NCT03830866|451334071|FG000|Overall Study|Death|90|||
125465170|NCT03830866|451334072|FG001|Overall Study|Death|111|||
125465171|NCT03830866|451334071|FG000|Overall Study|Lost to Follow-up|7|||
125465172|NCT03830866|451334072|FG001|Overall Study|Lost to Follow-up|7|||
125465173|NCT03830866|451334071|FG000|Overall Study|Withdrawal by Subject|19|||
125465174|NCT03830866|451334072|FG001|Overall Study|Withdrawal by Subject|16|||
125465175|NCT03830866|451334071|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
125465176|NCT03830866|451334072|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
125465177|NCT03830866|451334071|FG000|Overall Study|Other|1|||
125465178|NCT03830866|451334072|FG001|Overall Study|Other|1|||
125465179|NCT00311363|451334073|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
125465180|NCT00311363|451334074|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
125465181|NCT00311363|451334075|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
125465182|NCT00311363|451334073|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
125465183|NCT00311363|451334074|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
125465184|NCT00311363|451334075|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
125465185|NCT00311363|451334073|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
125465186|NCT00311363|451334074|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
125465187|NCT00311363|451334075|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
125465188|NCT00311363|451334073|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
125465189|NCT00311363|451334074|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
125465190|NCT00311363|451334075|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
125465191|NCT00311363|451334073|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
125465192|NCT00311363|451334074|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
125465193|NCT00311363|451334075|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
125465194|NCT00311363|451334073|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
125465195|NCT00311363|451334074|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
125465196|NCT00311363|451334075|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
125465197|NCT00311363|451334073|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
125465198|NCT00311363|451334074|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
125465199|NCT00311363|451334075|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
125465200|NCT00311363|451334073|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
125465201|NCT00311363|451334074|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
125465202|NCT00311363|451334075|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
125465203|NCT00311363|451334073|FG000|24-Week Single-Blind Treatment Period|Death|1|||
125465204|NCT00311363|451334074|FG001|24-Week Single-Blind Treatment Period|Death|0|||
125465205|NCT00311363|451334075|FG002|24-Week Single-Blind Treatment Period|Death|0|||
125465206|NCT00311363|451334073|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
125465207|NCT00311363|451334074|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
125465208|NCT00311363|451334075|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
125465209|NCT00311363|451334073|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
125465210|NCT00311363|451334074|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
125465211|NCT00311363|451334075|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
125465212|NCT00311363|451334073|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
125465213|NCT00311363|451334074|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
125465214|NCT00311363|451334075|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
125465215|NCT00311363|451334073|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
125465216|NCT00311363|451334074|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
125465217|NCT00311363|451334075|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
125465218|NCT00311363|451334073|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
125465219|NCT00311363|451334074|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
125465220|NCT00311363|451334075|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
125465221|NCT00311363|451334073|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
125465222|NCT00311363|451334074|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
125465223|NCT00311363|451334075|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
125465224|NCT01759771|451334078|FG000|Overall Study|Withdrawal by Subject|1|||
125465225|NCT01759771|451334079|FG001|Overall Study|Withdrawal by Subject|1|||
125465226|NCT03942042|451334080|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
125465227|NCT03942042|451334081|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
125465228|NCT03942042|451334080|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
125465229|NCT03942042|451334081|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
125465230|NCT01849055|451334084|FG000|Overall Study|Withdrawal by Subject|0|||
125465231|NCT01849055|451334085|FG001|Overall Study|Withdrawal by Subject|0|||
125465232|NCT01849055|451334086|FG002|Overall Study|Withdrawal by Subject|1|||
125465233|NCT01849055|451334087|FG003|Overall Study|Withdrawal by Subject|0|||
125465234|NCT01849055|451334088|FG004|Overall Study|Withdrawal by Subject|0|||
125465235|NCT01849055|451334089|FG005|Overall Study|Withdrawal by Subject|0|||
125465236|NCT01239316|451334090|FG000|Overall Study|Progression/Relapse|11|||
125465237|NCT01239316|451334090|FG000|Overall Study|Adverse Event|1|||
125465238|NCT02139943|451334091|FG000|Overall Study|Adverse Event|0|||
125465239|NCT02139943|451334092|FG001|Overall Study|Adverse Event|1|||
125465240|NCT02139943|451334093|FG002|Overall Study|Adverse Event|2|||
125465241|NCT02139943|451334091|FG000|Overall Study|Lost to Follow-up|3|||
125465242|NCT02139943|451334092|FG001|Overall Study|Lost to Follow-up|2|||
125465243|NCT02139943|451334093|FG002|Overall Study|Lost to Follow-up|2|||
125465244|NCT02139943|451334091|FG000|Overall Study|Withdrawal by Subject|4|||
125465245|NCT02139943|451334092|FG001|Overall Study|Withdrawal by Subject|3|||
125465246|NCT02139943|451334093|FG002|Overall Study|Withdrawal by Subject|0|||
125465247|NCT02139943|451334091|FG000|Overall Study|Other|0|||
125465248|NCT02139943|451334092|FG001|Overall Study|Other|0|||
125465249|NCT02139943|451334093|FG002|Overall Study|Other|1|||
125465250|NCT02139943|451334091|FG000|Overall Study|Participant wishes to discontinue|2|||
125465251|NCT02139943|451334092|FG001|Overall Study|Participant wishes to discontinue|0|||
125465252|NCT02139943|451334093|FG002|Overall Study|Participant wishes to discontinue|0|||
125465253|NCT02139943|451334091|FG000|Overall Study|Participant in Poor Compliance|1|||
125465254|NCT02139943|451334092|FG001|Overall Study|Participant in Poor Compliance|0|||
125465255|NCT02139943|451334093|FG002|Overall Study|Participant in Poor Compliance|1|||
125465256|NCT02139943|451334091|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
125465257|NCT02139943|451334092|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
125465258|NCT02139943|451334093|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
125465259|NCT00716859|451334096|FG000|Overall Study|Adverse Event|4|||
125465260|NCT00716859|451334097|FG001|Overall Study|Adverse Event|1|||
125465261|NCT00716859|451334096|FG000|Overall Study|Lack of Efficacy|3|||
125465262|NCT00716859|451334097|FG001|Overall Study|Lack of Efficacy|0|||
125465263|NCT00716859|451334096|FG000|Overall Study|Withdrawal by Subject|1|||
125465264|NCT00716859|451334097|FG001|Overall Study|Withdrawal by Subject|3|||
125465265|NCT00716859|451334096|FG000|Overall Study|Not treated|1|||
125465266|NCT00716859|451334097|FG001|Overall Study|Not treated|1|||
125465267|NCT03750968|451334098|FG000|Overall Study|Adverse Event|2|||
125465268|NCT03750968|451334099|FG001|Overall Study|Adverse Event|0|||
125465269|NCT03750968|451334098|FG000|Overall Study|Lost to Follow-up|1|||
125465270|NCT03750968|451334099|FG001|Overall Study|Lost to Follow-up|3|||
125465271|NCT00088413|451334102|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
125465272|NCT00088413|451334103|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
125465273|NCT00088413|451334104|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
125465274|NCT00088413|451334105|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
125465275|NCT00088413|451334102|FG000|Overall Study|Adverse Events/Side Effects|0|||
125465276|NCT00088413|451334103|FG001|Overall Study|Adverse Events/Side Effects|1|||
125465277|NCT00088413|451334104|FG002|Overall Study|Adverse Events/Side Effects|1|||
125465278|NCT00088413|451334105|FG003|Overall Study|Adverse Events/Side Effects|0|||
125465279|NCT00088413|451334102|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
125465280|NCT00088413|451334103|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
125465281|NCT00088413|451334104|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
125465282|NCT00088413|451334105|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
125465283|NCT00088413|451334102|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
125465284|NCT00088413|451334103|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
125465285|NCT00088413|451334104|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
125465286|NCT00088413|451334105|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
125465287|NCT00088413|451334102|FG000|Overall Study|Death|0|||
125465288|NCT00088413|451334103|FG001|Overall Study|Death|1|||
125465289|NCT00088413|451334104|FG002|Overall Study|Death|0|||
125465290|NCT00088413|451334105|FG003|Overall Study|Death|0|||
125465291|NCT00088413|451334102|FG000|Overall Study|Progressive disease|9|||
125465292|NCT00088413|451334103|FG001|Overall Study|Progressive disease|11|||
125465293|NCT00088413|451334104|FG002|Overall Study|Progressive disease|8|||
125465294|NCT00088413|451334105|FG003|Overall Study|Progressive disease|14|||
125465295|NCT00088413|451334102|FG000|Overall Study|Other|0|||
125465296|NCT00088413|451334103|FG001|Overall Study|Other|1|||
125465297|NCT00088413|451334104|FG002|Overall Study|Other|0|||
125465298|NCT00088413|451334105|FG003|Overall Study|Other|0|||
125465299|NCT00088413|451334102|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
125465300|NCT00088413|451334103|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
125465301|NCT00088413|451334104|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
125465302|NCT00088413|451334105|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
125465303|NCT01551355|451334108|FG000|Overall Study|Lost to Follow-up|51|||
125465304|NCT01551355|451334109|FG001|Overall Study|Lost to Follow-up|49|||
125465305|NCT01551355|451334110|FG002|Overall Study|Lost to Follow-up|34|||
125465306|NCT01551355|451334111|FG003|Overall Study|Lost to Follow-up|24|||
125465307|NCT01551355|451334112|FG004|Overall Study|Lost to Follow-up|9|||
125465308|NCT01551355|451334113|FG005|Overall Study|Lost to Follow-up|6|||
125465309|NCT00411216|451334114|FG000|Overall Study|Ten participants were entered into the c|0|||
125465310|NCT00411216|451334115|FG001|Overall Study|Ten participants were entered into the c|2|||
125465311|NCT02918071|451334116|FG000|Overall Study|Withdrawal by Subject|2|||
125465312|NCT02918071|451334116|FG000|Overall Study|Lost to Follow-up|1|||
125465313|NCT00203411|451334119|FG000|Follow-up|Progressive Disease|4|||
125465314|NCT02531113|451334122|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
125465315|NCT02531113|451334122|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
125465316|NCT02531113|451334122|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
125465317|NCT02531113|451334122|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
125465318|NCT02531113|451334122|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
125465319|NCT02531113|451334122|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
125465320|NCT02531113|451334122|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
125465321|NCT02531113|451334122|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
125465322|NCT00632424|451334123|FG000|Overall Study|Disease Progression|17|||
125465323|NCT00632424|451334123|FG000|Overall Study|Study Drug Toxicity|1|||
125465324|NCT03122886|451335294|FG000|Overall Study|Withdrawal by Subject|1|||
125465325|NCT03122886|451335295|FG001|Overall Study|Withdrawal by Subject|2|||
125465326|NCT03422276|451335296|FG000|Overall Study|Withdrawal by Subject|21|||
125465327|NCT03422276|451335297|FG001|Overall Study|Withdrawal by Subject|25|||
125465328|NCT03422276|451335298|FG002|Overall Study|Withdrawal by Subject|14|||
125465329|NCT03422276|451335299|FG003|Overall Study|Withdrawal by Subject|16|||
125465330|NCT03422276|451335296|FG000|Overall Study|Death|14|||
125465331|NCT03422276|451335297|FG001|Overall Study|Death|21|||
125465332|NCT03422276|451335298|FG002|Overall Study|Death|3|||
125465333|NCT03422276|451335299|FG003|Overall Study|Death|1|||
125465334|NCT03422276|451335296|FG000|Overall Study|Discontinued, ineligible|4|||
125465335|NCT03422276|451335297|FG001|Overall Study|Discontinued, ineligible|3|||
125465336|NCT03422276|451335298|FG002|Overall Study|Discontinued, ineligible|0|||
125465337|NCT03422276|451335299|FG003|Overall Study|Discontinued, ineligible|0|||
125465338|NCT03422276|451335296|FG000|Overall Study|Lost to Follow-up|15|||
125465339|NCT03422276|451335297|FG001|Overall Study|Lost to Follow-up|8|||
125465340|NCT03422276|451335298|FG002|Overall Study|Lost to Follow-up|13|||
125465341|NCT03422276|451335299|FG003|Overall Study|Lost to Follow-up|4|||
125465342|NCT03422276|451335296|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
125465343|NCT03422276|451335297|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
125295923|NCT03442296|450709574|FG000|12 Month Follow-up|Incomplete measurement|1|||
125295924|NCT03442296|450709575|FG001|12 Month Follow-up|Incomplete measurement|1|||
125465344|NCT03422276|451335298|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
125485367|NCT02240238|451412505|FG002|Phase 1|Sponsor termination|0|||
125465345|NCT03422276|451335299|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
125465346|NCT03422276|451335296|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
125465347|NCT03422276|451335297|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
125465348|NCT03422276|451335298|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
125465349|NCT03422276|451335299|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
125465350|NCT03422276|451335296|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
125465351|NCT03422276|451335297|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
125465352|NCT03422276|451335298|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
125465353|NCT03422276|451335299|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
125465354|NCT03422276|451335296|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
125465355|NCT03422276|451335297|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
125465356|NCT03422276|451335298|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
125465357|NCT03422276|451335299|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
125465358|NCT03422276|451335296|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
125465359|NCT03422276|451335297|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
125465360|NCT03422276|451335298|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
125465361|NCT03422276|451335299|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
125465362|NCT05985044|451335300|FG000|Overall Study|Death|6|||
125295925|NCT00707954|450711402|FG000|Overall Study|Physician Decision|0|||
125465363|NCT05985044|451335300|FG000|Overall Study|Lost to Follow-up|4|||
125465364|NCT05985044|451335300|FG000|Overall Study|Incapacitation|3|||
125465365|NCT05985044|451335300|FG000|Overall Study|Withdrawal by Subject|2|||
125465366|NCT05644444|451335301|FG000|Tolerance Phase|Adverse Event|0|||
125465367|NCT05644444|451335302|FG001|Tolerance Phase|Adverse Event|2|||
125465368|NCT05644444|451335301|FG000|Treatment Phase|Adverse Event|0|||
125465369|NCT05644444|451335302|FG001|Treatment Phase|Adverse Event|2|||
125465370|NCT03936660|451335303|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
125465371|NCT03936660|451335304|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
125465372|NCT04723394|451335306|FG000|Overall Study|Adverse Event|0|||
125465373|NCT04723394|451335307|FG001|Overall Study|Adverse Event|3|||
125465374|NCT04723394|451335306|FG000|Overall Study|Death|8|||
125465375|NCT04723394|451335307|FG001|Overall Study|Death|8|||
125465376|NCT04723394|451335306|FG000|Overall Study|Lost to Follow-up|20|||
125465377|NCT04723394|451335307|FG001|Overall Study|Lost to Follow-up|17|||
125465378|NCT04723394|451335306|FG000|Overall Study|Physician Decision|1|||
125465379|NCT04723394|451335307|FG001|Overall Study|Physician Decision|0|||
125465380|NCT04723394|451335306|FG000|Overall Study|Withdrawal by Subject|20|||
125465381|NCT04723394|451335307|FG001|Overall Study|Withdrawal by Subject|34|||
125465382|NCT04723394|451335306|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
125465383|NCT04723394|451335307|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
125465384|NCT02765100|451335313|FG000|Overall Study|subject found ineligible after baseline|1|||
125465385|NCT02765100|451335314|FG001|Overall Study|subject found ineligible after baseline|1|||
125465386|NCT02765100|451335313|FG000|Overall Study|Lost to Follow-up|0|||
125465387|NCT02765100|451335314|FG001|Overall Study|Lost to Follow-up|1|||
125465388|NCT02675244|451335315|FG000|Overall Study|Death|9|||
125465389|NCT02675244|451335316|FG001|Overall Study|Death|6|||
125465390|NCT02675244|451335315|FG000|Overall Study|Withdrawal by Subject|3|||
125465391|NCT02675244|451335316|FG001|Overall Study|Withdrawal by Subject|6|||
125465392|NCT02675244|451335315|FG000|Overall Study|Lost to Follow-up|1|||
125465393|NCT02675244|451335316|FG001|Overall Study|Lost to Follow-up|1|||
125465394|NCT02675244|451335315|FG000|Overall Study|Ongoing at 2 Years|190|||
125465395|NCT02675244|451335316|FG001|Overall Study|Ongoing at 2 Years|185|||
125465396|NCT02652442|451335317|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
125465397|NCT00914589|451335324|FG000|Overall Study|Adverse Event|1|||
125465398|NCT00914589|451335325|FG001|Overall Study|Adverse Event|0|||
125465399|NCT00914589|451335326|FG002|Overall Study|Adverse Event|1|||
125465400|NCT00914589|451335324|FG000|Overall Study|Protocol Violation|8|||
125465401|NCT00914589|451335325|FG001|Overall Study|Protocol Violation|6|||
125465402|NCT00914589|451335326|FG002|Overall Study|Protocol Violation|3|||
125465403|NCT00914589|451335324|FG000|Overall Study|unclassified|16|||
125465404|NCT00914589|451335325|FG001|Overall Study|unclassified|9|||
125465405|NCT00914589|451335326|FG002|Overall Study|unclassified|7|||
125465406|NCT00914589|451335324|FG000|Overall Study|Death|0|||
125465407|NCT00914589|451335325|FG001|Overall Study|Death|1|||
125465408|NCT00914589|451335326|FG002|Overall Study|Death|1|||
125465409|NCT03036813|451335331|FG000|Overall Study|Adverse Event|6|||
125465410|NCT03036813|451335332|FG001|Overall Study|Adverse Event|11|||
125465411|NCT03036813|451335333|FG002|Overall Study|Adverse Event|6|||
125465412|NCT03036813|451335331|FG000|Overall Study|Withdrawal by Subject|12|||
125295926|NCT00707954|450711403|FG001|Overall Study|Physician Decision|0|||
125295927|NCT00707954|450711404|FG002|Overall Study|Physician Decision|0|||
125465413|NCT03036813|451335332|FG001|Overall Study|Withdrawal by Subject|6|||
125465414|NCT03036813|451335333|FG002|Overall Study|Withdrawal by Subject|10|||
125465415|NCT03036813|451335331|FG000|Overall Study|Lost to Follow-up|1|||
125465416|NCT03036813|451335332|FG001|Overall Study|Lost to Follow-up|1|||
125465417|NCT03036813|451335333|FG002|Overall Study|Lost to Follow-up|0|||
125465418|NCT03036813|451335331|FG000|Overall Study|Physician Decision|2|||
125465419|NCT03036813|451335332|FG001|Overall Study|Physician Decision|1|||
125465420|NCT03036813|451335333|FG002|Overall Study|Physician Decision|1|||
125465421|NCT03036813|451335331|FG000|Overall Study|Non-Compliance|1|||
125465422|NCT03036813|451335332|FG001|Overall Study|Non-Compliance|5|||
125465423|NCT03036813|451335333|FG002|Overall Study|Non-Compliance|3|||
125465424|NCT03036813|451335331|FG000|Overall Study|Pregnancy|0|||
125465425|NCT03036813|451335332|FG001|Overall Study|Pregnancy|0|||
125465426|NCT03036813|451335333|FG002|Overall Study|Pregnancy|1|||
125465427|NCT03036813|451335331|FG000|Overall Study|Other|0|||
125465428|NCT03036813|451335332|FG001|Overall Study|Other|3|||
125465429|NCT03036813|451335333|FG002|Overall Study|Other|5|||
125465430|NCT01102231|451335334|FG000|Overall Study|Protocol Violation|3|||
125465431|NCT01102231|451335334|FG000|Overall Study|Lack of Efficacy|2|||
125465432|NCT01102231|451335334|FG000|Overall Study|Death|2|||
125465433|NCT01102231|451335334|FG000|Overall Study|Adverse Event|3|||
125465434|NCT01102231|451335334|FG000|Overall Study|Withdrawal by Subject|1|||
125465435|NCT01102231|451335334|FG000|Overall Study|Did not received the treatment|4|||
125465436|NCT03903822|451335335|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
125465437|NCT03903822|451335336|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
125465438|NCT03903822|451335337|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
125465439|NCT03903822|451335338|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
125465440|NCT03903822|451335339|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
125465441|NCT03903822|451335340|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
125465442|NCT03903822|451335341|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
125465443|NCT03903822|451335342|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
125465444|NCT03903822|451335335|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
125465445|NCT03903822|451335336|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
125465446|NCT03903822|451335337|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
125465447|NCT03903822|451335338|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
125465448|NCT03903822|451335339|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
125465449|NCT03903822|451335340|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
125465450|NCT03903822|451335341|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
125465451|NCT03903822|451335342|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
125465452|NCT03903822|451335335|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
125465453|NCT03903822|451335336|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
125465454|NCT03903822|451335337|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
125465455|NCT03903822|451335338|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
125465456|NCT03903822|451335339|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
125465457|NCT03903822|451335340|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
125465458|NCT03903822|451335341|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
125465459|NCT03903822|451335342|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
125465460|NCT03903822|451335335|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
125465461|NCT03903822|451335336|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
125465462|NCT03903822|451335337|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
125465463|NCT03903822|451335338|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
125465464|NCT03903822|451335339|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
125465465|NCT03903822|451335340|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
125465466|NCT03903822|451335341|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
125465467|NCT03903822|451335342|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
125465468|NCT03903822|451335335|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
125465469|NCT03903822|451335336|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
125465470|NCT03903822|451335337|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
125465471|NCT03903822|451335338|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
125465472|NCT03903822|451335339|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
125465473|NCT03903822|451335340|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
125465474|NCT03903822|451335341|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
125465475|NCT03903822|451335342|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
125465476|NCT03903822|451335335|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
125465477|NCT03903822|451335336|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
125465478|NCT03903822|451335337|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
125465479|NCT03903822|451335338|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
125465480|NCT03903822|451335339|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
125465481|NCT03903822|451335340|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
125465482|NCT03903822|451335341|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
125465483|NCT03903822|451335342|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
125465484|NCT03903822|451335335|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
125465485|NCT03903822|451335336|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
125465486|NCT03903822|451335337|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
125465487|NCT03903822|451335338|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
125465488|NCT03903822|451335339|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
125465489|NCT03903822|451335340|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
125465490|NCT03903822|451335341|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
125465491|NCT03903822|451335342|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
125465492|NCT03903822|451335335|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
125465493|NCT03903822|451335336|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
125465494|NCT03903822|451335337|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
125465495|NCT03903822|451335338|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
125465496|NCT03903822|451335339|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
125465497|NCT03903822|451335340|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
125465498|NCT03903822|451335341|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
125465499|NCT03903822|451335342|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
125465500|NCT03903822|451335335|FG000|Treatment Phase (6 Weeks)|Other|2|||
125465501|NCT03903822|451335336|FG001|Treatment Phase (6 Weeks)|Other|1|||
125465502|NCT03903822|451335337|FG002|Treatment Phase (6 Weeks)|Other|0|||
125465503|NCT03903822|451335338|FG003|Treatment Phase (6 Weeks)|Other|0|||
125465504|NCT03903822|451335339|FG004|Treatment Phase (6 Weeks)|Other|1|||
125465505|NCT03903822|451335340|FG005|Treatment Phase (6 Weeks)|Other|1|||
125465506|NCT03903822|451335341|FG006|Treatment Phase (6 Weeks)|Other|0|||
125465507|NCT03903822|451335342|FG007|Treatment Phase (6 Weeks)|Other|0|||
125465508|NCT03903822|451335335|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
125465509|NCT03903822|451335336|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
125465510|NCT03903822|451335337|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
125465511|NCT03903822|451335338|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
125465512|NCT03903822|451335339|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
125465513|NCT03903822|451335340|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
125465514|NCT03903822|451335341|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
125465515|NCT03903822|451335342|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
125465516|NCT03903822|451335335|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
125465517|NCT03903822|451335336|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
125465518|NCT03903822|451335337|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
125465519|NCT03903822|451335338|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
125465520|NCT03903822|451335339|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
125465521|NCT03903822|451335340|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
125465522|NCT03903822|451335341|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
125465523|NCT03903822|451335342|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
125465524|NCT03903822|451335335|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
125465525|NCT03903822|451335336|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
125465526|NCT03903822|451335337|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
125465527|NCT03903822|451335338|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
125465528|NCT03903822|451335339|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
125465529|NCT03903822|451335340|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
125465530|NCT03903822|451335341|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
125465531|NCT03903822|451335342|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
125465532|NCT03903822|451335335|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
125465533|NCT03903822|451335336|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
125465534|NCT03903822|451335337|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
125465535|NCT03903822|451335338|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
125465536|NCT03903822|451335339|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
125465537|NCT03903822|451335340|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
125465538|NCT03903822|451335341|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
125465539|NCT03903822|451335342|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
125465540|NCT03903822|451335335|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
125465541|NCT03903822|451335336|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
125465542|NCT03903822|451335337|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
125465543|NCT03903822|451335338|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
125465544|NCT03903822|451335339|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
125465545|NCT03903822|451335340|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
125465546|NCT03903822|451335341|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
125465547|NCT03903822|451335342|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
125465548|NCT03903822|451335335|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
125465549|NCT03903822|451335336|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
125465550|NCT03903822|451335337|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
125465551|NCT03903822|451335338|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
125465552|NCT03903822|451335339|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
125465553|NCT03903822|451335340|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
125465554|NCT03903822|451335341|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
125465555|NCT03903822|451335342|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
125465556|NCT03903822|451335335|FG000|Follow up Phase (4 Weeks)|Other|1|||
125465557|NCT03903822|451335336|FG001|Follow up Phase (4 Weeks)|Other|1|||
125465558|NCT03903822|451335337|FG002|Follow up Phase (4 Weeks)|Other|0|||
125465559|NCT03903822|451335338|FG003|Follow up Phase (4 Weeks)|Other|0|||
125465560|NCT03903822|451335339|FG004|Follow up Phase (4 Weeks)|Other|0|||
125465561|NCT03903822|451335340|FG005|Follow up Phase (4 Weeks)|Other|0|||
125465562|NCT03903822|451335341|FG006|Follow up Phase (4 Weeks)|Other|0|||
125465563|NCT03903822|451335342|FG007|Follow up Phase (4 Weeks)|Other|0|||
125465564|NCT00785512|451335343|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
125465565|NCT00785512|451335344|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
125465566|NCT00785512|451335343|FG000|Overall Study|Adverse Event|0|||
125465567|NCT00785512|451335344|FG001|Overall Study|Adverse Event|0|||
125465568|NCT00785512|451335343|FG000|Overall Study|Lack of Efficacy|0|||
125465569|NCT00785512|451335344|FG001|Overall Study|Lack of Efficacy|2|||
125465570|NCT00785512|451335343|FG000|Overall Study|Withdrawal by Subject|0|||
125465571|NCT00785512|451335344|FG001|Overall Study|Withdrawal by Subject|1|||
125465572|NCT00785512|451335343|FG000|Overall Study|Lost to Follow-up|3|||
125465573|NCT00785512|451335344|FG001|Overall Study|Lost to Follow-up|0|||
125465574|NCT00785512|451335343|FG000|Overall Study|Precedure Refused|0|||
125465575|NCT00785512|451335344|FG001|Overall Study|Precedure Refused|0|||
125465576|NCT00785512|451335343|FG000|Overall Study|IVRS Programing Error|0|||
125465577|NCT00785512|451335344|FG001|Overall Study|IVRS Programing Error|0|||
125465578|NCT00785512|451335343|FG000|Overall Study|Physician Decision|0|||
125465579|NCT00785512|451335344|FG001|Overall Study|Physician Decision|0|||
125465580|NCT00785512|451335343|FG000|Overall Study|Lack of compliance|0|||
125465581|NCT00785512|451335344|FG001|Overall Study|Lack of compliance|1|||
125465582|NCT00529100|451335348|FG000|Overall Study|Adverse Event|0|||
125465583|NCT00529100|451335349|FG001|Overall Study|Adverse Event|5|||
125465584|NCT00529100|451335348|FG000|Overall Study|Protocol Violation|0|||
125465585|NCT00529100|451335349|FG001|Overall Study|Protocol Violation|1|||
125465586|NCT00529100|451335348|FG000|Overall Study|Progressive Disease|0|||
125465587|NCT00529100|451335349|FG001|Overall Study|Progressive Disease|1|||
125465588|NCT00529100|451335348|FG000|Overall Study|Withdrawal by Subject|0|||
125465589|NCT00529100|451335349|FG001|Overall Study|Withdrawal by Subject|1|||
125465590|NCT00529100|451335348|FG000|Overall Study|Participant Ineligibility|0|||
125465591|NCT00529100|451335349|FG001|Overall Study|Participant Ineligibility|1|||
125465592|NCT03733119|451335350|FG000|Overall Study|Physician Decision|2|||
125465593|NCT03733119|451335351|FG001|Overall Study|Physician Decision|1|||
125465594|NCT03733119|451335350|FG000|Overall Study|ineligible to treat per protocol|0|||
125465595|NCT03733119|451335351|FG001|Overall Study|ineligible to treat per protocol|1|||
125465596|NCT00807937|451335358|FG000|Overall Study|Adverse Event|12|||
125465597|NCT00807937|451335359|FG001|Overall Study|Adverse Event|12|||
125465598|NCT00807937|451335360|FG002|Overall Study|Adverse Event|5|||
125465599|NCT00807937|451335361|FG003|Overall Study|Adverse Event|4|||
125465600|NCT00807937|451335358|FG000|Overall Study|Protocol Violation|4|||
125465601|NCT00807937|451335359|FG001|Overall Study|Protocol Violation|5|||
125465602|NCT00807937|451335360|FG002|Overall Study|Protocol Violation|3|||
125465603|NCT00807937|451335361|FG003|Overall Study|Protocol Violation|3|||
125465604|NCT00807937|451335358|FG000|Overall Study|Withdrawal by Subject|5|||
125465605|NCT00807937|451335359|FG001|Overall Study|Withdrawal by Subject|4|||
125465606|NCT00807937|451335360|FG002|Overall Study|Withdrawal by Subject|1|||
125465607|NCT00807937|451335361|FG003|Overall Study|Withdrawal by Subject|4|||
125465608|NCT00807937|451335358|FG000|Overall Study|Lost to Follow-up|4|||
125465609|NCT00807937|451335359|FG001|Overall Study|Lost to Follow-up|0|||
125465610|NCT00807937|451335360|FG002|Overall Study|Lost to Follow-up|2|||
125465611|NCT00807937|451335361|FG003|Overall Study|Lost to Follow-up|1|||
125465612|NCT00807937|451335358|FG000|Overall Study|Lack of Efficacy|0|||
125465613|NCT00807937|451335359|FG001|Overall Study|Lack of Efficacy|0|||
125465614|NCT00807937|451335360|FG002|Overall Study|Lack of Efficacy|1|||
125465615|NCT00807937|451335361|FG003|Overall Study|Lack of Efficacy|2|||
125465616|NCT00807937|451335358|FG000|Overall Study|Intake of prohibited medicine|0|||
125465617|NCT00807937|451335359|FG001|Overall Study|Intake of prohibited medicine|0|||
125465618|NCT00807937|451335360|FG002|Overall Study|Intake of prohibited medicine|2|||
125465619|NCT00807937|451335361|FG003|Overall Study|Intake of prohibited medicine|0|||
125465620|NCT00807937|451335358|FG000|Overall Study|All other reasons (not provided)|2|||
125465621|NCT00807937|451335359|FG001|Overall Study|All other reasons (not provided)|4|||
125465622|NCT00807937|451335360|FG002|Overall Study|All other reasons (not provided)|0|||
125465623|NCT00807937|451335361|FG003|Overall Study|All other reasons (not provided)|1|||
125465624|NCT03485950|451335373|FG000|Overall Study|Adverse Event|1|||
125465625|NCT03485950|451335374|FG001|Overall Study|Adverse Event|0|||
125465626|NCT03485950|451335373|FG000|Overall Study|Death|3|||
125465627|NCT03485950|451335374|FG001|Overall Study|Death|2|||
125465628|NCT03485950|451335373|FG000|Overall Study|Withdrawal by Subject|3|||
125465629|NCT03485950|451335374|FG001|Overall Study|Withdrawal by Subject|0|||
125465630|NCT00988858|451335376|FG000|Overall Study|Adverse Event|7|||
125465631|NCT00988858|451335376|FG000|Overall Study|Death|1|||
125465632|NCT00988858|451335376|FG000|Overall Study|Physician Decision|1|||
125465633|NCT00988858|451335376|FG000|Overall Study|Sponsor Decision|1|||
125465634|NCT03764475|451335377|FG000|Overall Study|Adverse Event|11|||
125465635|NCT03764475|451335378|FG001|Overall Study|Adverse Event|2|||
125465636|NCT03764475|451335377|FG000|Overall Study|Lost to Follow-up|24|||
125465637|NCT03764475|451335378|FG001|Overall Study|Lost to Follow-up|10|||
125465638|NCT03764475|451335377|FG000|Overall Study|Withdrawal by Subject|26|||
125465639|NCT03764475|451335378|FG001|Overall Study|Withdrawal by Subject|10|||
125465640|NCT03764475|451335377|FG000|Overall Study|Lack of Efficacy|3|||
125465641|NCT03764475|451335378|FG001|Overall Study|Lack of Efficacy|0|||
125465642|NCT03764475|451335377|FG000|Overall Study|COVID-19 Disruption|2|||
125465643|NCT03764475|451335378|FG001|Overall Study|COVID-19 Disruption|0|||
125465644|NCT05510245|451335382|FG000|Overall Study|Withdrawal by Subject|1|||
125465645|NCT05510245|451335383|FG001|Overall Study|Withdrawal by Subject|0|||
125465646|NCT05510245|451335384|FG002|Overall Study|Withdrawal by Subject|0|||
125465647|NCT00970359|451335386|FG000|Overall Study|Not Treated|4|||
125465648|NCT01061671|451335387|FG000|Overall Study|Withdrawal by Subject|16|||
125465649|NCT01061671|451335388|FG001|Overall Study|Withdrawal by Subject|20|||
125465650|NCT01061671|451335387|FG000|Overall Study|Lost to Follow-up|3|||
125465651|NCT01061671|451335388|FG001|Overall Study|Lost to Follow-up|5|||
125465652|NCT01061671|451335387|FG000|Overall Study|Death|28|||
125465653|NCT01061671|451335388|FG001|Overall Study|Death|30|||
125465654|NCT00068601|451335389|FG000|Overall Study|Ineligible|11|||
125465655|NCT00068601|451335390|FG001|Overall Study|Ineligible|13|||
125465656|NCT00068601|451335389|FG000|Overall Study|Not evaluable: withdrew consent|5|||
125295928|NCT00707954|450711405|FG003|Overall Study|Physician Decision|0|||
125295929|NCT00707954|450711406|FG004|Overall Study|Physician Decision|1|||
125465657|NCT00068601|451335390|FG001|Overall Study|Not evaluable: withdrew consent|4|||
125465658|NCT00068601|451335389|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
125465659|NCT00068601|451335390|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
125465660|NCT00068601|451335389|FG000|Overall Study|Death|11|||
125465661|NCT00068601|451335390|FG001|Overall Study|Death|3|||
125465662|NCT00068601|451335389|FG000|Overall Study|Lost to Follow-up|3|||
125465663|NCT00068601|451335390|FG001|Overall Study|Lost to Follow-up|2|||
125465664|NCT00068601|451335389|FG000|Overall Study|Missing primary outcome data|30|||
125465665|NCT00068601|451335390|FG001|Overall Study|Missing primary outcome data|34|||
125295930|NCT01306656|450711407|FG000|Overall Study|Lost to Follow-up|1|||
125295931|NCT01306656|450711408|FG001|Overall Study|Lost to Follow-up|0|||
125295932|NCT01286077|450711409|FG000|Overall Study|Adverse Event|2|||
125295933|NCT01286077|450711410|FG001|Overall Study|Adverse Event|0|||
125295934|NCT01286077|450711409|FG000|Overall Study|Death|1|||
125295935|NCT01286077|450711410|FG001|Overall Study|Death|0|||
125295936|NCT01286077|450711409|FG000|Overall Study|Protocol Violation|1|||
125295937|NCT01286077|450711410|FG001|Overall Study|Protocol Violation|1|||
125295938|NCT01286077|450711409|FG000|Overall Study|Withdrawal by Subject|0|||
125295939|NCT01286077|450711410|FG001|Overall Study|Withdrawal by Subject|2|||
125295940|NCT01286077|450711409|FG000|Overall Study|Intercurrent illness|1|||
125295941|NCT01286077|450711410|FG001|Overall Study|Intercurrent illness|0|||
125295942|NCT01286077|450711409|FG000|Overall Study|Non-compliance|1|||
125295943|NCT01286077|450711410|FG001|Overall Study|Non-compliance|0|||
125295944|NCT01286077|450711409|FG000|Overall Study|The subject starts with alternative MMY|0|||
125295945|NCT01286077|450711410|FG001|Overall Study|The subject starts with alternative MMY|3|||
125295946|NCT01286077|450711409|FG000|Overall Study|Patient's decision to stop treatment|3|||
125295947|NCT01286077|450711410|FG001|Overall Study|Patient's decision to stop treatment|0|||
125295948|NCT01286077|450711409|FG000|Overall Study|Progression of disease|0|||
125465666|NCT00223795|451335399|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
125465667|NCT00223795|451335400|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
125465668|NCT00223795|451335399|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
125465669|NCT00223795|451335400|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
125465670|NCT04732338|451335402|FG000|Overall Study|Lost to Follow-up|3|||
125465671|NCT04732338|451335403|FG001|Overall Study|Lost to Follow-up|3|||
125465672|NCT01803555|451335407|FG000|Overall Study|Adverse Event|3|||
125465673|NCT01803555|451335408|FG001|Overall Study|Adverse Event|2|||
125465674|NCT01803555|451335407|FG000|Overall Study|Withdrawal by Subject|3|||
125465675|NCT01803555|451335408|FG001|Overall Study|Withdrawal by Subject|3|||
125465676|NCT01803555|451335407|FG000|Overall Study|Non-compliance|1|||
125295949|NCT01286077|450711410|FG001|Overall Study|Progression of disease|1|||
125295950|NCT01286077|450711409|FG000|Overall Study|refill medication not received in time|1|||
125295951|NCT01286077|450711410|FG001|Overall Study|refill medication not received in time|0|||
125295952|NCT01571232|450711411|FG000|Overall Study|Lost to Follow-up|0|||
125295953|NCT01571232|450711412|FG001|Overall Study|Lost to Follow-up|1|||
125295954|NCT01571232|450711411|FG000|Overall Study|Withdrawal by Subject|1|||
125295955|NCT01571232|450711412|FG001|Overall Study|Withdrawal by Subject|0|||
125295956|NCT03517969|450711414|FG000|Overall Study|Never started protocol treatment|3|||
125465677|NCT01803555|451335408|FG001|Overall Study|Non-compliance|1|||
125465678|NCT01803555|451335407|FG000|Overall Study|Protocol Violation|3|||
125465679|NCT01803555|451335408|FG001|Overall Study|Protocol Violation|5|||
125465680|NCT01803555|451335407|FG000|Overall Study|Lost to Follow-up|0|||
125465681|NCT01803555|451335408|FG001|Overall Study|Lost to Follow-up|2|||
125465682|NCT01803555|451335407|FG000|Overall Study|Other than specified|3|||
125465683|NCT01803555|451335408|FG001|Overall Study|Other than specified|5|||
125295957|NCT03517969|450711415|FG001|Overall Study|Never started protocol treatment|5|||
125295958|NCT03517969|450711414|FG000|Overall Study|Disease progression|11|||
125465684|NCT00774852|451335410|FG000|Overall Study|Adverse Event|9|||
125465685|NCT00774852|451335411|FG001|Overall Study|Adverse Event|6|||
125465686|NCT00774852|451335410|FG000|Overall Study|Death|2|||
125465687|NCT00774852|451335411|FG001|Overall Study|Death|1|||
125465688|NCT00774852|451335410|FG000|Overall Study|Lack of Efficacy|3|||
125465689|NCT00774852|451335411|FG001|Overall Study|Lack of Efficacy|7|||
125465690|NCT00774852|451335410|FG000|Overall Study|Lost to Follow-up|9|||
125465691|NCT00774852|451335411|FG001|Overall Study|Lost to Follow-up|5|||
125465692|NCT00774852|451335410|FG000|Overall Study|Physician Decision|2|||
125465693|NCT00774852|451335411|FG001|Overall Study|Physician Decision|6|||
125465694|NCT00774852|451335410|FG000|Overall Study|Pregnancy|1|||
125465695|NCT00774852|451335411|FG001|Overall Study|Pregnancy|2|||
125465696|NCT00774852|451335410|FG000|Overall Study|Withdrawal by Subject|2|||
125465697|NCT00774852|451335411|FG001|Overall Study|Withdrawal by Subject|2|||
125465698|NCT00774852|451335410|FG000|Overall Study|Non-responder|15|||
125465699|NCT00774852|451335411|FG001|Overall Study|Non-responder|11|||
125465700|NCT00774852|451335410|FG000|Overall Study|Subject non-compliance|0|||
125465701|NCT00774852|451335411|FG001|Overall Study|Subject non-compliance|1|||
125465702|NCT00774852|451335410|FG000|Overall Study|Protocol Violation|1|||
125465703|NCT00774852|451335411|FG001|Overall Study|Protocol Violation|0|||
125465704|NCT00774852|451335410|FG000|Overall Study|Subject received prohibited medication|1|||
125465705|NCT00774852|451335411|FG001|Overall Study|Subject received prohibited medication|0|||
125465706|NCT03997916|451335412|FG000|Overall Study|Protocol Violation|35|||
125465707|NCT03482635|451335416|FG000|Overall Study|Lack of Efficacy|0|||
125465708|NCT03482635|451335417|FG001|Overall Study|Lack of Efficacy|0|||
125465709|NCT03482635|451335418|FG002|Overall Study|Lack of Efficacy|1|||
125465710|NCT03482635|451335419|FG003|Overall Study|Lack of Efficacy|3|||
125465711|NCT03482635|451335416|FG000|Overall Study|Adverse Event|2|||
125465712|NCT03482635|451335417|FG001|Overall Study|Adverse Event|2|||
125465713|NCT03482635|451335418|FG002|Overall Study|Adverse Event|0|||
125465714|NCT03482635|451335419|FG003|Overall Study|Adverse Event|3|||
125465715|NCT03482635|451335416|FG000|Overall Study|Withdrawal by Subject|2|||
125465716|NCT03482635|451335417|FG001|Overall Study|Withdrawal by Subject|1|||
125465717|NCT03482635|451335418|FG002|Overall Study|Withdrawal by Subject|0|||
125465718|NCT03482635|451335419|FG003|Overall Study|Withdrawal by Subject|1|||
125465719|NCT03482635|451335416|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
125465720|NCT03482635|451335417|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
125465721|NCT03482635|451335418|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
125465722|NCT03482635|451335419|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
125465723|NCT03482635|451335416|FG000|Overall Study|Not treated|0|||
125465724|NCT03482635|451335417|FG001|Overall Study|Not treated|0|||
125465725|NCT03482635|451335418|FG002|Overall Study|Not treated|0|||
125465726|NCT03482635|451335419|FG003|Overall Study|Not treated|1|||
125465727|NCT02279095|451336848|FG000|Overall Study|Non-Compliance|1|||
125465728|NCT02279095|451336848|FG000|Overall Study|Withdrawal by Subject|8|||
125465729|NCT02279095|451336848|FG000|Overall Study|Adverse Event|2|||
125465730|NCT02279095|451336848|FG000|Overall Study|Other|7|||
125465731|NCT02279095|451336848|FG000|Overall Study|Lost to Follow-up|1|||
125465732|NCT05938413|451336849|FG000|Overall Study|Lost to Follow-up|1|||
125465733|NCT05938413|451336850|FG001|Overall Study|Lost to Follow-up|7|||
125465734|NCT05938413|451336849|FG000|Overall Study|Withdrawal by Subject|1|||
125465735|NCT05938413|451336850|FG001|Overall Study|Withdrawal by Subject|1|||
125465736|NCT04817670|451336856|FG000|Overall Study|Withdrawal by Subject|1|||
125465737|NCT04817670|451336857|FG001|Overall Study|Withdrawal by Subject|0|||
125465738|NCT04817670|451336858|FG002|Overall Study|Withdrawal by Subject|0|||
125465739|NCT04817670|451336859|FG003|Overall Study|Withdrawal by Subject|0|||
125465740|NCT04817670|451336860|FG004|Overall Study|Withdrawal by Subject|0|||
125465741|NCT04817670|451336856|FG000|Overall Study|Lost to Follow-up|0|||
125295959|NCT03517969|450711415|FG001|Overall Study|Disease progression|16|||
125295960|NCT03517969|450711414|FG000|Overall Study|PSA progression|8|||
125295961|NCT03517969|450711415|FG001|Overall Study|PSA progression|1|||
125295962|NCT03517969|450711414|FG000|Overall Study|Clinical progression|4|||
125295963|NCT03517969|450711415|FG001|Overall Study|Clinical progression|2|||
125465742|NCT04817670|451336857|FG001|Overall Study|Lost to Follow-up|0|||
125465743|NCT04817670|451336858|FG002|Overall Study|Lost to Follow-up|1|||
125465744|NCT04817670|451336859|FG003|Overall Study|Lost to Follow-up|0|||
125465745|NCT04817670|451336860|FG004|Overall Study|Lost to Follow-up|0|||
125465746|NCT03312907|451336861|FG000|Overall Study|Adverse Event|1|||
125465747|NCT03312907|451336862|FG001|Overall Study|Adverse Event|6|||
125465748|NCT03312907|451336863|FG002|Overall Study|Adverse Event|1|||
125465749|NCT03312907|451336861|FG000|Overall Study|Protocol Violation|2|||
125465750|NCT03312907|451336862|FG001|Overall Study|Protocol Violation|3|||
125465751|NCT03312907|451336863|FG002|Overall Study|Protocol Violation|4|||
125465752|NCT03312907|451336861|FG000|Overall Study|Lost to Follow-up|2|||
125465753|NCT03312907|451336862|FG001|Overall Study|Lost to Follow-up|3|||
125465754|NCT03312907|451336863|FG002|Overall Study|Lost to Follow-up|2|||
125465755|NCT03312907|451336861|FG000|Overall Study|Physician Decision|3|||
125295964|NCT03517969|450711414|FG000|Overall Study|Adverse Event|5|||
125295965|NCT03517969|450711415|FG001|Overall Study|Adverse Event|4|||
125295966|NCT03517969|450711414|FG000|Overall Study|Intercurrent illness|1|||
125465756|NCT03312907|451336862|FG001|Overall Study|Physician Decision|4|||
125465757|NCT03312907|451336863|FG002|Overall Study|Physician Decision|2|||
125465758|NCT03312907|451336861|FG000|Overall Study|Withdrawal by Subject|9|||
125465759|NCT03312907|451336862|FG001|Overall Study|Withdrawal by Subject|14|||
125465760|NCT03312907|451336863|FG002|Overall Study|Withdrawal by Subject|10|||
125465761|NCT01780298|451336868|FG000|Overall Study|Physician Decision|1|||
125465762|NCT01780298|451336869|FG001|Overall Study|Physician Decision|5|||
125465763|NCT01780298|451336870|FG002|Overall Study|Physician Decision|1|||
125465764|NCT01780298|451336871|FG003|Overall Study|Physician Decision|1|||
125465765|NCT01780298|451336868|FG000|Overall Study|Subject not matched|1|||
125465766|NCT01780298|451336869|FG001|Overall Study|Subject not matched|0|||
125465767|NCT01780298|451336870|FG002|Overall Study|Subject not matched|1|||
125465768|NCT01780298|451336871|FG003|Overall Study|Subject not matched|0|||
125465769|NCT01780298|451336868|FG000|Overall Study|Adverse Event|0|||
125465770|NCT01780298|451336869|FG001|Overall Study|Adverse Event|0|||
125465771|NCT01780298|451336870|FG002|Overall Study|Adverse Event|2|||
125465772|NCT01780298|451336871|FG003|Overall Study|Adverse Event|0|||
125465773|NCT04907474|451336876|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
125465774|NCT04907474|451336877|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
125465775|NCT04259450|451336880|FG000|Overall Study|Adverse event/ Toxicity|0|||
125465776|NCT04259450|451336881|FG001|Overall Study|Adverse event/ Toxicity|3|||
125465777|NCT04259450|451336882|FG002|Overall Study|Adverse event/ Toxicity|0|||
125465778|NCT04259450|451336883|FG003|Overall Study|Adverse event/ Toxicity|1|||
125465779|NCT04259450|451336884|FG004|Overall Study|Adverse event/ Toxicity|0|||
125465780|NCT04259450|451336885|FG005|Overall Study|Adverse event/ Toxicity|0|||
125465781|NCT04259450|451336886|FG006|Overall Study|Adverse event/ Toxicity|0|||
125465782|NCT04259450|451336887|FG007|Overall Study|Adverse event/ Toxicity|1|||
125465783|NCT04259450|451336888|FG008|Overall Study|Adverse event/ Toxicity|0|||
125465784|NCT04259450|451336889|FG009|Overall Study|Adverse event/ Toxicity|3|||
125465785|NCT04259450|451336880|FG000|Overall Study|Disease progression|2|||
125465786|NCT04259450|451336881|FG001|Overall Study|Disease progression|3|||
125465787|NCT04259450|451336882|FG002|Overall Study|Disease progression|4|||
125465788|NCT04259450|451336883|FG003|Overall Study|Disease progression|4|||
125465789|NCT04259450|451336884|FG004|Overall Study|Disease progression|6|||
125465790|NCT04259450|451336885|FG005|Overall Study|Disease progression|6|||
125465791|NCT04259450|451336886|FG006|Overall Study|Disease progression|6|||
125465792|NCT04259450|451336887|FG007|Overall Study|Disease progression|15|||
125465793|NCT04259450|451336888|FG008|Overall Study|Disease progression|6|||
125465794|NCT04259450|451336889|FG009|Overall Study|Disease progression|18|||
125465795|NCT04259450|451336880|FG000|Overall Study|Death|0|||
125465796|NCT04259450|451336881|FG001|Overall Study|Death|0|||
125465797|NCT04259450|451336882|FG002|Overall Study|Death|0|||
125465798|NCT04259450|451336883|FG003|Overall Study|Death|0|||
125465799|NCT04259450|451336884|FG004|Overall Study|Death|0|||
125465800|NCT04259450|451336885|FG005|Overall Study|Death|0|||
125465801|NCT04259450|451336886|FG006|Overall Study|Death|0|||
125465802|NCT04259450|451336887|FG007|Overall Study|Death|1|||
125465803|NCT04259450|451336888|FG008|Overall Study|Death|1|||
125465804|NCT04259450|451336889|FG009|Overall Study|Death|0|||
125465805|NCT04259450|451336880|FG000|Overall Study|Withdrawal by Subject|0|||
125465806|NCT04259450|451336881|FG001|Overall Study|Withdrawal by Subject|0|||
125465807|NCT04259450|451336882|FG002|Overall Study|Withdrawal by Subject|0|||
125465808|NCT04259450|451336883|FG003|Overall Study|Withdrawal by Subject|0|||
125465809|NCT04259450|451336884|FG004|Overall Study|Withdrawal by Subject|0|||
125465810|NCT04259450|451336885|FG005|Overall Study|Withdrawal by Subject|0|||
125465811|NCT04259450|451336886|FG006|Overall Study|Withdrawal by Subject|0|||
125465812|NCT04259450|451336887|FG007|Overall Study|Withdrawal by Subject|1|||
125465813|NCT04259450|451336888|FG008|Overall Study|Withdrawal by Subject|0|||
125465814|NCT04259450|451336889|FG009|Overall Study|Withdrawal by Subject|0|||
125465815|NCT04259450|451336880|FG000|Overall Study|Other than listed|0|||
125465816|NCT04259450|451336881|FG001|Overall Study|Other than listed|0|||
125465817|NCT04259450|451336882|FG002|Overall Study|Other than listed|0|||
125465818|NCT04259450|451336883|FG003|Overall Study|Other than listed|0|||
125465819|NCT04259450|451336884|FG004|Overall Study|Other than listed|0|||
125465820|NCT04259450|451336885|FG005|Overall Study|Other than listed|0|||
125465821|NCT04259450|451336886|FG006|Overall Study|Other than listed|0|||
125465822|NCT04259450|451336887|FG007|Overall Study|Other than listed|1|||
125465823|NCT04259450|451336888|FG008|Overall Study|Other than listed|1|||
125465824|NCT04259450|451336889|FG009|Overall Study|Other than listed|2|||
125465825|NCT01534494|451336890|FG000|Overall Study|Withdrawal by Subject|1|||
125465826|NCT02724592|451336891|FG000|Overall Study|Lost to Follow-up|4|||
125465827|NCT02724592|451336892|FG001|Overall Study|Lost to Follow-up|1|||
125465828|NCT02584829|451336893|FG000|Overall Study|Physician Decision|1|||
125295967|NCT03517969|450711415|FG001|Overall Study|Intercurrent illness|2|||
125465829|NCT02584829|451336894|FG001|Overall Study|Physician Decision|0|||
125465830|NCT02584829|451336893|FG000|Overall Study|Withdrawal by Subject|0|||
125465831|NCT02584829|451336894|FG001|Overall Study|Withdrawal by Subject|1|||
125465832|NCT02584829|451336893|FG000|Overall Study|Progressive Disease|0|||
125465833|NCT02584829|451336894|FG001|Overall Study|Progressive Disease|3|||
125465834|NCT01939899|451336896|FG000|Lead-in Dose Finding Phase|Death|0|||
125465835|NCT01939899|451336897|FG001|Lead-in Dose Finding Phase|Death|3|||
125465836|NCT01939899|451336898|FG002|Lead-in Dose Finding Phase|Death|1|||
125465837|NCT01939899|451336899|FG003|Lead-in Dose Finding Phase|Death|0|||
125465838|NCT01939899|451336900|FG004|Lead-in Dose Finding Phase|Death|0|||
125465839|NCT01939899|451336896|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
125465840|NCT01939899|451336897|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
125465841|NCT01939899|451336898|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
125465842|NCT01939899|451336899|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
125465843|NCT01939899|451336900|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
125465844|NCT01939899|451336896|FG000|Lead-in Dose Finding Phase|Other|0|||
125465845|NCT01939899|451336897|FG001|Lead-in Dose Finding Phase|Other|0|||
125465846|NCT01939899|451336898|FG002|Lead-in Dose Finding Phase|Other|1|||
125465847|NCT01939899|451336899|FG003|Lead-in Dose Finding Phase|Other|0|||
125465848|NCT01939899|451336900|FG004|Lead-in Dose Finding Phase|Other|0|||
125465849|NCT01939899|451336896|FG000|Phase 2|Withdrawal by Subject|0|||
125465850|NCT01939899|451336897|FG001|Phase 2|Withdrawal by Subject|0|||
125465851|NCT01939899|451336898|FG002|Phase 2|Withdrawal by Subject|0|||
125465852|NCT01939899|451336899|FG003|Phase 2|Withdrawal by Subject|2|||
125465853|NCT01939899|451336900|FG004|Phase 2|Withdrawal by Subject|0|||
125465854|NCT01939899|451336896|FG000|Phase 2|Disease Progression|0|||
125465855|NCT01939899|451336897|FG001|Phase 2|Disease Progression|0|||
125465856|NCT01939899|451336898|FG002|Phase 2|Disease Progression|0|||
125465857|NCT01939899|451336899|FG003|Phase 2|Disease Progression|9|||
125465858|NCT01939899|451336900|FG004|Phase 2|Disease Progression|1|||
125465859|NCT00585052|451336901|FG000|Overall Study|Withdrawal by Subject|1|||
125465860|NCT00371787|451336902|FG000|Overall Study|Withdrawal by Subject|3|||
125465861|NCT00371787|451336903|FG001|Overall Study|Withdrawal by Subject|1|||
125465862|NCT00277355|451336904|FG000|Overall Study|Withdrawal by Subject|3|||
125465863|NCT00277355|451336905|FG001|Overall Study|Withdrawal by Subject|3|||
125465864|NCT00277355|451336904|FG000|Overall Study|Lost to Follow-up|2|||
125465865|NCT00277355|451336905|FG001|Overall Study|Lost to Follow-up|2|||
125465866|NCT00277355|451336904|FG000|Overall Study|Adverse Event|5|||
125465867|NCT00277355|451336905|FG001|Overall Study|Adverse Event|0|||
125465868|NCT00277355|451336904|FG000|Overall Study|Death|3|||
125465869|NCT00277355|451336905|FG001|Overall Study|Death|0|||
125465870|NCT00277355|451336904|FG000|Overall Study|Physician Decision|1|||
125465871|NCT00277355|451336905|FG001|Overall Study|Physician Decision|0|||
125465872|NCT05489484|451336911|FG000|Overall Study|withdrawn|1|||
125465873|NCT00444600|451336914|FG000|Overall Study|Death|7|||
125465874|NCT00444600|451336915|FG001|Overall Study|Death|5|||
125465875|NCT00444600|451336916|FG002|Overall Study|Death|3|||
125465876|NCT00444600|451336917|FG003|Overall Study|Death|2|||
125465877|NCT00444600|451336914|FG000|Overall Study|Dropped|11|||
125465878|NCT00444600|451336915|FG001|Overall Study|Dropped|11|||
125465879|NCT00444600|451336916|FG002|Overall Study|Dropped|7|||
125465880|NCT00444600|451336917|FG003|Overall Study|Dropped|7|||
125465881|NCT00444600|451336914|FG000|Overall Study|Missed visit|1|||
125465882|NCT00444600|451336915|FG001|Overall Study|Missed visit|0|||
125465883|NCT00444600|451336916|FG002|Overall Study|Missed visit|0|||
125465884|NCT00444600|451336917|FG003|Overall Study|Missed visit|1|||
125465885|NCT05132478|451336918|FG000|Overall Study|did not complete survey after consent|1|||
125465886|NCT05132478|451336919|FG001|Overall Study|did not complete survey after consent|1|||
125465887|NCT05132478|451336918|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
125465888|NCT05132478|451336919|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
125465889|NCT01414738|451336922|FG000|Overall Study|Death|26|||
125465890|NCT01414738|451336922|FG000|Overall Study|Refused testing|5|||
125465891|NCT01414738|451336922|FG000|Overall Study|Lost to Follow-up|2|||
125465892|NCT01414738|451336922|FG000|Overall Study|Refused, disease progression|8|||
125465893|NCT01414738|451336922|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
125465894|NCT01839331|451336923|FG000|Overall Study|Early Termination|3|||
125465895|NCT01839331|451336924|FG001|Overall Study|Early Termination|0|||
125465896|NCT01839331|451336925|FG002|Overall Study|Early Termination|1|||
125465897|NCT01839331|451336926|FG003|Overall Study|Early Termination|2|||
125465898|NCT01839331|451336923|FG000|Overall Study|Protocol Violation|1|||
125465899|NCT01839331|451336924|FG001|Overall Study|Protocol Violation|6|||
125465900|NCT01839331|451336925|FG002|Overall Study|Protocol Violation|4|||
125465901|NCT01839331|451336926|FG003|Overall Study|Protocol Violation|3|||
125465902|NCT04056624|451336927|FG000|Overall Study|Withdrawal by Subject|0|||
125465903|NCT04056624|451336928|FG001|Overall Study|Withdrawal by Subject|0|||
125465904|NCT04056624|451336929|FG002|Overall Study|Withdrawal by Subject|1|||
125465905|NCT04056624|451336927|FG000|Overall Study|Protocol Violation|1|||
125465906|NCT04056624|451336928|FG001|Overall Study|Protocol Violation|2|||
125465907|NCT04056624|451336929|FG002|Overall Study|Protocol Violation|0|||
125465908|NCT00703820|451336932|FG000|Overall Study|Adverse Event|12|||
125465909|NCT00703820|451336933|FG001|Overall Study|Adverse Event|17|||
125465910|NCT00703820|451336932|FG000|Overall Study|Death|5|||
125465911|NCT00703820|451336933|FG001|Overall Study|Death|0|||
125465912|NCT00703820|451336932|FG000|Overall Study|Lack of Efficacy|11|||
125465913|NCT00703820|451336933|FG001|Overall Study|Lack of Efficacy|11|||
125465914|NCT00703820|451336932|FG000|Overall Study|Received non-protocol therapy|1|||
125465915|NCT00703820|451336933|FG001|Overall Study|Received non-protocol therapy|0|||
125465916|NCT00703820|451336932|FG000|Overall Study|Physician Decision|4|||
125465917|NCT00703820|451336933|FG001|Overall Study|Physician Decision|5|||
125465918|NCT00703820|451336932|FG000|Overall Study|Withdrawal by Subject|2|||
125465919|NCT00703820|451336933|FG001|Overall Study|Withdrawal by Subject|1|||
125465920|NCT03531840|451336936|FG000|Overall Study|Death on study|3|||
125465921|NCT03531840|451336937|FG001|Overall Study|Death on study|2|||
125465922|NCT03531840|451336938|FG002|Overall Study|Death on study|1|||
125465923|NCT03531840|451336939|FG003|Overall Study|Death on study|2|||
125465924|NCT03531840|451336936|FG000|Overall Study|Death during follow up|2|||
125465925|NCT03531840|451336937|FG001|Overall Study|Death during follow up|3|||
125465926|NCT03531840|451336938|FG002|Overall Study|Death during follow up|4|||
125465927|NCT03531840|451336939|FG003|Overall Study|Death during follow up|1|||
125465928|NCT00761605|451336941|FG000|Overall Study|Adverse Event|26|||
125465929|NCT00761605|451336941|FG000|Overall Study|Death|2|||
125465930|NCT00761605|451336941|FG000|Overall Study|Lack of Efficacy|26|||
125465931|NCT00761605|451336941|FG000|Overall Study|Lost to Follow-up|29|||
125465932|NCT00761605|451336941|FG000|Overall Study|Withdrawal by Subject|37|||
125465933|NCT00761605|451336941|FG000|Overall Study|Other|21|||
125465934|NCT02267824|451336942|FG000|Overall Study|Pregnancy|1|||
125465935|NCT02267824|451336943|FG001|Overall Study|Pregnancy|1|||
125465936|NCT02267824|451336942|FG000|Overall Study|Lost to Follow-up|4|||
125465937|NCT02267824|451336943|FG001|Overall Study|Lost to Follow-up|0|||
125465938|NCT02267824|451336942|FG000|Overall Study|Protocol Violation|3|||
125465939|NCT02267824|451336943|FG001|Overall Study|Protocol Violation|0|||
125465940|NCT02267824|451336942|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
125465941|NCT02267824|451336943|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
125465942|NCT00350792|451336944|FG000|Overall Study|Adverse Event|11|||
125295968|NCT03517969|450711414|FG000|Overall Study|Death|1|||
125295969|NCT03517969|450711415|FG001|Overall Study|Death|1|||
125295970|NCT03517969|450711414|FG000|Overall Study|Withdrawal by Subject|1|||
125295971|NCT03517969|450711415|FG001|Overall Study|Withdrawal by Subject|2|||
125295972|NCT03517969|450711414|FG000|Overall Study|Physician Decision|1|||
125295973|NCT03517969|450711415|FG001|Overall Study|Physician Decision|1|||
125295974|NCT03517969|450711414|FG000|Overall Study|No clinical benefit|1|||
125295975|NCT03517969|450711415|FG001|Overall Study|No clinical benefit|0|||
125295976|NCT03517969|450711414|FG000|Overall Study|Delayed treatment for dental treatment|1|||
125295977|NCT03517969|450711415|FG001|Overall Study|Delayed treatment for dental treatment|0|||
125295978|NCT03517969|450711414|FG000|Overall Study|Difficult to maintain appointment|0|||
125295979|NCT03517969|450711415|FG001|Overall Study|Difficult to maintain appointment|1|||
125295980|NCT03517969|450711414|FG000|Overall Study|Protocol Violation|0|||
125295981|NCT03517969|450711415|FG001|Overall Study|Protocol Violation|1|||
125295982|NCT03344172|450711422|FG000|Overall Study|Received <1 dose of treatment|1|||
125295983|NCT03344172|450711423|FG001|Overall Study|Received <1 dose of treatment|0|||
125295984|NCT03779503|450711424|FG000|First Intervention|Adverse Event|0|||
125295985|NCT03779503|450711425|FG001|First Intervention|Adverse Event|1|||
125295986|NCT03779503|450711424|FG000|First Intervention|Withdrawal by Subject|1|||
125295987|NCT03779503|450711425|FG001|First Intervention|Withdrawal by Subject|0|||
125295988|NCT01177969|450711426|FG000|Overall Study|Protocol Violation|2|||
125295989|NCT01177969|450711427|FG001|Overall Study|Protocol Violation|1|||
125295990|NCT01177969|450711426|FG000|Overall Study|Withdrawal by Subject|1|||
125295991|NCT01177969|450711427|FG001|Overall Study|Withdrawal by Subject|2|||
125295992|NCT03629912|450711428|FG000|Overall Study|Lost to Follow-up|19|||
125295993|NCT03629912|450711429|FG001|Overall Study|Lost to Follow-up|7|||
125295994|NCT03629912|450711430|FG002|Overall Study|Lost to Follow-up|5|||
125295995|NCT03629912|450711431|FG003|Overall Study|Lost to Follow-up|1|||
125295996|NCT03629912|450711428|FG000|Overall Study|Withdrawal by Subject|6|||
125295997|NCT03629912|450711429|FG001|Overall Study|Withdrawal by Subject|0|||
125295998|NCT03629912|450711430|FG002|Overall Study|Withdrawal by Subject|1|||
125295999|NCT03629912|450711431|FG003|Overall Study|Withdrawal by Subject|2|||
125296000|NCT03629912|450711428|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
125296001|NCT03629912|450711429|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
125465943|NCT00350792|451336944|FG000|Overall Study|Death from Study Disease|1|||
125465944|NCT00350792|451336944|FG000|Overall Study|Death from Study Drug Toxicity|1|||
125465945|NCT00350792|451336944|FG000|Overall Study|Death Not Study Drug Related|2|||
125465946|NCT00350792|451336944|FG000|Overall Study|Protocol Violation|1|||
125465947|NCT00350792|451336944|FG000|Overall Study|Withdrawal by Subject|4|||
125465948|NCT00350792|451336944|FG000|Overall Study|Physician Decision|2|||
125296002|NCT03629912|450711430|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
125296003|NCT03629912|450711431|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
125296004|NCT03629912|450711428|FG000|Overall Study|Death|1|||
125296005|NCT03629912|450711429|FG001|Overall Study|Death|0|||
125296006|NCT03629912|450711430|FG002|Overall Study|Death|0|||
125296007|NCT03629912|450711431|FG003|Overall Study|Death|0|||
125296008|NCT00687609|450711432|FG000|Overall Study|Physician Decision|1|||
125296009|NCT00687609|450711432|FG000|Overall Study|Withdrawal by Subject|2|||
125296010|NCT00908037|450711433|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296011|NCT00908037|450711434|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296012|NCT00908037|450711435|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296013|NCT00908037|450711436|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296014|NCT00908037|450711437|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
125296015|NCT00908037|450711438|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296016|NCT00908037|450711439|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
125296017|NCT00908037|450711440|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296018|NCT00908037|450711441|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
125296019|NCT00908037|450711442|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296020|NCT00908037|450711443|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296021|NCT00908037|450711444|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
125296022|NCT00908037|450711433|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296023|NCT00908037|450711434|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296024|NCT00908037|450711435|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296025|NCT00908037|450711436|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296026|NCT00908037|450711437|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
125296027|NCT00908037|450711438|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296028|NCT00908037|450711439|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296029|NCT00908037|450711440|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296030|NCT00908037|450711441|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
125296031|NCT00908037|450711442|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296032|NCT00908037|450711443|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296033|NCT00908037|450711444|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
125296034|NCT00908037|450711433|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296035|NCT00908037|450711434|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296036|NCT00908037|450711435|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296037|NCT00908037|450711436|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
125296038|NCT00908037|450711437|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296039|NCT00908037|450711438|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296040|NCT00908037|450711439|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
125296041|NCT00908037|450711440|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296042|NCT00908037|450711441|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296043|NCT00908037|450711442|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296044|NCT00908037|450711443|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296045|NCT00908037|450711444|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
125296046|NCT00908037|450711433|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296047|NCT00908037|450711434|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296048|NCT00908037|450711435|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296049|NCT00908037|450711436|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296050|NCT00908037|450711437|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296051|NCT00908037|450711438|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296052|NCT00908037|450711439|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296053|NCT00908037|450711440|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296054|NCT00908037|450711441|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296055|NCT00908037|450711442|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296056|NCT00908037|450711443|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
125296057|NCT00908037|450711444|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
125296058|NCT00908037|450711433|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296059|NCT00908037|450711434|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296060|NCT00908037|450711435|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296061|NCT00908037|450711436|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296062|NCT00908037|450711437|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296063|NCT00908037|450711438|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296064|NCT00908037|450711439|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296065|NCT00908037|450711440|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296066|NCT00908037|450711441|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296067|NCT00908037|450711442|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
125296068|NCT00908037|450711443|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
125296069|NCT00908037|450711444|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
125465949|NCT00350792|451336944|FG000|Overall Study|Lack of Efficacy|11|||
125465950|NCT03451721|451336945|FG000|Overall Study|Death|1|||
125296070|NCT00908037|450711433|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296071|NCT00908037|450711434|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296072|NCT00908037|450711435|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296073|NCT00908037|450711436|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296074|NCT00908037|450711437|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296075|NCT00908037|450711438|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296076|NCT00908037|450711439|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296077|NCT00908037|450711440|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296078|NCT00908037|450711441|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296079|NCT00908037|450711442|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
125296080|NCT00908037|450711443|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296081|NCT00908037|450711444|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
125296082|NCT00908037|450711433|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296083|NCT00908037|450711434|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296084|NCT00908037|450711435|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296085|NCT00908037|450711436|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296086|NCT00908037|450711437|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296087|NCT00908037|450711438|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296088|NCT00908037|450711439|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296089|NCT00908037|450711440|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296090|NCT00908037|450711441|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296091|NCT00908037|450711442|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296092|NCT00908037|450711443|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
125296093|NCT00908037|450711444|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
125296094|NCT00908037|450711433|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296095|NCT00908037|450711434|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296096|NCT00908037|450711435|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296097|NCT00908037|450711436|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296098|NCT00908037|450711437|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296099|NCT00908037|450711438|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296100|NCT00908037|450711439|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296101|NCT00908037|450711440|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296102|NCT00908037|450711441|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125465951|NCT01985334|451336946|FG000|Overall Study|Administrative problems|1|||
125465952|NCT01985334|451336947|FG001|Overall Study|Administrative problems|1|||
125465953|NCT01985334|451336948|FG002|Overall Study|Administrative problems|0|||
125465954|NCT01985334|451336949|FG003|Overall Study|Administrative problems|2|||
125465955|NCT01985334|451336950|FG004|Overall Study|Administrative problems|0|||
125465956|NCT01985334|451336951|FG005|Overall Study|Administrative problems|1|||
125465957|NCT01985334|451336952|FG006|Overall Study|Administrative problems|1|||
125465958|NCT01985334|451336953|FG007|Overall Study|Administrative problems|3|||
125465959|NCT01985334|451336946|FG000|Overall Study|Death|1|||
125465960|NCT01985334|451336947|FG001|Overall Study|Death|0|||
125465961|NCT01985334|451336948|FG002|Overall Study|Death|0|||
125465962|NCT01985334|451336949|FG003|Overall Study|Death|3|||
125465963|NCT01985334|451336950|FG004|Overall Study|Death|0|||
125465964|NCT01985334|451336951|FG005|Overall Study|Death|0|||
125465965|NCT01985334|451336952|FG006|Overall Study|Death|1|||
125465966|NCT01985334|451336953|FG007|Overall Study|Death|2|||
125465967|NCT01985334|451336946|FG000|Overall Study|Worsening of disease|0|||
125465968|NCT01985334|451336947|FG001|Overall Study|Worsening of disease|0|||
125465969|NCT01985334|451336948|FG002|Overall Study|Worsening of disease|0|||
125465970|NCT01985334|451336949|FG003|Overall Study|Worsening of disease|1|||
125465971|NCT01985334|451336950|FG004|Overall Study|Worsening of disease|0|||
125465972|NCT01985334|451336951|FG005|Overall Study|Worsening of disease|3|||
125465973|NCT01985334|451336952|FG006|Overall Study|Worsening of disease|0|||
125465974|NCT01985334|451336953|FG007|Overall Study|Worsening of disease|1|||
125465975|NCT01985334|451336946|FG000|Overall Study|Other|2|||
125465976|NCT01985334|451336947|FG001|Overall Study|Other|9|||
125465977|NCT01985334|451336948|FG002|Overall Study|Other|7|||
125465978|NCT01985334|451336949|FG003|Overall Study|Other|17|||
125465979|NCT01985334|451336950|FG004|Overall Study|Other|4|||
125465980|NCT01985334|451336951|FG005|Overall Study|Other|8|||
125465981|NCT01985334|451336952|FG006|Overall Study|Other|4|||
125465982|NCT01985334|451336953|FG007|Overall Study|Other|7|||
125296103|NCT00908037|450711442|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
125465983|NCT01985334|451336946|FG000|Overall Study|Protocol deviation|6|||
125465984|NCT01985334|451336947|FG001|Overall Study|Protocol deviation|31|||
125465985|NCT01985334|451336948|FG002|Overall Study|Protocol deviation|25|||
125465986|NCT01985334|451336949|FG003|Overall Study|Protocol deviation|84|||
125465987|NCT01985334|451336950|FG004|Overall Study|Protocol deviation|17|||
125465988|NCT01985334|451336951|FG005|Overall Study|Protocol deviation|47|||
125465989|NCT01985334|451336952|FG006|Overall Study|Protocol deviation|15|||
125465990|NCT01985334|451336953|FG007|Overall Study|Protocol deviation|42|||
125465991|NCT01985334|451336946|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
125465992|NCT01985334|451336947|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
125465993|NCT01985334|451336948|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
125465994|NCT01985334|451336949|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
125465995|NCT01985334|451336950|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
125465996|NCT01985334|451336951|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
125465997|NCT01985334|451336952|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
125465998|NCT01985334|451336953|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
125465999|NCT01985334|451336946|FG000|Overall Study|Subject withdrawal of consent|3|||
125466000|NCT01985334|451336947|FG001|Overall Study|Subject withdrawal of consent|6|||
125466001|NCT01985334|451336948|FG002|Overall Study|Subject withdrawal of consent|2|||
125466002|NCT01985334|451336949|FG003|Overall Study|Subject withdrawal of consent|28|||
125466003|NCT01985334|451336950|FG004|Overall Study|Subject withdrawal of consent|4|||
125466004|NCT01985334|451336951|FG005|Overall Study|Subject withdrawal of consent|19|||
125466005|NCT01985334|451336952|FG006|Overall Study|Subject withdrawal of consent|0|||
125466006|NCT01985334|451336953|FG007|Overall Study|Subject withdrawal of consent|20|||
125466007|NCT01985334|451336946|FG000|Overall Study|Adverse Event|0|||
125466008|NCT01985334|451336947|FG001|Overall Study|Adverse Event|8|||
125466009|NCT01985334|451336948|FG002|Overall Study|Adverse Event|2|||
125466010|NCT01985334|451336949|FG003|Overall Study|Adverse Event|26|||
125466011|NCT01985334|451336950|FG004|Overall Study|Adverse Event|3|||
125466012|NCT01985334|451336951|FG005|Overall Study|Adverse Event|18|||
125466013|NCT01985334|451336952|FG006|Overall Study|Adverse Event|3|||
125466014|NCT01985334|451336953|FG007|Overall Study|Adverse Event|15|||
125466015|NCT01985334|451336946|FG000|Overall Study|Other|4|||
125466016|NCT01985334|451336947|FG001|Overall Study|Other|2|||
125466017|NCT01985334|451336948|FG002|Overall Study|Other|3|||
125466018|NCT01985334|451336949|FG003|Overall Study|Other|10|||
125466019|NCT01985334|451336950|FG004|Overall Study|Other|1|||
125466020|NCT01985334|451336951|FG005|Overall Study|Other|6|||
125466021|NCT01985334|451336952|FG006|Overall Study|Other|2|||
125466022|NCT01985334|451336953|FG007|Overall Study|Other|2|||
125466023|NCT01985334|451336946|FG000|Overall Study|Medication non-compliance|0|||
125466024|NCT01985334|451336947|FG001|Overall Study|Medication non-compliance|4|||
125466025|NCT01985334|451336948|FG002|Overall Study|Medication non-compliance|1|||
125466026|NCT01985334|451336949|FG003|Overall Study|Medication non-compliance|6|||
125466027|NCT01985334|451336950|FG004|Overall Study|Medication non-compliance|2|||
125466028|NCT01985334|451336951|FG005|Overall Study|Medication non-compliance|3|||
125466029|NCT01985334|451336952|FG006|Overall Study|Medication non-compliance|1|||
125296104|NCT00908037|450711443|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296105|NCT00908037|450711444|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
125296106|NCT00908037|450711433|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296107|NCT00908037|450711434|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296108|NCT00908037|450711435|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296109|NCT00908037|450711436|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296110|NCT00908037|450711437|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296111|NCT00908037|450711438|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296112|NCT00908037|450711439|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296113|NCT00908037|450711440|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296114|NCT00908037|450711441|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296115|NCT00908037|450711442|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296116|NCT00908037|450711443|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
125296117|NCT00908037|450711444|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
125296118|NCT00869401|450711446|FG000|Overall Study|Withdrawal by Subject|0|||
125296119|NCT00869401|450711447|FG001|Overall Study|Withdrawal by Subject|0|||
125296120|NCT00869401|450711448|FG002|Overall Study|Withdrawal by Subject|0|||
125296121|NCT00869401|450711449|FG003|Overall Study|Withdrawal by Subject|5|||
125296122|NCT00869401|450711450|FG004|Overall Study|Withdrawal by Subject|3|||
125296123|NCT01147900|450711451|FG000|At Year 10|Lost to Follow-up|0|||
125296124|NCT01147900|450711452|FG001|At Year 10|Lost to Follow-up|1|||
125466030|NCT01985334|451336953|FG007|Overall Study|Medication non-compliance|3|||
125466031|NCT01985334|451336946|FG000|Overall Study|Use of prohibited treatment|1|||
125466032|NCT01985334|451336947|FG001|Overall Study|Use of prohibited treatment|4|||
125466033|NCT01985334|451336948|FG002|Overall Study|Use of prohibited treatment|1|||
125466034|NCT01985334|451336949|FG003|Overall Study|Use of prohibited treatment|2|||
125466035|NCT01985334|451336950|FG004|Overall Study|Use of prohibited treatment|1|||
125466036|NCT01985334|451336951|FG005|Overall Study|Use of prohibited treatment|6|||
125296125|NCT01147900|450711453|FG002|At Year 10|Lost to Follow-up|0|||
125296126|NCT00581360|450711456|FG000|Overall Study|Withdrawal by Subject|1|||
125296127|NCT04405245|450711457|FG000|Overall Study|Adverse Event|0|||
125296128|NCT04405245|450711458|FG001|Overall Study|Adverse Event|1|||
125296129|NCT04405245|450711459|FG002|Overall Study|Adverse Event|0|||
125466037|NCT01985334|451336952|FG006|Overall Study|Use of prohibited treatment|2|||
125466038|NCT01985334|451336953|FG007|Overall Study|Use of prohibited treatment|0|||
125466039|NCT01985334|451336946|FG000|Overall Study|Investigator decision|0|||
125466040|NCT01985334|451336947|FG001|Overall Study|Investigator decision|3|||
125466041|NCT01985334|451336948|FG002|Overall Study|Investigator decision|0|||
125466042|NCT01985334|451336949|FG003|Overall Study|Investigator decision|7|||
125466043|NCT01985334|451336950|FG004|Overall Study|Investigator decision|1|||
125466044|NCT01985334|451336951|FG005|Overall Study|Investigator decision|1|||
125466045|NCT01985334|451336952|FG006|Overall Study|Investigator decision|0|||
125466046|NCT01985334|451336953|FG007|Overall Study|Investigator decision|4|||
125466047|NCT01985334|451336946|FG000|Overall Study|Lost to Follow-up|0|||
125466048|NCT01985334|451336947|FG001|Overall Study|Lost to Follow-up|2|||
125466049|NCT01985334|451336948|FG002|Overall Study|Lost to Follow-up|0|||
125466050|NCT01985334|451336949|FG003|Overall Study|Lost to Follow-up|3|||
125466051|NCT01985334|451336950|FG004|Overall Study|Lost to Follow-up|1|||
125466052|NCT01985334|451336951|FG005|Overall Study|Lost to Follow-up|4|||
125466053|NCT01985334|451336952|FG006|Overall Study|Lost to Follow-up|0|||
125466054|NCT01985334|451336953|FG007|Overall Study|Lost to Follow-up|3|||
125466055|NCT01290341|451336954|FG000|Overall Study|Protocol Violation|7|||
125466056|NCT01290341|451336955|FG001|Overall Study|Protocol Violation|3|||
125296130|NCT02391961|450711460|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
125466057|NCT01290341|451336954|FG000|Overall Study|Adverse Event|1|||
125466058|NCT01290341|451336955|FG001|Overall Study|Adverse Event|0|||
125466059|NCT01290341|451336954|FG000|Overall Study|Lost to Follow-up|21|||
125466060|NCT01290341|451336955|FG001|Overall Study|Lost to Follow-up|10|||
125466061|NCT01290341|451336954|FG000|Overall Study|Withdrawal by Subject|19|||
125466062|NCT01290341|451336955|FG001|Overall Study|Withdrawal by Subject|5|||
125466063|NCT01290341|451336954|FG000|Overall Study|Negative baseline culture and others|44|||
125466064|NCT01290341|451336955|FG001|Overall Study|Negative baseline culture and others|11|||
125466065|NCT00396084|451336958|FG000|Overall Study|Adverse Event|0|||
125466066|NCT00396084|451336959|FG001|Overall Study|Adverse Event|0|||
125466067|NCT00396084|451336960|FG002|Overall Study|Adverse Event|0|||
125466068|NCT00396084|451336961|FG003|Overall Study|Adverse Event|0|||
125466069|NCT00396084|451336962|FG004|Overall Study|Adverse Event|1|||
125466070|NCT00396084|451336963|FG005|Overall Study|Adverse Event|2|||
125466071|NCT00396084|451336958|FG000|Overall Study|Withdrawal by Subject|0|||
125466072|NCT00396084|451336959|FG001|Overall Study|Withdrawal by Subject|0|||
125466073|NCT00396084|451336960|FG002|Overall Study|Withdrawal by Subject|0|||
125466074|NCT00396084|451336961|FG003|Overall Study|Withdrawal by Subject|1|||
125466075|NCT00396084|451336962|FG004|Overall Study|Withdrawal by Subject|0|||
125466076|NCT00396084|451336963|FG005|Overall Study|Withdrawal by Subject|0|||
125466077|NCT02708108|451336964|FG000|Overall Study|Death|1|||
125466078|NCT02708108|451336965|FG001|Overall Study|Death|2|||
125466079|NCT02708108|451336964|FG000|Overall Study|Regimen change|1|||
125466080|NCT02708108|451336965|FG001|Overall Study|Regimen change|0|||
125466081|NCT02708108|451336964|FG000|Overall Study|No MRD and no imaging available|0|||
125466082|NCT02708108|451336965|FG001|Overall Study|No MRD and no imaging available|1|||
125466083|NCT00510887|451336966|FG000|Overall Study|Lost to Follow-up|1|||
125466084|NCT00390299|451336972|FG000|Overall Study|Cancellation|1|||
125466085|NCT00390299|451336973|FG001|Overall Study|Cancellation|0|||
125466086|NCT00390299|451336974|FG002|Overall Study|Cancellation|0|||
125296131|NCT02391961|450711461|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
125296132|NCT02391961|450711460|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
125296133|NCT02391961|450711461|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
125296134|NCT02391961|450711460|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125296135|NCT02391961|450711461|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
125296136|NCT00491608|450711465|FG000|Overall Study|Death|2|||
125466087|NCT00390299|451336975|FG003|Overall Study|Cancellation|0|||
125466088|NCT00390299|451336976|FG004|Overall Study|Cancellation|0|||
125466089|NCT01565148|451336981|FG000|Overall Study|Withdrawal by Subject|1|||
125466090|NCT01565148|451336982|FG001|Overall Study|Withdrawal by Subject|1|||
125466091|NCT01565148|451336983|FG002|Overall Study|Withdrawal by Subject|1|||
125466092|NCT01565148|451336984|FG003|Overall Study|Withdrawal by Subject|2|||
125466093|NCT01565148|451336981|FG000|Overall Study|Lost to Follow-up|4|||
125466094|NCT01565148|451336982|FG001|Overall Study|Lost to Follow-up|4|||
125466095|NCT01565148|451336983|FG002|Overall Study|Lost to Follow-up|0|||
125466096|NCT01565148|451336984|FG003|Overall Study|Lost to Follow-up|3|||
125466097|NCT01565148|451336981|FG000|Overall Study|Rescue Therapy|8|||
125466098|NCT01565148|451336982|FG001|Overall Study|Rescue Therapy|5|||
125466099|NCT01565148|451336983|FG002|Overall Study|Rescue Therapy|5|||
125466100|NCT01565148|451336984|FG003|Overall Study|Rescue Therapy|8|||
125466101|NCT01565148|451336981|FG000|Overall Study|Death|0|||
125466102|NCT01565148|451336982|FG001|Overall Study|Death|0|||
125466103|NCT01565148|451336983|FG002|Overall Study|Death|1|||
125466104|NCT01565148|451336984|FG003|Overall Study|Death|0|||
125466105|NCT01565148|451336981|FG000|Overall Study|Physician Decision|2|||
125466106|NCT01565148|451336982|FG001|Overall Study|Physician Decision|5|||
125466107|NCT01565148|451336983|FG002|Overall Study|Physician Decision|0|||
125466108|NCT01565148|451336984|FG003|Overall Study|Physician Decision|0|||
125466109|NCT05368831|451336986|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
125466110|NCT01199575|451336988|FG000|Overall Study|Withdrawal by Subject|5|||
125466111|NCT02409667|451336989|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
125466112|NCT02409667|451336990|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
125466113|NCT02409667|451336991|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
125466114|NCT02409667|451336992|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
125466115|NCT02409667|451336993|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
125466116|NCT02409667|451336989|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
125466117|NCT02409667|451336990|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
125466118|NCT02409667|451336991|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
125466119|NCT02409667|451336992|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
125466120|NCT02409667|451336993|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
125466121|NCT02409667|451336989|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
125466122|NCT02409667|451336990|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
125466123|NCT02409667|451336991|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
125466124|NCT02409667|451336992|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
125466125|NCT02409667|451336993|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
125466126|NCT02409667|451336989|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
125466127|NCT02409667|451336990|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
125296137|NCT00491608|450711465|FG000|Overall Study|Withdrawal by Subject|1|||
125296138|NCT00025155|450711466|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
125296139|NCT00025155|450711466|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
125296140|NCT00413374|450711467|FG000|Overall Study|Ineligible due to screening criteria.|3|||
125296141|NCT00413374|450711468|FG001|Overall Study|Ineligible due to screening criteria.|0|||
125296142|NCT00413374|450711467|FG000|Overall Study|Adverse Event|1|||
125296143|NCT00413374|450711468|FG001|Overall Study|Adverse Event|0|||
125296144|NCT00413374|450711467|FG000|Overall Study|Lost to Follow-up|1|||
125296145|NCT00413374|450711468|FG001|Overall Study|Lost to Follow-up|0|||
125466128|NCT02409667|451336991|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
125466129|NCT02409667|451336992|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
125466130|NCT02409667|451336993|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
125466131|NCT02409667|451336989|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
125466132|NCT02409667|451336990|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
125466133|NCT02409667|451336991|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
125466134|NCT02409667|451336992|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
125466135|NCT02409667|451336993|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
125466136|NCT02409667|451336989|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
125466137|NCT02409667|451336990|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
125296146|NCT00413374|450711467|FG000|Overall Study|Surgery|1|||
125296147|NCT00413374|450711468|FG001|Overall Study|Surgery|0|||
125296148|NCT00552760|450711469|FG000|Overall Study|Adverse Event|3|||
125296149|NCT00552760|450711470|FG001|Overall Study|Adverse Event|5|||
125296150|NCT00552760|450711469|FG000|Overall Study|Relapsed- Depressed Event|10|||
125296151|NCT00552760|450711470|FG001|Overall Study|Relapsed- Depressed Event|16|||
125296152|NCT00552760|450711469|FG000|Overall Study|Relapse- Manic Event|3|||
125296153|NCT00552760|450711470|FG001|Overall Study|Relapse- Manic Event|3|||
125296154|NCT00552760|450711469|FG000|Overall Study|Relapsed- Mixed Event|3|||
125296155|NCT00552760|450711470|FG001|Overall Study|Relapsed- Mixed Event|5|||
125296156|NCT00552760|450711469|FG000|Overall Study|Protocol Violation|0|||
125296157|NCT00552760|450711470|FG001|Overall Study|Protocol Violation|1|||
125296158|NCT00552760|450711469|FG000|Overall Study|Lost to Follow-up|1|||
125466138|NCT02409667|451336991|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
125466139|NCT02409667|451336992|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
125466140|NCT02409667|451336993|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
125466141|NCT02409667|451336989|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
125466142|NCT02409667|451336990|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
125466143|NCT02409667|451336991|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
125466144|NCT02409667|451336992|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
125296159|NCT00552760|450711470|FG001|Overall Study|Lost to Follow-up|1|||
125296160|NCT00552760|450711469|FG000|Overall Study|Non-compliance|1|||
125296161|NCT00552760|450711470|FG001|Overall Study|Non-compliance|1|||
125296162|NCT00552760|450711469|FG000|Overall Study|Medical Condition|1|||
125296163|NCT00552760|450711470|FG001|Overall Study|Medical Condition|1|||
125466145|NCT02409667|451336993|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
125466146|NCT02409667|451336989|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
125466147|NCT02409667|451336990|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
125466148|NCT02409667|451336991|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
125466149|NCT02409667|451336992|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
125466150|NCT02409667|451336993|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
125466151|NCT02409667|451336989|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
125466152|NCT02409667|451336990|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
125466153|NCT02409667|451336991|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
125466154|NCT02409667|451336992|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
125466155|NCT02409667|451336993|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
125466156|NCT02409667|451336989|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
125466157|NCT02409667|451336990|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
125466158|NCT02409667|451336991|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
125296164|NCT00552760|450711469|FG000|Overall Study|Withdrawal by Subject|3|||
125296165|NCT00552760|450711470|FG001|Overall Study|Withdrawal by Subject|0|||
125296166|NCT00552760|450711469|FG000|Overall Study|Medication Change|1|||
125296167|NCT00552760|450711470|FG001|Overall Study|Medication Change|0|||
125296168|NCT00924404|450711474|FG000|Overall Study|Lost to Follow-up|6|||
125296169|NCT00924404|450711475|FG001|Overall Study|Lost to Follow-up|4|||
125296170|NCT02613169|450711476|FG000|Overall Study|Withdrawal by Subject|4|||
125296171|NCT02613169|450711477|FG001|Overall Study|Withdrawal by Subject|1|||
125296172|NCT02613169|450711476|FG000|Overall Study|Lost to Follow-up|0|||
125296173|NCT02613169|450711477|FG001|Overall Study|Lost to Follow-up|5|||
125296174|NCT02613169|450711476|FG000|Overall Study|HIV|0|||
125296175|NCT02613169|450711477|FG001|Overall Study|HIV|2|||
125296176|NCT02613169|450711476|FG000|Overall Study|No TB infection endpoint|14|||
125296177|NCT02613169|450711477|FG001|Overall Study|No TB infection endpoint|9|||
125296178|NCT00343382|450711478|FG000|Overall Study|Adverse Event|2|||
125296179|NCT00343382|450711479|FG001|Overall Study|Adverse Event|10|||
125296180|NCT00343382|450711480|FG002|Overall Study|Adverse Event|7|||
125296181|NCT00343382|450711478|FG000|Overall Study|Withdrawal by Subject|1|||
125296182|NCT00343382|450711479|FG001|Overall Study|Withdrawal by Subject|2|||
125296183|NCT00343382|450711480|FG002|Overall Study|Withdrawal by Subject|6|||
125296184|NCT00343382|450711478|FG000|Overall Study|Other Reason Not Specified|1|||
125296185|NCT00343382|450711479|FG001|Overall Study|Other Reason Not Specified|2|||
125296186|NCT00343382|450711480|FG002|Overall Study|Other Reason Not Specified|4|||
125296187|NCT02976103|450711481|FG000|Overall Study|Withdrawal by Subject|1|||
125296188|NCT02976103|450711482|FG001|Overall Study|Withdrawal by Subject|0|||
125296189|NCT02976103|450711481|FG000|Overall Study|Lost to Follow-up|12|||
125296190|NCT02976103|450711482|FG001|Overall Study|Lost to Follow-up|8|||
125296191|NCT01985360|450711483|FG000|Overall Study|Withdrawal by Subject|4|||
125296192|NCT01985360|450711484|FG001|Overall Study|Withdrawal by Subject|0|||
125296193|NCT01985360|450711483|FG000|Overall Study|Lost to Follow-up|5|||
125296194|NCT01985360|450711484|FG001|Overall Study|Lost to Follow-up|3|||
125296195|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
125296196|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
125296197|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
125296198|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
125296199|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
125296200|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
125296201|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
125296202|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
125296203|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
125296204|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
125296205|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
125296206|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
125296207|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
125296208|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
125296209|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
125296210|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
125296211|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
125466159|NCT02409667|451336992|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
125466160|NCT02409667|451336993|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
125296212|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
125296213|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
125296214|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
125296215|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
125296216|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
125296217|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
125296218|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
125485368|NCT02240238|451412506|FG003|Phase 1|Sponsor termination|0|||
125296219|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
125296220|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
125296221|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
125296222|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
125296223|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
125296224|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
125296225|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
125466161|NCT02409667|451336989|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
125466162|NCT02409667|451336990|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
125466163|NCT02409667|451336991|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
125466164|NCT02409667|451336992|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
125466165|NCT02409667|451336993|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
125466166|NCT02409667|451336989|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
125466167|NCT02409667|451336990|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
125466168|NCT02409667|451336991|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
125466169|NCT02409667|451336992|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
125466170|NCT02409667|451336993|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
125466171|NCT02409667|451336989|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
125466172|NCT02409667|451336990|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
125296226|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
125466173|NCT02409667|451336991|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
125466174|NCT02409667|451336992|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
125466175|NCT02409667|451336993|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
125466176|NCT02409667|451336989|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
125466177|NCT02409667|451336990|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
125466178|NCT02409667|451336991|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
125466179|NCT02409667|451336992|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
125466180|NCT02409667|451336993|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
125466181|NCT02409667|451336989|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
125466182|NCT02409667|451336990|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
125466183|NCT02409667|451336991|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
125466184|NCT02409667|451336992|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
125466185|NCT02409667|451336993|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
125466186|NCT02409667|451336989|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
125466187|NCT02409667|451336990|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
125466188|NCT02409667|451336991|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
125466189|NCT02409667|451336992|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
125466190|NCT02409667|451336993|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
125296227|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
125296228|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
125296229|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
125296230|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
125296231|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
125296232|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
125296233|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
125296234|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
125296235|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
125296236|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
125296237|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
125296238|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
125296239|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296240|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296241|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
125296242|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296243|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296244|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
125296245|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296246|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296247|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296248|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296249|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
125296250|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
125296251|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125296252|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125296253|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125296254|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125466191|NCT03960463|451338131|FG000|Overall Study|Withdrawal by Subject|2|||
125466192|NCT03960463|451338132|FG001|Overall Study|Withdrawal by Subject|0|||
125466193|NCT02980276|451338136|FG000|Overall Study|Withdrawal by Subject|4|||
125466194|NCT02980276|451338137|FG001|Overall Study|Withdrawal by Subject|4|||
125466195|NCT02980276|451338136|FG000|Overall Study|Physician Decision|0|||
125466196|NCT02980276|451338137|FG001|Overall Study|Physician Decision|1|||
125466197|NCT02980276|451338136|FG000|Overall Study|Lost to Follow-up|18|||
125296255|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125296256|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125296257|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125296258|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125466198|NCT02980276|451338137|FG001|Overall Study|Lost to Follow-up|18|||
125466199|NCT02980276|451338136|FG000|Overall Study|Death|1|||
125466200|NCT02980276|451338137|FG001|Overall Study|Death|0|||
125466201|NCT02980276|451338136|FG000|Overall Study|Miscellaneous other|10|||
125466202|NCT02980276|451338137|FG001|Overall Study|Miscellaneous other|4|||
125466203|NCT04139668|451338138|FG000|Overall Study|Withdrawal by Subject|1|||
125466204|NCT03025789|451338139|FG000|Overall Study|Lack of Efficacy|6|||
125466205|NCT03025789|451338140|FG001|Overall Study|Lack of Efficacy|1|||
125466206|NCT03025789|451338139|FG000|Overall Study|Death|1|||
125466207|NCT03025789|451338140|FG001|Overall Study|Death|0|||
125466208|NCT03025789|451338139|FG000|Overall Study|Withdrawal by Subject|0|||
125466209|NCT03025789|451338140|FG001|Overall Study|Withdrawal by Subject|2|||
125466210|NCT02581215|451338142|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
125466211|NCT02581215|451338143|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
125466212|NCT02581215|451338142|FG000|Overall Study|Eligibility Criteria Not Met|0|||
125466213|NCT02581215|451338143|FG001|Overall Study|Eligibility Criteria Not Met|1|||
125466214|NCT03613740|451338144|FG000|Overall Study|Lost to Follow-up|1|||
125466215|NCT03613740|451338145|FG001|Overall Study|Lost to Follow-up|1|||
125466216|NCT02411084|451338146|FG000|Overall Study|Lack of Efficacy|6|||
125466217|NCT02411084|451338147|FG001|Overall Study|Lack of Efficacy|3|||
125466218|NCT02411084|451338146|FG000|Overall Study|Death|5|||
125466219|NCT02411084|451338147|FG001|Overall Study|Death|4|||
125466220|NCT02411084|451338146|FG000|Overall Study|Adverse Event|2|||
125466221|NCT02411084|451338147|FG001|Overall Study|Adverse Event|1|||
125466222|NCT02411084|451338146|FG000|Overall Study|Other reasons|0|||
125466223|NCT02411084|451338147|FG001|Overall Study|Other reasons|5|||
125466224|NCT00802464|451338151|FG000|Month 0 - Month 8|Adverse Event|0|||
125466225|NCT00802464|451338152|FG001|Month 0 - Month 8|Adverse Event|1|||
125466226|NCT00802464|451338153|FG002|Month 0 - Month 8|Adverse Event|1|||
125466227|NCT00802464|451338154|FG003|Month 0 - Month 8|Adverse Event|2|||
125466228|NCT00802464|451338151|FG000|Month 0 - Month 8|Protocol Violation|0|||
125466229|NCT00802464|451338152|FG001|Month 0 - Month 8|Protocol Violation|0|||
125466230|NCT00802464|451338153|FG002|Month 0 - Month 8|Protocol Violation|1|||
125466231|NCT00802464|451338154|FG003|Month 0 - Month 8|Protocol Violation|0|||
125466232|NCT00802464|451338151|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
125466233|NCT00802464|451338152|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
125466234|NCT00802464|451338153|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
125466235|NCT00802464|451338154|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
125466236|NCT00802464|451338151|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
125466237|NCT00802464|451338152|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
125466238|NCT00802464|451338153|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
125466239|NCT00802464|451338154|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
125466240|NCT00802464|451338151|FG000|Month 0 - Month 8|Other|0|||
125466241|NCT00802464|451338152|FG001|Month 0 - Month 8|Other|0|||
125466242|NCT00802464|451338153|FG002|Month 0 - Month 8|Other|1|||
125466243|NCT00802464|451338154|FG003|Month 0 - Month 8|Other|0|||
125466244|NCT00802464|451338151|FG000|Month 8 - Month 14|Adverse Event|0|||
125466245|NCT00802464|451338152|FG001|Month 8 - Month 14|Adverse Event|1|||
125466246|NCT00802464|451338153|FG002|Month 8 - Month 14|Adverse Event|0|||
125466247|NCT00802464|451338154|FG003|Month 8 - Month 14|Adverse Event|0|||
125466248|NCT00802464|451338151|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
125296259|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125466249|NCT00802464|451338152|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
125466250|NCT00802464|451338153|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
125466251|NCT00802464|451338154|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
125466252|NCT00802464|451338151|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
125466253|NCT00802464|451338152|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
125466254|NCT00802464|451338153|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
125466255|NCT00802464|451338154|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
125466256|NCT00402246|451338155|FG000|Overall Study|Death|62|||
125466257|NCT00402246|451338156|FG001|Overall Study|Death|58|||
125466258|NCT00402246|451338155|FG000|Overall Study|Lost to Follow-up|20|||
125466259|NCT00402246|451338156|FG001|Overall Study|Lost to Follow-up|28|||
125466260|NCT00402246|451338155|FG000|Overall Study|Withdrawal by Subject|72|||
125466261|NCT00402246|451338156|FG001|Overall Study|Withdrawal by Subject|87|||
125466262|NCT00402246|451338155|FG000|Overall Study|Physician Decision|24|||
125466263|NCT00402246|451338156|FG001|Overall Study|Physician Decision|26|||
125466264|NCT00402246|451338155|FG000|Overall Study|Protocol Violation|25|||
125466265|NCT00402246|451338156|FG001|Overall Study|Protocol Violation|24|||
125466266|NCT00402246|451338155|FG000|Overall Study|Missed Final Visit|1|||
125466267|NCT00402246|451338156|FG001|Overall Study|Missed Final Visit|2|||
125466268|NCT00402246|451338155|FG000|Overall Study|Insurance Issues|2|||
125466269|NCT00402246|451338156|FG001|Overall Study|Insurance Issues|1|||
125466270|NCT00402246|451338155|FG000|Overall Study|Heart Transplant|0|||
125466271|NCT00402246|451338156|FG001|Overall Study|Heart Transplant|1|||
125466272|NCT00402246|451338155|FG000|Overall Study|Patient's device explanted|6|||
125466273|NCT00402246|451338156|FG001|Overall Study|Patient's device explanted|2|||
125466274|NCT00402246|451338155|FG000|Overall Study|Center Closure|5|||
125466275|NCT00402246|451338156|FG001|Overall Study|Center Closure|3|||
125466276|NCT00402246|451338155|FG000|Overall Study|Deterioriating Condition|3|||
125466277|NCT00402246|451338156|FG001|Overall Study|Deterioriating Condition|2|||
125466278|NCT00434304|451338161|FG000|Overall Study|Adverse Event|14|||
125466279|NCT00434304|451338161|FG000|Overall Study|Lack of Efficacy|2|||
125466280|NCT00434304|451338161|FG000|Overall Study|Withdrawal by Subject|4|||
125466281|NCT00858117|451338170|FG000|Treatment on Study|Adverse Event|2|||
125466282|NCT00858117|451338170|FG000|Follow up for 5 Years|Death|4|||
125466283|NCT00858117|451338170|FG000|Follow up for 5 Years|No further data collected for study|9|||
125466284|NCT04425863|451338171|FG000|Overall Study|Death|0|||
125466285|NCT04425863|451338172|FG001|Overall Study|Death|0|||
125466286|NCT04425863|451338173|FG002|Overall Study|Death|1|||
125466287|NCT01854385|451338177|FG000|Pre-Treatment|Withdrawal by Subject|4|||
125466288|NCT01854385|451338177|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
125466289|NCT01854385|451338177|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
125466290|NCT01854385|451338177|FG000|Pre-Treatment|Unable to come for study visits|1|||
125466291|NCT01854385|451338177|FG000|Treatment|Lost to Follow-up|1|||
125466292|NCT02597920|451338180|FG000|Overall Study|Worsening of other pre-existing disease|0|||
125466293|NCT02597920|451338181|FG001|Overall Study|Worsening of other pre-existing disease|1|||
125466294|NCT02597920|451338182|FG002|Overall Study|Worsening of other pre-existing disease|0|||
125466295|NCT02597920|451338180|FG000|Overall Study|Other adverse event|20|||
125466296|NCT02597920|451338181|FG001|Overall Study|Other adverse event|30|||
125466297|NCT02597920|451338182|FG002|Overall Study|Other adverse event|0|||
125466298|NCT02597920|451338180|FG000|Overall Study|Lost to Follow-up|7|||
125466299|NCT02597920|451338181|FG001|Overall Study|Lost to Follow-up|9|||
125466300|NCT02597920|451338182|FG002|Overall Study|Lost to Follow-up|0|||
125466301|NCT02597920|451338180|FG000|Overall Study|Refuse to continue in the study|3|||
125466302|NCT02597920|451338181|FG001|Overall Study|Refuse to continue in the study|13|||
125466303|NCT02597920|451338182|FG002|Overall Study|Refuse to continue in the study|1|||
125466304|NCT02597920|451338180|FG000|Overall Study|Other than specified|10|||
125466305|NCT02597920|451338181|FG001|Overall Study|Other than specified|31|||
125466306|NCT02597920|451338182|FG002|Overall Study|Other than specified|5|||
125466307|NCT02597920|451338180|FG000|Overall Study|Other|1|||
125466308|NCT02597920|451338181|FG001|Overall Study|Other|0|||
125466309|NCT02597920|451338182|FG002|Overall Study|Other|0|||
125466310|NCT00642850|451338183|FG000|Overall Study|Death|7|||
125466311|NCT00642850|451338183|FG000|Overall Study|Adverse Event|2|||
125466312|NCT00642850|451338183|FG000|Overall Study|Lack of Efficacy|1|||
125466313|NCT00642850|451338183|FG000|Overall Study|Protocol Violation|2|||
125466314|NCT00642850|451338183|FG000|Overall Study|Kidney transplantation|8|||
125466315|NCT00642850|451338183|FG000|Overall Study|Blood transfusion|6|||
125466316|NCT00642850|451338183|FG000|Overall Study|Other reasons|7|||
125466317|NCT00106080|451338186|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
125466318|NCT00106080|451338187|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
125466319|NCT02549170|451338188|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
125466320|NCT02549170|451338189|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
125466321|NCT02549170|451338190|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
125466322|NCT02549170|451338191|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
125466323|NCT02549170|451338192|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
125466324|NCT02549170|451338188|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
125466325|NCT02549170|451338189|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
125466326|NCT02549170|451338190|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
125466327|NCT02549170|451338191|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
125466328|NCT02549170|451338192|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
125466329|NCT02549170|451338188|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
125466330|NCT02549170|451338189|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
125466331|NCT02549170|451338190|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
125466332|NCT02549170|451338191|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
125485369|NCT02240238|451412507|FG004|Phase 1|Sponsor termination|0|||
125466333|NCT02549170|451338192|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
125466334|NCT02379819|451338193|FG000|Overall Study|Withdrawal by Subject|10|||
125466335|NCT02379819|451338193|FG000|Overall Study|Death|2|||
125466336|NCT02379819|451338193|FG000|Overall Study|Lack of Efficacy|1|||
125466337|NCT02379819|451338193|FG000|Overall Study|Lost to Follow-up|1|||
125466338|NCT03988023|451338199|FG000|Overall Study|Non-compliance|3|||
125466339|NCT03988023|451338200|FG001|Overall Study|Non-compliance|0|||
125466340|NCT03988023|451338199|FG000|Overall Study|Withdrawal by Subject|39|||
125466341|NCT03988023|451338200|FG001|Overall Study|Withdrawal by Subject|37|||
125466342|NCT03988023|451338199|FG000|Overall Study|Adverse Event|0|||
125466343|NCT03988023|451338200|FG001|Overall Study|Adverse Event|2|||
125466344|NCT03988023|451338199|FG000|Overall Study|Physician Decision|0|||
125466345|NCT03988023|451338200|FG001|Overall Study|Physician Decision|1|||
125466346|NCT03988023|451338199|FG000|Overall Study|Lost to Follow-up|5|||
125466347|NCT03988023|451338200|FG001|Overall Study|Lost to Follow-up|8|||
125466348|NCT03988023|451338199|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
125466349|NCT03988023|451338200|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
125466350|NCT03988023|451338199|FG000|Overall Study|Lack of Efficacy|3|||
125466351|NCT03988023|451338200|FG001|Overall Study|Lack of Efficacy|1|||
125466352|NCT03988023|451338199|FG000|Overall Study|COVID-19 pandemic|225|||
125466353|NCT03988023|451338200|FG001|Overall Study|COVID-19 pandemic|227|||
125466354|NCT03703336|451338201|FG000|Overall Study|Parent withdrew consent|29|||
125466355|NCT03703336|451338202|FG001|Overall Study|Parent withdrew consent|8|||
125466356|NCT03703336|451338201|FG000|Overall Study|Migration|3|||
125466357|NCT03703336|451338202|FG001|Overall Study|Migration|3|||
125466358|NCT03703336|451338201|FG000|Overall Study|Protocol Violation|3|||
125466359|NCT03703336|451338202|FG001|Overall Study|Protocol Violation|1|||
125466360|NCT03703336|451338201|FG000|Overall Study|Physician Decision|2|||
125466361|NCT03703336|451338202|FG001|Overall Study|Physician Decision|0|||
125466362|NCT03703336|451338201|FG000|Overall Study|Adverse Event|0|||
125466363|NCT03703336|451338202|FG001|Overall Study|Adverse Event|2|||
125466364|NCT03703336|451338201|FG000|Overall Study|Lost to Follow-up|1|||
125466365|NCT03703336|451338202|FG001|Overall Study|Lost to Follow-up|0|||
125466366|NCT02088853|451338205|FG000|Overall Study|Pregnancy|1|||
125466367|NCT02088853|451338206|FG001|Overall Study|Pregnancy|0|||
125466368|NCT02568683|451338207|FG000|Overall Study|Death|0|||
125466369|NCT02568683|451338208|FG001|Overall Study|Death|2|||
125466370|NCT02568683|451338207|FG000|Overall Study|Withdrew Consent|1|||
125466371|NCT02568683|451338208|FG001|Overall Study|Withdrew Consent|0|||
125466372|NCT02568683|451338207|FG000|Overall Study|Study Terminated By Sponsor|5|||
125466373|NCT02568683|451338208|FG001|Overall Study|Study Terminated By Sponsor|2|||
125466374|NCT01736215|451338209|FG000|Overall Study|Early termination of erythropoietin use|1|||
125466375|NCT01736215|451338209|FG000|Overall Study|Adverse Event|4|||
125466376|NCT01736215|451338209|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
125466377|NCT01736215|451338209|FG000|Overall Study|Insufficient data to perform analysis|8|||
125466378|NCT01248936|451338215|FG000|Overall Study|Sponsor Decision|259|||
125466379|NCT01248936|451338215|FG000|Overall Study|Progression of Disease|50|||
125466380|NCT01248936|451338215|FG000|Overall Study|Death|26|||
125466381|NCT01248936|451338215|FG000|Overall Study|Withdrawal of Consent|20|||
125466382|NCT01248936|451338215|FG000|Overall Study|Adverse Event|8|||
125466383|NCT01248936|451338215|FG000|Overall Study|Lost to Follow-up|7|||
125466384|NCT01248936|451338215|FG000|Overall Study|Refused Treatment|1|||
125466385|NCT01248936|451338215|FG000|Overall Study|Other reason|3|||
125466386|NCT03930420|451338216|FG000|Overall Study|Withdrawal by Subject|7|||
125466387|NCT03930420|451338217|FG001|Overall Study|Withdrawal by Subject|9|||
125466388|NCT04556981|451338218|FG000|Overall Study|Death|0|||
125466389|NCT04556981|451338219|FG001|Overall Study|Death|1|||
125466390|NCT04556981|451338218|FG000|Overall Study|Lost to Follow-up|2|||
125466391|NCT04556981|451338219|FG001|Overall Study|Lost to Follow-up|11|||
125466392|NCT04556981|451338218|FG000|Overall Study|Moved from the study area|1|||
125466393|NCT04556981|451338219|FG001|Overall Study|Moved from the study area|4|||
125466394|NCT04556981|451338218|FG000|Overall Study|Withdrawal by Subject|2|||
125466395|NCT04556981|451338219|FG001|Overall Study|Withdrawal by Subject|2|||
125466396|NCT04556981|451338218|FG000|Overall Study|Other|2|||
125466397|NCT04556981|451338219|FG001|Overall Study|Other|1|||
125466398|NCT00440011|451338231|FG000|Overall Study|Adverse Event|2|||
125466399|NCT00440011|451338232|FG001|Overall Study|Adverse Event|0|||
125466400|NCT00440011|451338231|FG000|Overall Study|Lost to Follow-up|0|||
125466401|NCT00440011|451338232|FG001|Overall Study|Lost to Follow-up|2|||
125466402|NCT00440011|451338231|FG000|Overall Study|Protocol Violation|1|||
125466403|NCT00440011|451338232|FG001|Overall Study|Protocol Violation|1|||
125466404|NCT00440011|451338231|FG000|Overall Study|Withdrawal by Subject|1|||
125466405|NCT00440011|451338232|FG001|Overall Study|Withdrawal by Subject|0|||
125466406|NCT00419341|451338233|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
125466407|NCT00419341|451338233|FG000|Wash in/Wash Out Period|Adverse Event|2|||
125466408|NCT00419341|451338233|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
125466409|NCT00419341|451338233|FG000|Efficacy Period|Withdrawal by Subject|6|||
125466410|NCT00419341|451338233|FG000|Efficacy Period|Protocol Violation|1|||
125466411|NCT00419341|451338233|FG000|Efficacy Period|Lost to Follow-up|1|||
125466412|NCT00419341|451338233|FG000|Efficacy Period|Non-compliance|1|||
125466413|NCT00419341|451338233|FG000|Efficacy Period|Termination of study site|1|||
125466414|NCT01925339|451338241|FG000|Overall Study|Adverse Event|2|||
125466415|NCT01925339|451338242|FG001|Overall Study|Adverse Event|0|||
125466416|NCT01538719|451338243|FG000|Overall Study|Lost to Follow-up|2|||
125466417|NCT01538719|451338244|FG001|Overall Study|Lost to Follow-up|0|||
125466418|NCT03664960|451338245|FG000|Overall Study|Adverse Event|0|||
125466419|NCT03664960|451338246|FG001|Overall Study|Adverse Event|3|||
125466420|NCT03664960|451338245|FG000|Overall Study|Lost to Follow-up|3|||
125466421|NCT03664960|451338246|FG001|Overall Study|Lost to Follow-up|2|||
125466422|NCT03664960|451338245|FG000|Overall Study|Physician Decision|1|||
125466423|NCT03664960|451338246|FG001|Overall Study|Physician Decision|0|||
125466424|NCT03664960|451338245|FG000|Overall Study|Withdrawal by Subject|3|||
125466425|NCT03664960|451338246|FG001|Overall Study|Withdrawal by Subject|14|||
125466426|NCT03664960|451338245|FG000|Overall Study|Sponsor Decision|1|||
125466427|NCT03664960|451338246|FG001|Overall Study|Sponsor Decision|1|||
125466428|NCT03664960|451338245|FG000|Overall Study|Other|1|||
125466429|NCT03664960|451338246|FG001|Overall Study|Other|2|||
125466430|NCT03783026|451340003|FG000|Treatment Phase|Adverse Event|15|||
125466431|NCT03783026|451340003|FG000|Treatment Phase|Lack of Efficacy|11|||
125466432|NCT03783026|451340003|FG000|Treatment Phase|Withdrawal by Subject|6|||
125466433|NCT03783026|451340003|FG000|Treatment Phase|Lost to Follow-up|2|||
125466434|NCT03783026|451340003|FG000|Treatment Phase|Protocol Deviation|8|||
125466435|NCT03783026|451340003|FG000|Treatment Phase|Did Not Receive Treatment|1|||
125466436|NCT03783026|451340003|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
125466437|NCT05568615|451340022|FG000|Overall Study|Death|1|||
125466438|NCT05568615|451340022|FG000|Overall Study|Physician Decision|1|||
125466439|NCT03529110|451340023|FG000|Overall Study|Progressive Disease|66|||
125466440|NCT03529110|451340024|FG001|Overall Study|Progressive Disease|158|||
125466441|NCT03529110|451340023|FG000|Overall Study|Clinical Progression|4|||
125466442|NCT03529110|451340024|FG001|Overall Study|Clinical Progression|12|||
125466443|NCT03529110|451340023|FG000|Overall Study|Adverse Event|35|||
125466444|NCT03529110|451340024|FG001|Overall Study|Adverse Event|17|||
125466445|NCT03529110|451340023|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
125466446|NCT03529110|451340024|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
125466447|NCT03529110|451340023|FG000|Overall Study|Lack of Efficacy|3|||
125466448|NCT03529110|451340024|FG001|Overall Study|Lack of Efficacy|3|||
125466449|NCT03529110|451340023|FG000|Overall Study|Physician Decision|2|||
125466450|NCT03529110|451340024|FG001|Overall Study|Physician Decision|8|||
125466451|NCT03529110|451340023|FG000|Overall Study|Miscellaneous|2|||
125466452|NCT03529110|451340024|FG001|Overall Study|Miscellaneous|5|||
125466453|NCT03237481|451340025|FG000|Overall Study|Lost to Follow-up|1|||
125466454|NCT03237481|451340026|FG001|Overall Study|Lost to Follow-up|0|||
125466455|NCT03237481|451340027|FG002|Overall Study|Lost to Follow-up|0|||
125466456|NCT03237481|451340025|FG000|Overall Study|Protocol Violation|1|||
125466457|NCT03237481|451340026|FG001|Overall Study|Protocol Violation|0|||
125466458|NCT03237481|451340027|FG002|Overall Study|Protocol Violation|0|||
125466459|NCT03237481|451340025|FG000|Overall Study|Withdrawal by Subject|3|||
125466460|NCT03237481|451340026|FG001|Overall Study|Withdrawal by Subject|2|||
125466461|NCT03237481|451340027|FG002|Overall Study|Withdrawal by Subject|1|||
125466462|NCT04999085|451340031|FG000|Overall Study|Death|1|||
125466463|NCT03873779|451340033|FG000|Overall Study|Withdrawal by Subject|1|||
125466464|NCT04279574|451340036|FG000|Overall Study|Death|1|||
125466465|NCT04279574|451340037|FG001|Overall Study|Death|0|||
125466466|NCT04279574|451340036|FG000|Overall Study|lost restoration, tooth fracture|1|||
125296260|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
125296261|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296262|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296263|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
125296264|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296265|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296266|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296267|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296268|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296269|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125466467|NCT04279574|451340037|FG001|Overall Study|lost restoration, tooth fracture|0|||
125466468|NCT04279574|451340036|FG000|Overall Study|Lost to Follow-up|0|||
125466469|NCT04279574|451340037|FG001|Overall Study|Lost to Follow-up|1|||
125466470|NCT04188379|451340038|FG000|Overall Study|Withdrawal by Subject|10|||
125466471|NCT04188379|451340039|FG001|Overall Study|Withdrawal by Subject|3|||
125466472|NCT04188379|451340038|FG000|Overall Study|Physician Decision|0|||
125466473|NCT04188379|451340039|FG001|Overall Study|Physician Decision|1|||
125466474|NCT04188379|451340038|FG000|Overall Study|Adverse Event|3|||
125466475|NCT04188379|451340039|FG001|Overall Study|Adverse Event|1|||
125466476|NCT04188379|451340038|FG000|Overall Study|Pregnancy|1|||
125466477|NCT04188379|451340039|FG001|Overall Study|Pregnancy|0|||
125296270|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296271|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
125296272|NCT02914561|450711485|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
125296273|NCT02914561|450711486|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
125296274|NCT02914561|450711487|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
125296275|NCT02914561|450711488|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
125296276|NCT02914561|450711489|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
125296277|NCT02914561|450711490|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
125296278|NCT02914561|450711491|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
125296279|NCT02914561|450711492|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
125296280|NCT02914561|450711493|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
125296281|NCT02914561|450711494|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
125296282|NCT02914561|450711495|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
125296283|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
125296284|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
125296285|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
125296286|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
125296287|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
125296288|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
125296289|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
125296290|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
125296291|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
125296292|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
125296293|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
125296294|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
125296295|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
125296296|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
125296297|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
125296298|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
125296299|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
125296300|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
125296301|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
125296302|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
125296303|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
125296304|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
125296305|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
125296306|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
125296307|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
125296308|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
125296309|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
125296310|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
125296311|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
125296312|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
125296313|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
125296314|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
125296315|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
125296316|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296317|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296318|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296319|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296320|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296321|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296322|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
125296323|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296324|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
125296325|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
125296326|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
125296327|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
125296328|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
125296329|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
125296330|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
125296331|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
125466478|NCT04188379|451340038|FG000|Overall Study|Lack of Efficacy|8|||
125466479|NCT04188379|451340039|FG001|Overall Study|Lack of Efficacy|5|||
125466480|NCT04188379|451340038|FG000|Overall Study|Other|0|||
125296332|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
125296333|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
125296334|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
125296335|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
125296336|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
125296337|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
125296338|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296339|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296340|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296341|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296342|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296343|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296344|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
125296345|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296346|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
125296347|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296348|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
125296349|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296350|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296351|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296352|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296353|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296354|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296355|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296356|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296357|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
125296358|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296359|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
125296360|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296361|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296362|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296363|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296364|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296365|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296366|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
125296367|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296368|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296369|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296370|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
125296371|NCT02914561|450711485|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296372|NCT02914561|450711486|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296373|NCT02914561|450711487|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296374|NCT02914561|450711488|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296375|NCT02914561|450711489|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296376|NCT02914561|450711490|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296377|NCT02914561|450711491|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296378|NCT02914561|450711492|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
125296379|NCT02914561|450711493|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
125296380|NCT02914561|450711494|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
125296381|NCT02914561|450711495|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
125296382|NCT01455220|450711498|FG000|Overall Study|screen fail|30|||
125296383|NCT04881747|450711499|FG000|Period 2 Washout|Adverse Event|1|||
125296384|NCT04881747|450711500|FG001|Period 2 Washout|Adverse Event|0|||
125296385|NCT04881747|450711501|FG002|Period 2 Washout|Adverse Event|0|||
125296386|NCT04881747|450711502|FG003|Period 2 Washout|Adverse Event|0|||
125296387|NCT04881747|450711503|FG004|Period 2 Washout|Adverse Event|1|||
125296388|NCT04881747|450711504|FG005|Period 2 Washout|Adverse Event|0|||
125296389|NCT04881747|450711499|FG000|Period 2 Washout|Withdrawal by Subject|1|||
125296390|NCT04881747|450711500|FG001|Period 2 Washout|Withdrawal by Subject|0|||
125296391|NCT04881747|450711501|FG002|Period 2 Washout|Withdrawal by Subject|0|||
125296392|NCT04881747|450711502|FG003|Period 2 Washout|Withdrawal by Subject|1|||
125296393|NCT04881747|450711503|FG004|Period 2 Washout|Withdrawal by Subject|0|||
125296394|NCT04881747|450711504|FG005|Period 2 Washout|Withdrawal by Subject|0|||
125296395|NCT04598269|450711505|FG000|Overall Study|Adverse Event|0|||
125296396|NCT04598269|450711506|FG001|Overall Study|Adverse Event|3|||
125296397|NCT04598269|450711505|FG000|Overall Study|Withdrawal by Subject|1|||
125296398|NCT04598269|450711506|FG001|Overall Study|Withdrawal by Subject|4|||
125296399|NCT04598269|450711505|FG000|Overall Study|Lost to Follow-up|1|||
125296400|NCT04598269|450711506|FG001|Overall Study|Lost to Follow-up|0|||
125296401|NCT04598269|450711505|FG000|Overall Study|Not Treated|2|||
125296402|NCT04598269|450711506|FG001|Overall Study|Not Treated|0|||
125296403|NCT03869333|450711511|FG000|Overall Study|Lost to Follow-up|1|||
125296404|NCT03869333|450711512|FG001|Overall Study|Lost to Follow-up|0|||
125296405|NCT03869333|450711513|FG002|Overall Study|Lost to Follow-up|0|||
125296406|NCT03869333|450711514|FG003|Overall Study|Lost to Follow-up|0|||
125296407|NCT03869333|450711511|FG000|Overall Study|Pregnancy|1|||
125296408|NCT03869333|450711512|FG001|Overall Study|Pregnancy|0|||
125296409|NCT03869333|450711513|FG002|Overall Study|Pregnancy|0|||
125296410|NCT03869333|450711514|FG003|Overall Study|Pregnancy|0|||
125296411|NCT03869333|450711511|FG000|Overall Study|Physician Decision|0|||
125296412|NCT03869333|450711512|FG001|Overall Study|Physician Decision|1|||
125296413|NCT03869333|450711513|FG002|Overall Study|Physician Decision|0|||
125296414|NCT03869333|450711514|FG003|Overall Study|Physician Decision|0|||
125296415|NCT02598128|450711515|FG000|Period A: Days -7 to -1|Adverse Event|1|||
125296416|NCT02598128|450711516|FG001|Period A: Days -7 to -1|Adverse Event|0|||
125296417|NCT02598128|450711517|FG002|Period A: Days -7 to -1|Adverse Event|0|||
125296418|NCT02598128|450711518|FG003|Period A: Days -7 to -1|Adverse Event|0|||
125296419|NCT03134183|450711521|FG000|Overall Study|Withdrawal by Subject|1|||
125296420|NCT03134183|450711522|FG001|Overall Study|Withdrawal by Subject|1|||
125296421|NCT00845065|450711523|FG000|Overall Study|Adverse Event|3|||
125296422|NCT00845065|450711524|FG001|Overall Study|Adverse Event|23|||
125296423|NCT00845065|450711523|FG000|Overall Study|Lack of Efficacy|43|||
125296424|NCT00845065|450711524|FG001|Overall Study|Lack of Efficacy|21|||
125296425|NCT00845065|450711523|FG000|Overall Study|Non-Medical Reasons|1|||
125296426|NCT00845065|450711524|FG001|Overall Study|Non-Medical Reasons|11|||
125296427|NCT00162266|450711525|FG000|Double-Blind Period|Adverse Event|5|||
125296428|NCT00162266|450711526|FG001|Double-Blind Period|Adverse Event|9|||
125296429|NCT00162266|450711527|FG002|Double-Blind Period|Adverse Event|11|||
125296430|NCT00162266|450711528|FG003|Double-Blind Period|Adverse Event|0|||
125296431|NCT00162266|450711525|FG000|Double-Blind Period|Death|0|||
125296432|NCT00162266|450711526|FG001|Double-Blind Period|Death|1|||
125296433|NCT00162266|450711527|FG002|Double-Blind Period|Death|0|||
125296434|NCT00162266|450711528|FG003|Double-Blind Period|Death|0|||
125296435|NCT00162266|450711525|FG000|Double-Blind Period|Lost to Follow-up|1|||
125296436|NCT00162266|450711526|FG001|Double-Blind Period|Lost to Follow-up|2|||
125296437|NCT00162266|450711527|FG002|Double-Blind Period|Lost to Follow-up|0|||
125296438|NCT00162266|450711528|FG003|Double-Blind Period|Lost to Follow-up|0|||
125296439|NCT00162266|450711525|FG000|Double-Blind Period|Other Reason|1|||
125296440|NCT00162266|450711526|FG001|Double-Blind Period|Other Reason|0|||
125296441|NCT00162266|450711527|FG002|Double-Blind Period|Other Reason|1|||
125296442|NCT00162266|450711528|FG003|Double-Blind Period|Other Reason|0|||
125296443|NCT00162266|450711525|FG000|Double-Blind Period|Lack of Efficacy|13|||
125296444|NCT00162266|450711526|FG001|Double-Blind Period|Lack of Efficacy|17|||
125296445|NCT00162266|450711527|FG002|Double-Blind Period|Lack of Efficacy|30|||
125296446|NCT00162266|450711528|FG003|Double-Blind Period|Lack of Efficacy|0|||
125296447|NCT00162266|450711525|FG000|Double-Blind Period|Withdrawal by Subject|5|||
125296448|NCT00162266|450711526|FG001|Double-Blind Period|Withdrawal by Subject|2|||
125296449|NCT00162266|450711527|FG002|Double-Blind Period|Withdrawal by Subject|6|||
125296450|NCT00162266|450711528|FG003|Double-Blind Period|Withdrawal by Subject|0|||
125296451|NCT00162266|450711525|FG000|Open-Label Period|Death|0|||
125296452|NCT00162266|450711526|FG001|Open-Label Period|Death|0|||
125296453|NCT00162266|450711527|FG002|Open-Label Period|Death|0|||
125296454|NCT00162266|450711528|FG003|Open-Label Period|Death|7|||
125296455|NCT00162266|450711525|FG000|Open-Label Period|Adverse Event|0|||
125296456|NCT00162266|450711526|FG001|Open-Label Period|Adverse Event|0|||
125296457|NCT00162266|450711527|FG002|Open-Label Period|Adverse Event|0|||
125296458|NCT00162266|450711528|FG003|Open-Label Period|Adverse Event|46|||
125296459|NCT00162266|450711525|FG000|Open-Label Period|Lack of Efficacy|0|||
125296460|NCT00162266|450711526|FG001|Open-Label Period|Lack of Efficacy|0|||
125296461|NCT00162266|450711527|FG002|Open-Label Period|Lack of Efficacy|0|||
125296462|NCT00162266|450711528|FG003|Open-Label Period|Lack of Efficacy|26|||
125296463|NCT00162266|450711525|FG000|Open-Label Period|Lost to Follow-up|0|||
125296464|NCT00162266|450711526|FG001|Open-Label Period|Lost to Follow-up|0|||
125466481|NCT04188379|451340039|FG001|Overall Study|Other|3|||
125296465|NCT00162266|450711527|FG002|Open-Label Period|Lost to Follow-up|0|||
125296466|NCT00162266|450711528|FG003|Open-Label Period|Lost to Follow-up|3|||
125296467|NCT00162266|450711525|FG000|Open-Label Period|Withdrawal by Subject|0|||
125296468|NCT00162266|450711526|FG001|Open-Label Period|Withdrawal by Subject|0|||
125296469|NCT00162266|450711527|FG002|Open-Label Period|Withdrawal by Subject|0|||
125296470|NCT00162266|450711528|FG003|Open-Label Period|Withdrawal by Subject|31|||
125296471|NCT00162266|450711525|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
125296472|NCT00162266|450711526|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
125296473|NCT00162266|450711527|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
125296474|NCT00162266|450711528|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
125296475|NCT00162266|450711525|FG000|Open-Label Period|Other Reasons|0|||
125296476|NCT00162266|450711526|FG001|Open-Label Period|Other Reasons|0|||
125296477|NCT00162266|450711527|FG002|Open-Label Period|Other Reasons|0|||
125296478|NCT00162266|450711528|FG003|Open-Label Period|Other Reasons|15|||
125296479|NCT01198509|450711529|FG000|Overall Study|Withdrawal by Subject|1|||
125296480|NCT01198509|450711530|FG001|Overall Study|Withdrawal by Subject|0|||
125296481|NCT01198509|450711531|FG002|Overall Study|Withdrawal by Subject|0|||
125296482|NCT01198509|450711532|FG003|Overall Study|Withdrawal by Subject|0|||
125296483|NCT01198509|450711533|FG004|Overall Study|Withdrawal by Subject|0|||
125296484|NCT01198509|450711534|FG005|Overall Study|Withdrawal by Subject|0|||
125296485|NCT00499746|450711535|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
125296486|NCT00499746|450711535|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
125296487|NCT00499746|450711535|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
125296488|NCT00499746|450711535|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
125296489|NCT03480009|450711538|FG000|Overall Study|Lost to Follow-up|4|||
125296490|NCT03480009|450711539|FG001|Overall Study|Lost to Follow-up|5|||
125296491|NCT03480009|450711540|FG002|Overall Study|Lost to Follow-up|4|||
125296492|NCT03480009|450711541|FG003|Overall Study|Lost to Follow-up|0|||
125296493|NCT01638559|450711543|FG000|Overall Study|Lost to Follow-up|1|||
125296494|NCT01638559|450711543|FG000|Overall Study|Withdrawal by Subject|1|||
125296495|NCT01638559|450711543|FG000|Overall Study|Subject declined to travel for biopsy|1|||
125296496|NCT00483002|450711546|FG000|Overall Study|Adverse Event|68|||
125296497|NCT00483002|450711546|FG000|Overall Study|Lack of Efficacy|555|||
125296498|NCT00483002|450711546|FG000|Overall Study|Lost to Follow-up|962|||
125296499|NCT00483002|450711546|FG000|Overall Study|Other|2|||
125296500|NCT00483002|450711546|FG000|Overall Study|Other|967|||
125296501|NCT00772109|450711547|FG000|Overall Study|Serious adverse event|1|||
125296502|NCT00772109|450711548|FG001|Overall Study|Serious adverse event|0|||
125296503|NCT00772109|450711549|FG002|Overall Study|Serious adverse event|1|||
125296504|NCT00772109|450711550|FG003|Overall Study|Serious adverse event|0|||
125296505|NCT00772109|450711547|FG000|Overall Study|Protocol Violation|5|||
125296506|NCT00772109|450711548|FG001|Overall Study|Protocol Violation|8|||
125296507|NCT00772109|450711549|FG002|Overall Study|Protocol Violation|7|||
125296508|NCT00772109|450711550|FG003|Overall Study|Protocol Violation|6|||
125296509|NCT00772109|450711547|FG000|Overall Study|Lost to Follow-up|7|||
125296510|NCT00772109|450711548|FG001|Overall Study|Lost to Follow-up|3|||
125296511|NCT00772109|450711549|FG002|Overall Study|Lost to Follow-up|5|||
125296512|NCT00772109|450711550|FG003|Overall Study|Lost to Follow-up|9|||
125296513|NCT00772109|450711547|FG000|Overall Study|Withdrawal by Subject|8|||
125296514|NCT00772109|450711548|FG001|Overall Study|Withdrawal by Subject|8|||
125296515|NCT00772109|450711549|FG002|Overall Study|Withdrawal by Subject|6|||
125296516|NCT00772109|450711550|FG003|Overall Study|Withdrawal by Subject|16|||
125296517|NCT01624090|450711551|FG000|Overall Study|DLT, taken off therapy|0|||
125296518|NCT01624090|450711552|FG001|Overall Study|DLT, taken off therapy|1|||
125296519|NCT01624090|450711553|FG002|Overall Study|DLT, taken off therapy|0|||
125296520|NCT01624090|450711554|FG003|Overall Study|DLT, taken off therapy|0|||
125296521|NCT01624090|450711551|FG000|Overall Study|Withdrew prior to treatment|0|||
125296522|NCT01624090|450711552|FG001|Overall Study|Withdrew prior to treatment|1|||
125296523|NCT01624090|450711553|FG002|Overall Study|Withdrew prior to treatment|0|||
125296524|NCT01624090|450711554|FG003|Overall Study|Withdrew prior to treatment|0|||
125296525|NCT01624090|450711551|FG000|Overall Study|Died on study|0|||
125296526|NCT01624090|450711552|FG001|Overall Study|Died on study|0|||
125296527|NCT01624090|450711553|FG002|Overall Study|Died on study|2|||
125296528|NCT01624090|450711554|FG003|Overall Study|Died on study|0|||
125296529|NCT01624090|450711551|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
125296530|NCT01624090|450711552|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
125296531|NCT01624090|450711553|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
125296532|NCT01624090|450711554|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
125296533|NCT01624090|450711551|FG000|Overall Study|Dose escalated|0|||
125296534|NCT01624090|450711552|FG001|Overall Study|Dose escalated|0|||
125296535|NCT01624090|450711553|FG002|Overall Study|Dose escalated|3|||
125296536|NCT01624090|450711554|FG003|Overall Study|Dose escalated|0|||
125296537|NCT00752726|450711555|FG000|Overall Study|Lost to Follow-up|2|||
125296538|NCT00752726|450711556|FG001|Overall Study|Lost to Follow-up|1|||
125296539|NCT00752726|450711555|FG000|Overall Study|Adverse Event|3|||
125296540|NCT00752726|450711556|FG001|Overall Study|Adverse Event|0|||
125296541|NCT00752726|450711555|FG000|Overall Study|Withdrawal by Subject|5|||
125296542|NCT00752726|450711556|FG001|Overall Study|Withdrawal by Subject|10|||
125296543|NCT00752726|450711555|FG000|Overall Study|Other Reason|1|||
125296544|NCT00752726|450711556|FG001|Overall Study|Other Reason|2|||
125296545|NCT01403116|450711557|FG000|Overall Study|Adverse Event|7|||
125296546|NCT01403116|450711558|FG001|Overall Study|Adverse Event|4|||
125296547|NCT01403116|450711557|FG000|Overall Study|Lost to Follow-up|7|||
125296548|NCT01403116|450711558|FG001|Overall Study|Lost to Follow-up|5|||
125296549|NCT01403116|450711557|FG000|Overall Study|Withdrawal by Subject|12|||
125296550|NCT01403116|450711558|FG001|Overall Study|Withdrawal by Subject|15|||
125296551|NCT01403116|450711557|FG000|Overall Study|Non-compliance of study drug|3|||
125296552|NCT01403116|450711558|FG001|Overall Study|Non-compliance of study drug|0|||
125296553|NCT01403116|450711557|FG000|Overall Study|Protocol Violation|0|||
125296554|NCT01403116|450711558|FG001|Overall Study|Protocol Violation|1|||
125296555|NCT01403116|450711557|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
125296556|NCT01403116|450711558|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
125296557|NCT01403116|450711557|FG000|Overall Study|Hct >54%|2|||
125296558|NCT01403116|450711558|FG001|Overall Study|Hct >54%|0|||
125296559|NCT01403116|450711557|FG000|Overall Study|unable to keep appointments|0|||
125296560|NCT01403116|450711558|FG001|Overall Study|unable to keep appointments|2|||
125296561|NCT01895309|450711559|FG000|Overall Study|Adverse Event|13|||
125296562|NCT01895309|450711560|FG001|Overall Study|Adverse Event|17|||
125296563|NCT01895309|450711559|FG000|Overall Study|Protocol Violation|1|||
125296564|NCT01895309|450711560|FG001|Overall Study|Protocol Violation|0|||
125296565|NCT01895309|450711559|FG000|Overall Study|Lack of Efficacy|1|||
125296566|NCT01895309|450711560|FG001|Overall Study|Lack of Efficacy|3|||
125296567|NCT01895309|450711559|FG000|Overall Study|Lost to Follow-up|1|||
125296568|NCT01895309|450711560|FG001|Overall Study|Lost to Follow-up|3|||
125296569|NCT01895309|450711559|FG000|Overall Study|Physician Decision|15|||
125296570|NCT01895309|450711560|FG001|Overall Study|Physician Decision|10|||
125296571|NCT01895309|450711559|FG000|Overall Study|Withdrawal by Subject|9|||
125296572|NCT01895309|450711560|FG001|Overall Study|Withdrawal by Subject|18|||
125296573|NCT00042666|450711561|FG000|Overall Study|Adverse Event|2|||
125296574|NCT00042666|450711561|FG000|Overall Study|Death|4|||
125296575|NCT00042666|450711561|FG000|Overall Study|Protocol Violation|1|||
125296576|NCT00042666|450711561|FG000|Overall Study|Participant/Physician Perception|1|||
125296577|NCT00042666|450711561|FG000|Overall Study|Progressive Disease|41|||
125296578|NCT00042666|450711561|FG000|Overall Study|Other|1|||
125296579|NCT00042666|450711561|FG000|Overall Study|Other|4|||
125296580|NCT04232215|450711562|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
125296581|NCT04232215|450711563|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
125296582|NCT04046250|450711579|FG000|Overall Study|Death|0|||
125296583|NCT04046250|450711580|FG001|Overall Study|Death|1|||
125296584|NCT04046250|450711579|FG000|Overall Study|Withdrawal by Subject|3|||
125296585|NCT04046250|450711580|FG001|Overall Study|Withdrawal by Subject|3|||
125296586|NCT04576897|450711585|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
125296587|NCT00527332|450711586|FG000|Overall Study|Protocol Violation|4|||
125296588|NCT00527332|450711587|FG001|Overall Study|Protocol Violation|8|||
125296589|NCT00527332|450711586|FG000|Overall Study|Withdrew consent|5|||
125296590|NCT00527332|450711587|FG001|Overall Study|Withdrew consent|1|||
125296591|NCT02666105|450711588|FG000|Overall Study|Death|1|||
125296592|NCT01078168|450711589|FG000|Overall Study|Physician Decision|0|||
125296593|NCT01078168|450711590|FG001|Overall Study|Physician Decision|1|||
125296594|NCT01264419|450711592|FG000|Overall Study|Lost to Follow-up|3|||
125296595|NCT00358436|450713824|FG000|Overall Study|Adverse Event|29|||
125296596|NCT00358436|450713825|FG001|Overall Study|Adverse Event|13|||
125296597|NCT00358436|450713824|FG000|Overall Study|Lack of Efficacy|34|||
125296598|NCT00358436|450713825|FG001|Overall Study|Lack of Efficacy|36|||
125296599|NCT00358436|450713824|FG000|Overall Study|Lost to Follow-up|11|||
125296600|NCT00358436|450713825|FG001|Overall Study|Lost to Follow-up|6|||
125296601|NCT00358436|450713824|FG000|Overall Study|Protocol Violation|8|||
125296602|NCT00358436|450713825|FG001|Overall Study|Protocol Violation|3|||
125296603|NCT00358436|450713824|FG000|Overall Study|Withdrawal by Subject|40|||
125296604|NCT00358436|450713825|FG001|Overall Study|Withdrawal by Subject|17|||
125296605|NCT00358436|450713824|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
125296606|NCT00358436|450713825|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
125296607|NCT00358436|450713824|FG000|Overall Study|COPD exacerbation|22|||
125296608|NCT00358436|450713825|FG001|Overall Study|COPD exacerbation|10|||
125296609|NCT00358436|450713824|FG000|Overall Study|Other|6|||
125296610|NCT00358436|450713825|FG001|Overall Study|Other|1|||
125296611|NCT02905006|450713827|FG000|Overall Study|Adverse Event|1|||
125296612|NCT02905006|450713828|FG001|Overall Study|Adverse Event|1|||
125296613|NCT02905006|450713829|FG002|Overall Study|Adverse Event|1|||
125296614|NCT02905006|450713830|FG003|Overall Study|Adverse Event|1|||
125296615|NCT02905006|450713831|FG004|Overall Study|Adverse Event|0|||
125296616|NCT02905006|450713832|FG005|Overall Study|Adverse Event|1|||
125296617|NCT02905006|450713827|FG000|Overall Study|Lack of Efficacy|1|||
125296618|NCT02905006|450713828|FG001|Overall Study|Lack of Efficacy|0|||
125296619|NCT02905006|450713829|FG002|Overall Study|Lack of Efficacy|0|||
125296620|NCT02905006|450713830|FG003|Overall Study|Lack of Efficacy|0|||
125296621|NCT02905006|450713831|FG004|Overall Study|Lack of Efficacy|0|||
125296622|NCT02905006|450713832|FG005|Overall Study|Lack of Efficacy|0|||
125296623|NCT02905006|450713827|FG000|Overall Study|Protocol Violation|2|||
125296624|NCT02905006|450713828|FG001|Overall Study|Protocol Violation|0|||
125296625|NCT02905006|450713829|FG002|Overall Study|Protocol Violation|0|||
125296626|NCT02905006|450713830|FG003|Overall Study|Protocol Violation|0|||
125296627|NCT02905006|450713831|FG004|Overall Study|Protocol Violation|0|||
125296628|NCT02905006|450713832|FG005|Overall Study|Protocol Violation|0|||
125296629|NCT02905006|450713827|FG000|Overall Study|Lost to Follow-up|0|||
125296630|NCT02905006|450713828|FG001|Overall Study|Lost to Follow-up|0|||
125296631|NCT02905006|450713829|FG002|Overall Study|Lost to Follow-up|0|||
125296632|NCT02905006|450713830|FG003|Overall Study|Lost to Follow-up|1|||
125296633|NCT02905006|450713831|FG004|Overall Study|Lost to Follow-up|1|||
125466482|NCT02566902|451340043|FG000|Overall Study|Protocol Violation|2|||
125466483|NCT02566902|451340044|FG001|Overall Study|Protocol Violation|1|||
125466484|NCT03112174|451340047|FG000|Overall Study|Withdrawal by Subject|3|||
125466485|NCT03112174|451340048|FG001|Overall Study|Withdrawal by Subject|0|||
125466486|NCT03112174|451340049|FG002|Overall Study|Withdrawal by Subject|11|||
125466487|NCT03112174|451340050|FG003|Overall Study|Withdrawal by Subject|9|||
125466488|NCT03112174|451340051|FG004|Overall Study|Withdrawal by Subject|7|||
125466489|NCT03112174|451340047|FG000|Overall Study|Lost to Follow-up|1|||
125466490|NCT03112174|451340048|FG001|Overall Study|Lost to Follow-up|1|||
125466491|NCT03112174|451340049|FG002|Overall Study|Lost to Follow-up|2|||
125466492|NCT03112174|451340050|FG003|Overall Study|Lost to Follow-up|3|||
125466493|NCT03112174|451340051|FG004|Overall Study|Lost to Follow-up|2|||
125466494|NCT03112174|451340047|FG000|Overall Study|Death|8|||
125466495|NCT03112174|451340048|FG001|Overall Study|Death|3|||
125466496|NCT03112174|451340049|FG002|Overall Study|Death|67|||
125466497|NCT03112174|451340050|FG003|Overall Study|Death|73|||
125466498|NCT03112174|451340051|FG004|Overall Study|Death|18|||
125466499|NCT03112174|451340047|FG000|Overall Study|Other, Not Specified|1|||
125466500|NCT03112174|451340048|FG001|Overall Study|Other, Not Specified|0|||
125466501|NCT03112174|451340049|FG002|Overall Study|Other, Not Specified|1|||
125466502|NCT03112174|451340050|FG003|Overall Study|Other, Not Specified|2|||
125466503|NCT03112174|451340051|FG004|Overall Study|Other, Not Specified|0|||
125466504|NCT05773313|451340054|FG000|Overall Study|Lost to Follow-up|3|||
125466505|NCT02748317|451340055|FG000|Overall Study|Withdrawal by Subject|14|||
125466506|NCT02748317|451340055|FG000|Overall Study|Lost to Follow-up|8|||
125466507|NCT02748317|451340055|FG000|Overall Study|Death|1|||
125466508|NCT00332241|451340056|FG000|Overall Study|Lack of Efficacy|6|||
125466509|NCT00332241|451340057|FG001|Overall Study|Lack of Efficacy|1|||
125466510|NCT00332241|451340056|FG000|Overall Study|Adverse Event|3|||
125466511|NCT00332241|451340057|FG001|Overall Study|Adverse Event|5|||
125466512|NCT00332241|451340056|FG000|Overall Study|Withdrawal by Subject|2|||
125466513|NCT00332241|451340057|FG001|Overall Study|Withdrawal by Subject|1|||
125466514|NCT00332241|451340056|FG000|Overall Study|Lost to Follow-up|4|||
125466515|NCT00332241|451340057|FG001|Overall Study|Lost to Follow-up|1|||
125466516|NCT05262738|451340058|FG000|Overall Study|Withdrawal by Subject|1|||
125466517|NCT05262738|451340059|FG001|Overall Study|Withdrawal by Subject|0|||
125466518|NCT02374463|451340061|FG000|Overall Study|Withdrawal by Subject|3|||
125466519|NCT02374463|451340062|FG001|Overall Study|Withdrawal by Subject|3|||
125466520|NCT01471691|451340065|FG000|Overall Study|Lack of Efficacy|0|||
125466521|NCT01471691|451340066|FG001|Overall Study|Lack of Efficacy|1|||
125466522|NCT01808339|451340067|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
125466523|NCT01808339|451340068|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
125466524|NCT01808339|451340069|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
125466525|NCT01808339|451340070|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
125466526|NCT01808339|451340071|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
125466527|NCT01808339|451340072|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
125466528|NCT01808339|451340067|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125466529|NCT01808339|451340068|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125466530|NCT01808339|451340069|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125466531|NCT01808339|451340070|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
125466532|NCT01808339|451340071|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125466533|NCT01808339|451340072|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
125466534|NCT01808339|451340067|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
125466535|NCT01808339|451340068|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
125466536|NCT01808339|451340069|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
125466537|NCT01808339|451340070|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
125466538|NCT01808339|451340071|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
125466539|NCT01808339|451340072|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
125466540|NCT02622568|451340073|FG000|Overall Study|Lost to Follow-up|5|||
125466541|NCT02622568|451340074|FG001|Overall Study|Lost to Follow-up|5|||
125466542|NCT01266122|451340076|FG000|Overall Study|Lost to Follow-up|6|||
125296634|NCT02905006|450713832|FG005|Overall Study|Lost to Follow-up|0|||
125466543|NCT01266122|451340077|FG001|Overall Study|Lost to Follow-up|6|||
125466544|NCT00421889|451340078|FG000|Overall Study|Adverse Event|1|||
125466545|NCT00421889|451340079|FG001|Overall Study|Adverse Event|0|||
125466546|NCT00421889|451340080|FG002|Overall Study|Adverse Event|1|||
125466547|NCT00421889|451340081|FG003|Overall Study|Adverse Event|1|||
125466548|NCT00421889|451340082|FG004|Overall Study|Adverse Event|1|||
125466549|NCT00421889|451340083|FG005|Overall Study|Adverse Event|4|||
125466550|NCT00421889|451340084|FG006|Overall Study|Adverse Event|1|||
125466551|NCT00421889|451340085|FG007|Overall Study|Adverse Event|0|||
125466552|NCT00421889|451340086|FG008|Overall Study|Adverse Event|2|||
125466553|NCT00421889|451340078|FG000|Overall Study|Withdrawal by Subject|1|||
125296635|NCT02905006|450713827|FG000|Overall Study|Withdrawal by Subject|0|||
125466554|NCT00421889|451340079|FG001|Overall Study|Withdrawal by Subject|3|||
125466555|NCT00421889|451340080|FG002|Overall Study|Withdrawal by Subject|0|||
125466556|NCT00421889|451340081|FG003|Overall Study|Withdrawal by Subject|0|||
125466557|NCT00421889|451340082|FG004|Overall Study|Withdrawal by Subject|2|||
125466558|NCT00421889|451340083|FG005|Overall Study|Withdrawal by Subject|0|||
125466559|NCT00421889|451340084|FG006|Overall Study|Withdrawal by Subject|0|||
125466560|NCT00421889|451340085|FG007|Overall Study|Withdrawal by Subject|0|||
125466561|NCT00421889|451340086|FG008|Overall Study|Withdrawal by Subject|0|||
125466562|NCT00421889|451340078|FG000|Overall Study|Death|0|||
125466563|NCT00421889|451340079|FG001|Overall Study|Death|0|||
125466564|NCT00421889|451340080|FG002|Overall Study|Death|0|||
125466565|NCT00421889|451340081|FG003|Overall Study|Death|0|||
125296636|NCT02905006|450713828|FG001|Overall Study|Withdrawal by Subject|0|||
125296637|NCT02905006|450713829|FG002|Overall Study|Withdrawal by Subject|1|||
125296638|NCT02905006|450713830|FG003|Overall Study|Withdrawal by Subject|1|||
125296639|NCT02905006|450713831|FG004|Overall Study|Withdrawal by Subject|0|||
125296640|NCT02905006|450713832|FG005|Overall Study|Withdrawal by Subject|1|||
125296641|NCT02905006|450713827|FG000|Overall Study|Screening exclusion criteria met|1|||
125296642|NCT02905006|450713828|FG001|Overall Study|Screening exclusion criteria met|0|||
125296643|NCT02905006|450713829|FG002|Overall Study|Screening exclusion criteria met|0|||
125296644|NCT02905006|450713830|FG003|Overall Study|Screening exclusion criteria met|0|||
125466566|NCT00421889|451340082|FG004|Overall Study|Death|1|||
125466567|NCT00421889|451340083|FG005|Overall Study|Death|1|||
125466568|NCT00421889|451340084|FG006|Overall Study|Death|0|||
125466569|NCT00421889|451340085|FG007|Overall Study|Death|0|||
125466570|NCT00421889|451340086|FG008|Overall Study|Death|0|||
125466571|NCT00421889|451340078|FG000|Overall Study|Progressive disease|3|||
125466572|NCT00421889|451340079|FG001|Overall Study|Progressive disease|2|||
125466573|NCT00421889|451340080|FG002|Overall Study|Progressive disease|2|||
125466574|NCT00421889|451340081|FG003|Overall Study|Progressive disease|3|||
125466575|NCT00421889|451340082|FG004|Overall Study|Progressive disease|2|||
125466576|NCT00421889|451340083|FG005|Overall Study|Progressive disease|21|||
125466577|NCT00421889|451340084|FG006|Overall Study|Progressive disease|3|||
125466578|NCT00421889|451340085|FG007|Overall Study|Progressive disease|1|||
125466579|NCT00421889|451340086|FG008|Overall Study|Progressive disease|5|||
125466580|NCT00421889|451340078|FG000|Overall Study|Patient/Investigator request|0|||
125466581|NCT00421889|451340079|FG001|Overall Study|Patient/Investigator request|0|||
125466582|NCT00421889|451340080|FG002|Overall Study|Patient/Investigator request|0|||
125466583|NCT00421889|451340081|FG003|Overall Study|Patient/Investigator request|0|||
125466584|NCT00421889|451340082|FG004|Overall Study|Patient/Investigator request|0|||
125466585|NCT00421889|451340083|FG005|Overall Study|Patient/Investigator request|9|||
125466586|NCT00421889|451340084|FG006|Overall Study|Patient/Investigator request|0|||
125466587|NCT00421889|451340085|FG007|Overall Study|Patient/Investigator request|1|||
125466588|NCT00421889|451340086|FG008|Overall Study|Patient/Investigator request|3|||
125466589|NCT00421889|451340078|FG000|Overall Study|Lost to Follow-up|0|||
125466590|NCT00421889|451340079|FG001|Overall Study|Lost to Follow-up|0|||
125466591|NCT00421889|451340080|FG002|Overall Study|Lost to Follow-up|0|||
125466592|NCT00421889|451340081|FG003|Overall Study|Lost to Follow-up|0|||
125466593|NCT00421889|451340082|FG004|Overall Study|Lost to Follow-up|0|||
125466594|NCT00421889|451340083|FG005|Overall Study|Lost to Follow-up|0|||
125466595|NCT00421889|451340084|FG006|Overall Study|Lost to Follow-up|0|||
125466596|NCT00421889|451340085|FG007|Overall Study|Lost to Follow-up|0|||
125466597|NCT00421889|451340086|FG008|Overall Study|Lost to Follow-up|1|||
125466598|NCT03756571|451340087|FG000|Overall Study|Lost to Follow-up|1|||
125466599|NCT03756571|451340088|FG001|Overall Study|Lost to Follow-up|1|||
125466600|NCT00978042|451340089|FG000|Initial Treatment Period|Treated in Error|0|||
125466601|NCT00978042|451340090|FG001|Initial Treatment Period|Treated in Error|3|||
125466602|NCT00978042|451340089|FG000|Initial Treatment Period|Ineligibility|1|||
125466603|NCT00978042|451340090|FG001|Initial Treatment Period|Ineligibility|0|||
125466604|NCT00978042|451340089|FG000|Initial Treatment Period|Lost to Follow-up|21|||
125466605|NCT00978042|451340090|FG001|Initial Treatment Period|Lost to Follow-up|3|||
125466606|NCT00978042|451340089|FG000|Initial Treatment Period|Adverse Event|2|||
125466607|NCT00978042|451340090|FG001|Initial Treatment Period|Adverse Event|0|||
125296645|NCT02905006|450713831|FG004|Overall Study|Screening exclusion criteria met|0|||
125466608|NCT00978042|451340089|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
125466609|NCT00978042|451340090|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
125466610|NCT00978042|451340089|FG000|Initial Treatment Period|Consent withdrawn|22|||
125466611|NCT00978042|451340090|FG001|Initial Treatment Period|Consent withdrawn|9|||
125466612|NCT00978042|451340089|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
125466613|NCT00978042|451340090|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
125466614|NCT00520546|451340091|FG000|Overall Study|Withdrawal by Subject|1|||
125466615|NCT00520546|451340091|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
125466616|NCT02101281|451340092|FG000|Overall Study|Adverse Event|0|||
125466617|NCT02101281|451340093|FG001|Overall Study|Adverse Event|1|||
125466618|NCT04452318|451340094|FG000|Overall Study|Physician Decision|1|||
125296646|NCT02905006|450713832|FG005|Overall Study|Screening exclusion criteria met|0|||
125466619|NCT04452318|451340095|FG001|Overall Study|Physician Decision|2|||
125466620|NCT04452318|451340096|FG002|Overall Study|Physician Decision|0|||
125466621|NCT04452318|451340097|FG003|Overall Study|Physician Decision|2|||
125466622|NCT04452318|451340098|FG004|Overall Study|Physician Decision|0|||
125466623|NCT04452318|451340099|FG005|Overall Study|Physician Decision|2|||
125466624|NCT04452318|451340100|FG006|Overall Study|Physician Decision|5|||
125466625|NCT04452318|451340094|FG000|Overall Study|Death|2|||
125466626|NCT04452318|451340095|FG001|Overall Study|Death|3|||
125466627|NCT04452318|451340096|FG002|Overall Study|Death|0|||
125466628|NCT04452318|451340097|FG003|Overall Study|Death|0|||
125296647|NCT02905006|450713827|FG000|Overall Study|Lab withdrawal criterion met|0|||
125296648|NCT02905006|450713828|FG001|Overall Study|Lab withdrawal criterion met|1|||
125296649|NCT02905006|450713829|FG002|Overall Study|Lab withdrawal criterion met|2|||
125296650|NCT02905006|450713830|FG003|Overall Study|Lab withdrawal criterion met|2|||
125296651|NCT02905006|450713831|FG004|Overall Study|Lab withdrawal criterion met|2|||
125296652|NCT02905006|450713832|FG005|Overall Study|Lab withdrawal criterion met|1|||
125296653|NCT02905006|450713827|FG000|Overall Study|Positive for Tuberculosis|0|||
125296654|NCT02905006|450713828|FG001|Overall Study|Positive for Tuberculosis|1|||
125296655|NCT02905006|450713829|FG002|Overall Study|Positive for Tuberculosis|0|||
125296656|NCT02905006|450713830|FG003|Overall Study|Positive for Tuberculosis|0|||
125296657|NCT02905006|450713831|FG004|Overall Study|Positive for Tuberculosis|0|||
125296658|NCT02905006|450713832|FG005|Overall Study|Positive for Tuberculosis|0|||
125296659|NCT02905006|450713827|FG000|Overall Study|Subject positive for Hep B|0|||
125296660|NCT02905006|450713828|FG001|Overall Study|Subject positive for Hep B|0|||
125296661|NCT02905006|450713829|FG002|Overall Study|Subject positive for Hep B|1|||
125296662|NCT02905006|450713830|FG003|Overall Study|Subject positive for Hep B|0|||
125296663|NCT02905006|450713831|FG004|Overall Study|Subject positive for Hep B|0|||
125296664|NCT02905006|450713832|FG005|Overall Study|Subject positive for Hep B|0|||
125296665|NCT02905006|450713827|FG000|Overall Study|Patient moved abroad|0|||
125296666|NCT02905006|450713828|FG001|Overall Study|Patient moved abroad|0|||
125296667|NCT02905006|450713829|FG002|Overall Study|Patient moved abroad|0|||
125296668|NCT02905006|450713830|FG003|Overall Study|Patient moved abroad|1|||
125296669|NCT02905006|450713831|FG004|Overall Study|Patient moved abroad|0|||
125296670|NCT02905006|450713832|FG005|Overall Study|Patient moved abroad|0|||
125296671|NCT02905006|450713827|FG000|Overall Study|Patient randomized by mistake|0|||
125296672|NCT02905006|450713828|FG001|Overall Study|Patient randomized by mistake|0|||
125296673|NCT02905006|450713829|FG002|Overall Study|Patient randomized by mistake|0|||
125296674|NCT02905006|450713830|FG003|Overall Study|Patient randomized by mistake|0|||
125296675|NCT02905006|450713831|FG004|Overall Study|Patient randomized by mistake|0|||
125296676|NCT02905006|450713832|FG005|Overall Study|Patient randomized by mistake|1|||
125296677|NCT04201093|450713837|FG000|Overall Study|Adverse Event|6|||
125296678|NCT04201093|450713838|FG001|Overall Study|Adverse Event|29|||
125296679|NCT04201093|450713839|FG002|Overall Study|Adverse Event|35|||
125296680|NCT04201093|450713837|FG000|Overall Study|Death|2|||
125296681|NCT04201093|450713838|FG001|Overall Study|Death|1|||
125296682|NCT04201093|450713839|FG002|Overall Study|Death|0|||
125296683|NCT04201093|450713837|FG000|Overall Study|Lack of Efficacy|5|||
125296684|NCT04201093|450713838|FG001|Overall Study|Lack of Efficacy|1|||
125296685|NCT04201093|450713839|FG002|Overall Study|Lack of Efficacy|2|||
125466629|NCT04452318|451340098|FG004|Overall Study|Death|0|||
125466630|NCT04452318|451340099|FG005|Overall Study|Death|0|||
125466631|NCT04452318|451340100|FG006|Overall Study|Death|0|||
125466632|NCT04452318|451340094|FG000|Overall Study|Lost to Follow-up|38|||
125466633|NCT04452318|451340095|FG001|Overall Study|Lost to Follow-up|28|||
125466634|NCT04452318|451340096|FG002|Overall Study|Lost to Follow-up|0|||
125466635|NCT04452318|451340097|FG003|Overall Study|Lost to Follow-up|3|||
125466636|NCT04452318|451340098|FG004|Overall Study|Lost to Follow-up|3|||
125466637|NCT04452318|451340099|FG005|Overall Study|Lost to Follow-up|2|||
125466638|NCT04452318|451340100|FG006|Overall Study|Lost to Follow-up|1|||
125466639|NCT04452318|451340094|FG000|Overall Study|Withdrawal by Subject|46|||
125466640|NCT04452318|451340095|FG001|Overall Study|Withdrawal by Subject|40|||
125466641|NCT04452318|451340096|FG002|Overall Study|Withdrawal by Subject|0|||
125466642|NCT04452318|451340097|FG003|Overall Study|Withdrawal by Subject|18|||
125466643|NCT04452318|451340098|FG004|Overall Study|Withdrawal by Subject|6|||
125466644|NCT04452318|451340099|FG005|Overall Study|Withdrawal by Subject|8|||
125466645|NCT04452318|451340100|FG006|Overall Study|Withdrawal by Subject|6|||
125466646|NCT03951805|451340102|FG000|Overall Study|Adverse Event|1|||
125466647|NCT03951805|451340103|FG001|Overall Study|Adverse Event|0|||
125466648|NCT03951805|451340104|FG002|Overall Study|Adverse Event|0|||
125466649|NCT03951805|451340105|FG003|Overall Study|Adverse Event|0|||
125466650|NCT00604669|451340106|FG000|Overall Study|lack of information in chart|7|||
125296686|NCT04201093|450713837|FG000|Overall Study|Lost to Follow-up|0|||
125296687|NCT04201093|450713838|FG001|Overall Study|Lost to Follow-up|0|||
125296688|NCT04201093|450713839|FG002|Overall Study|Lost to Follow-up|1|||
125296689|NCT04201093|450713837|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
125296690|NCT04201093|450713838|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
125296691|NCT04201093|450713839|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
125466651|NCT01695954|451340107|FG000|Overall Study|Withdrawal by Subject|4|||
125466652|NCT01695954|451340108|FG001|Overall Study|Withdrawal by Subject|0|||
125466653|NCT01695954|451340107|FG000|Overall Study|Adverse Event|0|||
125466654|NCT01695954|451340108|FG001|Overall Study|Adverse Event|2|||
125466655|NCT04328727|451340110|FG000|Overall Study|Guardian Decision|1|||
125466656|NCT04328727|451340110|FG000|Overall Study|Participant decision|4|||
125466657|NCT04328727|451340110|FG000|Overall Study|Death|3|||
125466658|NCT03684044|451340111|FG000|Overall Study|Adverse Event|3|||
125466659|NCT03684044|451340112|FG001|Overall Study|Adverse Event|0|||
125466660|NCT03684044|451340111|FG000|Overall Study|Death|4|||
125466661|NCT03684044|451340112|FG001|Overall Study|Death|7|||
125466662|NCT03684044|451340111|FG000|Overall Study|Lost to Follow-up|3|||
125466663|NCT03684044|451340112|FG001|Overall Study|Lost to Follow-up|2|||
125466664|NCT03684044|451340111|FG000|Overall Study|Patient Not Available|0|||
125466665|NCT03684044|451340112|FG001|Overall Study|Patient Not Available|2|||
125466666|NCT03684044|451340111|FG000|Overall Study|Physician Decision|1|||
125466667|NCT03684044|451340112|FG001|Overall Study|Physician Decision|0|||
125466668|NCT03684044|451340111|FG000|Overall Study|Withdrawal by Subject|11|||
125466669|NCT03684044|451340112|FG001|Overall Study|Withdrawal by Subject|9|||
125466670|NCT00595413|451340113|FG000|Overall Study|Adverse Event|0|||
125466671|NCT00595413|451340114|FG001|Overall Study|Adverse Event|2|||
125466672|NCT00595413|451340115|FG002|Overall Study|Adverse Event|1|||
125466673|NCT00595413|451340116|FG003|Overall Study|Adverse Event|1|||
125466674|NCT00595413|451340113|FG000|Overall Study|Lost to Follow-up|2|||
125466675|NCT00595413|451340114|FG001|Overall Study|Lost to Follow-up|2|||
125466676|NCT00595413|451340115|FG002|Overall Study|Lost to Follow-up|1|||
125466677|NCT00595413|451340116|FG003|Overall Study|Lost to Follow-up|3|||
125466678|NCT00595413|451340113|FG000|Overall Study|Death|0|||
125466679|NCT00595413|451340114|FG001|Overall Study|Death|0|||
125466680|NCT00595413|451340115|FG002|Overall Study|Death|1|||
125466681|NCT00595413|451340116|FG003|Overall Study|Death|0|||
125466682|NCT00595413|451340113|FG000|Overall Study|Other|5|||
125466683|NCT00595413|451340114|FG001|Overall Study|Other|1|||
125466684|NCT00595413|451340115|FG002|Overall Study|Other|5|||
125466685|NCT00595413|451340116|FG003|Overall Study|Other|0|||
125466686|NCT04149002|451340117|FG000|Overall Study|Lost to Follow-up|1|||
125466687|NCT04149002|451340118|FG001|Overall Study|Lost to Follow-up|0|||
125466688|NCT04149002|451340117|FG000|Overall Study|Withdrawal by Subject|1|||
125466689|NCT04149002|451340118|FG001|Overall Study|Withdrawal by Subject|0|||
125466690|NCT04629950|451340119|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
125466691|NCT04629950|451340120|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
125466692|NCT04629950|451340121|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
125466693|NCT04629950|451340122|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
125466694|NCT04629950|451340119|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
125466695|NCT04629950|451340120|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
125466696|NCT04629950|451340121|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
125466697|NCT04629950|451340122|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
125466698|NCT04629950|451340119|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
125466699|NCT04629950|451340120|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
125466700|NCT04629950|451340121|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
125466701|NCT04629950|451340122|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
125466702|NCT04629950|451340119|FG000|Extension Study|Withdrawal by Subject|0|||
125466703|NCT04629950|451340120|FG001|Extension Study|Withdrawal by Subject|0|||
125466704|NCT04629950|451340121|FG002|Extension Study|Withdrawal by Subject|1|||
125466705|NCT04629950|451340122|FG003|Extension Study|Withdrawal by Subject|0|||
125466706|NCT04629950|451340119|FG000|Extension Study|Adverse Event|0|||
125466707|NCT04629950|451340120|FG001|Extension Study|Adverse Event|0|||
125466708|NCT04629950|451340121|FG002|Extension Study|Adverse Event|0|||
125466709|NCT04629950|451340122|FG003|Extension Study|Adverse Event|1|||
125466710|NCT03233633|451340123|FG000|Overall Study|Adverse Event|2|||
125466711|NCT03233633|451340123|FG000|Overall Study|Less Than 3 Days of Data|6|||
125466712|NCT01198145|451340125|FG000|Overall Study|Withdrawal by Subject|1|||
125466713|NCT01198145|451340126|FG001|Overall Study|Withdrawal by Subject|1|||
125296692|NCT04201093|450713837|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
125296693|NCT04201093|450713838|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
125466714|NCT01697969|451340129|FG000|Overall Study|Did not meet inc/exc criteria|3|||
125466715|NCT01561989|451340130|FG000|Overall Study|accural target not met.|5|||
125466716|NCT01561989|451340131|FG001|Overall Study|accural target not met.|6|||
125466717|NCT03447249|451340134|FG000|Overall Study|Adverse Event|1|||
125466718|NCT03447249|451340135|FG001|Overall Study|Adverse Event|0|||
125466719|NCT03447249|451340134|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
125466720|NCT03447249|451340135|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
125466721|NCT03447249|451340134|FG000|Overall Study|Other|3|||
125466722|NCT03447249|451340135|FG001|Overall Study|Other|0|||
125466723|NCT00609336|451340136|FG000|Overall Study|Protocol Violation|3|||
125466724|NCT00609336|451340136|FG000|Overall Study|Death|1|||
125466725|NCT00609336|451340136|FG000|Overall Study|LA or Met at Surgery|9|||
125466726|NCT02238483|451340137|FG000|Overall Study|Withdrawal by Subject|2|||
125466727|NCT02238483|451340138|FG001|Overall Study|Withdrawal by Subject|7|||
125296694|NCT04201093|450713839|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
125296695|NCT04201093|450713837|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
125296696|NCT04201093|450713838|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
125296697|NCT04201093|450713839|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
125296698|NCT04201093|450713837|FG000|Overall Study|Physician Decision|1|||
125296699|NCT04201093|450713838|FG001|Overall Study|Physician Decision|0|||
125296700|NCT04201093|450713839|FG002|Overall Study|Physician Decision|0|||
125420393|NCT03137303|451163607|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
125420394|NCT03137303|451163606|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
125420395|NCT03137303|451163607|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
125420396|NCT03137303|451163606|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
125420397|NCT03137303|451163607|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
125420398|NCT03561090|451163610|FG000|Overall Study|Adverse Event|11|||
125420399|NCT03561090|451163611|FG001|Overall Study|Adverse Event|7|||
125420400|NCT03561090|451163610|FG000|Overall Study|Non-Compliance With Study Drug|2|||
125420401|NCT03561090|451163611|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125420402|NCT03561090|451163610|FG000|Overall Study|Protocol Violation|2|||
125420403|NCT03561090|451163611|FG001|Overall Study|Protocol Violation|2|||
125420404|NCT03561090|451163610|FG000|Overall Study|Withdrawal by Subject|7|||
125420405|NCT03561090|451163611|FG001|Overall Study|Withdrawal by Subject|7|||
125420406|NCT03561090|451163610|FG000|Overall Study|Lost to Follow-up|7|||
125420407|NCT03561090|451163611|FG001|Overall Study|Lost to Follow-up|2|||
125420408|NCT03561090|451163610|FG000|Overall Study|Study Terminated by Sponsor|10|||
125420409|NCT03561090|451163611|FG001|Overall Study|Study Terminated by Sponsor|15|||
125420410|NCT03561090|451163610|FG000|Overall Study|Randomized by Mistake|1|||
125420411|NCT03561090|451163611|FG001|Overall Study|Randomized by Mistake|1|||
125420412|NCT03561090|451163610|FG000|Overall Study|Other Not Specified|0|||
125420413|NCT03561090|451163611|FG001|Overall Study|Other Not Specified|2|||
125420414|NCT04162769|451163618|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
125420415|NCT04162769|451163619|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
125420416|NCT04162769|451163620|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
125420417|NCT04162769|451163621|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
125420418|NCT04162769|451163618|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
125420419|NCT04162769|451163619|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
125420420|NCT04162769|451163620|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
125420421|NCT04162769|451163621|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
125420422|NCT04162769|451163618|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
125420423|NCT04162769|451163619|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
125420424|NCT04162769|451163620|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
125420425|NCT04162769|451163621|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
125420426|NCT04162769|451163618|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
125420427|NCT04162769|451163619|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
125420428|NCT04162769|451163620|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
125420429|NCT04162769|451163621|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
125420430|NCT04162769|451163618|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
125420431|NCT04162769|451163619|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
125420432|NCT04162769|451163620|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
125420433|NCT04162769|451163621|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
125420434|NCT04162769|451163618|FG000|Double-blind Treatment (12-Week)|Other|0|||
125420435|NCT04162769|451163619|FG001|Double-blind Treatment (12-Week)|Other|1|||
125420436|NCT04162769|451163620|FG002|Double-blind Treatment (12-Week)|Other|1|||
125420437|NCT04162769|451163621|FG003|Double-blind Treatment (12-Week)|Other|0|||
125420438|NCT04162769|451163618|FG000|OLE Period (52-Week)|Adverse Event|0|||
125420439|NCT04162769|451163619|FG001|OLE Period (52-Week)|Adverse Event|0|||
125420440|NCT04162769|451163620|FG002|OLE Period (52-Week)|Adverse Event|0|||
125420441|NCT04162769|451163621|FG003|OLE Period (52-Week)|Adverse Event|5|||
125420442|NCT04162769|451163618|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
125420443|NCT04162769|451163619|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
125420444|NCT04162769|451163620|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
125420445|NCT04162769|451163621|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
125420446|NCT04162769|451163618|FG000|OLE Period (52-Week)|Physician Decision|0|||
125420447|NCT04162769|451163619|FG001|OLE Period (52-Week)|Physician Decision|0|||
125420448|NCT04162769|451163620|FG002|OLE Period (52-Week)|Physician Decision|0|||
125420449|NCT04162769|451163621|FG003|OLE Period (52-Week)|Physician Decision|1|||
125420450|NCT04162769|451163618|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
125420451|NCT04162769|451163619|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
125420452|NCT04162769|451163620|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
125420453|NCT04162769|451163621|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
125420454|NCT04162769|451163618|FG000|OLE Period (52-Week)|Protocol deviation|0|||
125466728|NCT02238483|451340137|FG000|Overall Study|Lost to Follow-up|1|||
125466729|NCT02238483|451340138|FG001|Overall Study|Lost to Follow-up|1|||
125466730|NCT02238483|451340137|FG000|Overall Study|Protocol Violation|1|||
125466731|NCT02238483|451340138|FG001|Overall Study|Protocol Violation|2|||
125466732|NCT02238483|451340137|FG000|Overall Study|Death|1|||
125466733|NCT02238483|451340138|FG001|Overall Study|Death|0|||
125466734|NCT02238483|451340137|FG000|Overall Study|Adverse Event|7|||
125466735|NCT02238483|451340138|FG001|Overall Study|Adverse Event|3|||
125466736|NCT02238483|451340137|FG000|Overall Study|Withdrawn due to physician decision|1|||
125466737|NCT02238483|451340138|FG001|Overall Study|Withdrawn due to physician decision|0|||
125466738|NCT02238483|451340137|FG000|Overall Study|Completion status not recorded|1|||
125296701|NCT04201093|450713837|FG000|Overall Study|Protocol Deviation|1|||
125296702|NCT04201093|450713838|FG001|Overall Study|Protocol Deviation|0|||
125296703|NCT04201093|450713839|FG002|Overall Study|Protocol Deviation|0|||
125296704|NCT04201093|450713837|FG000|Overall Study|Site Terminated by Sponsor|5|||
125296705|NCT04201093|450713838|FG001|Overall Study|Site Terminated by Sponsor|3|||
125296706|NCT04201093|450713839|FG002|Overall Study|Site Terminated by Sponsor|1|||
125296707|NCT04201093|450713837|FG000|Overall Study|Withdrawal by Subject|7|||
125296708|NCT04201093|450713838|FG001|Overall Study|Withdrawal by Subject|8|||
125296709|NCT04201093|450713839|FG002|Overall Study|Withdrawal by Subject|15|||
125296710|NCT04201093|450713837|FG000|Overall Study|Other|0|||
125296711|NCT04201093|450713838|FG001|Overall Study|Other|1|||
125296712|NCT04201093|450713839|FG002|Overall Study|Other|2|||
125296713|NCT00881504|450713840|FG000|Overall Study|Withdrawal by Subject|1|||
125296714|NCT00007020|450713841|FG000|Overall Study|Death|16|||
125296715|NCT00007020|450713841|FG000|Overall Study|Lost to Follow-up|13|||
125296716|NCT00007020|450713841|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
125296717|NCT00007020|450713841|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
125296718|NCT00007020|450713841|FG000|Overall Study|Pt cared for by outside physician|4|||
125296719|NCT00007020|450713841|FG000|Overall Study|No evidence of treatment|6|||
125296720|NCT01276223|450713842|FG000|Overall Study|Adverse Event|7|||
125296721|NCT01276223|450713843|FG001|Overall Study|Adverse Event|4|||
125296722|NCT01276223|450713844|FG002|Overall Study|Adverse Event|1|||
125296723|NCT01276223|450713842|FG000|Overall Study|Lost to Follow-up|0|||
125296724|NCT01276223|450713843|FG001|Overall Study|Lost to Follow-up|0|||
125296725|NCT01276223|450713844|FG002|Overall Study|Lost to Follow-up|1|||
125296726|NCT01276223|450713842|FG000|Overall Study|Other|0|||
125296727|NCT01276223|450713843|FG001|Overall Study|Other|0|||
125296728|NCT01276223|450713844|FG002|Overall Study|Other|1|||
125296729|NCT01276223|450713842|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
125296730|NCT01276223|450713843|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
125296731|NCT01276223|450713844|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
125296732|NCT01276223|450713842|FG000|Overall Study|Protocol Violation|1|||
125296733|NCT01276223|450713843|FG001|Overall Study|Protocol Violation|0|||
125296734|NCT01276223|450713844|FG002|Overall Study|Protocol Violation|0|||
125296735|NCT02455076|450713846|FG000|Inpatient|Withdrawal by Subject|1|||
125296736|NCT02455076|450713847|FG001|Inpatient|Withdrawal by Subject|0|||
125296737|NCT02455076|450713848|FG002|Inpatient|Withdrawal by Subject|0|||
125296738|NCT02455076|450713849|FG003|Inpatient|Withdrawal by Subject|0|||
125296739|NCT02455076|450713850|FG004|Inpatient|Withdrawal by Subject|0|||
125296740|NCT02455076|450713846|FG000|Inpatient|Discharged <24 h after admission|0|||
125296741|NCT02455076|450713847|FG001|Inpatient|Discharged <24 h after admission|1|||
125296742|NCT02455076|450713848|FG002|Inpatient|Discharged <24 h after admission|0|||
125296743|NCT02455076|450713849|FG003|Inpatient|Discharged <24 h after admission|0|||
125296744|NCT02455076|450713850|FG004|Inpatient|Discharged <24 h after admission|0|||
125296745|NCT02455076|450713846|FG000|Inpatient|Adverse Event|3|||
125296746|NCT02455076|450713847|FG001|Inpatient|Adverse Event|0|||
125296747|NCT02455076|450713848|FG002|Inpatient|Adverse Event|0|||
125296748|NCT02455076|450713849|FG003|Inpatient|Adverse Event|0|||
125296749|NCT02455076|450713850|FG004|Inpatient|Adverse Event|0|||
125296750|NCT02455076|450713846|FG000|Outpatient|Adverse Event|0|||
125296751|NCT02455076|450713847|FG001|Outpatient|Adverse Event|0|||
125296752|NCT02455076|450713848|FG002|Outpatient|Adverse Event|0|||
125296753|NCT02455076|450713849|FG003|Outpatient|Adverse Event|5|||
125296754|NCT02455076|450713850|FG004|Outpatient|Adverse Event|0|||
125296755|NCT02455076|450713846|FG000|Outpatient|Lost to Follow-up|0|||
125296756|NCT02455076|450713847|FG001|Outpatient|Lost to Follow-up|0|||
125296757|NCT02455076|450713848|FG002|Outpatient|Lost to Follow-up|0|||
125466739|NCT02238483|451340138|FG001|Overall Study|Completion status not recorded|1|||
125466740|NCT02238483|451340137|FG000|Overall Study|Illness in family member|1|||
125466741|NCT02238483|451340138|FG001|Overall Study|Illness in family member|0|||
125466742|NCT02677896|451340140|FG000|Double Blind Period (up to 35 Months)|Death|117|||
125296758|NCT02455076|450713849|FG003|Outpatient|Lost to Follow-up|1|||
125296759|NCT02455076|450713850|FG004|Outpatient|Lost to Follow-up|12|||
125296760|NCT04051827|450713851|FG000|Overall Study|Death|1|||
125466743|NCT02677896|451340141|FG001|Double Blind Period (up to 35 Months)|Death|197|||
125296761|NCT04051827|450713851|FG000|Overall Study|Withdrawal by Subject|4|||
125296762|NCT04051827|450713851|FG000|Overall Study|Progressive disease|16|||
125296763|NCT04051827|450713851|FG000|Overall Study|Physician Decision|1|||
125296764|NCT04051827|450713851|FG000|Overall Study|Other|4|||
125296765|NCT03743064|450713856|FG000|Overall Study|Adverse Event|7|||
125296766|NCT03743064|450713857|FG001|Overall Study|Adverse Event|9|||
125296767|NCT03743064|450713856|FG000|Overall Study|Death|25|||
125296768|NCT03743064|450713857|FG001|Overall Study|Death|28|||
125296769|NCT03743064|450713856|FG000|Overall Study|Lost to Follow-up|3|||
125296770|NCT03743064|450713857|FG001|Overall Study|Lost to Follow-up|6|||
125296771|NCT03743064|450713856|FG000|Overall Study|Withdrawal by Subject|28|||
125296772|NCT03743064|450713857|FG001|Overall Study|Withdrawal by Subject|25|||
125296773|NCT03743064|450713856|FG000|Overall Study|Physician Decision|2|||
125296774|NCT03743064|450713857|FG001|Overall Study|Physician Decision|4|||
125296775|NCT03743064|450713856|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
125296776|NCT03743064|450713857|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
125296777|NCT02771626|450713860|FG000|Overall Study|Adverse Event|1|||
125296778|NCT02771626|450713861|FG001|Overall Study|Adverse Event|5|||
125296779|NCT02771626|450713862|FG002|Overall Study|Adverse Event|3|||
125296780|NCT02771626|450713863|FG003|Overall Study|Adverse Event|0|||
125296781|NCT02771626|450713864|FG004|Overall Study|Adverse Event|1|||
125296782|NCT02771626|450713865|FG005|Overall Study|Adverse Event|1|||
125296783|NCT02771626|450713860|FG000|Overall Study|Radiologic Disease Progression|6|||
125296784|NCT02771626|450713861|FG001|Overall Study|Radiologic Disease Progression|13|||
125296785|NCT02771626|450713862|FG002|Overall Study|Radiologic Disease Progression|10|||
125296786|NCT02771626|450713863|FG003|Overall Study|Radiologic Disease Progression|7|||
125296787|NCT02771626|450713864|FG004|Overall Study|Radiologic Disease Progression|28|||
125296788|NCT02771626|450713865|FG005|Overall Study|Radiologic Disease Progression|15|||
125296789|NCT02771626|450713860|FG000|Overall Study|Symptomatic Deterioration|0|||
125296790|NCT02771626|450713861|FG001|Overall Study|Symptomatic Deterioration|4|||
125296791|NCT02771626|450713862|FG002|Overall Study|Symptomatic Deterioration|2|||
125296792|NCT02771626|450713863|FG003|Overall Study|Symptomatic Deterioration|0|||
125296793|NCT02771626|450713864|FG004|Overall Study|Symptomatic Deterioration|5|||
125296794|NCT02771626|450713865|FG005|Overall Study|Symptomatic Deterioration|2|||
125296795|NCT02771626|450713860|FG000|Overall Study|Participant Request|0|||
125296796|NCT02771626|450713861|FG001|Overall Study|Participant Request|1|||
125296797|NCT02771626|450713862|FG002|Overall Study|Participant Request|0|||
125296798|NCT02771626|450713863|FG003|Overall Study|Participant Request|2|||
125296799|NCT02771626|450713864|FG004|Overall Study|Participant Request|0|||
125296800|NCT02771626|450713865|FG005|Overall Study|Participant Request|1|||
125296801|NCT02771626|450713860|FG000|Overall Study|Investigator Decision|0|||
125296802|NCT02771626|450713861|FG001|Overall Study|Investigator Decision|1|||
125296803|NCT02771626|450713862|FG002|Overall Study|Investigator Decision|0|||
125296804|NCT02771626|450713863|FG003|Overall Study|Investigator Decision|0|||
125296805|NCT02771626|450713864|FG004|Overall Study|Investigator Decision|1|||
125296806|NCT02771626|450713865|FG005|Overall Study|Investigator Decision|0|||
125296807|NCT02771626|450713860|FG000|Overall Study|Study Termination by Sponsor|0|||
125296808|NCT02771626|450713861|FG001|Overall Study|Study Termination by Sponsor|2|||
125296809|NCT02771626|450713862|FG002|Overall Study|Study Termination by Sponsor|1|||
125296810|NCT02771626|450713863|FG003|Overall Study|Study Termination by Sponsor|0|||
125296811|NCT02771626|450713864|FG004|Overall Study|Study Termination by Sponsor|1|||
125296812|NCT02771626|450713865|FG005|Overall Study|Study Termination by Sponsor|0|||
125296813|NCT02771626|450713860|FG000|Overall Study|Informed Consent Withdrawn|0|||
125296814|NCT02771626|450713861|FG001|Overall Study|Informed Consent Withdrawn|0|||
125296815|NCT02771626|450713862|FG002|Overall Study|Informed Consent Withdrawn|1|||
125296816|NCT02771626|450713863|FG003|Overall Study|Informed Consent Withdrawn|0|||
125296817|NCT02771626|450713864|FG004|Overall Study|Informed Consent Withdrawn|1|||
125296818|NCT02771626|450713865|FG005|Overall Study|Informed Consent Withdrawn|1|||
125296819|NCT02771626|450713860|FG000|Overall Study|Other, Not Specified|1|||
125296820|NCT02771626|450713861|FG001|Overall Study|Other, Not Specified|0|||
125296821|NCT02771626|450713862|FG002|Overall Study|Other, Not Specified|0|||
125296822|NCT02771626|450713863|FG003|Overall Study|Other, Not Specified|0|||
125296823|NCT02771626|450713864|FG004|Overall Study|Other, Not Specified|0|||
125296824|NCT02771626|450713865|FG005|Overall Study|Other, Not Specified|1|||
125296825|NCT00635089|450713867|FG000|Overall Study|Adverse Event|7|||
125296826|NCT00635089|450713867|FG000|Overall Study|Lack of Efficacy|28|||
125296827|NCT00635089|450713867|FG000|Overall Study|Protocol Deviation|4|||
125296828|NCT00635089|450713867|FG000|Overall Study|Lost to Follow-up|8|||
125296829|NCT00635089|450713867|FG000|Overall Study|Other|31|||
125296830|NCT00444067|450713868|FG000|Overall Study|Lost to Follow-up|0|||
125296831|NCT00444067|450713869|FG001|Overall Study|Lost to Follow-up|1|||
125296832|NCT01300455|450713870|FG000|Washout|Withdrawal by Subject|1|||
125296833|NCT01300455|450713871|FG001|Washout|Withdrawal by Subject|0|||
125296834|NCT02528357|450713872|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296835|NCT02528357|450713873|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
125296836|NCT02528357|450713874|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296837|NCT02528357|450713875|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296838|NCT02528357|450713876|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296839|NCT02528357|450713877|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296840|NCT02528357|450713878|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296841|NCT02528357|450713879|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296842|NCT02528357|450713880|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296843|NCT02528357|450713881|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296844|NCT02528357|450713882|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296845|NCT02528357|450713883|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296846|NCT02528357|450713884|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296847|NCT02528357|450713885|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296848|NCT02528357|450713886|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296849|NCT02528357|450713887|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296850|NCT02528357|450713888|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296851|NCT02528357|450713889|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296852|NCT02528357|450713890|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
125296853|NCT02528357|450713872|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296854|NCT02528357|450713873|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296855|NCT02528357|450713874|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296856|NCT02528357|450713875|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
125296857|NCT02528357|450713876|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296858|NCT02528357|450713877|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
125296859|NCT02528357|450713878|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296860|NCT02528357|450713879|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
125296861|NCT02528357|450713880|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296862|NCT02528357|450713881|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296863|NCT02528357|450713882|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296864|NCT02528357|450713883|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296865|NCT02528357|450713884|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296866|NCT02528357|450713885|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296867|NCT02528357|450713886|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296868|NCT02528357|450713887|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296869|NCT02528357|450713888|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296870|NCT02528357|450713889|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296871|NCT02528357|450713890|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
125296872|NCT02528357|450713872|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296873|NCT02528357|450713873|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296874|NCT02528357|450713874|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
125296875|NCT02528357|450713875|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296876|NCT02528357|450713876|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
125296877|NCT02528357|450713877|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296878|NCT02528357|450713878|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
125296879|NCT02528357|450713879|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
125296880|NCT02528357|450713880|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296881|NCT02528357|450713881|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296882|NCT02528357|450713882|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296883|NCT02528357|450713883|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296884|NCT02528357|450713884|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296885|NCT02528357|450713885|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296886|NCT02528357|450713886|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296887|NCT02528357|450713887|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296888|NCT02528357|450713888|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296889|NCT02528357|450713889|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296890|NCT02528357|450713890|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
125296891|NCT02528357|450713872|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296892|NCT02528357|450713873|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296893|NCT02528357|450713874|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296894|NCT02528357|450713875|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296895|NCT02528357|450713876|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
125296896|NCT02528357|450713877|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296897|NCT02528357|450713878|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125303177|NCT03100058|450736661|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125296898|NCT02528357|450713879|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296899|NCT02528357|450713880|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296900|NCT02528357|450713881|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296901|NCT02528357|450713882|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296902|NCT02528357|450713883|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296903|NCT02528357|450713884|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296904|NCT02528357|450713885|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296905|NCT02528357|450713886|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296906|NCT02528357|450713887|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296907|NCT02528357|450713888|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296908|NCT02528357|450713889|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296909|NCT02528357|450713890|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296910|NCT02528357|450713872|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296911|NCT02528357|450713873|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296912|NCT02528357|450713874|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296913|NCT02528357|450713875|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296914|NCT02528357|450713876|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296915|NCT02528357|450713877|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296916|NCT02528357|450713878|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296917|NCT02528357|450713879|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296918|NCT02528357|450713880|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296919|NCT02528357|450713881|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296920|NCT02528357|450713882|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296921|NCT02528357|450713883|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296922|NCT02528357|450713884|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296923|NCT02528357|450713885|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
125296924|NCT02528357|450713886|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
125296925|NCT02528357|450713887|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296926|NCT02528357|450713888|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296927|NCT02528357|450713889|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296928|NCT02528357|450713890|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
125296929|NCT02528357|450713872|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296930|NCT02528357|450713873|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296931|NCT02528357|450713874|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296932|NCT02528357|450713875|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296933|NCT02528357|450713876|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296934|NCT02528357|450713877|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296935|NCT02528357|450713878|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296936|NCT02528357|450713879|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296937|NCT02528357|450713880|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296938|NCT02528357|450713881|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296939|NCT02528357|450713882|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296940|NCT02528357|450713883|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296941|NCT02528357|450713884|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296942|NCT02528357|450713885|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
125296943|NCT02528357|450713886|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296944|NCT02528357|450713887|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296945|NCT02528357|450713888|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296946|NCT02528357|450713889|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296947|NCT02528357|450713890|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
125296948|NCT02528357|450713872|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296949|NCT02528357|450713873|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296950|NCT02528357|450713874|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296951|NCT02528357|450713875|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296952|NCT02528357|450713876|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296953|NCT02528357|450713877|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296954|NCT02528357|450713878|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296955|NCT02528357|450713879|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125485370|NCT02240238|451412508|FG005|Phase 1|Sponsor termination|1|||
125296956|NCT02528357|450713880|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296957|NCT02528357|450713881|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296958|NCT02528357|450713882|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
125296959|NCT02528357|450713883|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296960|NCT02528357|450713884|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
125296961|NCT02528357|450713885|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
125296962|NCT02528357|450713886|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
125296963|NCT02528357|450713887|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296964|NCT02528357|450713888|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296965|NCT02528357|450713889|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296966|NCT02528357|450713890|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
125296967|NCT02528357|450713872|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296968|NCT02528357|450713873|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296969|NCT02528357|450713874|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296970|NCT02528357|450713875|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296971|NCT02528357|450713876|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296972|NCT02528357|450713877|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296973|NCT02528357|450713878|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296974|NCT02528357|450713879|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296975|NCT02528357|450713880|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
125296976|NCT02528357|450713881|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
125296977|NCT02528357|450713882|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296978|NCT02528357|450713883|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
125296979|NCT02528357|450713884|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
125296980|NCT02528357|450713885|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
125296981|NCT02528357|450713886|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
125296982|NCT02528357|450713887|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296983|NCT02528357|450713888|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296984|NCT02528357|450713889|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296985|NCT02528357|450713890|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125296986|NCT02528357|450713872|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296987|NCT02528357|450713873|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296988|NCT02528357|450713874|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296989|NCT02528357|450713875|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296990|NCT02528357|450713876|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296991|NCT02528357|450713877|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296992|NCT02528357|450713878|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296993|NCT02528357|450713879|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296994|NCT02528357|450713880|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296995|NCT02528357|450713881|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296996|NCT02528357|450713882|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296997|NCT02528357|450713883|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296998|NCT02528357|450713884|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125296999|NCT02528357|450713885|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125297000|NCT02528357|450713886|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125297001|NCT02528357|450713887|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125297002|NCT02528357|450713888|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
125297003|NCT02528357|450713889|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125297004|NCT02528357|450713890|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
125297005|NCT02528357|450713872|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297006|NCT02528357|450713873|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297007|NCT02528357|450713874|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297008|NCT02528357|450713875|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297009|NCT02528357|450713876|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297010|NCT02528357|450713877|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125485371|NCT02240238|451412509|FG006|Phase 1|Sponsor termination|0|||
125297011|NCT02528357|450713878|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297012|NCT02528357|450713879|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297013|NCT02528357|450713880|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297014|NCT02528357|450713881|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297015|NCT02528357|450713882|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297016|NCT02528357|450713883|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297017|NCT02528357|450713884|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297018|NCT02528357|450713885|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297019|NCT02528357|450713886|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297020|NCT02528357|450713887|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
125297021|NCT02528357|450713888|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
125297022|NCT02528357|450713889|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
125297023|NCT02528357|450713890|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
125297024|NCT02438813|450713896|FG000|Overall Study|Patient Decision|59|||
125297025|NCT02438813|450713896|FG000|Overall Study|Patient Lost to Follow-Up|137|||
125297026|NCT02438813|450713896|FG000|Overall Study|Study Ended by Sponsor|80|||
125297027|NCT02438813|450713896|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
125297028|NCT01927055|450713897|FG000|Open-label|Adverse Event|6|||
125297029|NCT01927055|450713898|FG001|Open-label|Adverse Event|0|||
125297030|NCT01927055|450713899|FG002|Open-label|Adverse Event|0|||
125297031|NCT01927055|450713897|FG000|Open-label|Withdrawal by Subject|1|||
125297032|NCT01927055|450713898|FG001|Open-label|Withdrawal by Subject|0|||
125297033|NCT01927055|450713899|FG002|Open-label|Withdrawal by Subject|0|||
125297034|NCT01927055|450713897|FG000|Open-label|Study Stopped|4|||
125297035|NCT01927055|450713898|FG001|Open-label|Study Stopped|0|||
125297036|NCT01927055|450713899|FG002|Open-label|Study Stopped|0|||
125297037|NCT01927055|450713897|FG000|Open-label|Supine Hypertension|4|||
125297038|NCT01927055|450713898|FG001|Open-label|Supine Hypertension|0|||
125297039|NCT01927055|450713899|FG002|Open-label|Supine Hypertension|0|||
125297040|NCT01927055|450713897|FG000|Open-label|Difficulty attending study visits|1|||
125297041|NCT01927055|450713898|FG001|Open-label|Difficulty attending study visits|0|||
125297042|NCT01927055|450713899|FG002|Open-label|Difficulty attending study visits|0|||
125297043|NCT01927055|450713897|FG000|Double-Blind|Adverse Event|0|||
125297044|NCT01927055|450713898|FG001|Double-Blind|Adverse Event|1|||
125297045|NCT01927055|450713899|FG002|Double-Blind|Adverse Event|1|||
125297046|NCT01927055|450713897|FG000|Double-Blind|Protocol Violation|0|||
125297047|NCT01927055|450713898|FG001|Double-Blind|Protocol Violation|0|||
125297048|NCT01927055|450713899|FG002|Double-Blind|Protocol Violation|1|||
125297049|NCT01927055|450713897|FG000|Double-Blind|Withdrawal by Subject|0|||
125297050|NCT01927055|450713898|FG001|Double-Blind|Withdrawal by Subject|2|||
125297051|NCT01927055|450713899|FG002|Double-Blind|Withdrawal by Subject|3|||
125297052|NCT01927055|450713897|FG000|Double-Blind|Study Stopped|0|||
125297053|NCT01927055|450713898|FG001|Double-Blind|Study Stopped|7|||
125297054|NCT01927055|450713899|FG002|Double-Blind|Study Stopped|7|||
125297055|NCT01927055|450713897|FG000|Double-Blind|Supine Hypertension|0|||
125297056|NCT01927055|450713898|FG001|Double-Blind|Supine Hypertension|0|||
125297057|NCT01927055|450713899|FG002|Double-Blind|Supine Hypertension|1|||
125297058|NCT01927055|450713897|FG000|Double-Blind|Extended Vacation|0|||
125297059|NCT01927055|450713898|FG001|Double-Blind|Extended Vacation|1|||
125297060|NCT01927055|450713899|FG002|Double-Blind|Extended Vacation|0|||
125297061|NCT00619489|450713902|FG000|Overall Study|Adverse Event|0|||
125297062|NCT00619489|450713903|FG001|Overall Study|Adverse Event|7|||
125297063|NCT00619489|450713902|FG000|Overall Study|Withdrawal by Subject|1|||
125297064|NCT00619489|450713903|FG001|Overall Study|Withdrawal by Subject|1|||
125297065|NCT00619489|450713902|FG000|Overall Study|Lack of Efficacy|0|||
125297066|NCT00619489|450713903|FG001|Overall Study|Lack of Efficacy|11|||
125297067|NCT00619489|450713902|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
125297068|NCT00619489|450713903|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
125297069|NCT02966015|450713904|FG000|Inclusion Visit|did not answer questionnaire|8|||
125297070|NCT02966015|450713905|FG001|Inclusion Visit|did not answer questionnaire|3|||
125297071|NCT01183468|450713914|FG000|Overall Study|Lost to Follow-up|2|||
125297072|NCT01183468|450713915|FG001|Overall Study|Lost to Follow-up|1|||
125297073|NCT01183468|450713916|FG002|Overall Study|Lost to Follow-up|0|||
125297074|NCT01183468|450713917|FG003|Overall Study|Lost to Follow-up|0|||
125297075|NCT01183468|450713914|FG000|Overall Study|Physician Decision|1|||
125297076|NCT01183468|450713915|FG001|Overall Study|Physician Decision|0|||
125297077|NCT01183468|450713916|FG002|Overall Study|Physician Decision|0|||
125297078|NCT01183468|450713917|FG003|Overall Study|Physician Decision|0|||
125297079|NCT01183468|450713914|FG000|Overall Study|Withdrawal by Subject|0|||
125297080|NCT01183468|450713915|FG001|Overall Study|Withdrawal by Subject|1|||
125297081|NCT01183468|450713916|FG002|Overall Study|Withdrawal by Subject|0|||
125297082|NCT01183468|450713917|FG003|Overall Study|Withdrawal by Subject|0|||
125297083|NCT02228096|450713926|FG000|Overall Study|Study terminated by Sponsor|24|||
125297084|NCT02228096|450713926|FG000|Overall Study|Lack of Efficacy|18|||
125297085|NCT02228096|450713926|FG000|Overall Study|Death|12|||
125297086|NCT02228096|450713926|FG000|Overall Study|Physician Decision|3|||
125297087|NCT02228096|450713926|FG000|Overall Study|Subject/guardian decision|2|||
125297088|NCT02228096|450713926|FG000|Overall Study|New therapy for study indication|1|||
125297089|NCT02228096|450713926|FG000|Overall Study|Enrolled, not infused|11|||
125297090|NCT00558272|450713927|FG000|Overall Study|Adverse Event|10|||
125297091|NCT00558272|450713928|FG001|Overall Study|Adverse Event|0|||
125297092|NCT00558272|450713927|FG000|Overall Study|Death|1|||
125297093|NCT00558272|450713928|FG001|Overall Study|Death|0|||
125297094|NCT00558272|450713927|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
125297095|NCT00558272|450713928|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
125297096|NCT00558272|450713927|FG000|Overall Study|AZ study team decision|0|||
125297097|NCT00558272|450713928|FG001|Overall Study|AZ study team decision|1|||
125297098|NCT00558272|450713927|FG000|Overall Study|Incorrectly enrolled|1|||
125297099|NCT00558272|450713928|FG001|Overall Study|Incorrectly enrolled|0|||
125297100|NCT00558272|450713927|FG000|Overall Study|Withdrawal by Subject|0|||
125297101|NCT00558272|450713928|FG001|Overall Study|Withdrawal by Subject|1|||
125297102|NCT00454649|450713929|FG000|Overall Study|Lack of Efficacy|2|||
125297103|NCT00454649|450713930|FG001|Overall Study|Lack of Efficacy|2|||
125297104|NCT00454649|450713931|FG002|Overall Study|Lack of Efficacy|10|||
125297105|NCT00454649|450713932|FG003|Overall Study|Lack of Efficacy|3|||
125297106|NCT00454649|450713933|FG004|Overall Study|Lack of Efficacy|0|||
125297107|NCT00454649|450713934|FG005|Overall Study|Lack of Efficacy|4|||
125297108|NCT00454649|450713935|FG006|Overall Study|Lack of Efficacy|5|||
125297109|NCT00454649|450713936|FG007|Overall Study|Lack of Efficacy|13|||
125297110|NCT00454649|450713937|FG008|Overall Study|Lack of Efficacy|10|||
125297111|NCT00454649|450713938|FG009|Overall Study|Lack of Efficacy|2|||
125297112|NCT00454649|450713929|FG000|Overall Study|Adverse Event|0|||
125297113|NCT00454649|450713930|FG001|Overall Study|Adverse Event|1|||
125297114|NCT00454649|450713931|FG002|Overall Study|Adverse Event|3|||
125297115|NCT00454649|450713932|FG003|Overall Study|Adverse Event|0|||
125297116|NCT00454649|450713933|FG004|Overall Study|Adverse Event|1|||
125297117|NCT00454649|450713934|FG005|Overall Study|Adverse Event|2|||
125297118|NCT00454649|450713935|FG006|Overall Study|Adverse Event|3|||
125297119|NCT00454649|450713936|FG007|Overall Study|Adverse Event|4|||
125297120|NCT00454649|450713937|FG008|Overall Study|Adverse Event|6|||
125297121|NCT00454649|450713938|FG009|Overall Study|Adverse Event|2|||
125297122|NCT00454649|450713929|FG000|Overall Study|Lost to Follow-up|0|||
125297123|NCT00454649|450713930|FG001|Overall Study|Lost to Follow-up|0|||
125297124|NCT00454649|450713931|FG002|Overall Study|Lost to Follow-up|1|||
125297125|NCT00454649|450713932|FG003|Overall Study|Lost to Follow-up|0|||
125297126|NCT00454649|450713933|FG004|Overall Study|Lost to Follow-up|0|||
125297127|NCT00454649|450713934|FG005|Overall Study|Lost to Follow-up|0|||
125297128|NCT00454649|450713935|FG006|Overall Study|Lost to Follow-up|1|||
125297129|NCT00454649|450713936|FG007|Overall Study|Lost to Follow-up|0|||
125297130|NCT00454649|450713937|FG008|Overall Study|Lost to Follow-up|0|||
125297131|NCT00454649|450713938|FG009|Overall Study|Lost to Follow-up|0|||
125297132|NCT00454649|450713929|FG000|Overall Study|Other|1|||
125297133|NCT00454649|450713930|FG001|Overall Study|Other|1|||
125297134|NCT00454649|450713931|FG002|Overall Study|Other|5|||
125297135|NCT00454649|450713932|FG003|Overall Study|Other|3|||
125297136|NCT00454649|450713933|FG004|Overall Study|Other|0|||
125297137|NCT00454649|450713934|FG005|Overall Study|Other|0|||
125297138|NCT00454649|450713935|FG006|Overall Study|Other|0|||
125297139|NCT00454649|450713936|FG007|Overall Study|Other|0|||
125297140|NCT00454649|450713937|FG008|Overall Study|Other|3|||
125297141|NCT00454649|450713938|FG009|Overall Study|Other|1|||
125297142|NCT00454649|450713929|FG000|Overall Study|Withdrawal by Subject|0|||
125297143|NCT00454649|450713930|FG001|Overall Study|Withdrawal by Subject|0|||
125297144|NCT00454649|450713931|FG002|Overall Study|Withdrawal by Subject|0|||
125485372|NCT02240238|451412510|FG007|Phase 1|Sponsor termination|0|||
125297145|NCT00454649|450713932|FG003|Overall Study|Withdrawal by Subject|0|||
125297146|NCT00454649|450713933|FG004|Overall Study|Withdrawal by Subject|0|||
125297147|NCT00454649|450713934|FG005|Overall Study|Withdrawal by Subject|1|||
125297148|NCT00454649|450713935|FG006|Overall Study|Withdrawal by Subject|0|||
125297149|NCT00454649|450713936|FG007|Overall Study|Withdrawal by Subject|2|||
125297150|NCT00454649|450713937|FG008|Overall Study|Withdrawal by Subject|1|||
125297151|NCT00454649|450713938|FG009|Overall Study|Withdrawal by Subject|0|||
125297152|NCT02745535|450713939|FG000|Overall Study|Death|1|||
125297153|NCT02745535|450713939|FG000|Overall Study|Adverse Event|3|||
125297154|NCT02745535|450713939|FG000|Overall Study|Lost to Follow-up|2|||
125297155|NCT01789606|450713940|FG000|Overall Study|Participant not Purchased the Product|0|||
125297156|NCT01789606|450713941|FG001|Overall Study|Participant not Purchased the Product|20|||
125297157|NCT01789606|450713940|FG000|Overall Study|Withdrawal by Subject|0|||
125297158|NCT01789606|450713941|FG001|Overall Study|Withdrawal by Subject|1|||
125297159|NCT01789606|450713940|FG000|Overall Study|Ineligible|6|||
125297160|NCT01789606|450713941|FG001|Overall Study|Ineligible|2|||
125297161|NCT01789606|450713940|FG000|Overall Study|Administrative Reasons|17|||
125297162|NCT01789606|450713941|FG001|Overall Study|Administrative Reasons|6|||
125297163|NCT01789606|450713940|FG000|Overall Study|No Study Medication Taken|0|||
125297164|NCT01789606|450713941|FG001|Overall Study|No Study Medication Taken|1|||
125297165|NCT01789606|450713940|FG000|Overall Study|Protocol Violation|0|||
125297166|NCT01789606|450713941|FG001|Overall Study|Protocol Violation|55|||
125297167|NCT01789606|450713940|FG000|Overall Study|Adverse Event|0|||
125297168|NCT01789606|450713941|FG001|Overall Study|Adverse Event|3|||
125297169|NCT01789606|450713940|FG000|Overall Study|Lost to Follow-up|0|||
125297170|NCT01789606|450713941|FG001|Overall Study|Lost to Follow-up|14|||
125297171|NCT01789606|450713940|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
125297172|NCT01789606|450713941|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
125297173|NCT01291277|450713942|FG000|Overall Study|Death|2|||
125297174|NCT01291277|450713943|FG001|Overall Study|Death|2|||
125297175|NCT01291277|450713942|FG000|Overall Study|Lost to Follow-up|3|||
125297176|NCT01291277|450713943|FG001|Overall Study|Lost to Follow-up|1|||
125297177|NCT00849108|450713944|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
125297178|NCT00849108|450713945|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
125297179|NCT00849108|450713944|FG000|Cohort 2 Efficacy|Adverse Event|0|||
125297180|NCT00849108|450713945|FG001|Cohort 2 Efficacy|Adverse Event|1|||
125297181|NCT00849108|450713944|FG000|Cohort 2 Efficacy|Other|0|||
125297182|NCT00849108|450713945|FG001|Cohort 2 Efficacy|Other|9|||
125297183|NCT01563172|450713949|FG000|Overall Study|Adverse Event|5|||
125466744|NCT02677896|451340140|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
125466745|NCT02677896|451340141|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
125466746|NCT02677896|451340140|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
125466747|NCT02677896|451340141|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
125466748|NCT02677896|451340140|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
125466749|NCT02677896|451340141|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
125466750|NCT02677896|451340140|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
125466751|NCT02677896|451340141|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
125466752|NCT02677896|451340140|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
125466753|NCT02677896|451340141|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
125466754|NCT02677896|451340140|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
125466755|NCT02677896|451340141|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
125466756|NCT02677896|451340140|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
125466757|NCT02677896|451340141|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
125466758|NCT02677896|451340140|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
125466759|NCT02677896|451340141|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
125466760|NCT02677896|451340140|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
125466761|NCT02677896|451340141|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
125466762|NCT02677896|451340140|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
125466763|NCT02677896|451340141|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
125466764|NCT02677896|451340140|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
125466765|NCT02677896|451340141|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
125466766|NCT02677896|451340140|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
125466767|NCT02677896|451340141|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
125466768|NCT02677896|451340140|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
125466769|NCT02677896|451340141|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
125466770|NCT01388361|451340142|FG000|Overall Study|Adverse Event|0|||
125466771|NCT01388361|451340143|FG001|Overall Study|Adverse Event|5|||
125466772|NCT01388361|451340144|FG002|Overall Study|Adverse Event|1|||
125466773|NCT01388361|451340142|FG000|Overall Study|Protocol Violation|0|||
125466774|NCT01388361|451340143|FG001|Overall Study|Protocol Violation|0|||
125466775|NCT01388361|451340144|FG002|Overall Study|Protocol Violation|2|||
125466776|NCT01388361|451340142|FG000|Overall Study|Withdrawal criteria|12|||
125466777|NCT01388361|451340143|FG001|Overall Study|Withdrawal criteria|7|||
125466778|NCT01388361|451340144|FG002|Overall Study|Withdrawal criteria|10|||
125466779|NCT01388361|451340142|FG000|Overall Study|Unclassified|0|||
125466780|NCT01388361|451340143|FG001|Overall Study|Unclassified|0|||
125466781|NCT01388361|451340144|FG002|Overall Study|Unclassified|1|||
125466782|NCT00539734|451340145|FG000|Overall Study|Protocol Violation|1|||
125466783|NCT01070069|451340146|FG000|Overall Study|Death|1|||
125297184|NCT01563172|450713949|FG000|Overall Study|Lost to Follow-up|2|||
125466784|NCT01070069|451340147|FG001|Overall Study|Death|0|||
125466785|NCT01070069|451340148|FG002|Overall Study|Death|2|||
125466786|NCT01070069|451340149|FG003|Overall Study|Death|0|||
125466787|NCT01070069|451340150|FG004|Overall Study|Death|1|||
125466788|NCT01070069|451340146|FG000|Overall Study|Withdrawal by Subject|1|||
125297185|NCT01563172|450713949|FG000|Overall Study|Other (Protocol deviation)|5|||
125297186|NCT01563172|450713949|FG000|Overall Study|Other (Not specified)|1|||
125297187|NCT01105377|450713950|FG000|Overall Study|Withdrawal by Subject|0|||
125297188|NCT01105377|450713951|FG001|Overall Study|Withdrawal by Subject|1|||
125466789|NCT01070069|451340147|FG001|Overall Study|Withdrawal by Subject|1|||
125466790|NCT01070069|451340148|FG002|Overall Study|Withdrawal by Subject|4|||
125466791|NCT01070069|451340149|FG003|Overall Study|Withdrawal by Subject|0|||
125466792|NCT01070069|451340150|FG004|Overall Study|Withdrawal by Subject|0|||
125466793|NCT01070069|451340146|FG000|Overall Study|Lost to Follow-up|4|||
125466794|NCT01070069|451340147|FG001|Overall Study|Lost to Follow-up|1|||
125466795|NCT01070069|451340148|FG002|Overall Study|Lost to Follow-up|0|||
125466796|NCT01070069|451340149|FG003|Overall Study|Lost to Follow-up|0|||
125466797|NCT01070069|451340150|FG004|Overall Study|Lost to Follow-up|3|||
125466798|NCT03565315|451340153|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
125466799|NCT03565315|451340154|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
125466800|NCT03565315|451340155|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
125466801|NCT03565315|451340156|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
125466802|NCT04200365|451340157|FG000|Overall Study|Adverse Event|2|||
125466803|NCT04200365|451340157|FG000|Overall Study|Progressive Disease|4|||
125466804|NCT04200365|451340157|FG000|Overall Study|Lack of Efficacy|1|||
125466805|NCT04200365|451340157|FG000|Overall Study|Study Closure|4|||
125466806|NCT01499199|451340158|FG000|Overall Study|Adverse Event|1|||
125466807|NCT01499199|451340158|FG000|Overall Study|Lack of Efficacy|1|||
125466808|NCT02692417|451340159|FG000|Overall Study|Withdrawal by Subject|5|||
125466809|NCT02692417|451340160|FG001|Overall Study|Withdrawal by Subject|1|||
125466810|NCT02692417|451340159|FG000|Overall Study|Adverse Event|1|||
125466811|NCT02692417|451340160|FG001|Overall Study|Adverse Event|0|||
125466812|NCT02539225|451340168|FG000|Part A|Adverse Event|13|||
125466813|NCT02539225|451340169|FG001|Part A|Adverse Event|4|||
125466814|NCT02539225|451340168|FG000|Part A|Withdrawal by Subject|2|||
125466815|NCT02539225|451340169|FG001|Part A|Withdrawal by Subject|4|||
125466816|NCT02539225|451340168|FG000|Part A|Physician Decision|4|||
125466817|NCT02539225|451340169|FG001|Part A|Physician Decision|7|||
125466818|NCT02539225|451340168|FG000|Part A|Did Not Receive study Drug|1|||
125466819|NCT02539225|451340169|FG001|Part A|Did Not Receive study Drug|1|||
125466820|NCT02539225|451340168|FG000|Pre Treatment for Part B|Progressive disease|1|||
125466821|NCT02539225|451340169|FG001|Pre Treatment for Part B|Progressive disease|1|||
125466822|NCT02539225|451340168|FG000|Pre Treatment for Part B|Adverse Event|1|||
125466823|NCT02539225|451340169|FG001|Pre Treatment for Part B|Adverse Event|1|||
125466824|NCT02539225|451340168|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
125466825|NCT02539225|451340169|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
125466826|NCT02539225|451340168|FG000|Pre Treatment for Part B|Physician Decision|2|||
125466827|NCT02539225|451340169|FG001|Pre Treatment for Part B|Physician Decision|0|||
125466828|NCT02539225|451340168|FG000|Part B|Adverse Event|4|||
125466829|NCT02539225|451340169|FG001|Part B|Adverse Event|4|||
125466830|NCT02539225|451340168|FG000|Part B|Withdrawal by Subject|0|||
125466831|NCT02539225|451340169|FG001|Part B|Withdrawal by Subject|3|||
125466832|NCT02539225|451340168|FG000|Part B|Physician Decision|0|||
125466833|NCT02539225|451340169|FG001|Part B|Physician Decision|9|||
125466834|NCT04766034|451340170|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
125466835|NCT04766034|451340171|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
125466836|NCT04766034|451340172|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
125466837|NCT04766034|451340173|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
125466838|NCT04766034|451340174|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
125466839|NCT04766034|451340170|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
125466840|NCT04766034|451340171|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
125466841|NCT04766034|451340172|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
125466842|NCT04766034|451340173|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
125466843|NCT04766034|451340174|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
125466844|NCT04766034|451340170|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
125466845|NCT04766034|451340171|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
125466846|NCT04766034|451340172|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
125466847|NCT04766034|451340173|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
125466848|NCT04766034|451340174|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
125466849|NCT04766034|451340170|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
125466850|NCT04766034|451340171|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
125466851|NCT04766034|451340172|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
125466852|NCT04766034|451340173|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
125466853|NCT04766034|451340174|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
125466854|NCT01976312|451340175|FG000|Overall Study|Pregnancy|0|||
125466855|NCT01976312|451340176|FG001|Overall Study|Pregnancy|1|||
125466856|NCT01976312|451340175|FG000|Overall Study|Lost to Follow-up|2|||
125466857|NCT01976312|451340176|FG001|Overall Study|Lost to Follow-up|0|||
125466858|NCT01976312|451340175|FG000|Overall Study|Withdrawal by Subject|7|||
125466859|NCT01976312|451340176|FG001|Overall Study|Withdrawal by Subject|2|||
125466860|NCT01976312|451340175|FG000|Overall Study|Adverse Event|6|||
125466861|NCT01976312|451340176|FG001|Overall Study|Adverse Event|6|||
125466862|NCT01976312|451340175|FG000|Overall Study|Protocol Violation|2|||
125466863|NCT01976312|451340176|FG001|Overall Study|Protocol Violation|0|||
125466864|NCT02556138|451340181|FG000|Overall Study|Withdrawal by Subject|1|||
125466865|NCT04048382|451340182|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
125466866|NCT04048382|451340183|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
125466867|NCT04048382|451340182|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
125466868|NCT04048382|451340183|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
125466869|NCT04048382|451340182|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
125466870|NCT04048382|451340183|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
125466871|NCT01205048|451340188|FG000|Overall Study|Withdrawal by Subject|14|||
125466872|NCT01205048|451340188|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
125466873|NCT01205048|451340188|FG000|Overall Study|Lost to Follow-up|4|||
125466874|NCT01205048|451340188|FG000|Overall Study|Other|2|||
125466875|NCT01255670|451340189|FG000|Overall Study|Adverse Event|10|||
125466876|NCT01255670|451340190|FG001|Overall Study|Adverse Event|10|||
125466877|NCT01255670|451340189|FG000|Overall Study|Lost to Follow-up|16|||
125466878|NCT01255670|451340190|FG001|Overall Study|Lost to Follow-up|10|||
125466879|NCT02269475|451340191|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
125466880|NCT02269475|451340192|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
125466881|NCT02269475|451340191|FG000|Overall Study|Withdrawal by Subject|0|||
125466882|NCT02269475|451340192|FG001|Overall Study|Withdrawal by Subject|1|||
125466883|NCT01037985|451340193|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
125466884|NCT01037985|451340194|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
125466885|NCT01037985|451340193|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
125466886|NCT01037985|451340194|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
125466887|NCT01037985|451340193|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
125466888|NCT01037985|451340194|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
125466889|NCT01037985|451340193|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
125466890|NCT01037985|451340194|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
125466891|NCT00823472|451340195|FG000|Overall Study|Physician Decision|24|||
125466892|NCT00823472|451340196|FG001|Overall Study|Physician Decision|28|||
125466893|NCT01609218|451340197|FG000|Period 1|Adverse Event|3|||
125466894|NCT01609218|451340198|FG001|Period 1|Adverse Event|5|||
125466895|NCT01609218|451340197|FG000|Period 1|Sponsor Decision|0|||
125466896|NCT01609218|451340198|FG001|Period 1|Sponsor Decision|1|||
125466897|NCT01609218|451340197|FG000|Period 2|Adverse Event|1|||
125466898|NCT01609218|451340198|FG001|Period 2|Adverse Event|0|||
125466899|NCT04428112|451340199|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
125466900|NCT04428112|451340200|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
125466901|NCT04428112|451340199|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
125466902|NCT04428112|451340200|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
125466903|NCT04428112|451340199|FG000|Overall Study|Withdrawal by Subject|9|||
125466904|NCT04428112|451340200|FG001|Overall Study|Withdrawal by Subject|4|||
125466905|NCT04428112|451340199|FG000|Overall Study|Lost to Follow-up|27|||
125466906|NCT04428112|451340200|FG001|Overall Study|Lost to Follow-up|7|||
125466907|NCT01207492|451340201|FG000|Overall Study|Still on study|1|||
125466908|NCT01207492|451340201|FG000|Overall Study|Withdrawal by Subject|9|||
125466909|NCT01207492|451340201|FG000|Overall Study|Physician Decision|1|||
125466910|NCT01207492|451340201|FG000|Overall Study|Progressive disease|3|||
125466911|NCT01207492|451340201|FG000|Overall Study|Toxicity|1|||
125466912|NCT04814186|451342333|FG000|Treatment Phase|Adverse Event|1|||
125466913|NCT04814186|451342333|FG000|Treatment Phase|Death|6|||
125466914|NCT04814186|451342333|FG000|Treatment Phase|Withdrawal by Subject|2|||
125466915|NCT04814186|451342333|FG000|Treatment Phase|Other|1|||
125466916|NCT04814186|451342333|FG000|Follow-Up Phase|Adverse Event|1|||
125466917|NCT04814186|451342333|FG000|Follow-Up Phase|Death|6|||
125466918|NCT04814186|451342333|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
125466919|NCT04814186|451342333|FG000|Follow-Up Phase|Other|1|||
125466920|NCT01853748|451342339|FG000|Allocation|Withdrawal by Subject|1|||
125466921|NCT01853748|451342340|FG001|Allocation|Withdrawal by Subject|13|||
125466922|NCT01853748|451342339|FG000|Allocation|not sufficient to receive intervention|0|||
125466923|NCT01853748|451342340|FG001|Allocation|not sufficient to receive intervention|1|||
125466924|NCT01853748|451342339|FG000|Follow-Up|Withdrawal by Subject|7|||
125466925|NCT01853748|451342340|FG001|Follow-Up|Withdrawal by Subject|6|||
125466926|NCT01853748|451342339|FG000|Follow-Up|Adverse Event|67|||
125466927|NCT01853748|451342340|FG001|Follow-Up|Adverse Event|7|||
125466928|NCT01853748|451342339|FG000|Follow-Up|not available for data collection|16|||
125466929|NCT01853748|451342340|FG001|Follow-Up|not available for data collection|4|||
125466930|NCT04043455|451342354|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
125466931|NCT04043455|451342355|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
125466932|NCT04043455|451342356|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
125466933|NCT04043455|451342357|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
125466934|NCT04043455|451342358|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
125466935|NCT04043455|451342359|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
125466936|NCT04043455|451342354|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
125466937|NCT04043455|451342355|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
125466938|NCT04043455|451342356|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
125466939|NCT04043455|451342357|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
125466940|NCT04043455|451342358|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
125466941|NCT04043455|451342359|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
125466942|NCT04043455|451342354|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
125466943|NCT04043455|451342355|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
125466944|NCT04043455|451342356|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
125466945|NCT04043455|451342357|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
125466946|NCT04043455|451342358|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
125466947|NCT04043455|451342359|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
125466948|NCT04043455|451342354|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
125466949|NCT04043455|451342355|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
125466950|NCT04043455|451342356|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
125466951|NCT04043455|451342357|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
125466952|NCT04043455|451342358|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
125466953|NCT04043455|451342359|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
125466954|NCT04043455|451342354|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
125466955|NCT04043455|451342355|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
125466956|NCT04043455|451342356|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
125466957|NCT04043455|451342357|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
125466958|NCT04043455|451342358|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
125466959|NCT04043455|451342359|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
125466960|NCT04043455|451342354|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
125466961|NCT04043455|451342355|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
125466962|NCT04043455|451342356|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
125466963|NCT04043455|451342357|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
125466964|NCT04043455|451342358|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
125466965|NCT04043455|451342359|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
125466966|NCT04043455|451342354|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
125466967|NCT04043455|451342355|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
125466968|NCT04043455|451342356|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
125466969|NCT04043455|451342357|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
125466970|NCT04043455|451342358|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
125466971|NCT04043455|451342359|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
125466972|NCT04043455|451342354|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
125466973|NCT04043455|451342355|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
125466974|NCT04043455|451342356|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
125466975|NCT04043455|451342357|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
125466976|NCT04043455|451342358|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
125466977|NCT04043455|451342359|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
125466978|NCT04043455|451342354|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
125466979|NCT04043455|451342355|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
125466980|NCT04043455|451342356|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
125466981|NCT04043455|451342357|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
125466982|NCT04043455|451342358|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
125466983|NCT04043455|451342359|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
125466984|NCT04043455|451342354|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
125466985|NCT04043455|451342355|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
125466986|NCT04043455|451342356|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
125466987|NCT04043455|451342357|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
125466988|NCT04043455|451342358|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
125466989|NCT04043455|451342359|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
125466990|NCT04043455|451342354|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
125297189|NCT02014584|450713958|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
125466991|NCT04043455|451342355|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
125466992|NCT04043455|451342356|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
125466993|NCT04043455|451342357|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
125466994|NCT04043455|451342358|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
125466995|NCT04043455|451342359|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
125466996|NCT05194917|451342360|FG000|Overall Study|Lost to Follow-up|7|||
125466997|NCT05194917|451342361|FG001|Overall Study|Lost to Follow-up|5|||
125466998|NCT05194917|451342362|FG002|Overall Study|Lost to Follow-up|6|||
125466999|NCT05194917|451342363|FG003|Overall Study|Lost to Follow-up|5|||
125467000|NCT04922021|451342368|FG000|Overall Study|Withdrawal by Subject|4|||
125467001|NCT04922021|451342369|FG001|Overall Study|Withdrawal by Subject|10|||
125467002|NCT04922021|451342368|FG000|Overall Study|Adverse Event|2|||
125467003|NCT04922021|451342369|FG001|Overall Study|Adverse Event|2|||
125467004|NCT04922021|451342368|FG000|Overall Study|Lack of Efficacy|0|||
125467005|NCT04922021|451342369|FG001|Overall Study|Lack of Efficacy|1|||
125467006|NCT04922021|451342368|FG000|Overall Study|Multiple reasons|1|||
125467007|NCT04922021|451342369|FG001|Overall Study|Multiple reasons|0|||
125467008|NCT02544074|451342381|FG000|Overall Study|Withdrawal by Subject|0|||
125467009|NCT02544074|451342382|FG001|Overall Study|Withdrawal by Subject|1|||
125467010|NCT02544074|451342383|FG002|Overall Study|Withdrawal by Subject|0|||
125467011|NCT02544074|451342384|FG003|Overall Study|Withdrawal by Subject|0|||
125467012|NCT02544074|451342385|FG004|Overall Study|Withdrawal by Subject|0|||
125467013|NCT02544074|451342386|FG005|Overall Study|Withdrawal by Subject|0|||
125467014|NCT02544074|451342387|FG006|Overall Study|Withdrawal by Subject|0|||
125467015|NCT02544074|451342388|FG007|Overall Study|Withdrawal by Subject|0|||
125467016|NCT02544074|451342389|FG008|Overall Study|Withdrawal by Subject|0|||
125467017|NCT02544074|451342390|FG009|Overall Study|Withdrawal by Subject|0|||
125467018|NCT02544074|451342391|FG010|Overall Study|Withdrawal by Subject|0|||
125467019|NCT02544074|451342392|FG011|Overall Study|Withdrawal by Subject|0|||
125467020|NCT02544074|451342393|FG012|Overall Study|Withdrawal by Subject|0|||
125467021|NCT02544074|451342394|FG013|Overall Study|Withdrawal by Subject|0|||
125467022|NCT02544074|451342395|FG014|Overall Study|Withdrawal by Subject|0|||
125467023|NCT02544074|451342396|FG015|Overall Study|Withdrawal by Subject|0|||
125467024|NCT02544074|451342397|FG016|Overall Study|Withdrawal by Subject|0|||
125467025|NCT02544074|451342398|FG017|Overall Study|Withdrawal by Subject|0|||
125467026|NCT02544074|451342399|FG018|Overall Study|Withdrawal by Subject|0|||
125467027|NCT02544074|451342400|FG019|Overall Study|Withdrawal by Subject|0|||
125467028|NCT02544074|451342401|FG020|Overall Study|Withdrawal by Subject|0|||
125467029|NCT02544074|451342381|FG000|Overall Study|Tablet error|0|||
125467030|NCT02544074|451342382|FG001|Overall Study|Tablet error|0|||
125467031|NCT02544074|451342383|FG002|Overall Study|Tablet error|0|||
125467032|NCT02544074|451342384|FG003|Overall Study|Tablet error|0|||
125467033|NCT02544074|451342385|FG004|Overall Study|Tablet error|0|||
125467034|NCT02544074|451342386|FG005|Overall Study|Tablet error|1|||
125467035|NCT02544074|451342387|FG006|Overall Study|Tablet error|0|||
125467036|NCT02544074|451342388|FG007|Overall Study|Tablet error|0|||
125467037|NCT02544074|451342389|FG008|Overall Study|Tablet error|0|||
125467038|NCT02544074|451342390|FG009|Overall Study|Tablet error|1|||
125467039|NCT02544074|451342391|FG010|Overall Study|Tablet error|0|||
125467040|NCT02544074|451342392|FG011|Overall Study|Tablet error|0|||
125467041|NCT02544074|451342393|FG012|Overall Study|Tablet error|0|||
125467042|NCT02544074|451342394|FG013|Overall Study|Tablet error|0|||
125467043|NCT02544074|451342395|FG014|Overall Study|Tablet error|0|||
125467044|NCT02544074|451342396|FG015|Overall Study|Tablet error|0|||
125467045|NCT02544074|451342397|FG016|Overall Study|Tablet error|0|||
125467046|NCT02544074|451342398|FG017|Overall Study|Tablet error|0|||
125467047|NCT02544074|451342399|FG018|Overall Study|Tablet error|0|||
125467048|NCT02544074|451342400|FG019|Overall Study|Tablet error|0|||
125467049|NCT02544074|451342401|FG020|Overall Study|Tablet error|0|||
125467050|NCT03189524|451342402|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
125467051|NCT03189524|451342403|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
125467052|NCT03189524|451342404|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
125467053|NCT03189524|451342402|FG000|Overall Study|Death|2|||
125467054|NCT03189524|451342403|FG001|Overall Study|Death|2|||
125467055|NCT03189524|451342404|FG002|Overall Study|Death|1|||
125467056|NCT03189524|451342402|FG000|Overall Study|Lost to Follow-up|1|||
125467057|NCT03189524|451342403|FG001|Overall Study|Lost to Follow-up|0|||
125467058|NCT03189524|451342404|FG002|Overall Study|Lost to Follow-up|8|||
125297190|NCT02014584|450713959|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
125467059|NCT03189524|451342402|FG000|Overall Study|Withdrawal by Subject|1|||
125467060|NCT03189524|451342403|FG001|Overall Study|Withdrawal by Subject|1|||
125467061|NCT03189524|451342404|FG002|Overall Study|Withdrawal by Subject|3|||
125467062|NCT03189524|451342402|FG000|Overall Study|Progressive Disease|0|||
125467063|NCT03189524|451342403|FG001|Overall Study|Progressive Disease|2|||
125297191|NCT02014584|450713960|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
125467064|NCT03189524|451342404|FG002|Overall Study|Progressive Disease|0|||
125297192|NCT02014584|450713961|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
125297193|NCT02014584|450713962|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
125297194|NCT02014584|450713963|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
125467065|NCT02723955|451342405|FG000|Escalation Phase|Death|1|||
125467066|NCT02723955|451342406|FG001|Escalation Phase|Death|1|||
125467067|NCT02723955|451342407|FG002|Escalation Phase|Death|2|||
125467068|NCT02723955|451342408|FG003|Escalation Phase|Death|7|||
125467069|NCT02723955|451342409|FG004|Escalation Phase|Death|18|||
125467070|NCT02723955|451342410|FG005|Escalation Phase|Death|17|||
125467071|NCT02723955|451342411|FG006|Escalation Phase|Death|11|||
125467072|NCT02723955|451342412|FG007|Escalation Phase|Death|21|||
125467073|NCT02723955|451342413|FG008|Escalation Phase|Death|3|||
125467074|NCT02723955|451342414|FG009|Escalation Phase|Death|0|||
125467075|NCT02723955|451342415|FG010|Escalation Phase|Death|0|||
125467076|NCT02723955|451342416|FG011|Escalation Phase|Death|0|||
125467077|NCT02723955|451342417|FG012|Escalation Phase|Death|2|||
125467078|NCT02723955|451342418|FG013|Escalation Phase|Death|4|||
125467079|NCT02723955|451342419|FG014|Escalation Phase|Death|5|||
125467080|NCT02723955|451342420|FG015|Escalation Phase|Death|6|||
125467081|NCT02723955|451342421|FG016|Escalation Phase|Death|6|||
125467082|NCT02723955|451342422|FG017|Escalation Phase|Death|7|||
125467083|NCT02723955|451342423|FG018|Escalation Phase|Death|1|||
125467084|NCT02723955|451342424|FG019|Escalation Phase|Death|3|||
125467085|NCT02723955|451342425|FG020|Escalation Phase|Death|13|||
125467086|NCT02723955|451342426|FG021|Escalation Phase|Death|3|||
125467087|NCT02723955|451342427|FG022|Escalation Phase|Death|2|||
125467088|NCT02723955|451342428|FG023|Escalation Phase|Death|4|||
125467089|NCT02723955|451342429|FG024|Escalation Phase|Death|31|||
125467090|NCT02723955|451342430|FG025|Escalation Phase|Death|7|||
125467091|NCT02723955|451342431|FG026|Escalation Phase|Death|13|||
125467092|NCT02723955|451342432|FG027|Escalation Phase|Death|0|||
125467093|NCT02723955|451342433|FG028|Escalation Phase|Death|1|||
125467094|NCT02723955|451342434|FG029|Escalation Phase|Death|0|||
125467095|NCT02723955|451342435|FG030|Escalation Phase|Death|0|||
125467096|NCT02723955|451342436|FG031|Escalation Phase|Death|0|||
125467097|NCT02723955|451342437|FG032|Escalation Phase|Death|0|||
125467098|NCT02723955|451342438|FG033|Escalation Phase|Death|0|||
125467099|NCT02723955|451342439|FG034|Escalation Phase|Death|0|||
125467100|NCT02723955|451342440|FG035|Escalation Phase|Death|0|||
125467101|NCT02723955|451342441|FG036|Escalation Phase|Death|0|||
125467102|NCT02723955|451342442|FG037|Escalation Phase|Death|0|||
125467103|NCT02723955|451342443|FG038|Escalation Phase|Death|0|||
125467104|NCT02723955|451342444|FG039|Escalation Phase|Death|0|||
125467105|NCT02723955|451342445|FG040|Escalation Phase|Death|0|||
125467106|NCT02723955|451342446|FG041|Escalation Phase|Death|0|||
125467107|NCT02723955|451342447|FG042|Escalation Phase|Death|0|||
125467108|NCT02723955|451342405|FG000|Escalation Phase|Lost to Follow-up|0|||
125467109|NCT02723955|451342406|FG001|Escalation Phase|Lost to Follow-up|0|||
125467110|NCT02723955|451342407|FG002|Escalation Phase|Lost to Follow-up|0|||
125467111|NCT02723955|451342408|FG003|Escalation Phase|Lost to Follow-up|0|||
125467112|NCT02723955|451342409|FG004|Escalation Phase|Lost to Follow-up|0|||
125467113|NCT02723955|451342410|FG005|Escalation Phase|Lost to Follow-up|2|||
125467114|NCT02723955|451342411|FG006|Escalation Phase|Lost to Follow-up|1|||
125467115|NCT02723955|451342412|FG007|Escalation Phase|Lost to Follow-up|1|||
125467116|NCT02723955|451342413|FG008|Escalation Phase|Lost to Follow-up|1|||
125297195|NCT02014584|450713958|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
125297196|NCT02014584|450713959|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
125297197|NCT02014584|450713960|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
125467117|NCT02723955|451342414|FG009|Escalation Phase|Lost to Follow-up|0|||
125467118|NCT02723955|451342415|FG010|Escalation Phase|Lost to Follow-up|0|||
125297198|NCT02014584|450713961|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
125297199|NCT02014584|450713962|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
125297200|NCT02014584|450713963|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
125297201|NCT02014584|450713958|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
125297202|NCT02014584|450713959|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
125297203|NCT02014584|450713960|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
125467119|NCT02723955|451342416|FG011|Escalation Phase|Lost to Follow-up|0|||
125467120|NCT02723955|451342417|FG012|Escalation Phase|Lost to Follow-up|1|||
125467121|NCT02723955|451342418|FG013|Escalation Phase|Lost to Follow-up|0|||
125467122|NCT02723955|451342419|FG014|Escalation Phase|Lost to Follow-up|0|||
125297204|NCT02014584|450713961|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
125297205|NCT02014584|450713962|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
125467123|NCT02723955|451342420|FG015|Escalation Phase|Lost to Follow-up|0|||
125467124|NCT02723955|451342421|FG016|Escalation Phase|Lost to Follow-up|1|||
125467125|NCT02723955|451342422|FG017|Escalation Phase|Lost to Follow-up|2|||
125467126|NCT02723955|451342423|FG018|Escalation Phase|Lost to Follow-up|0|||
125467127|NCT02723955|451342424|FG019|Escalation Phase|Lost to Follow-up|1|||
125467128|NCT02723955|451342425|FG020|Escalation Phase|Lost to Follow-up|2|||
125467129|NCT02723955|451342426|FG021|Escalation Phase|Lost to Follow-up|1|||
125467130|NCT02723955|451342427|FG022|Escalation Phase|Lost to Follow-up|0|||
125467131|NCT02723955|451342428|FG023|Escalation Phase|Lost to Follow-up|0|||
125467132|NCT02723955|451342429|FG024|Escalation Phase|Lost to Follow-up|1|||
125467133|NCT02723955|451342430|FG025|Escalation Phase|Lost to Follow-up|1|||
125467134|NCT02723955|451342431|FG026|Escalation Phase|Lost to Follow-up|3|||
125467135|NCT02723955|451342432|FG027|Escalation Phase|Lost to Follow-up|0|||
125467136|NCT02723955|451342433|FG028|Escalation Phase|Lost to Follow-up|1|||
125467137|NCT02723955|451342434|FG029|Escalation Phase|Lost to Follow-up|0|||
125467138|NCT02723955|451342435|FG030|Escalation Phase|Lost to Follow-up|0|||
125467139|NCT02723955|451342436|FG031|Escalation Phase|Lost to Follow-up|0|||
125467140|NCT02723955|451342437|FG032|Escalation Phase|Lost to Follow-up|0|||
125467141|NCT02723955|451342438|FG033|Escalation Phase|Lost to Follow-up|0|||
125467142|NCT02723955|451342439|FG034|Escalation Phase|Lost to Follow-up|0|||
125467143|NCT02723955|451342440|FG035|Escalation Phase|Lost to Follow-up|0|||
125467144|NCT02723955|451342441|FG036|Escalation Phase|Lost to Follow-up|0|||
125467145|NCT02723955|451342442|FG037|Escalation Phase|Lost to Follow-up|0|||
125467146|NCT02723955|451342443|FG038|Escalation Phase|Lost to Follow-up|0|||
125467147|NCT02723955|451342444|FG039|Escalation Phase|Lost to Follow-up|0|||
125467148|NCT02723955|451342445|FG040|Escalation Phase|Lost to Follow-up|0|||
125467149|NCT02723955|451342446|FG041|Escalation Phase|Lost to Follow-up|0|||
125467150|NCT02723955|451342447|FG042|Escalation Phase|Lost to Follow-up|0|||
125467151|NCT02723955|451342405|FG000|Escalation Phase|Physician Decision|0|||
125467152|NCT02723955|451342406|FG001|Escalation Phase|Physician Decision|0|||
125467153|NCT02723955|451342407|FG002|Escalation Phase|Physician Decision|0|||
125467154|NCT02723955|451342408|FG003|Escalation Phase|Physician Decision|0|||
125467155|NCT02723955|451342409|FG004|Escalation Phase|Physician Decision|0|||
125467156|NCT02723955|451342410|FG005|Escalation Phase|Physician Decision|2|||
125467157|NCT02723955|451342411|FG006|Escalation Phase|Physician Decision|0|||
125467158|NCT02723955|451342412|FG007|Escalation Phase|Physician Decision|0|||
125467159|NCT02723955|451342413|FG008|Escalation Phase|Physician Decision|0|||
125467160|NCT02723955|451342414|FG009|Escalation Phase|Physician Decision|0|||
125467161|NCT02723955|451342415|FG010|Escalation Phase|Physician Decision|0|||
125467162|NCT02723955|451342416|FG011|Escalation Phase|Physician Decision|0|||
125467163|NCT02723955|451342417|FG012|Escalation Phase|Physician Decision|0|||
125467164|NCT02723955|451342418|FG013|Escalation Phase|Physician Decision|0|||
125467165|NCT02723955|451342419|FG014|Escalation Phase|Physician Decision|0|||
125467166|NCT02723955|451342420|FG015|Escalation Phase|Physician Decision|0|||
125297206|NCT02014584|450713963|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
125467167|NCT02723955|451342421|FG016|Escalation Phase|Physician Decision|0|||
125467168|NCT02723955|451342422|FG017|Escalation Phase|Physician Decision|0|||
125467169|NCT02723955|451342423|FG018|Escalation Phase|Physician Decision|0|||
125467170|NCT02723955|451342424|FG019|Escalation Phase|Physician Decision|0|||
125467171|NCT02723955|451342425|FG020|Escalation Phase|Physician Decision|0|||
125467172|NCT02723955|451342426|FG021|Escalation Phase|Physician Decision|0|||
125467173|NCT02723955|451342427|FG022|Escalation Phase|Physician Decision|0|||
125467174|NCT02723955|451342428|FG023|Escalation Phase|Physician Decision|0|||
125467175|NCT02723955|451342429|FG024|Escalation Phase|Physician Decision|0|||
125467176|NCT02723955|451342430|FG025|Escalation Phase|Physician Decision|0|||
125467177|NCT02723955|451342431|FG026|Escalation Phase|Physician Decision|2|||
125467178|NCT02723955|451342432|FG027|Escalation Phase|Physician Decision|0|||
125467179|NCT02723955|451342433|FG028|Escalation Phase|Physician Decision|0|||
125467180|NCT02723955|451342434|FG029|Escalation Phase|Physician Decision|0|||
125467181|NCT02723955|451342435|FG030|Escalation Phase|Physician Decision|0|||
125467182|NCT02723955|451342436|FG031|Escalation Phase|Physician Decision|0|||
125467183|NCT02723955|451342437|FG032|Escalation Phase|Physician Decision|0|||
125297207|NCT02014584|450713958|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
125297208|NCT02014584|450713959|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
125297209|NCT02014584|450713960|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
125297210|NCT02014584|450713961|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
125297211|NCT02014584|450713962|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
125297212|NCT02014584|450713963|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
125297213|NCT02014584|450713958|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
125297214|NCT02014584|450713959|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
125297215|NCT02014584|450713960|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
125467184|NCT02723955|451342438|FG033|Escalation Phase|Physician Decision|0|||
125467185|NCT02723955|451342439|FG034|Escalation Phase|Physician Decision|0|||
125467186|NCT02723955|451342440|FG035|Escalation Phase|Physician Decision|0|||
125467187|NCT02723955|451342441|FG036|Escalation Phase|Physician Decision|0|||
125467188|NCT02723955|451342442|FG037|Escalation Phase|Physician Decision|0|||
125467189|NCT02723955|451342443|FG038|Escalation Phase|Physician Decision|0|||
125467190|NCT02723955|451342444|FG039|Escalation Phase|Physician Decision|0|||
125467191|NCT02723955|451342445|FG040|Escalation Phase|Physician Decision|0|||
125467192|NCT02723955|451342446|FG041|Escalation Phase|Physician Decision|0|||
125467193|NCT02723955|451342447|FG042|Escalation Phase|Physician Decision|0|||
125467194|NCT02723955|451342405|FG000|Escalation Phase|Withdrawal by Subject|0|||
125467195|NCT02723955|451342406|FG001|Escalation Phase|Withdrawal by Subject|0|||
125467196|NCT02723955|451342407|FG002|Escalation Phase|Withdrawal by Subject|0|||
125467197|NCT02723955|451342408|FG003|Escalation Phase|Withdrawal by Subject|0|||
125467198|NCT02723955|451342409|FG004|Escalation Phase|Withdrawal by Subject|1|||
125467199|NCT02723955|451342410|FG005|Escalation Phase|Withdrawal by Subject|1|||
125467200|NCT02723955|451342411|FG006|Escalation Phase|Withdrawal by Subject|1|||
125467201|NCT02723955|451342412|FG007|Escalation Phase|Withdrawal by Subject|1|||
125467202|NCT02723955|451342413|FG008|Escalation Phase|Withdrawal by Subject|0|||
125467203|NCT02723955|451342414|FG009|Escalation Phase|Withdrawal by Subject|0|||
125467204|NCT02723955|451342415|FG010|Escalation Phase|Withdrawal by Subject|0|||
125467205|NCT02723955|451342416|FG011|Escalation Phase|Withdrawal by Subject|0|||
125467206|NCT02723955|451342417|FG012|Escalation Phase|Withdrawal by Subject|1|||
125467207|NCT02723955|451342418|FG013|Escalation Phase|Withdrawal by Subject|0|||
125467208|NCT02723955|451342419|FG014|Escalation Phase|Withdrawal by Subject|0|||
125467209|NCT02723955|451342420|FG015|Escalation Phase|Withdrawal by Subject|0|||
125467210|NCT02723955|451342421|FG016|Escalation Phase|Withdrawal by Subject|1|||
125467211|NCT02723955|451342422|FG017|Escalation Phase|Withdrawal by Subject|0|||
125467212|NCT02723955|451342423|FG018|Escalation Phase|Withdrawal by Subject|0|||
125467213|NCT02723955|451342424|FG019|Escalation Phase|Withdrawal by Subject|0|||
125467214|NCT02723955|451342425|FG020|Escalation Phase|Withdrawal by Subject|0|||
125467215|NCT02723955|451342426|FG021|Escalation Phase|Withdrawal by Subject|0|||
125467216|NCT02723955|451342427|FG022|Escalation Phase|Withdrawal by Subject|0|||
125467217|NCT02723955|451342428|FG023|Escalation Phase|Withdrawal by Subject|2|||
125467218|NCT02723955|451342429|FG024|Escalation Phase|Withdrawal by Subject|0|||
125467219|NCT02723955|451342430|FG025|Escalation Phase|Withdrawal by Subject|1|||
125467220|NCT02723955|451342431|FG026|Escalation Phase|Withdrawal by Subject|0|||
125467221|NCT02723955|451342432|FG027|Escalation Phase|Withdrawal by Subject|0|||
125467222|NCT02723955|451342433|FG028|Escalation Phase|Withdrawal by Subject|1|||
125467223|NCT02723955|451342434|FG029|Escalation Phase|Withdrawal by Subject|0|||
125467224|NCT02723955|451342435|FG030|Escalation Phase|Withdrawal by Subject|0|||
125467225|NCT02723955|451342436|FG031|Escalation Phase|Withdrawal by Subject|0|||
125467226|NCT02723955|451342437|FG032|Escalation Phase|Withdrawal by Subject|0|||
125467227|NCT02723955|451342438|FG033|Escalation Phase|Withdrawal by Subject|0|||
125467228|NCT02723955|451342439|FG034|Escalation Phase|Withdrawal by Subject|0|||
125467229|NCT02723955|451342440|FG035|Escalation Phase|Withdrawal by Subject|0|||
125467230|NCT02723955|451342441|FG036|Escalation Phase|Withdrawal by Subject|0|||
125467231|NCT02723955|451342442|FG037|Escalation Phase|Withdrawal by Subject|0|||
125467232|NCT02723955|451342443|FG038|Escalation Phase|Withdrawal by Subject|0|||
125467233|NCT02723955|451342444|FG039|Escalation Phase|Withdrawal by Subject|0|||
125467234|NCT02723955|451342445|FG040|Escalation Phase|Withdrawal by Subject|0|||
125467235|NCT02723955|451342446|FG041|Escalation Phase|Withdrawal by Subject|0|||
125467236|NCT02723955|451342447|FG042|Escalation Phase|Withdrawal by Subject|0|||
125467237|NCT02723955|451342405|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467238|NCT02723955|451342406|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467239|NCT02723955|451342407|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125297216|NCT02014584|450713961|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
125297217|NCT02014584|450713962|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
125297218|NCT02014584|450713963|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
125297219|NCT01555125|450713964|FG000|Induction Period|Lost to Follow-up|0|||
125297220|NCT01555125|450713965|FG001|Induction Period|Lost to Follow-up|2|||
125297221|NCT01555125|450713966|FG002|Induction Period|Lost to Follow-up|0|||
125297222|NCT01555125|450713967|FG003|Induction Period|Lost to Follow-up|0|||
125297223|NCT01555125|450713968|FG004|Induction Period|Lost to Follow-up|0|||
125467240|NCT02723955|451342408|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467241|NCT02723955|451342409|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
125467242|NCT02723955|451342410|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
125467243|NCT02723955|451342411|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
125467244|NCT02723955|451342412|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
125467245|NCT02723955|451342413|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
125467246|NCT02723955|451342414|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467247|NCT02723955|451342415|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467248|NCT02723955|451342416|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467249|NCT02723955|451342417|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467250|NCT02723955|451342418|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467251|NCT02723955|451342419|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125297224|NCT01555125|450713964|FG000|Induction Period|Adverse Event|0|||
125297225|NCT01555125|450713965|FG001|Induction Period|Adverse Event|1|||
125467252|NCT02723955|451342420|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467253|NCT02723955|451342421|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467254|NCT02723955|451342422|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467255|NCT02723955|451342423|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467256|NCT02723955|451342424|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467257|NCT02723955|451342425|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467258|NCT02723955|451342426|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467259|NCT02723955|451342427|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467260|NCT02723955|451342428|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467261|NCT02723955|451342429|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467262|NCT02723955|451342430|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467263|NCT02723955|451342431|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467264|NCT02723955|451342432|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467265|NCT02723955|451342433|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467266|NCT02723955|451342434|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467267|NCT02723955|451342435|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467268|NCT02723955|451342436|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467269|NCT02723955|451342437|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467270|NCT02723955|451342438|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467271|NCT02723955|451342439|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467272|NCT02723955|451342440|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467273|NCT02723955|451342441|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467274|NCT02723955|451342442|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467275|NCT02723955|451342443|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467276|NCT02723955|451342444|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467277|NCT02723955|451342445|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467278|NCT02723955|451342446|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467279|NCT02723955|451342447|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
125467280|NCT02723955|451342405|FG000|Escalation Phase|Site Closed|0|||
125467281|NCT02723955|451342406|FG001|Escalation Phase|Site Closed|0|||
125467282|NCT02723955|451342407|FG002|Escalation Phase|Site Closed|0|||
125467283|NCT02723955|451342408|FG003|Escalation Phase|Site Closed|0|||
125467284|NCT02723955|451342409|FG004|Escalation Phase|Site Closed|0|||
125467285|NCT02723955|451342410|FG005|Escalation Phase|Site Closed|0|||
125467286|NCT02723955|451342411|FG006|Escalation Phase|Site Closed|0|||
125467287|NCT02723955|451342412|FG007|Escalation Phase|Site Closed|0|||
125467288|NCT02723955|451342413|FG008|Escalation Phase|Site Closed|0|||
125467289|NCT02723955|451342414|FG009|Escalation Phase|Site Closed|0|||
125467290|NCT02723955|451342415|FG010|Escalation Phase|Site Closed|0|||
125467291|NCT02723955|451342416|FG011|Escalation Phase|Site Closed|0|||
125297226|NCT01555125|450713966|FG002|Induction Period|Adverse Event|0|||
125297227|NCT01555125|450713967|FG003|Induction Period|Adverse Event|0|||
125297228|NCT01555125|450713968|FG004|Induction Period|Adverse Event|1|||
125297229|NCT01555125|450713964|FG000|Induction Period|Subject / guardian decision|0|||
125467292|NCT02723955|451342417|FG012|Escalation Phase|Site Closed|0|||
125467293|NCT02723955|451342418|FG013|Escalation Phase|Site Closed|0|||
125467294|NCT02723955|451342419|FG014|Escalation Phase|Site Closed|0|||
125297230|NCT01555125|450713965|FG001|Induction Period|Subject / guardian decision|0|||
125297231|NCT01555125|450713966|FG002|Induction Period|Subject / guardian decision|0|||
125297232|NCT01555125|450713967|FG003|Induction Period|Subject / guardian decision|0|||
125297233|NCT01555125|450713968|FG004|Induction Period|Subject / guardian decision|2|||
125467295|NCT02723955|451342420|FG015|Escalation Phase|Site Closed|1|||
125467296|NCT02723955|451342421|FG016|Escalation Phase|Site Closed|0|||
125467297|NCT02723955|451342422|FG017|Escalation Phase|Site Closed|2|||
125467298|NCT02723955|451342423|FG018|Escalation Phase|Site Closed|0|||
125467299|NCT02723955|451342424|FG019|Escalation Phase|Site Closed|0|||
125467300|NCT02723955|451342425|FG020|Escalation Phase|Site Closed|1|||
125467301|NCT02723955|451342426|FG021|Escalation Phase|Site Closed|0|||
125467302|NCT02723955|451342427|FG022|Escalation Phase|Site Closed|0|||
125467303|NCT02723955|451342428|FG023|Escalation Phase|Site Closed|0|||
125467304|NCT02723955|451342429|FG024|Escalation Phase|Site Closed|3|||
125467305|NCT02723955|451342430|FG025|Escalation Phase|Site Closed|1|||
125297234|NCT01555125|450713964|FG000|Induction Period|Death|1|||
125297235|NCT01555125|450713965|FG001|Induction Period|Death|0|||
125467306|NCT02723955|451342431|FG026|Escalation Phase|Site Closed|3|||
125467307|NCT02723955|451342432|FG027|Escalation Phase|Site Closed|1|||
125467308|NCT02723955|451342433|FG028|Escalation Phase|Site Closed|1|||
125297236|NCT01555125|450713966|FG002|Induction Period|Death|0|||
125297237|NCT01555125|450713967|FG003|Induction Period|Death|0|||
125297238|NCT01555125|450713968|FG004|Induction Period|Death|0|||
125297239|NCT01555125|450713964|FG000|Maintenance Period|Adverse Event|1|||
125297240|NCT01555125|450713965|FG001|Maintenance Period|Adverse Event|1|||
125297241|NCT01555125|450713966|FG002|Maintenance Period|Adverse Event|0|||
125297242|NCT01555125|450713967|FG003|Maintenance Period|Adverse Event|0|||
125297243|NCT01555125|450713968|FG004|Maintenance Period|Adverse Event|0|||
125297244|NCT01555125|450713964|FG000|Maintenance Period|Subject / guardian decision|1|||
125297245|NCT01555125|450713965|FG001|Maintenance Period|Subject / guardian decision|2|||
125297246|NCT01555125|450713966|FG002|Maintenance Period|Subject / guardian decision|0|||
125467309|NCT02723955|451342434|FG029|Escalation Phase|Site Closed|0|||
125467310|NCT02723955|451342435|FG030|Escalation Phase|Site Closed|0|||
125467311|NCT02723955|451342436|FG031|Escalation Phase|Site Closed|0|||
125467312|NCT02723955|451342437|FG032|Escalation Phase|Site Closed|0|||
125467313|NCT02723955|451342438|FG033|Escalation Phase|Site Closed|0|||
125467314|NCT02723955|451342439|FG034|Escalation Phase|Site Closed|0|||
125467315|NCT02723955|451342440|FG035|Escalation Phase|Site Closed|0|||
125467316|NCT02723955|451342441|FG036|Escalation Phase|Site Closed|0|||
125467317|NCT02723955|451342442|FG037|Escalation Phase|Site Closed|0|||
125467318|NCT02723955|451342443|FG038|Escalation Phase|Site Closed|0|||
125467319|NCT02723955|451342444|FG039|Escalation Phase|Site Closed|0|||
125467320|NCT02723955|451342445|FG040|Escalation Phase|Site Closed|0|||
125467321|NCT02723955|451342446|FG041|Escalation Phase|Site Closed|0|||
125467322|NCT02723955|451342447|FG042|Escalation Phase|Site Closed|0|||
125467323|NCT02723955|451342405|FG000|Expansion Phase|Death|0|||
125467324|NCT02723955|451342406|FG001|Expansion Phase|Death|0|||
125467325|NCT02723955|451342407|FG002|Expansion Phase|Death|0|||
125467326|NCT02723955|451342408|FG003|Expansion Phase|Death|0|||
125467327|NCT02723955|451342409|FG004|Expansion Phase|Death|0|||
125467328|NCT02723955|451342410|FG005|Expansion Phase|Death|0|||
125467329|NCT02723955|451342411|FG006|Expansion Phase|Death|0|||
125467330|NCT02723955|451342412|FG007|Expansion Phase|Death|0|||
125467331|NCT02723955|451342413|FG008|Expansion Phase|Death|0|||
125467332|NCT02723955|451342414|FG009|Expansion Phase|Death|25|||
125467333|NCT02723955|451342415|FG010|Expansion Phase|Death|69|||
125467334|NCT02723955|451342416|FG011|Expansion Phase|Death|48|||
125467335|NCT02723955|451342417|FG012|Expansion Phase|Death|0|||
125467336|NCT02723955|451342418|FG013|Expansion Phase|Death|0|||
125467337|NCT02723955|451342419|FG014|Expansion Phase|Death|0|||
125467338|NCT02723955|451342420|FG015|Expansion Phase|Death|0|||
125467339|NCT02723955|451342421|FG016|Expansion Phase|Death|0|||
125467340|NCT02723955|451342422|FG017|Expansion Phase|Death|0|||
125467341|NCT02723955|451342423|FG018|Expansion Phase|Death|0|||
125467342|NCT02723955|451342424|FG019|Expansion Phase|Death|0|||
125467343|NCT02723955|451342425|FG020|Expansion Phase|Death|0|||
125467344|NCT02723955|451342426|FG021|Expansion Phase|Death|0|||
125467345|NCT02723955|451342427|FG022|Expansion Phase|Death|0|||
125467346|NCT02723955|451342428|FG023|Expansion Phase|Death|0|||
125467347|NCT02723955|451342429|FG024|Expansion Phase|Death|0|||
125467348|NCT02723955|451342430|FG025|Expansion Phase|Death|0|||
125467349|NCT02723955|451342431|FG026|Expansion Phase|Death|0|||
125467350|NCT02723955|451342432|FG027|Expansion Phase|Death|0|||
125467351|NCT02723955|451342433|FG028|Expansion Phase|Death|0|||
125467352|NCT02723955|451342434|FG029|Expansion Phase|Death|12|||
125467353|NCT02723955|451342435|FG030|Expansion Phase|Death|202|||
125467354|NCT02723955|451342436|FG031|Expansion Phase|Death|31|||
125467355|NCT02723955|451342437|FG032|Expansion Phase|Death|17|||
125297247|NCT01555125|450713967|FG003|Maintenance Period|Subject / guardian decision|0|||
125297248|NCT01555125|450713968|FG004|Maintenance Period|Subject / guardian decision|0|||
125420455|NCT04162769|451163619|FG001|OLE Period (52-Week)|Protocol deviation|0|||
125420456|NCT04162769|451163620|FG002|OLE Period (52-Week)|Protocol deviation|0|||
125420457|NCT04162769|451163621|FG003|OLE Period (52-Week)|Protocol deviation|2|||
125420458|NCT01358968|451163628|FG000|Period 2|Adverse Event|0|||
125297249|NCT01555125|450713964|FG000|Maintenance Period|Lost to Follow-up|2|||
125297250|NCT01555125|450713965|FG001|Maintenance Period|Lost to Follow-up|0|||
125420459|NCT01358968|451163629|FG001|Period 2|Adverse Event|1|||
125420460|NCT01358968|451163630|FG002|Period 2|Adverse Event|0|||
125420461|NCT01358968|451163631|FG003|Period 2|Adverse Event|0|||
125420462|NCT01358968|451163628|FG000|Continued Access Phase|Progression of Disease|0|||
125420463|NCT01358968|451163629|FG001|Continued Access Phase|Progression of Disease|0|||
125420464|NCT01358968|451163630|FG002|Continued Access Phase|Progression of Disease|8|||
125420465|NCT01358968|451163631|FG003|Continued Access Phase|Progression of Disease|4|||
125420466|NCT01358968|451163628|FG000|Continued Access Phase|Protocol Violation|0|||
125467356|NCT02723955|451342438|FG033|Expansion Phase|Death|2|||
125467357|NCT02723955|451342439|FG034|Expansion Phase|Death|3|||
125467358|NCT02723955|451342440|FG035|Expansion Phase|Death|3|||
125467359|NCT02723955|451342441|FG036|Expansion Phase|Death|1|||
125467360|NCT02723955|451342442|FG037|Expansion Phase|Death|0|||
125467361|NCT02723955|451342443|FG038|Expansion Phase|Death|0|||
125467362|NCT02723955|451342444|FG039|Expansion Phase|Death|0|||
125467363|NCT02723955|451342445|FG040|Expansion Phase|Death|0|||
125467364|NCT02723955|451342446|FG041|Expansion Phase|Death|0|||
125467365|NCT02723955|451342447|FG042|Expansion Phase|Death|0|||
125467366|NCT02723955|451342405|FG000|Expansion Phase|Lost to Follow-up|0|||
125467367|NCT02723955|451342406|FG001|Expansion Phase|Lost to Follow-up|0|||
125467368|NCT02723955|451342407|FG002|Expansion Phase|Lost to Follow-up|0|||
125467369|NCT02723955|451342408|FG003|Expansion Phase|Lost to Follow-up|0|||
125467370|NCT02723955|451342409|FG004|Expansion Phase|Lost to Follow-up|0|||
125467371|NCT02723955|451342410|FG005|Expansion Phase|Lost to Follow-up|0|||
125297251|NCT01555125|450713966|FG002|Maintenance Period|Lost to Follow-up|0|||
125297252|NCT01555125|450713967|FG003|Maintenance Period|Lost to Follow-up|1|||
125297253|NCT01555125|450713968|FG004|Maintenance Period|Lost to Follow-up|0|||
125297254|NCT01555125|450713964|FG000|Maintenance Period|Lack of Efficacy|6|||
125297255|NCT01555125|450713965|FG001|Maintenance Period|Lack of Efficacy|1|||
125297256|NCT01555125|450713966|FG002|Maintenance Period|Lack of Efficacy|3|||
125467372|NCT02723955|451342411|FG006|Expansion Phase|Lost to Follow-up|0|||
125467373|NCT02723955|451342412|FG007|Expansion Phase|Lost to Follow-up|0|||
125467374|NCT02723955|451342413|FG008|Expansion Phase|Lost to Follow-up|0|||
125467375|NCT02723955|451342414|FG009|Expansion Phase|Lost to Follow-up|0|||
125467376|NCT02723955|451342415|FG010|Expansion Phase|Lost to Follow-up|4|||
125467377|NCT02723955|451342416|FG011|Expansion Phase|Lost to Follow-up|1|||
125467378|NCT02723955|451342417|FG012|Expansion Phase|Lost to Follow-up|0|||
125467379|NCT02723955|451342418|FG013|Expansion Phase|Lost to Follow-up|0|||
125467380|NCT02723955|451342419|FG014|Expansion Phase|Lost to Follow-up|0|||
125467381|NCT02723955|451342420|FG015|Expansion Phase|Lost to Follow-up|0|||
125467382|NCT02723955|451342421|FG016|Expansion Phase|Lost to Follow-up|0|||
125467383|NCT02723955|451342422|FG017|Expansion Phase|Lost to Follow-up|0|||
125297257|NCT01555125|450713967|FG003|Maintenance Period|Lack of Efficacy|0|||
125297258|NCT01555125|450713968|FG004|Maintenance Period|Lack of Efficacy|0|||
125297259|NCT01555125|450713964|FG000|Maintenance Period|Physician Decision|0|||
125297260|NCT01555125|450713965|FG001|Maintenance Period|Physician Decision|0|||
125297261|NCT01555125|450713966|FG002|Maintenance Period|Physician Decision|1|||
125297262|NCT01555125|450713967|FG003|Maintenance Period|Physician Decision|0|||
125467384|NCT02723955|451342423|FG018|Expansion Phase|Lost to Follow-up|0|||
125467385|NCT02723955|451342424|FG019|Expansion Phase|Lost to Follow-up|0|||
125467386|NCT02723955|451342425|FG020|Expansion Phase|Lost to Follow-up|0|||
125467387|NCT02723955|451342426|FG021|Expansion Phase|Lost to Follow-up|0|||
125297263|NCT01555125|450713968|FG004|Maintenance Period|Physician Decision|0|||
125297264|NCT01555125|450713964|FG000|Maintenance Period|Death|0|||
125297265|NCT01555125|450713965|FG001|Maintenance Period|Death|0|||
125297266|NCT01555125|450713966|FG002|Maintenance Period|Death|0|||
125297267|NCT01555125|450713967|FG003|Maintenance Period|Death|1|||
125467388|NCT02723955|451342427|FG022|Expansion Phase|Lost to Follow-up|0|||
125467389|NCT02723955|451342428|FG023|Expansion Phase|Lost to Follow-up|0|||
125467390|NCT02723955|451342429|FG024|Expansion Phase|Lost to Follow-up|0|||
125467391|NCT02723955|451342430|FG025|Expansion Phase|Lost to Follow-up|0|||
125467392|NCT02723955|451342431|FG026|Expansion Phase|Lost to Follow-up|0|||
125467393|NCT02723955|451342432|FG027|Expansion Phase|Lost to Follow-up|0|||
125467394|NCT02723955|451342433|FG028|Expansion Phase|Lost to Follow-up|0|||
125467395|NCT02723955|451342434|FG029|Expansion Phase|Lost to Follow-up|1|||
125467396|NCT02723955|451342435|FG030|Expansion Phase|Lost to Follow-up|19|||
125467397|NCT02723955|451342436|FG031|Expansion Phase|Lost to Follow-up|2|||
125467398|NCT02723955|451342437|FG032|Expansion Phase|Lost to Follow-up|1|||
125467399|NCT02723955|451342438|FG033|Expansion Phase|Lost to Follow-up|0|||
125467400|NCT02723955|451342439|FG034|Expansion Phase|Lost to Follow-up|0|||
125467401|NCT02723955|451342440|FG035|Expansion Phase|Lost to Follow-up|0|||
125467402|NCT02723955|451342441|FG036|Expansion Phase|Lost to Follow-up|0|||
125467403|NCT02723955|451342442|FG037|Expansion Phase|Lost to Follow-up|0|||
125467404|NCT02723955|451342443|FG038|Expansion Phase|Lost to Follow-up|0|||
125467405|NCT02723955|451342444|FG039|Expansion Phase|Lost to Follow-up|0|||
125467406|NCT02723955|451342445|FG040|Expansion Phase|Lost to Follow-up|0|||
125467407|NCT02723955|451342446|FG041|Expansion Phase|Lost to Follow-up|0|||
125467408|NCT02723955|451342447|FG042|Expansion Phase|Lost to Follow-up|0|||
125467409|NCT02723955|451342405|FG000|Expansion Phase|Physician Decision|0|||
125467410|NCT02723955|451342406|FG001|Expansion Phase|Physician Decision|0|||
125467411|NCT02723955|451342407|FG002|Expansion Phase|Physician Decision|0|||
125467412|NCT02723955|451342408|FG003|Expansion Phase|Physician Decision|0|||
125467413|NCT02723955|451342409|FG004|Expansion Phase|Physician Decision|0|||
125467414|NCT02723955|451342410|FG005|Expansion Phase|Physician Decision|0|||
125467415|NCT02723955|451342411|FG006|Expansion Phase|Physician Decision|0|||
125467416|NCT02723955|451342412|FG007|Expansion Phase|Physician Decision|0|||
125297268|NCT01555125|450713968|FG004|Maintenance Period|Death|0|||
125297269|NCT01555125|450713964|FG000|Extension|Adverse Event|1|||
125297270|NCT01555125|450713965|FG001|Extension|Adverse Event|2|||
125297271|NCT01555125|450713966|FG002|Extension|Adverse Event|1|||
125297272|NCT01555125|450713967|FG003|Extension|Adverse Event|1|||
125297273|NCT01555125|450713968|FG004|Extension|Adverse Event|0|||
125467417|NCT02723955|451342413|FG008|Expansion Phase|Physician Decision|0|||
125467418|NCT02723955|451342414|FG009|Expansion Phase|Physician Decision|0|||
125467419|NCT02723955|451342415|FG010|Expansion Phase|Physician Decision|0|||
125467420|NCT02723955|451342416|FG011|Expansion Phase|Physician Decision|0|||
125467421|NCT02723955|451342417|FG012|Expansion Phase|Physician Decision|0|||
125467422|NCT02723955|451342418|FG013|Expansion Phase|Physician Decision|0|||
125467423|NCT02723955|451342419|FG014|Expansion Phase|Physician Decision|0|||
125467424|NCT02723955|451342420|FG015|Expansion Phase|Physician Decision|0|||
125467425|NCT02723955|451342421|FG016|Expansion Phase|Physician Decision|0|||
125467426|NCT02723955|451342422|FG017|Expansion Phase|Physician Decision|0|||
125467427|NCT02723955|451342423|FG018|Expansion Phase|Physician Decision|0|||
125467428|NCT02723955|451342424|FG019|Expansion Phase|Physician Decision|0|||
125467429|NCT02723955|451342425|FG020|Expansion Phase|Physician Decision|0|||
125467430|NCT02723955|451342426|FG021|Expansion Phase|Physician Decision|0|||
125467431|NCT02723955|451342427|FG022|Expansion Phase|Physician Decision|0|||
125467432|NCT02723955|451342428|FG023|Expansion Phase|Physician Decision|0|||
125467433|NCT02723955|451342429|FG024|Expansion Phase|Physician Decision|0|||
125467434|NCT02723955|451342430|FG025|Expansion Phase|Physician Decision|0|||
125467435|NCT02723955|451342431|FG026|Expansion Phase|Physician Decision|0|||
125467436|NCT02723955|451342432|FG027|Expansion Phase|Physician Decision|0|||
125467437|NCT02723955|451342433|FG028|Expansion Phase|Physician Decision|0|||
125467438|NCT02723955|451342434|FG029|Expansion Phase|Physician Decision|0|||
125467439|NCT02723955|451342435|FG030|Expansion Phase|Physician Decision|1|||
125467440|NCT02723955|451342436|FG031|Expansion Phase|Physician Decision|1|||
125467441|NCT02723955|451342437|FG032|Expansion Phase|Physician Decision|0|||
125467442|NCT02723955|451342438|FG033|Expansion Phase|Physician Decision|0|||
125467443|NCT02723955|451342439|FG034|Expansion Phase|Physician Decision|0|||
125297274|NCT01555125|450713964|FG000|Extension|Protocol deviation|1|||
125297275|NCT01555125|450713965|FG001|Extension|Protocol deviation|0|||
125297276|NCT01555125|450713966|FG002|Extension|Protocol deviation|0|||
125297277|NCT01555125|450713967|FG003|Extension|Protocol deviation|0|||
125297278|NCT01555125|450713968|FG004|Extension|Protocol deviation|0|||
125297279|NCT01555125|450713964|FG000|Extension|Lack of Efficacy|7|||
125297280|NCT01555125|450713965|FG001|Extension|Lack of Efficacy|6|||
125297281|NCT01555125|450713966|FG002|Extension|Lack of Efficacy|3|||
125297282|NCT01555125|450713967|FG003|Extension|Lack of Efficacy|0|||
125297283|NCT01555125|450713968|FG004|Extension|Lack of Efficacy|0|||
125420467|NCT01358968|451163629|FG001|Continued Access Phase|Protocol Violation|0|||
125420468|NCT01358968|451163630|FG002|Continued Access Phase|Protocol Violation|0|||
125420469|NCT01358968|451163631|FG003|Continued Access Phase|Protocol Violation|2|||
125420470|NCT01358968|451163628|FG000|Continued Access Phase|Withdrawal by Subject|0|||
125420471|NCT01358968|451163629|FG001|Continued Access Phase|Withdrawal by Subject|0|||
125420472|NCT01358968|451163630|FG002|Continued Access Phase|Withdrawal by Subject|3|||
125420473|NCT01358968|451163631|FG003|Continued Access Phase|Withdrawal by Subject|0|||
125420474|NCT01358968|451163628|FG000|Continued Access Phase|Death|0|||
125420475|NCT01358968|451163629|FG001|Continued Access Phase|Death|0|||
125420476|NCT01358968|451163630|FG002|Continued Access Phase|Death|1|||
125420477|NCT01358968|451163631|FG003|Continued Access Phase|Death|1|||
125420478|NCT00868439|451163640|FG000|Overall Study|Adverse Event|4|||
125420479|NCT00868439|451163641|FG001|Overall Study|Adverse Event|3|||
125420480|NCT00868439|451163640|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
125420481|NCT00868439|451163641|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
125420482|NCT00868439|451163640|FG000|Overall Study|Death|0|||
125420483|NCT00868439|451163641|FG001|Overall Study|Death|1|||
125420484|NCT00868439|451163640|FG000|Overall Study|Protocol Violation|1|||
125420485|NCT00868439|451163641|FG001|Overall Study|Protocol Violation|1|||
125420486|NCT00868439|451163640|FG000|Overall Study|Physician Decision|1|||
125420487|NCT00868439|451163641|FG001|Overall Study|Physician Decision|0|||
125420488|NCT00868439|451163640|FG000|Overall Study|Withdrawal by Subject|0|||
125420489|NCT00868439|451163641|FG001|Overall Study|Withdrawal by Subject|1|||
125420490|NCT00476476|451163642|FG000|Overall Study|Adverse Event|2|||
125420491|NCT00476476|451163643|FG001|Overall Study|Adverse Event|7|||
125420492|NCT00476476|451163642|FG000|Overall Study|Progressive Disease|0|||
125420493|NCT00476476|451163643|FG001|Overall Study|Progressive Disease|17|||
125420494|NCT00971048|451163648|FG000|Overall Study|Protocol Violation|1|||
125420495|NCT00971048|451163649|FG001|Overall Study|Protocol Violation|2|||
125420496|NCT00971048|451163650|FG002|Overall Study|Protocol Violation|0|||
125420497|NCT00971048|451163651|FG003|Overall Study|Protocol Violation|1|||
125420498|NCT00971048|451163648|FG000|Overall Study|Adverse Event|0|||
125420499|NCT00971048|451163649|FG001|Overall Study|Adverse Event|0|||
125420500|NCT00971048|451163650|FG002|Overall Study|Adverse Event|1|||
125420501|NCT00971048|451163651|FG003|Overall Study|Adverse Event|0|||
125420502|NCT00971048|451163648|FG000|Overall Study|Physician Decision|0|||
125420503|NCT00971048|451163649|FG001|Overall Study|Physician Decision|0|||
125420504|NCT00971048|451163650|FG002|Overall Study|Physician Decision|0|||
125420505|NCT00971048|451163651|FG003|Overall Study|Physician Decision|1|||
125420506|NCT03321396|451163659|FG000|Overall Study|Physician Decision|1|||
125420507|NCT01540851|451163663|FG000|Overall Study|Lost to Follow-up|14|||
125420508|NCT01540851|451163664|FG001|Overall Study|Lost to Follow-up|15|||
125420509|NCT01540851|451163663|FG000|Overall Study|Withdrawal by Subject|7|||
125467444|NCT02723955|451342440|FG035|Expansion Phase|Physician Decision|0|||
125467445|NCT02723955|451342441|FG036|Expansion Phase|Physician Decision|0|||
125467446|NCT02723955|451342442|FG037|Expansion Phase|Physician Decision|0|||
125467447|NCT02723955|451342443|FG038|Expansion Phase|Physician Decision|0|||
125467448|NCT02723955|451342444|FG039|Expansion Phase|Physician Decision|0|||
125467449|NCT02723955|451342445|FG040|Expansion Phase|Physician Decision|0|||
125467450|NCT02723955|451342446|FG041|Expansion Phase|Physician Decision|0|||
125467451|NCT02723955|451342447|FG042|Expansion Phase|Physician Decision|0|||
125467452|NCT02723955|451342405|FG000|Expansion Phase|Withdrawal by Subject|0|||
125467453|NCT02723955|451342406|FG001|Expansion Phase|Withdrawal by Subject|0|||
125467454|NCT02723955|451342407|FG002|Expansion Phase|Withdrawal by Subject|0|||
125467455|NCT02723955|451342408|FG003|Expansion Phase|Withdrawal by Subject|0|||
125467456|NCT02723955|451342409|FG004|Expansion Phase|Withdrawal by Subject|0|||
125467457|NCT02723955|451342410|FG005|Expansion Phase|Withdrawal by Subject|0|||
125467458|NCT02723955|451342411|FG006|Expansion Phase|Withdrawal by Subject|0|||
125467459|NCT02723955|451342412|FG007|Expansion Phase|Withdrawal by Subject|0|||
125467460|NCT02723955|451342413|FG008|Expansion Phase|Withdrawal by Subject|0|||
125467461|NCT02723955|451342414|FG009|Expansion Phase|Withdrawal by Subject|2|||
125467462|NCT02723955|451342415|FG010|Expansion Phase|Withdrawal by Subject|1|||
125467463|NCT02723955|451342416|FG011|Expansion Phase|Withdrawal by Subject|0|||
125467464|NCT02723955|451342417|FG012|Expansion Phase|Withdrawal by Subject|0|||
125467465|NCT02723955|451342418|FG013|Expansion Phase|Withdrawal by Subject|0|||
125467466|NCT02723955|451342419|FG014|Expansion Phase|Withdrawal by Subject|0|||
125467467|NCT02723955|451342420|FG015|Expansion Phase|Withdrawal by Subject|0|||
125467468|NCT02723955|451342421|FG016|Expansion Phase|Withdrawal by Subject|0|||
125467469|NCT02723955|451342422|FG017|Expansion Phase|Withdrawal by Subject|0|||
125467470|NCT02723955|451342423|FG018|Expansion Phase|Withdrawal by Subject|0|||
125467471|NCT02723955|451342424|FG019|Expansion Phase|Withdrawal by Subject|0|||
125467472|NCT02723955|451342425|FG020|Expansion Phase|Withdrawal by Subject|0|||
125467473|NCT02723955|451342426|FG021|Expansion Phase|Withdrawal by Subject|0|||
125467474|NCT02723955|451342427|FG022|Expansion Phase|Withdrawal by Subject|0|||
125467475|NCT02723955|451342428|FG023|Expansion Phase|Withdrawal by Subject|0|||
125467476|NCT02723955|451342429|FG024|Expansion Phase|Withdrawal by Subject|0|||
125467477|NCT02723955|451342430|FG025|Expansion Phase|Withdrawal by Subject|0|||
125467478|NCT02723955|451342431|FG026|Expansion Phase|Withdrawal by Subject|0|||
125467479|NCT02723955|451342432|FG027|Expansion Phase|Withdrawal by Subject|0|||
125467480|NCT02723955|451342433|FG028|Expansion Phase|Withdrawal by Subject|0|||
125467481|NCT02723955|451342434|FG029|Expansion Phase|Withdrawal by Subject|0|||
125467482|NCT02723955|451342435|FG030|Expansion Phase|Withdrawal by Subject|8|||
125467483|NCT02723955|451342436|FG031|Expansion Phase|Withdrawal by Subject|4|||
125467484|NCT02723955|451342437|FG032|Expansion Phase|Withdrawal by Subject|0|||
125467485|NCT02723955|451342438|FG033|Expansion Phase|Withdrawal by Subject|0|||
125467486|NCT02723955|451342439|FG034|Expansion Phase|Withdrawal by Subject|0|||
125467487|NCT02723955|451342440|FG035|Expansion Phase|Withdrawal by Subject|1|||
125467488|NCT02723955|451342441|FG036|Expansion Phase|Withdrawal by Subject|0|||
125297284|NCT01555125|450713964|FG000|Extension|Lost to Follow-up|2|||
125297285|NCT01555125|450713965|FG001|Extension|Lost to Follow-up|1|||
125297286|NCT01555125|450713966|FG002|Extension|Lost to Follow-up|2|||
125297287|NCT01555125|450713967|FG003|Extension|Lost to Follow-up|0|||
125297288|NCT01555125|450713968|FG004|Extension|Lost to Follow-up|0|||
125297289|NCT01555125|450713964|FG000|Extension|Study terminated by sponsor|32|||
125297290|NCT01555125|450713965|FG001|Extension|Study terminated by sponsor|33|||
125297291|NCT01555125|450713966|FG002|Extension|Study terminated by sponsor|16|||
125297292|NCT01555125|450713967|FG003|Extension|Study terminated by sponsor|20|||
125297293|NCT01555125|450713968|FG004|Extension|Study terminated by sponsor|0|||
125297294|NCT01555125|450713964|FG000|Extension|Subject/guardian decision|1|||
125297295|NCT01555125|450713965|FG001|Extension|Subject/guardian decision|9|||
125297296|NCT01555125|450713966|FG002|Extension|Subject/guardian decision|1|||
125297297|NCT01555125|450713967|FG003|Extension|Subject/guardian decision|0|||
125297298|NCT01555125|450713968|FG004|Extension|Subject/guardian decision|0|||
125297299|NCT01555125|450713964|FG000|Extension|Technical Problems|1|||
125297300|NCT01555125|450713965|FG001|Extension|Technical Problems|0|||
125297301|NCT01555125|450713966|FG002|Extension|Technical Problems|0|||
125297302|NCT01555125|450713967|FG003|Extension|Technical Problems|1|||
125467489|NCT02723955|451342442|FG037|Expansion Phase|Withdrawal by Subject|0|||
125467490|NCT02723955|451342443|FG038|Expansion Phase|Withdrawal by Subject|0|||
125467491|NCT02723955|451342444|FG039|Expansion Phase|Withdrawal by Subject|0|||
125467492|NCT02723955|451342445|FG040|Expansion Phase|Withdrawal by Subject|0|||
125467493|NCT02723955|451342446|FG041|Expansion Phase|Withdrawal by Subject|0|||
125467494|NCT02723955|451342447|FG042|Expansion Phase|Withdrawal by Subject|0|||
125467495|NCT02723955|451342405|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467496|NCT02723955|451342406|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125297303|NCT01555125|450713968|FG004|Extension|Technical Problems|0|||
125297304|NCT01555125|450713964|FG000|Follow-Up Period|Lost to Follow-up|1|||
125297305|NCT01555125|450713965|FG001|Follow-Up Period|Lost to Follow-up|0|||
125467497|NCT02723955|451342407|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467498|NCT02723955|451342408|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467499|NCT02723955|451342409|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467500|NCT02723955|451342410|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467501|NCT02723955|451342411|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467502|NCT02723955|451342412|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467503|NCT02723955|451342413|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467504|NCT02723955|451342414|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
125467505|NCT02723955|451342415|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
125467506|NCT02723955|451342416|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
125467507|NCT02723955|451342417|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467508|NCT02723955|451342418|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467509|NCT02723955|451342419|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467510|NCT02723955|451342420|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467511|NCT02723955|451342421|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467512|NCT02723955|451342422|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467513|NCT02723955|451342423|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467514|NCT02723955|451342424|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467515|NCT02723955|451342425|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467516|NCT02723955|451342426|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467517|NCT02723955|451342427|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467518|NCT02723955|451342428|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467519|NCT02723955|451342429|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467520|NCT02723955|451342430|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467521|NCT02723955|451342431|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467522|NCT02723955|451342432|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467523|NCT02723955|451342433|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467524|NCT02723955|451342434|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467525|NCT02723955|451342435|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
125467526|NCT02723955|451342436|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467527|NCT02723955|451342437|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467528|NCT02723955|451342438|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467529|NCT02723955|451342439|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467530|NCT02723955|451342440|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467531|NCT02723955|451342441|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467532|NCT02723955|451342442|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467533|NCT02723955|451342443|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467534|NCT02723955|451342444|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467535|NCT02723955|451342445|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467536|NCT02723955|451342446|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467537|NCT02723955|451342447|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
125467538|NCT02723955|451342405|FG000|Expansion Phase|Site Closed|0|||
125467539|NCT02723955|451342406|FG001|Expansion Phase|Site Closed|0|||
125467540|NCT02723955|451342407|FG002|Expansion Phase|Site Closed|0|||
125467541|NCT02723955|451342408|FG003|Expansion Phase|Site Closed|0|||
125467542|NCT02723955|451342409|FG004|Expansion Phase|Site Closed|0|||
125467543|NCT02723955|451342410|FG005|Expansion Phase|Site Closed|0|||
125467544|NCT02723955|451342411|FG006|Expansion Phase|Site Closed|0|||
125467545|NCT02723955|451342412|FG007|Expansion Phase|Site Closed|0|||
125467546|NCT02723955|451342413|FG008|Expansion Phase|Site Closed|0|||
125467547|NCT02723955|451342414|FG009|Expansion Phase|Site Closed|1|||
125467548|NCT02723955|451342415|FG010|Expansion Phase|Site Closed|2|||
125467549|NCT02723955|451342416|FG011|Expansion Phase|Site Closed|6|||
125467550|NCT02723955|451342417|FG012|Expansion Phase|Site Closed|0|||
125467551|NCT02723955|451342418|FG013|Expansion Phase|Site Closed|0|||
125297306|NCT01555125|450713966|FG002|Follow-Up Period|Lost to Follow-up|0|||
125297307|NCT01555125|450713967|FG003|Follow-Up Period|Lost to Follow-up|0|||
125467552|NCT02723955|451342419|FG014|Expansion Phase|Site Closed|0|||
125467553|NCT02723955|451342420|FG015|Expansion Phase|Site Closed|0|||
125467554|NCT02723955|451342421|FG016|Expansion Phase|Site Closed|0|||
125467555|NCT02723955|451342422|FG017|Expansion Phase|Site Closed|0|||
125467556|NCT02723955|451342423|FG018|Expansion Phase|Site Closed|0|||
125467557|NCT02723955|451342424|FG019|Expansion Phase|Site Closed|0|||
125467558|NCT02723955|451342425|FG020|Expansion Phase|Site Closed|0|||
125467559|NCT02723955|451342426|FG021|Expansion Phase|Site Closed|0|||
125467560|NCT02723955|451342427|FG022|Expansion Phase|Site Closed|0|||
125467561|NCT02723955|451342428|FG023|Expansion Phase|Site Closed|0|||
125297308|NCT01555125|450713968|FG004|Follow-Up Period|Lost to Follow-up|0|||
125297309|NCT01555125|450713964|FG000|Follow-Up Period|Subject / guardian decision|3|||
125297310|NCT01555125|450713965|FG001|Follow-Up Period|Subject / guardian decision|1|||
125297311|NCT01555125|450713966|FG002|Follow-Up Period|Subject / guardian decision|1|||
125467562|NCT02723955|451342429|FG024|Expansion Phase|Site Closed|0|||
125467563|NCT02723955|451342430|FG025|Expansion Phase|Site Closed|0|||
125467564|NCT02723955|451342431|FG026|Expansion Phase|Site Closed|0|||
125467565|NCT02723955|451342432|FG027|Expansion Phase|Site Closed|0|||
125467566|NCT02723955|451342433|FG028|Expansion Phase|Site Closed|0|||
125467567|NCT02723955|451342434|FG029|Expansion Phase|Site Closed|0|||
125467568|NCT02723955|451342435|FG030|Expansion Phase|Site Closed|8|||
125467569|NCT02723955|451342436|FG031|Expansion Phase|Site Closed|4|||
125467570|NCT02723955|451342437|FG032|Expansion Phase|Site Closed|2|||
125467571|NCT02723955|451342438|FG033|Expansion Phase|Site Closed|2|||
125467572|NCT02723955|451342439|FG034|Expansion Phase|Site Closed|0|||
125467573|NCT02723955|451342440|FG035|Expansion Phase|Site Closed|0|||
125467574|NCT02723955|451342441|FG036|Expansion Phase|Site Closed|0|||
125467575|NCT02723955|451342442|FG037|Expansion Phase|Site Closed|0|||
125467576|NCT02723955|451342443|FG038|Expansion Phase|Site Closed|0|||
125467577|NCT02723955|451342444|FG039|Expansion Phase|Site Closed|0|||
125467578|NCT02723955|451342445|FG040|Expansion Phase|Site Closed|0|||
125467579|NCT02723955|451342446|FG041|Expansion Phase|Site Closed|0|||
125467580|NCT02723955|451342447|FG042|Expansion Phase|Site Closed|0|||
125467581|NCT02723955|451342405|FG000|Crossover/ Re-treatment Phase|Death|0|||
125467582|NCT02723955|451342406|FG001|Crossover/ Re-treatment Phase|Death|0|||
125467583|NCT02723955|451342407|FG002|Crossover/ Re-treatment Phase|Death|0|||
125467584|NCT02723955|451342408|FG003|Crossover/ Re-treatment Phase|Death|0|||
125467585|NCT02723955|451342409|FG004|Crossover/ Re-treatment Phase|Death|0|||
125467586|NCT02723955|451342410|FG005|Crossover/ Re-treatment Phase|Death|0|||
125467587|NCT02723955|451342411|FG006|Crossover/ Re-treatment Phase|Death|0|||
125467588|NCT02723955|451342412|FG007|Crossover/ Re-treatment Phase|Death|0|||
125467589|NCT02723955|451342413|FG008|Crossover/ Re-treatment Phase|Death|0|||
125467590|NCT02723955|451342414|FG009|Crossover/ Re-treatment Phase|Death|0|||
125467591|NCT02723955|451342415|FG010|Crossover/ Re-treatment Phase|Death|0|||
125467592|NCT02723955|451342416|FG011|Crossover/ Re-treatment Phase|Death|0|||
125467593|NCT02723955|451342417|FG012|Crossover/ Re-treatment Phase|Death|0|||
125467594|NCT02723955|451342418|FG013|Crossover/ Re-treatment Phase|Death|0|||
125297312|NCT01555125|450713967|FG003|Follow-Up Period|Subject / guardian decision|1|||
125297313|NCT01555125|450713968|FG004|Follow-Up Period|Subject / guardian decision|0|||
125297314|NCT02651220|450713969|FG000|Overall Study|Adverse Event|1|||
125297315|NCT02651220|450713970|FG001|Overall Study|Adverse Event|5|||
125297316|NCT02651220|450713971|FG002|Overall Study|Adverse Event|1|||
125297317|NCT02651220|450713969|FG000|Overall Study|Lost to Follow-up|8|||
125297318|NCT02651220|450713970|FG001|Overall Study|Lost to Follow-up|14|||
125297319|NCT02651220|450713971|FG002|Overall Study|Lost to Follow-up|14|||
125297320|NCT02651220|450713969|FG000|Overall Study|Non-Compliance with Study Drug|4|||
125297321|NCT02651220|450713970|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125297322|NCT02651220|450713971|FG002|Overall Study|Non-Compliance with Study Drug|1|||
125297323|NCT02651220|450713969|FG000|Overall Study|Pregnancy|1|||
125297324|NCT02651220|450713970|FG001|Overall Study|Pregnancy|0|||
125297325|NCT02651220|450713971|FG002|Overall Study|Pregnancy|1|||
125297326|NCT02651220|450713969|FG000|Overall Study|Protocol Violation|0|||
125297327|NCT02651220|450713970|FG001|Overall Study|Protocol Violation|0|||
125297328|NCT02651220|450713971|FG002|Overall Study|Protocol Violation|1|||
125297329|NCT02651220|450713969|FG000|Overall Study|Withdrawal by Subject|5|||
125297330|NCT02651220|450713970|FG001|Overall Study|Withdrawal by Subject|6|||
125297331|NCT02651220|450713971|FG002|Overall Study|Withdrawal by Subject|8|||
125297332|NCT02651220|450713969|FG000|Overall Study|Miscellaneous|4|||
125297333|NCT02651220|450713970|FG001|Overall Study|Miscellaneous|1|||
125297334|NCT02651220|450713971|FG002|Overall Study|Miscellaneous|2|||
125297335|NCT02651220|450713969|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125297336|NCT02651220|450713970|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125467595|NCT02723955|451342419|FG014|Crossover/ Re-treatment Phase|Death|0|||
125467596|NCT02723955|451342420|FG015|Crossover/ Re-treatment Phase|Death|0|||
125467597|NCT02723955|451342421|FG016|Crossover/ Re-treatment Phase|Death|0|||
125467598|NCT02723955|451342422|FG017|Crossover/ Re-treatment Phase|Death|0|||
125467599|NCT02723955|451342423|FG018|Crossover/ Re-treatment Phase|Death|0|||
125467600|NCT02723955|451342424|FG019|Crossover/ Re-treatment Phase|Death|0|||
125297337|NCT02651220|450713971|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
125297338|NCT00279812|450713976|FG000|Overall Study|Protocol Violation|1|||
125297339|NCT00279812|450713977|FG001|Overall Study|Protocol Violation|1|||
125297340|NCT00279812|450713978|FG002|Overall Study|Protocol Violation|0|||
125297341|NCT00279812|450713979|FG003|Overall Study|Protocol Violation|0|||
125297342|NCT00279812|450713980|FG004|Overall Study|Protocol Violation|1|||
125297343|NCT00279812|450713981|FG005|Overall Study|Protocol Violation|0|||
125297344|NCT00279812|450713976|FG000|Overall Study|Withdrawal by Subject|0|||
125297345|NCT00279812|450713977|FG001|Overall Study|Withdrawal by Subject|4|||
125297346|NCT00279812|450713978|FG002|Overall Study|Withdrawal by Subject|2|||
125297347|NCT00279812|450713979|FG003|Overall Study|Withdrawal by Subject|0|||
125297348|NCT00279812|450713980|FG004|Overall Study|Withdrawal by Subject|0|||
125297349|NCT00279812|450713981|FG005|Overall Study|Withdrawal by Subject|0|||
125297350|NCT00279812|450713976|FG000|Overall Study|Adverse Event|0|||
125297351|NCT00279812|450713977|FG001|Overall Study|Adverse Event|1|||
125297352|NCT00279812|450713978|FG002|Overall Study|Adverse Event|1|||
125297353|NCT00279812|450713979|FG003|Overall Study|Adverse Event|0|||
125297354|NCT00279812|450713980|FG004|Overall Study|Adverse Event|2|||
125297355|NCT00279812|450713981|FG005|Overall Study|Adverse Event|1|||
125297356|NCT01274429|450713982|FG000|Overall Study|Study closed do to lack of funding|5|||
125297357|NCT01879072|450713990|FG000|Overall Study|Withdrawal by Subject|121|||
125297358|NCT01879072|450713990|FG000|Overall Study|Not Transplanted|30|||
125297359|NCT05327361|450713991|FG000|Overall Study|Lost to Follow-up|4|||
125297360|NCT01439373|450714001|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
125297361|NCT01439373|450714002|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
125297362|NCT01439373|450714001|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
125297363|NCT01439373|450714002|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
125297364|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
125297365|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
125297366|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
125297367|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
125297368|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
125297369|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
125297370|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
125297371|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
125297372|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Death|0|||
125297373|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Death|1|||
125297374|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
125297375|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
125297376|NCT03281304|450714003|FG000|Treatment Phase (up to 42 Months)|Other|0|||
125297377|NCT03281304|450714004|FG001|Treatment Phase (up to 42 Months)|Other|2|||
125420510|NCT01540851|451163664|FG001|Overall Study|Withdrawal by Subject|3|||
125420511|NCT01654549|451163665|FG000|Overall Study|H.pylori eradication not successful|0|||
125420512|NCT01654549|451163666|FG001|Overall Study|H.pylori eradication not successful|1|||
125420513|NCT00937924|451163669|FG000|Overall Study|Lost to Follow-up|44|||
125420514|NCT00937924|451163670|FG001|Overall Study|Lost to Follow-up|44|||
125420515|NCT00937924|451163671|FG002|Overall Study|Lost to Follow-up|41|||
125420516|NCT00224874|451163672|FG000|Overall Study|Withdrawal by Subject|0|||
125420517|NCT00224874|451163673|FG001|Overall Study|Withdrawal by Subject|0|||
125420518|NCT00224874|451163674|FG002|Overall Study|Withdrawal by Subject|1|||
125420519|NCT00224874|451163675|FG003|Overall Study|Withdrawal by Subject|0|||
125420520|NCT02633137|451163680|FG000|Overall Study|Adverse Event|1|||
125420521|NCT02633137|451163680|FG000|Overall Study|Lack of Efficacy|2|||
125420522|NCT02633137|451163680|FG000|Overall Study|Withdrawal by Subject|1|||
125420523|NCT01324271|451163683|FG000|Overall Study|Lost to Follow-up|3|||
125420524|NCT01324271|451163684|FG001|Overall Study|Lost to Follow-up|0|||
125420525|NCT01324271|451163683|FG000|Overall Study|Physician Decision|1|||
125420526|NCT01324271|451163684|FG001|Overall Study|Physician Decision|0|||
125420527|NCT05130970|451163685|FG000|Overall Study|Adverse Event|1|||
125420528|NCT05130970|451163686|FG001|Overall Study|Adverse Event|1|||
125420529|NCT05130970|451163685|FG000|Overall Study|Death|0|||
125420530|NCT05130970|451163686|FG001|Overall Study|Death|1|||
125420531|NCT05130970|451163685|FG000|Overall Study|Lost to Follow-up|0|||
125420532|NCT05130970|451163686|FG001|Overall Study|Lost to Follow-up|1|||
125420533|NCT05130970|451163685|FG000|Overall Study|Physician Decision|0|||
125420534|NCT05130970|451163686|FG001|Overall Study|Physician Decision|1|||
125420535|NCT05130970|451163685|FG000|Overall Study|Withdrawal by Subject|1|||
125420536|NCT05130970|451163686|FG001|Overall Study|Withdrawal by Subject|1|||
125420537|NCT01371851|451163689|FG000|Overall Study|Lost to Follow-up|5|||
125420538|NCT01371851|451163690|FG001|Overall Study|Lost to Follow-up|8|||
125420539|NCT01371851|451163689|FG000|Overall Study|was arrested and put in jail|0|||
125420540|NCT01371851|451163690|FG001|Overall Study|was arrested and put in jail|1|||
125420541|NCT01371851|451163689|FG000|Overall Study|non study related adverse event|1|||
125420542|NCT01371851|451163690|FG001|Overall Study|non study related adverse event|0|||
125420543|NCT01371851|451163689|FG000|Overall Study|Blood Pressure outside study parameters|2|||
125467601|NCT02723955|451342425|FG020|Crossover/ Re-treatment Phase|Death|0|||
125467602|NCT02723955|451342426|FG021|Crossover/ Re-treatment Phase|Death|0|||
125467603|NCT02723955|451342427|FG022|Crossover/ Re-treatment Phase|Death|0|||
125467604|NCT02723955|451342428|FG023|Crossover/ Re-treatment Phase|Death|0|||
125467605|NCT02723955|451342429|FG024|Crossover/ Re-treatment Phase|Death|0|||
125467606|NCT02723955|451342430|FG025|Crossover/ Re-treatment Phase|Death|0|||
125467607|NCT02723955|451342431|FG026|Crossover/ Re-treatment Phase|Death|0|||
125467608|NCT02723955|451342432|FG027|Crossover/ Re-treatment Phase|Death|0|||
125467609|NCT02723955|451342433|FG028|Crossover/ Re-treatment Phase|Death|0|||
125467610|NCT02723955|451342434|FG029|Crossover/ Re-treatment Phase|Death|0|||
125467611|NCT02723955|451342435|FG030|Crossover/ Re-treatment Phase|Death|0|||
125467612|NCT02723955|451342436|FG031|Crossover/ Re-treatment Phase|Death|0|||
125467613|NCT02723955|451342437|FG032|Crossover/ Re-treatment Phase|Death|0|||
125467614|NCT02723955|451342438|FG033|Crossover/ Re-treatment Phase|Death|0|||
125467615|NCT02723955|451342439|FG034|Crossover/ Re-treatment Phase|Death|0|||
125467616|NCT02723955|451342440|FG035|Crossover/ Re-treatment Phase|Death|0|||
125467617|NCT02723955|451342441|FG036|Crossover/ Re-treatment Phase|Death|0|||
125467618|NCT02723955|451342442|FG037|Crossover/ Re-treatment Phase|Death|1|||
125467619|NCT02723955|451342443|FG038|Crossover/ Re-treatment Phase|Death|14|||
125467620|NCT02723955|451342444|FG039|Crossover/ Re-treatment Phase|Death|32|||
125467621|NCT02723955|451342445|FG040|Crossover/ Re-treatment Phase|Death|2|||
125467622|NCT02723955|451342446|FG041|Crossover/ Re-treatment Phase|Death|1|||
125467623|NCT02723955|451342447|FG042|Crossover/ Re-treatment Phase|Death|0|||
125467624|NCT02723955|451342405|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467625|NCT02723955|451342406|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467626|NCT02723955|451342407|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467627|NCT02723955|451342408|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467628|NCT02723955|451342409|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467629|NCT02723955|451342410|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467630|NCT02723955|451342411|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467631|NCT02723955|451342412|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467632|NCT02723955|451342413|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467633|NCT02723955|451342414|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467634|NCT02723955|451342415|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467635|NCT02723955|451342416|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467636|NCT02723955|451342417|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467637|NCT02723955|451342418|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467638|NCT02723955|451342419|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467639|NCT02723955|451342420|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467640|NCT02723955|451342421|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467641|NCT02723955|451342422|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467642|NCT02723955|451342423|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467643|NCT02723955|451342424|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467644|NCT02723955|451342425|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467645|NCT02723955|451342426|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467646|NCT02723955|451342427|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467647|NCT02723955|451342428|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467648|NCT02723955|451342429|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467649|NCT02723955|451342430|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467650|NCT02723955|451342431|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467651|NCT02723955|451342432|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467652|NCT02723955|451342433|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467653|NCT02723955|451342434|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467654|NCT02723955|451342435|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467655|NCT02723955|451342436|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467656|NCT02723955|451342437|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467657|NCT02723955|451342438|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467658|NCT02723955|451342439|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467659|NCT02723955|451342440|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467660|NCT02723955|451342441|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467661|NCT02723955|451342442|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467662|NCT02723955|451342443|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467663|NCT02723955|451342444|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
125467664|NCT02723955|451342445|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467665|NCT02723955|451342446|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467666|NCT02723955|451342447|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
125467667|NCT02723955|451342405|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467668|NCT02723955|451342406|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467669|NCT02723955|451342407|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467670|NCT02723955|451342408|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467671|NCT02723955|451342409|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467672|NCT02723955|451342410|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467673|NCT02723955|451342411|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467674|NCT02723955|451342412|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467675|NCT02723955|451342413|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467676|NCT02723955|451342414|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467677|NCT02723955|451342415|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467678|NCT02723955|451342416|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467679|NCT02723955|451342417|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467680|NCT02723955|451342418|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467681|NCT02723955|451342419|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467682|NCT02723955|451342420|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467683|NCT02723955|451342421|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467684|NCT02723955|451342422|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467685|NCT02723955|451342423|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467686|NCT02723955|451342424|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467687|NCT02723955|451342425|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467688|NCT02723955|451342426|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467689|NCT02723955|451342427|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467690|NCT02723955|451342428|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467691|NCT02723955|451342429|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467692|NCT02723955|451342430|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467693|NCT02723955|451342431|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467694|NCT02723955|451342432|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467695|NCT02723955|451342433|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467696|NCT02723955|451342434|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467697|NCT02723955|451342435|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467698|NCT02723955|451342436|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467699|NCT02723955|451342437|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
125297378|NCT03281304|450714003|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
125297379|NCT03281304|450714004|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
125297380|NCT00626405|450714005|FG000|Overall Study|Deemed Ineligible|1|||
125297381|NCT00626405|450714006|FG001|Overall Study|Deemed Ineligible|0|||
125297382|NCT00626405|450714005|FG000|Overall Study|Withdrawal by Subject|0|||
125297383|NCT00626405|450714006|FG001|Overall Study|Withdrawal by Subject|1|||
125297384|NCT03834220|450714007|FG000|Overall Study|Adverse Event|1|||
125297385|NCT03834220|450714008|FG001|Overall Study|Adverse Event|0|||
125297386|NCT03834220|450714009|FG002|Overall Study|Adverse Event|0|||
125297387|NCT03834220|450714007|FG000|Overall Study|Death|8|||
125467700|NCT02723955|451342438|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467701|NCT02723955|451342439|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467702|NCT02723955|451342440|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467703|NCT02723955|451342441|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467704|NCT02723955|451342442|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467705|NCT02723955|451342443|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
125467706|NCT02723955|451342444|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
125467707|NCT02723955|451342445|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467708|NCT02723955|451342446|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
125467709|NCT02723955|451342447|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
125467710|NCT02723955|451342405|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
125467711|NCT02723955|451342406|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
125297388|NCT03834220|450714008|FG001|Overall Study|Death|1|||
125297389|NCT03834220|450714009|FG002|Overall Study|Death|17|||
125297390|NCT03834220|450714007|FG000|Overall Study|Reason not Specified|9|||
125297391|NCT03834220|450714008|FG001|Overall Study|Reason not Specified|0|||
125297392|NCT03834220|450714009|FG002|Overall Study|Reason not Specified|6|||
125297393|NCT03834220|450714007|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
125297394|NCT03834220|450714008|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
125297395|NCT03834220|450714009|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
125297396|NCT03834220|450714007|FG000|Overall Study|Withdrawal of Consent|2|||
125297397|NCT03834220|450714008|FG001|Overall Study|Withdrawal of Consent|2|||
125297398|NCT03834220|450714009|FG002|Overall Study|Withdrawal of Consent|2|||
125297399|NCT02593318|450714010|FG000|Overall Study|Withdrawal by Subject|1|||
125297400|NCT02593318|450714011|FG001|Overall Study|Withdrawal by Subject|1|||
125297401|NCT02720692|450715595|FG000|Overall Study|Withdrawal by Subject|3|||
125297402|NCT02720692|450715596|FG001|Overall Study|Withdrawal by Subject|0|||
125297403|NCT02720692|450715595|FG000|Overall Study|Physician Decision|1|||
125297404|NCT02720692|450715596|FG001|Overall Study|Physician Decision|0|||
125297405|NCT02720692|450715595|FG000|Overall Study|Lost to Follow-up|8|||
125297406|NCT02720692|450715596|FG001|Overall Study|Lost to Follow-up|3|||
125297407|NCT02720692|450715595|FG000|Overall Study|Subject unable to return for visit|1|||
125297408|NCT02720692|450715596|FG001|Overall Study|Subject unable to return for visit|0|||
125297409|NCT05011513|450715597|FG000|Overall Study|Death|0|||
125297410|NCT05011513|450715598|FG001|Overall Study|Death|1|||
125297411|NCT05011513|450715597|FG000|Overall Study|Lost to Follow-up|4|||
125297412|NCT05011513|450715598|FG001|Overall Study|Lost to Follow-up|0|||
125297413|NCT05011513|450715597|FG000|Overall Study|Withdrawal by Subject|18|||
125297414|NCT05011513|450715598|FG001|Overall Study|Withdrawal by Subject|17|||
125297415|NCT05011513|450715597|FG000|Overall Study|Other|4|||
125297416|NCT05011513|450715598|FG001|Overall Study|Other|2|||
125297417|NCT03878758|450715599|FG000|Overall Study|Withdrawal by Subject|1|||
125297418|NCT03878758|450715599|FG000|Overall Study|Protocol defined|2|||
125297419|NCT03878758|450715599|FG000|Overall Study|Improper consent documentation|1|||
125297420|NCT02315560|450715600|FG000|Overall Study|noncompliance by subjects|3|||
125297421|NCT02100969|450715602|FG000|Overall Study|Did not pass screening phase|1|||
125297422|NCT01629953|450715603|FG000|Overall Study|Death|3|||
125297423|NCT01629953|450715604|FG001|Overall Study|Death|1|||
125297424|NCT01629953|450715603|FG000|Overall Study|Lost to Follow-up|10|||
125297425|NCT01629953|450715604|FG001|Overall Study|Lost to Follow-up|14|||
125297426|NCT06359080|450715605|FG000|Overall Study|Withdrawal by Subject|3|||
125297427|NCT00306527|450715608|FG000|Overall Study|Lost to Follow-up|3|||
125297428|NCT00306527|450715609|FG001|Overall Study|Lost to Follow-up|4|||
125297429|NCT00306527|450715610|FG002|Overall Study|Lost to Follow-up|3|||
125297430|NCT00306527|450715611|FG003|Overall Study|Lost to Follow-up|0|||
125297431|NCT00306527|450715608|FG000|Overall Study|Withdrawal by Subject|2|||
125297432|NCT00306527|450715609|FG001|Overall Study|Withdrawal by Subject|3|||
125297433|NCT00306527|450715610|FG002|Overall Study|Withdrawal by Subject|0|||
125297434|NCT00306527|450715611|FG003|Overall Study|Withdrawal by Subject|3|||
125297435|NCT00306527|450715608|FG000|Overall Study|Adverse Event|0|||
125297436|NCT00306527|450715609|FG001|Overall Study|Adverse Event|0|||
125297437|NCT00306527|450715610|FG002|Overall Study|Adverse Event|1|||
125297438|NCT00306527|450715611|FG003|Overall Study|Adverse Event|1|||
125297439|NCT00306527|450715608|FG000|Overall Study|Death|1|||
125297440|NCT00306527|450715609|FG001|Overall Study|Death|0|||
125297441|NCT00306527|450715610|FG002|Overall Study|Death|1|||
125297442|NCT00306527|450715611|FG003|Overall Study|Death|2|||
125297443|NCT04037254|450715612|FG000|Overall Study|Protocol Violation|1|||
125297444|NCT04037254|450715613|FG001|Overall Study|Protocol Violation|0|||
125297445|NCT04037254|450715614|FG002|Overall Study|Protocol Violation|0|||
125297446|NCT04037254|450715615|FG003|Overall Study|Protocol Violation|0|||
125297447|NCT04037254|450715616|FG004|Overall Study|Protocol Violation|0|||
125297448|NCT04037254|450715612|FG000|Overall Study|Withdrawal by Subject|0|||
125297449|NCT04037254|450715613|FG001|Overall Study|Withdrawal by Subject|0|||
125297450|NCT04037254|450715614|FG002|Overall Study|Withdrawal by Subject|1|||
125297451|NCT04037254|450715615|FG003|Overall Study|Withdrawal by Subject|0|||
125297452|NCT04037254|450715616|FG004|Overall Study|Withdrawal by Subject|0|||
125297453|NCT04037254|450715612|FG000|Overall Study|Delayed or incomplete treatment|0|||
125297454|NCT04037254|450715613|FG001|Overall Study|Delayed or incomplete treatment|2|||
125297455|NCT04037254|450715614|FG002|Overall Study|Delayed or incomplete treatment|1|||
125297456|NCT04037254|450715615|FG003|Overall Study|Delayed or incomplete treatment|0|||
125467712|NCT02723955|451342407|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
125467713|NCT02723955|451342408|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
125467714|NCT02723955|451342409|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
125297457|NCT04037254|450715616|FG004|Overall Study|Delayed or incomplete treatment|0|||
125297458|NCT01023672|450715617|FG000|Overall Study|Worsening disease|2|||
125297459|NCT01023672|450715617|FG000|Overall Study|Death|1|||
125297460|NCT02504580|450715618|FG000|Overall Study|Other|1|||
125297461|NCT02504580|450715619|FG001|Overall Study|Other|0|||
125297462|NCT02504580|450715620|FG002|Overall Study|Other|0|||
125297463|NCT02504580|450715621|FG003|Overall Study|Other|2|||
125297464|NCT02504580|450715622|FG004|Overall Study|Other|1|||
125297465|NCT02504580|450715623|FG005|Overall Study|Other|1|||
125297466|NCT02504580|450715624|FG006|Overall Study|Other|1|||
125297467|NCT02504580|450715625|FG007|Overall Study|Other|2|||
125297468|NCT02504580|450715626|FG008|Overall Study|Other|0|||
125297469|NCT02504580|450715627|FG009|Overall Study|Other|0|||
125297470|NCT02504580|450715628|FG010|Overall Study|Other|0|||
125297471|NCT02504580|450715629|FG011|Overall Study|Other|2|||
125297472|NCT02504580|450715618|FG000|Overall Study|Subject refusal to continue|0|||
125297473|NCT02504580|450715619|FG001|Overall Study|Subject refusal to continue|1|||
125297474|NCT02504580|450715620|FG002|Overall Study|Subject refusal to continue|0|||
125297475|NCT02504580|450715621|FG003|Overall Study|Subject refusal to continue|0|||
125297476|NCT02504580|450715622|FG004|Overall Study|Subject refusal to continue|0|||
125297477|NCT02504580|450715623|FG005|Overall Study|Subject refusal to continue|0|||
125297478|NCT02504580|450715624|FG006|Overall Study|Subject refusal to continue|0|||
125420544|NCT01371851|451163690|FG001|Overall Study|Blood Pressure outside study parameters|0|||
125420545|NCT00833638|451163691|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
125420546|NCT00833638|451163692|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
125420547|NCT00833638|451163693|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
125420548|NCT00833638|451163691|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
125420549|NCT00833638|451163692|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
125420550|NCT00833638|451163693|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
125467715|NCT02723955|451342410|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
125297479|NCT02504580|450715625|FG007|Overall Study|Subject refusal to continue|0|||
125297480|NCT02504580|450715626|FG008|Overall Study|Subject refusal to continue|0|||
125297481|NCT02504580|450715627|FG009|Overall Study|Subject refusal to continue|0|||
125467716|NCT02723955|451342411|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
125467717|NCT02723955|451342412|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
125467718|NCT02723955|451342413|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
125467719|NCT02723955|451342414|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
125467720|NCT02723955|451342415|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
125467721|NCT02723955|451342416|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
125467722|NCT02723955|451342417|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
125467723|NCT02723955|451342418|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
125467724|NCT02723955|451342419|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
125467725|NCT02723955|451342420|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
125467726|NCT02723955|451342421|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
125467727|NCT02723955|451342422|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
125467728|NCT02723955|451342423|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
125467729|NCT02723955|451342424|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
125467730|NCT02723955|451342425|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
125467731|NCT02723955|451342426|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
125467732|NCT02723955|451342427|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
125467733|NCT02723955|451342428|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
125467734|NCT02723955|451342429|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
125467735|NCT02723955|451342430|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
125467736|NCT02723955|451342431|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
125467737|NCT02723955|451342432|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
125467738|NCT02723955|451342433|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
125467739|NCT02723955|451342434|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
125467740|NCT02723955|451342435|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
125467741|NCT02723955|451342436|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
125467742|NCT02723955|451342437|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
125467743|NCT02723955|451342438|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
125467744|NCT02723955|451342439|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
125467745|NCT02723955|451342440|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
125467746|NCT02723955|451342441|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
125467747|NCT02723955|451342442|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
125467748|NCT02723955|451342443|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
125467749|NCT02723955|451342444|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
125467750|NCT02723955|451342445|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
125467751|NCT02723955|451342446|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
125467752|NCT02723955|451342447|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
125467753|NCT04300647|451342448|FG000|Pre-Crossover|Death|19|||
125467754|NCT04300647|451342449|FG001|Pre-Crossover|Death|58|||
125467755|NCT04300647|451342450|FG002|Pre-Crossover|Death|0|||
125467756|NCT04300647|451342448|FG000|Pre-Crossover|Lost to Follow-up|0|||
125467757|NCT04300647|451342449|FG001|Pre-Crossover|Lost to Follow-up|3|||
125467758|NCT04300647|451342450|FG002|Pre-Crossover|Lost to Follow-up|0|||
125467759|NCT04300647|451342448|FG000|Pre-Crossover|Withdrawal by Subject|2|||
125467760|NCT04300647|451342449|FG001|Pre-Crossover|Withdrawal by Subject|4|||
125467761|NCT04300647|451342450|FG002|Pre-Crossover|Withdrawal by Subject|0|||
125467762|NCT04300647|451342448|FG000|Pre-Crossover|On-going in Study|24|||
125467763|NCT04300647|451342449|FG001|Pre-Crossover|On-going in Study|61|||
125467764|NCT04300647|451342450|FG002|Pre-Crossover|On-going in Study|0|||
125467765|NCT04300647|451342448|FG000|Post-Crossover|Death|0|||
125467766|NCT04300647|451342449|FG001|Post-Crossover|Death|0|||
125467767|NCT04300647|451342450|FG002|Post-Crossover|Death|3|||
125467768|NCT04300647|451342448|FG000|Post-Crossover|Lost to Follow-up|0|||
125467769|NCT04300647|451342449|FG001|Post-Crossover|Lost to Follow-up|0|||
125467770|NCT04300647|451342450|FG002|Post-Crossover|Lost to Follow-up|1|||
125467771|NCT04300647|451342448|FG000|Post-Crossover|Withdrawal by Subject|0|||
125467772|NCT04300647|451342449|FG001|Post-Crossover|Withdrawal by Subject|0|||
125467773|NCT04300647|451342450|FG002|Post-Crossover|Withdrawal by Subject|1|||
125467774|NCT04300647|451342448|FG000|Post-Crossover|On-going in Study|0|||
125467775|NCT04300647|451342449|FG001|Post-Crossover|On-going in Study|0|||
125467776|NCT04300647|451342450|FG002|Post-Crossover|On-going in Study|8|||
125467777|NCT02824029|451342453|FG000|Overall Study|Didn't receive treatment|2|||
125467778|NCT02824029|451342453|FG000|Overall Study|Patient decision to discontinue treatment|3|||
125467779|NCT02824029|451342453|FG000|Overall Study|Non-compliant|5|||
125297482|NCT02504580|450715628|FG010|Overall Study|Subject refusal to continue|0|||
125467780|NCT02824029|451342453|FG000|Overall Study|Progression of disease|15|||
125467781|NCT02824029|451342453|FG000|Overall Study|Inadequate response to therapy|2|||
125467782|NCT02824029|451342453|FG000|Overall Study|Possible progression per treating physician|1|||
125467783|NCT01693120|451342458|FG000|Enrollment|Lost to Follow-up|1|||
125467784|NCT01693120|451342458|FG000|Enrollment|Withdrawal by Subject|10|||
125467785|NCT01693120|451342458|FG000|Enrollment|Protocol Violation|46|||
125467786|NCT01693120|451342458|FG000|Enrollment|Physician Decision|3|||
125467787|NCT01693120|451342458|FG000|Enrollment|Adverse Event|1|||
125467788|NCT01693120|451342458|FG000|Enrollment|Study closed|8|||
125467789|NCT01693120|451342458|FG000|Enrollment|Other|1|||
125467790|NCT01693120|451342458|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
125467791|NCT01693120|451342458|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
125467792|NCT01693120|451342458|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
125297483|NCT02504580|450715629|FG011|Overall Study|Subject refusal to continue|0|||
125297484|NCT00448747|450715630|FG000|Overall Study|collapsed veins|1|||
125297485|NCT00448747|450715631|FG001|Overall Study|collapsed veins|0|||
125297486|NCT02429791|450715634|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
125297487|NCT02429791|450715635|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
125297488|NCT02429791|450715634|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
125297489|NCT02429791|450715635|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
125297490|NCT02429791|450715634|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
125297491|NCT02429791|450715635|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
125297492|NCT02429791|450715634|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
125467793|NCT01693120|451342458|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
125467794|NCT01693120|451342458|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
125467795|NCT04153565|451342459|FG000|Overall Study|Death|13|||
125467796|NCT03990649|451342469|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
125467797|NCT03990649|451342470|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
125467798|NCT03990649|451342471|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
125467799|NCT03990649|451342469|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
125467800|NCT03990649|451342470|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
125467801|NCT03990649|451342471|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
125467802|NCT03990649|451342469|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
125467803|NCT03990649|451342470|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
125467804|NCT03990649|451342471|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
125467805|NCT03990649|451342469|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
125467806|NCT03990649|451342470|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
125467807|NCT03990649|451342471|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
125467808|NCT03990649|451342469|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
125467809|NCT03990649|451342470|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
125467810|NCT03990649|451342471|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
125467811|NCT03990649|451342469|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
125467812|NCT03990649|451342470|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
125467813|NCT03990649|451342471|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
125467814|NCT03990649|451342469|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
125467815|NCT03990649|451342470|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
125467816|NCT03990649|451342471|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
125467817|NCT00505934|451342472|FG000|Overall Study|Adverse Event|1|||
125467818|NCT00505934|451342472|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
125467819|NCT00505934|451342472|FG000|Overall Study|Other: IV dose needed to be changed|1|||
125467820|NCT03050814|451342475|FG000|Overall Study|Screen failures|0|||
125467821|NCT03050814|451342476|FG001|Overall Study|Screen failures|0|||
125467822|NCT03050814|451342477|FG002|Overall Study|Screen failures|4|||
125467823|NCT01443845|451342478|FG000|Overall Study|Protocol Violation|43|||
125467824|NCT01443845|451342479|FG001|Overall Study|Protocol Violation|45|||
125467825|NCT01443845|451342478|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
125467826|NCT01443845|451342479|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
125467827|NCT01443845|451342478|FG000|Overall Study|Deterioration in pulmonary function|1|||
125467828|NCT01443845|451342479|FG001|Overall Study|Deterioration in pulmonary function|4|||
125467829|NCT01443845|451342478|FG000|Overall Study|Lack of Efficacy|10|||
125467830|NCT01443845|451342479|FG001|Overall Study|Lack of Efficacy|5|||
125467831|NCT01443845|451342478|FG000|Overall Study|Adverse Event|64|||
125467832|NCT01443845|451342479|FG001|Overall Study|Adverse Event|138|||
125467833|NCT01443845|451342478|FG000|Overall Study|Withdrawal by Subject|63|||
125467834|NCT01443845|451342479|FG001|Overall Study|Withdrawal by Subject|67|||
125467835|NCT01443845|451342478|FG000|Overall Study|Military Conflict - Site Terminated|20|||
125467836|NCT01443845|451342479|FG001|Overall Study|Military Conflict - Site Terminated|21|||
125467837|NCT01443845|451342478|FG000|Overall Study|Lost to Follow-up|9|||
125467838|NCT01443845|451342479|FG001|Overall Study|Lost to Follow-up|13|||
125467839|NCT05137236|451342483|FG000|Part A|Other than Specified|1|||
125467840|NCT05137236|451342484|FG001|Part A|Other than Specified|0|||
125467841|NCT05137236|451342485|FG002|Part A|Other than Specified|0|||
125297493|NCT02429791|450715635|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
125297494|NCT02429791|450715634|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
125297495|NCT02429791|450715635|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
125467842|NCT05137236|451342486|FG003|Part A|Other than Specified|0|||
125467843|NCT05137236|451342487|FG004|Part A|Other than Specified|0|||
125467844|NCT05137236|451342488|FG005|Part A|Other than Specified|0|||
125467845|NCT05137236|451342489|FG006|Part A|Other than Specified|0|||
125467846|NCT05137236|451342490|FG007|Part A|Other than Specified|0|||
125467847|NCT05137236|451342483|FG000|Part A|Withdrawal by Subject|0|||
125467848|NCT05137236|451342484|FG001|Part A|Withdrawal by Subject|4|||
125467849|NCT05137236|451342485|FG002|Part A|Withdrawal by Subject|1|||
125467850|NCT05137236|451342486|FG003|Part A|Withdrawal by Subject|1|||
125467851|NCT05137236|451342487|FG004|Part A|Withdrawal by Subject|3|||
125467852|NCT05137236|451342488|FG005|Part A|Withdrawal by Subject|2|||
125467853|NCT05137236|451342489|FG006|Part A|Withdrawal by Subject|0|||
125467854|NCT05137236|451342490|FG007|Part A|Withdrawal by Subject|0|||
125467855|NCT05137236|451342483|FG000|Part A|Lost to Follow-up|5|||
125467856|NCT05137236|451342484|FG001|Part A|Lost to Follow-up|7|||
125467857|NCT05137236|451342485|FG002|Part A|Lost to Follow-up|1|||
125467858|NCT05137236|451342486|FG003|Part A|Lost to Follow-up|3|||
125467859|NCT05137236|451342487|FG004|Part A|Lost to Follow-up|3|||
125467860|NCT05137236|451342488|FG005|Part A|Lost to Follow-up|8|||
125467861|NCT05137236|451342489|FG006|Part A|Lost to Follow-up|0|||
125467862|NCT05137236|451342490|FG007|Part A|Lost to Follow-up|0|||
125467863|NCT05137236|451342483|FG000|Part B|Withdrawal by Subject|0|||
125467864|NCT05137236|451342484|FG001|Part B|Withdrawal by Subject|0|||
125467865|NCT05137236|451342485|FG002|Part B|Withdrawal by Subject|0|||
125467866|NCT05137236|451342486|FG003|Part B|Withdrawal by Subject|0|||
125467867|NCT05137236|451342487|FG004|Part B|Withdrawal by Subject|0|||
125467868|NCT05137236|451342488|FG005|Part B|Withdrawal by Subject|0|||
125467869|NCT05137236|451342489|FG006|Part B|Withdrawal by Subject|0|||
125467870|NCT05137236|451342490|FG007|Part B|Withdrawal by Subject|2|||
125467871|NCT05137236|451342483|FG000|Part B|Lost to Follow-up|0|||
125467872|NCT05137236|451342484|FG001|Part B|Lost to Follow-up|0|||
125467873|NCT05137236|451342485|FG002|Part B|Lost to Follow-up|0|||
125467874|NCT05137236|451342486|FG003|Part B|Lost to Follow-up|0|||
125467875|NCT05137236|451342487|FG004|Part B|Lost to Follow-up|0|||
125467876|NCT05137236|451342488|FG005|Part B|Lost to Follow-up|0|||
125467877|NCT05137236|451342489|FG006|Part B|Lost to Follow-up|5|||
125467878|NCT05137236|451342490|FG007|Part B|Lost to Follow-up|5|||
125467879|NCT05137236|451342483|FG000|Part B|Death|0|||
125467880|NCT05137236|451342484|FG001|Part B|Death|0|||
125467881|NCT05137236|451342485|FG002|Part B|Death|0|||
125467882|NCT05137236|451342486|FG003|Part B|Death|0|||
125467883|NCT05137236|451342487|FG004|Part B|Death|0|||
125467884|NCT05137236|451342488|FG005|Part B|Death|0|||
125467885|NCT05137236|451342489|FG006|Part B|Death|0|||
125467886|NCT05137236|451342490|FG007|Part B|Death|2|||
125467887|NCT02724956|451342491|FG000|Overall Study|Physician Decision|1|||
125467888|NCT02724956|451342492|FG001|Overall Study|Physician Decision|0|||
125467889|NCT02724956|451342491|FG000|Overall Study|Lack of Efficacy|0|||
125467890|NCT02724956|451342492|FG001|Overall Study|Lack of Efficacy|1|||
125467891|NCT02724956|451342491|FG000|Overall Study|Withdrawal by Subject|0|||
125467892|NCT02724956|451342492|FG001|Overall Study|Withdrawal by Subject|1|||
125467893|NCT01000480|451342494|FG000|Induction Phase|Adverse Event|2|||
125467894|NCT01000480|451342494|FG000|Induction Phase|Lost to Follow-up|1|||
125467895|NCT01000480|451342494|FG000|Induction Phase|Physician Decision|1|||
125467896|NCT01000480|451342494|FG000|Induction Phase|Entry Criteria Not Met|3|||
125467897|NCT01000480|451342494|FG000|Concurrent Therapy Phase|Adverse Event|4|||
125467898|NCT01000480|451342494|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
125467899|NCT01000480|451342494|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
125467900|NCT01000480|451342494|FG000|Concurrent Therapy Phase|Physician Decision|1|||
125467901|NCT00174382|451342496|FG000|Overall Study|Death|2|||
125467902|NCT00174382|451342496|FG000|Overall Study|Adverse Event|19|||
125467903|NCT00174382|451342496|FG000|Overall Study|Withdrawal by Subject|6|||
125467904|NCT00174382|451342496|FG000|Overall Study|Protocol Violation|3|||
125467905|NCT00174382|451342496|FG000|Overall Study|Arrived early for last visit in error|1|||
125467906|NCT00174382|451342496|FG000|Overall Study|Subject felt pill not effective enough|1|||
125467907|NCT00174382|451342496|FG000|Overall Study|Lost to Follow-up|1|||
125467908|NCT02574455|451342498|FG000|Overall Study|Death|197|||
125467909|NCT02574455|451342499|FG001|Overall Study|Death|210|||
125467910|NCT02574455|451342498|FG000|Overall Study|Withdrawal of Consent|11|||
125467911|NCT02574455|451342499|FG001|Overall Study|Withdrawal of Consent|28|||
125467912|NCT02574455|451342498|FG000|Overall Study|Lost to Follow-up|4|||
125467913|NCT02574455|451342499|FG001|Overall Study|Lost to Follow-up|4|||
125467914|NCT02574455|451342498|FG000|Overall Study|Sponsor's Decision|55|||
125467915|NCT02574455|451342499|FG001|Overall Study|Sponsor's Decision|20|||
125467916|NCT02372253|451342510|FG000|Overall Study|Non Compliance|2|||
125467917|NCT02372253|451342511|FG001|Overall Study|Non Compliance|0|||
125467918|NCT00393484|451342512|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
125467919|NCT00393484|451342513|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
125467920|NCT00393484|451342512|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
125467921|NCT00393484|451342513|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
125467922|NCT00393484|451342512|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
125467923|NCT00393484|451342513|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
125467924|NCT00393484|451342512|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
125467925|NCT00393484|451342513|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
125467926|NCT00393484|451342512|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
125467927|NCT00393484|451342513|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
125467928|NCT00393484|451342512|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
125467929|NCT00393484|451342513|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
125467930|NCT00393484|451342512|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
125467931|NCT00393484|451342513|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
125467932|NCT00393484|451342512|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
125467933|NCT00393484|451342513|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
125467934|NCT00393484|451342512|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
125467935|NCT00393484|451342513|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
125467936|NCT00393484|451342512|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
125467937|NCT00393484|451342513|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
125467938|NCT03201562|451342516|FG000|Overall Study|Physician Decision|0|||
125467939|NCT03201562|451342517|FG001|Overall Study|Physician Decision|0|||
125467940|NCT03201562|451342518|FG002|Overall Study|Physician Decision|1|||
125467941|NCT03201562|451342516|FG000|Overall Study|Adverse Event|0|||
125467942|NCT03201562|451342517|FG001|Overall Study|Adverse Event|0|||
125467943|NCT03201562|451342518|FG002|Overall Study|Adverse Event|1|||
125467944|NCT03201562|451342516|FG000|Overall Study|Lost to Follow-up|0|||
125467945|NCT03201562|451342517|FG001|Overall Study|Lost to Follow-up|1|||
125467946|NCT03201562|451342518|FG002|Overall Study|Lost to Follow-up|2|||
125467947|NCT00001277|451342519|FG000|Overall Study|Adverse Event|0|||
125467948|NCT00001277|451342520|FG001|Overall Study|Adverse Event|0|||
125467949|NCT00001277|451342521|FG002|Overall Study|Adverse Event|1|||
125467950|NCT00001277|451342519|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
125467951|NCT00001277|451342520|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
125467952|NCT00001277|451342521|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
125467953|NCT03101371|451342525|FG000|Overall Study|Physician Decision|0|||
125467954|NCT03101371|451342526|FG001|Overall Study|Physician Decision|1|||
125467955|NCT03101371|451342525|FG000|Overall Study|Lost to Follow-up|1|||
125467956|NCT03101371|451342526|FG001|Overall Study|Lost to Follow-up|4|||
125467957|NCT03101371|451342525|FG000|Overall Study|Did not meet eligibility criteria|2|||
125467958|NCT03101371|451342526|FG001|Overall Study|Did not meet eligibility criteria|1|||
125467959|NCT02318134|451342527|FG000|Overall Study|Withdrawal by Subject|2|||
125467960|NCT02318134|451342528|FG001|Overall Study|Withdrawal by Subject|1|||
125467961|NCT02730871|451342529|FG000|Overall Study|Adverse Event|6|||
125467962|NCT02730871|451342530|FG001|Overall Study|Adverse Event|0|||
125467963|NCT04019444|451342531|FG000|Overall Study|Withdrawal by Subject|0|||
125467964|NCT04019444|451342532|FG001|Overall Study|Withdrawal by Subject|1|||
125467965|NCT04019444|451342533|FG002|Overall Study|Withdrawal by Subject|0|||
125467966|NCT04019444|451342534|FG003|Overall Study|Withdrawal by Subject|1|||
125467967|NCT04019444|451342531|FG000|Overall Study|Solicited Event|0|||
125467968|NCT04019444|451342532|FG001|Overall Study|Solicited Event|0|||
125467969|NCT04019444|451342533|FG002|Overall Study|Solicited Event|2|||
125467970|NCT04019444|451342534|FG003|Overall Study|Solicited Event|0|||
125467971|NCT02769858|451342540|FG000|Overall Study|Withdrawal by Subject|2|||
125467972|NCT02807779|451342541|FG000|Overall Study|Lost to Follow-up|1|||
125467973|NCT02807779|451342542|FG001|Overall Study|Lost to Follow-up|0|||
125467974|NCT02807779|451342543|FG002|Overall Study|Lost to Follow-up|0|||
125467975|NCT02807779|451342541|FG000|Overall Study|Physician Decision|2|||
125467976|NCT02807779|451342542|FG001|Overall Study|Physician Decision|0|||
125467977|NCT02807779|451342543|FG002|Overall Study|Physician Decision|1|||
125467978|NCT02807779|451342541|FG000|Overall Study|Death|1|||
125467979|NCT02807779|451342542|FG001|Overall Study|Death|1|||
125467980|NCT02807779|451342543|FG002|Overall Study|Death|0|||
125467981|NCT02576509|451344037|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
125467982|NCT02576509|451344038|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
125467983|NCT02576509|451344037|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
125467984|NCT02576509|451344038|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
125467985|NCT02576509|451344037|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
125467986|NCT02576509|451344038|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
125467987|NCT02576509|451344037|FG000|Treatment Period|Disease progression|263|||
125467988|NCT02576509|451344038|FG001|Treatment Period|Disease progression|244|||
125467989|NCT02576509|451344037|FG000|Treatment Period|Study drug toxicity|37|||
125467990|NCT02576509|451344038|FG001|Treatment Period|Study drug toxicity|41|||
125467991|NCT02576509|451344037|FG000|Treatment Period|Death|1|||
125467992|NCT02576509|451344038|FG001|Treatment Period|Death|1|||
125297496|NCT02429791|450715634|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
125297497|NCT02429791|450715635|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
125467993|NCT02576509|451344037|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
125467994|NCT02576509|451344038|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
125467995|NCT02576509|451344037|FG000|Treatment Period|Participant request to stop treatment|8|||
125467996|NCT02576509|451344038|FG001|Treatment Period|Participant request to stop treatment|18|||
125467997|NCT02576509|451344037|FG000|Treatment Period|Participant withdrew consent|3|||
125297498|NCT02429791|450715634|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
125297499|NCT02429791|450715635|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
125297500|NCT02429791|450715634|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
125297501|NCT02429791|450715635|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
125297502|NCT02429791|450715634|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
125297503|NCT02429791|450715635|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
125297504|NCT02429791|450715634|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
125297505|NCT02429791|450715635|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
125297506|NCT02429791|450715634|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
125297507|NCT02429791|450715635|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
125297508|NCT02429791|450715634|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
125297509|NCT02429791|450715635|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
125297510|NCT02429791|450715634|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
125297511|NCT02429791|450715635|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
125297512|NCT02429791|450715634|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
125297513|NCT02429791|450715635|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
125297514|NCT02429791|450715634|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
125297515|NCT02429791|450715635|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
125297516|NCT02429791|450715634|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
125297517|NCT02429791|450715635|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
125297518|NCT02429791|450715634|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
125297519|NCT02429791|450715635|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
125297520|NCT02429791|450715634|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
125297521|NCT02429791|450715635|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
125297522|NCT02166463|450715636|FG000|Overall Study|Lost to Follow-up|0|||
125297523|NCT02166463|450715637|FG001|Overall Study|Lost to Follow-up|1|||
125297524|NCT02166463|450715636|FG000|Overall Study|Physician Decision|10|||
125297525|NCT02166463|450715637|FG001|Overall Study|Physician Decision|10|||
125297526|NCT02166463|450715636|FG000|Overall Study|Ineligible|11|||
125297527|NCT02166463|450715637|FG001|Overall Study|Ineligible|2|||
125297528|NCT02166463|450715636|FG000|Overall Study|Progressive Disease|9|||
125297529|NCT02166463|450715637|FG001|Overall Study|Progressive Disease|6|||
125297530|NCT02166463|450715636|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
125297531|NCT02166463|450715637|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
125297532|NCT02166463|450715636|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
125297533|NCT02166463|450715637|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
125297534|NCT02166463|450715636|FG000|Overall Study|Refusal of further protocol therapy|5|||
125297535|NCT02166463|450715637|FG001|Overall Study|Refusal of further protocol therapy|6|||
125297536|NCT05856227|450715638|FG000|Overall Study|Adverse Event|0|||
125297537|NCT05856227|450715639|FG001|Overall Study|Adverse Event|1|||
125297538|NCT05856227|450715638|FG000|Overall Study|Due to Investigator absence|1|||
125297539|NCT05856227|450715639|FG001|Overall Study|Due to Investigator absence|0|||
125297540|NCT05856227|450715638|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
125297541|NCT05856227|450715639|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
125297542|NCT00771615|450715640|FG000|Overall Study|Withdrawal by Subject|0|||
125297543|NCT00771615|450715641|FG001|Overall Study|Withdrawal by Subject|1|||
125297544|NCT00771615|450715642|FG002|Overall Study|Withdrawal by Subject|0|||
125297545|NCT00771615|450715643|FG003|Overall Study|Withdrawal by Subject|0|||
125297546|NCT00771615|450715644|FG004|Overall Study|Withdrawal by Subject|0|||
125297547|NCT00771615|450715645|FG005|Overall Study|Withdrawal by Subject|0|||
125297548|NCT00771615|450715646|FG006|Overall Study|Withdrawal by Subject|0|||
125297549|NCT00771615|450715647|FG007|Overall Study|Withdrawal by Subject|1|||
125297550|NCT00771615|450715648|FG008|Overall Study|Withdrawal by Subject|0|||
125297551|NCT00771615|450715640|FG000|Overall Study|Lost to Follow-up|1|||
125297552|NCT00771615|450715641|FG001|Overall Study|Lost to Follow-up|1|||
125297553|NCT00771615|450715642|FG002|Overall Study|Lost to Follow-up|1|||
125297554|NCT00771615|450715643|FG003|Overall Study|Lost to Follow-up|1|||
125297555|NCT00771615|450715644|FG004|Overall Study|Lost to Follow-up|0|||
125297556|NCT00771615|450715645|FG005|Overall Study|Lost to Follow-up|1|||
125467998|NCT02576509|451344038|FG001|Treatment Period|Participant withdrew consent|7|||
125467999|NCT02576509|451344037|FG000|Treatment Period|Lost to Follow-up|0|||
125468000|NCT02576509|451344038|FG001|Treatment Period|Lost to Follow-up|1|||
125468001|NCT02576509|451344037|FG000|Treatment Period|Maximum clinical benefit|1|||
125468002|NCT02576509|451344038|FG001|Treatment Period|Maximum clinical benefit|0|||
125468003|NCT02576509|451344037|FG000|Treatment Period|Poor/non-compliance|1|||
125468004|NCT02576509|451344038|FG001|Treatment Period|Poor/non-compliance|1|||
125468005|NCT02576509|451344037|FG000|Treatment Period|Participant no longer meets criteria|1|||
125468006|NCT02576509|451344038|FG001|Treatment Period|Participant no longer meets criteria|0|||
125468007|NCT02576509|451344037|FG000|Treatment Period|Other reason|12|||
125468008|NCT02576509|451344038|FG001|Treatment Period|Other reason|8|||
125468009|NCT02576509|451344037|FG000|Treatment Period|NOT REPORTED|1|||
125468010|NCT02576509|451344038|FG001|Treatment Period|NOT REPORTED|0|||
125468011|NCT02576509|451344037|FG000|Treatment Period|Administrative reason by sponsor|0|||
125468012|NCT02576509|451344038|FG001|Treatment Period|Administrative reason by sponsor|1|||
125468013|NCT04688450|451344039|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
125297557|NCT00771615|450715646|FG006|Overall Study|Lost to Follow-up|1|||
125297558|NCT00771615|450715647|FG007|Overall Study|Lost to Follow-up|0|||
125297559|NCT00771615|450715648|FG008|Overall Study|Lost to Follow-up|0|||
125297560|NCT02478164|450715649|FG000|Overall Study|Lack of Efficacy|13|||
125297561|NCT02478164|450715649|FG000|Overall Study|Adverse Event|1|||
125297562|NCT02478164|450715649|FG000|Overall Study|Withdrawal by Subject|1|||
125297563|NCT04588389|450715650|FG000|Overall Study|Issues with anesthesia during surgery|2|||
125297564|NCT04588389|450715651|FG001|Overall Study|Issues with anesthesia during surgery|0|||
125297565|NCT04588389|450715652|FG002|Overall Study|Issues with anesthesia during surgery|0|||
125297566|NCT05147662|450715665|FG000|Overall Study|Withdrawal by parent/guardian|3|||
125297567|NCT05147662|450715665|FG000|Overall Study|Assigned to treatment but never treated|1|||
125297568|NCT04676867|450715666|FG000|Overall Study|Screen failure|0|||
125297569|NCT04676867|450715667|FG001|Overall Study|Screen failure|0|||
125297570|NCT04676867|450715668|FG002|Overall Study|Screen failure|6|||
125297571|NCT04676867|450715669|FG003|Overall Study|Screen failure|2|||
125297572|NCT04676867|450715666|FG000|Overall Study|Death|0|||
125297573|NCT04676867|450715667|FG001|Overall Study|Death|0|||
125297574|NCT04676867|450715668|FG002|Overall Study|Death|1|||
125297575|NCT04676867|450715669|FG003|Overall Study|Death|0|||
125297576|NCT04676867|450715666|FG000|Overall Study|Withdrawal by Subject|2|||
125297577|NCT04676867|450715667|FG001|Overall Study|Withdrawal by Subject|2|||
125297578|NCT04676867|450715668|FG002|Overall Study|Withdrawal by Subject|4|||
125297579|NCT04676867|450715669|FG003|Overall Study|Withdrawal by Subject|4|||
125297580|NCT04676867|450715666|FG000|Overall Study|Lost to Follow-up|1|||
125297581|NCT04676867|450715667|FG001|Overall Study|Lost to Follow-up|0|||
125297582|NCT04676867|450715668|FG002|Overall Study|Lost to Follow-up|0|||
125297583|NCT04676867|450715669|FG003|Overall Study|Lost to Follow-up|0|||
125297584|NCT00549770|450715670|FG000|Overall Study|Protocol deviation|1|||
125297585|NCT00549770|450715671|FG001|Overall Study|Protocol deviation|1|||
125297586|NCT00549770|450715672|FG002|Overall Study|Protocol deviation|1|||
125297587|NCT00549770|450715673|FG003|Overall Study|Protocol deviation|2|||
125297588|NCT00549770|450715674|FG004|Overall Study|Protocol deviation|2|||
125297589|NCT00549770|450715675|FG005|Overall Study|Protocol deviation|2|||
125297590|NCT00549770|450715676|FG006|Overall Study|Protocol deviation|1|||
125297591|NCT00549770|450715677|FG007|Overall Study|Protocol deviation|2|||
125297592|NCT00549770|450715670|FG000|Overall Study|Administrative problems|0|||
125297593|NCT00549770|450715671|FG001|Overall Study|Administrative problems|1|||
125297594|NCT00549770|450715672|FG002|Overall Study|Administrative problems|0|||
125297595|NCT00549770|450715673|FG003|Overall Study|Administrative problems|0|||
125297596|NCT00549770|450715674|FG004|Overall Study|Administrative problems|0|||
125297597|NCT00549770|450715675|FG005|Overall Study|Administrative problems|0|||
125297598|NCT00549770|450715676|FG006|Overall Study|Administrative problems|0|||
125297599|NCT00549770|450715677|FG007|Overall Study|Administrative problems|1|||
125297600|NCT00549770|450715670|FG000|Overall Study|Lost to Follow-up|0|||
125297601|NCT00549770|450715671|FG001|Overall Study|Lost to Follow-up|0|||
125297602|NCT00549770|450715672|FG002|Overall Study|Lost to Follow-up|2|||
125297603|NCT00549770|450715673|FG003|Overall Study|Lost to Follow-up|2|||
125297604|NCT00549770|450715674|FG004|Overall Study|Lost to Follow-up|3|||
125297605|NCT00549770|450715675|FG005|Overall Study|Lost to Follow-up|2|||
125297606|NCT00549770|450715676|FG006|Overall Study|Lost to Follow-up|0|||
125297607|NCT00549770|450715677|FG007|Overall Study|Lost to Follow-up|0|||
125297608|NCT00549770|450715670|FG000|Overall Study|Withdrawal by Subject|4|||
125468014|NCT04688450|451344039|FG000|Overall Study|Withdrawal by Subject|1|||
125468015|NCT01353313|451344042|FG000|Overall Study|Lost to Follow-up|22|||
125468016|NCT01353313|451344043|FG001|Overall Study|Lost to Follow-up|23|||
125468017|NCT01353313|451344042|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
125468018|NCT01353313|451344043|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
125468019|NCT04755660|451344044|FG000|Overall Study|Lost to Follow-up|1|||
125468020|NCT04755660|451344045|FG001|Overall Study|Lost to Follow-up|1|||
125468021|NCT04755660|451344046|FG002|Overall Study|Lost to Follow-up|0|||
125468022|NCT04755660|451344044|FG000|Overall Study|Withdrawal by Subject|0|||
125468023|NCT04755660|451344045|FG001|Overall Study|Withdrawal by Subject|1|||
125297609|NCT00549770|450715671|FG001|Overall Study|Withdrawal by Subject|6|||
125297610|NCT00549770|450715672|FG002|Overall Study|Withdrawal by Subject|4|||
125297611|NCT00549770|450715673|FG003|Overall Study|Withdrawal by Subject|5|||
125297612|NCT00549770|450715674|FG004|Overall Study|Withdrawal by Subject|6|||
125297613|NCT00549770|450715675|FG005|Overall Study|Withdrawal by Subject|6|||
125297614|NCT00549770|450715676|FG006|Overall Study|Withdrawal by Subject|4|||
125297615|NCT00549770|450715677|FG007|Overall Study|Withdrawal by Subject|9|||
125297616|NCT00549770|450715670|FG000|Overall Study|Lack of Efficacy|1|||
125297617|NCT00549770|450715671|FG001|Overall Study|Lack of Efficacy|0|||
125468024|NCT04755660|451344046|FG002|Overall Study|Withdrawal by Subject|1|||
125468025|NCT04755660|451344044|FG000|Overall Study|Physician Decision|0|||
125468026|NCT04755660|451344045|FG001|Overall Study|Physician Decision|0|||
125468027|NCT04755660|451344046|FG002|Overall Study|Physician Decision|1|||
125468028|NCT00670046|451344055|FG000|Overall Study|Lost to Follow-up|1|||
125468029|NCT00670046|451344056|FG001|Overall Study|Lost to Follow-up|1|||
125468030|NCT00670046|451344055|FG000|Overall Study|Withdrawal by Subject|0|||
125297618|NCT00549770|450715672|FG002|Overall Study|Lack of Efficacy|2|||
125297619|NCT00549770|450715673|FG003|Overall Study|Lack of Efficacy|3|||
125297620|NCT00549770|450715674|FG004|Overall Study|Lack of Efficacy|5|||
125297621|NCT00549770|450715675|FG005|Overall Study|Lack of Efficacy|1|||
125297622|NCT00549770|450715676|FG006|Overall Study|Lack of Efficacy|3|||
125297623|NCT00549770|450715677|FG007|Overall Study|Lack of Efficacy|8|||
125297624|NCT00549770|450715670|FG000|Overall Study|Abnormal test procedure results|0|||
125297625|NCT00549770|450715671|FG001|Overall Study|Abnormal test procedure results|0|||
125297626|NCT00549770|450715672|FG002|Overall Study|Abnormal test procedure results|0|||
125297627|NCT00549770|450715673|FG003|Overall Study|Abnormal test procedure results|2|||
125297628|NCT00549770|450715674|FG004|Overall Study|Abnormal test procedure results|0|||
125297629|NCT00549770|450715675|FG005|Overall Study|Abnormal test procedure results|1|||
125297630|NCT00549770|450715676|FG006|Overall Study|Abnormal test procedure results|1|||
125297631|NCT00549770|450715677|FG007|Overall Study|Abnormal test procedure results|1|||
125297632|NCT00549770|450715670|FG000|Overall Study|Abnormal laboratory values|0|||
125297633|NCT00549770|450715671|FG001|Overall Study|Abnormal laboratory values|0|||
125297634|NCT00549770|450715672|FG002|Overall Study|Abnormal laboratory values|0|||
125297635|NCT00549770|450715673|FG003|Overall Study|Abnormal laboratory values|0|||
125297636|NCT00549770|450715674|FG004|Overall Study|Abnormal laboratory values|0|||
125297637|NCT00549770|450715675|FG005|Overall Study|Abnormal laboratory values|1|||
125297638|NCT00549770|450715676|FG006|Overall Study|Abnormal laboratory values|0|||
125297639|NCT00549770|450715677|FG007|Overall Study|Abnormal laboratory values|0|||
125468031|NCT00670046|451344056|FG001|Overall Study|Withdrawal by Subject|1|||
125468032|NCT00431834|451344063|FG000|Overall Study|Withdrawal by Subject|7|||
125468033|NCT00431834|451344063|FG000|Overall Study|Death|3|||
125468034|NCT00431834|451344063|FG000|Overall Study|Missed Endpoint Visit|2|||
125468035|NCT00431834|451344063|FG000|Overall Study|Lost to Follow-up|1|||
125297640|NCT00549770|450715670|FG000|Overall Study|Adverse Event|1|||
125297641|NCT00549770|450715671|FG001|Overall Study|Adverse Event|3|||
125297642|NCT00549770|450715672|FG002|Overall Study|Adverse Event|1|||
125297643|NCT00549770|450715673|FG003|Overall Study|Adverse Event|2|||
125297644|NCT00549770|450715674|FG004|Overall Study|Adverse Event|1|||
125297645|NCT00549770|450715675|FG005|Overall Study|Adverse Event|0|||
125468036|NCT02461628|451344069|FG000|Overall Study|Refused to complete survey|4|||
125468037|NCT02461628|451344070|FG001|Overall Study|Refused to complete survey|7|||
125468038|NCT02647905|451344073|FG000|Overall Study|Lost to Follow-up|1|||
125468039|NCT02647905|451344073|FG000|Overall Study|Withdrawal by Subject|2|||
125468040|NCT02015520|451344074|FG000|Overall Study|Lack of Efficacy|1|||
125468041|NCT02015520|451344075|FG001|Overall Study|Lack of Efficacy|0|||
125468042|NCT02015520|451344076|FG002|Overall Study|Lack of Efficacy|3|||
125468043|NCT02015520|451344077|FG003|Overall Study|Lack of Efficacy|2|||
125468044|NCT02015520|451344074|FG000|Overall Study|Adverse Event|0|||
125468045|NCT02015520|451344075|FG001|Overall Study|Adverse Event|0|||
125468046|NCT02015520|451344076|FG002|Overall Study|Adverse Event|0|||
125468047|NCT02015520|451344077|FG003|Overall Study|Adverse Event|1|||
125468048|NCT02015520|451344074|FG000|Overall Study|Withdrawal by Subject|2|||
125468049|NCT02015520|451344075|FG001|Overall Study|Withdrawal by Subject|2|||
125297646|NCT00549770|450715676|FG006|Overall Study|Adverse Event|5|||
125297647|NCT00549770|450715677|FG007|Overall Study|Adverse Event|4|||
125297648|NCT01079936|450715678|FG000|Phase I: MTD|First Remission Status|2|||
125297649|NCT01079936|450715679|FG001|Phase I: MTD|First Remission Status|0|||
125297650|NCT01079936|450715680|FG002|Phase I: MTD|First Remission Status|0|||
125297651|NCT01079936|450715681|FG003|Phase I: MTD|First Remission Status|0|||
125297652|NCT01079936|450715682|FG004|Phase I: MTD|First Remission Status|0|||
125297653|NCT01079936|450715678|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
125297654|NCT01079936|450715679|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
125297655|NCT01079936|450715680|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
125297656|NCT01079936|450715681|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
125297657|NCT01079936|450715682|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
125468050|NCT02015520|451344076|FG002|Overall Study|Withdrawal by Subject|1|||
125468051|NCT02015520|451344077|FG003|Overall Study|Withdrawal by Subject|0|||
125297658|NCT01079936|450715678|FG000|Phase II|Adverse Event|0|||
125297659|NCT01079936|450715679|FG001|Phase II|Adverse Event|0|||
125297660|NCT01079936|450715680|FG002|Phase II|Adverse Event|1|||
125297661|NCT01079936|450715681|FG003|Phase II|Adverse Event|0|||
125297662|NCT01079936|450715682|FG004|Phase II|Adverse Event|0|||
125297663|NCT01079936|450715678|FG000|Phase II|Insurance Issue|0|||
125297664|NCT01079936|450715679|FG001|Phase II|Insurance Issue|0|||
125468052|NCT02015520|451344074|FG000|Overall Study|Death|1|||
125468053|NCT02015520|451344075|FG001|Overall Study|Death|0|||
125468054|NCT02015520|451344076|FG002|Overall Study|Death|0|||
125297665|NCT01079936|450715680|FG002|Phase II|Insurance Issue|0|||
125297666|NCT01079936|450715681|FG003|Phase II|Insurance Issue|0|||
125297667|NCT01079936|450715682|FG004|Phase II|Insurance Issue|1|||
125297668|NCT00548717|450715683|FG000|Overall Study|Death|5|||
125297669|NCT00548717|450715684|FG001|Overall Study|Death|2|||
125297670|NCT00548717|450715683|FG000|Overall Study|Relapse|3|||
125297671|NCT00548717|450715684|FG001|Overall Study|Relapse|0|||
125297672|NCT00548717|450715683|FG000|Overall Study|Alternative treatment for GVHD|1|||
125297673|NCT00548717|450715684|FG001|Overall Study|Alternative treatment for GVHD|0|||
125297674|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
125297675|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
125297676|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
125297677|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
125297678|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
125297679|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
125297680|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
125297681|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
125297682|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
125297683|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
125297684|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
125297685|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
125297686|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
125297687|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
125297688|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
125297689|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
125297690|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
125297691|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
125297692|NCT01302054|450715685|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
125297693|NCT01302054|450715686|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
125297694|NCT01302054|450715687|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
125297695|NCT01302054|450715685|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
125297696|NCT01302054|450715686|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
125297697|NCT01302054|450715687|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
125297698|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
125297699|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
125297700|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
125297701|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
125297702|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
125297703|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
125297704|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
125297705|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
125297706|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
125297707|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
125297708|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
125297709|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
125297710|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
125297711|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
125297712|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
125297713|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
125297714|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
125297715|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
125297716|NCT01302054|450715685|FG000|Double-Blind Treatment Phase|Other|0|||
125297717|NCT01302054|450715686|FG001|Double-Blind Treatment Phase|Other|4|||
125297718|NCT01302054|450715687|FG002|Double-Blind Treatment Phase|Other|9|||
125297719|NCT00847015|450715688|FG000|Overall Study|Withdrawal by Subject|1|||
125297720|NCT00847015|450715688|FG000|Overall Study|declined any surgery|1|||
125297721|NCT00847015|450715688|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
125297722|NCT02809053|450715689|FG000|Overall Study|Death|0|||
125297723|NCT02809053|450715690|FG001|Overall Study|Death|1|||
125297724|NCT02809053|450715689|FG000|Overall Study|Lost to Follow-up|3|||
125297725|NCT02809053|450715690|FG001|Overall Study|Lost to Follow-up|1|||
125297726|NCT02809053|450715689|FG000|Overall Study|Withdrawal by Subject|2|||
125297727|NCT02809053|450715690|FG001|Overall Study|Withdrawal by Subject|3|||
125297728|NCT02809053|450715689|FG000|Overall Study|Disease Progression|2|||
125297729|NCT02809053|450715690|FG001|Overall Study|Disease Progression|1|||
125297730|NCT02565810|450715693|FG000|Overall Study|Withdrawal by Subject|1|||
125297731|NCT01732913|450715700|FG000|Overall Study|Study Terminated by Sponsor|105|||
125297732|NCT01732913|450715701|FG001|Overall Study|Study Terminated by Sponsor|55|||
125297733|NCT01732913|450715700|FG000|Overall Study|Withdrawal by Subject|27|||
125297734|NCT01732913|450715701|FG001|Overall Study|Withdrawal by Subject|4|||
125297735|NCT01732913|450715700|FG000|Overall Study|Physician Decision|14|||
125297736|NCT01732913|450715701|FG001|Overall Study|Physician Decision|7|||
125297737|NCT01732913|450715700|FG000|Overall Study|Other|7|||
125297738|NCT01732913|450715701|FG001|Overall Study|Other|1|||
125297739|NCT01732913|450715700|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
125297740|NCT01732913|450715701|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
125297741|NCT02925741|450715702|FG000|Overall Study|Withdrawal by Subject|11|||
125297742|NCT02925741|450715703|FG001|Overall Study|Withdrawal by Subject|0|||
125297743|NCT05086510|450715704|FG000|Overall Study|Lost to Follow-up|0|||
125297744|NCT05086510|450715705|FG001|Overall Study|Lost to Follow-up|2|||
125297745|NCT05086510|450715704|FG000|Overall Study|Death|0|||
125297746|NCT05086510|450715705|FG001|Overall Study|Death|2|||
125297747|NCT03022981|450715706|FG000|Overall Study|Adverse Event|0|||
125297748|NCT03022981|450715707|FG001|Overall Study|Adverse Event|1|||
125297749|NCT03022981|450715708|FG002|Overall Study|Adverse Event|0|||
125297750|NCT03022981|450715706|FG000|Overall Study|Investigator's Discretion|0|||
125297751|NCT03022981|450715707|FG001|Overall Study|Investigator's Discretion|1|||
125297752|NCT03022981|450715708|FG002|Overall Study|Investigator's Discretion|2|||
125297753|NCT03022981|450715706|FG000|Overall Study|Lost to Follow-up|6|||
125297754|NCT03022981|450715707|FG001|Overall Study|Lost to Follow-up|2|||
125297755|NCT03022981|450715708|FG002|Overall Study|Lost to Follow-up|1|||
125297756|NCT03022981|450715706|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125297757|NCT03022981|450715707|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125297758|NCT03022981|450715708|FG002|Overall Study|Non-Compliance With Study Drug|2|||
125297759|NCT03022981|450715706|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
125297760|NCT03022981|450715707|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
125297761|NCT03022981|450715708|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
125297762|NCT00295932|450715709|FG000|Overall Study|Not Treated|0|||
125297763|NCT00295932|450715710|FG001|Overall Study|Not Treated|0|||
125297764|NCT00295932|450715711|FG002|Overall Study|Not Treated|0|||
125297765|NCT00295932|450715712|FG003|Overall Study|Not Treated|0|||
125297766|NCT00295932|450715713|FG004|Overall Study|Not Treated|0|||
125297767|NCT00295932|450715714|FG005|Overall Study|Not Treated|0|||
125297768|NCT00295932|450715715|FG006|Overall Study|Not Treated|0|||
125297769|NCT00295932|450715716|FG007|Overall Study|Not Treated|0|||
125297770|NCT00295932|450715717|FG008|Overall Study|Not Treated|0|||
125297771|NCT00295932|450715718|FG009|Overall Study|Not Treated|0|||
125297772|NCT00295932|450715719|FG010|Overall Study|Not Treated|1|||
125297773|NCT04891107|450715720|FG000|Overall Study|Physician Decision|1|||
125297774|NCT04891107|450715720|FG000|Overall Study|Withdrawal by Subject|1|||
125297775|NCT04891107|450715720|FG000|Overall Study|Screen failure after consent|1|||
125297776|NCT01571453|450715721|FG000|Overall Study|Adverse Event|14|||
125297777|NCT01571453|450715722|FG001|Overall Study|Adverse Event|32|||
125297778|NCT01571453|450715721|FG000|Overall Study|Lack of Efficacy|8|||
125297779|NCT01571453|450715722|FG001|Overall Study|Lack of Efficacy|3|||
125297780|NCT01571453|450715721|FG000|Overall Study|Non-compliance|2|||
125297781|NCT01571453|450715722|FG001|Overall Study|Non-compliance|4|||
125297782|NCT01571453|450715721|FG000|Overall Study|Protocol Violation|1|||
125297783|NCT01571453|450715722|FG001|Overall Study|Protocol Violation|5|||
125297784|NCT01571453|450715721|FG000|Overall Study|Withdrawal of consent|5|||
125297785|NCT01571453|450715722|FG001|Overall Study|Withdrawal of consent|13|||
125297786|NCT01571453|450715721|FG000|Overall Study|Lost to Follow-up|4|||
125297787|NCT01571453|450715722|FG001|Overall Study|Lost to Follow-up|2|||
125297788|NCT01571453|450715721|FG000|Overall Study|Administrative or other reason(s)|4|||
125297789|NCT01571453|450715722|FG001|Overall Study|Administrative or other reason(s)|3|||
125297790|NCT00084487|450715729|FG000|Overall Study|Death|1|||
125297791|NCT03040986|450715731|FG000|Overall Study|Hospice|1|||
125297792|NCT03040986|450715732|FG001|Overall Study|Hospice|0|||
125297793|NCT03040986|450715731|FG000|Overall Study|Adverse Event|2|||
125468055|NCT02015520|451344077|FG003|Overall Study|Death|0|||
125468056|NCT02015520|451344074|FG000|Overall Study|Lost to Follow-up|0|||
125468057|NCT02015520|451344075|FG001|Overall Study|Lost to Follow-up|0|||
125468058|NCT02015520|451344076|FG002|Overall Study|Lost to Follow-up|1|||
125468059|NCT02015520|451344077|FG003|Overall Study|Lost to Follow-up|0|||
125297794|NCT03040986|450715732|FG001|Overall Study|Adverse Event|1|||
125297795|NCT03040986|450715731|FG000|Overall Study|Disease progression on study|3|||
125468060|NCT02015520|451344074|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
125297796|NCT03040986|450715732|FG001|Overall Study|Disease progression on study|1|||
125297797|NCT02273960|450715733|FG000|Short Term Period|Lost to Follow-up|1|||
125297798|NCT02273960|450715734|FG001|Short Term Period|Lost to Follow-up|0|||
125297799|NCT02273960|450715735|FG002|Short Term Period|Lost to Follow-up|0|||
125297800|NCT02273960|450715736|FG003|Short Term Period|Lost to Follow-up|0|||
125297801|NCT02273960|450715733|FG000|Short Term Period|Lack of Efficacy|0|||
125297802|NCT02273960|450715734|FG001|Short Term Period|Lack of Efficacy|0|||
125297803|NCT02273960|450715735|FG002|Short Term Period|Lack of Efficacy|0|||
125297804|NCT02273960|450715736|FG003|Short Term Period|Lack of Efficacy|1|||
125297805|NCT02273960|450715733|FG000|Short Term Period|ST complete, not entering LTE|4|||
125297806|NCT02273960|450715734|FG001|Short Term Period|ST complete, not entering LTE|6|||
125468061|NCT02015520|451344075|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
125297807|NCT02273960|450715735|FG002|Short Term Period|ST complete, not entering LTE|4|||
125297808|NCT02273960|450715736|FG003|Short Term Period|ST complete, not entering LTE|5|||
125468062|NCT02015520|451344076|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
125468063|NCT02015520|451344077|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
125468064|NCT02015520|451344074|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
125468065|NCT02015520|451344075|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
125468066|NCT02015520|451344076|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
125468067|NCT02015520|451344077|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
125468068|NCT05119855|451344078|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
125468069|NCT05119855|451344079|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
125468070|NCT05119855|451344078|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
125468071|NCT05119855|451344079|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
125468072|NCT05119855|451344078|FG000|Overall Study|Lost to Follow-up|6|||
125468073|NCT05119855|451344079|FG001|Overall Study|Lost to Follow-up|8|||
125468074|NCT02932579|451344080|FG000|Overall Study|Withdrawal by Subject|4|||
125468075|NCT02932579|451344081|FG001|Overall Study|Withdrawal by Subject|1|||
125468076|NCT01972724|451344082|FG000|Double-Blind|Rescue Criteria Met|1|||
125468077|NCT01972724|451344083|FG001|Double-Blind|Rescue Criteria Met|0|||
125468078|NCT01972724|451344084|FG002|Double-Blind|Rescue Criteria Met|0|||
125468079|NCT01972724|451344082|FG000|Double-Blind|Adverse Event|1|||
125468080|NCT01972724|451344083|FG001|Double-Blind|Adverse Event|0|||
125468081|NCT01972724|451344084|FG002|Double-Blind|Adverse Event|0|||
125468082|NCT01972724|451344082|FG000|Double-Blind|Withdrawal of Consent|2|||
125468083|NCT01972724|451344083|FG001|Double-Blind|Withdrawal of Consent|1|||
125468084|NCT01972724|451344084|FG002|Double-Blind|Withdrawal of Consent|0|||
125468085|NCT01972724|451344082|FG000|Double-Blind|Significant Protocol Deviation|5|||
125468086|NCT01972724|451344083|FG001|Double-Blind|Significant Protocol Deviation|8|||
125468087|NCT01972724|451344084|FG002|Double-Blind|Significant Protocol Deviation|0|||
125468088|NCT01972724|451344082|FG000|Open-Label|Withdrew Consent|0|||
125468089|NCT01972724|451344083|FG001|Open-Label|Withdrew Consent|0|||
125468090|NCT01972724|451344084|FG002|Open-Label|Withdrew Consent|3|||
125468091|NCT01972724|451344082|FG000|Open-Label|Significant Protocol Deviation|0|||
125468092|NCT01972724|451344083|FG001|Open-Label|Significant Protocol Deviation|0|||
125468093|NCT01972724|451344084|FG002|Open-Label|Significant Protocol Deviation|2|||
125468094|NCT00111813|451344091|FG000|Overall Study|Adverse Event|1|||
125468095|NCT00111813|451344092|FG001|Overall Study|Adverse Event|2|||
125468096|NCT00111813|451344093|FG002|Overall Study|Adverse Event|4|||
125468097|NCT00111813|451344094|FG003|Overall Study|Adverse Event|2|||
125468098|NCT00111813|451344095|FG004|Overall Study|Adverse Event|2|||
125468099|NCT00111813|451344096|FG005|Overall Study|Adverse Event|2|||
125468100|NCT00111813|451344091|FG000|Overall Study|Progressive disease|2|||
125468101|NCT00111813|451344092|FG001|Overall Study|Progressive disease|1|||
125468102|NCT00111813|451344093|FG002|Overall Study|Progressive disease|5|||
125468103|NCT00111813|451344094|FG003|Overall Study|Progressive disease|3|||
125468104|NCT00111813|451344095|FG004|Overall Study|Progressive disease|4|||
125468105|NCT00111813|451344096|FG005|Overall Study|Progressive disease|3|||
125468106|NCT00111813|451344091|FG000|Overall Study|Lack of Efficacy|0|||
125468107|NCT00111813|451344092|FG001|Overall Study|Lack of Efficacy|0|||
125468108|NCT00111813|451344093|FG002|Overall Study|Lack of Efficacy|0|||
125468109|NCT00111813|451344094|FG003|Overall Study|Lack of Efficacy|0|||
125468110|NCT00111813|451344095|FG004|Overall Study|Lack of Efficacy|0|||
125468111|NCT00111813|451344096|FG005|Overall Study|Lack of Efficacy|1|||
125468112|NCT00111813|451344091|FG000|Overall Study|Other|0|||
125468113|NCT00111813|451344092|FG001|Overall Study|Other|0|||
125468114|NCT00111813|451344093|FG002|Overall Study|Other|1|||
125468115|NCT00111813|451344094|FG003|Overall Study|Other|0|||
125468116|NCT00111813|451344095|FG004|Overall Study|Other|0|||
125468117|NCT00111813|451344096|FG005|Overall Study|Other|0|||
125468118|NCT02121002|451344098|FG000|Overall Study|Physician Decision|2|||
125468119|NCT02121002|451344099|FG001|Overall Study|Physician Decision|0|||
125468120|NCT02121002|451344100|FG002|Overall Study|Physician Decision|0|||
125468121|NCT02121002|451344098|FG000|Overall Study|Withdrawal by Subject|3|||
125468122|NCT02121002|451344099|FG001|Overall Study|Withdrawal by Subject|1|||
125468123|NCT02121002|451344100|FG002|Overall Study|Withdrawal by Subject|4|||
125468124|NCT02121002|451344098|FG000|Overall Study|Protocol Violation|1|||
125468125|NCT02121002|451344099|FG001|Overall Study|Protocol Violation|2|||
125468126|NCT02121002|451344100|FG002|Overall Study|Protocol Violation|4|||
125468127|NCT02121002|451344098|FG000|Overall Study|Concomitant therapy|0|||
125468128|NCT02121002|451344099|FG001|Overall Study|Concomitant therapy|1|||
125468129|NCT02121002|451344100|FG002|Overall Study|Concomitant therapy|1|||
125468130|NCT02121002|451344098|FG000|Overall Study|Others|1|||
125468131|NCT02121002|451344099|FG001|Overall Study|Others|0|||
125468132|NCT02121002|451344100|FG002|Overall Study|Others|1|||
125297809|NCT02273960|450715733|FG000|Long Term Extension|Death|0|||
125468133|NCT00296036|451344101|FG000|Overall Study|Withdrawal by Subject|1|||
125468134|NCT00296036|451344102|FG001|Overall Study|Withdrawal by Subject|0|||
125468135|NCT00296036|451344103|FG002|Overall Study|Withdrawal by Subject|2|||
125485373|NCT02240238|451412511|FG008|Phase 1|Sponsor termination|0|||
125468136|NCT00296036|451344104|FG003|Overall Study|Withdrawal by Subject|1|||
125468137|NCT00296036|451344105|FG004|Overall Study|Withdrawal by Subject|2|||
125468138|NCT00296036|451344106|FG005|Overall Study|Withdrawal by Subject|1|||
125468139|NCT00296036|451344101|FG000|Overall Study|Protocol Violation|0|||
125468140|NCT00296036|451344102|FG001|Overall Study|Protocol Violation|0|||
125468141|NCT00296036|451344103|FG002|Overall Study|Protocol Violation|0|||
125468142|NCT00296036|451344104|FG003|Overall Study|Protocol Violation|0|||
125468143|NCT00296036|451344105|FG004|Overall Study|Protocol Violation|0|||
125468144|NCT00296036|451344106|FG005|Overall Study|Protocol Violation|3|||
125468145|NCT03403413|451344107|FG000|Overall Study|Lack of Efficacy|2|||
125468146|NCT03655262|451344108|FG000|Overall Study|Withdrawal by Subject|0|||
125468147|NCT03655262|451344109|FG001|Overall Study|Withdrawal by Subject|0|||
125468148|NCT03655262|451344110|FG002|Overall Study|Withdrawal by Subject|1|||
125468149|NCT04583423|451344113|FG000|Overall Study|Lost to Follow-up|0|||
125468150|NCT04583423|451344114|FG001|Overall Study|Lost to Follow-up|1|||
125468151|NCT04583423|451344115|FG002|Overall Study|Lost to Follow-up|0|||
125468152|NCT04583423|451344116|FG003|Overall Study|Lost to Follow-up|2|||
125468153|NCT04583423|451344113|FG000|Overall Study|Study Terminated by Sponsor|32|||
125468154|NCT04583423|451344114|FG001|Overall Study|Study Terminated by Sponsor|35|||
125468155|NCT04583423|451344115|FG002|Overall Study|Study Terminated by Sponsor|36|||
125468156|NCT04583423|451344116|FG003|Overall Study|Study Terminated by Sponsor|33|||
125468157|NCT04583423|451344113|FG000|Overall Study|Withdrawal by Subject|3|||
125468158|NCT04583423|451344114|FG001|Overall Study|Withdrawal by Subject|1|||
125468159|NCT04583423|451344115|FG002|Overall Study|Withdrawal by Subject|2|||
125468160|NCT04583423|451344116|FG003|Overall Study|Withdrawal by Subject|1|||
125468161|NCT00603954|451344124|FG000|Overall Study|Protocol Violation|1|||
125468162|NCT00603954|451344125|FG001|Overall Study|Protocol Violation|2|||
125468163|NCT00580866|451344128|FG000|Overall Study|Lost to Follow-up|2|||
125468164|NCT00580866|451344129|FG001|Overall Study|Lost to Follow-up|2|||
125468165|NCT02477605|451344130|FG000|Overall Study|Discontinued prior to treatment|1|||
125468166|NCT02477605|451344131|FG001|Overall Study|Discontinued prior to treatment|0|||
125468167|NCT02477605|451344130|FG000|Overall Study|Lost to Follow-up|0|||
125468168|NCT02477605|451344131|FG001|Overall Study|Lost to Follow-up|2|||
125468169|NCT02477605|451344130|FG000|Overall Study|Withdrawal by Subject|0|||
125468170|NCT02477605|451344131|FG001|Overall Study|Withdrawal by Subject|1|||
125468171|NCT02477605|451344130|FG000|Overall Study|Administered gas during surgery|0|||
125468172|NCT02477605|451344131|FG001|Overall Study|Administered gas during surgery|1|||
125468173|NCT00567489|451344132|FG000|Overall Study|Adverse Event|6|||
125468174|NCT00567489|451344133|FG001|Overall Study|Adverse Event|14|||
125468175|NCT00567489|451344132|FG000|Overall Study|Physician Decision|0|||
125468176|NCT00567489|451344133|FG001|Overall Study|Physician Decision|4|||
125468177|NCT00567489|451344132|FG000|Overall Study|Withdrawal by Subject|0|||
125468178|NCT00567489|451344133|FG001|Overall Study|Withdrawal by Subject|2|||
125468179|NCT00567489|451344132|FG000|Overall Study|Renal Transplantation|0|||
125468180|NCT00567489|451344133|FG001|Overall Study|Renal Transplantation|3|||
125468181|NCT00567489|451344132|FG000|Overall Study|Other|1|||
125468182|NCT00567489|451344133|FG001|Overall Study|Other|0|||
125468183|NCT03101930|451344138|FG000|Overall Study|Withdrawal by Subject|2|||
125468184|NCT03101930|451344139|FG001|Overall Study|Withdrawal by Subject|1|||
125468185|NCT03101930|451344140|FG002|Overall Study|Withdrawal by Subject|2|||
125468186|NCT01083316|451344141|FG000|Overall Study|Adverse Event|2|||
125468187|NCT01083316|451344141|FG000|Overall Study|Withdrawal by Subject|1|||
125468188|NCT00065260|451344142|FG000|Overall Study|Death|0|||
125468189|NCT00065260|451344143|FG001|Overall Study|Death|1|||
125468190|NCT02178098|451344146|FG000|Overall Study|Withdrawal by Subject|0|||
125468191|NCT02178098|451344147|FG001|Overall Study|Withdrawal by Subject|6|||
125468192|NCT02178098|451344146|FG000|Overall Study|Adverse Event|1|||
125468193|NCT02178098|451344147|FG001|Overall Study|Adverse Event|2|||
125468194|NCT02178098|451344146|FG000|Overall Study|Protocol Violation|1|||
125468195|NCT02178098|451344147|FG001|Overall Study|Protocol Violation|1|||
125468196|NCT02178098|451344146|FG000|Overall Study|Lost to Follow-up|0|||
125468197|NCT02178098|451344147|FG001|Overall Study|Lost to Follow-up|1|||
125468198|NCT02178098|451344146|FG000|Overall Study|Sponsor Request|1|||
125468199|NCT02178098|451344147|FG001|Overall Study|Sponsor Request|0|||
125297810|NCT02273960|450715734|FG001|Long Term Extension|Death|0|||
125297811|NCT02273960|450715735|FG002|Long Term Extension|Death|0|||
125468200|NCT02178098|451344146|FG000|Overall Study|Other|2|||
125468201|NCT02178098|451344147|FG001|Overall Study|Other|2|||
125468202|NCT01109524|451344150|FG000|Overall Study|Disease Progression|29|||
125468203|NCT01109524|451344150|FG000|Overall Study|Study Drug toxicity|6|||
125468204|NCT01109524|451344150|FG000|Overall Study|Adverse Event|4|||
125468205|NCT01109524|451344150|FG000|Overall Study|Withdrawal by Subject|2|||
125468206|NCT01109524|451344150|FG000|Overall Study|Maximum clinical benefit|3|||
125468207|NCT01109524|451344150|FG000|Overall Study|Death|2|||
125468208|NCT01109524|451344150|FG000|Overall Study|No longer meets criteria|2|||
125468209|NCT01109524|451344150|FG000|Overall Study|Participant requested to end treatment|4|||
125468210|NCT01109524|451344150|FG000|Overall Study|Other|5|||
125468211|NCT00031694|451344166|FG000|Overall Study|Adverse Event|12|||
125468212|NCT00031694|451344166|FG000|Overall Study|Death|2|||
125468213|NCT00031694|451344166|FG000|Overall Study|Withdrawal by Subject|5|||
125468214|NCT04939246|451344169|FG000|After Treatment|Death|4|||
125468215|NCT04939246|451344169|FG000|After Treatment|Lost to Follow-up|1|||
125468216|NCT04939246|451344169|FG000|After Treatment|Discharged to hospice|2|||
125468217|NCT04994509|451344170|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
125468218|NCT04994509|451344171|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
125468219|NCT04994509|451344172|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
125468220|NCT04994509|451344170|FG000|Overall Study|Withdrew Consent|73|||
125468221|NCT04994509|451344171|FG001|Overall Study|Withdrew Consent|72|||
125468222|NCT04994509|451344172|FG002|Overall Study|Withdrew Consent|46|||
125468223|NCT04994509|451344170|FG000|Overall Study|Lost to Follow-up|39|||
125468224|NCT04994509|451344171|FG001|Overall Study|Lost to Follow-up|36|||
125468225|NCT04994509|451344172|FG002|Overall Study|Lost to Follow-up|26|||
125297812|NCT02273960|450715736|FG003|Long Term Extension|Death|1|||
125297813|NCT04033068|450715737|FG000|Overall Study|Withdrawal by Subject|0|||
125297814|NCT04033068|450715738|FG001|Overall Study|Withdrawal by Subject|0|||
125297815|NCT04033068|450715739|FG002|Overall Study|Withdrawal by Subject|1|||
125297816|NCT04033068|450715740|FG003|Overall Study|Withdrawal by Subject|0|||
125297817|NCT04033068|450715737|FG000|Overall Study|Lost to Follow-up|0|||
125297818|NCT04033068|450715738|FG001|Overall Study|Lost to Follow-up|1|||
125297819|NCT04033068|450715739|FG002|Overall Study|Lost to Follow-up|0|||
125297820|NCT04033068|450715740|FG003|Overall Study|Lost to Follow-up|0|||
125297821|NCT04033068|450715737|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
125297822|NCT04033068|450715738|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
125297823|NCT04033068|450715739|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
125468226|NCT04994509|451344170|FG000|Overall Study|HIV-1 Infection|4|||
125468227|NCT04994509|451344171|FG001|Overall Study|HIV-1 Infection|20|||
125468228|NCT04994509|451344172|FG002|Overall Study|HIV-1 Infection|12|||
125468229|NCT04994509|451344170|FG000|Overall Study|Investigator's Discretion|9|||
125468230|NCT04994509|451344171|FG001|Overall Study|Investigator's Discretion|8|||
125468231|NCT04994509|451344172|FG002|Overall Study|Investigator's Discretion|11|||
125468232|NCT04994509|451344170|FG000|Overall Study|Randomized but Never Treated|10|||
125468233|NCT04994509|451344171|FG001|Overall Study|Randomized but Never Treated|10|||
125468234|NCT04994509|451344172|FG002|Overall Study|Randomized but Never Treated|3|||
125468235|NCT04994509|451344170|FG000|Overall Study|Pregnancy|5|||
125468236|NCT04994509|451344171|FG001|Overall Study|Pregnancy|5|||
125468237|NCT04994509|451344172|FG002|Overall Study|Pregnancy|0|||
125468238|NCT04994509|451344170|FG000|Overall Study|Death|0|||
125468239|NCT04994509|451344171|FG001|Overall Study|Death|5|||
125468240|NCT04994509|451344172|FG002|Overall Study|Death|0|||
125468241|NCT04994509|451344170|FG000|Overall Study|Adverse Event|2|||
125468242|NCT04994509|451344171|FG001|Overall Study|Adverse Event|1|||
125468243|NCT04994509|451344172|FG002|Overall Study|Adverse Event|0|||
125468244|NCT04994509|451344170|FG000|Overall Study|Non-compliance With Study Drug|1|||
125468245|NCT04994509|451344171|FG001|Overall Study|Non-compliance With Study Drug|1|||
125468246|NCT04994509|451344172|FG002|Overall Study|Non-compliance With Study Drug|1|||
125468247|NCT04994509|451344170|FG000|Overall Study|Withdrew Assent|3|||
125468248|NCT04994509|451344171|FG001|Overall Study|Withdrew Assent|0|||
125468249|NCT04994509|451344172|FG002|Overall Study|Withdrew Assent|0|||
125468250|NCT04994509|451344170|FG000|Overall Study|Protocol Violation|1|||
125468251|NCT04994509|451344171|FG001|Overall Study|Protocol Violation|0|||
125468252|NCT04994509|451344172|FG002|Overall Study|Protocol Violation|0|||
125468253|NCT04278586|451345461|FG000|Overall Study|Withdrawal by Subject|13|||
125468254|NCT04278586|451345462|FG001|Overall Study|Withdrawal by Subject|6|||
125468255|NCT04278586|451345461|FG000|Overall Study|Lost to Follow-up|37|||
125468256|NCT04278586|451345462|FG001|Overall Study|Lost to Follow-up|24|||
125468257|NCT05386238|451345466|FG000|Overall Study|Lost to Follow-up|3|||
125468258|NCT05386238|451345467|FG001|Overall Study|Lost to Follow-up|2|||
125468259|NCT05386238|451345466|FG000|Overall Study|Withdrawal by Subject|0|||
125468260|NCT05386238|451345467|FG001|Overall Study|Withdrawal by Subject|1|||
125297824|NCT04033068|450715740|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
125297825|NCT02039856|450715741|FG000|Overall Study|Death|5|||
125297826|NCT02039856|450715742|FG001|Overall Study|Death|3|||
125297827|NCT02039856|450715741|FG000|Overall Study|Partial survey completion|61|||
125468261|NCT04714320|451345468|FG000|Overall Study|Voluntary Withdrawal|4|||
125468262|NCT04714320|451345469|FG001|Overall Study|Voluntary Withdrawal|1|||
125468263|NCT04714320|451345470|FG002|Overall Study|Voluntary Withdrawal|2|||
125297828|NCT02039856|450715742|FG001|Overall Study|Partial survey completion|26|||
125297829|NCT02039856|450715741|FG000|Overall Study|Lost to Follow-up|388|||
125297830|NCT02039856|450715742|FG001|Overall Study|Lost to Follow-up|206|||
125468264|NCT04714320|451345468|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
125468265|NCT04714320|451345469|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
125468266|NCT04714320|451345470|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
125468267|NCT04714320|451345468|FG000|Overall Study|Reason Not Specified|1|||
125468268|NCT04714320|451345469|FG001|Overall Study|Reason Not Specified|3|||
125485374|NCT02240238|451412512|FG009|Phase 1|Sponsor termination|0|||
125297831|NCT02039856|450715741|FG000|Overall Study|Withdrawal by Subject|1573|||
125468269|NCT04714320|451345470|FG002|Overall Study|Reason Not Specified|3|||
125468270|NCT05057897|451345471|FG000|Overall Study|Site closure|2|||
125468271|NCT05057897|451345472|FG001|Overall Study|Site closure|2|||
125468272|NCT05057897|451345471|FG000|Overall Study|Death|1|||
125468273|NCT05057897|451345472|FG001|Overall Study|Death|0|||
125468274|NCT03346538|451345473|FG000|Overall Study|Physician Decision|0|||
125468275|NCT03346538|451345474|FG001|Overall Study|Physician Decision|1|||
125468276|NCT03346538|451345475|FG002|Overall Study|Physician Decision|0|||
125468277|NCT03346538|451345473|FG000|Overall Study|Withdrawal by Subject|3|||
125468278|NCT03346538|451345474|FG001|Overall Study|Withdrawal by Subject|2|||
125468279|NCT03346538|451345475|FG002|Overall Study|Withdrawal by Subject|0|||
125468280|NCT03346538|451345473|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
125468281|NCT03346538|451345474|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
125468282|NCT03346538|451345475|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
125468283|NCT05672667|451345476|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
125468284|NCT04524390|451345477|FG000|Double Blind|Consent Withdrawal by subject|2|||
125468285|NCT04524390|451345478|FG001|Double Blind|Consent Withdrawal by subject|1|||
125468286|NCT04524390|451345479|FG002|Double Blind|Consent Withdrawal by subject|0|||
125468287|NCT04524390|451345477|FG000|Double Blind|Adverse Event|5|||
125468288|NCT04524390|451345478|FG001|Double Blind|Adverse Event|3|||
125468289|NCT04524390|451345479|FG002|Double Blind|Adverse Event|0|||
125468290|NCT04524390|451345477|FG000|Double Blind|Liver Transplant|5|||
125468291|NCT04524390|451345478|FG001|Double Blind|Liver Transplant|6|||
125468292|NCT04524390|451345479|FG002|Double Blind|Liver Transplant|0|||
125468293|NCT04524390|451345477|FG000|Double Blind|Disease Progression|0|||
125468294|NCT04524390|451345478|FG001|Double Blind|Disease Progression|1|||
125468295|NCT04524390|451345479|FG002|Double Blind|Disease Progression|0|||
125468296|NCT04524390|451345477|FG000|Open-Label|Drug interruption criteria|0|||
125468297|NCT04524390|451345478|FG001|Open-Label|Drug interruption criteria|0|||
125468298|NCT04524390|451345479|FG002|Open-Label|Drug interruption criteria|1|||
125468299|NCT04524390|451345477|FG000|Open-Label|Liver Transplant|0|||
125468300|NCT04524390|451345478|FG001|Open-Label|Liver Transplant|0|||
125468301|NCT04524390|451345479|FG002|Open-Label|Liver Transplant|1|||
125468302|NCT04524390|451345477|FG000|Open-Label|Disease Progression|0|||
125468303|NCT04524390|451345478|FG001|Open-Label|Disease Progression|0|||
125468304|NCT04524390|451345479|FG002|Open-Label|Disease Progression|1|||
125468305|NCT04524390|451345477|FG000|Open-Label|Adverse Event|0|||
125468306|NCT04524390|451345478|FG001|Open-Label|Adverse Event|0|||
125468307|NCT04524390|451345479|FG002|Open-Label|Adverse Event|3|||
125468308|NCT04524390|451345477|FG000|Open-Label|Study Termination by sponsor|0|||
125468309|NCT04524390|451345478|FG001|Open-Label|Study Termination by sponsor|0|||
125468310|NCT04524390|451345479|FG002|Open-Label|Study Termination by sponsor|45|||
125468311|NCT04540913|451345485|FG000|Overall Study|Withdrawal by Subject|14|||
125468312|NCT04540913|451345486|FG001|Overall Study|Withdrawal by Subject|3|||
125468313|NCT03438188|451345487|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
125468314|NCT03438188|451345488|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
125468315|NCT03438188|451345489|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
125468316|NCT03438188|451345487|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
125468317|NCT03438188|451345488|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
125468318|NCT03438188|451345489|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
125468319|NCT03438188|451345487|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
125468320|NCT03438188|451345488|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
125468321|NCT03438188|451345489|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
125468322|NCT03438188|451345487|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
125468323|NCT03438188|451345488|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
125468324|NCT03438188|451345489|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
125468325|NCT03438188|451345487|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
125468326|NCT03438188|451345488|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
125468327|NCT03438188|451345489|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
125468328|NCT00792636|451345490|FG000|Overall Study|Protocol Violation|17|||
125468329|NCT00792636|451345491|FG001|Overall Study|Protocol Violation|23|||
125468330|NCT00792636|451345492|FG002|Overall Study|Protocol Violation|20|||
125468331|NCT00792636|451345490|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
125468332|NCT00792636|451345491|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
125468333|NCT00792636|451345492|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
125468334|NCT00792636|451345490|FG000|Overall Study|Lost to Follow-up|13|||
125468335|NCT00792636|451345491|FG001|Overall Study|Lost to Follow-up|19|||
125468336|NCT00792636|451345492|FG002|Overall Study|Lost to Follow-up|14|||
125468337|NCT00792636|451345490|FG000|Overall Study|Withdrew Consent|10|||
125468338|NCT00792636|451345491|FG001|Overall Study|Withdrew Consent|13|||
125468339|NCT00792636|451345492|FG002|Overall Study|Withdrew Consent|9|||
125420551|NCT00833638|451163691|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
125420552|NCT00833638|451163692|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
125420553|NCT00833638|451163693|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
125420554|NCT00833638|451163691|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
125420555|NCT00833638|451163692|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
125420556|NCT00833638|451163693|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
125420557|NCT00833638|451163691|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
125420558|NCT00833638|451163692|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
125420559|NCT00833638|451163693|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
125420560|NCT00833638|451163691|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
125420561|NCT00833638|451163692|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
125420562|NCT00833638|451163693|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
125420563|NCT00833638|451163691|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
125420564|NCT00833638|451163692|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
125420565|NCT00833638|451163693|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
125420566|NCT00833638|451163691|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
125420567|NCT00833638|451163692|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
125420568|NCT00833638|451163693|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
125420569|NCT00833638|451163691|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
125420570|NCT00833638|451163692|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
125420571|NCT00833638|451163693|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
125420572|NCT01669122|451163694|FG000|Period I|Lost to Follow-up|1|||
125420573|NCT01669122|451163694|FG000|Washout Period II|Protocol Violation|2|||
125420574|NCT03543254|451163695|FG000|Overall Study|Lost to Follow-up|1|||
125420575|NCT01261338|451163696|FG000|Overall Study|Withdrawal by Subject|3|||
125420576|NCT01261338|451163697|FG001|Overall Study|Withdrawal by Subject|2|||
125420577|NCT00234065|451163698|FG000|Overall Study|Adverse Event|268|||
125420578|NCT00234065|451163699|FG001|Overall Study|Adverse Event|166|||
125420579|NCT00234065|451163698|FG000|Overall Study|Withdrawal by Subject|73|||
125420580|NCT00234065|451163699|FG001|Overall Study|Withdrawal by Subject|56|||
125420581|NCT00234065|451163698|FG000|Overall Study|Physician Decision|23|||
125420582|NCT00234065|451163699|FG001|Overall Study|Physician Decision|22|||
125420583|NCT00234065|451163698|FG000|Overall Study|Not Classified|111|||
125420584|NCT00234065|451163699|FG001|Overall Study|Not Classified|112|||
125420585|NCT05374421|451163700|FG000|Overall Study|Withdrawal by Subject|3|||
125420586|NCT05374421|451163701|FG001|Overall Study|Withdrawal by Subject|4|||
125420587|NCT05132699|451163702|FG000|Overall Study|Withdrawal by Subject|3|||
125420588|NCT05132699|451163703|FG001|Overall Study|Withdrawal by Subject|0|||
125420589|NCT02899728|451163704|FG000|Overall Study|Withdrawal by Subject|1|||
125420590|NCT02899728|451163705|FG001|Overall Study|Withdrawal by Subject|1|||
125420591|NCT05557942|451163706|FG000|Overall Study|Death|0|||
125420592|NCT05557942|451163707|FG001|Overall Study|Death|0|||
125420593|NCT05557942|451163708|FG002|Overall Study|Death|0|||
125420594|NCT05557942|451163709|FG003|Overall Study|Death|2|||
125420595|NCT05557942|451163710|FG004|Overall Study|Death|1|||
125420596|NCT05557942|451163711|FG005|Overall Study|Death|1|||
125420597|NCT05557942|451163706|FG000|Overall Study|Physician Decision|1|||
125420598|NCT05557942|451163707|FG001|Overall Study|Physician Decision|1|||
125420599|NCT05557942|451163708|FG002|Overall Study|Physician Decision|2|||
125420600|NCT05557942|451163709|FG003|Overall Study|Physician Decision|3|||
125420601|NCT05557942|451163710|FG004|Overall Study|Physician Decision|0|||
125420602|NCT05557942|451163711|FG005|Overall Study|Physician Decision|2|||
125420603|NCT05557942|451163706|FG000|Overall Study|Study terminated by sponsor|17|||
125420604|NCT05557942|451163707|FG001|Overall Study|Study terminated by sponsor|17|||
125420605|NCT05557942|451163708|FG002|Overall Study|Study terminated by sponsor|14|||
125420606|NCT05557942|451163709|FG003|Overall Study|Study terminated by sponsor|40|||
125420607|NCT05557942|451163710|FG004|Overall Study|Study terminated by sponsor|45|||
125420608|NCT05557942|451163711|FG005|Overall Study|Study terminated by sponsor|37|||
125420609|NCT05557942|451163706|FG000|Overall Study|Protocol Violation|0|||
125420610|NCT05557942|451163707|FG001|Overall Study|Protocol Violation|0|||
125420611|NCT05557942|451163708|FG002|Overall Study|Protocol Violation|0|||
125420612|NCT05557942|451163709|FG003|Overall Study|Protocol Violation|0|||
125420613|NCT05557942|451163710|FG004|Overall Study|Protocol Violation|0|||
125420614|NCT05557942|451163711|FG005|Overall Study|Protocol Violation|1|||
125420615|NCT05557942|451163706|FG000|Overall Study|Withdrawal by Subject|0|||
125420616|NCT05557942|451163707|FG001|Overall Study|Withdrawal by Subject|0|||
125420617|NCT05557942|451163708|FG002|Overall Study|Withdrawal by Subject|0|||
125420618|NCT05557942|451163709|FG003|Overall Study|Withdrawal by Subject|0|||
125420619|NCT05557942|451163710|FG004|Overall Study|Withdrawal by Subject|2|||
125420620|NCT05557942|451163711|FG005|Overall Study|Withdrawal by Subject|0|||
125420621|NCT02477618|451163712|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
125420622|NCT02477618|451163713|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
125420623|NCT02477618|451163712|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
125420624|NCT02477618|451163713|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
125468340|NCT00792636|451345490|FG000|Overall Study|Lack of Efficacy|3|||
125468341|NCT00792636|451345491|FG001|Overall Study|Lack of Efficacy|4|||
125468342|NCT00792636|451345492|FG002|Overall Study|Lack of Efficacy|13|||
125468343|NCT00792636|451345490|FG000|Overall Study|Adverse Event|4|||
125468344|NCT00792636|451345491|FG001|Overall Study|Adverse Event|2|||
125468345|NCT00792636|451345492|FG002|Overall Study|Adverse Event|3|||
125468346|NCT00792636|451345490|FG000|Overall Study|Investigator Discretion|2|||
125468347|NCT00792636|451345491|FG001|Overall Study|Investigator Discretion|0|||
125468348|NCT00792636|451345492|FG002|Overall Study|Investigator Discretion|2|||
125468349|NCT01610297|451345493|FG000|Overall Study|Lost to Follow-up|1|||
125468350|NCT01007396|451345497|FG000|Overall Study|Lost to Follow-up|47|||
125468351|NCT02590432|451345498|FG000|Open-label Treatment Period|Adverse Event|97|||
125468352|NCT02590432|451345499|FG001|Open-label Treatment Period|Adverse Event|79|||
125468353|NCT02590432|451345500|FG002|Open-label Treatment Period|Adverse Event|0|||
125468354|NCT02590432|451345501|FG003|Open-label Treatment Period|Adverse Event|0|||
125468355|NCT02590432|451345502|FG004|Open-label Treatment Period|Adverse Event|0|||
125468356|NCT02590432|451345503|FG005|Open-label Treatment Period|Adverse Event|0|||
125468357|NCT02590432|451345504|FG006|Open-label Treatment Period|Adverse Event|0|||
125468358|NCT02590432|451345505|FG007|Open-label Treatment Period|Adverse Event|0|||
125468359|NCT02590432|451345506|FG008|Open-label Treatment Period|Adverse Event|0|||
125468360|NCT02590432|451345498|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
125468361|NCT02590432|451345499|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
125468362|NCT02590432|451345500|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
125468363|NCT02590432|451345501|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
125468364|NCT02590432|451345502|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
125468365|NCT02590432|451345503|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
125468366|NCT02590432|451345504|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
125468367|NCT02590432|451345505|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
125468368|NCT02590432|451345506|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
125468369|NCT02590432|451345498|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
125468370|NCT02590432|451345499|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
125468371|NCT02590432|451345500|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
125468372|NCT02590432|451345501|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
125468373|NCT02590432|451345502|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
125468374|NCT02590432|451345503|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
125468375|NCT02590432|451345504|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
125468376|NCT02590432|451345505|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
125468377|NCT02590432|451345506|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
125468378|NCT02590432|451345498|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
125468379|NCT02590432|451345499|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
125468380|NCT02590432|451345500|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
125468381|NCT02590432|451345501|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
125468382|NCT02590432|451345502|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
125468383|NCT02590432|451345503|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
125468384|NCT02590432|451345504|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
125468385|NCT02590432|451345505|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
125468386|NCT02590432|451345506|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
125468387|NCT02590432|451345498|FG000|Open-label Treatment Period|Protocol Violation|10|||
125468388|NCT02590432|451345499|FG001|Open-label Treatment Period|Protocol Violation|4|||
125468389|NCT02590432|451345500|FG002|Open-label Treatment Period|Protocol Violation|0|||
125468390|NCT02590432|451345501|FG003|Open-label Treatment Period|Protocol Violation|0|||
125468391|NCT02590432|451345502|FG004|Open-label Treatment Period|Protocol Violation|0|||
125468392|NCT02590432|451345503|FG005|Open-label Treatment Period|Protocol Violation|0|||
125468393|NCT02590432|451345504|FG006|Open-label Treatment Period|Protocol Violation|0|||
125468394|NCT02590432|451345505|FG007|Open-label Treatment Period|Protocol Violation|0|||
125468395|NCT02590432|451345506|FG008|Open-label Treatment Period|Protocol Violation|0|||
125468396|NCT02590432|451345498|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
125468397|NCT02590432|451345499|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
125468398|NCT02590432|451345500|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
125468399|NCT02590432|451345501|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
125468400|NCT02590432|451345502|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
125468401|NCT02590432|451345503|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
125468402|NCT02590432|451345504|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
125468403|NCT02590432|451345505|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
125468404|NCT02590432|451345506|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
125468405|NCT02590432|451345498|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
125468406|NCT02590432|451345499|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
125468407|NCT02590432|451345500|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
125468408|NCT02590432|451345501|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
125468409|NCT02590432|451345502|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
125468410|NCT02590432|451345503|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
125468411|NCT02590432|451345504|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
125468412|NCT02590432|451345505|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
125468413|NCT02590432|451345506|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
125468414|NCT02590432|451345498|FG000|Double-blind Treatment Period|Adverse Event|0|||
125468415|NCT02590432|451345499|FG001|Double-blind Treatment Period|Adverse Event|0|||
125468416|NCT02590432|451345500|FG002|Double-blind Treatment Period|Adverse Event|14|||
125468417|NCT02590432|451345501|FG003|Double-blind Treatment Period|Adverse Event|12|||
125468418|NCT02590432|451345502|FG004|Double-blind Treatment Period|Adverse Event|6|||
125468419|NCT02590432|451345503|FG005|Double-blind Treatment Period|Adverse Event|22|||
125468420|NCT02590432|451345504|FG006|Double-blind Treatment Period|Adverse Event|20|||
125468421|NCT02590432|451345505|FG007|Double-blind Treatment Period|Adverse Event|0|||
125468422|NCT02590432|451345506|FG008|Double-blind Treatment Period|Adverse Event|0|||
125468423|NCT02590432|451345498|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
125468424|NCT02590432|451345499|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
125468425|NCT02590432|451345500|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
125468426|NCT02590432|451345501|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
125468427|NCT02590432|451345502|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
125468428|NCT02590432|451345503|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
125468429|NCT02590432|451345504|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
125468430|NCT02590432|451345505|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
125468431|NCT02590432|451345506|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
125468432|NCT02590432|451345498|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
125468433|NCT02590432|451345499|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
125468434|NCT02590432|451345500|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
125468435|NCT02590432|451345501|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
125468436|NCT02590432|451345502|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
125468437|NCT02590432|451345503|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
125468438|NCT02590432|451345504|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
125468439|NCT02590432|451345505|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
125468440|NCT02590432|451345506|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
125468441|NCT02590432|451345498|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
125468442|NCT02590432|451345499|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
125468443|NCT02590432|451345500|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
125468444|NCT02590432|451345501|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
125468445|NCT02590432|451345502|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
125468446|NCT02590432|451345503|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
125468447|NCT02590432|451345504|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
125468448|NCT02590432|451345505|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
125468449|NCT02590432|451345506|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
125420625|NCT02477618|451163712|FG000|Overall Study|Adverse Event|1|||
125420626|NCT02477618|451163713|FG001|Overall Study|Adverse Event|1|||
125420627|NCT02477618|451163712|FG000|Overall Study|Transferred Away from Study Site|1|||
125420628|NCT02477618|451163713|FG001|Overall Study|Transferred Away from Study Site|0|||
125420629|NCT02477618|451163712|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
125420630|NCT02477618|451163713|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
125420631|NCT02057874|451166079|FG000|Overall Study|participant did not return for scan|1|||
125420632|NCT01738984|451166080|FG000|Overall Study|Pregnancy|4|||
125420633|NCT01738984|451166081|FG001|Overall Study|Pregnancy|0|||
125420634|NCT01738984|451166080|FG000|Overall Study|Withdrawal by Subject|1|||
125420635|NCT01738984|451166081|FG001|Overall Study|Withdrawal by Subject|0|||
125420636|NCT01738984|451166080|FG000|Overall Study|Lost to Follow-up|59|||
125420637|NCT01738984|451166081|FG001|Overall Study|Lost to Follow-up|39|||
125420638|NCT01258608|451166086|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
125420639|NCT01258608|451166087|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
125420640|NCT01258608|451166086|FG000|Overall Study|Clinical progression|1|||
125420641|NCT01258608|451166087|FG001|Overall Study|Clinical progression|0|||
125420642|NCT01258608|451166086|FG000|Overall Study|Sponsor decision|0|||
125420643|NCT01258608|451166087|FG001|Overall Study|Sponsor decision|1|||
125420644|NCT01258608|451166086|FG000|Overall Study|Physician Decision|6|||
125420645|NCT01258608|451166087|FG001|Overall Study|Physician Decision|1|||
125420646|NCT01258608|451166086|FG000|Overall Study|Lost to Follow-up|0|||
125420647|NCT01258608|451166087|FG001|Overall Study|Lost to Follow-up|1|||
125420648|NCT01258608|451166086|FG000|Overall Study|Lack of compliance|1|||
125420649|NCT01258608|451166087|FG001|Overall Study|Lack of compliance|0|||
125420650|NCT01258608|451166086|FG000|Overall Study|Lack of Efficacy|0|||
125420651|NCT01258608|451166087|FG001|Overall Study|Lack of Efficacy|1|||
125420652|NCT01258608|451166086|FG000|Overall Study|Adverse Event|6|||
125420653|NCT01258608|451166087|FG001|Overall Study|Adverse Event|10|||
125420654|NCT01258608|451166086|FG000|Overall Study|Withdrawal by Subject|6|||
125420655|NCT01258608|451166087|FG001|Overall Study|Withdrawal by Subject|5|||
125468450|NCT02590432|451345498|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
125468451|NCT02590432|451345499|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
125468452|NCT02590432|451345500|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
125468453|NCT02590432|451345501|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
125468454|NCT02590432|451345502|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
125468455|NCT02590432|451345503|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
125468456|NCT02590432|451345504|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
125468457|NCT02590432|451345505|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
125468458|NCT02590432|451345506|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
125468459|NCT02590432|451345498|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
125468460|NCT02590432|451345499|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
125468461|NCT02590432|451345500|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
125468462|NCT02590432|451345501|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
125468463|NCT02590432|451345502|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
125468464|NCT02590432|451345503|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
125468465|NCT02590432|451345504|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
125468466|NCT02590432|451345505|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
125468467|NCT02590432|451345506|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
125468468|NCT02590432|451345498|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
125468469|NCT02590432|451345499|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
125468470|NCT02590432|451345500|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
125468471|NCT02590432|451345501|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
125468472|NCT02590432|451345502|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
125468473|NCT02590432|451345503|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
125468474|NCT02590432|451345504|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
125468475|NCT02590432|451345505|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
125468476|NCT02590432|451345506|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
125468477|NCT02590432|451345498|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
125468478|NCT02590432|451345499|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
125468479|NCT02590432|451345500|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
125468480|NCT02590432|451345501|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
125468481|NCT02590432|451345502|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
125468482|NCT02590432|451345503|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
125468483|NCT02590432|451345504|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
125468484|NCT02590432|451345505|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
125468485|NCT02590432|451345506|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
125468486|NCT02590432|451345498|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
125468487|NCT02590432|451345499|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
125468488|NCT02590432|451345500|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
125468489|NCT02590432|451345501|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
125468490|NCT02590432|451345502|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
125468491|NCT02590432|451345503|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
125468492|NCT02590432|451345504|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
125468493|NCT02590432|451345505|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
125468494|NCT02590432|451345506|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
125468495|NCT02590432|451345498|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
125468496|NCT02590432|451345499|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
125468497|NCT02590432|451345500|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
125468498|NCT02590432|451345501|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
125468499|NCT02590432|451345502|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
125468500|NCT02590432|451345503|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
125468501|NCT02590432|451345504|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
125468502|NCT02590432|451345505|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
125468503|NCT02590432|451345506|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
125468504|NCT02590432|451345498|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
125468505|NCT02590432|451345499|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
125468506|NCT02590432|451345500|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
125468507|NCT02590432|451345501|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
125468508|NCT02590432|451345502|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
125468509|NCT02590432|451345503|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
125468510|NCT02590432|451345504|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
125468511|NCT02590432|451345505|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
125468512|NCT02590432|451345506|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
125468513|NCT02590432|451345498|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
125468514|NCT02590432|451345499|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
125468515|NCT02590432|451345500|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
125468516|NCT02590432|451345501|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
125468517|NCT02590432|451345502|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
125468518|NCT02590432|451345503|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
125468519|NCT02590432|451345504|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
125468520|NCT02590432|451345505|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
125468521|NCT02590432|451345506|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
125468522|NCT02740231|451345511|FG000|Overall Study|Withdrawal by Subject|1|||
125468523|NCT02740231|451345512|FG001|Overall Study|Withdrawal by Subject|1|||
125468524|NCT02740231|451345513|FG002|Overall Study|Withdrawal by Subject|1|||
125468525|NCT02740231|451345514|FG003|Overall Study|Withdrawal by Subject|0|||
125468526|NCT02740231|451345511|FG000|Overall Study|Lack of Efficacy|0|||
125468527|NCT02740231|451345512|FG001|Overall Study|Lack of Efficacy|1|||
125468528|NCT02740231|451345513|FG002|Overall Study|Lack of Efficacy|0|||
125468529|NCT02740231|451345514|FG003|Overall Study|Lack of Efficacy|4|||
125468530|NCT02740231|451345511|FG000|Overall Study|Lost to Follow-up|1|||
125468531|NCT02740231|451345512|FG001|Overall Study|Lost to Follow-up|3|||
125468532|NCT02740231|451345513|FG002|Overall Study|Lost to Follow-up|0|||
125468533|NCT02740231|451345514|FG003|Overall Study|Lost to Follow-up|3|||
125468534|NCT02740231|451345511|FG000|Overall Study|Adverse Event|0|||
125468535|NCT02740231|451345512|FG001|Overall Study|Adverse Event|1|||
125468536|NCT02740231|451345513|FG002|Overall Study|Adverse Event|0|||
125468537|NCT02740231|451345514|FG003|Overall Study|Adverse Event|1|||
125468538|NCT00243503|451345515|FG000|Overall Study|Adverse Event|11|||
125468539|NCT00243503|451345515|FG000|Overall Study|Withdrawal by Subject|1|||
125468540|NCT00243503|451345515|FG000|Overall Study|Lack of Efficacy|44|||
125468541|NCT00243503|451345515|FG000|Overall Study|Death|1|||
125468542|NCT00243503|451345515|FG000|Overall Study|Other|1|||
125468543|NCT03076515|451345520|FG000|Overall Study|DMC decision based on interim analysis|25|||
125468544|NCT03076515|451345521|FG001|Overall Study|DMC decision based on interim analysis|29|||
125468545|NCT02374307|451345522|FG000|3-months Follow-up|Lost to Follow-up|1|||
125468546|NCT02374307|451345523|FG001|3-months Follow-up|Lost to Follow-up|2|||
125468547|NCT02374307|451345522|FG000|3-months Follow-up|Withdrawal by Subject|1|||
125468548|NCT02374307|451345523|FG001|3-months Follow-up|Withdrawal by Subject|4|||
125468549|NCT02374307|451345522|FG000|3-months Follow-up|Death|1|||
125468550|NCT02374307|451345523|FG001|3-months Follow-up|Death|2|||
125468551|NCT02374307|451345522|FG000|3-months Follow-up|Missed first follow-up|5|||
125468552|NCT02374307|451345523|FG001|3-months Follow-up|Missed first follow-up|1|||
125468553|NCT02374307|451345522|FG000|6-months Follow-up|Lost to Follow-up|1|||
125468554|NCT02374307|451345523|FG001|6-months Follow-up|Lost to Follow-up|2|||
125468555|NCT02374307|451345522|FG000|6-months Follow-up|Death|2|||
125468556|NCT02374307|451345523|FG001|6-months Follow-up|Death|1|||
125468557|NCT02374307|451345522|FG000|6-months Follow-up|Withdrawal by Subject|0|||
125468558|NCT02374307|451345523|FG001|6-months Follow-up|Withdrawal by Subject|3|||
125468559|NCT00999167|451345524|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
125468560|NCT00999167|451345525|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
125468561|NCT00999167|451345526|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
125468562|NCT00999167|451345524|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
125468563|NCT00999167|451345525|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
125468564|NCT00999167|451345526|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
125468565|NCT00999167|451345524|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
125468566|NCT00999167|451345525|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
125468567|NCT00999167|451345526|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
125468568|NCT00999167|451345524|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
125468569|NCT00999167|451345525|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
125468570|NCT00999167|451345526|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
125297832|NCT02039856|450715742|FG001|Overall Study|Withdrawal by Subject|618|||
125297833|NCT02409342|450715743|FG000|Overall Study|Death|211|||
125468571|NCT00999167|451345524|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
125468572|NCT00999167|451345525|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
125468573|NCT00999167|451345526|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
125297834|NCT02409342|450715744|FG001|Overall Study|Death|201|||
125468574|NCT00999167|451345524|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
125468575|NCT00999167|451345525|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
125468576|NCT00999167|451345526|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
125468577|NCT00999167|451345524|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
125297835|NCT02409342|450715743|FG000|Overall Study|Withdrawal by Subject|24|||
125468578|NCT00999167|451345525|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
125468579|NCT00999167|451345526|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
125468580|NCT00999167|451345524|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
125468581|NCT00999167|451345525|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
125468582|NCT00999167|451345526|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
125468583|NCT02554786|451345527|FG000|Overall Study|Subject/guardian decision|29|||
125468584|NCT02554786|451345528|FG001|Overall Study|Subject/guardian decision|17|||
125468585|NCT02554786|451345529|FG002|Overall Study|Subject/guardian decision|18|||
125468586|NCT02554786|451345530|FG003|Overall Study|Subject/guardian decision|30|||
125468587|NCT02554786|451345531|FG004|Overall Study|Subject/guardian decision|20|||
125468588|NCT02554786|451345527|FG000|Overall Study|Lost to Follow-up|4|||
125468589|NCT02554786|451345528|FG001|Overall Study|Lost to Follow-up|3|||
125468590|NCT02554786|451345529|FG002|Overall Study|Lost to Follow-up|4|||
125468591|NCT02554786|451345530|FG003|Overall Study|Lost to Follow-up|2|||
125297836|NCT02409342|450715744|FG001|Overall Study|Withdrawal by Subject|17|||
125297837|NCT02409342|450715743|FG000|Overall Study|Study Terminated By Sponsor|48|||
125297838|NCT02409342|450715744|FG001|Overall Study|Study Terminated By Sponsor|59|||
125297839|NCT02409342|450715743|FG000|Overall Study|Lost to Follow-up|3|||
125297840|NCT02409342|450715744|FG001|Overall Study|Lost to Follow-up|5|||
125297841|NCT02409342|450715743|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
125297842|NCT02409342|450715744|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
125297843|NCT02409342|450715743|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
125297844|NCT02409342|450715744|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
125297845|NCT02409342|450715743|FG000|Overall Study|Sponsor Decision|1|||
125297846|NCT02409342|450715744|FG001|Overall Study|Sponsor Decision|0|||
125297847|NCT03908970|450715745|FG000|Overall Study|Adverse Event|7|||
125297848|NCT03908970|450715746|FG001|Overall Study|Adverse Event|21|||
125297849|NCT03908970|450715745|FG000|Overall Study|Physician Decision|1|||
125297850|NCT03908970|450715746|FG001|Overall Study|Physician Decision|4|||
125297851|NCT03908970|450715745|FG000|Overall Study|Withdrawal by Subject|9|||
125297852|NCT03908970|450715746|FG001|Overall Study|Withdrawal by Subject|22|||
125297853|NCT00417963|450717170|FG000|Overall Study|Lost to Follow-up|3|||
125297854|NCT00417963|450717170|FG000|Overall Study|Withdrawal by Subject|18|||
125297855|NCT00417963|450717170|FG000|Overall Study|Death|17|||
125297856|NCT00417963|450717170|FG000|Overall Study|Study device could not be deployed|3|||
125297857|NCT00477152|450717182|FG000|Overall Study|Parent withdrew consent|2|||
125297858|NCT00477152|450717182|FG000|Overall Study|Adverse Event|1|||
125297859|NCT00387725|450717185|FG000|Overall Study|Adverse Event|0|||
125297860|NCT00387725|450717186|FG001|Overall Study|Adverse Event|0|||
125297861|NCT00387725|450717187|FG002|Overall Study|Adverse Event|0|||
125297862|NCT00387725|450717188|FG003|Overall Study|Adverse Event|1|||
125297863|NCT00387725|450717185|FG000|Overall Study|Protocol Violation|0|||
125297864|NCT00387725|450717186|FG001|Overall Study|Protocol Violation|1|||
125297865|NCT00387725|450717187|FG002|Overall Study|Protocol Violation|0|||
125297866|NCT00387725|450717188|FG003|Overall Study|Protocol Violation|0|||
125297867|NCT00387725|450717185|FG000|Overall Study|Withdrawal by Subject|1|||
125297868|NCT00387725|450717186|FG001|Overall Study|Withdrawal by Subject|0|||
125297869|NCT00387725|450717187|FG002|Overall Study|Withdrawal by Subject|1|||
125297870|NCT00387725|450717188|FG003|Overall Study|Withdrawal by Subject|0|||
125297871|NCT00387725|450717185|FG000|Overall Study|Parent/legal guardian request|0|||
125297872|NCT00387725|450717186|FG001|Overall Study|Parent/legal guardian request|0|||
125297873|NCT00387725|450717187|FG002|Overall Study|Parent/legal guardian request|1|||
125297874|NCT00387725|450717188|FG003|Overall Study|Parent/legal guardian request|1|||
125297875|NCT00568126|450717189|FG000|Overall Study|Adverse Event|3|||
125297876|NCT00568126|450717190|FG001|Overall Study|Adverse Event|0|||
125297877|NCT00568126|450717189|FG000|Overall Study|Withdrawal by Subject|2|||
125468592|NCT02554786|451345531|FG004|Overall Study|Lost to Follow-up|2|||
125468593|NCT02554786|451345527|FG000|Overall Study|Protocol deviation|1|||
125468594|NCT02554786|451345528|FG001|Overall Study|Protocol deviation|3|||
125468595|NCT02554786|451345529|FG002|Overall Study|Protocol deviation|3|||
125468596|NCT02554786|451345530|FG003|Overall Study|Protocol deviation|4|||
125468597|NCT02554786|451345531|FG004|Overall Study|Protocol deviation|2|||
125468598|NCT02554786|451345527|FG000|Overall Study|Technical problems|1|||
125468599|NCT02554786|451345528|FG001|Overall Study|Technical problems|1|||
125468600|NCT02554786|451345529|FG002|Overall Study|Technical problems|0|||
125297878|NCT00568126|450717190|FG001|Overall Study|Withdrawal by Subject|3|||
125297879|NCT00568126|450717189|FG000|Overall Study|Lost to Follow-up|4|||
125297880|NCT00568126|450717190|FG001|Overall Study|Lost to Follow-up|3|||
125297881|NCT00568126|450717189|FG000|Overall Study|Lack of Efficacy|0|||
125468601|NCT02554786|451345530|FG003|Overall Study|Technical problems|2|||
125468602|NCT02554786|451345531|FG004|Overall Study|Technical problems|1|||
125468603|NCT02554786|451345527|FG000|Overall Study|Adverse Event|0|||
125468604|NCT02554786|451345528|FG001|Overall Study|Adverse Event|0|||
125468605|NCT02554786|451345529|FG002|Overall Study|Adverse Event|0|||
125297882|NCT00568126|450717190|FG001|Overall Study|Lack of Efficacy|1|||
125297883|NCT00568126|450717189|FG000|Overall Study|Physician Decision|2|||
125468606|NCT02554786|451345530|FG003|Overall Study|Adverse Event|0|||
125468607|NCT02554786|451345531|FG004|Overall Study|Adverse Event|2|||
125468608|NCT02554786|451345527|FG000|Overall Study|Death|0|||
125468609|NCT02554786|451345528|FG001|Overall Study|Death|0|||
125468610|NCT02554786|451345529|FG002|Overall Study|Death|0|||
125468611|NCT02554786|451345530|FG003|Overall Study|Death|1|||
125468612|NCT02554786|451345531|FG004|Overall Study|Death|0|||
125468613|NCT02554786|451345527|FG000|Overall Study|Non-compliance with study treatment|0|||
125468614|NCT02554786|451345528|FG001|Overall Study|Non-compliance with study treatment|1|||
125468615|NCT02554786|451345529|FG002|Overall Study|Non-compliance with study treatment|1|||
125468616|NCT02554786|451345530|FG003|Overall Study|Non-compliance with study treatment|0|||
125468617|NCT02554786|451345531|FG004|Overall Study|Non-compliance with study treatment|1|||
125468618|NCT02554786|451345527|FG000|Overall Study|Physician Decision|0|||
125468619|NCT02554786|451345528|FG001|Overall Study|Physician Decision|1|||
125468620|NCT02554786|451345529|FG002|Overall Study|Physician Decision|4|||
125468621|NCT02554786|451345530|FG003|Overall Study|Physician Decision|1|||
125468622|NCT02554786|451345531|FG004|Overall Study|Physician Decision|1|||
125468623|NCT02554786|451345527|FG000|Overall Study|Pregnancy|0|||
125468624|NCT02554786|451345528|FG001|Overall Study|Pregnancy|0|||
125468625|NCT02554786|451345529|FG002|Overall Study|Pregnancy|0|||
125468626|NCT02554786|451345530|FG003|Overall Study|Pregnancy|1|||
125468627|NCT02554786|451345531|FG004|Overall Study|Pregnancy|1|||
125468628|NCT05052996|451345532|FG000|Overall Study|Still on study|0|||
125468629|NCT05052996|451345533|FG001|Overall Study|Still on study|0|||
125468630|NCT05052996|451345534|FG002|Overall Study|Still on study|47|||
125468631|NCT05052996|451345535|FG003|Overall Study|Still on study|44|||
125468632|NCT05052996|451345532|FG000|Overall Study|Cohort terminated by sponsor|21|||
125468633|NCT05052996|451345533|FG001|Overall Study|Cohort terminated by sponsor|12|||
125297884|NCT00568126|450717190|FG001|Overall Study|Physician Decision|2|||
125297885|NCT01272869|450717191|FG000|Period 2 (14 Days)|Adverse Event|1|||
125297886|NCT01272869|450717192|FG001|Period 2 (14 Days)|Adverse Event|0|||
125297887|NCT00859937|450717193|FG000|Overall Study|Protocol Violation|1|||
125297888|NCT00859937|450717194|FG001|Overall Study|Protocol Violation|0|||
125297889|NCT02911142|450717195|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
125297890|NCT02911142|450717195|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
125297891|NCT02911142|450717195|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
125297892|NCT02911142|450717195|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
125297893|NCT02883062|450717196|FG000|Overall Study|Withdrawal by Subject|6|||
125297894|NCT02883062|450717197|FG001|Overall Study|Withdrawal by Subject|0|||
125297895|NCT02888743|450717198|FG000|Overall Study|Withdrawal by Subject|1|||
125297896|NCT02888743|450717199|FG001|Overall Study|Withdrawal by Subject|2|||
125297897|NCT02888743|450717200|FG002|Overall Study|Withdrawal by Subject|2|||
125297898|NCT02888743|450717201|FG003|Overall Study|Withdrawal by Subject|0|||
125297899|NCT02888743|450717202|FG004|Overall Study|Withdrawal by Subject|1|||
125297900|NCT02888743|450717198|FG000|Overall Study|Disease progression before treatment|2|||
125297901|NCT02888743|450717199|FG001|Overall Study|Disease progression before treatment|0|||
125297902|NCT02888743|450717200|FG002|Overall Study|Disease progression before treatment|2|||
125297903|NCT02888743|450717201|FG003|Overall Study|Disease progression before treatment|0|||
125297904|NCT02888743|450717202|FG004|Overall Study|Disease progression before treatment|0|||
125297905|NCT02888743|450717198|FG000|Overall Study|Patient ineligible|1|||
125297906|NCT02888743|450717199|FG001|Overall Study|Patient ineligible|2|||
125297907|NCT02888743|450717200|FG002|Overall Study|Patient ineligible|0|||
125297908|NCT02888743|450717201|FG003|Overall Study|Patient ineligible|0|||
125297909|NCT02888743|450717202|FG004|Overall Study|Patient ineligible|0|||
125297910|NCT05779007|450717203|FG000|Overall Study|not meeting eligibility criteria|3517|||
125297911|NCT05779007|450717204|FG001|Overall Study|not meeting eligibility criteria|2009|||
125297912|NCT01424566|450717205|FG000|Single-blind Treatment|Adverse Event|71|||
125297913|NCT01424566|450717206|FG001|Single-blind Treatment|Adverse Event|0|||
125297914|NCT01424566|450717207|FG002|Single-blind Treatment|Adverse Event|0|||
125297915|NCT01424566|450717205|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
125297916|NCT01424566|450717206|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
125297917|NCT01424566|450717207|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
125297918|NCT01424566|450717205|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
125297919|NCT01424566|450717206|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
125297920|NCT01424566|450717207|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
125297921|NCT01424566|450717205|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
125468634|NCT05052996|451345534|FG002|Overall Study|Cohort terminated by sponsor|0|||
125468635|NCT05052996|451345535|FG003|Overall Study|Cohort terminated by sponsor|0|||
125468636|NCT05052996|451345532|FG000|Overall Study|Withdrew consent|1|||
125468637|NCT05052996|451345533|FG001|Overall Study|Withdrew consent|0|||
125468638|NCT05052996|451345534|FG002|Overall Study|Withdrew consent|1|||
125468639|NCT05052996|451345535|FG003|Overall Study|Withdrew consent|2|||
125468640|NCT05052996|451345532|FG000|Overall Study|Lost to Follow-up|1|||
125468641|NCT05052996|451345533|FG001|Overall Study|Lost to Follow-up|0|||
125468642|NCT05052996|451345534|FG002|Overall Study|Lost to Follow-up|0|||
125468643|NCT05052996|451345535|FG003|Overall Study|Lost to Follow-up|2|||
125297922|NCT01424566|450717206|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
125297923|NCT01424566|450717207|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
125297924|NCT01424566|450717205|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
125297925|NCT01424566|450717206|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
125297926|NCT01424566|450717207|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
125297927|NCT01424566|450717205|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
125297928|NCT01424566|450717206|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
125297929|NCT01424566|450717207|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
125297930|NCT01424566|450717205|FG000|Double-blind Treatment|Adverse Event|0|||
125297931|NCT01424566|450717206|FG001|Double-blind Treatment|Adverse Event|21|||
125297932|NCT01424566|450717207|FG002|Double-blind Treatment|Adverse Event|13|||
125297933|NCT01424566|450717205|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
125297934|NCT01424566|450717206|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
125297935|NCT01424566|450717207|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
125297936|NCT01424566|450717205|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
125297937|NCT01424566|450717206|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
125297938|NCT01424566|450717207|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
125297939|NCT01424566|450717205|FG000|Double-blind Treatment|Lack of Efficacy|0|||
125297940|NCT01424566|450717206|FG001|Double-blind Treatment|Lack of Efficacy|1|||
125297941|NCT01424566|450717207|FG002|Double-blind Treatment|Lack of Efficacy|1|||
125297942|NCT04816721|450717208|FG000|Overall Study|Withdrawal by Subject|0|||
125297943|NCT04816721|450717209|FG001|Overall Study|Withdrawal by Subject|2|||
125297944|NCT04816721|450717210|FG002|Overall Study|Withdrawal by Subject|0|||
125297945|NCT04816721|450717211|FG003|Overall Study|Withdrawal by Subject|1|||
125297946|NCT04816721|450717212|FG004|Overall Study|Withdrawal by Subject|1|||
125297947|NCT04816721|450717213|FG005|Overall Study|Withdrawal by Subject|0|||
125297948|NCT04816721|450717214|FG006|Overall Study|Withdrawal by Subject|0|||
125297949|NCT04816721|450717215|FG007|Overall Study|Withdrawal by Subject|0|||
125297950|NCT04816721|450717208|FG000|Overall Study|Miscellaneous|0|||
125297951|NCT04816721|450717209|FG001|Overall Study|Miscellaneous|0|||
125297952|NCT04816721|450717210|FG002|Overall Study|Miscellaneous|0|||
125297953|NCT04816721|450717211|FG003|Overall Study|Miscellaneous|0|||
125297954|NCT04816721|450717212|FG004|Overall Study|Miscellaneous|0|||
125297955|NCT04816721|450717213|FG005|Overall Study|Miscellaneous|1|||
125297956|NCT04816721|450717214|FG006|Overall Study|Miscellaneous|0|||
125297957|NCT04816721|450717215|FG007|Overall Study|Miscellaneous|0|||
125297958|NCT04816721|450717208|FG000|Overall Study|Lost to Follow-up|0|||
125297959|NCT04816721|450717209|FG001|Overall Study|Lost to Follow-up|0|||
125297960|NCT04816721|450717210|FG002|Overall Study|Lost to Follow-up|0|||
125297961|NCT04816721|450717211|FG003|Overall Study|Lost to Follow-up|1|||
125297962|NCT04816721|450717212|FG004|Overall Study|Lost to Follow-up|0|||
125297963|NCT04816721|450717213|FG005|Overall Study|Lost to Follow-up|0|||
125297964|NCT04816721|450717214|FG006|Overall Study|Lost to Follow-up|0|||
125297965|NCT04816721|450717215|FG007|Overall Study|Lost to Follow-up|0|||
125297966|NCT00026312|450717216|FG000|Overall Study|Adverse Event|0|||
125297967|NCT00026312|450717217|FG001|Overall Study|Adverse Event|32|||
125297968|NCT00026312|450717216|FG000|Overall Study|Death|1|||
125297969|NCT00026312|450717217|FG001|Overall Study|Death|7|||
125297970|NCT00026312|450717216|FG000|Overall Study|Lack of Efficacy|19|||
125297971|NCT00026312|450717217|FG001|Overall Study|Lack of Efficacy|114|||
125297972|NCT00026312|450717216|FG000|Overall Study|Lost to Follow-up|0|||
125297973|NCT00026312|450717217|FG001|Overall Study|Lost to Follow-up|5|||
125297974|NCT00026312|450717216|FG000|Overall Study|Physician Decision|1|||
125297975|NCT00026312|450717217|FG001|Overall Study|Physician Decision|37|||
125297976|NCT00026312|450717216|FG000|Overall Study|Protocol Violation|0|||
125297977|NCT00026312|450717217|FG001|Overall Study|Protocol Violation|3|||
125297978|NCT00026312|450717216|FG000|Overall Study|Withdrawal by Subject|1|||
125297979|NCT00026312|450717217|FG001|Overall Study|Withdrawal by Subject|6|||
125297980|NCT00026312|450717216|FG000|Overall Study|Ineligible|4|||
125297981|NCT00026312|450717217|FG001|Overall Study|Ineligible|5|||
125297982|NCT00026312|450717216|FG000|Overall Study|Entry onto another COG study|0|||
125297983|NCT00026312|450717217|FG001|Overall Study|Entry onto another COG study|1|||
125297984|NCT00026312|450717216|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
125297985|NCT00026312|450717217|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
125468644|NCT05052996|451345532|FG000|Overall Study|Adverse Event|0|||
125297986|NCT01638546|450717218|FG000|Overall Study|Adverse Event|1|||
125297987|NCT01638546|450717219|FG001|Overall Study|Adverse Event|3|||
125297988|NCT03194438|450717222|FG000|Overall Study|Withdrawal by Subject|2|||
125297989|NCT02294734|450717223|FG000|Overall Study|Adverse Event|5|||
125297990|NCT02294734|450717224|FG001|Overall Study|Adverse Event|5|||
125297991|NCT02294734|450717223|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
125297992|NCT02294734|450717224|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
125297993|NCT02294734|450717223|FG000|Overall Study|Lost to Follow-up|2|||
125297994|NCT02294734|450717224|FG001|Overall Study|Lost to Follow-up|0|||
125297995|NCT02294734|450717223|FG000|Overall Study|Physician Decision|2|||
125297996|NCT02294734|450717224|FG001|Overall Study|Physician Decision|1|||
125297997|NCT02294734|450717223|FG000|Overall Study|Withdrawal by Subject|4|||
125297998|NCT02294734|450717224|FG001|Overall Study|Withdrawal by Subject|2|||
125297999|NCT03157583|450717225|FG000|Overall Study|Other (did not meet study criteria)|1|||
125298000|NCT01141478|450717229|FG000|Overall Study|Withdrawal by Subject|1|||
125298001|NCT01141478|450717230|FG001|Overall Study|Withdrawal by Subject|1|||
125298002|NCT02250664|450717240|FG000|Overall Study|Lost to Follow-up|18|||
125298003|NCT02250664|450717241|FG001|Overall Study|Lost to Follow-up|28|||
125298004|NCT02250664|450717242|FG002|Overall Study|Lost to Follow-up|33|||
125298005|NCT02250664|450717240|FG000|Overall Study|Personal Reasons|7|||
125298006|NCT02250664|450717241|FG001|Overall Study|Personal Reasons|8|||
125298007|NCT02250664|450717242|FG002|Overall Study|Personal Reasons|14|||
125298008|NCT02250664|450717240|FG000|Overall Study|Adverse Event|6|||
125298009|NCT02250664|450717241|FG001|Overall Study|Adverse Event|3|||
125298010|NCT02250664|450717242|FG002|Overall Study|Adverse Event|8|||
125298011|NCT02250664|450717240|FG000|Overall Study|Incarcerated|2|||
125298012|NCT02250664|450717241|FG001|Overall Study|Incarcerated|1|||
125298013|NCT02250664|450717242|FG002|Overall Study|Incarcerated|2|||
125298014|NCT02250664|450717240|FG000|Overall Study|Withdrawal by Subject|0|||
125298015|NCT02250664|450717241|FG001|Overall Study|Withdrawal by Subject|1|||
125298016|NCT02250664|450717242|FG002|Overall Study|Withdrawal by Subject|2|||
125298017|NCT02250664|450717240|FG000|Overall Study|Death|0|||
125298018|NCT02250664|450717241|FG001|Overall Study|Death|1|||
125298019|NCT02250664|450717242|FG002|Overall Study|Death|1|||
125298020|NCT02250664|450717240|FG000|Overall Study|Physician Decision|1|||
125298021|NCT02250664|450717241|FG001|Overall Study|Physician Decision|3|||
125298022|NCT02250664|450717242|FG002|Overall Study|Physician Decision|1|||
125298023|NCT02250664|450717240|FG000|Overall Study|Protocol Violation|1|||
125298024|NCT02250664|450717241|FG001|Overall Study|Protocol Violation|0|||
125298025|NCT02250664|450717242|FG002|Overall Study|Protocol Violation|1|||
125298026|NCT02250664|450717240|FG000|Overall Study|Reason unknown|1|||
125298027|NCT02250664|450717241|FG001|Overall Study|Reason unknown|0|||
125298028|NCT02250664|450717242|FG002|Overall Study|Reason unknown|0|||
125298029|NCT03847909|450717243|FG000|Overall Study|Withdrawal by Subject|1|||
125298030|NCT03847909|450717244|FG001|Overall Study|Withdrawal by Subject|1|||
125298031|NCT00117793|450717245|FG000|Overall Study|Withdrawal by Subject|12|||
125298032|NCT04268173|450717246|FG000|Overall Study|Lost to Follow-up|75|||
125298033|NCT04268173|450717247|FG001|Overall Study|Lost to Follow-up|108|||
125298034|NCT00975143|450717248|FG000|Overall Study|Adverse Event|19|||
125298035|NCT00975143|450717249|FG001|Overall Study|Adverse Event|15|||
125298036|NCT00975143|450717248|FG000|Overall Study|Withdrawal by Subject|15|||
125468645|NCT05052996|451345533|FG001|Overall Study|Adverse Event|0|||
125468646|NCT05052996|451345534|FG002|Overall Study|Adverse Event|2|||
125468647|NCT05052996|451345535|FG003|Overall Study|Adverse Event|0|||
125468648|NCT05052996|451345532|FG000|Overall Study|Randomized but never treated|0|||
125468649|NCT05052996|451345533|FG001|Overall Study|Randomized but never treated|0|||
125468650|NCT05052996|451345534|FG002|Overall Study|Randomized but never treated|1|||
125468651|NCT05052996|451345535|FG003|Overall Study|Randomized but never treated|1|||
125468652|NCT05052996|451345532|FG000|Overall Study|Protocol Violation|1|||
125468653|NCT05052996|451345533|FG001|Overall Study|Protocol Violation|0|||
125468654|NCT05052996|451345534|FG002|Overall Study|Protocol Violation|0|||
125468655|NCT05052996|451345535|FG003|Overall Study|Protocol Violation|0|||
125468656|NCT04704284|451345536|FG000|Overall Study|Withdrawal by Subject|1|||
125468657|NCT00522951|451345538|FG000|Period 1|body motion|0|||
125468658|NCT00522951|451345539|FG001|Period 1|body motion|1|||
125468659|NCT00522951|451345538|FG000|Washout Period|Adverse Event|0|||
125468660|NCT00522951|451345539|FG001|Washout Period|Adverse Event|1|||
125468661|NCT00522951|451345538|FG000|Washout Period|Death|0|||
125468662|NCT00522951|451345539|FG001|Washout Period|Death|1|||
125468663|NCT00522951|451345538|FG000|Period 2|Withdrawal by Subject|1|||
125468664|NCT00522951|451345539|FG001|Period 2|Withdrawal by Subject|0|||
125468665|NCT00522951|451345538|FG000|Period 2|residual contrast medium|1|||
125468666|NCT00522951|451345539|FG001|Period 2|residual contrast medium|1|||
125468667|NCT00087139|451345540|FG000|Overall Study|Adverse Event|18|||
125468668|NCT00087139|451345541|FG001|Overall Study|Adverse Event|17|||
125468669|NCT00087139|451345542|FG002|Overall Study|Adverse Event|13|||
125468670|NCT00087139|451345540|FG000|Overall Study|Death|2|||
125298037|NCT00975143|450717249|FG001|Overall Study|Withdrawal by Subject|15|||
125298038|NCT00975143|450717248|FG000|Overall Study|Lost to Follow-up|20|||
125298039|NCT00975143|450717249|FG001|Overall Study|Lost to Follow-up|16|||
125298040|NCT00975143|450717248|FG000|Overall Study|Non-compliance|5|||
125298041|NCT00975143|450717249|FG001|Overall Study|Non-compliance|8|||
125298042|NCT00975143|450717248|FG000|Overall Study|Physician Decision|1|||
125298043|NCT00975143|450717249|FG001|Overall Study|Physician Decision|2|||
125298044|NCT00975143|450717248|FG000|Overall Study|Details not available|10|||
125298045|NCT00975143|450717249|FG001|Overall Study|Details not available|4|||
125468671|NCT00087139|451345541|FG001|Overall Study|Death|1|||
125468672|NCT00087139|451345542|FG002|Overall Study|Death|0|||
125468673|NCT00087139|451345540|FG000|Overall Study|Withdrawal by Subject|3|||
125468674|NCT00087139|451345541|FG001|Overall Study|Withdrawal by Subject|2|||
125468675|NCT00087139|451345542|FG002|Overall Study|Withdrawal by Subject|2|||
125468676|NCT00087139|451345540|FG000|Overall Study|Physician Decision|1|||
125468677|NCT00087139|451345541|FG001|Overall Study|Physician Decision|1|||
125468678|NCT00087139|451345542|FG002|Overall Study|Physician Decision|1|||
125468679|NCT00087139|451345540|FG000|Overall Study|Disease progression|9|||
125468680|NCT00087139|451345541|FG001|Overall Study|Disease progression|19|||
125468681|NCT00087139|451345542|FG002|Overall Study|Disease progression|12|||
125468682|NCT00087139|451345540|FG000|Overall Study|Ineligible|4|||
125468683|NCT00087139|451345541|FG001|Overall Study|Ineligible|7|||
125468684|NCT00087139|451345542|FG002|Overall Study|Ineligible|4|||
125468685|NCT00087139|451345540|FG000|Overall Study|Symptomatic deterioration|1|||
125468686|NCT00087139|451345541|FG001|Overall Study|Symptomatic deterioration|1|||
125468687|NCT00087139|451345542|FG002|Overall Study|Symptomatic deterioration|3|||
125468688|NCT00087139|451345540|FG000|Overall Study|Use of coumadin|1|||
125298046|NCT01375608|450717250|FG000|Overall Study|Withdrawal by Subject|2|||
125298047|NCT00545103|450717251|FG000|Overall Study|Lack of Efficacy|48|||
125298048|NCT00545103|450717252|FG001|Overall Study|Lack of Efficacy|45|||
125298049|NCT00545103|450717253|FG002|Overall Study|Lack of Efficacy|31|||
125298050|NCT00545103|450717254|FG003|Overall Study|Lack of Efficacy|27|||
125298051|NCT00545103|450717251|FG000|Overall Study|Withdrawal by Subject|6|||
125298052|NCT00545103|450717252|FG001|Overall Study|Withdrawal by Subject|10|||
125298053|NCT00545103|450717253|FG002|Overall Study|Withdrawal by Subject|18|||
125298054|NCT00545103|450717254|FG003|Overall Study|Withdrawal by Subject|22|||
125298055|NCT00545103|450717251|FG000|Overall Study|Adverse Event|11|||
125298056|NCT00545103|450717252|FG001|Overall Study|Adverse Event|12|||
125298057|NCT00545103|450717253|FG002|Overall Study|Adverse Event|17|||
125298058|NCT00545103|450717254|FG003|Overall Study|Adverse Event|10|||
125298059|NCT00545103|450717251|FG000|Overall Study|Lost to Follow-up|4|||
125298060|NCT00545103|450717252|FG001|Overall Study|Lost to Follow-up|6|||
125298061|NCT00545103|450717253|FG002|Overall Study|Lost to Follow-up|3|||
125298062|NCT00545103|450717254|FG003|Overall Study|Lost to Follow-up|4|||
125298063|NCT00545103|450717251|FG000|Overall Study|Protocol Violation|1|||
125298064|NCT00545103|450717252|FG001|Overall Study|Protocol Violation|2|||
125298065|NCT00545103|450717253|FG002|Overall Study|Protocol Violation|3|||
125298066|NCT00545103|450717254|FG003|Overall Study|Protocol Violation|0|||
125298067|NCT00545103|450717251|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
125298068|NCT00545103|450717252|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
125298069|NCT00545103|450717253|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
125298070|NCT00545103|450717254|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
125298071|NCT00545103|450717251|FG000|Overall Study|Difficult to open package|0|||
125298072|NCT00545103|450717252|FG001|Overall Study|Difficult to open package|0|||
125298073|NCT00545103|450717253|FG002|Overall Study|Difficult to open package|0|||
125298074|NCT00545103|450717254|FG003|Overall Study|Difficult to open package|1|||
125298075|NCT00545103|450717251|FG000|Overall Study|Investigational product not taken|1|||
125298076|NCT00545103|450717252|FG001|Overall Study|Investigational product not taken|0|||
125298077|NCT00545103|450717253|FG002|Overall Study|Investigational product not taken|0|||
125298078|NCT00545103|450717254|FG003|Overall Study|Investigational product not taken|1|||
125298079|NCT00545103|450717251|FG000|Overall Study|Wish to start a family|0|||
125298080|NCT00545103|450717252|FG001|Overall Study|Wish to start a family|0|||
125298081|NCT00545103|450717253|FG002|Overall Study|Wish to start a family|0|||
125298082|NCT00545103|450717254|FG003|Overall Study|Wish to start a family|1|||
125298083|NCT00545103|450717251|FG000|Overall Study|Diverticulitis crisis|0|||
125298084|NCT00545103|450717252|FG001|Overall Study|Diverticulitis crisis|0|||
125298085|NCT00545103|450717253|FG002|Overall Study|Diverticulitis crisis|0|||
125298086|NCT00545103|450717254|FG003|Overall Study|Diverticulitis crisis|1|||
125298087|NCT00545103|450717251|FG000|Overall Study|Personal reasons|1|||
125298088|NCT00545103|450717252|FG001|Overall Study|Personal reasons|0|||
125298089|NCT00545103|450717253|FG002|Overall Study|Personal reasons|0|||
125298090|NCT00545103|450717254|FG003|Overall Study|Personal reasons|0|||
125298091|NCT00545103|450717251|FG000|Overall Study|Subject's decision|1|||
125298092|NCT00545103|450717252|FG001|Overall Study|Subject's decision|0|||
125298093|NCT00545103|450717253|FG002|Overall Study|Subject's decision|0|||
125298094|NCT00545103|450717254|FG003|Overall Study|Subject's decision|0|||
125468689|NCT00087139|451345541|FG001|Overall Study|Use of coumadin|0|||
125298095|NCT00545103|450717251|FG000|Overall Study|Noncompliance|0|||
125298096|NCT00545103|450717252|FG001|Overall Study|Noncompliance|1|||
125298097|NCT00545103|450717253|FG002|Overall Study|Noncompliance|0|||
125298098|NCT00545103|450717254|FG003|Overall Study|Noncompliance|0|||
125298099|NCT00545103|450717251|FG000|Overall Study|Investigator decision|0|||
125298100|NCT00545103|450717252|FG001|Overall Study|Investigator decision|0|||
125298101|NCT00545103|450717253|FG002|Overall Study|Investigator decision|1|||
125298102|NCT00545103|450717254|FG003|Overall Study|Investigator decision|0|||
125468690|NCT00087139|451345542|FG002|Overall Study|Use of coumadin|0|||
125298103|NCT00545103|450717251|FG000|Overall Study|Subject moved|0|||
125298104|NCT00545103|450717252|FG001|Overall Study|Subject moved|1|||
125468691|NCT00087139|451345540|FG000|Overall Study|Response achieved|0|||
125468692|NCT00087139|451345541|FG001|Overall Study|Response achieved|1|||
125468693|NCT00087139|451345542|FG002|Overall Study|Response achieved|0|||
125468694|NCT00087139|451345540|FG000|Overall Study|Extradural disease|0|||
125298105|NCT00545103|450717253|FG002|Overall Study|Subject moved|0|||
125298106|NCT00545103|450717254|FG003|Overall Study|Subject moved|0|||
125298107|NCT00545103|450717251|FG000|Overall Study|Use of prohibited medication|0|||
125298108|NCT00545103|450717252|FG001|Overall Study|Use of prohibited medication|0|||
125298109|NCT00545103|450717253|FG002|Overall Study|Use of prohibited medication|1|||
125298110|NCT00545103|450717254|FG003|Overall Study|Use of prohibited medication|0|||
125298111|NCT00545103|450717251|FG000|Overall Study|Does not want to take study drug anymore|1|||
125298112|NCT00545103|450717252|FG001|Overall Study|Does not want to take study drug anymore|0|||
125298113|NCT00545103|450717253|FG002|Overall Study|Does not want to take study drug anymore|1|||
125298114|NCT00545103|450717254|FG003|Overall Study|Does not want to take study drug anymore|0|||
125298115|NCT00545103|450717251|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
125298116|NCT00545103|450717252|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
125298117|NCT00545103|450717253|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
125298118|NCT00545103|450717254|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
125298119|NCT00545103|450717251|FG000|Overall Study|Death|0|||
125298120|NCT00545103|450717252|FG001|Overall Study|Death|1|||
125298121|NCT00545103|450717253|FG002|Overall Study|Death|0|||
125298122|NCT00545103|450717254|FG003|Overall Study|Death|0|||
125298123|NCT01953913|450717255|FG000|Overall Study|Disease Progression|349|||
125298124|NCT01953913|450717255|FG000|Overall Study|Worsening of underlying cancer|22|||
125298125|NCT01953913|450717255|FG000|Overall Study|Adverse Event|20|||
125298126|NCT01953913|450717255|FG000|Overall Study|Protocol Violation|6|||
125298127|NCT01953913|450717255|FG000|Overall Study|Lost to Follow-up|4|||
125298128|NCT01953913|450717255|FG000|Overall Study|Withdrawal by Subject|32|||
125298129|NCT01953913|450717255|FG000|Overall Study|Other than listed|108|||
125298130|NCT01953913|450717255|FG000|Overall Study|Not Treated|1|||
125298131|NCT00082381|450717256|FG000|Overall Study|Adverse Event|27|||
125298132|NCT00082381|450717257|FG001|Overall Study|Adverse Event|2|||
125298133|NCT00082381|450717256|FG000|Overall Study|Lost to Follow-up|5|||
125298134|NCT00082381|450717257|FG001|Overall Study|Lost to Follow-up|7|||
125298135|NCT00082381|450717256|FG000|Overall Study|Patient Decision|8|||
125298136|NCT00082381|450717257|FG001|Overall Study|Patient Decision|4|||
125298137|NCT00082381|450717256|FG000|Overall Study|Physician Decision|1|||
125298138|NCT00082381|450717257|FG001|Overall Study|Physician Decision|2|||
125298139|NCT00082381|450717256|FG000|Overall Study|Protocol Violation|10|||
125298140|NCT00082381|450717257|FG001|Overall Study|Protocol Violation|11|||
125298141|NCT00082381|450717256|FG000|Overall Study|Loss of Glucose Control|4|||
125298142|NCT00082381|450717257|FG001|Overall Study|Loss of Glucose Control|0|||
125298143|NCT02049138|450717258|FG000|Overall Study|Adverse Event|46|||
125298144|NCT02049138|450717259|FG001|Overall Study|Adverse Event|25|||
125298145|NCT02049138|450717260|FG002|Overall Study|Adverse Event|1|||
125298146|NCT02049138|450717258|FG000|Overall Study|Withdrawal by Subject|57|||
125298147|NCT02049138|450717259|FG001|Overall Study|Withdrawal by Subject|21|||
125298148|NCT02049138|450717260|FG002|Overall Study|Withdrawal by Subject|5|||
125298149|NCT02049138|450717258|FG000|Overall Study|Lost to Follow-up|18|||
125298150|NCT02049138|450717259|FG001|Overall Study|Lost to Follow-up|5|||
125298151|NCT02049138|450717260|FG002|Overall Study|Lost to Follow-up|1|||
125298152|NCT02049138|450717258|FG000|Overall Study|Lack of Efficacy|10|||
125298153|NCT02049138|450717259|FG001|Overall Study|Lack of Efficacy|26|||
125298154|NCT02049138|450717260|FG002|Overall Study|Lack of Efficacy|1|||
125298155|NCT02049138|450717258|FG000|Overall Study|Non-Compliance|15|||
125298156|NCT02049138|450717259|FG001|Overall Study|Non-Compliance|6|||
125298157|NCT02049138|450717260|FG002|Overall Study|Non-Compliance|0|||
125298158|NCT02049138|450717258|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
125298159|NCT02049138|450717259|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
125298160|NCT02049138|450717260|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
125298161|NCT02049138|450717258|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
125298162|NCT02049138|450717259|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
125298163|NCT02049138|450717260|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
125298164|NCT02049138|450717258|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
125298165|NCT02049138|450717259|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
125298166|NCT02049138|450717260|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
125298167|NCT02049138|450717258|FG000|Overall Study|Other|15|||
125298168|NCT02049138|450717259|FG001|Overall Study|Other|13|||
125298169|NCT02049138|450717260|FG002|Overall Study|Other|0|||
125298170|NCT02049138|450717258|FG000|Overall Study|Missing|0|||
125298171|NCT02049138|450717259|FG001|Overall Study|Missing|1|||
125298172|NCT02049138|450717260|FG002|Overall Study|Missing|0|||
125298173|NCT00884832|450717261|FG000|Overall Study|Withdrawal by Subject|0|||
125298174|NCT00884832|450717262|FG001|Overall Study|Withdrawal by Subject|1|||
125298175|NCT02096263|450717263|FG000|Overall Study|Adverse Event|1|||
125298176|NCT02096263|450717264|FG001|Overall Study|Adverse Event|0|||
125298177|NCT02096263|450717265|FG002|Overall Study|Adverse Event|1|||
125420656|NCT02943408|451166089|FG000|Overall Study|Lost to Follow-up|7|||
125420657|NCT02943408|451166090|FG001|Overall Study|Lost to Follow-up|1|||
125420658|NCT02943408|451166089|FG000|Overall Study|Withdrawal by Subject|0|||
125298178|NCT02096263|450717263|FG000|Overall Study|Lost to Follow-up|14|||
125298179|NCT02096263|450717264|FG001|Overall Study|Lost to Follow-up|18|||
125298180|NCT02096263|450717265|FG002|Overall Study|Lost to Follow-up|15|||
125298181|NCT02096263|450717263|FG000|Overall Study|Other|7|||
125298182|NCT02096263|450717264|FG001|Overall Study|Other|9|||
125298183|NCT02096263|450717265|FG002|Overall Study|Other|6|||
125298184|NCT02096263|450717263|FG000|Overall Study|Sponsor study termination|0|||
125298185|NCT02096263|450717264|FG001|Overall Study|Sponsor study termination|0|||
125298186|NCT02096263|450717265|FG002|Overall Study|Sponsor study termination|1|||
125298187|NCT02096263|450717263|FG000|Overall Study|Protocol Violation|7|||
125298188|NCT02096263|450717264|FG001|Overall Study|Protocol Violation|2|||
125298189|NCT02096263|450717265|FG002|Overall Study|Protocol Violation|8|||
125298190|NCT02096263|450717263|FG000|Overall Study|Withdrawal by Subject|5|||
125298191|NCT02096263|450717264|FG001|Overall Study|Withdrawal by Subject|7|||
125298192|NCT02096263|450717265|FG002|Overall Study|Withdrawal by Subject|8|||
125298193|NCT02337725|450717266|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
125298194|NCT02337725|450717267|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
125298195|NCT02337725|450717266|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
125298196|NCT02337725|450717267|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
125298197|NCT02337725|450717266|FG000|Overall Study|Major Protocol Deviation|0|||
125298198|NCT02337725|450717267|FG001|Overall Study|Major Protocol Deviation|1|||
125298199|NCT02337725|450717266|FG000|Overall Study|Voluntary Withdrawal|14|||
125298200|NCT02337725|450717267|FG001|Overall Study|Voluntary Withdrawal|3|||
125298201|NCT02337725|450717266|FG000|Overall Study|Lack of Efficacy|4|||
125298202|NCT02337725|450717267|FG001|Overall Study|Lack of Efficacy|0|||
125298203|NCT03322423|450717268|FG000|Period 1|Subject no longer eligible|0|||
125298204|NCT03322423|450717269|FG001|Period 1|Subject no longer eligible|1|||
125298205|NCT03322423|450717268|FG000|Period 1|Withdrawal by Subject|0|||
125298206|NCT03322423|450717269|FG001|Period 1|Withdrawal by Subject|1|||
125298207|NCT03322423|450717268|FG000|Period 1|Incorrect Lens Dispensed|1|||
125298208|NCT03322423|450717269|FG001|Period 1|Incorrect Lens Dispensed|0|||
125298209|NCT03322423|450717268|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
125298210|NCT03322423|450717269|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
125298211|NCT03322423|450717268|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
125298212|NCT03322423|450717269|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
125298213|NCT03322423|450717268|FG000|Period 2|Protocol Violation|1|||
125298214|NCT03322423|450717269|FG001|Period 2|Protocol Violation|0|||
125298215|NCT03322423|450717268|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
125298216|NCT03322423|450717269|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
125298217|NCT02453555|450717270|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
125298218|NCT02453555|450717271|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
125298219|NCT02453555|450717272|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
125298220|NCT02453555|450717273|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
125298221|NCT02453555|450717274|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
125298222|NCT02453555|450717275|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
125298223|NCT02453555|450717270|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
125298224|NCT02453555|450717271|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
125298225|NCT02453555|450717272|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
125298226|NCT02453555|450717273|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
125298227|NCT02453555|450717274|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
125298228|NCT02453555|450717275|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
125298229|NCT02453555|450717270|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
125298230|NCT02453555|450717271|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
125298231|NCT02453555|450717272|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125298232|NCT02453555|450717273|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125298233|NCT02453555|450717274|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125298234|NCT02453555|450717275|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
125298235|NCT02453555|450717270|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
125298236|NCT02453555|450717271|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
125298237|NCT02453555|450717272|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
125298238|NCT02453555|450717273|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
125298239|NCT02453555|450717274|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
125298240|NCT02453555|450717275|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
125298241|NCT02453555|450717270|FG000|Extension Period|Adverse Event|0|||
125298242|NCT02453555|450717271|FG001|Extension Period|Adverse Event|0|||
125298243|NCT02453555|450717272|FG002|Extension Period|Adverse Event|1|||
125298244|NCT02453555|450717273|FG003|Extension Period|Adverse Event|2|||
125298245|NCT02453555|450717274|FG004|Extension Period|Adverse Event|1|||
125298246|NCT02453555|450717275|FG005|Extension Period|Adverse Event|1|||
125298247|NCT02453555|450717270|FG000|Extension Period|Protocol Violation|0|||
125298248|NCT02453555|450717271|FG001|Extension Period|Protocol Violation|0|||
125298249|NCT02453555|450717272|FG002|Extension Period|Protocol Violation|1|||
125298250|NCT02453555|450717273|FG003|Extension Period|Protocol Violation|0|||
125298251|NCT02453555|450717274|FG004|Extension Period|Protocol Violation|0|||
125298252|NCT02453555|450717275|FG005|Extension Period|Protocol Violation|0|||
125298253|NCT02453555|450717270|FG000|Extension Period|Withdrawal by Subject|0|||
125298254|NCT02453555|450717271|FG001|Extension Period|Withdrawal by Subject|0|||
125298255|NCT02453555|450717272|FG002|Extension Period|Withdrawal by Subject|1|||
125298256|NCT02453555|450717273|FG003|Extension Period|Withdrawal by Subject|0|||
125298257|NCT02453555|450717274|FG004|Extension Period|Withdrawal by Subject|0|||
125298258|NCT02453555|450717275|FG005|Extension Period|Withdrawal by Subject|0|||
125298259|NCT00500760|450717276|FG000|Overall Study|Death|32|||
125298260|NCT00500760|450717277|FG001|Overall Study|Death|15|||
125298261|NCT00500760|450717276|FG000|Overall Study|Withdrawal by Subject|5|||
125298262|NCT00500760|450717277|FG001|Overall Study|Withdrawal by Subject|7|||
125298263|NCT00500760|450717276|FG000|Overall Study|Administrative decision|2|||
125298264|NCT00500760|450717277|FG001|Overall Study|Administrative decision|0|||
125298265|NCT00500760|450717276|FG000|Overall Study|Lost to Follow-up|3|||
125298266|NCT00500760|450717277|FG001|Overall Study|Lost to Follow-up|0|||
125298267|NCT00500760|450717276|FG000|Overall Study|Other|1|||
125298268|NCT00500760|450717277|FG001|Overall Study|Other|2|||
125298269|NCT00129961|450717279|FG000|Overall Study|Adverse Event|1|||
125298270|NCT00129961|450717280|FG001|Overall Study|Adverse Event|0|||
125298271|NCT00129961|450717279|FG000|Overall Study|Death|1|||
125298272|NCT00129961|450717280|FG001|Overall Study|Death|1|||
125298273|NCT00129961|450717279|FG000|Overall Study|Withdrawal by Sponsor|14|||
125298274|NCT00129961|450717280|FG001|Overall Study|Withdrawal by Sponsor|20|||
125298275|NCT00129961|450717279|FG000|Overall Study|Physician Decision|1|||
125298276|NCT00129961|450717280|FG001|Overall Study|Physician Decision|0|||
125298277|NCT00129961|450717279|FG000|Overall Study|Withdrawal by Subject|2|||
125298278|NCT00129961|450717280|FG001|Overall Study|Withdrawal by Subject|1|||
125298279|NCT00129961|450717279|FG000|Overall Study|Missing Record|0|||
125298280|NCT00129961|450717280|FG001|Overall Study|Missing Record|1|||
125298281|NCT03178669|450717281|FG000|Overall Study|Adverse Event|4|||
125298282|NCT03178669|450717282|FG001|Overall Study|Adverse Event|1|||
125298283|NCT03178669|450717283|FG002|Overall Study|Adverse Event|4|||
125298284|NCT03178669|450717284|FG003|Overall Study|Adverse Event|2|||
125298285|NCT03178669|450717285|FG004|Overall Study|Adverse Event|2|||
125298286|NCT03178669|450717281|FG000|Overall Study|Lack of Efficacy|0|||
125298287|NCT03178669|450717282|FG001|Overall Study|Lack of Efficacy|0|||
125298288|NCT03178669|450717283|FG002|Overall Study|Lack of Efficacy|2|||
125298289|NCT03178669|450717284|FG003|Overall Study|Lack of Efficacy|0|||
125298290|NCT03178669|450717285|FG004|Overall Study|Lack of Efficacy|1|||
125298291|NCT03178669|450717281|FG000|Overall Study|Physician Decision|0|||
125298292|NCT03178669|450717282|FG001|Overall Study|Physician Decision|0|||
125298293|NCT03178669|450717283|FG002|Overall Study|Physician Decision|0|||
125298294|NCT03178669|450717284|FG003|Overall Study|Physician Decision|0|||
125298295|NCT03178669|450717285|FG004|Overall Study|Physician Decision|1|||
125298296|NCT03178669|450717281|FG000|Overall Study|Withdrawal by Subject|1|||
125298297|NCT03178669|450717282|FG001|Overall Study|Withdrawal by Subject|0|||
125298298|NCT03178669|450717283|FG002|Overall Study|Withdrawal by Subject|1|||
125298299|NCT03178669|450717284|FG003|Overall Study|Withdrawal by Subject|1|||
125298300|NCT03178669|450717285|FG004|Overall Study|Withdrawal by Subject|0|||
125298301|NCT03178669|450717281|FG000|Overall Study|Lost to Follow-up|0|||
125298302|NCT03178669|450717282|FG001|Overall Study|Lost to Follow-up|0|||
125468695|NCT00087139|451345541|FG001|Overall Study|Extradural disease|0|||
125468696|NCT00087139|451345542|FG002|Overall Study|Extradural disease|1|||
125468697|NCT00976495|451345543|FG000|Overall Study|Withdrawal by Subject|0|||
125468698|NCT00976495|451345544|FG001|Overall Study|Withdrawal by Subject|1|||
125468699|NCT00976495|451345545|FG002|Overall Study|Withdrawal by Subject|0|||
125468700|NCT00331136|451345546|FG000|Overall Study|Adverse Event|3|||
125468701|NCT00331136|451345547|FG001|Overall Study|Adverse Event|5|||
125468702|NCT00331136|451345548|FG002|Overall Study|Adverse Event|0|||
125468703|NCT00331136|451345549|FG003|Overall Study|Adverse Event|1|||
125298303|NCT03178669|450717283|FG002|Overall Study|Lost to Follow-up|0|||
125298304|NCT03178669|450717284|FG003|Overall Study|Lost to Follow-up|1|||
125298305|NCT03178669|450717285|FG004|Overall Study|Lost to Follow-up|0|||
125298306|NCT01600092|450717286|FG000|Overall Study|Adverse Event|2|||
125298307|NCT01600092|450717287|FG001|Overall Study|Adverse Event|0|||
125298308|NCT01600092|450717286|FG000|Overall Study|Lost to Follow-up|4|||
125468704|NCT00331136|451345546|FG000|Overall Study|Withdrawal by Subject|0|||
125468705|NCT00331136|451345547|FG001|Overall Study|Withdrawal by Subject|1|||
125298309|NCT01600092|450717287|FG001|Overall Study|Lost to Follow-up|6|||
125298310|NCT01600092|450717286|FG000|Overall Study|Withdrawal by parent/guardian|8|||
125298311|NCT01600092|450717287|FG001|Overall Study|Withdrawal by parent/guardian|6|||
125298312|NCT01600092|450717286|FG000|Overall Study|Physician Decision|1|||
125298313|NCT01600092|450717287|FG001|Overall Study|Physician Decision|1|||
125298314|NCT01600092|450717286|FG000|Overall Study|Randomized but not vaccinated|3|||
125298315|NCT01600092|450717287|FG001|Overall Study|Randomized but not vaccinated|3|||
125468706|NCT00331136|451345548|FG002|Overall Study|Withdrawal by Subject|0|||
125468707|NCT00331136|451345549|FG003|Overall Study|Withdrawal by Subject|0|||
125468708|NCT00331136|451345546|FG000|Overall Study|Lost to Follow-up|0|||
125468709|NCT00331136|451345547|FG001|Overall Study|Lost to Follow-up|1|||
125468710|NCT00331136|451345548|FG002|Overall Study|Lost to Follow-up|0|||
125468711|NCT00331136|451345549|FG003|Overall Study|Lost to Follow-up|0|||
125468712|NCT00331136|451345546|FG000|Overall Study|Protocol Violation|1|||
125468713|NCT00331136|451345547|FG001|Overall Study|Protocol Violation|0|||
125468714|NCT00331136|451345548|FG002|Overall Study|Protocol Violation|0|||
125468715|NCT00331136|451345549|FG003|Overall Study|Protocol Violation|0|||
125468716|NCT00331136|451345546|FG000|Overall Study|Not treated|1|||
125468717|NCT00331136|451345547|FG001|Overall Study|Not treated|0|||
125468718|NCT00331136|451345548|FG002|Overall Study|Not treated|0|||
125468719|NCT00331136|451345549|FG003|Overall Study|Not treated|0|||
125468720|NCT02321514|451345552|FG000|Overall Study|Death|15|||
125468721|NCT02321514|451345552|FG000|Overall Study|Missed Visit|7|||
125468722|NCT02321514|451345552|FG000|Overall Study|Study Exit|3|||
125468723|NCT03432858|451345557|FG000|Overall Study|Protocol Violation|2|||
125468724|NCT03432858|451345558|FG001|Overall Study|Protocol Violation|1|||
125468725|NCT03432858|451345559|FG002|Overall Study|Protocol Violation|9|||
125468726|NCT03432858|451345557|FG000|Overall Study|Withdrawal by Subject|0|||
125468727|NCT03432858|451345558|FG001|Overall Study|Withdrawal by Subject|1|||
125468728|NCT03432858|451345559|FG002|Overall Study|Withdrawal by Subject|1|||
125468729|NCT03432858|451345557|FG000|Overall Study|Procedure canceled/rescheduled|0|||
125468730|NCT03432858|451345558|FG001|Overall Study|Procedure canceled/rescheduled|9|||
125468731|NCT03432858|451345559|FG002|Overall Study|Procedure canceled/rescheduled|6|||
125468732|NCT03432858|451345557|FG000|Overall Study|Required postop mobilization with splinting|0|||
125468733|NCT03432858|451345558|FG001|Overall Study|Required postop mobilization with splinting|0|||
125468734|NCT03432858|451345559|FG002|Overall Study|Required postop mobilization with splinting|1|||
125468735|NCT01044303|451345563|FG000|Overall Study|Lost to Follow-up|2|||
125468736|NCT04992390|451345576|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
125468737|NCT04992390|451345577|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
125468738|NCT04992390|451345578|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
125468739|NCT04992390|451345576|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
125468740|NCT04992390|451345577|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
125468741|NCT04992390|451345578|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
125468742|NCT04992390|451345576|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
125468743|NCT04992390|451345577|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
125468744|NCT04992390|451345578|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
125298316|NCT00079677|450717288|FG000|Overall Study|Adverse Event|5|||
125298317|NCT00079677|450717289|FG001|Overall Study|Adverse Event|6|||
125298318|NCT00079677|450717288|FG000|Overall Study|Lack of Efficacy|1|||
125298319|NCT00079677|450717289|FG001|Overall Study|Lack of Efficacy|0|||
125298320|NCT00079677|450717288|FG000|Overall Study|Lost to Follow-up|2|||
125298321|NCT00079677|450717289|FG001|Overall Study|Lost to Follow-up|2|||
125298322|NCT00079677|450717288|FG000|Overall Study|Physician Decision|3|||
125298323|NCT00079677|450717289|FG001|Overall Study|Physician Decision|0|||
125298324|NCT00079677|450717288|FG000|Overall Study|Protocol Violation|2|||
125298325|NCT00079677|450717289|FG001|Overall Study|Protocol Violation|3|||
125298326|NCT00079677|450717288|FG000|Overall Study|Withdrawal by Subject|5|||
125298327|NCT00079677|450717289|FG001|Overall Study|Withdrawal by Subject|3|||
125298328|NCT00079677|450717288|FG000|Overall Study|Miscellaneous|2|||
125298329|NCT00079677|450717289|FG001|Overall Study|Miscellaneous|0|||
125298330|NCT00565136|450717290|FG000|Overall Study|Lost to Follow-up|1|||
125298331|NCT00565136|450717290|FG000|Overall Study|Withdrawal by Subject|1|||
125468745|NCT04992390|451345576|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
125468746|NCT04992390|451345577|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
125468747|NCT04992390|451345578|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
125298332|NCT00565136|450717290|FG000|Overall Study|Protocol Violation|1|||
125298333|NCT04284774|450717292|FG000|Overall Study|Progressive disease|5|||
125468748|NCT04992390|451345576|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
125468749|NCT04992390|451345577|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
125468750|NCT04992390|451345578|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
125468751|NCT04992390|451345576|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
125468752|NCT04992390|451345577|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
125468753|NCT04992390|451345578|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
125298334|NCT01270256|450717293|FG000|Overall Study|Withdrawal by Subject|1|||
125298335|NCT01270256|450717294|FG001|Overall Study|Withdrawal by Subject|0|||
125298336|NCT02879578|450717295|FG000|Overall Study|Adverse Event|1|||
125298337|NCT02879578|450717296|FG001|Overall Study|Adverse Event|2|||
125298338|NCT02879578|450717297|FG002|Overall Study|Adverse Event|14|||
125468754|NCT04992390|451345576|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
125468755|NCT04992390|451345577|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
125468756|NCT04992390|451345578|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
125468757|NCT04992390|451345576|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
125468758|NCT04992390|451345577|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
125468759|NCT04992390|451345578|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
125468760|NCT04992390|451345576|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
125468761|NCT04992390|451345577|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
125468762|NCT04992390|451345578|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
125468763|NCT04992390|451345576|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
125468764|NCT04992390|451345577|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
125468765|NCT04992390|451345578|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
125468766|NCT04992390|451345576|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
125468767|NCT04992390|451345577|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
125468768|NCT04992390|451345578|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
125468769|NCT04992390|451345576|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
125468770|NCT04992390|451345577|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
125468771|NCT04992390|451345578|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
125468772|NCT04992390|451345576|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
125468773|NCT04992390|451345577|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
125468774|NCT04992390|451345578|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
125468775|NCT04992390|451345576|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
125468776|NCT04992390|451345577|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
125468777|NCT04992390|451345578|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
125468778|NCT04992390|451345576|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
125468779|NCT04992390|451345577|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
125468780|NCT04992390|451345578|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
125468781|NCT04992390|451345576|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
125468782|NCT04992390|451345577|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
125468783|NCT04992390|451345578|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
125468784|NCT01303445|451345579|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
125468785|NCT01303445|451345580|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
125468786|NCT01303445|451345579|FG000|Second Intervention (7 Days)|Adverse Event|0|||
125468787|NCT01303445|451345580|FG001|Second Intervention (7 Days)|Adverse Event|2|||
125468788|NCT01303445|451345579|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
125468789|NCT01303445|451345580|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
125468790|NCT01303445|451345579|FG000|Washout (14 Days)|Protocol Violation|1|||
125468791|NCT01303445|451345580|FG001|Washout (14 Days)|Protocol Violation|0|||
125468792|NCT01303445|451345579|FG000|Washout (14 Days)|Lost to Follow-up|0|||
125468793|NCT01303445|451345580|FG001|Washout (14 Days)|Lost to Follow-up|2|||
125468794|NCT01303445|451345579|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
125468795|NCT01303445|451345580|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
125468796|NCT01303445|451345579|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
125468797|NCT01303445|451345580|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
125468798|NCT01216176|451347625|FG000|Overall Study|Adverse Event|0|||
125468799|NCT01216176|451347626|FG001|Overall Study|Adverse Event|8|||
125468800|NCT01216176|451347627|FG002|Overall Study|Adverse Event|0|||
125468801|NCT01216176|451347625|FG000|Overall Study|Physician Decision|0|||
125468802|NCT01216176|451347626|FG001|Overall Study|Physician Decision|0|||
125468803|NCT01216176|451347627|FG002|Overall Study|Physician Decision|1|||
125468804|NCT03725722|451347630|FG000|Overall Study|Lack of Efficacy|2|||
125468805|NCT03725722|451347631|FG001|Overall Study|Lack of Efficacy|1|||
125468806|NCT03725722|451347632|FG002|Overall Study|Lack of Efficacy|2|||
125468807|NCT03725722|451347633|FG003|Overall Study|Lack of Efficacy|0|||
125468808|NCT03725722|451347634|FG004|Overall Study|Lack of Efficacy|2|||
125468809|NCT03725722|451347630|FG000|Overall Study|Adverse Event|2|||
125468810|NCT03725722|451347631|FG001|Overall Study|Adverse Event|2|||
125468811|NCT03725722|451347632|FG002|Overall Study|Adverse Event|1|||
125468812|NCT03725722|451347633|FG003|Overall Study|Adverse Event|0|||
125468813|NCT03725722|451347634|FG004|Overall Study|Adverse Event|6|||
125468814|NCT03725722|451347630|FG000|Overall Study|Withdrawal by Subject|4|||
125468815|NCT03725722|451347631|FG001|Overall Study|Withdrawal by Subject|1|||
125468816|NCT03725722|451347632|FG002|Overall Study|Withdrawal by Subject|0|||
125468817|NCT03725722|451347633|FG003|Overall Study|Withdrawal by Subject|4|||
125468818|NCT03725722|451347634|FG004|Overall Study|Withdrawal by Subject|4|||
125468819|NCT03725722|451347630|FG000|Overall Study|Lost to Follow-up|3|||
125468820|NCT03725722|451347631|FG001|Overall Study|Lost to Follow-up|1|||
125298339|NCT02879578|450717295|FG000|Overall Study|Protocol Violation|0|||
125298340|NCT02879578|450717296|FG001|Overall Study|Protocol Violation|1|||
125298341|NCT02879578|450717297|FG002|Overall Study|Protocol Violation|1|||
125468821|NCT03725722|451347632|FG002|Overall Study|Lost to Follow-up|2|||
125468822|NCT03725722|451347633|FG003|Overall Study|Lost to Follow-up|2|||
125468823|NCT03725722|451347634|FG004|Overall Study|Lost to Follow-up|1|||
125468824|NCT03725722|451347630|FG000|Overall Study|Personal reasons|0|||
125468825|NCT03725722|451347631|FG001|Overall Study|Personal reasons|0|||
125468826|NCT03725722|451347632|FG002|Overall Study|Personal reasons|1|||
125468827|NCT03725722|451347633|FG003|Overall Study|Personal reasons|0|||
125468828|NCT03725722|451347634|FG004|Overall Study|Personal reasons|1|||
125468829|NCT03725722|451347630|FG000|Overall Study|COVID-19 situation|0|||
125468830|NCT03725722|451347631|FG001|Overall Study|COVID-19 situation|1|||
125468831|NCT03725722|451347632|FG002|Overall Study|COVID-19 situation|0|||
125468832|NCT03725722|451347633|FG003|Overall Study|COVID-19 situation|0|||
125468833|NCT03725722|451347634|FG004|Overall Study|COVID-19 situation|0|||
125468834|NCT05505045|451347635|FG000|Overall Study|Withdrawal by Subject|2|||
125468835|NCT05505045|451347636|FG001|Overall Study|Withdrawal by Subject|1|||
125468836|NCT01643070|451347637|FG000|Overall Study|Withdrawal by Subject|3|||
125468837|NCT01643070|451347638|FG001|Overall Study|Withdrawal by Subject|1|||
125468838|NCT01643070|451347637|FG000|Overall Study|Death|1|||
125468839|NCT01643070|451347638|FG001|Overall Study|Death|0|||
125468840|NCT01643070|451347637|FG000|Overall Study|Pregressive disease|0|||
125468841|NCT01643070|451347638|FG001|Overall Study|Pregressive disease|2|||
125468842|NCT01600014|451347639|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
125468843|NCT01600014|451347640|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
125468844|NCT01600014|451347639|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
125468845|NCT01600014|451347640|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
125468846|NCT01600014|451347639|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
125468847|NCT01600014|451347640|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
125468848|NCT01600014|451347639|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
125468849|NCT01600014|451347640|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
125468850|NCT01600014|451347639|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
125468851|NCT01600014|451347640|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
125468852|NCT01600014|451347639|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
125468853|NCT01600014|451347640|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
125468854|NCT01600014|451347639|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
125468855|NCT01600014|451347640|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
125468856|NCT01600014|451347639|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
125468857|NCT01600014|451347640|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
125298342|NCT02879578|450717295|FG000|Overall Study|Withdrawal by Subject|8|||
125298343|NCT02879578|450717296|FG001|Overall Study|Withdrawal by Subject|6|||
125468858|NCT01600014|451347639|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
125468859|NCT01600014|451347640|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
125468860|NCT01600014|451347639|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
125468861|NCT01600014|451347640|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
125468862|NCT01600014|451347639|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
125468863|NCT01600014|451347640|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
125468864|NCT01600014|451347639|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
125468865|NCT01600014|451347640|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
125468866|NCT01600014|451347639|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
125468867|NCT01600014|451347640|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
125298344|NCT02879578|450717297|FG002|Overall Study|Withdrawal by Subject|9|||
125298345|NCT02879578|450717295|FG000|Overall Study|Lost to Follow-up|1|||
125298346|NCT02879578|450717296|FG001|Overall Study|Lost to Follow-up|0|||
125298347|NCT02879578|450717297|FG002|Overall Study|Lost to Follow-up|4|||
125298348|NCT02879578|450717295|FG000|Overall Study|Physician Decision|0|||
125298349|NCT02879578|450717296|FG001|Overall Study|Physician Decision|0|||
125298350|NCT02879578|450717297|FG002|Overall Study|Physician Decision|4|||
125298351|NCT02925728|450717303|FG000|Overall Study|Death|3|||
125298352|NCT02925728|450717304|FG001|Overall Study|Death|5|||
125298353|NCT02925728|450717303|FG000|Overall Study|Physician Decision|1|||
125298354|NCT02925728|450717304|FG001|Overall Study|Physician Decision|0|||
125298355|NCT02925728|450717303|FG000|Overall Study|Withdrawal by Subject|1|||
125298356|NCT02925728|450717304|FG001|Overall Study|Withdrawal by Subject|0|||
125298357|NCT05098509|450717305|FG000|Overall Study|Withdrawal by Subject|0|||
125298358|NCT05098509|450717306|FG001|Overall Study|Withdrawal by Subject|0|||
125298359|NCT05098509|450717307|FG002|Overall Study|Withdrawal by Subject|1|||
125298360|NCT05098509|450717308|FG003|Overall Study|Withdrawal by Subject|0|||
125298361|NCT05098509|450717305|FG000|Overall Study|Early study termination|1|||
125298362|NCT05098509|450717306|FG001|Overall Study|Early study termination|1|||
125298363|NCT05098509|450717307|FG002|Overall Study|Early study termination|1|||
125298364|NCT05098509|450717308|FG003|Overall Study|Early study termination|0|||
125298365|NCT00324233|450717311|FG000|First Period|unable to insert catheter|1|||
125298366|NCT00324233|450717312|FG001|First Period|unable to insert catheter|0|||
125468868|NCT01600014|451347639|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
125298367|NCT00324233|450717311|FG000|Second Period|unable to insert catheter|1|||
125298368|NCT00324233|450717312|FG001|Second Period|unable to insert catheter|1|||
125298369|NCT00324233|450717311|FG000|Second Period|Protocol Violation|4|||
125468869|NCT01600014|451347640|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
125298370|NCT00324233|450717312|FG001|Second Period|Protocol Violation|6|||
125468870|NCT01600014|451347639|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
125298371|NCT00086411|450717320|FG000|Overall Study|Lost to Follow-up|11|||
125298372|NCT00086411|450717321|FG001|Overall Study|Lost to Follow-up|11|||
125298373|NCT00086411|450717322|FG002|Overall Study|Lost to Follow-up|13|||
125298374|NCT00086411|450717323|FG003|Overall Study|Lost to Follow-up|12|||
125298375|NCT03667690|450719887|FG000|Overall Study|Adverse Event|0|||
125298376|NCT03667690|450719888|FG001|Overall Study|Adverse Event|3|||
125298377|NCT03667690|450719887|FG000|Overall Study|Death|22|||
125298378|NCT03667690|450719888|FG001|Overall Study|Death|21|||
125298379|NCT03667690|450719887|FG000|Overall Study|Lost to Follow-up|4|||
125298380|NCT03667690|450719888|FG001|Overall Study|Lost to Follow-up|5|||
125298381|NCT03667690|450719887|FG000|Overall Study|Withdrawal by Subject|7|||
125298382|NCT03667690|450719888|FG001|Overall Study|Withdrawal by Subject|8|||
125298383|NCT03667690|450719887|FG000|Overall Study|Subject could not return for additional investigational product|1|||
125298384|NCT03667690|450719888|FG001|Overall Study|Subject could not return for additional investigational product|0|||
125298385|NCT03667690|450719887|FG000|Overall Study|Subject discharged to hospice care|2|||
125298386|NCT03667690|450719888|FG001|Overall Study|Subject discharged to hospice care|0|||
125298387|NCT03667690|450719887|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
125298388|NCT03667690|450719888|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
125298389|NCT03667690|450719887|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
125298390|NCT03667690|450719888|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
125298391|NCT03667690|450719887|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
125298392|NCT03667690|450719888|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
125298393|NCT03667690|450719887|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
125298394|NCT03667690|450719888|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
125298395|NCT03667690|450719887|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
125298396|NCT03667690|450719888|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
125298397|NCT00321464|450719892|FG000|Overall Study|Death|169|||
125298398|NCT00321464|450719893|FG001|Overall Study|Death|174|||
125298399|NCT00321464|450719892|FG000|Overall Study|Disease progression|124|||
125298400|NCT00321464|450719893|FG001|Overall Study|Disease progression|124|||
125298401|NCT00321464|450719892|FG000|Overall Study|Withdrawal by Subject|117|||
125298402|NCT00321464|450719893|FG001|Overall Study|Withdrawal by Subject|118|||
125298403|NCT00321464|450719892|FG000|Overall Study|Participant request|57|||
125298404|NCT00321464|450719893|FG001|Overall Study|Participant request|61|||
125298405|NCT00321464|450719892|FG000|Overall Study|Adverse Event|43|||
125298406|NCT00321464|450719893|FG001|Overall Study|Adverse Event|28|||
125298407|NCT00321464|450719892|FG000|Overall Study|Physician Decision|15|||
125298408|NCT00321464|450719893|FG001|Overall Study|Physician Decision|14|||
125298409|NCT00321464|450719892|FG000|Overall Study|Noncompliance|4|||
125298410|NCT00321464|450719893|FG001|Overall Study|Noncompliance|10|||
125298411|NCT00321464|450719892|FG000|Overall Study|Lost to Follow-up|7|||
125298412|NCT00321464|450719893|FG001|Overall Study|Lost to Follow-up|8|||
125298413|NCT00321464|450719892|FG000|Overall Study|Protocol deviation|0|||
125298414|NCT00321464|450719893|FG001|Overall Study|Protocol deviation|2|||
125298415|NCT00321464|450719892|FG000|Overall Study|Ineligibility determined|2|||
125298416|NCT00321464|450719893|FG001|Overall Study|Ineligibility determined|1|||
125298417|NCT00321464|450719892|FG000|Overall Study|Other|21|||
125298418|NCT00321464|450719893|FG001|Overall Study|Other|18|||
125298419|NCT04327024|450719894|FG000|Overall Study|Death|1|||
125298420|NCT04327024|450719895|FG001|Overall Study|Death|2|||
125298421|NCT04327024|450719896|FG002|Overall Study|Death|1|||
125298422|NCT04327024|450719894|FG000|Overall Study|Non-compliance with study drug|0|||
125298423|NCT04327024|450719895|FG001|Overall Study|Non-compliance with study drug|1|||
125298424|NCT04327024|450719896|FG002|Overall Study|Non-compliance with study drug|0|||
125298425|NCT04327024|450719894|FG000|Overall Study|Withdrawal by Subject|1|||
125298426|NCT04327024|450719895|FG001|Overall Study|Withdrawal by Subject|1|||
125298427|NCT04327024|450719896|FG002|Overall Study|Withdrawal by Subject|2|||
125298428|NCT01192568|450719900|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
125298429|NCT01192568|450719901|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
125298430|NCT01192568|450719902|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
125298431|NCT01192568|450719903|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
125298432|NCT01192568|450719900|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
125298433|NCT01192568|450719901|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
125298434|NCT01192568|450719902|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
125298435|NCT01192568|450719903|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
125298436|NCT00652951|450719904|FG000|Booster Phase|Adverse event, non-fatal|0|||
125298437|NCT00652951|450719905|FG001|Booster Phase|Adverse event, non-fatal|1|||
125298438|NCT00652951|450719906|FG002|Booster Phase|Adverse event, non-fatal|0|||
125298439|NCT00652951|450719904|FG000|Booster Phase|Other|1|||
125298440|NCT00652951|450719905|FG001|Booster Phase|Other|0|||
125298441|NCT00652951|450719906|FG002|Booster Phase|Other|0|||
125298442|NCT02593825|450719907|FG000|Intervention|Lost to Follow-up|10|||
125298443|NCT02593825|450719908|FG001|Intervention|Lost to Follow-up|12|||
125298444|NCT01206582|450719909|FG000|Overall Study|Withdrew prior to study|1|||
125298445|NCT01206582|450719910|FG001|Overall Study|Withdrew prior to study|0|||
125298446|NCT01206582|450719909|FG000|Overall Study|Discontinued intervention before week 8|1|||
125298447|NCT01206582|450719910|FG001|Overall Study|Discontinued intervention before week 8|2|||
125298448|NCT02522325|450719911|FG000|Overall Study|Adverse Event|0|||
125298449|NCT02522325|450719912|FG001|Overall Study|Adverse Event|1|||
125298450|NCT01209078|450719913|FG000|Overall Study|Adverse Event|5|||
125298451|NCT01209078|450719914|FG001|Overall Study|Adverse Event|0|||
125298452|NCT01209078|450719913|FG000|Overall Study|Lost to Follow-up|4|||
125298453|NCT01209078|450719914|FG001|Overall Study|Lost to Follow-up|0|||
125298454|NCT01209078|450719913|FG000|Overall Study|Physician Decision|5|||
125298455|NCT01209078|450719914|FG001|Overall Study|Physician Decision|2|||
125298456|NCT01209078|450719913|FG000|Overall Study|Withdrawal by Subject|2|||
125298457|NCT01209078|450719914|FG001|Overall Study|Withdrawal by Subject|1|||
125298458|NCT00924508|450719915|FG000|Overall Study|Withdrawal by Subject|3|||
125298459|NCT00495625|450719916|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
125298460|NCT01912339|450719917|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
125298461|NCT01912339|450719918|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
125298462|NCT01912339|450719919|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
125298463|NCT01912339|450719917|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
125298464|NCT01912339|450719918|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
125298465|NCT01912339|450719919|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
125298466|NCT01912339|450719917|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
125298467|NCT01912339|450719918|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
125298468|NCT01912339|450719919|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
125298469|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
125298470|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
125298471|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
125298472|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
125298473|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
125298474|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
125298475|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
125298476|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
125298477|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
125420659|NCT02943408|451166090|FG001|Overall Study|Withdrawal by Subject|1|||
125420660|NCT01621126|451166093|FG000|Overall Study|Physician Decision|6|||
125420661|NCT00886340|451166094|FG000|Overall Study|Withdrawal by Subject|0|||
125420662|NCT00886340|451166095|FG001|Overall Study|Withdrawal by Subject|7|||
125420663|NCT01949311|451166097|FG000|Overall Study|Lost to Follow-up|73|||
125420664|NCT01949311|451166097|FG000|Overall Study|Terminated by Sponsor|708|||
125420665|NCT01949311|451166097|FG000|Overall Study|Withdrawal by Subject|375|||
125420666|NCT01949311|451166097|FG000|Overall Study|Lack of Efficacy|50|||
125420667|NCT01949311|451166097|FG000|Overall Study|Protocol Deviation|34|||
125420668|NCT01949311|451166097|FG000|Overall Study|Pregnancy|20|||
125420669|NCT01949311|451166097|FG000|Overall Study|Physician Decision|9|||
125420670|NCT01949311|451166097|FG000|Overall Study|Other|4|||
125420671|NCT01949311|451166097|FG000|Overall Study|Adverse Event|107|||
125420672|NCT02338154|451166098|FG000|Overall Study|Death|46|||
125420673|NCT02338154|451166098|FG000|Overall Study|Valve Implant Failure|17|||
125420674|NCT02338154|451166098|FG000|Overall Study|Valve Explant|11|||
125420675|NCT02338154|451166098|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
125420676|NCT02338154|451166098|FG000|Overall Study|Lost to Follow-up|8|||
125420677|NCT02338154|451166098|FG000|Overall Study|Other Reason|3|||
125420678|NCT02338154|451166098|FG000|Overall Study|Patients Without Exit Form|47|||
125420679|NCT02338154|451166098|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
125420680|NCT02120027|451166099|FG000|Overall Study|Adverse Event|4|||
125420681|NCT02120027|451166100|FG001|Overall Study|Adverse Event|5|||
125420682|NCT02120027|451166099|FG000|Overall Study|Lack of Efficacy|3|||
125420683|NCT02120027|451166100|FG001|Overall Study|Lack of Efficacy|5|||
125420684|NCT02120027|451166099|FG000|Overall Study|Lost to Follow-up|5|||
125420685|NCT02120027|451166100|FG001|Overall Study|Lost to Follow-up|13|||
125420686|NCT02120027|451166099|FG000|Overall Study|Other|4|||
125420687|NCT02120027|451166100|FG001|Overall Study|Other|0|||
125420688|NCT02120027|451166099|FG000|Overall Study|Physician Decision|4|||
125420689|NCT02120027|451166100|FG001|Overall Study|Physician Decision|3|||
125420690|NCT02120027|451166099|FG000|Overall Study|Protocol Violation|18|||
125420691|NCT02120027|451166100|FG001|Overall Study|Protocol Violation|21|||
125420692|NCT02120027|451166099|FG000|Overall Study|Study terminated by Sponsor|45|||
125420693|NCT02120027|451166100|FG001|Overall Study|Study terminated by Sponsor|47|||
125420694|NCT02120027|451166099|FG000|Overall Study|Withdrawal by Subject|33|||
125420695|NCT02120027|451166100|FG001|Overall Study|Withdrawal by Subject|25|||
125420696|NCT00447057|451166105|FG000|Overall Study|Adverse Event|4|||
125420697|NCT00447057|451166106|FG001|Overall Study|Adverse Event|10|||
125420698|NCT00447057|451166107|FG002|Overall Study|Adverse Event|0|||
125420699|NCT00447057|451166108|FG003|Overall Study|Adverse Event|3|||
125298478|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
125298479|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
125298480|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
125298481|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
125298482|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
125298483|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
125298484|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
125298485|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
125298486|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
125298487|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
125298488|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
125298489|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
125298490|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
125298491|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
125298492|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
125298493|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
125298494|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
125298495|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
125298496|NCT01912339|450719917|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
125298497|NCT01912339|450719918|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
125298498|NCT01912339|450719919|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
125298499|NCT01754493|450719920|FG000|Overall Study|Adverse Event|1|||
125298500|NCT01754493|450719920|FG000|Overall Study|Lost to Follow-up|3|||
125298501|NCT01754493|450719920|FG000|Overall Study|Withdrawal by Subject|1|||
125298502|NCT01754493|450719920|FG000|Overall Study|Moved out of town|1|||
125298503|NCT01754493|450719920|FG000|Overall Study|Scheduling conflict|1|||
125298504|NCT01543776|450719921|FG000|Overall Study|Withdrawal by Subject|2|||
125298505|NCT01543776|450719922|FG001|Overall Study|Withdrawal by Subject|2|||
125298506|NCT03055013|450719924|FG000|Overall Study|Adverse Event|78|||
125298507|NCT03055013|450719925|FG001|Overall Study|Adverse Event|0|||
125298508|NCT03055013|450719924|FG000|Overall Study|Death|6|||
125298509|NCT03055013|450719925|FG001|Overall Study|Death|0|||
125298510|NCT03055013|450719924|FG000|Overall Study|Disease relapse|33|||
125298511|NCT03055013|450719925|FG001|Overall Study|Disease relapse|0|||
125298512|NCT03055013|450719924|FG000|Overall Study|Withdrawal by Subject|28|||
125298513|NCT03055013|450719925|FG001|Overall Study|Withdrawal by Subject|0|||
125298514|NCT03055013|450719924|FG000|Overall Study|Other complicating disease|5|||
125298515|NCT03055013|450719925|FG001|Overall Study|Other complicating disease|0|||
125298516|NCT03055013|450719924|FG000|Overall Study|Physician Decision|1|||
125298517|NCT03055013|450719925|FG001|Overall Study|Physician Decision|0|||
125298518|NCT03055013|450719924|FG000|Overall Study|Benign mass/non-RCC|4|||
125298519|NCT03055013|450719925|FG001|Overall Study|Benign mass/non-RCC|0|||
125298520|NCT03055013|450719924|FG000|Overall Study|Enrolled in another trial|1|||
125298521|NCT03055013|450719925|FG001|Overall Study|Enrolled in another trial|0|||
125298522|NCT03055013|450719924|FG000|Overall Study|Non-protocol therapy|1|||
125298523|NCT03055013|450719925|FG001|Overall Study|Non-protocol therapy|0|||
125298524|NCT03055013|450719924|FG000|Overall Study|Incompliance|1|||
125298525|NCT03055013|450719925|FG001|Overall Study|Incompliance|0|||
125298526|NCT03055013|450719924|FG000|Overall Study|Insurance issues|1|||
125298527|NCT03055013|450719925|FG001|Overall Study|Insurance issues|0|||
125298528|NCT03055013|450719924|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
125298529|NCT03055013|450719925|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
125298530|NCT03055013|450719924|FG000|Overall Study|Did not receive nivolumab|10|||
125298531|NCT03055013|450719925|FG001|Overall Study|Did not receive nivolumab|0|||
125298532|NCT03055013|450719924|FG000|Overall Study|Did not receive surgery|0|||
125298533|NCT03055013|450719925|FG001|Overall Study|Did not receive surgery|28|||
125298534|NCT02207491|450719926|FG000|Overall Study|Adverse Event|20|||
125298535|NCT02207491|450719927|FG001|Overall Study|Adverse Event|4|||
125298536|NCT02207491|450719926|FG000|Overall Study|Withdrawal by Subject|3|||
125298537|NCT02207491|450719927|FG001|Overall Study|Withdrawal by Subject|2|||
125298538|NCT02207491|450719926|FG000|Overall Study|Non-compliant|0|||
125298539|NCT02207491|450719927|FG001|Overall Study|Non-compliant|1|||
125298540|NCT02207491|450719926|FG000|Overall Study|Lost to Follow-up|0|||
125298541|NCT02207491|450719927|FG001|Overall Study|Lost to Follow-up|1|||
125298542|NCT02207491|450719926|FG000|Overall Study|Lack of Efficacy|3|||
125298543|NCT02207491|450719927|FG001|Overall Study|Lack of Efficacy|0|||
125298544|NCT02207491|450719926|FG000|Overall Study|Physician Decision|2|||
125298545|NCT02207491|450719927|FG001|Overall Study|Physician Decision|0|||
125298546|NCT02207491|450719926|FG000|Overall Study|Protocol Violation|3|||
125298547|NCT02207491|450719927|FG001|Overall Study|Protocol Violation|5|||
125298548|NCT00126776|450719928|FG000|Overall Study|follow up complete on all patients|0|||
125298549|NCT00126776|450719929|FG001|Overall Study|follow up complete on all patients|0|||
125298550|NCT00599755|450719930|FG000|Overall Study|Adverse Event|11|||
125298551|NCT00599755|450719930|FG000|Overall Study|Withdrawal by Subject|2|||
125298552|NCT00599755|450719930|FG000|Overall Study|Progression of Disease|3|||
125298553|NCT00599755|450719930|FG000|Overall Study|Other Reason|2|||
125298554|NCT00599755|450719930|FG000|Overall Study|No data available|1|||
125298555|NCT03626545|450719934|FG000|Overall Study|Progressive disease|3|||
125298556|NCT03626545|450719935|FG001|Overall Study|Progressive disease|82|||
125298557|NCT03626545|450719936|FG002|Overall Study|Progressive disease|85|||
125298558|NCT03626545|450719934|FG000|Overall Study|Adverse Event|3|||
125298559|NCT03626545|450719935|FG001|Overall Study|Adverse Event|13|||
125298560|NCT03626545|450719936|FG002|Overall Study|Adverse Event|10|||
125298561|NCT03626545|450719934|FG000|Overall Study|Physician Decision|1|||
125298562|NCT03626545|450719935|FG001|Overall Study|Physician Decision|18|||
125298563|NCT03626545|450719936|FG002|Overall Study|Physician Decision|14|||
125298564|NCT03626545|450719934|FG000|Overall Study|Subject Decision|0|||
125298565|NCT03626545|450719935|FG001|Overall Study|Subject Decision|5|||
125298566|NCT03626545|450719936|FG002|Overall Study|Subject Decision|5|||
125298567|NCT03626545|450719934|FG000|Overall Study|Death|1|||
125298568|NCT03626545|450719935|FG001|Overall Study|Death|1|||
125298569|NCT03626545|450719936|FG002|Overall Study|Death|1|||
125468871|NCT01600014|451347640|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
125468872|NCT01600014|451347639|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
125468873|NCT01600014|451347640|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
125468874|NCT01600014|451347639|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
125298570|NCT03626545|450719934|FG000|Overall Study|Protocol Deviation|0|||
125298571|NCT03626545|450719935|FG001|Overall Study|Protocol Deviation|1|||
125298572|NCT03626545|450719936|FG002|Overall Study|Protocol Deviation|1|||
125298573|NCT03626545|450719934|FG000|Overall Study|Guardian Decision|0|||
125298574|NCT03626545|450719935|FG001|Overall Study|Guardian Decision|0|||
125298575|NCT03626545|450719936|FG002|Overall Study|Guardian Decision|1|||
125298576|NCT01939366|450719937|FG000|Overall Study|Adverse Event|8|||
125298577|NCT01939366|450719938|FG001|Overall Study|Adverse Event|17|||
125298578|NCT01939366|450719939|FG002|Overall Study|Adverse Event|30|||
125298579|NCT01939366|450719940|FG003|Overall Study|Adverse Event|8|||
125298580|NCT01939366|450719941|FG004|Overall Study|Adverse Event|5|||
125298581|NCT01939366|450719937|FG000|Overall Study|Lack of Efficacy|2|||
125298582|NCT01939366|450719938|FG001|Overall Study|Lack of Efficacy|1|||
125298583|NCT01939366|450719939|FG002|Overall Study|Lack of Efficacy|1|||
125298584|NCT01939366|450719940|FG003|Overall Study|Lack of Efficacy|1|||
125298585|NCT01939366|450719941|FG004|Overall Study|Lack of Efficacy|3|||
125298586|NCT01939366|450719937|FG000|Overall Study|Lost to Follow-up|1|||
125298587|NCT01939366|450719938|FG001|Overall Study|Lost to Follow-up|1|||
125298588|NCT01939366|450719939|FG002|Overall Study|Lost to Follow-up|0|||
125298589|NCT01939366|450719940|FG003|Overall Study|Lost to Follow-up|0|||
125298590|NCT01939366|450719941|FG004|Overall Study|Lost to Follow-up|0|||
125298591|NCT01939366|450719937|FG000|Overall Study|Withdrawal by Subject|1|||
125298592|NCT01939366|450719938|FG001|Overall Study|Withdrawal by Subject|0|||
125298593|NCT01939366|450719939|FG002|Overall Study|Withdrawal by Subject|2|||
125298594|NCT01939366|450719940|FG003|Overall Study|Withdrawal by Subject|2|||
125298595|NCT01939366|450719941|FG004|Overall Study|Withdrawal by Subject|3|||
125298596|NCT01939366|450719937|FG000|Overall Study|Inclusion criteria not met|0|||
125298597|NCT01939366|450719938|FG001|Overall Study|Inclusion criteria not met|1|||
125298598|NCT01939366|450719939|FG002|Overall Study|Inclusion criteria not met|1|||
125298599|NCT01939366|450719940|FG003|Overall Study|Inclusion criteria not met|0|||
125298600|NCT01939366|450719941|FG004|Overall Study|Inclusion criteria not met|1|||
125298601|NCT01939366|450719937|FG000|Overall Study|Other|0|||
125298602|NCT01939366|450719938|FG001|Overall Study|Other|0|||
125298603|NCT01939366|450719939|FG002|Overall Study|Other|2|||
125298604|NCT01939366|450719940|FG003|Overall Study|Other|2|||
125298605|NCT01939366|450719941|FG004|Overall Study|Other|1|||
125298606|NCT01939366|450719937|FG000|Overall Study|Protocol Violation|0|||
125468875|NCT01600014|451347640|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
125298607|NCT01939366|450719938|FG001|Overall Study|Protocol Violation|0|||
125298608|NCT01939366|450719939|FG002|Overall Study|Protocol Violation|0|||
125298609|NCT01939366|450719940|FG003|Overall Study|Protocol Violation|1|||
125298610|NCT01939366|450719941|FG004|Overall Study|Protocol Violation|0|||
125298611|NCT01939366|450719937|FG000|Overall Study|Sponsor decision|0|||
125298612|NCT01939366|450719938|FG001|Overall Study|Sponsor decision|0|||
125298613|NCT01939366|450719939|FG002|Overall Study|Sponsor decision|0|||
125298614|NCT01939366|450719940|FG003|Overall Study|Sponsor decision|0|||
125298615|NCT01939366|450719941|FG004|Overall Study|Sponsor decision|2|||
125298616|NCT01939366|450719937|FG000|Overall Study|GCP non-compliance at site|2|||
125298617|NCT01939366|450719938|FG001|Overall Study|GCP non-compliance at site|3|||
125298618|NCT01939366|450719939|FG002|Overall Study|GCP non-compliance at site|2|||
125298619|NCT01939366|450719940|FG003|Overall Study|GCP non-compliance at site|3|||
125298620|NCT01939366|450719941|FG004|Overall Study|GCP non-compliance at site|3|||
125298621|NCT03909152|450719942|FG000|Overall Study|Adverse Event|14|||
125298622|NCT03909152|450719943|FG001|Overall Study|Adverse Event|5|||
125298623|NCT03909152|450719944|FG002|Overall Study|Adverse Event|1|||
125298624|NCT03909152|450719945|FG003|Overall Study|Adverse Event|14|||
125298625|NCT02615691|450719946|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
125298626|NCT02615691|450719946|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
125298627|NCT02615691|450719946|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
125298628|NCT02615691|450719946|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
125298629|NCT02017522|450719947|FG000|Overall Study|Withdrawal by Subject|1|||
125298630|NCT00615030|450719949|FG000|Period I|Administrative problem|0|||
125298631|NCT00615030|450719950|FG001|Period I|Administrative problem|0|||
125298632|NCT00615030|450719951|FG002|Period I|Administrative problem|0|||
125298633|NCT00615030|450719952|FG003|Period I|Administrative problem|0|||
125298634|NCT00615030|450719953|FG004|Period I|Administrative problem|1|||
125298635|NCT00615030|450719954|FG005|Period I|Administrative problem|0|||
125298636|NCT00615030|450719955|FG006|Period I|Administrative problem|0|||
125298637|NCT00615030|450719956|FG007|Period I|Administrative problem|0|||
125298638|NCT00615030|450719957|FG008|Period I|Administrative problem|0|||
125298639|NCT00615030|450719958|FG009|Period I|Administrative problem|0|||
125298640|NCT00615030|450719959|FG010|Period I|Administrative problem|0|||
125298641|NCT00615030|450719960|FG011|Period I|Administrative problem|0|||
125298642|NCT00615030|450719949|FG000|Period I|Protocol deviation|1|||
125298643|NCT00615030|450719950|FG001|Period I|Protocol deviation|0|||
125298644|NCT00615030|450719951|FG002|Period I|Protocol deviation|0|||
125298645|NCT00615030|450719952|FG003|Period I|Protocol deviation|0|||
125298646|NCT00615030|450719953|FG004|Period I|Protocol deviation|0|||
125298647|NCT00615030|450719954|FG005|Period I|Protocol deviation|0|||
125298648|NCT00615030|450719955|FG006|Period I|Protocol deviation|0|||
125298649|NCT00615030|450719956|FG007|Period I|Protocol deviation|0|||
125298650|NCT00615030|450719957|FG008|Period I|Protocol deviation|0|||
125298651|NCT00615030|450719958|FG009|Period I|Protocol deviation|0|||
125298652|NCT00615030|450719959|FG010|Period I|Protocol deviation|0|||
125298653|NCT00615030|450719960|FG011|Period I|Protocol deviation|0|||
125298654|NCT00615030|450719949|FG000|Period I|Subject withdrew consent|0|||
125298655|NCT00615030|450719950|FG001|Period I|Subject withdrew consent|0|||
125298656|NCT00615030|450719951|FG002|Period I|Subject withdrew consent|0|||
125298657|NCT00615030|450719952|FG003|Period I|Subject withdrew consent|0|||
125298658|NCT00615030|450719953|FG004|Period I|Subject withdrew consent|0|||
125298659|NCT00615030|450719954|FG005|Period I|Subject withdrew consent|0|||
125298660|NCT00615030|450719955|FG006|Period I|Subject withdrew consent|0|||
125298661|NCT00615030|450719956|FG007|Period I|Subject withdrew consent|0|||
125298662|NCT00615030|450719957|FG008|Period I|Subject withdrew consent|1|||
125298663|NCT00615030|450719958|FG009|Period I|Subject withdrew consent|0|||
125298664|NCT00615030|450719959|FG010|Period I|Subject withdrew consent|1|||
125298665|NCT00615030|450719960|FG011|Period I|Subject withdrew consent|1|||
125298666|NCT00615030|450719949|FG000|Period I|Abnormal laboratory value(s)|0|||
125298667|NCT00615030|450719950|FG001|Period I|Abnormal laboratory value(s)|0|||
125298668|NCT00615030|450719951|FG002|Period I|Abnormal laboratory value(s)|0|||
125298669|NCT00615030|450719952|FG003|Period I|Abnormal laboratory value(s)|0|||
125298670|NCT00615030|450719953|FG004|Period I|Abnormal laboratory value(s)|0|||
125298671|NCT00615030|450719954|FG005|Period I|Abnormal laboratory value(s)|1|||
125298672|NCT00615030|450719955|FG006|Period I|Abnormal laboratory value(s)|0|||
125298673|NCT00615030|450719956|FG007|Period I|Abnormal laboratory value(s)|0|||
125298674|NCT00615030|450719957|FG008|Period I|Abnormal laboratory value(s)|0|||
125298675|NCT00615030|450719958|FG009|Period I|Abnormal laboratory value(s)|0|||
125298676|NCT00615030|450719959|FG010|Period I|Abnormal laboratory value(s)|0|||
125298677|NCT00615030|450719960|FG011|Period I|Abnormal laboratory value(s)|0|||
125298678|NCT00615030|450719949|FG000|Period II|Adverse Event|0|||
125298679|NCT00615030|450719950|FG001|Period II|Adverse Event|0|||
125298680|NCT00615030|450719951|FG002|Period II|Adverse Event|1|||
125298681|NCT00615030|450719952|FG003|Period II|Adverse Event|0|||
125298682|NCT00615030|450719953|FG004|Period II|Adverse Event|0|||
125298683|NCT00615030|450719954|FG005|Period II|Adverse Event|0|||
125298684|NCT00615030|450719955|FG006|Period II|Adverse Event|0|||
125298685|NCT00615030|450719956|FG007|Period II|Adverse Event|0|||
125298686|NCT00615030|450719957|FG008|Period II|Adverse Event|1|||
125298687|NCT00615030|450719958|FG009|Period II|Adverse Event|0|||
125298688|NCT00615030|450719959|FG010|Period II|Adverse Event|0|||
125298689|NCT00615030|450719960|FG011|Period II|Adverse Event|0|||
125298690|NCT00615030|450719949|FG000|Period II|Subject withdrew consent|0|||
125298691|NCT00615030|450719950|FG001|Period II|Subject withdrew consent|0|||
125298692|NCT00615030|450719951|FG002|Period II|Subject withdrew consent|0|||
125298693|NCT00615030|450719952|FG003|Period II|Subject withdrew consent|1|||
125298694|NCT00615030|450719953|FG004|Period II|Subject withdrew consent|0|||
125298695|NCT00615030|450719954|FG005|Period II|Subject withdrew consent|0|||
125298696|NCT00615030|450719955|FG006|Period II|Subject withdrew consent|1|||
125298697|NCT00615030|450719956|FG007|Period II|Subject withdrew consent|0|||
125298698|NCT00615030|450719957|FG008|Period II|Subject withdrew consent|0|||
125298699|NCT00615030|450719958|FG009|Period II|Subject withdrew consent|0|||
125298700|NCT00615030|450719959|FG010|Period II|Subject withdrew consent|0|||
125298701|NCT00615030|450719960|FG011|Period II|Subject withdrew consent|0|||
125298702|NCT00615030|450719949|FG000|Period III|Administrative problems|1|||
125298703|NCT00615030|450719950|FG001|Period III|Administrative problems|0|||
125298704|NCT00615030|450719951|FG002|Period III|Administrative problems|0|||
125298705|NCT00615030|450719952|FG003|Period III|Administrative problems|1|||
125298706|NCT00615030|450719953|FG004|Period III|Administrative problems|0|||
125298707|NCT00615030|450719954|FG005|Period III|Administrative problems|0|||
125298708|NCT00615030|450719955|FG006|Period III|Administrative problems|0|||
125298709|NCT00615030|450719956|FG007|Period III|Administrative problems|0|||
125298710|NCT00615030|450719957|FG008|Period III|Administrative problems|0|||
125298711|NCT00615030|450719958|FG009|Period III|Administrative problems|0|||
125298712|NCT00615030|450719959|FG010|Period III|Administrative problems|0|||
125298713|NCT00615030|450719960|FG011|Period III|Administrative problems|0|||
125298714|NCT00151476|450719961|FG000|FAP Identified Subjects|Protocol Violation|0|||
125298715|NCT00151476|450719962|FG001|FAP Identified Subjects|Protocol Violation|1|||
125298716|NCT00151476|450719961|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
125298717|NCT00151476|450719962|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
125468876|NCT03481777|451347643|FG000|Overall Study|Withdrawal by Subject|36|||
125468877|NCT03481777|451347644|FG001|Overall Study|Withdrawal by Subject|31|||
125468878|NCT03481777|451347643|FG000|Overall Study|Non stroke = non target population|277|||
125468879|NCT03481777|451347644|FG001|Overall Study|Non stroke = non target population|254|||
125298718|NCT00151476|450719961|FG000|FAP Analyzed Subjects|Other study participation|0|||
125298719|NCT00151476|450719962|FG001|FAP Analyzed Subjects|Other study participation|1|||
125298720|NCT03446456|450719963|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
125298721|NCT03446456|450719964|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
125298722|NCT03446456|450719963|FG000|Overall Study|Lost to Follow-up|1|||
125298723|NCT03446456|450719964|FG001|Overall Study|Lost to Follow-up|3|||
125298724|NCT03446456|450719963|FG000|Overall Study|Participant failed the toxicology test|1|||
125298725|NCT03446456|450719964|FG001|Overall Study|Participant failed the toxicology test|0|||
125298726|NCT03446456|450719963|FG000|Overall Study|Break down of the experimental equipment|1|||
125298727|NCT03446456|450719964|FG001|Overall Study|Break down of the experimental equipment|0|||
125298728|NCT04099511|450719971|FG000|Overall Study|Lost to Follow-up|2|||
125298729|NCT04099511|450719972|FG001|Overall Study|Lost to Follow-up|2|||
125468880|NCT05696080|451347645|FG000|Overall Study|Lost to Follow-up|2|||
125468881|NCT05696080|451347646|FG001|Overall Study|Lost to Follow-up|1|||
125468882|NCT05696080|451347645|FG000|Overall Study|Physician Decision|1|||
125468883|NCT05696080|451347646|FG001|Overall Study|Physician Decision|0|||
125468884|NCT05696080|451347645|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
125468885|NCT05696080|451347646|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
125298730|NCT04099511|450719971|FG000|Overall Study|Withdrawal by Subject|8|||
125298731|NCT04099511|450719972|FG001|Overall Study|Withdrawal by Subject|4|||
125298732|NCT03002311|450719977|FG000|Overall Study|Lost to Follow-up|13|||
125298733|NCT03002311|450719978|FG001|Overall Study|Lost to Follow-up|26|||
125298734|NCT03002311|450719977|FG000|Overall Study|Referral provider called to schedule app|3|||
125298735|NCT03002311|450719978|FG001|Overall Study|Referral provider called to schedule app|3|||
125298736|NCT03002311|450719977|FG000|Overall Study|Physician Decision|3|||
125298737|NCT03002311|450719978|FG001|Overall Study|Physician Decision|1|||
125298738|NCT03908476|450719979|FG000|Overall Study|Death|3|||
125298739|NCT03908476|450719980|FG001|Overall Study|Death|0|||
125298740|NCT03908476|450719979|FG000|Overall Study|Lost to Follow-up|3|||
125298741|NCT03908476|450719980|FG001|Overall Study|Lost to Follow-up|1|||
125298742|NCT03908476|450719979|FG000|Overall Study|Withdrawal by Subject|7|||
125298743|NCT03908476|450719980|FG001|Overall Study|Withdrawal by Subject|1|||
125298744|NCT03908476|450719979|FG000|Overall Study|Physician Decision|2|||
125298745|NCT03908476|450719980|FG001|Overall Study|Physician Decision|0|||
125298746|NCT03908476|450719979|FG000|Overall Study|System Explanted and not Replaced|4|||
125298747|NCT03908476|450719980|FG001|Overall Study|System Explanted and not Replaced|0|||
125298748|NCT03908476|450719979|FG000|Overall Study|Intrathecal Pump|1|||
125298749|NCT03908476|450719980|FG001|Overall Study|Intrathecal Pump|0|||
125298750|NCT03908476|450719979|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
125298751|NCT03908476|450719980|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
125298752|NCT05194267|450719981|FG000|Overall Study|Withdrawal by Subject|2|||
125298753|NCT00802893|450719982|FG000|Overall Study|study terminated|3|||
125298754|NCT02868229|450719983|FG000|Overall Study|Adverse Event|1|||
125298755|NCT02868229|450719984|FG001|Overall Study|Adverse Event|0|||
125298756|NCT02868229|450719985|FG002|Overall Study|Adverse Event|0|||
125298757|NCT02868229|450719986|FG003|Overall Study|Adverse Event|1|||
125298758|NCT02868229|450719983|FG000|Overall Study|Death|0|||
125298759|NCT02868229|450719984|FG001|Overall Study|Death|0|||
125298760|NCT02868229|450719985|FG002|Overall Study|Death|1|||
125298761|NCT02868229|450719986|FG003|Overall Study|Death|1|||
125298762|NCT02868229|450719983|FG000|Overall Study|Missed dose|0|||
125468886|NCT05696080|451347645|FG000|Overall Study|Withdrawal by Subject|12|||
125468887|NCT05696080|451347646|FG001|Overall Study|Withdrawal by Subject|0|||
125298763|NCT02868229|450719984|FG001|Overall Study|Missed dose|0|||
125298764|NCT02868229|450719985|FG002|Overall Study|Missed dose|0|||
125298765|NCT02868229|450719986|FG003|Overall Study|Missed dose|3|||
125298766|NCT00320424|450719987|FG000|Overall Study|Adverse Event|3|||
125298767|NCT00320424|450719987|FG000|Overall Study|Other|3|||
125298768|NCT06151288|450719988|FG000|Overall Study|Lost to Follow-up|4|||
125298769|NCT06151288|450719989|FG001|Overall Study|Lost to Follow-up|2|||
125298770|NCT06151288|450719990|FG002|Overall Study|Lost to Follow-up|4|||
125298771|NCT06151288|450719991|FG003|Overall Study|Lost to Follow-up|3|||
125298772|NCT06151288|450719988|FG000|Overall Study|Withdrawal by Subject|4|||
125298773|NCT06151288|450719989|FG001|Overall Study|Withdrawal by Subject|5|||
125298774|NCT06151288|450719990|FG002|Overall Study|Withdrawal by Subject|1|||
125298775|NCT06151288|450719991|FG003|Overall Study|Withdrawal by Subject|1|||
125298776|NCT00658814|450719992|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
125298777|NCT00658814|450719993|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
125298778|NCT00658814|450719992|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
125298779|NCT00658814|450719993|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
125298780|NCT00658814|450719992|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
125298781|NCT00658814|450719993|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
125298782|NCT00658814|450719992|FG000|Remission Induction Chemotherapy|Death|1|||
125298783|NCT00658814|450719993|FG001|Remission Induction Chemotherapy|Death|4|||
125298784|NCT00658814|450719992|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
125298785|NCT00658814|450719993|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
125298786|NCT00658814|450719992|FG000|Remission Induction Chemotherapy|Not eligible|1|||
125298787|NCT00658814|450719993|FG001|Remission Induction Chemotherapy|Not eligible|2|||
125298788|NCT00658814|450719992|FG000|Consolidation Therapy|Not protocol specified|0|||
125298789|NCT00658814|450719993|FG001|Consolidation Therapy|Not protocol specified|1|||
125298790|NCT00658814|450719992|FG000|Consolidation Therapy|Not eligible|2|||
125298791|NCT00658814|450719993|FG001|Consolidation Therapy|Not eligible|2|||
125298792|NCT00658814|450719992|FG000|Maintenance Therapy|Adverse Event|1|||
125298793|NCT00658814|450719993|FG001|Maintenance Therapy|Adverse Event|1|||
125298794|NCT00658814|450719992|FG000|Maintenance Therapy|Not protocol specified|1|||
125298795|NCT00658814|450719993|FG001|Maintenance Therapy|Not protocol specified|0|||
125298796|NCT00658814|450719992|FG000|Maintenance Therapy|Not eligible|1|||
125298797|NCT00658814|450719993|FG001|Maintenance Therapy|Not eligible|0|||
125298798|NCT00231413|450720001|FG000|Overall Study|Non-serious AE|0|||
125298799|NCT00231413|450720002|FG001|Overall Study|Non-serious AE|0|||
125298800|NCT00231413|450720003|FG002|Overall Study|Non-serious AE|1|||
125298801|NCT00231413|450720004|FG003|Overall Study|Non-serious AE|0|||
125298802|NCT00231413|450720005|FG004|Overall Study|Non-serious AE|0|||
125298803|NCT00231413|450720006|FG005|Overall Study|Non-serious AE|0|||
125298804|NCT00231413|450720007|FG006|Overall Study|Non-serious AE|1|||
125298805|NCT00231413|450720001|FG000|Overall Study|Withdrawal by Subject|3|||
125298806|NCT00231413|450720002|FG001|Overall Study|Withdrawal by Subject|1|||
125298807|NCT00231413|450720003|FG002|Overall Study|Withdrawal by Subject|4|||
125298808|NCT00231413|450720004|FG003|Overall Study|Withdrawal by Subject|2|||
125298809|NCT00231413|450720005|FG004|Overall Study|Withdrawal by Subject|2|||
125298810|NCT00231413|450720006|FG005|Overall Study|Withdrawal by Subject|0|||
125468888|NCT04038957|451347654|FG000|Overall Study|Withdrawal by Subject|1|||
125468889|NCT04038957|451347654|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
125468890|NCT03821844|451347655|FG000|Overall Study|Death|37|||
125468891|NCT03821844|451347656|FG001|Overall Study|Death|31|||
125468892|NCT03821844|451347655|FG000|Overall Study|Discharged|10|||
125468893|NCT03821844|451347656|FG001|Overall Study|Discharged|14|||
125298811|NCT00231413|450720007|FG006|Overall Study|Withdrawal by Subject|3|||
125298812|NCT00231413|450720001|FG000|Overall Study|Migrated/moved from study area|0|||
125298813|NCT00231413|450720002|FG001|Overall Study|Migrated/moved from study area|0|||
125298814|NCT00231413|450720003|FG002|Overall Study|Migrated/moved from study area|1|||
125298815|NCT00231413|450720004|FG003|Overall Study|Migrated/moved from study area|0|||
125298816|NCT00231413|450720005|FG004|Overall Study|Migrated/moved from study area|0|||
125298817|NCT00231413|450720006|FG005|Overall Study|Migrated/moved from study area|1|||
125298818|NCT00231413|450720007|FG006|Overall Study|Migrated/moved from study area|0|||
125298819|NCT00231413|450720001|FG000|Overall Study|Lost to Follow-up|4|||
125298820|NCT00231413|450720002|FG001|Overall Study|Lost to Follow-up|4|||
125298821|NCT00231413|450720003|FG002|Overall Study|Lost to Follow-up|1|||
125298822|NCT00231413|450720004|FG003|Overall Study|Lost to Follow-up|1|||
125298823|NCT00231413|450720005|FG004|Overall Study|Lost to Follow-up|1|||
125298824|NCT00231413|450720006|FG005|Overall Study|Lost to Follow-up|4|||
125298825|NCT00231413|450720007|FG006|Overall Study|Lost to Follow-up|0|||
125298826|NCT00231413|450720001|FG000|Overall Study|Pregnancy|1|||
125298827|NCT00231413|450720002|FG001|Overall Study|Pregnancy|0|||
125298828|NCT00231413|450720003|FG002|Overall Study|Pregnancy|0|||
125468894|NCT03821844|451347655|FG000|Overall Study|Not present in facility at followup|2|||
125468895|NCT03821844|451347656|FG001|Overall Study|Not present in facility at followup|3|||
125298829|NCT00231413|450720004|FG003|Overall Study|Pregnancy|0|||
125298830|NCT00231413|450720005|FG004|Overall Study|Pregnancy|0|||
125298831|NCT00231413|450720006|FG005|Overall Study|Pregnancy|0|||
125298832|NCT00231413|450720007|FG006|Overall Study|Pregnancy|0|||
125298833|NCT02708485|450720008|FG000|Overall Study|Withdrawal by Subject|3|||
125298834|NCT02708485|450720009|FG001|Overall Study|Withdrawal by Subject|2|||
125298835|NCT03266172|450720010|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
125298836|NCT03266172|450720011|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
125298837|NCT03266172|450720012|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
125298838|NCT03266172|450720010|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
125298839|NCT03266172|450720011|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
125298840|NCT03266172|450720012|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
125298841|NCT03266172|450720010|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
125298842|NCT03266172|450720011|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
125298843|NCT03266172|450720012|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
125298844|NCT03266172|450720010|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
125298845|NCT03266172|450720011|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
125298846|NCT03266172|450720012|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
125298847|NCT03266172|450720010|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
125298848|NCT03266172|450720011|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
125298849|NCT03266172|450720012|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
125298850|NCT03266172|450720010|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
125298851|NCT03266172|450720011|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
125298852|NCT03266172|450720012|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
125298853|NCT01554514|450720015|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
125298854|NCT01554514|450720015|FG000|Overall Study|Physician Decision|1|||
125298855|NCT05222555|450720016|FG000|Overall Study|Ongoing|2|||
125298856|NCT05222555|450720017|FG001|Overall Study|Ongoing|18|||
125298857|NCT05222555|450720016|FG000|Overall Study|Adverse Event|1|||
125298858|NCT05222555|450720017|FG001|Overall Study|Adverse Event|1|||
125298859|NCT05222555|450720016|FG000|Overall Study|Death|0|||
125298860|NCT05222555|450720017|FG001|Overall Study|Death|6|||
125298861|NCT05222555|450720016|FG000|Overall Study|Withdrawal by Subject|0|||
125298862|NCT05222555|450720017|FG001|Overall Study|Withdrawal by Subject|11|||
125298863|NCT00300365|450720020|FG000|Overall Study|Lost to Follow-up|1|||
125298864|NCT00300365|450720021|FG001|Overall Study|Lost to Follow-up|0|||
125298865|NCT00300365|450720020|FG000|Overall Study|Physician Decision|2|||
125298866|NCT00300365|450720021|FG001|Overall Study|Physician Decision|0|||
125298867|NCT00300365|450720020|FG000|Overall Study|Withdrawal by Subject|1|||
125298868|NCT00300365|450720021|FG001|Overall Study|Withdrawal by Subject|0|||
125298869|NCT00300365|450720020|FG000|Overall Study|Adverse Event|0|||
125298870|NCT00300365|450720021|FG001|Overall Study|Adverse Event|2|||
125298871|NCT01422824|450720022|FG000|Overall Study|Case record form not evaluated|1|||
125298872|NCT01422824|450720022|FG000|Overall Study|Lost to Follow-up|37|||
125298873|NCT01581619|450720023|FG000|Overall Study|Withdrawal by Subject|1|||
125298874|NCT01581619|450720023|FG000|Overall Study|Lost to Follow-up|1|||
125298875|NCT01818492|450720024|FG000|Overall Study|Adverse Event|2|||
125298876|NCT01818492|450720024|FG000|Overall Study|Death|3|||
125298877|NCT01818492|450720024|FG000|Overall Study|Withdrawal by Subject|1|||
125298878|NCT01818492|450720024|FG000|Overall Study|Additional therapy when not allowed PP|4|||
125298879|NCT00109577|450720026|FG000|Overall Study|Withdrawal by Subject|3|||
125298880|NCT00109577|450720027|FG001|Overall Study|Withdrawal by Subject|3|||
125298881|NCT00587847|450720028|FG000|Overall Study|Lack of Efficacy|5|||
125298882|NCT00587847|450720028|FG000|Overall Study|Adverse Event|2|||
125298883|NCT02986854|450720030|FG000|Overall Study|Withdrawal by Subject|0|||
125298884|NCT02986854|450720031|FG001|Overall Study|Withdrawal by Subject|1|||
125298885|NCT02986854|450720032|FG002|Overall Study|Withdrawal by Subject|1|||
125298886|NCT02986854|450720030|FG000|Overall Study|Lost to Follow-up|3|||
125298887|NCT02986854|450720031|FG001|Overall Study|Lost to Follow-up|11|||
125298888|NCT02986854|450720032|FG002|Overall Study|Lost to Follow-up|2|||
125298889|NCT01972789|450720035|FG000|Overall Study|Adverse Event|11|||
125298890|NCT01972789|450720036|FG001|Overall Study|Adverse Event|4|||
125298891|NCT01972789|450720035|FG000|Overall Study|Subject withdrew consent|14|||
125298892|NCT01972789|450720036|FG001|Overall Study|Subject withdrew consent|12|||
125298893|NCT01972789|450720035|FG000|Overall Study|Lost to Follow-up|4|||
125298894|NCT01972789|450720036|FG001|Overall Study|Lost to Follow-up|7|||
125298895|NCT01972789|450720035|FG000|Overall Study|Death|7|||
125298896|NCT01972789|450720036|FG001|Overall Study|Death|5|||
125298897|NCT01972789|450720035|FG000|Overall Study|Protocol deviation|1|||
125298898|NCT01972789|450720036|FG001|Overall Study|Protocol deviation|0|||
125298899|NCT01972789|450720035|FG000|Overall Study|Physician Decision|3|||
125298900|NCT01972789|450720036|FG001|Overall Study|Physician Decision|2|||
125298901|NCT03268941|450721561|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
125298902|NCT03268941|450721562|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
125298903|NCT03268941|450721563|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
125298904|NCT03268941|450721564|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
125298905|NCT03268941|450721565|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
125298906|NCT03268941|450721566|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
125298907|NCT03268941|450721567|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
125298908|NCT03268941|450721561|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
125298909|NCT03268941|450721562|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
125298910|NCT03268941|450721563|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
125298911|NCT03268941|450721564|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
125298912|NCT03268941|450721565|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
125298913|NCT03268941|450721566|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
125298914|NCT03268941|450721567|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
125298915|NCT03268941|450721561|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
125298916|NCT03268941|450721562|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
125298917|NCT03268941|450721563|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
125298918|NCT03268941|450721564|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
125298919|NCT03268941|450721565|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
125298920|NCT03268941|450721566|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
125298921|NCT03268941|450721567|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
125298922|NCT03268941|450721561|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
125298923|NCT03268941|450721562|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
125298924|NCT03268941|450721563|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
125298925|NCT03268941|450721564|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
125298926|NCT03268941|450721565|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
125468896|NCT01998984|451347661|FG000|Overall Study|Adverse Event|0|||
125468897|NCT01998984|451347662|FG001|Overall Study|Adverse Event|0|||
125468898|NCT01998984|451347663|FG002|Overall Study|Adverse Event|0|||
125468899|NCT01998984|451347664|FG003|Overall Study|Adverse Event|1|||
125468900|NCT01998984|451347661|FG000|Overall Study|Lost to Follow-up|0|||
125468901|NCT01998984|451347662|FG001|Overall Study|Lost to Follow-up|1|||
125298927|NCT03268941|450721566|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
125298928|NCT03268941|450721567|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
125298929|NCT03268941|450721561|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
125298930|NCT03268941|450721562|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
125298931|NCT03268941|450721563|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
125298932|NCT03268941|450721564|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
125298933|NCT03268941|450721565|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
125298934|NCT03268941|450721566|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
125298935|NCT03268941|450721567|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
125298936|NCT01216683|450721568|FG000|Induction|Never started treatment|0|||
125298937|NCT01216683|450721569|FG001|Induction|Never started treatment|6|||
125298938|NCT01216683|450721570|FG002|Induction|Never started treatment|3|||
125298939|NCT01216683|450721568|FG000|Induction|Lack of Efficacy|4|||
125298940|NCT01216683|450721569|FG001|Induction|Lack of Efficacy|3|||
125298941|NCT01216683|450721570|FG002|Induction|Lack of Efficacy|7|||
125298942|NCT01216683|450721568|FG000|Induction|Adverse Event|0|||
125298943|NCT01216683|450721569|FG001|Induction|Adverse Event|5|||
125298944|NCT01216683|450721570|FG002|Induction|Adverse Event|5|||
125298945|NCT01216683|450721568|FG000|Induction|Death|0|||
125298946|NCT01216683|450721569|FG001|Induction|Death|0|||
125298947|NCT01216683|450721570|FG002|Induction|Death|2|||
125298948|NCT01216683|450721568|FG000|Induction|Withdrawal by Subject|0|||
125298949|NCT01216683|450721569|FG001|Induction|Withdrawal by Subject|4|||
125468902|NCT01998984|451347663|FG002|Overall Study|Lost to Follow-up|0|||
125468903|NCT01998984|451347664|FG003|Overall Study|Lost to Follow-up|1|||
125468904|NCT01998984|451347661|FG000|Overall Study|Withdrawal by Subject|0|||
125468905|NCT01998984|451347662|FG001|Overall Study|Withdrawal by Subject|0|||
125468906|NCT01998984|451347663|FG002|Overall Study|Withdrawal by Subject|1|||
125468907|NCT01998984|451347664|FG003|Overall Study|Withdrawal by Subject|0|||
125468908|NCT01998984|451347661|FG000|Overall Study|Other|0|||
125468909|NCT01998984|451347662|FG001|Overall Study|Other|0|||
125468910|NCT01998984|451347663|FG002|Overall Study|Other|0|||
125468911|NCT01998984|451347664|FG003|Overall Study|Other|1|||
125468912|NCT01843374|451347666|FG000|Overall Study|Death|155|||
125468913|NCT01843374|451347667|FG001|Overall Study|Death|313|||
125468914|NCT01843374|451347666|FG000|Overall Study|Withdrawal by Subject|14|||
125468915|NCT01843374|451347667|FG001|Overall Study|Withdrawal by Subject|20|||
125468916|NCT01843374|451347666|FG000|Overall Study|Withdrawing due to Other reason|20|||
125468917|NCT01843374|451347667|FG001|Overall Study|Withdrawing due to Other reason|46|||
125468918|NCT03397108|451347668|FG000|Overall Study|Lost to Follow-up|15|||
125468919|NCT03397108|451347669|FG001|Overall Study|Lost to Follow-up|0|||
125468920|NCT03397108|451347668|FG000|Overall Study|Insufficient milk production|3|||
125468921|NCT03397108|451347669|FG001|Overall Study|Insufficient milk production|2|||
125298950|NCT01216683|450721570|FG002|Induction|Withdrawal by Subject|2|||
125298951|NCT01216683|450721568|FG000|Induction|Other disease|0|||
125298952|NCT01216683|450721569|FG001|Induction|Other disease|1|||
125298953|NCT01216683|450721570|FG002|Induction|Other disease|2|||
125298954|NCT01216683|450721568|FG000|Continuation|Lack of Efficacy|3|||
125298955|NCT01216683|450721569|FG001|Continuation|Lack of Efficacy|2|||
125298956|NCT01216683|450721570|FG002|Continuation|Lack of Efficacy|7|||
125298957|NCT01216683|450721568|FG000|Continuation|Adverse Event|5|||
125298958|NCT01216683|450721569|FG001|Continuation|Adverse Event|3|||
125298959|NCT01216683|450721570|FG002|Continuation|Adverse Event|16|||
125298960|NCT01216683|450721568|FG000|Continuation|Death|1|||
125298961|NCT01216683|450721569|FG001|Continuation|Death|0|||
125468922|NCT03397108|451347668|FG000|Overall Study|Withdrawal by Subject|2|||
125468923|NCT03397108|451347669|FG001|Overall Study|Withdrawal by Subject|0|||
125468924|NCT03554265|451347670|FG000|Overall Study|Withdrawal by Subject|2|||
125468925|NCT03554265|451347671|FG001|Overall Study|Withdrawal by Subject|2|||
125298962|NCT01216683|450721570|FG002|Continuation|Death|2|||
125298963|NCT01216683|450721568|FG000|Continuation|Withdrawal by Subject|4|||
125298964|NCT01216683|450721569|FG001|Continuation|Withdrawal by Subject|5|||
125298965|NCT01216683|450721570|FG002|Continuation|Withdrawal by Subject|9|||
125298966|NCT01216683|450721568|FG000|Continuation|Other diseases|0|||
125298967|NCT01216683|450721569|FG001|Continuation|Other diseases|2|||
125298968|NCT01216683|450721570|FG002|Continuation|Other diseases|1|||
125298969|NCT01216683|450721568|FG000|Continuation|Physician Decision|1|||
125298970|NCT01216683|450721569|FG001|Continuation|Physician Decision|0|||
125298971|NCT01216683|450721570|FG002|Continuation|Physician Decision|1|||
125298972|NCT01216683|450721568|FG000|Continuation|Non-compliance|1|||
125298973|NCT01216683|450721569|FG001|Continuation|Non-compliance|0|||
125298974|NCT01216683|450721570|FG002|Continuation|Non-compliance|1|||
125298975|NCT01216683|450721568|FG000|Continuation|Insurance change|0|||
125298976|NCT01216683|450721569|FG001|Continuation|Insurance change|1|||
125298977|NCT01216683|450721570|FG002|Continuation|Insurance change|0|||
125298978|NCT01216683|450721568|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
125298979|NCT01216683|450721569|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
125298980|NCT01216683|450721570|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
125298981|NCT01216683|450721568|FG000|Continuation|Not reported|0|||
125298982|NCT01216683|450721569|FG001|Continuation|Not reported|0|||
125298983|NCT01216683|450721570|FG002|Continuation|Not reported|1|||
125298984|NCT01216683|450721568|FG000|Continuation|Never started treatment|0|||
125298985|NCT01216683|450721569|FG001|Continuation|Never started treatment|1|||
125298986|NCT01216683|450721570|FG002|Continuation|Never started treatment|5|||
125298987|NCT02503501|450721572|FG000|Overall Study|Physician Decision|1|||
125298988|NCT02503501|450721573|FG001|Overall Study|Physician Decision|0|||
125298989|NCT02503501|450721572|FG000|Overall Study|Protocol Violation|0|||
125298990|NCT02503501|450721573|FG001|Overall Study|Protocol Violation|1|||
125298991|NCT02503501|450721572|FG000|Overall Study|Withdrawal by Subject|0|||
125298992|NCT02503501|450721573|FG001|Overall Study|Withdrawal by Subject|2|||
125298993|NCT01740401|450721574|FG000|Overall Study|Progression of disease|6|||
125298994|NCT01740401|450721574|FG000|Overall Study|Adverse Event|2|||
125298995|NCT01740401|450721574|FG000|Overall Study|Did not reach primary endpoint|2|||
125298996|NCT02806960|450721575|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
125298997|NCT02806960|450721576|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
125298998|NCT02806960|450721577|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
125298999|NCT02806960|450721578|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
125299000|NCT03495102|450721579|FG000|Overall Study|Adverse Event|5|||
125299001|NCT03495102|450721580|FG001|Overall Study|Adverse Event|7|||
125299002|NCT03495102|450721581|FG002|Overall Study|Adverse Event|10|||
125299003|NCT03495102|450721579|FG000|Overall Study|Death|3|||
125299004|NCT03495102|450721580|FG001|Overall Study|Death|4|||
125299005|NCT03495102|450721581|FG002|Overall Study|Death|4|||
125299006|NCT03495102|450721579|FG000|Overall Study|Lost to Follow-up|15|||
125299007|NCT03495102|450721580|FG001|Overall Study|Lost to Follow-up|16|||
125299008|NCT03495102|450721581|FG002|Overall Study|Lost to Follow-up|17|||
125299009|NCT03495102|450721579|FG000|Overall Study|Physician Decision|2|||
125299010|NCT03495102|450721580|FG001|Overall Study|Physician Decision|0|||
125299011|NCT03495102|450721581|FG002|Overall Study|Physician Decision|2|||
125468926|NCT03554265|451347672|FG002|Overall Study|Withdrawal by Subject|3|||
125468927|NCT03554265|451347670|FG000|Overall Study|Physician Decision|0|||
125468928|NCT03554265|451347671|FG001|Overall Study|Physician Decision|0|||
125299012|NCT03495102|450721579|FG000|Overall Study|Withdrawal by Subject|25|||
125299013|NCT03495102|450721580|FG001|Overall Study|Withdrawal by Subject|36|||
125299014|NCT03495102|450721581|FG002|Overall Study|Withdrawal by Subject|18|||
125299015|NCT03495102|450721579|FG000|Overall Study|Protocol Violation|1|||
125299016|NCT03495102|450721580|FG001|Overall Study|Protocol Violation|1|||
125299017|NCT03495102|450721581|FG002|Overall Study|Protocol Violation|0|||
125299018|NCT03495102|450721579|FG000|Overall Study|Site Closure|3|||
125299019|NCT03495102|450721580|FG001|Overall Study|Site Closure|1|||
125299020|NCT03495102|450721581|FG002|Overall Study|Site Closure|2|||
125299021|NCT03495102|450721579|FG000|Overall Study|Non-compliance|1|||
125299022|NCT03495102|450721580|FG001|Overall Study|Non-compliance|0|||
125299023|NCT03495102|450721581|FG002|Overall Study|Non-compliance|0|||
125299024|NCT03495102|450721579|FG000|Overall Study|Participant Duplicated at Another Site|0|||
125299025|NCT03495102|450721580|FG001|Overall Study|Participant Duplicated at Another Site|0|||
125299026|NCT03495102|450721581|FG002|Overall Study|Participant Duplicated at Another Site|1|||
125299027|NCT03495102|450721579|FG000|Overall Study|Primary Care Physician Recommendation|0|||
125299028|NCT03495102|450721580|FG001|Overall Study|Primary Care Physician Recommendation|1|||
125299029|NCT03495102|450721581|FG002|Overall Study|Primary Care Physician Recommendation|0|||
125468929|NCT03554265|451347672|FG002|Overall Study|Physician Decision|1|||
125468930|NCT02605837|451347673|FG000|Overall Study|Adverse Event|3|||
125299030|NCT03495102|450721579|FG000|Overall Study|Relocated to Another Country|0|||
125299031|NCT03495102|450721580|FG001|Overall Study|Relocated to Another Country|1|||
125299032|NCT03495102|450721581|FG002|Overall Study|Relocated to Another Country|0|||
125299033|NCT03495102|450721579|FG000|Overall Study|Participant was in Rehabilitation|1|||
125299034|NCT03495102|450721580|FG001|Overall Study|Participant was in Rehabilitation|0|||
125299035|NCT03495102|450721581|FG002|Overall Study|Participant was in Rehabilitation|0|||
125299036|NCT01161537|450721587|FG000|Part B|Withdrawal by Subject|2|||
125299037|NCT03464019|450721591|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
125299038|NCT03464019|450721592|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
125299039|NCT03464019|450721593|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
125299040|NCT03464019|450721591|FG000|NODE-301 Part 1|Ablation|0|||
125299041|NCT03464019|450721592|FG001|NODE-301 Part 1|Ablation|0|||
125299042|NCT03464019|450721593|FG002|NODE-301 Part 1|Ablation|16|||
125299043|NCT03464019|450721591|FG000|NODE-301 Part 1|Test Dose Failure|0|||
125299044|NCT03464019|450721592|FG001|NODE-301 Part 1|Test Dose Failure|0|||
125299045|NCT03464019|450721593|FG002|NODE-301 Part 1|Test Dose Failure|8|||
125299046|NCT03464019|450721591|FG000|NODE-301 Part 1|Adverse Event|0|||
125299047|NCT03464019|450721592|FG001|NODE-301 Part 1|Adverse Event|0|||
125299048|NCT03464019|450721593|FG002|NODE-301 Part 1|Adverse Event|5|||
125299049|NCT03464019|450721591|FG000|NODE-301 Part 1|Physician Decision|0|||
125299050|NCT03464019|450721592|FG001|NODE-301 Part 1|Physician Decision|0|||
125299051|NCT03464019|450721593|FG002|NODE-301 Part 1|Physician Decision|4|||
125299052|NCT03464019|450721591|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
125299053|NCT03464019|450721592|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
125299054|NCT03464019|450721593|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
125299055|NCT03464019|450721591|FG000|NODE-301 Part 1|Protocol Violation|0|||
125299056|NCT03464019|450721592|FG001|NODE-301 Part 1|Protocol Violation|0|||
125299057|NCT03464019|450721593|FG002|NODE-301 Part 1|Protocol Violation|2|||
125299058|NCT03464019|450721591|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
125299059|NCT03464019|450721592|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
125299060|NCT03464019|450721593|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
125299061|NCT03464019|450721591|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
125299062|NCT03464019|450721592|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
125299063|NCT03464019|450721593|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
125299064|NCT03464019|450721591|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
125299065|NCT03464019|450721592|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
125299066|NCT03464019|450721593|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
125299067|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
125299068|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
125299069|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
125299070|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
125299071|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
125299072|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
125299073|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
125299074|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
125299075|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
125299076|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
125299077|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
125299078|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
125299079|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
125299080|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
125299081|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
125299082|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
125299083|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
125468931|NCT02605837|451347674|FG001|Overall Study|Adverse Event|1|||
125468932|NCT02605837|451347673|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125299084|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
125299085|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
125299086|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
125299087|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
125299088|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
125299089|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
125299090|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
125299091|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
125299092|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
125299093|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
125299094|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
125299095|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
125299096|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
125299097|NCT03464019|450721591|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
125299098|NCT03464019|450721592|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
125468933|NCT02605837|451347674|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125468934|NCT02605837|451347673|FG000|Overall Study|Withdrawal by Subject|8|||
125468935|NCT02605837|451347674|FG001|Overall Study|Withdrawal by Subject|8|||
125468936|NCT02605837|451347673|FG000|Overall Study|Physician Decision|0|||
125299099|NCT03464019|450721593|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
125299100|NCT00511134|450721594|FG000|Overall Study|Withdrawal by Subject|0|||
125299101|NCT00511134|450721595|FG001|Overall Study|Withdrawal by Subject|2|||
125299102|NCT01949090|450721596|FG000|Overall Study|Serious Adverse Event|0|||
125299103|NCT01949090|450721597|FG001|Overall Study|Serious Adverse Event|1|||
125299104|NCT01949090|450721598|FG002|Overall Study|Serious Adverse Event|2|||
125299105|NCT01949090|450721599|FG003|Overall Study|Serious Adverse Event|0|||
125299106|NCT01949090|450721600|FG004|Overall Study|Serious Adverse Event|1|||
125299107|NCT01949090|450721596|FG000|Overall Study|Withdrawal by Subject|2|||
125299108|NCT01949090|450721597|FG001|Overall Study|Withdrawal by Subject|0|||
125299109|NCT01949090|450721598|FG002|Overall Study|Withdrawal by Subject|0|||
125299110|NCT01949090|450721599|FG003|Overall Study|Withdrawal by Subject|0|||
125299111|NCT01949090|450721600|FG004|Overall Study|Withdrawal by Subject|1|||
125299112|NCT01949090|450721596|FG000|Overall Study|Protocol non-compliance|0|||
125299113|NCT01949090|450721597|FG001|Overall Study|Protocol non-compliance|0|||
125299114|NCT01949090|450721598|FG002|Overall Study|Protocol non-compliance|0|||
125299115|NCT01949090|450721599|FG003|Overall Study|Protocol non-compliance|0|||
125299116|NCT01949090|450721600|FG004|Overall Study|Protocol non-compliance|1|||
125299117|NCT01949090|450721596|FG000|Overall Study|Lost to Follow-up|2|||
125299118|NCT01949090|450721597|FG001|Overall Study|Lost to Follow-up|1|||
125299119|NCT01949090|450721598|FG002|Overall Study|Lost to Follow-up|0|||
125299120|NCT01949090|450721599|FG003|Overall Study|Lost to Follow-up|1|||
125299121|NCT01949090|450721600|FG004|Overall Study|Lost to Follow-up|1|||
125299122|NCT03459365|450721601|FG000|Overall Study|Withdrawal by Subject|6|||
125299123|NCT03459365|450721601|FG000|Overall Study|Protocol Violation|8|||
125299124|NCT00567359|450721604|FG000|Overall Study|Withdrawal by Subject|1|||
125299125|NCT00785980|450721605|FG000|7 Day Washout Period|Protocol Violation|3|||
125299126|NCT00528801|450721606|FG000|Overall Study|Withdrawal by Subject|1|||
125299127|NCT00528801|450721607|FG001|Overall Study|Withdrawal by Subject|1|||
125299128|NCT00528801|450721606|FG000|Overall Study|Protocol Violation|11|||
125299129|NCT00528801|450721607|FG001|Overall Study|Protocol Violation|5|||
125299130|NCT00528801|450721606|FG000|Overall Study|Lost to Follow-up|15|||
125299131|NCT00528801|450721607|FG001|Overall Study|Lost to Follow-up|4|||
125299132|NCT00528801|450721606|FG000|Overall Study|Administrative Reasons|0|||
125299133|NCT00528801|450721607|FG001|Overall Study|Administrative Reasons|1|||
125299134|NCT00344500|450721608|FG000|Overall Study|Adverse Event|6|||
125299135|NCT00344500|450721609|FG001|Overall Study|Adverse Event|2|||
125299136|NCT00344500|450721610|FG002|Overall Study|Adverse Event|0|||
125299137|NCT00344500|450721608|FG000|Overall Study|Lost to Follow-up|5|||
125299138|NCT00344500|450721609|FG001|Overall Study|Lost to Follow-up|13|||
125299139|NCT00344500|450721610|FG002|Overall Study|Lost to Follow-up|1|||
125299140|NCT00344500|450721608|FG000|Overall Study|Withdrawal by Subject|7|||
125299141|NCT00344500|450721609|FG001|Overall Study|Withdrawal by Subject|10|||
125299142|NCT00344500|450721610|FG002|Overall Study|Withdrawal by Subject|0|||
125299143|NCT00344500|450721608|FG000|Overall Study|Protocol Violation|4|||
125299144|NCT00344500|450721609|FG001|Overall Study|Protocol Violation|7|||
125468937|NCT02605837|451347674|FG001|Overall Study|Physician Decision|1|||
125468938|NCT05056246|451347675|FG000|Overall Study|Adverse Event|0|||
125468939|NCT05056246|451347676|FG001|Overall Study|Adverse Event|0|||
125468940|NCT05056246|451347677|FG002|Overall Study|Adverse Event|0|||
125468941|NCT05056246|451347678|FG003|Overall Study|Adverse Event|0|||
125468942|NCT05056246|451347679|FG004|Overall Study|Adverse Event|1|||
125468943|NCT05056246|451347675|FG000|Overall Study|Lost to Follow-up|0|||
125468944|NCT05056246|451347676|FG001|Overall Study|Lost to Follow-up|0|||
125299145|NCT00344500|450721610|FG002|Overall Study|Protocol Violation|1|||
125299146|NCT00344500|450721608|FG000|Overall Study|Not Noted|1|||
125299147|NCT00344500|450721609|FG001|Overall Study|Not Noted|3|||
125299148|NCT00344500|450721610|FG002|Overall Study|Not Noted|0|||
125299149|NCT04680975|450721616|FG000|Overall Study|Adverse Event|3|||
125299150|NCT04680975|450721616|FG000|Overall Study|Death|1|||
125299151|NCT04680975|450721616|FG000|Overall Study|Progressive Disease|1|||
125299152|NCT04680975|450721616|FG000|Overall Study|Withdrawal by Subject|1|||
125299153|NCT02702414|450721617|FG000|Overall Study|Death|96|||
125299154|NCT02702414|450721618|FG001|Overall Study|Death|42|||
125299155|NCT02702414|450721617|FG000|Overall Study|Lost to Follow-up|0|||
125299156|NCT02702414|450721618|FG001|Overall Study|Lost to Follow-up|1|||
125299157|NCT02702414|450721617|FG000|Overall Study|Withdrawal by Subject|0|||
125299158|NCT02702414|450721618|FG001|Overall Study|Withdrawal by Subject|1|||
125299159|NCT02702414|450721617|FG000|Overall Study|Protocol Violation|1|||
125468945|NCT05056246|451347677|FG002|Overall Study|Lost to Follow-up|0|||
125299160|NCT02702414|450721618|FG001|Overall Study|Protocol Violation|0|||
125299161|NCT02702414|450721617|FG000|Overall Study|Sponsor Decision|8|||
125468946|NCT05056246|451347678|FG003|Overall Study|Lost to Follow-up|2|||
125468947|NCT05056246|451347679|FG004|Overall Study|Lost to Follow-up|0|||
125485375|NCT02240238|451412513|FG010|Phase 1|Sponsor termination|0|||
125299162|NCT02702414|450721618|FG001|Overall Study|Sponsor Decision|7|||
125299163|NCT02596230|450721619|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
125299164|NCT02596230|450721620|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
125299165|NCT02596230|450721621|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
125299166|NCT02596230|450721622|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
125299167|NCT02596230|450721623|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
125299168|NCT02596230|450721619|FG000|Objective 2, One Year|Lost to Follow-up|0|||
125299169|NCT02596230|450721620|FG001|Objective 2, One Year|Lost to Follow-up|41|||
125299170|NCT02596230|450721621|FG002|Objective 2, One Year|Lost to Follow-up|41|||
125299171|NCT02596230|450721622|FG003|Objective 2, One Year|Lost to Follow-up|32|||
125299172|NCT02596230|450721623|FG004|Objective 2, One Year|Lost to Follow-up|46|||
125299173|NCT02596230|450721619|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
125299174|NCT02596230|450721620|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
125299175|NCT02596230|450721621|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
125299176|NCT02596230|450721622|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
125299177|NCT02596230|450721623|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
125299178|NCT02596230|450721619|FG000|Objective 2, One Year|Adverse drug reaction|0|||
125299179|NCT02596230|450721620|FG001|Objective 2, One Year|Adverse drug reaction|1|||
125299180|NCT02596230|450721621|FG002|Objective 2, One Year|Adverse drug reaction|0|||
125299181|NCT02596230|450721622|FG003|Objective 2, One Year|Adverse drug reaction|0|||
125299182|NCT02596230|450721623|FG004|Objective 2, One Year|Adverse drug reaction|0|||
125299183|NCT02596230|450721619|FG000|Objective 2, One Year|Death|0|||
125299184|NCT02596230|450721620|FG001|Objective 2, One Year|Death|12|||
125299185|NCT02596230|450721621|FG002|Objective 2, One Year|Death|41|||
125299186|NCT02596230|450721622|FG003|Objective 2, One Year|Death|21|||
125299187|NCT02596230|450721623|FG004|Objective 2, One Year|Death|30|||
125299188|NCT02596230|450721619|FG000|Objective 2, One Year|Other|0|||
125299189|NCT02596230|450721620|FG001|Objective 2, One Year|Other|3|||
125299190|NCT02596230|450721621|FG002|Objective 2, One Year|Other|2|||
125299191|NCT02596230|450721622|FG003|Objective 2, One Year|Other|0|||
125299192|NCT02596230|450721623|FG004|Objective 2, One Year|Other|0|||
125299193|NCT02271945|450721624|FG000|Overall Study|Death|3|||
125299194|NCT02271945|450721625|FG001|Overall Study|Death|3|||
125299195|NCT02271945|450721624|FG000|Overall Study|Withdrawal by Subject|1|||
125468948|NCT05056246|451347675|FG000|Overall Study|Withdrawal by Subject|0|||
125468949|NCT05056246|451347676|FG001|Overall Study|Withdrawal by Subject|1|||
125468950|NCT05056246|451347677|FG002|Overall Study|Withdrawal by Subject|0|||
125468951|NCT05056246|451347678|FG003|Overall Study|Withdrawal by Subject|0|||
125468952|NCT05056246|451347679|FG004|Overall Study|Withdrawal by Subject|0|||
125468953|NCT05656911|451347690|FG000|Treatment Phase|Physician Decision|2|||
125468954|NCT05656911|451347691|FG001|Treatment Phase|Physician Decision|0|||
125468955|NCT05656911|451347690|FG000|Treatment Phase|Lack of Efficacy|6|||
125299196|NCT02271945|450721625|FG001|Overall Study|Withdrawal by Subject|1|||
125299197|NCT02271945|450721624|FG000|Overall Study|Other|1|||
125299198|NCT02271945|450721625|FG001|Overall Study|Other|1|||
125299199|NCT00290498|450721626|FG000|Overall Study|Death|2|||
125468956|NCT05656911|451347691|FG001|Treatment Phase|Lack of Efficacy|3|||
125468957|NCT05656911|451347690|FG000|Treatment Phase|Subject Decision|4|||
125468958|NCT05656911|451347691|FG001|Treatment Phase|Subject Decision|2|||
125468959|NCT05656911|451347690|FG000|Treatment Phase|Other Reasons|1|||
125468960|NCT05656911|451347691|FG001|Treatment Phase|Other Reasons|0|||
125468961|NCT05656911|451347690|FG000|Treatment Phase|Adverse Event|3|||
125468962|NCT05656911|451347691|FG001|Treatment Phase|Adverse Event|1|||
125468963|NCT05656911|451347690|FG000|Follow-up Phase|Subject Decision|0|||
125468964|NCT05656911|451347691|FG001|Follow-up Phase|Subject Decision|1|||
125468965|NCT05656911|451347690|FG000|Follow-up Phase|Missing|1|||
125468966|NCT05656911|451347691|FG001|Follow-up Phase|Missing|0|||
125468967|NCT03088813|451347692|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
125299200|NCT00290498|450721627|FG001|Overall Study|Death|0|||
125299201|NCT00290498|450721626|FG000|Overall Study|Physician Decision|1|||
125299202|NCT00290498|450721627|FG001|Overall Study|Physician Decision|0|||
125468968|NCT03088813|451347693|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
125468969|NCT03088813|451347694|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
125299203|NCT00290498|450721626|FG000|Overall Study|Withdrawal by Subject|1|||
125299204|NCT00290498|450721627|FG001|Overall Study|Withdrawal by Subject|0|||
125299205|NCT00290498|450721626|FG000|Overall Study|Ineligible|3|||
125299206|NCT00290498|450721627|FG001|Overall Study|Ineligible|0|||
125299207|NCT00290498|450721626|FG000|Overall Study|Non-Compliance|1|||
125299208|NCT00290498|450721627|FG001|Overall Study|Non-Compliance|0|||
125299209|NCT01716104|450721629|FG000|Overall Study|Do not meet inclusion criteria|6|||
125299210|NCT01716104|450721630|FG001|Overall Study|Do not meet inclusion criteria|7|||
125299211|NCT03129360|450721631|FG000|Overall Study|Did not meet entry criteria|0|||
125299212|NCT03129360|450721632|FG001|Overall Study|Did not meet entry criteria|2|||
125468970|NCT03088813|451347695|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
125468971|NCT03088813|451347692|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
125299213|NCT03129360|450721633|FG002|Overall Study|Did not meet entry criteria|1|||
125299214|NCT03129360|450721631|FG000|Overall Study|Excluded due to motion in scanner|1|||
125299215|NCT03129360|450721632|FG001|Overall Study|Excluded due to motion in scanner|0|||
125299216|NCT03129360|450721633|FG002|Overall Study|Excluded due to motion in scanner|0|||
125299217|NCT05026853|450721634|FG000|Overall Study|Cancelled appointment|1|||
125299218|NCT05026853|450721635|FG001|Overall Study|Cancelled appointment|0|||
125299219|NCT05026853|450721634|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
125299220|NCT05026853|450721635|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
125299221|NCT05026853|450721634|FG000|Overall Study|Did not complete 12-week survey|16|||
125299222|NCT05026853|450721635|FG001|Overall Study|Did not complete 12-week survey|16|||
125299223|NCT03006887|450721636|FG000|Overall Study|Adverse Event|1|||
125299224|NCT03836677|450721637|FG000|Period 1|Adverse Event|0|||
125299225|NCT03836677|450721638|FG001|Period 1|Adverse Event|1|||
125299226|NCT03836677|450721637|FG000|Period 2|Severe non-compliance to protocol|1|||
125299227|NCT03836677|450721638|FG001|Period 2|Severe non-compliance to protocol|0|||
125299228|NCT01729208|450721639|FG000|Baseline|Physician Decision|5|||
125299229|NCT01729208|450721640|FG001|Baseline|Physician Decision|4|||
125299230|NCT01729208|450721639|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
125299231|NCT01729208|450721640|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
125299232|NCT01729208|450721639|FG000|12 Months Follow-up|Lost to Follow-up|3|||
125299233|NCT01729208|450721640|FG001|12 Months Follow-up|Lost to Follow-up|3|||
125299234|NCT01729208|450721639|FG000|24 Months Follow-up|Lost to Follow-up|3|||
125299235|NCT01729208|450721640|FG001|24 Months Follow-up|Lost to Follow-up|0|||
125299236|NCT01729208|450721639|FG000|36 Months Follow-up|Physician Decision|1|||
125299237|NCT01729208|450721640|FG001|36 Months Follow-up|Physician Decision|0|||
125299238|NCT01729208|450721639|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
125299239|NCT01729208|450721640|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
125299240|NCT02428413|450721642|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
125299241|NCT02428413|450721643|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
125299242|NCT02428413|450721642|FG000|Overall Study|Protocol Violation|1|||
125299243|NCT02428413|450721643|FG001|Overall Study|Protocol Violation|2|||
125299244|NCT02428413|450721642|FG000|Overall Study|Case Cancelled|2|||
125299245|NCT02428413|450721643|FG001|Overall Study|Case Cancelled|0|||
125299246|NCT02428413|450721642|FG000|Overall Study|Missed Cases|1|||
125299247|NCT02428413|450721643|FG001|Overall Study|Missed Cases|2|||
125299248|NCT02428413|450721642|FG000|Overall Study|Nurse Refusal|1|||
125299249|NCT02428413|450721643|FG001|Overall Study|Nurse Refusal|0|||
125299250|NCT03688100|450721646|FG000|Overall Study|Lost to Follow-up|21|||
125299251|NCT03688100|450721647|FG001|Overall Study|Lost to Follow-up|15|||
125299252|NCT03688100|450721648|FG002|Overall Study|Lost to Follow-up|15|||
125299253|NCT03688100|450721649|FG003|Overall Study|Lost to Follow-up|18|||
125299254|NCT03688100|450721646|FG000|Overall Study|Withdrawal by Subject|19|||
125299255|NCT03688100|450721647|FG001|Overall Study|Withdrawal by Subject|16|||
125299256|NCT03688100|450721648|FG002|Overall Study|Withdrawal by Subject|0|||
125299257|NCT03688100|450721649|FG003|Overall Study|Withdrawal by Subject|0|||
125299258|NCT03688100|450721646|FG000|Overall Study|Death|36|||
125299259|NCT03688100|450721647|FG001|Overall Study|Death|27|||
125299260|NCT03688100|450721648|FG002|Overall Study|Death|0|||
125299261|NCT03688100|450721649|FG003|Overall Study|Death|0|||
125299262|NCT02345330|450721652|FG000|Overall Study|Death|1|||
125299263|NCT02345330|450721652|FG000|Overall Study|Progressive Disease|2|||
125299264|NCT00494507|450721653|FG000|Double-Blind Phase|Adverse Event|2|||
125299265|NCT00494507|450721654|FG001|Double-Blind Phase|Adverse Event|0|||
125299266|NCT00494507|450721655|FG002|Double-Blind Phase|Adverse Event|1|||
125299267|NCT00494507|450721656|FG003|Double-Blind Phase|Adverse Event|0|||
125299268|NCT00494507|450721653|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
125299269|NCT00494507|450721654|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
125299270|NCT00494507|450721655|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
125299271|NCT00494507|450721656|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
125468972|NCT03088813|451347693|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
125468973|NCT03088813|451347694|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
125468974|NCT03088813|451347695|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
125468975|NCT03088813|451347692|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
125468976|NCT03088813|451347693|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
125468977|NCT03088813|451347694|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
125299272|NCT00494507|450721653|FG000|Double-Blind Phase|Subject Non-compliance|0|||
125299273|NCT00494507|450721654|FG001|Double-Blind Phase|Subject Non-compliance|0|||
125299274|NCT00494507|450721655|FG002|Double-Blind Phase|Subject Non-compliance|1|||
125299275|NCT00494507|450721656|FG003|Double-Blind Phase|Subject Non-compliance|0|||
125299276|NCT00494507|450721653|FG000|Double-Blind Phase|Negative DNA test|0|||
125299277|NCT00494507|450721654|FG001|Double-Blind Phase|Negative DNA test|0|||
125299278|NCT00494507|450721655|FG002|Double-Blind Phase|Negative DNA test|0|||
125299279|NCT00494507|450721656|FG003|Double-Blind Phase|Negative DNA test|1|||
125299280|NCT00494507|450721653|FG000|Open-Label Phase|Adverse Event|0|||
125299281|NCT00494507|450721654|FG001|Open-Label Phase|Adverse Event|1|||
125299282|NCT00494507|450721655|FG002|Open-Label Phase|Adverse Event|5|||
125299283|NCT00494507|450721656|FG003|Open-Label Phase|Adverse Event|3|||
125299284|NCT00494507|450721653|FG000|Open-Label Phase|Worsening Disease|0|||
125299285|NCT00494507|450721654|FG001|Open-Label Phase|Worsening Disease|0|||
125299286|NCT00494507|450721655|FG002|Open-Label Phase|Worsening Disease|0|||
125299287|NCT00494507|450721656|FG003|Open-Label Phase|Worsening Disease|2|||
125299288|NCT02437084|450721657|FG000|Overall Study|Withdrawal by Subject|2|||
125299289|NCT02437084|450721657|FG000|Overall Study|Physician Decision|1|||
125299290|NCT03729245|450721658|FG000|Overall Study|Lost to Follow-up|5|||
125299291|NCT03729245|450721659|FG001|Overall Study|Lost to Follow-up|6|||
125299292|NCT03729245|450721658|FG000|Overall Study|Withdrawal by Subject|16|||
125299293|NCT03729245|450721659|FG001|Overall Study|Withdrawal by Subject|19|||
125299294|NCT03729245|450721658|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
125299295|NCT03729245|450721659|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
125299296|NCT00989781|450721663|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
125299297|NCT00989781|450721664|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
125299298|NCT00694304|450721665|FG000|Overall Study|Adverse Event|42|||
125299299|NCT00694304|450721665|FG000|Overall Study|Lack of Efficacy|35|||
125299300|NCT00694304|450721665|FG000|Overall Study|Non-compliance With Study Product|16|||
125299301|NCT00694304|450721665|FG000|Overall Study|Protocol Violation|6|||
125299302|NCT00694304|450721665|FG000|Overall Study|Withdrawal of Consent|61|||
125299303|NCT00694304|450721665|FG000|Overall Study|Lost to Follow-up|15|||
125299304|NCT00694304|450721665|FG000|Overall Study|Administrative or Other Reasons|32|||
125299305|NCT04566692|450721666|FG000|Overall Study|Adverse Event|2|||
125299306|NCT04566692|450721667|FG001|Overall Study|Adverse Event|0|||
125299307|NCT04566692|450721666|FG000|Overall Study|Withdrawal by Subject|1|||
125299308|NCT04566692|450721667|FG001|Overall Study|Withdrawal by Subject|1|||
125468978|NCT03088813|451347695|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
125468979|NCT03088813|451347692|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
125468980|NCT03088813|451347693|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
125299309|NCT00671437|450721668|FG000|Overall Study|Progressive disease before C1 week 8|8|||
125299310|NCT00671437|450721668|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
125299311|NCT00671437|450721668|FG000|Overall Study|Adverse Event|3|||
125299312|NCT00671437|450721668|FG000|Overall Study|Ineligible post-hoc|1|||
125299313|NCT03203291|450721671|FG000|Overall Study|Withdrawal by Subject|1|||
125299314|NCT00377364|450721676|FG000|Overall Study|Lost to Follow-up|1|||
125299315|NCT00377364|450721677|FG001|Overall Study|Lost to Follow-up|0|||
125299316|NCT00377364|450721676|FG000|Overall Study|Withdrawal by Subject|1|||
125299317|NCT00377364|450721677|FG001|Overall Study|Withdrawal by Subject|0|||
125299318|NCT02540265|450721680|FG000|Overall Study|Lost to Follow-up|0|||
125468981|NCT03088813|451347694|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
125468982|NCT03088813|451347695|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
125468983|NCT03088813|451347692|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
125468984|NCT03088813|451347693|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
125468985|NCT03088813|451347694|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
125468986|NCT03088813|451347695|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
125299319|NCT02540265|450721681|FG001|Overall Study|Lost to Follow-up|0|||
125299320|NCT02540265|450721682|FG002|Overall Study|Lost to Follow-up|1|||
125299321|NCT03157037|450721685|FG000|Overall Study|Death|1|||
125299322|NCT02102399|450721689|FG000|Overall Study|Withdrawal by Subject|6|||
125299323|NCT02102399|450721690|FG001|Overall Study|Withdrawal by Subject|4|||
125299324|NCT03101085|450721691|FG000|Overall Study|Lost to Follow-up|0|||
125299325|NCT03101085|450721692|FG001|Overall Study|Lost to Follow-up|1|||
125299326|NCT00695864|450721693|FG000|Placebo|Withdrawal by Subject|1|||
125299327|NCT00695864|450721693|FG000|Placebo|Physician Decision|4|||
125299328|NCT01704456|450721694|FG000|Overall Study|Lost to Follow-up|8|||
125299329|NCT01704456|450721695|FG001|Overall Study|Lost to Follow-up|14|||
125299330|NCT00718770|450721696|FG000|Overall Study|Adverse Event|1|||
125299331|NCT00718770|450721696|FG000|Overall Study|Lack of Efficacy|1|||
125299332|NCT00718770|450721696|FG000|Overall Study|Lack of Efficacy|1|||
125299333|NCT00718770|450721696|FG000|Overall Study|Adverse Event|1|||
125299334|NCT00718770|450721696|FG000|Overall Study|Lack of Efficacy|1|||
125299335|NCT00718770|450721696|FG000|Overall Study|Adverse Event|1|||
125299336|NCT00718770|450721696|FG000|Overall Study|Lack of Efficacy|1|||
125299337|NCT00718770|450721696|FG000|Overall Study|Adverse Event|1|||
125299338|NCT00498355|450721697|FG000|Overall Study|Lost to Follow-up|1|||
125299339|NCT04583956|450721698|FG000|Overall Study|Death|9|||
125468987|NCT03088813|451347692|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
125299340|NCT04583956|450721699|FG001|Overall Study|Death|11|||
125299341|NCT04583956|450721698|FG000|Overall Study|Lost to Follow-up|7|||
125299342|NCT04583956|450721699|FG001|Overall Study|Lost to Follow-up|9|||
125299343|NCT04583956|450721698|FG000|Overall Study|Protocol Violation|2|||
125299344|NCT04583956|450721699|FG001|Overall Study|Protocol Violation|0|||
125299345|NCT04583956|450721698|FG000|Overall Study|Withdrawal by Subject|0|||
125299346|NCT04583956|450721699|FG001|Overall Study|Withdrawal by Subject|2|||
125299347|NCT04583956|450721698|FG000|Overall Study|Randomized but not dosed|2|||
125299348|NCT04583956|450721699|FG001|Overall Study|Randomized but not dosed|3|||
125299349|NCT04583956|450721698|FG000|Overall Study|Withdrawal of consent before product administration|1|||
125299350|NCT04583956|450721699|FG001|Overall Study|Withdrawal of consent before product administration|0|||
125299351|NCT04407234|450721706|FG000|Overall Study|Adverse Event|3|||
125299352|NCT04407234|450721707|FG001|Overall Study|Adverse Event|3|||
125299353|NCT00727558|450721708|FG000|Overall Study|Lens issue|0|||
125299354|NCT00727558|450721709|FG001|Overall Study|Lens issue|1|||
125299355|NCT00727558|450721708|FG000|Overall Study|Adverse Event|0|||
125299356|NCT00727558|450721709|FG001|Overall Study|Adverse Event|1|||
125299357|NCT00727558|450721708|FG000|Overall Study|Subject unable to return for follow-up|1|||
125299358|NCT00727558|450721709|FG001|Overall Study|Subject unable to return for follow-up|1|||
125299359|NCT00727558|450721708|FG000|Overall Study|Lost to Follow-up|1|||
125299360|NCT00727558|450721709|FG001|Overall Study|Lost to Follow-up|0|||
125299361|NCT02100475|450723629|FG000|Overall Study|Unclassified|1|||
125299362|NCT02100475|450723630|FG001|Overall Study|Unclassified|2|||
125299363|NCT02100475|450723629|FG000|Overall Study|Withdrawal criteria|1|||
125299364|NCT02100475|450723630|FG001|Overall Study|Withdrawal criteria|0|||
125299365|NCT04599465|450723631|FG000|Overall Study|Physician Decision|1|||
125299366|NCT04599465|450723631|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
125299367|NCT02814175|450723634|FG000|Part 1|Adverse Event|2|||
125299368|NCT02814175|450723635|FG001|Part 1|Adverse Event|3|||
125299369|NCT02814175|450723636|FG002|Part 1|Adverse Event|0|||
125299370|NCT02814175|450723637|FG003|Part 1|Adverse Event|0|||
125299371|NCT02814175|450723638|FG004|Part 1|Adverse Event|0|||
125299372|NCT02814175|450723639|FG005|Part 1|Adverse Event|0|||
125299373|NCT02814175|450723634|FG000|Part 1|Withdrawal Consent|8|||
125299374|NCT02814175|450723635|FG001|Part 1|Withdrawal Consent|1|||
125299375|NCT02814175|450723636|FG002|Part 1|Withdrawal Consent|0|||
125299376|NCT02814175|450723637|FG003|Part 1|Withdrawal Consent|0|||
125299377|NCT02814175|450723638|FG004|Part 1|Withdrawal Consent|0|||
125299378|NCT02814175|450723639|FG005|Part 1|Withdrawal Consent|0|||
125299379|NCT02814175|450723634|FG000|Part 1|Lost to Follow-up|1|||
125299380|NCT02814175|450723635|FG001|Part 1|Lost to Follow-up|0|||
125299381|NCT02814175|450723636|FG002|Part 1|Lost to Follow-up|0|||
125299382|NCT02814175|450723637|FG003|Part 1|Lost to Follow-up|0|||
125299383|NCT02814175|450723638|FG004|Part 1|Lost to Follow-up|0|||
125299384|NCT02814175|450723639|FG005|Part 1|Lost to Follow-up|0|||
125299385|NCT02814175|450723634|FG000|Part 1|Lack of Efficacy|1|||
125299386|NCT02814175|450723635|FG001|Part 1|Lack of Efficacy|2|||
125299387|NCT02814175|450723636|FG002|Part 1|Lack of Efficacy|0|||
125299388|NCT02814175|450723637|FG003|Part 1|Lack of Efficacy|0|||
125299389|NCT02814175|450723638|FG004|Part 1|Lack of Efficacy|0|||
125299390|NCT02814175|450723639|FG005|Part 1|Lack of Efficacy|0|||
125299391|NCT02814175|450723634|FG000|Part 2|Adverse Event|0|||
125299392|NCT02814175|450723635|FG001|Part 2|Adverse Event|0|||
125299393|NCT02814175|450723636|FG002|Part 2|Adverse Event|0|||
125299394|NCT02814175|450723637|FG003|Part 2|Adverse Event|1|||
125299395|NCT02814175|450723638|FG004|Part 2|Adverse Event|1|||
125299396|NCT02814175|450723639|FG005|Part 2|Adverse Event|2|||
125299397|NCT02814175|450723634|FG000|Part 2|Withdrawal Consent|0|||
125299398|NCT02814175|450723635|FG001|Part 2|Withdrawal Consent|0|||
125299399|NCT02814175|450723636|FG002|Part 2|Withdrawal Consent|0|||
125299400|NCT02814175|450723637|FG003|Part 2|Withdrawal Consent|2|||
125299401|NCT02814175|450723638|FG004|Part 2|Withdrawal Consent|1|||
125299402|NCT02814175|450723639|FG005|Part 2|Withdrawal Consent|1|||
125299403|NCT02814175|450723634|FG000|Part 2|Lost to Follow-up|0|||
125299404|NCT02814175|450723635|FG001|Part 2|Lost to Follow-up|0|||
125299405|NCT02814175|450723636|FG002|Part 2|Lost to Follow-up|0|||
125468988|NCT03088813|451347693|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
125468989|NCT03088813|451347694|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
125468990|NCT03088813|451347695|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
125299406|NCT02814175|450723637|FG003|Part 2|Lost to Follow-up|1|||
125299407|NCT02814175|450723638|FG004|Part 2|Lost to Follow-up|0|||
125299408|NCT02814175|450723639|FG005|Part 2|Lost to Follow-up|0|||
125299409|NCT02814175|450723634|FG000|Part 2|Lack of Efficacy|0|||
125299410|NCT02814175|450723635|FG001|Part 2|Lack of Efficacy|0|||
125299411|NCT02814175|450723636|FG002|Part 2|Lack of Efficacy|0|||
125299412|NCT02814175|450723637|FG003|Part 2|Lack of Efficacy|0|||
125299413|NCT02814175|450723638|FG004|Part 2|Lack of Efficacy|0|||
125299414|NCT02814175|450723639|FG005|Part 2|Lack of Efficacy|3|||
125299415|NCT03416127|450723640|FG000|Overall Study|Withdrawal by Subject|0|||
125299416|NCT03416127|450723641|FG001|Overall Study|Withdrawal by Subject|1|||
125299417|NCT03416127|450723642|FG002|Overall Study|Withdrawal by Subject|1|||
125299418|NCT02702180|450723643|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
125299419|NCT02702180|450723644|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
125299420|NCT02702180|450723645|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125299421|NCT02702180|450723643|FG000|Double-blind Treatment Period|Adverse Event|0|||
125299422|NCT02702180|450723644|FG001|Double-blind Treatment Period|Adverse Event|0|||
125299423|NCT02702180|450723645|FG002|Double-blind Treatment Period|Adverse Event|1|||
125299424|NCT02702180|450723643|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
125299425|NCT02702180|450723644|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
125299426|NCT02702180|450723645|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
125299427|NCT02702180|450723643|FG000|Double-blind Treatment Period|Protocol Violation|0|||
125299428|NCT02702180|450723644|FG001|Double-blind Treatment Period|Protocol Violation|0|||
125299429|NCT02702180|450723645|FG002|Double-blind Treatment Period|Protocol Violation|2|||
125299430|NCT02702180|450723643|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
125299431|NCT02702180|450723644|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
125299432|NCT02702180|450723645|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
125299433|NCT02702180|450723643|FG000|Open-label Treatment Period|Withdrawn in error|0|||
125299434|NCT02702180|450723644|FG001|Open-label Treatment Period|Withdrawn in error|0|||
125299435|NCT02702180|450723645|FG002|Open-label Treatment Period|Withdrawn in error|1|||
125299436|NCT02397057|450723646|FG000|Overall Study|Withdrawal by Subject|6|||
125299437|NCT02397057|450723647|FG001|Overall Study|Withdrawal by Subject|7|||
125299438|NCT02397057|450723646|FG000|Overall Study|Lost to Follow-up|4|||
125299439|NCT02397057|450723647|FG001|Overall Study|Lost to Follow-up|3|||
125299440|NCT02397057|450723646|FG000|Overall Study|Death|1|||
125299441|NCT02397057|450723647|FG001|Overall Study|Death|0|||
125299442|NCT02397057|450723646|FG000|Overall Study|Adverse Event|0|||
125299443|NCT02397057|450723647|FG001|Overall Study|Adverse Event|1|||
125299444|NCT02397057|450723646|FG000|Overall Study|Physician Decision|0|||
125299445|NCT02397057|450723647|FG001|Overall Study|Physician Decision|1|||
125299446|NCT02397057|450723646|FG000|Overall Study|Subject did not receive study drug|0|||
125299447|NCT02397057|450723647|FG001|Overall Study|Subject did not receive study drug|1|||
125299448|NCT00753454|450723652|FG000|Overall Study|Adverse Event|4|||
125299449|NCT00753454|450723652|FG000|Overall Study|Lack of Efficacy|1|||
125299450|NCT00753454|450723652|FG000|Overall Study|Lost to Follow-up|3|||
125299451|NCT00753454|450723652|FG000|Overall Study|Withdrawal by Subject|5|||
125299452|NCT00753454|450723652|FG000|Overall Study|Investigator Decision|1|||
125299453|NCT03927144|450723653|FG000|Core Phase|Adverse Event|9|||
125299454|NCT03927144|450723654|FG001|Core Phase|Adverse Event|5|||
125299455|NCT03927144|450723653|FG000|Core Phase|Lost to Follow-up|3|||
125299456|NCT03927144|450723654|FG001|Core Phase|Lost to Follow-up|2|||
125299457|NCT03927144|450723653|FG000|Core Phase|New Therapy for Study Indication|0|||
125299458|NCT03927144|450723654|FG001|Core Phase|New Therapy for Study Indication|1|||
125299459|NCT03927144|450723653|FG000|Core Phase|No Longer Clinically Benefiting|4|||
125299460|NCT03927144|450723654|FG001|Core Phase|No Longer Clinically Benefiting|4|||
125299461|NCT03927144|450723653|FG000|Core Phase|Physician Decision|2|||
125299462|NCT03927144|450723654|FG001|Core Phase|Physician Decision|8|||
125299463|NCT03927144|450723653|FG000|Core Phase|Protocol Violation|2|||
125299464|NCT03927144|450723654|FG001|Core Phase|Protocol Violation|2|||
125299465|NCT03927144|450723653|FG000|Core Phase|Withdrawal by Subject|16|||
125299466|NCT03927144|450723654|FG001|Core Phase|Withdrawal by Subject|40|||
125299467|NCT03927144|450723653|FG000|Extension Phase|Adverse Event|2|||
125299468|NCT03927144|450723654|FG001|Extension Phase|Adverse Event|1|||
125299469|NCT03927144|450723653|FG000|Extension Phase|No longer clinically benefiting|4|||
125299470|NCT03927144|450723654|FG001|Extension Phase|No longer clinically benefiting|5|||
125299471|NCT03927144|450723653|FG000|Extension Phase|Pregnancy|1|||
125299472|NCT03927144|450723654|FG001|Extension Phase|Pregnancy|0|||
125299473|NCT03927144|450723653|FG000|Extension Phase|Protocol Violation|0|||
125299474|NCT03927144|450723654|FG001|Extension Phase|Protocol Violation|1|||
125299475|NCT03927144|450723653|FG000|Extension Phase|Withdrawal by Subject|8|||
125299476|NCT03927144|450723654|FG001|Extension Phase|Withdrawal by Subject|3|||
125299477|NCT01452919|450723657|FG000|Open-Label Treatment|Adverse Event|5|||
125299478|NCT01452919|450723658|FG001|Open-Label Treatment|Adverse Event|0|||
125299479|NCT01452919|450723659|FG002|Open-Label Treatment|Adverse Event|0|||
125299480|NCT01452919|450723657|FG000|Open-Label Treatment|Lost to Follow-up|4|||
125299481|NCT01452919|450723658|FG001|Open-Label Treatment|Lost to Follow-up|0|||
125299482|NCT01452919|450723659|FG002|Open-Label Treatment|Lost to Follow-up|0|||
125299483|NCT01452919|450723657|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
125299484|NCT01452919|450723658|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
125299485|NCT01452919|450723659|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
125299486|NCT01452919|450723657|FG000|Open-Label Treatment|Protocol Violation|4|||
125299487|NCT01452919|450723658|FG001|Open-Label Treatment|Protocol Violation|0|||
125299488|NCT01452919|450723659|FG002|Open-Label Treatment|Protocol Violation|0|||
125299489|NCT01452919|450723657|FG000|Open-Label Treatment|Sponsor Decision|1|||
125299490|NCT01452919|450723658|FG001|Open-Label Treatment|Sponsor Decision|0|||
125299491|NCT01452919|450723659|FG002|Open-Label Treatment|Sponsor Decision|0|||
125299492|NCT01452919|450723657|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
125299493|NCT01452919|450723658|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
125299494|NCT01452919|450723659|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
125299495|NCT01452919|450723657|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
125299496|NCT01452919|450723658|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
125299497|NCT01452919|450723659|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
125299498|NCT01452919|450723657|FG000|Randomization Treatment|Adverse Event|0|||
125299499|NCT01452919|450723658|FG001|Randomization Treatment|Adverse Event|0|||
125299500|NCT01452919|450723659|FG002|Randomization Treatment|Adverse Event|2|||
125299501|NCT01452919|450723657|FG000|Randomization Treatment|Sponsor Decision|0|||
125299502|NCT01452919|450723658|FG001|Randomization Treatment|Sponsor Decision|1|||
125299503|NCT01452919|450723659|FG002|Randomization Treatment|Sponsor Decision|0|||
125299504|NCT01452919|450723657|FG000|Randomization Treatment|Withdrawal by Subject|0|||
125299505|NCT01452919|450723658|FG001|Randomization Treatment|Withdrawal by Subject|1|||
125299506|NCT01452919|450723659|FG002|Randomization Treatment|Withdrawal by Subject|0|||
125299507|NCT01452919|450723657|FG000|Randomization Treatment|Subject is moving or has moved|0|||
125299508|NCT01452919|450723658|FG001|Randomization Treatment|Subject is moving or has moved|1|||
125299509|NCT01452919|450723659|FG002|Randomization Treatment|Subject is moving or has moved|0|||
125299510|NCT02421588|450723660|FG000|Overall Study|Non-treatment-related AE|8|||
125299511|NCT02421588|450723661|FG001|Overall Study|Non-treatment-related AE|8|||
125299512|NCT02421588|450723660|FG000|Overall Study|Progressive disease|152|||
125299513|NCT02421588|450723661|FG001|Overall Study|Progressive disease|135|||
125299514|NCT02421588|450723660|FG000|Overall Study|Death|11|||
125299515|NCT02421588|450723661|FG001|Overall Study|Death|3|||
125299516|NCT02421588|450723660|FG000|Overall Study|Physician Decision|8|||
125299517|NCT02421588|450723661|FG001|Overall Study|Physician Decision|17|||
125299518|NCT02421588|450723660|FG000|Overall Study|Other reason not specified|3|||
125299519|NCT02421588|450723661|FG001|Overall Study|Other reason not specified|1|||
125299520|NCT02421588|450723660|FG000|Overall Study|Symptomatic deterioration|13|||
125299521|NCT02421588|450723661|FG001|Overall Study|Symptomatic deterioration|19|||
125299522|NCT02421588|450723660|FG000|Overall Study|Treatment-related AE|10|||
125299523|NCT02421588|450723661|FG001|Overall Study|Treatment-related AE|14|||
125299524|NCT02421588|450723660|FG000|Overall Study|Withdrawal by Subject|14|||
125299525|NCT02421588|450723661|FG001|Overall Study|Withdrawal by Subject|16|||
125299526|NCT02421588|450723660|FG000|Overall Study|Not treated|2|||
125299527|NCT02421588|450723661|FG001|Overall Study|Not treated|8|||
125299528|NCT01359943|450723662|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
125299529|NCT01359943|450723663|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
125299530|NCT01359943|450723664|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
125299531|NCT01359943|450723662|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
125299532|NCT01359943|450723663|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
125299533|NCT01359943|450723664|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
125299534|NCT01359943|450723662|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
125299535|NCT01359943|450723663|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
125299536|NCT01359943|450723664|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
125299537|NCT01359943|450723662|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
125299538|NCT01359943|450723663|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
125299539|NCT01359943|450723664|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
125299540|NCT01359943|450723662|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
125299541|NCT01359943|450723663|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
125299542|NCT01359943|450723664|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
125299543|NCT01359943|450723662|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
125299544|NCT01359943|450723663|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
125299545|NCT01359943|450723664|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
125299546|NCT01359943|450723662|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
125299547|NCT01359943|450723663|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
125299548|NCT01359943|450723664|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
125299549|NCT01359943|450723662|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
125299550|NCT01359943|450723663|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
125299551|NCT01359943|450723664|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
125299552|NCT01359943|450723662|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
125299553|NCT01359943|450723663|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
125299554|NCT01359943|450723664|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
125299555|NCT01359943|450723662|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
125299556|NCT01359943|450723663|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
125299557|NCT01359943|450723664|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
125299558|NCT01359943|450723662|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
125299559|NCT01359943|450723663|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
125299560|NCT01359943|450723664|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
125299561|NCT01359943|450723662|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
125299562|NCT01359943|450723663|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
125299563|NCT01359943|450723664|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
125299564|NCT01359943|450723662|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
125299565|NCT01359943|450723663|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
125299566|NCT01359943|450723664|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
125299567|NCT01359943|450723662|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
125468991|NCT03088813|451347692|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
125299568|NCT01359943|450723663|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
125299569|NCT01359943|450723664|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
125299570|NCT01359943|450723662|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
125299571|NCT01359943|450723663|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
125299572|NCT01359943|450723664|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
125468992|NCT03088813|451347693|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
125468993|NCT03088813|451347694|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
125468994|NCT03088813|451347695|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
125468995|NCT02780388|451347696|FG000|Overall Study|Lost to Follow-up|0|||
125468996|NCT02780388|451347697|FG001|Overall Study|Lost to Follow-up|1|||
125468997|NCT02780388|451347698|FG002|Overall Study|Lost to Follow-up|0|||
125468998|NCT02780388|451347699|FG003|Overall Study|Lost to Follow-up|0|||
125468999|NCT02780388|451347700|FG004|Overall Study|Lost to Follow-up|0|||
125469000|NCT02780388|451347696|FG000|Overall Study|Withdrawal by Subject|1|||
125469001|NCT02780388|451347697|FG001|Overall Study|Withdrawal by Subject|1|||
125469002|NCT02780388|451347698|FG002|Overall Study|Withdrawal by Subject|0|||
125469003|NCT02780388|451347699|FG003|Overall Study|Withdrawal by Subject|0|||
125469004|NCT02780388|451347700|FG004|Overall Study|Withdrawal by Subject|0|||
125469005|NCT04527146|451347701|FG000|Overall Study|Withdrawal by Subject|12|||
125469006|NCT04527146|451347702|FG001|Overall Study|Withdrawal by Subject|15|||
125469007|NCT04527146|451347703|FG002|Overall Study|Withdrawal by Subject|7|||
125299589|NCT02540668|450723679|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
125299590|NCT02540668|450723680|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
125299591|NCT03270891|450723681|FG000|Overall Study|Lost to Follow-up|3|||
125299592|NCT03270891|450723682|FG001|Overall Study|Lost to Follow-up|6|||
125299593|NCT03270891|450723683|FG002|Overall Study|Lost to Follow-up|0|||
125299594|NCT03270891|450723681|FG000|Overall Study|Withdrawal by Subject|1|||
125299595|NCT03270891|450723682|FG001|Overall Study|Withdrawal by Subject|0|||
125299596|NCT03270891|450723683|FG002|Overall Study|Withdrawal by Subject|0|||
125299597|NCT03270891|450723681|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
125299598|NCT03270891|450723682|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
125299599|NCT03270891|450723683|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
125299600|NCT02516592|450723685|FG000|Overall Study|Patient withdrew consent|5|||
125299601|NCT02516592|450723686|FG001|Overall Study|Patient withdrew consent|2|||
125299602|NCT02516592|450723685|FG000|Overall Study|Protocol deviation|4|||
125299603|NCT02516592|450723686|FG001|Overall Study|Protocol deviation|4|||
125299604|NCT02516592|450723685|FG000|Overall Study|Lost to Follow-up|2|||
125299605|NCT02516592|450723686|FG001|Overall Study|Lost to Follow-up|3|||
125299606|NCT02516592|450723685|FG000|Overall Study|Patient/guardian decision|2|||
125299607|NCT02516592|450723686|FG001|Overall Study|Patient/guardian decision|1|||
125299608|NCT02516592|450723685|FG000|Overall Study|Adverse Event|1|||
125299609|NCT02516592|450723686|FG001|Overall Study|Adverse Event|2|||
125299610|NCT02516592|450723685|FG000|Overall Study|Abnormal test procedure result|1|||
125299611|NCT02516592|450723686|FG001|Overall Study|Abnormal test procedure result|0|||
125299612|NCT02516592|450723685|FG000|Overall Study|Death|1|||
125299613|NCT02516592|450723686|FG001|Overall Study|Death|1|||
125299614|NCT01286740|450723687|FG000|Overall Study|Enrolled but not treated|1|||
125299615|NCT01286740|450723687|FG000|Overall Study|Protocol Violation|1|||
125299616|NCT01110382|450723689|FG000|Overall Study|Withdrawal by Subject|0|||
125299617|NCT01110382|450723690|FG001|Overall Study|Withdrawal by Subject|1|||
125299618|NCT01110382|450723689|FG000|Overall Study|Protocol Violation|0|||
125299619|NCT01110382|450723690|FG001|Overall Study|Protocol Violation|1|||
125299620|NCT01753401|450723693|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
125299621|NCT01753401|450723694|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
125299622|NCT01753401|450723695|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
125299623|NCT01753401|450723696|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
125299624|NCT01753401|450723693|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
125299625|NCT01753401|450723694|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
125299626|NCT01753401|450723695|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
125469008|NCT04527146|451347704|FG003|Overall Study|Withdrawal by Subject|16|||
125469009|NCT04527146|451347701|FG000|Overall Study|Lost to Follow-up|13|||
125469010|NCT04527146|451347702|FG001|Overall Study|Lost to Follow-up|9|||
125299627|NCT01753401|450723696|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
125299628|NCT01753401|450723693|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
125299629|NCT01753401|450723694|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
125299630|NCT01753401|450723695|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
125299631|NCT01753401|450723696|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
125299632|NCT01753401|450723693|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
125299633|NCT01753401|450723694|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
125299634|NCT01753401|450723695|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
125299635|NCT01753401|450723696|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
125299636|NCT01753401|450723693|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
125299637|NCT01753401|450723694|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
125469011|NCT04527146|451347703|FG002|Overall Study|Lost to Follow-up|16|||
125469012|NCT04527146|451347704|FG003|Overall Study|Lost to Follow-up|13|||
125469013|NCT04527146|451347701|FG000|Overall Study|Death|0|||
125469014|NCT04527146|451347702|FG001|Overall Study|Death|1|||
125469015|NCT04527146|451347703|FG002|Overall Study|Death|1|||
125469016|NCT04527146|451347704|FG003|Overall Study|Death|0|||
125469017|NCT04527146|451347701|FG000|Overall Study|Adverse Event|0|||
125469018|NCT04527146|451347702|FG001|Overall Study|Adverse Event|0|||
125469019|NCT04527146|451347703|FG002|Overall Study|Adverse Event|1|||
125469020|NCT04527146|451347704|FG003|Overall Study|Adverse Event|0|||
125469021|NCT04527146|451347701|FG000|Overall Study|Ineligible after randomization|2|||
125469022|NCT04527146|451347702|FG001|Overall Study|Ineligible after randomization|0|||
125469023|NCT04527146|451347703|FG002|Overall Study|Ineligible after randomization|2|||
125469024|NCT04527146|451347704|FG003|Overall Study|Ineligible after randomization|2|||
125469025|NCT04527146|451347701|FG000|Overall Study|Moved to a different group|6|||
125469026|NCT04527146|451347702|FG001|Overall Study|Moved to a different group|3|||
125469027|NCT04527146|451347703|FG002|Overall Study|Moved to a different group|0|||
125469028|NCT04527146|451347704|FG003|Overall Study|Moved to a different group|2|||
125469029|NCT05107401|451347705|FG000|Overall Study|Lost to Follow-up|13|||
125469030|NCT05107401|451347706|FG001|Overall Study|Lost to Follow-up|12|||
125469031|NCT01903811|451347718|FG000|Overall Study|No measurable disease|1|||
125469032|NCT01903811|451347719|FG001|Overall Study|No measurable disease|1|||
125469033|NCT01903811|451347718|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
125469034|NCT01903811|451347719|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
125469035|NCT01903811|451347718|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
125469036|NCT01903811|451347719|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
125469037|NCT01903811|451347718|FG000|Overall Study|Withdrawal by Subject|0|||
125469038|NCT01903811|451347719|FG001|Overall Study|Withdrawal by Subject|1|||
125469039|NCT04468776|451347720|FG000|Overall Study|Lost to Follow-up|4|||
125469040|NCT04468776|451347721|FG001|Overall Study|Lost to Follow-up|3|||
125469041|NCT04468776|451347722|FG002|Overall Study|Lost to Follow-up|4|||
125299638|NCT01753401|450723695|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
125299639|NCT01753401|450723696|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
125299640|NCT01753401|450723693|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
125299641|NCT01753401|450723694|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
125469042|NCT04468776|451347720|FG000|Overall Study|Withdrawal by Subject|1|||
125469043|NCT04468776|451347721|FG001|Overall Study|Withdrawal by Subject|10|||
125469044|NCT04468776|451347722|FG002|Overall Study|Withdrawal by Subject|4|||
125469045|NCT04468776|451347720|FG000|Overall Study|Physician Decision|0|||
125469046|NCT04468776|451347721|FG001|Overall Study|Physician Decision|1|||
125469047|NCT04468776|451347722|FG002|Overall Study|Physician Decision|1|||
125469048|NCT01704079|451347726|FG000|Overall Study|Withdrawal by Subject|5|||
125469049|NCT01704079|451347727|FG001|Overall Study|Withdrawal by Subject|7|||
125469050|NCT01704079|451347726|FG000|Overall Study|Lost to Follow-up|2|||
125469051|NCT01704079|451347727|FG001|Overall Study|Lost to Follow-up|5|||
125469052|NCT01704079|451347726|FG000|Overall Study|Adverse Event|4|||
125469053|NCT01704079|451347727|FG001|Overall Study|Adverse Event|7|||
125469054|NCT01704079|451347726|FG000|Overall Study|Protocol Violation|1|||
125469055|NCT01704079|451347727|FG001|Overall Study|Protocol Violation|0|||
125469056|NCT01704079|451347726|FG000|Overall Study|Subject noncompliance|2|||
125469057|NCT01704079|451347727|FG001|Overall Study|Subject noncompliance|3|||
125469058|NCT01704079|451347726|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
125469059|NCT01704079|451347727|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
125469060|NCT02991807|451347728|FG000|Overall Study|Withdrawal by Subject|2|||
125469061|NCT02991807|451347729|FG001|Overall Study|Withdrawal by Subject|1|||
125469062|NCT02991807|451347728|FG000|Overall Study|Physician Decision|0|||
125469063|NCT02991807|451347729|FG001|Overall Study|Physician Decision|1|||
125469064|NCT02991807|451347728|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
125469065|NCT02991807|451347729|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
125469066|NCT02300298|451347732|FG000|Disposition for Nintedanib|Progressive disease|10|||
125469067|NCT02300298|451347733|FG001|Disposition for Nintedanib|Progressive disease|0|||
125469068|NCT02300298|451347732|FG000|Disposition for Docetaxel|Progressive disease|0|||
125469069|NCT02300298|451347733|FG001|Disposition for Docetaxel|Progressive disease|6|||
125469070|NCT02300298|451347732|FG000|Disposition for Docetaxel|other adverse event|0|||
125469071|NCT02300298|451347733|FG001|Disposition for Docetaxel|other adverse event|4|||
125469072|NCT03285763|451347734|FG000|Overall Study|Death|470|||
125469073|NCT03285763|451347734|FG000|Overall Study|Lost to Follow-up|18|||
125469074|NCT03285763|451347734|FG000|Overall Study|Physician Decision|2|||
125469075|NCT03285763|451347734|FG000|Overall Study|Study Terminated By Sponsor|79|||
125469076|NCT03285763|451347734|FG000|Overall Study|Withdrawal by Subject|33|||
125469077|NCT03624972|451347735|FG000|Overall Study|Lost to Follow-up|2|||
125299642|NCT01753401|450723695|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
125469078|NCT03624972|451347736|FG001|Overall Study|Lost to Follow-up|0|||
125469079|NCT03624972|451347737|FG002|Overall Study|Lost to Follow-up|0|||
125469080|NCT03624972|451347735|FG000|Overall Study|Withdrawal by Subject|0|||
125469081|NCT03624972|451347736|FG001|Overall Study|Withdrawal by Subject|2|||
125469082|NCT03624972|451347737|FG002|Overall Study|Withdrawal by Subject|0|||
125469083|NCT03456076|451347738|FG000|Overall Study|Withdrawal by Subject|5|||
125469084|NCT03456076|451347739|FG001|Overall Study|Withdrawal by Subject|9|||
125469085|NCT03456076|451347738|FG000|Overall Study|Protocol deviation|0|||
125469086|NCT03456076|451347739|FG001|Overall Study|Protocol deviation|1|||
125469087|NCT03456076|451347738|FG000|Overall Study|Lost to Follow-up|0|||
125469088|NCT03456076|451347739|FG001|Overall Study|Lost to Follow-up|1|||
125469089|NCT03456076|451347738|FG000|Overall Study|Death|2|||
125469090|NCT03456076|451347739|FG001|Overall Study|Death|5|||
125469091|NCT03456076|451347738|FG000|Overall Study|Study ongoing|123|||
125469092|NCT03456076|451347739|FG001|Overall Study|Study ongoing|111|||
125469093|NCT04579250|451347741|FG000|Overall Study|Withdrawal by Subject|1|||
125469094|NCT04579250|451347742|FG001|Overall Study|Withdrawal by Subject|1|||
125469095|NCT04579250|451347743|FG002|Overall Study|Withdrawal by Subject|0|||
125469096|NCT04579250|451347741|FG000|Overall Study|Lost to Follow-up|1|||
125469097|NCT04579250|451347742|FG001|Overall Study|Lost to Follow-up|1|||
125469098|NCT04579250|451347743|FG002|Overall Study|Lost to Follow-up|0|||
125469099|NCT04579250|451347741|FG000|Overall Study|Moved from area|0|||
125469100|NCT04579250|451347742|FG001|Overall Study|Moved from area|1|||
125469101|NCT04579250|451347743|FG002|Overall Study|Moved from area|2|||
125469102|NCT04711135|451347748|FG000|Overall Study|Physician Decision|0|||
125469103|NCT04711135|451347749|FG001|Overall Study|Physician Decision|1|||
125469104|NCT04711135|451347748|FG000|Overall Study|Ongoing treatment|0|||
125469105|NCT04711135|451347749|FG001|Overall Study|Ongoing treatment|1|||
125469106|NCT00998881|451347750|FG000|Overall Study|Adverse Event|2|||
125469107|NCT00998881|451347751|FG001|Overall Study|Adverse Event|2|||
125469108|NCT00998881|451347750|FG000|Overall Study|Lack of Efficacy|1|||
125469109|NCT00998881|451347751|FG001|Overall Study|Lack of Efficacy|0|||
125469110|NCT00998881|451347750|FG000|Overall Study|Physician Decision|3|||
125469111|NCT00998881|451347751|FG001|Overall Study|Physician Decision|0|||
125469112|NCT00998881|451347750|FG000|Overall Study|Withdrawal by Subject|1|||
125469113|NCT00998881|451347751|FG001|Overall Study|Withdrawal by Subject|0|||
125299643|NCT01753401|450723696|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
125299644|NCT01753401|450723693|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
125299645|NCT01753401|450723694|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
125299646|NCT01753401|450723695|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
125299647|NCT01753401|450723696|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
125299648|NCT01353911|450723697|FG000|Overall Study|Lost to Follow-up|2|||
125299649|NCT01353911|450723698|FG001|Overall Study|Lost to Follow-up|6|||
125299650|NCT01353911|450723699|FG002|Overall Study|Lost to Follow-up|4|||
125299651|NCT01353911|450723700|FG003|Overall Study|Lost to Follow-up|0|||
125299652|NCT01353911|450723701|FG004|Overall Study|Lost to Follow-up|4|||
125299653|NCT01353911|450723702|FG005|Overall Study|Lost to Follow-up|4|||
125299654|NCT01353911|450723703|FG006|Overall Study|Lost to Follow-up|3|||
125299655|NCT01353911|450723704|FG007|Overall Study|Lost to Follow-up|6|||
125299656|NCT01353911|450723697|FG000|Overall Study|Withdrawal by Subject|2|||
125299657|NCT01353911|450723698|FG001|Overall Study|Withdrawal by Subject|3|||
125299658|NCT01353911|450723699|FG002|Overall Study|Withdrawal by Subject|4|||
125299659|NCT01353911|450723700|FG003|Overall Study|Withdrawal by Subject|2|||
125299660|NCT01353911|450723701|FG004|Overall Study|Withdrawal by Subject|2|||
125299661|NCT01353911|450723702|FG005|Overall Study|Withdrawal by Subject|3|||
125299662|NCT01353911|450723703|FG006|Overall Study|Withdrawal by Subject|3|||
125299663|NCT01353911|450723704|FG007|Overall Study|Withdrawal by Subject|9|||
125299664|NCT01353911|450723697|FG000|Overall Study|Status Not Recorded|4|||
125299665|NCT01353911|450723698|FG001|Overall Study|Status Not Recorded|0|||
125299666|NCT01353911|450723699|FG002|Overall Study|Status Not Recorded|1|||
125299667|NCT01353911|450723700|FG003|Overall Study|Status Not Recorded|0|||
125299668|NCT01353911|450723701|FG004|Overall Study|Status Not Recorded|0|||
125299669|NCT01353911|450723702|FG005|Overall Study|Status Not Recorded|0|||
125299670|NCT01353911|450723703|FG006|Overall Study|Status Not Recorded|0|||
125299671|NCT01353911|450723704|FG007|Overall Study|Status Not Recorded|0|||
125299672|NCT00462748|450723709|FG000|Overall Study|Adverse Event|7|||
125299673|NCT00462748|450723710|FG001|Overall Study|Adverse Event|5|||
125299674|NCT00462748|450723711|FG002|Overall Study|Adverse Event|9|||
125299675|NCT00462748|450723709|FG000|Overall Study|Protocol Violation|0|||
125299676|NCT00462748|450723710|FG001|Overall Study|Protocol Violation|2|||
125469114|NCT00998881|451347750|FG000|Overall Study|Personal matter|1|||
125469115|NCT00998881|451347751|FG001|Overall Study|Personal matter|0|||
125469116|NCT00818246|451347753|FG000|Overall Study|Impossible to match pictures|5|||
125469117|NCT02006758|451347757|FG000|Overall Study|Protocol Violation|1|||
125469118|NCT02006758|451347757|FG000|Overall Study|Death|1|||
125299677|NCT00462748|450723711|FG002|Overall Study|Protocol Violation|1|||
125299678|NCT00462748|450723709|FG000|Overall Study|Withdrew consent|3|||
125299679|NCT00462748|450723710|FG001|Overall Study|Withdrew consent|3|||
125299680|NCT00462748|450723711|FG002|Overall Study|Withdrew consent|0|||
125299681|NCT00462748|450723709|FG000|Overall Study|Lost to Follow-up|1|||
125469119|NCT02006758|451347757|FG000|Overall Study|Lost to Follow-up|4|||
125469120|NCT02006758|451347757|FG000|Overall Study|Withdrawal by Subject|4|||
125299682|NCT00462748|450723710|FG001|Overall Study|Lost to Follow-up|1|||
125299683|NCT00462748|450723711|FG002|Overall Study|Lost to Follow-up|1|||
125299684|NCT00462748|450723709|FG000|Overall Study|Discontinued after 41 days Rx|1|||
125299685|NCT00462748|450723710|FG001|Overall Study|Discontinued after 41 days Rx|0|||
125299686|NCT00462748|450723711|FG002|Overall Study|Discontinued after 41 days Rx|0|||
125299687|NCT03233438|450723712|FG000|Overall Study|Lost to Follow-up|4|||
125299688|NCT03233438|450723713|FG001|Overall Study|Lost to Follow-up|9|||
125299689|NCT03233438|450723712|FG000|Overall Study|Withdrawal by Subject|2|||
125299690|NCT03233438|450723713|FG001|Overall Study|Withdrawal by Subject|1|||
125299691|NCT03233438|450723712|FG000|Overall Study|No recording of dalbavancin|0|||
125299692|NCT03233438|450723713|FG001|Overall Study|No recording of dalbavancin|1|||
125299693|NCT03429543|450723714|FG000|Overall Study|Adverse Event|1|||
125299694|NCT03429543|450723715|FG001|Overall Study|Adverse Event|1|||
125299695|NCT03429543|450723716|FG002|Overall Study|Adverse Event|0|||
125299696|NCT03429543|450723717|FG003|Overall Study|Adverse Event|0|||
125299697|NCT03429543|450723718|FG004|Overall Study|Adverse Event|0|||
125299698|NCT03429543|450723719|FG005|Overall Study|Adverse Event|2|||
125299699|NCT03429543|450723720|FG006|Overall Study|Adverse Event|0|||
125299700|NCT03429543|450723714|FG000|Overall Study|Lost to Follow-up|1|||
125299701|NCT03429543|450723715|FG001|Overall Study|Lost to Follow-up|0|||
125299702|NCT03429543|450723716|FG002|Overall Study|Lost to Follow-up|0|||
125299703|NCT03429543|450723717|FG003|Overall Study|Lost to Follow-up|0|||
125299704|NCT03429543|450723718|FG004|Overall Study|Lost to Follow-up|1|||
125299705|NCT03429543|450723719|FG005|Overall Study|Lost to Follow-up|0|||
125299706|NCT03429543|450723720|FG006|Overall Study|Lost to Follow-up|0|||
125299707|NCT03429543|450723714|FG000|Overall Study|Withdrawal by Subject|5|||
125299708|NCT03429543|450723715|FG001|Overall Study|Withdrawal by Subject|0|||
125299709|NCT03429543|450723716|FG002|Overall Study|Withdrawal by Subject|1|||
125299710|NCT03429543|450723717|FG003|Overall Study|Withdrawal by Subject|2|||
125299711|NCT03429543|450723718|FG004|Overall Study|Withdrawal by Subject|6|||
125299712|NCT03429543|450723719|FG005|Overall Study|Withdrawal by Subject|3|||
125299713|NCT03429543|450723720|FG006|Overall Study|Withdrawal by Subject|1|||
125299714|NCT03429543|450723714|FG000|Overall Study|Other reason than listed|0|||
125299715|NCT03429543|450723715|FG001|Overall Study|Other reason than listed|1|||
125299716|NCT03429543|450723716|FG002|Overall Study|Other reason than listed|0|||
125299717|NCT03429543|450723717|FG003|Overall Study|Other reason than listed|0|||
125299718|NCT03429543|450723718|FG004|Overall Study|Other reason than listed|4|||
125299719|NCT03429543|450723719|FG005|Overall Study|Other reason than listed|4|||
125299720|NCT03429543|450723720|FG006|Overall Study|Other reason than listed|0|||
125299721|NCT03429543|450723714|FG000|Overall Study|Not treated|0|||
125299722|NCT03429543|450723715|FG001|Overall Study|Not treated|0|||
125299723|NCT03429543|450723716|FG002|Overall Study|Not treated|0|||
125299724|NCT03429543|450723717|FG003|Overall Study|Not treated|0|||
125299725|NCT03429543|450723718|FG004|Overall Study|Not treated|1|||
125299726|NCT03429543|450723719|FG005|Overall Study|Not treated|0|||
125299727|NCT03429543|450723720|FG006|Overall Study|Not treated|0|||
125299728|NCT03615066|450723721|FG000|Main Study|Withdrew Consent|0|||
125299729|NCT03615066|450723722|FG001|Main Study|Withdrew Consent|1|||
125299730|NCT03615066|450723723|FG002|Main Study|Withdrew Consent|1|||
125299731|NCT03615066|450723721|FG000|Main Study|Lost to Follow-up|0|||
125299732|NCT03615066|450723722|FG001|Main Study|Lost to Follow-up|0|||
125299733|NCT03615066|450723723|FG002|Main Study|Lost to Follow-up|1|||
125299734|NCT03615066|450723721|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
125299735|NCT03615066|450723722|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
125299736|NCT03615066|450723723|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
125299737|NCT03615066|450723721|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
125299738|NCT03615066|450723722|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
125299739|NCT03615066|450723723|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
125469121|NCT02006758|451347757|FG000|Overall Study|Procedurally excluded|1|||
125469122|NCT02006758|451347757|FG000|Overall Study|Other|2|||
125469123|NCT04788641|451347759|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
125299740|NCT03615066|450723721|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
125299741|NCT03615066|450723722|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
125299742|NCT03615066|450723723|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
125299743|NCT00576576|450723737|FG000|Overall Study|Lost to Follow-up|6|||
125299744|NCT00576576|450723737|FG000|Overall Study|Protocol Violation|1|||
125299745|NCT01805037|450723743|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
125299746|NCT01805037|450723744|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
125299747|NCT01805037|450723743|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
125299748|NCT01805037|450723744|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
125299749|NCT01805037|450723743|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
125299750|NCT01805037|450723744|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
125299751|NCT01805037|450723743|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
125299752|NCT01805037|450723744|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
125299753|NCT01805037|450723743|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
125299754|NCT01805037|450723744|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
125299755|NCT01805037|450723743|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
125299756|NCT01805037|450723744|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
125299757|NCT01805037|450723743|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
125299758|NCT01805037|450723744|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
125299759|NCT01805037|450723743|FG000|Follow Up (up to 3 Years)|Death|0|||
125299760|NCT01805037|450723744|FG001|Follow Up (up to 3 Years)|Death|2|||
125299761|NCT01805037|450723743|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
125299762|NCT01805037|450723744|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
125299763|NCT01805037|450723743|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
125299764|NCT01805037|450723744|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
125299765|NCT02177838|450723748|FG000|Overall Study|Withdrawal by Subject|1|||
125299766|NCT02177838|450723748|FG000|Overall Study|Physician Decision|1|||
125299767|NCT02177838|450723748|FG000|Overall Study|Death|1|||
125299768|NCT03517566|450723751|FG000|Overall Study|Adverse Event|5|||
125299769|NCT03517566|450723752|FG001|Overall Study|Adverse Event|2|||
125299770|NCT03517566|450723753|FG002|Overall Study|Adverse Event|2|||
125299771|NCT03517566|450723754|FG003|Overall Study|Adverse Event|8|||
125469124|NCT04788641|451347760|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
125469125|NCT04788641|451347761|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
125469126|NCT04788641|451347762|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
125469127|NCT04788641|451347759|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
125469128|NCT04788641|451347760|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
125469129|NCT04788641|451347761|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
125469130|NCT04788641|451347762|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
125469131|NCT04788641|451347759|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
125469132|NCT04788641|451347760|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
125469133|NCT04788641|451347761|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
125469134|NCT04788641|451347762|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
125469135|NCT03283371|451347763|FG000|Placebo-controlled|Adverse Event|1|||
125469136|NCT03283371|451347764|FG001|Placebo-controlled|Adverse Event|1|||
125469137|NCT03283371|451347765|FG002|Placebo-controlled|Adverse Event|0|||
125469138|NCT03283371|451347766|FG003|Placebo-controlled|Adverse Event|0|||
125469139|NCT03283371|451347763|FG000|Placebo-controlled|Lack of Efficacy|1|||
125469140|NCT03283371|451347764|FG001|Placebo-controlled|Lack of Efficacy|0|||
125469141|NCT03283371|451347765|FG002|Placebo-controlled|Lack of Efficacy|0|||
125469142|NCT03283371|451347766|FG003|Placebo-controlled|Lack of Efficacy|0|||
125469143|NCT03283371|451347763|FG000|Placebo-controlled|Withdrawal by Subject|1|||
125469144|NCT03283371|451347764|FG001|Placebo-controlled|Withdrawal by Subject|1|||
125469145|NCT03283371|451347765|FG002|Placebo-controlled|Withdrawal by Subject|0|||
125469146|NCT03283371|451347766|FG003|Placebo-controlled|Withdrawal by Subject|0|||
125469147|NCT03283371|451347763|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
125469148|NCT03283371|451347764|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
125469149|NCT03283371|451347765|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
125469150|NCT03283371|451347766|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
125469151|NCT03283371|451347763|FG000|Open-label Phase|Adverse Event|0|||
125469152|NCT03283371|451347764|FG001|Open-label Phase|Adverse Event|0|||
125469153|NCT03283371|451347765|FG002|Open-label Phase|Adverse Event|2|||
125469154|NCT03283371|451347766|FG003|Open-label Phase|Adverse Event|0|||
125469155|NCT03283371|451347763|FG000|Open-label Phase|Withdrawal by Subject|0|||
125469156|NCT03283371|451347764|FG001|Open-label Phase|Withdrawal by Subject|0|||
125469157|NCT03283371|451347765|FG002|Open-label Phase|Withdrawal by Subject|1|||
125469158|NCT03283371|451347766|FG003|Open-label Phase|Withdrawal by Subject|0|||
125469159|NCT03283371|451347763|FG000|Open-label Phase|Other|0|||
125469160|NCT03283371|451347764|FG001|Open-label Phase|Other|0|||
125469161|NCT03283371|451347765|FG002|Open-label Phase|Other|1|||
125469162|NCT03283371|451347766|FG003|Open-label Phase|Other|1|||
125469163|NCT02462759|451347767|FG000|Part 1: Double Blind|Death|1|||
125469164|NCT02462759|451347768|FG001|Part 1: Double Blind|Death|0|||
125469165|NCT02462759|451347769|FG002|Part 1: Double Blind|Death|0|||
125469166|NCT00093015|451347770|FG000|Overall Study|Withdrawal by Subject|194|||
125469167|NCT00093015|451347771|FG001|Overall Study|Withdrawal by Subject|171|||
125469168|NCT00093015|451347770|FG000|Overall Study|Lost to Follow-up|96|||
125469169|NCT00093015|451347771|FG001|Overall Study|Lost to Follow-up|108|||
125469170|NCT00093015|451347770|FG000|Overall Study|Death|375|||
125469171|NCT00093015|451347771|FG001|Overall Study|Death|385|||
125469172|NCT04600752|451347774|FG000|Overall Study|Physician Decision|0|||
125469173|NCT04600752|451347775|FG001|Overall Study|Physician Decision|0|||
125469174|NCT04600752|451347776|FG002|Overall Study|Physician Decision|1|||
125299772|NCT03517566|450723755|FG004|Overall Study|Adverse Event|7|||
125299773|NCT03517566|450723751|FG000|Overall Study|Lack of Efficacy|3|||
125299774|NCT03517566|450723752|FG001|Overall Study|Lack of Efficacy|2|||
125299775|NCT03517566|450723753|FG002|Overall Study|Lack of Efficacy|1|||
125299776|NCT03517566|450723754|FG003|Overall Study|Lack of Efficacy|1|||
125299777|NCT03517566|450723755|FG004|Overall Study|Lack of Efficacy|4|||
125299778|NCT03517566|450723751|FG000|Overall Study|Lost to Follow-up|3|||
125469175|NCT04600752|451347774|FG000|Overall Study|Adverse Event|0|||
125469176|NCT04600752|451347775|FG001|Overall Study|Adverse Event|1|||
125469177|NCT04600752|451347776|FG002|Overall Study|Adverse Event|0|||
125469178|NCT04600752|451347774|FG000|Overall Study|Withdrawal by Subject|2|||
125469179|NCT04600752|451347775|FG001|Overall Study|Withdrawal by Subject|1|||
125469180|NCT04600752|451347776|FG002|Overall Study|Withdrawal by Subject|0|||
125469181|NCT04600752|451347774|FG000|Overall Study|Lack of Efficacy|1|||
125469182|NCT04600752|451347775|FG001|Overall Study|Lack of Efficacy|0|||
125469183|NCT04600752|451347776|FG002|Overall Study|Lack of Efficacy|0|||
125469184|NCT02794480|451347777|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
125469185|NCT02794480|451347778|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
125469186|NCT02794480|451347779|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
125469187|NCT02794480|451347780|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
125469188|NCT02794480|451347777|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
125469189|NCT02794480|451347778|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
125469190|NCT02794480|451347779|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
125469191|NCT02794480|451347780|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
125469192|NCT02794480|451347777|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125469193|NCT02794480|451347778|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125469194|NCT02794480|451347779|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125469195|NCT02794480|451347780|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
125469196|NCT02794480|451347777|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125469197|NCT02794480|451347778|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
125469198|NCT02794480|451347779|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125469199|NCT02794480|451347780|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
125469200|NCT02794480|451347777|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
125469201|NCT02794480|451347778|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125469202|NCT02794480|451347779|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125469203|NCT02794480|451347780|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
125469204|NCT01017146|451347781|FG000|Overall Study|Adverse Event|11|||
125469205|NCT01017146|451347782|FG001|Overall Study|Adverse Event|1|||
125469206|NCT01017146|451347781|FG000|Overall Study|Lost to Follow-up|14|||
125469207|NCT01017146|451347782|FG001|Overall Study|Lost to Follow-up|14|||
125469208|NCT01017146|451347781|FG000|Overall Study|Noncompliance with Study Product|1|||
125469209|NCT01017146|451347782|FG001|Overall Study|Noncompliance with Study Product|1|||
125469210|NCT01017146|451347781|FG000|Overall Study|Withdrawal by Subject|32|||
125469211|NCT01017146|451347782|FG001|Overall Study|Withdrawal by Subject|16|||
125469212|NCT01017146|451347781|FG000|Overall Study|Relocation|0|||
125469213|NCT01017146|451347782|FG001|Overall Study|Relocation|4|||
125469214|NCT01017146|451347781|FG000|Overall Study|Pregnancy|2|||
125469215|NCT01017146|451347782|FG001|Overall Study|Pregnancy|1|||
125469216|NCT01017146|451347781|FG000|Overall Study|Protocol Violation|2|||
125469217|NCT01017146|451347782|FG001|Overall Study|Protocol Violation|0|||
125469218|NCT01017146|451347781|FG000|Overall Study|Took Excluded Medication|2|||
125469219|NCT01017146|451347782|FG001|Overall Study|Took Excluded Medication|0|||
125469220|NCT01017146|451347781|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
125469221|NCT01017146|451347782|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
125469222|NCT01017146|451347781|FG000|Overall Study|Change in Work Situation|1|||
125469223|NCT01017146|451347782|FG001|Overall Study|Change in Work Situation|0|||
125469224|NCT01747486|451347783|FG000|Stage 1|Physician Decision|3|||
125469225|NCT01747486|451347784|FG001|Stage 1|Physician Decision|0|||
125469226|NCT01747486|451347783|FG000|Stage 1|Withdrawal by Subject|4|||
125469227|NCT01747486|451347784|FG001|Stage 1|Withdrawal by Subject|3|||
125469228|NCT01747486|451347783|FG000|Stage 1|Disease progression|4|||
125469229|NCT01747486|451347784|FG001|Stage 1|Disease progression|9|||
125469230|NCT01747486|451347783|FG000|Stage 1|Death|1|||
125299779|NCT03517566|450723752|FG001|Overall Study|Lost to Follow-up|1|||
125299780|NCT03517566|450723753|FG002|Overall Study|Lost to Follow-up|1|||
125299781|NCT03517566|450723754|FG003|Overall Study|Lost to Follow-up|1|||
125299782|NCT03517566|450723755|FG004|Overall Study|Lost to Follow-up|0|||
125299783|NCT03517566|450723751|FG000|Overall Study|Physician Decision|1|||
125299784|NCT03517566|450723752|FG001|Overall Study|Physician Decision|1|||
125299785|NCT03517566|450723753|FG002|Overall Study|Physician Decision|0|||
125469231|NCT01747486|451347784|FG001|Stage 1|Death|1|||
125469232|NCT01747486|451347783|FG000|Stage 2|Physician Decision|2|||
125469233|NCT01747486|451347784|FG001|Stage 2|Physician Decision|0|||
125469234|NCT01747486|451347783|FG000|Stage 2|Withdrawal by Subject|1|||
125469235|NCT01747486|451347784|FG001|Stage 2|Withdrawal by Subject|0|||
125469236|NCT01747486|451347783|FG000|Stage 2|New Cancer Therapy|3|||
125469237|NCT01747486|451347784|FG001|Stage 2|New Cancer Therapy|0|||
125469238|NCT01747486|451347783|FG000|Stage 2|Disease Progression|3|||
125299786|NCT03517566|450723754|FG003|Overall Study|Physician Decision|1|||
125299787|NCT03517566|450723755|FG004|Overall Study|Physician Decision|0|||
125299788|NCT03517566|450723751|FG000|Overall Study|Pregnancy|0|||
125299789|NCT03517566|450723752|FG001|Overall Study|Pregnancy|1|||
125469239|NCT01747486|451347784|FG001|Stage 2|Disease Progression|0|||
125469240|NCT01771731|451347788|FG000|Overall Study|Physician Decision|1|||
125469241|NCT01771731|451347789|FG001|Overall Study|Physician Decision|0|||
125469242|NCT01771731|451347788|FG000|Overall Study|Protocol Violation|0|||
125469243|NCT01771731|451347789|FG001|Overall Study|Protocol Violation|1|||
125469244|NCT01771731|451347788|FG000|Overall Study|Adverse event: Pain Crisis|1|||
125469245|NCT01771731|451347789|FG001|Overall Study|Adverse event: Pain Crisis|1|||
125469246|NCT04128319|451347790|FG000|Overall Study|Death|3|||
125469247|NCT04484935|451347791|FG000|Overall Study|Other|0|||
125469248|NCT04484935|451347792|FG001|Overall Study|Other|1|||
125469249|NCT04484935|451347791|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125469250|NCT04484935|451347792|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125469251|NCT04484935|451347791|FG000|Overall Study|Lost to Follow-up|1|||
125469252|NCT04484935|451347792|FG001|Overall Study|Lost to Follow-up|0|||
125469253|NCT04484935|451347791|FG000|Overall Study|Death|2|||
125469254|NCT04484935|451347792|FG001|Overall Study|Death|1|||
125469255|NCT01094184|451347793|FG000|Overall Study|Death|35|||
125469256|NCT01094184|451347794|FG001|Overall Study|Death|11|||
125469257|NCT03892564|451347795|FG000|Overall Study|Withdrawal by Subject|2|||
125469258|NCT03398148|451349692|FG000|Substudy 1 Period 1|Adverse Event|5|||
125469259|NCT03398148|451349693|FG001|Substudy 1 Period 1|Adverse Event|2|||
125469260|NCT03398148|451349694|FG002|Substudy 1 Period 1|Adverse Event|2|||
125469261|NCT03398148|451349695|FG003|Substudy 1 Period 1|Adverse Event|0|||
125469262|NCT03398148|451349696|FG004|Substudy 1 Period 1|Adverse Event|8|||
125469263|NCT03398148|451349697|FG005|Substudy 1 Period 1|Adverse Event|0|||
125469264|NCT03398148|451349698|FG006|Substudy 1 Period 1|Adverse Event|0|||
125469265|NCT03398148|451349699|FG007|Substudy 1 Period 1|Adverse Event|0|||
125469266|NCT03398148|451349700|FG008|Substudy 1 Period 1|Adverse Event|0|||
125469267|NCT03398148|451349701|FG009|Substudy 1 Period 1|Adverse Event|0|||
125469268|NCT03398148|451349702|FG010|Substudy 1 Period 1|Adverse Event|0|||
125469269|NCT03398148|451349703|FG011|Substudy 1 Period 1|Adverse Event|0|||
125469270|NCT03398148|451349704|FG012|Substudy 1 Period 1|Adverse Event|0|||
125469271|NCT03398148|451349705|FG013|Substudy 1 Period 1|Adverse Event|0|||
125469272|NCT03398148|451349706|FG014|Substudy 1 Period 1|Adverse Event|0|||
125469273|NCT03398148|451349692|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
125469274|NCT03398148|451349693|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
125469275|NCT03398148|451349694|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
125469276|NCT03398148|451349695|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
125469277|NCT03398148|451349696|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
125469278|NCT03398148|451349697|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
125469279|NCT03398148|451349698|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
125469280|NCT03398148|451349699|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
125469281|NCT03398148|451349700|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
125469282|NCT03398148|451349701|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
125469283|NCT03398148|451349702|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
125469284|NCT03398148|451349703|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
125469285|NCT03398148|451349704|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
125469286|NCT03398148|451349705|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
125469287|NCT03398148|451349706|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
125469288|NCT03398148|451349692|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
125469289|NCT03398148|451349693|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
125469290|NCT03398148|451349694|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
125469291|NCT03398148|451349695|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
125469292|NCT03398148|451349696|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
125469293|NCT03398148|451349697|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
125469294|NCT03398148|451349698|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
125469295|NCT03398148|451349699|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
125469296|NCT03398148|451349700|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
125469297|NCT03398148|451349701|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
125469298|NCT03398148|451349702|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
125469299|NCT03398148|451349703|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
125469300|NCT03398148|451349704|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
125469301|NCT03398148|451349705|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
125469302|NCT03398148|451349706|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
125469303|NCT03398148|451349692|FG000|Substudy 1 Period 1|Other|0|||
125469304|NCT03398148|451349693|FG001|Substudy 1 Period 1|Other|1|||
125469305|NCT03398148|451349694|FG002|Substudy 1 Period 1|Other|0|||
125469306|NCT03398148|451349695|FG003|Substudy 1 Period 1|Other|0|||
125469307|NCT03398148|451349696|FG004|Substudy 1 Period 1|Other|3|||
125469308|NCT03398148|451349697|FG005|Substudy 1 Period 1|Other|0|||
125469309|NCT03398148|451349698|FG006|Substudy 1 Period 1|Other|0|||
125469310|NCT03398148|451349699|FG007|Substudy 1 Period 1|Other|0|||
125469311|NCT03398148|451349700|FG008|Substudy 1 Period 1|Other|0|||
125469312|NCT03398148|451349701|FG009|Substudy 1 Period 1|Other|0|||
125469313|NCT03398148|451349702|FG010|Substudy 1 Period 1|Other|0|||
125469314|NCT03398148|451349703|FG011|Substudy 1 Period 1|Other|0|||
125469315|NCT03398148|451349704|FG012|Substudy 1 Period 1|Other|0|||
125299790|NCT03517566|450723753|FG002|Overall Study|Pregnancy|0|||
125469316|NCT03398148|451349705|FG013|Substudy 1 Period 1|Other|0|||
125469317|NCT03398148|451349706|FG014|Substudy 1 Period 1|Other|0|||
125469318|NCT03398148|451349692|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469319|NCT03398148|451349693|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469320|NCT03398148|451349694|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469321|NCT03398148|451349695|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469322|NCT03398148|451349696|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
125469323|NCT03398148|451349697|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469324|NCT03398148|451349698|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469325|NCT03398148|451349699|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469326|NCT03398148|451349700|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469327|NCT03398148|451349701|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469328|NCT03398148|451349702|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469329|NCT03398148|451349703|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469330|NCT03398148|451349704|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469331|NCT03398148|451349705|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469332|NCT03398148|451349706|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
125469333|NCT03398148|451349692|FG000|Substudy 1 Period 2|Adverse Event|0|||
125469334|NCT03398148|451349693|FG001|Substudy 1 Period 2|Adverse Event|0|||
125469335|NCT03398148|451349694|FG002|Substudy 1 Period 2|Adverse Event|0|||
125469336|NCT03398148|451349695|FG003|Substudy 1 Period 2|Adverse Event|0|||
125469337|NCT03398148|451349696|FG004|Substudy 1 Period 2|Adverse Event|0|||
125469338|NCT03398148|451349697|FG005|Substudy 1 Period 2|Adverse Event|2|||
125469339|NCT03398148|451349698|FG006|Substudy 1 Period 2|Adverse Event|4|||
125469340|NCT03398148|451349699|FG007|Substudy 1 Period 2|Adverse Event|0|||
125469341|NCT03398148|451349700|FG008|Substudy 1 Period 2|Adverse Event|0|||
125469342|NCT03398148|451349701|FG009|Substudy 1 Period 2|Adverse Event|0|||
125469343|NCT03398148|451349702|FG010|Substudy 1 Period 2|Adverse Event|0|||
125469344|NCT03398148|451349703|FG011|Substudy 1 Period 2|Adverse Event|0|||
125469345|NCT03398148|451349704|FG012|Substudy 1 Period 2|Adverse Event|0|||
125469346|NCT03398148|451349705|FG013|Substudy 1 Period 2|Adverse Event|0|||
125469347|NCT03398148|451349706|FG014|Substudy 1 Period 2|Adverse Event|0|||
125469348|NCT03398148|451349692|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125469349|NCT03398148|451349693|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125469350|NCT03398148|451349694|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125469351|NCT03398148|451349695|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125469352|NCT03398148|451349696|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125469353|NCT03398148|451349697|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125469354|NCT03398148|451349698|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
125469355|NCT03398148|451349699|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
125469356|NCT03398148|451349700|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125469357|NCT03398148|451349701|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125469358|NCT03398148|451349702|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125469359|NCT03398148|451349703|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125469360|NCT03398148|451349704|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125469361|NCT03398148|451349705|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125469362|NCT03398148|451349706|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
125469363|NCT03398148|451349692|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
125469364|NCT03398148|451349693|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
125469365|NCT03398148|451349694|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
125469366|NCT03398148|451349695|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
125469367|NCT03398148|451349696|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
125469368|NCT03398148|451349697|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
125469369|NCT03398148|451349698|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
125469370|NCT03398148|451349699|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
125469371|NCT03398148|451349700|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
125469372|NCT03398148|451349701|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
125469373|NCT03398148|451349702|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
125469374|NCT03398148|451349703|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
125469375|NCT03398148|451349704|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
125469376|NCT03398148|451349705|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
125469377|NCT03398148|451349706|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
125469378|NCT03398148|451349692|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469379|NCT03398148|451349693|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469380|NCT03398148|451349694|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469381|NCT03398148|451349695|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469382|NCT03398148|451349696|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469383|NCT03398148|451349697|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469384|NCT03398148|451349698|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
125469385|NCT03398148|451349699|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469386|NCT03398148|451349700|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469387|NCT03398148|451349701|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469388|NCT03398148|451349702|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469389|NCT03398148|451349703|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469390|NCT03398148|451349704|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469391|NCT03398148|451349705|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469392|NCT03398148|451349706|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469393|NCT03398148|451349692|FG000|Substudy 1 Period 2|Other|0|||
125469394|NCT03398148|451349693|FG001|Substudy 1 Period 2|Other|0|||
125469395|NCT03398148|451349694|FG002|Substudy 1 Period 2|Other|0|||
125469396|NCT03398148|451349695|FG003|Substudy 1 Period 2|Other|0|||
125469397|NCT03398148|451349696|FG004|Substudy 1 Period 2|Other|0|||
125469398|NCT03398148|451349697|FG005|Substudy 1 Period 2|Other|0|||
125469399|NCT03398148|451349698|FG006|Substudy 1 Period 2|Other|1|||
125469400|NCT03398148|451349699|FG007|Substudy 1 Period 2|Other|0|||
125469401|NCT03398148|451349700|FG008|Substudy 1 Period 2|Other|0|||
125469402|NCT03398148|451349701|FG009|Substudy 1 Period 2|Other|0|||
125469403|NCT03398148|451349702|FG010|Substudy 1 Period 2|Other|0|||
125469404|NCT03398148|451349703|FG011|Substudy 1 Period 2|Other|0|||
125469405|NCT03398148|451349704|FG012|Substudy 1 Period 2|Other|0|||
125469406|NCT03398148|451349705|FG013|Substudy 1 Period 2|Other|0|||
125469407|NCT03398148|451349706|FG014|Substudy 1 Period 2|Other|0|||
125469408|NCT03398148|451349692|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469409|NCT03398148|451349693|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469410|NCT03398148|451349694|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469411|NCT03398148|451349695|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469412|NCT03398148|451349696|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469413|NCT03398148|451349697|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469414|NCT03398148|451349698|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
125469415|NCT03398148|451349699|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469416|NCT03398148|451349700|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469417|NCT03398148|451349701|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469418|NCT03398148|451349702|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469419|NCT03398148|451349703|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469420|NCT03398148|451349704|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469421|NCT03398148|451349705|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469422|NCT03398148|451349706|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
125469423|NCT03398148|451349692|FG000|Substudy 2 Period 1|Adverse Event|0|||
125469424|NCT03398148|451349693|FG001|Substudy 2 Period 1|Adverse Event|0|||
125469425|NCT03398148|451349694|FG002|Substudy 2 Period 1|Adverse Event|0|||
125469426|NCT03398148|451349695|FG003|Substudy 2 Period 1|Adverse Event|0|||
125469427|NCT03398148|451349696|FG004|Substudy 2 Period 1|Adverse Event|0|||
125469428|NCT03398148|451349697|FG005|Substudy 2 Period 1|Adverse Event|0|||
125469429|NCT03398148|451349698|FG006|Substudy 2 Period 1|Adverse Event|0|||
125469430|NCT03398148|451349699|FG007|Substudy 2 Period 1|Adverse Event|0|||
125469431|NCT03398148|451349700|FG008|Substudy 2 Period 1|Adverse Event|0|||
125469432|NCT03398148|451349701|FG009|Substudy 2 Period 1|Adverse Event|12|||
125469433|NCT03398148|451349702|FG010|Substudy 2 Period 1|Adverse Event|2|||
125469434|NCT03398148|451349703|FG011|Substudy 2 Period 1|Adverse Event|0|||
125469435|NCT03398148|451349704|FG012|Substudy 2 Period 1|Adverse Event|0|||
125469436|NCT03398148|451349705|FG013|Substudy 2 Period 1|Adverse Event|0|||
125469437|NCT03398148|451349706|FG014|Substudy 2 Period 1|Adverse Event|0|||
125469438|NCT03398148|451349692|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
125469439|NCT03398148|451349693|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
125469440|NCT03398148|451349694|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
125469441|NCT03398148|451349695|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
125469442|NCT03398148|451349696|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
125469443|NCT03398148|451349697|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
125469444|NCT03398148|451349698|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
125469445|NCT03398148|451349699|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
125469446|NCT03398148|451349700|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
125469447|NCT03398148|451349701|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
125469448|NCT03398148|451349702|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
125469449|NCT03398148|451349703|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
125469450|NCT03398148|451349704|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
125299791|NCT03517566|450723754|FG003|Overall Study|Pregnancy|0|||
125469451|NCT03398148|451349705|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
125299792|NCT03517566|450723755|FG004|Overall Study|Pregnancy|0|||
125299793|NCT03517566|450723751|FG000|Overall Study|Protocol Deviation|0|||
125469452|NCT03398148|451349706|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
125469453|NCT03398148|451349692|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
125469454|NCT03398148|451349693|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
125469455|NCT03398148|451349694|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
125469456|NCT03398148|451349695|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
125469457|NCT03398148|451349696|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
125469458|NCT03398148|451349697|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
125469459|NCT03398148|451349698|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
125469460|NCT03398148|451349699|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
125469461|NCT03398148|451349700|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
125469462|NCT03398148|451349701|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
125469463|NCT03398148|451349702|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
125299794|NCT03517566|450723752|FG001|Overall Study|Protocol Deviation|1|||
125469464|NCT03398148|451349703|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
125469465|NCT03398148|451349704|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
125469466|NCT03398148|451349705|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
125469467|NCT03398148|451349706|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
125469468|NCT03398148|451349692|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469469|NCT03398148|451349693|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469470|NCT03398148|451349694|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469471|NCT03398148|451349695|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469472|NCT03398148|451349696|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469473|NCT03398148|451349697|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469474|NCT03398148|451349698|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469475|NCT03398148|451349699|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469476|NCT03398148|451349700|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469477|NCT03398148|451349701|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469478|NCT03398148|451349702|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
125469479|NCT03398148|451349703|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469480|NCT03398148|451349704|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469481|NCT03398148|451349705|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469482|NCT03398148|451349706|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
125469483|NCT03398148|451349692|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469484|NCT03398148|451349693|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469485|NCT03398148|451349694|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469486|NCT03398148|451349695|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469487|NCT03398148|451349696|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469488|NCT03398148|451349697|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469489|NCT03398148|451349698|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469490|NCT03398148|451349699|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469491|NCT03398148|451349700|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469492|NCT03398148|451349701|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469493|NCT03398148|451349702|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
125469494|NCT03398148|451349703|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469495|NCT03398148|451349704|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469496|NCT03398148|451349705|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469497|NCT03398148|451349706|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
125469498|NCT03398148|451349692|FG000|Substudy 2 Period 1|Other|0|||
125469499|NCT03398148|451349693|FG001|Substudy 2 Period 1|Other|0|||
125469500|NCT03398148|451349694|FG002|Substudy 2 Period 1|Other|0|||
125469501|NCT03398148|451349695|FG003|Substudy 2 Period 1|Other|0|||
125469502|NCT03398148|451349696|FG004|Substudy 2 Period 1|Other|0|||
125469503|NCT03398148|451349697|FG005|Substudy 2 Period 1|Other|0|||
125469504|NCT03398148|451349698|FG006|Substudy 2 Period 1|Other|0|||
125469505|NCT03398148|451349699|FG007|Substudy 2 Period 1|Other|0|||
125469506|NCT03398148|451349700|FG008|Substudy 2 Period 1|Other|0|||
125469507|NCT03398148|451349701|FG009|Substudy 2 Period 1|Other|4|||
125469508|NCT03398148|451349702|FG010|Substudy 2 Period 1|Other|4|||
125469509|NCT03398148|451349703|FG011|Substudy 2 Period 1|Other|0|||
125469510|NCT03398148|451349704|FG012|Substudy 2 Period 1|Other|0|||
125469511|NCT03398148|451349705|FG013|Substudy 2 Period 1|Other|0|||
125469512|NCT03398148|451349706|FG014|Substudy 2 Period 1|Other|0|||
125469513|NCT03398148|451349692|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469514|NCT03398148|451349693|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469515|NCT03398148|451349694|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469516|NCT03398148|451349695|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469517|NCT03398148|451349696|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469518|NCT03398148|451349697|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469519|NCT03398148|451349698|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469520|NCT03398148|451349699|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469521|NCT03398148|451349700|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469522|NCT03398148|451349701|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469523|NCT03398148|451349702|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
125469524|NCT03398148|451349703|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469525|NCT03398148|451349704|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469526|NCT03398148|451349705|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469527|NCT03398148|451349706|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
125469528|NCT03398148|451349692|FG000|Substudy 2 Period 2|Adverse Event|0|||
125469529|NCT03398148|451349693|FG001|Substudy 2 Period 2|Adverse Event|0|||
125469530|NCT03398148|451349694|FG002|Substudy 2 Period 2|Adverse Event|0|||
125469531|NCT03398148|451349695|FG003|Substudy 2 Period 2|Adverse Event|0|||
125469532|NCT03398148|451349696|FG004|Substudy 2 Period 2|Adverse Event|0|||
125469533|NCT03398148|451349697|FG005|Substudy 2 Period 2|Adverse Event|0|||
125469534|NCT03398148|451349698|FG006|Substudy 2 Period 2|Adverse Event|0|||
125469535|NCT03398148|451349699|FG007|Substudy 2 Period 2|Adverse Event|0|||
125469536|NCT03398148|451349700|FG008|Substudy 2 Period 2|Adverse Event|0|||
125469537|NCT03398148|451349701|FG009|Substudy 2 Period 2|Adverse Event|0|||
125469538|NCT03398148|451349702|FG010|Substudy 2 Period 2|Adverse Event|0|||
125469539|NCT03398148|451349703|FG011|Substudy 2 Period 2|Adverse Event|0|||
125469540|NCT03398148|451349704|FG012|Substudy 2 Period 2|Adverse Event|0|||
125469541|NCT03398148|451349705|FG013|Substudy 2 Period 2|Adverse Event|1|||
125469542|NCT03398148|451349706|FG014|Substudy 2 Period 2|Adverse Event|3|||
125469543|NCT03398148|451349692|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
125469544|NCT03398148|451349693|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
125469545|NCT03398148|451349694|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
125469546|NCT03398148|451349695|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
125469547|NCT03398148|451349696|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
125469548|NCT03398148|451349697|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
125469549|NCT03398148|451349698|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
125469550|NCT03398148|451349699|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
125469551|NCT03398148|451349700|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
125469552|NCT03398148|451349701|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
125469553|NCT03398148|451349702|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
125469554|NCT03398148|451349703|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
125469555|NCT03398148|451349704|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
125469556|NCT03398148|451349705|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
125469557|NCT03398148|451349706|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
125469558|NCT03398148|451349692|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
125469559|NCT03398148|451349693|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
125469560|NCT03398148|451349694|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
125469561|NCT03398148|451349695|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
125469562|NCT03398148|451349696|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
125469563|NCT03398148|451349697|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
125469564|NCT03398148|451349698|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
125469565|NCT03398148|451349699|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
125469566|NCT03398148|451349700|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
125469567|NCT03398148|451349701|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
125469568|NCT03398148|451349702|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
125469569|NCT03398148|451349703|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
125469570|NCT03398148|451349704|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
125469571|NCT03398148|451349705|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
125469572|NCT03398148|451349706|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
125469573|NCT03398148|451349692|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
125469574|NCT03398148|451349693|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
125469575|NCT03398148|451349694|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
125469576|NCT03398148|451349695|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
125469577|NCT03398148|451349696|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
125469578|NCT03398148|451349697|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
125469579|NCT03398148|451349698|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
125469580|NCT03398148|451349699|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
125469581|NCT03398148|451349700|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
125469582|NCT03398148|451349701|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
125469583|NCT03398148|451349702|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
125469584|NCT03398148|451349703|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
125469585|NCT03398148|451349704|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
125469586|NCT03398148|451349705|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
125469587|NCT03398148|451349706|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
125469588|NCT03398148|451349692|FG000|Substudy 2 Period 2|Other|0|||
125469589|NCT03398148|451349693|FG001|Substudy 2 Period 2|Other|0|||
125469590|NCT03398148|451349694|FG002|Substudy 2 Period 2|Other|0|||
125469591|NCT03398148|451349695|FG003|Substudy 2 Period 2|Other|0|||
125469592|NCT03398148|451349696|FG004|Substudy 2 Period 2|Other|0|||
125469593|NCT03398148|451349697|FG005|Substudy 2 Period 2|Other|0|||
125469594|NCT03398148|451349698|FG006|Substudy 2 Period 2|Other|0|||
125469595|NCT03398148|451349699|FG007|Substudy 2 Period 2|Other|0|||
125469596|NCT03398148|451349700|FG008|Substudy 2 Period 2|Other|0|||
125469597|NCT03398148|451349701|FG009|Substudy 2 Period 2|Other|0|||
125469598|NCT03398148|451349702|FG010|Substudy 2 Period 2|Other|0|||
125469599|NCT03398148|451349703|FG011|Substudy 2 Period 2|Other|0|||
125469600|NCT03398148|451349704|FG012|Substudy 2 Period 2|Other|0|||
125469601|NCT03398148|451349705|FG013|Substudy 2 Period 2|Other|1|||
125469602|NCT03398148|451349706|FG014|Substudy 2 Period 2|Other|1|||
125299795|NCT03517566|450723753|FG002|Overall Study|Protocol Deviation|0|||
125469603|NCT03398148|451349692|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
125469604|NCT03398148|451349693|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
125469605|NCT03398148|451349694|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
125469606|NCT03398148|451349695|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
125469607|NCT03398148|451349696|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
125469608|NCT03398148|451349697|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
125469609|NCT03398148|451349698|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
125469610|NCT03398148|451349699|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
125469611|NCT03398148|451349700|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
125469612|NCT03398148|451349701|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
125469613|NCT03398148|451349702|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
125469614|NCT03398148|451349703|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
125469615|NCT03398148|451349704|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
125469616|NCT03398148|451349705|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
125469617|NCT03398148|451349706|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
125469618|NCT02791230|451349707|FG000|Overall Study|Adverse Event|10|||
125469619|NCT02791230|451349708|FG001|Overall Study|Adverse Event|9|||
125469620|NCT02791230|451349709|FG002|Overall Study|Adverse Event|66|||
125469621|NCT02791230|451349707|FG000|Overall Study|Death|38|||
125469622|NCT02791230|451349708|FG001|Overall Study|Death|25|||
125469623|NCT02791230|451349709|FG002|Overall Study|Death|184|||
125469624|NCT02791230|451349707|FG000|Overall Study|Lack of Efficacy|1|||
125469625|NCT02791230|451349708|FG001|Overall Study|Lack of Efficacy|0|||
125469626|NCT02791230|451349709|FG002|Overall Study|Lack of Efficacy|3|||
125469627|NCT02791230|451349707|FG000|Overall Study|Lost to Follow-up|0|||
125469628|NCT02791230|451349708|FG001|Overall Study|Lost to Follow-up|0|||
125469629|NCT02791230|451349709|FG002|Overall Study|Lost to Follow-up|10|||
125469630|NCT02791230|451349707|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
125469631|NCT02791230|451349708|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
125469632|NCT02791230|451349709|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
125469633|NCT02791230|451349707|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
125469634|NCT02791230|451349708|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
125469635|NCT02791230|451349709|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
125469636|NCT02791230|451349707|FG000|Overall Study|Study sites terminated by sponsor|1|||
125469637|NCT02791230|451349708|FG001|Overall Study|Study sites terminated by sponsor|0|||
125469638|NCT02791230|451349709|FG002|Overall Study|Study sites terminated by sponsor|5|||
125469639|NCT02791230|451349707|FG000|Overall Study|Other|9|||
125469640|NCT02791230|451349708|FG001|Overall Study|Other|1|||
125469641|NCT02791230|451349709|FG002|Overall Study|Other|28|||
125469642|NCT02791230|451349707|FG000|Overall Study|Protocol Violation|0|||
125469643|NCT02791230|451349708|FG001|Overall Study|Protocol Violation|0|||
125469644|NCT02791230|451349709|FG002|Overall Study|Protocol Violation|4|||
125469645|NCT02791230|451349707|FG000|Overall Study|Withdrawal by Subject|24|||
125469646|NCT02791230|451349708|FG001|Overall Study|Withdrawal by Subject|13|||
125469647|NCT02791230|451349709|FG002|Overall Study|Withdrawal by Subject|172|||
125469648|NCT02791230|451349707|FG000|Overall Study|Enrolled but not treated|0|||
125469649|NCT02791230|451349708|FG001|Overall Study|Enrolled but not treated|0|||
125469650|NCT02791230|451349709|FG002|Overall Study|Enrolled but not treated|5|||
125469651|NCT01259401|451349710|FG000|4-month Follow-up|Death|0|||
125469652|NCT01259401|451349711|FG001|4-month Follow-up|Death|1|||
125469653|NCT01259401|451349710|FG000|4-month Follow-up|Lost to Follow-up|0|||
125469654|NCT01259401|451349711|FG001|4-month Follow-up|Lost to Follow-up|1|||
125469655|NCT04201834|451349719|FG000|Overall Study|Screen fail|1|||
125469656|NCT00212355|451349720|FG000|Overall Study|Adverse Event|1|||
125469657|NCT00212355|451349720|FG000|Overall Study|Withdrawal by Subject|1|||
125469658|NCT00212355|451349720|FG000|Overall Study|A change of address|1|||
125469659|NCT04310735|451349726|FG000|Overall Study|Withdrawal by Subject|1|||
125469660|NCT04310735|451349727|FG001|Overall Study|Withdrawal by Subject|3|||
125469661|NCT04310735|451349728|FG002|Overall Study|Withdrawal by Subject|8|||
125469662|NCT04310735|451349726|FG000|Overall Study|Equipment malfunction|0|||
125469663|NCT04310735|451349727|FG001|Overall Study|Equipment malfunction|1|||
125469664|NCT04310735|451349728|FG002|Overall Study|Equipment malfunction|0|||
125469665|NCT04104321|451349729|FG000|Overall Study|didn't take the study drug|3|||
125469666|NCT03954184|451349732|FG000|Overall Study|Lost to Follow-up|500|||
125469667|NCT03954184|451349733|FG001|Overall Study|Lost to Follow-up|0|||
125469668|NCT03398200|451349734|FG000|Overall Study|Withdrawal by Subject|0|||
125469669|NCT03398200|451349735|FG001|Overall Study|Withdrawal by Subject|1|||
125469670|NCT01649271|451349736|FG000|Overall Study|Progressive disease|4|||
125469671|NCT01649271|451349737|FG001|Overall Study|Progressive disease|5|||
125469672|NCT01649271|451349736|FG000|Overall Study|Other Adverse Event|0|||
125469673|NCT01649271|451349737|FG001|Overall Study|Other Adverse Event|2|||
125469674|NCT01649271|451349736|FG000|Overall Study|Withdrawal by Subject|1|||
125469675|NCT01649271|451349737|FG001|Overall Study|Withdrawal by Subject|0|||
125469676|NCT01649271|451349736|FG000|Overall Study|Other than stated above|1|||
125469677|NCT01649271|451349737|FG001|Overall Study|Other than stated above|0|||
125469678|NCT05756075|451349740|FG000|Overall Study|Withdrawal by Subject|16|||
125469679|NCT05756075|451349741|FG001|Overall Study|Withdrawal by Subject|9|||
125469680|NCT02652260|451349742|FG000|Base Study|Pregnancy|0|||
125469681|NCT02652260|451349743|FG001|Base Study|Pregnancy|1|||
125469682|NCT02652260|451349742|FG000|Base Study|Withdrawal by Subject|0|||
125469683|NCT02652260|451349743|FG001|Base Study|Withdrawal by Subject|1|||
125469684|NCT02652260|451349742|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
125469685|NCT02652260|451349743|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
125469686|NCT02652260|451349742|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
125469687|NCT02652260|451349743|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
125469688|NCT02652260|451349742|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
125469689|NCT02652260|451349743|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
125469690|NCT02652260|451349742|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
125469691|NCT02652260|451349743|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
125469692|NCT02652260|451349742|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
125469693|NCT02652260|451349743|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
125469694|NCT02652260|451349742|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
125469695|NCT02652260|451349743|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
125469696|NCT02652260|451349742|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
125469697|NCT02652260|451349743|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
125469698|NCT02652260|451349742|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
125469699|NCT02652260|451349743|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
125469700|NCT02652260|451349742|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
125469701|NCT02652260|451349743|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
125469702|NCT02652260|451349742|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
125469703|NCT02652260|451349743|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
125469704|NCT02652260|451349742|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
125469705|NCT02652260|451349743|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
125469706|NCT02652260|451349742|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
125469707|NCT02652260|451349743|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
125469708|NCT03899961|451349744|FG000|Overall Study|-delivery prior to|2|||
125469709|NCT03899961|451349745|FG001|Overall Study|-delivery prior to|7|||
125469710|NCT03899961|451349744|FG000|Overall Study|req general anesth|1|||
125469711|NCT03899961|451349745|FG001|Overall Study|req general anesth|2|||
125469712|NCT03899961|451349744|FG000|Overall Study|capacity|5|||
125469713|NCT03899961|451349745|FG001|Overall Study|capacity|6|||
125469714|NCT03899961|451349744|FG000|Overall Study|Withdrawal by Subject|1|||
125469715|NCT03899961|451349745|FG001|Overall Study|Withdrawal by Subject|1|||
125469716|NCT02837510|451349746|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
125469717|NCT02837510|451349747|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
125469718|NCT02837510|451349746|FG000|Washout (2 Weeks)|Adverse Event|0|||
125469719|NCT02837510|451349747|FG001|Washout (2 Weeks)|Adverse Event|1|||
125469720|NCT02837510|451349746|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
125469721|NCT02837510|451349747|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
125469722|NCT02837510|451349746|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
125469723|NCT02837510|451349747|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
125469724|NCT02837510|451349746|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
125469725|NCT02837510|451349747|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
125469726|NCT02837510|451349746|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
125469727|NCT02837510|451349747|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
125469728|NCT04440176|451349752|FG000|Overall Study|Withdrawal by Subject|5|||
125469729|NCT04440176|451349753|FG001|Overall Study|Withdrawal by Subject|3|||
125469730|NCT04440176|451349752|FG000|Overall Study|Withdrawal by parent/guardian|4|||
125469731|NCT04440176|451349753|FG001|Overall Study|Withdrawal by parent/guardian|5|||
125469732|NCT04440176|451349752|FG000|Overall Study|Adverse Event|2|||
125469733|NCT04440176|451349753|FG001|Overall Study|Adverse Event|6|||
125469734|NCT04440176|451349752|FG000|Overall Study|Lost to Follow-up|22|||
125469735|NCT04440176|451349753|FG001|Overall Study|Lost to Follow-up|23|||
125469736|NCT04440176|451349752|FG000|Overall Study|Medication error without associated adverse event|0|||
125469737|NCT04440176|451349753|FG001|Overall Study|Medication error without associated adverse event|1|||
125469738|NCT04440176|451349752|FG000|Overall Study|No longer met eligibility criteria|7|||
125469739|NCT04440176|451349753|FG001|Overall Study|No longer met eligibility criteria|1|||
125469740|NCT04440176|451349752|FG000|Overall Study|Other|1|||
125469741|NCT04440176|451349753|FG001|Overall Study|Other|2|||
125469742|NCT04440176|451349752|FG000|Overall Study|Protocol deviation|6|||
125469743|NCT04440176|451349753|FG001|Overall Study|Protocol deviation|8|||
125469744|NCT04440176|451349752|FG000|Overall Study|Randomized but not vaccinated|6|||
125469745|NCT04440176|451349753|FG001|Overall Study|Randomized but not vaccinated|3|||
125469746|NCT04608045|451349754|FG000|Overall Study|Physician Decision|1|||
125469747|NCT03517553|451349755|FG000|Overall Study|Withdrawal by Subject|2|||
125469748|NCT03271151|451349756|FG000|Overall Study|Lost to Follow-up|1|||
125469749|NCT03271151|451349757|FG001|Overall Study|Lost to Follow-up|3|||
125299796|NCT03517566|450723754|FG003|Overall Study|Protocol Deviation|1|||
125299797|NCT03517566|450723755|FG004|Overall Study|Protocol Deviation|1|||
125299798|NCT03517566|450723751|FG000|Overall Study|Study terminated by Sponsor|11|||
125299799|NCT03517566|450723752|FG001|Overall Study|Study terminated by Sponsor|5|||
125299800|NCT03517566|450723753|FG002|Overall Study|Study terminated by Sponsor|6|||
125299801|NCT03517566|450723754|FG003|Overall Study|Study terminated by Sponsor|14|||
125299802|NCT03517566|450723755|FG004|Overall Study|Study terminated by Sponsor|12|||
125469750|NCT03271151|451349756|FG000|Overall Study|Withdrawal by Subject|1|||
125469751|NCT03271151|451349757|FG001|Overall Study|Withdrawal by Subject|0|||
125469752|NCT03575052|451349758|FG000|Overall Study|Adverse Event|6|||
125469753|NCT03575052|451349759|FG001|Overall Study|Adverse Event|10|||
125469754|NCT03575052|451349758|FG000|Overall Study|Not further specified|5|||
125469755|NCT03575052|451349759|FG001|Overall Study|Not further specified|7|||
125469756|NCT03575052|451349758|FG000|Overall Study|Withdrawal by Subject|5|||
125469757|NCT03575052|451349759|FG001|Overall Study|Withdrawal by Subject|6|||
125469758|NCT03575052|451349758|FG000|Overall Study|Lost to Follow-up|3|||
125469759|NCT03575052|451349759|FG001|Overall Study|Lost to Follow-up|0|||
125469760|NCT03575052|451349758|FG000|Overall Study|Death|2|||
125469761|NCT03575052|451349759|FG001|Overall Study|Death|1|||
125469762|NCT03575052|451349758|FG000|Overall Study|Lack of Efficacy|2|||
125469763|NCT03575052|451349759|FG001|Overall Study|Lack of Efficacy|1|||
125469764|NCT03575052|451349758|FG000|Overall Study|Study drug noncompliance|1|||
125469765|NCT03575052|451349759|FG001|Overall Study|Study drug noncompliance|2|||
125469766|NCT03575052|451349758|FG000|Overall Study|Protocol Violation|0|||
125469767|NCT03575052|451349759|FG001|Overall Study|Protocol Violation|2|||
125469768|NCT03575052|451349758|FG000|Overall Study|Physician Decision|1|||
125469769|NCT03575052|451349759|FG001|Overall Study|Physician Decision|0|||
125469770|NCT03103321|451349760|FG000|Overall Study|Protocol Violation|1|||
125469771|NCT03103321|451349761|FG001|Overall Study|Protocol Violation|1|||
125469772|NCT03103321|451349762|FG002|Overall Study|Protocol Violation|1|||
125469773|NCT03103321|451349763|FG003|Overall Study|Protocol Violation|0|||
125469774|NCT04247542|451349764|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
125469775|NCT04247542|451349765|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
125469776|NCT04247542|451349766|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
125469777|NCT04247542|451349764|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
125469778|NCT04247542|451349765|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
125469779|NCT04247542|451349766|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
125469780|NCT04118452|451349767|FG000|Overall Study|Lost to Follow-up|5|||
125469781|NCT04118452|451349768|FG001|Overall Study|Lost to Follow-up|5|||
125469782|NCT04118452|451349767|FG000|Overall Study|Withdrawal by Subject|17|||
125469783|NCT04118452|451349768|FG001|Overall Study|Withdrawal by Subject|17|||
125469784|NCT05086744|451349769|FG000|Part A|Adverse Event|0|||
125469785|NCT05086744|451349770|FG001|Part A|Adverse Event|1|||
125469786|NCT05086744|451349769|FG000|Part A|Lack of Efficacy|3|||
125469787|NCT05086744|451349770|FG001|Part A|Lack of Efficacy|0|||
125469788|NCT05086744|451349769|FG000|Part A|Protocol deviation|1|||
125469789|NCT05086744|451349770|FG001|Part A|Protocol deviation|0|||
125469790|NCT05086744|451349769|FG000|Part A|Subject decision|1|||
125469791|NCT05086744|451349770|FG001|Part A|Subject decision|0|||
125299803|NCT03517566|450723751|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
125299804|NCT03517566|450723752|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
125299805|NCT03517566|450723753|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
125299806|NCT03517566|450723754|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
125299807|NCT03517566|450723755|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
125299808|NCT03927404|450723758|FG000|Overall Study|Withdrawal by Subject|1|||
125299809|NCT04311463|450723759|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
125299810|NCT04311463|450723760|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
125299811|NCT04311463|450723759|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
125469792|NCT05086744|451349769|FG000|Part B|Adverse Event|0|||
125469793|NCT05086744|451349770|FG001|Part B|Adverse Event|1|||
125469794|NCT05086744|451349769|FG000|Part B|Lack of Efficacy|0|||
125469795|NCT05086744|451349770|FG001|Part B|Lack of Efficacy|1|||
125469796|NCT05086744|451349769|FG000|Part B|Study terminated by sponsor|1|||
125469797|NCT05086744|451349770|FG001|Part B|Study terminated by sponsor|6|||
125469798|NCT04300231|451349771|FG000|Overall Study|Protocol Violation|4|||
125469799|NCT04300231|451349772|FG001|Overall Study|Protocol Violation|3|||
125469800|NCT04300231|451349773|FG002|Overall Study|Protocol Violation|0|||
125469801|NCT04300231|451349774|FG003|Overall Study|Protocol Violation|2|||
125469802|NCT05986565|451349780|FG000|Overall Study|Lost to Follow-up|8|||
125469803|NCT05986565|451349781|FG001|Overall Study|Lost to Follow-up|3|||
125299812|NCT04311463|450723760|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
125299813|NCT04311463|450723759|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
125299814|NCT04311463|450723760|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
125469804|NCT05986565|451349780|FG000|Overall Study|Withdrawal by Subject|0|||
125469805|NCT05986565|451349781|FG001|Overall Study|Withdrawal by Subject|1|||
125469806|NCT02058108|451349787|FG000|Overall Study|Abnormal Laboratory Values|0|||
125469807|NCT02058108|451349788|FG001|Overall Study|Abnormal Laboratory Values|1|||
125469808|NCT02058108|451349787|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
125469809|NCT02058108|451349788|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
125469810|NCT02058108|451349787|FG000|Overall Study|No longer requires study drug|0|||
125469811|NCT02058108|451349788|FG001|Overall Study|No longer requires study drug|1|||
125469812|NCT02058108|451349787|FG000|Overall Study|Withdrawal by Subject|1|||
125469813|NCT02058108|451349788|FG001|Overall Study|Withdrawal by Subject|0|||
125469814|NCT02058108|451349787|FG000|Overall Study|Administrative problems|3|||
125469815|NCT02058108|451349788|FG001|Overall Study|Administrative problems|3|||
125469816|NCT02058108|451349787|FG000|Overall Study|Protocol Violation|0|||
125469817|NCT02058108|451349788|FG001|Overall Study|Protocol Violation|1|||
125469818|NCT01121991|451349789|FG000|Overall Study|Lack of Ovarian Response|2|||
125469819|NCT01121991|451349789|FG000|Overall Study|No Oocytes Retrieved|3|||
125469820|NCT01121991|451349789|FG000|Overall Study|No Fertilization|1|||
125469821|NCT05171777|451349801|FG000|Treatment Crossover Period|Adverse Event|9|||
125469822|NCT05171777|451349802|FG001|Treatment Crossover Period|Adverse Event|6|||
125469823|NCT05171777|451349803|FG002|Treatment Crossover Period|Adverse Event|0|||
125469824|NCT05171777|451349804|FG003|Treatment Crossover Period|Adverse Event|0|||
125469825|NCT05171777|451349801|FG000|Treatment Crossover Period|Death|5|||
125469826|NCT05171777|451349802|FG001|Treatment Crossover Period|Death|5|||
125469827|NCT05171777|451349803|FG002|Treatment Crossover Period|Death|0|||
125469828|NCT05171777|451349804|FG003|Treatment Crossover Period|Death|0|||
125469829|NCT05171777|451349801|FG000|Treatment Crossover Period|Disease Relapse|0|||
125469830|NCT05171777|451349802|FG001|Treatment Crossover Period|Disease Relapse|1|||
125469831|NCT05171777|451349803|FG002|Treatment Crossover Period|Disease Relapse|0|||
125469832|NCT05171777|451349804|FG003|Treatment Crossover Period|Disease Relapse|0|||
125469833|NCT05171777|451349801|FG000|Treatment Crossover Period|Reason not Specified|2|||
125469834|NCT05171777|451349802|FG001|Treatment Crossover Period|Reason not Specified|1|||
125469835|NCT05171777|451349803|FG002|Treatment Crossover Period|Reason not Specified|0|||
125469836|NCT05171777|451349804|FG003|Treatment Crossover Period|Reason not Specified|0|||
125469837|NCT05171777|451349801|FG000|Treatment Crossover Period|Physician Decision|0|||
125469838|NCT05171777|451349802|FG001|Treatment Crossover Period|Physician Decision|1|||
125469839|NCT05171777|451349803|FG002|Treatment Crossover Period|Physician Decision|0|||
125469840|NCT05171777|451349804|FG003|Treatment Crossover Period|Physician Decision|0|||
125469841|NCT05171777|451349801|FG000|Treatment Crossover Period|Progressive Disease|13|||
125469842|NCT05171777|451349802|FG001|Treatment Crossover Period|Progressive Disease|9|||
125469843|NCT05171777|451349803|FG002|Treatment Crossover Period|Progressive Disease|0|||
125469844|NCT05171777|451349804|FG003|Treatment Crossover Period|Progressive Disease|0|||
125469845|NCT05171777|451349801|FG000|Treatment Crossover Period|Protocol Violation|0|||
125469846|NCT05171777|451349802|FG001|Treatment Crossover Period|Protocol Violation|2|||
125469847|NCT05171777|451349803|FG002|Treatment Crossover Period|Protocol Violation|0|||
125469848|NCT05171777|451349804|FG003|Treatment Crossover Period|Protocol Violation|0|||
125469849|NCT05171777|451349801|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
125469850|NCT05171777|451349802|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
125469851|NCT05171777|451349803|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
125469852|NCT05171777|451349804|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
125469853|NCT05171777|451349801|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
125469854|NCT05171777|451349802|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
125469855|NCT05171777|451349803|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
125469856|NCT05171777|451349804|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
125469857|NCT05171777|451349801|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
125469858|NCT05171777|451349802|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
125469859|NCT05171777|451349803|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
125469860|NCT05171777|451349804|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
125469861|NCT05171777|451349801|FG000|Treatment Continuation Period|Death|0|||
125469862|NCT05171777|451349802|FG001|Treatment Continuation Period|Death|0|||
125469863|NCT05171777|451349803|FG002|Treatment Continuation Period|Death|1|||
125469864|NCT05171777|451349804|FG003|Treatment Continuation Period|Death|6|||
125469865|NCT05171777|451349801|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
125469866|NCT05171777|451349802|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
125469867|NCT05171777|451349803|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
125469868|NCT05171777|451349804|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
125469869|NCT02538341|451349805|FG000|Overall Study|Lost to Follow-up|51|||
125469870|NCT02538341|451349806|FG001|Overall Study|Lost to Follow-up|46|||
125469871|NCT02538341|451349805|FG000|Overall Study|Withdrawal by Subject|3|||
125469872|NCT02538341|451349806|FG001|Overall Study|Withdrawal by Subject|1|||
125469873|NCT02538341|451349805|FG000|Overall Study|Death|2|||
125469874|NCT02538341|451349806|FG001|Overall Study|Death|0|||
125469875|NCT00632749|451349807|FG000|Overall Study|Progressive disease|3|||
125469876|NCT00632749|451349808|FG001|Overall Study|Progressive disease|2|||
125469877|NCT00632749|451349809|FG002|Overall Study|Progressive disease|2|||
125469878|NCT00632749|451349810|FG003|Overall Study|Progressive disease|2|||
125469879|NCT00632749|451349811|FG004|Overall Study|Progressive disease|4|||
125299815|NCT00737633|450723766|FG000|Overall Study|Study terminated by sponsor|44|||
125299816|NCT00737633|450723767|FG001|Overall Study|Study terminated by sponsor|55|||
125299817|NCT00737633|450723766|FG000|Overall Study|Lost to Follow-up|0|||
125469880|NCT00632749|451349812|FG005|Overall Study|Progressive disease|4|||
125469881|NCT00632749|451349813|FG006|Overall Study|Progressive disease|3|||
125469882|NCT00632749|451349814|FG007|Overall Study|Progressive disease|2|||
125469883|NCT00632749|451349815|FG008|Overall Study|Progressive disease|3|||
125469884|NCT00632749|451349816|FG009|Overall Study|Progressive disease|2|||
125469885|NCT00632749|451349817|FG010|Overall Study|Progressive disease|4|||
125469886|NCT00632749|451349818|FG011|Overall Study|Progressive disease|3|||
125469887|NCT00632749|451349819|FG012|Overall Study|Progressive disease|2|||
125469888|NCT00632749|451349820|FG013|Overall Study|Progressive disease|4|||
125469889|NCT00632749|451349807|FG000|Overall Study|Other Adverse event|1|||
125469890|NCT00632749|451349808|FG001|Overall Study|Other Adverse event|1|||
125469891|NCT00632749|451349809|FG002|Overall Study|Other Adverse event|1|||
125469892|NCT00632749|451349810|FG003|Overall Study|Other Adverse event|1|||
125469893|NCT00632749|451349811|FG004|Overall Study|Other Adverse event|2|||
125469894|NCT00632749|451349812|FG005|Overall Study|Other Adverse event|4|||
125469895|NCT00632749|451349813|FG006|Overall Study|Other Adverse event|1|||
125469896|NCT00632749|451349814|FG007|Overall Study|Other Adverse event|2|||
125469897|NCT00632749|451349815|FG008|Overall Study|Other Adverse event|2|||
125469898|NCT00632749|451349816|FG009|Overall Study|Other Adverse event|0|||
125469899|NCT00632749|451349817|FG010|Overall Study|Other Adverse event|1|||
125469900|NCT00632749|451349818|FG011|Overall Study|Other Adverse event|0|||
125469901|NCT00632749|451349819|FG012|Overall Study|Other Adverse event|1|||
125469902|NCT00632749|451349820|FG013|Overall Study|Other Adverse event|0|||
125469903|NCT00632749|451349807|FG000|Overall Study|Refuse to continue medication|0|||
125469904|NCT00632749|451349808|FG001|Overall Study|Refuse to continue medication|0|||
125469905|NCT00632749|451349809|FG002|Overall Study|Refuse to continue medication|0|||
125469906|NCT00632749|451349810|FG003|Overall Study|Refuse to continue medication|1|||
125469907|NCT00632749|451349811|FG004|Overall Study|Refuse to continue medication|0|||
125469908|NCT00632749|451349812|FG005|Overall Study|Refuse to continue medication|0|||
125469909|NCT00632749|451349813|FG006|Overall Study|Refuse to continue medication|0|||
125469910|NCT00632749|451349814|FG007|Overall Study|Refuse to continue medication|0|||
125469911|NCT00632749|451349815|FG008|Overall Study|Refuse to continue medication|0|||
125469912|NCT00632749|451349816|FG009|Overall Study|Refuse to continue medication|1|||
125469913|NCT00632749|451349817|FG010|Overall Study|Refuse to continue medication|0|||
125469914|NCT00632749|451349818|FG011|Overall Study|Refuse to continue medication|0|||
125469915|NCT00632749|451349819|FG012|Overall Study|Refuse to continue medication|0|||
125469916|NCT00632749|451349820|FG013|Overall Study|Refuse to continue medication|0|||
125469917|NCT00632749|451349807|FG000|Overall Study|Reason other than those specified above|0|||
125469918|NCT00632749|451349808|FG001|Overall Study|Reason other than those specified above|2|||
125469919|NCT00632749|451349809|FG002|Overall Study|Reason other than those specified above|0|||
125469920|NCT00632749|451349810|FG003|Overall Study|Reason other than those specified above|0|||
125469921|NCT00632749|451349811|FG004|Overall Study|Reason other than those specified above|1|||
125469922|NCT00632749|451349812|FG005|Overall Study|Reason other than those specified above|0|||
125469923|NCT00632749|451349813|FG006|Overall Study|Reason other than those specified above|1|||
125469924|NCT00632749|451349814|FG007|Overall Study|Reason other than those specified above|0|||
125469925|NCT00632749|451349815|FG008|Overall Study|Reason other than those specified above|0|||
125469926|NCT00632749|451349816|FG009|Overall Study|Reason other than those specified above|0|||
125469927|NCT00632749|451349817|FG010|Overall Study|Reason other than those specified above|2|||
125469928|NCT00632749|451349818|FG011|Overall Study|Reason other than those specified above|1|||
125469929|NCT00632749|451349819|FG012|Overall Study|Reason other than those specified above|0|||
125469930|NCT00632749|451349820|FG013|Overall Study|Reason other than those specified above|2|||
125469931|NCT03988842|451349823|FG000|Overall Study|Death|1|||
125469932|NCT01227265|451349825|FG000|Overall Study|Did Not Receive Treatment|1|||
125469933|NCT01227265|451349826|FG001|Overall Study|Did Not Receive Treatment|2|||
125469934|NCT01227265|451349827|FG002|Overall Study|Did Not Receive Treatment|0|||
125469935|NCT01227265|451349825|FG000|Overall Study|Administrative|1|||
125469936|NCT01227265|451349826|FG001|Overall Study|Administrative|0|||
125469937|NCT01227265|451349827|FG002|Overall Study|Administrative|2|||
125469938|NCT01227265|451349825|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
125469939|NCT01227265|451349826|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
125469940|NCT01227265|451349827|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
125469941|NCT01227265|451349825|FG000|Overall Study|Protocol Violation|2|||
125469942|NCT01227265|451349826|FG001|Overall Study|Protocol Violation|1|||
125469943|NCT01227265|451349827|FG002|Overall Study|Protocol Violation|0|||
125469944|NCT01227265|451349825|FG000|Overall Study|Withdrawal by Subject|7|||
125469945|NCT01227265|451349826|FG001|Overall Study|Withdrawal by Subject|7|||
125469946|NCT01227265|451349827|FG002|Overall Study|Withdrawal by Subject|3|||
125469947|NCT01227265|451349825|FG000|Overall Study|Lost to Follow-up|2|||
125469948|NCT01227265|451349826|FG001|Overall Study|Lost to Follow-up|0|||
125469949|NCT01227265|451349827|FG002|Overall Study|Lost to Follow-up|3|||
125469950|NCT01227265|451349825|FG000|Overall Study|Adverse Event|6|||
125469951|NCT01227265|451349826|FG001|Overall Study|Adverse Event|10|||
125469952|NCT01227265|451349827|FG002|Overall Study|Adverse Event|5|||
125469953|NCT03690206|451349829|FG000|Overall Study|Withdrawal by Subject|2|||
125469954|NCT03690206|451349830|FG001|Overall Study|Withdrawal by Subject|0|||
125469955|NCT03690206|451349831|FG002|Overall Study|Withdrawal by Subject|0|||
125469956|NCT03690206|451349829|FG000|Overall Study|ICF withdrawal|2|||
125469957|NCT03690206|451349830|FG001|Overall Study|ICF withdrawal|0|||
125469958|NCT03690206|451349831|FG002|Overall Study|ICF withdrawal|0|||
125469959|NCT05028582|451349832|FG000|Overall Study|Lost to Follow-up|11|||
125469960|NCT05028582|451349833|FG001|Overall Study|Lost to Follow-up|9|||
125469961|NCT05028582|451349832|FG000|Overall Study|Withdrawal by Subject|9|||
125469962|NCT05028582|451349833|FG001|Overall Study|Withdrawal by Subject|10|||
125469963|NCT05028582|451349832|FG000|Overall Study|Adverse Event|5|||
125469964|NCT05028582|451349833|FG001|Overall Study|Adverse Event|2|||
125469965|NCT05028582|451349832|FG000|Overall Study|Miscellaneous|3|||
125469966|NCT05028582|451349833|FG001|Overall Study|Miscellaneous|2|||
125469967|NCT05028582|451349832|FG000|Overall Study|Lack of Efficacy|3|||
125469968|NCT05028582|451349833|FG001|Overall Study|Lack of Efficacy|1|||
125469969|NCT05028582|451349832|FG000|Overall Study|Physician Decision|0|||
125469970|NCT05028582|451349833|FG001|Overall Study|Physician Decision|1|||
125469971|NCT01959698|451349834|FG000|Overall Study|Adverse Event|0|||
125469972|NCT01959698|451349835|FG001|Overall Study|Adverse Event|0|||
125469973|NCT01959698|451349836|FG002|Overall Study|Adverse Event|0|||
125469974|NCT01959698|451349837|FG003|Overall Study|Adverse Event|0|||
125469975|NCT01959698|451349838|FG004|Overall Study|Adverse Event|0|||
125469976|NCT01959698|451349839|FG005|Overall Study|Adverse Event|0|||
125469977|NCT01959698|451349840|FG006|Overall Study|Adverse Event|1|||
125469978|NCT01959698|451349834|FG000|Overall Study|Physician Decision|1|||
125469979|NCT01959698|451349835|FG001|Overall Study|Physician Decision|0|||
125469980|NCT01959698|451349836|FG002|Overall Study|Physician Decision|1|||
125469981|NCT01959698|451349837|FG003|Overall Study|Physician Decision|2|||
125469982|NCT01959698|451349838|FG004|Overall Study|Physician Decision|0|||
125469983|NCT01959698|451349839|FG005|Overall Study|Physician Decision|3|||
125469984|NCT01959698|451349840|FG006|Overall Study|Physician Decision|3|||
125469985|NCT04402294|451349841|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
125469986|NCT04402294|451349842|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
125469987|NCT04402294|451349841|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
125469988|NCT04402294|451349842|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
125469989|NCT05478525|451351720|FG000|Overall Study|Withdrawal by Subject|0|||
125469990|NCT05478525|451351721|FG001|Overall Study|Withdrawal by Subject|1|||
125469991|NCT05478525|451351722|FG002|Overall Study|Withdrawal by Subject|2|||
125469992|NCT05478525|451351723|FG003|Overall Study|Withdrawal by Subject|0|||
125469993|NCT05478525|451351720|FG000|Overall Study|COVID-19 Infection|2|||
125469994|NCT05478525|451351721|FG001|Overall Study|COVID-19 Infection|0|||
125469995|NCT05478525|451351722|FG002|Overall Study|COVID-19 Infection|1|||
125469996|NCT05478525|451351723|FG003|Overall Study|COVID-19 Infection|1|||
125469997|NCT05644002|451351726|FG000|Overall Study|Lost to Follow-up|1|||
125469998|NCT05644002|451351727|FG001|Overall Study|Lost to Follow-up|2|||
125469999|NCT05644002|451351726|FG000|Overall Study|Withdrawal by Subject|0|||
125470000|NCT05644002|451351727|FG001|Overall Study|Withdrawal by Subject|1|||
125470001|NCT04842500|451351728|FG000|Overall Study|Withdrawal by Subject|4|||
125470002|NCT04842500|451351729|FG001|Overall Study|Withdrawal by Subject|1|||
125470003|NCT04842500|451351730|FG002|Overall Study|Withdrawal by Subject|2|||
125470004|NCT04842500|451351731|FG003|Overall Study|Withdrawal by Subject|3|||
125470005|NCT04842500|451351728|FG000|Overall Study|Protocol Violation|1|||
125470006|NCT04842500|451351729|FG001|Overall Study|Protocol Violation|0|||
125470007|NCT04842500|451351730|FG002|Overall Study|Protocol Violation|0|||
125470008|NCT04842500|451351731|FG003|Overall Study|Protocol Violation|1|||
125470009|NCT05104697|451351733|FG000|Overall Study|Withdrawal by Subject|0|||
125470010|NCT05104697|451351734|FG001|Overall Study|Withdrawal by Subject|1|||
125470011|NCT03845465|451351735|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
125470012|NCT03845465|451351736|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
125470013|NCT03845465|451351735|FG000|6-month Data Collection|Withdrawal by Subject|0|||
125470014|NCT03845465|451351736|FG001|6-month Data Collection|Withdrawal by Subject|2|||
125470015|NCT03845465|451351735|FG000|12-month Data Collection|Withdrawal by Subject|0|||
125470016|NCT03845465|451351736|FG001|12-month Data Collection|Withdrawal by Subject|2|||
125470017|NCT03547908|451351737|FG000|Blinded Phase|Lost to Follow-up|3|||
125470018|NCT03547908|451351738|FG001|Blinded Phase|Lost to Follow-up|3|||
125470019|NCT03547908|451351739|FG002|Blinded Phase|Lost to Follow-up|0|||
125470020|NCT03547908|451351740|FG003|Blinded Phase|Lost to Follow-up|0|||
125470021|NCT03547908|451351737|FG000|Blinded Phase|Withdrew Consent|2|||
125470022|NCT03547908|451351738|FG001|Blinded Phase|Withdrew Consent|3|||
125470023|NCT03547908|451351739|FG002|Blinded Phase|Withdrew Consent|0|||
125470024|NCT03547908|451351740|FG003|Blinded Phase|Withdrew Consent|0|||
125470025|NCT03547908|451351737|FG000|Blinded Phase|Investigator's Discretion|2|||
125299818|NCT00737633|450723767|FG001|Overall Study|Lost to Follow-up|1|||
125470026|NCT03547908|451351738|FG001|Blinded Phase|Investigator's Discretion|1|||
125470027|NCT03547908|451351739|FG002|Blinded Phase|Investigator's Discretion|0|||
125470028|NCT03547908|451351740|FG003|Blinded Phase|Investigator's Discretion|0|||
125470029|NCT03547908|451351737|FG000|Blinded Phase|Death|2|||
125470030|NCT03547908|451351738|FG001|Blinded Phase|Death|0|||
125470031|NCT03547908|451351739|FG002|Blinded Phase|Death|0|||
125470032|NCT03547908|451351740|FG003|Blinded Phase|Death|0|||
125470033|NCT03547908|451351737|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
125470034|NCT03547908|451351738|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
125470035|NCT03547908|451351739|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
125470036|NCT03547908|451351740|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
125470037|NCT03547908|451351737|FG000|Blinded Phase|Adverse Event|1|||
125470038|NCT03547908|451351738|FG001|Blinded Phase|Adverse Event|0|||
125470039|NCT03547908|451351739|FG002|Blinded Phase|Adverse Event|0|||
125470040|NCT03547908|451351740|FG003|Blinded Phase|Adverse Event|0|||
125470041|NCT03547908|451351737|FG000|Blinded Phase|Randomized But Never Treated|1|||
125470042|NCT03547908|451351738|FG001|Blinded Phase|Randomized But Never Treated|0|||
125470043|NCT03547908|451351739|FG002|Blinded Phase|Randomized But Never Treated|0|||
125470044|NCT03547908|451351740|FG003|Blinded Phase|Randomized But Never Treated|0|||
125470045|NCT03547908|451351737|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
125470046|NCT03547908|451351738|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
125470047|NCT03547908|451351739|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
125470048|NCT03547908|451351740|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
125470049|NCT03547908|451351737|FG000|Open-label Extension Phase|Death|0|||
125470050|NCT03547908|451351738|FG001|Open-label Extension Phase|Death|0|||
125470051|NCT03547908|451351739|FG002|Open-label Extension Phase|Death|1|||
125470052|NCT03547908|451351740|FG003|Open-label Extension Phase|Death|0|||
125470053|NCT03416023|451351743|FG000|Overall Study|Exclusion criteria failure|1|||
125470054|NCT03416023|451351743|FG000|Overall Study|Withdrawal by Subject|6|||
125470055|NCT03416023|451351743|FG000|Overall Study|Explanted|7|||
125470056|NCT03416023|451351743|FG000|Overall Study|Physician Decision|1|||
125470057|NCT03416023|451351743|FG000|Overall Study|Lost to Follow-up|1|||
125470058|NCT03416023|451351743|FG000|Overall Study|Death|1|||
125470059|NCT05419505|451351744|FG000|Overall Study|Adverse Event|0|||
125470060|NCT05419505|451351745|FG001|Overall Study|Adverse Event|0|||
125470061|NCT05419505|451351746|FG002|Overall Study|Adverse Event|0|||
125470062|NCT05419505|451351747|FG003|Overall Study|Adverse Event|1|||
125470063|NCT05419505|451351748|FG004|Overall Study|Adverse Event|0|||
125470064|NCT05419505|451351749|FG005|Overall Study|Adverse Event|0|||
125470065|NCT05419505|451351750|FG006|Overall Study|Adverse Event|0|||
125470066|NCT05419505|451351751|FG007|Overall Study|Adverse Event|0|||
125470067|NCT05419505|451351744|FG000|Overall Study|Withdrawal by Subject|1|||
125470068|NCT05419505|451351745|FG001|Overall Study|Withdrawal by Subject|2|||
125470069|NCT05419505|451351746|FG002|Overall Study|Withdrawal by Subject|0|||
125470070|NCT05419505|451351747|FG003|Overall Study|Withdrawal by Subject|0|||
125470071|NCT05419505|451351748|FG004|Overall Study|Withdrawal by Subject|0|||
125470072|NCT05419505|451351749|FG005|Overall Study|Withdrawal by Subject|0|||
125470073|NCT05419505|451351750|FG006|Overall Study|Withdrawal by Subject|1|||
125470074|NCT05419505|451351751|FG007|Overall Study|Withdrawal by Subject|0|||
125470075|NCT05419505|451351744|FG000|Overall Study|Lost to Follow-up|2|||
125470076|NCT05419505|451351745|FG001|Overall Study|Lost to Follow-up|1|||
125470077|NCT05419505|451351746|FG002|Overall Study|Lost to Follow-up|0|||
125470078|NCT05419505|451351747|FG003|Overall Study|Lost to Follow-up|0|||
125470079|NCT05419505|451351748|FG004|Overall Study|Lost to Follow-up|1|||
125470080|NCT05419505|451351749|FG005|Overall Study|Lost to Follow-up|2|||
125470081|NCT05419505|451351750|FG006|Overall Study|Lost to Follow-up|0|||
125470082|NCT05419505|451351751|FG007|Overall Study|Lost to Follow-up|1|||
125470083|NCT03358875|451351752|FG000|Overall Study|Death|409|||
125470084|NCT03358875|451351753|FG001|Overall Study|Death|223|||
125470085|NCT03358875|451351752|FG000|Overall Study|Study Closed by Sponsor|66|||
125470086|NCT03358875|451351753|FG001|Overall Study|Study Closed by Sponsor|29|||
125470087|NCT03358875|451351752|FG000|Overall Study|Withdrawal by Subject|13|||
125470088|NCT03358875|451351753|FG001|Overall Study|Withdrawal by Subject|16|||
125470089|NCT03358875|451351752|FG000|Overall Study|Lost to Follow-up|13|||
125470090|NCT03358875|451351753|FG001|Overall Study|Lost to Follow-up|2|||
125470091|NCT03358875|451351752|FG000|Overall Study|Miscellaneous|33|||
125470092|NCT03358875|451351753|FG001|Overall Study|Miscellaneous|0|||
125470093|NCT03358875|451351752|FG000|Overall Study|Remained on Study|1|||
125470094|NCT03358875|451351753|FG001|Overall Study|Remained on Study|0|||
125470095|NCT01064440|451351758|FG000|Overall Study|Lost to Follow-up|1|||
125470096|NCT01064440|451351759|FG001|Overall Study|Lost to Follow-up|1|||
125470097|NCT01064440|451351760|FG002|Overall Study|Lost to Follow-up|1|||
125470098|NCT01064440|451351758|FG000|Overall Study|Non-compliance|0|||
125299819|NCT00737633|450723766|FG000|Overall Study|protocol non-compliance|0|||
125299820|NCT00737633|450723767|FG001|Overall Study|protocol non-compliance|1|||
125470099|NCT01064440|451351759|FG001|Overall Study|Non-compliance|1|||
125470100|NCT01064440|451351760|FG002|Overall Study|Non-compliance|0|||
125470101|NCT01064440|451351758|FG000|Overall Study|Death|1|||
125470102|NCT01064440|451351759|FG001|Overall Study|Death|0|||
125470103|NCT01064440|451351760|FG002|Overall Study|Death|1|||
125470104|NCT01064440|451351758|FG000|Overall Study|Withdrawal by Subject|0|||
125470105|NCT01064440|451351759|FG001|Overall Study|Withdrawal by Subject|1|||
125470106|NCT01064440|451351760|FG002|Overall Study|Withdrawal by Subject|1|||
125470107|NCT01064440|451351758|FG000|Overall Study|Other: amputation|1|||
125470108|NCT01064440|451351759|FG001|Overall Study|Other: amputation|0|||
125470109|NCT01064440|451351760|FG002|Overall Study|Other: amputation|0|||
125470110|NCT06194214|451351762|FG000|Overall Study|Adverse Event|1|||
125470111|NCT05288283|451351768|FG000|Overall Study|Study Terminated Early|1|||
125470112|NCT05288283|451351769|FG001|Overall Study|Study Terminated Early|1|||
125470113|NCT01046136|451351770|FG000|Overall Study|Withdrawal by Subject|0|||
125470114|NCT01046136|451351771|FG001|Overall Study|Withdrawal by Subject|4|||
125470115|NCT01046136|451351770|FG000|Overall Study|Physician Decision|1|||
125470116|NCT01046136|451351771|FG001|Overall Study|Physician Decision|1|||
125470117|NCT01046136|451351770|FG000|Overall Study|Lost to Follow-up|3|||
125470118|NCT01046136|451351771|FG001|Overall Study|Lost to Follow-up|3|||
125470119|NCT04759833|451351775|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
125470120|NCT04759833|451351776|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
125470121|NCT04759833|451351777|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
125470122|NCT04759833|451351778|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
125470123|NCT04759833|451351779|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
125470124|NCT04759833|451351775|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
125470125|NCT04759833|451351776|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
125470126|NCT04759833|451351777|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
125470127|NCT04759833|451351778|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
125470128|NCT04759833|451351779|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
125470129|NCT04759833|451351775|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
125470130|NCT04759833|451351776|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
125470131|NCT04759833|451351777|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
125470132|NCT04759833|451351778|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
125470133|NCT04759833|451351779|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
125470134|NCT04759833|451351775|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
125470135|NCT04759833|451351776|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
125470136|NCT04759833|451351777|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
125470137|NCT04759833|451351778|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
125470138|NCT04759833|451351779|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
125470139|NCT04759833|451351775|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
125470140|NCT04759833|451351776|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
125470141|NCT04759833|451351777|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
125470142|NCT04759833|451351778|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
125470143|NCT04759833|451351779|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
125470144|NCT04759833|451351775|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
125470145|NCT04759833|451351776|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
125470146|NCT04759833|451351777|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
125470147|NCT04759833|451351778|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
125470148|NCT04759833|451351779|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
125470149|NCT04759833|451351775|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
125470150|NCT04759833|451351776|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
125470151|NCT04759833|451351777|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
125470152|NCT04759833|451351778|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
125470153|NCT04759833|451351779|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
125470154|NCT04759833|451351775|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
125470155|NCT04759833|451351776|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
125470156|NCT04759833|451351777|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
125470157|NCT04759833|451351778|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
125470158|NCT04759833|451351779|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
125470159|NCT04759833|451351775|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
125470160|NCT04759833|451351776|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
125470161|NCT04759833|451351777|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
125470162|NCT04759833|451351778|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
125470163|NCT04759833|451351779|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
125470164|NCT04759833|451351775|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
125470165|NCT04759833|451351776|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
125470166|NCT04759833|451351777|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
125470167|NCT04759833|451351778|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
125470168|NCT04759833|451351779|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
125470169|NCT04759833|451351775|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
125470170|NCT04759833|451351776|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
125470171|NCT04759833|451351777|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
125470172|NCT04759833|451351778|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
125470173|NCT04759833|451351779|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
125470174|NCT04759833|451351775|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
125470175|NCT04759833|451351776|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
125470176|NCT04759833|451351777|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
125470177|NCT04759833|451351778|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
125470178|NCT04759833|451351779|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
125470179|NCT04759833|451351775|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
125470180|NCT04759833|451351776|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
125470181|NCT04759833|451351777|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
125470182|NCT04759833|451351778|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
125470183|NCT04759833|451351779|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
125470184|NCT03446157|451351780|FG000|Overall Study|Death|11|||
125470185|NCT03446157|451351781|FG001|Overall Study|Death|9|||
125470186|NCT03446157|451351780|FG000|Overall Study|Lost to Follow-up|0|||
125470187|NCT03446157|451351781|FG001|Overall Study|Lost to Follow-up|1|||
125470188|NCT03446157|451351780|FG000|Overall Study|Withdrawal by Subject|2|||
125470189|NCT03446157|451351781|FG001|Overall Study|Withdrawal by Subject|1|||
125470190|NCT00411151|451351782|FG000|Overall Study|Death|38|||
125470191|NCT00411151|451351782|FG000|Overall Study|Withdrawal by Subject|2|||
125470192|NCT00411151|451351782|FG000|Overall Study|Lost to Follow-up|2|||
125470193|NCT00411151|451351782|FG000|Overall Study|Protocol Violation|1|||
125470194|NCT00411151|451351782|FG000|Overall Study|Trial prematurely closed|4|||
125470195|NCT00409838|451351785|FG000|Short-term Period|Adverse Event|0|||
125470196|NCT00409838|451351786|FG001|Short-term Period|Adverse Event|1|||
125470197|NCT00409838|451351785|FG000|Short-term Period|Lost to Follow-up|0|||
125470198|NCT00409838|451351786|FG001|Short-term Period|Lost to Follow-up|1|||
125470199|NCT00409838|451351785|FG000|Short-term Period|Withdrawal by Subject|2|||
125470200|NCT00409838|451351786|FG001|Short-term Period|Withdrawal by Subject|3|||
125470201|NCT00409838|451351785|FG000|Short-term Period|Never Treated|1|||
125470202|NCT00409838|451351786|FG001|Short-term Period|Never Treated|0|||
125470203|NCT00409838|451351785|FG000|Long-term Extension Period|Adverse Event|10|||
125470204|NCT00409838|451351786|FG001|Long-term Extension Period|Adverse Event|0|||
125470205|NCT00409838|451351785|FG000|Long-term Extension Period|Death|1|||
125470206|NCT00409838|451351786|FG001|Long-term Extension Period|Death|0|||
125470207|NCT00409838|451351785|FG000|Long-term Extension Period|Lack of Efficacy|2|||
125470208|NCT00409838|451351786|FG001|Long-term Extension Period|Lack of Efficacy|0|||
125470209|NCT00409838|451351785|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
125470210|NCT00409838|451351786|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
125470211|NCT00409838|451351785|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
125470212|NCT00409838|451351786|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
125470213|NCT00409838|451351785|FG000|Long-term Extension Period|Pregnancy|1|||
125470214|NCT00409838|451351786|FG001|Long-term Extension Period|Pregnancy|0|||
125470215|NCT01619410|451351787|FG000|Overall Study|Lost to Follow-up|7|||
125470216|NCT01619410|451351788|FG001|Overall Study|Lost to Follow-up|4|||
125470217|NCT01250769|451351789|FG000|Overall Study|Withdrawal by Subject|0|||
125470218|NCT01250769|451351790|FG001|Overall Study|Withdrawal by Subject|1|||
125470219|NCT01250769|451351791|FG002|Overall Study|Withdrawal by Subject|1|||
125470220|NCT01250769|451351792|FG003|Overall Study|Withdrawal by Subject|0|||
125470221|NCT01250769|451351789|FG000|Overall Study|Adverse Event|0|||
125470222|NCT01250769|451351790|FG001|Overall Study|Adverse Event|0|||
125470223|NCT01250769|451351791|FG002|Overall Study|Adverse Event|1|||
125470224|NCT01250769|451351792|FG003|Overall Study|Adverse Event|0|||
125470225|NCT02538900|451351793|FG000|Overall Study|Death|2|||
125470226|NCT02538900|451351794|FG001|Overall Study|Death|2|||
125470227|NCT02538900|451351795|FG002|Overall Study|Death|2|||
125470228|NCT02538900|451351793|FG000|Overall Study|Withdrawal by Subject|18|||
125470229|NCT02538900|451351794|FG001|Overall Study|Withdrawal by Subject|16|||
125470230|NCT02538900|451351795|FG002|Overall Study|Withdrawal by Subject|15|||
125470231|NCT04110054|451351796|FG000|Overall Study|COVID-19 reason other than AE|0|||
125470232|NCT04110054|451351797|FG001|Overall Study|COVID-19 reason other than AE|0|||
125470233|NCT04110054|451351798|FG002|Overall Study|COVID-19 reason other than AE|2|||
125470234|NCT04110054|451351799|FG003|Overall Study|COVID-19 reason other than AE|0|||
125470235|NCT04110054|451351796|FG000|Overall Study|Withdrawal by Subject|0|||
125470236|NCT04110054|451351797|FG001|Overall Study|Withdrawal by Subject|3|||
125470237|NCT04110054|451351798|FG002|Overall Study|Withdrawal by Subject|2|||
125470238|NCT04110054|451351799|FG003|Overall Study|Withdrawal by Subject|0|||
125470239|NCT04110054|451351796|FG000|Overall Study|Adverse Event|1|||
125470240|NCT04110054|451351797|FG001|Overall Study|Adverse Event|1|||
125470241|NCT04110054|451351798|FG002|Overall Study|Adverse Event|4|||
125470242|NCT04110054|451351799|FG003|Overall Study|Adverse Event|3|||
125470243|NCT02874534|451351800|FG000|Overall Study|Withdrawal by Subject|5|||
125470244|NCT02874534|451351801|FG001|Overall Study|Withdrawal by Subject|8|||
125470245|NCT02874534|451351800|FG000|Overall Study|Lost to Follow-up|2|||
125470246|NCT02874534|451351801|FG001|Overall Study|Lost to Follow-up|2|||
125470247|NCT02874534|451351800|FG000|Overall Study|Ongoing in study|1|||
125470248|NCT02874534|451351801|FG001|Overall Study|Ongoing in study|1|||
125470249|NCT02923180|451351803|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
125470250|NCT02923180|451351803|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
125470251|NCT01989455|451351804|FG000|Overall Study|Adverse Event|0|||
125470252|NCT01989455|451351805|FG001|Overall Study|Adverse Event|1|||
125470253|NCT01989455|451351806|FG002|Overall Study|Adverse Event|0|||
125470254|NCT01989455|451351807|FG003|Overall Study|Adverse Event|0|||
125470255|NCT01989455|451351808|FG004|Overall Study|Adverse Event|0|||
125470256|NCT01989455|451351804|FG000|Overall Study|Withdrawal by Subject|0|||
125470257|NCT01989455|451351805|FG001|Overall Study|Withdrawal by Subject|1|||
125470258|NCT01989455|451351806|FG002|Overall Study|Withdrawal by Subject|0|||
125470259|NCT01989455|451351807|FG003|Overall Study|Withdrawal by Subject|0|||
125470260|NCT01989455|451351808|FG004|Overall Study|Withdrawal by Subject|0|||
125470261|NCT01989455|451351804|FG000|Overall Study|Technical problems with infusion|0|||
125470262|NCT01989455|451351805|FG001|Overall Study|Technical problems with infusion|0|||
125470263|NCT01989455|451351806|FG002|Overall Study|Technical problems with infusion|1|||
125470264|NCT01989455|451351807|FG003|Overall Study|Technical problems with infusion|0|||
125470265|NCT01989455|451351808|FG004|Overall Study|Technical problems with infusion|1|||
125470266|NCT00632203|451351809|FG000|Overall Study|Did not start study treatment|1|||
125470267|NCT00632203|451351810|FG001|Overall Study|Did not start study treatment|0|||
125470268|NCT04287985|451351813|FG000|Overall Study|Adverse Event|1|||
125470269|NCT04287985|451351814|FG001|Overall Study|Adverse Event|0|||
125470270|NCT04287985|451351815|FG002|Overall Study|Adverse Event|0|||
125470271|NCT04287985|451351816|FG003|Overall Study|Adverse Event|0|||
125470272|NCT04287985|451351813|FG000|Overall Study|Protocol Violation|0|||
125470273|NCT04287985|451351814|FG001|Overall Study|Protocol Violation|1|||
125470274|NCT04287985|451351815|FG002|Overall Study|Protocol Violation|0|||
125470275|NCT04287985|451351816|FG003|Overall Study|Protocol Violation|0|||
125470276|NCT04287985|451351813|FG000|Overall Study|Physician Decision|0|||
125470277|NCT04287985|451351814|FG001|Overall Study|Physician Decision|0|||
125470278|NCT04287985|451351815|FG002|Overall Study|Physician Decision|0|||
125470279|NCT04287985|451351816|FG003|Overall Study|Physician Decision|1|||
125470280|NCT04287985|451351813|FG000|Overall Study|Withdrawal by Subject|2|||
125470281|NCT04287985|451351814|FG001|Overall Study|Withdrawal by Subject|1|||
125470282|NCT04287985|451351815|FG002|Overall Study|Withdrawal by Subject|1|||
125470283|NCT04287985|451351816|FG003|Overall Study|Withdrawal by Subject|2|||
125470284|NCT01340066|451351821|FG000|Placebo Run in Period|Screen Failures|27|||
125470285|NCT01340066|451351822|FG001|Placebo Run in Period|Screen Failures|0|||
125470286|NCT01340066|451351823|FG002|Placebo Run in Period|Screen Failures|0|||
125470287|NCT01340066|451351821|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
125470288|NCT01340066|451351822|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
125470289|NCT01340066|451351823|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
125470290|NCT01340066|451351821|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
125470291|NCT01340066|451351822|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
125470292|NCT01340066|451351823|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
125470293|NCT01340066|451351821|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
125470294|NCT01340066|451351822|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
125470295|NCT01340066|451351823|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
125470296|NCT02789020|451351824|FG000|Overall Study|Withdrawal by Subject|6|||
125470297|NCT02789020|451351825|FG001|Overall Study|Withdrawal by Subject|5|||
125470298|NCT03771352|451351836|FG000|Overall Study|Screen failure|2|||
125470299|NCT03771352|451351836|FG000|Overall Study|Withdrawal by Subject|2|||
125470300|NCT04238247|451351837|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
125470301|NCT04238247|451351838|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
125470302|NCT04238247|451351839|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
125470303|NCT04238247|451351840|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
125470304|NCT04238247|451351837|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
125470305|NCT04238247|451351838|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
125470306|NCT04238247|451351839|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
125470307|NCT04238247|451351840|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
125470308|NCT04238247|451351837|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
125470309|NCT04238247|451351838|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
125470310|NCT04238247|451351839|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
125470311|NCT04238247|451351840|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
125470312|NCT04238247|451351837|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
125470313|NCT04238247|451351838|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
125470314|NCT04238247|451351839|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
125470315|NCT04238247|451351840|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
125470316|NCT05064735|451351841|FG000|Overall Study|Withdrawal by Subject|7|||
125470317|NCT05064735|451351842|FG001|Overall Study|Withdrawal by Subject|8|||
125470318|NCT05064735|451351841|FG000|Overall Study|Lost to Follow-up|7|||
125470319|NCT05064735|451351842|FG001|Overall Study|Lost to Follow-up|2|||
125470320|NCT05064735|451351841|FG000|Overall Study|Physician Decision|2|||
125470321|NCT05064735|451351842|FG001|Overall Study|Physician Decision|1|||
125470322|NCT05064735|451351841|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
125470323|NCT05064735|451351842|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
125470324|NCT05064735|451351841|FG000|Overall Study|Site Closure|7|||
125470325|NCT05064735|451351842|FG001|Overall Study|Site Closure|2|||
125470326|NCT03380390|451351843|FG000|Overall Study|Adverse Event|3|||
125470327|NCT02886286|451351844|FG000|Overall Study|pump motor stall|0|||
125470328|NCT02886286|451351845|FG001|Overall Study|pump motor stall|1|||
125470329|NCT02376790|451351846|FG000|Overall Study|Withdrawal by Subject|43|||
125470330|NCT02376790|451351847|FG001|Overall Study|Withdrawal by Subject|36|||
125470331|NCT02376790|451351848|FG002|Overall Study|Withdrawal by Subject|37|||
125470332|NCT02376790|451351846|FG000|Overall Study|Decision by Sponsor|2|||
125470333|NCT02376790|451351847|FG001|Overall Study|Decision by Sponsor|1|||
125470334|NCT02376790|451351848|FG002|Overall Study|Decision by Sponsor|4|||
125470335|NCT02376790|451351846|FG000|Overall Study|Lost to Follow-up|15|||
125470336|NCT02376790|451351847|FG001|Overall Study|Lost to Follow-up|10|||
125470337|NCT02376790|451351848|FG002|Overall Study|Lost to Follow-up|12|||
125470338|NCT03014453|451351849|FG000|Overall Study|Lost to Follow-up|12|||
125470339|NCT03014453|451351849|FG000|Overall Study|Discontinued GER|3|||
125470340|NCT03014453|451351849|FG000|Overall Study|Excluded|19|||
125470341|NCT03014453|451351849|FG000|Overall Study|Refused to take part in|37|||
125470342|NCT00901901|451351850|FG000|Treatment Period|Adverse Event|120|||
125470343|NCT00901901|451351851|FG001|Treatment Period|Adverse Event|128|||
125470344|NCT00901901|451351850|FG000|Treatment Period|Withdrawal by Subject|26|||
125470345|NCT00901901|451351851|FG001|Treatment Period|Withdrawal by Subject|24|||
125470346|NCT00901901|451351850|FG000|Treatment Period|Physician Decision|2|||
125470347|NCT00901901|451351851|FG001|Treatment Period|Physician Decision|2|||
125470348|NCT00901901|451351850|FG000|Treatment Period|Lost to Follow-up|3|||
125470349|NCT00901901|451351851|FG001|Treatment Period|Lost to Follow-up|5|||
125470350|NCT00901901|451351850|FG000|Treatment Period|Noncompliance with study medication|4|||
125470351|NCT00901901|451351851|FG001|Treatment Period|Noncompliance with study medication|1|||
125470352|NCT00901901|451351850|FG000|Treatment Period|Missing|1|||
125470353|NCT00901901|451351851|FG001|Treatment Period|Missing|0|||
125470354|NCT00901901|451351850|FG000|Treatment Period|Never treated|0|||
125470355|NCT00901901|451351851|FG001|Treatment Period|Never treated|3|||
125470356|NCT00901901|451351850|FG000|Treatment Period|Protocol driven decision point|0|||
125470357|NCT00901901|451351851|FG001|Treatment Period|Protocol driven decision point|2|||
125470358|NCT00901901|451351850|FG000|Treatment Period|Study terminated by sponsor|2|||
125470359|NCT00901901|451351851|FG001|Treatment Period|Study terminated by sponsor|0|||
125470360|NCT00901901|451351850|FG000|Treatment Period|Protocol Violation|5|||
125470361|NCT00901901|451351851|FG001|Treatment Period|Protocol Violation|9|||
125470362|NCT00901901|451351850|FG000|Treatment Period|Switch to commercial drug|1|||
125470363|NCT00901901|451351851|FG001|Treatment Period|Switch to commercial drug|1|||
125470364|NCT00901901|451351850|FG000|Treatment Period|Transfer to treatment continuation study|5|||
125470365|NCT00901901|451351851|FG001|Treatment Period|Transfer to treatment continuation study|2|||
125470366|NCT00901901|451351850|FG000|Follow-up Period|Death|181|||
125470367|NCT00901901|451351851|FG001|Follow-up Period|Death|208|||
125470368|NCT00901901|451351850|FG000|Follow-up Period|Protocol driven decision point|47|||
125470369|NCT00901901|451351851|FG001|Follow-up Period|Protocol driven decision point|36|||
125470370|NCT00901901|451351850|FG000|Follow-up Period|Withdrawal by Subject|6|||
125470371|NCT00901901|451351851|FG001|Follow-up Period|Withdrawal by Subject|9|||
125470372|NCT00901901|451351850|FG000|Follow-up Period|Lost to Follow-up|12|||
125470373|NCT00901901|451351851|FG001|Follow-up Period|Lost to Follow-up|8|||
125470374|NCT00901901|451351850|FG000|Follow-up Period|Missing|94|||
125470375|NCT00901901|451351851|FG001|Follow-up Period|Missing|80|||
125470376|NCT02272816|451351852|FG000|Overall Study|Adverse Event|1|||
125470377|NCT01136876|451351853|FG000|Overall Study|Lost to Follow-up|0|||
125470378|NCT01136876|451351854|FG001|Overall Study|Lost to Follow-up|1|||
125470379|NCT01136876|451351853|FG000|Overall Study|Physician Decision|3|||
125470380|NCT01136876|451351854|FG001|Overall Study|Physician Decision|5|||
125470381|NCT01136876|451351853|FG000|Overall Study|Missing NGAL measurement|2|||
125470382|NCT01136876|451351854|FG001|Overall Study|Missing NGAL measurement|5|||
125470383|NCT00976937|451351857|FG000|Overall Study|Adverse Event|4|||
125470384|NCT00976937|451351858|FG001|Overall Study|Adverse Event|5|||
125470385|NCT00976937|451351857|FG000|Overall Study|Lost to Follow-up|2|||
125470386|NCT00976937|451351858|FG001|Overall Study|Lost to Follow-up|1|||
125470387|NCT00976937|451351857|FG000|Overall Study|Withdrawal by Subject|5|||
125470388|NCT00976937|451351858|FG001|Overall Study|Withdrawal by Subject|3|||
125470389|NCT00976937|451351857|FG000|Overall Study|Poor compliance to protocol|3|||
125470390|NCT00976937|451351858|FG001|Overall Study|Poor compliance to protocol|0|||
125470391|NCT00976937|451351857|FG000|Overall Study|Personal and Familial Reason|2|||
125470392|NCT00976937|451351858|FG001|Overall Study|Personal and Familial Reason|2|||
125470393|NCT01011946|451351859|FG000|Overall Study|Transferred to another hospital|2|||
125470394|NCT01011946|451351859|FG000|Overall Study|No pathological lab value|1|||
125470395|NCT04820686|451351860|FG000|Overall Study|Withdrawal by Subject|5|||
125470396|NCT04820686|451351861|FG001|Overall Study|Withdrawal by Subject|2|||
125470397|NCT04820686|451351862|FG002|Overall Study|Withdrawal by Subject|3|||
125470398|NCT04820686|451351860|FG000|Overall Study|Study Termination|25|||
125470399|NCT04820686|451351861|FG001|Overall Study|Study Termination|13|||
125470400|NCT04820686|451351862|FG002|Overall Study|Study Termination|14|||
125470401|NCT04820686|451351860|FG000|Overall Study|Adverse Event|0|||
125470402|NCT04820686|451351861|FG001|Overall Study|Adverse Event|1|||
125470403|NCT04820686|451351862|FG002|Overall Study|Adverse Event|0|||
125470404|NCT01424670|451351863|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
125470405|NCT01424670|451351864|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
125470406|NCT01424670|451351863|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
125470407|NCT01424670|451351864|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
125470408|NCT01424670|451351863|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
125470409|NCT01424670|451351864|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
125470410|NCT01424670|451351863|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
125470411|NCT01424670|451351864|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
125470412|NCT01424670|451351863|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
125470413|NCT01424670|451351864|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
125470414|NCT01424670|451351863|FG000|Continuation Period|Adverse Event|13|||
125470415|NCT01424670|451351864|FG001|Continuation Period|Adverse Event|5|||
125470416|NCT01424670|451351863|FG000|Continuation Period|Lost to Follow-up|2|||
125470417|NCT01424670|451351864|FG001|Continuation Period|Lost to Follow-up|0|||
125470418|NCT01424670|451351863|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
125470419|NCT01424670|451351864|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
125470420|NCT01424670|451351863|FG000|Continuation Period|Physician Decision|5|||
125470421|NCT01424670|451351864|FG001|Continuation Period|Physician Decision|4|||
125470422|NCT01424670|451351863|FG000|Continuation Period|Withdrawal by Subject|13|||
125470423|NCT01424670|451351864|FG001|Continuation Period|Withdrawal by Subject|4|||
125470424|NCT02891915|451351867|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
125470425|NCT02891915|451351868|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
125470426|NCT02891915|451351867|FG000|Overall Study|Withdrawal by Subject|3|||
125470427|NCT02891915|451351868|FG001|Overall Study|Withdrawal by Subject|3|||
125470428|NCT02891915|451351867|FG000|Overall Study|Became Ineligible After Enrollment|2|||
125470429|NCT02891915|451351868|FG001|Overall Study|Became Ineligible After Enrollment|1|||
125470430|NCT02891915|451351867|FG000|Overall Study|Lost to Follow-up|1|||
125470431|NCT02891915|451351868|FG001|Overall Study|Lost to Follow-up|4|||
125470432|NCT02891915|451351867|FG000|Overall Study|Physician Decision|1|||
125470433|NCT02891915|451351868|FG001|Overall Study|Physician Decision|0|||
125470434|NCT00709098|451351869|FG000|Double-blind Period|Withdrawal of consent|3|||
125470435|NCT00709098|451351870|FG001|Double-blind Period|Withdrawal of consent|3|||
125470436|NCT00709098|451351871|FG002|Double-blind Period|Withdrawal of consent|0|||
125470437|NCT00709098|451351869|FG000|Double-blind Period|Administrative reason|1|||
125470438|NCT00709098|451351870|FG001|Double-blind Period|Administrative reason|3|||
125470439|NCT00709098|451351871|FG002|Double-blind Period|Administrative reason|0|||
125470440|NCT00709098|451351869|FG000|Double-blind Period|Death|1|||
125470441|NCT00709098|451351870|FG001|Double-blind Period|Death|1|||
125470442|NCT00709098|451351871|FG002|Double-blind Period|Death|0|||
125470443|NCT00709098|451351869|FG000|Double-blind Period|Lost to Follow-up|1|||
125470444|NCT00709098|451351870|FG001|Double-blind Period|Lost to Follow-up|1|||
125470445|NCT00709098|451351871|FG002|Double-blind Period|Lost to Follow-up|0|||
125470446|NCT00709098|451351869|FG000|Open-label Period|Withdrawal of consent|0|||
125470447|NCT00709098|451351870|FG001|Open-label Period|Withdrawal of consent|0|||
125470448|NCT00709098|451351871|FG002|Open-label Period|Withdrawal of consent|7|||
125470449|NCT00709098|451351869|FG000|Open-label Period|Administrative reason|0|||
125470450|NCT00709098|451351870|FG001|Open-label Period|Administrative reason|0|||
125470451|NCT00709098|451351871|FG002|Open-label Period|Administrative reason|5|||
125470452|NCT00709098|451351869|FG000|Open-label Period|Death|0|||
125470453|NCT00709098|451351870|FG001|Open-label Period|Death|0|||
125470454|NCT00709098|451351871|FG002|Open-label Period|Death|1|||
125470455|NCT00709098|451351869|FG000|Open-label Period|Lost to Follow-up|0|||
125470456|NCT00709098|451351870|FG001|Open-label Period|Lost to Follow-up|0|||
125470457|NCT00709098|451351871|FG002|Open-label Period|Lost to Follow-up|1|||
125470458|NCT03481816|451351873|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
125470459|NCT03481816|451351874|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
125470460|NCT03481816|451351873|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
125470461|NCT03481816|451351874|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
125470462|NCT03481816|451351873|FG000|Dose Expansion|Withdrawal by Subject|0|||
125470463|NCT03481816|451351874|FG001|Dose Expansion|Withdrawal by Subject|2|||
125470464|NCT03481816|451351873|FG000|Dose Expansion|Physician Decision|0|||
125470465|NCT03481816|451351874|FG001|Dose Expansion|Physician Decision|5|||
125470466|NCT01091168|451351877|FG000|Overall Study|Progressive disease|250|||
125470467|NCT01091168|451351878|FG001|Overall Study|Progressive disease|234|||
125470468|NCT01091168|451351877|FG000|Overall Study|Adverse Event|21|||
125470469|NCT01091168|451351878|FG001|Overall Study|Adverse Event|24|||
125470470|NCT01091168|451351877|FG000|Overall Study|Lost to Follow-up|0|||
125470471|NCT01091168|451351878|FG001|Overall Study|Lost to Follow-up|1|||
125470472|NCT01091168|451351877|FG000|Overall Study|Physician, patient's decision, other|27|||
125470473|NCT01091168|451351878|FG001|Overall Study|Physician, patient's decision, other|37|||
125470474|NCT03582722|451351881|FG000|Overall Study|Lost to Follow-up|1|||
125470475|NCT03582722|451351882|FG001|Overall Study|Lost to Follow-up|4|||
125470476|NCT03582722|451351881|FG000|Overall Study|Withdrawal by Subject|3|||
125470477|NCT03582722|451351882|FG001|Overall Study|Withdrawal by Subject|3|||
125470478|NCT06024174|451351883|FG000|Overall Study|Other Reasons|1|||
125470479|NCT06024174|451351883|FG000|Overall Study|Study terminated by Sponsor|4|||
125470480|NCT03481660|451353885|FG000|Overall Study|Adverse Event|5|||
125470481|NCT03481660|451353886|FG001|Overall Study|Adverse Event|4|||
125470482|NCT03481660|451353885|FG000|Overall Study|Death|13|||
125470483|NCT03481660|451353886|FG001|Overall Study|Death|9|||
125470484|NCT03481660|451353885|FG000|Overall Study|Lost to Follow-up|2|||
125470485|NCT03481660|451353886|FG001|Overall Study|Lost to Follow-up|2|||
125470486|NCT03481660|451353885|FG000|Overall Study|Physician Decision|2|||
125470487|NCT03481660|451353886|FG001|Overall Study|Physician Decision|3|||
125470488|NCT03481660|451353885|FG000|Overall Study|Withdrawal by Subject|14|||
125470489|NCT03481660|451353886|FG001|Overall Study|Withdrawal by Subject|7|||
125470490|NCT03012841|451353887|FG000|Overall Study|Protocol Violation|0|||
125470491|NCT03012841|451353888|FG001|Overall Study|Protocol Violation|10|||
125470492|NCT03012841|451353887|FG000|Overall Study|Lost to Follow-up|6|||
125470493|NCT03012841|451353888|FG001|Overall Study|Lost to Follow-up|1|||
125470494|NCT03012841|451353887|FG000|Overall Study|Withdrawal by Subject|6|||
125470495|NCT03012841|451353888|FG001|Overall Study|Withdrawal by Subject|0|||
125470496|NCT03012841|451353887|FG000|Overall Study|Unable to complete 12 month visit|6|||
125470497|NCT03012841|451353888|FG001|Overall Study|Unable to complete 12 month visit|0|||
125470498|NCT03012841|451353887|FG000|Overall Study|Subject relocation|1|||
125470499|NCT03012841|451353888|FG001|Overall Study|Subject relocation|0|||
125470500|NCT03012841|451353887|FG000|Overall Study|Seasonal winter travel|1|||
125470501|NCT03012841|451353888|FG001|Overall Study|Seasonal winter travel|0|||
125470502|NCT03012841|451353887|FG000|Overall Study|Physician Decision|0|||
125470503|NCT03012841|451353888|FG001|Overall Study|Physician Decision|2|||
125470504|NCT03012841|451353887|FG000|Overall Study|No ablation performed|0|||
125470505|NCT03012841|451353888|FG001|Overall Study|No ablation performed|2|||
125470506|NCT03012841|451353887|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
125470507|NCT03012841|451353888|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
125470508|NCT03012841|451353887|FG000|Overall Study|Insurance change|0|||
125470509|NCT03012841|451353888|FG001|Overall Study|Insurance change|1|||
125470510|NCT00186992|451353889|FG000|Overall Study|Withdrawal by Subject|5|||
125470511|NCT00186992|451353889|FG000|Overall Study|Physician's discretion|13|||
125470512|NCT00186992|451353889|FG000|Overall Study|PI Discretion|4|||
125470513|NCT00186992|451353889|FG000|Overall Study|Ineligible|2|||
125470514|NCT00186992|451353889|FG000|Overall Study|Lost to Follow-up|2|||
125470515|NCT00186992|451353889|FG000|Overall Study|Still on Study|9|||
125470516|NCT03683069|451353890|FG000|Overall Study|see limitations|12|||
125470517|NCT03683069|451353891|FG001|Overall Study|see limitations|13|||
125470518|NCT03769168|451353892|FG000|Overall Study|Adverse Event|0|||
125470519|NCT03769168|451353893|FG001|Overall Study|Adverse Event|1|||
125470520|NCT03769168|451353892|FG000|Overall Study|Lack of Efficacy|2|||
125299821|NCT01300260|450723768|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
125299822|NCT01300260|450723769|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
125470521|NCT03769168|451353893|FG001|Overall Study|Lack of Efficacy|4|||
125470522|NCT03769168|451353892|FG000|Overall Study|Post study access to treatment|3|||
125470523|NCT03769168|451353893|FG001|Overall Study|Post study access to treatment|11|||
125470524|NCT03769168|451353892|FG000|Overall Study|Physician Decision|1|||
125470525|NCT03769168|451353893|FG001|Overall Study|Physician Decision|4|||
125470526|NCT03769168|451353892|FG000|Overall Study|Subject Decision|2|||
125470527|NCT03769168|451353893|FG001|Overall Study|Subject Decision|4|||
125470528|NCT03769168|451353892|FG000|Overall Study|Guardian decision|1|||
125470529|NCT03769168|451353893|FG001|Overall Study|Guardian decision|0|||
125470530|NCT04941287|451353894|FG000|Overall Study|Rapid decline before starting treatment|3|||
125470531|NCT04941287|451353895|FG001|Overall Study|Rapid decline before starting treatment|1|||
125470532|NCT04065048|451353896|FG000|Overall Study|Withdrawal by Subject|1|||
125470533|NCT04065048|451353897|FG001|Overall Study|Withdrawal by Subject|2|||
125470534|NCT04065048|451353898|FG002|Overall Study|Withdrawal by Subject|1|||
125470535|NCT04065048|451353899|FG003|Overall Study|Withdrawal by Subject|1|||
125470536|NCT04065048|451353896|FG000|Overall Study|Adverse Event|1|||
125470537|NCT04065048|451353897|FG001|Overall Study|Adverse Event|0|||
125470538|NCT04065048|451353898|FG002|Overall Study|Adverse Event|1|||
125470539|NCT04065048|451353899|FG003|Overall Study|Adverse Event|0|||
125470540|NCT05096819|451353908|FG000|Overall Study|Withdrawal by Subject|3|||
125470541|NCT05096819|451353909|FG001|Overall Study|Withdrawal by Subject|0|||
125470542|NCT05307978|451353910|FG000|Overall Study|Lost to Follow-up|0|||
125470543|NCT05307978|451353911|FG001|Overall Study|Lost to Follow-up|1|||
125470544|NCT05307978|451353912|FG002|Overall Study|Lost to Follow-up|0|||
125470545|NCT05307978|451353913|FG003|Overall Study|Lost to Follow-up|4|||
125470546|NCT05307978|451353914|FG004|Overall Study|Lost to Follow-up|0|||
125470547|NCT05307978|451353915|FG005|Overall Study|Lost to Follow-up|0|||
125470548|NCT05307978|451353916|FG006|Overall Study|Lost to Follow-up|1|||
125470549|NCT03324984|451353917|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
125470550|NCT03324984|451353918|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
125470551|NCT04607044|451353923|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
125470552|NCT04607044|451353923|FG000|Overall Study|Adverse Event|1|||
125470553|NCT04607044|451353923|FG000|Overall Study|Did not receive study device|3|||
125470554|NCT04607044|451353923|FG000|Overall Study|Death|1|||
125470555|NCT05075408|451353924|FG000|Overall Study|Withdrawal by Subject|5|||
125470556|NCT05075408|451353925|FG001|Overall Study|Withdrawal by Subject|3|||
125470557|NCT05075408|451353926|FG002|Overall Study|Withdrawal by Subject|4|||
125470558|NCT05075408|451353924|FG000|Overall Study|Adverse Event|5|||
125470559|NCT05075408|451353925|FG001|Overall Study|Adverse Event|7|||
125470560|NCT05075408|451353926|FG002|Overall Study|Adverse Event|8|||
125470561|NCT05075408|451353924|FG000|Overall Study|Protocol Violation|0|||
125470562|NCT05075408|451353925|FG001|Overall Study|Protocol Violation|1|||
125470563|NCT05075408|451353926|FG002|Overall Study|Protocol Violation|0|||
125470564|NCT05075408|451353924|FG000|Overall Study|Lost to Follow-up|2|||
125470565|NCT05075408|451353925|FG001|Overall Study|Lost to Follow-up|1|||
125470566|NCT05075408|451353926|FG002|Overall Study|Lost to Follow-up|1|||
125470567|NCT05075408|451353924|FG000|Overall Study|Physician Decision|1|||
125470568|NCT05075408|451353925|FG001|Overall Study|Physician Decision|0|||
125470569|NCT05075408|451353926|FG002|Overall Study|Physician Decision|0|||
125470570|NCT05075408|451353924|FG000|Overall Study|Other-unspecified|3|||
125470571|NCT05075408|451353925|FG001|Overall Study|Other-unspecified|2|||
125470572|NCT05075408|451353926|FG002|Overall Study|Other-unspecified|0|||
125470573|NCT04878354|451353930|FG000|Overall Study|Adverse Event|4|||
125470574|NCT04878354|451353931|FG001|Overall Study|Adverse Event|13|||
125470575|NCT04878354|451353930|FG000|Overall Study|Withdrawal by Subject|14|||
125470576|NCT04878354|451353931|FG001|Overall Study|Withdrawal by Subject|12|||
125470577|NCT04878354|451353930|FG000|Overall Study|Lost to Follow-up|4|||
125470578|NCT04878354|451353931|FG001|Overall Study|Lost to Follow-up|1|||
125470579|NCT04878354|451353930|FG000|Overall Study|Lack of Efficacy|1|||
125470580|NCT04878354|451353931|FG001|Overall Study|Lack of Efficacy|0|||
125470581|NCT04878354|451353930|FG000|Overall Study|Protocol Violation|0|||
125470582|NCT04878354|451353931|FG001|Overall Study|Protocol Violation|1|||
125470583|NCT04878354|451353930|FG000|Overall Study|"Reason stated as other in CRF"|2|||
125470584|NCT04878354|451353931|FG001|Overall Study|"Reason stated as other in CRF"|3|||
125470585|NCT01631214|451353937|FG000|Overall Study|Withdrawal by Subject|276|||
125470586|NCT01631214|451353938|FG001|Overall Study|Withdrawal by Subject|290|||
125470587|NCT01631214|451353937|FG000|Overall Study|Death|113|||
125470588|NCT01631214|451353938|FG001|Overall Study|Death|106|||
125470589|NCT01631214|451353937|FG000|Overall Study|Lost to Follow-up|54|||
125470590|NCT01631214|451353938|FG001|Overall Study|Lost to Follow-up|40|||
125470591|NCT01631214|451353937|FG000|Overall Study|Adverse Event|45|||
125470592|NCT01631214|451353938|FG001|Overall Study|Adverse Event|45|||
125470593|NCT01631214|451353937|FG000|Overall Study|Other|22|||
125470594|NCT01631214|451353938|FG001|Overall Study|Other|19|||
125470595|NCT01631214|451353937|FG000|Overall Study|Noncompliance|16|||
125470596|NCT01631214|451353938|FG001|Overall Study|Noncompliance|15|||
125470597|NCT01631214|451353937|FG000|Overall Study|Requirement for Alternative Therapy|8|||
125470598|NCT01631214|451353938|FG001|Overall Study|Requirement for Alternative Therapy|3|||
125470599|NCT01631214|451353937|FG000|Overall Study|Protocol Deviation|4|||
125470600|NCT01631214|451353938|FG001|Overall Study|Protocol Deviation|3|||
125470601|NCT01631214|451353937|FG000|Overall Study|Ineligibility determined|5|||
125470602|NCT01631214|451353938|FG001|Overall Study|Ineligibility determined|2|||
125470603|NCT01631214|451353937|FG000|Overall Study|Administrative Decision|1|||
125470604|NCT01631214|451353938|FG001|Overall Study|Administrative Decision|0|||
125470605|NCT04093362|451353945|FG000|Overall Study|Study Termination|1|||
125470606|NCT04093362|451353946|FG001|Overall Study|Study Termination|1|||
125470607|NCT04093362|451353945|FG000|Overall Study|Withdrawal of Consent|1|||
125470608|NCT04093362|451353946|FG001|Overall Study|Withdrawal of Consent|0|||
125470609|NCT04093362|451353945|FG000|Overall Study|Death|1|||
125470610|NCT04093362|451353946|FG001|Overall Study|Death|3|||
125470611|NCT04093362|451353945|FG000|Overall Study|Reason not Specified|1|||
125470612|NCT04093362|451353946|FG001|Overall Study|Reason not Specified|2|||
125470613|NCT04847999|451353947|FG000|Overall Study|Lost to Follow-up|0|||
125470614|NCT04847999|451353948|FG001|Overall Study|Lost to Follow-up|1|||
125470615|NCT02879448|451353949|FG000|Overall Study|Death|251|||
125470616|NCT02879448|451353950|FG001|Overall Study|Death|263|||
125470617|NCT02879448|451353949|FG000|Overall Study|Lost to Follow-up|23|||
125470618|NCT02879448|451353950|FG001|Overall Study|Lost to Follow-up|28|||
125470619|NCT02879448|451353949|FG000|Overall Study|Withdrawal by Subject|42|||
125470620|NCT02879448|451353950|FG001|Overall Study|Withdrawal by Subject|79|||
125470621|NCT02879448|451353949|FG000|Overall Study|Other Reasons|8|||
125470622|NCT02879448|451353950|FG001|Overall Study|Other Reasons|12|||
125470623|NCT03433339|451353951|FG000|Overall Study|Lost to Follow-up|2|||
125470624|NCT03433339|451353952|FG001|Overall Study|Lost to Follow-up|0|||
125470625|NCT03433339|451353951|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
125470626|NCT03433339|451353952|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
125470627|NCT03433339|451353951|FG000|Overall Study|Withdrawal by Subject|0|||
125470628|NCT03433339|451353952|FG001|Overall Study|Withdrawal by Subject|2|||
125470629|NCT05952076|451353953|FG000|Overall Study|Death|1|||
125470630|NCT05952076|451353954|FG001|Overall Study|Death|1|||
125470631|NCT05952076|451353953|FG000|Overall Study|Lost to Follow-up|0|||
125470632|NCT05952076|451353954|FG001|Overall Study|Lost to Follow-up|1|||
125470633|NCT00894543|451353971|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
125470634|NCT00894543|451353972|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
125470635|NCT00894543|451353971|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
125470636|NCT00894543|451353972|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
125470637|NCT04048681|451353973|FG000|Overall Study|family emergency|0|||
125470638|NCT04048681|451353974|FG001|Overall Study|family emergency|0|||
125470639|NCT04048681|451353975|FG002|Overall Study|family emergency|0|||
125470640|NCT04048681|451353976|FG003|Overall Study|family emergency|1|||
125470641|NCT04048681|451353977|FG004|Overall Study|family emergency|0|||
125470642|NCT01532388|451353978|FG000|3-month Follow-up|Lost to Follow-up|68|||
125470643|NCT01532388|451353979|FG001|3-month Follow-up|Lost to Follow-up|68|||
125470644|NCT01532388|451353978|FG000|6-month Follow-up|Lost to Follow-up|74|||
125470645|NCT01532388|451353979|FG001|6-month Follow-up|Lost to Follow-up|66|||
125470646|NCT01532388|451353978|FG000|12-month Follow-up|Lost to Follow-up|69|||
125470647|NCT01532388|451353979|FG001|12-month Follow-up|Lost to Follow-up|67|||
125470648|NCT02919449|451353980|FG000|Overall Study|Withdrawal by Subject|1|||
125470649|NCT02919449|451353980|FG000|Overall Study|Investigator decision|1|||
125470650|NCT00727909|451353981|FG000|Overall Study|Withdrawal by Subject|5|||
125470651|NCT00727909|451353982|FG001|Overall Study|Withdrawal by Subject|11|||
125470652|NCT00727909|451353983|FG002|Overall Study|Withdrawal by Subject|8|||
125470653|NCT00727909|451353984|FG003|Overall Study|Withdrawal by Subject|5|||
125470654|NCT00727909|451353981|FG000|Overall Study|Death|0|||
125470655|NCT00727909|451353982|FG001|Overall Study|Death|0|||
125470656|NCT00727909|451353983|FG002|Overall Study|Death|1|||
125470657|NCT00727909|451353984|FG003|Overall Study|Death|0|||
125470658|NCT03578536|451353989|FG000|Overall Study|Lost to Follow-up|1|||
125470659|NCT05198310|451353990|FG000|Overall Study|Lost to Follow-up|0|||
125470660|NCT05198310|451353991|FG001|Overall Study|Lost to Follow-up|1|||
125470661|NCT05198310|451353992|FG002|Overall Study|Lost to Follow-up|0|||
125470662|NCT05198310|451353993|FG003|Overall Study|Lost to Follow-up|0|||
125470663|NCT05198310|451353994|FG004|Overall Study|Lost to Follow-up|0|||
125470664|NCT05198310|451353995|FG005|Overall Study|Lost to Follow-up|0|||
125470665|NCT05198310|451353996|FG006|Overall Study|Lost to Follow-up|0|||
125470666|NCT05198310|451353997|FG007|Overall Study|Lost to Follow-up|0|||
125470667|NCT05198310|451353990|FG000|Overall Study|Withdrawal by Subject|0|||
125470668|NCT05198310|451353991|FG001|Overall Study|Withdrawal by Subject|0|||
125470669|NCT05198310|451353992|FG002|Overall Study|Withdrawal by Subject|0|||
125470670|NCT05198310|451353993|FG003|Overall Study|Withdrawal by Subject|2|||
125470671|NCT05198310|451353994|FG004|Overall Study|Withdrawal by Subject|0|||
125470672|NCT05198310|451353995|FG005|Overall Study|Withdrawal by Subject|2|||
125470673|NCT05198310|451353996|FG006|Overall Study|Withdrawal by Subject|1|||
125470674|NCT05198310|451353997|FG007|Overall Study|Withdrawal by Subject|3|||
125470675|NCT04436107|451353998|FG000|Overall Study|Sponsor Ended Study|2|||
125470676|NCT04436107|451353999|FG001|Overall Study|Sponsor Ended Study|4|||
125470677|NCT04436107|451354000|FG002|Overall Study|Sponsor Ended Study|8|||
125470678|NCT04436107|451354001|FG003|Overall Study|Sponsor Ended Study|20|||
125470679|NCT04436107|451353998|FG000|Overall Study|Death|3|||
125470680|NCT04436107|451353999|FG001|Overall Study|Death|5|||
125470681|NCT04436107|451354000|FG002|Overall Study|Death|3|||
125470682|NCT04436107|451354001|FG003|Overall Study|Death|18|||
125470683|NCT04436107|451353998|FG000|Overall Study|Withdrawal by Subject|1|||
125470684|NCT04436107|451353999|FG001|Overall Study|Withdrawal by Subject|1|||
125470685|NCT04436107|451354000|FG002|Overall Study|Withdrawal by Subject|0|||
125470686|NCT04436107|451354001|FG003|Overall Study|Withdrawal by Subject|1|||
125470687|NCT00448669|451354004|FG000|Overall Study|Lost to Follow-up|52|||
125470688|NCT00448669|451354005|FG001|Overall Study|Lost to Follow-up|63|||
125470689|NCT00448669|451354004|FG000|Overall Study|Withdrawal by Subject|90|||
125470690|NCT00448669|451354005|FG001|Overall Study|Withdrawal by Subject|74|||
125470691|NCT00448669|451354004|FG000|Overall Study|Relocated|49|||
125470692|NCT00448669|451354005|FG001|Overall Study|Relocated|36|||
125470693|NCT00448669|451354004|FG000|Overall Study|Were withdrawn by investigator|10|||
125470694|NCT00448669|451354005|FG001|Overall Study|Were withdrawn by investigator|6|||
125470695|NCT00448669|451354004|FG000|Overall Study|Death|2|||
125470696|NCT00448669|451354005|FG001|Overall Study|Death|4|||
125470697|NCT00448669|451354004|FG000|Overall Study|Had other reasons|5|||
125470698|NCT00448669|451354005|FG001|Overall Study|Had other reasons|6|||
125470699|NCT00448669|451354004|FG000|Overall Study|HIV-infected at enrollment|1|||
125470700|NCT00448669|451354005|FG001|Overall Study|HIV-infected at enrollment|2|||
125470701|NCT00448669|451354004|FG000|Overall Study|Never started drug|9|||
125470702|NCT00448669|451354005|FG001|Overall Study|Never started drug|7|||
125470703|NCT02638337|451354006|FG000|Overall Study|Adverse Event|6|||
125470704|NCT02638337|451354007|FG001|Overall Study|Adverse Event|10|||
125470705|NCT02638337|451354006|FG000|Overall Study|Protocol Violation|3|||
125470706|NCT02638337|451354007|FG001|Overall Study|Protocol Violation|0|||
125470707|NCT02638337|451354006|FG000|Overall Study|Withdrawal by Subject|13|||
125470708|NCT02638337|451354007|FG001|Overall Study|Withdrawal by Subject|16|||
125470709|NCT02638337|451354006|FG000|Overall Study|Lost to Follow-up|7|||
125470710|NCT02638337|451354007|FG001|Overall Study|Lost to Follow-up|7|||
125470711|NCT02638337|451354006|FG000|Overall Study|Other - Miscellaneous|4|||
125470712|NCT02638337|451354007|FG001|Overall Study|Other - Miscellaneous|3|||
125470713|NCT03338816|451354017|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
125470714|NCT03338816|451354018|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
125470715|NCT03338816|451354019|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
125470716|NCT03338816|451354020|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
125470717|NCT03338816|451354017|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
125470718|NCT03338816|451354018|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
125470719|NCT03338816|451354019|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
125470720|NCT03338816|451354020|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
125470721|NCT03338816|451354017|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
125470722|NCT03338816|451354018|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
125470723|NCT03338816|451354019|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
125470724|NCT03338816|451354020|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
125470725|NCT03338816|451354017|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
125470726|NCT03338816|451354018|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
125470727|NCT03338816|451354019|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
125470728|NCT03338816|451354020|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
125470729|NCT03338816|451354017|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
125470730|NCT03338816|451354018|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
125470731|NCT03338816|451354019|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
125470732|NCT03338816|451354020|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
125470733|NCT03338816|451354017|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
125470734|NCT03338816|451354018|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
125470735|NCT03338816|451354019|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
125470736|NCT03338816|451354020|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
125470737|NCT03338816|451354017|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
125470738|NCT03338816|451354018|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
125470739|NCT03338816|451354019|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
125470740|NCT03338816|451354020|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
125470741|NCT03092726|451354025|FG000|Overall Study|Adverse Event|3|||
125470742|NCT03092726|451354026|FG001|Overall Study|Adverse Event|10|||
125470743|NCT03092726|451354025|FG000|Overall Study|Lack of Efficacy|0|||
125470744|NCT03092726|451354026|FG001|Overall Study|Lack of Efficacy|1|||
125470745|NCT03092726|451354025|FG000|Overall Study|Lost to Follow-up|1|||
125470746|NCT03092726|451354026|FG001|Overall Study|Lost to Follow-up|0|||
125470747|NCT03092726|451354025|FG000|Overall Study|Withdrawal by Subject|5|||
125470748|NCT03092726|451354026|FG001|Overall Study|Withdrawal by Subject|3|||
125470749|NCT04950127|451354027|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
125470750|NCT04950127|451354028|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
125470751|NCT04950127|451354029|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
125470752|NCT04950127|451354030|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
125470753|NCT04950127|451354031|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
125470754|NCT04950127|451354032|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
125470755|NCT04950127|451354027|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
125470756|NCT04950127|451354028|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
125470757|NCT04950127|451354029|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
125470758|NCT04950127|451354030|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
125470759|NCT04950127|451354031|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
125470760|NCT04950127|451354032|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
125470761|NCT04950127|451354027|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
125470762|NCT04950127|451354028|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
125470763|NCT04950127|451354029|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
125470764|NCT04950127|451354030|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
125470765|NCT04950127|451354031|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
125470766|NCT04950127|451354032|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
125470767|NCT04950127|451354027|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
125470768|NCT04950127|451354028|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
125470769|NCT04950127|451354029|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
125470770|NCT04950127|451354030|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
125470771|NCT04950127|451354031|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
125470772|NCT04950127|451354032|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
125470773|NCT04950127|451354027|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
125470774|NCT04950127|451354028|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
125470775|NCT04950127|451354029|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
125470776|NCT04950127|451354030|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
125470777|NCT04950127|451354031|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
125470778|NCT04950127|451354032|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
125470779|NCT03833167|451354037|FG000|Overall Study|Withdrawal by Subject|4|||
125470780|NCT03833167|451354038|FG001|Overall Study|Withdrawal by Subject|6|||
125470781|NCT03833167|451354037|FG000|Overall Study|Ongoing|186|||
125470782|NCT03833167|451354038|FG001|Overall Study|Ongoing|194|||
125470783|NCT03833167|451354037|FG000|Overall Study|Lost to Follow-up|1|||
125470784|NCT03833167|451354038|FG001|Overall Study|Lost to Follow-up|1|||
125470785|NCT03833167|451354037|FG000|Overall Study|Physician Decision|0|||
125470786|NCT03833167|451354038|FG001|Overall Study|Physician Decision|2|||
125470787|NCT03833167|451354037|FG000|Overall Study|Death|34|||
125470788|NCT03833167|451354038|FG001|Overall Study|Death|22|||
125470789|NCT01948661|451354040|FG000|Overall Study|Withdrawal by Subject|2|||
125470790|NCT01948661|451354041|FG001|Overall Study|Withdrawal by Subject|4|||
125470791|NCT03271489|451354042|FG000|Double-Blind (DB) Period|Adverse Event|4|||
125470792|NCT03271489|451354043|FG001|Double-Blind (DB) Period|Adverse Event|1|||
125470793|NCT03271489|451354042|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
125470794|NCT03271489|451354043|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
125470795|NCT03271489|451354042|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
125470796|NCT03271489|451354043|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
125470797|NCT03271489|451354042|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
125470798|NCT03271489|451354043|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
125470799|NCT03271489|451354042|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
125470800|NCT03271489|451354043|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
125470801|NCT03271489|451354042|FG000|Double-Blind (DB) Period|Other|6|||
125470802|NCT03271489|451354043|FG001|Double-Blind (DB) Period|Other|1|||
125470803|NCT03271489|451354042|FG000|Double-Blind (DB) Period|Missing|1|||
125470804|NCT03271489|451354043|FG001|Double-Blind (DB) Period|Missing|0|||
125470805|NCT03271489|451354042|FG000|Open-Label (OL) Period|Adverse Event|2|||
125470806|NCT03271489|451354043|FG001|Open-Label (OL) Period|Adverse Event|0|||
125470807|NCT03271489|451354042|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
125470808|NCT03271489|451354043|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
125470809|NCT03271489|451354042|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
125470810|NCT03271489|451354043|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
125470811|NCT03271489|451354042|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
125470812|NCT03271489|451354043|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
125470813|NCT03271489|451354042|FG000|Open-Label (OL) Period|No Specified|2|||
125470814|NCT03271489|451354043|FG001|Open-Label (OL) Period|No Specified|2|||
125470815|NCT03271489|451354042|FG000|Open-Label (OL) Period|Missing|2|||
125470816|NCT03271489|451354043|FG001|Open-Label (OL) Period|Missing|0|||
125470817|NCT03271489|451354042|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
125470818|NCT03271489|451354043|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
125470819|NCT03271489|451354042|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
125470820|NCT03271489|451354043|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
125470821|NCT03271489|451354042|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
125470822|NCT03271489|451354043|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
125470823|NCT03271489|451354042|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
125470824|NCT03271489|451354043|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
125470825|NCT03271489|451354042|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
125470826|NCT03271489|451354043|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
125470827|NCT03271489|451354042|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
125470828|NCT03271489|451354043|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
125470829|NCT03271489|451354042|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
125470830|NCT03271489|451354043|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
125470831|NCT03271489|451354042|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
125470832|NCT03271489|451354043|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
125470833|NCT02860130|451354044|FG000|Overall Study|Adverse Event|2|||
125470834|NCT02860130|451354045|FG001|Overall Study|Adverse Event|3|||
125470835|NCT02860130|451354044|FG000|Overall Study|Protocol Violation|1|||
125470836|NCT02860130|451354045|FG001|Overall Study|Protocol Violation|1|||
125470837|NCT02860130|451354044|FG000|Overall Study|Withdrawal by Subject|0|||
125470838|NCT02860130|451354045|FG001|Overall Study|Withdrawal by Subject|2|||
125470839|NCT02860130|451354044|FG000|Overall Study|Physician Decision|2|||
125470840|NCT02860130|451354045|FG001|Overall Study|Physician Decision|2|||
125470841|NCT02860130|451354044|FG000|Overall Study|Other|2|||
125470842|NCT02860130|451354045|FG001|Overall Study|Other|1|||
125470843|NCT03330795|451354046|FG000|Overall Study|Death|3|||
125470844|NCT03330795|451354046|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
125470845|NCT05575076|451354048|FG000|Overall Study|Adverse Event|24|||
125470846|NCT05575076|451354048|FG000|Overall Study|Death|7|||
125470847|NCT05575076|451354048|FG000|Overall Study|Lost to Follow-up|16|||
125470848|NCT05575076|451354048|FG000|Overall Study|Non-Compliance|3|||
125470849|NCT05575076|451354048|FG000|Overall Study|Physician Decision|6|||
125470850|NCT05575076|451354048|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
125470851|NCT05575076|451354048|FG000|Overall Study|Withdrawal by Subject|71|||
125470852|NCT05575076|451354048|FG000|Overall Study|Study Terminated by Sponsor|630|||
125470853|NCT05575076|451354048|FG000|Overall Study|Other|17|||
125470854|NCT01127373|451354049|FG000|Overall Study|Not Treated|3|||
125470855|NCT01127373|451354049|FG000|Overall Study|Lost to Follow-up|7|||
125470856|NCT01127373|451354049|FG000|Overall Study|Withdrawal by Subject|1|||
125470857|NCT01127373|451354049|FG000|Overall Study|Disease progression|1|||
125470858|NCT01426412|451354056|FG000|Overall Study|Withdrawal by Subject|1|||
125470859|NCT01426412|451354057|FG001|Overall Study|Withdrawal by Subject|0|||
125470860|NCT01426412|451354058|FG002|Overall Study|Withdrawal by Subject|0|||
125470861|NCT01426412|451354059|FG003|Overall Study|Withdrawal by Subject|0|||
125470862|NCT01426412|451354060|FG004|Overall Study|Withdrawal by Subject|1|||
125470863|NCT01426412|451354061|FG005|Overall Study|Withdrawal by Subject|0|||
125470864|NCT01426412|451354062|FG006|Overall Study|Withdrawal by Subject|0|||
125470865|NCT01426412|451354063|FG007|Overall Study|Withdrawal by Subject|3|||
125470866|NCT01426412|451354064|FG008|Overall Study|Withdrawal by Subject|1|||
125470867|NCT05450458|451354065|FG000|Overall Study|Lost to Follow-up|4|||
125470868|NCT00262301|451354067|FG000|Double-blind Phase|Lost to Follow-up|1|||
125470869|NCT00262301|451354068|FG001|Double-blind Phase|Lost to Follow-up|0|||
125470870|NCT00262301|451354069|FG002|Double-blind Phase|Lost to Follow-up|0|||
125470871|NCT00262301|451354067|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
125470872|NCT00262301|451354068|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
125470873|NCT00262301|451354069|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
125470874|NCT04567615|451354074|FG000|Randomization|Participant withdrew consent|1|||
125470875|NCT04567615|451354075|FG001|Randomization|Participant withdrew consent|0|||
125470876|NCT04567615|451354076|FG002|Randomization|Participant withdrew consent|0|||
125470877|NCT04567615|451354074|FG000|Randomization|Adverse event unrelated to study drug|0|||
125470878|NCT04567615|451354075|FG001|Randomization|Adverse event unrelated to study drug|1|||
125470879|NCT04567615|451354076|FG002|Randomization|Adverse event unrelated to study drug|0|||
125470880|NCT04567615|451354074|FG000|Treatment Period|Participant Withdrew Consent|2|||
125470881|NCT04567615|451354075|FG001|Treatment Period|Participant Withdrew Consent|5|||
125470882|NCT04567615|451354076|FG002|Treatment Period|Participant Withdrew Consent|1|||
125470883|NCT04567615|451354074|FG000|Treatment Period|Death|1|||
125470884|NCT04567615|451354075|FG001|Treatment Period|Death|2|||
125470885|NCT04567615|451354076|FG002|Treatment Period|Death|0|||
125470886|NCT04567615|451354074|FG000|Treatment Period|Lost to Follow-up|0|||
125470887|NCT04567615|451354075|FG001|Treatment Period|Lost to Follow-up|1|||
125470888|NCT04567615|451354076|FG002|Treatment Period|Lost to Follow-up|0|||
125470889|NCT04567615|451354074|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
125470890|NCT04567615|451354075|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
125470891|NCT04567615|451354076|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
125470892|NCT04567615|451354074|FG000|Treatment Period|Disease Progression|85|||
125470893|NCT04567615|451354075|FG001|Treatment Period|Disease Progression|63|||
125470894|NCT04567615|451354076|FG002|Treatment Period|Disease Progression|16|||
125470895|NCT04567615|451354074|FG000|Treatment Period|Study Drug Toxicity|3|||
125470896|NCT04567615|451354075|FG001|Treatment Period|Study Drug Toxicity|10|||
125470897|NCT04567615|451354076|FG002|Treatment Period|Study Drug Toxicity|4|||
125470898|NCT04567615|451354074|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
125470899|NCT04567615|451354075|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
125470900|NCT04567615|451354076|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
125470901|NCT04567615|451354074|FG000|Treatment Period|Other Reasons|1|||
125470902|NCT04567615|451354075|FG001|Treatment Period|Other Reasons|2|||
125470903|NCT04567615|451354076|FG002|Treatment Period|Other Reasons|0|||
125470904|NCT04567615|451354074|FG000|Treatment Period|Still On-going Treatment|21|||
125470905|NCT04567615|451354075|FG001|Treatment Period|Still On-going Treatment|22|||
125470906|NCT04567615|451354076|FG002|Treatment Period|Still On-going Treatment|2|||
125470907|NCT02152137|451355809|FG000|Overall Study|Withdrawal by Subject|1|||
125470908|NCT02152137|451355809|FG000|Overall Study|Originally assigned to Arm B|3|||
125470909|NCT05510232|451355810|FG000|Overall Study|Withdrawal by Subject|2|||
125470910|NCT05510232|451355811|FG001|Overall Study|Withdrawal by Subject|7|||
125470911|NCT05510232|451355812|FG002|Overall Study|Withdrawal by Subject|6|||
125299823|NCT01300260|450723768|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
125470912|NCT05307783|451355819|FG000|Overall Study|Death|7|||
125470913|NCT05307783|451355819|FG000|Overall Study|Lost to Follow-up|4|||
125470914|NCT04883645|451355820|FG000|Overall Study|Death|1|||
125470915|NCT05687903|451355821|FG000|Overall Study|Protocol Deviation|1|||
125470916|NCT05687903|451355822|FG001|Overall Study|Protocol Deviation|1|||
125470917|NCT05687903|451355823|FG002|Overall Study|Protocol Deviation|0|||
125470918|NCT05687903|451355824|FG003|Overall Study|Protocol Deviation|1|||
125470919|NCT05687903|451355825|FG004|Overall Study|Protocol Deviation|0|||
125470920|NCT04855760|451355826|FG000|Overall Study|Adverse Event|21|||
125470921|NCT04855760|451355826|FG000|Overall Study|Withdrawal by Subject|116|||
125470922|NCT04855760|451355826|FG000|Overall Study|Lack of Efficacy|21|||
125470923|NCT04855760|451355826|FG000|Overall Study|Lost to Follow-up|49|||
125470924|NCT04855760|451355826|FG000|Overall Study|Protocol Violation|2|||
125470925|NCT04855760|451355826|FG000|Overall Study|Physician Decision|5|||
125470926|NCT04855760|451355826|FG000|Overall Study|Pregnancy|1|||
125470927|NCT04855760|451355826|FG000|Overall Study|Non-Compliance with Study Drug|11|||
125470928|NCT04855760|451355826|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
125470929|NCT04855760|451355826|FG000|Overall Study|Study Completed by Sponsor|202|||
125470930|NCT04855760|451355826|FG000|Overall Study|Other|13|||
125470931|NCT05613205|451355827|FG000|Overall Study|Lost to Follow-up|0|||
125470932|NCT05613205|451355828|FG001|Overall Study|Lost to Follow-up|0|||
125470933|NCT05613205|451355829|FG002|Overall Study|Lost to Follow-up|1|||
125470934|NCT05613205|451355830|FG003|Overall Study|Lost to Follow-up|1|||
125470935|NCT05613205|451355831|FG004|Overall Study|Lost to Follow-up|0|||
125470936|NCT05613205|451355827|FG000|Overall Study|Withdrawal by Subject|0|||
125470937|NCT05613205|451355828|FG001|Overall Study|Withdrawal by Subject|0|||
125470938|NCT05613205|451355829|FG002|Overall Study|Withdrawal by Subject|1|||
125470939|NCT05613205|451355830|FG003|Overall Study|Withdrawal by Subject|1|||
125470940|NCT05613205|451355831|FG004|Overall Study|Withdrawal by Subject|0|||
125470941|NCT04869982|451355834|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
125470942|NCT04869982|451355835|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
125470943|NCT04869982|451355834|FG000|Overall Study|Migrated / moved from the study area|1|||
125470944|NCT04869982|451355835|FG001|Overall Study|Migrated / moved from the study area|1|||
125470945|NCT04869982|451355834|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
125470946|NCT04869982|451355835|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
125470947|NCT04869982|451355834|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
125470948|NCT04869982|451355835|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
125470949|NCT04869982|451355834|FG000|Overall Study|Solicited adverse event|2|||
125470950|NCT04869982|451355835|FG001|Overall Study|Solicited adverse event|1|||
125470951|NCT04112316|451355837|FG000|First Period (8 Weeks)|Protocol Violation|1|||
125470952|NCT04112316|451355838|FG001|First Period (8 Weeks)|Protocol Violation|0|||
125470953|NCT04112316|451355837|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
125470954|NCT04112316|451355838|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
125470955|NCT03857620|451355839|FG000|Overall Study|Death|4|||
125470956|NCT03857620|451355840|FG001|Overall Study|Death|5|||
125470957|NCT03857620|451355841|FG002|Overall Study|Death|7|||
125470958|NCT03857620|451355839|FG000|Overall Study|Lost to Follow-up|2|||
125470959|NCT03857620|451355840|FG001|Overall Study|Lost to Follow-up|5|||
125470960|NCT03857620|451355841|FG002|Overall Study|Lost to Follow-up|3|||
125470961|NCT03857620|451355839|FG000|Overall Study|Disease progression or relapse after study registration|1|||
125470962|NCT03857620|451355840|FG001|Overall Study|Disease progression or relapse after study registration|5|||
125470963|NCT03857620|451355841|FG002|Overall Study|Disease progression or relapse after study registration|1|||
125470964|NCT03857620|451355839|FG000|Overall Study|Ineligible|5|||
125470965|NCT03857620|451355840|FG001|Overall Study|Ineligible|0|||
125470966|NCT03857620|451355841|FG002|Overall Study|Ineligible|2|||
125470967|NCT03857620|451355839|FG000|Overall Study|No malignancy|1|||
125470968|NCT03857620|451355840|FG001|Overall Study|No malignancy|0|||
125470969|NCT03857620|451355841|FG002|Overall Study|No malignancy|1|||
125470970|NCT03857620|451355839|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
125470971|NCT03857620|451355840|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
125470972|NCT03857620|451355841|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
125470973|NCT03857620|451355839|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
125470974|NCT03857620|451355840|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
125470975|NCT03857620|451355841|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
125470976|NCT03857620|451355839|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
125470977|NCT03857620|451355840|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
125470978|NCT03857620|451355841|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
125470979|NCT03857620|451355839|FG000|Overall Study|Surgery not performed, patient decision|0|||
125470980|NCT03857620|451355840|FG001|Overall Study|Surgery not performed, patient decision|3|||
125470981|NCT03857620|451355841|FG002|Overall Study|Surgery not performed, patient decision|1|||
125470982|NCT03857620|451355839|FG000|Overall Study|Surgery not performed, other reason|3|||
125470983|NCT03857620|451355840|FG001|Overall Study|Surgery not performed, other reason|1|||
125470984|NCT03857620|451355841|FG002|Overall Study|Surgery not performed, other reason|4|||
125470985|NCT03857620|451355839|FG000|Overall Study|Worsening performance status after surgery performed|0|||
125299824|NCT01300260|450723769|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
125470986|NCT03857620|451355840|FG001|Overall Study|Worsening performance status after surgery performed|1|||
125470987|NCT03857620|451355841|FG002|Overall Study|Worsening performance status after surgery performed|1|||
125470988|NCT02473250|451355842|FG000|Overall Study|Lost to Follow-up|10|||
125470989|NCT02473250|451355842|FG000|Overall Study|Physician Decision|5|||
125470990|NCT02473250|451355842|FG000|Overall Study|Did not tolerate medication washout|3|||
125470991|NCT02473250|451355842|FG000|Overall Study|Antidepressant effect of divalproex|2|||
125470992|NCT04143061|451355846|FG000|Overall Study|Protocol Deviation|0|||
125470993|NCT04143061|451355847|FG001|Overall Study|Protocol Deviation|0|||
125470994|NCT04143061|451355848|FG002|Overall Study|Protocol Deviation|0|||
125470995|NCT04143061|451355849|FG003|Overall Study|Protocol Deviation|0|||
125470996|NCT04143061|451355850|FG004|Overall Study|Protocol Deviation|0|||
125470997|NCT04143061|451355851|FG005|Overall Study|Protocol Deviation|0|||
125470998|NCT04143061|451355852|FG006|Overall Study|Protocol Deviation|5|||
125470999|NCT04143061|451355853|FG007|Overall Study|Protocol Deviation|5|||
125471000|NCT04143061|451355846|FG000|Overall Study|Withdrawal by Subject|2|||
125471001|NCT04143061|451355847|FG001|Overall Study|Withdrawal by Subject|0|||
125471002|NCT04143061|451355848|FG002|Overall Study|Withdrawal by Subject|0|||
125471003|NCT04143061|451355849|FG003|Overall Study|Withdrawal by Subject|0|||
125471004|NCT04143061|451355850|FG004|Overall Study|Withdrawal by Subject|0|||
125471005|NCT04143061|451355851|FG005|Overall Study|Withdrawal by Subject|1|||
125471006|NCT04143061|451355852|FG006|Overall Study|Withdrawal by Subject|0|||
125471007|NCT04143061|451355853|FG007|Overall Study|Withdrawal by Subject|0|||
125471008|NCT04143061|451355846|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125471009|NCT04143061|451355847|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125471010|NCT04143061|451355848|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125471011|NCT04143061|451355849|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125471012|NCT04143061|451355850|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
125471013|NCT04143061|451355851|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
125471014|NCT04143061|451355852|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
125471015|NCT04143061|451355853|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
125471016|NCT03602014|451355856|FG000|Overall Study|Lost to Follow-up|2|||
125471017|NCT03602014|451355857|FG001|Overall Study|Lost to Follow-up|0|||
125471018|NCT03602014|451355858|FG002|Overall Study|Lost to Follow-up|0|||
125471019|NCT01898494|451355859|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
125471020|NCT01898494|451355860|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
125471021|NCT01898494|451355861|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
125471022|NCT01898494|451355862|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
125471023|NCT01898494|451355863|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
125471024|NCT01898494|451355859|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
125471025|NCT01898494|451355860|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
125471026|NCT01898494|451355861|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
125471027|NCT01898494|451355862|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
125471028|NCT01898494|451355863|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
125471029|NCT01898494|451355859|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
125471030|NCT01898494|451355860|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
125471031|NCT01898494|451355861|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
125471032|NCT01898494|451355862|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
125471033|NCT01898494|451355863|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
125471034|NCT01898494|451355859|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
125471035|NCT01898494|451355860|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
125471036|NCT01898494|451355861|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
125471037|NCT01898494|451355862|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
125471038|NCT01898494|451355863|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
125471039|NCT01898494|451355859|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
125471040|NCT01898494|451355860|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
125471041|NCT01898494|451355861|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
125471042|NCT01898494|451355862|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
125471043|NCT01898494|451355863|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
125471044|NCT01898494|451355859|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
125471045|NCT01898494|451355860|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
125471046|NCT01898494|451355861|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
125471047|NCT01898494|451355862|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
125471048|NCT01898494|451355863|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
125471049|NCT01898494|451355859|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
125471050|NCT01898494|451355860|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
125471051|NCT01898494|451355861|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
125471052|NCT01898494|451355862|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
125471053|NCT01898494|451355863|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
125471054|NCT01898494|451355859|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
125471055|NCT01898494|451355860|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
125471056|NCT01898494|451355861|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
125471057|NCT01898494|451355862|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
125299825|NCT01300260|450723768|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
125471058|NCT01898494|451355863|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
125471059|NCT01898494|451355859|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
125471060|NCT01898494|451355860|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
125471061|NCT01898494|451355861|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
125471062|NCT01898494|451355862|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
125471063|NCT01898494|451355863|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
125471064|NCT01898494|451355859|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
125471065|NCT01898494|451355860|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
125471066|NCT01898494|451355861|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
125471067|NCT01898494|451355862|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
125471068|NCT01898494|451355863|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
125471069|NCT01898494|451355859|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
125471070|NCT01898494|451355860|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
125471071|NCT01898494|451355861|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
125471072|NCT01898494|451355862|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
125471073|NCT01898494|451355863|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
125471074|NCT01898494|451355859|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
125471075|NCT01898494|451355860|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
125471076|NCT01898494|451355861|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
125471077|NCT01898494|451355862|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
125471078|NCT01898494|451355863|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
125471079|NCT01898494|451355859|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
125471080|NCT01898494|451355860|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
125471081|NCT01898494|451355861|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
125471082|NCT01898494|451355862|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
125471083|NCT01898494|451355863|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
125471084|NCT01898494|451355859|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
125471085|NCT01898494|451355860|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
125471086|NCT01898494|451355861|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
125471087|NCT01898494|451355862|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
125471088|NCT01898494|451355863|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
125471089|NCT03289039|451355864|FG000|Overall Study|Withdrawal by Subject|0|||
125471090|NCT03289039|451355865|FG001|Overall Study|Withdrawal by Subject|1|||
125471091|NCT03289039|451355864|FG000|Overall Study|Became ineligible prior to treatment start|0|||
125471092|NCT03289039|451355865|FG001|Overall Study|Became ineligible prior to treatment start|1|||
125471093|NCT03289039|451355864|FG000|Overall Study|progressed before treatment start|1|||
125471094|NCT03289039|451355865|FG001|Overall Study|progressed before treatment start|0|||
125471095|NCT04732494|451355868|FG000|Overall Study|Death|39|||
125471096|NCT04732494|451355869|FG001|Overall Study|Death|36|||
125471097|NCT04732494|451355868|FG000|Overall Study|Study Closed by Sponsor|20|||
125471098|NCT04732494|451355869|FG001|Overall Study|Study Closed by Sponsor|15|||
125471099|NCT04732494|451355868|FG000|Overall Study|Withdrawal by Subject|2|||
125471100|NCT04732494|451355869|FG001|Overall Study|Withdrawal by Subject|7|||
125471101|NCT04732494|451355868|FG000|Overall Study|Lost to Follow-up|1|||
125471102|NCT04732494|451355869|FG001|Overall Study|Lost to Follow-up|5|||
125471103|NCT01718743|451355870|FG000|Overall Study|Physician Decision|7|||
125471104|NCT01718743|451355870|FG000|Overall Study|Withdrawal by Subject|14|||
125471105|NCT01718743|451355870|FG000|Overall Study|Progressive Disease|22|||
125471106|NCT01718743|451355870|FG000|Overall Study|Toxicity|1|||
125471107|NCT01718743|451355870|FG000|Overall Study|Malignancy|1|||
125471108|NCT03897686|451355871|FG000|Overall Study|Protocol Violation|1|||
125471109|NCT03897686|451355872|FG001|Overall Study|Protocol Violation|1|||
125471110|NCT03897686|451355871|FG000|Overall Study|Withdrawal by Subject|1|||
125471111|NCT03897686|451355872|FG001|Overall Study|Withdrawal by Subject|1|||
125471112|NCT04905407|451355873|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
125471113|NCT04905407|451355874|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
125471114|NCT04905407|451355875|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
125471115|NCT04905407|451355876|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
125471116|NCT04905407|451355873|FG000|Part 1 and Part 2|Death|7|||
125471117|NCT04905407|451355874|FG001|Part 1 and Part 2|Death|7|||
125471118|NCT04905407|451355875|FG002|Part 1 and Part 2|Death|7|||
125471119|NCT04905407|451355876|FG003|Part 1 and Part 2|Death|0|||
125471120|NCT04905407|451355873|FG000|Part 1 and Part 2|Other than specified|0|||
125471121|NCT04905407|451355874|FG001|Part 1 and Part 2|Other than specified|0|||
125471122|NCT04905407|451355875|FG002|Part 1 and Part 2|Other than specified|1|||
125471123|NCT04905407|451355876|FG003|Part 1 and Part 2|Other than specified|0|||
125471124|NCT04905407|451355873|FG000|Part 3|Death|0|||
125471125|NCT04905407|451355874|FG001|Part 3|Death|0|||
125471126|NCT04905407|451355875|FG002|Part 3|Death|0|||
125471127|NCT04905407|451355876|FG003|Part 3|Death|2|||
125471128|NCT03263026|451355879|FG000|Overall Study|Withdrawal by Subject|1|||
125471129|NCT03263026|451355880|FG001|Overall Study|Withdrawal by Subject|0|||
125471130|NCT03263026|451355879|FG000|Overall Study|Death|1|||
125471131|NCT03263026|451355880|FG001|Overall Study|Death|0|||
125471132|NCT03263026|451355879|FG000|Overall Study|Other/ Various|41|||
125471133|NCT03263026|451355880|FG001|Overall Study|Other/ Various|29|||
125471134|NCT03739996|451355883|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
125471135|NCT03739996|451355883|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
125471136|NCT03739996|451355883|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
125471137|NCT03739996|451355883|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
125471138|NCT03739996|451355883|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
125471139|NCT03739996|451355883|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
125471140|NCT03739996|451355883|FG000|Step 3 (SOC ART)|Death|1|||
125471141|NCT03739996|451355883|FG000|Step 3 (SOC ART)|Participant moved|1|||
125471142|NCT01673984|451355884|FG000|Overall Study|Adverse Event|1|||
125471143|NCT01673984|451355885|FG001|Overall Study|Adverse Event|0|||
125471144|NCT01673984|451355884|FG000|Overall Study|Study termination|9|||
125471145|NCT01673984|451355885|FG001|Overall Study|Study termination|6|||
125471146|NCT02553642|451355886|FG000|Overall Study|Withdrawal by Subject|0|||
125471147|NCT02553642|451355887|FG001|Overall Study|Withdrawal by Subject|3|||
125471148|NCT02553642|451355886|FG000|Overall Study|Physician Decision|0|||
125471149|NCT02553642|451355887|FG001|Overall Study|Physician Decision|1|||
125471150|NCT02553642|451355886|FG000|Overall Study|Additional cancer dx|0|||
125471151|NCT02553642|451355887|FG001|Overall Study|Additional cancer dx|1|||
125471152|NCT02553642|451355886|FG000|Overall Study|Never started treatment|0|||
125471153|NCT02553642|451355887|FG001|Overall Study|Never started treatment|1|||
125471154|NCT04437433|451355888|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
125471155|NCT04437433|451355889|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
125471156|NCT04437433|451355888|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
125471157|NCT04437433|451355889|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
125471158|NCT04437433|451355888|FG000|Overall Study|Adverse Event|9|||
125471159|NCT04437433|451355889|FG001|Overall Study|Adverse Event|0|||
125471160|NCT04437433|451355888|FG000|Overall Study|Lack of Efficacy|4|||
125471161|NCT04437433|451355889|FG001|Overall Study|Lack of Efficacy|0|||
125471162|NCT04437433|451355888|FG000|Overall Study|Withdrawal by Subject|4|||
125471163|NCT04437433|451355889|FG001|Overall Study|Withdrawal by Subject|1|||
125471164|NCT04437433|451355888|FG000|Overall Study|Protocol Deviation|0|||
125471165|NCT04437433|451355889|FG001|Overall Study|Protocol Deviation|1|||
125471166|NCT04437433|451355888|FG000|Overall Study|Other, not specified|0|||
125471167|NCT04437433|451355889|FG001|Overall Study|Other, not specified|1|||
125471168|NCT02697136|451355893|FG000|Overall Study|Adverse Event|3|||
125471169|NCT02697136|451355894|FG001|Overall Study|Adverse Event|0|||
125471170|NCT01095796|451355895|FG000|Overall Study|Randomized but Not Treated|5|||
125471171|NCT01095796|451355896|FG001|Overall Study|Randomized but Not Treated|2|||
125471172|NCT01095796|451355895|FG000|Overall Study|Adverse Event|9|||
125471173|NCT01095796|451355896|FG001|Overall Study|Adverse Event|19|||
125471174|NCT01095796|451355895|FG000|Overall Study|Death|3|||
125471175|NCT01095796|451355896|FG001|Overall Study|Death|2|||
125471176|NCT01095796|451355895|FG000|Overall Study|Pregnancy|2|||
125471177|NCT01095796|451355896|FG001|Overall Study|Pregnancy|0|||
125471178|NCT01095796|451355895|FG000|Overall Study|Lack of Efficacy|5|||
125471179|NCT01095796|451355896|FG001|Overall Study|Lack of Efficacy|3|||
125471180|NCT01095796|451355895|FG000|Overall Study|Investigator's Discretion|7|||
125471181|NCT01095796|451355896|FG001|Overall Study|Investigator's Discretion|2|||
125471182|NCT01095796|451355895|FG000|Overall Study|Withdrew Consent|16|||
125471183|NCT01095796|451355896|FG001|Overall Study|Withdrew Consent|22|||
125471184|NCT01095796|451355895|FG000|Overall Study|Lost to Follow-up|27|||
125471185|NCT01095796|451355896|FG001|Overall Study|Lost to Follow-up|29|||
125471186|NCT01095796|451355895|FG000|Overall Study|Participant Noncompliance|5|||
125471187|NCT01095796|451355896|FG001|Overall Study|Participant Noncompliance|10|||
125471188|NCT01095796|451355895|FG000|Overall Study|Protocol Violation|1|||
125471189|NCT01095796|451355896|FG001|Overall Study|Protocol Violation|0|||
125471190|NCT01095796|451355895|FG000|Overall Study|Participant Transferred to Another Study|215|||
125471191|NCT01095796|451355896|FG001|Overall Study|Participant Transferred to Another Study|200|||
125471192|NCT04116736|451355899|FG000|Overall Study|Withdrew consent during study|3|||
125471193|NCT04116736|451355900|FG001|Overall Study|Withdrew consent during study|1|||
125471194|NCT04116736|451355899|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
125471195|NCT04116736|451355900|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
125471196|NCT04116736|451355899|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
125471197|NCT04116736|451355900|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
125471198|NCT04116736|451355899|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
125471199|NCT04116736|451355900|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
125471200|NCT04116736|451355899|FG000|Overall Study|Subject was enrolled in error|2|||
125471201|NCT04116736|451355900|FG001|Overall Study|Subject was enrolled in error|0|||
125471202|NCT04116736|451355899|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
125471203|NCT04116736|451355900|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
125471204|NCT04116736|451355899|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
125471205|NCT04116736|451355900|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
125471206|NCT04116736|451355899|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
125471207|NCT04116736|451355900|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
125471208|NCT05512962|451355904|FG000|Overall Study|Withdrawal by Subject|1|||
125471209|NCT05512962|451355905|FG001|Overall Study|Withdrawal by Subject|0|||
125471210|NCT04157348|451355906|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
125471211|NCT04157348|451355907|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
125471212|NCT04157348|451355906|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
125471213|NCT04157348|451355907|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
125471214|NCT04157348|451355906|FG000|Double-blind Treatment Period|Adverse Event|0|||
125471215|NCT04157348|451355907|FG001|Double-blind Treatment Period|Adverse Event|1|||
125471216|NCT04157348|451355906|FG000|Open-label Extension Period|Adverse Event|1|||
125471217|NCT04157348|451355907|FG001|Open-label Extension Period|Adverse Event|1|||
125471218|NCT04157348|451355906|FG000|Open-label Extension Period|Death|0|||
125471219|NCT04157348|451355907|FG001|Open-label Extension Period|Death|1|||
125471220|NCT04157348|451355906|FG000|Open-label Extension Period|Lack of Efficacy|2|||
125471221|NCT04157348|451355907|FG001|Open-label Extension Period|Lack of Efficacy|2|||
125471222|NCT04157348|451355906|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
125471223|NCT04157348|451355907|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
125471224|NCT04157348|451355906|FG000|Open-label Extension Period|Ongoing|60|||
125471225|NCT04157348|451355907|FG001|Open-label Extension Period|Ongoing|57|||
125471226|NCT04157348|451355906|FG000|Open-label Extension Period|other reasons|1|||
125471227|NCT04157348|451355907|FG001|Open-label Extension Period|other reasons|1|||
125471228|NCT02965846|451355908|FG000|Overall Study|Lost to Follow-up|1|||
125471229|NCT02965846|451355909|FG001|Overall Study|Lost to Follow-up|0|||
125471230|NCT02965846|451355910|FG002|Overall Study|Lost to Follow-up|0|||
125471231|NCT02965846|451355908|FG000|Overall Study|Withdrawal by Subject|0|||
125471232|NCT02965846|451355909|FG001|Overall Study|Withdrawal by Subject|1|||
125471233|NCT02965846|451355910|FG002|Overall Study|Withdrawal by Subject|0|||
125471234|NCT02965846|451355908|FG000|Overall Study|Study Terminated By Sponsor|4|||
125471235|NCT02965846|451355909|FG001|Overall Study|Study Terminated By Sponsor|4|||
125471236|NCT02965846|451355910|FG002|Overall Study|Study Terminated By Sponsor|0|||
125471237|NCT02965846|451355908|FG000|Overall Study|Participants not randomized|0|||
125471238|NCT02965846|451355909|FG001|Overall Study|Participants not randomized|0|||
125471239|NCT02965846|451355910|FG002|Overall Study|Participants not randomized|33|||
125471240|NCT01084707|451355911|FG000|Overall Study|Withdrawal by Subject|6|||
125471241|NCT00879333|451355914|FG000|Overall Study|Adverse Event|94|||
125471242|NCT00879333|451355915|FG001|Overall Study|Adverse Event|34|||
125471243|NCT00879333|451355914|FG000|Overall Study|Abnormal Laboratory Value|1|||
125471244|NCT00879333|451355915|FG001|Overall Study|Abnormal Laboratory Value|0|||
125471245|NCT00879333|451355914|FG000|Overall Study|Withdrawal by Subject|20|||
125471246|NCT00879333|451355915|FG001|Overall Study|Withdrawal by Subject|7|||
125471247|NCT00879333|451355914|FG000|Overall Study|Lost to Follow-up|2|||
125471248|NCT00879333|451355915|FG001|Overall Study|Lost to Follow-up|1|||
125471249|NCT00879333|451355914|FG000|Overall Study|Administrative Problems|2|||
125471250|NCT00879333|451355915|FG001|Overall Study|Administrative Problems|0|||
125471251|NCT00879333|451355914|FG000|Overall Study|Death|16|||
125471252|NCT00879333|451355915|FG001|Overall Study|Death|5|||
125471253|NCT00879333|451355914|FG000|Overall Study|Disease Progression|292|||
125471254|NCT00879333|451355915|FG001|Overall Study|Disease Progression|169|||
125471255|NCT00879333|451355914|FG000|Overall Study|Protocol Violation|1|||
125471256|NCT00879333|451355915|FG001|Overall Study|Protocol Violation|1|||
125471257|NCT02671435|451355918|FG000|Overall Study|Death|1|||
125471258|NCT02671435|451355919|FG001|Overall Study|Death|3|||
125471259|NCT02671435|451355920|FG002|Overall Study|Death|0|||
125471260|NCT02671435|451355921|FG003|Overall Study|Death|16|||
125471261|NCT02671435|451355922|FG004|Overall Study|Death|14|||
125471262|NCT02671435|451355923|FG005|Overall Study|Death|29|||
125471263|NCT02671435|451355924|FG006|Overall Study|Death|34|||
125471264|NCT02671435|451355925|FG007|Overall Study|Death|28|||
125471265|NCT02671435|451355926|FG008|Overall Study|Death|19|||
125471266|NCT02671435|451355927|FG009|Overall Study|Death|10|||
125471267|NCT02671435|451355928|FG010|Overall Study|Death|8|||
125471268|NCT02671435|451355929|FG011|Overall Study|Death|29|||
125471269|NCT02671435|451355930|FG012|Overall Study|Death|29|||
125471270|NCT02671435|451355931|FG013|Overall Study|Death|29|||
125471271|NCT02671435|451355932|FG014|Overall Study|Death|27|||
125471272|NCT02671435|451355918|FG000|Overall Study|Lost to Follow-up|0|||
125471273|NCT02671435|451355919|FG001|Overall Study|Lost to Follow-up|0|||
125471274|NCT02671435|451355920|FG002|Overall Study|Lost to Follow-up|1|||
125471275|NCT02671435|451355921|FG003|Overall Study|Lost to Follow-up|0|||
125471276|NCT02671435|451355922|FG004|Overall Study|Lost to Follow-up|1|||
125471277|NCT02671435|451355923|FG005|Overall Study|Lost to Follow-up|1|||
125471278|NCT02671435|451355924|FG006|Overall Study|Lost to Follow-up|2|||
125471279|NCT02671435|451355925|FG007|Overall Study|Lost to Follow-up|2|||
125471280|NCT02671435|451355926|FG008|Overall Study|Lost to Follow-up|0|||
125471281|NCT02671435|451355927|FG009|Overall Study|Lost to Follow-up|2|||
125471282|NCT02671435|451355928|FG010|Overall Study|Lost to Follow-up|0|||
125471283|NCT02671435|451355929|FG011|Overall Study|Lost to Follow-up|3|||
125471284|NCT02671435|451355930|FG012|Overall Study|Lost to Follow-up|3|||
125471285|NCT02671435|451355931|FG013|Overall Study|Lost to Follow-up|2|||
125471286|NCT02671435|451355932|FG014|Overall Study|Lost to Follow-up|0|||
125471287|NCT02671435|451355918|FG000|Overall Study|Withdrawal by Subject|2|||
125471288|NCT02671435|451355919|FG001|Overall Study|Withdrawal by Subject|0|||
125471289|NCT02671435|451355920|FG002|Overall Study|Withdrawal by Subject|2|||
125471290|NCT02671435|451355921|FG003|Overall Study|Withdrawal by Subject|2|||
125471291|NCT02671435|451355922|FG004|Overall Study|Withdrawal by Subject|2|||
125471292|NCT02671435|451355923|FG005|Overall Study|Withdrawal by Subject|7|||
125471293|NCT02671435|451355924|FG006|Overall Study|Withdrawal by Subject|2|||
125471294|NCT02671435|451355925|FG007|Overall Study|Withdrawal by Subject|7|||
125471295|NCT02671435|451355926|FG008|Overall Study|Withdrawal by Subject|1|||
125471296|NCT02671435|451355927|FG009|Overall Study|Withdrawal by Subject|1|||
125299826|NCT01300260|450723769|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
125299827|NCT00293020|450723776|FG000|Overall Study|Withdrawal by Subject|34|||
125299828|NCT00293020|450723776|FG000|Overall Study|Adverse Event|30|||
125299829|NCT00293020|450723776|FG000|Overall Study|Death|32|||
125299830|NCT00293020|450723776|FG000|Overall Study|Lack of Efficacy|12|||
125299831|NCT00293020|450723776|FG000|Overall Study|Lost to Follow-up|4|||
125299832|NCT00293020|450723776|FG000|Overall Study|Protocol Violation|6|||
125299833|NCT00293020|450723776|FG000|Overall Study|Physician Decision|21|||
125471297|NCT02671435|451355928|FG010|Overall Study|Withdrawal by Subject|2|||
125471298|NCT02671435|451355929|FG011|Overall Study|Withdrawal by Subject|4|||
125471299|NCT02671435|451355930|FG012|Overall Study|Withdrawal by Subject|4|||
125471300|NCT02671435|451355931|FG013|Overall Study|Withdrawal by Subject|4|||
125471301|NCT02671435|451355932|FG014|Overall Study|Withdrawal by Subject|2|||
125471302|NCT02671435|451355918|FG000|Overall Study|Un-specified|0|||
125471303|NCT02671435|451355919|FG001|Overall Study|Un-specified|0|||
125471304|NCT02671435|451355920|FG002|Overall Study|Un-specified|0|||
125471305|NCT02671435|451355921|FG003|Overall Study|Un-specified|0|||
125471306|NCT02671435|451355922|FG004|Overall Study|Un-specified|1|||
125471307|NCT02671435|451355923|FG005|Overall Study|Un-specified|3|||
125471308|NCT02671435|451355924|FG006|Overall Study|Un-specified|2|||
125471309|NCT02671435|451355925|FG007|Overall Study|Un-specified|3|||
125471310|NCT02671435|451355926|FG008|Overall Study|Un-specified|0|||
125471311|NCT02671435|451355927|FG009|Overall Study|Un-specified|5|||
125471312|NCT02671435|451355928|FG010|Overall Study|Un-specified|8|||
125471313|NCT02671435|451355929|FG011|Overall Study|Un-specified|4|||
125471314|NCT02671435|451355930|FG012|Overall Study|Un-specified|5|||
125471315|NCT02671435|451355931|FG013|Overall Study|Un-specified|9|||
125471316|NCT02671435|451355932|FG014|Overall Study|Un-specified|8|||
125471317|NCT02412748|451355935|FG000|Overall Study|Lost to Follow-up|38|||
125471318|NCT02412748|451355936|FG001|Overall Study|Lost to Follow-up|39|||
125471319|NCT03069313|451355937|FG000|Overall Study|Adverse Event|5|||
125471320|NCT01872078|451355941|FG000|Overall Study|Adverse Event|0|||
125471321|NCT01872078|451355942|FG001|Overall Study|Adverse Event|0|||
125471322|NCT01872078|451355943|FG002|Overall Study|Adverse Event|1|||
125471323|NCT01872078|451355944|FG003|Overall Study|Adverse Event|0|||
125471324|NCT01872078|451355941|FG000|Overall Study|Dose administration non-compliance|0|||
125471325|NCT01872078|451355942|FG001|Overall Study|Dose administration non-compliance|0|||
125471326|NCT01872078|451355943|FG002|Overall Study|Dose administration non-compliance|0|||
125471327|NCT01872078|451355944|FG003|Overall Study|Dose administration non-compliance|1|||
125471328|NCT01872078|451355941|FG000|Overall Study|Protocol Violation|0|||
125471329|NCT01872078|451355942|FG001|Overall Study|Protocol Violation|0|||
125471330|NCT01872078|451355943|FG002|Overall Study|Protocol Violation|1|||
125471331|NCT01872078|451355944|FG003|Overall Study|Protocol Violation|0|||
125299834|NCT00293020|450723776|FG000|Overall Study|Other Reason|22|||
125299835|NCT00293020|450723776|FG000|Overall Study|No dose taken|1|||
125471332|NCT01872078|451355941|FG000|Overall Study|Withdrawal by Subject|0|||
125471333|NCT01872078|451355942|FG001|Overall Study|Withdrawal by Subject|0|||
125471334|NCT01872078|451355943|FG002|Overall Study|Withdrawal by Subject|1|||
125471335|NCT01872078|451355944|FG003|Overall Study|Withdrawal by Subject|0|||
125471336|NCT01872078|451355941|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
125471337|NCT01872078|451355942|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
125471338|NCT01872078|451355943|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
125471339|NCT01872078|451355944|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
125471340|NCT00761189|451355945|FG000|Overall Study|Adverse Event|42|||
125471341|NCT00761189|451355945|FG000|Overall Study|Lack of Efficacy|45|||
125299836|NCT01147848|450723779|FG000|Run-in Period|Screen Failure|623|||
125471342|NCT00761189|451355945|FG000|Overall Study|Lost to Follow-up|36|||
125471343|NCT00761189|451355945|FG000|Overall Study|Withdrawal by Subject|49|||
125471344|NCT00761189|451355945|FG000|Overall Study|Other|13|||
125471345|NCT01494922|451355946|FG000|Overall Study|Adverse Event|1|||
125471346|NCT02759016|451355947|FG000|Overall Study|Not treated with BI 836826|1|||
125471347|NCT02759016|451355948|FG001|Overall Study|Not treated with BI 836826|0|||
125471348|NCT02759016|451355947|FG000|Overall Study|Progressive disease|1|||
125471349|NCT02759016|451355948|FG001|Overall Study|Progressive disease|0|||
125471350|NCT02759016|451355947|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
125299837|NCT01147848|450723780|FG001|Run-in Period|Screen Failure|0|||
125471351|NCT02759016|451355948|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
125471352|NCT02759016|451355947|FG000|Overall Study|Other not defined above|2|||
125471353|NCT02759016|451355948|FG001|Overall Study|Other not defined above|1|||
125471354|NCT03939312|451355949|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
125471355|NCT03939312|451355949|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
125471356|NCT03939312|451355949|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
125471357|NCT03939312|451355949|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
125471358|NCT03939312|451355949|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
125471359|NCT03939312|451355949|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
125471360|NCT03939312|451355949|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
125471361|NCT03939312|451355949|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
125471362|NCT03939312|451355949|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
125471363|NCT03939312|451355949|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
125471364|NCT03939312|451355949|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
125471365|NCT03939312|451355949|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
125471366|NCT02119650|451355950|FG000|Overall Study|Adverse Event|3|||
125471367|NCT02119650|451355951|FG001|Overall Study|Adverse Event|4|||
125471368|NCT02119650|451355950|FG000|Overall Study|Subject decision|2|||
125471369|NCT02119650|451355951|FG001|Overall Study|Subject decision|3|||
125471370|NCT02119650|451355950|FG000|Overall Study|Disease progression|11|||
125471371|NCT02119650|451355951|FG001|Overall Study|Disease progression|14|||
125471372|NCT02119650|451355950|FG000|Overall Study|Death|5|||
125471373|NCT02119650|451355951|FG001|Overall Study|Death|1|||
125471374|NCT02119650|451355950|FG000|Overall Study|Noncompliance with study treatment|1|||
125471375|NCT02119650|451355951|FG001|Overall Study|Noncompliance with study treatment|1|||
125471376|NCT02119650|451355950|FG000|Overall Study|Study terminated by the sponsor|1|||
125471377|NCT02119650|451355951|FG001|Overall Study|Study terminated by the sponsor|0|||
125471378|NCT02119650|451355950|FG000|Overall Study|Physician Decision|0|||
125471379|NCT02119650|451355951|FG001|Overall Study|Physician Decision|2|||
125471380|NCT02119650|451355950|FG000|Overall Study|Multiple reasons for termination|2|||
125471381|NCT02119650|451355951|FG001|Overall Study|Multiple reasons for termination|1|||
125471382|NCT01721291|451355952|FG000|Overall Study|Withdrawal by Subject|1|||
125471383|NCT01721291|451355953|FG001|Overall Study|Withdrawal by Subject|0|||
125471384|NCT01721291|451355952|FG000|Overall Study|did not like the treatment|1|||
125471385|NCT01721291|451355953|FG001|Overall Study|did not like the treatment|0|||
125471386|NCT04059354|451357141|FG000|Overall Study|COVID-19 pandemic|3|||
125471387|NCT05403801|451357142|FG000|Overall Study|Withdrawal by Subject|2|||
125471388|NCT03651895|451357144|FG000|First Drug Assignment|Adverse Event|4|||
125471389|NCT03651895|451357145|FG001|First Drug Assignment|Adverse Event|5|||
125471390|NCT03651895|451357144|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
125471391|NCT03651895|451357145|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
125471392|NCT02525692|451357146|FG000|Overall Study|Withdrawal by Subject|1|||
125471393|NCT02525692|451357147|FG001|Overall Study|Withdrawal by Subject|1|||
125471394|NCT02525692|451357148|FG002|Overall Study|Withdrawal by Subject|0|||
125471395|NCT02525692|451357149|FG003|Overall Study|Withdrawal by Subject|5|||
125471396|NCT02525692|451357150|FG004|Overall Study|Withdrawal by Subject|0|||
125471397|NCT02525692|451357151|FG005|Overall Study|Withdrawal by Subject|1|||
125471398|NCT02525692|451357146|FG000|Overall Study|Death|16|||
125471399|NCT02525692|451357147|FG001|Overall Study|Death|18|||
125471400|NCT02525692|451357148|FG002|Overall Study|Death|7|||
125471401|NCT02525692|451357149|FG003|Overall Study|Death|20|||
125471402|NCT02525692|451357150|FG004|Overall Study|Death|3|||
125471403|NCT02525692|451357151|FG005|Overall Study|Death|6|||
125471404|NCT02525692|451357146|FG000|Overall Study|Lost to Follow-up|0|||
125471405|NCT02525692|451357147|FG001|Overall Study|Lost to Follow-up|0|||
125471406|NCT02525692|451357148|FG002|Overall Study|Lost to Follow-up|1|||
125471407|NCT02525692|451357149|FG003|Overall Study|Lost to Follow-up|5|||
125471408|NCT02525692|451357150|FG004|Overall Study|Lost to Follow-up|0|||
125471409|NCT02525692|451357151|FG005|Overall Study|Lost to Follow-up|0|||
125471410|NCT02396199|451357152|FG000|Overall Study|Lost to Follow-up|1|||
125471411|NCT02396199|451357152|FG000|Overall Study|Death|4|||
125471412|NCT02349412|451357156|FG000|Overall Study|Withdrawal by Subject|7|||
125471413|NCT02349412|451357157|FG001|Overall Study|Withdrawal by Subject|7|||
125299838|NCT01147848|450723781|FG002|Run-in Period|Screen Failure|0|||
125471414|NCT04337372|451357158|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
125471415|NCT04337372|451357159|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
125471416|NCT04337372|451357160|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
125471417|NCT04337372|451357161|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
125471418|NCT04337372|451357158|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
125471419|NCT04337372|451357159|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
125471420|NCT04337372|451357160|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
125471421|NCT04337372|451357161|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
125471422|NCT04337372|451357158|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
125471423|NCT04337372|451357159|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
125471424|NCT04337372|451357160|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
125471425|NCT04337372|451357161|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
125471426|NCT04337372|451357158|FG000|Day 2: EEG Measures|Protocol Violation|6|||
125471427|NCT04337372|451357159|FG001|Day 2: EEG Measures|Protocol Violation|6|||
125471428|NCT04337372|451357160|FG002|Day 2: EEG Measures|Protocol Violation|5|||
125471429|NCT04337372|451357161|FG003|Day 2: EEG Measures|Protocol Violation|17|||
125471430|NCT03460236|451357162|FG000|Overall Study|failed radiographic screening|16|||
125471431|NCT03460236|451357162|FG000|Overall Study|Withdrawal by Subject|11|||
125471432|NCT00979576|451357165|FG000|Combination Treatment Phase|Progressive disease|3|||
125471433|NCT00979576|451357166|FG001|Combination Treatment Phase|Progressive disease|1|||
125471434|NCT00979576|451357167|FG002|Combination Treatment Phase|Progressive disease|5|||
125471435|NCT00979576|451357165|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
125471436|NCT00979576|451357166|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
125471437|NCT00979576|451357167|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
125471438|NCT00979576|451357165|FG000|Combination Treatment Phase|Adverse Event|0|||
125471439|NCT00979576|451357166|FG001|Combination Treatment Phase|Adverse Event|2|||
125471440|NCT00979576|451357167|FG002|Combination Treatment Phase|Adverse Event|2|||
125471441|NCT00979576|451357165|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
125471442|NCT00979576|451357166|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
125471443|NCT00979576|451357167|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
125471444|NCT04840199|451357168|FG000|Overall Study|Study Terminated by Sponsor|8|||
125471445|NCT04840199|451357169|FG001|Overall Study|Study Terminated by Sponsor|9|||
125471446|NCT04840199|451357168|FG000|Overall Study|Lost to Follow-up|0|||
125471447|NCT04840199|451357169|FG001|Overall Study|Lost to Follow-up|2|||
125471448|NCT04840199|451357168|FG000|Overall Study|Withdrawal by Subject|2|||
125471449|NCT04840199|451357169|FG001|Overall Study|Withdrawal by Subject|0|||
125471450|NCT04840199|451357168|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
125471451|NCT04840199|451357169|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
125471452|NCT00567398|451357170|FG000|Overall Study|Adverse Event|6|||
125471453|NCT00567398|451357171|FG001|Overall Study|Adverse Event|14|||
125471454|NCT00567398|451357170|FG000|Overall Study|Physician Decision|0|||
125471455|NCT00567398|451357171|FG001|Overall Study|Physician Decision|4|||
125471456|NCT00567398|451357170|FG000|Overall Study|Withdrawal by Subject|0|||
125471457|NCT00567398|451357171|FG001|Overall Study|Withdrawal by Subject|2|||
125471458|NCT00567398|451357170|FG000|Overall Study|Renal Transplantation|0|||
125471459|NCT00567398|451357171|FG001|Overall Study|Renal Transplantation|3|||
125471460|NCT00567398|451357170|FG000|Overall Study|Other|1|||
125471461|NCT00567398|451357171|FG001|Overall Study|Other|0|||
125471462|NCT02201108|451357172|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
125471463|NCT02201108|451357173|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
125471464|NCT02201108|451357174|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
125471465|NCT02201108|451357172|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
125471466|NCT02201108|451357173|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
125471467|NCT02201108|451357174|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
125471468|NCT02201108|451357172|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
125471469|NCT02201108|451357173|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
125471470|NCT02201108|451357174|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
125471471|NCT02201108|451357172|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
125471472|NCT02201108|451357173|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
125471473|NCT02201108|451357174|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
125471474|NCT02201108|451357172|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
125471475|NCT02201108|451357173|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
125471476|NCT02201108|451357174|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
125471477|NCT02201108|451357172|FG000|Open Label Period (up to Week 192)|Other reason|4|||
125471478|NCT02201108|451357173|FG001|Open Label Period (up to Week 192)|Other reason|7|||
125471479|NCT02201108|451357174|FG002|Open Label Period (up to Week 192)|Other reason|0|||
125471480|NCT02201108|451357172|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
125471481|NCT02201108|451357173|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
125471482|NCT02201108|451357174|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
125471483|NCT02201108|451357172|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
125471484|NCT02201108|451357173|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
125471485|NCT02201108|451357174|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
125471486|NCT02201108|451357172|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
125471487|NCT02201108|451357173|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
125471488|NCT02201108|451357174|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
125471489|NCT03055377|451357184|FG000|Treatment Phase|Lost to Follow-up|28|||
125471490|NCT03055377|451357185|FG001|Treatment Phase|Lost to Follow-up|24|||
125471491|NCT03055377|451357184|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
125471492|NCT03055377|451357185|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
125471493|NCT05215847|451357186|FG000|Overall Study|Lost to Follow-up|1|||
125471494|NCT03157167|451357187|FG000|Overall Study|Withdrawal by Subject|1|||
125471495|NCT03157167|451357188|FG001|Overall Study|Withdrawal by Subject|0|||
125471496|NCT03157167|451357189|FG002|Overall Study|Withdrawal by Subject|0|||
125471497|NCT06023082|451357192|FG000|Overall Study|Withdrawal by Subject|2|||
125471498|NCT06023082|451357192|FG000|Overall Study|Lost to Follow-up|15|||
125471499|NCT06023082|451357192|FG000|Overall Study|Side effects|5|||
125471500|NCT04823611|451357193|FG000|Overall Study|Adverse Event|2|||
125471501|NCT04823611|451357194|FG001|Overall Study|Adverse Event|0|||
125471502|NCT04823611|451357195|FG002|Overall Study|Adverse Event|1|||
125471503|NCT04823611|451357196|FG003|Overall Study|Adverse Event|0|||
125471504|NCT04823611|451357197|FG004|Overall Study|Adverse Event|0|||
125471505|NCT04823611|451357198|FG005|Overall Study|Adverse Event|0|||
125471506|NCT04823611|451357199|FG006|Overall Study|Adverse Event|0|||
125471507|NCT05444192|451357200|FG000|Overall Study|Lost to Follow-up|1|||
125471508|NCT05444192|451357201|FG001|Overall Study|Lost to Follow-up|0|||
125471509|NCT05623345|451357203|FG000|Overall Study|Withdrawal by Subject|14|||
125471510|NCT05623345|451357204|FG001|Overall Study|Withdrawal by Subject|0|||
125471511|NCT05623345|451357205|FG002|Overall Study|Withdrawal by Subject|9|||
125471512|NCT05623345|451357206|FG003|Overall Study|Withdrawal by Subject|20|||
125471513|NCT05623345|451357203|FG000|Overall Study|Lost to Follow-up|3|||
125471514|NCT05623345|451357204|FG001|Overall Study|Lost to Follow-up|0|||
125471515|NCT05623345|451357205|FG002|Overall Study|Lost to Follow-up|7|||
125471516|NCT05623345|451357206|FG003|Overall Study|Lost to Follow-up|2|||
125471517|NCT05623345|451357203|FG000|Overall Study|Termination of Study By Sponsor|37|||
125471518|NCT05623345|451357204|FG001|Overall Study|Termination of Study By Sponsor|4|||
125471519|NCT05623345|451357205|FG002|Overall Study|Termination of Study By Sponsor|40|||
125471520|NCT05623345|451357206|FG003|Overall Study|Termination of Study By Sponsor|38|||
125471521|NCT01385176|451357207|FG000|Randomization Phase|Death|1|||
125471522|NCT01385176|451357208|FG001|Randomization Phase|Death|2|||
125471523|NCT01385176|451357207|FG000|6-18 Month All VNS Active|Death|1|||
125471524|NCT01385176|451357208|FG001|6-18 Month All VNS Active|Death|2|||
125471525|NCT01385176|451357207|FG000|6-18 Month All VNS Active|Physician Decision|0|||
125471526|NCT01385176|451357208|FG001|6-18 Month All VNS Active|Physician Decision|1|||
125471527|NCT01385176|451357207|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
125471528|NCT01385176|451357208|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
125471529|NCT01385176|451357207|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
125471530|NCT01385176|451357208|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
125471531|NCT05384730|451357209|FG000|Overall Study|Adverse Event|1|||
125471532|NCT05384730|451357210|FG001|Overall Study|Adverse Event|0|||
125471533|NCT05384730|451357209|FG000|Overall Study|Lack of social support|2|||
125471534|NCT05384730|451357210|FG001|Overall Study|Lack of social support|0|||
125471535|NCT05384730|451357209|FG000|Overall Study|Hospital readmission|2|||
125471536|NCT05384730|451357210|FG001|Overall Study|Hospital readmission|0|||
125471537|NCT05384730|451357209|FG000|Overall Study|Disease progression|5|||
125471538|NCT05384730|451357210|FG001|Overall Study|Disease progression|0|||
125471539|NCT05384730|451357209|FG000|Overall Study|Overwhelmed with College commitments|0|||
125471540|NCT05384730|451357210|FG001|Overall Study|Overwhelmed with College commitments|2|||
125471541|NCT01772472|451357211|FG000|Overall Study|Death|126|||
125471542|NCT01772472|451357212|FG001|Overall Study|Death|94|||
125471543|NCT01772472|451357211|FG000|Overall Study|Lost to Follow-up|51|||
125471544|NCT01772472|451357212|FG001|Overall Study|Lost to Follow-up|50|||
125471545|NCT01772472|451357211|FG000|Overall Study|Other|9|||
125471546|NCT01772472|451357212|FG001|Overall Study|Other|7|||
125471547|NCT01772472|451357211|FG000|Overall Study|Physician Decision|1|||
125471548|NCT01772472|451357212|FG001|Overall Study|Physician Decision|7|||
125471549|NCT01772472|451357211|FG000|Overall Study|Withdrawal by Subject|115|||
125471550|NCT01772472|451357212|FG001|Overall Study|Withdrawal by Subject|90|||
125471551|NCT01772472|451357211|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
125471552|NCT01772472|451357212|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
125471553|NCT04431726|451357221|FG000|Overall Study|Ongoing in the Study|55|||
125471554|NCT04093752|451357223|FG000|Overall Study|Adverse Event|7|||
125471555|NCT04093752|451357224|FG001|Overall Study|Adverse Event|19|||
125471556|NCT04093752|451357225|FG002|Overall Study|Adverse Event|18|||
125471557|NCT04093752|451357226|FG003|Overall Study|Adverse Event|4|||
125471558|NCT04093752|451357223|FG000|Overall Study|Withdrawal by Subject|6|||
125471559|NCT04093752|451357224|FG001|Overall Study|Withdrawal by Subject|6|||
125471560|NCT04093752|451357225|FG002|Overall Study|Withdrawal by Subject|8|||
125471561|NCT04093752|451357226|FG003|Overall Study|Withdrawal by Subject|20|||
125471562|NCT04093752|451357223|FG000|Overall Study|Lost to Follow-up|2|||
125471563|NCT04093752|451357224|FG001|Overall Study|Lost to Follow-up|1|||
125471564|NCT04093752|451357225|FG002|Overall Study|Lost to Follow-up|1|||
125471565|NCT04093752|451357226|FG003|Overall Study|Lost to Follow-up|1|||
125471566|NCT04093752|451357223|FG000|Overall Study|Death|0|||
125471567|NCT04093752|451357224|FG001|Overall Study|Death|0|||
125471568|NCT04093752|451357225|FG002|Overall Study|Death|1|||
125471569|NCT04093752|451357226|FG003|Overall Study|Death|2|||
125471570|NCT04093752|451357223|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
125471571|NCT04093752|451357224|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
125471572|NCT04093752|451357225|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
125471573|NCT04093752|451357226|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
125471574|NCT04093752|451357223|FG000|Overall Study|Covid 19|0|||
125471575|NCT04093752|451357224|FG001|Overall Study|Covid 19|0|||
125471576|NCT04093752|451357225|FG002|Overall Study|Covid 19|0|||
125471577|NCT04093752|451357226|FG003|Overall Study|Covid 19|1|||
125471578|NCT04093752|451357223|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
125471579|NCT04093752|451357224|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
125471580|NCT04093752|451357225|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
125471581|NCT04093752|451357226|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
125471582|NCT04093752|451357223|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
125471583|NCT04093752|451357224|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
125471584|NCT04093752|451357225|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
125471585|NCT04093752|451357226|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
125471586|NCT04093752|451357223|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
125471587|NCT04093752|451357224|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
125471588|NCT04093752|451357225|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
125471589|NCT04093752|451357226|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
125471590|NCT01101451|451357227|FG000|Overall Study|Eligible and never treated|0|||
125471591|NCT01101451|451357228|FG001|Overall Study|Eligible and never treated|5|||
125471592|NCT01101451|451357227|FG000|Overall Study|Ineligible and treated|12|||
125471593|NCT01101451|451357228|FG001|Overall Study|Ineligible and treated|8|||
125471594|NCT01101451|451357227|FG000|Overall Study|Ineligible and never treated|2|||
125471595|NCT01101451|451357228|FG001|Overall Study|Ineligible and never treated|2|||
125471596|NCT04854096|451357229|FG000|Overall Study|Adverse Event|1|||
125471597|NCT04854096|451357230|FG001|Overall Study|Adverse Event|0|||
125471598|NCT04854096|451357229|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
125471599|NCT04854096|451357230|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
125471600|NCT04854096|451357229|FG000|Overall Study|Withdrawal by Subject|1|||
125471601|NCT04854096|451357230|FG001|Overall Study|Withdrawal by Subject|0|||
125471602|NCT04854096|451357229|FG000|Overall Study|Other reasons|1|||
125471603|NCT04854096|451357230|FG001|Overall Study|Other reasons|0|||
125471604|NCT04757610|451357231|FG000|Overall Study|Adverse Event|13|||
125471605|NCT04757610|451357232|FG001|Overall Study|Adverse Event|10|||
125471606|NCT04757610|451357233|FG002|Overall Study|Adverse Event|5|||
125471607|NCT04757610|451357231|FG000|Overall Study|Death|5|||
125471608|NCT04757610|451357232|FG001|Overall Study|Death|13|||
125471609|NCT04757610|451357233|FG002|Overall Study|Death|8|||
125471610|NCT04757610|451357231|FG000|Overall Study|Lack of Efficacy|1|||
125471611|NCT04757610|451357232|FG001|Overall Study|Lack of Efficacy|2|||
125471612|NCT04757610|451357233|FG002|Overall Study|Lack of Efficacy|3|||
125471613|NCT04757610|451357231|FG000|Overall Study|Lost to Follow-up|7|||
125471614|NCT04757610|451357232|FG001|Overall Study|Lost to Follow-up|2|||
125471615|NCT04757610|451357233|FG002|Overall Study|Lost to Follow-up|7|||
125471616|NCT04757610|451357231|FG000|Overall Study|Physician Decision|4|||
125471617|NCT04757610|451357232|FG001|Overall Study|Physician Decision|1|||
125471618|NCT04757610|451357233|FG002|Overall Study|Physician Decision|2|||
125471619|NCT04757610|451357231|FG000|Overall Study|Withdrawal by Subject|26|||
125471620|NCT04757610|451357232|FG001|Overall Study|Withdrawal by Subject|25|||
125471621|NCT04757610|451357233|FG002|Overall Study|Withdrawal by Subject|25|||
125471622|NCT04757610|451357231|FG000|Overall Study|Study Terminated by Sponsor|105|||
125471623|NCT04757610|451357232|FG001|Overall Study|Study Terminated by Sponsor|105|||
125471624|NCT04757610|451357233|FG002|Overall Study|Study Terminated by Sponsor|110|||
125471625|NCT04757610|451357231|FG000|Overall Study|Randomized in Error|1|||
125471626|NCT04757610|451357232|FG001|Overall Study|Randomized in Error|0|||
125471627|NCT04757610|451357233|FG002|Overall Study|Randomized in Error|0|||
125471628|NCT00073749|451357234|FG000|Overall Study|Disease Progression|2|||
125471629|NCT00073749|451357235|FG001|Overall Study|Disease Progression|0|||
125471630|NCT00073749|451357236|FG002|Overall Study|Disease Progression|3|||
125471631|NCT00073749|451357237|FG003|Overall Study|Disease Progression|2|||
125471632|NCT00073749|451357238|FG004|Overall Study|Disease Progression|3|||
125471633|NCT00073749|451357239|FG005|Overall Study|Disease Progression|1|||
125471634|NCT00073749|451357240|FG006|Overall Study|Disease Progression|3|||
125471635|NCT00073749|451357234|FG000|Overall Study|Death|0|||
125471636|NCT00073749|451357235|FG001|Overall Study|Death|1|||
125471637|NCT00073749|451357236|FG002|Overall Study|Death|1|||
125471638|NCT00073749|451357237|FG003|Overall Study|Death|0|||
125471639|NCT00073749|451357238|FG004|Overall Study|Death|0|||
125471640|NCT00073749|451357239|FG005|Overall Study|Death|0|||
125471641|NCT00073749|451357240|FG006|Overall Study|Death|29|||
125471642|NCT00073749|451357234|FG000|Overall Study|Adverse Event|0|||
125471643|NCT00073749|451357235|FG001|Overall Study|Adverse Event|3|||
125471644|NCT00073749|451357236|FG002|Overall Study|Adverse Event|6|||
125471645|NCT00073749|451357237|FG003|Overall Study|Adverse Event|4|||
125471646|NCT00073749|451357238|FG004|Overall Study|Adverse Event|2|||
125471647|NCT00073749|451357239|FG005|Overall Study|Adverse Event|1|||
125471648|NCT00073749|451357240|FG006|Overall Study|Adverse Event|0|||
125471649|NCT00073749|451357234|FG000|Overall Study|Physician Decision|0|||
125471650|NCT00073749|451357235|FG001|Overall Study|Physician Decision|0|||
125471651|NCT00073749|451357236|FG002|Overall Study|Physician Decision|1|||
125471652|NCT00073749|451357237|FG003|Overall Study|Physician Decision|0|||
125471653|NCT00073749|451357238|FG004|Overall Study|Physician Decision|0|||
125471654|NCT00073749|451357239|FG005|Overall Study|Physician Decision|2|||
125471655|NCT00073749|451357240|FG006|Overall Study|Physician Decision|0|||
125471656|NCT00073749|451357234|FG000|Overall Study|Withdrawal by Subject|0|||
125471657|NCT00073749|451357235|FG001|Overall Study|Withdrawal by Subject|1|||
125471658|NCT00073749|451357236|FG002|Overall Study|Withdrawal by Subject|0|||
125471659|NCT00073749|451357237|FG003|Overall Study|Withdrawal by Subject|0|||
125471660|NCT00073749|451357238|FG004|Overall Study|Withdrawal by Subject|1|||
125471661|NCT00073749|451357239|FG005|Overall Study|Withdrawal by Subject|0|||
125471662|NCT00073749|451357240|FG006|Overall Study|Withdrawal by Subject|2|||
125471663|NCT00073749|451357234|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
125471664|NCT00073749|451357235|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
125471665|NCT00073749|451357236|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
125471666|NCT00073749|451357237|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
125471667|NCT00073749|451357238|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
125471668|NCT00073749|451357239|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
125471669|NCT00073749|451357240|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
125471670|NCT00073749|451357234|FG000|Overall Study|Lost to Follow-up|0|||
125471671|NCT00073749|451357235|FG001|Overall Study|Lost to Follow-up|0|||
125471672|NCT00073749|451357236|FG002|Overall Study|Lost to Follow-up|0|||
125471673|NCT00073749|451357237|FG003|Overall Study|Lost to Follow-up|0|||
125471674|NCT00073749|451357238|FG004|Overall Study|Lost to Follow-up|0|||
125471675|NCT00073749|451357239|FG005|Overall Study|Lost to Follow-up|0|||
125471676|NCT00073749|451357240|FG006|Overall Study|Lost to Follow-up|2|||
125471677|NCT00073749|451357234|FG000|Overall Study|Other|0|||
125471678|NCT00073749|451357235|FG001|Overall Study|Other|0|||
125471679|NCT00073749|451357236|FG002|Overall Study|Other|0|||
125471680|NCT00073749|451357237|FG003|Overall Study|Other|0|||
125471681|NCT00073749|451357238|FG004|Overall Study|Other|0|||
125471682|NCT00073749|451357239|FG005|Overall Study|Other|2|||
125471683|NCT00073749|451357240|FG006|Overall Study|Other|0|||
125471684|NCT04154384|451357241|FG000|Overall Study|Lost to Follow-up|24|||
125471685|NCT04154384|451357242|FG001|Overall Study|Lost to Follow-up|33|||
125471686|NCT04154384|451357243|FG002|Overall Study|Lost to Follow-up|0|||
125471687|NCT04154384|451357241|FG000|Overall Study|Withdrawal by Subject|7|||
125471688|NCT04154384|451357242|FG001|Overall Study|Withdrawal by Subject|18|||
125471689|NCT04154384|451357243|FG002|Overall Study|Withdrawal by Subject|0|||
125471690|NCT04154384|451357241|FG000|Overall Study|Missing outcome data|1|||
125471691|NCT04154384|451357242|FG001|Overall Study|Missing outcome data|0|||
125471692|NCT04154384|451357243|FG002|Overall Study|Missing outcome data|0|||
125471693|NCT05048186|451357244|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
125471694|NCT05048186|451357245|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
125471695|NCT05048186|451357244|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
125471696|NCT05048186|451357245|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
125471697|NCT00951379|451357246|FG000|Overall Study|Adverse Event|4|||
125471698|NCT00951379|451357247|FG001|Overall Study|Adverse Event|1|||
125471699|NCT00951379|451357246|FG000|Overall Study|Withdrawal by Subject|1|||
125471700|NCT00951379|451357247|FG001|Overall Study|Withdrawal by Subject|0|||
125471701|NCT00951379|451357246|FG000|Overall Study|Noncompliance|1|||
125471702|NCT00951379|451357247|FG001|Overall Study|Noncompliance|0|||
125471703|NCT00951379|451357246|FG000|Overall Study|Disease Progression|0|||
125471704|NCT00951379|451357247|FG001|Overall Study|Disease Progression|1|||
125471705|NCT04218266|451357248|FG000|Overall Study|Death|1|||
125471706|NCT04218266|451357249|FG001|Overall Study|Death|2|||
125471707|NCT04218266|451357250|FG002|Overall Study|Death|3|||
125471708|NCT04218266|451357248|FG000|Overall Study|Adverse Event|13|||
125471709|NCT04218266|451357249|FG001|Overall Study|Adverse Event|14|||
125471710|NCT04218266|451357250|FG002|Overall Study|Adverse Event|11|||
125471711|NCT04218266|451357248|FG000|Overall Study|Other|7|||
125471712|NCT04218266|451357249|FG001|Overall Study|Other|5|||
125471713|NCT04218266|451357250|FG002|Overall Study|Other|14|||
125471714|NCT04218266|451357248|FG000|Overall Study|Physician Decision|1|||
125471715|NCT04218266|451357249|FG001|Overall Study|Physician Decision|3|||
125471716|NCT04218266|451357250|FG002|Overall Study|Physician Decision|2|||
125471717|NCT04218266|451357248|FG000|Overall Study|Non-compliance with study drug|0|||
125471718|NCT04218266|451357249|FG001|Overall Study|Non-compliance with study drug|0|||
125471719|NCT04218266|451357250|FG002|Overall Study|Non-compliance with study drug|1|||
125471720|NCT04218266|451357248|FG000|Overall Study|Withdrawal by Subject|1|||
125471721|NCT04218266|451357249|FG001|Overall Study|Withdrawal by Subject|3|||
125471722|NCT04218266|451357250|FG002|Overall Study|Withdrawal by Subject|1|||
125471723|NCT04218266|451357248|FG000|Overall Study|Study drug never administered|2|||
125471724|NCT04218266|451357249|FG001|Overall Study|Study drug never administered|0|||
125471725|NCT04218266|451357250|FG002|Overall Study|Study drug never administered|0|||
125471726|NCT02742519|451357252|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
125471727|NCT02742519|451357253|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
125471728|NCT02742519|451357254|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
125471729|NCT02742519|451357252|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
125471730|NCT02742519|451357253|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
125471731|NCT02742519|451357254|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
125471732|NCT02742519|451357252|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
125471733|NCT02742519|451357253|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
125471734|NCT02742519|451357254|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
125471735|NCT04377308|451357255|FG000|Overall Study|Withdrawal by Subject|0|||
125471736|NCT04377308|451357256|FG001|Overall Study|Withdrawal by Subject|1|||
125471737|NCT03580369|451357257|FG000|Overall Study|No treatment due to mis-randomization|1|||
125471738|NCT03580369|451357258|FG001|Overall Study|No treatment due to mis-randomization|0|||
125471739|NCT03580369|451357259|FG002|Overall Study|No treatment due to mis-randomization|0|||
125471740|NCT03580369|451357260|FG003|Overall Study|No treatment due to mis-randomization|0|||
125471741|NCT03580369|451357261|FG004|Overall Study|No treatment due to mis-randomization|3|||
125471742|NCT03580369|451357262|FG005|Overall Study|No treatment due to mis-randomization|0|||
125471743|NCT03580369|451357263|FG006|Overall Study|No treatment due to mis-randomization|0|||
125471744|NCT03580369|451357264|FG007|Overall Study|No treatment due to mis-randomization|0|||
125471745|NCT03580369|451357257|FG000|Overall Study|Reason unknown|0|||
125471746|NCT03580369|451357258|FG001|Overall Study|Reason unknown|0|||
125471747|NCT03580369|451357259|FG002|Overall Study|Reason unknown|1|||
125471748|NCT03580369|451357260|FG003|Overall Study|Reason unknown|0|||
125471749|NCT03580369|451357261|FG004|Overall Study|Reason unknown|0|||
125471750|NCT03580369|451357262|FG005|Overall Study|Reason unknown|0|||
125471751|NCT03580369|451357263|FG006|Overall Study|Reason unknown|0|||
125471752|NCT03580369|451357264|FG007|Overall Study|Reason unknown|0|||
125471753|NCT03580369|451357257|FG000|Overall Study|Technical problems|0|||
125471754|NCT03580369|451357258|FG001|Overall Study|Technical problems|0|||
125471755|NCT03580369|451357259|FG002|Overall Study|Technical problems|0|||
125471756|NCT03580369|451357260|FG003|Overall Study|Technical problems|0|||
125471757|NCT03580369|451357261|FG004|Overall Study|Technical problems|1|||
125471758|NCT03580369|451357262|FG005|Overall Study|Technical problems|0|||
125471759|NCT03580369|451357263|FG006|Overall Study|Technical problems|2|||
125471760|NCT03580369|451357264|FG007|Overall Study|Technical problems|0|||
125471761|NCT03580369|451357257|FG000|Overall Study|Pregnancy|2|||
125471762|NCT03580369|451357258|FG001|Overall Study|Pregnancy|0|||
125471763|NCT03580369|451357259|FG002|Overall Study|Pregnancy|3|||
125471764|NCT03580369|451357260|FG003|Overall Study|Pregnancy|0|||
125471765|NCT03580369|451357261|FG004|Overall Study|Pregnancy|2|||
125471766|NCT03580369|451357262|FG005|Overall Study|Pregnancy|0|||
125471767|NCT03580369|451357263|FG006|Overall Study|Pregnancy|0|||
125471768|NCT03580369|451357264|FG007|Overall Study|Pregnancy|0|||
125471769|NCT03580369|451357257|FG000|Overall Study|Lost to Follow-up|2|||
125471770|NCT03580369|451357258|FG001|Overall Study|Lost to Follow-up|0|||
125471771|NCT03580369|451357259|FG002|Overall Study|Lost to Follow-up|2|||
125471772|NCT03580369|451357260|FG003|Overall Study|Lost to Follow-up|0|||
125471773|NCT03580369|451357261|FG004|Overall Study|Lost to Follow-up|3|||
125471774|NCT03580369|451357262|FG005|Overall Study|Lost to Follow-up|0|||
125471775|NCT03580369|451357263|FG006|Overall Study|Lost to Follow-up|1|||
125471776|NCT03580369|451357264|FG007|Overall Study|Lost to Follow-up|0|||
125471777|NCT03580369|451357257|FG000|Overall Study|Physician Decision|4|||
125471778|NCT03580369|451357258|FG001|Overall Study|Physician Decision|0|||
125471779|NCT03580369|451357259|FG002|Overall Study|Physician Decision|4|||
125471780|NCT03580369|451357260|FG003|Overall Study|Physician Decision|1|||
125471781|NCT03580369|451357261|FG004|Overall Study|Physician Decision|1|||
125471782|NCT03580369|451357262|FG005|Overall Study|Physician Decision|0|||
125471783|NCT03580369|451357263|FG006|Overall Study|Physician Decision|0|||
125471784|NCT03580369|451357264|FG007|Overall Study|Physician Decision|0|||
125471785|NCT03580369|451357257|FG000|Overall Study|Lack of Efficacy|3|||
125471786|NCT03580369|451357258|FG001|Overall Study|Lack of Efficacy|0|||
125471787|NCT03580369|451357259|FG002|Overall Study|Lack of Efficacy|7|||
125299839|NCT01147848|450723779|FG000|Run-in Period|Run-in Failure|135|||
125299840|NCT01147848|450723780|FG001|Run-in Period|Run-in Failure|0|||
125471788|NCT03580369|451357260|FG003|Overall Study|Lack of Efficacy|0|||
125471789|NCT03580369|451357261|FG004|Overall Study|Lack of Efficacy|2|||
125471790|NCT03580369|451357262|FG005|Overall Study|Lack of Efficacy|0|||
125471791|NCT03580369|451357263|FG006|Overall Study|Lack of Efficacy|3|||
125471792|NCT03580369|451357264|FG007|Overall Study|Lack of Efficacy|0|||
125471793|NCT03580369|451357257|FG000|Overall Study|Protocol Violation|6|||
125471794|NCT03580369|451357258|FG001|Overall Study|Protocol Violation|0|||
125471795|NCT03580369|451357259|FG002|Overall Study|Protocol Violation|6|||
125471796|NCT03580369|451357260|FG003|Overall Study|Protocol Violation|1|||
125471797|NCT03580369|451357261|FG004|Overall Study|Protocol Violation|8|||
125471798|NCT03580369|451357262|FG005|Overall Study|Protocol Violation|2|||
125471799|NCT03580369|451357263|FG006|Overall Study|Protocol Violation|1|||
125299841|NCT01147848|450723781|FG002|Run-in Period|Run-in Failure|0|||
125471800|NCT03580369|451357264|FG007|Overall Study|Protocol Violation|0|||
125471801|NCT03580369|451357257|FG000|Overall Study|Adverse Event|7|||
125471802|NCT03580369|451357258|FG001|Overall Study|Adverse Event|0|||
125471803|NCT03580369|451357259|FG002|Overall Study|Adverse Event|14|||
125471804|NCT03580369|451357260|FG003|Overall Study|Adverse Event|1|||
125471805|NCT03580369|451357261|FG004|Overall Study|Adverse Event|6|||
125471806|NCT03580369|451357262|FG005|Overall Study|Adverse Event|0|||
125471807|NCT03580369|451357263|FG006|Overall Study|Adverse Event|1|||
125471808|NCT03580369|451357264|FG007|Overall Study|Adverse Event|0|||
125471809|NCT03580369|451357257|FG000|Overall Study|Withdrawal by Subject|19|||
125471810|NCT03580369|451357258|FG001|Overall Study|Withdrawal by Subject|0|||
125471811|NCT03580369|451357259|FG002|Overall Study|Withdrawal by Subject|17|||
125471812|NCT03580369|451357260|FG003|Overall Study|Withdrawal by Subject|0|||
125471813|NCT03580369|451357261|FG004|Overall Study|Withdrawal by Subject|16|||
125471814|NCT03580369|451357262|FG005|Overall Study|Withdrawal by Subject|1|||
125471815|NCT03580369|451357263|FG006|Overall Study|Withdrawal by Subject|7|||
125471816|NCT03580369|451357264|FG007|Overall Study|Withdrawal by Subject|0|||
125471817|NCT04774237|451357268|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
125471818|NCT04774237|451357269|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
125471819|NCT04774237|451357270|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
125471820|NCT04774237|451357271|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
125471821|NCT04774237|451357272|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
125471822|NCT04774237|451357273|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
125471823|NCT03744312|451358503|FG000|Overall Study|Withdrawal by Subject|0|||
125471824|NCT03744312|451358504|FG001|Overall Study|Withdrawal by Subject|1|||
125471825|NCT03744312|451358503|FG000|Overall Study|Screen fail|0|||
125471826|NCT03744312|451358504|FG001|Overall Study|Screen fail|1|||
125471827|NCT05134337|451358505|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
125471828|NCT05134337|451358506|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
125471829|NCT03152786|451358507|FG000|Overall Study|Withdrawal by Subject|2|||
125471830|NCT03152786|451358508|FG001|Overall Study|Withdrawal by Subject|1|||
125471831|NCT04923347|451358509|FG000|Overall Study|Withdrawal by Subject|14|||
125471832|NCT04924062|451358510|FG000|Overall Study|Death|49|||
125471833|NCT04924062|451358511|FG001|Overall Study|Death|63|||
125471834|NCT04924062|451358510|FG000|Overall Study|Participant On-going|26|||
125471835|NCT04924062|451358511|FG001|Overall Study|Participant On-going|20|||
125471836|NCT00753090|451358516|FG000|Overall Study|Withdrawal by Subject|10|||
125471837|NCT00753090|451358517|FG001|Overall Study|Withdrawal by Subject|10|||
125471838|NCT00753090|451358516|FG000|Overall Study|Death|17|||
125471839|NCT00753090|451358517|FG001|Overall Study|Death|6|||
125471840|NCT00753090|451358516|FG000|Overall Study|Study Prosthesis Removed|12|||
125471841|NCT00753090|451358517|FG001|Overall Study|Study Prosthesis Removed|3|||
125471842|NCT00753090|451358516|FG000|Overall Study|Lost to Follow-up|2|||
125471843|NCT00753090|451358517|FG001|Overall Study|Lost to Follow-up|2|||
125471844|NCT00753090|451358516|FG000|Overall Study|Other|127|||
125471845|NCT00753090|451358517|FG001|Overall Study|Other|75|||
125471846|NCT06066541|451358524|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
125471847|NCT06066541|451358525|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
125471848|NCT06066541|451358526|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
125471849|NCT06066541|451358527|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
125471850|NCT06066541|451358528|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
125471851|NCT06066541|451358529|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
125471852|NCT06066541|451358530|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
125471853|NCT06066541|451358524|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
125471854|NCT06066541|451358525|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
125471855|NCT06066541|451358526|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
125471856|NCT06066541|451358527|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
125471857|NCT06066541|451358528|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
125471858|NCT06066541|451358529|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
125471859|NCT06066541|451358530|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
125299842|NCT01147848|450723779|FG000|Randomized Phase|Adverse Event|0|||
125299843|NCT01147848|450723780|FG001|Randomized Phase|Adverse Event|6|||
125299844|NCT01147848|450723781|FG002|Randomized Phase|Adverse Event|8|||
125299845|NCT01147848|450723779|FG000|Randomized Phase|Lack of Efficacy|0|||
125471860|NCT02819843|451358531|FG000|Overall Study|Disease progression before RT|0|||
125471861|NCT02819843|451358532|FG001|Overall Study|Disease progression before RT|1|||
125471862|NCT03055858|451358534|FG000|Overall Study|Death|9|||
125471863|NCT03055858|451358534|FG000|Overall Study|Withdrawal by Subject|11|||
125471864|NCT03055858|451358534|FG000|Overall Study|Lost to Follow-up|6|||
125299846|NCT01147848|450723780|FG001|Randomized Phase|Lack of Efficacy|20|||
125471865|NCT03055858|451358534|FG000|Overall Study|Missed Follow-Up Visits|18|||
125471866|NCT04586920|451358535|FG000|Overall Study|Lost to Follow-up|0|||
125471867|NCT04586920|451358536|FG001|Overall Study|Lost to Follow-up|0|||
125299847|NCT01147848|450723781|FG002|Randomized Phase|Lack of Efficacy|11|||
125471868|NCT04586920|451358537|FG002|Overall Study|Lost to Follow-up|0|||
125471869|NCT04586920|451358538|FG003|Overall Study|Lost to Follow-up|0|||
125471870|NCT04586920|451358539|FG004|Overall Study|Lost to Follow-up|0|||
125471871|NCT04586920|451358540|FG005|Overall Study|Lost to Follow-up|0|||
125471872|NCT04586920|451358541|FG006|Overall Study|Lost to Follow-up|1|||
125471873|NCT04586920|451358542|FG007|Overall Study|Lost to Follow-up|1|||
125471874|NCT04586920|451358543|FG008|Overall Study|Lost to Follow-up|0|||
125471875|NCT04586920|451358544|FG009|Overall Study|Lost to Follow-up|1|||
125471876|NCT04586920|451358545|FG010|Overall Study|Lost to Follow-up|0|||
125471877|NCT04586920|451358546|FG011|Overall Study|Lost to Follow-up|0|||
125471878|NCT04586920|451358547|FG012|Overall Study|Lost to Follow-up|0|||
125471879|NCT04586920|451358548|FG013|Overall Study|Lost to Follow-up|1|||
125471880|NCT04586920|451358549|FG014|Overall Study|Lost to Follow-up|0|||
125471881|NCT04586920|451358550|FG015|Overall Study|Lost to Follow-up|0|||
125471882|NCT04586920|451358551|FG016|Overall Study|Lost to Follow-up|0|||
125471883|NCT04586920|451358552|FG017|Overall Study|Lost to Follow-up|0|||
125471884|NCT04586920|451358535|FG000|Overall Study|Withdrawal by Subject|0|||
125471885|NCT04586920|451358536|FG001|Overall Study|Withdrawal by Subject|0|||
125471886|NCT04586920|451358537|FG002|Overall Study|Withdrawal by Subject|0|||
125471887|NCT04586920|451358538|FG003|Overall Study|Withdrawal by Subject|0|||
125471888|NCT04586920|451358539|FG004|Overall Study|Withdrawal by Subject|0|||
125471889|NCT04586920|451358540|FG005|Overall Study|Withdrawal by Subject|0|||
125471890|NCT04586920|451358541|FG006|Overall Study|Withdrawal by Subject|0|||
125471891|NCT04586920|451358542|FG007|Overall Study|Withdrawal by Subject|1|||
125471892|NCT04586920|451358543|FG008|Overall Study|Withdrawal by Subject|0|||
125471893|NCT04586920|451358544|FG009|Overall Study|Withdrawal by Subject|1|||
125471894|NCT04586920|451358545|FG010|Overall Study|Withdrawal by Subject|0|||
125471895|NCT04586920|451358546|FG011|Overall Study|Withdrawal by Subject|1|||
125471896|NCT04586920|451358547|FG012|Overall Study|Withdrawal by Subject|0|||
125471897|NCT04586920|451358548|FG013|Overall Study|Withdrawal by Subject|0|||
125471898|NCT04586920|451358549|FG014|Overall Study|Withdrawal by Subject|0|||
125471899|NCT04586920|451358550|FG015|Overall Study|Withdrawal by Subject|0|||
125471900|NCT04586920|451358551|FG016|Overall Study|Withdrawal by Subject|0|||
125471901|NCT04586920|451358552|FG017|Overall Study|Withdrawal by Subject|0|||
125471902|NCT04052516|451358557|FG000|Overall Study|Withdrawal by Subject|4|||
125471903|NCT04052516|451358558|FG001|Overall Study|Withdrawal by Subject|5|||
125471904|NCT04052516|451358559|FG002|Overall Study|Withdrawal by Subject|6|||
125471905|NCT04052516|451358557|FG000|Overall Study|Adverse Event|3|||
125471906|NCT04052516|451358558|FG001|Overall Study|Adverse Event|2|||
125471907|NCT04052516|451358559|FG002|Overall Study|Adverse Event|8|||
125471908|NCT04052516|451358557|FG000|Overall Study|Lost to Follow-up|2|||
125471909|NCT04052516|451358558|FG001|Overall Study|Lost to Follow-up|5|||
125471910|NCT04052516|451358559|FG002|Overall Study|Lost to Follow-up|3|||
125471911|NCT04052516|451358557|FG000|Overall Study|Protocol Violation|1|||
125471912|NCT04052516|451358558|FG001|Overall Study|Protocol Violation|1|||
125471913|NCT04052516|451358559|FG002|Overall Study|Protocol Violation|0|||
125471914|NCT04052516|451358557|FG000|Overall Study|Death|1|||
125471915|NCT04052516|451358558|FG001|Overall Study|Death|0|||
125471916|NCT04052516|451358559|FG002|Overall Study|Death|0|||
125471917|NCT04052516|451358557|FG000|Overall Study|Physician Decision|0|||
125471918|NCT04052516|451358558|FG001|Overall Study|Physician Decision|1|||
125471919|NCT04052516|451358559|FG002|Overall Study|Physician Decision|0|||
125471920|NCT04052516|451358557|FG000|Overall Study|Pregnancy|1|||
125471921|NCT04052516|451358558|FG001|Overall Study|Pregnancy|0|||
125471922|NCT04052516|451358559|FG002|Overall Study|Pregnancy|0|||
125471923|NCT04052516|451358557|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
125471924|NCT04052516|451358558|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
125471925|NCT04052516|451358559|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
125471926|NCT04052516|451358557|FG000|Overall Study|Reason not recorded|0|||
125471927|NCT04052516|451358558|FG001|Overall Study|Reason not recorded|1|||
125471928|NCT04052516|451358559|FG002|Overall Study|Reason not recorded|0|||
125471929|NCT03948763|451358560|FG000|Overall Study|Sponsor's decision|0|||
125471930|NCT03948763|451358561|FG001|Overall Study|Sponsor's decision|2|||
125471931|NCT03948763|451358562|FG002|Overall Study|Sponsor's decision|6|||
125471932|NCT03948763|451358563|FG003|Overall Study|Sponsor's decision|4|||
125471933|NCT03948763|451358564|FG004|Overall Study|Sponsor's decision|0|||
125471934|NCT03948763|451358560|FG000|Overall Study|Physician Decision|0|||
125471935|NCT03948763|451358561|FG001|Overall Study|Physician Decision|0|||
125299848|NCT01147848|450723779|FG000|Randomized Phase|Protocol Violation|0|||
125471936|NCT03948763|451358562|FG002|Overall Study|Physician Decision|1|||
125471937|NCT03948763|451358563|FG003|Overall Study|Physician Decision|0|||
125471938|NCT03948763|451358564|FG004|Overall Study|Physician Decision|0|||
125471939|NCT03948763|451358560|FG000|Overall Study|Lost to Follow-up|0|||
125471940|NCT03948763|451358561|FG001|Overall Study|Lost to Follow-up|0|||
125471941|NCT03948763|451358562|FG002|Overall Study|Lost to Follow-up|0|||
125471942|NCT03948763|451358563|FG003|Overall Study|Lost to Follow-up|0|||
125471943|NCT03948763|451358564|FG004|Overall Study|Lost to Follow-up|1|||
125471944|NCT03948763|451358560|FG000|Overall Study|Death|2|||
125471945|NCT03948763|451358561|FG001|Overall Study|Death|12|||
125471946|NCT03948763|451358562|FG002|Overall Study|Death|13|||
125471947|NCT03948763|451358563|FG003|Overall Study|Death|10|||
125471948|NCT03948763|451358564|FG004|Overall Study|Death|11|||
125471949|NCT03948763|451358560|FG000|Overall Study|Withdrawal by Subject|1|||
125471950|NCT03948763|451358561|FG001|Overall Study|Withdrawal by Subject|1|||
125471951|NCT03948763|451358562|FG002|Overall Study|Withdrawal by Subject|0|||
125471952|NCT03948763|451358563|FG003|Overall Study|Withdrawal by Subject|2|||
125471953|NCT03948763|451358564|FG004|Overall Study|Withdrawal by Subject|4|||
125471954|NCT05415436|451358565|FG000|Overall Study|Surgeon cancelled procedure|1|||
125471955|NCT05415436|451358566|FG001|Overall Study|Surgeon cancelled procedure|0|||
125471956|NCT05415436|451358565|FG000|Overall Study|Death|1|||
125471957|NCT05415436|451358566|FG001|Overall Study|Death|0|||
125471958|NCT02597946|451358583|FG000|Overall Study|Withdrawal by Subject|1|||
125471959|NCT02597946|451358583|FG000|Overall Study|Progressive disease|16|||
125471960|NCT02597946|451358583|FG000|Overall Study|Other than above|1|||
125471961|NCT05058391|451358590|FG000|Overall Study|Adverse Event|1|||
125471962|NCT05136404|451358591|FG000|Period 1|Adverse Event|0|||
125471963|NCT05136404|451358592|FG001|Period 1|Adverse Event|1|||
125471964|NCT05136404|451358593|FG002|Period 1|Adverse Event|1|||
125471965|NCT05136404|451358591|FG000|Period 2|Inappropriate Behavior|0|||
125471966|NCT05136404|451358592|FG001|Period 2|Inappropriate Behavior|0|||
125471967|NCT05136404|451358593|FG002|Period 2|Inappropriate Behavior|1|||
125471968|NCT05136404|451358591|FG000|Period 3|Adverse Event|0|||
125471969|NCT05136404|451358592|FG001|Period 3|Adverse Event|0|||
125471970|NCT05136404|451358593|FG002|Period 3|Adverse Event|1|||
125471971|NCT03584516|451358594|FG000|Part 1|Death|2|||
125471972|NCT03584516|451358595|FG001|Part 1|Death|3|||
125471973|NCT03584516|451358596|FG002|Part 1|Death|0|||
125471974|NCT03584516|451358597|FG003|Part 1|Death|0|||
125471975|NCT03584516|451358598|FG004|Part 1|Death|0|||
125471976|NCT03584516|451358599|FG005|Part 1|Death|0|||
125471977|NCT03584516|451358594|FG000|Part 1|Withdrawal by Subject|2|||
125471978|NCT03584516|451358595|FG001|Part 1|Withdrawal by Subject|0|||
125471979|NCT03584516|451358596|FG002|Part 1|Withdrawal by Subject|0|||
125471980|NCT03584516|451358597|FG003|Part 1|Withdrawal by Subject|0|||
125471981|NCT03584516|451358598|FG004|Part 1|Withdrawal by Subject|0|||
125471982|NCT03584516|451358599|FG005|Part 1|Withdrawal by Subject|0|||
125471983|NCT03584516|451358594|FG000|Part 1|Lost to Follow-up|1|||
125471984|NCT03584516|451358595|FG001|Part 1|Lost to Follow-up|0|||
125471985|NCT03584516|451358596|FG002|Part 1|Lost to Follow-up|0|||
125471986|NCT03584516|451358597|FG003|Part 1|Lost to Follow-up|0|||
125299849|NCT01147848|450723780|FG001|Randomized Phase|Protocol Violation|7|||
125299850|NCT01147848|450723781|FG002|Randomized Phase|Protocol Violation|10|||
125299851|NCT01147848|450723779|FG000|Randomized Phase|Lost to Follow-up|0|||
125299852|NCT01147848|450723780|FG001|Randomized Phase|Lost to Follow-up|5|||
125299853|NCT01147848|450723781|FG002|Randomized Phase|Lost to Follow-up|7|||
125299854|NCT01147848|450723779|FG000|Randomized Phase|Physician Decision|0|||
125299855|NCT01147848|450723780|FG001|Randomized Phase|Physician Decision|0|||
125299856|NCT01147848|450723781|FG002|Randomized Phase|Physician Decision|1|||
125299857|NCT01147848|450723779|FG000|Randomized Phase|Withdrawal by Subject|0|||
125299858|NCT01147848|450723780|FG001|Randomized Phase|Withdrawal by Subject|7|||
125299859|NCT01147848|450723781|FG002|Randomized Phase|Withdrawal by Subject|9|||
125299860|NCT03180307|450723782|FG000|Overall Study|Lost to Follow-up|2|||
125299861|NCT03180307|450723783|FG001|Overall Study|Lost to Follow-up|0|||
125299862|NCT03180307|450723782|FG000|Overall Study|Death|1|||
125471987|NCT03584516|451358598|FG004|Part 1|Lost to Follow-up|0|||
125471988|NCT03584516|451358599|FG005|Part 1|Lost to Follow-up|0|||
125471989|NCT03584516|451358594|FG000|Part 1|Study Terminated by Sponsor|0|||
125471990|NCT03584516|451358595|FG001|Part 1|Study Terminated by Sponsor|2|||
125471991|NCT03584516|451358596|FG002|Part 1|Study Terminated by Sponsor|0|||
125471992|NCT03584516|451358597|FG003|Part 1|Study Terminated by Sponsor|0|||
125471993|NCT03584516|451358598|FG004|Part 1|Study Terminated by Sponsor|0|||
125471994|NCT03584516|451358599|FG005|Part 1|Study Terminated by Sponsor|0|||
125471995|NCT03584516|451358594|FG000|Part 1 Expansion|Death|0|||
125471996|NCT03584516|451358595|FG001|Part 1 Expansion|Death|0|||
125471997|NCT03584516|451358596|FG002|Part 1 Expansion|Death|9|||
125471998|NCT03584516|451358597|FG003|Part 1 Expansion|Death|8|||
125471999|NCT03584516|451358598|FG004|Part 1 Expansion|Death|4|||
125472000|NCT03584516|451358599|FG005|Part 1 Expansion|Death|5|||
125472001|NCT03584516|451358594|FG000|Part 1 Expansion|Lost to Follow-up|0|||
125472002|NCT03584516|451358595|FG001|Part 1 Expansion|Lost to Follow-up|0|||
125472003|NCT03584516|451358596|FG002|Part 1 Expansion|Lost to Follow-up|0|||
125472004|NCT03584516|451358597|FG003|Part 1 Expansion|Lost to Follow-up|1|||
125472005|NCT03584516|451358598|FG004|Part 1 Expansion|Lost to Follow-up|0|||
125472006|NCT03584516|451358599|FG005|Part 1 Expansion|Lost to Follow-up|0|||
125472007|NCT03584516|451358594|FG000|Part 1 Expansion|Physician Decision|0|||
125472008|NCT03584516|451358595|FG001|Part 1 Expansion|Physician Decision|0|||
125299863|NCT03180307|450723783|FG001|Overall Study|Death|0|||
125299864|NCT03180307|450723782|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
125472009|NCT03584516|451358596|FG002|Part 1 Expansion|Physician Decision|4|||
125472010|NCT03584516|451358597|FG003|Part 1 Expansion|Physician Decision|3|||
125472011|NCT03584516|451358598|FG004|Part 1 Expansion|Physician Decision|2|||
125472012|NCT03584516|451358599|FG005|Part 1 Expansion|Physician Decision|3|||
125472013|NCT03584516|451358594|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
125472014|NCT03584516|451358595|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
125472015|NCT03584516|451358596|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
125472016|NCT03584516|451358597|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
125472017|NCT03584516|451358598|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
125472018|NCT03584516|451358599|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
125472019|NCT03584516|451358594|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
125472020|NCT03584516|451358595|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
125472021|NCT03584516|451358596|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
125472022|NCT03584516|451358597|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
125472023|NCT03584516|451358598|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
125472024|NCT03584516|451358599|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
125472025|NCT03584516|451358594|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
125472026|NCT03584516|451358595|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
125472027|NCT03584516|451358596|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
125472028|NCT03584516|451358597|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
125472029|NCT03584516|451358598|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
125472030|NCT03584516|451358599|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
125472031|NCT03584516|451358594|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
125472032|NCT03584516|451358595|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
125472033|NCT03584516|451358596|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
125472034|NCT03584516|451358597|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
125472035|NCT03584516|451358598|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
125472036|NCT03584516|451358599|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
125472037|NCT04868110|451358601|FG000|Overall Study|Withdrawal by Subject|3|||
125472038|NCT04868110|451358602|FG001|Overall Study|Withdrawal by Subject|4|||
125472039|NCT04511702|451358611|FG000|Overall Study|Lost to Follow-up|3|||
125472040|NCT04511702|451358612|FG001|Overall Study|Lost to Follow-up|0|||
125472041|NCT04511702|451358613|FG002|Overall Study|Lost to Follow-up|4|||
125472042|NCT04511702|451358611|FG000|Overall Study|Withdrawal by Subject|17|||
125472043|NCT04511702|451358612|FG001|Overall Study|Withdrawal by Subject|1|||
125472044|NCT04511702|451358613|FG002|Overall Study|Withdrawal by Subject|8|||
125472045|NCT01894061|451358614|FG000|Overall Study|Screen failure|1|||
125472046|NCT01894061|451358614|FG000|Overall Study|Withdrawal by Subject|1|||
125472047|NCT02840474|451358617|FG000|Overall Study|Lost to Follow-up|1|||
125472048|NCT02840474|451358618|FG001|Overall Study|Lost to Follow-up|0|||
125472049|NCT03192891|451358619|FG000|Overall Study|Lost to Follow-up|55|||
125472050|NCT05141903|451358620|FG000|Overall Study|Withdrawal by Subject|0|||
125472051|NCT05141903|451358621|FG001|Overall Study|Withdrawal by Subject|1|||
125472052|NCT05141903|451358622|FG002|Overall Study|Withdrawal by Subject|1|||
125472053|NCT05141903|451358623|FG003|Overall Study|Withdrawal by Subject|0|||
125472054|NCT05141903|451358624|FG004|Overall Study|Withdrawal by Subject|0|||
125472055|NCT05141903|451358620|FG000|Overall Study|Other|1|||
125472056|NCT05141903|451358621|FG001|Overall Study|Other|1|||
125472057|NCT05141903|451358622|FG002|Overall Study|Other|0|||
125472058|NCT05141903|451358623|FG003|Overall Study|Other|0|||
125472059|NCT05141903|451358624|FG004|Overall Study|Other|0|||
125472060|NCT03089398|451358627|FG000|Overall Study|Death|4|||
125472061|NCT03089398|451358628|FG001|Overall Study|Death|9|||
125472062|NCT03089398|451358627|FG000|Overall Study|Lost to Follow-up|21|||
125472063|NCT03089398|451358628|FG001|Overall Study|Lost to Follow-up|30|||
125472064|NCT03089398|451358627|FG000|Overall Study|Withdrawal by Subject|2|||
125472065|NCT03089398|451358628|FG001|Overall Study|Withdrawal by Subject|2|||
125472066|NCT05062265|451358629|FG000|Overall Study|Withdrawal by Subject|1|||
125472067|NCT05062265|451358630|FG001|Overall Study|Withdrawal by Subject|0|||
125472068|NCT05439603|451358631|FG000|Overall Study|met withdrawal criteria|2|||
125472069|NCT02682316|451358634|FG000|Overall Study|Benign Final Pathology|27|||
125472070|NCT02682316|451358635|FG001|Overall Study|Benign Final Pathology|26|||
125472071|NCT02682316|451358634|FG000|Overall Study|Reoperation before 30 days|7|||
125472072|NCT02682316|451358635|FG001|Overall Study|Reoperation before 30 days|6|||
125472073|NCT02682316|451358634|FG000|Overall Study|Ineligible|1|||
125472074|NCT02682316|451358635|FG001|Overall Study|Ineligible|0|||
125472075|NCT02682316|451358634|FG000|Overall Study|Death|1|||
125472076|NCT02682316|451358635|FG001|Overall Study|Death|0|||
125472077|NCT02682316|451358634|FG000|Overall Study|Lost to Follow-up|7|||
125472078|NCT02682316|451358635|FG001|Overall Study|Lost to Follow-up|3|||
125472083|NCT00150813|451358639|FG000|Overall Study|Adverse Event|1|||
125472084|NCT00150813|451358639|FG000|Overall Study|Lack of Efficacy|1|||
125472085|NCT00150813|451358639|FG000|Overall Study|Lost to Follow-up|5|||
125472086|NCT00150813|451358639|FG000|Overall Study|Withdrawal by Subject|5|||
125472087|NCT00150813|451358639|FG000|Overall Study|Remission|3|||
125472088|NCT00150813|451358639|FG000|Overall Study|Planned pregancy|1|||
125472089|NCT00150813|451358639|FG000|Overall Study|Switch to commercially available LEV|2|||
125472090|NCT03052608|451358641|FG000|Treatment Phase|Adverse Event|10|||
125472091|NCT03052608|451358642|FG001|Treatment Phase|Adverse Event|12|||
125472092|NCT03052608|451358641|FG000|Treatment Phase|Death|6|||
125472093|NCT03052608|451358642|FG001|Treatment Phase|Death|4|||
125472094|NCT03052608|451358641|FG000|Treatment Phase|Withdrawal by Subject|4|||
125472095|NCT03052608|451358642|FG001|Treatment Phase|Withdrawal by Subject|12|||
125472096|NCT03052608|451358641|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
125472097|NCT03052608|451358642|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
125472098|NCT03052608|451358641|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
125472099|NCT03052608|451358642|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
125472100|NCT03052608|451358641|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
125472101|NCT03052608|451358642|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
125472102|NCT03052608|451358641|FG000|Treatment Phase|Ongoing|103|||
125472103|NCT03052608|451358642|FG001|Treatment Phase|Ongoing|31|||
125472104|NCT03052608|451358641|FG000|Long-Term Follow-up Phase|Death|23|||
125472105|NCT03052608|451358642|FG001|Long-Term Follow-up Phase|Death|28|||
125472106|NCT03052608|451358641|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
125472107|NCT03052608|451358642|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
125472108|NCT03052608|451358641|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
125472109|NCT03052608|451358642|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
125472110|NCT03052608|451358641|FG000|Long-Term Follow-up Phase|Ongoing|122|||
125472111|NCT03052608|451358642|FG001|Long-Term Follow-up Phase|Ongoing|99|||
125472112|NCT03113500|451358643|FG000|Overall Study|Withdrawal by Subject|1|||
125472113|NCT03424811|451360530|FG000|Overall Study|Lost to Follow-up|9|||
125472114|NCT03424811|451360531|FG001|Overall Study|Lost to Follow-up|0|||
125472115|NCT02728557|451360543|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
125472116|NCT02728557|451360544|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
125472117|NCT02728557|451360543|FG000|Overall Study|Dissatisfaction with research tasks|0|||
125472118|NCT02728557|451360544|FG001|Overall Study|Dissatisfaction with research tasks|1|||
125472119|NCT02728557|451360543|FG000|Overall Study|Scheduling or change in availability|1|||
125472120|NCT02728557|451360544|FG001|Overall Study|Scheduling or change in availability|1|||
125472121|NCT03416010|451360545|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
125472122|NCT03416010|451360546|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
125472123|NCT03416010|451360545|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
125472124|NCT03416010|451360546|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
125472125|NCT03416010|451360545|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
125472126|NCT03416010|451360546|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
125472127|NCT03416010|451360545|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
125472128|NCT03416010|451360546|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
125472129|NCT03416010|451360545|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
125472130|NCT03416010|451360546|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
125472131|NCT03416010|451360545|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
125472132|NCT03416010|451360546|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
125472133|NCT03416010|451360545|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
125472134|NCT03416010|451360546|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
125472135|NCT03819686|451360549|FG000|Overall Study|Lost to Follow-up|2|||
125472136|NCT03819686|451360550|FG001|Overall Study|Lost to Follow-up|3|||
125472137|NCT01938547|451360564|FG000|Overall Study|Physician Decision|1|||
125472138|NCT05038566|451360565|FG000|Overall Study|Technical Difficulties with the Device|0|||
125472139|NCT05038566|451360566|FG001|Overall Study|Technical Difficulties with the Device|1|||
125472140|NCT04842643|451360567|FG000|Overall Study|Physician Decision|1|||
125472141|NCT04842643|451360567|FG000|Overall Study|Other|1|||
125472142|NCT05387447|451360571|FG000|Overall Study|Participants changed their minds about study participation.|3|||
125472143|NCT05387447|451360572|FG001|Overall Study|Participants changed their minds about study participation.|5|||
125472144|NCT03391466|451360575|FG000|Overall Study|Death|82|||
125472145|NCT03391466|451360576|FG001|Overall Study|Death|85|||
125472146|NCT03391466|451360575|FG000|Overall Study|Still on study|93|||
125472147|NCT03391466|451360576|FG001|Overall Study|Still on study|74|||
125472148|NCT03391466|451360575|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
125472149|NCT03391466|451360576|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
125472150|NCT03391466|451360575|FG000|Overall Study|Lost to Follow-up|5|||
125472151|NCT03391466|451360576|FG001|Overall Study|Lost to Follow-up|5|||
125472152|NCT03391466|451360575|FG000|Overall Study|Investigator decision|0|||
125472153|NCT03391466|451360576|FG001|Overall Study|Investigator decision|1|||
125472154|NCT03391466|451360575|FG000|Overall Study|Other|0|||
125472155|NCT03391466|451360576|FG001|Overall Study|Other|1|||
125472156|NCT03655132|451360577|FG000|Overall Study|Lost to Follow-up|2|||
125472157|NCT03655132|451360578|FG001|Overall Study|Lost to Follow-up|1|||
125472158|NCT03655132|451360577|FG000|Overall Study|Withdrawal by Subject|0|||
125472159|NCT03655132|451360578|FG001|Overall Study|Withdrawal by Subject|1|||
125472160|NCT03655132|451360577|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
125472161|NCT03655132|451360578|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
125472162|NCT05919082|451360582|FG000|Overall Study|Adverse Event|3|||
125472163|NCT05919082|451360583|FG001|Overall Study|Adverse Event|0|||
125472164|NCT05919082|451360582|FG000|Overall Study|Lost to Follow-up|0|||
125472165|NCT05919082|451360583|FG001|Overall Study|Lost to Follow-up|1|||
125472166|NCT05919082|451360582|FG000|Overall Study|Withdrawal by Subject|8|||
125472167|NCT05919082|451360583|FG001|Overall Study|Withdrawal by Subject|9|||
125472168|NCT05919082|451360582|FG000|Overall Study|Lack of Efficacy|0|||
125472169|NCT05919082|451360583|FG001|Overall Study|Lack of Efficacy|1|||
125472170|NCT05919082|451360582|FG000|Overall Study|Investigator Decision|1|||
125472171|NCT05919082|451360583|FG001|Overall Study|Investigator Decision|0|||
125472172|NCT05249439|451360589|FG000|Overall Study|Withdrawal by Subject|2|||
125472173|NCT05249439|451360590|FG001|Overall Study|Withdrawal by Subject|5|||
125472174|NCT05249439|451360589|FG000|Overall Study|Physician Decision|3|||
125472175|NCT05249439|451360590|FG001|Overall Study|Physician Decision|1|||
125472176|NCT01707030|451360591|FG000|Overall Study|Death|1|||
125472177|NCT01707030|451360592|FG001|Overall Study|Death|1|||
125472178|NCT01707030|451360591|FG000|Overall Study|Withdrawal by Subject|2|||
125472179|NCT01707030|451360592|FG001|Overall Study|Withdrawal by Subject|3|||
125472180|NCT01707030|451360591|FG000|Overall Study|Lost to Follow-up|8|||
125472181|NCT01707030|451360592|FG001|Overall Study|Lost to Follow-up|13|||
125472182|NCT04820855|451360593|FG000|Overall Study|Lost to Follow-up|6|||
125472183|NCT04820855|451360594|FG001|Overall Study|Lost to Follow-up|9|||
125472184|NCT03526861|451360597|FG000|Initial Treatment Period|Not dosed|1|||
125472185|NCT03526861|451360598|FG001|Initial Treatment Period|Not dosed|1|||
125472186|NCT03526861|451360599|FG002|Initial Treatment Period|Not dosed|1|||
125472187|NCT03526861|451360600|FG003|Initial Treatment Period|Not dosed|0|||
125472188|NCT03526861|451360601|FG004|Initial Treatment Period|Not dosed|0|||
125472189|NCT03526861|451360602|FG005|Initial Treatment Period|Not dosed|0|||
125472190|NCT03526861|451360603|FG006|Initial Treatment Period|Not dosed|0|||
125472191|NCT03526861|451360604|FG007|Initial Treatment Period|Not dosed|0|||
125472192|NCT03526861|451360605|FG008|Initial Treatment Period|Not dosed|0|||
125472193|NCT03526861|451360597|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
125472194|NCT03526861|451360598|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
125472195|NCT03526861|451360599|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
125472196|NCT03526861|451360600|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472197|NCT03526861|451360601|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472198|NCT03526861|451360602|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472199|NCT03526861|451360603|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472200|NCT03526861|451360604|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472201|NCT03526861|451360605|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472202|NCT03526861|451360597|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
125472203|NCT03526861|451360598|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
125472204|NCT03526861|451360599|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
125472205|NCT03526861|451360600|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
125472206|NCT03526861|451360601|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
125472207|NCT03526861|451360602|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
125472208|NCT03526861|451360603|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
125472209|NCT03526861|451360604|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
125472210|NCT03526861|451360605|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
125472211|NCT03526861|451360597|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125472212|NCT03526861|451360598|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125472213|NCT03526861|451360599|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125472214|NCT03526861|451360600|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
125472215|NCT03526861|451360601|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
125472216|NCT03526861|451360602|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125299865|NCT03180307|450723783|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
125299866|NCT04349033|450723785|FG000|Overall Study|Lost to Follow-up|3|||
125299867|NCT04349033|450723786|FG001|Overall Study|Lost to Follow-up|1|||
125299868|NCT04349033|450723787|FG002|Overall Study|Lost to Follow-up|1|||
125472217|NCT03526861|451360603|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
125472218|NCT03526861|451360604|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125472219|NCT03526861|451360605|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125472220|NCT03526861|451360597|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
125472221|NCT03526861|451360598|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
125472222|NCT03526861|451360599|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
125472223|NCT03526861|451360600|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
125472224|NCT03526861|451360601|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
125472225|NCT03526861|451360602|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
125472226|NCT03526861|451360603|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
125472227|NCT03526861|451360604|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
125472228|NCT03526861|451360605|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
125472229|NCT03526861|451360597|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472230|NCT03526861|451360598|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472231|NCT03526861|451360599|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472232|NCT03526861|451360600|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
125472233|NCT03526861|451360601|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472234|NCT03526861|451360602|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472235|NCT03526861|451360603|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472236|NCT03526861|451360604|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472237|NCT03526861|451360605|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472238|NCT03526861|451360597|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125472239|NCT03526861|451360598|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125472240|NCT03526861|451360599|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125472241|NCT03526861|451360600|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125472242|NCT03526861|451360601|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125472243|NCT03526861|451360602|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125472244|NCT03526861|451360603|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125472245|NCT03526861|451360604|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
125472246|NCT03526861|451360605|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
125472247|NCT03526861|451360597|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
125472248|NCT03526861|451360598|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
125472249|NCT03526861|451360599|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
125472250|NCT03526861|451360600|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
125472251|NCT03526861|451360601|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
125472252|NCT03526861|451360602|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
125472253|NCT03526861|451360603|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
125472254|NCT03526861|451360604|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
125472255|NCT03526861|451360605|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
125472256|NCT03526861|451360597|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472257|NCT03526861|451360598|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472258|NCT03526861|451360599|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472259|NCT03526861|451360600|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472260|NCT03526861|451360601|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472261|NCT03526861|451360602|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472262|NCT03526861|451360603|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125472263|NCT03526861|451360604|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
125485376|NCT02240238|451412514|FG011|Phase 1|Sponsor termination|0|||
125472264|NCT03526861|451360605|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
125472265|NCT05862870|451360606|FG000|Overall Study|Lost to Follow-up|3|||
125472266|NCT00650104|451360615|FG000|Overall Study|Adverse Event|17|||
125472267|NCT00650104|451360615|FG000|Overall Study|Death|2|||
125472268|NCT00650104|451360615|FG000|Overall Study|Withdrawal by Subject|11|||
125472269|NCT00650104|451360615|FG000|Overall Study|Physician Decision|7|||
125472270|NCT00650104|451360615|FG000|Overall Study|Lost to Follow-up|1|||
125472271|NCT00650104|451360615|FG000|Overall Study|Non-compliance|2|||
125472272|NCT00650104|451360615|FG000|Overall Study|Sponsor Terminated Dosing|1|||
125472273|NCT00931710|451360616|FG000|Overall Study|Adverse Event|16|||
125472274|NCT00931710|451360617|FG001|Overall Study|Adverse Event|10|||
125472275|NCT00931710|451360616|FG000|Overall Study|Abnormal test procedure results|2|||
125472276|NCT00931710|451360617|FG001|Overall Study|Abnormal test procedure results|0|||
125472277|NCT00931710|451360616|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
125472278|NCT00931710|451360617|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
125472279|NCT00931710|451360616|FG000|Overall Study|Patient withdrew consent|4|||
125472280|NCT00931710|451360617|FG001|Overall Study|Patient withdrew consent|9|||
125472281|NCT00931710|451360616|FG000|Overall Study|Lost to Follow-up|6|||
125472282|NCT00931710|451360617|FG001|Overall Study|Lost to Follow-up|5|||
125472283|NCT00931710|451360616|FG000|Overall Study|Protocol deviation|1|||
125472284|NCT00931710|451360617|FG001|Overall Study|Protocol deviation|2|||
125472285|NCT01376700|451360618|FG000|Overall Study|Sponsor terminated study early|8|||
125472286|NCT01376700|451360618|FG000|Overall Study|Low or high titer inhibitor|8|||
125472287|NCT00601900|451360630|FG000|Overall Study|Withdrawal by Subject|0|||
125472288|NCT00601900|451360631|FG001|Overall Study|Withdrawal by Subject|3|||
125472289|NCT00274469|451360635|FG000|Overall Study|Death|63|||
125472290|NCT00274469|451360636|FG001|Overall Study|Death|74|||
125472291|NCT00274469|451360635|FG000|Overall Study|Did not consent to OS follow-up|16|||
125472292|NCT00274469|451360636|FG001|Overall Study|Did not consent to OS follow-up|19|||
125472293|NCT02140645|451360641|FG000|Overall Study|Not linked|5489|||
125472294|NCT02140645|451360642|FG001|Overall Study|Not linked|61654|||
125472295|NCT02140645|451360643|FG002|Overall Study|Not linked|4236|||
125472296|NCT02140645|451360644|FG003|Overall Study|Not linked|13833|||
125472297|NCT02140645|451360645|FG004|Overall Study|Not linked|3286|||
125472298|NCT02140645|451360646|FG005|Overall Study|Not linked|70896|||
125472299|NCT00593489|451360653|FG000|Allocation|did not attend workshop; allocation not|2|||
125472300|NCT00593489|451360654|FG001|Allocation|did not attend workshop; allocation not|1|||
125472301|NCT00611559|451360655|FG000|Overall Study|Lost to Follow-up|0|||
125472302|NCT00611559|451360656|FG001|Overall Study|Lost to Follow-up|1|||
125472303|NCT00611559|451360657|FG002|Overall Study|Lost to Follow-up|0|||
125472304|NCT00611559|451360655|FG000|Overall Study|Protocol Violation|1|||
125472305|NCT00611559|451360656|FG001|Overall Study|Protocol Violation|0|||
125472306|NCT00611559|451360657|FG002|Overall Study|Protocol Violation|1|||
125472307|NCT04095104|451360658|FG000|Overall Study|Withdrawal by Subject|0|||
125472308|NCT04095104|451360659|FG001|Overall Study|Withdrawal by Subject|1|||
125472309|NCT03912831|451360662|FG000|Overall Study|Death|1|||
125472310|NCT03912831|451360663|FG001|Overall Study|Death|1|||
125472311|NCT03912831|451360664|FG002|Overall Study|Death|1|||
125472312|NCT03912831|451360665|FG003|Overall Study|Death|1|||
125472313|NCT03912831|451360666|FG004|Overall Study|Death|1|||
125472314|NCT03912831|451360667|FG005|Overall Study|Death|1|||
125472315|NCT03912831|451360662|FG000|Overall Study|Reason not Specified|0|||
125472316|NCT03912831|451360663|FG001|Overall Study|Reason not Specified|0|||
125472317|NCT03912831|451360664|FG002|Overall Study|Reason not Specified|0|||
125472318|NCT03912831|451360665|FG003|Overall Study|Reason not Specified|0|||
125472319|NCT03912831|451360666|FG004|Overall Study|Reason not Specified|1|||
125472320|NCT03912831|451360667|FG005|Overall Study|Reason not Specified|0|||
125472321|NCT03912831|451360662|FG000|Overall Study|Withdrawal by Participant|0|||
125472322|NCT03912831|451360663|FG001|Overall Study|Withdrawal by Participant|0|||
125299869|NCT03596450|450723788|FG000|Overall Study|Death|9|||
125299870|NCT03596450|450723789|FG001|Overall Study|Death|9|||
125299871|NCT03596450|450723788|FG000|Overall Study|Protocol Violation|18|||
125299872|NCT03596450|450723789|FG001|Overall Study|Protocol Violation|26|||
125299873|NCT03596450|450723788|FG000|Overall Study|Lost to Follow-up|50|||
125299874|NCT03596450|450723789|FG001|Overall Study|Lost to Follow-up|56|||
125472323|NCT03912831|451360664|FG002|Overall Study|Withdrawal by Participant|0|||
125472324|NCT03912831|451360665|FG003|Overall Study|Withdrawal by Participant|0|||
125472325|NCT03912831|451360666|FG004|Overall Study|Withdrawal by Participant|1|||
125472326|NCT03912831|451360667|FG005|Overall Study|Withdrawal by Participant|0|||
125472327|NCT03527160|451360668|FG000|Overall Study|No urine collected|13|||
125472328|NCT03527160|451360668|FG000|Overall Study|No clinical serum creatinine collected|6|||
125472329|NCT03527160|451360668|FG000|Overall Study|Did not meet inclusion|2|||
125472330|NCT02910713|451360671|FG000|Overall Study|Protocol Violation|2|||
125299875|NCT03596450|450723788|FG000|Overall Study|Adverse Event|14|||
125472331|NCT02910713|451360671|FG000|Overall Study|Subject Choice|4|||
125472332|NCT02910713|451360671|FG000|Overall Study|Received One Application|10|||
125472333|NCT02910713|451360671|FG000|Overall Study|Received Neither Application|18|||
125472334|NCT02910713|451360671|FG000|Overall Study|Enrollment cap|7|||
125472335|NCT02910713|451360671|FG000|Overall Study|Investigator Discretion|1|||
125472336|NCT04442126|451360673|FG000|Overall Study|Withdrawal by Subject|0|||
125472337|NCT04442126|451360674|FG001|Overall Study|Withdrawal by Subject|0|||
125472338|NCT04442126|451360675|FG002|Overall Study|Withdrawal by Subject|0|||
125472339|NCT04442126|451360676|FG003|Overall Study|Withdrawal by Subject|2|||
125472340|NCT04442126|451360677|FG004|Overall Study|Withdrawal by Subject|1|||
125472341|NCT04442126|451360678|FG005|Overall Study|Withdrawal by Subject|0|||
125472342|NCT04442126|451360679|FG006|Overall Study|Withdrawal by Subject|1|||
125472343|NCT04442126|451360680|FG007|Overall Study|Withdrawal by Subject|1|||
125299876|NCT03596450|450723789|FG001|Overall Study|Adverse Event|7|||
125299877|NCT03596450|450723788|FG000|Overall Study|Withdrawal by Subject|38|||
125299878|NCT03596450|450723789|FG001|Overall Study|Withdrawal by Subject|36|||
125472344|NCT04442126|451360681|FG008|Overall Study|Withdrawal by Subject|3|||
125472345|NCT04442126|451360673|FG000|Overall Study|Death|1|||
125472346|NCT04442126|451360674|FG001|Overall Study|Death|0|||
125472347|NCT04442126|451360675|FG002|Overall Study|Death|0|||
125472348|NCT04442126|451360676|FG003|Overall Study|Death|1|||
125472349|NCT04442126|451360677|FG004|Overall Study|Death|2|||
125472350|NCT04442126|451360678|FG005|Overall Study|Death|2|||
125472351|NCT04442126|451360679|FG006|Overall Study|Death|4|||
125472352|NCT04442126|451360680|FG007|Overall Study|Death|1|||
125472353|NCT04442126|451360681|FG008|Overall Study|Death|5|||
125472354|NCT04442126|451360673|FG000|Overall Study|Study Terminated by Sponsor|0|||
125472355|NCT04442126|451360674|FG001|Overall Study|Study Terminated by Sponsor|0|||
125472356|NCT04442126|451360675|FG002|Overall Study|Study Terminated by Sponsor|0|||
125472357|NCT04442126|451360676|FG003|Overall Study|Study Terminated by Sponsor|0|||
125472358|NCT04442126|451360677|FG004|Overall Study|Study Terminated by Sponsor|0|||
125472359|NCT04442126|451360678|FG005|Overall Study|Study Terminated by Sponsor|1|||
125472360|NCT04442126|451360679|FG006|Overall Study|Study Terminated by Sponsor|4|||
125472361|NCT04442126|451360680|FG007|Overall Study|Study Terminated by Sponsor|2|||
125472362|NCT04442126|451360681|FG008|Overall Study|Study Terminated by Sponsor|10|||
125472363|NCT04442126|451360673|FG000|Overall Study|Lost to Follow-up|0|||
125472364|NCT04442126|451360674|FG001|Overall Study|Lost to Follow-up|0|||
125472365|NCT04442126|451360675|FG002|Overall Study|Lost to Follow-up|0|||
125472366|NCT04442126|451360676|FG003|Overall Study|Lost to Follow-up|0|||
125472367|NCT04442126|451360677|FG004|Overall Study|Lost to Follow-up|0|||
125472368|NCT04442126|451360678|FG005|Overall Study|Lost to Follow-up|0|||
125472369|NCT04442126|451360679|FG006|Overall Study|Lost to Follow-up|0|||
125472370|NCT04442126|451360680|FG007|Overall Study|Lost to Follow-up|1|||
125472371|NCT04442126|451360681|FG008|Overall Study|Lost to Follow-up|2|||
125472372|NCT04442126|451360673|FG000|Overall Study|Progressive Disease|0|||
125472373|NCT04442126|451360674|FG001|Overall Study|Progressive Disease|1|||
125472374|NCT04442126|451360675|FG002|Overall Study|Progressive Disease|3|||
125472375|NCT04442126|451360676|FG003|Overall Study|Progressive Disease|0|||
125472376|NCT04442126|451360677|FG004|Overall Study|Progressive Disease|3|||
125472377|NCT04442126|451360678|FG005|Overall Study|Progressive Disease|0|||
125472378|NCT04442126|451360679|FG006|Overall Study|Progressive Disease|0|||
125472379|NCT04442126|451360680|FG007|Overall Study|Progressive Disease|0|||
125472380|NCT04442126|451360681|FG008|Overall Study|Progressive Disease|0|||
125472381|NCT04442126|451360673|FG000|Overall Study|Other|0|||
125472382|NCT04442126|451360674|FG001|Overall Study|Other|0|||
125472383|NCT04442126|451360675|FG002|Overall Study|Other|0|||
125472384|NCT04442126|451360676|FG003|Overall Study|Other|0|||
125472385|NCT04442126|451360677|FG004|Overall Study|Other|0|||
125472386|NCT04442126|451360678|FG005|Overall Study|Other|0|||
125472387|NCT04442126|451360679|FG006|Overall Study|Other|0|||
125472388|NCT04442126|451360680|FG007|Overall Study|Other|0|||
125472389|NCT04442126|451360681|FG008|Overall Study|Other|1|||
125472390|NCT06450405|451360682|FG000|Overall Study|Study funding terminated.|0|||
125472391|NCT06450405|451360683|FG001|Overall Study|Study funding terminated.|2|||
125472392|NCT03767517|451360684|FG000|Overall Study|Lost to Follow-up|16|||
125472393|NCT03767517|451360685|FG001|Overall Study|Lost to Follow-up|10|||
125472394|NCT03767517|451360684|FG000|Overall Study|Death|2|||
125472395|NCT03767517|451360685|FG001|Overall Study|Death|3|||
125472396|NCT05113966|451361573|FG000|Overall Study|Death|21|||
125472397|NCT05113966|451361573|FG000|Overall Study|Study Terminated by Sponsor|9|||
125472398|NCT05386355|451361574|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
125299879|NCT03596450|450723788|FG000|Overall Study|Accidentally Randomized|2|||
125472399|NCT05386355|451361575|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
125472400|NCT05386355|451361576|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
125472401|NCT05386355|451361577|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
125472402|NCT06143670|451361578|FG000|Overall Study|Lost to Follow-up|0|||
125472403|NCT06143670|451361579|FG001|Overall Study|Lost to Follow-up|1|||
125472404|NCT06143670|451361578|FG000|Overall Study|Withdrawal by Subject|3|||
125472405|NCT06143670|451361579|FG001|Overall Study|Withdrawal by Subject|0|||
125472406|NCT03747484|451361580|FG000|Overall Study|Lack of Efficacy|0|||
125472407|NCT03747484|451361581|FG001|Overall Study|Lack of Efficacy|1|||
125472408|NCT03747484|451361582|FG002|Overall Study|Lack of Efficacy|1|||
125472409|NCT03747484|451361583|FG003|Overall Study|Lack of Efficacy|2|||
125472410|NCT03747484|451361584|FG004|Overall Study|Lack of Efficacy|2|||
125472411|NCT03833245|451361585|FG000|Overall Study|Death|0|||
125472412|NCT03833245|451361586|FG001|Overall Study|Death|1|||
125472413|NCT03775109|451361587|FG000|Overall Study|Adverse Event|1|||
125472414|NCT03775109|451361588|FG001|Overall Study|Adverse Event|0|||
125472415|NCT03775109|451361587|FG000|Overall Study|COVID-19 outbreak|2|||
125472416|NCT03775109|451361588|FG001|Overall Study|COVID-19 outbreak|0|||
125472417|NCT03775109|451361587|FG000|Overall Study|Lost to Follow-up|0|||
125472418|NCT03775109|451361588|FG001|Overall Study|Lost to Follow-up|2|||
125472419|NCT03775109|451361587|FG000|Overall Study|Withdrawal by Subject|1|||
125472420|NCT03775109|451361588|FG001|Overall Study|Withdrawal by Subject|1|||
125472421|NCT03775109|451361587|FG000|Overall Study|Death|0|||
125472422|NCT03775109|451361588|FG001|Overall Study|Death|1|||
125472423|NCT03775109|451361587|FG000|Overall Study|Lack of Efficacy|1|||
125472424|NCT03775109|451361588|FG001|Overall Study|Lack of Efficacy|0|||
125472425|NCT03347383|451361589|FG000|Overall Study|Death|39|||
125472426|NCT03347383|451361589|FG000|Overall Study|Withdrawal by Subject|3|||
125472427|NCT03347383|451361589|FG000|Overall Study|Lost to Follow-up|9|||
125472428|NCT05691452|451361591|FG000|Overall Study|Withdrawal by Subject|1|||
125472429|NCT05691452|451361592|FG001|Overall Study|Withdrawal by Subject|1|||
125472430|NCT05691452|451361593|FG002|Overall Study|Withdrawal by Subject|0|||
125472431|NCT05691452|451361591|FG000|Overall Study|Physician Decision|1|||
125472432|NCT05691452|451361592|FG001|Overall Study|Physician Decision|0|||
125472433|NCT05691452|451361593|FG002|Overall Study|Physician Decision|0|||
125472434|NCT05691452|451361591|FG000|Overall Study|Lost to Follow-up|0|||
125472435|NCT05691452|451361592|FG001|Overall Study|Lost to Follow-up|0|||
125472436|NCT05691452|451361593|FG002|Overall Study|Lost to Follow-up|1|||
125472437|NCT05691452|451361591|FG000|Overall Study|Adverse Event|0|||
125472438|NCT05691452|451361592|FG001|Overall Study|Adverse Event|0|||
125472439|NCT05691452|451361593|FG002|Overall Study|Adverse Event|1|||
125472440|NCT00739648|451361596|FG000|Overall Study|Adverse Event|3|||
125472441|NCT00739648|451361597|FG001|Overall Study|Adverse Event|15|||
125472442|NCT00739648|451361596|FG000|Overall Study|Withdrawal by Subject|13|||
125472443|NCT00739648|451361597|FG001|Overall Study|Withdrawal by Subject|25|||
125472444|NCT00739648|451361596|FG000|Overall Study|Lost to Follow-up|4|||
125472445|NCT00739648|451361597|FG001|Overall Study|Lost to Follow-up|7|||
125472446|NCT00739648|451361596|FG000|Overall Study|Death|2|||
125472447|NCT00739648|451361597|FG001|Overall Study|Death|0|||
125472448|NCT00739648|451361596|FG000|Overall Study|Do not know|4|||
125472449|NCT00739648|451361597|FG001|Overall Study|Do not know|6|||
125472450|NCT05110495|451361598|FG000|Overall Study|Lost to Follow-up|1|||
125472451|NCT05110495|451361598|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
125472452|NCT01757665|451361599|FG000|Overall Study|Still on Study - Visit Completed|240|||
125472453|NCT01757665|451361600|FG001|Overall Study|Still on Study - Visit Completed|30|||
125472454|NCT01757665|451361599|FG000|Overall Study|Still on Study - Visit Pending|398|||
125472455|NCT01757665|451361600|FG001|Overall Study|Still on Study - Visit Pending|40|||
125472456|NCT01757665|451361599|FG000|Overall Study|Still on Study - Missed Visit|14|||
125472457|NCT01757665|451361600|FG001|Overall Study|Still on Study - Missed Visit|1|||
125472458|NCT01757665|451361599|FG000|Overall Study|Death|25|||
125472459|NCT01757665|451361600|FG001|Overall Study|Death|8|||
125472460|NCT01757665|451361599|FG000|Overall Study|Explant|1|||
125472461|NCT01757665|451361600|FG001|Overall Study|Explant|2|||
125472462|NCT01757665|451361599|FG000|Overall Study|Withdrawal by Subject|10|||
125472463|NCT01757665|451361600|FG001|Overall Study|Withdrawal by Subject|0|||
125472464|NCT01757665|451361599|FG000|Overall Study|Lost to Follow-up|1|||
125472465|NCT01757665|451361600|FG001|Overall Study|Lost to Follow-up|1|||
125472466|NCT01757665|451361599|FG000|Overall Study|Not Implanted with Device|5|||
125299880|NCT03596450|450723789|FG001|Overall Study|Accidentally Randomized|0|||
125472467|NCT01757665|451361600|FG001|Overall Study|Not Implanted with Device|1|||
125472468|NCT04716634|451361603|FG000|Overall Study|Death|24|||
125472469|NCT04716634|451361604|FG001|Overall Study|Death|24|||
125472470|NCT04716634|451361605|FG002|Overall Study|Death|8|||
125472471|NCT04716634|451361603|FG000|Overall Study|Closed by Sponsor|4|||
125472472|NCT04716634|451361604|FG001|Overall Study|Closed by Sponsor|4|||
125472473|NCT04716634|451361605|FG002|Overall Study|Closed by Sponsor|5|||
125472474|NCT04716634|451361603|FG000|Overall Study|Lost to Follow-up|1|||
125472475|NCT04716634|451361604|FG001|Overall Study|Lost to Follow-up|0|||
125472476|NCT04716634|451361605|FG002|Overall Study|Lost to Follow-up|1|||
125472477|NCT04716634|451361603|FG000|Overall Study|Withdrawal by Subject|0|||
125472478|NCT04716634|451361604|FG001|Overall Study|Withdrawal by Subject|0|||
125472479|NCT04716634|451361605|FG002|Overall Study|Withdrawal by Subject|1|||
125472480|NCT04703322|451361609|FG000|Overall Study|Ongoing|8|||
125472481|NCT04703322|451361609|FG000|Overall Study|Withdrawal by Subject|1|||
125472482|NCT06311084|451361610|FG000|Overall Study|Lost to Follow-up|14|||
125472483|NCT03988634|451361611|FG000|Double-Blind|Adverse Event|4|||
125472484|NCT03988634|451361612|FG001|Double-Blind|Adverse Event|0|||
125472485|NCT03988634|451361613|FG002|Double-Blind|Adverse Event|0|||
125472486|NCT03988634|451361611|FG000|Double-Blind|Death|18|||
125472487|NCT03988634|451361612|FG001|Double-Blind|Death|26|||
125472488|NCT03988634|451361613|FG002|Double-Blind|Death|0|||
125472489|NCT03988634|451361611|FG000|Double-Blind|Lost to Follow-up|6|||
125472490|NCT03988634|451361612|FG001|Double-Blind|Lost to Follow-up|7|||
125472491|NCT03988634|451361613|FG002|Double-Blind|Lost to Follow-up|0|||
125472492|NCT03988634|451361611|FG000|Double-Blind|Physician Decision|9|||
125472493|NCT03988634|451361612|FG001|Double-Blind|Physician Decision|5|||
125472494|NCT03988634|451361613|FG002|Double-Blind|Physician Decision|0|||
125472495|NCT03988634|451361611|FG000|Double-Blind|Subject decision|24|||
125472496|NCT03988634|451361612|FG001|Double-Blind|Subject decision|13|||
125472497|NCT03988634|451361613|FG002|Double-Blind|Subject decision|0|||
125472498|NCT03988634|451361611|FG000|Open-Label|Adverse Event|0|||
125472499|NCT03988634|451361612|FG001|Open-Label|Adverse Event|0|||
125472500|NCT03988634|451361613|FG002|Open-Label|Adverse Event|7|||
125472501|NCT03988634|451361611|FG000|Open-Label|Physician Decision|0|||
125472502|NCT03988634|451361612|FG001|Open-Label|Physician Decision|0|||
125472503|NCT03988634|451361613|FG002|Open-Label|Physician Decision|1|||
125472504|NCT03988634|451361611|FG000|Open-Label|Technical problems|0|||
125472505|NCT03988634|451361612|FG001|Open-Label|Technical problems|0|||
125472506|NCT03988634|451361613|FG002|Open-Label|Technical problems|1|||
125472507|NCT04725240|451361614|FG000|Overall Study|Adverse Event|2|||
125472508|NCT02249949|451361620|FG000|Overall Study|Cancelled prior to treatment|2|||
125472509|NCT02867384|451361623|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
125472510|NCT02867384|451361624|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
125472511|NCT02867384|451361625|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
125472512|NCT02867384|451361623|FG000|Overall Study|Progression/ Relapse|15|||
125472513|NCT02867384|451361624|FG001|Overall Study|Progression/ Relapse|19|||
125472514|NCT02867384|451361625|FG002|Overall Study|Progression/ Relapse|0|||
125472515|NCT02867384|451361623|FG000|Overall Study|Adverse Event|13|||
125472516|NCT02867384|451361624|FG001|Overall Study|Adverse Event|1|||
125472517|NCT02867384|451361625|FG002|Overall Study|Adverse Event|0|||
125472518|NCT02867384|451361623|FG000|Overall Study|Withdrawal by Subject|6|||
125472519|NCT02867384|451361624|FG001|Overall Study|Withdrawal by Subject|5|||
125472520|NCT02867384|451361625|FG002|Overall Study|Withdrawal by Subject|0|||
125472521|NCT02867384|451361623|FG000|Overall Study|Physician Decision|1|||
125472522|NCT02867384|451361624|FG001|Overall Study|Physician Decision|2|||
125472523|NCT02867384|451361625|FG002|Overall Study|Physician Decision|0|||
125472524|NCT02867384|451361623|FG000|Overall Study|Patient compliance|1|||
125472525|NCT02867384|451361624|FG001|Overall Study|Patient compliance|0|||
125472526|NCT02867384|451361625|FG002|Overall Study|Patient compliance|0|||
125472527|NCT02867384|451361623|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
125472528|NCT02867384|451361624|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
125472529|NCT02867384|451361625|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
125472530|NCT02867384|451361623|FG000|Overall Study|Never start treatment|0|||
125472531|NCT02867384|451361624|FG001|Overall Study|Never start treatment|0|||
125472532|NCT02867384|451361625|FG002|Overall Study|Never start treatment|3|||
125472533|NCT05633407|451361633|FG000|Overall Study|Physician Decision|2|||
125472534|NCT05633407|451361634|FG001|Overall Study|Physician Decision|0|||
125472535|NCT05633407|451361633|FG000|Overall Study|Adverse Event|1|||
125472536|NCT05633407|451361634|FG001|Overall Study|Adverse Event|0|||
125472537|NCT05633407|451361633|FG000|Overall Study|Withdrawal by Subject|1|||
125472538|NCT05633407|451361634|FG001|Overall Study|Withdrawal by Subject|0|||
125472539|NCT05633407|451361633|FG000|Overall Study|Other|1|||
125472540|NCT05633407|451361634|FG001|Overall Study|Other|1|||
125472541|NCT02500758|451361635|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
125472542|NCT02500758|451361636|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
125472543|NCT02500758|451361635|FG000|Washout (1 Week)|Lost to Follow-up|2|||
125472544|NCT02500758|451361636|FG001|Washout (1 Week)|Lost to Follow-up|2|||
125472545|NCT02500758|451361635|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
125472546|NCT02500758|451361636|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
125472547|NCT02500758|451361635|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
125472548|NCT02500758|451361636|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
125472549|NCT02500758|451361635|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
125472550|NCT02500758|451361636|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
125472551|NCT04999592|451361639|FG000|Overall Study|Withdrawal by Subject|1|||
125472552|NCT04999592|451361640|FG001|Overall Study|Withdrawal by Subject|0|||
125472553|NCT05179395|451361641|FG000|Overall Study|Lack of Efficacy|1|||
125472554|NCT05792423|451361645|FG000|Overall Study|Withdrawal by Subject|2|||
125472555|NCT02471638|451361646|FG000|Overall Study|Early Term Withdrawal|10|||
125472556|NCT05338086|451362655|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
125472557|NCT05338086|451362656|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
125472558|NCT05338086|451362657|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
125472559|NCT05338086|451362658|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
125472560|NCT05338086|451362659|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
125472561|NCT05338086|451362655|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
125472562|NCT05338086|451362656|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
125472563|NCT05338086|451362657|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
125472564|NCT05338086|451362658|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
125472565|NCT05338086|451362659|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
125472566|NCT05338086|451362655|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
125472567|NCT05338086|451362656|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
125472568|NCT05338086|451362657|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
125472569|NCT05338086|451362658|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
125472570|NCT05338086|451362659|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
125472571|NCT05338086|451362655|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
125472572|NCT05338086|451362656|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
125472573|NCT05338086|451362657|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
125472574|NCT05338086|451362658|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
125472575|NCT05338086|451362659|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
125472576|NCT05338086|451362655|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
125472577|NCT05338086|451362656|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
125472578|NCT05338086|451362657|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
125472579|NCT05338086|451362658|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
125472580|NCT05338086|451362659|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
125472581|NCT05338086|451362655|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
125472582|NCT05338086|451362656|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
125472583|NCT05338086|451362657|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
125472584|NCT05338086|451362658|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
125472585|NCT05338086|451362659|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
125472586|NCT05338086|451362655|FG000|Transition Period (M12 to M18)|Death|0|||
125472587|NCT05338086|451362656|FG001|Transition Period (M12 to M18)|Death|0|||
125472588|NCT05338086|451362657|FG002|Transition Period (M12 to M18)|Death|1|||
125472589|NCT05338086|451362658|FG003|Transition Period (M12 to M18)|Death|0|||
125472590|NCT05338086|451362659|FG004|Transition Period (M12 to M18)|Death|0|||
125472591|NCT05338086|451362655|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
125472592|NCT05338086|451362656|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
125472593|NCT05338086|451362657|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
125472594|NCT05338086|451362658|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
125472595|NCT05338086|451362659|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
125472596|NCT05338086|451362655|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
125472597|NCT05338086|451362656|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
125472598|NCT05338086|451362657|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
125472599|NCT05338086|451362658|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
125472600|NCT05338086|451362659|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
125472601|NCT05338086|451362655|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
125472602|NCT05338086|451362656|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
125472603|NCT05338086|451362657|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
125472604|NCT05338086|451362658|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
125472605|NCT05338086|451362659|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
125472606|NCT03940703|451362660|FG000|Overall Study|Still under treatment|31|||
125472607|NCT03940703|451362661|FG001|Overall Study|Still under treatment|0|||
125472608|NCT04533022|451362662|FG000|Overall Study|Withdrawal by Subject|15|||
125472609|NCT04533022|451362662|FG000|Overall Study|Adverse Event|6|||
125472610|NCT04533022|451362662|FG000|Overall Study|Death|1|||
125472611|NCT04533022|451362662|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
125472612|NCT04533022|451362662|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
125472613|NCT02163447|451362663|FG000|Overall Study|Withdrawal by Subject|2|||
125472614|NCT02163447|451362664|FG001|Overall Study|Withdrawal by Subject|0|||
125472615|NCT02163447|451362665|FG002|Overall Study|Withdrawal by Subject|1|||
125472616|NCT02163447|451362663|FG000|Overall Study|Lost to Follow-up|1|||
125472617|NCT02163447|451362664|FG001|Overall Study|Lost to Follow-up|3|||
125472618|NCT02163447|451362665|FG002|Overall Study|Lost to Follow-up|0|||
125472619|NCT02163447|451362663|FG000|Overall Study|Moved out of study area|2|||
125472620|NCT02163447|451362664|FG001|Overall Study|Moved out of study area|3|||
125472621|NCT02163447|451362665|FG002|Overall Study|Moved out of study area|2|||
125472622|NCT02163447|451362663|FG000|Overall Study|Became HIV infected at time of delivery|1|||
125472623|NCT02163447|451362664|FG001|Overall Study|Became HIV infected at time of delivery|0|||
125299881|NCT03596450|450723788|FG000|Overall Study|Other reasons|48|||
125299882|NCT03596450|450723789|FG001|Overall Study|Other reasons|53|||
125472624|NCT02163447|451362665|FG002|Overall Study|Became HIV infected at time of delivery|0|||
125299883|NCT03596450|450723788|FG000|Overall Study|Pregnancy|2|||
125299884|NCT03596450|450723789|FG001|Overall Study|Pregnancy|0|||
125472625|NCT04521478|451362667|FG000|Overall Study|Protocol Violation|2|||
125472626|NCT04521478|451362668|FG001|Overall Study|Protocol Violation|0|||
125472627|NCT04521478|451362669|FG002|Overall Study|Protocol Violation|1|||
125472628|NCT04521478|451362670|FG003|Overall Study|Protocol Violation|0|||
125472629|NCT04521478|451362671|FG004|Overall Study|Protocol Violation|0|||
125472630|NCT04521478|451362672|FG005|Overall Study|Protocol Violation|0|||
125472631|NCT04521478|451362667|FG000|Overall Study|Technical Problems|0|||
125472632|NCT04521478|451362668|FG001|Overall Study|Technical Problems|0|||
125472633|NCT04521478|451362669|FG002|Overall Study|Technical Problems|0|||
125472634|NCT04521478|451362670|FG003|Overall Study|Technical Problems|1|||
125472635|NCT04521478|451362671|FG004|Overall Study|Technical Problems|0|||
125472636|NCT04521478|451362672|FG005|Overall Study|Technical Problems|0|||
125472637|NCT04521478|451362667|FG000|Overall Study|Burden of Study Procedures|1|||
125472638|NCT04521478|451362668|FG001|Overall Study|Burden of Study Procedures|0|||
125472639|NCT04521478|451362669|FG002|Overall Study|Burden of Study Procedures|0|||
125472640|NCT04521478|451362670|FG003|Overall Study|Burden of Study Procedures|1|||
125472641|NCT04521478|451362671|FG004|Overall Study|Burden of Study Procedures|0|||
125472642|NCT04521478|451362672|FG005|Overall Study|Burden of Study Procedures|1|||
125472643|NCT04521478|451362667|FG000|Overall Study|Lack of Efficacy|0|||
125472644|NCT04521478|451362668|FG001|Overall Study|Lack of Efficacy|0|||
125472645|NCT04521478|451362669|FG002|Overall Study|Lack of Efficacy|0|||
125472646|NCT04521478|451362670|FG003|Overall Study|Lack of Efficacy|0|||
125472647|NCT04521478|451362671|FG004|Overall Study|Lack of Efficacy|1|||
125472648|NCT04521478|451362672|FG005|Overall Study|Lack of Efficacy|1|||
125472649|NCT04521478|451362667|FG000|Overall Study|Adverse Event|7|||
125472650|NCT04521478|451362668|FG001|Overall Study|Adverse Event|0|||
125472651|NCT04521478|451362669|FG002|Overall Study|Adverse Event|2|||
125472652|NCT04521478|451362670|FG003|Overall Study|Adverse Event|1|||
125472653|NCT04521478|451362671|FG004|Overall Study|Adverse Event|2|||
125472654|NCT04521478|451362672|FG005|Overall Study|Adverse Event|7|||
125472655|NCT04521478|451362667|FG000|Overall Study|No Reason Available|0|||
125472656|NCT04521478|451362668|FG001|Overall Study|No Reason Available|2|||
125472657|NCT04521478|451362669|FG002|Overall Study|No Reason Available|0|||
125472658|NCT04521478|451362670|FG003|Overall Study|No Reason Available|0|||
125472659|NCT04521478|451362671|FG004|Overall Study|No Reason Available|1|||
125472660|NCT04521478|451362672|FG005|Overall Study|No Reason Available|0|||
125472661|NCT04521478|451362667|FG000|Overall Study|Other than listed|3|||
125472662|NCT04521478|451362668|FG001|Overall Study|Other than listed|3|||
125472663|NCT04521478|451362669|FG002|Overall Study|Other than listed|3|||
125472664|NCT04521478|451362670|FG003|Overall Study|Other than listed|2|||
125472665|NCT04521478|451362671|FG004|Overall Study|Other than listed|3|||
125472666|NCT04521478|451362672|FG005|Overall Study|Other than listed|3|||
125472667|NCT04521478|451362667|FG000|Overall Study|Not treated|0|||
125472668|NCT04521478|451362668|FG001|Overall Study|Not treated|0|||
125472669|NCT04521478|451362669|FG002|Overall Study|Not treated|0|||
125472670|NCT04521478|451362670|FG003|Overall Study|Not treated|0|||
125472671|NCT04521478|451362671|FG004|Overall Study|Not treated|0|||
125472672|NCT04521478|451362672|FG005|Overall Study|Not treated|1|||
125472673|NCT05320432|451362680|FG000|Overall Study|Withdrawal by Subject|0|||
125472674|NCT05320432|451362681|FG001|Overall Study|Withdrawal by Subject|2|||
125472675|NCT04173663|451362688|FG000|Overall Study|Withdrawal by Subject|1|||
125472676|NCT04173663|451362689|FG001|Overall Study|Withdrawal by Subject|6|||
125472677|NCT04173663|451362688|FG000|Overall Study|Lost to Follow-up|17|||
125472678|NCT04173663|451362689|FG001|Overall Study|Lost to Follow-up|24|||
125472679|NCT04850807|451362691|FG000|Overall Study|Death|50|||
125472680|NCT04850807|451362692|FG001|Overall Study|Death|55|||
125472681|NCT04850807|451362691|FG000|Overall Study|Discharged|17|||
125472682|NCT04850807|451362692|FG001|Overall Study|Discharged|13|||
125472683|NCT04850807|451362691|FG000|Overall Study|Incomplete baseline data|3|||
125472684|NCT04850807|451362692|FG001|Overall Study|Incomplete baseline data|2|||
125472685|NCT02187003|451362696|FG000|Overall Study|Adverse Event|2|||
125472686|NCT02187003|451362697|FG001|Overall Study|Adverse Event|0|||
125472687|NCT02187003|451362696|FG000|Overall Study|Lost to Follow-up|14|||
125472688|NCT02187003|451362697|FG001|Overall Study|Lost to Follow-up|10|||
125472689|NCT02187003|451362696|FG000|Overall Study|Withdrawal by Subject|3|||
125472690|NCT02187003|451362697|FG001|Overall Study|Withdrawal by Subject|7|||
125472691|NCT02187003|451362696|FG000|Overall Study|Protocol Violation|2|||
125472692|NCT02187003|451362697|FG001|Overall Study|Protocol Violation|4|||
125472693|NCT02187003|451362696|FG000|Overall Study|Other|5|||
125472694|NCT02187003|451362697|FG001|Overall Study|Other|5|||
125472695|NCT02187003|451362696|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125472696|NCT02187003|451362697|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
125472697|NCT05816551|451362698|FG000|Overall Study|Withdrawal by Subject|0|||
125472698|NCT05816551|451362699|FG001|Overall Study|Withdrawal by Subject|1|||
125472699|NCT05816551|451362698|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
125472700|NCT05816551|451362699|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
125472701|NCT02630823|451362706|FG000|Overall Study|Withdrawal by Subject|1|||
125472702|NCT02630823|451362706|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
125472703|NCT04593472|451362707|FG000|Overall Study|Death|31|||
125472704|NCT04593472|451362708|FG001|Overall Study|Death|27|||
125472705|NCT04593472|451362707|FG000|Overall Study|Withdrawal by Subject|12|||
125472706|NCT04593472|451362708|FG001|Overall Study|Withdrawal by Subject|12|||
125472707|NCT04593472|451362707|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
125472708|NCT04593472|451362708|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
125472709|NCT04593472|451362707|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
125472710|NCT04593472|451362708|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
125472711|NCT04593472|451362707|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
125472712|NCT04593472|451362708|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
125472713|NCT04593472|451362707|FG000|Overall Study|Lost to Follow-up|0|||
125472714|NCT04593472|451362708|FG001|Overall Study|Lost to Follow-up|2|||
125472715|NCT04593472|451362707|FG000|Overall Study|Still collecting 24-month assessment|17|||
125472716|NCT04593472|451362708|FG001|Overall Study|Still collecting 24-month assessment|10|||
125472717|NCT04178733|451362709|FG000|Overall Study|Investigator Decision|0|||
125472718|NCT04178733|451362710|FG001|Overall Study|Investigator Decision|0|||
125472719|NCT04178733|451362711|FG002|Overall Study|Investigator Decision|0|||
125472720|NCT04178733|451362712|FG003|Overall Study|Investigator Decision|1|||
125472721|NCT04178733|451362713|FG004|Overall Study|Investigator Decision|2|||
125472722|NCT05461131|451362728|FG000|Overall Study|Lost to Follow-up|0|||
125472723|NCT05461131|451362729|FG001|Overall Study|Lost to Follow-up|2|||
125472724|NCT03101904|451362734|FG000|Wash Out (10 Days)|Adverse Event|1|||
125472725|NCT03101904|451362735|FG001|Wash Out (10 Days)|Adverse Event|0|||
125472726|NCT03101904|451362734|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
125472727|NCT03101904|451362735|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
125472728|NCT04538417|451362736|FG000|Overall Study|Withdrawal by Subject|2|||
125472729|NCT04549168|451362740|FG000|Randomization Phase|Adverse Event|0|||
125472730|NCT04549168|451362741|FG001|Randomization Phase|Adverse Event|0|||
125472731|NCT04549168|451362742|FG002|Randomization Phase|Adverse Event|1|||
125472732|NCT04549168|451362740|FG000|Randomization Phase|Other|0|||
125472733|NCT04549168|451362741|FG001|Randomization Phase|Other|2|||
125472734|NCT04549168|451362742|FG002|Randomization Phase|Other|0|||
125472735|NCT04549168|451362740|FG000|Randomization Phase|Withdrawal by Subject|0|||
125472736|NCT04549168|451362741|FG001|Randomization Phase|Withdrawal by Subject|2|||
125472737|NCT04549168|451362742|FG002|Randomization Phase|Withdrawal by Subject|1|||
125472738|NCT05054374|451362746|FG000|Overall Study|Withdrawal by Subject|1|||
125472739|NCT05054374|451362747|FG001|Overall Study|Withdrawal by Subject|0|||
125472740|NCT05054374|451362748|FG002|Overall Study|Withdrawal by Subject|0|||
125472741|NCT05054374|451362749|FG003|Overall Study|Withdrawal by Subject|0|||
125472742|NCT05054374|451362746|FG000|Overall Study|Progressive Disease|5|||
125472743|NCT05054374|451362747|FG001|Overall Study|Progressive Disease|0|||
125472744|NCT05054374|451362748|FG002|Overall Study|Progressive Disease|0|||
125472745|NCT05054374|451362749|FG003|Overall Study|Progressive Disease|0|||
125472746|NCT03453619|451362750|FG000|Core Study (Part A)|Physician Decision|0|||
125472747|NCT03453619|451362751|FG001|Core Study (Part A)|Physician Decision|0|||
125472748|NCT03453619|451362752|FG002|Core Study (Part A)|Physician Decision|2|||
125472749|NCT03453619|451362753|FG003|Core Study (Part A)|Physician Decision|0|||
125472750|NCT03453619|451362750|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
125472751|NCT03453619|451362751|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
125472752|NCT03453619|451362752|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
125472753|NCT03453619|451362753|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
125472754|NCT03453619|451362750|FG000|Core Study (Part A)|Other|0|||
125472755|NCT03453619|451362751|FG001|Core Study (Part A)|Other|1|||
125472756|NCT03453619|451362752|FG002|Core Study (Part A)|Other|0|||
125472757|NCT03453619|451362753|FG003|Core Study (Part A)|Other|0|||
125472758|NCT03453619|451362750|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
125472759|NCT03453619|451362751|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
125472760|NCT03453619|451362752|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
125472761|NCT03453619|451362753|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
125472762|NCT03453619|451362750|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
125472763|NCT03453619|451362751|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
125472764|NCT03453619|451362752|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
125472765|NCT03453619|451362753|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
125472766|NCT03453619|451362750|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
125472767|NCT03453619|451362751|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
125472768|NCT03453619|451362752|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
125472769|NCT03453619|451362753|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
125299885|NCT02332291|450723790|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
125472770|NCT03453619|451362750|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
125472771|NCT03453619|451362751|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
125472772|NCT03453619|451362752|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
125472773|NCT03453619|451362753|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
125472774|NCT03625882|451363924|FG000|Overall Study|Protocol Violation|3|||
125472775|NCT03484702|451363930|FG000|Treatment Period|Death|3|||
125472776|NCT03484702|451363931|FG001|Treatment Period|Death|1|||
125472777|NCT03484702|451363932|FG002|Treatment Period|Death|0|||
125472778|NCT03484702|451363933|FG003|Treatment Period|Death|0|||
125472779|NCT03484702|451363934|FG004|Treatment Period|Death|0|||
125472780|NCT03484702|451363935|FG005|Treatment Period|Death|0|||
125472781|NCT03484702|451363930|FG000|Treatment Period|Adverse Event|1|||
125472782|NCT03484702|451363931|FG001|Treatment Period|Adverse Event|0|||
125472783|NCT03484702|451363932|FG002|Treatment Period|Adverse Event|0|||
125472784|NCT03484702|451363933|FG003|Treatment Period|Adverse Event|0|||
125472785|NCT03484702|451363934|FG004|Treatment Period|Adverse Event|0|||
125472786|NCT03484702|451363935|FG005|Treatment Period|Adverse Event|0|||
125472787|NCT03484702|451363930|FG000|Treatment Period|Participant Withdrew from Study|0|||
125472788|NCT03484702|451363931|FG001|Treatment Period|Participant Withdrew from Study|1|||
125472789|NCT03484702|451363932|FG002|Treatment Period|Participant Withdrew from Study|0|||
125472790|NCT03484702|451363933|FG003|Treatment Period|Participant Withdrew from Study|0|||
125472791|NCT03484702|451363934|FG004|Treatment Period|Participant Withdrew from Study|0|||
125472792|NCT03484702|451363935|FG005|Treatment Period|Participant Withdrew from Study|0|||
125472793|NCT03484702|451363930|FG000|Treatment Period|Physician Decision|0|||
125472794|NCT03484702|451363931|FG001|Treatment Period|Physician Decision|1|||
125472795|NCT03484702|451363932|FG002|Treatment Period|Physician Decision|0|||
125472796|NCT03484702|451363933|FG003|Treatment Period|Physician Decision|0|||
125472797|NCT03484702|451363934|FG004|Treatment Period|Physician Decision|0|||
125472798|NCT03484702|451363935|FG005|Treatment Period|Physician Decision|1|||
125472799|NCT02651324|451363938|FG000|Overall Study|drug not administered, due dispensing issue|1|||
125472800|NCT02651324|451363939|FG001|Overall Study|drug not administered, due dispensing issue|0|||
125472801|NCT04833777|451363942|FG000|Overall Study|Lost to Follow-up|1|||
125472802|NCT04833777|451363943|FG001|Overall Study|Lost to Follow-up|0|||
125472803|NCT03896516|451363944|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
125472804|NCT03896516|451363945|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
125472805|NCT03896516|451363944|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
125472806|NCT03896516|451363945|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
125472807|NCT03896516|451363944|FG000|Washout Period|Physician Decision|3|||
125472808|NCT03896516|451363945|FG001|Washout Period|Physician Decision|1|||
125472809|NCT03896516|451363944|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
125472810|NCT03896516|451363945|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
125472811|NCT03648840|451363950|FG000|First IV Infusion Session|Adverse Event|0|||
125472812|NCT03648840|451363951|FG001|First IV Infusion Session|Adverse Event|2|||
125472813|NCT03648840|451363950|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
125472814|NCT03648840|451363951|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
125472815|NCT03648840|451363950|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
125472816|NCT03648840|451363951|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
125472817|NCT03648840|451363950|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
125472818|NCT03648840|451363951|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
125472819|NCT05382936|451363954|FG000|Overall Study|Progressive Disease|3|||
125472820|NCT05382936|451363955|FG001|Overall Study|Progressive Disease|5|||
125472821|NCT05382936|451363956|FG002|Overall Study|Progressive Disease|2|||
125472822|NCT05382936|451363957|FG003|Overall Study|Progressive Disease|5|||
125472823|NCT05382936|451363954|FG000|Overall Study|Adverse Event|0|||
125472824|NCT05382936|451363955|FG001|Overall Study|Adverse Event|1|||
125472825|NCT05382936|451363956|FG002|Overall Study|Adverse Event|1|||
125472826|NCT05382936|451363957|FG003|Overall Study|Adverse Event|0|||
125472827|NCT05382936|451363954|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
125472828|NCT05382936|451363955|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
125472829|NCT05382936|451363956|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
125472830|NCT05382936|451363957|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
125472831|NCT05382936|451363954|FG000|Overall Study|Withdrawal by Subject|0|||
125472832|NCT05382936|451363955|FG001|Overall Study|Withdrawal by Subject|0|||
125472833|NCT05382936|451363956|FG002|Overall Study|Withdrawal by Subject|1|||
125299886|NCT02332291|450723791|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
125299887|NCT02332291|450723790|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
125299888|NCT02332291|450723791|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
125472834|NCT05382936|451363957|FG003|Overall Study|Withdrawal by Subject|1|||
125472835|NCT01195831|451363958|FG000|Overall Study|Lost to Follow-up|2|||
125472836|NCT01195831|451363959|FG001|Overall Study|Lost to Follow-up|4|||
125472837|NCT01195831|451363958|FG000|Overall Study|Withdrawal by Subject|2|||
125472838|NCT01195831|451363959|FG001|Overall Study|Withdrawal by Subject|2|||
125472839|NCT01195831|451363958|FG000|Overall Study|Adverse Event|4|||
125472840|NCT01195831|451363959|FG001|Overall Study|Adverse Event|2|||
125472841|NCT01195831|451363958|FG000|Overall Study|Protocol Violation|0|||
125472842|NCT01195831|451363959|FG001|Overall Study|Protocol Violation|2|||
125472843|NCT03713086|451363960|FG000|Overall Study|Withdrawal by Subject|0|||
125472844|NCT03713086|451363961|FG001|Overall Study|Withdrawal by Subject|2|||
125472845|NCT03713086|451363962|FG002|Overall Study|Withdrawal by Subject|1|||
125472846|NCT03713086|451363963|FG003|Overall Study|Withdrawal by Subject|0|||
125472847|NCT03713086|451363960|FG000|Overall Study|Lost to Follow-up|0|||
125472848|NCT03713086|451363961|FG001|Overall Study|Lost to Follow-up|1|||
125472849|NCT03713086|451363962|FG002|Overall Study|Lost to Follow-up|0|||
125472850|NCT03713086|451363963|FG003|Overall Study|Lost to Follow-up|1|||
125472851|NCT02662062|451363968|FG000|Overall Study|Withdrawal by Subject|1|||
125472852|NCT00676715|451363970|FG000|Treatment Period (TP)|Adverse Event|0|||
125472853|NCT00676715|451363971|FG001|Treatment Period (TP)|Adverse Event|3|||
125472854|NCT00676715|451363972|FG002|Treatment Period (TP)|Adverse Event|2|||
125472855|NCT00676715|451363973|FG003|Treatment Period (TP)|Adverse Event|2|||
125472856|NCT00676715|451363970|FG000|Treatment Period (TP)|Death|0|||
125472857|NCT00676715|451363971|FG001|Treatment Period (TP)|Death|0|||
125472858|NCT00676715|451363972|FG002|Treatment Period (TP)|Death|1|||
125472859|NCT00676715|451363973|FG003|Treatment Period (TP)|Death|0|||
125472860|NCT00676715|451363970|FG000|Treatment Period (TP)|Failure to return|1|||
125472861|NCT00676715|451363971|FG001|Treatment Period (TP)|Failure to return|0|||
125472862|NCT00676715|451363972|FG002|Treatment Period (TP)|Failure to return|0|||
125472863|NCT00676715|451363973|FG003|Treatment Period (TP)|Failure to return|0|||
125472864|NCT00676715|451363970|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
125299889|NCT02332291|450723790|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
125299890|NCT02332291|450723791|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
125299891|NCT02332291|450723790|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
125299892|NCT02332291|450723791|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
125299893|NCT02332291|450723790|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
125299894|NCT02332291|450723791|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
125299895|NCT02332291|450723790|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
125299896|NCT02332291|450723791|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
125299897|NCT01990859|450723792|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
125299898|NCT01990859|450723792|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
125299899|NCT02262754|450723794|FG000|Overall Study|Adverse Event|3|||
125299900|NCT02262754|450723795|FG001|Overall Study|Adverse Event|4|||
125299901|NCT02262754|450723796|FG002|Overall Study|Adverse Event|0|||
125299902|NCT02262754|450723794|FG000|Overall Study|Lack of Efficacy|2|||
125299903|NCT02262754|450723795|FG001|Overall Study|Lack of Efficacy|0|||
125299904|NCT02262754|450723796|FG002|Overall Study|Lack of Efficacy|1|||
125299905|NCT02262754|450723794|FG000|Overall Study|Lost to Follow-up|0|||
125299906|NCT02262754|450723795|FG001|Overall Study|Lost to Follow-up|0|||
125299907|NCT02262754|450723796|FG002|Overall Study|Lost to Follow-up|1|||
125299908|NCT02262754|450723794|FG000|Overall Study|No longer meets eligibility criteria|0|||
125299909|NCT02262754|450723795|FG001|Overall Study|No longer meets eligibility criteria|1|||
125299910|NCT02262754|450723796|FG002|Overall Study|No longer meets eligibility criteria|0|||
125299911|NCT02262754|450723794|FG000|Overall Study|Study terminated by sponsor|5|||
125299912|NCT02262754|450723795|FG001|Overall Study|Study terminated by sponsor|4|||
125299913|NCT02262754|450723796|FG002|Overall Study|Study terminated by sponsor|4|||
125299914|NCT02262754|450723794|FG000|Overall Study|Protocol Violation|1|||
125299915|NCT02262754|450723795|FG001|Overall Study|Protocol Violation|0|||
125299916|NCT02262754|450723796|FG002|Overall Study|Protocol Violation|0|||
125299917|NCT02262754|450723794|FG000|Overall Study|Withdrawal by Subject|1|||
125299918|NCT02262754|450723795|FG001|Overall Study|Withdrawal by Subject|0|||
125299919|NCT02262754|450723796|FG002|Overall Study|Withdrawal by Subject|1|||
125299920|NCT02262754|450723794|FG000|Overall Study|Other|4|||
125299921|NCT02262754|450723795|FG001|Overall Study|Other|0|||
125299922|NCT02262754|450723796|FG002|Overall Study|Other|2|||
125299923|NCT02577016|450723797|FG000|Overall Study|Adverse Event|2|||
125299924|NCT02577016|450723798|FG001|Overall Study|Adverse Event|1|||
125299925|NCT02577016|450723797|FG000|Overall Study|Physician Decision|0|||
125299926|NCT02577016|450723798|FG001|Overall Study|Physician Decision|1|||
125299927|NCT02126839|450723799|FG000|Overall Study|Adverse Event|0|||
125299928|NCT02126839|450723800|FG001|Overall Study|Adverse Event|1|||
125472865|NCT00676715|451363971|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
125472866|NCT00676715|451363972|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
125472867|NCT00676715|451363973|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
125472868|NCT00676715|451363970|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
125472869|NCT00676715|451363971|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
125472870|NCT00676715|451363972|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
125472871|NCT00676715|451363973|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
125472872|NCT00676715|451363970|FG000|Treatment Period (TP)|Withdrew consent|3|||
125472873|NCT00676715|451363971|FG001|Treatment Period (TP)|Withdrew consent|3|||
125472874|NCT00676715|451363972|FG002|Treatment Period (TP)|Withdrew consent|3|||
125472875|NCT00676715|451363973|FG003|Treatment Period (TP)|Withdrew consent|3|||
125472876|NCT00676715|451363970|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
125472877|NCT00676715|451363971|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
125299929|NCT02126839|450723799|FG000|Overall Study|Withdrawal by Subject|1|||
125485377|NCT02240238|451412503|FG000|Phase 1|Withdrawal by Subject|0|||
125299930|NCT02126839|450723800|FG001|Overall Study|Withdrawal by Subject|0|||
125299931|NCT02126839|450723799|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125472878|NCT00676715|451363972|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
125472879|NCT00676715|451363973|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
125472880|NCT00676715|451363970|FG000|Treatment Period (TP)|Administrative|0|||
125472881|NCT00676715|451363971|FG001|Treatment Period (TP)|Administrative|0|||
125472882|NCT00676715|451363972|FG002|Treatment Period (TP)|Administrative|0|||
125472883|NCT00676715|451363973|FG003|Treatment Period (TP)|Administrative|1|||
125472884|NCT00676715|451363970|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
125472885|NCT00676715|451363971|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
125472886|NCT00676715|451363972|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
125472887|NCT00676715|451363973|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
125472888|NCT00676715|451363970|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
125472889|NCT00676715|451363971|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
125472890|NCT00676715|451363972|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
125472891|NCT00676715|451363973|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
125472892|NCT00676715|451363970|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
125472893|NCT00676715|451363971|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
125472894|NCT00676715|451363972|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
125472895|NCT00676715|451363973|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
125472896|NCT00676715|451363970|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
125472897|NCT00676715|451363971|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
125472898|NCT00676715|451363972|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
125472899|NCT00676715|451363973|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
125472900|NCT00676715|451363970|FG000|Treatment-free Period (TFP)|Death|1|||
125472901|NCT00676715|451363971|FG001|Treatment-free Period (TFP)|Death|1|||
125472902|NCT00676715|451363972|FG002|Treatment-free Period (TFP)|Death|1|||
125472903|NCT00676715|451363973|FG003|Treatment-free Period (TFP)|Death|0|||
125472904|NCT00676715|451363970|FG000|Open Label Extension (OLE)|Reason not provided|3|||
125472905|NCT00676715|451363971|FG001|Open Label Extension (OLE)|Reason not provided|4|||
125472906|NCT00676715|451363972|FG002|Open Label Extension (OLE)|Reason not provided|1|||
125472907|NCT00676715|451363973|FG003|Open Label Extension (OLE)|Reason not provided|4|||
125472908|NCT00676715|451363970|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
125472909|NCT00676715|451363971|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
125472910|NCT00676715|451363972|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
125472911|NCT00676715|451363973|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
125472912|NCT00676715|451363970|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
125472913|NCT00676715|451363971|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
125472914|NCT00676715|451363972|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
125472915|NCT00676715|451363973|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
125472916|NCT00676715|451363970|FG000|Open Label Extension (OLE)|Adverse Event|0|||
125472917|NCT00676715|451363971|FG001|Open Label Extension (OLE)|Adverse Event|3|||
125472918|NCT00676715|451363972|FG002|Open Label Extension (OLE)|Adverse Event|1|||
125472919|NCT00676715|451363973|FG003|Open Label Extension (OLE)|Adverse Event|0|||
125472920|NCT00676715|451363970|FG000|Open Label Extension (OLE)|Death|2|||
125472921|NCT00676715|451363971|FG001|Open Label Extension (OLE)|Death|0|||
125472922|NCT00676715|451363972|FG002|Open Label Extension (OLE)|Death|2|||
125472923|NCT00676715|451363973|FG003|Open Label Extension (OLE)|Death|2|||
125472924|NCT01820260|451363974|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
125472925|NCT01820260|451363975|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
125472926|NCT01820260|451363976|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
125472927|NCT01820260|451363977|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
125472928|NCT01820260|451363978|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
125472929|NCT01820260|451363979|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
125472930|NCT01820260|451363980|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
125472931|NCT01820260|451363981|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
125472932|NCT01820260|451363982|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
125472933|NCT01820260|451363983|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
125472934|NCT01820260|451363984|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
125299932|NCT02126839|450723800|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125299933|NCT02126839|450723799|FG000|Overall Study|Protocol Violation|2|||
125299934|NCT02126839|450723800|FG001|Overall Study|Protocol Violation|3|||
125472935|NCT01820260|451363985|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
125472936|NCT01820260|451363986|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
125472937|NCT01820260|451363987|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
125472938|NCT01820260|451363974|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
125472939|NCT01820260|451363975|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
125472940|NCT01820260|451363976|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
125472941|NCT01820260|451363977|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
125299935|NCT02126839|450723799|FG000|Overall Study|Sponsor request|0|||
125472942|NCT01820260|451363978|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
125472943|NCT01820260|451363979|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
125472944|NCT01820260|451363980|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
125472945|NCT01820260|451363981|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
125472946|NCT01820260|451363982|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
125472947|NCT01820260|451363983|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
125472948|NCT01820260|451363984|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
125472949|NCT01820260|451363985|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
125472950|NCT01820260|451363986|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
125472951|NCT01820260|451363987|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
125472952|NCT04831281|451363989|FG000|Overall Study|Adverse Event|1|||
125472953|NCT04831281|451363990|FG001|Overall Study|Adverse Event|0|||
125472954|NCT04831281|451363991|FG002|Overall Study|Adverse Event|3|||
125472955|NCT04831281|451363989|FG000|Overall Study|Withdrawal by Subject|0|||
125472956|NCT04831281|451363990|FG001|Overall Study|Withdrawal by Subject|1|||
125472957|NCT04831281|451363991|FG002|Overall Study|Withdrawal by Subject|2|||
125472958|NCT04831281|451363989|FG000|Overall Study|Undetermined|1|||
125472959|NCT04831281|451363990|FG001|Overall Study|Undetermined|1|||
125472960|NCT04831281|451363991|FG002|Overall Study|Undetermined|0|||
125472961|NCT02097420|451363992|FG000|Overall Study|Death|6|||
125472962|NCT02097420|451363992|FG000|Overall Study|Valve explanted|13|||
125472963|NCT02097420|451363992|FG000|Overall Study|Other Reason|1|||
125472964|NCT03161379|451364002|FG000|Overall Study|Withdrawal by Subject|4|||
125472965|NCT03161379|451364002|FG000|Overall Study|disease progression during chemotherapy|5|||
125472966|NCT03161379|451364002|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
125472967|NCT03161379|451364002|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
125472968|NCT02728076|451364003|FG000|Overall Study|Physician Decision|4|||
125472969|NCT04089371|451364009|FG000|Overall Study|Withdrawal by Subject|0|||
125472970|NCT04089371|451364010|FG001|Overall Study|Withdrawal by Subject|1|||
125472971|NCT04089371|451364009|FG000|Overall Study|Study terminated early|0|||
125472972|NCT04089371|451364010|FG001|Overall Study|Study terminated early|9|||
125472973|NCT04936035|451364014|FG000|Overall Study|Adverse Event|0|||
125472974|NCT04936035|451364015|FG001|Overall Study|Adverse Event|1|||
125472975|NCT04936035|451364016|FG002|Overall Study|Adverse Event|0|||
125472976|NCT04936035|451364017|FG003|Overall Study|Adverse Event|0|||
125472977|NCT04936035|451364018|FG004|Overall Study|Adverse Event|0|||
125472978|NCT04936035|451364014|FG000|Overall Study|Death|0|||
125472979|NCT04936035|451364015|FG001|Overall Study|Death|0|||
125472980|NCT04936035|451364016|FG002|Overall Study|Death|0|||
125472981|NCT04936035|451364017|FG003|Overall Study|Death|1|||
125472982|NCT04936035|451364018|FG004|Overall Study|Death|0|||
125472983|NCT04936035|451364014|FG000|Overall Study|Lost to Follow-up|0|||
125472984|NCT04936035|451364015|FG001|Overall Study|Lost to Follow-up|1|||
125472985|NCT04936035|451364016|FG002|Overall Study|Lost to Follow-up|1|||
125472986|NCT04936035|451364017|FG003|Overall Study|Lost to Follow-up|2|||
125472987|NCT04936035|451364018|FG004|Overall Study|Lost to Follow-up|1|||
125472988|NCT04936035|451364014|FG000|Overall Study|Physician Decision|0|||
125472989|NCT04936035|451364015|FG001|Overall Study|Physician Decision|1|||
125472990|NCT04936035|451364016|FG002|Overall Study|Physician Decision|0|||
125472991|NCT04936035|451364017|FG003|Overall Study|Physician Decision|0|||
125472992|NCT04936035|451364018|FG004|Overall Study|Physician Decision|0|||
125472993|NCT04936035|451364014|FG000|Overall Study|Protocol Deviation|0|||
125472994|NCT04936035|451364015|FG001|Overall Study|Protocol Deviation|0|||
125472995|NCT04936035|451364016|FG002|Overall Study|Protocol Deviation|1|||
125472996|NCT04936035|451364017|FG003|Overall Study|Protocol Deviation|0|||
125472997|NCT04936035|451364018|FG004|Overall Study|Protocol Deviation|0|||
125472998|NCT04936035|451364014|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
125472999|NCT04936035|451364015|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
125473000|NCT04936035|451364016|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
125299936|NCT02126839|450723800|FG001|Overall Study|Sponsor request|1|||
125299937|NCT02126839|450723799|FG000|Overall Study|Lost to Follow-up|1|||
125299938|NCT02126839|450723800|FG001|Overall Study|Lost to Follow-up|4|||
125473001|NCT04936035|451364017|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
125473002|NCT04936035|451364018|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
125473003|NCT04936035|451364014|FG000|Overall Study|Reason Unknown|0|||
125473004|NCT04936035|451364015|FG001|Overall Study|Reason Unknown|0|||
125473005|NCT04936035|451364016|FG002|Overall Study|Reason Unknown|0|||
125473006|NCT04936035|451364017|FG003|Overall Study|Reason Unknown|0|||
125473007|NCT04936035|451364018|FG004|Overall Study|Reason Unknown|1|||
125473008|NCT04936035|451364014|FG000|Overall Study|Withdrawal by Subject|1|||
125299939|NCT02126839|450723799|FG000|Overall Study|Other|5|||
125473009|NCT04936035|451364015|FG001|Overall Study|Withdrawal by Subject|0|||
125473010|NCT04936035|451364016|FG002|Overall Study|Withdrawal by Subject|0|||
125473011|NCT04936035|451364017|FG003|Overall Study|Withdrawal by Subject|0|||
125473012|NCT04936035|451364018|FG004|Overall Study|Withdrawal by Subject|0|||
125473013|NCT04936035|451364014|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
125299940|NCT02126839|450723800|FG001|Overall Study|Other|5|||
125473014|NCT04936035|451364015|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
125473015|NCT04936035|451364016|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
125473016|NCT04936035|451364017|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
125473017|NCT04936035|451364018|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
125473018|NCT04936035|451364014|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
125473019|NCT04936035|451364015|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
125473020|NCT04936035|451364016|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
125473021|NCT04936035|451364017|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
125473022|NCT04936035|451364018|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
125473023|NCT04936035|451364014|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
125473024|NCT04936035|451364015|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
125473025|NCT04936035|451364016|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
125473026|NCT04936035|451364017|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
125473027|NCT04936035|451364018|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
125473028|NCT04314895|451364029|FG000|Overall Study|Lost to Follow-up|1|||
125473029|NCT04314895|451364029|FG000|Overall Study|Death|10|||
125473030|NCT04314895|451364029|FG000|Overall Study|Physician Decision|2|||
125473031|NCT03941860|451364030|FG000|Overall Study|Withdrawal by Subject|0|||
125473032|NCT03941860|451364031|FG001|Overall Study|Withdrawal by Subject|1|||
125473033|NCT03396588|451364035|FG000|Overall Study|Physician Decision|2|||
125473034|NCT03396588|451364036|FG001|Overall Study|Physician Decision|3|||
125473035|NCT00812461|451364037|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
125473036|NCT00812461|451364038|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
125473037|NCT00812461|451364037|FG000|All Treated Patients|Adverse Event|8|||
125473038|NCT00812461|451364038|FG001|All Treated Patients|Adverse Event|15|||
125473039|NCT00812461|451364037|FG000|All Treated Patients|Lack of Efficacy|13|||
125473040|NCT00812461|451364038|FG001|All Treated Patients|Lack of Efficacy|7|||
125473041|NCT00812461|451364037|FG000|All Treated Patients|Non-compliance|6|||
125473042|NCT00812461|451364038|FG001|All Treated Patients|Non-compliance|9|||
125473043|NCT00812461|451364037|FG000|All Treated Patients|Protocol Violation|36|||
125473044|NCT00812461|451364038|FG001|All Treated Patients|Protocol Violation|27|||
125473045|NCT00812461|451364037|FG000|All Treated Patients|Withdrawal by Subject|45|||
125473046|NCT00812461|451364038|FG001|All Treated Patients|Withdrawal by Subject|54|||
125473047|NCT00812461|451364037|FG000|All Treated Patients|Lost to Follow-up|11|||
125473048|NCT00812461|451364038|FG001|All Treated Patients|Lost to Follow-up|14|||
125473049|NCT00812461|451364037|FG000|All Treated Patients|Other Reason|13|||
125473050|NCT00812461|451364038|FG001|All Treated Patients|Other Reason|21|||
125473051|NCT04402489|451365674|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
125473052|NCT04402489|451365675|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
125473053|NCT04402489|451365676|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
125473054|NCT04402489|451365677|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
125473055|NCT04402489|451365678|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
125473056|NCT04402489|451365674|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
125473057|NCT04402489|451365675|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
125473058|NCT04402489|451365676|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
125473059|NCT04402489|451365677|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
125473060|NCT04402489|451365678|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
125473061|NCT04402489|451365674|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
125473062|NCT04402489|451365675|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
125473063|NCT04402489|451365676|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
125473064|NCT04402489|451365677|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
125473065|NCT04402489|451365678|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
125473066|NCT04402489|451365674|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
125473067|NCT04402489|451365675|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
125473068|NCT04402489|451365676|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
125473069|NCT04402489|451365677|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
125473070|NCT04402489|451365678|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
125473071|NCT04402489|451365674|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
125473072|NCT04402489|451365675|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
125473073|NCT04402489|451365676|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
125473074|NCT04402489|451365677|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
125473075|NCT04402489|451365678|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
125473076|NCT04402489|451365674|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
125473077|NCT04402489|451365675|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
125473078|NCT04402489|451365676|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
125473079|NCT04402489|451365677|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
125473080|NCT04402489|451365678|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
125473081|NCT02287311|451365685|FG000|Cohort 1: Dose Level 1|Death|2|||
125473082|NCT02287311|451365686|FG001|Cohort 1: Dose Level 1|Death|0|||
125473083|NCT02287311|451365687|FG002|Cohort 1: Dose Level 1|Death|0|||
125473084|NCT02287311|451365688|FG003|Cohort 1: Dose Level 1|Death|3|||
125473085|NCT02287311|451365689|FG004|Cohort 1: Dose Level 1|Death|0|||
125473086|NCT02287311|451365690|FG005|Cohort 1: Dose Level 1|Death|0|||
125473087|NCT02287311|451365691|FG006|Cohort 1: Dose Level 1|Death|1|||
125473088|NCT02287311|451365692|FG007|Cohort 1: Dose Level 1|Death|0|||
125473089|NCT02287311|451365693|FG008|Cohort 1: Dose Level 1|Death|0|||
125473090|NCT02287311|451365685|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
125473091|NCT02287311|451365686|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
125473092|NCT02287311|451365687|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
125473093|NCT02287311|451365688|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
125473094|NCT02287311|451365689|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
125473095|NCT02287311|451365690|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
125473096|NCT02287311|451365691|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
125473097|NCT02287311|451365692|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
125473098|NCT02287311|451365693|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
125473099|NCT02287311|451365685|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
125473100|NCT02287311|451365686|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
125473101|NCT02287311|451365687|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
125473102|NCT02287311|451365688|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
125473103|NCT02287311|451365689|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
125473104|NCT02287311|451365690|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
125473105|NCT02287311|451365691|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
125473106|NCT02287311|451365692|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
125473107|NCT02287311|451365693|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
125473108|NCT02287311|451365685|FG000|Cohort 2: Dose Level 2|Death|0|||
125473109|NCT02287311|451365686|FG001|Cohort 2: Dose Level 2|Death|2|||
125473110|NCT02287311|451365687|FG002|Cohort 2: Dose Level 2|Death|0|||
125473111|NCT02287311|451365688|FG003|Cohort 2: Dose Level 2|Death|0|||
125473112|NCT02287311|451365689|FG004|Cohort 2: Dose Level 2|Death|2|||
125473113|NCT02287311|451365690|FG005|Cohort 2: Dose Level 2|Death|0|||
125473114|NCT02287311|451365691|FG006|Cohort 2: Dose Level 2|Death|0|||
125473115|NCT02287311|451365692|FG007|Cohort 2: Dose Level 2|Death|2|||
125473116|NCT02287311|451365693|FG008|Cohort 2: Dose Level 2|Death|0|||
125473117|NCT02287311|451365685|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
125473118|NCT02287311|451365686|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
125473119|NCT02287311|451365687|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
125473120|NCT02287311|451365688|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
125473121|NCT02287311|451365689|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
125473122|NCT02287311|451365690|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
125473123|NCT02287311|451365691|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
125473124|NCT02287311|451365692|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
125473125|NCT02287311|451365693|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
125473126|NCT02287311|451365685|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
125473127|NCT02287311|451365686|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
125473128|NCT02287311|451365687|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
125473129|NCT02287311|451365688|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
125473130|NCT02287311|451365689|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
125473131|NCT02287311|451365690|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
125473132|NCT02287311|451365691|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
125473133|NCT02287311|451365692|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
125473134|NCT02287311|451365693|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
125473135|NCT02287311|451365685|FG000|Cohort 3: Dose Level 3|Death|0|||
125473136|NCT02287311|451365686|FG001|Cohort 3: Dose Level 3|Death|0|||
125473137|NCT02287311|451365687|FG002|Cohort 3: Dose Level 3|Death|4|||
125473138|NCT02287311|451365688|FG003|Cohort 3: Dose Level 3|Death|0|||
125473139|NCT02287311|451365689|FG004|Cohort 3: Dose Level 3|Death|0|||
125473140|NCT02287311|451365690|FG005|Cohort 3: Dose Level 3|Death|4|||
125473141|NCT02287311|451365691|FG006|Cohort 3: Dose Level 3|Death|0|||
125473142|NCT02287311|451365692|FG007|Cohort 3: Dose Level 3|Death|0|||
125473143|NCT02287311|451365693|FG008|Cohort 3: Dose Level 3|Death|2|||
125473144|NCT02287311|451365685|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
125473145|NCT02287311|451365686|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
125473146|NCT02287311|451365687|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
125473147|NCT02287311|451365688|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
125473148|NCT02287311|451365689|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
125473149|NCT02287311|451365690|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
125473150|NCT02287311|451365691|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
125473151|NCT02287311|451365692|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
125473152|NCT02287311|451365693|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
125473153|NCT02287311|451365685|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
125473154|NCT02287311|451365686|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
125473155|NCT02287311|451365687|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
125473156|NCT02287311|451365688|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
125473157|NCT02287311|451365689|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
125473158|NCT02287311|451365690|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
125473159|NCT02287311|451365691|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
125473160|NCT02287311|451365692|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
125473161|NCT02287311|451365693|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
125473162|NCT05418296|451365694|FG000|Overall Study|Withdrawal by Subject|4|||
125473163|NCT05418296|451365695|FG001|Overall Study|Withdrawal by Subject|1|||
125473164|NCT01857934|451365696|FG000|Overall Study|Relapse or progression|2|||
125473165|NCT01857934|451365696|FG000|Overall Study|Unacceptable toxicity|3|||
125473166|NCT01857934|451365696|FG000|Overall Study|Unwillingness or inability to comply|2|||
125473167|NCT01857934|451365696|FG000|Overall Study|Physician Decision|3|||
125473168|NCT05406921|451365703|FG000|Overall Study|Withdrawal by Subject|25|||
125473169|NCT05406921|451365704|FG001|Overall Study|Withdrawal by Subject|0|||
125473170|NCT05406921|451365705|FG002|Overall Study|Withdrawal by Subject|25|||
125473171|NCT05406921|451365703|FG000|Overall Study|Protocol Violation|0|||
125473172|NCT05406921|451365704|FG001|Overall Study|Protocol Violation|12|||
125473173|NCT05406921|451365705|FG002|Overall Study|Protocol Violation|0|||
125473174|NCT00616967|451365710|FG000|Overall Study|Withdrawal by Subject|0|||
125473175|NCT00616967|451365711|FG001|Overall Study|Withdrawal by Subject|0|||
125473176|NCT00616967|451365712|FG002|Overall Study|Withdrawal by Subject|1|||
125473177|NCT05059262|451365713|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
125473178|NCT05059262|451365714|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
125473179|NCT05059262|451365713|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
125473180|NCT05059262|451365714|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
125473181|NCT05059262|451365713|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
125473182|NCT05059262|451365714|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
125473183|NCT05059262|451365713|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
125473184|NCT05059262|451365714|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
125473185|NCT05059262|451365713|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
125473186|NCT05059262|451365714|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
125473187|NCT05059262|451365713|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
125473188|NCT05059262|451365714|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
125473189|NCT05059262|451365713|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
125473190|NCT05059262|451365714|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
125473191|NCT05059262|451365713|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
125473192|NCT05059262|451365714|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
125473193|NCT05059262|451365713|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
125473194|NCT05059262|451365714|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
125473195|NCT02312960|451365726|FG000|Overall Study|Death|24|||
125473196|NCT02312960|451365727|FG001|Overall Study|Death|32|||
125473197|NCT02312960|451365728|FG002|Overall Study|Death|25|||
125473198|NCT02312960|451365729|FG003|Overall Study|Death|11|||
125473199|NCT02312960|451365730|FG004|Overall Study|Death|5|||
125473200|NCT02312960|451365731|FG005|Overall Study|Death|5|||
125473201|NCT02312960|451365732|FG006|Overall Study|Death|8|||
125473202|NCT02312960|451365733|FG007|Overall Study|Death|5|||
125473203|NCT02312960|451365734|FG008|Overall Study|Death|7|||
125473204|NCT02312960|451365735|FG009|Overall Study|Death|3|||
125473205|NCT02312960|451365736|FG010|Overall Study|Death|3|||
125473206|NCT02312960|451365737|FG011|Overall Study|Death|1|||
125473207|NCT02312960|451365738|FG012|Overall Study|Death|25|||
125473208|NCT02312960|451365739|FG013|Overall Study|Death|19|||
125473209|NCT02312960|451365726|FG000|Overall Study|Missing|0|||
125473210|NCT02312960|451365727|FG001|Overall Study|Missing|0|||
125473211|NCT02312960|451365728|FG002|Overall Study|Missing|2|||
125473212|NCT02312960|451365729|FG003|Overall Study|Missing|0|||
125473213|NCT02312960|451365730|FG004|Overall Study|Missing|0|||
125473214|NCT02312960|451365731|FG005|Overall Study|Missing|0|||
125473215|NCT02312960|451365732|FG006|Overall Study|Missing|0|||
125473216|NCT02312960|451365733|FG007|Overall Study|Missing|0|||
125473217|NCT02312960|451365734|FG008|Overall Study|Missing|0|||
125473218|NCT02312960|451365735|FG009|Overall Study|Missing|0|||
125473219|NCT02312960|451365736|FG010|Overall Study|Missing|0|||
125473220|NCT02312960|451365737|FG011|Overall Study|Missing|0|||
125473221|NCT02312960|451365738|FG012|Overall Study|Missing|0|||
125473222|NCT02312960|451365739|FG013|Overall Study|Missing|0|||
125473223|NCT02312960|451365726|FG000|Overall Study|Lost to Follow-up|0|||
125473224|NCT02312960|451365727|FG001|Overall Study|Lost to Follow-up|0|||
125473225|NCT02312960|451365728|FG002|Overall Study|Lost to Follow-up|1|||
125473226|NCT02312960|451365729|FG003|Overall Study|Lost to Follow-up|0|||
125473227|NCT02312960|451365730|FG004|Overall Study|Lost to Follow-up|0|||
125473228|NCT02312960|451365731|FG005|Overall Study|Lost to Follow-up|0|||
125473229|NCT02312960|451365732|FG006|Overall Study|Lost to Follow-up|1|||
125473230|NCT02312960|451365733|FG007|Overall Study|Lost to Follow-up|1|||
125473231|NCT02312960|451365734|FG008|Overall Study|Lost to Follow-up|0|||
125473232|NCT02312960|451365735|FG009|Overall Study|Lost to Follow-up|1|||
125473233|NCT02312960|451365736|FG010|Overall Study|Lost to Follow-up|0|||
125473234|NCT02312960|451365737|FG011|Overall Study|Lost to Follow-up|0|||
125473235|NCT02312960|451365738|FG012|Overall Study|Lost to Follow-up|1|||
125473236|NCT02312960|451365739|FG013|Overall Study|Lost to Follow-up|0|||
125473237|NCT02312960|451365726|FG000|Overall Study|Withdrawal by Subject|1|||
125473238|NCT02312960|451365727|FG001|Overall Study|Withdrawal by Subject|2|||
125473239|NCT02312960|451365728|FG002|Overall Study|Withdrawal by Subject|0|||
125473240|NCT02312960|451365729|FG003|Overall Study|Withdrawal by Subject|0|||
125473241|NCT02312960|451365730|FG004|Overall Study|Withdrawal by Subject|1|||
125473242|NCT02312960|451365731|FG005|Overall Study|Withdrawal by Subject|0|||
125473243|NCT02312960|451365732|FG006|Overall Study|Withdrawal by Subject|1|||
125473244|NCT02312960|451365733|FG007|Overall Study|Withdrawal by Subject|2|||
125473245|NCT02312960|451365734|FG008|Overall Study|Withdrawal by Subject|2|||
125473246|NCT02312960|451365735|FG009|Overall Study|Withdrawal by Subject|3|||
125473247|NCT02312960|451365736|FG010|Overall Study|Withdrawal by Subject|0|||
125473248|NCT02312960|451365737|FG011|Overall Study|Withdrawal by Subject|0|||
125473249|NCT02312960|451365738|FG012|Overall Study|Withdrawal by Subject|2|||
125473250|NCT02312960|451365739|FG013|Overall Study|Withdrawal by Subject|0|||
125473251|NCT03281291|451365741|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
125473252|NCT03281291|451365742|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
125473253|NCT03281291|451365743|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
125473254|NCT03281291|451365744|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
125473255|NCT03281291|451365745|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
125473256|NCT03281291|451365741|FG000|Overall Study|Protocol Deviation|2|||
125473257|NCT03281291|451365742|FG001|Overall Study|Protocol Deviation|0|||
125473258|NCT03281291|451365743|FG002|Overall Study|Protocol Deviation|1|||
125473259|NCT03281291|451365744|FG003|Overall Study|Protocol Deviation|2|||
125473260|NCT03281291|451365745|FG004|Overall Study|Protocol Deviation|1|||
125473261|NCT03281291|451365741|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
125473262|NCT03281291|451365742|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
125473263|NCT03281291|451365743|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
125473264|NCT03281291|451365744|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
125473265|NCT03281291|451365745|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
125473266|NCT03281291|451365741|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
125473267|NCT03281291|451365742|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
125473268|NCT03281291|451365743|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
125473269|NCT03281291|451365744|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
125473270|NCT03281291|451365745|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
125473271|NCT03281291|451365741|FG000|Overall Study|Lost to Follow-up|10|||
125473272|NCT03281291|451365742|FG001|Overall Study|Lost to Follow-up|10|||
125473273|NCT03281291|451365743|FG002|Overall Study|Lost to Follow-up|4|||
125473274|NCT03281291|451365744|FG003|Overall Study|Lost to Follow-up|6|||
125473275|NCT03281291|451365745|FG004|Overall Study|Lost to Follow-up|10|||
125473276|NCT03281291|451365741|FG000|Overall Study|Other|0|||
125473277|NCT03281291|451365742|FG001|Overall Study|Other|2|||
125473278|NCT03281291|451365743|FG002|Overall Study|Other|0|||
125473279|NCT03281291|451365744|FG003|Overall Study|Other|2|||
125473280|NCT03281291|451365745|FG004|Overall Study|Other|1|||
125473281|NCT04382898|451365746|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
125473282|NCT04382898|451365747|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
125473283|NCT04382898|451365748|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
125473284|NCT04382898|451365749|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
125473285|NCT04382898|451365750|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
125473286|NCT04382898|451365746|FG000|Part 1: Dose Titration|Death|6|||
125473287|NCT04382898|451365747|FG001|Part 1: Dose Titration|Death|0|||
125473288|NCT04382898|451365748|FG002|Part 1: Dose Titration|Death|0|||
125473289|NCT04382898|451365749|FG003|Part 1: Dose Titration|Death|0|||
125473290|NCT04382898|451365750|FG004|Part 1: Dose Titration|Death|0|||
125473291|NCT04382898|451365746|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125473292|NCT04382898|451365747|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125473293|NCT04382898|451365748|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
125473294|NCT04382898|451365749|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125473295|NCT04382898|451365750|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
125473296|NCT04382898|451365746|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
125473297|NCT04382898|451365747|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
125473298|NCT04382898|451365748|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
125473299|NCT04382898|451365749|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
125473300|NCT04382898|451365750|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
125473301|NCT04382898|451365746|FG000|Part 2: Dose Expansion|Death|0|||
125473302|NCT04382898|451365747|FG001|Part 2: Dose Expansion|Death|17|||
125473303|NCT04382898|451365748|FG002|Part 2: Dose Expansion|Death|13|||
125473304|NCT04382898|451365749|FG003|Part 2: Dose Expansion|Death|1|||
125473305|NCT04382898|451365750|FG004|Part 2: Dose Expansion|Death|0|||
125473306|NCT04382898|451365746|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
125473307|NCT04382898|451365747|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
125473308|NCT04382898|451365748|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
125473309|NCT04382898|451365749|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
125473310|NCT04382898|451365750|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
125473311|NCT04382898|451365746|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
125473312|NCT04382898|451365747|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
125473313|NCT04382898|451365748|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
125473314|NCT04382898|451365749|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
125473315|NCT04382898|451365750|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
125473316|NCT04382898|451365746|FG000|Part 2: Dose Expansion|Other|0|||
125299941|NCT00812565|450723801|FG000|Overall Study|Did Not Receive Study Medication|1|||
125299942|NCT00812565|450723802|FG001|Overall Study|Did Not Receive Study Medication|1|||
125299943|NCT00812565|450723803|FG002|Overall Study|Did Not Receive Study Medication|0|||
125299944|NCT00812565|450723804|FG003|Overall Study|Did Not Receive Study Medication|0|||
125299945|NCT00812565|450723805|FG004|Overall Study|Did Not Receive Study Medication|0|||
125299946|NCT00812565|450723806|FG005|Overall Study|Did Not Receive Study Medication|0|||
125299947|NCT00812565|450723807|FG006|Overall Study|Did Not Receive Study Medication|0|||
125299948|NCT00812565|450723808|FG007|Overall Study|Did Not Receive Study Medication|0|||
125299949|NCT00812565|450723801|FG000|Overall Study|Adverse Event|0|||
125299950|NCT00812565|450723802|FG001|Overall Study|Adverse Event|0|||
125299951|NCT00812565|450723803|FG002|Overall Study|Adverse Event|0|||
125299952|NCT00812565|450723804|FG003|Overall Study|Adverse Event|2|||
125299953|NCT00812565|450723805|FG004|Overall Study|Adverse Event|0|||
125299954|NCT00812565|450723806|FG005|Overall Study|Adverse Event|0|||
125299955|NCT00812565|450723807|FG006|Overall Study|Adverse Event|0|||
125299956|NCT00812565|450723808|FG007|Overall Study|Adverse Event|1|||
125299957|NCT00812565|450723801|FG000|Overall Study|Did Not Come to Study Visit|1|||
125299958|NCT00812565|450723802|FG001|Overall Study|Did Not Come to Study Visit|0|||
125299959|NCT00812565|450723803|FG002|Overall Study|Did Not Come to Study Visit|0|||
125299960|NCT00812565|450723804|FG003|Overall Study|Did Not Come to Study Visit|0|||
125299961|NCT00812565|450723805|FG004|Overall Study|Did Not Come to Study Visit|0|||
125299962|NCT00812565|450723806|FG005|Overall Study|Did Not Come to Study Visit|0|||
125299963|NCT00812565|450723807|FG006|Overall Study|Did Not Come to Study Visit|0|||
125299964|NCT00812565|450723808|FG007|Overall Study|Did Not Come to Study Visit|0|||
125299965|NCT00812565|450723801|FG000|Overall Study|Withdrawal of Consent|1|||
125299966|NCT00812565|450723802|FG001|Overall Study|Withdrawal of Consent|0|||
125299967|NCT00812565|450723803|FG002|Overall Study|Withdrawal of Consent|0|||
125299968|NCT00812565|450723804|FG003|Overall Study|Withdrawal of Consent|0|||
125299969|NCT00812565|450723805|FG004|Overall Study|Withdrawal of Consent|1|||
125299970|NCT00812565|450723806|FG005|Overall Study|Withdrawal of Consent|0|||
125299971|NCT00812565|450723807|FG006|Overall Study|Withdrawal of Consent|0|||
125299972|NCT00812565|450723808|FG007|Overall Study|Withdrawal of Consent|0|||
125299973|NCT00812565|450723801|FG000|Overall Study|Reason Not Specified|0|||
125299974|NCT00812565|450723802|FG001|Overall Study|Reason Not Specified|0|||
125299975|NCT00812565|450723803|FG002|Overall Study|Reason Not Specified|0|||
125299976|NCT00812565|450723804|FG003|Overall Study|Reason Not Specified|0|||
125299977|NCT00812565|450723805|FG004|Overall Study|Reason Not Specified|0|||
125299978|NCT00812565|450723806|FG005|Overall Study|Reason Not Specified|1|||
125299979|NCT00812565|450723807|FG006|Overall Study|Reason Not Specified|0|||
125299980|NCT00812565|450723808|FG007|Overall Study|Reason Not Specified|0|||
125299981|NCT00765063|450725854|FG000|Overall Study|Lack of Efficacy|5|||
125299982|NCT00765063|450725854|FG000|Overall Study|Withdrawal by Subject|1|||
125299983|NCT00765063|450725854|FG000|Overall Study|Other|16|||
125299984|NCT00765063|450725854|FG000|Overall Study|Protocol Violation|6|||
125299985|NCT00765063|450725854|FG000|Overall Study|Adverse Event|4|||
125299986|NCT03614325|450725855|FG000|Overall Study|Withdrawal by Subject|0|||
125299987|NCT03614325|450725856|FG001|Overall Study|Withdrawal by Subject|2|||
125299988|NCT03614325|450725855|FG000|Overall Study|Surgery Cancelled|2|||
125299989|NCT03614325|450725856|FG001|Overall Study|Surgery Cancelled|1|||
125299990|NCT03614325|450725855|FG000|Overall Study|Lost to Follow-up|2|||
125299991|NCT03614325|450725856|FG001|Overall Study|Lost to Follow-up|1|||
125299992|NCT03614325|450725855|FG000|Overall Study|Surgery never scheduled|1|||
125299993|NCT03614325|450725856|FG001|Overall Study|Surgery never scheduled|0|||
125299994|NCT01041287|450725857|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
125473317|NCT04382898|451365747|FG001|Part 2: Dose Expansion|Other|0|||
125299995|NCT01041287|450725858|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
125299996|NCT01041287|450725857|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
125299997|NCT01041287|450725858|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
125299998|NCT01673620|450725864|FG000|Overall Study|Adverse Event|1|||
125299999|NCT01673620|450725865|FG001|Overall Study|Adverse Event|0|||
125300000|NCT01597635|450725867|FG000|Part A|Adverse Event|3|||
125473318|NCT04382898|451365748|FG002|Part 2: Dose Expansion|Other|1|||
125473319|NCT04382898|451365749|FG003|Part 2: Dose Expansion|Other|0|||
125300001|NCT01597635|450725868|FG001|Part A|Adverse Event|0|||
125300002|NCT01597635|450725869|FG002|Part A|Adverse Event|0|||
125300003|NCT01597635|450725867|FG000|Part B|Adverse Event|0|||
125300004|NCT01597635|450725868|FG001|Part B|Adverse Event|0|||
125300005|NCT01597635|450725869|FG002|Part B|Adverse Event|1|||
125300006|NCT01597635|450725867|FG000|Part B|Protocol Violation|0|||
125300007|NCT01597635|450725868|FG001|Part B|Protocol Violation|1|||
125300008|NCT01597635|450725869|FG002|Part B|Protocol Violation|0|||
125300009|NCT01597635|450725867|FG000|Part B|Protocol-defined stopping criteria|0|||
125300010|NCT01597635|450725868|FG001|Part B|Protocol-defined stopping criteria|4|||
125300011|NCT01597635|450725869|FG002|Part B|Protocol-defined stopping criteria|3|||
125300012|NCT01597635|450725867|FG000|Part B|Withdrawal by Subject|0|||
125300013|NCT01597635|450725868|FG001|Part B|Withdrawal by Subject|1|||
125300014|NCT01597635|450725869|FG002|Part B|Withdrawal by Subject|0|||
125300015|NCT01363661|450725870|FG000|Overall Study|Adverse Event|9|||
125473320|NCT04382898|451365750|FG004|Part 2: Dose Expansion|Other|0|||
125473321|NCT05229120|451365751|FG000|Overall Study|Withdrawal by Subject|8|||
125473322|NCT02900924|451365752|FG000|Overall Study|Death|52|||
125473323|NCT02900924|451365752|FG000|Overall Study|Lost to Follow-up|4|||
125473324|NCT02900924|451365752|FG000|Overall Study|Withdrawal by Subject|20|||
125473325|NCT02900924|451365752|FG000|Overall Study|Missed Visit|33|||
125473326|NCT02365766|451365772|FG000|Overall Study|Withdrawal by Subject|0|||
125473327|NCT02365766|451365773|FG001|Overall Study|Withdrawal by Subject|0|||
125473328|NCT02365766|451365774|FG002|Overall Study|Withdrawal by Subject|1|||
125473329|NCT02365766|451365772|FG000|Overall Study|Eligibility Criteria Not Met|0|||
125473330|NCT02365766|451365773|FG001|Overall Study|Eligibility Criteria Not Met|0|||
125473331|NCT02365766|451365774|FG002|Overall Study|Eligibility Criteria Not Met|1|||
125473332|NCT05956002|451365776|FG000|Treatment Period 3|Adverse Event|0|||
125473333|NCT05956002|451365777|FG001|Treatment Period 3|Adverse Event|0|||
125473334|NCT05956002|451365778|FG002|Treatment Period 3|Adverse Event|1|||
125473335|NCT05956002|451365779|FG003|Treatment Period 3|Adverse Event|0|||
125473336|NCT02307565|451365782|FG000|Overall Study|Adverse Event|3|||
125473337|NCT02307565|451365783|FG001|Overall Study|Adverse Event|2|||
125473338|NCT02307565|451365782|FG000|Overall Study|Withdrawal by Subject|2|||
125473339|NCT02307565|451365783|FG001|Overall Study|Withdrawal by Subject|2|||
125473340|NCT03385629|451365784|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
125473341|NCT03385629|451365785|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
125473342|NCT03385629|451365784|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
125473343|NCT03385629|451365785|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
125473344|NCT03385629|451365784|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
125473345|NCT03385629|451365785|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
125473346|NCT02281955|451365794|FG000|Overall Study|Death|1|||
125473347|NCT02913872|451365795|FG000|Overall Study|Withdrawal by Subject|1|||
125473348|NCT03978871|451365796|FG000|Overall Study|Lost to Follow-up|11|||
125473349|NCT03978871|451365797|FG001|Overall Study|Lost to Follow-up|12|||
125473350|NCT04072822|451365798|FG000|Treatment|Adverse Event|9|||
125473351|NCT04072822|451365799|FG001|Treatment|Adverse Event|5|||
125473352|NCT04072822|451365798|FG000|Treatment|Met Stopping Criteria|13|||
125473353|NCT04072822|451365799|FG001|Treatment|Met Stopping Criteria|24|||
125473354|NCT04072822|451365798|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
125473355|NCT04072822|451365799|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
125473356|NCT04072822|451365798|FG000|Treatment|Withdrawal by Subject|0|||
125473357|NCT04072822|451365799|FG001|Treatment|Withdrawal by Subject|2|||
125473358|NCT04072822|451365798|FG000|Treatment|Death|0|||
125473359|NCT04072822|451365799|FG001|Treatment|Death|2|||
125473360|NCT04072822|451365798|FG000|Treatment|Lost to Follow-up|11|||
125473361|NCT04072822|451365799|FG001|Treatment|Lost to Follow-up|3|||
125473362|NCT04072822|451365798|FG000|Treatment|Physician Decision|1|||
125473363|NCT04072822|451365799|FG001|Treatment|Physician Decision|0|||
125300016|NCT01363661|450725871|FG001|Overall Study|Adverse Event|2|||
125300017|NCT01363661|450725870|FG000|Overall Study|Withdrawal by Subject|1|||
125300018|NCT01363661|450725871|FG001|Overall Study|Withdrawal by Subject|1|||
125473364|NCT04072822|451365798|FG000|Treatment|Other|7|||
125300019|NCT01363661|450725870|FG000|Overall Study|Protocol Violation|1|||
125300020|NCT01363661|450725871|FG001|Overall Study|Protocol Violation|0|||
125300021|NCT01363661|450725870|FG000|Overall Study|Lost to Follow-up|3|||
125300022|NCT01363661|450725871|FG001|Overall Study|Lost to Follow-up|1|||
125300023|NCT01971008|450725872|FG000|Overall Study|Protocol Violation|2|||
125300024|NCT01971008|450725873|FG001|Overall Study|Protocol Violation|1|||
125300025|NCT03775512|450725874|FG000|Overall Study|Death|1|||
125300026|NCT03775512|450725875|FG001|Overall Study|Death|1|||
125300027|NCT03775512|450725874|FG000|Overall Study|Withdrawal by Subject|7|||
125300028|NCT03775512|450725875|FG001|Overall Study|Withdrawal by Subject|4|||
125473365|NCT04072822|451365799|FG001|Treatment|Other|9|||
125473366|NCT04072822|451365798|FG000|Follow-up|Withdrawal by Subject|1|||
125473367|NCT04072822|451365799|FG001|Follow-up|Withdrawal by Subject|0|||
125473368|NCT04072822|451365798|FG000|Follow-up|Lost to Follow-up|5|||
125473369|NCT04072822|451365799|FG001|Follow-up|Lost to Follow-up|4|||
125473370|NCT04391894|451365801|FG000|Overall Study|Adverse Event|1|||
125473371|NCT04391894|451365802|FG001|Overall Study|Adverse Event|1|||
125473372|NCT04391894|451365803|FG002|Overall Study|Adverse Event|1|||
125473373|NCT04391894|451365804|FG003|Overall Study|Adverse Event|1|||
125473374|NCT04391894|451365805|FG004|Overall Study|Adverse Event|1|||
125473375|NCT04391894|451365801|FG000|Overall Study|Lost to Follow-up|1|||
125473376|NCT04391894|451365802|FG001|Overall Study|Lost to Follow-up|0|||
125473377|NCT04391894|451365803|FG002|Overall Study|Lost to Follow-up|0|||
125473378|NCT04391894|451365804|FG003|Overall Study|Lost to Follow-up|0|||
125473379|NCT04391894|451365805|FG004|Overall Study|Lost to Follow-up|0|||
125473380|NCT04391894|451365801|FG000|Overall Study|Protocol Violation|0|||
125473381|NCT04391894|451365802|FG001|Overall Study|Protocol Violation|0|||
125473382|NCT04391894|451365803|FG002|Overall Study|Protocol Violation|0|||
125473383|NCT04391894|451365804|FG003|Overall Study|Protocol Violation|1|||
125473384|NCT04391894|451365805|FG004|Overall Study|Protocol Violation|0|||
125473385|NCT04391894|451365801|FG000|Overall Study|Withdrawal by Subject|2|||
125473386|NCT04391894|451365802|FG001|Overall Study|Withdrawal by Subject|0|||
125473387|NCT04391894|451365803|FG002|Overall Study|Withdrawal by Subject|3|||
125473388|NCT04391894|451365804|FG003|Overall Study|Withdrawal by Subject|0|||
125473389|NCT04391894|451365805|FG004|Overall Study|Withdrawal by Subject|1|||
125473390|NCT04391894|451365801|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
125473391|NCT04391894|451365802|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
125473392|NCT04391894|451365803|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
125473393|NCT04391894|451365804|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
125473394|NCT04391894|451365805|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
125473395|NCT02323321|451365809|FG000|Overall Study|Re-Transplant|1|||
125473396|NCT02323321|451365809|FG000|Overall Study|Death|12|||
125473397|NCT00446225|451365810|FG000|Overall Study|Protocol Violation|1|||
125473398|NCT00446225|451365811|FG001|Overall Study|Protocol Violation|0|||
125473399|NCT04450342|451365812|FG000|Overall Study|Adverse Event|1|||
125473400|NCT04450342|451365813|FG001|Overall Study|Adverse Event|1|||
125473401|NCT04450342|451365814|FG002|Overall Study|Adverse Event|0|||
125473402|NCT04450342|451365812|FG000|Overall Study|Device not used|1|||
125473403|NCT04450342|451365813|FG001|Overall Study|Device not used|0|||
125473404|NCT04450342|451365814|FG002|Overall Study|Device not used|0|||
125473405|NCT04450342|451365812|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
125473406|NCT04450342|451365813|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
125473407|NCT04450342|451365814|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
125473408|NCT04450342|451365812|FG000|Overall Study|Physician Decision|1|||
125473409|NCT04450342|451365813|FG001|Overall Study|Physician Decision|0|||
125473410|NCT04450342|451365814|FG002|Overall Study|Physician Decision|1|||
125473411|NCT04450342|451365812|FG000|Overall Study|Protocol Deviation|0|||
125473412|NCT04450342|451365813|FG001|Overall Study|Protocol Deviation|1|||
125473413|NCT04450342|451365814|FG002|Overall Study|Protocol Deviation|0|||
125473414|NCT04450342|451365812|FG000|Overall Study|Reoperation|1|||
125473415|NCT04450342|451365813|FG001|Overall Study|Reoperation|1|||
125473416|NCT04450342|451365814|FG002|Overall Study|Reoperation|0|||
125473417|NCT04450342|451365812|FG000|Overall Study|Screen Failures|0|||
125473418|NCT04450342|451365813|FG001|Overall Study|Screen Failures|0|||
125473419|NCT04450342|451365814|FG002|Overall Study|Screen Failures|2|||
125473420|NCT04450342|451365812|FG000|Overall Study|Site Terminated by Sponsor|1|||
125473421|NCT04450342|451365813|FG001|Overall Study|Site Terminated by Sponsor|1|||
125473422|NCT04450342|451365814|FG002|Overall Study|Site Terminated by Sponsor|1|||
125473423|NCT04450342|451365812|FG000|Overall Study|Study Terminated by Sponsor|31|||
125473424|NCT04450342|451365813|FG001|Overall Study|Study Terminated by Sponsor|29|||
125473425|NCT04450342|451365814|FG002|Overall Study|Study Terminated by Sponsor|6|||
125473426|NCT04450342|451365812|FG000|Overall Study|Withdrawal by Subject|0|||
125473427|NCT04450342|451365813|FG001|Overall Study|Withdrawal by Subject|1|||
125473428|NCT04450342|451365814|FG002|Overall Study|Withdrawal by Subject|2|||
125473429|NCT00220740|451365815|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
125473430|NCT00220740|451365816|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
125473431|NCT00220740|451365815|FG000|Efficacy Period|Adverse Event|1|||
125473432|NCT00220740|451365816|FG001|Efficacy Period|Adverse Event|1|||
125473433|NCT00220740|451365815|FG000|Efficacy Period|Withdrawal by Subject|1|||
125473434|NCT00220740|451365816|FG001|Efficacy Period|Withdrawal by Subject|0|||
125473435|NCT00220740|451365815|FG000|Efficacy Period|Protocol Violation|1|||
125473436|NCT00220740|451365816|FG001|Efficacy Period|Protocol Violation|0|||
125473437|NCT00220740|451365815|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
125473438|NCT00220740|451365816|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
125473439|NCT01057433|451365817|FG000|Overall Study|Adverse Event|1|||
125473440|NCT02811679|451365818|FG000|Overall Study|Adverse Event|1|||
125473441|NCT02811679|451365818|FG000|Overall Study|Lack of Efficacy|6|||
125473442|NCT02811679|451365818|FG000|Overall Study|Early study closure due to slow accrual|3|||
125473443|NCT03361748|451365821|FG000|Overall Study|Death|77|||
125473444|NCT03361748|451365821|FG000|Overall Study|Lost to Follow-up|4|||
125473445|NCT03361748|451365821|FG000|Overall Study|Withdrawal by Subject|20|||
125473446|NCT02814838|451365827|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
125473447|NCT02814838|451365828|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
125473448|NCT02814838|451365827|FG000|Overall Study|Consent withdrawal|1|||
125473449|NCT02814838|451365828|FG001|Overall Study|Consent withdrawal|1|||
125473450|NCT01361711|451365830|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
125473451|NCT01361711|451365830|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
125473452|NCT01361711|451365830|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
125473453|NCT01361711|451365830|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
125473454|NCT01361711|451365830|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
125473455|NCT01361711|451365830|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
125473456|NCT01361711|451365830|FG000|Completed Week 18 of Treatment|Other|9|||
125473457|NCT01361711|451365830|FG000|10 Year Follow-up|Still in follow-up|22|||
125473458|NCT01361711|451365830|FG000|10 Year Follow-up|Death|7|||
125473459|NCT01361711|451365830|FG000|10 Year Follow-up|Developed new cancer|1|||
125473460|NCT01361711|451365830|FG000|10 Year Follow-up|Lost to Follow-up|2|||
125473461|NCT01361711|451365830|FG000|10 Year Follow-up|New treatment started|6|||
125473462|NCT01361711|451365830|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
125473463|NCT01361711|451365830|FG000|10 Year Follow-up|Progressive Disease|1|||
125473464|NCT02596126|451365831|FG000|Overall Study|Lost to Follow-up|12|||
125473465|NCT02596126|451365832|FG001|Overall Study|Lost to Follow-up|21|||
125473466|NCT02596126|451365831|FG000|Overall Study|Protocol Violation|7|||
125473467|NCT02596126|451365832|FG001|Overall Study|Protocol Violation|9|||
125473468|NCT04630262|451367657|FG000|Overall Study|Intraoperative Screen Failure|5|||
125473469|NCT04630262|451367657|FG000|Overall Study|Study terminated prematurely|71|||
125473470|NCT04630262|451367657|FG000|Overall Study|Withdrawal by Subject|2|||
125473471|NCT04630262|451367657|FG000|Overall Study|Physician Decision|2|||
125473472|NCT04638998|451367663|FG000|Overall Study|Withdrawal by Subject|1|||
125473473|NCT04638998|451367664|FG001|Overall Study|Withdrawal by Subject|3|||
125473474|NCT03692676|451367665|FG000|Overall Study|exclude patients with prior use|4424|||
125473475|NCT03692676|451367666|FG001|Overall Study|exclude patients with prior use|24726|||
125473476|NCT03692676|451367667|FG002|Overall Study|exclude patients with prior use|0|||
125473477|NCT03692676|451367668|FG003|Overall Study|exclude patients with prior use|0|||
125473478|NCT03692676|451367665|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
125473479|NCT03692676|451367666|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
125473480|NCT03692676|451367667|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
125473481|NCT03692676|451367668|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
125473482|NCT03692676|451367665|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
125473483|NCT03692676|451367666|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
125473484|NCT03692676|451367667|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
125473485|NCT03692676|451367668|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
125473486|NCT03692676|451367665|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
125473487|NCT03692676|451367666|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
125473488|NCT03692676|451367667|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
125473489|NCT03692676|451367668|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
125473490|NCT03692676|451367665|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
125473491|NCT03692676|451367666|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
125473492|NCT03692676|451367667|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
125473493|NCT03692676|451367668|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
125473494|NCT03692676|451367665|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
125473495|NCT03692676|451367666|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
125473496|NCT03692676|451367667|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
125473497|NCT03692676|451367668|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
125473498|NCT03692676|451367665|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
125473499|NCT03692676|451367666|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
125473500|NCT03692676|451367667|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
125473501|NCT03692676|451367668|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
125473502|NCT03692676|451367665|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
125473503|NCT03692676|451367666|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
125473504|NCT03692676|451367667|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
125473505|NCT03692676|451367668|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
125473506|NCT03692676|451367665|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
125473507|NCT03692676|451367666|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
125473508|NCT03692676|451367667|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
125473509|NCT03692676|451367668|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
125485378|NCT02240238|451412504|FG001|Phase 1|Withdrawal by Subject|0|||
125300029|NCT03775512|450725874|FG000|Overall Study|Lost to Follow-up|5|||
125473510|NCT03692676|451367665|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
125473511|NCT03692676|451367666|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
125473512|NCT03692676|451367667|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
125473513|NCT03692676|451367668|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
125473514|NCT03692676|451367665|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
125473515|NCT03692676|451367666|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
125473516|NCT03692676|451367667|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
125473517|NCT03692676|451367668|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
125473518|NCT03692676|451367665|FG000|Overall Study|Other|0|||
125473519|NCT03692676|451367666|FG001|Overall Study|Other|805|||
125473520|NCT03692676|451367667|FG002|Overall Study|Other|758|||
125473521|NCT03692676|451367668|FG003|Overall Study|Other|277|||
125473522|NCT03692676|451367665|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
125473523|NCT03692676|451367666|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
125473524|NCT03692676|451367667|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
125473525|NCT03692676|451367668|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
125473526|NCT01180634|451367670|FG000|Overall Study|Adverse Event|4|||
125473527|NCT01180634|451367671|FG001|Overall Study|Adverse Event|1|||
125473528|NCT01180634|451367670|FG000|Overall Study|Miscellaneous|2|||
125473529|NCT01180634|451367671|FG001|Overall Study|Miscellaneous|0|||
125473530|NCT01180634|451367670|FG000|Overall Study|Withdrawal by Subject|4|||
125473531|NCT01180634|451367671|FG001|Overall Study|Withdrawal by Subject|0|||
125473532|NCT03692611|451367672|FG000|Overall Study|Found to be ineligible postrandomization|3|||
125473533|NCT03692611|451367673|FG001|Overall Study|Found to be ineligible postrandomization|0|||
125473534|NCT04419168|451367674|FG000|Overall Study|Protocol Violation|1|||
125473535|NCT04419168|451367675|FG001|Overall Study|Protocol Violation|1|||
125473536|NCT04419168|451367674|FG000|Overall Study|Lost to Follow-up|7|||
125473537|NCT04419168|451367675|FG001|Overall Study|Lost to Follow-up|7|||
125473538|NCT04419168|451367674|FG000|Overall Study|Missed 6-month Visit|48|||
125473539|NCT04419168|451367675|FG001|Overall Study|Missed 6-month Visit|45|||
125473540|NCT04490915|451367676|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
125473541|NCT04490915|451367677|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
125473542|NCT04490915|451367676|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125473543|NCT04490915|451367677|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125473544|NCT04490915|451367676|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125473545|NCT04490915|451367677|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
125473546|NCT04490915|451367676|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
125473547|NCT04490915|451367677|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
125473548|NCT04490915|451367676|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
125473549|NCT04490915|451367677|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
125473550|NCT04490915|451367676|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
125473551|NCT04490915|451367677|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
125473552|NCT04490915|451367676|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
125473553|NCT04490915|451367677|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
125473554|NCT05009251|451367678|FG000|Overall Study|Protocol Violation|100|||
125473555|NCT05009251|451367679|FG001|Overall Study|Protocol Violation|105|||
125473556|NCT05009251|451367680|FG002|Overall Study|Protocol Violation|119|||
125473557|NCT05009251|451367681|FG003|Overall Study|Protocol Violation|120|||
125473558|NCT05009251|451367682|FG004|Overall Study|Protocol Violation|119|||
125473559|NCT05009251|451367678|FG000|Overall Study|Death|25|||
125473560|NCT05009251|451367679|FG001|Overall Study|Death|22|||
125473561|NCT05009251|451367680|FG002|Overall Study|Death|24|||
125473562|NCT05009251|451367681|FG003|Overall Study|Death|19|||
125473563|NCT05009251|451367682|FG004|Overall Study|Death|15|||
125473564|NCT05374837|451367683|FG000|Overall Study|Lost to Follow-up|17|||
125473565|NCT05374837|451367684|FG001|Overall Study|Lost to Follow-up|18|||
125473566|NCT03786783|451367688|FG000|Overall Study|Death|1|||
125473567|NCT03786783|451367688|FG000|Overall Study|Physician Decision|6|||
125473568|NCT03786783|451367688|FG000|Overall Study|Withdrawal by Subject|2|||
125473569|NCT03786783|451367688|FG000|Overall Study|Disease Progression|7|||
125473570|NCT03786783|451367688|FG000|Overall Study|Patient/Parent Refusal|4|||
125473571|NCT02910583|451367689|FG000|Overall Study|Death|7|||
125473572|NCT02910583|451367690|FG001|Overall Study|Death|3|||
125473573|NCT02910583|451367689|FG000|Overall Study|Lost to Follow-up|1|||
125473574|NCT02910583|451367690|FG001|Overall Study|Lost to Follow-up|0|||
125473575|NCT02910583|451367689|FG000|Overall Study|Withdrawal by Subject|12|||
125473576|NCT02910583|451367690|FG001|Overall Study|Withdrawal by Subject|8|||
125473577|NCT02910583|451367689|FG000|Overall Study|Other, Not Specified|6|||
125300030|NCT03775512|450725875|FG001|Overall Study|Lost to Follow-up|5|||
125300031|NCT03775512|450725874|FG000|Overall Study|Excluded before Catheter insertion|14|||
125473578|NCT02910583|451367690|FG001|Overall Study|Other, Not Specified|3|||
125473579|NCT01331005|451367692|FG000|Overall Study|Lost to Follow-up|2|||
125473580|NCT01331005|451367693|FG001|Overall Study|Lost to Follow-up|1|||
125473581|NCT01331005|451367692|FG000|Overall Study|Withdrawal by Subject|2|||
125473582|NCT01331005|451367693|FG001|Overall Study|Withdrawal by Subject|3|||
125473583|NCT02029443|451367696|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
125473584|NCT02029443|451367697|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
125473585|NCT02029443|451367698|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
125473586|NCT02029443|451367699|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
125473587|NCT02029443|451367700|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
125473588|NCT02029443|451367696|FG000|Overall Study|Death|13|||
125473589|NCT02029443|451367697|FG001|Overall Study|Death|2|||
125473590|NCT02029443|451367698|FG002|Overall Study|Death|2|||
125473591|NCT02029443|451367699|FG003|Overall Study|Death|11|||
125473592|NCT02029443|451367700|FG004|Overall Study|Death|2|||
125473593|NCT02029443|451367696|FG000|Overall Study|Lost to Follow-up|1|||
125473594|NCT02029443|451367697|FG001|Overall Study|Lost to Follow-up|0|||
125473595|NCT02029443|451367698|FG002|Overall Study|Lost to Follow-up|1|||
125473596|NCT02029443|451367699|FG003|Overall Study|Lost to Follow-up|1|||
125473597|NCT02029443|451367700|FG004|Overall Study|Lost to Follow-up|0|||
125473598|NCT02029443|451367696|FG000|Overall Study|Started other anti-cancer therapy|17|||
125473599|NCT02029443|451367697|FG001|Overall Study|Started other anti-cancer therapy|4|||
125473600|NCT02029443|451367698|FG002|Overall Study|Started other anti-cancer therapy|7|||
125473601|NCT02029443|451367699|FG003|Overall Study|Started other anti-cancer therapy|9|||
125473602|NCT02029443|451367700|FG004|Overall Study|Started other anti-cancer therapy|3|||
125473603|NCT02029443|451367696|FG000|Overall Study|Withdrawal by Subject|3|||
125473604|NCT02029443|451367697|FG001|Overall Study|Withdrawal by Subject|1|||
125473605|NCT02029443|451367698|FG002|Overall Study|Withdrawal by Subject|1|||
125473606|NCT02029443|451367699|FG003|Overall Study|Withdrawal by Subject|1|||
125473607|NCT02029443|451367700|FG004|Overall Study|Withdrawal by Subject|0|||
125473608|NCT02029443|451367696|FG000|Overall Study|Other|6|||
125473609|NCT02029443|451367697|FG001|Overall Study|Other|6|||
125473610|NCT02029443|451367698|FG002|Overall Study|Other|4|||
125473611|NCT02029443|451367699|FG003|Overall Study|Other|2|||
125473612|NCT02029443|451367700|FG004|Overall Study|Other|0|||
125473613|NCT03393975|451367703|FG000|Urgent Treatment Period|Physician Decision|0|||
125473614|NCT03393975|451367704|FG001|Urgent Treatment Period|Physician Decision|0|||
125473615|NCT03393975|451367705|FG002|Urgent Treatment Period|Physician Decision|0|||
125473616|NCT03393975|451367706|FG003|Urgent Treatment Period|Physician Decision|1|||
125473617|NCT03393975|451367703|FG000|Prophylaxis Period 1|Reason not Specified|0|||
125473618|NCT03393975|451367704|FG001|Prophylaxis Period 1|Reason not Specified|1|||
125473619|NCT03393975|451367705|FG002|Prophylaxis Period 1|Reason not Specified|0|||
125473620|NCT03393975|451367706|FG003|Prophylaxis Period 1|Reason not Specified|0|||
125473621|NCT03393975|451367703|FG000|Prophylaxis Period 2|Reason not Specified|0|||
125473622|NCT03393975|451367704|FG001|Prophylaxis Period 2|Reason not Specified|1|||
125473623|NCT03393975|451367705|FG002|Prophylaxis Period 2|Reason not Specified|0|||
125473624|NCT03393975|451367706|FG003|Prophylaxis Period 2|Reason not Specified|0|||
125473625|NCT04083235|451367707|FG000|Overall Study|Death|252|||
125473626|NCT04083235|451367708|FG001|Overall Study|Death|277|||
125473627|NCT04083235|451367707|FG000|Overall Study|Withdrawal by Subject|13|||
125473628|NCT04083235|451367708|FG001|Overall Study|Withdrawal by Subject|17|||
125473629|NCT04083235|451367707|FG000|Overall Study|Lost to Follow-up|1|||
125473630|NCT04083235|451367708|FG001|Overall Study|Lost to Follow-up|1|||
125473631|NCT04083235|451367707|FG000|Overall Study|Does not meet entry criteria|1|||
125473632|NCT04083235|451367708|FG001|Overall Study|Does not meet entry criteria|0|||
125473633|NCT04083235|451367707|FG000|Overall Study|Did not receive treatment|13|||
125473634|NCT04083235|451367708|FG001|Overall Study|Did not receive treatment|8|||
125473635|NCT04083235|451367707|FG000|Overall Study|Ongoing at the time of DCO|44|||
125473636|NCT04083235|451367708|FG001|Overall Study|Ongoing at the time of DCO|7|||
125473637|NCT03016169|451367711|FG000|Overall Study|Lost to Follow-up|4|||
125473638|NCT03016169|451367711|FG000|Overall Study|Death|54|||
125473639|NCT03016169|451367711|FG000|Overall Study|Device Explant|11|||
125473640|NCT03016169|451367711|FG000|Overall Study|Withdrawal by Subject|19|||
125473641|NCT03016169|451367711|FG000|Overall Study|Other Reasons|1|||
125473642|NCT05458011|451367712|FG000|DB Period (12 Weeks)|Adverse Event|2|||
125473643|NCT05458011|451367713|FG001|DB Period (12 Weeks)|Adverse Event|1|||
125473644|NCT05458011|451367714|FG002|DB Period (12 Weeks)|Adverse Event|1|||
125473645|NCT05458011|451367712|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
125473646|NCT05458011|451367713|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
125473647|NCT05458011|451367714|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
125473648|NCT05458011|451367712|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
125473649|NCT05458011|451367713|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
125473650|NCT05458011|451367714|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
125473651|NCT05458011|451367712|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
125473652|NCT05458011|451367713|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
125473653|NCT05458011|451367714|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
125473654|NCT05458011|451367712|FG000|OL Period (12 Weeks)|Adverse Event|1|||
125473655|NCT05458011|451367713|FG001|OL Period (12 Weeks)|Adverse Event|2|||
125473656|NCT05458011|451367714|FG002|OL Period (12 Weeks)|Adverse Event|1|||
125473657|NCT05458011|451367712|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
125473658|NCT05458011|451367713|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
125473659|NCT05458011|451367714|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
125473660|NCT02724878|451367731|FG000|Overall Study|Still on Active Therapy|15|||
125473661|NCT02724878|451367731|FG000|Overall Study|Disease Progression|31|||
125473662|NCT02724878|451367731|FG000|Overall Study|Toxicity|5|||
125473663|NCT02724878|451367731|FG000|Overall Study|Death|1|||
125473664|NCT02724878|451367731|FG000|Overall Study|Withdrawal by Subject|4|||
125473665|NCT02724878|451367731|FG000|Overall Study|Lost to Follow-up|2|||
125473666|NCT02724878|451367731|FG000|Overall Study|Protocol Violation|1|||
125473667|NCT02724878|451367731|FG000|Overall Study|Ineligible for Study Drug|5|||
125473668|NCT02724878|451367731|FG000|Overall Study|not started|1|||
125473669|NCT04838262|451367733|FG000|Overall Study|Withdrawal by Subject|9|||
125473670|NCT04838262|451367734|FG001|Overall Study|Withdrawal by Subject|4|||
125473671|NCT05082909|451367735|FG000|Overall Study|Protocol Violation|0|||
125473672|NCT05082909|451367736|FG001|Overall Study|Protocol Violation|0|||
125473673|NCT05082909|451367737|FG002|Overall Study|Protocol Violation|1|||
125473674|NCT05082909|451367738|FG003|Overall Study|Protocol Violation|0|||
125473675|NCT05082909|451367739|FG004|Overall Study|Protocol Violation|0|||
125473676|NCT05082909|451367740|FG005|Overall Study|Protocol Violation|0|||
125473677|NCT03175029|451367743|FG000|Overall Study|Withdrawal by Subject|2|||
125473678|NCT03175029|451367744|FG001|Overall Study|Withdrawal by Subject|1|||
125473679|NCT03175029|451367743|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
125473680|NCT03175029|451367744|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
125473681|NCT05227209|451367749|FG000|Overall Study|Adverse Event|11|||
125473682|NCT05227209|451367749|FG000|Overall Study|Lost to Follow-up|1|||
125473683|NCT05227209|451367749|FG000|Overall Study|Withdrawal by Subject|7|||
125473684|NCT05227209|451367749|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
125473685|NCT04950660|451367750|FG000|Overall Study|Protocol Violation|4|||
125473686|NCT04950660|451367751|FG001|Overall Study|Protocol Violation|2|||
125473687|NCT04950660|451367750|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
125473688|NCT04950660|451367751|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
125473689|NCT04950660|451367750|FG000|Overall Study|Withdrawal by Subject|0|||
125473690|NCT04950660|451367751|FG001|Overall Study|Withdrawal by Subject|1|||
125473691|NCT04950660|451367750|FG000|Overall Study|Hypotension|1|||
125473692|NCT04950660|451367751|FG001|Overall Study|Hypotension|0|||
125473693|NCT05524233|451367754|FG000|Overall Study|Lost to Follow-up|2|||
125473694|NCT05524233|451367754|FG000|Overall Study|Adverse Event|2|||
125473695|NCT05524233|451367754|FG000|Overall Study|Withdrawal by Subject|1|||
125473696|NCT02530671|451367757|FG000|Overall Study|Lost to Follow-up|2|||
125473697|NCT02530671|451367758|FG001|Overall Study|Lost to Follow-up|0|||
125473698|NCT02530671|451367757|FG000|Overall Study|Withdrawal by Subject|1|||
125473699|NCT02530671|451367758|FG001|Overall Study|Withdrawal by Subject|0|||
125473700|NCT04390048|451367759|FG000|Overall Study|Withdrawal by Subject|1|||
125473701|NCT04390048|451367760|FG001|Overall Study|Withdrawal by Subject|3|||
125473702|NCT03126019|451367761|FG000|Overall Study|Death|5|||
125473703|NCT03126019|451367762|FG001|Overall Study|Death|27|||
125473704|NCT03126019|451367761|FG000|Overall Study|Lost to Follow-up|2|||
125473705|NCT03126019|451367762|FG001|Overall Study|Lost to Follow-up|4|||
125473706|NCT03126019|451367761|FG000|Overall Study|Withdrawal by Subject|1|||
125473707|NCT03126019|451367762|FG001|Overall Study|Withdrawal by Subject|9|||
125473708|NCT03126019|451367761|FG000|Overall Study|Physician Decision|1|||
125473709|NCT03126019|451367762|FG001|Overall Study|Physician Decision|0|||
125473710|NCT03126019|451367761|FG000|Overall Study|Transitioned to Rollover Study|0|||
125473711|NCT03126019|451367762|FG001|Overall Study|Transitioned to Rollover Study|11|||
125473712|NCT03126019|451367761|FG000|Overall Study|Did Not Return to Site for Care|0|||
125473713|NCT03126019|451367762|FG001|Overall Study|Did Not Return to Site for Care|1|||
125473714|NCT03126019|451367761|FG000|Overall Study|Site Closed|0|||
125473715|NCT03126019|451367762|FG001|Overall Study|Site Closed|1|||
125473716|NCT01566695|451367763|FG000|Overall Study|Lack of Efficacy|1|||
125473717|NCT01566695|451367764|FG001|Overall Study|Lack of Efficacy|0|||
125473718|NCT01566695|451367763|FG000|Overall Study|Adverse Event|3|||
125473719|NCT01566695|451367764|FG001|Overall Study|Adverse Event|0|||
125473720|NCT01566695|451367763|FG000|Overall Study|Death|79|||
125473721|NCT01566695|451367764|FG001|Overall Study|Death|86|||
125473722|NCT01566695|451367763|FG000|Overall Study|Withdrawal by Subject|13|||
125473723|NCT01566695|451367764|FG001|Overall Study|Withdrawal by Subject|12|||
125473724|NCT01566695|451367763|FG000|Overall Study|Lost to Follow-up|0|||
125473725|NCT01566695|451367764|FG001|Overall Study|Lost to Follow-up|3|||
125473726|NCT01566695|451367763|FG000|Overall Study|Other reasons|11|||
125473727|NCT01566695|451367764|FG001|Overall Study|Other reasons|8|||
125473728|NCT03763708|451367765|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
125300032|NCT03775512|450725875|FG001|Overall Study|Excluded before Catheter insertion|5|||
125485379|NCT02240238|451412505|FG002|Phase 1|Withdrawal by Subject|0|||
125473729|NCT03763708|451367766|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
125473730|NCT03763708|451367767|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
125473731|NCT03763708|451367768|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
125473732|NCT03763708|451367769|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
125473733|NCT03763708|451367770|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
125473734|NCT03763708|451367771|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
125473735|NCT03763708|451367772|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
125473736|NCT03763708|451367773|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
125473737|NCT03763708|451367765|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
125473738|NCT03763708|451367766|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
125473739|NCT03763708|451367767|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
125473740|NCT03763708|451367768|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
125473741|NCT03763708|451367769|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
125473742|NCT03763708|451367770|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
125473743|NCT03763708|451367771|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
125473744|NCT03763708|451367772|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
125473745|NCT03763708|451367773|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
125473746|NCT03763708|451367765|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
125473747|NCT03763708|451367766|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
125473748|NCT03763708|451367767|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
125473749|NCT03763708|451367768|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
125473750|NCT03763708|451367769|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
125473751|NCT03763708|451367770|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
125473752|NCT03763708|451367771|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
125473753|NCT03763708|451367772|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
125473754|NCT03763708|451367773|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
125473755|NCT03763708|451367765|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
125473756|NCT03763708|451367766|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
125473757|NCT03763708|451367767|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
125473758|NCT03763708|451367768|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
125473759|NCT03763708|451367769|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
125473760|NCT03763708|451367770|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
125473761|NCT03763708|451367771|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
125473762|NCT03763708|451367772|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
125473763|NCT03763708|451367773|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
125473764|NCT03763708|451367765|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
125473765|NCT03763708|451367766|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
125473766|NCT03763708|451367767|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
125473767|NCT03763708|451367768|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
125473768|NCT03763708|451367769|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
125473769|NCT03763708|451367770|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
125473770|NCT03763708|451367771|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
125473771|NCT03763708|451367772|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
125473772|NCT03763708|451367773|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
125473773|NCT03763708|451367765|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
125473774|NCT03763708|451367766|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
125473775|NCT03763708|451367767|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
125473776|NCT03763708|451367768|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
125473777|NCT03763708|451367769|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
125473778|NCT03763708|451367770|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
125473779|NCT03763708|451367771|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
125473780|NCT03763708|451367772|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
125473781|NCT03763708|451367773|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
125473782|NCT03763708|451367765|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
125473783|NCT03763708|451367766|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
125473784|NCT03763708|451367767|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
125473785|NCT03763708|451367768|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
125473786|NCT03763708|451367769|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
125473787|NCT03763708|451367770|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
125473788|NCT03763708|451367771|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
125300033|NCT03775512|450725874|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
125473789|NCT03763708|451367772|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
125473790|NCT03763708|451367773|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
125473791|NCT03763708|451367765|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
125473792|NCT03763708|451367766|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
125473793|NCT03763708|451367767|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
125473794|NCT03763708|451367768|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
125473795|NCT03763708|451367769|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
125473796|NCT03763708|451367770|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
125473797|NCT03763708|451367771|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
125473798|NCT03763708|451367772|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
125473799|NCT03763708|451367773|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
125473800|NCT03763708|451367765|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
125473801|NCT03763708|451367766|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
125473802|NCT03763708|451367767|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
125473803|NCT03763708|451367768|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
125473804|NCT03763708|451367769|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
125473805|NCT03763708|451367770|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
125473806|NCT03763708|451367771|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
125473807|NCT03763708|451367772|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
125473808|NCT03763708|451367773|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
125473809|NCT05470400|451367776|FG000|Overall Study|Lost to Follow-up|0|||
125473810|NCT05470400|451367777|FG001|Overall Study|Lost to Follow-up|0|||
125473811|NCT05470400|451367778|FG002|Overall Study|Lost to Follow-up|0|||
125473812|NCT05470400|451367779|FG003|Overall Study|Lost to Follow-up|0|||
125473813|NCT05470400|451367780|FG004|Overall Study|Lost to Follow-up|0|||
125473814|NCT05470400|451367781|FG005|Overall Study|Lost to Follow-up|0|||
125473815|NCT05470400|451367782|FG006|Overall Study|Lost to Follow-up|0|||
125473816|NCT05470400|451367783|FG007|Overall Study|Lost to Follow-up|1|||
125473817|NCT05470400|451367776|FG000|Overall Study|Withdrawal by Subject|1|||
125473818|NCT05470400|451367777|FG001|Overall Study|Withdrawal by Subject|0|||
125473819|NCT05470400|451367778|FG002|Overall Study|Withdrawal by Subject|0|||
125473820|NCT05470400|451367779|FG003|Overall Study|Withdrawal by Subject|0|||
125473821|NCT05470400|451367780|FG004|Overall Study|Withdrawal by Subject|0|||
125473822|NCT05470400|451367781|FG005|Overall Study|Withdrawal by Subject|1|||
125473823|NCT05470400|451367782|FG006|Overall Study|Withdrawal by Subject|0|||
125473824|NCT05470400|451367783|FG007|Overall Study|Withdrawal by Subject|2|||
125473825|NCT01809691|451367787|FG000|Overall Study|Currently on Treatment|192|||
125473826|NCT01809691|451367788|FG001|Overall Study|Currently on Treatment|100|||
125473827|NCT01809691|451367787|FG000|Overall Study|No Protocol Treatment|10|||
125473828|NCT01809691|451367788|FG001|Overall Study|No Protocol Treatment|11|||
125473829|NCT01809691|451367787|FG000|Overall Study|Adverse Event|80|||
125473830|NCT01809691|451367788|FG001|Overall Study|Adverse Event|21|||
125473831|NCT01809691|451367787|FG000|Overall Study|Disease Progression|226|||
125473832|NCT01809691|451367788|FG001|Overall Study|Disease Progression|372|||
125473833|NCT01809691|451367787|FG000|Overall Study|Death|26|||
125473834|NCT01809691|451367788|FG001|Overall Study|Death|13|||
125473835|NCT01809691|451367787|FG000|Overall Study|Participant Refusal|70|||
125473836|NCT01809691|451367788|FG001|Overall Study|Participant Refusal|72|||
125473837|NCT01809691|451367787|FG000|Overall Study|Other, Not Specified|34|||
125473838|NCT01809691|451367788|FG001|Overall Study|Other, Not Specified|52|||
125300034|NCT03775512|450725875|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
125300035|NCT03775512|450725874|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
125300036|NCT03775512|450725875|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
125473839|NCT04401800|451367791|FG000|Overall Study|Death|17|||
125473840|NCT04401800|451367791|FG000|Overall Study|Lost to Follow-up|5|||
125473841|NCT04401800|451367791|FG000|Overall Study|Withdrawal by Subject|4|||
125473842|NCT04533347|451367795|FG000|Overall Study|Adverse Event|1|||
125473843|NCT04533347|451367796|FG001|Overall Study|Adverse Event|2|||
125473844|NCT04533347|451367795|FG000|Overall Study|Lost to Follow-up|2|||
125473845|NCT04533347|451367796|FG001|Overall Study|Lost to Follow-up|0|||
125473846|NCT04533347|451367795|FG000|Overall Study|Withdrawal by Subject|1|||
125473847|NCT04533347|451367796|FG001|Overall Study|Withdrawal by Subject|0|||
125473848|NCT04831216|451367800|FG000|Overall Study|Lost to Follow-up|32|||
125473849|NCT05268302|451367805|FG000|Overall Study|Death|0|||
125473850|NCT05268302|451367806|FG001|Overall Study|Death|1|||
125473851|NCT04285567|451367807|FG000|Overall Study|Death|3|||
125473852|NCT04285567|451367808|FG001|Overall Study|Death|3|||
125473853|NCT04285567|451367807|FG000|Overall Study|Lost to Follow-up|1|||
125473854|NCT04285567|451367808|FG001|Overall Study|Lost to Follow-up|1|||
125473855|NCT04285567|451367807|FG000|Overall Study|Reason Not Specified|1|||
125473856|NCT04285567|451367808|FG001|Overall Study|Reason Not Specified|1|||
125473857|NCT04285567|451367807|FG000|Overall Study|Physician Decision|2|||
125473858|NCT04285567|451367808|FG001|Overall Study|Physician Decision|1|||
125473859|NCT04285567|451367807|FG000|Overall Study|Withdrawal by Subject|2|||
125473860|NCT04285567|451367808|FG001|Overall Study|Withdrawal by Subject|6|||
125473861|NCT04285567|451367807|FG000|Overall Study|Adverse Event|1|||
125300037|NCT01378325|450725876|FG000|Overall Study|Protocol Violation|0|||
125473862|NCT04285567|451367808|FG001|Overall Study|Adverse Event|0|||
125473863|NCT04285567|451367807|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
125473864|NCT04285567|451367808|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
125473865|NCT05319860|451367810|FG000|Overall Study|Death|1|||
125473866|NCT05319860|451367811|FG001|Overall Study|Death|1|||
125473867|NCT05319860|451367810|FG000|Overall Study|Lost to Follow-up|3|||
125473868|NCT05319860|451367811|FG001|Overall Study|Lost to Follow-up|1|||
125473869|NCT05319860|451367810|FG000|Overall Study|Withdrawal by Subject|1|||
125473870|NCT05319860|451367811|FG001|Overall Study|Withdrawal by Subject|7|||
125473871|NCT05063994|451369718|FG000|Cortef Run-In|Withdrawal of Consent|1|||
125473872|NCT05063994|451369719|FG001|Cortef Run-In|Withdrawal of Consent|0|||
125473873|NCT05063994|451369720|FG002|Cortef Run-In|Withdrawal of Consent|0|||
125473874|NCT05063994|451369718|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
125473875|NCT05063994|451369719|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
125473876|NCT05063994|451369720|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
125473877|NCT05063994|451369718|FG000|Treatment|Physician Decision|0|||
125473878|NCT05063994|451369719|FG001|Treatment|Physician Decision|0|||
125473879|NCT05063994|451369720|FG002|Treatment|Physician Decision|1|||
125473880|NCT05063994|451369718|FG000|Treatment|Withdrawal by Subject|0|||
125473881|NCT05063994|451369719|FG001|Treatment|Withdrawal by Subject|0|||
125473882|NCT05063994|451369720|FG002|Treatment|Withdrawal by Subject|1|||
125473883|NCT05063994|451369718|FG000|Treatment|Withdrawal of Consent|0|||
125473884|NCT05063994|451369719|FG001|Treatment|Withdrawal of Consent|0|||
125473885|NCT05063994|451369720|FG002|Treatment|Withdrawal of Consent|1|||
125473886|NCT02549339|451369723|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
125473887|NCT02549339|451369724|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
125473888|NCT02549339|451369723|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
125473889|NCT02549339|451369724|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
125473890|NCT02549339|451369723|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
125473891|NCT02549339|451369724|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
125473892|NCT02549339|451369723|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
125473893|NCT02549339|451369724|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
125473894|NCT02549339|451369723|FG000|12-month Follow-up|Lack of Efficacy|0|||
125473895|NCT02549339|451369724|FG001|12-month Follow-up|Lack of Efficacy|2|||
125473896|NCT02549339|451369723|FG000|12-month Follow-up|Withdrawal by Subject|8|||
125473897|NCT02549339|451369724|FG001|12-month Follow-up|Withdrawal by Subject|3|||
125473898|NCT02549339|451369723|FG000|12-month Follow-up|Lost to Follow-up|1|||
125473899|NCT02549339|451369724|FG001|12-month Follow-up|Lost to Follow-up|3|||
125473900|NCT02549339|451369723|FG000|12-month Follow-up|Other|0|||
125473901|NCT02549339|451369724|FG001|12-month Follow-up|Other|3|||
125473902|NCT04263311|451369726|FG000|Overall Study|Lost to Follow-up|1|||
125473903|NCT04263311|451369727|FG001|Overall Study|Lost to Follow-up|2|||
125473904|NCT04263311|451369728|FG002|Overall Study|Lost to Follow-up|0|||
125473905|NCT04263311|451369726|FG000|Overall Study|Health Issues|1|||
125473906|NCT04263311|451369727|FG001|Overall Study|Health Issues|0|||
125473907|NCT04263311|451369728|FG002|Overall Study|Health Issues|0|||
125473908|NCT04263311|451369726|FG000|Overall Study|Left the country|1|||
125473909|NCT04263311|451369727|FG001|Overall Study|Left the country|0|||
125473910|NCT04263311|451369728|FG002|Overall Study|Left the country|0|||
125473911|NCT04263311|451369726|FG000|Overall Study|Unable to maintain time commitment|1|||
125473912|NCT04263311|451369727|FG001|Overall Study|Unable to maintain time commitment|0|||
125473913|NCT04263311|451369728|FG002|Overall Study|Unable to maintain time commitment|0|||
125473914|NCT04263311|451369726|FG000|Overall Study|No longer interested|1|||
125473915|NCT04263311|451369727|FG001|Overall Study|No longer interested|0|||
125473916|NCT04263311|451369728|FG002|Overall Study|No longer interested|0|||
125473917|NCT04263311|451369726|FG000|Overall Study|Ineligible post consent|0|||
125473918|NCT04263311|451369727|FG001|Overall Study|Ineligible post consent|0|||
125473919|NCT04263311|451369728|FG002|Overall Study|Ineligible post consent|5|||
125473920|NCT02954341|451369731|FG000|Overall Study|Attempted Implant unsuccessful|5|||
125473921|NCT02954341|451369731|FG000|Overall Study|Death|90|||
125473922|NCT02954341|451369731|FG000|Overall Study|Withdrawal by Subject|4|||
125473923|NCT02954341|451369731|FG000|Overall Study|Physician Decision|13|||
125473924|NCT02954341|451369731|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
125473925|NCT02954341|451369731|FG000|Overall Study|Not implanted due to physician's decision|1|||
125473926|NCT02954341|451369731|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
125473927|NCT01426425|451369734|FG000|Overall Study|Exited prior to EP study|22|||
125473928|NCT01426425|451369734|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
125473929|NCT01426425|451369734|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
125473930|NCT00512070|451369742|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
125473931|NCT00512070|451369743|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
125473932|NCT00512070|451369744|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
125473933|NCT00512070|451369742|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
125473934|NCT00512070|451369743|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
125473935|NCT00512070|451369744|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
125473936|NCT02506959|451369745|FG000|Overall Study|Physician Decision|2|||
125473937|NCT02506959|451369746|FG001|Overall Study|Physician Decision|1|||
125473938|NCT03932682|451369748|FG000|Overall Study|Death|1|||
125473939|NCT03932682|451369749|FG001|Overall Study|Death|2|||
125473940|NCT03932682|451369748|FG000|Overall Study|Withdrawal by Subject|37|||
125473941|NCT03932682|451369749|FG001|Overall Study|Withdrawal by Subject|45|||
125473942|NCT03932682|451369748|FG000|Overall Study|Lost to Follow-up|19|||
125473943|NCT03932682|451369749|FG001|Overall Study|Lost to Follow-up|25|||
125473944|NCT03932682|451369748|FG000|Overall Study|Protocol Violation|0|||
125473945|NCT03932682|451369749|FG001|Overall Study|Protocol Violation|2|||
125473946|NCT03932682|451369748|FG000|Overall Study|Other|9|||
125473947|NCT03932682|451369749|FG001|Overall Study|Other|23|||
125473948|NCT04806594|451369752|FG000|Overall Study|Withdrawal by Subject|2|||
125473949|NCT04806594|451369752|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
125473950|NCT02543281|451369753|FG000|Overall Study|Lost to Follow-up|0|||
125473951|NCT02543281|451369754|FG001|Overall Study|Lost to Follow-up|0|||
125473952|NCT02543281|451369755|FG002|Overall Study|Lost to Follow-up|1|||
125473953|NCT03143153|451369756|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
125473954|NCT03143153|451369757|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
125300038|NCT01378325|450725877|FG001|Overall Study|Protocol Violation|1|||
125300039|NCT00767806|450725880|FG000|Overall Study|Adverse Event|30|||
125300040|NCT00767806|450725881|FG001|Overall Study|Adverse Event|11|||
125300041|NCT00767806|450725880|FG000|Overall Study|Withdrawal by Subject|8|||
125300042|NCT00767806|450725881|FG001|Overall Study|Withdrawal by Subject|13|||
125300043|NCT00767806|450725880|FG000|Overall Study|Protocol Violation|6|||
125300044|NCT00767806|450725881|FG001|Overall Study|Protocol Violation|5|||
125300045|NCT00767806|450725880|FG000|Overall Study|Lack of Efficacy|1|||
125300046|NCT00767806|450725881|FG001|Overall Study|Lack of Efficacy|9|||
125300047|NCT00767806|450725880|FG000|Overall Study|Physician Decision|4|||
125300048|NCT00767806|450725881|FG001|Overall Study|Physician Decision|3|||
125300049|NCT00767806|450725880|FG000|Overall Study|Lost to Follow-up|1|||
125300050|NCT00767806|450725881|FG001|Overall Study|Lost to Follow-up|4|||
125300051|NCT00767806|450725880|FG000|Overall Study|Entry Criteria Not Met|1|||
125300052|NCT00767806|450725881|FG001|Overall Study|Entry Criteria Not Met|1|||
125300053|NCT00767806|450725880|FG000|Overall Study|Sponsor Decision|0|||
125473955|NCT03143153|451369758|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
125473956|NCT03143153|451369756|FG000|Pre-Treatment|Participant withdrew consent|0|||
125473957|NCT03143153|451369757|FG001|Pre-Treatment|Participant withdrew consent|1|||
125473958|NCT03143153|451369758|FG002|Pre-Treatment|Participant withdrew consent|12|||
125473959|NCT03143153|451369756|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
125473960|NCT03143153|451369757|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
125473961|NCT03143153|451369758|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
125473962|NCT03143153|451369756|FG000|Pre-Treatment|Other Reasons|1|||
125473963|NCT03143153|451369757|FG001|Pre-Treatment|Other Reasons|2|||
125473964|NCT03143153|451369758|FG002|Pre-Treatment|Other Reasons|1|||
125473965|NCT03143153|451369756|FG000|Pre-Treatment|Disease Progression|1|||
125473966|NCT03143153|451369757|FG001|Pre-Treatment|Disease Progression|1|||
125473967|NCT03143153|451369758|FG002|Pre-Treatment|Disease Progression|2|||
125473968|NCT03143153|451369756|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
125473969|NCT03143153|451369757|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
125473970|NCT03143153|451369758|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
125473971|NCT03143153|451369756|FG000|Treatment|Disease progression|174|||
125473972|NCT03143153|451369757|FG001|Treatment|Disease progression|184|||
125473973|NCT03143153|451369758|FG002|Treatment|Disease progression|193|||
125473974|NCT03143153|451369756|FG000|Treatment|Study drug toxicity|59|||
125473975|NCT03143153|451369757|FG001|Treatment|Study drug toxicity|33|||
125473976|NCT03143153|451369758|FG002|Treatment|Study drug toxicity|40|||
125473977|NCT03143153|451369756|FG000|Treatment|Death|5|||
125473978|NCT03143153|451369757|FG001|Treatment|Death|3|||
125473979|NCT03143153|451369758|FG002|Treatment|Death|4|||
125473980|NCT03143153|451369756|FG000|Treatment|Adverse event unrelated to study drug|19|||
125473981|NCT03143153|451369757|FG001|Treatment|Adverse event unrelated to study drug|28|||
125473982|NCT03143153|451369758|FG002|Treatment|Adverse event unrelated to study drug|12|||
125473983|NCT03143153|451369756|FG000|Treatment|Participant request to discontinue study treatment|13|||
125473984|NCT03143153|451369757|FG001|Treatment|Participant request to discontinue study treatment|15|||
125473985|NCT03143153|451369758|FG002|Treatment|Participant request to discontinue study treatment|20|||
125473986|NCT03143153|451369756|FG000|Treatment|Participant withdrew consent|3|||
125473987|NCT03143153|451369757|FG001|Treatment|Participant withdrew consent|4|||
125473988|NCT03143153|451369758|FG002|Treatment|Participant withdrew consent|12|||
125473989|NCT03143153|451369756|FG000|Treatment|Pregnancy|1|||
125473990|NCT03143153|451369757|FG001|Treatment|Pregnancy|0|||
125473991|NCT03143153|451369758|FG002|Treatment|Pregnancy|0|||
125473992|NCT03143153|451369756|FG000|Treatment|Maximum clinical benefit|1|||
125473993|NCT03143153|451369757|FG001|Treatment|Maximum clinical benefit|3|||
125473994|NCT03143153|451369758|FG002|Treatment|Maximum clinical benefit|4|||
125473995|NCT03143153|451369756|FG000|Treatment|Completed treatment as per Protocol|13|||
125473996|NCT03143153|451369757|FG001|Treatment|Completed treatment as per Protocol|8|||
125473997|NCT03143153|451369758|FG002|Treatment|Completed treatment as per Protocol|0|||
125473998|NCT03143153|451369756|FG000|Treatment|Other reasons|12|||
125473999|NCT03143153|451369757|FG001|Treatment|Other reasons|7|||
125300054|NCT00767806|450725881|FG001|Overall Study|Sponsor Decision|1|||
125300055|NCT02489942|450725882|FG000|Overall Study|Request by patient|602|||
125300056|NCT02489942|450725882|FG000|Overall Study|Improvement/remission|157|||
125300057|NCT02489942|450725882|FG000|Overall Study|No change/Progressive disease|263|||
125300058|NCT02489942|450725882|FG000|Overall Study|Adverse Event|522|||
125300059|NCT02489942|450725882|FG000|Overall Study|Other personal reasons|1218|||
125474000|NCT03143153|451369758|FG002|Treatment|Other reasons|15|||
125474001|NCT03143153|451369756|FG000|Treatment|Not reported|1|||
125474002|NCT03143153|451369757|FG001|Treatment|Not reported|0|||
125474003|NCT03143153|451369758|FG002|Treatment|Not reported|0|||
125474004|NCT02312557|451369759|FG000|Overall Study|Survival follow-up|4|||
125474005|NCT04237298|451369760|FG000|Overall Study|Lost to Follow-up|4|||
125474006|NCT04237298|451369761|FG001|Overall Study|Lost to Follow-up|5|||
125474007|NCT02736409|451369767|FG000|Overall Study|Withdrawal by Subject|4|||
125474008|NCT02736409|451369768|FG001|Overall Study|Withdrawal by Subject|2|||
125474009|NCT02736409|451369769|FG002|Overall Study|Withdrawal by Subject|17|||
125474010|NCT02736409|451369770|FG003|Overall Study|Withdrawal by Subject|3|||
125474011|NCT02736409|451369767|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125474012|NCT02736409|451369768|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125474013|NCT02736409|451369769|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125474014|NCT02736409|451369770|FG003|Overall Study|Non-Compliance with Study Drug|1|||
125474015|NCT02736409|451369767|FG000|Overall Study|Adverse Event|0|||
125474016|NCT02736409|451369768|FG001|Overall Study|Adverse Event|1|||
125474017|NCT02736409|451369769|FG002|Overall Study|Adverse Event|5|||
125474018|NCT02736409|451369770|FG003|Overall Study|Adverse Event|4|||
125474019|NCT02736409|451369767|FG000|Overall Study|Other|0|||
125474020|NCT02736409|451369768|FG001|Overall Study|Other|0|||
125474021|NCT02736409|451369769|FG002|Overall Study|Other|1|||
125474022|NCT02736409|451369770|FG003|Overall Study|Other|1|||
125474023|NCT02736409|451369767|FG000|Overall Study|Pregnancy|0|||
125474024|NCT02736409|451369768|FG001|Overall Study|Pregnancy|0|||
125474025|NCT02736409|451369769|FG002|Overall Study|Pregnancy|1|||
125474026|NCT02736409|451369770|FG003|Overall Study|Pregnancy|0|||
125474027|NCT02736409|451369767|FG000|Overall Study|Lost to Follow-up|0|||
125474028|NCT02736409|451369768|FG001|Overall Study|Lost to Follow-up|0|||
125474029|NCT02736409|451369769|FG002|Overall Study|Lost to Follow-up|2|||
125474030|NCT02736409|451369770|FG003|Overall Study|Lost to Follow-up|1|||
125474031|NCT02736409|451369767|FG000|Overall Study|Physician Decision|0|||
125474032|NCT02736409|451369768|FG001|Overall Study|Physician Decision|0|||
125474033|NCT02736409|451369769|FG002|Overall Study|Physician Decision|0|||
125474034|NCT02736409|451369770|FG003|Overall Study|Physician Decision|2|||
125474035|NCT04556656|451369776|FG000|Overall Study|Withdrawal by Subject|14|||
125474036|NCT04556656|451369777|FG001|Overall Study|Withdrawal by Subject|12|||
125474037|NCT04556656|451369776|FG000|Overall Study|Physician Decision|1|||
125474038|NCT04556656|451369777|FG001|Overall Study|Physician Decision|0|||
125474039|NCT04556656|451369776|FG000|Overall Study|Adverse Event|4|||
125474040|NCT04556656|451369777|FG001|Overall Study|Adverse Event|7|||
125474041|NCT04556656|451369776|FG000|Overall Study|Death|4|||
125474042|NCT04556656|451369777|FG001|Overall Study|Death|0|||
125474043|NCT04556656|451369776|FG000|Overall Study|Lost to Follow-up|3|||
125474044|NCT04556656|451369777|FG001|Overall Study|Lost to Follow-up|2|||
125474045|NCT04556656|451369776|FG000|Overall Study|Not further specified|2|||
125474046|NCT04556656|451369777|FG001|Overall Study|Not further specified|1|||
125474047|NCT05323084|451369801|FG000|Period 2 - Washout|Lost to Follow-up|0|||
125300060|NCT02489942|450725882|FG000|Overall Study|Lost to Follow-up|456|||
125300061|NCT02489942|450725882|FG000|Overall Study|Not continuously investigated|7|||
125300062|NCT02489942|450725882|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
125300063|NCT02489942|450725882|FG000|Overall Study|Multiple registration|1|||
125300064|NCT02489942|450725882|FG000|Overall Study|No patient visit after entry|100|||
125300065|NCT02489942|450725882|FG000|Overall Study|No treatment with Jardiance|2|||
125300066|NCT02489942|450725882|FG000|Overall Study|Patient received Jardiance before registration|1|||
125300067|NCT02489942|450725882|FG000|Overall Study|No CRF collected|86|||
125300068|NCT00858208|450725883|FG000|Overall Study|Adverse Event|3|||
125300069|NCT00858208|450725883|FG000|Overall Study|Lost to Follow-up|26|||
125300070|NCT00858208|450725883|FG000|Overall Study|Participant refused|40|||
125300071|NCT00858208|450725883|FG000|Overall Study|Other|10|||
125300072|NCT01393639|450725884|FG000|Overall Study|Protocol Violation|0|||
125300073|NCT01393639|450725885|FG001|Overall Study|Protocol Violation|0|||
125300074|NCT01393639|450725886|FG002|Overall Study|Protocol Violation|0|||
125474048|NCT05323084|451369802|FG001|Period 2 - Washout|Lost to Follow-up|1|||
125300075|NCT01393639|450725887|FG003|Overall Study|Protocol Violation|1|||
125300076|NCT01393639|450725888|FG004|Overall Study|Protocol Violation|0|||
125300077|NCT01393639|450725889|FG005|Overall Study|Protocol Violation|0|||
125474049|NCT04382404|451369803|FG000|Overall Study|Adverse Event|1|||
125300078|NCT01393639|450725890|FG006|Overall Study|Protocol Violation|0|||
125300079|NCT01393639|450725884|FG000|Overall Study|Other|0|||
125300080|NCT01393639|450725885|FG001|Overall Study|Other|2|||
125474050|NCT04382404|451369803|FG000|Overall Study|Lost to Follow-up|2|||
125474051|NCT02960893|451369805|FG000|Randomization Phase (8-week)|Adverse Event|5|||
125474052|NCT02960893|451369806|FG001|Randomization Phase (8-week)|Adverse Event|0|||
125474053|NCT02960893|451369805|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
125474054|NCT02960893|451369806|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
125474055|NCT02960893|451369805|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
125474056|NCT02960893|451369806|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
125474057|NCT02960893|451369805|FG000|Extension Phase (48-week)|Adverse Event|2|||
125474058|NCT02960893|451369806|FG001|Extension Phase (48-week)|Adverse Event|3|||
125474059|NCT02960893|451369805|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
125474060|NCT02960893|451369806|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
125474061|NCT02960893|451369805|FG000|Extension Phase (48-week)|Other Reason|2|||
125474062|NCT02960893|451369806|FG001|Extension Phase (48-week)|Other Reason|1|||
125474063|NCT02960893|451369805|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
125474064|NCT02960893|451369806|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
125474065|NCT02960893|451369805|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
125474066|NCT02960893|451369806|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
125474067|NCT05687916|451369808|FG000|Overall Study|Adverse Event|1|||
125474068|NCT05687916|451369809|FG001|Overall Study|Adverse Event|2|||
125474069|NCT05687916|451369810|FG002|Overall Study|Adverse Event|0|||
125474070|NCT05687916|451369808|FG000|Overall Study|Withdrawal by Subject|1|||
125474071|NCT05687916|451369809|FG001|Overall Study|Withdrawal by Subject|0|||
125474072|NCT05687916|451369810|FG002|Overall Study|Withdrawal by Subject|1|||
125474073|NCT05687916|451369808|FG000|Overall Study|Protocol Violation|0|||
125474074|NCT05687916|451369809|FG001|Overall Study|Protocol Violation|2|||
125474075|NCT05687916|451369810|FG002|Overall Study|Protocol Violation|1|||
125474076|NCT05687916|451369808|FG000|Overall Study|Reason not Specified|1|||
125474077|NCT05687916|451369809|FG001|Overall Study|Reason not Specified|0|||
125474078|NCT05687916|451369810|FG002|Overall Study|Reason not Specified|0|||
125474079|NCT04485039|451369820|FG000|TPOXX Only|Adverse Event|2|||
125474080|NCT04485039|451369820|FG000|TPOXX Only|Physician Decision|1|||
125474081|NCT04485039|451369820|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
125474082|NCT04485039|451369820|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
125474083|NCT04005716|451369821|FG000|Overall Study|Death|175|||
125474084|NCT04005716|451369822|FG001|Overall Study|Death|196|||
125474085|NCT04005716|451369821|FG000|Overall Study|Withdrawal by Subject|1|||
125474086|NCT04005716|451369822|FG001|Overall Study|Withdrawal by Subject|6|||
125474087|NCT04005716|451369821|FG000|Overall Study|Lost to Follow-up|2|||
125474088|NCT04005716|451369822|FG001|Overall Study|Lost to Follow-up|2|||
125474089|NCT04021602|451369825|FG000|Overall Study|Lost to Follow-up|3|||
125474090|NCT04021602|451369826|FG001|Overall Study|Lost to Follow-up|3|||
125474091|NCT04021602|451369827|FG002|Overall Study|Lost to Follow-up|1|||
125474092|NCT04021602|451369825|FG000|Overall Study|Adverse Event|1|||
125474093|NCT04021602|451369826|FG001|Overall Study|Adverse Event|0|||
125474094|NCT04021602|451369827|FG002|Overall Study|Adverse Event|1|||
125474095|NCT02783300|451369828|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474096|NCT02783300|451369829|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474097|NCT02783300|451369830|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474098|NCT02783300|451369831|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474099|NCT02783300|451369832|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474100|NCT02783300|451369833|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474101|NCT02783300|451369834|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
125474102|NCT02783300|451369835|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474103|NCT02783300|451369836|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474104|NCT02783300|451369837|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474105|NCT02783300|451369838|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474106|NCT02783300|451369839|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474107|NCT02783300|451369840|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474108|NCT02783300|451369841|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474109|NCT02783300|451369842|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474110|NCT02783300|451369843|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474111|NCT02783300|451369844|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474112|NCT02783300|451369845|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125300081|NCT01393639|450725886|FG002|Overall Study|Other|0|||
125300082|NCT01393639|450725887|FG003|Overall Study|Other|2|||
125300083|NCT01393639|450725888|FG004|Overall Study|Other|1|||
125300084|NCT01393639|450725889|FG005|Overall Study|Other|0|||
125300085|NCT01393639|450725890|FG006|Overall Study|Other|1|||
125300086|NCT01393639|450725884|FG000|Overall Study|Withdrawal by Subject|1|||
125300087|NCT01393639|450725885|FG001|Overall Study|Withdrawal by Subject|1|||
125300088|NCT01393639|450725886|FG002|Overall Study|Withdrawal by Subject|0|||
125300089|NCT01393639|450725887|FG003|Overall Study|Withdrawal by Subject|0|||
125300090|NCT01393639|450725888|FG004|Overall Study|Withdrawal by Subject|0|||
125300091|NCT01393639|450725889|FG005|Overall Study|Withdrawal by Subject|0|||
125300092|NCT01393639|450725890|FG006|Overall Study|Withdrawal by Subject|1|||
125474113|NCT02783300|451369846|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474114|NCT02783300|451369847|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474115|NCT02783300|451369848|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125300093|NCT01393639|450725884|FG000|Overall Study|Medication error without associated AE|0|||
125474116|NCT02783300|451369849|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125300094|NCT01393639|450725885|FG001|Overall Study|Medication error without associated AE|0|||
125300095|NCT01393639|450725886|FG002|Overall Study|Medication error without associated AE|0|||
125300096|NCT01393639|450725887|FG003|Overall Study|Medication error without associated AE|0|||
125300097|NCT01393639|450725888|FG004|Overall Study|Medication error without associated AE|0|||
125300098|NCT01393639|450725889|FG005|Overall Study|Medication error without associated AE|0|||
125300099|NCT01393639|450725890|FG006|Overall Study|Medication error without associated AE|1|||
125300100|NCT01393639|450725884|FG000|Overall Study|Lost to Follow-up|0|||
125300101|NCT01393639|450725885|FG001|Overall Study|Lost to Follow-up|1|||
125300102|NCT01393639|450725886|FG002|Overall Study|Lost to Follow-up|0|||
125300103|NCT01393639|450725887|FG003|Overall Study|Lost to Follow-up|0|||
125300104|NCT01393639|450725888|FG004|Overall Study|Lost to Follow-up|0|||
125300105|NCT01393639|450725889|FG005|Overall Study|Lost to Follow-up|0|||
125300106|NCT01393639|450725890|FG006|Overall Study|Lost to Follow-up|1|||
125474117|NCT02783300|451369850|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474118|NCT02783300|451369851|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474119|NCT02783300|451369852|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474120|NCT02783300|451369853|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474121|NCT02783300|451369854|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
125474122|NCT02783300|451369828|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474123|NCT02783300|451369829|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474124|NCT02783300|451369830|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474125|NCT02783300|451369831|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
125474126|NCT02783300|451369832|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474127|NCT02783300|451369833|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474128|NCT02783300|451369834|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474129|NCT02783300|451369835|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474130|NCT02783300|451369836|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474131|NCT02783300|451369837|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474132|NCT02783300|451369838|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474133|NCT02783300|451369839|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474134|NCT02783300|451369840|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474135|NCT02783300|451369841|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474136|NCT02783300|451369842|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474137|NCT02783300|451369843|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474138|NCT02783300|451369844|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474139|NCT02783300|451369845|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474140|NCT02783300|451369846|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474141|NCT02783300|451369847|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474142|NCT02783300|451369848|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474143|NCT02783300|451369849|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474144|NCT02783300|451369850|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474145|NCT02783300|451369851|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474146|NCT02783300|451369852|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474147|NCT02783300|451369853|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474148|NCT02783300|451369854|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
125474149|NCT02783300|451369828|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
125474150|NCT02783300|451369829|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
125474151|NCT02783300|451369830|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
125474152|NCT02783300|451369831|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
125474153|NCT02783300|451369832|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
125474154|NCT02783300|451369833|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
125474155|NCT02783300|451369834|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
125474156|NCT02783300|451369835|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
125474157|NCT02783300|451369836|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
125474158|NCT02783300|451369837|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
125474159|NCT02783300|451369838|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
125474160|NCT02783300|451369839|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
125474161|NCT02783300|451369840|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
125474162|NCT02783300|451369841|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
125474163|NCT02783300|451369842|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
125474164|NCT02783300|451369843|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
125474165|NCT02783300|451369844|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
125474166|NCT02783300|451369845|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
125474167|NCT02783300|451369846|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
125474168|NCT02783300|451369847|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
125474169|NCT02783300|451369848|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
125474170|NCT02783300|451369849|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
125474171|NCT02783300|451369850|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
125474172|NCT02783300|451369851|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
125300107|NCT01393639|450725884|FG000|Overall Study|Lack of Efficacy|0|||
125300108|NCT01393639|450725885|FG001|Overall Study|Lack of Efficacy|0|||
125300109|NCT01393639|450725886|FG002|Overall Study|Lack of Efficacy|0|||
125474173|NCT02783300|451369852|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
125474174|NCT02783300|451369853|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
125474175|NCT02783300|451369854|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
125474176|NCT02783300|451369828|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474177|NCT02783300|451369829|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474178|NCT02783300|451369830|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474179|NCT02783300|451369831|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474180|NCT02783300|451369832|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474181|NCT02783300|451369833|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474182|NCT02783300|451369834|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
125474183|NCT02783300|451369835|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474184|NCT02783300|451369836|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474185|NCT02783300|451369837|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474186|NCT02783300|451369838|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474187|NCT02783300|451369839|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474188|NCT02783300|451369840|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
125474189|NCT02783300|451369841|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474190|NCT02783300|451369842|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474191|NCT02783300|451369843|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474192|NCT02783300|451369844|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474193|NCT02783300|451369845|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474194|NCT02783300|451369846|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474195|NCT02783300|451369847|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474196|NCT02783300|451369848|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474197|NCT02783300|451369849|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474198|NCT02783300|451369850|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474199|NCT02783300|451369851|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474200|NCT02783300|451369852|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474201|NCT02783300|451369853|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474202|NCT02783300|451369854|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
125474203|NCT02783300|451369828|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474204|NCT02783300|451369829|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474205|NCT02783300|451369830|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474206|NCT02783300|451369831|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474207|NCT02783300|451369832|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
125474208|NCT02783300|451369833|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474209|NCT02783300|451369834|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
125474210|NCT02783300|451369835|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474211|NCT02783300|451369836|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474212|NCT02783300|451369837|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
125474213|NCT02783300|451369838|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474214|NCT02783300|451369839|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474215|NCT02783300|451369840|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
125474216|NCT02783300|451369841|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474217|NCT02783300|451369842|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474218|NCT02783300|451369843|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474219|NCT02783300|451369844|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474220|NCT02783300|451369845|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474221|NCT02783300|451369846|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474222|NCT02783300|451369847|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474223|NCT02783300|451369848|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474224|NCT02783300|451369849|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474225|NCT02783300|451369850|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474226|NCT02783300|451369851|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474227|NCT02783300|451369852|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474228|NCT02783300|451369853|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474229|NCT02783300|451369854|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
125474230|NCT02783300|451369828|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474231|NCT02783300|451369829|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474232|NCT02783300|451369830|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474233|NCT02783300|451369831|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474234|NCT02783300|451369832|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474235|NCT02783300|451369833|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125300110|NCT01393639|450725887|FG003|Overall Study|Lack of Efficacy|0|||
125300111|NCT01393639|450725888|FG004|Overall Study|Lack of Efficacy|0|||
125300112|NCT01393639|450725889|FG005|Overall Study|Lack of Efficacy|0|||
125474236|NCT02783300|451369834|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474237|NCT02783300|451369835|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474238|NCT02783300|451369836|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474239|NCT02783300|451369837|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474240|NCT02783300|451369838|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474241|NCT02783300|451369839|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474242|NCT02783300|451369840|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474243|NCT02783300|451369841|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474244|NCT02783300|451369842|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474245|NCT02783300|451369843|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
125474246|NCT02783300|451369844|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474247|NCT02783300|451369845|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
125474248|NCT02783300|451369846|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
125474249|NCT02783300|451369847|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
125474250|NCT02783300|451369848|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474251|NCT02783300|451369849|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474252|NCT02783300|451369850|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474253|NCT02783300|451369851|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474254|NCT02783300|451369852|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
125474255|NCT02783300|451369853|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474256|NCT02783300|451369854|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
125474257|NCT02783300|451369828|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474258|NCT02783300|451369829|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474259|NCT02783300|451369830|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474260|NCT02783300|451369831|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474261|NCT02783300|451369832|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474262|NCT02783300|451369833|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474263|NCT02783300|451369834|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474264|NCT02783300|451369835|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474265|NCT02783300|451369836|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474266|NCT02783300|451369837|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474267|NCT02783300|451369838|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474268|NCT02783300|451369839|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474269|NCT02783300|451369840|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474270|NCT02783300|451369841|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474271|NCT02783300|451369842|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474272|NCT02783300|451369843|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474273|NCT02783300|451369844|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
125474274|NCT02783300|451369845|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474275|NCT02783300|451369846|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
125474276|NCT02783300|451369847|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
125474277|NCT02783300|451369848|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474278|NCT02783300|451369849|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474279|NCT02783300|451369850|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474280|NCT02783300|451369851|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474281|NCT02783300|451369852|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474282|NCT02783300|451369853|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474283|NCT02783300|451369854|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
125474284|NCT02783300|451369828|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474285|NCT02783300|451369829|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474286|NCT02783300|451369830|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474287|NCT02783300|451369831|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474288|NCT02783300|451369832|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474289|NCT02783300|451369833|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474290|NCT02783300|451369834|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474291|NCT02783300|451369835|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474292|NCT02783300|451369836|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474293|NCT02783300|451369837|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474294|NCT02783300|451369838|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474295|NCT02783300|451369839|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474296|NCT02783300|451369840|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474297|NCT02783300|451369841|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474298|NCT02783300|451369842|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474299|NCT02783300|451369843|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474300|NCT02783300|451369844|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
125474301|NCT02783300|451369845|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474302|NCT02783300|451369846|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
125474303|NCT02783300|451369847|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
125474304|NCT02783300|451369848|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
125474305|NCT02783300|451369849|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474306|NCT02783300|451369850|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125300113|NCT01393639|450725890|FG006|Overall Study|Lack of Efficacy|1|||
125300114|NCT01393639|450725884|FG000|Overall Study|Adverse Event|2|||
125300115|NCT01393639|450725885|FG001|Overall Study|Adverse Event|3|||
125300116|NCT01393639|450725886|FG002|Overall Study|Adverse Event|1|||
125300117|NCT01393639|450725887|FG003|Overall Study|Adverse Event|2|||
125300118|NCT01393639|450725888|FG004|Overall Study|Adverse Event|0|||
125300119|NCT01393639|450725889|FG005|Overall Study|Adverse Event|2|||
125474307|NCT02783300|451369851|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474308|NCT02783300|451369852|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474309|NCT02783300|451369853|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474310|NCT02783300|451369854|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
125474311|NCT02783300|451369828|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474312|NCT02783300|451369829|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474313|NCT02783300|451369830|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474314|NCT02783300|451369831|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474315|NCT02783300|451369832|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474316|NCT02783300|451369833|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474317|NCT02783300|451369834|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474318|NCT02783300|451369835|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474319|NCT02783300|451369836|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474320|NCT02783300|451369837|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474321|NCT02783300|451369838|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474322|NCT02783300|451369839|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474323|NCT02783300|451369840|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474324|NCT02783300|451369841|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474325|NCT02783300|451369842|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474326|NCT02783300|451369843|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
125474327|NCT02783300|451369844|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474328|NCT02783300|451369845|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474329|NCT02783300|451369846|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474330|NCT02783300|451369847|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474331|NCT02783300|451369848|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474332|NCT02783300|451369849|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474333|NCT02783300|451369850|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
125474334|NCT02783300|451369851|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474335|NCT02783300|451369852|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474336|NCT02783300|451369853|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474337|NCT02783300|451369854|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
125474338|NCT02783300|451369828|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474339|NCT02783300|451369829|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474340|NCT02783300|451369830|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474341|NCT02783300|451369831|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474342|NCT02783300|451369832|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474343|NCT02783300|451369833|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474344|NCT02783300|451369834|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474345|NCT02783300|451369835|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474346|NCT02783300|451369836|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474347|NCT02783300|451369837|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474348|NCT02783300|451369838|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474349|NCT02783300|451369839|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474350|NCT02783300|451369840|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125300120|NCT01393639|450725890|FG006|Overall Study|Adverse Event|3|||
125300121|NCT00679172|450725891|FG000|Overall Study|Non-compliance|1|||
125300122|NCT00679172|450725892|FG001|Overall Study|Non-compliance|1|||
125300123|NCT00679172|450725893|FG002|Overall Study|Non-compliance|0|||
125474351|NCT02783300|451369841|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
125474352|NCT02783300|451369842|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
125474353|NCT02783300|451369843|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
125474354|NCT02783300|451369844|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
125474355|NCT02783300|451369845|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474356|NCT02783300|451369846|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
125474357|NCT02783300|451369847|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
125474358|NCT02783300|451369848|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474359|NCT02783300|451369849|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474360|NCT02783300|451369850|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474361|NCT02783300|451369851|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474362|NCT02783300|451369852|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474363|NCT02783300|451369853|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474364|NCT02783300|451369854|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
125474365|NCT02783300|451369828|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474366|NCT02783300|451369829|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474367|NCT02783300|451369830|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474368|NCT02783300|451369831|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474369|NCT02783300|451369832|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474370|NCT02783300|451369833|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474371|NCT02783300|451369834|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474372|NCT02783300|451369835|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474373|NCT02783300|451369836|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474374|NCT02783300|451369837|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474375|NCT02783300|451369838|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474376|NCT02783300|451369839|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474377|NCT02783300|451369840|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474378|NCT02783300|451369841|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
125474379|NCT02783300|451369842|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
125474380|NCT02783300|451369843|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
125474381|NCT02783300|451369844|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
125474382|NCT02783300|451369845|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
125474383|NCT02783300|451369846|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
125474384|NCT02783300|451369847|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
125474385|NCT02783300|451369848|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
125474386|NCT02783300|451369849|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
125474387|NCT02783300|451369850|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
125474388|NCT02783300|451369851|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
125474389|NCT02783300|451369852|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
125474390|NCT02783300|451369853|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
125474391|NCT02783300|451369854|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
125474392|NCT02783300|451369828|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474393|NCT02783300|451369829|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474394|NCT02783300|451369830|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474395|NCT02783300|451369831|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474396|NCT02783300|451369832|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474397|NCT02783300|451369833|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474398|NCT02783300|451369834|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474399|NCT02783300|451369835|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474400|NCT02783300|451369836|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474401|NCT02783300|451369837|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474402|NCT02783300|451369838|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474403|NCT02783300|451369839|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474404|NCT02783300|451369840|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474405|NCT02783300|451369841|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474406|NCT02783300|451369842|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474407|NCT02783300|451369843|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474408|NCT02783300|451369844|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474409|NCT02783300|451369845|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474410|NCT02783300|451369846|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474411|NCT02783300|451369847|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474412|NCT02783300|451369848|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474413|NCT02783300|451369849|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474414|NCT02783300|451369850|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474415|NCT02783300|451369851|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474416|NCT02783300|451369852|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474417|NCT02783300|451369853|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
125474418|NCT02783300|451369854|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
125474419|NCT02783300|451369828|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474420|NCT02783300|451369829|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474421|NCT02783300|451369830|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474422|NCT02783300|451369831|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474423|NCT02783300|451369832|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474424|NCT02783300|451369833|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474425|NCT02783300|451369834|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474426|NCT02783300|451369835|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474427|NCT02783300|451369836|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474428|NCT02783300|451369837|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474429|NCT02783300|451369838|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474430|NCT02783300|451369839|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474431|NCT02783300|451369840|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474432|NCT02783300|451369841|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474433|NCT02783300|451369842|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474434|NCT02783300|451369843|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474435|NCT02783300|451369844|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474436|NCT02783300|451369845|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474437|NCT02783300|451369846|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474438|NCT02783300|451369847|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474439|NCT02783300|451369848|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474440|NCT02783300|451369849|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474441|NCT02783300|451369850|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474442|NCT02783300|451369851|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474443|NCT02783300|451369852|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474444|NCT02783300|451369853|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
125474445|NCT02783300|451369854|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
125474446|NCT03535272|451369855|FG000|Overall Study|Lost to Follow-up|71|||
125474447|NCT03535272|451369856|FG001|Overall Study|Lost to Follow-up|73|||
125474448|NCT03892616|451369859|FG000|Washout Period 2|Met discontinuation criterion|0|||
125474449|NCT03892616|451369860|FG001|Washout Period 2|Met discontinuation criterion|0|||
125474450|NCT03892616|451369861|FG002|Washout Period 2|Met discontinuation criterion|0|||
125474451|NCT03892616|451369862|FG003|Washout Period 2|Met discontinuation criterion|0|||
125474452|NCT03892616|451369863|FG004|Washout Period 2|Met discontinuation criterion|0|||
125474453|NCT03892616|451369864|FG005|Washout Period 2|Met discontinuation criterion|0|||
125474454|NCT03892616|451369865|FG006|Washout Period 2|Met discontinuation criterion|0|||
125474455|NCT03892616|451369866|FG007|Washout Period 2|Met discontinuation criterion|0|||
125474456|NCT03892616|451369867|FG008|Washout Period 2|Met discontinuation criterion|1|||
125474457|NCT03892616|451369868|FG009|Washout Period 2|Met discontinuation criterion|0|||
125474458|NCT03892616|451369869|FG010|Washout Period 2|Met discontinuation criterion|0|||
125474459|NCT03892616|451369870|FG011|Washout Period 2|Met discontinuation criterion|0|||
125474460|NCT00378105|451369871|FG000|Overall Study|Adverse Event|3|||
125474461|NCT00378105|451369872|FG001|Overall Study|Adverse Event|1|||
125474462|NCT00378105|451369871|FG000|Overall Study|Withdrawal by Subject|3|||
125474463|NCT00378105|451369872|FG001|Overall Study|Withdrawal by Subject|3|||
125474464|NCT00378105|451369871|FG000|Overall Study|Death|1|||
125474465|NCT00378105|451369872|FG001|Overall Study|Death|0|||
125474466|NCT00378105|451369871|FG000|Overall Study|Going to transplant|7|||
125474467|NCT00378105|451369872|FG001|Overall Study|Going to transplant|8|||
125474468|NCT00378105|451369871|FG000|Overall Study|Progressive disease|3|||
125474469|NCT00378105|451369872|FG001|Overall Study|Progressive disease|3|||
125474470|NCT00378105|451369871|FG000|Overall Study|remain on study|3|||
125474471|NCT00378105|451369872|FG001|Overall Study|remain on study|11|||
125474472|NCT00378105|451369871|FG000|Overall Study|Physician Decision|0|||
125474473|NCT00378105|451369872|FG001|Overall Study|Physician Decision|2|||
125474474|NCT00378105|451369871|FG000|Overall Study|Going non-protocol therapy|0|||
125300124|NCT00679172|450725894|FG003|Overall Study|Non-compliance|1|||
125300125|NCT00679172|450725895|FG004|Overall Study|Non-compliance|0|||
125300126|NCT00679172|450725891|FG000|Overall Study|Other not specified|0|||
125300127|NCT00679172|450725892|FG001|Overall Study|Other not specified|0|||
125300128|NCT00679172|450725893|FG002|Overall Study|Other not specified|1|||
125474475|NCT00378105|451369872|FG001|Overall Study|Going non-protocol therapy|1|||
125474476|NCT00378105|451369871|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
125474477|NCT00378105|451369872|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
125474478|NCT05192200|451369873|FG000|Treatment Period|Other|1|||
125474479|NCT05192200|451369873|FG000|Treatment Period|Lack of Efficacy|1|||
125474480|NCT05192200|451369873|FG000|Treatment Period|Withdrawal by Subject|1|||
125474481|NCT05192200|451369873|FG000|Follow-up|Withdrawal by Subject|1|||
125474482|NCT03907397|451369874|FG000|Overall Study|Lost to Follow-up|0|||
125474483|NCT03907397|451369875|FG001|Overall Study|Lost to Follow-up|1|||
125474484|NCT03907397|451369874|FG000|Overall Study|Physician Decision|2|||
125474485|NCT03907397|451369875|FG001|Overall Study|Physician Decision|1|||
125474486|NCT03907397|451369874|FG000|Overall Study|Withdrawal by Subject|5|||
125474487|NCT03907397|451369875|FG001|Overall Study|Withdrawal by Subject|4|||
125474488|NCT03907397|451369874|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
125474489|NCT03907397|451369875|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
125474490|NCT03930342|451369885|FG000|Overall Study|Lost to Follow-up|70|||
125474491|NCT03930342|451369886|FG001|Overall Study|Lost to Follow-up|77|||
125474492|NCT05021640|451371689|FG000|Overall Study|Lost to Follow-up|0|||
125474493|NCT05021640|451371690|FG001|Overall Study|Lost to Follow-up|0|||
125474494|NCT05021640|451371691|FG002|Overall Study|Lost to Follow-up|0|||
125474495|NCT05021640|451371692|FG003|Overall Study|Lost to Follow-up|0|||
125474496|NCT05021640|451371693|FG004|Overall Study|Lost to Follow-up|1|||
125474497|NCT04737772|451371694|FG000|Phase 2 Study|Lost to Follow-up|15|||
125474498|NCT04737772|451371695|FG001|Phase 2 Study|Lost to Follow-up|15|||
125474499|NCT04737772|451371694|FG000|Phase 2 Study|Withdrawal by Subject|0|||
125474500|NCT04737772|451371695|FG001|Phase 2 Study|Withdrawal by Subject|1|||
125474501|NCT04737772|451371694|FG000|Phase 2 Study|Did not take any coaching calls|4|||
125474502|NCT04737772|451371695|FG001|Phase 2 Study|Did not take any coaching calls|0|||
125474503|NCT04737772|451371694|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
125474504|NCT04737772|451371695|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
125474505|NCT04737772|451371694|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
125474506|NCT04737772|451371695|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
125474507|NCT05691309|451371696|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
125474508|NCT05691309|451371696|FG000|Overall Study|vancomycin levels not evaluable|2|||
125474509|NCT03376321|451371698|FG000|Overall Study|Other|5|||
125474510|NCT03376321|451371699|FG001|Overall Study|Other|1|||
125474511|NCT03376321|451371698|FG000|Overall Study|Withdrawal by Subject|8|||
125474512|NCT03376321|451371699|FG001|Overall Study|Withdrawal by Subject|14|||
125474513|NCT03376321|451371698|FG000|Overall Study|Lost to Follow-up|1|||
125474514|NCT03376321|451371699|FG001|Overall Study|Lost to Follow-up|7|||
125474515|NCT03376321|451371698|FG000|Overall Study|Death|4|||
125474516|NCT03376321|451371699|FG001|Overall Study|Death|0|||
125474517|NCT03376321|451371698|FG000|Overall Study|Randomized, not treated|5|||
125474518|NCT03376321|451371699|FG001|Overall Study|Randomized, not treated|3|||
125474519|NCT02992925|451371704|FG000|Cohort 2|Physician Decision|0|||
125474520|NCT02992925|451371705|FG001|Cohort 2|Physician Decision|0|||
125474521|NCT02992925|451371706|FG002|Cohort 2|Physician Decision|1|||
125474522|NCT02992925|451371707|FG003|Cohort 2|Physician Decision|0|||
125474523|NCT02992925|451371704|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
125474524|NCT02992925|451371705|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
125474525|NCT02992925|451371706|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
125474526|NCT02992925|451371707|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
125474527|NCT01804816|451371708|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
125474528|NCT01804816|451371708|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
125474529|NCT04421378|451371714|FG000|Overall Study|Adverse Event|2|||
125474530|NCT04421378|451371715|FG001|Overall Study|Adverse Event|7|||
125474531|NCT04421378|451371716|FG002|Overall Study|Adverse Event|0|||
125474532|NCT04421378|451371717|FG003|Overall Study|Adverse Event|1|||
125474533|NCT04421378|451371718|FG004|Overall Study|Adverse Event|0|||
125474534|NCT04421378|451371714|FG000|Overall Study|Physician Decision|1|||
125474535|NCT04421378|451371715|FG001|Overall Study|Physician Decision|2|||
125474536|NCT04421378|451371716|FG002|Overall Study|Physician Decision|0|||
125474537|NCT04421378|451371717|FG003|Overall Study|Physician Decision|0|||
125474538|NCT04421378|451371718|FG004|Overall Study|Physician Decision|0|||
125474539|NCT04421378|451371714|FG000|Overall Study|Progressive Disease|16|||
125474540|NCT04421378|451371715|FG001|Overall Study|Progressive Disease|4|||
125474541|NCT04421378|451371716|FG002|Overall Study|Progressive Disease|18|||
125474542|NCT04421378|451371717|FG003|Overall Study|Progressive Disease|11|||
125474543|NCT04421378|451371718|FG004|Overall Study|Progressive Disease|3|||
125300129|NCT00679172|450725894|FG003|Overall Study|Other not specified|0|||
125300130|NCT00679172|450725895|FG004|Overall Study|Other not specified|0|||
125474544|NCT04421378|451371714|FG000|Overall Study|Study Terminated by Sponsor|0|||
125474545|NCT04421378|451371715|FG001|Overall Study|Study Terminated by Sponsor|1|||
125474546|NCT04421378|451371716|FG002|Overall Study|Study Terminated by Sponsor|1|||
125474547|NCT04421378|451371717|FG003|Overall Study|Study Terminated by Sponsor|0|||
125474548|NCT04421378|451371718|FG004|Overall Study|Study Terminated by Sponsor|0|||
125474549|NCT04421378|451371714|FG000|Overall Study|Withdrawal by Subject|3|||
125474550|NCT04421378|451371715|FG001|Overall Study|Withdrawal by Subject|1|||
125474551|NCT04421378|451371716|FG002|Overall Study|Withdrawal by Subject|0|||
125474552|NCT04421378|451371717|FG003|Overall Study|Withdrawal by Subject|2|||
125474553|NCT04421378|451371718|FG004|Overall Study|Withdrawal by Subject|0|||
125474554|NCT04421378|451371714|FG000|Overall Study|Other|1|||
125474555|NCT04421378|451371715|FG001|Overall Study|Other|0|||
125474556|NCT04421378|451371716|FG002|Overall Study|Other|0|||
125474557|NCT04421378|451371717|FG003|Overall Study|Other|0|||
125474558|NCT04421378|451371718|FG004|Overall Study|Other|0|||
125474559|NCT04150718|451371719|FG000|Overall Study|Withdrawal by Subject|2|||
125474560|NCT04150718|451371720|FG001|Overall Study|Withdrawal by Subject|7|||
125474561|NCT04150718|451371721|FG002|Overall Study|Withdrawal by Subject|1|||
125474562|NCT04150718|451371719|FG000|Overall Study|Lost to Follow-up|1|||
125474563|NCT04150718|451371720|FG001|Overall Study|Lost to Follow-up|2|||
125474564|NCT04150718|451371721|FG002|Overall Study|Lost to Follow-up|0|||
125474565|NCT04150718|451371719|FG000|Overall Study|Ineligible|1|||
125474566|NCT04150718|451371720|FG001|Overall Study|Ineligible|0|||
125474567|NCT04150718|451371721|FG002|Overall Study|Ineligible|10|||
125474568|NCT02592330|451371722|FG000|Overall Study|Withdrawal by Subject|1|||
125474569|NCT02592330|451371723|FG001|Overall Study|Withdrawal by Subject|0|||
125474570|NCT02592330|451371722|FG000|Overall Study|Failed Biopsy|1|||
125474571|NCT02592330|451371723|FG001|Overall Study|Failed Biopsy|0|||
125474572|NCT03090152|451371724|FG000|Overall Study|Withdrawal by Subject|0|||
125474573|NCT03090152|451371725|FG001|Overall Study|Withdrawal by Subject|2|||
125474574|NCT03090152|451371726|FG002|Overall Study|Withdrawal by Subject|1|||
125474575|NCT03090152|451371724|FG000|Overall Study|Surgery Canceled|1|||
125474576|NCT03090152|451371725|FG001|Overall Study|Surgery Canceled|0|||
125474577|NCT03090152|451371726|FG002|Overall Study|Surgery Canceled|0|||
125474578|NCT03090152|451371724|FG000|Overall Study|Epidural catheter could not be placed|0|||
125474579|NCT03090152|451371725|FG001|Overall Study|Epidural catheter could not be placed|2|||
125474580|NCT03090152|451371726|FG002|Overall Study|Epidural catheter could not be placed|0|||
125474581|NCT03958955|451371727|FG000|Overall Study|Adverse Event|1|||
125474582|NCT04673929|451371728|FG000|Overall Study|Death|73|||
125474583|NCT04673929|451371728|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
125474584|NCT02927769|451371730|FG000|Induction Phase|Study drug toxicity|1|||
125474585|NCT02927769|451371731|FG001|Induction Phase|Study drug toxicity|1|||
125474586|NCT02927769|451371730|FG000|Induction Phase|Disease progression|0|||
125474587|NCT02927769|451371731|FG001|Induction Phase|Disease progression|1|||
125474588|NCT02927769|451371730|FG000|Intensification Phase|Study drug toxicity|1|||
125474589|NCT02927769|451371731|FG001|Intensification Phase|Study drug toxicity|0|||
125474590|NCT02807636|451371732|FG000|Overall Study|Lost to Follow-up|10|||
125474591|NCT02807636|451371733|FG001|Overall Study|Lost to Follow-up|13|||
125474592|NCT02807636|451371734|FG002|Overall Study|Lost to Follow-up|6|||
125474593|NCT02807636|451371732|FG000|Overall Study|Protocol Deviation|1|||
125474594|NCT02807636|451371733|FG001|Overall Study|Protocol Deviation|0|||
125474595|NCT02807636|451371734|FG002|Overall Study|Protocol Deviation|0|||
125474596|NCT02807636|451371732|FG000|Overall Study|Symptomatic Deterioration|0|||
125474597|NCT02807636|451371733|FG001|Overall Study|Symptomatic Deterioration|1|||
125474598|NCT02807636|451371734|FG002|Overall Study|Symptomatic Deterioration|0|||
125474599|NCT02807636|451371732|FG000|Overall Study|Withdrawal by Subject|39|||
125474600|NCT02807636|451371733|FG001|Overall Study|Withdrawal by Subject|28|||
125474601|NCT02807636|451371734|FG002|Overall Study|Withdrawal by Subject|24|||
125474602|NCT02807636|451371732|FG000|Overall Study|Death|303|||
125474603|NCT02807636|451371733|FG001|Overall Study|Death|332|||
125474604|NCT02807636|451371734|FG002|Overall Study|Death|272|||
125474605|NCT02807636|451371732|FG000|Overall Study|Study Terminated By Sponsor|47|||
125474606|NCT02807636|451371733|FG001|Overall Study|Study Terminated By Sponsor|76|||
125474607|NCT02807636|451371734|FG002|Overall Study|Study Terminated By Sponsor|60|||
125474608|NCT02807636|451371732|FG000|Overall Study|Physician Decision|0|||
125474609|NCT02807636|451371733|FG001|Overall Study|Physician Decision|1|||
125474610|NCT02807636|451371734|FG002|Overall Study|Physician Decision|0|||
125474611|NCT04088630|451371735|FG000|Overall Study|Lost to Follow-up|3|||
125474612|NCT04088630|451371736|FG001|Overall Study|Lost to Follow-up|2|||
125474613|NCT04088630|451371737|FG002|Overall Study|Lost to Follow-up|6|||
125474614|NCT04088630|451371735|FG000|Overall Study|Death|3|||
125474615|NCT04088630|451371736|FG001|Overall Study|Death|1|||
125474616|NCT04088630|451371737|FG002|Overall Study|Death|1|||
125474617|NCT04088630|451371735|FG000|Overall Study|Physician Decision|0|||
125474618|NCT04088630|451371736|FG001|Overall Study|Physician Decision|1|||
125474619|NCT04088630|451371737|FG002|Overall Study|Physician Decision|1|||
125474620|NCT03315754|451371738|FG000|Overall Study|COVID-19 complications leading to death|1|||
125474621|NCT03315754|451371738|FG000|Overall Study|insurance coverage issue|1|||
125474622|NCT04024813|451371739|FG000|Overall Study|Study terminated by Sponsor|1|||
125474623|NCT05034952|451371740|FG000|Overall Study|Adverse Event|1|||
125474624|NCT05034952|451371741|FG001|Overall Study|Adverse Event|0|||
125474625|NCT05034952|451371742|FG002|Overall Study|Adverse Event|0|||
125474626|NCT05034952|451371743|FG003|Overall Study|Adverse Event|0|||
125474627|NCT05034952|451371740|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
125474628|NCT05034952|451371741|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
125474629|NCT05034952|451371742|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
125474630|NCT05034952|451371743|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
125474631|NCT05034952|451371740|FG000|Overall Study|Lost to Follow-up|1|||
125474632|NCT05034952|451371741|FG001|Overall Study|Lost to Follow-up|4|||
125474633|NCT05034952|451371742|FG002|Overall Study|Lost to Follow-up|3|||
125474634|NCT05034952|451371743|FG003|Overall Study|Lost to Follow-up|3|||
125474635|NCT05034952|451371740|FG000|Overall Study|Other|0|||
125474636|NCT05034952|451371741|FG001|Overall Study|Other|0|||
125474637|NCT05034952|451371742|FG002|Overall Study|Other|0|||
125474638|NCT05034952|451371743|FG003|Overall Study|Other|1|||
125474639|NCT04783935|451371760|FG000|Overall Study|Withdrawal by Subject|6|||
125474640|NCT04783935|451371760|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
125474641|NCT04783935|451371760|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
125474642|NCT04783935|451371760|FG000|Overall Study|Lost to Follow-up|3|||
125474643|NCT04783935|451371760|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
125474644|NCT02437318|451371762|FG000|Overall Study|Progressive disease|207|||
125474645|NCT02437318|451371763|FG001|Overall Study|Progressive disease|240|||
125474646|NCT02437318|451371762|FG000|Overall Study|Subject/guardian decision|24|||
125474647|NCT02437318|451371763|FG001|Overall Study|Subject/guardian decision|11|||
125474648|NCT02437318|451371762|FG000|Overall Study|Physician Decision|29|||
125474649|NCT02437318|451371763|FG001|Overall Study|Physician Decision|22|||
125474650|NCT02437318|451371762|FG000|Overall Study|Adverse Event|14|||
125474651|NCT02437318|451371763|FG001|Overall Study|Adverse Event|4|||
125474652|NCT02437318|451371762|FG000|Overall Study|Death|4|||
125474653|NCT02437318|451371763|FG001|Overall Study|Death|4|||
125474654|NCT02437318|451371762|FG000|Overall Study|Protocol deviation|5|||
125474655|NCT02437318|451371763|FG001|Overall Study|Protocol deviation|7|||
125474656|NCT02437318|451371762|FG000|Overall Study|Sponsor decision|1|||
125474657|NCT02437318|451371763|FG001|Overall Study|Sponsor decision|0|||
125474658|NCT00920621|451371767|FG000|Overall Study|Lost to Follow-up|16|||
125474659|NCT00920621|451371768|FG001|Overall Study|Lost to Follow-up|17|||
125474660|NCT00920621|451371769|FG002|Overall Study|Lost to Follow-up|19|||
125474661|NCT00920621|451371770|FG003|Overall Study|Lost to Follow-up|21|||
125474662|NCT00920621|451371767|FG000|Overall Study|Fetal/neonatal deaths|16|||
125474663|NCT00920621|451371768|FG001|Overall Study|Fetal/neonatal deaths|14|||
125474664|NCT00920621|451371769|FG002|Overall Study|Fetal/neonatal deaths|16|||
125474665|NCT00920621|451371770|FG003|Overall Study|Fetal/neonatal deaths|14|||
125474666|NCT00920621|451371767|FG000|Overall Study|Blood sample not collected|22|||
125474667|NCT00920621|451371768|FG001|Overall Study|Blood sample not collected|14|||
125474668|NCT00920621|451371769|FG002|Overall Study|Blood sample not collected|0|||
125474669|NCT00920621|451371770|FG003|Overall Study|Blood sample not collected|0|||
125474670|NCT06074523|451371771|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
125474671|NCT06074523|451371771|FG000|Overall Study|Withdrawal by Subject|1|||
125474672|NCT04245501|451371772|FG000|Overall Study|Adverse Event|2|||
125474673|NCT04245501|451371773|FG001|Overall Study|Adverse Event|0|||
125474674|NCT04245501|451371772|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
125474675|NCT04245501|451371773|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
125474676|NCT00961571|451371774|FG000|Overall Study|Physician Decision|39|||
125474677|NCT05337748|451371778|FG000|Overall Study|Withdrawal by Subject|1|||
125474678|NCT05337748|451371779|FG001|Overall Study|Withdrawal by Subject|0|||
125474679|NCT05337748|451371778|FG000|Overall Study|Death|1|||
125474680|NCT05337748|451371779|FG001|Overall Study|Death|0|||
125474681|NCT04321031|451371785|FG000|Overall Study|Adverse Event|0|||
125474682|NCT04321031|451371786|FG001|Overall Study|Adverse Event|2|||
125474683|NCT04321031|451371787|FG002|Overall Study|Adverse Event|2|||
125474684|NCT04321031|451371788|FG003|Overall Study|Adverse Event|2|||
125474685|NCT04321031|451371789|FG004|Overall Study|Adverse Event|2|||
125474686|NCT04321031|451371790|FG005|Overall Study|Adverse Event|2|||
125474687|NCT04321031|451371791|FG006|Overall Study|Adverse Event|0|||
125300131|NCT00793325|450725896|FG000|Overall Study|Protocol Violation|18|||
125300132|NCT00793325|450725896|FG000|Overall Study|Lost to Follow-up|1|||
125300133|NCT01815840|450725897|FG000|Overall Study|Missing|1|||
125300134|NCT01815840|450725898|FG001|Overall Study|Missing|0|||
125300135|NCT01815840|450725897|FG000|Overall Study|Withdrew Consent|31|||
125300136|NCT01815840|450725898|FG001|Overall Study|Withdrew Consent|30|||
125300137|NCT01815840|450725897|FG000|Overall Study|Administrative/Other|1|||
125300138|NCT01815840|450725898|FG001|Overall Study|Administrative/Other|3|||
125300139|NCT01815840|450725897|FG000|Overall Study|Adverse Event|10|||
125300140|NCT01815840|450725898|FG001|Overall Study|Adverse Event|16|||
125300141|NCT01815840|450725897|FG000|Overall Study|Death|2|||
125300142|NCT01815840|450725898|FG001|Overall Study|Death|2|||
125300143|NCT01815840|450725897|FG000|Overall Study|Disease progression|3|||
125474688|NCT04321031|451371785|FG000|Overall Study|Lost to Follow-up|0|||
125474689|NCT04321031|451371786|FG001|Overall Study|Lost to Follow-up|0|||
125474690|NCT04321031|451371787|FG002|Overall Study|Lost to Follow-up|0|||
125474691|NCT04321031|451371788|FG003|Overall Study|Lost to Follow-up|1|||
125474692|NCT04321031|451371789|FG004|Overall Study|Lost to Follow-up|0|||
125474693|NCT04321031|451371790|FG005|Overall Study|Lost to Follow-up|2|||
125474694|NCT04321031|451371791|FG006|Overall Study|Lost to Follow-up|1|||
125474695|NCT04321031|451371785|FG000|Overall Study|Withdrawal by Subject|2|||
125300144|NCT01815840|450725898|FG001|Overall Study|Disease progression|2|||
125300145|NCT01815840|450725897|FG000|Overall Study|Investigators Decision|2|||
125474696|NCT04321031|451371786|FG001|Overall Study|Withdrawal by Subject|2|||
125474697|NCT04321031|451371787|FG002|Overall Study|Withdrawal by Subject|1|||
125474698|NCT04321031|451371788|FG003|Overall Study|Withdrawal by Subject|3|||
125474699|NCT04321031|451371789|FG004|Overall Study|Withdrawal by Subject|1|||
125474700|NCT04321031|451371790|FG005|Overall Study|Withdrawal by Subject|0|||
125474701|NCT04321031|451371791|FG006|Overall Study|Withdrawal by Subject|1|||
125474702|NCT04321031|451371785|FG000|Overall Study|Non-compliance with study drug|0|||
125474703|NCT04321031|451371786|FG001|Overall Study|Non-compliance with study drug|0|||
125474704|NCT04321031|451371787|FG002|Overall Study|Non-compliance with study drug|0|||
125474705|NCT04321031|451371788|FG003|Overall Study|Non-compliance with study drug|0|||
125474706|NCT04321031|451371789|FG004|Overall Study|Non-compliance with study drug|0|||
125474707|NCT04321031|451371790|FG005|Overall Study|Non-compliance with study drug|1|||
125474708|NCT04321031|451371791|FG006|Overall Study|Non-compliance with study drug|0|||
125474709|NCT04321031|451371785|FG000|Overall Study|Other|0|||
125474710|NCT04321031|451371786|FG001|Overall Study|Other|0|||
125474711|NCT04321031|451371787|FG002|Overall Study|Other|0|||
125474712|NCT04321031|451371788|FG003|Overall Study|Other|1|||
125474713|NCT04321031|451371789|FG004|Overall Study|Other|0|||
125474714|NCT04321031|451371790|FG005|Overall Study|Other|0|||
125474715|NCT04321031|451371791|FG006|Overall Study|Other|0|||
125474716|NCT01415154|451371792|FG000|Overall Study|Lack of Efficacy|4|||
125474717|NCT01415154|451371793|FG001|Overall Study|Lack of Efficacy|5|||
125474718|NCT01415154|451371792|FG000|Overall Study|Withdrawal by Subject|7|||
125474719|NCT01415154|451371793|FG001|Overall Study|Withdrawal by Subject|8|||
125474720|NCT01415154|451371792|FG000|Overall Study|Lost to Follow-up|1|||
125474721|NCT01415154|451371793|FG001|Overall Study|Lost to Follow-up|4|||
125474722|NCT01415154|451371792|FG000|Overall Study|Protocol Violation|0|||
125474723|NCT01415154|451371793|FG001|Overall Study|Protocol Violation|1|||
125474724|NCT01415154|451371792|FG000|Overall Study|Satisfactory Response|0|||
125474725|NCT01415154|451371793|FG001|Overall Study|Satisfactory Response|1|||
125474726|NCT01415154|451371792|FG000|Overall Study|Adverse Event|1|||
125474727|NCT01415154|451371793|FG001|Overall Study|Adverse Event|1|||
125474728|NCT00170573|451371795|FG000|Overall Study|Violation of inclusion criteria|13|||
125474729|NCT05536440|451371796|FG000|Overall Study|Adverse Event|0|||
125474730|NCT05536440|451371797|FG001|Overall Study|Adverse Event|0|||
125474731|NCT05536440|451371798|FG002|Overall Study|Adverse Event|0|||
125474732|NCT05536440|451371799|FG003|Overall Study|Adverse Event|0|||
125474733|NCT05536440|451371800|FG004|Overall Study|Adverse Event|0|||
125474734|NCT05536440|451371801|FG005|Overall Study|Adverse Event|0|||
125474735|NCT05536440|451371802|FG006|Overall Study|Adverse Event|0|||
125474736|NCT05536440|451371803|FG007|Overall Study|Adverse Event|0|||
125474737|NCT05536440|451371804|FG008|Overall Study|Adverse Event|1|||
125474738|NCT06283173|451371805|FG000|Overall Study|Did not show for first visit|10|||
125474739|NCT06283173|451371805|FG000|Overall Study|Lost to Follow-up|12|||
125474740|NCT06283173|451371805|FG000|Overall Study|Physician Decision|7|||
125474741|NCT04784559|451371807|FG000|Overall Study|Withdrawal by Subject|3|||
125474742|NCT04784559|451371808|FG001|Overall Study|Withdrawal by Subject|2|||
125474743|NCT04784559|451371809|FG002|Overall Study|Withdrawal by Subject|1|||
125474744|NCT04784559|451371807|FG000|Overall Study|Death|2|||
125474745|NCT04784559|451371808|FG001|Overall Study|Death|1|||
125474746|NCT04784559|451371809|FG002|Overall Study|Death|2|||
125474747|NCT04784559|451371807|FG000|Overall Study|Lost to Follow-up|0|||
125474748|NCT04784559|451371808|FG001|Overall Study|Lost to Follow-up|0|||
125474749|NCT04784559|451371809|FG002|Overall Study|Lost to Follow-up|2|||
125474750|NCT04784559|451371807|FG000|Overall Study|Participant worsened, PI decision|1|||
125474751|NCT04784559|451371808|FG001|Overall Study|Participant worsened, PI decision|0|||
125474752|NCT04784559|451371809|FG002|Overall Study|Participant worsened, PI decision|0|||
125474753|NCT04784559|451371807|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
125474754|NCT04784559|451371808|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
125474755|NCT04784559|451371809|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
125474756|NCT04784559|451371807|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
125474757|NCT04784559|451371808|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
125474758|NCT04784559|451371809|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
125474759|NCT04784559|451371807|FG000|Overall Study|Did not meet all inclusion criteria|0|||
125474760|NCT04784559|451371808|FG001|Overall Study|Did not meet all inclusion criteria|1|||
125474761|NCT04784559|451371809|FG002|Overall Study|Did not meet all inclusion criteria|0|||
125474762|NCT04784559|451371807|FG000|Overall Study|The participant was transferred to IRCU|0|||
125474763|NCT04784559|451371808|FG001|Overall Study|The participant was transferred to IRCU|1|||
125474764|NCT04784559|451371809|FG002|Overall Study|The participant was transferred to IRCU|0|||
125474765|NCT04784559|451371807|FG000|Overall Study|SAE|0|||
125474766|NCT04784559|451371808|FG001|Overall Study|SAE|1|||
125474767|NCT04784559|451371809|FG002|Overall Study|SAE|0|||
125474768|NCT04784559|451371807|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
125474769|NCT04784559|451371808|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
125474770|NCT04784559|451371809|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
125474771|NCT03138512|451371810|FG000|Randomization|Participants withdrew consent|0|||
125474772|NCT03138512|451371811|FG001|Randomization|Participants withdrew consent|1|||
125474773|NCT03138512|451371812|FG002|Randomization|Participants withdrew consent|1|||
125474774|NCT03138512|451371813|FG003|Randomization|Participants withdrew consent|0|||
125474775|NCT03138512|451371814|FG004|Randomization|Participants withdrew consent|0|||
125474776|NCT03138512|451371810|FG000|Randomization|Participant no longer meets study criteria|0|||
125474777|NCT03138512|451371811|FG001|Randomization|Participant no longer meets study criteria|3|||
125474778|NCT03138512|451371812|FG002|Randomization|Participant no longer meets study criteria|1|||
125474779|NCT03138512|451371813|FG003|Randomization|Participant no longer meets study criteria|1|||
125474780|NCT03138512|451371814|FG004|Randomization|Participant no longer meets study criteria|3|||
125474781|NCT03138512|451371810|FG000|Randomization|Other reasons|1|||
125474782|NCT03138512|451371811|FG001|Randomization|Other reasons|0|||
125474783|NCT03138512|451371812|FG002|Randomization|Other reasons|0|||
125474784|NCT03138512|451371813|FG003|Randomization|Other reasons|0|||
125474785|NCT03138512|451371814|FG004|Randomization|Other reasons|0|||
125474786|NCT03138512|451371810|FG000|Treatment Part A|Disease recurrence|10|||
125474787|NCT03138512|451371811|FG001|Treatment Part A|Disease recurrence|20|||
125474788|NCT03138512|451371812|FG002|Treatment Part A|Disease recurrence|0|||
125474789|NCT03138512|451371813|FG003|Treatment Part A|Disease recurrence|0|||
125474790|NCT03138512|451371814|FG004|Treatment Part A|Disease recurrence|0|||
125474791|NCT03138512|451371810|FG000|Treatment Part A|Study Drug Toxicity|132|||
125474792|NCT03138512|451371811|FG001|Treatment Part A|Study Drug Toxicity|5|||
125474793|NCT03138512|451371812|FG002|Treatment Part A|Study Drug Toxicity|0|||
125474794|NCT03138512|451371813|FG003|Treatment Part A|Study Drug Toxicity|0|||
125474795|NCT03138512|451371814|FG004|Treatment Part A|Study Drug Toxicity|0|||
125474796|NCT03138512|451371810|FG000|Treatment Part A|Death|1|||
125474797|NCT03138512|451371811|FG001|Treatment Part A|Death|0|||
125474798|NCT03138512|451371812|FG002|Treatment Part A|Death|0|||
125474799|NCT03138512|451371813|FG003|Treatment Part A|Death|0|||
125474800|NCT03138512|451371814|FG004|Treatment Part A|Death|0|||
125474801|NCT03138512|451371810|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
125474802|NCT03138512|451371811|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
125474803|NCT03138512|451371812|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
125474804|NCT03138512|451371813|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
125474805|NCT03138512|451371814|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
125474806|NCT03138512|451371810|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
125474807|NCT03138512|451371811|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
125474808|NCT03138512|451371812|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
125474809|NCT03138512|451371813|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
125474810|NCT03138512|451371814|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
125474811|NCT03138512|451371810|FG000|Treatment Part A|Participant withdrew consent|2|||
125474812|NCT03138512|451371811|FG001|Treatment Part A|Participant withdrew consent|4|||
125474813|NCT03138512|451371812|FG002|Treatment Part A|Participant withdrew consent|0|||
125474814|NCT03138512|451371813|FG003|Treatment Part A|Participant withdrew consent|0|||
125474815|NCT03138512|451371814|FG004|Treatment Part A|Participant withdrew consent|0|||
125474816|NCT03138512|451371810|FG000|Treatment Part A|Lost to Follow-up|0|||
125474817|NCT03138512|451371811|FG001|Treatment Part A|Lost to Follow-up|1|||
125474818|NCT03138512|451371812|FG002|Treatment Part A|Lost to Follow-up|0|||
125474819|NCT03138512|451371813|FG003|Treatment Part A|Lost to Follow-up|0|||
125474820|NCT03138512|451371814|FG004|Treatment Part A|Lost to Follow-up|0|||
125474821|NCT03138512|451371810|FG000|Treatment Part A|Poor/non-compliance|1|||
125474822|NCT03138512|451371811|FG001|Treatment Part A|Poor/non-compliance|0|||
125474823|NCT03138512|451371812|FG002|Treatment Part A|Poor/non-compliance|0|||
125474824|NCT03138512|451371813|FG003|Treatment Part A|Poor/non-compliance|0|||
125474825|NCT03138512|451371814|FG004|Treatment Part A|Poor/non-compliance|0|||
125474826|NCT03138512|451371810|FG000|Treatment Part A|Pregnancy|0|||
125474827|NCT03138512|451371811|FG001|Treatment Part A|Pregnancy|1|||
125474828|NCT03138512|451371812|FG002|Treatment Part A|Pregnancy|0|||
125474829|NCT03138512|451371813|FG003|Treatment Part A|Pregnancy|0|||
125474830|NCT03138512|451371814|FG004|Treatment Part A|Pregnancy|0|||
125474831|NCT03138512|451371810|FG000|Treatment Part A|Other reasons|11|||
125474832|NCT03138512|451371811|FG001|Treatment Part A|Other reasons|8|||
125474833|NCT03138512|451371812|FG002|Treatment Part A|Other reasons|0|||
125474834|NCT03138512|451371813|FG003|Treatment Part A|Other reasons|0|||
125474835|NCT03138512|451371814|FG004|Treatment Part A|Other reasons|0|||
125474836|NCT03138512|451371810|FG000|Treatment Part B|Disease recurrence|0|||
125474837|NCT03138512|451371811|FG001|Treatment Part B|Disease recurrence|0|||
125474838|NCT03138512|451371812|FG002|Treatment Part B|Disease recurrence|6|||
125474839|NCT03138512|451371813|FG003|Treatment Part B|Disease recurrence|12|||
125474840|NCT03138512|451371814|FG004|Treatment Part B|Disease recurrence|10|||
125474841|NCT03138512|451371810|FG000|Treatment Part B|Study drug toxicity|0|||
125474842|NCT03138512|451371811|FG001|Treatment Part B|Study drug toxicity|0|||
125474843|NCT03138512|451371812|FG002|Treatment Part B|Study drug toxicity|63|||
125474844|NCT03138512|451371813|FG003|Treatment Part B|Study drug toxicity|3|||
125474845|NCT03138512|451371814|FG004|Treatment Part B|Study drug toxicity|45|||
125474846|NCT03138512|451371810|FG000|Treatment Part B|Death|0|||
125474847|NCT03138512|451371811|FG001|Treatment Part B|Death|0|||
125474848|NCT03138512|451371812|FG002|Treatment Part B|Death|1|||
125474849|NCT03138512|451371813|FG003|Treatment Part B|Death|0|||
125474850|NCT03138512|451371814|FG004|Treatment Part B|Death|0|||
125474851|NCT03138512|451371810|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
125474852|NCT03138512|451371811|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
125474853|NCT03138512|451371812|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
125474854|NCT03138512|451371813|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
125474855|NCT03138512|451371814|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
125474856|NCT03138512|451371810|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
125474857|NCT03138512|451371811|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
125474858|NCT03138512|451371812|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
125474859|NCT03138512|451371813|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
125474860|NCT03138512|451371814|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
125474861|NCT03138512|451371810|FG000|Treatment Part B|Participant withdrew consent|0|||
125474862|NCT03138512|451371811|FG001|Treatment Part B|Participant withdrew consent|0|||
125474863|NCT03138512|451371812|FG002|Treatment Part B|Participant withdrew consent|1|||
125474864|NCT03138512|451371813|FG003|Treatment Part B|Participant withdrew consent|1|||
125474865|NCT03138512|451371814|FG004|Treatment Part B|Participant withdrew consent|2|||
125474866|NCT03138512|451371810|FG000|Treatment Part B|Lost to Follow-up|0|||
125474867|NCT03138512|451371811|FG001|Treatment Part B|Lost to Follow-up|0|||
125474868|NCT03138512|451371812|FG002|Treatment Part B|Lost to Follow-up|0|||
125474869|NCT03138512|451371813|FG003|Treatment Part B|Lost to Follow-up|1|||
125474870|NCT03138512|451371814|FG004|Treatment Part B|Lost to Follow-up|0|||
125474871|NCT03138512|451371810|FG000|Treatment Part B|Poor/non-compliance|0|||
125474872|NCT03138512|451371811|FG001|Treatment Part B|Poor/non-compliance|0|||
125474873|NCT03138512|451371812|FG002|Treatment Part B|Poor/non-compliance|1|||
125474874|NCT03138512|451371813|FG003|Treatment Part B|Poor/non-compliance|1|||
125474875|NCT03138512|451371814|FG004|Treatment Part B|Poor/non-compliance|1|||
125474876|NCT03138512|451371810|FG000|Treatment Part B|Other reasons|0|||
125474877|NCT03138512|451371811|FG001|Treatment Part B|Other reasons|0|||
125474878|NCT03138512|451371812|FG002|Treatment Part B|Other reasons|3|||
125474879|NCT03138512|451371813|FG003|Treatment Part B|Other reasons|1|||
125474880|NCT03138512|451371814|FG004|Treatment Part B|Other reasons|5|||
125474881|NCT03332017|451371815|FG000|Overall Study|Lost to Follow-up|1|||
125474882|NCT03332017|451371816|FG001|Overall Study|Lost to Follow-up|2|||
125474883|NCT03332017|451371815|FG000|Overall Study|Death|17|||
125474884|NCT03332017|451371816|FG001|Overall Study|Death|16|||
125474885|NCT03332017|451371815|FG000|Overall Study|Withdrawal by Subject|6|||
125474886|NCT03332017|451371816|FG001|Overall Study|Withdrawal by Subject|14|||
125474887|NCT03332017|451371815|FG000|Overall Study|Other|1|||
125474888|NCT03332017|451371816|FG001|Overall Study|Other|3|||
125474889|NCT03332017|451371815|FG000|Overall Study|Remained in Study (Ongoing)|47|||
125474890|NCT03332017|451371816|FG001|Overall Study|Remained in Study (Ongoing)|110|||
125474891|NCT01261312|451371817|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
125474892|NCT01261312|451371818|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
125474893|NCT01261312|451371819|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
125474894|NCT01261312|451371820|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
125474895|NCT01261312|451371821|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
125300146|NCT01815840|450725898|FG001|Overall Study|Investigators Decision|3|||
125300147|NCT01815840|450725897|FG000|Overall Study|Lost to Follow-up|3|||
125474896|NCT01261312|451371822|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
125474897|NCT01261312|451371823|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
125474898|NCT01261312|451371824|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
125474899|NCT01261312|451371825|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
125474900|NCT01261312|451371826|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
125474901|NCT01261312|451371827|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
125474902|NCT01261312|451371828|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
125474903|NCT01261312|451371829|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
125474904|NCT01261312|451371817|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
125474905|NCT01261312|451371818|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
125474906|NCT01261312|451371819|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
125474907|NCT01261312|451371820|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
125474908|NCT01261312|451371821|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
125474909|NCT01261312|451371822|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
125474910|NCT01261312|451371823|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
125474911|NCT01261312|451371824|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
125300148|NCT01815840|450725898|FG001|Overall Study|Lost to Follow-up|6|||
125474912|NCT01261312|451371825|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
125474913|NCT01261312|451371826|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
125474914|NCT01261312|451371827|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
125474915|NCT01261312|451371828|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
125474916|NCT01261312|451371829|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
125474917|NCT01261312|451371817|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
125474918|NCT01261312|451371818|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
125474919|NCT01261312|451371819|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
125474920|NCT01261312|451371820|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
125474921|NCT01261312|451371821|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
125474922|NCT01261312|451371822|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
125474923|NCT01261312|451371823|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
125474924|NCT01261312|451371824|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
125474925|NCT01261312|451371825|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
125474926|NCT01261312|451371826|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
125474927|NCT01261312|451371827|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
125474928|NCT01261312|451371828|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
125474929|NCT01261312|451371829|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
125474930|NCT01261312|451371817|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
125474931|NCT01261312|451371818|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
125474932|NCT01261312|451371819|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
125474933|NCT01261312|451371820|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
125474934|NCT01261312|451371821|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
125474935|NCT01261312|451371822|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
125474936|NCT01261312|451371823|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
125474937|NCT01261312|451371824|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
125474938|NCT01261312|451371825|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
125474939|NCT01261312|451371826|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
125474940|NCT01261312|451371827|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
125474941|NCT01261312|451371828|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
125474942|NCT01261312|451371829|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
125474943|NCT01261312|451371817|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
125474944|NCT01261312|451371818|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
125474945|NCT01261312|451371819|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
125474946|NCT01261312|451371820|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
125474947|NCT01261312|451371821|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
125474948|NCT01261312|451371822|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
125474949|NCT01261312|451371823|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
125474950|NCT01261312|451371824|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
125474951|NCT01261312|451371825|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
125474952|NCT01261312|451371826|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
125474953|NCT01261312|451371827|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
125474954|NCT01261312|451371828|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
125474955|NCT01261312|451371829|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
125474956|NCT01261312|451371817|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
125474957|NCT01261312|451371818|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
125474958|NCT01261312|451371819|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
125474959|NCT01261312|451371820|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
125474960|NCT01261312|451371821|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
125474961|NCT01261312|451371822|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
125474962|NCT01261312|451371823|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
125474963|NCT01261312|451371824|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
125474964|NCT01261312|451371825|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
125474965|NCT01261312|451371826|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
125474966|NCT01261312|451371827|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
125474967|NCT01261312|451371828|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
125474968|NCT01261312|451371829|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
125474969|NCT01261312|451371817|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
125474970|NCT01261312|451371818|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
125300149|NCT01815840|450725897|FG000|Overall Study|Refused Treatment|5|||
125300150|NCT01815840|450725898|FG001|Overall Study|Refused Treatment|1|||
125300151|NCT01815840|450725897|FG000|Overall Study|Sponsor Termination Treatment|1|||
125474971|NCT01261312|451371819|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
125474972|NCT01261312|451371820|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
125474973|NCT01261312|451371821|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
125474974|NCT01261312|451371822|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
125474975|NCT01261312|451371823|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
125474976|NCT01261312|451371824|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
125474977|NCT01261312|451371825|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
125474978|NCT01261312|451371826|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
125474979|NCT01261312|451371827|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
125474980|NCT01261312|451371828|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
125474981|NCT01261312|451371829|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
125474982|NCT01261312|451371817|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
125474983|NCT01261312|451371818|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
125474984|NCT01261312|451371819|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
125474985|NCT01261312|451371820|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
125474986|NCT01261312|451371821|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
125474987|NCT01261312|451371822|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
125474988|NCT01261312|451371823|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
125474989|NCT01261312|451371824|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
125474990|NCT01261312|451371825|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
125474991|NCT01261312|451371826|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
125474992|NCT01261312|451371827|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
125474993|NCT01261312|451371828|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
125474994|NCT01261312|451371829|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
125474995|NCT01261312|451371817|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
125474996|NCT01261312|451371818|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
125474997|NCT01261312|451371819|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
125474998|NCT01261312|451371820|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
125474999|NCT01261312|451371821|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
125475000|NCT01261312|451371822|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
125475001|NCT01261312|451371823|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
125475002|NCT01261312|451371824|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
125475003|NCT01261312|451371825|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
125475004|NCT01261312|451371826|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
125475005|NCT01261312|451371827|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
125475006|NCT01261312|451371828|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
125475007|NCT01261312|451371829|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
125475008|NCT01261312|451371817|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
125475009|NCT01261312|451371818|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
125475010|NCT01261312|451371819|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
125475011|NCT01261312|451371820|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
125475012|NCT01261312|451371821|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
125475013|NCT01261312|451371822|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
125475014|NCT01261312|451371823|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
125475015|NCT01261312|451371824|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
125475016|NCT01261312|451371825|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
125475017|NCT01261312|451371826|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
125475018|NCT01261312|451371827|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
125475019|NCT01261312|451371828|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
125475020|NCT01261312|451371829|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
125475021|NCT01261312|451371817|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
125475022|NCT01261312|451371818|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
125475023|NCT01261312|451371819|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
125475024|NCT01261312|451371820|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
125475025|NCT01261312|451371821|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
125475026|NCT01261312|451371822|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
125475027|NCT01261312|451371823|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
125475028|NCT01261312|451371824|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
125475029|NCT01261312|451371825|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
125475030|NCT01261312|451371826|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
125475031|NCT01261312|451371827|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
125475032|NCT01261312|451371828|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
125475033|NCT01261312|451371829|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
125475034|NCT01261312|451371817|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
125475035|NCT01261312|451371818|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
125475036|NCT01261312|451371819|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
125475037|NCT01261312|451371820|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
125475038|NCT01261312|451371821|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
125475039|NCT01261312|451371822|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
125475040|NCT01261312|451371823|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
125475041|NCT01261312|451371824|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
125475042|NCT01261312|451371825|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
125475043|NCT01261312|451371826|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
125475044|NCT01261312|451371827|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
125475045|NCT01261312|451371828|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
125475046|NCT01261312|451371829|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
125475047|NCT01261312|451371817|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
125475048|NCT01261312|451371818|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
125475049|NCT01261312|451371819|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
125475050|NCT01261312|451371820|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
125475051|NCT01261312|451371821|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
125475052|NCT01261312|451371822|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
125475053|NCT01261312|451371823|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
125475054|NCT01261312|451371824|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
125475055|NCT01261312|451371825|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
125475056|NCT01261312|451371826|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
125475057|NCT01261312|451371827|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
125475058|NCT01261312|451371828|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
125475059|NCT01261312|451371829|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
125475060|NCT01261312|451371817|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
125475061|NCT01261312|451371818|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
125475062|NCT01261312|451371819|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
125475063|NCT01261312|451371820|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
125475064|NCT01261312|451371821|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
125475065|NCT01261312|451371822|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
125475066|NCT01261312|451371823|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
125475067|NCT01261312|451371824|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
125475068|NCT01261312|451371825|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
125475069|NCT01261312|451371826|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
125475070|NCT01261312|451371827|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
125475071|NCT01261312|451371828|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
125475072|NCT01261312|451371829|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
125475073|NCT01261312|451371817|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
125475074|NCT01261312|451371818|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
125475075|NCT01261312|451371819|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
125475076|NCT01261312|451371820|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
125475077|NCT01261312|451371821|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
125475078|NCT01261312|451371822|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
125475079|NCT01261312|451371823|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
125475080|NCT01261312|451371824|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
125475081|NCT01261312|451371825|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
125475082|NCT01261312|451371826|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
125475083|NCT01261312|451371827|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
125475084|NCT01261312|451371828|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
125475085|NCT01261312|451371829|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
125475086|NCT01261312|451371817|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
125475087|NCT01261312|451371818|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
125475088|NCT01261312|451371819|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
125475089|NCT01261312|451371820|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
125475090|NCT01261312|451371821|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
125475091|NCT01261312|451371822|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
125475092|NCT01261312|451371823|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
125475093|NCT01261312|451371824|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
125475094|NCT01261312|451371825|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
125475095|NCT01261312|451371826|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
125475096|NCT01261312|451371827|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
125475097|NCT01261312|451371828|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
125475098|NCT01261312|451371829|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
125475099|NCT01261312|451371817|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
125475100|NCT01261312|451371818|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
125475101|NCT01261312|451371819|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
125475102|NCT01261312|451371820|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
125475103|NCT01261312|451371821|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
125475104|NCT01261312|451371822|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
125475105|NCT01261312|451371823|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
125475106|NCT01261312|451371824|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
125485380|NCT02240238|451412506|FG003|Phase 1|Withdrawal by Subject|0|||
125475107|NCT01261312|451371825|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
125475108|NCT01261312|451371826|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
125475109|NCT01261312|451371827|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
125475110|NCT01261312|451371828|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
125475111|NCT01261312|451371829|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
125475112|NCT01261312|451371817|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
125475113|NCT01261312|451371818|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
125475114|NCT01261312|451371819|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
125475115|NCT01261312|451371820|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
125475116|NCT01261312|451371821|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
125475117|NCT01261312|451371822|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
125475118|NCT01261312|451371823|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
125475119|NCT01261312|451371824|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
125475120|NCT01261312|451371825|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
125475121|NCT01261312|451371826|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
125475122|NCT01261312|451371827|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
125475123|NCT01261312|451371828|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
125475124|NCT01261312|451371829|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
125475125|NCT01261312|451371817|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
125475126|NCT01261312|451371818|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
125475127|NCT01261312|451371819|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
125475128|NCT01261312|451371820|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
125475129|NCT01261312|451371821|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
125475130|NCT01261312|451371822|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
125475131|NCT01261312|451371823|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
125475132|NCT01261312|451371824|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
125475133|NCT01261312|451371825|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
125475134|NCT01261312|451371826|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
125475135|NCT01261312|451371827|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
125475136|NCT01261312|451371828|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
125475137|NCT01261312|451371829|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
125475138|NCT01261312|451371817|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
125475139|NCT01261312|451371818|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
125475140|NCT01261312|451371819|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
125475141|NCT01261312|451371820|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
125475142|NCT01261312|451371821|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
125475143|NCT01261312|451371822|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
125475144|NCT01261312|451371823|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
125475145|NCT01261312|451371824|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
125475146|NCT01261312|451371825|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
125475147|NCT01261312|451371826|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
125475148|NCT01261312|451371827|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
125475149|NCT01261312|451371828|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
125475150|NCT01261312|451371829|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
125475151|NCT01261312|451371817|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
125475152|NCT01261312|451371818|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
125475153|NCT01261312|451371819|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
125475154|NCT01261312|451371820|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
125475155|NCT01261312|451371821|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
125475156|NCT01261312|451371822|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
125475157|NCT01261312|451371823|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
125475158|NCT01261312|451371824|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
125475159|NCT01261312|451371825|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
125475160|NCT01261312|451371826|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
125475161|NCT01261312|451371827|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
125475162|NCT01261312|451371828|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
125475163|NCT01261312|451371829|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
125475164|NCT01261312|451371817|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
125475165|NCT01261312|451371818|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
125475166|NCT01261312|451371819|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
125475167|NCT01261312|451371820|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
125475168|NCT01261312|451371821|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
125475169|NCT01261312|451371822|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
125475170|NCT01261312|451371823|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
125475171|NCT01261312|451371824|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
125475172|NCT01261312|451371825|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
125475173|NCT01261312|451371826|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
125475174|NCT01261312|451371827|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
125475175|NCT01261312|451371828|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
125475176|NCT01261312|451371829|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
125475177|NCT01261312|451371817|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
125475178|NCT01261312|451371818|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
125475179|NCT01261312|451371819|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
125475180|NCT01261312|451371820|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
125475181|NCT01261312|451371821|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
125475182|NCT01261312|451371822|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
125475183|NCT01261312|451371823|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
125475184|NCT01261312|451371824|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
125475185|NCT01261312|451371825|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
125475186|NCT01261312|451371826|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
125475187|NCT01261312|451371827|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
125475188|NCT01261312|451371828|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
125475189|NCT01261312|451371829|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
125475190|NCT01261312|451371817|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
125475191|NCT01261312|451371818|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
125475192|NCT01261312|451371819|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
125475193|NCT01261312|451371820|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
125475194|NCT01261312|451371821|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
125475195|NCT01261312|451371822|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
125475196|NCT01261312|451371823|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
125475197|NCT01261312|451371824|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
125475198|NCT01261312|451371825|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
125475199|NCT01261312|451371826|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
125475200|NCT01261312|451371827|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
125475201|NCT01261312|451371828|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
125475202|NCT01261312|451371829|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
125475203|NCT01261312|451371817|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
125475204|NCT01261312|451371818|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
125475205|NCT01261312|451371819|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
125475206|NCT01261312|451371820|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
125475207|NCT01261312|451371821|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
125475208|NCT01261312|451371822|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
125475209|NCT01261312|451371823|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
125475210|NCT01261312|451371824|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
125475211|NCT01261312|451371825|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
125475212|NCT01261312|451371826|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
125475213|NCT01261312|451371827|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
125475214|NCT01261312|451371828|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
125475215|NCT01261312|451371829|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
125475216|NCT01261312|451371817|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
125475217|NCT01261312|451371818|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
125475218|NCT01261312|451371819|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
125475219|NCT01261312|451371820|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
125475220|NCT01261312|451371821|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
125475221|NCT01261312|451371822|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
125475222|NCT01261312|451371823|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
125475223|NCT01261312|451371824|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
125475224|NCT01261312|451371825|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
125475225|NCT01261312|451371826|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
125475226|NCT01261312|451371827|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
125475227|NCT01261312|451371828|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
125475228|NCT01261312|451371829|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
125475229|NCT01261312|451371817|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
125475230|NCT01261312|451371818|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
125475231|NCT01261312|451371819|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
125475232|NCT01261312|451371820|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
125475233|NCT01261312|451371821|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
125475234|NCT01261312|451371822|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
125475235|NCT01261312|451371823|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
125475236|NCT01261312|451371824|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
125475237|NCT01261312|451371825|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
125475238|NCT01261312|451371826|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
125475239|NCT01261312|451371827|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
125475240|NCT01261312|451371828|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
125475241|NCT01261312|451371829|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
125475242|NCT01261312|451371817|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
125475243|NCT01261312|451371818|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
125475244|NCT01261312|451371819|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
125475245|NCT01261312|451371820|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
125475246|NCT01261312|451371821|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
125475247|NCT01261312|451371822|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
125475248|NCT01261312|451371823|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
125475249|NCT01261312|451371824|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
125475250|NCT01261312|451371825|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
125475251|NCT01261312|451371826|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
125300152|NCT01815840|450725898|FG001|Overall Study|Sponsor Termination Treatment|0|||
125300153|NCT03221842|450725900|FG000|Period 1 (Open-label)|Adverse Event|4|||
125300154|NCT03221842|450725901|FG001|Period 1 (Open-label)|Adverse Event|0|||
125300155|NCT03221842|450725900|FG000|Period 1 (Open-label)|Physician Decision|2|||
125300156|NCT03221842|450725901|FG001|Period 1 (Open-label)|Physician Decision|0|||
125300157|NCT03221842|450725900|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
125300158|NCT03221842|450725901|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
125300159|NCT03221842|450725900|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
125300160|NCT03221842|450725901|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
125300161|NCT03221842|450725900|FG000|Period 1 (Open-label)|Other|2|||
125300162|NCT03221842|450725901|FG001|Period 1 (Open-label)|Other|0|||
125300163|NCT03221842|450725900|FG000|Period 2 (Randomized, Blinded)|Death|0|||
125300164|NCT03221842|450725901|FG001|Period 2 (Randomized, Blinded)|Death|1|||
125300165|NCT03221842|450725900|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
125300166|NCT03221842|450725901|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
125300167|NCT00704288|450725902|FG000|Overall Treatment Period|Adverse Event|11|||
125475252|NCT01261312|451371827|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
125475253|NCT01261312|451371828|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
125475254|NCT01261312|451371829|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
125475255|NCT03436745|451371836|FG000|Overall Study|Ineligible|0|||
125475256|NCT03436745|451371837|FG001|Overall Study|Ineligible|0|||
125475257|NCT03436745|451371838|FG002|Overall Study|Ineligible|1|||
125475258|NCT03406871|451371842|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
125475259|NCT03406871|451371843|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
125475260|NCT03406871|451371844|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
125475261|NCT03406871|451371842|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
125475262|NCT03406871|451371843|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
125475263|NCT03406871|451371844|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
125475264|NCT03406871|451371842|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
125475265|NCT03406871|451371843|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
125475266|NCT03406871|451371844|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
125475267|NCT03406871|451371842|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
125475268|NCT03406871|451371843|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
125475269|NCT03406871|451371844|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
125475270|NCT03406871|451371842|FG000|Expansion Cohort(Final Analysis)|Death|0|||
125475271|NCT03406871|451371843|FG001|Expansion Cohort(Final Analysis)|Death|1|||
125475272|NCT03406871|451371844|FG002|Expansion Cohort(Final Analysis)|Death|0|||
125475273|NCT03406871|451371842|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
125475274|NCT03406871|451371843|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
125475275|NCT03406871|451371844|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
125475276|NCT04588298|451371845|FG000|Overall Study|Adverse Event|0|||
125475277|NCT04588298|451371846|FG001|Overall Study|Adverse Event|0|||
125475278|NCT04588298|451371847|FG002|Overall Study|Adverse Event|1|||
125475279|NCT04588298|451371848|FG003|Overall Study|Adverse Event|0|||
125475280|NCT04588298|451371849|FG004|Overall Study|Adverse Event|2|||
125475281|NCT04588298|451371845|FG000|Overall Study|Withdrawal by Subject|1|||
125475282|NCT04588298|451371846|FG001|Overall Study|Withdrawal by Subject|0|||
125475283|NCT04588298|451371847|FG002|Overall Study|Withdrawal by Subject|0|||
125475284|NCT04588298|451371848|FG003|Overall Study|Withdrawal by Subject|1|||
125475285|NCT04588298|451371849|FG004|Overall Study|Withdrawal by Subject|0|||
125475286|NCT03792555|451371852|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
125475287|NCT03792555|451371853|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
125300168|NCT00704288|450725903|FG001|Overall Treatment Period|Adverse Event|8|||
125300169|NCT00704288|450725904|FG002|Overall Treatment Period|Adverse Event|22|||
125475288|NCT03792555|451371854|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
125475289|NCT03792555|451371852|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
125475290|NCT03792555|451371853|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
125475291|NCT03792555|451371854|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
125475292|NCT03792555|451371852|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
125475293|NCT03792555|451371853|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
125475294|NCT03792555|451371854|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
125475295|NCT01580488|451373438|FG000|Overall Study|Withdrawal by Subject|1|||
125475296|NCT03738228|451373439|FG000|Overall Study|Never received study treatment|2|||
125475297|NCT03738228|451373440|FG001|Overall Study|Never received study treatment|2|||
125475298|NCT03338790|451373448|FG000|Overall Study|Disease Progression|65|||
125475299|NCT03338790|451373449|FG001|Overall Study|Disease Progression|43|||
125475300|NCT03338790|451373450|FG002|Overall Study|Disease Progression|50|||
125475301|NCT03338790|451373451|FG003|Overall Study|Disease Progression|37|||
125475302|NCT03338790|451373448|FG000|Overall Study|Study Drug Toxicity|9|||
125475303|NCT03338790|451373449|FG001|Overall Study|Study Drug Toxicity|8|||
125475304|NCT03338790|451373450|FG002|Overall Study|Study Drug Toxicity|15|||
125475305|NCT03338790|451373451|FG003|Overall Study|Study Drug Toxicity|0|||
125475306|NCT03338790|451373448|FG000|Overall Study|Death|1|||
125475307|NCT03338790|451373449|FG001|Overall Study|Death|1|||
125475308|NCT03338790|451373450|FG002|Overall Study|Death|1|||
125475309|NCT03338790|451373451|FG003|Overall Study|Death|0|||
125475310|NCT03338790|451373448|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
125475311|NCT03338790|451373449|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
125475312|NCT03338790|451373450|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
125475313|NCT03338790|451373451|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
125475314|NCT03338790|451373448|FG000|Overall Study|Participant request to discontinue study treatment|3|||
125475315|NCT03338790|451373449|FG001|Overall Study|Participant request to discontinue study treatment|3|||
125475316|NCT03338790|451373450|FG002|Overall Study|Participant request to discontinue study treatment|2|||
125475317|NCT03338790|451373451|FG003|Overall Study|Participant request to discontinue study treatment|1|||
125475318|NCT03338790|451373448|FG000|Overall Study|Poor/non-compliance|0|||
125475319|NCT03338790|451373449|FG001|Overall Study|Poor/non-compliance|1|||
125475320|NCT03338790|451373450|FG002|Overall Study|Poor/non-compliance|0|||
125475321|NCT03338790|451373451|FG003|Overall Study|Poor/non-compliance|0|||
125475322|NCT03338790|451373448|FG000|Overall Study|Participant withdrew consent|1|||
125475323|NCT03338790|451373449|FG001|Overall Study|Participant withdrew consent|0|||
125475324|NCT03338790|451373450|FG002|Overall Study|Participant withdrew consent|1|||
125475325|NCT03338790|451373451|FG003|Overall Study|Participant withdrew consent|1|||
125475326|NCT03338790|451373448|FG000|Overall Study|Other reasons|0|||
125475327|NCT03338790|451373449|FG001|Overall Study|Other reasons|5|||
125475328|NCT03338790|451373450|FG002|Overall Study|Other reasons|0|||
125475329|NCT03338790|451373451|FG003|Overall Study|Other reasons|2|||
125475330|NCT03338790|451373448|FG000|Overall Study|Not reported|0|||
125475331|NCT03338790|451373449|FG001|Overall Study|Not reported|0|||
125475332|NCT03338790|451373450|FG002|Overall Study|Not reported|1|||
125475333|NCT03338790|451373451|FG003|Overall Study|Not reported|0|||
125475334|NCT03338790|451373448|FG000|Overall Study|Completed treatment period|1|||
125475335|NCT03338790|451373449|FG001|Overall Study|Completed treatment period|2|||
125475336|NCT03338790|451373450|FG002|Overall Study|Completed treatment period|0|||
125475337|NCT03338790|451373451|FG003|Overall Study|Completed treatment period|0|||
125475338|NCT03366649|451373453|FG000|Overall Study|Failed preoperative screening|4|||
125475339|NCT03366649|451373454|FG001|Overall Study|Failed preoperative screening|0|||
125475340|NCT03366649|451373455|FG002|Overall Study|Failed preoperative screening|0|||
125475341|NCT03366649|451373453|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
125475342|NCT03366649|451373454|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
125475343|NCT03366649|451373455|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
125475344|NCT03673111|451373456|FG000|Overall Study|Protocol Violation|0|||
125475345|NCT03673111|451373457|FG001|Overall Study|Protocol Violation|0|||
125475346|NCT03673111|451373458|FG002|Overall Study|Protocol Violation|0|||
125475347|NCT03673111|451373459|FG003|Overall Study|Protocol Violation|0|||
125475348|NCT03673111|451373460|FG004|Overall Study|Protocol Violation|0|||
125475349|NCT03673111|451373461|FG005|Overall Study|Protocol Violation|0|||
125475350|NCT03673111|451373462|FG006|Overall Study|Protocol Violation|0|||
125475351|NCT03673111|451373463|FG007|Overall Study|Protocol Violation|0|||
125475352|NCT03673111|451373464|FG008|Overall Study|Protocol Violation|0|||
125475353|NCT03673111|451373465|FG009|Overall Study|Protocol Violation|0|||
125475354|NCT03673111|451373466|FG010|Overall Study|Protocol Violation|1|||
125475355|NCT03673111|451373467|FG011|Overall Study|Protocol Violation|0|||
125475356|NCT03673111|451373468|FG012|Overall Study|Protocol Violation|0|||
125475357|NCT03673111|451373469|FG013|Overall Study|Protocol Violation|0|||
125475358|NCT03673111|451373456|FG000|Overall Study|Adverse Event|1|||
125475359|NCT03673111|451373457|FG001|Overall Study|Adverse Event|0|||
125475360|NCT03673111|451373458|FG002|Overall Study|Adverse Event|0|||
125475361|NCT03673111|451373459|FG003|Overall Study|Adverse Event|0|||
125475362|NCT03673111|451373460|FG004|Overall Study|Adverse Event|0|||
125475363|NCT03673111|451373461|FG005|Overall Study|Adverse Event|0|||
125475364|NCT03673111|451373462|FG006|Overall Study|Adverse Event|0|||
125475365|NCT03673111|451373463|FG007|Overall Study|Adverse Event|0|||
125475366|NCT03673111|451373464|FG008|Overall Study|Adverse Event|0|||
125475367|NCT03673111|451373465|FG009|Overall Study|Adverse Event|0|||
125475368|NCT03673111|451373466|FG010|Overall Study|Adverse Event|0|||
125475369|NCT03673111|451373467|FG011|Overall Study|Adverse Event|0|||
125475370|NCT03673111|451373468|FG012|Overall Study|Adverse Event|0|||
125475371|NCT03673111|451373469|FG013|Overall Study|Adverse Event|0|||
125475372|NCT03846505|451373470|FG000|Treatment Phase|Withdrawal by Subject|9|||
125475373|NCT03846505|451373471|FG001|Treatment Phase|Withdrawal by Subject|11|||
125475374|NCT03846505|451373470|FG000|Treatment Phase|Lost to Follow-up|6|||
125475375|NCT03846505|451373471|FG001|Treatment Phase|Lost to Follow-up|2|||
125475376|NCT03846505|451373470|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
125475377|NCT03846505|451373471|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
125475378|NCT03846505|451373470|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
125475379|NCT03846505|451373471|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
125475380|NCT01744782|451373478|FG000|Overall Study|Death|1|||
125475387|NCT02120456|451373482|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
125475388|NCT02120456|451373483|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
125475389|NCT02120456|451373484|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
125475390|NCT02120456|451373485|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
125475391|NCT02120456|451373486|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
125475392|NCT02120456|451373487|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
125475393|NCT02120456|451373488|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
125475394|NCT02120456|451373489|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
125475395|NCT02120456|451373490|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
125475396|NCT02120456|451373482|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
125475397|NCT02120456|451373483|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
125475398|NCT02120456|451373484|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
125475399|NCT02120456|451373485|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
125475400|NCT02120456|451373486|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
125475401|NCT02120456|451373487|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
125475402|NCT02120456|451373488|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
125475403|NCT02120456|451373489|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
125475404|NCT02120456|451373490|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
125475405|NCT02120456|451373482|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
125475406|NCT02120456|451373483|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
125475407|NCT02120456|451373484|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
125475408|NCT02120456|451373485|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
125475409|NCT02120456|451373486|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
125475410|NCT02120456|451373487|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
125475411|NCT02120456|451373488|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
125475412|NCT02120456|451373489|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
125475413|NCT02120456|451373490|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
125475414|NCT02243709|451373491|FG000|Phase 1|Lost to Follow-up|0|||
125475415|NCT02243709|451373492|FG001|Phase 1|Lost to Follow-up|1|||
125475416|NCT02243709|451373491|FG000|Phase 1|Withdrawal by Subject|1|||
125475417|NCT02243709|451373492|FG001|Phase 1|Withdrawal by Subject|0|||
125475418|NCT02243709|451373491|FG000|Phase 1|Protocol Violation|0|||
125475419|NCT02243709|451373492|FG001|Phase 1|Protocol Violation|1|||
125475420|NCT02243709|451373491|FG000|Phase 1|Adverse Event|0|||
125475421|NCT02243709|451373492|FG001|Phase 1|Adverse Event|1|||
125475422|NCT03443323|451373495|FG000|Overall Study|Lost to Follow-up|2|||
125475423|NCT03443323|451373496|FG001|Overall Study|Lost to Follow-up|2|||
125475424|NCT03443323|451373495|FG000|Overall Study|PI withdrawal|1|||
125475425|NCT03443323|451373496|FG001|Overall Study|PI withdrawal|0|||
125475426|NCT04610892|451373497|FG000|Overall Study|Adverse Event|1|||
125475427|NCT04610892|451373498|FG001|Overall Study|Adverse Event|0|||
125475428|NCT04610892|451373499|FG002|Overall Study|Adverse Event|0|||
125475429|NCT04610892|451373500|FG003|Overall Study|Adverse Event|1|||
125475430|NCT04610892|451373501|FG004|Overall Study|Adverse Event|3|||
125475431|NCT04610892|451373497|FG000|Overall Study|Death|0|||
125475432|NCT04610892|451373498|FG001|Overall Study|Death|1|||
125475433|NCT04610892|451373499|FG002|Overall Study|Death|0|||
125475434|NCT04610892|451373500|FG003|Overall Study|Death|1|||
125475435|NCT04610892|451373501|FG004|Overall Study|Death|0|||
125475436|NCT04610892|451373497|FG000|Overall Study|Withdrawal by Subject|3|||
125475437|NCT04610892|451373498|FG001|Overall Study|Withdrawal by Subject|2|||
125475438|NCT04610892|451373499|FG002|Overall Study|Withdrawal by Subject|0|||
125475439|NCT04610892|451373500|FG003|Overall Study|Withdrawal by Subject|6|||
125475440|NCT04610892|451373501|FG004|Overall Study|Withdrawal by Subject|6|||
125475441|NCT04610892|451373497|FG000|Overall Study|Subjects who did not receive treatment|1|||
125475442|NCT04610892|451373498|FG001|Overall Study|Subjects who did not receive treatment|0|||
125475443|NCT04610892|451373499|FG002|Overall Study|Subjects who did not receive treatment|0|||
125475444|NCT04610892|451373500|FG003|Overall Study|Subjects who did not receive treatment|0|||
125475445|NCT04610892|451373501|FG004|Overall Study|Subjects who did not receive treatment|2|||
125475446|NCT05520190|451373502|FG000|Overall Study|Lost to Follow-up|7|||
125475447|NCT05520190|451373502|FG000|Overall Study|Withdrawal by Subject|2|||
125475448|NCT03683719|451373503|FG000|Overall Study|Lack of Efficacy|1|||
125475449|NCT03683719|451373504|FG001|Overall Study|Lack of Efficacy|3|||
125475450|NCT03683719|451373505|FG002|Overall Study|Lack of Efficacy|4|||
125475451|NCT03683719|451373506|FG003|Overall Study|Lack of Efficacy|0|||
125475452|NCT03683719|451373507|FG004|Overall Study|Lack of Efficacy|4|||
125475453|NCT03683719|451373503|FG000|Overall Study|Adverse Event|6|||
125475454|NCT03683719|451373504|FG001|Overall Study|Adverse Event|6|||
125475455|NCT03683719|451373505|FG002|Overall Study|Adverse Event|0|||
125475456|NCT03683719|451373506|FG003|Overall Study|Adverse Event|1|||
125475457|NCT03683719|451373507|FG004|Overall Study|Adverse Event|3|||
125475458|NCT03683719|451373503|FG000|Overall Study|Withdrawal by Subject|4|||
125475459|NCT03683719|451373504|FG001|Overall Study|Withdrawal by Subject|4|||
125475460|NCT03683719|451373505|FG002|Overall Study|Withdrawal by Subject|3|||
125475461|NCT03683719|451373506|FG003|Overall Study|Withdrawal by Subject|5|||
125475462|NCT03683719|451373507|FG004|Overall Study|Withdrawal by Subject|5|||
125475463|NCT03683719|451373503|FG000|Overall Study|Lost to Follow-up|1|||
125475464|NCT03683719|451373504|FG001|Overall Study|Lost to Follow-up|0|||
125475465|NCT03683719|451373505|FG002|Overall Study|Lost to Follow-up|0|||
125475466|NCT03683719|451373506|FG003|Overall Study|Lost to Follow-up|1|||
125475467|NCT03683719|451373507|FG004|Overall Study|Lost to Follow-up|1|||
125475468|NCT03683719|451373503|FG000|Overall Study|Other personal reasons|0|||
125475469|NCT03683719|451373504|FG001|Overall Study|Other personal reasons|0|||
125475470|NCT03683719|451373505|FG002|Overall Study|Other personal reasons|1|||
125475471|NCT03683719|451373506|FG003|Overall Study|Other personal reasons|0|||
125475472|NCT03683719|451373507|FG004|Overall Study|Other personal reasons|1|||
125475473|NCT04896476|451373513|FG000|Overall Study|Withdrawal by Subject|1|||
125475474|NCT04896476|451373513|FG000|Overall Study|Lost to Follow-up|2|||
125475475|NCT03476187|451373514|FG000|Overall Study|Protocol Violation|7|||
125475476|NCT03476187|451373514|FG000|Overall Study|Physician Decision|5|||
125475477|NCT03135548|451373516|FG000|Overall Study|Lost to Follow-up|3|||
125475478|NCT03135548|451373517|FG001|Overall Study|Lost to Follow-up|0|||
125475479|NCT03135548|451373518|FG002|Overall Study|Lost to Follow-up|0|||
125475480|NCT03135548|451373516|FG000|Overall Study|Withdrawal by Subject|2|||
125475481|NCT03135548|451373517|FG001|Overall Study|Withdrawal by Subject|2|||
125475482|NCT03135548|451373518|FG002|Overall Study|Withdrawal by Subject|1|||
125475483|NCT03135548|451373516|FG000|Overall Study|Other than listed|0|||
125475484|NCT03135548|451373517|FG001|Overall Study|Other than listed|2|||
125475485|NCT03135548|451373518|FG002|Overall Study|Other than listed|2|||
125475486|NCT03924986|451373519|FG000|Overall Study|Death|57|||
125475487|NCT03924986|451373520|FG001|Overall Study|Death|66|||
125475488|NCT03924986|451373519|FG000|Overall Study|Study Concluded by Sponsor|51|||
125475489|NCT03924986|451373520|FG001|Overall Study|Study Concluded by Sponsor|41|||
125475490|NCT03924986|451373519|FG000|Overall Study|Withdrawal by Subject|15|||
125475491|NCT03924986|451373520|FG001|Overall Study|Withdrawal by Subject|20|||
125475492|NCT03924986|451373519|FG000|Overall Study|Lost to Follow-up|7|||
125475493|NCT03924986|451373520|FG001|Overall Study|Lost to Follow-up|5|||
125475494|NCT03924986|451373519|FG000|Overall Study|Miscellaneous|1|||
125475495|NCT03924986|451373520|FG001|Overall Study|Miscellaneous|0|||
125475496|NCT03445988|451373523|FG000|Overall Study|Lost to Follow-up|14|||
125475497|NCT03445988|451373524|FG001|Overall Study|Lost to Follow-up|26|||
125475498|NCT03445988|451373525|FG002|Overall Study|Lost to Follow-up|27|||
125475499|NCT03445988|451373526|FG003|Overall Study|Lost to Follow-up|66|||
125475500|NCT03445988|451373523|FG000|Overall Study|Withdrawal by Subject|7|||
125300170|NCT00704288|450725902|FG000|Overall Treatment Period|Death|0|||
125300171|NCT00704288|450725903|FG001|Overall Treatment Period|Death|0|||
125475501|NCT03445988|451373524|FG001|Overall Study|Withdrawal by Subject|4|||
125475502|NCT03445988|451373525|FG002|Overall Study|Withdrawal by Subject|3|||
125475503|NCT03445988|451373526|FG003|Overall Study|Withdrawal by Subject|5|||
125475504|NCT03445988|451373523|FG000|Overall Study|Death (unrelated to study)|5|||
125475505|NCT03445988|451373524|FG001|Overall Study|Death (unrelated to study)|1|||
125475506|NCT03445988|451373525|FG002|Overall Study|Death (unrelated to study)|2|||
125475507|NCT03445988|451373526|FG003|Overall Study|Death (unrelated to study)|4|||
125475508|NCT03988608|451373529|FG000|Overall Study|Adverse Event|1|||
125475509|NCT03988608|451373529|FG000|Overall Study|Lost to Follow-up|1|||
125475510|NCT03988608|451373529|FG000|Overall Study|Withdrawal by Subject|3|||
125475511|NCT03988608|451373529|FG000|Overall Study|Death|1|||
125475512|NCT02689284|451373534|FG000|Overall Study|Adverse Event|1|||
125475513|NCT02689284|451373535|FG001|Overall Study|Adverse Event|8|||
125475514|NCT02689284|451373534|FG000|Overall Study|Death|0|||
125475515|NCT02689284|451373535|FG001|Overall Study|Death|1|||
125475516|NCT02689284|451373534|FG000|Overall Study|Physician Decision|1|||
125475517|NCT02689284|451373535|FG001|Overall Study|Physician Decision|2|||
125475518|NCT02689284|451373534|FG000|Overall Study|Withdrawal by Subject|0|||
125475519|NCT02689284|451373535|FG001|Overall Study|Withdrawal by Subject|1|||
125475520|NCT02689284|451373534|FG000|Overall Study|progression of cancer|1|||
125475521|NCT02689284|451373535|FG001|Overall Study|progression of cancer|72|||
125475522|NCT02689284|451373534|FG000|Overall Study|decreased heart function|0|||
125475523|NCT02689284|451373535|FG001|Overall Study|decreased heart function|1|||
125475524|NCT02689284|451373534|FG000|Overall Study|concern for anemia|0|||
125475525|NCT02689284|451373535|FG001|Overall Study|concern for anemia|1|||
125475526|NCT02689284|451373534|FG000|Overall Study|no measurable cancer for evaluation|0|||
125475527|NCT02689284|451373535|FG001|Overall Study|no measurable cancer for evaluation|1|||
125475528|NCT05592418|451373536|FG000|Overall Study|Adverse Event|1|||
125475529|NCT05592418|451373537|FG001|Overall Study|Adverse Event|0|||
125475530|NCT05592418|451373536|FG000|Overall Study|Lost to Follow-up|1|||
125475531|NCT05592418|451373537|FG001|Overall Study|Lost to Follow-up|3|||
125475532|NCT05592418|451373536|FG000|Overall Study|Withdrawal by Subject|2|||
125475533|NCT05592418|451373537|FG001|Overall Study|Withdrawal by Subject|7|||
125475534|NCT05569252|451373540|FG000|Overall Study|Adverse event (central vision loss)|1|||
125475535|NCT05569252|451373541|FG001|Overall Study|Adverse event (central vision loss)|0|||
125475536|NCT05569252|451373542|FG002|Overall Study|Adverse event (central vision loss)|0|||
125475537|NCT05569252|451373543|FG003|Overall Study|Adverse event (central vision loss)|0|||
125475538|NCT03665597|451373544|FG000|Period 1|Adverse Event|1|||
125475539|NCT03665597|451373545|FG001|Period 1|Adverse Event|0|||
125475540|NCT03665597|451373546|FG002|Period 1|Adverse Event|0|||
125475541|NCT03665597|451373547|FG003|Period 1|Adverse Event|1|||
125475542|NCT03665597|451373548|FG004|Period 1|Adverse Event|0|||
125475543|NCT03665597|451373549|FG005|Period 1|Adverse Event|0|||
125475544|NCT03665597|451373550|FG006|Period 1|Adverse Event|0|||
125475545|NCT03665597|451373544|FG000|Period 1|Screen Failure|0|||
125475546|NCT03665597|451373545|FG001|Period 1|Screen Failure|0|||
125475547|NCT03665597|451373546|FG002|Period 1|Screen Failure|0|||
125475548|NCT03665597|451373547|FG003|Period 1|Screen Failure|1|||
125475549|NCT03665597|451373548|FG004|Period 1|Screen Failure|0|||
125475550|NCT03665597|451373549|FG005|Period 1|Screen Failure|0|||
125475551|NCT03665597|451373550|FG006|Period 1|Screen Failure|0|||
125475552|NCT03665597|451373544|FG000|Period 1|Death|0|||
125475553|NCT03665597|451373545|FG001|Period 1|Death|0|||
125475554|NCT03665597|451373546|FG002|Period 1|Death|0|||
125475555|NCT03665597|451373547|FG003|Period 1|Death|0|||
125475556|NCT03665597|451373548|FG004|Period 1|Death|0|||
125475557|NCT03665597|451373549|FG005|Period 1|Death|0|||
125475558|NCT03665597|451373550|FG006|Period 1|Death|45|||
125475559|NCT03665597|451373544|FG000|Period 1|Withdrawal by Subject|0|||
125475560|NCT03665597|451373545|FG001|Period 1|Withdrawal by Subject|0|||
125475561|NCT03665597|451373546|FG002|Period 1|Withdrawal by Subject|0|||
125475562|NCT03665597|451373547|FG003|Period 1|Withdrawal by Subject|0|||
125475563|NCT03665597|451373548|FG004|Period 1|Withdrawal by Subject|0|||
125475564|NCT03665597|451373549|FG005|Period 1|Withdrawal by Subject|0|||
125475565|NCT03665597|451373550|FG006|Period 1|Withdrawal by Subject|5|||
125475566|NCT03665597|451373544|FG000|Period 2|Adverse Event|0|||
125475567|NCT03665597|451373545|FG001|Period 2|Adverse Event|0|||
125475568|NCT03665597|451373546|FG002|Period 2|Adverse Event|0|||
125475569|NCT03665597|451373547|FG003|Period 2|Adverse Event|0|||
125475570|NCT03665597|451373548|FG004|Period 2|Adverse Event|0|||
125475571|NCT03665597|451373549|FG005|Period 2|Adverse Event|1|||
125475572|NCT03665597|451373550|FG006|Period 2|Adverse Event|0|||
125475573|NCT03665597|451373544|FG000|Period 3|Adverse Event|0|||
125475574|NCT03665597|451373545|FG001|Period 3|Adverse Event|1|||
125475575|NCT03665597|451373546|FG002|Period 3|Adverse Event|0|||
125475576|NCT03665597|451373547|FG003|Period 3|Adverse Event|0|||
125475577|NCT03665597|451373548|FG004|Period 3|Adverse Event|0|||
125475578|NCT03665597|451373549|FG005|Period 3|Adverse Event|0|||
125475579|NCT03665597|451373550|FG006|Period 3|Adverse Event|0|||
125475580|NCT03665597|451373544|FG000|Period 3|Death|0|||
125475581|NCT03665597|451373545|FG001|Period 3|Death|0|||
125475582|NCT03665597|451373546|FG002|Period 3|Death|0|||
125475583|NCT03665597|451373547|FG003|Period 3|Death|0|||
125475584|NCT03665597|451373548|FG004|Period 3|Death|1|||
125475585|NCT03665597|451373549|FG005|Period 3|Death|0|||
125475586|NCT03665597|451373550|FG006|Period 3|Death|0|||
125475587|NCT03665597|451373544|FG000|Period 4|Adverse Event|2|||
125475588|NCT03665597|451373545|FG001|Period 4|Adverse Event|2|||
125475589|NCT03665597|451373546|FG002|Period 4|Adverse Event|2|||
125475590|NCT03665597|451373547|FG003|Period 4|Adverse Event|2|||
125475591|NCT03665597|451373548|FG004|Period 4|Adverse Event|1|||
125475592|NCT03665597|451373549|FG005|Period 4|Adverse Event|0|||
125475593|NCT03665597|451373550|FG006|Period 4|Adverse Event|0|||
125475594|NCT03665597|451373544|FG000|Period 4|Death|0|||
125475595|NCT03665597|451373545|FG001|Period 4|Death|0|||
125475596|NCT03665597|451373546|FG002|Period 4|Death|2|||
125475597|NCT03665597|451373547|FG003|Period 4|Death|0|||
125475598|NCT03665597|451373548|FG004|Period 4|Death|0|||
125475599|NCT03665597|451373549|FG005|Period 4|Death|0|||
125475600|NCT03665597|451373550|FG006|Period 4|Death|0|||
125475601|NCT03665597|451373544|FG000|Period 4|Physician Decision|1|||
125475602|NCT03665597|451373545|FG001|Period 4|Physician Decision|2|||
125475603|NCT03665597|451373546|FG002|Period 4|Physician Decision|0|||
125475604|NCT03665597|451373547|FG003|Period 4|Physician Decision|0|||
125475605|NCT03665597|451373548|FG004|Period 4|Physician Decision|0|||
125475606|NCT03665597|451373549|FG005|Period 4|Physician Decision|0|||
125475607|NCT03665597|451373550|FG006|Period 4|Physician Decision|0|||
125475608|NCT03110315|451373551|FG000|Overall Study|Withdrawal by Subject|1|||
125475609|NCT03110315|451373552|FG001|Overall Study|Withdrawal by Subject|0|||
125475610|NCT00450658|451373556|FG000|Overall Study|Adverse Event|24|||
125475611|NCT00450658|451373557|FG001|Overall Study|Adverse Event|15|||
125475612|NCT00450658|451373556|FG000|Overall Study|Withdrawal by Subject|43|||
125475613|NCT00450658|451373557|FG001|Overall Study|Withdrawal by Subject|26|||
125475614|NCT00450658|451373556|FG000|Overall Study|Lost to Follow-up|22|||
125475615|NCT00450658|451373557|FG001|Overall Study|Lost to Follow-up|5|||
125475616|NCT00450658|451373556|FG000|Overall Study|UGI ulcer|33|||
125475617|NCT00450658|451373557|FG001|Overall Study|UGI ulcer|34|||
125475618|NCT00450658|451373556|FG000|Overall Study|misc|21|||
125475619|NCT00450658|451373557|FG001|Overall Study|misc|10|||
125475620|NCT04727554|451373560|FG000|Overall Study|Lost to Follow-up|0|||
125475621|NCT04727554|451373561|FG001|Overall Study|Lost to Follow-up|1|||
125475622|NCT04727554|451373560|FG000|Overall Study|Death|2|||
125475623|NCT04727554|451373561|FG001|Overall Study|Death|6|||
125475624|NCT04727554|451373560|FG000|Overall Study|Withdrawal by Subject|1|||
125475625|NCT04727554|451373561|FG001|Overall Study|Withdrawal by Subject|0|||
125475626|NCT05763823|451373562|FG000|Overall Study|Death|6|||
125475627|NCT05763823|451373562|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125475628|NCT05763823|451373562|FG000|Overall Study|Withdrawal by Subject|6|||
125475629|NCT05371652|451373566|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
125475630|NCT05371652|451373566|FG000|Overall Study|Withdrawal by Subject|12|||
125475631|NCT05371652|451373566|FG000|Overall Study|Adverse Event|1|||
125475632|NCT05371652|451373566|FG000|Overall Study|Other|11|||
125475633|NCT05134233|451373571|FG000|Overall Study|Pregnancy|1|||
125475634|NCT05134233|451373571|FG000|Overall Study|MEP value too low|2|||
125475635|NCT05134233|451373571|FG000|Overall Study|Lost to Follow-up|1|||
125475636|NCT01573442|451373572|FG000|Overall Study|Cancels|9|||
125475637|NCT01573442|451373573|FG001|Overall Study|Cancels|10|||
125475638|NCT02724631|451373576|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
125475639|NCT04763265|451373580|FG000|Overall Study|Adverse Event|1|||
125475640|NCT04763265|451373581|FG001|Overall Study|Adverse Event|0|||
125475641|NCT04763265|451373580|FG000|Overall Study|Lost to Follow-up|2|||
125475642|NCT04763265|451373581|FG001|Overall Study|Lost to Follow-up|4|||
125475643|NCT04763265|451373580|FG000|Overall Study|Withdrawal by Subject|0|||
125475644|NCT04763265|451373581|FG001|Overall Study|Withdrawal by Subject|1|||
125475645|NCT05609760|451373594|FG000|Overall Study|Lost to Follow-up|0|||
125475646|NCT05609760|451373595|FG001|Overall Study|Lost to Follow-up|1|||
125475647|NCT05609760|451373594|FG000|Overall Study|Withdrawal by Subject|1|||
125475648|NCT05609760|451373595|FG001|Overall Study|Withdrawal by Subject|0|||
125475649|NCT04049643|451373596|FG000|Overall Study|Lack of Efficacy|1|||
125475650|NCT04049643|451373597|FG001|Overall Study|Lack of Efficacy|1|||
125475651|NCT04049643|451373598|FG002|Overall Study|Lack of Efficacy|0|||
125475652|NCT04049643|451373596|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
125475653|NCT04049643|451373597|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
125475654|NCT04049643|451373598|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
125475655|NCT05089734|451373599|FG000|Overall Study|Still on study|122|||
125475656|NCT05089734|451373600|FG001|Overall Study|Still on study|101|||
125475657|NCT05089734|451373599|FG000|Overall Study|Death|161|||
125475658|NCT05089734|451373600|FG001|Overall Study|Death|179|||
125475659|NCT05089734|451373599|FG000|Overall Study|Withdrew consent|11|||
125475660|NCT05089734|451373600|FG001|Overall Study|Withdrew consent|24|||
125475661|NCT05089734|451373599|FG000|Overall Study|Lost to Follow-up|5|||
125475662|NCT05089734|451373600|FG001|Overall Study|Lost to Follow-up|0|||
125475663|NCT05302596|451373601|FG000|Overall Study|Withdrawal by Subject|1|||
125475664|NCT05302596|451373602|FG001|Overall Study|Withdrawal by Subject|1|||
125475665|NCT04060355|451375245|FG000|Overall Study|Lost to Follow-up|41|||
125475666|NCT01140880|451375250|FG000|Overall Study|Death|0|||
125475667|NCT01140880|451375251|FG001|Overall Study|Death|1|||
125475668|NCT01140880|451375250|FG000|Overall Study|Withdrawal by Subject|6|||
125475669|NCT01140880|451375251|FG001|Overall Study|Withdrawal by Subject|3|||
125475670|NCT01140880|451375250|FG000|Overall Study|Lost to Follow-up|8|||
125475671|NCT01140880|451375251|FG001|Overall Study|Lost to Follow-up|10|||
125475672|NCT01140880|451375250|FG000|Overall Study|Protocol Violation|0|||
125475673|NCT01140880|451375251|FG001|Overall Study|Protocol Violation|30|||
125475674|NCT03131648|451375253|FG000|Initial Treatment Period|Not dosed|2|||
125475675|NCT03131648|451375254|FG001|Initial Treatment Period|Not dosed|2|||
125475676|NCT03131648|451375255|FG002|Initial Treatment Period|Not dosed|0|||
125475677|NCT03131648|451375256|FG003|Initial Treatment Period|Not dosed|0|||
125475678|NCT03131648|451375257|FG004|Initial Treatment Period|Not dosed|0|||
125475679|NCT03131648|451375258|FG005|Initial Treatment Period|Not dosed|0|||
125475680|NCT03131648|451375259|FG006|Initial Treatment Period|Not dosed|0|||
125475681|NCT03131648|451375260|FG007|Initial Treatment Period|Not dosed|0|||
125475682|NCT03131648|451375253|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
125475683|NCT03131648|451375254|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
125475684|NCT03131648|451375255|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
125475685|NCT03131648|451375256|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
125475686|NCT03131648|451375257|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
125475687|NCT03131648|451375258|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
125475688|NCT03131648|451375259|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
125475689|NCT03131648|451375260|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
125475690|NCT03131648|451375253|FG000|Open-label Treatment|Discontinued IMP|0|||
125475691|NCT03131648|451375254|FG001|Open-label Treatment|Discontinued IMP|0|||
125475692|NCT03131648|451375255|FG002|Open-label Treatment|Discontinued IMP|0|||
125475693|NCT03131648|451375256|FG003|Open-label Treatment|Discontinued IMP|0|||
125475694|NCT03131648|451375257|FG004|Open-label Treatment|Discontinued IMP|0|||
125475695|NCT03131648|451375258|FG005|Open-label Treatment|Discontinued IMP|0|||
125475696|NCT03131648|451375259|FG006|Open-label Treatment|Discontinued IMP|112|||
125475697|NCT03131648|451375260|FG007|Open-label Treatment|Discontinued IMP|0|||
125475698|NCT03131648|451375253|FG000|Open-label Treatment|Completed Week 50|0|||
125475699|NCT03131648|451375254|FG001|Open-label Treatment|Completed Week 50|0|||
125475700|NCT03131648|451375255|FG002|Open-label Treatment|Completed Week 50|0|||
125475701|NCT03131648|451375256|FG003|Open-label Treatment|Completed Week 50|0|||
125475702|NCT03131648|451375257|FG004|Open-label Treatment|Completed Week 50|0|||
125475703|NCT03131648|451375258|FG005|Open-label Treatment|Completed Week 50|0|||
125475704|NCT03131648|451375259|FG006|Open-label Treatment|Completed Week 50|6|||
125475705|NCT03131648|451375260|FG007|Open-label Treatment|Completed Week 50|0|||
125475706|NCT03131648|451375253|FG000|Maintenance Treatment Period|Not dosed|0|||
125300172|NCT00704288|450725904|FG002|Overall Treatment Period|Death|1|||
125300173|NCT00704288|450725902|FG000|Overall Treatment Period|Physician Decision|0|||
125300174|NCT00704288|450725903|FG001|Overall Treatment Period|Physician Decision|2|||
125300175|NCT00704288|450725904|FG002|Overall Treatment Period|Physician Decision|0|||
125475707|NCT03131648|451375254|FG001|Maintenance Treatment Period|Not dosed|0|||
125475708|NCT03131648|451375255|FG002|Maintenance Treatment Period|Not dosed|3|||
125475709|NCT03131648|451375256|FG003|Maintenance Treatment Period|Not dosed|2|||
125475710|NCT03131648|451375257|FG004|Maintenance Treatment Period|Not dosed|1|||
125475711|NCT03131648|451375258|FG005|Maintenance Treatment Period|Not dosed|0|||
125475712|NCT03131648|451375259|FG006|Maintenance Treatment Period|Not dosed|0|||
125300176|NCT00704288|450725902|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
125300177|NCT00704288|450725903|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
125300178|NCT00704288|450725904|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
125300179|NCT00704288|450725902|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
125300180|NCT00704288|450725903|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
125300181|NCT00704288|450725904|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
125475713|NCT03131648|451375260|FG007|Maintenance Treatment Period|Not dosed|0|||
125475714|NCT03131648|451375253|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
125475715|NCT03131648|451375254|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
125475716|NCT03131648|451375255|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
125475717|NCT03131648|451375256|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
125475718|NCT03131648|451375257|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
125475719|NCT03131648|451375258|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
125475720|NCT03131648|451375259|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
125475721|NCT03131648|451375260|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
125475722|NCT03131648|451375253|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
125475723|NCT03131648|451375254|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
125475724|NCT03131648|451375255|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
125475725|NCT03131648|451375256|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
125475726|NCT03131648|451375257|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
125475727|NCT03131648|451375258|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
125300182|NCT00704288|450725902|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
125300183|NCT00704288|450725903|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
125475728|NCT03131648|451375259|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
125475729|NCT03131648|451375260|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
125475730|NCT03131648|451375253|FG000|Maintenance Treatment Period|Completed Week 50|0|||
125475731|NCT03131648|451375254|FG001|Maintenance Treatment Period|Completed Week 50|0|||
125475732|NCT03131648|451375255|FG002|Maintenance Treatment Period|Completed Week 50|0|||
125475733|NCT03131648|451375256|FG003|Maintenance Treatment Period|Completed Week 50|0|||
125475734|NCT03131648|451375257|FG004|Maintenance Treatment Period|Completed Week 50|1|||
125475735|NCT03131648|451375258|FG005|Maintenance Treatment Period|Completed Week 50|0|||
125475736|NCT03131648|451375259|FG006|Maintenance Treatment Period|Completed Week 50|0|||
125475737|NCT03131648|451375260|FG007|Maintenance Treatment Period|Completed Week 50|0|||
125475738|NCT03131648|451375253|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
125475739|NCT03131648|451375254|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
125475740|NCT03131648|451375255|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
125475741|NCT03131648|451375256|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
125475742|NCT03131648|451375257|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
125475743|NCT03131648|451375258|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
125475744|NCT03131648|451375259|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
125475745|NCT03131648|451375260|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
125475746|NCT02671903|451375261|FG000|Period 0 (Run-In)|Death|0|||
125475747|NCT02671903|451375262|FG001|Period 0 (Run-In)|Death|0|||
125475748|NCT02671903|451375263|FG002|Period 0 (Run-In)|Death|3|||
125475749|NCT02671903|451375261|FG000|Period 0 (Run-In)|Physician Decision|0|||
125475750|NCT02671903|451375262|FG001|Period 0 (Run-In)|Physician Decision|0|||
125475751|NCT02671903|451375263|FG002|Period 0 (Run-In)|Physician Decision|4|||
125475752|NCT02671903|451375261|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
125475753|NCT02671903|451375262|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
125475754|NCT02671903|451375263|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
125475755|NCT02671903|451375261|FG000|Period 0 (Run-In)|Protocol Violation|0|||
125475756|NCT02671903|451375262|FG001|Period 0 (Run-In)|Protocol Violation|0|||
125475757|NCT02671903|451375263|FG002|Period 0 (Run-In)|Protocol Violation|1|||
125475758|NCT02671903|451375261|FG000|Period 0 (Run-In)|Adverse Event|0|||
125475759|NCT02671903|451375262|FG001|Period 0 (Run-In)|Adverse Event|0|||
125475760|NCT02671903|451375263|FG002|Period 0 (Run-In)|Adverse Event|1|||
125475761|NCT02671903|451375261|FG000|Period 0 (Run-In)|Implantation Failure|0|||
125475762|NCT02671903|451375262|FG001|Period 0 (Run-In)|Implantation Failure|0|||
125475763|NCT02671903|451375263|FG002|Period 0 (Run-In)|Implantation Failure|2|||
125475764|NCT02671903|451375261|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
125475765|NCT02671903|451375262|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
125475766|NCT02671903|451375263|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
125475767|NCT04258709|451375264|FG000|Overall Study|Lost to Follow-up|10|||
125475768|NCT04258709|451375265|FG001|Overall Study|Lost to Follow-up|4|||
125475769|NCT04258709|451375264|FG000|Overall Study|Withdrawal by Subject|1|||
125475770|NCT04258709|451375265|FG001|Overall Study|Withdrawal by Subject|0|||
125475771|NCT04258709|451375264|FG000|Overall Study|Fetal demise|0|||
125475772|NCT04258709|451375265|FG001|Overall Study|Fetal demise|1|||
125475773|NCT04258709|451375264|FG000|Overall Study|Protocol Violation|1|||
125475774|NCT04258709|451375265|FG001|Overall Study|Protocol Violation|1|||
125475775|NCT05633953|451375266|FG000|Overall Study|Adverse Event|7|||
125475776|NCT05633953|451375266|FG000|Overall Study|Death|30|||
125475777|NCT05633953|451375266|FG000|Overall Study|Lost to Follow-up|1|||
125475778|NCT05633953|451375266|FG000|Overall Study|Osilodrostat discontinued|4|||
125475779|NCT05633953|451375266|FG000|Overall Study|Physician Decision|1|||
125475780|NCT05633953|451375266|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
125475781|NCT05633953|451375266|FG000|Overall Study|Progressive disease|2|||
125475782|NCT03047928|451375267|FG000|Overall Study|Adverse Event|0|||
125475783|NCT03047928|451375268|FG001|Overall Study|Adverse Event|2|||
125475784|NCT03047928|451375269|FG002|Overall Study|Adverse Event|0|||
125475785|NCT03047928|451375267|FG000|Overall Study|Protocol Violation|0|||
125475786|NCT03047928|451375268|FG001|Overall Study|Protocol Violation|1|||
125475787|NCT03047928|451375269|FG002|Overall Study|Protocol Violation|0|||
125475788|NCT03047928|451375267|FG000|Overall Study|included in another protocol|0|||
125475789|NCT03047928|451375268|FG001|Overall Study|included in another protocol|1|||
125475790|NCT03047928|451375269|FG002|Overall Study|included in another protocol|0|||
125475791|NCT02729311|451375270|FG000|Overall Study|Withdrawal by Subject|8|||
125475792|NCT02729311|451375271|FG001|Overall Study|Withdrawal by Subject|2|||
125475793|NCT05324124|451375272|FG000|Period 1|Withdrawal by Subject|1|||
125475794|NCT05324124|451375273|FG001|Period 1|Withdrawal by Subject|0|||
125475795|NCT05324124|451375272|FG000|Period 1|Physician Decision|0|||
125475796|NCT05324124|451375273|FG001|Period 1|Physician Decision|1|||
125475797|NCT04034251|451375274|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
125475798|NCT04034251|451375275|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
125475799|NCT04034251|451375276|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
125475800|NCT02287610|451375277|FG000|Overall Study|Lost to Follow-up|3|||
125475801|NCT02287610|451375277|FG000|Overall Study|Withdrawal by Subject|8|||
125475802|NCT02287610|451375277|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
125475803|NCT05273749|451375279|FG000|Overall Study|Adverse Event|14|||
125475804|NCT05273749|451375280|FG001|Overall Study|Adverse Event|8|||
125475805|NCT05273749|451375279|FG000|Overall Study|Lack of Efficacy|2|||
125475806|NCT05273749|451375280|FG001|Overall Study|Lack of Efficacy|8|||
125475807|NCT05273749|451375279|FG000|Overall Study|Physician Decision|0|||
125475808|NCT05273749|451375280|FG001|Overall Study|Physician Decision|2|||
125475809|NCT05273749|451375279|FG000|Overall Study|Withdrawal by Subject|14|||
125475810|NCT05273749|451375280|FG001|Overall Study|Withdrawal by Subject|16|||
125475811|NCT05273749|451375279|FG000|Overall Study|Lost to Follow-up|10|||
125475812|NCT05273749|451375280|FG001|Overall Study|Lost to Follow-up|10|||
125475813|NCT05273749|451375279|FG000|Overall Study|Pregnancy|1|||
125475814|NCT05273749|451375280|FG001|Overall Study|Pregnancy|0|||
125475815|NCT05273749|451375279|FG000|Overall Study|Non-Compliance|3|||
125475816|NCT05273749|451375280|FG001|Overall Study|Non-Compliance|2|||
125475817|NCT05273749|451375279|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
125475818|NCT05273749|451375280|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
125475819|NCT04956861|451375281|FG000|Overall Study|Withdrawal by Subject|4|||
125475820|NCT04956861|451375282|FG001|Overall Study|Withdrawal by Subject|4|||
125475821|NCT04956861|451375283|FG002|Overall Study|Withdrawal by Subject|2|||
125475822|NCT04956861|451375281|FG000|Overall Study|Physician Decision|4|||
125475823|NCT04956861|451375282|FG001|Overall Study|Physician Decision|5|||
125475824|NCT04956861|451375283|FG002|Overall Study|Physician Decision|1|||
125475825|NCT05247489|451375286|FG000|Overall Study|Lost to Follow-up|5|||
125475826|NCT05247489|451375287|FG001|Overall Study|Lost to Follow-up|1|||
125475827|NCT05247489|451375286|FG000|Overall Study|Withdrawal by Subject|6|||
125475828|NCT05247489|451375287|FG001|Overall Study|Withdrawal by Subject|7|||
125475829|NCT05247489|451375286|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
125475830|NCT05247489|451375287|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
125475831|NCT05247489|451375286|FG000|Overall Study|Left Country|1|||
125475832|NCT05247489|451375287|FG001|Overall Study|Left Country|0|||
125475833|NCT05247489|451375286|FG000|Overall Study|Noncompliance with Investigational Product|1|||
125475834|NCT05247489|451375287|FG001|Overall Study|Noncompliance with Investigational Product|0|||
125475835|NCT05247489|451375286|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
125475836|NCT05247489|451375287|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
125475837|NCT03771898|451375288|FG000|Overall Study|Adverse Event|1|||
125475838|NCT03771898|451375289|FG001|Overall Study|Adverse Event|0|||
125475839|NCT03771898|451375290|FG002|Overall Study|Adverse Event|0|||
125475840|NCT03771898|451375291|FG003|Overall Study|Adverse Event|0|||
125475841|NCT03771898|451375292|FG004|Overall Study|Adverse Event|0|||
125475842|NCT03771898|451375288|FG000|Overall Study|Lost to Follow-up|1|||
125475843|NCT03771898|451375289|FG001|Overall Study|Lost to Follow-up|1|||
125475844|NCT03771898|451375290|FG002|Overall Study|Lost to Follow-up|1|||
125475845|NCT03771898|451375291|FG003|Overall Study|Lost to Follow-up|0|||
125475846|NCT03771898|451375292|FG004|Overall Study|Lost to Follow-up|0|||
125475847|NCT03771898|451375288|FG000|Overall Study|Withdrawal by parent/guardian|1|||
125475848|NCT03771898|451375289|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125475849|NCT03771898|451375290|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125475850|NCT03771898|451375291|FG003|Overall Study|Withdrawal by parent/guardian|0|||
125475851|NCT03771898|451375292|FG004|Overall Study|Withdrawal by parent/guardian|0|||
125475852|NCT03771898|451375288|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
125475853|NCT03771898|451375289|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
125475854|NCT03771898|451375290|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
125475855|NCT03771898|451375291|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
125475856|NCT03771898|451375292|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
125475857|NCT04541706|451375293|FG000|Overall Study|Withdrawal by Subject|3|||
125475858|NCT04541706|451375293|FG000|Overall Study|Progressive disease|33|||
125475859|NCT04541706|451375293|FG000|Overall Study|Physician Decision|1|||
125475860|NCT04541706|451375293|FG000|Overall Study|Lost to Follow-up|2|||
125475861|NCT04541706|451375293|FG000|Overall Study|Death|5|||
125475862|NCT04541706|451375293|FG000|Overall Study|Adverse Event|1|||
125475863|NCT05563246|451375294|FG000|Overall Study|Withdrawal by Subject|1|||
125475864|NCT05563246|451375295|FG001|Overall Study|Withdrawal by Subject|2|||
125475865|NCT05563246|451375296|FG002|Overall Study|Withdrawal by Subject|0|||
125475866|NCT05563246|451375297|FG003|Overall Study|Withdrawal by Subject|0|||
125475867|NCT05563246|451375294|FG000|Overall Study|Protocol Deviation|0|||
125475868|NCT05563246|451375295|FG001|Overall Study|Protocol Deviation|1|||
125475869|NCT05563246|451375296|FG002|Overall Study|Protocol Deviation|0|||
125475870|NCT05563246|451375297|FG003|Overall Study|Protocol Deviation|0|||
125475871|NCT05563246|451375294|FG000|Overall Study|Physician Decision|0|||
125475872|NCT05563246|451375295|FG001|Overall Study|Physician Decision|1|||
125475873|NCT05563246|451375296|FG002|Overall Study|Physician Decision|0|||
125475874|NCT05563246|451375297|FG003|Overall Study|Physician Decision|0|||
125475875|NCT05563246|451375294|FG000|Overall Study|Adverse Event|0|||
125475876|NCT05563246|451375295|FG001|Overall Study|Adverse Event|0|||
125475877|NCT05563246|451375296|FG002|Overall Study|Adverse Event|2|||
125475878|NCT05563246|451375297|FG003|Overall Study|Adverse Event|0|||
125475879|NCT05563246|451375294|FG000|Overall Study|Lost to Follow-up|0|||
125475880|NCT05563246|451375295|FG001|Overall Study|Lost to Follow-up|0|||
125475881|NCT05563246|451375296|FG002|Overall Study|Lost to Follow-up|1|||
125475882|NCT05563246|451375297|FG003|Overall Study|Lost to Follow-up|0|||
125475883|NCT01416831|451375300|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
125475884|NCT01416831|451375301|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
125475885|NCT05215314|451375302|FG000|Overall Study|Lost to Follow-up|2|||
125475886|NCT05215314|451375303|FG001|Overall Study|Lost to Follow-up|2|||
125475887|NCT05215314|451375302|FG000|Overall Study|Withdrawal by Subject|2|||
125475888|NCT05215314|451375303|FG001|Overall Study|Withdrawal by Subject|0|||
125475889|NCT05215314|451375302|FG000|Overall Study|Physician Decision|1|||
125475890|NCT05215314|451375303|FG001|Overall Study|Physician Decision|0|||
125475891|NCT04294225|451375308|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
125475892|NCT04294225|451375308|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
125475893|NCT04294225|451375308|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
125475894|NCT04294225|451375308|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
125475895|NCT04294225|451375308|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
125475896|NCT04812535|451375309|FG000|Overall Study|Withdrawal by Subject|0|||
125475897|NCT04812535|451375310|FG001|Overall Study|Withdrawal by Subject|0|||
125475898|NCT04812535|451375311|FG002|Overall Study|Withdrawal by Subject|0|||
125475899|NCT04812535|451375312|FG003|Overall Study|Withdrawal by Subject|1|||
125475900|NCT04812535|451375309|FG000|Overall Study|Death|7|||
125475901|NCT04812535|451375310|FG001|Overall Study|Death|2|||
125475902|NCT04812535|451375311|FG002|Overall Study|Death|4|||
125475903|NCT04812535|451375312|FG003|Overall Study|Death|1|||
125475904|NCT04812535|451375309|FG000|Overall Study|Due to premature study termination by sponsor|2|||
125475905|NCT04812535|451375310|FG001|Overall Study|Due to premature study termination by sponsor|0|||
125475906|NCT04812535|451375311|FG002|Overall Study|Due to premature study termination by sponsor|1|||
125475907|NCT04812535|451375312|FG003|Overall Study|Due to premature study termination by sponsor|3|||
125475908|NCT03336333|451375313|FG000|Overall Study|Remained on study at time of data cut-off|202|||
125475909|NCT03336333|451375314|FG001|Overall Study|Remained on study at time of data cut-off|219|||
125475910|NCT03336333|451375315|FG002|Overall Study|Remained on study at time of data cut-off|102|||
125475911|NCT03336333|451375313|FG000|Overall Study|Death|14|||
125475912|NCT03336333|451375314|FG001|Overall Study|Death|16|||
125475913|NCT03336333|451375315|FG002|Overall Study|Death|8|||
125475914|NCT03336333|451375313|FG000|Overall Study|Withdrawal by Subject|16|||
125475915|NCT03336333|451375314|FG001|Overall Study|Withdrawal by Subject|5|||
125475916|NCT03336333|451375315|FG002|Overall Study|Withdrawal by Subject|1|||
125475917|NCT03336333|451375313|FG000|Overall Study|Physician Decision|5|||
125475918|NCT03336333|451375314|FG001|Overall Study|Physician Decision|1|||
125475919|NCT03336333|451375315|FG002|Overall Study|Physician Decision|0|||
125475920|NCT03336333|451375313|FG000|Overall Study|Lost to Follow-up|1|||
125475921|NCT03336333|451375314|FG001|Overall Study|Lost to Follow-up|0|||
125475922|NCT03336333|451375315|FG002|Overall Study|Lost to Follow-up|0|||
125475923|NCT03623321|451375322|FG000|Overall Study|Adverse Event|32|||
125475924|NCT03623321|451375322|FG000|Overall Study|Death|9|||
125475925|NCT03623321|451375322|FG000|Overall Study|Lack of Efficacy|9|||
125475926|NCT03623321|451375322|FG000|Overall Study|Lost to Follow-up|6|||
125475927|NCT03623321|451375322|FG000|Overall Study|Noncompliance with study drug|6|||
125475928|NCT03623321|451375322|FG000|Overall Study|Use of prohibited medication|3|||
125475929|NCT03623321|451375322|FG000|Overall Study|Physician Decision|5|||
125475930|NCT03623321|451375322|FG000|Overall Study|Protocol Violation|1|||
125475931|NCT03623321|451375322|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
125475932|NCT03623321|451375322|FG000|Overall Study|Not further specified|43|||
125475933|NCT01785719|451375324|FG000|4-week Baseline Evaluation|Physician Decision|1|||
125475934|NCT01785719|451375325|FG001|4-week Baseline Evaluation|Physician Decision|0|||
125475935|NCT01785719|451375324|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
125475936|NCT01785719|451375325|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
125475937|NCT01785719|451375324|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
125475938|NCT01785719|451375325|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
125475939|NCT01785719|451375324|FG000|4-week Baseline Evaluation|Pregnancy|0|||
125475940|NCT01785719|451375325|FG001|4-week Baseline Evaluation|Pregnancy|2|||
125475941|NCT01785719|451375324|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
125475942|NCT01785719|451375325|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
125475943|NCT01785719|451375324|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
125475944|NCT01785719|451375325|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
125475945|NCT01785719|451375324|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
125475946|NCT01785719|451375325|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
125475947|NCT01785719|451375324|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
125475948|NCT01785719|451375325|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
125475949|NCT01785719|451375324|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
125475950|NCT01785719|451375325|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
125475951|NCT01785719|451375324|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
125475952|NCT01785719|451375325|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
125475953|NCT01785719|451375324|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
125475954|NCT01785719|451375325|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
125475955|NCT01785719|451375324|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
125475956|NCT01785719|451375325|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
125475957|NCT01785719|451375324|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
125475958|NCT01785719|451375325|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
125475959|NCT01785719|451375324|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
125475960|NCT01785719|451375325|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
125475961|NCT01785719|451375324|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
125475962|NCT01785719|451375325|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
125475963|NCT03699709|451375337|FG000|Overall Study|Death|1|||
125475964|NCT03699709|451375338|FG001|Overall Study|Death|2|||
125475965|NCT03699709|451375337|FG000|Overall Study|Lost to Follow-up|10|||
125475966|NCT03699709|451375338|FG001|Overall Study|Lost to Follow-up|3|||
125475967|NCT03699709|451375337|FG000|Overall Study|Withdrawal by Subject|5|||
125475968|NCT03699709|451375338|FG001|Overall Study|Withdrawal by Subject|0|||
125475969|NCT03699709|451375337|FG000|Overall Study|incarcerated|1|||
125475970|NCT03699709|451375338|FG001|Overall Study|incarcerated|0|||
125475971|NCT03699709|451375337|FG000|Overall Study|scheduled, but no show|0|||
125475972|NCT03699709|451375338|FG001|Overall Study|scheduled, but no show|1|||
125475973|NCT05368103|451375339|FG000|Overall Study|Withdrawal by Subject|4|||
125475974|NCT05368103|451375339|FG000|Overall Study|Lost to Follow-up|1|||
125475975|NCT05368103|451375339|FG000|Overall Study|Lack of Efficacy|3|||
125475976|NCT04739956|451375350|FG000|Overall Study|Withdrawal by Subject|1|||
125475977|NCT04739956|451375351|FG001|Overall Study|Withdrawal by Subject|1|||
125475978|NCT03519581|451375354|FG000|Overall Study|Lost to Follow-up|3|||
125475979|NCT03519581|451375355|FG001|Overall Study|Lost to Follow-up|2|||
125475980|NCT03519581|451375354|FG000|Overall Study|Adverse Event|5|||
125475981|NCT03519581|451375355|FG001|Overall Study|Adverse Event|2|||
125475982|NCT03519581|451375354|FG000|Overall Study|Withdrawal by Subject|2|||
125475983|NCT03519581|451375355|FG001|Overall Study|Withdrawal by Subject|0|||
125475984|NCT03519581|451375354|FG000|Overall Study|Change to insurance|2|||
125475985|NCT03519581|451375355|FG001|Overall Study|Change to insurance|1|||
125475986|NCT03519581|451375354|FG000|Overall Study|Other|2|||
125475987|NCT03519581|451375355|FG001|Overall Study|Other|4|||
125475988|NCT05268393|451375356|FG000|Overall Study|Withdrawal by Subject|2|||
125475989|NCT05268393|451375357|FG001|Overall Study|Withdrawal by Subject|1|||
125475990|NCT03396926|451375358|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
125475991|NCT03396926|451375359|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
125475992|NCT05256706|451375360|FG000|Overall Study|Lost to Follow-up|9|||
125475993|NCT05256706|451375361|FG001|Overall Study|Lost to Follow-up|3|||
125475994|NCT05256706|451375360|FG000|Overall Study|Withdrawal by Subject|7|||
125475995|NCT05256706|451375361|FG001|Overall Study|Withdrawal by Subject|11|||
125475996|NCT05256706|451375360|FG000|Overall Study|Screen Failures|3|||
125475997|NCT05256706|451375361|FG001|Overall Study|Screen Failures|0|||
125475998|NCT04410042|451375363|FG000|Overall Study|Not Eligible|1|||
125475999|NCT04410042|451375364|FG001|Overall Study|Not Eligible|1|||
125476000|NCT03850678|451375367|FG000|Overall Study|Withdrawal by Subject|3|||
125476001|NCT03850678|451375368|FG001|Overall Study|Withdrawal by Subject|0|||
125476002|NCT03850678|451375367|FG000|Overall Study|Experimenter Error|1|||
125476003|NCT03850678|451375368|FG001|Overall Study|Experimenter Error|1|||
125476004|NCT03850678|451375367|FG000|Overall Study|Did Not Condition To Experiment|7|||
125476005|NCT03850678|451375368|FG001|Overall Study|Did Not Condition To Experiment|2|||
125476006|NCT03720795|451375369|FG000|Phase 1|Lost to Follow-up|4|||
125476007|NCT03720795|451375369|FG000|Phase 1|Withdrawal by Subject|6|||
125476008|NCT03720795|451375369|FG000|Phase 1|Protocol Violation|1|||
125476009|NCT03720795|451375369|FG000|Phase 1|Other|1|||
125476010|NCT03720795|451375369|FG000|Phase 2|Lost to Follow-up|5|||
125476011|NCT03720795|451375369|FG000|Phase 2|Withdrawal by Subject|10|||
125476012|NCT03720795|451375369|FG000|Phase 2|Protocol Violation|2|||
125476013|NCT03720795|451375369|FG000|3 Month Follow Up|Lost to Follow-up|2|||
125476014|NCT03891667|451375370|FG000|Overall Study|Physician Decision|1|||
125476015|NCT03891667|451375371|FG001|Overall Study|Physician Decision|1|||
125476016|NCT03891667|451375370|FG000|Overall Study|COVID related pause|1|||
125476017|NCT03891667|451375371|FG001|Overall Study|COVID related pause|0|||
125476018|NCT03891667|451375370|FG000|Overall Study|Withdrawal by Subject|0|||
125476019|NCT03891667|451375371|FG001|Overall Study|Withdrawal by Subject|1|||
125476020|NCT03891667|451375370|FG000|Overall Study|Adverse Event|0|||
125476021|NCT03891667|451375371|FG001|Overall Study|Adverse Event|1|||
125476022|NCT03302494|451375372|FG000|Overall Study|Other|7|||
125476023|NCT03302494|451375373|FG001|Overall Study|Other|4|||
125476024|NCT03302494|451375374|FG002|Overall Study|Other|6|||
125476025|NCT03302494|451375372|FG000|Overall Study|Withdrawal by Subject|10|||
125476026|NCT03302494|451375373|FG001|Overall Study|Withdrawal by Subject|2|||
125476027|NCT03302494|451375374|FG002|Overall Study|Withdrawal by Subject|9|||
125476028|NCT03302494|451375372|FG000|Overall Study|Study Terminated by Sponsor|32|||
125485381|NCT02240238|451412507|FG004|Phase 1|Withdrawal by Subject|0|||
125476029|NCT03302494|451375373|FG001|Overall Study|Study Terminated by Sponsor|29|||
125476030|NCT03302494|451375374|FG002|Overall Study|Study Terminated by Sponsor|30|||
125476031|NCT03302494|451375372|FG000|Overall Study|Physician Decision|1|||
125476032|NCT03302494|451375373|FG001|Overall Study|Physician Decision|0|||
125476033|NCT03302494|451375374|FG002|Overall Study|Physician Decision|1|||
125476034|NCT03302494|451375372|FG000|Overall Study|Lost to Follow-up|1|||
125476035|NCT03302494|451375373|FG001|Overall Study|Lost to Follow-up|3|||
125476036|NCT03302494|451375374|FG002|Overall Study|Lost to Follow-up|3|||
125476037|NCT03302494|451375372|FG000|Overall Study|Death|13|||
125476038|NCT03302494|451375373|FG001|Overall Study|Death|11|||
125476039|NCT03302494|451375374|FG002|Overall Study|Death|4|||
125476040|NCT03302494|451375372|FG000|Overall Study|Adverse Event|1|||
125476041|NCT03302494|451375373|FG001|Overall Study|Adverse Event|2|||
125476042|NCT03302494|451375374|FG002|Overall Study|Adverse Event|0|||
125476043|NCT03302494|451375372|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
125476044|NCT03302494|451375373|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
125476045|NCT03302494|451375374|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
125476046|NCT05076708|451375376|FG000|Overall Study|Withdrawal by Subject|4|||
125476047|NCT05076708|451375376|FG000|Overall Study|Lost to study during switch phase|8|||
125476048|NCT03269136|451375379|FG000|Part 1: Dose Escalation|Other|0|||
125476049|NCT03269136|451375380|FG001|Part 1: Dose Escalation|Other|0|||
125476050|NCT03269136|451375381|FG002|Part 1: Dose Escalation|Other|0|||
125476051|NCT03269136|451375382|FG003|Part 1: Dose Escalation|Other|0|||
125476052|NCT03269136|451375383|FG004|Part 1: Dose Escalation|Other|0|||
125476053|NCT03269136|451375384|FG005|Part 1: Dose Escalation|Other|0|||
125476054|NCT03269136|451375385|FG006|Part 1: Dose Escalation|Other|0|||
125476055|NCT03269136|451375386|FG007|Part 1: Dose Escalation|Other|0|||
125476056|NCT03269136|451375387|FG008|Part 1: Dose Escalation|Other|0|||
125476057|NCT03269136|451375388|FG009|Part 1: Dose Escalation|Other|0|||
125476058|NCT03269136|451375389|FG010|Part 1: Dose Escalation|Other|1|||
125476059|NCT03269136|451375390|FG011|Part 1: Dose Escalation|Other|1|||
125476060|NCT03269136|451375391|FG012|Part 1: Dose Escalation|Other|1|||
125476061|NCT03269136|451375392|FG013|Part 1: Dose Escalation|Other|0|||
125476062|NCT03269136|451375393|FG014|Part 1: Dose Escalation|Other|3|||
125476063|NCT03269136|451375394|FG015|Part 1: Dose Escalation|Other|1|||
125476064|NCT03269136|451375395|FG016|Part 1: Dose Escalation|Other|1|||
125476065|NCT03269136|451375396|FG017|Part 1: Dose Escalation|Other|0|||
125476066|NCT03269136|451375379|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476067|NCT03269136|451375380|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476068|NCT03269136|451375381|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476069|NCT03269136|451375382|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476070|NCT03269136|451375383|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476071|NCT03269136|451375384|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476072|NCT03269136|451375385|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
125476073|NCT03269136|451375386|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476074|NCT03269136|451375387|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
125476075|NCT03269136|451375388|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476076|NCT03269136|451375389|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476077|NCT03269136|451375390|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476078|NCT03269136|451375391|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
125476079|NCT03269136|451375392|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476080|NCT03269136|451375393|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476081|NCT03269136|451375394|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476082|NCT03269136|451375395|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476083|NCT03269136|451375396|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
125476084|NCT03269136|451375379|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476085|NCT03269136|451375380|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476086|NCT03269136|451375381|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476087|NCT03269136|451375382|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476088|NCT03269136|451375383|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476089|NCT03269136|451375384|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476090|NCT03269136|451375385|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476091|NCT03269136|451375386|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
125476092|NCT03269136|451375387|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476093|NCT03269136|451375388|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476094|NCT03269136|451375389|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476095|NCT03269136|451375390|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476096|NCT03269136|451375391|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476097|NCT03269136|451375392|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476098|NCT03269136|451375393|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476099|NCT03269136|451375394|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125485382|NCT02240238|451412508|FG005|Phase 1|Withdrawal by Subject|2|||
125476100|NCT03269136|451375395|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476101|NCT03269136|451375396|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
125476102|NCT03269136|451375379|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476103|NCT03269136|451375380|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476104|NCT03269136|451375381|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476105|NCT03269136|451375382|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476106|NCT03269136|451375383|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476107|NCT03269136|451375384|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476108|NCT03269136|451375385|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476109|NCT03269136|451375386|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476110|NCT03269136|451375387|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476111|NCT03269136|451375388|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
125476112|NCT03269136|451375389|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476113|NCT03269136|451375390|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476114|NCT03269136|451375391|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476115|NCT03269136|451375392|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476116|NCT03269136|451375393|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476117|NCT03269136|451375394|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476118|NCT03269136|451375395|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476119|NCT03269136|451375396|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
125476120|NCT03269136|451375379|FG000|Part 1: Dose Escalation|Death|0|||
125476121|NCT03269136|451375380|FG001|Part 1: Dose Escalation|Death|0|||
125476122|NCT03269136|451375381|FG002|Part 1: Dose Escalation|Death|0|||
125476123|NCT03269136|451375382|FG003|Part 1: Dose Escalation|Death|0|||
125476124|NCT03269136|451375383|FG004|Part 1: Dose Escalation|Death|0|||
125476125|NCT03269136|451375384|FG005|Part 1: Dose Escalation|Death|0|||
125476126|NCT03269136|451375385|FG006|Part 1: Dose Escalation|Death|0|||
125476127|NCT03269136|451375386|FG007|Part 1: Dose Escalation|Death|0|||
125476128|NCT03269136|451375387|FG008|Part 1: Dose Escalation|Death|0|||
125476129|NCT03269136|451375388|FG009|Part 1: Dose Escalation|Death|1|||
125476130|NCT03269136|451375389|FG010|Part 1: Dose Escalation|Death|0|||
125476131|NCT03269136|451375390|FG011|Part 1: Dose Escalation|Death|1|||
125476132|NCT03269136|451375391|FG012|Part 1: Dose Escalation|Death|0|||
125476133|NCT03269136|451375392|FG013|Part 1: Dose Escalation|Death|1|||
125476134|NCT03269136|451375393|FG014|Part 1: Dose Escalation|Death|0|||
125476135|NCT03269136|451375394|FG015|Part 1: Dose Escalation|Death|0|||
125476136|NCT03269136|451375395|FG016|Part 1: Dose Escalation|Death|2|||
125476137|NCT03269136|451375396|FG017|Part 1: Dose Escalation|Death|0|||
125476138|NCT03269136|451375379|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
125476139|NCT03269136|451375380|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
125476140|NCT03269136|451375381|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
125476141|NCT03269136|451375382|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
125476142|NCT03269136|451375383|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
125476143|NCT03269136|451375384|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
125476144|NCT03269136|451375385|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
125476145|NCT03269136|451375386|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
125476146|NCT03269136|451375387|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
125476147|NCT03269136|451375388|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
125476148|NCT03269136|451375389|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
125476149|NCT03269136|451375390|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
125476150|NCT03269136|451375391|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
125476151|NCT03269136|451375392|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
125476152|NCT03269136|451375393|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
125476153|NCT03269136|451375394|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
125476154|NCT03269136|451375395|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
125476155|NCT03269136|451375396|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
125476156|NCT03269136|451375379|FG000|Part 1: Dose Escalation|Adverse Event|0|||
125476157|NCT03269136|451375380|FG001|Part 1: Dose Escalation|Adverse Event|0|||
125476158|NCT03269136|451375381|FG002|Part 1: Dose Escalation|Adverse Event|0|||
125476159|NCT03269136|451375382|FG003|Part 1: Dose Escalation|Adverse Event|0|||
125476160|NCT03269136|451375383|FG004|Part 1: Dose Escalation|Adverse Event|0|||
125476161|NCT03269136|451375384|FG005|Part 1: Dose Escalation|Adverse Event|0|||
125476162|NCT03269136|451375385|FG006|Part 1: Dose Escalation|Adverse Event|2|||
125476163|NCT03269136|451375386|FG007|Part 1: Dose Escalation|Adverse Event|0|||
125476164|NCT03269136|451375387|FG008|Part 1: Dose Escalation|Adverse Event|0|||
125476165|NCT03269136|451375388|FG009|Part 1: Dose Escalation|Adverse Event|0|||
125476166|NCT03269136|451375389|FG010|Part 1: Dose Escalation|Adverse Event|1|||
125476167|NCT03269136|451375390|FG011|Part 1: Dose Escalation|Adverse Event|2|||
125476168|NCT03269136|451375391|FG012|Part 1: Dose Escalation|Adverse Event|0|||
125476169|NCT03269136|451375392|FG013|Part 1: Dose Escalation|Adverse Event|1|||
125476170|NCT03269136|451375393|FG014|Part 1: Dose Escalation|Adverse Event|0|||
125476171|NCT03269136|451375394|FG015|Part 1: Dose Escalation|Adverse Event|0|||
125476172|NCT03269136|451375395|FG016|Part 1: Dose Escalation|Adverse Event|1|||
125476173|NCT03269136|451375396|FG017|Part 1: Dose Escalation|Adverse Event|0|||
125476174|NCT03269136|451375379|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
125476175|NCT03269136|451375380|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
125476176|NCT03269136|451375381|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
125476177|NCT03269136|451375382|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
125476178|NCT03269136|451375383|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
125476179|NCT03269136|451375384|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
125476180|NCT03269136|451375385|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
125476181|NCT03269136|451375386|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
125476182|NCT03269136|451375387|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
125476183|NCT03269136|451375388|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
125476184|NCT03269136|451375389|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
125476185|NCT03269136|451375390|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
125476186|NCT03269136|451375391|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
125476187|NCT03269136|451375392|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
125476188|NCT03269136|451375393|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
125476189|NCT03269136|451375394|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
125476190|NCT03269136|451375395|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
125476191|NCT03269136|451375396|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
125476192|NCT03269136|451375379|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476193|NCT03269136|451375380|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476194|NCT03269136|451375381|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476195|NCT03269136|451375382|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476196|NCT03269136|451375383|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476197|NCT03269136|451375384|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476198|NCT03269136|451375385|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476199|NCT03269136|451375386|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476200|NCT03269136|451375387|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476201|NCT03269136|451375388|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476202|NCT03269136|451375389|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476203|NCT03269136|451375390|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476204|NCT03269136|451375391|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
125476205|NCT03269136|451375392|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
125476206|NCT03269136|451375393|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
125476207|NCT03269136|451375394|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476208|NCT03269136|451375395|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
125476209|NCT03269136|451375396|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
125476210|NCT03269136|451375379|FG000|Part 2A: Dose Expansion|Other|0|||
125476211|NCT03269136|451375380|FG001|Part 2A: Dose Expansion|Other|0|||
125476212|NCT03269136|451375381|FG002|Part 2A: Dose Expansion|Other|0|||
125476213|NCT03269136|451375382|FG003|Part 2A: Dose Expansion|Other|0|||
125476214|NCT03269136|451375383|FG004|Part 2A: Dose Expansion|Other|0|||
125476215|NCT03269136|451375384|FG005|Part 2A: Dose Expansion|Other|0|||
125476216|NCT03269136|451375385|FG006|Part 2A: Dose Expansion|Other|0|||
125476217|NCT03269136|451375386|FG007|Part 2A: Dose Expansion|Other|0|||
125476218|NCT03269136|451375387|FG008|Part 2A: Dose Expansion|Other|0|||
125476219|NCT03269136|451375388|FG009|Part 2A: Dose Expansion|Other|0|||
125476220|NCT03269136|451375389|FG010|Part 2A: Dose Expansion|Other|0|||
125476221|NCT03269136|451375390|FG011|Part 2A: Dose Expansion|Other|0|||
125476222|NCT03269136|451375391|FG012|Part 2A: Dose Expansion|Other|0|||
125476223|NCT03269136|451375392|FG013|Part 2A: Dose Expansion|Other|0|||
125476224|NCT03269136|451375393|FG014|Part 2A: Dose Expansion|Other|0|||
125476225|NCT03269136|451375394|FG015|Part 2A: Dose Expansion|Other|0|||
125476226|NCT03269136|451375395|FG016|Part 2A: Dose Expansion|Other|0|||
125476227|NCT03269136|451375396|FG017|Part 2A: Dose Expansion|Other|1|||
125476228|NCT03269136|451375379|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476229|NCT03269136|451375380|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476230|NCT03269136|451375381|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476231|NCT03269136|451375382|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476232|NCT03269136|451375383|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476233|NCT03269136|451375384|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476234|NCT03269136|451375385|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476235|NCT03269136|451375386|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476236|NCT03269136|451375387|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476237|NCT03269136|451375388|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476238|NCT03269136|451375389|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476239|NCT03269136|451375390|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476240|NCT03269136|451375391|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476241|NCT03269136|451375392|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476242|NCT03269136|451375393|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476243|NCT03269136|451375394|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476244|NCT03269136|451375395|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
125476245|NCT03269136|451375396|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
125476246|NCT03269136|451375379|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
125476247|NCT03269136|451375380|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
125476248|NCT03269136|451375381|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
125476249|NCT03269136|451375382|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
125476250|NCT03269136|451375383|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
125476251|NCT03269136|451375384|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
125476252|NCT03269136|451375385|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
125476253|NCT03269136|451375386|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
125476254|NCT03269136|451375387|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
125476255|NCT03269136|451375388|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
125476256|NCT03269136|451375389|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
125476257|NCT03269136|451375390|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
125476258|NCT03269136|451375391|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
125476259|NCT03269136|451375392|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
125476260|NCT03269136|451375393|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
125476261|NCT03269136|451375394|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
125476262|NCT03269136|451375395|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
125476263|NCT03269136|451375396|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
125476264|NCT03269136|451375379|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
125476265|NCT03269136|451375380|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
125476266|NCT03269136|451375381|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
125476267|NCT03269136|451375382|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
125476268|NCT03269136|451375383|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
125476269|NCT03269136|451375384|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
125476270|NCT03269136|451375385|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
125476271|NCT03269136|451375386|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
125476272|NCT03269136|451375387|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
125476273|NCT03269136|451375388|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
125476274|NCT03269136|451375389|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
125476275|NCT03269136|451375390|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
125476276|NCT03269136|451375391|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
125476277|NCT03269136|451375392|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
125476278|NCT03269136|451375393|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
125476279|NCT03269136|451375394|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
125476280|NCT03269136|451375395|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
125476281|NCT03269136|451375396|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
125476282|NCT03269136|451375379|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
125476283|NCT03269136|451375380|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
125476284|NCT03269136|451375381|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
125476285|NCT03269136|451375382|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
125476286|NCT03269136|451375383|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
125476287|NCT03269136|451375384|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
125476288|NCT03269136|451375385|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
125476289|NCT03269136|451375386|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
125476290|NCT03269136|451375387|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
125476291|NCT03269136|451375388|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
125476292|NCT03269136|451375389|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
125476293|NCT03269136|451375390|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
125476294|NCT03269136|451375391|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
125476295|NCT03269136|451375392|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
125476296|NCT03269136|451375393|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
125476297|NCT03269136|451375394|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
125476298|NCT03269136|451375395|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
125476299|NCT03269136|451375396|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
125476300|NCT04353661|451377504|FG000|Overall Study|Protocol Violation|0|||
125476301|NCT04353661|451377505|FG001|Overall Study|Protocol Violation|0|||
125476302|NCT04353661|451377506|FG002|Overall Study|Protocol Violation|1|||
125476303|NCT04353661|451377504|FG000|Overall Study|Study termination by the Sponsor|1|||
125476304|NCT04353661|451377505|FG001|Overall Study|Study termination by the Sponsor|1|||
125476305|NCT04353661|451377506|FG002|Overall Study|Study termination by the Sponsor|1|||
125476306|NCT00667251|451377507|FG000|Overall Study|Disease progression|232|||
125476307|NCT00667251|451377508|FG001|Overall Study|Disease progression|203|||
125476308|NCT00667251|451377507|FG000|Overall Study|Toxicity|44|||
125476309|NCT00667251|451377508|FG001|Overall Study|Toxicity|23|||
125476310|NCT00667251|451377507|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
125476311|NCT00667251|451377508|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
125476312|NCT00667251|451377507|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
125476313|NCT00667251|451377508|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
125476314|NCT00667251|451377507|FG000|Overall Study|Symptomatic progression|8|||
125476315|NCT00667251|451377508|FG001|Overall Study|Symptomatic progression|4|||
125476316|NCT00667251|451377507|FG000|Overall Study|Death|6|||
125476317|NCT00667251|451377508|FG001|Overall Study|Death|11|||
125476318|NCT00667251|451377507|FG000|Overall Study|Intercurrent illness|5|||
125476319|NCT00667251|451377508|FG001|Overall Study|Intercurrent illness|6|||
125476320|NCT00667251|451377507|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
125476321|NCT00667251|451377508|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
125476322|NCT00667251|451377507|FG000|Overall Study|Randomized not Treated|4|||
125476323|NCT00667251|451377508|FG001|Overall Study|Randomized not Treated|1|||
125476324|NCT02727699|451377509|FG000|Overall Study|Adverse Event|2|||
125476325|NCT02727699|451377510|FG001|Overall Study|Adverse Event|0|||
125476326|NCT02727699|451377509|FG000|Overall Study|Withdrawal by Subject|5|||
125476327|NCT02727699|451377510|FG001|Overall Study|Withdrawal by Subject|3|||
125476328|NCT02727699|451377509|FG000|Overall Study|Protocol Violation|0|||
125476329|NCT02727699|451377510|FG001|Overall Study|Protocol Violation|1|||
125476330|NCT02727699|451377509|FG000|Overall Study|Physician Decision|0|||
125476331|NCT02727699|451377510|FG001|Overall Study|Physician Decision|1|||
125476332|NCT02727699|451377509|FG000|Overall Study|Lost to Follow-up|1|||
125476333|NCT02727699|451377510|FG001|Overall Study|Lost to Follow-up|0|||
125476334|NCT02727699|451377509|FG000|Overall Study|Sponsor Decision|1|||
125476335|NCT02727699|451377510|FG001|Overall Study|Sponsor Decision|0|||
125476336|NCT02995434|451377511|FG000|Overall Study|Adverse Event|1|||
125476337|NCT02995434|451377512|FG001|Overall Study|Adverse Event|0|||
125476338|NCT02995434|451377511|FG000|Overall Study|Withdrawal by Subject|6|||
125476339|NCT02995434|451377512|FG001|Overall Study|Withdrawal by Subject|3|||
125476340|NCT03779204|451377513|FG000|Overall Study|Lost to Follow-up|2|||
125476341|NCT03779204|451377514|FG001|Overall Study|Lost to Follow-up|0|||
125476342|NCT04318548|451377524|FG000|Overall Study|Adverse Event|0|||
125476343|NCT04318548|451377525|FG001|Overall Study|Adverse Event|0|||
125476344|NCT04318548|451377526|FG002|Overall Study|Adverse Event|1|||
125476345|NCT04318548|451377524|FG000|Overall Study|Lost to Follow-up|6|||
125476346|NCT04318548|451377525|FG001|Overall Study|Lost to Follow-up|13|||
125476347|NCT04318548|451377526|FG002|Overall Study|Lost to Follow-up|9|||
125476348|NCT04318548|451377524|FG000|Overall Study|Protocol Violation|1|||
125476349|NCT04318548|451377525|FG001|Overall Study|Protocol Violation|0|||
125476350|NCT04318548|451377526|FG002|Overall Study|Protocol Violation|2|||
125476351|NCT04318548|451377524|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
125476352|NCT04318548|451377525|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
125476353|NCT04318548|451377526|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
125476354|NCT04318548|451377524|FG000|Overall Study|Migrated / moved from the study area|0|||
125476355|NCT04318548|451377525|FG001|Overall Study|Migrated / moved from the study area|0|||
125476356|NCT04318548|451377526|FG002|Overall Study|Migrated / moved from the study area|1|||
125476357|NCT04318548|451377524|FG000|Overall Study|Other|1|||
125476358|NCT04318548|451377525|FG001|Overall Study|Other|2|||
125476359|NCT04318548|451377526|FG002|Overall Study|Other|3|||
125476360|NCT04179500|451377527|FG000|Treatment|Withdrawal by Subject|1|||
125476361|NCT04179500|451377527|FG000|Treatment|Adverse Event|2|||
125476362|NCT04179500|451377527|FG000|Treatment|pyrazinamide resistance|1|||
125476363|NCT04927065|451377528|FG000|First Booster|Adverse Event|1|||
125476364|NCT04927065|451377529|FG001|First Booster|Adverse Event|0|||
125476365|NCT04927065|451377530|FG002|First Booster|Adverse Event|0|||
125476366|NCT04927065|451377531|FG003|First Booster|Adverse Event|0|||
125476367|NCT04927065|451377532|FG004|First Booster|Adverse Event|0|||
125476368|NCT04927065|451377533|FG005|First Booster|Adverse Event|0|||
125476369|NCT04927065|451377534|FG006|First Booster|Adverse Event|0|||
125476370|NCT04927065|451377535|FG007|First Booster|Adverse Event|1|||
125476371|NCT04927065|451377536|FG008|First Booster|Adverse Event|0|||
125476372|NCT04927065|451377537|FG009|First Booster|Adverse Event|0|||
125476373|NCT04927065|451377538|FG010|First Booster|Adverse Event|0|||
125476374|NCT04927065|451377539|FG011|First Booster|Adverse Event|0|||
125476375|NCT04927065|451377540|FG012|First Booster|Adverse Event|0|||
125476376|NCT04927065|451377541|FG013|First Booster|Adverse Event|0|||
125476377|NCT04927065|451377542|FG014|First Booster|Adverse Event|0|||
125476378|NCT04927065|451377543|FG015|First Booster|Adverse Event|0|||
125476379|NCT04927065|451377528|FG000|First Booster|Death|1|||
125476380|NCT04927065|451377529|FG001|First Booster|Death|0|||
125476381|NCT04927065|451377530|FG002|First Booster|Death|0|||
125476382|NCT04927065|451377531|FG003|First Booster|Death|1|||
125476383|NCT04927065|451377532|FG004|First Booster|Death|0|||
125476384|NCT04927065|451377533|FG005|First Booster|Death|1|||
125476385|NCT04927065|451377534|FG006|First Booster|Death|0|||
125476386|NCT04927065|451377535|FG007|First Booster|Death|0|||
125476387|NCT04927065|451377536|FG008|First Booster|Death|0|||
125476388|NCT04927065|451377537|FG009|First Booster|Death|0|||
125476389|NCT04927065|451377538|FG010|First Booster|Death|0|||
125476390|NCT04927065|451377539|FG011|First Booster|Death|0|||
125476391|NCT04927065|451377540|FG012|First Booster|Death|0|||
125476392|NCT04927065|451377541|FG013|First Booster|Death|0|||
125476393|NCT04927065|451377542|FG014|First Booster|Death|0|||
125476394|NCT04927065|451377543|FG015|First Booster|Death|0|||
125476395|NCT04927065|451377528|FG000|First Booster|Lost to Follow-up|8|||
125476396|NCT04927065|451377529|FG001|First Booster|Lost to Follow-up|20|||
125476397|NCT04927065|451377530|FG002|First Booster|Lost to Follow-up|0|||
125476398|NCT04927065|451377531|FG003|First Booster|Lost to Follow-up|11|||
125476399|NCT04927065|451377532|FG004|First Booster|Lost to Follow-up|43|||
125476400|NCT04927065|451377533|FG005|First Booster|Lost to Follow-up|30|||
125476401|NCT04927065|451377534|FG006|First Booster|Lost to Follow-up|28|||
125476402|NCT04927065|451377535|FG007|First Booster|Lost to Follow-up|23|||
125476403|NCT04927065|451377536|FG008|First Booster|Lost to Follow-up|4|||
125476404|NCT04927065|451377537|FG009|First Booster|Lost to Follow-up|15|||
125476405|NCT04927065|451377538|FG010|First Booster|Lost to Follow-up|0|||
125476406|NCT04927065|451377539|FG011|First Booster|Lost to Follow-up|0|||
125476407|NCT04927065|451377540|FG012|First Booster|Lost to Follow-up|0|||
125476408|NCT04927065|451377541|FG013|First Booster|Lost to Follow-up|0|||
125476409|NCT04927065|451377542|FG014|First Booster|Lost to Follow-up|0|||
125476410|NCT04927065|451377543|FG015|First Booster|Lost to Follow-up|0|||
125476411|NCT04927065|451377528|FG000|First Booster|Physician Decision|1|||
125476412|NCT04927065|451377529|FG001|First Booster|Physician Decision|0|||
125476413|NCT04927065|451377530|FG002|First Booster|Physician Decision|0|||
125476414|NCT04927065|451377531|FG003|First Booster|Physician Decision|3|||
125476415|NCT04927065|451377532|FG004|First Booster|Physician Decision|1|||
125476416|NCT04927065|451377533|FG005|First Booster|Physician Decision|1|||
125476417|NCT04927065|451377534|FG006|First Booster|Physician Decision|0|||
125476418|NCT04927065|451377535|FG007|First Booster|Physician Decision|3|||
125476419|NCT04927065|451377536|FG008|First Booster|Physician Decision|0|||
125476420|NCT04927065|451377537|FG009|First Booster|Physician Decision|0|||
125476421|NCT04927065|451377538|FG010|First Booster|Physician Decision|0|||
125476422|NCT04927065|451377539|FG011|First Booster|Physician Decision|0|||
125476423|NCT04927065|451377540|FG012|First Booster|Physician Decision|0|||
125476424|NCT04927065|451377541|FG013|First Booster|Physician Decision|0|||
125476425|NCT04927065|451377542|FG014|First Booster|Physician Decision|0|||
125476426|NCT04927065|451377543|FG015|First Booster|Physician Decision|0|||
125476427|NCT04927065|451377528|FG000|First Booster|Protocol Violation|4|||
125476428|NCT04927065|451377529|FG001|First Booster|Protocol Violation|4|||
125476429|NCT04927065|451377530|FG002|First Booster|Protocol Violation|0|||
125476430|NCT04927065|451377531|FG003|First Booster|Protocol Violation|3|||
125476431|NCT04927065|451377532|FG004|First Booster|Protocol Violation|0|||
125476432|NCT04927065|451377533|FG005|First Booster|Protocol Violation|0|||
125476433|NCT04927065|451377534|FG006|First Booster|Protocol Violation|0|||
125476434|NCT04927065|451377535|FG007|First Booster|Protocol Violation|2|||
125476435|NCT04927065|451377536|FG008|First Booster|Protocol Violation|0|||
125476436|NCT04927065|451377537|FG009|First Booster|Protocol Violation|0|||
125476437|NCT04927065|451377538|FG010|First Booster|Protocol Violation|0|||
125476438|NCT04927065|451377539|FG011|First Booster|Protocol Violation|0|||
125476439|NCT04927065|451377540|FG012|First Booster|Protocol Violation|0|||
125476440|NCT04927065|451377541|FG013|First Booster|Protocol Violation|0|||
125476441|NCT04927065|451377542|FG014|First Booster|Protocol Violation|0|||
125476442|NCT04927065|451377543|FG015|First Booster|Protocol Violation|0|||
125476443|NCT04927065|451377528|FG000|First Booster|Withdrawal by Subject|8|||
125476444|NCT04927065|451377529|FG001|First Booster|Withdrawal by Subject|23|||
125476445|NCT04927065|451377530|FG002|First Booster|Withdrawal by Subject|0|||
125476446|NCT04927065|451377531|FG003|First Booster|Withdrawal by Subject|19|||
125476447|NCT04927065|451377532|FG004|First Booster|Withdrawal by Subject|20|||
125300184|NCT00704288|450725904|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
125300185|NCT00704288|450725902|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
125300186|NCT00704288|450725903|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
125300187|NCT00704288|450725904|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
125300188|NCT00704288|450725902|FG000|Overall Treatment Period|Roll-over to another study|1|||
125300189|NCT00704288|450725903|FG001|Overall Treatment Period|Roll-over to another study|0|||
125300190|NCT00704288|450725904|FG002|Overall Treatment Period|Roll-over to another study|4|||
125300191|NCT00704288|450725902|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
125300192|NCT00704288|450725903|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
125300193|NCT00704288|450725904|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
125300194|NCT00704288|450725902|FG000|Extended Post Treatment Follow Up Period|Death|41|||
125300195|NCT00704288|450725903|FG001|Extended Post Treatment Follow Up Period|Death|50|||
125300196|NCT00704288|450725904|FG002|Extended Post Treatment Follow Up Period|Death|93|||
125300197|NCT00704288|450725902|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
125300198|NCT00704288|450725903|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
125476448|NCT04927065|451377533|FG005|First Booster|Withdrawal by Subject|15|||
125476449|NCT04927065|451377534|FG006|First Booster|Withdrawal by Subject|6|||
125476450|NCT04927065|451377535|FG007|First Booster|Withdrawal by Subject|24|||
125476451|NCT04927065|451377536|FG008|First Booster|Withdrawal by Subject|0|||
125476452|NCT04927065|451377537|FG009|First Booster|Withdrawal by Subject|4|||
125476453|NCT04927065|451377538|FG010|First Booster|Withdrawal by Subject|0|||
125476454|NCT04927065|451377539|FG011|First Booster|Withdrawal by Subject|0|||
125476455|NCT04927065|451377540|FG012|First Booster|Withdrawal by Subject|0|||
125476456|NCT04927065|451377541|FG013|First Booster|Withdrawal by Subject|0|||
125476457|NCT04927065|451377542|FG014|First Booster|Withdrawal by Subject|0|||
125476458|NCT04927065|451377543|FG015|First Booster|Withdrawal by Subject|0|||
125476459|NCT04927065|451377528|FG000|First Booster|Other Than Specified|1|||
125476460|NCT04927065|451377529|FG001|First Booster|Other Than Specified|1|||
125476461|NCT04927065|451377530|FG002|First Booster|Other Than Specified|0|||
125476462|NCT04927065|451377531|FG003|First Booster|Other Than Specified|1|||
125300199|NCT00704288|450725904|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
125300200|NCT00704288|450725902|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
125300201|NCT00704288|450725903|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
125300202|NCT00704288|450725904|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
125300203|NCT00704288|450725902|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
125300204|NCT00704288|450725903|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
125300205|NCT00704288|450725904|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
125300206|NCT04395690|450725905|FG000|Overall Study|Lost to Follow-up|1|||
125300207|NCT04395690|450725906|FG001|Overall Study|Lost to Follow-up|1|||
125300208|NCT03387020|450725908|FG000|Overall Study|Adverse Event|0|||
125300209|NCT03387020|450725909|FG001|Overall Study|Adverse Event|2|||
125300210|NCT03387020|450725910|FG002|Overall Study|Adverse Event|0|||
125300211|NCT03387020|450725908|FG000|Overall Study|Withdrawal by Subject|2|||
125476463|NCT04927065|451377532|FG004|First Booster|Other Than Specified|2|||
125476464|NCT04927065|451377533|FG005|First Booster|Other Than Specified|3|||
125476465|NCT04927065|451377534|FG006|First Booster|Other Than Specified|2|||
125476466|NCT04927065|451377535|FG007|First Booster|Other Than Specified|6|||
125476467|NCT04927065|451377536|FG008|First Booster|Other Than Specified|0|||
125476468|NCT04927065|451377537|FG009|First Booster|Other Than Specified|4|||
125476469|NCT04927065|451377538|FG010|First Booster|Other Than Specified|0|||
125476470|NCT04927065|451377539|FG011|First Booster|Other Than Specified|0|||
125476471|NCT04927065|451377540|FG012|First Booster|Other Than Specified|0|||
125476472|NCT04927065|451377541|FG013|First Booster|Other Than Specified|0|||
125476473|NCT04927065|451377542|FG014|First Booster|Other Than Specified|0|||
125476474|NCT04927065|451377543|FG015|First Booster|Other Than Specified|0|||
125476475|NCT04927065|451377528|FG000|Second Booster|Death|0|||
125476476|NCT04927065|451377529|FG001|Second Booster|Death|0|||
125476477|NCT04927065|451377530|FG002|Second Booster|Death|0|||
125476478|NCT04927065|451377531|FG003|Second Booster|Death|0|||
125476479|NCT04927065|451377532|FG004|Second Booster|Death|0|||
125476480|NCT04927065|451377533|FG005|Second Booster|Death|0|||
125476481|NCT04927065|451377534|FG006|Second Booster|Death|0|||
125476482|NCT04927065|451377535|FG007|Second Booster|Death|0|||
125476483|NCT04927065|451377536|FG008|Second Booster|Death|0|||
125476484|NCT04927065|451377537|FG009|Second Booster|Death|0|||
125476485|NCT04927065|451377538|FG010|Second Booster|Death|2|||
125476486|NCT04927065|451377539|FG011|Second Booster|Death|0|||
125476487|NCT04927065|451377540|FG012|Second Booster|Death|2|||
125476488|NCT04927065|451377541|FG013|Second Booster|Death|2|||
125476489|NCT04927065|451377542|FG014|Second Booster|Death|0|||
125476490|NCT04927065|451377543|FG015|Second Booster|Death|0|||
125476491|NCT04927065|451377528|FG000|Second Booster|Lost to Follow-up|0|||
125476492|NCT04927065|451377529|FG001|Second Booster|Lost to Follow-up|0|||
125476493|NCT04927065|451377530|FG002|Second Booster|Lost to Follow-up|3|||
125476494|NCT04927065|451377531|FG003|Second Booster|Lost to Follow-up|0|||
125476495|NCT04927065|451377532|FG004|Second Booster|Lost to Follow-up|0|||
125476496|NCT04927065|451377533|FG005|Second Booster|Lost to Follow-up|0|||
125476497|NCT04927065|451377534|FG006|Second Booster|Lost to Follow-up|0|||
125476498|NCT04927065|451377535|FG007|Second Booster|Lost to Follow-up|0|||
125476499|NCT04927065|451377536|FG008|Second Booster|Lost to Follow-up|0|||
125476500|NCT04927065|451377537|FG009|Second Booster|Lost to Follow-up|0|||
125476501|NCT04927065|451377538|FG010|Second Booster|Lost to Follow-up|14|||
125476502|NCT04927065|451377539|FG011|Second Booster|Lost to Follow-up|10|||
125476503|NCT04927065|451377540|FG012|Second Booster|Lost to Follow-up|13|||
125476504|NCT04927065|451377541|FG013|Second Booster|Lost to Follow-up|16|||
125476505|NCT04927065|451377542|FG014|Second Booster|Lost to Follow-up|0|||
125476506|NCT04927065|451377543|FG015|Second Booster|Lost to Follow-up|0|||
125476507|NCT04927065|451377528|FG000|Second Booster|Physician Decision|0|||
125476508|NCT04927065|451377529|FG001|Second Booster|Physician Decision|0|||
125476509|NCT04927065|451377530|FG002|Second Booster|Physician Decision|0|||
125476510|NCT04927065|451377531|FG003|Second Booster|Physician Decision|0|||
125476511|NCT04927065|451377532|FG004|Second Booster|Physician Decision|0|||
125476512|NCT04927065|451377533|FG005|Second Booster|Physician Decision|0|||
125300212|NCT03387020|450725909|FG001|Overall Study|Withdrawal by Subject|0|||
125300213|NCT03387020|450725910|FG002|Overall Study|Withdrawal by Subject|0|||
125476513|NCT04927065|451377534|FG006|Second Booster|Physician Decision|0|||
125476514|NCT04927065|451377535|FG007|Second Booster|Physician Decision|0|||
125476515|NCT04927065|451377536|FG008|Second Booster|Physician Decision|0|||
125476516|NCT04927065|451377537|FG009|Second Booster|Physician Decision|0|||
125476517|NCT04927065|451377538|FG010|Second Booster|Physician Decision|0|||
125476518|NCT04927065|451377539|FG011|Second Booster|Physician Decision|3|||
125476519|NCT04927065|451377540|FG012|Second Booster|Physician Decision|0|||
125476520|NCT04927065|451377541|FG013|Second Booster|Physician Decision|1|||
125476521|NCT04927065|451377542|FG014|Second Booster|Physician Decision|0|||
125476522|NCT04927065|451377543|FG015|Second Booster|Physician Decision|0|||
125300214|NCT00434642|450725911|FG000|Blinded Treatment Phase|Adverse Event|12|||
125476523|NCT04927065|451377528|FG000|Second Booster|Withdrawal by Subject|0|||
125476524|NCT04927065|451377529|FG001|Second Booster|Withdrawal by Subject|0|||
125476525|NCT04927065|451377530|FG002|Second Booster|Withdrawal by Subject|4|||
125476526|NCT04927065|451377531|FG003|Second Booster|Withdrawal by Subject|0|||
125476527|NCT04927065|451377532|FG004|Second Booster|Withdrawal by Subject|0|||
125476528|NCT04927065|451377533|FG005|Second Booster|Withdrawal by Subject|0|||
125476529|NCT04927065|451377534|FG006|Second Booster|Withdrawal by Subject|0|||
125476530|NCT04927065|451377535|FG007|Second Booster|Withdrawal by Subject|0|||
125476531|NCT04927065|451377536|FG008|Second Booster|Withdrawal by Subject|0|||
125476532|NCT04927065|451377537|FG009|Second Booster|Withdrawal by Subject|0|||
125476533|NCT04927065|451377538|FG010|Second Booster|Withdrawal by Subject|3|||
125476534|NCT04927065|451377539|FG011|Second Booster|Withdrawal by Subject|16|||
125476535|NCT04927065|451377540|FG012|Second Booster|Withdrawal by Subject|13|||
125476536|NCT04927065|451377541|FG013|Second Booster|Withdrawal by Subject|9|||
125476537|NCT04927065|451377542|FG014|Second Booster|Withdrawal by Subject|0|||
125476538|NCT04927065|451377543|FG015|Second Booster|Withdrawal by Subject|0|||
125476539|NCT04927065|451377528|FG000|Second Booster|Other Than Specified|0|||
125476540|NCT04927065|451377529|FG001|Second Booster|Other Than Specified|0|||
125476541|NCT04927065|451377530|FG002|Second Booster|Other Than Specified|0|||
125476542|NCT04927065|451377531|FG003|Second Booster|Other Than Specified|0|||
125476543|NCT04927065|451377532|FG004|Second Booster|Other Than Specified|0|||
125476544|NCT04927065|451377533|FG005|Second Booster|Other Than Specified|0|||
125476545|NCT04927065|451377534|FG006|Second Booster|Other Than Specified|0|||
125476546|NCT04927065|451377535|FG007|Second Booster|Other Than Specified|0|||
125476547|NCT04927065|451377536|FG008|Second Booster|Other Than Specified|0|||
125476548|NCT04927065|451377537|FG009|Second Booster|Other Than Specified|0|||
125476549|NCT04927065|451377538|FG010|Second Booster|Other Than Specified|1|||
125476550|NCT04927065|451377539|FG011|Second Booster|Other Than Specified|1|||
125476551|NCT04927065|451377540|FG012|Second Booster|Other Than Specified|4|||
125476552|NCT04927065|451377541|FG013|Second Booster|Other Than Specified|0|||
125476553|NCT04927065|451377542|FG014|Second Booster|Other Than Specified|0|||
125476554|NCT04927065|451377543|FG015|Second Booster|Other Than Specified|0|||
125476555|NCT04927065|451377528|FG000|Third Booster|Lost to Follow-up|0|||
125476556|NCT04927065|451377529|FG001|Third Booster|Lost to Follow-up|0|||
125476557|NCT04927065|451377530|FG002|Third Booster|Lost to Follow-up|0|||
125476558|NCT04927065|451377531|FG003|Third Booster|Lost to Follow-up|0|||
125476559|NCT04927065|451377532|FG004|Third Booster|Lost to Follow-up|0|||
125476560|NCT04927065|451377533|FG005|Third Booster|Lost to Follow-up|0|||
125476561|NCT04927065|451377534|FG006|Third Booster|Lost to Follow-up|0|||
125476562|NCT04927065|451377535|FG007|Third Booster|Lost to Follow-up|0|||
125476563|NCT04927065|451377536|FG008|Third Booster|Lost to Follow-up|0|||
125476564|NCT04927065|451377537|FG009|Third Booster|Lost to Follow-up|0|||
125476565|NCT04927065|451377538|FG010|Third Booster|Lost to Follow-up|0|||
125476566|NCT04927065|451377539|FG011|Third Booster|Lost to Follow-up|0|||
125476567|NCT04927065|451377540|FG012|Third Booster|Lost to Follow-up|0|||
125476568|NCT04927065|451377541|FG013|Third Booster|Lost to Follow-up|0|||
125476569|NCT04927065|451377542|FG014|Third Booster|Lost to Follow-up|0|||
125476570|NCT04927065|451377543|FG015|Third Booster|Lost to Follow-up|1|||
125476571|NCT04927065|451377528|FG000|Third Booster|Withdrawal by Subject|0|||
125476572|NCT04927065|451377529|FG001|Third Booster|Withdrawal by Subject|0|||
125476573|NCT04927065|451377530|FG002|Third Booster|Withdrawal by Subject|0|||
125476574|NCT04927065|451377531|FG003|Third Booster|Withdrawal by Subject|0|||
125476575|NCT04927065|451377532|FG004|Third Booster|Withdrawal by Subject|0|||
125476576|NCT04927065|451377533|FG005|Third Booster|Withdrawal by Subject|0|||
125476577|NCT04927065|451377534|FG006|Third Booster|Withdrawal by Subject|0|||
125476578|NCT04927065|451377535|FG007|Third Booster|Withdrawal by Subject|0|||
125476579|NCT04927065|451377536|FG008|Third Booster|Withdrawal by Subject|0|||
125476580|NCT04927065|451377537|FG009|Third Booster|Withdrawal by Subject|0|||
125476581|NCT04927065|451377538|FG010|Third Booster|Withdrawal by Subject|0|||
125476582|NCT04927065|451377539|FG011|Third Booster|Withdrawal by Subject|0|||
125476583|NCT04927065|451377540|FG012|Third Booster|Withdrawal by Subject|0|||
125476584|NCT04927065|451377541|FG013|Third Booster|Withdrawal by Subject|0|||
125476585|NCT04927065|451377542|FG014|Third Booster|Withdrawal by Subject|0|||
125476586|NCT04927065|451377543|FG015|Third Booster|Withdrawal by Subject|1|||
125476587|NCT04241068|451377546|FG000|Core Treatment Period|Adverse Event|91|||
125476588|NCT04241068|451377546|FG000|Core Treatment Period|Change of Treatment|4|||
125476589|NCT04241068|451377546|FG000|Core Treatment Period|Consent Withdrawn|143|||
125476590|NCT04241068|451377546|FG000|Core Treatment Period|Death|26|||
125476591|NCT04241068|451377546|FG000|Core Treatment Period|Disease Progression|67|||
125476592|NCT04241068|451377546|FG000|Core Treatment Period|Investigator Decision|40|||
125476593|NCT04241068|451377546|FG000|Core Treatment Period|Loss of Capacity|9|||
125476594|NCT04241068|451377546|FG000|Core Treatment Period|Lost to Follow-up|11|||
125476595|NCT04241068|451377546|FG000|Core Treatment Period|Relocation|4|||
125476596|NCT04241068|451377546|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
125476597|NCT04241068|451377546|FG000|Core Treatment Period|Study Visit Burden|40|||
125476598|NCT04241068|451377546|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
125476599|NCT04241068|451377546|FG000|Core Treatment Period|Missing|2|||
125476600|NCT04241068|451377546|FG000|Core Treatment Period|Reason Not Specified|41|||
125476601|NCT04241068|451377546|FG000|LTE Period|Adverse Event|19|||
125476602|NCT04241068|451377546|FG000|LTE Period|Change of Treatment|1|||
125476603|NCT04241068|451377546|FG000|LTE Period|Consent Withdrawn|71|||
125476604|NCT04241068|451377546|FG000|LTE Period|Death|8|||
125476605|NCT04241068|451377546|FG000|LTE Period|Disease Progression|11|||
125476606|NCT04241068|451377546|FG000|LTE Period|Investigator Decision|12|||
125476607|NCT04241068|451377546|FG000|LTE Period|Loss of Capacity|2|||
125476608|NCT04241068|451377546|FG000|LTE Period|Lost to Follow-up|7|||
125476609|NCT04241068|451377546|FG000|LTE Period|Relocation|6|||
125476610|NCT04241068|451377546|FG000|LTE Period|Site Terminated by Sponsor|26|||
125476611|NCT04241068|451377546|FG000|LTE Period|Study Terminated by Sponsor|276|||
125476612|NCT04241068|451377546|FG000|LTE Period|Study Visit Burden|10|||
125476613|NCT04241068|451377546|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
125476614|NCT04241068|451377546|FG000|LTE Period|Reason Not Specified|65|||
125476615|NCT04492007|451377547|FG000|Overall Study|Lost to Follow-up|1|||
125476616|NCT04492007|451377548|FG001|Overall Study|Lost to Follow-up|1|||
125476617|NCT04492007|451377549|FG002|Overall Study|Lost to Follow-up|2|||
125476618|NCT04492007|451377550|FG003|Overall Study|Lost to Follow-up|2|||
125476619|NCT04492007|451377547|FG000|Overall Study|Protocol Violation|1|||
125476620|NCT04492007|451377548|FG001|Overall Study|Protocol Violation|1|||
125476621|NCT04492007|451377549|FG002|Overall Study|Protocol Violation|1|||
125476622|NCT04492007|451377550|FG003|Overall Study|Protocol Violation|1|||
125476623|NCT04492007|451377547|FG000|Overall Study|Withdrawal by Subject|0|||
125476624|NCT04492007|451377548|FG001|Overall Study|Withdrawal by Subject|0|||
125476625|NCT04492007|451377549|FG002|Overall Study|Withdrawal by Subject|1|||
125476626|NCT04492007|451377550|FG003|Overall Study|Withdrawal by Subject|1|||
125476627|NCT04347161|451377551|FG000|Overall Study|Death|0|||
125476628|NCT04347161|451377552|FG001|Overall Study|Death|2|||
125476629|NCT04347161|451377551|FG000|Overall Study|Withdrawal by Subject|1|||
125476630|NCT04347161|451377552|FG001|Overall Study|Withdrawal by Subject|0|||
125476631|NCT04347161|451377551|FG000|Overall Study|Lost to Follow-up|0|||
125476632|NCT04347161|451377552|FG001|Overall Study|Lost to Follow-up|1|||
125476633|NCT04347161|451377551|FG000|Overall Study|No longer on study medication|1|||
125476634|NCT04347161|451377552|FG001|Overall Study|No longer on study medication|1|||
125476635|NCT04169373|451377553|FG000|Week 1 to Week 14|Adverse Event|1|||
125476636|NCT04169373|451377554|FG001|Week 1 to Week 14|Adverse Event|0|||
125476637|NCT04169373|451377555|FG002|Week 1 to Week 14|Adverse Event|1|||
125476638|NCT04169373|451377556|FG003|Week 1 to Week 14|Adverse Event|2|||
125476639|NCT04169373|451377553|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
125476640|NCT04169373|451377554|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
125476641|NCT04169373|451377555|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
125476642|NCT04169373|451377556|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
125476643|NCT04169373|451377553|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
125476644|NCT04169373|451377554|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
125476645|NCT04169373|451377555|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
125476646|NCT04169373|451377556|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
125476647|NCT04169373|451377553|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
125476648|NCT04169373|451377554|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
125476649|NCT04169373|451377555|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
125476650|NCT04169373|451377556|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
125476651|NCT04169373|451377553|FG000|Week 1 to Week 14|Other|1|||
125476652|NCT04169373|451377554|FG001|Week 1 to Week 14|Other|3|||
125476653|NCT04169373|451377555|FG002|Week 1 to Week 14|Other|3|||
125476654|NCT04169373|451377556|FG003|Week 1 to Week 14|Other|5|||
125476655|NCT04169373|451377553|FG000|Week 14 to Week 52|Adverse Event|1|||
125476656|NCT04169373|451377554|FG001|Week 14 to Week 52|Adverse Event|0|||
125476657|NCT04169373|451377555|FG002|Week 14 to Week 52|Adverse Event|0|||
125476658|NCT04169373|451377556|FG003|Week 14 to Week 52|Adverse Event|1|||
125476659|NCT04169373|451377553|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
125476660|NCT04169373|451377554|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
125476661|NCT04169373|451377555|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
125476662|NCT04169373|451377556|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
125476663|NCT04169373|451377553|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
125476664|NCT04169373|451377554|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
125476665|NCT04169373|451377555|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
125476666|NCT04169373|451377556|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
125476667|NCT04169373|451377553|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
125476668|NCT04169373|451377554|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
125476669|NCT04169373|451377555|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
125476670|NCT04169373|451377556|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
125476671|NCT04169373|451377553|FG000|Week 14 to Week 52|Other|4|||
125476672|NCT04169373|451377554|FG001|Week 14 to Week 52|Other|5|||
125476673|NCT04169373|451377555|FG002|Week 14 to Week 52|Other|4|||
125476674|NCT04169373|451377556|FG003|Week 14 to Week 52|Other|5|||
125476675|NCT04169373|451377553|FG000|Week 14 to Week 52|Ongoing|0|||
125476676|NCT04169373|451377554|FG001|Week 14 to Week 52|Ongoing|1|||
125476677|NCT04169373|451377555|FG002|Week 14 to Week 52|Ongoing|0|||
125476678|NCT04169373|451377556|FG003|Week 14 to Week 52|Ongoing|0|||
125476679|NCT01999075|451377559|FG000|Overall Study|Lost to Follow-up|0|||
125476680|NCT01999075|451377560|FG001|Overall Study|Lost to Follow-up|2|||
125476681|NCT01999075|451377559|FG000|Overall Study|Withdrawal by Subject|2|||
125476682|NCT01999075|451377560|FG001|Overall Study|Withdrawal by Subject|7|||
125476683|NCT01999075|451377559|FG000|Overall Study|Enrolled in drug trial|3|||
125476684|NCT01999075|451377560|FG001|Overall Study|Enrolled in drug trial|1|||
125476685|NCT01999075|451377559|FG000|Overall Study|Became ineligible|0|||
125476686|NCT01999075|451377560|FG001|Overall Study|Became ineligible|2|||
125476687|NCT01413100|451377562|FG000|Overall Study|Withdrawal by Subject|1|||
125476688|NCT05369403|451377563|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
125476689|NCT05369403|451377564|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
125476690|NCT05369403|451377565|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
125476691|NCT05369403|451377563|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
125476692|NCT05369403|451377564|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
125476693|NCT05369403|451377565|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
125476694|NCT05369403|451377563|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
125476695|NCT05369403|451377564|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
125476696|NCT05369403|451377565|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
125476697|NCT05369403|451377563|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
125476698|NCT05369403|451377564|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
125476699|NCT05369403|451377565|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
125476700|NCT05369403|451377563|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
125476701|NCT05369403|451377564|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
125476702|NCT05369403|451377565|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
125476703|NCT05369403|451377563|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
125476704|NCT05369403|451377564|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
125476705|NCT05369403|451377565|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
125476706|NCT05369403|451377563|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
125476707|NCT05369403|451377564|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
125476708|NCT05369403|451377565|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
125476709|NCT05369403|451377563|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
125476710|NCT05369403|451377564|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
125476711|NCT05369403|451377565|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
125476712|NCT05369403|451377563|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
125476713|NCT05369403|451377564|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
125476714|NCT05369403|451377565|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
125476715|NCT05369403|451377563|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
125476716|NCT05369403|451377564|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
125476717|NCT05369403|451377565|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
125476718|NCT05369403|451377563|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
125476719|NCT05369403|451377564|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
125476720|NCT05369403|451377565|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
125476721|NCT05948670|451377568|FG000|Overall Study|Protocol Violation|6|||
125476722|NCT05948670|451377569|FG001|Overall Study|Protocol Violation|8|||
125476723|NCT05948670|451377568|FG000|Overall Study|Withdrawal by Subject|0|||
125476724|NCT05948670|451377569|FG001|Overall Study|Withdrawal by Subject|1|||
125476725|NCT02907099|451377570|FG000|Overall Study|Adverse Event|1|||
125476726|NCT02907099|451377570|FG000|Overall Study|Withdrawal by Subject|2|||
125476727|NCT02907099|451377570|FG000|Overall Study|Screen Fail|2|||
125476728|NCT04562649|451377572|FG000|Overall Study|Withdrawal by Subject|11|||
125476729|NCT04562649|451377573|FG001|Overall Study|Withdrawal by Subject|8|||
125476730|NCT04562649|451377572|FG000|Overall Study|Lost to Follow-up|26|||
125476731|NCT04562649|451377573|FG001|Overall Study|Lost to Follow-up|20|||
125476732|NCT03675282|451377574|FG000|Overall Study|Lost to Follow-up|4|||
125476733|NCT03675282|451377575|FG001|Overall Study|Lost to Follow-up|8|||
125476734|NCT03675282|451377576|FG002|Overall Study|Lost to Follow-up|1|||
125476735|NCT03675282|451377577|FG003|Overall Study|Lost to Follow-up|0|||
125476736|NCT03675282|451377578|FG004|Overall Study|Lost to Follow-up|2|||
125476737|NCT03675282|451377579|FG005|Overall Study|Lost to Follow-up|7|||
125476738|NCT03675282|451377574|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
125476739|NCT03675282|451377575|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
125476740|NCT03675282|451377576|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
125300215|NCT00434642|450725912|FG001|Blinded Treatment Phase|Adverse Event|58|||
125300216|NCT00434642|450725911|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
125300217|NCT00434642|450725912|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
125300218|NCT00434642|450725911|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
125300219|NCT00434642|450725912|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
125300220|NCT00434642|450725911|FG000|Blinded Treatment Phase|Physician Decision|19|||
125300221|NCT00434642|450725912|FG001|Blinded Treatment Phase|Physician Decision|27|||
125300222|NCT00434642|450725911|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
125300223|NCT00434642|450725912|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
125476741|NCT03675282|451377577|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
125476742|NCT03675282|451377578|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
125476743|NCT03675282|451377579|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
125476744|NCT03675282|451377574|FG000|Overall Study|Physician Decision|1|||
125476745|NCT03675282|451377575|FG001|Overall Study|Physician Decision|0|||
125476746|NCT03675282|451377576|FG002|Overall Study|Physician Decision|0|||
125476747|NCT03675282|451377577|FG003|Overall Study|Physician Decision|0|||
125476748|NCT03675282|451377578|FG004|Overall Study|Physician Decision|0|||
125476749|NCT03675282|451377579|FG005|Overall Study|Physician Decision|0|||
125476750|NCT03056040|451377583|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
125476751|NCT03056040|451377584|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
125476752|NCT03056040|451377583|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
125476753|NCT03056040|451377584|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
125476754|NCT03056040|451377583|FG000|Primary Evaluation Period|Pregnancy|0|||
125476755|NCT03056040|451377584|FG001|Primary Evaluation Period|Pregnancy|1|||
125476756|NCT03056040|451377583|FG000|Primary Evaluation Period|Randomized, not treated|1|||
125476757|NCT03056040|451377584|FG001|Primary Evaluation Period|Randomized, not treated|1|||
125476758|NCT03056040|451377583|FG000|Extension Period|Physician Decision|3|||
125476759|NCT03056040|451377584|FG001|Extension Period|Physician Decision|3|||
125476760|NCT03056040|451377583|FG000|Extension Period|Lost to Follow-up|0|||
125476761|NCT03056040|451377584|FG001|Extension Period|Lost to Follow-up|1|||
125476762|NCT03056040|451377583|FG000|Extension Period|Death|0|||
125476763|NCT03056040|451377584|FG001|Extension Period|Death|3|||
125476764|NCT03056040|451377583|FG000|Extension Period|Withdrawal by Subject|1|||
125476765|NCT03056040|451377584|FG001|Extension Period|Withdrawal by Subject|0|||
125476766|NCT04977947|451377585|FG000|Overall Study|Lost to Follow-up|1|||
125476767|NCT04977947|451377586|FG001|Overall Study|Lost to Follow-up|1|||
125476768|NCT04029688|451377587|FG000|Overall Study|Death|8|||
125476769|NCT04029688|451377588|FG001|Overall Study|Death|3|||
125476770|NCT04029688|451377589|FG002|Overall Study|Death|6|||
125476771|NCT04029688|451377590|FG003|Overall Study|Death|2|||
125476772|NCT04029688|451377591|FG004|Overall Study|Death|5|||
125476773|NCT04029688|451377592|FG005|Overall Study|Death|0|||
125476774|NCT04029688|451377593|FG006|Overall Study|Death|2|||
125476775|NCT04029688|451377594|FG007|Overall Study|Death|3|||
125476776|NCT04029688|451377587|FG000|Overall Study|Study Terminated by Sponsor|0|||
125476777|NCT04029688|451377588|FG001|Overall Study|Study Terminated by Sponsor|0|||
125476778|NCT04029688|451377589|FG002|Overall Study|Study Terminated by Sponsor|0|||
125476779|NCT04029688|451377590|FG003|Overall Study|Study Terminated by Sponsor|0|||
125476780|NCT04029688|451377591|FG004|Overall Study|Study Terminated by Sponsor|1|||
125476781|NCT04029688|451377592|FG005|Overall Study|Study Terminated by Sponsor|3|||
125476782|NCT04029688|451377593|FG006|Overall Study|Study Terminated by Sponsor|1|||
125476783|NCT04029688|451377594|FG007|Overall Study|Study Terminated by Sponsor|3|||
125476784|NCT04029688|451377587|FG000|Overall Study|Withdrawal by Subject|0|||
125476785|NCT04029688|451377588|FG001|Overall Study|Withdrawal by Subject|0|||
125476786|NCT04029688|451377589|FG002|Overall Study|Withdrawal by Subject|0|||
125476787|NCT04029688|451377590|FG003|Overall Study|Withdrawal by Subject|1|||
125476788|NCT04029688|451377591|FG004|Overall Study|Withdrawal by Subject|0|||
125476789|NCT04029688|451377592|FG005|Overall Study|Withdrawal by Subject|0|||
125476790|NCT04029688|451377593|FG006|Overall Study|Withdrawal by Subject|0|||
125476791|NCT04029688|451377594|FG007|Overall Study|Withdrawal by Subject|0|||
125476792|NCT05875142|451377595|FG000|Overall Study|Lost to Follow-up|0|||
125476793|NCT05875142|451377596|FG001|Overall Study|Lost to Follow-up|1|||
125476794|NCT05875142|451377597|FG002|Overall Study|Lost to Follow-up|1|||
125476795|NCT05784662|451377598|FG000|Overall Study|Lost to Follow-up|21|||
125476796|NCT05784662|451377599|FG001|Overall Study|Lost to Follow-up|17|||
125476797|NCT04274764|451377600|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
125476798|NCT04274764|451377601|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
125476799|NCT02677298|451377602|FG000|Double Blind Phase|Adverse Event|2|||
125476800|NCT02677298|451377603|FG001|Double Blind Phase|Adverse Event|1|||
125476801|NCT02677298|451377604|FG002|Double Blind Phase|Adverse Event|0|||
125476802|NCT02677298|451377602|FG000|Double Blind Phase|Physician Decision|5|||
125476803|NCT02677298|451377603|FG001|Double Blind Phase|Physician Decision|0|||
125476804|NCT02677298|451377604|FG002|Double Blind Phase|Physician Decision|0|||
125476805|NCT02677298|451377602|FG000|Double Blind Phase|Lost to Follow-up|11|||
125476806|NCT02677298|451377603|FG001|Double Blind Phase|Lost to Follow-up|7|||
125476807|NCT02677298|451377604|FG002|Double Blind Phase|Lost to Follow-up|0|||
125476808|NCT02677298|451377602|FG000|Double Blind Phase|Withdrawal by Subject|11|||
125476809|NCT02677298|451377603|FG001|Double Blind Phase|Withdrawal by Subject|8|||
125476810|NCT02677298|451377604|FG002|Double Blind Phase|Withdrawal by Subject|0|||
125476811|NCT02677298|451377602|FG000|Double Blind Phase|No study drug available at site|0|||
125476812|NCT02677298|451377603|FG001|Double Blind Phase|No study drug available at site|1|||
125476813|NCT02677298|451377604|FG002|Double Blind Phase|No study drug available at site|0|||
125476814|NCT02677298|451377602|FG000|Open Label Phase|Adverse Event|0|||
125476815|NCT02677298|451377603|FG001|Open Label Phase|Adverse Event|0|||
125476816|NCT02677298|451377604|FG002|Open Label Phase|Adverse Event|4|||
125476817|NCT02677298|451377602|FG000|Open Label Phase|Physician Decision|0|||
125476818|NCT02677298|451377603|FG001|Open Label Phase|Physician Decision|0|||
125476819|NCT02677298|451377604|FG002|Open Label Phase|Physician Decision|1|||
125476820|NCT02677298|451377602|FG000|Open Label Phase|Lost to Follow-up|0|||
125476821|NCT02677298|451377603|FG001|Open Label Phase|Lost to Follow-up|0|||
125476822|NCT02677298|451377604|FG002|Open Label Phase|Lost to Follow-up|17|||
125476823|NCT02677298|451377602|FG000|Open Label Phase|Withdrawal by Subject|0|||
125476824|NCT02677298|451377603|FG001|Open Label Phase|Withdrawal by Subject|0|||
125476825|NCT02677298|451377604|FG002|Open Label Phase|Withdrawal by Subject|38|||
125476826|NCT03611621|451377605|FG000|Overall Study|Graft loss|3|||
125476827|NCT03611621|451377605|FG000|Overall Study|Death|3|||
125476828|NCT03611621|451377605|FG000|Overall Study|Lost to Follow-up|1|||
125476829|NCT03039023|451377619|FG000|Overall Study|Withdrawal by Subject|1|||
125476830|NCT03039023|451377620|FG001|Overall Study|Withdrawal by Subject|0|||
125476831|NCT03039023|451377621|FG002|Overall Study|Withdrawal by Subject|1|||
125476832|NCT03039023|451377622|FG003|Overall Study|Withdrawal by Subject|1|||
125476833|NCT03039023|451377623|FG004|Overall Study|Withdrawal by Subject|0|||
125476834|NCT03039023|451377619|FG000|Overall Study|Physician Decision|0|||
125476835|NCT03039023|451377620|FG001|Overall Study|Physician Decision|0|||
125476836|NCT03039023|451377621|FG002|Overall Study|Physician Decision|0|||
125476837|NCT03039023|451377622|FG003|Overall Study|Physician Decision|1|||
125476838|NCT03039023|451377623|FG004|Overall Study|Physician Decision|0|||
125476839|NCT04130438|451377624|FG000|Overall Study|Lost to Follow-up|0|||
125476840|NCT04130438|451377625|FG001|Overall Study|Lost to Follow-up|0|||
125476841|NCT04130438|451377626|FG002|Overall Study|Lost to Follow-up|1|||
125476842|NCT04764448|451377628|FG000|Overall Study|Study terminated by sponsor|2|||
125476843|NCT04764448|451377629|FG001|Overall Study|Study terminated by sponsor|2|||
125476844|NCT04764448|451377630|FG002|Overall Study|Study terminated by sponsor|5|||
125476845|NCT04764448|451377628|FG000|Overall Study|Withdrawal by Subject|3|||
125476846|NCT04764448|451377629|FG001|Overall Study|Withdrawal by Subject|3|||
125476847|NCT04764448|451377630|FG002|Overall Study|Withdrawal by Subject|1|||
125476848|NCT01997840|451377631|FG000|Overall Study|Lost to Follow-up|0|||
125476849|NCT01997840|451377632|FG001|Overall Study|Lost to Follow-up|0|||
125476850|NCT01997840|451377633|FG002|Overall Study|Lost to Follow-up|1|||
125476851|NCT01997840|451377634|FG003|Overall Study|Lost to Follow-up|0|||
125476852|NCT01997840|451377631|FG000|Overall Study|Withdrawal by participant|0|||
125476853|NCT01997840|451377632|FG001|Overall Study|Withdrawal by participant|0|||
125476854|NCT01997840|451377633|FG002|Overall Study|Withdrawal by participant|8|||
125476855|NCT01997840|451377634|FG003|Overall Study|Withdrawal by participant|1|||
125476856|NCT01997840|451377631|FG000|Overall Study|Physician Decision|0|||
125476857|NCT01997840|451377632|FG001|Overall Study|Physician Decision|0|||
125476858|NCT01997840|451377633|FG002|Overall Study|Physician Decision|3|||
125476859|NCT01997840|451377634|FG003|Overall Study|Physician Decision|0|||
125476860|NCT01997840|451377631|FG000|Overall Study|Progressive disease|3|||
125476861|NCT01997840|451377632|FG001|Overall Study|Progressive disease|4|||
125476862|NCT01997840|451377633|FG002|Overall Study|Progressive disease|57|||
125476863|NCT01997840|451377634|FG003|Overall Study|Progressive disease|8|||
125476864|NCT01997840|451377631|FG000|Overall Study|Other reasons|0|||
125476865|NCT01997840|451377632|FG001|Overall Study|Other reasons|0|||
125476866|NCT01997840|451377633|FG002|Overall Study|Other reasons|1|||
125476867|NCT01997840|451377634|FG003|Overall Study|Other reasons|0|||
125476868|NCT01997840|451377631|FG000|Overall Study|Adverse Event|0|||
125476869|NCT01997840|451377632|FG001|Overall Study|Adverse Event|0|||
125476870|NCT01997840|451377633|FG002|Overall Study|Adverse Event|15|||
125476871|NCT01997840|451377634|FG003|Overall Study|Adverse Event|2|||
125476872|NCT01494662|451377642|FG000|Overall Study|Withdrawal by Subject|0|||
125476873|NCT01494662|451377643|FG001|Overall Study|Withdrawal by Subject|0|||
125476874|NCT01494662|451377644|FG002|Overall Study|Withdrawal by Subject|1|||
125476875|NCT01494662|451377645|FG003|Overall Study|Withdrawal by Subject|0|||
125476876|NCT01494662|451377646|FG004|Overall Study|Withdrawal by Subject|0|||
125476877|NCT01494662|451377647|FG005|Overall Study|Withdrawal by Subject|0|||
125476878|NCT01494662|451377648|FG006|Overall Study|Withdrawal by Subject|0|||
125476879|NCT01494662|451377642|FG000|Overall Study|Physician Decision|0|||
125476880|NCT01494662|451377643|FG001|Overall Study|Physician Decision|0|||
125476881|NCT01494662|451377644|FG002|Overall Study|Physician Decision|1|||
125476882|NCT01494662|451377645|FG003|Overall Study|Physician Decision|0|||
125476883|NCT01494662|451377646|FG004|Overall Study|Physician Decision|0|||
125476884|NCT01494662|451377647|FG005|Overall Study|Physician Decision|0|||
125476885|NCT01494662|451377648|FG006|Overall Study|Physician Decision|0|||
125476886|NCT05311384|451377649|FG000|Overall Study|Uncontrolled health conditions|2|||
125476887|NCT05311384|451377649|FG000|Overall Study|Withdrawal by Subject|1|||
125476888|NCT04322643|451377650|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
125476889|NCT05710107|451377656|FG000|Overall Study|Withdrawal by Subject|1|||
125476890|NCT05710107|451377657|FG001|Overall Study|Withdrawal by Subject|1|||
125476891|NCT05710107|451377656|FG000|Overall Study|Lost to Follow-up|8|||
125476892|NCT05710107|451377657|FG001|Overall Study|Lost to Follow-up|9|||
125476893|NCT05710107|451377656|FG000|Overall Study|Unable to place assigned block|2|||
125476894|NCT05710107|451377657|FG001|Overall Study|Unable to place assigned block|0|||
125476895|NCT05710107|451377656|FG000|Overall Study|Withdrawn by study team|0|||
125476896|NCT05710107|451377657|FG001|Overall Study|Withdrawn by study team|1|||
125476917|NCT04717492|451377663|FG000|Overall Study|Withdrawal by Subject|2|||
125476918|NCT04717492|451377664|FG001|Overall Study|Withdrawal by Subject|13|||
125476919|NCT04717492|451377663|FG000|Overall Study|Lost to Follow-up|2|||
125476920|NCT04717492|451377664|FG001|Overall Study|Lost to Follow-up|9|||
125476921|NCT04456517|451377665|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
125476922|NCT04456517|451377666|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
125476923|NCT04055090|451377667|FG000|Overall Study|screen failure|1|||
125476924|NCT04055090|451377668|FG001|Overall Study|screen failure|0|||
125476925|NCT04055090|451377667|FG000|Overall Study|Withdrawal by Subject|1|||
125476926|NCT04055090|451377668|FG001|Overall Study|Withdrawal by Subject|0|||
125476927|NCT05071807|451377669|FG000|Overall Study|Withdrawal by Subject|4|||
125476928|NCT05071807|451377670|FG001|Overall Study|Withdrawal by Subject|0|||
125476929|NCT05071807|451377669|FG000|Overall Study|Unrelated medical issues|3|||
125476930|NCT05071807|451377670|FG001|Overall Study|Unrelated medical issues|0|||
125476931|NCT05071807|451377669|FG000|Overall Study|Relocated|0|||
125476932|NCT05071807|451377670|FG001|Overall Study|Relocated|1|||
125476933|NCT04072380|451377672|FG000|Overall Study|Adverse Event|4|||
125476934|NCT04072380|451377673|FG001|Overall Study|Adverse Event|6|||
125476935|NCT04072380|451377674|FG002|Overall Study|Adverse Event|0|||
125476936|NCT04072380|451377672|FG000|Overall Study|Withdrawal by Subject|3|||
125476937|NCT04072380|451377673|FG001|Overall Study|Withdrawal by Subject|1|||
125476938|NCT04072380|451377674|FG002|Overall Study|Withdrawal by Subject|1|||
125476939|NCT04072380|451377672|FG000|Overall Study|Physician Decision|2|||
125476940|NCT04072380|451377673|FG001|Overall Study|Physician Decision|0|||
125476941|NCT04072380|451377674|FG002|Overall Study|Physician Decision|0|||
125476942|NCT04072380|451377672|FG000|Overall Study|Protocol Violation|0|||
125476943|NCT04072380|451377673|FG001|Overall Study|Protocol Violation|2|||
125476944|NCT04072380|451377674|FG002|Overall Study|Protocol Violation|3|||
125476945|NCT04072380|451377672|FG000|Overall Study|Intercurrent Illness and Others|3|||
125476946|NCT04072380|451377673|FG001|Overall Study|Intercurrent Illness and Others|5|||
125476947|NCT04072380|451377674|FG002|Overall Study|Intercurrent Illness and Others|6|||
125476948|NCT05551637|451377675|FG000|Overall Study|Lack of Efficacy|0|||
125476949|NCT05551637|451377676|FG001|Overall Study|Lack of Efficacy|6|||
125476950|NCT05551637|451377675|FG000|Overall Study|Lost to Follow-up|1|||
125476951|NCT05551637|451377676|FG001|Overall Study|Lost to Follow-up|1|||
125476952|NCT05282173|451377678|FG000|Overall Study|Missed|3|||
125476953|NCT05282173|451377679|FG001|Overall Study|Missed|2|||
125476954|NCT05282173|451377680|FG002|Overall Study|Missed|4|||
125476955|NCT05351554|451377681|FG000|Overall Study|Study terminated by sponsor|1|||
125476956|NCT03774082|451377682|FG000|Overall Study|Death|6|||
125476957|NCT03774082|451377683|FG001|Overall Study|Death|3|||
125476958|NCT03774082|451377684|FG002|Overall Study|Death|2|||
125476959|NCT03774082|451377682|FG000|Overall Study|Subject decision|0|||
125476960|NCT03774082|451377683|FG001|Overall Study|Subject decision|3|||
125476961|NCT03774082|451377684|FG002|Overall Study|Subject decision|0|||
125476962|NCT03774082|451377682|FG000|Overall Study|Lost to Follow-up|2|||
125476963|NCT03774082|451377683|FG001|Overall Study|Lost to Follow-up|0|||
125476964|NCT03774082|451377684|FG002|Overall Study|Lost to Follow-up|0|||
125476965|NCT03774082|451377682|FG000|Overall Study|Guardian decision|0|||
125476966|NCT03774082|451377683|FG001|Overall Study|Guardian decision|0|||
125476967|NCT03774082|451377684|FG002|Overall Study|Guardian decision|1|||
125476968|NCT03774082|451377682|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
125476969|NCT03774082|451377683|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
125476970|NCT03774082|451377684|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
125476971|NCT05093829|451377685|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
125476972|NCT05093829|451377686|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
125476973|NCT05093829|451377687|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
125476974|NCT05093829|451377688|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
125476975|NCT05093829|451377689|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
125476976|NCT03792256|451379183|FG000|Overall Study|Death|0|||
125476977|NCT03792256|451379184|FG001|Overall Study|Death|1|||
125476978|NCT03792256|451379183|FG000|Overall Study|Lack of Efficacy|0|||
125476979|NCT03792256|451379184|FG001|Overall Study|Lack of Efficacy|1|||
125476980|NCT03792256|451379183|FG000|Overall Study|Withdrawal by Subject|0|||
125476981|NCT03792256|451379184|FG001|Overall Study|Withdrawal by Subject|1|||
125476982|NCT01748448|451379187|FG000|Treatment Period|Consent withdrawn by subject|1|||
125476983|NCT01748448|451379188|FG001|Treatment Period|Consent withdrawn by subject|0|||
125476984|NCT01748448|451379187|FG000|Treatment Period|Adverse Event|1|||
125476985|NCT01748448|451379188|FG001|Treatment Period|Adverse Event|0|||
125476986|NCT01748448|451379187|FG000|Treatment Period|Personal|0|||
125476987|NCT01748448|451379188|FG001|Treatment Period|Personal|1|||
125476988|NCT03232138|451379200|FG000|Overall Study|Physician Decision|1|||
125476989|NCT03232138|451379201|FG001|Overall Study|Physician Decision|0|||
125476990|NCT03232138|451379200|FG000|Overall Study|Adverse Event|2|||
125476991|NCT03232138|451379201|FG001|Overall Study|Adverse Event|0|||
125476992|NCT03232138|451379200|FG000|Overall Study|Withdrawal by Subject|1|||
125476993|NCT03232138|451379201|FG001|Overall Study|Withdrawal by Subject|2|||
125476994|NCT04142788|451379202|FG000|Overall Study|Trial terminated prematurely|2|||
125476995|NCT04142788|451379203|FG001|Overall Study|Trial terminated prematurely|2|||
125476996|NCT03920111|451379204|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
125476997|NCT03920111|451379205|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
125476998|NCT03920111|451379206|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
125476999|NCT05516147|451379207|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
125477000|NCT03853746|451379211|FG000|Overall Study|Withdrawal by Subject|1|||
125477001|NCT00999804|451379212|FG000|Overall Study|Lack of Efficacy|9|||
125477002|NCT00999804|451379213|FG001|Overall Study|Lack of Efficacy|2|||
125477003|NCT00999804|451379212|FG000|Overall Study|Adverse Event|4|||
125477004|NCT00999804|451379213|FG001|Overall Study|Adverse Event|3|||
125477005|NCT00999804|451379212|FG000|Overall Study|Withdrawal by Subject|4|||
125477006|NCT00999804|451379213|FG001|Overall Study|Withdrawal by Subject|0|||
125477007|NCT00999804|451379212|FG000|Overall Study|Death|1|||
125477008|NCT00999804|451379213|FG001|Overall Study|Death|0|||
125477009|NCT00999804|451379212|FG000|Overall Study|Ineligible|3|||
125477010|NCT00999804|451379213|FG001|Overall Study|Ineligible|0|||
125477011|NCT04166773|451379227|FG000|Overall Study|Adverse Event|2|||
125477012|NCT04166773|451379228|FG001|Overall Study|Adverse Event|0|||
125477013|NCT04166773|451379229|FG002|Overall Study|Adverse Event|2|||
125477014|NCT04166773|451379230|FG003|Overall Study|Adverse Event|1|||
125477015|NCT04166773|451379227|FG000|Overall Study|Lost to Follow-up|4|||
125477016|NCT04166773|451379228|FG001|Overall Study|Lost to Follow-up|2|||
125477017|NCT04166773|451379229|FG002|Overall Study|Lost to Follow-up|1|||
125477018|NCT04166773|451379230|FG003|Overall Study|Lost to Follow-up|3|||
125477019|NCT04166773|451379227|FG000|Overall Study|Physician Decision|0|||
125477020|NCT04166773|451379228|FG001|Overall Study|Physician Decision|0|||
125477021|NCT04166773|451379229|FG002|Overall Study|Physician Decision|0|||
125477022|NCT04166773|451379230|FG003|Overall Study|Physician Decision|1|||
125477023|NCT04166773|451379227|FG000|Overall Study|Withdrawal by Subject|1|||
125477024|NCT04166773|451379228|FG001|Overall Study|Withdrawal by Subject|1|||
125477025|NCT04166773|451379229|FG002|Overall Study|Withdrawal by Subject|2|||
125477026|NCT04166773|451379230|FG003|Overall Study|Withdrawal by Subject|5|||
125477027|NCT04952909|451379237|FG000|Overall Study|Death|3|||
125477028|NCT03150810|451379244|FG000|Overall Study|Death|4|||
125477029|NCT03150810|451379245|FG001|Overall Study|Death|8|||
125477030|NCT03150810|451379246|FG002|Overall Study|Death|7|||
125477031|NCT03150810|451379247|FG003|Overall Study|Death|2|||
125300224|NCT00434642|450725911|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
125477032|NCT03150810|451379248|FG004|Overall Study|Death|2|||
125477033|NCT03150810|451379249|FG005|Overall Study|Death|10|||
125300225|NCT00434642|450725912|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
125300226|NCT00434642|450725911|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
125477034|NCT03150810|451379250|FG006|Overall Study|Death|8|||
125477035|NCT03150810|451379251|FG007|Overall Study|Death|6|||
125477036|NCT03150810|451379252|FG008|Overall Study|Death|18|||
125477037|NCT03150810|451379253|FG009|Overall Study|Death|3|||
125477038|NCT03150810|451379254|FG010|Overall Study|Death|19|||
125477039|NCT03150810|451379255|FG011|Overall Study|Death|1|||
125477040|NCT03150810|451379256|FG012|Overall Study|Death|19|||
125477041|NCT03150810|451379244|FG000|Overall Study|Withdrawal by Subject|0|||
125477042|NCT03150810|451379245|FG001|Overall Study|Withdrawal by Subject|1|||
125477043|NCT03150810|451379246|FG002|Overall Study|Withdrawal by Subject|1|||
125477044|NCT03150810|451379247|FG003|Overall Study|Withdrawal by Subject|1|||
125477045|NCT03150810|451379248|FG004|Overall Study|Withdrawal by Subject|0|||
125477046|NCT03150810|451379249|FG005|Overall Study|Withdrawal by Subject|0|||
125477047|NCT03150810|451379250|FG006|Overall Study|Withdrawal by Subject|2|||
125477048|NCT03150810|451379251|FG007|Overall Study|Withdrawal by Subject|0|||
125477049|NCT03150810|451379252|FG008|Overall Study|Withdrawal by Subject|2|||
125477050|NCT03150810|451379253|FG009|Overall Study|Withdrawal by Subject|0|||
125477051|NCT03150810|451379254|FG010|Overall Study|Withdrawal by Subject|1|||
125477052|NCT03150810|451379255|FG011|Overall Study|Withdrawal by Subject|0|||
125477053|NCT03150810|451379256|FG012|Overall Study|Withdrawal by Subject|1|||
125477054|NCT03150810|451379244|FG000|Overall Study|Sponsor Decision|0|||
125477055|NCT03150810|451379245|FG001|Overall Study|Sponsor Decision|2|||
125477056|NCT03150810|451379246|FG002|Overall Study|Sponsor Decision|0|||
125477057|NCT03150810|451379247|FG003|Overall Study|Sponsor Decision|0|||
125477058|NCT03150810|451379248|FG004|Overall Study|Sponsor Decision|1|||
125477059|NCT03150810|451379249|FG005|Overall Study|Sponsor Decision|1|||
125477060|NCT03150810|451379250|FG006|Overall Study|Sponsor Decision|0|||
125477061|NCT03150810|451379251|FG007|Overall Study|Sponsor Decision|0|||
125477062|NCT03150810|451379252|FG008|Overall Study|Sponsor Decision|1|||
125477063|NCT03150810|451379253|FG009|Overall Study|Sponsor Decision|0|||
125477064|NCT03150810|451379254|FG010|Overall Study|Sponsor Decision|0|||
125477065|NCT03150810|451379255|FG011|Overall Study|Sponsor Decision|0|||
125477066|NCT03150810|451379256|FG012|Overall Study|Sponsor Decision|5|||
125477067|NCT03150810|451379244|FG000|Overall Study|Lost to Follow-up|0|||
125477068|NCT03150810|451379245|FG001|Overall Study|Lost to Follow-up|1|||
125477069|NCT03150810|451379246|FG002|Overall Study|Lost to Follow-up|1|||
125477070|NCT03150810|451379247|FG003|Overall Study|Lost to Follow-up|0|||
125477071|NCT03150810|451379248|FG004|Overall Study|Lost to Follow-up|0|||
125477072|NCT03150810|451379249|FG005|Overall Study|Lost to Follow-up|0|||
125477073|NCT03150810|451379250|FG006|Overall Study|Lost to Follow-up|1|||
125477074|NCT03150810|451379251|FG007|Overall Study|Lost to Follow-up|0|||
125477075|NCT03150810|451379252|FG008|Overall Study|Lost to Follow-up|0|||
125477076|NCT03150810|451379253|FG009|Overall Study|Lost to Follow-up|0|||
125477077|NCT03150810|451379254|FG010|Overall Study|Lost to Follow-up|1|||
125477078|NCT03150810|451379255|FG011|Overall Study|Lost to Follow-up|0|||
125477079|NCT03150810|451379256|FG012|Overall Study|Lost to Follow-up|0|||
125477080|NCT03150810|451379244|FG000|Overall Study|Physician Decision|0|||
125477081|NCT03150810|451379245|FG001|Overall Study|Physician Decision|0|||
125477082|NCT03150810|451379246|FG002|Overall Study|Physician Decision|0|||
125477083|NCT03150810|451379247|FG003|Overall Study|Physician Decision|0|||
125477084|NCT03150810|451379248|FG004|Overall Study|Physician Decision|0|||
125477085|NCT03150810|451379249|FG005|Overall Study|Physician Decision|1|||
125477086|NCT03150810|451379250|FG006|Overall Study|Physician Decision|1|||
125477087|NCT03150810|451379251|FG007|Overall Study|Physician Decision|0|||
125477088|NCT03150810|451379252|FG008|Overall Study|Physician Decision|0|||
125477089|NCT03150810|451379253|FG009|Overall Study|Physician Decision|0|||
125477090|NCT03150810|451379254|FG010|Overall Study|Physician Decision|0|||
125477091|NCT03150810|451379255|FG011|Overall Study|Physician Decision|0|||
125477092|NCT03150810|451379256|FG012|Overall Study|Physician Decision|0|||
125477093|NCT03150810|451379244|FG000|Overall Study|Site withdrawal from study|0|||
125477094|NCT03150810|451379245|FG001|Overall Study|Site withdrawal from study|1|||
125477095|NCT03150810|451379246|FG002|Overall Study|Site withdrawal from study|0|||
125477096|NCT03150810|451379247|FG003|Overall Study|Site withdrawal from study|0|||
125477097|NCT03150810|451379248|FG004|Overall Study|Site withdrawal from study|0|||
125477098|NCT03150810|451379249|FG005|Overall Study|Site withdrawal from study|0|||
125477099|NCT03150810|451379250|FG006|Overall Study|Site withdrawal from study|0|||
125477100|NCT03150810|451379251|FG007|Overall Study|Site withdrawal from study|0|||
125300227|NCT00434642|450725912|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
125300228|NCT00434642|450725911|FG000|Open-label Treatment Phase|Adverse Event|0|||
125477101|NCT03150810|451379252|FG008|Overall Study|Site withdrawal from study|0|||
125477102|NCT03150810|451379253|FG009|Overall Study|Site withdrawal from study|1|||
125477103|NCT03150810|451379254|FG010|Overall Study|Site withdrawal from study|1|||
125477104|NCT03150810|451379255|FG011|Overall Study|Site withdrawal from study|0|||
125477105|NCT03150810|451379256|FG012|Overall Study|Site withdrawal from study|0|||
125477106|NCT03150810|451379244|FG000|Overall Study|Hospice|0|||
125477107|NCT03150810|451379245|FG001|Overall Study|Hospice|0|||
125477108|NCT03150810|451379246|FG002|Overall Study|Hospice|0|||
125477109|NCT03150810|451379247|FG003|Overall Study|Hospice|0|||
125477110|NCT03150810|451379248|FG004|Overall Study|Hospice|0|||
125477111|NCT03150810|451379249|FG005|Overall Study|Hospice|1|||
125477112|NCT03150810|451379250|FG006|Overall Study|Hospice|0|||
125477113|NCT03150810|451379251|FG007|Overall Study|Hospice|0|||
125477114|NCT03150810|451379252|FG008|Overall Study|Hospice|0|||
125477115|NCT03150810|451379253|FG009|Overall Study|Hospice|0|||
125477116|NCT03150810|451379254|FG010|Overall Study|Hospice|0|||
125477117|NCT03150810|451379255|FG011|Overall Study|Hospice|0|||
125477118|NCT03150810|451379256|FG012|Overall Study|Hospice|0|||
125477119|NCT03150810|451379244|FG000|Overall Study|Participant relocated abroad.|0|||
125477120|NCT03150810|451379245|FG001|Overall Study|Participant relocated abroad.|0|||
125477121|NCT03150810|451379246|FG002|Overall Study|Participant relocated abroad.|0|||
125477122|NCT03150810|451379247|FG003|Overall Study|Participant relocated abroad.|0|||
125477123|NCT03150810|451379248|FG004|Overall Study|Participant relocated abroad.|0|||
125477124|NCT03150810|451379249|FG005|Overall Study|Participant relocated abroad.|1|||
125477125|NCT03150810|451379250|FG006|Overall Study|Participant relocated abroad.|0|||
125477126|NCT03150810|451379251|FG007|Overall Study|Participant relocated abroad.|0|||
125477127|NCT03150810|451379252|FG008|Overall Study|Participant relocated abroad.|0|||
125477128|NCT03150810|451379253|FG009|Overall Study|Participant relocated abroad.|0|||
125477129|NCT03150810|451379254|FG010|Overall Study|Participant relocated abroad.|0|||
125477130|NCT03150810|451379255|FG011|Overall Study|Participant relocated abroad.|0|||
125477131|NCT03150810|451379256|FG012|Overall Study|Participant relocated abroad.|0|||
125477132|NCT03150810|451379244|FG000|Overall Study|Transferred care to oncologist|0|||
125477133|NCT03150810|451379245|FG001|Overall Study|Transferred care to oncologist|0|||
125477134|NCT03150810|451379246|FG002|Overall Study|Transferred care to oncologist|0|||
125477135|NCT03150810|451379247|FG003|Overall Study|Transferred care to oncologist|0|||
125477136|NCT03150810|451379248|FG004|Overall Study|Transferred care to oncologist|0|||
125477137|NCT03150810|451379249|FG005|Overall Study|Transferred care to oncologist|0|||
125477138|NCT03150810|451379250|FG006|Overall Study|Transferred care to oncologist|2|||
125477139|NCT03150810|451379251|FG007|Overall Study|Transferred care to oncologist|0|||
125477140|NCT03150810|451379252|FG008|Overall Study|Transferred care to oncologist|0|||
125477141|NCT03150810|451379253|FG009|Overall Study|Transferred care to oncologist|0|||
125477142|NCT03150810|451379254|FG010|Overall Study|Transferred care to oncologist|0|||
125477143|NCT03150810|451379255|FG011|Overall Study|Transferred care to oncologist|0|||
125477144|NCT03150810|451379256|FG012|Overall Study|Transferred care to oncologist|0|||
125477145|NCT05116787|451379257|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
125477146|NCT05116787|451379258|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
125477147|NCT05116787|451379257|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
125477148|NCT05116787|451379258|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
125477149|NCT05116787|451379257|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
125477150|NCT05116787|451379258|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
125477151|NCT05116787|451379257|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
125477152|NCT05116787|451379258|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
125477153|NCT05478499|451379265|FG000|Overall Study|Adverse Event|4|||
125477154|NCT05478499|451379266|FG001|Overall Study|Adverse Event|2|||
125477155|NCT05478499|451379265|FG000|Overall Study|Withdrawal by Subject|3|||
125477156|NCT05478499|451379266|FG001|Overall Study|Withdrawal by Subject|2|||
125477157|NCT05478499|451379265|FG000|Overall Study|Lack of Efficacy|1|||
125477158|NCT05478499|451379266|FG001|Overall Study|Lack of Efficacy|0|||
125477159|NCT05478499|451379265|FG000|Overall Study|Lost to Follow-up|1|||
125477160|NCT05478499|451379266|FG001|Overall Study|Lost to Follow-up|0|||
125477161|NCT05478499|451379265|FG000|Overall Study|Other reasons|0|||
125477162|NCT05478499|451379266|FG001|Overall Study|Other reasons|1|||
125477163|NCT02962895|451379267|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
125477164|NCT02962895|451379268|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
125477165|NCT02962895|451379269|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
125477166|NCT02962895|451379270|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
125477167|NCT02962895|451379271|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
125477168|NCT02962895|451379272|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
125477169|NCT02962895|451379273|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
125477170|NCT02962895|451379267|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
125477171|NCT02962895|451379268|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
125477172|NCT02962895|451379269|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
125477173|NCT02962895|451379270|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
125477174|NCT02962895|451379271|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
125477175|NCT02962895|451379272|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
125477176|NCT02962895|451379273|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
125477177|NCT02962895|451379267|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
125477178|NCT02962895|451379268|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
125477179|NCT02962895|451379269|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
125300229|NCT00434642|450725912|FG001|Open-label Treatment Phase|Adverse Event|5|||
125477180|NCT02962895|451379270|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
125477181|NCT02962895|451379271|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
125477182|NCT02962895|451379272|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
125477183|NCT02962895|451379273|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
125477184|NCT02962895|451379267|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
125477185|NCT02962895|451379268|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
125485383|NCT02240238|451412509|FG006|Phase 1|Withdrawal by Subject|0|||
125477186|NCT02962895|451379269|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
125477187|NCT02962895|451379270|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
125477188|NCT02962895|451379271|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
125477189|NCT02962895|451379272|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
125477190|NCT02962895|451379273|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
125477191|NCT02962895|451379267|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
125477192|NCT02962895|451379268|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
125477193|NCT02962895|451379269|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
125477194|NCT02962895|451379270|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
125477195|NCT02962895|451379271|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
125477196|NCT02962895|451379272|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
125477197|NCT02962895|451379273|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
125477198|NCT02962895|451379267|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
125477199|NCT02962895|451379268|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
125477200|NCT02962895|451379269|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
125477201|NCT02962895|451379270|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
125477202|NCT02962895|451379271|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
125477203|NCT02962895|451379272|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
125477204|NCT02962895|451379273|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
125477205|NCT02962895|451379267|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
125477206|NCT02962895|451379268|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
125477207|NCT02962895|451379269|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
125477208|NCT02962895|451379270|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
125477209|NCT02962895|451379271|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
125477210|NCT02962895|451379272|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
125477211|NCT02962895|451379273|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
125477212|NCT02962895|451379267|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
125477213|NCT02962895|451379268|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
125477214|NCT02962895|451379269|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
125477215|NCT02962895|451379270|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
125477216|NCT02962895|451379271|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
125477217|NCT02962895|451379272|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
125477218|NCT02962895|451379273|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
125477219|NCT02962895|451379267|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
125477220|NCT02962895|451379268|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
125477221|NCT02962895|451379269|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
125477222|NCT02962895|451379270|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
125477223|NCT02962895|451379271|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
125477224|NCT02962895|451379272|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
125477225|NCT02962895|451379273|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
125477226|NCT02962895|451379267|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
125477227|NCT02962895|451379268|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
125477228|NCT02962895|451379269|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
125477229|NCT02962895|451379270|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
125477230|NCT02962895|451379271|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
125477231|NCT02962895|451379272|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
125477232|NCT02962895|451379273|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
125477233|NCT02962895|451379267|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
125477234|NCT02962895|451379268|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
125477235|NCT02962895|451379269|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
125477236|NCT02962895|451379270|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
125477237|NCT02962895|451379271|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
125477238|NCT02962895|451379272|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
125477239|NCT02962895|451379273|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
125477240|NCT02962895|451379267|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
125477241|NCT02962895|451379268|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
125300230|NCT00434642|450725911|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
125300231|NCT00434642|450725912|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
125300232|NCT04512976|450725917|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
125300233|NCT04512976|450725918|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
125300234|NCT04512976|450725919|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
125300235|NCT04512976|450725920|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
125477242|NCT02962895|451379269|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
125485384|NCT02240238|451412510|FG007|Phase 1|Withdrawal by Subject|0|||
125477243|NCT02962895|451379270|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
125477244|NCT02962895|451379271|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
125477245|NCT02962895|451379272|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
125477246|NCT02962895|451379273|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
125477247|NCT02962895|451379267|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
125477248|NCT02962895|451379268|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
125477249|NCT02962895|451379269|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
125477250|NCT02962895|451379270|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
125477251|NCT02962895|451379271|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
125477252|NCT02962895|451379272|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
125477253|NCT02962895|451379273|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
125477254|NCT02962895|451379267|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
125477255|NCT02962895|451379268|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
125477256|NCT02962895|451379269|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
125477257|NCT02962895|451379270|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
125477258|NCT02962895|451379271|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
125477259|NCT02962895|451379272|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
125477260|NCT02962895|451379273|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
125477261|NCT05481320|451379274|FG000|Overall Study|Withdrawal by Subject|1|||
125477262|NCT05481320|451379275|FG001|Overall Study|Withdrawal by Subject|1|||
125477263|NCT05481320|451379274|FG000|Overall Study|Care recipent passed away|0|||
125477264|NCT05481320|451379275|FG001|Overall Study|Care recipent passed away|1|||
125477265|NCT05481320|451379274|FG000|Overall Study|Out-of-window assessment|0|||
125477266|NCT05481320|451379275|FG001|Overall Study|Out-of-window assessment|1|||
125477267|NCT05481320|451379274|FG000|Overall Study|No longer a primary caregiver|3|||
125477268|NCT05481320|451379275|FG001|Overall Study|No longer a primary caregiver|0|||
125477269|NCT05481320|451379274|FG000|Overall Study|Unable to contact|1|||
125477270|NCT05481320|451379275|FG001|Overall Study|Unable to contact|0|||
125477271|NCT05894577|451379276|FG000|Overall Study|No receipt of study drug|14|||
125477272|NCT05894577|451379277|FG001|Overall Study|No receipt of study drug|13|||
125477273|NCT05894577|451379276|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
125477274|NCT05894577|451379277|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
125477275|NCT05894577|451379276|FG000|Overall Study|Screen Fail|2|||
125477276|NCT05894577|451379277|FG001|Overall Study|Screen Fail|0|||
125477277|NCT05894577|451379276|FG000|Overall Study|Study drug recall|86|||
125477278|NCT05894577|451379277|FG001|Overall Study|Study drug recall|63|||
125477279|NCT03476460|451379281|FG000|Overall Study|Withdrawal by Subject|3|||
125477280|NCT03476460|451379282|FG001|Overall Study|Withdrawal by Subject|2|||
125477281|NCT03476460|451379281|FG000|Overall Study|Non-compliance with treatment|3|||
125477282|NCT03476460|451379282|FG001|Overall Study|Non-compliance with treatment|0|||
125477283|NCT03476460|451379281|FG000|Overall Study|Missing laboratory tests|5|||
125477284|NCT03476460|451379282|FG001|Overall Study|Missing laboratory tests|5|||
125477285|NCT03476460|451379281|FG000|Overall Study|Adverse Event|0|||
125477286|NCT03476460|451379282|FG001|Overall Study|Adverse Event|1|||
125477287|NCT01606215|451379290|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
125477288|NCT01606215|451379291|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
125477289|NCT04592549|451379292|FG000|Overall Study|Withdrawal by Subject|0|||
125477290|NCT04592549|451379293|FG001|Overall Study|Withdrawal by Subject|1|||
125477291|NCT04592549|451379294|FG002|Overall Study|Withdrawal by Subject|0|||
125477292|NCT04592549|451379295|FG003|Overall Study|Withdrawal by Subject|1|||
125477293|NCT04592549|451379296|FG004|Overall Study|Withdrawal by Subject|1|||
125477294|NCT04592549|451379297|FG005|Overall Study|Withdrawal by Subject|0|||
125477295|NCT04592549|451379292|FG000|Overall Study|Lost to Follow-up|2|||
125477296|NCT04592549|451379293|FG001|Overall Study|Lost to Follow-up|0|||
125477297|NCT04592549|451379294|FG002|Overall Study|Lost to Follow-up|0|||
125477298|NCT04592549|451379295|FG003|Overall Study|Lost to Follow-up|1|||
125477299|NCT04592549|451379296|FG004|Overall Study|Lost to Follow-up|1|||
125477300|NCT04592549|451379297|FG005|Overall Study|Lost to Follow-up|1|||
125477301|NCT05184192|451379298|FG000|Overall Study|Lost to Follow-up|4|||
125477302|NCT05184192|451379299|FG001|Overall Study|Lost to Follow-up|7|||
125300236|NCT04512976|450725921|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
125300237|NCT04512976|450725922|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
125300238|NCT00527982|450725923|FG000|Overall Study|Physician Decision|1|||
125300239|NCT00527982|450725924|FG001|Overall Study|Physician Decision|0|||
125477303|NCT05184192|451379298|FG000|Overall Study|Adverse Event|1|||
125300240|NCT02241343|450725929|FG000|Overall Study|Adverse Event|1|||
125477304|NCT05184192|451379299|FG001|Overall Study|Adverse Event|4|||
125477305|NCT05184192|451379298|FG000|Overall Study|PI withdrawal|1|||
125477306|NCT05184192|451379299|FG001|Overall Study|PI withdrawal|2|||
125477307|NCT05184192|451379298|FG000|Overall Study|Withdrew due to adverse effect|1|||
125477308|NCT05184192|451379299|FG001|Overall Study|Withdrew due to adverse effect|0|||
125477309|NCT05184192|451379298|FG000|Overall Study|Medication schedule|1|||
125477310|NCT05184192|451379299|FG001|Overall Study|Medication schedule|0|||
125477311|NCT05184192|451379298|FG000|Overall Study|Concern for adverse effects|0|||
125477312|NCT05184192|451379299|FG001|Overall Study|Concern for adverse effects|4|||
125477313|NCT03640312|451379308|FG000|Overall Study|Lost to Follow-up|3|||
125477314|NCT03640312|451379309|FG001|Overall Study|Lost to Follow-up|6|||
125300241|NCT04541628|450725932|FG000|Overall Study|Study Terminated|1|||
125300242|NCT04541628|450725933|FG001|Overall Study|Study Terminated|1|||
125300243|NCT04541628|450725934|FG002|Overall Study|Study Terminated|1|||
125300244|NCT05011058|450725938|FG000|Overall Study|Sponsor Decision|2|||
125300245|NCT05011058|450725939|FG001|Overall Study|Sponsor Decision|0|||
125300246|NCT05011058|450725940|FG002|Overall Study|Sponsor Decision|14|||
125477315|NCT04948697|451379310|FG000|Overall Study|Progressive disease|27|||
125477316|NCT04948697|451379311|FG001|Overall Study|Progressive disease|18|||
125477317|NCT04948697|451379310|FG000|Overall Study|Adverse Event|14|||
125477318|NCT04948697|451379311|FG001|Overall Study|Adverse Event|4|||
125477319|NCT04948697|451379310|FG000|Overall Study|Participant moved to long term extension study|7|||
125477320|NCT04948697|451379311|FG001|Overall Study|Participant moved to long term extension study|4|||
125477321|NCT04948697|451379310|FG000|Overall Study|Withdrawal by Subject|10|||
125477322|NCT04948697|451379311|FG001|Overall Study|Withdrawal by Subject|0|||
125477323|NCT04948697|451379310|FG000|Overall Study|Closed by Sponsor|3|||
125477324|NCT04948697|451379311|FG001|Overall Study|Closed by Sponsor|2|||
125477325|NCT04948697|451379310|FG000|Overall Study|Physician Decision|0|||
125477326|NCT04948697|451379311|FG001|Overall Study|Physician Decision|2|||
125477327|NCT04948697|451379310|FG000|Overall Study|Lost to Follow-up|0|||
125477328|NCT04948697|451379311|FG001|Overall Study|Lost to Follow-up|1|||
125477329|NCT04948697|451379310|FG000|Overall Study|Other-Miscellaneous|1|||
125477330|NCT04948697|451379311|FG001|Overall Study|Other-Miscellaneous|0|||
125477331|NCT04948697|451379310|FG000|Overall Study|Randomized but not treated|0|||
125477332|NCT04948697|451379311|FG001|Overall Study|Randomized but not treated|1|||
125477333|NCT04177823|451380699|FG000|Overall Study|Physician Decision|1|||
125477334|NCT04177823|451380699|FG000|Overall Study|Withdrawal by Subject|1|||
125477335|NCT05178316|451380702|FG000|Overall Study|Adverse Event|5|||
125477336|NCT05178316|451380703|FG001|Overall Study|Adverse Event|4|||
125477337|NCT05178316|451380704|FG002|Overall Study|Adverse Event|9|||
125477338|NCT05178316|451380702|FG000|Overall Study|Enrolled in Error|1|||
125477339|NCT05178316|451380703|FG001|Overall Study|Enrolled in Error|2|||
125477340|NCT05178316|451380704|FG002|Overall Study|Enrolled in Error|1|||
125477341|NCT05178316|451380702|FG000|Overall Study|Lost to Follow-up|3|||
125477342|NCT05178316|451380703|FG001|Overall Study|Lost to Follow-up|15|||
125477343|NCT05178316|451380704|FG002|Overall Study|Lost to Follow-up|11|||
125477344|NCT05178316|451380702|FG000|Overall Study|Noncompliance|1|||
125477345|NCT05178316|451380703|FG001|Overall Study|Noncompliance|3|||
125477346|NCT05178316|451380704|FG002|Overall Study|Noncompliance|1|||
125477347|NCT05178316|451380702|FG000|Overall Study|Other|0|||
125477348|NCT05178316|451380703|FG001|Overall Study|Other|1|||
125477349|NCT05178316|451380704|FG002|Overall Study|Other|0|||
125477350|NCT05178316|451380702|FG000|Overall Study|Physician Decision|0|||
125477351|NCT05178316|451380703|FG001|Overall Study|Physician Decision|3|||
125477352|NCT05178316|451380704|FG002|Overall Study|Physician Decision|2|||
125477353|NCT05178316|451380702|FG000|Overall Study|Protocol deviation|1|||
125477354|NCT05178316|451380703|FG001|Overall Study|Protocol deviation|0|||
125477355|NCT05178316|451380704|FG002|Overall Study|Protocol deviation|1|||
125477356|NCT05178316|451380702|FG000|Overall Study|Sponsor decision|1|||
125477357|NCT05178316|451380703|FG001|Overall Study|Sponsor decision|0|||
125477358|NCT05178316|451380704|FG002|Overall Study|Sponsor decision|1|||
125477359|NCT05178316|451380702|FG000|Overall Study|Withdrawal by Subject|5|||
125477360|NCT05178316|451380703|FG001|Overall Study|Withdrawal by Subject|11|||
125477361|NCT05178316|451380704|FG002|Overall Study|Withdrawal by Subject|5|||
125477362|NCT03457142|451380705|FG000|Overall Study|Death|1|||
125477363|NCT04760678|451380706|FG000|Overall Study|Death|13|||
125477364|NCT04760678|451380706|FG000|Overall Study|Lost to Follow-up|48|||
125300247|NCT05011058|450725941|FG003|Overall Study|Sponsor Decision|0|||
125300248|NCT05011058|450725942|FG004|Overall Study|Sponsor Decision|0|||
125477365|NCT04760678|451380706|FG000|Overall Study|Withdrawal by Subject|1|||
125477366|NCT03338933|451380711|FG000|Screening Visit|Lost to Follow-up|1|||
125477367|NCT03338933|451380712|FG001|Screening Visit|Lost to Follow-up|3|||
125477368|NCT03338933|451380713|FG002|Screening Visit|Lost to Follow-up|1|||
125477369|NCT03338933|451380714|FG003|Screening Visit|Lost to Follow-up|4|||
125477370|NCT03338933|451380711|FG000|Screening Visit|Screen fail after consent|2|||
125477371|NCT03338933|451380712|FG001|Screening Visit|Screen fail after consent|7|||
125477372|NCT03338933|451380713|FG002|Screening Visit|Screen fail after consent|1|||
125477373|NCT03338933|451380714|FG003|Screening Visit|Screen fail after consent|4|||
125477374|NCT03338933|451380711|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
125477375|NCT03338933|451380712|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
125477376|NCT03338933|451380713|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
125477377|NCT03338933|451380714|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
125300249|NCT05011058|450725943|FG005|Overall Study|Sponsor Decision|1|||
125485385|NCT02240238|451412511|FG008|Phase 1|Withdrawal by Subject|0|||
125477378|NCT03338933|451380711|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
125477379|NCT03338933|451380712|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
125477380|NCT03338933|451380713|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
125477381|NCT03338933|451380714|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
125477382|NCT03338933|451380711|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
125477383|NCT03338933|451380712|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
125477384|NCT03338933|451380713|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
125477385|NCT03338933|451380714|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
125477386|NCT02924272|451380718|FG000|Overall Study|Site Terminated by Sponsor|4|||
125477387|NCT02924272|451380719|FG001|Overall Study|Site Terminated by Sponsor|1|||
125477388|NCT02924272|451380718|FG000|Overall Study|Withdrawal by Subject|2|||
125477389|NCT02924272|451380719|FG001|Overall Study|Withdrawal by Subject|0|||
125477390|NCT02924272|451380718|FG000|Overall Study|Adverse Event|3|||
125477391|NCT02924272|451380719|FG001|Overall Study|Adverse Event|0|||
125477392|NCT02924272|451380718|FG000|Overall Study|Progressive Disease|11|||
125477393|NCT02924272|451380719|FG001|Overall Study|Progressive Disease|8|||
125477394|NCT02924272|451380718|FG000|Overall Study|Clinical Deterioration|1|||
125477395|NCT02924272|451380719|FG001|Overall Study|Clinical Deterioration|0|||
125477396|NCT02924272|451380718|FG000|Overall Study|Death|1|||
125477397|NCT02924272|451380719|FG001|Overall Study|Death|0|||
125477398|NCT02924272|451380718|FG000|Overall Study|Reason Not Specified|1|||
125477399|NCT02924272|451380719|FG001|Overall Study|Reason Not Specified|0|||
125477400|NCT02100813|451380724|FG000|Overall Study|Adverse Event|0|||
125477401|NCT02100813|451380725|FG001|Overall Study|Adverse Event|0|||
125477402|NCT02100813|451380726|FG002|Overall Study|Adverse Event|0|||
125477403|NCT02100813|451380727|FG003|Overall Study|Adverse Event|0|||
125477404|NCT02100813|451380728|FG004|Overall Study|Adverse Event|0|||
125477405|NCT02100813|451380729|FG005|Overall Study|Adverse Event|0|||
125477406|NCT02100813|451380730|FG006|Overall Study|Adverse Event|0|||
125477407|NCT02100813|451380731|FG007|Overall Study|Adverse Event|1|||
125477408|NCT03575897|451380733|FG000|Overall Study|Lost to Follow-up|12|||
125477409|NCT03575897|451380734|FG001|Overall Study|Lost to Follow-up|13|||
125477410|NCT04359108|451380735|FG000|Overall Study|Withdrawal by Subject|1|||
125477411|NCT04359108|451380736|FG001|Overall Study|Withdrawal by Subject|0|||
125477412|NCT04359108|451380735|FG000|Overall Study|Unable or too feeble to walk independently|0|||
125477413|NCT04359108|451380736|FG001|Overall Study|Unable or too feeble to walk independently|2|||
125477414|NCT04359108|451380735|FG000|Overall Study|Argus II system stopped functioning|0|||
125477415|NCT04359108|451380736|FG001|Overall Study|Argus II system stopped functioning|1|||
125477416|NCT04359108|451380735|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
125477417|NCT04359108|451380736|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
125477418|NCT06393088|451380737|FG000|Overall Study|Withdrawal by Subject|0|||
125477419|NCT06393088|451380738|FG001|Overall Study|Withdrawal by Subject|2|||
125477420|NCT02515773|451380739|FG000|Overall Study|Withdrawal by Subject|12|||
125477421|NCT02515773|451380740|FG001|Overall Study|Withdrawal by Subject|2|||
125477422|NCT02515773|451380739|FG000|Overall Study|Lost to Follow-up|119|||
125477423|NCT02515773|451380740|FG001|Overall Study|Lost to Follow-up|126|||
125477424|NCT02515773|451380739|FG000|Overall Study|Discharged from Clinic Services|53|||
125477425|NCT02515773|451380740|FG001|Overall Study|Discharged from Clinic Services|84|||
125477426|NCT02515773|451380739|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
125477427|NCT02515773|451380740|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
125477428|NCT02515773|451380739|FG000|Overall Study|Follow-up at non-study site|8|||
125477429|NCT02515773|451380740|FG001|Overall Study|Follow-up at non-study site|16|||
125477430|NCT02515773|451380739|FG000|Overall Study|Moved from area|9|||
125477431|NCT02515773|451380740|FG001|Overall Study|Moved from area|14|||
125477432|NCT04176965|451380741|FG000|Overall Study|Death|1|||
125477433|NCT04176965|451380742|FG001|Overall Study|Death|2|||
125477434|NCT04176965|451380741|FG000|Overall Study|Lost to Follow-up|10|||
125477435|NCT04176965|451380742|FG001|Overall Study|Lost to Follow-up|2|||
125477436|NCT04176965|451380741|FG000|Overall Study|Withdrawal by Subject|6|||
125477437|NCT04176965|451380742|FG001|Overall Study|Withdrawal by Subject|1|||
125477438|NCT03903146|451380743|FG000|Overall Study|Lost to Follow-up|6|||
125477439|NCT03903146|451380744|FG001|Overall Study|Lost to Follow-up|4|||
125477440|NCT03903146|451380743|FG000|Overall Study|Withdrawal by Subject|0|||
125300250|NCT05011058|450725944|FG006|Overall Study|Sponsor Decision|0|||
125300251|NCT05011058|450725945|FG007|Overall Study|Sponsor Decision|5|||
125300252|NCT01192412|450725946|FG000|Overall Study|Lost to Follow-up|2|||
125477441|NCT03903146|451380744|FG001|Overall Study|Withdrawal by Subject|1|||
125477442|NCT02919683|451380745|FG000|Post-Surgery Follow-Up|Death|2|||
125477443|NCT02919683|451380746|FG001|Post-Surgery Follow-Up|Death|2|||
125477444|NCT02919683|451380745|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
125477445|NCT02919683|451380746|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
125477446|NCT03652688|451380747|FG000|Baseline|Withdrawal by Subject|0|||
125477447|NCT03652688|451380748|FG001|Baseline|Withdrawal by Subject|3|||
125477448|NCT03652688|451380747|FG000|Follow-up|Lost to Follow-up|56|||
125477449|NCT03652688|451380748|FG001|Follow-up|Lost to Follow-up|54|||
125477450|NCT03468218|451380749|FG000|Overall Study|Adverse Event|5|||
125477451|NCT03468218|451380749|FG000|Overall Study|Progressive Disease|16|||
125477452|NCT03468218|451380749|FG000|Overall Study|Death|1|||
125477453|NCT03468218|451380749|FG000|Overall Study|Alternate therapy|1|||
125477454|NCT03468218|451380749|FG000|Overall Study|Withdrawal by Subject|2|||
125477455|NCT03829410|451380751|FG000|Overall Study|Adverse Event|1|||
125477456|NCT03829410|451380752|FG001|Overall Study|Adverse Event|0|||
125477457|NCT03829410|451380753|FG002|Overall Study|Adverse Event|1|||
125477458|NCT03829410|451380754|FG003|Overall Study|Adverse Event|4|||
125477459|NCT03829410|451380751|FG000|Overall Study|Physician Decision|0|||
125477460|NCT03829410|451380752|FG001|Overall Study|Physician Decision|0|||
125477461|NCT03829410|451380753|FG002|Overall Study|Physician Decision|0|||
125477462|NCT03829410|451380754|FG003|Overall Study|Physician Decision|2|||
125477463|NCT03829410|451380751|FG000|Overall Study|Disease Progressing|3|||
125477464|NCT03829410|451380752|FG001|Overall Study|Disease Progressing|4|||
125477465|NCT03829410|451380753|FG002|Overall Study|Disease Progressing|2|||
125477466|NCT03829410|451380754|FG003|Overall Study|Disease Progressing|31|||
125477467|NCT03829410|451380751|FG000|Overall Study|Miscellaneous|2|||
125477468|NCT03829410|451380752|FG001|Overall Study|Miscellaneous|4|||
125477469|NCT03829410|451380753|FG002|Overall Study|Miscellaneous|3|||
125477470|NCT03829410|451380754|FG003|Overall Study|Miscellaneous|10|||
125477471|NCT03033576|451380755|FG000|Overall Study|Ineligible|1|||
125477472|NCT03033576|451380756|FG001|Overall Study|Ineligible|1|||
125477473|NCT03033576|451380755|FG000|Overall Study|Adverse Event|4|||
125477474|NCT03033576|451380756|FG001|Overall Study|Adverse Event|20|||
125477475|NCT03033576|451380755|FG000|Overall Study|Progression/relapse|9|||
125477476|NCT03033576|451380756|FG001|Overall Study|Progression/relapse|36|||
125477477|NCT03033576|451380755|FG000|Overall Study|Death|1|||
125477478|NCT03033576|451380756|FG001|Overall Study|Death|1|||
125477479|NCT03033576|451380755|FG000|Overall Study|Patient refusal|1|||
125477480|NCT03033576|451380756|FG001|Overall Study|Patient refusal|6|||
125477481|NCT03033576|451380755|FG000|Overall Study|Other, unspecified reasons|0|||
125477482|NCT03033576|451380756|FG001|Overall Study|Other, unspecified reasons|4|||
125477483|NCT03033576|451380755|FG000|Overall Study|Currently on protocol therapy|0|||
125477484|NCT03033576|451380756|FG001|Overall Study|Currently on protocol therapy|2|||
125477485|NCT05179837|451380757|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
125477486|NCT05179837|451380757|FG000|Overall Study|Device malfunctioned|1|||
125477487|NCT05179837|451380757|FG000|Overall Study|Image quality too low|2|||
125477488|NCT03719443|451380758|FG000|Overall Study|Lost to Follow-up|0|||
125477489|NCT03719443|451380759|FG001|Overall Study|Lost to Follow-up|0|||
125477490|NCT03719443|451380760|FG002|Overall Study|Lost to Follow-up|1|||
125477491|NCT03719443|451380761|FG003|Overall Study|Lost to Follow-up|0|||
125477492|NCT03719443|451380762|FG004|Overall Study|Lost to Follow-up|1|||
125477493|NCT03719443|451380763|FG005|Overall Study|Lost to Follow-up|0|||
125477494|NCT03719443|451380764|FG006|Overall Study|Lost to Follow-up|1|||
125477495|NCT03719443|451380758|FG000|Overall Study|Withdrawal by Subject|0|||
125477496|NCT03719443|451380759|FG001|Overall Study|Withdrawal by Subject|0|||
125477497|NCT03719443|451380760|FG002|Overall Study|Withdrawal by Subject|1|||
125477498|NCT03719443|451380761|FG003|Overall Study|Withdrawal by Subject|0|||
125477499|NCT03719443|451380762|FG004|Overall Study|Withdrawal by Subject|0|||
125477500|NCT03719443|451380763|FG005|Overall Study|Withdrawal by Subject|0|||
125477501|NCT03719443|451380764|FG006|Overall Study|Withdrawal by Subject|0|||
125477502|NCT05051124|451380765|FG000|Overall Study|Lost to Follow-up|2|||
125477503|NCT05051124|451380765|FG000|Overall Study|Withdrawal by Subject|1|||
125477504|NCT05051124|451380765|FG000|Overall Study|Residential relocation|2|||
125477505|NCT05051124|451380765|FG000|Overall Study|Death|1|||
125477506|NCT04782973|451380766|FG000|Overall Study|Withdrawal by Subject|5|||
125477507|NCT04782973|451380766|FG000|Overall Study|Protocol Violation|6|||
125477508|NCT04782973|451380766|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
125477509|NCT04924660|451380767|FG000|United States|Death|29|||
125477510|NCT04924660|451380768|FG001|United States|Death|32|||
125477511|NCT04924660|451380769|FG002|United States|Death|34|||
125477512|NCT04924660|451380770|FG003|United States|Death|25|||
125477513|NCT04924660|451380771|FG004|United States|Death|26|||
125477514|NCT04924660|451380772|FG005|United States|Death|23|||
125477515|NCT04924660|451380767|FG000|United States|Lost to Follow-up|15|||
125477516|NCT04924660|451380768|FG001|United States|Lost to Follow-up|10|||
125477517|NCT04924660|451380769|FG002|United States|Lost to Follow-up|13|||
125477518|NCT04924660|451380770|FG003|United States|Lost to Follow-up|5|||
125477519|NCT04924660|451380771|FG004|United States|Lost to Follow-up|19|||
125477520|NCT04924660|451380772|FG005|United States|Lost to Follow-up|20|||
125477521|NCT04924660|451380767|FG000|United States|Withdrawal by Subject|8|||
125477522|NCT04924660|451380768|FG001|United States|Withdrawal by Subject|3|||
125477523|NCT04924660|451380769|FG002|United States|Withdrawal by Subject|3|||
125477524|NCT04924660|451380770|FG003|United States|Withdrawal by Subject|3|||
125477525|NCT04924660|451380771|FG004|United States|Withdrawal by Subject|8|||
125477526|NCT04924660|451380772|FG005|United States|Withdrawal by Subject|4|||
125477527|NCT04924660|451380767|FG000|Spain|Death|0|||
125477528|NCT04924660|451380768|FG001|Spain|Death|0|||
125477529|NCT04924660|451380769|FG002|Spain|Death|0|||
125477530|NCT04924660|451380770|FG003|Spain|Death|0|||
125477531|NCT04924660|451380771|FG004|Spain|Death|0|||
125477532|NCT04924660|451380772|FG005|Spain|Death|2|||
125477533|NCT04924660|451380767|FG000|Spain|Lost to Follow-up|0|||
125477534|NCT04924660|451380768|FG001|Spain|Lost to Follow-up|0|||
125477535|NCT04924660|451380769|FG002|Spain|Lost to Follow-up|0|||
125477536|NCT04924660|451380770|FG003|Spain|Lost to Follow-up|0|||
125477537|NCT04924660|451380771|FG004|Spain|Lost to Follow-up|1|||
125477538|NCT04924660|451380772|FG005|Spain|Lost to Follow-up|0|||
125477539|NCT04924660|451380767|FG000|Brazil|Death|0|||
125477540|NCT04924660|451380768|FG001|Brazil|Death|0|||
125477541|NCT04924660|451380769|FG002|Brazil|Death|0|||
125477542|NCT04924660|451380770|FG003|Brazil|Death|0|||
125477543|NCT04924660|451380771|FG004|Brazil|Death|1|||
125477544|NCT04924660|451380772|FG005|Brazil|Death|0|||
125477545|NCT04924660|451380767|FG000|Italy|Lost to Follow-up|0|||
125477546|NCT04924660|451380768|FG001|Italy|Lost to Follow-up|0|||
125477547|NCT04924660|451380769|FG002|Italy|Lost to Follow-up|0|||
125477548|NCT04924660|451380770|FG003|Italy|Lost to Follow-up|0|||
125477549|NCT04924660|451380771|FG004|Italy|Lost to Follow-up|0|||
125477550|NCT04924660|451380772|FG005|Italy|Lost to Follow-up|1|||
125477551|NCT04924660|451380767|FG000|South Africa|Death|0|||
125477552|NCT04924660|451380768|FG001|South Africa|Death|0|||
125477553|NCT04924660|451380769|FG002|South Africa|Death|0|||
125477554|NCT04924660|451380770|FG003|South Africa|Death|0|||
125477555|NCT04924660|451380771|FG004|South Africa|Death|0|||
125477556|NCT04924660|451380772|FG005|South Africa|Death|1|||
125477557|NCT04924660|451380767|FG000|South Africa|Lost to Follow-up|0|||
125477558|NCT04924660|451380768|FG001|South Africa|Lost to Follow-up|0|||
125477559|NCT04924660|451380769|FG002|South Africa|Lost to Follow-up|0|||
125477560|NCT04924660|451380770|FG003|South Africa|Lost to Follow-up|0|||
125477561|NCT04924660|451380771|FG004|South Africa|Lost to Follow-up|0|||
125477562|NCT04924660|451380772|FG005|South Africa|Lost to Follow-up|1|||
125477563|NCT06205407|451380773|FG000|Period 2|Withdrawal by Subject|0|||
125477564|NCT06205407|451380774|FG001|Period 2|Withdrawal by Subject|1|||
125477565|NCT06205407|451380773|FG000|Period 2|Adverse Event|2|||
125477566|NCT06205407|451380774|FG001|Period 2|Adverse Event|1|||
125477567|NCT03557697|451380775|FG000|Overall Study|Withdrawal by Subject|2|||
125477568|NCT03557697|451380776|FG001|Overall Study|Withdrawal by Subject|4|||
125477569|NCT06491433|451380777|FG000|Overall Study|Protocol Violation|51|||
125477570|NCT06491433|451380777|FG000|Overall Study|consent withdrawal|2|||
125477571|NCT06491433|451380777|FG000|Overall Study|screen failure|1|||
125477572|NCT04749615|451380779|FG000|Overall Study|Lost to Follow-up|6|||
125477573|NCT04749615|451380780|FG001|Overall Study|Lost to Follow-up|10|||
125477574|NCT03611491|451380781|FG000|Overall Study|Lost to Follow-up|1|||
125477575|NCT04676022|451380782|FG000|Overall Study|Screen Failure/|1|||
125477576|NCT04676022|451380783|FG001|Overall Study|Screen Failure/|1|||
125477577|NCT04676022|451380784|FG002|Overall Study|Screen Failure/|85|||
125477578|NCT04676022|451380782|FG000|Overall Study|Lost to Follow-up|1|||
125477579|NCT04676022|451380783|FG001|Overall Study|Lost to Follow-up|1|||
125477580|NCT04676022|451380784|FG002|Overall Study|Lost to Follow-up|0|||
125477581|NCT04676022|451380782|FG000|Overall Study|Adverse Event|2|||
125477582|NCT04676022|451380783|FG001|Overall Study|Adverse Event|0|||
125477583|NCT04676022|451380784|FG002|Overall Study|Adverse Event|1|||
125477584|NCT04676022|451380782|FG000|Overall Study|Physician Decision|2|||
125477585|NCT04676022|451380783|FG001|Overall Study|Physician Decision|0|||
125477586|NCT04676022|451380784|FG002|Overall Study|Physician Decision|1|||
125477587|NCT04676022|451380782|FG000|Overall Study|Withdrawal by Subject|3|||
125477588|NCT04676022|451380783|FG001|Overall Study|Withdrawal by Subject|1|||
125477589|NCT04676022|451380784|FG002|Overall Study|Withdrawal by Subject|6|||
125477590|NCT04676022|451380782|FG000|Overall Study|Will not move forward with permanent implant|6|||
125477591|NCT04676022|451380783|FG001|Overall Study|Will not move forward with permanent implant|0|||
125477592|NCT04676022|451380784|FG002|Overall Study|Will not move forward with permanent implant|0|||
125477593|NCT04676022|451380782|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
125477594|NCT04676022|451380783|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
125477595|NCT04676022|451380784|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
125477596|NCT03194217|451380799|FG000|Overall Study|Adverse Event|0|||
125477597|NCT03194217|451380800|FG001|Overall Study|Adverse Event|2|||
125477598|NCT03194217|451380801|FG002|Overall Study|Adverse Event|3|||
125477599|NCT03194217|451380802|FG003|Overall Study|Adverse Event|3|||
125477600|NCT03194217|451380799|FG000|Overall Study|Failure to meet randomisation criteria|0|||
125477601|NCT03194217|451380800|FG001|Overall Study|Failure to meet randomisation criteria|0|||
125477602|NCT03194217|451380801|FG002|Overall Study|Failure to meet randomisation criteria|0|||
125477603|NCT03194217|451380802|FG003|Overall Study|Failure to meet randomisation criteria|1|||
125477604|NCT03194217|451380799|FG000|Overall Study|Other|0|||
125477605|NCT03194217|451380800|FG001|Overall Study|Other|1|||
125477606|NCT03194217|451380801|FG002|Overall Study|Other|1|||
125477607|NCT03194217|451380802|FG003|Overall Study|Other|0|||
125477608|NCT04509674|451380803|FG000|Overall Study|Not treated|33|||
125477609|NCT04509674|451380804|FG001|Overall Study|Not treated|26|||
125477610|NCT04509674|451380803|FG000|Overall Study|Protocol Violation|9|||
125477611|NCT04509674|451380804|FG001|Overall Study|Protocol Violation|10|||
125477612|NCT04509674|451380803|FG000|Overall Study|Lost to Follow-up|31|||
125477613|NCT04509674|451380804|FG001|Overall Study|Lost to Follow-up|39|||
125477614|NCT04509674|451380803|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
125477615|NCT04509674|451380804|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
125477616|NCT04509674|451380803|FG000|Overall Study|Adverse event, serious fatal event|11|||
125477617|NCT04509674|451380804|FG001|Overall Study|Adverse event, serious fatal event|4|||
125477618|NCT04509674|451380803|FG000|Overall Study|Adverse event, non-fatal event|107|||
125477619|NCT04509674|451380804|FG001|Overall Study|Adverse event, non-fatal event|118|||
125477620|NCT04509674|451380803|FG000|Overall Study|Other reason than listed|106|||
125477621|NCT04509674|451380804|FG001|Overall Study|Other reason than listed|95|||
125477622|NCT03197662|451380805|FG000|Overall Study|Withdrawn by family|0|||
125477623|NCT03197662|451380806|FG001|Overall Study|Withdrawn by family|2|||
125477624|NCT04495894|451380816|FG000|Overall Study|Withdrawal by Subject|2|||
125477625|NCT04495894|451380817|FG001|Overall Study|Withdrawal by Subject|0|||
125477626|NCT04495894|451380818|FG002|Overall Study|Withdrawal by Subject|2|||
125477627|NCT04495894|451380819|FG003|Overall Study|Withdrawal by Subject|3|||
125477628|NCT04495894|451380816|FG000|Overall Study|Early termination|0|||
125477629|NCT04495894|451380817|FG001|Overall Study|Early termination|0|||
125477630|NCT04495894|451380818|FG002|Overall Study|Early termination|3|||
125477631|NCT04495894|451380819|FG003|Overall Study|Early termination|0|||
125477632|NCT03364647|451380821|FG000|Overall Study|Withdrawal by Subject|3|||
125477633|NCT03364647|451380822|FG001|Overall Study|Withdrawal by Subject|1|||
125477634|NCT05579899|451380823|FG000|Overall Study|Lost to Follow-up|3|||
125477635|NCT05579899|451380824|FG001|Overall Study|Lost to Follow-up|1|||
125477636|NCT05579899|451380823|FG000|Overall Study|Adverse Event|0|||
125477637|NCT05579899|451380824|FG001|Overall Study|Adverse Event|3|||
125477638|NCT05579899|451380823|FG000|Overall Study|Pregnancy|0|||
125477639|NCT05579899|451380824|FG001|Overall Study|Pregnancy|1|||
125477640|NCT05579899|451380823|FG000|Overall Study|Withdrawal by Subject|0|||
125477641|NCT05579899|451380824|FG001|Overall Study|Withdrawal by Subject|3|||
125477642|NCT04064164|451380827|FG000|Overall Study|Withdrawal by Subject|8|||
125477643|NCT04064164|451380828|FG001|Overall Study|Withdrawal by Subject|8|||
125477644|NCT01000961|451380830|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
125477645|NCT01000961|451380831|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
125477646|NCT01000961|451380830|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
125477647|NCT01000961|451380831|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
125477648|NCT05030233|451380843|FG000|Overall Study|withdrawn for transfer|1|||
125477649|NCT05030233|451380844|FG001|Overall Study|withdrawn for transfer|0|||
125477650|NCT03365882|451380845|FG000|Randomization|Still Receiving Protocol Treatment|2|||
125477651|NCT03365882|451380846|FG001|Randomization|Still Receiving Protocol Treatment|0|||
125477652|NCT03365882|451380845|FG000|Randomization|Adverse Event|1|||
125477653|NCT03365882|451380846|FG001|Randomization|Adverse Event|2|||
125477654|NCT03365882|451380845|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
125477655|NCT03365882|451380846|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
125477656|NCT03365882|451380845|FG000|Randomization|Progression/Relapse|21|||
125477657|NCT03365882|451380846|FG001|Randomization|Progression/Relapse|3|||
125477658|NCT03365882|451380845|FG000|Randomization|Death|1|||
125477659|NCT03365882|451380846|FG001|Randomization|Death|0|||
125477660|NCT03365882|451380845|FG000|Randomization|Other - Not Protocol Specified|1|||
125477661|NCT03365882|451380846|FG001|Randomization|Other - Not Protocol Specified|1|||
125477662|NCT03365882|451380845|FG000|Randomization|Major Protocol Deviation|0|||
125477663|NCT03365882|451380846|FG001|Randomization|Major Protocol Deviation|1|||
125477664|NCT03365882|451380845|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
125477665|NCT03365882|451380846|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
125477666|NCT03365882|451380845|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
125477667|NCT03365882|451380846|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
125477668|NCT03365882|451380845|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
125477669|NCT03365882|451380846|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
125300253|NCT01192412|450725947|FG001|Overall Study|Lost to Follow-up|1|||
125300254|NCT01192412|450725946|FG000|Overall Study|Withdrawal by Subject|2|||
125300255|NCT01192412|450725947|FG001|Overall Study|Withdrawal by Subject|1|||
125477670|NCT03365882|451380845|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
125477671|NCT03365882|451380846|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
125477672|NCT04229992|451383054|FG000|Overall Study|Withdrawal by Subject|0|||
125477673|NCT04229992|451383055|FG001|Overall Study|Withdrawal by Subject|2|||
125477674|NCT04229992|451383056|FG002|Overall Study|Withdrawal by Subject|1|||
125477675|NCT04229992|451383057|FG003|Overall Study|Withdrawal by Subject|1|||
125477676|NCT04229992|451383054|FG000|Overall Study|Adverse Event|1|||
125477677|NCT04229992|451383055|FG001|Overall Study|Adverse Event|1|||
125300256|NCT00308074|450725951|FG000|Overall Study|Withdrawal by Subject|1|||
125477678|NCT04229992|451383056|FG002|Overall Study|Adverse Event|3|||
125477679|NCT04229992|451383057|FG003|Overall Study|Adverse Event|1|||
125477680|NCT04229992|451383054|FG000|Overall Study|Lost to Follow-up|0|||
125477681|NCT04229992|451383055|FG001|Overall Study|Lost to Follow-up|0|||
125477682|NCT04229992|451383056|FG002|Overall Study|Lost to Follow-up|0|||
125477683|NCT04229992|451383057|FG003|Overall Study|Lost to Follow-up|1|||
125477684|NCT03770273|451383058|FG000|Overall Study|Adverse Event|2|||
125477685|NCT03770273|451383059|FG001|Overall Study|Adverse Event|0|||
125477686|NCT03770273|451383058|FG000|Overall Study|Lost to Follow-up|1|||
125477687|NCT03770273|451383059|FG001|Overall Study|Lost to Follow-up|1|||
125477688|NCT00418886|451383060|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
125477689|NCT00418886|451383061|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
125477690|NCT00418886|451383060|FG000|Randomized Period|Death|122|||
125477691|NCT00418886|451383061|FG001|Randomized Period|Death|147|||
125477692|NCT00418886|451383060|FG000|Randomized Period|Withdrawal by Subject|9|||
125477693|NCT00418886|451383061|FG001|Randomized Period|Withdrawal by Subject|10|||
125477694|NCT00418886|451383060|FG000|Randomized Period|Lost to Follow-up|4|||
125477695|NCT00418886|451383061|FG001|Randomized Period|Lost to Follow-up|6|||
125477696|NCT00418886|451383060|FG000|Randomized Period|withdrawn due to other reason|1|||
125477697|NCT00418886|451383061|FG001|Randomized Period|withdrawn due to other reason|0|||
125477698|NCT00418886|451383060|FG000|Randomized Period|randomised but no treatment received|0|||
125477699|NCT00418886|451383061|FG001|Randomized Period|randomised but no treatment received|1|||
125477700|NCT04060654|451383062|FG000|Overall Study|Withdrawal by Subject|1|||
125477701|NCT04060654|451383062|FG000|Overall Study|Lost to Follow-up|5|||
125477702|NCT03707951|451383063|FG000|Overall Study|Lost to Follow-up|8|||
125477703|NCT03707951|451383064|FG001|Overall Study|Lost to Follow-up|17|||
125477704|NCT03707951|451383063|FG000|Overall Study|Withdrawal by Subject|6|||
125477705|NCT03707951|451383064|FG001|Overall Study|Withdrawal by Subject|6|||
125477706|NCT04887129|451383065|FG000|Overall Study|Lost to Follow-up|0|||
125477707|NCT04887129|451383066|FG001|Overall Study|Lost to Follow-up|24|||
125477708|NCT04887129|451383065|FG000|Overall Study|Withdrawal by Subject|9|||
125477709|NCT04887129|451383066|FG001|Overall Study|Withdrawal by Subject|57|||
125477710|NCT04887129|451383065|FG000|Overall Study|Other|2|||
125477711|NCT04887129|451383066|FG001|Overall Study|Other|9|||
125477712|NCT02921230|451383073|FG000|Overall Study|Withdrawal by Subject|20|||
125477713|NCT02921230|451383074|FG001|Overall Study|Withdrawal by Subject|8|||
125477714|NCT02921230|451383073|FG000|Overall Study|Death|12|||
125477715|NCT02921230|451383074|FG001|Overall Study|Death|3|||
125477716|NCT02921230|451383073|FG000|Overall Study|Protocol Violation|17|||
125477717|NCT02921230|451383074|FG001|Overall Study|Protocol Violation|6|||
125477718|NCT02921230|451383073|FG000|Overall Study|Early completion|5|||
125477719|NCT02921230|451383074|FG001|Overall Study|Early completion|1|||
125477720|NCT02921230|451383073|FG000|Overall Study|Pending data entry|1|||
125477721|NCT02921230|451383074|FG001|Overall Study|Pending data entry|0|||
125477722|NCT03436290|451383075|FG000|Overall Study|Post-randomization Exclusion|1|||
125477723|NCT03436290|451383076|FG001|Overall Study|Post-randomization Exclusion|0|||
125477724|NCT03436290|451383075|FG000|Overall Study|Death|6|||
125477725|NCT03436290|451383076|FG001|Overall Study|Death|0|||
125477726|NCT03436290|451383075|FG000|Overall Study|Withdrawal by Subject|4|||
125477727|NCT03436290|451383076|FG001|Overall Study|Withdrawal by Subject|0|||
125477728|NCT03436290|451383075|FG000|Overall Study|Protocol Violation|30|||
125477729|NCT03436290|451383076|FG001|Overall Study|Protocol Violation|0|||
125477730|NCT05177848|451383081|FG000|Overall Study|Lost to Follow-up|1|||
125477731|NCT05177848|451383082|FG001|Overall Study|Lost to Follow-up|4|||
125477732|NCT05177848|451383081|FG000|Overall Study|Discontinued|2|||
125477733|NCT05177848|451383082|FG001|Overall Study|Discontinued|1|||
125477734|NCT01084876|451383083|FG000|Main Study Treatment Period|Adverse Event|12|||
125477735|NCT01084876|451383084|FG001|Main Study Treatment Period|Adverse Event|7|||
125477736|NCT01084876|451383083|FG000|Main Study Treatment Period|Disease Progression|41|||
125477737|NCT01084876|451383084|FG001|Main Study Treatment Period|Disease Progression|24|||
125477738|NCT01084876|451383083|FG000|Main Study Treatment Period|Physician Decision|2|||
125477739|NCT01084876|451383084|FG001|Main Study Treatment Period|Physician Decision|0|||
125477740|NCT01084876|451383083|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
125477741|NCT01084876|451383084|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
125477742|NCT01084876|451383083|FG000|Main Study Treatment Period|Other Reason|0|||
125477743|NCT01084876|451383084|FG001|Main Study Treatment Period|Other Reason|1|||
125477744|NCT01084876|451383083|FG000|Main Study Treatment Period|Other|0|||
125477745|NCT01084876|451383084|FG001|Main Study Treatment Period|Other|1|||
125477746|NCT01084876|451383083|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
125477747|NCT01084876|451383084|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
125477748|NCT01084876|451383083|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
125477749|NCT01084876|451383084|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
125477750|NCT01084876|451383083|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
125477751|NCT01084876|451383084|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
125477752|NCT01084876|451383083|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
125477753|NCT01084876|451383084|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
125477754|NCT01084876|451383083|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
125477755|NCT01084876|451383084|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
125477756|NCT01084876|451383083|FG000|Treatment Period Beyond Cycle 8|Other|6|||
125477757|NCT01084876|451383084|FG001|Treatment Period Beyond Cycle 8|Other|9|||
125477758|NCT04971395|451383085|FG000|Overall Study|Withdrawal by Subject|0|||
125477759|NCT04971395|451383086|FG001|Overall Study|Withdrawal by Subject|1|||
125477760|NCT04971395|451383087|FG002|Overall Study|Withdrawal by Subject|0|||
125477761|NCT03771417|451383088|FG000|Overall Study|Withdrawal by Subject|1|||
125477762|NCT03771417|451383089|FG001|Overall Study|Withdrawal by Subject|0|||
125477763|NCT03771417|451383090|FG002|Overall Study|Withdrawal by Subject|0|||
125477764|NCT03771417|451383088|FG000|Overall Study|Covid-19 Shutdown|0|||
125477765|NCT03771417|451383089|FG001|Overall Study|Covid-19 Shutdown|1|||
125477766|NCT03771417|451383090|FG002|Overall Study|Covid-19 Shutdown|0|||
125477767|NCT04342494|451383092|FG000|Overall Study|Questionnaire partially completed|1|||
125477768|NCT04342494|451383093|FG001|Overall Study|Questionnaire partially completed|0|||
125477769|NCT04342494|451383094|FG002|Overall Study|Questionnaire partially completed|2|||
125477770|NCT04342494|451383095|FG003|Overall Study|Questionnaire partially completed|0|||
125477771|NCT04342494|451383096|FG004|Overall Study|Questionnaire partially completed|1|||
125477772|NCT04342494|451383092|FG000|Overall Study|Lost to Follow-up|49|||
125477773|NCT04342494|451383093|FG001|Overall Study|Lost to Follow-up|38|||
125477774|NCT04342494|451383094|FG002|Overall Study|Lost to Follow-up|34|||
125477775|NCT04342494|451383095|FG003|Overall Study|Lost to Follow-up|34|||
125477776|NCT04342494|451383096|FG004|Overall Study|Lost to Follow-up|35|||
125477777|NCT01214616|451383099|FG000|Overall Study|Progressive disease|2|||
125477778|NCT01214616|451383100|FG001|Overall Study|Progressive disease|2|||
125477779|NCT01214616|451383101|FG002|Overall Study|Progressive disease|2|||
125477780|NCT01214616|451383102|FG003|Overall Study|Progressive disease|4|||
125477781|NCT01214616|451383099|FG000|Overall Study|Dose limiting toxicity|0|||
125477782|NCT01214616|451383100|FG001|Overall Study|Dose limiting toxicity|2|||
125477783|NCT01214616|451383101|FG002|Overall Study|Dose limiting toxicity|0|||
125477784|NCT01214616|451383102|FG003|Overall Study|Dose limiting toxicity|0|||
125477785|NCT01214616|451383099|FG000|Overall Study|Other adverse events|0|||
125477786|NCT01214616|451383100|FG001|Overall Study|Other adverse events|1|||
125477787|NCT01214616|451383101|FG002|Overall Study|Other adverse events|1|||
125477788|NCT01214616|451383102|FG003|Overall Study|Other adverse events|1|||
125477789|NCT01214616|451383099|FG000|Overall Study|Withdrawal by Subject|1|||
125477790|NCT01214616|451383100|FG001|Overall Study|Withdrawal by Subject|0|||
125477791|NCT01214616|451383101|FG002|Overall Study|Withdrawal by Subject|0|||
125477792|NCT01214616|451383102|FG003|Overall Study|Withdrawal by Subject|1|||
125477793|NCT03721952|451383103|FG000|Overall Study|Lost to Follow-up|0|||
125477794|NCT03721952|451383104|FG001|Overall Study|Lost to Follow-up|0|||
125477795|NCT03721952|451383105|FG002|Overall Study|Lost to Follow-up|2|||
125477796|NCT03721952|451383106|FG003|Overall Study|Lost to Follow-up|0|||
125477797|NCT03721952|451383107|FG004|Overall Study|Lost to Follow-up|0|||
125477798|NCT03721952|451383103|FG000|Overall Study|Protocol Violation|0|||
125300257|NCT01329939|450725954|FG000|Overall Study|Lost to Follow-up|3|||
125300258|NCT01329939|450725955|FG001|Overall Study|Lost to Follow-up|0|||
125300259|NCT01329939|450725956|FG002|Overall Study|Lost to Follow-up|1|||
125300260|NCT01329939|450725957|FG003|Overall Study|Lost to Follow-up|2|||
125300261|NCT01329939|450725954|FG000|Overall Study|Withdrawal by Subject|0|||
125300262|NCT01329939|450725955|FG001|Overall Study|Withdrawal by Subject|1|||
125300263|NCT01329939|450725956|FG002|Overall Study|Withdrawal by Subject|0|||
125300264|NCT01329939|450725957|FG003|Overall Study|Withdrawal by Subject|0|||
125300265|NCT01329939|450725954|FG000|Overall Study|Adverse Event|0|||
125300266|NCT01329939|450725955|FG001|Overall Study|Adverse Event|0|||
125300267|NCT01329939|450725956|FG002|Overall Study|Adverse Event|0|||
125300268|NCT01329939|450725957|FG003|Overall Study|Adverse Event|3|||
125300269|NCT02942485|450725958|FG000|Overall Study|Lost to Follow-up|1|||
125300270|NCT02942485|450725959|FG001|Overall Study|Lost to Follow-up|0|||
125300271|NCT04369950|450725961|FG000|Overall Study|Protocol Violation|2|||
125300272|NCT04369950|450725962|FG001|Overall Study|Protocol Violation|2|||
125300273|NCT00989963|450725963|FG000|Overall Study|Adverse Event|1|||
125300274|NCT00989963|450725964|FG001|Overall Study|Adverse Event|1|||
125300275|NCT00989963|450725965|FG002|Overall Study|Adverse Event|1|||
125300276|NCT01240200|450725966|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
125477799|NCT03721952|451383104|FG001|Overall Study|Protocol Violation|1|||
125477800|NCT03721952|451383105|FG002|Overall Study|Protocol Violation|0|||
125477801|NCT03721952|451383106|FG003|Overall Study|Protocol Violation|0|||
125477802|NCT03721952|451383107|FG004|Overall Study|Protocol Violation|0|||
125300277|NCT01240200|450725967|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
125300278|NCT01529034|450725968|FG000|Overall Study|Discontinued prior to study treatment|14|||
125477803|NCT03721952|451383103|FG000|Overall Study|Withdrawal by Subject|1|||
125477804|NCT03721952|451383104|FG001|Overall Study|Withdrawal by Subject|0|||
125477805|NCT03721952|451383105|FG002|Overall Study|Withdrawal by Subject|40|||
125477806|NCT03721952|451383106|FG003|Overall Study|Withdrawal by Subject|28|||
125477807|NCT03721952|451383107|FG004|Overall Study|Withdrawal by Subject|0|||
125485386|NCT02240238|451412512|FG009|Phase 1|Withdrawal by Subject|0|||
125300279|NCT01529034|450725968|FG000|Overall Study|Site closure|62|||
125300280|NCT01529034|450725968|FG000|Overall Study|Study termination|29|||
125300281|NCT01529034|450725968|FG000|Overall Study|Withdrawal by Subject|25|||
125300282|NCT01529034|450725968|FG000|Overall Study|No treated SCs within protocol window|13|||
125300283|NCT01529034|450725968|FG000|Overall Study|Noncompliance|8|||
125300284|NCT01529034|450725968|FG000|Overall Study|Caregiver no longer available|7|||
125300285|NCT01529034|450725968|FG000|Overall Study|Adverse Event|4|||
125300286|NCT01529034|450725968|FG000|Overall Study|Protocol Violation|4|||
125300287|NCT01529034|450725968|FG000|Overall Study|Lack of Efficacy|4|||
125300288|NCT01529034|450725968|FG000|Overall Study|Investigator no longer available|2|||
125300289|NCT01529034|450725968|FG000|Overall Study|Study drug not available|2|||
125300290|NCT03194646|450725972|FG000|Overall Study|Adverse Event|24|||
125300291|NCT03194646|450725973|FG001|Overall Study|Adverse Event|25|||
125300292|NCT03194646|450725974|FG002|Overall Study|Adverse Event|14|||
125300293|NCT03194646|450725975|FG003|Overall Study|Adverse Event|17|||
125300294|NCT03194646|450725972|FG000|Overall Study|Lack of Efficacy|4|||
125300295|NCT03194646|450725973|FG001|Overall Study|Lack of Efficacy|2|||
125300296|NCT03194646|450725974|FG002|Overall Study|Lack of Efficacy|2|||
125300297|NCT03194646|450725975|FG003|Overall Study|Lack of Efficacy|12|||
125300298|NCT03194646|450725972|FG000|Overall Study|Lost to Follow-up|30|||
125300299|NCT03194646|450725973|FG001|Overall Study|Lost to Follow-up|22|||
125300300|NCT03194646|450725974|FG002|Overall Study|Lost to Follow-up|12|||
125300301|NCT03194646|450725975|FG003|Overall Study|Lost to Follow-up|35|||
125300302|NCT03194646|450725972|FG000|Overall Study|Non-compliance with study drug|4|||
125300303|NCT03194646|450725973|FG001|Overall Study|Non-compliance with study drug|0|||
125300304|NCT03194646|450725974|FG002|Overall Study|Non-compliance with study drug|1|||
125300305|NCT03194646|450725975|FG003|Overall Study|Non-compliance with study drug|1|||
125300306|NCT03194646|450725972|FG000|Overall Study|Other|89|||
125300307|NCT03194646|450725973|FG001|Overall Study|Other|68|||
125300308|NCT03194646|450725974|FG002|Overall Study|Other|34|||
125300309|NCT03194646|450725975|FG003|Overall Study|Other|31|||
125300310|NCT03194646|450725972|FG000|Overall Study|Physician Decision|7|||
125300311|NCT03194646|450725973|FG001|Overall Study|Physician Decision|9|||
125300312|NCT03194646|450725974|FG002|Overall Study|Physician Decision|5|||
125300313|NCT03194646|450725975|FG003|Overall Study|Physician Decision|4|||
125300314|NCT03194646|450725972|FG000|Overall Study|Pregnancy|4|||
125300315|NCT03194646|450725973|FG001|Overall Study|Pregnancy|5|||
125300316|NCT03194646|450725974|FG002|Overall Study|Pregnancy|1|||
125300317|NCT03194646|450725975|FG003|Overall Study|Pregnancy|2|||
125300318|NCT03194646|450725972|FG000|Overall Study|Protocol Violation|4|||
125300319|NCT03194646|450725973|FG001|Overall Study|Protocol Violation|2|||
125300320|NCT03194646|450725974|FG002|Overall Study|Protocol Violation|1|||
125300321|NCT03194646|450725975|FG003|Overall Study|Protocol Violation|1|||
125300322|NCT03194646|450725972|FG000|Overall Study|Site terminated by sponsor|0|||
125300323|NCT03194646|450725973|FG001|Overall Study|Site terminated by sponsor|0|||
125300324|NCT03194646|450725974|FG002|Overall Study|Site terminated by sponsor|2|||
125300325|NCT03194646|450725975|FG003|Overall Study|Site terminated by sponsor|0|||
125300326|NCT03194646|450725972|FG000|Overall Study|Study terminated by sponsor|62|||
125300327|NCT03194646|450725973|FG001|Overall Study|Study terminated by sponsor|61|||
125300328|NCT03194646|450725974|FG002|Overall Study|Study terminated by sponsor|30|||
125300329|NCT03194646|450725975|FG003|Overall Study|Study terminated by sponsor|34|||
125300330|NCT03194646|450725972|FG000|Overall Study|Withdrawal by Subject|75|||
125300331|NCT03194646|450725973|FG001|Overall Study|Withdrawal by Subject|74|||
125300332|NCT03194646|450725974|FG002|Overall Study|Withdrawal by Subject|36|||
125300333|NCT03194646|450725975|FG003|Overall Study|Withdrawal by Subject|131|||
125300334|NCT03194646|450725972|FG000|Overall Study|Missing|1|||
125300335|NCT03194646|450725973|FG001|Overall Study|Missing|0|||
125300336|NCT03194646|450725974|FG002|Overall Study|Missing|1|||
125300337|NCT03194646|450725975|FG003|Overall Study|Missing|12|||
125477808|NCT05292365|451383108|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
125477809|NCT05292365|451383109|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
125477810|NCT05292365|451383110|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
125485387|NCT02240238|451412513|FG010|Phase 1|Withdrawal by Subject|0|||
125300338|NCT02649894|450725976|FG000|Overall Study|Adverse Event|1|||
125300339|NCT02649894|450725977|FG001|Overall Study|Adverse Event|0|||
125300340|NCT02649894|450725976|FG000|Overall Study|Physician Decision|0|||
125300341|NCT02649894|450725977|FG001|Overall Study|Physician Decision|1|||
125300342|NCT02649894|450725976|FG000|Overall Study|Withdrawal by Subject|5|||
125300343|NCT02649894|450725977|FG001|Overall Study|Withdrawal by Subject|2|||
125300344|NCT02649894|450725976|FG000|Overall Study|Lost to Follow-up|2|||
125300345|NCT02649894|450725977|FG001|Overall Study|Lost to Follow-up|1|||
125300346|NCT02649894|450725976|FG000|Overall Study|Death|30|||
125300347|NCT02649894|450725977|FG001|Overall Study|Death|7|||
125300348|NCT02649894|450725976|FG000|Overall Study|Other, not specified|6|||
125300349|NCT02649894|450725977|FG001|Overall Study|Other, not specified|0|||
125300350|NCT00719680|450725978|FG000|Overall Study|Adverse Event|1|||
125300351|NCT00719680|450725978|FG000|Overall Study|Lost to Follow-up|1|||
125300352|NCT00719680|450725978|FG000|Overall Study|Withdrawal by Subject|3|||
125300353|NCT02141360|450725979|FG000|Overall Study|Withdrawal by Subject|6|||
125300354|NCT02141360|450725980|FG001|Overall Study|Withdrawal by Subject|0|||
125300355|NCT02141360|450725981|FG002|Overall Study|Withdrawal by Subject|0|||
125300356|NCT02141360|450725979|FG000|Overall Study|Study Terminated before Visit|1|||
125300357|NCT02141360|450725980|FG001|Overall Study|Study Terminated before Visit|0|||
125300358|NCT02141360|450725981|FG002|Overall Study|Study Terminated before Visit|0|||
125300359|NCT04071158|450725982|FG000|Overall Study|Lost to Follow-up|1|||
125300360|NCT04071158|450725983|FG001|Overall Study|Lost to Follow-up|2|||
125300361|NCT04071158|450725984|FG002|Overall Study|Lost to Follow-up|3|||
125300362|NCT04071158|450725985|FG003|Overall Study|Lost to Follow-up|3|||
125300363|NCT04071158|450725986|FG004|Overall Study|Lost to Follow-up|5|||
125300364|NCT04071158|450725982|FG000|Overall Study|Randomized but not treated|2|||
125300365|NCT04071158|450725983|FG001|Overall Study|Randomized but not treated|2|||
125300366|NCT04071158|450725984|FG002|Overall Study|Randomized but not treated|0|||
125300367|NCT04071158|450725985|FG003|Overall Study|Randomized but not treated|0|||
125300368|NCT04071158|450725986|FG004|Overall Study|Randomized but not treated|0|||
125300369|NCT01178099|450725987|FG000|Overall Study|Physician Decision|0|||
125300370|NCT01178099|450725988|FG001|Overall Study|Physician Decision|1|||
125300371|NCT05198843|450725989|FG000|Overall Study|Lack of Efficacy|1|||
125300372|NCT01641822|450725991|FG000|Run-in Phase|Noncompliance with study drug|1|||
125300373|NCT01641822|450725992|FG001|Run-in Phase|Noncompliance with study drug|0|||
125300374|NCT01641822|450725993|FG002|Run-in Phase|Noncompliance with study drug|0|||
125300375|NCT01641822|450725991|FG000|Run-in Phase|Adverse Event|3|||
125300376|NCT01641822|450725992|FG001|Run-in Phase|Adverse Event|0|||
125300377|NCT01641822|450725993|FG002|Run-in Phase|Adverse Event|0|||
125300378|NCT01641822|450725991|FG000|Run-in Phase|Withdrew consent|1|||
125300379|NCT01641822|450725992|FG001|Run-in Phase|Withdrew consent|0|||
125300380|NCT01641822|450725993|FG002|Run-in Phase|Withdrew consent|0|||
125300381|NCT01641822|450725991|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
125300382|NCT01641822|450725992|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
125300383|NCT01641822|450725993|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
125300384|NCT01641822|450725991|FG000|Comparative Phase|Noncompliance with study drug|0|||
125300385|NCT01641822|450725992|FG001|Comparative Phase|Noncompliance with study drug|1|||
125300386|NCT01641822|450725993|FG002|Comparative Phase|Noncompliance with study drug|0|||
125300387|NCT01641822|450725991|FG000|Comparative Phase|Investigator's discretion|0|||
125300388|NCT01641822|450725992|FG001|Comparative Phase|Investigator's discretion|0|||
125300389|NCT01641822|450725993|FG002|Comparative Phase|Investigator's discretion|1|||
125300390|NCT01641822|450725991|FG000|Comparative Phase|Pregnancy|0|||
125300391|NCT01641822|450725992|FG001|Comparative Phase|Pregnancy|0|||
125300392|NCT01641822|450725993|FG002|Comparative Phase|Pregnancy|1|||
125300393|NCT01641822|450725991|FG000|Comparative Phase|Adverse event, serious fatal|0|||
125300394|NCT01641822|450725992|FG001|Comparative Phase|Adverse event, serious fatal|1|||
125300395|NCT01641822|450725993|FG002|Comparative Phase|Adverse event, serious fatal|0|||
125300396|NCT01641822|450725991|FG000|Comparative Phase|Withdrew consent|0|||
125300397|NCT01641822|450725992|FG001|Comparative Phase|Withdrew consent|3|||
125300398|NCT01641822|450725993|FG002|Comparative Phase|Withdrew consent|7|||
125300399|NCT01641822|450725991|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
125300400|NCT01641822|450725992|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
125300401|NCT01641822|450725993|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
125300402|NCT00454584|450725994|FG000|Controlled Period|Adverse Event|5|||
125300403|NCT00454584|450725995|FG001|Controlled Period|Adverse Event|2|||
125300404|NCT00454584|450725996|FG002|Controlled Period|Adverse Event|1|||
125300405|NCT00454584|450725997|FG003|Controlled Period|Adverse Event|0|||
125300406|NCT00454584|450725998|FG004|Controlled Period|Adverse Event|0|||
125300407|NCT00454584|450725999|FG005|Controlled Period|Adverse Event|0|||
125300408|NCT00454584|450725994|FG000|Controlled Period|Lost to Follow-up|1|||
125300409|NCT00454584|450725995|FG001|Controlled Period|Lost to Follow-up|2|||
125300410|NCT00454584|450725996|FG002|Controlled Period|Lost to Follow-up|2|||
125300411|NCT00454584|450725997|FG003|Controlled Period|Lost to Follow-up|0|||
125300412|NCT00454584|450725998|FG004|Controlled Period|Lost to Follow-up|0|||
125300413|NCT00454584|450725999|FG005|Controlled Period|Lost to Follow-up|0|||
125300414|NCT00454584|450725994|FG000|Controlled Period|Other|5|||
125300415|NCT00454584|450725995|FG001|Controlled Period|Other|4|||
125300416|NCT00454584|450725996|FG002|Controlled Period|Other|2|||
125300417|NCT00454584|450725997|FG003|Controlled Period|Other|0|||
125300418|NCT00454584|450725998|FG004|Controlled Period|Other|0|||
125300419|NCT00454584|450725999|FG005|Controlled Period|Other|0|||
125300420|NCT00454584|450725994|FG000|After Controlled Period|Adverse Event|0|||
125300421|NCT00454584|450725995|FG001|After Controlled Period|Adverse Event|0|||
125300422|NCT00454584|450725996|FG002|After Controlled Period|Adverse Event|0|||
125300423|NCT00454584|450725997|FG003|After Controlled Period|Adverse Event|9|||
125300424|NCT00454584|450725998|FG004|After Controlled Period|Adverse Event|3|||
125300425|NCT00454584|450725999|FG005|After Controlled Period|Adverse Event|9|||
125300426|NCT00454584|450725994|FG000|After Controlled Period|Lack of Efficacy|0|||
125300427|NCT00454584|450725995|FG001|After Controlled Period|Lack of Efficacy|0|||
125300428|NCT00454584|450725996|FG002|After Controlled Period|Lack of Efficacy|0|||
125300429|NCT00454584|450725997|FG003|After Controlled Period|Lack of Efficacy|1|||
125300430|NCT00454584|450725998|FG004|After Controlled Period|Lack of Efficacy|0|||
125300431|NCT00454584|450725999|FG005|After Controlled Period|Lack of Efficacy|0|||
125300432|NCT00454584|450725994|FG000|After Controlled Period|Lost to Follow-up|0|||
125300433|NCT00454584|450725995|FG001|After Controlled Period|Lost to Follow-up|0|||
125300434|NCT00454584|450725996|FG002|After Controlled Period|Lost to Follow-up|0|||
125300435|NCT00454584|450725997|FG003|After Controlled Period|Lost to Follow-up|2|||
125300436|NCT00454584|450725998|FG004|After Controlled Period|Lost to Follow-up|4|||
125300437|NCT00454584|450725999|FG005|After Controlled Period|Lost to Follow-up|6|||
125300438|NCT00454584|450725994|FG000|After Controlled Period|Other|0|||
125300439|NCT00454584|450725995|FG001|After Controlled Period|Other|0|||
125300440|NCT00454584|450725996|FG002|After Controlled Period|Other|0|||
125300441|NCT00454584|450725997|FG003|After Controlled Period|Other|1|||
125300442|NCT00454584|450725998|FG004|After Controlled Period|Other|0|||
125300443|NCT00454584|450725999|FG005|After Controlled Period|Other|0|||
125300444|NCT00454584|450725994|FG000|After Controlled Period|Other|0|||
125300445|NCT00454584|450725995|FG001|After Controlled Period|Other|0|||
125300446|NCT00454584|450725996|FG002|After Controlled Period|Other|0|||
125300447|NCT00454584|450725997|FG003|After Controlled Period|Other|13|||
125300448|NCT00454584|450725998|FG004|After Controlled Period|Other|5|||
125300449|NCT00454584|450725999|FG005|After Controlled Period|Other|17|||
125300450|NCT02421601|450726000|FG000|Overall Study|Adverse Event|4|||
125300451|NCT02421601|450726000|FG000|Overall Study|Lack of Efficacy|5|||
125300452|NCT02421601|450726000|FG000|Overall Study|Physician Decision|1|||
125300453|NCT02421601|450726000|FG000|Overall Study|Withdrawal by Subject|31|||
125300454|NCT02421601|450726000|FG000|Overall Study|Others|41|||
125300455|NCT00470418|450726001|FG000|Overall Study|Withdrawal by Subject|1|||
125300456|NCT00470418|450726002|FG001|Overall Study|Withdrawal by Subject|0|||
125300457|NCT00599638|450726003|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
125300458|NCT00599638|450726004|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
125300459|NCT00599638|450726005|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
125300460|NCT00599638|450726006|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
125300461|NCT00599638|450726003|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
125300462|NCT00599638|450726004|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
125300463|NCT00599638|450726005|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
125300464|NCT00599638|450726006|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
125300465|NCT00599638|450726003|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
125300466|NCT00599638|450726004|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
125300467|NCT00599638|450726005|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
125300468|NCT00599638|450726006|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
125300469|NCT00599638|450726003|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
125300470|NCT00599638|450726004|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
125300471|NCT00599638|450726005|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
125300472|NCT00599638|450726006|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
125300473|NCT00599638|450726003|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
125300474|NCT00599638|450726004|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
125300475|NCT00599638|450726005|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
125300476|NCT00599638|450726006|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
125300477|NCT00599638|450726003|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
125300478|NCT00599638|450726004|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
125300479|NCT00599638|450726005|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
125300480|NCT00599638|450726006|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
125300481|NCT00599638|450726003|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
125300482|NCT00599638|450726004|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
125300483|NCT00599638|450726005|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
125300484|NCT00599638|450726006|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
125300485|NCT00599638|450726003|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
125300486|NCT00599638|450726004|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
125300487|NCT00599638|450726005|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
125300488|NCT00599638|450726006|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
125300489|NCT00599638|450726003|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
125300490|NCT00599638|450726004|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
125300491|NCT00599638|450726005|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
125300492|NCT00599638|450726006|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
125300493|NCT04058886|450726021|FG000|Overall Study|Withdrawal by Subject|4|||
125300494|NCT04058886|450726021|FG000|Overall Study|Inadequate deafness interpreter service|1|||
125300495|NCT02220712|450726029|FG000|Overall Study|Adverse Event|1|||
125300496|NCT02220712|450726029|FG000|Overall Study|Withdrawal by Subject|2|||
125300497|NCT02220712|450726029|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
125300498|NCT00760838|450726031|FG000|Overall Study|Adverse Event|1|||
125300499|NCT00760838|450726032|FG001|Overall Study|Adverse Event|1|||
125485388|NCT02240238|451412514|FG011|Phase 1|Withdrawal by Subject|0|||
125300500|NCT00760838|450726031|FG000|Overall Study|Lack of Efficacy|1|||
125300501|NCT00760838|450726032|FG001|Overall Study|Lack of Efficacy|0|||
125300502|NCT00760838|450726031|FG000|Overall Study|Lost to Follow-up|2|||
125300503|NCT00760838|450726032|FG001|Overall Study|Lost to Follow-up|0|||
125300504|NCT00760838|450726031|FG000|Overall Study|Withdrawal by Subject|1|||
125300505|NCT00760838|450726032|FG001|Overall Study|Withdrawal by Subject|1|||
125300506|NCT03624127|450726033|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
125300507|NCT03624127|450726034|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
125300508|NCT03624127|450726035|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
125300509|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
125300510|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
125300511|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
125300512|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Death|0|||
125300513|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Death|1|||
125300514|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Death|0|||
125300515|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
125300516|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
125300517|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
125300518|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
125300519|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
125300520|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
125300521|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
125300522|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
125300523|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
125300524|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
125300525|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
125300526|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
125300527|NCT03624127|450726033|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
125300528|NCT03624127|450726034|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
125300529|NCT03624127|450726035|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
125300530|NCT03624127|450726033|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
125300531|NCT03624127|450726034|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
125300532|NCT03624127|450726035|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
125300533|NCT03624127|450726033|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
125300534|NCT03624127|450726034|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
125300535|NCT03624127|450726035|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
125300536|NCT03624127|450726033|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
125300537|NCT03624127|450726034|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
125300538|NCT03624127|450726035|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
125300539|NCT03624127|450726033|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
125300540|NCT03624127|450726034|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
125300541|NCT03624127|450726035|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
125300542|NCT03624127|450726033|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
125300543|NCT03624127|450726034|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
125300544|NCT03624127|450726035|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
125300545|NCT03624127|450726033|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
125300546|NCT03624127|450726034|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
125300547|NCT03624127|450726035|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
125300548|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
125300549|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
125300550|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
125300551|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
125300552|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
125300553|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
125300554|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
125300555|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
125300556|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
125300557|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
125300558|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
125300559|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
125300560|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
125300561|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
125300562|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
125300563|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
125300564|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
125300565|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
125300566|NCT03624127|450726033|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
125300567|NCT03624127|450726034|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
125300568|NCT03624127|450726035|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
125300569|NCT02999633|450726036|FG000|Overall Study|Adverse Event|2|||
125300570|NCT02999633|450726036|FG000|Overall Study|Progressive disease|12|||
125300571|NCT02607228|450726037|FG000|Overall Study|Progressive Disease|4|||
125300572|NCT02607228|450726038|FG001|Overall Study|Progressive Disease|3|||
125300573|NCT02607228|450726039|FG002|Overall Study|Progressive Disease|1|||
125300574|NCT02607228|450726040|FG003|Overall Study|Progressive Disease|5|||
125300575|NCT02607228|450726041|FG004|Overall Study|Progressive Disease|4|||
125300576|NCT02607228|450726042|FG005|Overall Study|Progressive Disease|3|||
125300577|NCT02607228|450726043|FG006|Overall Study|Progressive Disease|1|||
125300578|NCT02607228|450726037|FG000|Overall Study|Adverse Event|1|||
125300579|NCT02607228|450726038|FG001|Overall Study|Adverse Event|0|||
125300580|NCT02607228|450726039|FG002|Overall Study|Adverse Event|1|||
125300581|NCT02607228|450726040|FG003|Overall Study|Adverse Event|0|||
125300582|NCT02607228|450726041|FG004|Overall Study|Adverse Event|1|||
125300583|NCT02607228|450726042|FG005|Overall Study|Adverse Event|1|||
125300584|NCT02607228|450726043|FG006|Overall Study|Adverse Event|1|||
125300585|NCT02607228|450726037|FG000|Overall Study|Investigator's Discretion|0|||
125300586|NCT02607228|450726038|FG001|Overall Study|Investigator's Discretion|0|||
125300587|NCT02607228|450726039|FG002|Overall Study|Investigator's Discretion|1|||
125300588|NCT02607228|450726040|FG003|Overall Study|Investigator's Discretion|0|||
125300589|NCT02607228|450726041|FG004|Overall Study|Investigator's Discretion|0|||
125300590|NCT02607228|450726042|FG005|Overall Study|Investigator's Discretion|1|||
125300591|NCT02607228|450726043|FG006|Overall Study|Investigator's Discretion|0|||
125300592|NCT02607228|450726037|FG000|Overall Study|Withdrew Consent|0|||
125300593|NCT02607228|450726038|FG001|Overall Study|Withdrew Consent|1|||
125300594|NCT02607228|450726039|FG002|Overall Study|Withdrew Consent|0|||
125300595|NCT02607228|450726040|FG003|Overall Study|Withdrew Consent|0|||
125300596|NCT02607228|450726041|FG004|Overall Study|Withdrew Consent|0|||
125300597|NCT02607228|450726042|FG005|Overall Study|Withdrew Consent|1|||
125300598|NCT02607228|450726043|FG006|Overall Study|Withdrew Consent|0|||
125300599|NCT02607228|450726037|FG000|Overall Study|Study Terminated by Sponsor|0|||
125300600|NCT02607228|450726038|FG001|Overall Study|Study Terminated by Sponsor|0|||
125300601|NCT02607228|450726039|FG002|Overall Study|Study Terminated by Sponsor|0|||
125300602|NCT02607228|450726040|FG003|Overall Study|Study Terminated by Sponsor|1|||
125300603|NCT02607228|450726041|FG004|Overall Study|Study Terminated by Sponsor|0|||
125300604|NCT02607228|450726042|FG005|Overall Study|Study Terminated by Sponsor|0|||
125300605|NCT02607228|450726043|FG006|Overall Study|Study Terminated by Sponsor|0|||
125300606|NCT00788710|450726044|FG000|Overall Study|Adverse Event|1|||
125300607|NCT00788710|450726045|FG001|Overall Study|Adverse Event|3|||
125300608|NCT00788710|450726046|FG002|Overall Study|Adverse Event|4|||
125300609|NCT00788710|450726044|FG000|Overall Study|Lack of Efficacy|0|||
125300610|NCT00788710|450726045|FG001|Overall Study|Lack of Efficacy|0|||
125300611|NCT00788710|450726046|FG002|Overall Study|Lack of Efficacy|1|||
125300612|NCT00788710|450726044|FG000|Overall Study|Lost to Follow-up|0|||
125300613|NCT00788710|450726045|FG001|Overall Study|Lost to Follow-up|1|||
125300614|NCT00788710|450726046|FG002|Overall Study|Lost to Follow-up|0|||
125300615|NCT00788710|450726044|FG000|Overall Study|Physician Decision|2|||
125300616|NCT00788710|450726045|FG001|Overall Study|Physician Decision|1|||
125300617|NCT00788710|450726046|FG002|Overall Study|Physician Decision|0|||
125300618|NCT00788710|450726044|FG000|Overall Study|Protocol Violation|0|||
125300619|NCT00788710|450726045|FG001|Overall Study|Protocol Violation|1|||
125300620|NCT00788710|450726046|FG002|Overall Study|Protocol Violation|1|||
125300621|NCT00788710|450726044|FG000|Overall Study|Withdrawal by Subject|2|||
125300622|NCT00788710|450726045|FG001|Overall Study|Withdrawal by Subject|2|||
125300623|NCT00788710|450726046|FG002|Overall Study|Withdrawal by Subject|0|||
125300624|NCT00605345|450726051|FG000|Overall Study|Withdrawal by Subject|1|||
125300625|NCT00605345|450726052|FG001|Overall Study|Withdrawal by Subject|0|||
125300626|NCT00605345|450726051|FG000|Overall Study|Adverse Event|0|||
125300627|NCT00605345|450726052|FG001|Overall Study|Adverse Event|1|||
125300628|NCT00605345|450726051|FG000|Overall Study|Protocol Violation|0|||
125300629|NCT00605345|450726052|FG001|Overall Study|Protocol Violation|2|||
125300630|NCT05066165|450727787|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
125300631|NCT05066165|450727788|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
125300632|NCT05066165|450727787|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
125300633|NCT05066165|450727788|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
125300634|NCT00742417|450727789|FG000|Randomized|Withdrawal by legal representative|0|||
125300635|NCT00742417|450727790|FG001|Randomized|Withdrawal by legal representative|1|||
125300636|NCT00742417|450727789|FG000|Randomized|Withdrawal by Subject|1|||
125300637|NCT00742417|450727790|FG001|Randomized|Withdrawal by Subject|0|||
125300638|NCT00742417|450727789|FG000|Randomized|Physician Decision|1|||
125300639|NCT00742417|450727790|FG001|Randomized|Physician Decision|0|||
125300640|NCT00742417|450727789|FG000|Intensive Period|Withdrawal by Subject|1|||
125300641|NCT00742417|450727790|FG001|Intensive Period|Withdrawal by Subject|1|||
125300642|NCT00742417|450727789|FG000|Intensive Period|Adverse Event|2|||
125300643|NCT00742417|450727790|FG001|Intensive Period|Adverse Event|0|||
125300644|NCT04566601|450727795|FG000|Overall Study|Other than listed|13|||
125300645|NCT04566601|450727796|FG001|Overall Study|Other than listed|4|||
125300646|NCT04566601|450727797|FG002|Overall Study|Other than listed|2|||
125300647|NCT04566601|450727798|FG003|Overall Study|Other than listed|1|||
125300648|NCT04566601|450727799|FG004|Overall Study|Other than listed|4|||
125300649|NCT04566601|450727795|FG000|Overall Study|Protocol deviation|3|||
125300650|NCT04566601|450727796|FG001|Overall Study|Protocol deviation|0|||
125300651|NCT04566601|450727797|FG002|Overall Study|Protocol deviation|1|||
125300652|NCT04566601|450727798|FG003|Overall Study|Protocol deviation|1|||
125300653|NCT04566601|450727799|FG004|Overall Study|Protocol deviation|1|||
125300654|NCT04566601|450727795|FG000|Overall Study|Technical problems|0|||
125300655|NCT04566601|450727796|FG001|Overall Study|Technical problems|0|||
125300656|NCT04566601|450727797|FG002|Overall Study|Technical problems|1|||
125300657|NCT04566601|450727798|FG003|Overall Study|Technical problems|0|||
125300658|NCT04566601|450727799|FG004|Overall Study|Technical problems|0|||
125300659|NCT04566601|450727795|FG000|Overall Study|No reason available|3|||
125300660|NCT04566601|450727796|FG001|Overall Study|No reason available|2|||
125300661|NCT04566601|450727797|FG002|Overall Study|No reason available|7|||
125300662|NCT04566601|450727798|FG003|Overall Study|No reason available|1|||
125300663|NCT04566601|450727799|FG004|Overall Study|No reason available|5|||
125300664|NCT04566601|450727795|FG000|Overall Study|Burden of study procedures|3|||
125300665|NCT04566601|450727796|FG001|Overall Study|Burden of study procedures|0|||
125300666|NCT04566601|450727797|FG002|Overall Study|Burden of study procedures|0|||
125300667|NCT04566601|450727798|FG003|Overall Study|Burden of study procedures|3|||
125300668|NCT04566601|450727799|FG004|Overall Study|Burden of study procedures|1|||
125300669|NCT04566601|450727795|FG000|Overall Study|Change of residence|2|||
125300670|NCT04566601|450727796|FG001|Overall Study|Change of residence|2|||
125300671|NCT04566601|450727797|FG002|Overall Study|Change of residence|0|||
125300672|NCT04566601|450727798|FG003|Overall Study|Change of residence|1|||
125300673|NCT04566601|450727799|FG004|Overall Study|Change of residence|2|||
125300674|NCT04566601|450727795|FG000|Overall Study|Perceived lack of efficacy|2|||
125300675|NCT04566601|450727796|FG001|Overall Study|Perceived lack of efficacy|0|||
125300676|NCT04566601|450727797|FG002|Overall Study|Perceived lack of efficacy|1|||
125300677|NCT04566601|450727798|FG003|Overall Study|Perceived lack of efficacy|1|||
125300678|NCT04566601|450727799|FG004|Overall Study|Perceived lack of efficacy|2|||
125300679|NCT04566601|450727795|FG000|Overall Study|Adverse Event|7|||
125300680|NCT04566601|450727796|FG001|Overall Study|Adverse Event|4|||
125300681|NCT04566601|450727797|FG002|Overall Study|Adverse Event|6|||
125300682|NCT04566601|450727798|FG003|Overall Study|Adverse Event|5|||
125300683|NCT04566601|450727799|FG004|Overall Study|Adverse Event|12|||
125300684|NCT00372697|450727802|FG000|Overall Study|Protocol Violation|1|||
125300685|NCT00372697|450727803|FG001|Overall Study|Protocol Violation|1|||
125300686|NCT01055314|450727804|FG000|Overall Study|Adverse Event|7|||
125300687|NCT01055314|450727805|FG001|Overall Study|Adverse Event|4|||
125300688|NCT01055314|450727804|FG000|Overall Study|Death|2|||
125300689|NCT01055314|450727805|FG001|Overall Study|Death|1|||
125300690|NCT01055314|450727804|FG000|Overall Study|Lack of Efficacy|11|||
125300691|NCT01055314|450727805|FG001|Overall Study|Lack of Efficacy|19|||
125300692|NCT01055314|450727804|FG000|Overall Study|Physician Decision|10|||
125300693|NCT01055314|450727805|FG001|Overall Study|Physician Decision|5|||
125300694|NCT01055314|450727804|FG000|Overall Study|Withdrawal by Subject|1|||
125300695|NCT01055314|450727805|FG001|Overall Study|Withdrawal by Subject|0|||
125300696|NCT01055314|450727804|FG000|Overall Study|Ineligible|3|||
125300697|NCT01055314|450727805|FG001|Overall Study|Ineligible|5|||
125300698|NCT01055314|450727804|FG000|Overall Study|Refusal of further protocol therapy|10|||
125300699|NCT01055314|450727805|FG001|Overall Study|Refusal of further protocol therapy|4|||
125300700|NCT01055314|450727804|FG000|Overall Study|No treatment|1|||
125300701|NCT01055314|450727805|FG001|Overall Study|No treatment|0|||
125477811|NCT05292365|451383111|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
125477812|NCT04633122|451383112|FG000|Overall Study|Remained on treatment|19|||
125477813|NCT04633122|451383113|FG001|Overall Study|Remained on treatment|14|||
125477814|NCT04633122|451383112|FG000|Overall Study|Survival follow-up stopped|22|||
125300702|NCT01279616|450727806|FG000|Overall Study|donor could not be located|5|||
125300703|NCT01279616|450727806|FG000|Overall Study|no signs of sickle cell disease|2|||
125477815|NCT04633122|451383113|FG001|Overall Study|Survival follow-up stopped|25|||
125477816|NCT04185298|451383114|FG000|Overall Study|Lost to Follow-up|1|||
125477817|NCT04185298|451383115|FG001|Overall Study|Lost to Follow-up|3|||
125300704|NCT02462720|450727807|FG000|Part 2|Withdrawal by Subject|1|||
125300705|NCT02462720|450727808|FG001|Part 2|Withdrawal by Subject|0|||
125300706|NCT02462720|450727807|FG000|Part 2|Protocol Violation|0|||
125300707|NCT02462720|450727808|FG001|Part 2|Protocol Violation|1|||
125477818|NCT04185298|451383114|FG000|Overall Study|Withdrawal by Subject|0|||
125477819|NCT04185298|451383115|FG001|Overall Study|Withdrawal by Subject|3|||
125477820|NCT01798498|451383116|FG000|Overall Study|Lost to Follow-up|1|||
125300708|NCT00183625|450727811|FG000|Overall Study|Withdrawal by Subject|18|||
125300709|NCT00183625|450727812|FG001|Overall Study|Withdrawal by Subject|18|||
125300710|NCT00183625|450727813|FG002|Overall Study|Withdrawal by Subject|19|||
125300711|NCT00183625|450727814|FG003|Overall Study|Withdrawal by Subject|14|||
125300712|NCT05249569|450727817|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
125300713|NCT03722524|450727818|FG000|Overall Study|Protocol Violation|86|||
125300714|NCT03722524|450727818|FG000|Overall Study|Adverse Event|7|||
125300715|NCT03722524|450727818|FG000|Overall Study|Lost to Follow-up|1|||
125477821|NCT03896789|451383117|FG000|Baseline|Lost to Follow-up|1|||
125477822|NCT03896789|451383118|FG001|Baseline|Lost to Follow-up|2|||
125477823|NCT03896789|451383117|FG000|Baseline|Death|3|||
125300716|NCT03722524|450727818|FG000|Overall Study|Reason is not stated|1|||
125300717|NCT03722524|450727818|FG000|Overall Study|Physician Decision|1|||
125300718|NCT03722524|450727818|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
125300719|NCT00646399|450727822|FG000|Overall Study|Death|63|||
125300720|NCT00646399|450727823|FG001|Overall Study|Death|53|||
125300721|NCT00646399|450727822|FG000|Overall Study|Withdrawal by Subject|9|||
125300722|NCT00646399|450727823|FG001|Overall Study|Withdrawal by Subject|10|||
125300723|NCT00646399|450727822|FG000|Overall Study|Other Reason|11|||
125300724|NCT00646399|450727823|FG001|Overall Study|Other Reason|11|||
125300725|NCT02473367|450727826|FG000|Wait 1|Withdrawal by Subject|1|||
125300726|NCT02473367|450727826|FG000|Period 4|Lost to Follow-up|1|||
125300727|NCT02678923|450727827|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
125300728|NCT02678923|450727828|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
125300729|NCT02678923|450727827|FG000|Overall Study|Withdrawal by Subject|3|||
125300730|NCT02678923|450727828|FG001|Overall Study|Withdrawal by Subject|2|||
125300731|NCT02678923|450727827|FG000|Overall Study|Lost to Follow-up|1|||
125300732|NCT02678923|450727828|FG001|Overall Study|Lost to Follow-up|0|||
125300733|NCT02678923|450727827|FG000|Overall Study|Did Not Return for Study Visits|1|||
125300734|NCT02678923|450727828|FG001|Overall Study|Did Not Return for Study Visits|0|||
125300735|NCT00455143|450727829|FG000|Overall Study|Physician Decision|1|||
125300736|NCT00455143|450727829|FG000|Overall Study|Withdrawal by Subject|1|||
125300737|NCT00455143|450727829|FG000|Overall Study|Staff was not avail to follow patient|2|||
125300738|NCT00455143|450727829|FG000|Overall Study|No longer met Inclusion Criteria|1|||
125300739|NCT00455143|450727829|FG000|Overall Study|Surgical time, staff not available|1|||
125300740|NCT01423916|450727832|FG000|Overall Study|Adverse Event|5|||
125300741|NCT01423916|450727833|FG001|Overall Study|Adverse Event|9|||
125300742|NCT01423916|450727834|FG002|Overall Study|Adverse Event|2|||
125300743|NCT01423916|450727832|FG000|Overall Study|Met Withdrawal Criteria|1|||
125300744|NCT01423916|450727833|FG001|Overall Study|Met Withdrawal Criteria|1|||
125300745|NCT01423916|450727834|FG002|Overall Study|Met Withdrawal Criteria|1|||
125300746|NCT01423916|450727832|FG000|Overall Study|Physician Decision|1|||
125300747|NCT01423916|450727833|FG001|Overall Study|Physician Decision|0|||
125300748|NCT01423916|450727834|FG002|Overall Study|Physician Decision|1|||
125300749|NCT01423916|450727832|FG000|Overall Study|Withdrawal by Subject|3|||
125300750|NCT01423916|450727833|FG001|Overall Study|Withdrawal by Subject|10|||
125300751|NCT01423916|450727834|FG002|Overall Study|Withdrawal by Subject|3|||
125300752|NCT01423916|450727832|FG000|Overall Study|Protocol Deviation|1|||
125300753|NCT01423916|450727833|FG001|Overall Study|Protocol Deviation|0|||
125300754|NCT01423916|450727834|FG002|Overall Study|Protocol Deviation|0|||
125300755|NCT01966445|450727837|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
125300756|NCT01966445|450727838|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
125300757|NCT01966445|450727839|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
125300758|NCT01966445|450727840|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
125300759|NCT01966445|450727841|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
125300760|NCT01966445|450727842|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
125300761|NCT01966445|450727843|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
125300762|NCT01966445|450727837|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
125300763|NCT01966445|450727838|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
125300764|NCT01966445|450727839|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
125300765|NCT01966445|450727840|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
125300766|NCT01966445|450727841|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
125300767|NCT01966445|450727842|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
125300768|NCT01966445|450727843|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
125300769|NCT01966445|450727837|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
125300770|NCT01966445|450727838|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
125300771|NCT01966445|450727839|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
125300772|NCT01966445|450727840|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
125300773|NCT01966445|450727841|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
125300774|NCT01966445|450727842|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
125300775|NCT01966445|450727843|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
125300776|NCT01966445|450727837|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
125300777|NCT01966445|450727838|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
125300778|NCT01966445|450727839|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
125300779|NCT01966445|450727840|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
125300780|NCT01966445|450727841|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
125300781|NCT01966445|450727842|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
125300782|NCT01966445|450727843|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
125300783|NCT01966445|450727837|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
125300784|NCT01966445|450727838|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
125300785|NCT01966445|450727839|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
125477824|NCT03896789|451383118|FG001|Baseline|Death|6|||
125300786|NCT01966445|450727840|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
125300787|NCT01966445|450727841|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
125300788|NCT01966445|450727842|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
125300789|NCT01966445|450727843|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
125300790|NCT01374178|450727846|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
125300791|NCT01374178|450727847|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
125300792|NCT01374178|450727846|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
125300793|NCT01374178|450727847|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
125300794|NCT04856904|450727850|FG000|Overall Study|Physician Decision|1|||
125300795|NCT04856904|450727851|FG001|Overall Study|Physician Decision|1|||
125300796|NCT04856904|450727850|FG000|Overall Study|Withdrawal by Subject|13|||
125300797|NCT04856904|450727851|FG001|Overall Study|Withdrawal by Subject|13|||
125300798|NCT04856904|450727850|FG000|Overall Study|Adverse Event|1|||
125300799|NCT04856904|450727851|FG001|Overall Study|Adverse Event|1|||
125300800|NCT04856904|450727850|FG000|Overall Study|Non-compliance with study drug|1|||
125300801|NCT04856904|450727851|FG001|Overall Study|Non-compliance with study drug|1|||
125300802|NCT04856904|450727850|FG000|Overall Study|Lost to Follow-up|4|||
125477825|NCT03896789|451383117|FG000|Post-Randomization|Lost to Follow-up|12|||
125477826|NCT03896789|451383118|FG001|Post-Randomization|Lost to Follow-up|11|||
125477827|NCT03896789|451383117|FG000|Post-Randomization|Death|12|||
125477828|NCT03896789|451383118|FG001|Post-Randomization|Death|13|||
125477829|NCT00227344|451383124|FG000|Overall Study|study terminated early|12|||
125477830|NCT00227344|451383125|FG001|Overall Study|study terminated early|5|||
125477831|NCT01987895|451383126|FG000|Overall Study|Withdrawal by Subject|12|||
125300803|NCT04856904|450727851|FG001|Overall Study|Lost to Follow-up|4|||
125300804|NCT04856904|450727850|FG000|Overall Study|Withdrawal by Subject|1|||
125300805|NCT04856904|450727851|FG001|Overall Study|Withdrawal by Subject|1|||
125300806|NCT04856904|450727850|FG000|Overall Study|Protocol Violation|1|||
125300807|NCT04856904|450727851|FG001|Overall Study|Protocol Violation|1|||
125300808|NCT00902174|450727852|FG000|Overall Study|Adverse Event|27|||
125300809|NCT00902174|450727853|FG001|Overall Study|Adverse Event|7|||
125300810|NCT00902174|450727852|FG000|Overall Study|Lack of Efficacy|1|||
125300811|NCT00902174|450727853|FG001|Overall Study|Lack of Efficacy|5|||
125300812|NCT00902174|450727852|FG000|Overall Study|Death|2|||
125300813|NCT00902174|450727853|FG001|Overall Study|Death|2|||
125300814|NCT00902174|450727852|FG000|Overall Study|Withdrawal by Subject|2|||
125300815|NCT00902174|450727853|FG001|Overall Study|Withdrawal by Subject|1|||
125300816|NCT00902174|450727852|FG000|Overall Study|Abnormal labs|1|||
125300817|NCT00902174|450727853|FG001|Overall Study|Abnormal labs|1|||
125300818|NCT00902174|450727852|FG000|Overall Study|Protocol Violation|1|||
125300819|NCT00902174|450727853|FG001|Overall Study|Protocol Violation|1|||
125300820|NCT00902174|450727852|FG000|Overall Study|Administration problem|0|||
125300821|NCT00902174|450727853|FG001|Overall Study|Administration problem|1|||
125300822|NCT00077649|450727854|FG000|Overall Study|Adverse Event|5|||
125300823|NCT00077649|450727855|FG001|Overall Study|Adverse Event|1|||
125300824|NCT00077649|450727856|FG002|Overall Study|Adverse Event|7|||
125300825|NCT00077649|450727857|FG003|Overall Study|Adverse Event|9|||
125300826|NCT00077649|450727854|FG000|Overall Study|Lack of Efficacy|5|||
125300827|NCT00077649|450727855|FG001|Overall Study|Lack of Efficacy|3|||
125300828|NCT00077649|450727856|FG002|Overall Study|Lack of Efficacy|3|||
125300829|NCT00077649|450727857|FG003|Overall Study|Lack of Efficacy|2|||
125300830|NCT00077649|450727854|FG000|Overall Study|Withdrawal by Subject|0|||
125300831|NCT00077649|450727855|FG001|Overall Study|Withdrawal by Subject|1|||
125300832|NCT00077649|450727856|FG002|Overall Study|Withdrawal by Subject|1|||
125300833|NCT00077649|450727857|FG003|Overall Study|Withdrawal by Subject|2|||
125300834|NCT00077649|450727854|FG000|Overall Study|Lost to Follow-up|2|||
125300835|NCT00077649|450727855|FG001|Overall Study|Lost to Follow-up|2|||
125300836|NCT00077649|450727856|FG002|Overall Study|Lost to Follow-up|3|||
125300837|NCT00077649|450727857|FG003|Overall Study|Lost to Follow-up|2|||
125300838|NCT00077649|450727854|FG000|Overall Study|Abnormality of Laboratory Test|1|||
125300839|NCT00077649|450727855|FG001|Overall Study|Abnormality of Laboratory Test|2|||
125477832|NCT01987895|451383127|FG001|Overall Study|Withdrawal by Subject|7|||
125477833|NCT01987895|451383126|FG000|Overall Study|Physician Decision|8|||
125300840|NCT00077649|450727856|FG002|Overall Study|Abnormality of Laboratory Test|1|||
125300841|NCT00077649|450727857|FG003|Overall Study|Abnormality of Laboratory Test|2|||
125300842|NCT00077649|450727854|FG000|Overall Study|Randomized but never dosed|1|||
125300843|NCT00077649|450727855|FG001|Overall Study|Randomized but never dosed|0|||
125300844|NCT00077649|450727856|FG002|Overall Study|Randomized but never dosed|0|||
125300845|NCT00077649|450727857|FG003|Overall Study|Randomized but never dosed|0|||
125300846|NCT02895945|450727859|FG000|Overall Study|Physician Decision|2|||
125300847|NCT02895945|450727860|FG001|Overall Study|Physician Decision|1|||
125300848|NCT00454181|450727864|FG000|Overall Study|Adverse Event|1|||
125300849|NCT00454181|450727865|FG001|Overall Study|Adverse Event|1|||
125300850|NCT00454181|450727864|FG000|Overall Study|Lost to Follow-up|11|||
125300851|NCT00454181|450727865|FG001|Overall Study|Lost to Follow-up|1|||
125300852|NCT00454181|450727864|FG000|Overall Study|Protocol Violation|1|||
125477834|NCT01987895|451383127|FG001|Overall Study|Physician Decision|10|||
125300853|NCT00454181|450727865|FG001|Overall Study|Protocol Violation|1|||
125300854|NCT00454181|450727864|FG000|Overall Study|Withdrawal by Subject|2|||
125300855|NCT00454181|450727865|FG001|Overall Study|Withdrawal by Subject|0|||
125300856|NCT04032080|450727866|FG000|Overall Study|Death|6|||
125300857|NCT03689855|450727871|FG000|Overall Study|Adverse Event|3|||
125300858|NCT03689855|450727871|FG000|Overall Study|Withdrawal by Subject|1|||
125300859|NCT00764673|450727872|FG000|Overall Study|Death|1|||
125300860|NCT00764673|450727872|FG000|Overall Study|Lost to Follow-up|3|||
125300861|NCT00764673|450727872|FG000|Overall Study|Withdrawal by Subject|6|||
125300862|NCT00764673|450727872|FG000|Overall Study|Revision of Device|2|||
125300863|NCT01438177|450727873|FG000|Overall Study|Withdrawal by Subject|1|||
125300864|NCT01438177|450727873|FG000|Overall Study|Initiation of new therapy|1|||
125300865|NCT01727336|450727874|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
125300866|NCT01727336|450727875|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
125300867|NCT01727336|450727876|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
125300868|NCT01727336|450727877|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
125300869|NCT01727336|450727878|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
125300870|NCT01727336|450727879|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
125300871|NCT01727336|450727874|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
125300872|NCT01727336|450727875|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
125300873|NCT01727336|450727876|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
125300874|NCT01727336|450727877|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
125300875|NCT01727336|450727878|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
125300876|NCT01727336|450727879|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
125300877|NCT01727336|450727874|FG000|Part 2 Blinded|Death|0|||
125300878|NCT01727336|450727875|FG001|Part 2 Blinded|Death|0|||
125300879|NCT01727336|450727876|FG002|Part 2 Blinded|Death|0|||
125300880|NCT01727336|450727877|FG003|Part 2 Blinded|Death|0|||
125300881|NCT01727336|450727878|FG004|Part 2 Blinded|Death|20|||
125300882|NCT01727336|450727879|FG005|Part 2 Blinded|Death|16|||
125300883|NCT01727336|450727874|FG000|Part 2 Blinded|Lack of Efficacy|0|||
125300884|NCT01727336|450727875|FG001|Part 2 Blinded|Lack of Efficacy|0|||
125300885|NCT01727336|450727876|FG002|Part 2 Blinded|Lack of Efficacy|0|||
125300886|NCT01727336|450727877|FG003|Part 2 Blinded|Lack of Efficacy|0|||
125300887|NCT01727336|450727878|FG004|Part 2 Blinded|Lack of Efficacy|42|||
125300888|NCT01727336|450727879|FG005|Part 2 Blinded|Lack of Efficacy|44|||
125300889|NCT01727336|450727874|FG000|Part 2 Blinded|Lost to Follow-up|0|||
125300890|NCT01727336|450727875|FG001|Part 2 Blinded|Lost to Follow-up|0|||
125300891|NCT01727336|450727876|FG002|Part 2 Blinded|Lost to Follow-up|0|||
125300892|NCT01727336|450727877|FG003|Part 2 Blinded|Lost to Follow-up|0|||
125300893|NCT01727336|450727878|FG004|Part 2 Blinded|Lost to Follow-up|0|||
125300894|NCT01727336|450727879|FG005|Part 2 Blinded|Lost to Follow-up|1|||
125300895|NCT01727336|450727874|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
125300896|NCT01727336|450727875|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
125300897|NCT01727336|450727876|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
125300898|NCT01727336|450727877|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
125300899|NCT01727336|450727878|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
125300900|NCT01727336|450727879|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
125300901|NCT01727336|450727874|FG000|Part 2 Blinded|use of prohibited medications|0|||
125300902|NCT01727336|450727875|FG001|Part 2 Blinded|use of prohibited medications|0|||
125477835|NCT01987895|451383126|FG000|Overall Study|Death|7|||
125477836|NCT01987895|451383127|FG001|Overall Study|Death|7|||
125477837|NCT01987895|451383126|FG000|Overall Study|Lost to Follow-up|3|||
125477838|NCT01987895|451383127|FG001|Overall Study|Lost to Follow-up|5|||
125477839|NCT01987895|451383126|FG000|Overall Study|randomized before giving IC|0|||
125477840|NCT01987895|451383127|FG001|Overall Study|randomized before giving IC|1|||
125477841|NCT05364671|451383128|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
125477842|NCT05364671|451383129|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
125300903|NCT01727336|450727876|FG002|Part 2 Blinded|use of prohibited medications|0|||
125300904|NCT01727336|450727877|FG003|Part 2 Blinded|use of prohibited medications|0|||
125300905|NCT01727336|450727878|FG004|Part 2 Blinded|use of prohibited medications|1|||
125300906|NCT01727336|450727879|FG005|Part 2 Blinded|use of prohibited medications|3|||
125300907|NCT00619099|450727880|FG000|Overall Study|Progressive Disease|7|||
125300908|NCT00619099|450727881|FG001|Overall Study|Progressive Disease|5|||
125300909|NCT00619099|450727880|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
125300910|NCT00619099|450727881|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
125300911|NCT00619099|450727880|FG000|Overall Study|Adverse Event|4|||
125300912|NCT00619099|450727881|FG001|Overall Study|Adverse Event|3|||
125300913|NCT00619099|450727880|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
125300914|NCT00619099|450727881|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
125477843|NCT05364671|451383128|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
125485389|NCT02240238|451412503|FG000|Phase 1|Physician Decision|0|||
125300915|NCT00619099|450727880|FG000|Overall Study|Withdrawal by Subject|10|||
125300916|NCT00619099|450727881|FG001|Overall Study|Withdrawal by Subject|2|||
125300917|NCT00619099|450727880|FG000|Overall Study|Physician Decision|9|||
125300918|NCT00619099|450727881|FG001|Overall Study|Physician Decision|6|||
125300919|NCT00885482|450727882|FG000|Overall Study|Pregnancy|1|||
125300920|NCT00885482|450727882|FG000|Overall Study|Lack of Efficacy|1|||
125300921|NCT00885482|450727882|FG000|Overall Study|Death|1|||
125300922|NCT00885482|450727882|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
125300923|NCT00084656|450727883|FG000|Overall Study|Other reasons|0|||
125300924|NCT00084656|450727884|FG001|Overall Study|Other reasons|12|||
125300925|NCT00084656|450727885|FG002|Overall Study|Other reasons|11|||
125300926|NCT00084656|450727883|FG000|Overall Study|Withdrawal by Subject|15|||
125300927|NCT00084656|450727884|FG001|Overall Study|Withdrawal by Subject|4|||
125300928|NCT00084656|450727885|FG002|Overall Study|Withdrawal by Subject|4|||
125300929|NCT00084656|450727883|FG000|Overall Study|Disease relapse|0|||
125300930|NCT00084656|450727884|FG001|Overall Study|Disease relapse|9|||
125300931|NCT00084656|450727885|FG002|Overall Study|Disease relapse|10|||
125300932|NCT00084656|450727883|FG000|Overall Study|Disease progression|9|||
125300933|NCT00084656|450727884|FG001|Overall Study|Disease progression|0|||
125300934|NCT00084656|450727885|FG002|Overall Study|Disease progression|0|||
125300935|NCT00084656|450727883|FG000|Overall Study|Lost to Follow-up|1|||
125300936|NCT00084656|450727884|FG001|Overall Study|Lost to Follow-up|0|||
125300937|NCT00084656|450727885|FG002|Overall Study|Lost to Follow-up|1|||
125300938|NCT02772978|450727886|FG000|Overall Study|Withdrawal by Subject|1|||
125300939|NCT02772978|450727887|FG001|Overall Study|Withdrawal by Subject|1|||
125300940|NCT00129467|450727888|FG000|Received Intervention|Death|1|||
125300941|NCT00129467|450727889|FG001|Received Intervention|Death|1|||
125300942|NCT00129467|450727888|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
125300943|NCT00129467|450727889|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
125300944|NCT00129467|450727888|FG000|Received Intervention|Delirium|2|||
125300945|NCT00129467|450727889|FG001|Received Intervention|Delirium|0|||
125300946|NCT00129467|450727888|FG000|Received Intervention|Withdrawal by Subject|1|||
125300947|NCT00129467|450727889|FG001|Received Intervention|Withdrawal by Subject|0|||
125300948|NCT00129467|450727888|FG000|Received Intervention|Nausea|1|||
125300949|NCT00129467|450727889|FG001|Received Intervention|Nausea|0|||
125477844|NCT05364671|451383129|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
125477845|NCT05364671|451383128|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
125477846|NCT05364671|451383129|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
125477847|NCT05364671|451383128|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
125477848|NCT05364671|451383129|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
125477849|NCT05364671|451383128|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
125477850|NCT05364671|451383129|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
125477851|NCT02359890|451383130|FG000|Overall Study|Not meeting eligibility|4|||
125477852|NCT02359890|451383130|FG000|Overall Study|Never treated with study catheter|6|||
125477853|NCT05256017|451383131|FG000|Treatment Period|Withdrawal by Subject|1|||
125300950|NCT00129467|450727888|FG000|Received Intervention|Intolerance to citalopram|0|||
125300951|NCT00129467|450727889|FG001|Received Intervention|Intolerance to citalopram|1|||
125300952|NCT00129467|450727888|FG000|Received Intervention|Dizzyness, fatigue|0|||
125300953|NCT00129467|450727889|FG001|Received Intervention|Dizzyness, fatigue|1|||
125300954|NCT00129467|450727888|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
125300955|NCT00129467|450727889|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
125300956|NCT00129467|450727888|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
125300957|NCT00129467|450727889|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
125300958|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
125300959|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
125300960|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
125300961|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
125300962|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
125300963|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
125300964|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
125300965|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
125300966|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
125300967|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
125300968|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
125300969|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
125300970|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
125477854|NCT05256017|451383132|FG001|Treatment Period|Withdrawal by Subject|1|||
125300971|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
125300972|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
125300973|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
125300974|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
125300975|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
125300976|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
125300977|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
125300978|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
125300979|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
125300980|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
125300981|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
125300982|NCT01532869|450727890|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
125300983|NCT01532869|450727891|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
125300984|NCT01532869|450727890|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
125477855|NCT05256017|451383131|FG000|Follow-up|Lost to Follow-up|7|||
125477856|NCT05256017|451383132|FG001|Follow-up|Lost to Follow-up|1|||
125477857|NCT05256017|451383131|FG000|Follow-up|Withdrawal by Subject|1|||
125477858|NCT05256017|451383132|FG001|Follow-up|Withdrawal by Subject|0|||
125477859|NCT05256017|451383131|FG000|Follow-up|Death|0|||
125477860|NCT05256017|451383132|FG001|Follow-up|Death|1|||
125477861|NCT05780437|451383135|FG000|Overall Study|Withdrawal by Subject|22|||
125477862|NCT05780437|451383136|FG001|Overall Study|Withdrawal by Subject|16|||
125477863|NCT04015167|451383137|FG000|Overall Study|Lost to Follow-up|40|||
125477864|NCT04015167|451383137|FG000|Overall Study|Adverse Event|5|||
125477865|NCT04015167|451383137|FG000|Overall Study|Withdrawal by Subject|2|||
125477866|NCT04015167|451383137|FG000|Overall Study|Subject went to jail|1|||
125477867|NCT03536754|451383138|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
125477868|NCT03536754|451383139|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
125477869|NCT03536754|451383140|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
125477870|NCT03536754|451383141|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
125477871|NCT03536754|451383142|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
125477872|NCT03536754|451383138|FG000|Open Label Extension|Other|0|||
125477873|NCT03536754|451383139|FG001|Open Label Extension|Other|0|||
125477874|NCT03536754|451383140|FG002|Open Label Extension|Other|0|||
125477875|NCT03536754|451383141|FG003|Open Label Extension|Other|0|||
125477876|NCT03536754|451383142|FG004|Open Label Extension|Other|1|||
125300985|NCT01532869|450727891|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
125300986|NCT01532869|450727890|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
125300987|NCT01532869|450727891|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
125300988|NCT01532869|450727890|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
125300989|NCT01532869|450727891|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
125300990|NCT01532869|450727890|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
125300991|NCT01532869|450727891|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
125300992|NCT01331291|450727892|FG000|Overall Study|Lack of Efficacy|2|||
125300993|NCT01331291|450727893|FG001|Overall Study|Lack of Efficacy|8|||
125300994|NCT01331291|450727892|FG000|Overall Study|Death|0|||
125300995|NCT01331291|450727893|FG001|Overall Study|Death|1|||
125300996|NCT01026220|450727894|FG000|Induction|Death|1|||
125300997|NCT01026220|450727895|FG001|Induction|Death|0|||
125300998|NCT01026220|450727896|FG002|Induction|Death|0|||
125300999|NCT01026220|450727894|FG000|Induction|Lack of Efficacy|2|||
125301000|NCT01026220|450727895|FG001|Induction|Lack of Efficacy|0|||
125301001|NCT01026220|450727896|FG002|Induction|Lack of Efficacy|0|||
125301002|NCT01026220|450727894|FG000|Induction|Physician Decision|12|||
125301003|NCT01026220|450727895|FG001|Induction|Physician Decision|0|||
125301004|NCT01026220|450727896|FG002|Induction|Physician Decision|0|||
125301005|NCT01026220|450727894|FG000|Induction|Withdrawal by Subject|9|||
125301006|NCT01026220|450727895|FG001|Induction|Withdrawal by Subject|0|||
125301007|NCT01026220|450727896|FG002|Induction|Withdrawal by Subject|0|||
125301008|NCT01026220|450727894|FG000|Induction|Ineligible|1|||
125301009|NCT01026220|450727895|FG001|Induction|Ineligible|0|||
125301010|NCT01026220|450727896|FG002|Induction|Ineligible|0|||
125301011|NCT01026220|450727894|FG000|Consolidation Maintenance|Death|0|||
125301012|NCT01026220|450727895|FG001|Consolidation Maintenance|Death|1|||
125301013|NCT01026220|450727896|FG002|Consolidation Maintenance|Death|0|||
125301014|NCT01026220|450727894|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
125301015|NCT01026220|450727895|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
125301016|NCT01026220|450727896|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
125477877|NCT03452579|451383143|FG000|Overall Study|Death|0|||
125477878|NCT03452579|451383144|FG001|Overall Study|Death|1|||
125477879|NCT03452579|451383143|FG000|Overall Study|Withdrawal by Subject|2|||
125301017|NCT01026220|450727894|FG000|Consolidation Maintenance|Physician Decision|0|||
125301018|NCT01026220|450727895|FG001|Consolidation Maintenance|Physician Decision|2|||
125301019|NCT01026220|450727896|FG002|Consolidation Maintenance|Physician Decision|7|||
125301020|NCT01026220|450727894|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
125301021|NCT01026220|450727895|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
125477880|NCT03452579|451383144|FG001|Overall Study|Withdrawal by Subject|0|||
125477881|NCT03452579|451383143|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
125477882|NCT03452579|451383144|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
125477883|NCT03452579|451383143|FG000|Overall Study|Physician Decision|1|||
125301022|NCT01026220|450727896|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
125477884|NCT03452579|451383144|FG001|Overall Study|Physician Decision|1|||
125301023|NCT00409344|450727898|FG000|Overall Study|no enrollment|0|||
125301024|NCT00409344|450727899|FG001|Overall Study|no enrollment|0|||
125301025|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
125301026|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
125301027|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
125301028|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
125301029|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
125301030|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
125301031|NCT01389323|450727900|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
125301032|NCT01389323|450727900|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
125301033|NCT01389323|450727900|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
125301034|NCT01389323|450727900|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
125301035|NCT01389323|450727900|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
125301036|NCT01424228|450727901|FG000|Overall Study|Withdrawal by Subject|27|||
125301037|NCT01424228|450727902|FG001|Overall Study|Withdrawal by Subject|11|||
125301038|NCT01424228|450727901|FG000|Overall Study|Adverse Event|10|||
125301039|NCT01424228|450727902|FG001|Overall Study|Adverse Event|14|||
125301040|NCT01424228|450727901|FG000|Overall Study|Sponsor's decision|9|||
125301041|NCT01424228|450727902|FG001|Overall Study|Sponsor's decision|12|||
125301042|NCT01424228|450727901|FG000|Overall Study|Lack of Efficacy|5|||
125301043|NCT01424228|450727902|FG001|Overall Study|Lack of Efficacy|7|||
125301044|NCT01424228|450727901|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
125301045|NCT01424228|450727902|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
125301046|NCT01424228|450727901|FG000|Overall Study|Non-compliance|2|||
125301047|NCT01424228|450727902|FG001|Overall Study|Non-compliance|0|||
125301048|NCT01424228|450727901|FG000|Overall Study|Worsening of symptoms|1|||
125301049|NCT01424228|450727902|FG001|Overall Study|Worsening of symptoms|0|||
125301050|NCT01424228|450727901|FG000|Overall Study|Unplanned journey|0|||
125301051|NCT01424228|450727902|FG001|Overall Study|Unplanned journey|1|||
125301052|NCT00844558|450727903|FG000|Overall Study|Withdrawal by Subject|9|||
125301053|NCT00844558|450727904|FG001|Overall Study|Withdrawal by Subject|2|||
125301054|NCT00844558|450727903|FG000|Overall Study|Death|1|||
125301055|NCT00844558|450727904|FG001|Overall Study|Death|0|||
125301056|NCT00844558|450727903|FG000|Overall Study|Protocol Violation|1|||
125301057|NCT00844558|450727904|FG001|Overall Study|Protocol Violation|1|||
125301058|NCT00844558|450727903|FG000|Overall Study|Lost to Follow-up|0|||
125301059|NCT00844558|450727904|FG001|Overall Study|Lost to Follow-up|1|||
125301060|NCT00844558|450727903|FG000|Overall Study|Physician Decision|1|||
125301061|NCT00844558|450727904|FG001|Overall Study|Physician Decision|0|||
125301062|NCT01894022|450727906|FG000|Overall Study|Death|1|||
125301063|NCT01894022|450727907|FG001|Overall Study|Death|0|||
125301064|NCT01894022|450727906|FG000|Overall Study|Adverse Event, non-fatal|1|||
125301065|NCT01894022|450727907|FG001|Overall Study|Adverse Event, non-fatal|0|||
125301066|NCT01894022|450727906|FG000|Overall Study|Study Closed/terminated|7|||
125301067|NCT01894022|450727907|FG001|Overall Study|Study Closed/terminated|10|||
125301068|NCT04496453|450727909|FG000|Overall Study|Lost to Follow-up|6|||
125301069|NCT00410605|450727910|FG000|Overall Study|Adverse Event|12|||
125301070|NCT00410605|450727910|FG000|Overall Study|Physician Decision|3|||
125301071|NCT00410605|450727910|FG000|Overall Study|Withdrawal by Subject|5|||
125301072|NCT00410605|450727910|FG000|Overall Study|Started Non-Protocol Therapy|3|||
125301073|NCT00410605|450727910|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
125301074|NCT00410605|450727910|FG000|Overall Study|Transferred to another Institution|1|||
125301075|NCT03235089|450727918|FG000|Overall Study|Lost to Follow-up|1|||
125301076|NCT03235089|450727919|FG001|Overall Study|Lost to Follow-up|1|||
125301077|NCT03235089|450727918|FG000|Overall Study|Physician Decision|2|||
125301078|NCT03235089|450727919|FG001|Overall Study|Physician Decision|2|||
125301079|NCT03238924|450727920|FG000|Overall Study|Withdrawal by Subject|2|||
125301080|NCT03238924|450727921|FG001|Overall Study|Withdrawal by Subject|2|||
125301081|NCT03576716|450727922|FG000|Overall Study|Withdrawal by Subject|0|||
125301082|NCT03576716|450727923|FG001|Overall Study|Withdrawal by Subject|1|||
125301083|NCT04356040|450727924|FG000|Overall Study|Death|2|||
125301084|NCT04356040|450727925|FG001|Overall Study|Death|0|||
125301085|NCT04356040|450727924|FG000|Overall Study|Lost to Follow-up|1|||
125301086|NCT04356040|450727925|FG001|Overall Study|Lost to Follow-up|0|||
125301087|NCT04356040|450727924|FG000|Overall Study|Physician Decision|0|||
125301088|NCT04356040|450727925|FG001|Overall Study|Physician Decision|1|||
125477885|NCT03452579|451383143|FG000|Overall Study|Adverse Event|1|||
125301089|NCT04356040|450727924|FG000|Overall Study|Withdrawal by Subject|13|||
125301090|NCT04356040|450727925|FG001|Overall Study|Withdrawal by Subject|1|||
125301091|NCT04356040|450727924|FG000|Overall Study|Enrollment Pause|10|||
125301092|NCT04356040|450727925|FG001|Overall Study|Enrollment Pause|0|||
125301093|NCT04356040|450727924|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
125301094|NCT04356040|450727925|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
125301095|NCT04356040|450727924|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
125477886|NCT03452579|451383144|FG001|Overall Study|Adverse Event|4|||
125477887|NCT03382652|451383148|FG000|Overall Study|Lost to Follow-up|6|||
125301096|NCT04356040|450727925|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
125301097|NCT04356040|450727924|FG000|Overall Study|PI left institution|3|||
125301098|NCT04356040|450727925|FG001|Overall Study|PI left institution|0|||
125301099|NCT01717326|450727926|FG000|Overall Study|Death|0|||
125301100|NCT01717326|450727927|FG001|Overall Study|Death|0|||
125301101|NCT01717326|450727928|FG002|Overall Study|Death|0|||
125301102|NCT01717326|450727929|FG003|Overall Study|Death|0|||
125301103|NCT01717326|450727930|FG004|Overall Study|Death|0|||
125301104|NCT01717326|450727931|FG005|Overall Study|Death|0|||
125301105|NCT01717326|450727932|FG006|Overall Study|Death|0|||
125301106|NCT01717326|450727933|FG007|Overall Study|Death|0|||
125301107|NCT01717326|450727934|FG008|Overall Study|Death|0|||
125301108|NCT01717326|450727935|FG009|Overall Study|Death|0|||
125301109|NCT01717326|450727936|FG010|Overall Study|Death|1|||
125301110|NCT01717326|450727937|FG011|Overall Study|Death|0|||
125301111|NCT01717326|450727938|FG012|Overall Study|Death|0|||
125477888|NCT03382652|451383148|FG000|Overall Study|Death|4|||
125477889|NCT03382652|451383148|FG000|Overall Study|Revision|5|||
125477890|NCT03382652|451383148|FG000|Overall Study|Patient withdrew|3|||
125477891|NCT03382652|451383148|FG000|Overall Study|Other reasons|21|||
125477892|NCT04858321|451383149|FG000|Overall Study|Withdrawal by Subject|3|||
125477893|NCT04810650|451383150|FG000|Overall Study|Disenrolled in error|0|||
125301112|NCT01717326|450727939|FG013|Overall Study|Death|0|||
125301113|NCT01717326|450727940|FG014|Overall Study|Death|0|||
125477894|NCT04810650|451383151|FG001|Overall Study|Disenrolled in error|0|||
125477895|NCT04810650|451383152|FG002|Overall Study|Disenrolled in error|0|||
125477896|NCT04810650|451383153|FG003|Overall Study|Disenrolled in error|0|||
125477897|NCT04810650|451383154|FG004|Overall Study|Disenrolled in error|0|||
125477898|NCT04810650|451383155|FG005|Overall Study|Disenrolled in error|0|||
125477899|NCT04810650|451383156|FG006|Overall Study|Disenrolled in error|0|||
125477900|NCT04810650|451383157|FG007|Overall Study|Disenrolled in error|0|||
125477901|NCT04810650|451383158|FG008|Overall Study|Disenrolled in error|1|||
125477902|NCT04810650|451383159|FG009|Overall Study|Disenrolled in error|0|||
125477903|NCT04810650|451383160|FG010|Overall Study|Disenrolled in error|0|||
125477904|NCT04810650|451383161|FG011|Overall Study|Disenrolled in error|0|||
125477905|NCT04810650|451383162|FG012|Overall Study|Disenrolled in error|0|||
125477906|NCT04810650|451383163|FG013|Overall Study|Disenrolled in error|0|||
125477907|NCT04810650|451383150|FG000|Overall Study|Death|0|||
125477908|NCT04810650|451383151|FG001|Overall Study|Death|0|||
125477909|NCT04810650|451383152|FG002|Overall Study|Death|0|||
125477910|NCT04810650|451383153|FG003|Overall Study|Death|0|||
125477911|NCT04810650|451383154|FG004|Overall Study|Death|0|||
125477912|NCT04810650|451383155|FG005|Overall Study|Death|0|||
125477913|NCT04810650|451383156|FG006|Overall Study|Death|2|||
125477914|NCT04810650|451383157|FG007|Overall Study|Death|2|||
125477915|NCT04810650|451383158|FG008|Overall Study|Death|0|||
125477916|NCT04810650|451383159|FG009|Overall Study|Death|1|||
125477917|NCT04810650|451383160|FG010|Overall Study|Death|0|||
125477918|NCT04810650|451383161|FG011|Overall Study|Death|0|||
125477919|NCT04810650|451383162|FG012|Overall Study|Death|2|||
125477920|NCT04810650|451383163|FG013|Overall Study|Death|1|||
125477921|NCT04810650|451383150|FG000|Overall Study|Moved/transferred care|0|||
125301114|NCT01717326|450727941|FG015|Overall Study|Death|0|||
125301115|NCT01717326|450727942|FG016|Overall Study|Death|0|||
125301116|NCT01717326|450727943|FG017|Overall Study|Death|0|||
125301117|NCT01717326|450727944|FG018|Overall Study|Death|0|||
125301118|NCT01717326|450727945|FG019|Overall Study|Death|0|||
125301119|NCT01717326|450727926|FG000|Overall Study|Lost to Follow-up|3|||
125301120|NCT01717326|450727927|FG001|Overall Study|Lost to Follow-up|0|||
125301121|NCT01717326|450727928|FG002|Overall Study|Lost to Follow-up|0|||
125301122|NCT01717326|450727929|FG003|Overall Study|Lost to Follow-up|2|||
125301123|NCT01717326|450727930|FG004|Overall Study|Lost to Follow-up|1|||
125301124|NCT01717326|450727931|FG005|Overall Study|Lost to Follow-up|0|||
125301125|NCT01717326|450727932|FG006|Overall Study|Lost to Follow-up|1|||
125477922|NCT04810650|451383151|FG001|Overall Study|Moved/transferred care|0|||
125477923|NCT04810650|451383152|FG002|Overall Study|Moved/transferred care|0|||
125477924|NCT04810650|451383153|FG003|Overall Study|Moved/transferred care|0|||
125477925|NCT04810650|451383154|FG004|Overall Study|Moved/transferred care|0|||
125477926|NCT04810650|451383155|FG005|Overall Study|Moved/transferred care|0|||
125477927|NCT04810650|451383156|FG006|Overall Study|Moved/transferred care|0|||
125301126|NCT01717326|450727933|FG007|Overall Study|Lost to Follow-up|0|||
125301127|NCT01717326|450727934|FG008|Overall Study|Lost to Follow-up|0|||
125301128|NCT01717326|450727935|FG009|Overall Study|Lost to Follow-up|0|||
125301129|NCT01717326|450727936|FG010|Overall Study|Lost to Follow-up|1|||
125301130|NCT01717326|450727937|FG011|Overall Study|Lost to Follow-up|0|||
125301131|NCT01717326|450727938|FG012|Overall Study|Lost to Follow-up|0|||
125301132|NCT01717326|450727939|FG013|Overall Study|Lost to Follow-up|0|||
125477928|NCT04810650|451383157|FG007|Overall Study|Moved/transferred care|1|||
125477929|NCT04810650|451383158|FG008|Overall Study|Moved/transferred care|12|||
125477930|NCT04810650|451383159|FG009|Overall Study|Moved/transferred care|10|||
125477931|NCT04810650|451383160|FG010|Overall Study|Moved/transferred care|0|||
125485390|NCT02240238|451412504|FG001|Phase 1|Physician Decision|0|||
125301133|NCT01717326|450727940|FG014|Overall Study|Lost to Follow-up|0|||
125301134|NCT01717326|450727941|FG015|Overall Study|Lost to Follow-up|2|||
125301135|NCT01717326|450727942|FG016|Overall Study|Lost to Follow-up|1|||
125301136|NCT01717326|450727943|FG017|Overall Study|Lost to Follow-up|0|||
125301137|NCT01717326|450727944|FG018|Overall Study|Lost to Follow-up|2|||
125301138|NCT01717326|450727945|FG019|Overall Study|Lost to Follow-up|3|||
125301139|NCT01717326|450727926|FG000|Overall Study|Physician Decision|0|||
125301140|NCT01717326|450727927|FG001|Overall Study|Physician Decision|0|||
125301141|NCT01717326|450727928|FG002|Overall Study|Physician Decision|0|||
125301142|NCT01717326|450727929|FG003|Overall Study|Physician Decision|0|||
125301143|NCT01717326|450727930|FG004|Overall Study|Physician Decision|0|||
125301144|NCT01717326|450727931|FG005|Overall Study|Physician Decision|0|||
125301145|NCT01717326|450727932|FG006|Overall Study|Physician Decision|0|||
125301146|NCT01717326|450727933|FG007|Overall Study|Physician Decision|0|||
125301147|NCT01717326|450727934|FG008|Overall Study|Physician Decision|0|||
125301148|NCT01717326|450727935|FG009|Overall Study|Physician Decision|1|||
125301149|NCT01717326|450727936|FG010|Overall Study|Physician Decision|0|||
125301150|NCT01717326|450727937|FG011|Overall Study|Physician Decision|0|||
125301151|NCT01717326|450727938|FG012|Overall Study|Physician Decision|0|||
125301152|NCT01717326|450727939|FG013|Overall Study|Physician Decision|0|||
125301153|NCT01717326|450727940|FG014|Overall Study|Physician Decision|0|||
125301154|NCT01717326|450727941|FG015|Overall Study|Physician Decision|0|||
125301155|NCT01717326|450727942|FG016|Overall Study|Physician Decision|0|||
125301156|NCT01717326|450727943|FG017|Overall Study|Physician Decision|0|||
125301157|NCT01717326|450727944|FG018|Overall Study|Physician Decision|0|||
125301158|NCT01717326|450727945|FG019|Overall Study|Physician Decision|0|||
125301159|NCT01717326|450727926|FG000|Overall Study|Protocol Violation|0|||
125301160|NCT01717326|450727927|FG001|Overall Study|Protocol Violation|0|||
125301161|NCT01717326|450727928|FG002|Overall Study|Protocol Violation|0|||
125301162|NCT01717326|450727929|FG003|Overall Study|Protocol Violation|0|||
125301163|NCT01717326|450727930|FG004|Overall Study|Protocol Violation|1|||
125301164|NCT01717326|450727931|FG005|Overall Study|Protocol Violation|0|||
125301165|NCT01717326|450727932|FG006|Overall Study|Protocol Violation|0|||
125301166|NCT01717326|450727933|FG007|Overall Study|Protocol Violation|0|||
125301167|NCT01717326|450727934|FG008|Overall Study|Protocol Violation|0|||
125301168|NCT01717326|450727935|FG009|Overall Study|Protocol Violation|0|||
125301169|NCT01717326|450727936|FG010|Overall Study|Protocol Violation|0|||
125301170|NCT01717326|450727937|FG011|Overall Study|Protocol Violation|0|||
125301171|NCT01717326|450727938|FG012|Overall Study|Protocol Violation|0|||
125301172|NCT01717326|450727939|FG013|Overall Study|Protocol Violation|0|||
125301173|NCT01717326|450727940|FG014|Overall Study|Protocol Violation|0|||
125301174|NCT01717326|450727941|FG015|Overall Study|Protocol Violation|0|||
125301175|NCT01717326|450727942|FG016|Overall Study|Protocol Violation|0|||
125301176|NCT01717326|450727943|FG017|Overall Study|Protocol Violation|0|||
125301177|NCT01717326|450727944|FG018|Overall Study|Protocol Violation|0|||
125301178|NCT01717326|450727945|FG019|Overall Study|Protocol Violation|0|||
125301179|NCT01717326|450727926|FG000|Overall Study|Withdrawal by Subject|0|||
125301180|NCT01717326|450727927|FG001|Overall Study|Withdrawal by Subject|1|||
125301181|NCT01717326|450727928|FG002|Overall Study|Withdrawal by Subject|0|||
125301182|NCT01717326|450727929|FG003|Overall Study|Withdrawal by Subject|0|||
125301183|NCT01717326|450727930|FG004|Overall Study|Withdrawal by Subject|0|||
125301184|NCT01717326|450727931|FG005|Overall Study|Withdrawal by Subject|0|||
125301185|NCT01717326|450727932|FG006|Overall Study|Withdrawal by Subject|0|||
125301186|NCT01717326|450727933|FG007|Overall Study|Withdrawal by Subject|0|||
125301187|NCT01717326|450727934|FG008|Overall Study|Withdrawal by Subject|0|||
125301188|NCT01717326|450727935|FG009|Overall Study|Withdrawal by Subject|1|||
125301189|NCT01717326|450727936|FG010|Overall Study|Withdrawal by Subject|0|||
125477932|NCT04810650|451383161|FG011|Overall Study|Moved/transferred care|0|||
125477933|NCT04810650|451383162|FG012|Overall Study|Moved/transferred care|0|||
125477934|NCT04810650|451383163|FG013|Overall Study|Moved/transferred care|0|||
125477935|NCT04810650|451383150|FG000|Overall Study|Lost to Follow-up|15|||
125477936|NCT04810650|451383151|FG001|Overall Study|Lost to Follow-up|12|||
125477937|NCT04810650|451383152|FG002|Overall Study|Lost to Follow-up|7|||
125477938|NCT04810650|451383153|FG003|Overall Study|Lost to Follow-up|9|||
125477939|NCT04810650|451383154|FG004|Overall Study|Lost to Follow-up|10|||
125301190|NCT01717326|450727937|FG011|Overall Study|Withdrawal by Subject|0|||
125301191|NCT01717326|450727938|FG012|Overall Study|Withdrawal by Subject|1|||
125301192|NCT01717326|450727939|FG013|Overall Study|Withdrawal by Subject|0|||
125301193|NCT01717326|450727940|FG014|Overall Study|Withdrawal by Subject|0|||
125301194|NCT01717326|450727941|FG015|Overall Study|Withdrawal by Subject|1|||
125301195|NCT01717326|450727942|FG016|Overall Study|Withdrawal by Subject|0|||
125301196|NCT01717326|450727943|FG017|Overall Study|Withdrawal by Subject|0|||
125301197|NCT01717326|450727944|FG018|Overall Study|Withdrawal by Subject|2|||
125301198|NCT01717326|450727945|FG019|Overall Study|Withdrawal by Subject|3|||
125301199|NCT02596945|450727948|FG000|Overall Study|No documentation of study drug dosing|3|||
125301200|NCT02596945|450727948|FG000|Overall Study|Other|32|||
125301201|NCT02596945|450727948|FG000|Overall Study|Change to hemodialysis|15|||
125477940|NCT04810650|451383155|FG005|Overall Study|Lost to Follow-up|6|||
125477941|NCT04810650|451383156|FG006|Overall Study|Lost to Follow-up|0|||
125301202|NCT02596945|450727948|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
125301203|NCT02596945|450727948|FG000|Overall Study|Withdrawal by Subject|1|||
125301204|NCT02596945|450727948|FG000|Overall Study|Missing|1|||
125301205|NCT00422383|450727949|FG000|Overall Study|Adverse Event|5|||
125301206|NCT00422383|450727950|FG001|Overall Study|Adverse Event|3|||
125301207|NCT00422383|450727951|FG002|Overall Study|Adverse Event|1|||
125301208|NCT00422383|450727952|FG003|Overall Study|Adverse Event|1|||
125301209|NCT00422383|450727953|FG004|Overall Study|Adverse Event|0|||
125301210|NCT00422383|450727949|FG000|Overall Study|Lack of Efficacy|4|||
125301211|NCT00422383|450727950|FG001|Overall Study|Lack of Efficacy|4|||
125301212|NCT00422383|450727951|FG002|Overall Study|Lack of Efficacy|2|||
125301213|NCT00422383|450727952|FG003|Overall Study|Lack of Efficacy|1|||
125301214|NCT00422383|450727953|FG004|Overall Study|Lack of Efficacy|1|||
125301215|NCT00422383|450727949|FG000|Overall Study|Lost to Follow-up|0|||
125301216|NCT00422383|450727950|FG001|Overall Study|Lost to Follow-up|1|||
125301217|NCT00422383|450727951|FG002|Overall Study|Lost to Follow-up|0|||
125301218|NCT00422383|450727952|FG003|Overall Study|Lost to Follow-up|0|||
125301219|NCT00422383|450727953|FG004|Overall Study|Lost to Follow-up|1|||
125301220|NCT00422383|450727949|FG000|Overall Study|Protocol Violation|1|||
125301221|NCT00422383|450727950|FG001|Overall Study|Protocol Violation|1|||
125301222|NCT00422383|450727951|FG002|Overall Study|Protocol Violation|1|||
125301223|NCT00422383|450727952|FG003|Overall Study|Protocol Violation|0|||
125301224|NCT00422383|450727953|FG004|Overall Study|Protocol Violation|0|||
125301225|NCT00422383|450727949|FG000|Overall Study|Withdrawal by Subject|5|||
125301226|NCT00422383|450727950|FG001|Overall Study|Withdrawal by Subject|5|||
125301227|NCT00422383|450727951|FG002|Overall Study|Withdrawal by Subject|0|||
125301228|NCT00422383|450727952|FG003|Overall Study|Withdrawal by Subject|0|||
125301229|NCT00422383|450727953|FG004|Overall Study|Withdrawal by Subject|1|||
125301230|NCT03738618|450730220|FG000|Overall Study|Protocol deviation|23|||
125301231|NCT03738618|450730221|FG001|Overall Study|Protocol deviation|0|||
125301232|NCT03738618|450730220|FG000|Overall Study|Adverse Event|4|||
125477942|NCT04810650|451383157|FG007|Overall Study|Lost to Follow-up|0|||
125477943|NCT04810650|451383158|FG008|Overall Study|Lost to Follow-up|0|||
125477944|NCT04810650|451383159|FG009|Overall Study|Lost to Follow-up|0|||
125477945|NCT04810650|451383160|FG010|Overall Study|Lost to Follow-up|1|||
125477946|NCT04810650|451383161|FG011|Overall Study|Lost to Follow-up|0|||
125477947|NCT04810650|451383162|FG012|Overall Study|Lost to Follow-up|3|||
125477948|NCT04810650|451383163|FG013|Overall Study|Lost to Follow-up|9|||
125477949|NCT04810650|451383150|FG000|Overall Study|Participant declined|0|||
125477950|NCT04810650|451383151|FG001|Overall Study|Participant declined|0|||
125477951|NCT04810650|451383152|FG002|Overall Study|Participant declined|0|||
125301233|NCT03738618|450730221|FG001|Overall Study|Adverse Event|0|||
125301234|NCT03738618|450730220|FG000|Overall Study|Lost to Follow-up|2|||
125301235|NCT03738618|450730221|FG001|Overall Study|Lost to Follow-up|0|||
125301236|NCT03738618|450730220|FG000|Overall Study|Randomization failure|1|||
125301237|NCT03738618|450730221|FG001|Overall Study|Randomization failure|0|||
125301238|NCT03738618|450730220|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
125301239|NCT03738618|450730221|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
125301240|NCT03738618|450730220|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
125301241|NCT03738618|450730221|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
125301242|NCT00649428|450730222|FG000|Overall Study|Adverse Event|2|||
125301243|NCT00649428|450730223|FG001|Overall Study|Adverse Event|2|||
125301244|NCT00649428|450730222|FG000|Overall Study|Withdrawal by Subject|6|||
125301245|NCT00649428|450730223|FG001|Overall Study|Withdrawal by Subject|6|||
125301246|NCT00649428|450730222|FG000|Overall Study|Lost to Follow-up|1|||
125301247|NCT00649428|450730223|FG001|Overall Study|Lost to Follow-up|3|||
125301248|NCT00649428|450730222|FG000|Overall Study|Insufficient manufacturing yield|5|||
125301249|NCT00649428|450730223|FG001|Overall Study|Insufficient manufacturing yield|1|||
125301250|NCT00649428|450730222|FG000|Overall Study|Protocol Violation|6|||
125301251|NCT00649428|450730223|FG001|Overall Study|Protocol Violation|2|||
125301252|NCT00649428|450730222|FG000|Overall Study|Physician Decision|0|||
125301253|NCT00649428|450730223|FG001|Overall Study|Physician Decision|1|||
125477952|NCT04810650|451383153|FG003|Overall Study|Participant declined|0|||
125477953|NCT04810650|451383154|FG004|Overall Study|Participant declined|0|||
125477954|NCT04810650|451383155|FG005|Overall Study|Participant declined|0|||
125301254|NCT01450098|450730224|FG000|Period 3|Protocol Violation|0|||
125301255|NCT01450098|450730225|FG001|Period 3|Protocol Violation|1|||
125301256|NCT01450098|450730224|FG000|Period 3|Withdrawal by Subject|0|||
125301257|NCT01450098|450730225|FG001|Period 3|Withdrawal by Subject|2|||
125301258|NCT01272635|450730228|FG000|Overall Study|Lost to Follow-up|31|||
125301259|NCT01272635|450730229|FG001|Overall Study|Lost to Follow-up|20|||
125301260|NCT01272635|450730230|FG002|Overall Study|Lost to Follow-up|31|||
125301261|NCT01272635|450730231|FG003|Overall Study|Lost to Follow-up|23|||
125301262|NCT01832155|450730232|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
125477955|NCT04810650|451383156|FG006|Overall Study|Participant declined|0|||
125477956|NCT04810650|451383157|FG007|Overall Study|Participant declined|0|||
125301263|NCT01832155|450730233|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
125301264|NCT01832155|450730232|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
125301265|NCT01832155|450730233|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
125301266|NCT02409719|450730241|FG000|Overall Study|Lost to Follow-up|3|||
125301267|NCT02409719|450730242|FG001|Overall Study|Lost to Follow-up|3|||
125301268|NCT02479139|450730243|FG000|Overall Study|Lost to Follow-up|2|||
125301269|NCT02479139|450730244|FG001|Overall Study|Lost to Follow-up|4|||
125301270|NCT02479139|450730245|FG002|Overall Study|Lost to Follow-up|4|||
125301271|NCT02479139|450730246|FG003|Overall Study|Lost to Follow-up|2|||
125301272|NCT02479139|450730247|FG004|Overall Study|Lost to Follow-up|3|||
125301273|NCT02479139|450730248|FG005|Overall Study|Lost to Follow-up|5|||
125301274|NCT02479139|450730243|FG000|Overall Study|Withdrew Consent|5|||
125301275|NCT02479139|450730244|FG001|Overall Study|Withdrew Consent|6|||
125301276|NCT02479139|450730245|FG002|Overall Study|Withdrew Consent|1|||
125301277|NCT02479139|450730246|FG003|Overall Study|Withdrew Consent|4|||
125301278|NCT02479139|450730247|FG004|Overall Study|Withdrew Consent|1|||
125301279|NCT02479139|450730248|FG005|Overall Study|Withdrew Consent|1|||
125301280|NCT02479139|450730243|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
125301281|NCT02479139|450730244|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
125301282|NCT02479139|450730245|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
125301283|NCT02479139|450730246|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
125301284|NCT02479139|450730247|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
125301285|NCT02479139|450730248|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
125301286|NCT02479139|450730243|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125301287|NCT02479139|450730244|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125301288|NCT02479139|450730245|FG002|Overall Study|Other Miscellaneous Reasons|1|||
125301289|NCT02479139|450730246|FG003|Overall Study|Other Miscellaneous Reasons|1|||
125301290|NCT02479139|450730247|FG004|Overall Study|Other Miscellaneous Reasons|1|||
125301291|NCT02479139|450730248|FG005|Overall Study|Other Miscellaneous Reasons|0|||
125301292|NCT00778895|450730251|FG000|Active Phase|Adverse Event|3|||
125301293|NCT00778895|450730252|FG001|Active Phase|Adverse Event|1|||
125301294|NCT00778895|450730253|FG002|Active Phase|Adverse Event|0|||
125301295|NCT00778895|450730251|FG000|Active Phase|Withdrawal by Subject|1|||
125301296|NCT00778895|450730252|FG001|Active Phase|Withdrawal by Subject|4|||
125301297|NCT00778895|450730253|FG002|Active Phase|Withdrawal by Subject|0|||
125301298|NCT00778895|450730251|FG000|Active Phase|Lost to Follow-up|1|||
125301299|NCT00778895|450730252|FG001|Active Phase|Lost to Follow-up|1|||
125301300|NCT00778895|450730253|FG002|Active Phase|Lost to Follow-up|0|||
125301301|NCT00778895|450730251|FG000|Active Phase|Other|2|||
125301302|NCT00778895|450730252|FG001|Active Phase|Other|0|||
125301303|NCT00778895|450730253|FG002|Active Phase|Other|0|||
125301304|NCT00778895|450730251|FG000|ESFU Phase|Adverse Event|2|||
125301305|NCT00778895|450730252|FG001|ESFU Phase|Adverse Event|1|||
125301306|NCT00778895|450730253|FG002|ESFU Phase|Adverse Event|0|||
125301307|NCT00778895|450730251|FG000|ESFU Phase|Withdrawal by Subject|1|||
125301308|NCT00778895|450730252|FG001|ESFU Phase|Withdrawal by Subject|4|||
125301309|NCT00778895|450730253|FG002|ESFU Phase|Withdrawal by Subject|0|||
125301310|NCT00778895|450730251|FG000|ESFU Phase|Lost to Follow-up|6|||
125301311|NCT00778895|450730252|FG001|ESFU Phase|Lost to Follow-up|7|||
125301312|NCT00778895|450730253|FG002|ESFU Phase|Lost to Follow-up|2|||
125301313|NCT00778895|450730251|FG000|ESFU Phase|Other|2|||
125301314|NCT00778895|450730252|FG001|ESFU Phase|Other|0|||
125301315|NCT00778895|450730253|FG002|ESFU Phase|Other|0|||
125301316|NCT02540993|450730254|FG000|Overall Study|Lost to Follow-up|5|||
125301317|NCT02540993|450730255|FG001|Overall Study|Lost to Follow-up|3|||
125301318|NCT02540993|450730254|FG000|Overall Study|Withdrawal by Subject|4|||
125301319|NCT02540993|450730255|FG001|Overall Study|Withdrawal by Subject|6|||
125301320|NCT02540993|450730254|FG000|Overall Study|GCP violations|33|||
125301321|NCT02540993|450730255|FG001|Overall Study|GCP violations|27|||
125301322|NCT03550404|450730256|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
125301323|NCT03550404|450730257|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
125477957|NCT04810650|451383158|FG008|Overall Study|Participant declined|0|||
125477958|NCT04810650|451383159|FG009|Overall Study|Participant declined|0|||
125477959|NCT04810650|451383160|FG010|Overall Study|Participant declined|2|||
125301324|NCT03550404|450730258|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
125301325|NCT03550404|450730256|FG000|Phase 2|Vacated position|1|||
125301326|NCT03550404|450730257|FG001|Phase 2|Vacated position|0|||
125301327|NCT03550404|450730258|FG002|Phase 2|Vacated position|0|||
125301328|NCT01009086|450730260|FG000|Overall Study|Lack of Efficacy|16|||
125301329|NCT01009086|450730261|FG001|Overall Study|Lack of Efficacy|15|||
125301330|NCT01009086|450730262|FG002|Overall Study|Lack of Efficacy|9|||
125301331|NCT01009086|450730260|FG000|Overall Study|Lost to Follow-up|4|||
125301332|NCT01009086|450730261|FG001|Overall Study|Lost to Follow-up|5|||
125301333|NCT01009086|450730262|FG002|Overall Study|Lost to Follow-up|3|||
125477960|NCT04810650|451383161|FG011|Overall Study|Participant declined|0|||
125301334|NCT01009086|450730260|FG000|Overall Study|Adverse Event|12|||
125301335|NCT01009086|450730261|FG001|Overall Study|Adverse Event|11|||
125301336|NCT01009086|450730262|FG002|Overall Study|Adverse Event|8|||
125301337|NCT01009086|450730260|FG000|Overall Study|Withdrawal by Subject|9|||
125301338|NCT01009086|450730261|FG001|Overall Study|Withdrawal by Subject|11|||
125301339|NCT01009086|450730262|FG002|Overall Study|Withdrawal by Subject|13|||
125301340|NCT01009086|450730260|FG000|Overall Study|Other|3|||
125301341|NCT01009086|450730261|FG001|Overall Study|Other|5|||
125301342|NCT01009086|450730262|FG002|Overall Study|Other|1|||
125301343|NCT05096312|450730263|FG000|Overall Study|Lost to Follow-up|2|||
125301344|NCT05096312|450730264|FG001|Overall Study|Lost to Follow-up|4|||
125301345|NCT05096312|450730263|FG000|Overall Study|Adverse Event|1|||
125301346|NCT05096312|450730264|FG001|Overall Study|Adverse Event|0|||
125301347|NCT03135210|450730265|FG000|Overall Study|Death|0|||
125301348|NCT03135210|450730266|FG001|Overall Study|Death|1|||
125301349|NCT00820222|450730269|FG000|Overall Study|Lost to Follow-up|10|||
125301350|NCT00820222|450730270|FG001|Overall Study|Lost to Follow-up|9|||
125301351|NCT00820222|450730269|FG000|Overall Study|Withdrawal by Subject|19|||
125301352|NCT00820222|450730270|FG001|Overall Study|Withdrawal by Subject|21|||
125301353|NCT00820222|450730269|FG000|Overall Study|Physician Decision|93|||
125301354|NCT00820222|450730270|FG001|Overall Study|Physician Decision|88|||
125301355|NCT00820222|450730269|FG000|Overall Study|Sponsor Terminated Study|43|||
125301356|NCT00820222|450730270|FG001|Overall Study|Sponsor Terminated Study|65|||
125301357|NCT00820222|450730269|FG000|Overall Study|Unkown|11|||
125301358|NCT00820222|450730270|FG001|Overall Study|Unkown|7|||
125301359|NCT00590577|450730271|FG000|Overall Study|Lack of Efficacy|31|||
125301360|NCT00590577|450730272|FG001|Overall Study|Lack of Efficacy|28|||
125301361|NCT00590577|450730273|FG002|Overall Study|Lack of Efficacy|23|||
125301362|NCT00590577|450730274|FG003|Overall Study|Lack of Efficacy|45|||
125301363|NCT00590577|450730271|FG000|Overall Study|Withdrawal by Subject|23|||
125301364|NCT00590577|450730272|FG001|Overall Study|Withdrawal by Subject|28|||
125301365|NCT00590577|450730273|FG002|Overall Study|Withdrawal by Subject|30|||
125301366|NCT00590577|450730274|FG003|Overall Study|Withdrawal by Subject|26|||
125301367|NCT00590577|450730271|FG000|Overall Study|Adverse Event|10|||
125301368|NCT00590577|450730272|FG001|Overall Study|Adverse Event|10|||
125301369|NCT00590577|450730273|FG002|Overall Study|Adverse Event|13|||
125301370|NCT00590577|450730274|FG003|Overall Study|Adverse Event|11|||
125301371|NCT00590577|450730271|FG000|Overall Study|Lost to Follow-up|12|||
125301372|NCT00590577|450730272|FG001|Overall Study|Lost to Follow-up|6|||
125301373|NCT00590577|450730273|FG002|Overall Study|Lost to Follow-up|6|||
125301374|NCT00590577|450730274|FG003|Overall Study|Lost to Follow-up|9|||
125301375|NCT00590577|450730271|FG000|Overall Study|Pregnancy|0|||
125301376|NCT00590577|450730272|FG001|Overall Study|Pregnancy|1|||
125301377|NCT00590577|450730273|FG002|Overall Study|Pregnancy|0|||
125301378|NCT00590577|450730274|FG003|Overall Study|Pregnancy|0|||
125301379|NCT00590577|450730271|FG000|Overall Study|Various reasons|1|||
125477961|NCT04810650|451383162|FG012|Overall Study|Participant declined|0|||
125477962|NCT04810650|451383163|FG013|Overall Study|Participant declined|0|||
125477963|NCT05794243|451383164|FG000|Overall Study|Withdrawal by Subject|1|||
125477964|NCT05794243|451383165|FG001|Overall Study|Withdrawal by Subject|0|||
125477965|NCT05794243|451383166|FG002|Overall Study|Withdrawal by Subject|1|||
125477966|NCT05794243|451383164|FG000|Overall Study|Physician Decision|0|||
125477967|NCT05794243|451383165|FG001|Overall Study|Physician Decision|3|||
125477968|NCT05794243|451383166|FG002|Overall Study|Physician Decision|1|||
125477969|NCT05057247|451383170|FG000|Overall Study|Death|4|||
125477970|NCT05057247|451383170|FG000|Overall Study|Physician Decision|3|||
125477971|NCT05057247|451383170|FG000|Overall Study|Progressive Disease|7|||
125477972|NCT05057247|451383170|FG000|Overall Study|Withdrawal by Subject|3|||
125477973|NCT05057247|451383170|FG000|Overall Study|Adverse Event|6|||
125477974|NCT05057247|451383170|FG000|Overall Study|Subject Non-Compliance|1|||
125477975|NCT05057247|451383170|FG000|Overall Study|On treatment|2|||
125301380|NCT00590577|450730272|FG001|Overall Study|Various reasons|3|||
125301381|NCT00590577|450730273|FG002|Overall Study|Various reasons|1|||
125301382|NCT00590577|450730274|FG003|Overall Study|Various reasons|2|||
125301383|NCT01229449|450730275|FG000|Overall Study|Withdrawal by Subject|0|||
125477976|NCT02761057|451383183|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
125477977|NCT02761057|451383184|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
125301384|NCT01229449|450730276|FG001|Overall Study|Withdrawal by Subject|3|||
125301385|NCT01229449|450730277|FG002|Overall Study|Withdrawal by Subject|0|||
125301386|NCT01229449|450730278|FG003|Overall Study|Withdrawal by Subject|1|||
125301387|NCT01229449|450730279|FG004|Overall Study|Withdrawal by Subject|1|||
125301388|NCT01229449|450730275|FG000|Overall Study|Lost to Follow-up|1|||
125301389|NCT01229449|450730276|FG001|Overall Study|Lost to Follow-up|1|||
125301390|NCT01229449|450730277|FG002|Overall Study|Lost to Follow-up|1|||
125301391|NCT01229449|450730278|FG003|Overall Study|Lost to Follow-up|0|||
125477978|NCT02761057|451383185|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
125477979|NCT02761057|451383186|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
125485391|NCT02240238|451412505|FG002|Phase 1|Physician Decision|0|||
125301392|NCT01229449|450730279|FG004|Overall Study|Lost to Follow-up|0|||
125301393|NCT01229449|450730275|FG000|Overall Study|Physician Decision|0|||
125301394|NCT01229449|450730276|FG001|Overall Study|Physician Decision|0|||
125301395|NCT01229449|450730277|FG002|Overall Study|Physician Decision|1|||
125301396|NCT01229449|450730278|FG003|Overall Study|Physician Decision|0|||
125301397|NCT01229449|450730279|FG004|Overall Study|Physician Decision|0|||
125477980|NCT02761057|451383183|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
125477981|NCT02761057|451383184|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
125477982|NCT02761057|451383185|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
125477983|NCT02761057|451383186|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
125477984|NCT02761057|451383183|FG000|Overall Study|Currently On Study Treatment|0|||
125477985|NCT02761057|451383184|FG001|Overall Study|Currently On Study Treatment|3|||
125477986|NCT02761057|451383185|FG002|Overall Study|Currently On Study Treatment|0|||
125477987|NCT02761057|451383186|FG003|Overall Study|Currently On Study Treatment|0|||
125477988|NCT02761057|451383183|FG000|Overall Study|Adverse Event|11|||
125477989|NCT02761057|451383184|FG001|Overall Study|Adverse Event|9|||
125477990|NCT02761057|451383185|FG002|Overall Study|Adverse Event|5|||
125477991|NCT02761057|451383186|FG003|Overall Study|Adverse Event|3|||
125477992|NCT02761057|451383183|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
125477993|NCT02761057|451383184|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
125477994|NCT02761057|451383185|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
125477995|NCT02761057|451383186|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
125477996|NCT02761057|451383183|FG000|Overall Study|Progression/Relapse|29|||
125477997|NCT02761057|451383184|FG001|Overall Study|Progression/Relapse|27|||
125477998|NCT02761057|451383185|FG002|Overall Study|Progression/Relapse|20|||
125477999|NCT02761057|451383186|FG003|Overall Study|Progression/Relapse|23|||
125478000|NCT02761057|451383183|FG000|Overall Study|Death|2|||
125478001|NCT02761057|451383184|FG001|Overall Study|Death|2|||
125478002|NCT02761057|451383185|FG002|Overall Study|Death|1|||
125478003|NCT02761057|451383186|FG003|Overall Study|Death|1|||
125478004|NCT02761057|451383183|FG000|Overall Study|Other - Not Protocol Specified|2|||
125478005|NCT02761057|451383184|FG001|Overall Study|Other - Not Protocol Specified|1|||
125478006|NCT02761057|451383185|FG002|Overall Study|Other - Not Protocol Specified|2|||
125478007|NCT02761057|451383186|FG003|Overall Study|Other - Not Protocol Specified|0|||
125478008|NCT04788511|451383187|FG000|Overall Study|Withdrawal by Subject|2|||
125478009|NCT04788511|451383188|FG001|Overall Study|Withdrawal by Subject|1|||
125301398|NCT01887353|450730296|FG000|Overall Study|Study stopped early|4|||
125301399|NCT01887353|450730297|FG001|Overall Study|Study stopped early|3|||
125301400|NCT00699335|450730298|FG000|Overall Study|Combination of multiple reasons|176|||
125301401|NCT00699335|450730298|FG000|Overall Study|Missing data|52|||
125301402|NCT03262441|450730299|FG000|Overall Study|Withdrawal by Subject|1|||
125301403|NCT01545050|450730300|FG000|Overall Study|Lack of Efficacy|0|||
125301404|NCT01545050|450730301|FG001|Overall Study|Lack of Efficacy|0|||
125301405|NCT01545050|450730302|FG002|Overall Study|Lack of Efficacy|0|||
125301406|NCT01545050|450730303|FG003|Overall Study|Lack of Efficacy|3|||
125301407|NCT01545050|450730304|FG004|Overall Study|Lack of Efficacy|2|||
125301408|NCT01545050|450730300|FG000|Overall Study|Adverse Event|1|||
125301409|NCT01545050|450730301|FG001|Overall Study|Adverse Event|1|||
125301410|NCT01545050|450730302|FG002|Overall Study|Adverse Event|2|||
125301411|NCT01545050|450730303|FG003|Overall Study|Adverse Event|2|||
125301412|NCT01545050|450730304|FG004|Overall Study|Adverse Event|0|||
125301413|NCT01545050|450730300|FG000|Overall Study|Discontinued study treatment|1|||
125301414|NCT01545050|450730301|FG001|Overall Study|Discontinued study treatment|0|||
125301415|NCT01545050|450730302|FG002|Overall Study|Discontinued study treatment|0|||
125301416|NCT01545050|450730303|FG003|Overall Study|Discontinued study treatment|0|||
125301417|NCT01545050|450730304|FG004|Overall Study|Discontinued study treatment|0|||
125301418|NCT01545050|450730300|FG000|Overall Study|Withdrawal by Subject|1|||
125301419|NCT01545050|450730301|FG001|Overall Study|Withdrawal by Subject|0|||
125301420|NCT01545050|450730302|FG002|Overall Study|Withdrawal by Subject|0|||
125301421|NCT01545050|450730303|FG003|Overall Study|Withdrawal by Subject|2|||
125301422|NCT01545050|450730304|FG004|Overall Study|Withdrawal by Subject|1|||
125301423|NCT01545050|450730300|FG000|Overall Study|Participant no longer meets study criteria|0|||
125301424|NCT01545050|450730301|FG001|Overall Study|Participant no longer meets study criteria|2|||
125301425|NCT01545050|450730302|FG002|Overall Study|Participant no longer meets study criteria|0|||
125301426|NCT01545050|450730303|FG003|Overall Study|Participant no longer meets study criteria|0|||
125301427|NCT01545050|450730304|FG004|Overall Study|Participant no longer meets study criteria|1|||
125301428|NCT01545050|450730300|FG000|Overall Study|Administrative reason by sponsor|4|||
125301429|NCT01545050|450730301|FG001|Overall Study|Administrative reason by sponsor|2|||
125478010|NCT04788511|451383187|FG000|Overall Study|Lost to Follow-up|2|||
125478011|NCT04788511|451383188|FG001|Overall Study|Lost to Follow-up|7|||
125478012|NCT04788511|451383187|FG000|Overall Study|Death|3|||
125478013|NCT04788511|451383188|FG001|Overall Study|Death|4|||
125301430|NCT01545050|450730302|FG002|Overall Study|Administrative reason by sponsor|3|||
125301431|NCT01545050|450730303|FG003|Overall Study|Administrative reason by sponsor|5|||
125301432|NCT01545050|450730304|FG004|Overall Study|Administrative reason by sponsor|5|||
125301433|NCT00559988|450730308|FG000|Overall Study|Death|147|||
125478014|NCT04652700|451383191|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
125478015|NCT04652700|451383192|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
125301434|NCT00559988|450730309|FG001|Overall Study|Death|140|||
125301435|NCT00559988|450730308|FG000|Overall Study|Withdrawal by Subject|152|||
125301436|NCT00559988|450730309|FG001|Overall Study|Withdrawal by Subject|139|||
125301437|NCT00559988|450730308|FG000|Overall Study|Lost to Follow-up|42|||
125301438|NCT00559988|450730309|FG001|Overall Study|Lost to Follow-up|56|||
125301439|NCT00559988|450730308|FG000|Overall Study|ICD device explanted|10|||
125301440|NCT00559988|450730309|FG001|Overall Study|ICD device explanted|17|||
125301441|NCT02249182|450730310|FG000|Treatment Phase|Lost to Follow-up|4|||
125301442|NCT02249182|450730311|FG001|Treatment Phase|Lost to Follow-up|0|||
125301443|NCT02249182|450730312|FG002|Treatment Phase|Lost to Follow-up|0|||
125301444|NCT02249182|450730313|FG003|Treatment Phase|Lost to Follow-up|0|||
125301445|NCT02249182|450730314|FG004|Treatment Phase|Lost to Follow-up|0|||
125301446|NCT01455194|450730315|FG000|Overall Study|Screen Failure|20|||
125301447|NCT01455194|450730316|FG001|Overall Study|Screen Failure|0|||
125301448|NCT01455194|450730317|FG002|Overall Study|Screen Failure|0|||
125301449|NCT01455194|450730318|FG003|Overall Study|Screen Failure|0|||
125301450|NCT01455194|450730315|FG000|Overall Study|Randomisation Failure|90|||
125301451|NCT01455194|450730316|FG001|Overall Study|Randomisation Failure|0|||
125301452|NCT01455194|450730317|FG002|Overall Study|Randomisation Failure|0|||
125301453|NCT01455194|450730318|FG003|Overall Study|Randomisation Failure|0|||
125301454|NCT01455194|450730315|FG000|Overall Study|Deterioration in asthma|12|||
125301455|NCT01455194|450730316|FG001|Overall Study|Deterioration in asthma|6|||
125301456|NCT01455194|450730317|FG002|Overall Study|Deterioration in asthma|14|||
125301457|NCT01455194|450730318|FG003|Overall Study|Deterioration in asthma|9|||
125301458|NCT01455194|450730315|FG000|Overall Study|Adverse Event|1|||
125301459|NCT01455194|450730316|FG001|Overall Study|Adverse Event|1|||
125301460|NCT01455194|450730317|FG002|Overall Study|Adverse Event|1|||
125301461|NCT01455194|450730318|FG003|Overall Study|Adverse Event|3|||
125301462|NCT01455194|450730315|FG000|Overall Study|Withdrawal by Subject|21|||
125301463|NCT01455194|450730316|FG001|Overall Study|Withdrawal by Subject|16|||
125301464|NCT01455194|450730317|FG002|Overall Study|Withdrawal by Subject|12|||
125301465|NCT01455194|450730318|FG003|Overall Study|Withdrawal by Subject|9|||
125301466|NCT01455194|450730315|FG000|Overall Study|Lost to Follow-up|2|||
125301467|NCT01455194|450730316|FG001|Overall Study|Lost to Follow-up|0|||
125301468|NCT01455194|450730317|FG002|Overall Study|Lost to Follow-up|1|||
125301469|NCT01455194|450730318|FG003|Overall Study|Lost to Follow-up|1|||
125301470|NCT01455194|450730315|FG000|Overall Study|Pregnancy|0|||
125301471|NCT01455194|450730316|FG001|Overall Study|Pregnancy|1|||
125301472|NCT01455194|450730317|FG002|Overall Study|Pregnancy|1|||
125301473|NCT01455194|450730318|FG003|Overall Study|Pregnancy|0|||
125301474|NCT01455194|450730315|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
125301475|NCT01455194|450730316|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
125301476|NCT01455194|450730317|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
125301477|NCT01455194|450730318|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
125301478|NCT01455194|450730315|FG000|Overall Study|Miscellaneous|4|||
125301479|NCT01455194|450730316|FG001|Overall Study|Miscellaneous|5|||
125301480|NCT01455194|450730317|FG002|Overall Study|Miscellaneous|1|||
125301481|NCT01455194|450730318|FG003|Overall Study|Miscellaneous|4|||
125301482|NCT02516228|450730321|FG000|Overall Study|Lost to Follow-up|1|||
125301483|NCT02516228|450730321|FG000|Overall Study|Withdrawal by Subject|1|||
125301484|NCT02516228|450730321|FG000|Overall Study|Physician Decision|1|||
125301485|NCT03916484|450730322|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125301486|NCT03916484|450730323|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
125301487|NCT03916484|450730324|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125301488|NCT03916484|450730325|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
125301489|NCT03916484|450730322|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
125301490|NCT03916484|450730323|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
125301491|NCT03916484|450730324|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
125301492|NCT03916484|450730325|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
125301493|NCT01092663|450730328|FG000|Overall Study|Withdrawal by Subject|3|||
125301494|NCT01092663|450730329|FG001|Overall Study|Withdrawal by Subject|2|||
125301495|NCT01092663|450730328|FG000|Overall Study|Glucose >300mg/dL|1|||
125301496|NCT01092663|450730329|FG001|Overall Study|Glucose >300mg/dL|0|||
125478016|NCT04652700|451383191|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
125478017|NCT04652700|451383192|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
125301497|NCT01092663|450730328|FG000|Overall Study|High fasting triglyceride|2|||
125301498|NCT01092663|450730329|FG001|Overall Study|High fasting triglyceride|0|||
125301499|NCT01092663|450730328|FG000|Overall Study|Adverse Event|1|||
125301500|NCT01092663|450730329|FG001|Overall Study|Adverse Event|1|||
125301501|NCT01092663|450730328|FG000|Overall Study|Protocol Violation|0|||
125301502|NCT01092663|450730329|FG001|Overall Study|Protocol Violation|1|||
125301503|NCT03688620|450730330|FG000|Overall Study|Other|0|||
125301504|NCT03688620|450730331|FG001|Overall Study|Other|0|||
125301505|NCT03688620|450730332|FG002|Overall Study|Other|1|||
125301506|NCT03688620|450730330|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
125301507|NCT03688620|450730331|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
125301508|NCT03688620|450730332|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
125301509|NCT03688620|450730330|FG000|Overall Study|Lost to Follow-up|16|||
125301510|NCT03688620|450730331|FG001|Overall Study|Lost to Follow-up|0|||
125301511|NCT03688620|450730332|FG002|Overall Study|Lost to Follow-up|1|||
125301512|NCT03688620|450730330|FG000|Overall Study|Withdrawal by Subject|0|||
125301513|NCT03688620|450730331|FG001|Overall Study|Withdrawal by Subject|0|||
125301514|NCT03688620|450730332|FG002|Overall Study|Withdrawal by Subject|6|||
125301515|NCT01008904|450730333|FG000|Overall Study|Lost to Follow-up|1|||
125301516|NCT01008904|450730333|FG000|Overall Study|Adverse Event|2|||
125301517|NCT01008904|450730333|FG000|Overall Study|unexpected unrelated surgery|1|||
125301518|NCT01183065|450730334|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
125301519|NCT02456857|450730335|FG000|Overall Study|Disease Progression|4|||
125301520|NCT00781859|450730336|FG000|Overall Study|Adverse Event|2|||
125301521|NCT00781859|450730337|FG001|Overall Study|Adverse Event|2|||
125301522|NCT00781859|450730336|FG000|Overall Study|Withdrawal by Subject|8|||
125301523|NCT00781859|450730337|FG001|Overall Study|Withdrawal by Subject|4|||
125301524|NCT00781859|450730336|FG000|Overall Study|Lost to Follow-up|6|||
125301525|NCT00781859|450730337|FG001|Overall Study|Lost to Follow-up|3|||
125301526|NCT00781859|450730336|FG000|Overall Study|Death|3|||
125301527|NCT00781859|450730337|FG001|Overall Study|Death|0|||
125301528|NCT01983774|450730341|FG000|Overall Study|Lung Transplant|0|||
125301529|NCT01983774|450730342|FG001|Overall Study|Lung Transplant|1|||
125301530|NCT01983774|450730341|FG000|Overall Study|Lost to Follow-up|1|||
125301531|NCT01983774|450730342|FG001|Overall Study|Lost to Follow-up|0|||
125301532|NCT01008449|450730343|FG000|Overall Study|Lost to Follow-up|29|||
125301533|NCT01008449|450730344|FG001|Overall Study|Lost to Follow-up|19|||
125301534|NCT01220180|450730345|FG000|Overall Study|Lost to Follow-up|76|||
125301535|NCT01220180|450730345|FG000|Overall Study|Other|72|||
125301536|NCT01220180|450730345|FG000|Overall Study|Adverse Event|35|||
125301537|NCT01220180|450730345|FG000|Overall Study|Lack of Efficacy|22|||
125301538|NCT01220180|450730345|FG000|Overall Study|Death|1|||
125301539|NCT01220180|450730345|FG000|Overall Study|Randomized but not treated|1|||
125301540|NCT01067469|450730351|FG000|Overall Study|Withdrawal by Subject|0|||
125301541|NCT01067469|450730352|FG001|Overall Study|Withdrawal by Subject|1|||
125301542|NCT01067469|450730351|FG000|Overall Study|Disease Progression|0|||
125301543|NCT01067469|450730352|FG001|Overall Study|Disease Progression|1|||
125301544|NCT01299116|450730354|FG000|Overall Study|Lost to Follow-up|65|||
125301545|NCT01299116|450730355|FG001|Overall Study|Lost to Follow-up|9|||
125301546|NCT01299116|450730356|FG002|Overall Study|Lost to Follow-up|11|||
125301547|NCT01123707|450730358|FG000|Overall Study|Lost to Follow-up|3|||
125301548|NCT01123707|450730359|FG001|Overall Study|Lost to Follow-up|1|||
125301549|NCT01123707|450730360|FG002|Overall Study|Lost to Follow-up|3|||
125301550|NCT01123707|450730361|FG003|Overall Study|Lost to Follow-up|2|||
125301551|NCT01123707|450730358|FG000|Overall Study|Adverse Event|5|||
125301552|NCT01123707|450730359|FG001|Overall Study|Adverse Event|7|||
125301553|NCT01123707|450730360|FG002|Overall Study|Adverse Event|5|||
125301554|NCT01123707|450730361|FG003|Overall Study|Adverse Event|3|||
125301555|NCT01123707|450730358|FG000|Overall Study|Sponsor Discontinued Study|30|||
125301556|NCT01123707|450730359|FG001|Overall Study|Sponsor Discontinued Study|24|||
125301557|NCT01123707|450730360|FG002|Overall Study|Sponsor Discontinued Study|25|||
125301558|NCT01123707|450730361|FG003|Overall Study|Sponsor Discontinued Study|40|||
125301559|NCT01123707|450730358|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
125301560|NCT01123707|450730359|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
125301561|NCT01123707|450730360|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
125301562|NCT01123707|450730361|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
125301563|NCT01123707|450730358|FG000|Overall Study|Investigator Withdrew Participant|0|||
125301564|NCT01123707|450730359|FG001|Overall Study|Investigator Withdrew Participant|1|||
125301565|NCT01123707|450730360|FG002|Overall Study|Investigator Withdrew Participant|1|||
125301566|NCT01123707|450730361|FG003|Overall Study|Investigator Withdrew Participant|1|||
125301567|NCT01123707|450730358|FG000|Overall Study|Subject Withdrew Consent|4|||
125301568|NCT01123707|450730359|FG001|Overall Study|Subject Withdrew Consent|5|||
125301569|NCT01123707|450730360|FG002|Overall Study|Subject Withdrew Consent|1|||
125301570|NCT01123707|450730361|FG003|Overall Study|Subject Withdrew Consent|2|||
125301571|NCT01123707|450730358|FG000|Overall Study|Lack of Efficacy|1|||
125301572|NCT01123707|450730359|FG001|Overall Study|Lack of Efficacy|2|||
125301573|NCT01123707|450730360|FG002|Overall Study|Lack of Efficacy|1|||
125301574|NCT01123707|450730361|FG003|Overall Study|Lack of Efficacy|0|||
125301575|NCT01123707|450730358|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
125301576|NCT01123707|450730359|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
125301577|NCT01123707|450730360|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
125301578|NCT01123707|450730361|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
125301579|NCT04378114|450730364|FG000|Overall Study|Withdrawal by Subject|5|||
125301580|NCT00629798|450730365|FG000|Overall Study|Not Treated|4|||
125301581|NCT01959243|450730368|FG000|Overall Study|Investigator Decision|3|||
125301582|NCT01959243|450730369|FG001|Overall Study|Investigator Decision|0|||
125301583|NCT01959243|450730368|FG000|Overall Study|Adverse Event|5|||
125301584|NCT01959243|450730369|FG001|Overall Study|Adverse Event|2|||
125301585|NCT01959243|450730368|FG000|Overall Study|Administrative reasons|2|||
125301586|NCT01959243|450730369|FG001|Overall Study|Administrative reasons|1|||
125301587|NCT01959243|450730368|FG000|Overall Study|Lost to Follow-up|3|||
125301588|NCT01959243|450730369|FG001|Overall Study|Lost to Follow-up|1|||
125301589|NCT00428844|450730370|FG000|Completed Study Drug Treatment|Adverse Event|2|||
125301590|NCT00428844|450730371|FG001|Completed Study Drug Treatment|Adverse Event|4|||
125301591|NCT00428844|450730372|FG002|Completed Study Drug Treatment|Adverse Event|4|||
125301592|NCT00428844|450730370|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
125301593|NCT00428844|450730371|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
125301594|NCT00428844|450730372|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
125301595|NCT00428844|450730370|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
125301596|NCT00428844|450730371|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
125301597|NCT00428844|450730372|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
125301598|NCT00428844|450730370|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
125301599|NCT00428844|450730371|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
125301600|NCT00428844|450730372|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
125301601|NCT00428844|450730370|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
125301602|NCT00428844|450730371|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
125301603|NCT00428844|450730372|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
125301604|NCT00428844|450730370|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
125301605|NCT00428844|450730371|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
125301606|NCT00428844|450730372|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
125301607|NCT00428844|450730370|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
125301608|NCT00428844|450730371|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
125301609|NCT00428844|450730372|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
125301610|NCT00428844|450730370|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
125301611|NCT00428844|450730371|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
125301612|NCT00428844|450730372|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
125301613|NCT00428844|450730370|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
125301614|NCT00428844|450730371|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
125301615|NCT00428844|450730372|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
125301616|NCT00488826|450730375|FG000|Overall Study|Withdrawal by Subject|40|||
125301617|NCT00488826|450730376|FG001|Overall Study|Withdrawal by Subject|35|||
125301618|NCT00488826|450730377|FG002|Overall Study|Withdrawal by Subject|19|||
125301619|NCT00488826|450730375|FG000|Overall Study|Protocol Violation|0|||
125301620|NCT00488826|450730376|FG001|Overall Study|Protocol Violation|0|||
125301621|NCT00488826|450730377|FG002|Overall Study|Protocol Violation|2|||
125301622|NCT00488826|450730375|FG000|Overall Study|Adverse Event|9|||
125301623|NCT00488826|450730376|FG001|Overall Study|Adverse Event|15|||
125301624|NCT00488826|450730377|FG002|Overall Study|Adverse Event|4|||
125301625|NCT00488826|450730375|FG000|Overall Study|Lost to Follow-up|5|||
125301626|NCT00488826|450730376|FG001|Overall Study|Lost to Follow-up|1|||
125301627|NCT00488826|450730377|FG002|Overall Study|Lost to Follow-up|0|||
125301628|NCT00488826|450730375|FG000|Overall Study|Protocol Deviations|2|||
125301629|NCT00488826|450730376|FG001|Overall Study|Protocol Deviations|1|||
125301630|NCT00488826|450730377|FG002|Overall Study|Protocol Deviations|1|||
125301631|NCT02292706|450730379|FG000|Overall Study|Lost to Follow-up|20|||
125301632|NCT02292706|450730380|FG001|Overall Study|Lost to Follow-up|44|||
125301633|NCT02292706|450730381|FG002|Overall Study|Lost to Follow-up|24|||
125301634|NCT02292706|450730382|FG003|Overall Study|Lost to Follow-up|61|||
125301635|NCT02292706|450730383|FG004|Overall Study|Lost to Follow-up|21|||
125301636|NCT02292706|450730384|FG005|Overall Study|Lost to Follow-up|52|||
125301637|NCT02292706|450730385|FG006|Overall Study|Lost to Follow-up|25|||
125301638|NCT02292706|450730386|FG007|Overall Study|Lost to Follow-up|0|||
125301639|NCT02292706|450730379|FG000|Overall Study|Withdrew consent|15|||
125301640|NCT02292706|450730380|FG001|Overall Study|Withdrew consent|56|||
125301641|NCT02292706|450730381|FG002|Overall Study|Withdrew consent|43|||
125301642|NCT02292706|450730382|FG003|Overall Study|Withdrew consent|36|||
125301643|NCT02292706|450730383|FG004|Overall Study|Withdrew consent|13|||
125301644|NCT02292706|450730384|FG005|Overall Study|Withdrew consent|51|||
125301645|NCT02292706|450730385|FG006|Overall Study|Withdrew consent|20|||
125301646|NCT02292706|450730386|FG007|Overall Study|Withdrew consent|0|||
125301647|NCT02292706|450730379|FG000|Overall Study|Death|3|||
125301648|NCT02292706|450730380|FG001|Overall Study|Death|11|||
125301649|NCT02292706|450730381|FG002|Overall Study|Death|16|||
125301650|NCT02292706|450730382|FG003|Overall Study|Death|22|||
125301651|NCT02292706|450730383|FG004|Overall Study|Death|8|||
125301652|NCT02292706|450730384|FG005|Overall Study|Death|17|||
125301653|NCT02292706|450730385|FG006|Overall Study|Death|3|||
125301654|NCT02292706|450730386|FG007|Overall Study|Death|0|||
125301655|NCT02292706|450730379|FG000|Overall Study|Study terminated by sponsor|0|||
125301656|NCT02292706|450730380|FG001|Overall Study|Study terminated by sponsor|9|||
125301657|NCT02292706|450730381|FG002|Overall Study|Study terminated by sponsor|4|||
125301658|NCT02292706|450730382|FG003|Overall Study|Study terminated by sponsor|21|||
125301659|NCT02292706|450730383|FG004|Overall Study|Study terminated by sponsor|11|||
125301660|NCT02292706|450730384|FG005|Overall Study|Study terminated by sponsor|13|||
125301661|NCT02292706|450730385|FG006|Overall Study|Study terminated by sponsor|3|||
125301662|NCT02292706|450730386|FG007|Overall Study|Study terminated by sponsor|0|||
125301663|NCT02292706|450730379|FG000|Overall Study|Investigator's discretion|4|||
125301664|NCT02292706|450730380|FG001|Overall Study|Investigator's discretion|9|||
125301665|NCT02292706|450730381|FG002|Overall Study|Investigator's discretion|7|||
125301666|NCT02292706|450730382|FG003|Overall Study|Investigator's discretion|11|||
125301667|NCT02292706|450730383|FG004|Overall Study|Investigator's discretion|4|||
125301668|NCT02292706|450730384|FG005|Overall Study|Investigator's discretion|10|||
125301669|NCT02292706|450730385|FG006|Overall Study|Investigator's discretion|1|||
125301670|NCT02292706|450730386|FG007|Overall Study|Investigator's discretion|0|||
125301671|NCT02292706|450730379|FG000|Overall Study|Liver transplant|1|||
125301672|NCT02292706|450730380|FG001|Overall Study|Liver transplant|1|||
125301673|NCT02292706|450730381|FG002|Overall Study|Liver transplant|11|||
125301674|NCT02292706|450730382|FG003|Overall Study|Liver transplant|16|||
125301675|NCT02292706|450730383|FG004|Overall Study|Liver transplant|5|||
125301676|NCT02292706|450730384|FG005|Overall Study|Liver transplant|6|||
125301677|NCT02292706|450730385|FG006|Overall Study|Liver transplant|5|||
125301678|NCT02292706|450730386|FG007|Overall Study|Liver transplant|0|||
125301679|NCT02292706|450730379|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
125301680|NCT02292706|450730380|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
125301681|NCT02292706|450730381|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
125301682|NCT02292706|450730382|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
125301683|NCT02292706|450730383|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
125301684|NCT02292706|450730384|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
125301685|NCT02292706|450730385|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
125301686|NCT02292706|450730386|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
125301687|NCT02292706|450730379|FG000|Overall Study|Subject terminated by sponsor|1|||
125301688|NCT02292706|450730380|FG001|Overall Study|Subject terminated by sponsor|0|||
125301689|NCT02292706|450730381|FG002|Overall Study|Subject terminated by sponsor|0|||
125301690|NCT02292706|450730382|FG003|Overall Study|Subject terminated by sponsor|2|||
125301691|NCT02292706|450730383|FG004|Overall Study|Subject terminated by sponsor|1|||
125301692|NCT02292706|450730384|FG005|Overall Study|Subject terminated by sponsor|0|||
125301693|NCT02292706|450730385|FG006|Overall Study|Subject terminated by sponsor|0|||
125301694|NCT02292706|450730386|FG007|Overall Study|Subject terminated by sponsor|0|||
125301695|NCT02292706|450730379|FG000|Overall Study|Missing|0|||
125301696|NCT02292706|450730380|FG001|Overall Study|Missing|0|||
125301697|NCT02292706|450730381|FG002|Overall Study|Missing|1|||
125301698|NCT02292706|450730382|FG003|Overall Study|Missing|1|||
125301699|NCT02292706|450730383|FG004|Overall Study|Missing|0|||
125301700|NCT02292706|450730384|FG005|Overall Study|Missing|1|||
125301701|NCT02292706|450730385|FG006|Overall Study|Missing|0|||
125301702|NCT02292706|450730386|FG007|Overall Study|Missing|0|||
125301703|NCT02292706|450730379|FG000|Overall Study|Virologic relapse or reinfection|1|||
125301704|NCT02292706|450730380|FG001|Overall Study|Virologic relapse or reinfection|0|||
125301705|NCT02292706|450730381|FG002|Overall Study|Virologic relapse or reinfection|0|||
125301706|NCT02292706|450730382|FG003|Overall Study|Virologic relapse or reinfection|1|||
125301707|NCT02292706|450730383|FG004|Overall Study|Virologic relapse or reinfection|0|||
125301708|NCT02292706|450730384|FG005|Overall Study|Virologic relapse or reinfection|1|||
125301709|NCT02292706|450730385|FG006|Overall Study|Virologic relapse or reinfection|0|||
125301710|NCT02292706|450730386|FG007|Overall Study|Virologic relapse or reinfection|0|||
125301711|NCT02725866|450730389|FG000|Overall Study|Failure to return|6|||
125301712|NCT02725866|450730389|FG000|Overall Study|Withdrew consent|3|||
125301713|NCT02725866|450730389|FG000|Overall Study|Insufficient virological response|1|||
125301714|NCT02725866|450730389|FG000|Overall Study|Other, not specified|4|||
125301715|NCT04667104|450730395|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
125301716|NCT04667104|450730396|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
125301717|NCT04667104|450730397|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
125301718|NCT03043651|450730398|FG000|Overall Study|Death|1|||
125301719|NCT03043651|450730398|FG000|Overall Study|Progressive Disease|2|||
125301720|NCT03043651|450730398|FG000|Overall Study|Adverse Event|2|||
125301721|NCT03043651|450730398|FG000|Overall Study|Withdrawal by Subject|4|||
125301722|NCT03043651|450730398|FG000|Overall Study|Study Terminated by Sponsor|39|||
125301723|NCT01630889|450730399|FG000|Overall Study|Death|2|||
125301724|NCT01630889|450730399|FG000|Overall Study|Withdrawal by Subject|1|||
125301725|NCT01630889|450730399|FG000|Overall Study|Other than Specified|2|||
125301726|NCT01630889|450730399|FG000|Overall Study|Lost to Follow-up|4|||
125301727|NCT01630889|450730399|FG000|Overall Study|Other|1|||
125301728|NCT03208088|450730404|FG000|Period 2|Withdrawal by Subject|0|||
125301729|NCT03208088|450730405|FG001|Period 2|Withdrawal by Subject|0|||
125301730|NCT03208088|450730406|FG002|Period 2|Withdrawal by Subject|0|||
125301731|NCT03208088|450730407|FG003|Period 2|Withdrawal by Subject|0|||
125301732|NCT03208088|450730408|FG004|Period 2|Withdrawal by Subject|0|||
125301733|NCT03208088|450730409|FG005|Period 2|Withdrawal by Subject|0|||
125301734|NCT03208088|450730410|FG006|Period 2|Withdrawal by Subject|0|||
125301735|NCT03208088|450730411|FG007|Period 2|Withdrawal by Subject|0|||
125301736|NCT03208088|450730412|FG008|Period 2|Withdrawal by Subject|1|||
125301737|NCT03208088|450730413|FG009|Period 2|Withdrawal by Subject|0|||
125301738|NCT03208088|450730404|FG000|Period 3|Unsatisfactory Test Article|0|||
125301739|NCT03208088|450730405|FG001|Period 3|Unsatisfactory Test Article|0|||
125301740|NCT03208088|450730406|FG002|Period 3|Unsatisfactory Test Article|0|||
125301741|NCT03208088|450730407|FG003|Period 3|Unsatisfactory Test Article|1|||
125301742|NCT03208088|450730408|FG004|Period 3|Unsatisfactory Test Article|0|||
125301743|NCT03208088|450730409|FG005|Period 3|Unsatisfactory Test Article|0|||
125301744|NCT03208088|450730410|FG006|Period 3|Unsatisfactory Test Article|0|||
125301745|NCT03208088|450730411|FG007|Period 3|Unsatisfactory Test Article|0|||
125301746|NCT03208088|450730412|FG008|Period 3|Unsatisfactory Test Article|0|||
125301747|NCT03208088|450730413|FG009|Period 3|Unsatisfactory Test Article|0|||
125301748|NCT03208088|450730404|FG000|Period 4|Unsatisfactory Test Article|0|||
125301749|NCT03208088|450730405|FG001|Period 4|Unsatisfactory Test Article|0|||
125301750|NCT03208088|450730406|FG002|Period 4|Unsatisfactory Test Article|0|||
125301751|NCT03208088|450730407|FG003|Period 4|Unsatisfactory Test Article|1|||
125301752|NCT03208088|450730408|FG004|Period 4|Unsatisfactory Test Article|0|||
125301753|NCT03208088|450730409|FG005|Period 4|Unsatisfactory Test Article|0|||
125301754|NCT03208088|450730410|FG006|Period 4|Unsatisfactory Test Article|0|||
125301755|NCT03208088|450730411|FG007|Period 4|Unsatisfactory Test Article|0|||
125301756|NCT03208088|450730412|FG008|Period 4|Unsatisfactory Test Article|0|||
125301757|NCT03208088|450730413|FG009|Period 4|Unsatisfactory Test Article|0|||
125301758|NCT00566254|450730415|FG000|Overall Study|Adverse Event|3|||
125301759|NCT00566254|450730416|FG001|Overall Study|Adverse Event|1|||
125301760|NCT00566254|450730415|FG000|Overall Study|Protocol Violation|1|||
125301761|NCT00566254|450730416|FG001|Overall Study|Protocol Violation|3|||
125301762|NCT00566254|450730415|FG000|Overall Study|Withdrawal by Subject|1|||
125301763|NCT00566254|450730416|FG001|Overall Study|Withdrawal by Subject|2|||
125301764|NCT00566254|450730415|FG000|Overall Study|Lack of Efficacy|5|||
125301765|NCT00566254|450730416|FG001|Overall Study|Lack of Efficacy|6|||
125301766|NCT00566254|450730415|FG000|Overall Study|Other|0|||
125301767|NCT00566254|450730416|FG001|Overall Study|Other|2|||
125301768|NCT00238238|450730417|FG000|Overall Study|Withdrawal by Subject|0|||
125301769|NCT00238238|450730418|FG001|Overall Study|Withdrawal by Subject|3|||
125301770|NCT00238238|450730419|FG002|Overall Study|Withdrawal by Subject|0|||
125301771|NCT01345669|450730420|FG000|Overall Study|Primary tumour recurrence|53|||
125301772|NCT01345669|450730421|FG001|Overall Study|Primary tumour recurrence|32|||
125301773|NCT01345669|450730420|FG000|Overall Study|Second primary tumour|4|||
125301774|NCT01345669|450730421|FG001|Overall Study|Second primary tumour|3|||
125301775|NCT01345669|450730420|FG000|Overall Study|Adverse Event|63|||
125301776|NCT01345669|450730421|FG001|Overall Study|Adverse Event|9|||
125301777|NCT01345669|450730420|FG000|Overall Study|Protocol Violation|3|||
125301778|NCT01345669|450730421|FG001|Overall Study|Protocol Violation|1|||
125301779|NCT01345669|450730420|FG000|Overall Study|Lost to Follow-up|1|||
125301780|NCT01345669|450730421|FG001|Overall Study|Lost to Follow-up|1|||
125301781|NCT01345669|450730420|FG000|Overall Study|Withdrawal by Subject|52|||
125301782|NCT01345669|450730421|FG001|Overall Study|Withdrawal by Subject|13|||
125301783|NCT01345669|450730420|FG000|Overall Study|Other Reasons|111|||
125301784|NCT01345669|450730421|FG001|Overall Study|Other Reasons|60|||
125301785|NCT01793883|450730422|FG000|Overall Study|Withdrawal by Subject|3|||
125301786|NCT01793883|450730423|FG001|Overall Study|Withdrawal by Subject|7|||
125301787|NCT01793883|450730424|FG002|Overall Study|Withdrawal by Subject|3|||
125301788|NCT01793883|450730422|FG000|Overall Study|Subject noncompliance|0|||
125301789|NCT01793883|450730423|FG001|Overall Study|Subject noncompliance|1|||
125301790|NCT01793883|450730424|FG002|Overall Study|Subject noncompliance|1|||
125301791|NCT01793883|450730422|FG000|Overall Study|Lost to Follow-up|5|||
125301792|NCT01793883|450730423|FG001|Overall Study|Lost to Follow-up|1|||
125301793|NCT01793883|450730424|FG002|Overall Study|Lost to Follow-up|3|||
125301794|NCT01793883|450730422|FG000|Overall Study|Randomized in error|1|||
125301795|NCT01793883|450730423|FG001|Overall Study|Randomized in error|0|||
125301796|NCT01793883|450730424|FG002|Overall Study|Randomized in error|0|||
125301797|NCT01793883|450730422|FG000|Overall Study|Unable to complete spriometry|1|||
125301798|NCT01793883|450730423|FG001|Overall Study|Unable to complete spriometry|0|||
125301799|NCT01793883|450730424|FG002|Overall Study|Unable to complete spriometry|0|||
125301800|NCT01793883|450730422|FG000|Overall Study|Unable to complete measurements|1|||
125301801|NCT01793883|450730423|FG001|Overall Study|Unable to complete measurements|0|||
125301802|NCT01793883|450730424|FG002|Overall Study|Unable to complete measurements|0|||
125301803|NCT01793883|450730422|FG000|Overall Study|Met exclusion criteria|1|||
125301804|NCT01793883|450730423|FG001|Overall Study|Met exclusion criteria|0|||
125301805|NCT01793883|450730424|FG002|Overall Study|Met exclusion criteria|0|||
125301806|NCT01793883|450730422|FG000|Overall Study|Dosing error|0|||
125301807|NCT01793883|450730423|FG001|Overall Study|Dosing error|1|||
125301808|NCT01793883|450730424|FG002|Overall Study|Dosing error|0|||
125301809|NCT01793883|450730422|FG000|Overall Study|Respiratory distress during spirometry|0|||
125301810|NCT01793883|450730423|FG001|Overall Study|Respiratory distress during spirometry|0|||
125301811|NCT01793883|450730424|FG002|Overall Study|Respiratory distress during spirometry|1|||
125301812|NCT02478255|450730425|FG000|Overall Study|Physician Decision|6|||
125301813|NCT02478255|450730426|FG001|Overall Study|Physician Decision|0|||
125301814|NCT02478255|450730425|FG000|Overall Study|Withdrawal by Subject|2|||
125301815|NCT02478255|450730426|FG001|Overall Study|Withdrawal by Subject|0|||
125301816|NCT00761527|450730427|FG000|Overall Study|Adverse Event|3|||
125301817|NCT00761527|450730427|FG000|Overall Study|Poor Compliance|8|||
125301818|NCT00761527|450730427|FG000|Overall Study|Lost to Follow-up|9|||
125301819|NCT00761527|450730427|FG000|Overall Study|Unknown reason|2|||
125301820|NCT01730586|450730428|FG000|Overall Study|Progressive Disease|2|||
125301821|NCT01730586|450730428|FG000|Overall Study|Inadequate Trial|8|||
125301822|NCT01730586|450730428|FG000|Overall Study|Adverse Event|2|||
125301823|NCT01730586|450730428|FG000|Overall Study|Hospice|1|||
125301824|NCT01431963|450730429|FG000|Overall Study|Adverse Event|18|||
125301825|NCT01431963|450730429|FG000|Overall Study|Lack of Efficacy|7|||
125301826|NCT01431963|450730429|FG000|Overall Study|Protocol Violation|1|||
125301827|NCT01431963|450730429|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
125301828|NCT01431963|450730429|FG000|Overall Study|Physician Decision|4|||
125301829|NCT01431963|450730429|FG000|Overall Study|Withdrawal by Subject|3|||
125301830|NCT00619307|450730430|FG000|Overall Study|Adverse Event|0|||
125301831|NCT00619307|450730431|FG001|Overall Study|Adverse Event|1|||
125301832|NCT00619307|450730430|FG000|Overall Study|Lost to Follow-up|0|||
125301833|NCT00619307|450730431|FG001|Overall Study|Lost to Follow-up|1|||
125301834|NCT00619307|450730430|FG000|Overall Study|Protocol Violation|3|||
125301835|NCT00619307|450730431|FG001|Overall Study|Protocol Violation|0|||
125301836|NCT00619307|450730430|FG000|Overall Study|Withdrew consent|1|||
125301837|NCT00619307|450730431|FG001|Overall Study|Withdrew consent|0|||
125301838|NCT00619307|450730430|FG000|Overall Study|Severe migraine|0|||
125301839|NCT00619307|450730431|FG001|Overall Study|Severe migraine|1|||
125301840|NCT00619307|450730430|FG000|Overall Study|MS attack plus steroids|0|||
125301841|NCT00619307|450730431|FG001|Overall Study|MS attack plus steroids|1|||
125301842|NCT00547521|450730432|FG000|Short Term Study (4 Months)|Adverse Event|1|||
125301843|NCT00547521|450730433|FG001|Short Term Study (4 Months)|Adverse Event|0|||
125301844|NCT00547521|450730432|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
125301845|NCT00547521|450730433|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
125301846|NCT00547521|450730432|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
125301847|NCT00547521|450730433|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
125301848|NCT00547521|450730432|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
125301849|NCT00547521|450730433|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
125301850|NCT00547521|450730432|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
125301851|NCT00547521|450730433|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
125301852|NCT00547521|450730432|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
125301853|NCT00547521|450730433|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
125301854|NCT00547521|450730432|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
125301855|NCT00547521|450730433|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
125301856|NCT00547521|450730432|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
125301857|NCT00547521|450730433|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
125301858|NCT00547521|450730432|FG000|Long Term Extension (LTE) Study|Other|0|||
125301859|NCT00547521|450730433|FG001|Long Term Extension (LTE) Study|Other|2|||
125301860|NCT00547521|450730432|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
125301861|NCT00547521|450730433|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
125301862|NCT01769196|450731854|FG000|Overall Study|Adverse Event|24|||
125301863|NCT01769196|450731855|FG001|Overall Study|Adverse Event|20|||
125301864|NCT01769196|450731854|FG000|Overall Study|Death|21|||
125301865|NCT01769196|450731855|FG001|Overall Study|Death|26|||
125301866|NCT01769196|450731854|FG000|Overall Study|Investigator Discretion|7|||
125301867|NCT01769196|450731855|FG001|Overall Study|Investigator Discretion|3|||
125301868|NCT01769196|450731854|FG000|Overall Study|Lack of Efficacy|3|||
125301869|NCT01769196|450731855|FG001|Overall Study|Lack of Efficacy|2|||
125301870|NCT01769196|450731854|FG000|Overall Study|Progressive disease|11|||
125301871|NCT01769196|450731855|FG001|Overall Study|Progressive disease|6|||
125301872|NCT01769196|450731854|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
125301873|NCT01769196|450731855|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
125301874|NCT01769196|450731854|FG000|Overall Study|Protocol Violation|0|||
125301875|NCT01769196|450731855|FG001|Overall Study|Protocol Violation|3|||
125301876|NCT01769196|450731854|FG000|Overall Study|Study terminated by sponsor|160|||
125301877|NCT01769196|450731855|FG001|Overall Study|Study terminated by sponsor|161|||
125301878|NCT01769196|450731854|FG000|Overall Study|Participant never dosed with study drug|1|||
125301879|NCT01769196|450731855|FG001|Overall Study|Participant never dosed with study drug|0|||
125301880|NCT01769196|450731854|FG000|Overall Study|Withdrew consent|36|||
125301881|NCT01769196|450731855|FG001|Overall Study|Withdrew consent|40|||
125301882|NCT03499314|450731856|FG000|Overall Study|Time Commitment|1|||
125301883|NCT03499314|450731857|FG001|Overall Study|Time Commitment|2|||
125301884|NCT03499314|450731856|FG000|Overall Study|Medical issue unrelated to research study|1|||
125301885|NCT03499314|450731857|FG001|Overall Study|Medical issue unrelated to research study|1|||
125301886|NCT00655629|450731860|FG000|Overall Study|Adverse Event|4|||
125301887|NCT00655629|450731861|FG001|Overall Study|Adverse Event|1|||
125301888|NCT00655629|450731860|FG000|Overall Study|Lack of Efficacy|2|||
125301889|NCT00655629|450731861|FG001|Overall Study|Lack of Efficacy|12|||
125301890|NCT00655629|450731860|FG000|Overall Study|Lost to Follow-up|4|||
125301891|NCT00655629|450731861|FG001|Overall Study|Lost to Follow-up|3|||
125301892|NCT00655629|450731860|FG000|Overall Study|Protocol Violation|5|||
125301893|NCT00655629|450731861|FG001|Overall Study|Protocol Violation|3|||
125478018|NCT04652700|451383191|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
125478019|NCT04652700|451383192|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
125478020|NCT04652700|451383191|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
125478021|NCT04652700|451383192|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
125478022|NCT04652700|451383191|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
125478023|NCT04652700|451383192|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
125478024|NCT04652700|451383191|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
125478025|NCT04652700|451383192|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
125478026|NCT04652700|451383191|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
125478027|NCT04652700|451383192|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
125478028|NCT04652700|451383191|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
125478029|NCT04652700|451383192|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
125478030|NCT04652700|451383191|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
125478031|NCT04652700|451383192|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
125478032|NCT06037369|451383195|FG000|Overall Study|Lost to Follow-up|0|||
125478033|NCT06037369|451383196|FG001|Overall Study|Lost to Follow-up|1|||
125478034|NCT04209465|451383197|FG000|Overall Study|Adverse Event|0|||
125478035|NCT04209465|451383198|FG001|Overall Study|Adverse Event|0|||
125478036|NCT04209465|451383199|FG002|Overall Study|Adverse Event|0|||
125478037|NCT04209465|451383200|FG003|Overall Study|Adverse Event|0|||
125478038|NCT04209465|451383201|FG004|Overall Study|Adverse Event|0|||
125478039|NCT04209465|451383202|FG005|Overall Study|Adverse Event|1|||
125478040|NCT04209465|451383203|FG006|Overall Study|Adverse Event|0|||
125478041|NCT04209465|451383204|FG007|Overall Study|Adverse Event|0|||
125478042|NCT04209465|451383205|FG008|Overall Study|Adverse Event|1|||
125478043|NCT04209465|451383206|FG009|Overall Study|Adverse Event|0|||
125478044|NCT04209465|451383207|FG010|Overall Study|Adverse Event|2|||
125478045|NCT04209465|451383208|FG011|Overall Study|Adverse Event|1|||
125478046|NCT04209465|451383209|FG012|Overall Study|Adverse Event|1|||
125478047|NCT04209465|451383197|FG000|Overall Study|Death|1|||
125478048|NCT04209465|451383198|FG001|Overall Study|Death|0|||
125478049|NCT04209465|451383199|FG002|Overall Study|Death|0|||
125478050|NCT04209465|451383200|FG003|Overall Study|Death|0|||
125478051|NCT04209465|451383201|FG004|Overall Study|Death|2|||
125478052|NCT04209465|451383202|FG005|Overall Study|Death|7|||
125478053|NCT04209465|451383203|FG006|Overall Study|Death|2|||
125478054|NCT04209465|451383204|FG007|Overall Study|Death|2|||
125478055|NCT04209465|451383205|FG008|Overall Study|Death|1|||
125478056|NCT04209465|451383206|FG009|Overall Study|Death|1|||
125478057|NCT04209465|451383207|FG010|Overall Study|Death|1|||
125478058|NCT04209465|451383208|FG011|Overall Study|Death|0|||
125478059|NCT04209465|451383209|FG012|Overall Study|Death|10|||
125478060|NCT04209465|451383197|FG000|Overall Study|Physician Decision|0|||
125478061|NCT04209465|451383198|FG001|Overall Study|Physician Decision|1|||
125478062|NCT04209465|451383199|FG002|Overall Study|Physician Decision|0|||
125478063|NCT04209465|451383200|FG003|Overall Study|Physician Decision|0|||
125478064|NCT04209465|451383201|FG004|Overall Study|Physician Decision|0|||
125478065|NCT04209465|451383202|FG005|Overall Study|Physician Decision|0|||
125478066|NCT04209465|451383203|FG006|Overall Study|Physician Decision|0|||
125478067|NCT04209465|451383204|FG007|Overall Study|Physician Decision|0|||
125478068|NCT04209465|451383205|FG008|Overall Study|Physician Decision|0|||
125478069|NCT04209465|451383206|FG009|Overall Study|Physician Decision|0|||
125478070|NCT04209465|451383207|FG010|Overall Study|Physician Decision|0|||
125478071|NCT04209465|451383208|FG011|Overall Study|Physician Decision|0|||
125478072|NCT04209465|451383209|FG012|Overall Study|Physician Decision|0|||
125478073|NCT04209465|451383197|FG000|Overall Study|Progressive Disease|0|||
125478074|NCT04209465|451383198|FG001|Overall Study|Progressive Disease|0|||
125478075|NCT04209465|451383199|FG002|Overall Study|Progressive Disease|1|||
125478076|NCT04209465|451383200|FG003|Overall Study|Progressive Disease|2|||
125478077|NCT04209465|451383201|FG004|Overall Study|Progressive Disease|8|||
125478078|NCT04209465|451383202|FG005|Overall Study|Progressive Disease|5|||
125478079|NCT04209465|451383203|FG006|Overall Study|Progressive Disease|3|||
125301894|NCT00655629|450731860|FG000|Overall Study|consent withdrawn|6|||
125478080|NCT04209465|451383204|FG007|Overall Study|Progressive Disease|4|||
125478081|NCT04209465|451383205|FG008|Overall Study|Progressive Disease|1|||
125301895|NCT00655629|450731861|FG001|Overall Study|consent withdrawn|4|||
125478082|NCT04209465|451383206|FG009|Overall Study|Progressive Disease|3|||
125478083|NCT04209465|451383207|FG010|Overall Study|Progressive Disease|2|||
125478084|NCT04209465|451383208|FG011|Overall Study|Progressive Disease|1|||
125478085|NCT04209465|451383209|FG012|Overall Study|Progressive Disease|0|||
125478086|NCT04209465|451383197|FG000|Overall Study|Withdrawal by Subject|0|||
125478087|NCT04209465|451383198|FG001|Overall Study|Withdrawal by Subject|0|||
125478088|NCT04209465|451383199|FG002|Overall Study|Withdrawal by Subject|0|||
125478089|NCT04209465|451383200|FG003|Overall Study|Withdrawal by Subject|0|||
125478090|NCT04209465|451383201|FG004|Overall Study|Withdrawal by Subject|0|||
125478091|NCT04209465|451383202|FG005|Overall Study|Withdrawal by Subject|1|||
125478092|NCT04209465|451383203|FG006|Overall Study|Withdrawal by Subject|2|||
125478093|NCT04209465|451383204|FG007|Overall Study|Withdrawal by Subject|0|||
125478094|NCT04209465|451383205|FG008|Overall Study|Withdrawal by Subject|1|||
125478095|NCT04209465|451383206|FG009|Overall Study|Withdrawal by Subject|0|||
125478096|NCT04209465|451383207|FG010|Overall Study|Withdrawal by Subject|0|||
125478097|NCT04209465|451383208|FG011|Overall Study|Withdrawal by Subject|2|||
125478098|NCT04209465|451383209|FG012|Overall Study|Withdrawal by Subject|2|||
125478099|NCT04209465|451383197|FG000|Overall Study|Lost to Follow-up|0|||
125478100|NCT04209465|451383198|FG001|Overall Study|Lost to Follow-up|0|||
125478101|NCT04209465|451383199|FG002|Overall Study|Lost to Follow-up|0|||
125478102|NCT04209465|451383200|FG003|Overall Study|Lost to Follow-up|0|||
125478103|NCT04209465|451383201|FG004|Overall Study|Lost to Follow-up|0|||
125478104|NCT04209465|451383202|FG005|Overall Study|Lost to Follow-up|1|||
125478105|NCT04209465|451383203|FG006|Overall Study|Lost to Follow-up|0|||
125478106|NCT04209465|451383204|FG007|Overall Study|Lost to Follow-up|0|||
125478107|NCT04209465|451383205|FG008|Overall Study|Lost to Follow-up|1|||
125478108|NCT04209465|451383206|FG009|Overall Study|Lost to Follow-up|0|||
125478109|NCT04209465|451383207|FG010|Overall Study|Lost to Follow-up|0|||
125478110|NCT04209465|451383208|FG011|Overall Study|Lost to Follow-up|1|||
125478111|NCT04209465|451383209|FG012|Overall Study|Lost to Follow-up|0|||
125478112|NCT04209465|451383197|FG000|Overall Study|Started new therapy|0|||
125478113|NCT04209465|451383198|FG001|Overall Study|Started new therapy|0|||
125478114|NCT04209465|451383199|FG002|Overall Study|Started new therapy|0|||
125478115|NCT04209465|451383200|FG003|Overall Study|Started new therapy|0|||
125478116|NCT04209465|451383201|FG004|Overall Study|Started new therapy|0|||
125478117|NCT04209465|451383202|FG005|Overall Study|Started new therapy|1|||
125478118|NCT04209465|451383203|FG006|Overall Study|Started new therapy|0|||
125478119|NCT04209465|451383204|FG007|Overall Study|Started new therapy|0|||
125478120|NCT04209465|451383205|FG008|Overall Study|Started new therapy|0|||
125478121|NCT04209465|451383206|FG009|Overall Study|Started new therapy|0|||
125478122|NCT04209465|451383207|FG010|Overall Study|Started new therapy|0|||
125478123|NCT04209465|451383208|FG011|Overall Study|Started new therapy|0|||
125478124|NCT04209465|451383209|FG012|Overall Study|Started new therapy|0|||
125478125|NCT04209465|451383197|FG000|Overall Study|Study terminated early by sponsor|0|||
125478126|NCT04209465|451383198|FG001|Overall Study|Study terminated early by sponsor|0|||
125478127|NCT04209465|451383199|FG002|Overall Study|Study terminated early by sponsor|0|||
125478128|NCT04209465|451383200|FG003|Overall Study|Study terminated early by sponsor|0|||
125478129|NCT04209465|451383201|FG004|Overall Study|Study terminated early by sponsor|0|||
125478130|NCT04209465|451383202|FG005|Overall Study|Study terminated early by sponsor|0|||
125478131|NCT04209465|451383203|FG006|Overall Study|Study terminated early by sponsor|3|||
125478132|NCT04209465|451383204|FG007|Overall Study|Study terminated early by sponsor|0|||
125478133|NCT04209465|451383205|FG008|Overall Study|Study terminated early by sponsor|0|||
125478134|NCT04209465|451383206|FG009|Overall Study|Study terminated early by sponsor|0|||
125478135|NCT04209465|451383207|FG010|Overall Study|Study terminated early by sponsor|0|||
125478136|NCT04209465|451383208|FG011|Overall Study|Study terminated early by sponsor|0|||
125478137|NCT04209465|451383209|FG012|Overall Study|Study terminated early by sponsor|3|||
125478138|NCT04209465|451383197|FG000|Overall Study|Other|0|||
125478139|NCT04209465|451383198|FG001|Overall Study|Other|0|||
125478140|NCT04209465|451383199|FG002|Overall Study|Other|0|||
125478141|NCT04209465|451383200|FG003|Overall Study|Other|0|||
125478142|NCT04209465|451383201|FG004|Overall Study|Other|0|||
125478143|NCT04209465|451383202|FG005|Overall Study|Other|0|||
125478144|NCT04209465|451383203|FG006|Overall Study|Other|0|||
125478145|NCT04209465|451383204|FG007|Overall Study|Other|0|||
125478146|NCT04209465|451383205|FG008|Overall Study|Other|1|||
125478147|NCT04209465|451383206|FG009|Overall Study|Other|0|||
125478148|NCT04209465|451383207|FG010|Overall Study|Other|0|||
125478149|NCT04209465|451383208|FG011|Overall Study|Other|0|||
125301896|NCT00705367|450731864|FG000|Long-term Extension Period|Adverse Event|2|||
125478150|NCT04209465|451383209|FG012|Overall Study|Other|0|||
125478151|NCT04277442|451383217|FG000|Overall Study|Death|1|||
125301897|NCT00705367|450731865|FG001|Long-term Extension Period|Adverse Event|0|||
125478152|NCT04876118|451383218|FG000|Overall Study|Pregnancy|1|||
125478153|NCT04876118|451383218|FG000|Overall Study|Withdrawal by Subject|14|||
125478154|NCT03092518|451383219|FG000|Overall Study|Ineligible|2|||
125478155|NCT02547987|451383220|FG000|Overall Study|Withdrawal by Subject|1|||
125478156|NCT02547987|451383220|FG000|Overall Study|Adverse Event|2|||
125478157|NCT04925986|451383221|FG000|Overall Study|Death|0|||
125478158|NCT04925986|451383222|FG001|Overall Study|Death|0|||
125478159|NCT04925986|451383223|FG002|Overall Study|Death|2|||
125478160|NCT04925986|451383224|FG003|Overall Study|Death|0|||
125478161|NCT04925986|451383221|FG000|Overall Study|Lack of Efficacy|1|||
125478162|NCT04925986|451383222|FG001|Overall Study|Lack of Efficacy|2|||
125478163|NCT04925986|451383223|FG002|Overall Study|Lack of Efficacy|0|||
125478164|NCT04925986|451383224|FG003|Overall Study|Lack of Efficacy|1|||
125478165|NCT04925986|451383221|FG000|Overall Study|Withdrawal by Subject|0|||
125478166|NCT04925986|451383222|FG001|Overall Study|Withdrawal by Subject|0|||
125485392|NCT02240238|451412506|FG003|Phase 1|Physician Decision|0|||
125478167|NCT04925986|451383223|FG002|Overall Study|Withdrawal by Subject|1|||
125478168|NCT04925986|451383224|FG003|Overall Study|Withdrawal by Subject|2|||
125478169|NCT06181760|451383225|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
125478170|NCT06181760|451383226|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
125478171|NCT06181760|451383227|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
125478172|NCT06181760|451383228|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
125478173|NCT04770532|451383229|FG000|Overall Study|Withdrawal by Subject|0|||
125478174|NCT04770532|451383230|FG001|Overall Study|Withdrawal by Subject|3|||
125478175|NCT04770532|451383229|FG000|Overall Study|Physician Decision|1|||
125478176|NCT04770532|451383230|FG001|Overall Study|Physician Decision|0|||
125478177|NCT04770532|451383229|FG000|Overall Study|Death|2|||
125478178|NCT04770532|451383230|FG001|Overall Study|Death|2|||
125478179|NCT04938492|451383231|FG000|Overall Study|Lost to Follow-up|17|||
125478180|NCT04938492|451383232|FG001|Overall Study|Lost to Follow-up|18|||
125478181|NCT04025554|451383233|FG000|Overall Study|Adverse Event|3|||
125478182|NCT04338061|451383236|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
125478183|NCT04338061|451383237|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
125478184|NCT04338061|451383236|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
125478185|NCT04338061|451383237|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
125478186|NCT04338061|451383236|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
125478187|NCT04338061|451383237|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
125478188|NCT04338061|451383236|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
125478189|NCT04338061|451383237|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
125478190|NCT04338061|451383236|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
125478191|NCT04338061|451383237|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
125478192|NCT04338061|451383236|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
125478193|NCT04338061|451383237|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
125478194|NCT04338061|451383236|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
125478195|NCT04338061|451383237|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
125478196|NCT04338061|451383236|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
125478197|NCT04338061|451383237|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
125478198|NCT04338061|451383236|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
125478199|NCT04338061|451383237|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
125478200|NCT04338061|451383236|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
125478201|NCT04338061|451383237|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
125478202|NCT04338061|451383236|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
125478203|NCT04338061|451383237|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
125478204|NCT04338061|451383236|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
125478205|NCT04338061|451383237|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
125485393|NCT02240238|451412507|FG004|Phase 1|Physician Decision|0|||
125485394|NCT02240238|451412508|FG005|Phase 1|Physician Decision|2|||
125485395|NCT02240238|451412509|FG006|Phase 1|Physician Decision|0|||
125485396|NCT02240238|451412510|FG007|Phase 1|Physician Decision|0|||
125485397|NCT02240238|451412511|FG008|Phase 1|Physician Decision|0|||
125485398|NCT02240238|451412512|FG009|Phase 1|Physician Decision|0|||
125485399|NCT02240238|451412513|FG010|Phase 1|Physician Decision|0|||
125485400|NCT02240238|451412514|FG011|Phase 1|Physician Decision|0|||
125485401|NCT02240238|451412503|FG000|Phase 2|Adverse Event|0|||
125485402|NCT02240238|451412504|FG001|Phase 2|Adverse Event|0|||
125485403|NCT02240238|451412505|FG002|Phase 2|Adverse Event|0|||
125485404|NCT02240238|451412506|FG003|Phase 2|Adverse Event|0|||
125485405|NCT02240238|451412507|FG004|Phase 2|Adverse Event|0|||
125485406|NCT02240238|451412508|FG005|Phase 2|Adverse Event|0|||
125485407|NCT02240238|451412509|FG006|Phase 2|Adverse Event|0|||
125485408|NCT02240238|451412510|FG007|Phase 2|Adverse Event|0|||
125485409|NCT02240238|451412511|FG008|Phase 2|Adverse Event|0|||
125485410|NCT02240238|451412512|FG009|Phase 2|Adverse Event|7|||
125485411|NCT02240238|451412513|FG010|Phase 2|Adverse Event|14|||
125301898|NCT00705367|450731864|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
125301899|NCT00705367|450731865|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
125301900|NCT00705367|450731864|FG000|Long-term Extension Period|Lack of Efficacy|1|||
125301901|NCT00705367|450731865|FG001|Long-term Extension Period|Lack of Efficacy|0|||
125485412|NCT02240238|451412514|FG011|Phase 2|Adverse Event|2|||
125485413|NCT02240238|451412503|FG000|Phase 2|Death|0|||
125301902|NCT00705367|450731864|FG000|Long-term Extension Period|No longer met study criteria|1|||
125485414|NCT02240238|451412504|FG001|Phase 2|Death|0|||
125485415|NCT02240238|451412505|FG002|Phase 2|Death|0|||
125485416|NCT02240238|451412506|FG003|Phase 2|Death|0|||
125485417|NCT02240238|451412507|FG004|Phase 2|Death|0|||
125485418|NCT02240238|451412508|FG005|Phase 2|Death|0|||
125485419|NCT02240238|451412509|FG006|Phase 2|Death|0|||
125485420|NCT02240238|451412510|FG007|Phase 2|Death|0|||
125485421|NCT02240238|451412511|FG008|Phase 2|Death|0|||
125485422|NCT02240238|451412512|FG009|Phase 2|Death|3|||
125485423|NCT02240238|451412513|FG010|Phase 2|Death|2|||
125485424|NCT02240238|451412514|FG011|Phase 2|Death|1|||
125478206|NCT02035787|451385831|FG000|Overall Study- 12 Months|Adverse Event|3|||
125478207|NCT02035787|451385832|FG001|Overall Study- 12 Months|Adverse Event|0|||
125478208|NCT02035787|451385831|FG000|Overall Study- 12 Months|Complete response|4|||
125478209|NCT02035787|451385832|FG001|Overall Study- 12 Months|Complete response|1|||
125478210|NCT02035787|451385831|FG000|Overall Study- 12 Months|Protocol Violation|1|||
125478211|NCT02035787|451385832|FG001|Overall Study- 12 Months|Protocol Violation|1|||
125478212|NCT06414213|451385833|FG000|Overall Study|Lost to Follow-up|1|||
125478213|NCT06414213|451385834|FG001|Overall Study|Lost to Follow-up|1|||
125478214|NCT06414213|451385835|FG002|Overall Study|Lost to Follow-up|3|||
125478215|NCT01396278|451385836|FG000|Overall Study|Adverse Event|0|||
125478216|NCT01396278|451385837|FG001|Overall Study|Adverse Event|0|||
125478217|NCT01396278|451385838|FG002|Overall Study|Adverse Event|0|||
125478218|NCT01396278|451385839|FG003|Overall Study|Adverse Event|2|||
125478219|NCT01396278|451385840|FG004|Overall Study|Adverse Event|0|||
125478220|NCT01396278|451385836|FG000|Overall Study|Withdraw due to trial termination|2|||
125478221|NCT01396278|451385837|FG001|Overall Study|Withdraw due to trial termination|1|||
125478222|NCT01396278|451385838|FG002|Overall Study|Withdraw due to trial termination|1|||
125478223|NCT01396278|451385839|FG003|Overall Study|Withdraw due to trial termination|0|||
125478224|NCT01396278|451385840|FG004|Overall Study|Withdraw due to trial termination|2|||
125478225|NCT04515576|451385843|FG000|Overall Study|Withdrawal by Subject|0|||
125478226|NCT04515576|451385844|FG001|Overall Study|Withdrawal by Subject|0|||
125478227|NCT04515576|451385845|FG002|Overall Study|Withdrawal by Subject|0|||
125478228|NCT04515576|451385846|FG003|Overall Study|Withdrawal by Subject|0|||
125478229|NCT04515576|451385847|FG004|Overall Study|Withdrawal by Subject|0|||
125478230|NCT04515576|451385848|FG005|Overall Study|Withdrawal by Subject|1|||
125478231|NCT05028634|451385849|FG000|Overall Study|Withdrawal by Subject|0|||
125478232|NCT05028634|451385850|FG001|Overall Study|Withdrawal by Subject|1|||
125478233|NCT04728347|451385851|FG000|Overall Study|Sponsor decision|0|||
125478234|NCT04728347|451385852|FG001|Overall Study|Sponsor decision|0|||
125478235|NCT04728347|451385853|FG002|Overall Study|Sponsor decision|1|||
125478236|NCT04728347|451385854|FG003|Overall Study|Sponsor decision|0|||
125478237|NCT03953508|451385855|FG000|Baseline|Lost to Follow-up|3|||
125478238|NCT03953508|451385856|FG001|Baseline|Lost to Follow-up|2|||
125478239|NCT03953508|451385855|FG000|6-month Follow-up|Lost to Follow-up|62|||
125478240|NCT03953508|451385856|FG001|6-month Follow-up|Lost to Follow-up|70|||
125478241|NCT05308004|451385861|FG000|Overall Study|Not seen by Palliative Care NP|0|||
125478242|NCT05308004|451385862|FG001|Overall Study|Not seen by Palliative Care NP|1|||
125478243|NCT01160211|451385865|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
125478244|NCT01160211|451385866|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
125478245|NCT01160211|451385867|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
125478246|NCT01160211|451385865|FG000|Overall Study|Lost to Follow-up|4|||
125478247|NCT01160211|451385866|FG001|Overall Study|Lost to Follow-up|8|||
125478248|NCT01160211|451385867|FG002|Overall Study|Lost to Follow-up|4|||
125478249|NCT01160211|451385865|FG000|Overall Study|Physician Decision|1|||
125478250|NCT01160211|451385866|FG001|Overall Study|Physician Decision|0|||
125478251|NCT01160211|451385867|FG002|Overall Study|Physician Decision|0|||
125478252|NCT01160211|451385865|FG000|Overall Study|Withdrawal by Subject|4|||
125478253|NCT01160211|451385866|FG001|Overall Study|Withdrawal by Subject|2|||
125478254|NCT01160211|451385867|FG002|Overall Study|Withdrawal by Subject|2|||
125478255|NCT01160211|451385865|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
125478256|NCT01160211|451385866|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
125478257|NCT01160211|451385867|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
125478258|NCT02577835|451385868|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
125478259|NCT05409183|451385869|FG000|Complete Study|Adverse Event|1|||
125478260|NCT05409183|451385870|FG001|Complete Study|Adverse Event|2|||
125478261|NCT05409183|451385869|FG000|Complete Study|Withdrawal by Subject|3|||
125478262|NCT05409183|451385870|FG001|Complete Study|Withdrawal by Subject|0|||
125478263|NCT02274662|451385871|FG000|Overall Study|Death|1|||
125478264|NCT02274662|451385871|FG000|Overall Study|Lost to Follow-up|3|||
125478265|NCT04806451|451385872|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
125301903|NCT00705367|450731865|FG001|Long-term Extension Period|No longer met study criteria|0|||
125301904|NCT00705367|450731864|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
125478266|NCT04806451|451385873|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
125478267|NCT04806451|451385872|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
125478268|NCT04806451|451385873|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
125478269|NCT04806451|451385872|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
125478270|NCT04806451|451385873|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
125478271|NCT05835336|451385874|FG000|Overall Study|Withdrawal by Subject|5|||
125478272|NCT05835336|451385874|FG000|Overall Study|Did not complete the personalization process|3|||
125478273|NCT02936752|451385875|FG000|Overall Study|Death|2|||
125478274|NCT02936752|451385876|FG001|Overall Study|Death|1|||
125478275|NCT02936752|451385875|FG000|Overall Study|Physician Decision|4|||
125478276|NCT02936752|451385876|FG001|Overall Study|Physician Decision|0|||
125478277|NCT02936752|451385875|FG000|Overall Study|Withdrawal by Subject|0|||
125478278|NCT02936752|451385876|FG001|Overall Study|Withdrawal by Subject|2|||
125478279|NCT04489771|451385877|FG000|Overall Study|Death|27|||
125478280|NCT04489771|451385878|FG001|Overall Study|Death|25|||
125478281|NCT04489771|451385877|FG000|Overall Study|Withdrawal by Subject|1|||
125478282|NCT04489771|451385878|FG001|Overall Study|Withdrawal by Subject|0|||
125478283|NCT04489771|451385877|FG000|Overall Study|Participants Ongoing in Study|50|||
125478284|NCT04489771|451385878|FG001|Overall Study|Participants Ongoing in Study|51|||
125478285|NCT02979522|451385885|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
125478286|NCT02979522|451385886|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
125478287|NCT02979522|451385885|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
125478288|NCT02979522|451385886|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
125478289|NCT04059484|451385890|FG000|Overall Study|Adverse Event|2|||
125478290|NCT04059484|451385891|FG001|Overall Study|Adverse Event|5|||
125478291|NCT04059484|451385890|FG000|Overall Study|Withdrawal by Subject|5|||
125478292|NCT04059484|451385891|FG001|Overall Study|Withdrawal by Subject|3|||
125478293|NCT04059484|451385890|FG000|Overall Study|Progressive disease|112|||
125478294|NCT04059484|451385891|FG001|Overall Study|Progressive disease|112|||
125478295|NCT04059484|451385890|FG000|Overall Study|Other|8|||
125478296|NCT04059484|451385891|FG001|Overall Study|Other|3|||
125478297|NCT04059484|451385890|FG000|Overall Study|Ongoing|20|||
125478298|NCT04059484|451385891|FG001|Overall Study|Ongoing|20|||
125478299|NCT02949362|451385892|FG000|Retrospective Period|Inform consent not signed by participant|4|||
125478300|NCT02949362|451385893|FG001|Retrospective Period|Inform consent not signed by participant|1|||
125478301|NCT02949362|451385894|FG002|Retrospective Period|Inform consent not signed by participant|0|||
125478302|NCT02949362|451385895|FG003|Retrospective Period|Inform consent not signed by participant|0|||
125478303|NCT02949362|451385892|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
125478304|NCT02949362|451385893|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
125478305|NCT02949362|451385894|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
125478306|NCT02949362|451385895|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
125478307|NCT02949362|451385892|FG000|Prospective Period|Other|0|||
125478308|NCT02949362|451385893|FG001|Prospective Period|Other|0|||
125478309|NCT02949362|451385894|FG002|Prospective Period|Other|0|||
125478310|NCT02949362|451385895|FG003|Prospective Period|Other|4|||
125478311|NCT03199469|451385899|FG000|Overall Study|Randomized, not treated|0|||
125478312|NCT03199469|451385900|FG001|Overall Study|Randomized, not treated|3|||
125478313|NCT03199469|451385899|FG000|Overall Study|Withdrawal by Subject|1|||
125478314|NCT03199469|451385900|FG001|Overall Study|Withdrawal by Subject|0|||
125478315|NCT03199469|451385899|FG000|Overall Study|Death|1|||
125478316|NCT03199469|451385900|FG001|Overall Study|Death|3|||
125478317|NCT03199469|451385899|FG000|Overall Study|Ongoing|5|||
125478318|NCT03199469|451385900|FG001|Overall Study|Ongoing|14|||
125478319|NCT05453773|451385904|FG000|Overall Study|Withdrawal by Subject|3|||
125478320|NCT05453773|451385904|FG000|Overall Study|Lost to Follow-up|3|||
125478321|NCT05453773|451385904|FG000|Overall Study|Difficult Blood Draw|3|||
125478322|NCT02023866|451385905|FG000|Overall Study|Non-compliance|2|||
125478323|NCT02023866|451385905|FG000|Overall Study|Adverse Event|3|||
125478324|NCT02023866|451385905|FG000|Overall Study|Withdrawal by Subject|1|||
125478325|NCT03307343|451385906|FG000|Overall Study|Withdrawal by Subject|1|||
125478326|NCT03307343|451385907|FG001|Overall Study|Withdrawal by Subject|2|||
125478327|NCT03307343|451385906|FG000|Overall Study|Pregnancy|0|||
125478328|NCT03307343|451385907|FG001|Overall Study|Pregnancy|2|||
125478329|NCT03307343|451385906|FG000|Overall Study|Physician Decision|1|||
125478330|NCT03307343|451385907|FG001|Overall Study|Physician Decision|0|||
125478331|NCT03307343|451385906|FG000|Overall Study|Lost to Follow-up|0|||
125478332|NCT03307343|451385907|FG001|Overall Study|Lost to Follow-up|2|||
125478333|NCT04683744|451385908|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
125478334|NCT04683744|451385909|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
125478335|NCT04683744|451385910|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
125478336|NCT03447470|451385913|FG000|Overall Study|Death|0|||
125478337|NCT03447470|451385914|FG001|Overall Study|Death|1|||
125478338|NCT03447470|451385915|FG002|Overall Study|Death|3|||
125478339|NCT03447470|451385916|FG003|Overall Study|Death|0|||
125478340|NCT03447470|451385917|FG004|Overall Study|Death|1|||
125478341|NCT03447470|451385918|FG005|Overall Study|Death|0|||
125478342|NCT03447470|451385919|FG006|Overall Study|Death|3|||
125478343|NCT03447470|451385920|FG007|Overall Study|Death|3|||
125478344|NCT03447470|451385921|FG008|Overall Study|Death|1|||
125478345|NCT03447470|451385913|FG000|Overall Study|Withdrawal by Subject|1|||
125478346|NCT03447470|451385914|FG001|Overall Study|Withdrawal by Subject|0|||
125478347|NCT03447470|451385915|FG002|Overall Study|Withdrawal by Subject|0|||
125478348|NCT03447470|451385916|FG003|Overall Study|Withdrawal by Subject|0|||
125478349|NCT03447470|451385917|FG004|Overall Study|Withdrawal by Subject|1|||
125478350|NCT03447470|451385918|FG005|Overall Study|Withdrawal by Subject|0|||
125478351|NCT03447470|451385919|FG006|Overall Study|Withdrawal by Subject|1|||
125478352|NCT03447470|451385920|FG007|Overall Study|Withdrawal by Subject|1|||
125478353|NCT03447470|451385921|FG008|Overall Study|Withdrawal by Subject|3|||
125478354|NCT03447470|451385913|FG000|Overall Study|Treatment discontinued|3|||
125478355|NCT03447470|451385914|FG001|Overall Study|Treatment discontinued|2|||
125478356|NCT03447470|451385915|FG002|Overall Study|Treatment discontinued|4|||
125478357|NCT03447470|451385916|FG003|Overall Study|Treatment discontinued|6|||
125478358|NCT03447470|451385917|FG004|Overall Study|Treatment discontinued|2|||
125478359|NCT03447470|451385918|FG005|Overall Study|Treatment discontinued|1|||
125478360|NCT03447470|451385919|FG006|Overall Study|Treatment discontinued|2|||
125478361|NCT03447470|451385920|FG007|Overall Study|Treatment discontinued|4|||
125478362|NCT03447470|451385921|FG008|Overall Study|Treatment discontinued|3|||
125478363|NCT04624633|451385922|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
125478364|NCT04624633|451385923|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
125478365|NCT04624633|451385922|FG000|Overall Study|Death|1|||
125478366|NCT04624633|451385923|FG001|Overall Study|Death|0|||
125478367|NCT04316871|451385924|FG000|Overall Study|Protocol Violation|2|||
125478368|NCT04316871|451385925|FG001|Overall Study|Protocol Violation|2|||
125478369|NCT04316871|451385926|FG002|Overall Study|Protocol Violation|2|||
125478370|NCT04316871|451385927|FG003|Overall Study|Protocol Violation|2|||
125478371|NCT05087992|451385928|FG000|Overall Study|Adverse Event|0|||
125478372|NCT05087992|451385929|FG001|Overall Study|Adverse Event|1|||
125478373|NCT05087992|451385930|FG002|Overall Study|Adverse Event|0|||
125478374|NCT05087992|451385928|FG000|Overall Study|Withdrawal by Subject|2|||
125478375|NCT05087992|451385929|FG001|Overall Study|Withdrawal by Subject|0|||
125478376|NCT05087992|451385930|FG002|Overall Study|Withdrawal by Subject|0|||
125478377|NCT05087992|451385928|FG000|Overall Study|clinical disease progression|3|||
125478378|NCT05087992|451385929|FG001|Overall Study|clinical disease progression|1|||
125478379|NCT05087992|451385930|FG002|Overall Study|clinical disease progression|0|||
125478380|NCT05087992|451385928|FG000|Overall Study|objective disease progression|4|||
125478381|NCT05087992|451385929|FG001|Overall Study|objective disease progression|1|||
125478382|NCT05087992|451385930|FG002|Overall Study|objective disease progression|0|||
125478383|NCT01842542|451385931|FG000|Overall Study|Withdrawal by Subject|2|||
125478384|NCT01842542|451385931|FG000|Overall Study|Lack of Efficacy|1|||
125478385|NCT01842542|451385931|FG000|Overall Study|Protocol Non-compliance|2|||
125478386|NCT01842542|451385931|FG000|Overall Study|Lost to Follow-up|1|||
125478387|NCT01369355|451385938|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
125478388|NCT01369355|451385939|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
125478389|NCT01369355|451385940|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
125478390|NCT01369355|451385941|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
125478391|NCT01369355|451385942|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
125478392|NCT01369355|451385943|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
125478393|NCT01369355|451385944|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
125478394|NCT01369355|451385945|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
125478395|NCT01369355|451385946|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
125478396|NCT01369355|451385938|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
125478397|NCT01369355|451385939|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
125478398|NCT01369355|451385940|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
125478399|NCT01369355|451385941|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
125478400|NCT01369355|451385942|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
125478401|NCT01369355|451385943|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
125478402|NCT01369355|451385944|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
125478403|NCT01369355|451385945|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
125478404|NCT01369355|451385946|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
125478405|NCT01369355|451385938|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
125478406|NCT01369355|451385939|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
125478407|NCT01369355|451385940|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
125478408|NCT01369355|451385941|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
125478409|NCT01369355|451385942|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
125478410|NCT01369355|451385943|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
125478411|NCT01369355|451385944|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
125478412|NCT01369355|451385945|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
125478413|NCT01369355|451385946|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
125301905|NCT00705367|450731865|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
125478414|NCT01369355|451385938|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
125478415|NCT01369355|451385939|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
125478416|NCT01369355|451385940|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
125478417|NCT01369355|451385941|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
125478418|NCT01369355|451385942|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
125478419|NCT01369355|451385943|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
125478420|NCT01369355|451385944|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
125478421|NCT01369355|451385945|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
125478422|NCT01369355|451385946|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
125478423|NCT01369355|451385938|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
125478424|NCT01369355|451385939|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
125478425|NCT01369355|451385940|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
125478426|NCT01369355|451385941|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
125478427|NCT01369355|451385942|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
125478428|NCT01369355|451385943|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
125478429|NCT01369355|451385944|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
125478430|NCT01369355|451385945|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
125478431|NCT01369355|451385946|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
125478432|NCT01369355|451385938|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
125478433|NCT01369355|451385939|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
125478434|NCT01369355|451385940|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
125478435|NCT01369355|451385941|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
125478436|NCT01369355|451385942|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
125478437|NCT01369355|451385943|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
125478438|NCT01369355|451385944|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
125478439|NCT01369355|451385945|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
125478440|NCT01369355|451385946|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
125478441|NCT01369355|451385938|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
125478442|NCT01369355|451385939|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
125478443|NCT01369355|451385940|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
125478444|NCT01369355|451385941|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
125478445|NCT01369355|451385942|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
125478446|NCT01369355|451385943|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
125478447|NCT01369355|451385944|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
125478448|NCT01369355|451385945|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
125478449|NCT01369355|451385946|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
125478450|NCT01369355|451385938|FG000|Long-term Extension (Week 44-272)|Death|0|||
125478451|NCT01369355|451385939|FG001|Long-term Extension (Week 44-272)|Death|0|||
125478452|NCT01369355|451385940|FG002|Long-term Extension (Week 44-272)|Death|0|||
125478453|NCT01369355|451385941|FG003|Long-term Extension (Week 44-272)|Death|0|||
125478454|NCT01369355|451385942|FG004|Long-term Extension (Week 44-272)|Death|0|||
125478455|NCT01369355|451385943|FG005|Long-term Extension (Week 44-272)|Death|0|||
125478456|NCT01369355|451385944|FG006|Long-term Extension (Week 44-272)|Death|0|||
125478457|NCT01369355|451385945|FG007|Long-term Extension (Week 44-272)|Death|1|||
125478458|NCT01369355|451385946|FG008|Long-term Extension (Week 44-272)|Death|3|||
125478459|NCT01369355|451385938|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
125478460|NCT01369355|451385939|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
125478461|NCT01369355|451385940|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
125478462|NCT01369355|451385941|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
125478463|NCT01369355|451385942|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
125478464|NCT01369355|451385943|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
125478465|NCT01369355|451385944|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
125478466|NCT01369355|451385945|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
125478467|NCT01369355|451385946|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
125478468|NCT01369355|451385938|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
125478469|NCT01369355|451385939|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
125478470|NCT01369355|451385940|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
125478471|NCT01369355|451385941|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
125478472|NCT01369355|451385942|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
125478473|NCT01369355|451385943|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
125478474|NCT01369355|451385944|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
125478475|NCT01369355|451385945|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
125478476|NCT01369355|451385946|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
125478477|NCT01369355|451385938|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
125478478|NCT01369355|451385939|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
125478479|NCT01369355|451385940|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
125478480|NCT01369355|451385941|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
125478481|NCT01369355|451385942|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
125478482|NCT01369355|451385943|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
125478483|NCT01369355|451385944|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
125478484|NCT01369355|451385945|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
125478485|NCT01369355|451385946|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
125478486|NCT01369355|451385938|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
125478487|NCT01369355|451385939|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
125478488|NCT01369355|451385940|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
125478489|NCT01369355|451385941|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
125478490|NCT01369355|451385942|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
125478491|NCT01369355|451385943|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
125478492|NCT01369355|451385944|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
125478493|NCT01369355|451385945|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
125478494|NCT01369355|451385946|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
125478495|NCT01369355|451385938|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
125478496|NCT01369355|451385939|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
125478497|NCT01369355|451385940|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
125478498|NCT01369355|451385941|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
125478499|NCT01369355|451385942|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
125478500|NCT01369355|451385943|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
125478501|NCT01369355|451385944|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
125478502|NCT01369355|451385945|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
125478503|NCT01369355|451385946|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
125478504|NCT01369355|451385938|FG000|Long-term Extension (Week 44-272)|Other|0|||
125478505|NCT01369355|451385939|FG001|Long-term Extension (Week 44-272)|Other|0|||
125478506|NCT01369355|451385940|FG002|Long-term Extension (Week 44-272)|Other|0|||
125478507|NCT01369355|451385941|FG003|Long-term Extension (Week 44-272)|Other|0|||
125478508|NCT01369355|451385942|FG004|Long-term Extension (Week 44-272)|Other|0|||
125478509|NCT01369355|451385943|FG005|Long-term Extension (Week 44-272)|Other|0|||
125478510|NCT01369355|451385944|FG006|Long-term Extension (Week 44-272)|Other|110|||
125478511|NCT01369355|451385945|FG007|Long-term Extension (Week 44-272)|Other|9|||
125478512|NCT01369355|451385946|FG008|Long-term Extension (Week 44-272)|Other|17|||
125478513|NCT01824394|451385949|FG000|Overall Study|Early Termination|1|||
125478514|NCT01824394|451385950|FG001|Overall Study|Early Termination|1|||
125478515|NCT01824394|451385951|FG002|Overall Study|Early Termination|3|||
125478516|NCT01824394|451385949|FG000|Overall Study|Withdrawn due to Study Termination|91|||
125478517|NCT01824394|451385950|FG001|Overall Study|Withdrawn due to Study Termination|83|||
125478518|NCT01824394|451385951|FG002|Overall Study|Withdrawn due to Study Termination|41|||
125478519|NCT01824394|451385949|FG000|Overall Study|Lost to Follow-up|0|||
125478520|NCT01824394|451385950|FG001|Overall Study|Lost to Follow-up|9|||
125478521|NCT01824394|451385951|FG002|Overall Study|Lost to Follow-up|3|||
125478522|NCT01824394|451385949|FG000|Overall Study|Death|3|||
125478523|NCT01824394|451385950|FG001|Overall Study|Death|2|||
125478524|NCT01824394|451385951|FG002|Overall Study|Death|4|||
125478525|NCT01824394|451385949|FG000|Overall Study|Discontinued Subjects|1|||
125478526|NCT01824394|451385950|FG001|Overall Study|Discontinued Subjects|1|||
125478527|NCT01824394|451385951|FG002|Overall Study|Discontinued Subjects|2|||
125478528|NCT01824394|451385949|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
125478529|NCT01824394|451385950|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
125478530|NCT01824394|451385951|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
125478531|NCT05603143|451385952|FG000|Overall Study|Withdrew consent|6|||
125478532|NCT05603143|451385953|FG001|Overall Study|Withdrew consent|2|||
125478533|NCT05603143|451385952|FG000|Overall Study|Randomized but never treated|0|||
125478534|NCT05603143|451385953|FG001|Overall Study|Randomized but never treated|3|||
125478535|NCT05603143|451385952|FG000|Overall Study|Adverse Event|2|||
125478536|NCT05603143|451385953|FG001|Overall Study|Adverse Event|0|||
125478537|NCT05603143|451385952|FG000|Overall Study|Death|0|||
125478538|NCT05603143|451385953|FG001|Overall Study|Death|1|||
125478539|NCT05603143|451385952|FG000|Overall Study|Investigator's discretion|1|||
125478540|NCT05603143|451385953|FG001|Overall Study|Investigator's discretion|0|||
125478541|NCT05603143|451385952|FG000|Overall Study|Lost to Follow-up|0|||
125478542|NCT05603143|451385953|FG001|Overall Study|Lost to Follow-up|1|||
125478543|NCT05603143|451385952|FG000|Overall Study|Protocol Violation|0|||
125478544|NCT05603143|451385953|FG001|Overall Study|Protocol Violation|1|||
125478545|NCT05783102|451385954|FG000|Overall Study|Lost to Follow-up|1|||
125478546|NCT05783102|451385954|FG000|Overall Study|Withdrawal by Subject|2|||
125478547|NCT05647304|451385955|FG000|Overall Study|Withdrawal by Subject|1|||
125478548|NCT05647304|451385956|FG001|Overall Study|Withdrawal by Subject|0|||
125478549|NCT05008835|451385957|FG000|Overall Study|Adverse Event|5|||
125478550|NCT05008835|451385958|FG001|Overall Study|Adverse Event|2|||
125478551|NCT05008835|451385959|FG002|Overall Study|Adverse Event|1|||
125478552|NCT05008835|451385957|FG000|Overall Study|Lack of Efficacy|0|||
125478553|NCT05008835|451385958|FG001|Overall Study|Lack of Efficacy|0|||
125478554|NCT05008835|451385959|FG002|Overall Study|Lack of Efficacy|1|||
125478555|NCT05008835|451385957|FG000|Overall Study|Study terminated by sponsor|0|||
125478556|NCT05008835|451385958|FG001|Overall Study|Study terminated by sponsor|0|||
125478557|NCT05008835|451385959|FG002|Overall Study|Study terminated by sponsor|1|||
125478558|NCT05008835|451385957|FG000|Overall Study|Not further specified|3|||
125478559|NCT05008835|451385958|FG001|Overall Study|Not further specified|2|||
125478560|NCT05008835|451385959|FG002|Overall Study|Not further specified|1|||
125478561|NCT04171999|451385960|FG000|Overall Study|deemed ineligible after randomization|2|||
125478562|NCT04171999|451385961|FG001|Overall Study|deemed ineligible after randomization|1|||
125478563|NCT04505904|451385962|FG000|Overall Study|Withdrawal by Subject|1|||
125478564|NCT04505904|451385963|FG001|Overall Study|Withdrawal by Subject|2|||
125478565|NCT04505904|451385964|FG002|Overall Study|Withdrawal by Subject|0|||
125478566|NCT04505904|451385965|FG003|Overall Study|Withdrawal by Subject|0|||
125478567|NCT04505904|451385962|FG000|Overall Study|Physician Decision|1|||
125478568|NCT04505904|451385963|FG001|Overall Study|Physician Decision|0|||
125478569|NCT04505904|451385964|FG002|Overall Study|Physician Decision|0|||
125478570|NCT04505904|451385965|FG003|Overall Study|Physician Decision|0|||
125478571|NCT04505904|451385962|FG000|Overall Study|Adverse Event|0|||
125478572|NCT04505904|451385963|FG001|Overall Study|Adverse Event|1|||
125478573|NCT04505904|451385964|FG002|Overall Study|Adverse Event|0|||
125478574|NCT04505904|451385965|FG003|Overall Study|Adverse Event|0|||
125478575|NCT03544281|451385966|FG000|Main Study Phase|Death|3|||
125478576|NCT03544281|451385967|FG001|Main Study Phase|Death|2|||
125478577|NCT03544281|451385968|FG002|Main Study Phase|Death|6|||
125478578|NCT03544281|451385969|FG003|Main Study Phase|Death|8|||
125478579|NCT03544281|451385970|FG004|Main Study Phase|Death|4|||
125478580|NCT03544281|451385971|FG005|Main Study Phase|Death|2|||
125478581|NCT03544281|451385972|FG006|Main Study Phase|Death|4|||
125478582|NCT03544281|451385973|FG007|Main Study Phase|Death|5|||
125478583|NCT03544281|451385974|FG008|Main Study Phase|Death|5|||
125478584|NCT03544281|451385975|FG009|Main Study Phase|Death|8|||
125478585|NCT03544281|451385976|FG010|Main Study Phase|Death|6|||
125478586|NCT03544281|451385977|FG011|Main Study Phase|Death|4|||
125478587|NCT03544281|451385978|FG012|Main Study Phase|Death|0|||
125478588|NCT03544281|451385979|FG013|Main Study Phase|Death|0|||
125478589|NCT03544281|451385980|FG014|Main Study Phase|Death|0|||
125478590|NCT03544281|451385981|FG015|Main Study Phase|Death|0|||
125478591|NCT03544281|451385982|FG016|Main Study Phase|Death|0|||
125478592|NCT03544281|451385983|FG017|Main Study Phase|Death|0|||
125478593|NCT03544281|451385984|FG018|Main Study Phase|Death|0|||
125478594|NCT03544281|451385985|FG019|Main Study Phase|Death|0|||
125478595|NCT03544281|451385986|FG020|Main Study Phase|Death|0|||
125478596|NCT03544281|451385987|FG021|Main Study Phase|Death|0|||
125478597|NCT03544281|451385966|FG000|Main Study Phase|Lost to Follow-up|0|||
125478598|NCT03544281|451385967|FG001|Main Study Phase|Lost to Follow-up|0|||
125478599|NCT03544281|451385968|FG002|Main Study Phase|Lost to Follow-up|0|||
125478600|NCT03544281|451385969|FG003|Main Study Phase|Lost to Follow-up|0|||
125478601|NCT03544281|451385970|FG004|Main Study Phase|Lost to Follow-up|0|||
125478602|NCT03544281|451385971|FG005|Main Study Phase|Lost to Follow-up|0|||
125478603|NCT03544281|451385972|FG006|Main Study Phase|Lost to Follow-up|0|||
125478604|NCT03544281|451385973|FG007|Main Study Phase|Lost to Follow-up|0|||
125478605|NCT03544281|451385974|FG008|Main Study Phase|Lost to Follow-up|0|||
125478606|NCT03544281|451385975|FG009|Main Study Phase|Lost to Follow-up|0|||
125478607|NCT03544281|451385976|FG010|Main Study Phase|Lost to Follow-up|1|||
125478608|NCT03544281|451385977|FG011|Main Study Phase|Lost to Follow-up|0|||
125478609|NCT03544281|451385978|FG012|Main Study Phase|Lost to Follow-up|0|||
125478610|NCT03544281|451385979|FG013|Main Study Phase|Lost to Follow-up|0|||
125478611|NCT03544281|451385980|FG014|Main Study Phase|Lost to Follow-up|0|||
125478612|NCT03544281|451385981|FG015|Main Study Phase|Lost to Follow-up|0|||
125478613|NCT03544281|451385982|FG016|Main Study Phase|Lost to Follow-up|0|||
125478614|NCT03544281|451385983|FG017|Main Study Phase|Lost to Follow-up|0|||
125478615|NCT03544281|451385984|FG018|Main Study Phase|Lost to Follow-up|0|||
125478616|NCT03544281|451385985|FG019|Main Study Phase|Lost to Follow-up|0|||
125478617|NCT03544281|451385986|FG020|Main Study Phase|Lost to Follow-up|0|||
125478618|NCT03544281|451385987|FG021|Main Study Phase|Lost to Follow-up|0|||
125478619|NCT03544281|451385966|FG000|Main Study Phase|Physician Decision|0|||
125478620|NCT03544281|451385967|FG001|Main Study Phase|Physician Decision|0|||
125478621|NCT03544281|451385968|FG002|Main Study Phase|Physician Decision|0|||
125478622|NCT03544281|451385969|FG003|Main Study Phase|Physician Decision|0|||
125478623|NCT03544281|451385970|FG004|Main Study Phase|Physician Decision|0|||
125478624|NCT03544281|451385971|FG005|Main Study Phase|Physician Decision|0|||
125478625|NCT03544281|451385972|FG006|Main Study Phase|Physician Decision|0|||
125478626|NCT03544281|451385973|FG007|Main Study Phase|Physician Decision|1|||
125478627|NCT03544281|451385974|FG008|Main Study Phase|Physician Decision|0|||
125478628|NCT03544281|451385975|FG009|Main Study Phase|Physician Decision|0|||
125478629|NCT03544281|451385976|FG010|Main Study Phase|Physician Decision|0|||
125478630|NCT03544281|451385977|FG011|Main Study Phase|Physician Decision|0|||
125478631|NCT03544281|451385978|FG012|Main Study Phase|Physician Decision|0|||
125478632|NCT03544281|451385979|FG013|Main Study Phase|Physician Decision|0|||
125478633|NCT03544281|451385980|FG014|Main Study Phase|Physician Decision|0|||
125478634|NCT03544281|451385981|FG015|Main Study Phase|Physician Decision|0|||
125478635|NCT03544281|451385982|FG016|Main Study Phase|Physician Decision|0|||
125478636|NCT03544281|451385983|FG017|Main Study Phase|Physician Decision|0|||
125478637|NCT03544281|451385984|FG018|Main Study Phase|Physician Decision|0|||
125478638|NCT03544281|451385985|FG019|Main Study Phase|Physician Decision|0|||
125478639|NCT03544281|451385986|FG020|Main Study Phase|Physician Decision|0|||
125478640|NCT03544281|451385987|FG021|Main Study Phase|Physician Decision|0|||
125478641|NCT03544281|451385966|FG000|Main Study Phase|Withdrawal by Subject|2|||
125478642|NCT03544281|451385967|FG001|Main Study Phase|Withdrawal by Subject|0|||
125478643|NCT03544281|451385968|FG002|Main Study Phase|Withdrawal by Subject|1|||
125478644|NCT03544281|451385969|FG003|Main Study Phase|Withdrawal by Subject|2|||
125478645|NCT03544281|451385970|FG004|Main Study Phase|Withdrawal by Subject|0|||
125478646|NCT03544281|451385971|FG005|Main Study Phase|Withdrawal by Subject|0|||
125478647|NCT03544281|451385972|FG006|Main Study Phase|Withdrawal by Subject|0|||
125301906|NCT03149055|450731870|FG000|Overall Study|Not treated|4|||
125301907|NCT04440813|450731871|FG000|Overall Study|Lost to Follow-up|5|||
125301908|NCT04440813|450731872|FG001|Overall Study|Lost to Follow-up|5|||
125301909|NCT02629822|450731873|FG000|Base Study|Lost to Follow-up|2|||
125301910|NCT02629822|450731873|FG000|Base Study|Non-Compliance With Study Drug|1|||
125301911|NCT02629822|450731873|FG000|Extension Study|Adverse Event|1|||
125301912|NCT02629822|450731873|FG000|Extension Study|Lost to Follow-up|1|||
125301913|NCT00741013|450731874|FG000|Overall Study|Adverse Event|1|||
125301914|NCT00741013|450731875|FG001|Overall Study|Adverse Event|0|||
125301915|NCT00741013|450731876|FG002|Overall Study|Adverse Event|0|||
125301916|NCT00741013|450731874|FG000|Overall Study|Withdrawal by Subject|0|||
125301917|NCT00741013|450731875|FG001|Overall Study|Withdrawal by Subject|0|||
125301918|NCT00741013|450731876|FG002|Overall Study|Withdrawal by Subject|1|||
125301919|NCT00741013|450731874|FG000|Overall Study|Discovered failed screen after enrolled|0|||
125301920|NCT00741013|450731875|FG001|Overall Study|Discovered failed screen after enrolled|2|||
125301921|NCT00741013|450731876|FG002|Overall Study|Discovered failed screen after enrolled|0|||
125301922|NCT00193180|450731880|FG000|Overall Study|Lack of Efficacy|1|||
125301923|NCT00193180|450731880|FG000|Overall Study|Adverse Event|8|||
125301924|NCT00193180|450731880|FG000|Overall Study|Protocol Violation|1|||
125301925|NCT00539305|450731881|FG000|Overall Study|Adverse Event|1|||
125301926|NCT00539305|450731882|FG001|Overall Study|Adverse Event|0|||
125301927|NCT00539305|450731881|FG000|Overall Study|Substance Use|0|||
125301928|NCT00539305|450731882|FG001|Overall Study|Substance Use|1|||
125301929|NCT00539305|450731881|FG000|Overall Study|Withdrawal by Subject|0|||
125301930|NCT00539305|450731882|FG001|Overall Study|Withdrawal by Subject|1|||
125301931|NCT01331109|450731894|FG000|Overall Study|Adverse Event|6|||
125301932|NCT01331109|450731894|FG000|Overall Study|Lack of Efficacy|2|||
125301933|NCT01331109|450731894|FG000|Overall Study|Protocol Violation|3|||
125301934|NCT01331109|450731894|FG000|Overall Study|Withdrawal by Subject|7|||
125301935|NCT01331109|450731894|FG000|Overall Study|Lost to Follow-up|1|||
125301936|NCT01331109|450731894|FG000|Overall Study|Study Terminated by Sponsor|38|||
125301937|NCT00661622|450731897|FG000|Overall Study|Protocol Violation|1|||
125301938|NCT00661622|450731898|FG001|Overall Study|Protocol Violation|0|||
125301939|NCT00098306|450731903|FG000|Double Blind|Randomized, not treated|9|||
125301940|NCT00098306|450731904|FG001|Double Blind|Randomized, not treated|5|||
125301941|NCT00098306|450731905|FG002|Double Blind|Randomized, not treated|2|||
125301942|NCT00098306|450731906|FG003|Double Blind|Randomized, not treated|0|||
125301943|NCT00098306|450731907|FG004|Double Blind|Randomized, not treated|0|||
125301944|NCT00098306|450731908|FG005|Double Blind|Randomized, not treated|0|||
125478648|NCT03544281|451385973|FG007|Main Study Phase|Withdrawal by Subject|0|||
125478649|NCT03544281|451385974|FG008|Main Study Phase|Withdrawal by Subject|2|||
125478650|NCT03544281|451385975|FG009|Main Study Phase|Withdrawal by Subject|3|||
125478651|NCT03544281|451385976|FG010|Main Study Phase|Withdrawal by Subject|0|||
125478652|NCT03544281|451385977|FG011|Main Study Phase|Withdrawal by Subject|4|||
125478653|NCT03544281|451385978|FG012|Main Study Phase|Withdrawal by Subject|0|||
125478654|NCT03544281|451385979|FG013|Main Study Phase|Withdrawal by Subject|0|||
125478655|NCT03544281|451385980|FG014|Main Study Phase|Withdrawal by Subject|0|||
125478656|NCT03544281|451385981|FG015|Main Study Phase|Withdrawal by Subject|0|||
125478657|NCT03544281|451385982|FG016|Main Study Phase|Withdrawal by Subject|0|||
125478658|NCT03544281|451385983|FG017|Main Study Phase|Withdrawal by Subject|0|||
125478659|NCT03544281|451385984|FG018|Main Study Phase|Withdrawal by Subject|0|||
125478660|NCT03544281|451385985|FG019|Main Study Phase|Withdrawal by Subject|0|||
125478661|NCT03544281|451385986|FG020|Main Study Phase|Withdrawal by Subject|0|||
125478662|NCT03544281|451385987|FG021|Main Study Phase|Withdrawal by Subject|0|||
125478663|NCT03544281|451385966|FG000|Main Study Phase|Ongoing|3|||
125478664|NCT03544281|451385967|FG001|Main Study Phase|Ongoing|1|||
125478665|NCT03544281|451385968|FG002|Main Study Phase|Ongoing|2|||
125478666|NCT03544281|451385969|FG003|Main Study Phase|Ongoing|4|||
125478667|NCT03544281|451385970|FG004|Main Study Phase|Ongoing|2|||
125478668|NCT03544281|451385971|FG005|Main Study Phase|Ongoing|4|||
125478669|NCT03544281|451385972|FG006|Main Study Phase|Ongoing|4|||
125478670|NCT03544281|451385973|FG007|Main Study Phase|Ongoing|0|||
125478671|NCT03544281|451385974|FG008|Main Study Phase|Ongoing|2|||
125301945|NCT00098306|450731909|FG006|Double Blind|Randomized, not treated|0|||
125301946|NCT00098306|450731903|FG000|Double Blind|Ongoing at cut-off date|151|||
125301947|NCT00098306|450731904|FG001|Double Blind|Ongoing at cut-off date|166|||
125301948|NCT00098306|450731905|FG002|Double Blind|Ongoing at cut-off date|72|||
125301949|NCT00098306|450731906|FG003|Double Blind|Ongoing at cut-off date|0|||
125478672|NCT03544281|451385975|FG009|Main Study Phase|Ongoing|2|||
125301950|NCT00098306|450731907|FG004|Double Blind|Ongoing at cut-off date|0|||
125301951|NCT00098306|450731908|FG005|Double Blind|Ongoing at cut-off date|0|||
125301952|NCT00098306|450731909|FG006|Double Blind|Ongoing at cut-off date|0|||
125478673|NCT03544281|451385976|FG010|Main Study Phase|Ongoing|1|||
125478674|NCT03544281|451385977|FG011|Main Study Phase|Ongoing|0|||
125478675|NCT03544281|451385978|FG012|Main Study Phase|Ongoing|0|||
125478676|NCT03544281|451385979|FG013|Main Study Phase|Ongoing|0|||
125478677|NCT03544281|451385980|FG014|Main Study Phase|Ongoing|0|||
125478678|NCT03544281|451385981|FG015|Main Study Phase|Ongoing|0|||
125478679|NCT03544281|451385982|FG016|Main Study Phase|Ongoing|0|||
125478680|NCT03544281|451385983|FG017|Main Study Phase|Ongoing|0|||
125478681|NCT03544281|451385984|FG018|Main Study Phase|Ongoing|0|||
125301953|NCT00098306|450731903|FG000|Double Blind|Adverse Event|11|||
125301954|NCT00098306|450731904|FG001|Double Blind|Adverse Event|10|||
125301955|NCT00098306|450731905|FG002|Double Blind|Adverse Event|6|||
125301956|NCT00098306|450731906|FG003|Double Blind|Adverse Event|0|||
125301957|NCT00098306|450731907|FG004|Double Blind|Adverse Event|0|||
125301958|NCT00098306|450731908|FG005|Double Blind|Adverse Event|0|||
125301959|NCT00098306|450731909|FG006|Double Blind|Adverse Event|0|||
125301960|NCT00098306|450731903|FG000|Double Blind|Lack of Efficacy|43|||
125301961|NCT00098306|450731904|FG001|Double Blind|Lack of Efficacy|34|||
125301962|NCT00098306|450731905|FG002|Double Blind|Lack of Efficacy|17|||
125301963|NCT00098306|450731906|FG003|Double Blind|Lack of Efficacy|0|||
125301964|NCT00098306|450731907|FG004|Double Blind|Lack of Efficacy|0|||
125301965|NCT00098306|450731908|FG005|Double Blind|Lack of Efficacy|0|||
125301966|NCT00098306|450731909|FG006|Double Blind|Lack of Efficacy|0|||
125301967|NCT00098306|450731903|FG000|Double Blind|Death|1|||
125301968|NCT00098306|450731904|FG001|Double Blind|Death|4|||
125301969|NCT00098306|450731905|FG002|Double Blind|Death|1|||
125301970|NCT00098306|450731906|FG003|Double Blind|Death|0|||
125301971|NCT00098306|450731907|FG004|Double Blind|Death|0|||
125301972|NCT00098306|450731908|FG005|Double Blind|Death|0|||
125301973|NCT00098306|450731909|FG006|Double Blind|Death|0|||
125301974|NCT00098306|450731903|FG000|Double Blind|Participant defaulted|19|||
125301975|NCT00098306|450731904|FG001|Double Blind|Participant defaulted|18|||
125301976|NCT00098306|450731905|FG002|Double Blind|Participant defaulted|11|||
125301977|NCT00098306|450731906|FG003|Double Blind|Participant defaulted|0|||
125301978|NCT00098306|450731907|FG004|Double Blind|Participant defaulted|0|||
125301979|NCT00098306|450731908|FG005|Double Blind|Participant defaulted|0|||
125301980|NCT00098306|450731909|FG006|Double Blind|Participant defaulted|0|||
125301981|NCT00098306|450731903|FG000|Double Blind|Un-specified|7|||
125301982|NCT00098306|450731904|FG001|Double Blind|Un-specified|3|||
125301983|NCT00098306|450731905|FG002|Double Blind|Un-specified|11|||
125301984|NCT00098306|450731906|FG003|Double Blind|Un-specified|0|||
125301985|NCT00098306|450731907|FG004|Double Blind|Un-specified|0|||
125301986|NCT00098306|450731908|FG005|Double Blind|Un-specified|0|||
125301987|NCT00098306|450731909|FG006|Double Blind|Un-specified|0|||
125301988|NCT00098306|450731903|FG000|Open Label|Lack of Efficacy|0|||
125301989|NCT00098306|450731904|FG001|Open Label|Lack of Efficacy|0|||
125301990|NCT00098306|450731905|FG002|Open Label|Lack of Efficacy|0|||
125301991|NCT00098306|450731906|FG003|Open Label|Lack of Efficacy|13|||
125301992|NCT00098306|450731907|FG004|Open Label|Lack of Efficacy|0|||
125301993|NCT00098306|450731908|FG005|Open Label|Lack of Efficacy|0|||
125301994|NCT00098306|450731909|FG006|Open Label|Lack of Efficacy|0|||
125301995|NCT00098306|450731903|FG000|Open Label|Adverse Event|0|||
125301996|NCT00098306|450731904|FG001|Open Label|Adverse Event|0|||
125301997|NCT00098306|450731905|FG002|Open Label|Adverse Event|0|||
125301998|NCT00098306|450731906|FG003|Open Label|Adverse Event|2|||
125301999|NCT00098306|450731907|FG004|Open Label|Adverse Event|0|||
125302000|NCT00098306|450731908|FG005|Open Label|Adverse Event|0|||
125302001|NCT00098306|450731909|FG006|Open Label|Adverse Event|0|||
125302002|NCT00098306|450731903|FG000|Open Label|Death|0|||
125302003|NCT00098306|450731904|FG001|Open Label|Death|0|||
125302004|NCT00098306|450731905|FG002|Open Label|Death|0|||
125302005|NCT00098306|450731906|FG003|Open Label|Death|4|||
125302006|NCT00098306|450731907|FG004|Open Label|Death|0|||
125302007|NCT00098306|450731908|FG005|Open Label|Death|0|||
125478682|NCT03544281|451385985|FG019|Main Study Phase|Ongoing|0|||
125478683|NCT03544281|451385986|FG020|Main Study Phase|Ongoing|0|||
125478684|NCT03544281|451385987|FG021|Main Study Phase|Ongoing|0|||
125478685|NCT03544281|451385966|FG000|Main Study Phase|Investigator Site Closed|0|||
125302008|NCT00098306|450731909|FG006|Open Label|Death|0|||
125302009|NCT00098306|450731903|FG000|Open Label|Participant defaulted|0|||
125302010|NCT00098306|450731904|FG001|Open Label|Participant defaulted|0|||
125302011|NCT00098306|450731905|FG002|Open Label|Participant defaulted|0|||
125302012|NCT00098306|450731906|FG003|Open Label|Participant defaulted|24|||
125302013|NCT00098306|450731907|FG004|Open Label|Participant defaulted|0|||
125302014|NCT00098306|450731908|FG005|Open Label|Participant defaulted|0|||
125302015|NCT00098306|450731909|FG006|Open Label|Participant defaulted|0|||
125478686|NCT03544281|451385967|FG001|Main Study Phase|Investigator Site Closed|0|||
125478687|NCT03544281|451385968|FG002|Main Study Phase|Investigator Site Closed|0|||
125302016|NCT00098306|450731903|FG000|Open Label|Un-specified|0|||
125302017|NCT00098306|450731904|FG001|Open Label|Un-specified|0|||
125302018|NCT00098306|450731905|FG002|Open Label|Un-specified|0|||
125302019|NCT00098306|450731906|FG003|Open Label|Un-specified|15|||
125302020|NCT00098306|450731907|FG004|Open Label|Un-specified|0|||
125302021|NCT00098306|450731908|FG005|Open Label|Un-specified|0|||
125302022|NCT00098306|450731909|FG006|Open Label|Un-specified|0|||
125302023|NCT00098306|450731903|FG000|Open Label|Ongoing at cut-off date|0|||
125302024|NCT00098306|450731904|FG001|Open Label|Ongoing at cut-off date|0|||
125302025|NCT00098306|450731905|FG002|Open Label|Ongoing at cut-off date|0|||
125302026|NCT00098306|450731906|FG003|Open Label|Ongoing at cut-off date|269|||
125478688|NCT03544281|451385969|FG003|Main Study Phase|Investigator Site Closed|0|||
125302027|NCT00098306|450731907|FG004|Open Label|Ongoing at cut-off date|62|||
125302028|NCT00098306|450731908|FG005|Open Label|Ongoing at cut-off date|0|||
125302029|NCT00098306|450731909|FG006|Open Label|Ongoing at cut-off date|0|||
125302030|NCT00098306|450731903|FG000|Observational Phase|Death|0|||
125302031|NCT00098306|450731904|FG001|Observational Phase|Death|0|||
125302032|NCT00098306|450731905|FG002|Observational Phase|Death|0|||
125302033|NCT00098306|450731906|FG003|Observational Phase|Death|0|||
125302034|NCT00098306|450731907|FG004|Observational Phase|Death|0|||
125302035|NCT00098306|450731908|FG005|Observational Phase|Death|5|||
125302036|NCT00098306|450731909|FG006|Observational Phase|Death|4|||
125302037|NCT00098306|450731903|FG000|Observational Phase|Participant defaulted|0|||
125302038|NCT00098306|450731904|FG001|Observational Phase|Participant defaulted|0|||
125302039|NCT00098306|450731905|FG002|Observational Phase|Participant defaulted|0|||
125478689|NCT03544281|451385970|FG004|Main Study Phase|Investigator Site Closed|0|||
125478690|NCT03544281|451385971|FG005|Main Study Phase|Investigator Site Closed|0|||
125478691|NCT03544281|451385972|FG006|Main Study Phase|Investigator Site Closed|0|||
125478692|NCT03544281|451385973|FG007|Main Study Phase|Investigator Site Closed|0|||
125478693|NCT03544281|451385974|FG008|Main Study Phase|Investigator Site Closed|0|||
125478694|NCT03544281|451385975|FG009|Main Study Phase|Investigator Site Closed|1|||
125478695|NCT03544281|451385976|FG010|Main Study Phase|Investigator Site Closed|0|||
125478696|NCT03544281|451385977|FG011|Main Study Phase|Investigator Site Closed|0|||
125478697|NCT03544281|451385978|FG012|Main Study Phase|Investigator Site Closed|0|||
125478698|NCT03544281|451385979|FG013|Main Study Phase|Investigator Site Closed|0|||
125478699|NCT03544281|451385980|FG014|Main Study Phase|Investigator Site Closed|0|||
125478700|NCT03544281|451385981|FG015|Main Study Phase|Investigator Site Closed|0|||
125478701|NCT03544281|451385982|FG016|Main Study Phase|Investigator Site Closed|0|||
125478702|NCT03544281|451385983|FG017|Main Study Phase|Investigator Site Closed|0|||
125478703|NCT03544281|451385984|FG018|Main Study Phase|Investigator Site Closed|0|||
125478704|NCT03544281|451385985|FG019|Main Study Phase|Investigator Site Closed|0|||
125478705|NCT03544281|451385986|FG020|Main Study Phase|Investigator Site Closed|0|||
125478706|NCT03544281|451385987|FG021|Main Study Phase|Investigator Site Closed|0|||
125478707|NCT03544281|451385966|FG000|Main Study Phase|Did not receive study treatment|0|||
125478708|NCT03544281|451385967|FG001|Main Study Phase|Did not receive study treatment|0|||
125478709|NCT03544281|451385968|FG002|Main Study Phase|Did not receive study treatment|0|||
125478710|NCT03544281|451385969|FG003|Main Study Phase|Did not receive study treatment|0|||
125478711|NCT03544281|451385970|FG004|Main Study Phase|Did not receive study treatment|0|||
125478712|NCT03544281|451385971|FG005|Main Study Phase|Did not receive study treatment|0|||
125478713|NCT03544281|451385972|FG006|Main Study Phase|Did not receive study treatment|1|||
125478714|NCT03544281|451385973|FG007|Main Study Phase|Did not receive study treatment|0|||
125478715|NCT03544281|451385974|FG008|Main Study Phase|Did not receive study treatment|0|||
125478716|NCT03544281|451385975|FG009|Main Study Phase|Did not receive study treatment|0|||
125478717|NCT03544281|451385976|FG010|Main Study Phase|Did not receive study treatment|0|||
125478718|NCT03544281|451385977|FG011|Main Study Phase|Did not receive study treatment|0|||
125478719|NCT03544281|451385978|FG012|Main Study Phase|Did not receive study treatment|0|||
125478720|NCT03544281|451385979|FG013|Main Study Phase|Did not receive study treatment|0|||
125478721|NCT03544281|451385980|FG014|Main Study Phase|Did not receive study treatment|0|||
125478722|NCT03544281|451385981|FG015|Main Study Phase|Did not receive study treatment|0|||
125478723|NCT03544281|451385982|FG016|Main Study Phase|Did not receive study treatment|0|||
125478724|NCT03544281|451385983|FG017|Main Study Phase|Did not receive study treatment|0|||
125478725|NCT03544281|451385984|FG018|Main Study Phase|Did not receive study treatment|0|||
125478726|NCT03544281|451385985|FG019|Main Study Phase|Did not receive study treatment|0|||
125478727|NCT03544281|451385986|FG020|Main Study Phase|Did not receive study treatment|0|||
125478728|NCT03544281|451385987|FG021|Main Study Phase|Did not receive study treatment|0|||
125478729|NCT03544281|451385966|FG000|PACT Phase|Adverse Event|0|||
125478730|NCT03544281|451385967|FG001|PACT Phase|Adverse Event|0|||
125478731|NCT03544281|451385968|FG002|PACT Phase|Adverse Event|0|||
125478732|NCT03544281|451385969|FG003|PACT Phase|Adverse Event|0|||
125478733|NCT03544281|451385970|FG004|PACT Phase|Adverse Event|0|||
125478734|NCT03544281|451385971|FG005|PACT Phase|Adverse Event|0|||
125478735|NCT03544281|451385972|FG006|PACT Phase|Adverse Event|0|||
125302040|NCT00098306|450731906|FG003|Observational Phase|Participant defaulted|0|||
125478736|NCT03544281|451385973|FG007|PACT Phase|Adverse Event|0|||
125478737|NCT03544281|451385974|FG008|PACT Phase|Adverse Event|0|||
125478738|NCT03544281|451385975|FG009|PACT Phase|Adverse Event|0|||
125478739|NCT03544281|451385976|FG010|PACT Phase|Adverse Event|0|||
125302041|NCT00098306|450731907|FG004|Observational Phase|Participant defaulted|0|||
125302042|NCT00098306|450731908|FG005|Observational Phase|Participant defaulted|34|||
125302043|NCT00098306|450731909|FG006|Observational Phase|Participant defaulted|18|||
125478740|NCT03544281|451385977|FG011|PACT Phase|Adverse Event|0|||
125478741|NCT03544281|451385978|FG012|PACT Phase|Adverse Event|1|||
125478742|NCT03544281|451385979|FG013|PACT Phase|Adverse Event|0|||
125478743|NCT03544281|451385980|FG014|PACT Phase|Adverse Event|0|||
125302044|NCT00098306|450731903|FG000|Observational Phase|Un-specified|0|||
125302045|NCT00098306|450731904|FG001|Observational Phase|Un-specified|0|||
125478744|NCT03544281|451385981|FG015|PACT Phase|Adverse Event|0|||
125478745|NCT03544281|451385982|FG016|PACT Phase|Adverse Event|0|||
125302046|NCT00098306|450731905|FG002|Observational Phase|Un-specified|0|||
125478746|NCT03544281|451385983|FG017|PACT Phase|Adverse Event|1|||
125478747|NCT03544281|451385984|FG018|PACT Phase|Adverse Event|1|||
125478748|NCT03544281|451385985|FG019|PACT Phase|Adverse Event|0|||
125478749|NCT03544281|451385986|FG020|PACT Phase|Adverse Event|0|||
125478750|NCT03544281|451385987|FG021|PACT Phase|Adverse Event|0|||
125478751|NCT04282148|451385991|FG000|Overall Study|Death|7|||
125478752|NCT04282148|451385991|FG000|Overall Study|Withdrawal by Subject|1|||
125478753|NCT04282148|451385991|FG000|Overall Study|Physician Decision|1|||
125478754|NCT02683447|451385997|FG000|Overall Study|Lost to Follow-up|2|||
125478755|NCT03448107|451385998|FG000|Overall Study|Lost to Follow-up|229|||
125478756|NCT03448107|451385999|FG001|Overall Study|Lost to Follow-up|258|||
125478757|NCT03115476|451386000|FG000|LP0084-1369|Death|1|||
125478758|NCT03115476|451386001|FG001|LP0084-1369|Death|0|||
125478759|NCT03115476|451386002|FG002|LP0084-1369|Death|2|||
125478760|NCT03115476|451386000|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
125478761|NCT03115476|451386001|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
125478762|NCT03115476|451386002|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
125478763|NCT02489903|451386003|FG000|Screening|Screen Failure|24|||
125478764|NCT02489903|451386004|FG001|Screening|Screen Failure|0|||
125478765|NCT02489903|451386005|FG002|Screening|Screen Failure|0|||
125478766|NCT02489903|451386006|FG003|Screening|Screen Failure|8|||
125478767|NCT02489903|451386003|FG000|Randomized and Received Treatment|Protocol Violation|0|||
125478768|NCT02489903|451386004|FG001|Randomized and Received Treatment|Protocol Violation|1|||
125478769|NCT02489903|451386005|FG002|Randomized and Received Treatment|Protocol Violation|0|||
125478770|NCT02489903|451386006|FG003|Randomized and Received Treatment|Protocol Violation|0|||
125478771|NCT02489903|451386003|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
125478772|NCT02489903|451386004|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
125478773|NCT02489903|451386005|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
125478774|NCT02489903|451386006|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
125478775|NCT02489903|451386003|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
125478776|NCT02489903|451386004|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
125478777|NCT02489903|451386005|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
125478778|NCT02489903|451386006|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
125478779|NCT02489903|451386003|FG000|Randomized and Received Treatment|Death|10|||
125478780|NCT02489903|451386004|FG001|Randomized and Received Treatment|Death|1|||
125478781|NCT02489903|451386005|FG002|Randomized and Received Treatment|Death|0|||
125478782|NCT02489903|451386006|FG003|Randomized and Received Treatment|Death|0|||
125478783|NCT05257486|451386010|FG000|Overall Study|Protocol Violation|3|||
125478784|NCT04542317|451386011|FG000|Overall Study|Care recipients passed away|18|||
125478785|NCT04542317|451386012|FG001|Overall Study|Care recipients passed away|13|||
125478786|NCT04542317|451386011|FG000|Overall Study|No longer a primary caregiver|5|||
125478787|NCT04542317|451386012|FG001|Overall Study|No longer a primary caregiver|1|||
125478788|NCT04542317|451386011|FG000|Overall Study|Withdrawal by Subject|4|||
125478789|NCT04542317|451386012|FG001|Overall Study|Withdrawal by Subject|2|||
125478790|NCT04542317|451386011|FG000|Overall Study|Caregivers passed away|0|||
125478791|NCT04542317|451386012|FG001|Overall Study|Caregivers passed away|2|||
125478792|NCT04700163|451386013|FG000|Overall Study|Lost to Follow-up|0|||
125478793|NCT04700163|451386014|FG001|Overall Study|Lost to Follow-up|0|||
125478794|NCT04700163|451386015|FG002|Overall Study|Lost to Follow-up|0|||
125478795|NCT04700163|451386016|FG003|Overall Study|Lost to Follow-up|0|||
125478796|NCT04700163|451386017|FG004|Overall Study|Lost to Follow-up|0|||
125478797|NCT04700163|451386018|FG005|Overall Study|Lost to Follow-up|1|||
125478798|NCT03976362|451386021|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
125478799|NCT03976362|451386022|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
125478800|NCT03976362|451386023|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
125478801|NCT03976362|451386021|FG000|Induction Phase|Death|62|||
125478802|NCT03976362|451386022|FG001|Induction Phase|Death|0|||
125478803|NCT03976362|451386023|FG002|Induction Phase|Death|0|||
125478804|NCT03976362|451386021|FG000|Maintenance Phase|Participants Ongoing|0|||
125478805|NCT03976362|451386022|FG001|Maintenance Phase|Participants Ongoing|106|||
125478806|NCT03976362|451386023|FG002|Maintenance Phase|Participants Ongoing|103|||
125478807|NCT03976362|451386021|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125478808|NCT03976362|451386022|FG001|Maintenance Phase|Withdrawal by Subject|4|||
125478809|NCT03976362|451386023|FG002|Maintenance Phase|Withdrawal by Subject|4|||
125478810|NCT03976362|451386021|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
125478811|NCT03976362|451386022|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
125478812|NCT03976362|451386023|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
125478813|NCT03976362|451386021|FG000|Maintenance Phase|Death|0|||
125478814|NCT03976362|451386022|FG001|Maintenance Phase|Death|186|||
125478815|NCT03976362|451386023|FG002|Maintenance Phase|Death|187|||
125478816|NCT00613106|451386024|FG000|Overall Study|Adverse Event|3|||
125478817|NCT00613106|451386025|FG001|Overall Study|Adverse Event|1|||
125478818|NCT00613106|451386024|FG000|Overall Study|Withdrawal by Subject|6|||
125478819|NCT00613106|451386025|FG001|Overall Study|Withdrawal by Subject|3|||
125478820|NCT00613106|451386024|FG000|Overall Study|Lost to Follow-up|7|||
125478821|NCT00613106|451386025|FG001|Overall Study|Lost to Follow-up|2|||
125478822|NCT00613106|451386024|FG000|Overall Study|misc|4|||
125478823|NCT00613106|451386025|FG001|Overall Study|misc|3|||
125478824|NCT05126433|451386030|FG000|Overall Study|Withdrawal by Subject|3|||
125478825|NCT05126433|451386031|FG001|Overall Study|Withdrawal by Subject|0|||
125478826|NCT05126433|451386032|FG002|Overall Study|Withdrawal by Subject|4|||
125478827|NCT05126433|451386030|FG000|Overall Study|Death|9|||
125478828|NCT05126433|451386031|FG001|Overall Study|Death|3|||
125478829|NCT05126433|451386032|FG002|Overall Study|Death|5|||
125478830|NCT05126433|451386030|FG000|Overall Study|Study Terminated by sponsor|0|||
125478831|NCT05126433|451386031|FG001|Overall Study|Study Terminated by sponsor|1|||
125478832|NCT05126433|451386032|FG002|Overall Study|Study Terminated by sponsor|2|||
125478833|NCT05126433|451386030|FG000|Overall Study|Progressive Disease|1|||
125478834|NCT05126433|451386031|FG001|Overall Study|Progressive Disease|4|||
125478835|NCT05126433|451386032|FG002|Overall Study|Progressive Disease|3|||
125478836|NCT05126433|451386030|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
125478837|NCT05126433|451386031|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
125478838|NCT05126433|451386032|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
125478839|NCT05084508|451386038|FG000|Overall Study|Lost to Follow-up|6|||
125478840|NCT05084508|451386039|FG001|Overall Study|Lost to Follow-up|3|||
125478841|NCT05084508|451386040|FG002|Overall Study|Lost to Follow-up|7|||
125478842|NCT05084508|451386041|FG003|Overall Study|Lost to Follow-up|3|||
125478843|NCT05084508|451386038|FG000|Overall Study|Withdrawal by Subject|0|||
125478844|NCT05084508|451386039|FG001|Overall Study|Withdrawal by Subject|2|||
125478845|NCT05084508|451386040|FG002|Overall Study|Withdrawal by Subject|3|||
125478846|NCT05084508|451386041|FG003|Overall Study|Withdrawal by Subject|1|||
125478847|NCT05084508|451386038|FG000|Overall Study|Other|0|||
125478848|NCT05084508|451386039|FG001|Overall Study|Other|0|||
125478849|NCT05084508|451386040|FG002|Overall Study|Other|0|||
125478850|NCT05084508|451386041|FG003|Overall Study|Other|1|||
125478851|NCT05296525|451386042|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
125478852|NCT05296525|451386043|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
125478853|NCT05296525|451386044|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
125478854|NCT05296525|451386045|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
125478855|NCT04065841|451386050|FG000|Overall Study|Adverse Event|4|||
125478856|NCT04065841|451386051|FG001|Overall Study|Adverse Event|2|||
125478857|NCT04065841|451386052|FG002|Overall Study|Adverse Event|10|||
125478858|NCT04065841|451386053|FG003|Overall Study|Adverse Event|1|||
125478859|NCT04065841|451386050|FG000|Overall Study|Lost to Follow-up|1|||
125478860|NCT04065841|451386051|FG001|Overall Study|Lost to Follow-up|2|||
125478861|NCT04065841|451386052|FG002|Overall Study|Lost to Follow-up|2|||
125478862|NCT04065841|451386053|FG003|Overall Study|Lost to Follow-up|2|||
125478863|NCT04065841|451386050|FG000|Overall Study|Physician Decision|1|||
125478864|NCT04065841|451386051|FG001|Overall Study|Physician Decision|0|||
125478865|NCT04065841|451386052|FG002|Overall Study|Physician Decision|0|||
125478866|NCT04065841|451386053|FG003|Overall Study|Physician Decision|0|||
125478867|NCT04065841|451386050|FG000|Overall Study|Protocol Violation|0|||
125478868|NCT04065841|451386051|FG001|Overall Study|Protocol Violation|1|||
125478869|NCT04065841|451386052|FG002|Overall Study|Protocol Violation|0|||
125478870|NCT04065841|451386053|FG003|Overall Study|Protocol Violation|0|||
125478871|NCT04065841|451386050|FG000|Overall Study|Study terminated by Sponsor|22|||
125478872|NCT04065841|451386051|FG001|Overall Study|Study terminated by Sponsor|16|||
125478873|NCT04065841|451386052|FG002|Overall Study|Study terminated by Sponsor|28|||
125478874|NCT04065841|451386053|FG003|Overall Study|Study terminated by Sponsor|17|||
125478875|NCT04065841|451386050|FG000|Overall Study|Withdrawal by Subject|1|||
125478876|NCT04065841|451386051|FG001|Overall Study|Withdrawal by Subject|1|||
125478877|NCT04065841|451386052|FG002|Overall Study|Withdrawal by Subject|2|||
125478878|NCT04065841|451386053|FG003|Overall Study|Withdrawal by Subject|0|||
125478879|NCT01420237|451386054|FG000|Overall Study|Death|13|||
125478880|NCT01420237|451386054|FG000|Overall Study|Withdrawal by Subject|41|||
125478881|NCT01420237|451386054|FG000|Overall Study|Lost to Follow-up|32|||
125478882|NCT01420237|451386054|FG000|Overall Study|Adverse Event|10|||
125478883|NCT01420237|451386054|FG000|Overall Study|Investigative Site Termination|43|||
125478884|NCT01420237|451386054|FG000|Overall Study|Censored because study device not implanted|21|||
125478885|NCT01420237|451386054|FG000|Overall Study|Censored because surgery not performed|2|||
125478886|NCT01420237|451386054|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
125478887|NCT01420237|451386054|FG000|Overall Study|Sponsor terminated study early|127|||
125478888|NCT03631784|451386056|FG000|Overall Study|Participants Ongoing|1|||
125478889|NCT03631784|451386057|FG001|Overall Study|Participants Ongoing|0|||
125478890|NCT03631784|451386056|FG000|Overall Study|Withdrawal by Subject|3|||
125478891|NCT03631784|451386057|FG001|Overall Study|Withdrawal by Subject|3|||
125478892|NCT03631784|451386056|FG000|Overall Study|Sponsor's Decision|36|||
125478893|NCT03631784|451386057|FG001|Overall Study|Sponsor's Decision|52|||
125478894|NCT03631784|451386056|FG000|Overall Study|Lost to Follow-up|1|||
125478895|NCT03631784|451386057|FG001|Overall Study|Lost to Follow-up|0|||
125478896|NCT03631784|451386056|FG000|Overall Study|Death|71|||
125478897|NCT03631784|451386057|FG001|Overall Study|Death|49|||
125478898|NCT04437615|451386058|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
125478899|NCT05653427|451387958|FG000|Overall Study|Study Terminated by Sponsor|13|||
125478900|NCT04256941|451387966|FG000|Overall Study|Withdrawal by Subject|0|||
125478901|NCT04256941|451387967|FG001|Overall Study|Withdrawal by Subject|1|||
125478902|NCT04256941|451387966|FG000|Overall Study|Death|1|||
125478903|NCT04256941|451387967|FG001|Overall Study|Death|0|||
125478904|NCT04256941|451387966|FG000|Overall Study|Disease Progession|0|||
125478905|NCT04256941|451387967|FG001|Overall Study|Disease Progession|2|||
125478906|NCT02908477|451387974|FG000|Overall Study|Withdrawal by Subject|8|||
125478907|NCT02908477|451387975|FG001|Overall Study|Withdrawal by Subject|28|||
125478908|NCT02140554|451387976|FG000|Overall Study|Withdrawal of consent|1|||
125478909|NCT02140554|451387977|FG001|Overall Study|Withdrawal of consent|0|||
125478910|NCT02140554|451387978|FG002|Overall Study|Withdrawal of consent|4|||
125478911|NCT02140554|451387976|FG000|Overall Study|Physician Decision|1|||
125478912|NCT02140554|451387977|FG001|Overall Study|Physician Decision|0|||
125478913|NCT02140554|451387978|FG002|Overall Study|Physician Decision|2|||
125478914|NCT02140554|451387976|FG000|Overall Study|Death|0|||
125478915|NCT02140554|451387977|FG001|Overall Study|Death|0|||
125478916|NCT02140554|451387978|FG002|Overall Study|Death|1|||
125478917|NCT02140554|451387976|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
125478918|NCT02140554|451387977|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
125478919|NCT02140554|451387978|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
125478920|NCT05590403|451387979|FG000|Overall Study|Lost to Follow-up|13|||
125478921|NCT05590403|451387980|FG001|Overall Study|Lost to Follow-up|1|||
125478922|NCT05590403|451387981|FG002|Overall Study|Lost to Follow-up|7|||
125478923|NCT05590403|451387982|FG003|Overall Study|Lost to Follow-up|3|||
125478924|NCT05590403|451387983|FG004|Overall Study|Lost to Follow-up|4|||
125478925|NCT05590403|451387979|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
125478926|NCT05590403|451387980|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
125478927|NCT05590403|451387981|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
125478928|NCT05590403|451387982|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
125478929|NCT05590403|451387983|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
125478930|NCT05590403|451387979|FG000|Overall Study|Other|2|||
125478931|NCT05590403|451387980|FG001|Overall Study|Other|0|||
125478932|NCT05590403|451387981|FG002|Overall Study|Other|2|||
125478933|NCT05590403|451387982|FG003|Overall Study|Other|2|||
125478934|NCT05590403|451387983|FG004|Overall Study|Other|0|||
125478935|NCT05590403|451387979|FG000|Overall Study|Migrated / moved from the study area|1|||
125478936|NCT05590403|451387980|FG001|Overall Study|Migrated / moved from the study area|1|||
125478937|NCT05590403|451387981|FG002|Overall Study|Migrated / moved from the study area|0|||
125478938|NCT05590403|451387982|FG003|Overall Study|Migrated / moved from the study area|3|||
125478939|NCT05590403|451387983|FG004|Overall Study|Migrated / moved from the study area|1|||
125478940|NCT05590403|451387979|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
125478941|NCT05590403|451387980|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
125478942|NCT05590403|451387981|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
125478943|NCT05590403|451387982|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
125478944|NCT05590403|451387983|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
125478945|NCT05659537|451387984|FG000|Overall Study|Adverse Event|5|||
125478946|NCT05659537|451387984|FG000|Overall Study|Lost to Follow-up|4|||
125478947|NCT05659537|451387984|FG000|Overall Study|Withdrawal by Subject|13|||
125478948|NCT05659537|451387984|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
125478949|NCT05659537|451387984|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
125478950|NCT05659537|451387984|FG000|Overall Study|Participant was suffering from anaemia|1|||
125478951|NCT04856163|451387986|FG000|Overall Study|Lost to Follow-up|97|||
125478952|NCT04856163|451387987|FG001|Overall Study|Lost to Follow-up|100|||
125478953|NCT04526704|451387996|FG000|Overall Study|Adverse Event|1|||
125478954|NCT04526704|451387997|FG001|Overall Study|Adverse Event|0|||
125478955|NCT04526704|451387996|FG000|Overall Study|Physician Decision|1|||
125478956|NCT04526704|451387997|FG001|Overall Study|Physician Decision|0|||
125478957|NCT04526704|451387996|FG000|Overall Study|Withdrawal by Subject|2|||
125478958|NCT04526704|451387997|FG001|Overall Study|Withdrawal by Subject|0|||
125478959|NCT00881621|451387998|FG000|Overall Study|Physician Decision|34|||
125478960|NCT03936322|451388003|FG000|Overall Study|Lost to Follow-up|1|||
125478961|NCT03936322|451388003|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
125478962|NCT05434078|451388005|FG000|Overall Study|Lost to Follow-up|2|||
125478963|NCT05434078|451388006|FG001|Overall Study|Lost to Follow-up|1|||
125478964|NCT05434078|451388005|FG000|Overall Study|Withdrawal by Subject|1|||
125478965|NCT05434078|451388006|FG001|Overall Study|Withdrawal by Subject|0|||
125478966|NCT02734290|451388010|FG000|Overall Study|Adverse Event|1|||
125478967|NCT02734290|451388011|FG001|Overall Study|Adverse Event|0|||
125478968|NCT02734290|451388010|FG000|Overall Study|Death|1|||
125478969|NCT02734290|451388011|FG001|Overall Study|Death|0|||
125478970|NCT03158129|451388012|FG000|Overall Study|Adverse Event|0|||
125478971|NCT03158129|451388013|FG001|Overall Study|Adverse Event|1|||
125478972|NCT03158129|451388014|FG002|Overall Study|Adverse Event|0|||
125478973|NCT03158129|451388015|FG003|Overall Study|Adverse Event|0|||
125478974|NCT03158129|451388012|FG000|Overall Study|Death|0|||
125478975|NCT03158129|451388013|FG001|Overall Study|Death|0|||
125478976|NCT03158129|451388014|FG002|Overall Study|Death|0|||
125478977|NCT03158129|451388015|FG003|Overall Study|Death|1|||
125478978|NCT03158129|451388012|FG000|Overall Study|High surgical risk|1|||
125478979|NCT03158129|451388013|FG001|Overall Study|High surgical risk|1|||
125478980|NCT03158129|451388014|FG002|Overall Study|High surgical risk|0|||
125478981|NCT03158129|451388015|FG003|Overall Study|High surgical risk|0|||
125478982|NCT03158129|451388012|FG000|Overall Study|Progression|1|||
125478983|NCT03158129|451388013|FG001|Overall Study|Progression|1|||
125478984|NCT03158129|451388014|FG002|Overall Study|Progression|0|||
125478985|NCT03158129|451388015|FG003|Overall Study|Progression|0|||
125478986|NCT03158129|451388012|FG000|Overall Study|Lack of resectability|0|||
125478987|NCT03158129|451388013|FG001|Overall Study|Lack of resectability|1|||
125478988|NCT03158129|451388014|FG002|Overall Study|Lack of resectability|0|||
125478989|NCT03158129|451388015|FG003|Overall Study|Lack of resectability|0|||
125478990|NCT03158129|451388012|FG000|Overall Study|Declined surgery|0|||
125478991|NCT03158129|451388013|FG001|Overall Study|Declined surgery|1|||
125478992|NCT03158129|451388014|FG002|Overall Study|Declined surgery|0|||
125478993|NCT03158129|451388015|FG003|Overall Study|Declined surgery|0|||
125478994|NCT03158129|451388012|FG000|Overall Study|No longer surgical candidate|0|||
125478995|NCT03158129|451388013|FG001|Overall Study|No longer surgical candidate|0|||
125478996|NCT03158129|451388014|FG002|Overall Study|No longer surgical candidate|0|||
125478997|NCT03158129|451388015|FG003|Overall Study|No longer surgical candidate|1|||
125478998|NCT03867500|451388020|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
125478999|NCT00554788|451388021|FG000|Overall Study|Adverse Event|0|||
125479000|NCT00554788|451388022|FG001|Overall Study|Adverse Event|1|||
125479001|NCT00554788|451388023|FG002|Overall Study|Adverse Event|2|||
125479002|NCT00554788|451388021|FG000|Overall Study|Lost to Follow-up|4|||
125479003|NCT00554788|451388022|FG001|Overall Study|Lost to Follow-up|3|||
125479004|NCT00554788|451388023|FG002|Overall Study|Lost to Follow-up|3|||
125479005|NCT00554788|451388021|FG000|Overall Study|Physician Decision|1|||
125479006|NCT00554788|451388022|FG001|Overall Study|Physician Decision|1|||
125479007|NCT00554788|451388023|FG002|Overall Study|Physician Decision|3|||
125479008|NCT00554788|451388021|FG000|Overall Study|Withdrawal by Subject|0|||
125479009|NCT00554788|451388022|FG001|Overall Study|Withdrawal by Subject|0|||
125479010|NCT00554788|451388023|FG002|Overall Study|Withdrawal by Subject|1|||
125479011|NCT00554788|451388021|FG000|Overall Study|Refusal of further protocol therapy|0|||
125479012|NCT00554788|451388022|FG001|Overall Study|Refusal of further protocol therapy|1|||
125479013|NCT00554788|451388023|FG002|Overall Study|Refusal of further protocol therapy|1|||
125479014|NCT00554788|451388021|FG000|Overall Study|Progressive disease|0|||
125479015|NCT00554788|451388022|FG001|Overall Study|Progressive disease|0|||
125479016|NCT00554788|451388023|FG002|Overall Study|Progressive disease|3|||
125479017|NCT00554788|451388021|FG000|Overall Study|Ineligible|2|||
125479018|NCT00554788|451388022|FG001|Overall Study|Ineligible|0|||
125479019|NCT00554788|451388023|FG002|Overall Study|Ineligible|1|||
125479020|NCT03897465|451388024|FG000|Overall Study|Lost to Follow-up|2|||
125479021|NCT03897465|451388025|FG001|Overall Study|Lost to Follow-up|1|||
125479022|NCT03897465|451388024|FG000|Overall Study|Adverse Event|2|||
125479023|NCT03897465|451388025|FG001|Overall Study|Adverse Event|0|||
125479024|NCT03897465|451388024|FG000|Overall Study|complete healing by V2|1|||
125479025|NCT03897465|451388025|FG001|Overall Study|complete healing by V2|0|||
125479026|NCT03897465|451388024|FG000|Overall Study|occurence of exclusion criterion|1|||
125479027|NCT03897465|451388025|FG001|Overall Study|occurence of exclusion criterion|1|||
125479028|NCT03897465|451388024|FG000|Overall Study|Other|1|||
125479029|NCT03897465|451388025|FG001|Overall Study|Other|0|||
125479030|NCT05119023|451388027|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
125479031|NCT05119023|451388027|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
125479032|NCT05119023|451388027|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
125479033|NCT02485938|451388045|FG000|Overall Study|Withdrawal of consent|2|||
125479034|NCT02485938|451388046|FG001|Overall Study|Withdrawal of consent|0|||
125479035|NCT04963270|451388047|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
125479036|NCT04963270|451388048|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
125479037|NCT04963270|451388049|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
125479038|NCT04963270|451388050|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
125479039|NCT04963270|451388047|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
125479040|NCT04963270|451388048|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
125479041|NCT04963270|451388049|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
125479042|NCT04963270|451388050|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
125479043|NCT04963270|451388047|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
125479044|NCT04963270|451388048|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
125479045|NCT04963270|451388049|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
125479046|NCT04963270|451388050|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
125479047|NCT04963270|451388047|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
125479048|NCT04963270|451388048|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
125479049|NCT04963270|451388049|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
125479050|NCT04963270|451388050|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
125479051|NCT04963270|451388047|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
125479052|NCT04963270|451388048|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
125479053|NCT04963270|451388049|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
125479054|NCT04963270|451388050|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
125479055|NCT04963270|451388047|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
125479056|NCT04963270|451388048|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
125479057|NCT04963270|451388049|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
125479058|NCT04963270|451388050|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
125479059|NCT04963270|451388047|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
125479060|NCT04963270|451388048|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
125479061|NCT04963270|451388049|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
125479062|NCT04963270|451388050|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
125479063|NCT04963270|451388047|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
125479064|NCT04963270|451388048|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
125479065|NCT04963270|451388049|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
125479066|NCT04963270|451388050|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
125479067|NCT04963270|451388047|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
125479068|NCT04963270|451388048|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
125479069|NCT04963270|451388049|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
125479070|NCT04963270|451388050|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
125479071|NCT04963270|451388047|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
125479072|NCT04963270|451388048|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
125479073|NCT04963270|451388049|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
125479074|NCT04963270|451388050|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
125479075|NCT04963270|451388047|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
125479076|NCT04963270|451388048|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
125479077|NCT04963270|451388049|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
125479078|NCT04963270|451388050|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
125479079|NCT04963270|451388047|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
125479080|NCT04963270|451388048|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
125479081|NCT04963270|451388049|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
125479082|NCT04963270|451388050|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
125479083|NCT04963270|451388047|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
125479084|NCT04963270|451388048|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
125479085|NCT04963270|451388049|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
125479086|NCT04963270|451388050|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
125479087|NCT04963270|451388047|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
125479088|NCT04963270|451388048|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
125479089|NCT04963270|451388049|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
125479090|NCT04963270|451388050|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
125479091|NCT04927364|451388055|FG000|Overall Study|Withdrawal by Subject|3|||
125479092|NCT04927364|451388055|FG000|Overall Study|Unable to complete preassessment MRI|1|||
125479093|NCT04091750|451388058|FG000|Overall Study|Adverse Event|4|||
125479094|NCT04091750|451388058|FG000|Overall Study|Withdrawal by Subject|1|||
125479095|NCT02919306|451388059|FG000|Overall Study|Withdrawal by Subject|1|||
125479096|NCT02919306|451388060|FG001|Overall Study|Withdrawal by Subject|0|||
125479097|NCT02919306|451388059|FG000|Overall Study|Protocol Violation|1|||
125479098|NCT02919306|451388060|FG001|Overall Study|Protocol Violation|0|||
125479099|NCT04473222|451388061|FG000|Overall Study|Lost to Follow-up|13|||
125479100|NCT04473222|451388062|FG001|Overall Study|Lost to Follow-up|13|||
125479101|NCT04473222|451388061|FG000|Overall Study|Withdrawal by Subject|0|||
125479102|NCT04473222|451388062|FG001|Overall Study|Withdrawal by Subject|1|||
125479103|NCT04473222|451388061|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
125479104|NCT04473222|451388062|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
125479105|NCT04293055|451388063|FG000|Overall Study|Lost to Follow-up|1|||
125479106|NCT04293055|451388064|FG001|Overall Study|Lost to Follow-up|1|||
125479107|NCT04293055|451388063|FG000|Overall Study|Did not trigger randomization|6|||
125479108|NCT04293055|451388064|FG001|Overall Study|Did not trigger randomization|5|||
125479109|NCT03560609|451388065|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
125479110|NCT03560609|451388066|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
125479111|NCT04195698|451388075|FG000|Overall Study|Adverse Event|4|||
125479112|NCT04195698|451388076|FG001|Overall Study|Adverse Event|11|||
125479113|NCT04195698|451388075|FG000|Overall Study|Withdrawal by Subject|9|||
125479114|NCT04195698|451388076|FG001|Overall Study|Withdrawal by Subject|10|||
125479115|NCT04195698|451388075|FG000|Overall Study|Lost to Follow-up|5|||
125479116|NCT04195698|451388076|FG001|Overall Study|Lost to Follow-up|4|||
125479117|NCT04195698|451388075|FG000|Overall Study|Lack of Efficacy|2|||
125479118|NCT04195698|451388076|FG001|Overall Study|Lack of Efficacy|10|||
125479119|NCT04195698|451388075|FG000|Overall Study|Other|5|||
125479120|NCT04195698|451388076|FG001|Overall Study|Other|4|||
125479121|NCT05459688|451388077|FG000|Overall Study|Lost to Follow-up|6|||
125479122|NCT05459688|451388077|FG000|Overall Study|Physician Decision|1|||
125479123|NCT05459688|451388077|FG000|Overall Study|Withdrawal by Subject|19|||
125479124|NCT05459688|451388077|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
125479125|NCT06424236|451388080|FG000|Overall Study|Adverse Event|0|||
125479126|NCT06424236|451388081|FG001|Overall Study|Adverse Event|1|||
125479127|NCT06424236|451388082|FG002|Overall Study|Adverse Event|0|||
125479128|NCT06424236|451388080|FG000|Overall Study|Withdrawal by Subject|3|||
125479129|NCT06424236|451388081|FG001|Overall Study|Withdrawal by Subject|1|||
125479130|NCT06424236|451388082|FG002|Overall Study|Withdrawal by Subject|2|||
125479131|NCT06424236|451388080|FG000|Overall Study|Physician Decision|0|||
125479132|NCT06424236|451388081|FG001|Overall Study|Physician Decision|1|||
125479133|NCT06424236|451388082|FG002|Overall Study|Physician Decision|0|||
125479134|NCT06424236|451388080|FG000|Overall Study|Study Terminated by Sponsor|11|||
125479135|NCT06424236|451388081|FG001|Overall Study|Study Terminated by Sponsor|20|||
125479136|NCT06424236|451388082|FG002|Overall Study|Study Terminated by Sponsor|16|||
125479137|NCT06424236|451388080|FG000|Overall Study|Lost to Follow-up|0|||
125479138|NCT06424236|451388081|FG001|Overall Study|Lost to Follow-up|1|||
125479139|NCT06424236|451388082|FG002|Overall Study|Lost to Follow-up|0|||
125479140|NCT06424236|451388080|FG000|Overall Study|Disease Progression|0|||
125479141|NCT06424236|451388081|FG001|Overall Study|Disease Progression|1|||
125479142|NCT06424236|451388082|FG002|Overall Study|Disease Progression|2|||
125479143|NCT06424236|451388080|FG000|Overall Study|Other|0|||
125479144|NCT06424236|451388081|FG001|Overall Study|Other|0|||
125479145|NCT06424236|451388082|FG002|Overall Study|Other|1|||
125479146|NCT01959425|451388083|FG000|Overall Study|Withdrawal by Subject|5|||
125479147|NCT01959425|451388084|FG001|Overall Study|Withdrawal by Subject|4|||
125479148|NCT01959425|451388083|FG000|Overall Study|Lost to Follow-up|1|||
125479149|NCT01959425|451388084|FG001|Overall Study|Lost to Follow-up|0|||
125479150|NCT01959425|451388083|FG000|Overall Study|Discontinued Subjects|6|||
125479151|NCT01959425|451388084|FG001|Overall Study|Discontinued Subjects|4|||
125479152|NCT04625283|451388085|FG000|Overall Study|post randomization exclusion|28|||
125479153|NCT04625283|451388086|FG001|Overall Study|post randomization exclusion|20|||
125479154|NCT02817776|451388087|FG000|Overall Study|Excluded|33|||
125479155|NCT02817776|451388087|FG000|Overall Study|Lost to Follow-up|20|||
125479156|NCT02817776|451388087|FG000|Overall Study|Withdrawal by Subject|33|||
125479157|NCT02817776|451388087|FG000|Overall Study|Death|2|||
125479158|NCT04632992|451388091|FG000|Overall Study|Adverse Event|0|||
125479159|NCT04632992|451388092|FG001|Overall Study|Adverse Event|0|||
125479160|NCT04632992|451388093|FG002|Overall Study|Adverse Event|0|||
125479161|NCT04632992|451388094|FG003|Overall Study|Adverse Event|0|||
125479162|NCT04632992|451388095|FG004|Overall Study|Adverse Event|0|||
125479163|NCT04632992|451388096|FG005|Overall Study|Adverse Event|0|||
125479164|NCT04632992|451388097|FG006|Overall Study|Adverse Event|0|||
125479165|NCT04632992|451388098|FG007|Overall Study|Adverse Event|0|||
125479166|NCT04632992|451388099|FG008|Overall Study|Adverse Event|0|||
125479167|NCT04632992|451388100|FG009|Overall Study|Adverse Event|0|||
125479168|NCT04632992|451388101|FG010|Overall Study|Adverse Event|0|||
125479169|NCT04632992|451388102|FG011|Overall Study|Adverse Event|0|||
125479170|NCT04632992|451388103|FG012|Overall Study|Adverse Event|1|||
125302047|NCT00098306|450731906|FG003|Observational Phase|Un-specified|0|||
125302048|NCT00098306|450731907|FG004|Observational Phase|Un-specified|0|||
125302049|NCT00098306|450731908|FG005|Observational Phase|Un-specified|7|||
125302050|NCT00098306|450731909|FG006|Observational Phase|Un-specified|4|||
125302051|NCT00932165|450731910|FG000|Overall Study|Lost to Follow-up|1|||
125302052|NCT00588094|450731911|FG000|Overall Study|Adverse Event|3|||
125302053|NCT00588094|450731911|FG000|Overall Study|Progression of Disease|2|||
125302054|NCT01336023|450731912|FG000|Week 0 to Week 26|Adverse Event|8|||
125302055|NCT01336023|450731913|FG001|Week 0 to Week 26|Adverse Event|10|||
125302056|NCT01336023|450731914|FG002|Week 0 to Week 26|Adverse Event|24|||
125479171|NCT04632992|451388104|FG013|Overall Study|Adverse Event|0|||
125479172|NCT04632992|451388091|FG000|Overall Study|Death|17|||
125479173|NCT04632992|451388092|FG001|Overall Study|Death|1|||
125479174|NCT04632992|451388093|FG002|Overall Study|Death|14|||
125302057|NCT01336023|450731912|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
125302058|NCT01336023|450731913|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
125302059|NCT01336023|450731914|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
125302060|NCT01336023|450731912|FG000|Week 0 to Week 26|Protocol Violation|1|||
125479175|NCT04632992|451388094|FG003|Overall Study|Death|14|||
125479176|NCT04632992|451388095|FG004|Overall Study|Death|13|||
125479177|NCT04632992|451388096|FG005|Overall Study|Death|6|||
125479178|NCT04632992|451388097|FG006|Overall Study|Death|7|||
125479179|NCT04632992|451388098|FG007|Overall Study|Death|12|||
125479180|NCT04632992|451388099|FG008|Overall Study|Death|15|||
125479181|NCT04632992|451388100|FG009|Overall Study|Death|20|||
125479182|NCT04632992|451388101|FG010|Overall Study|Death|8|||
125479183|NCT04632992|451388102|FG011|Overall Study|Death|2|||
125479184|NCT04632992|451388103|FG012|Overall Study|Death|10|||
125479185|NCT04632992|451388104|FG013|Overall Study|Death|1|||
125479186|NCT04632992|451388091|FG000|Overall Study|Lost to Follow-up|1|||
125479187|NCT04632992|451388092|FG001|Overall Study|Lost to Follow-up|0|||
125479188|NCT04632992|451388093|FG002|Overall Study|Lost to Follow-up|1|||
125479189|NCT04632992|451388094|FG003|Overall Study|Lost to Follow-up|0|||
125479190|NCT04632992|451388095|FG004|Overall Study|Lost to Follow-up|2|||
125479191|NCT04632992|451388096|FG005|Overall Study|Lost to Follow-up|0|||
125479192|NCT04632992|451388097|FG006|Overall Study|Lost to Follow-up|1|||
125479193|NCT04632992|451388098|FG007|Overall Study|Lost to Follow-up|1|||
125479194|NCT04632992|451388099|FG008|Overall Study|Lost to Follow-up|1|||
125479195|NCT04632992|451388100|FG009|Overall Study|Lost to Follow-up|1|||
125479196|NCT04632992|451388101|FG010|Overall Study|Lost to Follow-up|2|||
125479197|NCT04632992|451388102|FG011|Overall Study|Lost to Follow-up|0|||
125479198|NCT04632992|451388103|FG012|Overall Study|Lost to Follow-up|0|||
125479199|NCT04632992|451388104|FG013|Overall Study|Lost to Follow-up|0|||
125479200|NCT04632992|451388091|FG000|Overall Study|Reason not Specified|2|||
125479201|NCT04632992|451388092|FG001|Overall Study|Reason not Specified|0|||
125479202|NCT04632992|451388093|FG002|Overall Study|Reason not Specified|1|||
125479203|NCT04632992|451388094|FG003|Overall Study|Reason not Specified|1|||
125479204|NCT04632992|451388095|FG004|Overall Study|Reason not Specified|0|||
125479205|NCT04632992|451388096|FG005|Overall Study|Reason not Specified|0|||
125479206|NCT04632992|451388097|FG006|Overall Study|Reason not Specified|0|||
125479207|NCT04632992|451388098|FG007|Overall Study|Reason not Specified|0|||
125479208|NCT04632992|451388099|FG008|Overall Study|Reason not Specified|0|||
125479209|NCT04632992|451388100|FG009|Overall Study|Reason not Specified|0|||
125479210|NCT04632992|451388101|FG010|Overall Study|Reason not Specified|1|||
125479211|NCT04632992|451388102|FG011|Overall Study|Reason not Specified|0|||
125479212|NCT04632992|451388103|FG012|Overall Study|Reason not Specified|0|||
125479213|NCT04632992|451388104|FG013|Overall Study|Reason not Specified|0|||
125479214|NCT04632992|451388091|FG000|Overall Study|Physician Decision|0|||
125479215|NCT04632992|451388092|FG001|Overall Study|Physician Decision|0|||
125479216|NCT04632992|451388093|FG002|Overall Study|Physician Decision|0|||
125479217|NCT04632992|451388094|FG003|Overall Study|Physician Decision|2|||
125479218|NCT04632992|451388095|FG004|Overall Study|Physician Decision|1|||
125479219|NCT04632992|451388096|FG005|Overall Study|Physician Decision|0|||
125479220|NCT04632992|451388097|FG006|Overall Study|Physician Decision|0|||
125479221|NCT04632992|451388098|FG007|Overall Study|Physician Decision|0|||
125479222|NCT04632992|451388099|FG008|Overall Study|Physician Decision|0|||
125479223|NCT04632992|451388100|FG009|Overall Study|Physician Decision|0|||
125479224|NCT04632992|451388101|FG010|Overall Study|Physician Decision|0|||
125479225|NCT04632992|451388102|FG011|Overall Study|Physician Decision|0|||
125479226|NCT04632992|451388103|FG012|Overall Study|Physician Decision|3|||
125479227|NCT04632992|451388104|FG013|Overall Study|Physician Decision|0|||
125479228|NCT04632992|451388091|FG000|Overall Study|Progressive Disease|0|||
125479229|NCT04632992|451388092|FG001|Overall Study|Progressive Disease|0|||
125479230|NCT04632992|451388093|FG002|Overall Study|Progressive Disease|0|||
125479231|NCT04632992|451388094|FG003|Overall Study|Progressive Disease|0|||
125479232|NCT04632992|451388095|FG004|Overall Study|Progressive Disease|1|||
125479233|NCT04632992|451388096|FG005|Overall Study|Progressive Disease|0|||
125479234|NCT04632992|451388097|FG006|Overall Study|Progressive Disease|0|||
125479235|NCT04632992|451388098|FG007|Overall Study|Progressive Disease|0|||
125479236|NCT04632992|451388099|FG008|Overall Study|Progressive Disease|0|||
125479237|NCT04632992|451388100|FG009|Overall Study|Progressive Disease|1|||
125479238|NCT04632992|451388101|FG010|Overall Study|Progressive Disease|1|||
125479239|NCT04632992|451388102|FG011|Overall Study|Progressive Disease|0|||
125479240|NCT04632992|451388103|FG012|Overall Study|Progressive Disease|2|||
125479241|NCT04632992|451388104|FG013|Overall Study|Progressive Disease|0|||
125479242|NCT04632992|451388091|FG000|Overall Study|Withdrawal by Subject|4|||
125479243|NCT04632992|451388092|FG001|Overall Study|Withdrawal by Subject|1|||
125302061|NCT01336023|450731913|FG001|Week 0 to Week 26|Protocol Violation|2|||
125302062|NCT01336023|450731914|FG002|Week 0 to Week 26|Protocol Violation|0|||
125479244|NCT04632992|451388093|FG002|Overall Study|Withdrawal by Subject|5|||
125302063|NCT01336023|450731912|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
125302064|NCT01336023|450731913|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
125479245|NCT04632992|451388094|FG003|Overall Study|Withdrawal by Subject|4|||
125479246|NCT04632992|451388095|FG004|Overall Study|Withdrawal by Subject|3|||
125479247|NCT04632992|451388096|FG005|Overall Study|Withdrawal by Subject|3|||
125479248|NCT04632992|451388097|FG006|Overall Study|Withdrawal by Subject|0|||
125479249|NCT04632992|451388098|FG007|Overall Study|Withdrawal by Subject|5|||
125302065|NCT01336023|450731914|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
125479250|NCT04632992|451388099|FG008|Overall Study|Withdrawal by Subject|0|||
125479251|NCT04632992|451388100|FG009|Overall Study|Withdrawal by Subject|2|||
125479252|NCT04632992|451388101|FG010|Overall Study|Withdrawal by Subject|8|||
125479253|NCT04632992|451388102|FG011|Overall Study|Withdrawal by Subject|0|||
125479254|NCT04632992|451388103|FG012|Overall Study|Withdrawal by Subject|1|||
125479255|NCT04632992|451388104|FG013|Overall Study|Withdrawal by Subject|1|||
125479256|NCT04187833|451388105|FG000|Overall Study|Withdrawal by Subject|1|||
125479257|NCT03097549|451388106|FG000|Overall Study|Withdrawal by Subject|1|||
125479258|NCT03097549|451388107|FG001|Overall Study|Withdrawal by Subject|0|||
125479259|NCT03097549|451388106|FG000|Overall Study|Lost to Follow-up|1|||
125479260|NCT03097549|451388107|FG001|Overall Study|Lost to Follow-up|0|||
125479261|NCT02547233|451388108|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
125479262|NCT02547233|451388109|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
125479263|NCT02547233|451388108|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
125479264|NCT02547233|451388109|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
125479265|NCT02547233|451388108|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
125479266|NCT02547233|451388109|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
125479267|NCT02547233|451388108|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
125479268|NCT02547233|451388109|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
125479269|NCT02547233|451388108|FG000|12-month Follow-up|Withdrawal by Subject|10|||
125479270|NCT02547233|451388109|FG001|12-month Follow-up|Withdrawal by Subject|10|||
125479271|NCT02547233|451388108|FG000|12-month Follow-up|Lost to Follow-up|3|||
125479272|NCT02547233|451388109|FG001|12-month Follow-up|Lost to Follow-up|3|||
125479273|NCT02547233|451388108|FG000|12-month Follow-up|Lack of Efficacy|1|||
125479274|NCT02547233|451388109|FG001|12-month Follow-up|Lack of Efficacy|2|||
125479275|NCT02547233|451388108|FG000|12-month Follow-up|Protocol Violation|0|||
125479276|NCT02547233|451388109|FG001|12-month Follow-up|Protocol Violation|1|||
125479277|NCT02547233|451388108|FG000|12-month Follow-up|Other|0|||
125479278|NCT02547233|451388109|FG001|12-month Follow-up|Other|1|||
125479279|NCT02146378|451388110|FG000|Overall Study|No information of administration|2|||
125479280|NCT03603600|451388111|FG000|Overall Study|Withdrawal by Subject|5|||
125479281|NCT03603600|451388112|FG001|Overall Study|Withdrawal by Subject|7|||
125479282|NCT03603600|451388111|FG000|Overall Study|Lost to Follow-up|2|||
125479283|NCT03603600|451388112|FG001|Overall Study|Lost to Follow-up|3|||
125479284|NCT03603600|451388111|FG000|Overall Study|Death|3|||
125479285|NCT03603600|451388112|FG001|Overall Study|Death|1|||
125479286|NCT03603600|451388111|FG000|Overall Study|Physician Decision|2|||
125479287|NCT03603600|451388112|FG001|Overall Study|Physician Decision|1|||
125479288|NCT03603600|451388111|FG000|Overall Study|Other reason|1|||
125479289|NCT03603600|451388112|FG001|Overall Study|Other reason|0|||
125479290|NCT05170009|451388113|FG000|Overall Study|Physician Decision|0|||
125479291|NCT05170009|451388114|FG001|Overall Study|Physician Decision|1|||
125479292|NCT03524612|451388115|FG000|Overall Study|Lack of Efficacy|10|||
125479293|NCT03524612|451388115|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
125479294|NCT03524612|451388115|FG000|Overall Study|Adverse Event|10|||
125479295|NCT03524612|451388115|FG000|Overall Study|Withdrawal by Subject|7|||
125479296|NCT03524612|451388115|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
125479297|NCT03524612|451388115|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
125479298|NCT03524612|451388115|FG000|Overall Study|New therapy for study indication|6|||
125479299|NCT03524612|451388115|FG000|Overall Study|Death|3|||
125479300|NCT03524612|451388115|FG000|Overall Study|Lost to Follow-up|2|||
125479301|NCT03524612|451388115|FG000|Overall Study|Protocol Violation|1|||
125479302|NCT05457647|451388116|FG000|Overall Study|Lost to Follow-up|3|||
125479303|NCT04137289|451388117|FG000|Overall Study|Death|0|||
125479304|NCT04137289|451388118|FG001|Overall Study|Death|0|||
125479305|NCT04137289|451388119|FG002|Overall Study|Death|0|||
125479306|NCT04137289|451388120|FG003|Overall Study|Death|0|||
125479307|NCT04137289|451388121|FG004|Overall Study|Death|0|||
125479308|NCT04137289|451388122|FG005|Overall Study|Death|0|||
125479309|NCT04137289|451388123|FG006|Overall Study|Death|1|||
125479310|NCT04137289|451388124|FG007|Overall Study|Death|0|||
125479311|NCT04137289|451388125|FG008|Overall Study|Death|0|||
125479312|NCT04137289|451388117|FG000|Overall Study|Clinical disease progression|0|||
125479313|NCT04137289|451388118|FG001|Overall Study|Clinical disease progression|0|||
125479314|NCT04137289|451388119|FG002|Overall Study|Clinical disease progression|0|||
125479315|NCT04137289|451388120|FG003|Overall Study|Clinical disease progression|4|||
125479316|NCT04137289|451388121|FG004|Overall Study|Clinical disease progression|4|||
125479317|NCT04137289|451388122|FG005|Overall Study|Clinical disease progression|2|||
125479318|NCT04137289|451388123|FG006|Overall Study|Clinical disease progression|5|||
125479319|NCT04137289|451388124|FG007|Overall Study|Clinical disease progression|1|||
125479320|NCT04137289|451388125|FG008|Overall Study|Clinical disease progression|0|||
125479321|NCT04137289|451388117|FG000|Overall Study|Lost to Follow-up|0|||
125479322|NCT04137289|451388118|FG001|Overall Study|Lost to Follow-up|0|||
125479323|NCT04137289|451388119|FG002|Overall Study|Lost to Follow-up|0|||
125479324|NCT04137289|451388120|FG003|Overall Study|Lost to Follow-up|1|||
125479325|NCT04137289|451388121|FG004|Overall Study|Lost to Follow-up|0|||
125479326|NCT04137289|451388122|FG005|Overall Study|Lost to Follow-up|0|||
125479327|NCT04137289|451388123|FG006|Overall Study|Lost to Follow-up|0|||
125479328|NCT04137289|451388124|FG007|Overall Study|Lost to Follow-up|0|||
125479329|NCT04137289|451388125|FG008|Overall Study|Lost to Follow-up|0|||
125479330|NCT04137289|451388117|FG000|Overall Study|Adverse Event|0|||
125479331|NCT04137289|451388118|FG001|Overall Study|Adverse Event|0|||
125479332|NCT04137289|451388119|FG002|Overall Study|Adverse Event|1|||
125479333|NCT04137289|451388120|FG003|Overall Study|Adverse Event|0|||
125479334|NCT04137289|451388121|FG004|Overall Study|Adverse Event|0|||
125479335|NCT04137289|451388122|FG005|Overall Study|Adverse Event|1|||
125479336|NCT04137289|451388123|FG006|Overall Study|Adverse Event|0|||
125479337|NCT04137289|451388124|FG007|Overall Study|Adverse Event|0|||
125479338|NCT04137289|451388125|FG008|Overall Study|Adverse Event|0|||
125479339|NCT04137289|451388117|FG000|Overall Study|Lack of clinical benefit|0|||
125479340|NCT04137289|451388118|FG001|Overall Study|Lack of clinical benefit|0|||
125479341|NCT04137289|451388119|FG002|Overall Study|Lack of clinical benefit|0|||
125479342|NCT04137289|451388120|FG003|Overall Study|Lack of clinical benefit|0|||
125479343|NCT04137289|451388121|FG004|Overall Study|Lack of clinical benefit|0|||
125479344|NCT04137289|451388122|FG005|Overall Study|Lack of clinical benefit|0|||
125479345|NCT04137289|451388123|FG006|Overall Study|Lack of clinical benefit|0|||
125479346|NCT04137289|451388124|FG007|Overall Study|Lack of clinical benefit|0|||
125479347|NCT04137289|451388125|FG008|Overall Study|Lack of clinical benefit|1|||
125479348|NCT04137289|451388117|FG000|Overall Study|Objective disease progression|1|||
125479349|NCT04137289|451388118|FG001|Overall Study|Objective disease progression|1|||
125479350|NCT04137289|451388119|FG002|Overall Study|Objective disease progression|6|||
125479351|NCT04137289|451388120|FG003|Overall Study|Objective disease progression|18|||
125479352|NCT04137289|451388121|FG004|Overall Study|Objective disease progression|12|||
125479353|NCT04137289|451388122|FG005|Overall Study|Objective disease progression|20|||
125479354|NCT04137289|451388123|FG006|Overall Study|Objective disease progression|18|||
125479355|NCT04137289|451388124|FG007|Overall Study|Objective disease progression|7|||
125479356|NCT04137289|451388125|FG008|Overall Study|Objective disease progression|6|||
125479357|NCT04492722|451388126|FG000|Overall Study|Adverse Event|7|||
125479358|NCT04492722|451388127|FG001|Overall Study|Adverse Event|2|||
125479359|NCT04492722|451388128|FG002|Overall Study|Adverse Event|3|||
125479360|NCT04492722|451388129|FG003|Overall Study|Adverse Event|0|||
125479361|NCT04492722|451388126|FG000|Overall Study|Death|0|||
125479362|NCT04492722|451388127|FG001|Overall Study|Death|0|||
125479363|NCT04492722|451388128|FG002|Overall Study|Death|0|||
125479364|NCT04492722|451388129|FG003|Overall Study|Death|1|||
125479365|NCT04492722|451388126|FG000|Overall Study|Lost to Follow-up|0|||
125479366|NCT04492722|451388127|FG001|Overall Study|Lost to Follow-up|1|||
125479367|NCT04492722|451388128|FG002|Overall Study|Lost to Follow-up|0|||
125479368|NCT04492722|451388129|FG003|Overall Study|Lost to Follow-up|1|||
125479369|NCT04492722|451388126|FG000|Overall Study|Physician Decision|0|||
125479370|NCT04492722|451388127|FG001|Overall Study|Physician Decision|3|||
125479371|NCT04492722|451388128|FG002|Overall Study|Physician Decision|1|||
125479372|NCT04492722|451388129|FG003|Overall Study|Physician Decision|1|||
125479373|NCT04492722|451388126|FG000|Overall Study|Withdrawal by Subject|6|||
125479374|NCT04492722|451388127|FG001|Overall Study|Withdrawal by Subject|6|||
125479375|NCT04492722|451388128|FG002|Overall Study|Withdrawal by Subject|0|||
125479376|NCT04492722|451388129|FG003|Overall Study|Withdrawal by Subject|3|||
125479377|NCT04492722|451388126|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
125479378|NCT04492722|451388127|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
125479379|NCT04492722|451388128|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
125479380|NCT04492722|451388129|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
125479381|NCT04492722|451388126|FG000|Overall Study|Due to Covid-19 pandemic|7|||
125479382|NCT04492722|451388127|FG001|Overall Study|Due to Covid-19 pandemic|3|||
125479383|NCT04492722|451388128|FG002|Overall Study|Due to Covid-19 pandemic|7|||
125479384|NCT04492722|451388129|FG003|Overall Study|Due to Covid-19 pandemic|6|||
125479385|NCT04492722|451388126|FG000|Overall Study|Failure to meet randomisation criteria|2|||
125302066|NCT01336023|450731912|FG000|Week 0 to Week 26|Unclassified|5|||
125302067|NCT01336023|450731913|FG001|Week 0 to Week 26|Unclassified|16|||
125302068|NCT01336023|450731914|FG002|Week 0 to Week 26|Unclassified|9|||
125302069|NCT01336023|450731912|FG000|Week 27 to 52|Adverse Event|1|||
125302070|NCT01336023|450731913|FG001|Week 27 to 52|Adverse Event|5|||
125302071|NCT01336023|450731914|FG002|Week 27 to 52|Adverse Event|2|||
125302072|NCT01336023|450731912|FG000|Week 27 to 52|Protocol Violation|0|||
125302073|NCT01336023|450731913|FG001|Week 27 to 52|Protocol Violation|2|||
125302074|NCT01336023|450731914|FG002|Week 27 to 52|Protocol Violation|1|||
125479386|NCT04492722|451388127|FG001|Overall Study|Failure to meet randomisation criteria|3|||
125479387|NCT04492722|451388128|FG002|Overall Study|Failure to meet randomisation criteria|4|||
125479388|NCT04492722|451388129|FG003|Overall Study|Failure to meet randomisation criteria|2|||
125479389|NCT04492722|451388126|FG000|Overall Study|Early termination from the study|54|||
125479390|NCT04492722|451388127|FG001|Overall Study|Early termination from the study|51|||
125479391|NCT04492722|451388128|FG002|Overall Study|Early termination from the study|50|||
125479392|NCT04492722|451388129|FG003|Overall Study|Early termination from the study|50|||
125302075|NCT01336023|450731912|FG000|Week 27 to 52|Withdrawal Criteria|14|||
125479393|NCT04492722|451388126|FG000|Overall Study|Missing|3|||
125479394|NCT04492722|451388127|FG001|Overall Study|Missing|0|||
125479395|NCT04492722|451388128|FG002|Overall Study|Missing|0|||
125302076|NCT01336023|450731913|FG001|Week 27 to 52|Withdrawal Criteria|19|||
125302077|NCT01336023|450731914|FG002|Week 27 to 52|Withdrawal Criteria|16|||
125302078|NCT01336023|450731912|FG000|Week 27 to 52|Unclassified|13|||
125302079|NCT01336023|450731913|FG001|Week 27 to 52|Unclassified|18|||
125479396|NCT04492722|451388129|FG003|Overall Study|Missing|5|||
125479397|NCT04492722|451388126|FG000|Overall Study|Participants who did not receive treatment|0|||
125479398|NCT04492722|451388127|FG001|Overall Study|Participants who did not receive treatment|1|||
125479399|NCT04492722|451388128|FG002|Overall Study|Participants who did not receive treatment|4|||
125479400|NCT04492722|451388129|FG003|Overall Study|Participants who did not receive treatment|0|||
125479401|NCT05329220|451388130|FG000|Active Trial Period|Adverse Event|0|||
125479402|NCT05329220|451388131|FG001|Active Trial Period|Adverse Event|0|||
125479403|NCT05329220|451388132|FG002|Active Trial Period|Adverse Event|0|||
125479404|NCT05329220|451388133|FG003|Active Trial Period|Adverse Event|0|||
125479405|NCT05329220|451388134|FG004|Active Trial Period|Adverse Event|1|||
125479406|NCT05329220|451388135|FG005|Active Trial Period|Adverse Event|0|||
125479407|NCT05329220|451388130|FG000|Active Trial Period|Lost to Follow-up|0|||
125479408|NCT05329220|451388131|FG001|Active Trial Period|Lost to Follow-up|0|||
125479409|NCT05329220|451388132|FG002|Active Trial Period|Lost to Follow-up|0|||
125479410|NCT05329220|451388133|FG003|Active Trial Period|Lost to Follow-up|0|||
125479411|NCT05329220|451388134|FG004|Active Trial Period|Lost to Follow-up|32|||
125479412|NCT05329220|451388135|FG005|Active Trial Period|Lost to Follow-up|28|||
125479413|NCT05329220|451388130|FG000|Active Trial Period|Physician Decision|0|||
125479414|NCT05329220|451388131|FG001|Active Trial Period|Physician Decision|0|||
125479415|NCT05329220|451388132|FG002|Active Trial Period|Physician Decision|0|||
125479416|NCT05329220|451388133|FG003|Active Trial Period|Physician Decision|0|||
125479417|NCT05329220|451388134|FG004|Active Trial Period|Physician Decision|2|||
125479418|NCT05329220|451388135|FG005|Active Trial Period|Physician Decision|0|||
125479419|NCT05329220|451388130|FG000|Active Trial Period|Protocol Violation|0|||
125479420|NCT05329220|451388131|FG001|Active Trial Period|Protocol Violation|0|||
125479421|NCT05329220|451388132|FG002|Active Trial Period|Protocol Violation|0|||
125479422|NCT05329220|451388133|FG003|Active Trial Period|Protocol Violation|0|||
125479423|NCT05329220|451388134|FG004|Active Trial Period|Protocol Violation|1|||
125479424|NCT05329220|451388135|FG005|Active Trial Period|Protocol Violation|3|||
125479425|NCT05329220|451388130|FG000|Active Trial Period|Withdrawal by Subject|0|||
125479426|NCT05329220|451388131|FG001|Active Trial Period|Withdrawal by Subject|0|||
125479427|NCT05329220|451388132|FG002|Active Trial Period|Withdrawal by Subject|0|||
125479428|NCT05329220|451388133|FG003|Active Trial Period|Withdrawal by Subject|1|||
125479429|NCT05329220|451388134|FG004|Active Trial Period|Withdrawal by Subject|12|||
125479430|NCT05329220|451388135|FG005|Active Trial Period|Withdrawal by Subject|13|||
125479431|NCT05329220|451388130|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
125479432|NCT05329220|451388131|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
125479433|NCT05329220|451388132|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
125479434|NCT05329220|451388133|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
125479435|NCT05329220|451388134|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
125479436|NCT05329220|451388135|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
125479437|NCT05329220|451388130|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
125479438|NCT05329220|451388131|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
125479439|NCT05329220|451388132|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
125479440|NCT05329220|451388133|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
125479441|NCT05329220|451388134|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
125479442|NCT05329220|451388135|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
125479443|NCT05329220|451388130|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
125479444|NCT05329220|451388131|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
125479445|NCT05329220|451388132|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
125479446|NCT05329220|451388133|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
125479447|NCT05329220|451388134|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
125479448|NCT05329220|451388135|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
125479449|NCT05329220|451388130|FG000|Follow-up Period|Adverse Event|0|||
125479450|NCT05329220|451388131|FG001|Follow-up Period|Adverse Event|0|||
125479451|NCT05329220|451388132|FG002|Follow-up Period|Adverse Event|0|||
125479452|NCT05329220|451388133|FG003|Follow-up Period|Adverse Event|0|||
125479453|NCT05329220|451388134|FG004|Follow-up Period|Adverse Event|2|||
125302080|NCT01336023|450731914|FG002|Week 27 to 52|Unclassified|9|||
125302081|NCT01361178|450731920|FG000|Overall Study|Death|13|||
125302082|NCT01361178|450731921|FG001|Overall Study|Death|0|||
125479454|NCT05329220|451388135|FG005|Follow-up Period|Adverse Event|1|||
125479455|NCT05329220|451388130|FG000|Follow-up Period|Death|0|||
125479456|NCT05329220|451388131|FG001|Follow-up Period|Death|0|||
125479457|NCT05329220|451388132|FG002|Follow-up Period|Death|1|||
125302083|NCT00391625|450731922|FG000|Month 14|Withdrawal by Subject|1|||
125479458|NCT05329220|451388133|FG003|Follow-up Period|Death|1|||
125479459|NCT05329220|451388134|FG004|Follow-up Period|Death|0|||
125479460|NCT05329220|451388135|FG005|Follow-up Period|Death|1|||
125479461|NCT05329220|451388130|FG000|Follow-up Period|Lost to Follow-up|0|||
125479462|NCT05329220|451388131|FG001|Follow-up Period|Lost to Follow-up|1|||
125479463|NCT05329220|451388132|FG002|Follow-up Period|Lost to Follow-up|2|||
125479464|NCT05329220|451388133|FG003|Follow-up Period|Lost to Follow-up|2|||
125479465|NCT05329220|451388134|FG004|Follow-up Period|Lost to Follow-up|113|||
125479466|NCT05329220|451388135|FG005|Follow-up Period|Lost to Follow-up|89|||
125479467|NCT05329220|451388130|FG000|Follow-up Period|Physician Decision|0|||
125479468|NCT05329220|451388131|FG001|Follow-up Period|Physician Decision|0|||
125479469|NCT05329220|451388132|FG002|Follow-up Period|Physician Decision|0|||
125479470|NCT05329220|451388133|FG003|Follow-up Period|Physician Decision|0|||
125479471|NCT05329220|451388134|FG004|Follow-up Period|Physician Decision|2|||
125479472|NCT05329220|451388135|FG005|Follow-up Period|Physician Decision|2|||
125479473|NCT05329220|451388130|FG000|Follow-up Period|Protocol Violation|0|||
125479474|NCT05329220|451388131|FG001|Follow-up Period|Protocol Violation|0|||
125479475|NCT05329220|451388132|FG002|Follow-up Period|Protocol Violation|0|||
125479476|NCT05329220|451388133|FG003|Follow-up Period|Protocol Violation|0|||
125479477|NCT05329220|451388134|FG004|Follow-up Period|Protocol Violation|0|||
125479478|NCT05329220|451388135|FG005|Follow-up Period|Protocol Violation|1|||
125479479|NCT05329220|451388130|FG000|Follow-up Period|Withdrawal by Subject|0|||
125479480|NCT05329220|451388131|FG001|Follow-up Period|Withdrawal by Subject|0|||
125479481|NCT05329220|451388132|FG002|Follow-up Period|Withdrawal by Subject|1|||
125479482|NCT05329220|451388133|FG003|Follow-up Period|Withdrawal by Subject|1|||
125479483|NCT05329220|451388134|FG004|Follow-up Period|Withdrawal by Subject|34|||
125479484|NCT05329220|451388135|FG005|Follow-up Period|Withdrawal by Subject|35|||
125479485|NCT05329220|451388130|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
125479486|NCT05329220|451388131|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
125479487|NCT05329220|451388132|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
125479488|NCT05329220|451388133|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
125479489|NCT05329220|451388134|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
125479490|NCT05329220|451388135|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
125479491|NCT05329220|451388130|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
125479492|NCT05329220|451388131|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
125479493|NCT05329220|451388132|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
125479494|NCT05329220|451388133|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
125479495|NCT05329220|451388134|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
125479496|NCT05329220|451388135|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
125479497|NCT05329220|451388130|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
125479498|NCT05329220|451388131|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
125479499|NCT05329220|451388132|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
125479500|NCT05329220|451388133|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
125479501|NCT05329220|451388134|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
125479502|NCT05329220|451388135|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
125479503|NCT05329220|451388130|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
125479504|NCT05329220|451388131|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
125302084|NCT00391625|450731922|FG000|Month 50|Physician Decision|1|||
125302085|NCT03997825|450731923|FG000|Overall Study|Death|3|||
125302086|NCT03997825|450731923|FG000|Overall Study|Lost to Follow-up|10|||
125302087|NCT03997825|450731923|FG000|Overall Study|Withdrawal by Subject|3|||
125302088|NCT03997825|450731923|FG000|Overall Study|Refused participation|1|||
125302089|NCT00383162|450731924|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
125302090|NCT00383162|450731925|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
125302091|NCT00383162|450731924|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
125302092|NCT00383162|450731925|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
125302093|NCT00383162|450731924|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
125479505|NCT05329220|451388132|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
125479506|NCT05329220|451388133|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
125479507|NCT05329220|451388134|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
125479508|NCT05329220|451388135|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
125479509|NCT05329220|451388130|FG000|Follow-up Period|EARLY TERMINATION|0|||
125479510|NCT05329220|451388131|FG001|Follow-up Period|EARLY TERMINATION|0|||
125479511|NCT05329220|451388132|FG002|Follow-up Period|EARLY TERMINATION|0|||
125479512|NCT05329220|451388133|FG003|Follow-up Period|EARLY TERMINATION|0|||
125479513|NCT05329220|451388134|FG004|Follow-up Period|EARLY TERMINATION|0|||
125479514|NCT05329220|451388135|FG005|Follow-up Period|EARLY TERMINATION|1|||
125479515|NCT05329220|451388130|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
125485425|NCT02240238|451412503|FG000|Phase 2|Disease progression|0|||
125302094|NCT00383162|450731925|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
125479516|NCT05329220|451388131|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
125479517|NCT05329220|451388132|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
125479518|NCT05329220|451388133|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
125479519|NCT05329220|451388134|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
125479520|NCT05329220|451388135|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
125479521|NCT05329220|451388130|FG000|Follow-up Period|DROPPED|0|||
125479522|NCT05329220|451388131|FG001|Follow-up Period|DROPPED|0|||
125479523|NCT05329220|451388132|FG002|Follow-up Period|DROPPED|0|||
125479524|NCT05329220|451388133|FG003|Follow-up Period|DROPPED|0|||
125479525|NCT05329220|451388134|FG004|Follow-up Period|DROPPED|0|||
125479526|NCT05329220|451388135|FG005|Follow-up Period|DROPPED|1|||
125479527|NCT05329220|451388130|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
125479528|NCT05329220|451388131|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
125479529|NCT05329220|451388132|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
125479530|NCT05329220|451388133|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
125479531|NCT05329220|451388134|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
125479532|NCT05329220|451388135|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
125479533|NCT02601313|451388136|FG000|Overall Study|Death|2|||
125479534|NCT02601313|451388137|FG001|Overall Study|Death|41|||
125479535|NCT02601313|451388138|FG002|Overall Study|Death|6|||
125479536|NCT02601313|451388136|FG000|Overall Study|Enrolled but never treated|0|||
125479537|NCT02601313|451388137|FG001|Overall Study|Enrolled but never treated|6|||
125479538|NCT02601313|451388138|FG002|Overall Study|Enrolled but never treated|3|||
125479539|NCT02601313|451388136|FG000|Overall Study|Enrolled, did not initiate AC|4|||
125479540|NCT02601313|451388137|FG001|Overall Study|Enrolled, did not initiate AC|0|||
125479541|NCT02601313|451388138|FG002|Overall Study|Enrolled, did not initiate AC|0|||
125479542|NCT02601313|451388136|FG000|Overall Study|Full consent withdrawal|0|||
125479543|NCT02601313|451388137|FG001|Overall Study|Full consent withdrawal|3|||
125479544|NCT02601313|451388138|FG002|Overall Study|Full consent withdrawal|2|||
125479545|NCT02601313|451388136|FG000|Overall Study|Lost to Follow-up|0|||
125479546|NCT02601313|451388137|FG001|Overall Study|Lost to Follow-up|1|||
125479547|NCT02601313|451388138|FG002|Overall Study|Lost to Follow-up|1|||
125479548|NCT03766009|451389971|FG000|Usual Care|Death|0|||
125479549|NCT03766009|451389972|FG001|Usual Care|Death|0|||
125479550|NCT03766009|451389973|FG002|Usual Care|Death|0|||
125479551|NCT03766009|451389974|FG003|Usual Care|Death|1|||
125479552|NCT03766009|451389975|FG004|Usual Care|Death|0|||
125479553|NCT03766009|451389976|FG005|Usual Care|Death|0|||
125479554|NCT03766009|451389971|FG000|Usual Care|Lost to Follow-up|0|||
125479555|NCT03766009|451389972|FG001|Usual Care|Lost to Follow-up|0|||
125479556|NCT03766009|451389973|FG002|Usual Care|Lost to Follow-up|0|||
125479557|NCT03766009|451389974|FG003|Usual Care|Lost to Follow-up|1|||
125479558|NCT03766009|451389975|FG004|Usual Care|Lost to Follow-up|0|||
125479559|NCT03766009|451389976|FG005|Usual Care|Lost to Follow-up|0|||
125479560|NCT03766009|451389971|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
125479561|NCT03766009|451389972|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
125479562|NCT03766009|451389973|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
125479563|NCT03766009|451389974|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
125479564|NCT03766009|451389975|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
125479565|NCT03766009|451389976|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
125479566|NCT03766009|451389971|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
125479567|NCT03766009|451389972|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
125479568|NCT03766009|451389973|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
125479569|NCT03766009|451389974|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
125479570|NCT03766009|451389975|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
125479571|NCT03766009|451389976|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
125479572|NCT03766009|451389971|FG000|Usual Care|No treatment or declined surgery|0|||
125479573|NCT03766009|451389972|FG001|Usual Care|No treatment or declined surgery|0|||
125479574|NCT03766009|451389973|FG002|Usual Care|No treatment or declined surgery|0|||
125479575|NCT03766009|451389974|FG003|Usual Care|No treatment or declined surgery|2|||
125479576|NCT03766009|451389975|FG004|Usual Care|No treatment or declined surgery|0|||
125479577|NCT03766009|451389976|FG005|Usual Care|No treatment or declined surgery|0|||
125479578|NCT03766009|451389971|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
125479579|NCT03766009|451389972|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
125479580|NCT03766009|451389973|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
125479581|NCT03766009|451389974|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
125479582|NCT03766009|451389975|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
125485426|NCT02240238|451412504|FG001|Phase 2|Disease progression|0|||
125479583|NCT03766009|451389976|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
125479584|NCT03766009|451389971|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
125479585|NCT03766009|451389972|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
125479586|NCT03766009|451389973|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
125479587|NCT03766009|451389974|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
125479588|NCT03766009|451389975|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
125479589|NCT03766009|451389976|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
125479590|NCT03766009|451389971|FG000|Usual Care|Ineligible|0|||
125479591|NCT03766009|451389972|FG001|Usual Care|Ineligible|1|||
125479592|NCT03766009|451389973|FG002|Usual Care|Ineligible|0|||
125479593|NCT03766009|451389974|FG003|Usual Care|Ineligible|0|||
125479594|NCT03766009|451389975|FG004|Usual Care|Ineligible|0|||
125479595|NCT03766009|451389976|FG005|Usual Care|Ineligible|0|||
125479596|NCT03766009|451389971|FG000|Usual Care|Other: Staff turnover|0|||
125479597|NCT03766009|451389972|FG001|Usual Care|Other: Staff turnover|0|||
125479598|NCT03766009|451389973|FG002|Usual Care|Other: Staff turnover|0|||
125479599|NCT03766009|451389974|FG003|Usual Care|Other: Staff turnover|0|||
125479600|NCT03766009|451389975|FG004|Usual Care|Other: Staff turnover|0|||
125479601|NCT03766009|451389976|FG005|Usual Care|Other: Staff turnover|2|||
125479602|NCT04552223|451389977|FG000|Overall Study|Withdrawal by Subject|1|||
125479603|NCT03869866|451389978|FG000|Overall Study|Protocol Violation|1|||
125479604|NCT03869866|451389978|FG000|Overall Study|Withdrawal by Subject|3|||
125479605|NCT00506519|451389980|FG000|Overall Study|Death|4|||
125479606|NCT00506519|451389981|FG001|Overall Study|Death|6|||
125479607|NCT00506519|451389982|FG002|Overall Study|Death|0|||
125479608|NCT00506519|451389980|FG000|Overall Study|Adverse Event|1|||
125479609|NCT00506519|451389981|FG001|Overall Study|Adverse Event|0|||
125479610|NCT00506519|451389982|FG002|Overall Study|Adverse Event|0|||
125479611|NCT01186367|451389983|FG000|Overall Study|Lost to Follow-up|7|||
125479612|NCT01186367|451389984|FG001|Overall Study|Lost to Follow-up|4|||
125479613|NCT01186367|451389985|FG002|Overall Study|Lost to Follow-up|7|||
125479614|NCT01186367|451389983|FG000|Overall Study|Did not receive study treatment|0|||
125479615|NCT01186367|451389984|FG001|Overall Study|Did not receive study treatment|1|||
125479616|NCT01186367|451389985|FG002|Overall Study|Did not receive study treatment|0|||
125479617|NCT02975882|451389986|FG000|Overall Study|Adverse Event|1|||
125479618|NCT02975882|451389987|FG001|Overall Study|Adverse Event|2|||
125479619|NCT02975882|451389988|FG002|Overall Study|Adverse Event|1|||
125479620|NCT02975882|451389989|FG003|Overall Study|Adverse Event|1|||
125479621|NCT02975882|451389986|FG000|Overall Study|Death|0|||
125479622|NCT02975882|451389987|FG001|Overall Study|Death|1|||
125479623|NCT02975882|451389988|FG002|Overall Study|Death|0|||
125479624|NCT02975882|451389989|FG003|Overall Study|Death|0|||
125479625|NCT02975882|451389986|FG000|Overall Study|Lack of Efficacy|3|||
125479626|NCT02975882|451389987|FG001|Overall Study|Lack of Efficacy|7|||
125479627|NCT02975882|451389988|FG002|Overall Study|Lack of Efficacy|4|||
125479628|NCT02975882|451389989|FG003|Overall Study|Lack of Efficacy|3|||
125479629|NCT02975882|451389986|FG000|Overall Study|Physician Decision|0|||
125479630|NCT02975882|451389987|FG001|Overall Study|Physician Decision|2|||
125479631|NCT02975882|451389988|FG002|Overall Study|Physician Decision|4|||
125479632|NCT02975882|451389989|FG003|Overall Study|Physician Decision|2|||
125479633|NCT02975882|451389986|FG000|Overall Study|Ineligible|0|||
125479634|NCT02975882|451389987|FG001|Overall Study|Ineligible|1|||
125479635|NCT02975882|451389988|FG002|Overall Study|Ineligible|0|||
125479636|NCT02975882|451389989|FG003|Overall Study|Ineligible|0|||
125479637|NCT02737436|451389990|FG000|Washout Period|Lost to Follow-up|5|||
125479638|NCT02737436|451389991|FG001|Washout Period|Lost to Follow-up|11|||
125479639|NCT02737436|451389990|FG000|Data Analysis|Scanning data problems|5|||
125479640|NCT02737436|451389991|FG001|Data Analysis|Scanning data problems|8|||
125479641|NCT02105766|451389992|FG000|Overall Study|Physician Decision|1|||
125479642|NCT02105766|451389993|FG001|Overall Study|Physician Decision|1|||
125479643|NCT02105766|451389994|FG002|Overall Study|Physician Decision|0|||
125479644|NCT02105766|451389992|FG000|Overall Study|Lost to Follow-up|2|||
125479645|NCT02105766|451389993|FG001|Overall Study|Lost to Follow-up|0|||
125479646|NCT02105766|451389994|FG002|Overall Study|Lost to Follow-up|0|||
125479647|NCT02105766|451389992|FG000|Overall Study|Death|1|||
125479648|NCT02105766|451389993|FG001|Overall Study|Death|1|||
125479649|NCT02105766|451389994|FG002|Overall Study|Death|0|||
125479650|NCT03701399|451389995|FG000|Overall Study|Adverse Event|3|||
125479651|NCT03701399|451389996|FG001|Overall Study|Adverse Event|5|||
125479652|NCT03701399|451389995|FG000|Overall Study|Withdrawal by Subject|6|||
125479653|NCT03701399|451389996|FG001|Overall Study|Withdrawal by Subject|3|||
125479654|NCT03701399|451389995|FG000|Overall Study|Investigators decision|1|||
125479655|NCT03701399|451389996|FG001|Overall Study|Investigators decision|2|||
125479656|NCT03701399|451389995|FG000|Overall Study|Lost to Follow-up|1|||
125479657|NCT03701399|451389996|FG001|Overall Study|Lost to Follow-up|2|||
125479658|NCT03701399|451389995|FG000|Overall Study|Death|1|||
125479659|NCT03701399|451389996|FG001|Overall Study|Death|1|||
125479660|NCT03701399|451389995|FG000|Overall Study|Randomized but not treated|1|||
125485427|NCT02240238|451412505|FG002|Phase 2|Disease progression|0|||
125479661|NCT03701399|451389996|FG001|Overall Study|Randomized but not treated|0|||
125479662|NCT03134196|451390004|FG000|Overall Study|Death|2|||
125479663|NCT03134196|451390005|FG001|Overall Study|Death|1|||
125479664|NCT03134196|451390004|FG000|Overall Study|Lost to Follow-up|13|||
125479665|NCT03134196|451390005|FG001|Overall Study|Lost to Follow-up|15|||
125479666|NCT03134196|451390004|FG000|Overall Study|Physician Decision|0|||
125479667|NCT03134196|451390005|FG001|Overall Study|Physician Decision|1|||
125479668|NCT03134196|451390004|FG000|Overall Study|Withdrawal by Subject|19|||
125479669|NCT03134196|451390005|FG001|Overall Study|Withdrawal by Subject|12|||
125479670|NCT03134196|451390004|FG000|Overall Study|Site Unable to Contact Participant|2|||
125479671|NCT03134196|451390005|FG001|Overall Study|Site Unable to Contact Participant|0|||
125479672|NCT03134196|451390004|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
125479673|NCT03134196|451390005|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
125479674|NCT03134196|451390004|FG000|Overall Study|Scheduling Conflict|1|||
125479675|NCT03134196|451390005|FG001|Overall Study|Scheduling Conflict|0|||
125479676|NCT06516705|451390010|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
125479677|NCT06516705|451390011|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
125479678|NCT06516705|451390010|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
125479679|NCT06516705|451390011|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
125479680|NCT06516705|451390010|FG000|T3 ( 3 Month After Education)|covid-19|1|||
125479681|NCT06516705|451390011|FG001|T3 ( 3 Month After Education)|covid-19|2|||
125479682|NCT06516705|451390010|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
125479683|NCT06516705|451390011|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
125479684|NCT06516705|451390010|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
125479685|NCT06516705|451390011|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
125479686|NCT06516705|451390010|FG000|T4 ( 6 Month After Education)|covid-19|3|||
125479687|NCT06516705|451390011|FG001|T4 ( 6 Month After Education)|covid-19|2|||
125479688|NCT06516705|451390010|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
125479689|NCT06516705|451390011|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
125479690|NCT04719390|451390012|FG000|Overall Study|Withdrawal by Subject|1|||
125479691|NCT04292223|451390013|FG000|Overall Study|Adverse Event|1|||
125479692|NCT04292223|451390013|FG000|Overall Study|Lost to Follow-up|1|||
125479693|NCT04292223|451390013|FG000|Overall Study|Noncompliance with study drug|2|||
125479694|NCT04292223|451390013|FG000|Overall Study|Patient moved out of the state|1|||
125479695|NCT00753545|451390014|FG000|Overall Study|Death|98|||
125479696|NCT00753545|451390015|FG001|Overall Study|Death|112|||
125479697|NCT00753545|451390014|FG000|Overall Study|Lost to Follow-up|2|||
125479698|NCT00753545|451390015|FG001|Overall Study|Lost to Follow-up|3|||
125479699|NCT00753545|451390014|FG000|Overall Study|Protocol Violation|1|||
125479700|NCT00753545|451390015|FG001|Overall Study|Protocol Violation|0|||
125479701|NCT00753545|451390014|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
125479702|NCT00753545|451390015|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
125479703|NCT06190691|451390016|FG000|Overall Study|Adverse Event|2|||
125479704|NCT06190691|451390017|FG001|Overall Study|Adverse Event|0|||
125479705|NCT06190691|451390018|FG002|Overall Study|Adverse Event|0|||
125479706|NCT06190691|451390019|FG003|Overall Study|Adverse Event|0|||
125479707|NCT05746455|451390020|FG000|Overall Study|Discharged from Clinical Service|1|||
125479708|NCT05746455|451390020|FG000|Overall Study|Lost to Follow-up|1|||
125479709|NCT03016754|451390024|FG000|Overall Study|Death|5|||
125479710|NCT03016754|451390025|FG001|Overall Study|Death|4|||
125479711|NCT03016754|451390026|FG002|Overall Study|Death|5|||
125479712|NCT03016754|451390027|FG003|Overall Study|Death|1|||
125479713|NCT03016754|451390024|FG000|Overall Study|Lost to Follow-up|23|||
125479714|NCT03016754|451390025|FG001|Overall Study|Lost to Follow-up|17|||
125479715|NCT03016754|451390026|FG002|Overall Study|Lost to Follow-up|4|||
125479716|NCT03016754|451390027|FG003|Overall Study|Lost to Follow-up|2|||
125479717|NCT03016754|451390024|FG000|Overall Study|Withdrawal by Subject|6|||
125479718|NCT03016754|451390025|FG001|Overall Study|Withdrawal by Subject|6|||
125479719|NCT03016754|451390026|FG002|Overall Study|Withdrawal by Subject|2|||
125479720|NCT03016754|451390027|FG003|Overall Study|Withdrawal by Subject|2|||
125479721|NCT03016754|451390024|FG000|Overall Study|Other/Unknown|2|||
125479722|NCT03016754|451390025|FG001|Overall Study|Other/Unknown|4|||
125479723|NCT03016754|451390026|FG002|Overall Study|Other/Unknown|2|||
125479724|NCT03016754|451390027|FG003|Overall Study|Other/Unknown|1|||
125479725|NCT03016754|451390024|FG000|Overall Study|Protocol Violation|0|||
125479726|NCT03016754|451390025|FG001|Overall Study|Protocol Violation|0|||
125479727|NCT03016754|451390026|FG002|Overall Study|Protocol Violation|0|||
125479728|NCT03016754|451390027|FG003|Overall Study|Protocol Violation|4|||
125479729|NCT03839940|451390028|FG000|Overall Study|Withdrawal by Subject|3|||
125479730|NCT03839940|451390029|FG001|Overall Study|Withdrawal by Subject|0|||
125479731|NCT03839940|451390028|FG000|Overall Study|Protocol Violation|0|||
125479732|NCT03839940|451390029|FG001|Overall Study|Protocol Violation|1|||
125479733|NCT03839940|451390028|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
125479734|NCT03839940|451390029|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
125479735|NCT03241745|451390030|FG000|Overall Study|Adverse Event|7|||
125479736|NCT03241745|451390030|FG000|Overall Study|Death|1|||
125479737|NCT03241745|451390030|FG000|Overall Study|Withdrawal by Subject|5|||
125479738|NCT03241745|451390030|FG000|Overall Study|Treatment delay >28 days|2|||
125479739|NCT03241745|451390030|FG000|Overall Study|Lack of Efficacy|14|||
125479740|NCT03023410|451390031|FG000|Overall Study|study termination|0|||
125479741|NCT03023410|451390032|FG001|Overall Study|study termination|1|||
125479742|NCT04799899|451390034|FG000|Overall Study|Lost to Follow-up|2|||
125479743|NCT04799899|451390035|FG001|Overall Study|Lost to Follow-up|4|||
125479744|NCT00470704|451390036|FG000|Overall Study|Withdrawal by Subject|4|||
125479745|NCT00470704|451390037|FG001|Overall Study|Withdrawal by Subject|3|||
125479746|NCT00470704|451390036|FG000|Overall Study|Relapse/Progression|37|||
125479747|NCT00470704|451390037|FG001|Overall Study|Relapse/Progression|42|||
125479748|NCT00470704|451390036|FG000|Overall Study|toxicity|0|||
125479749|NCT00470704|451390037|FG001|Overall Study|toxicity|1|||
125479750|NCT04019873|451390038|FG000|Overall Study|Discontinued from the treatment|1|||
125479751|NCT04019873|451390039|FG001|Overall Study|Discontinued from the treatment|39|||
125479752|NCT04019873|451390040|FG002|Overall Study|Discontinued from the treatment|2|||
125479753|NCT04908722|451390050|FG000|Overall Study|Protocol deviation|1|||
125479754|NCT04908722|451390051|FG001|Overall Study|Protocol deviation|0|||
125479755|NCT04908722|451390052|FG002|Overall Study|Protocol deviation|0|||
125479756|NCT04908722|451390053|FG003|Overall Study|Protocol deviation|0|||
125479757|NCT04908722|451390054|FG004|Overall Study|Protocol deviation|0|||
125479758|NCT04908722|451390055|FG005|Overall Study|Protocol deviation|1|||
125479759|NCT04908722|451390050|FG000|Overall Study|Lost to Follow-up|33|||
125479760|NCT04908722|451390051|FG001|Overall Study|Lost to Follow-up|33|||
125479761|NCT04908722|451390052|FG002|Overall Study|Lost to Follow-up|36|||
125479762|NCT04908722|451390053|FG003|Overall Study|Lost to Follow-up|30|||
125479763|NCT04908722|451390054|FG004|Overall Study|Lost to Follow-up|32|||
125479764|NCT04908722|451390055|FG005|Overall Study|Lost to Follow-up|34|||
125479765|NCT04908722|451390050|FG000|Overall Study|Physician Decision|1|||
125479766|NCT04908722|451390051|FG001|Overall Study|Physician Decision|1|||
125479767|NCT04908722|451390052|FG002|Overall Study|Physician Decision|1|||
125479768|NCT04908722|451390053|FG003|Overall Study|Physician Decision|2|||
125479769|NCT04908722|451390054|FG004|Overall Study|Physician Decision|0|||
125479770|NCT04908722|451390055|FG005|Overall Study|Physician Decision|0|||
125479771|NCT04908722|451390050|FG000|Overall Study|Death|1|||
125479772|NCT04908722|451390051|FG001|Overall Study|Death|0|||
125479773|NCT04908722|451390052|FG002|Overall Study|Death|0|||
125479774|NCT04908722|451390053|FG003|Overall Study|Death|0|||
125479775|NCT04908722|451390054|FG004|Overall Study|Death|0|||
125479776|NCT04908722|451390055|FG005|Overall Study|Death|1|||
125479777|NCT04908722|451390050|FG000|Overall Study|Withdrawal by Subject|12|||
125479778|NCT04908722|451390051|FG001|Overall Study|Withdrawal by Subject|8|||
125479779|NCT04908722|451390052|FG002|Overall Study|Withdrawal by Subject|7|||
125479780|NCT04908722|451390053|FG003|Overall Study|Withdrawal by Subject|6|||
125479781|NCT04908722|451390054|FG004|Overall Study|Withdrawal by Subject|12|||
125479782|NCT04908722|451390055|FG005|Overall Study|Withdrawal by Subject|14|||
125479783|NCT04908722|451390050|FG000|Overall Study|Other|3|||
125479784|NCT04908722|451390051|FG001|Overall Study|Other|1|||
125479785|NCT04908722|451390052|FG002|Overall Study|Other|3|||
125479786|NCT04908722|451390053|FG003|Overall Study|Other|2|||
125479787|NCT04908722|451390054|FG004|Overall Study|Other|4|||
125479788|NCT04908722|451390055|FG005|Overall Study|Other|1|||
125479789|NCT04908722|451390050|FG000|Overall Study|Initiated prohibited medication|0|||
125479790|NCT04908722|451390051|FG001|Overall Study|Initiated prohibited medication|0|||
125479791|NCT04908722|451390052|FG002|Overall Study|Initiated prohibited medication|0|||
125479792|NCT04908722|451390053|FG003|Overall Study|Initiated prohibited medication|1|||
125479793|NCT04908722|451390054|FG004|Overall Study|Initiated prohibited medication|0|||
125479794|NCT04908722|451390055|FG005|Overall Study|Initiated prohibited medication|1|||
125479795|NCT04908722|451390050|FG000|Overall Study|Randomized but not vaccinated|3|||
125479796|NCT04908722|451390051|FG001|Overall Study|Randomized but not vaccinated|1|||
125479797|NCT04908722|451390052|FG002|Overall Study|Randomized but not vaccinated|2|||
125479798|NCT04908722|451390053|FG003|Overall Study|Randomized but not vaccinated|2|||
125479799|NCT04908722|451390054|FG004|Overall Study|Randomized but not vaccinated|3|||
125479800|NCT04908722|451390055|FG005|Overall Study|Randomized but not vaccinated|4|||
125479801|NCT02319759|451390056|FG000|Week 0 - 16|Lack of Efficacy|1|||
125479802|NCT02319759|451390057|FG001|Week 0 - 16|Lack of Efficacy|0|||
125479803|NCT02319759|451390058|FG002|Week 0 - 16|Lack of Efficacy|0|||
125479804|NCT02319759|451390059|FG003|Week 0 - 16|Lack of Efficacy|0|||
125479805|NCT02319759|451390060|FG004|Week 0 - 16|Lack of Efficacy|0|||
125479806|NCT02319759|451390056|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
125479807|NCT02319759|451390057|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
125479808|NCT02319759|451390058|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
125479809|NCT02319759|451390059|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
125479810|NCT02319759|451390060|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
125479811|NCT02319759|451390056|FG000|Week 16 - 24|Lack of Efficacy|1|||
125479812|NCT02319759|451390057|FG001|Week 16 - 24|Lack of Efficacy|0|||
125479813|NCT02319759|451390058|FG002|Week 16 - 24|Lack of Efficacy|1|||
125479814|NCT02319759|451390059|FG003|Week 16 - 24|Lack of Efficacy|0|||
125479815|NCT02319759|451390060|FG004|Week 16 - 24|Lack of Efficacy|0|||
125479816|NCT02319759|451390056|FG000|Week 16 - 24|Lost to Follow-up|1|||
125479817|NCT02319759|451390057|FG001|Week 16 - 24|Lost to Follow-up|0|||
125479818|NCT02319759|451390058|FG002|Week 16 - 24|Lost to Follow-up|0|||
125479819|NCT02319759|451390059|FG003|Week 16 - 24|Lost to Follow-up|0|||
125479820|NCT02319759|451390060|FG004|Week 16 - 24|Lost to Follow-up|0|||
125479821|NCT02319759|451390056|FG000|Week 16 - 24|Withdrawal by Subject|0|||
125479822|NCT02319759|451390057|FG001|Week 16 - 24|Withdrawal by Subject|0|||
125479823|NCT02319759|451390058|FG002|Week 16 - 24|Withdrawal by Subject|2|||
125479824|NCT02319759|451390059|FG003|Week 16 - 24|Withdrawal by Subject|0|||
125479825|NCT02319759|451390060|FG004|Week 16 - 24|Withdrawal by Subject|0|||
125479826|NCT02319759|451390056|FG000|Week 24 - 56|Adverse Event|0|||
125479827|NCT02319759|451390057|FG001|Week 24 - 56|Adverse Event|0|||
125479828|NCT02319759|451390058|FG002|Week 24 - 56|Adverse Event|2|||
125479829|NCT02319759|451390059|FG003|Week 24 - 56|Adverse Event|0|||
125479830|NCT02319759|451390060|FG004|Week 24 - 56|Adverse Event|0|||
125479831|NCT02319759|451390056|FG000|Week 24 - 56|Lack of Efficacy|0|||
125479832|NCT02319759|451390057|FG001|Week 24 - 56|Lack of Efficacy|0|||
125479833|NCT02319759|451390058|FG002|Week 24 - 56|Lack of Efficacy|0|||
125479834|NCT02319759|451390059|FG003|Week 24 - 56|Lack of Efficacy|2|||
125479835|NCT02319759|451390060|FG004|Week 24 - 56|Lack of Efficacy|1|||
125479836|NCT02319759|451390056|FG000|Week 24 - 56|Withdrawal by Subject|0|||
125479837|NCT02319759|451390057|FG001|Week 24 - 56|Withdrawal by Subject|1|||
125479838|NCT02319759|451390058|FG002|Week 24 - 56|Withdrawal by Subject|0|||
125479839|NCT02319759|451390059|FG003|Week 24 - 56|Withdrawal by Subject|0|||
125479840|NCT02319759|451390060|FG004|Week 24 - 56|Withdrawal by Subject|0|||
125479841|NCT02319759|451390056|FG000|Week 24 - 56|Lost to Follow-up|0|||
125479842|NCT02319759|451390057|FG001|Week 24 - 56|Lost to Follow-up|0|||
125479843|NCT02319759|451390058|FG002|Week 24 - 56|Lost to Follow-up|0|||
125479844|NCT02319759|451390059|FG003|Week 24 - 56|Lost to Follow-up|0|||
125479845|NCT02319759|451390060|FG004|Week 24 - 56|Lost to Follow-up|1|||
125479846|NCT03339713|451390062|FG000|Overall Study|Lost to Follow-up|2|||
125479847|NCT03339713|451390063|FG001|Overall Study|Lost to Follow-up|1|||
125479848|NCT03339713|451390062|FG000|Overall Study|Protocol Violation|1|||
125479849|NCT03339713|451390063|FG001|Overall Study|Protocol Violation|0|||
125479850|NCT03339713|451390062|FG000|Overall Study|Withdrawal by Subject|1|||
125479851|NCT03339713|451390063|FG001|Overall Study|Withdrawal by Subject|1|||
125479852|NCT01902173|451390064|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
125479853|NCT01902173|451390065|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
125479854|NCT01902173|451390066|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
125479855|NCT01902173|451390067|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
125479856|NCT01902173|451390068|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
125479857|NCT01902173|451390069|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
125479858|NCT01902173|451390064|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
125479859|NCT01902173|451390065|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
125479860|NCT01902173|451390066|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
125479861|NCT01902173|451390067|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
125479862|NCT01902173|451390068|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
125479863|NCT01902173|451390069|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
125479864|NCT01902173|451390064|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
125479865|NCT01902173|451390065|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
125479866|NCT01902173|451390066|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
125479867|NCT01902173|451390067|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
125479868|NCT01902173|451390068|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
125479869|NCT01902173|451390069|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
125479870|NCT01902173|451390064|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
125479871|NCT01902173|451390065|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
125479872|NCT01902173|451390066|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
125479873|NCT01902173|451390067|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
125479874|NCT01902173|451390068|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
125479875|NCT01902173|451390069|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
125479876|NCT01902173|451390064|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
125479877|NCT01902173|451390065|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
125479878|NCT01902173|451390066|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
125479879|NCT01902173|451390067|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
125479880|NCT01902173|451390068|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
125479881|NCT01902173|451390069|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
125302095|NCT00383162|450731924|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
125302096|NCT00383162|450731925|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
125302097|NCT00383162|450731924|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
125479882|NCT01902173|451390064|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
125479883|NCT01902173|451390065|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
125479884|NCT01902173|451390066|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
125479885|NCT01902173|451390067|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
125479886|NCT01902173|451390068|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
125479887|NCT01902173|451390069|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
125479888|NCT01902173|451390064|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
125479889|NCT01902173|451390065|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
125479890|NCT01902173|451390066|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
125479891|NCT01902173|451390067|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
125479892|NCT01902173|451390068|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
125479893|NCT01902173|451390069|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
125479894|NCT01902173|451390064|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
125479895|NCT01902173|451390065|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
125479896|NCT01902173|451390066|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
125479897|NCT01902173|451390067|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
125479898|NCT01902173|451390068|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
125479899|NCT01902173|451390069|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
125479900|NCT01902173|451390064|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
125479901|NCT01902173|451390065|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
125479902|NCT01902173|451390066|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
125479903|NCT01902173|451390067|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
125479904|NCT01902173|451390068|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
125479905|NCT01902173|451390069|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
125479906|NCT01902173|451390064|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
125479907|NCT01902173|451390065|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
125479908|NCT01902173|451390066|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
125479909|NCT01902173|451390067|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
125479910|NCT01902173|451390068|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
125479911|NCT01902173|451390069|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
125479912|NCT01902173|451390064|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
125479913|NCT01902173|451390065|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
125479914|NCT01902173|451390066|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
125479915|NCT01902173|451390067|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
125479916|NCT01902173|451390068|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
125479917|NCT01902173|451390069|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
125479918|NCT01902173|451390064|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
125479919|NCT01902173|451390065|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
125479920|NCT01902173|451390066|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
125479921|NCT01902173|451390067|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
125479922|NCT01902173|451390068|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
125479923|NCT01902173|451390069|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
125479924|NCT01902173|451390064|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
125479925|NCT01902173|451390065|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
125479926|NCT01902173|451390066|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
125479927|NCT01902173|451390067|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
125479928|NCT01902173|451390068|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
125479929|NCT01902173|451390069|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
125479930|NCT01902173|451390064|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
125479931|NCT01902173|451390065|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
125479932|NCT01902173|451390066|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
125479933|NCT01902173|451390067|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
125479934|NCT01902173|451390068|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
125479935|NCT01902173|451390069|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
125479936|NCT02262728|451390071|FG000|Follow-up Phase (3 Years)|Death|0|||
125479937|NCT02262728|451390072|FG001|Follow-up Phase (3 Years)|Death|1|||
125479938|NCT02262728|451390071|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
125479939|NCT02262728|451390072|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
125479940|NCT02262728|451390071|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
125479941|NCT02262728|451390072|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
125479942|NCT05540665|451390073|FG000|Overall Study|Study terminated by sponsor|6|||
125479943|NCT05540665|451390074|FG001|Overall Study|Study terminated by sponsor|6|||
125479944|NCT05540665|451390075|FG002|Overall Study|Study terminated by sponsor|7|||
125479945|NCT02619838|451390076|FG000|Overall Study|Lost to Follow-up|9|||
125479946|NCT02619838|451390076|FG000|Overall Study|Withdrawal by Subject|15|||
125479947|NCT04066244|451390079|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
125479948|NCT04066244|451390080|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
125479949|NCT04066244|451390081|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
125479950|NCT04066244|451390082|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
125479951|NCT04066244|451390083|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
125479952|NCT04066244|451390084|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
125479953|NCT04066244|451390079|FG000|Part 2 (Cohort 5)|Death|0|||
125479954|NCT04066244|451390080|FG001|Part 2 (Cohort 5)|Death|0|||
125479955|NCT04066244|451390081|FG002|Part 2 (Cohort 5)|Death|0|||
125479956|NCT04066244|451390082|FG003|Part 2 (Cohort 5)|Death|0|||
125479957|NCT04066244|451390083|FG004|Part 2 (Cohort 5)|Death|0|||
125479958|NCT04066244|451390084|FG005|Part 2 (Cohort 5)|Death|2|||
125479959|NCT04066244|451390079|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
125479960|NCT04066244|451390080|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
125479961|NCT04066244|451390081|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
125479962|NCT04066244|451390082|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
125479963|NCT04066244|451390083|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
125479964|NCT04066244|451390084|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
125479965|NCT04066244|451390079|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
125479966|NCT04066244|451390080|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
125479967|NCT04066244|451390081|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
125479968|NCT04066244|451390082|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
125479969|NCT04066244|451390083|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
125479970|NCT04066244|451390084|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
125479971|NCT01073566|451390085|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
125479972|NCT01073566|451390086|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
125479973|NCT05006872|451390108|FG000|Overall Study|Lost to Follow-up|37|||
125479974|NCT05006872|451390109|FG001|Overall Study|Lost to Follow-up|31|||
125479975|NCT02268253|451390113|FG000|Stage 1|Withdrawal by Subject|1|||
125479976|NCT02268253|451390114|FG001|Stage 1|Withdrawal by Subject|0|||
125479977|NCT02268253|451390115|FG002|Stage 1|Withdrawal by Subject|0|||
125479978|NCT02268253|451390116|FG003|Stage 1|Withdrawal by Subject|0|||
125479979|NCT02268253|451390117|FG004|Stage 1|Withdrawal by Subject|0|||
125479980|NCT02268253|451390118|FG005|Stage 1|Withdrawal by Subject|0|||
125479981|NCT02268253|451390119|FG006|Stage 1|Withdrawal by Subject|0|||
125479982|NCT02268253|451390113|FG000|Stage 1|Death|0|||
125479983|NCT02268253|451390114|FG001|Stage 1|Death|2|||
125479984|NCT02268253|451390115|FG002|Stage 1|Death|2|||
125479985|NCT02268253|451390116|FG003|Stage 1|Death|2|||
125479986|NCT02268253|451390117|FG004|Stage 1|Death|1|||
125479987|NCT02268253|451390118|FG005|Stage 1|Death|1|||
125479988|NCT02268253|451390119|FG006|Stage 1|Death|0|||
125479989|NCT02268253|451390113|FG000|Stage 2|Disease Recurrence/ Progression|0|||
125479990|NCT02268253|451390114|FG001|Stage 2|Disease Recurrence/ Progression|0|||
125479991|NCT02268253|451390115|FG002|Stage 2|Disease Recurrence/ Progression|1|||
125479992|NCT02268253|451390116|FG003|Stage 2|Disease Recurrence/ Progression|0|||
125479993|NCT02268253|451390117|FG004|Stage 2|Disease Recurrence/ Progression|0|||
125479994|NCT02268253|451390118|FG005|Stage 2|Disease Recurrence/ Progression|0|||
125479995|NCT02268253|451390119|FG006|Stage 2|Disease Recurrence/ Progression|0|||
125479996|NCT02268253|451390113|FG000|Stage 2|Withdrawal by Subject|0|||
125479997|NCT02268253|451390114|FG001|Stage 2|Withdrawal by Subject|0|||
125479998|NCT02268253|451390115|FG002|Stage 2|Withdrawal by Subject|2|||
125479999|NCT02268253|451390116|FG003|Stage 2|Withdrawal by Subject|0|||
125480000|NCT02268253|451390117|FG004|Stage 2|Withdrawal by Subject|0|||
125480001|NCT02268253|451390118|FG005|Stage 2|Withdrawal by Subject|2|||
125480002|NCT02268253|451390119|FG006|Stage 2|Withdrawal by Subject|0|||
125480003|NCT02268253|451390113|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
125480004|NCT02268253|451390114|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
125480005|NCT02268253|451390115|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
125480006|NCT02268253|451390116|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
125480007|NCT02268253|451390117|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
125480008|NCT02268253|451390118|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
125480009|NCT02268253|451390119|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
125480010|NCT02268253|451390113|FG000|Stage 2|Death|0|||
125480011|NCT02268253|451390114|FG001|Stage 2|Death|0|||
125480012|NCT02268253|451390115|FG002|Stage 2|Death|19|||
125480013|NCT02268253|451390116|FG003|Stage 2|Death|0|||
125480014|NCT02268253|451390117|FG004|Stage 2|Death|0|||
125480015|NCT02268253|451390118|FG005|Stage 2|Death|20|||
125480016|NCT02268253|451390119|FG006|Stage 2|Death|1|||
125480017|NCT02268253|451390113|FG000|Stage 2|Lost to Follow-up|0|||
125480018|NCT02268253|451390114|FG001|Stage 2|Lost to Follow-up|0|||
125480019|NCT02268253|451390115|FG002|Stage 2|Lost to Follow-up|0|||
125480020|NCT02268253|451390116|FG003|Stage 2|Lost to Follow-up|0|||
125480021|NCT02268253|451390117|FG004|Stage 2|Lost to Follow-up|0|||
125480022|NCT02268253|451390118|FG005|Stage 2|Lost to Follow-up|4|||
125480023|NCT02268253|451390119|FG006|Stage 2|Lost to Follow-up|0|||
125480024|NCT02268253|451390113|FG000|Stage 2|Transferred to Hospice|0|||
125480025|NCT02268253|451390114|FG001|Stage 2|Transferred to Hospice|0|||
125480026|NCT02268253|451390115|FG002|Stage 2|Transferred to Hospice|0|||
125480027|NCT02268253|451390116|FG003|Stage 2|Transferred to Hospice|0|||
125480028|NCT02268253|451390117|FG004|Stage 2|Transferred to Hospice|0|||
125480029|NCT02268253|451390118|FG005|Stage 2|Transferred to Hospice|2|||
125480030|NCT02268253|451390119|FG006|Stage 2|Transferred to Hospice|0|||
125480031|NCT02268253|451390113|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
125480032|NCT02268253|451390114|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
125480033|NCT02268253|451390115|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
125480034|NCT02268253|451390116|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
125480035|NCT02268253|451390117|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
125480036|NCT02268253|451390118|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
125480037|NCT02268253|451390119|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
125480038|NCT02268253|451390113|FG000|Stage 3A|Withdrawal by Subject|0|||
125480039|NCT02268253|451390114|FG001|Stage 3A|Withdrawal by Subject|0|||
125480040|NCT02268253|451390115|FG002|Stage 3A|Withdrawal by Subject|2|||
125480041|NCT02268253|451390116|FG003|Stage 3A|Withdrawal by Subject|0|||
125480042|NCT02268253|451390117|FG004|Stage 3A|Withdrawal by Subject|0|||
125480043|NCT02268253|451390118|FG005|Stage 3A|Withdrawal by Subject|0|||
125480044|NCT02268253|451390119|FG006|Stage 3A|Withdrawal by Subject|0|||
125480045|NCT02268253|451390113|FG000|Stage 3A|Physician Decision|0|||
125480046|NCT02268253|451390114|FG001|Stage 3A|Physician Decision|0|||
125480047|NCT02268253|451390115|FG002|Stage 3A|Physician Decision|2|||
125480048|NCT02268253|451390116|FG003|Stage 3A|Physician Decision|0|||
125480049|NCT02268253|451390117|FG004|Stage 3A|Physician Decision|0|||
125480050|NCT02268253|451390118|FG005|Stage 3A|Physician Decision|0|||
125480051|NCT02268253|451390119|FG006|Stage 3A|Physician Decision|0|||
125480052|NCT02268253|451390113|FG000|Stage 3A|Study Terminated by Sponsor|0|||
125480053|NCT02268253|451390114|FG001|Stage 3A|Study Terminated by Sponsor|0|||
125480054|NCT02268253|451390115|FG002|Stage 3A|Study Terminated by Sponsor|2|||
125480055|NCT02268253|451390116|FG003|Stage 3A|Study Terminated by Sponsor|0|||
125480056|NCT02268253|451390117|FG004|Stage 3A|Study Terminated by Sponsor|0|||
125480057|NCT02268253|451390118|FG005|Stage 3A|Study Terminated by Sponsor|0|||
125480058|NCT02268253|451390119|FG006|Stage 3A|Study Terminated by Sponsor|0|||
125480059|NCT02268253|451390113|FG000|Stage 3A|Lost to Follow-up|0|||
125480060|NCT02268253|451390114|FG001|Stage 3A|Lost to Follow-up|0|||
125480061|NCT02268253|451390115|FG002|Stage 3A|Lost to Follow-up|1|||
125480062|NCT02268253|451390116|FG003|Stage 3A|Lost to Follow-up|0|||
125480063|NCT02268253|451390117|FG004|Stage 3A|Lost to Follow-up|0|||
125480064|NCT02268253|451390118|FG005|Stage 3A|Lost to Follow-up|0|||
125480065|NCT02268253|451390119|FG006|Stage 3A|Lost to Follow-up|0|||
125480066|NCT02268253|451390113|FG000|Stage 3A|Death|0|||
125480067|NCT02268253|451390114|FG001|Stage 3A|Death|0|||
125480068|NCT02268253|451390115|FG002|Stage 3A|Death|5|||
125480069|NCT02268253|451390116|FG003|Stage 3A|Death|0|||
125480070|NCT02268253|451390117|FG004|Stage 3A|Death|0|||
125480071|NCT02268253|451390118|FG005|Stage 3A|Death|0|||
125480072|NCT02268253|451390119|FG006|Stage 3A|Death|0|||
125480073|NCT05362487|451390122|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
125480074|NCT04096040|451390123|FG000|Overall Study|Protocol Violation|12|||
125480075|NCT04096040|451390123|FG000|Overall Study|Non-compliant site|4|||
125480076|NCT04973254|451390126|FG000|Overall Study|Not adherent|0|||
125480077|NCT04973254|451390127|FG001|Overall Study|Not adherent|1|||
125480078|NCT04973254|451390128|FG002|Overall Study|Not adherent|0|||
125480079|NCT05415722|451390134|FG000|Overall Study|Lost to Follow-up|0|||
125480080|NCT05415722|451390135|FG001|Overall Study|Lost to Follow-up|2|||
125480081|NCT05415722|451390136|FG002|Overall Study|Lost to Follow-up|0|||
125480082|NCT05415722|451390137|FG003|Overall Study|Lost to Follow-up|1|||
125480083|NCT05415722|451390138|FG004|Overall Study|Lost to Follow-up|0|||
125480084|NCT05415722|451390139|FG005|Overall Study|Lost to Follow-up|0|||
125480085|NCT05415722|451390140|FG006|Overall Study|Lost to Follow-up|1|||
125480086|NCT05415722|451390134|FG000|Overall Study|Physician Decision|0|||
125480087|NCT05415722|451390135|FG001|Overall Study|Physician Decision|0|||
125480088|NCT05415722|451390136|FG002|Overall Study|Physician Decision|0|||
125480089|NCT05415722|451390137|FG003|Overall Study|Physician Decision|1|||
125480090|NCT05415722|451390138|FG004|Overall Study|Physician Decision|0|||
125480091|NCT05415722|451390139|FG005|Overall Study|Physician Decision|0|||
125480092|NCT05415722|451390140|FG006|Overall Study|Physician Decision|1|||
125480093|NCT05415722|451390134|FG000|Overall Study|Protocol Violation|0|||
125480094|NCT05415722|451390135|FG001|Overall Study|Protocol Violation|0|||
125480095|NCT05415722|451390136|FG002|Overall Study|Protocol Violation|0|||
125480096|NCT05415722|451390137|FG003|Overall Study|Protocol Violation|1|||
125480097|NCT05415722|451390138|FG004|Overall Study|Protocol Violation|0|||
125480098|NCT05415722|451390139|FG005|Overall Study|Protocol Violation|0|||
125480099|NCT05415722|451390140|FG006|Overall Study|Protocol Violation|0|||
125480100|NCT05415722|451390134|FG000|Overall Study|Sponsor Discretion|0|||
125480101|NCT05415722|451390135|FG001|Overall Study|Sponsor Discretion|0|||
125480102|NCT05415722|451390136|FG002|Overall Study|Sponsor Discretion|0|||
125480103|NCT05415722|451390137|FG003|Overall Study|Sponsor Discretion|0|||
125480104|NCT05415722|451390138|FG004|Overall Study|Sponsor Discretion|1|||
125480105|NCT05415722|451390139|FG005|Overall Study|Sponsor Discretion|1|||
125480106|NCT05415722|451390140|FG006|Overall Study|Sponsor Discretion|0|||
125480107|NCT05415722|451390134|FG000|Overall Study|Withdrawal by Subject|0|||
125480108|NCT05415722|451390135|FG001|Overall Study|Withdrawal by Subject|1|||
125480109|NCT05415722|451390136|FG002|Overall Study|Withdrawal by Subject|0|||
125480110|NCT05415722|451390137|FG003|Overall Study|Withdrawal by Subject|1|||
125480111|NCT05415722|451390138|FG004|Overall Study|Withdrawal by Subject|1|||
125480112|NCT05415722|451390139|FG005|Overall Study|Withdrawal by Subject|0|||
125480113|NCT05415722|451390140|FG006|Overall Study|Withdrawal by Subject|1|||
125480114|NCT04629716|451390141|FG000|Overall Study|Lost to Follow-up|7|||
125480115|NCT04629716|451390142|FG001|Overall Study|Lost to Follow-up|3|||
125480116|NCT04537715|451390143|FG000|Overall Study|Death|3|||
125480117|NCT04537715|451390144|FG001|Overall Study|Death|1|||
125480118|NCT04537715|451390143|FG000|Overall Study|Withdrawal by Subject|3|||
125480119|NCT04537715|451390144|FG001|Overall Study|Withdrawal by Subject|1|||
125480120|NCT04537715|451390143|FG000|Overall Study|Other|4|||
125480121|NCT04537715|451390144|FG001|Overall Study|Other|3|||
125480122|NCT04537715|451390143|FG000|Overall Study|Progressive disease|1|||
125480123|NCT04537715|451390144|FG001|Overall Study|Progressive disease|0|||
125480124|NCT03461276|451390145|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
125480125|NCT03461276|451390146|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
125480126|NCT03461276|451390145|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
125480127|NCT03461276|451390146|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
125480128|NCT03461276|451390145|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
125480129|NCT03461276|451390146|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
125480130|NCT03461276|451390145|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
125480131|NCT03461276|451390146|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
125480132|NCT03461276|451390145|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
125480133|NCT03461276|451390146|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
125480134|NCT03461276|451390145|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
125480135|NCT03461276|451390146|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
125480136|NCT03461276|451390145|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
125480137|NCT03461276|451390146|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
125480138|NCT03461276|451390145|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
125480139|NCT03461276|451390146|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
125480140|NCT03461276|451390145|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
125480141|NCT03461276|451390146|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
125480142|NCT03461276|451390145|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
125480143|NCT03461276|451390146|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
125480144|NCT03865498|451390148|FG000|Overall Study|Lack of Efficacy|12|||
125480145|NCT03865498|451390149|FG001|Overall Study|Lack of Efficacy|11|||
125480146|NCT03865498|451390148|FG000|Overall Study|Lost to Follow-up|125|||
125480147|NCT03865498|451390149|FG001|Overall Study|Lost to Follow-up|133|||
125480148|NCT03865498|451390148|FG000|Overall Study|Withdrawal by Subject|2|||
125480149|NCT03865498|451390149|FG001|Overall Study|Withdrawal by Subject|4|||
125480150|NCT03270501|451390156|FG000|Overall Study|Screen failure|6|||
125480151|NCT03270501|451390156|FG000|Overall Study|Lost to Follow-up|2|||
125480152|NCT03270501|451390156|FG000|Overall Study|Adverse Event|1|||
125480153|NCT03812679|451392259|FG000|Overall Study|Adverse Event|2|||
125480154|NCT03812679|451392259|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
125480155|NCT03812679|451392259|FG000|Overall Study|Renal transplant|1|||
125480156|NCT03812679|451392259|FG000|Overall Study|Withdrawal by Subject|1|||
125480157|NCT03812679|451392259|FG000|Overall Study|Termination of study|2|||
125480158|NCT03812679|451392259|FG000|Overall Study|Water device replacement|1|||
125480159|NCT05486078|451392260|FG000|Overall Study|4 drop out and one withdrawn|5|||
125480160|NCT02985957|451392261|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125480161|NCT02985957|451392262|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125480162|NCT02985957|451392263|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125480163|NCT02985957|451392264|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125480164|NCT02985957|451392265|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
125480165|NCT02985957|451392266|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125480166|NCT02985957|451392267|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
125480167|NCT02985957|451392261|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
125480168|NCT02985957|451392262|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
125480169|NCT02985957|451392263|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
125480170|NCT02985957|451392264|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
125480171|NCT02985957|451392265|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
125480172|NCT02985957|451392266|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
125480173|NCT02985957|451392267|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
125480174|NCT02985957|451392261|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
125480175|NCT02985957|451392262|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
125480176|NCT02985957|451392263|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
125480177|NCT02985957|451392264|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
125480178|NCT02985957|451392265|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
125480179|NCT02985957|451392266|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
125480180|NCT02985957|451392267|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
125480181|NCT02985957|451392261|FG000|Treatment Period|Death|0|||
125480182|NCT02985957|451392262|FG001|Treatment Period|Death|0|||
125480183|NCT02985957|451392263|FG002|Treatment Period|Death|0|||
125480184|NCT02985957|451392264|FG003|Treatment Period|Death|0|||
125480185|NCT02985957|451392265|FG004|Treatment Period|Death|1|||
125480186|NCT02985957|451392266|FG005|Treatment Period|Death|0|||
125480187|NCT02985957|451392267|FG006|Treatment Period|Death|0|||
125480188|NCT02985957|451392261|FG000|Treatment Period|Participant withdrew consent|0|||
125480189|NCT02985957|451392262|FG001|Treatment Period|Participant withdrew consent|0|||
125480190|NCT02985957|451392263|FG002|Treatment Period|Participant withdrew consent|0|||
125480191|NCT02985957|451392264|FG003|Treatment Period|Participant withdrew consent|1|||
125480192|NCT02985957|451392265|FG004|Treatment Period|Participant withdrew consent|3|||
125480193|NCT02985957|451392266|FG005|Treatment Period|Participant withdrew consent|0|||
125480194|NCT02985957|451392267|FG006|Treatment Period|Participant withdrew consent|1|||
125480195|NCT02985957|451392261|FG000|Treatment Period|Lost to Follow-up|0|||
125480196|NCT02985957|451392262|FG001|Treatment Period|Lost to Follow-up|0|||
125480197|NCT02985957|451392263|FG002|Treatment Period|Lost to Follow-up|0|||
125480198|NCT02985957|451392264|FG003|Treatment Period|Lost to Follow-up|0|||
125480199|NCT02985957|451392265|FG004|Treatment Period|Lost to Follow-up|1|||
125480200|NCT02985957|451392266|FG005|Treatment Period|Lost to Follow-up|0|||
125480201|NCT02985957|451392267|FG006|Treatment Period|Lost to Follow-up|0|||
125480202|NCT02985957|451392261|FG000|Treatment Period|Other reasons|0|||
125480203|NCT02985957|451392262|FG001|Treatment Period|Other reasons|0|||
125480204|NCT02985957|451392263|FG002|Treatment Period|Other reasons|1|||
125480205|NCT02985957|451392264|FG003|Treatment Period|Other reasons|3|||
125480206|NCT02985957|451392265|FG004|Treatment Period|Other reasons|6|||
125480207|NCT02985957|451392266|FG005|Treatment Period|Other reasons|0|||
125480208|NCT02985957|451392267|FG006|Treatment Period|Other reasons|1|||
125480209|NCT02985957|451392261|FG000|Treatment Period|Not reported|0|||
125480210|NCT02985957|451392262|FG001|Treatment Period|Not reported|1|||
125480211|NCT02985957|451392263|FG002|Treatment Period|Not reported|2|||
125480212|NCT02985957|451392264|FG003|Treatment Period|Not reported|5|||
125480213|NCT02985957|451392265|FG004|Treatment Period|Not reported|0|||
125480214|NCT02985957|451392266|FG005|Treatment Period|Not reported|0|||
125480215|NCT02985957|451392267|FG006|Treatment Period|Not reported|0|||
125480216|NCT02985957|451392261|FG000|Treatment Period|Maximum clinical benefit|0|||
125480217|NCT02985957|451392262|FG001|Treatment Period|Maximum clinical benefit|0|||
125480218|NCT02985957|451392263|FG002|Treatment Period|Maximum clinical benefit|1|||
125480219|NCT02985957|451392264|FG003|Treatment Period|Maximum clinical benefit|1|||
125480220|NCT02985957|451392265|FG004|Treatment Period|Maximum clinical benefit|0|||
125480221|NCT02985957|451392266|FG005|Treatment Period|Maximum clinical benefit|0|||
125480222|NCT02985957|451392267|FG006|Treatment Period|Maximum clinical benefit|2|||
125480223|NCT02985957|451392261|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
125480224|NCT02985957|451392262|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
125480225|NCT02985957|451392263|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
125480226|NCT02985957|451392264|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
125480227|NCT02985957|451392265|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
125480228|NCT02985957|451392266|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
125480229|NCT02985957|451392267|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
125480230|NCT02985957|451392261|FG000|Treatment Period|Study drug toxicity|1|||
125480231|NCT02985957|451392262|FG001|Treatment Period|Study drug toxicity|23|||
125480232|NCT02985957|451392263|FG002|Treatment Period|Study drug toxicity|20|||
125480233|NCT02985957|451392264|FG003|Treatment Period|Study drug toxicity|11|||
125480234|NCT02985957|451392265|FG004|Treatment Period|Study drug toxicity|19|||
125480235|NCT02985957|451392266|FG005|Treatment Period|Study drug toxicity|3|||
125480236|NCT02985957|451392267|FG006|Treatment Period|Study drug toxicity|5|||
125480237|NCT02985957|451392261|FG000|Treatment Period|Disease progression|0|||
125480238|NCT02985957|451392262|FG001|Treatment Period|Disease progression|16|||
125480239|NCT02985957|451392263|FG002|Treatment Period|Disease progression|20|||
125480240|NCT02985957|451392264|FG003|Treatment Period|Disease progression|39|||
125480241|NCT02985957|451392265|FG004|Treatment Period|Disease progression|29|||
125480242|NCT02985957|451392266|FG005|Treatment Period|Disease progression|11|||
125480243|NCT02985957|451392267|FG006|Treatment Period|Disease progression|28|||
125480244|NCT02985957|451392261|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
125480245|NCT02985957|451392262|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
125480246|NCT02985957|451392263|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
125480247|NCT02985957|451392264|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
125480248|NCT02985957|451392265|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
125480249|NCT02985957|451392266|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
125480250|NCT02985957|451392267|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
125480251|NCT02985957|451392261|FG000|Treatment Period|Poor/Non-Compliance|0|||
125480252|NCT02985957|451392262|FG001|Treatment Period|Poor/Non-Compliance|0|||
125480253|NCT02985957|451392263|FG002|Treatment Period|Poor/Non-Compliance|0|||
125480254|NCT02985957|451392264|FG003|Treatment Period|Poor/Non-Compliance|0|||
125480255|NCT02985957|451392265|FG004|Treatment Period|Poor/Non-Compliance|1|||
125480256|NCT02985957|451392266|FG005|Treatment Period|Poor/Non-Compliance|1|||
125480257|NCT02985957|451392267|FG006|Treatment Period|Poor/Non-Compliance|0|||
125480258|NCT02985957|451392261|FG000|Treatment Period|Continuing in Treatment Period|0|||
125480259|NCT02985957|451392262|FG001|Treatment Period|Continuing in Treatment Period|1|||
125480260|NCT02985957|451392263|FG002|Treatment Period|Continuing in Treatment Period|0|||
125480261|NCT02985957|451392264|FG003|Treatment Period|Continuing in Treatment Period|4|||
125480262|NCT02985957|451392265|FG004|Treatment Period|Continuing in Treatment Period|4|||
125480263|NCT02985957|451392266|FG005|Treatment Period|Continuing in Treatment Period|0|||
125480264|NCT02985957|451392267|FG006|Treatment Period|Continuing in Treatment Period|0|||
125480265|NCT04802967|451392274|FG000|Part B|Withdrawal by Subject|0|||
125480266|NCT04802967|451392275|FG001|Part B|Withdrawal by Subject|0|||
125480267|NCT04802967|451392276|FG002|Part B|Withdrawal by Subject|0|||
125480268|NCT04802967|451392277|FG003|Part B|Withdrawal by Subject|0|||
125480269|NCT04802967|451392278|FG004|Part B|Withdrawal by Subject|0|||
125480270|NCT04802967|451392279|FG005|Part B|Withdrawal by Subject|1|||
125480271|NCT04802967|451392280|FG006|Part B|Withdrawal by Subject|0|||
125480272|NCT04802967|451392281|FG007|Part B|Withdrawal by Subject|0|||
125480273|NCT04802967|451392282|FG008|Part B|Withdrawal by Subject|0|||
125480274|NCT04802967|451392283|FG009|Part B|Withdrawal by Subject|0|||
125480275|NCT03945292|451392286|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
125480276|NCT03945292|451392287|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
125480277|NCT03945292|451392288|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
125480278|NCT03945292|451392289|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
125480279|NCT03945292|451392290|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
125480280|NCT03945292|451392291|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
125480281|NCT03945292|451392292|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
125480282|NCT03945292|451392293|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
125480283|NCT03945292|451392286|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
125480284|NCT03945292|451392287|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
125480285|NCT03945292|451392288|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
125480286|NCT03945292|451392289|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
125480287|NCT03945292|451392290|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
125480288|NCT03945292|451392291|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
125480289|NCT03945292|451392292|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
125480290|NCT03945292|451392293|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
125480291|NCT03945292|451392286|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
125480292|NCT03945292|451392287|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
125480293|NCT03945292|451392288|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
125480294|NCT03945292|451392289|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
125480295|NCT03945292|451392290|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
125480296|NCT03945292|451392291|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
125480297|NCT03945292|451392292|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
125480298|NCT03945292|451392293|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
125480299|NCT04295798|451392294|FG000|Overall Study|Lost to Follow-up|1|||
125480300|NCT03524118|451392302|FG000|Overall Study|Lost to Follow-up|0|||
125480301|NCT03524118|451392303|FG001|Overall Study|Lost to Follow-up|0|||
125480302|NCT03524118|451392304|FG002|Overall Study|Lost to Follow-up|0|||
125480303|NCT03524118|451392305|FG003|Overall Study|Lost to Follow-up|0|||
125480304|NCT03524118|451392306|FG004|Overall Study|Lost to Follow-up|1|||
125480305|NCT03524118|451392307|FG005|Overall Study|Lost to Follow-up|0|||
125480306|NCT03524118|451392302|FG000|Overall Study|Other|0|||
125480307|NCT03524118|451392303|FG001|Overall Study|Other|1|||
125480308|NCT03524118|451392304|FG002|Overall Study|Other|0|||
125480309|NCT03524118|451392305|FG003|Overall Study|Other|0|||
125480310|NCT03524118|451392306|FG004|Overall Study|Other|1|||
125480311|NCT03524118|451392307|FG005|Overall Study|Other|1|||
125480312|NCT03524118|451392302|FG000|Overall Study|Physician Decision|0|||
125480313|NCT03524118|451392303|FG001|Overall Study|Physician Decision|0|||
125480314|NCT03524118|451392304|FG002|Overall Study|Physician Decision|0|||
125480315|NCT03524118|451392305|FG003|Overall Study|Physician Decision|0|||
125480316|NCT03524118|451392306|FG004|Overall Study|Physician Decision|1|||
125480317|NCT03524118|451392307|FG005|Overall Study|Physician Decision|0|||
125480318|NCT03524118|451392302|FG000|Overall Study|Protocol Violation|0|||
125480319|NCT03524118|451392303|FG001|Overall Study|Protocol Violation|0|||
125480320|NCT03524118|451392304|FG002|Overall Study|Protocol Violation|1|||
125480321|NCT03524118|451392305|FG003|Overall Study|Protocol Violation|0|||
125480322|NCT03524118|451392306|FG004|Overall Study|Protocol Violation|1|||
125480323|NCT03524118|451392307|FG005|Overall Study|Protocol Violation|0|||
125480324|NCT03524118|451392302|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125480325|NCT03524118|451392303|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125480326|NCT03524118|451392304|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125480327|NCT03524118|451392305|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
125480328|NCT03524118|451392306|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
125480329|NCT03524118|451392307|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
125480330|NCT04650269|451392313|FG000|Overall Study|Death|3|||
125480331|NCT04650269|451392313|FG000|Overall Study|Lost to Follow-up|6|||
125480332|NCT04987320|451392314|FG000|Overall Study|Withdrawal by Subject|0|||
125480333|NCT04987320|451392315|FG001|Overall Study|Withdrawal by Subject|1|||
125480334|NCT01437709|451392316|FG000|Overall Study|Adverse Event|0|||
125480335|NCT01437709|451392317|FG001|Overall Study|Adverse Event|1|||
125480336|NCT01437709|451392318|FG002|Overall Study|Adverse Event|0|||
125480337|NCT01437709|451392316|FG000|Overall Study|Pt trasnferred care|0|||
125480338|NCT01437709|451392317|FG001|Overall Study|Pt trasnferred care|1|||
125480339|NCT01437709|451392318|FG002|Overall Study|Pt trasnferred care|0|||
125480340|NCT00085735|451392319|FG000|Overall Study|Adverse Event|1|||
125480341|NCT00085735|451392320|FG001|Overall Study|Adverse Event|0|||
125480342|NCT00085735|451392321|FG002|Overall Study|Adverse Event|0|||
125480343|NCT00085735|451392322|FG003|Overall Study|Adverse Event|0|||
125480344|NCT00085735|451392323|FG004|Overall Study|Adverse Event|0|||
125480345|NCT00085735|451392324|FG005|Overall Study|Adverse Event|0|||
125480346|NCT00085735|451392319|FG000|Overall Study|Lack of Efficacy|2|||
125480347|NCT00085735|451392320|FG001|Overall Study|Lack of Efficacy|4|||
125480348|NCT00085735|451392321|FG002|Overall Study|Lack of Efficacy|6|||
125480349|NCT00085735|451392322|FG003|Overall Study|Lack of Efficacy|3|||
125480350|NCT00085735|451392323|FG004|Overall Study|Lack of Efficacy|4|||
125480351|NCT00085735|451392324|FG005|Overall Study|Lack of Efficacy|3|||
125480352|NCT00085735|451392319|FG000|Overall Study|Lost to Follow-up|0|||
125480353|NCT00085735|451392320|FG001|Overall Study|Lost to Follow-up|1|||
125480354|NCT00085735|451392321|FG002|Overall Study|Lost to Follow-up|0|||
125480355|NCT00085735|451392322|FG003|Overall Study|Lost to Follow-up|0|||
125480356|NCT00085735|451392323|FG004|Overall Study|Lost to Follow-up|1|||
125480357|NCT00085735|451392324|FG005|Overall Study|Lost to Follow-up|0|||
125480358|NCT00085735|451392319|FG000|Overall Study|Physician Decision|2|||
125480359|NCT00085735|451392320|FG001|Overall Study|Physician Decision|3|||
125480360|NCT00085735|451392321|FG002|Overall Study|Physician Decision|2|||
125480361|NCT00085735|451392322|FG003|Overall Study|Physician Decision|3|||
125480362|NCT00085735|451392323|FG004|Overall Study|Physician Decision|11|||
125480363|NCT00085735|451392324|FG005|Overall Study|Physician Decision|8|||
125480364|NCT00085735|451392319|FG000|Overall Study|Protocol Violation|1|||
125480365|NCT00085735|451392320|FG001|Overall Study|Protocol Violation|0|||
125480366|NCT00085735|451392321|FG002|Overall Study|Protocol Violation|0|||
125480367|NCT00085735|451392322|FG003|Overall Study|Protocol Violation|0|||
125480368|NCT00085735|451392323|FG004|Overall Study|Protocol Violation|0|||
125480369|NCT00085735|451392324|FG005|Overall Study|Protocol Violation|0|||
125480370|NCT00085735|451392319|FG000|Overall Study|Withdrawal by Subject|1|||
125480371|NCT00085735|451392320|FG001|Overall Study|Withdrawal by Subject|0|||
125480372|NCT00085735|451392321|FG002|Overall Study|Withdrawal by Subject|4|||
125480373|NCT00085735|451392322|FG003|Overall Study|Withdrawal by Subject|5|||
125480374|NCT00085735|451392323|FG004|Overall Study|Withdrawal by Subject|7|||
125480375|NCT00085735|451392324|FG005|Overall Study|Withdrawal by Subject|8|||
125480376|NCT00085735|451392319|FG000|Overall Study|Patient ineligible|1|||
125480377|NCT00085735|451392320|FG001|Overall Study|Patient ineligible|0|||
125480378|NCT00085735|451392321|FG002|Overall Study|Patient ineligible|3|||
125480379|NCT00085735|451392322|FG003|Overall Study|Patient ineligible|7|||
125480380|NCT00085735|451392323|FG004|Overall Study|Patient ineligible|17|||
125480381|NCT00085735|451392324|FG005|Overall Study|Patient ineligible|8|||
125480382|NCT00085735|451392319|FG000|Overall Study|Excess residual disease|2|||
125480383|NCT00085735|451392320|FG001|Overall Study|Excess residual disease|2|||
125480384|NCT00085735|451392321|FG002|Overall Study|Excess residual disease|1|||
125480385|NCT00085735|451392322|FG003|Overall Study|Excess residual disease|1|||
125480386|NCT00085735|451392323|FG004|Overall Study|Excess residual disease|1|||
125480387|NCT00085735|451392324|FG005|Overall Study|Excess residual disease|4|||
125480388|NCT00085735|451392319|FG000|Overall Study|Reason not documented|1|||
125480389|NCT00085735|451392320|FG001|Overall Study|Reason not documented|0|||
125480390|NCT00085735|451392321|FG002|Overall Study|Reason not documented|1|||
125480391|NCT00085735|451392322|FG003|Overall Study|Reason not documented|0|||
125480392|NCT00085735|451392323|FG004|Overall Study|Reason not documented|1|||
125480393|NCT00085735|451392324|FG005|Overall Study|Reason not documented|0|||
125480394|NCT00085735|451392319|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
125480395|NCT00085735|451392320|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
125480396|NCT00085735|451392321|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
125480397|NCT00085735|451392322|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
125480398|NCT00085735|451392323|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
125480399|NCT00085735|451392324|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
125480400|NCT01824875|451392325|FG000|Overall Study|Disease progression|22|||
125480401|NCT01824875|451392326|FG001|Overall Study|Disease progression|15|||
125480402|NCT01824875|451392325|FG000|Overall Study|Withdrawal by Subject|5|||
125480403|NCT01824875|451392326|FG001|Overall Study|Withdrawal by Subject|4|||
125480404|NCT01824875|451392325|FG000|Overall Study|Adverse Event|4|||
125480405|NCT01824875|451392326|FG001|Overall Study|Adverse Event|10|||
125480406|NCT01824875|451392325|FG000|Overall Study|Alternative therapy|3|||
125480407|NCT01824875|451392326|FG001|Overall Study|Alternative therapy|0|||
125480408|NCT01824875|451392325|FG000|Overall Study|Complicating disease|1|||
125480409|NCT01824875|451392326|FG001|Overall Study|Complicating disease|0|||
125480410|NCT01824875|451392325|FG000|Overall Study|Physician Decision|0|||
125480411|NCT01824875|451392326|FG001|Overall Study|Physician Decision|1|||
125480412|NCT01824875|451392325|FG000|Overall Study|Non-compliance|1|||
125480413|NCT01824875|451392326|FG001|Overall Study|Non-compliance|1|||
125480414|NCT01824875|451392325|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
125480415|NCT01824875|451392326|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
125480416|NCT01824875|451392325|FG000|Overall Study|Administrative issues|0|||
125480417|NCT01824875|451392326|FG001|Overall Study|Administrative issues|2|||
125480418|NCT01824875|451392325|FG000|Overall Study|Ineligible or never started treatment|9|||
125480419|NCT01824875|451392326|FG001|Overall Study|Ineligible or never started treatment|5|||
125480420|NCT01824875|451392325|FG000|Overall Study|Other|0|||
125480421|NCT01824875|451392326|FG001|Overall Study|Other|2|||
125480422|NCT01715285|451392327|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
125480423|NCT01715285|451392328|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
125480424|NCT01715285|451392329|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
125480425|NCT01715285|451392327|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
125480426|NCT01715285|451392328|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
125480427|NCT01715285|451392329|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
125480428|NCT01715285|451392327|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
125480429|NCT01715285|451392328|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
125480430|NCT01715285|451392329|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
125480431|NCT01715285|451392327|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
125480432|NCT01715285|451392328|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
125480433|NCT01715285|451392329|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
125480434|NCT01715285|451392327|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
125480435|NCT01715285|451392328|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
125480436|NCT01715285|451392329|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
125480437|NCT01715285|451392327|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
125480438|NCT01715285|451392328|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
125480439|NCT01715285|451392329|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
125480440|NCT01715285|451392327|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
125480441|NCT01715285|451392328|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
125480442|NCT01715285|451392329|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
125480443|NCT01715285|451392327|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
125480444|NCT01715285|451392328|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
125480445|NCT01715285|451392329|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
125480446|NCT01715285|451392327|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
125480447|NCT01715285|451392328|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
125480448|NCT01715285|451392329|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
125480449|NCT01715285|451392327|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
125480450|NCT01715285|451392328|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
125480451|NCT01715285|451392329|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
125480452|NCT01715285|451392327|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
125480453|NCT01715285|451392328|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
125480454|NCT01715285|451392329|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
125480455|NCT01715285|451392327|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
125480456|NCT01715285|451392328|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
125480457|NCT01715285|451392329|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
125480458|NCT01715285|451392327|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
125480459|NCT01715285|451392328|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
125480460|NCT01715285|451392329|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
125480461|NCT01715285|451392327|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
125480462|NCT01715285|451392328|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
125480463|NCT01715285|451392329|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
125480464|NCT02598388|451392330|FG000|Overall Study|Lost to Follow-up|1|||
125480465|NCT02598388|451392331|FG001|Overall Study|Lost to Follow-up|0|||
125480466|NCT02598388|451392332|FG002|Overall Study|Lost to Follow-up|1|||
125480467|NCT02598388|451392333|FG003|Overall Study|Lost to Follow-up|0|||
125480468|NCT02598388|451392334|FG004|Overall Study|Lost to Follow-up|5|||
125480469|NCT02598388|451392335|FG005|Overall Study|Lost to Follow-up|1|||
125480470|NCT02598388|451392336|FG006|Overall Study|Lost to Follow-up|2|||
125480471|NCT02598388|451392337|FG007|Overall Study|Lost to Follow-up|1|||
125480472|NCT02598388|451392338|FG008|Overall Study|Lost to Follow-up|0|||
125480473|NCT02598388|451392339|FG009|Overall Study|Lost to Follow-up|0|||
125480474|NCT02598388|451392340|FG010|Overall Study|Lost to Follow-up|1|||
125480475|NCT02598388|451392341|FG011|Overall Study|Lost to Follow-up|0|||
125480476|NCT02598388|451392330|FG000|Overall Study|Withdrawal by Subject|0|||
125480477|NCT02598388|451392331|FG001|Overall Study|Withdrawal by Subject|0|||
125480478|NCT02598388|451392332|FG002|Overall Study|Withdrawal by Subject|0|||
125480479|NCT02598388|451392333|FG003|Overall Study|Withdrawal by Subject|0|||
125480480|NCT02598388|451392334|FG004|Overall Study|Withdrawal by Subject|2|||
125480481|NCT02598388|451392335|FG005|Overall Study|Withdrawal by Subject|0|||
125480482|NCT02598388|451392336|FG006|Overall Study|Withdrawal by Subject|2|||
125480483|NCT02598388|451392337|FG007|Overall Study|Withdrawal by Subject|0|||
125480484|NCT02598388|451392338|FG008|Overall Study|Withdrawal by Subject|0|||
125480485|NCT02598388|451392339|FG009|Overall Study|Withdrawal by Subject|1|||
125480486|NCT02598388|451392340|FG010|Overall Study|Withdrawal by Subject|0|||
125480487|NCT02598388|451392341|FG011|Overall Study|Withdrawal by Subject|0|||
125480488|NCT02598388|451392330|FG000|Overall Study|Other|0|||
125480489|NCT02598388|451392331|FG001|Overall Study|Other|0|||
125480490|NCT02598388|451392332|FG002|Overall Study|Other|1|||
125480491|NCT02598388|451392333|FG003|Overall Study|Other|0|||
125480492|NCT02598388|451392334|FG004|Overall Study|Other|3|||
125480493|NCT02598388|451392335|FG005|Overall Study|Other|0|||
125480494|NCT02598388|451392336|FG006|Overall Study|Other|1|||
125480495|NCT02598388|451392337|FG007|Overall Study|Other|0|||
125480496|NCT02598388|451392338|FG008|Overall Study|Other|0|||
125480497|NCT02598388|451392339|FG009|Overall Study|Other|0|||
125480498|NCT02598388|451392340|FG010|Overall Study|Other|0|||
125480499|NCT02598388|451392341|FG011|Overall Study|Other|0|||
125480500|NCT03628924|451392342|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
125480501|NCT03628924|451392343|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
125480502|NCT03628924|451392344|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
125480503|NCT03628924|451392345|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
125480504|NCT03628924|451392346|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
125480505|NCT03628924|451392347|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
125480506|NCT03628924|451392348|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
125480507|NCT03628924|451392342|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
125480508|NCT03628924|451392343|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
125480509|NCT03628924|451392344|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
125480510|NCT03628924|451392345|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
125480511|NCT03628924|451392346|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
125480512|NCT03628924|451392347|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
125480513|NCT03628924|451392348|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
125480514|NCT03628924|451392342|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
125480515|NCT03628924|451392343|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
125480516|NCT03628924|451392344|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
125480517|NCT03628924|451392345|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
125480518|NCT03628924|451392346|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
125480519|NCT03628924|451392347|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
125480520|NCT03628924|451392348|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
125480521|NCT03628924|451392342|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
125480522|NCT03628924|451392343|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
125480523|NCT03628924|451392344|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
125480524|NCT03628924|451392345|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
125480525|NCT03628924|451392346|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
125480526|NCT03628924|451392347|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
125480527|NCT03628924|451392348|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
125480528|NCT03628924|451392342|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
125480529|NCT03628924|451392343|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
125480530|NCT03628924|451392344|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
125480531|NCT03628924|451392345|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
125480532|NCT03628924|451392346|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
125480533|NCT03628924|451392347|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
125480534|NCT03628924|451392348|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
125480535|NCT03628924|451392342|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
125480536|NCT03628924|451392343|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
125480537|NCT03628924|451392344|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
125480538|NCT03628924|451392345|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
125480539|NCT03628924|451392346|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
125480540|NCT03628924|451392347|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
125480541|NCT03628924|451392348|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
125480542|NCT03628924|451392342|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
125480543|NCT03628924|451392343|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
125480544|NCT03628924|451392344|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
125480545|NCT03628924|451392345|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
125480546|NCT03628924|451392346|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
125480547|NCT03628924|451392347|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
125480548|NCT03628924|451392348|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
125480549|NCT03628924|451392342|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
125480550|NCT03628924|451392343|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
125480551|NCT03628924|451392344|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
125480552|NCT03628924|451392345|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
125480553|NCT03628924|451392346|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
125480554|NCT03628924|451392347|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
125480555|NCT03628924|451392348|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
125480556|NCT03628924|451392342|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
125480557|NCT03628924|451392343|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
125480558|NCT03628924|451392344|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
125480559|NCT03628924|451392345|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
125480560|NCT03628924|451392346|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
125480561|NCT03628924|451392347|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
125480562|NCT03628924|451392348|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
125480563|NCT03628924|451392342|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
125480564|NCT03628924|451392343|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
125480565|NCT03628924|451392344|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
125480566|NCT03628924|451392345|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
125480567|NCT03628924|451392346|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
125480568|NCT03628924|451392347|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
125480569|NCT03628924|451392348|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
125480570|NCT03474679|451392355|FG000|Overall Study|Death|7|||
125480571|NCT03474679|451392355|FG000|Overall Study|Withdrawal by Subject|1|||
125480572|NCT04971681|451392364|FG000|Followup|Lost to Follow-up|1|||
125480573|NCT04971681|451392365|FG001|Followup|Lost to Follow-up|0|||
125480574|NCT00686335|451392366|FG000|Run-in Period|Adverse Event|1|||
125480575|NCT00686335|451392366|FG000|Run-in Period|asthma exacerbation|1|||
125480576|NCT00686335|451392366|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
125480577|NCT04149704|451392367|FG000|Three Month Follow-up|Death|2|||
125480578|NCT04149704|451392368|FG001|Three Month Follow-up|Death|0|||
125480579|NCT04149704|451392369|FG002|Three Month Follow-up|Death|0|||
125480580|NCT04149704|451392370|FG003|Three Month Follow-up|Death|0|||
125480581|NCT04149704|451392367|FG000|Three Month Follow-up|Lost to Follow-up|1|||
125480582|NCT04149704|451392368|FG001|Three Month Follow-up|Lost to Follow-up|4|||
125480583|NCT04149704|451392369|FG002|Three Month Follow-up|Lost to Follow-up|5|||
125480584|NCT04149704|451392370|FG003|Three Month Follow-up|Lost to Follow-up|5|||
125480585|NCT04149704|451392367|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
125480586|NCT04149704|451392368|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
125480587|NCT04149704|451392369|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
125480588|NCT04149704|451392370|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
125480589|NCT04149704|451392367|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
125480590|NCT04149704|451392368|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
125480591|NCT04149704|451392369|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
125480592|NCT04149704|451392370|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
125480593|NCT04332926|451392371|FG000|Overall Study|Withdrawal by Subject|6|||
125480594|NCT04332926|451392371|FG000|Overall Study|Physician Decision|6|||
125480595|NCT04111536|451392378|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
125480596|NCT04111536|451392379|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
125480597|NCT04111536|451392378|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
125480598|NCT04111536|451392379|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
125480599|NCT04111536|451392378|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
125480600|NCT04111536|451392379|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
125480601|NCT04111536|451392378|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
125480602|NCT04111536|451392379|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
125480603|NCT04350463|451392380|FG000|Overall Study|Other reason|0|||
125480604|NCT04350463|451392381|FG001|Overall Study|Other reason|0|||
125480605|NCT04350463|451392382|FG002|Overall Study|Other reason|0|||
125480606|NCT04350463|451392383|FG003|Overall Study|Other reason|1|||
125480607|NCT04350463|451392380|FG000|Overall Study|Lost to Follow-up|0|||
125480608|NCT04350463|451392381|FG001|Overall Study|Lost to Follow-up|0|||
125480609|NCT04350463|451392382|FG002|Overall Study|Lost to Follow-up|0|||
125480610|NCT04350463|451392383|FG003|Overall Study|Lost to Follow-up|2|||
125480611|NCT04350463|451392380|FG000|Overall Study|Withdrawal by Subject|4|||
125480612|NCT04350463|451392381|FG001|Overall Study|Withdrawal by Subject|0|||
125480613|NCT04350463|451392382|FG002|Overall Study|Withdrawal by Subject|1|||
125480614|NCT04350463|451392383|FG003|Overall Study|Withdrawal by Subject|4|||
125480615|NCT04350463|451392380|FG000|Overall Study|Adverse Event|0|||
125480616|NCT04350463|451392381|FG001|Overall Study|Adverse Event|0|||
125480617|NCT04350463|451392382|FG002|Overall Study|Adverse Event|0|||
125480618|NCT04350463|451392383|FG003|Overall Study|Adverse Event|2|||
125480619|NCT04350463|451392380|FG000|Overall Study|Death|27|||
125480620|NCT04350463|451392381|FG001|Overall Study|Death|2|||
125480621|NCT04350463|451392382|FG002|Overall Study|Death|13|||
125480622|NCT04350463|451392383|FG003|Overall Study|Death|26|||
125480623|NCT05672069|451392385|FG000|Overall Study|Implant removal|1|||
125480624|NCT05672069|451392385|FG000|Overall Study|Lost to Follow-up|2|||
125480625|NCT06019559|451392386|FG000|Overall Study|Withdrawal by Subject|7|||
125480626|NCT06019559|451392387|FG001|Overall Study|Withdrawal by Subject|6|||
125480627|NCT06019559|451392388|FG002|Overall Study|Withdrawal by Subject|5|||
125480628|NCT06019559|451392386|FG000|Overall Study|Lost to Follow-up|2|||
125480629|NCT06019559|451392387|FG001|Overall Study|Lost to Follow-up|0|||
125480630|NCT06019559|451392388|FG002|Overall Study|Lost to Follow-up|3|||
125480631|NCT05949788|451392389|FG000|Overall Study|severe birth deformity|2|||
125480632|NCT05949788|451392390|FG001|Overall Study|severe birth deformity|7|||
125480633|NCT05949788|451392389|FG000|Overall Study|twin-twin transfusion syndrome|2|||
125480634|NCT05949788|451392390|FG001|Overall Study|twin-twin transfusion syndrome|7|||
125480635|NCT05949788|451392389|FG000|Overall Study|neonatal hemolytic disease|3|||
125480636|NCT05949788|451392390|FG001|Overall Study|neonatal hemolytic disease|8|||
125480637|NCT05949788|451392389|FG000|Overall Study|death within 14 days after birth|2|||
125480638|NCT05949788|451392390|FG001|Overall Study|death within 14 days after birth|6|||
125480639|NCT05949788|451392389|FG000|Overall Study|transfer to another hospital|2|||
125480640|NCT05949788|451392390|FG001|Overall Study|transfer to another hospital|6|||
125480641|NCT05213390|451392391|FG000|Overall Study|Withdrawal by Subject|2|||
125480642|NCT05213390|451392391|FG000|Overall Study|Lost to Follow-up|12|||
125480643|NCT05213390|451392391|FG000|Overall Study|Protocol Violation|9|||
125480644|NCT01824537|451392392|FG000|Overall Study|Lost to Follow-up|78|||
125480645|NCT01824537|451392393|FG001|Overall Study|Lost to Follow-up|87|||
125480646|NCT06215521|451392402|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
125480647|NCT06215521|451392403|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
125480648|NCT06215521|451392404|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
125480649|NCT06215521|451392405|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
125480650|NCT06215521|451392406|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
125480651|NCT06215521|451392407|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
125480652|NCT03808818|451392411|FG000|Overall Study|Death|6|||
125480653|NCT03808818|451392412|FG001|Overall Study|Death|6|||
125480654|NCT03808818|451392411|FG000|Overall Study|Withdrawal by Subject|7|||
125480655|NCT03808818|451392412|FG001|Overall Study|Withdrawal by Subject|18|||
125480656|NCT03808818|451392411|FG000|Overall Study|Lost to Follow-up|31|||
125480657|NCT03808818|451392412|FG001|Overall Study|Lost to Follow-up|33|||
125480658|NCT03858634|451392413|FG000|Overall Study|Withdrawal by Subject|1|||
125480659|NCT03858634|451392414|FG001|Overall Study|Withdrawal by Subject|0|||
125480660|NCT03858634|451392413|FG000|Overall Study|Adverse Event|1|||
125480661|NCT03858634|451392414|FG001|Overall Study|Adverse Event|0|||
125480662|NCT03858634|451392413|FG000|Overall Study|Lost to Follow-up|0|||
125480663|NCT03858634|451392414|FG001|Overall Study|Lost to Follow-up|1|||
125480664|NCT03858634|451392413|FG000|Overall Study|Other, Not Specified|1|||
125480665|NCT03858634|451392414|FG001|Overall Study|Other, Not Specified|1|||
125480666|NCT04676763|451392415|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
125480667|NCT04676763|451392416|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
125480668|NCT04676763|451392417|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
125480669|NCT04676763|451392415|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
125480670|NCT04676763|451392416|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
125480671|NCT04676763|451392417|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
125480672|NCT04676763|451392415|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
125480673|NCT04676763|451392416|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
125480674|NCT04676763|451392417|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
125480675|NCT03031470|451392419|FG000|Overall Study|Adverse Event|3|||
125480676|NCT03031470|451392420|FG001|Overall Study|Adverse Event|0|||
125480677|NCT03031470|451392419|FG000|Overall Study|Death|3|||
125480678|NCT03031470|451392420|FG001|Overall Study|Death|1|||
125480679|NCT03031470|451392419|FG000|Overall Study|Lost to Follow-up|1|||
125480680|NCT03031470|451392420|FG001|Overall Study|Lost to Follow-up|1|||
125480681|NCT03031470|451392419|FG000|Overall Study|Withdrawal by Subject|1|||
125480682|NCT03031470|451392420|FG001|Overall Study|Withdrawal by Subject|0|||
125480683|NCT03031470|451392419|FG000|Overall Study|Protocol entry criteria not met|0|||
125480684|NCT03031470|451392420|FG001|Overall Study|Protocol entry criteria not met|1|||
125480685|NCT03031470|451392419|FG000|Overall Study|Cancel the operation|0|||
125480686|NCT03031470|451392420|FG001|Overall Study|Cancel the operation|1|||
125480687|NCT04623671|451392423|FG000|Overall Study|Adverse Event|0|||
125480688|NCT04623671|451392424|FG001|Overall Study|Adverse Event|1|||
125480689|NCT04623671|451392423|FG000|Overall Study|Lost to Follow-up|2|||
125480690|NCT04623671|451392424|FG001|Overall Study|Lost to Follow-up|1|||
125480691|NCT04623671|451392423|FG000|Overall Study|Death|5|||
125480692|NCT04623671|451392424|FG001|Overall Study|Death|5|||
125480693|NCT04663737|451392425|FG000|Overall Study|Withdrawal by Subject|2|||
125480694|NCT04663737|451392426|FG001|Overall Study|Withdrawal by Subject|0|||
125480695|NCT01943409|451392430|FG000|Overall Study|resumed oral/entral|24|||
125480696|NCT01943409|451392431|FG001|Overall Study|resumed oral/entral|20|||
125480697|NCT01943409|451392430|FG000|Overall Study|Protocol Violation|14|||
125480698|NCT01943409|451392431|FG001|Overall Study|Protocol Violation|24|||
125480699|NCT01943409|451392430|FG000|Overall Study|Death|3|||
125480700|NCT01943409|451392431|FG001|Overall Study|Death|1|||
125480701|NCT01943409|451392430|FG000|Overall Study|Withdrawal by Subject|4|||
125480702|NCT01943409|451392431|FG001|Overall Study|Withdrawal by Subject|3|||
125480703|NCT02310646|451392432|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
125480704|NCT02310646|451392433|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
125480705|NCT02310646|451392432|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
125480706|NCT02310646|451392433|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
125480707|NCT03848065|451392434|FG000|Overall Study|Death|0|||
125480708|NCT03848065|451392435|FG001|Overall Study|Death|1|||
125480709|NCT03848065|451392436|FG002|Overall Study|Death|0|||
125480710|NCT03848065|451392434|FG000|Overall Study|Lost to Follow-up|0|||
125480711|NCT03848065|451392435|FG001|Overall Study|Lost to Follow-up|0|||
125480712|NCT03848065|451392436|FG002|Overall Study|Lost to Follow-up|1|||
125480713|NCT03848065|451392434|FG000|Overall Study|Physician Decision|0|||
125480714|NCT03848065|451392435|FG001|Overall Study|Physician Decision|0|||
125480715|NCT03848065|451392436|FG002|Overall Study|Physician Decision|1|||
125480716|NCT03496168|451392443|FG000|Overall Study|Other Reasons|1|||
125480717|NCT03496168|451392443|FG000|Overall Study|Adverse Event|1|||
125480718|NCT05869383|451392444|FG000|Overall Study|Withdrawal by Subject|2|||
125480719|NCT05869383|451392445|FG001|Overall Study|Withdrawal by Subject|0|||
125480720|NCT04137367|451392446|FG000|Overall Study|Lost to Follow-up|8|||
125480721|NCT04137367|451392447|FG001|Overall Study|Lost to Follow-up|6|||
125480722|NCT04137367|451392448|FG002|Overall Study|Lost to Follow-up|4|||
125480723|NCT03907878|451392449|FG000|Treatment Period|Withdrawal by Subject|5|||
125480724|NCT03907878|451392449|FG000|Treatment Period|Adverse Event|4|||
125480725|NCT03907878|451392449|FG000|Treatment Period|Lack of Efficacy|1|||
125480726|NCT03907878|451392449|FG000|Treatment Period|Protocol Violation|1|||
125480727|NCT03907878|451392449|FG000|Follow-up Period|Adverse Event|3|||
125480728|NCT03907878|451392449|FG000|Follow-up Period|Withdrawal by Subject|3|||
125480729|NCT05144009|451392450|FG000|Overall Study|Lost to Follow-up|0|||
125480730|NCT05144009|451392451|FG001|Overall Study|Lost to Follow-up|1|||
125480731|NCT05144009|451392450|FG000|Overall Study|Study Termination by the Sponsor|11|||
125480732|NCT05144009|451392451|FG001|Overall Study|Study Termination by the Sponsor|11|||
125480733|NCT05144009|451392450|FG000|Overall Study|Disease Progression|1|||
125480734|NCT05144009|451392451|FG001|Overall Study|Disease Progression|0|||
125480735|NCT05144009|451392450|FG000|Overall Study|Participant Decision|0|||
125480736|NCT05144009|451392451|FG001|Overall Study|Participant Decision|2|||
125480737|NCT05144009|451392450|FG000|Overall Study|Death|5|||
125480738|NCT05144009|451392451|FG001|Overall Study|Death|10|||
125480739|NCT04499924|451392452|FG000|Overall Study|Study termination by sponsor|4|||
125480740|NCT04499924|451392453|FG001|Overall Study|Study termination by sponsor|6|||
125480741|NCT04499924|451392452|FG000|Overall Study|Withdrawal by Subject|1|||
125480742|NCT04499924|451392453|FG001|Overall Study|Withdrawal by Subject|3|||
125480743|NCT01648023|451392454|FG000|Overall Study|Screen Fail Post Randomization|1|||
125480744|NCT01648023|451392455|FG001|Overall Study|Screen Fail Post Randomization|2|||
125480745|NCT00433329|451394503|FG000|Overall Study|Adverse Event|9|||
125480746|NCT00433329|451394503|FG000|Overall Study|Death|4|||
125480747|NCT00433329|451394503|FG000|Overall Study|Withdrew consent|3|||
125480748|NCT00433329|451394503|FG000|Overall Study|Discontinued sildenafil|2|||
125480749|NCT00433329|451394503|FG000|Overall Study|Moved out of state|1|||
125480750|NCT00433329|451394503|FG000|Overall Study|Lost to Follow-up|1|||
125480751|NCT00433329|451394503|FG000|Overall Study|Physician Decision|1|||
125480752|NCT01098812|451394504|FG000|Overall Study|Death|2|||
125480753|NCT01098812|451394505|FG001|Overall Study|Death|0|||
125480754|NCT01098812|451394506|FG002|Overall Study|Death|1|||
125480755|NCT01098812|451394504|FG000|Overall Study|Lost to Follow-up|0|||
125480756|NCT01098812|451394505|FG001|Overall Study|Lost to Follow-up|1|||
125480757|NCT01098812|451394506|FG002|Overall Study|Lost to Follow-up|0|||
125480758|NCT01129102|451394507|FG000|Overall Study|No study drug treatment|2|||
125480759|NCT01129102|451394508|FG001|Overall Study|No study drug treatment|3|||
125480760|NCT01129102|451394509|FG002|Overall Study|No study drug treatment|1|||
125480761|NCT01129102|451394507|FG000|Overall Study|Withdrawal by Subject|2|||
125480762|NCT01129102|451394508|FG001|Overall Study|Withdrawal by Subject|0|||
125480763|NCT01129102|451394509|FG002|Overall Study|Withdrawal by Subject|3|||
125480764|NCT01129102|451394507|FG000|Overall Study|Protocol Violation|0|||
125480765|NCT01129102|451394508|FG001|Overall Study|Protocol Violation|1|||
125480766|NCT01129102|451394509|FG002|Overall Study|Protocol Violation|1|||
125480767|NCT01129102|451394507|FG000|Overall Study|Pregnancy|0|||
125480768|NCT01129102|451394508|FG001|Overall Study|Pregnancy|0|||
125480769|NCT01129102|451394509|FG002|Overall Study|Pregnancy|1|||
125480770|NCT01129102|451394507|FG000|Overall Study|Adverse Event|2|||
125480771|NCT01129102|451394508|FG001|Overall Study|Adverse Event|2|||
125480772|NCT01129102|451394509|FG002|Overall Study|Adverse Event|1|||
125480773|NCT01129102|451394507|FG000|Overall Study|Lost to Follow-up|2|||
125480774|NCT01129102|451394508|FG001|Overall Study|Lost to Follow-up|0|||
125480775|NCT01129102|451394509|FG002|Overall Study|Lost to Follow-up|0|||
125480776|NCT03379675|451394514|FG000|Overall Study|Lost to Follow-up|0|||
125480777|NCT03379675|451394515|FG001|Overall Study|Lost to Follow-up|1|||
125480778|NCT03379675|451394516|FG002|Overall Study|Lost to Follow-up|0|||
125480779|NCT03379675|451394514|FG000|Overall Study|Adverse Event|2|||
125480780|NCT03379675|451394515|FG001|Overall Study|Adverse Event|0|||
125480781|NCT03379675|451394516|FG002|Overall Study|Adverse Event|0|||
125480782|NCT03379675|451394514|FG000|Overall Study|Withdrawal by Subject|2|||
125480783|NCT03379675|451394515|FG001|Overall Study|Withdrawal by Subject|1|||
125480784|NCT03379675|451394516|FG002|Overall Study|Withdrawal by Subject|2|||
125480785|NCT03462030|451394520|FG000|Overall Study|Withdrawal by Subject|1|||
125480786|NCT03462030|451394521|FG001|Overall Study|Withdrawal by Subject|1|||
125480787|NCT03381196|451394522|FG000|Overall Study|Withdrawal by Subject|7|||
125480788|NCT03381196|451394523|FG001|Overall Study|Withdrawal by Subject|7|||
125480789|NCT03381196|451394522|FG000|Overall Study|Other|0|||
125480790|NCT03381196|451394523|FG001|Overall Study|Other|1|||
125480791|NCT03381196|451394522|FG000|Overall Study|Lost to Follow-up|5|||
125480792|NCT03381196|451394523|FG001|Overall Study|Lost to Follow-up|4|||
125480793|NCT03381196|451394522|FG000|Overall Study|Death|0|||
125480794|NCT03381196|451394523|FG001|Overall Study|Death|1|||
125480795|NCT03381196|451394522|FG000|Overall Study|Adverse Event|1|||
125480796|NCT03381196|451394523|FG001|Overall Study|Adverse Event|0|||
125480797|NCT03381196|451394522|FG000|Overall Study|Randomized, not treated|3|||
125480798|NCT03381196|451394523|FG001|Overall Study|Randomized, not treated|6|||
125480799|NCT02675751|451394524|FG000|Overall Study|Lost to Follow-up|16|||
125480800|NCT03371381|451394525|FG000|Overall Study|Death|5|||
125480801|NCT03371381|451394525|FG000|Overall Study|Study terminated by sponsor|3|||
125480802|NCT03371381|451394525|FG000|Overall Study|Other|4|||
125480803|NCT02979327|451394526|FG000|First Intervention|Protocol Violation|1|||
125480804|NCT02979327|451394527|FG001|First Intervention|Protocol Violation|0|||
125480805|NCT05020249|451394528|FG000|Overall Study|Protocol Violation|1|||
125480806|NCT05020249|451394529|FG001|Overall Study|Protocol Violation|0|||
125480807|NCT01539083|451394538|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
125480808|NCT01539083|451394539|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
125480809|NCT01539083|451394540|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
125480810|NCT01539083|451394538|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
125480811|NCT01539083|451394539|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
125480812|NCT01539083|451394540|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
125480813|NCT01539083|451394538|FG000|Before Randomization (VCD Induction)|Death|6|||
125480814|NCT01539083|451394539|FG001|Before Randomization (VCD Induction)|Death|0|||
125480815|NCT01539083|451394540|FG002|Before Randomization (VCD Induction)|Death|0|||
125480816|NCT01539083|451394538|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
125480817|NCT01539083|451394539|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
125480818|NCT01539083|451394540|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
125480819|NCT01539083|451394538|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
125480820|NCT01539083|451394539|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
125480821|NCT01539083|451394540|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
125480822|NCT01539083|451394538|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
125480823|NCT01539083|451394539|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
125480824|NCT01539083|451394540|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
125480825|NCT01539083|451394538|FG000|Before Randomization (VCD Induction)|Other|5|||
125480826|NCT01539083|451394539|FG001|Before Randomization (VCD Induction)|Other|0|||
125480827|NCT01539083|451394540|FG002|Before Randomization (VCD Induction)|Other|0|||
125480828|NCT01539083|451394538|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
125480829|NCT01539083|451394539|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
125480830|NCT01539083|451394540|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
125480831|NCT01539083|451394538|FG000|After Randomization (TP and VTP)|Other|0|||
125480832|NCT01539083|451394539|FG001|After Randomization (TP and VTP)|Other|1|||
125480833|NCT01539083|451394540|FG002|After Randomization (TP and VTP)|Other|1|||
125480834|NCT01539083|451394538|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
125480835|NCT01539083|451394539|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
125480836|NCT01539083|451394540|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
125480837|NCT01539083|451394538|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
125480838|NCT01539083|451394539|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
125480839|NCT01539083|451394540|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
125480840|NCT01539083|451394538|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
125480841|NCT01539083|451394539|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
125480842|NCT01539083|451394540|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
125480843|NCT01539083|451394538|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
125480844|NCT01539083|451394539|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
125480845|NCT01539083|451394540|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
125480846|NCT01539083|451394538|FG000|After Randomization (TP and VTP)|Death|0|||
125480847|NCT01539083|451394539|FG001|After Randomization (TP and VTP)|Death|6|||
125480848|NCT01539083|451394540|FG002|After Randomization (TP and VTP)|Death|11|||
125480849|NCT05499377|451394541|FG000|Overall Study|Withdrawal by Subject|2|||
125480850|NCT05499377|451394542|FG001|Overall Study|Withdrawal by Subject|0|||
125480851|NCT05499377|451394541|FG000|Overall Study|Physician Decision|1|||
125480852|NCT05499377|451394542|FG001|Overall Study|Physician Decision|0|||
125480853|NCT02573493|451394543|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
125480854|NCT02573493|451394544|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
125480855|NCT02573493|451394545|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
125480856|NCT02573493|451394546|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
125480857|NCT02677805|451394552|FG000|Double Blind Phase|Lost to Follow-up|8|||
125480858|NCT02677805|451394553|FG001|Double Blind Phase|Lost to Follow-up|3|||
125480859|NCT02677805|451394554|FG002|Double Blind Phase|Lost to Follow-up|0|||
125480860|NCT02677805|451394552|FG000|Double Blind Phase|Withdrawal by Subject|5|||
125480861|NCT02677805|451394553|FG001|Double Blind Phase|Withdrawal by Subject|2|||
125480862|NCT02677805|451394554|FG002|Double Blind Phase|Withdrawal by Subject|0|||
125480863|NCT02677805|451394552|FG000|Open Label Phase|Lost to Follow-up|0|||
125480864|NCT02677805|451394553|FG001|Open Label Phase|Lost to Follow-up|0|||
125480865|NCT02677805|451394554|FG002|Open Label Phase|Lost to Follow-up|10|||
125480866|NCT02677805|451394552|FG000|Open Label Phase|Withdrawal by Subject|0|||
125480867|NCT02677805|451394553|FG001|Open Label Phase|Withdrawal by Subject|0|||
125480868|NCT02677805|451394554|FG002|Open Label Phase|Withdrawal by Subject|6|||
125480869|NCT05714761|451394555|FG000|Overall Study|Lost to Follow-up|3|||
125480870|NCT05714761|451394555|FG000|Overall Study|Withdrawal by Subject|3|||
125480871|NCT05714761|451394555|FG000|Overall Study|unblinding of sensor data|1|||
125480872|NCT05714761|451394555|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
125480873|NCT05714761|451394555|FG000|Overall Study|did not return second CGM sensor|4|||
125480874|NCT03150173|451394556|FG000|Overall Study|Lost to Follow-up|13|||
125480875|NCT03150173|451394557|FG001|Overall Study|Lost to Follow-up|5|||
125480876|NCT02191618|451394564|FG000|Overall Study|Withdrawal by Subject|3|||
125480877|NCT02191618|451394564|FG000|Overall Study|Missed Visit|4|||
125480878|NCT01802788|451394567|FG000|Overall Study|Withdrawal by Subject|102|||
125480879|NCT01802788|451394568|FG001|Overall Study|Withdrawal by Subject|5|||
125480880|NCT01802788|451394567|FG000|Overall Study|Death|382|||
125480881|NCT01802788|451394568|FG001|Overall Study|Death|18|||
125480882|NCT01802788|451394567|FG000|Overall Study|Lost to Follow-up|31|||
125480883|NCT01802788|451394568|FG001|Overall Study|Lost to Follow-up|2|||
125480884|NCT01802788|451394567|FG000|Overall Study|Physician Decision|3|||
125480885|NCT01802788|451394568|FG001|Overall Study|Physician Decision|0|||
125480886|NCT01802788|451394567|FG000|Overall Study|Patient Non-Compliance|1|||
125480887|NCT01802788|451394568|FG001|Overall Study|Patient Non-Compliance|0|||
125480888|NCT01802788|451394567|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
125480889|NCT01802788|451394568|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
125480890|NCT01802788|451394567|FG000|Overall Study|Other Reasons|19|||
125480891|NCT01802788|451394568|FG001|Overall Study|Other Reasons|0|||
125480892|NCT03011333|451394575|FG000|Overall Study|Lost to Follow-up|0|||
125480893|NCT03011333|451394576|FG001|Overall Study|Lost to Follow-up|1|||
125480894|NCT03011333|451394577|FG002|Overall Study|Lost to Follow-up|0|||
125480895|NCT03011333|451394578|FG003|Overall Study|Lost to Follow-up|1|||
125480896|NCT03011333|451394579|FG004|Overall Study|Lost to Follow-up|4|||
125480897|NCT03011333|451394580|FG005|Overall Study|Lost to Follow-up|4|||
125480898|NCT03011333|451394581|FG006|Overall Study|Lost to Follow-up|5|||
125480899|NCT05269667|451394586|FG000|Overall Study|Study Terminated by Sponsor|4|||
125480900|NCT04599062|451394592|FG000|Overall Study|Physician Decision|1|||
125480901|NCT04599062|451394593|FG001|Overall Study|Physician Decision|0|||
125480902|NCT04074759|451394595|FG000|Overall Study|Withdrawal by Subject|0|||
125480903|NCT04074759|451394596|FG001|Overall Study|Withdrawal by Subject|0|||
125480904|NCT04074759|451394597|FG002|Overall Study|Withdrawal by Subject|0|||
125480905|NCT04074759|451394598|FG003|Overall Study|Withdrawal by Subject|0|||
125480906|NCT04074759|451394599|FG004|Overall Study|Withdrawal by Subject|0|||
125480907|NCT04074759|451394600|FG005|Overall Study|Withdrawal by Subject|2|||
125480908|NCT04074759|451394601|FG006|Overall Study|Withdrawal by Subject|0|||
125480909|NCT04074759|451394602|FG007|Overall Study|Withdrawal by Subject|2|||
125480910|NCT04074759|451394603|FG008|Overall Study|Withdrawal by Subject|1|||
125480911|NCT04074759|451394604|FG009|Overall Study|Withdrawal by Subject|2|||
125480912|NCT04074759|451394605|FG010|Overall Study|Withdrawal by Subject|9|||
125480913|NCT04074759|451394606|FG011|Overall Study|Withdrawal by Subject|2|||
125480914|NCT04074759|451394607|FG012|Overall Study|Withdrawal by Subject|1|||
125480915|NCT04074759|451394608|FG013|Overall Study|Withdrawal by Subject|3|||
125480916|NCT04074759|451394609|FG014|Overall Study|Withdrawal by Subject|2|||
125480917|NCT04074759|451394610|FG015|Overall Study|Withdrawal by Subject|0|||
125480918|NCT04074759|451394611|FG016|Overall Study|Withdrawal by Subject|0|||
125480919|NCT04074759|451394612|FG017|Overall Study|Withdrawal by Subject|3|||
125480920|NCT04074759|451394613|FG018|Overall Study|Withdrawal by Subject|1|||
125480921|NCT04074759|451394595|FG000|Overall Study|Death|1|||
125480922|NCT04074759|451394596|FG001|Overall Study|Death|0|||
125480923|NCT04074759|451394597|FG002|Overall Study|Death|1|||
125480924|NCT04074759|451394598|FG003|Overall Study|Death|1|||
125480925|NCT04074759|451394599|FG004|Overall Study|Death|2|||
125480926|NCT04074759|451394600|FG005|Overall Study|Death|0|||
125480927|NCT04074759|451394601|FG006|Overall Study|Death|1|||
125480928|NCT04074759|451394602|FG007|Overall Study|Death|0|||
125480929|NCT04074759|451394603|FG008|Overall Study|Death|3|||
125480930|NCT04074759|451394604|FG009|Overall Study|Death|2|||
125480931|NCT04074759|451394605|FG010|Overall Study|Death|4|||
125480932|NCT04074759|451394606|FG011|Overall Study|Death|1|||
125480933|NCT04074759|451394607|FG012|Overall Study|Death|0|||
125480934|NCT04074759|451394608|FG013|Overall Study|Death|2|||
125480935|NCT04074759|451394609|FG014|Overall Study|Death|1|||
125480936|NCT04074759|451394610|FG015|Overall Study|Death|0|||
125480937|NCT04074759|451394611|FG016|Overall Study|Death|1|||
125480938|NCT04074759|451394612|FG017|Overall Study|Death|0|||
125480939|NCT04074759|451394613|FG018|Overall Study|Death|1|||
125480940|NCT04074759|451394595|FG000|Overall Study|Lost to Follow-up|0|||
125480941|NCT04074759|451394596|FG001|Overall Study|Lost to Follow-up|0|||
125480942|NCT04074759|451394597|FG002|Overall Study|Lost to Follow-up|0|||
125480943|NCT04074759|451394598|FG003|Overall Study|Lost to Follow-up|0|||
125480944|NCT04074759|451394599|FG004|Overall Study|Lost to Follow-up|0|||
125480945|NCT04074759|451394600|FG005|Overall Study|Lost to Follow-up|0|||
125480946|NCT04074759|451394601|FG006|Overall Study|Lost to Follow-up|0|||
125480947|NCT04074759|451394602|FG007|Overall Study|Lost to Follow-up|0|||
125480948|NCT04074759|451394603|FG008|Overall Study|Lost to Follow-up|0|||
125480949|NCT04074759|451394604|FG009|Overall Study|Lost to Follow-up|0|||
125480950|NCT04074759|451394605|FG010|Overall Study|Lost to Follow-up|1|||
125480951|NCT04074759|451394606|FG011|Overall Study|Lost to Follow-up|0|||
125480952|NCT04074759|451394607|FG012|Overall Study|Lost to Follow-up|0|||
125480953|NCT04074759|451394608|FG013|Overall Study|Lost to Follow-up|0|||
125480954|NCT04074759|451394609|FG014|Overall Study|Lost to Follow-up|0|||
125480955|NCT04074759|451394610|FG015|Overall Study|Lost to Follow-up|0|||
125480956|NCT04074759|451394611|FG016|Overall Study|Lost to Follow-up|1|||
125480957|NCT04074759|451394612|FG017|Overall Study|Lost to Follow-up|0|||
125480958|NCT04074759|451394613|FG018|Overall Study|Lost to Follow-up|1|||
125480959|NCT04074759|451394595|FG000|Overall Study|Other|0|||
125480960|NCT04074759|451394596|FG001|Overall Study|Other|1|||
125480961|NCT04074759|451394597|FG002|Overall Study|Other|1|||
125480962|NCT04074759|451394598|FG003|Overall Study|Other|0|||
125480963|NCT04074759|451394599|FG004|Overall Study|Other|2|||
125480964|NCT04074759|451394600|FG005|Overall Study|Other|1|||
125480965|NCT04074759|451394601|FG006|Overall Study|Other|2|||
125480966|NCT04074759|451394602|FG007|Overall Study|Other|1|||
125480967|NCT04074759|451394603|FG008|Overall Study|Other|1|||
125480968|NCT04074759|451394604|FG009|Overall Study|Other|4|||
125480969|NCT04074759|451394605|FG010|Overall Study|Other|4|||
125480970|NCT04074759|451394606|FG011|Overall Study|Other|2|||
125480971|NCT04074759|451394607|FG012|Overall Study|Other|0|||
125480972|NCT04074759|451394608|FG013|Overall Study|Other|0|||
125480973|NCT04074759|451394609|FG014|Overall Study|Other|0|||
125480974|NCT04074759|451394610|FG015|Overall Study|Other|1|||
125480975|NCT04074759|451394611|FG016|Overall Study|Other|0|||
125480976|NCT04074759|451394612|FG017|Overall Study|Other|0|||
125480977|NCT04074759|451394613|FG018|Overall Study|Other|0|||
125480978|NCT04074759|451394595|FG000|Overall Study|Missing end of study status|0|||
125480979|NCT04074759|451394596|FG001|Overall Study|Missing end of study status|0|||
125480980|NCT04074759|451394597|FG002|Overall Study|Missing end of study status|0|||
125480981|NCT04074759|451394598|FG003|Overall Study|Missing end of study status|0|||
125480982|NCT04074759|451394599|FG004|Overall Study|Missing end of study status|0|||
125480983|NCT04074759|451394600|FG005|Overall Study|Missing end of study status|0|||
125480984|NCT04074759|451394601|FG006|Overall Study|Missing end of study status|0|||
125480985|NCT04074759|451394602|FG007|Overall Study|Missing end of study status|0|||
125480986|NCT04074759|451394603|FG008|Overall Study|Missing end of study status|0|||
125480987|NCT04074759|451394604|FG009|Overall Study|Missing end of study status|0|||
125480988|NCT04074759|451394605|FG010|Overall Study|Missing end of study status|2|||
125480989|NCT04074759|451394606|FG011|Overall Study|Missing end of study status|0|||
125480990|NCT04074759|451394607|FG012|Overall Study|Missing end of study status|0|||
125480991|NCT04074759|451394608|FG013|Overall Study|Missing end of study status|0|||
125480992|NCT04074759|451394609|FG014|Overall Study|Missing end of study status|0|||
125480993|NCT04074759|451394610|FG015|Overall Study|Missing end of study status|0|||
125480994|NCT04074759|451394611|FG016|Overall Study|Missing end of study status|1|||
125480995|NCT04074759|451394612|FG017|Overall Study|Missing end of study status|0|||
125480996|NCT04074759|451394613|FG018|Overall Study|Missing end of study status|0|||
125480997|NCT02231164|451394622|FG000|Overall Study|Adverse Event|1|||
125480998|NCT02231164|451394623|FG001|Overall Study|Adverse Event|1|||
125480999|NCT02231164|451394622|FG000|Overall Study|Lack of Efficacy|4|||
125481000|NCT02231164|451394623|FG001|Overall Study|Lack of Efficacy|3|||
125481001|NCT02231164|451394622|FG000|Overall Study|Withdrawal by Subject|1|||
125481002|NCT02231164|451394623|FG001|Overall Study|Withdrawal by Subject|2|||
125481003|NCT04436276|451394624|FG000|Overall Study|Adverse Event|0|||
125481004|NCT04436276|451394625|FG001|Overall Study|Adverse Event|0|||
125481005|NCT04436276|451394626|FG002|Overall Study|Adverse Event|0|||
125481006|NCT04436276|451394627|FG003|Overall Study|Adverse Event|0|||
125481007|NCT04436276|451394628|FG004|Overall Study|Adverse Event|0|||
125481008|NCT04436276|451394629|FG005|Overall Study|Adverse Event|0|||
125481009|NCT04436276|451394630|FG006|Overall Study|Adverse Event|0|||
125481010|NCT04436276|451394631|FG007|Overall Study|Adverse Event|0|||
125481011|NCT04436276|451394632|FG008|Overall Study|Adverse Event|0|||
125481012|NCT04436276|451394633|FG009|Overall Study|Adverse Event|0|||
125481013|NCT04436276|451394634|FG010|Overall Study|Adverse Event|0|||
125481014|NCT04436276|451394635|FG011|Overall Study|Adverse Event|0|||
125481015|NCT04436276|451394636|FG012|Overall Study|Adverse Event|0|||
125481016|NCT04436276|451394637|FG013|Overall Study|Adverse Event|0|||
125481017|NCT04436276|451394638|FG014|Overall Study|Adverse Event|0|||
125481018|NCT04436276|451394639|FG015|Overall Study|Adverse Event|0|||
125481019|NCT04436276|451394640|FG016|Overall Study|Adverse Event|1|||
125481020|NCT04436276|451394641|FG017|Overall Study|Adverse Event|0|||
125481021|NCT04436276|451394642|FG018|Overall Study|Adverse Event|0|||
125481022|NCT04436276|451394643|FG019|Overall Study|Adverse Event|0|||
125481023|NCT04436276|451394644|FG020|Overall Study|Adverse Event|0|||
125481024|NCT04436276|451394645|FG021|Overall Study|Adverse Event|0|||
125481025|NCT04436276|451394646|FG022|Overall Study|Adverse Event|0|||
125481026|NCT04436276|451394624|FG000|Overall Study|Death|0|||
125481027|NCT04436276|451394625|FG001|Overall Study|Death|0|||
125481028|NCT04436276|451394626|FG002|Overall Study|Death|0|||
125481029|NCT04436276|451394627|FG003|Overall Study|Death|0|||
125481030|NCT04436276|451394628|FG004|Overall Study|Death|0|||
125481031|NCT04436276|451394629|FG005|Overall Study|Death|0|||
125481032|NCT04436276|451394630|FG006|Overall Study|Death|0|||
125481033|NCT04436276|451394631|FG007|Overall Study|Death|0|||
125481034|NCT04436276|451394632|FG008|Overall Study|Death|0|||
125481035|NCT04436276|451394633|FG009|Overall Study|Death|0|||
125481036|NCT04436276|451394634|FG010|Overall Study|Death|0|||
125481037|NCT04436276|451394635|FG011|Overall Study|Death|0|||
125481038|NCT04436276|451394636|FG012|Overall Study|Death|1|||
125481039|NCT04436276|451394637|FG013|Overall Study|Death|0|||
125481040|NCT04436276|451394638|FG014|Overall Study|Death|1|||
125481041|NCT04436276|451394639|FG015|Overall Study|Death|0|||
125481042|NCT04436276|451394640|FG016|Overall Study|Death|0|||
125481043|NCT04436276|451394641|FG017|Overall Study|Death|0|||
125481044|NCT04436276|451394642|FG018|Overall Study|Death|0|||
125481045|NCT04436276|451394643|FG019|Overall Study|Death|2|||
125481046|NCT04436276|451394644|FG020|Overall Study|Death|0|||
125481047|NCT04436276|451394645|FG021|Overall Study|Death|1|||
125481048|NCT04436276|451394646|FG022|Overall Study|Death|0|||
125481049|NCT04436276|451394624|FG000|Overall Study|Lost to Follow-up|0|||
125481050|NCT04436276|451394625|FG001|Overall Study|Lost to Follow-up|2|||
125481051|NCT04436276|451394626|FG002|Overall Study|Lost to Follow-up|2|||
125481052|NCT04436276|451394627|FG003|Overall Study|Lost to Follow-up|1|||
125481053|NCT04436276|451394628|FG004|Overall Study|Lost to Follow-up|4|||
125481054|NCT04436276|451394629|FG005|Overall Study|Lost to Follow-up|1|||
125481055|NCT04436276|451394630|FG006|Overall Study|Lost to Follow-up|0|||
125481056|NCT04436276|451394631|FG007|Overall Study|Lost to Follow-up|0|||
125481057|NCT04436276|451394632|FG008|Overall Study|Lost to Follow-up|1|||
125481058|NCT04436276|451394633|FG009|Overall Study|Lost to Follow-up|0|||
125481059|NCT04436276|451394634|FG010|Overall Study|Lost to Follow-up|5|||
125481060|NCT04436276|451394635|FG011|Overall Study|Lost to Follow-up|5|||
125481061|NCT04436276|451394636|FG012|Overall Study|Lost to Follow-up|4|||
125481062|NCT04436276|451394637|FG013|Overall Study|Lost to Follow-up|1|||
125481063|NCT04436276|451394638|FG014|Overall Study|Lost to Follow-up|7|||
125481064|NCT04436276|451394639|FG015|Overall Study|Lost to Follow-up|7|||
125481065|NCT04436276|451394640|FG016|Overall Study|Lost to Follow-up|1|||
125481066|NCT04436276|451394641|FG017|Overall Study|Lost to Follow-up|0|||
125481067|NCT04436276|451394642|FG018|Overall Study|Lost to Follow-up|1|||
125481068|NCT04436276|451394643|FG019|Overall Study|Lost to Follow-up|1|||
125481069|NCT04436276|451394644|FG020|Overall Study|Lost to Follow-up|2|||
125481070|NCT04436276|451394645|FG021|Overall Study|Lost to Follow-up|1|||
125481071|NCT04436276|451394646|FG022|Overall Study|Lost to Follow-up|1|||
125481072|NCT04436276|451394624|FG000|Overall Study|Physician Decision|1|||
125481073|NCT04436276|451394625|FG001|Overall Study|Physician Decision|0|||
125481074|NCT04436276|451394626|FG002|Overall Study|Physician Decision|2|||
125481075|NCT04436276|451394627|FG003|Overall Study|Physician Decision|1|||
125481076|NCT04436276|451394628|FG004|Overall Study|Physician Decision|0|||
125481077|NCT04436276|451394629|FG005|Overall Study|Physician Decision|0|||
125481078|NCT04436276|451394630|FG006|Overall Study|Physician Decision|0|||
125481079|NCT04436276|451394631|FG007|Overall Study|Physician Decision|0|||
125481080|NCT04436276|451394632|FG008|Overall Study|Physician Decision|0|||
125481081|NCT04436276|451394633|FG009|Overall Study|Physician Decision|0|||
125481082|NCT04436276|451394634|FG010|Overall Study|Physician Decision|0|||
125481083|NCT04436276|451394635|FG011|Overall Study|Physician Decision|1|||
125481084|NCT04436276|451394636|FG012|Overall Study|Physician Decision|2|||
125481085|NCT04436276|451394637|FG013|Overall Study|Physician Decision|0|||
125481086|NCT04436276|451394638|FG014|Overall Study|Physician Decision|0|||
125481087|NCT04436276|451394639|FG015|Overall Study|Physician Decision|0|||
125481088|NCT04436276|451394640|FG016|Overall Study|Physician Decision|0|||
125481089|NCT04436276|451394641|FG017|Overall Study|Physician Decision|0|||
125481090|NCT04436276|451394642|FG018|Overall Study|Physician Decision|0|||
125481091|NCT04436276|451394643|FG019|Overall Study|Physician Decision|0|||
125481092|NCT04436276|451394644|FG020|Overall Study|Physician Decision|1|||
125481093|NCT04436276|451394645|FG021|Overall Study|Physician Decision|2|||
125481094|NCT04436276|451394646|FG022|Overall Study|Physician Decision|0|||
125481095|NCT04436276|451394624|FG000|Overall Study|Protocol Violation|0|||
125481096|NCT04436276|451394625|FG001|Overall Study|Protocol Violation|0|||
125481097|NCT04436276|451394626|FG002|Overall Study|Protocol Violation|0|||
125481098|NCT04436276|451394627|FG003|Overall Study|Protocol Violation|0|||
125481099|NCT04436276|451394628|FG004|Overall Study|Protocol Violation|0|||
125481100|NCT04436276|451394629|FG005|Overall Study|Protocol Violation|0|||
125481101|NCT04436276|451394630|FG006|Overall Study|Protocol Violation|0|||
125302098|NCT00383162|450731925|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
125302099|NCT00383162|450731924|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
125302100|NCT00383162|450731925|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
125302101|NCT00383162|450731924|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
125302102|NCT00383162|450731925|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
125302103|NCT00383162|450731924|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
125302104|NCT00383162|450731925|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
125302105|NCT00383162|450731924|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
125302106|NCT00383162|450731925|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
125302107|NCT05392803|450731926|FG000|Overall Study|Lost to Follow-up|0|||
125302108|NCT05392803|450731927|FG001|Overall Study|Lost to Follow-up|2|||
125302109|NCT01069705|450731928|FG000|Overall Study|Adverse Event|1|||
125302110|NCT01069705|450731928|FG000|Overall Study|Withdrawal by Subject|2|||
125302111|NCT02726022|450731929|FG000|Overall Study|Adverse Event|14|||
125302112|NCT02726022|450731929|FG000|Overall Study|Treatment Failure|8|||
125302113|NCT02726022|450731929|FG000|Overall Study|Poor Compliance|13|||
125302114|NCT02726022|450731929|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
125302115|NCT00915551|450731930|FG000|Overall Study|Withdrawal by Subject|0|||
125302116|NCT00915551|450731931|FG001|Overall Study|Withdrawal by Subject|1|||
125302117|NCT00235716|450731932|FG000|Overall Study|Death|26|||
125302118|NCT00235716|450731933|FG001|Overall Study|Death|39|||
125302119|NCT00235716|450731934|FG002|Overall Study|Death|32|||
125302120|NCT00235716|450731935|FG003|Overall Study|Death|31|||
125302121|NCT00235716|450731932|FG000|Overall Study|Withdrawal by Subject|23|||
125302122|NCT00235716|450731933|FG001|Overall Study|Withdrawal by Subject|19|||
125302123|NCT00235716|450731934|FG002|Overall Study|Withdrawal by Subject|17|||
125302124|NCT00235716|450731935|FG003|Overall Study|Withdrawal by Subject|18|||
125302125|NCT00235716|450731932|FG000|Overall Study|Lost to Follow-up|12|||
125302126|NCT00235716|450731933|FG001|Overall Study|Lost to Follow-up|7|||
125302127|NCT00235716|450731934|FG002|Overall Study|Lost to Follow-up|14|||
125302128|NCT00235716|450731935|FG003|Overall Study|Lost to Follow-up|10|||
125302129|NCT00235716|450731932|FG000|Overall Study|Adverse Event|1|||
125302130|NCT00235716|450731933|FG001|Overall Study|Adverse Event|1|||
125302131|NCT00235716|450731934|FG002|Overall Study|Adverse Event|1|||
125302132|NCT00235716|450731935|FG003|Overall Study|Adverse Event|0|||
125302133|NCT00235716|450731932|FG000|Overall Study|Physician Decision|0|||
125302134|NCT00235716|450731933|FG001|Overall Study|Physician Decision|1|||
125302135|NCT00235716|450731934|FG002|Overall Study|Physician Decision|1|||
125302136|NCT00235716|450731935|FG003|Overall Study|Physician Decision|3|||
125302137|NCT04390841|450731936|FG000|Overall Study|Withdrawal by Subject|2|||
125302138|NCT02188849|450731947|FG000|Overall Study|Lost to Follow-up|3|||
125302139|NCT02188849|450731948|FG001|Overall Study|Lost to Follow-up|8|||
125302140|NCT05090852|450731959|FG000|Overall Study|Physician Decision|5|||
125302141|NCT01196416|450731960|FG000|Overall Study|Withdrawal by Subject|2|||
125302142|NCT00504894|450731961|FG000|Overall Study|fMRI technical problems|1|||
125302143|NCT00504894|450731962|FG001|Overall Study|fMRI technical problems|1|||
125302144|NCT00504894|450731963|FG002|Overall Study|fMRI technical problems|0|||
125302145|NCT00504894|450731961|FG000|Overall Study|Withdrawal by Subject|0|||
125302146|NCT00504894|450731962|FG001|Overall Study|Withdrawal by Subject|1|||
125302147|NCT00504894|450731963|FG002|Overall Study|Withdrawal by Subject|0|||
125302148|NCT00504894|450731961|FG000|Overall Study|Infusion technical problems|0|||
125302149|NCT00504894|450731962|FG001|Overall Study|Infusion technical problems|1|||
125302150|NCT00504894|450731963|FG002|Overall Study|Infusion technical problems|0|||
125481102|NCT04436276|451394631|FG007|Overall Study|Protocol Violation|0|||
125481103|NCT04436276|451394632|FG008|Overall Study|Protocol Violation|0|||
125302151|NCT00504894|450731961|FG000|Overall Study|poor subject data|2|||
125302152|NCT00504894|450731962|FG001|Overall Study|poor subject data|0|||
125302153|NCT00504894|450731963|FG002|Overall Study|poor subject data|0|||
125302154|NCT00148941|450731965|FG000|Overall Study|Lost to Follow-up|17|||
125302155|NCT00148941|450731966|FG001|Overall Study|Lost to Follow-up|24|||
125302156|NCT00148941|450731967|FG002|Overall Study|Lost to Follow-up|18|||
125302157|NCT00148941|450731968|FG003|Overall Study|Lost to Follow-up|22|||
125302158|NCT00148941|450731965|FG000|Overall Study|Withdrawal by Subject|1|||
125302159|NCT00148941|450731966|FG001|Overall Study|Withdrawal by Subject|0|||
125302160|NCT00148941|450731967|FG002|Overall Study|Withdrawal by Subject|1|||
125302161|NCT00148941|450731968|FG003|Overall Study|Withdrawal by Subject|0|||
125481104|NCT04436276|451394633|FG009|Overall Study|Protocol Violation|0|||
125481105|NCT04436276|451394634|FG010|Overall Study|Protocol Violation|0|||
125481106|NCT04436276|451394635|FG011|Overall Study|Protocol Violation|0|||
125302162|NCT00148941|450731965|FG000|Overall Study|Other|0|||
125302163|NCT00148941|450731966|FG001|Overall Study|Other|0|||
125302164|NCT00148941|450731967|FG002|Overall Study|Other|1|||
125302165|NCT00148941|450731968|FG003|Overall Study|Other|2|||
125302166|NCT03244826|450731969|FG000|Overall Study|Withdrawal by Subject|2|||
125302167|NCT03244826|450731970|FG001|Overall Study|Withdrawal by Subject|0|||
125302168|NCT03244826|450731969|FG000|Overall Study|Transplant delayed or withdrawn|12|||
125302169|NCT03244826|450731970|FG001|Overall Study|Transplant delayed or withdrawn|10|||
125302170|NCT02673684|450731971|FG000|Overall Study|Study not completed d/t loss of funding|9|||
125302171|NCT02673684|450731972|FG001|Overall Study|Study not completed d/t loss of funding|8|||
125302172|NCT00416455|450731978|FG000|Overall Study|PET / CT not done|3|||
125302173|NCT00416455|450731979|FG001|Overall Study|PET / CT not done|5|||
125302174|NCT00416455|450731978|FG000|Overall Study|PET / CT poor quality|2|||
125302175|NCT00416455|450731979|FG001|Overall Study|PET / CT poor quality|1|||
125302176|NCT00416455|450731978|FG000|Overall Study|Inadequate pathology|11|||
125302177|NCT00416455|450731979|FG001|Overall Study|Inadequate pathology|2|||
125302178|NCT04079114|450731981|FG000|Overall Study|Study prematuely terminated.|166|||
125302179|NCT04699461|450731988|FG000|Overall Study|Withdrawal by Subject|1|||
125302180|NCT04699461|450731989|FG001|Overall Study|Withdrawal by Subject|0|||
125302181|NCT04699461|450731988|FG000|Overall Study|Study termination by sponsor|2|||
125302182|NCT04699461|450731989|FG001|Overall Study|Study termination by sponsor|1|||
125302183|NCT04699461|450731988|FG000|Overall Study|Death|1|||
125302184|NCT04699461|450731989|FG001|Overall Study|Death|0|||
125302185|NCT04699461|450731988|FG000|Overall Study|Radiographic progression|0|||
125302186|NCT04699461|450731989|FG001|Overall Study|Radiographic progression|1|||
125302187|NCT03068767|450731991|FG000|Overall Study|Lost to Follow-up|7|||
125481107|NCT04436276|451394636|FG012|Overall Study|Protocol Violation|0|||
125481108|NCT04436276|451394637|FG013|Overall Study|Protocol Violation|1|||
125481109|NCT04436276|451394638|FG014|Overall Study|Protocol Violation|0|||
125481110|NCT04436276|451394639|FG015|Overall Study|Protocol Violation|1|||
125481111|NCT04436276|451394640|FG016|Overall Study|Protocol Violation|0|||
125481112|NCT04436276|451394641|FG017|Overall Study|Protocol Violation|0|||
125481113|NCT04436276|451394642|FG018|Overall Study|Protocol Violation|0|||
125481114|NCT04436276|451394643|FG019|Overall Study|Protocol Violation|0|||
125481115|NCT04436276|451394644|FG020|Overall Study|Protocol Violation|0|||
125481116|NCT04436276|451394645|FG021|Overall Study|Protocol Violation|0|||
125481117|NCT04436276|451394646|FG022|Overall Study|Protocol Violation|0|||
125481118|NCT04436276|451394624|FG000|Overall Study|Withdrawal by Subject|25|||
125481119|NCT04436276|451394625|FG001|Overall Study|Withdrawal by Subject|22|||
125481120|NCT04436276|451394626|FG002|Overall Study|Withdrawal by Subject|24|||
125481121|NCT04436276|451394627|FG003|Overall Study|Withdrawal by Subject|23|||
125481122|NCT04436276|451394628|FG004|Overall Study|Withdrawal by Subject|14|||
125481123|NCT04436276|451394629|FG005|Overall Study|Withdrawal by Subject|0|||
125481124|NCT04436276|451394630|FG006|Overall Study|Withdrawal by Subject|0|||
125481125|NCT04436276|451394631|FG007|Overall Study|Withdrawal by Subject|1|||
125481126|NCT04436276|451394632|FG008|Overall Study|Withdrawal by Subject|0|||
125481127|NCT04436276|451394633|FG009|Overall Study|Withdrawal by Subject|1|||
125481128|NCT04436276|451394634|FG010|Overall Study|Withdrawal by Subject|17|||
125481129|NCT04436276|451394635|FG011|Overall Study|Withdrawal by Subject|7|||
125481130|NCT04436276|451394636|FG012|Overall Study|Withdrawal by Subject|10|||
125481131|NCT04436276|451394637|FG013|Overall Study|Withdrawal by Subject|6|||
125481132|NCT04436276|451394638|FG014|Overall Study|Withdrawal by Subject|20|||
125481133|NCT04436276|451394639|FG015|Overall Study|Withdrawal by Subject|6|||
125481134|NCT04436276|451394640|FG016|Overall Study|Withdrawal by Subject|11|||
125481135|NCT04436276|451394641|FG017|Overall Study|Withdrawal by Subject|4|||
125481136|NCT04436276|451394642|FG018|Overall Study|Withdrawal by Subject|14|||
125481137|NCT04436276|451394643|FG019|Overall Study|Withdrawal by Subject|24|||
125481138|NCT04436276|451394644|FG020|Overall Study|Withdrawal by Subject|24|||
125481139|NCT04436276|451394645|FG021|Overall Study|Withdrawal by Subject|16|||
125481140|NCT04436276|451394646|FG022|Overall Study|Withdrawal by Subject|14|||
125481141|NCT04436276|451394624|FG000|Overall Study|Other|3|||
125481142|NCT04436276|451394625|FG001|Overall Study|Other|2|||
125481143|NCT04436276|451394626|FG002|Overall Study|Other|5|||
125481144|NCT04436276|451394627|FG003|Overall Study|Other|9|||
125481145|NCT04436276|451394628|FG004|Overall Study|Other|23|||
125302188|NCT03068767|450731992|FG001|Overall Study|Lost to Follow-up|3|||
125302189|NCT03068767|450731991|FG000|Overall Study|Protocol Violation|3|||
125302190|NCT03068767|450731992|FG001|Overall Study|Protocol Violation|0|||
125302191|NCT00061633|450731993|FG000|Overall Study|Adverse Event|1|||
125302192|NCT00061633|450731994|FG001|Overall Study|Adverse Event|2|||
125302193|NCT00061633|450731993|FG000|Overall Study|Withdrawal by Subject|2|||
125481146|NCT04436276|451394629|FG005|Overall Study|Other|1|||
125481147|NCT04436276|451394630|FG006|Overall Study|Other|0|||
125481148|NCT04436276|451394631|FG007|Overall Study|Other|0|||
125481149|NCT04436276|451394632|FG008|Overall Study|Other|0|||
125481150|NCT04436276|451394633|FG009|Overall Study|Other|0|||
125481151|NCT04436276|451394634|FG010|Overall Study|Other|3|||
125481152|NCT04436276|451394635|FG011|Overall Study|Other|1|||
125481153|NCT04436276|451394636|FG012|Overall Study|Other|1|||
125302194|NCT00061633|450731994|FG001|Overall Study|Withdrawal by Subject|2|||
125302195|NCT00061633|450731993|FG000|Overall Study|Lost to Follow-up|1|||
125302196|NCT00061633|450731994|FG001|Overall Study|Lost to Follow-up|4|||
125302197|NCT00061633|450731993|FG000|Overall Study|Other|1|||
125302198|NCT00061633|450731994|FG001|Overall Study|Other|1|||
125302199|NCT00061633|450731993|FG000|Overall Study|Never received study treatment|0|||
125302200|NCT00061633|450731994|FG001|Overall Study|Never received study treatment|2|||
125302201|NCT02921087|450731997|FG000|Overall Study|Withdrawal by Subject|0|||
125302202|NCT02921087|450731998|FG001|Overall Study|Withdrawal by Subject|1|||
125302203|NCT00687531|450731999|FG000|Overall Study|Did not meet protocol eligibility|104|||
125302204|NCT00687531|450731999|FG000|Overall Study|Adverse Event|5|||
125302205|NCT00687531|450731999|FG000|Overall Study|Lost to Follow-up|26|||
125302206|NCT03848949|450732000|FG000|Overall Study|Lost to Follow-up|5|||
125302207|NCT03848949|450732001|FG001|Overall Study|Lost to Follow-up|7|||
125302208|NCT02353728|450732002|FG000|Overall Study|Subject non-compliance|1|||
125302209|NCT02301624|450732005|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
125302210|NCT02301624|450732006|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
125302211|NCT02301624|450732005|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
125302212|NCT02301624|450732006|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
125302213|NCT02301624|450732005|FG000|Open-label Maintenance Phase|Adverse Event|2|||
125302214|NCT02301624|450732006|FG001|Open-label Maintenance Phase|Adverse Event|5|||
125302215|NCT02301624|450732005|FG000|Open-label Maintenance Phase|Physician Decision|3|||
125302216|NCT02301624|450732006|FG001|Open-label Maintenance Phase|Physician Decision|3|||
125302217|NCT02301624|450732005|FG000|Open-label Maintenance Phase|Death|2|||
125302218|NCT02301624|450732006|FG001|Open-label Maintenance Phase|Death|1|||
125302219|NCT02301624|450732005|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
125302220|NCT02301624|450732006|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
125302221|NCT00895310|450732007|FG000|Overall Study|Withdrawal by Subject|1|||
125302222|NCT03109184|450733919|FG000|Overall Study|Lost to Follow-up|6|||
125302223|NCT03109184|450733920|FG001|Overall Study|Lost to Follow-up|6|||
125302224|NCT03109184|450733919|FG000|Overall Study|Withdrawal by Subject|1|||
125302225|NCT03109184|450733920|FG001|Overall Study|Withdrawal by Subject|1|||
125302226|NCT00602420|450733921|FG000|Overall Study|Death|1|||
125302227|NCT00602420|450733922|FG001|Overall Study|Death|4|||
125302228|NCT00602420|450733921|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
125302229|NCT00602420|450733922|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
125302230|NCT00602420|450733921|FG000|Overall Study|Withdrawal by Subject|18|||
125302231|NCT00602420|450733922|FG001|Overall Study|Withdrawal by Subject|17|||
125302232|NCT00602420|450733921|FG000|Overall Study|Adverse Event|1|||
125302233|NCT00602420|450733922|FG001|Overall Study|Adverse Event|0|||
125302234|NCT00703924|450733931|FG000|Overall Study|Withdrawal by Subject|1|||
125302235|NCT00703924|450733932|FG001|Overall Study|Withdrawal by Subject|1|||
125302236|NCT03077919|450733933|FG000|Overall Study|Lost to Follow-up|4|||
125302237|NCT03077919|450733934|FG001|Overall Study|Lost to Follow-up|1|||
125302238|NCT01031979|450733937|FG000|Overall Study|Lost to Follow-up|5|||
125302239|NCT01031979|450733938|FG001|Overall Study|Lost to Follow-up|4|||
125302240|NCT03592368|450733940|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
125302241|NCT03592368|450733941|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
125302242|NCT03592368|450733942|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
125302243|NCT03592368|450733943|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
125302244|NCT03592368|450733940|FG000|Overall Study|Adverse Event|0|||
125302245|NCT03592368|450733941|FG001|Overall Study|Adverse Event|0|||
125302246|NCT03592368|450733942|FG002|Overall Study|Adverse Event|0|||
125302247|NCT03592368|450733943|FG003|Overall Study|Adverse Event|1|||
125302248|NCT03592368|450733940|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
125302249|NCT03592368|450733941|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
125302250|NCT03592368|450733942|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
125302251|NCT03592368|450733943|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
125302252|NCT03831100|450733944|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
125302253|NCT03831100|450733945|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
125302254|NCT02008227|450733949|FG000|Overall Study|Lost to Follow-up|7|||
125302255|NCT02008227|450733950|FG001|Overall Study|Lost to Follow-up|9|||
125302256|NCT02008227|450733949|FG000|Overall Study|Death|494|||
125302257|NCT02008227|450733950|FG001|Overall Study|Death|485|||
125302258|NCT02008227|450733949|FG000|Overall Study|Withdrawal by Subject|67|||
125302259|NCT02008227|450733950|FG001|Overall Study|Withdrawal by Subject|36|||
125481154|NCT04436276|451394637|FG013|Overall Study|Other|2|||
125481155|NCT04436276|451394638|FG014|Overall Study|Other|3|||
125302260|NCT02008227|450733949|FG000|Overall Study|Study Terminated By Sponsor|44|||
125481156|NCT04436276|451394639|FG015|Overall Study|Other|0|||
125481157|NCT04436276|451394640|FG016|Overall Study|Other|0|||
125302261|NCT02008227|450733950|FG001|Overall Study|Study Terminated By Sponsor|83|||
125481158|NCT04436276|451394641|FG017|Overall Study|Other|6|||
125481159|NCT04436276|451394642|FG018|Overall Study|Other|1|||
125481160|NCT04436276|451394643|FG019|Overall Study|Other|0|||
125481161|NCT04436276|451394644|FG020|Overall Study|Other|2|||
125481162|NCT04436276|451394645|FG021|Overall Study|Other|2|||
125481163|NCT04436276|451394646|FG022|Overall Study|Other|60|||
125481164|NCT03931174|451394647|FG000|Providers|Staff left organization|26|||
125481165|NCT03931174|451394648|FG001|Providers|Staff left organization|25|||
125481166|NCT03931174|451394647|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
125481167|NCT03931174|451394648|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
125481168|NCT03931174|451394647|FG000|Providers|Lost to Follow-up|4|||
125481169|NCT03931174|451394648|FG001|Providers|Lost to Follow-up|4|||
125481170|NCT03931174|451394647|FG000|Patients|Post-consent screening failure|1|||
125481171|NCT03931174|451394648|FG001|Patients|Post-consent screening failure|1|||
125481172|NCT03931174|451394647|FG000|Patients|Death|1|||
125302262|NCT01618695|450733954|FG000|Core Phase|Adverse Event|4|||
125302263|NCT01618695|450733955|FG001|Core Phase|Adverse Event|5|||
125302264|NCT01618695|450733956|FG002|Core Phase|Adverse Event|15|||
125302265|NCT01618695|450733957|FG003|Core Phase|Adverse Event|20|||
125302266|NCT01618695|450733954|FG000|Core Phase|Lost to Follow-up|0|||
125481173|NCT03931174|451394648|FG001|Patients|Death|1|||
125481174|NCT03931174|451394647|FG000|Patients|Lost to Follow-up|60|||
125481175|NCT03931174|451394648|FG001|Patients|Lost to Follow-up|89|||
125481176|NCT03322267|451394649|FG000|Overall Study|Lack of Efficacy|11|||
125481177|NCT03322267|451394649|FG000|Overall Study|Adverse Event|1|||
125481178|NCT03322267|451394649|FG000|Overall Study|Withdrawal by Subject|2|||
125481179|NCT03852472|451394659|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
125481180|NCT03852472|451394660|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
125302267|NCT01618695|450733955|FG001|Core Phase|Lost to Follow-up|0|||
125302268|NCT01618695|450733956|FG002|Core Phase|Lost to Follow-up|1|||
125481181|NCT03852472|451394661|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
125481182|NCT03852472|451394662|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
125481183|NCT03852472|451394663|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
125481184|NCT03852472|451394659|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
125481185|NCT03852472|451394660|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
125481186|NCT03852472|451394661|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
125481187|NCT03852472|451394662|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
125481188|NCT03852472|451394663|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
125481189|NCT03852472|451394659|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
125481190|NCT03852472|451394660|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
125481191|NCT03852472|451394661|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
125481192|NCT03852472|451394662|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
125481193|NCT03852472|451394663|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
125481194|NCT03852472|451394659|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
125481195|NCT03852472|451394660|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
125481196|NCT03852472|451394661|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
125481197|NCT03852472|451394662|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
125481198|NCT03852472|451394663|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
125481199|NCT03852472|451394659|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
125481200|NCT03852472|451394660|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
125481201|NCT03852472|451394661|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
125481202|NCT03852472|451394662|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
125481203|NCT03852472|451394663|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
125481204|NCT03852472|451394659|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
125481205|NCT03852472|451394660|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
125302269|NCT01618695|450733957|FG003|Core Phase|Lost to Follow-up|0|||
125302270|NCT01618695|450733954|FG000|Core Phase|Withdrawal by Subject|16|||
125302271|NCT01618695|450733955|FG001|Core Phase|Withdrawal by Subject|11|||
125302272|NCT01618695|450733956|FG002|Core Phase|Withdrawal by Subject|9|||
125302273|NCT01618695|450733957|FG003|Core Phase|Withdrawal by Subject|13|||
125302274|NCT01618695|450733954|FG000|Core Phase|Pregnancy|2|||
125302275|NCT01618695|450733955|FG001|Core Phase|Pregnancy|0|||
125481206|NCT03852472|451394661|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
125481207|NCT03852472|451394662|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
125481208|NCT03852472|451394663|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
125481209|NCT03852472|451394659|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
125481210|NCT03852472|451394660|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
125481211|NCT03852472|451394661|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
125481212|NCT03852472|451394662|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
125302276|NCT01618695|450733956|FG002|Core Phase|Pregnancy|0|||
125302277|NCT01618695|450733957|FG003|Core Phase|Pregnancy|0|||
125302278|NCT01618695|450733954|FG000|Core Phase|Lack of Efficacy|1|||
125302279|NCT01618695|450733955|FG001|Core Phase|Lack of Efficacy|2|||
125302280|NCT01618695|450733956|FG002|Core Phase|Lack of Efficacy|1|||
125302281|NCT01618695|450733957|FG003|Core Phase|Lack of Efficacy|1|||
125302282|NCT01618695|450733954|FG000|Core Phase|Other than specified|1|||
125302283|NCT01618695|450733955|FG001|Core Phase|Other than specified|2|||
125302284|NCT01618695|450733956|FG002|Core Phase|Other than specified|2|||
125302285|NCT01618695|450733957|FG003|Core Phase|Other than specified|2|||
125302286|NCT01618695|450733954|FG000|Core Phase|Not treated|1|||
125302287|NCT01618695|450733955|FG001|Core Phase|Not treated|0|||
125302288|NCT01618695|450733956|FG002|Core Phase|Not treated|2|||
125302289|NCT01618695|450733957|FG003|Core Phase|Not treated|0|||
125302290|NCT01618695|450733954|FG000|Extension Phase|Lack of Efficacy|17|||
125302291|NCT01618695|450733955|FG001|Extension Phase|Lack of Efficacy|33|||
125302292|NCT01618695|450733956|FG002|Extension Phase|Lack of Efficacy|26|||
125302293|NCT01618695|450733957|FG003|Extension Phase|Lack of Efficacy|24|||
125302294|NCT01618695|450733954|FG000|Extension Phase|Pregnancy|2|||
125302295|NCT01618695|450733955|FG001|Extension Phase|Pregnancy|0|||
125302296|NCT01618695|450733956|FG002|Extension Phase|Pregnancy|1|||
125302297|NCT01618695|450733957|FG003|Extension Phase|Pregnancy|1|||
125302298|NCT01618695|450733954|FG000|Extension Phase|Withdrawal by Subject|43|||
125302299|NCT01618695|450733955|FG001|Extension Phase|Withdrawal by Subject|48|||
125302300|NCT01618695|450733956|FG002|Extension Phase|Withdrawal by Subject|42|||
125302301|NCT01618695|450733957|FG003|Extension Phase|Withdrawal by Subject|33|||
125302302|NCT01618695|450733954|FG000|Extension Phase|Adverse Event|18|||
125302303|NCT01618695|450733955|FG001|Extension Phase|Adverse Event|16|||
125302304|NCT01618695|450733956|FG002|Extension Phase|Adverse Event|9|||
125302305|NCT01618695|450733957|FG003|Extension Phase|Adverse Event|20|||
125302306|NCT01618695|450733954|FG000|Extension Phase|Lost to Follow-up|2|||
125302307|NCT01618695|450733955|FG001|Extension Phase|Lost to Follow-up|1|||
125302308|NCT01618695|450733956|FG002|Extension Phase|Lost to Follow-up|1|||
125481213|NCT03852472|451394663|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
125302309|NCT01618695|450733957|FG003|Extension Phase|Lost to Follow-up|1|||
125302310|NCT01618695|450733954|FG000|Extension Phase|Other than specified|13|||
125302311|NCT01618695|450733955|FG001|Extension Phase|Other than specified|18|||
125302312|NCT01618695|450733956|FG002|Extension Phase|Other than specified|13|||
125302313|NCT01618695|450733957|FG003|Extension Phase|Other than specified|18|||
125302314|NCT02454478|450733959|FG000|Overall Study|Incomplete DLT Evaluation|1|||
125302315|NCT01271725|450733963|FG000|Part A|Progressive disease according to RECIST|8|||
125302316|NCT01271725|450733964|FG001|Part A|Progressive disease according to RECIST|0|||
125481214|NCT03852472|451394659|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
125481215|NCT03852472|451394660|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
125481216|NCT03852472|451394661|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
125481217|NCT03852472|451394662|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
125481218|NCT03852472|451394663|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
125481219|NCT03852472|451394659|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
125481220|NCT03852472|451394660|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
125481221|NCT03852472|451394661|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
125481222|NCT03852472|451394662|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
125302317|NCT01271725|450733963|FG000|Part A|Clinical signs/symptoms of progression|2|||
125302318|NCT01271725|450733964|FG001|Part A|Clinical signs/symptoms of progression|0|||
125302319|NCT01271725|450733963|FG000|Part A|Other Adverse Event|8|||
125302320|NCT01271725|450733964|FG001|Part A|Other Adverse Event|0|||
125302321|NCT01271725|450733963|FG000|Part A|Lost to Follow-up|1|||
125302322|NCT01271725|450733964|FG001|Part A|Lost to Follow-up|0|||
125302323|NCT01271725|450733963|FG000|Part A|Withdrawal by Subject|12|||
125302324|NCT01271725|450733964|FG001|Part A|Withdrawal by Subject|0|||
125481223|NCT03852472|451394663|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
125481224|NCT03852472|451394659|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
125481225|NCT03852472|451394660|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
125302325|NCT01271725|450733963|FG000|Part A|Other than specified|3|||
125302326|NCT01271725|450733964|FG001|Part A|Other than specified|0|||
125302327|NCT01271725|450733963|FG000|Part A|Protocol Violation|1|||
125302328|NCT01271725|450733964|FG001|Part A|Protocol Violation|0|||
125302329|NCT01271725|450733963|FG000|Part B|Other than specified|0|||
125302330|NCT01271725|450733964|FG001|Part B|Other than specified|2|||
125302331|NCT01271725|450733963|FG000|Part B|Clinical signs/symptoms of progression|0|||
125302332|NCT01271725|450733964|FG001|Part B|Clinical signs/symptoms of progression|2|||
125302333|NCT01271725|450733963|FG000|Part B|Other Adverse Event|0|||
125302334|NCT01271725|450733964|FG001|Part B|Other Adverse Event|1|||
125302335|NCT01271725|450733963|FG000|Part B|Protocol Violation|0|||
125302336|NCT01271725|450733964|FG001|Part B|Protocol Violation|1|||
125302337|NCT01271725|450733963|FG000|Part B|Withdrawal by Subject|0|||
125302338|NCT01271725|450733964|FG001|Part B|Withdrawal by Subject|6|||
125302339|NCT03354273|450733965|FG000|Overall Study|Adverse Event|5|||
125302340|NCT03354273|450733965|FG000|Overall Study|Screen Failure|21|||
125302341|NCT03354273|450733965|FG000|Overall Study|Withdrawal by Subject|34|||
125302342|NCT03354273|450733965|FG000|Overall Study|Technical Problems|30|||
125302343|NCT03354273|450733965|FG000|Overall Study|Lost to Follow-up|4|||
125302344|NCT03354273|450733965|FG000|Overall Study|Investigator Decision|3|||
125302345|NCT03354273|450733965|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
125302346|NCT03354273|450733965|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
125302347|NCT03354273|450733965|FG000|Overall Study|COVID-19 Restrictions|9|||
125302348|NCT03354273|450733965|FG000|Overall Study|Other|5|||
125302349|NCT02950480|450733971|FG000|Overall Study|Withdrawal by Subject|1|||
125302350|NCT02950480|450733972|FG001|Overall Study|Withdrawal by Subject|0|||
125302351|NCT03229109|450733977|FG000|Overall Study|Withdrawal by Subject|0|||
125302352|NCT03229109|450733978|FG001|Overall Study|Withdrawal by Subject|0|||
125302353|NCT03229109|450733979|FG002|Overall Study|Withdrawal by Subject|0|||
125302354|NCT03229109|450733980|FG003|Overall Study|Withdrawal by Subject|1|||
125302355|NCT01835223|450733981|FG000|Overall Study|Adverse Event|1|||
125481226|NCT03852472|451394661|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
125481227|NCT03852472|451394662|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
125481228|NCT03852472|451394663|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
125481229|NCT03852472|451394659|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
125481230|NCT03852472|451394660|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
125481231|NCT03852472|451394661|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
125481232|NCT03852472|451394662|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
125481233|NCT03852472|451394663|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
125481234|NCT03852472|451394659|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
125481235|NCT03852472|451394660|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
125481236|NCT03852472|451394661|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
125481237|NCT03852472|451394662|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
125481238|NCT03852472|451394663|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
125481239|NCT03852472|451394659|FG000|Period 2 - Week 44|Adverse Event|0|||
125481240|NCT03852472|451394660|FG001|Period 2 - Week 44|Adverse Event|3|||
125481241|NCT03852472|451394661|FG002|Period 2 - Week 44|Adverse Event|1|||
125481242|NCT03852472|451394662|FG003|Period 2 - Week 44|Adverse Event|2|||
125481243|NCT03852472|451394663|FG004|Period 2 - Week 44|Adverse Event|2|||
125481244|NCT03852472|451394659|FG000|Period 2 - Week 44|COVID-19 Related|0|||
125481245|NCT03852472|451394660|FG001|Period 2 - Week 44|COVID-19 Related|0|||
125481246|NCT03852472|451394661|FG002|Period 2 - Week 44|COVID-19 Related|0|||
125481247|NCT03852472|451394662|FG003|Period 2 - Week 44|COVID-19 Related|1|||
125481248|NCT03852472|451394663|FG004|Period 2 - Week 44|COVID-19 Related|0|||
125481249|NCT03852472|451394659|FG000|Period 2 - Week 44|Reason not stated|0|||
125481250|NCT03852472|451394660|FG001|Period 2 - Week 44|Reason not stated|0|||
125481251|NCT03852472|451394661|FG002|Period 2 - Week 44|Reason not stated|0|||
125481252|NCT03852472|451394662|FG003|Period 2 - Week 44|Reason not stated|0|||
125481253|NCT03852472|451394663|FG004|Period 2 - Week 44|Reason not stated|1|||
125481254|NCT05977530|451394664|FG000|Overall Study|Withdrawal by Subject|1|||
125481255|NCT05977530|451394664|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
125481256|NCT06457802|451394665|FG000|Overall Study|Early termination of study prior to participant completion|2|||
125302356|NCT01835223|450733982|FG001|Overall Study|Adverse Event|0|||
125302357|NCT01835223|450733981|FG000|Overall Study|Withdrawal by Subject|2|||
125302358|NCT01835223|450733982|FG001|Overall Study|Withdrawal by Subject|0|||
125302359|NCT01835223|450733981|FG000|Overall Study|Disease progression|2|||
125302360|NCT01835223|450733982|FG001|Overall Study|Disease progression|1|||
125302361|NCT01835223|450733981|FG000|Overall Study|Became Inelligible|4|||
125302362|NCT01835223|450733982|FG001|Overall Study|Became Inelligible|0|||
125302363|NCT01504841|450733983|FG000|Overall Study|Withdrawal by Subject|1|||
125302364|NCT01504841|450733984|FG001|Overall Study|Withdrawal by Subject|1|||
125302365|NCT01504841|450733985|FG002|Overall Study|Withdrawal by Subject|0|||
125302366|NCT03679624|450733986|FG000|Overall Study|Adverse Event|1|||
125302367|NCT03679624|450733987|FG001|Overall Study|Adverse Event|0|||
125302368|NCT01610336|450733988|FG000|Overall Study|Progressive Disease|4|||
125302369|NCT01610336|450733989|FG001|Overall Study|Progressive Disease|6|||
125302370|NCT01610336|450733990|FG002|Overall Study|Progressive Disease|6|||
125481257|NCT06457802|451394666|FG001|Overall Study|Early termination of study prior to participant completion|2|||
125481258|NCT01467427|451394667|FG000|Overall Study|Withdrawal by Subject|1|||
125481259|NCT01467427|451394668|FG001|Overall Study|Withdrawal by Subject|0|||
125481260|NCT01467427|451394667|FG000|Overall Study|Not continuing in extension phase|0|||
125302371|NCT01610336|450733991|FG003|Overall Study|Progressive Disease|5|||
125302372|NCT01610336|450733992|FG004|Overall Study|Progressive Disease|3|||
125302373|NCT01610336|450733993|FG005|Overall Study|Progressive Disease|10|||
125302374|NCT01610336|450733994|FG006|Overall Study|Progressive Disease|1|||
125302375|NCT01610336|450733995|FG007|Overall Study|Progressive Disease|6|||
125302376|NCT01610336|450733996|FG008|Overall Study|Progressive Disease|6|||
125302377|NCT01610336|450733997|FG009|Overall Study|Progressive Disease|40|||
125302378|NCT01610336|450733998|FG010|Overall Study|Progressive Disease|36|||
125302379|NCT01610336|450733988|FG000|Overall Study|Adverse Event|0|||
125302380|NCT01610336|450733989|FG001|Overall Study|Adverse Event|0|||
125302381|NCT01610336|450733990|FG002|Overall Study|Adverse Event|0|||
125302382|NCT01610336|450733991|FG003|Overall Study|Adverse Event|1|||
125302383|NCT01610336|450733992|FG004|Overall Study|Adverse Event|1|||
125302384|NCT01610336|450733993|FG005|Overall Study|Adverse Event|1|||
125302385|NCT01610336|450733994|FG006|Overall Study|Adverse Event|0|||
125302386|NCT01610336|450733995|FG007|Overall Study|Adverse Event|0|||
125302387|NCT01610336|450733996|FG008|Overall Study|Adverse Event|2|||
125302388|NCT01610336|450733997|FG009|Overall Study|Adverse Event|8|||
125302389|NCT01610336|450733998|FG010|Overall Study|Adverse Event|6|||
125302390|NCT01610336|450733988|FG000|Overall Study|Subject/Guardian decision|1|||
125302391|NCT01610336|450733989|FG001|Overall Study|Subject/Guardian decision|1|||
125302392|NCT01610336|450733990|FG002|Overall Study|Subject/Guardian decision|0|||
125302393|NCT01610336|450733991|FG003|Overall Study|Subject/Guardian decision|1|||
125302394|NCT01610336|450733992|FG004|Overall Study|Subject/Guardian decision|0|||
125302395|NCT01610336|450733993|FG005|Overall Study|Subject/Guardian decision|0|||
125302396|NCT01610336|450733994|FG006|Overall Study|Subject/Guardian decision|0|||
125302397|NCT01610336|450733995|FG007|Overall Study|Subject/Guardian decision|1|||
125302398|NCT01610336|450733996|FG008|Overall Study|Subject/Guardian decision|0|||
125302399|NCT01610336|450733997|FG009|Overall Study|Subject/Guardian decision|2|||
125302400|NCT01610336|450733998|FG010|Overall Study|Subject/Guardian decision|2|||
125302401|NCT01610336|450733988|FG000|Overall Study|Death|0|||
125302402|NCT01610336|450733989|FG001|Overall Study|Death|0|||
125302403|NCT01610336|450733990|FG002|Overall Study|Death|0|||
125302404|NCT01610336|450733991|FG003|Overall Study|Death|0|||
125302405|NCT01610336|450733992|FG004|Overall Study|Death|0|||
125302406|NCT01610336|450733993|FG005|Overall Study|Death|1|||
125302407|NCT01610336|450733994|FG006|Overall Study|Death|3|||
125302408|NCT01610336|450733995|FG007|Overall Study|Death|0|||
125302409|NCT01610336|450733996|FG008|Overall Study|Death|0|||
125302410|NCT01610336|450733997|FG009|Overall Study|Death|1|||
125302411|NCT01610336|450733998|FG010|Overall Study|Death|2|||
125302412|NCT01610336|450733988|FG000|Overall Study|Non-Compliance with study treatment|0|||
125302413|NCT01610336|450733989|FG001|Overall Study|Non-Compliance with study treatment|0|||
125302414|NCT01610336|450733990|FG002|Overall Study|Non-Compliance with study treatment|0|||
125302415|NCT01610336|450733991|FG003|Overall Study|Non-Compliance with study treatment|0|||
125302416|NCT01610336|450733992|FG004|Overall Study|Non-Compliance with study treatment|0|||
125302417|NCT01610336|450733993|FG005|Overall Study|Non-Compliance with study treatment|0|||
125302418|NCT01610336|450733994|FG006|Overall Study|Non-Compliance with study treatment|0|||
125302419|NCT01610336|450733995|FG007|Overall Study|Non-Compliance with study treatment|0|||
125302420|NCT01610336|450733996|FG008|Overall Study|Non-Compliance with study treatment|0|||
125302421|NCT01610336|450733997|FG009|Overall Study|Non-Compliance with study treatment|1|||
125302422|NCT01610336|450733998|FG010|Overall Study|Non-Compliance with study treatment|0|||
125481261|NCT01467427|451394668|FG001|Overall Study|Not continuing in extension phase|2|||
125481262|NCT01467427|451394667|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
125481263|NCT01467427|451394668|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
125481264|NCT01467427|451394667|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
125481265|NCT01467427|451394668|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
125481266|NCT01467427|451394667|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
125481267|NCT01467427|451394668|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
125481268|NCT01467427|451394667|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
125481269|NCT01467427|451394668|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
125481270|NCT03161028|451394669|FG000|Overall Study|Withdrawal by Subject|6|||
125481271|NCT03161028|451394670|FG001|Overall Study|Withdrawal by Subject|4|||
125481272|NCT03161028|451394669|FG000|Overall Study|Adverse Event|5|||
125481273|NCT03161028|451394670|FG001|Overall Study|Adverse Event|1|||
125481274|NCT03161028|451394669|FG000|Overall Study|Study drug side effects|2|||
125481275|NCT03161028|451394670|FG001|Overall Study|Study drug side effects|2|||
125481276|NCT03161028|451394669|FG000|Overall Study|Administrative PD/UP|4|||
125481277|NCT03161028|451394670|FG001|Overall Study|Administrative PD/UP|2|||
125481278|NCT03161028|451394669|FG000|Overall Study|Lost to Follow-up|2|||
125302423|NCT01610336|450733988|FG000|Overall Study|Physician Decision|0|||
125302424|NCT01610336|450733989|FG001|Overall Study|Physician Decision|0|||
125302425|NCT01610336|450733990|FG002|Overall Study|Physician Decision|0|||
125302426|NCT01610336|450733991|FG003|Overall Study|Physician Decision|0|||
125302427|NCT01610336|450733992|FG004|Overall Study|Physician Decision|0|||
125302428|NCT01610336|450733993|FG005|Overall Study|Physician Decision|0|||
125302429|NCT01610336|450733994|FG006|Overall Study|Physician Decision|1|||
125302430|NCT01610336|450733995|FG007|Overall Study|Physician Decision|0|||
125302431|NCT01610336|450733996|FG008|Overall Study|Physician Decision|0|||
125302432|NCT01610336|450733997|FG009|Overall Study|Physician Decision|0|||
125302433|NCT01610336|450733998|FG010|Overall Study|Physician Decision|0|||
125302434|NCT01610336|450733988|FG000|Overall Study|Protocol Deviation|0|||
125302435|NCT01610336|450733989|FG001|Overall Study|Protocol Deviation|0|||
125302436|NCT01610336|450733990|FG002|Overall Study|Protocol Deviation|0|||
125481279|NCT03161028|451394670|FG001|Overall Study|Lost to Follow-up|0|||
125302437|NCT01610336|450733991|FG003|Overall Study|Protocol Deviation|0|||
125302438|NCT01610336|450733992|FG004|Overall Study|Protocol Deviation|0|||
125302439|NCT01610336|450733993|FG005|Overall Study|Protocol Deviation|0|||
125302440|NCT01610336|450733994|FG006|Overall Study|Protocol Deviation|0|||
125302441|NCT01610336|450733995|FG007|Overall Study|Protocol Deviation|0|||
125302442|NCT01610336|450733996|FG008|Overall Study|Protocol Deviation|0|||
125302443|NCT01610336|450733997|FG009|Overall Study|Protocol Deviation|1|||
125302444|NCT01610336|450733998|FG010|Overall Study|Protocol Deviation|0|||
125302445|NCT01610336|450733988|FG000|Overall Study|Transfer to another trial|0|||
125302446|NCT01610336|450733989|FG001|Overall Study|Transfer to another trial|0|||
125302447|NCT01610336|450733990|FG002|Overall Study|Transfer to another trial|0|||
125302448|NCT01610336|450733991|FG003|Overall Study|Transfer to another trial|0|||
125302449|NCT01610336|450733992|FG004|Overall Study|Transfer to another trial|0|||
125302450|NCT01610336|450733993|FG005|Overall Study|Transfer to another trial|0|||
125302451|NCT01610336|450733994|FG006|Overall Study|Transfer to another trial|0|||
125302452|NCT01610336|450733995|FG007|Overall Study|Transfer to another trial|0|||
125302453|NCT01610336|450733996|FG008|Overall Study|Transfer to another trial|0|||
125302454|NCT01610336|450733997|FG009|Overall Study|Transfer to another trial|0|||
125302455|NCT01610336|450733998|FG010|Overall Study|Transfer to another trial|1|||
125302456|NCT01559675|450734001|FG000|Overall Study|Protocol Violation|1|||
125302457|NCT01559675|450734002|FG001|Overall Study|Protocol Violation|2|||
125302458|NCT01559675|450734001|FG000|Overall Study|2nd operation on same patient excluded|14|||
125302459|NCT01559675|450734002|FG001|Overall Study|2nd operation on same patient excluded|12|||
125302460|NCT01496469|450734003|FG000|Overall Study|Adverse Event|1|||
125302461|NCT01496469|450734004|FG001|Overall Study|Adverse Event|0|||
125302462|NCT01496469|450734003|FG000|Overall Study|Protocol Violation|2|||
125302463|NCT01496469|450734004|FG001|Overall Study|Protocol Violation|0|||
125302464|NCT01496469|450734003|FG000|Overall Study|Lost to Follow-up|1|||
125302465|NCT01496469|450734004|FG001|Overall Study|Lost to Follow-up|1|||
125302466|NCT01496469|450734003|FG000|Overall Study|Withdrawal by Subject|4|||
125302467|NCT01496469|450734004|FG001|Overall Study|Withdrawal by Subject|4|||
125302468|NCT01496469|450734003|FG000|Overall Study|BP exceeds protocol limits|1|||
125302469|NCT01496469|450734004|FG001|Overall Study|BP exceeds protocol limits|2|||
125302470|NCT01496469|450734003|FG000|Overall Study|Other|1|||
125302471|NCT01496469|450734004|FG001|Overall Study|Other|1|||
125302472|NCT00291018|450734005|FG000|Overall Study|Not Consented or Declined PAS|12|||
125302473|NCT00291018|450734006|FG001|Overall Study|Not Consented or Declined PAS|15|||
125302474|NCT00291018|450734007|FG002|Overall Study|Not Consented or Declined PAS|15|||
125302475|NCT00291018|450734005|FG000|Overall Study|Death|3|||
125302476|NCT00291018|450734006|FG001|Overall Study|Death|3|||
125302477|NCT00291018|450734007|FG002|Overall Study|Death|4|||
125302478|NCT00291018|450734005|FG000|Overall Study|Withdrawal by Subject|2|||
125302479|NCT00291018|450734006|FG001|Overall Study|Withdrawal by Subject|8|||
125302480|NCT00291018|450734007|FG002|Overall Study|Withdrawal by Subject|1|||
125302481|NCT00291018|450734005|FG000|Overall Study|Failures|5|||
125302482|NCT00291018|450734006|FG001|Overall Study|Failures|12|||
125302483|NCT00291018|450734007|FG002|Overall Study|Failures|5|||
125302484|NCT00291018|450734005|FG000|Overall Study|Lost to Follow-up|3|||
125302485|NCT00291018|450734006|FG001|Overall Study|Lost to Follow-up|4|||
125302486|NCT00291018|450734007|FG002|Overall Study|Lost to Follow-up|18|||
125302487|NCT00630344|450734008|FG000|Overall Study|Adverse Event|5|||
125302488|NCT00630344|450734008|FG000|Overall Study|Progressive Disease|19|||
125302489|NCT00630344|450734008|FG000|Overall Study|Physician Decision|9|||
125302490|NCT00630344|450734008|FG000|Overall Study|Withdrawal by Subject|1|||
125302491|NCT00630344|450734008|FG000|Overall Study|Intercurrent Illness|1|||
125302492|NCT00630344|450734008|FG000|Overall Study|Other|1|||
125302493|NCT01357551|450734009|FG000|Overall Study|Withdrawal by Subject|6|||
125302494|NCT01357551|450734010|FG001|Overall Study|Withdrawal by Subject|4|||
125302495|NCT01357551|450734009|FG000|Overall Study|Death|0|||
125302496|NCT01357551|450734010|FG001|Overall Study|Death|1|||
125302497|NCT01357551|450734009|FG000|Overall Study|Lost to Follow-up|16|||
125302498|NCT01357551|450734010|FG001|Overall Study|Lost to Follow-up|6|||
125302499|NCT00774800|450734011|FG000|Intervention 4|Withdrawal by Subject|1|||
125302500|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
125302501|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
125302502|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
125302503|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
125302504|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Death|2|||
125302505|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Death|2|||
125302506|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Death|0|||
125302507|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Death|0|||
125302508|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
125302509|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
125302510|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
125302511|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
125302512|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
125302513|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
125302514|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
125485428|NCT02240238|451412506|FG003|Phase 2|Disease progression|0|||
125302515|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
125302516|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
125302517|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
125302518|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
125302519|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
125302520|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
125302521|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
125302522|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
125302523|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
125302524|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
125302525|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
125302526|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
125302527|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
125302528|NCT03068754|450734018|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
125302529|NCT03068754|450734019|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
125302530|NCT03068754|450734020|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
125302531|NCT03068754|450734021|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
125302532|NCT03068754|450734018|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
125302533|NCT03068754|450734019|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
125302534|NCT03068754|450734020|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
125302535|NCT03068754|450734021|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
125302536|NCT03068754|450734018|FG000|Open Label Extension Period (OLE)|Death|0|||
125302537|NCT03068754|450734019|FG001|Open Label Extension Period (OLE)|Death|0|||
125302538|NCT03068754|450734020|FG002|Open Label Extension Period (OLE)|Death|0|||
125302539|NCT03068754|450734021|FG003|Open Label Extension Period (OLE)|Death|1|||
125302540|NCT03068754|450734018|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
125302541|NCT03068754|450734019|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
125302542|NCT03068754|450734020|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
125302543|NCT03068754|450734021|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
125302544|NCT03068754|450734018|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
125302545|NCT03068754|450734019|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
125302546|NCT03068754|450734020|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
125302547|NCT03068754|450734021|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
125302548|NCT03068754|450734018|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
125302549|NCT03068754|450734019|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
125302550|NCT03068754|450734020|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
125302551|NCT03068754|450734021|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
125302552|NCT03068754|450734018|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
125302553|NCT03068754|450734019|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
125302554|NCT03068754|450734020|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
125302555|NCT03068754|450734021|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
125302556|NCT00666965|450734022|FG000|Overall Study|Adverse Event|0|||
125302557|NCT00666965|450734023|FG001|Overall Study|Adverse Event|2|||
125302558|NCT00666965|450734024|FG002|Overall Study|Adverse Event|1|||
125302559|NCT00666965|450734025|FG003|Overall Study|Adverse Event|9|||
125302560|NCT00666965|450734022|FG000|Overall Study|Lack of Efficacy|1|||
125302561|NCT00666965|450734023|FG001|Overall Study|Lack of Efficacy|1|||
125302562|NCT00666965|450734024|FG002|Overall Study|Lack of Efficacy|0|||
125302563|NCT00666965|450734025|FG003|Overall Study|Lack of Efficacy|0|||
125302564|NCT00666965|450734022|FG000|Overall Study|Protocol Violation|0|||
125302565|NCT00666965|450734023|FG001|Overall Study|Protocol Violation|0|||
125302566|NCT00666965|450734024|FG002|Overall Study|Protocol Violation|0|||
125302567|NCT00666965|450734025|FG003|Overall Study|Protocol Violation|2|||
125302568|NCT00666965|450734022|FG000|Overall Study|Discontinuation criteria|2|||
125302569|NCT00666965|450734023|FG001|Overall Study|Discontinuation criteria|1|||
125302570|NCT00666965|450734024|FG002|Overall Study|Discontinuation criteria|1|||
125302571|NCT00666965|450734025|FG003|Overall Study|Discontinuation criteria|2|||
125302572|NCT00666965|450734022|FG000|Overall Study|Withdrawal by Subject|0|||
125302573|NCT00666965|450734023|FG001|Overall Study|Withdrawal by Subject|0|||
125302574|NCT00666965|450734024|FG002|Overall Study|Withdrawal by Subject|0|||
125302575|NCT00666965|450734025|FG003|Overall Study|Withdrawal by Subject|2|||
125302576|NCT02202538|450734029|FG000|Overall Study|Withdrawal by Subject|5|||
125302577|NCT02202538|450734029|FG000|Overall Study|Did not meet all inclusion criteria|2|||
125302578|NCT02202538|450734029|FG000|Overall Study|Investigator Decision|1|||
125481280|NCT03161028|451394669|FG000|Overall Study|Unable to comply with procedures|1|||
125481281|NCT03161028|451394670|FG001|Overall Study|Unable to comply with procedures|1|||
125302579|NCT01853878|450734030|FG000|Overall Study|Recurrence|2|||
125302580|NCT01853878|450734031|FG001|Overall Study|Recurrence|0|||
125302581|NCT01853878|450734030|FG000|Overall Study|Adverse Event|2|||
125302582|NCT01853878|450734031|FG001|Overall Study|Adverse Event|0|||
125481282|NCT00736723|451394671|FG000|Overall Study|Withdrawal by Subject|4|||
125481283|NCT00736723|451394672|FG001|Overall Study|Withdrawal by Subject|3|||
125481284|NCT03492216|451394673|FG000|Overall Study|Death|1|||
125481285|NCT03492216|451394674|FG001|Overall Study|Death|0|||
125481286|NCT03492216|451394675|FG002|Overall Study|Death|4|||
125481287|NCT03492216|451394676|FG003|Overall Study|Death|0|||
125481288|NCT03492216|451394673|FG000|Overall Study|Withdrawal by Subject|5|||
125481289|NCT03492216|451394674|FG001|Overall Study|Withdrawal by Subject|3|||
125481290|NCT03492216|451394675|FG002|Overall Study|Withdrawal by Subject|1|||
125481291|NCT03492216|451394676|FG003|Overall Study|Withdrawal by Subject|1|||
125481292|NCT03492216|451394673|FG000|Overall Study|Lost to Follow-up|9|||
125481293|NCT03492216|451394674|FG001|Overall Study|Lost to Follow-up|2|||
125481294|NCT03492216|451394675|FG002|Overall Study|Lost to Follow-up|7|||
125481295|NCT03492216|451394676|FG003|Overall Study|Lost to Follow-up|8|||
125481296|NCT03492216|451394673|FG000|Overall Study|Moved|5|||
125481297|NCT03492216|451394674|FG001|Overall Study|Moved|3|||
125481298|NCT03492216|451394675|FG002|Overall Study|Moved|3|||
125481299|NCT03492216|451394676|FG003|Overall Study|Moved|5|||
125481300|NCT03492216|451394673|FG000|Overall Study|Too ill|0|||
125481301|NCT03492216|451394674|FG001|Overall Study|Too ill|1|||
125481302|NCT03492216|451394675|FG002|Overall Study|Too ill|0|||
125481303|NCT03492216|451394676|FG003|Overall Study|Too ill|0|||
125481304|NCT03492216|451394673|FG000|Overall Study|Incarcerated|0|||
125481305|NCT03492216|451394674|FG001|Overall Study|Incarcerated|0|||
125481306|NCT03492216|451394675|FG002|Overall Study|Incarcerated|2|||
125481307|NCT03492216|451394676|FG003|Overall Study|Incarcerated|0|||
125481308|NCT04016662|451396328|FG000|Run-In Phase|Death|1|||
125481309|NCT04016662|451396328|FG000|Run-In Phase|Withdrawal by Subject|11|||
125481310|NCT04016662|451396328|FG000|Run-In Phase|Not meeting screening eligibility|9|||
125481311|NCT04016662|451396328|FG000|Run-In Phase|Physician Decision|3|||
125481312|NCT04016662|451396328|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
125481313|NCT04016662|451396328|FG000|PLGS (12 Weeks)|Death|1|||
125481314|NCT04016662|451396328|FG000|SAP (12 Weeks)|Death|1|||
125481315|NCT03021096|451396329|FG000|Overall Study|Lost to Follow-up|4|||
125481316|NCT03021096|451396329|FG000|Overall Study|Protocol Violation|2|||
125481317|NCT00764751|451396339|FG000|Overall Study|Adverse Event|1|||
125481318|NCT00764751|451396340|FG001|Overall Study|Adverse Event|1|||
125481319|NCT00764751|451396339|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
125481320|NCT00764751|451396340|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
125481321|NCT02998268|451396346|FG000|Overall Study|Adverse Event|0|||
125481322|NCT02998268|451396347|FG001|Overall Study|Adverse Event|2|||
125481323|NCT02998268|451396346|FG000|Overall Study|Withdrawal by Subject|0|||
125481324|NCT02998268|451396347|FG001|Overall Study|Withdrawal by Subject|1|||
125481325|NCT05399459|451396348|FG000|Overall Study|Randomized but not treated|29|||
125481326|NCT05399459|451396349|FG001|Overall Study|Randomized but not treated|30|||
125302583|NCT01853878|450734030|FG000|Overall Study|Withdrawal by Subject|3|||
125302584|NCT01853878|450734031|FG001|Overall Study|Withdrawal by Subject|1|||
125302585|NCT01853878|450734030|FG000|Overall Study|Migrated/moved from the study area|1|||
125302586|NCT01853878|450734031|FG001|Overall Study|Migrated/moved from the study area|0|||
125302587|NCT01853878|450734030|FG000|Overall Study|Other|55|||
125302588|NCT01853878|450734031|FG001|Overall Study|Other|43|||
125302589|NCT02161757|450734032|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
125302590|NCT02161757|450734033|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
125302591|NCT02161757|450734034|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
125302592|NCT02161757|450734032|FG000|Treatment Through Study Completion|Adverse Event|1|||
125302593|NCT02161757|450734033|FG001|Treatment Through Study Completion|Adverse Event|1|||
125302594|NCT02161757|450734034|FG002|Treatment Through Study Completion|Adverse Event|0|||
125302595|NCT02161757|450734032|FG000|Treatment Through Study Completion|Protocol Violation|0|||
125302596|NCT02161757|450734033|FG001|Treatment Through Study Completion|Protocol Violation|1|||
125302597|NCT02161757|450734034|FG002|Treatment Through Study Completion|Protocol Violation|2|||
125302598|NCT02161757|450734032|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
125302599|NCT02161757|450734033|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
125302600|NCT02161757|450734034|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
125481327|NCT05399459|451396350|FG002|Overall Study|Randomized but not treated|38|||
125481328|NCT05399459|451396348|FG000|Overall Study|Lost to Follow-up|1|||
125481329|NCT05399459|451396349|FG001|Overall Study|Lost to Follow-up|0|||
125481330|NCT05399459|451396350|FG002|Overall Study|Lost to Follow-up|0|||
125481331|NCT03020199|451396353|FG000|Treatment Period|Adverse Event|0|||
125481332|NCT03020199|451396354|FG001|Treatment Period|Adverse Event|2|||
125302601|NCT02161757|450734032|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
125302602|NCT02161757|450734033|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
125481333|NCT03020199|451396353|FG000|Treatment Period|Lack of Efficacy|1|||
125481334|NCT03020199|451396354|FG001|Treatment Period|Lack of Efficacy|6|||
125481335|NCT03020199|451396353|FG000|Treatment Period|Lost to Follow-up|1|||
125481336|NCT03020199|451396354|FG001|Treatment Period|Lost to Follow-up|6|||
125481337|NCT03020199|451396353|FG000|Treatment Period|Physician Decision|0|||
125302603|NCT02161757|450734034|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
125302604|NCT02161757|450734032|FG000|Treatment Through Study Completion|Other|20|||
125302605|NCT02161757|450734033|FG001|Treatment Through Study Completion|Other|19|||
125302606|NCT02161757|450734034|FG002|Treatment Through Study Completion|Other|12|||
125302607|NCT02161757|450734032|FG000|Treatment Through Study Completion|Death|2|||
125302608|NCT02161757|450734033|FG001|Treatment Through Study Completion|Death|1|||
125481338|NCT03020199|451396354|FG001|Treatment Period|Physician Decision|1|||
125481339|NCT03020199|451396353|FG000|Treatment Period|Subject/guardian decision|8|||
125302609|NCT02161757|450734034|FG002|Treatment Through Study Completion|Death|1|||
125302610|NCT00767819|450734037|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
125302611|NCT00767819|450734038|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
125302612|NCT00767819|450734039|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
125302613|NCT00767819|450734037|FG000|Overall Study|Withdrawal by Subject|1|||
125302614|NCT00767819|450734038|FG001|Overall Study|Withdrawal by Subject|1|||
125302615|NCT00767819|450734039|FG002|Overall Study|Withdrawal by Subject|0|||
125302616|NCT00767819|450734037|FG000|Overall Study|Administrative problems|0|||
125302617|NCT00767819|450734038|FG001|Overall Study|Administrative problems|1|||
125302618|NCT00767819|450734039|FG002|Overall Study|Administrative problems|0|||
125302619|NCT00767819|450734037|FG000|Overall Study|Death|2|||
125302620|NCT00767819|450734038|FG001|Overall Study|Death|3|||
125302621|NCT00767819|450734039|FG002|Overall Study|Death|0|||
125302622|NCT00767819|450734037|FG000|Overall Study|Adverse Event|2|||
125302623|NCT00767819|450734038|FG001|Overall Study|Adverse Event|0|||
125302624|NCT00767819|450734039|FG002|Overall Study|Adverse Event|0|||
125302625|NCT00767819|450734037|FG000|Overall Study|Abnormal lab values|1|||
125302626|NCT00767819|450734038|FG001|Overall Study|Abnormal lab values|0|||
125302627|NCT00767819|450734039|FG002|Overall Study|Abnormal lab values|0|||
125302628|NCT00767819|450734037|FG000|Overall Study|Lost to Follow-up|1|||
125302629|NCT00767819|450734038|FG001|Overall Study|Lost to Follow-up|0|||
125302630|NCT00767819|450734039|FG002|Overall Study|Lost to Follow-up|0|||
125302631|NCT00465647|450734044|FG000|Overall Study|Administrative|2|||
125302632|NCT00465647|450734045|FG001|Overall Study|Administrative|2|||
125302633|NCT00465647|450734046|FG002|Overall Study|Administrative|3|||
125302634|NCT00465647|450734047|FG003|Overall Study|Administrative|2|||
125302635|NCT00465647|450734044|FG000|Overall Study|Adverse Event|2|||
125302636|NCT00465647|450734045|FG001|Overall Study|Adverse Event|0|||
125302637|NCT00465647|450734046|FG002|Overall Study|Adverse Event|3|||
125302638|NCT00465647|450734047|FG003|Overall Study|Adverse Event|2|||
125302639|NCT00465647|450734044|FG000|Overall Study|Withdrawal by Subject|1|||
125302640|NCT00465647|450734045|FG001|Overall Study|Withdrawal by Subject|2|||
125302641|NCT00465647|450734046|FG002|Overall Study|Withdrawal by Subject|2|||
125302642|NCT00465647|450734047|FG003|Overall Study|Withdrawal by Subject|7|||
125302643|NCT00465647|450734044|FG000|Overall Study|"The other reasons included loss of IV"|8|||
125302644|NCT00465647|450734045|FG001|Overall Study|"The other reasons included loss of IV"|4|||
125302645|NCT00465647|450734046|FG002|Overall Study|"The other reasons included loss of IV"|3|||
125302646|NCT00465647|450734047|FG003|Overall Study|"The other reasons included loss of IV"|2|||
125302647|NCT03916081|450734048|FG000|Overall Study|Adverse Event|1|||
125302648|NCT03916081|450734049|FG001|Overall Study|Adverse Event|0|||
125302649|NCT03916081|450734050|FG002|Overall Study|Adverse Event|0|||
125302650|NCT03916081|450734048|FG000|Overall Study|Physician Decision|0|||
125302651|NCT03916081|450734049|FG001|Overall Study|Physician Decision|0|||
125302652|NCT03916081|450734050|FG002|Overall Study|Physician Decision|1|||
125481340|NCT03020199|451396354|FG001|Treatment Period|Subject/guardian decision|15|||
125481341|NCT03020199|451396353|FG000|Treatment Period|Subjects not treated|3|||
125481342|NCT03020199|451396354|FG001|Treatment Period|Subjects not treated|4|||
125481343|NCT03020199|451396353|FG000|Follow-up Period|Disease relapse|32|||
125302653|NCT03916081|450734048|FG000|Overall Study|Lost to Follow-up|0|||
125302654|NCT03916081|450734049|FG001|Overall Study|Lost to Follow-up|1|||
125302655|NCT03916081|450734050|FG002|Overall Study|Lost to Follow-up|0|||
125302656|NCT03916081|450734048|FG000|Overall Study|Withdrawal by Subject|3|||
125302657|NCT03916081|450734049|FG001|Overall Study|Withdrawal by Subject|0|||
125302658|NCT03916081|450734050|FG002|Overall Study|Withdrawal by Subject|1|||
125302659|NCT03916081|450734048|FG000|Overall Study|Worsening of AD|0|||
125302660|NCT03916081|450734049|FG001|Overall Study|Worsening of AD|0|||
125302661|NCT03916081|450734050|FG002|Overall Study|Worsening of AD|1|||
125302662|NCT01339897|450734051|FG000|Overall Study|Adverse Event|1|||
125302663|NCT01339897|450734052|FG001|Overall Study|Adverse Event|0|||
125302664|NCT01339897|450734053|FG002|Overall Study|Adverse Event|0|||
125302665|NCT01339897|450734054|FG003|Overall Study|Adverse Event|1|||
125302666|NCT00847197|450734057|FG000|Overall Study|Adverse Event|21|||
125302667|NCT00847197|450734058|FG001|Overall Study|Adverse Event|3|||
125481344|NCT03020199|451396354|FG001|Follow-up Period|Disease relapse|7|||
125481345|NCT03020199|451396353|FG000|Follow-up Period|Lack of Efficacy|1|||
125302668|NCT00847197|450734057|FG000|Overall Study|Protocol Violation|0|||
125302669|NCT00847197|450734058|FG001|Overall Study|Protocol Violation|1|||
125302670|NCT00847197|450734057|FG000|Overall Study|Withdrawal by Subject|3|||
125302671|NCT00847197|450734058|FG001|Overall Study|Withdrawal by Subject|1|||
125302672|NCT00622388|450734059|FG000|Overall Study|Disease Progression|47|||
125302673|NCT00622388|450734059|FG000|Overall Study|Adverse Event|6|||
125302674|NCT00622388|450734059|FG000|Overall Study|Protocol Violation|3|||
125302675|NCT00622388|450734059|FG000|Overall Study|Participant Refusal|1|||
125302676|NCT00622388|450734059|FG000|Overall Study|Death|3|||
125302677|NCT00622388|450734059|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
125302678|NCT00622388|450734059|FG000|Overall Study|Took Prohibited Medication|2|||
125302679|NCT00622388|450734059|FG000|Overall Study|Withdrew Consent|1|||
125302680|NCT00622388|450734059|FG000|Overall Study|Insurance Expired|1|||
125302681|NCT00348309|450734060|FG000|Overall Study|Adverse Event|56|||
125302682|NCT00348309|450734061|FG001|Overall Study|Adverse Event|28|||
125302683|NCT00348309|450734062|FG002|Overall Study|Adverse Event|63|||
125302684|NCT00348309|450734060|FG000|Overall Study|Lost to Follow-up|6|||
125302685|NCT00348309|450734061|FG001|Overall Study|Lost to Follow-up|7|||
125302686|NCT00348309|450734062|FG002|Overall Study|Lost to Follow-up|4|||
125302687|NCT00348309|450734060|FG000|Overall Study|Protocol Violation|7|||
125302688|NCT00348309|450734061|FG001|Overall Study|Protocol Violation|12|||
125481346|NCT03020199|451396354|FG001|Follow-up Period|Lack of Efficacy|2|||
125481347|NCT03020199|451396353|FG000|Follow-up Period|Lost to Follow-up|4|||
125481348|NCT03020199|451396354|FG001|Follow-up Period|Lost to Follow-up|6|||
125481349|NCT03020199|451396353|FG000|Follow-up Period|Physician Decision|2|||
125481350|NCT03020199|451396354|FG001|Follow-up Period|Physician Decision|2|||
125481351|NCT03020199|451396353|FG000|Follow-up Period|Protocol Violation|1|||
125481352|NCT03020199|451396354|FG001|Follow-up Period|Protocol Violation|2|||
125481353|NCT03020199|451396353|FG000|Follow-up Period|Study terminated by Sponsor|6|||
125481354|NCT03020199|451396354|FG001|Follow-up Period|Study terminated by Sponsor|3|||
125481355|NCT03020199|451396353|FG000|Follow-up Period|Subject/guardian decision|14|||
125302689|NCT00348309|450734062|FG002|Overall Study|Protocol Violation|7|||
125302690|NCT00348309|450734060|FG000|Overall Study|Withdrawal by Subject|33|||
125302691|NCT00348309|450734061|FG001|Overall Study|Withdrawal by Subject|37|||
125302692|NCT00348309|450734062|FG002|Overall Study|Withdrawal by Subject|40|||
125302693|NCT00348309|450734060|FG000|Overall Study|Non-compliance|8|||
125302694|NCT00348309|450734061|FG001|Overall Study|Non-compliance|6|||
125302695|NCT00348309|450734062|FG002|Overall Study|Non-compliance|8|||
125302696|NCT00348309|450734060|FG000|Overall Study|Death of caregiver|1|||
125481356|NCT03020199|451396354|FG001|Follow-up Period|Subject/guardian decision|9|||
125481357|NCT05583578|451396355|FG000|Overall Study|Withdrawal by Subject|2|||
125481358|NCT05583578|451396356|FG001|Overall Study|Withdrawal by Subject|0|||
125481359|NCT04005794|451396359|FG000|Overall Study|Lost to Follow-up|0|||
125481360|NCT04005794|451396360|FG001|Overall Study|Lost to Follow-up|4|||
125481361|NCT04005794|451396361|FG002|Overall Study|Lost to Follow-up|0|||
125481362|NCT04313972|451396362|FG000|Overall Study|Withdrawal by Subject|0|||
125481363|NCT04313972|451396363|FG001|Overall Study|Withdrawal by Subject|1|||
125481364|NCT02547363|451396364|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
125481365|NCT02547363|451396365|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
125481366|NCT02547363|451396364|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
125481367|NCT02547363|451396365|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
125481368|NCT02547363|451396364|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
125481369|NCT02547363|451396365|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
125481370|NCT02547363|451396364|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
125481371|NCT02547363|451396365|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
125481372|NCT02547363|451396364|FG000|12-month Follow-up|Withdrawal by Subject|4|||
125481373|NCT02547363|451396365|FG001|12-month Follow-up|Withdrawal by Subject|3|||
125481374|NCT02547363|451396364|FG000|12-month Follow-up|Lost to Follow-up|4|||
125481375|NCT02547363|451396365|FG001|12-month Follow-up|Lost to Follow-up|1|||
125481376|NCT02547363|451396364|FG000|12-month Follow-up|Lack of Efficacy|1|||
125302697|NCT00348309|450734061|FG001|Overall Study|Death of caregiver|0|||
125302698|NCT00348309|450734062|FG002|Overall Study|Death of caregiver|1|||
125302699|NCT00348309|450734060|FG000|Overall Study|Lack of insight, dementia|1|||
125302700|NCT00348309|450734061|FG001|Overall Study|Lack of insight, dementia|0|||
125302701|NCT00348309|450734062|FG002|Overall Study|Lack of insight, dementia|0|||
125302702|NCT00348309|450734060|FG000|Overall Study|Wrong bottle allocated|1|||
125302703|NCT00348309|450734061|FG001|Overall Study|Wrong bottle allocated|0|||
125481377|NCT02547363|451396365|FG001|12-month Follow-up|Lack of Efficacy|1|||
125481378|NCT02547363|451396364|FG000|12-month Follow-up|Other|1|||
125481379|NCT02547363|451396365|FG001|12-month Follow-up|Other|0|||
125481380|NCT05201079|451396378|FG000|Overall Study|Adverse Event|7|||
125481381|NCT05201079|451396379|FG001|Overall Study|Adverse Event|11|||
125481382|NCT05201079|451396378|FG000|Overall Study|Death|1|||
125481383|NCT05201079|451396379|FG001|Overall Study|Death|1|||
125481384|NCT05201079|451396378|FG000|Overall Study|Lack of Efficacy|0|||
125481385|NCT05201079|451396379|FG001|Overall Study|Lack of Efficacy|2|||
125481386|NCT05201079|451396378|FG000|Overall Study|Lost to Follow-up|0|||
125481387|NCT05201079|451396379|FG001|Overall Study|Lost to Follow-up|1|||
125481388|NCT05201079|451396378|FG000|Overall Study|Physician Decision|1|||
125302704|NCT00348309|450734062|FG002|Overall Study|Wrong bottle allocated|0|||
125302705|NCT00348309|450734060|FG000|Overall Study|Caregiver sick|1|||
125481389|NCT05201079|451396379|FG001|Overall Study|Physician Decision|1|||
125481390|NCT05201079|451396378|FG000|Overall Study|Protocol Violation|1|||
125481391|NCT05201079|451396379|FG001|Overall Study|Protocol Violation|0|||
125481392|NCT05201079|451396378|FG000|Overall Study|Withdrawal by Subject|1|||
125481393|NCT05201079|451396379|FG001|Overall Study|Withdrawal by Subject|0|||
125481394|NCT05201079|451396378|FG000|Overall Study|Forbidden medication|9|||
125481395|NCT05201079|451396379|FG001|Overall Study|Forbidden medication|5|||
125481396|NCT05201079|451396378|FG000|Overall Study|Transfer to another hospital|0|||
125481397|NCT05201079|451396379|FG001|Overall Study|Transfer to another hospital|1|||
125481398|NCT05201079|451396378|FG000|Overall Study|Clinical condition|1|||
125481399|NCT05201079|451396379|FG001|Overall Study|Clinical condition|0|||
125481400|NCT05201079|451396378|FG000|Overall Study|SAE and sepsis|1|||
125302706|NCT00348309|450734061|FG001|Overall Study|Caregiver sick|0|||
125302707|NCT00348309|450734062|FG002|Overall Study|Caregiver sick|0|||
125302708|NCT00348309|450734060|FG000|Overall Study|Use of prohibited medication|5|||
125302709|NCT00348309|450734061|FG001|Overall Study|Use of prohibited medication|2|||
125302710|NCT00348309|450734062|FG002|Overall Study|Use of prohibited medication|2|||
125302711|NCT00348309|450734060|FG000|Overall Study|Caregiver withdrawal|3|||
125302712|NCT00348309|450734061|FG001|Overall Study|Caregiver withdrawal|0|||
125302713|NCT00348309|450734062|FG002|Overall Study|Caregiver withdrawal|7|||
125302714|NCT00348309|450734060|FG000|Overall Study|Unable to complete ET visit|1|||
125481401|NCT05201079|451396379|FG001|Overall Study|SAE and sepsis|0|||
125481402|NCT05808257|451396382|FG000|Overall Study|Lost to Follow-up|8|||
125481403|NCT05808257|451396383|FG001|Overall Study|Lost to Follow-up|8|||
125481404|NCT04568486|451396384|FG000|Overall Study|Withdrawal by Subject|26|||
125481405|NCT04568486|451396384|FG000|Overall Study|Lost to Follow-up|7|||
125481406|NCT04042233|451396385|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
125481407|NCT04042233|451396386|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
125481408|NCT04042233|451396385|FG000|Overall Study|Protocol Violation|0|||
125481409|NCT04042233|451396386|FG001|Overall Study|Protocol Violation|2|||
125481410|NCT04907851|451396389|FG000|Overall Study|Consent withdrawn|1|||
125481411|NCT04907851|451396390|FG001|Overall Study|Consent withdrawn|2|||
125481412|NCT04907851|451396391|FG002|Overall Study|Consent withdrawn|0|||
125481413|NCT04907851|451396389|FG000|Overall Study|Death|5|||
125481414|NCT04907851|451396390|FG001|Overall Study|Death|15|||
125302715|NCT00348309|450734061|FG001|Overall Study|Unable to complete ET visit|0|||
125302716|NCT00348309|450734062|FG002|Overall Study|Unable to complete ET visit|0|||
125302717|NCT00348309|450734060|FG000|Overall Study|PI closing medical practice|1|||
125302718|NCT00348309|450734061|FG001|Overall Study|PI closing medical practice|0|||
125302719|NCT00348309|450734062|FG002|Overall Study|PI closing medical practice|0|||
125302720|NCT00348309|450734060|FG000|Overall Study|Principal investigator's decision|1|||
125302721|NCT00348309|450734061|FG001|Overall Study|Principal investigator's decision|0|||
125302722|NCT00348309|450734062|FG002|Overall Study|Principal investigator's decision|0|||
125302723|NCT00348309|450734060|FG000|Overall Study|No disponibility of medication|1|||
125302724|NCT00348309|450734061|FG001|Overall Study|No disponibility of medication|0|||
125302725|NCT00348309|450734062|FG002|Overall Study|No disponibility of medication|0|||
125302726|NCT00348309|450734060|FG000|Overall Study|Worsened neurodegenerative disease|1|||
125302727|NCT00348309|450734061|FG001|Overall Study|Worsened neurodegenerative disease|0|||
125302728|NCT00348309|450734062|FG002|Overall Study|Worsened neurodegenerative disease|0|||
125302729|NCT00348309|450734060|FG000|Overall Study|Cognitive and behaviour worsening|2|||
125302730|NCT00348309|450734061|FG001|Overall Study|Cognitive and behaviour worsening|0|||
125302731|NCT00348309|450734062|FG002|Overall Study|Cognitive and behaviour worsening|0|||
125302732|NCT00348309|450734060|FG000|Overall Study|Worsening of alzheimer|1|||
125302733|NCT00348309|450734061|FG001|Overall Study|Worsening of alzheimer|0|||
125302734|NCT00348309|450734062|FG002|Overall Study|Worsening of alzheimer|1|||
125302735|NCT00348309|450734060|FG000|Overall Study|Did not appear in time for Visit 3|1|||
125302736|NCT00348309|450734061|FG001|Overall Study|Did not appear in time for Visit 3|0|||
125302737|NCT00348309|450734062|FG002|Overall Study|Did not appear in time for Visit 3|0|||
125302738|NCT00348309|450734060|FG000|Overall Study|Participant died|2|||
125302739|NCT00348309|450734061|FG001|Overall Study|Participant died|1|||
125302740|NCT00348309|450734062|FG002|Overall Study|Participant died|1|||
125302741|NCT00348309|450734060|FG000|Overall Study|Decision of sponsor|1|||
125302742|NCT00348309|450734061|FG001|Overall Study|Decision of sponsor|0|||
125302743|NCT00348309|450734062|FG002|Overall Study|Decision of sponsor|0|||
125302744|NCT00348309|450734060|FG000|Overall Study|Ineffectiveness of treatment|0|||
125302745|NCT00348309|450734061|FG001|Overall Study|Ineffectiveness of treatment|1|||
125302746|NCT00348309|450734062|FG002|Overall Study|Ineffectiveness of treatment|0|||
125302747|NCT00348309|450734060|FG000|Overall Study|A foul of exclusion criteria|0|||
125481415|NCT04907851|451396391|FG002|Overall Study|Death|10|||
125481416|NCT01210807|451396396|FG000|Overall Study|Lost to Follow-up|1|||
125481417|NCT01210807|451396397|FG001|Overall Study|Lost to Follow-up|2|||
125302748|NCT00348309|450734061|FG001|Overall Study|A foul of exclusion criteria|1|||
125481418|NCT01210807|451396396|FG000|Overall Study|Not implanted bilaterally|2|||
125481419|NCT01210807|451396397|FG001|Overall Study|Not implanted bilaterally|1|||
125481420|NCT05281562|451396399|FG000|Overall Study|Ineligible patient|1|||
125302749|NCT00348309|450734062|FG002|Overall Study|A foul of exclusion criteria|0|||
125302750|NCT00348309|450734060|FG000|Overall Study|Participant was hospitalized|0|||
125302751|NCT00348309|450734061|FG001|Overall Study|Participant was hospitalized|1|||
125302752|NCT00348309|450734062|FG002|Overall Study|Participant was hospitalized|0|||
125302753|NCT00348309|450734060|FG000|Overall Study|Sponsor refuseal|0|||
125302754|NCT00348309|450734061|FG001|Overall Study|Sponsor refuseal|1|||
125302755|NCT00348309|450734062|FG002|Overall Study|Sponsor refuseal|1|||
125302756|NCT00348309|450734060|FG000|Overall Study|Forgot often medication|0|||
125302757|NCT00348309|450734061|FG001|Overall Study|Forgot often medication|1|||
125302758|NCT00348309|450734062|FG002|Overall Study|Forgot often medication|0|||
125302759|NCT00348309|450734060|FG000|Overall Study|Medical Monitor decision|0|||
125302760|NCT00348309|450734061|FG001|Overall Study|Medical Monitor decision|0|||
125302761|NCT00348309|450734062|FG002|Overall Study|Medical Monitor decision|1|||
125302762|NCT00348309|450734060|FG000|Overall Study|Increased dose of Aricept|0|||
125302763|NCT00348309|450734061|FG001|Overall Study|Increased dose of Aricept|0|||
125302764|NCT00348309|450734062|FG002|Overall Study|Increased dose of Aricept|1|||
125302765|NCT00348309|450734060|FG000|Overall Study|Site closure|0|||
125302766|NCT00348309|450734061|FG001|Overall Study|Site closure|0|||
125302767|NCT00348309|450734062|FG002|Overall Study|Site closure|1|||
125302768|NCT00348309|450734060|FG000|Overall Study|Adverse event not attended|0|||
125302769|NCT00348309|450734061|FG001|Overall Study|Adverse event not attended|0|||
125302770|NCT00348309|450734062|FG002|Overall Study|Adverse event not attended|1|||
125302771|NCT00348309|450734060|FG000|Overall Study|ECG abnormal|0|||
125302772|NCT00348309|450734061|FG001|Overall Study|ECG abnormal|0|||
125302773|NCT00348309|450734062|FG002|Overall Study|ECG abnormal|2|||
125302774|NCT00348309|450734060|FG000|Overall Study|Cardiologist recommendations|0|||
125302775|NCT00348309|450734061|FG001|Overall Study|Cardiologist recommendations|0|||
125302776|NCT00348309|450734062|FG002|Overall Study|Cardiologist recommendations|1|||
125302777|NCT00348309|450734060|FG000|Overall Study|HCV career|0|||
125302778|NCT00348309|450734061|FG001|Overall Study|HCV career|0|||
125302779|NCT00348309|450734062|FG002|Overall Study|HCV career|1|||
125302780|NCT01894243|450734063|FG000|Overall Study|Adverse Event|0|||
125302781|NCT01894243|450734064|FG001|Overall Study|Adverse Event|1|||
125302782|NCT01894243|450734065|FG002|Overall Study|Adverse Event|2|||
125302783|NCT01894243|450734063|FG000|Overall Study|Death|0|||
125481421|NCT05281562|451396400|FG001|Overall Study|Ineligible patient|0|||
125302784|NCT01894243|450734064|FG001|Overall Study|Death|0|||
125302785|NCT01894243|450734065|FG002|Overall Study|Death|3|||
125302786|NCT01894243|450734063|FG000|Overall Study|Lack of Efficacy|3|||
125302787|NCT01894243|450734064|FG001|Overall Study|Lack of Efficacy|3|||
125302788|NCT01894243|450734065|FG002|Overall Study|Lack of Efficacy|1|||
125302789|NCT01894243|450734063|FG000|Overall Study|Condition under investigation worsened|8|||
125302790|NCT01894243|450734064|FG001|Overall Study|Condition under investigation worsened|6|||
125302791|NCT01894243|450734065|FG002|Overall Study|Condition under investigation worsened|2|||
125302792|NCT01894243|450734063|FG000|Overall Study|Subject decision|1|||
125302793|NCT01894243|450734064|FG001|Overall Study|Subject decision|0|||
125302794|NCT01894243|450734065|FG002|Overall Study|Subject decision|0|||
125302795|NCT01894243|450734063|FG000|Overall Study|Other|1|||
125302796|NCT01894243|450734064|FG001|Overall Study|Other|0|||
125302797|NCT01894243|450734065|FG002|Overall Study|Other|0|||
125302798|NCT01620944|450734069|FG000|Overall Study|Early termination of Study|2|||
125302799|NCT01620944|450734070|FG001|Overall Study|Early termination of Study|1|||
125481422|NCT05477186|451396404|FG000|Overall Study|Vaccine not administered|0|||
125481423|NCT05477186|451396405|FG001|Overall Study|Vaccine not administered|2|||
125481424|NCT05477186|451396406|FG002|Overall Study|Vaccine not administered|1|||
125302800|NCT01364389|450734072|FG000|Overall Study|Withdrawal by Subject|0|||
125302801|NCT01364389|450734073|FG001|Overall Study|Withdrawal by Subject|1|||
125302802|NCT01364389|450734074|FG002|Overall Study|Withdrawal by Subject|0|||
125302803|NCT01364389|450734072|FG000|Overall Study|Protocol deviation|0|||
125302804|NCT01364389|450734073|FG001|Overall Study|Protocol deviation|0|||
125302805|NCT01364389|450734074|FG002|Overall Study|Protocol deviation|1|||
125302806|NCT01364389|450734072|FG000|Overall Study|Administrative problems|1|||
125302807|NCT01364389|450734073|FG001|Overall Study|Administrative problems|0|||
125302808|NCT01364389|450734074|FG002|Overall Study|Administrative problems|0|||
125302809|NCT01364389|450734072|FG000|Overall Study|Adverse Event|1|||
125302810|NCT01364389|450734073|FG001|Overall Study|Adverse Event|0|||
125302811|NCT01364389|450734074|FG002|Overall Study|Adverse Event|0|||
125481425|NCT05477186|451396407|FG003|Overall Study|Vaccine not administered|0|||
125302812|NCT02687581|450734075|FG000|Overall Study|Withdrawal by Subject|1|||
125302813|NCT02687581|450734076|FG001|Overall Study|Withdrawal by Subject|0|||
125302814|NCT02687581|450734077|FG002|Overall Study|Withdrawal by Subject|0|||
125302815|NCT02687581|450734078|FG003|Overall Study|Withdrawal by Subject|1|||
125302816|NCT02687581|450734075|FG000|Overall Study|Lost to Follow-up|2|||
125302817|NCT02687581|450734076|FG001|Overall Study|Lost to Follow-up|2|||
125302818|NCT02687581|450734077|FG002|Overall Study|Lost to Follow-up|0|||
125302819|NCT02687581|450734078|FG003|Overall Study|Lost to Follow-up|0|||
125302820|NCT02687581|450734075|FG000|Overall Study|the device is too small for the patient.|1|||
125481426|NCT05477186|451396408|FG004|Overall Study|Vaccine not administered|1|||
125302821|NCT02687581|450734076|FG001|Overall Study|the device is too small for the patient.|0|||
125302822|NCT02687581|450734077|FG002|Overall Study|the device is too small for the patient.|0|||
125302823|NCT02687581|450734078|FG003|Overall Study|the device is too small for the patient.|0|||
125302824|NCT02554981|450734081|FG000|Overall Study|Adverse Event|1|||
125302825|NCT02554981|450734081|FG000|Overall Study|Administrative Reasons|1|||
125302826|NCT02554981|450734081|FG000|Overall Study|Other Miscellaneous Reasons|3|||
125302827|NCT01114438|450734082|FG000|Overall Study|Adverse Event|10|||
125302828|NCT01114438|450734082|FG000|Overall Study|concomitant medication|1|||
125302829|NCT01114438|450734082|FG000|Overall Study|Physician Decision|1|||
125481427|NCT05477186|451396409|FG005|Overall Study|Vaccine not administered|0|||
125481428|NCT05477186|451396410|FG006|Overall Study|Vaccine not administered|0|||
125481429|NCT05477186|451396404|FG000|Overall Study|Withdrawal by Subject|1|||
125481430|NCT05477186|451396405|FG001|Overall Study|Withdrawal by Subject|0|||
125481431|NCT05477186|451396406|FG002|Overall Study|Withdrawal by Subject|0|||
125481432|NCT05477186|451396407|FG003|Overall Study|Withdrawal by Subject|0|||
125302830|NCT01114438|450734082|FG000|Overall Study|Withdrawal by Subject|2|||
125302831|NCT00991406|450734087|FG000|Overall Study|One participant did not respond to FES.|1|||
125302832|NCT03597061|450734088|FG000|Overall Study|Lost to Follow-up|1|||
125302833|NCT03597061|450734089|FG001|Overall Study|Lost to Follow-up|0|||
125302834|NCT03597061|450734088|FG000|Overall Study|Protocol Violation|0|||
125302835|NCT03597061|450734089|FG001|Overall Study|Protocol Violation|1|||
125302836|NCT02160145|450734090|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
125302837|NCT02160145|450734091|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
125481433|NCT05477186|451396408|FG004|Overall Study|Withdrawal by Subject|0|||
125481434|NCT05477186|451396409|FG005|Overall Study|Withdrawal by Subject|1|||
125481435|NCT05477186|451396410|FG006|Overall Study|Withdrawal by Subject|0|||
125481436|NCT05477186|451396404|FG000|Overall Study|Lost to Follow-up|1|||
125481437|NCT05477186|451396405|FG001|Overall Study|Lost to Follow-up|0|||
125481438|NCT05477186|451396406|FG002|Overall Study|Lost to Follow-up|2|||
125302838|NCT02160145|450734092|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
125302839|NCT02160145|450734090|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
125302840|NCT02160145|450734091|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
125302841|NCT02160145|450734092|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
125302842|NCT02160145|450734090|FG000|Randomized Double-blind Period|Subject decision|0|||
125302843|NCT02160145|450734091|FG001|Randomized Double-blind Period|Subject decision|21|||
125302844|NCT02160145|450734092|FG002|Randomized Double-blind Period|Subject decision|20|||
125302845|NCT02160145|450734090|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
125302846|NCT02160145|450734091|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
125302847|NCT02160145|450734092|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
125302848|NCT02160145|450734090|FG000|Randomized Double-blind Period|Physician Decision|0|||
125302849|NCT02160145|450734091|FG001|Randomized Double-blind Period|Physician Decision|7|||
125302850|NCT02160145|450734092|FG002|Randomized Double-blind Period|Physician Decision|5|||
125302851|NCT00375518|450734093|FG000|Overall Study|Withdrawal by Subject|2|||
125302852|NCT00375518|450734094|FG001|Overall Study|Withdrawal by Subject|10|||
125302853|NCT00375518|450734093|FG000|Overall Study|Patient Not Treated|6|||
125302854|NCT00375518|450734094|FG001|Overall Study|Patient Not Treated|6|||
125481439|NCT05477186|451396407|FG003|Overall Study|Lost to Follow-up|1|||
125481440|NCT05477186|451396408|FG004|Overall Study|Lost to Follow-up|1|||
125481441|NCT05477186|451396409|FG005|Overall Study|Lost to Follow-up|0|||
125481442|NCT05477186|451396410|FG006|Overall Study|Lost to Follow-up|2|||
125481443|NCT00324805|451396411|FG000|Overall Study|Adverse Event|62|||
125481444|NCT00324805|451396412|FG001|Overall Study|Adverse Event|203|||
125481445|NCT00324805|451396411|FG000|Overall Study|Progression|7|||
125481446|NCT00324805|451396412|FG001|Overall Study|Progression|35|||
125481447|NCT00324805|451396411|FG000|Overall Study|Withdrawal by Subject|51|||
125481448|NCT00324805|451396412|FG001|Overall Study|Withdrawal by Subject|174|||
125481449|NCT00324805|451396411|FG000|Overall Study|Death|6|||
125302855|NCT00375518|450734093|FG000|Overall Study|Death|0|||
125302856|NCT00375518|450734094|FG001|Overall Study|Death|1|||
125302857|NCT01108523|450734095|FG000|Overall Study|Protocol Violation|4|||
125302858|NCT03755661|450734100|FG000|Overall Study|Lost to Follow-up|1|||
125302859|NCT03755661|450734101|FG001|Overall Study|Lost to Follow-up|0|||
125302860|NCT02277119|450734102|FG000|Overall Study|Lack of Efficacy|1|||
125302861|NCT02277119|450734103|FG001|Overall Study|Lack of Efficacy|1|||
125302862|NCT02277119|450734104|FG002|Overall Study|Lack of Efficacy|1|||
125302863|NCT02277119|450734102|FG000|Overall Study|Protocol Violation|2|||
125302864|NCT02277119|450734103|FG001|Overall Study|Protocol Violation|3|||
125302865|NCT02277119|450734104|FG002|Overall Study|Protocol Violation|7|||
125481450|NCT00324805|451396412|FG001|Overall Study|Death|9|||
125481451|NCT00324805|451396411|FG000|Overall Study|Alternative therapy|4|||
125481452|NCT00324805|451396412|FG001|Overall Study|Alternative therapy|8|||
125481453|NCT00324805|451396411|FG000|Overall Study|Other complicating disease|1|||
125481454|NCT00324805|451396412|FG001|Overall Study|Other complicating disease|9|||
125481455|NCT00324805|451396411|FG000|Overall Study|Other reasons|7|||
125481456|NCT00324805|451396412|FG001|Overall Study|Other reasons|26|||
125481457|NCT00324805|451396411|FG000|Overall Study|Other|0|||
125481458|NCT00324805|451396412|FG001|Overall Study|Other|2|||
125481459|NCT00324805|451396411|FG000|Overall Study|Did not start therapy|12|||
125481460|NCT00324805|451396412|FG001|Overall Study|Did not start therapy|17|||
125481461|NCT05792085|451396414|FG000|Overall Study|Death|0|||
125481462|NCT05792085|451396415|FG001|Overall Study|Death|0|||
125481463|NCT05792085|451396416|FG002|Overall Study|Death|0|||
125481464|NCT05792085|451396417|FG003|Overall Study|Death|0|||
125481465|NCT05792085|451396418|FG004|Overall Study|Death|1|||
125481466|NCT01919554|451396420|FG000|Overall Study|Withdrawal by Subject|0|||
125481467|NCT01919554|451396421|FG001|Overall Study|Withdrawal by Subject|0|||
125481468|NCT01919554|451396422|FG002|Overall Study|Withdrawal by Subject|1|||
125481469|NCT01919554|451396423|FG003|Overall Study|Withdrawal by Subject|1|||
125481470|NCT04797897|451396431|FG000|Overall Study|Study Termination by Sponsor|1|||
125481471|NCT04797897|451396432|FG001|Overall Study|Study Termination by Sponsor|1|||
125481472|NCT01544114|451396436|FG000|Overall Study|Withdrawal by Subject|0|||
125481473|NCT01544114|451396437|FG001|Overall Study|Withdrawal by Subject|0|||
125481474|NCT01544114|451396438|FG002|Overall Study|Withdrawal by Subject|3|||
125302866|NCT03521141|450736598|FG000|Overall Study|Death|1|||
125302867|NCT03521141|450736599|FG001|Overall Study|Death|0|||
125302868|NCT03521141|450736600|FG002|Overall Study|Death|1|||
125302869|NCT01702025|450736603|FG000|Overall Study|Equipment failure|1|||
125302870|NCT01702025|450736604|FG001|Overall Study|Equipment failure|0|||
125302871|NCT01702025|450736605|FG002|Overall Study|Equipment failure|0|||
125302872|NCT01702025|450736606|FG003|Overall Study|Equipment failure|0|||
125302873|NCT01702025|450736603|FG000|Overall Study|Adverse Event|1|||
125302874|NCT01702025|450736604|FG001|Overall Study|Adverse Event|1|||
125302875|NCT01702025|450736605|FG002|Overall Study|Adverse Event|1|||
125302876|NCT01702025|450736606|FG003|Overall Study|Adverse Event|0|||
125302877|NCT04207749|450736609|FG000|Overall Study|Lost to Follow-up|0|||
125302878|NCT04207749|450736610|FG001|Overall Study|Lost to Follow-up|2|||
125302879|NCT04207749|450736609|FG000|Overall Study|Protocol Violation|0|||
125302880|NCT04207749|450736610|FG001|Overall Study|Protocol Violation|1|||
125302881|NCT04207749|450736609|FG000|Overall Study|Withdrawal by Subject|3|||
125302882|NCT04207749|450736610|FG001|Overall Study|Withdrawal by Subject|0|||
125302883|NCT04207749|450736609|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
125302884|NCT04207749|450736610|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
125302885|NCT05362058|450736611|FG000|Treatment Period|Adverse Event|3|||
125302886|NCT05362058|450736612|FG001|Treatment Period|Adverse Event|3|||
125302887|NCT05362058|450736611|FG000|Treatment Period|Assigned treatment by mistake|3|||
125302888|NCT05362058|450736612|FG001|Treatment Period|Assigned treatment by mistake|4|||
125302889|NCT05362058|450736611|FG000|Treatment Period|Death|1|||
125302890|NCT05362058|450736612|FG001|Treatment Period|Death|1|||
125302891|NCT05362058|450736611|FG000|Treatment Period|Lost to Follow-up|6|||
125302892|NCT05362058|450736612|FG001|Treatment Period|Lost to Follow-up|3|||
125302893|NCT05362058|450736611|FG000|Treatment Period|Non-compliance with study drug|0|||
125302894|NCT05362058|450736612|FG001|Treatment Period|Non-compliance with study drug|1|||
125302895|NCT05362058|450736611|FG000|Treatment Period|Physician Decision|1|||
125302896|NCT05362058|450736612|FG001|Treatment Period|Physician Decision|0|||
125302897|NCT05362058|450736611|FG000|Treatment Period|Protocol deviation|1|||
125302898|NCT05362058|450736612|FG001|Treatment Period|Protocol deviation|0|||
125302899|NCT05362058|450736611|FG000|Treatment Period|Withdrawal by Subject|10|||
125302900|NCT05362058|450736612|FG001|Treatment Period|Withdrawal by Subject|11|||
125302901|NCT05362058|450736611|FG000|Follow-Up Period|Death|1|||
125302902|NCT05362058|450736612|FG001|Follow-Up Period|Death|0|||
125302903|NCT05362058|450736611|FG000|Follow-Up Period|Lost to Follow-up|2|||
125302904|NCT05362058|450736612|FG001|Follow-Up Period|Lost to Follow-up|1|||
125302905|NCT05362058|450736611|FG000|Follow-Up Period|Protocol deviation|1|||
125302906|NCT05362058|450736612|FG001|Follow-Up Period|Protocol deviation|1|||
125302907|NCT05362058|450736611|FG000|Follow-Up Period|Withdrawal by Subject|0|||
125302908|NCT05362058|450736612|FG001|Follow-Up Period|Withdrawal by Subject|3|||
125302909|NCT00930553|450736615|FG000|Overall Study|Adverse Event|1|||
125302910|NCT00930553|450736615|FG000|Overall Study|Lack of Efficacy|7|||
125302911|NCT00930553|450736615|FG000|Overall Study|Physician Decision|39|||
125302912|NCT00930553|450736615|FG000|Overall Study|Protocol Violation|1|||
125481475|NCT01544114|451396436|FG000|Overall Study|Lost to Follow-up|0|||
125481476|NCT01544114|451396437|FG001|Overall Study|Lost to Follow-up|2|||
125481477|NCT01544114|451396438|FG002|Overall Study|Lost to Follow-up|0|||
125481478|NCT01544114|451396436|FG000|Overall Study|Adverse Event|1|||
125302913|NCT00930553|450736615|FG000|Overall Study|Pregnancy|1|||
125302914|NCT00930553|450736615|FG000|Overall Study|Withdrawal by Subject|88|||
125481479|NCT01544114|451396437|FG001|Overall Study|Adverse Event|1|||
125481480|NCT01544114|451396438|FG002|Overall Study|Adverse Event|2|||
125481481|NCT01544114|451396436|FG000|Overall Study|Protocol Violation|0|||
125481482|NCT01544114|451396437|FG001|Overall Study|Protocol Violation|1|||
125302915|NCT00930553|450736615|FG000|Overall Study|Lost to Follow-up|25|||
125302916|NCT00930553|450736615|FG000|Overall Study|Death|9|||
125302917|NCT00930553|450736615|FG000|Overall Study|Study terminated by sponsor|24|||
125302918|NCT00930553|450736615|FG000|Overall Study|Other than specified above|28|||
125302919|NCT00413036|450736616|FG000|Overall Study|Adverse Event|44|||
125302920|NCT00413036|450736616|FG000|Overall Study|Lack of Efficacy|129|||
125302921|NCT00413036|450736616|FG000|Overall Study|Withdrawal by Subject|7|||
125302922|NCT00413036|450736616|FG000|Overall Study|Death|9|||
125302923|NCT00413036|450736616|FG000|Overall Study|Other|26|||
125302924|NCT00413036|450736616|FG000|Overall Study|Missing|2|||
125302925|NCT04042909|450736617|FG000|Overall Study|Withdrawal by Subject|1|||
125302926|NCT04042909|450736618|FG001|Overall Study|Withdrawal by Subject|0|||
125302927|NCT04042909|450736619|FG002|Overall Study|Withdrawal by Subject|0|||
125302928|NCT04042909|450736617|FG000|Overall Study|duplicate cases|2|||
125302929|NCT04042909|450736618|FG001|Overall Study|duplicate cases|0|||
125302930|NCT04042909|450736619|FG002|Overall Study|duplicate cases|0|||
125302931|NCT04042909|450736617|FG000|Overall Study|technical problem|0|||
125302932|NCT04042909|450736618|FG001|Overall Study|technical problem|1|||
125302933|NCT04042909|450736619|FG002|Overall Study|technical problem|0|||
125302934|NCT01369641|450736620|FG000|Overall Study|Withdrawal by Subject|1|||
125302935|NCT00842543|450736621|FG000|Overall Study|Withdrawal by Subject|2|||
125302936|NCT00842543|450736622|FG001|Overall Study|Withdrawal by Subject|0|||
125302937|NCT00842543|450736623|FG002|Overall Study|Withdrawal by Subject|3|||
125302938|NCT00842543|450736624|FG003|Overall Study|Withdrawal by Subject|4|||
125302939|NCT01483183|450736629|FG000|Overall Study|Physician Decision|0|||
125302940|NCT01483183|450736630|FG001|Overall Study|Physician Decision|0|||
125302941|NCT01483183|450736631|FG002|Overall Study|Physician Decision|0|||
125302942|NCT01483183|450736632|FG003|Overall Study|Physician Decision|0|||
125302943|NCT01483183|450736633|FG004|Overall Study|Physician Decision|0|||
125302944|NCT01483183|450736634|FG005|Overall Study|Physician Decision|0|||
125302945|NCT01483183|450736635|FG006|Overall Study|Physician Decision|2|||
125302946|NCT01483183|450736636|FG007|Overall Study|Physician Decision|0|||
125302947|NCT01483183|450736637|FG008|Overall Study|Physician Decision|0|||
125302948|NCT01483183|450736638|FG009|Overall Study|Physician Decision|0|||
125302949|NCT01483183|450736629|FG000|Overall Study|Withdrawal by Subject|0|||
125302950|NCT01483183|450736630|FG001|Overall Study|Withdrawal by Subject|0|||
125302951|NCT01483183|450736631|FG002|Overall Study|Withdrawal by Subject|0|||
125302952|NCT01483183|450736632|FG003|Overall Study|Withdrawal by Subject|0|||
125302953|NCT01483183|450736633|FG004|Overall Study|Withdrawal by Subject|0|||
125302954|NCT01483183|450736634|FG005|Overall Study|Withdrawal by Subject|0|||
125302955|NCT01483183|450736635|FG006|Overall Study|Withdrawal by Subject|0|||
125302956|NCT01483183|450736636|FG007|Overall Study|Withdrawal by Subject|0|||
125302957|NCT01483183|450736637|FG008|Overall Study|Withdrawal by Subject|0|||
125302958|NCT01483183|450736638|FG009|Overall Study|Withdrawal by Subject|1|||
125302959|NCT00239928|450736639|FG000|Overall Study|Lack of Efficacy|1|||
125302960|NCT00239928|450736639|FG000|Overall Study|Adverse Event|4|||
125302961|NCT00239928|450736639|FG000|Overall Study|Not need to continue study|3|||
125302962|NCT00239928|450736639|FG000|Overall Study|Withdrawal by Subject|2|||
125302963|NCT00286494|450736640|FG000|Overall Study|Hyperglycemic rescue|12|||
125302964|NCT00286494|450736641|FG001|Overall Study|Hyperglycemic rescue|19|||
125302965|NCT00286494|450736642|FG002|Overall Study|Hyperglycemic rescue|18|||
125302966|NCT00286494|450736640|FG000|Overall Study|Withdrawal by Subject|2|||
125302967|NCT00286494|450736641|FG001|Overall Study|Withdrawal by Subject|10|||
125302968|NCT00286494|450736642|FG002|Overall Study|Withdrawal by Subject|9|||
125302969|NCT00286494|450736640|FG000|Overall Study|Adverse Event|3|||
125302970|NCT00286494|450736641|FG001|Overall Study|Adverse Event|8|||
125302971|NCT00286494|450736642|FG002|Overall Study|Adverse Event|6|||
125302972|NCT00286494|450736640|FG000|Overall Study|Physician Decision|5|||
125302973|NCT00286494|450736641|FG001|Overall Study|Physician Decision|5|||
125302974|NCT00286494|450736642|FG002|Overall Study|Physician Decision|1|||
125302975|NCT00286494|450736640|FG000|Overall Study|Lost to Follow-up|3|||
125302976|NCT00286494|450736641|FG001|Overall Study|Lost to Follow-up|1|||
125302977|NCT00286494|450736642|FG002|Overall Study|Lost to Follow-up|3|||
125302978|NCT00286494|450736640|FG000|Overall Study|Protocol Violation|1|||
125302979|NCT00286494|450736641|FG001|Overall Study|Protocol Violation|1|||
125302980|NCT00286494|450736642|FG002|Overall Study|Protocol Violation|2|||
125302981|NCT04776317|450736643|FG000|Overall Study|Physician Decision|0|||
125302982|NCT04776317|450736644|FG001|Overall Study|Physician Decision|1|||
125302983|NCT04776317|450736645|FG002|Overall Study|Physician Decision|0|||
125302984|NCT04776317|450736646|FG003|Overall Study|Physician Decision|0|||
125302985|NCT04776317|450736647|FG004|Overall Study|Physician Decision|0|||
125302986|NCT04776317|450736648|FG005|Overall Study|Physician Decision|0|||
125302987|NCT04776317|450736649|FG006|Overall Study|Physician Decision|0|||
125302988|NCT04776317|450736650|FG007|Overall Study|Physician Decision|0|||
125302989|NCT04776317|450736651|FG008|Overall Study|Physician Decision|0|||
125481483|NCT01544114|451396438|FG002|Overall Study|Protocol Violation|0|||
125302990|NCT04776317|450736652|FG009|Overall Study|Physician Decision|0|||
125302991|NCT04776317|450736653|FG010|Overall Study|Physician Decision|0|||
125302992|NCT04776317|450736654|FG011|Overall Study|Physician Decision|0|||
125302993|NCT04776317|450736655|FG012|Overall Study|Physician Decision|0|||
125302994|NCT04776317|450736656|FG013|Overall Study|Physician Decision|0|||
125302995|NCT04776317|450736657|FG014|Overall Study|Physician Decision|0|||
125302996|NCT04776317|450736643|FG000|Overall Study|Protocol Violation|0|||
125302997|NCT04776317|450736644|FG001|Overall Study|Protocol Violation|0|||
125302998|NCT04776317|450736645|FG002|Overall Study|Protocol Violation|1|||
125302999|NCT04776317|450736646|FG003|Overall Study|Protocol Violation|0|||
125303000|NCT04776317|450736647|FG004|Overall Study|Protocol Violation|0|||
125303001|NCT04776317|450736648|FG005|Overall Study|Protocol Violation|0|||
125303002|NCT04776317|450736649|FG006|Overall Study|Protocol Violation|0|||
125303003|NCT04776317|450736650|FG007|Overall Study|Protocol Violation|0|||
125303004|NCT04776317|450736651|FG008|Overall Study|Protocol Violation|0|||
125303005|NCT04776317|450736652|FG009|Overall Study|Protocol Violation|0|||
125303006|NCT04776317|450736653|FG010|Overall Study|Protocol Violation|0|||
125303007|NCT04776317|450736654|FG011|Overall Study|Protocol Violation|0|||
125303008|NCT04776317|450736655|FG012|Overall Study|Protocol Violation|0|||
125303009|NCT04776317|450736656|FG013|Overall Study|Protocol Violation|0|||
125303010|NCT04776317|450736657|FG014|Overall Study|Protocol Violation|0|||
125303011|NCT04776317|450736643|FG000|Overall Study|Withdrawal by Subject|0|||
125303012|NCT04776317|450736644|FG001|Overall Study|Withdrawal by Subject|0|||
125303013|NCT04776317|450736645|FG002|Overall Study|Withdrawal by Subject|0|||
125303014|NCT04776317|450736646|FG003|Overall Study|Withdrawal by Subject|0|||
125303015|NCT04776317|450736647|FG004|Overall Study|Withdrawal by Subject|1|||
125303016|NCT04776317|450736648|FG005|Overall Study|Withdrawal by Subject|0|||
125303017|NCT04776317|450736649|FG006|Overall Study|Withdrawal by Subject|0|||
125481484|NCT03024437|451396453|FG000|Overall Study|Adverse Event|0|||
125481485|NCT03024437|451396454|FG001|Overall Study|Adverse Event|1|||
125481486|NCT03024437|451396455|FG002|Overall Study|Adverse Event|3|||
125481487|NCT03024437|451396456|FG003|Overall Study|Adverse Event|5|||
125481488|NCT03024437|451396457|FG004|Overall Study|Adverse Event|0|||
125481489|NCT03024437|451396453|FG000|Overall Study|Physician Decision|1|||
125481490|NCT03024437|451396454|FG001|Overall Study|Physician Decision|0|||
125481491|NCT03024437|451396455|FG002|Overall Study|Physician Decision|0|||
125481492|NCT03024437|451396456|FG003|Overall Study|Physician Decision|1|||
125481493|NCT03024437|451396457|FG004|Overall Study|Physician Decision|0|||
125481494|NCT03024437|451396453|FG000|Overall Study|Disease progression, relapse|1|||
125481495|NCT03024437|451396454|FG001|Overall Study|Disease progression, relapse|0|||
125481496|NCT03024437|451396455|FG002|Overall Study|Disease progression, relapse|0|||
125481497|NCT03024437|451396456|FG003|Overall Study|Disease progression, relapse|3|||
125481498|NCT03024437|451396457|FG004|Overall Study|Disease progression, relapse|0|||
125481499|NCT03024437|451396453|FG000|Overall Study|Disease progression, refractory disease|4|||
125481500|NCT03024437|451396454|FG001|Overall Study|Disease progression, refractory disease|4|||
125481501|NCT03024437|451396455|FG002|Overall Study|Disease progression, refractory disease|2|||
125481502|NCT03024437|451396456|FG003|Overall Study|Disease progression, refractory disease|2|||
125481503|NCT03024437|451396457|FG004|Overall Study|Disease progression, refractory disease|1|||
125481504|NCT03024437|451396453|FG000|Overall Study|Newly diagnosed cancer|0|||
125481505|NCT03024437|451396454|FG001|Overall Study|Newly diagnosed cancer|0|||
125481506|NCT03024437|451396455|FG002|Overall Study|Newly diagnosed cancer|0|||
125481507|NCT03024437|451396456|FG003|Overall Study|Newly diagnosed cancer|1|||
125481508|NCT03024437|451396457|FG004|Overall Study|Newly diagnosed cancer|0|||
125481509|NCT03024437|451396453|FG000|Overall Study|Moved out of state|0|||
125481510|NCT03024437|451396454|FG001|Overall Study|Moved out of state|1|||
125481511|NCT03024437|451396455|FG002|Overall Study|Moved out of state|0|||
125481512|NCT03024437|451396456|FG003|Overall Study|Moved out of state|0|||
125481513|NCT03024437|451396457|FG004|Overall Study|Moved out of state|0|||
125481514|NCT03024437|451396453|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
125481515|NCT03024437|451396454|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
125481516|NCT03024437|451396455|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
125481517|NCT03024437|451396456|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
125481518|NCT03024437|451396457|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
125481519|NCT04625465|451396458|FG000|Overall Study|Lost to Follow-up|2|||
125481520|NCT04625465|451396459|FG001|Overall Study|Lost to Follow-up|2|||
125481521|NCT04625465|451396460|FG002|Overall Study|Lost to Follow-up|1|||
125481522|NCT04625465|451396461|FG003|Overall Study|Lost to Follow-up|0|||
125481523|NCT04625465|451396462|FG004|Overall Study|Lost to Follow-up|0|||
125481524|NCT04625465|451396463|FG005|Overall Study|Lost to Follow-up|2|||
125481525|NCT04625465|451396464|FG006|Overall Study|Lost to Follow-up|0|||
125481526|NCT04625465|451396465|FG007|Overall Study|Lost to Follow-up|0|||
125481527|NCT04625465|451396458|FG000|Overall Study|Death|1|||
125481528|NCT04625465|451396459|FG001|Overall Study|Death|0|||
125303018|NCT04776317|450736650|FG007|Overall Study|Withdrawal by Subject|0|||
125303019|NCT04776317|450736651|FG008|Overall Study|Withdrawal by Subject|0|||
125303020|NCT04776317|450736652|FG009|Overall Study|Withdrawal by Subject|0|||
125303021|NCT04776317|450736653|FG010|Overall Study|Withdrawal by Subject|0|||
125481529|NCT04625465|451396460|FG002|Overall Study|Death|0|||
125481530|NCT04625465|451396461|FG003|Overall Study|Death|0|||
125303022|NCT04776317|450736654|FG011|Overall Study|Withdrawal by Subject|0|||
125481531|NCT04625465|451396462|FG004|Overall Study|Death|0|||
125481532|NCT04625465|451396463|FG005|Overall Study|Death|0|||
125481533|NCT04625465|451396464|FG006|Overall Study|Death|0|||
125481534|NCT04625465|451396465|FG007|Overall Study|Death|0|||
125481535|NCT04625465|451396458|FG000|Overall Study|Withdrawal by Subject|1|||
125481536|NCT04625465|451396459|FG001|Overall Study|Withdrawal by Subject|0|||
125481537|NCT04625465|451396460|FG002|Overall Study|Withdrawal by Subject|4|||
125481538|NCT04625465|451396461|FG003|Overall Study|Withdrawal by Subject|4|||
125481539|NCT04625465|451396462|FG004|Overall Study|Withdrawal by Subject|4|||
125481540|NCT04625465|451396463|FG005|Overall Study|Withdrawal by Subject|0|||
125481541|NCT04625465|451396464|FG006|Overall Study|Withdrawal by Subject|0|||
125481542|NCT04625465|451396465|FG007|Overall Study|Withdrawal by Subject|0|||
125481547|NCT05566639|451396468|FG000|Overall Study|Adverse Event|1|||
125481548|NCT05566639|451396469|FG001|Overall Study|Adverse Event|1|||
125481549|NCT05566639|451396468|FG000|Overall Study|Serious Adverse Event|1|||
125481550|NCT05566639|451396469|FG001|Overall Study|Serious Adverse Event|3|||
125481551|NCT05566639|451396468|FG000|Overall Study|Death|44|||
125481552|NCT05566639|451396469|FG001|Overall Study|Death|45|||
125481553|NCT05566639|451396468|FG000|Overall Study|Lost to Follow-up|467|||
125481554|NCT05566639|451396469|FG001|Overall Study|Lost to Follow-up|461|||
125481555|NCT05566639|451396468|FG000|Overall Study|Physician Decision|45|||
125481556|NCT05566639|451396469|FG001|Overall Study|Physician Decision|44|||
125481557|NCT05566639|451396468|FG000|Overall Study|Protocol Deviation|4|||
125481558|NCT05566639|451396469|FG001|Overall Study|Protocol Deviation|4|||
125481559|NCT05566639|451396468|FG000|Overall Study|Withdrawal by Subject|277|||
125481560|NCT05566639|451396469|FG001|Overall Study|Withdrawal by Subject|271|||
125481561|NCT05566639|451396468|FG000|Overall Study|Other Than Specified|52|||
125481562|NCT05566639|451396469|FG001|Overall Study|Other Than Specified|64|||
125481563|NCT05239455|451396471|FG000|Overall Study|Adverse Event|1|||
125481564|NCT05239455|451396471|FG000|Overall Study|Sponsor Decision|5|||
125481565|NCT05239455|451396471|FG000|Overall Study|Incomplete Blood Collection|1|||
125481566|NCT02589522|451396472|FG000|Overall Study|Physician Decision|1|||
125481567|NCT02589522|451396473|FG001|Overall Study|Physician Decision|2|||
125481568|NCT02589522|451396474|FG002|Overall Study|Physician Decision|0|||
125481569|NCT02589522|451396472|FG000|Overall Study|Did not start treatment|1|||
125481570|NCT02589522|451396473|FG001|Overall Study|Did not start treatment|0|||
125481571|NCT02589522|451396474|FG002|Overall Study|Did not start treatment|0|||
125481572|NCT03800654|451396475|FG000|Overall Study|Time constraints|3|||
125481573|NCT03800654|451396476|FG001|Overall Study|Time constraints|3|||
125481574|NCT03800654|451396477|FG002|Overall Study|Time constraints|3|||
125481575|NCT03800654|451396475|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
125481576|NCT03800654|451396476|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
125481577|NCT03800654|451396477|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
125481578|NCT03800654|451396475|FG000|Overall Study|Lost to Follow-up|2|||
125481579|NCT03800654|451396476|FG001|Overall Study|Lost to Follow-up|1|||
125481580|NCT03800654|451396477|FG002|Overall Study|Lost to Follow-up|6|||
125481581|NCT03800654|451396475|FG000|Overall Study|Medical Health Issue|0|||
125481582|NCT03800654|451396476|FG001|Overall Study|Medical Health Issue|0|||
125481583|NCT03800654|451396477|FG002|Overall Study|Medical Health Issue|1|||
125481584|NCT03800654|451396475|FG000|Overall Study|Personal Issues|0|||
125481585|NCT03800654|451396476|FG001|Overall Study|Personal Issues|2|||
125481586|NCT03800654|451396477|FG002|Overall Study|Personal Issues|0|||
125481587|NCT03800654|451396475|FG000|Overall Study|Protocol Violation|0|||
125481588|NCT03800654|451396476|FG001|Overall Study|Protocol Violation|1|||
125481589|NCT03800654|451396477|FG002|Overall Study|Protocol Violation|0|||
125481590|NCT04159415|451396478|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
125481591|NCT04159415|451396479|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
125481592|NCT04159415|451396480|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
125481593|NCT04159415|451396481|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
125481594|NCT04159415|451396482|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
125481595|NCT04159415|451396483|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
125481596|NCT04159415|451396484|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
125481597|NCT04159415|451396485|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
125481598|NCT01799265|451396486|FG000|Overall Study|Lost to Follow-up|1|||
125481599|NCT01799265|451396487|FG001|Overall Study|Lost to Follow-up|0|||
125481600|NCT01799265|451396486|FG000|Overall Study|Protocol Violation|2|||
125481601|NCT01799265|451396487|FG001|Overall Study|Protocol Violation|1|||
125481602|NCT01799265|451396486|FG000|Overall Study|inadequate sleep study|0|||
125481603|NCT01799265|451396487|FG001|Overall Study|inadequate sleep study|2|||
125481604|NCT03459729|451396488|FG000|Overall Study|Physician Decision|2|||
125481605|NCT06182033|451396489|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
125481606|NCT06182033|451396490|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
125481607|NCT06182033|451396489|FG000|Overall Study|Target child relocation|1|||
125481608|NCT06182033|451396490|FG001|Overall Study|Target child relocation|1|||
125481609|NCT06182033|451396489|FG000|Overall Study|Withdrawal by Subject|1|||
125481610|NCT06182033|451396490|FG001|Overall Study|Withdrawal by Subject|0|||
125481611|NCT02364557|451396491|FG000|Overall Study|Protocol Violation|3|||
125481612|NCT02364557|451396492|FG001|Overall Study|Protocol Violation|1|||
125481613|NCT04200456|451396497|FG000|Overall Study|Physician Decision|0|||
125481614|NCT04200456|451396498|FG001|Overall Study|Physician Decision|1|||
125481615|NCT04200456|451396497|FG000|Overall Study|Withdrawal by Subject|2|||
125481616|NCT04200456|451396498|FG001|Overall Study|Withdrawal by Subject|2|||
125481617|NCT04200456|451396497|FG000|Overall Study|Lack of Efficacy|1|||
125481618|NCT04200456|451396498|FG001|Overall Study|Lack of Efficacy|1|||
125481619|NCT04200456|451396497|FG000|Overall Study|Adverse event, non-fatal|0|||
125481620|NCT04200456|451396498|FG001|Overall Study|Adverse event, non-fatal|1|||
125481621|NCT04200456|451396497|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
125481622|NCT04200456|451396498|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
125481623|NCT04828005|451396499|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
125481624|NCT04828005|451396500|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
125481625|NCT04828005|451396501|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
125481626|NCT04828005|451396502|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
125481627|NCT04828005|451396499|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
125481628|NCT04828005|451396500|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
125481629|NCT04828005|451396501|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
125481630|NCT04828005|451396502|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
125481631|NCT04828005|451396499|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
125481632|NCT04828005|451396500|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
125481633|NCT04828005|451396501|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
125481634|NCT04828005|451396502|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
125481635|NCT04828005|451396499|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
125481636|NCT04828005|451396500|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
125481637|NCT04828005|451396501|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
125481638|NCT04828005|451396502|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
125481639|NCT04828005|451396499|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
125481640|NCT04828005|451396500|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
125481641|NCT04828005|451396501|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
125481642|NCT04828005|451396502|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
125481643|NCT04828005|451396499|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
125481644|NCT04828005|451396500|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
125481645|NCT04828005|451396501|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
125481646|NCT04828005|451396502|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
125481647|NCT04828005|451396499|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
125481648|NCT04828005|451396500|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
125481649|NCT04828005|451396501|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
125481650|NCT04828005|451396502|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
125481651|NCT04828005|451396499|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
125481652|NCT04828005|451396500|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
125481653|NCT04828005|451396501|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
125481654|NCT04828005|451396502|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
125481655|NCT04828005|451396499|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
125481656|NCT04828005|451396500|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
125481657|NCT04828005|451396501|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
125481658|NCT04828005|451396502|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
125481659|NCT02043678|451397664|FG000|Overall Study|Never treated|11|||
125481660|NCT02043678|451397665|FG001|Overall Study|Never treated|9|||
125481661|NCT02043678|451397664|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
125481662|NCT02043678|451397665|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
125481663|NCT02043678|451397664|FG000|Overall Study|AE without clinical PD|54|||
125481664|NCT02043678|451397665|FG001|Overall Study|AE without clinical PD|36|||
125481665|NCT02043678|451397664|FG000|Overall Study|Lost to Follow-up|1|||
125481666|NCT02043678|451397665|FG001|Overall Study|Lost to Follow-up|1|||
125481667|NCT02043678|451397664|FG000|Overall Study|Other|10|||
125481668|NCT02043678|451397665|FG001|Overall Study|Other|14|||
125481669|NCT02043678|451397664|FG000|Overall Study|Clinical PD|114|||
125481670|NCT02043678|451397665|FG001|Overall Study|Clinical PD|148|||
125481671|NCT02043678|451397664|FG000|Overall Study|Radiological PD|100|||
125481672|NCT02043678|451397665|FG001|Overall Study|Radiological PD|90|||
125481673|NCT02043678|451397664|FG000|Overall Study|Protocol-driven decision point|59|||
125481674|NCT02043678|451397665|FG001|Overall Study|Protocol-driven decision point|58|||
125481675|NCT02043678|451397664|FG000|Overall Study|Withdrawal by Subject|16|||
125481676|NCT02043678|451397665|FG001|Overall Study|Withdrawal by Subject|20|||
125481677|NCT02043678|451397664|FG000|Overall Study|Protocol Violation|1|||
125481678|NCT02043678|451397665|FG001|Overall Study|Protocol Violation|0|||
125481679|NCT02043678|451397664|FG000|Overall Study|Deterioration of general conditions|1|||
125481680|NCT02043678|451397665|FG001|Overall Study|Deterioration of general conditions|1|||
125481681|NCT02043678|451397664|FG000|Overall Study|Logistical difficulties|2|||
125485429|NCT02240238|451412507|FG004|Phase 2|Disease progression|0|||
125481682|NCT02043678|451397665|FG001|Overall Study|Logistical difficulties|0|||
125481683|NCT02043678|451397664|FG000|Overall Study|Non-compliance with study drug|3|||
125481684|NCT02043678|451397665|FG001|Overall Study|Non-compliance with study drug|1|||
125481685|NCT02043678|451397664|FG000|Overall Study|Physician Decision|4|||
125481686|NCT02043678|451397665|FG001|Overall Study|Physician Decision|3|||
125481687|NCT02043678|451397664|FG000|Overall Study|Subject decision|0|||
125481688|NCT02043678|451397665|FG001|Overall Study|Subject decision|1|||
125481689|NCT02043678|451397664|FG000|Overall Study|Switching to other therapy|3|||
125481690|NCT02043678|451397665|FG001|Overall Study|Switching to other therapy|2|||
125481691|NCT02043678|451397664|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
125481692|NCT02043678|451397665|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
125481693|NCT02043678|451397664|FG000|Overall Study|Missing|1|||
125481694|NCT02043678|451397665|FG001|Overall Study|Missing|0|||
125481695|NCT02043678|451397664|FG000|Overall Study|Adverse Event|0|||
125481696|NCT02043678|451397665|FG001|Overall Study|Adverse Event|1|||
125481697|NCT05543629|451397666|FG000|Overall Study|Death|1|||
125481698|NCT05543629|451397667|FG001|Overall Study|Death|0|||
125481699|NCT05543629|451397668|FG002|Overall Study|Death|1|||
125481700|NCT05543629|451397669|FG003|Overall Study|Death|0|||
125481701|NCT05543629|451397670|FG004|Overall Study|Death|0|||
125481702|NCT05543629|451397671|FG005|Overall Study|Death|1|||
125481703|NCT05543629|451397672|FG006|Overall Study|Death|2|||
125481704|NCT05543629|451397673|FG007|Overall Study|Death|2|||
125481705|NCT05543629|451397666|FG000|Overall Study|Other Reasons|0|||
125481706|NCT05543629|451397667|FG001|Overall Study|Other Reasons|0|||
125481707|NCT05543629|451397668|FG002|Overall Study|Other Reasons|0|||
125481708|NCT05543629|451397669|FG003|Overall Study|Other Reasons|0|||
125481709|NCT05543629|451397670|FG004|Overall Study|Other Reasons|1|||
125481710|NCT05543629|451397671|FG005|Overall Study|Other Reasons|0|||
125481711|NCT05543629|451397672|FG006|Overall Study|Other Reasons|0|||
125481712|NCT05543629|451397673|FG007|Overall Study|Other Reasons|0|||
125481713|NCT05543629|451397666|FG000|Overall Study|Physician Decision|0|||
125481714|NCT05543629|451397667|FG001|Overall Study|Physician Decision|0|||
125481715|NCT05543629|451397668|FG002|Overall Study|Physician Decision|3|||
125481716|NCT05543629|451397669|FG003|Overall Study|Physician Decision|0|||
125481717|NCT05543629|451397670|FG004|Overall Study|Physician Decision|0|||
125481718|NCT05543629|451397671|FG005|Overall Study|Physician Decision|0|||
125481719|NCT05543629|451397672|FG006|Overall Study|Physician Decision|1|||
125481720|NCT05543629|451397673|FG007|Overall Study|Physician Decision|0|||
125481721|NCT05543629|451397666|FG000|Overall Study|Study terminated by Sponsor|1|||
125481722|NCT05543629|451397667|FG001|Overall Study|Study terminated by Sponsor|0|||
125481723|NCT05543629|451397668|FG002|Overall Study|Study terminated by Sponsor|0|||
125481724|NCT05543629|451397669|FG003|Overall Study|Study terminated by Sponsor|1|||
125481725|NCT05543629|451397670|FG004|Overall Study|Study terminated by Sponsor|0|||
125481726|NCT05543629|451397671|FG005|Overall Study|Study terminated by Sponsor|4|||
125481727|NCT05543629|451397672|FG006|Overall Study|Study terminated by Sponsor|1|||
125481728|NCT05543629|451397673|FG007|Overall Study|Study terminated by Sponsor|0|||
125481729|NCT05543629|451397666|FG000|Overall Study|Withdrawal by Subject|1|||
125481730|NCT05543629|451397667|FG001|Overall Study|Withdrawal by Subject|1|||
125481731|NCT05543629|451397668|FG002|Overall Study|Withdrawal by Subject|0|||
125481732|NCT05543629|451397669|FG003|Overall Study|Withdrawal by Subject|2|||
125481733|NCT05543629|451397670|FG004|Overall Study|Withdrawal by Subject|1|||
125481734|NCT05543629|451397671|FG005|Overall Study|Withdrawal by Subject|1|||
125481735|NCT05543629|451397672|FG006|Overall Study|Withdrawal by Subject|1|||
125481736|NCT05543629|451397673|FG007|Overall Study|Withdrawal by Subject|1|||
125481737|NCT05543629|451397666|FG000|Overall Study|Not Reported|2|||
125481738|NCT05543629|451397667|FG001|Overall Study|Not Reported|2|||
125481739|NCT05543629|451397668|FG002|Overall Study|Not Reported|0|||
125481740|NCT05543629|451397669|FG003|Overall Study|Not Reported|0|||
125481741|NCT05543629|451397670|FG004|Overall Study|Not Reported|1|||
125481742|NCT05543629|451397671|FG005|Overall Study|Not Reported|1|||
125481743|NCT05543629|451397672|FG006|Overall Study|Not Reported|3|||
125481744|NCT05543629|451397673|FG007|Overall Study|Not Reported|0|||
125481745|NCT04568603|451397674|FG000|Overall Study|Physician Decision|1|||
125481746|NCT03904147|451397675|FG000|Overall Study|Death|15|||
125481747|NCT03904147|451397676|FG001|Overall Study|Death|13|||
125481748|NCT03904147|451397677|FG002|Overall Study|Death|15|||
125481749|NCT03904147|451397675|FG000|Overall Study|Withdrawal by Subject|7|||
125481750|NCT03904147|451397676|FG001|Overall Study|Withdrawal by Subject|12|||
125481751|NCT03904147|451397677|FG002|Overall Study|Withdrawal by Subject|1|||
125481752|NCT03904147|451397675|FG000|Overall Study|1Y visit completed after 365 days|1|||
125481753|NCT03904147|451397676|FG001|Overall Study|1Y visit completed after 365 days|1|||
125481754|NCT03904147|451397677|FG002|Overall Study|1Y visit completed after 365 days|0|||
125481755|NCT04307355|451397681|FG000|Overall Study|Non-Compliance|3|||
125481756|NCT04307355|451397682|FG001|Overall Study|Non-Compliance|3|||
125481757|NCT04307355|451397683|FG002|Overall Study|Non-Compliance|0|||
125481758|NCT04225273|451397685|FG000|Overall Study|Lost to Follow-up|3|||
125481759|NCT04413708|451397687|FG000|Overall Study|Lost to Follow-up|1|||
125481760|NCT04413708|451397688|FG001|Overall Study|Lost to Follow-up|2|||
125481761|NCT02861300|451397689|FG000|Overall Study|Death|0|||
125481762|NCT02861300|451397690|FG001|Overall Study|Death|0|||
125481763|NCT02861300|451397691|FG002|Overall Study|Death|0|||
125481764|NCT02861300|451397692|FG003|Overall Study|Death|0|||
125481765|NCT02861300|451397693|FG004|Overall Study|Death|0|||
125481766|NCT02861300|451397694|FG005|Overall Study|Death|0|||
125481767|NCT02861300|451397695|FG006|Overall Study|Death|24|||
125481768|NCT02861300|451397689|FG000|Overall Study|Delay in treatment|0|||
125481769|NCT02861300|451397690|FG001|Overall Study|Delay in treatment|0|||
125481770|NCT02861300|451397691|FG002|Overall Study|Delay in treatment|0|||
125481771|NCT02861300|451397692|FG003|Overall Study|Delay in treatment|0|||
125481772|NCT02861300|451397693|FG004|Overall Study|Delay in treatment|0|||
125481773|NCT02861300|451397694|FG005|Overall Study|Delay in treatment|1|||
125481774|NCT02861300|451397695|FG006|Overall Study|Delay in treatment|0|||
125481775|NCT02861300|451397689|FG000|Overall Study|Disease Progression|0|||
125481776|NCT02861300|451397690|FG001|Overall Study|Disease Progression|1|||
125481777|NCT02861300|451397691|FG002|Overall Study|Disease Progression|0|||
125481778|NCT02861300|451397692|FG003|Overall Study|Disease Progression|0|||
125481779|NCT02861300|451397693|FG004|Overall Study|Disease Progression|0|||
125481780|NCT02861300|451397694|FG005|Overall Study|Disease Progression|0|||
125481781|NCT02861300|451397695|FG006|Overall Study|Disease Progression|2|||
125481782|NCT02861300|451397689|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
125481783|NCT02861300|451397690|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
125481784|NCT02861300|451397691|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
125481785|NCT02861300|451397692|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
125481786|NCT02861300|451397693|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
125481787|NCT02861300|451397694|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
125481788|NCT02861300|451397695|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
125481789|NCT02861300|451397689|FG000|Overall Study|Clinical Complications|0|||
125481790|NCT02861300|451397690|FG001|Overall Study|Clinical Complications|0|||
125481791|NCT02861300|451397691|FG002|Overall Study|Clinical Complications|0|||
125481792|NCT02861300|451397692|FG003|Overall Study|Clinical Complications|0|||
125481793|NCT02861300|451397693|FG004|Overall Study|Clinical Complications|0|||
125481794|NCT02861300|451397694|FG005|Overall Study|Clinical Complications|0|||
125481795|NCT02861300|451397695|FG006|Overall Study|Clinical Complications|1|||
125481796|NCT03133546|451397696|FG000|Overall Study|Death|46|||
125481797|NCT03133546|451397697|FG001|Overall Study|Death|43|||
125481798|NCT03133546|451397696|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
125481799|NCT03133546|451397697|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
125481800|NCT06103188|451397699|FG000|Overall Study|Lost to Follow-up|1|||
125481801|NCT06103188|451397700|FG001|Overall Study|Lost to Follow-up|6|||
125481802|NCT06103188|451397701|FG002|Overall Study|Lost to Follow-up|4|||
125481803|NCT01175356|451397706|FG000|Overall Study|Death|1|||
125481804|NCT01175356|451397706|FG000|Overall Study|Lack of Efficacy|12|||
125481805|NCT01175356|451397706|FG000|Overall Study|Lost to Follow-up|1|||
125481806|NCT01175356|451397706|FG000|Overall Study|Physician Decision|23|||
125481807|NCT01175356|451397706|FG000|Overall Study|Ineligible|1|||
125481808|NCT01175356|451397706|FG000|Overall Study|Treatment Slot Not Available|18|||
125481809|NCT01175356|451397706|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
125481810|NCT01175356|451397706|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
125481811|NCT01175356|451397706|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
125481812|NCT01175356|451397706|FG000|Overall Study|Inadequate stem cell for transplant|1|||
125481813|NCT01175356|451397706|FG000|Overall Study|Initiation other tx prior to completion|9|||
125481814|NCT05386030|451397711|FG000|Overall Study|Death|1|||
125481815|NCT05386030|451397712|FG001|Overall Study|Death|0|||
125481816|NCT05386030|451397711|FG000|Overall Study|Physician Decision|2|||
125481817|NCT05386030|451397712|FG001|Overall Study|Physician Decision|1|||
125481818|NCT05386030|451397711|FG000|Overall Study|Lost to Follow-up|19|||
125481819|NCT05386030|451397712|FG001|Overall Study|Lost to Follow-up|7|||
125481820|NCT05386030|451397711|FG000|Overall Study|Withdrawal by Subject|20|||
125481821|NCT05386030|451397712|FG001|Overall Study|Withdrawal by Subject|10|||
125481822|NCT05386030|451397711|FG000|Overall Study|Eligibility criteria violation|1|||
125481823|NCT05386030|451397712|FG001|Overall Study|Eligibility criteria violation|1|||
125481824|NCT05386030|451397711|FG000|Overall Study|Personal Reasons|1|||
125481825|NCT05386030|451397712|FG001|Overall Study|Personal Reasons|0|||
125481826|NCT04719832|451397713|FG000|Overall Study|Adverse Event|2|||
125481827|NCT04719832|451397714|FG001|Overall Study|Adverse Event|0|||
125481828|NCT04719832|451397713|FG000|Overall Study|Lack of Efficacy|2|||
125481829|NCT04719832|451397714|FG001|Overall Study|Lack of Efficacy|4|||
125481830|NCT04719832|451397713|FG000|Overall Study|Lost to Follow-up|0|||
125481831|NCT04719832|451397714|FG001|Overall Study|Lost to Follow-up|2|||
125481832|NCT04719832|451397713|FG000|Overall Study|Physician Decision|0|||
125481833|NCT04719832|451397714|FG001|Overall Study|Physician Decision|1|||
125481834|NCT04719832|451397713|FG000|Overall Study|Pregnancy|1|||
125481835|NCT04719832|451397714|FG001|Overall Study|Pregnancy|1|||
125481836|NCT04719832|451397713|FG000|Overall Study|Withdrawal by Subject|5|||
125481837|NCT04719832|451397714|FG001|Overall Study|Withdrawal by Subject|5|||
125481838|NCT04719832|451397713|FG000|Overall Study|Randomized, not treated|0|||
125485430|NCT02240238|451412508|FG005|Phase 2|Disease progression|0|||
125481839|NCT04719832|451397714|FG001|Overall Study|Randomized, not treated|2|||
125481840|NCT04719832|451397713|FG000|Overall Study|GCP violations|4|||
125481841|NCT04719832|451397714|FG001|Overall Study|GCP violations|7|||
125481842|NCT04880863|451397717|FG000|Overall Study|Adverse Event|1|||
125481843|NCT04880863|451397717|FG000|Overall Study|Patient decision|2|||
125481844|NCT04880863|451397717|FG000|Overall Study|Confirmed Disease Progression|15|||
125481845|NCT04880863|451397717|FG000|Overall Study|Death|3|||
125481846|NCT04880863|451397717|FG000|Overall Study|Physician Decision|4|||
125481847|NCT04880863|451397717|FG000|Overall Study|Unconfirmed Disease Progression|4|||
125481848|NCT04880863|451397717|FG000|Overall Study|Withdrawal by Subject|2|||
125481849|NCT04880863|451397717|FG000|Overall Study|Study discontinuation by the sponsor|4|||
125481850|NCT04880863|451397717|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
125481851|NCT04880863|451397717|FG000|Overall Study|Not received study drug NAP|2|||
125481852|NCT04898673|451397718|FG000|Overall Study|Screenfail|1|||
125481853|NCT04898673|451397719|FG001|Overall Study|Screenfail|0|||
125481854|NCT03899259|451397722|FG000|Overall Study|Adverse Event|5|||
125481855|NCT03899259|451397723|FG001|Overall Study|Adverse Event|4|||
125481856|NCT03899259|451397724|FG002|Overall Study|Adverse Event|6|||
125481857|NCT03899259|451397722|FG000|Overall Study|Lack of Efficacy|5|||
125481858|NCT03899259|451397723|FG001|Overall Study|Lack of Efficacy|0|||
125481859|NCT03899259|451397724|FG002|Overall Study|Lack of Efficacy|2|||
125481860|NCT03899259|451397722|FG000|Overall Study|Pregnancy|3|||
125481861|NCT03899259|451397723|FG001|Overall Study|Pregnancy|0|||
125481862|NCT03899259|451397724|FG002|Overall Study|Pregnancy|1|||
125481863|NCT03899259|451397722|FG000|Overall Study|Physician Decision|0|||
125481864|NCT03899259|451397723|FG001|Overall Study|Physician Decision|1|||
125481865|NCT03899259|451397724|FG002|Overall Study|Physician Decision|0|||
125481866|NCT03899259|451397722|FG000|Overall Study|Protocol Deviation|1|||
125481867|NCT03899259|451397723|FG001|Overall Study|Protocol Deviation|1|||
125481868|NCT03899259|451397724|FG002|Overall Study|Protocol Deviation|1|||
125481869|NCT03899259|451397722|FG000|Overall Study|Withdrawal by Subject|8|||
125481870|NCT03899259|451397723|FG001|Overall Study|Withdrawal by Subject|10|||
125481871|NCT03899259|451397724|FG002|Overall Study|Withdrawal by Subject|12|||
125481872|NCT03899259|451397722|FG000|Overall Study|Lost to Follow-up|5|||
125481873|NCT03899259|451397723|FG001|Overall Study|Lost to Follow-up|6|||
125481874|NCT03899259|451397724|FG002|Overall Study|Lost to Follow-up|2|||
125481875|NCT03899259|451397722|FG000|Overall Study|Lack of Adherence|1|||
125481876|NCT03899259|451397723|FG001|Overall Study|Lack of Adherence|0|||
125481877|NCT03899259|451397724|FG002|Overall Study|Lack of Adherence|0|||
125481878|NCT03899259|451397722|FG000|Overall Study|Screen Failure|1|||
125481879|NCT03899259|451397723|FG001|Overall Study|Screen Failure|0|||
125481880|NCT03899259|451397724|FG002|Overall Study|Screen Failure|0|||
125481881|NCT03899259|451397722|FG000|Overall Study|Ongoing Study Participation|127|||
125481882|NCT03899259|451397723|FG001|Overall Study|Ongoing Study Participation|134|||
125481883|NCT03899259|451397724|FG002|Overall Study|Ongoing Study Participation|210|||
125481884|NCT05670587|451397725|FG000|Overall Study|Withdrawal by Subject|3|||
125481885|NCT01197378|451397726|FG000|Overall Study|Adverse Event|3|||
125481886|NCT01197378|451397726|FG000|Overall Study|Withdrawal by Subject|1|||
125481887|NCT01197378|451397726|FG000|Overall Study|Physician Decision|1|||
125481888|NCT01197378|451397726|FG000|Overall Study|Other|2|||
125481889|NCT01733316|451397727|FG000|RP103 Phase|Non-compliance|1|||
125481890|NCT01733316|451397727|FG000|Long Term Extension Phase|Adverse Event|1|||
125481891|NCT01733316|451397727|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
125481892|NCT01733316|451397727|FG000|Long Term Extension Phase|Sponsor Decision|2|||
125481893|NCT03058289|451397728|FG000|Overall Study|Radiographic Deterioration|0|||
125481894|NCT03058289|451397729|FG001|Overall Study|Radiographic Deterioration|3|||
125481895|NCT03058289|451397730|FG002|Overall Study|Radiographic Deterioration|1|||
125481896|NCT03058289|451397731|FG003|Overall Study|Radiographic Deterioration|2|||
125481897|NCT03058289|451397732|FG004|Overall Study|Radiographic Deterioration|6|||
125481898|NCT03058289|451397733|FG005|Overall Study|Radiographic Deterioration|3|||
125481899|NCT03058289|451397734|FG006|Overall Study|Radiographic Deterioration|0|||
125481900|NCT03058289|451397735|FG007|Overall Study|Radiographic Deterioration|4|||
125481901|NCT03058289|451397736|FG008|Overall Study|Radiographic Deterioration|2|||
125481902|NCT03058289|451397728|FG000|Overall Study|Adverse Event|2|||
125481903|NCT03058289|451397729|FG001|Overall Study|Adverse Event|0|||
125481904|NCT03058289|451397730|FG002|Overall Study|Adverse Event|1|||
125481905|NCT03058289|451397731|FG003|Overall Study|Adverse Event|3|||
125481906|NCT03058289|451397732|FG004|Overall Study|Adverse Event|1|||
125481907|NCT03058289|451397733|FG005|Overall Study|Adverse Event|0|||
125481908|NCT03058289|451397734|FG006|Overall Study|Adverse Event|1|||
125481909|NCT03058289|451397735|FG007|Overall Study|Adverse Event|3|||
125481910|NCT03058289|451397736|FG008|Overall Study|Adverse Event|0|||
125481911|NCT03058289|451397728|FG000|Overall Study|Withdrawal by Subject|0|||
125481912|NCT03058289|451397729|FG001|Overall Study|Withdrawal by Subject|0|||
125481913|NCT03058289|451397730|FG002|Overall Study|Withdrawal by Subject|0|||
125481914|NCT03058289|451397731|FG003|Overall Study|Withdrawal by Subject|2|||
125481915|NCT03058289|451397732|FG004|Overall Study|Withdrawal by Subject|0|||
125481916|NCT03058289|451397733|FG005|Overall Study|Withdrawal by Subject|2|||
125481917|NCT03058289|451397734|FG006|Overall Study|Withdrawal by Subject|0|||
125481918|NCT03058289|451397735|FG007|Overall Study|Withdrawal by Subject|4|||
125481919|NCT03058289|451397736|FG008|Overall Study|Withdrawal by Subject|1|||
125481920|NCT03058289|451397728|FG000|Overall Study|Physician Decision|1|||
125481921|NCT03058289|451397729|FG001|Overall Study|Physician Decision|0|||
125481922|NCT03058289|451397730|FG002|Overall Study|Physician Decision|0|||
125481923|NCT03058289|451397731|FG003|Overall Study|Physician Decision|2|||
125481924|NCT03058289|451397732|FG004|Overall Study|Physician Decision|1|||
125481925|NCT03058289|451397733|FG005|Overall Study|Physician Decision|0|||
125481926|NCT03058289|451397734|FG006|Overall Study|Physician Decision|2|||
125481927|NCT03058289|451397735|FG007|Overall Study|Physician Decision|3|||
125481928|NCT03058289|451397736|FG008|Overall Study|Physician Decision|0|||
125481929|NCT03058289|451397728|FG000|Overall Study|Clinical Deterioration|2|||
125481930|NCT03058289|451397729|FG001|Overall Study|Clinical Deterioration|0|||
125481931|NCT03058289|451397730|FG002|Overall Study|Clinical Deterioration|0|||
125481932|NCT03058289|451397731|FG003|Overall Study|Clinical Deterioration|2|||
125481933|NCT03058289|451397732|FG004|Overall Study|Clinical Deterioration|1|||
125481934|NCT03058289|451397733|FG005|Overall Study|Clinical Deterioration|1|||
125481935|NCT03058289|451397734|FG006|Overall Study|Clinical Deterioration|0|||
125481936|NCT03058289|451397735|FG007|Overall Study|Clinical Deterioration|3|||
125481937|NCT03058289|451397736|FG008|Overall Study|Clinical Deterioration|2|||
125481938|NCT03058289|451397728|FG000|Overall Study|Lost to Follow-up|0|||
125481939|NCT03058289|451397729|FG001|Overall Study|Lost to Follow-up|0|||
125481940|NCT03058289|451397730|FG002|Overall Study|Lost to Follow-up|0|||
125481941|NCT03058289|451397731|FG003|Overall Study|Lost to Follow-up|0|||
125481942|NCT03058289|451397732|FG004|Overall Study|Lost to Follow-up|1|||
125481943|NCT03058289|451397733|FG005|Overall Study|Lost to Follow-up|0|||
125481944|NCT03058289|451397734|FG006|Overall Study|Lost to Follow-up|0|||
125481945|NCT03058289|451397735|FG007|Overall Study|Lost to Follow-up|0|||
125481946|NCT03058289|451397736|FG008|Overall Study|Lost to Follow-up|0|||
125481947|NCT03058289|451397728|FG000|Overall Study|Refused Further Treatment|0|||
125481948|NCT03058289|451397729|FG001|Overall Study|Refused Further Treatment|0|||
125481949|NCT03058289|451397730|FG002|Overall Study|Refused Further Treatment|1|||
125481950|NCT03058289|451397731|FG003|Overall Study|Refused Further Treatment|0|||
125481951|NCT03058289|451397732|FG004|Overall Study|Refused Further Treatment|1|||
125481952|NCT03058289|451397733|FG005|Overall Study|Refused Further Treatment|0|||
125481953|NCT03058289|451397734|FG006|Overall Study|Refused Further Treatment|0|||
125481954|NCT03058289|451397735|FG007|Overall Study|Refused Further Treatment|0|||
125481955|NCT03058289|451397736|FG008|Overall Study|Refused Further Treatment|0|||
125481956|NCT03058289|451397728|FG000|Overall Study|Rapid Progression of Disease|0|||
125481957|NCT03058289|451397729|FG001|Overall Study|Rapid Progression of Disease|0|||
125481958|NCT03058289|451397730|FG002|Overall Study|Rapid Progression of Disease|0|||
125481959|NCT03058289|451397731|FG003|Overall Study|Rapid Progression of Disease|1|||
125481960|NCT03058289|451397732|FG004|Overall Study|Rapid Progression of Disease|0|||
125481961|NCT03058289|451397733|FG005|Overall Study|Rapid Progression of Disease|0|||
125481962|NCT03058289|451397734|FG006|Overall Study|Rapid Progression of Disease|0|||
125481963|NCT03058289|451397735|FG007|Overall Study|Rapid Progression of Disease|0|||
125481964|NCT03058289|451397736|FG008|Overall Study|Rapid Progression of Disease|0|||
125481965|NCT05546411|451397739|FG000|Overall Study|Progressive Disease|1|||
125481966|NCT05546411|451397740|FG001|Overall Study|Progressive Disease|0|||
125481967|NCT05546411|451397739|FG000|Overall Study|Adverse Event|0|||
125481968|NCT05546411|451397740|FG001|Overall Study|Adverse Event|1|||
125481969|NCT05546411|451397739|FG000|Overall Study|Metastatic disease|1|||
125481970|NCT05546411|451397740|FG001|Overall Study|Metastatic disease|0|||
125481971|NCT02606422|451397741|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
125481972|NCT02606422|451397742|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
125481973|NCT02606422|451397741|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
125481974|NCT02606422|451397742|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
125481975|NCT02606422|451397741|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
125481976|NCT02606422|451397742|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
125481977|NCT02606422|451397741|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
125481978|NCT02606422|451397742|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
125481979|NCT02151981|451397746|FG000|Overall Study|Death|184|||
125481980|NCT02151981|451397747|FG001|Overall Study|Death|88|||
125481981|NCT02151981|451397746|FG000|Overall Study|Lost to Follow-up|7|||
125481982|NCT02151981|451397747|FG001|Overall Study|Lost to Follow-up|1|||
125481983|NCT02151981|451397746|FG000|Overall Study|Withdrawal by Subject|27|||
125481984|NCT02151981|451397747|FG001|Overall Study|Withdrawal by Subject|21|||
125481985|NCT02151981|451397746|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125481986|NCT02151981|451397747|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125481987|NCT02151981|451397746|FG000|Overall Study|Other reasons|1|||
125481988|NCT02151981|451397747|FG001|Overall Study|Other reasons|2|||
125481989|NCT01946789|451397751|FG000|Overall Study|Death|0|||
125481990|NCT01946789|451397752|FG001|Overall Study|Death|2|||
125481991|NCT01946789|451397753|FG002|Overall Study|Death|1|||
125481992|NCT01946789|451397754|FG003|Overall Study|Death|1|||
125481993|NCT01946789|451397755|FG004|Overall Study|Death|1|||
125481994|NCT01946789|451397756|FG005|Overall Study|Death|1|||
125481995|NCT01946789|451397757|FG006|Overall Study|Death|3|||
125481996|NCT01946789|451397758|FG007|Overall Study|Death|1|||
125481997|NCT01946789|451397759|FG008|Overall Study|Death|2|||
125481998|NCT01946789|451397751|FG000|Overall Study|Progressive Disease|0|||
125481999|NCT01946789|451397752|FG001|Overall Study|Progressive Disease|0|||
125482000|NCT01946789|451397753|FG002|Overall Study|Progressive Disease|1|||
125482001|NCT01946789|451397754|FG003|Overall Study|Progressive Disease|0|||
125482002|NCT01946789|451397755|FG004|Overall Study|Progressive Disease|0|||
125482003|NCT01946789|451397756|FG005|Overall Study|Progressive Disease|2|||
125482004|NCT01946789|451397757|FG006|Overall Study|Progressive Disease|0|||
125482005|NCT01946789|451397758|FG007|Overall Study|Progressive Disease|0|||
125482006|NCT01946789|451397759|FG008|Overall Study|Progressive Disease|0|||
125482007|NCT01946789|451397751|FG000|Overall Study|Withdrawal by Subject|0|||
125482008|NCT01946789|451397752|FG001|Overall Study|Withdrawal by Subject|0|||
125482009|NCT01946789|451397753|FG002|Overall Study|Withdrawal by Subject|0|||
125482010|NCT01946789|451397754|FG003|Overall Study|Withdrawal by Subject|2|||
125482011|NCT01946789|451397755|FG004|Overall Study|Withdrawal by Subject|1|||
125482012|NCT01946789|451397756|FG005|Overall Study|Withdrawal by Subject|0|||
125482013|NCT01946789|451397757|FG006|Overall Study|Withdrawal by Subject|1|||
125482014|NCT01946789|451397758|FG007|Overall Study|Withdrawal by Subject|0|||
125482015|NCT01946789|451397759|FG008|Overall Study|Withdrawal by Subject|0|||
125482016|NCT05374798|451397760|FG000|Overall Study|Lost to Follow-up|2|||
125482017|NCT05374798|451397760|FG000|Overall Study|Withdrawal by Subject|2|||
125482018|NCT05374798|451397760|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
125482019|NCT05576155|451397761|FG000|Overall Study|Withdrawal by Subject|1|||
125482020|NCT05576155|451397762|FG001|Overall Study|Withdrawal by Subject|1|||
125482021|NCT01275677|451397766|FG000|Overall Study|Not at risk for recurrence.|1|||
125482022|NCT01275677|451397767|FG001|Overall Study|Not at risk for recurrence.|1|||
125482023|NCT01275677|451397766|FG000|Overall Study|No follow-up|26|||
125482024|NCT01275677|451397767|FG001|Overall Study|No follow-up|37|||
125482025|NCT01275677|451397766|FG000|Overall Study|No clinical follow up.|1|||
125482026|NCT01275677|451397767|FG001|Overall Study|No clinical follow up.|4|||
125482027|NCT04409353|451397773|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
125482028|NCT04409353|451397774|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
125482029|NCT04409353|451397775|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
125482030|NCT04409353|451397773|FG000|Overall Study|Lost to Follow-up|6|||
125482031|NCT04409353|451397774|FG001|Overall Study|Lost to Follow-up|8|||
125482032|NCT04409353|451397775|FG002|Overall Study|Lost to Follow-up|7|||
125482033|NCT04409353|451397773|FG000|Overall Study|Major surgery during participation window|4|||
125482034|NCT04409353|451397774|FG001|Overall Study|Major surgery during participation window|3|||
125482035|NCT04409353|451397775|FG002|Overall Study|Major surgery during participation window|3|||
125482036|NCT04409353|451397773|FG000|Overall Study|Life event occurred during participation window|3|||
125482037|NCT04409353|451397774|FG001|Overall Study|Life event occurred during participation window|2|||
125482038|NCT04409353|451397775|FG002|Overall Study|Life event occurred during participation window|4|||
125482039|NCT04409353|451397773|FG000|Overall Study|Lack of Efficacy|4|||
125482040|NCT04409353|451397774|FG001|Overall Study|Lack of Efficacy|1|||
125482041|NCT04409353|451397775|FG002|Overall Study|Lack of Efficacy|3|||
125482042|NCT04409353|451397773|FG000|Overall Study|Adverse Event|2|||
125482043|NCT04409353|451397774|FG001|Overall Study|Adverse Event|1|||
125482044|NCT04409353|451397775|FG002|Overall Study|Adverse Event|1|||
125482045|NCT04409353|451397773|FG000|Overall Study|Disease burden - unable to participate|0|||
125482046|NCT04409353|451397774|FG001|Overall Study|Disease burden - unable to participate|1|||
125482047|NCT04409353|451397775|FG002|Overall Study|Disease burden - unable to participate|1|||
125482048|NCT04409353|451397773|FG000|Overall Study|Intervention too complicated|1|||
125482049|NCT04409353|451397774|FG001|Overall Study|Intervention too complicated|0|||
125482050|NCT04409353|451397775|FG002|Overall Study|Intervention too complicated|1|||
125482051|NCT04081103|451397776|FG000|Overall Study|Adverse Event|1|||
125482052|NCT04081103|451397777|FG001|Overall Study|Adverse Event|1|||
125482053|NCT04081103|451397778|FG002|Overall Study|Adverse Event|1|||
125482054|NCT04081103|451397776|FG000|Overall Study|Physician Decision|0|||
125482055|NCT04081103|451397777|FG001|Overall Study|Physician Decision|0|||
125482056|NCT04081103|451397778|FG002|Overall Study|Physician Decision|1|||
125482057|NCT05309291|451397779|FG000|Overall Study|Adverse Event|0|||
125482058|NCT05309291|451397780|FG001|Overall Study|Adverse Event|1|||
125482059|NCT05209152|451397783|FG000|Overall Study|Sponsor decision|1|||
125482060|NCT05209152|451397784|FG001|Overall Study|Sponsor decision|2|||
125482061|NCT05209152|451397783|FG000|Overall Study|Death|3|||
125482062|NCT05209152|451397784|FG001|Overall Study|Death|1|||
125482063|NCT03287817|451399898|FG000|Overall Study|Progressive disease|4|||
125482064|NCT03287817|451399899|FG001|Overall Study|Progressive disease|2|||
125482065|NCT03287817|451399900|FG002|Overall Study|Progressive disease|3|||
125482066|NCT03287817|451399901|FG003|Overall Study|Progressive disease|10|||
125482067|NCT03287817|451399902|FG004|Overall Study|Progressive disease|8|||
125482068|NCT03287817|451399898|FG000|Overall Study|Death|0|||
125482069|NCT03287817|451399899|FG001|Overall Study|Death|0|||
125482070|NCT03287817|451399900|FG002|Overall Study|Death|2|||
125482071|NCT03287817|451399901|FG003|Overall Study|Death|3|||
125482072|NCT03287817|451399902|FG004|Overall Study|Death|4|||
125482073|NCT03287817|451399898|FG000|Overall Study|Physician Decision|0|||
125482074|NCT03287817|451399899|FG001|Overall Study|Physician Decision|0|||
125482075|NCT03287817|451399900|FG002|Overall Study|Physician Decision|0|||
125482076|NCT03287817|451399901|FG003|Overall Study|Physician Decision|1|||
125482077|NCT03287817|451399902|FG004|Overall Study|Physician Decision|0|||
125482078|NCT03287817|451399898|FG000|Overall Study|Withdrawal by Subject|0|||
125482079|NCT03287817|451399899|FG001|Overall Study|Withdrawal by Subject|0|||
125482080|NCT03287817|451399900|FG002|Overall Study|Withdrawal by Subject|0|||
125482081|NCT03287817|451399901|FG003|Overall Study|Withdrawal by Subject|0|||
125482082|NCT03287817|451399902|FG004|Overall Study|Withdrawal by Subject|4|||
125482083|NCT06181227|451399903|FG000|Overall Study|Study terminated by sponsor|7|||
125482084|NCT06181227|451399904|FG001|Overall Study|Study terminated by sponsor|9|||
125482085|NCT03854227|451399908|FG000|Overall Study|Adverse Event|0|||
125482086|NCT03854227|451399909|FG001|Overall Study|Adverse Event|0|||
125482087|NCT03854227|451399910|FG002|Overall Study|Adverse Event|0|||
125482088|NCT03854227|451399911|FG003|Overall Study|Adverse Event|1|||
125482089|NCT03854227|451399912|FG004|Overall Study|Adverse Event|0|||
125482090|NCT03854227|451399913|FG005|Overall Study|Adverse Event|0|||
125482091|NCT03854227|451399914|FG006|Overall Study|Adverse Event|1|||
125482092|NCT03854227|451399915|FG007|Overall Study|Adverse Event|0|||
125482093|NCT03854227|451399916|FG008|Overall Study|Adverse Event|0|||
125482094|NCT03854227|451399917|FG009|Overall Study|Adverse Event|3|||
125482095|NCT03854227|451399918|FG010|Overall Study|Adverse Event|0|||
125482096|NCT03854227|451399919|FG011|Overall Study|Adverse Event|1|||
125482097|NCT03854227|451399908|FG000|Overall Study|Death|0|||
125482098|NCT03854227|451399909|FG001|Overall Study|Death|0|||
125482099|NCT03854227|451399910|FG002|Overall Study|Death|0|||
125482100|NCT03854227|451399911|FG003|Overall Study|Death|0|||
125482101|NCT03854227|451399912|FG004|Overall Study|Death|0|||
125482102|NCT03854227|451399913|FG005|Overall Study|Death|1|||
125482103|NCT03854227|451399914|FG006|Overall Study|Death|0|||
125482104|NCT03854227|451399915|FG007|Overall Study|Death|0|||
125482105|NCT03854227|451399916|FG008|Overall Study|Death|0|||
125482106|NCT03854227|451399917|FG009|Overall Study|Death|1|||
125482107|NCT03854227|451399918|FG010|Overall Study|Death|0|||
125482108|NCT03854227|451399919|FG011|Overall Study|Death|1|||
125482109|NCT03854227|451399908|FG000|Overall Study|Physician Decision|0|||
125482110|NCT03854227|451399909|FG001|Overall Study|Physician Decision|0|||
125482111|NCT03854227|451399910|FG002|Overall Study|Physician Decision|0|||
125482112|NCT03854227|451399911|FG003|Overall Study|Physician Decision|0|||
125482113|NCT03854227|451399912|FG004|Overall Study|Physician Decision|0|||
125482114|NCT03854227|451399913|FG005|Overall Study|Physician Decision|1|||
125482115|NCT03854227|451399914|FG006|Overall Study|Physician Decision|0|||
125482116|NCT03854227|451399915|FG007|Overall Study|Physician Decision|0|||
125482117|NCT03854227|451399916|FG008|Overall Study|Physician Decision|1|||
125482118|NCT03854227|451399917|FG009|Overall Study|Physician Decision|1|||
125482119|NCT03854227|451399918|FG010|Overall Study|Physician Decision|0|||
125482120|NCT03854227|451399919|FG011|Overall Study|Physician Decision|1|||
125482121|NCT03854227|451399908|FG000|Overall Study|Progressive disease|1|||
125482122|NCT03854227|451399909|FG001|Overall Study|Progressive disease|1|||
125482123|NCT03854227|451399910|FG002|Overall Study|Progressive disease|1|||
125482124|NCT03854227|451399911|FG003|Overall Study|Progressive disease|2|||
125482125|NCT03854227|451399912|FG004|Overall Study|Progressive disease|3|||
125482126|NCT03854227|451399913|FG005|Overall Study|Progressive disease|1|||
125482127|NCT03854227|451399914|FG006|Overall Study|Progressive disease|2|||
125482128|NCT03854227|451399915|FG007|Overall Study|Progressive disease|5|||
125482129|NCT03854227|451399916|FG008|Overall Study|Progressive disease|2|||
125482130|NCT03854227|451399917|FG009|Overall Study|Progressive disease|5|||
125482131|NCT03854227|451399918|FG010|Overall Study|Progressive disease|1|||
125482132|NCT03854227|451399919|FG011|Overall Study|Progressive disease|6|||
125482133|NCT03854227|451399908|FG000|Overall Study|Study terminated by sponsor|0|||
125482134|NCT03854227|451399909|FG001|Overall Study|Study terminated by sponsor|0|||
125482135|NCT03854227|451399910|FG002|Overall Study|Study terminated by sponsor|0|||
125482136|NCT03854227|451399911|FG003|Overall Study|Study terminated by sponsor|0|||
125482137|NCT03854227|451399912|FG004|Overall Study|Study terminated by sponsor|0|||
125482138|NCT03854227|451399913|FG005|Overall Study|Study terminated by sponsor|0|||
125482139|NCT03854227|451399914|FG006|Overall Study|Study terminated by sponsor|0|||
125482140|NCT03854227|451399915|FG007|Overall Study|Study terminated by sponsor|0|||
125482141|NCT03854227|451399916|FG008|Overall Study|Study terminated by sponsor|0|||
125482142|NCT03854227|451399917|FG009|Overall Study|Study terminated by sponsor|1|||
125482143|NCT03854227|451399918|FG010|Overall Study|Study terminated by sponsor|0|||
125482144|NCT03854227|451399919|FG011|Overall Study|Study terminated by sponsor|0|||
125482145|NCT03854227|451399908|FG000|Overall Study|Withdrawal by Subject|0|||
125482146|NCT03854227|451399909|FG001|Overall Study|Withdrawal by Subject|0|||
125482147|NCT03854227|451399910|FG002|Overall Study|Withdrawal by Subject|1|||
125482148|NCT03854227|451399911|FG003|Overall Study|Withdrawal by Subject|0|||
125482149|NCT03854227|451399912|FG004|Overall Study|Withdrawal by Subject|0|||
125482150|NCT03854227|451399913|FG005|Overall Study|Withdrawal by Subject|0|||
125482151|NCT03854227|451399914|FG006|Overall Study|Withdrawal by Subject|0|||
125482152|NCT03854227|451399915|FG007|Overall Study|Withdrawal by Subject|0|||
125482153|NCT03854227|451399916|FG008|Overall Study|Withdrawal by Subject|0|||
125482154|NCT03854227|451399917|FG009|Overall Study|Withdrawal by Subject|1|||
125482155|NCT03854227|451399918|FG010|Overall Study|Withdrawal by Subject|1|||
125482156|NCT03854227|451399919|FG011|Overall Study|Withdrawal by Subject|0|||
125482157|NCT03854227|451399908|FG000|Overall Study|Disease relapse|0|||
125482158|NCT03854227|451399909|FG001|Overall Study|Disease relapse|0|||
125482159|NCT03854227|451399910|FG002|Overall Study|Disease relapse|0|||
125482160|NCT03854227|451399911|FG003|Overall Study|Disease relapse|0|||
125482161|NCT03854227|451399912|FG004|Overall Study|Disease relapse|0|||
125482162|NCT03854227|451399913|FG005|Overall Study|Disease relapse|0|||
125482163|NCT03854227|451399914|FG006|Overall Study|Disease relapse|0|||
125482164|NCT03854227|451399915|FG007|Overall Study|Disease relapse|0|||
125482165|NCT03854227|451399916|FG008|Overall Study|Disease relapse|1|||
125482166|NCT03854227|451399917|FG009|Overall Study|Disease relapse|0|||
125482167|NCT03854227|451399918|FG010|Overall Study|Disease relapse|0|||
125482168|NCT03854227|451399919|FG011|Overall Study|Disease relapse|0|||
125482169|NCT03854227|451399908|FG000|Overall Study|Global deterioration of health status|0|||
125482170|NCT03854227|451399909|FG001|Overall Study|Global deterioration of health status|0|||
125482171|NCT03854227|451399910|FG002|Overall Study|Global deterioration of health status|0|||
125482172|NCT03854227|451399911|FG003|Overall Study|Global deterioration of health status|0|||
125482173|NCT03854227|451399912|FG004|Overall Study|Global deterioration of health status|0|||
125482174|NCT03854227|451399913|FG005|Overall Study|Global deterioration of health status|1|||
125482175|NCT03854227|451399914|FG006|Overall Study|Global deterioration of health status|0|||
125482176|NCT03854227|451399915|FG007|Overall Study|Global deterioration of health status|1|||
125482177|NCT03854227|451399916|FG008|Overall Study|Global deterioration of health status|0|||
125482178|NCT03854227|451399917|FG009|Overall Study|Global deterioration of health status|0|||
125482179|NCT03854227|451399918|FG010|Overall Study|Global deterioration of health status|0|||
125482180|NCT03854227|451399919|FG011|Overall Study|Global deterioration of health status|0|||
125482181|NCT03854227|451399908|FG000|Overall Study|Refused further treatment|0|||
125482182|NCT03854227|451399909|FG001|Overall Study|Refused further treatment|0|||
125482183|NCT03854227|451399910|FG002|Overall Study|Refused further treatment|0|||
125482184|NCT03854227|451399911|FG003|Overall Study|Refused further treatment|0|||
125482185|NCT03854227|451399912|FG004|Overall Study|Refused further treatment|0|||
125482186|NCT03854227|451399913|FG005|Overall Study|Refused further treatment|0|||
125482187|NCT03854227|451399914|FG006|Overall Study|Refused further treatment|0|||
125482188|NCT03854227|451399915|FG007|Overall Study|Refused further treatment|0|||
125482189|NCT03854227|451399916|FG008|Overall Study|Refused further treatment|0|||
125482190|NCT03854227|451399917|FG009|Overall Study|Refused further treatment|1|||
125482191|NCT03854227|451399918|FG010|Overall Study|Refused further treatment|0|||
125482192|NCT03854227|451399919|FG011|Overall Study|Refused further treatment|1|||
125482193|NCT03854227|451399908|FG000|Overall Study|Other|0|||
125482194|NCT03854227|451399909|FG001|Overall Study|Other|0|||
125482195|NCT03854227|451399910|FG002|Overall Study|Other|0|||
125482196|NCT03854227|451399911|FG003|Overall Study|Other|0|||
125482197|NCT03854227|451399912|FG004|Overall Study|Other|0|||
125482198|NCT03854227|451399913|FG005|Overall Study|Other|0|||
125482199|NCT03854227|451399914|FG006|Overall Study|Other|0|||
125482200|NCT03854227|451399915|FG007|Overall Study|Other|0|||
125482201|NCT03854227|451399916|FG008|Overall Study|Other|1|||
125482202|NCT03854227|451399917|FG009|Overall Study|Other|1|||
125482203|NCT03854227|451399918|FG010|Overall Study|Other|0|||
125482204|NCT03854227|451399919|FG011|Overall Study|Other|0|||
125482205|NCT03668236|451399920|FG000|90-day Follow-up|Withdrawal by Subject|3|||
125482206|NCT03668236|451399921|FG001|90-day Follow-up|Withdrawal by Subject|2|||
125482207|NCT03668236|451399920|FG000|90-day Follow-up|Lost to Follow-up|3|||
125482208|NCT03668236|451399921|FG001|90-day Follow-up|Lost to Follow-up|1|||
125482209|NCT03668236|451399920|FG000|Baseline Characteristics|Lost to Follow-up|9|||
125482210|NCT03668236|451399921|FG001|Baseline Characteristics|Lost to Follow-up|5|||
125482211|NCT03668236|451399920|FG000|1-year Follow-up|Withdrawal by Subject|17|||
125482212|NCT03668236|451399921|FG001|1-year Follow-up|Withdrawal by Subject|15|||
125482213|NCT06132282|451399927|FG000|Overall Study|Lost to Follow-up|31|||
125482214|NCT04376502|451399933|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
125482215|NCT03748953|451399934|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
125482216|NCT03748953|451399935|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
125482217|NCT03748953|451399934|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
125482218|NCT03748953|451399935|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
125482219|NCT03748953|451399934|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
125482220|NCT03748953|451399935|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
125482221|NCT03748953|451399934|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
125482222|NCT03748953|451399935|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
125482223|NCT03748953|451399934|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
125485431|NCT02240238|451412509|FG006|Phase 2|Disease progression|0|||
125482224|NCT03748953|451399935|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
125482225|NCT04044768|451399937|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
125482226|NCT04044768|451399938|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
125482227|NCT01574274|451399939|FG000|Overall Study|Ineligible|0|||
125482228|NCT01574274|451399940|FG001|Overall Study|Ineligible|1|||
125482229|NCT01574274|451399939|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
125482230|NCT01574274|451399940|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
125482231|NCT01574274|451399939|FG000|Overall Study|Ph+ B-ALL|3|||
125482232|NCT01574274|451399940|FG001|Overall Study|Ph+ B-ALL|4|||
125482233|NCT01574274|451399939|FG000|Overall Study|Induction Death|2|||
125482234|NCT01574274|451399940|FG001|Overall Study|Induction Death|0|||
125482235|NCT01574274|451399939|FG000|Overall Study|Induction Failure|4|||
125482236|NCT01574274|451399940|FG001|Overall Study|Induction Failure|1|||
125482237|NCT01574274|451399939|FG000|Overall Study|Adverse Event|16|||
125482238|NCT01574274|451399940|FG001|Overall Study|Adverse Event|13|||
125482239|NCT01574274|451399939|FG000|Overall Study|Remission Death|1|||
125482240|NCT01574274|451399940|FG001|Overall Study|Remission Death|0|||
125482241|NCT01574274|451399939|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
125482242|NCT01574274|451399940|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
125482243|NCT01574274|451399939|FG000|Overall Study|Other, unknown|3|||
125482244|NCT01574274|451399940|FG001|Overall Study|Other, unknown|2|||
125482245|NCT05089019|451399941|FG000|Period 1|Withdrawal by Subject|0|||
125482246|NCT05089019|451399942|FG001|Period 1|Withdrawal by Subject|1|||
125482247|NCT05089019|451399941|FG000|Washout Period|Adverse Event|3|||
125482248|NCT05089019|451399942|FG001|Washout Period|Adverse Event|4|||
125482249|NCT05089019|451399941|FG000|Washout Period|Lost to Follow-up|1|||
125482250|NCT05089019|451399942|FG001|Washout Period|Lost to Follow-up|0|||
125482251|NCT05089019|451399941|FG000|Washout Period|Physician Decision|2|||
125482252|NCT05089019|451399942|FG001|Washout Period|Physician Decision|0|||
125482253|NCT05089019|451399941|FG000|Washout Period|Withdrawal by Subject|6|||
125482254|NCT05089019|451399942|FG001|Washout Period|Withdrawal by Subject|3|||
125482255|NCT05089019|451399941|FG000|Period 2|Adverse Event|4|||
125482256|NCT05089019|451399942|FG001|Period 2|Adverse Event|2|||
125482257|NCT05089019|451399941|FG000|Period 2|Lost to Follow-up|1|||
125482258|NCT05089019|451399942|FG001|Period 2|Lost to Follow-up|0|||
125482259|NCT05089019|451399941|FG000|Period 2|Withdrawal by Subject|0|||
125482260|NCT05089019|451399942|FG001|Period 2|Withdrawal by Subject|1|||
125482261|NCT01593917|451399947|FG000|Overall Study|Death|67|||
125482262|NCT01593917|451399947|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
125482263|NCT01593917|451399947|FG000|Overall Study|Withdrawal by Subject|23|||
125482264|NCT01593917|451399947|FG000|Overall Study|Lost to Follow-up|12|||
125482265|NCT01593917|451399947|FG000|Overall Study|Protocol Violation|5|||
125482266|NCT01593917|451399947|FG000|Overall Study|Physician Decision|3|||
125482267|NCT03216057|451399950|FG000|Overall Study|Lost to Follow-up|2|||
125482268|NCT03216057|451399951|FG001|Overall Study|Lost to Follow-up|2|||
125482269|NCT04564742|451399952|FG000|Overall Study|Lost to Follow-up|1|||
125482270|NCT04564742|451399953|FG001|Overall Study|Lost to Follow-up|0|||
125482271|NCT04564742|451399952|FG000|Overall Study|Consent Withdrawal|4|||
125482272|NCT04564742|451399953|FG001|Overall Study|Consent Withdrawal|4|||
125482273|NCT03313076|451399957|FG000|Overall Study|Withdrawal by Subject|2|||
125482274|NCT03313076|451399958|FG001|Overall Study|Withdrawal by Subject|0|||
125482275|NCT03313076|451399959|FG002|Overall Study|Withdrawal by Subject|0|||
125482276|NCT03313076|451399960|FG003|Overall Study|Withdrawal by Subject|0|||
125482277|NCT03313076|451399957|FG000|Overall Study|Lost to Follow-up|0|||
125482278|NCT03313076|451399958|FG001|Overall Study|Lost to Follow-up|2|||
125482279|NCT03313076|451399959|FG002|Overall Study|Lost to Follow-up|2|||
125482280|NCT03313076|451399960|FG003|Overall Study|Lost to Follow-up|2|||
125482281|NCT04119843|451399961|FG000|Overall Study|Adverse Event|3|||
125482282|NCT04119843|451399961|FG000|Overall Study|Death|1|||
125482283|NCT02841579|451399962|FG000|Overall Study|Death|1|||
125482284|NCT02841579|451399962|FG000|Overall Study|Adverse Event|1|||
125482285|NCT02841579|451399962|FG000|Overall Study|Lack of Efficacy|9|||
125482286|NCT04233216|451399968|FG000|Overall Study|Lost to Follow-up|1|||
125482287|NCT04233216|451399969|FG001|Overall Study|Lost to Follow-up|0|||
125482288|NCT04233216|451399970|FG002|Overall Study|Lost to Follow-up|2|||
125482289|NCT04233216|451399971|FG003|Overall Study|Lost to Follow-up|0|||
125482290|NCT04233216|451399968|FG000|Overall Study|Physician Decision|0|||
125482291|NCT04233216|451399969|FG001|Overall Study|Physician Decision|3|||
125482292|NCT04233216|451399970|FG002|Overall Study|Physician Decision|0|||
125482293|NCT04233216|451399971|FG003|Overall Study|Physician Decision|2|||
125482294|NCT04233216|451399968|FG000|Overall Study|Withdrawal by Subject|0|||
125482295|NCT04233216|451399969|FG001|Overall Study|Withdrawal by Subject|2|||
125482296|NCT04233216|451399970|FG002|Overall Study|Withdrawal by Subject|1|||
125482297|NCT04233216|451399971|FG003|Overall Study|Withdrawal by Subject|0|||
125482298|NCT03652389|451399972|FG000|Overall Study|Lost to Follow-up|1|||
125482299|NCT03652389|451399973|FG001|Overall Study|Lost to Follow-up|5|||
125482300|NCT03652389|451399972|FG000|Overall Study|Withdrawal by Subject|5|||
125482301|NCT03652389|451399973|FG001|Overall Study|Withdrawal by Subject|1|||
125482302|NCT03652389|451399972|FG000|Overall Study|New diagnosis|2|||
125482303|NCT03652389|451399973|FG001|Overall Study|New diagnosis|0|||
125482304|NCT05270408|451399974|FG000|Started Treatment|Withdrawal by Subject|0|||
125482305|NCT05270408|451399975|FG001|Started Treatment|Withdrawal by Subject|0|||
125482306|NCT05270408|451399976|FG002|Started Treatment|Withdrawal by Subject|3|||
125482307|NCT05270408|451399974|FG000|Started Treatment|Adverse Event|0|||
125482308|NCT05270408|451399975|FG001|Started Treatment|Adverse Event|0|||
125482309|NCT05270408|451399976|FG002|Started Treatment|Adverse Event|1|||
125482310|NCT05270408|451399974|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
125482311|NCT05270408|451399975|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
125482312|NCT05270408|451399976|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
125482313|NCT03768505|451399977|FG000|Overall Study|sponsor decision|76|||
125482314|NCT03768505|451399977|FG000|Overall Study|Death|35|||
125482315|NCT03768505|451399977|FG000|Overall Study|Other -Various|30|||
125482316|NCT03768505|451399977|FG000|Overall Study|Withdrawal by Subject|22|||
125482317|NCT03768505|451399977|FG000|Overall Study|Lost to Follow-up|6|||
125482318|NCT04032704|451399979|FG000|Part A|Withdrawal by Subject|0|||
125482319|NCT04032704|451399980|FG001|Part A|Withdrawal by Subject|0|||
125482320|NCT04032704|451399981|FG002|Part A|Withdrawal by Subject|3|||
125482321|NCT04032704|451399982|FG003|Part A|Withdrawal by Subject|0|||
125482322|NCT04032704|451399983|FG004|Part A|Withdrawal by Subject|1|||
125482323|NCT04032704|451399984|FG005|Part A|Withdrawal by Subject|7|||
125482324|NCT04032704|451399985|FG006|Part A|Withdrawal by Subject|0|||
125482325|NCT04032704|451399986|FG007|Part A|Withdrawal by Subject|0|||
125482326|NCT04032704|451399987|FG008|Part A|Withdrawal by Subject|0|||
125482327|NCT04032704|451399988|FG009|Part A|Withdrawal by Subject|0|||
125482328|NCT04032704|451399989|FG010|Part A|Withdrawal by Subject|0|||
125482329|NCT04032704|451399990|FG011|Part A|Withdrawal by Subject|0|||
125482330|NCT04032704|451399991|FG012|Part A|Withdrawal by Subject|0|||
125482331|NCT04032704|451399992|FG013|Part A|Withdrawal by Subject|0|||
125482332|NCT04032704|451399993|FG014|Part A|Withdrawal by Subject|0|||
125482333|NCT04032704|451399994|FG015|Part A|Withdrawal by Subject|0|||
125482334|NCT04032704|451399995|FG016|Part A|Withdrawal by Subject|0|||
125482335|NCT04032704|451399996|FG017|Part A|Withdrawal by Subject|0|||
125482336|NCT04032704|451399979|FG000|Part A|Lost to Follow-up|1|||
125482337|NCT04032704|451399980|FG001|Part A|Lost to Follow-up|0|||
125482338|NCT04032704|451399981|FG002|Part A|Lost to Follow-up|0|||
125482339|NCT04032704|451399982|FG003|Part A|Lost to Follow-up|0|||
125482340|NCT04032704|451399983|FG004|Part A|Lost to Follow-up|0|||
125482341|NCT04032704|451399984|FG005|Part A|Lost to Follow-up|0|||
125482342|NCT04032704|451399985|FG006|Part A|Lost to Follow-up|0|||
125482343|NCT04032704|451399986|FG007|Part A|Lost to Follow-up|0|||
125482344|NCT04032704|451399987|FG008|Part A|Lost to Follow-up|0|||
125482345|NCT04032704|451399988|FG009|Part A|Lost to Follow-up|0|||
125482346|NCT04032704|451399989|FG010|Part A|Lost to Follow-up|0|||
125482347|NCT04032704|451399990|FG011|Part A|Lost to Follow-up|0|||
125482348|NCT04032704|451399991|FG012|Part A|Lost to Follow-up|0|||
125482349|NCT04032704|451399992|FG013|Part A|Lost to Follow-up|0|||
125482350|NCT04032704|451399993|FG014|Part A|Lost to Follow-up|0|||
125482351|NCT04032704|451399994|FG015|Part A|Lost to Follow-up|0|||
125482352|NCT04032704|451399995|FG016|Part A|Lost to Follow-up|0|||
125482353|NCT04032704|451399996|FG017|Part A|Lost to Follow-up|0|||
125482354|NCT04032704|451399979|FG000|Part A|Death|9|||
125482355|NCT04032704|451399980|FG001|Part A|Death|2|||
125482356|NCT04032704|451399981|FG002|Part A|Death|10|||
125482357|NCT04032704|451399982|FG003|Part A|Death|7|||
125482358|NCT04032704|451399983|FG004|Part A|Death|4|||
125482359|NCT04032704|451399984|FG005|Part A|Death|5|||
125482360|NCT04032704|451399985|FG006|Part A|Death|0|||
125482361|NCT04032704|451399986|FG007|Part A|Death|0|||
125482362|NCT04032704|451399987|FG008|Part A|Death|0|||
125482363|NCT04032704|451399988|FG009|Part A|Death|0|||
125482364|NCT04032704|451399989|FG010|Part A|Death|0|||
125482365|NCT04032704|451399990|FG011|Part A|Death|0|||
125482366|NCT04032704|451399991|FG012|Part A|Death|0|||
125482367|NCT04032704|451399992|FG013|Part A|Death|0|||
125482368|NCT04032704|451399993|FG014|Part A|Death|0|||
125482369|NCT04032704|451399994|FG015|Part A|Death|0|||
125482370|NCT04032704|451399995|FG016|Part A|Death|0|||
125303023|NCT04776317|450736655|FG012|Overall Study|Withdrawal by Subject|0|||
125482371|NCT04032704|451399996|FG017|Part A|Death|0|||
125482372|NCT04032704|451399979|FG000|Part B|Other|0|||
125482373|NCT04032704|451399980|FG001|Part B|Other|0|||
125482374|NCT04032704|451399981|FG002|Part B|Other|0|||
125482375|NCT04032704|451399982|FG003|Part B|Other|0|||
125482376|NCT04032704|451399983|FG004|Part B|Other|0|||
125482377|NCT04032704|451399984|FG005|Part B|Other|0|||
125482378|NCT04032704|451399985|FG006|Part B|Other|0|||
125482379|NCT04032704|451399986|FG007|Part B|Other|1|||
125482380|NCT04032704|451399987|FG008|Part B|Other|2|||
125482381|NCT04032704|451399988|FG009|Part B|Other|1|||
125482382|NCT04032704|451399989|FG010|Part B|Other|1|||
125482383|NCT04032704|451399990|FG011|Part B|Other|1|||
125482384|NCT04032704|451399991|FG012|Part B|Other|5|||
125482385|NCT04032704|451399992|FG013|Part B|Other|13|||
125482386|NCT04032704|451399993|FG014|Part B|Other|0|||
125482387|NCT04032704|451399994|FG015|Part B|Other|0|||
125482388|NCT04032704|451399995|FG016|Part B|Other|0|||
125482389|NCT04032704|451399996|FG017|Part B|Other|0|||
125482390|NCT04032704|451399979|FG000|Part B|Study termination by Sponsor|0|||
125482391|NCT04032704|451399980|FG001|Part B|Study termination by Sponsor|0|||
125482392|NCT04032704|451399981|FG002|Part B|Study termination by Sponsor|0|||
125482393|NCT04032704|451399982|FG003|Part B|Study termination by Sponsor|0|||
125482394|NCT04032704|451399983|FG004|Part B|Study termination by Sponsor|0|||
125482395|NCT04032704|451399984|FG005|Part B|Study termination by Sponsor|0|||
125482396|NCT04032704|451399985|FG006|Part B|Study termination by Sponsor|0|||
125482397|NCT04032704|451399986|FG007|Part B|Study termination by Sponsor|0|||
125482398|NCT04032704|451399987|FG008|Part B|Study termination by Sponsor|1|||
125482399|NCT04032704|451399988|FG009|Part B|Study termination by Sponsor|0|||
125482400|NCT04032704|451399989|FG010|Part B|Study termination by Sponsor|0|||
125482401|NCT04032704|451399990|FG011|Part B|Study termination by Sponsor|0|||
125482402|NCT04032704|451399991|FG012|Part B|Study termination by Sponsor|0|||
125482403|NCT04032704|451399992|FG013|Part B|Study termination by Sponsor|0|||
125482404|NCT04032704|451399993|FG014|Part B|Study termination by Sponsor|0|||
125482405|NCT04032704|451399994|FG015|Part B|Study termination by Sponsor|0|||
125482406|NCT04032704|451399995|FG016|Part B|Study termination by Sponsor|0|||
125482407|NCT04032704|451399996|FG017|Part B|Study termination by Sponsor|0|||
125482408|NCT04032704|451399979|FG000|Part B|Withdrawal by Subject|0|||
125482409|NCT04032704|451399980|FG001|Part B|Withdrawal by Subject|0|||
125482410|NCT04032704|451399981|FG002|Part B|Withdrawal by Subject|0|||
125482411|NCT04032704|451399982|FG003|Part B|Withdrawal by Subject|0|||
125482412|NCT04032704|451399983|FG004|Part B|Withdrawal by Subject|0|||
125482413|NCT04032704|451399984|FG005|Part B|Withdrawal by Subject|0|||
125482414|NCT04032704|451399985|FG006|Part B|Withdrawal by Subject|3|||
125482415|NCT04032704|451399986|FG007|Part B|Withdrawal by Subject|2|||
125482416|NCT04032704|451399987|FG008|Part B|Withdrawal by Subject|2|||
125482417|NCT04032704|451399988|FG009|Part B|Withdrawal by Subject|1|||
125482418|NCT04032704|451399989|FG010|Part B|Withdrawal by Subject|4|||
125482419|NCT04032704|451399990|FG011|Part B|Withdrawal by Subject|6|||
125482420|NCT04032704|451399991|FG012|Part B|Withdrawal by Subject|2|||
125482421|NCT04032704|451399992|FG013|Part B|Withdrawal by Subject|1|||
125482422|NCT04032704|451399993|FG014|Part B|Withdrawal by Subject|0|||
125482423|NCT04032704|451399994|FG015|Part B|Withdrawal by Subject|1|||
125482424|NCT04032704|451399995|FG016|Part B|Withdrawal by Subject|0|||
125482425|NCT04032704|451399996|FG017|Part B|Withdrawal by Subject|0|||
125482426|NCT04032704|451399979|FG000|Part B|Lost to Follow-up|0|||
125482427|NCT04032704|451399980|FG001|Part B|Lost to Follow-up|0|||
125482428|NCT04032704|451399981|FG002|Part B|Lost to Follow-up|0|||
125482429|NCT04032704|451399982|FG003|Part B|Lost to Follow-up|0|||
125482430|NCT04032704|451399983|FG004|Part B|Lost to Follow-up|0|||
125482431|NCT04032704|451399984|FG005|Part B|Lost to Follow-up|0|||
125482432|NCT04032704|451399985|FG006|Part B|Lost to Follow-up|0|||
125482433|NCT04032704|451399986|FG007|Part B|Lost to Follow-up|0|||
125482434|NCT04032704|451399987|FG008|Part B|Lost to Follow-up|0|||
125482435|NCT04032704|451399988|FG009|Part B|Lost to Follow-up|0|||
125482436|NCT04032704|451399989|FG010|Part B|Lost to Follow-up|0|||
125482437|NCT04032704|451399990|FG011|Part B|Lost to Follow-up|1|||
125482438|NCT04032704|451399991|FG012|Part B|Lost to Follow-up|0|||
125482439|NCT04032704|451399992|FG013|Part B|Lost to Follow-up|0|||
125482440|NCT04032704|451399993|FG014|Part B|Lost to Follow-up|0|||
125482441|NCT04032704|451399994|FG015|Part B|Lost to Follow-up|0|||
125482442|NCT04032704|451399995|FG016|Part B|Lost to Follow-up|0|||
125482443|NCT04032704|451399996|FG017|Part B|Lost to Follow-up|0|||
125482444|NCT04032704|451399979|FG000|Part B|Death|0|||
125482445|NCT04032704|451399980|FG001|Part B|Death|0|||
125482446|NCT04032704|451399981|FG002|Part B|Death|0|||
125482447|NCT04032704|451399982|FG003|Part B|Death|0|||
125482448|NCT04032704|451399983|FG004|Part B|Death|0|||
125482449|NCT04032704|451399984|FG005|Part B|Death|0|||
125482450|NCT04032704|451399985|FG006|Part B|Death|13|||
125482451|NCT04032704|451399986|FG007|Part B|Death|13|||
125482452|NCT04032704|451399987|FG008|Part B|Death|14|||
125482453|NCT04032704|451399988|FG009|Part B|Death|12|||
125482454|NCT04032704|451399989|FG010|Part B|Death|12|||
125482455|NCT04032704|451399990|FG011|Part B|Death|13|||
125482456|NCT04032704|451399991|FG012|Part B|Death|7|||
125482457|NCT04032704|451399992|FG013|Part B|Death|17|||
125482458|NCT04032704|451399993|FG014|Part B|Death|2|||
125482459|NCT04032704|451399994|FG015|Part B|Death|1|||
125482460|NCT04032704|451399995|FG016|Part B|Death|2|||
125482461|NCT04032704|451399996|FG017|Part B|Death|2|||
125482462|NCT02465268|451400000|FG000|Overall Study|Withdrawal by Subject|4|||
125482463|NCT02465268|451400001|FG001|Overall Study|Withdrawal by Subject|3|||
125482464|NCT02465268|451400002|FG002|Overall Study|Withdrawal by Subject|1|||
125482465|NCT02465268|451400000|FG000|Overall Study|Not evaluable per protocol criteria|3|||
125482466|NCT02465268|451400001|FG001|Overall Study|Not evaluable per protocol criteria|2|||
125482467|NCT02465268|451400002|FG002|Overall Study|Not evaluable per protocol criteria|1|||
125482468|NCT02465268|451400000|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
125482469|NCT02465268|451400001|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
125482470|NCT02465268|451400002|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
125482471|NCT02465268|451400000|FG000|Overall Study|Study drug did not pass QA/QC|1|||
125482472|NCT02465268|451400001|FG001|Overall Study|Study drug did not pass QA/QC|0|||
125482473|NCT02465268|451400002|FG002|Overall Study|Study drug did not pass QA/QC|0|||
125482474|NCT02465268|451400000|FG000|Overall Study|Adverse Event|0|||
125482475|NCT02465268|451400001|FG001|Overall Study|Adverse Event|1|||
125482476|NCT02465268|451400002|FG002|Overall Study|Adverse Event|0|||
125482477|NCT02465268|451400000|FG000|Overall Study|Physician Decision|0|||
125482478|NCT02465268|451400001|FG001|Overall Study|Physician Decision|1|||
125482479|NCT02465268|451400002|FG002|Overall Study|Physician Decision|0|||
125482480|NCT01501955|451400005|FG000|Overall Study|Withdrawal by Subject|1|||
125482481|NCT01501955|451400006|FG001|Overall Study|Withdrawal by Subject|0|||
125482482|NCT01501955|451400005|FG000|Overall Study|Adverse Event|1|||
125482483|NCT01501955|451400006|FG001|Overall Study|Adverse Event|3|||
125482484|NCT02993159|451400007|FG000|Overall Study|Withdrawal by Subject|1|||
125482485|NCT02993159|451400008|FG001|Overall Study|Withdrawal by Subject|3|||
125482486|NCT02993159|451400007|FG000|Overall Study|Protocol Violation|1|||
125482487|NCT02993159|451400008|FG001|Overall Study|Protocol Violation|0|||
125482488|NCT02993159|451400007|FG000|Overall Study|Opted out of surgery|2|||
125482489|NCT02993159|451400008|FG001|Overall Study|Opted out of surgery|0|||
125482490|NCT02993159|451400007|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
125482491|NCT02993159|451400008|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
125482492|NCT02993159|451400007|FG000|Overall Study|Physician Decision|0|||
125482493|NCT02993159|451400008|FG001|Overall Study|Physician Decision|1|||
125482494|NCT00248287|451400014|FG000|Overall Study|Adverse Event|11|||
125482495|NCT00248287|451400015|FG001|Overall Study|Adverse Event|10|||
125482496|NCT00248287|451400014|FG000|Overall Study|Death|1|||
125482497|NCT00248287|451400015|FG001|Overall Study|Death|0|||
125482498|NCT00248287|451400014|FG000|Overall Study|Lost to Follow-up|0|||
125482499|NCT00248287|451400015|FG001|Overall Study|Lost to Follow-up|1|||
125482500|NCT00248287|451400014|FG000|Overall Study|Investigator Request|4|||
125482501|NCT00248287|451400015|FG001|Overall Study|Investigator Request|3|||
125482502|NCT00248287|451400014|FG000|Overall Study|Patient Request|5|||
125482503|NCT00248287|451400015|FG001|Overall Study|Patient Request|3|||
125482504|NCT00248287|451400014|FG000|Overall Study|Other|3|||
125482505|NCT00248287|451400015|FG001|Overall Study|Other|2|||
125482506|NCT04524442|451400024|FG000|Overall Study|Subject Decision|1|||
125482507|NCT05228457|451400025|FG000|Overall Study|Withdrawal by Subject|1|||
125482508|NCT05228457|451400026|FG001|Overall Study|Withdrawal by Subject|1|||
125482509|NCT03213691|451400029|FG000|Overall Study|Adverse Event|2|||
125482510|NCT03213691|451400029|FG000|Overall Study|Death|3|||
125482511|NCT03213691|451400029|FG000|Overall Study|Physician Decision|1|||
125482512|NCT03213691|451400029|FG000|Overall Study|Progressive Disease|14|||
125482513|NCT03213691|451400029|FG000|Overall Study|Ineligible|1|||
125482514|NCT01152450|451400032|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
125482515|NCT01152450|451400033|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
125482516|NCT01152450|451400034|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
125482517|NCT01152450|451400035|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
125482518|NCT01152450|451400036|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
125482519|NCT01152450|451400037|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
125482520|NCT01152450|451400032|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
125482521|NCT01152450|451400033|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
125482522|NCT01152450|451400034|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
125482523|NCT01152450|451400035|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
125482524|NCT01152450|451400036|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
125482525|NCT01152450|451400037|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
125482526|NCT01152450|451400032|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
125482527|NCT01152450|451400033|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
125482528|NCT01152450|451400034|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
125482529|NCT01152450|451400035|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
125482530|NCT01152450|451400036|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
125482531|NCT01152450|451400037|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
125482532|NCT02966873|451400038|FG000|Overall Study|Lost to Follow-up|16|||
125482533|NCT02966873|451400039|FG001|Overall Study|Lost to Follow-up|15|||
125482534|NCT04753697|451400040|FG000|Induction Phase|Withdrawal by Subject|12|||
125482535|NCT04753697|451400041|FG001|Induction Phase|Withdrawal by Subject|5|||
125482536|NCT04753697|451400042|FG002|Induction Phase|Withdrawal by Subject|6|||
125482537|NCT04753697|451400040|FG000|Induction Phase|Physician Decision|1|||
125482538|NCT04753697|451400041|FG001|Induction Phase|Physician Decision|0|||
125482539|NCT04753697|451400042|FG002|Induction Phase|Physician Decision|0|||
125482540|NCT04753697|451400040|FG000|Induction Phase|Lost to Follow-up|2|||
125482541|NCT04753697|451400041|FG001|Induction Phase|Lost to Follow-up|2|||
125482542|NCT04753697|451400042|FG002|Induction Phase|Lost to Follow-up|1|||
125482543|NCT04753697|451400040|FG000|Induction Phase|Lack of Efficacy|1|||
125482544|NCT04753697|451400041|FG001|Induction Phase|Lack of Efficacy|0|||
125482545|NCT04753697|451400042|FG002|Induction Phase|Lack of Efficacy|0|||
125482546|NCT04753697|451400040|FG000|Maintenance Phase|Physician Decision|0|||
125482547|NCT04753697|451400041|FG001|Maintenance Phase|Physician Decision|0|||
125482548|NCT04753697|451400042|FG002|Maintenance Phase|Physician Decision|1|||
125482549|NCT04753697|451400040|FG000|Maintenance Phase|Withdrawal by Subject|3|||
125482550|NCT04753697|451400041|FG001|Maintenance Phase|Withdrawal by Subject|4|||
125482551|NCT04753697|451400042|FG002|Maintenance Phase|Withdrawal by Subject|6|||
125482552|NCT04753697|451400040|FG000|Maintenance Phase|Lost to Follow-up|2|||
125482553|NCT04753697|451400041|FG001|Maintenance Phase|Lost to Follow-up|2|||
125482554|NCT04753697|451400042|FG002|Maintenance Phase|Lost to Follow-up|0|||
125482555|NCT04753697|451400040|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
125482556|NCT04753697|451400041|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
125482557|NCT04753697|451400042|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
125482558|NCT04753697|451400040|FG000|Maintenance Phase|Adverse Event|0|||
125482559|NCT04753697|451400041|FG001|Maintenance Phase|Adverse Event|1|||
125482560|NCT04753697|451400042|FG002|Maintenance Phase|Adverse Event|1|||
125482561|NCT04753697|451400040|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
125482562|NCT04753697|451400041|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
125482563|NCT04753697|451400042|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
125482564|NCT02626533|451400043|FG000|Overall Study|Protocol Violation|14|||
125482565|NCT02626533|451400043|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
125482566|NCT02626533|451400043|FG000|Overall Study|Withdrawal by Subject|1|||
125482567|NCT02723591|451400046|FG000|Overall Study|Adverse Event|48|||
125482568|NCT02723591|451400047|FG001|Overall Study|Adverse Event|40|||
125482569|NCT02723591|451400046|FG000|Overall Study|Death|2|||
125482570|NCT02723591|451400047|FG001|Overall Study|Death|2|||
125482571|NCT02723591|451400046|FG000|Overall Study|Lack of Efficacy|4|||
125482572|NCT02723591|451400047|FG001|Overall Study|Lack of Efficacy|3|||
125482573|NCT02723591|451400046|FG000|Overall Study|Lost to Follow-up|1|||
125482574|NCT02723591|451400047|FG001|Overall Study|Lost to Follow-up|7|||
125482575|NCT02723591|451400046|FG000|Overall Study|Protocol Violation|20|||
125482576|NCT02723591|451400047|FG001|Overall Study|Protocol Violation|23|||
125482577|NCT02723591|451400046|FG000|Overall Study|Withdrawal by Subject|4|||
125482578|NCT02723591|451400047|FG001|Overall Study|Withdrawal by Subject|8|||
125482579|NCT02723591|451400046|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
125482580|NCT02723591|451400047|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
125482581|NCT02723591|451400046|FG000|Overall Study|Miscellaneous|5|||
125482582|NCT02723591|451400047|FG001|Overall Study|Miscellaneous|6|||
125482583|NCT03691935|451400048|FG000|Overall Study|Physician Decision|2|||
125482584|NCT03691935|451400049|FG001|Overall Study|Physician Decision|1|||
125482585|NCT03691935|451400048|FG000|Overall Study|Adverse Event|3|||
125482586|NCT03691935|451400049|FG001|Overall Study|Adverse Event|0|||
125482587|NCT03034356|451400061|FG000|Baseline|Lost to Follow-up|2|||
125482588|NCT03034356|451400062|FG001|Baseline|Lost to Follow-up|4|||
125482589|NCT03034356|451400061|FG000|Baseline|Withdrawal by Subject|2|||
125482590|NCT03034356|451400062|FG001|Baseline|Withdrawal by Subject|0|||
125482591|NCT03034356|451400061|FG000|Baseline|Physician Decision|0|||
125482592|NCT03034356|451400062|FG001|Baseline|Physician Decision|1|||
125482593|NCT03034356|451400061|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
125482594|NCT03034356|451400062|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
125482595|NCT03034356|451400061|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
125482596|NCT03034356|451400062|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
125482597|NCT03034356|451400061|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
125482598|NCT03034356|451400062|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
125482599|NCT03034356|451400061|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
125482600|NCT03034356|451400062|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
125482601|NCT02823145|451400063|FG000|Enrollment|Other|1|||
125482602|NCT02823145|451400064|FG001|Enrollment|Other|0|||
125482603|NCT02823145|451400063|FG000|Treatment|Adverse Event|0|||
125482604|NCT02823145|451400064|FG001|Treatment|Adverse Event|11|||
125482605|NCT02823145|451400063|FG000|Treatment|Death|0|||
125482606|NCT02823145|451400064|FG001|Treatment|Death|3|||
125482607|NCT02823145|451400063|FG000|Treatment|Family Decision|0|||
125482608|NCT02823145|451400064|FG001|Treatment|Family Decision|1|||
125482609|NCT02823145|451400063|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
125482610|NCT02823145|451400064|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
125482611|NCT02823145|451400063|FG000|Treatment|Lack of Efficacy|0|||
125482612|NCT02823145|451400064|FG001|Treatment|Lack of Efficacy|48|||
125482613|NCT02823145|451400063|FG000|Treatment|Non-Compliance With E-Diary|0|||
125482614|NCT02823145|451400064|FG001|Treatment|Non-Compliance With E-Diary|1|||
125482615|NCT02823145|451400063|FG000|Treatment|Physician Decision|0|||
125482616|NCT02823145|451400064|FG001|Treatment|Physician Decision|2|||
125482617|NCT02823145|451400063|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
125482618|NCT02823145|451400064|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
125482619|NCT02823145|451400063|FG000|Treatment|Subject needed to take prohibited medication|0|||
125482620|NCT02823145|451400064|FG001|Treatment|Subject needed to take prohibited medication|1|||
125482621|NCT02823145|451400063|FG000|Treatment|Subject transferred to direct access programme|0|||
125482622|NCT02823145|451400064|FG001|Treatment|Subject transferred to direct access programme|1|||
125482623|NCT02823145|451400063|FG000|Treatment|Switching to commercially available drug|0|||
125482624|NCT02823145|451400064|FG001|Treatment|Switching to commercially available drug|11|||
125482625|NCT02823145|451400063|FG000|Treatment|Transitioned to commercial supply of medication|0|||
125482626|NCT02823145|451400064|FG001|Treatment|Transitioned to commercial supply of medication|1|||
125482627|NCT02823145|451400063|FG000|Treatment|Withdrawal By Caregiver|0|||
125482628|NCT02823145|451400064|FG001|Treatment|Withdrawal By Caregiver|1|||
125482629|NCT02823145|451400063|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
125482630|NCT02823145|451400064|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
125482631|NCT02823145|451400063|FG000|Treatment|Withdrawal by Subject|0|||
125482632|NCT02823145|451400064|FG001|Treatment|Withdrawal by Subject|16|||
125482633|NCT02823145|451400063|FG000|Treatment|Reason unknown|0|||
125482634|NCT02823145|451400064|FG001|Treatment|Reason unknown|1|||
125482635|NCT05292391|451400065|FG000|Overall Study|Lost to Follow-up|0|||
125482636|NCT05292391|451400066|FG001|Overall Study|Lost to Follow-up|0|||
125482637|NCT05292391|451400067|FG002|Overall Study|Lost to Follow-up|0|||
125482638|NCT05292391|451400068|FG003|Overall Study|Lost to Follow-up|1|||
125482639|NCT05292391|451400069|FG004|Overall Study|Lost to Follow-up|0|||
125482640|NCT05809453|451401555|FG000|Overall Study|Withdrawal by Subject|1|||
125482641|NCT05809453|451401556|FG001|Overall Study|Withdrawal by Subject|0|||
125482642|NCT05809453|451401557|FG002|Overall Study|Withdrawal by Subject|0|||
125482643|NCT05809453|451401558|FG003|Overall Study|Withdrawal by Subject|0|||
125482644|NCT02696707|451401559|FG000|Per Protocol Population|Physician Decision|2|||
125482645|NCT02696707|451401560|FG001|Per Protocol Population|Physician Decision|1|||
125482646|NCT02696707|451401559|FG000|Per Protocol Population|Participant Decision|0|||
125482647|NCT02696707|451401560|FG001|Per Protocol Population|Participant Decision|2|||
125482648|NCT02696707|451401559|FG000|Completed Study as Planned|Reason = LVEF|2|||
125482649|NCT02696707|451401560|FG001|Completed Study as Planned|Reason = LVEF|2|||
125482650|NCT02696707|451401559|FG000|Completed Study as Planned|Protocol Violation|2|||
125482651|NCT02696707|451401560|FG001|Completed Study as Planned|Protocol Violation|6|||
125482652|NCT02696707|451401559|FG000|Completed Study as Planned|Metastatic disease|3|||
125482653|NCT02696707|451401560|FG001|Completed Study as Planned|Metastatic disease|0|||
125482654|NCT02696707|451401559|FG000|Completed Study as Planned|Location|1|||
125482655|NCT02696707|451401560|FG001|Completed Study as Planned|Location|1|||
125482656|NCT05251909|451401565|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
125482657|NCT05251909|451401566|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
125482658|NCT05543915|451401567|FG000|Overall Study|Lost to Follow-up|0|||
125482659|NCT05543915|451401568|FG001|Overall Study|Lost to Follow-up|1|||
125482660|NCT02815566|451401573|FG000|Overall Study|Adverse Event|1|||
125482661|NCT02815566|451401574|FG001|Overall Study|Adverse Event|1|||
125482662|NCT02815566|451401573|FG000|Overall Study|Withdrawal by Subject|1|||
125482663|NCT02815566|451401574|FG001|Overall Study|Withdrawal by Subject|0|||
125482664|NCT02815566|451401573|FG000|Overall Study|Lost to Follow-up|0|||
125482665|NCT02815566|451401574|FG001|Overall Study|Lost to Follow-up|1|||
125482666|NCT03252847|451401577|FG000|Overall Study|Withdrawal by Subject|0|||
125482667|NCT03252847|451401578|FG001|Overall Study|Withdrawal by Subject|0|||
125482668|NCT03252847|451401579|FG002|Overall Study|Withdrawal by Subject|1|||
125482669|NCT03252847|451401580|FG003|Overall Study|Withdrawal by Subject|0|||
125482670|NCT03252847|451401581|FG004|Overall Study|Withdrawal by Subject|0|||
125482671|NCT03252847|451401582|FG005|Overall Study|Withdrawal by Subject|0|||
125482672|NCT03252847|451401583|FG006|Overall Study|Withdrawal by Subject|0|||
125482673|NCT03252847|451401577|FG000|Overall Study|Other: Patient decision|0|||
125482674|NCT03252847|451401578|FG001|Overall Study|Other: Patient decision|0|||
125482675|NCT03252847|451401579|FG002|Overall Study|Other: Patient decision|0|||
125482676|NCT03252847|451401580|FG003|Overall Study|Other: Patient decision|0|||
125482677|NCT03252847|451401581|FG004|Overall Study|Other: Patient decision|1|||
125482678|NCT03252847|451401582|FG005|Overall Study|Other: Patient decision|0|||
125482679|NCT03252847|451401583|FG006|Overall Study|Other: Patient decision|0|||
125482680|NCT05034328|451401584|FG000|Overall Study|Protocol Violation|1|||
125482681|NCT05034328|451401585|FG001|Overall Study|Protocol Violation|0|||
125482682|NCT05034328|451401584|FG000|Overall Study|Lost to Follow-up|0|||
125482683|NCT05034328|451401585|FG001|Overall Study|Lost to Follow-up|10|||
125482684|NCT04992520|451401586|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
125482685|NCT04992520|451401587|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
125482686|NCT04992520|451401588|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
125482687|NCT04992520|451401589|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
125482688|NCT04992520|451401590|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
125482689|NCT04992520|451401591|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
125482690|NCT04992520|451401586|FG000|Part A: First Challenge|Non-compliance|0|||
125482691|NCT04992520|451401587|FG001|Part A: First Challenge|Non-compliance|0|||
125482692|NCT04992520|451401588|FG002|Part A: First Challenge|Non-compliance|0|||
125482693|NCT04992520|451401589|FG003|Part A: First Challenge|Non-compliance|1|||
125482694|NCT04992520|451401590|FG004|Part A: First Challenge|Non-compliance|0|||
125482695|NCT04992520|451401591|FG005|Part A: First Challenge|Non-compliance|0|||
125482696|NCT04992520|451401586|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
125482697|NCT04992520|451401587|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
125485432|NCT02240238|451412510|FG007|Phase 2|Disease progression|0|||
125482698|NCT04992520|451401588|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
125482699|NCT04992520|451401589|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
125482700|NCT04992520|451401590|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
125482701|NCT04992520|451401591|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
125482702|NCT04992520|451401586|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
125482703|NCT04992520|451401587|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
125482704|NCT04992520|451401588|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
125482705|NCT04992520|451401589|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
125482706|NCT04992520|451401590|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
125482707|NCT04992520|451401591|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
125482708|NCT03625167|451401594|FG000|Overall Study|Protocol Violation|5|||
125482709|NCT02969707|451401597|FG000|Overall Study|Withdrawal by Subject|6|||
125482710|NCT02969707|451401598|FG001|Overall Study|Withdrawal by Subject|5|||
125482711|NCT02969707|451401597|FG000|Overall Study|Severe anxiety|0|||
125482712|NCT02969707|451401598|FG001|Overall Study|Severe anxiety|1|||
125482713|NCT02969707|451401597|FG000|Overall Study|Positive toxicology screen|0|||
125482714|NCT02969707|451401598|FG001|Overall Study|Positive toxicology screen|2|||
125482715|NCT02969707|451401597|FG000|Overall Study|Claustrophobia|2|||
125482716|NCT02969707|451401598|FG001|Overall Study|Claustrophobia|2|||
125482717|NCT02969707|451401597|FG000|Overall Study|Non-compliance|1|||
125482718|NCT02969707|451401598|FG001|Overall Study|Non-compliance|2|||
125482719|NCT02427464|451401602|FG000|Overall Study|Adverse Event|6|||
125482720|NCT02427464|451401603|FG001|Overall Study|Adverse Event|1|||
125482721|NCT02427464|451401602|FG000|Overall Study|Lost to Follow-up|16|||
125482722|NCT02427464|451401603|FG001|Overall Study|Lost to Follow-up|5|||
125482723|NCT02427464|451401602|FG000|Overall Study|Physician Decision|2|||
125482724|NCT02427464|451401603|FG001|Overall Study|Physician Decision|0|||
125482725|NCT02427464|451401602|FG000|Overall Study|Withdrawal by Subject|10|||
125482726|NCT02427464|451401603|FG001|Overall Study|Withdrawal by Subject|8|||
125482727|NCT02427464|451401602|FG000|Overall Study|Noncompliance|16|||
125482728|NCT02427464|451401603|FG001|Overall Study|Noncompliance|10|||
125482729|NCT02714257|451401604|FG000|Overall Study|Withdrawal by Subject|6|||
125482730|NCT02714257|451401605|FG001|Overall Study|Withdrawal by Subject|11|||
125482731|NCT02714257|451401604|FG000|Overall Study|Death|3|||
125482732|NCT02714257|451401605|FG001|Overall Study|Death|4|||
125482733|NCT02714257|451401604|FG000|Overall Study|Lost to Follow-up|1|||
125482734|NCT02714257|451401605|FG001|Overall Study|Lost to Follow-up|6|||
125482735|NCT04103580|451401606|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
125482736|NCT04103580|451401607|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
125482737|NCT04103580|451401606|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
125482738|NCT04103580|451401607|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
125482739|NCT04103580|451401606|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
125482740|NCT04103580|451401607|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
125482741|NCT04103580|451401606|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
125482742|NCT04103580|451401607|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
125482743|NCT04103580|451401606|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
125482744|NCT04103580|451401607|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
125482745|NCT04103580|451401606|FG000|Phase 1 Active Caregiving|Other|3|||
125482746|NCT04103580|451401607|FG001|Phase 1 Active Caregiving|Other|3|||
125482747|NCT04103580|451401606|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
125482748|NCT04103580|451401607|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
125482749|NCT04103580|451401606|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
125482750|NCT04103580|451401607|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
125482751|NCT04103580|451401606|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
125482752|NCT04103580|451401607|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
125482753|NCT04103580|451401606|FG000|Phase 2 Bereavement|Other|8|||
125482754|NCT04103580|451401607|FG001|Phase 2 Bereavement|Other|6|||
125482755|NCT04145440|451401608|FG000|Overall Study|Physician Decision|3|||
125482756|NCT04145440|451401609|FG001|Overall Study|Physician Decision|0|||
125482757|NCT04145440|451401608|FG000|Overall Study|Use of prohibited therapy|2|||
125482758|NCT04145440|451401609|FG001|Overall Study|Use of prohibited therapy|3|||
125482759|NCT00104676|451401610|FG000|Overall Study|Death|3|||
125482760|NCT00104676|451401611|FG001|Overall Study|Death|2|||
125482761|NCT00104676|451401610|FG000|Overall Study|Withdrawal by Subject|0|||
125482762|NCT00104676|451401611|FG001|Overall Study|Withdrawal by Subject|2|||
125482763|NCT00104676|451401610|FG000|Overall Study|treatment interruption|4|||
125482764|NCT00104676|451401611|FG001|Overall Study|treatment interruption|10|||
125482765|NCT03766685|451401627|FG000|Overall Study|Lost to Follow-up|1|||
125482766|NCT03766685|451401628|FG001|Overall Study|Lost to Follow-up|1|||
125482767|NCT03766685|451401629|FG002|Overall Study|Lost to Follow-up|0|||
125482768|NCT03766685|451401630|FG003|Overall Study|Lost to Follow-up|0|||
125482769|NCT03766685|451401627|FG000|Overall Study|Adverse Event, not fatal|0|||
125482770|NCT03766685|451401628|FG001|Overall Study|Adverse Event, not fatal|1|||
125482771|NCT03766685|451401629|FG002|Overall Study|Adverse Event, not fatal|0|||
125482772|NCT03766685|451401630|FG003|Overall Study|Adverse Event, not fatal|1|||
125482773|NCT03766685|451401627|FG000|Overall Study|Withdrawal by Subject|0|||
125482774|NCT03766685|451401628|FG001|Overall Study|Withdrawal by Subject|2|||
125482775|NCT03766685|451401629|FG002|Overall Study|Withdrawal by Subject|0|||
125482776|NCT03766685|451401630|FG003|Overall Study|Withdrawal by Subject|0|||
125482777|NCT03766685|451401627|FG000|Overall Study|Protocol Violation|0|||
125482778|NCT03766685|451401628|FG001|Overall Study|Protocol Violation|1|||
125482779|NCT03766685|451401629|FG002|Overall Study|Protocol Violation|0|||
125482780|NCT03766685|451401630|FG003|Overall Study|Protocol Violation|0|||
125482781|NCT03766685|451401627|FG000|Overall Study|Non-compliance|0|||
125482782|NCT03766685|451401628|FG001|Overall Study|Non-compliance|2|||
125482783|NCT03766685|451401629|FG002|Overall Study|Non-compliance|0|||
125482784|NCT03766685|451401630|FG003|Overall Study|Non-compliance|0|||
125482785|NCT05297565|451401633|FG000|Overall Study|Other Reasons|0|||
125482786|NCT05297565|451401634|FG001|Overall Study|Other Reasons|1|||
125482787|NCT05297565|451401633|FG000|Overall Study|Physician Decision|0|||
125482788|NCT05297565|451401634|FG001|Overall Study|Physician Decision|1|||
125482789|NCT05297565|451401633|FG000|Overall Study|Disease recurrence|1|||
125482790|NCT05297565|451401634|FG001|Overall Study|Disease recurrence|0|||
125482791|NCT05139810|451401650|FG000|Overall Study|Voluntary Withdrawal|2|||
125482792|NCT05139810|451401651|FG001|Overall Study|Voluntary Withdrawal|1|||
125482793|NCT05139810|451401652|FG002|Overall Study|Voluntary Withdrawal|0|||
125482794|NCT05139810|451401650|FG000|Overall Study|Pregnancy|1|||
125482795|NCT05139810|451401651|FG001|Overall Study|Pregnancy|0|||
125482796|NCT05139810|451401652|FG002|Overall Study|Pregnancy|0|||
125482797|NCT05139810|451401650|FG000|Overall Study|Roll Over to CS7|19|||
125482798|NCT05139810|451401651|FG001|Overall Study|Roll Over to CS7|44|||
125482799|NCT05139810|451401652|FG002|Overall Study|Roll Over to CS7|20|||
125482800|NCT04054193|451401664|FG000|Cycle 1|Physician Decision|1|||
125482801|NCT04054193|451401664|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
125482802|NCT04054193|451401664|FG000|Cycle 1|Allocated but not treated|3|||
125482803|NCT04054193|451401664|FG000|Cycles 2-3|Physician Decision|2|||
125482804|NCT04054193|451401664|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
125482805|NCT04054193|451401664|FG000|Cycles 2-3|Various reasons|17|||
125482806|NCT03084536|451401665|FG000|Overall Study|Determined to be ineligible|0|||
125482807|NCT03084536|451401666|FG001|Overall Study|Determined to be ineligible|0|||
125482808|NCT03084536|451401667|FG002|Overall Study|Determined to be ineligible|16|||
125482809|NCT03084536|451401665|FG000|Overall Study|Withdrawal by Subject|0|||
125482810|NCT03084536|451401666|FG001|Overall Study|Withdrawal by Subject|0|||
125482811|NCT03084536|451401667|FG002|Overall Study|Withdrawal by Subject|4|||
125482812|NCT03084536|451401665|FG000|Overall Study|Physician Decision|0|||
125482813|NCT03084536|451401666|FG001|Overall Study|Physician Decision|0|||
125482814|NCT03084536|451401667|FG002|Overall Study|Physician Decision|3|||
125482815|NCT03084536|451401665|FG000|Overall Study|Death|0|||
125482816|NCT03084536|451401666|FG001|Overall Study|Death|0|||
125482817|NCT03084536|451401667|FG002|Overall Study|Death|1|||
125482818|NCT03084536|451401665|FG000|Overall Study|Lost to Follow-up|0|||
125482819|NCT03084536|451401666|FG001|Overall Study|Lost to Follow-up|0|||
125482820|NCT03084536|451401667|FG002|Overall Study|Lost to Follow-up|1|||
125482821|NCT03084536|451401665|FG000|Overall Study|Protocol Violation|0|||
125482822|NCT03084536|451401666|FG001|Overall Study|Protocol Violation|0|||
125482823|NCT03084536|451401667|FG002|Overall Study|Protocol Violation|1|||
125482824|NCT03084536|451401665|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
125482825|NCT03084536|451401666|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
125482826|NCT03084536|451401667|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
125482827|NCT05704543|451401668|FG000|Overall Study|Withdrawal by Subject|1|||
125482828|NCT05704543|451401669|FG001|Overall Study|Withdrawal by Subject|1|||
125482829|NCT05704543|451401670|FG002|Overall Study|Withdrawal by Subject|0|||
125482830|NCT05704543|451401671|FG003|Overall Study|Withdrawal by Subject|2|||
125482831|NCT05704543|451401668|FG000|Overall Study|Lost to Follow-up|1|||
125482832|NCT05704543|451401669|FG001|Overall Study|Lost to Follow-up|2|||
125482833|NCT05704543|451401670|FG002|Overall Study|Lost to Follow-up|0|||
125482834|NCT05704543|451401671|FG003|Overall Study|Lost to Follow-up|0|||
125482835|NCT04830800|451401680|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
125482836|NCT04830800|451401681|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
125482837|NCT04830800|451401682|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
125482838|NCT04830800|451401683|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
125482839|NCT04830800|451401684|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
125482840|NCT03816332|451401687|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
125482841|NCT03816332|451401687|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
125482842|NCT03710603|451401688|FG000|Overall Study|Adverse Event|1|||
125482843|NCT03710603|451401689|FG001|Overall Study|Adverse Event|0|||
125482844|NCT03710603|451401688|FG000|Overall Study|Death|44|||
125482845|NCT03710603|451401689|FG001|Overall Study|Death|34|||
125482846|NCT03710603|451401688|FG000|Overall Study|Lost to Follow-up|3|||
125482847|NCT03710603|451401689|FG001|Overall Study|Lost to Follow-up|5|||
125482848|NCT03710603|451401688|FG000|Overall Study|Withdrawal by Subject|11|||
125482849|NCT03710603|451401689|FG001|Overall Study|Withdrawal by Subject|10|||
125482850|NCT01456949|451401690|FG000|Enrollment|PI death- incomplete data|6|||
125482851|NCT01456949|451401690|FG000|Enrollment|Death|1|||
125482852|NCT01456949|451401690|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
125482853|NCT01456949|451401690|FG000|Enrollment|Physician Decision|10|||
125482854|NCT01456949|451401690|FG000|Enrollment|Withdrawal by Subject|7|||
125482855|NCT01456949|451401690|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
125482856|NCT01456949|451401690|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
125482857|NCT01456949|451401690|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
125482858|NCT01456949|451401690|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
125482859|NCT01456949|451401690|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
125482860|NCT01456949|451401690|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
125482861|NCT01456949|451401690|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
125482862|NCT01456949|451401690|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
125482863|NCT03785964|451401691|FG000|Overall Study|Adverse Event|14|||
125482864|NCT03785964|451401692|FG001|Overall Study|Adverse Event|1|||
125482865|NCT03785964|451401691|FG000|Overall Study|Unqualified Clinical Progression|1|||
125482866|NCT03785964|451401692|FG001|Overall Study|Unqualified Clinical Progression|1|||
125482867|NCT03785964|451401691|FG000|Overall Study|Participant non-compliance|1|||
125482868|NCT03785964|451401692|FG001|Overall Study|Participant non-compliance|1|||
125482869|NCT03785964|451401691|FG000|Overall Study|Not treated|1|||
125482870|NCT03785964|451401692|FG001|Overall Study|Not treated|0|||
125482871|NCT03785964|451401691|FG000|Overall Study|Other reason|5|||
125482872|NCT03785964|451401692|FG001|Overall Study|Other reason|11|||
125482873|NCT03785964|451401691|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
125482874|NCT03785964|451401692|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
125482875|NCT04857723|451401708|FG000|Overall Study|Withdrawal by Subject|2|||
125482876|NCT03221426|451401709|FG000|Overall Study|Ongoing in study|212|||
125482877|NCT03221426|451401710|FG001|Overall Study|Ongoing in study|193|||
125482878|NCT03221426|451401711|FG002|Overall Study|Ongoing in study|61|||
125482879|NCT03221426|451401712|FG003|Overall Study|Ongoing in study|55|||
125482880|NCT03221426|451401709|FG000|Overall Study|Withdrawal by Subject|12|||
125482881|NCT03221426|451401710|FG001|Overall Study|Withdrawal by Subject|4|||
125482882|NCT03221426|451401711|FG002|Overall Study|Withdrawal by Subject|2|||
125482883|NCT03221426|451401712|FG003|Overall Study|Withdrawal by Subject|3|||
125482884|NCT03221426|451401709|FG000|Overall Study|Lost to Follow-up|4|||
125482885|NCT03221426|451401710|FG001|Overall Study|Lost to Follow-up|1|||
125482886|NCT03221426|451401711|FG002|Overall Study|Lost to Follow-up|1|||
125482887|NCT03221426|451401712|FG003|Overall Study|Lost to Follow-up|0|||
125482888|NCT03221426|451401709|FG000|Overall Study|Death|174|||
125482889|NCT03221426|451401710|FG001|Overall Study|Death|204|||
125482890|NCT03221426|451401711|FG002|Overall Study|Death|36|||
125482891|NCT03221426|451401712|FG003|Overall Study|Death|45|||
125482892|NCT03257410|451403793|FG000|Overall Study|Adverse Event|2|||
125482893|NCT03257410|451403794|FG001|Overall Study|Adverse Event|3|||
125482894|NCT03257410|451403793|FG000|Overall Study|Protocol Violation|1|||
125482895|NCT03257410|451403794|FG001|Overall Study|Protocol Violation|2|||
125482896|NCT03257410|451403793|FG000|Overall Study|Lost to Follow-up|1|||
125482897|NCT03257410|451403794|FG001|Overall Study|Lost to Follow-up|0|||
125482898|NCT03257410|451403793|FG000|Overall Study|Withdrawal by Subject|1|||
125482899|NCT03257410|451403794|FG001|Overall Study|Withdrawal by Subject|2|||
125482900|NCT03257410|451403793|FG000|Overall Study|Physician Decision|1|||
125482901|NCT03257410|451403794|FG001|Overall Study|Physician Decision|1|||
125482902|NCT03257410|451403793|FG000|Overall Study|Renal transplantation|2|||
125482903|NCT03257410|451403794|FG001|Overall Study|Renal transplantation|0|||
125482904|NCT03257410|451403793|FG000|Overall Study|Switch to peritoneal dialysis|1|||
125482905|NCT03257410|451403794|FG001|Overall Study|Switch to peritoneal dialysis|0|||
125482906|NCT03257410|451403793|FG000|Overall Study|Death|3|||
125482907|NCT03257410|451403794|FG001|Overall Study|Death|2|||
125482908|NCT03257410|451403793|FG000|Overall Study|Change to another dialysis center|2|||
125482909|NCT03257410|451403794|FG001|Overall Study|Change to another dialysis center|2|||
125482910|NCT03257410|451403793|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
125482911|NCT03257410|451403794|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
125482912|NCT03257410|451403793|FG000|Overall Study|Miscellaneous|2|||
125482913|NCT03257410|451403794|FG001|Overall Study|Miscellaneous|2|||
125482914|NCT03257410|451403793|FG000|Overall Study|Other|0|||
125482915|NCT03257410|451403794|FG001|Overall Study|Other|1|||
125482916|NCT02561247|451403795|FG000|Overall Study|Protocol Violation|1|||
125482917|NCT02561247|451403795|FG000|Overall Study|Withdrawal by Subject|1|||
125482918|NCT02561247|451403795|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
125482919|NCT02276885|451403796|FG000|Overall Study|Withdrawal by Subject|2|||
125482920|NCT02276885|451403797|FG001|Overall Study|Withdrawal by Subject|0|||
125482921|NCT02276885|451403796|FG000|Overall Study|Lost to Follow-up|5|||
125482922|NCT02276885|451403797|FG001|Overall Study|Lost to Follow-up|2|||
125482923|NCT04171141|451403800|FG000|Overall Study|Adverse Event|0|||
125482924|NCT04171141|451403801|FG001|Overall Study|Adverse Event|0|||
125482925|NCT04171141|451403802|FG002|Overall Study|Adverse Event|2|||
125482926|NCT04171141|451403803|FG003|Overall Study|Adverse Event|0|||
125482927|NCT04171141|451403804|FG004|Overall Study|Adverse Event|0|||
125482928|NCT04171141|451403805|FG005|Overall Study|Adverse Event|0|||
125482929|NCT04171141|451403806|FG006|Overall Study|Adverse Event|0|||
125482930|NCT04171141|451403807|FG007|Overall Study|Adverse Event|0|||
125482931|NCT04171141|451403808|FG008|Overall Study|Adverse Event|0|||
125482932|NCT04171141|451403809|FG009|Overall Study|Adverse Event|0|||
125482933|NCT04171141|451403810|FG010|Overall Study|Adverse Event|0|||
125482934|NCT04171141|451403811|FG011|Overall Study|Adverse Event|0|||
125482935|NCT04171141|451403812|FG012|Overall Study|Adverse Event|0|||
125482936|NCT04171141|451403813|FG013|Overall Study|Adverse Event|2|||
125482937|NCT04171141|451403814|FG014|Overall Study|Adverse Event|0|||
125482938|NCT04171141|451403815|FG015|Overall Study|Adverse Event|0|||
125482939|NCT04171141|451403800|FG000|Overall Study|Physician Decision|0|||
125482940|NCT04171141|451403801|FG001|Overall Study|Physician Decision|0|||
125482941|NCT04171141|451403802|FG002|Overall Study|Physician Decision|0|||
125482942|NCT04171141|451403803|FG003|Overall Study|Physician Decision|0|||
125482943|NCT04171141|451403804|FG004|Overall Study|Physician Decision|1|||
125482944|NCT04171141|451403805|FG005|Overall Study|Physician Decision|0|||
125482945|NCT04171141|451403806|FG006|Overall Study|Physician Decision|0|||
125482946|NCT04171141|451403807|FG007|Overall Study|Physician Decision|0|||
125482947|NCT04171141|451403808|FG008|Overall Study|Physician Decision|0|||
125482948|NCT04171141|451403809|FG009|Overall Study|Physician Decision|0|||
125482949|NCT04171141|451403810|FG010|Overall Study|Physician Decision|0|||
125482950|NCT04171141|451403811|FG011|Overall Study|Physician Decision|0|||
125482951|NCT04171141|451403812|FG012|Overall Study|Physician Decision|0|||
125482952|NCT04171141|451403813|FG013|Overall Study|Physician Decision|0|||
125482953|NCT04171141|451403814|FG014|Overall Study|Physician Decision|0|||
125482954|NCT04171141|451403815|FG015|Overall Study|Physician Decision|1|||
125482955|NCT04171141|451403800|FG000|Overall Study|Progressive disease|2|||
125482956|NCT04171141|451403801|FG001|Overall Study|Progressive disease|3|||
125482957|NCT04171141|451403802|FG002|Overall Study|Progressive disease|4|||
125482958|NCT04171141|451403803|FG003|Overall Study|Progressive disease|7|||
125482959|NCT04171141|451403804|FG004|Overall Study|Progressive disease|1|||
125482960|NCT04171141|451403805|FG005|Overall Study|Progressive disease|8|||
125482961|NCT04171141|451403806|FG006|Overall Study|Progressive disease|4|||
125482962|NCT04171141|451403807|FG007|Overall Study|Progressive disease|6|||
125482963|NCT04171141|451403808|FG008|Overall Study|Progressive disease|7|||
125482964|NCT04171141|451403809|FG009|Overall Study|Progressive disease|3|||
125482965|NCT04171141|451403810|FG010|Overall Study|Progressive disease|4|||
125482966|NCT04171141|451403811|FG011|Overall Study|Progressive disease|3|||
125482967|NCT04171141|451403812|FG012|Overall Study|Progressive disease|4|||
125482968|NCT04171141|451403813|FG013|Overall Study|Progressive disease|2|||
125482969|NCT04171141|451403814|FG014|Overall Study|Progressive disease|4|||
125482970|NCT04171141|451403815|FG015|Overall Study|Progressive disease|1|||
125482971|NCT04171141|451403800|FG000|Overall Study|Withdrawal by Subject|0|||
125482972|NCT04171141|451403801|FG001|Overall Study|Withdrawal by Subject|0|||
125482973|NCT04171141|451403802|FG002|Overall Study|Withdrawal by Subject|0|||
125482974|NCT04171141|451403803|FG003|Overall Study|Withdrawal by Subject|1|||
125482975|NCT04171141|451403804|FG004|Overall Study|Withdrawal by Subject|0|||
125482976|NCT04171141|451403805|FG005|Overall Study|Withdrawal by Subject|0|||
125482977|NCT04171141|451403806|FG006|Overall Study|Withdrawal by Subject|1|||
125482978|NCT04171141|451403807|FG007|Overall Study|Withdrawal by Subject|0|||
125482979|NCT04171141|451403808|FG008|Overall Study|Withdrawal by Subject|0|||
125482980|NCT04171141|451403809|FG009|Overall Study|Withdrawal by Subject|1|||
125482981|NCT04171141|451403810|FG010|Overall Study|Withdrawal by Subject|0|||
125482982|NCT04171141|451403811|FG011|Overall Study|Withdrawal by Subject|0|||
125482983|NCT04171141|451403812|FG012|Overall Study|Withdrawal by Subject|0|||
125482984|NCT04171141|451403813|FG013|Overall Study|Withdrawal by Subject|0|||
125482985|NCT04171141|451403814|FG014|Overall Study|Withdrawal by Subject|0|||
125482986|NCT04171141|451403815|FG015|Overall Study|Withdrawal by Subject|0|||
125482987|NCT04171141|451403800|FG000|Overall Study|Global deterioration of health status|0|||
125482988|NCT04171141|451403801|FG001|Overall Study|Global deterioration of health status|0|||
125482989|NCT04171141|451403802|FG002|Overall Study|Global deterioration of health status|0|||
125482990|NCT04171141|451403803|FG003|Overall Study|Global deterioration of health status|1|||
125482991|NCT04171141|451403804|FG004|Overall Study|Global deterioration of health status|0|||
125482992|NCT04171141|451403805|FG005|Overall Study|Global deterioration of health status|2|||
125482993|NCT04171141|451403806|FG006|Overall Study|Global deterioration of health status|1|||
125482994|NCT04171141|451403807|FG007|Overall Study|Global deterioration of health status|0|||
125482995|NCT04171141|451403808|FG008|Overall Study|Global deterioration of health status|1|||
125482996|NCT04171141|451403809|FG009|Overall Study|Global deterioration of health status|0|||
125482997|NCT04171141|451403810|FG010|Overall Study|Global deterioration of health status|0|||
125482998|NCT04171141|451403811|FG011|Overall Study|Global deterioration of health status|0|||
125482999|NCT04171141|451403812|FG012|Overall Study|Global deterioration of health status|0|||
125483000|NCT04171141|451403813|FG013|Overall Study|Global deterioration of health status|0|||
125483001|NCT04171141|451403814|FG014|Overall Study|Global deterioration of health status|1|||
125483002|NCT04171141|451403815|FG015|Overall Study|Global deterioration of health status|1|||
125483003|NCT04858451|451403818|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
125483004|NCT04858451|451403819|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
125483005|NCT04858451|451403820|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
125483006|NCT04858451|451403821|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
125483007|NCT04858451|451403822|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
125483008|NCT04858451|451403823|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
125483009|NCT04858451|451403824|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
125483010|NCT04858451|451403825|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
125483011|NCT04858451|451403826|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
125483012|NCT04858451|451403818|FG000|Part 2|Discontinued|0|||
125483013|NCT04858451|451403819|FG001|Part 2|Discontinued|0|||
125483014|NCT04858451|451403820|FG002|Part 2|Discontinued|0|||
125483015|NCT04858451|451403821|FG003|Part 2|Discontinued|0|||
125483016|NCT04858451|451403822|FG004|Part 2|Discontinued|0|||
125483017|NCT04858451|451403823|FG005|Part 2|Discontinued|0|||
125483018|NCT04858451|451403824|FG006|Part 2|Discontinued|0|||
125483019|NCT04858451|451403825|FG007|Part 2|Discontinued|0|||
125483020|NCT04858451|451403826|FG008|Part 2|Discontinued|63|||
125483021|NCT03314454|451403827|FG000|Overall Study|Protocol Violation|1|||
125483022|NCT04314713|451403829|FG000|Overall Study|Lost to Follow-up|0|||
125483023|NCT04314713|451403830|FG001|Overall Study|Lost to Follow-up|0|||
125483024|NCT04314713|451403831|FG002|Overall Study|Lost to Follow-up|0|||
125483025|NCT04314713|451403832|FG003|Overall Study|Lost to Follow-up|1|||
125483026|NCT04314713|451403833|FG004|Overall Study|Lost to Follow-up|0|||
125483027|NCT04314713|451403834|FG005|Overall Study|Lost to Follow-up|0|||
125483028|NCT02927236|451403835|FG000|Characterization Phase|Physician Decision|0|||
125483029|NCT02927236|451403836|FG001|Characterization Phase|Physician Decision|3|||
125483030|NCT02927236|451403837|FG002|Characterization Phase|Physician Decision|0|||
125483031|NCT02927236|451403838|FG003|Characterization Phase|Physician Decision|2|||
125483032|NCT02927236|451403835|FG000|Characterization Phase|Lost to Follow-up|0|||
125483033|NCT02927236|451403836|FG001|Characterization Phase|Lost to Follow-up|0|||
125483034|NCT02927236|451403837|FG002|Characterization Phase|Lost to Follow-up|0|||
125483035|NCT02927236|451403838|FG003|Characterization Phase|Lost to Follow-up|3|||
125483036|NCT02927236|451403835|FG000|Characterization Phase|Withdrawal by Subject|1|||
125483037|NCT02927236|451403836|FG001|Characterization Phase|Withdrawal by Subject|0|||
125483038|NCT02927236|451403837|FG002|Characterization Phase|Withdrawal by Subject|0|||
125483039|NCT02927236|451403838|FG003|Characterization Phase|Withdrawal by Subject|1|||
125483040|NCT02927236|451403835|FG000|Treatment Phase|Adverse Event|1|||
125483041|NCT02927236|451403836|FG001|Treatment Phase|Adverse Event|0|||
125483042|NCT02927236|451403837|FG002|Treatment Phase|Adverse Event|1|||
125483043|NCT02927236|451403838|FG003|Treatment Phase|Adverse Event|1|||
125483044|NCT02927236|451403835|FG000|Treatment Phase|Protocol Violation|3|||
125483045|NCT02927236|451403836|FG001|Treatment Phase|Protocol Violation|0|||
125483046|NCT02927236|451403837|FG002|Treatment Phase|Protocol Violation|0|||
125483047|NCT02927236|451403838|FG003|Treatment Phase|Protocol Violation|1|||
125483048|NCT02927236|451403835|FG000|Treatment Phase|Lost to Follow-up|1|||
125483049|NCT02927236|451403836|FG001|Treatment Phase|Lost to Follow-up|0|||
125483050|NCT02927236|451403837|FG002|Treatment Phase|Lost to Follow-up|0|||
125483051|NCT02927236|451403838|FG003|Treatment Phase|Lost to Follow-up|0|||
125483052|NCT02927236|451403835|FG000|Follow-up Phase|Lost to Follow-up|1|||
125483053|NCT02927236|451403836|FG001|Follow-up Phase|Lost to Follow-up|0|||
125483054|NCT02927236|451403837|FG002|Follow-up Phase|Lost to Follow-up|1|||
125483055|NCT02927236|451403838|FG003|Follow-up Phase|Lost to Follow-up|0|||
125483056|NCT03656510|451403842|FG000|Overall Study|Lost to Follow-up|1|||
125483057|NCT03656510|451403843|FG001|Overall Study|Lost to Follow-up|0|||
125483058|NCT03656510|451403844|FG002|Overall Study|Lost to Follow-up|0|||
125483059|NCT03656510|451403845|FG003|Overall Study|Lost to Follow-up|0|||
125483060|NCT03656510|451403846|FG004|Overall Study|Lost to Follow-up|0|||
125483061|NCT03656510|451403847|FG005|Overall Study|Lost to Follow-up|0|||
125483062|NCT03656510|451403842|FG000|Overall Study|Withdrawal by Subject|1|||
125483063|NCT03656510|451403843|FG001|Overall Study|Withdrawal by Subject|1|||
125483064|NCT03656510|451403844|FG002|Overall Study|Withdrawal by Subject|0|||
125483065|NCT03656510|451403845|FG003|Overall Study|Withdrawal by Subject|1|||
125483066|NCT03656510|451403846|FG004|Overall Study|Withdrawal by Subject|0|||
125483067|NCT03656510|451403847|FG005|Overall Study|Withdrawal by Subject|0|||
125483068|NCT05496231|451403851|FG000|Overall Study|Adverse Event|1|||
125483069|NCT05496231|451403852|FG001|Overall Study|Adverse Event|1|||
125483070|NCT05496231|451403853|FG002|Overall Study|Adverse Event|0|||
125483071|NCT05496231|451403854|FG003|Overall Study|Adverse Event|4|||
125483072|NCT05496231|451403851|FG000|Overall Study|Withdrawal by Subject|5|||
125483073|NCT05496231|451403852|FG001|Overall Study|Withdrawal by Subject|5|||
125483074|NCT05496231|451403853|FG002|Overall Study|Withdrawal by Subject|4|||
125483075|NCT05496231|451403854|FG003|Overall Study|Withdrawal by Subject|11|||
125483076|NCT05496231|451403851|FG000|Overall Study|Migrated/moved from the study area|3|||
125483077|NCT05496231|451403852|FG001|Overall Study|Migrated/moved from the study area|5|||
125483078|NCT05496231|451403853|FG002|Overall Study|Migrated/moved from the study area|3|||
125483079|NCT05496231|451403854|FG003|Overall Study|Migrated/moved from the study area|3|||
125483080|NCT05496231|451403851|FG000|Overall Study|Lost to Follow-up|13|||
125483081|NCT05496231|451403852|FG001|Overall Study|Lost to Follow-up|6|||
125483082|NCT05496231|451403853|FG002|Overall Study|Lost to Follow-up|11|||
125483083|NCT05496231|451403854|FG003|Overall Study|Lost to Follow-up|6|||
125483084|NCT05496231|451403851|FG000|Overall Study|Other|9|||
125483085|NCT05496231|451403852|FG001|Overall Study|Other|7|||
125483086|NCT05496231|451403853|FG002|Overall Study|Other|7|||
125483087|NCT05496231|451403854|FG003|Overall Study|Other|8|||
125483088|NCT05940194|451403859|FG000|Overall Study|Adverse Event|0|||
125483089|NCT05940194|451403860|FG001|Overall Study|Adverse Event|1|||
125483090|NCT05940194|451403861|FG002|Overall Study|Adverse Event|0|||
125483091|NCT05940194|451403859|FG000|Overall Study|Migrated/Moved from the study area|2|||
125483092|NCT05940194|451403860|FG001|Overall Study|Migrated/Moved from the study area|2|||
125483093|NCT05940194|451403861|FG002|Overall Study|Migrated/Moved from the study area|4|||
125483094|NCT03085810|451403862|FG000|Main Study|Withdrawal by Subject|77|||
125483095|NCT03085810|451403863|FG001|Main Study|Withdrawal by Subject|0|||
125483096|NCT03085810|451403864|FG002|Main Study|Withdrawal by Subject|0|||
125483097|NCT03085810|451403862|FG000|Main Study|Terminated By Sponsor|14|||
125483098|NCT03085810|451403863|FG001|Main Study|Terminated By Sponsor|0|||
125483099|NCT03085810|451403864|FG002|Main Study|Terminated By Sponsor|0|||
125483100|NCT03085810|451403862|FG000|Main Study|Protocol Violation|15|||
125483101|NCT03085810|451403863|FG001|Main Study|Protocol Violation|0|||
125483102|NCT03085810|451403864|FG002|Main Study|Protocol Violation|0|||
125483103|NCT03085810|451403862|FG000|Main Study|Physician Decision|13|||
125483104|NCT03085810|451403863|FG001|Main Study|Physician Decision|0|||
125483105|NCT03085810|451403864|FG002|Main Study|Physician Decision|0|||
125483106|NCT03085810|451403862|FG000|Main Study|Lost to Follow-up|17|||
125483107|NCT03085810|451403863|FG001|Main Study|Lost to Follow-up|0|||
125483108|NCT03085810|451403864|FG002|Main Study|Lost to Follow-up|0|||
125483109|NCT03085810|451403862|FG000|Main Study|Adverse Event|25|||
125483110|NCT03085810|451403863|FG001|Main Study|Adverse Event|0|||
125483111|NCT03085810|451403864|FG002|Main Study|Adverse Event|0|||
125483112|NCT03085810|451403862|FG000|Main Study|Pregnancy|7|||
125483113|NCT03085810|451403863|FG001|Main Study|Pregnancy|0|||
125483114|NCT03085810|451403864|FG002|Main Study|Pregnancy|0|||
125483115|NCT03085810|451403862|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
125483116|NCT03085810|451403863|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
125483117|NCT03085810|451403864|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
125483118|NCT03085810|451403862|FG000|Main Study|Lack of Efficacy|10|||
125483119|NCT03085810|451403863|FG001|Main Study|Lack of Efficacy|0|||
125483120|NCT03085810|451403864|FG002|Main Study|Lack of Efficacy|0|||
125483121|NCT03085810|451403862|FG000|Main Study|Death|12|||
125483122|NCT03085810|451403863|FG001|Main Study|Death|0|||
125483123|NCT03085810|451403864|FG002|Main Study|Death|0|||
125483124|NCT03085810|451403862|FG000|Main Study|Disease progression|1|||
125483125|NCT03085810|451403863|FG001|Main Study|Disease progression|0|||
125483126|NCT03085810|451403864|FG002|Main Study|Disease progression|0|||
125483127|NCT03085810|451403862|FG000|Main Study|Site Closure|3|||
125483128|NCT03085810|451403863|FG001|Main Study|Site Closure|0|||
125483129|NCT03085810|451403864|FG002|Main Study|Site Closure|0|||
125483130|NCT03085810|451403862|FG000|Main Study|Planned pregnancy|17|||
125483131|NCT03085810|451403863|FG001|Main Study|Planned pregnancy|0|||
125483132|NCT03085810|451403864|FG002|Main Study|Planned pregnancy|0|||
125483133|NCT03085810|451403862|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
125483134|NCT03085810|451403863|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
125483135|NCT03085810|451403864|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
125483136|NCT03085810|451403862|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
125483137|NCT03085810|451403863|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
125483138|NCT03085810|451403864|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
125483139|NCT03085810|451403862|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
125483140|NCT03085810|451403863|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
125483141|NCT03085810|451403864|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
125483142|NCT03085810|451403862|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
125483143|NCT03085810|451403863|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
125483144|NCT03085810|451403864|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
125483145|NCT01959607|451403867|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
125483146|NCT01959607|451403868|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
125483147|NCT01959607|451403869|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
125483148|NCT01959607|451403870|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
125483149|NCT05073458|451403872|FG000|24-week Double-blind Period|Adverse Event|1|||
125483150|NCT05073458|451403873|FG001|24-week Double-blind Period|Adverse Event|0|||
125483151|NCT05073458|451403872|FG000|24-week Double-blind Period|Physician Decision|1|||
125483152|NCT05073458|451403873|FG001|24-week Double-blind Period|Physician Decision|0|||
125483153|NCT05073458|451403872|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
125483154|NCT05073458|451403873|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
125483155|NCT05073458|451403872|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
125483156|NCT05073458|451403873|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
125483157|NCT05073458|451403872|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
125483158|NCT05073458|451403873|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
125483159|NCT05073458|451403872|FG000|24-week Open-label Period|Adverse Event|1|||
125483160|NCT05073458|451403873|FG001|24-week Open-label Period|Adverse Event|2|||
125483161|NCT03235544|451403877|FG000|Overall Study|Death|11|||
125483162|NCT03235544|451403878|FG001|Overall Study|Death|31|||
125483163|NCT03235544|451403879|FG002|Overall Study|Death|19|||
125483164|NCT03235544|451403880|FG003|Overall Study|Death|34|||
125483165|NCT03235544|451403877|FG000|Overall Study|Lost to Follow-up|0|||
125483166|NCT03235544|451403878|FG001|Overall Study|Lost to Follow-up|1|||
125483167|NCT03235544|451403879|FG002|Overall Study|Lost to Follow-up|1|||
125483168|NCT03235544|451403880|FG003|Overall Study|Lost to Follow-up|1|||
125483169|NCT03235544|451403877|FG000|Overall Study|Withdrawal by Subject|0|||
125483170|NCT03235544|451403878|FG001|Overall Study|Withdrawal by Subject|3|||
125483171|NCT03235544|451403879|FG002|Overall Study|Withdrawal by Subject|1|||
125483172|NCT03235544|451403880|FG003|Overall Study|Withdrawal by Subject|5|||
125483173|NCT03235544|451403877|FG000|Overall Study|Disease Progression|0|||
125483174|NCT03235544|451403878|FG001|Overall Study|Disease Progression|1|||
125483175|NCT03235544|451403879|FG002|Overall Study|Disease Progression|0|||
125483176|NCT03235544|451403880|FG003|Overall Study|Disease Progression|2|||
125483177|NCT03235544|451403877|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
125483178|NCT03235544|451403878|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
125483179|NCT03235544|451403879|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
125483180|NCT03235544|451403880|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
125483181|NCT03235544|451403877|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
125483182|NCT03235544|451403878|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
125483183|NCT03235544|451403879|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
125483184|NCT03235544|451403880|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
125483185|NCT00950742|451403881|FG000|Overall Study|Other Adverse Event|1|||
125483186|NCT00950742|451403882|FG001|Overall Study|Other Adverse Event|0|||
125483187|NCT00950742|451403881|FG000|Overall Study|Withdrawal by Subject|3|||
125483188|NCT00950742|451403882|FG001|Overall Study|Withdrawal by Subject|0|||
125483189|NCT00950742|451403881|FG000|Overall Study|Progressive Disease|6|||
125483190|NCT00950742|451403882|FG001|Overall Study|Progressive Disease|2|||
125483191|NCT00950742|451403881|FG000|Overall Study|Dose limiting toxicity|6|||
125483192|NCT00950742|451403882|FG001|Overall Study|Dose limiting toxicity|0|||
125483193|NCT04447755|451403883|FG000|Overall Study|Death|8|||
125483194|NCT04447755|451403884|FG001|Overall Study|Death|14|||
125483195|NCT04447755|451403885|FG002|Overall Study|Death|8|||
125483196|NCT04447755|451403886|FG003|Overall Study|Death|9|||
125483197|NCT04447755|451403887|FG004|Overall Study|Death|7|||
125483198|NCT04447755|451403888|FG005|Overall Study|Death|7|||
125483199|NCT04447755|451403889|FG006|Overall Study|Death|40|||
125483200|NCT04447755|451403883|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125483201|NCT04447755|451403884|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125483202|NCT04447755|451403885|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
125483203|NCT04447755|451403886|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
125483204|NCT04447755|451403887|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
125483205|NCT04447755|451403888|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
125483206|NCT04447755|451403889|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
125483207|NCT04447755|451403883|FG000|Overall Study|Ongoing in Study|1|||
125483208|NCT04447755|451403884|FG001|Overall Study|Ongoing in Study|2|||
125483209|NCT04447755|451403885|FG002|Overall Study|Ongoing in Study|0|||
125483210|NCT04447755|451403886|FG003|Overall Study|Ongoing in Study|0|||
125483211|NCT04447755|451403887|FG004|Overall Study|Ongoing in Study|2|||
125483212|NCT04447755|451403888|FG005|Overall Study|Ongoing in Study|2|||
125483213|NCT04447755|451403889|FG006|Overall Study|Ongoing in Study|26|||
125483214|NCT03701763|451403893|FG000|Placebo-controlled Phase|Adverse Event|1|||
125483215|NCT03701763|451403894|FG001|Placebo-controlled Phase|Adverse Event|5|||
125483216|NCT03701763|451403895|FG002|Placebo-controlled Phase|Adverse Event|0|||
125483217|NCT03701763|451403896|FG003|Placebo-controlled Phase|Adverse Event|0|||
125483218|NCT03701763|451403893|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
125483219|NCT03701763|451403894|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
125483220|NCT03701763|451403895|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
125483221|NCT03701763|451403896|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
125483222|NCT03701763|451403893|FG000|Placebo-controlled Phase|Miscellaneous|2|||
125483223|NCT03701763|451403894|FG001|Placebo-controlled Phase|Miscellaneous|0|||
125483224|NCT03701763|451403895|FG002|Placebo-controlled Phase|Miscellaneous|0|||
125483225|NCT03701763|451403896|FG003|Placebo-controlled Phase|Miscellaneous|0|||
125483226|NCT03701763|451403893|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
125483227|NCT03701763|451403894|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
125483228|NCT03701763|451403895|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
125483229|NCT03701763|451403896|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
125483230|NCT03701763|451403893|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
125483231|NCT03701763|451403894|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
125483232|NCT03701763|451403895|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
125483233|NCT03701763|451403896|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
125483234|NCT03701763|451403893|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
125483235|NCT03701763|451403894|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
125483236|NCT03701763|451403895|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
125483237|NCT03701763|451403896|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
125483238|NCT03701763|451403893|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
125483239|NCT03701763|451403894|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
125483240|NCT03701763|451403895|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
125483241|NCT03701763|451403896|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
125483242|NCT03701763|451403893|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
125483243|NCT03701763|451403894|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
125483244|NCT03701763|451403895|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
125483245|NCT03701763|451403896|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
125483246|NCT03701763|451403893|FG000|Apremilast Extension Phase|Adverse Event|0|||
125483247|NCT03701763|451403894|FG001|Apremilast Extension Phase|Adverse Event|0|||
125483248|NCT03701763|451403895|FG002|Apremilast Extension Phase|Adverse Event|3|||
125483249|NCT03701763|451403896|FG003|Apremilast Extension Phase|Adverse Event|1|||
125483250|NCT03701763|451403893|FG000|Apremilast Extension Phase|Miscellaneous|0|||
125483251|NCT03701763|451403894|FG001|Apremilast Extension Phase|Miscellaneous|0|||
125483252|NCT03701763|451403895|FG002|Apremilast Extension Phase|Miscellaneous|2|||
125483253|NCT03701763|451403896|FG003|Apremilast Extension Phase|Miscellaneous|1|||
125483254|NCT03701763|451403893|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
125483255|NCT03701763|451403894|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
125483256|NCT03701763|451403895|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
125483257|NCT03701763|451403896|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
125483258|NCT03701763|451403893|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
125483259|NCT03701763|451403894|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
125483260|NCT03701763|451403895|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
125483261|NCT03701763|451403896|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
125483262|NCT03701763|451403893|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
125483263|NCT03701763|451403894|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
125483264|NCT03701763|451403895|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
125483265|NCT03701763|451403896|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
125483266|NCT03701763|451403893|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
125483267|NCT03701763|451403894|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
125483268|NCT03701763|451403895|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
125483269|NCT03701763|451403896|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
125483270|NCT03701763|451403893|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
125483271|NCT03701763|451403894|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
125483272|NCT03701763|451403895|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
125483273|NCT03701763|451403896|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
125483274|NCT03701763|451403893|FG000|14-Week Observational Follow-up Phase|Other|0|||
125483275|NCT03701763|451403894|FG001|14-Week Observational Follow-up Phase|Other|0|||
125483276|NCT03701763|451403895|FG002|14-Week Observational Follow-up Phase|Other|1|||
125483277|NCT03701763|451403896|FG003|14-Week Observational Follow-up Phase|Other|0|||
125483278|NCT03701763|451403893|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
125483279|NCT03701763|451403894|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
125483280|NCT03701763|451403895|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
125483281|NCT03701763|451403896|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
125483282|NCT03701763|451403893|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
125483283|NCT03701763|451403894|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
125483284|NCT03701763|451403895|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
125483285|NCT03701763|451403896|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
125483286|NCT00592852|451403898|FG000|Overall Study|Non-compliance|1|||
125483287|NCT00592852|451403898|FG000|Overall Study|Adverse Event|3|||
125483288|NCT00592852|451403898|FG000|Overall Study|Found ineligible|1|||
125483289|NCT00592852|451403898|FG000|Overall Study|Withdrawal by Subject|1|||
125483290|NCT02589795|451403902|FG000|Overall Study|Lost to Follow-up|1|||
125483291|NCT02589795|451403903|FG001|Overall Study|Lost to Follow-up|0|||
125483292|NCT02589795|451403904|FG002|Overall Study|Lost to Follow-up|0|||
125483293|NCT02589795|451403902|FG000|Overall Study|Withdrawal by Subject|0|||
125483294|NCT02589795|451403903|FG001|Overall Study|Withdrawal by Subject|0|||
125483295|NCT02589795|451403904|FG002|Overall Study|Withdrawal by Subject|2|||
125483296|NCT02589795|451403902|FG000|Overall Study|Protocol Violation|0|||
125483297|NCT02589795|451403903|FG001|Overall Study|Protocol Violation|0|||
125483298|NCT02589795|451403904|FG002|Overall Study|Protocol Violation|1|||
125483299|NCT03599661|451403906|FG000|Overall Study|Lost to Follow-up|9|||
125483300|NCT04909801|451403907|FG000|Overall Study|Lack of Efficacy|2|||
125483301|NCT04909801|451403908|FG001|Overall Study|Lack of Efficacy|1|||
125483302|NCT04909801|451403907|FG000|Overall Study|Adverse Event|1|||
125483303|NCT04909801|451403908|FG001|Overall Study|Adverse Event|2|||
125483304|NCT04909801|451403907|FG000|Overall Study|Participant request to discontinue study treatment|1|||
125483305|NCT04909801|451403908|FG001|Overall Study|Participant request to discontinue study treatment|2|||
125483306|NCT04909801|451403907|FG000|Overall Study|Withdrawal by Subject|2|||
125483307|NCT04909801|451403908|FG001|Overall Study|Withdrawal by Subject|1|||
125483308|NCT04909801|451403907|FG000|Overall Study|other reasons|1|||
125483309|NCT04909801|451403908|FG001|Overall Study|other reasons|1|||
125483310|NCT04117347|451403911|FG000|Overall Study|Adverse Event|0|||
125483311|NCT04117347|451403912|FG001|Overall Study|Adverse Event|0|||
125483312|NCT04117347|451403913|FG002|Overall Study|Adverse Event|1|||
125483313|NCT04117347|451403911|FG000|Overall Study|No time for study|0|||
125483314|NCT04117347|451403912|FG001|Overall Study|No time for study|2|||
125483315|NCT04117347|451403913|FG002|Overall Study|No time for study|0|||
125483316|NCT04117347|451403911|FG000|Overall Study|Family emergency|1|||
125483317|NCT04117347|451403912|FG001|Overall Study|Family emergency|0|||
125483318|NCT04117347|451403913|FG002|Overall Study|Family emergency|0|||
125483319|NCT05194956|451403914|FG000|Washout Period|Withdrawal by Subject|0|||
125483320|NCT05194956|451403915|FG001|Washout Period|Withdrawal by Subject|2|||
125483321|NCT03687086|451403916|FG000|Overall Study|Withdrawal by Subject|3|||
125483322|NCT03687086|451403917|FG001|Overall Study|Withdrawal by Subject|4|||
125483323|NCT03687086|451403916|FG000|Overall Study|Lost to Follow-up|1|||
125483324|NCT03687086|451403917|FG001|Overall Study|Lost to Follow-up|1|||
125483325|NCT03687086|451403916|FG000|Overall Study|Death|1|||
125483326|NCT03687086|451403917|FG001|Overall Study|Death|0|||
125483327|NCT03687086|451403916|FG000|Overall Study|Incomplete assessment|0|||
125483328|NCT03687086|451403917|FG001|Overall Study|Incomplete assessment|2|||
125483329|NCT02505984|451403918|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
125483330|NCT02505984|451403919|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
125483331|NCT02505984|451403918|FG000|Overall Study|Unreliable self-report data|1|||
125483332|NCT02505984|451403919|FG001|Overall Study|Unreliable self-report data|0|||
125483333|NCT02505984|451403918|FG000|Overall Study|Study blind opened during assessment|0|||
125483334|NCT02505984|451403919|FG001|Overall Study|Study blind opened during assessment|1|||
125483335|NCT02505984|451403918|FG000|Overall Study|Noncompliance with study protocol|0|||
125483336|NCT02505984|451403919|FG001|Overall Study|Noncompliance with study protocol|1|||
125483337|NCT04201262|451403920|FG000|Overall Study|Adverse Event|1|||
125483338|NCT04201262|451403921|FG001|Overall Study|Adverse Event|2|||
125483339|NCT04201262|451403920|FG000|Overall Study|Continuing in the study|57|||
125483340|NCT04201262|451403921|FG001|Overall Study|Continuing in the study|0|||
125483341|NCT04201262|451403920|FG000|Overall Study|Withdrawal by Subject|0|||
125483342|NCT04201262|451403921|FG001|Overall Study|Withdrawal by Subject|1|||
125483343|NCT05446168|451403922|FG000|Overall Study|Physician Decision|0|||
125483344|NCT05446168|451403923|FG001|Overall Study|Physician Decision|1|||
125483345|NCT03511664|451403924|FG000|Overall Study|Death|457|||
125483346|NCT03511664|451403925|FG001|Overall Study|Death|201|||
125483347|NCT03511664|451403926|FG002|Overall Study|Death|21|||
125483348|NCT03511664|451403924|FG000|Overall Study|Withdrew consent|40|||
125483349|NCT03511664|451403925|FG001|Overall Study|Withdrew consent|63|||
125483350|NCT03511664|451403926|FG002|Overall Study|Withdrew consent|3|||
125483351|NCT03511664|451403924|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
125483352|NCT03511664|451403925|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
125483353|NCT03511664|451403926|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
125483354|NCT03511664|451403924|FG000|Overall Study|Lost to Follow-up|8|||
125483355|NCT03511664|451403925|FG001|Overall Study|Lost to Follow-up|5|||
125483356|NCT03511664|451403926|FG002|Overall Study|Lost to Follow-up|0|||
125303024|NCT04776317|450736656|FG013|Overall Study|Withdrawal by Subject|0|||
125303025|NCT04776317|450736657|FG014|Overall Study|Withdrawal by Subject|0|||
125483357|NCT03511664|451403924|FG000|Overall Study|Physician Decision|2|||
125483358|NCT03511664|451403925|FG001|Overall Study|Physician Decision|1|||
125483359|NCT03511664|451403926|FG002|Overall Study|Physician Decision|0|||
125483360|NCT03511664|451403924|FG000|Overall Study|Patient non-compliance|1|||
125483361|NCT03511664|451403925|FG001|Overall Study|Patient non-compliance|0|||
125483362|NCT03511664|451403926|FG002|Overall Study|Patient non-compliance|0|||
125483363|NCT05192109|451403933|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
125483364|NCT05192109|451403934|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
125483365|NCT05192109|451403935|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
125483366|NCT05192109|451403936|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
125483367|NCT05192109|451403933|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
125483368|NCT05192109|451403934|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
125483369|NCT05192109|451403935|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
125483370|NCT05192109|451403936|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
125483371|NCT04498390|451403937|FG000|Overall Study|Adverse Event|0|||
125483372|NCT04498390|451403938|FG001|Overall Study|Adverse Event|0|||
125483373|NCT04498390|451403939|FG002|Overall Study|Adverse Event|1|||
125483374|NCT04498390|451403940|FG003|Overall Study|Adverse Event|0|||
125483375|NCT04498390|451403941|FG004|Overall Study|Adverse Event|0|||
125483376|NCT04498390|451403937|FG000|Overall Study|Withdrawal by Subject|0|||
125483377|NCT04498390|451403938|FG001|Overall Study|Withdrawal by Subject|0|||
125483378|NCT04498390|451403939|FG002|Overall Study|Withdrawal by Subject|0|||
125483379|NCT04498390|451403940|FG003|Overall Study|Withdrawal by Subject|1|||
125483380|NCT04498390|451403941|FG004|Overall Study|Withdrawal by Subject|0|||
125483381|NCT04971109|451403948|FG000|Overall Study|Adverse Event|4|||
125483382|NCT04971109|451403949|FG001|Overall Study|Adverse Event|3|||
125483383|NCT04971109|451403948|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
125483384|NCT04971109|451403949|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
125483385|NCT04971109|451403948|FG000|Overall Study|Lost to Follow-up|8|||
125483386|NCT04971109|451403949|FG001|Overall Study|Lost to Follow-up|2|||
125483387|NCT04971109|451403948|FG000|Overall Study|Physician Decision|5|||
125483388|NCT04971109|451403949|FG001|Overall Study|Physician Decision|0|||
125483389|NCT04971109|451403948|FG000|Overall Study|Protocol Violation|0|||
125483390|NCT04971109|451403949|FG001|Overall Study|Protocol Violation|1|||
125483391|NCT04971109|451403948|FG000|Overall Study|Withdrawal by Subject|18|||
125483392|NCT04971109|451403949|FG001|Overall Study|Withdrawal by Subject|3|||
125483393|NCT04971109|451403948|FG000|Overall Study|Subject was randomized in error|1|||
125483394|NCT04971109|451403949|FG001|Overall Study|Subject was randomized in error|0|||
125483395|NCT04577963|451403952|FG000|Part 2|Death|0|||
125483396|NCT04577963|451403953|FG001|Part 2|Death|1|||
125483397|NCT04577963|451403954|FG002|Part 2|Death|8|||
125483398|NCT04577963|451403955|FG003|Part 2|Death|0|||
125483399|NCT04577963|451403956|FG004|Part 2|Death|20|||
125483400|NCT04577963|451403952|FG000|Part 2|Lost to Follow-up|0|||
125483401|NCT04577963|451403953|FG001|Part 2|Lost to Follow-up|0|||
125483402|NCT04577963|451403954|FG002|Part 2|Lost to Follow-up|0|||
125483403|NCT04577963|451403955|FG003|Part 2|Lost to Follow-up|0|||
125483404|NCT04577963|451403956|FG004|Part 2|Lost to Follow-up|2|||
125483405|NCT04577963|451403952|FG000|Part 2|Withdrawal by Subject|0|||
125483406|NCT04577963|451403953|FG001|Part 2|Withdrawal by Subject|0|||
125483407|NCT04577963|451403954|FG002|Part 2|Withdrawal by Subject|0|||
125483408|NCT04577963|451403955|FG003|Part 2|Withdrawal by Subject|0|||
125483409|NCT04577963|451403956|FG004|Part 2|Withdrawal by Subject|10|||
125483410|NCT04577963|451403952|FG000|Part 2|Progressive disease|0|||
125483411|NCT04577963|451403953|FG001|Part 2|Progressive disease|0|||
125483412|NCT04577963|451403954|FG002|Part 2|Progressive disease|0|||
125483413|NCT04577963|451403955|FG003|Part 2|Progressive disease|0|||
125483414|NCT04577963|451403956|FG004|Part 2|Progressive disease|2|||
125483415|NCT04577963|451403952|FG000|Part 2|Investigator decision|0|||
125483416|NCT04577963|451403953|FG001|Part 2|Investigator decision|0|||
125483417|NCT04577963|451403954|FG002|Part 2|Investigator decision|0|||
125483418|NCT04577963|451403955|FG003|Part 2|Investigator decision|0|||
125483419|NCT04577963|451403956|FG004|Part 2|Investigator decision|1|||
125483420|NCT04577963|451403952|FG000|Part 2|Sponsor terminated study|0|||
125483421|NCT04577963|451403953|FG001|Part 2|Sponsor terminated study|0|||
125483422|NCT04577963|451403954|FG002|Part 2|Sponsor terminated study|3|||
125483423|NCT04577963|451403955|FG003|Part 2|Sponsor terminated study|1|||
125483424|NCT04577963|451403956|FG004|Part 2|Sponsor terminated study|4|||
125483425|NCT02709161|451403957|FG000|Overall Study|Withdrawal by Subject|1|||
125483426|NCT02709161|451403958|FG001|Overall Study|Withdrawal by Subject|0|||
125483427|NCT04231149|451405733|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
125483428|NCT04231149|451405734|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
125483429|NCT04231149|451405735|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
125483430|NCT04231149|451405736|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
125483431|NCT04231149|451405737|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
125483432|NCT04979442|451405739|FG000|Overall Study|Death|43|||
125483433|NCT04979442|451405740|FG001|Overall Study|Death|30|||
125483434|NCT04979442|451405739|FG000|Overall Study|Withdrawal by Subject|8|||
125483435|NCT04979442|451405740|FG001|Overall Study|Withdrawal by Subject|13|||
125483436|NCT04979442|451405739|FG000|Overall Study|Physician Decision|1|||
125483437|NCT04979442|451405740|FG001|Overall Study|Physician Decision|1|||
125483438|NCT04979442|451405739|FG000|Overall Study|Lost to Follow-up|0|||
125483439|NCT04979442|451405740|FG001|Overall Study|Lost to Follow-up|2|||
125483440|NCT04979442|451405739|FG000|Overall Study|do not want to continue|0|||
125483441|NCT04979442|451405740|FG001|Overall Study|do not want to continue|1|||
125483442|NCT04298983|451405743|FG000|Overall Study|Adverse Event|4|||
125483443|NCT04298983|451405743|FG000|Overall Study|Lack of Efficacy|3|||
125483444|NCT02116530|451405745|FG000|Overall Study|Withdrawal by Subject|1|||
125483445|NCT02116530|451405746|FG001|Overall Study|Withdrawal by Subject|2|||
125483446|NCT02116530|451405745|FG000|Overall Study|Adverse Event|4|||
125483447|NCT02116530|451405746|FG001|Overall Study|Adverse Event|0|||
125483448|NCT02116530|451405745|FG000|Overall Study|Physician Decision|1|||
125483449|NCT02116530|451405746|FG001|Overall Study|Physician Decision|0|||
125483450|NCT02116530|451405745|FG000|Overall Study|Lost to Follow-up|1|||
125483451|NCT02116530|451405746|FG001|Overall Study|Lost to Follow-up|0|||
125483452|NCT02116530|451405745|FG000|Overall Study|Other Medical Problems|2|||
125483453|NCT02116530|451405746|FG001|Overall Study|Other Medical Problems|2|||
125483454|NCT05029622|451405749|FG000|Overall Study|Lost to Follow-up|1|||
125483455|NCT05671653|451405750|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
125483456|NCT05671653|451405751|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
125483457|NCT05671653|451405752|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
125483458|NCT05671653|451405753|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
125483459|NCT05671653|451405754|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
125483460|NCT05671653|451405755|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
125483461|NCT05671653|451405756|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
125483462|NCT05671653|451405757|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
125483463|NCT05671653|451405758|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
125483464|NCT05671653|451405759|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
125483465|NCT05671653|451405760|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
125483466|NCT05671653|451405761|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
125483467|NCT05671653|451405762|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
125483468|NCT05671653|451405750|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
125483469|NCT05671653|451405751|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
125483470|NCT05671653|451405752|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
125483471|NCT05671653|451405753|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
125483472|NCT05671653|451405754|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
125483473|NCT05671653|451405755|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
125483474|NCT05671653|451405756|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
125483475|NCT05671653|451405757|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
125483476|NCT05671653|451405758|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
125483477|NCT05671653|451405759|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
125483478|NCT05671653|451405760|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
125483479|NCT05671653|451405761|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
125483480|NCT05671653|451405762|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
125483481|NCT05671653|451405750|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
125483482|NCT05671653|451405751|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
125483483|NCT05671653|451405752|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
125483484|NCT05671653|451405753|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
125483485|NCT05671653|451405754|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
125483486|NCT05671653|451405755|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
125483487|NCT05671653|451405756|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
125483488|NCT05671653|451405757|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
125483489|NCT05671653|451405758|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
125483490|NCT05671653|451405759|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
125483491|NCT05671653|451405760|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
125483492|NCT05671653|451405761|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
125483493|NCT05671653|451405762|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
125483494|NCT05671653|451405750|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
125483495|NCT05671653|451405751|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
125483496|NCT05671653|451405752|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
125483497|NCT05671653|451405753|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
125483498|NCT05671653|451405754|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
125483499|NCT05671653|451405755|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
125483500|NCT05671653|451405756|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
125483501|NCT05671653|451405757|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
125483502|NCT05671653|451405758|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
125483503|NCT05671653|451405759|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
125483504|NCT05671653|451405760|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
125483505|NCT05671653|451405761|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
125483506|NCT05671653|451405762|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
125483507|NCT05671653|451405750|FG000|Cohort 2 Period 2|Adverse Event|0|||
125483508|NCT05671653|451405751|FG001|Cohort 2 Period 2|Adverse Event|0|||
125483509|NCT05671653|451405752|FG002|Cohort 2 Period 2|Adverse Event|0|||
125483510|NCT05671653|451405753|FG003|Cohort 2 Period 2|Adverse Event|0|||
125483511|NCT05671653|451405754|FG004|Cohort 2 Period 2|Adverse Event|0|||
125483512|NCT05671653|451405755|FG005|Cohort 2 Period 2|Adverse Event|0|||
125483513|NCT05671653|451405756|FG006|Cohort 2 Period 2|Adverse Event|0|||
125483514|NCT05671653|451405757|FG007|Cohort 2 Period 2|Adverse Event|0|||
125483515|NCT05671653|451405758|FG008|Cohort 2 Period 2|Adverse Event|0|||
125483516|NCT05671653|451405759|FG009|Cohort 2 Period 2|Adverse Event|0|||
125483517|NCT05671653|451405760|FG010|Cohort 2 Period 2|Adverse Event|1|||
125483518|NCT05671653|451405761|FG011|Cohort 2 Period 2|Adverse Event|0|||
125483519|NCT05671653|451405762|FG012|Cohort 2 Period 2|Adverse Event|0|||
125483520|NCT05671653|451405750|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
125483521|NCT05671653|451405751|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
125483522|NCT05671653|451405752|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
125483523|NCT05671653|451405753|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
125483524|NCT05671653|451405754|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
125483525|NCT05671653|451405755|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
125483526|NCT05671653|451405756|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
125483527|NCT05671653|451405757|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
125483528|NCT05671653|451405758|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
125483529|NCT05671653|451405759|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
125483530|NCT05671653|451405760|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
125483531|NCT05671653|451405761|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
125483532|NCT05671653|451405762|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
125483533|NCT05671653|451405750|FG000|Cohort 2 Period 2|Pregnancy|0|||
125483534|NCT05671653|451405751|FG001|Cohort 2 Period 2|Pregnancy|0|||
125483535|NCT05671653|451405752|FG002|Cohort 2 Period 2|Pregnancy|0|||
125483536|NCT05671653|451405753|FG003|Cohort 2 Period 2|Pregnancy|0|||
125483537|NCT05671653|451405754|FG004|Cohort 2 Period 2|Pregnancy|0|||
125483538|NCT05671653|451405755|FG005|Cohort 2 Period 2|Pregnancy|0|||
125483539|NCT05671653|451405756|FG006|Cohort 2 Period 2|Pregnancy|0|||
125483540|NCT05671653|451405757|FG007|Cohort 2 Period 2|Pregnancy|0|||
125483541|NCT05671653|451405758|FG008|Cohort 2 Period 2|Pregnancy|0|||
125483542|NCT05671653|451405759|FG009|Cohort 2 Period 2|Pregnancy|0|||
125483543|NCT05671653|451405760|FG010|Cohort 2 Period 2|Pregnancy|1|||
125483544|NCT05671653|451405761|FG011|Cohort 2 Period 2|Pregnancy|0|||
125483545|NCT05671653|451405762|FG012|Cohort 2 Period 2|Pregnancy|0|||
125483546|NCT05671653|451405750|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
125483547|NCT05671653|451405751|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
125483548|NCT05671653|451405752|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
125483549|NCT05671653|451405753|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
125483550|NCT05671653|451405754|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
125483551|NCT05671653|451405755|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
125483552|NCT05671653|451405756|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
125483553|NCT05671653|451405757|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
125483554|NCT05671653|451405758|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
125483555|NCT05671653|451405759|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
125483556|NCT05671653|451405760|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
125483557|NCT05671653|451405761|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
125483558|NCT05671653|451405762|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
125483559|NCT05671653|451405750|FG000|Cohort 2 Period 2|Other|0|||
125483560|NCT05671653|451405751|FG001|Cohort 2 Period 2|Other|0|||
125483561|NCT05671653|451405752|FG002|Cohort 2 Period 2|Other|0|||
125483562|NCT05671653|451405753|FG003|Cohort 2 Period 2|Other|0|||
125483563|NCT05671653|451405754|FG004|Cohort 2 Period 2|Other|0|||
125483564|NCT05671653|451405755|FG005|Cohort 2 Period 2|Other|0|||
125483565|NCT05671653|451405756|FG006|Cohort 2 Period 2|Other|0|||
125483566|NCT05671653|451405757|FG007|Cohort 2 Period 2|Other|0|||
125483567|NCT05671653|451405758|FG008|Cohort 2 Period 2|Other|0|||
125483568|NCT05671653|451405759|FG009|Cohort 2 Period 2|Other|0|||
125483569|NCT05671653|451405760|FG010|Cohort 2 Period 2|Other|1|||
125483570|NCT05671653|451405761|FG011|Cohort 2 Period 2|Other|0|||
125483571|NCT05671653|451405762|FG012|Cohort 2 Period 2|Other|0|||
125483572|NCT05671653|451405750|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
125483573|NCT05671653|451405751|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
125483574|NCT05671653|451405752|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
125483575|NCT05671653|451405753|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
125483576|NCT05671653|451405754|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
125483577|NCT05671653|451405755|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
125483578|NCT05671653|451405756|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
125483579|NCT05671653|451405757|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
125483580|NCT05671653|451405758|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
125483581|NCT05671653|451405759|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
125483582|NCT05671653|451405760|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
125303026|NCT02524158|450736659|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
125303027|NCT02524158|450736660|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
125303028|NCT02524158|450736659|FG000|12-weeks Assessment|Lost to Follow-up|18|||
125483583|NCT05671653|451405761|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
125483584|NCT05671653|451405762|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
125483585|NCT03974178|451405763|FG000|Overall Study|Death|0|||
125483586|NCT03974178|451405764|FG001|Overall Study|Death|1|||
125483587|NCT05526430|451405765|FG000|Overall Study|Withdrawal by Subject|0|||
125483588|NCT05526430|451405766|FG001|Overall Study|Withdrawal by Subject|2|||
125483589|NCT05526430|451405767|FG002|Overall Study|Withdrawal by Subject|0|||
125303029|NCT02524158|450736660|FG001|12-weeks Assessment|Lost to Follow-up|12|||
125483590|NCT05526430|451405768|FG003|Overall Study|Withdrawal by Subject|0|||
125483591|NCT04508309|451405769|FG000|Overall Study|Death|0|||
125483592|NCT04508309|451405770|FG001|Overall Study|Death|0|||
125483593|NCT04508309|451405771|FG002|Overall Study|Death|0|||
125483594|NCT04508309|451405772|FG003|Overall Study|Death|0|||
125483595|NCT04508309|451405773|FG004|Overall Study|Death|1|||
125483596|NCT04508309|451405769|FG000|Overall Study|Lost to Follow-up|0|||
125483597|NCT04508309|451405770|FG001|Overall Study|Lost to Follow-up|0|||
125483598|NCT04508309|451405771|FG002|Overall Study|Lost to Follow-up|1|||
125483599|NCT04508309|451405772|FG003|Overall Study|Lost to Follow-up|1|||
125483600|NCT04508309|451405773|FG004|Overall Study|Lost to Follow-up|0|||
125483601|NCT04508309|451405769|FG000|Overall Study|Withdrawal by Subject|0|||
125483602|NCT04508309|451405770|FG001|Overall Study|Withdrawal by Subject|0|||
125483603|NCT04508309|451405771|FG002|Overall Study|Withdrawal by Subject|0|||
125483604|NCT04508309|451405772|FG003|Overall Study|Withdrawal by Subject|0|||
125483605|NCT04508309|451405773|FG004|Overall Study|Withdrawal by Subject|1|||
125483606|NCT02305888|451405777|FG000|Overall Study|Lost to Follow-up|0|||
125483607|NCT02305888|451405778|FG001|Overall Study|Lost to Follow-up|0|||
125483608|NCT02305888|451405779|FG002|Overall Study|Lost to Follow-up|1|||
125483609|NCT02305888|451405777|FG000|Overall Study|Adverse Event|0|||
125483610|NCT02305888|451405778|FG001|Overall Study|Adverse Event|1|||
125483611|NCT02305888|451405779|FG002|Overall Study|Adverse Event|0|||
125483612|NCT06232590|451405780|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
125483613|NCT06232590|451405781|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
125483614|NCT04914676|451405782|FG000|Overall Study|Study termination|3|||
125483615|NCT04914676|451405783|FG001|Overall Study|Study termination|0|||
125483616|NCT05200403|451405784|FG000|Overall Study|Withdrawal by Subject|4|||
125483617|NCT05200403|451405785|FG001|Overall Study|Withdrawal by Subject|2|||
125483618|NCT05200403|451405786|FG002|Overall Study|Withdrawal by Subject|6|||
125483619|NCT03913442|451405787|FG000|Overall Study|Adverse Event|0|||
125483620|NCT03913442|451405788|FG001|Overall Study|Adverse Event|3|||
125483621|NCT03913442|451405787|FG000|Overall Study|Withdrawal by Subject|5|||
125483622|NCT03913442|451405788|FG001|Overall Study|Withdrawal by Subject|5|||
125483623|NCT03913442|451405787|FG000|Overall Study|Terminations|2|||
125483624|NCT03913442|451405788|FG001|Overall Study|Terminations|1|||
125483625|NCT03913442|451405787|FG000|Overall Study|Lost to Follow-up|2|||
125483626|NCT03913442|451405788|FG001|Overall Study|Lost to Follow-up|2|||
125483627|NCT02460458|451405789|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
125483628|NCT02460458|451405789|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
125483629|NCT02460458|451405789|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
125483630|NCT02460458|451405789|FG000|First Prospective Phase|Lost to Follow-up|84|||
125483631|NCT02460458|451405789|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
125483632|NCT05436262|451405790|FG000|Pre-Randomization|Withdrawal by Subject|1|||
125483633|NCT05436262|451405791|FG001|Pre-Randomization|Withdrawal by Subject|0|||
125483634|NCT05436262|451405792|FG002|Pre-Randomization|Withdrawal by Subject|0|||
125483635|NCT05436262|451405790|FG000|Randomization|Withdrawal by Subject|0|||
125483636|NCT05436262|451405791|FG001|Randomization|Withdrawal by Subject|1|||
125483637|NCT05436262|451405792|FG002|Randomization|Withdrawal by Subject|0|||
125483638|NCT05299073|451405793|FG000|Overall Study|Withdrawal by Subject|0|||
125483639|NCT05299073|451405794|FG001|Overall Study|Withdrawal by Subject|0|||
125483640|NCT05299073|451405795|FG002|Overall Study|Withdrawal by Subject|1|||
125483641|NCT05299073|451405793|FG000|Overall Study|Adverse Event|0|||
125483642|NCT05299073|451405794|FG001|Overall Study|Adverse Event|1|||
125483643|NCT05299073|451405795|FG002|Overall Study|Adverse Event|0|||
125483644|NCT05299073|451405793|FG000|Overall Study|Lost to Follow-up|0|||
125483645|NCT05299073|451405794|FG001|Overall Study|Lost to Follow-up|1|||
125483646|NCT05299073|451405795|FG002|Overall Study|Lost to Follow-up|0|||
125483647|NCT03952338|451405796|FG000|Overall Study|Lost to Follow-up|11|||
125483648|NCT03952338|451405797|FG001|Overall Study|Lost to Follow-up|17|||
125483649|NCT03952338|451405796|FG000|Overall Study|Withdrawal by Subject|1|||
125483650|NCT03952338|451405797|FG001|Overall Study|Withdrawal by Subject|1|||
125483651|NCT03952338|451405796|FG000|Overall Study|Protocol Violation|1|||
125483652|NCT03952338|451405797|FG001|Overall Study|Protocol Violation|0|||
125483653|NCT04850898|451405798|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
125483654|NCT04850898|451405799|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
125483655|NCT05002088|451405800|FG000|Overall Study|Withdrawal by Subject|9|||
125483656|NCT05002088|451405801|FG001|Overall Study|Withdrawal by Subject|0|||
125483657|NCT05002088|451405800|FG000|Overall Study|Lost to Follow-up|0|||
125483658|NCT05002088|451405801|FG001|Overall Study|Lost to Follow-up|1|||
125483659|NCT05002088|451405800|FG000|Overall Study|Death|16|||
125483660|NCT05002088|451405801|FG001|Overall Study|Death|2|||
125483661|NCT05002088|451405800|FG000|Overall Study|Protocol Violation|25|||
125483662|NCT05002088|451405801|FG001|Overall Study|Protocol Violation|7|||
125483663|NCT04068181|451405802|FG000|Overall Study|Death|17|||
125483664|NCT04068181|451405803|FG001|Overall Study|Death|12|||
125483665|NCT04068181|451405804|FG002|Overall Study|Death|4|||
125483666|NCT04068181|451405805|FG003|Overall Study|Death|7|||
125483667|NCT04068181|451405802|FG000|Overall Study|Lost to Follow-up|1|||
125483668|NCT04068181|451405803|FG001|Overall Study|Lost to Follow-up|0|||
125483669|NCT04068181|451405804|FG002|Overall Study|Lost to Follow-up|0|||
125483670|NCT04068181|451405805|FG003|Overall Study|Lost to Follow-up|0|||
125483671|NCT04068181|451405802|FG000|Overall Study|Withdrawal of consent from study|3|||
125483672|NCT04068181|451405803|FG001|Overall Study|Withdrawal of consent from study|0|||
125483673|NCT04068181|451405804|FG002|Overall Study|Withdrawal of consent from study|0|||
125483674|NCT04068181|451405805|FG003|Overall Study|Withdrawal of consent from study|0|||
125483675|NCT05070728|451405806|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
125483676|NCT05070728|451405807|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
125483677|NCT04770402|451405814|FG000|Overall Study|Lost to Follow-up|1|||
125483678|NCT04770402|451405815|FG001|Overall Study|Lost to Follow-up|2|||
125483679|NCT04770402|451405814|FG000|Overall Study|Non-compliance|1|||
125483680|NCT04770402|451405815|FG001|Overall Study|Non-compliance|0|||
125483681|NCT04770402|451405814|FG000|Overall Study|Withdrawal by Subject|0|||
125483682|NCT04770402|451405815|FG001|Overall Study|Withdrawal by Subject|1|||
125483683|NCT04550221|451405817|FG000|Overall Study|Lost to Follow-up|0|||
125483684|NCT04550221|451405818|FG001|Overall Study|Lost to Follow-up|4|||
125483685|NCT04550221|451405817|FG000|Overall Study|Withdrawn|3|||
125483686|NCT04550221|451405818|FG001|Overall Study|Withdrawn|0|||
125483687|NCT04550221|451405817|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
125483688|NCT04550221|451405818|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
125483689|NCT04811040|451405819|FG000|Overall Study|Lost to Follow-up|2|||
125483690|NCT04811040|451405820|FG001|Overall Study|Lost to Follow-up|0|||
125483691|NCT04811040|451405821|FG002|Overall Study|Lost to Follow-up|0|||
125483692|NCT04811040|451405822|FG003|Overall Study|Lost to Follow-up|0|||
125483693|NCT04811040|451405819|FG000|Overall Study|Withdrew consent|1|||
125483694|NCT04811040|451405820|FG001|Overall Study|Withdrew consent|1|||
125483695|NCT04811040|451405821|FG002|Overall Study|Withdrew consent|0|||
125483696|NCT04811040|451405822|FG003|Overall Study|Withdrew consent|0|||
125483697|NCT05274074|451405823|FG000|Overall Study|Lost to Follow-up|2|||
125483698|NCT05274074|451405824|FG001|Overall Study|Lost to Follow-up|3|||
125483699|NCT05274074|451405823|FG000|Overall Study|Withdrawal by Subject|1|||
125483700|NCT05274074|451405824|FG001|Overall Study|Withdrawal by Subject|2|||
125483703|NCT01828099|451405826|FG000|Treatment Period|Adverse Event|24|||
125483704|NCT01828099|451405827|FG001|Treatment Period|Adverse Event|23|||
125483705|NCT01828099|451405826|FG000|Treatment Period|Death|10|||
125420700|NCT00447057|451166105|FG000|Overall Study|Death due to study disease|6|||
125420701|NCT00447057|451166106|FG001|Overall Study|Death due to study disease|4|||
125420702|NCT00447057|451166107|FG002|Overall Study|Death due to study disease|1|||
125420703|NCT00447057|451166108|FG003|Overall Study|Death due to study disease|1|||
125420704|NCT00447057|451166105|FG000|Overall Study|Lost to Follow-up|0|||
125420705|NCT00447057|451166106|FG001|Overall Study|Lost to Follow-up|1|||
125420706|NCT00447057|451166107|FG002|Overall Study|Lost to Follow-up|0|||
125420707|NCT00447057|451166108|FG003|Overall Study|Lost to Follow-up|0|||
125420708|NCT00447057|451166105|FG000|Overall Study|Entry criteria not met|1|||
125420709|NCT00447057|451166106|FG001|Overall Study|Entry criteria not met|1|||
125420710|NCT00447057|451166107|FG002|Overall Study|Entry criteria not met|0|||
125420711|NCT00447057|451166108|FG003|Overall Study|Entry criteria not met|0|||
125420712|NCT00447057|451166105|FG000|Overall Study|Protocol Violation|0|||
125420713|NCT00447057|451166106|FG001|Overall Study|Protocol Violation|1|||
125420714|NCT00447057|451166107|FG002|Overall Study|Protocol Violation|0|||
125420715|NCT00447057|451166108|FG003|Overall Study|Protocol Violation|0|||
125420716|NCT00447057|451166105|FG000|Overall Study|Withdrawal by Subject|4|||
125420717|NCT00447057|451166106|FG001|Overall Study|Withdrawal by Subject|5|||
125420718|NCT00447057|451166107|FG002|Overall Study|Withdrawal by Subject|1|||
125420719|NCT00447057|451166108|FG003|Overall Study|Withdrawal by Subject|1|||
125420720|NCT00447057|451166105|FG000|Overall Study|Physician Decision|9|||
125420721|NCT00447057|451166106|FG001|Overall Study|Physician Decision|6|||
125420722|NCT00447057|451166107|FG002|Overall Study|Physician Decision|3|||
125420723|NCT00447057|451166108|FG003|Overall Study|Physician Decision|1|||
125420724|NCT00447057|451166105|FG000|Overall Study|Sponsor decision|1|||
125420725|NCT00447057|451166106|FG001|Overall Study|Sponsor decision|1|||
125420726|NCT00447057|451166107|FG002|Overall Study|Sponsor decision|0|||
125420727|NCT00447057|451166108|FG003|Overall Study|Sponsor decision|0|||
125420728|NCT00447057|451166105|FG000|Overall Study|Progressive disease|58|||
125420729|NCT00447057|451166106|FG001|Overall Study|Progressive disease|43|||
125420730|NCT00447057|451166107|FG002|Overall Study|Progressive disease|13|||
125420731|NCT00447057|451166108|FG003|Overall Study|Progressive disease|18|||
125420732|NCT00447057|451166105|FG000|Overall Study|Death due to adverse event|0|||
125483706|NCT01828099|451405827|FG001|Treatment Period|Death|12|||
125483707|NCT01828099|451405826|FG000|Treatment Period|Lost to Follow-up|2|||
125420733|NCT00447057|451166106|FG001|Overall Study|Death due to adverse event|0|||
125420734|NCT00447057|451166107|FG002|Overall Study|Death due to adverse event|1|||
125420735|NCT00447057|451166108|FG003|Overall Study|Death due to adverse event|2|||
125420736|NCT00447057|451166105|FG000|Overall Study|Death, study drug related|0|||
125420737|NCT00447057|451166106|FG001|Overall Study|Death, study drug related|1|||
125420738|NCT00447057|451166107|FG002|Overall Study|Death, study drug related|0|||
125483708|NCT01828099|451405827|FG001|Treatment Period|Lost to Follow-up|1|||
125483709|NCT01828099|451405826|FG000|Treatment Period|Non-compliance with study treatment|1|||
125483710|NCT01828099|451405827|FG001|Treatment Period|Non-compliance with study treatment|0|||
125483711|NCT01828099|451405826|FG000|Treatment Period|Physician Decision|17|||
125483712|NCT01828099|451405827|FG001|Treatment Period|Physician Decision|16|||
125483713|NCT01828099|451405826|FG000|Treatment Period|Progressive disease|99|||
125483714|NCT01828099|451405827|FG001|Treatment Period|Progressive disease|107|||
125483715|NCT01828099|451405826|FG000|Treatment Period|Subject/guardian decision|22|||
125483716|NCT01828099|451405827|FG001|Treatment Period|Subject/guardian decision|26|||
125483717|NCT01828099|451405826|FG000|Treatment Period|Study terminated by Sponsor|13|||
125483718|NCT01828099|451405827|FG001|Treatment Period|Study terminated by Sponsor|1|||
125483719|NCT01828099|451405826|FG000|Treatment Period|Protocol deviation|1|||
125483720|NCT01828099|451405827|FG001|Treatment Period|Protocol deviation|0|||
125483721|NCT01828099|451405826|FG000|Treatment Period|No longer requires treatment|0|||
125483722|NCT01828099|451405827|FG001|Treatment Period|No longer requires treatment|1|||
125483723|NCT01828099|451405826|FG000|Extension-treatment Phase|Adverse Event|0|||
125483724|NCT01828099|451405827|FG001|Extension-treatment Phase|Adverse Event|17|||
125483725|NCT01828099|451405826|FG000|Extension-treatment Phase|Death|0|||
125483726|NCT01828099|451405827|FG001|Extension-treatment Phase|Death|11|||
125483727|NCT01828099|451405826|FG000|Extension-treatment Phase|Physician Decision|0|||
125483728|NCT01828099|451405827|FG001|Extension-treatment Phase|Physician Decision|5|||
125483729|NCT01828099|451405826|FG000|Extension-treatment Phase|Progressive disease|0|||
125483730|NCT01828099|451405827|FG001|Extension-treatment Phase|Progressive disease|54|||
125483731|NCT01828099|451405826|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
125483732|NCT01828099|451405827|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
125483733|NCT01828099|451405826|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
125483734|NCT01828099|451405827|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
125483735|NCT04568434|451405846|FG000|Overall Study|Voluntary Withdrawal|0|||
125483736|NCT04568434|451405847|FG001|Overall Study|Voluntary Withdrawal|1|||
125483737|NCT04568434|451405848|FG002|Overall Study|Voluntary Withdrawal|1|||
125483738|NCT04568434|451405846|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
125483739|NCT04568434|451405847|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
125483740|NCT04568434|451405848|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
125483741|NCT04568434|451405846|FG000|Overall Study|Investigator Judgement|1|||
125483742|NCT04568434|451405847|FG001|Overall Study|Investigator Judgement|0|||
125483743|NCT04568434|451405848|FG002|Overall Study|Investigator Judgement|0|||
125483744|NCT03905798|451405849|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
125483745|NCT05485779|451405850|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
125483746|NCT05485779|451405851|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
125483747|NCT05485779|451405852|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
125483748|NCT05485779|451405853|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
125483749|NCT05485779|451405854|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
125483750|NCT05485779|451405855|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
125483751|NCT05485779|451405856|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
125483752|NCT05485779|451405857|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
125483753|NCT05485779|451405858|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
125483754|NCT05485779|451405859|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
125483755|NCT05485779|451405860|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
125483756|NCT05485779|451405850|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
125483757|NCT05485779|451405851|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
125483758|NCT05485779|451405852|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
125483759|NCT05485779|451405853|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
125483760|NCT05485779|451405854|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
125483761|NCT05485779|451405855|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
125483762|NCT05485779|451405856|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
125483763|NCT05485779|451405857|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
125483764|NCT05485779|451405858|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
125483765|NCT05485779|451405859|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
125483766|NCT05485779|451405860|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
125483767|NCT05485779|451405850|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
125483768|NCT05485779|451405851|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
125483769|NCT05485779|451405852|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
125483770|NCT05485779|451405853|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
125483771|NCT05485779|451405854|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
125483772|NCT05485779|451405855|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
125483773|NCT05485779|451405856|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
125485433|NCT02240238|451412511|FG008|Phase 2|Disease progression|0|||
125483774|NCT05485779|451405857|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
125483775|NCT05485779|451405858|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
125483776|NCT05485779|451405859|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
125483777|NCT05485779|451405860|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
125483778|NCT04515849|451405863|FG000|Overall Study|Adverse Event|0|||
125483779|NCT04515849|451405864|FG001|Overall Study|Adverse Event|0|||
125483780|NCT04515849|451405865|FG002|Overall Study|Adverse Event|0|||
125483781|NCT04515849|451405866|FG003|Overall Study|Adverse Event|1|||
125483782|NCT04515849|451405867|FG004|Overall Study|Adverse Event|2|||
125483783|NCT04515849|451405863|FG000|Overall Study|Death|2|||
125483784|NCT04515849|451405864|FG001|Overall Study|Death|0|||
125483785|NCT04515849|451405865|FG002|Overall Study|Death|0|||
125483786|NCT04515849|451405866|FG003|Overall Study|Death|0|||
125483787|NCT04515849|451405867|FG004|Overall Study|Death|0|||
125483788|NCT04515849|451405863|FG000|Overall Study|Other:family emergency|0|||
125483789|NCT04515849|451405864|FG001|Overall Study|Other:family emergency|0|||
125483790|NCT04515849|451405865|FG002|Overall Study|Other:family emergency|0|||
125483791|NCT04515849|451405866|FG003|Overall Study|Other:family emergency|1|||
125483792|NCT04515849|451405867|FG004|Overall Study|Other:family emergency|0|||
125483793|NCT04515849|451405863|FG000|Overall Study|Other:randomised by error|0|||
125483794|NCT04515849|451405864|FG001|Overall Study|Other:randomised by error|1|||
125483795|NCT04515849|451405865|FG002|Overall Study|Other:randomised by error|0|||
125483796|NCT04515849|451405866|FG003|Overall Study|Other:randomised by error|0|||
125483797|NCT04515849|451405867|FG004|Overall Study|Other:randomised by error|0|||
125483798|NCT04515849|451405863|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
125483799|NCT04515849|451405864|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
125483800|NCT04515849|451405865|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
125483801|NCT04515849|451405866|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
125483802|NCT04515849|451405867|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
125483803|NCT04515849|451405863|FG000|Overall Study|Physician Decision|0|||
125483804|NCT04515849|451405864|FG001|Overall Study|Physician Decision|1|||
125483805|NCT04515849|451405865|FG002|Overall Study|Physician Decision|0|||
125483806|NCT04515849|451405866|FG003|Overall Study|Physician Decision|0|||
125483807|NCT04515849|451405867|FG004|Overall Study|Physician Decision|0|||
125483808|NCT04515849|451405863|FG000|Overall Study|Withdrawal by Subject|1|||
125483809|NCT04515849|451405864|FG001|Overall Study|Withdrawal by Subject|2|||
125483810|NCT04515849|451405865|FG002|Overall Study|Withdrawal by Subject|1|||
125483811|NCT04515849|451405866|FG003|Overall Study|Withdrawal by Subject|0|||
125483812|NCT04515849|451405867|FG004|Overall Study|Withdrawal by Subject|0|||
125483813|NCT05370040|451405868|FG000|Overall Study|Lost to Follow-up|0|||
125483814|NCT05370040|451405869|FG001|Overall Study|Lost to Follow-up|0|||
125483815|NCT05370040|451405870|FG002|Overall Study|Lost to Follow-up|1|||
125483816|NCT05370040|451405871|FG003|Overall Study|Lost to Follow-up|0|||
125483817|NCT05370040|451405872|FG004|Overall Study|Lost to Follow-up|1|||
125483818|NCT05370040|451405873|FG005|Overall Study|Lost to Follow-up|0|||
125483819|NCT05093842|451405879|FG000|Overall Study|Pregnancy loss|1|||
125483820|NCT05093842|451405880|FG001|Overall Study|Pregnancy loss|1|||
125483821|NCT05093842|451405879|FG000|Overall Study|Lost to Follow-up|6|||
125483822|NCT05093842|451405880|FG001|Overall Study|Lost to Follow-up|0|||
125483823|NCT05093842|451405879|FG000|Overall Study|Physician Decision|0|||
125483824|NCT05093842|451405880|FG001|Overall Study|Physician Decision|1|||
125483825|NCT03987022|451405882|FG000|Overall Study|Lost to Follow-up|2|||
125483826|NCT03987022|451405883|FG001|Overall Study|Lost to Follow-up|2|||
125483827|NCT03987022|451405882|FG000|Overall Study|Withdrawal by Subject|1|||
125483828|NCT03987022|451405883|FG001|Overall Study|Withdrawal by Subject|0|||
125483829|NCT02887521|451405886|FG000|Overall Study|Withdrawal by Subject|0|||
125483830|NCT02887521|451405887|FG001|Overall Study|Withdrawal by Subject|3|||
125303030|NCT02524158|450736659|FG000|6-month Assessment|Withdrawal by Subject|1|||
125303031|NCT02524158|450736660|FG001|6-month Assessment|Withdrawal by Subject|1|||
125483831|NCT03663569|451407199|FG000|Overall Study|Discontinuation of study|11|||
125303032|NCT02524158|450736659|FG000|6-month Assessment|Lost to Follow-up|21|||
125303033|NCT02524158|450736660|FG001|6-month Assessment|Lost to Follow-up|20|||
125303034|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
125303035|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
125303036|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
125483832|NCT03663569|451407199|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
125483833|NCT03663569|451407199|FG000|Overall Study|Deceased patient|6|||
125483834|NCT03663569|451407199|FG000|Overall Study|Lost to Follow-up|18|||
125483835|NCT03663569|451407199|FG000|Overall Study|Withdrawal of consent|5|||
125303037|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
125303038|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
125483836|NCT03663569|451407199|FG000|Overall Study|Patient's request|11|||
125483837|NCT03663569|451407199|FG000|Overall Study|Adverse Event|4|||
125483838|NCT03663569|451407199|FG000|Overall Study|Not come to second visit|3|||
125483839|NCT03663569|451407199|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
125483840|NCT03663569|451407199|FG000|Overall Study|Serious adverse event|1|||
125483841|NCT05877976|451407200|FG000|Overall Study|Lost to Follow-up|31|||
125483842|NCT04248725|451407201|FG000|Post-Treatment|Lost to Follow-up|6|||
125483843|NCT04248725|451407202|FG001|Post-Treatment|Lost to Follow-up|5|||
125483844|NCT04248725|451407201|FG000|6-Month Follow Up|Lost to Follow-up|9|||
125483845|NCT04248725|451407202|FG001|6-Month Follow Up|Lost to Follow-up|8|||
125483846|NCT05622812|451407203|FG000|Overall Study|Withdrawal by Subject|1|||
125483847|NCT05622812|451407204|FG001|Overall Study|Withdrawal by Subject|4|||
125483848|NCT05622812|451407203|FG000|Overall Study|Lost to Follow-up|2|||
125483849|NCT05622812|451407204|FG001|Overall Study|Lost to Follow-up|1|||
125483850|NCT02844465|451407205|FG000|Overall Study|Screen Failure|36|||
125483851|NCT02844465|451407205|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
125483852|NCT02844465|451407205|FG000|Overall Study|Withdrawal by Subject|5|||
125483853|NCT02844465|451407205|FG000|Overall Study|Lost to Follow-up|1|||
125483854|NCT02844465|451407205|FG000|Overall Study|Retreatment|1|||
125483855|NCT03819153|451407207|FG000|Overall Study|Withdrawal by Subject|20|||
125483856|NCT03819153|451407208|FG001|Overall Study|Withdrawal by Subject|28|||
125483857|NCT03819153|451407207|FG000|Overall Study|Lost to Follow-up|23|||
125483858|NCT03819153|451407208|FG001|Overall Study|Lost to Follow-up|30|||
125483859|NCT03240016|451407210|FG000|Overall Study|Adverse Event|9|||
125483860|NCT03240016|451407210|FG000|Overall Study|Withdrawal by Subject|7|||
125483861|NCT03240016|451407210|FG000|Overall Study|Death|1|||
125483862|NCT03240016|451407210|FG000|Overall Study|Physician Decision|2|||
125483863|NCT05452460|451407218|FG000|Overall Study|Lost to Follow-up|3|||
125483864|NCT05452460|451407219|FG001|Overall Study|Lost to Follow-up|3|||
125483865|NCT05452460|451407218|FG000|Overall Study|Did not receive intervention|1|||
125483866|NCT05452460|451407219|FG001|Overall Study|Did not receive intervention|0|||
125483867|NCT04362254|451407224|FG000|Overall Study|Adverse Event|1|||
125483868|NCT04362254|451407224|FG000|Overall Study|Protocol Violation|1|||
125483869|NCT04362254|451407224|FG000|Overall Study|Due to early termination of the trial|10|||
125483870|NCT05469464|451407227|FG000|Overall Study|Withdrawal by Subject|8|||
125483871|NCT05469464|451407228|FG001|Overall Study|Withdrawal by Subject|7|||
125483872|NCT05469464|451407229|FG002|Overall Study|Withdrawal by Subject|4|||
125483873|NCT05469464|451407230|FG003|Overall Study|Withdrawal by Subject|5|||
125483874|NCT05469464|451407227|FG000|Overall Study|Adverse Event|8|||
125483875|NCT05469464|451407228|FG001|Overall Study|Adverse Event|14|||
125483876|NCT05469464|451407229|FG002|Overall Study|Adverse Event|13|||
125483877|NCT05469464|451407230|FG003|Overall Study|Adverse Event|2|||
125483878|NCT05469464|451407227|FG000|Overall Study|Lost to Follow-up|2|||
125483879|NCT05469464|451407228|FG001|Overall Study|Lost to Follow-up|5|||
125483880|NCT05469464|451407229|FG002|Overall Study|Lost to Follow-up|3|||
125483881|NCT05469464|451407230|FG003|Overall Study|Lost to Follow-up|3|||
125483882|NCT05469464|451407227|FG000|Overall Study|Lack of Efficacy|4|||
125483883|NCT05469464|451407228|FG001|Overall Study|Lack of Efficacy|1|||
125483884|NCT05469464|451407229|FG002|Overall Study|Lack of Efficacy|2|||
125483885|NCT05469464|451407230|FG003|Overall Study|Lack of Efficacy|2|||
125483886|NCT05469464|451407227|FG000|Overall Study|Physician Decision|0|||
125483887|NCT05469464|451407228|FG001|Overall Study|Physician Decision|0|||
125483888|NCT05469464|451407229|FG002|Overall Study|Physician Decision|0|||
125483889|NCT05469464|451407230|FG003|Overall Study|Physician Decision|1|||
125483890|NCT01208662|451407231|FG000|Induction and Consolidation|Disease Progression|23|||
125483891|NCT01208662|451407232|FG001|Induction and Consolidation|Disease Progression|13|||
125483892|NCT01208662|451407233|FG002|Induction and Consolidation|Disease Progression|0|||
125483893|NCT01208662|451407231|FG000|Induction and Consolidation|Adverse Event|16|||
125483894|NCT01208662|451407232|FG001|Induction and Consolidation|Adverse Event|18|||
125483895|NCT01208662|451407233|FG002|Induction and Consolidation|Adverse Event|2|||
125483896|NCT01208662|451407231|FG000|Induction and Consolidation|MD or Participant Decision|16|||
125483897|NCT01208662|451407232|FG001|Induction and Consolidation|MD or Participant Decision|34|||
125483898|NCT01208662|451407233|FG002|Induction and Consolidation|MD or Participant Decision|4|||
125483899|NCT01208662|451407231|FG000|Induction and Consolidation|Death|1|||
125483900|NCT01208662|451407232|FG001|Induction and Consolidation|Death|3|||
125483901|NCT01208662|451407233|FG002|Induction and Consolidation|Death|1|||
125483902|NCT01208662|451407231|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
125483903|NCT01208662|451407232|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
125483904|NCT01208662|451407233|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
125483905|NCT01208662|451407231|FG000|Maintenance|Disease Progression|156|||
125483906|NCT01208662|451407232|FG001|Maintenance|Disease Progression|102|||
125483907|NCT01208662|451407233|FG002|Maintenance|Disease Progression|0|||
125483908|NCT01208662|451407231|FG000|Maintenance|Adverse Event|12|||
125483909|NCT01208662|451407232|FG001|Maintenance|Adverse Event|28|||
125483910|NCT01208662|451407233|FG002|Maintenance|Adverse Event|0|||
125483911|NCT01208662|451407231|FG000|Maintenance|MD or Participant Decision|24|||
125483912|NCT01208662|451407232|FG001|Maintenance|MD or Participant Decision|36|||
125483913|NCT01208662|451407233|FG002|Maintenance|MD or Participant Decision|0|||
125483914|NCT01208662|451407231|FG000|Maintenance|Death|0|||
125483915|NCT01208662|451407232|FG001|Maintenance|Death|3|||
125483916|NCT01208662|451407233|FG002|Maintenance|Death|0|||
125483917|NCT01208662|451407231|FG000|Maintenance|Discontinued for other reasons|21|||
125483918|NCT01208662|451407232|FG001|Maintenance|Discontinued for other reasons|31|||
125483919|NCT01208662|451407233|FG002|Maintenance|Discontinued for other reasons|0|||
125483920|NCT01208662|451407231|FG000|Maintenance|Still on Treatment|78|||
125483921|NCT01208662|451407232|FG001|Maintenance|Still on Treatment|89|||
125483922|NCT01208662|451407233|FG002|Maintenance|Still on Treatment|0|||
125483923|NCT00321048|451407234|FG000|Overall Study|Withdrawal by Subject|6|||
125483924|NCT00321048|451407235|FG001|Overall Study|Withdrawal by Subject|8|||
125483925|NCT04707625|451407236|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
125483926|NCT06473662|451407237|FG000|Overall Study|Withdrawal by Subject|1|||
125483927|NCT06473662|451407238|FG001|Overall Study|Withdrawal by Subject|6|||
125483928|NCT06473662|451407239|FG002|Overall Study|Withdrawal by Subject|5|||
125483929|NCT06473662|451407237|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
125483930|NCT06473662|451407238|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
125483931|NCT06473662|451407239|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
125483932|NCT06473662|451407237|FG000|Overall Study|Starting HbA1c below 7%|0|||
125483933|NCT06473662|451407238|FG001|Overall Study|Starting HbA1c below 7%|1|||
125483934|NCT06473662|451407239|FG002|Overall Study|Starting HbA1c below 7%|1|||
125483935|NCT06473662|451407237|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
125483936|NCT06473662|451407238|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
125483937|NCT06473662|451407239|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
125483938|NCT06473662|451407237|FG000|Overall Study|Did not take medication|2|||
125483939|NCT06473662|451407238|FG001|Overall Study|Did not take medication|3|||
125483940|NCT06473662|451407239|FG002|Overall Study|Did not take medication|2|||
125483941|NCT03463044|451407240|FG000|Overall Study|Lost to Follow-up|0|||
125483942|NCT03463044|451407241|FG001|Overall Study|Lost to Follow-up|0|||
125483943|NCT03463044|451407242|FG002|Overall Study|Lost to Follow-up|0|||
125483944|NCT03463044|451407243|FG003|Overall Study|Lost to Follow-up|0|||
125483945|NCT03463044|451407244|FG004|Overall Study|Lost to Follow-up|0|||
125483946|NCT03463044|451407245|FG005|Overall Study|Lost to Follow-up|0|||
125483947|NCT03463044|451407246|FG006|Overall Study|Lost to Follow-up|0|||
125483948|NCT03463044|451407247|FG007|Overall Study|Lost to Follow-up|1|||
125483949|NCT03463044|451407248|FG008|Overall Study|Lost to Follow-up|0|||
125483950|NCT05764525|451407249|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
125483951|NCT05764525|451407250|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
125483952|NCT05764525|451407249|FG000|Overall Study|Withdrawal by Subject|4|||
125483953|NCT05764525|451407250|FG001|Overall Study|Withdrawal by Subject|8|||
125483954|NCT05764525|451407249|FG000|Overall Study|Physician Decision|1|||
125483955|NCT05764525|451407250|FG001|Overall Study|Physician Decision|0|||
125483956|NCT03334630|451407251|FG000|Overall Study|Withdrawal by Subject|7|||
125483957|NCT03334630|451407252|FG001|Overall Study|Withdrawal by Subject|7|||
125483958|NCT03334630|451407251|FG000|Overall Study|Lost to Follow-up|3|||
125483959|NCT03334630|451407252|FG001|Overall Study|Lost to Follow-up|1|||
125483960|NCT03334630|451407251|FG000|Overall Study|Adverse Event|0|||
125483961|NCT03334630|451407252|FG001|Overall Study|Adverse Event|1|||
125483962|NCT03334630|451407251|FG000|Overall Study|Physician Decision|1|||
125483963|NCT03334630|451407252|FG001|Overall Study|Physician Decision|1|||
125483964|NCT03334630|451407251|FG000|Overall Study|Enrollment closed|2|||
125483965|NCT03334630|451407252|FG001|Overall Study|Enrollment closed|1|||
125483966|NCT03334630|451407251|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
125483967|NCT03334630|451407252|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
125483968|NCT03334630|451407251|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
125483969|NCT03334630|451407252|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
125483970|NCT03030261|451407257|FG000|Overall Study|Still receiving continuation therapy|5|||
125483971|NCT03910478|451407261|FG000|Overall Study|Death|13|||
125483972|NCT03910478|451407262|FG001|Overall Study|Death|6|||
125483973|NCT03910478|451407261|FG000|Overall Study|Withdrawal by Subject|23|||
125483974|NCT03910478|451407262|FG001|Overall Study|Withdrawal by Subject|2|||
125483975|NCT03910478|451407261|FG000|Overall Study|Physician Decision|5|||
125483976|NCT03910478|451407262|FG001|Overall Study|Physician Decision|0|||
125483977|NCT03910478|451407261|FG000|Overall Study|Protocol Violation|1|||
125483978|NCT03910478|451407262|FG001|Overall Study|Protocol Violation|0|||
125483979|NCT03910478|451407261|FG000|Overall Study|Failure to meet continuation criteria|2|||
125483980|NCT03910478|451407262|FG001|Overall Study|Failure to meet continuation criteria|0|||
125483981|NCT03910478|451407261|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
125483982|NCT03910478|451407262|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
125483983|NCT05293171|451407263|FG000|Washout 5 to 7 Days|Adverse Event|1|||
125483984|NCT05293171|451407264|FG001|Washout 5 to 7 Days|Adverse Event|1|||
125483985|NCT05293171|451407265|FG002|Washout 5 to 7 Days|Adverse Event|0|||
125483986|NCT05293171|451407266|FG003|Washout 5 to 7 Days|Adverse Event|0|||
125483987|NCT05293171|451407267|FG004|Washout 5 to 7 Days|Adverse Event|0|||
125483988|NCT05293171|451407268|FG005|Washout 5 to 7 Days|Adverse Event|0|||
125483989|NCT05293171|451407269|FG006|Washout 5 to 7 Days|Adverse Event|0|||
125483990|NCT05293171|451407270|FG007|Washout 5 to 7 Days|Adverse Event|0|||
125483991|NCT05293171|451407271|FG008|Washout 5 to 7 Days|Adverse Event|0|||
125483992|NCT05293171|451407272|FG009|Washout 5 to 7 Days|Adverse Event|0|||
125483993|NCT05293171|451407273|FG010|Washout 5 to 7 Days|Adverse Event|0|||
125483994|NCT05293171|451407274|FG011|Washout 5 to 7 Days|Adverse Event|0|||
125483995|NCT05293171|451407263|FG000|Washout 5 to 7 Days|Adverse Event|0|||
125483996|NCT05293171|451407264|FG001|Washout 5 to 7 Days|Adverse Event|0|||
125483997|NCT05293171|451407265|FG002|Washout 5 to 7 Days|Adverse Event|0|||
125483998|NCT05293171|451407266|FG003|Washout 5 to 7 Days|Adverse Event|0|||
125483999|NCT05293171|451407267|FG004|Washout 5 to 7 Days|Adverse Event|0|||
125484000|NCT05293171|451407268|FG005|Washout 5 to 7 Days|Adverse Event|1|||
125484001|NCT05293171|451407269|FG006|Washout 5 to 7 Days|Adverse Event|0|||
125484002|NCT05293171|451407270|FG007|Washout 5 to 7 Days|Adverse Event|0|||
125484003|NCT05293171|451407271|FG008|Washout 5 to 7 Days|Adverse Event|0|||
125484004|NCT05293171|451407272|FG009|Washout 5 to 7 Days|Adverse Event|0|||
125484005|NCT05293171|451407273|FG010|Washout 5 to 7 Days|Adverse Event|0|||
125484006|NCT05293171|451407274|FG011|Washout 5 to 7 Days|Adverse Event|0|||
125484007|NCT04066205|451407277|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
125484008|NCT04066205|451407278|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
125484009|NCT04066205|451407277|FG000|T2 Immediate Post-Intervention|did not respond|5|||
125484010|NCT04066205|451407278|FG001|T2 Immediate Post-Intervention|did not respond|3|||
125484011|NCT01712490|451407281|FG000|Overall Study|Ongoing|601|||
125484012|NCT01712490|451407282|FG001|Overall Study|Ongoing|586|||
125484013|NCT01712490|451407281|FG000|Overall Study|Other|11|||
125484014|NCT01712490|451407282|FG001|Overall Study|Other|11|||
125484015|NCT01712490|451407281|FG000|Overall Study|Withdrawal by Subject|36|||
125484016|NCT01712490|451407282|FG001|Overall Study|Withdrawal by Subject|44|||
125484017|NCT01712490|451407281|FG000|Overall Study|Lost to Follow-up|16|||
125484018|NCT01712490|451407282|FG001|Overall Study|Lost to Follow-up|29|||
125484019|NCT03478956|451407283|FG000|Randomized Treatment Period|Adverse Event|1|||
125484020|NCT03478956|451407284|FG001|Randomized Treatment Period|Adverse Event|0|||
125484021|NCT03478956|451407285|FG002|Randomized Treatment Period|Adverse Event|0|||
125484022|NCT03478956|451407286|FG003|Randomized Treatment Period|Adverse Event|0|||
125484023|NCT03478956|451407283|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
125484024|NCT03478956|451407284|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
125484025|NCT03478956|451407285|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
125484026|NCT03478956|451407286|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
125484027|NCT03478956|451407283|FG000|Open Label Extension Period|Adverse Event|0|||
125484028|NCT03478956|451407284|FG001|Open Label Extension Period|Adverse Event|0|||
125484029|NCT03478956|451407285|FG002|Open Label Extension Period|Adverse Event|4|||
125484030|NCT03478956|451407286|FG003|Open Label Extension Period|Adverse Event|0|||
125484031|NCT03478956|451407283|FG000|Open Label Extension Period|Lack of Efficacy|0|||
125484032|NCT03478956|451407284|FG001|Open Label Extension Period|Lack of Efficacy|0|||
125484033|NCT03478956|451407285|FG002|Open Label Extension Period|Lack of Efficacy|8|||
125484034|NCT03478956|451407286|FG003|Open Label Extension Period|Lack of Efficacy|0|||
125484035|NCT03478956|451407283|FG000|Open Label Extension Period|Reason Not Provided|0|||
125484036|NCT03478956|451407284|FG001|Open Label Extension Period|Reason Not Provided|0|||
125484037|NCT03478956|451407285|FG002|Open Label Extension Period|Reason Not Provided|1|||
125484038|NCT03478956|451407286|FG003|Open Label Extension Period|Reason Not Provided|0|||
125484039|NCT03478956|451407283|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
125484040|NCT03478956|451407284|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
125484041|NCT03478956|451407285|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
125484042|NCT03478956|451407286|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
125484043|NCT03478956|451407283|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
125484044|NCT03478956|451407284|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
125484045|NCT03478956|451407285|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
125484046|NCT03478956|451407286|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
125484047|NCT03478956|451407283|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
125484048|NCT03478956|451407284|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
125484049|NCT03478956|451407285|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
125484050|NCT03478956|451407286|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
125484051|NCT04800211|451407287|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
125484052|NCT04800211|451407288|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
125484053|NCT04800211|451407289|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
125484054|NCT04800211|451407287|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
125484055|NCT04800211|451407288|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
125484056|NCT04800211|451407289|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
125484057|NCT04800211|451407287|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
125484058|NCT04800211|451407288|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
125484059|NCT04800211|451407289|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
125484060|NCT04800211|451407287|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
125484061|NCT04800211|451407288|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
125484062|NCT04800211|451407289|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
125484063|NCT04800211|451407287|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
125484064|NCT04800211|451407288|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
125484065|NCT04800211|451407289|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
125484066|NCT04800211|451407287|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
125484067|NCT04800211|451407288|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
125484068|NCT04800211|451407289|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
125484069|NCT04800211|451407287|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
125484070|NCT04800211|451407288|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
125484071|NCT04800211|451407289|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
125484072|NCT04800211|451407287|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
125484073|NCT04800211|451407288|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
125484074|NCT04800211|451407289|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
125484075|NCT04800211|451407287|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
125484076|NCT04800211|451407288|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
125484077|NCT04800211|451407289|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
125484078|NCT04800211|451407287|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
125484079|NCT04800211|451407288|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
125484080|NCT04800211|451407289|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
125484081|NCT04800211|451407287|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
125484082|NCT04800211|451407288|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
125484083|NCT04800211|451407289|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
125484084|NCT05170841|451407290|FG000|Single Dose Phase|Adverse Event|1|||
125484085|NCT05170841|451407291|FG001|Single Dose Phase|Adverse Event|2|||
125484086|NCT05170841|451407292|FG002|Single Dose Phase|Adverse Event|0|||
125484087|NCT05170841|451407293|FG003|Single Dose Phase|Adverse Event|2|||
125484088|NCT05170841|451407290|FG000|Multiple Dose Phase|Adverse Event|1|||
125484089|NCT05170841|451407291|FG001|Multiple Dose Phase|Adverse Event|2|||
125484090|NCT05170841|451407292|FG002|Multiple Dose Phase|Adverse Event|1|||
125484091|NCT05170841|451407293|FG003|Multiple Dose Phase|Adverse Event|4|||
125484092|NCT05170841|451407290|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
125484093|NCT05170841|451407291|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
125484094|NCT05170841|451407292|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
125484095|NCT05170841|451407293|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
125484096|NCT05123586|451407296|FG000|Overall Study|Physician Decision|1|||
125484097|NCT05123586|451407297|FG001|Overall Study|Physician Decision|1|||
125484098|NCT05123586|451407296|FG000|Overall Study|Withdrawal by Subject|0|||
125484099|NCT05123586|451407297|FG001|Overall Study|Withdrawal by Subject|3|||
125484100|NCT04865289|451407298|FG000|Overall Study|Participant ongoing in study|47|||
125484101|NCT04865289|451407299|FG001|Overall Study|Participant ongoing in study|35|||
125484102|NCT04865289|451407298|FG000|Overall Study|Death|27|||
125484103|NCT04865289|451407299|FG001|Overall Study|Death|21|||
125484104|NCT02733159|451407300|FG000|Overall Study|Adverse Event|1|||
125484105|NCT02733159|451407300|FG000|Overall Study|Lack of disease progression|1|||
125484106|NCT06122194|451407301|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
125484107|NCT06122194|451407302|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
125484108|NCT06122194|451407303|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
125484109|NCT06122194|451407304|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
125484110|NCT02724969|451407311|FG000|Overall Study|Lost to Follow-up|12|||
125484111|NCT02724969|451407312|FG001|Overall Study|Lost to Follow-up|6|||
125484112|NCT02724969|451407311|FG000|Overall Study|Withdrawal by Subject|3|||
125484113|NCT02724969|451407312|FG001|Overall Study|Withdrawal by Subject|3|||
125484114|NCT02724969|451407311|FG000|Overall Study|Infant demise|0|||
125484115|NCT02724969|451407312|FG001|Overall Study|Infant demise|2|||
125484116|NCT03571581|451407313|FG000|Overall Study|Death|2|||
125484117|NCT03571581|451407313|FG000|Overall Study|Withdrawal by Subject|2|||
125484118|NCT01309672|451407314|FG000|Overall Study|Lack of Efficacy|20|||
125484119|NCT01309672|451407314|FG000|Overall Study|Other|9|||
125484120|NCT01309672|451407314|FG000|Overall Study|Adverse Event|5|||
125484121|NCT01309672|451407314|FG000|Overall Study|Withdrawal by Subject|3|||
125484122|NCT03626220|451407316|FG000|Overall Study|Withdrawal by Subject|2|||
125484123|NCT03626220|451407317|FG001|Overall Study|Withdrawal by Subject|0|||
125484124|NCT03916185|451408772|FG000|Overall Study|Lost to Follow-up|0|||
125484125|NCT03916185|451408773|FG001|Overall Study|Lost to Follow-up|1|||
125484126|NCT03916185|451408774|FG002|Overall Study|Lost to Follow-up|0|||
125484127|NCT03916185|451408775|FG003|Overall Study|Lost to Follow-up|0|||
125484128|NCT03916185|451408772|FG000|Overall Study|Moved|1|||
125484129|NCT03916185|451408773|FG001|Overall Study|Moved|0|||
125484130|NCT03916185|451408774|FG002|Overall Study|Moved|0|||
125484131|NCT03916185|451408775|FG003|Overall Study|Moved|1|||
125484132|NCT03916185|451408772|FG000|Overall Study|Not Able to Get to Clinic|1|||
125484133|NCT03916185|451408773|FG001|Overall Study|Not Able to Get to Clinic|0|||
125484134|NCT03916185|451408774|FG002|Overall Study|Not Able to Get to Clinic|0|||
125484135|NCT03916185|451408775|FG003|Overall Study|Not Able to Get to Clinic|0|||
125484136|NCT02593773|451408789|FG000|Overall Study|Voluntary Withdrawal|3|||
125484137|NCT02593773|451408789|FG000|Overall Study|Study Terminated by Sponsor|31|||
125484138|NCT02593773|451408789|FG000|Overall Study|Death|1|||
125484139|NCT04471246|451408797|FG000|Overall Study|Lost to Follow-up|2|||
125484140|NCT04471246|451408798|FG001|Overall Study|Lost to Follow-up|2|||
125484141|NCT03386578|451408800|FG000|PK Component|Lost to Follow-up|0|||
125484142|NCT03386578|451408801|FG001|PK Component|Lost to Follow-up|1|||
125484143|NCT03386578|451408802|FG002|PK Component|Lost to Follow-up|0|||
125484144|NCT03386578|451408803|FG003|PK Component|Lost to Follow-up|0|||
125484145|NCT03386578|451408804|FG004|PK Component|Lost to Follow-up|0|||
125484146|NCT03386578|451408805|FG005|PK Component|Lost to Follow-up|0|||
125484147|NCT03386578|451408806|FG006|PK Component|Lost to Follow-up|1|||
125484148|NCT03386578|451408807|FG007|PK Component|Lost to Follow-up|0|||
125484149|NCT03386578|451408808|FG008|PK Component|Lost to Follow-up|0|||
125484150|NCT03386578|451408809|FG009|PK Component|Lost to Follow-up|0|||
125484151|NCT03386578|451408800|FG000|PK Component|Stillbirth/Abortion|0|||
125484152|NCT03386578|451408801|FG001|PK Component|Stillbirth/Abortion|0|||
125484153|NCT03386578|451408802|FG002|PK Component|Stillbirth/Abortion|0|||
125484154|NCT03386578|451408803|FG003|PK Component|Stillbirth/Abortion|0|||
125484155|NCT03386578|451408804|FG004|PK Component|Stillbirth/Abortion|0|||
125484156|NCT03386578|451408805|FG005|PK Component|Stillbirth/Abortion|2|||
125484157|NCT03386578|451408806|FG006|PK Component|Stillbirth/Abortion|0|||
125484158|NCT03386578|451408807|FG007|PK Component|Stillbirth/Abortion|0|||
125484159|NCT03386578|451408808|FG008|PK Component|Stillbirth/Abortion|0|||
125484160|NCT03386578|451408809|FG009|PK Component|Stillbirth/Abortion|0|||
125484161|NCT03386578|451408800|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
125484162|NCT03386578|451408801|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
125484163|NCT03386578|451408802|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
125484164|NCT03386578|451408803|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
125484165|NCT03386578|451408804|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
125484166|NCT03386578|451408805|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
125484167|NCT03386578|451408806|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
125484168|NCT03386578|451408807|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
125484169|NCT03386578|451408808|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
125484170|NCT03386578|451408809|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
125484171|NCT03386578|451408800|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
125484172|NCT03386578|451408801|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
125484173|NCT03386578|451408802|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
125484174|NCT03386578|451408803|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
125484175|NCT03386578|451408804|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
125484176|NCT03386578|451408805|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
125484177|NCT03386578|451408806|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
125484178|NCT03386578|451408807|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
125484179|NCT03386578|451408808|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
125484180|NCT03386578|451408809|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
125484181|NCT03386578|451408800|FG000|PrEP Comparison Component Step 1|Death|0|||
125484182|NCT03386578|451408801|FG001|PrEP Comparison Component Step 1|Death|0|||
125484183|NCT03386578|451408802|FG002|PrEP Comparison Component Step 1|Death|1|||
125484184|NCT03386578|451408803|FG003|PrEP Comparison Component Step 1|Death|0|||
125484185|NCT03386578|451408804|FG004|PrEP Comparison Component Step 1|Death|0|||
125484186|NCT03386578|451408805|FG005|PrEP Comparison Component Step 1|Death|0|||
125484187|NCT03386578|451408806|FG006|PrEP Comparison Component Step 1|Death|0|||
125484188|NCT03386578|451408807|FG007|PrEP Comparison Component Step 1|Death|9|||
125484189|NCT03386578|451408808|FG008|PrEP Comparison Component Step 1|Death|5|||
125484190|NCT03386578|451408809|FG009|PrEP Comparison Component Step 1|Death|0|||
125484191|NCT03386578|451408800|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
125484192|NCT03386578|451408801|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
125484193|NCT03386578|451408802|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
125484194|NCT03386578|451408803|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
125484195|NCT03386578|451408804|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
125484196|NCT03386578|451408805|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
125484197|NCT03386578|451408806|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
125484198|NCT03386578|451408807|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
125484199|NCT03386578|451408808|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
125303039|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
125484200|NCT03386578|451408809|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
125484201|NCT03386578|451408800|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
125484202|NCT03386578|451408801|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
125484203|NCT03386578|451408802|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
125303040|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
125484204|NCT03386578|451408803|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
125484205|NCT03386578|451408804|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
125484206|NCT03386578|451408805|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
125484207|NCT03386578|451408806|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
125484208|NCT03386578|451408807|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
125484209|NCT03386578|451408808|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
125484210|NCT03386578|451408809|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
125484211|NCT03386578|451408800|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
125484212|NCT03386578|451408801|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
125484213|NCT03386578|451408802|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
125484214|NCT03386578|451408803|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
125484215|NCT03386578|451408804|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
125484216|NCT03386578|451408805|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
125484217|NCT03386578|451408806|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
125484218|NCT03386578|451408807|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
125484219|NCT03386578|451408808|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
125484220|NCT03386578|451408809|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
125484221|NCT05907174|451408810|FG000|3-Month Assessment|Withdrawal by Subject|0|||
125484222|NCT05907174|451408811|FG001|3-Month Assessment|Withdrawal by Subject|0|||
125484223|NCT05907174|451408812|FG002|3-Month Assessment|Withdrawal by Subject|0|||
125484224|NCT05907174|451408813|FG003|3-Month Assessment|Withdrawal by Subject|1|||
125484225|NCT05907174|451408810|FG000|3-Month Assessment|Lost to Follow-up|1|||
125484226|NCT05907174|451408811|FG001|3-Month Assessment|Lost to Follow-up|1|||
125484227|NCT05907174|451408812|FG002|3-Month Assessment|Lost to Follow-up|1|||
125484228|NCT05907174|451408813|FG003|3-Month Assessment|Lost to Follow-up|1|||
125484229|NCT05907174|451408810|FG000|6-Month Assessment|Death|0|||
125484230|NCT05907174|451408811|FG001|6-Month Assessment|Death|0|||
125484231|NCT05907174|451408812|FG002|6-Month Assessment|Death|3|||
125484232|NCT05907174|451408813|FG003|6-Month Assessment|Death|0|||
125484233|NCT05907174|451408810|FG000|6-Month Assessment|Withdrawal by Subject|0|||
125484234|NCT05907174|451408811|FG001|6-Month Assessment|Withdrawal by Subject|0|||
125484235|NCT05907174|451408812|FG002|6-Month Assessment|Withdrawal by Subject|1|||
125484236|NCT05907174|451408813|FG003|6-Month Assessment|Withdrawal by Subject|1|||
125484237|NCT05907174|451408810|FG000|6-Month Assessment|Lost to Follow-up|0|||
125484238|NCT05907174|451408811|FG001|6-Month Assessment|Lost to Follow-up|1|||
125484239|NCT05907174|451408812|FG002|6-Month Assessment|Lost to Follow-up|1|||
125484240|NCT05907174|451408813|FG003|6-Month Assessment|Lost to Follow-up|1|||
125484241|NCT04766892|451408818|FG000|Overall Study|Withdrawal by Subject|1|||
125484242|NCT04766892|451408818|FG000|Overall Study|Lost to Follow-up|1|||
125484243|NCT04766892|451408818|FG000|Overall Study|Adverse Event|3|||
125484244|NCT04766892|451408818|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
125484245|NCT02668692|451408819|FG000|Overall Study|Adverse Event|1|||
125484246|NCT02668692|451408820|FG001|Overall Study|Adverse Event|0|||
125484247|NCT01627574|451408825|FG000|Overall Study|Withdrawal by Subject|8|||
125484248|NCT01627574|451408826|FG001|Overall Study|Withdrawal by Subject|5|||
125484249|NCT01627574|451408825|FG000|Overall Study|Lost to Follow-up|13|||
125484250|NCT01627574|451408826|FG001|Overall Study|Lost to Follow-up|13|||
125484251|NCT04730739|451408827|FG000|Overall Study|Death|1|||
125484252|NCT04677738|451408831|FG000|Overall Study|Withdrawal by Subject|4|||
125484253|NCT04677738|451408832|FG001|Overall Study|Withdrawal by Subject|2|||
125484254|NCT04707469|451408833|FG000|Overall Study|Site closure|0|||
125484255|NCT04707469|451408834|FG001|Overall Study|Site closure|2|||
125484256|NCT04707469|451408835|FG002|Overall Study|Site closure|0|||
125484257|NCT04707469|451408833|FG000|Overall Study|Physician Decision|2|||
125484258|NCT04707469|451408834|FG001|Overall Study|Physician Decision|2|||
125484259|NCT04707469|451408835|FG002|Overall Study|Physician Decision|2|||
125484260|NCT04707469|451408833|FG000|Overall Study|Death|1|||
125484261|NCT04707469|451408834|FG001|Overall Study|Death|6|||
125484262|NCT04707469|451408835|FG002|Overall Study|Death|2|||
125484263|NCT04707469|451408833|FG000|Overall Study|Lost to Follow-up|9|||
125484264|NCT04707469|451408834|FG001|Overall Study|Lost to Follow-up|19|||
125484265|NCT04707469|451408835|FG002|Overall Study|Lost to Follow-up|14|||
125303041|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
125303042|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
125303043|NCT03100058|450736670|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
125484266|NCT04707469|451408833|FG000|Overall Study|Withdrawal by Subject|17|||
125484267|NCT04707469|451408834|FG001|Overall Study|Withdrawal by Subject|16|||
125484268|NCT04707469|451408835|FG002|Overall Study|Withdrawal by Subject|12|||
125484269|NCT03734679|451408841|FG000|Overall Study|Missed Visit|1|||
125484270|NCT03249090|451408843|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
125484271|NCT03249090|451408844|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
125484272|NCT03249090|451408843|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
125485434|NCT02240238|451412512|FG009|Phase 2|Disease progression|5|||
125484273|NCT03249090|451408844|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
125484274|NCT03249090|451408843|FG000|3 Month Time Point|Voluntary withdrawal|6|||
125484275|NCT03249090|451408844|FG001|3 Month Time Point|Voluntary withdrawal|3|||
125484276|NCT03249090|451408843|FG000|3 Month Time Point|Changed oncology practice|4|||
125484277|NCT03249090|451408844|FG001|3 Month Time Point|Changed oncology practice|2|||
125484278|NCT03249090|451408843|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
125484279|NCT03249090|451408844|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
125484280|NCT03249090|451408843|FG000|12 Month Time Point|Voluntary withdrawal|35|||
125484281|NCT03249090|451408844|FG001|12 Month Time Point|Voluntary withdrawal|4|||
125484282|NCT03249090|451408843|FG000|12 Month Time Point|Changed oncology practice|20|||
125484283|NCT03249090|451408844|FG001|12 Month Time Point|Changed oncology practice|9|||
125484284|NCT03362476|451408854|FG000|Overall Study|Withdrawal by Subject|0|||
125484285|NCT03362476|451408855|FG001|Overall Study|Withdrawal by Subject|1|||
125484286|NCT05974501|451408856|FG000|Overall Study|Physician Decision|0|||
125484287|NCT05974501|451408857|FG001|Overall Study|Physician Decision|1|||
125484288|NCT04270942|451408858|FG000|Overall Study|Death|1|||
125484289|NCT04295512|451408870|FG000|Overall Study|Lack of family response to schedule assessment|0|||
125484290|NCT04295512|451408871|FG001|Overall Study|Lack of family response to schedule assessment|0|||
125484291|NCT04295512|451408872|FG002|Overall Study|Lack of family response to schedule assessment|0|||
125484292|NCT04295512|451408873|FG003|Overall Study|Lack of family response to schedule assessment|2|||
125484293|NCT04295512|451408870|FG000|Overall Study|Therapist did not refer eligible family|7|||
125484294|NCT04295512|451408871|FG001|Overall Study|Therapist did not refer eligible family|7|||
125484295|NCT04295512|451408872|FG002|Overall Study|Therapist did not refer eligible family|0|||
125484296|NCT04295512|451408873|FG003|Overall Study|Therapist did not refer eligible family|0|||
125484297|NCT05623228|451408879|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
125484298|NCT05623228|451408880|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
125484299|NCT05623228|451408881|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
125484300|NCT05623228|451408882|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
125484301|NCT05623228|451408883|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
125484302|NCT05623228|451408884|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
125484303|NCT05623228|451408885|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
125484304|NCT05623228|451408886|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
125484305|NCT05623228|451408879|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
125484306|NCT05623228|451408880|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
125484307|NCT05623228|451408881|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
125484308|NCT05623228|451408882|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
125484309|NCT05623228|451408883|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
125484310|NCT05623228|451408884|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
125484311|NCT05623228|451408885|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
125484312|NCT05623228|451408886|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
125484313|NCT04737330|451408888|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
125484314|NCT04737330|451408889|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
125484315|NCT04737330|451408888|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
125484316|NCT04737330|451408889|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
125484317|NCT04737330|451408888|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
125484318|NCT04737330|451408889|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
125484319|NCT04737330|451408888|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
125484320|NCT04737330|451408889|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
125484321|NCT04737330|451408888|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
125484322|NCT04737330|451408889|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
125484323|NCT04737330|451408888|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
125484324|NCT04737330|451408889|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
125484325|NCT04625725|451408890|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
125484326|NCT04625725|451408891|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
125484327|NCT04625725|451408892|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
125484328|NCT04625725|451408893|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
125484329|NCT04625725|451408894|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
125484330|NCT04625725|451408895|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
125484331|NCT04625725|451408890|FG000|Provent Main Study|Withdrawal by Subject|242|||
125484332|NCT04625725|451408891|FG001|Provent Main Study|Withdrawal by Subject|144|||
125484333|NCT04625725|451408892|FG002|Provent Main Study|Withdrawal by Subject|0|||
125484334|NCT04625725|451408893|FG003|Provent Main Study|Withdrawal by Subject|0|||
125484335|NCT04625725|451408894|FG004|Provent Main Study|Withdrawal by Subject|0|||
125484336|NCT04625725|451408895|FG005|Provent Main Study|Withdrawal by Subject|0|||
125484337|NCT04625725|451408890|FG000|Provent Main Study|Physician Decision|5|||
125484338|NCT04625725|451408891|FG001|Provent Main Study|Physician Decision|0|||
125484339|NCT04625725|451408892|FG002|Provent Main Study|Physician Decision|0|||
125484340|NCT04625725|451408893|FG003|Provent Main Study|Physician Decision|0|||
125484341|NCT04625725|451408894|FG004|Provent Main Study|Physician Decision|0|||
125484342|NCT04625725|451408895|FG005|Provent Main Study|Physician Decision|0|||
125484343|NCT04625725|451408890|FG000|Provent Main Study|Protocol Violation|1|||
125484344|NCT04625725|451408891|FG001|Provent Main Study|Protocol Violation|0|||
125484345|NCT04625725|451408892|FG002|Provent Main Study|Protocol Violation|0|||
125484346|NCT04625725|451408893|FG003|Provent Main Study|Protocol Violation|0|||
125484347|NCT04625725|451408894|FG004|Provent Main Study|Protocol Violation|0|||
125484348|NCT04625725|451408895|FG005|Provent Main Study|Protocol Violation|0|||
125484349|NCT04625725|451408890|FG000|Provent Main Study|Lost to Follow-up|357|||
125484350|NCT04625725|451408891|FG001|Provent Main Study|Lost to Follow-up|200|||
125484351|NCT04625725|451408892|FG002|Provent Main Study|Lost to Follow-up|0|||
125484352|NCT04625725|451408893|FG003|Provent Main Study|Lost to Follow-up|0|||
125484353|NCT04625725|451408894|FG004|Provent Main Study|Lost to Follow-up|0|||
125484354|NCT04625725|451408895|FG005|Provent Main Study|Lost to Follow-up|0|||
125484355|NCT04625725|451408890|FG000|Provent Main Study|Death|22|||
125484356|NCT04625725|451408891|FG001|Provent Main Study|Death|10|||
125484357|NCT04625725|451408892|FG002|Provent Main Study|Death|0|||
125484358|NCT04625725|451408893|FG003|Provent Main Study|Death|0|||
125484359|NCT04625725|451408894|FG004|Provent Main Study|Death|0|||
125484360|NCT04625725|451408895|FG005|Provent Main Study|Death|0|||
125484361|NCT04625725|451408890|FG000|Provent Main Study|Adverse Event|2|||
125484362|NCT04625725|451408891|FG001|Provent Main Study|Adverse Event|1|||
125484363|NCT04625725|451408892|FG002|Provent Main Study|Adverse Event|0|||
125484364|NCT04625725|451408893|FG003|Provent Main Study|Adverse Event|0|||
125484365|NCT04625725|451408894|FG004|Provent Main Study|Adverse Event|0|||
125484366|NCT04625725|451408895|FG005|Provent Main Study|Adverse Event|0|||
125484367|NCT04625725|451408890|FG000|Provent Main Study|Participants dosed in sub-study|310|||
125484368|NCT04625725|451408891|FG001|Provent Main Study|Participants dosed in sub-study|193|||
125484369|NCT04625725|451408892|FG002|Provent Main Study|Participants dosed in sub-study|0|||
125484370|NCT04625725|451408893|FG003|Provent Main Study|Participants dosed in sub-study|0|||
125484371|NCT04625725|451408894|FG004|Provent Main Study|Participants dosed in sub-study|0|||
125484372|NCT04625725|451408895|FG005|Provent Main Study|Participants dosed in sub-study|0|||
125484373|NCT04625725|451408890|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
125484374|NCT04625725|451408891|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
125484375|NCT04625725|451408892|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
125484376|NCT04625725|451408893|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
125484377|NCT04625725|451408894|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
125484378|NCT04625725|451408895|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
125484379|NCT04625725|451408890|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
125484380|NCT04625725|451408891|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
125484381|NCT04625725|451408892|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
125484382|NCT04625725|451408893|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
125484383|NCT04625725|451408894|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
125484384|NCT04625725|451408895|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
125484385|NCT04625725|451408890|FG000|Provent Main Study|INCARCERATION|3|||
125484386|NCT04625725|451408891|FG001|Provent Main Study|INCARCERATION|0|||
125484387|NCT04625725|451408892|FG002|Provent Main Study|INCARCERATION|0|||
125484388|NCT04625725|451408893|FG003|Provent Main Study|INCARCERATION|0|||
125484389|NCT04625725|451408894|FG004|Provent Main Study|INCARCERATION|0|||
125484390|NCT04625725|451408895|FG005|Provent Main Study|INCARCERATION|0|||
125484391|NCT04625725|451408890|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
125484392|NCT04625725|451408891|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
125484393|NCT04625725|451408892|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
125484394|NCT04625725|451408893|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
125484395|NCT04625725|451408894|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
125484396|NCT04625725|451408895|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
125484397|NCT04625725|451408890|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
125484398|NCT04625725|451408891|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
125484399|NCT04625725|451408892|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
125484400|NCT04625725|451408893|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
125484401|NCT04625725|451408894|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
125484402|NCT04625725|451408895|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
125484403|NCT04625725|451408890|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
125484404|NCT04625725|451408891|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
125484405|NCT04625725|451408892|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
125484406|NCT04625725|451408893|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
125484407|NCT04625725|451408894|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
125484408|NCT04625725|451408895|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
125484409|NCT04625725|451408890|FG000|Provent Main Study|MISSING REASON|0|||
125484410|NCT04625725|451408891|FG001|Provent Main Study|MISSING REASON|1|||
125484411|NCT04625725|451408892|FG002|Provent Main Study|MISSING REASON|0|||
125484412|NCT04625725|451408893|FG003|Provent Main Study|MISSING REASON|0|||
125484413|NCT04625725|451408894|FG004|Provent Main Study|MISSING REASON|0|||
125484414|NCT04625725|451408895|FG005|Provent Main Study|MISSING REASON|0|||
125484415|NCT04625725|451408890|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
125484416|NCT04625725|451408891|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
125484417|NCT04625725|451408892|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
125484418|NCT04625725|451408893|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
125484419|NCT04625725|451408894|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
125484420|NCT04625725|451408895|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
125484421|NCT04625725|451408890|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
125484422|NCT04625725|451408891|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
125484423|NCT04625725|451408892|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
125484424|NCT04625725|451408893|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
125484425|NCT04625725|451408894|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
125484426|NCT04625725|451408895|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
125484427|NCT04625725|451408890|FG000|Provent Sub Study|Lost to Follow-up|0|||
125484428|NCT04625725|451408891|FG001|Provent Sub Study|Lost to Follow-up|0|||
125484429|NCT04625725|451408892|FG002|Provent Sub Study|Lost to Follow-up|20|||
125484430|NCT04625725|451408893|FG003|Provent Sub Study|Lost to Follow-up|10|||
125484431|NCT04625725|451408894|FG004|Provent Sub Study|Lost to Follow-up|6|||
125484432|NCT04625725|451408895|FG005|Provent Sub Study|Lost to Follow-up|4|||
125484433|NCT04625725|451408890|FG000|Provent Sub Study|Death|0|||
125484434|NCT04625725|451408891|FG001|Provent Sub Study|Death|0|||
125484435|NCT04625725|451408892|FG002|Provent Sub Study|Death|8|||
125484436|NCT04625725|451408893|FG003|Provent Sub Study|Death|5|||
125484437|NCT04625725|451408894|FG004|Provent Sub Study|Death|0|||
125484438|NCT04625725|451408895|FG005|Provent Sub Study|Death|1|||
125484439|NCT04625725|451408890|FG000|Provent Sub Study|Adverse Event|0|||
125484440|NCT04625725|451408891|FG001|Provent Sub Study|Adverse Event|0|||
125484441|NCT04625725|451408892|FG002|Provent Sub Study|Adverse Event|0|||
125484442|NCT04625725|451408893|FG003|Provent Sub Study|Adverse Event|0|||
125484443|NCT04625725|451408894|FG004|Provent Sub Study|Adverse Event|0|||
125484444|NCT04625725|451408895|FG005|Provent Sub Study|Adverse Event|1|||
125484445|NCT04625725|451408890|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
125484446|NCT04625725|451408891|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
125484447|NCT04625725|451408892|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
125484448|NCT04625725|451408893|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
125484449|NCT04625725|451408894|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
125484450|NCT04625725|451408895|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
125484451|NCT04625725|451408890|FG000|Provent Sub Study|Withdrawal by Subject|0|||
125484452|NCT04625725|451408891|FG001|Provent Sub Study|Withdrawal by Subject|0|||
125484453|NCT04625725|451408892|FG002|Provent Sub Study|Withdrawal by Subject|11|||
125484454|NCT04625725|451408893|FG003|Provent Sub Study|Withdrawal by Subject|13|||
125484455|NCT04625725|451408894|FG004|Provent Sub Study|Withdrawal by Subject|5|||
125484456|NCT04625725|451408895|FG005|Provent Sub Study|Withdrawal by Subject|6|||
125484457|NCT04625725|451408890|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
125484458|NCT04625725|451408891|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
125484459|NCT04625725|451408892|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
125484460|NCT04625725|451408893|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
125484461|NCT04625725|451408894|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
125484462|NCT04625725|451408895|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
125484463|NCT03298451|451408899|FG000|Overall Study|Death|275|||
125484464|NCT03298451|451408900|FG001|Overall Study|Death|260|||
125484465|NCT03298451|451408901|FG002|Overall Study|Death|122|||
125484466|NCT03298451|451408902|FG003|Overall Study|Death|280|||
125484467|NCT03298451|451408899|FG000|Overall Study|Lost to Follow-up|1|||
125484468|NCT03298451|451408900|FG001|Overall Study|Lost to Follow-up|1|||
125484469|NCT03298451|451408901|FG002|Overall Study|Lost to Follow-up|0|||
125484470|NCT03298451|451408902|FG003|Overall Study|Lost to Follow-up|7|||
125484471|NCT03298451|451408899|FG000|Overall Study|Withdrawal by Subject|9|||
125484472|NCT03298451|451408900|FG001|Overall Study|Withdrawal by Subject|7|||
125484473|NCT03298451|451408901|FG002|Overall Study|Withdrawal by Subject|1|||
125484474|NCT03298451|451408902|FG003|Overall Study|Withdrawal by Subject|20|||
125484475|NCT01651403|451408905|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
125484476|NCT01651403|451408906|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
125484477|NCT01651403|451408905|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
125484478|NCT01651403|451408906|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
125484479|NCT01651403|451408905|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
125484480|NCT01651403|451408906|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
125484481|NCT01651403|451408905|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
125484482|NCT01651403|451408906|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
125484483|NCT01651403|451408905|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
125484484|NCT01651403|451408906|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
125484485|NCT01651403|451408905|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
125484486|NCT01651403|451408906|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
125484487|NCT05873556|451408907|FG000|Overall Study|Lost to Follow-up|4|||
125484488|NCT05873556|451408908|FG001|Overall Study|Lost to Follow-up|1|||
125484489|NCT03381586|451408909|FG000|Overall Study|Adverse Event|1|||
125484490|NCT03381586|451408910|FG001|Overall Study|Adverse Event|1|||
125484491|NCT03381586|451408909|FG000|Overall Study|Protocol Violation|1|||
125484492|NCT03381586|451408910|FG001|Overall Study|Protocol Violation|0|||
125484493|NCT03381586|451408909|FG000|Overall Study|Withdrawal by Subject|1|||
125484494|NCT03381586|451408910|FG001|Overall Study|Withdrawal by Subject|2|||
125484495|NCT05299723|451410083|FG000|Overall Study|Withdrawal by Subject|0|||
125484496|NCT05299723|451410084|FG001|Overall Study|Withdrawal by Subject|2|||
125484497|NCT05299723|451410085|FG002|Overall Study|Withdrawal by Subject|0|||
125484498|NCT03220035|451410086|FG000|Overall Study|Adverse Event|1|||
125484499|NCT03220035|451410086|FG000|Overall Study|Protocol Violation|1|||
125484500|NCT03220035|451410086|FG000|Overall Study|Progressive Disease|2|||
125484501|NCT05934942|451410092|FG000|Run-in Period|Not treated|1|||
125484502|NCT05934942|451410092|FG000|Run-in Period|Withdrawal by Subject|1|||
125484503|NCT04447040|451410093|FG000|Overall Study|Lost to Follow-up|2|||
125484504|NCT04447040|451410094|FG001|Overall Study|Lost to Follow-up|1|||
125484505|NCT04447040|451410095|FG002|Overall Study|Lost to Follow-up|3|||
125484506|NCT04447040|451410096|FG003|Overall Study|Lost to Follow-up|3|||
125484507|NCT04447040|451410097|FG004|Overall Study|Lost to Follow-up|1|||
125484508|NCT04447040|451410098|FG005|Overall Study|Lost to Follow-up|3|||
125484509|NCT04447040|451410093|FG000|Overall Study|Withdrawal by Subject|0|||
125484510|NCT04447040|451410094|FG001|Overall Study|Withdrawal by Subject|1|||
125484511|NCT04447040|451410095|FG002|Overall Study|Withdrawal by Subject|1|||
125484512|NCT04447040|451410096|FG003|Overall Study|Withdrawal by Subject|1|||
125484513|NCT04447040|451410097|FG004|Overall Study|Withdrawal by Subject|0|||
125484514|NCT04447040|451410098|FG005|Overall Study|Withdrawal by Subject|0|||
125484515|NCT04076618|451410099|FG000|Overall Study|Lost to Follow-up|2|||
125484516|NCT04076618|451410100|FG001|Overall Study|Lost to Follow-up|1|||
125484517|NCT04076618|451410101|FG002|Overall Study|Lost to Follow-up|3|||
125484518|NCT04076618|451410099|FG000|Overall Study|Withdrawal by Subject|3|||
125303044|NCT03100058|450736671|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
125303045|NCT03100058|450736672|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
125484519|NCT04076618|451410100|FG001|Overall Study|Withdrawal by Subject|1|||
125484520|NCT04076618|451410101|FG002|Overall Study|Withdrawal by Subject|2|||
125484521|NCT04076618|451410099|FG000|Overall Study|Relocated out of state|0|||
125484522|NCT04076618|451410100|FG001|Overall Study|Relocated out of state|2|||
125484523|NCT04076618|451410101|FG002|Overall Study|Relocated out of state|0|||
125484524|NCT04076618|451410099|FG000|Overall Study|COVID concerns|0|||
125484525|NCT04076618|451410100|FG001|Overall Study|COVID concerns|1|||
125484526|NCT04076618|451410101|FG002|Overall Study|COVID concerns|0|||
125484527|NCT04076618|451410099|FG000|Overall Study|Adverse Event|0|||
125484528|NCT04076618|451410100|FG001|Overall Study|Adverse Event|0|||
125484529|NCT04076618|451410101|FG002|Overall Study|Adverse Event|2|||
125484530|NCT01928394|451410102|FG000|Treatment Period|Disease progression|17|||
125484531|NCT01928394|451410103|FG001|Treatment Period|Disease progression|2|||
125484532|NCT01928394|451410104|FG002|Treatment Period|Disease progression|12|||
125484533|NCT01928394|451410105|FG003|Treatment Period|Disease progression|48|||
125484534|NCT01928394|451410106|FG004|Treatment Period|Disease progression|3|||
125484535|NCT01928394|451410107|FG005|Treatment Period|Disease progression|25|||
125484536|NCT01928394|451410108|FG006|Treatment Period|Disease progression|38|||
125484537|NCT01928394|451410109|FG007|Treatment Period|Disease progression|16|||
125484538|NCT01928394|451410110|FG008|Treatment Period|Disease progression|3|||
125484539|NCT01928394|451410111|FG009|Treatment Period|Disease progression|11|||
125484540|NCT01928394|451410112|FG010|Treatment Period|Disease progression|22|||
125484541|NCT01928394|451410113|FG011|Treatment Period|Disease progression|73|||
125484542|NCT01928394|451410114|FG012|Treatment Period|Disease progression|38|||
125484543|NCT01928394|451410115|FG013|Treatment Period|Disease progression|118|||
125484544|NCT01928394|451410116|FG014|Treatment Period|Disease progression|59|||
125484545|NCT01928394|451410117|FG015|Treatment Period|Disease progression|1|||
125484546|NCT01928394|451410118|FG016|Treatment Period|Disease progression|43|||
125303046|NCT03100058|450736673|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
125484547|NCT01928394|451410119|FG017|Treatment Period|Disease progression|56|||
125484548|NCT01928394|451410120|FG018|Treatment Period|Disease progression|50|||
125484549|NCT01928394|451410121|FG019|Treatment Period|Disease progression|71|||
125484550|NCT01928394|451410122|FG020|Treatment Period|Disease progression|30|||
125484551|NCT01928394|451410123|FG021|Treatment Period|Disease progression|31|||
125484552|NCT01928394|451410124|FG022|Treatment Period|Disease progression|31|||
125484553|NCT01928394|451410102|FG000|Treatment Period|Study drug toxicity|1|||
125484554|NCT01928394|451410103|FG001|Treatment Period|Study drug toxicity|1|||
125484555|NCT01928394|451410104|FG002|Treatment Period|Study drug toxicity|3|||
125484556|NCT01928394|451410105|FG003|Treatment Period|Study drug toxicity|3|||
125484557|NCT01928394|451410106|FG004|Treatment Period|Study drug toxicity|0|||
125484558|NCT01928394|451410107|FG005|Treatment Period|Study drug toxicity|9|||
125484559|NCT01928394|451410108|FG006|Treatment Period|Study drug toxicity|7|||
125484560|NCT01928394|451410109|FG007|Treatment Period|Study drug toxicity|1|||
125484561|NCT01928394|451410110|FG008|Treatment Period|Study drug toxicity|0|||
125484562|NCT01928394|451410111|FG009|Treatment Period|Study drug toxicity|5|||
125484563|NCT01928394|451410112|FG010|Treatment Period|Study drug toxicity|2|||
125484564|NCT01928394|451410113|FG011|Treatment Period|Study drug toxicity|3|||
125484565|NCT01928394|451410114|FG012|Treatment Period|Study drug toxicity|7|||
125484566|NCT01928394|451410115|FG013|Treatment Period|Study drug toxicity|5|||
125484567|NCT01928394|451410116|FG014|Treatment Period|Study drug toxicity|12|||
125484568|NCT01928394|451410117|FG015|Treatment Period|Study drug toxicity|0|||
125484569|NCT01928394|451410118|FG016|Treatment Period|Study drug toxicity|3|||
125484570|NCT01928394|451410119|FG017|Treatment Period|Study drug toxicity|3|||
125484571|NCT01928394|451410120|FG018|Treatment Period|Study drug toxicity|12|||
125484572|NCT01928394|451410121|FG019|Treatment Period|Study drug toxicity|15|||
125484573|NCT01928394|451410122|FG020|Treatment Period|Study drug toxicity|4|||
125484574|NCT01928394|451410123|FG021|Treatment Period|Study drug toxicity|7|||
125484575|NCT01928394|451410124|FG022|Treatment Period|Study drug toxicity|4|||
125484576|NCT01928394|451410102|FG000|Treatment Period|AE unrelated to study drug|0|||
125484577|NCT01928394|451410103|FG001|Treatment Period|AE unrelated to study drug|0|||
125484578|NCT01928394|451410104|FG002|Treatment Period|AE unrelated to study drug|2|||
125484579|NCT01928394|451410105|FG003|Treatment Period|AE unrelated to study drug|3|||
125484580|NCT01928394|451410106|FG004|Treatment Period|AE unrelated to study drug|0|||
125484581|NCT01928394|451410107|FG005|Treatment Period|AE unrelated to study drug|5|||
125484582|NCT01928394|451410108|FG006|Treatment Period|AE unrelated to study drug|1|||
125484583|NCT01928394|451410109|FG007|Treatment Period|AE unrelated to study drug|0|||
125484584|NCT01928394|451410110|FG008|Treatment Period|AE unrelated to study drug|0|||
125484585|NCT01928394|451410111|FG009|Treatment Period|AE unrelated to study drug|2|||
125484586|NCT01928394|451410112|FG010|Treatment Period|AE unrelated to study drug|0|||
125484587|NCT01928394|451410113|FG011|Treatment Period|AE unrelated to study drug|12|||
125484588|NCT01928394|451410114|FG012|Treatment Period|AE unrelated to study drug|6|||
125484589|NCT01928394|451410115|FG013|Treatment Period|AE unrelated to study drug|13|||
125484590|NCT01928394|451410116|FG014|Treatment Period|AE unrelated to study drug|6|||
125484591|NCT01928394|451410117|FG015|Treatment Period|AE unrelated to study drug|1|||
125484592|NCT01928394|451410118|FG016|Treatment Period|AE unrelated to study drug|1|||
125484593|NCT01928394|451410119|FG017|Treatment Period|AE unrelated to study drug|6|||
125484594|NCT01928394|451410120|FG018|Treatment Period|AE unrelated to study drug|3|||
125484595|NCT01928394|451410121|FG019|Treatment Period|AE unrelated to study drug|5|||
125484596|NCT01928394|451410122|FG020|Treatment Period|AE unrelated to study drug|1|||
125484597|NCT01928394|451410123|FG021|Treatment Period|AE unrelated to study drug|1|||
125484598|NCT01928394|451410124|FG022|Treatment Period|AE unrelated to study drug|0|||
125303047|NCT03100058|450736661|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
125303048|NCT03100058|450736662|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
125484599|NCT01928394|451410102|FG000|Treatment Period|Participant request to stop therapy|0|||
125484600|NCT01928394|451410103|FG001|Treatment Period|Participant request to stop therapy|0|||
125484601|NCT01928394|451410104|FG002|Treatment Period|Participant request to stop therapy|0|||
125484602|NCT01928394|451410105|FG003|Treatment Period|Participant request to stop therapy|0|||
125484603|NCT01928394|451410106|FG004|Treatment Period|Participant request to stop therapy|0|||
125484604|NCT01928394|451410107|FG005|Treatment Period|Participant request to stop therapy|3|||
125484605|NCT01928394|451410108|FG006|Treatment Period|Participant request to stop therapy|3|||
125484606|NCT01928394|451410109|FG007|Treatment Period|Participant request to stop therapy|0|||
125484607|NCT01928394|451410110|FG008|Treatment Period|Participant request to stop therapy|0|||
125484608|NCT01928394|451410111|FG009|Treatment Period|Participant request to stop therapy|0|||
125484609|NCT01928394|451410112|FG010|Treatment Period|Participant request to stop therapy|3|||
125484610|NCT01928394|451410113|FG011|Treatment Period|Participant request to stop therapy|2|||
125484611|NCT01928394|451410114|FG012|Treatment Period|Participant request to stop therapy|1|||
125484612|NCT01928394|451410115|FG013|Treatment Period|Participant request to stop therapy|2|||
125484613|NCT01928394|451410116|FG014|Treatment Period|Participant request to stop therapy|4|||
125303049|NCT03100058|450736663|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
125303050|NCT03100058|450736664|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
125484614|NCT01928394|451410117|FG015|Treatment Period|Participant request to stop therapy|0|||
125484615|NCT01928394|451410118|FG016|Treatment Period|Participant request to stop therapy|1|||
125484616|NCT01928394|451410119|FG017|Treatment Period|Participant request to stop therapy|3|||
125484617|NCT01928394|451410120|FG018|Treatment Period|Participant request to stop therapy|1|||
125484618|NCT01928394|451410121|FG019|Treatment Period|Participant request to stop therapy|1|||
125484619|NCT01928394|451410122|FG020|Treatment Period|Participant request to stop therapy|3|||
125484620|NCT01928394|451410123|FG021|Treatment Period|Participant request to stop therapy|1|||
125485435|NCT02240238|451412513|FG010|Phase 2|Disease progression|11|||
125484621|NCT01928394|451410124|FG022|Treatment Period|Participant request to stop therapy|3|||
125484622|NCT01928394|451410102|FG000|Treatment Period|Participant withdrew consent|0|||
125484623|NCT01928394|451410103|FG001|Treatment Period|Participant withdrew consent|0|||
125484624|NCT01928394|451410104|FG002|Treatment Period|Participant withdrew consent|1|||
125484625|NCT01928394|451410105|FG003|Treatment Period|Participant withdrew consent|1|||
125484626|NCT01928394|451410106|FG004|Treatment Period|Participant withdrew consent|0|||
125484627|NCT01928394|451410107|FG005|Treatment Period|Participant withdrew consent|1|||
125484628|NCT01928394|451410108|FG006|Treatment Period|Participant withdrew consent|0|||
125484629|NCT01928394|451410109|FG007|Treatment Period|Participant withdrew consent|1|||
125484630|NCT01928394|451410110|FG008|Treatment Period|Participant withdrew consent|0|||
125484631|NCT01928394|451410111|FG009|Treatment Period|Participant withdrew consent|0|||
125484632|NCT01928394|451410112|FG010|Treatment Period|Participant withdrew consent|1|||
125484633|NCT01928394|451410113|FG011|Treatment Period|Participant withdrew consent|1|||
125484634|NCT01928394|451410114|FG012|Treatment Period|Participant withdrew consent|1|||
125484635|NCT01928394|451410115|FG013|Treatment Period|Participant withdrew consent|0|||
125484636|NCT01928394|451410116|FG014|Treatment Period|Participant withdrew consent|2|||
125484637|NCT01928394|451410117|FG015|Treatment Period|Participant withdrew consent|0|||
125484638|NCT01928394|451410118|FG016|Treatment Period|Participant withdrew consent|2|||
125484639|NCT01928394|451410119|FG017|Treatment Period|Participant withdrew consent|1|||
125484640|NCT01928394|451410120|FG018|Treatment Period|Participant withdrew consent|1|||
125484641|NCT01928394|451410121|FG019|Treatment Period|Participant withdrew consent|1|||
125484642|NCT01928394|451410122|FG020|Treatment Period|Participant withdrew consent|0|||
125484643|NCT01928394|451410123|FG021|Treatment Period|Participant withdrew consent|2|||
125484644|NCT01928394|451410124|FG022|Treatment Period|Participant withdrew consent|0|||
125484645|NCT01928394|451410102|FG000|Treatment Period|Poor/non-compliance|0|||
125484646|NCT01928394|451410103|FG001|Treatment Period|Poor/non-compliance|0|||
125484647|NCT01928394|451410104|FG002|Treatment Period|Poor/non-compliance|0|||
125484648|NCT01928394|451410105|FG003|Treatment Period|Poor/non-compliance|1|||
125484649|NCT01928394|451410106|FG004|Treatment Period|Poor/non-compliance|0|||
125484650|NCT01928394|451410107|FG005|Treatment Period|Poor/non-compliance|0|||
125484651|NCT01928394|451410108|FG006|Treatment Period|Poor/non-compliance|0|||
125484652|NCT01928394|451410109|FG007|Treatment Period|Poor/non-compliance|0|||
125484653|NCT01928394|451410110|FG008|Treatment Period|Poor/non-compliance|0|||
125484654|NCT01928394|451410111|FG009|Treatment Period|Poor/non-compliance|0|||
125484655|NCT01928394|451410112|FG010|Treatment Period|Poor/non-compliance|0|||
125484656|NCT01928394|451410113|FG011|Treatment Period|Poor/non-compliance|0|||
125484657|NCT01928394|451410114|FG012|Treatment Period|Poor/non-compliance|1|||
125484658|NCT01928394|451410115|FG013|Treatment Period|Poor/non-compliance|0|||
125484659|NCT01928394|451410116|FG014|Treatment Period|Poor/non-compliance|1|||
125484660|NCT01928394|451410117|FG015|Treatment Period|Poor/non-compliance|0|||
125484661|NCT01928394|451410118|FG016|Treatment Period|Poor/non-compliance|0|||
125484662|NCT01928394|451410119|FG017|Treatment Period|Poor/non-compliance|1|||
125484663|NCT01928394|451410120|FG018|Treatment Period|Poor/non-compliance|0|||
125484664|NCT01928394|451410121|FG019|Treatment Period|Poor/non-compliance|1|||
125484665|NCT01928394|451410122|FG020|Treatment Period|Poor/non-compliance|0|||
125484666|NCT01928394|451410123|FG021|Treatment Period|Poor/non-compliance|0|||
125484667|NCT01928394|451410124|FG022|Treatment Period|Poor/non-compliance|0|||
125484668|NCT01928394|451410102|FG000|Treatment Period|other reason|0|||
125484669|NCT01928394|451410103|FG001|Treatment Period|other reason|0|||
125484670|NCT01928394|451410104|FG002|Treatment Period|other reason|0|||
125484671|NCT01928394|451410105|FG003|Treatment Period|other reason|0|||
125484672|NCT01928394|451410106|FG004|Treatment Period|other reason|0|||
125484673|NCT01928394|451410107|FG005|Treatment Period|other reason|0|||
125484674|NCT01928394|451410108|FG006|Treatment Period|other reason|0|||
125484675|NCT01928394|451410109|FG007|Treatment Period|other reason|0|||
125484676|NCT01928394|451410110|FG008|Treatment Period|other reason|0|||
125484677|NCT01928394|451410111|FG009|Treatment Period|other reason|0|||
125484678|NCT01928394|451410112|FG010|Treatment Period|other reason|1|||
125484679|NCT01928394|451410113|FG011|Treatment Period|other reason|1|||
125484680|NCT01928394|451410114|FG012|Treatment Period|other reason|1|||
125484681|NCT01928394|451410115|FG013|Treatment Period|other reason|0|||
125484682|NCT01928394|451410116|FG014|Treatment Period|other reason|1|||
125484683|NCT01928394|451410117|FG015|Treatment Period|other reason|0|||
125484684|NCT01928394|451410118|FG016|Treatment Period|other reason|0|||
125484685|NCT01928394|451410119|FG017|Treatment Period|other reason|0|||
125484686|NCT01928394|451410120|FG018|Treatment Period|other reason|2|||
125484687|NCT01928394|451410121|FG019|Treatment Period|other reason|2|||
125484688|NCT01928394|451410122|FG020|Treatment Period|other reason|0|||
125484689|NCT01928394|451410123|FG021|Treatment Period|other reason|0|||
125484690|NCT01928394|451410124|FG022|Treatment Period|other reason|0|||
125484691|NCT01928394|451410102|FG000|Treatment Period|Maximum clinical benefit|0|||
125484692|NCT01928394|451410103|FG001|Treatment Period|Maximum clinical benefit|0|||
125484693|NCT01928394|451410104|FG002|Treatment Period|Maximum clinical benefit|0|||
125484694|NCT01928394|451410105|FG003|Treatment Period|Maximum clinical benefit|0|||
125484695|NCT01928394|451410106|FG004|Treatment Period|Maximum clinical benefit|0|||
125484696|NCT01928394|451410107|FG005|Treatment Period|Maximum clinical benefit|0|||
125484697|NCT01928394|451410108|FG006|Treatment Period|Maximum clinical benefit|0|||
125484698|NCT01928394|451410109|FG007|Treatment Period|Maximum clinical benefit|0|||
125484699|NCT01928394|451410110|FG008|Treatment Period|Maximum clinical benefit|0|||
125484700|NCT01928394|451410111|FG009|Treatment Period|Maximum clinical benefit|0|||
125484701|NCT01928394|451410112|FG010|Treatment Period|Maximum clinical benefit|1|||
125484702|NCT01928394|451410113|FG011|Treatment Period|Maximum clinical benefit|1|||
125484703|NCT01928394|451410114|FG012|Treatment Period|Maximum clinical benefit|0|||
125484704|NCT01928394|451410115|FG013|Treatment Period|Maximum clinical benefit|0|||
125484705|NCT01928394|451410116|FG014|Treatment Period|Maximum clinical benefit|1|||
125484706|NCT01928394|451410117|FG015|Treatment Period|Maximum clinical benefit|0|||
125484707|NCT01928394|451410118|FG016|Treatment Period|Maximum clinical benefit|0|||
125484708|NCT01928394|451410119|FG017|Treatment Period|Maximum clinical benefit|1|||
125484709|NCT01928394|451410120|FG018|Treatment Period|Maximum clinical benefit|1|||
125484710|NCT01928394|451410121|FG019|Treatment Period|Maximum clinical benefit|0|||
125484711|NCT01928394|451410122|FG020|Treatment Period|Maximum clinical benefit|2|||
125484712|NCT01928394|451410123|FG021|Treatment Period|Maximum clinical benefit|0|||
125484713|NCT01928394|451410124|FG022|Treatment Period|Maximum clinical benefit|0|||
125484714|NCT01928394|451410102|FG000|Treatment Period|Lost to Follow-up|0|||
125484715|NCT01928394|451410103|FG001|Treatment Period|Lost to Follow-up|0|||
125484716|NCT01928394|451410104|FG002|Treatment Period|Lost to Follow-up|0|||
125484717|NCT01928394|451410105|FG003|Treatment Period|Lost to Follow-up|0|||
125484718|NCT01928394|451410106|FG004|Treatment Period|Lost to Follow-up|0|||
125484719|NCT01928394|451410107|FG005|Treatment Period|Lost to Follow-up|0|||
125484720|NCT01928394|451410108|FG006|Treatment Period|Lost to Follow-up|0|||
125484721|NCT01928394|451410109|FG007|Treatment Period|Lost to Follow-up|0|||
125484722|NCT01928394|451410110|FG008|Treatment Period|Lost to Follow-up|0|||
125484723|NCT01928394|451410111|FG009|Treatment Period|Lost to Follow-up|0|||
125484724|NCT01928394|451410112|FG010|Treatment Period|Lost to Follow-up|0|||
125484725|NCT01928394|451410113|FG011|Treatment Period|Lost to Follow-up|0|||
125484726|NCT01928394|451410114|FG012|Treatment Period|Lost to Follow-up|0|||
125484727|NCT01928394|451410115|FG013|Treatment Period|Lost to Follow-up|0|||
125484728|NCT01928394|451410116|FG014|Treatment Period|Lost to Follow-up|0|||
125484729|NCT01928394|451410117|FG015|Treatment Period|Lost to Follow-up|0|||
125484730|NCT01928394|451410118|FG016|Treatment Period|Lost to Follow-up|0|||
125484731|NCT01928394|451410119|FG017|Treatment Period|Lost to Follow-up|0|||
125484732|NCT01928394|451410120|FG018|Treatment Period|Lost to Follow-up|0|||
125484733|NCT01928394|451410121|FG019|Treatment Period|Lost to Follow-up|0|||
125484734|NCT01928394|451410122|FG020|Treatment Period|Lost to Follow-up|0|||
125484735|NCT01928394|451410123|FG021|Treatment Period|Lost to Follow-up|0|||
125484736|NCT01928394|451410124|FG022|Treatment Period|Lost to Follow-up|1|||
125484737|NCT01928394|451410102|FG000|Treatment Period|Death|0|||
125484738|NCT01928394|451410103|FG001|Treatment Period|Death|0|||
125484739|NCT01928394|451410104|FG002|Treatment Period|Death|0|||
125484740|NCT01928394|451410105|FG003|Treatment Period|Death|0|||
125484741|NCT01928394|451410106|FG004|Treatment Period|Death|0|||
125484742|NCT01928394|451410107|FG005|Treatment Period|Death|0|||
125484743|NCT01928394|451410108|FG006|Treatment Period|Death|0|||
125484744|NCT01928394|451410109|FG007|Treatment Period|Death|0|||
125484745|NCT01928394|451410110|FG008|Treatment Period|Death|0|||
125484746|NCT01928394|451410111|FG009|Treatment Period|Death|0|||
125484747|NCT01928394|451410112|FG010|Treatment Period|Death|0|||
125484748|NCT01928394|451410113|FG011|Treatment Period|Death|0|||
125484749|NCT01928394|451410114|FG012|Treatment Period|Death|0|||
125484750|NCT01928394|451410115|FG013|Treatment Period|Death|1|||
125484751|NCT01928394|451410116|FG014|Treatment Period|Death|2|||
125484752|NCT01928394|451410117|FG015|Treatment Period|Death|0|||
125484753|NCT01928394|451410118|FG016|Treatment Period|Death|0|||
125484754|NCT01928394|451410119|FG017|Treatment Period|Death|0|||
125484755|NCT01928394|451410120|FG018|Treatment Period|Death|0|||
125484756|NCT01928394|451410121|FG019|Treatment Period|Death|0|||
125484757|NCT01928394|451410122|FG020|Treatment Period|Death|0|||
125484758|NCT01928394|451410123|FG021|Treatment Period|Death|0|||
125484759|NCT01928394|451410124|FG022|Treatment Period|Death|0|||
125484760|NCT01928394|451410102|FG000|Follow-up Period|Participant withdrew consent|3|||
125484761|NCT01928394|451410103|FG001|Follow-up Period|Participant withdrew consent|0|||
125484762|NCT01928394|451410104|FG002|Follow-up Period|Participant withdrew consent|1|||
125484763|NCT01928394|451410105|FG003|Follow-up Period|Participant withdrew consent|4|||
125484764|NCT01928394|451410106|FG004|Follow-up Period|Participant withdrew consent|0|||
125484765|NCT01928394|451410107|FG005|Follow-up Period|Participant withdrew consent|2|||
125484766|NCT01928394|451410108|FG006|Follow-up Period|Participant withdrew consent|5|||
125484767|NCT01928394|451410109|FG007|Follow-up Period|Participant withdrew consent|1|||
125484768|NCT01928394|451410110|FG008|Follow-up Period|Participant withdrew consent|0|||
125484769|NCT01928394|451410111|FG009|Follow-up Period|Participant withdrew consent|0|||
125484770|NCT01928394|451410112|FG010|Follow-up Period|Participant withdrew consent|5|||
125484771|NCT01928394|451410113|FG011|Follow-up Period|Participant withdrew consent|8|||
125484772|NCT01928394|451410114|FG012|Follow-up Period|Participant withdrew consent|2|||
125484773|NCT01928394|451410115|FG013|Follow-up Period|Participant withdrew consent|12|||
125484774|NCT01928394|451410116|FG014|Follow-up Period|Participant withdrew consent|7|||
125484775|NCT01928394|451410117|FG015|Follow-up Period|Participant withdrew consent|0|||
125484776|NCT01928394|451410118|FG016|Follow-up Period|Participant withdrew consent|5|||
125484777|NCT01928394|451410119|FG017|Follow-up Period|Participant withdrew consent|3|||
125484778|NCT01928394|451410120|FG018|Follow-up Period|Participant withdrew consent|2|||
125484779|NCT01928394|451410121|FG019|Follow-up Period|Participant withdrew consent|7|||
125484780|NCT01928394|451410122|FG020|Follow-up Period|Participant withdrew consent|4|||
125484781|NCT01928394|451410123|FG021|Follow-up Period|Participant withdrew consent|6|||
125484782|NCT01928394|451410124|FG022|Follow-up Period|Participant withdrew consent|2|||
125484783|NCT01928394|451410102|FG000|Follow-up Period|Death|0|||
125484784|NCT01928394|451410103|FG001|Follow-up Period|Death|0|||
125484785|NCT01928394|451410104|FG002|Follow-up Period|Death|2|||
125484786|NCT01928394|451410105|FG003|Follow-up Period|Death|6|||
125484787|NCT01928394|451410106|FG004|Follow-up Period|Death|0|||
125484788|NCT01928394|451410107|FG005|Follow-up Period|Death|6|||
125484789|NCT01928394|451410108|FG006|Follow-up Period|Death|6|||
125484790|NCT01928394|451410109|FG007|Follow-up Period|Death|2|||
125484791|NCT01928394|451410110|FG008|Follow-up Period|Death|1|||
125484792|NCT01928394|451410111|FG009|Follow-up Period|Death|2|||
125484793|NCT01928394|451410112|FG010|Follow-up Period|Death|4|||
125484794|NCT01928394|451410113|FG011|Follow-up Period|Death|12|||
125484795|NCT01928394|451410114|FG012|Follow-up Period|Death|11|||
125484796|NCT01928394|451410115|FG013|Follow-up Period|Death|25|||
125484797|NCT01928394|451410116|FG014|Follow-up Period|Death|18|||
125484798|NCT01928394|451410117|FG015|Follow-up Period|Death|0|||
125484799|NCT01928394|451410118|FG016|Follow-up Period|Death|6|||
125484800|NCT01928394|451410119|FG017|Follow-up Period|Death|5|||
125484801|NCT01928394|451410120|FG018|Follow-up Period|Death|13|||
125484802|NCT01928394|451410121|FG019|Follow-up Period|Death|13|||
125484803|NCT01928394|451410122|FG020|Follow-up Period|Death|5|||
125484804|NCT01928394|451410123|FG021|Follow-up Period|Death|3|||
125484805|NCT01928394|451410124|FG022|Follow-up Period|Death|2|||
125484806|NCT01928394|451410102|FG000|Follow-up Period|other reason|0|||
125484807|NCT01928394|451410103|FG001|Follow-up Period|other reason|0|||
125484808|NCT01928394|451410104|FG002|Follow-up Period|other reason|0|||
125484809|NCT01928394|451410105|FG003|Follow-up Period|other reason|0|||
125484810|NCT01928394|451410106|FG004|Follow-up Period|other reason|0|||
125484811|NCT01928394|451410107|FG005|Follow-up Period|other reason|0|||
125484812|NCT01928394|451410108|FG006|Follow-up Period|other reason|1|||
125484813|NCT01928394|451410109|FG007|Follow-up Period|other reason|3|||
125484814|NCT01928394|451410110|FG008|Follow-up Period|other reason|0|||
125484815|NCT01928394|451410111|FG009|Follow-up Period|other reason|0|||
125484816|NCT01928394|451410112|FG010|Follow-up Period|other reason|2|||
125484817|NCT01928394|451410113|FG011|Follow-up Period|other reason|1|||
125484818|NCT01928394|451410114|FG012|Follow-up Period|other reason|0|||
125484819|NCT01928394|451410115|FG013|Follow-up Period|other reason|1|||
125484820|NCT01928394|451410116|FG014|Follow-up Period|other reason|4|||
125484821|NCT01928394|451410117|FG015|Follow-up Period|other reason|0|||
125484822|NCT01928394|451410118|FG016|Follow-up Period|other reason|2|||
125484823|NCT01928394|451410119|FG017|Follow-up Period|other reason|0|||
125484824|NCT01928394|451410120|FG018|Follow-up Period|other reason|1|||
125484825|NCT01928394|451410121|FG019|Follow-up Period|other reason|1|||
125484826|NCT01928394|451410122|FG020|Follow-up Period|other reason|0|||
125484827|NCT01928394|451410123|FG021|Follow-up Period|other reason|0|||
125484828|NCT01928394|451410124|FG022|Follow-up Period|other reason|1|||
125484829|NCT01928394|451410102|FG000|Follow-up Period|Lost to Follow-up|0|||
125484830|NCT01928394|451410103|FG001|Follow-up Period|Lost to Follow-up|0|||
125484831|NCT01928394|451410104|FG002|Follow-up Period|Lost to Follow-up|0|||
125484832|NCT01928394|451410105|FG003|Follow-up Period|Lost to Follow-up|0|||
125484833|NCT01928394|451410106|FG004|Follow-up Period|Lost to Follow-up|0|||
125484834|NCT01928394|451410107|FG005|Follow-up Period|Lost to Follow-up|0|||
125484835|NCT01928394|451410108|FG006|Follow-up Period|Lost to Follow-up|0|||
125484836|NCT01928394|451410109|FG007|Follow-up Period|Lost to Follow-up|0|||
125484837|NCT01928394|451410110|FG008|Follow-up Period|Lost to Follow-up|0|||
125484838|NCT01928394|451410111|FG009|Follow-up Period|Lost to Follow-up|0|||
125484839|NCT01928394|451410112|FG010|Follow-up Period|Lost to Follow-up|0|||
125484840|NCT01928394|451410113|FG011|Follow-up Period|Lost to Follow-up|1|||
125484841|NCT01928394|451410114|FG012|Follow-up Period|Lost to Follow-up|1|||
125484842|NCT01928394|451410115|FG013|Follow-up Period|Lost to Follow-up|0|||
125484843|NCT01928394|451410116|FG014|Follow-up Period|Lost to Follow-up|1|||
125484844|NCT01928394|451410117|FG015|Follow-up Period|Lost to Follow-up|0|||
125484845|NCT01928394|451410118|FG016|Follow-up Period|Lost to Follow-up|1|||
125484846|NCT01928394|451410119|FG017|Follow-up Period|Lost to Follow-up|0|||
125484847|NCT01928394|451410120|FG018|Follow-up Period|Lost to Follow-up|0|||
125484848|NCT01928394|451410121|FG019|Follow-up Period|Lost to Follow-up|0|||
125484849|NCT01928394|451410122|FG020|Follow-up Period|Lost to Follow-up|0|||
125484850|NCT01928394|451410123|FG021|Follow-up Period|Lost to Follow-up|0|||
125484851|NCT01928394|451410124|FG022|Follow-up Period|Lost to Follow-up|1|||
125484852|NCT04433208|451410125|FG000|Overall Study|Withdrawal by Subject|0|||
125484853|NCT04433208|451410126|FG001|Overall Study|Withdrawal by Subject|1|||
125484854|NCT04433208|451410127|FG002|Overall Study|Withdrawal by Subject|1|||
125484855|NCT04433208|451410128|FG003|Overall Study|Withdrawal by Subject|0|||
125484856|NCT04433208|451410129|FG004|Overall Study|Withdrawal by Subject|2|||
125484857|NCT04433208|451410130|FG005|Overall Study|Withdrawal by Subject|1|||
125420739|NCT00447057|451166108|FG003|Overall Study|Death, study drug related|0|||
125420740|NCT03151005|451166111|FG000|Overall Study|Lost to Follow-up|5|||
125420741|NCT03151005|451166112|FG001|Overall Study|Lost to Follow-up|5|||
125420742|NCT00605293|451166113|FG000|Overall Study|Death|2|||
125420743|NCT00605293|451166114|FG001|Overall Study|Death|1|||
125420744|NCT00605293|451166113|FG000|Overall Study|Insufficient Therapeutic Response|2|||
125420745|NCT00605293|451166114|FG001|Overall Study|Insufficient Therapeutic Response|0|||
125420746|NCT00605293|451166113|FG000|Overall Study|Adverse Event|1|||
125420747|NCT00605293|451166114|FG001|Overall Study|Adverse Event|0|||
125420748|NCT00605293|451166113|FG000|Overall Study|Holidays Dialysis Out|1|||
125420749|NCT00605293|451166114|FG001|Overall Study|Holidays Dialysis Out|0|||
125420750|NCT00605293|451166113|FG000|Overall Study|Blood Transfusion|7|||
125420751|NCT00605293|451166114|FG001|Overall Study|Blood Transfusion|1|||
125420752|NCT00605293|451166113|FG000|Overall Study|Renal Transplantation|3|||
125420753|NCT00605293|451166114|FG001|Overall Study|Renal Transplantation|1|||
125420754|NCT00605293|451166113|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
125420755|NCT00605293|451166114|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
125420756|NCT00605293|451166113|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
125420757|NCT00605293|451166114|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
125420758|NCT00605293|451166113|FG000|Overall Study|Principal Investigator Decision|0|||
125420759|NCT00605293|451166114|FG001|Overall Study|Principal Investigator Decision|1|||
125420760|NCT00725452|451166115|FG000|Overall Study|Adverse Event|3|||
125420761|NCT00725452|451166115|FG000|Overall Study|Lack of Efficacy|2|||
125420762|NCT00725452|451166115|FG000|Overall Study|Reason not specified|1|||
125420763|NCT00725452|451166115|FG000|Overall Study|Physician Decision|1|||
125420764|NCT00725452|451166115|FG000|Overall Study|Withdrawal by Subject|3|||
125420765|NCT00725452|451166115|FG000|Overall Study|Lost to Follow-up|1|||
125420766|NCT00620750|451166117|FG000|Overall Study|Lost to Follow-up|25|||
125420767|NCT02163733|451166118|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
125420768|NCT02163733|451166119|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
125420769|NCT02163733|451166120|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
125420770|NCT02163733|451166118|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
125420771|NCT02163733|451166119|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
125420772|NCT02163733|451166120|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
125420773|NCT04477187|451166121|FG000|Overall Study|Lost to Follow-up|2|||
125420774|NCT02633800|451166122|FG000|Overall Study|Death|3|||
125420775|NCT02633800|451166123|FG001|Overall Study|Death|3|||
125420776|NCT02633800|451166122|FG000|Overall Study|Reason not provided|1|||
125420777|NCT02633800|451166123|FG001|Overall Study|Reason not provided|0|||
125420778|NCT02633800|451166122|FG000|Overall Study|Radiologic(al) progression|23|||
125420779|NCT02633800|451166123|FG001|Overall Study|Radiologic(al) progression|23|||
125420780|NCT02633800|451166122|FG000|Overall Study|Clinical progression|3|||
125420781|NCT02633800|451166123|FG001|Overall Study|Clinical progression|6|||
125420782|NCT02633800|451166122|FG000|Overall Study|Study terminated by sponsor|6|||
125420783|NCT02633800|451166123|FG001|Overall Study|Study terminated by sponsor|5|||
125420784|NCT02633800|451166122|FG000|Overall Study|Adverse event, non-fatal|7|||
125420785|NCT02633800|451166123|FG001|Overall Study|Adverse event, non-fatal|2|||
125420786|NCT02633800|451166122|FG000|Overall Study|Withdrawal by Subject|0|||
125420787|NCT02633800|451166123|FG001|Overall Study|Withdrawal by Subject|3|||
125420788|NCT02633800|451166122|FG000|Overall Study|Patient Request|1|||
125420789|NCT02633800|451166123|FG001|Overall Study|Patient Request|1|||
125420790|NCT00082173|451166124|FG000|Overall Study|Withdrawal by Subject|3|||
125420791|NCT00082173|451166125|FG001|Overall Study|Withdrawal by Subject|5|||
125420792|NCT00082173|451166124|FG000|Overall Study|Lost to Follow-up|1|||
125420793|NCT00082173|451166125|FG001|Overall Study|Lost to Follow-up|0|||
125420794|NCT00082173|451166124|FG000|Overall Study|Adverse Event|1|||
125420795|NCT00082173|451166125|FG001|Overall Study|Adverse Event|0|||
125420796|NCT00082173|451166124|FG000|Overall Study|Culture negative or resistant at baselin|5|||
125420797|NCT00082173|451166125|FG001|Overall Study|Culture negative or resistant at baselin|6|||
125420798|NCT01733732|451166126|FG000|Overall Study|Adverse Event|1|||
125420799|NCT01733732|451166127|FG001|Overall Study|Adverse Event|0|||
125420800|NCT01733732|451166126|FG000|Overall Study|Did not attend all study visits|1|||
125420801|NCT01733732|451166127|FG001|Overall Study|Did not attend all study visits|0|||
125420802|NCT00746590|451166128|FG000|Overall Study|Death|1|||
125420803|NCT00464815|451166132|FG000|Overall Study|Withdrawal by Subject|6|||
125420804|NCT00464815|451166133|FG001|Overall Study|Withdrawal by Subject|3|||
125420805|NCT01260350|451166144|FG000|Overall Study|Lack of Efficacy|0|||
125420806|NCT01260350|451166145|FG001|Overall Study|Lack of Efficacy|0|||
125420807|NCT01260350|451166146|FG002|Overall Study|Lack of Efficacy|0|||
125420808|NCT01260350|451166147|FG003|Overall Study|Lack of Efficacy|0|||
125420809|NCT01260350|451166148|FG004|Overall Study|Lack of Efficacy|0|||
125420810|NCT01260350|451166149|FG005|Overall Study|Lack of Efficacy|0|||
125484858|NCT04433208|451410125|FG000|Overall Study|Lost to Follow-up|0|||
125484859|NCT04433208|451410126|FG001|Overall Study|Lost to Follow-up|0|||
125484860|NCT04433208|451410127|FG002|Overall Study|Lost to Follow-up|0|||
125484861|NCT04433208|451410128|FG003|Overall Study|Lost to Follow-up|0|||
125484862|NCT04433208|451410129|FG004|Overall Study|Lost to Follow-up|0|||
125484863|NCT04433208|451410130|FG005|Overall Study|Lost to Follow-up|1|||
125484864|NCT04299464|451410133|FG000|Overall Study|Adverse Event|1|||
125484865|NCT04299464|451410134|FG001|Overall Study|Adverse Event|0|||
125484866|NCT04299464|451410135|FG002|Overall Study|Adverse Event|2|||
125484867|NCT04299464|451410133|FG000|Overall Study|Non-compliance with Study Drug|1|||
125484868|NCT04299464|451410134|FG001|Overall Study|Non-compliance with Study Drug|0|||
125484869|NCT04299464|451410135|FG002|Overall Study|Non-compliance with Study Drug|0|||
125484870|NCT04299464|451410133|FG000|Overall Study|Reason not Specified|0|||
125484871|NCT04299464|451410134|FG001|Overall Study|Reason not Specified|1|||
125484872|NCT04299464|451410135|FG002|Overall Study|Reason not Specified|3|||
125484873|NCT04299464|451410133|FG000|Overall Study|Physician Decision|0|||
125484874|NCT04299464|451410134|FG001|Overall Study|Physician Decision|1|||
125484875|NCT04299464|451410135|FG002|Overall Study|Physician Decision|1|||
125484876|NCT04299464|451410133|FG000|Overall Study|Withdrawal by Subject|0|||
125484877|NCT04299464|451410134|FG001|Overall Study|Withdrawal by Subject|2|||
125484878|NCT04299464|451410135|FG002|Overall Study|Withdrawal by Subject|1|||
125484879|NCT01868997|451410138|FG000|Overall Study|Adverse Event|2|||
125484880|NCT01868997|451410139|FG001|Overall Study|Adverse Event|5|||
125484881|NCT01868997|451410138|FG000|Overall Study|Lack of Efficacy|2|||
125484882|NCT01868997|451410139|FG001|Overall Study|Lack of Efficacy|0|||
125484883|NCT01868997|451410138|FG000|Overall Study|Other|3|||
125484884|NCT01868997|451410139|FG001|Overall Study|Other|1|||
125484885|NCT02052882|451410140|FG000|Overall Study|Not treated|11|||
125484886|NCT02052882|451410140|FG000|Overall Study|Protocol Violation|1|||
125484887|NCT02052882|451410140|FG000|Overall Study|Inadequate testing|1|||
125484888|NCT04778397|451410141|FG000|Overall Study|Death|59|||
125484889|NCT04778397|451410142|FG001|Overall Study|Death|54|||
125484890|NCT04778397|451410143|FG002|Overall Study|Death|11|||
125484891|NCT04778397|451410144|FG003|Overall Study|Death|9|||
125484892|NCT04778397|451410141|FG000|Overall Study|Study Terminated by Sponsor|34|||
125484893|NCT04778397|451410142|FG001|Overall Study|Study Terminated by Sponsor|42|||
125484894|NCT04778397|451410143|FG002|Overall Study|Study Terminated by Sponsor|15|||
125484895|NCT04778397|451410144|FG003|Overall Study|Study Terminated by Sponsor|12|||
125484896|NCT04778397|451410141|FG000|Overall Study|Withdrew Consent|5|||
125484897|NCT04778397|451410142|FG001|Overall Study|Withdrew Consent|4|||
125484898|NCT04778397|451410143|FG002|Overall Study|Withdrew Consent|1|||
125484899|NCT04778397|451410144|FG003|Overall Study|Withdrew Consent|1|||
125484900|NCT04778397|451410141|FG000|Overall Study|Reason Not Specified|1|||
125484901|NCT04778397|451410142|FG001|Overall Study|Reason Not Specified|3|||
125484902|NCT04778397|451410143|FG002|Overall Study|Reason Not Specified|0|||
125484903|NCT04778397|451410144|FG003|Overall Study|Reason Not Specified|2|||
125484904|NCT04778397|451410141|FG000|Overall Study|Lost to Follow-up|2|||
125484905|NCT04778397|451410142|FG001|Overall Study|Lost to Follow-up|1|||
125484906|NCT04778397|451410143|FG002|Overall Study|Lost to Follow-up|0|||
125484907|NCT04778397|451410144|FG003|Overall Study|Lost to Follow-up|1|||
125484908|NCT05906784|451410146|FG000|Overall Study|Lost to Follow-up|2|||
125484909|NCT05906784|451410147|FG001|Overall Study|Lost to Follow-up|1|||
125484910|NCT05906784|451410148|FG002|Overall Study|Lost to Follow-up|1|||
125484911|NCT05906784|451410149|FG003|Overall Study|Lost to Follow-up|1|||
125484912|NCT01346540|451410155|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
125484913|NCT01346540|451410156|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
125484914|NCT01346540|451410155|FG000|Overall Study|Adverse Event|0|||
125484915|NCT01346540|451410156|FG001|Overall Study|Adverse Event|4|||
125484916|NCT05147116|451410158|FG000|Overall Study|Withdrawal by Subject|0|||
125484917|NCT05147116|451410159|FG001|Overall Study|Withdrawal by Subject|1|||
125484918|NCT03672916|451410160|FG000|Overall Study|Death|6|||
125484919|NCT03672916|451410160|FG000|Overall Study|Lost to Follow-up|29|||
125484920|NCT03672916|451410160|FG000|Overall Study|Adverse Event|6|||
125484921|NCT03672916|451410160|FG000|Overall Study|Withdrawal by Subject|11|||
125303051|NCT03100058|450736665|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
125303052|NCT03100058|450736666|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
125484922|NCT04197336|451410161|FG000|Overall Study|Withdrawal by Subject|1|||
125484923|NCT04585815|451410162|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
125484924|NCT04585815|451410163|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
125484925|NCT04585815|451410164|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
125484926|NCT04585815|451410165|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
125484927|NCT04585815|451410166|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
125484928|NCT04585815|451410167|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
125484929|NCT04585815|451410168|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
125484930|NCT04585815|451410162|FG000|Sub-study A- Treatment Phase|Death|0|||
125484931|NCT04585815|451410163|FG001|Sub-study A- Treatment Phase|Death|1|||
125484932|NCT04585815|451410164|FG002|Sub-study A- Treatment Phase|Death|0|||
125484933|NCT04585815|451410165|FG003|Sub-study A- Treatment Phase|Death|0|||
125484934|NCT04585815|451410166|FG004|Sub-study A- Treatment Phase|Death|0|||
125484935|NCT04585815|451410167|FG005|Sub-study A- Treatment Phase|Death|0|||
125484936|NCT04585815|451410168|FG006|Sub-study A- Treatment Phase|Death|0|||
125484937|NCT04585815|451410162|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
125484938|NCT04585815|451410163|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
125484939|NCT04585815|451410164|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
125484940|NCT04585815|451410165|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
125484941|NCT04585815|451410166|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
125484942|NCT04585815|451410167|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
125484943|NCT04585815|451410168|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
125484944|NCT04585815|451410162|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
125484945|NCT04585815|451410163|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
125484946|NCT04585815|451410164|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
125484947|NCT04585815|451410165|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
125484948|NCT04585815|451410166|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
125484949|NCT04585815|451410167|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
125484950|NCT04585815|451410168|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
125484951|NCT04585815|451410162|FG000|Sub-study A- Treatment Phase|Other|1|||
125484952|NCT04585815|451410163|FG001|Sub-study A- Treatment Phase|Other|0|||
125484953|NCT04585815|451410164|FG002|Sub-study A- Treatment Phase|Other|0|||
125484954|NCT04585815|451410165|FG003|Sub-study A- Treatment Phase|Other|0|||
125484955|NCT04585815|451410166|FG004|Sub-study A- Treatment Phase|Other|0|||
125484956|NCT04585815|451410167|FG005|Sub-study A- Treatment Phase|Other|0|||
125484957|NCT04585815|451410168|FG006|Sub-study A- Treatment Phase|Other|0|||
125484958|NCT04585815|451410162|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
125484959|NCT04585815|451410163|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
125484960|NCT04585815|451410164|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
125484961|NCT04585815|451410165|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
125484962|NCT04585815|451410166|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
125484963|NCT04585815|451410167|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
125484964|NCT04585815|451410168|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
125484965|NCT04585815|451410162|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
125484966|NCT04585815|451410163|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
125484967|NCT04585815|451410164|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
125484968|NCT04585815|451410165|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
125484969|NCT04585815|451410166|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
125484970|NCT04585815|451410167|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
125484971|NCT04585815|451410168|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
125484972|NCT04585815|451410162|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
125484973|NCT04585815|451410163|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
125484974|NCT04585815|451410164|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
125484975|NCT04585815|451410165|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
125484976|NCT04585815|451410166|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
125484977|NCT04585815|451410167|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
125484978|NCT04585815|451410168|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
125484979|NCT04585815|451410162|FG000|Sub-study B- Treatment Phase|Death|0|||
125484980|NCT04585815|451410163|FG001|Sub-study B- Treatment Phase|Death|0|||
125484981|NCT04585815|451410164|FG002|Sub-study B- Treatment Phase|Death|0|||
125484982|NCT04585815|451410165|FG003|Sub-study B- Treatment Phase|Death|1|||
125484983|NCT04585815|451410166|FG004|Sub-study B- Treatment Phase|Death|0|||
125484984|NCT04585815|451410167|FG005|Sub-study B- Treatment Phase|Death|0|||
125484985|NCT04585815|451410168|FG006|Sub-study B- Treatment Phase|Death|0|||
125484986|NCT04585815|451410162|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
125484987|NCT04585815|451410163|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
125484988|NCT04585815|451410164|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
125484989|NCT04585815|451410165|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
125484990|NCT04585815|451410166|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
125484991|NCT04585815|451410167|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
125484992|NCT04585815|451410168|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
125484993|NCT04585815|451410162|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
125484994|NCT04585815|451410163|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
125484995|NCT04585815|451410164|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
125484996|NCT04585815|451410165|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
125484997|NCT04585815|451410166|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
125484998|NCT04585815|451410167|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
125484999|NCT04585815|451410168|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
125485000|NCT04585815|451410162|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
125485001|NCT04585815|451410163|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
125485002|NCT04585815|451410164|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
125485003|NCT04585815|451410165|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
125485004|NCT04585815|451410166|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
125485005|NCT04585815|451410167|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
125485006|NCT04585815|451410168|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
125485007|NCT04585815|451410162|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
125485008|NCT04585815|451410163|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
125485009|NCT04585815|451410164|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
125485010|NCT04585815|451410165|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
125485011|NCT04585815|451410166|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
125485012|NCT04585815|451410167|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
125485013|NCT04585815|451410168|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
125485014|NCT04585815|451410162|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
125485015|NCT04585815|451410163|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
125485016|NCT04585815|451410164|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
125485017|NCT04585815|451410165|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
125485018|NCT04585815|451410166|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
125485019|NCT04585815|451410167|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
125485020|NCT04585815|451410168|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
125485021|NCT04585815|451410162|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
125485022|NCT04585815|451410163|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
125485023|NCT04585815|451410164|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
125485024|NCT04585815|451410165|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
125485025|NCT04585815|451410166|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
125485026|NCT04585815|451410167|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
125485027|NCT04585815|451410168|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
125485028|NCT04585815|451410162|FG000|Sub-study B- Follow-up Phase|Death|0|||
125485029|NCT04585815|451410163|FG001|Sub-study B- Follow-up Phase|Death|0|||
125485030|NCT04585815|451410164|FG002|Sub-study B- Follow-up Phase|Death|1|||
125485031|NCT04585815|451410165|FG003|Sub-study B- Follow-up Phase|Death|3|||
125485032|NCT04585815|451410166|FG004|Sub-study B- Follow-up Phase|Death|0|||
125485033|NCT04585815|451410167|FG005|Sub-study B- Follow-up Phase|Death|0|||
125485034|NCT04585815|451410168|FG006|Sub-study B- Follow-up Phase|Death|1|||
125485035|NCT04587453|451410174|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
125485036|NCT04587453|451410175|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
125485037|NCT04141891|451410178|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
125485038|NCT04141891|451410179|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
125485039|NCT04141891|451410178|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
125485040|NCT04141891|451410179|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
125485041|NCT04141891|451410178|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
125485042|NCT04141891|451410179|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
125485043|NCT04141891|451410178|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
125485044|NCT04141891|451410179|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
125485045|NCT04141891|451410178|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
125485046|NCT04141891|451410179|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
125485047|NCT04141891|451410178|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
125485048|NCT04141891|451410179|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
125485049|NCT04141891|451410178|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
125485050|NCT04141891|451410179|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
125485051|NCT04141891|451410178|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
125485052|NCT04141891|451410179|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
125485053|NCT04141891|451410178|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
125485054|NCT04141891|451410179|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
125485055|NCT04141891|451410178|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
125485056|NCT04141891|451410179|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
125485057|NCT04141891|451410178|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
125485058|NCT04141891|451410179|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
125485059|NCT04141891|451410178|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
125485060|NCT04141891|451410179|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
125485061|NCT04141891|451410178|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
125485062|NCT04141891|451410179|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
125485063|NCT04141891|451410178|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
125485064|NCT04141891|451410179|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
125485065|NCT05090683|451410187|FG000|Overall Study|Lost to Follow-up|10|||
125485066|NCT05090683|451410188|FG001|Overall Study|Lost to Follow-up|2|||
125485067|NCT05090683|451410187|FG000|Overall Study|Withdrawal by Subject|15|||
125485068|NCT05090683|451410188|FG001|Overall Study|Withdrawal by Subject|0|||
125485069|NCT04032847|451410191|FG000|Overall Study|Study termination by sponsor|8|||
125485070|NCT04032847|451410192|FG001|Overall Study|Study termination by sponsor|0|||
125485071|NCT04032847|451410193|FG002|Overall Study|Study termination by sponsor|4|||
125485072|NCT04032847|451410191|FG000|Overall Study|Death|12|||
125485073|NCT04032847|451410192|FG001|Overall Study|Death|0|||
125485074|NCT04032847|451410193|FG002|Overall Study|Death|0|||
125485075|NCT04032847|451410191|FG000|Overall Study|Progressive disease|2|||
125485076|NCT04032847|451410192|FG001|Overall Study|Progressive disease|0|||
125485077|NCT04032847|451410193|FG002|Overall Study|Progressive disease|1|||
125485078|NCT03213665|451410194|FG000|Overall Study|Adverse Event|1|||
125485079|NCT03213665|451410194|FG000|Overall Study|Physician Decision|2|||
125485080|NCT03213665|451410194|FG000|Overall Study|Withdrawal by Subject|3|||
125485081|NCT03213665|451410194|FG000|Overall Study|Progressive Disease|13|||
125485082|NCT03056573|451410195|FG000|Overall Study|Death|2|||
125485083|NCT03056573|451410196|FG001|Overall Study|Death|4|||
125485084|NCT03056573|451410195|FG000|Overall Study|Withdrawal by Subject|2|||
125485085|NCT03056573|451410196|FG001|Overall Study|Withdrawal by Subject|0|||
125485086|NCT03056573|451410195|FG000|Overall Study|Lost to Follow-up|1|||
125485087|NCT03056573|451410196|FG001|Overall Study|Lost to Follow-up|1|||
125485088|NCT04689256|451410197|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
125485089|NCT04689256|451410198|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
125485090|NCT05104463|451410201|FG000|Overall Study|Adverse Event|1|||
125485091|NCT05104463|451410202|FG001|Overall Study|Adverse Event|1|||
125485092|NCT05104463|451410201|FG000|Overall Study|Lost to Follow-up|1|||
125485093|NCT05104463|451410202|FG001|Overall Study|Lost to Follow-up|1|||
125485094|NCT05104463|451410201|FG000|Overall Study|Physician Decision|1|||
125485095|NCT05104463|451410202|FG001|Overall Study|Physician Decision|0|||
125485096|NCT05104463|451410201|FG000|Overall Study|Protocol Violation|0|||
125485097|NCT05104463|451410202|FG001|Overall Study|Protocol Violation|2|||
125485098|NCT05104463|451410201|FG000|Overall Study|Withdrawal by Subject|1|||
125485099|NCT05104463|451410202|FG001|Overall Study|Withdrawal by Subject|1|||
125485100|NCT05267470|451410204|FG000|Overall Study|Decision by sponsor|0|||
125485101|NCT05267470|451410205|FG001|Overall Study|Decision by sponsor|3|||
125485102|NCT05267470|451410206|FG002|Overall Study|Decision by sponsor|19|||
125485103|NCT05267470|451410207|FG003|Overall Study|Decision by sponsor|7|||
125485104|NCT05267470|451410208|FG004|Overall Study|Decision by sponsor|3|||
125485105|NCT05267470|451410204|FG000|Overall Study|Withdrawal by Subject|1|||
125485106|NCT05267470|451410205|FG001|Overall Study|Withdrawal by Subject|1|||
125485107|NCT05267470|451410206|FG002|Overall Study|Withdrawal by Subject|2|||
125485108|NCT05267470|451410207|FG003|Overall Study|Withdrawal by Subject|2|||
125485109|NCT05267470|451410208|FG004|Overall Study|Withdrawal by Subject|0|||
125485110|NCT05267470|451410204|FG000|Overall Study|Death|3|||
125485111|NCT05267470|451410205|FG001|Overall Study|Death|5|||
125485112|NCT05267470|451410206|FG002|Overall Study|Death|8|||
125485113|NCT05267470|451410207|FG003|Overall Study|Death|18|||
125485114|NCT05267470|451410208|FG004|Overall Study|Death|1|||
125485115|NCT05267470|451410204|FG000|Overall Study|Lost to Follow-up|0|||
125485116|NCT05267470|451410205|FG001|Overall Study|Lost to Follow-up|0|||
125485117|NCT05267470|451410206|FG002|Overall Study|Lost to Follow-up|0|||
125485118|NCT05267470|451410207|FG003|Overall Study|Lost to Follow-up|1|||
125485119|NCT05267470|451410208|FG004|Overall Study|Lost to Follow-up|0|||
125485120|NCT04230681|451410215|FG000|Overall Study|Physician Decision|2|||
125485121|NCT04230681|451410216|FG001|Overall Study|Physician Decision|3|||
125485122|NCT04230681|451410215|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
125485123|NCT04230681|451410216|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
125485124|NCT04230681|451410215|FG000|Overall Study|IV inadvertently removed|0|||
125485125|NCT04230681|451410216|FG001|Overall Study|IV inadvertently removed|1|||
125485126|NCT00696111|451412430|FG000|Overall Study|Withdrawal by Subject|17|||
125485127|NCT02433379|451412431|FG000|Overall Study|Screen Failures|55|||
125485128|NCT02433379|451412431|FG000|Overall Study|Death|57|||
125485129|NCT02433379|451412431|FG000|Overall Study|Total Withdrawals|209|||
125485130|NCT02038777|451412434|FG000|Overall Study|Death|0|||
125485131|NCT02038777|451412435|FG001|Overall Study|Death|2|||
125303053|NCT03100058|450736667|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
125485132|NCT02038777|451412436|FG002|Overall Study|Death|0|||
125485133|NCT02038777|451412437|FG003|Overall Study|Death|1|||
125485134|NCT02038777|451412438|FG004|Overall Study|Death|2|||
125485135|NCT02038777|451412439|FG005|Overall Study|Death|4|||
125485136|NCT02038777|451412440|FG006|Overall Study|Death|0|||
125303054|NCT03100058|450736668|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
125485137|NCT02038777|451412441|FG007|Overall Study|Death|11|||
125485138|NCT02038777|451412434|FG000|Overall Study|Lost to Follow-up|0|||
125485139|NCT02038777|451412435|FG001|Overall Study|Lost to Follow-up|0|||
125485140|NCT02038777|451412436|FG002|Overall Study|Lost to Follow-up|0|||
125485141|NCT02038777|451412437|FG003|Overall Study|Lost to Follow-up|1|||
125485142|NCT02038777|451412438|FG004|Overall Study|Lost to Follow-up|0|||
125485143|NCT02038777|451412439|FG005|Overall Study|Lost to Follow-up|0|||
125485144|NCT02038777|451412440|FG006|Overall Study|Lost to Follow-up|0|||
125485145|NCT02038777|451412441|FG007|Overall Study|Lost to Follow-up|0|||
125485146|NCT02038777|451412434|FG000|Overall Study|Other|0|||
125485147|NCT02038777|451412435|FG001|Overall Study|Other|1|||
125485148|NCT02038777|451412436|FG002|Overall Study|Other|0|||
125485149|NCT02038777|451412437|FG003|Overall Study|Other|2|||
125485150|NCT02038777|451412438|FG004|Overall Study|Other|1|||
125485151|NCT02038777|451412439|FG005|Overall Study|Other|0|||
125485152|NCT02038777|451412440|FG006|Overall Study|Other|0|||
125485153|NCT02038777|451412441|FG007|Overall Study|Other|0|||
125485154|NCT02038777|451412434|FG000|Overall Study|Randomized but not treated|0|||
125485155|NCT02038777|451412435|FG001|Overall Study|Randomized but not treated|1|||
125485156|NCT02038777|451412436|FG002|Overall Study|Randomized but not treated|0|||
125485157|NCT02038777|451412437|FG003|Overall Study|Randomized but not treated|0|||
125485158|NCT02038777|451412438|FG004|Overall Study|Randomized but not treated|0|||
125485159|NCT02038777|451412439|FG005|Overall Study|Randomized but not treated|0|||
125485160|NCT02038777|451412440|FG006|Overall Study|Randomized but not treated|0|||
125485161|NCT02038777|451412441|FG007|Overall Study|Randomized but not treated|0|||
125485162|NCT02038777|451412434|FG000|Overall Study|Started Chemotherapy|1|||
125485163|NCT02038777|451412435|FG001|Overall Study|Started Chemotherapy|0|||
125485164|NCT02038777|451412436|FG002|Overall Study|Started Chemotherapy|3|||
125485165|NCT02038777|451412437|FG003|Overall Study|Started Chemotherapy|0|||
125485166|NCT02038777|451412438|FG004|Overall Study|Started Chemotherapy|0|||
125485167|NCT02038777|451412439|FG005|Overall Study|Started Chemotherapy|0|||
125485168|NCT02038777|451412440|FG006|Overall Study|Started Chemotherapy|0|||
125485169|NCT02038777|451412441|FG007|Overall Study|Started Chemotherapy|0|||
125485170|NCT02038777|451412434|FG000|Overall Study|participation terminated by sponsor|0|||
125485171|NCT02038777|451412435|FG001|Overall Study|participation terminated by sponsor|0|||
125485172|NCT02038777|451412436|FG002|Overall Study|participation terminated by sponsor|0|||
125485173|NCT02038777|451412437|FG003|Overall Study|participation terminated by sponsor|0|||
125485174|NCT02038777|451412438|FG004|Overall Study|participation terminated by sponsor|0|||
125485175|NCT02038777|451412439|FG005|Overall Study|participation terminated by sponsor|0|||
125485176|NCT02038777|451412440|FG006|Overall Study|participation terminated by sponsor|1|||
125485177|NCT02038777|451412441|FG007|Overall Study|participation terminated by sponsor|1|||
125485178|NCT03676192|451412442|FG000|Induction Study Period|Adverse Event|21|||
125485179|NCT03676192|451412443|FG001|Induction Study Period|Adverse Event|20|||
125485180|NCT03676192|451412442|FG000|Induction Study Period|Death|23|||
125485181|NCT03676192|451412443|FG001|Induction Study Period|Death|20|||
125485182|NCT03676192|451412442|FG000|Induction Study Period|Lost to Follow-up|3|||
125485183|NCT03676192|451412443|FG001|Induction Study Period|Lost to Follow-up|3|||
125485184|NCT03676192|451412442|FG000|Induction Study Period|Physician Decision|6|||
125485185|NCT03676192|451412443|FG001|Induction Study Period|Physician Decision|3|||
125485186|NCT03676192|451412442|FG000|Induction Study Period|Progressive Disease|32|||
125485187|NCT03676192|451412443|FG001|Induction Study Period|Progressive Disease|21|||
125485188|NCT03676192|451412442|FG000|Induction Study Period|Protocol Violation|1|||
125485189|NCT03676192|451412443|FG001|Induction Study Period|Protocol Violation|2|||
125485190|NCT03676192|451412442|FG000|Induction Study Period|Withdrawal by Subject|20|||
125485191|NCT03676192|451412443|FG001|Induction Study Period|Withdrawal by Subject|15|||
125485192|NCT04079218|451412444|FG000|Overall Study|Death|1|||
125485193|NCT04079218|451412445|FG001|Overall Study|Death|0|||
125485194|NCT04079218|451412444|FG000|Overall Study|Withdrawal by Subject|3|||
125485195|NCT04079218|451412445|FG001|Overall Study|Withdrawal by Subject|0|||
125485196|NCT04079218|451412444|FG000|Overall Study|Physician Decision|4|||
125485197|NCT04079218|451412445|FG001|Overall Study|Physician Decision|0|||
125485198|NCT04079218|451412444|FG000|Overall Study|Lost to Follow-up|0|||
125485199|NCT04079218|451412445|FG001|Overall Study|Lost to Follow-up|1|||
125485200|NCT02694822|451412448|FG000|Phase 1|Death|2|||
125485201|NCT02694822|451412449|FG001|Phase 1|Death|1|||
125485202|NCT02694822|451412450|FG002|Phase 1|Death|6|||
125485203|NCT02694822|451412451|FG003|Phase 1|Death|6|||
125485204|NCT02694822|451412452|FG004|Phase 1|Death|3|||
125485205|NCT02694822|451412453|FG005|Phase 1|Death|0|||
125485206|NCT02694822|451412448|FG000|Phase 1|Withdrawal by Subject|2|||
125485207|NCT02694822|451412449|FG001|Phase 1|Withdrawal by Subject|2|||
125485208|NCT02694822|451412450|FG002|Phase 1|Withdrawal by Subject|4|||
125485209|NCT02694822|451412451|FG003|Phase 1|Withdrawal by Subject|8|||
125485210|NCT02694822|451412452|FG004|Phase 1|Withdrawal by Subject|1|||
125485211|NCT02694822|451412453|FG005|Phase 1|Withdrawal by Subject|0|||
125485212|NCT02694822|451412448|FG000|Phase 2|Death|0|||
125303055|NCT03100058|450736669|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
125485213|NCT02694822|451412449|FG001|Phase 2|Death|0|||
125485214|NCT02694822|451412450|FG002|Phase 2|Death|0|||
125485215|NCT02694822|451412451|FG003|Phase 2|Death|0|||
125485216|NCT02694822|451412452|FG004|Phase 2|Death|0|||
125485217|NCT02694822|451412453|FG005|Phase 2|Death|26|||
125485218|NCT02694822|451412448|FG000|Phase 2|Withdrawal by Subject|0|||
125485219|NCT02694822|451412449|FG001|Phase 2|Withdrawal by Subject|0|||
125485220|NCT02694822|451412450|FG002|Phase 2|Withdrawal by Subject|0|||
125485221|NCT02694822|451412451|FG003|Phase 2|Withdrawal by Subject|0|||
125485222|NCT02694822|451412452|FG004|Phase 2|Withdrawal by Subject|0|||
125485223|NCT02694822|451412453|FG005|Phase 2|Withdrawal by Subject|13|||
125485224|NCT02694822|451412448|FG000|Phase 2|Administrative Study Closure|0|||
125485225|NCT02694822|451412449|FG001|Phase 2|Administrative Study Closure|0|||
125485226|NCT02694822|451412450|FG002|Phase 2|Administrative Study Closure|0|||
125485227|NCT02694822|451412451|FG003|Phase 2|Administrative Study Closure|0|||
125485228|NCT02694822|451412452|FG004|Phase 2|Administrative Study Closure|0|||
125485229|NCT02694822|451412453|FG005|Phase 2|Administrative Study Closure|2|||
125485230|NCT02694822|451412448|FG000|Phase 2|Lost to Follow-up|0|||
125485231|NCT02694822|451412449|FG001|Phase 2|Lost to Follow-up|0|||
125485232|NCT02694822|451412450|FG002|Phase 2|Lost to Follow-up|0|||
125485233|NCT02694822|451412451|FG003|Phase 2|Lost to Follow-up|0|||
125485234|NCT02694822|451412452|FG004|Phase 2|Lost to Follow-up|0|||
125485235|NCT02694822|451412453|FG005|Phase 2|Lost to Follow-up|1|||
125485236|NCT02694822|451412448|FG000|Phase 2|Participant Transferred to Another Site|0|||
125485237|NCT02694822|451412449|FG001|Phase 2|Participant Transferred to Another Site|0|||
125485238|NCT02694822|451412450|FG002|Phase 2|Participant Transferred to Another Site|0|||
125485239|NCT02694822|451412451|FG003|Phase 2|Participant Transferred to Another Site|0|||
125485240|NCT02694822|451412452|FG004|Phase 2|Participant Transferred to Another Site|0|||
125485241|NCT02694822|451412453|FG005|Phase 2|Participant Transferred to Another Site|1|||
125485242|NCT02424617|451412454|FG000|Overall Study|Adverse Event|0|||
125485243|NCT02424617|451412455|FG001|Overall Study|Adverse Event|1|||
125485244|NCT02424617|451412456|FG002|Overall Study|Adverse Event|0|||
125485245|NCT02424617|451412457|FG003|Overall Study|Adverse Event|0|||
125485246|NCT02424617|451412454|FG000|Overall Study|Investigator Decision|0|||
125485247|NCT02424617|451412455|FG001|Overall Study|Investigator Decision|0|||
125485248|NCT02424617|451412456|FG002|Overall Study|Investigator Decision|0|||
125485249|NCT02424617|451412457|FG003|Overall Study|Investigator Decision|1|||
125485250|NCT02424617|451412454|FG000|Overall Study|Withdrawal by Subject|1|||
125485251|NCT02424617|451412455|FG001|Overall Study|Withdrawal by Subject|1|||
125485252|NCT02424617|451412456|FG002|Overall Study|Withdrawal by Subject|0|||
125485253|NCT02424617|451412457|FG003|Overall Study|Withdrawal by Subject|1|||
125485254|NCT02424617|451412454|FG000|Overall Study|Progressive Disease|7|||
125485255|NCT02424617|451412455|FG001|Overall Study|Progressive Disease|6|||
125485256|NCT02424617|451412456|FG002|Overall Study|Progressive Disease|11|||
125485257|NCT02424617|451412457|FG003|Overall Study|Progressive Disease|10|||
125485258|NCT02424617|451412454|FG000|Overall Study|Other|0|||
125485259|NCT02424617|451412455|FG001|Overall Study|Other|0|||
125485260|NCT02424617|451412456|FG002|Overall Study|Other|0|||
125485261|NCT02424617|451412457|FG003|Overall Study|Other|1|||
125485262|NCT04294641|451412465|FG000|Overall Study|Screen failure|4|||
125485263|NCT04314778|451412482|FG000|Overall Study|Lost to Follow-up|5|||
125485264|NCT04314778|451412483|FG001|Overall Study|Lost to Follow-up|3|||
125485265|NCT04024020|451412486|FG000|Overall Study|Withdrawal by Subject|2|||
125485266|NCT04024020|451412487|FG001|Overall Study|Withdrawal by Subject|2|||
125485267|NCT05646355|451412488|FG000|Overall Study|Lost to Follow-up|1|||
125485268|NCT05646355|451412489|FG001|Overall Study|Lost to Follow-up|0|||
125485269|NCT05646355|451412488|FG000|Overall Study|translated materials not available for pilot|2|||
125485270|NCT05646355|451412489|FG001|Overall Study|translated materials not available for pilot|0|||
125485271|NCT05646355|451412488|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
125485272|NCT05646355|451412489|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
125485273|NCT03523572|451412492|FG000|Dose Escalation|Progressive disease|1|||
125485274|NCT03523572|451412493|FG001|Dose Escalation|Progressive disease|0|||
125485275|NCT03523572|451412494|FG002|Dose Escalation|Progressive disease|0|||
125485276|NCT03523572|451412495|FG003|Dose Escalation|Progressive disease|0|||
125485277|NCT03523572|451412496|FG004|Dose Escalation|Progressive disease|0|||
125485278|NCT03523572|451412497|FG005|Dose Escalation|Progressive disease|0|||
125485279|NCT03523572|451412492|FG000|Dose Escalation|Clinical Progression|0|||
125485280|NCT03523572|451412493|FG001|Dose Escalation|Clinical Progression|1|||
125485281|NCT03523572|451412494|FG002|Dose Escalation|Clinical Progression|0|||
125485282|NCT03523572|451412495|FG003|Dose Escalation|Clinical Progression|0|||
125485283|NCT03523572|451412496|FG004|Dose Escalation|Clinical Progression|0|||
125485284|NCT03523572|451412497|FG005|Dose Escalation|Clinical Progression|0|||
125485285|NCT03523572|451412492|FG000|Dose Escalation|Adverse Event|2|||
125485286|NCT03523572|451412493|FG001|Dose Escalation|Adverse Event|0|||
125485287|NCT03523572|451412494|FG002|Dose Escalation|Adverse Event|0|||
125485288|NCT03523572|451412495|FG003|Dose Escalation|Adverse Event|0|||
125485289|NCT03523572|451412496|FG004|Dose Escalation|Adverse Event|0|||
125485290|NCT03523572|451412497|FG005|Dose Escalation|Adverse Event|0|||
125485291|NCT03523572|451412492|FG000|Dose Escalation|Physician Decision|1|||
125485292|NCT03523572|451412493|FG001|Dose Escalation|Physician Decision|1|||
125485293|NCT03523572|451412494|FG002|Dose Escalation|Physician Decision|0|||
125485294|NCT03523572|451412495|FG003|Dose Escalation|Physician Decision|0|||
125485295|NCT03523572|451412496|FG004|Dose Escalation|Physician Decision|0|||
125485296|NCT03523572|451412497|FG005|Dose Escalation|Physician Decision|0|||
125485297|NCT03523572|451412492|FG000|Dose Expansion|Progressive Disease|0|||
125485298|NCT03523572|451412493|FG001|Dose Expansion|Progressive Disease|0|||
125485299|NCT03523572|451412494|FG002|Dose Expansion|Progressive Disease|9|||
125485461|NCT02240238|451412503|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
125485462|NCT02240238|451412504|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
125485463|NCT02240238|451412505|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
125485464|NCT02240238|451412506|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
125485465|NCT02240238|451412507|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
125485466|NCT02240238|451412508|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
125485467|NCT02240238|451412509|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
125485468|NCT02240238|451412510|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
125485469|NCT02240238|451412511|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
125485470|NCT02240238|451412512|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
125485471|NCT02240238|451412513|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
125485472|NCT02240238|451412514|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
125485473|NCT02240238|451412503|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
125485474|NCT02240238|451412504|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
125485475|NCT02240238|451412505|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
125485476|NCT02240238|451412506|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
125485477|NCT02240238|451412507|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
125485478|NCT02240238|451412508|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
125485479|NCT02240238|451412509|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
125485480|NCT02240238|451412510|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
125485481|NCT02240238|451412511|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
125485482|NCT02240238|451412512|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
125485483|NCT02240238|451412513|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
125485484|NCT02240238|451412514|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
125485485|NCT02240238|451412503|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
125485486|NCT02240238|451412504|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
125485487|NCT02240238|451412505|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
125485488|NCT02240238|451412506|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
125485489|NCT02240238|451412507|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
125485490|NCT02240238|451412508|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
125485491|NCT02240238|451412509|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
125485492|NCT02240238|451412510|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
125485493|NCT02240238|451412511|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
125485494|NCT02240238|451412512|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
125485495|NCT02240238|451412513|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
125485496|NCT02240238|451412514|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
125485497|NCT02240238|451412503|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
125485498|NCT02240238|451412504|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
125485499|NCT02240238|451412505|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
125485500|NCT02240238|451412506|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
125485501|NCT02240238|451412507|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
125485502|NCT02240238|451412508|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
125485503|NCT02240238|451412509|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
125485504|NCT02240238|451412510|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
125485505|NCT02240238|451412511|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
125485506|NCT02240238|451412512|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
125485507|NCT02240238|451412513|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
125485508|NCT02240238|451412514|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
125485509|NCT02240238|451412503|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
125485510|NCT02240238|451412504|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
125485511|NCT02240238|451412505|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
125485512|NCT02240238|451412506|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
125485513|NCT02240238|451412507|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
125485514|NCT02240238|451412508|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
125485515|NCT02240238|451412509|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
125485516|NCT02240238|451412510|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
125485517|NCT02240238|451412511|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
125485518|NCT02240238|451412512|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
125485519|NCT02240238|451412513|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
125485520|NCT02240238|451412514|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
125485521|NCT02240238|451412503|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
125485522|NCT02240238|451412504|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
125485523|NCT02240238|451412505|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
125485524|NCT02240238|451412506|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
125485525|NCT02240238|451412507|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
125485526|NCT02240238|451412508|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
125485527|NCT02240238|451412509|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
125485528|NCT02240238|451412510|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
125485529|NCT02240238|451412511|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
125485530|NCT02240238|451412512|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
125485531|NCT02240238|451412513|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
125485532|NCT02240238|451412514|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
125485533|NCT02240238|451412503|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
125485534|NCT02240238|451412504|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
125485535|NCT02240238|451412505|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
125485536|NCT02240238|451412506|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
125485537|NCT02240238|451412507|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
125485538|NCT02240238|451412508|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
125485539|NCT02240238|451412509|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
125485540|NCT02240238|451412510|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
125485541|NCT02240238|451412511|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
125485542|NCT02240238|451412512|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
125485543|NCT02240238|451412513|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
125485544|NCT02240238|451412514|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
125485545|NCT02240238|451412503|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
125485546|NCT02240238|451412504|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
125485547|NCT02240238|451412505|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
125485548|NCT02240238|451412506|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
125485549|NCT02240238|451412507|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
125485550|NCT02240238|451412508|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
125485551|NCT02240238|451412509|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
125485552|NCT02240238|451412510|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
125485553|NCT02240238|451412511|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
125485554|NCT02240238|451412512|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
125485555|NCT02240238|451412513|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
125485556|NCT02240238|451412514|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
125485557|NCT02315703|451412515|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
125485558|NCT02315703|451412516|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
125485559|NCT02315703|451412517|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
125485560|NCT02315703|451412518|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
125485561|NCT02315703|451412519|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
125303183|NCT03100058|450736667|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303184|NCT03100058|450736668|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303185|NCT03100058|450736669|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303186|NCT03100058|450736670|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
125303187|NCT03100058|450736671|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
125303188|NCT03100058|450736672|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
125303189|NCT03100058|450736673|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
125303190|NCT03100058|450736661|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125485562|NCT02315703|451412520|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
125485563|NCT02315703|451412521|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
125485564|NCT02315703|451412522|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
125485565|NCT02315703|451412515|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
125485566|NCT02315703|451412516|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
125485567|NCT02315703|451412517|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
125485568|NCT02315703|451412518|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
125485569|NCT02315703|451412519|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
125485570|NCT02315703|451412520|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
125303191|NCT03100058|450736662|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125303192|NCT03100058|450736663|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125309878|NCT00947115|450760199|FG000|Overall Study|Lost to Follow-up|11|||
125485571|NCT02315703|451412521|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
125485572|NCT02315703|451412522|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
125485573|NCT02315703|451412515|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
125485574|NCT02315703|451412516|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
125485575|NCT02315703|451412517|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
125485576|NCT02315703|451412518|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
125485577|NCT02315703|451412519|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
125485578|NCT02315703|451412520|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
125485579|NCT02315703|451412521|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
125485580|NCT02315703|451412522|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
125485581|NCT02315703|451412515|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
125485582|NCT02315703|451412516|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
125485583|NCT02315703|451412517|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
125485584|NCT02315703|451412518|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
125485585|NCT02315703|451412519|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
125485586|NCT02315703|451412520|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
125485587|NCT02315703|451412521|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
125485588|NCT02315703|451412522|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
125485589|NCT02315703|451412515|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
125485590|NCT02315703|451412516|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
125485591|NCT02315703|451412517|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
125485592|NCT02315703|451412518|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
125485593|NCT02315703|451412519|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
125485594|NCT02315703|451412520|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
125485595|NCT02315703|451412521|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
125485596|NCT02315703|451412522|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
125485597|NCT02315703|451412515|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
125485598|NCT02315703|451412516|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
125485599|NCT02315703|451412517|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
125485600|NCT02315703|451412518|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
125485601|NCT02315703|451412519|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
125485602|NCT02315703|451412520|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
125485603|NCT02315703|451412521|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
125485604|NCT02315703|451412522|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
125485605|NCT02315703|451412515|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
125485606|NCT02315703|451412516|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
125485607|NCT02315703|451412517|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
125485608|NCT02315703|451412518|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
125485609|NCT02315703|451412519|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
125485610|NCT02315703|451412520|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
125485611|NCT02315703|451412521|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
125485612|NCT02315703|451412522|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
125485613|NCT02315703|451412515|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
125485614|NCT02315703|451412516|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
125485615|NCT02315703|451412517|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
125485616|NCT02315703|451412518|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
125485617|NCT02315703|451412519|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
125485618|NCT02315703|451412520|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
125485619|NCT02315703|451412521|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
125485620|NCT02315703|451412522|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
125485621|NCT02315703|451412515|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
125485622|NCT02315703|451412516|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
125485623|NCT02315703|451412517|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
125485624|NCT02315703|451412518|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
125485625|NCT02315703|451412519|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
125485626|NCT02315703|451412520|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
125485627|NCT02315703|451412521|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
125485628|NCT02315703|451412522|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
125485629|NCT03519178|451412523|FG000|PF-06873600 Treatment|Adverse Event|0|||
125485630|NCT03519178|451412524|FG001|PF-06873600 Treatment|Adverse Event|0|||
125485631|NCT03519178|451412525|FG002|PF-06873600 Treatment|Adverse Event|0|||
125485632|NCT03519178|451412526|FG003|PF-06873600 Treatment|Adverse Event|0|||
125485633|NCT03519178|451412527|FG004|PF-06873600 Treatment|Adverse Event|0|||
125485634|NCT03519178|451412528|FG005|PF-06873600 Treatment|Adverse Event|0|||
125485635|NCT03519178|451412529|FG006|PF-06873600 Treatment|Adverse Event|0|||
125485636|NCT03519178|451412530|FG007|PF-06873600 Treatment|Adverse Event|2|||
125485637|NCT03519178|451412531|FG008|PF-06873600 Treatment|Adverse Event|1|||
125485638|NCT03519178|451412532|FG009|PF-06873600 Treatment|Adverse Event|0|||
125485639|NCT03519178|451412533|FG010|PF-06873600 Treatment|Adverse Event|0|||
125485640|NCT03519178|451412534|FG011|PF-06873600 Treatment|Adverse Event|0|||
125485641|NCT03519178|451412535|FG012|PF-06873600 Treatment|Adverse Event|1|||
125485642|NCT03519178|451412536|FG013|PF-06873600 Treatment|Adverse Event|3|||
125485643|NCT03519178|451412537|FG014|PF-06873600 Treatment|Adverse Event|2|||
125485644|NCT03519178|451412523|FG000|PF-06873600 Treatment|Death|0|||
125485645|NCT03519178|451412524|FG001|PF-06873600 Treatment|Death|0|||
125485646|NCT03519178|451412525|FG002|PF-06873600 Treatment|Death|0|||
125485647|NCT03519178|451412526|FG003|PF-06873600 Treatment|Death|0|||
125485648|NCT03519178|451412527|FG004|PF-06873600 Treatment|Death|0|||
125485649|NCT03519178|451412528|FG005|PF-06873600 Treatment|Death|0|||
125485650|NCT03519178|451412529|FG006|PF-06873600 Treatment|Death|0|||
125485651|NCT03519178|451412530|FG007|PF-06873600 Treatment|Death|0|||
125485652|NCT03519178|451412531|FG008|PF-06873600 Treatment|Death|1|||
125485653|NCT03519178|451412532|FG009|PF-06873600 Treatment|Death|1|||
125485654|NCT03519178|451412533|FG010|PF-06873600 Treatment|Death|0|||
125485655|NCT03519178|451412534|FG011|PF-06873600 Treatment|Death|0|||
125485656|NCT03519178|451412535|FG012|PF-06873600 Treatment|Death|0|||
125485657|NCT03519178|451412536|FG013|PF-06873600 Treatment|Death|0|||
125485658|NCT03519178|451412537|FG014|PF-06873600 Treatment|Death|1|||
125485659|NCT03519178|451412523|FG000|PF-06873600 Treatment|Physician Decision|0|||
125485660|NCT03519178|451412524|FG001|PF-06873600 Treatment|Physician Decision|0|||
125485661|NCT03519178|451412525|FG002|PF-06873600 Treatment|Physician Decision|0|||
125485662|NCT03519178|451412526|FG003|PF-06873600 Treatment|Physician Decision|0|||
125485663|NCT03519178|451412527|FG004|PF-06873600 Treatment|Physician Decision|0|||
125485664|NCT03519178|451412528|FG005|PF-06873600 Treatment|Physician Decision|0|||
125485665|NCT03519178|451412529|FG006|PF-06873600 Treatment|Physician Decision|0|||
125485666|NCT03519178|451412530|FG007|PF-06873600 Treatment|Physician Decision|1|||
125485667|NCT03519178|451412531|FG008|PF-06873600 Treatment|Physician Decision|0|||
125485668|NCT03519178|451412532|FG009|PF-06873600 Treatment|Physician Decision|0|||
125485669|NCT03519178|451412533|FG010|PF-06873600 Treatment|Physician Decision|1|||
125485670|NCT03519178|451412534|FG011|PF-06873600 Treatment|Physician Decision|0|||
125485671|NCT03519178|451412535|FG012|PF-06873600 Treatment|Physician Decision|0|||
125485672|NCT03519178|451412536|FG013|PF-06873600 Treatment|Physician Decision|4|||
125485673|NCT03519178|451412537|FG014|PF-06873600 Treatment|Physician Decision|1|||
125485674|NCT03519178|451412523|FG000|PF-06873600 Treatment|Progressive disease|1|||
125485675|NCT03519178|451412524|FG001|PF-06873600 Treatment|Progressive disease|1|||
125485676|NCT03519178|451412525|FG002|PF-06873600 Treatment|Progressive disease|1|||
125485677|NCT03519178|451412526|FG003|PF-06873600 Treatment|Progressive disease|1|||
125485678|NCT03519178|451412527|FG004|PF-06873600 Treatment|Progressive disease|6|||
125485679|NCT03519178|451412528|FG005|PF-06873600 Treatment|Progressive disease|7|||
125485680|NCT03519178|451412529|FG006|PF-06873600 Treatment|Progressive disease|3|||
125485681|NCT03519178|451412530|FG007|PF-06873600 Treatment|Progressive disease|7|||
125485682|NCT03519178|451412531|FG008|PF-06873600 Treatment|Progressive disease|3|||
125485683|NCT03519178|451412532|FG009|PF-06873600 Treatment|Progressive disease|5|||
125485684|NCT03519178|451412533|FG010|PF-06873600 Treatment|Progressive disease|4|||
125485685|NCT03519178|451412534|FG011|PF-06873600 Treatment|Progressive disease|3|||
125485686|NCT03519178|451412535|FG012|PF-06873600 Treatment|Progressive disease|4|||
125485687|NCT03519178|451412536|FG013|PF-06873600 Treatment|Progressive disease|28|||
125485688|NCT03519178|451412537|FG014|PF-06873600 Treatment|Progressive disease|7|||
125485689|NCT03519178|451412523|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
125485690|NCT03519178|451412524|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
125485691|NCT03519178|451412525|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
125485692|NCT03519178|451412526|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
125485693|NCT03519178|451412527|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
125485694|NCT03519178|451412528|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
125485695|NCT03519178|451412529|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
125485696|NCT03519178|451412530|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
125485697|NCT03519178|451412531|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
125485698|NCT03519178|451412532|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
125485699|NCT03519178|451412533|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
125303193|NCT03100058|450736664|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125485700|NCT03519178|451412534|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
125485701|NCT03519178|451412535|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
125485702|NCT03519178|451412536|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
125485703|NCT03519178|451412537|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
125485704|NCT03519178|451412523|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
125303194|NCT03100058|450736665|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125485705|NCT03519178|451412524|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
125485706|NCT03519178|451412525|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
125485707|NCT03519178|451412526|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
125303195|NCT03100058|450736666|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125485708|NCT03519178|451412527|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
125485709|NCT03519178|451412528|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
125485710|NCT03519178|451412529|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
125485711|NCT03519178|451412530|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
125485712|NCT03519178|451412531|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
125485713|NCT03519178|451412532|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
125485714|NCT03519178|451412533|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
125485715|NCT03519178|451412534|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
125485716|NCT03519178|451412535|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
125485717|NCT03519178|451412536|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
125485718|NCT03519178|451412537|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
125485719|NCT03519178|451412523|FG000|PF-06873600 Treatment|Refused further treatment|0|||
125485720|NCT03519178|451412524|FG001|PF-06873600 Treatment|Refused further treatment|1|||
125485721|NCT03519178|451412525|FG002|PF-06873600 Treatment|Refused further treatment|0|||
125485722|NCT03519178|451412526|FG003|PF-06873600 Treatment|Refused further treatment|0|||
125485723|NCT03519178|451412527|FG004|PF-06873600 Treatment|Refused further treatment|1|||
125485724|NCT03519178|451412528|FG005|PF-06873600 Treatment|Refused further treatment|0|||
125485725|NCT03519178|451412529|FG006|PF-06873600 Treatment|Refused further treatment|0|||
125485726|NCT03519178|451412530|FG007|PF-06873600 Treatment|Refused further treatment|0|||
125485727|NCT03519178|451412531|FG008|PF-06873600 Treatment|Refused further treatment|0|||
125485728|NCT03519178|451412532|FG009|PF-06873600 Treatment|Refused further treatment|0|||
125485729|NCT03519178|451412533|FG010|PF-06873600 Treatment|Refused further treatment|0|||
125485730|NCT03519178|451412534|FG011|PF-06873600 Treatment|Refused further treatment|0|||
125485731|NCT03519178|451412535|FG012|PF-06873600 Treatment|Refused further treatment|0|||
125485732|NCT03519178|451412536|FG013|PF-06873600 Treatment|Refused further treatment|0|||
125485733|NCT03519178|451412537|FG014|PF-06873600 Treatment|Refused further treatment|1|||
125485734|NCT03519178|451412523|FG000|PF-06873600 Treatment|Other|0|||
125485735|NCT03519178|451412524|FG001|PF-06873600 Treatment|Other|0|||
125485736|NCT03519178|451412525|FG002|PF-06873600 Treatment|Other|0|||
125485737|NCT03519178|451412526|FG003|PF-06873600 Treatment|Other|0|||
125485738|NCT03519178|451412527|FG004|PF-06873600 Treatment|Other|0|||
125485739|NCT03519178|451412528|FG005|PF-06873600 Treatment|Other|0|||
125485740|NCT03519178|451412529|FG006|PF-06873600 Treatment|Other|0|||
125485741|NCT03519178|451412530|FG007|PF-06873600 Treatment|Other|0|||
125485742|NCT03519178|451412531|FG008|PF-06873600 Treatment|Other|1|||
125485743|NCT03519178|451412532|FG009|PF-06873600 Treatment|Other|0|||
125485744|NCT03519178|451412533|FG010|PF-06873600 Treatment|Other|0|||
125485745|NCT03519178|451412534|FG011|PF-06873600 Treatment|Other|0|||
125485746|NCT03519178|451412535|FG012|PF-06873600 Treatment|Other|0|||
125485747|NCT03519178|451412536|FG013|PF-06873600 Treatment|Other|1|||
125485748|NCT03519178|451412537|FG014|PF-06873600 Treatment|Other|3|||
125485749|NCT03519178|451412523|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
125485750|NCT03519178|451412524|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
125485751|NCT03519178|451412525|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
125485752|NCT03519178|451412526|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
125485753|NCT03519178|451412527|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
125485754|NCT03519178|451412528|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
125485755|NCT03519178|451412529|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
125485756|NCT03519178|451412530|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
125485757|NCT03519178|451412531|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
125485758|NCT03519178|451412532|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
125485759|NCT03519178|451412533|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
125485760|NCT03519178|451412534|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
125485761|NCT03519178|451412535|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
125485762|NCT03519178|451412536|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
125485763|NCT03519178|451412537|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
125485764|NCT03519178|451412523|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
125485765|NCT03519178|451412524|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
125485766|NCT03519178|451412525|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
125485767|NCT03519178|451412526|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
125485768|NCT03519178|451412527|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
125485769|NCT03519178|451412528|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
125485770|NCT03519178|451412529|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
125485771|NCT03519178|451412530|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
125485772|NCT03519178|451412531|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
125485773|NCT03519178|451412532|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
125485774|NCT03519178|451412533|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
125485775|NCT03519178|451412534|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
125485776|NCT03519178|451412535|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
125485777|NCT03519178|451412536|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
125485778|NCT03519178|451412537|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
125485779|NCT03519178|451412523|FG000|PF-06873600 Treatment|Ongoing|0|||
125485780|NCT03519178|451412524|FG001|PF-06873600 Treatment|Ongoing|0|||
125485781|NCT03519178|451412525|FG002|PF-06873600 Treatment|Ongoing|0|||
125485782|NCT03519178|451412526|FG003|PF-06873600 Treatment|Ongoing|0|||
125485783|NCT03519178|451412527|FG004|PF-06873600 Treatment|Ongoing|0|||
125485784|NCT03519178|451412528|FG005|PF-06873600 Treatment|Ongoing|0|||
125485785|NCT03519178|451412529|FG006|PF-06873600 Treatment|Ongoing|0|||
125485786|NCT03519178|451412530|FG007|PF-06873600 Treatment|Ongoing|0|||
125485787|NCT03519178|451412531|FG008|PF-06873600 Treatment|Ongoing|0|||
125485788|NCT03519178|451412532|FG009|PF-06873600 Treatment|Ongoing|0|||
125485789|NCT03519178|451412533|FG010|PF-06873600 Treatment|Ongoing|0|||
125485790|NCT03519178|451412534|FG011|PF-06873600 Treatment|Ongoing|0|||
125485791|NCT03519178|451412535|FG012|PF-06873600 Treatment|Ongoing|0|||
125485792|NCT03519178|451412536|FG013|PF-06873600 Treatment|Ongoing|1|||
125485793|NCT03519178|451412537|FG014|PF-06873600 Treatment|Ongoing|6|||
125485794|NCT03519178|451412523|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485795|NCT03519178|451412524|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485796|NCT03519178|451412525|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485797|NCT03519178|451412526|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485798|NCT03519178|451412527|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485799|NCT03519178|451412528|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485800|NCT03519178|451412529|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485801|NCT03519178|451412530|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485802|NCT03519178|451412531|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485803|NCT03519178|451412532|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485804|NCT03519178|451412533|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485805|NCT03519178|451412534|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485806|NCT03519178|451412535|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485807|NCT03519178|451412536|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
125485808|NCT03519178|451412537|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
125485809|NCT03519178|451412523|FG000|Disposition for Fluvestrant Treatment|Death|0|||
125485810|NCT03519178|451412524|FG001|Disposition for Fluvestrant Treatment|Death|0|||
125485811|NCT03519178|451412525|FG002|Disposition for Fluvestrant Treatment|Death|0|||
125485812|NCT03519178|451412526|FG003|Disposition for Fluvestrant Treatment|Death|0|||
125485813|NCT03519178|451412527|FG004|Disposition for Fluvestrant Treatment|Death|0|||
125485814|NCT03519178|451412528|FG005|Disposition for Fluvestrant Treatment|Death|0|||
125485815|NCT03519178|451412529|FG006|Disposition for Fluvestrant Treatment|Death|0|||
125485816|NCT03519178|451412530|FG007|Disposition for Fluvestrant Treatment|Death|0|||
125485817|NCT03519178|451412531|FG008|Disposition for Fluvestrant Treatment|Death|0|||
125485818|NCT03519178|451412532|FG009|Disposition for Fluvestrant Treatment|Death|1|||
125485819|NCT03519178|451412533|FG010|Disposition for Fluvestrant Treatment|Death|0|||
125485820|NCT03519178|451412534|FG011|Disposition for Fluvestrant Treatment|Death|0|||
125485821|NCT03519178|451412535|FG012|Disposition for Fluvestrant Treatment|Death|0|||
125485822|NCT03519178|451412536|FG013|Disposition for Fluvestrant Treatment|Death|0|||
125485823|NCT03519178|451412537|FG014|Disposition for Fluvestrant Treatment|Death|1|||
125485824|NCT03519178|451412523|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485825|NCT03519178|451412524|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485826|NCT03519178|451412525|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485827|NCT03519178|451412526|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485828|NCT03519178|451412527|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485829|NCT03519178|451412528|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485830|NCT03519178|451412529|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485831|NCT03519178|451412530|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485832|NCT03519178|451412531|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485833|NCT03519178|451412532|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485834|NCT03519178|451412533|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485835|NCT03519178|451412534|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485836|NCT03519178|451412535|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485837|NCT03519178|451412536|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
125485838|NCT03519178|451412537|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
125485839|NCT03519178|451412523|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125485840|NCT03519178|451412524|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125485841|NCT03519178|451412525|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125485842|NCT03519178|451412526|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125485843|NCT03519178|451412527|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125485844|NCT03519178|451412528|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125485845|NCT03519178|451412529|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125485846|NCT03519178|451412530|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125485847|NCT03519178|451412531|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125485848|NCT03519178|451412532|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125485849|NCT03519178|451412533|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125485850|NCT03519178|451412534|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125485851|NCT03519178|451412535|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
125485852|NCT03519178|451412536|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
125303196|NCT03100058|450736667|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125303197|NCT03100058|450736668|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125303198|NCT03100058|450736669|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125303199|NCT03100058|450736670|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125303200|NCT03100058|450736671|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
125303201|NCT03100058|450736672|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125303202|NCT03100058|450736673|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
125303203|NCT03100058|450736661|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303204|NCT03100058|450736662|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303205|NCT03100058|450736663|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303206|NCT03100058|450736664|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303207|NCT03100058|450736665|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303208|NCT03100058|450736666|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303209|NCT03100058|450736667|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303210|NCT03100058|450736668|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303211|NCT03100058|450736669|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303212|NCT03100058|450736670|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125303213|NCT03100058|450736671|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125485853|NCT03519178|451412537|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
125485854|NCT03519178|451412523|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
125485855|NCT03519178|451412524|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
125485856|NCT03519178|451412525|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
125485857|NCT03519178|451412526|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
125485858|NCT03519178|451412527|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
125485859|NCT03519178|451412528|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
125485860|NCT03519178|451412529|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
125485861|NCT03519178|451412530|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
125485862|NCT03519178|451412531|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
125485863|NCT03519178|451412532|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
125485864|NCT03519178|451412533|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
125485865|NCT03519178|451412534|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
125485866|NCT03519178|451412535|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
125485867|NCT03519178|451412536|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
125485868|NCT03519178|451412537|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
125485869|NCT03519178|451412523|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
125485870|NCT03519178|451412524|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
125485871|NCT03519178|451412525|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
125485872|NCT03519178|451412526|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
125485873|NCT03519178|451412527|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
125485874|NCT03519178|451412528|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
125485875|NCT03519178|451412529|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
125485876|NCT03519178|451412530|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
125485877|NCT03519178|451412531|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
125485878|NCT03519178|451412532|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
125485879|NCT03519178|451412533|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
125485880|NCT03519178|451412534|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
125485881|NCT03519178|451412535|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
125485882|NCT03519178|451412536|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
125485883|NCT03519178|451412537|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
125485884|NCT03519178|451412523|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
125485885|NCT03519178|451412524|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
125485886|NCT03519178|451412525|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
125485887|NCT03519178|451412526|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
125485888|NCT03519178|451412527|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
125485889|NCT03519178|451412528|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
125485890|NCT03519178|451412529|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
125485891|NCT03519178|451412530|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
125485892|NCT03519178|451412531|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
125303214|NCT03100058|450736672|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
125485893|NCT03519178|451412532|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
125485894|NCT03519178|451412533|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
125485895|NCT03519178|451412534|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
125485896|NCT03519178|451412535|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
125485897|NCT03519178|451412536|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
125485898|NCT03519178|451412537|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
125485899|NCT03519178|451412523|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
125485900|NCT03519178|451412524|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
125485901|NCT03519178|451412525|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
125485902|NCT03519178|451412526|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
125485903|NCT03519178|451412527|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
125485904|NCT03519178|451412528|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
125485905|NCT03519178|451412529|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
125485906|NCT03519178|451412530|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
125485907|NCT03519178|451412531|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
125485908|NCT03519178|451412532|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
125485909|NCT03519178|451412533|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
125485910|NCT03519178|451412534|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
125485911|NCT03519178|451412535|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
125485912|NCT03519178|451412536|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
125485913|NCT03519178|451412537|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
125485914|NCT03519178|451412523|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485915|NCT03519178|451412524|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485916|NCT03519178|451412525|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485917|NCT03519178|451412526|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485918|NCT03519178|451412527|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485919|NCT03519178|451412528|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485920|NCT03519178|451412529|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485921|NCT03519178|451412530|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485922|NCT03519178|451412531|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485923|NCT03519178|451412532|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485924|NCT03519178|451412533|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485925|NCT03519178|451412534|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485926|NCT03519178|451412535|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485927|NCT03519178|451412536|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
125485928|NCT03519178|451412537|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
125485929|NCT03519178|451412523|FG000|Disposition for Fluvestrant Treatment|Other|0|||
125485930|NCT03519178|451412524|FG001|Disposition for Fluvestrant Treatment|Other|0|||
125485931|NCT03519178|451412525|FG002|Disposition for Fluvestrant Treatment|Other|0|||
125485932|NCT03519178|451412526|FG003|Disposition for Fluvestrant Treatment|Other|0|||
125485933|NCT03519178|451412527|FG004|Disposition for Fluvestrant Treatment|Other|0|||
125485934|NCT03519178|451412528|FG005|Disposition for Fluvestrant Treatment|Other|0|||
125485935|NCT03519178|451412529|FG006|Disposition for Fluvestrant Treatment|Other|0|||
125485936|NCT03519178|451412530|FG007|Disposition for Fluvestrant Treatment|Other|0|||
125485937|NCT03519178|451412531|FG008|Disposition for Fluvestrant Treatment|Other|0|||
125485938|NCT03519178|451412532|FG009|Disposition for Fluvestrant Treatment|Other|0|||
125485939|NCT03519178|451412533|FG010|Disposition for Fluvestrant Treatment|Other|0|||
125485940|NCT03519178|451412534|FG011|Disposition for Fluvestrant Treatment|Other|0|||
125485941|NCT03519178|451412535|FG012|Disposition for Fluvestrant Treatment|Other|0|||
125485942|NCT03519178|451412536|FG013|Disposition for Fluvestrant Treatment|Other|1|||
125485943|NCT03519178|451412537|FG014|Disposition for Fluvestrant Treatment|Other|3|||
125485944|NCT03519178|451412523|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
125485945|NCT03519178|451412524|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
125485946|NCT03519178|451412525|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
125485947|NCT03519178|451412526|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
125485948|NCT03519178|451412527|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
125485949|NCT03519178|451412528|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
125485950|NCT03519178|451412529|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
125485951|NCT03519178|451412530|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
125485952|NCT03519178|451412531|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
125485953|NCT03519178|451412532|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
125485954|NCT03519178|451412533|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
125485955|NCT03519178|451412534|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
125485956|NCT03519178|451412535|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
125303215|NCT03100058|450736673|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
125303216|NCT03100058|450736661|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303217|NCT03100058|450736662|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125485957|NCT03519178|451412536|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
125485958|NCT03519178|451412537|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
125485959|NCT03519178|451412523|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
125485960|NCT03519178|451412524|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
125485961|NCT03519178|451412525|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
125485962|NCT03519178|451412526|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
125485963|NCT03519178|451412527|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
125485964|NCT03519178|451412528|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
125485965|NCT03519178|451412529|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
125485966|NCT03519178|451412530|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
125485967|NCT03519178|451412531|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
125485968|NCT03519178|451412532|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
125485969|NCT03519178|451412533|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
125485970|NCT03519178|451412534|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
125485971|NCT03519178|451412535|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
125485972|NCT03519178|451412536|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
125485973|NCT03519178|451412537|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
125485974|NCT03519178|451412523|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
125485975|NCT03519178|451412524|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
125485976|NCT03519178|451412525|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
125485977|NCT03519178|451412526|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
125485978|NCT03519178|451412527|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
125485979|NCT03519178|451412528|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
125485980|NCT03519178|451412529|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
125485981|NCT03519178|451412530|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
125485982|NCT03519178|451412531|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
125485983|NCT03519178|451412532|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
125485984|NCT03519178|451412533|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
125485985|NCT03519178|451412534|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
125485986|NCT03519178|451412535|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
125485987|NCT03519178|451412536|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
125485988|NCT03519178|451412537|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
125485989|NCT03519178|451412523|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125485990|NCT03519178|451412524|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125485991|NCT03519178|451412525|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125485992|NCT03519178|451412526|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125485993|NCT03519178|451412527|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125485994|NCT03519178|451412528|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125485995|NCT03519178|451412529|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125485996|NCT03519178|451412530|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125485997|NCT03519178|451412531|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125485998|NCT03519178|451412532|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125485999|NCT03519178|451412533|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
125486000|NCT03519178|451412534|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125486001|NCT03519178|451412535|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125486002|NCT03519178|451412536|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125486003|NCT03519178|451412537|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
125486004|NCT03519178|451412523|FG000|Follow-Up|Death|0|||
125486005|NCT03519178|451412524|FG001|Follow-Up|Death|0|||
125486006|NCT03519178|451412525|FG002|Follow-Up|Death|1|||
125486007|NCT03519178|451412526|FG003|Follow-Up|Death|0|||
125486008|NCT03519178|451412527|FG004|Follow-Up|Death|0|||
125486009|NCT03519178|451412528|FG005|Follow-Up|Death|0|||
125486010|NCT03519178|451412529|FG006|Follow-Up|Death|0|||
125486011|NCT03519178|451412530|FG007|Follow-Up|Death|0|||
125486012|NCT03519178|451412531|FG008|Follow-Up|Death|3|||
125486013|NCT03519178|451412532|FG009|Follow-Up|Death|1|||
125486014|NCT03519178|451412533|FG010|Follow-Up|Death|0|||
125486015|NCT03519178|451412534|FG011|Follow-Up|Death|0|||
125486016|NCT03519178|451412535|FG012|Follow-Up|Death|2|||
125303218|NCT03100058|450736663|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303219|NCT03100058|450736664|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303220|NCT03100058|450736665|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125486017|NCT03519178|451412536|FG013|Follow-Up|Death|0|||
125486018|NCT03519178|451412537|FG014|Follow-Up|Death|0|||
125486019|NCT03519178|451412523|FG000|Follow-Up|Lost to Follow-up|0|||
125486020|NCT03519178|451412524|FG001|Follow-Up|Lost to Follow-up|0|||
125486021|NCT03519178|451412525|FG002|Follow-Up|Lost to Follow-up|0|||
125486022|NCT03519178|451412526|FG003|Follow-Up|Lost to Follow-up|0|||
125486023|NCT03519178|451412527|FG004|Follow-Up|Lost to Follow-up|0|||
125486024|NCT03519178|451412528|FG005|Follow-Up|Lost to Follow-up|3|||
125486025|NCT03519178|451412529|FG006|Follow-Up|Lost to Follow-up|1|||
125486026|NCT03519178|451412530|FG007|Follow-Up|Lost to Follow-up|4|||
125486027|NCT03519178|451412531|FG008|Follow-Up|Lost to Follow-up|1|||
125486028|NCT03519178|451412532|FG009|Follow-Up|Lost to Follow-up|0|||
125486029|NCT03519178|451412533|FG010|Follow-Up|Lost to Follow-up|0|||
125486030|NCT03519178|451412534|FG011|Follow-Up|Lost to Follow-up|0|||
125486031|NCT03519178|451412535|FG012|Follow-Up|Lost to Follow-up|0|||
125486032|NCT03519178|451412536|FG013|Follow-Up|Lost to Follow-up|0|||
125486033|NCT03519178|451412537|FG014|Follow-Up|Lost to Follow-up|0|||
125486034|NCT03519178|451412523|FG000|Follow-Up|Withdrawal by Subject|1|||
125486035|NCT03519178|451412524|FG001|Follow-Up|Withdrawal by Subject|2|||
125486036|NCT03519178|451412525|FG002|Follow-Up|Withdrawal by Subject|2|||
125486037|NCT03519178|451412526|FG003|Follow-Up|Withdrawal by Subject|3|||
125486038|NCT03519178|451412527|FG004|Follow-Up|Withdrawal by Subject|5|||
125486039|NCT03519178|451412528|FG005|Follow-Up|Withdrawal by Subject|1|||
125486040|NCT03519178|451412529|FG006|Follow-Up|Withdrawal by Subject|2|||
125486041|NCT03519178|451412530|FG007|Follow-Up|Withdrawal by Subject|6|||
125486042|NCT03519178|451412531|FG008|Follow-Up|Withdrawal by Subject|5|||
125486043|NCT03519178|451412532|FG009|Follow-Up|Withdrawal by Subject|2|||
125486044|NCT03519178|451412533|FG010|Follow-Up|Withdrawal by Subject|3|||
125486045|NCT03519178|451412534|FG011|Follow-Up|Withdrawal by Subject|5|||
125486046|NCT03519178|451412535|FG012|Follow-Up|Withdrawal by Subject|2|||
125486047|NCT03519178|451412536|FG013|Follow-Up|Withdrawal by Subject|0|||
125486048|NCT03519178|451412537|FG014|Follow-Up|Withdrawal by Subject|0|||
125486049|NCT03519178|451412523|FG000|Follow-Up|Other|0|||
125486050|NCT03519178|451412524|FG001|Follow-Up|Other|0|||
125486051|NCT03519178|451412525|FG002|Follow-Up|Other|0|||
125486052|NCT03519178|451412526|FG003|Follow-Up|Other|0|||
125486053|NCT03519178|451412527|FG004|Follow-Up|Other|0|||
125486054|NCT03519178|451412528|FG005|Follow-Up|Other|0|||
125486055|NCT03519178|451412529|FG006|Follow-Up|Other|0|||
125486056|NCT03519178|451412530|FG007|Follow-Up|Other|1|||
125486057|NCT03519178|451412531|FG008|Follow-Up|Other|0|||
125486058|NCT03519178|451412532|FG009|Follow-Up|Other|0|||
125486059|NCT03519178|451412533|FG010|Follow-Up|Other|0|||
125486060|NCT03519178|451412534|FG011|Follow-Up|Other|0|||
125486061|NCT03519178|451412535|FG012|Follow-Up|Other|0|||
125486062|NCT03519178|451412536|FG013|Follow-Up|Other|0|||
125486063|NCT03519178|451412537|FG014|Follow-Up|Other|0|||
125486064|NCT03519178|451412523|FG000|Long-term Follow-up|Death|0|||
125486065|NCT03519178|451412524|FG001|Long-term Follow-up|Death|0|||
125486066|NCT03519178|451412525|FG002|Long-term Follow-up|Death|0|||
125486067|NCT03519178|451412526|FG003|Long-term Follow-up|Death|0|||
125486068|NCT03519178|451412527|FG004|Long-term Follow-up|Death|0|||
125486069|NCT03519178|451412528|FG005|Long-term Follow-up|Death|0|||
125486070|NCT03519178|451412529|FG006|Long-term Follow-up|Death|0|||
125486071|NCT03519178|451412530|FG007|Long-term Follow-up|Death|0|||
125486072|NCT03519178|451412531|FG008|Long-term Follow-up|Death|0|||
125486073|NCT03519178|451412532|FG009|Long-term Follow-up|Death|0|||
125486074|NCT03519178|451412533|FG010|Long-term Follow-up|Death|0|||
125486075|NCT03519178|451412534|FG011|Long-term Follow-up|Death|0|||
125486076|NCT03519178|451412535|FG012|Long-term Follow-up|Death|0|||
125486077|NCT03519178|451412536|FG013|Long-term Follow-up|Death|4|||
125303221|NCT03100058|450736666|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303222|NCT03100058|450736667|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303223|NCT03100058|450736668|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303224|NCT03100058|450736669|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125486078|NCT03519178|451412537|FG014|Long-term Follow-up|Death|4|||
125486079|NCT03519178|451412523|FG000|Long-term Follow-up|Lost to Follow-up|0|||
125486080|NCT03519178|451412524|FG001|Long-term Follow-up|Lost to Follow-up|0|||
125486081|NCT03519178|451412525|FG002|Long-term Follow-up|Lost to Follow-up|0|||
125486082|NCT03519178|451412526|FG003|Long-term Follow-up|Lost to Follow-up|0|||
125486083|NCT03519178|451412527|FG004|Long-term Follow-up|Lost to Follow-up|0|||
125486084|NCT03519178|451412528|FG005|Long-term Follow-up|Lost to Follow-up|0|||
125486085|NCT03519178|451412529|FG006|Long-term Follow-up|Lost to Follow-up|0|||
125486086|NCT03519178|451412530|FG007|Long-term Follow-up|Lost to Follow-up|0|||
125486087|NCT03519178|451412531|FG008|Long-term Follow-up|Lost to Follow-up|0|||
125486088|NCT03519178|451412532|FG009|Long-term Follow-up|Lost to Follow-up|0|||
125486089|NCT03519178|451412533|FG010|Long-term Follow-up|Lost to Follow-up|0|||
125486090|NCT03519178|451412534|FG011|Long-term Follow-up|Lost to Follow-up|0|||
125486091|NCT03519178|451412535|FG012|Long-term Follow-up|Lost to Follow-up|0|||
125486092|NCT03519178|451412536|FG013|Long-term Follow-up|Lost to Follow-up|1|||
125486093|NCT03519178|451412537|FG014|Long-term Follow-up|Lost to Follow-up|1|||
125486094|NCT03519178|451412523|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
125486095|NCT03519178|451412524|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
125486096|NCT03519178|451412525|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
125486097|NCT03519178|451412526|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
125486098|NCT03519178|451412527|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
125486099|NCT03519178|451412528|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
125486100|NCT03519178|451412529|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
125486101|NCT03519178|451412530|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
125486102|NCT03519178|451412531|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
125486103|NCT03519178|451412532|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
125486104|NCT03519178|451412533|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
125486105|NCT03519178|451412534|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
125486106|NCT03519178|451412535|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
125486107|NCT03519178|451412536|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
125486108|NCT03519178|451412537|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
125486109|NCT03519178|451412523|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
125486110|NCT03519178|451412524|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
125486111|NCT03519178|451412525|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
125486112|NCT03519178|451412526|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
125486113|NCT03519178|451412527|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
125486114|NCT03519178|451412528|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
125486115|NCT03519178|451412529|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
125486116|NCT03519178|451412530|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
125486117|NCT03519178|451412531|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
125486118|NCT03519178|451412532|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
125486119|NCT03519178|451412533|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
125486120|NCT03519178|451412534|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
125486121|NCT03519178|451412535|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
125486122|NCT03519178|451412536|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
125486123|NCT03519178|451412537|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
125486124|NCT03519178|451412523|FG000|Long-term Follow-up|Other|0|||
125486125|NCT03519178|451412524|FG001|Long-term Follow-up|Other|0|||
125486126|NCT03519178|451412525|FG002|Long-term Follow-up|Other|0|||
125486127|NCT03519178|451412526|FG003|Long-term Follow-up|Other|0|||
125486128|NCT03519178|451412527|FG004|Long-term Follow-up|Other|0|||
125486129|NCT03519178|451412528|FG005|Long-term Follow-up|Other|0|||
125486130|NCT03519178|451412529|FG006|Long-term Follow-up|Other|0|||
125486131|NCT03519178|451412530|FG007|Long-term Follow-up|Other|0|||
125486132|NCT03519178|451412531|FG008|Long-term Follow-up|Other|0|||
125486133|NCT03519178|451412532|FG009|Long-term Follow-up|Other|0|||
125486134|NCT03519178|451412533|FG010|Long-term Follow-up|Other|0|||
125486135|NCT03519178|451412534|FG011|Long-term Follow-up|Other|0|||
125486136|NCT03519178|451412535|FG012|Long-term Follow-up|Other|0|||
125486137|NCT03519178|451412536|FG013|Long-term Follow-up|Other|0|||
125486138|NCT03519178|451412537|FG014|Long-term Follow-up|Other|1|||
125486139|NCT03519178|451412523|FG000|Long-term Follow-up|Ongoing|0|||
125486140|NCT03519178|451412524|FG001|Long-term Follow-up|Ongoing|0|||
125486141|NCT03519178|451412525|FG002|Long-term Follow-up|Ongoing|0|||
125486142|NCT03519178|451412526|FG003|Long-term Follow-up|Ongoing|0|||
125486143|NCT03519178|451412527|FG004|Long-term Follow-up|Ongoing|0|||
125486144|NCT03519178|451412528|FG005|Long-term Follow-up|Ongoing|0|||
125486145|NCT03519178|451412529|FG006|Long-term Follow-up|Ongoing|0|||
125486146|NCT03519178|451412530|FG007|Long-term Follow-up|Ongoing|0|||
125486147|NCT03519178|451412531|FG008|Long-term Follow-up|Ongoing|0|||
125486148|NCT03519178|451412532|FG009|Long-term Follow-up|Ongoing|0|||
125486149|NCT03519178|451412533|FG010|Long-term Follow-up|Ongoing|0|||
125303225|NCT03100058|450736670|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
125303226|NCT03100058|450736671|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303227|NCT03100058|450736672|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303228|NCT03100058|450736673|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
125303229|NCT03671304|450736675|FG000|Overall Study|study terminated|7|||
125486150|NCT03519178|451412534|FG011|Long-term Follow-up|Ongoing|0|||
125486151|NCT03519178|451412535|FG012|Long-term Follow-up|Ongoing|0|||
125486152|NCT03519178|451412536|FG013|Long-term Follow-up|Ongoing|1|||
125486153|NCT03519178|451412537|FG014|Long-term Follow-up|Ongoing|0|||
125486154|NCT03476343|451412559|FG000|Overall Study|Clinical exam moved to another scanner|7|||
125486155|NCT03476343|451412559|FG000|Overall Study|Clinical order cancelled|4|||
125486156|NCT03476343|451412559|FG000|Overall Study|Neonate did not settle down for the scan|1|||
125486157|NCT03088878|451412560|FG000|Overall Study|Adverse Event|0|||
125486158|NCT03088878|451412561|FG001|Overall Study|Adverse Event|0|||
125486159|NCT03088878|451412562|FG002|Overall Study|Adverse Event|0|||
125486160|NCT03088878|451412563|FG003|Overall Study|Adverse Event|0|||
125486161|NCT03088878|451412564|FG004|Overall Study|Adverse Event|4|||
125486162|NCT03088878|451412565|FG005|Overall Study|Adverse Event|2|||
125486163|NCT03088878|451412566|FG006|Overall Study|Adverse Event|1|||
125486164|NCT03088878|451412567|FG007|Overall Study|Adverse Event|0|||
125486165|NCT03088878|451412568|FG008|Overall Study|Adverse Event|0|||
125486166|NCT03088878|451412569|FG009|Overall Study|Adverse Event|0|||
125486167|NCT03088878|451412570|FG010|Overall Study|Adverse Event|0|||
125486168|NCT03088878|451412571|FG011|Overall Study|Adverse Event|0|||
125486169|NCT03088878|451412572|FG012|Overall Study|Adverse Event|5|||
125486170|NCT03088878|451412573|FG013|Overall Study|Adverse Event|3|||
125486171|NCT03088878|451412560|FG000|Overall Study|Clinical Progression|0|||
125532341|NCT01162863|451580088|FG001|Overall Study|Lack of Efficacy|0|||
125486172|NCT03088878|451412561|FG001|Overall Study|Clinical Progression|0|||
125486173|NCT03088878|451412562|FG002|Overall Study|Clinical Progression|0|||
125486174|NCT03088878|451412563|FG003|Overall Study|Clinical Progression|0|||
125486175|NCT03088878|451412564|FG004|Overall Study|Clinical Progression|2|||
125486176|NCT03088878|451412565|FG005|Overall Study|Clinical Progression|0|||
125486177|NCT03088878|451412566|FG006|Overall Study|Clinical Progression|0|||
125486178|NCT03088878|451412567|FG007|Overall Study|Clinical Progression|0|||
125486179|NCT03088878|451412568|FG008|Overall Study|Clinical Progression|0|||
125486180|NCT03088878|451412569|FG009|Overall Study|Clinical Progression|0|||
125486181|NCT03088878|451412570|FG010|Overall Study|Clinical Progression|0|||
125486182|NCT03088878|451412571|FG011|Overall Study|Clinical Progression|0|||
125486183|NCT03088878|451412572|FG012|Overall Study|Clinical Progression|0|||
125486184|NCT03088878|451412573|FG013|Overall Study|Clinical Progression|0|||
125486185|NCT03088878|451412560|FG000|Overall Study|Death|0|||
125486186|NCT03088878|451412561|FG001|Overall Study|Death|0|||
125486187|NCT03088878|451412562|FG002|Overall Study|Death|0|||
125486188|NCT03088878|451412563|FG003|Overall Study|Death|0|||
125486189|NCT03088878|451412564|FG004|Overall Study|Death|2|||
125486190|NCT03088878|451412565|FG005|Overall Study|Death|0|||
125486191|NCT03088878|451412566|FG006|Overall Study|Death|0|||
125486192|NCT03088878|451412567|FG007|Overall Study|Death|0|||
125486193|NCT03088878|451412568|FG008|Overall Study|Death|0|||
125486194|NCT03088878|451412569|FG009|Overall Study|Death|0|||
125486195|NCT03088878|451412570|FG010|Overall Study|Death|0|||
125486196|NCT03088878|451412571|FG011|Overall Study|Death|1|||
125486197|NCT03088878|451412572|FG012|Overall Study|Death|0|||
125486198|NCT03088878|451412573|FG013|Overall Study|Death|0|||
125486199|NCT03088878|451412560|FG000|Overall Study|Disease Progression|1|||
125486200|NCT03088878|451412561|FG001|Overall Study|Disease Progression|2|||
125486201|NCT03088878|451412562|FG002|Overall Study|Disease Progression|3|||
125486202|NCT03088878|451412563|FG003|Overall Study|Disease Progression|0|||
125486203|NCT03088878|451412564|FG004|Overall Study|Disease Progression|3|||
125486204|NCT03088878|451412565|FG005|Overall Study|Disease Progression|0|||
125486205|NCT03088878|451412566|FG006|Overall Study|Disease Progression|0|||
125486206|NCT03088878|451412567|FG007|Overall Study|Disease Progression|0|||
125486207|NCT03088878|451412568|FG008|Overall Study|Disease Progression|0|||
125486208|NCT03088878|451412569|FG009|Overall Study|Disease Progression|0|||
125486209|NCT03088878|451412570|FG010|Overall Study|Disease Progression|0|||
125486210|NCT03088878|451412571|FG011|Overall Study|Disease Progression|0|||
125486211|NCT03088878|451412572|FG012|Overall Study|Disease Progression|1|||
125486212|NCT03088878|451412573|FG013|Overall Study|Disease Progression|1|||
125486213|NCT03088878|451412560|FG000|Overall Study|Initiation of Alternative Treatment|0|||
125486214|NCT03088878|451412561|FG001|Overall Study|Initiation of Alternative Treatment|0|||
125486215|NCT03088878|451412562|FG002|Overall Study|Initiation of Alternative Treatment|0|||
125486216|NCT03088878|451412563|FG003|Overall Study|Initiation of Alternative Treatment|1|||
125486217|NCT03088878|451412564|FG004|Overall Study|Initiation of Alternative Treatment|0|||
125486218|NCT03088878|451412565|FG005|Overall Study|Initiation of Alternative Treatment|0|||
125486219|NCT03088878|451412566|FG006|Overall Study|Initiation of Alternative Treatment|0|||
125486220|NCT03088878|451412567|FG007|Overall Study|Initiation of Alternative Treatment|1|||
125486221|NCT03088878|451412568|FG008|Overall Study|Initiation of Alternative Treatment|1|||
125486222|NCT03088878|451412569|FG009|Overall Study|Initiation of Alternative Treatment|0|||
125486223|NCT03088878|451412570|FG010|Overall Study|Initiation of Alternative Treatment|0|||
125303230|NCT00479856|450736677|FG000|Overall Study|Adverse Event|1|||
125303231|NCT00479856|450736677|FG000|Overall Study|Withdrawal by Subject|1|||
125303232|NCT00479856|450736677|FG000|Overall Study|Physician Decision|1|||
125303233|NCT02760810|450736678|FG000|Overall Study|Protocol Violation|1|||
125486224|NCT03088878|451412571|FG011|Overall Study|Initiation of Alternative Treatment|0|||
125486225|NCT03088878|451412572|FG012|Overall Study|Initiation of Alternative Treatment|0|||
125486226|NCT03088878|451412573|FG013|Overall Study|Initiation of Alternative Treatment|0|||
125486227|NCT03088878|451412560|FG000|Overall Study|Withdrawal by Subject|0|||
125486228|NCT03088878|451412561|FG001|Overall Study|Withdrawal by Subject|0|||
125486229|NCT03088878|451412562|FG002|Overall Study|Withdrawal by Subject|0|||
125486230|NCT03088878|451412563|FG003|Overall Study|Withdrawal by Subject|1|||
125486231|NCT03088878|451412564|FG004|Overall Study|Withdrawal by Subject|4|||
125303234|NCT02690714|450736679|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
125303235|NCT02690714|450736679|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
125303236|NCT04294147|450736680|FG000|Overall Study|Protocol Violation|2|||
125303237|NCT04294147|450736681|FG001|Overall Study|Protocol Violation|0|||
125303238|NCT01240135|450736682|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
125486232|NCT03088878|451412565|FG005|Overall Study|Withdrawal by Subject|1|||
125486233|NCT03088878|451412566|FG006|Overall Study|Withdrawal by Subject|1|||
125486234|NCT03088878|451412567|FG007|Overall Study|Withdrawal by Subject|0|||
125486235|NCT03088878|451412568|FG008|Overall Study|Withdrawal by Subject|1|||
125486236|NCT03088878|451412569|FG009|Overall Study|Withdrawal by Subject|2|||
125486237|NCT03088878|451412570|FG010|Overall Study|Withdrawal by Subject|0|||
125486238|NCT03088878|451412571|FG011|Overall Study|Withdrawal by Subject|2|||
125486239|NCT03088878|451412572|FG012|Overall Study|Withdrawal by Subject|1|||
125486240|NCT03088878|451412573|FG013|Overall Study|Withdrawal by Subject|0|||
125486241|NCT03088878|451412560|FG000|Overall Study|Terminated by Sponsor|2|||
125486242|NCT03088878|451412561|FG001|Overall Study|Terminated by Sponsor|1|||
125303239|NCT01240135|450736683|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
125303240|NCT01240135|450736682|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
125486243|NCT03088878|451412562|FG002|Overall Study|Terminated by Sponsor|0|||
125486244|NCT03088878|451412563|FG003|Overall Study|Terminated by Sponsor|1|||
125486245|NCT03088878|451412564|FG004|Overall Study|Terminated by Sponsor|6|||
125486246|NCT03088878|451412565|FG005|Overall Study|Terminated by Sponsor|0|||
125486247|NCT03088878|451412566|FG006|Overall Study|Terminated by Sponsor|0|||
125486248|NCT03088878|451412567|FG007|Overall Study|Terminated by Sponsor|0|||
125486249|NCT03088878|451412568|FG008|Overall Study|Terminated by Sponsor|0|||
125486250|NCT03088878|451412569|FG009|Overall Study|Terminated by Sponsor|0|||
125486251|NCT03088878|451412570|FG010|Overall Study|Terminated by Sponsor|3|||
125486252|NCT03088878|451412571|FG011|Overall Study|Terminated by Sponsor|13|||
125486253|NCT03088878|451412572|FG012|Overall Study|Terminated by Sponsor|2|||
125486254|NCT03088878|451412573|FG013|Overall Study|Terminated by Sponsor|1|||
125486255|NCT03088878|451412560|FG000|Overall Study|Completed 2 years of Treatment|0|||
125486256|NCT03088878|451412561|FG001|Overall Study|Completed 2 years of Treatment|0|||
125486257|NCT03088878|451412562|FG002|Overall Study|Completed 2 years of Treatment|0|||
125486258|NCT03088878|451412563|FG003|Overall Study|Completed 2 years of Treatment|0|||
125486259|NCT03088878|451412564|FG004|Overall Study|Completed 2 years of Treatment|0|||
125486260|NCT03088878|451412565|FG005|Overall Study|Completed 2 years of Treatment|0|||
125486261|NCT03088878|451412566|FG006|Overall Study|Completed 2 years of Treatment|1|||
125486262|NCT03088878|451412567|FG007|Overall Study|Completed 2 years of Treatment|0|||
125486263|NCT03088878|451412568|FG008|Overall Study|Completed 2 years of Treatment|0|||
125486264|NCT03088878|451412569|FG009|Overall Study|Completed 2 years of Treatment|1|||
125486265|NCT03088878|451412570|FG010|Overall Study|Completed 2 years of Treatment|0|||
125486266|NCT03088878|451412571|FG011|Overall Study|Completed 2 years of Treatment|0|||
125486267|NCT03088878|451412572|FG012|Overall Study|Completed 2 years of Treatment|8|||
125486268|NCT03088878|451412573|FG013|Overall Study|Completed 2 years of Treatment|3|||
125486269|NCT03088878|451412560|FG000|Overall Study|Physician Decision|0|||
125486270|NCT03088878|451412561|FG001|Overall Study|Physician Decision|0|||
125486271|NCT03088878|451412562|FG002|Overall Study|Physician Decision|0|||
125486272|NCT03088878|451412563|FG003|Overall Study|Physician Decision|0|||
125486273|NCT03088878|451412564|FG004|Overall Study|Physician Decision|0|||
125486274|NCT03088878|451412565|FG005|Overall Study|Physician Decision|0|||
125486275|NCT03088878|451412566|FG006|Overall Study|Physician Decision|0|||
125486276|NCT03088878|451412567|FG007|Overall Study|Physician Decision|2|||
125486277|NCT03088878|451412568|FG008|Overall Study|Physician Decision|1|||
125486278|NCT03088878|451412569|FG009|Overall Study|Physician Decision|0|||
125486279|NCT03088878|451412570|FG010|Overall Study|Physician Decision|0|||
125486280|NCT03088878|451412571|FG011|Overall Study|Physician Decision|0|||
125486281|NCT03088878|451412572|FG012|Overall Study|Physician Decision|0|||
125486282|NCT03088878|451412573|FG013|Overall Study|Physician Decision|1|||
125486283|NCT03088878|451412560|FG000|Overall Study|COVID Related noncompliance|0|||
125486284|NCT03088878|451412561|FG001|Overall Study|COVID Related noncompliance|0|||
125486285|NCT03088878|451412562|FG002|Overall Study|COVID Related noncompliance|0|||
125486286|NCT03088878|451412563|FG003|Overall Study|COVID Related noncompliance|0|||
125486287|NCT03088878|451412564|FG004|Overall Study|COVID Related noncompliance|0|||
125486288|NCT03088878|451412565|FG005|Overall Study|COVID Related noncompliance|0|||
125486289|NCT03088878|451412566|FG006|Overall Study|COVID Related noncompliance|0|||
125486290|NCT03088878|451412567|FG007|Overall Study|COVID Related noncompliance|0|||
125486291|NCT03088878|451412568|FG008|Overall Study|COVID Related noncompliance|0|||
125486292|NCT03088878|451412569|FG009|Overall Study|COVID Related noncompliance|0|||
125486293|NCT03088878|451412570|FG010|Overall Study|COVID Related noncompliance|0|||
125486294|NCT03088878|451412571|FG011|Overall Study|COVID Related noncompliance|0|||
125486295|NCT03088878|451412572|FG012|Overall Study|COVID Related noncompliance|0|||
125486296|NCT03088878|451412573|FG013|Overall Study|COVID Related noncompliance|1|||
125486297|NCT03088878|451412560|FG000|Overall Study|Drug or Study Noncompliance|0|||
125486298|NCT03088878|451412561|FG001|Overall Study|Drug or Study Noncompliance|0|||
125486299|NCT03088878|451412562|FG002|Overall Study|Drug or Study Noncompliance|0|||
125486300|NCT03088878|451412563|FG003|Overall Study|Drug or Study Noncompliance|0|||
125486301|NCT03088878|451412564|FG004|Overall Study|Drug or Study Noncompliance|0|||
125303241|NCT01240135|450736683|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
125303242|NCT01371305|450736684|FG000|Overall Study|Adverse Event|0|||
125486302|NCT03088878|451412565|FG005|Overall Study|Drug or Study Noncompliance|0|||
125486303|NCT03088878|451412566|FG006|Overall Study|Drug or Study Noncompliance|0|||
125486304|NCT03088878|451412567|FG007|Overall Study|Drug or Study Noncompliance|0|||
125486305|NCT03088878|451412568|FG008|Overall Study|Drug or Study Noncompliance|0|||
125486306|NCT03088878|451412569|FG009|Overall Study|Drug or Study Noncompliance|0|||
125486307|NCT03088878|451412570|FG010|Overall Study|Drug or Study Noncompliance|0|||
125486308|NCT03088878|451412571|FG011|Overall Study|Drug or Study Noncompliance|0|||
125486309|NCT03088878|451412572|FG012|Overall Study|Drug or Study Noncompliance|1|||
125303243|NCT01371305|450736685|FG001|Overall Study|Adverse Event|0|||
125486310|NCT03088878|451412573|FG013|Overall Study|Drug or Study Noncompliance|0|||
125486311|NCT01221948|451412592|FG000|Overall Study|Physician Decision|5|||
125486312|NCT01221948|451412592|FG000|Overall Study|Withdrawal by Subject|2|||
125486313|NCT01221948|451412592|FG000|Overall Study|not disclosed|2|||
125486314|NCT01221948|451412592|FG000|Overall Study|Death|1|||
125486315|NCT01221948|451412592|FG000|Overall Study|Protocol Violation|4|||
125486316|NCT00746096|451412593|FG000|Overall Study|Adverse Event|1|||
125486317|NCT00746096|451412594|FG001|Overall Study|Adverse Event|0|||
125486318|NCT00746096|451412593|FG000|Overall Study|Withdrawal by Subject|5|||
125486319|NCT00746096|451412594|FG001|Overall Study|Withdrawal by Subject|1|||
125486320|NCT00746096|451412593|FG000|Overall Study|Lost to Follow-up|2|||
125486321|NCT00746096|451412594|FG001|Overall Study|Lost to Follow-up|1|||
125486322|NCT00746096|451412593|FG000|Overall Study|Protocol Violation|1|||
125486323|NCT00746096|451412594|FG001|Overall Study|Protocol Violation|0|||
125486324|NCT00746096|451412593|FG000|Overall Study|No study drug treatment|1|||
125486325|NCT00746096|451412594|FG001|Overall Study|No study drug treatment|1|||
125486326|NCT04059185|451412595|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
125486327|NCT04059185|451412596|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
125486328|NCT04059185|451412597|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
125486329|NCT04059185|451412595|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
125486330|NCT04059185|451412596|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
125486331|NCT04059185|451412597|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
125486332|NCT04059185|451412595|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
125486333|NCT04059185|451412596|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
125486334|NCT04059185|451412597|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
125486335|NCT04059185|451412595|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
125486336|NCT04059185|451412596|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
125486337|NCT04059185|451412597|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
125486338|NCT04059185|451412595|FG000|Longitudinal Assessment-Adults Only|Death|4|||
125486339|NCT04059185|451412596|FG001|Longitudinal Assessment-Adults Only|Death|4|||
125486340|NCT04059185|451412597|FG002|Longitudinal Assessment-Adults Only|Death|3|||
125486341|NCT03756662|451412598|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
125486342|NCT03295721|451412606|FG000|Overall Study|Adverse Event|1|||
125486343|NCT03295721|451412607|FG001|Overall Study|Adverse Event|0|||
125486344|NCT03295721|451412608|FG002|Overall Study|Adverse Event|0|||
125486345|NCT03295721|451412606|FG000|Overall Study|Lost to Follow-up|1|||
125486346|NCT03295721|451412607|FG001|Overall Study|Lost to Follow-up|1|||
125486347|NCT03295721|451412608|FG002|Overall Study|Lost to Follow-up|1|||
125486348|NCT03295721|451412606|FG000|Overall Study|Withdrawal by Subject|1|||
125486349|NCT03295721|451412607|FG001|Overall Study|Withdrawal by Subject|0|||
125486350|NCT03295721|451412608|FG002|Overall Study|Withdrawal by Subject|1|||
125486351|NCT03295721|451412606|FG000|Overall Study|Death|0|||
125486352|NCT03295721|451412607|FG001|Overall Study|Death|0|||
125486353|NCT03295721|451412608|FG002|Overall Study|Death|1|||
125486354|NCT03325985|451412611|FG000|Overall Study|Lost to Follow-up|122|||
125486355|NCT03325985|451412612|FG001|Overall Study|Lost to Follow-up|26|||
125486356|NCT03325985|451412613|FG002|Overall Study|Lost to Follow-up|141|||
125486357|NCT03325985|451412614|FG003|Overall Study|Lost to Follow-up|28|||
125486358|NCT03325985|451412611|FG000|Overall Study|Death|99|||
125486359|NCT03325985|451412612|FG001|Overall Study|Death|36|||
125486360|NCT03325985|451412613|FG002|Overall Study|Death|94|||
125486361|NCT03325985|451412614|FG003|Overall Study|Death|32|||
125486362|NCT02684227|451412616|FG000|Overall Study|Adverse Event|1|||
125486363|NCT02684227|451412617|FG001|Overall Study|Adverse Event|7|||
125486364|NCT02684227|451412616|FG000|Overall Study|Death|0|||
125486365|NCT02684227|451412617|FG001|Overall Study|Death|2|||
125486366|NCT02684227|451412616|FG000|Overall Study|Withdrawal by Subject|0|||
125486367|NCT02684227|451412617|FG001|Overall Study|Withdrawal by Subject|1|||
125486368|NCT02684227|451412616|FG000|Overall Study|Progressive Disease|0|||
125486369|NCT02684227|451412617|FG001|Overall Study|Progressive Disease|2|||
125303244|NCT01371305|450736686|FG002|Overall Study|Adverse Event|0|||
125303245|NCT01371305|450736687|FG003|Overall Study|Adverse Event|2|||
125303246|NCT01371305|450736688|FG004|Overall Study|Adverse Event|1|||
125303247|NCT01371305|450736689|FG005|Overall Study|Adverse Event|0|||
125303248|NCT01371305|450736684|FG000|Overall Study|Study terminated by sponsor|0|||
125303249|NCT01371305|450736685|FG001|Overall Study|Study terminated by sponsor|0|||
125486370|NCT03606408|451412618|FG000|Overall Study|Adverse Event|13|||
125486371|NCT03606408|451412618|FG000|Overall Study|Withdrawal by Subject|7|||
125486372|NCT03606408|451412618|FG000|Overall Study|Physician Decision|4|||
125486373|NCT03606408|451412618|FG000|Overall Study|Lack of Efficacy|2|||
125486374|NCT03606408|451412618|FG000|Overall Study|Death|1|||
125486375|NCT03606408|451412618|FG000|Overall Study|new therapy for study indication|1|||
125486376|NCT03556293|451412619|FG000|Overall Study|Ineligible for analysis|1904|||
125486377|NCT03556293|451412620|FG001|Overall Study|Ineligible for analysis|1471|||
125486378|NCT03556293|451412621|FG002|Overall Study|Ineligible for analysis|1091|||
125486379|NCT03556293|451412622|FG003|Overall Study|Ineligible for analysis|1269|||
125486380|NCT05828017|451412629|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
125486381|NCT05012163|451412630|FG000|Overall Study|Protocol Violation|0|||
125486382|NCT05012163|451412631|FG001|Overall Study|Protocol Violation|0|||
125486383|NCT05012163|451412632|FG002|Overall Study|Protocol Violation|1|||
125486384|NCT05012163|451412633|FG003|Overall Study|Protocol Violation|1|||
125486385|NCT04132518|451412640|FG000|Overall Study|Prematurely withdrawn from the study|0|||
125486386|NCT04132518|451412641|FG001|Overall Study|Prematurely withdrawn from the study|9|||
125486387|NCT04132518|451412642|FG002|Overall Study|Prematurely withdrawn from the study|1|||
125486388|NCT05524402|451412644|FG000|Overall Study|Withdrawal by Subject|3|||
125486389|NCT05524402|451412645|FG001|Overall Study|Withdrawal by Subject|1|||
125486390|NCT05524402|451412644|FG000|Overall Study|Lost to Follow-up|2|||
125486391|NCT05524402|451412645|FG001|Overall Study|Lost to Follow-up|1|||
125486392|NCT04428203|451412647|FG000|Overall Study|Adverse Event|1|||
125486393|NCT04428203|451412648|FG001|Overall Study|Adverse Event|0|||
125486394|NCT04428203|451412649|FG002|Overall Study|Adverse Event|0|||
125486395|NCT04428203|451412647|FG000|Overall Study|Withdrawal by Subject|1|||
125486396|NCT04428203|451412648|FG001|Overall Study|Withdrawal by Subject|0|||
125486397|NCT04428203|451412649|FG002|Overall Study|Withdrawal by Subject|1|||
125486398|NCT03308877|451413943|FG000|Overall Study|Lost to Follow-up|32|||
125486399|NCT03308877|451413944|FG001|Overall Study|Lost to Follow-up|28|||
125486400|NCT04359654|451413952|FG000|Overall Study|Withdrawal by Subject|1|||
125486401|NCT04359654|451413953|FG001|Overall Study|Withdrawal by Subject|0|||
125486402|NCT04359654|451413952|FG000|Overall Study|Adverse Event|0|||
125486403|NCT04359654|451413953|FG001|Overall Study|Adverse Event|1|||
125486404|NCT05863156|451413956|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
125486405|NCT05863156|451413957|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
125486406|NCT05863156|451413958|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
125486407|NCT05216406|451413961|FG000|Overall Study|Lost to Follow-up|8|||
125486408|NCT05216406|451413962|FG001|Overall Study|Lost to Follow-up|9|||
125486409|NCT04690582|451413963|FG000|Overall Study|Withdrawal by Subject|6|||
125486410|NCT04690582|451413964|FG001|Overall Study|Withdrawal by Subject|4|||
125486411|NCT03711474|451413965|FG000|Overall Study|Physician Decision|2|||
125486412|NCT03711474|451413966|FG001|Overall Study|Physician Decision|0|||
125486413|NCT03625115|451413969|FG000|Overall Study|Withdrawal by Subject|4|||
125486414|NCT03625115|451413970|FG001|Overall Study|Withdrawal by Subject|7|||
125486415|NCT03625115|451413969|FG000|Overall Study|Lost to Follow-up|17|||
125486416|NCT03625115|451413970|FG001|Overall Study|Lost to Follow-up|24|||
125486417|NCT04101357|451413972|FG000|Overall Study|Death|1|||
125486418|NCT04101357|451413973|FG001|Overall Study|Death|1|||
125486419|NCT04101357|451413974|FG002|Overall Study|Death|1|||
125486420|NCT04101357|451413975|FG003|Overall Study|Death|2|||
125486421|NCT04101357|451413976|FG004|Overall Study|Death|4|||
125486422|NCT04101357|451413977|FG005|Overall Study|Death|11|||
125486423|NCT04101357|451413978|FG006|Overall Study|Death|4|||
125486424|NCT04101357|451413979|FG007|Overall Study|Death|4|||
125486425|NCT04101357|451413980|FG008|Overall Study|Death|5|||
125486426|NCT04101357|451413981|FG009|Overall Study|Death|2|||
125486427|NCT04101357|451413982|FG010|Overall Study|Death|3|||
125486428|NCT04101357|451413972|FG000|Overall Study|Trial closure|0|||
125486429|NCT04101357|451413973|FG001|Overall Study|Trial closure|0|||
125486430|NCT04101357|451413974|FG002|Overall Study|Trial closure|0|||
125486431|NCT04101357|451413975|FG003|Overall Study|Trial closure|0|||
125486432|NCT04101357|451413976|FG004|Overall Study|Trial closure|0|||
125486433|NCT04101357|451413977|FG005|Overall Study|Trial closure|2|||
125486434|NCT04101357|451413978|FG006|Overall Study|Trial closure|2|||
125486435|NCT04101357|451413979|FG007|Overall Study|Trial closure|0|||
125486436|NCT04101357|451413980|FG008|Overall Study|Trial closure|0|||
125486437|NCT04101357|451413981|FG009|Overall Study|Trial closure|0|||
125486438|NCT04101357|451413982|FG010|Overall Study|Trial closure|1|||
125486439|NCT04101357|451413972|FG000|Overall Study|Lost to Follow-up|0|||
125486440|NCT04101357|451413973|FG001|Overall Study|Lost to Follow-up|0|||
125486441|NCT04101357|451413974|FG002|Overall Study|Lost to Follow-up|0|||
125486442|NCT04101357|451413975|FG003|Overall Study|Lost to Follow-up|1|||
125486443|NCT04101357|451413976|FG004|Overall Study|Lost to Follow-up|0|||
125486444|NCT04101357|451413977|FG005|Overall Study|Lost to Follow-up|0|||
125486445|NCT04101357|451413978|FG006|Overall Study|Lost to Follow-up|0|||
125486446|NCT04101357|451413979|FG007|Overall Study|Lost to Follow-up|1|||
125486447|NCT04101357|451413980|FG008|Overall Study|Lost to Follow-up|0|||
125486448|NCT04101357|451413981|FG009|Overall Study|Lost to Follow-up|0|||
125486449|NCT04101357|451413982|FG010|Overall Study|Lost to Follow-up|0|||
125486450|NCT04101357|451413972|FG000|Overall Study|Withdrawal by Subject|1|||
125486451|NCT04101357|451413973|FG001|Overall Study|Withdrawal by Subject|0|||
125486452|NCT04101357|451413974|FG002|Overall Study|Withdrawal by Subject|0|||
125486453|NCT04101357|451413975|FG003|Overall Study|Withdrawal by Subject|0|||
125486454|NCT04101357|451413976|FG004|Overall Study|Withdrawal by Subject|0|||
125486455|NCT04101357|451413977|FG005|Overall Study|Withdrawal by Subject|0|||
125486456|NCT04101357|451413978|FG006|Overall Study|Withdrawal by Subject|0|||
125486457|NCT04101357|451413979|FG007|Overall Study|Withdrawal by Subject|0|||
125486458|NCT04101357|451413980|FG008|Overall Study|Withdrawal by Subject|1|||
125486459|NCT04101357|451413981|FG009|Overall Study|Withdrawal by Subject|1|||
125486460|NCT04101357|451413982|FG010|Overall Study|Withdrawal by Subject|0|||
125486461|NCT04101357|451413972|FG000|Overall Study|Other|0|||
125486462|NCT04101357|451413973|FG001|Overall Study|Other|0|||
125486463|NCT04101357|451413974|FG002|Overall Study|Other|0|||
125486464|NCT04101357|451413975|FG003|Overall Study|Other|0|||
125486465|NCT04101357|451413976|FG004|Overall Study|Other|0|||
125486466|NCT04101357|451413977|FG005|Overall Study|Other|1|||
125486467|NCT04101357|451413978|FG006|Overall Study|Other|2|||
125486468|NCT04101357|451413979|FG007|Overall Study|Other|1|||
125486469|NCT04101357|451413980|FG008|Overall Study|Other|0|||
125486470|NCT04101357|451413981|FG009|Overall Study|Other|0|||
125486471|NCT04101357|451413982|FG010|Overall Study|Other|0|||
125486472|NCT04101357|451413972|FG000|Overall Study|Enrolled but not treated|0|||
125486473|NCT04101357|451413973|FG001|Overall Study|Enrolled but not treated|0|||
125486474|NCT04101357|451413974|FG002|Overall Study|Enrolled but not treated|0|||
125486475|NCT04101357|451413975|FG003|Overall Study|Enrolled but not treated|0|||
125486476|NCT04101357|451413976|FG004|Overall Study|Enrolled but not treated|0|||
125486477|NCT04101357|451413977|FG005|Overall Study|Enrolled but not treated|1|||
125486478|NCT04101357|451413978|FG006|Overall Study|Enrolled but not treated|1|||
125486479|NCT04101357|451413979|FG007|Overall Study|Enrolled but not treated|0|||
125486480|NCT04101357|451413980|FG008|Overall Study|Enrolled but not treated|0|||
125486481|NCT04101357|451413981|FG009|Overall Study|Enrolled but not treated|0|||
125486482|NCT04101357|451413982|FG010|Overall Study|Enrolled but not treated|0|||
125486483|NCT05868382|451413983|FG000|Overall Study|Lost to Follow-up|5|||
125486484|NCT05868382|451413984|FG001|Overall Study|Lost to Follow-up|0|||
125486485|NCT05868382|451413985|FG002|Overall Study|Lost to Follow-up|6|||
125486486|NCT05868382|451413986|FG003|Overall Study|Lost to Follow-up|4|||
125486487|NCT05868382|451413987|FG004|Overall Study|Lost to Follow-up|2|||
125486488|NCT05868382|451413988|FG005|Overall Study|Lost to Follow-up|6|||
125486489|NCT05868382|451413983|FG000|Overall Study|Withdrawal by Subject|1|||
125486490|NCT05868382|451413984|FG001|Overall Study|Withdrawal by Subject|0|||
125486491|NCT05868382|451413985|FG002|Overall Study|Withdrawal by Subject|0|||
125486492|NCT05868382|451413986|FG003|Overall Study|Withdrawal by Subject|0|||
125486493|NCT05868382|451413987|FG004|Overall Study|Withdrawal by Subject|1|||
125486494|NCT05868382|451413988|FG005|Overall Study|Withdrawal by Subject|0|||
125486495|NCT02497950|451413989|FG000|Overall Study|Death|209|||
125486496|NCT02497950|451413989|FG000|Overall Study|Transplanted|85|||
125486497|NCT02497950|451413989|FG000|Overall Study|Explanted|8|||
125486498|NCT02497950|451413989|FG000|Overall Study|Device Permanently Deactivated|4|||
125486499|NCT02497950|451413989|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
125486500|NCT02497950|451413989|FG000|Overall Study|Lost to Follow-up|6|||
125486501|NCT02497950|451413989|FG000|Overall Study|Withdrawal by Subject|2|||
125486502|NCT02497950|451413989|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
125486503|NCT02497950|451413989|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
125486504|NCT01236781|451413990|FG000|Overall Study|Ineligible|2|||
125486505|NCT01236781|451413991|FG001|Overall Study|Ineligible|1|||
125486506|NCT01236781|451413990|FG000|Overall Study|Did not complete study imaging|5|||
125486507|NCT01236781|451413991|FG001|Overall Study|Did not complete study imaging|0|||
125486508|NCT01009788|451414004|FG000|Overall Study|Withdrawal by Subject|1|||
125486509|NCT01009788|451414005|FG001|Overall Study|Withdrawal by Subject|0|||
125486510|NCT04308681|451414006|FG000|Pre-Treatment|Not reported|1|||
125486511|NCT04308681|451414007|FG001|Pre-Treatment|Not reported|1|||
125486512|NCT04308681|451414008|FG002|Pre-Treatment|Not reported|0|||
125486513|NCT04308681|451414009|FG003|Pre-Treatment|Not reported|0|||
125486514|NCT04308681|451414010|FG004|Pre-Treatment|Not reported|0|||
125486515|NCT04308681|451414011|FG005|Pre-Treatment|Not reported|2|||
125486516|NCT04308681|451414012|FG006|Pre-Treatment|Not reported|0|||
125486517|NCT04308681|451414013|FG007|Pre-Treatment|Not reported|0|||
125486518|NCT04308681|451414006|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
125486519|NCT04308681|451414007|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
125486520|NCT04308681|451414008|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
125486521|NCT04308681|451414009|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
125486522|NCT04308681|451414010|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
125486523|NCT04308681|451414011|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
125303250|NCT01371305|450736686|FG002|Overall Study|Study terminated by sponsor|0|||
125303251|NCT01371305|450736687|FG003|Overall Study|Study terminated by sponsor|0|||
125486524|NCT04308681|451414012|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
125486525|NCT04308681|451414013|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
125486526|NCT04308681|451414006|FG000|Treatment up to Week 26|Other reasons|2|||
125486527|NCT04308681|451414007|FG001|Treatment up to Week 26|Other reasons|0|||
125486528|NCT04308681|451414008|FG002|Treatment up to Week 26|Other reasons|0|||
125486529|NCT04308681|451414009|FG003|Treatment up to Week 26|Other reasons|0|||
125486530|NCT04308681|451414010|FG004|Treatment up to Week 26|Other reasons|1|||
125486531|NCT04308681|451414011|FG005|Treatment up to Week 26|Other reasons|1|||
125486532|NCT04308681|451414012|FG006|Treatment up to Week 26|Other reasons|0|||
125486533|NCT04308681|451414013|FG007|Treatment up to Week 26|Other reasons|0|||
125486534|NCT04308681|451414006|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
125486535|NCT04308681|451414007|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
125486536|NCT04308681|451414008|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
125486537|NCT04308681|451414009|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
125486538|NCT04308681|451414010|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
125486539|NCT04308681|451414011|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
125486540|NCT04308681|451414012|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
125486541|NCT04308681|451414013|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
125486542|NCT04308681|451414006|FG000|Treatment up to Week 26|Adverse Event|6|||
125486543|NCT04308681|451414007|FG001|Treatment up to Week 26|Adverse Event|5|||
125486544|NCT04308681|451414008|FG002|Treatment up to Week 26|Adverse Event|5|||
125486545|NCT04308681|451414009|FG003|Treatment up to Week 26|Adverse Event|0|||
125486546|NCT04308681|451414010|FG004|Treatment up to Week 26|Adverse Event|6|||
125486547|NCT04308681|451414011|FG005|Treatment up to Week 26|Adverse Event|1|||
125486548|NCT04308681|451414012|FG006|Treatment up to Week 26|Adverse Event|0|||
125486549|NCT04308681|451414013|FG007|Treatment up to Week 26|Adverse Event|0|||
125486550|NCT04308681|451414006|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
125486551|NCT04308681|451414007|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
125486552|NCT04308681|451414008|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
125486553|NCT04308681|451414009|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
125486554|NCT04308681|451414010|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
125486555|NCT04308681|451414011|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
125486556|NCT04308681|451414012|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
125486557|NCT04308681|451414013|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
125486558|NCT04308681|451414006|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
125486559|NCT04308681|451414007|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
125486560|NCT04308681|451414008|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
125486561|NCT04308681|451414009|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
125486562|NCT04308681|451414010|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
125486563|NCT04308681|451414011|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
125486564|NCT04308681|451414012|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
125486565|NCT04308681|451414013|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
125486566|NCT04308681|451414006|FG000|OTE - 26 Weeks|Death|0|||
125486567|NCT04308681|451414007|FG001|OTE - 26 Weeks|Death|1|||
125486568|NCT04308681|451414008|FG002|OTE - 26 Weeks|Death|0|||
125486569|NCT04308681|451414009|FG003|OTE - 26 Weeks|Death|0|||
125486570|NCT04308681|451414010|FG004|OTE - 26 Weeks|Death|0|||
125486571|NCT04308681|451414011|FG005|OTE - 26 Weeks|Death|0|||
125486572|NCT04308681|451414012|FG006|OTE - 26 Weeks|Death|1|||
125486573|NCT04308681|451414013|FG007|OTE - 26 Weeks|Death|0|||
125486574|NCT04308681|451414006|FG000|OTE - 26 Weeks|Adverse Event|0|||
125486575|NCT04308681|451414007|FG001|OTE - 26 Weeks|Adverse Event|2|||
125486576|NCT04308681|451414008|FG002|OTE - 26 Weeks|Adverse Event|8|||
125486577|NCT04308681|451414009|FG003|OTE - 26 Weeks|Adverse Event|3|||
125486578|NCT04308681|451414010|FG004|OTE - 26 Weeks|Adverse Event|0|||
125486579|NCT04308681|451414011|FG005|OTE - 26 Weeks|Adverse Event|1|||
125486580|NCT04308681|451414012|FG006|OTE - 26 Weeks|Adverse Event|2|||
125486581|NCT04308681|451414013|FG007|OTE - 26 Weeks|Adverse Event|0|||
125486582|NCT04308681|451414006|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
125486583|NCT04308681|451414007|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
125486584|NCT04308681|451414008|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
125486585|NCT04308681|451414009|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
125486586|NCT04308681|451414010|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
125486587|NCT04308681|451414011|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
125486588|NCT04308681|451414012|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
125486589|NCT04308681|451414013|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
125486590|NCT05565820|451414014|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
125486591|NCT05565820|451414015|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
125486592|NCT05565820|451414014|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
125486593|NCT05565820|451414015|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
125486594|NCT00429364|451414017|FG000|Overall Study|Withdrawal by Subject|11|||
125486595|NCT00429364|451414018|FG001|Overall Study|Withdrawal by Subject|5|||
125486596|NCT00429364|451414017|FG000|Overall Study|Physician Decision|4|||
125486597|NCT00429364|451414018|FG001|Overall Study|Physician Decision|2|||
125486598|NCT00429364|451414017|FG000|Overall Study|Lost to Follow-up|7|||
125486599|NCT00429364|451414018|FG001|Overall Study|Lost to Follow-up|6|||
125486600|NCT00429364|451414017|FG000|Overall Study|Death|0|||
125486601|NCT00429364|451414018|FG001|Overall Study|Death|1|||
125486602|NCT00429364|451414017|FG000|Overall Study|Underwent aortic root surgery|10|||
125532342|NCT01162863|451580089|FG002|Overall Study|Lack of Efficacy|0|||
125486603|NCT00429364|451414018|FG001|Overall Study|Underwent aortic root surgery|18|||
125486604|NCT00429364|451414017|FG000|Overall Study|Pregnancy|0|||
125486605|NCT00429364|451414018|FG001|Overall Study|Pregnancy|1|||
125486606|NCT04871529|451414019|FG000|Overall Study|Withdrawal by Subject|0|||
125486607|NCT04871529|451414020|FG001|Overall Study|Withdrawal by Subject|1|||
125486608|NCT04871529|451414019|FG000|Overall Study|Death|0|||
125486609|NCT04871529|451414020|FG001|Overall Study|Death|1|||
125486610|NCT04871529|451414019|FG000|Overall Study|Not protocol specified|0|||
125486611|NCT04871529|451414020|FG001|Overall Study|Not protocol specified|1|||
125486612|NCT04003246|451414023|FG000|Overall Study|Death|9|||
125486613|NCT05237284|451414029|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
125486614|NCT05237284|451414030|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
125486615|NCT05237284|451414031|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
125486616|NCT05237284|451414032|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
125486617|NCT05237284|451414029|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
125486618|NCT05237284|451414030|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
125486619|NCT05237284|451414031|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
125486620|NCT05237284|451414032|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
125486621|NCT05237284|451414029|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
125486622|NCT05237284|451414030|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
125486623|NCT05237284|451414031|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
125486624|NCT05237284|451414032|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
125486625|NCT05237284|451414029|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
125486626|NCT05237284|451414030|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
125486627|NCT05237284|451414031|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
125486628|NCT05237284|451414032|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
125486629|NCT05237284|451414029|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
125486630|NCT05237284|451414030|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
125486631|NCT05237284|451414031|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
125486632|NCT05237284|451414032|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
125486633|NCT05237284|451414029|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
125486634|NCT05237284|451414030|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
125486635|NCT05237284|451414031|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
125486636|NCT05237284|451414032|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
125486637|NCT05237284|451414029|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
125486638|NCT05237284|451414030|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
125486639|NCT05237284|451414031|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
125486640|NCT05237284|451414032|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
125486641|NCT05237284|451414029|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
125486642|NCT05237284|451414030|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
125486643|NCT05237284|451414031|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
125486644|NCT05237284|451414032|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
125486645|NCT05237284|451414029|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
125486646|NCT05237284|451414030|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
125486647|NCT05237284|451414031|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
125486648|NCT05237284|451414032|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
125486649|NCT03733925|451414036|FG000|Overall Study|Lost to Follow-up|1|||
125486650|NCT03733925|451414036|FG000|Overall Study|Withdrawal by Subject|2|||
125486651|NCT03733925|451414036|FG000|Overall Study|Adverse Event|2|||
125486652|NCT03733925|451414036|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125486653|NCT03213873|451414037|FG000|Overall Study|Withdrawal by Subject|8|||
125486654|NCT03213873|451414038|FG001|Overall Study|Withdrawal by Subject|9|||
125486655|NCT03213873|451414037|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
125486656|NCT03213873|451414038|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
125486657|NCT03213873|451414037|FG000|Overall Study|Lost to Follow-up|0|||
125486658|NCT03213873|451414038|FG001|Overall Study|Lost to Follow-up|2|||
125486659|NCT02852655|451414044|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
125486660|NCT02852655|451414045|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
125486661|NCT02852655|451414046|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
125486662|NCT02852655|451414044|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
125486663|NCT02852655|451414045|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
125486664|NCT02852655|451414046|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
125486665|NCT02852655|451414044|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
125486666|NCT02852655|451414045|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
125486667|NCT02852655|451414046|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
125303252|NCT01371305|450736688|FG004|Overall Study|Study terminated by sponsor|3|||
125303253|NCT01371305|450736689|FG005|Overall Study|Study terminated by sponsor|1|||
125486668|NCT02852655|451414044|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
125486669|NCT02852655|451414045|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
125486670|NCT02852655|451414046|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
125486671|NCT02852655|451414044|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
125486672|NCT02852655|451414045|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
125486673|NCT02852655|451414046|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
125486674|NCT02852655|451414044|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
125486675|NCT02852655|451414045|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
125486676|NCT02852655|451414046|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
125486677|NCT02852655|451414044|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
125486678|NCT02852655|451414045|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
125486679|NCT02852655|451414046|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
125486680|NCT02852655|451414044|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
125486681|NCT02852655|451414045|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
125486682|NCT02852655|451414046|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
125486683|NCT02852655|451414044|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
125486684|NCT02852655|451414045|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
125486685|NCT02852655|451414046|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
125486686|NCT02834390|451414050|FG000|Induction Phase|Progressive disease|0|||
125486687|NCT02834390|451414051|FG001|Induction Phase|Progressive disease|1|||
125486688|NCT02834390|451414050|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
125486689|NCT02834390|451414051|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
125486690|NCT02834390|451414050|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
125486691|NCT02834390|451414051|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
125486692|NCT02834390|451414050|FG000|Consolidation Phase|Physician Decision|1|||
125486693|NCT02834390|451414051|FG001|Consolidation Phase|Physician Decision|1|||
125486694|NCT04544007|451414052|FG000|Overall Study|Withdrawal by Subject|1|||
125486695|NCT04544007|451414052|FG000|Overall Study|Confirmed Progressive Disease|1|||
125486696|NCT02998528|451414053|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
125486697|NCT02998528|451414054|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
125486698|NCT02998528|451414055|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
125486699|NCT02998528|451414053|FG000|Randomization Period|Participant withdrew consent|0|||
125486700|NCT02998528|451414054|FG001|Randomization Period|Participant withdrew consent|3|||
125486701|NCT02998528|451414055|FG002|Randomization Period|Participant withdrew consent|0|||
125486702|NCT02998528|451414053|FG000|Randomization Period|Participant no longer meets study criteria|1|||
125486703|NCT02998528|451414054|FG001|Randomization Period|Participant no longer meets study criteria|3|||
125486704|NCT02998528|451414055|FG002|Randomization Period|Participant no longer meets study criteria|2|||
125486705|NCT02998528|451414053|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
125486706|NCT02998528|451414054|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
125486707|NCT02998528|451414055|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
125486708|NCT02998528|451414053|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
125486709|NCT02998528|451414054|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
125486710|NCT02998528|451414055|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
125486711|NCT02998528|451414053|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
125486712|NCT02998528|451414054|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
125486713|NCT02998528|451414055|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
125486714|NCT02998528|451414053|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
125486715|NCT02998528|451414054|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
125486716|NCT02998528|451414055|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
125486717|NCT02998528|451414053|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
125486718|NCT02998528|451414054|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
125486719|NCT02998528|451414055|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
125486720|NCT02998528|451414053|FG000|Neoadjuvant Treatment Period|Death|1|||
125486721|NCT02998528|451414054|FG001|Neoadjuvant Treatment Period|Death|0|||
125486722|NCT02998528|451414055|FG002|Neoadjuvant Treatment Period|Death|0|||
125486723|NCT02998528|451414053|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
125486724|NCT02998528|451414054|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
125303254|NCT01371305|450736684|FG000|Overall Study|Subject request|0|||
125303255|NCT01371305|450736685|FG001|Overall Study|Subject request|0|||
125486725|NCT02998528|451414055|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
125486726|NCT02998528|451414053|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
125486727|NCT02998528|451414054|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
125486728|NCT02998528|451414055|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
125303256|NCT01371305|450736686|FG002|Overall Study|Subject request|0|||
125303257|NCT01371305|450736687|FG003|Overall Study|Subject request|0|||
125303258|NCT01371305|450736688|FG004|Overall Study|Subject request|0|||
125486729|NCT02998528|451414053|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
125486730|NCT02998528|451414054|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
125486731|NCT02998528|451414055|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
125486732|NCT02998528|451414053|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
125486733|NCT02998528|451414054|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
125486734|NCT02998528|451414055|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
125486735|NCT02998528|451414053|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
125486736|NCT02998528|451414054|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
125486737|NCT02998528|451414055|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
125486738|NCT02998528|451414053|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
125486739|NCT02998528|451414054|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
125486740|NCT02998528|451414055|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
125486741|NCT02413489|451414058|FG000|Overall Study|Death|11|||
125486742|NCT02413489|451414059|FG001|Overall Study|Death|3|||
125486743|NCT02413489|451414060|FG002|Overall Study|Death|4|||
125486744|NCT02413489|451414058|FG000|Overall Study|Withdrawal by Subject|2|||
125486745|NCT02413489|451414059|FG001|Overall Study|Withdrawal by Subject|0|||
125486746|NCT02413489|451414060|FG002|Overall Study|Withdrawal by Subject|0|||
125486747|NCT02413489|451414058|FG000|Overall Study|Study Terminated By Sponsor|2|||
125486748|NCT02413489|451414059|FG001|Overall Study|Study Terminated By Sponsor|13|||
125486749|NCT02413489|451414060|FG002|Overall Study|Study Terminated By Sponsor|1|||
125486750|NCT04247802|451414061|FG000|Overall Study|Withdrawal by Subject|1|||
125486751|NCT04247802|451414062|FG001|Overall Study|Withdrawal by Subject|3|||
125486752|NCT04247802|451414061|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
125486753|NCT04247802|451414062|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
125486754|NCT02575950|451414063|FG000|Overall Study|Withdrawal by Subject|0|||
125486755|NCT02575950|451414064|FG001|Overall Study|Withdrawal by Subject|0|||
125486756|NCT02575950|451414065|FG002|Overall Study|Withdrawal by Subject|0|||
125486757|NCT02575950|451414066|FG003|Overall Study|Withdrawal by Subject|2|||
125486758|NCT02575950|451414063|FG000|Overall Study|Lost to Follow-up|0|||
125486759|NCT02575950|451414064|FG001|Overall Study|Lost to Follow-up|1|||
125486760|NCT02575950|451414065|FG002|Overall Study|Lost to Follow-up|0|||
125486761|NCT02575950|451414066|FG003|Overall Study|Lost to Follow-up|3|||
125486762|NCT03209973|451415300|FG000|Overall Study|Withdrawal by Subject|7|||
125486763|NCT03209973|451415300|FG000|Overall Study|Lost to Follow-up|2|||
125486764|NCT03209973|451415300|FG000|Overall Study|Death|8|||
125486765|NCT03209973|451415300|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
125486766|NCT03209973|451415300|FG000|Overall Study|Sponsor Decision|18|||
125486767|NCT03209973|451415300|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
125486768|NCT03209973|451415300|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
125486769|NCT05218096|451415301|FG000|Primary Evaluation|Withdrawal by Subject|0|||
125486770|NCT05218096|451415302|FG001|Primary Evaluation|Withdrawal by Subject|0|||
125486771|NCT05218096|451415303|FG002|Primary Evaluation|Withdrawal by Subject|2|||
125486772|NCT05218096|451415304|FG003|Primary Evaluation|Withdrawal by Subject|0|||
125486773|NCT05218096|451415305|FG004|Primary Evaluation|Withdrawal by Subject|0|||
125486774|NCT05218096|451415301|FG000|Primary Evaluation|Physician Decision|1|||
125486775|NCT05218096|451415302|FG001|Primary Evaluation|Physician Decision|0|||
125486776|NCT05218096|451415303|FG002|Primary Evaluation|Physician Decision|0|||
125486777|NCT05218096|451415304|FG003|Primary Evaluation|Physician Decision|0|||
125486778|NCT05218096|451415305|FG004|Primary Evaluation|Physician Decision|0|||
125486779|NCT05218096|451415301|FG000|Extended Treatment|Clinical Deterioration|1|||
125486780|NCT05218096|451415302|FG001|Extended Treatment|Clinical Deterioration|1|||
125486781|NCT05218096|451415303|FG002|Extended Treatment|Clinical Deterioration|0|||
125486782|NCT05218096|451415304|FG003|Extended Treatment|Clinical Deterioration|0|||
125486783|NCT05218096|451415305|FG004|Extended Treatment|Clinical Deterioration|0|||
125486784|NCT05218096|451415301|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
125486785|NCT05218096|451415302|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
125486786|NCT05218096|451415303|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
125486787|NCT05218096|451415304|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
125486788|NCT05218096|451415305|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
125486789|NCT05218096|451415301|FG000|Extended Treatment|Withdrawal by Subject|1|||
125486790|NCT05218096|451415302|FG001|Extended Treatment|Withdrawal by Subject|3|||
125486791|NCT05218096|451415303|FG002|Extended Treatment|Withdrawal by Subject|0|||
125486792|NCT05218096|451415304|FG003|Extended Treatment|Withdrawal by Subject|2|||
125486793|NCT05218096|451415305|FG004|Extended Treatment|Withdrawal by Subject|2|||
125486794|NCT05218096|451415301|FG000|Extended Treatment|Lack of Efficacy|3|||
125486795|NCT05218096|451415302|FG001|Extended Treatment|Lack of Efficacy|0|||
125486796|NCT05218096|451415303|FG002|Extended Treatment|Lack of Efficacy|0|||
125486797|NCT05218096|451415304|FG003|Extended Treatment|Lack of Efficacy|0|||
125486798|NCT05218096|451415305|FG004|Extended Treatment|Lack of Efficacy|0|||
125486799|NCT05218096|451415301|FG000|Extended Treatment|Physician Decision|0|||
125486800|NCT05218096|451415302|FG001|Extended Treatment|Physician Decision|1|||
125486801|NCT05218096|451415303|FG002|Extended Treatment|Physician Decision|0|||
125486802|NCT05218096|451415304|FG003|Extended Treatment|Physician Decision|0|||
125486803|NCT05218096|451415305|FG004|Extended Treatment|Physician Decision|0|||
125486804|NCT05218096|451415301|FG000|Open-label Extension|Adverse Event|1|||
125486805|NCT05218096|451415302|FG001|Open-label Extension|Adverse Event|0|||
125486806|NCT05218096|451415303|FG002|Open-label Extension|Adverse Event|0|||
125486807|NCT05218096|451415304|FG003|Open-label Extension|Adverse Event|0|||
125486808|NCT05218096|451415305|FG004|Open-label Extension|Adverse Event|1|||
125486809|NCT05218096|451415301|FG000|Open-label Extension|Pregnancy|0|||
125486810|NCT05218096|451415302|FG001|Open-label Extension|Pregnancy|0|||
125486811|NCT05218096|451415303|FG002|Open-label Extension|Pregnancy|0|||
125486812|NCT05218096|451415304|FG003|Open-label Extension|Pregnancy|0|||
125486813|NCT05218096|451415305|FG004|Open-label Extension|Pregnancy|1|||
125486814|NCT05218096|451415301|FG000|Open-label Extension|Lack of Efficacy|1|||
125486815|NCT05218096|451415302|FG001|Open-label Extension|Lack of Efficacy|2|||
125486816|NCT05218096|451415303|FG002|Open-label Extension|Lack of Efficacy|0|||
125486817|NCT05218096|451415304|FG003|Open-label Extension|Lack of Efficacy|0|||
125486818|NCT05218096|451415305|FG004|Open-label Extension|Lack of Efficacy|0|||
125486819|NCT05218096|451415301|FG000|Open-label Extension|Lost to Follow-up|1|||
125486820|NCT05218096|451415302|FG001|Open-label Extension|Lost to Follow-up|0|||
125486821|NCT05218096|451415303|FG002|Open-label Extension|Lost to Follow-up|0|||
125486822|NCT05218096|451415304|FG003|Open-label Extension|Lost to Follow-up|0|||
125486823|NCT05218096|451415305|FG004|Open-label Extension|Lost to Follow-up|0|||
125486824|NCT05218096|451415301|FG000|Open-label Extension|Death|0|||
125486825|NCT05218096|451415302|FG001|Open-label Extension|Death|0|||
125486826|NCT05218096|451415303|FG002|Open-label Extension|Death|0|||
125486827|NCT05218096|451415304|FG003|Open-label Extension|Death|1|||
125486828|NCT05218096|451415305|FG004|Open-label Extension|Death|0|||
125486829|NCT05218096|451415301|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
125486830|NCT05218096|451415302|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
125486831|NCT05218096|451415303|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
125486832|NCT05218096|451415304|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
125486833|NCT05218096|451415305|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
125486834|NCT04797195|451415314|FG000|Overall Study|Death|8|||
125486835|NCT04797195|451415315|FG001|Overall Study|Death|15|||
125486836|NCT04797195|451415314|FG000|Overall Study|Change from PD|15|||
125486837|NCT04797195|451415315|FG001|Overall Study|Change from PD|15|||
125486838|NCT04797195|451415314|FG000|Overall Study|Withdrawal by Subject|3|||
125486839|NCT04797195|451415315|FG001|Overall Study|Withdrawal by Subject|2|||
125486840|NCT04660539|451415318|FG000|Overall Study|Adverse Event|10|||
125486841|NCT04660539|451415318|FG000|Overall Study|Lack of Efficacy|4|||
125486842|NCT04660539|451415318|FG000|Overall Study|Lost to Follow-up|5|||
125486843|NCT04660539|451415318|FG000|Overall Study|Non-Compliance With Study Drug|3|||
125486844|NCT04660539|451415318|FG000|Overall Study|Reason not Specified|12|||
125486845|NCT04660539|451415318|FG000|Overall Study|Pregnancy|2|||
125486846|NCT04660539|451415318|FG000|Overall Study|Protocol Violation|2|||
125486847|NCT04660539|451415318|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
125486848|NCT04660539|451415318|FG000|Overall Study|Withdrawal by Subject|21|||
125486849|NCT05256654|451415319|FG000|Overall Study|Adverse Event|0|||
125486850|NCT05256654|451415320|FG001|Overall Study|Adverse Event|0|||
125486851|NCT05256654|451415321|FG002|Overall Study|Adverse Event|1|||
125486852|NCT05256654|451415322|FG003|Overall Study|Adverse Event|0|||
125486853|NCT05256654|451415319|FG000|Overall Study|Lost to Follow-up|0|||
125486854|NCT05256654|451415320|FG001|Overall Study|Lost to Follow-up|0|||
125486855|NCT05256654|451415321|FG002|Overall Study|Lost to Follow-up|0|||
125486856|NCT05256654|451415322|FG003|Overall Study|Lost to Follow-up|1|||
125486857|NCT05256654|451415319|FG000|Overall Study|Withdrawal by Subject|1|||
125486858|NCT05256654|451415320|FG001|Overall Study|Withdrawal by Subject|2|||
125486859|NCT05256654|451415321|FG002|Overall Study|Withdrawal by Subject|1|||
125486860|NCT05256654|451415322|FG003|Overall Study|Withdrawal by Subject|3|||
125486861|NCT05256654|451415319|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
125486862|NCT05256654|451415320|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
125486863|NCT05256654|451415321|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
125303259|NCT01371305|450736689|FG005|Overall Study|Subject request|1|||
125303260|NCT02891382|450736692|FG000|Overall Study|Lost to Follow-up|3|||
125486864|NCT05256654|451415322|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
125486865|NCT05256654|451415319|FG000|Overall Study|Other|0|||
125486866|NCT05256654|451415320|FG001|Overall Study|Other|0|||
125486867|NCT05256654|451415321|FG002|Overall Study|Other|0|||
125303261|NCT02891382|450736693|FG001|Overall Study|Lost to Follow-up|4|||
125486868|NCT05256654|451415322|FG003|Overall Study|Other|1|||
125486869|NCT05167864|451415325|FG000|Overall Study|Lost to Follow-up|7|||
125303262|NCT02891382|450736694|FG002|Overall Study|Lost to Follow-up|5|||
125486870|NCT05167864|451415326|FG001|Overall Study|Lost to Follow-up|6|||
125486871|NCT05167864|451415327|FG002|Overall Study|Lost to Follow-up|7|||
125486872|NCT05167864|451415328|FG003|Overall Study|Lost to Follow-up|9|||
125486873|NCT03852550|451415329|FG000|Overall Study|Lost to Follow-up|4|||
125486874|NCT03852550|451415330|FG001|Overall Study|Lost to Follow-up|3|||
125486875|NCT03852550|451415329|FG000|Overall Study|Only parent outcomes completed|0|||
125486876|NCT03852550|451415330|FG001|Overall Study|Only parent outcomes completed|1|||
125486877|NCT03852550|451415329|FG000|Overall Study|Withdrawal by Subject|1|||
125486878|NCT03852550|451415330|FG001|Overall Study|Withdrawal by Subject|0|||
125486879|NCT05204654|451415331|FG000|Overall Study|Study terminated due to time restraint|2|||
125486880|NCT05204654|451415332|FG001|Overall Study|Study terminated due to time restraint|2|||
125486881|NCT05207956|451415347|FG000|Overall Study|Lost to follow up|1|||
125486882|NCT05207956|451415348|FG001|Overall Study|Lost to follow up|2|||
125486883|NCT02296684|451415349|FG000|Overall Study|Withdrawal by Subject|0|||
125486884|NCT02296684|451415350|FG001|Overall Study|Withdrawal by Subject|1|||
125486885|NCT02296684|451415351|FG002|Overall Study|Withdrawal by Subject|1|||
125486886|NCT02296684|451415349|FG000|Overall Study|Death|2|||
125486887|NCT02296684|451415350|FG001|Overall Study|Death|0|||
125486888|NCT02296684|451415351|FG002|Overall Study|Death|0|||
125486889|NCT01254864|451415354|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
125486890|NCT01254864|451415355|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
125486891|NCT01254864|451415356|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
125486892|NCT01254864|451415354|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
125486893|NCT01254864|451415355|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
125486894|NCT01254864|451415356|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
125486895|NCT01254864|451415354|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
125486896|NCT01254864|451415355|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
125486897|NCT01254864|451415356|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
125486898|NCT01254864|451415354|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
125486899|NCT01254864|451415355|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
125486900|NCT01254864|451415356|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
125486901|NCT01254864|451415354|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
125486902|NCT01254864|451415355|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
125486903|NCT01254864|451415356|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
125486904|NCT01254864|451415354|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
125486905|NCT01254864|451415355|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
125486906|NCT01254864|451415356|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
125486907|NCT01254864|451415354|FG000|Randomization Phase|Adverse Event|0|||
125486908|NCT01254864|451415355|FG001|Randomization Phase|Adverse Event|5|||
125486909|NCT01254864|451415356|FG002|Randomization Phase|Adverse Event|17|||
125486910|NCT01254864|451415354|FG000|Randomization Phase|Death|0|||
125486911|NCT01254864|451415355|FG001|Randomization Phase|Death|1|||
125486912|NCT01254864|451415356|FG002|Randomization Phase|Death|0|||
125486913|NCT01254864|451415354|FG000|Randomization Phase|Lost to Follow-up|0|||
125486914|NCT01254864|451415355|FG001|Randomization Phase|Lost to Follow-up|0|||
125486915|NCT01254864|451415356|FG002|Randomization Phase|Lost to Follow-up|1|||
125486916|NCT01254864|451415354|FG000|Randomization Phase|Physician Decision|0|||
125486917|NCT01254864|451415355|FG001|Randomization Phase|Physician Decision|20|||
125486918|NCT01254864|451415356|FG002|Randomization Phase|Physician Decision|25|||
125486919|NCT01254864|451415354|FG000|Randomization Phase|Withdrawal by Subject|0|||
125486920|NCT01254864|451415355|FG001|Randomization Phase|Withdrawal by Subject|4|||
125486921|NCT01254864|451415356|FG002|Randomization Phase|Withdrawal by Subject|2|||
125486922|NCT01254864|451415354|FG000|Randomization Phase|Non-Compliance|0|||
125486923|NCT01254864|451415355|FG001|Randomization Phase|Non-Compliance|1|||
125486924|NCT01254864|451415356|FG002|Randomization Phase|Non-Compliance|0|||
125486925|NCT01254864|451415354|FG000|Randomization Phase|Comorbidities|0|||
125486926|NCT01254864|451415355|FG001|Randomization Phase|Comorbidities|2|||
125486927|NCT01254864|451415356|FG002|Randomization Phase|Comorbidities|1|||
125486928|NCT01828112|451415359|FG000|Treatment Phase|Adverse Event|7|||
125486929|NCT01828112|451415360|FG001|Treatment Phase|Adverse Event|8|||
125486930|NCT01828112|451415361|FG002|Treatment Phase|Adverse Event|0|||
125486931|NCT01828112|451415359|FG000|Treatment Phase|Death|9|||
125486932|NCT01828112|451415360|FG001|Treatment Phase|Death|5|||
125486933|NCT01828112|451415361|FG002|Treatment Phase|Death|0|||
125486934|NCT01828112|451415359|FG000|Treatment Phase|No longer required treatment|0|||
125486935|NCT01828112|451415360|FG001|Treatment Phase|No longer required treatment|1|||
125486936|NCT01828112|451415361|FG002|Treatment Phase|No longer required treatment|0|||
125486937|NCT01828112|451415359|FG000|Treatment Phase|Physician Decision|6|||
125486938|NCT01828112|451415360|FG001|Treatment Phase|Physician Decision|7|||
125486939|NCT01828112|451415361|FG002|Treatment Phase|Physician Decision|0|||
125303263|NCT02891382|450736695|FG003|Overall Study|Lost to Follow-up|3|||
125303264|NCT02891382|450736696|FG004|Overall Study|Lost to Follow-up|4|||
125486940|NCT01828112|451415359|FG000|Treatment Phase|Pregnancy|1|||
125486941|NCT01828112|451415360|FG001|Treatment Phase|Pregnancy|0|||
125303265|NCT01628965|450736697|FG000|Overall Study|Adverse Event|30|||
125486942|NCT01828112|451415361|FG002|Treatment Phase|Pregnancy|0|||
125486943|NCT01828112|451415359|FG000|Treatment Phase|Progressive disease|79|||
125486944|NCT01828112|451415360|FG001|Treatment Phase|Progressive disease|87|||
125486945|NCT01828112|451415361|FG002|Treatment Phase|Progressive disease|0|||
125486946|NCT01828112|451415359|FG000|Treatment Phase|Study terminated by sponsor|1|||
125486947|NCT01828112|451415360|FG001|Treatment Phase|Study terminated by sponsor|0|||
125486948|NCT01828112|451415361|FG002|Treatment Phase|Study terminated by sponsor|0|||
125486949|NCT01828112|451415359|FG000|Treatment Phase|Subject/guardian decision|12|||
125486950|NCT01828112|451415360|FG001|Treatment Phase|Subject/guardian decision|8|||
125486951|NCT01828112|451415361|FG002|Treatment Phase|Subject/guardian decision|0|||
125486952|NCT01828112|451415359|FG000|Extension Treatment Phase|Adverse Event|0|||
125486953|NCT01828112|451415360|FG001|Extension Treatment Phase|Adverse Event|0|||
125486954|NCT01828112|451415361|FG002|Extension Treatment Phase|Adverse Event|6|||
125486955|NCT01828112|451415359|FG000|Extension Treatment Phase|Death|0|||
125486956|NCT01828112|451415360|FG001|Extension Treatment Phase|Death|0|||
125486957|NCT01828112|451415361|FG002|Extension Treatment Phase|Death|17|||
125486958|NCT01828112|451415359|FG000|Extension Treatment Phase|Physician Decision|0|||
125486959|NCT01828112|451415360|FG001|Extension Treatment Phase|Physician Decision|0|||
125486960|NCT01828112|451415361|FG002|Extension Treatment Phase|Physician Decision|5|||
125486961|NCT01828112|451415359|FG000|Extension Treatment Phase|Progressive disease|0|||
125486962|NCT01828112|451415360|FG001|Extension Treatment Phase|Progressive disease|0|||
125486963|NCT01828112|451415361|FG002|Extension Treatment Phase|Progressive disease|46|||
125486964|NCT01828112|451415359|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
125486965|NCT01828112|451415360|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
125486966|NCT01828112|451415361|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
125486967|NCT01828112|451415359|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
125486968|NCT01828112|451415360|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
125486969|NCT01828112|451415361|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
125486970|NCT02446236|451415371|FG000|Overall Study|Screen Failure|1|||
125486971|NCT02446236|451415372|FG001|Overall Study|Screen Failure|0|||
125486972|NCT02446236|451415373|FG002|Overall Study|Screen Failure|1|||
125486973|NCT02446236|451415371|FG000|Overall Study|Actively Receiving Therapy|0|||
125303266|NCT01628965|450736697|FG000|Overall Study|Lack of Efficacy|7|||
125303267|NCT01628965|450736697|FG000|Overall Study|Withdrawal by Subject|3|||
125486974|NCT02446236|451415372|FG001|Overall Study|Actively Receiving Therapy|0|||
125486975|NCT02446236|451415373|FG002|Overall Study|Actively Receiving Therapy|1|||
125486976|NCT05184452|451415374|FG000|Overall Study|Lost to Follow-up|0|||
125486977|NCT05184452|451415375|FG001|Overall Study|Lost to Follow-up|0|||
125486978|NCT05184452|451415376|FG002|Overall Study|Lost to Follow-up|0|||
125486979|NCT05184452|451415377|FG003|Overall Study|Lost to Follow-up|0|||
125486980|NCT05184452|451415378|FG004|Overall Study|Lost to Follow-up|0|||
125486981|NCT05184452|451415379|FG005|Overall Study|Lost to Follow-up|2|||
125303268|NCT01628965|450736697|FG000|Overall Study|Lost to Follow-up|1|||
125303269|NCT01628965|450736697|FG000|Overall Study|Discontinuation criteria|8|||
125303270|NCT02828020|450736698|FG000|Treatment Period|Adverse Event|3|||
125303271|NCT02828020|450736699|FG001|Treatment Period|Adverse Event|1|||
125303272|NCT02828020|450736700|FG002|Treatment Period|Adverse Event|1|||
125303273|NCT02828020|450736698|FG000|Treatment Period|Withdrawal of Consent|10|||
125303274|NCT02828020|450736699|FG001|Treatment Period|Withdrawal of Consent|14|||
125303275|NCT02828020|450736700|FG002|Treatment Period|Withdrawal of Consent|9|||
125303276|NCT02828020|450736698|FG000|Treatment Period|Lost to Follow-up|21|||
125303277|NCT02828020|450736699|FG001|Treatment Period|Lost to Follow-up|24|||
125303278|NCT02828020|450736700|FG002|Treatment Period|Lost to Follow-up|18|||
125303279|NCT02828020|450736698|FG000|Treatment Period|Lack of Qualifying Event|44|||
125303280|NCT02828020|450736699|FG001|Treatment Period|Lack of Qualifying Event|53|||
125303281|NCT02828020|450736700|FG002|Treatment Period|Lack of Qualifying Event|43|||
125303282|NCT02828020|450736698|FG000|Treatment Period|Pregnancy|0|||
125303283|NCT02828020|450736699|FG001|Treatment Period|Pregnancy|2|||
125303284|NCT02828020|450736700|FG002|Treatment Period|Pregnancy|0|||
125303285|NCT02828020|450736698|FG000|Treatment Period|Protocol Violation|2|||
125303286|NCT02828020|450736699|FG001|Treatment Period|Protocol Violation|4|||
125486982|NCT05184452|451415380|FG006|Overall Study|Lost to Follow-up|0|||
125486983|NCT05184452|451415381|FG007|Overall Study|Lost to Follow-up|0|||
125486984|NCT05184452|451415382|FG008|Overall Study|Lost to Follow-up|0|||
125486985|NCT05184452|451415383|FG009|Overall Study|Lost to Follow-up|1|||
125486986|NCT05184452|451415374|FG000|Overall Study|Withdrawal by Subject|0|||
125486987|NCT05184452|451415375|FG001|Overall Study|Withdrawal by Subject|0|||
125303287|NCT02828020|450736700|FG002|Treatment Period|Protocol Violation|7|||
125303288|NCT02828020|450736698|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
125303289|NCT02828020|450736699|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
125486988|NCT05184452|451415376|FG002|Overall Study|Withdrawal by Subject|0|||
125486989|NCT05184452|451415377|FG003|Overall Study|Withdrawal by Subject|0|||
125486990|NCT05184452|451415378|FG004|Overall Study|Withdrawal by Subject|0|||
125486991|NCT05184452|451415379|FG005|Overall Study|Withdrawal by Subject|1|||
125486992|NCT05184452|451415380|FG006|Overall Study|Withdrawal by Subject|0|||
125486993|NCT05184452|451415381|FG007|Overall Study|Withdrawal by Subject|0|||
125486994|NCT05184452|451415382|FG008|Overall Study|Withdrawal by Subject|0|||
125486995|NCT05184452|451415383|FG009|Overall Study|Withdrawal by Subject|1|||
125486996|NCT05586490|451415384|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
125486997|NCT05586490|451415385|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
125486998|NCT05586490|451415386|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
125486999|NCT05586490|451415387|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
125487000|NCT05586490|451415388|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
125487001|NCT05586490|451415384|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
125487002|NCT05586490|451415385|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
125487003|NCT05586490|451415386|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
125487004|NCT05586490|451415387|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
125487005|NCT05586490|451415388|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
125487006|NCT05586490|451415384|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
125487007|NCT05586490|451415385|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
125487008|NCT05586490|451415386|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
125487009|NCT05586490|451415387|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
125487010|NCT05586490|451415388|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
125487011|NCT04786119|451415389|FG000|Overall Study|Withdrawal by Subject|2|||
125487012|NCT05076266|451415390|FG000|Overall Study|Survey not complete - Participant refusal|2|||
125487013|NCT05076266|451415391|FG001|Overall Study|Survey not complete - Participant refusal|0|||
125487014|NCT05425420|451415392|FG000|Overall Study|Physician Decision|1|||
125487015|NCT05425420|451415392|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
125487016|NCT05280574|451415393|FG000|Overall Study|Withdrawal by Subject|0|||
125487017|NCT05280574|451415394|FG001|Overall Study|Withdrawal by Subject|2|||
125487018|NCT05280574|451415395|FG002|Overall Study|Withdrawal by Subject|0|||
125487019|NCT02361216|451415403|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
125487020|NCT02361216|451415404|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
125487021|NCT02361216|451415403|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
125487022|NCT02361216|451415404|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
125487023|NCT02361216|451415403|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
125487024|NCT02361216|451415404|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
125487025|NCT02361216|451415403|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
125487026|NCT02361216|451415404|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
125487027|NCT02361216|451415403|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
125487028|NCT02361216|451415404|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
125487029|NCT02361216|451415403|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
125487030|NCT02361216|451415404|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
125487031|NCT02988661|451415412|FG000|Overall Study|Death|2|||
125487032|NCT02988661|451415413|FG001|Overall Study|Death|18|||
125487033|NCT02988661|451415412|FG000|Overall Study|Lost to Follow-up|0|||
125487034|NCT02988661|451415413|FG001|Overall Study|Lost to Follow-up|33|||
125487035|NCT02988661|451415412|FG000|Overall Study|Withdrawal by Subject|0|||
125487036|NCT02988661|451415413|FG001|Overall Study|Withdrawal by Subject|6|||
125487037|NCT02988661|451415412|FG000|Overall Study|Unable to complete the 18-month survey|1|||
125487038|NCT02988661|451415413|FG001|Overall Study|Unable to complete the 18-month survey|27|||
125487039|NCT03213678|451415421|FG000|Overall Study|Death|1|||
125487040|NCT03213678|451415421|FG000|Overall Study|Physician Decision|1|||
125487041|NCT03213678|451415421|FG000|Overall Study|Progressive disease|16|||
125487042|NCT04218851|451415422|FG000|Overall Study|Death|1|||
125487043|NCT04218851|451415423|FG001|Overall Study|Death|3|||
125487044|NCT05645757|451417848|FG000|Overall Study|Enrolled but treatment not administered|0|||
125487045|NCT05645757|451417849|FG001|Overall Study|Enrolled but treatment not administered|0|||
125487046|NCT05645757|451417850|FG002|Overall Study|Enrolled but treatment not administered|0|||
125487047|NCT05645757|451417851|FG003|Overall Study|Enrolled but treatment not administered|0|||
125487048|NCT05645757|451417852|FG004|Overall Study|Enrolled but treatment not administered|1|||
125487049|NCT05645757|451417853|FG005|Overall Study|Enrolled but treatment not administered|1|||
125487050|NCT05645757|451417854|FG006|Overall Study|Enrolled but treatment not administered|0|||
125487051|NCT05645757|451417855|FG007|Overall Study|Enrolled but treatment not administered|0|||
125487052|NCT03924635|451417856|FG000|Overall Study|Withdrawal by Subject|2|||
125487053|NCT03924635|451417857|FG001|Overall Study|Withdrawal by Subject|4|||
125487054|NCT00539591|451417858|FG000|Overall Study|Toxicity|3|||
125487055|NCT00539591|451417859|FG001|Overall Study|Toxicity|0|||
125487056|NCT00539591|451417860|FG002|Overall Study|Toxicity|0|||
125487057|NCT00539591|451417858|FG000|Overall Study|Disease progression|2|||
125487058|NCT00539591|451417859|FG001|Overall Study|Disease progression|2|||
125487059|NCT00539591|451417860|FG002|Overall Study|Disease progression|3|||
125487060|NCT01960452|451417861|FG000|Overall Study|Withdrawal by Subject|2|||
125487061|NCT01960452|451417862|FG001|Overall Study|Withdrawal by Subject|1|||
125487062|NCT01960452|451417861|FG000|Overall Study|Sleep apnea in Night 1|1|||
125487063|NCT01960452|451417862|FG001|Overall Study|Sleep apnea in Night 1|0|||
125487064|NCT01960452|451417861|FG000|Overall Study|Poor Sleep in Night 1|0|||
125487065|NCT01960452|451417862|FG001|Overall Study|Poor Sleep in Night 1|2|||
125487066|NCT01960452|451417861|FG000|Overall Study|No Sex/Age Match Night 1|1|||
125487067|NCT01960452|451417862|FG001|Overall Study|No Sex/Age Match Night 1|0|||
125487068|NCT01960452|451417861|FG000|Overall Study|No Sex/Age Match Night 2|0|||
125487069|NCT01960452|451417862|FG001|Overall Study|No Sex/Age Match Night 2|2|||
125487070|NCT01960452|451417861|FG000|Overall Study|Technical Difficulties Night 2|2|||
125487071|NCT01960452|451417862|FG001|Overall Study|Technical Difficulties Night 2|0|||
125487072|NCT04414722|451417863|FG000|Overall Study|Lost to Follow-up|3|||
125487073|NCT04414722|451417864|FG001|Overall Study|Lost to Follow-up|4|||
125487074|NCT04414722|451417865|FG002|Overall Study|Lost to Follow-up|3|||
125487075|NCT04414722|451417866|FG003|Overall Study|Lost to Follow-up|2|||
125487076|NCT04414722|451417867|FG004|Overall Study|Lost to Follow-up|3|||
125487077|NCT04414722|451417863|FG000|Overall Study|Withdrawal by Subject|6|||
125487078|NCT04414722|451417864|FG001|Overall Study|Withdrawal by Subject|3|||
125487079|NCT04414722|451417865|FG002|Overall Study|Withdrawal by Subject|1|||
125487080|NCT04414722|451417866|FG003|Overall Study|Withdrawal by Subject|5|||
125487081|NCT04414722|451417867|FG004|Overall Study|Withdrawal by Subject|1|||
125487082|NCT04414722|451417863|FG000|Overall Study|Physician Decision|0|||
125487083|NCT04414722|451417864|FG001|Overall Study|Physician Decision|1|||
125487084|NCT04414722|451417865|FG002|Overall Study|Physician Decision|2|||
125487085|NCT04414722|451417866|FG003|Overall Study|Physician Decision|0|||
125487086|NCT04414722|451417867|FG004|Overall Study|Physician Decision|0|||
125487087|NCT04414722|451417863|FG000|Overall Study|Non-participatory|0|||
125487088|NCT04414722|451417864|FG001|Overall Study|Non-participatory|1|||
125487089|NCT04414722|451417865|FG002|Overall Study|Non-participatory|1|||
125487090|NCT04414722|451417866|FG003|Overall Study|Non-participatory|0|||
125487091|NCT04414722|451417867|FG004|Overall Study|Non-participatory|0|||
125487092|NCT03655028|451417870|FG000|12-weeks Follow up|Death|1|||
125487093|NCT03655028|451417871|FG001|12-weeks Follow up|Death|0|||
125487094|NCT03655028|451417870|FG000|12-weeks Follow up|Physician Decision|3|||
125487095|NCT03655028|451417871|FG001|12-weeks Follow up|Physician Decision|3|||
125487096|NCT03655028|451417870|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
125487097|NCT03655028|451417871|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
125487098|NCT03655028|451417870|FG000|12-weeks Follow up|Lost to Follow-up|4|||
125487099|NCT03655028|451417871|FG001|12-weeks Follow up|Lost to Follow-up|4|||
125487100|NCT03655028|451417870|FG000|24-weeks|Lost to Follow-up|1|||
125487101|NCT03655028|451417871|FG001|24-weeks|Lost to Follow-up|1|||
125487102|NCT03655028|451417870|FG000|24-weeks|Death|0|||
125487103|NCT03655028|451417871|FG001|24-weeks|Death|1|||
125487104|NCT03513302|451417872|FG000|First Intervention (14 Days)|Screen failure|15|||
125487105|NCT03513302|451417873|FG001|First Intervention (14 Days)|Screen failure|16|||
125487106|NCT05618587|451417874|FG000|Overall Study|Lost to Follow-up|2|||
125487107|NCT05618587|451417875|FG001|Overall Study|Lost to Follow-up|0|||
125487108|NCT04862416|451417880|FG000|Overall Study|Withdrawal by Subject|0|||
125487109|NCT04862416|451417881|FG001|Overall Study|Withdrawal by Subject|1|||
125487110|NCT04862416|451417882|FG002|Overall Study|Withdrawal by Subject|0|||
125487111|NCT04862416|451417883|FG003|Overall Study|Withdrawal by Subject|1|||
125487112|NCT04862416|451417884|FG004|Overall Study|Withdrawal by Subject|0|||
125487113|NCT04862416|451417885|FG005|Overall Study|Withdrawal by Subject|0|||
125487114|NCT04862416|451417886|FG006|Overall Study|Withdrawal by Subject|0|||
125487115|NCT04862416|451417887|FG007|Overall Study|Withdrawal by Subject|0|||
125487116|NCT03442309|451417888|FG000|Overall Study|Lost to Follow-up|1676|||
125487117|NCT03442309|451417889|FG001|Overall Study|Lost to Follow-up|1642|||
125487118|NCT04862234|451417890|FG000|Overall Study|Surgery cancellation|1|||
125487119|NCT04862234|451417891|FG001|Overall Study|Surgery cancellation|2|||
125487120|NCT04862234|451417890|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
125487121|NCT04862234|451417891|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
125487122|NCT04862234|451417890|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
125487123|NCT04862234|451417891|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
125303290|NCT02828020|450736700|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
125303291|NCT02828020|450736698|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
125303292|NCT02828020|450736699|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
125303293|NCT02828020|450736700|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
125487124|NCT03292484|451417897|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
125487125|NCT03292484|451417897|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
125487126|NCT03292484|451417897|FG000|Overall Study|Protocol Violation|2|||
125487127|NCT03292484|451417897|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
125487128|NCT03292484|451417897|FG000|Overall Study|Sponsor decision|349|||
125487129|NCT03292484|451417897|FG000|Overall Study|Lost to Follow-up|7|||
125487130|NCT03292484|451417897|FG000|Overall Study|Coronavirus Disease 2019|1|||
125487131|NCT03292484|451417897|FG000|Overall Study|Other|20|||
125487132|NCT05290493|451417898|FG000|Overall Study|Withdrawal by Subject|2|||
125487133|NCT05290493|451417899|FG001|Overall Study|Withdrawal by Subject|2|||
125487134|NCT05290493|451417898|FG000|Overall Study|Adverse Event|1|||
125487135|NCT05290493|451417899|FG001|Overall Study|Adverse Event|0|||
125487136|NCT03677141|451417903|FG000|Overall Study|Death|2|||
125487137|NCT03677141|451417904|FG001|Overall Study|Death|1|||
125487138|NCT03677141|451417905|FG002|Overall Study|Death|6|||
125487139|NCT03677141|451417906|FG003|Overall Study|Death|9|||
125487140|NCT03677141|451417907|FG004|Overall Study|Death|5|||
125487141|NCT03677141|451417908|FG005|Overall Study|Death|3|||
125487142|NCT03677141|451417903|FG000|Overall Study|Lost to Follow-up|0|||
125487143|NCT03677141|451417904|FG001|Overall Study|Lost to Follow-up|0|||
125487144|NCT03677141|451417905|FG002|Overall Study|Lost to Follow-up|0|||
125487145|NCT03677141|451417906|FG003|Overall Study|Lost to Follow-up|2|||
125487146|NCT03677141|451417907|FG004|Overall Study|Lost to Follow-up|0|||
125487147|NCT03677141|451417908|FG005|Overall Study|Lost to Follow-up|0|||
125487148|NCT03677141|451417903|FG000|Overall Study|Screen failure or enrolled in error|0|||
125487149|NCT03677141|451417904|FG001|Overall Study|Screen failure or enrolled in error|0|||
125487150|NCT03677141|451417905|FG002|Overall Study|Screen failure or enrolled in error|0|||
125487151|NCT03677141|451417906|FG003|Overall Study|Screen failure or enrolled in error|0|||
125487152|NCT03677141|451417907|FG004|Overall Study|Screen failure or enrolled in error|2|||
125487153|NCT03677141|451417908|FG005|Overall Study|Screen failure or enrolled in error|0|||
125487154|NCT03677141|451417903|FG000|Overall Study|Physician Decision|0|||
125487155|NCT03677141|451417904|FG001|Overall Study|Physician Decision|0|||
125487156|NCT03677141|451417905|FG002|Overall Study|Physician Decision|0|||
125487157|NCT03677141|451417906|FG003|Overall Study|Physician Decision|0|||
125487158|NCT03677141|451417907|FG004|Overall Study|Physician Decision|1|||
125487159|NCT03677141|451417908|FG005|Overall Study|Physician Decision|0|||
125487160|NCT03677141|451417903|FG000|Overall Study|Withdrawal by Subject|0|||
125487161|NCT03677141|451417904|FG001|Overall Study|Withdrawal by Subject|0|||
125487162|NCT03677141|451417905|FG002|Overall Study|Withdrawal by Subject|1|||
125487163|NCT03677141|451417906|FG003|Overall Study|Withdrawal by Subject|1|||
125487164|NCT03677141|451417907|FG004|Overall Study|Withdrawal by Subject|1|||
125487165|NCT03677141|451417908|FG005|Overall Study|Withdrawal by Subject|0|||
125487166|NCT05838027|451417912|FG000|Overall Study|Lost to Follow-up|5|||
125487167|NCT05838027|451417913|FG001|Overall Study|Lost to Follow-up|1|||
125487168|NCT05838027|451417912|FG000|Overall Study|Withdrawal by Subject|1|||
125487169|NCT05838027|451417913|FG001|Overall Study|Withdrawal by Subject|0|||
125487170|NCT04056611|451417919|FG000|Overall Study|Physician Decision|1|||
125487171|NCT02631746|451417920|FG000|Overall Study|Lack of Efficacy|3|||
125487172|NCT04571619|451417921|FG000|Phase 1|Death|22|||
125487173|NCT04571619|451417922|FG001|Phase 1|Death|18|||
125487174|NCT04571619|451417921|FG000|Phase 1|Withdrawal by Subject|7|||
125487175|NCT04571619|451417922|FG001|Phase 1|Withdrawal by Subject|2|||
125487176|NCT04571619|451417921|FG000|Phase 2|Death|13|||
125487177|NCT04571619|451417922|FG001|Phase 2|Death|16|||
125487178|NCT04571619|451417921|FG000|Phase 2|Withdrawal by Subject|6|||
125487179|NCT04571619|451417922|FG001|Phase 2|Withdrawal by Subject|4|||
125487180|NCT04709419|451417924|FG000|Overall Study|Physician Decision|1|||
125487181|NCT04709419|451417925|FG001|Overall Study|Physician Decision|0|||
125487182|NCT05683340|451417926|FG000|Overall Study|Adverse Event|1|||
125487183|NCT05683340|451417927|FG001|Overall Study|Adverse Event|1|||
125487184|NCT05683340|451417926|FG000|Overall Study|Protocol Violation|1|||
125487185|NCT05683340|451417927|FG001|Overall Study|Protocol Violation|0|||
125487186|NCT05683340|451417926|FG000|Overall Study|Withdrawal by Subject|0|||
125487187|NCT05683340|451417927|FG001|Overall Study|Withdrawal by Subject|2|||
125487188|NCT02224144|451417928|FG000|Overall Study|Lost to Follow-up|3|||
125487189|NCT02224144|451417929|FG001|Overall Study|Lost to Follow-up|1|||
125487190|NCT02224144|451417928|FG000|Overall Study|Death|2|||
125487191|NCT02224144|451417929|FG001|Overall Study|Death|0|||
125487192|NCT02224144|451417928|FG000|Overall Study|Withdrawal by Subject|0|||
125487193|NCT02224144|451417929|FG001|Overall Study|Withdrawal by Subject|1|||
125487194|NCT03505008|451417930|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
125487195|NCT03505008|451417931|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
125487196|NCT03505008|451417932|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
125487197|NCT03505008|451417933|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
125487198|NCT03505008|451417930|FG000|Before Week 24 Randomization|Adverse Event|10|||
125487199|NCT03505008|451417931|FG001|Before Week 24 Randomization|Adverse Event|0|||
125487200|NCT03505008|451417932|FG002|Before Week 24 Randomization|Adverse Event|0|||
125487201|NCT03505008|451417933|FG003|Before Week 24 Randomization|Adverse Event|0|||
125487202|NCT03505008|451417930|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
125487203|NCT03505008|451417931|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
125487204|NCT03505008|451417932|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
125487205|NCT03505008|451417933|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
125487206|NCT03505008|451417930|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
125487207|NCT03505008|451417931|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
125487208|NCT03505008|451417932|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
125487209|NCT03505008|451417933|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
125487210|NCT03505008|451417930|FG000|Before Week 24 Randomization|Physician Decision|2|||
125487211|NCT03505008|451417931|FG001|Before Week 24 Randomization|Physician Decision|0|||
125487212|NCT03505008|451417932|FG002|Before Week 24 Randomization|Physician Decision|0|||
125487213|NCT03505008|451417933|FG003|Before Week 24 Randomization|Physician Decision|0|||
125487214|NCT03505008|451417930|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
125487215|NCT03505008|451417931|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
125487216|NCT03505008|451417932|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
125487217|NCT03505008|451417933|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
125487218|NCT03505008|451417930|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
125487219|NCT03505008|451417931|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
125487220|NCT03505008|451417932|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
125487221|NCT03505008|451417933|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
125487222|NCT03505008|451417930|FG000|Before Week 24 Randomization|Complication|1|||
125487223|NCT03505008|451417931|FG001|Before Week 24 Randomization|Complication|0|||
125487224|NCT03505008|451417932|FG002|Before Week 24 Randomization|Complication|0|||
125487225|NCT03505008|451417933|FG003|Before Week 24 Randomization|Complication|0|||
125487226|NCT03505008|451417930|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
125487227|NCT03505008|451417931|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
125487228|NCT03505008|451417932|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
125487229|NCT03505008|451417933|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
125487230|NCT03505008|451417930|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
125487231|NCT03505008|451417931|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
125487232|NCT03505008|451417932|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
125487233|NCT03505008|451417933|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
125487234|NCT03505008|451417930|FG000|After Week 24 Randomization|Adverse Event|0|||
125487235|NCT03505008|451417931|FG001|After Week 24 Randomization|Adverse Event|1|||
125487236|NCT03505008|451417932|FG002|After Week 24 Randomization|Adverse Event|2|||
125487237|NCT03505008|451417933|FG003|After Week 24 Randomization|Adverse Event|2|||
125487238|NCT03505008|451417930|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
125487239|NCT03505008|451417931|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
125487240|NCT03505008|451417932|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
125487241|NCT03505008|451417933|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
125487242|NCT03505008|451417930|FG000|After Week 24 Randomization|Protocol Violation|0|||
125487243|NCT03505008|451417931|FG001|After Week 24 Randomization|Protocol Violation|0|||
125487244|NCT03505008|451417932|FG002|After Week 24 Randomization|Protocol Violation|1|||
125487245|NCT03505008|451417933|FG003|After Week 24 Randomization|Protocol Violation|0|||
125487246|NCT02962076|451417936|FG000|Overall Study|MHED tracer not available|5|||
125487247|NCT02962076|451417936|FG000|Overall Study|Protocol Violation|1|||
125487248|NCT02962076|451417936|FG000|Overall Study|Physician Decision|1|||
125487249|NCT04741776|451417937|FG000|Overall Study|Withdrawal by Subject|7|||
125487250|NCT04741776|451417938|FG001|Overall Study|Withdrawal by Subject|10|||
125487251|NCT04741776|451417939|FG002|Overall Study|Withdrawal by Subject|10|||
125487252|NCT04741776|451417940|FG003|Overall Study|Withdrawal by Subject|17|||
125487253|NCT04741776|451417937|FG000|Overall Study|Death|0|||
125487254|NCT04741776|451417938|FG001|Overall Study|Death|0|||
125487255|NCT04741776|451417939|FG002|Overall Study|Death|1|||
125487256|NCT04741776|451417940|FG003|Overall Study|Death|0|||
125487257|NCT04089865|451417941|FG000|Overall Study|Withdrawal by Subject|2|||
125487258|NCT04089865|451417942|FG001|Overall Study|Withdrawal by Subject|2|||
125487259|NCT04089865|451417943|FG002|Overall Study|Withdrawal by Subject|7|||
125487260|NCT04089865|451417944|FG003|Overall Study|Withdrawal by Subject|2|||
125487261|NCT02780700|451417954|FG000|Overall Study|Progressive disease|1|||
125487262|NCT01730937|451417955|FG000|Overall Study|Protocol Violation|5|||
125487263|NCT01730937|451417956|FG001|Overall Study|Protocol Violation|11|||
125487264|NCT03824366|451417970|FG000|Overall Study|Death|1|||
125487265|NCT03824366|451417970|FG000|Overall Study|Previously unidentified metal artifact|1|||
125487266|NCT03824366|451417970|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
125487267|NCT03824366|451417970|FG000|Overall Study|Withdrawal by Subject|1|||
125487268|NCT05069896|451417975|FG000|Overall Study|Adverse Event|0|||
125487269|NCT05069896|451417976|FG001|Overall Study|Adverse Event|1|||
125487270|NCT05069896|451417977|FG002|Overall Study|Adverse Event|1|||
125487271|NCT05069896|451417978|FG003|Overall Study|Adverse Event|0|||
125487272|NCT05069896|451417979|FG004|Overall Study|Adverse Event|0|||
125487273|NCT05069896|451417980|FG005|Overall Study|Adverse Event|0|||
125487274|NCT05069896|451417975|FG000|Overall Study|Lost to Follow-up|0|||
125303294|NCT02828020|450736698|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
125303295|NCT02828020|450736699|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
125303296|NCT02828020|450736700|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
125487275|NCT05069896|451417976|FG001|Overall Study|Lost to Follow-up|0|||
125487276|NCT05069896|451417977|FG002|Overall Study|Lost to Follow-up|1|||
125487277|NCT05069896|451417978|FG003|Overall Study|Lost to Follow-up|0|||
125487278|NCT05069896|451417979|FG004|Overall Study|Lost to Follow-up|1|||
125487279|NCT05069896|451417980|FG005|Overall Study|Lost to Follow-up|2|||
125487280|NCT04820322|451417981|FG000|Overall Study|Adverse Event|1|||
125487281|NCT04820322|451417982|FG001|Overall Study|Adverse Event|0|||
125487282|NCT00323856|451417986|FG000|Overall Study|Withdrawal by Subject|1|||
125487283|NCT00323856|451417986|FG000|Overall Study|Was uncooperative and noncompliant|1|||
125487284|NCT00323856|451417986|FG000|Overall Study|Reason not specified|1|||
125487285|NCT00323856|451417986|FG000|Overall Study|Missing|2|||
125487286|NCT03156465|451417992|FG000|Overall Study|Withdrawal by Subject|2|||
125487287|NCT05715528|451418002|FG000|Overall Study|Randomized but never treated|11|||
125487288|NCT05715528|451418003|FG001|Overall Study|Randomized but never treated|13|||
125487289|NCT05715528|451418002|FG000|Overall Study|Withdrew consent|7|||
125487290|NCT05715528|451418003|FG001|Overall Study|Withdrew consent|15|||
125487291|NCT05715528|451418002|FG000|Overall Study|Lost to Follow-up|5|||
125487292|NCT05715528|451418003|FG001|Overall Study|Lost to Follow-up|13|||
125487293|NCT05715528|451418002|FG000|Overall Study|Investigator's discretion|3|||
125487294|NCT05715528|451418003|FG001|Overall Study|Investigator's discretion|1|||
125487295|NCT05715528|451418002|FG000|Overall Study|Protocol Violation|2|||
125487296|NCT05715528|451418003|FG001|Overall Study|Protocol Violation|0|||
125487297|NCT05715528|451418002|FG000|Overall Study|Non-compliance with study drug|0|||
125487298|NCT05715528|451418003|FG001|Overall Study|Non-compliance with study drug|1|||
125487299|NCT03485729|451418007|FG000|Overall Study|Withdrawal by Subject|0|||
125487300|NCT03485729|451418008|FG001|Overall Study|Withdrawal by Subject|0|||
125487301|NCT03485729|451418009|FG002|Overall Study|Withdrawal by Subject|1|||
125487302|NCT03485729|451418007|FG000|Overall Study|Disease progression|8|||
125487303|NCT03485729|451418008|FG001|Overall Study|Disease progression|13|||
125487304|NCT03485729|451418009|FG002|Overall Study|Disease progression|1|||
125487305|NCT03485729|451418007|FG000|Overall Study|Hospice care|1|||
125487306|NCT03485729|451418008|FG001|Overall Study|Hospice care|0|||
125487307|NCT03485729|451418009|FG002|Overall Study|Hospice care|0|||
125487308|NCT03485729|451418007|FG000|Overall Study|Poor performance status|1|||
125487309|NCT03485729|451418008|FG001|Overall Study|Poor performance status|0|||
125487310|NCT03485729|451418009|FG002|Overall Study|Poor performance status|0|||
125487311|NCT03485729|451418007|FG000|Overall Study|Illness|0|||
125487312|NCT03485729|451418008|FG001|Overall Study|Illness|1|||
125487313|NCT03485729|451418009|FG002|Overall Study|Illness|0|||
125487314|NCT05035654|451418011|FG000|Overall Study|Physician Decision|0|||
125487315|NCT05035654|451418012|FG001|Overall Study|Physician Decision|1|||
125487316|NCT05035654|451418013|FG002|Overall Study|Physician Decision|0|||
125487317|NCT05035654|451418011|FG000|Overall Study|Adverse Event|0|||
125487318|NCT05035654|451418012|FG001|Overall Study|Adverse Event|1|||
125487319|NCT05035654|451418013|FG002|Overall Study|Adverse Event|0|||
125487320|NCT05035654|451418011|FG000|Overall Study|Withdrawal by Subject|0|||
125487321|NCT05035654|451418012|FG001|Overall Study|Withdrawal by Subject|0|||
125487322|NCT05035654|451418013|FG002|Overall Study|Withdrawal by Subject|4|||
125487323|NCT05035654|451418011|FG000|Overall Study|Bilateral Dislodgement|1|||
125487324|NCT05035654|451418012|FG001|Overall Study|Bilateral Dislodgement|0|||
125487325|NCT05035654|451418013|FG002|Overall Study|Bilateral Dislodgement|0|||
125487326|NCT04880733|451418014|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
125487327|NCT04880733|451418015|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
125487328|NCT04880733|451418016|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
125487329|NCT04880733|451418014|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
125487330|NCT04880733|451418015|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
125487331|NCT04880733|451418016|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
125487332|NCT04880733|451418014|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
125487333|NCT04880733|451418015|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
125487334|NCT04880733|451418016|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
125487335|NCT04880733|451418014|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
125487336|NCT04880733|451418015|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
125487337|NCT04880733|451418016|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
125487338|NCT04880733|451418014|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
125487339|NCT04880733|451418015|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
125487340|NCT04880733|451418016|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
125487341|NCT04934072|451418019|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
125487342|NCT04934072|451418020|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
125487343|NCT04934072|451418021|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
125487344|NCT04934072|451418022|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
125487345|NCT04934072|451418023|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
125487346|NCT04934072|451418019|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
125487347|NCT04934072|451418020|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
125487348|NCT04934072|451418021|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
125487349|NCT04934072|451418022|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
125487350|NCT04934072|451418023|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
125487351|NCT04934072|451418019|FG000|Day 0 to Week 52|Other|3|||
125487352|NCT04934072|451418020|FG001|Day 0 to Week 52|Other|1|||
125487353|NCT04934072|451418021|FG002|Day 0 to Week 52|Other|0|||
125487354|NCT04934072|451418022|FG003|Day 0 to Week 52|Other|0|||
125487355|NCT04934072|451418023|FG004|Day 0 to Week 52|Other|0|||
125487356|NCT04934072|451418019|FG000|Day 0 to Week 52|Adverse Event|1|||
125487357|NCT04934072|451418020|FG001|Day 0 to Week 52|Adverse Event|3|||
125487358|NCT04934072|451418021|FG002|Day 0 to Week 52|Adverse Event|0|||
125487359|NCT04934072|451418022|FG003|Day 0 to Week 52|Adverse Event|0|||
125487360|NCT04934072|451418023|FG004|Day 0 to Week 52|Adverse Event|0|||
125487361|NCT04934072|451418019|FG000|Week 52 to Week 78|Adverse Event|0|||
125487362|NCT04934072|451418020|FG001|Week 52 to Week 78|Adverse Event|0|||
125487363|NCT04934072|451418021|FG002|Week 52 to Week 78|Adverse Event|0|||
125487364|NCT04934072|451418022|FG003|Week 52 to Week 78|Adverse Event|1|||
125487365|NCT04934072|451418023|FG004|Week 52 to Week 78|Adverse Event|1|||
125487366|NCT04934072|451418019|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
125487367|NCT04934072|451418020|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
125487368|NCT04934072|451418021|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
125487369|NCT04934072|451418022|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
125487370|NCT04934072|451418023|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
125487371|NCT04934072|451418019|FG000|Week 52 to Week 78|Other|0|||
125487372|NCT04934072|451418020|FG001|Week 52 to Week 78|Other|0|||
125487373|NCT04934072|451418021|FG002|Week 52 to Week 78|Other|1|||
125487374|NCT04934072|451418022|FG003|Week 52 to Week 78|Other|0|||
125487375|NCT04934072|451418023|FG004|Week 52 to Week 78|Other|0|||
125487376|NCT03174275|451418025|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
125487377|NCT03174275|451418025|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
125487378|NCT03174275|451418025|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
125487379|NCT03174275|451418025|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
125487380|NCT03174275|451418025|FG000|Adjuvant Chemotherapy|Progression|1|||
125487381|NCT03174275|451418025|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
125487382|NCT03174275|451418025|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
125487383|NCT03174275|451418025|FG000|Adjuvant Durvalumab|Progression|1|||
125487384|NCT03174275|451418025|FG000|Adjuvant Durvalumab|Adverse Event|3|||
125487385|NCT03174275|451418025|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
125487386|NCT03174275|451418025|FG000|Adjuvant Radiotherapy|Progression|1|||
125487387|NCT03174275|451418025|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
125487388|NCT04456296|451418026|FG000|Overall Study|Withdrawal by Subject|14|||
125487389|NCT04456296|451418027|FG001|Overall Study|Withdrawal by Subject|21|||
125487390|NCT04456296|451418028|FG002|Overall Study|Withdrawal by Subject|21|||
125487391|NCT04456296|451418026|FG000|Overall Study|Adverse Event|2|||
125487392|NCT04456296|451418027|FG001|Overall Study|Adverse Event|2|||
125487393|NCT04456296|451418028|FG002|Overall Study|Adverse Event|2|||
125487394|NCT04456296|451418026|FG000|Overall Study|Death|1|||
125487395|NCT04456296|451418027|FG001|Overall Study|Death|0|||
125487396|NCT04456296|451418028|FG002|Overall Study|Death|0|||
125487397|NCT04456296|451418026|FG000|Overall Study|Lost to Follow-up|3|||
125487398|NCT04456296|451418027|FG001|Overall Study|Lost to Follow-up|5|||
125487399|NCT04456296|451418028|FG002|Overall Study|Lost to Follow-up|6|||
125487400|NCT04456296|451418026|FG000|Overall Study|Other than specified|0|||
125487401|NCT04456296|451418027|FG001|Overall Study|Other than specified|1|||
125487402|NCT04456296|451418028|FG002|Overall Study|Other than specified|4|||
125487403|NCT04456296|451418026|FG000|Overall Study|Randomized, not treated|2|||
125487404|NCT04456296|451418027|FG001|Overall Study|Randomized, not treated|1|||
125487405|NCT04456296|451418028|FG002|Overall Study|Randomized, not treated|0|||
125487406|NCT02997202|451418029|FG000|Overall Study|Miscellaneous|2|||
125487407|NCT02997202|451418030|FG001|Overall Study|Miscellaneous|2|||
125487408|NCT02997202|451418029|FG000|Overall Study|Withdrawal by Subject|8|||
125487409|NCT02997202|451418030|FG001|Overall Study|Withdrawal by Subject|12|||
125487410|NCT02997202|451418029|FG000|Overall Study|Lost to Follow-up|5|||
125487411|NCT02997202|451418030|FG001|Overall Study|Lost to Follow-up|3|||
125487412|NCT02997202|451418029|FG000|Overall Study|Death|41|||
125487413|NCT02997202|451418030|FG001|Overall Study|Death|45|||
125487414|NCT04271046|451418032|FG000|Overall Study|Death|0|||
125487415|NCT04271046|451418033|FG001|Overall Study|Death|2|||
125303297|NCT02828020|450736698|FG000|Safety Follow-up Period|Protocol Violation|0|||
125303298|NCT02828020|450736699|FG001|Safety Follow-up Period|Protocol Violation|2|||
125487416|NCT04271046|451418034|FG002|Overall Study|Death|0|||
125487417|NCT04271046|451418035|FG003|Overall Study|Death|2|||
125487418|NCT04271046|451418032|FG000|Overall Study|Lost to Follow-up|12|||
125487419|NCT04271046|451418033|FG001|Overall Study|Lost to Follow-up|12|||
125487420|NCT04271046|451418034|FG002|Overall Study|Lost to Follow-up|11|||
125487421|NCT04271046|451418035|FG003|Overall Study|Lost to Follow-up|11|||
125487422|NCT04271046|451418032|FG000|Overall Study|Patient with Dementia Died|2|||
125487423|NCT04271046|451418033|FG001|Overall Study|Patient with Dementia Died|0|||
125487424|NCT04271046|451418034|FG002|Overall Study|Patient with Dementia Died|2|||
125487425|NCT04271046|451418035|FG003|Overall Study|Patient with Dementia Died|0|||
125487426|NCT04271046|451418032|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
125487427|NCT04271046|451418033|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
125487428|NCT04271046|451418034|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
125487429|NCT04271046|451418035|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
125487430|NCT00303459|451418036|FG000|Overall Study|Death|33|||
125487431|NCT00303459|451418037|FG001|Overall Study|Death|44|||
125487432|NCT00303459|451418036|FG000|Overall Study|Withdrawal of consent|32|||
125487433|NCT00303459|451418037|FG001|Overall Study|Withdrawal of consent|26|||
125487434|NCT00303459|451418036|FG000|Overall Study|Lost to Follow-up|5|||
125487435|NCT00303459|451418037|FG001|Overall Study|Lost to Follow-up|4|||
125487436|NCT00303459|451418036|FG000|Overall Study|Administrative reason|7|||
125487437|NCT00303459|451418037|FG001|Overall Study|Administrative reason|7|||
125487438|NCT00303459|451418036|FG000|Overall Study|Decision by the investigator|5|||
125487439|NCT00303459|451418037|FG001|Overall Study|Decision by the investigator|7|||
125487440|NCT00303459|451418036|FG000|Overall Study|Lung transplantation|1|||
125487441|NCT00303459|451418037|FG001|Overall Study|Lung transplantation|1|||
125487442|NCT04129554|451418038|FG000|Overall Study|Withdrawal by Subject|4|||
125487443|NCT04129554|451418039|FG001|Overall Study|Withdrawal by Subject|3|||
125487444|NCT04129554|451418038|FG000|Overall Study|Other|0|||
125487445|NCT04129554|451418039|FG001|Overall Study|Other|2|||
125487446|NCT01570361|451418040|FG000|Overall Study|Subject discontinued|1|||
125487447|NCT01570361|451418041|FG001|Overall Study|Subject discontinued|2|||
125487448|NCT01570361|451418040|FG000|Overall Study|Sponsor closing the study|51|||
125487449|NCT01570361|451418041|FG001|Overall Study|Sponsor closing the study|50|||
125487450|NCT01570361|451418040|FG000|Overall Study|Subject excluded|5|||
125487451|NCT01570361|451418041|FG001|Overall Study|Subject excluded|3|||
125487452|NCT01570361|451418040|FG000|Overall Study|Subject withdrew consent|14|||
125487453|NCT01570361|451418041|FG001|Overall Study|Subject withdrew consent|9|||
125487454|NCT01570361|451418040|FG000|Overall Study|Adverse Event|2|||
125487455|NCT01570361|451418041|FG001|Overall Study|Adverse Event|1|||
125487456|NCT01570361|451418040|FG000|Overall Study|Lost to Follow-up|4|||
125487457|NCT01570361|451418041|FG001|Overall Study|Lost to Follow-up|4|||
125487458|NCT01570361|451418040|FG000|Overall Study|Death|5|||
125487459|NCT01570361|451418041|FG001|Overall Study|Death|4|||
125487460|NCT01570361|451418040|FG000|Overall Study|Other|0|||
125487461|NCT01570361|451418041|FG001|Overall Study|Other|2|||
125487462|NCT03993392|451418049|FG000|Overall Study|Withdrawal by Subject|3|||
125487463|NCT03993392|451418049|FG000|Overall Study|Lost to Follow-up|2|||
125487464|NCT03993392|451418049|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
125487465|NCT04826471|451420082|FG000|Overall Study|Lost to Follow-up|2|||
125487466|NCT04826471|451420082|FG000|Overall Study|Protocol Violation|3|||
125487467|NCT04826471|451420082|FG000|Overall Study|Withdrawal by Subject|1|||
125487468|NCT04304144|451420084|FG000|DLT Observation Period|Physician Decision|0|||
125487469|NCT04304144|451420085|FG001|DLT Observation Period|Physician Decision|1|||
125487470|NCT04304144|451420086|FG002|DLT Observation Period|Physician Decision|0|||
125487471|NCT04304144|451420087|FG003|DLT Observation Period|Physician Decision|0|||
125487472|NCT04304144|451420084|FG000|Continued Treatment Period|Adverse Event|0|||
125487473|NCT04304144|451420085|FG001|Continued Treatment Period|Adverse Event|1|||
125487474|NCT04304144|451420086|FG002|Continued Treatment Period|Adverse Event|0|||
125487475|NCT04304144|451420087|FG003|Continued Treatment Period|Adverse Event|0|||
125487476|NCT04304144|451420084|FG000|Continued Treatment Period|Death|0|||
125487477|NCT04304144|451420085|FG001|Continued Treatment Period|Death|0|||
125487478|NCT04304144|451420086|FG002|Continued Treatment Period|Death|1|||
125487479|NCT04304144|451420087|FG003|Continued Treatment Period|Death|2|||
125487480|NCT04304144|451420084|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
125487481|NCT04304144|451420085|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
125487482|NCT04304144|451420086|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
125487483|NCT04304144|451420087|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
125487484|NCT04304144|451420084|FG000|Continued Treatment Period|Other than specified|2|||
125487485|NCT04304144|451420085|FG001|Continued Treatment Period|Other than specified|0|||
125487486|NCT04304144|451420086|FG002|Continued Treatment Period|Other than specified|1|||
125487487|NCT04304144|451420087|FG003|Continued Treatment Period|Other than specified|1|||
125487488|NCT04615273|451420090|FG000|Overall Study|Withdrawal by Subject|3|||
125487489|NCT04615273|451420091|FG001|Overall Study|Withdrawal by Subject|1|||
125487490|NCT04615273|451420092|FG002|Overall Study|Withdrawal by Subject|2|||
125487491|NCT04615273|451420090|FG000|Overall Study|Adverse Event|1|||
125487492|NCT04615273|451420091|FG001|Overall Study|Adverse Event|0|||
125487493|NCT04615273|451420092|FG002|Overall Study|Adverse Event|1|||
125487494|NCT04615273|451420090|FG000|Overall Study|Lost to Follow-up|0|||
125487495|NCT04615273|451420091|FG001|Overall Study|Lost to Follow-up|1|||
125487496|NCT04615273|451420092|FG002|Overall Study|Lost to Follow-up|0|||
125487497|NCT04615273|451420090|FG000|Overall Study|Physician Decision|0|||
125487498|NCT04615273|451420091|FG001|Overall Study|Physician Decision|0|||
125487499|NCT04615273|451420092|FG002|Overall Study|Physician Decision|1|||
125487500|NCT04615273|451420090|FG000|Overall Study|Other|0|||
125487501|NCT04615273|451420091|FG001|Overall Study|Other|1|||
125487502|NCT04615273|451420092|FG002|Overall Study|Other|0|||
125487503|NCT04615273|451420090|FG000|Overall Study|Randomized but not treated|1|||
125487504|NCT04615273|451420091|FG001|Overall Study|Randomized but not treated|3|||
125487505|NCT04615273|451420092|FG002|Overall Study|Randomized but not treated|1|||
125487506|NCT03673501|451420095|FG000|Overall Study|Participants ongoing.|36|||
125487507|NCT03673501|451420096|FG001|Overall Study|Participants ongoing.|24|||
125487508|NCT04599634|451420097|FG000|Overall Study|Dose limiting toxicity|0|||
125487509|NCT04599634|451420098|FG001|Overall Study|Dose limiting toxicity|0|||
125487510|NCT04599634|451420099|FG002|Overall Study|Dose limiting toxicity|2|||
125487511|NCT04599634|451420100|FG003|Overall Study|Dose limiting toxicity|0|||
125487512|NCT04999111|451420101|FG000|Overall Study|Lost to Follow-up|21|||
125487513|NCT04999111|451420102|FG001|Overall Study|Lost to Follow-up|16|||
125487514|NCT04999111|451420103|FG002|Overall Study|Lost to Follow-up|2|||
125487515|NCT04999111|451420104|FG003|Overall Study|Lost to Follow-up|26|||
125487516|NCT04999111|451420105|FG004|Overall Study|Lost to Follow-up|30|||
125487517|NCT04999111|451420106|FG005|Overall Study|Lost to Follow-up|6|||
125487518|NCT04999111|451420101|FG000|Overall Study|Physician Decision|1|||
125487519|NCT04999111|451420102|FG001|Overall Study|Physician Decision|3|||
125487520|NCT04999111|451420103|FG002|Overall Study|Physician Decision|0|||
125487521|NCT04999111|451420104|FG003|Overall Study|Physician Decision|1|||
125487522|NCT04999111|451420105|FG004|Overall Study|Physician Decision|2|||
125487523|NCT04999111|451420106|FG005|Overall Study|Physician Decision|0|||
125487524|NCT04999111|451420101|FG000|Overall Study|Withdrawal by Subject|23|||
125487525|NCT04999111|451420102|FG001|Overall Study|Withdrawal by Subject|29|||
125487526|NCT04999111|451420103|FG002|Overall Study|Withdrawal by Subject|15|||
125487527|NCT04999111|451420104|FG003|Overall Study|Withdrawal by Subject|30|||
125487528|NCT04999111|451420105|FG004|Overall Study|Withdrawal by Subject|35|||
125487529|NCT04999111|451420106|FG005|Overall Study|Withdrawal by Subject|10|||
125487530|NCT04999111|451420101|FG000|Overall Study|Other|6|||
125487531|NCT04999111|451420102|FG001|Overall Study|Other|6|||
125487532|NCT04999111|451420103|FG002|Overall Study|Other|3|||
125487533|NCT04999111|451420104|FG003|Overall Study|Other|8|||
125487534|NCT04999111|451420105|FG004|Overall Study|Other|8|||
125487535|NCT04999111|451420106|FG005|Overall Study|Other|5|||
125487536|NCT04999111|451420101|FG000|Overall Study|Non-compliance with study schedule|1|||
125487537|NCT04999111|451420102|FG001|Overall Study|Non-compliance with study schedule|0|||
125487538|NCT04999111|451420103|FG002|Overall Study|Non-compliance with study schedule|0|||
125487539|NCT04999111|451420104|FG003|Overall Study|Non-compliance with study schedule|1|||
125487540|NCT04999111|451420105|FG004|Overall Study|Non-compliance with study schedule|1|||
125487541|NCT04999111|451420106|FG005|Overall Study|Non-compliance with study schedule|1|||
125487542|NCT04999111|451420101|FG000|Overall Study|Randomized but not vaccinated|1|||
125487543|NCT04999111|451420102|FG001|Overall Study|Randomized but not vaccinated|2|||
125487544|NCT04999111|451420103|FG002|Overall Study|Randomized but not vaccinated|0|||
125487545|NCT04999111|451420104|FG003|Overall Study|Randomized but not vaccinated|3|||
125487546|NCT04999111|451420105|FG004|Overall Study|Randomized but not vaccinated|3|||
125487547|NCT04999111|451420106|FG005|Overall Study|Randomized but not vaccinated|0|||
125487548|NCT04999111|451420101|FG000|Overall Study|Adverse Event|1|||
125487549|NCT04999111|451420102|FG001|Overall Study|Adverse Event|1|||
125487550|NCT04999111|451420103|FG002|Overall Study|Adverse Event|0|||
125487551|NCT04999111|451420104|FG003|Overall Study|Adverse Event|0|||
125487552|NCT04999111|451420105|FG004|Overall Study|Adverse Event|0|||
125487553|NCT04999111|451420106|FG005|Overall Study|Adverse Event|0|||
125487554|NCT04999111|451420101|FG000|Overall Study|Initiated prohibited medication|0|||
125487555|NCT04999111|451420102|FG001|Overall Study|Initiated prohibited medication|0|||
125487556|NCT04999111|451420103|FG002|Overall Study|Initiated prohibited medication|0|||
125487557|NCT04999111|451420104|FG003|Overall Study|Initiated prohibited medication|0|||
125487558|NCT04999111|451420105|FG004|Overall Study|Initiated prohibited medication|1|||
125487559|NCT04999111|451420106|FG005|Overall Study|Initiated prohibited medication|0|||
125487560|NCT03714815|451420107|FG000|Overall Study|Physician Decision|2|||
125487561|NCT03714815|451420107|FG000|Overall Study|Withdrawal by Subject|2|||
125487562|NCT03714815|451420107|FG000|Overall Study|Death|11|||
125487563|NCT01314105|451420111|FG000|Overall Study|Progressive Disease|6|||
125487564|NCT01314105|451420112|FG001|Overall Study|Progressive Disease|10|||
125487565|NCT01314105|451420111|FG000|Overall Study|Refused to continue taking medication|0|||
125487566|NCT01314105|451420112|FG001|Overall Study|Refused to continue taking medication|1|||
125487567|NCT01314105|451420111|FG000|Overall Study|Other Adverse Event|1|||
125487568|NCT01314105|451420112|FG001|Overall Study|Other Adverse Event|1|||
125487569|NCT02056834|451420113|FG000|Overall Study|Lost to Follow-up|7|||
125487570|NCT06106022|451420114|FG000|Overall Study|Lost to Follow-up|1|||
125487571|NCT06106022|451420115|FG001|Overall Study|Lost to Follow-up|0|||
125487572|NCT06106022|451420114|FG000|Overall Study|Voluntary Withdrawal|0|||
125487573|NCT06106022|451420115|FG001|Overall Study|Voluntary Withdrawal|2|||
125487574|NCT03276676|451420117|FG000|Overall Study|Withdrawal by Subject|2|||
125487575|NCT03276676|451420118|FG001|Overall Study|Withdrawal by Subject|1|||
125487576|NCT03583333|451420121|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
125303299|NCT02828020|450736700|FG002|Safety Follow-up Period|Protocol Violation|1|||
125487577|NCT03583333|451420122|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
125487578|NCT03583333|451420121|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
125487579|NCT03583333|451420122|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
125487580|NCT03583333|451420121|FG000|Overall Study|Withdrawal by Subject|9|||
125487581|NCT03583333|451420122|FG001|Overall Study|Withdrawal by Subject|5|||
125487582|NCT03583333|451420121|FG000|Overall Study|Physician Decision|3|||
125303300|NCT02828020|450736698|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
125487583|NCT03583333|451420122|FG001|Overall Study|Physician Decision|2|||
125487584|NCT03583333|451420121|FG000|Overall Study|Death|12|||
125487585|NCT03583333|451420122|FG001|Overall Study|Death|7|||
125487586|NCT03926130|451420123|FG000|Overall Study|Adverse Event|9|||
125487587|NCT03926130|451420124|FG001|Overall Study|Adverse Event|11|||
125487588|NCT03926130|451420125|FG002|Overall Study|Adverse Event|2|||
125487589|NCT03926130|451420126|FG003|Overall Study|Adverse Event|0|||
125487590|NCT03926130|451420123|FG000|Overall Study|Death|2|||
125487591|NCT03926130|451420124|FG001|Overall Study|Death|0|||
125487592|NCT03926130|451420125|FG002|Overall Study|Death|1|||
125487593|NCT03926130|451420126|FG003|Overall Study|Death|0|||
125487594|NCT03926130|451420123|FG000|Overall Study|Lack of Efficacy|14|||
125487595|NCT03926130|451420124|FG001|Overall Study|Lack of Efficacy|11|||
125487596|NCT03926130|451420125|FG002|Overall Study|Lack of Efficacy|7|||
125487597|NCT03926130|451420126|FG003|Overall Study|Lack of Efficacy|1|||
125487598|NCT03926130|451420123|FG000|Overall Study|Lost to Follow-up|0|||
125487599|NCT03926130|451420124|FG001|Overall Study|Lost to Follow-up|7|||
125487600|NCT03926130|451420125|FG002|Overall Study|Lost to Follow-up|1|||
125487601|NCT03926130|451420126|FG003|Overall Study|Lost to Follow-up|0|||
125487602|NCT03926130|451420123|FG000|Overall Study|As Reported by Investigator|2|||
125487603|NCT03926130|451420124|FG001|Overall Study|As Reported by Investigator|6|||
125487604|NCT03926130|451420125|FG002|Overall Study|As Reported by Investigator|6|||
125487605|NCT03926130|451420126|FG003|Overall Study|As Reported by Investigator|0|||
125487606|NCT03926130|451420123|FG000|Overall Study|Physician Decision|3|||
125487607|NCT03926130|451420124|FG001|Overall Study|Physician Decision|2|||
125487608|NCT03926130|451420125|FG002|Overall Study|Physician Decision|1|||
125487609|NCT03926130|451420126|FG003|Overall Study|Physician Decision|0|||
125487610|NCT03926130|451420123|FG000|Overall Study|Pregnancy|2|||
125487611|NCT03926130|451420124|FG001|Overall Study|Pregnancy|2|||
125487612|NCT03926130|451420125|FG002|Overall Study|Pregnancy|1|||
125487613|NCT03926130|451420126|FG003|Overall Study|Pregnancy|0|||
125487614|NCT03926130|451420123|FG000|Overall Study|Withdrawal by Subject|20|||
125487615|NCT03926130|451420124|FG001|Overall Study|Withdrawal by Subject|28|||
125487616|NCT03926130|451420125|FG002|Overall Study|Withdrawal by Subject|18|||
125487617|NCT03926130|451420126|FG003|Overall Study|Withdrawal by Subject|1|||
125487618|NCT03926130|451420123|FG000|Overall Study|Non-Compliance|1|||
125487619|NCT03926130|451420124|FG001|Overall Study|Non-Compliance|1|||
125487620|NCT03926130|451420125|FG002|Overall Study|Non-Compliance|0|||
125487621|NCT03926130|451420126|FG003|Overall Study|Non-Compliance|0|||
125487622|NCT03926130|451420123|FG000|Overall Study|Disposition Not Captured|0|||
125487623|NCT03926130|451420124|FG001|Overall Study|Disposition Not Captured|2|||
125487624|NCT03926130|451420125|FG002|Overall Study|Disposition Not Captured|1|||
125487625|NCT03926130|451420126|FG003|Overall Study|Disposition Not Captured|0|||
125487626|NCT04469270|451420127|FG000|Overall Study|Adverse Event|2|||
125487627|NCT04469270|451420128|FG001|Overall Study|Adverse Event|0|||
125487628|NCT04469270|451420127|FG000|Overall Study|Lost to Follow-up|4|||
125487629|NCT04469270|451420128|FG001|Overall Study|Lost to Follow-up|3|||
125487630|NCT04469270|451420127|FG000|Overall Study|Withdrawal by Subject|7|||
125487631|NCT04469270|451420128|FG001|Overall Study|Withdrawal by Subject|3|||
125487632|NCT04469270|451420127|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
125487633|NCT04469270|451420128|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
125487634|NCT04469270|451420127|FG000|Overall Study|missing|1|||
125487635|NCT04469270|451420128|FG001|Overall Study|missing|0|||
125487636|NCT04068831|451420137|FG000|Overall Study|Disease Progression|10|||
125487637|NCT04068831|451420138|FG001|Overall Study|Disease Progression|8|||
125487638|NCT04086121|451420139|FG000|Overall Study|Other than listed|8|||
125487639|NCT04086121|451420139|FG000|Overall Study|Withdrawal by Subject|3|||
125487640|NCT04086121|451420139|FG000|Overall Study|Lost to Follow-up|2|||
125487641|NCT04086121|451420139|FG000|Overall Study|Adverse Event|1|||
125487642|NCT04580914|451420142|FG000|Overall Study|Withdrawal by Subject|6|||
125487643|NCT04580914|451420142|FG000|Overall Study|Lost to Follow-up|2|||
125487644|NCT03580356|451420143|FG000|Treatment Period|Withdrawal by Subject|13|||
125487645|NCT03580356|451420144|FG001|Treatment Period|Withdrawal by Subject|0|||
125487646|NCT03580356|451420145|FG002|Treatment Period|Withdrawal by Subject|13|||
125487647|NCT03580356|451420146|FG003|Treatment Period|Withdrawal by Subject|1|||
125487648|NCT03580356|451420147|FG004|Treatment Period|Withdrawal by Subject|17|||
125487649|NCT03580356|451420148|FG005|Treatment Period|Withdrawal by Subject|0|||
125487650|NCT03580356|451420149|FG006|Treatment Period|Withdrawal by Subject|5|||
125487651|NCT03580356|451420150|FG007|Treatment Period|Withdrawal by Subject|0|||
125487652|NCT03580356|451420143|FG000|Treatment Period|Adverse Event|10|||
125487653|NCT03580356|451420144|FG001|Treatment Period|Adverse Event|0|||
125487654|NCT03580356|451420145|FG002|Treatment Period|Adverse Event|13|||
125487655|NCT03580356|451420146|FG003|Treatment Period|Adverse Event|0|||
125487656|NCT03580356|451420147|FG004|Treatment Period|Adverse Event|5|||
125303301|NCT02828020|450736699|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
125487657|NCT03580356|451420148|FG005|Treatment Period|Adverse Event|0|||
125487658|NCT03580356|451420149|FG006|Treatment Period|Adverse Event|8|||
125487659|NCT03580356|451420150|FG007|Treatment Period|Adverse Event|0|||
125487660|NCT03580356|451420143|FG000|Treatment Period|Protocol Violation|5|||
125487661|NCT03580356|451420144|FG001|Treatment Period|Protocol Violation|0|||
125487662|NCT03580356|451420145|FG002|Treatment Period|Protocol Violation|6|||
125487663|NCT03580356|451420146|FG003|Treatment Period|Protocol Violation|1|||
125487664|NCT03580356|451420147|FG004|Treatment Period|Protocol Violation|9|||
125487665|NCT03580356|451420148|FG005|Treatment Period|Protocol Violation|1|||
125487666|NCT03580356|451420149|FG006|Treatment Period|Protocol Violation|1|||
125487667|NCT03580356|451420150|FG007|Treatment Period|Protocol Violation|0|||
125487668|NCT03580356|451420143|FG000|Treatment Period|Lack of Efficacy|6|||
125487669|NCT03580356|451420144|FG001|Treatment Period|Lack of Efficacy|0|||
125487670|NCT03580356|451420145|FG002|Treatment Period|Lack of Efficacy|2|||
125487671|NCT03580356|451420146|FG003|Treatment Period|Lack of Efficacy|0|||
125487672|NCT03580356|451420147|FG004|Treatment Period|Lack of Efficacy|3|||
125487673|NCT03580356|451420148|FG005|Treatment Period|Lack of Efficacy|0|||
125487674|NCT03580356|451420149|FG006|Treatment Period|Lack of Efficacy|3|||
125487675|NCT03580356|451420150|FG007|Treatment Period|Lack of Efficacy|0|||
125487676|NCT03580356|451420143|FG000|Treatment Period|Pregnancy|1|||
125487677|NCT03580356|451420144|FG001|Treatment Period|Pregnancy|0|||
125487678|NCT03580356|451420145|FG002|Treatment Period|Pregnancy|7|||
125487679|NCT03580356|451420146|FG003|Treatment Period|Pregnancy|0|||
125487680|NCT03580356|451420147|FG004|Treatment Period|Pregnancy|2|||
125487681|NCT03580356|451420148|FG005|Treatment Period|Pregnancy|0|||
125487682|NCT03580356|451420149|FG006|Treatment Period|Pregnancy|1|||
125487683|NCT03580356|451420150|FG007|Treatment Period|Pregnancy|0|||
125487684|NCT03580356|451420143|FG000|Treatment Period|Physician Decision|2|||
125487685|NCT03580356|451420144|FG001|Treatment Period|Physician Decision|0|||
125487686|NCT03580356|451420145|FG002|Treatment Period|Physician Decision|1|||
125487687|NCT03580356|451420146|FG003|Treatment Period|Physician Decision|0|||
125487688|NCT03580356|451420147|FG004|Treatment Period|Physician Decision|4|||
125487689|NCT03580356|451420148|FG005|Treatment Period|Physician Decision|0|||
125487690|NCT03580356|451420149|FG006|Treatment Period|Physician Decision|2|||
125487691|NCT03580356|451420150|FG007|Treatment Period|Physician Decision|0|||
125487692|NCT03580356|451420143|FG000|Treatment Period|Lost to Follow-up|1|||
125487693|NCT03580356|451420144|FG001|Treatment Period|Lost to Follow-up|1|||
125487694|NCT03580356|451420145|FG002|Treatment Period|Lost to Follow-up|1|||
125487695|NCT03580356|451420146|FG003|Treatment Period|Lost to Follow-up|0|||
125487696|NCT03580356|451420147|FG004|Treatment Period|Lost to Follow-up|3|||
125487697|NCT03580356|451420148|FG005|Treatment Period|Lost to Follow-up|0|||
125487698|NCT03580356|451420149|FG006|Treatment Period|Lost to Follow-up|1|||
125487699|NCT03580356|451420150|FG007|Treatment Period|Lost to Follow-up|0|||
125487700|NCT03580356|451420143|FG000|Treatment Period|Death|0|||
125487701|NCT03580356|451420144|FG001|Treatment Period|Death|0|||
125487702|NCT03580356|451420145|FG002|Treatment Period|Death|1|||
125487703|NCT03580356|451420146|FG003|Treatment Period|Death|0|||
125487704|NCT03580356|451420147|FG004|Treatment Period|Death|0|||
125487705|NCT03580356|451420148|FG005|Treatment Period|Death|0|||
125487706|NCT03580356|451420149|FG006|Treatment Period|Death|0|||
125487707|NCT03580356|451420150|FG007|Treatment Period|Death|0|||
125487708|NCT03580356|451420143|FG000|Treatment Period|Technical problems|0|||
125487709|NCT03580356|451420144|FG001|Treatment Period|Technical problems|0|||
125487710|NCT03580356|451420145|FG002|Treatment Period|Technical problems|0|||
125487711|NCT03580356|451420146|FG003|Treatment Period|Technical problems|0|||
125487712|NCT03580356|451420147|FG004|Treatment Period|Technical problems|1|||
125487713|NCT03580356|451420148|FG005|Treatment Period|Technical problems|0|||
125487714|NCT03580356|451420149|FG006|Treatment Period|Technical problems|0|||
125487715|NCT03580356|451420150|FG007|Treatment Period|Technical problems|0|||
125487716|NCT03580356|451420143|FG000|Treatment Period|Misrandomized, no treatment|0|||
125487717|NCT03580356|451420144|FG001|Treatment Period|Misrandomized, no treatment|0|||
125487718|NCT03580356|451420145|FG002|Treatment Period|Misrandomized, no treatment|1|||
125487719|NCT03580356|451420146|FG003|Treatment Period|Misrandomized, no treatment|0|||
125487720|NCT03580356|451420147|FG004|Treatment Period|Misrandomized, no treatment|2|||
125487721|NCT03580356|451420148|FG005|Treatment Period|Misrandomized, no treatment|0|||
125487722|NCT03580356|451420149|FG006|Treatment Period|Misrandomized, no treatment|0|||
125487723|NCT03580356|451420150|FG007|Treatment Period|Misrandomized, no treatment|0|||
125487724|NCT03580356|451420143|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
125487725|NCT03580356|451420144|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
125487726|NCT03580356|451420145|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
125487727|NCT03580356|451420146|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
125487728|NCT03580356|451420147|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
125487729|NCT03580356|451420148|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
125487730|NCT03580356|451420149|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
125487731|NCT03580356|451420150|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
125487732|NCT03580356|451420143|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
125487733|NCT03580356|451420144|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
125487734|NCT03580356|451420145|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
125487735|NCT03580356|451420146|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
125487736|NCT03580356|451420147|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
125487737|NCT03580356|451420148|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
125487738|NCT03580356|451420149|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
125487739|NCT03580356|451420150|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
125487740|NCT03580356|451420143|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
125487741|NCT03580356|451420144|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
125487742|NCT03580356|451420145|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
125487743|NCT03580356|451420146|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
125487744|NCT03580356|451420147|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
125487745|NCT03580356|451420148|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
125487746|NCT03580356|451420149|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
125487747|NCT03580356|451420150|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
125487748|NCT03580356|451420143|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
125487749|NCT03580356|451420144|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
125487750|NCT03580356|451420145|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
125487751|NCT03580356|451420146|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
125487752|NCT03580356|451420147|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
125487753|NCT03580356|451420148|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
125487754|NCT03580356|451420149|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
125487755|NCT03580356|451420150|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
125487756|NCT03580356|451420143|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
125487757|NCT03580356|451420144|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
125487758|NCT03580356|451420145|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
125487759|NCT03580356|451420146|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
125487760|NCT03580356|451420147|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
125487761|NCT03580356|451420148|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
125487762|NCT03580356|451420149|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
125487763|NCT03580356|451420150|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
125487764|NCT03580356|451420143|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
125487765|NCT03580356|451420144|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
125487766|NCT03580356|451420145|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
125487767|NCT03580356|451420146|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
125487768|NCT03580356|451420147|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
125487769|NCT03580356|451420148|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
125487770|NCT03580356|451420149|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
125487771|NCT03580356|451420150|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
125487772|NCT03580356|451420143|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
125487773|NCT03580356|451420144|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
125487774|NCT03580356|451420145|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
125487775|NCT03580356|451420146|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
125487776|NCT03580356|451420147|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
125487777|NCT03580356|451420148|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
125487778|NCT03580356|451420149|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
125487779|NCT03580356|451420150|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
125487780|NCT03118518|451420152|FG000|Overall Study|Early Exit after treatment|2|||
125487781|NCT03118518|451420153|FG001|Overall Study|Early Exit after treatment|8|||
125487782|NCT03118518|451420152|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
125487783|NCT03118518|451420153|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
125487784|NCT03536884|451420157|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
125487785|NCT03536884|451420158|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
125487786|NCT03536884|451420159|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
125487787|NCT03536884|451420160|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
125487788|NCT03536884|451420161|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
125487789|NCT03536884|451420162|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
125487790|NCT03536884|451420163|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
125487791|NCT03536884|451420164|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
125487792|NCT03536884|451420165|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
125487793|NCT03536884|451420166|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
125487794|NCT03536884|451420167|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
125487795|NCT03536884|451420168|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
125487796|NCT03536884|451420157|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
125487797|NCT03536884|451420158|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
125487798|NCT03536884|451420159|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
125487799|NCT03536884|451420160|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
125487800|NCT03536884|451420161|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
125487801|NCT03536884|451420162|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
125487802|NCT03536884|451420163|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
125487803|NCT03536884|451420164|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
125487804|NCT03536884|451420165|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
125487805|NCT03536884|451420166|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
125487806|NCT03536884|451420167|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
125487807|NCT03536884|451420168|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
125487808|NCT03536884|451420157|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
125487809|NCT03536884|451420158|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
125487810|NCT03536884|451420159|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
125487811|NCT03536884|451420160|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
125487812|NCT03536884|451420161|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
125487813|NCT03536884|451420162|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
125487814|NCT03536884|451420163|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
125487815|NCT03536884|451420164|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
125487816|NCT03536884|451420165|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
125487817|NCT03536884|451420166|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
125487818|NCT03536884|451420167|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
125487819|NCT03536884|451420168|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
125487820|NCT03536884|451420157|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
125487821|NCT03536884|451420158|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
125487822|NCT03536884|451420159|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
125487823|NCT03536884|451420160|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
125487824|NCT03536884|451420161|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
125487825|NCT03536884|451420162|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
125487826|NCT03536884|451420163|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
125487827|NCT03536884|451420164|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
125487828|NCT03536884|451420165|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
125487829|NCT03536884|451420166|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
125487830|NCT03536884|451420167|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
125487831|NCT03536884|451420168|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
125487832|NCT03536884|451420157|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
125487833|NCT03536884|451420158|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
125487834|NCT03536884|451420159|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
125487835|NCT03536884|451420160|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
125487836|NCT03536884|451420161|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
125487837|NCT03536884|451420162|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
125487838|NCT03536884|451420163|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
125487839|NCT03536884|451420164|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
125487840|NCT03536884|451420165|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
125487841|NCT03536884|451420166|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
125487842|NCT03536884|451420167|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
125487843|NCT03536884|451420168|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
125487844|NCT03536884|451420157|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
125487845|NCT03536884|451420158|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
125487846|NCT03536884|451420159|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
125487847|NCT03536884|451420160|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
125487848|NCT03536884|451420161|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
125487849|NCT03536884|451420162|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
125487850|NCT03536884|451420163|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
125487851|NCT03536884|451420164|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
125487852|NCT03536884|451420165|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
125487853|NCT03536884|451420166|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
125487854|NCT03536884|451420167|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
125303302|NCT02828020|450736700|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
125303303|NCT00379912|450736703|FG000|Overall Study|Lack of Efficacy|1|||
125303304|NCT00379912|450736704|FG001|Overall Study|Lack of Efficacy|0|||
125303305|NCT01128946|450736705|FG000|Period I|Protocol Violation|0|||
125303306|NCT01128946|450736706|FG001|Period I|Protocol Violation|1|||
125303307|NCT01128946|450736707|FG002|Period I|Protocol Violation|0|||
125303308|NCT01128946|450736708|FG003|Period I|Protocol Violation|0|||
125303309|NCT01128946|450736705|FG000|Period I|Withdrawal by Subject|0|||
125303310|NCT01128946|450736706|FG001|Period I|Withdrawal by Subject|0|||
125303311|NCT01128946|450736707|FG002|Period I|Withdrawal by Subject|1|||
125303312|NCT01128946|450736708|FG003|Period I|Withdrawal by Subject|1|||
125303313|NCT01128946|450736705|FG000|Period II|Protocol Violation|0|||
125303314|NCT01128946|450736706|FG001|Period II|Protocol Violation|1|||
125487855|NCT03536884|451420168|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
125487856|NCT03536884|451420157|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
125487857|NCT03536884|451420158|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
125487858|NCT03536884|451420159|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
125487859|NCT03536884|451420160|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
125487860|NCT03536884|451420161|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
125487861|NCT03536884|451420162|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
125487862|NCT03536884|451420163|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
125487863|NCT03536884|451420164|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
125487864|NCT03536884|451420165|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
125487865|NCT03536884|451420166|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
125487866|NCT03536884|451420167|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
125487867|NCT03536884|451420168|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
125487868|NCT03536884|451420157|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
125487869|NCT03536884|451420158|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
125487870|NCT03536884|451420159|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
125487871|NCT03536884|451420160|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
125487872|NCT03536884|451420161|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
125487873|NCT03536884|451420162|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
125487874|NCT03536884|451420163|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
125487875|NCT03536884|451420164|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
125487876|NCT03536884|451420165|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
125487877|NCT03536884|451420166|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
125487878|NCT03536884|451420167|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
125487879|NCT03536884|451420168|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
125487880|NCT03536884|451420157|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
125487881|NCT03536884|451420158|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
125487882|NCT03536884|451420159|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
125487883|NCT03536884|451420160|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
125487884|NCT03536884|451420161|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
125487885|NCT03536884|451420162|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
125487886|NCT03536884|451420163|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
125487887|NCT03536884|451420164|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
125487888|NCT03536884|451420165|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
125487889|NCT03536884|451420166|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
125487890|NCT03536884|451420167|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
125487891|NCT03536884|451420168|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
125487892|NCT03536884|451420157|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
125487893|NCT03536884|451420158|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
125487894|NCT03536884|451420159|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
125487895|NCT03536884|451420160|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
125487896|NCT03536884|451420161|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
125487897|NCT03536884|451420162|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
125487898|NCT03536884|451420163|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
125487899|NCT03536884|451420164|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
125487900|NCT03536884|451420165|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
125487901|NCT03536884|451420166|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
125487902|NCT03536884|451420167|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
125487903|NCT03536884|451420168|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
125487904|NCT03536884|451420157|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
125487905|NCT03536884|451420158|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
125487906|NCT03536884|451420159|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
125487907|NCT03536884|451420160|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
125487908|NCT03536884|451420161|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
125487909|NCT03536884|451420162|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
125487910|NCT03536884|451420163|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
125487911|NCT03536884|451420164|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
125487912|NCT03536884|451420165|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
125487913|NCT03536884|451420166|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
125303315|NCT01128946|450736707|FG002|Period II|Protocol Violation|0|||
125487914|NCT03536884|451420167|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
125487915|NCT03536884|451420168|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
125487916|NCT03536884|451420157|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
125487917|NCT03536884|451420158|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
125487918|NCT03536884|451420159|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
125487919|NCT03536884|451420160|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
125487920|NCT03536884|451420161|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
125487921|NCT03536884|451420162|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
125487922|NCT03536884|451420163|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
125487923|NCT03536884|451420164|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
125487924|NCT03536884|451420165|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
125487925|NCT03536884|451420166|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
125487926|NCT03536884|451420167|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
125487927|NCT03536884|451420168|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
125487928|NCT03536884|451420157|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
125487929|NCT03536884|451420158|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
125487930|NCT03536884|451420159|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
125487931|NCT03536884|451420160|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
125487932|NCT03536884|451420161|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
125487933|NCT03536884|451420162|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
125487934|NCT03536884|451420163|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
125487935|NCT03536884|451420164|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
125487936|NCT03536884|451420165|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
125487937|NCT03536884|451420166|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
125487938|NCT03536884|451420167|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
125487939|NCT03536884|451420168|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
125487940|NCT03536884|451420157|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
125487941|NCT03536884|451420158|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
125487942|NCT03536884|451420159|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
125487943|NCT03536884|451420160|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
125487944|NCT03536884|451420161|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
125487945|NCT03536884|451420162|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
125487946|NCT03536884|451420163|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
125487947|NCT03536884|451420164|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
125487948|NCT03536884|451420165|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
125487949|NCT03536884|451420166|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
125487950|NCT03536884|451420167|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
125487951|NCT03536884|451420168|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
125487952|NCT03536884|451420157|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
125487953|NCT03536884|451420158|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
125487954|NCT03536884|451420159|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
125487955|NCT03536884|451420160|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
125487956|NCT03536884|451420161|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
125487957|NCT03536884|451420162|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
125487958|NCT03536884|451420163|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
125487959|NCT03536884|451420164|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
125487960|NCT03536884|451420165|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
125487961|NCT03536884|451420166|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
125487962|NCT03536884|451420167|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
125487963|NCT03536884|451420168|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
125487964|NCT03536884|451420157|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
125487965|NCT03536884|451420158|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
125487966|NCT03536884|451420159|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
125487967|NCT03536884|451420160|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
125487968|NCT03536884|451420161|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
125487969|NCT03536884|451420162|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
125487970|NCT03536884|451420163|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
125487971|NCT03536884|451420164|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
125487972|NCT03536884|451420165|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
125487973|NCT03536884|451420166|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
125487974|NCT03536884|451420167|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
125487975|NCT03536884|451420168|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
125487976|NCT03536884|451420157|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
125487977|NCT03536884|451420158|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
125487978|NCT03536884|451420159|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
125487979|NCT03536884|451420160|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
125487980|NCT03536884|451420161|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
125487981|NCT03536884|451420162|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
125487982|NCT03536884|451420163|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
125487983|NCT03536884|451420164|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
125487984|NCT03536884|451420165|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
125487985|NCT03536884|451420166|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
125487986|NCT03536884|451420167|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
125303316|NCT01128946|450736708|FG003|Period II|Protocol Violation|0|||
125487987|NCT03536884|451420168|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
125487988|NCT03536884|451420157|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
125487989|NCT03536884|451420158|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
125487990|NCT03536884|451420159|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
125487991|NCT03536884|451420160|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
125487992|NCT03536884|451420161|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
125487993|NCT03536884|451420162|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
125487994|NCT03536884|451420163|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
125487995|NCT03536884|451420164|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
125487996|NCT03536884|451420165|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
125487997|NCT03536884|451420166|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
125487998|NCT03536884|451420167|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
125487999|NCT03536884|451420168|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
125488000|NCT03536884|451420157|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
125488001|NCT03536884|451420158|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
125488002|NCT03536884|451420159|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
125488003|NCT03536884|451420160|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
125488004|NCT03536884|451420161|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
125488005|NCT03536884|451420162|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
125488006|NCT03536884|451420163|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
125488007|NCT03536884|451420164|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
125488008|NCT03536884|451420165|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
125488009|NCT03536884|451420166|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
125488010|NCT03536884|451420167|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
125488011|NCT03536884|451420168|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
125488012|NCT03536884|451420157|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
125488013|NCT03536884|451420158|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
125488014|NCT03536884|451420159|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
125488015|NCT03536884|451420160|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
125488016|NCT03536884|451420161|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
125488017|NCT03536884|451420162|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
125488018|NCT03536884|451420163|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
125488019|NCT03536884|451420164|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
125488020|NCT03536884|451420165|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
125488021|NCT03536884|451420166|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
125488022|NCT03536884|451420167|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
125488023|NCT03536884|451420168|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
125488024|NCT03536884|451420157|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
125488025|NCT03536884|451420158|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
125488026|NCT03536884|451420159|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
125488027|NCT03536884|451420160|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
125488028|NCT03536884|451420161|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
125488029|NCT03536884|451420162|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
125488030|NCT03536884|451420163|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
125488031|NCT03536884|451420164|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
125488032|NCT03536884|451420165|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
125488033|NCT03536884|451420166|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
125488034|NCT03536884|451420167|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
125488035|NCT03536884|451420168|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
125488036|NCT03536884|451420157|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125488037|NCT03536884|451420158|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125488038|NCT03536884|451420159|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125488039|NCT03536884|451420160|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125488040|NCT03536884|451420161|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125488041|NCT03536884|451420162|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125488042|NCT03536884|451420163|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125488043|NCT03536884|451420164|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125488044|NCT03536884|451420165|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
125488045|NCT03536884|451420166|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
125488046|NCT03536884|451420167|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
125488047|NCT03536884|451420168|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
125488048|NCT03536884|451420157|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125488049|NCT03536884|451420158|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125488050|NCT03536884|451420159|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125488051|NCT03536884|451420160|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125488052|NCT03536884|451420161|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125488053|NCT03536884|451420162|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125488054|NCT03536884|451420163|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125488055|NCT03536884|451420164|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125488056|NCT03536884|451420165|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
125488057|NCT03536884|451420166|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
125488058|NCT03536884|451420167|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
125488059|NCT03536884|451420168|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
125488060|NCT03536884|451420157|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
125488061|NCT03536884|451420158|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
125488062|NCT03536884|451420159|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
125488063|NCT03536884|451420160|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
125488064|NCT03536884|451420161|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
125488065|NCT03536884|451420162|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
125488066|NCT03536884|451420163|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
125488067|NCT03536884|451420164|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
125488068|NCT03536884|451420165|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
125488069|NCT03536884|451420166|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
125488070|NCT03536884|451420167|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
125488071|NCT03536884|451420168|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
125488072|NCT03536884|451420157|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
125488073|NCT03536884|451420158|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
125488074|NCT03536884|451420159|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
125488075|NCT03536884|451420160|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
125488076|NCT03536884|451420161|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
125488077|NCT03536884|451420162|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
125488078|NCT03536884|451420163|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
125488079|NCT03536884|451420164|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
125488080|NCT03536884|451420165|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
125488081|NCT03536884|451420166|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
125488082|NCT03536884|451420167|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
125488083|NCT03536884|451420168|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
125488084|NCT03536884|451420157|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
125488085|NCT03536884|451420158|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
125488086|NCT03536884|451420159|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
125488087|NCT03536884|451420160|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
125488088|NCT03536884|451420161|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
125488089|NCT03536884|451420162|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
125488090|NCT03536884|451420163|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
125488091|NCT03536884|451420164|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
125488092|NCT03536884|451420165|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
125488093|NCT03536884|451420166|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
125488094|NCT03536884|451420167|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
125488095|NCT03536884|451420168|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
125488096|NCT02367040|451420190|FG000|Overall Study|Lost to Follow-up|1|||
125488097|NCT02367040|451420191|FG001|Overall Study|Lost to Follow-up|1|||
125488098|NCT02367040|451420190|FG000|Overall Study|Lack of Efficacy|1|||
125488099|NCT02367040|451420191|FG001|Overall Study|Lack of Efficacy|0|||
125488100|NCT02367040|451420190|FG000|Overall Study|Additional primary malignancy|0|||
125488101|NCT02367040|451420191|FG001|Overall Study|Additional primary malignancy|1|||
125488102|NCT02367040|451420190|FG000|Overall Study|AE not associated with clinical disease progression|114|||
125488103|NCT02367040|451420191|FG001|Overall Study|AE not associated with clinical disease progression|11|||
125488104|NCT02367040|451420190|FG000|Overall Study|AE associated with clinical disease progression|1|||
125488105|NCT02367040|451420191|FG001|Overall Study|AE associated with clinical disease progression|3|||
125488106|NCT02367040|451420190|FG000|Overall Study|Physician Decision|2|||
125488107|NCT02367040|451420191|FG001|Overall Study|Physician Decision|8|||
125488108|NCT02367040|451420190|FG000|Overall Study|Non-compliance with study drug|1|||
125488109|NCT02367040|451420191|FG001|Overall Study|Non-compliance with study drug|0|||
125488110|NCT02367040|451420190|FG000|Overall Study|Failure to meet continuation criteria|1|||
125488111|NCT02367040|451420191|FG001|Overall Study|Failure to meet continuation criteria|0|||
125303317|NCT01128946|450736705|FG000|Period II|Withdrawal by Subject|0|||
125303318|NCT01128946|450736706|FG001|Period II|Withdrawal by Subject|0|||
125303319|NCT01128946|450736707|FG002|Period II|Withdrawal by Subject|0|||
125303320|NCT01128946|450736708|FG003|Period II|Withdrawal by Subject|1|||
125303321|NCT01128946|450736705|FG000|Period III|Protocol Violation|1|||
125303322|NCT01128946|450736706|FG001|Period III|Protocol Violation|0|||
125488112|NCT02367040|451420190|FG000|Overall Study|Switching to other therapy|2|||
125488113|NCT02367040|451420191|FG001|Overall Study|Switching to other therapy|0|||
125488114|NCT02367040|451420190|FG000|Overall Study|Withdrawal by Subject|46|||
125488115|NCT02367040|451420191|FG001|Overall Study|Withdrawal by Subject|16|||
125488116|NCT02367040|451420190|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
125488117|NCT02367040|451420191|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
125488118|NCT02367040|451420190|FG000|Overall Study|Patient decision|39|||
125488119|NCT02367040|451420191|FG001|Overall Study|Patient decision|14|||
125488120|NCT02367040|451420190|FG000|Overall Study|Required procedure failed|1|||
125488121|NCT02367040|451420191|FG001|Overall Study|Required procedure failed|0|||
125488122|NCT02367040|451420190|FG000|Overall Study|Randomized by mistake with study treatment|1|||
125488123|NCT02367040|451420191|FG001|Overall Study|Randomized by mistake with study treatment|0|||
125488124|NCT02367040|451420190|FG000|Overall Study|Protocol Violation|1|||
125488125|NCT02367040|451420191|FG001|Overall Study|Protocol Violation|0|||
125488126|NCT02367040|451420190|FG000|Overall Study|Progressive disease - radiological progression|51|||
125488127|NCT02367040|451420191|FG001|Overall Study|Progressive disease - radiological progression|78|||
125488128|NCT02367040|451420190|FG000|Overall Study|Progressive disease - clinical progression|6|||
125488129|NCT02367040|451420191|FG001|Overall Study|Progressive disease - clinical progression|6|||
125488130|NCT02367040|451420190|FG000|Overall Study|Drug not administered|3|||
125488131|NCT02367040|451420191|FG001|Overall Study|Drug not administered|2|||
125488132|NCT02367040|451420190|FG000|Overall Study|Progressive disease|0|||
125488133|NCT02367040|451420191|FG001|Overall Study|Progressive disease|1|||
125488134|NCT02367040|451420190|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
125488135|NCT02367040|451420191|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
125488136|NCT02367040|451420190|FG000|Overall Study|Death|2|||
125488137|NCT02367040|451420191|FG001|Overall Study|Death|0|||
125488138|NCT05856435|451420205|FG000|Overall Study|Lost to Follow-up|6|||
125488139|NCT02323880|451420206|FG000|Overall Study|Adverse Event|2|||
125488140|NCT02323880|451420207|FG001|Overall Study|Adverse Event|0|||
125488141|NCT02323880|451420208|FG002|Overall Study|Adverse Event|1|||
125488142|NCT02323880|451420209|FG003|Overall Study|Adverse Event|1|||
125488143|NCT02323880|451420210|FG004|Overall Study|Adverse Event|1|||
125488144|NCT02323880|451420211|FG005|Overall Study|Adverse Event|0|||
125488145|NCT02323880|451420212|FG006|Overall Study|Adverse Event|1|||
125488146|NCT02323880|451420213|FG007|Overall Study|Adverse Event|0|||
125488147|NCT02323880|451420206|FG000|Overall Study|Death|0|||
125488148|NCT02323880|451420207|FG001|Overall Study|Death|0|||
125488149|NCT02323880|451420208|FG002|Overall Study|Death|0|||
125488150|NCT02323880|451420209|FG003|Overall Study|Death|0|||
125488151|NCT02323880|451420210|FG004|Overall Study|Death|0|||
125488152|NCT02323880|451420211|FG005|Overall Study|Death|1|||
125488153|NCT02323880|451420212|FG006|Overall Study|Death|0|||
125488154|NCT02323880|451420213|FG007|Overall Study|Death|0|||
125488155|NCT02323880|451420206|FG000|Overall Study|Lack of Efficacy|4|||
125488156|NCT02323880|451420207|FG001|Overall Study|Lack of Efficacy|11|||
125488157|NCT02323880|451420208|FG002|Overall Study|Lack of Efficacy|5|||
125488158|NCT02323880|451420209|FG003|Overall Study|Lack of Efficacy|5|||
125488159|NCT02323880|451420210|FG004|Overall Study|Lack of Efficacy|4|||
125488160|NCT02323880|451420211|FG005|Overall Study|Lack of Efficacy|8|||
125488161|NCT02323880|451420212|FG006|Overall Study|Lack of Efficacy|4|||
125488162|NCT02323880|451420213|FG007|Overall Study|Lack of Efficacy|6|||
125488163|NCT02323880|451420206|FG000|Overall Study|Physician Decision|0|||
125488164|NCT02323880|451420207|FG001|Overall Study|Physician Decision|0|||
125488165|NCT02323880|451420208|FG002|Overall Study|Physician Decision|0|||
125488166|NCT02323880|451420209|FG003|Overall Study|Physician Decision|0|||
125488167|NCT02323880|451420210|FG004|Overall Study|Physician Decision|1|||
125488168|NCT02323880|451420211|FG005|Overall Study|Physician Decision|1|||
125488169|NCT02323880|451420212|FG006|Overall Study|Physician Decision|1|||
125488170|NCT02323880|451420213|FG007|Overall Study|Physician Decision|0|||
125488171|NCT02323880|451420206|FG000|Overall Study|Withdrawal by Subject|0|||
125488172|NCT02323880|451420207|FG001|Overall Study|Withdrawal by Subject|2|||
125488173|NCT02323880|451420208|FG002|Overall Study|Withdrawal by Subject|0|||
125488174|NCT02323880|451420209|FG003|Overall Study|Withdrawal by Subject|0|||
125303323|NCT01128946|450736707|FG002|Period III|Protocol Violation|0|||
125488175|NCT02323880|451420210|FG004|Overall Study|Withdrawal by Subject|0|||
125488176|NCT02323880|451420211|FG005|Overall Study|Withdrawal by Subject|0|||
125488177|NCT02323880|451420212|FG006|Overall Study|Withdrawal by Subject|0|||
125488178|NCT02323880|451420213|FG007|Overall Study|Withdrawal by Subject|0|||
125488179|NCT05660434|451420216|FG000|Overall Study|Never obtained study materials|2|||
125488180|NCT05660434|451420217|FG001|Overall Study|Never obtained study materials|1|||
125488181|NCT05424380|451420218|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
125488182|NCT05424380|451420219|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
125488183|NCT05424380|451420220|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
125488184|NCT05424380|451420221|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
125488185|NCT05424380|451420222|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
125488186|NCT05424380|451420223|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
125488187|NCT05424380|451420218|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
125488188|NCT05424380|451420219|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
125488189|NCT05424380|451420220|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
125488190|NCT05424380|451420221|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
125488191|NCT05424380|451420222|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
125488192|NCT05424380|451420223|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
125488193|NCT05424380|451420218|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
125488194|NCT05424380|451420219|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
125488195|NCT05424380|451420220|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
125488196|NCT05424380|451420221|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
125488197|NCT05424380|451420222|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
125488198|NCT05424380|451420223|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
125488199|NCT05424380|451420218|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
125488200|NCT05424380|451420219|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
125488201|NCT05424380|451420220|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
125488202|NCT05424380|451420221|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
125488203|NCT05424380|451420222|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
125488204|NCT05424380|451420223|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
125488205|NCT05424380|451420218|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
125488206|NCT05424380|451420219|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
125488207|NCT05424380|451420220|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
125488208|NCT05424380|451420221|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
125488209|NCT05424380|451420222|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
125488210|NCT05424380|451420223|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
125488211|NCT05424380|451420218|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
125488212|NCT05424380|451420219|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
125488213|NCT05424380|451420220|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
125488214|NCT05424380|451420221|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
125488215|NCT05424380|451420222|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
125488216|NCT05424380|451420223|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
125488217|NCT05424380|451420218|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
125488218|NCT05424380|451420219|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
125488219|NCT05424380|451420220|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
125488220|NCT05424380|451420221|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
125488221|NCT05424380|451420222|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
125488222|NCT05424380|451420223|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
125488223|NCT05424380|451420218|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
125488224|NCT05424380|451420219|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
125488225|NCT05424380|451420220|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
125488226|NCT05424380|451420221|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
125488227|NCT05424380|451420222|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
125488228|NCT05424380|451420223|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
125488229|NCT05424380|451420218|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
125488230|NCT05424380|451420219|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
125488231|NCT05424380|451420220|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
125488232|NCT05424380|451420221|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
125488233|NCT05424380|451420222|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
125488234|NCT05424380|451420223|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
125488235|NCT05424380|451420218|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
125488236|NCT05424380|451420219|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
125488237|NCT05424380|451420220|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
125488238|NCT05424380|451420221|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
125488239|NCT05424380|451420222|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
125488240|NCT05424380|451420223|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
125488241|NCT05424380|451420218|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
125488242|NCT05424380|451420219|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
125488243|NCT05424380|451420220|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
125488244|NCT05424380|451420221|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
125488245|NCT05424380|451420222|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
125488246|NCT05424380|451420223|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
125488247|NCT05424380|451420218|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
125488248|NCT05424380|451420219|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
125488249|NCT05424380|451420220|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
125488250|NCT05424380|451420221|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
125488251|NCT05424380|451420222|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
125488252|NCT05424380|451420223|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
125488253|NCT05424380|451420218|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
125488254|NCT05424380|451420219|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
125488255|NCT05424380|451420220|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
125488256|NCT05424380|451420221|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
125488257|NCT05424380|451420222|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
125488258|NCT05424380|451420223|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
125488259|NCT05424380|451420218|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
125488260|NCT05424380|451420219|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
125488261|NCT05424380|451420220|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
125488262|NCT05424380|451420221|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
125488263|NCT05424380|451420222|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
125488264|NCT05424380|451420223|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
125488265|NCT02909686|451420224|FG000|Overall Study|Physician Decision|3|||
125488266|NCT02909686|451420224|FG000|Overall Study|Withdrawal by Subject|2|||
125488267|NCT03858517|451420225|FG000|Overall Study|Adverse Event|1|||
125488268|NCT03858517|451420225|FG000|Overall Study|Lost to Follow-up|1|||
125488269|NCT03858517|451420225|FG000|Overall Study|removed for being incarcerated|1|||
125488270|NCT03858517|451420225|FG000|Overall Study|Sponsor Closure|48|||
125488271|NCT01820611|451420230|FG000|Overall Study|Death|8|||
125488272|NCT01820611|451420230|FG000|Overall Study|Adverse Event|1|||
125488273|NCT01820611|451420230|FG000|Overall Study|Withdrawal by Subject|9|||
125488274|NCT05736458|451420231|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
125488275|NCT05736458|451420232|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
125488276|NCT05736458|451420233|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
125488277|NCT05736458|451420231|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
125488278|NCT05736458|451420232|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
125488279|NCT05736458|451420233|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
125488280|NCT05736458|451420231|FG000|TMS/fMRI #1|Physician Decision|0|||
125488281|NCT05736458|451420232|FG001|TMS/fMRI #1|Physician Decision|0|||
125488282|NCT05736458|451420233|FG002|TMS/fMRI #1|Physician Decision|2|||
125488283|NCT05736458|451420231|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
125488284|NCT05736458|451420232|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
125488285|NCT05736458|451420233|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
125488286|NCT02990338|451420234|FG000|Overall Study|Randomized and not treated|4|||
125488287|NCT02990338|451420235|FG001|Overall Study|Randomized and not treated|2|||
125488288|NCT02990338|451420234|FG000|Overall Study|Adverse Event|23|||
125488289|NCT02990338|451420235|FG001|Overall Study|Adverse Event|22|||
125488290|NCT02990338|451420234|FG000|Overall Study|Progressive disease|118|||
125488291|NCT02990338|451420235|FG001|Overall Study|Progressive disease|107|||
125488292|NCT02990338|451420234|FG000|Overall Study|Poor compliance to protocol|0|||
125488293|NCT02990338|451420235|FG001|Overall Study|Poor compliance to protocol|1|||
125488294|NCT02990338|451420234|FG000|Overall Study|Withdrawal by Subject|6|||
125488295|NCT02990338|451420235|FG001|Overall Study|Withdrawal by Subject|8|||
125488296|NCT02990338|451420234|FG000|Overall Study|Physician's decision|2|||
125488297|NCT02990338|451420235|FG001|Overall Study|Physician's decision|6|||
125488298|NCT02990338|451420234|FG000|Overall Study|Treatment extension study|0|||
125488299|NCT02990338|451420235|FG001|Overall Study|Treatment extension study|6|||
125488300|NCT02990338|451420234|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
125488301|NCT02990338|451420235|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
125488302|NCT02990338|451420234|FG000|Overall Study|Continue with therapy available commercially|0|||
125488303|NCT02990338|451420235|FG001|Overall Study|Continue with therapy available commercially|1|||
125488304|NCT04479761|451420237|FG000|Overall Study|could not perform the balance tasks|1|||
125488305|NCT04479761|451420238|FG001|Overall Study|could not perform the balance tasks|0|||
125488306|NCT04479761|451420239|FG002|Overall Study|could not perform the balance tasks|0|||
125488307|NCT04479761|451420237|FG000|Overall Study|Adverse Event|1|||
125488308|NCT04479761|451420238|FG001|Overall Study|Adverse Event|0|||
125488309|NCT04479761|451420239|FG002|Overall Study|Adverse Event|0|||
125488310|NCT04479761|451420237|FG000|Overall Study|one control did not meet screening criteria|0|||
125488311|NCT04479761|451420238|FG001|Overall Study|one control did not meet screening criteria|0|||
125488312|NCT04479761|451420239|FG002|Overall Study|one control did not meet screening criteria|1|||
125488313|NCT04479761|451420237|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
125488314|NCT04479761|451420238|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
125488315|NCT04479761|451420239|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
125488316|NCT04186819|451420240|FG000|Overall Study|Adverse Event|1|||
125488317|NCT04186819|451420240|FG000|Overall Study|Lost to Follow-up|1|||
125488318|NCT04186819|451420240|FG000|Overall Study|Opted for EBRT|1|||
125488319|NCT04186819|451420240|FG000|Overall Study|Opted SBRT|1|||
125488320|NCT04186819|451420240|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
125488321|NCT04186819|451420240|FG000|Overall Study|Physician Decision|1|||
125488322|NCT04186819|451420240|FG000|Overall Study|RP Delayed|1|||
125488323|NCT04186819|451420240|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
125488324|NCT04186819|451420240|FG000|Overall Study|Subject declined for financial reasons|1|||
125532343|NCT01162863|451580087|FG000|Overall Study|Adverse Event|0|||
125488325|NCT04186819|451420240|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
125488326|NCT04186819|451420240|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
125488327|NCT04186819|451420240|FG000|Overall Study|The subject opted for other treatment option|2|||
125488328|NCT04186819|451420240|FG000|Overall Study|The subject opted for other treatment options|1|||
125488329|NCT04186819|451420240|FG000|Overall Study|Withdrawal by Subject|3|||
125488330|NCT04186819|451420240|FG000|Overall Study|Reason not specified|1|||
125488331|NCT03252288|451420246|FG000|Overall Study|Death|1|||
125488332|NCT03252288|451420247|FG001|Overall Study|Death|0|||
125488333|NCT03252288|451420248|FG002|Overall Study|Death|0|||
125488334|NCT03252288|451420246|FG000|Overall Study|Death|11|||
125488335|NCT03252288|451420247|FG001|Overall Study|Death|0|||
125488336|NCT03252288|451420248|FG002|Overall Study|Death|0|||
125488337|NCT03252288|451420246|FG000|Overall Study|Withdrawal by Subject|2|||
125488338|NCT03252288|451420247|FG001|Overall Study|Withdrawal by Subject|0|||
125488339|NCT03252288|451420248|FG002|Overall Study|Withdrawal by Subject|0|||
125488340|NCT03252288|451420246|FG000|Overall Study|Lost to Follow-up|79|||
125488341|NCT03252288|451420247|FG001|Overall Study|Lost to Follow-up|0|||
125488342|NCT03252288|451420248|FG002|Overall Study|Lost to Follow-up|0|||
125488343|NCT03252288|451420246|FG000|Overall Study|Loss of baseline data on tablets|6|||
125488344|NCT03252288|451420247|FG001|Overall Study|Loss of baseline data on tablets|0|||
125488345|NCT03252288|451420248|FG002|Overall Study|Loss of baseline data on tablets|0|||
125488346|NCT05900154|451420252|FG000|Follow-Up Period|Lost to Follow-up|1|||
125488347|NCT05900154|451420253|FG001|Follow-Up Period|Lost to Follow-up|2|||
125488348|NCT05900154|451420254|FG002|Follow-Up Period|Lost to Follow-up|1|||
125488349|NCT05900154|451420255|FG003|Follow-Up Period|Lost to Follow-up|0|||
125488350|NCT05900154|451420256|FG004|Follow-Up Period|Lost to Follow-up|1|||
125488351|NCT05900154|451420257|FG005|Follow-Up Period|Lost to Follow-up|1|||
125488352|NCT05962814|451420260|FG000|Overall Study|failed eligibility|1|||
125488353|NCT02865538|451420261|FG000|Overall Study|Withdrawal by Subject|0|||
125488354|NCT02865538|451420262|FG001|Overall Study|Withdrawal by Subject|0|||
125488355|NCT02865538|451420263|FG002|Overall Study|Withdrawal by Subject|1|||
125488356|NCT02865538|451420264|FG003|Overall Study|Withdrawal by Subject|0|||
125488357|NCT02865538|451420265|FG004|Overall Study|Withdrawal by Subject|0|||
125488358|NCT02865538|451420261|FG000|Overall Study|Lost to Follow-up|1|||
125488359|NCT02865538|451420262|FG001|Overall Study|Lost to Follow-up|0|||
125488360|NCT02865538|451420263|FG002|Overall Study|Lost to Follow-up|0|||
125488361|NCT02865538|451420264|FG003|Overall Study|Lost to Follow-up|0|||
125488362|NCT02865538|451420265|FG004|Overall Study|Lost to Follow-up|0|||
125488363|NCT03106740|451421488|FG000|Overall Study|Lost to Follow-up|2|||
125488364|NCT03106740|451421489|FG001|Overall Study|Lost to Follow-up|2|||
125488365|NCT03106740|451421488|FG000|Overall Study|Withdrawal by Subject|2|||
125488366|NCT03106740|451421489|FG001|Overall Study|Withdrawal by Subject|4|||
125488367|NCT03106740|451421488|FG000|Overall Study|Physician Decision|0|||
125488368|NCT03106740|451421489|FG001|Overall Study|Physician Decision|1|||
125488369|NCT03106740|451421488|FG000|Overall Study|Partial data|1|||
125488370|NCT03106740|451421489|FG001|Overall Study|Partial data|0|||
125488371|NCT04565990|451421490|FG000|Overall Study|Death|5|||
125303324|NCT01128946|450736708|FG003|Period III|Protocol Violation|0|||
125303325|NCT00621140|450736709|FG000|Overall Study|Adverse Event|4|||
125303326|NCT00621140|450736710|FG001|Overall Study|Adverse Event|5|||
125303327|NCT00621140|450736709|FG000|Overall Study|Lost to Follow-up|1|||
125303328|NCT00621140|450736710|FG001|Overall Study|Lost to Follow-up|2|||
125303329|NCT00621140|450736709|FG000|Overall Study|Withdrawal by Subject|4|||
125303330|NCT00621140|450736710|FG001|Overall Study|Withdrawal by Subject|6|||
125303331|NCT00621140|450736709|FG000|Overall Study|Other incl. lack of efficacy|6|||
125303332|NCT00621140|450736710|FG001|Overall Study|Other incl. lack of efficacy|5|||
125303333|NCT01138501|450736711|FG000|Overall Study|Protocol Violation|2|||
125303334|NCT01138501|450736711|FG000|Overall Study|Withdrawal by Subject|3|||
125303335|NCT00360568|450736713|FG000|Overall Study|Adverse Event|1|||
125303336|NCT00360568|450736714|FG001|Overall Study|Adverse Event|2|||
125303337|NCT00360568|450736713|FG000|Overall Study|Lack of Efficacy|1|||
125303338|NCT00360568|450736714|FG001|Overall Study|Lack of Efficacy|0|||
125303339|NCT00360568|450736713|FG000|Overall Study|Withdrawal by Subject|0|||
125303340|NCT00360568|450736714|FG001|Overall Study|Withdrawal by Subject|3|||
125303341|NCT02873338|450736719|FG000|Overall Study|Adverse Event|0|||
125303342|NCT02873338|450736720|FG001|Overall Study|Adverse Event|2|||
125488372|NCT04565990|451421490|FG000|Overall Study|Lost to Follow-up|1|||
125488373|NCT04565990|451421490|FG000|Overall Study|Withdrawal by Subject|1|||
125488374|NCT04797858|451421491|FG000|Overall Study|Withdrawal by Subject|0|||
125488375|NCT04797858|451421492|FG001|Overall Study|Withdrawal by Subject|1|||
125303343|NCT02873338|450736721|FG002|Overall Study|Adverse Event|1|||
125303344|NCT02873338|450736719|FG000|Overall Study|Death|2|||
125303345|NCT02873338|450736720|FG001|Overall Study|Death|1|||
125303346|NCT02873338|450736721|FG002|Overall Study|Death|1|||
125303347|NCT02873338|450736719|FG000|Overall Study|Withdrawal by Subject|2|||
125488376|NCT04797858|451421491|FG000|Overall Study|Excluded due to administrative error|7|||
125488377|NCT04797858|451421492|FG001|Overall Study|Excluded due to administrative error|8|||
125488378|NCT05363163|451421502|FG000|Overall Study|Withdrawal by Subject|13|||
125488379|NCT02839265|451421506|FG000|Overall Study|Screen Failure|2|||
125488380|NCT02839265|451421506|FG000|Overall Study|Death|1|||
125488381|NCT02839265|451421506|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
125488382|NCT05552508|451421507|FG000|Overall Study|Adverse Event|3|||
125488383|NCT06037668|451421508|FG000|Overall Study|Lost to Follow-up|1|||
125488384|NCT06037668|451421509|FG001|Overall Study|Lost to Follow-up|1|||
125488385|NCT06037668|451421508|FG000|Overall Study|Protocol Violation|1|||
125488386|NCT06037668|451421509|FG001|Overall Study|Protocol Violation|0|||
125488387|NCT06037668|451421508|FG000|Overall Study|Withdrawal by Subject|1|||
125488388|NCT06037668|451421509|FG001|Overall Study|Withdrawal by Subject|0|||
125488389|NCT06037668|451421508|FG000|Overall Study|Other Study Discontinuation Reason|1|||
125488390|NCT06037668|451421509|FG001|Overall Study|Other Study Discontinuation Reason|0|||
125488391|NCT05285137|451421511|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
125488392|NCT05285137|451421512|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
125488393|NCT05285137|451421513|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
125488394|NCT05285137|451421514|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
125488395|NCT05285137|451421515|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
125488396|NCT05285137|451421516|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
125488397|NCT05285137|451421517|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
125488398|NCT05285137|451421518|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
125488399|NCT05285137|451421519|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
125488400|NCT05285137|451421511|FG000|Overall Study|Lost to Follow-up|0|||
125488401|NCT05285137|451421512|FG001|Overall Study|Lost to Follow-up|0|||
125488402|NCT05285137|451421513|FG002|Overall Study|Lost to Follow-up|1|||
125488403|NCT05285137|451421514|FG003|Overall Study|Lost to Follow-up|3|||
125488404|NCT05285137|451421515|FG004|Overall Study|Lost to Follow-up|0|||
125488405|NCT05285137|451421516|FG005|Overall Study|Lost to Follow-up|0|||
125488406|NCT05285137|451421517|FG006|Overall Study|Lost to Follow-up|1|||
125488407|NCT05285137|451421518|FG007|Overall Study|Lost to Follow-up|0|||
125488408|NCT05285137|451421519|FG008|Overall Study|Lost to Follow-up|0|||
125488409|NCT05285137|451421511|FG000|Overall Study|Physician Decision|0|||
125488410|NCT05285137|451421512|FG001|Overall Study|Physician Decision|1|||
125488411|NCT05285137|451421513|FG002|Overall Study|Physician Decision|0|||
125488412|NCT05285137|451421514|FG003|Overall Study|Physician Decision|0|||
125488413|NCT05285137|451421515|FG004|Overall Study|Physician Decision|0|||
125488414|NCT05285137|451421516|FG005|Overall Study|Physician Decision|0|||
125488415|NCT05285137|451421517|FG006|Overall Study|Physician Decision|0|||
125488416|NCT05285137|451421518|FG007|Overall Study|Physician Decision|0|||
125488417|NCT05285137|451421519|FG008|Overall Study|Physician Decision|0|||
125488418|NCT05285137|451421511|FG000|Overall Study|Pregnancy|0|||
125488419|NCT05285137|451421512|FG001|Overall Study|Pregnancy|0|||
125488420|NCT05285137|451421513|FG002|Overall Study|Pregnancy|0|||
125488421|NCT05285137|451421514|FG003|Overall Study|Pregnancy|0|||
125488422|NCT05285137|451421515|FG004|Overall Study|Pregnancy|0|||
125488423|NCT05285137|451421516|FG005|Overall Study|Pregnancy|0|||
125488424|NCT05285137|451421517|FG006|Overall Study|Pregnancy|1|||
125488425|NCT05285137|451421518|FG007|Overall Study|Pregnancy|0|||
125488426|NCT05285137|451421519|FG008|Overall Study|Pregnancy|0|||
125488427|NCT05285137|451421511|FG000|Overall Study|Withdrawal by Subject|0|||
125488428|NCT05285137|451421512|FG001|Overall Study|Withdrawal by Subject|1|||
125488429|NCT05285137|451421513|FG002|Overall Study|Withdrawal by Subject|2|||
125488430|NCT05285137|451421514|FG003|Overall Study|Withdrawal by Subject|1|||
125488431|NCT05285137|451421515|FG004|Overall Study|Withdrawal by Subject|0|||
125488432|NCT05285137|451421516|FG005|Overall Study|Withdrawal by Subject|0|||
125488433|NCT05285137|451421517|FG006|Overall Study|Withdrawal by Subject|0|||
125488434|NCT05285137|451421518|FG007|Overall Study|Withdrawal by Subject|0|||
125488435|NCT05285137|451421519|FG008|Overall Study|Withdrawal by Subject|1|||
125488436|NCT03717935|451421520|FG000|Overall Study|Withdrawal by Subject|0|||
125488437|NCT03717935|451421521|FG001|Overall Study|Withdrawal by Subject|2|||
125488438|NCT03484819|451421526|FG000|Overall Study|Death|2|||
125488439|NCT03484819|451421526|FG000|Overall Study|Adverse Event|2|||
125488440|NCT03484819|451421526|FG000|Overall Study|Physician Decision|1|||
125488441|NCT03484819|451421526|FG000|Overall Study|Withdrawal by Subject|2|||
125488442|NCT03484819|451421526|FG000|Overall Study|Disease Progression|4|||
125488443|NCT03484819|451421526|FG000|Overall Study|Complicating Condition|1|||
125488444|NCT01199133|451421531|FG000|Year 1|Adverse Event|16|||
125488445|NCT01199133|451421532|FG001|Year 1|Adverse Event|4|||
125488446|NCT01199133|451421531|FG000|Year 1|Withdrawal by Subject|8|||
125488447|NCT01199133|451421532|FG001|Year 1|Withdrawal by Subject|4|||
125488448|NCT01199133|451421531|FG000|Year 1|Any other reason not above-mentioned|6|||
125488449|NCT01199133|451421532|FG001|Year 1|Any other reason not above-mentioned|7|||
125488450|NCT01199133|451421531|FG000|Year 2|Adverse Event|1|||
125488451|NCT01199133|451421532|FG001|Year 2|Adverse Event|0|||
125488452|NCT01199133|451421531|FG000|Year 2|Withdrawal by Subject|1|||
125488453|NCT01199133|451421532|FG001|Year 2|Withdrawal by Subject|1|||
125488454|NCT01199133|451421531|FG000|Year 2|Any other reason not above-mentioned|1|||
125488455|NCT01199133|451421532|FG001|Year 2|Any other reason not above-mentioned|2|||
125488456|NCT03988621|451421533|FG000|Overall Study|Lost to Follow-up|16|||
125488457|NCT03988621|451421534|FG001|Overall Study|Lost to Follow-up|17|||
125488458|NCT03988621|451421533|FG000|Overall Study|Withdrawal by Subject|14|||
125488459|NCT03988621|451421534|FG001|Overall Study|Withdrawal by Subject|7|||
125488460|NCT03988621|451421533|FG000|Overall Study|Patient Lost to Follow Up|15|||
125488461|NCT03988621|451421534|FG001|Overall Study|Patient Lost to Follow Up|15|||
125488462|NCT03988621|451421533|FG000|Overall Study|Patient death|1|||
125488463|NCT03988621|451421534|FG001|Overall Study|Patient death|5|||
125488464|NCT05013385|451421535|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
125488465|NCT04629339|451421538|FG000|Overall Study|Death|1|||
125488466|NCT04629339|451421539|FG001|Overall Study|Death|0|||
125488467|NCT04629339|451421540|FG002|Overall Study|Death|2|||
125488468|NCT04629339|451421541|FG003|Overall Study|Death|2|||
125488469|NCT04629339|451421542|FG004|Overall Study|Death|0|||
125488470|NCT04629339|451421538|FG000|Overall Study|Disease Progression|0|||
125488471|NCT04629339|451421539|FG001|Overall Study|Disease Progression|0|||
125488472|NCT04629339|451421540|FG002|Overall Study|Disease Progression|1|||
125488473|NCT04629339|451421541|FG003|Overall Study|Disease Progression|1|||
125488474|NCT04629339|451421542|FG004|Overall Study|Disease Progression|0|||
125488475|NCT04629339|451421538|FG000|Overall Study|Lost to Follow-up|0|||
125488476|NCT04629339|451421539|FG001|Overall Study|Lost to Follow-up|0|||
125488477|NCT04629339|451421540|FG002|Overall Study|Lost to Follow-up|0|||
125488478|NCT04629339|451421541|FG003|Overall Study|Lost to Follow-up|1|||
125488479|NCT04629339|451421542|FG004|Overall Study|Lost to Follow-up|0|||
125488480|NCT04629339|451421538|FG000|Overall Study|Physician Decision|0|||
125488481|NCT04629339|451421539|FG001|Overall Study|Physician Decision|1|||
125488482|NCT04629339|451421540|FG002|Overall Study|Physician Decision|0|||
125488483|NCT04629339|451421541|FG003|Overall Study|Physician Decision|0|||
125488484|NCT04629339|451421542|FG004|Overall Study|Physician Decision|0|||
125488485|NCT04629339|451421538|FG000|Overall Study|Study Terminated by Sponsor|0|||
125488486|NCT04629339|451421539|FG001|Overall Study|Study Terminated by Sponsor|0|||
125488487|NCT04629339|451421540|FG002|Overall Study|Study Terminated by Sponsor|0|||
125488488|NCT04629339|451421541|FG003|Overall Study|Study Terminated by Sponsor|1|||
125488489|NCT04629339|451421542|FG004|Overall Study|Study Terminated by Sponsor|0|||
125488490|NCT04629339|451421538|FG000|Overall Study|Withdrawal by Subject|0|||
125488491|NCT04629339|451421539|FG001|Overall Study|Withdrawal by Subject|0|||
125488492|NCT04629339|451421540|FG002|Overall Study|Withdrawal by Subject|2|||
125488493|NCT04629339|451421541|FG003|Overall Study|Withdrawal by Subject|2|||
125488494|NCT04629339|451421542|FG004|Overall Study|Withdrawal by Subject|0|||
125488495|NCT01447719|451421545|FG000|Overall Study|Image acquisition failure|2|||
125488496|NCT01447719|451421545|FG000|Overall Study|Invalid image or not imaged|3|||
125488497|NCT01447719|451421545|FG000|Overall Study|Subject still living at end of study|79|||
125488498|NCT01447719|451421545|FG000|Overall Study|Withdrawal by Subject|2|||
125488499|NCT01447719|451421545|FG000|Overall Study|Family withdrew autopsy consent|7|||
125488500|NCT03914469|451421548|FG000|Overall Study|Lost to Follow-up|1|||
125488501|NCT03914469|451421549|FG001|Overall Study|Lost to Follow-up|4|||
125488502|NCT01121588|451421556|FG000|Overall Study|Death|5|||
125488503|NCT01121588|451421557|FG001|Overall Study|Death|3|||
125488504|NCT01121588|451421558|FG002|Overall Study|Death|13|||
125488505|NCT01121588|451421556|FG000|Overall Study|Study Terminated by Sponsor|1|||
125488506|NCT01121588|451421557|FG001|Overall Study|Study Terminated by Sponsor|1|||
125488507|NCT01121588|451421558|FG002|Overall Study|Study Terminated by Sponsor|0|||
125488508|NCT01121588|451421556|FG000|Overall Study|Participant Refused Further Followup|2|||
125488509|NCT01121588|451421557|FG001|Overall Study|Participant Refused Further Followup|0|||
125488510|NCT01121588|451421558|FG002|Overall Study|Participant Refused Further Followup|2|||
125488511|NCT01121588|451421556|FG000|Overall Study|Lost to Follow-up|0|||
125488512|NCT01121588|451421557|FG001|Overall Study|Lost to Follow-up|1|||
125303348|NCT02873338|450736720|FG001|Overall Study|Withdrawal by Subject|1|||
125303349|NCT02873338|450736721|FG002|Overall Study|Withdrawal by Subject|3|||
125303350|NCT02873338|450736719|FG000|Overall Study|Lack of Efficacy|0|||
125488513|NCT01121588|451421558|FG002|Overall Study|Lost to Follow-up|1|||
125488514|NCT01121588|451421556|FG000|Overall Study|Non-Specified Reasons|9|||
125488515|NCT01121588|451421557|FG001|Overall Study|Non-Specified Reasons|4|||
125488516|NCT01121588|451421558|FG002|Overall Study|Non-Specified Reasons|2|||
125303351|NCT02873338|450736720|FG001|Overall Study|Lack of Efficacy|2|||
125303352|NCT02873338|450736721|FG002|Overall Study|Lack of Efficacy|0|||
125488517|NCT02938923|451421566|FG000|Overall Study|Death|1|||
125488518|NCT02938923|451421567|FG001|Overall Study|Death|0|||
125488519|NCT02938923|451421568|FG002|Overall Study|Death|0|||
125488520|NCT02938923|451421566|FG000|Overall Study|Physician Decision|0|||
125488521|NCT02938923|451421567|FG001|Overall Study|Physician Decision|2|||
125488522|NCT02938923|451421568|FG002|Overall Study|Physician Decision|0|||
125488523|NCT02938923|451421566|FG000|Overall Study|Withdrawal by Subject|0|||
125488524|NCT02938923|451421567|FG001|Overall Study|Withdrawal by Subject|1|||
125488525|NCT02938923|451421568|FG002|Overall Study|Withdrawal by Subject|1|||
125303353|NCT02873338|450736719|FG000|Overall Study|Other or Missing|14|||
125488526|NCT04583280|451421572|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
125488527|NCT04583280|451421573|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
125488528|NCT03606512|451421576|FG000|Overall Study|Lost to Follow-up|0|||
125488529|NCT03606512|451421577|FG001|Overall Study|Lost to Follow-up|1|||
125488530|NCT03606512|451421576|FG000|Overall Study|'moved from study area|0|||
125488531|NCT03606512|451421577|FG001|Overall Study|'moved from study area|1|||
125488532|NCT05513937|451421578|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
125488533|NCT05513937|451421579|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
125488534|NCT05513937|451421580|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
125488535|NCT05513937|451421581|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
125488536|NCT05513937|451421578|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
125488537|NCT05513937|451421579|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
125488538|NCT05513937|451421580|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
125488539|NCT05513937|451421581|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
125488540|NCT05513937|451421578|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
125488541|NCT05513937|451421579|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
125488542|NCT05513937|451421580|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
125488543|NCT05513937|451421581|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
125488544|NCT05513937|451421578|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
125488545|NCT05513937|451421579|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
125488546|NCT05513937|451421580|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
125488547|NCT05513937|451421581|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
125488548|NCT05513937|451421578|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
125488549|NCT05513937|451421579|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
125488550|NCT05513937|451421580|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
125488551|NCT05513937|451421581|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
125488552|NCT05513937|451421578|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
125488553|NCT05513937|451421579|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
125488554|NCT05513937|451421580|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
125488555|NCT05513937|451421581|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
125488556|NCT02846545|451421582|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
125488557|NCT02846545|451421583|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
125488558|NCT02846545|451421582|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
125488559|NCT02846545|451421583|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
125488560|NCT02846545|451421582|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
125488561|NCT02846545|451421583|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
125488562|NCT02846545|451421582|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
125488563|NCT02846545|451421583|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
125488564|NCT02846545|451421582|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
125488565|NCT02846545|451421583|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
125488566|NCT03691298|451421586|FG000|Overall Study|Lost to Follow-up|8|||
125488567|NCT03691298|451421586|FG000|Overall Study|Sponsor terminated study|2|||
125488568|NCT02492711|451421590|FG000|Overall Study|Adverse Event|9|||
125488569|NCT02492711|451421591|FG001|Overall Study|Adverse Event|9|||
125488570|NCT02492711|451421592|FG002|Overall Study|Adverse Event|2|||
125488571|NCT02492711|451421590|FG000|Overall Study|Death|3|||
125488572|NCT02492711|451421591|FG001|Overall Study|Death|3|||
125488573|NCT02492711|451421592|FG002|Overall Study|Death|0|||
125488574|NCT02492711|451421590|FG000|Overall Study|Withdrawal by Subject|10|||
125488575|NCT02492711|451421591|FG001|Overall Study|Withdrawal by Subject|16|||
125488576|NCT02492711|451421592|FG002|Overall Study|Withdrawal by Subject|5|||
125488577|NCT02492711|451421590|FG000|Overall Study|Physician Decision|10|||
125488578|NCT02492711|451421591|FG001|Overall Study|Physician Decision|6|||
125488579|NCT02492711|451421592|FG002|Overall Study|Physician Decision|4|||
125488580|NCT02492711|451421590|FG000|Overall Study|Lost to Follow-up|0|||
125488581|NCT02492711|451421591|FG001|Overall Study|Lost to Follow-up|0|||
125488582|NCT02492711|451421592|FG002|Overall Study|Lost to Follow-up|1|||
125488583|NCT02492711|451421590|FG000|Overall Study|study treatment delay|2|||
125488584|NCT02492711|451421591|FG001|Overall Study|study treatment delay|1|||
125488585|NCT02492711|451421592|FG002|Overall Study|study treatment delay|0|||
125488586|NCT02492711|451421590|FG000|Overall Study|change in chemotherapy|0|||
125488587|NCT02492711|451421591|FG001|Overall Study|change in chemotherapy|1|||
125488588|NCT02492711|451421592|FG002|Overall Study|change in chemotherapy|0|||
125488589|NCT02492711|451421590|FG000|Overall Study|never treated|2|||
125488590|NCT02492711|451421591|FG001|Overall Study|never treated|4|||
125488591|NCT02492711|451421592|FG002|Overall Study|never treated|0|||
125303354|NCT02873338|450736720|FG001|Overall Study|Other or Missing|15|||
125303355|NCT02873338|450736721|FG002|Overall Study|Other or Missing|13|||
125303356|NCT03657095|450736722|FG000|Overall Study|Withdrawal by Subject|1|||
125488592|NCT02492711|451421590|FG000|Overall Study|Other|0|||
125488593|NCT02492711|451421591|FG001|Overall Study|Other|0|||
125488594|NCT02492711|451421592|FG002|Overall Study|Other|1|||
125488595|NCT03245840|451421598|FG000|Overall Study|Adverse Event|6|||
125488596|NCT03245840|451421599|FG001|Overall Study|Adverse Event|0|||
125488597|NCT03245840|451421598|FG000|Overall Study|Death|2|||
125488598|NCT03245840|451421599|FG001|Overall Study|Death|0|||
125488599|NCT03245840|451421598|FG000|Overall Study|Withdrawal by Subject|31|||
125488600|NCT03245840|451421599|FG001|Overall Study|Withdrawal by Subject|1|||
125488601|NCT03245840|451421598|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
125488602|NCT03245840|451421599|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125488603|NCT03245840|451421598|FG000|Overall Study|Physician Decision|4|||
125488604|NCT03245840|451421599|FG001|Overall Study|Physician Decision|1|||
125488605|NCT03245840|451421598|FG000|Overall Study|Study Terminated by Sponsor|56|||
125488606|NCT03245840|451421599|FG001|Overall Study|Study Terminated by Sponsor|6|||
125488607|NCT03245840|451421598|FG000|Overall Study|Site Terminated by Sponsor|4|||
125488608|NCT03245840|451421599|FG001|Overall Study|Site Terminated by Sponsor|0|||
125488609|NCT03245840|451421598|FG000|Overall Study|Lost to Follow-up|12|||
125488610|NCT03245840|451421599|FG001|Overall Study|Lost to Follow-up|2|||
125488611|NCT03245840|451421598|FG000|Overall Study|Pregnancy|2|||
125488612|NCT03245840|451421599|FG001|Overall Study|Pregnancy|0|||
125488613|NCT03245840|451421598|FG000|Overall Study|Non-Compliance with Study Drug|2|||
125488614|NCT03245840|451421599|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125488615|NCT03245840|451421598|FG000|Overall Study|Not treated|1|||
125488616|NCT03245840|451421599|FG001|Overall Study|Not treated|1|||
125488617|NCT04505410|451421601|FG000|Overall Study|Adverse Event|2|||
125488618|NCT04505410|451421602|FG001|Overall Study|Adverse Event|0|||
125488619|NCT04505410|451421601|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
125488620|NCT04505410|451421602|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
125488621|NCT04505410|451421601|FG000|Overall Study|did not want to follow diet|1|||
125488622|NCT04505410|451421602|FG001|Overall Study|did not want to follow diet|0|||
125488623|NCT04505410|451421601|FG000|Overall Study|flare up of ulcerative colitis|0|||
125488624|NCT04505410|451421602|FG001|Overall Study|flare up of ulcerative colitis|1|||
125488625|NCT04505410|451421601|FG000|Overall Study|Lost to Follow-up|0|||
125488626|NCT04505410|451421602|FG001|Overall Study|Lost to Follow-up|2|||
125488627|NCT04505410|451421601|FG000|Overall Study|Lost to Follow-up|1|||
125488628|NCT04505410|451421602|FG001|Overall Study|Lost to Follow-up|0|||
125488629|NCT04505410|451421601|FG000|Overall Study|initiated another diet on their own|0|||
125488630|NCT04505410|451421602|FG001|Overall Study|initiated another diet on their own|2|||
125488631|NCT01586910|451422743|FG000|Overall Study|Death|4|||
125488632|NCT01586910|451422744|FG001|Overall Study|Death|4|||
125488633|NCT01586910|451422743|FG000|Overall Study|Withdrawal by Subject|6|||
125488634|NCT01586910|451422744|FG001|Overall Study|Withdrawal by Subject|43|||
125488635|NCT01586910|451422743|FG000|Overall Study|Physician withdrew Subject|5|||
125488636|NCT01586910|451422744|FG001|Overall Study|Physician withdrew Subject|24|||
125488637|NCT02437136|451422749|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
125488638|NCT02437136|451422750|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
125488639|NCT02437136|451422751|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
125488640|NCT02437136|451422752|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
125488641|NCT02437136|451422753|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
125488642|NCT02437136|451422754|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
125488643|NCT02437136|451422755|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
125488644|NCT02437136|451422749|FG000|Expansion (Phase 2)|Death|0|||
125488645|NCT02437136|451422750|FG001|Expansion (Phase 2)|Death|0|||
125488646|NCT02437136|451422751|FG002|Expansion (Phase 2)|Death|0|||
125488647|NCT02437136|451422752|FG003|Expansion (Phase 2)|Death|6|||
125488648|NCT02437136|451422753|FG004|Expansion (Phase 2)|Death|37|||
125488649|NCT02437136|451422754|FG005|Expansion (Phase 2)|Death|29|||
125488650|NCT02437136|451422755|FG006|Expansion (Phase 2)|Death|24|||
125488651|NCT02437136|451422749|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
125488652|NCT02437136|451422750|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
125488653|NCT02437136|451422751|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
125488654|NCT02437136|451422752|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
125488655|NCT02437136|451422753|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
125488656|NCT02437136|451422754|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
125488657|NCT02437136|451422755|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
125488658|NCT02437136|451422749|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
125488659|NCT02437136|451422750|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
125488660|NCT02437136|451422751|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
125488661|NCT02437136|451422752|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
125488662|NCT02437136|451422753|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
125488663|NCT02437136|451422754|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
125488664|NCT02437136|451422755|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
125488665|NCT03640286|451422763|FG000|Overall Study|Adverse Event|6|||
125488666|NCT03640286|451422764|FG001|Overall Study|Adverse Event|6|||
125488667|NCT03640286|451422763|FG000|Overall Study|Lost to Follow-up|3|||
125488668|NCT03640286|451422764|FG001|Overall Study|Lost to Follow-up|6|||
125488669|NCT03640286|451422763|FG000|Overall Study|Pregnancy|1|||
125488670|NCT03640286|451422764|FG001|Overall Study|Pregnancy|0|||
125488671|NCT03640286|451422763|FG000|Overall Study|Withdrawal by Subject|10|||
125532344|NCT01162863|451580088|FG001|Overall Study|Adverse Event|1|||
125488672|NCT03640286|451422764|FG001|Overall Study|Withdrawal by Subject|10|||
125488673|NCT03640286|451422763|FG000|Overall Study|Non-compliance|4|||
125488674|NCT03640286|451422764|FG001|Overall Study|Non-compliance|10|||
125488675|NCT03640286|451422763|FG000|Overall Study|Medication change|1|||
125488676|NCT03640286|451422764|FG001|Overall Study|Medication change|0|||
125488677|NCT03640286|451422763|FG000|Overall Study|Other|1|||
125488678|NCT03640286|451422764|FG001|Overall Study|Other|2|||
125488679|NCT03640286|451422763|FG000|Overall Study|Joined another lifestyle program|0|||
125488680|NCT03640286|451422764|FG001|Overall Study|Joined another lifestyle program|1|||
125488681|NCT05524116|451422765|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
125488682|NCT05524116|451422766|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
125488683|NCT05524116|451422765|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
125488684|NCT05524116|451422766|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
125488685|NCT05524116|451422765|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
125488686|NCT05524116|451422766|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
125488687|NCT05524116|451422765|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
125488688|NCT05524116|451422766|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
125488689|NCT05524116|451422765|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
125488690|NCT05524116|451422766|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
125488691|NCT03181516|451422767|FG000|Overall Study|Withdrawal by Subject|14|||
125488692|NCT03181516|451422768|FG001|Overall Study|Withdrawal by Subject|7|||
125488693|NCT03181516|451422767|FG000|Overall Study|Lost to Follow-up|2|||
125488694|NCT03181516|451422768|FG001|Overall Study|Lost to Follow-up|2|||
125488695|NCT05405985|451422769|FG000|Overall Study|Withdrawal by Subject|1|||
125488696|NCT05405985|451422770|FG001|Overall Study|Withdrawal by Subject|0|||
125488697|NCT03635424|451422771|FG000|Overall Study|Adverse Event|1|||
125488698|NCT03635424|451422771|FG000|Overall Study|Death|1|||
125488699|NCT03635424|451422771|FG000|Overall Study|Device not implanted|1|||
125488700|NCT05533190|451422772|FG000|Overall Study|Lost to Follow-up|19|||
125488701|NCT05533190|451422773|FG001|Overall Study|Lost to Follow-up|7|||
125488702|NCT05533190|451422772|FG000|Overall Study|Failed to download app|1|||
125488703|NCT05533190|451422773|FG001|Overall Study|Failed to download app|0|||
125488704|NCT05533190|451422772|FG000|Overall Study|Thought app was a scam|1|||
125488705|NCT05533190|451422773|FG001|Overall Study|Thought app was a scam|0|||
125488706|NCT05533190|451422772|FG000|Overall Study|Withdrawal by Subject|2|||
125488707|NCT05533190|451422773|FG001|Overall Study|Withdrawal by Subject|0|||
125488708|NCT01917084|451422774|FG000|Overall Study|Withdrawal by Subject|1|||
125488709|NCT04451772|451422782|FG000|Overall Study|Adverse Event|1|||
125488710|NCT04451772|451422783|FG001|Overall Study|Adverse Event|0|||
125488711|NCT04451772|451422784|FG002|Overall Study|Adverse Event|1|||
125488712|NCT04451772|451422785|FG003|Overall Study|Adverse Event|1|||
125488713|NCT04451772|451422786|FG004|Overall Study|Adverse Event|0|||
125488714|NCT04451772|451422787|FG005|Overall Study|Adverse Event|3|||
125488715|NCT04451772|451422782|FG000|Overall Study|Withdrawal by Subject|2|||
125488716|NCT04451772|451422783|FG001|Overall Study|Withdrawal by Subject|7|||
125488717|NCT04451772|451422784|FG002|Overall Study|Withdrawal by Subject|2|||
125488718|NCT04451772|451422785|FG003|Overall Study|Withdrawal by Subject|1|||
125488719|NCT04451772|451422786|FG004|Overall Study|Withdrawal by Subject|1|||
125488720|NCT04451772|451422787|FG005|Overall Study|Withdrawal by Subject|0|||
125488721|NCT04451772|451422782|FG000|Overall Study|Other, not specified|1|||
125488722|NCT04451772|451422783|FG001|Overall Study|Other, not specified|2|||
125488723|NCT04451772|451422784|FG002|Overall Study|Other, not specified|1|||
125488724|NCT04451772|451422785|FG003|Overall Study|Other, not specified|0|||
125488725|NCT04451772|451422786|FG004|Overall Study|Other, not specified|0|||
125488726|NCT04451772|451422787|FG005|Overall Study|Other, not specified|1|||
125488727|NCT04451772|451422782|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
125488728|NCT04451772|451422783|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
125488729|NCT04451772|451422784|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
125488730|NCT04451772|451422785|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
125488731|NCT04451772|451422786|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
125488732|NCT04451772|451422787|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
125488733|NCT04167553|451422788|FG000|Overall Study|Withdrawal by Subject|1|||
125488734|NCT04167553|451422789|FG001|Overall Study|Withdrawal by Subject|0|||
125488735|NCT04167553|451422790|FG002|Overall Study|Withdrawal by Subject|1|||
125488736|NCT04167553|451422791|FG003|Overall Study|Withdrawal by Subject|2|||
125488737|NCT04167553|451422792|FG004|Overall Study|Withdrawal by Subject|1|||
125309879|NCT00947115|450760200|FG001|Overall Study|Lost to Follow-up|12|||
125488738|NCT04167553|451422793|FG005|Overall Study|Withdrawal by Subject|0|||
125488739|NCT04167553|451422794|FG006|Overall Study|Withdrawal by Subject|0|||
125488740|NCT04167553|451422788|FG000|Overall Study|Physician Decision|0|||
125488741|NCT04167553|451422789|FG001|Overall Study|Physician Decision|0|||
125488742|NCT04167553|451422790|FG002|Overall Study|Physician Decision|0|||
125488743|NCT04167553|451422791|FG003|Overall Study|Physician Decision|0|||
125488744|NCT04167553|451422792|FG004|Overall Study|Physician Decision|2|||
125488745|NCT04167553|451422793|FG005|Overall Study|Physician Decision|2|||
125488746|NCT04167553|451422794|FG006|Overall Study|Physician Decision|0|||
125488747|NCT04167553|451422788|FG000|Overall Study|Lost to Follow-up|0|||
125488748|NCT04167553|451422789|FG001|Overall Study|Lost to Follow-up|0|||
125488749|NCT04167553|451422790|FG002|Overall Study|Lost to Follow-up|2|||
125488750|NCT04167553|451422791|FG003|Overall Study|Lost to Follow-up|0|||
125488751|NCT04167553|451422792|FG004|Overall Study|Lost to Follow-up|0|||
125488752|NCT04167553|451422793|FG005|Overall Study|Lost to Follow-up|0|||
125488753|NCT04167553|451422794|FG006|Overall Study|Lost to Follow-up|0|||
125488754|NCT02828358|451422800|FG000|Overall Study|Physician Decision|7|||
125488755|NCT02828358|451422801|FG001|Overall Study|Physician Decision|1|||
125488756|NCT02828358|451422800|FG000|Overall Study|Treatment Failure|6|||
125488757|NCT02828358|451422801|FG001|Overall Study|Treatment Failure|0|||
125488758|NCT02828358|451422800|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
125488759|NCT02828358|451422801|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
125488760|NCT02828358|451422800|FG000|Overall Study|Refusal of further protocol therapy|2|||
125488761|NCT02828358|451422801|FG001|Overall Study|Refusal of further protocol therapy|0|||
125488762|NCT02828358|451422800|FG000|Overall Study|Relapse|25|||
125488763|NCT02828358|451422801|FG001|Overall Study|Relapse|0|||
125488764|NCT02828358|451422800|FG000|Overall Study|Still on therapy|5|||
125488765|NCT02828358|451422801|FG001|Overall Study|Still on therapy|0|||
125488766|NCT05224544|451422804|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
125488767|NCT05224544|451422805|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
125488768|NCT04804540|451422806|FG000|Overall Study|Adverse Event|26|||
125488769|NCT04804540|451422807|FG001|Overall Study|Adverse Event|13|||
125488770|NCT05172232|451422808|FG000|Overall Study|Lost to Follow-up|3|||
125488771|NCT01828021|451422809|FG000|Overall Study|Adverse Event|5|||
125488772|NCT01828021|451422809|FG000|Overall Study|Lack of Efficacy|17|||
125488773|NCT01828021|451422809|FG000|Overall Study|Withdrawal by Subject|2|||
125488774|NCT01828021|451422809|FG000|Overall Study|Ileal obstruction, unrelated|1|||
125488775|NCT00844415|451422810|FG000|Overall Study|Withdrawal by Subject|1|||
125488776|NCT02473445|451422811|FG000|Overall Study|Withdrawal by Subject|2|||
125488777|NCT02473445|451422811|FG000|Overall Study|Sponsor Decision|20|||
125488778|NCT04881461|451422812|FG000|Overall Study|Adverse Event|2|||
125488779|NCT04881461|451422813|FG001|Overall Study|Adverse Event|4|||
125488780|NCT04881461|451422812|FG000|Overall Study|Withdrawal by Subject|19|||
125488781|NCT04881461|451422813|FG001|Overall Study|Withdrawal by Subject|19|||
125488782|NCT04881461|451422812|FG000|Overall Study|Lost to Follow-up|4|||
125488783|NCT04881461|451422813|FG001|Overall Study|Lost to Follow-up|4|||
125488784|NCT04881461|451422812|FG000|Overall Study|Lack of Efficacy|1|||
125488785|NCT04881461|451422813|FG001|Overall Study|Lack of Efficacy|0|||
125488786|NCT04881461|451422812|FG000|Overall Study|"Reason stated as other in CRF"|1|||
125488787|NCT04881461|451422813|FG001|Overall Study|"Reason stated as other in CRF"|2|||
125488788|NCT03015532|451422814|FG000|Overall Study|Adverse Event|0|||
125488789|NCT03015532|451422815|FG001|Overall Study|Adverse Event|0|||
125488790|NCT03015532|451422816|FG002|Overall Study|Adverse Event|0|||
125488791|NCT03015532|451422817|FG003|Overall Study|Adverse Event|0|||
125488792|NCT03015532|451422818|FG004|Overall Study|Adverse Event|0|||
125488793|NCT03015532|451422819|FG005|Overall Study|Adverse Event|2|||
125488794|NCT03015532|451422820|FG006|Overall Study|Adverse Event|1|||
125488795|NCT03015532|451422821|FG007|Overall Study|Adverse Event|0|||
125488796|NCT03015532|451422814|FG000|Overall Study|Withdrawal by Subject|0|||
125488797|NCT03015532|451422815|FG001|Overall Study|Withdrawal by Subject|0|||
125488798|NCT03015532|451422816|FG002|Overall Study|Withdrawal by Subject|0|||
125488799|NCT03015532|451422817|FG003|Overall Study|Withdrawal by Subject|0|||
125488800|NCT03015532|451422818|FG004|Overall Study|Withdrawal by Subject|0|||
125488801|NCT03015532|451422819|FG005|Overall Study|Withdrawal by Subject|0|||
125488802|NCT03015532|451422820|FG006|Overall Study|Withdrawal by Subject|1|||
125488803|NCT03015532|451422821|FG007|Overall Study|Withdrawal by Subject|0|||
125488804|NCT05970861|451422822|FG000|Overall Study|Physician Decision|4|||
125488805|NCT05970861|451422823|FG001|Overall Study|Physician Decision|4|||
125488806|NCT05970861|451422822|FG000|Overall Study|Lost to Follow-up|4|||
125488807|NCT05970861|451422823|FG001|Overall Study|Lost to Follow-up|3|||
125488808|NCT05100628|451422824|FG000|Overall Study|Progressive Disease|1|||
125488809|NCT05100628|451422825|FG001|Overall Study|Progressive Disease|0|||
125488810|NCT05100628|451422826|FG002|Overall Study|Progressive Disease|0|||
125488811|NCT05100628|451422827|FG003|Overall Study|Progressive Disease|0|||
125488812|NCT05100628|451422824|FG000|Overall Study|Study Terminated by Sponsor|0|||
125488813|NCT05100628|451422825|FG001|Overall Study|Study Terminated by Sponsor|0|||
125488814|NCT05100628|451422826|FG002|Overall Study|Study Terminated by Sponsor|3|||
125488815|NCT05100628|451422827|FG003|Overall Study|Study Terminated by Sponsor|0|||
125488816|NCT05100628|451422824|FG000|Overall Study|unkown|0|||
125488817|NCT05100628|451422825|FG001|Overall Study|unkown|1|||
125488818|NCT05100628|451422826|FG002|Overall Study|unkown|0|||
125488819|NCT05100628|451422827|FG003|Overall Study|unkown|0|||
125488820|NCT00677365|451422832|FG000|Overall Study|Adverse Event|2|||
125488821|NCT00677365|451422833|FG001|Overall Study|Adverse Event|1|||
125488822|NCT00677365|451422834|FG002|Overall Study|Adverse Event|1|||
125488823|NCT00677365|451422835|FG003|Overall Study|Adverse Event|2|||
125488824|NCT00677365|451422832|FG000|Overall Study|Withdrawal by Subject|0|||
125488825|NCT00677365|451422833|FG001|Overall Study|Withdrawal by Subject|0|||
125488826|NCT00677365|451422834|FG002|Overall Study|Withdrawal by Subject|1|||
125488827|NCT00677365|451422835|FG003|Overall Study|Withdrawal by Subject|0|||
125488828|NCT00677365|451422832|FG000|Overall Study|Other reason|0|||
125488829|NCT00677365|451422833|FG001|Overall Study|Other reason|0|||
125488830|NCT00677365|451422834|FG002|Overall Study|Other reason|0|||
125488831|NCT00677365|451422835|FG003|Overall Study|Other reason|1|||
125488832|NCT05422885|451422836|FG000|Overall Study|Lost to Follow-up|1|||
125488833|NCT05422885|451422836|FG000|Overall Study|Withdrawal by Subject|2|||
125488834|NCT02542631|451422839|FG000|Overall Study|Adverse Event|1|||
125488835|NCT02542631|451422840|FG001|Overall Study|Adverse Event|1|||
125488836|NCT02542631|451422839|FG000|Overall Study|Sponsor Termination|1|||
125488837|NCT02542631|451422840|FG001|Overall Study|Sponsor Termination|0|||
125488838|NCT02542631|451422839|FG000|Overall Study|Withdrawal by Subject|11|||
125488839|NCT02542631|451422840|FG001|Overall Study|Withdrawal by Subject|16|||
125488840|NCT02542631|451422839|FG000|Overall Study|Protocol Violation|1|||
125488841|NCT02542631|451422840|FG001|Overall Study|Protocol Violation|1|||
125488842|NCT02542631|451422839|FG000|Overall Study|Physician Decision|6|||
125488843|NCT02542631|451422840|FG001|Overall Study|Physician Decision|4|||
125488844|NCT02542631|451422839|FG000|Overall Study|Lost to Follow-up|6|||
125488845|NCT02542631|451422840|FG001|Overall Study|Lost to Follow-up|5|||
125488846|NCT02542631|451422839|FG000|Overall Study|Death|1|||
125488847|NCT02542631|451422840|FG001|Overall Study|Death|2|||
125488848|NCT02542631|451422839|FG000|Overall Study|Other|2|||
125488849|NCT02542631|451422840|FG001|Overall Study|Other|1|||
125488850|NCT02542631|451422839|FG000|Overall Study|Used Prohibited Medication|2|||
125488851|NCT02542631|451422840|FG001|Overall Study|Used Prohibited Medication|1|||
125488852|NCT02641730|451422841|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
125488853|NCT02641730|451422842|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
125488854|NCT02641730|451422843|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
125488855|NCT02641730|451422844|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
125488856|NCT02641730|451422845|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
125488857|NCT02641730|451422841|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
125488858|NCT02641730|451422842|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
125488859|NCT02641730|451422843|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
125488860|NCT02641730|451422844|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
125488861|NCT02641730|451422845|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
125488862|NCT02641730|451422841|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
125488863|NCT02641730|451422842|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
125488864|NCT02641730|451422843|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
125488865|NCT02641730|451422844|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
125488866|NCT02641730|451422845|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
125488867|NCT02641730|451422841|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
125488868|NCT02641730|451422842|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
125488869|NCT02641730|451422843|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
125488870|NCT02641730|451422844|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
125488871|NCT02641730|451422845|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
125488872|NCT02641730|451422841|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
125488873|NCT02641730|451422842|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
125488874|NCT02641730|451422843|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
125488875|NCT02641730|451422844|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
125488876|NCT02641730|451422845|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
125488877|NCT02641730|451422841|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
125488878|NCT02641730|451422842|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
125488879|NCT02641730|451422843|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
125488880|NCT02641730|451422844|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
125488881|NCT02641730|451422845|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
125488882|NCT00319046|451422846|FG000|Overall Study|withdrawal of subject's consent|7|||
125488883|NCT00319046|451422846|FG000|Overall Study|administrative reason|1|||
125488884|NCT00721149|451422847|FG000|Overall Study|Physician Decision|1|||
125488885|NCT00631475|451422849|FG000|Overall Study|Death|18|||
125488886|NCT00631475|451422849|FG000|Overall Study|Adverse Event|14|||
125488887|NCT00631475|451422849|FG000|Overall Study|Withdrew consent|5|||
125488888|NCT00631475|451422849|FG000|Overall Study|Preparation for lung transplant|8|||
125488889|NCT05158504|451422850|FG000|Overall Study|Lost to Follow-up|2|||
125488890|NCT05158504|451422851|FG001|Overall Study|Lost to Follow-up|3|||
125488891|NCT05652010|451422852|FG000|First Intervention|Withdrawal by Subject|0|||
125303357|NCT03657095|450736723|FG001|Overall Study|Withdrawal by Subject|1|||
125488892|NCT05652010|451422853|FG001|First Intervention|Withdrawal by Subject|1|||
125488893|NCT05652010|451422852|FG000|Second Intervention|Withdrawal by Subject|1|||
125488894|NCT05652010|451422853|FG001|Second Intervention|Withdrawal by Subject|0|||
125488895|NCT04707768|451422857|FG000|Overall Study|Adverse Event|9|||
125488896|NCT04707768|451422858|FG001|Overall Study|Adverse Event|18|||
125488897|NCT04707768|451422859|FG002|Overall Study|Adverse Event|3|||
125488898|NCT04707768|451422857|FG000|Overall Study|Investigator's Discretion|8|||
125488899|NCT04707768|451422858|FG001|Overall Study|Investigator's Discretion|4|||
125488900|NCT04707768|451422859|FG002|Overall Study|Investigator's Discretion|3|||
125488901|NCT04707768|451422857|FG000|Overall Study|Withdrawal by Subject|6|||
125488902|NCT04707768|451422858|FG001|Overall Study|Withdrawal by Subject|8|||
125488903|NCT04707768|451422859|FG002|Overall Study|Withdrawal by Subject|2|||
125488904|NCT04707768|451422857|FG000|Overall Study|Lack of Efficacy|1|||
125488905|NCT04707768|451422858|FG001|Overall Study|Lack of Efficacy|3|||
125488906|NCT04707768|451422859|FG002|Overall Study|Lack of Efficacy|0|||
125488907|NCT04707768|451422857|FG000|Overall Study|Lost to Follow-up|0|||
125488908|NCT04707768|451422858|FG001|Overall Study|Lost to Follow-up|0|||
125488909|NCT04707768|451422859|FG002|Overall Study|Lost to Follow-up|3|||
125488910|NCT04707768|451422857|FG000|Overall Study|Death|13|||
125488911|NCT04707768|451422858|FG001|Overall Study|Death|11|||
125488912|NCT04707768|451422859|FG002|Overall Study|Death|13|||
125488913|NCT04707768|451422857|FG000|Overall Study|Protocol Violation|2|||
125488914|NCT04707768|451422858|FG001|Overall Study|Protocol Violation|1|||
125488915|NCT04707768|451422859|FG002|Overall Study|Protocol Violation|0|||
125488916|NCT04707768|451422857|FG000|Overall Study|Non Compliance with Study Drug|1|||
125488917|NCT04707768|451422858|FG001|Overall Study|Non Compliance with Study Drug|0|||
125488918|NCT04707768|451422859|FG002|Overall Study|Non Compliance with Study Drug|0|||
125488919|NCT04707768|451422857|FG000|Overall Study|Transplant|4|||
125488920|NCT04707768|451422858|FG001|Overall Study|Transplant|4|||
125488921|NCT04707768|451422859|FG002|Overall Study|Transplant|8|||
125488922|NCT04707768|451422857|FG000|Overall Study|Other|9|||
125488923|NCT04707768|451422858|FG001|Overall Study|Other|5|||
125488924|NCT04707768|451422859|FG002|Overall Study|Other|2|||
125488925|NCT02518048|451422860|FG000|Overall Study|Withdrawal by Subject|1|||
125488926|NCT04282980|451424195|FG000|Overall Study|Remained on treatment|6|||
125488927|NCT04282980|451424195|FG000|Overall Study|Survival follow-up|11|||
125488928|NCT04282980|451424195|FG000|Overall Study|Withdrawal of informed consent|1|||
125488929|NCT04282980|451424195|FG000|Overall Study|Lost to Follow-up|1|||
125488930|NCT03571386|451424197|FG000|Overall Study|scheduling conflict|4|||
125488931|NCT03571386|451424198|FG001|Overall Study|scheduling conflict|0|||
125488932|NCT03571386|451424197|FG000|Overall Study|Withdrawal by Subject|15|||
125488933|NCT03571386|451424198|FG001|Overall Study|Withdrawal by Subject|5|||
125488934|NCT04311632|451424199|FG000|Overall Study|Withdrawal by Subject|0|||
125488935|NCT04311632|451424200|FG001|Overall Study|Withdrawal by Subject|0|||
125488936|NCT04311632|451424201|FG002|Overall Study|Withdrawal by Subject|1|||
125488937|NCT04605159|451424202|FG000|Overall Study|Adverse Event|6|||
125488938|NCT04605159|451424203|FG001|Overall Study|Adverse Event|3|||
125488939|NCT04605159|451424204|FG002|Overall Study|Adverse Event|21|||
125488940|NCT04605159|451424205|FG003|Overall Study|Adverse Event|4|||
125488941|NCT04605159|451424202|FG000|Overall Study|Lost to Follow-up|74|||
125488942|NCT04605159|451424203|FG001|Overall Study|Lost to Follow-up|45|||
125488943|NCT04605159|451424204|FG002|Overall Study|Lost to Follow-up|119|||
125488944|NCT04605159|451424205|FG003|Overall Study|Lost to Follow-up|80|||
125488945|NCT04605159|451424202|FG000|Overall Study|Protocol Violation|4|||
125488946|NCT04605159|451424203|FG001|Overall Study|Protocol Violation|5|||
125488947|NCT04605159|451424204|FG002|Overall Study|Protocol Violation|2|||
125488948|NCT04605159|451424205|FG003|Overall Study|Protocol Violation|0|||
125488949|NCT04605159|451424202|FG000|Overall Study|Withdrawal by Subject|66|||
125488950|NCT04605159|451424203|FG001|Overall Study|Withdrawal by Subject|37|||
125488951|NCT04605159|451424204|FG002|Overall Study|Withdrawal by Subject|68|||
125488952|NCT04605159|451424205|FG003|Overall Study|Withdrawal by Subject|50|||
125488953|NCT04605159|451424202|FG000|Overall Study|Migrated / moved from the study area|32|||
125488954|NCT04605159|451424203|FG001|Overall Study|Migrated / moved from the study area|22|||
125488955|NCT04605159|451424204|FG002|Overall Study|Migrated / moved from the study area|41|||
125488956|NCT04605159|451424205|FG003|Overall Study|Migrated / moved from the study area|21|||
125488957|NCT04605159|451424202|FG000|Overall Study|Other|1|||
125303358|NCT03657095|450736722|FG000|Overall Study|Adverse Event|0|||
125488958|NCT04605159|451424203|FG001|Overall Study|Other|2|||
125488959|NCT04605159|451424204|FG002|Overall Study|Other|7|||
125488960|NCT04605159|451424205|FG003|Overall Study|Other|3|||
125488961|NCT02278211|451424206|FG000|Overall Study|Unable to analyse PET scan|2|||
125488962|NCT04158739|451424207|FG000|Overall Study|Adverse Event|1|||
125488963|NCT04158739|451424208|FG001|Overall Study|Adverse Event|0|||
125488964|NCT04158739|451424207|FG000|Overall Study|Death|0|||
125488965|NCT04158739|451424208|FG001|Overall Study|Death|1|||
125303359|NCT03657095|450736723|FG001|Overall Study|Adverse Event|3|||
125488966|NCT04158739|451424207|FG000|Overall Study|Lack of Efficacy|3|||
125488967|NCT04158739|451424208|FG001|Overall Study|Lack of Efficacy|7|||
125488968|NCT04158739|451424207|FG000|Overall Study|Physician Decision|0|||
125488969|NCT04158739|451424208|FG001|Overall Study|Physician Decision|1|||
125488970|NCT04158739|451424207|FG000|Overall Study|Withdrawal by Subject|3|||
125488971|NCT04158739|451424208|FG001|Overall Study|Withdrawal by Subject|0|||
125488972|NCT04778410|451424209|FG000|Safety Run-in Period|Death|5|||
125488973|NCT04778410|451424210|FG001|Safety Run-in Period|Death|6|||
125488974|NCT04778410|451424211|FG002|Safety Run-in Period|Death|0|||
125488975|NCT04778410|451424212|FG003|Safety Run-in Period|Death|0|||
125488976|NCT04778410|451424213|FG004|Safety Run-in Period|Death|0|||
125488977|NCT04778410|451424214|FG005|Safety Run-in Period|Death|0|||
125488978|NCT04778410|451424209|FG000|Phase 2 Period|Death|0|||
125303360|NCT03657095|450736722|FG000|Overall Study|Study Terminated by Sponsor|58|||
125303361|NCT03657095|450736723|FG001|Overall Study|Study Terminated by Sponsor|49|||
125488979|NCT04778410|451424210|FG001|Phase 2 Period|Death|0|||
125488980|NCT04778410|451424211|FG002|Phase 2 Period|Death|0|||
125488981|NCT04778410|451424212|FG003|Phase 2 Period|Death|5|||
125488982|NCT04778410|451424213|FG004|Phase 2 Period|Death|18|||
125488983|NCT04778410|451424214|FG005|Phase 2 Period|Death|0|||
125303362|NCT00830180|450736724|FG000|Overall Study|Adverse Event|6|||
125303363|NCT00830180|450736724|FG000|Overall Study|Death|11|||
125303364|NCT00830180|450736724|FG000|Overall Study|Insufficient clinical response|1|||
125303365|NCT00830180|450736724|FG000|Overall Study|Withdrawal by Subject|5|||
125303366|NCT00830180|450736724|FG000|Overall Study|Progressive disease|2|||
125488984|NCT04778410|451424209|FG000|Phase 2 Period|Lost to Follow-up|0|||
125488985|NCT04778410|451424210|FG001|Phase 2 Period|Lost to Follow-up|0|||
125488986|NCT04778410|451424211|FG002|Phase 2 Period|Lost to Follow-up|0|||
125488987|NCT04778410|451424212|FG003|Phase 2 Period|Lost to Follow-up|1|||
125488988|NCT04778410|451424213|FG004|Phase 2 Period|Lost to Follow-up|1|||
125488989|NCT04778410|451424214|FG005|Phase 2 Period|Lost to Follow-up|0|||
125488990|NCT04778410|451424209|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
125488991|NCT04778410|451424210|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
125488992|NCT04778410|451424211|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
125488993|NCT04778410|451424212|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
125488994|NCT04778410|451424213|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
125488995|NCT04778410|451424214|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
125488996|NCT04778410|451424209|FG000|Phase 2 Period|Withdrew Consent|0|||
125488997|NCT04778410|451424210|FG001|Phase 2 Period|Withdrew Consent|0|||
125488998|NCT04778410|451424211|FG002|Phase 2 Period|Withdrew Consent|0|||
125488999|NCT04778410|451424212|FG003|Phase 2 Period|Withdrew Consent|0|||
125489000|NCT04778410|451424213|FG004|Phase 2 Period|Withdrew Consent|2|||
125489001|NCT04778410|451424214|FG005|Phase 2 Period|Withdrew Consent|0|||
125489002|NCT02944968|451424215|FG000|Overall Study|Subject excluded before study procedure|1|||
125489003|NCT02944968|451424215|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
125489004|NCT02905331|451424216|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
125489005|NCT02905331|451424217|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
125489006|NCT02905331|451424218|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
125489007|NCT02905331|451424216|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
125489008|NCT02905331|451424217|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
125489009|NCT02905331|451424218|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
125489010|NCT02905331|451424216|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
125489011|NCT02905331|451424217|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
125489012|NCT02905331|451424218|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
125489013|NCT02905331|451424216|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
125489014|NCT02905331|451424217|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
125489015|NCT02905331|451424218|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
125489016|NCT02905331|451424216|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
125489017|NCT02905331|451424217|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
125489018|NCT02905331|451424218|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
125489019|NCT01385202|451424219|FG000|Overall Study|Lost to Follow-up|6|||
125489020|NCT01385202|451424219|FG000|Overall Study|Not Eligible|11|||
125489021|NCT01385202|451424219|FG000|Overall Study|Withdrawn|1|||
125489022|NCT03681262|451424220|FG000|Overall Study|Continuing on study|3|||
125489023|NCT03681262|451424221|FG001|Overall Study|Continuing on study|3|||
125489024|NCT03681262|451424220|FG000|Overall Study|Lost to Follow-up|1|||
125489025|NCT03681262|451424221|FG001|Overall Study|Lost to Follow-up|0|||
125303367|NCT00830180|450736724|FG000|Overall Study|Other - Unspecified|1|||
125303368|NCT01990612|450736725|FG000|Overall Study|Lost to Follow-up|2|||
125303369|NCT01990612|450736726|FG001|Overall Study|Lost to Follow-up|1|||
125489026|NCT04102111|451424223|FG000|Overall Study|Withdrawal by Subject|2|||
125489027|NCT04102111|451424224|FG001|Overall Study|Withdrawal by Subject|3|||
125489028|NCT04102111|451424223|FG000|Overall Study|Adverse Event|1|||
125489029|NCT04102111|451424224|FG001|Overall Study|Adverse Event|1|||
125489030|NCT04102111|451424223|FG000|Overall Study|Study terminated by sponsor|1|||
125489031|NCT04102111|451424224|FG001|Overall Study|Study terminated by sponsor|3|||
125489032|NCT02782676|451424225|FG000|Overall Study|Lost to Follow-up|0|||
125489033|NCT02782676|451424226|FG001|Overall Study|Lost to Follow-up|1|||
125489034|NCT04614948|451424227|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
125489035|NCT04614948|451424228|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
125489036|NCT04614948|451424229|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
125303370|NCT01990612|450736725|FG000|Overall Study|Withdrawal by Subject|5|||
125303371|NCT01990612|450736726|FG001|Overall Study|Withdrawal by Subject|2|||
125489037|NCT04614948|451424227|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
125489038|NCT04614948|451424228|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
125489039|NCT04614948|451424229|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
125489040|NCT04614948|451424227|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
125489041|NCT04614948|451424228|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
125489042|NCT04614948|451424229|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
125489043|NCT04614948|451424227|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
125489044|NCT04614948|451424228|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
125489045|NCT04614948|451424229|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
125489046|NCT04614948|451424227|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
125489047|NCT04614948|451424228|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
125489048|NCT04614948|451424229|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
125489049|NCT04614948|451424227|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
125489050|NCT04614948|451424228|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
125489051|NCT04614948|451424229|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
125489052|NCT04614948|451424227|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
125489053|NCT04614948|451424228|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
125489054|NCT04614948|451424229|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
125489055|NCT04614948|451424227|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
125489056|NCT04614948|451424228|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
125489057|NCT04614948|451424229|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
125489058|NCT04614948|451424227|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
125489059|NCT04614948|451424228|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
125489060|NCT04614948|451424229|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
125489061|NCT04614948|451424227|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
125489062|NCT04614948|451424228|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
125489063|NCT04614948|451424229|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
125489064|NCT04614948|451424227|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
125489065|NCT04614948|451424228|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
125489066|NCT04614948|451424229|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
125489067|NCT04614948|451424227|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
125489068|NCT04614948|451424228|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
125489069|NCT04614948|451424229|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
125489070|NCT04614948|451424227|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
125489071|NCT04614948|451424228|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
125489072|NCT04614948|451424229|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
125489073|NCT04614948|451424227|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
125489074|NCT04614948|451424228|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
125489075|NCT04614948|451424229|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
125489076|NCT04614948|451424227|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
125489077|NCT04614948|451424228|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
125489078|NCT04614948|451424229|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
125489079|NCT04614948|451424227|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
125489080|NCT04614948|451424228|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
125489081|NCT04614948|451424229|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
125489082|NCT04614948|451424227|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
125489083|NCT04614948|451424228|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
125489084|NCT04614948|451424229|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
125489085|NCT04614948|451424227|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
125489086|NCT04614948|451424228|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
125489087|NCT04614948|451424229|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
125489088|NCT04614948|451424227|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
125489089|NCT04614948|451424228|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
125489090|NCT04614948|451424229|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
125489091|NCT04614948|451424227|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
125489092|NCT04614948|451424228|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
125489093|NCT04614948|451424229|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
125489094|NCT04614948|451424227|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
125489095|NCT04614948|451424228|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
125489096|NCT04614948|451424229|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
125489097|NCT04614948|451424227|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
125489098|NCT04614948|451424228|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
125489099|NCT04614948|451424229|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
125489100|NCT04614948|451424227|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
125489101|NCT04614948|451424228|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
125489102|NCT04614948|451424229|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
125489103|NCT04055012|451424230|FG000|Overall Study|Withdrawal by Subject|1|||
125489104|NCT04055012|451424231|FG001|Overall Study|Withdrawal by Subject|3|||
125489105|NCT04055012|451424232|FG002|Overall Study|Withdrawal by Subject|1|||
125489106|NCT04055012|451424233|FG003|Overall Study|Withdrawal by Subject|0|||
125489107|NCT04055012|451424230|FG000|Overall Study|Metformin Recall|1|||
125489108|NCT04055012|451424231|FG001|Overall Study|Metformin Recall|1|||
125489109|NCT04055012|451424232|FG002|Overall Study|Metformin Recall|1|||
125489110|NCT04055012|451424233|FG003|Overall Study|Metformin Recall|0|||
125489111|NCT03663205|451424236|FG000|Overall Study|Death|144|||
125489112|NCT03663205|451424237|FG001|Overall Study|Death|69|||
125489113|NCT03663205|451424236|FG000|Overall Study|Sponsor decision|53|||
125489114|NCT03663205|451424237|FG001|Overall Study|Sponsor decision|19|||
125489115|NCT03663205|451424236|FG000|Overall Study|Withdrawal by Subject|8|||
125489116|NCT03663205|451424237|FG001|Overall Study|Withdrawal by Subject|11|||
125489117|NCT03663205|451424236|FG000|Overall Study|Lost to Follow-up|7|||
125489118|NCT03663205|451424237|FG001|Overall Study|Lost to Follow-up|9|||
125489119|NCT03663205|451424236|FG000|Overall Study|Transferred to long term extension study|11|||
125489120|NCT03663205|451424237|FG001|Overall Study|Transferred to long term extension study|3|||
125489121|NCT02326974|451424238|FG000|Overall Study|Withdrawal by Subject|2|||
125489122|NCT02326974|451424238|FG000|Overall Study|failed heterogenity evaluation|5|||
125489123|NCT02577354|451424239|FG000|Overall Study|Lack of Efficacy|4|||
125489124|NCT02577354|451424240|FG001|Overall Study|Lack of Efficacy|4|||
125489125|NCT02577354|451424239|FG000|Overall Study|Lost to Follow-up|3|||
125489126|NCT02577354|451424240|FG001|Overall Study|Lost to Follow-up|1|||
125489127|NCT02577354|451424239|FG000|Overall Study|Missed Visit|4|||
125489128|NCT02577354|451424240|FG001|Overall Study|Missed Visit|3|||
125489129|NCT02577354|451424239|FG000|Overall Study|Adverse Event|4|||
125489130|NCT02577354|451424240|FG001|Overall Study|Adverse Event|5|||
125489131|NCT04924400|451424244|FG000|Overall Study|Lost to Follow-up|3|||
125489132|NCT04924400|451424245|FG001|Overall Study|Lost to Follow-up|0|||
125489133|NCT04424316|451424246|FG000|Overall Study|Adverse Event|0|||
125489134|NCT04424316|451424247|FG001|Overall Study|Adverse Event|1|||
125489135|NCT04424316|451424248|FG002|Overall Study|Adverse Event|0|||
125489136|NCT04424316|451424249|FG003|Overall Study|Adverse Event|0|||
125489137|NCT04424316|451424246|FG000|Overall Study|Death|1|||
125489138|NCT04424316|451424247|FG001|Overall Study|Death|0|||
125489139|NCT04424316|451424248|FG002|Overall Study|Death|8|||
125489140|NCT04424316|451424249|FG003|Overall Study|Death|14|||
125489141|NCT04424316|451424246|FG000|Overall Study|Lost to Follow-up|93|||
125489142|NCT04424316|451424247|FG001|Overall Study|Lost to Follow-up|88|||
125489143|NCT04424316|451424248|FG002|Overall Study|Lost to Follow-up|224|||
125489144|NCT04424316|451424249|FG003|Overall Study|Lost to Follow-up|211|||
125489145|NCT04424316|451424246|FG000|Overall Study|No longer met eligibility criteria|1|||
125489146|NCT04424316|451424247|FG001|Overall Study|No longer met eligibility criteria|0|||
125489147|NCT04424316|451424248|FG002|Overall Study|No longer met eligibility criteria|0|||
125489148|NCT04424316|451424249|FG003|Overall Study|No longer met eligibility criteria|0|||
125489149|NCT04424316|451424246|FG000|Overall Study|Other|15|||
125489150|NCT04424316|451424247|FG001|Overall Study|Other|11|||
125489151|NCT04424316|451424248|FG002|Overall Study|Other|34|||
125489152|NCT04424316|451424249|FG003|Overall Study|Other|45|||
125489153|NCT04424316|451424246|FG000|Overall Study|Physician Decision|1|||
125489154|NCT04424316|451424247|FG001|Overall Study|Physician Decision|0|||
125489155|NCT04424316|451424248|FG002|Overall Study|Physician Decision|1|||
125489156|NCT04424316|451424249|FG003|Overall Study|Physician Decision|1|||
125489157|NCT04424316|451424246|FG000|Overall Study|Protocol Violation|0|||
125303372|NCT01068158|450736734|FG000|Overall Study|Withdrawal by Subject|1|||
125489158|NCT04424316|451424247|FG001|Overall Study|Protocol Violation|1|||
125489159|NCT04424316|451424248|FG002|Overall Study|Protocol Violation|0|||
125489160|NCT04424316|451424249|FG003|Overall Study|Protocol Violation|0|||
125489161|NCT04424316|451424246|FG000|Overall Study|Withdrawal by Subject|71|||
125489162|NCT04424316|451424247|FG001|Overall Study|Withdrawal by Subject|77|||
125489163|NCT04424316|451424248|FG002|Overall Study|Withdrawal by Subject|0|||
125489164|NCT04424316|451424249|FG003|Overall Study|Withdrawal by Subject|0|||
125489165|NCT04424316|451424246|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125489166|NCT04424316|451424247|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125303373|NCT01068158|450736735|FG001|Overall Study|Withdrawal by Subject|2|||
125489167|NCT04424316|451424248|FG002|Overall Study|Withdrawal by parent/guardian|74|||
125489168|NCT04424316|451424249|FG003|Overall Study|Withdrawal by parent/guardian|81|||
125489169|NCT04424316|451424246|FG000|Overall Study|Randomized but not vaccinated|13|||
125489170|NCT04424316|451424247|FG001|Overall Study|Randomized but not vaccinated|21|||
125489171|NCT04424316|451424248|FG002|Overall Study|Randomized but not vaccinated|0|||
125489172|NCT04424316|451424249|FG003|Overall Study|Randomized but not vaccinated|0|||
125303374|NCT01068158|450736734|FG000|Overall Study|Lost to Follow-up|7|||
125303375|NCT01068158|450736735|FG001|Overall Study|Lost to Follow-up|0|||
125489173|NCT04424316|451424246|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
125532345|NCT01162863|451580089|FG002|Overall Study|Adverse Event|0|||
125489174|NCT04424316|451424247|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
125489175|NCT04424316|451424248|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
125489176|NCT04424316|451424249|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
125489177|NCT00412607|451424252|FG000|Overall Study|Withdrawal by Subject|9|||
125489178|NCT00412607|451424252|FG000|Overall Study|Lost to Follow-up|19|||
125489179|NCT00412607|451424252|FG000|Overall Study|Death|61|||
125489180|NCT00412607|451424252|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
125489181|NCT04109066|451424254|FG000|Pre-treatment|Participant withdrew consent|2|||
125489182|NCT04109066|451424255|FG001|Pre-treatment|Participant withdrew consent|0|||
125489183|NCT04109066|451424254|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
125489184|NCT04109066|451424255|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
125489185|NCT04109066|451424254|FG000|Treatment|Lack of Efficacy|2|||
125489186|NCT04109066|451424255|FG001|Treatment|Lack of Efficacy|4|||
125489187|NCT04109066|451424254|FG000|Treatment|Adverse Event|23|||
125489188|NCT04109066|451424255|FG001|Treatment|Adverse Event|7|||
125489189|NCT04109066|451424254|FG000|Treatment|Participant request to discontinue Study treatment|15|||
125489190|NCT04109066|451424255|FG001|Treatment|Participant request to discontinue Study treatment|14|||
125489191|NCT04109066|451424254|FG000|Treatment|Withdrawal by Subject|8|||
125489192|NCT04109066|451424255|FG001|Treatment|Withdrawal by Subject|8|||
125489193|NCT04109066|451424254|FG000|Treatment|Death|3|||
125489194|NCT04109066|451424255|FG001|Treatment|Death|0|||
125489195|NCT04109066|451424254|FG000|Treatment|Participant no longer meets study criteria|2|||
125489196|NCT04109066|451424255|FG001|Treatment|Participant no longer meets study criteria|2|||
125489197|NCT04109066|451424254|FG000|Treatment|Administrative reasons by sponsor|2|||
125489198|NCT04109066|451424255|FG001|Treatment|Administrative reasons by sponsor|3|||
125489199|NCT04109066|451424254|FG000|Treatment|Other reasons|17|||
125489200|NCT04109066|451424255|FG001|Treatment|Other reasons|23|||
125489201|NCT04109066|451424254|FG000|Treatment|Disease Progression|4|||
125489202|NCT04109066|451424255|FG001|Treatment|Disease Progression|7|||
125489203|NCT04109066|451424254|FG000|Treatment|Study drug toxicity|12|||
125489204|NCT04109066|451424255|FG001|Treatment|Study drug toxicity|5|||
125489205|NCT04109066|451424254|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
125489206|NCT04109066|451424255|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
125489207|NCT04109066|451424254|FG000|Treatment|Disease Recurrence|0|||
125489208|NCT04109066|451424255|FG001|Treatment|Disease Recurrence|2|||
125489209|NCT04109066|451424254|FG000|Treatment|Not reported|4|||
125489210|NCT04109066|451424255|FG001|Treatment|Not reported|8|||
125489211|NCT05741294|451424257|FG000|Overall Study|Lost to Follow-up|3|||
125489212|NCT05741294|451424257|FG000|Overall Study|Protocol deviation|3|||
125489213|NCT05741294|451424257|FG000|Overall Study|Withdrawal by Subject|1|||
125489214|NCT04675034|451424260|FG000|Overall Study|Lost to Follow-up|1|||
125489215|NCT04675034|451424261|FG001|Overall Study|Lost to Follow-up|1|||
125489216|NCT04675034|451424262|FG002|Overall Study|Lost to Follow-up|0|||
125489217|NCT04675034|451424263|FG003|Overall Study|Lost to Follow-up|2|||
125489218|NCT04675034|451424264|FG004|Overall Study|Lost to Follow-up|0|||
125489219|NCT04675034|451424260|FG000|Overall Study|Protocol Violation|1|||
125489220|NCT04675034|451424261|FG001|Overall Study|Protocol Violation|0|||
125489221|NCT04675034|451424262|FG002|Overall Study|Protocol Violation|0|||
125489222|NCT04675034|451424263|FG003|Overall Study|Protocol Violation|1|||
125489223|NCT04675034|451424264|FG004|Overall Study|Protocol Violation|3|||
125489224|NCT04675034|451424260|FG000|Overall Study|Withdrawal by Subject|9|||
125489225|NCT04675034|451424261|FG001|Overall Study|Withdrawal by Subject|3|||
125489226|NCT04675034|451424262|FG002|Overall Study|Withdrawal by Subject|4|||
125489227|NCT04675034|451424263|FG003|Overall Study|Withdrawal by Subject|8|||
125489228|NCT04675034|451424264|FG004|Overall Study|Withdrawal by Subject|6|||
125489229|NCT04163991|451424265|FG000|Overall Study|Adverse Event|0|||
125489230|NCT04163991|451424266|FG001|Overall Study|Adverse Event|0|||
125489231|NCT04163991|451424267|FG002|Overall Study|Adverse Event|0|||
125489232|NCT04163991|451424268|FG003|Overall Study|Adverse Event|1|||
125489233|NCT04163991|451424269|FG004|Overall Study|Adverse Event|0|||
125303376|NCT01068158|450736734|FG000|Overall Study|Protocol Violation|0|||
125489234|NCT04163991|451424265|FG000|Overall Study|Death|0|||
125489235|NCT04163991|451424266|FG001|Overall Study|Death|0|||
125489236|NCT04163991|451424267|FG002|Overall Study|Death|1|||
125489237|NCT04163991|451424268|FG003|Overall Study|Death|0|||
125489238|NCT04163991|451424269|FG004|Overall Study|Death|0|||
125489239|NCT04163991|451424265|FG000|Overall Study|Lost to Follow-up|0|||
125489240|NCT04163991|451424266|FG001|Overall Study|Lost to Follow-up|1|||
125489241|NCT04163991|451424267|FG002|Overall Study|Lost to Follow-up|0|||
125489242|NCT04163991|451424268|FG003|Overall Study|Lost to Follow-up|0|||
125489243|NCT04163991|451424269|FG004|Overall Study|Lost to Follow-up|0|||
125489244|NCT04163991|451424265|FG000|Overall Study|Withdrawal by Subject|1|||
125489245|NCT04163991|451424266|FG001|Overall Study|Withdrawal by Subject|1|||
125489246|NCT04163991|451424267|FG002|Overall Study|Withdrawal by Subject|3|||
125489247|NCT04163991|451424268|FG003|Overall Study|Withdrawal by Subject|1|||
125489248|NCT04163991|451424269|FG004|Overall Study|Withdrawal by Subject|1|||
125489249|NCT04163991|451424265|FG000|Overall Study|Other, Not Specified|0|||
125489250|NCT04163991|451424266|FG001|Overall Study|Other, Not Specified|1|||
125489251|NCT04163991|451424267|FG002|Overall Study|Other, Not Specified|1|||
125489252|NCT04163991|451424268|FG003|Overall Study|Other, Not Specified|1|||
125489253|NCT04163991|451424269|FG004|Overall Study|Other, Not Specified|0|||
125489254|NCT04078152|451424270|FG000|Overall Study|Other|83|||
125489255|NCT04078152|451424271|FG001|Overall Study|Other|22|||
125489256|NCT04078152|451424272|FG002|Overall Study|Other|25|||
125489257|NCT04078152|451424270|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
125489258|NCT04078152|451424271|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
125489259|NCT04078152|451424272|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
125489260|NCT04078152|451424270|FG000|Overall Study|Withdrawal by Subject|5|||
125489261|NCT04078152|451424271|FG001|Overall Study|Withdrawal by Subject|0|||
125489262|NCT04078152|451424272|FG002|Overall Study|Withdrawal by Subject|1|||
125489263|NCT04078152|451424270|FG000|Overall Study|Death|10|||
125489264|NCT04078152|451424271|FG001|Overall Study|Death|2|||
125489265|NCT04078152|451424272|FG002|Overall Study|Death|12|||
125489266|NCT04078152|451424270|FG000|Overall Study|Adverse Event|1|||
125489267|NCT04078152|451424271|FG001|Overall Study|Adverse Event|0|||
125489268|NCT04078152|451424272|FG002|Overall Study|Adverse Event|0|||
125489269|NCT02510235|451424273|FG000|Overall Study|Withdrawal by Subject|1|||
125489270|NCT02510235|451424274|FG001|Overall Study|Withdrawal by Subject|0|||
125489271|NCT05890105|451424275|FG000|Overall Study|Adverse Event|1|||
125489272|NCT05890105|451424276|FG001|Overall Study|Adverse Event|0|||
125489273|NCT05890105|451424277|FG002|Overall Study|Adverse Event|0|||
125489274|NCT05890105|451424275|FG000|Overall Study|Other|1|||
125489275|NCT05890105|451424276|FG001|Overall Study|Other|2|||
125489276|NCT05890105|451424277|FG002|Overall Study|Other|0|||
125489277|NCT04678856|451424278|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
125489278|NCT04678856|451424279|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
125489279|NCT04678856|451424278|FG000|Overall Study|Withdrawal by Subject|5|||
125489280|NCT04678856|451424279|FG001|Overall Study|Withdrawal by Subject|1|||
125489281|NCT03367156|451425320|FG000|Overall Study|Lack of interest|3|||
125489282|NCT03367156|451425321|FG001|Overall Study|Lack of interest|1|||
125489283|NCT03367156|451425320|FG000|Overall Study|Death|2|||
125489284|NCT03367156|451425321|FG001|Overall Study|Death|0|||
125489285|NCT03367156|451425320|FG000|Overall Study|Lost to Follow-up|2|||
125489286|NCT03367156|451425321|FG001|Overall Study|Lost to Follow-up|1|||
125489287|NCT03367156|451425320|FG000|Overall Study|Became ineligible|1|||
125489288|NCT03367156|451425321|FG001|Overall Study|Became ineligible|2|||
125489289|NCT03367156|451425320|FG000|Overall Study|Hospitalization|1|||
125489290|NCT03367156|451425321|FG001|Overall Study|Hospitalization|0|||
125489291|NCT03367156|451425320|FG000|Overall Study|Concerned about Treatment|11|||
125489292|NCT03367156|451425321|FG001|Overall Study|Concerned about Treatment|3|||
125489293|NCT03367156|451425320|FG000|Overall Study|Started new treatment|4|||
125489294|NCT03367156|451425321|FG001|Overall Study|Started new treatment|1|||
125489295|NCT05507437|451425322|FG000|Overall Study|Withdrawal by Subject|1|||
125489296|NCT05507437|451425323|FG001|Overall Study|Withdrawal by Subject|1|||
125489297|NCT05507437|451425322|FG000|Overall Study|Death|3|||
125489298|NCT05507437|451425323|FG001|Overall Study|Death|0|||
125489299|NCT04084574|451425325|FG000|Overall Study|Lost to Follow-up|1|||
125489300|NCT04084574|451425326|FG001|Overall Study|Lost to Follow-up|0|||
125489301|NCT04084574|451425325|FG000|Overall Study|Physician Decision|1|||
125489302|NCT04084574|451425326|FG001|Overall Study|Physician Decision|0|||
125489303|NCT04084574|451425325|FG000|Overall Study|Relocated out of state|1|||
125489304|NCT04084574|451425326|FG001|Overall Study|Relocated out of state|0|||
125489305|NCT00942877|451425327|FG000|Overall Study|Refused further treatment|1|||
125489306|NCT00942877|451425328|FG001|Overall Study|Refused further treatment|1|||
125489307|NCT00942877|451425327|FG000|Overall Study|Patient was not treated|1|||
125489308|NCT00942877|451425328|FG001|Overall Study|Patient was not treated|0|||
125489309|NCT00942877|451425327|FG000|Overall Study|Adverse Event|1|||
125489310|NCT00942877|451425328|FG001|Overall Study|Adverse Event|0|||
125489311|NCT00942877|451425327|FG000|Overall Study|Progressive disease|42|||
125489312|NCT00942877|451425328|FG001|Overall Study|Progressive disease|3|||
125489313|NCT00887198|451425331|FG000|Randomized Period|Ongoing|42|||
125489314|NCT00887198|451425332|FG001|Randomized Period|Ongoing|0|||
125489315|NCT00887198|451425333|FG002|Randomized Period|Ongoing|0|||
125489316|NCT00887198|451425331|FG000|Randomized Period|Adverse Event|50|||
125489317|NCT00887198|451425332|FG001|Randomized Period|Adverse Event|33|||
125489318|NCT00887198|451425333|FG002|Randomized Period|Adverse Event|0|||
125489319|NCT00887198|451425331|FG000|Randomized Period|Lost to Follow-up|1|||
125489320|NCT00887198|451425332|FG001|Randomized Period|Lost to Follow-up|0|||
125489321|NCT00887198|451425333|FG002|Randomized Period|Lost to Follow-up|0|||
125489322|NCT00887198|451425331|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
125489323|NCT00887198|451425332|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
125489324|NCT00887198|451425333|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
125489325|NCT00887198|451425331|FG000|Randomized Period|Withdrawal by Subject|41|||
125489326|NCT00887198|451425332|FG001|Randomized Period|Withdrawal by Subject|56|||
125489327|NCT00887198|451425333|FG002|Randomized Period|Withdrawal by Subject|0|||
125489328|NCT00887198|451425331|FG000|Randomized Period|Progressive disease|366|||
125489329|NCT00887198|451425332|FG001|Randomized Period|Progressive disease|370|||
125489330|NCT00887198|451425333|FG002|Randomized Period|Progressive disease|0|||
125489331|NCT00887198|451425331|FG000|Randomized Period|Other|42|||
125489332|NCT00887198|451425332|FG001|Randomized Period|Other|30|||
125489333|NCT00887198|451425333|FG002|Randomized Period|Other|0|||
125489334|NCT00887198|451425331|FG000|Randomized Period|Randomized, Not treated|4|||
125489335|NCT00887198|451425332|FG001|Randomized Period|Randomized, Not treated|2|||
125489336|NCT00887198|451425333|FG002|Randomized Period|Randomized, Not treated|0|||
125489337|NCT00887198|451425331|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
125489338|NCT00887198|451425332|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
125489339|NCT00887198|451425333|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
125489340|NCT00887198|451425331|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
125489341|NCT00887198|451425332|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
125489342|NCT00887198|451425333|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
125489343|NCT00887198|451425331|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
125489344|NCT00887198|451425332|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
125489345|NCT00887198|451425333|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
125489346|NCT00887198|451425331|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
125489347|NCT00887198|451425332|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
125489348|NCT00887198|451425333|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
125489349|NCT00887198|451425331|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
125489350|NCT00887198|451425332|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
125489351|NCT00887198|451425333|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
125489352|NCT00887198|451425331|FG000|Cross Over (Placebo to AA)|Other|0|||
125489353|NCT00887198|451425332|FG001|Cross Over (Placebo to AA)|Other|0|||
125489354|NCT00887198|451425333|FG002|Cross Over (Placebo to AA)|Other|19|||
125489355|NCT03334695|451425334|FG000|Overall Study|Lost to Follow-up|3|||
125489356|NCT03334695|451425335|FG001|Overall Study|Lost to Follow-up|3|||
125489357|NCT03334695|451425334|FG000|Overall Study|Physician Decision|1|||
125489358|NCT03334695|451425335|FG001|Overall Study|Physician Decision|2|||
125489359|NCT03334695|451425334|FG000|Overall Study|Protocol Violation|0|||
125489360|NCT03334695|451425335|FG001|Overall Study|Protocol Violation|1|||
125489361|NCT05007080|451425336|FG000|Overall Study|Lost to Follow-up|0|||
125489362|NCT05007080|451425337|FG001|Overall Study|Lost to Follow-up|1|||
125489363|NCT05007080|451425338|FG002|Overall Study|Lost to Follow-up|0|||
125489364|NCT05007080|451425339|FG003|Overall Study|Lost to Follow-up|1|||
125489365|NCT05007080|451425340|FG004|Overall Study|Lost to Follow-up|1|||
125489366|NCT05007080|451425341|FG005|Overall Study|Lost to Follow-up|1|||
125489367|NCT05007080|451425336|FG000|Overall Study|Death|0|||
125489368|NCT05007080|451425337|FG001|Overall Study|Death|1|||
125489369|NCT05007080|451425338|FG002|Overall Study|Death|0|||
125489370|NCT05007080|451425339|FG003|Overall Study|Death|0|||
125489371|NCT05007080|451425340|FG004|Overall Study|Death|0|||
125489372|NCT05007080|451425341|FG005|Overall Study|Death|0|||
125489373|NCT05007080|451425336|FG000|Overall Study|Withdrawal by Subject|1|||
125489374|NCT05007080|451425337|FG001|Overall Study|Withdrawal by Subject|2|||
125489375|NCT05007080|451425338|FG002|Overall Study|Withdrawal by Subject|0|||
125489376|NCT05007080|451425339|FG003|Overall Study|Withdrawal by Subject|2|||
125489377|NCT05007080|451425340|FG004|Overall Study|Withdrawal by Subject|1|||
125489378|NCT05007080|451425341|FG005|Overall Study|Withdrawal by Subject|1|||
125489379|NCT05007080|451425336|FG000|Overall Study|Other|1|||
125489380|NCT05007080|451425337|FG001|Overall Study|Other|0|||
125489381|NCT05007080|451425338|FG002|Overall Study|Other|1|||
125489382|NCT05007080|451425339|FG003|Overall Study|Other|1|||
125489383|NCT05007080|451425340|FG004|Overall Study|Other|0|||
125489384|NCT05007080|451425341|FG005|Overall Study|Other|2|||
125489385|NCT05007080|451425336|FG000|Overall Study|Randomized not vaccinated|0|||
125489386|NCT05007080|451425337|FG001|Overall Study|Randomized not vaccinated|0|||
125489387|NCT05007080|451425338|FG002|Overall Study|Randomized not vaccinated|0|||
125489388|NCT05007080|451425339|FG003|Overall Study|Randomized not vaccinated|0|||
125489389|NCT05007080|451425340|FG004|Overall Study|Randomized not vaccinated|0|||
125489390|NCT05007080|451425341|FG005|Overall Study|Randomized not vaccinated|1|||
125489391|NCT02874742|451425342|FG000|Overall Study|Death|0|||
125489392|NCT02874742|451425343|FG001|Overall Study|Death|1|||
125489393|NCT02874742|451425344|FG002|Overall Study|Death|0|||
125489394|NCT02874742|451425342|FG000|Overall Study|Lost to Follow-up|5|||
125489395|NCT02874742|451425343|FG001|Overall Study|Lost to Follow-up|4|||
125303377|NCT01068158|450736735|FG001|Overall Study|Protocol Violation|2|||
125489396|NCT02874742|451425344|FG002|Overall Study|Lost to Follow-up|1|||
125489397|NCT02874742|451425342|FG000|Overall Study|Withdrawal by Subject|17|||
125303378|NCT01300572|450736736|FG000|Overall Study|HAMA + post dosimetry|1|||
125303379|NCT00411632|450736738|FG000|Overall Study|Death|1|||
125489398|NCT02874742|451425343|FG001|Overall Study|Withdrawal by Subject|8|||
125489399|NCT02874742|451425344|FG002|Overall Study|Withdrawal by Subject|0|||
125489400|NCT02874742|451425342|FG000|Overall Study|Other|4|||
125489401|NCT02874742|451425343|FG001|Overall Study|Other|1|||
125489402|NCT02874742|451425344|FG002|Overall Study|Other|0|||
125489403|NCT02874742|451425342|FG000|Overall Study|Progressive Disease|1|||
125489404|NCT02874742|451425343|FG001|Overall Study|Progressive Disease|0|||
125489405|NCT02874742|451425344|FG002|Overall Study|Progressive Disease|0|||
125489406|NCT02874742|451425342|FG000|Overall Study|Screen Failure|0|||
125489407|NCT02874742|451425343|FG001|Overall Study|Screen Failure|2|||
125489408|NCT02874742|451425344|FG002|Overall Study|Screen Failure|0|||
125489409|NCT05070741|451425354|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
125489410|NCT03582033|451425355|FG000|Part A|Other|0|||
125489411|NCT03582033|451425356|FG001|Part A|Other|0|||
125489412|NCT03582033|451425357|FG002|Part A|Other|0|||
125489413|NCT03582033|451425358|FG003|Part A|Other|0|||
125489414|NCT03582033|451425359|FG004|Part A|Other|2|||
125489415|NCT03582033|451425360|FG005|Part A|Other|0|||
125489416|NCT03582033|451425361|FG006|Part A|Other|0|||
125489417|NCT03582033|451425362|FG007|Part A|Other|0|||
125489418|NCT03582033|451425363|FG008|Part A|Other|0|||
125489419|NCT03582033|451425364|FG009|Part A|Other|0|||
125489420|NCT03582033|451425355|FG000|Part A|Death|1|||
125489421|NCT03582033|451425356|FG001|Part A|Death|1|||
125489422|NCT03582033|451425357|FG002|Part A|Death|2|||
125489423|NCT03582033|451425358|FG003|Part A|Death|4|||
125489424|NCT03582033|451425359|FG004|Part A|Death|11|||
125489425|NCT03582033|451425360|FG005|Part A|Death|0|||
125489426|NCT03582033|451425361|FG006|Part A|Death|0|||
125489427|NCT03582033|451425362|FG007|Part A|Death|0|||
125489428|NCT03582033|451425363|FG008|Part A|Death|0|||
125489429|NCT03582033|451425364|FG009|Part A|Death|0|||
125489430|NCT03582033|451425355|FG000|Part A|Lost to Follow-up|0|||
125489431|NCT03582033|451425356|FG001|Part A|Lost to Follow-up|0|||
125489432|NCT03582033|451425357|FG002|Part A|Lost to Follow-up|0|||
125489433|NCT03582033|451425358|FG003|Part A|Lost to Follow-up|0|||
125489434|NCT03582033|451425359|FG004|Part A|Lost to Follow-up|1|||
125489435|NCT03582033|451425360|FG005|Part A|Lost to Follow-up|0|||
125489436|NCT03582033|451425361|FG006|Part A|Lost to Follow-up|0|||
125489437|NCT03582033|451425362|FG007|Part A|Lost to Follow-up|0|||
125489438|NCT03582033|451425363|FG008|Part A|Lost to Follow-up|0|||
125489439|NCT03582033|451425364|FG009|Part A|Lost to Follow-up|0|||
125489440|NCT03582033|451425355|FG000|Part A|Study terminated by sponsor|0|||
125489441|NCT03582033|451425356|FG001|Part A|Study terminated by sponsor|0|||
125489442|NCT03582033|451425357|FG002|Part A|Study terminated by sponsor|0|||
125489443|NCT03582033|451425358|FG003|Part A|Study terminated by sponsor|2|||
125489444|NCT03582033|451425359|FG004|Part A|Study terminated by sponsor|1|||
125489445|NCT03582033|451425360|FG005|Part A|Study terminated by sponsor|0|||
125489446|NCT03582033|451425361|FG006|Part A|Study terminated by sponsor|0|||
125489447|NCT03582033|451425362|FG007|Part A|Study terminated by sponsor|0|||
125489448|NCT03582033|451425363|FG008|Part A|Study terminated by sponsor|0|||
125489449|NCT03582033|451425364|FG009|Part A|Study terminated by sponsor|0|||
125489450|NCT03582033|451425355|FG000|Part A|Withdrawal by Subject|1|||
125489451|NCT03582033|451425356|FG001|Part A|Withdrawal by Subject|1|||
125489452|NCT03582033|451425357|FG002|Part A|Withdrawal by Subject|0|||
125489453|NCT03582033|451425358|FG003|Part A|Withdrawal by Subject|1|||
125489454|NCT03582033|451425359|FG004|Part A|Withdrawal by Subject|7|||
125489455|NCT03582033|451425360|FG005|Part A|Withdrawal by Subject|0|||
125489456|NCT03582033|451425361|FG006|Part A|Withdrawal by Subject|0|||
125489457|NCT03582033|451425362|FG007|Part A|Withdrawal by Subject|0|||
125489458|NCT03582033|451425363|FG008|Part A|Withdrawal by Subject|0|||
125489459|NCT03582033|451425364|FG009|Part A|Withdrawal by Subject|0|||
125489460|NCT03582033|451425355|FG000|Part B|Death|0|||
125489461|NCT03582033|451425356|FG001|Part B|Death|0|||
125489462|NCT03582033|451425357|FG002|Part B|Death|0|||
125489463|NCT03582033|451425358|FG003|Part B|Death|0|||
125489464|NCT03582033|451425359|FG004|Part B|Death|0|||
125489465|NCT03582033|451425360|FG005|Part B|Death|2|||
125489466|NCT03582033|451425361|FG006|Part B|Death|0|||
125489467|NCT03582033|451425362|FG007|Part B|Death|0|||
125489468|NCT03582033|451425363|FG008|Part B|Death|0|||
125489469|NCT03582033|451425364|FG009|Part B|Death|0|||
125489470|NCT03582033|451425355|FG000|Part B|Study terminated by sponsor|0|||
125489471|NCT03582033|451425356|FG001|Part B|Study terminated by sponsor|0|||
125489472|NCT03582033|451425357|FG002|Part B|Study terminated by sponsor|0|||
125489473|NCT03582033|451425358|FG003|Part B|Study terminated by sponsor|0|||
125489474|NCT03582033|451425359|FG004|Part B|Study terminated by sponsor|0|||
125489475|NCT03582033|451425360|FG005|Part B|Study terminated by sponsor|12|||
125489476|NCT03582033|451425361|FG006|Part B|Study terminated by sponsor|0|||
125303380|NCT01748825|450736753|FG000|Dose Escalation|Refused further treatment|2|||
125489477|NCT03582033|451425362|FG007|Part B|Study terminated by sponsor|0|||
125489478|NCT03582033|451425363|FG008|Part B|Study terminated by sponsor|0|||
125489479|NCT03582033|451425364|FG009|Part B|Study terminated by sponsor|0|||
125489480|NCT03582033|451425355|FG000|Part B|Withdrawal by Subject|0|||
125489481|NCT03582033|451425356|FG001|Part B|Withdrawal by Subject|0|||
125489482|NCT03582033|451425357|FG002|Part B|Withdrawal by Subject|0|||
125489483|NCT03582033|451425358|FG003|Part B|Withdrawal by Subject|0|||
125489484|NCT03582033|451425359|FG004|Part B|Withdrawal by Subject|0|||
125489485|NCT03582033|451425360|FG005|Part B|Withdrawal by Subject|6|||
125489486|NCT03582033|451425361|FG006|Part B|Withdrawal by Subject|0|||
125489487|NCT03582033|451425362|FG007|Part B|Withdrawal by Subject|0|||
125489488|NCT03582033|451425363|FG008|Part B|Withdrawal by Subject|0|||
125489489|NCT03582033|451425364|FG009|Part B|Withdrawal by Subject|0|||
125489490|NCT03582033|451425355|FG000|Part C|Other|0|||
125489491|NCT03582033|451425356|FG001|Part C|Other|0|||
125489492|NCT03582033|451425357|FG002|Part C|Other|0|||
125489493|NCT03582033|451425358|FG003|Part C|Other|0|||
125489494|NCT03582033|451425359|FG004|Part C|Other|0|||
125489495|NCT03582033|451425360|FG005|Part C|Other|0|||
125489496|NCT03582033|451425361|FG006|Part C|Other|2|||
125489497|NCT03582033|451425362|FG007|Part C|Other|0|||
125489498|NCT03582033|451425363|FG008|Part C|Other|0|||
125489499|NCT03582033|451425364|FG009|Part C|Other|0|||
125489500|NCT03582033|451425355|FG000|Part C|Death|0|||
125489501|NCT03582033|451425356|FG001|Part C|Death|0|||
125489502|NCT03582033|451425357|FG002|Part C|Death|0|||
125489503|NCT03582033|451425358|FG003|Part C|Death|0|||
125489504|NCT03582033|451425359|FG004|Part C|Death|0|||
125489505|NCT03582033|451425360|FG005|Part C|Death|0|||
125489506|NCT03582033|451425361|FG006|Part C|Death|6|||
125489507|NCT03582033|451425362|FG007|Part C|Death|1|||
125489508|NCT03582033|451425363|FG008|Part C|Death|2|||
125489509|NCT03582033|451425364|FG009|Part C|Death|0|||
125489510|NCT03582033|451425355|FG000|Part C|Study terminated by sponsor|0|||
125489511|NCT03582033|451425356|FG001|Part C|Study terminated by sponsor|0|||
125489512|NCT03582033|451425357|FG002|Part C|Study terminated by sponsor|0|||
125489513|NCT03582033|451425358|FG003|Part C|Study terminated by sponsor|0|||
125489514|NCT03582033|451425359|FG004|Part C|Study terminated by sponsor|0|||
125489515|NCT03582033|451425360|FG005|Part C|Study terminated by sponsor|0|||
125489516|NCT03582033|451425361|FG006|Part C|Study terminated by sponsor|3|||
125489517|NCT03582033|451425362|FG007|Part C|Study terminated by sponsor|3|||
125489518|NCT03582033|451425363|FG008|Part C|Study terminated by sponsor|2|||
125489519|NCT03582033|451425364|FG009|Part C|Study terminated by sponsor|0|||
125489520|NCT03582033|451425355|FG000|Part C|Withdrawal by Subject|0|||
125489521|NCT03582033|451425356|FG001|Part C|Withdrawal by Subject|0|||
125489522|NCT03582033|451425357|FG002|Part C|Withdrawal by Subject|0|||
125489523|NCT03582033|451425358|FG003|Part C|Withdrawal by Subject|0|||
125489524|NCT03582033|451425359|FG004|Part C|Withdrawal by Subject|0|||
125489525|NCT03582033|451425360|FG005|Part C|Withdrawal by Subject|0|||
125489526|NCT03582033|451425361|FG006|Part C|Withdrawal by Subject|1|||
125489527|NCT03582033|451425362|FG007|Part C|Withdrawal by Subject|2|||
125489528|NCT03582033|451425363|FG008|Part C|Withdrawal by Subject|1|||
125489529|NCT03582033|451425364|FG009|Part C|Withdrawal by Subject|0|||
125489530|NCT03582033|451425355|FG000|Part D|Death|0|||
125489531|NCT03582033|451425356|FG001|Part D|Death|0|||
125489532|NCT03582033|451425357|FG002|Part D|Death|0|||
125489533|NCT03582033|451425358|FG003|Part D|Death|0|||
125489534|NCT03582033|451425359|FG004|Part D|Death|0|||
125489535|NCT03582033|451425360|FG005|Part D|Death|0|||
125489536|NCT03582033|451425361|FG006|Part D|Death|0|||
125489537|NCT03582033|451425362|FG007|Part D|Death|0|||
125489538|NCT03582033|451425363|FG008|Part D|Death|0|||
125489539|NCT03582033|451425364|FG009|Part D|Death|1|||
125489540|NCT03582033|451425355|FG000|Part D|Study terminated by sponsor|0|||
125489541|NCT03582033|451425356|FG001|Part D|Study terminated by sponsor|0|||
125489542|NCT03582033|451425357|FG002|Part D|Study terminated by sponsor|0|||
125489543|NCT03582033|451425358|FG003|Part D|Study terminated by sponsor|0|||
125489544|NCT03582033|451425359|FG004|Part D|Study terminated by sponsor|0|||
125489545|NCT03582033|451425360|FG005|Part D|Study terminated by sponsor|0|||
125489546|NCT03582033|451425361|FG006|Part D|Study terminated by sponsor|0|||
125489547|NCT03582033|451425362|FG007|Part D|Study terminated by sponsor|0|||
125489548|NCT03582033|451425363|FG008|Part D|Study terminated by sponsor|0|||
125489549|NCT03582033|451425364|FG009|Part D|Study terminated by sponsor|4|||
125489550|NCT03812614|451425365|FG000|Intervention|Withdrawal by Subject|7|||
125489551|NCT03812614|451425366|FG001|Intervention|Withdrawal by Subject|2|||
125489552|NCT03812614|451425367|FG002|Intervention|Withdrawal by Subject|7|||
125489553|NCT03812614|451425368|FG003|Intervention|Withdrawal by Subject|2|||
125489554|NCT03812614|451425365|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
125489555|NCT03812614|451425366|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
125489556|NCT03812614|451425367|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
125489557|NCT03812614|451425368|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
125489558|NCT03812614|451425365|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
125489559|NCT03812614|451425366|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
125489560|NCT03812614|451425367|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
125489561|NCT03812614|451425368|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
125489562|NCT03812614|451425365|FG000|6-month Follow-up|Lost to Follow-up|0|||
125489563|NCT03812614|451425366|FG001|6-month Follow-up|Lost to Follow-up|0|||
125489564|NCT03812614|451425367|FG002|6-month Follow-up|Lost to Follow-up|12|||
125489565|NCT03812614|451425368|FG003|6-month Follow-up|Lost to Follow-up|8|||
125489566|NCT03812614|451425365|FG000|12-month Follow-up|Lost to Follow-up|18|||
125489567|NCT03812614|451425366|FG001|12-month Follow-up|Lost to Follow-up|17|||
125489568|NCT03812614|451425367|FG002|12-month Follow-up|Lost to Follow-up|5|||
125489569|NCT03812614|451425368|FG003|12-month Follow-up|Lost to Follow-up|2|||
125489570|NCT05205161|451425369|FG000|Overall Study|Study terminated by sponsor|3|||
125489571|NCT05205161|451425370|FG001|Overall Study|Study terminated by sponsor|3|||
125489572|NCT05205161|451425371|FG002|Overall Study|Study terminated by sponsor|1|||
125489573|NCT04214418|451425376|FG000|Overall Study|Withdrawal by Subject|1|||
125489574|NCT04214418|451425377|FG001|Overall Study|Withdrawal by Subject|0|||
125489575|NCT04214418|451425378|FG002|Overall Study|Withdrawal by Subject|0|||
125489576|NCT04214418|451425379|FG003|Overall Study|Withdrawal by Subject|0|||
125489577|NCT04214418|451425380|FG004|Overall Study|Withdrawal by Subject|0|||
125489578|NCT04214418|451425381|FG005|Overall Study|Withdrawal by Subject|0|||
125489579|NCT04214418|451425376|FG000|Overall Study|Adverse Event|0|||
125489580|NCT04214418|451425377|FG001|Overall Study|Adverse Event|2|||
125489581|NCT04214418|451425378|FG002|Overall Study|Adverse Event|0|||
125489582|NCT04214418|451425379|FG003|Overall Study|Adverse Event|0|||
125489583|NCT04214418|451425380|FG004|Overall Study|Adverse Event|0|||
125489584|NCT04214418|451425381|FG005|Overall Study|Adverse Event|0|||
125489585|NCT04214418|451425376|FG000|Overall Study|Death|1|||
125489586|NCT04214418|451425377|FG001|Overall Study|Death|0|||
125489587|NCT04214418|451425378|FG002|Overall Study|Death|0|||
125489588|NCT04214418|451425379|FG003|Overall Study|Death|0|||
125489589|NCT04214418|451425380|FG004|Overall Study|Death|0|||
125489590|NCT04214418|451425381|FG005|Overall Study|Death|0|||
125489591|NCT00450216|451425385|FG000|Overall Study|Adverse Event|38|||
125489592|NCT00450216|451425386|FG001|Overall Study|Adverse Event|23|||
125489593|NCT00450216|451425385|FG000|Overall Study|Withdrawal by Subject|48|||
125489594|NCT00450216|451425386|FG001|Overall Study|Withdrawal by Subject|26|||
125489595|NCT00450216|451425385|FG000|Overall Study|Lost to Follow-up|16|||
125489596|NCT00450216|451425386|FG001|Overall Study|Lost to Follow-up|9|||
125489597|NCT00450216|451425385|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
125489598|NCT00450216|451425386|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
125489599|NCT00450216|451425385|FG000|Overall Study|misc|21|||
125489600|NCT00450216|451425386|FG001|Overall Study|misc|20|||
125489601|NCT04206787|451425387|FG000|Overall Study|Other than listed|2|||
125489602|NCT04206787|451425387|FG000|Overall Study|Investigator decision|1|||
125489603|NCT04206787|451425387|FG000|Overall Study|Death|25|||
125489604|NCT04206787|451425387|FG000|Overall Study|Lost to Follow-up|9|||
125489605|NCT04206787|451425387|FG000|Overall Study|Withdrawal of consent|9|||
125489606|NCT05008055|451425388|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
125489607|NCT05008055|451425389|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
125489608|NCT05008055|451425390|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
125489609|NCT04635059|451425392|FG000|Overall Study|Study terminated early.|4|||
125489610|NCT03011034|451425393|FG000|Overall Study|Adverse Event|1|||
125489611|NCT03011034|451425394|FG001|Overall Study|Adverse Event|0|||
125489612|NCT05123027|451425401|FG000|Overall Study|Lost to Follow-up|17|||
125489613|NCT05123027|451425402|FG001|Overall Study|Lost to Follow-up|22|||
125489614|NCT05123027|451425401|FG000|Overall Study|Incarceration|3|||
125489615|NCT05123027|451425402|FG001|Overall Study|Incarceration|4|||
125489616|NCT05123027|451425401|FG000|Overall Study|Death|2|||
125489617|NCT05123027|451425402|FG001|Overall Study|Death|2|||
125489618|NCT05123027|451425401|FG000|Overall Study|Other|2|||
125489619|NCT05123027|451425402|FG001|Overall Study|Other|0|||
125489620|NCT03735979|451425403|FG000|Overall Study|Lost to Follow-up|1|||
125489621|NCT03735979|451425404|FG001|Overall Study|Lost to Follow-up|12|||
125489622|NCT03735979|451425405|FG002|Overall Study|Lost to Follow-up|14|||
125489623|NCT03735979|451425403|FG000|Overall Study|Withdrawal by Subject|1|||
125303381|NCT01748825|450736754|FG001|Dose Escalation|Refused further treatment|2|||
125303382|NCT01748825|450736755|FG002|Dose Escalation|Refused further treatment|0|||
125489624|NCT03735979|451425404|FG001|Overall Study|Withdrawal by Subject|5|||
125489625|NCT03735979|451425405|FG002|Overall Study|Withdrawal by Subject|2|||
125489626|NCT03735979|451425403|FG000|Overall Study|Not due to the above reasons|1|||
125489627|NCT03735979|451425404|FG001|Overall Study|Not due to the above reasons|0|||
125303383|NCT01748825|450736756|FG003|Dose Escalation|Refused further treatment|0|||
125303384|NCT01748825|450736757|FG004|Dose Escalation|Refused further treatment|1|||
125489628|NCT03735979|451425405|FG002|Overall Study|Not due to the above reasons|0|||
125489629|NCT00319111|451425408|FG000|Overall Study|Adverse Event|20|||
125489630|NCT00319111|451425408|FG000|Overall Study|Withdrawal of consent|11|||
125489631|NCT00319111|451425408|FG000|Overall Study|Death|9|||
125489632|NCT00319111|451425408|FG000|Overall Study|Lack of clinical improvement|4|||
125489633|NCT00319111|451425408|FG000|Overall Study|Administrative|2|||
125489634|NCT00319111|451425408|FG000|Overall Study|Treatment failure|1|||
125489635|NCT04743973|451425410|FG000|Overall Study|Withdrawal by Subject|5|||
125489636|NCT05654662|451425411|FG000|Overall Study|Withdrawal by Subject|1|||
125489637|NCT05654662|451425412|FG001|Overall Study|Withdrawal by Subject|0|||
125489638|NCT05654662|451425411|FG000|Overall Study|A death in the family|1|||
125489639|NCT05654662|451425412|FG001|Overall Study|A death in the family|0|||
125489640|NCT03165955|451425413|FG000|Treatment|Withdrawal by Subject|3|||
125489641|NCT03165955|451425413|FG000|Treatment|Death|1|||
125489642|NCT03165955|451425413|FG000|Treatment|Adverse Event|1|||
125489643|NCT03165955|451425413|FG000|Treatment|Progressive disease|3|||
125489644|NCT04499521|451425416|FG000|Overall Study|Disease Progression|1|||
125489645|NCT04499521|451425417|FG001|Overall Study|Disease Progression|0|||
125489646|NCT03990883|451425418|FG000|Blinded Treatment Phase|Adverse Event|1|||
125489647|NCT03990883|451425419|FG001|Blinded Treatment Phase|Adverse Event|1|||
125489648|NCT03990883|451425420|FG002|Blinded Treatment Phase|Adverse Event|0|||
125489649|NCT03990883|451425418|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
125489650|NCT03990883|451425419|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
125489651|NCT03990883|451425420|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
125489652|NCT03990883|451425418|FG000|Blinded Treatment Phase|Physician Decision|1|||
125489653|NCT03990883|451425419|FG001|Blinded Treatment Phase|Physician Decision|0|||
125489654|NCT03990883|451425420|FG002|Blinded Treatment Phase|Physician Decision|0|||
125489655|NCT03990883|451425418|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
125489656|NCT03990883|451425419|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
125489657|NCT03990883|451425420|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
125489658|NCT03990883|451425418|FG000|Blinded Treatment Phase|COVID-19|3|||
125489659|NCT03990883|451425419|FG001|Blinded Treatment Phase|COVID-19|2|||
125489660|NCT03990883|451425420|FG002|Blinded Treatment Phase|COVID-19|0|||
125489661|NCT03990883|451425418|FG000|Blinded Treatment Phase|Personal Reasons|6|||
125489662|NCT03990883|451425419|FG001|Blinded Treatment Phase|Personal Reasons|3|||
125489663|NCT03990883|451425420|FG002|Blinded Treatment Phase|Personal Reasons|0|||
125489664|NCT03990883|451425418|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
125489665|NCT03990883|451425419|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
125489666|NCT03990883|451425420|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
125489667|NCT03990883|451425418|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
125489668|NCT03990883|451425419|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
125489669|NCT03990883|451425420|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
125489670|NCT03990883|451425418|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
125489671|NCT03990883|451425419|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
125489672|NCT03990883|451425420|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
125489673|NCT04427007|451426310|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
125489674|NCT04427007|451426311|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
125489675|NCT04633278|451426312|FG000|Overall Study|Adverse Event|1|||
125489676|NCT04633278|451426313|FG001|Overall Study|Adverse Event|0|||
125489677|NCT04633278|451426312|FG000|Overall Study|Withdrawal by Subject|1|||
125489678|NCT04633278|451426313|FG001|Overall Study|Withdrawal by Subject|0|||
125489679|NCT04633278|451426312|FG000|Overall Study|Death|11|||
125489680|NCT04633278|451426313|FG001|Overall Study|Death|7|||
125489681|NCT04633278|451426312|FG000|Overall Study|Sponsor Decision|3|||
125489682|NCT04633278|451426313|FG001|Overall Study|Sponsor Decision|0|||
125489683|NCT04633278|451426312|FG000|Overall Study|Not Listed|1|||
125489684|NCT04633278|451426313|FG001|Overall Study|Not Listed|0|||
125489685|NCT05247034|451426314|FG000|Overall Study|Lost to Follow-up|3|||
125489686|NCT05247034|451426315|FG001|Overall Study|Lost to Follow-up|2|||
125489687|NCT05247034|451426314|FG000|Overall Study|Organizational problems when attending appointments|1|||
125489688|NCT05247034|451426315|FG001|Overall Study|Organizational problems when attending appointments|0|||
125489689|NCT03505710|451426316|FG000|Overall Study|Progressive Disease|24|||
125489690|NCT03505710|451426317|FG001|Overall Study|Progressive Disease|17|||
125489691|NCT03505710|451426318|FG002|Overall Study|Progressive Disease|43|||
125489692|NCT03505710|451426316|FG000|Overall Study|Clinical Progression|6|||
125489693|NCT03505710|451426317|FG001|Overall Study|Clinical Progression|8|||
125489694|NCT03505710|451426318|FG002|Overall Study|Clinical Progression|3|||
125489695|NCT03505710|451426316|FG000|Overall Study|Adverse Event|12|||
125489696|NCT03505710|451426317|FG001|Overall Study|Adverse Event|6|||
125489697|NCT03505710|451426318|FG002|Overall Study|Adverse Event|28|||
125489698|NCT03505710|451426316|FG000|Overall Study|Withdrawal by Subject|1|||
125489699|NCT03505710|451426317|FG001|Overall Study|Withdrawal by Subject|3|||
125303385|NCT01748825|450736758|FG005|Dose Escalation|Refused further treatment|2|||
125303386|NCT01748825|450736759|FG006|Dose Escalation|Refused further treatment|0|||
125303387|NCT01748825|450736760|FG007|Dose Escalation|Refused further treatment|0|||
125489700|NCT03505710|451426318|FG002|Overall Study|Withdrawal by Subject|7|||
125489701|NCT03505710|451426316|FG000|Overall Study|Physician Decision|1|||
125489702|NCT03505710|451426317|FG001|Overall Study|Physician Decision|1|||
125489703|NCT03505710|451426318|FG002|Overall Study|Physician Decision|2|||
125303388|NCT01748825|450736761|FG008|Dose Escalation|Refused further treatment|0|||
125489704|NCT03505710|451426316|FG000|Overall Study|Death|4|||
125489705|NCT03505710|451426317|FG001|Overall Study|Death|5|||
125489706|NCT03505710|451426318|FG002|Overall Study|Death|6|||
125489707|NCT03505710|451426316|FG000|Overall Study|Other Reasons|1|||
125489708|NCT03505710|451426317|FG001|Overall Study|Other Reasons|1|||
125489709|NCT03505710|451426318|FG002|Overall Study|Other Reasons|1|||
125489710|NCT03505710|451426316|FG000|Overall Study|Study Terminated by Sponsor|0|||
125489711|NCT03505710|451426317|FG001|Overall Study|Study Terminated by Sponsor|0|||
125489712|NCT03505710|451426318|FG002|Overall Study|Study Terminated by Sponsor|1|||
125489713|NCT04389957|451426322|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
125489714|NCT04389957|451426323|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
125489715|NCT04389957|451426324|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
125489716|NCT04389957|451426325|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
125489717|NCT04389957|451426326|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
125489718|NCT06655818|451426334|FG000|Overall Study|Withdrawal by Subject|1|||
125489719|NCT05147584|451426335|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
125489720|NCT05460871|451426336|FG000|Overall Study|Withdrawal by Subject|1|||
125489721|NCT05460871|451426337|FG001|Overall Study|Withdrawal by Subject|2|||
125489722|NCT04623775|451426348|FG000|Randomization|No Longer Meets Study Criteria|2|||
125489723|NCT04623775|451426349|FG001|Randomization|No Longer Meets Study Criteria|1|||
125489724|NCT04623775|451426350|FG002|Randomization|No Longer Meets Study Criteria|0|||
125489725|NCT04623775|451426351|FG003|Randomization|No Longer Meets Study Criteria|0|||
125489726|NCT04623775|451426348|FG000|Randomization|Withdrew Consent|0|||
125489727|NCT04623775|451426349|FG001|Randomization|Withdrew Consent|0|||
125489728|NCT04623775|451426350|FG002|Randomization|Withdrew Consent|0|||
125489729|NCT04623775|451426351|FG003|Randomization|Withdrew Consent|1|||
125489730|NCT04623775|451426348|FG000|Randomization|Other Reasons|0|||
125489731|NCT04623775|451426349|FG001|Randomization|Other Reasons|0|||
125489732|NCT04623775|451426350|FG002|Randomization|Other Reasons|0|||
125489733|NCT04623775|451426351|FG003|Randomization|Other Reasons|1|||
125489734|NCT04623775|451426348|FG000|Treatment Period|participant withdrew consent|4|||
125489735|NCT04623775|451426349|FG001|Treatment Period|participant withdrew consent|0|||
125489736|NCT04623775|451426350|FG002|Treatment Period|participant withdrew consent|1|||
125489737|NCT04623775|451426351|FG003|Treatment Period|participant withdrew consent|2|||
125489738|NCT04623775|451426348|FG000|Treatment Period|Death|3|||
125489739|NCT04623775|451426349|FG001|Treatment Period|Death|1|||
125489740|NCT04623775|451426350|FG002|Treatment Period|Death|4|||
125489741|NCT04623775|451426351|FG003|Treatment Period|Death|2|||
125489742|NCT04623775|451426348|FG000|Treatment Period|Lost to Follow-up|0|||
125489743|NCT04623775|451426349|FG001|Treatment Period|Lost to Follow-up|2|||
125489744|NCT04623775|451426350|FG002|Treatment Period|Lost to Follow-up|0|||
125489745|NCT04623775|451426351|FG003|Treatment Period|Lost to Follow-up|0|||
125489746|NCT04623775|451426348|FG000|Treatment Period|poor/non compliance|0|||
125489747|NCT04623775|451426349|FG001|Treatment Period|poor/non compliance|0|||
125489748|NCT04623775|451426350|FG002|Treatment Period|poor/non compliance|1|||
125489749|NCT04623775|451426351|FG003|Treatment Period|poor/non compliance|0|||
125489750|NCT04623775|451426348|FG000|Treatment Period|participant no longer meets study criteria|0|||
125489751|NCT04623775|451426349|FG001|Treatment Period|participant no longer meets study criteria|1|||
125489752|NCT04623775|451426350|FG002|Treatment Period|participant no longer meets study criteria|0|||
125489753|NCT04623775|451426351|FG003|Treatment Period|participant no longer meets study criteria|0|||
125489754|NCT04623775|451426348|FG000|Treatment Period|administrative reasons by sponsor|3|||
125489755|NCT04623775|451426349|FG001|Treatment Period|administrative reasons by sponsor|2|||
125489756|NCT04623775|451426350|FG002|Treatment Period|administrative reasons by sponsor|0|||
125489757|NCT04623775|451426351|FG003|Treatment Period|administrative reasons by sponsor|0|||
125489758|NCT04623775|451426348|FG000|Treatment Period|other reasons|2|||
125489759|NCT04623775|451426349|FG001|Treatment Period|other reasons|0|||
125489760|NCT04623775|451426350|FG002|Treatment Period|other reasons|1|||
125489761|NCT04623775|451426351|FG003|Treatment Period|other reasons|1|||
125489762|NCT04623775|451426348|FG000|Treatment Period|disease progression|40|||
125489763|NCT04623775|451426349|FG001|Treatment Period|disease progression|35|||
125489764|NCT04623775|451426350|FG002|Treatment Period|disease progression|63|||
125489765|NCT04623775|451426351|FG003|Treatment Period|disease progression|63|||
125489766|NCT04623775|451426348|FG000|Treatment Period|study drug toxicity|12|||
125489767|NCT04623775|451426349|FG001|Treatment Period|study drug toxicity|15|||
125489768|NCT04623775|451426350|FG002|Treatment Period|study drug toxicity|13|||
125489769|NCT04623775|451426351|FG003|Treatment Period|study drug toxicity|12|||
125489770|NCT04623775|451426348|FG000|Treatment Period|AE unrelated to study drug|4|||
125489771|NCT04623775|451426349|FG001|Treatment Period|AE unrelated to study drug|9|||
125489772|NCT04623775|451426350|FG002|Treatment Period|AE unrelated to study drug|12|||
125489773|NCT04623775|451426351|FG003|Treatment Period|AE unrelated to study drug|9|||
125489774|NCT04623775|451426348|FG000|Treatment Period|participant request to discontinue treatment|0|||
125303389|NCT01748825|450736762|FG009|Dose Escalation|Refused further treatment|0|||
125489775|NCT04623775|451426349|FG001|Treatment Period|participant request to discontinue treatment|2|||
125303390|NCT01748825|450736753|FG000|Dose Escalation|Switched to alternative treatment|0|||
125489776|NCT04623775|451426350|FG002|Treatment Period|participant request to discontinue treatment|2|||
125489777|NCT04623775|451426351|FG003|Treatment Period|participant request to discontinue treatment|0|||
125489778|NCT00964392|451426352|FG000|Overall Study|Withdrawal by Subject|4|||
125489779|NCT00964392|451426353|FG001|Overall Study|Withdrawal by Subject|6|||
125489780|NCT00964392|451426352|FG000|Overall Study|Lost to Follow-up|4|||
125489781|NCT00964392|451426353|FG001|Overall Study|Lost to Follow-up|10|||
125489782|NCT00964392|451426352|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
125489783|NCT00964392|451426353|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
125489784|NCT00964392|451426352|FG000|Overall Study|Not completed|44|||
125489785|NCT00964392|451426353|FG001|Overall Study|Not completed|168|||
125489786|NCT03652272|451426360|FG000|3 Month|Withdrawal by Subject|1|||
125489787|NCT03652272|451426361|FG001|3 Month|Withdrawal by Subject|1|||
125489788|NCT03652272|451426360|FG000|3 Month|Lost to Follow-up|16|||
125489789|NCT03652272|451426361|FG001|3 Month|Lost to Follow-up|14|||
125489790|NCT04173247|451426362|FG000|Overall Study|Withdrawal by Subject|0|||
125489791|NCT04173247|451426363|FG001|Overall Study|Withdrawal by Subject|2|||
125489792|NCT04173247|451426362|FG000|Overall Study|Death|1|||
125489793|NCT04173247|451426363|FG001|Overall Study|Death|0|||
125489794|NCT04173247|451426362|FG000|Overall Study|Physician Decision|1|||
125489795|NCT04173247|451426363|FG001|Overall Study|Physician Decision|0|||
125489796|NCT04214834|451426366|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
125489797|NCT04214834|451426367|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
125489798|NCT03884101|451426374|FG000|Overall Study|Participant Ongoing in Study|202|||
125489799|NCT03884101|451426375|FG001|Overall Study|Participant Ongoing in Study|186|||
125489800|NCT03884101|451426374|FG000|Overall Study|Death|212|||
125489801|NCT03884101|451426375|FG001|Overall Study|Death|224|||
125489802|NCT03884101|451426374|FG000|Overall Study|Lost to Follow-up|0|||
125489803|NCT03884101|451426375|FG001|Overall Study|Lost to Follow-up|1|||
125489804|NCT03884101|451426374|FG000|Overall Study|Withdrawal by Subject|6|||
125489805|NCT03884101|451426375|FG001|Overall Study|Withdrawal by Subject|11|||
125489806|NCT03370913|451426376|FG000|Overall Study|Death|1|||
125489807|NCT03370913|451426376|FG000|Overall Study|Lost to Follow-up|1|||
125489808|NCT03248479|451426386|FG000|Overall Study|Death|12|||
125489809|NCT03248479|451426387|FG001|Overall Study|Death|44|||
125489810|NCT03248479|451426388|FG002|Overall Study|Death|1|||
125489811|NCT03248479|451426389|FG003|Overall Study|Death|72|||
125489812|NCT03248479|451426390|FG004|Overall Study|Death|17|||
125489813|NCT03248479|451426391|FG005|Overall Study|Death|6|||
125489814|NCT03248479|451426392|FG006|Overall Study|Death|1|||
125489815|NCT03248479|451426393|FG007|Overall Study|Death|14|||
125489816|NCT03248479|451426394|FG008|Overall Study|Death|3|||
125489817|NCT03248479|451426395|FG009|Overall Study|Death|7|||
125489818|NCT03248479|451426396|FG010|Overall Study|Death|3|||
125489819|NCT03248479|451426397|FG011|Overall Study|Death|1|||
125489820|NCT03248479|451426398|FG012|Overall Study|Death|1|||
125489821|NCT03248479|451426386|FG000|Overall Study|Study terminated by sponsor|12|||
125489822|NCT03248479|451426387|FG001|Overall Study|Study terminated by sponsor|15|||
125489823|NCT03248479|451426388|FG002|Overall Study|Study terminated by sponsor|0|||
125489824|NCT03248479|451426389|FG003|Overall Study|Study terminated by sponsor|5|||
125489825|NCT03248479|451426390|FG004|Overall Study|Study terminated by sponsor|0|||
125489826|NCT03248479|451426391|FG005|Overall Study|Study terminated by sponsor|0|||
125489827|NCT03248479|451426392|FG006|Overall Study|Study terminated by sponsor|0|||
125489828|NCT03248479|451426393|FG007|Overall Study|Study terminated by sponsor|1|||
125489829|NCT03248479|451426394|FG008|Overall Study|Study terminated by sponsor|1|||
125489830|NCT03248479|451426395|FG009|Overall Study|Study terminated by sponsor|0|||
125489831|NCT03248479|451426396|FG010|Overall Study|Study terminated by sponsor|5|||
125489832|NCT03248479|451426397|FG011|Overall Study|Study terminated by sponsor|4|||
125489833|NCT03248479|451426398|FG012|Overall Study|Study terminated by sponsor|0|||
125489834|NCT03248479|451426386|FG000|Overall Study|Consent withdrawn|6|||
125489835|NCT03248479|451426387|FG001|Overall Study|Consent withdrawn|3|||
125489836|NCT03248479|451426388|FG002|Overall Study|Consent withdrawn|0|||
125489837|NCT03248479|451426389|FG003|Overall Study|Consent withdrawn|9|||
125489838|NCT03248479|451426390|FG004|Overall Study|Consent withdrawn|1|||
125489839|NCT03248479|451426391|FG005|Overall Study|Consent withdrawn|0|||
125489840|NCT03248479|451426392|FG006|Overall Study|Consent withdrawn|0|||
125489841|NCT03248479|451426393|FG007|Overall Study|Consent withdrawn|1|||
125489842|NCT03248479|451426394|FG008|Overall Study|Consent withdrawn|0|||
125489843|NCT03248479|451426395|FG009|Overall Study|Consent withdrawn|3|||
125489844|NCT03248479|451426396|FG010|Overall Study|Consent withdrawn|1|||
125489845|NCT03248479|451426397|FG011|Overall Study|Consent withdrawn|0|||
125489846|NCT03248479|451426398|FG012|Overall Study|Consent withdrawn|1|||
125489847|NCT03248479|451426386|FG000|Overall Study|Lost to Follow-up|2|||
125489848|NCT03248479|451426387|FG001|Overall Study|Lost to Follow-up|1|||
125489849|NCT03248479|451426388|FG002|Overall Study|Lost to Follow-up|0|||
125489850|NCT03248479|451426389|FG003|Overall Study|Lost to Follow-up|0|||
125489851|NCT03248479|451426390|FG004|Overall Study|Lost to Follow-up|0|||
125489852|NCT03248479|451426391|FG005|Overall Study|Lost to Follow-up|0|||
125303391|NCT01748825|450736754|FG001|Dose Escalation|Switched to alternative treatment|0|||
125489853|NCT03248479|451426392|FG006|Overall Study|Lost to Follow-up|0|||
125489854|NCT03248479|451426393|FG007|Overall Study|Lost to Follow-up|0|||
125489855|NCT03248479|451426394|FG008|Overall Study|Lost to Follow-up|0|||
125489856|NCT03248479|451426395|FG009|Overall Study|Lost to Follow-up|0|||
125489857|NCT03248479|451426396|FG010|Overall Study|Lost to Follow-up|0|||
125489858|NCT03248479|451426397|FG011|Overall Study|Lost to Follow-up|0|||
125489859|NCT03248479|451426398|FG012|Overall Study|Lost to Follow-up|1|||
125489860|NCT03248479|451426386|FG000|Overall Study|Not reported|0|||
125489861|NCT03248479|451426387|FG001|Overall Study|Not reported|0|||
125489862|NCT03248479|451426388|FG002|Overall Study|Not reported|0|||
125489863|NCT03248479|451426389|FG003|Overall Study|Not reported|1|||
125489864|NCT03248479|451426390|FG004|Overall Study|Not reported|1|||
125489865|NCT03248479|451426391|FG005|Overall Study|Not reported|0|||
125489866|NCT03248479|451426392|FG006|Overall Study|Not reported|0|||
125489867|NCT03248479|451426393|FG007|Overall Study|Not reported|1|||
125489868|NCT03248479|451426394|FG008|Overall Study|Not reported|1|||
125489869|NCT03248479|451426395|FG009|Overall Study|Not reported|0|||
125489870|NCT03248479|451426396|FG010|Overall Study|Not reported|0|||
125489871|NCT03248479|451426397|FG011|Overall Study|Not reported|0|||
125489872|NCT03248479|451426398|FG012|Overall Study|Not reported|0|||
125489873|NCT04679389|451426399|FG000|Overall Study|Adverse Event|1|||
125489874|NCT04679389|451426400|FG001|Overall Study|Adverse Event|0|||
125489875|NCT04679389|451426399|FG000|Overall Study|Protocol Violation|2|||
125489876|NCT04679389|451426400|FG001|Overall Study|Protocol Violation|0|||
125489877|NCT04679389|451426399|FG000|Overall Study|Physician Decision|3|||
125489878|NCT04679389|451426400|FG001|Overall Study|Physician Decision|5|||
125489879|NCT04679389|451426399|FG000|Overall Study|Withdrawal by Subject|5|||
125489880|NCT04679389|451426400|FG001|Overall Study|Withdrawal by Subject|7|||
125489881|NCT05112900|451426401|FG000|Overall Study|Withdrawal by Subject|960|||
125489882|NCT05112900|451426402|FG001|Overall Study|Withdrawal by Subject|921|||
125489883|NCT05112900|451426403|FG002|Overall Study|Withdrawal by Subject|968|||
125489884|NCT05541484|451426404|FG000|Overall Study|Withdrawal by Subject|1|||
125489885|NCT05541484|451426405|FG001|Overall Study|Withdrawal by Subject|0|||
125489886|NCT03279978|451426408|FG000|Overall Study|Withdrawal by Subject|0|||
125489887|NCT03279978|451426409|FG001|Overall Study|Withdrawal by Subject|1|||
125489888|NCT03279978|451426410|FG002|Overall Study|Withdrawal by Subject|0|||
125489889|NCT03279978|451426411|FG003|Overall Study|Withdrawal by Subject|0|||
125489890|NCT03279978|451426412|FG004|Overall Study|Withdrawal by Subject|0|||
125489891|NCT03279978|451426413|FG005|Overall Study|Withdrawal by Subject|0|||
125489892|NCT03279978|451426414|FG006|Overall Study|Withdrawal by Subject|0|||
125489893|NCT03279978|451426415|FG007|Overall Study|Withdrawal by Subject|0|||
125489894|NCT03279978|451426416|FG008|Overall Study|Withdrawal by Subject|0|||
125489895|NCT03279978|451426417|FG009|Overall Study|Withdrawal by Subject|1|||
125489896|NCT03279978|451426408|FG000|Overall Study|Lost to Follow-up|1|||
125489897|NCT03279978|451426409|FG001|Overall Study|Lost to Follow-up|0|||
125489898|NCT03279978|451426410|FG002|Overall Study|Lost to Follow-up|1|||
125489899|NCT03279978|451426411|FG003|Overall Study|Lost to Follow-up|0|||
125489900|NCT03279978|451426412|FG004|Overall Study|Lost to Follow-up|0|||
125489901|NCT03279978|451426413|FG005|Overall Study|Lost to Follow-up|0|||
125489902|NCT03279978|451426414|FG006|Overall Study|Lost to Follow-up|0|||
125489903|NCT03279978|451426415|FG007|Overall Study|Lost to Follow-up|0|||
125489904|NCT03279978|451426416|FG008|Overall Study|Lost to Follow-up|0|||
125489905|NCT03279978|451426417|FG009|Overall Study|Lost to Follow-up|0|||
125489906|NCT03279978|451426408|FG000|Overall Study|Other than stated above|0|||
125489907|NCT03279978|451426409|FG001|Overall Study|Other than stated above|0|||
125489908|NCT03279978|451426410|FG002|Overall Study|Other than stated above|0|||
125489909|NCT03279978|451426411|FG003|Overall Study|Other than stated above|0|||
125489910|NCT03279978|451426412|FG004|Overall Study|Other than stated above|0|||
125489911|NCT03279978|451426413|FG005|Overall Study|Other than stated above|0|||
125489912|NCT03279978|451426414|FG006|Overall Study|Other than stated above|1|||
125489913|NCT03279978|451426415|FG007|Overall Study|Other than stated above|0|||
125489914|NCT03279978|451426416|FG008|Overall Study|Other than stated above|0|||
125489915|NCT03279978|451426417|FG009|Overall Study|Other than stated above|0|||
125489916|NCT05525104|451426418|FG000|Overall Study|Failed caudal analgesia|1|||
125303392|NCT01748825|450736755|FG002|Dose Escalation|Switched to alternative treatment|0|||
125489917|NCT05525104|451426419|FG001|Overall Study|Failed caudal analgesia|3|||
125489918|NCT05525104|451426418|FG000|Overall Study|Premedication needed|0|||
125489919|NCT05525104|451426419|FG001|Overall Study|Premedication needed|1|||
125489920|NCT05525104|451426418|FG000|Overall Study|Protocol Violation|10|||
125489921|NCT05525104|451426419|FG001|Overall Study|Protocol Violation|0|||
125489922|NCT05525104|451426418|FG000|Overall Study|Cancelled operation|1|||
125489923|NCT05525104|451426419|FG001|Overall Study|Cancelled operation|0|||
125489924|NCT03636490|451427642|FG000|Overall Study|Dropped out or incomplete data|141|||
125303393|NCT01748825|450736756|FG003|Dose Escalation|Switched to alternative treatment|1|||
125489925|NCT04464564|451427645|FG000|Period A (Placebo lead-in)|Other|5|||
125489926|NCT04464564|451427646|FG001|Period A (Placebo lead-in)|Other|0|||
125489927|NCT04464564|451427647|FG002|Period A (Placebo lead-in)|Other|0|||
125489928|NCT04464564|451427648|FG003|Period A (Placebo lead-in)|Other|0|||
125489929|NCT04464564|451427645|FG000|Period B (Randomization Period)|Adverse Event|0|||
125489930|NCT04464564|451427646|FG001|Period B (Randomization Period)|Adverse Event|1|||
125489931|NCT04464564|451427647|FG002|Period B (Randomization Period)|Adverse Event|2|||
125489932|NCT04464564|451427648|FG003|Period B (Randomization Period)|Adverse Event|8|||
125489933|NCT04464564|451427645|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
125489934|NCT04464564|451427646|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
125489935|NCT04464564|451427647|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
125489936|NCT04464564|451427648|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
125489937|NCT04464564|451427645|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
125489938|NCT04464564|451427646|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
125489939|NCT04464564|451427647|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
125489940|NCT04464564|451427648|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
125489941|NCT04464564|451427645|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
125489942|NCT04464564|451427646|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
125489943|NCT04464564|451427647|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
125489944|NCT04464564|451427648|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
125489945|NCT04464564|451427645|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
125489946|NCT04464564|451427646|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
125489947|NCT04464564|451427647|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
125489948|NCT04464564|451427648|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
125489949|NCT04464564|451427645|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
125489950|NCT04464564|451427646|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
125489951|NCT04464564|451427647|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
125489952|NCT04464564|451427648|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
125489953|NCT04464564|451427645|FG000|Period B (Randomization Period)|Reason not Specified|0|||
125489954|NCT04464564|451427646|FG001|Period B (Randomization Period)|Reason not Specified|3|||
125489955|NCT04464564|451427647|FG002|Period B (Randomization Period)|Reason not Specified|3|||
125489956|NCT04464564|451427648|FG003|Period B (Randomization Period)|Reason not Specified|3|||
125489957|NCT02095691|451427655|FG000|Overall Study|Physician Decision|1|||
125489958|NCT03498521|451427656|FG000|Overall Study|Death|191|||
125489959|NCT03498521|451427657|FG001|Overall Study|Death|64|||
125489960|NCT03498521|451427658|FG002|Overall Study|Death|72|||
125489961|NCT03498521|451427656|FG000|Overall Study|Exclusion criteria|1|||
125489962|NCT03498521|451427657|FG001|Overall Study|Exclusion criteria|0|||
125489963|NCT03498521|451427658|FG002|Overall Study|Exclusion criteria|0|||
125489964|NCT03498521|451427656|FG000|Overall Study|Lost to Follow-up|3|||
125489965|NCT03498521|451427657|FG001|Overall Study|Lost to Follow-up|3|||
125489966|NCT03498521|451427658|FG002|Overall Study|Lost to Follow-up|3|||
125489967|NCT03498521|451427656|FG000|Overall Study|No profile due to technical failure|1|||
125489968|NCT03498521|451427657|FG001|Overall Study|No profile due to technical failure|0|||
125489969|NCT03498521|451427658|FG002|Overall Study|No profile due to technical failure|0|||
125489970|NCT03498521|451427656|FG000|Overall Study|Physician Decision|0|||
125489971|NCT03498521|451427657|FG001|Overall Study|Physician Decision|1|||
125489972|NCT03498521|451427658|FG002|Overall Study|Physician Decision|0|||
125489973|NCT03498521|451427656|FG000|Overall Study|Withdrawal by Subject|9|||
125489974|NCT03498521|451427657|FG001|Overall Study|Withdrawal by Subject|6|||
125489975|NCT03498521|451427658|FG002|Overall Study|Withdrawal by Subject|2|||
125489976|NCT03498521|451427656|FG000|Overall Study|Study ongoing|121|||
125489977|NCT03498521|451427657|FG001|Overall Study|Study ongoing|36|||
125489978|NCT03498521|451427658|FG002|Overall Study|Study ongoing|15|||
125489979|NCT02163694|451427660|FG000|Overall Study|Adverse event- related to progression|4|||
125489980|NCT02163694|451427661|FG001|Overall Study|Adverse event- related to progression|10|||
125489981|NCT02163694|451427660|FG000|Overall Study|Adverse event- not related to progression|7|||
125489982|NCT02163694|451427661|FG001|Overall Study|Adverse event- not related to progression|22|||
125489983|NCT02163694|451427660|FG000|Overall Study|Withdrew consent|13|||
125489984|NCT02163694|451427661|FG001|Overall Study|Withdrew consent|28|||
125489985|NCT02163694|451427660|FG000|Overall Study|Lost to Follow-up|2|||
125489986|NCT02163694|451427661|FG001|Overall Study|Lost to Follow-up|2|||
125489987|NCT02163694|451427660|FG000|Overall Study|Sponsor discontinued study|3|||
125489988|NCT02163694|451427661|FG001|Overall Study|Sponsor discontinued study|29|||
125489989|NCT02163694|451427660|FG000|Overall Study|Progressive disease per protocol|125|||
125489990|NCT02163694|451427661|FG001|Overall Study|Progressive disease per protocol|224|||
125489991|NCT02163694|451427660|FG000|Overall Study|Other, not specified|17|||
125489992|NCT02163694|451427661|FG001|Overall Study|Other, not specified|22|||
125489993|NCT02163694|451427660|FG000|Overall Study|Randomized but Not Treated|1|||
125489994|NCT02163694|451427661|FG001|Overall Study|Randomized but Not Treated|0|||
125489995|NCT02163694|451427660|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
125489996|NCT02163694|451427661|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
125303394|NCT01748825|450736757|FG004|Dose Escalation|Switched to alternative treatment|0|||
125489997|NCT04633538|451427662|FG000|Overall Study|Death|1|||
125489998|NCT04633538|451427662|FG000|Overall Study|Lost to Follow-up|3|||
125489999|NCT04633538|451427662|FG000|Overall Study|Withdrawal by Subject|1|||
125490000|NCT02938520|451427665|FG000|Overall Study|On-going at the time of analysis|258|||
125490001|NCT02938520|451427666|FG001|Overall Study|On-going at the time of analysis|261|||
125490002|NCT02938520|451427665|FG000|Overall Study|Physician Decision|2|||
125490003|NCT02938520|451427666|FG001|Overall Study|Physician Decision|5|||
125490004|NCT02938520|451427665|FG000|Overall Study|Lost to Follow-up|2|||
125490005|NCT02938520|451427666|FG001|Overall Study|Lost to Follow-up|2|||
125490006|NCT02938520|451427665|FG000|Overall Study|Withdrawal by Subject|7|||
125490007|NCT02938520|451427666|FG001|Overall Study|Withdrawal by Subject|7|||
125490008|NCT02938520|451427665|FG000|Overall Study|Protocol Violation|0|||
125490009|NCT02938520|451427666|FG001|Overall Study|Protocol Violation|1|||
125490010|NCT02938520|451427665|FG000|Overall Study|Lack of Efficacy|5|||
125490011|NCT02938520|451427666|FG001|Overall Study|Lack of Efficacy|3|||
125490012|NCT02938520|451427665|FG000|Overall Study|Adverse Event|9|||
125490013|NCT02938520|451427666|FG001|Overall Study|Adverse Event|4|||
125490014|NCT03372057|451427669|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
125490015|NCT03372057|451427670|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
125490016|NCT03372057|451427671|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
125490017|NCT03372057|451427669|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
125490018|NCT03372057|451427670|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
125490019|NCT03372057|451427671|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
125490020|NCT03372057|451427669|FG000|Dose Optimization Phase|Death|16|||
125490021|NCT03372057|451427670|FG001|Dose Optimization Phase|Death|11|||
125490022|NCT03372057|451427671|FG002|Dose Optimization Phase|Death|0|||
125490023|NCT03372057|451427669|FG000|Expansion Phase|Withdrawal by Subject|0|||
125490024|NCT03372057|451427670|FG001|Expansion Phase|Withdrawal by Subject|0|||
125490025|NCT03372057|451427671|FG002|Expansion Phase|Withdrawal by Subject|4|||
125490026|NCT03372057|451427669|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
125490027|NCT03372057|451427670|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
125490028|NCT03372057|451427671|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
125490029|NCT03372057|451427669|FG000|Expansion Phase|Death|0|||
125490030|NCT03372057|451427670|FG001|Expansion Phase|Death|0|||
125490031|NCT03372057|451427671|FG002|Expansion Phase|Death|78|||
125490032|NCT03372057|451427669|FG000|Expansion Phase|Progressive Disease|0|||
125490033|NCT03372057|451427670|FG001|Expansion Phase|Progressive Disease|0|||
125490034|NCT03372057|451427671|FG002|Expansion Phase|Progressive Disease|1|||
125490035|NCT03372057|451427669|FG000|Expansion Phase|Adverse Event|0|||
125490036|NCT03372057|451427670|FG001|Expansion Phase|Adverse Event|0|||
125490037|NCT03372057|451427671|FG002|Expansion Phase|Adverse Event|1|||
125490038|NCT05953740|451427672|FG000|Period 1|Physician Decision|0|||
125490039|NCT05953740|451427673|FG001|Period 1|Physician Decision|1|||
125490040|NCT05953740|451427674|FG002|Period 1|Physician Decision|0|||
125490041|NCT05953740|451427675|FG003|Period 1|Physician Decision|0|||
125490042|NCT05953740|451427676|FG004|Period 1|Physician Decision|0|||
125490043|NCT05953740|451427677|FG005|Period 1|Physician Decision|0|||
125490044|NCT05953740|451427678|FG006|Period 1|Physician Decision|0|||
125490045|NCT05953740|451427679|FG007|Period 1|Physician Decision|0|||
125490046|NCT05953740|451427672|FG000|Period 2|Withdrawal by Subject|0|||
125490047|NCT05953740|451427673|FG001|Period 2|Withdrawal by Subject|1|||
125490048|NCT05953740|451427674|FG002|Period 2|Withdrawal by Subject|1|||
125490049|NCT05953740|451427675|FG003|Period 2|Withdrawal by Subject|0|||
125490050|NCT05953740|451427676|FG004|Period 2|Withdrawal by Subject|0|||
125490051|NCT05953740|451427677|FG005|Period 2|Withdrawal by Subject|0|||
125490052|NCT05953740|451427678|FG006|Period 2|Withdrawal by Subject|0|||
125490053|NCT05953740|451427679|FG007|Period 2|Withdrawal by Subject|0|||
125490054|NCT03880955|451427680|FG000|Overall Study|Adverse Event|1|||
125490055|NCT03880955|451427680|FG000|Overall Study|Death|1|||
125490056|NCT03880955|451427680|FG000|Overall Study|Lost to Follow-up|12|||
125490057|NCT03880955|451427680|FG000|Overall Study|Withdrawal by Subject|4|||
125490058|NCT03880955|451427680|FG000|Overall Study|Missing- Study Site Closed|27|||
125490059|NCT01438853|451427708|FG000|Overall Study|Death|0|||
125490060|NCT01438853|451427709|FG001|Overall Study|Death|0|||
125490061|NCT01438853|451427710|FG002|Overall Study|Death|0|||
125490062|NCT01438853|451427711|FG003|Overall Study|Death|1|||
125490063|NCT01438853|451427708|FG000|Overall Study|Withdrawal by Subject|0|||
125309880|NCT00947115|450760201|FG002|Overall Study|Lost to Follow-up|8|||
125490064|NCT01438853|451427709|FG001|Overall Study|Withdrawal by Subject|0|||
125490065|NCT01438853|451427710|FG002|Overall Study|Withdrawal by Subject|1|||
125490066|NCT01438853|451427711|FG003|Overall Study|Withdrawal by Subject|0|||
125490067|NCT02624050|451427712|FG000|Overall Study|Physician Decision|4|||
125490068|NCT02624050|451427713|FG001|Overall Study|Physician Decision|0|||
125490069|NCT02624050|451427712|FG000|Overall Study|Protocol Violation|2|||
125490070|NCT02624050|451427713|FG001|Overall Study|Protocol Violation|0|||
125490071|NCT05215054|451427714|FG000|Overall Study|Lost to Follow-up|1|||
125490072|NCT05215054|451427715|FG001|Overall Study|Lost to Follow-up|1|||
125490073|NCT05215054|451427714|FG000|Overall Study|Protocol Violation|1|||
125490074|NCT05215054|451427715|FG001|Overall Study|Protocol Violation|1|||
125490075|NCT05215054|451427714|FG000|Overall Study|Withdrawal by Subject|4|||
125490076|NCT05215054|451427715|FG001|Overall Study|Withdrawal by Subject|4|||
125490077|NCT04330040|451427719|FG000|Overall Study|Other: Adverse event|5|||
125490078|NCT04330040|451427720|FG001|Overall Study|Other: Adverse event|0|||
125490079|NCT04330040|451427721|FG002|Overall Study|Other: Adverse event|0|||
125490080|NCT04330040|451427719|FG000|Overall Study|Disease progression|38|||
125490081|NCT04330040|451427720|FG001|Overall Study|Disease progression|10|||
125490082|NCT04330040|451427721|FG002|Overall Study|Disease progression|0|||
125490083|NCT04330040|451427719|FG000|Overall Study|Physician Decision|5|||
125490084|NCT04330040|451427720|FG001|Overall Study|Physician Decision|3|||
125490085|NCT04330040|451427721|FG002|Overall Study|Physician Decision|0|||
125490086|NCT04330040|451427719|FG000|Overall Study|Lost to Follow-up|1|||
125490087|NCT04330040|451427720|FG001|Overall Study|Lost to Follow-up|1|||
125490088|NCT04330040|451427721|FG002|Overall Study|Lost to Follow-up|0|||
125490089|NCT04330040|451427719|FG000|Overall Study|Death|2|||
125490090|NCT04330040|451427720|FG001|Overall Study|Death|1|||
125490091|NCT04330040|451427721|FG002|Overall Study|Death|0|||
125490092|NCT04330040|451427719|FG000|Overall Study|Withdrawal by Subject|3|||
125490093|NCT04330040|451427720|FG001|Overall Study|Withdrawal by Subject|3|||
125490094|NCT04330040|451427721|FG002|Overall Study|Withdrawal by Subject|0|||
125490095|NCT04330040|451427719|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
125490096|NCT04330040|451427720|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
125490097|NCT04330040|451427721|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
125490098|NCT04330040|451427719|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
125490099|NCT04330040|451427720|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
125490100|NCT04330040|451427721|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
125490101|NCT04330040|451427719|FG000|Overall Study|Other: Disease progression|1|||
125490102|NCT04330040|451427720|FG001|Overall Study|Other: Disease progression|0|||
125490103|NCT04330040|451427721|FG002|Overall Study|Other: Disease progression|0|||
125490104|NCT04330040|451427719|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
125490105|NCT04330040|451427720|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
125490106|NCT04330040|451427721|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
125490107|NCT04330040|451427719|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
125490108|NCT04330040|451427720|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
125490109|NCT04330040|451427721|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
125490110|NCT04330040|451427719|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
125490111|NCT04330040|451427720|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
125490112|NCT04330040|451427721|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
125490113|NCT00626795|451427724|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
125490114|NCT00626795|451427725|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
125490115|NCT00626795|451427726|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
125490116|NCT00626795|451427724|FG000|Blinded Treatment|Lack of Efficacy|2|||
125490117|NCT00626795|451427725|FG001|Blinded Treatment|Lack of Efficacy|0|||
125490118|NCT00626795|451427726|FG002|Blinded Treatment|Lack of Efficacy|0|||
125490119|NCT00626795|451427724|FG000|Blinded Treatment|Unacceptable adverse event|0|||
125490120|NCT00626795|451427725|FG001|Blinded Treatment|Unacceptable adverse event|0|||
125490121|NCT00626795|451427726|FG002|Blinded Treatment|Unacceptable adverse event|1|||
125490122|NCT00626795|451427724|FG000|Blinded Treatment|Protocol Violation|0|||
125490123|NCT00626795|451427725|FG001|Blinded Treatment|Protocol Violation|1|||
125490124|NCT00626795|451427726|FG002|Blinded Treatment|Protocol Violation|1|||
125490125|NCT00626795|451427724|FG000|Blinded Treatment|Withdrawal by Subject|1|||
125490126|NCT00626795|451427725|FG001|Blinded Treatment|Withdrawal by Subject|1|||
125490127|NCT00626795|451427726|FG002|Blinded Treatment|Withdrawal by Subject|0|||
125490128|NCT00626795|451427724|FG000|Blinded Treatment|Other reasons|2|||
125490129|NCT00626795|451427725|FG001|Blinded Treatment|Other reasons|0|||
125490130|NCT00626795|451427726|FG002|Blinded Treatment|Other reasons|2|||
125490131|NCT00626795|451427724|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
125490132|NCT00626795|451427725|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
125490133|NCT00626795|451427726|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
125490134|NCT04159519|451427727|FG000|Overall Study|Adverse Event|1|||
125490135|NCT04159519|451427728|FG001|Overall Study|Adverse Event|1|||
125490136|NCT04159519|451427727|FG000|Overall Study|Lack of Efficacy|1|||
125490137|NCT04159519|451427728|FG001|Overall Study|Lack of Efficacy|0|||
125490138|NCT04159519|451427727|FG000|Overall Study|Discontinued from study|1|||
125490139|NCT04159519|451427728|FG001|Overall Study|Discontinued from study|0|||
125490140|NCT04159519|451427727|FG000|Overall Study|Protocol Violation|1|||
125490141|NCT04159519|451427728|FG001|Overall Study|Protocol Violation|1|||
125490142|NCT04159519|451427727|FG000|Overall Study|Withdrawal by Subject|4|||
125490143|NCT04159519|451427728|FG001|Overall Study|Withdrawal by Subject|4|||
125490144|NCT02246127|451428501|FG000|First Course Treatment|Adverse Event|9|||
125490145|NCT02246127|451428502|FG001|First Course Treatment|Adverse Event|7|||
125490146|NCT02246127|451428501|FG000|First Course Treatment|Withdrawal by Subject|6|||
125490147|NCT02246127|451428502|FG001|First Course Treatment|Withdrawal by Subject|7|||
125490148|NCT02246127|451428501|FG000|First Course Treatment|Physician Decision|9|||
125490149|NCT02246127|451428502|FG001|First Course Treatment|Physician Decision|9|||
125490150|NCT02246127|451428501|FG000|First Course Treatment|Death|3|||
125490151|NCT02246127|451428502|FG001|First Course Treatment|Death|3|||
125490152|NCT02246127|451428501|FG000|First Course Treatment|Not reported reasons|6|||
125490153|NCT02246127|451428502|FG001|First Course Treatment|Not reported reasons|7|||
125490154|NCT02246127|451428501|FG000|First Course Treatment|Not treated|3|||
125490155|NCT02246127|451428502|FG001|First Course Treatment|Not treated|3|||
125490156|NCT05311176|451428505|FG000|Overall Study|Death|6|||
125490157|NCT05311176|451428505|FG000|Overall Study|Sponsor discontinued the study|1|||
125490158|NCT01880515|451428506|FG000|Overall Study|Lost to Follow-up|3|||
125490159|NCT01880515|451428507|FG001|Overall Study|Lost to Follow-up|2|||
125490160|NCT01880515|451428506|FG000|Overall Study|Disease Progression|5|||
125490161|NCT01880515|451428507|FG001|Overall Study|Disease Progression|7|||
125490162|NCT06262347|451428518|FG000|Overall Study|Lost to Follow-up|4|||
125490163|NCT06262347|451428519|FG001|Overall Study|Lost to Follow-up|3|||
125490164|NCT06262347|451428518|FG000|Overall Study|Withdrawal by Subject|0|||
125490165|NCT06262347|451428519|FG001|Overall Study|Withdrawal by Subject|1|||
125490166|NCT05830799|451428526|FG000|Overall Study|Withdrawal by Subject|1|||
125490167|NCT04560179|451428531|FG000|Overall Study|Physician Decision|1|||
125490168|NCT04560179|451428532|FG001|Overall Study|Physician Decision|0|||
125490169|NCT04560179|451428533|FG002|Overall Study|Physician Decision|0|||
125490170|NCT04560179|451428534|FG003|Overall Study|Physician Decision|0|||
125490171|NCT04560179|451428535|FG004|Overall Study|Physician Decision|0|||
125490172|NCT04560179|451428531|FG000|Overall Study|Adverse Event|0|||
125490173|NCT04560179|451428532|FG001|Overall Study|Adverse Event|0|||
125490174|NCT04560179|451428533|FG002|Overall Study|Adverse Event|0|||
125490175|NCT04560179|451428534|FG003|Overall Study|Adverse Event|1|||
125490176|NCT04560179|451428535|FG004|Overall Study|Adverse Event|0|||
125490177|NCT04631016|451428538|FG000|Overall Study|Adverse Event|3|||
125490178|NCT04631016|451428539|FG001|Overall Study|Adverse Event|0|||
125490179|NCT04631016|451428538|FG000|Overall Study|Withdrawal by Subject|5|||
125490180|NCT04631016|451428539|FG001|Overall Study|Withdrawal by Subject|4|||
125490181|NCT04631016|451428538|FG000|Overall Study|Reason unspecified|1|||
125490182|NCT04631016|451428539|FG001|Overall Study|Reason unspecified|0|||
125490183|NCT04631016|451428538|FG000|Overall Study|Failure to meet randomization criteria|2|||
125490184|NCT04631016|451428539|FG001|Overall Study|Failure to meet randomization criteria|1|||
125490185|NCT06010836|451428540|FG000|Overall Study|Lost to Follow-up|2|||
125490186|NCT06010836|451428541|FG001|Overall Study|Lost to Follow-up|2|||
125490187|NCT06010836|451428540|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
125490188|NCT06010836|451428541|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
125490189|NCT06010836|451428540|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
125490190|NCT06010836|451428541|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
125490191|NCT06010836|451428540|FG000|Overall Study|Did not receive intervention discussion|0|||
125490192|NCT06010836|451428541|FG001|Overall Study|Did not receive intervention discussion|4|||
125490193|NCT04496752|451428542|FG000|Second Assessment|Lost to Follow-up|3|||
125490194|NCT04496752|451428543|FG001|Second Assessment|Lost to Follow-up|3|||
125490195|NCT04496752|451428542|FG000|Second Assessment|Adverse Event|2|||
125490196|NCT04496752|451428543|FG001|Second Assessment|Adverse Event|0|||
125490197|NCT04524689|451428546|FG000|Overall Study|Withdrawal by Subject|1|||
125490198|NCT04524689|451428547|FG001|Overall Study|Withdrawal by Subject|1|||
125490199|NCT04524689|451428548|FG002|Overall Study|Withdrawal by Subject|0|||
125490200|NCT04524689|451428549|FG003|Overall Study|Withdrawal by Subject|0|||
125490201|NCT04524689|451428550|FG004|Overall Study|Withdrawal by Subject|1|||
125490202|NCT04524689|451428551|FG005|Overall Study|Withdrawal by Subject|0|||
125490203|NCT04524689|451428546|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
125490204|NCT04524689|451428547|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
125490205|NCT04524689|451428548|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
125490206|NCT04524689|451428549|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
125490207|NCT04524689|451428550|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
125490208|NCT04524689|451428551|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
125490209|NCT04524689|451428546|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
125490210|NCT04524689|451428547|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
125490211|NCT04524689|451428548|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
125490212|NCT04524689|451428549|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
125490213|NCT04524689|451428550|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
125490214|NCT04524689|451428551|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
125490215|NCT04967599|451428552|FG000|Overall Study|Lost to Follow-up|35|||
125490216|NCT04967599|451428553|FG001|Overall Study|Lost to Follow-up|19|||
125490217|NCT04967599|451428554|FG002|Overall Study|Lost to Follow-up|23|||
125490218|NCT04369911|451428555|FG000|Overall Study|Lost to Follow-up|3|||
125490219|NCT04369911|451428556|FG001|Overall Study|Lost to Follow-up|3|||
125490220|NCT04369911|451428555|FG000|Overall Study|Withdrawal by Subject|1|||
125303395|NCT01748825|450736758|FG005|Dose Escalation|Switched to alternative treatment|0|||
125490221|NCT04369911|451428556|FG001|Overall Study|Withdrawal by Subject|2|||
125490222|NCT05451693|451428557|FG000|Overall Study|Withdrawal by Subject|1|||
125490223|NCT05451693|451428558|FG001|Overall Study|Withdrawal by Subject|1|||
125490224|NCT03662022|451428559|FG000|Year 1 2019|prevalent case|83|||
125490225|NCT03662022|451428560|FG001|Year 1 2019|prevalent case|116|||
125490226|NCT03662022|451428561|FG002|Year 1 2019|prevalent case|158|||
125490227|NCT03662022|451428562|FG003|Year 1 2019|prevalent case|99|||
125490228|NCT03662022|451428559|FG000|Year 2 2020|incident case|18|||
125490229|NCT03662022|451428560|FG001|Year 2 2020|incident case|18|||
125490230|NCT03662022|451428561|FG002|Year 2 2020|incident case|16|||
125490231|NCT03662022|451428562|FG003|Year 2 2020|incident case|26|||
125490232|NCT03662022|451428559|FG000|Year 2 2020|other case|18|||
125490233|NCT03662022|451428560|FG001|Year 2 2020|other case|16|||
125490234|NCT03662022|451428561|FG002|Year 2 2020|other case|16|||
125490235|NCT03662022|451428562|FG003|Year 2 2020|other case|24|||
125490236|NCT03662022|451428559|FG000|Year 2 2020|Lost to Follow-up|1633|||
125490237|NCT03662022|451428560|FG001|Year 2 2020|Lost to Follow-up|1183|||
125490238|NCT03662022|451428561|FG002|Year 2 2020|Lost to Follow-up|1381|||
125490239|NCT03662022|451428562|FG003|Year 2 2020|Lost to Follow-up|2858|||
125490240|NCT03662022|451428559|FG000|Year 3 2021|incident case|24|||
125490241|NCT03662022|451428560|FG001|Year 3 2021|incident case|27|||
125490242|NCT03662022|451428561|FG002|Year 3 2021|incident case|24|||
125490243|NCT03662022|451428562|FG003|Year 3 2021|incident case|11|||
125490244|NCT03662022|451428559|FG000|Year 3 2021|other case|4|||
125490245|NCT03662022|451428560|FG001|Year 3 2021|other case|15|||
125490246|NCT03662022|451428561|FG002|Year 3 2021|other case|10|||
125490247|NCT03662022|451428562|FG003|Year 3 2021|other case|14|||
125490248|NCT03662022|451428559|FG000|Year 3 2021|Lost to Follow-up|179|||
125490249|NCT03662022|451428560|FG001|Year 3 2021|Lost to Follow-up|244|||
125490250|NCT03662022|451428561|FG002|Year 3 2021|Lost to Follow-up|480|||
125490251|NCT03662022|451428562|FG003|Year 3 2021|Lost to Follow-up|477|||
125490252|NCT03662022|451428559|FG000|Year 4 2022|incident case|25|||
125490253|NCT03662022|451428560|FG001|Year 4 2022|incident case|41|||
125490254|NCT03662022|451428561|FG002|Year 4 2022|incident case|28|||
125490255|NCT03662022|451428562|FG003|Year 4 2022|incident case|7|||
125490256|NCT03662022|451428559|FG000|Year 4 2022|other case|8|||
125490257|NCT03662022|451428560|FG001|Year 4 2022|other case|19|||
125490258|NCT03662022|451428561|FG002|Year 4 2022|other case|13|||
125490259|NCT03662022|451428562|FG003|Year 4 2022|other case|7|||
125490260|NCT03662022|451428559|FG000|Year 4 2022|Lost to Follow-up|986|||
125490261|NCT03662022|451428560|FG001|Year 4 2022|Lost to Follow-up|1079|||
125490262|NCT03662022|451428561|FG002|Year 4 2022|Lost to Follow-up|1236|||
125490263|NCT03662022|451428562|FG003|Year 4 2022|Lost to Follow-up|1826|||
125490264|NCT04490109|451428573|FG000|Overall Study|Lost to Follow-up|3|||
125490265|NCT04490109|451428574|FG001|Overall Study|Lost to Follow-up|10|||
125490266|NCT04490109|451428575|FG002|Overall Study|Lost to Follow-up|4|||
125490267|NCT04490109|451428573|FG000|Overall Study|Withdrawal by Subject|8|||
125490268|NCT04490109|451428574|FG001|Overall Study|Withdrawal by Subject|6|||
125490269|NCT04490109|451428575|FG002|Overall Study|Withdrawal by Subject|9|||
125490270|NCT04490109|451428573|FG000|Overall Study|Physician Decision|0|||
125490271|NCT04490109|451428574|FG001|Overall Study|Physician Decision|2|||
125490272|NCT04490109|451428575|FG002|Overall Study|Physician Decision|3|||
125490273|NCT04490109|451428573|FG000|Overall Study|Adverse Event|2|||
125490274|NCT04490109|451428574|FG001|Overall Study|Adverse Event|1|||
125490275|NCT04490109|451428575|FG002|Overall Study|Adverse Event|0|||
125490276|NCT04490109|451428573|FG000|Overall Study|Significant Non-Compliance|2|||
125303396|NCT01748825|450736759|FG006|Dose Escalation|Switched to alternative treatment|0|||
125303397|NCT01748825|450736760|FG007|Dose Escalation|Switched to alternative treatment|0|||
125303398|NCT01748825|450736761|FG008|Dose Escalation|Switched to alternative treatment|0|||
125303399|NCT01748825|450736762|FG009|Dose Escalation|Switched to alternative treatment|0|||
125303400|NCT01748825|450736753|FG000|Dose Escalation|Adverse Event|0|||
125303401|NCT01748825|450736754|FG001|Dose Escalation|Adverse Event|0|||
125303402|NCT01748825|450736755|FG002|Dose Escalation|Adverse Event|0|||
125303403|NCT01748825|450736756|FG003|Dose Escalation|Adverse Event|0|||
125303404|NCT01748825|450736757|FG004|Dose Escalation|Adverse Event|0|||
125490277|NCT04490109|451428574|FG001|Overall Study|Significant Non-Compliance|4|||
125490278|NCT04490109|451428575|FG002|Overall Study|Significant Non-Compliance|4|||
125490279|NCT04490109|451428573|FG000|Overall Study|Significant Clinical Event|0|||
125490280|NCT04490109|451428574|FG001|Overall Study|Significant Clinical Event|1|||
125490281|NCT04490109|451428575|FG002|Overall Study|Significant Clinical Event|0|||
125490282|NCT04490109|451428573|FG000|Overall Study|Other Reason|4|||
125490283|NCT04490109|451428574|FG001|Overall Study|Other Reason|1|||
125490284|NCT04490109|451428575|FG002|Overall Study|Other Reason|1|||
125490285|NCT03884439|451428578|FG000|Overall Study|No informed consent for publication of study results|38|||
125490286|NCT03884439|451428578|FG000|Overall Study|Contract violation/deficiency|7|||
125490287|NCT03904576|451428579|FG000|Washout Period|Protocol Violation|1|||
125490288|NCT03904576|451428580|FG001|Washout Period|Protocol Violation|1|||
125490289|NCT01756300|451428581|FG000|Overall Study|Death|1|||
125490290|NCT01756300|451428581|FG000|Overall Study|Withdrawal by Subject|1|||
125490291|NCT04780581|451428582|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
125490292|NCT04780581|451428583|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
125490293|NCT04780581|451428582|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
125490294|NCT04780581|451428583|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
125490295|NCT05836012|451429430|FG000|Overall Study|Lost to Follow-up|1|||
125490296|NCT05836012|451429431|FG001|Overall Study|Lost to Follow-up|0|||
125490297|NCT05836012|451429430|FG000|Overall Study|Withdrawal by Subject|1|||
125490298|NCT05836012|451429431|FG001|Overall Study|Withdrawal by Subject|3|||
125490299|NCT05836012|451429430|FG000|Overall Study|Reason not included in pre-specified categories|2|||
125490300|NCT05836012|451429431|FG001|Overall Study|Reason not included in pre-specified categories|1|||
125490301|NCT03817983|451429432|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
125490302|NCT03817983|451429433|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
125490303|NCT03817983|451429434|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
125490304|NCT03744676|451429435|FG000|Pre-Treatment Phase|Disease related complications|2|||
125490305|NCT03744676|451429435|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
125490306|NCT03744676|451429435|FG000|Pre-Treatment Phase|Death|7|||
125490307|NCT03744676|451429435|FG000|Pre-Treatment Phase|Other Reasons|7|||
125490308|NCT03744676|451429435|FG000|Treatment Phase|Participant withdrew consent|8|||
125490309|NCT03744676|451429435|FG000|Treatment Phase|Death|33|||
125490310|NCT03744676|451429435|FG000|Treatment Phase|other reasons|6|||
125490311|NCT03333915|451429436|FG000|Overall Study|Lost to Follow-up|0|||
125490312|NCT03333915|451429437|FG001|Overall Study|Lost to Follow-up|0|||
125490313|NCT03333915|451429438|FG002|Overall Study|Lost to Follow-up|1|||
125490314|NCT03333915|451429439|FG003|Overall Study|Lost to Follow-up|0|||
125490315|NCT03333915|451429440|FG004|Overall Study|Lost to Follow-up|0|||
125490316|NCT03333915|451429436|FG000|Overall Study|Disease Progression|0|||
125490317|NCT03333915|451429437|FG001|Overall Study|Disease Progression|1|||
125490318|NCT03333915|451429438|FG002|Overall Study|Disease Progression|0|||
125490319|NCT03333915|451429439|FG003|Overall Study|Disease Progression|0|||
125490320|NCT03333915|451429440|FG004|Overall Study|Disease Progression|0|||
125490321|NCT03333915|451429436|FG000|Overall Study|Death|0|||
125490322|NCT03333915|451429437|FG001|Overall Study|Death|0|||
125490323|NCT03333915|451429438|FG002|Overall Study|Death|0|||
125490324|NCT03333915|451429439|FG003|Overall Study|Death|37|||
125490325|NCT03333915|451429440|FG004|Overall Study|Death|18|||
125490326|NCT03333915|451429436|FG000|Overall Study|Sponsor's Decision|0|||
125490327|NCT03333915|451429437|FG001|Overall Study|Sponsor's Decision|0|||
125490328|NCT03333915|451429438|FG002|Overall Study|Sponsor's Decision|0|||
125490329|NCT03333915|451429439|FG003|Overall Study|Sponsor's Decision|48|||
125490330|NCT03333915|451429440|FG004|Overall Study|Sponsor's Decision|4|||
125490331|NCT03333915|451429436|FG000|Overall Study|Withdrawal by Subject|0|||
125490332|NCT03333915|451429437|FG001|Overall Study|Withdrawal by Subject|0|||
125490333|NCT03333915|451429438|FG002|Overall Study|Withdrawal by Subject|0|||
125490334|NCT03333915|451429439|FG003|Overall Study|Withdrawal by Subject|5|||
125490335|NCT03333915|451429440|FG004|Overall Study|Withdrawal by Subject|1|||
125490336|NCT05454514|451429444|FG000|Overall Study|Withdrawal by Subject|4|||
125490337|NCT05785130|451429445|FG000|Overall Study|Withdrawal by Subject|1|||
125490338|NCT05785130|451429446|FG001|Overall Study|Withdrawal by Subject|0|||
125490339|NCT05785130|451429445|FG000|Overall Study|Lack of Efficacy|0|||
125490340|NCT05785130|451429446|FG001|Overall Study|Lack of Efficacy|1|||
125490341|NCT02461134|451429451|FG000|Overall Study|Adverse Event|1|||
125490342|NCT04761198|451429452|FG000|Overall Study|Progressive Disease|1|||
125490343|NCT04761198|451429453|FG001|Overall Study|Progressive Disease|0|||
125490344|NCT04761198|451429454|FG002|Overall Study|Progressive Disease|0|||
125490345|NCT04761198|451429455|FG003|Overall Study|Progressive Disease|1|||
125490346|NCT04761198|451429456|FG004|Overall Study|Progressive Disease|4|||
125490347|NCT04761198|451429457|FG005|Overall Study|Progressive Disease|1|||
125490348|NCT04761198|451429458|FG006|Overall Study|Progressive Disease|2|||
125490349|NCT04761198|451429452|FG000|Overall Study|Protocol Violation|0|||
125490350|NCT04761198|451429453|FG001|Overall Study|Protocol Violation|0|||
125490351|NCT04761198|451429454|FG002|Overall Study|Protocol Violation|0|||
125490352|NCT04761198|451429455|FG003|Overall Study|Protocol Violation|0|||
125490353|NCT04761198|451429456|FG004|Overall Study|Protocol Violation|1|||
125490354|NCT04761198|451429457|FG005|Overall Study|Protocol Violation|0|||
125490355|NCT04761198|451429458|FG006|Overall Study|Protocol Violation|0|||
125490356|NCT04761198|451429452|FG000|Overall Study|Death|2|||
125490357|NCT04761198|451429453|FG001|Overall Study|Death|1|||
125303405|NCT01748825|450736758|FG005|Dose Escalation|Adverse Event|0|||
125490358|NCT04761198|451429454|FG002|Overall Study|Death|2|||
125303406|NCT01748825|450736759|FG006|Dose Escalation|Adverse Event|1|||
125490359|NCT04761198|451429455|FG003|Overall Study|Death|5|||
125490360|NCT04761198|451429456|FG004|Overall Study|Death|14|||
125490361|NCT04761198|451429457|FG005|Overall Study|Death|2|||
125490362|NCT04761198|451429458|FG006|Overall Study|Death|5|||
125490363|NCT04761198|451429452|FG000|Overall Study|Lost to Follow-up|0|||
125490364|NCT04761198|451429453|FG001|Overall Study|Lost to Follow-up|0|||
125490365|NCT04761198|451429454|FG002|Overall Study|Lost to Follow-up|0|||
125490366|NCT04761198|451429455|FG003|Overall Study|Lost to Follow-up|0|||
125490367|NCT04761198|451429456|FG004|Overall Study|Lost to Follow-up|1|||
125490368|NCT04761198|451429457|FG005|Overall Study|Lost to Follow-up|0|||
125490369|NCT04761198|451429458|FG006|Overall Study|Lost to Follow-up|0|||
125490370|NCT04761198|451429452|FG000|Overall Study|Withdrawal by Subject|2|||
125490371|NCT04761198|451429453|FG001|Overall Study|Withdrawal by Subject|0|||
125490372|NCT04761198|451429454|FG002|Overall Study|Withdrawal by Subject|1|||
125490373|NCT04761198|451429455|FG003|Overall Study|Withdrawal by Subject|0|||
125490374|NCT04761198|451429456|FG004|Overall Study|Withdrawal by Subject|2|||
125490375|NCT04761198|451429457|FG005|Overall Study|Withdrawal by Subject|0|||
125490376|NCT04761198|451429458|FG006|Overall Study|Withdrawal by Subject|1|||
125490377|NCT04761198|451429452|FG000|Overall Study|Study Terminated by Sponsor|6|||
125490378|NCT04761198|451429453|FG001|Overall Study|Study Terminated by Sponsor|0|||
125490379|NCT04761198|451429454|FG002|Overall Study|Study Terminated by Sponsor|5|||
125490380|NCT04761198|451429455|FG003|Overall Study|Study Terminated by Sponsor|3|||
125490381|NCT04761198|451429456|FG004|Overall Study|Study Terminated by Sponsor|10|||
125490382|NCT04761198|451429457|FG005|Overall Study|Study Terminated by Sponsor|1|||
125490383|NCT04761198|451429458|FG006|Overall Study|Study Terminated by Sponsor|2|||
125490384|NCT03533257|451429459|FG000|Overall Study|Adverse Event|4|||
125490385|NCT03533257|451429460|FG001|Overall Study|Adverse Event|2|||
125490386|NCT03533257|451429459|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
125490387|NCT03533257|451429460|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
125490388|NCT03250676|451429462|FG000|Overall Study|Adverse Event|0|||
125490389|NCT03250676|451429463|FG001|Overall Study|Adverse Event|0|||
125490390|NCT03250676|451429464|FG002|Overall Study|Adverse Event|0|||
125490391|NCT03250676|451429465|FG003|Overall Study|Adverse Event|1|||
125490392|NCT03250676|451429466|FG004|Overall Study|Adverse Event|2|||
125490393|NCT03250676|451429467|FG005|Overall Study|Adverse Event|9|||
125490394|NCT03250676|451429462|FG000|Overall Study|Withdrawal by Subject|1|||
125490395|NCT03250676|451429463|FG001|Overall Study|Withdrawal by Subject|0|||
125490396|NCT03250676|451429464|FG002|Overall Study|Withdrawal by Subject|0|||
125490397|NCT03250676|451429465|FG003|Overall Study|Withdrawal by Subject|1|||
125490398|NCT03250676|451429466|FG004|Overall Study|Withdrawal by Subject|1|||
125490399|NCT03250676|451429467|FG005|Overall Study|Withdrawal by Subject|2|||
125490400|NCT03250676|451429462|FG000|Overall Study|Physician Decision|0|||
125490401|NCT03250676|451429463|FG001|Overall Study|Physician Decision|0|||
125490402|NCT03250676|451429464|FG002|Overall Study|Physician Decision|0|||
125490403|NCT03250676|451429465|FG003|Overall Study|Physician Decision|2|||
125490404|NCT03250676|451429466|FG004|Overall Study|Physician Decision|0|||
125490405|NCT03250676|451429467|FG005|Overall Study|Physician Decision|3|||
125490406|NCT03250676|451429462|FG000|Overall Study|Withdrawal of consent|0|||
125490407|NCT03250676|451429463|FG001|Overall Study|Withdrawal of consent|0|||
125490408|NCT03250676|451429464|FG002|Overall Study|Withdrawal of consent|2|||
125490409|NCT03250676|451429465|FG003|Overall Study|Withdrawal of consent|0|||
125490410|NCT03250676|451429466|FG004|Overall Study|Withdrawal of consent|0|||
125490411|NCT03250676|451429467|FG005|Overall Study|Withdrawal of consent|2|||
125490412|NCT03250676|451429462|FG000|Overall Study|Other|1|||
125490413|NCT03250676|451429463|FG001|Overall Study|Other|0|||
125490414|NCT03250676|451429464|FG002|Overall Study|Other|0|||
125490415|NCT03250676|451429465|FG003|Overall Study|Other|0|||
125490416|NCT03250676|451429466|FG004|Overall Study|Other|0|||
125490417|NCT03250676|451429467|FG005|Overall Study|Other|0|||
125490418|NCT03250676|451429462|FG000|Overall Study|Disease progression|4|||
125490419|NCT03250676|451429463|FG001|Overall Study|Disease progression|12|||
125490420|NCT03250676|451429464|FG002|Overall Study|Disease progression|9|||
125490421|NCT03250676|451429465|FG003|Overall Study|Disease progression|7|||
125490422|NCT03250676|451429466|FG004|Overall Study|Disease progression|4|||
125490423|NCT03250676|451429467|FG005|Overall Study|Disease progression|88|||
125490424|NCT03587805|451429468|FG000|Overall Study|Adverse Event|72|||
125490425|NCT03587805|451429468|FG000|Overall Study|Death|1|||
125490426|NCT03587805|451429468|FG000|Overall Study|Lost to Follow-up|78|||
125490427|NCT03587805|451429468|FG000|Overall Study|Withdrawal by Subject|105|||
125490428|NCT03587805|451429468|FG000|Overall Study|Lack of Efficacy|119|||
125490429|NCT03587805|451429468|FG000|Overall Study|Reason unknown|26|||
125490430|NCT03587805|451429468|FG000|Overall Study|COVID_19 pandemic|4|||
125490431|NCT03587805|451429468|FG000|Overall Study|Various reasons|121|||
125490432|NCT03587805|451429468|FG000|Overall Study|Withdrawal by parent/guardian|3|||
125490433|NCT04626427|451429469|FG000|Overall Study|Death|1|||
125490434|NCT04626427|451429469|FG000|Overall Study|Withdrawal by Subject|1|||
125490435|NCT04626427|451429469|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
125490436|NCT04626427|451429469|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
125490437|NCT01651000|451429470|FG000|Overall Study|Adverse Event|2|||
125490438|NCT01651000|451429471|FG001|Overall Study|Adverse Event|8|||
125490439|NCT01651000|451429470|FG000|Overall Study|Lost to Follow-up|3|||
125490440|NCT01651000|451429471|FG001|Overall Study|Lost to Follow-up|2|||
125490441|NCT01651000|451429470|FG000|Overall Study|Protocol Violation|0|||
125490442|NCT01651000|451429471|FG001|Overall Study|Protocol Violation|3|||
125490443|NCT01651000|451429470|FG000|Overall Study|Withdrawal by Subject|2|||
125490444|NCT01651000|451429471|FG001|Overall Study|Withdrawal by Subject|10|||
125490445|NCT01651000|451429470|FG000|Overall Study|Subject noncompliance|0|||
125490446|NCT01651000|451429471|FG001|Overall Study|Subject noncompliance|3|||
125490447|NCT01651000|451429470|FG000|Overall Study|Lack of Efficacy|1|||
125490448|NCT01651000|451429471|FG001|Overall Study|Lack of Efficacy|1|||
125490449|NCT01651000|451429470|FG000|Overall Study|Physician Decision|1|||
125490450|NCT01651000|451429471|FG001|Overall Study|Physician Decision|0|||
125490451|NCT01651000|451429470|FG000|Overall Study|Administrative reason|1|||
125490452|NCT01651000|451429471|FG001|Overall Study|Administrative reason|0|||
125490453|NCT01651000|451429470|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
125490454|NCT01651000|451429471|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
125490455|NCT03982186|451429472|FG000|Overall Study|Lost to Follow-up|0|||
125490456|NCT03982186|451429473|FG001|Overall Study|Lost to Follow-up|1|||
125490457|NCT03982186|451429474|FG002|Overall Study|Lost to Follow-up|2|||
125490458|NCT03982186|451429475|FG003|Overall Study|Lost to Follow-up|1|||
125490459|NCT03982186|451429476|FG004|Overall Study|Lost to Follow-up|1|||
125490460|NCT03982186|451429477|FG005|Overall Study|Lost to Follow-up|0|||
125490461|NCT03982186|451429472|FG000|Overall Study|Physician Decision|0|||
125490462|NCT03982186|451429473|FG001|Overall Study|Physician Decision|1|||
125490463|NCT03982186|451429474|FG002|Overall Study|Physician Decision|0|||
125490464|NCT03982186|451429475|FG003|Overall Study|Physician Decision|0|||
125490465|NCT03982186|451429476|FG004|Overall Study|Physician Decision|0|||
125490466|NCT03982186|451429477|FG005|Overall Study|Physician Decision|0|||
125490467|NCT03982186|451429472|FG000|Overall Study|Withdrawal by Subject|3|||
125490468|NCT03982186|451429473|FG001|Overall Study|Withdrawal by Subject|4|||
125490469|NCT03982186|451429474|FG002|Overall Study|Withdrawal by Subject|1|||
125490470|NCT03982186|451429475|FG003|Overall Study|Withdrawal by Subject|7|||
125490471|NCT03982186|451429476|FG004|Overall Study|Withdrawal by Subject|2|||
125490472|NCT03982186|451429477|FG005|Overall Study|Withdrawal by Subject|0|||
125490473|NCT03982186|451429472|FG000|Overall Study|Randomized and not treated|0|||
125490474|NCT03982186|451429473|FG001|Overall Study|Randomized and not treated|0|||
125490475|NCT03982186|451429474|FG002|Overall Study|Randomized and not treated|0|||
125490476|NCT03982186|451429475|FG003|Overall Study|Randomized and not treated|1|||
125490477|NCT03982186|451429476|FG004|Overall Study|Randomized and not treated|0|||
125490478|NCT03982186|451429477|FG005|Overall Study|Randomized and not treated|0|||
125490479|NCT02765412|451429478|FG000|Overall Study|Death|482|||
125490480|NCT02765412|451429479|FG001|Overall Study|Death|855|||
125490481|NCT04244175|451430384|FG000|Overall Study|Adverse Event|3|||
125490482|NCT04244175|451430385|FG001|Overall Study|Adverse Event|2|||
125490483|NCT04244175|451430386|FG002|Overall Study|Adverse Event|5|||
125490484|NCT04244175|451430384|FG000|Overall Study|Lack of Efficacy|1|||
125490485|NCT04244175|451430385|FG001|Overall Study|Lack of Efficacy|0|||
125490486|NCT04244175|451430386|FG002|Overall Study|Lack of Efficacy|1|||
125490487|NCT04244175|451430384|FG000|Overall Study|Lost to Follow-up|1|||
125490488|NCT04244175|451430385|FG001|Overall Study|Lost to Follow-up|0|||
125490489|NCT04244175|451430386|FG002|Overall Study|Lost to Follow-up|0|||
125490490|NCT04244175|451430384|FG000|Overall Study|Non-compliance with study drug|1|||
125490491|NCT04244175|451430385|FG001|Overall Study|Non-compliance with study drug|0|||
125490492|NCT04244175|451430386|FG002|Overall Study|Non-compliance with study drug|1|||
125490493|NCT04244175|451430384|FG000|Overall Study|Protocol deviation|0|||
125490494|NCT04244175|451430385|FG001|Overall Study|Protocol deviation|1|||
125490495|NCT04244175|451430386|FG002|Overall Study|Protocol deviation|0|||
125490496|NCT04244175|451430384|FG000|Overall Study|Withdrawal by Subject|1|||
125490497|NCT04244175|451430385|FG001|Overall Study|Withdrawal by Subject|3|||
125490498|NCT04244175|451430386|FG002|Overall Study|Withdrawal by Subject|1|||
125490499|NCT04244175|451430384|FG000|Overall Study|Other, not specified|0|||
125490500|NCT04244175|451430385|FG001|Overall Study|Other, not specified|1|||
125490501|NCT04244175|451430386|FG002|Overall Study|Other, not specified|2|||
125490502|NCT04595331|451430387|FG000|Overall Study|Withdrawal by Subject|0|||
125490503|NCT04595331|451430388|FG001|Overall Study|Withdrawal by Subject|1|||
125490504|NCT04595331|451430387|FG000|Overall Study|Lost to Follow-up|0|||
125490505|NCT04595331|451430388|FG001|Overall Study|Lost to Follow-up|5|||
125490506|NCT04595331|451430387|FG000|Overall Study|Medical reason|0|||
125490507|NCT04595331|451430388|FG001|Overall Study|Medical reason|1|||
125303407|NCT01748825|450736760|FG007|Dose Escalation|Adverse Event|0|||
125490508|NCT03781089|451430389|FG000|Overall Study|Constipation|1|||
125490509|NCT03781089|451430390|FG001|Overall Study|Constipation|0|||
125490510|NCT03781089|451430389|FG000|Overall Study|Positive pregnancy test|0|||
125490511|NCT03781089|451430390|FG001|Overall Study|Positive pregnancy test|1|||
125490512|NCT05020353|451430391|FG000|Overall Study|Protocol Violation|7|||
125490513|NCT05020353|451430391|FG000|Overall Study|Withdrawal by Subject|33|||
125490514|NCT05985395|451430400|FG000|Overall Study|Physician Decision|2|||
125490515|NCT05985395|451430401|FG001|Overall Study|Physician Decision|1|||
125490516|NCT05985395|451430400|FG000|Overall Study|Withdrawal by Subject|1|||
125490517|NCT05985395|451430401|FG001|Overall Study|Withdrawal by Subject|0|||
125303408|NCT01748825|450736761|FG008|Dose Escalation|Adverse Event|0|||
125490518|NCT02777593|451430413|FG000|Overall Study|Still in study|1|||
125490519|NCT02777593|451430414|FG001|Overall Study|Still in study|32|||
125490520|NCT02777593|451430415|FG002|Overall Study|Still in study|3|||
125490521|NCT02777593|451430416|FG003|Overall Study|Still in study|6|||
125490522|NCT02777593|451430417|FG004|Overall Study|Still in study|5|||
125490523|NCT02777593|451430413|FG000|Overall Study|Death|21|||
125490524|NCT02777593|451430414|FG001|Overall Study|Death|28|||
125490525|NCT02777593|451430415|FG002|Overall Study|Death|0|||
125490526|NCT02777593|451430416|FG003|Overall Study|Death|5|||
125490527|NCT02777593|451430417|FG004|Overall Study|Death|0|||
125490528|NCT02777593|451430413|FG000|Overall Study|Withdrawal by Subject|8|||
125490529|NCT02777593|451430414|FG001|Overall Study|Withdrawal by Subject|4|||
125490530|NCT02777593|451430415|FG002|Overall Study|Withdrawal by Subject|1|||
125490531|NCT02777593|451430416|FG003|Overall Study|Withdrawal by Subject|1|||
125490532|NCT02777593|451430417|FG004|Overall Study|Withdrawal by Subject|0|||
125490533|NCT02777593|451430413|FG000|Overall Study|Lost to Follow-up|8|||
125490534|NCT02777593|451430414|FG001|Overall Study|Lost to Follow-up|16|||
125490535|NCT02777593|451430415|FG002|Overall Study|Lost to Follow-up|5|||
125490536|NCT02777593|451430416|FG003|Overall Study|Lost to Follow-up|0|||
125490537|NCT02777593|451430417|FG004|Overall Study|Lost to Follow-up|1|||
125490538|NCT02777593|451430413|FG000|Overall Study|Physician Decision|2|||
125490539|NCT02777593|451430414|FG001|Overall Study|Physician Decision|2|||
125490540|NCT02777593|451430415|FG002|Overall Study|Physician Decision|0|||
125490541|NCT02777593|451430416|FG003|Overall Study|Physician Decision|0|||
125490542|NCT02777593|451430417|FG004|Overall Study|Physician Decision|0|||
125490543|NCT02777593|451430413|FG000|Overall Study|Discontinued due to Other|1|||
125490544|NCT02777593|451430414|FG001|Overall Study|Discontinued due to Other|0|||
125490545|NCT02777593|451430415|FG002|Overall Study|Discontinued due to Other|0|||
125490546|NCT02777593|451430416|FG003|Overall Study|Discontinued due to Other|0|||
125490547|NCT02777593|451430417|FG004|Overall Study|Discontinued due to Other|0|||
125490548|NCT03547271|451430420|FG000|Overall Study|Adverse Event|1|||
125490549|NCT03547271|451430421|FG001|Overall Study|Adverse Event|1|||
125490550|NCT03547271|451430422|FG002|Overall Study|Adverse Event|0|||
125490551|NCT03547271|451430423|FG003|Overall Study|Adverse Event|0|||
125490552|NCT03547271|451430420|FG000|Overall Study|Protocol deviation|5|||
125490553|NCT03547271|451430421|FG001|Overall Study|Protocol deviation|7|||
125490554|NCT03547271|451430422|FG002|Overall Study|Protocol deviation|3|||
125490555|NCT03547271|451430423|FG003|Overall Study|Protocol deviation|0|||
125490556|NCT03547271|451430420|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
125490557|NCT03547271|451430421|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
125490558|NCT03547271|451430422|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
125490559|NCT03547271|451430423|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
125490560|NCT03547271|451430420|FG000|Overall Study|Lost to Follow-up|3|||
125490561|NCT03547271|451430421|FG001|Overall Study|Lost to Follow-up|3|||
125490562|NCT03547271|451430422|FG002|Overall Study|Lost to Follow-up|1|||
125490563|NCT03547271|451430423|FG003|Overall Study|Lost to Follow-up|0|||
125490564|NCT06065735|451430428|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
125490565|NCT06065735|451430429|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
125490566|NCT06065735|451430430|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
125490567|NCT06065735|451430428|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
125490568|NCT06065735|451430429|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
125490569|NCT06065735|451430430|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
125490570|NCT06065735|451430428|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
125490571|NCT06065735|451430429|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
125490572|NCT06065735|451430430|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
125490573|NCT06065735|451430428|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
125490574|NCT06065735|451430429|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
125490575|NCT06065735|451430430|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
125490576|NCT06065735|451430428|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
125490577|NCT06065735|451430429|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
125490578|NCT06065735|451430430|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
125490579|NCT02532621|451430431|FG000|Overall Study|Death|3|||
125490580|NCT02532621|451430431|FG000|Overall Study|Lost to Follow-up|3|||
125490581|NCT02532621|451430431|FG000|Overall Study|Withdrawal by Subject|6|||
125490582|NCT02532621|451430431|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
125490583|NCT02532621|451430431|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
125303409|NCT01748825|450736762|FG009|Dose Escalation|Adverse Event|0|||
125303410|NCT01748825|450736753|FG000|Dose Expansion|Refused further treatment|0|||
125490584|NCT03522298|451430432|FG000|Overall Study|Adverse Event|1|||
125490585|NCT03522298|451430433|FG001|Overall Study|Adverse Event|0|||
125490586|NCT03522298|451430434|FG002|Overall Study|Adverse Event|0|||
125490587|NCT03522298|451430435|FG003|Overall Study|Adverse Event|1|||
125490588|NCT03522298|451430432|FG000|Overall Study|Death|2|||
125303411|NCT01748825|450736754|FG001|Dose Expansion|Refused further treatment|0|||
125303412|NCT01748825|450736755|FG002|Dose Expansion|Refused further treatment|0|||
125490589|NCT03522298|451430433|FG001|Overall Study|Death|4|||
125490590|NCT03522298|451430434|FG002|Overall Study|Death|8|||
125490591|NCT03522298|451430435|FG003|Overall Study|Death|8|||
125490592|NCT03522298|451430432|FG000|Overall Study|Patient decision|0|||
125490593|NCT03522298|451430433|FG001|Overall Study|Patient decision|2|||
125490594|NCT03522298|451430434|FG002|Overall Study|Patient decision|2|||
125490595|NCT03522298|451430435|FG003|Overall Study|Patient decision|2|||
125490596|NCT04795245|451430438|FG000|Overall Study|Unkown reason|7|||
125490597|NCT04795245|451430438|FG000|Overall Study|Death|17|||
125490598|NCT04795245|451430438|FG000|Overall Study|Other than listed|19|||
125490599|NCT04795245|451430438|FG000|Overall Study|Adverse Event|143|||
125490600|NCT04795245|451430438|FG000|Overall Study|Progressive disease|512|||
125490601|NCT04795245|451430438|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
125490602|NCT02919917|451430439|FG000|Overall Study|Withdrawal by Subject|4|||
125490603|NCT02919917|451430440|FG001|Overall Study|Withdrawal by Subject|8|||
125490604|NCT03418740|451430441|FG000|Overall Study|Lost to Follow-up|13|||
125490605|NCT03418740|451430441|FG000|Overall Study|Scheduling Issues|7|||
125490606|NCT03418740|451430441|FG000|Overall Study|Withdrawal by Subject|2|||
125490607|NCT03418740|451430441|FG000|Overall Study|Unable to Continue Consent|1|||
125490608|NCT04157517|451430446|FG000|Overall Study|Death|1|||
125490609|NCT04157517|451430447|FG001|Overall Study|Death|2|||
125490610|NCT04157517|451430448|FG002|Overall Study|Death|2|||
125490611|NCT04157517|451430449|FG003|Overall Study|Death|3|||
125490612|NCT04157517|451430450|FG004|Overall Study|Death|3|||
125490613|NCT04157517|451430451|FG005|Overall Study|Death|4|||
125490614|NCT04157517|451430452|FG006|Overall Study|Death|1|||
125490615|NCT04157517|451430453|FG007|Overall Study|Death|2|||
125490616|NCT04157517|451430454|FG008|Overall Study|Death|4|||
125490617|NCT04157517|451430455|FG009|Overall Study|Death|0|||
125490618|NCT04157517|451430446|FG000|Overall Study|Withdrawal by Subject|1|||
125490619|NCT04157517|451430447|FG001|Overall Study|Withdrawal by Subject|1|||
125490620|NCT04157517|451430448|FG002|Overall Study|Withdrawal by Subject|1|||
125490621|NCT04157517|451430449|FG003|Overall Study|Withdrawal by Subject|0|||
125490622|NCT04157517|451430450|FG004|Overall Study|Withdrawal by Subject|0|||
125490623|NCT04157517|451430451|FG005|Overall Study|Withdrawal by Subject|1|||
125490624|NCT04157517|451430452|FG006|Overall Study|Withdrawal by Subject|0|||
125490625|NCT04157517|451430453|FG007|Overall Study|Withdrawal by Subject|0|||
125490626|NCT04157517|451430454|FG008|Overall Study|Withdrawal by Subject|1|||
125490627|NCT04157517|451430455|FG009|Overall Study|Withdrawal by Subject|0|||
125490628|NCT04157517|451430446|FG000|Overall Study|Other|1|||
125490629|NCT04157517|451430447|FG001|Overall Study|Other|0|||
125490630|NCT04157517|451430448|FG002|Overall Study|Other|0|||
125490631|NCT04157517|451430449|FG003|Overall Study|Other|0|||
125490632|NCT04157517|451430450|FG004|Overall Study|Other|0|||
125490633|NCT04157517|451430451|FG005|Overall Study|Other|1|||
125490634|NCT04157517|451430452|FG006|Overall Study|Other|2|||
125490635|NCT04157517|451430453|FG007|Overall Study|Other|7|||
125490636|NCT04157517|451430454|FG008|Overall Study|Other|7|||
125490637|NCT04157517|451430455|FG009|Overall Study|Other|0|||
125490638|NCT02933489|451430456|FG000|Overall Study|Ineligible|3|||
125490639|NCT02933489|451430457|FG001|Overall Study|Ineligible|3|||
125490640|NCT02933489|451430456|FG000|Overall Study|Withdrawal by Subject|27|||
125490641|NCT02933489|451430457|FG001|Overall Study|Withdrawal by Subject|18|||
125490642|NCT02933489|451430456|FG000|Overall Study|Unable to complete exams (other)|14|||
125490643|NCT02933489|451430457|FG001|Overall Study|Unable to complete exams (other)|7|||
125490644|NCT02994927|451430458|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125490645|NCT02994927|451430459|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125490646|NCT02994927|451430458|FG000|Overall Study|Did not meet eligibility criteria|0|||
125490647|NCT02994927|451430459|FG001|Overall Study|Did not meet eligibility criteria|1|||
125490648|NCT02994927|451430458|FG000|Overall Study|Physician Decision|4|||
125490649|NCT02994927|451430459|FG001|Overall Study|Physician Decision|3|||
125490650|NCT02994927|451430458|FG000|Overall Study|Death|4|||
125490651|NCT02994927|451430459|FG001|Overall Study|Death|2|||
125490652|NCT02994927|451430458|FG000|Overall Study|Adverse Event|2|||
125490653|NCT02994927|451430459|FG001|Overall Study|Adverse Event|1|||
125490654|NCT02994927|451430458|FG000|Overall Study|Withdrawal by Subject|3|||
125303413|NCT01748825|450736756|FG003|Dose Expansion|Refused further treatment|0|||
125303414|NCT01748825|450736757|FG004|Dose Expansion|Refused further treatment|0|||
125303415|NCT01748825|450736758|FG005|Dose Expansion|Refused further treatment|0|||
125490655|NCT02994927|451430459|FG001|Overall Study|Withdrawal by Subject|6|||
125490656|NCT02994927|451430458|FG000|Overall Study|Lost to Follow-up|2|||
125490657|NCT02994927|451430459|FG001|Overall Study|Lost to Follow-up|1|||
125490658|NCT04281498|451430460|FG000|Overall Study|Progression of disease|1|||
125490659|NCT04281498|451430460|FG000|Overall Study|Planned SCT|1|||
125490660|NCT04281498|451430460|FG000|Overall Study|Alternative Treatment|1|||
125490661|NCT03417284|451430724|FG000|Overall Study|Inadequate supply on study drug|1|||
125490662|NCT03417284|451430725|FG001|Overall Study|Inadequate supply on study drug|0|||
125490663|NCT03417284|451430726|FG002|Overall Study|Inadequate supply on study drug|0|||
125490664|NCT03417284|451430727|FG003|Overall Study|Inadequate supply on study drug|0|||
125490665|NCT03417284|451430724|FG000|Overall Study|Disease Progression|0|||
125490666|NCT03417284|451430725|FG001|Overall Study|Disease Progression|0|||
125490667|NCT03417284|451430726|FG002|Overall Study|Disease Progression|1|||
125490668|NCT03417284|451430727|FG003|Overall Study|Disease Progression|0|||
125490669|NCT05132400|451430728|FG000|Overall Study|Withdrawal by Subject|14|||
125490670|NCT05132400|451430729|FG001|Overall Study|Withdrawal by Subject|8|||
125490671|NCT05132400|451430728|FG000|Overall Study|Lost to Follow-up|132|||
125490672|NCT05132400|451430729|FG001|Overall Study|Lost to Follow-up|121|||
125490673|NCT02076009|451430731|FG000|Overall Study|Death|172|||
125490674|NCT02076009|451430732|FG001|Overall Study|Death|153|||
125490675|NCT02076009|451430731|FG000|Overall Study|Withdrawal by Subject|16|||
125490676|NCT02076009|451430732|FG001|Overall Study|Withdrawal by Subject|12|||
125490677|NCT02076009|451430731|FG000|Overall Study|Lost to Follow-up|4|||
125490678|NCT02076009|451430732|FG001|Overall Study|Lost to Follow-up|2|||
125490679|NCT02076009|451430731|FG000|Overall Study|Progressive Disease|1|||
125490680|NCT02076009|451430732|FG001|Overall Study|Progressive Disease|0|||
125490681|NCT02076009|451430731|FG000|Overall Study|Physician Decision|0|||
125490682|NCT02076009|451430732|FG001|Overall Study|Physician Decision|1|||
125490683|NCT02076009|451430731|FG000|Overall Study|End of data collection|90|||
125490684|NCT02076009|451430732|FG001|Overall Study|End of data collection|118|||
125490685|NCT01897441|451430739|FG000|Overall Study|Lost to Follow-up|0|||
125490686|NCT01897441|451430740|FG001|Overall Study|Lost to Follow-up|0|||
125490687|NCT01897441|451430741|FG002|Overall Study|Lost to Follow-up|1|||
125490688|NCT01897441|451430742|FG003|Overall Study|Lost to Follow-up|0|||
125490689|NCT01897441|451430743|FG004|Overall Study|Lost to Follow-up|0|||
125490690|NCT01897441|451430744|FG005|Overall Study|Lost to Follow-up|0|||
125490691|NCT01897441|451430739|FG000|Overall Study|Withdrawal by Subject|0|||
125490692|NCT01897441|451430740|FG001|Overall Study|Withdrawal by Subject|0|||
125490693|NCT01897441|451430741|FG002|Overall Study|Withdrawal by Subject|0|||
125490694|NCT01897441|451430742|FG003|Overall Study|Withdrawal by Subject|0|||
125490695|NCT01897441|451430743|FG004|Overall Study|Withdrawal by Subject|1|||
125490696|NCT01897441|451430744|FG005|Overall Study|Withdrawal by Subject|0|||
125490697|NCT01897441|451430739|FG000|Overall Study|Withdrawn by Provider|0|||
125490698|NCT01897441|451430740|FG001|Overall Study|Withdrawn by Provider|2|||
125490699|NCT01897441|451430741|FG002|Overall Study|Withdrawn by Provider|0|||
125490700|NCT01897441|451430742|FG003|Overall Study|Withdrawn by Provider|0|||
125490701|NCT01897441|451430743|FG004|Overall Study|Withdrawn by Provider|0|||
125490702|NCT01897441|451430744|FG005|Overall Study|Withdrawn by Provider|0|||
125490703|NCT04093869|451430754|FG000|Overall Study|Death|0|||
125490704|NCT04093869|451430755|FG001|Overall Study|Death|1|||
125490705|NCT04093869|451430754|FG000|Overall Study|Withdrawal by Subject|1|||
125490706|NCT04093869|451430755|FG001|Overall Study|Withdrawal by Subject|0|||
125490707|NCT02806726|451430760|FG000|Overall Study|Lost to Follow-up|1|||
125490708|NCT05129501|451430761|FG000|Overall Study|Lost to Follow-up|54|||
125490709|NCT05129501|451430762|FG001|Overall Study|Lost to Follow-up|41|||
125490710|NCT04166513|451430763|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
125490711|NCT04166513|451430764|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
125490712|NCT04166513|451430765|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
125490713|NCT04166513|451430766|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
125490714|NCT04166513|451430763|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
125490715|NCT04166513|451430764|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
125490716|NCT04166513|451430765|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
125490717|NCT04166513|451430766|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
125490718|NCT04166513|451430763|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
125490719|NCT04166513|451430764|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
125490720|NCT04166513|451430765|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
125490721|NCT04166513|451430766|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
125490722|NCT04166513|451430763|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
125490723|NCT04166513|451430764|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
125490724|NCT04166513|451430765|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
125490725|NCT04166513|451430766|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
125490726|NCT04166513|451430763|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
125490727|NCT04166513|451430764|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
125490728|NCT04166513|451430765|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
125490729|NCT04166513|451430766|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
125490730|NCT05866926|451430767|FG000|Overall Study|Death|16|||
125490731|NCT05866926|451430768|FG001|Overall Study|Death|9|||
125490732|NCT05866926|451430767|FG000|Overall Study|Lost to Follow-up|0|||
125490733|NCT05866926|451430768|FG001|Overall Study|Lost to Follow-up|1|||
125490734|NCT05866926|451430767|FG000|Overall Study|Adverse Event|1|||
125490735|NCT05866926|451430768|FG001|Overall Study|Adverse Event|0|||
125490736|NCT05866926|451430767|FG000|Overall Study|Withdrawal by Subject|5|||
125490737|NCT05866926|451430768|FG001|Overall Study|Withdrawal by Subject|1|||
125490738|NCT05866926|451430767|FG000|Overall Study|Disease progression|1|||
125490739|NCT05866926|451430768|FG001|Overall Study|Disease progression|0|||
125490740|NCT05866926|451430767|FG000|Overall Study|other causes|2|||
125490741|NCT05866926|451430768|FG001|Overall Study|other causes|1|||
125490742|NCT05267639|451431129|FG000|Overall Study|Withdrawal by Subject|1|||
125490743|NCT05267639|451431130|FG001|Overall Study|Withdrawal by Subject|0|||
125490744|NCT03816397|451431137|FG000|Overall Study|Censored at interim analysis date.|13|||
125490745|NCT03816397|451431138|FG001|Overall Study|Censored at interim analysis date.|6|||
125490746|NCT03816397|451431137|FG000|Overall Study|Withdrawal by Subject|1|||
125490747|NCT03816397|451431138|FG001|Overall Study|Withdrawal by Subject|1|||
125490748|NCT05718687|451431143|FG000|Overall Study|Withdrawal by Subject|3|||
125490749|NCT03493542|451431144|FG000|Base Study|Withdrawal by Subject|0|||
125490750|NCT03493542|451431145|FG001|Base Study|Withdrawal by Subject|4|||
125490751|NCT03493542|451431146|FG002|Base Study|Withdrawal by Subject|0|||
125490752|NCT03493542|451431144|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
125490753|NCT03493542|451431145|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
125490754|NCT03493542|451431146|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
125490755|NCT03493542|451431144|FG000|Extension Study|Withdrawal by Subject|0|||
125490756|NCT03493542|451431145|FG001|Extension Study|Withdrawal by Subject|0|||
125490757|NCT03493542|451431146|FG002|Extension Study|Withdrawal by Subject|25|||
125490758|NCT05485935|451431147|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
125490759|NCT05485935|451431148|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
125490760|NCT05485935|451431147|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
125490761|NCT05485935|451431148|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
125490762|NCT05485935|451431147|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
125490763|NCT05485935|451431148|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
125490764|NCT05485935|451431147|FG000|Period 2 (T2 and V3)|loss of contact|0|||
125490765|NCT05485935|451431148|FG001|Period 2 (T2 and V3)|loss of contact|1|||
125490766|NCT01527188|451431154|FG000|Overall Study|Adverse Event|5|||
125490767|NCT01527188|451431155|FG001|Overall Study|Adverse Event|5|||
125490768|NCT01527188|451431156|FG002|Overall Study|Adverse Event|11|||
125490769|NCT01527188|451431157|FG003|Overall Study|Adverse Event|0|||
125490770|NCT01527188|451431154|FG000|Overall Study|Withdrawal by Subject|3|||
125490771|NCT01527188|451431155|FG001|Overall Study|Withdrawal by Subject|6|||
125490772|NCT01527188|451431156|FG002|Overall Study|Withdrawal by Subject|4|||
125490773|NCT01527188|451431157|FG003|Overall Study|Withdrawal by Subject|4|||
125490774|NCT01527188|451431154|FG000|Overall Study|Any other reason not above-mentioned|6|||
125490775|NCT01527188|451431155|FG001|Overall Study|Any other reason not above-mentioned|7|||
125490776|NCT01527188|451431156|FG002|Overall Study|Any other reason not above-mentioned|8|||
125490777|NCT01527188|451431157|FG003|Overall Study|Any other reason not above-mentioned|8|||
125490778|NCT01265537|451431159|FG000|Overall Study|Adverse Event|2|||
125490779|NCT01265537|451431160|FG001|Overall Study|Adverse Event|1|||
125490780|NCT01265537|451431159|FG000|Overall Study|Physician Decision|0|||
125490781|NCT01265537|451431160|FG001|Overall Study|Physician Decision|1|||
125490782|NCT03782116|451431161|FG000|Completed Intervetion|Lost to Follow-up|11|||
125490783|NCT03782116|451431162|FG001|Completed Intervetion|Lost to Follow-up|7|||
125490784|NCT03782116|451431161|FG000|Completed Intervetion|Withdrawal by Subject|6|||
125490785|NCT03782116|451431162|FG001|Completed Intervetion|Withdrawal by Subject|5|||
125490786|NCT03782116|451431161|FG000|Included in Analysis|Protocol Violation|5|||
125490787|NCT03782116|451431162|FG001|Included in Analysis|Protocol Violation|5|||
125490788|NCT03512301|451431774|FG000|Overall Study|Protocol Violation|2|||
125490789|NCT03512301|451431774|FG000|Overall Study|Did Not Qualify|3|||
125490790|NCT03512301|451431774|FG000|Overall Study|Age-ineligible|1|||
125490791|NCT03512301|451431774|FG000|Overall Study|Inadequate fluency with the English language|3|||
125303416|NCT01748825|450736759|FG006|Dose Expansion|Refused further treatment|0|||
125303417|NCT01748825|450736760|FG007|Dose Expansion|Refused further treatment|0|||
125303418|NCT01748825|450736761|FG008|Dose Expansion|Refused further treatment|1|||
125303419|NCT01748825|450736762|FG009|Dose Expansion|Refused further treatment|1|||
125303420|NCT01748825|450736753|FG000|Dose Expansion|Switched to alternative treatment|0|||
125303421|NCT01748825|450736754|FG001|Dose Expansion|Switched to alternative treatment|0|||
125303422|NCT01748825|450736755|FG002|Dose Expansion|Switched to alternative treatment|0|||
125303423|NCT01748825|450736756|FG003|Dose Expansion|Switched to alternative treatment|0|||
125303424|NCT01748825|450736757|FG004|Dose Expansion|Switched to alternative treatment|0|||
125303425|NCT01748825|450736758|FG005|Dose Expansion|Switched to alternative treatment|0|||
125303426|NCT01748825|450736759|FG006|Dose Expansion|Switched to alternative treatment|0|||
125303427|NCT01748825|450736760|FG007|Dose Expansion|Switched to alternative treatment|0|||
125303428|NCT01748825|450736761|FG008|Dose Expansion|Switched to alternative treatment|0|||
125303429|NCT01748825|450736762|FG009|Dose Expansion|Switched to alternative treatment|1|||
125303430|NCT01748825|450736753|FG000|Dose Expansion|Adverse Event|0|||
125303431|NCT01748825|450736754|FG001|Dose Expansion|Adverse Event|0|||
125303432|NCT01748825|450736755|FG002|Dose Expansion|Adverse Event|0|||
125303433|NCT01748825|450736756|FG003|Dose Expansion|Adverse Event|0|||
125303434|NCT01748825|450736757|FG004|Dose Expansion|Adverse Event|0|||
125303435|NCT01748825|450736758|FG005|Dose Expansion|Adverse Event|0|||
125303436|NCT01748825|450736759|FG006|Dose Expansion|Adverse Event|0|||
125303437|NCT01748825|450736760|FG007|Dose Expansion|Adverse Event|0|||
125303438|NCT01748825|450736761|FG008|Dose Expansion|Adverse Event|0|||
125303439|NCT01748825|450736762|FG009|Dose Expansion|Adverse Event|3|||
125303440|NCT01748825|450736753|FG000|Dose Expansion|Physician Decision|0|||
125303441|NCT01748825|450736754|FG001|Dose Expansion|Physician Decision|0|||
125490792|NCT00447980|451431775|FG000|Overall Study|Withdrawal by Subject|1|||
125490793|NCT00447980|451431776|FG001|Overall Study|Withdrawal by Subject|1|||
125490794|NCT00447980|451431777|FG002|Overall Study|Withdrawal by Subject|4|||
125490795|NCT00447980|451431778|FG003|Overall Study|Withdrawal by Subject|4|||
125490796|NCT00447980|451431775|FG000|Overall Study|Lost to Follow-up|1|||
125490797|NCT00447980|451431776|FG001|Overall Study|Lost to Follow-up|1|||
125490798|NCT00447980|451431777|FG002|Overall Study|Lost to Follow-up|0|||
125490799|NCT00447980|451431778|FG003|Overall Study|Lost to Follow-up|0|||
125490800|NCT00447980|451431775|FG000|Overall Study|Did not proceed with surgery|3|||
125490801|NCT00447980|451431776|FG001|Overall Study|Did not proceed with surgery|3|||
125490802|NCT00447980|451431777|FG002|Overall Study|Did not proceed with surgery|2|||
125490803|NCT00447980|451431778|FG003|Overall Study|Did not proceed with surgery|2|||
125490804|NCT03635567|451431781|FG000|Overall Study|Lost to Follow-up|4|||
125490805|NCT03635567|451431782|FG001|Overall Study|Lost to Follow-up|1|||
125490806|NCT03635567|451431781|FG000|Overall Study|Withdrawal by Subject|11|||
125490807|NCT03635567|451431782|FG001|Overall Study|Withdrawal by Subject|16|||
125490808|NCT03635567|451431781|FG000|Overall Study|Sponsor Decision|99|||
125490809|NCT03635567|451431782|FG001|Overall Study|Sponsor Decision|57|||
125490810|NCT03635567|451431781|FG000|Overall Study|Death|194|||
125490811|NCT03635567|451431782|FG001|Overall Study|Death|235|||
125490812|NCT05157841|451431783|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
125490813|NCT05157841|451431784|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
125490814|NCT05157841|451431785|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
125490815|NCT05157841|451431783|FG000|Part A (14 Days)|Adverse Event|1|||
125490816|NCT05157841|451431784|FG001|Part A (14 Days)|Adverse Event|0|||
125490817|NCT05157841|451431785|FG002|Part A (14 Days)|Adverse Event|0|||
125490818|NCT05157841|451431783|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
125490819|NCT05157841|451431784|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
125490820|NCT05157841|451431785|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
125490821|NCT04933474|451431788|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
125490822|NCT04933474|451431789|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
125490823|NCT04933474|451431788|FG000|Overall Study|Lost to Follow-up|19|||
125490824|NCT04933474|451431789|FG001|Overall Study|Lost to Follow-up|9|||
125490825|NCT04933474|451431788|FG000|Overall Study|Life Burden - unable to participate|6|||
125490826|NCT04933474|451431789|FG001|Overall Study|Life Burden - unable to participate|2|||
125490827|NCT04933474|451431788|FG000|Overall Study|Disease Burden - unable to participate|4|||
125490828|NCT04933474|451431789|FG001|Overall Study|Disease Burden - unable to participate|1|||
125490829|NCT04933474|451431788|FG000|Overall Study|Surgery/Hospitalization|1|||
125490830|NCT04933474|451431789|FG001|Overall Study|Surgery/Hospitalization|2|||
125490831|NCT04933474|451431788|FG000|Overall Study|Dissatisfied with Intervention|1|||
125490832|NCT04933474|451431789|FG001|Overall Study|Dissatisfied with Intervention|1|||
125490833|NCT04933474|451431788|FG000|Overall Study|Withdrew interest in participation|1|||
125490834|NCT04933474|451431789|FG001|Overall Study|Withdrew interest in participation|0|||
125490835|NCT04933474|451431788|FG000|Overall Study|Had previously enrolled in the study|0|||
125490836|NCT04933474|451431789|FG001|Overall Study|Had previously enrolled in the study|1|||
125490837|NCT04174170|451431790|FG000|Placebo Run-in Period|Not Randomized|38|||
125490838|NCT04174170|451431791|FG001|Placebo Run-in Period|Not Randomized|0|||
125490839|NCT04174170|451431792|FG002|Placebo Run-in Period|Not Randomized|0|||
125490840|NCT04174170|451431793|FG003|Placebo Run-in Period|Not Randomized|0|||
125490841|NCT04174170|451431790|FG000|Double Blind Treatment Period|Adverse Event|0|||
125490842|NCT04174170|451431791|FG001|Double Blind Treatment Period|Adverse Event|9|||
125490843|NCT04174170|451431792|FG002|Double Blind Treatment Period|Adverse Event|9|||
125490844|NCT04174170|451431793|FG003|Double Blind Treatment Period|Adverse Event|8|||
125490845|NCT04174170|451431790|FG000|Double Blind Treatment Period|Death|0|||
125490846|NCT04174170|451431791|FG001|Double Blind Treatment Period|Death|1|||
125490847|NCT04174170|451431792|FG002|Double Blind Treatment Period|Death|0|||
125490848|NCT04174170|451431793|FG003|Double Blind Treatment Period|Death|0|||
125490849|NCT04174170|451431790|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
125490850|NCT04174170|451431791|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
125490851|NCT04174170|451431792|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
125490852|NCT04174170|451431793|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
125490853|NCT04174170|451431790|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
125490854|NCT04174170|451431791|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
125490855|NCT04174170|451431792|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
125490856|NCT04174170|451431793|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
125490857|NCT04174170|451431790|FG000|Double Blind Treatment Period|Physician Decision|0|||
125490858|NCT04174170|451431791|FG001|Double Blind Treatment Period|Physician Decision|1|||
125490859|NCT04174170|451431792|FG002|Double Blind Treatment Period|Physician Decision|0|||
125490860|NCT04174170|451431793|FG003|Double Blind Treatment Period|Physician Decision|1|||
125490861|NCT04174170|451431790|FG000|Double Blind Treatment Period|Pregnancy|0|||
125490862|NCT04174170|451431791|FG001|Double Blind Treatment Period|Pregnancy|1|||
125490863|NCT04174170|451431792|FG002|Double Blind Treatment Period|Pregnancy|0|||
125490864|NCT04174170|451431793|FG003|Double Blind Treatment Period|Pregnancy|1|||
125490865|NCT04174170|451431790|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
125490866|NCT04174170|451431791|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
125490867|NCT04174170|451431792|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
125490868|NCT04174170|451431793|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
125490869|NCT04174170|451431790|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
125490870|NCT04174170|451431791|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
125490871|NCT04174170|451431792|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
125490872|NCT04174170|451431793|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
125490873|NCT04174170|451431790|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
125490874|NCT04174170|451431791|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
125490875|NCT04174170|451431792|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
125490876|NCT04174170|451431793|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
125490877|NCT00942734|451431799|FG000|Overall Study|Adverse Event|2|||
125303442|NCT01748825|450736755|FG002|Dose Expansion|Physician Decision|0|||
125303443|NCT01748825|450736756|FG003|Dose Expansion|Physician Decision|0|||
125303444|NCT01748825|450736757|FG004|Dose Expansion|Physician Decision|0|||
125303445|NCT01748825|450736758|FG005|Dose Expansion|Physician Decision|0|||
125303446|NCT01748825|450736759|FG006|Dose Expansion|Physician Decision|0|||
125303447|NCT01748825|450736760|FG007|Dose Expansion|Physician Decision|0|||
125303448|NCT01748825|450736761|FG008|Dose Expansion|Physician Decision|1|||
125303449|NCT01748825|450736762|FG009|Dose Expansion|Physician Decision|0|||
125490878|NCT00942734|451431799|FG000|Overall Study|Protocol Violation|3|||
125490879|NCT00942734|451431799|FG000|Overall Study|Disease Progression|2|||
125490880|NCT00942734|451431799|FG000|Overall Study|Physician Decision|1|||
125490881|NCT04908930|451431808|FG000|Overall Study|Lost to Follow-up|1|||
125490882|NCT04908930|451431809|FG001|Overall Study|Lost to Follow-up|1|||
125490883|NCT04908930|451431810|FG002|Overall Study|Lost to Follow-up|0|||
125490884|NCT04908930|451431811|FG003|Overall Study|Lost to Follow-up|0|||
125490885|NCT04908930|451431812|FG004|Overall Study|Lost to Follow-up|0|||
125490886|NCT04908930|451431808|FG000|Overall Study|hardware in mouth|1|||
125490887|NCT04908930|451431809|FG001|Overall Study|hardware in mouth|1|||
125490888|NCT04908930|451431810|FG002|Overall Study|hardware in mouth|0|||
125490889|NCT04908930|451431811|FG003|Overall Study|hardware in mouth|0|||
125303450|NCT00852241|450736764|FG000|Overall Study|Physician Decision|18|||
125303451|NCT00118430|450736766|FG000|Overall Study|Withdrawal by Subject|6|||
125303452|NCT00118430|450736767|FG001|Overall Study|Withdrawal by Subject|2|||
125490890|NCT04908930|451431812|FG004|Overall Study|hardware in mouth|0|||
125490891|NCT04908930|451431808|FG000|Overall Study|wrong team|1|||
125490892|NCT04908930|451431809|FG001|Overall Study|wrong team|0|||
125490893|NCT04908930|451431810|FG002|Overall Study|wrong team|0|||
125490894|NCT04908930|451431811|FG003|Overall Study|wrong team|0|||
125490895|NCT04908930|451431812|FG004|Overall Study|wrong team|0|||
125490896|NCT04908930|451431808|FG000|Overall Study|quit team|2|||
125490897|NCT04908930|451431809|FG001|Overall Study|quit team|4|||
125490898|NCT04908930|451431810|FG002|Overall Study|quit team|0|||
125490899|NCT04908930|451431811|FG003|Overall Study|quit team|0|||
125490900|NCT04908930|451431812|FG004|Overall Study|quit team|0|||
125490901|NCT04908930|451431808|FG000|Overall Study|Withdrawal by Subject|1|||
125490902|NCT04908930|451431809|FG001|Overall Study|Withdrawal by Subject|2|||
125490903|NCT04908930|451431810|FG002|Overall Study|Withdrawal by Subject|0|||
125490904|NCT04908930|451431811|FG003|Overall Study|Withdrawal by Subject|0|||
125490905|NCT04908930|451431812|FG004|Overall Study|Withdrawal by Subject|0|||
125490906|NCT04908930|451431808|FG000|Overall Study|parent not liking program|0|||
125490907|NCT04908930|451431809|FG001|Overall Study|parent not liking program|1|||
125490908|NCT04908930|451431810|FG002|Overall Study|parent not liking program|0|||
125490909|NCT04908930|451431811|FG003|Overall Study|parent not liking program|0|||
125490910|NCT04908930|451431812|FG004|Overall Study|parent not liking program|0|||
125490911|NCT04586244|451431813|FG000|Overall Study|Lost to Follow-up|1|||
125490912|NCT04586244|451431814|FG001|Overall Study|Lost to Follow-up|0|||
125490913|NCT04586244|451431815|FG002|Overall Study|Lost to Follow-up|0|||
125490914|NCT04586244|451431816|FG003|Overall Study|Lost to Follow-up|1|||
125490915|NCT04586244|451431817|FG004|Overall Study|Lost to Follow-up|0|||
125490916|NCT04586244|451431813|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
125490917|NCT04586244|451431814|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
125490918|NCT04586244|451431815|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
125490919|NCT04586244|451431816|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
125490920|NCT04586244|451431817|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
125490921|NCT05771467|451431819|FG000|Overall Study|Lost to Follow-up|6|||
125490922|NCT05771467|451431820|FG001|Overall Study|Lost to Follow-up|3|||
125490923|NCT01220531|451431823|FG000|Overall Study|Death|7|||
125490924|NCT01220531|451431823|FG000|Overall Study|Lost to Follow-up|1|||
125490925|NCT04873232|451431824|FG000|Overall Study|Lost to Follow-up|1|||
125490926|NCT04873232|451431825|FG001|Overall Study|Lost to Follow-up|4|||
125303453|NCT00118430|450736768|FG002|Overall Study|Withdrawal by Subject|0|||
125303454|NCT00118430|450736766|FG000|Overall Study|Lost to Follow-up|15|||
125490927|NCT04873232|451431824|FG000|Overall Study|Withdrawal by Subject|1|||
125490928|NCT04873232|451431825|FG001|Overall Study|Withdrawal by Subject|0|||
125490929|NCT02325154|451431828|FG000|Overall Study|Physician Decision|1|||
125490930|NCT00709956|451431829|FG000|Overall Study|Withdrawal by Subject|1|||
125490931|NCT00709956|451431830|FG001|Overall Study|Withdrawal by Subject|1|||
125490932|NCT00709956|451431829|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
125490933|NCT00709956|451431830|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
125490934|NCT03008382|451431831|FG000|Overall Study|Withdrawal by Subject|2|||
125490935|NCT03008382|451431832|FG001|Overall Study|Withdrawal by Subject|5|||
125490936|NCT03008382|451431833|FG002|Overall Study|Withdrawal by Subject|2|||
125490937|NCT03008382|451431834|FG003|Overall Study|Withdrawal by Subject|0|||
125490938|NCT03008382|451431831|FG000|Overall Study|Protocol Violation|1|||
125490939|NCT03008382|451431832|FG001|Overall Study|Protocol Violation|0|||
125490940|NCT03008382|451431833|FG002|Overall Study|Protocol Violation|0|||
125490941|NCT03008382|451431834|FG003|Overall Study|Protocol Violation|0|||
125490942|NCT03008382|451431831|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
125490943|NCT03008382|451431832|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
125490944|NCT03008382|451431833|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
125490945|NCT03008382|451431834|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
125490946|NCT03008382|451431831|FG000|Overall Study|Lost to Follow-up|0|||
125490947|NCT03008382|451431832|FG001|Overall Study|Lost to Follow-up|0|||
125490948|NCT03008382|451431833|FG002|Overall Study|Lost to Follow-up|1|||
125490949|NCT03008382|451431834|FG003|Overall Study|Lost to Follow-up|0|||
125490950|NCT03008382|451431831|FG000|Overall Study|Screenfail|0|||
125490951|NCT03008382|451431832|FG001|Overall Study|Screenfail|0|||
125490952|NCT03008382|451431833|FG002|Overall Study|Screenfail|2|||
125490953|NCT03008382|451431834|FG003|Overall Study|Screenfail|0|||
125490954|NCT02611687|451432413|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
125490955|NCT02611687|451432414|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
125490956|NCT03983382|451432418|FG000|Overall Study|Death|1|||
125490957|NCT03983382|451432418|FG000|Overall Study|Lost to Follow-up|3|||
125490958|NCT03983382|451432418|FG000|Overall Study|Physician Decision|2|||
125490959|NCT03983382|451432418|FG000|Overall Study|Withdrawal by Subject|10|||
125490960|NCT03983382|451432418|FG000|Overall Study|Change in cancer treatment|2|||
125490961|NCT04165213|451432419|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
125490962|NCT04165213|451432420|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
125490963|NCT04165213|451432419|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
125490964|NCT04165213|451432420|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
125490965|NCT04165213|451432419|FG000|Clinician Enrollment|Termination from site|0|||
125490966|NCT04165213|451432420|FG001|Clinician Enrollment|Termination from site|1|||
125490967|NCT04165213|451432419|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
125490968|NCT04165213|451432420|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
125490969|NCT04165213|451432419|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
125490970|NCT04165213|451432420|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
125490971|NCT04165213|451432419|FG000|Caregiver Enrollment|Physician Decision|1|||
125490972|NCT04165213|451432420|FG001|Caregiver Enrollment|Physician Decision|0|||
125490973|NCT04165213|451432419|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
125490974|NCT04165213|451432420|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
125490975|NCT04165213|451432419|FG000|Caregiver Enrollment|PLWD death|2|||
125490976|NCT04165213|451432420|FG001|Caregiver Enrollment|PLWD death|0|||
125490977|NCT04165213|451432419|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
125490978|NCT04165213|451432420|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
125490979|NCT04165213|451432419|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
125490980|NCT04165213|451432420|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
125490981|NCT04165213|451432419|FG000|PLWD Enrollment|Lost to Follow-up|1|||
125490982|NCT04165213|451432420|FG001|PLWD Enrollment|Lost to Follow-up|1|||
125490983|NCT04165213|451432419|FG000|PLWD Enrollment|Physician Decision|1|||
125490984|NCT04165213|451432420|FG001|PLWD Enrollment|Physician Decision|0|||
125490985|NCT04165213|451432419|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
125490986|NCT04165213|451432420|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
125490987|NCT04165213|451432419|FG000|PLWD Enrollment|Death|2|||
125490988|NCT04165213|451432420|FG001|PLWD Enrollment|Death|0|||
125490989|NCT04165213|451432419|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
125490990|NCT04165213|451432420|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
125490991|NCT04772534|451432427|FG000|Overall Study|Physician Decision|1|||
125490992|NCT04772534|451432428|FG001|Overall Study|Physician Decision|0|||
125490993|NCT04772534|451432429|FG002|Overall Study|Physician Decision|0|||
125490994|NCT04772534|451432427|FG000|Overall Study|Withdrawal by Subject|3|||
125490995|NCT04772534|451432428|FG001|Overall Study|Withdrawal by Subject|0|||
125490996|NCT04772534|451432429|FG002|Overall Study|Withdrawal by Subject|1|||
125490997|NCT04194450|451432430|FG000|Overall Study|not eligible|1|||
125490998|NCT04194450|451432431|FG001|Overall Study|not eligible|0|||
125490999|NCT00328783|451432443|FG000|Overall Study|Could not tolerate ABC|21|||
125491000|NCT00328783|451432443|FG000|Overall Study|No heart in RT field|4|||
125491001|NCT00328783|451432443|FG000|Overall Study|Withdrawal by Subject|1|||
125491002|NCT03242915|451432451|FG000|Overall Study|Adverse Event|5|||
125491003|NCT03242915|451432452|FG001|Overall Study|Adverse Event|1|||
125491004|NCT03242915|451432451|FG000|Overall Study|Withdrawal by Subject|0|||
125491005|NCT03242915|451432452|FG001|Overall Study|Withdrawal by Subject|2|||
125491006|NCT03242915|451432451|FG000|Overall Study|Physician Decision|4|||
125491007|NCT03242915|451432452|FG001|Overall Study|Physician Decision|1|||
125491008|NCT05988398|451432453|FG000|Overall Study|Lack of time|21|||
125491009|NCT05988398|451432454|FG001|Overall Study|Lack of time|0|||
125491010|NCT05988398|451432453|FG000|Overall Study|Absent from school|0|||
125491011|NCT05988398|451432454|FG001|Overall Study|Absent from school|38|||
125491012|NCT05988398|451432453|FG000|Overall Study|Chose not to participate|0|||
125491013|NCT05988398|451432454|FG001|Overall Study|Chose not to participate|42|||
125491014|NCT05988398|451432453|FG000|Overall Study|Other commitments (e.g., sports)|0|||
125491015|NCT05988398|451432454|FG001|Overall Study|Other commitments (e.g., sports)|25|||
125491016|NCT03872466|451432467|FG000|Overall Study|Withdrawal by Subject|1|||
125491017|NCT03872466|451432468|FG001|Overall Study|Withdrawal by Subject|0|||
125491018|NCT03872466|451432467|FG000|Overall Study|Physician Decision|2|||
125491019|NCT03872466|451432468|FG001|Overall Study|Physician Decision|0|||
125491020|NCT01778686|451432469|FG000|Overall Study|Adverse Event|0|||
125491021|NCT01778686|451432470|FG001|Overall Study|Adverse Event|0|||
125491022|NCT01778686|451432471|FG002|Overall Study|Adverse Event|1|||
125491023|NCT01499368|451432472|FG000|Overall Study|Did not meet I/E criteria|8|||
125491024|NCT01499368|451432473|FG001|Overall Study|Did not meet I/E criteria|4|||
125491025|NCT01499368|451432474|FG002|Overall Study|Did not meet I/E criteria|4|||
125491026|NCT01499368|451432472|FG000|Overall Study|Prohibited Concomitant medication|1|||
125491027|NCT01499368|451432473|FG001|Overall Study|Prohibited Concomitant medication|1|||
125491028|NCT01499368|451432474|FG002|Overall Study|Prohibited Concomitant medication|0|||
125491029|NCT01499368|451432472|FG000|Overall Study|Withdrawal by Subject|11|||
125491030|NCT01499368|451432473|FG001|Overall Study|Withdrawal by Subject|10|||
125491031|NCT01499368|451432474|FG002|Overall Study|Withdrawal by Subject|8|||
125491032|NCT01499368|451432472|FG000|Overall Study|Lost to Follow-up|3|||
125491033|NCT01499368|451432473|FG001|Overall Study|Lost to Follow-up|2|||
125491034|NCT01499368|451432474|FG002|Overall Study|Lost to Follow-up|5|||
125491035|NCT01499368|451432472|FG000|Overall Study|Adverse Event|4|||
125491036|NCT01499368|451432473|FG001|Overall Study|Adverse Event|0|||
125491037|NCT01499368|451432474|FG002|Overall Study|Adverse Event|2|||
125491038|NCT01499368|451432472|FG000|Overall Study|Physician Decision|0|||
125491039|NCT01499368|451432473|FG001|Overall Study|Physician Decision|1|||
125491040|NCT01499368|451432474|FG002|Overall Study|Physician Decision|0|||
125491041|NCT01499368|451432472|FG000|Overall Study|Deviation from visit window|0|||
125491042|NCT01499368|451432473|FG001|Overall Study|Deviation from visit window|0|||
125491043|NCT01499368|451432474|FG002|Overall Study|Deviation from visit window|1|||
125491044|NCT01499368|451432472|FG000|Overall Study|Error of Prescriptions|0|||
125491045|NCT01499368|451432473|FG001|Overall Study|Error of Prescriptions|0|||
125491046|NCT01499368|451432474|FG002|Overall Study|Error of Prescriptions|1|||
125491047|NCT06059443|451432475|FG000|Overall Study|Withdrawal by Subject|2|||
125491048|NCT06059443|451432476|FG001|Overall Study|Withdrawal by Subject|0|||
125491049|NCT06059443|451432475|FG000|Overall Study|Lost to Follow-up|2|||
125491050|NCT06059443|451432476|FG001|Overall Study|Lost to Follow-up|2|||
125491051|NCT03092674|451432477|FG000|Overall Study|Adverse Event or Side Effects|1|||
125491052|NCT03092674|451432478|FG001|Overall Study|Adverse Event or Side Effects|4|||
125491053|NCT03092674|451432479|FG002|Overall Study|Adverse Event or Side Effects|4|||
125491054|NCT03092674|451432477|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
125491055|NCT03092674|451432478|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
125491056|NCT03092674|451432479|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
125491057|NCT03092674|451432477|FG000|Overall Study|Progression/Relapse|5|||
125491058|NCT03092674|451432478|FG001|Overall Study|Progression/Relapse|4|||
125491059|NCT03092674|451432479|FG002|Overall Study|Progression/Relapse|8|||
125491060|NCT03092674|451432477|FG000|Overall Study|Death|4|||
125491061|NCT03092674|451432478|FG001|Overall Study|Death|8|||
125491062|NCT03092674|451432479|FG002|Overall Study|Death|2|||
125491063|NCT03092674|451432477|FG000|Overall Study|Other - Not Protocol Specified|11|||
125491064|NCT03092674|451432478|FG001|Overall Study|Other - Not Protocol Specified|8|||
125491065|NCT03092674|451432479|FG002|Overall Study|Other - Not Protocol Specified|8|||
125491066|NCT01105091|451432480|FG000|Overall Study|Death|2|||
125491067|NCT01105091|451432481|FG001|Overall Study|Death|0|||
125491068|NCT03934931|451432959|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
125303455|NCT00118430|450736767|FG001|Overall Study|Lost to Follow-up|22|||
125491069|NCT03934931|451432960|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
125491070|NCT03934931|451432961|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
125491071|NCT04227899|451432963|FG000|Overall Study|Withdrawal by Subject|6|||
125491072|NCT04227899|451432964|FG001|Overall Study|Withdrawal by Subject|3|||
125491073|NCT04227899|451432963|FG000|Overall Study|Death|12|||
125491074|NCT04227899|451432964|FG001|Overall Study|Death|6|||
125491075|NCT04227899|451432963|FG000|Overall Study|Lost to Follow-up|2|||
125491076|NCT04227899|451432964|FG001|Overall Study|Lost to Follow-up|1|||
125303456|NCT00118430|450736768|FG002|Overall Study|Lost to Follow-up|28|||
125491077|NCT02989662|451432967|FG000|Overall Study|Lost to Follow-up|0|||
125491078|NCT02989662|451432968|FG001|Overall Study|Lost to Follow-up|0|||
125491079|NCT02989662|451432969|FG002|Overall Study|Lost to Follow-up|0|||
125491080|NCT02989662|451432970|FG003|Overall Study|Lost to Follow-up|2|||
125303457|NCT00659230|450736769|FG000|Overall Study|Lost to Follow-up|2|||
125491081|NCT02989662|451432967|FG000|Overall Study|Physician Decision|3|||
125491082|NCT02989662|451432968|FG001|Overall Study|Physician Decision|0|||
125491083|NCT02989662|451432969|FG002|Overall Study|Physician Decision|0|||
125491084|NCT02989662|451432970|FG003|Overall Study|Physician Decision|0|||
125491085|NCT02989662|451432967|FG000|Overall Study|Withdrawal by Subject|1|||
125491086|NCT02989662|451432968|FG001|Overall Study|Withdrawal by Subject|0|||
125491087|NCT02989662|451432969|FG002|Overall Study|Withdrawal by Subject|0|||
125491088|NCT02989662|451432970|FG003|Overall Study|Withdrawal by Subject|0|||
125491089|NCT00357682|451432971|FG000|Overall Study|Did not receive allocated Treatment|10|||
125491090|NCT00357682|451432972|FG001|Overall Study|Did not receive allocated Treatment|9|||
125491091|NCT00357682|451432973|FG002|Overall Study|Did not receive allocated Treatment|9|||
125491092|NCT00357682|451432974|FG003|Overall Study|Did not receive allocated Treatment|10|||
125491093|NCT00357682|451432971|FG000|Overall Study|Withdrew consent|6|||
125491094|NCT00357682|451432972|FG001|Overall Study|Withdrew consent|6|||
125491095|NCT00357682|451432973|FG002|Overall Study|Withdrew consent|5|||
125491096|NCT00357682|451432974|FG003|Overall Study|Withdrew consent|5|||
125491097|NCT00357682|451432971|FG000|Overall Study|Lost to Follow-up|39|||
125491098|NCT00357682|451432972|FG001|Overall Study|Lost to Follow-up|33|||
125491099|NCT00357682|451432973|FG002|Overall Study|Lost to Follow-up|26|||
125491100|NCT00357682|451432974|FG003|Overall Study|Lost to Follow-up|35|||
125491101|NCT00357682|451432971|FG000|Overall Study|Adverse Event|24|||
125491102|NCT00357682|451432972|FG001|Overall Study|Adverse Event|32|||
125491103|NCT00357682|451432973|FG002|Overall Study|Adverse Event|22|||
125491104|NCT00357682|451432974|FG003|Overall Study|Adverse Event|27|||
125491105|NCT00357682|451432971|FG000|Overall Study|Physician Decision|32|||
125491106|NCT00357682|451432972|FG001|Overall Study|Physician Decision|20|||
125491107|NCT00357682|451432973|FG002|Overall Study|Physician Decision|24|||
125491108|NCT00357682|451432974|FG003|Overall Study|Physician Decision|30|||
125491109|NCT00357682|451432971|FG000|Overall Study|Patient decision|73|||
125491110|NCT00357682|451432972|FG001|Overall Study|Patient decision|80|||
125491111|NCT00357682|451432973|FG002|Overall Study|Patient decision|51|||
125491112|NCT00357682|451432974|FG003|Overall Study|Patient decision|59|||
125491113|NCT00357682|451432971|FG000|Overall Study|Other reason|157|||
125491114|NCT00357682|451432972|FG001|Overall Study|Other reason|130|||
125491115|NCT00357682|451432973|FG002|Overall Study|Other reason|114|||
125491116|NCT00357682|451432974|FG003|Overall Study|Other reason|99|||
125491117|NCT04408755|451432978|FG000|Period A (Placebo lead-in)|Other|11|||
125491118|NCT04408755|451432979|FG001|Period A (Placebo lead-in)|Other|0|||
125491119|NCT04408755|451432980|FG002|Period A (Placebo lead-in)|Other|0|||
125491120|NCT04408755|451432981|FG003|Period A (Placebo lead-in)|Other|0|||
125491121|NCT04408755|451432978|FG000|Period B (Randomization Period)|Adverse Event|0|||
125491122|NCT04408755|451432979|FG001|Period B (Randomization Period)|Adverse Event|3|||
125491123|NCT04408755|451432980|FG002|Period B (Randomization Period)|Adverse Event|0|||
125491124|NCT04408755|451432981|FG003|Period B (Randomization Period)|Adverse Event|1|||
125491125|NCT04408755|451432978|FG000|Period B (Randomization Period)|Death|0|||
125491126|NCT04408755|451432979|FG001|Period B (Randomization Period)|Death|0|||
125491127|NCT04408755|451432980|FG002|Period B (Randomization Period)|Death|1|||
125491128|NCT04408755|451432981|FG003|Period B (Randomization Period)|Death|0|||
125491129|NCT04408755|451432978|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
125491130|NCT04408755|451432979|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
125491131|NCT04408755|451432980|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
125491132|NCT04408755|451432981|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
125491133|NCT04408755|451432978|FG000|Period B (Randomization Period)|Physician Decision|0|||
125491134|NCT04408755|451432979|FG001|Period B (Randomization Period)|Physician Decision|0|||
125491135|NCT04408755|451432980|FG002|Period B (Randomization Period)|Physician Decision|1|||
125491136|NCT04408755|451432981|FG003|Period B (Randomization Period)|Physician Decision|0|||
125491137|NCT04408755|451432978|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
125491138|NCT04408755|451432979|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
125491139|NCT04408755|451432980|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
125491140|NCT04408755|451432981|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
125491141|NCT04408755|451432978|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
125303458|NCT00659230|450736770|FG001|Overall Study|Lost to Follow-up|5|||
125491142|NCT04408755|451432979|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
125303459|NCT00659230|450736769|FG000|Overall Study|Lost source documentation|5|||
125303460|NCT00659230|450736770|FG001|Overall Study|Lost source documentation|4|||
125303461|NCT00659230|450736769|FG000|Overall Study|Did not return post-randomization|2|||
125303462|NCT00659230|450736770|FG001|Overall Study|Did not return post-randomization|3|||
125303463|NCT02069392|450736773|FG000|Overall Study|Withdrawal by Subject|4|||
125491143|NCT04408755|451432980|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
125491144|NCT04408755|451432981|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
125491145|NCT04408755|451432978|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
125491146|NCT04408755|451432979|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
125491147|NCT04408755|451432980|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
125303464|NCT02069392|450736774|FG001|Overall Study|Withdrawal by Subject|2|||
125491148|NCT04408755|451432981|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
125491149|NCT04408755|451432978|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
125491150|NCT04408755|451432979|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
125491151|NCT04408755|451432980|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
125491152|NCT04408755|451432981|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
125491153|NCT04408755|451432978|FG000|Period B (Randomization Period)|Reason not Specified|0|||
125491154|NCT04408755|451432979|FG001|Period B (Randomization Period)|Reason not Specified|1|||
125491155|NCT04408755|451432980|FG002|Period B (Randomization Period)|Reason not Specified|0|||
125491156|NCT04408755|451432981|FG003|Period B (Randomization Period)|Reason not Specified|2|||
125491157|NCT02726386|451432982|FG000|Overall Study|Adverse Event|17|||
125491158|NCT02726386|451432983|FG001|Overall Study|Adverse Event|20|||
125491159|NCT02726386|451432982|FG000|Overall Study|Withdrawal by Subject|14|||
125491160|NCT02726386|451432983|FG001|Overall Study|Withdrawal by Subject|28|||
125491161|NCT02726386|451432982|FG000|Overall Study|Other reasons|7|||
125491162|NCT02726386|451432983|FG001|Overall Study|Other reasons|8|||
125491163|NCT00308997|451432984|FG000|Overall Study|Subject feigned clinical data|0|||
125491164|NCT00308997|451432985|FG001|Overall Study|Subject feigned clinical data|1|||
125491165|NCT00308997|451432984|FG000|Overall Study|Unable to tolerate intervention|1|||
125491166|NCT00308997|451432985|FG001|Overall Study|Unable to tolerate intervention|0|||
125491167|NCT04490356|451432988|FG000|Overall Study|Lost to Follow-up|1|||
125491168|NCT03733626|451432989|FG000|Overall Study|Physician Decision|4|||
125491169|NCT03733626|451432990|FG001|Overall Study|Physician Decision|4|||
125491170|NCT05424718|451432993|FG000|Overall Study|Lost to Follow-up|5|||
125491171|NCT05424718|451432994|FG001|Overall Study|Lost to Follow-up|4|||
125491172|NCT03142009|451432995|FG000|Overall Study|Lost to Follow-up|45|||
125491173|NCT03142009|451432996|FG001|Overall Study|Lost to Follow-up|30|||
125491174|NCT01553149|451432999|FG000|Overall Study|Adverse Event|0|||
125491175|NCT01553149|451433000|FG001|Overall Study|Adverse Event|9|||
125491176|NCT01553149|451432999|FG000|Overall Study|Physician Decision|5|||
125491177|NCT01553149|451433000|FG001|Overall Study|Physician Decision|10|||
125491178|NCT01553149|451432999|FG000|Overall Study|Ineligible|0|||
125491179|NCT01553149|451433000|FG001|Overall Study|Ineligible|1|||
125491180|NCT03215706|451433010|FG000|Randomization|Adverse Event unrelated to study drug|1|||
125491181|NCT03215706|451433011|FG001|Randomization|Adverse Event unrelated to study drug|0|||
125491182|NCT03215706|451433010|FG000|Randomization|participant withdrew consent|1|||
125491183|NCT03215706|451433011|FG001|Randomization|participant withdrew consent|3|||
125491184|NCT03215706|451433010|FG000|Randomization|no longer meets study criteria|1|||
125491185|NCT03215706|451433011|FG001|Randomization|no longer meets study criteria|4|||
125491186|NCT03215706|451433010|FG000|Randomization|other reasons|0|||
125491187|NCT03215706|451433011|FG001|Randomization|other reasons|2|||
125491188|NCT03215706|451433010|FG000|Treatment Period|Disease Progression|150|||
125491189|NCT03215706|451433011|FG001|Treatment Period|Disease Progression|142|||
125491190|NCT03215706|451433010|FG000|Treatment Period|Study Drug Toxicity|53|||
125491191|NCT03215706|451433011|FG001|Treatment Period|Study Drug Toxicity|21|||
125491192|NCT03215706|451433010|FG000|Treatment Period|Death|2|||
125491193|NCT03215706|451433011|FG001|Treatment Period|Death|1|||
125491194|NCT03215706|451433010|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
125491195|NCT03215706|451433011|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
125491196|NCT03215706|451433010|FG000|Treatment Period|Request to D/C treatment|1|||
125491197|NCT03215706|451433011|FG001|Treatment Period|Request to D/C treatment|6|||
125491198|NCT03215706|451433010|FG000|Treatment Period|Participant withdrew consent|3|||
125491199|NCT03215706|451433011|FG001|Treatment Period|Participant withdrew consent|4|||
125491200|NCT03215706|451433010|FG000|Treatment Period|Lost to Follow-up|0|||
125491201|NCT03215706|451433011|FG001|Treatment Period|Lost to Follow-up|1|||
125491202|NCT03215706|451433010|FG000|Treatment Period|Other Reasons|4|||
125491203|NCT03215706|451433011|FG001|Treatment Period|Other Reasons|5|||
125491204|NCT03215706|451433010|FG000|Treatment Period|Ongoing in the treatment period|105|||
125491205|NCT03215706|451433011|FG001|Treatment Period|Ongoing in the treatment period|43|||
125491206|NCT00945724|451433012|FG000|Overall Study|Withdrawal by Subject|2|||
125491207|NCT00945724|451433012|FG000|Overall Study|Physician Decision|1|||
125491208|NCT00945724|451433012|FG000|Overall Study|Adverse Event|5|||
125491209|NCT00945724|451433012|FG000|Overall Study|Second malignancy|1|||
125491210|NCT00994643|451434004|FG000|Overall Study|Withdrawal by Subject|1|||
125491211|NCT05412004|451434006|FG000|Overall Study|Adverse Event|0|||
125491212|NCT05412004|451434007|FG001|Overall Study|Adverse Event|2|||
125491213|NCT05412004|451434008|FG002|Overall Study|Adverse Event|1|||
125491214|NCT05412004|451434009|FG003|Overall Study|Adverse Event|5|||
125491215|NCT05412004|451434006|FG000|Overall Study|Assigned Treatment by Mistake|5|||
125491216|NCT05412004|451434007|FG001|Overall Study|Assigned Treatment by Mistake|10|||
125491217|NCT05412004|451434008|FG002|Overall Study|Assigned Treatment by Mistake|2|||
125491218|NCT05412004|451434009|FG003|Overall Study|Assigned Treatment by Mistake|5|||
125491219|NCT05412004|451434006|FG000|Overall Study|Lost to Follow-up|3|||
125491220|NCT05412004|451434007|FG001|Overall Study|Lost to Follow-up|0|||
125491221|NCT05412004|451434008|FG002|Overall Study|Lost to Follow-up|0|||
125491222|NCT05412004|451434009|FG003|Overall Study|Lost to Follow-up|0|||
125491223|NCT05412004|451434006|FG000|Overall Study|Patient could not travel to site|0|||
125491224|NCT05412004|451434007|FG001|Overall Study|Patient could not travel to site|1|||
125491225|NCT05412004|451434008|FG002|Overall Study|Patient could not travel to site|0|||
125491226|NCT05412004|451434009|FG003|Overall Study|Patient could not travel to site|0|||
125491227|NCT05412004|451434006|FG000|Overall Study|Physician Decision|0|||
125491228|NCT05412004|451434007|FG001|Overall Study|Physician Decision|1|||
125491229|NCT05412004|451434008|FG002|Overall Study|Physician Decision|0|||
125491230|NCT05412004|451434009|FG003|Overall Study|Physician Decision|0|||
125491231|NCT05412004|451434006|FG000|Overall Study|Pregnancy|0|||
125491232|NCT05412004|451434007|FG001|Overall Study|Pregnancy|1|||
125491233|NCT05412004|451434008|FG002|Overall Study|Pregnancy|0|||
125491234|NCT05412004|451434009|FG003|Overall Study|Pregnancy|0|||
125491235|NCT05412004|451434006|FG000|Overall Study|Protocol Violation|1|||
125491236|NCT05412004|451434007|FG001|Overall Study|Protocol Violation|0|||
125491237|NCT05412004|451434008|FG002|Overall Study|Protocol Violation|0|||
125491238|NCT05412004|451434009|FG003|Overall Study|Protocol Violation|0|||
125491239|NCT05412004|451434006|FG000|Overall Study|Withdrawal by Subject|4|||
125491240|NCT05412004|451434007|FG001|Overall Study|Withdrawal by Subject|19|||
125491241|NCT05412004|451434008|FG002|Overall Study|Withdrawal by Subject|4|||
125491242|NCT05412004|451434009|FG003|Overall Study|Withdrawal by Subject|14|||
125491243|NCT05412004|451434006|FG000|Overall Study|Screen Failure|0|||
125491244|NCT05412004|451434007|FG001|Overall Study|Screen Failure|0|||
125491245|NCT05412004|451434008|FG002|Overall Study|Screen Failure|0|||
125491246|NCT05412004|451434009|FG003|Overall Study|Screen Failure|1|||
125491247|NCT05412004|451434006|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
125491248|NCT05412004|451434007|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
125491249|NCT05412004|451434008|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
125491250|NCT05412004|451434009|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
125491251|NCT00968149|451434010|FG000|Overall Study|Adverse Event|5|||
125491252|NCT00968149|451434011|FG001|Overall Study|Adverse Event|1|||
125491253|NCT00968149|451434010|FG000|Overall Study|Lack of Efficacy|0|||
125491254|NCT00968149|451434011|FG001|Overall Study|Lack of Efficacy|4|||
125491255|NCT00968149|451434010|FG000|Overall Study|Lost to Follow-up|0|||
125491256|NCT00968149|451434011|FG001|Overall Study|Lost to Follow-up|1|||
125491257|NCT00968149|451434010|FG000|Overall Study|Protocol Violation|4|||
125491258|NCT00968149|451434011|FG001|Overall Study|Protocol Violation|0|||
125491259|NCT00968149|451434010|FG000|Overall Study|Withdrawal by Subject|2|||
125491260|NCT00968149|451434011|FG001|Overall Study|Withdrawal by Subject|0|||
125491261|NCT02719574|451434012|FG000|Phase 1 (Dose Escalation)|Other|0|||
125491262|NCT02719574|451434013|FG001|Phase 1 (Dose Escalation)|Other|2|||
125491263|NCT02719574|451434014|FG002|Phase 1 (Dose Escalation)|Other|1|||
125491264|NCT02719574|451434015|FG003|Phase 1 (Dose Escalation)|Other|2|||
125491265|NCT02719574|451434016|FG004|Phase 1 (Dose Escalation)|Other|2|||
125491266|NCT02719574|451434017|FG005|Phase 1 (Dose Escalation)|Other|0|||
125491267|NCT02719574|451434018|FG006|Phase 1 (Dose Escalation)|Other|0|||
125491268|NCT02719574|451434019|FG007|Phase 1 (Dose Escalation)|Other|0|||
125491269|NCT02719574|451434020|FG008|Phase 1 (Dose Escalation)|Other|0|||
125491270|NCT02719574|451434021|FG009|Phase 1 (Dose Escalation)|Other|0|||
125491271|NCT02719574|451434022|FG010|Phase 1 (Dose Escalation)|Other|0|||
125491272|NCT02719574|451434023|FG011|Phase 1 (Dose Escalation)|Other|0|||
125491273|NCT02719574|451434024|FG012|Phase 1 (Dose Escalation)|Other|0|||
125491274|NCT02719574|451434025|FG013|Phase 1 (Dose Escalation)|Other|0|||
125491275|NCT02719574|451434026|FG014|Phase 1 (Dose Escalation)|Other|0|||
125491276|NCT02719574|451434027|FG015|Phase 1 (Dose Escalation)|Other|0|||
125491277|NCT02719574|451434028|FG016|Phase 1 (Dose Escalation)|Other|0|||
125491278|NCT02719574|451434012|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
125491279|NCT02719574|451434013|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
125491280|NCT02719574|451434014|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
125491281|NCT02719574|451434015|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
125491282|NCT02719574|451434016|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
125491283|NCT02719574|451434017|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
125491284|NCT02719574|451434018|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
125491285|NCT02719574|451434019|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
125491286|NCT02719574|451434020|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
125491287|NCT02719574|451434021|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
125491288|NCT02719574|451434022|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
125491289|NCT02719574|451434023|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
125491290|NCT02719574|451434024|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
125491291|NCT02719574|451434025|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
125491292|NCT02719574|451434026|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
125491293|NCT02719574|451434027|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
125491294|NCT02719574|451434028|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
125491295|NCT02719574|451434012|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125491296|NCT02719574|451434013|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
125491297|NCT02719574|451434014|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
125491298|NCT02719574|451434015|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125491299|NCT02719574|451434016|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
125491300|NCT02719574|451434017|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
125491301|NCT02719574|451434018|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125491302|NCT02719574|451434019|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125491303|NCT02719574|451434020|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125491304|NCT02719574|451434021|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125491305|NCT02719574|451434022|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125491306|NCT02719574|451434023|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125491307|NCT02719574|451434024|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125491308|NCT02719574|451434025|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125491309|NCT02719574|451434026|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125491310|NCT02719574|451434027|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125491311|NCT02719574|451434028|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
125491312|NCT02719574|451434012|FG000|Phase 1 (Dose Escalation)|Death|2|||
125491313|NCT02719574|451434013|FG001|Phase 1 (Dose Escalation)|Death|1|||
125491314|NCT02719574|451434014|FG002|Phase 1 (Dose Escalation)|Death|1|||
125491315|NCT02719574|451434015|FG003|Phase 1 (Dose Escalation)|Death|0|||
125491316|NCT02719574|451434016|FG004|Phase 1 (Dose Escalation)|Death|0|||
125491317|NCT02719574|451434017|FG005|Phase 1 (Dose Escalation)|Death|0|||
125491318|NCT02719574|451434018|FG006|Phase 1 (Dose Escalation)|Death|0|||
125491319|NCT02719574|451434019|FG007|Phase 1 (Dose Escalation)|Death|0|||
125491320|NCT02719574|451434020|FG008|Phase 1 (Dose Escalation)|Death|0|||
125491321|NCT02719574|451434021|FG009|Phase 1 (Dose Escalation)|Death|0|||
125491322|NCT02719574|451434022|FG010|Phase 1 (Dose Escalation)|Death|0|||
125491323|NCT02719574|451434023|FG011|Phase 1 (Dose Escalation)|Death|0|||
125491324|NCT02719574|451434024|FG012|Phase 1 (Dose Escalation)|Death|0|||
125491325|NCT02719574|451434025|FG013|Phase 1 (Dose Escalation)|Death|0|||
125491326|NCT02719574|451434026|FG014|Phase 1 (Dose Escalation)|Death|0|||
125491327|NCT02719574|451434027|FG015|Phase 1 (Dose Escalation)|Death|0|||
125491328|NCT02719574|451434028|FG016|Phase 1 (Dose Escalation)|Death|0|||
125491329|NCT02719574|451434012|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491330|NCT02719574|451434013|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
125491331|NCT02719574|451434014|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491332|NCT02719574|451434015|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491333|NCT02719574|451434016|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
125491334|NCT02719574|451434017|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
125491335|NCT02719574|451434018|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491336|NCT02719574|451434019|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491337|NCT02719574|451434020|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491338|NCT02719574|451434021|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491339|NCT02719574|451434022|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491340|NCT02719574|451434023|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491341|NCT02719574|451434024|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491342|NCT02719574|451434025|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491343|NCT02719574|451434026|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491344|NCT02719574|451434027|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491345|NCT02719574|451434028|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
125491346|NCT02719574|451434012|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491347|NCT02719574|451434013|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491348|NCT02719574|451434014|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491349|NCT02719574|451434015|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491350|NCT02719574|451434016|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
125491351|NCT02719574|451434017|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
125491352|NCT02719574|451434018|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491353|NCT02719574|451434019|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491354|NCT02719574|451434020|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491355|NCT02719574|451434021|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491356|NCT02719574|451434022|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491357|NCT02719574|451434023|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491358|NCT02719574|451434024|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491359|NCT02719574|451434025|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491360|NCT02719574|451434026|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491361|NCT02719574|451434027|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
125491362|NCT02719574|451434028|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
125303465|NCT00269633|450736775|FG000|Overall Study|Withdrawal by Subject|1|||
125303466|NCT00269633|450736776|FG001|Overall Study|Withdrawal by Subject|0|||
125491363|NCT02719574|451434012|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491364|NCT02719574|451434013|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491365|NCT02719574|451434014|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
125491366|NCT02719574|451434015|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491367|NCT02719574|451434016|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491368|NCT02719574|451434017|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491369|NCT02719574|451434018|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491370|NCT02719574|451434019|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491371|NCT02719574|451434020|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491372|NCT02719574|451434021|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491373|NCT02719574|451434022|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491374|NCT02719574|451434023|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491375|NCT02719574|451434024|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491376|NCT02719574|451434025|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491377|NCT02719574|451434026|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491378|NCT02719574|451434027|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491379|NCT02719574|451434028|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
125491380|NCT02719574|451434012|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491381|NCT02719574|451434013|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491382|NCT02719574|451434014|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491383|NCT02719574|451434015|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491384|NCT02719574|451434016|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491385|NCT02719574|451434017|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491386|NCT02719574|451434018|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
125491387|NCT02719574|451434019|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
125491388|NCT02719574|451434020|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
125491389|NCT02719574|451434021|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491390|NCT02719574|451434022|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491391|NCT02719574|451434023|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491392|NCT02719574|451434024|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491393|NCT02719574|451434025|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491394|NCT02719574|451434026|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491395|NCT02719574|451434027|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491396|NCT02719574|451434028|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
125491397|NCT02719574|451434012|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491398|NCT02719574|451434013|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491399|NCT02719574|451434014|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491400|NCT02719574|451434015|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491401|NCT02719574|451434016|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491402|NCT02719574|451434017|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491403|NCT02719574|451434018|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
125491404|NCT02719574|451434019|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
125491405|NCT02719574|451434020|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491406|NCT02719574|451434021|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491407|NCT02719574|451434022|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491408|NCT02719574|451434023|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491409|NCT02719574|451434024|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491410|NCT02719574|451434025|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491411|NCT02719574|451434026|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491412|NCT02719574|451434027|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491413|NCT02719574|451434028|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
125491414|NCT02719574|451434012|FG000|Phase 1 (Dose Expansion)|Death|0|||
125491415|NCT02719574|451434013|FG001|Phase 1 (Dose Expansion)|Death|0|||
125491416|NCT02719574|451434014|FG002|Phase 1 (Dose Expansion)|Death|0|||
125491417|NCT02719574|451434015|FG003|Phase 1 (Dose Expansion)|Death|0|||
125491418|NCT02719574|451434016|FG004|Phase 1 (Dose Expansion)|Death|0|||
125491419|NCT02719574|451434017|FG005|Phase 1 (Dose Expansion)|Death|0|||
125491420|NCT02719574|451434018|FG006|Phase 1 (Dose Expansion)|Death|1|||
125491421|NCT02719574|451434019|FG007|Phase 1 (Dose Expansion)|Death|6|||
125491422|NCT02719574|451434020|FG008|Phase 1 (Dose Expansion)|Death|0|||
125491423|NCT02719574|451434021|FG009|Phase 1 (Dose Expansion)|Death|0|||
125491424|NCT02719574|451434022|FG010|Phase 1 (Dose Expansion)|Death|0|||
125491425|NCT02719574|451434023|FG011|Phase 1 (Dose Expansion)|Death|0|||
125491426|NCT02719574|451434024|FG012|Phase 1 (Dose Expansion)|Death|0|||
125491427|NCT02719574|451434025|FG013|Phase 1 (Dose Expansion)|Death|0|||
125491428|NCT02719574|451434026|FG014|Phase 1 (Dose Expansion)|Death|0|||
125491429|NCT02719574|451434027|FG015|Phase 1 (Dose Expansion)|Death|0|||
125491430|NCT02719574|451434028|FG016|Phase 1 (Dose Expansion)|Death|0|||
125491431|NCT02719574|451434012|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491432|NCT02719574|451434013|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491433|NCT02719574|451434014|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491434|NCT02719574|451434015|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491435|NCT02719574|451434016|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491436|NCT02719574|451434017|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491437|NCT02719574|451434018|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
125491438|NCT02719574|451434019|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
125491439|NCT02719574|451434020|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491440|NCT02719574|451434021|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491441|NCT02719574|451434022|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491442|NCT02719574|451434023|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491443|NCT02719574|451434024|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491444|NCT02719574|451434025|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491445|NCT02719574|451434026|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491446|NCT02719574|451434027|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491447|NCT02719574|451434028|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
125491448|NCT02719574|451434012|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491449|NCT02719574|451434013|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491450|NCT02719574|451434014|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491451|NCT02719574|451434015|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491452|NCT02719574|451434016|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491453|NCT02719574|451434017|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491454|NCT02719574|451434018|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
125491455|NCT02719574|451434019|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
125491456|NCT02719574|451434020|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491457|NCT02719574|451434021|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491458|NCT02719574|451434022|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491459|NCT02719574|451434023|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491460|NCT02719574|451434024|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491461|NCT02719574|451434025|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491462|NCT02719574|451434026|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491463|NCT02719574|451434027|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491464|NCT02719574|451434028|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
125491465|NCT02719574|451434012|FG000|Phase 1 (Dose Expansion)|Other|0|||
125491466|NCT02719574|451434013|FG001|Phase 1 (Dose Expansion)|Other|0|||
125491467|NCT02719574|451434014|FG002|Phase 1 (Dose Expansion)|Other|0|||
125491468|NCT02719574|451434015|FG003|Phase 1 (Dose Expansion)|Other|0|||
125491469|NCT02719574|451434016|FG004|Phase 1 (Dose Expansion)|Other|0|||
125491470|NCT02719574|451434017|FG005|Phase 1 (Dose Expansion)|Other|0|||
125491471|NCT02719574|451434018|FG006|Phase 1 (Dose Expansion)|Other|1|||
125491472|NCT02719574|451434019|FG007|Phase 1 (Dose Expansion)|Other|7|||
125491473|NCT02719574|451434020|FG008|Phase 1 (Dose Expansion)|Other|0|||
125491474|NCT02719574|451434021|FG009|Phase 1 (Dose Expansion)|Other|0|||
125491475|NCT02719574|451434022|FG010|Phase 1 (Dose Expansion)|Other|0|||
125491476|NCT02719574|451434023|FG011|Phase 1 (Dose Expansion)|Other|0|||
125491477|NCT02719574|451434024|FG012|Phase 1 (Dose Expansion)|Other|0|||
125491478|NCT02719574|451434025|FG013|Phase 1 (Dose Expansion)|Other|0|||
125491479|NCT02719574|451434026|FG014|Phase 1 (Dose Expansion)|Other|0|||
125491480|NCT02719574|451434027|FG015|Phase 1 (Dose Expansion)|Other|0|||
125491481|NCT02719574|451434028|FG016|Phase 1 (Dose Expansion)|Other|0|||
125491482|NCT02719574|451434012|FG000|Phase 2|Protocol Defined Disease Progression|0|||
125491483|NCT02719574|451434013|FG001|Phase 2|Protocol Defined Disease Progression|0|||
125491484|NCT02719574|451434014|FG002|Phase 2|Protocol Defined Disease Progression|0|||
125491485|NCT02719574|451434015|FG003|Phase 2|Protocol Defined Disease Progression|0|||
125491486|NCT02719574|451434016|FG004|Phase 2|Protocol Defined Disease Progression|0|||
125491487|NCT02719574|451434017|FG005|Phase 2|Protocol Defined Disease Progression|0|||
125491488|NCT02719574|451434018|FG006|Phase 2|Protocol Defined Disease Progression|0|||
125491489|NCT02719574|451434019|FG007|Phase 2|Protocol Defined Disease Progression|0|||
125491490|NCT02719574|451434020|FG008|Phase 2|Protocol Defined Disease Progression|0|||
125491491|NCT02719574|451434021|FG009|Phase 2|Protocol Defined Disease Progression|65|||
125491492|NCT02719574|451434022|FG010|Phase 2|Protocol Defined Disease Progression|8|||
125491493|NCT02719574|451434023|FG011|Phase 2|Protocol Defined Disease Progression|2|||
125491494|NCT02719574|451434024|FG012|Phase 2|Protocol Defined Disease Progression|4|||
125491495|NCT02719574|451434025|FG013|Phase 2|Protocol Defined Disease Progression|9|||
125491496|NCT02719574|451434026|FG014|Phase 2|Protocol Defined Disease Progression|11|||
125491497|NCT02719574|451434027|FG015|Phase 2|Protocol Defined Disease Progression|3|||
125491498|NCT02719574|451434028|FG016|Phase 2|Protocol Defined Disease Progression|4|||
125491499|NCT02719574|451434012|FG000|Phase 2|Adverse Event|0|||
125491500|NCT02719574|451434013|FG001|Phase 2|Adverse Event|0|||
125491501|NCT02719574|451434014|FG002|Phase 2|Adverse Event|0|||
125491502|NCT02719574|451434015|FG003|Phase 2|Adverse Event|0|||
125491503|NCT02719574|451434016|FG004|Phase 2|Adverse Event|0|||
125491504|NCT02719574|451434017|FG005|Phase 2|Adverse Event|0|||
125491505|NCT02719574|451434018|FG006|Phase 2|Adverse Event|0|||
125491506|NCT02719574|451434019|FG007|Phase 2|Adverse Event|0|||
125491507|NCT02719574|451434020|FG008|Phase 2|Adverse Event|0|||
125491508|NCT02719574|451434021|FG009|Phase 2|Adverse Event|27|||
125491509|NCT02719574|451434022|FG010|Phase 2|Adverse Event|0|||
125491510|NCT02719574|451434023|FG011|Phase 2|Adverse Event|1|||
125491511|NCT02719574|451434024|FG012|Phase 2|Adverse Event|1|||
125491512|NCT02719574|451434025|FG013|Phase 2|Adverse Event|1|||
125491513|NCT02719574|451434026|FG014|Phase 2|Adverse Event|2|||
125491514|NCT02719574|451434027|FG015|Phase 2|Adverse Event|2|||
125491515|NCT02719574|451434028|FG016|Phase 2|Adverse Event|3|||
125491516|NCT02719574|451434012|FG000|Phase 2|Other|0|||
125491517|NCT02719574|451434013|FG001|Phase 2|Other|0|||
125491518|NCT02719574|451434014|FG002|Phase 2|Other|0|||
125491519|NCT02719574|451434015|FG003|Phase 2|Other|0|||
125491520|NCT02719574|451434016|FG004|Phase 2|Other|0|||
125491521|NCT02719574|451434017|FG005|Phase 2|Other|0|||
125491522|NCT02719574|451434018|FG006|Phase 2|Other|0|||
125491523|NCT02719574|451434019|FG007|Phase 2|Other|0|||
125491524|NCT02719574|451434020|FG008|Phase 2|Other|0|||
125491525|NCT02719574|451434021|FG009|Phase 2|Other|20|||
125491526|NCT02719574|451434022|FG010|Phase 2|Other|7|||
125491527|NCT02719574|451434023|FG011|Phase 2|Other|0|||
125491528|NCT02719574|451434024|FG012|Phase 2|Other|5|||
125491529|NCT02719574|451434025|FG013|Phase 2|Other|7|||
125491530|NCT02719574|451434026|FG014|Phase 2|Other|0|||
125491531|NCT02719574|451434027|FG015|Phase 2|Other|1|||
125491532|NCT02719574|451434028|FG016|Phase 2|Other|4|||
125491533|NCT02719574|451434012|FG000|Phase 2|Transplant|0|||
125491534|NCT02719574|451434013|FG001|Phase 2|Transplant|0|||
125491535|NCT02719574|451434014|FG002|Phase 2|Transplant|0|||
125491536|NCT02719574|451434015|FG003|Phase 2|Transplant|0|||
125491537|NCT02719574|451434016|FG004|Phase 2|Transplant|0|||
125491538|NCT02719574|451434017|FG005|Phase 2|Transplant|0|||
125491539|NCT02719574|451434018|FG006|Phase 2|Transplant|0|||
125491540|NCT02719574|451434019|FG007|Phase 2|Transplant|0|||
125491541|NCT02719574|451434020|FG008|Phase 2|Transplant|0|||
125491542|NCT02719574|451434021|FG009|Phase 2|Transplant|15|||
125491543|NCT02719574|451434022|FG010|Phase 2|Transplant|2|||
125491544|NCT02719574|451434023|FG011|Phase 2|Transplant|0|||
125491545|NCT02719574|451434024|FG012|Phase 2|Transplant|6|||
125491546|NCT02719574|451434025|FG013|Phase 2|Transplant|1|||
125491547|NCT02719574|451434026|FG014|Phase 2|Transplant|1|||
125303467|NCT04412707|450736777|FG000|Cycle 1|Death|0|||
125303468|NCT04412707|450736778|FG001|Cycle 1|Death|3|||
125303469|NCT04412707|450736777|FG000|Cycle 1|Disease progression|1|||
125303470|NCT04412707|450736778|FG001|Cycle 1|Disease progression|2|||
125303471|NCT04412707|450736777|FG000|Cycle 2|Death|0|||
125303472|NCT04412707|450736778|FG001|Cycle 2|Death|1|||
125303473|NCT04412707|450736777|FG000|Cycle 2|Disease progression|3|||
125303474|NCT04412707|450736778|FG001|Cycle 2|Disease progression|0|||
125303475|NCT04412707|450736777|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
125303476|NCT04412707|450736778|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
125303477|NCT04412707|450736777|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
125303478|NCT04412707|450736778|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
125303479|NCT04412707|450736777|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
125303480|NCT04412707|450736778|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
125303481|NCT04412707|450736777|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
125303482|NCT04412707|450736778|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
125303483|NCT02476006|450736779|FG000|Overall Study|Death|4|||
125303484|NCT02476006|450736779|FG000|Overall Study|Lack of treatment efficacy|2|||
125303485|NCT02476006|450736779|FG000|Overall Study|Pregnancy|1|||
125303486|NCT02476006|450736779|FG000|Overall Study|Participant did not wish to continue|39|||
125303487|NCT02476006|450736779|FG000|Overall Study|Adverse Event|41|||
125303488|NCT02476006|450736779|FG000|Overall Study|Poor compliance to study protocol|3|||
125303489|NCT02476006|450736779|FG000|Overall Study|Sponsor decision|6|||
125303490|NCT02476006|450736779|FG000|Overall Study|Lost to Follow-up|5|||
125303491|NCT02476006|450736779|FG000|Overall Study|Physician Decision|5|||
125303492|NCT02476006|450736779|FG000|Overall Study|Study ended treatment not available|4|||
125303493|NCT02476006|450736779|FG000|Overall Study|Switched to commercial drug|4|||
125303494|NCT02476006|450736779|FG000|Overall Study|Excluded from study|1|||
125303495|NCT02476006|450736779|FG000|Overall Study|Protocol Violation|1|||
125303496|NCT02476006|450736779|FG000|Overall Study|Enrolled but not treated|4|||
125303497|NCT03210961|450739445|FG000|Overall Study|Adverse Event|0|||
125303498|NCT03210961|450739446|FG001|Overall Study|Adverse Event|0|||
125303499|NCT03210961|450739447|FG002|Overall Study|Adverse Event|0|||
125303500|NCT03210961|450739448|FG003|Overall Study|Adverse Event|0|||
125303501|NCT03210961|450739449|FG004|Overall Study|Adverse Event|0|||
125303502|NCT03210961|450739450|FG005|Overall Study|Adverse Event|0|||
125303503|NCT03210961|450739451|FG006|Overall Study|Adverse Event|0|||
125303504|NCT03210961|450739452|FG007|Overall Study|Adverse Event|0|||
125491548|NCT02719574|451434027|FG015|Phase 2|Transplant|0|||
125491549|NCT02719574|451434028|FG016|Phase 2|Transplant|0|||
125491550|NCT02719574|451434012|FG000|Phase 2|Death|0|||
125491551|NCT02719574|451434013|FG001|Phase 2|Death|0|||
125303505|NCT03210961|450739453|FG008|Overall Study|Adverse Event|0|||
125303506|NCT03210961|450739454|FG009|Overall Study|Adverse Event|0|||
125303507|NCT03210961|450739455|FG010|Overall Study|Adverse Event|0|||
125303508|NCT03210961|450739456|FG011|Overall Study|Adverse Event|0|||
125303509|NCT03210961|450739457|FG012|Overall Study|Adverse Event|0|||
125491552|NCT02719574|451434014|FG002|Phase 2|Death|0|||
125303510|NCT03210961|450739458|FG013|Overall Study|Adverse Event|1|||
125303511|NCT03210961|450739459|FG014|Overall Study|Adverse Event|0|||
125303512|NCT03210961|450739445|FG000|Overall Study|Lost to Follow-up|0|||
125491553|NCT02719574|451434015|FG003|Phase 2|Death|0|||
125491554|NCT02719574|451434016|FG004|Phase 2|Death|0|||
125491555|NCT02719574|451434017|FG005|Phase 2|Death|0|||
125491556|NCT02719574|451434018|FG006|Phase 2|Death|0|||
125491557|NCT02719574|451434019|FG007|Phase 2|Death|0|||
125491558|NCT02719574|451434020|FG008|Phase 2|Death|0|||
125491559|NCT02719574|451434021|FG009|Phase 2|Death|14|||
125491560|NCT02719574|451434022|FG010|Phase 2|Death|0|||
125491561|NCT02719574|451434023|FG011|Phase 2|Death|0|||
125491562|NCT02719574|451434024|FG012|Phase 2|Death|1|||
125491563|NCT02719574|451434025|FG013|Phase 2|Death|1|||
125491564|NCT02719574|451434026|FG014|Phase 2|Death|2|||
125491565|NCT02719574|451434027|FG015|Phase 2|Death|0|||
125491566|NCT02719574|451434028|FG016|Phase 2|Death|0|||
125491567|NCT02719574|451434012|FG000|Phase 2|Investigator Decision|0|||
125491568|NCT02719574|451434013|FG001|Phase 2|Investigator Decision|0|||
125491569|NCT02719574|451434014|FG002|Phase 2|Investigator Decision|0|||
125491570|NCT02719574|451434015|FG003|Phase 2|Investigator Decision|0|||
125491571|NCT02719574|451434016|FG004|Phase 2|Investigator Decision|0|||
125491572|NCT02719574|451434017|FG005|Phase 2|Investigator Decision|0|||
125491573|NCT02719574|451434018|FG006|Phase 2|Investigator Decision|0|||
125491574|NCT02719574|451434019|FG007|Phase 2|Investigator Decision|0|||
125491575|NCT02719574|451434020|FG008|Phase 2|Investigator Decision|0|||
125491576|NCT02719574|451434021|FG009|Phase 2|Investigator Decision|6|||
125491577|NCT02719574|451434022|FG010|Phase 2|Investigator Decision|1|||
125491578|NCT02719574|451434023|FG011|Phase 2|Investigator Decision|2|||
125491579|NCT02719574|451434024|FG012|Phase 2|Investigator Decision|3|||
125491580|NCT02719574|451434025|FG013|Phase 2|Investigator Decision|1|||
125491581|NCT02719574|451434026|FG014|Phase 2|Investigator Decision|3|||
125491582|NCT02719574|451434027|FG015|Phase 2|Investigator Decision|2|||
125491583|NCT02719574|451434028|FG016|Phase 2|Investigator Decision|0|||
125491584|NCT02719574|451434012|FG000|Phase 2|Withdrawal by Subject|0|||
125491585|NCT02719574|451434013|FG001|Phase 2|Withdrawal by Subject|0|||
125491586|NCT02719574|451434014|FG002|Phase 2|Withdrawal by Subject|0|||
125491587|NCT02719574|451434015|FG003|Phase 2|Withdrawal by Subject|0|||
125491588|NCT02719574|451434016|FG004|Phase 2|Withdrawal by Subject|0|||
125491589|NCT02719574|451434017|FG005|Phase 2|Withdrawal by Subject|0|||
125491590|NCT02719574|451434018|FG006|Phase 2|Withdrawal by Subject|0|||
125491591|NCT02719574|451434019|FG007|Phase 2|Withdrawal by Subject|0|||
125491592|NCT02719574|451434020|FG008|Phase 2|Withdrawal by Subject|0|||
125491593|NCT02719574|451434021|FG009|Phase 2|Withdrawal by Subject|5|||
125491594|NCT02719574|451434022|FG010|Phase 2|Withdrawal by Subject|0|||
125491595|NCT02719574|451434023|FG011|Phase 2|Withdrawal by Subject|0|||
125491596|NCT02719574|451434024|FG012|Phase 2|Withdrawal by Subject|0|||
125491597|NCT02719574|451434025|FG013|Phase 2|Withdrawal by Subject|1|||
125491598|NCT02719574|451434026|FG014|Phase 2|Withdrawal by Subject|1|||
125491599|NCT02719574|451434027|FG015|Phase 2|Withdrawal by Subject|2|||
125491600|NCT02719574|451434028|FG016|Phase 2|Withdrawal by Subject|0|||
125491601|NCT02719574|451434012|FG000|Phase 2|Protocol Violation|0|||
125491602|NCT02719574|451434013|FG001|Phase 2|Protocol Violation|0|||
125491603|NCT02719574|451434014|FG002|Phase 2|Protocol Violation|0|||
125491604|NCT02719574|451434015|FG003|Phase 2|Protocol Violation|0|||
125491605|NCT02719574|451434016|FG004|Phase 2|Protocol Violation|0|||
125491606|NCT02719574|451434017|FG005|Phase 2|Protocol Violation|0|||
125491607|NCT02719574|451434018|FG006|Phase 2|Protocol Violation|0|||
125491608|NCT02719574|451434019|FG007|Phase 2|Protocol Violation|0|||
125491609|NCT02719574|451434020|FG008|Phase 2|Protocol Violation|0|||
125491610|NCT02719574|451434021|FG009|Phase 2|Protocol Violation|1|||
125491611|NCT02719574|451434022|FG010|Phase 2|Protocol Violation|0|||
125491612|NCT02719574|451434023|FG011|Phase 2|Protocol Violation|0|||
125491613|NCT02719574|451434024|FG012|Phase 2|Protocol Violation|0|||
125491614|NCT02719574|451434025|FG013|Phase 2|Protocol Violation|0|||
125491615|NCT02719574|451434026|FG014|Phase 2|Protocol Violation|0|||
125491616|NCT02719574|451434027|FG015|Phase 2|Protocol Violation|0|||
125491617|NCT02719574|451434028|FG016|Phase 2|Protocol Violation|0|||
125491618|NCT02720068|451434032|FG000|Overall Study|Adverse Event|0|||
125491619|NCT02720068|451434033|FG001|Overall Study|Adverse Event|0|||
125491620|NCT02720068|451434034|FG002|Overall Study|Adverse Event|0|||
125491621|NCT02720068|451434035|FG003|Overall Study|Adverse Event|0|||
125491622|NCT02720068|451434036|FG004|Overall Study|Adverse Event|0|||
125491623|NCT02720068|451434037|FG005|Overall Study|Adverse Event|0|||
125491624|NCT02720068|451434038|FG006|Overall Study|Adverse Event|0|||
125491625|NCT02720068|451434039|FG007|Overall Study|Adverse Event|0|||
125491626|NCT02720068|451434040|FG008|Overall Study|Adverse Event|0|||
125491627|NCT02720068|451434041|FG009|Overall Study|Adverse Event|0|||
125491628|NCT02720068|451434042|FG010|Overall Study|Adverse Event|0|||
125491629|NCT02720068|451434043|FG011|Overall Study|Adverse Event|1|||
125491630|NCT02720068|451434044|FG012|Overall Study|Adverse Event|0|||
125491631|NCT02720068|451434045|FG013|Overall Study|Adverse Event|0|||
125491632|NCT02720068|451434046|FG014|Overall Study|Adverse Event|0|||
125491633|NCT02720068|451434047|FG015|Overall Study|Adverse Event|0|||
125491634|NCT02720068|451434048|FG016|Overall Study|Adverse Event|0|||
125491635|NCT02720068|451434049|FG017|Overall Study|Adverse Event|0|||
125491636|NCT02720068|451434032|FG000|Overall Study|Death|1|||
125491637|NCT02720068|451434033|FG001|Overall Study|Death|3|||
125491638|NCT02720068|451434034|FG002|Overall Study|Death|2|||
125491639|NCT02720068|451434035|FG003|Overall Study|Death|1|||
125491640|NCT02720068|451434036|FG004|Overall Study|Death|2|||
125491641|NCT02720068|451434037|FG005|Overall Study|Death|1|||
125491642|NCT02720068|451434038|FG006|Overall Study|Death|2|||
125491643|NCT02720068|451434039|FG007|Overall Study|Death|2|||
125491644|NCT02720068|451434040|FG008|Overall Study|Death|3|||
125491645|NCT02720068|451434041|FG009|Overall Study|Death|1|||
125491646|NCT02720068|451434042|FG010|Overall Study|Death|20|||
125491647|NCT02720068|451434043|FG011|Overall Study|Death|166|||
125491648|NCT02720068|451434044|FG012|Overall Study|Death|34|||
125491649|NCT02720068|451434045|FG013|Overall Study|Death|30|||
125491650|NCT02720068|451434046|FG014|Overall Study|Death|45|||
125491651|NCT02720068|451434047|FG015|Overall Study|Death|16|||
125491652|NCT02720068|451434048|FG016|Overall Study|Death|20|||
125491653|NCT02720068|451434049|FG017|Overall Study|Death|28|||
125491654|NCT02720068|451434032|FG000|Overall Study|Lost to Follow-up|0|||
125491655|NCT02720068|451434033|FG001|Overall Study|Lost to Follow-up|0|||
125491656|NCT02720068|451434034|FG002|Overall Study|Lost to Follow-up|0|||
125491657|NCT02720068|451434035|FG003|Overall Study|Lost to Follow-up|0|||
125491658|NCT02720068|451434036|FG004|Overall Study|Lost to Follow-up|0|||
125491659|NCT02720068|451434037|FG005|Overall Study|Lost to Follow-up|0|||
125491660|NCT02720068|451434038|FG006|Overall Study|Lost to Follow-up|0|||
125491661|NCT02720068|451434039|FG007|Overall Study|Lost to Follow-up|0|||
125491662|NCT02720068|451434040|FG008|Overall Study|Lost to Follow-up|0|||
125491663|NCT02720068|451434041|FG009|Overall Study|Lost to Follow-up|0|||
125491664|NCT02720068|451434042|FG010|Overall Study|Lost to Follow-up|0|||
125491665|NCT02720068|451434043|FG011|Overall Study|Lost to Follow-up|1|||
125491666|NCT02720068|451434044|FG012|Overall Study|Lost to Follow-up|0|||
125491667|NCT02720068|451434045|FG013|Overall Study|Lost to Follow-up|1|||
125491668|NCT02720068|451434046|FG014|Overall Study|Lost to Follow-up|2|||
125491669|NCT02720068|451434047|FG015|Overall Study|Lost to Follow-up|0|||
125491670|NCT02720068|451434048|FG016|Overall Study|Lost to Follow-up|0|||
125491671|NCT02720068|451434049|FG017|Overall Study|Lost to Follow-up|1|||
125491672|NCT02720068|451434032|FG000|Overall Study|Physician Decision|0|||
125491673|NCT02720068|451434033|FG001|Overall Study|Physician Decision|0|||
125491674|NCT02720068|451434034|FG002|Overall Study|Physician Decision|0|||
125491675|NCT02720068|451434035|FG003|Overall Study|Physician Decision|1|||
125491676|NCT02720068|451434036|FG004|Overall Study|Physician Decision|0|||
125491677|NCT02720068|451434037|FG005|Overall Study|Physician Decision|0|||
125491678|NCT02720068|451434038|FG006|Overall Study|Physician Decision|0|||
125491679|NCT02720068|451434039|FG007|Overall Study|Physician Decision|0|||
125491680|NCT02720068|451434040|FG008|Overall Study|Physician Decision|0|||
125491681|NCT02720068|451434041|FG009|Overall Study|Physician Decision|0|||
125491682|NCT02720068|451434042|FG010|Overall Study|Physician Decision|0|||
125491683|NCT02720068|451434043|FG011|Overall Study|Physician Decision|1|||
125491684|NCT02720068|451434044|FG012|Overall Study|Physician Decision|0|||
125491685|NCT02720068|451434045|FG013|Overall Study|Physician Decision|0|||
125491686|NCT02720068|451434046|FG014|Overall Study|Physician Decision|0|||
125491687|NCT02720068|451434047|FG015|Overall Study|Physician Decision|0|||
125491688|NCT02720068|451434048|FG016|Overall Study|Physician Decision|0|||
125491689|NCT02720068|451434049|FG017|Overall Study|Physician Decision|1|||
125491690|NCT02720068|451434032|FG000|Overall Study|Progressive Disease|2|||
125491691|NCT02720068|451434033|FG001|Overall Study|Progressive Disease|3|||
125491692|NCT02720068|451434034|FG002|Overall Study|Progressive Disease|1|||
125491693|NCT02720068|451434035|FG003|Overall Study|Progressive Disease|1|||
125491694|NCT02720068|451434036|FG004|Overall Study|Progressive Disease|1|||
125491695|NCT02720068|451434037|FG005|Overall Study|Progressive Disease|2|||
125491696|NCT02720068|451434038|FG006|Overall Study|Progressive Disease|1|||
125491697|NCT02720068|451434039|FG007|Overall Study|Progressive Disease|1|||
125491698|NCT02720068|451434040|FG008|Overall Study|Progressive Disease|0|||
125491699|NCT02720068|451434041|FG009|Overall Study|Progressive Disease|1|||
125491700|NCT02720068|451434042|FG010|Overall Study|Progressive Disease|0|||
125491701|NCT02720068|451434043|FG011|Overall Study|Progressive Disease|4|||
125491702|NCT02720068|451434044|FG012|Overall Study|Progressive Disease|1|||
125491703|NCT02720068|451434045|FG013|Overall Study|Progressive Disease|0|||
125491704|NCT02720068|451434046|FG014|Overall Study|Progressive Disease|0|||
125491705|NCT02720068|451434047|FG015|Overall Study|Progressive Disease|0|||
125491706|NCT02720068|451434048|FG016|Overall Study|Progressive Disease|0|||
125491707|NCT02720068|451434049|FG017|Overall Study|Progressive Disease|0|||
125491708|NCT02720068|451434032|FG000|Overall Study|Sponsor Decision|0|||
125491709|NCT02720068|451434033|FG001|Overall Study|Sponsor Decision|0|||
125491710|NCT02720068|451434034|FG002|Overall Study|Sponsor Decision|0|||
125491711|NCT02720068|451434035|FG003|Overall Study|Sponsor Decision|0|||
125491712|NCT02720068|451434036|FG004|Overall Study|Sponsor Decision|0|||
125491713|NCT02720068|451434037|FG005|Overall Study|Sponsor Decision|0|||
125491714|NCT02720068|451434038|FG006|Overall Study|Sponsor Decision|0|||
125491715|NCT02720068|451434039|FG007|Overall Study|Sponsor Decision|0|||
125491716|NCT02720068|451434040|FG008|Overall Study|Sponsor Decision|0|||
125491717|NCT02720068|451434041|FG009|Overall Study|Sponsor Decision|0|||
125491718|NCT02720068|451434042|FG010|Overall Study|Sponsor Decision|0|||
125491719|NCT02720068|451434043|FG011|Overall Study|Sponsor Decision|6|||
125491720|NCT02720068|451434044|FG012|Overall Study|Sponsor Decision|3|||
125491721|NCT02720068|451434045|FG013|Overall Study|Sponsor Decision|2|||
125491722|NCT02720068|451434046|FG014|Overall Study|Sponsor Decision|4|||
125491723|NCT02720068|451434047|FG015|Overall Study|Sponsor Decision|4|||
125491724|NCT02720068|451434048|FG016|Overall Study|Sponsor Decision|0|||
125491725|NCT02720068|451434049|FG017|Overall Study|Sponsor Decision|8|||
125491726|NCT02720068|451434032|FG000|Overall Study|Withdrawal by Subject|0|||
125491727|NCT02720068|451434033|FG001|Overall Study|Withdrawal by Subject|0|||
125491728|NCT02720068|451434034|FG002|Overall Study|Withdrawal by Subject|0|||
125491729|NCT02720068|451434035|FG003|Overall Study|Withdrawal by Subject|0|||
125491730|NCT02720068|451434036|FG004|Overall Study|Withdrawal by Subject|0|||
125491731|NCT02720068|451434037|FG005|Overall Study|Withdrawal by Subject|0|||
125491732|NCT02720068|451434038|FG006|Overall Study|Withdrawal by Subject|0|||
125491733|NCT02720068|451434039|FG007|Overall Study|Withdrawal by Subject|0|||
125491734|NCT02720068|451434040|FG008|Overall Study|Withdrawal by Subject|0|||
125491735|NCT02720068|451434041|FG009|Overall Study|Withdrawal by Subject|1|||
125491736|NCT02720068|451434042|FG010|Overall Study|Withdrawal by Subject|0|||
125491737|NCT02720068|451434043|FG011|Overall Study|Withdrawal by Subject|27|||
125491738|NCT02720068|451434044|FG012|Overall Study|Withdrawal by Subject|2|||
125491739|NCT02720068|451434045|FG013|Overall Study|Withdrawal by Subject|8|||
125491740|NCT02720068|451434046|FG014|Overall Study|Withdrawal by Subject|7|||
125491741|NCT02720068|451434047|FG015|Overall Study|Withdrawal by Subject|0|||
125491742|NCT02720068|451434048|FG016|Overall Study|Withdrawal by Subject|0|||
125491743|NCT02720068|451434049|FG017|Overall Study|Withdrawal by Subject|2|||
125491744|NCT02720068|451434032|FG000|Overall Study|Protocol Violation|0|||
125491745|NCT02720068|451434033|FG001|Overall Study|Protocol Violation|0|||
125491746|NCT02720068|451434034|FG002|Overall Study|Protocol Violation|0|||
125491747|NCT02720068|451434035|FG003|Overall Study|Protocol Violation|0|||
125303513|NCT03210961|450739446|FG001|Overall Study|Lost to Follow-up|0|||
125303514|NCT03210961|450739447|FG002|Overall Study|Lost to Follow-up|0|||
125303515|NCT03210961|450739448|FG003|Overall Study|Lost to Follow-up|0|||
125303516|NCT03210961|450739449|FG004|Overall Study|Lost to Follow-up|0|||
125303517|NCT03210961|450739450|FG005|Overall Study|Lost to Follow-up|0|||
125303518|NCT03210961|450739451|FG006|Overall Study|Lost to Follow-up|0|||
125303519|NCT03210961|450739452|FG007|Overall Study|Lost to Follow-up|0|||
125303520|NCT03210961|450739453|FG008|Overall Study|Lost to Follow-up|0|||
125303521|NCT03210961|450739454|FG009|Overall Study|Lost to Follow-up|0|||
125303522|NCT03210961|450739455|FG010|Overall Study|Lost to Follow-up|0|||
125303523|NCT03210961|450739456|FG011|Overall Study|Lost to Follow-up|0|||
125303524|NCT03210961|450739457|FG012|Overall Study|Lost to Follow-up|0|||
125303525|NCT03210961|450739458|FG013|Overall Study|Lost to Follow-up|0|||
125303526|NCT03210961|450739459|FG014|Overall Study|Lost to Follow-up|1|||
125303527|NCT03210961|450739445|FG000|Overall Study|Withdrawal by Subject|0|||
125303528|NCT03210961|450739446|FG001|Overall Study|Withdrawal by Subject|0|||
125303529|NCT03210961|450739447|FG002|Overall Study|Withdrawal by Subject|0|||
125303530|NCT03210961|450739448|FG003|Overall Study|Withdrawal by Subject|0|||
125303531|NCT03210961|450739449|FG004|Overall Study|Withdrawal by Subject|0|||
125303532|NCT03210961|450739450|FG005|Overall Study|Withdrawal by Subject|0|||
125303533|NCT03210961|450739451|FG006|Overall Study|Withdrawal by Subject|0|||
125303534|NCT03210961|450739452|FG007|Overall Study|Withdrawal by Subject|0|||
125303535|NCT03210961|450739453|FG008|Overall Study|Withdrawal by Subject|0|||
125303536|NCT03210961|450739454|FG009|Overall Study|Withdrawal by Subject|0|||
125303537|NCT03210961|450739455|FG010|Overall Study|Withdrawal by Subject|0|||
125303538|NCT03210961|450739456|FG011|Overall Study|Withdrawal by Subject|0|||
125303539|NCT03210961|450739457|FG012|Overall Study|Withdrawal by Subject|0|||
125303540|NCT03210961|450739458|FG013|Overall Study|Withdrawal by Subject|0|||
125303541|NCT03210961|450739459|FG014|Overall Study|Withdrawal by Subject|1|||
125303542|NCT03210961|450739445|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303543|NCT03210961|450739446|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303544|NCT03210961|450739447|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303545|NCT03210961|450739448|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303546|NCT03210961|450739449|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303547|NCT03210961|450739450|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303548|NCT03210961|450739451|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303549|NCT03210961|450739452|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303550|NCT03210961|450739453|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303551|NCT03210961|450739454|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
125491748|NCT02720068|451434036|FG004|Overall Study|Protocol Violation|0|||
125303552|NCT03210961|450739455|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303553|NCT03210961|450739456|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303554|NCT03210961|450739457|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
125303555|NCT03210961|450739458|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
125303556|NCT03210961|450739459|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
125491749|NCT02720068|451434037|FG005|Overall Study|Protocol Violation|0|||
125303557|NCT03210961|450739445|FG000|Overall Study|Other|0|||
125303558|NCT03210961|450739446|FG001|Overall Study|Other|0|||
125303559|NCT03210961|450739447|FG002|Overall Study|Other|0|||
125491750|NCT02720068|451434038|FG006|Overall Study|Protocol Violation|0|||
125491751|NCT02720068|451434039|FG007|Overall Study|Protocol Violation|0|||
125491752|NCT02720068|451434040|FG008|Overall Study|Protocol Violation|0|||
125491753|NCT02720068|451434041|FG009|Overall Study|Protocol Violation|0|||
125491754|NCT02720068|451434042|FG010|Overall Study|Protocol Violation|1|||
125491755|NCT02720068|451434043|FG011|Overall Study|Protocol Violation|0|||
125491756|NCT02720068|451434044|FG012|Overall Study|Protocol Violation|0|||
125491757|NCT02720068|451434045|FG013|Overall Study|Protocol Violation|0|||
125491758|NCT02720068|451434046|FG014|Overall Study|Protocol Violation|1|||
125491759|NCT02720068|451434047|FG015|Overall Study|Protocol Violation|0|||
125491760|NCT02720068|451434048|FG016|Overall Study|Protocol Violation|1|||
125491761|NCT02720068|451434049|FG017|Overall Study|Protocol Violation|0|||
125491762|NCT00495677|451434050|FG000|Stage 1 (25 Days)|Adverse Event|0|||
125491763|NCT00495677|451434051|FG001|Stage 1 (25 Days)|Adverse Event|0|||
125491764|NCT00495677|451434052|FG002|Stage 1 (25 Days)|Adverse Event|1|||
125491765|NCT00495677|451434053|FG003|Stage 1 (25 Days)|Adverse Event|0|||
125491766|NCT00495677|451434054|FG004|Stage 1 (25 Days)|Adverse Event|0|||
125491767|NCT00495677|451434055|FG005|Stage 1 (25 Days)|Adverse Event|0|||
125491768|NCT00495677|451434056|FG006|Stage 1 (25 Days)|Adverse Event|0|||
125491769|NCT04664881|451434060|FG000|Overall Study|Withdrawal by Subject|1|||
125491770|NCT04664881|451434061|FG001|Overall Study|Withdrawal by Subject|8|||
125491771|NCT04664881|451434060|FG000|Overall Study|Physician Decision|0|||
125491772|NCT04664881|451434061|FG001|Overall Study|Physician Decision|5|||
125491773|NCT04664881|451434060|FG000|Overall Study|Lost to Follow-up|1|||
125491774|NCT04664881|451434061|FG001|Overall Study|Lost to Follow-up|0|||
125491775|NCT02231749|451434062|FG000|Overall Study|Disease progression|229|||
125491776|NCT02231749|451434063|FG001|Overall Study|Disease progression|297|||
125491777|NCT02231749|451434062|FG000|Overall Study|Study Drug Toxicity|134|||
125491778|NCT02231749|451434063|FG001|Overall Study|Study Drug Toxicity|63|||
125491779|NCT02231749|451434062|FG000|Overall Study|Death|1|||
125303560|NCT03210961|450739448|FG003|Overall Study|Other|1|||
125303561|NCT03210961|450739449|FG004|Overall Study|Other|0|||
125303562|NCT03210961|450739450|FG005|Overall Study|Other|0|||
125303563|NCT03210961|450739451|FG006|Overall Study|Other|1|||
125303564|NCT03210961|450739452|FG007|Overall Study|Other|0|||
125303565|NCT03210961|450739453|FG008|Overall Study|Other|0|||
125303566|NCT03210961|450739454|FG009|Overall Study|Other|0|||
125303567|NCT03210961|450739455|FG010|Overall Study|Other|1|||
125303568|NCT03210961|450739456|FG011|Overall Study|Other|0|||
125303569|NCT03210961|450739457|FG012|Overall Study|Other|2|||
125303570|NCT03210961|450739458|FG013|Overall Study|Other|2|||
125303571|NCT03210961|450739459|FG014|Overall Study|Other|0|||
125303572|NCT01487265|450739460|FG000|Overall Study|Adverse Event|8|||
125303573|NCT01487265|450739460|FG000|Overall Study|Withdrawal by Subject|5|||
125303574|NCT01487265|450739460|FG000|Overall Study|Disease Progression|21|||
125303575|NCT01487265|450739460|FG000|Overall Study|Death|2|||
125303576|NCT01487265|450739460|FG000|Overall Study|Still on Treatment|1|||
125303577|NCT02291419|450739461|FG000|Overall Study|Early study termination|1|||
125303578|NCT02291419|450739462|FG001|Overall Study|Early study termination|5|||
125303579|NCT00965575|450739466|FG000|Overall Study|subject unwillingness to swallow study c|1|||
125303580|NCT00965575|450739467|FG001|Overall Study|subject unwillingness to swallow study c|0|||
125303581|NCT01732770|450739474|FG000|Overall Study|Lost to Follow-up|2|||
125303582|NCT01732770|450739475|FG001|Overall Study|Lost to Follow-up|3|||
125303583|NCT01732770|450739474|FG000|Overall Study|Withdrawal by Subject|5|||
125303584|NCT01732770|450739475|FG001|Overall Study|Withdrawal by Subject|3|||
125303585|NCT01732770|450739474|FG000|Overall Study|Decision by Sponsor|2|||
125303586|NCT01732770|450739475|FG001|Overall Study|Decision by Sponsor|2|||
125303587|NCT01732770|450739474|FG000|Overall Study|Death|1|||
125303588|NCT01732770|450739475|FG001|Overall Study|Death|0|||
125303589|NCT03047031|450739476|FG000|Overall Study|Other than listed|1|||
125303590|NCT03047031|450739477|FG001|Overall Study|Other than listed|0|||
125303591|NCT03047031|450739478|FG002|Overall Study|Other than listed|0|||
125303592|NCT03047031|450739476|FG000|Overall Study|Lost to Follow-up|4|||
125303593|NCT03047031|450739477|FG001|Overall Study|Lost to Follow-up|0|||
125303594|NCT03047031|450739478|FG002|Overall Study|Lost to Follow-up|0|||
125303595|NCT03047031|450739476|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
125303596|NCT03047031|450739477|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
125303597|NCT03047031|450739478|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
125303598|NCT03047031|450739476|FG000|Overall Study|Adverse Event|1|||
125303599|NCT03047031|450739477|FG001|Overall Study|Adverse Event|0|||
125303600|NCT03047031|450739478|FG002|Overall Study|Adverse Event|0|||
125303601|NCT03047031|450739476|FG000|Overall Study|Withdrawal by Subject|2|||
125303602|NCT03047031|450739477|FG001|Overall Study|Withdrawal by Subject|0|||
125303603|NCT03047031|450739478|FG002|Overall Study|Withdrawal by Subject|0|||
125303604|NCT03047031|450739476|FG000|Overall Study|Change to other medication|2|||
125303605|NCT03047031|450739477|FG001|Overall Study|Change to other medication|0|||
125491780|NCT02231749|451434063|FG001|Overall Study|Death|1|||
125491781|NCT02231749|451434062|FG000|Overall Study|AE unrelated to Study drug|32|||
125303606|NCT03047031|450739478|FG002|Overall Study|Change to other medication|0|||
125491782|NCT02231749|451434063|FG001|Overall Study|AE unrelated to Study drug|31|||
125303607|NCT03047031|450739476|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
125303608|NCT03047031|450739477|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
125491783|NCT02231749|451434062|FG000|Overall Study|Participant's request to discontinue|10|||
125491784|NCT02231749|451434063|FG001|Overall Study|Participant's request to discontinue|21|||
125491785|NCT02231749|451434062|FG000|Overall Study|Participant withdrew Consent|8|||
125303609|NCT03047031|450739478|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
125303610|NCT01959841|450739479|FG000|Overall Study|Adverse Event|1|||
125303611|NCT01959841|450739480|FG001|Overall Study|Adverse Event|3|||
125303612|NCT01959841|450739481|FG002|Overall Study|Adverse Event|2|||
125491786|NCT02231749|451434063|FG001|Overall Study|Participant withdrew Consent|15|||
125491787|NCT02231749|451434062|FG000|Overall Study|Lost to Follow-up|1|||
125491788|NCT02231749|451434063|FG001|Overall Study|Lost to Follow-up|2|||
125491789|NCT02231749|451434062|FG000|Overall Study|Maximum Clinical Benefit|5|||
125491790|NCT02231749|451434063|FG001|Overall Study|Maximum Clinical Benefit|8|||
125491791|NCT02231749|451434062|FG000|Overall Study|Poor/Non-Compliance|0|||
125491792|NCT02231749|451434063|FG001|Overall Study|Poor/Non-Compliance|3|||
125491793|NCT02231749|451434062|FG000|Overall Study|Pregnancy|1|||
125491794|NCT02231749|451434063|FG001|Overall Study|Pregnancy|0|||
125491795|NCT02231749|451434062|FG000|Overall Study|other|0|||
125491796|NCT02231749|451434063|FG001|Overall Study|other|8|||
125491797|NCT02231749|451434062|FG000|Overall Study|No longer meets Study Criteria|1|||
125491798|NCT02231749|451434063|FG001|Overall Study|No longer meets Study Criteria|0|||
125491799|NCT03786926|451434068|FG000|Overall Study|Adverse Event|0|||
125491800|NCT03786926|451434069|FG001|Overall Study|Adverse Event|0|||
125491801|NCT03786926|451434070|FG002|Overall Study|Adverse Event|0|||
125491802|NCT03786926|451434071|FG003|Overall Study|Adverse Event|0|||
125491803|NCT03786926|451434072|FG004|Overall Study|Adverse Event|0|||
125491804|NCT03786926|451434073|FG005|Overall Study|Adverse Event|0|||
125491805|NCT03786926|451434074|FG006|Overall Study|Adverse Event|0|||
125491806|NCT03786926|451434075|FG007|Overall Study|Adverse Event|1|||
125491807|NCT03786926|451434076|FG008|Overall Study|Adverse Event|1|||
125491808|NCT03786926|451434077|FG009|Overall Study|Adverse Event|0|||
125491809|NCT03786926|451434078|FG010|Overall Study|Adverse Event|1|||
125491810|NCT03786926|451434068|FG000|Overall Study|Progressive disease|3|||
125491811|NCT03786926|451434069|FG001|Overall Study|Progressive disease|0|||
125491812|NCT03786926|451434070|FG002|Overall Study|Progressive disease|3|||
125491813|NCT03786926|451434071|FG003|Overall Study|Progressive disease|1|||
125491814|NCT03786926|451434072|FG004|Overall Study|Progressive disease|2|||
125491815|NCT03786926|451434073|FG005|Overall Study|Progressive disease|2|||
125491816|NCT03786926|451434074|FG006|Overall Study|Progressive disease|1|||
125491817|NCT03786926|451434075|FG007|Overall Study|Progressive disease|6|||
125491818|NCT03786926|451434076|FG008|Overall Study|Progressive disease|1|||
125491819|NCT03786926|451434077|FG009|Overall Study|Progressive disease|1|||
125491820|NCT03786926|451434078|FG010|Overall Study|Progressive disease|1|||
125491821|NCT03786926|451434068|FG000|Overall Study|Death|0|||
125491822|NCT03786926|451434069|FG001|Overall Study|Death|1|||
125491823|NCT03786926|451434070|FG002|Overall Study|Death|1|||
125491824|NCT03786926|451434071|FG003|Overall Study|Death|0|||
125491825|NCT03786926|451434072|FG004|Overall Study|Death|0|||
125491826|NCT03786926|451434073|FG005|Overall Study|Death|0|||
125491827|NCT03786926|451434074|FG006|Overall Study|Death|0|||
125491828|NCT03786926|451434075|FG007|Overall Study|Death|0|||
125491829|NCT03786926|451434076|FG008|Overall Study|Death|0|||
125491830|NCT03786926|451434077|FG009|Overall Study|Death|1|||
125491831|NCT03786926|451434078|FG010|Overall Study|Death|2|||
125491832|NCT03786926|451434068|FG000|Overall Study|Physician Decision|0|||
125491833|NCT03786926|451434069|FG001|Overall Study|Physician Decision|1|||
125491834|NCT03786926|451434070|FG002|Overall Study|Physician Decision|0|||
125491835|NCT03786926|451434071|FG003|Overall Study|Physician Decision|1|||
125491836|NCT03786926|451434072|FG004|Overall Study|Physician Decision|2|||
125491837|NCT03786926|451434073|FG005|Overall Study|Physician Decision|0|||
125491838|NCT03786926|451434074|FG006|Overall Study|Physician Decision|0|||
125491839|NCT03786926|451434075|FG007|Overall Study|Physician Decision|2|||
125491840|NCT03786926|451434076|FG008|Overall Study|Physician Decision|1|||
125491841|NCT03786926|451434077|FG009|Overall Study|Physician Decision|1|||
125491842|NCT03786926|451434078|FG010|Overall Study|Physician Decision|0|||
125491843|NCT03786926|451434068|FG000|Overall Study|Withdrawal by Subject|0|||
125491844|NCT03786926|451434069|FG001|Overall Study|Withdrawal by Subject|1|||
125491845|NCT03786926|451434070|FG002|Overall Study|Withdrawal by Subject|1|||
125303613|NCT01959841|450739479|FG000|Overall Study|Lack of Efficacy|5|||
125491846|NCT03786926|451434071|FG003|Overall Study|Withdrawal by Subject|0|||
125491847|NCT03786926|451434072|FG004|Overall Study|Withdrawal by Subject|0|||
125491848|NCT03786926|451434073|FG005|Overall Study|Withdrawal by Subject|0|||
125491849|NCT03786926|451434074|FG006|Overall Study|Withdrawal by Subject|1|||
125491850|NCT03786926|451434075|FG007|Overall Study|Withdrawal by Subject|0|||
125491851|NCT03786926|451434076|FG008|Overall Study|Withdrawal by Subject|1|||
125303614|NCT01959841|450739480|FG001|Overall Study|Lack of Efficacy|0|||
125491852|NCT03786926|451434077|FG009|Overall Study|Withdrawal by Subject|0|||
125491853|NCT03786926|451434078|FG010|Overall Study|Withdrawal by Subject|1|||
125491854|NCT03786926|451434068|FG000|Overall Study|Study terminated by Sponsor|0|||
125491855|NCT03786926|451434069|FG001|Overall Study|Study terminated by Sponsor|0|||
125491856|NCT03786926|451434070|FG002|Overall Study|Study terminated by Sponsor|0|||
125491857|NCT03786926|451434071|FG003|Overall Study|Study terminated by Sponsor|0|||
125491858|NCT03786926|451434072|FG004|Overall Study|Study terminated by Sponsor|1|||
125491859|NCT03786926|451434073|FG005|Overall Study|Study terminated by Sponsor|0|||
125491860|NCT03786926|451434074|FG006|Overall Study|Study terminated by Sponsor|0|||
125491861|NCT03786926|451434075|FG007|Overall Study|Study terminated by Sponsor|4|||
125491862|NCT03786926|451434076|FG008|Overall Study|Study terminated by Sponsor|0|||
125491863|NCT03786926|451434077|FG009|Overall Study|Study terminated by Sponsor|0|||
125491864|NCT03786926|451434078|FG010|Overall Study|Study terminated by Sponsor|0|||
125491865|NCT03786926|451434068|FG000|Overall Study|Anti-neoplasm treatment|0|||
125491866|NCT03786926|451434069|FG001|Overall Study|Anti-neoplasm treatment|0|||
125491867|NCT03786926|451434070|FG002|Overall Study|Anti-neoplasm treatment|0|||
125491868|NCT03786926|451434071|FG003|Overall Study|Anti-neoplasm treatment|0|||
125491869|NCT03786926|451434072|FG004|Overall Study|Anti-neoplasm treatment|1|||
125491870|NCT03786926|451434073|FG005|Overall Study|Anti-neoplasm treatment|0|||
125491871|NCT03786926|451434074|FG006|Overall Study|Anti-neoplasm treatment|1|||
125491872|NCT03786926|451434075|FG007|Overall Study|Anti-neoplasm treatment|0|||
125491873|NCT03786926|451434076|FG008|Overall Study|Anti-neoplasm treatment|0|||
125491874|NCT03786926|451434077|FG009|Overall Study|Anti-neoplasm treatment|0|||
125491875|NCT03786926|451434078|FG010|Overall Study|Anti-neoplasm treatment|0|||
125491876|NCT03786926|451434068|FG000|Overall Study|Other|0|||
125491877|NCT03786926|451434069|FG001|Overall Study|Other|0|||
125491878|NCT03786926|451434070|FG002|Overall Study|Other|0|||
125491879|NCT03786926|451434071|FG003|Overall Study|Other|1|||
125491880|NCT03786926|451434072|FG004|Overall Study|Other|0|||
125491881|NCT03786926|451434073|FG005|Overall Study|Other|1|||
125491882|NCT03786926|451434074|FG006|Overall Study|Other|0|||
125491883|NCT03786926|451434075|FG007|Overall Study|Other|0|||
125491884|NCT03786926|451434076|FG008|Overall Study|Other|2|||
125491885|NCT03786926|451434077|FG009|Overall Study|Other|0|||
125491886|NCT03786926|451434078|FG010|Overall Study|Other|0|||
125491887|NCT05875701|451434082|FG000|Overall Study|Lost to Follow-up|2|||
125491888|NCT05875701|451434083|FG001|Overall Study|Lost to Follow-up|0|||
125491889|NCT05875701|451434082|FG000|Overall Study|Withdrawal by Subject|1|||
125491890|NCT05875701|451434083|FG001|Overall Study|Withdrawal by Subject|1|||
125491891|NCT04174560|451434085|FG000|Overall Study|Lost to Follow-up|1|||
125491892|NCT04174560|451434086|FG001|Overall Study|Lost to Follow-up|0|||
125491893|NCT04174560|451434087|FG002|Overall Study|Lost to Follow-up|0|||
125491894|NCT04174560|451434088|FG003|Overall Study|Lost to Follow-up|0|||
125491895|NCT04174560|451434085|FG000|Overall Study|Withdrawal by Subject|0|||
125491896|NCT04174560|451434086|FG001|Overall Study|Withdrawal by Subject|0|||
125491897|NCT04174560|451434087|FG002|Overall Study|Withdrawal by Subject|2|||
125491898|NCT04174560|451434088|FG003|Overall Study|Withdrawal by Subject|0|||
125491899|NCT04046549|451434092|FG000|Overall Study|Adverse Event|1|||
125491900|NCT04046549|451434092|FG000|Overall Study|Physician Decision|1|||
125491901|NCT04046549|451434092|FG000|Overall Study|Withdrawal by Subject|3|||
125491902|NCT04046549|451434092|FG000|Overall Study|Other, Not Specified|5|||
125491903|NCT04012567|451434093|FG000|Overall Study|Lost to Follow-up|0|||
125491904|NCT04012567|451434094|FG001|Overall Study|Lost to Follow-up|1|||
125491905|NCT04012567|451434093|FG000|Overall Study|Withdrawal by Subject|1|||
125491906|NCT04012567|451434094|FG001|Overall Study|Withdrawal by Subject|0|||
125491907|NCT03705793|451434832|FG000|Overall Study|Lost to Follow-up|3|||
125491908|NCT03705793|451434833|FG001|Overall Study|Lost to Follow-up|4|||
125491909|NCT03705793|451434832|FG000|Overall Study|Withdrawal by Subject|2|||
125491910|NCT03705793|451434833|FG001|Overall Study|Withdrawal by Subject|1|||
125491911|NCT00113360|451434837|FG000|Overall Study|Adverse Event|3|||
125491912|NCT00113360|451434837|FG000|Overall Study|Subject required surgery|1|||
125491913|NCT00113360|451434837|FG000|Overall Study|Did not meet eligibility criteria|3|||
125491914|NCT02467270|451434840|FG000|Overall Study|Participants Never Treated|0|||
125491915|NCT02467270|451434841|FG001|Overall Study|Participants Never Treated|1|||
125491916|NCT02467270|451434842|FG002|Overall Study|Participants Never Treated|0|||
125491917|NCT02467270|451434840|FG000|Overall Study|Ongoing|50|||
125491918|NCT02467270|451434841|FG001|Overall Study|Ongoing|41|||
125491919|NCT02467270|451434842|FG002|Overall Study|Ongoing|43|||
125491920|NCT02467270|451434840|FG000|Overall Study|Adverse Event|16|||
125491921|NCT02467270|451434841|FG001|Overall Study|Adverse Event|15|||
125491922|NCT02467270|451434842|FG002|Overall Study|Adverse Event|14|||
125491923|NCT02467270|451434840|FG000|Overall Study|Progressive Disease|7|||
125491924|NCT02467270|451434841|FG001|Overall Study|Progressive Disease|7|||
125491925|NCT02467270|451434842|FG002|Overall Study|Progressive Disease|4|||
125491926|NCT02467270|451434840|FG000|Overall Study|Death|2|||
125491927|NCT02467270|451434841|FG001|Overall Study|Death|0|||
125491928|NCT02467270|451434842|FG002|Overall Study|Death|2|||
125491929|NCT02467270|451434840|FG000|Overall Study|Lack of Efficacy|12|||
125491930|NCT02467270|451434841|FG001|Overall Study|Lack of Efficacy|18|||
125491931|NCT02467270|451434842|FG002|Overall Study|Lack of Efficacy|23|||
125491932|NCT02467270|451434840|FG000|Overall Study|Non-compliance With Study Drug|0|||
125491933|NCT02467270|451434841|FG001|Overall Study|Non-compliance With Study Drug|2|||
125491934|NCT02467270|451434842|FG002|Overall Study|Non-compliance With Study Drug|1|||
125491935|NCT02467270|451434840|FG000|Overall Study|Lost to Follow-up|2|||
125491936|NCT02467270|451434841|FG001|Overall Study|Lost to Follow-up|1|||
125491937|NCT02467270|451434842|FG002|Overall Study|Lost to Follow-up|0|||
125491938|NCT02467270|451434840|FG000|Overall Study|Pregnancy|0|||
125491939|NCT02467270|451434841|FG001|Overall Study|Pregnancy|1|||
125491940|NCT02467270|451434842|FG002|Overall Study|Pregnancy|0|||
125491941|NCT02467270|451434840|FG000|Overall Study|Physician Decision|0|||
125491942|NCT02467270|451434841|FG001|Overall Study|Physician Decision|4|||
125491943|NCT02467270|451434842|FG002|Overall Study|Physician Decision|1|||
125491944|NCT02467270|451434840|FG000|Overall Study|Withdrawal by Subject|4|||
125491945|NCT02467270|451434841|FG001|Overall Study|Withdrawal by Subject|3|||
125491946|NCT02467270|451434842|FG002|Overall Study|Withdrawal by Subject|5|||
125491947|NCT02467270|451434840|FG000|Overall Study|Reason not Specified|1|||
125491948|NCT02467270|451434841|FG001|Overall Study|Reason not Specified|2|||
125491949|NCT02467270|451434842|FG002|Overall Study|Reason not Specified|1|||
125491950|NCT04129164|451434849|FG000|Overall Study|Non-compliance with procedures|0|||
125491951|NCT04129164|451434850|FG001|Overall Study|Non-compliance with procedures|0|||
125491952|NCT04129164|451434851|FG002|Overall Study|Non-compliance with procedures|2|||
125491953|NCT04129164|451434852|FG003|Overall Study|Non-compliance with procedures|0|||
125491954|NCT04129164|451434849|FG000|Overall Study|Adverse Event|0|||
125491955|NCT04129164|451434850|FG001|Overall Study|Adverse Event|0|||
125491956|NCT04129164|451434851|FG002|Overall Study|Adverse Event|2|||
125491957|NCT04129164|451434852|FG003|Overall Study|Adverse Event|0|||
125491958|NCT04129164|451434849|FG000|Overall Study|Pregnancy|0|||
125491959|NCT04129164|451434850|FG001|Overall Study|Pregnancy|0|||
125491960|NCT04129164|451434851|FG002|Overall Study|Pregnancy|0|||
125491961|NCT04129164|451434852|FG003|Overall Study|Pregnancy|1|||
125491962|NCT04129164|451434849|FG000|Overall Study|Withdrawal by Subject|3|||
125491963|NCT04129164|451434850|FG001|Overall Study|Withdrawal by Subject|2|||
125491964|NCT04129164|451434851|FG002|Overall Study|Withdrawal by Subject|4|||
125491965|NCT04129164|451434852|FG003|Overall Study|Withdrawal by Subject|6|||
125491966|NCT04129164|451434849|FG000|Overall Study|Death|0|||
125491967|NCT04129164|451434850|FG001|Overall Study|Death|1|||
125491968|NCT04129164|451434851|FG002|Overall Study|Death|0|||
125491969|NCT04129164|451434852|FG003|Overall Study|Death|0|||
125491970|NCT04129164|451434849|FG000|Overall Study|Lost to Follow-up|0|||
125491971|NCT04129164|451434850|FG001|Overall Study|Lost to Follow-up|1|||
125491972|NCT04129164|451434851|FG002|Overall Study|Lost to Follow-up|0|||
125491973|NCT04129164|451434852|FG003|Overall Study|Lost to Follow-up|0|||
125491974|NCT03868930|451434853|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
125491975|NCT03868930|451434854|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
125491976|NCT03868930|451434853|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
125491977|NCT03868930|451434854|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
125491978|NCT03868930|451434853|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
125491979|NCT03868930|451434854|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
125491980|NCT03868930|451434853|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
125491981|NCT03868930|451434854|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
125491982|NCT03868930|451434853|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
125491983|NCT03868930|451434854|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
125491984|NCT03286114|451434857|FG000|Overall Study|Adverse Event|6|||
125491985|NCT03286114|451434857|FG000|Overall Study|Death|3|||
125491986|NCT01773993|451434858|FG000|Overall Study|No Visit After Treatment|35|||
125491987|NCT02656706|451434864|FG000|Overall Study|Insurance Denial|1|||
125491988|NCT03725332|451434865|FG000|Overall Study|Adverse Event|5|||
125491989|NCT03725332|451434866|FG001|Overall Study|Adverse Event|10|||
125491990|NCT03725332|451434865|FG000|Overall Study|Death|1|||
125491991|NCT03725332|451434866|FG001|Overall Study|Death|3|||
125491992|NCT03725332|451434865|FG000|Overall Study|Lost to Follow-up|43|||
125491993|NCT03725332|451434866|FG001|Overall Study|Lost to Follow-up|122|||
125491994|NCT03725332|451434865|FG000|Overall Study|Withdrawal by Subject|0|||
125491995|NCT03725332|451434866|FG001|Overall Study|Withdrawal by Subject|1|||
125491996|NCT03725332|451434865|FG000|Overall Study|Duplicate enrollment|0|||
125491997|NCT03725332|451434866|FG001|Overall Study|Duplicate enrollment|1|||
125491998|NCT03725332|451434865|FG000|Overall Study|Did not consent|0|||
125491999|NCT03725332|451434866|FG001|Overall Study|Did not consent|1|||
125492000|NCT05707351|451434869|FG000|Overall Study|Withdrawal by Subject|2|||
125492001|NCT05707351|451434869|FG000|Overall Study|Reason Not Specified|1|||
125492002|NCT02951052|451434873|FG000|Overall Study|Adverse Event|13|||
125492003|NCT02951052|451434874|FG001|Overall Study|Adverse Event|5|||
125492004|NCT02951052|451434873|FG000|Overall Study|Withdrawal by Subject|1|||
125492005|NCT02951052|451434874|FG001|Overall Study|Withdrawal by Subject|5|||
125492006|NCT02951052|451434873|FG000|Overall Study|Physician Decision|2|||
125492007|NCT02951052|451434874|FG001|Overall Study|Physician Decision|0|||
125492008|NCT02951052|451434873|FG000|Overall Study|Lost to Follow-up|1|||
125492009|NCT02951052|451434874|FG001|Overall Study|Lost to Follow-up|1|||
125492010|NCT02951052|451434873|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
125492011|NCT02951052|451434874|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
125492012|NCT02951052|451434873|FG000|Overall Study|Protocol Violation|5|||
125492013|NCT02951052|451434874|FG001|Overall Study|Protocol Violation|3|||
125492014|NCT02951052|451434873|FG000|Overall Study|Lack of Efficacy|3|||
125492015|NCT02951052|451434874|FG001|Overall Study|Lack of Efficacy|4|||
125492016|NCT02951052|451434873|FG000|Overall Study|Ongoing|1|||
125492017|NCT02951052|451434874|FG001|Overall Study|Ongoing|0|||
125492018|NCT03891758|451434882|FG000|Overall Study|Adverse Event|2|||
125492019|NCT03891758|451434883|FG001|Overall Study|Adverse Event|0|||
125492020|NCT03891758|451434882|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125492021|NCT03891758|451434883|FG001|Overall Study|Withdrawal by parent/guardian|2|||
125492022|NCT05795153|451435574|FG000|Overall Study|Adverse Event|2|||
125492023|NCT05795153|451435574|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125492024|NCT05795153|451435574|FG000|Overall Study|Lost to Follow-up|1|||
125492025|NCT05795153|451435574|FG000|Overall Study|Subject decision|2|||
125492026|NCT04644029|451435577|FG000|Overall Study|Death|1|||
125492027|NCT04644029|451435578|FG001|Overall Study|Death|0|||
125492028|NCT04644029|451435577|FG000|Overall Study|Physician Decision|1|||
125492029|NCT04644029|451435578|FG001|Overall Study|Physician Decision|2|||
125492030|NCT04644029|451435577|FG000|Overall Study|Withdrawal by Subject|21|||
125492031|NCT04644029|451435578|FG001|Overall Study|Withdrawal by Subject|19|||
125492032|NCT04644029|451435577|FG000|Overall Study|Lost to Follow-up|31|||
125492033|NCT04644029|451435578|FG001|Overall Study|Lost to Follow-up|34|||
125492034|NCT04644029|451435577|FG000|Overall Study|Study Terminated by Sponsor|308|||
125492035|NCT04644029|451435578|FG001|Overall Study|Study Terminated by Sponsor|309|||
125492036|NCT04644029|451435577|FG000|Overall Study|Randomized in Error|2|||
125492037|NCT04644029|451435578|FG001|Overall Study|Randomized in Error|1|||
125492038|NCT04644029|451435577|FG000|Overall Study|Other|0|||
125492039|NCT04644029|451435578|FG001|Overall Study|Other|1|||
125492040|NCT00739908|451435579|FG000|Overall Study|Adverse Event|5|||
125492041|NCT00739908|451435580|FG001|Overall Study|Adverse Event|6|||
125492042|NCT00739908|451435579|FG000|Overall Study|Withdrawal by Subject|4|||
125492043|NCT00739908|451435580|FG001|Overall Study|Withdrawal by Subject|2|||
125492044|NCT00739908|451435579|FG000|Overall Study|Lost to Follow-up|14|||
125492045|NCT00739908|451435580|FG001|Overall Study|Lost to Follow-up|9|||
125492046|NCT00739908|451435579|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
125492047|NCT00739908|451435580|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
125492048|NCT00739908|451435579|FG000|Overall Study|Non-Compliance With Study Medication|0|||
125492049|NCT00739908|451435580|FG001|Overall Study|Non-Compliance With Study Medication|3|||
125492050|NCT00739908|451435579|FG000|Overall Study|Lack of Efficacy|0|||
125492051|NCT00739908|451435580|FG001|Overall Study|Lack of Efficacy|1|||
125492052|NCT00739908|451435579|FG000|Overall Study|Relocation|0|||
125492053|NCT00739908|451435580|FG001|Overall Study|Relocation|1|||
125492054|NCT03875313|451435581|FG000|Overall Study|Withdrawal by Subject|1|||
125492055|NCT03875313|451435582|FG001|Overall Study|Withdrawal by Subject|3|||
125492056|NCT03875313|451435583|FG002|Overall Study|Withdrawal by Subject|0|||
125492057|NCT03875313|451435584|FG003|Overall Study|Withdrawal by Subject|0|||
125492058|NCT03875313|451435585|FG004|Overall Study|Withdrawal by Subject|0|||
125492059|NCT03875313|451435581|FG000|Overall Study|Death|0|||
125492060|NCT03875313|451435582|FG001|Overall Study|Death|0|||
125492061|NCT03875313|451435583|FG002|Overall Study|Death|0|||
125492062|NCT03875313|451435584|FG003|Overall Study|Death|0|||
125492063|NCT03875313|451435585|FG004|Overall Study|Death|1|||
125492064|NCT03875313|451435581|FG000|Overall Study|Lost to Follow-up|0|||
125492065|NCT03875313|451435582|FG001|Overall Study|Lost to Follow-up|0|||
125492066|NCT03875313|451435583|FG002|Overall Study|Lost to Follow-up|0|||
125492067|NCT03875313|451435584|FG003|Overall Study|Lost to Follow-up|0|||
125492068|NCT03875313|451435585|FG004|Overall Study|Lost to Follow-up|1|||
125492069|NCT03875313|451435581|FG000|Overall Study|Study Termination by Sponsor|0|||
125492070|NCT03875313|451435582|FG001|Overall Study|Study Termination by Sponsor|1|||
125492071|NCT03875313|451435583|FG002|Overall Study|Study Termination by Sponsor|1|||
125492072|NCT03875313|451435584|FG003|Overall Study|Study Termination by Sponsor|0|||
125492073|NCT03875313|451435585|FG004|Overall Study|Study Termination by Sponsor|1|||
125492074|NCT03875313|451435581|FG000|Overall Study|New Anticancer Treatment|0|||
125492075|NCT03875313|451435582|FG001|Overall Study|New Anticancer Treatment|1|||
125492076|NCT03875313|451435583|FG002|Overall Study|New Anticancer Treatment|2|||
125492077|NCT03875313|451435584|FG003|Overall Study|New Anticancer Treatment|1|||
125492078|NCT03875313|451435585|FG004|Overall Study|New Anticancer Treatment|0|||
125492079|NCT03875313|451435581|FG000|Overall Study|Other, Not Specified|2|||
125492080|NCT03875313|451435582|FG001|Overall Study|Other, Not Specified|11|||
125492081|NCT03875313|451435583|FG002|Overall Study|Other, Not Specified|3|||
125492082|NCT03875313|451435584|FG003|Overall Study|Other, Not Specified|3|||
125492083|NCT03875313|451435585|FG004|Overall Study|Other, Not Specified|1|||
125492084|NCT04121546|451435586|FG000|Overall Study|Lost to Follow-up|1|||
125492085|NCT04121546|451435587|FG001|Overall Study|Lost to Follow-up|3|||
125492086|NCT01046825|451435590|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
125492087|NCT01046825|451435591|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
125492088|NCT01046825|451435592|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
125492089|NCT01046825|451435593|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
125492090|NCT01046825|451435594|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
125492091|NCT01046825|451435590|FG000|Overall Study|Physician Decision|0|||
125492092|NCT01046825|451435591|FG001|Overall Study|Physician Decision|1|||
125492093|NCT01046825|451435592|FG002|Overall Study|Physician Decision|2|||
125492094|NCT01046825|451435593|FG003|Overall Study|Physician Decision|0|||
125492095|NCT01046825|451435594|FG004|Overall Study|Physician Decision|0|||
125492096|NCT01046825|451435590|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
125492097|NCT01046825|451435591|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
125492098|NCT01046825|451435592|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
125492099|NCT01046825|451435593|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
125492100|NCT01046825|451435594|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
125492101|NCT01046825|451435590|FG000|Overall Study|Found to be ineligible|0|||
125492102|NCT01046825|451435591|FG001|Overall Study|Found to be ineligible|1|||
125492103|NCT01046825|451435592|FG002|Overall Study|Found to be ineligible|0|||
125492104|NCT01046825|451435593|FG003|Overall Study|Found to be ineligible|0|||
125492105|NCT01046825|451435594|FG004|Overall Study|Found to be ineligible|0|||
125492106|NCT01046825|451435590|FG000|Overall Study|Death|0|||
125492107|NCT01046825|451435591|FG001|Overall Study|Death|0|||
125492108|NCT01046825|451435592|FG002|Overall Study|Death|0|||
125492109|NCT01046825|451435593|FG003|Overall Study|Death|1|||
125492110|NCT01046825|451435594|FG004|Overall Study|Death|0|||
125492111|NCT01046825|451435590|FG000|Overall Study|Did not submit biology samples|0|||
125492112|NCT01046825|451435591|FG001|Overall Study|Did not submit biology samples|0|||
125492113|NCT01046825|451435592|FG002|Overall Study|Did not submit biology samples|0|||
125492114|NCT01046825|451435593|FG003|Overall Study|Did not submit biology samples|0|||
125492115|NCT01046825|451435594|FG004|Overall Study|Did not submit biology samples|13|||
125492116|NCT02075554|451435596|FG000|Overall Study|Lost to Follow-up|7|||
125492117|NCT02075554|451435596|FG000|Overall Study|Withdrawal by Subject|5|||
125492118|NCT02075554|451435596|FG000|Overall Study|Physician Decision|3|||
125492119|NCT04993677|451435603|FG000|Overall Study|Lost to Follow-up|1|||
125492120|NCT04993677|451435604|FG001|Overall Study|Lost to Follow-up|0|||
125492121|NCT04993677|451435605|FG002|Overall Study|Lost to Follow-up|0|||
125492122|NCT04993677|451435606|FG003|Overall Study|Lost to Follow-up|0|||
125492123|NCT04993677|451435603|FG000|Overall Study|Death|11|||
125492124|NCT04993677|451435604|FG001|Overall Study|Death|8|||
125492125|NCT04993677|451435605|FG002|Overall Study|Death|3|||
125492126|NCT04993677|451435606|FG003|Overall Study|Death|1|||
125492127|NCT04993677|451435603|FG000|Overall Study|Subject withdrawal of consent|4|||
125492128|NCT04993677|451435604|FG001|Overall Study|Subject withdrawal of consent|3|||
125492129|NCT04993677|451435605|FG002|Overall Study|Subject withdrawal of consent|0|||
125492130|NCT04993677|451435606|FG003|Overall Study|Subject withdrawal of consent|2|||
125492131|NCT04993677|451435603|FG000|Overall Study|Study termination by sponsor|3|||
125492132|NCT04993677|451435604|FG001|Overall Study|Study termination by sponsor|25|||
125492133|NCT04993677|451435605|FG002|Overall Study|Study termination by sponsor|3|||
125492134|NCT04993677|451435606|FG003|Overall Study|Study termination by sponsor|3|||
125492135|NCT04993677|451435603|FG000|Overall Study|Other|2|||
125492136|NCT04993677|451435604|FG001|Overall Study|Other|3|||
125492137|NCT04993677|451435605|FG002|Overall Study|Other|3|||
125492138|NCT04993677|451435606|FG003|Overall Study|Other|2|||
125492139|NCT00003222|451435613|FG000|Overall Study|Physician Decision|0|||
125492140|NCT00003222|451435614|FG001|Overall Study|Physician Decision|1|||
125492141|NCT03248492|451435615|FG000|Overall Study|Progressive Disease|24|||
125492142|NCT03248492|451435616|FG001|Overall Study|Progressive Disease|23|||
125492143|NCT03248492|451435617|FG002|Overall Study|Progressive Disease|11|||
125492144|NCT03248492|451435618|FG003|Overall Study|Progressive Disease|66|||
125492145|NCT03248492|451435619|FG004|Overall Study|Progressive Disease|1|||
125492146|NCT03248492|451435615|FG000|Overall Study|Adverse Event|14|||
125492147|NCT03248492|451435616|FG001|Overall Study|Adverse Event|13|||
125492148|NCT03248492|451435617|FG002|Overall Study|Adverse Event|9|||
125492149|NCT03248492|451435618|FG003|Overall Study|Adverse Event|22|||
125492150|NCT03248492|451435619|FG004|Overall Study|Adverse Event|2|||
125492151|NCT03248492|451435615|FG000|Overall Study|Withdrawal by Subject|5|||
125492152|NCT03248492|451435616|FG001|Overall Study|Withdrawal by Subject|4|||
125492153|NCT03248492|451435617|FG002|Overall Study|Withdrawal by Subject|0|||
125492154|NCT03248492|451435618|FG003|Overall Study|Withdrawal by Subject|8|||
125492155|NCT03248492|451435619|FG004|Overall Study|Withdrawal by Subject|1|||
125492156|NCT03248492|451435615|FG000|Overall Study|Physician Decision|1|||
125492157|NCT03248492|451435616|FG001|Overall Study|Physician Decision|1|||
125492158|NCT03248492|451435617|FG002|Overall Study|Physician Decision|1|||
125492159|NCT03248492|451435618|FG003|Overall Study|Physician Decision|7|||
125492160|NCT03248492|451435619|FG004|Overall Study|Physician Decision|0|||
125492161|NCT03248492|451435615|FG000|Overall Study|Death|1|||
125492162|NCT03248492|451435616|FG001|Overall Study|Death|1|||
125492163|NCT03248492|451435617|FG002|Overall Study|Death|0|||
125492164|NCT03248492|451435618|FG003|Overall Study|Death|6|||
125492165|NCT03248492|451435619|FG004|Overall Study|Death|0|||
125492166|NCT03248492|451435615|FG000|Overall Study|Study Terminated by Sponsor|3|||
125492167|NCT03248492|451435616|FG001|Overall Study|Study Terminated by Sponsor|1|||
125492168|NCT03248492|451435617|FG002|Overall Study|Study Terminated by Sponsor|0|||
125492169|NCT03248492|451435618|FG003|Overall Study|Study Terminated by Sponsor|7|||
125492170|NCT03248492|451435619|FG004|Overall Study|Study Terminated by Sponsor|0|||
125492171|NCT03248492|451435615|FG000|Overall Study|Other|2|||
125492172|NCT03248492|451435616|FG001|Overall Study|Other|5|||
125492173|NCT03248492|451435617|FG002|Overall Study|Other|0|||
125492174|NCT03248492|451435618|FG003|Overall Study|Other|14|||
125492175|NCT03248492|451435619|FG004|Overall Study|Other|0|||
125492176|NCT03767335|451435620|FG000|Overall Study|Physician Decision|1|||
125492177|NCT03767335|451435621|FG001|Overall Study|Physician Decision|1|||
125492178|NCT03767335|451435622|FG002|Overall Study|Physician Decision|0|||
125492179|NCT03767335|451435620|FG000|Overall Study|Withdrawal by Subject|0|||
125492180|NCT03767335|451435621|FG001|Overall Study|Withdrawal by Subject|0|||
125492181|NCT03767335|451435622|FG002|Overall Study|Withdrawal by Subject|6|||
125492182|NCT03767335|451435620|FG000|Overall Study|Participant excluded from efficacy population|0|||
125492183|NCT03767335|451435621|FG001|Overall Study|Participant excluded from efficacy population|0|||
125492184|NCT03767335|451435622|FG002|Overall Study|Participant excluded from efficacy population|1|||
125492185|NCT03767335|451435620|FG000|Overall Study|Death|0|||
125492186|NCT03767335|451435621|FG001|Overall Study|Death|0|||
125492187|NCT03767335|451435622|FG002|Overall Study|Death|2|||
125492188|NCT03767335|451435620|FG000|Overall Study|Progressive Disease|2|||
125492189|NCT03767335|451435621|FG001|Overall Study|Progressive Disease|2|||
125492190|NCT03767335|451435622|FG002|Overall Study|Progressive Disease|2|||
125492191|NCT03767335|451435620|FG000|Overall Study|Disease progression needing additional medication|0|||
125492192|NCT03767335|451435621|FG001|Overall Study|Disease progression needing additional medication|0|||
125492193|NCT03767335|451435622|FG002|Overall Study|Disease progression needing additional medication|17|||
125492194|NCT03767335|451435620|FG000|Overall Study|Sponsor decision|0|||
125492195|NCT03767335|451435621|FG001|Overall Study|Sponsor decision|0|||
125492196|NCT03767335|451435622|FG002|Overall Study|Sponsor decision|2|||
125492197|NCT03767335|451435620|FG000|Overall Study|Other Medical Reasons|0|||
125492198|NCT03767335|451435621|FG001|Overall Study|Other Medical Reasons|0|||
125492199|NCT03767335|451435622|FG002|Overall Study|Other Medical Reasons|3|||
125492200|NCT03705390|451435623|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
125492201|NCT03705390|451435623|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
125492202|NCT04495621|451435625|FG000|Overall Study|Withdrawal by Subject|0|||
125492203|NCT04495621|451435626|FG001|Overall Study|Withdrawal by Subject|3|||
125492204|NCT04495621|451435625|FG000|Overall Study|Death|7|||
125492205|NCT04495621|451435626|FG001|Overall Study|Death|11|||
125492206|NCT04495621|451435625|FG000|Overall Study|Investigator Decision|0|||
125492207|NCT04495621|451435626|FG001|Overall Study|Investigator Decision|7|||
125492208|NCT04495621|451435625|FG000|Overall Study|Lost to Follow-up|0|||
125492209|NCT04495621|451435626|FG001|Overall Study|Lost to Follow-up|1|||
125492210|NCT04757753|451435632|FG000|Overall Study|Lost to Follow-up|7|||
125492211|NCT04757753|451435633|FG001|Overall Study|Lost to Follow-up|7|||
125492212|NCT04757753|451435632|FG000|Overall Study|Withdrawal by Subject|0|||
125492213|NCT04757753|451435633|FG001|Overall Study|Withdrawal by Subject|3|||
125492214|NCT04757753|451435632|FG000|Overall Study|Endodontic treatment failure|1|||
125492215|NCT04757753|451435633|FG001|Overall Study|Endodontic treatment failure|2|||
125492216|NCT04757753|451435632|FG000|Overall Study|Tooth fracture/extraction|3|||
125492217|NCT04757753|451435633|FG001|Overall Study|Tooth fracture/extraction|0|||
125492218|NCT01313559|451435634|FG000|Overall Study|Withdrawal by Subject|1|||
125492219|NCT01313559|451435635|FG001|Overall Study|Withdrawal by Subject|2|||
125492220|NCT01313559|451435634|FG000|Overall Study|Disease progression|1|||
125492221|NCT01313559|451435635|FG001|Overall Study|Disease progression|0|||
125492222|NCT01313559|451435634|FG000|Overall Study|Rising PSA|2|||
125492223|NCT01313559|451435635|FG001|Overall Study|Rising PSA|0|||
125492224|NCT03201939|451435642|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
125303615|NCT01959841|450739481|FG002|Overall Study|Lack of Efficacy|0|||
125303616|NCT01959841|450739479|FG000|Overall Study|Lost to Follow-up|1|||
125303617|NCT01959841|450739480|FG001|Overall Study|Lost to Follow-up|1|||
125303618|NCT01959841|450739481|FG002|Overall Study|Lost to Follow-up|0|||
125303619|NCT01959841|450739479|FG000|Overall Study|Physician Decision|0|||
125303620|NCT01959841|450739480|FG001|Overall Study|Physician Decision|2|||
125303621|NCT01959841|450739481|FG002|Overall Study|Physician Decision|3|||
125492225|NCT03201939|451435643|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
125492226|NCT04908514|451435648|FG000|Overall Study|Lost to Follow-up|2|||
125492227|NCT04908514|451435648|FG000|Overall Study|Withdrawal by Subject|1|||
125492228|NCT05180539|451436183|FG000|Overall Study|Lost to Follow-up|27|||
125303622|NCT01959841|450739479|FG000|Overall Study|Protocol Violation|16|||
125303623|NCT01959841|450739480|FG001|Overall Study|Protocol Violation|23|||
125303624|NCT01959841|450739481|FG002|Overall Study|Protocol Violation|16|||
125492229|NCT05180539|451436184|FG001|Overall Study|Lost to Follow-up|30|||
125492230|NCT02566889|451436187|FG000|Overall Study|Withdrawal by Subject|3|||
125303625|NCT01959841|450739479|FG000|Overall Study|Withdrawal by Subject|7|||
125303626|NCT01959841|450739480|FG001|Overall Study|Withdrawal by Subject|7|||
125492231|NCT02566889|451436188|FG001|Overall Study|Withdrawal by Subject|1|||
125492232|NCT02566889|451436187|FG000|Overall Study|Adverse Event|4|||
125492233|NCT02566889|451436188|FG001|Overall Study|Adverse Event|2|||
125492234|NCT02566889|451436187|FG000|Overall Study|Other|6|||
125492235|NCT02566889|451436188|FG001|Overall Study|Other|2|||
125492236|NCT04518943|451436189|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
125492237|NCT04518943|451436190|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
125492238|NCT04518943|451436191|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
125492239|NCT04518943|451436192|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
125492240|NCT04518943|451436193|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
125492241|NCT04518943|451436194|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
125492242|NCT04518943|451436195|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
125492243|NCT04518943|451436196|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
125492244|NCT04518943|451436197|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
125492245|NCT04518943|451436198|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
125492246|NCT04518943|451436199|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
125492247|NCT04518943|451436200|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
125492248|NCT04518943|451436201|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
125492249|NCT04518943|451436202|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
125492250|NCT04518943|451436203|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
125492251|NCT04518943|451436204|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
125492252|NCT03699163|451436205|FG000|Overall Study|Physician Decision|12|||
125492253|NCT03699163|451436206|FG001|Overall Study|Physician Decision|0|||
125492254|NCT03699163|451436205|FG000|Overall Study|failed QC measures|205|||
125492255|NCT03699163|451436206|FG001|Overall Study|failed QC measures|206|||
125492256|NCT02701283|451436224|FG000|Overall Study|Death|25|||
125492257|NCT02701283|451436225|FG001|Overall Study|Death|29|||
125492258|NCT02701283|451436226|FG002|Overall Study|Death|19|||
125492259|NCT02701283|451436224|FG000|Overall Study|Lost to Follow-up|3|||
125492260|NCT02701283|451436225|FG001|Overall Study|Lost to Follow-up|8|||
125492261|NCT02701283|451436226|FG002|Overall Study|Lost to Follow-up|1|||
125492262|NCT02701283|451436224|FG000|Overall Study|Withdrawal by Subject|12|||
125492263|NCT02701283|451436225|FG001|Overall Study|Withdrawal by Subject|41|||
125492264|NCT02701283|451436226|FG002|Overall Study|Withdrawal by Subject|1|||
125492265|NCT02701283|451436224|FG000|Overall Study|Missed 2-year visit|22|||
125492266|NCT02701283|451436225|FG001|Overall Study|Missed 2-year visit|27|||
125492267|NCT02701283|451436226|FG002|Overall Study|Missed 2-year visit|0|||
125492268|NCT02701283|451436224|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
125492269|NCT02701283|451436225|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
125492270|NCT02701283|451436226|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
125492271|NCT01830595|451436230|FG000|First Period|Withdrawal by Subject|1|||
125492272|NCT01830595|451436231|FG001|First Period|Withdrawal by Subject|3|||
125492273|NCT01830595|451436230|FG000|Washout|Withdrawal by Subject|2|||
125492274|NCT01830595|451436231|FG001|Washout|Withdrawal by Subject|2|||
125492275|NCT04940624|451436232|FG000|Overall Study|Adverse Event|4|||
125492276|NCT04940624|451436233|FG001|Overall Study|Adverse Event|11|||
125492277|NCT04940624|451436232|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
125492278|NCT04940624|451436233|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
125492279|NCT04940624|451436232|FG000|Overall Study|Physician Decision|1|||
125492280|NCT04940624|451436233|FG001|Overall Study|Physician Decision|0|||
125492281|NCT04940624|451436232|FG000|Overall Study|Lost to Follow-up|1|||
125492282|NCT04940624|451436233|FG001|Overall Study|Lost to Follow-up|0|||
125492283|NCT04940624|451436232|FG000|Overall Study|Reason Not Specified|1|||
125492284|NCT04940624|451436233|FG001|Overall Study|Reason Not Specified|0|||
125492285|NCT04479787|451436240|FG000|Through 6 Months|Withdrawal by Subject|16|||
125492286|NCT04479787|451436241|FG001|Through 6 Months|Withdrawal by Subject|14|||
125492287|NCT04479787|451436240|FG000|Through 6 Months|Unsuccessful Trial|17|||
125492288|NCT04479787|451436241|FG001|Through 6 Months|Unsuccessful Trial|0|||
125492289|NCT04479787|451436240|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
125492290|NCT04479787|451436241|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
125492291|NCT04479787|451436240|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
125492292|NCT04479787|451436241|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
125492293|NCT04479787|451436240|FG000|Through 6 Months|Lost to Follow-up|3|||
125492294|NCT04479787|451436241|FG001|Through 6 Months|Lost to Follow-up|2|||
125492295|NCT04479787|451436240|FG000|Through 6 Months|Death|3|||
125492296|NCT04479787|451436241|FG001|Through 6 Months|Death|0|||
125492297|NCT04479787|451436240|FG000|Through 6 Months|Inclusion/Exclusion|2|||
125492298|NCT04479787|451436241|FG001|Through 6 Months|Inclusion/Exclusion|1|||
125492299|NCT04479787|451436240|FG000|Through 6 Months|Subject Became Pregnant|1|||
125492300|NCT04479787|451436241|FG001|Through 6 Months|Subject Became Pregnant|1|||
125492301|NCT04479787|451436240|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
125492302|NCT04479787|451436241|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
125492303|NCT04479787|451436240|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
125492304|NCT04479787|451436241|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
125492305|NCT04479787|451436240|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
125492306|NCT04479787|451436241|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
125492307|NCT04479787|451436240|FG000|After 6 Months|Withdrawal by Subject|3|||
125492308|NCT04479787|451436241|FG001|After 6 Months|Withdrawal by Subject|13|||
125492309|NCT04479787|451436240|FG000|After 6 Months|Unsuccessful Trial|0|||
125492310|NCT04479787|451436241|FG001|After 6 Months|Unsuccessful Trial|7|||
125492311|NCT04479787|451436240|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
125492312|NCT04479787|451436241|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
125492313|NCT04479787|451436240|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
125492314|NCT04479787|451436241|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
125492315|NCT04479787|451436240|FG000|After 6 Months|Death|2|||
125492316|NCT04479787|451436241|FG001|After 6 Months|Death|0|||
125492317|NCT04479787|451436240|FG000|After 6 Months|Lost to Follow-up|1|||
125492318|NCT04479787|451436241|FG001|After 6 Months|Lost to Follow-up|1|||
125492319|NCT04479787|451436240|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
125492320|NCT04479787|451436241|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
125492321|NCT04479787|451436240|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
125492322|NCT04479787|451436241|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
125492323|NCT04479787|451436240|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
125492324|NCT04479787|451436241|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
125492325|NCT04479787|451436240|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
125492326|NCT04479787|451436241|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
125492327|NCT04755595|451436243|FG000|Overall Study|Lost to Follow-up|1|||
125492328|NCT05039021|451436947|FG000|Overall Study|Death|1|||
125492329|NCT05039021|451436947|FG000|Overall Study|Lost to Follow-up|3|||
125492330|NCT03653364|451436950|FG000|Overall Study|Withdrawal by Subject|1|||
125492331|NCT03653364|451436950|FG000|Overall Study|Enrolled in Error|1|||
125492332|NCT03653364|451436950|FG000|Overall Study|Death|1|||
125492333|NCT00686595|451436951|FG000|Overall Study|Adverse Event|3|||
125492334|NCT00686595|451436951|FG000|Overall Study|Protocol Violation|1|||
125492335|NCT00686595|451436951|FG000|Overall Study|Lost to Follow-up|1|||
125492336|NCT00686595|451436951|FG000|Overall Study|Lack of Efficacy|1|||
125492337|NCT00686595|451436951|FG000|Overall Study|Poor Compliance|1|||
125492338|NCT03213457|451436954|FG000|Screening Period|Withdrawal by Subject|0|||
125492339|NCT03213457|451436955|FG001|Screening Period|Withdrawal by Subject|1|||
125492340|NCT03213457|451436956|FG002|Screening Period|Withdrawal by Subject|0|||
125492341|NCT03213457|451436954|FG000|Screening Period|Other|1|||
125492342|NCT03213457|451436955|FG001|Screening Period|Other|0|||
125492343|NCT03213457|451436956|FG002|Screening Period|Other|0|||
125492344|NCT03213457|451436954|FG000|Double-Blind Period|Adverse Event|3|||
125492345|NCT03213457|451436955|FG001|Double-Blind Period|Adverse Event|2|||
125492346|NCT03213457|451436956|FG002|Double-Blind Period|Adverse Event|7|||
125492347|NCT03213457|451436954|FG000|Double-Blind Period|Withdrawal by Subject|14|||
125492348|NCT03213457|451436955|FG001|Double-Blind Period|Withdrawal by Subject|2|||
125492349|NCT03213457|451436956|FG002|Double-Blind Period|Withdrawal by Subject|14|||
125492350|NCT03213457|451436954|FG000|Double-Blind Period|Lost to Follow-up|2|||
125492351|NCT03213457|451436955|FG001|Double-Blind Period|Lost to Follow-up|3|||
125492352|NCT03213457|451436956|FG002|Double-Blind Period|Lost to Follow-up|9|||
125492353|NCT03213457|451436954|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
125492354|NCT03213457|451436955|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
125492355|NCT03213457|451436956|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
125492356|NCT03213457|451436954|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
125492357|NCT03213457|451436955|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
125492358|NCT03213457|451436956|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
125492359|NCT03213457|451436954|FG000|Double-Blind Period|Pregnancy|5|||
125492360|NCT03213457|451436955|FG001|Double-Blind Period|Pregnancy|0|||
125492361|NCT03213457|451436956|FG002|Double-Blind Period|Pregnancy|0|||
125492362|NCT03213457|451436954|FG000|Double-Blind Period|Other|10|||
125492363|NCT03213457|451436955|FG001|Double-Blind Period|Other|3|||
125492364|NCT03213457|451436956|FG002|Double-Blind Period|Other|17|||
125492365|NCT03213457|451436954|FG000|Open-Label Period|Adverse Event|1|||
125492366|NCT03213457|451436955|FG001|Open-Label Period|Adverse Event|2|||
125492367|NCT03213457|451436956|FG002|Open-Label Period|Adverse Event|2|||
125492368|NCT03213457|451436954|FG000|Open-Label Period|Withdrawal by Subject|12|||
125492369|NCT03213457|451436955|FG001|Open-Label Period|Withdrawal by Subject|5|||
125492370|NCT03213457|451436956|FG002|Open-Label Period|Withdrawal by Subject|24|||
125492371|NCT03213457|451436954|FG000|Open-Label Period|Lost to Follow-up|1|||
125492372|NCT03213457|451436955|FG001|Open-Label Period|Lost to Follow-up|2|||
125492373|NCT03213457|451436956|FG002|Open-Label Period|Lost to Follow-up|8|||
125492374|NCT03213457|451436954|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
125492375|NCT03213457|451436955|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
125492376|NCT03213457|451436956|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
125492377|NCT03213457|451436954|FG000|Open-Label Period|Non-compliance with study procedures|1|||
125492378|NCT03213457|451436955|FG001|Open-Label Period|Non-compliance with study procedures|1|||
125492379|NCT03213457|451436956|FG002|Open-Label Period|Non-compliance with study procedures|2|||
125492380|NCT03213457|451436954|FG000|Open-Label Period|Exclusionary medications|0|||
125492381|NCT03213457|451436955|FG001|Open-Label Period|Exclusionary medications|0|||
125492382|NCT03213457|451436956|FG002|Open-Label Period|Exclusionary medications|1|||
125492383|NCT03213457|451436954|FG000|Open-Label Period|Other|1|||
125492384|NCT03213457|451436955|FG001|Open-Label Period|Other|1|||
125492385|NCT03213457|451436956|FG002|Open-Label Period|Other|6|||
125492386|NCT03213457|451436954|FG000|Follow-Up Period|Adverse Event|16|||
125492387|NCT03213457|451436955|FG001|Follow-Up Period|Adverse Event|8|||
125492388|NCT03213457|451436956|FG002|Follow-Up Period|Adverse Event|37|||
125492389|NCT03213457|451436954|FG000|Follow-Up Period|Withdrawal by Subject|18|||
125492390|NCT03213457|451436955|FG001|Follow-Up Period|Withdrawal by Subject|11|||
125492391|NCT03213457|451436956|FG002|Follow-Up Period|Withdrawal by Subject|55|||
125492392|NCT03213457|451436954|FG000|Follow-Up Period|Lost to Follow-up|28|||
125492393|NCT03213457|451436955|FG001|Follow-Up Period|Lost to Follow-up|15|||
125492394|NCT03213457|451436956|FG002|Follow-Up Period|Lost to Follow-up|50|||
125492395|NCT03213457|451436954|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
125492396|NCT03213457|451436955|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
125492397|NCT03213457|451436956|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
125492398|NCT03213457|451436954|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
125492399|NCT03213457|451436955|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
125492400|NCT03213457|451436956|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
125492401|NCT03213457|451436954|FG000|Follow-Up Period|Pregnancy|7|||
125492402|NCT03213457|451436955|FG001|Follow-Up Period|Pregnancy|0|||
125492403|NCT03213457|451436956|FG002|Follow-Up Period|Pregnancy|18|||
125492404|NCT03213457|451436954|FG000|Follow-Up Period|Exclusionary medications|1|||
125492405|NCT03213457|451436955|FG001|Follow-Up Period|Exclusionary medications|1|||
125492406|NCT03213457|451436956|FG002|Follow-Up Period|Exclusionary medications|5|||
125492407|NCT03213457|451436954|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
125492408|NCT03213457|451436955|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
125492409|NCT03213457|451436956|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
125492410|NCT03213457|451436954|FG000|Follow-Up Period|Other|14|||
125492411|NCT03213457|451436955|FG001|Follow-Up Period|Other|10|||
125492412|NCT03213457|451436956|FG002|Follow-Up Period|Other|31|||
125492413|NCT05934292|451436958|FG000|Overall Study|Lost to Follow-up|0|||
125492414|NCT05934292|451436959|FG001|Overall Study|Lost to Follow-up|0|||
125492415|NCT05934292|451436960|FG002|Overall Study|Lost to Follow-up|1|||
125492416|NCT05934292|451436961|FG003|Overall Study|Lost to Follow-up|0|||
125492417|NCT05714059|451436964|FG000|Overall Study|Withdrawal by Subject|2|||
125492418|NCT05714059|451436965|FG001|Overall Study|Withdrawal by Subject|2|||
125492419|NCT05714059|451436964|FG000|Overall Study|Adverse Event|0|||
125492420|NCT05714059|451436965|FG001|Overall Study|Adverse Event|1|||
125492421|NCT05714059|451436964|FG000|Overall Study|Lost to Follow-up|0|||
125492422|NCT05714059|451436965|FG001|Overall Study|Lost to Follow-up|1|||
125492423|NCT05714059|451436964|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
125492424|NCT05714059|451436965|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
125492425|NCT05714059|451436964|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
125492426|NCT05714059|451436965|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
125492427|NCT04899674|451436966|FG000|Test|Adverse Event|1|||
125492428|NCT03774472|451436967|FG000|Overall Study|Physician Decision|1|||
125492429|NCT03774472|451436968|FG001|Overall Study|Physician Decision|0|||
125492430|NCT03774472|451436969|FG002|Overall Study|Physician Decision|0|||
125492431|NCT03774472|451436967|FG000|Overall Study|Progression prior to 4 weeks|0|||
125492432|NCT03774472|451436968|FG001|Overall Study|Progression prior to 4 weeks|1|||
125492433|NCT03774472|451436969|FG002|Overall Study|Progression prior to 4 weeks|0|||
125492434|NCT03774472|451436967|FG000|Overall Study|Withdrawal by Subject|0|||
125492435|NCT03774472|451436968|FG001|Overall Study|Withdrawal by Subject|1|||
125492436|NCT03774472|451436969|FG002|Overall Study|Withdrawal by Subject|0|||
125492437|NCT05155306|451436970|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
125492438|NCT05155306|451436971|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
125492439|NCT05155306|451436972|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
125492440|NCT05155306|451436973|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
125492441|NCT05155306|451436970|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
125492442|NCT05155306|451436971|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
125492443|NCT05155306|451436972|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
125492444|NCT05155306|451436973|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
125492445|NCT05116774|451436975|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
125492446|NCT05116774|451436976|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
125492447|NCT05116774|451436975|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
125492448|NCT05116774|451436976|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
125492449|NCT05116774|451436975|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
125492450|NCT05116774|451436976|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
125492451|NCT05116774|451436975|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
125492452|NCT05116774|451436976|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
125492453|NCT03150862|451436977|FG000|Overall Study|Death|2|||
125492454|NCT03150862|451436978|FG001|Overall Study|Death|7|||
125492455|NCT03150862|451436979|FG002|Overall Study|Death|8|||
125492456|NCT03150862|451436980|FG003|Overall Study|Death|27|||
125492457|NCT03150862|451436981|FG004|Overall Study|Death|4|||
125492458|NCT03150862|451436982|FG005|Overall Study|Death|8|||
125492459|NCT03150862|451436983|FG006|Overall Study|Death|6|||
125492460|NCT03150862|451436984|FG007|Overall Study|Death|21|||
125492461|NCT03150862|451436977|FG000|Overall Study|Withdrawal by Subject|1|||
125492462|NCT03150862|451436978|FG001|Overall Study|Withdrawal by Subject|1|||
125492463|NCT03150862|451436979|FG002|Overall Study|Withdrawal by Subject|0|||
125492464|NCT03150862|451436980|FG003|Overall Study|Withdrawal by Subject|3|||
125492465|NCT03150862|451436981|FG004|Overall Study|Withdrawal by Subject|1|||
125492466|NCT03150862|451436982|FG005|Overall Study|Withdrawal by Subject|1|||
125492467|NCT03150862|451436983|FG006|Overall Study|Withdrawal by Subject|1|||
125492468|NCT03150862|451436984|FG007|Overall Study|Withdrawal by Subject|3|||
125492469|NCT03150862|451436977|FG000|Overall Study|Lost to Follow-up|0|||
125492470|NCT03150862|451436978|FG001|Overall Study|Lost to Follow-up|0|||
125492471|NCT03150862|451436979|FG002|Overall Study|Lost to Follow-up|1|||
125492472|NCT03150862|451436980|FG003|Overall Study|Lost to Follow-up|0|||
125492473|NCT03150862|451436981|FG004|Overall Study|Lost to Follow-up|0|||
125492474|NCT03150862|451436982|FG005|Overall Study|Lost to Follow-up|0|||
125492475|NCT03150862|451436983|FG006|Overall Study|Lost to Follow-up|0|||
125492476|NCT03150862|451436984|FG007|Overall Study|Lost to Follow-up|2|||
125492477|NCT03150862|451436977|FG000|Overall Study|Sponsor's decision|0|||
125492478|NCT03150862|451436978|FG001|Overall Study|Sponsor's decision|0|||
125492479|NCT03150862|451436979|FG002|Overall Study|Sponsor's decision|0|||
125492480|NCT03150862|451436980|FG003|Overall Study|Sponsor's decision|10|||
125492481|NCT03150862|451436981|FG004|Overall Study|Sponsor's decision|3|||
125492482|NCT03150862|451436982|FG005|Overall Study|Sponsor's decision|0|||
125492483|NCT03150862|451436983|FG006|Overall Study|Sponsor's decision|1|||
125492484|NCT03150862|451436984|FG007|Overall Study|Sponsor's decision|1|||
125492485|NCT03150862|451436977|FG000|Overall Study|Change in Methylation status|0|||
125492486|NCT03150862|451436978|FG001|Overall Study|Change in Methylation status|0|||
125492487|NCT03150862|451436979|FG002|Overall Study|Change in Methylation status|0|||
125492488|NCT03150862|451436980|FG003|Overall Study|Change in Methylation status|0|||
125492489|NCT03150862|451436981|FG004|Overall Study|Change in Methylation status|1|||
125492490|NCT03150862|451436982|FG005|Overall Study|Change in Methylation status|0|||
125492491|NCT03150862|451436983|FG006|Overall Study|Change in Methylation status|0|||
125492492|NCT03150862|451436984|FG007|Overall Study|Change in Methylation status|0|||
125492493|NCT03150862|451436977|FG000|Overall Study|Roll over in to Long Term Extension|0|||
125492494|NCT03150862|451436978|FG001|Overall Study|Roll over in to Long Term Extension|0|||
125492495|NCT03150862|451436979|FG002|Overall Study|Roll over in to Long Term Extension|0|||
125492496|NCT03150862|451436980|FG003|Overall Study|Roll over in to Long Term Extension|0|||
125492497|NCT03150862|451436981|FG004|Overall Study|Roll over in to Long Term Extension|0|||
125492498|NCT03150862|451436982|FG005|Overall Study|Roll over in to Long Term Extension|0|||
125492499|NCT03150862|451436983|FG006|Overall Study|Roll over in to Long Term Extension|0|||
125492500|NCT03150862|451436984|FG007|Overall Study|Roll over in to Long Term Extension|1|||
125492501|NCT03150862|451436977|FG000|Overall Study|Progressive Disease|0|||
125492502|NCT03150862|451436978|FG001|Overall Study|Progressive Disease|0|||
125492503|NCT03150862|451436979|FG002|Overall Study|Progressive Disease|0|||
125492504|NCT03150862|451436980|FG003|Overall Study|Progressive Disease|0|||
125492505|NCT03150862|451436981|FG004|Overall Study|Progressive Disease|0|||
125492506|NCT03150862|451436982|FG005|Overall Study|Progressive Disease|0|||
125492507|NCT03150862|451436983|FG006|Overall Study|Progressive Disease|0|||
125492508|NCT03150862|451436984|FG007|Overall Study|Progressive Disease|2|||
125492509|NCT04158141|451436987|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
125492510|NCT04158141|451436988|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
125492511|NCT04158141|451436989|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
125492512|NCT04158141|451436987|FG000|Step 1: Registration|Adverse Event|1|||
125492513|NCT04158141|451436988|FG001|Step 1: Registration|Adverse Event|0|||
125492514|NCT04158141|451436989|FG002|Step 1: Registration|Adverse Event|0|||
125492515|NCT04158141|451436987|FG000|Step 1: Registration|Withdrawal by Subject|1|||
125492516|NCT04158141|451436988|FG001|Step 1: Registration|Withdrawal by Subject|0|||
125492517|NCT04158141|451436989|FG002|Step 1: Registration|Withdrawal by Subject|0|||
125492518|NCT04158141|451436987|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
125492519|NCT04158141|451436988|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
125492520|NCT04158141|451436989|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
125492521|NCT04505722|451436994|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
125492522|NCT04505722|451436995|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
125492523|NCT04505722|451436996|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
125492524|NCT04505722|451436994|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
125492525|NCT04505722|451436995|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
125492526|NCT04505722|451436996|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
125492527|NCT04505722|451436994|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
125492528|NCT04505722|451436995|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
125492529|NCT04505722|451436996|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
125492530|NCT04505722|451436994|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
125492531|NCT04505722|451436995|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
125492532|NCT04505722|451436996|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
125492533|NCT04505722|451436994|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
125492534|NCT04505722|451436995|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
125492535|NCT04505722|451436996|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
125492536|NCT04505722|451436994|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
125492537|NCT04505722|451436995|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
125492538|NCT04505722|451436996|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
125492539|NCT04505722|451436994|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
125492540|NCT04505722|451436995|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
125492541|NCT04505722|451436996|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
125492542|NCT04505722|451436994|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
125492543|NCT04505722|451436995|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
125492544|NCT04505722|451436996|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
125492545|NCT04505722|451436994|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
125492546|NCT04505722|451436995|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
125492547|NCT04505722|451436996|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
125492548|NCT04505722|451436994|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
125492549|NCT04505722|451436995|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
125492550|NCT04505722|451436996|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
125492551|NCT04505722|451436994|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
125492552|NCT04505722|451436995|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
125492553|NCT04505722|451436996|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
125492554|NCT04505722|451436994|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
125492555|NCT04505722|451436995|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
125492556|NCT04505722|451436996|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
125492557|NCT04505722|451436994|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
125492558|NCT04505722|451436995|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
125492559|NCT04505722|451436996|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
125492560|NCT04505722|451436994|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
125492561|NCT04505722|451436995|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
125492562|NCT04505722|451436996|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
125492563|NCT04505722|451436994|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
125492564|NCT04505722|451436995|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
125492565|NCT04505722|451436996|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
125492566|NCT00319696|451436997|FG000|Overall Study|Adverse Event|36|||
125492567|NCT00319696|451436997|FG000|Overall Study|withdrawal of consent|14|||
125492568|NCT00319696|451436997|FG000|Overall Study|administrative|7|||
125492569|NCT00319696|451436997|FG000|Overall Study|Lost to Follow-up|3|||
125492570|NCT02206828|451436998|FG000|Overall Study|Lost to Follow-up|7|||
125492571|NCT04977583|451437694|FG000|Overall Study|Lost to Follow-up|8|||
125492572|NCT04977583|451437695|FG001|Overall Study|Lost to Follow-up|4|||
125492573|NCT04977583|451437696|FG002|Overall Study|Lost to Follow-up|13|||
125492574|NCT04977583|451437694|FG000|Overall Study|Withdrawal by Subject|3|||
125492575|NCT04977583|451437695|FG001|Overall Study|Withdrawal by Subject|2|||
125492576|NCT04977583|451437696|FG002|Overall Study|Withdrawal by Subject|1|||
125492577|NCT02422615|451437697|FG000|Treatment Period|Progressive disease|314|||
125492578|NCT02422615|451437698|FG001|Treatment Period|Progressive disease|200|||
125492579|NCT02422615|451437697|FG000|Treatment Period|Adverse Event|51|||
125492580|NCT02422615|451437698|FG001|Treatment Period|Adverse Event|9|||
125492581|NCT02422615|451437697|FG000|Treatment Period|Physician Decision|32|||
125492582|NCT02422615|451437698|FG001|Treatment Period|Physician Decision|8|||
125492583|NCT02422615|451437697|FG000|Treatment Period|Subject/guardian decision|38|||
125492584|NCT02422615|451437698|FG001|Treatment Period|Subject/guardian decision|8|||
125492585|NCT02422615|451437697|FG000|Treatment Period|Death|2|||
125492586|NCT02422615|451437698|FG001|Treatment Period|Death|1|||
125492587|NCT02422615|451437697|FG000|Treatment Period|Technical problems|0|||
125492588|NCT02422615|451437698|FG001|Treatment Period|Technical problems|1|||
125492589|NCT02422615|451437697|FG000|Treatment Period|Protocol deviation|1|||
125492590|NCT02422615|451437698|FG001|Treatment Period|Protocol deviation|1|||
125492591|NCT02422615|451437697|FG000|Treatment Period|Study terminated as per protocol|46|||
125492592|NCT02422615|451437698|FG001|Treatment Period|Study terminated as per protocol|14|||
125492593|NCT02422615|451437697|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
125492594|NCT02422615|451437698|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125492595|NCT02422615|451437697|FG000|Post-treatment Efficacy Follow-up|Death|2|||
125492596|NCT02422615|451437698|FG001|Post-treatment Efficacy Follow-up|Death|1|||
125492597|NCT02422615|451437697|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
125492598|NCT02422615|451437698|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125492599|NCT02422615|451437697|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
125492600|NCT02422615|451437698|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
125492601|NCT02422615|451437697|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
125492602|NCT02422615|451437698|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
125492603|NCT02422615|451437697|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
125492604|NCT02422615|451437698|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
125492605|NCT01639131|451437699|FG000|Overall Study|Disease Progression|6|||
125492606|NCT01105975|451437706|FG000|Overall Study|Adverse Event|2|||
125492607|NCT01105975|451437707|FG001|Overall Study|Adverse Event|1|||
125492608|NCT01105975|451437708|FG002|Overall Study|Adverse Event|5|||
125492609|NCT01105975|451437709|FG003|Overall Study|Adverse Event|1|||
125492610|NCT01105975|451437710|FG004|Overall Study|Adverse Event|0|||
125492611|NCT01105975|451437711|FG005|Overall Study|Adverse Event|1|||
125492612|NCT01105975|451437712|FG006|Overall Study|Adverse Event|2|||
125492613|NCT01105975|451437713|FG007|Overall Study|Adverse Event|4|||
125492614|NCT01105975|451437714|FG008|Overall Study|Adverse Event|1|||
125492615|NCT01105975|451437715|FG009|Overall Study|Adverse Event|4|||
125492616|NCT01105975|451437706|FG000|Overall Study|Withdrawal by Subject|2|||
125492617|NCT01105975|451437707|FG001|Overall Study|Withdrawal by Subject|2|||
125492618|NCT01105975|451437708|FG002|Overall Study|Withdrawal by Subject|2|||
125492619|NCT01105975|451437709|FG003|Overall Study|Withdrawal by Subject|0|||
125492620|NCT01105975|451437710|FG004|Overall Study|Withdrawal by Subject|4|||
125492621|NCT01105975|451437711|FG005|Overall Study|Withdrawal by Subject|1|||
125492622|NCT01105975|451437712|FG006|Overall Study|Withdrawal by Subject|2|||
125492623|NCT01105975|451437713|FG007|Overall Study|Withdrawal by Subject|1|||
125492624|NCT01105975|451437714|FG008|Overall Study|Withdrawal by Subject|0|||
125492625|NCT01105975|451437715|FG009|Overall Study|Withdrawal by Subject|3|||
125492626|NCT01105975|451437706|FG000|Overall Study|Lost to Follow-up|1|||
125492627|NCT01105975|451437707|FG001|Overall Study|Lost to Follow-up|0|||
125492628|NCT01105975|451437708|FG002|Overall Study|Lost to Follow-up|0|||
125492629|NCT01105975|451437709|FG003|Overall Study|Lost to Follow-up|1|||
125492630|NCT01105975|451437710|FG004|Overall Study|Lost to Follow-up|1|||
125492631|NCT01105975|451437711|FG005|Overall Study|Lost to Follow-up|0|||
125492632|NCT01105975|451437712|FG006|Overall Study|Lost to Follow-up|0|||
125492633|NCT01105975|451437713|FG007|Overall Study|Lost to Follow-up|0|||
125492634|NCT01105975|451437714|FG008|Overall Study|Lost to Follow-up|1|||
125492635|NCT01105975|451437715|FG009|Overall Study|Lost to Follow-up|0|||
125492636|NCT01105975|451437706|FG000|Overall Study|Physician Decision|0|||
125492637|NCT01105975|451437707|FG001|Overall Study|Physician Decision|0|||
125492638|NCT01105975|451437708|FG002|Overall Study|Physician Decision|0|||
125492639|NCT01105975|451437709|FG003|Overall Study|Physician Decision|0|||
125492640|NCT01105975|451437710|FG004|Overall Study|Physician Decision|0|||
125492641|NCT01105975|451437711|FG005|Overall Study|Physician Decision|0|||
125492642|NCT01105975|451437712|FG006|Overall Study|Physician Decision|2|||
125492643|NCT01105975|451437713|FG007|Overall Study|Physician Decision|0|||
125492644|NCT01105975|451437714|FG008|Overall Study|Physician Decision|0|||
125492645|NCT01105975|451437715|FG009|Overall Study|Physician Decision|0|||
125492646|NCT01105975|451437706|FG000|Overall Study|Protocol Violation|0|||
125492647|NCT01105975|451437707|FG001|Overall Study|Protocol Violation|2|||
125492648|NCT01105975|451437708|FG002|Overall Study|Protocol Violation|2|||
125492649|NCT01105975|451437709|FG003|Overall Study|Protocol Violation|0|||
125492650|NCT01105975|451437710|FG004|Overall Study|Protocol Violation|1|||
125492651|NCT01105975|451437711|FG005|Overall Study|Protocol Violation|1|||
125492652|NCT01105975|451437712|FG006|Overall Study|Protocol Violation|1|||
125303627|NCT01959841|450739481|FG002|Overall Study|Withdrawal by Subject|5|||
125303628|NCT01959841|450739479|FG000|Overall Study|Clinical laboratory value|2|||
125303629|NCT01959841|450739480|FG001|Overall Study|Clinical laboratory value|6|||
125303630|NCT01959841|450739481|FG002|Overall Study|Clinical laboratory value|6|||
125492653|NCT01105975|451437713|FG007|Overall Study|Protocol Violation|1|||
125492654|NCT01105975|451437714|FG008|Overall Study|Protocol Violation|2|||
125303631|NCT01959841|450739479|FG000|Overall Study|Platelet count below on day1 or 4|11|||
125492655|NCT01105975|451437715|FG009|Overall Study|Protocol Violation|2|||
125492656|NCT01105975|451437706|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
125492657|NCT01105975|451437707|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
125492658|NCT01105975|451437708|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
125492659|NCT01105975|451437709|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
125492660|NCT01105975|451437710|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
125492661|NCT01105975|451437711|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
125492662|NCT01105975|451437712|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
125492663|NCT01105975|451437713|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
125492664|NCT01105975|451437714|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
125492665|NCT01105975|451437715|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
125492666|NCT03776812|451437721|FG000|Overall Study|Death|27|||
125492667|NCT03776812|451437722|FG001|Overall Study|Death|19|||
125492668|NCT03776812|451437723|FG002|Overall Study|Death|29|||
125492669|NCT03776812|451437721|FG000|Overall Study|Withdrawal by Subject|1|||
125492670|NCT03776812|451437722|FG001|Overall Study|Withdrawal by Subject|7|||
125492671|NCT03776812|451437723|FG002|Overall Study|Withdrawal by Subject|1|||
125492672|NCT03776812|451437721|FG000|Overall Study|Lost to Follow-up|0|||
125492673|NCT03776812|451437722|FG001|Overall Study|Lost to Follow-up|1|||
125492674|NCT03776812|451437723|FG002|Overall Study|Lost to Follow-up|0|||
125492675|NCT03776812|451437721|FG000|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
125492676|NCT03776812|451437722|FG001|Overall Study|Still on study as of March 22, 2021 data cutoff date|33|||
125492677|NCT03776812|451437723|FG002|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
125492678|NCT00087685|451437729|FG000|Overall Study|Adverse Event|5|||
125492679|NCT00087685|451437729|FG000|Overall Study|Non-Compliance|1|||
125492680|NCT00087685|451437729|FG000|Overall Study|Progressive Disease|5|||
125492681|NCT00087685|451437729|FG000|Overall Study|Withdrawal by Subject|3|||
125492682|NCT05018143|451437730|FG000|Overall Study|Lost to Follow-up|5|||
125492683|NCT05018143|451437731|FG001|Overall Study|Lost to Follow-up|4|||
125492684|NCT05018143|451437730|FG000|Overall Study|Withdrawal by Subject|0|||
125492685|NCT05018143|451437731|FG001|Overall Study|Withdrawal by Subject|1|||
125492686|NCT06688357|451437732|FG000|Overall Study|Adverse Event|0|||
125492687|NCT06688357|451437733|FG001|Overall Study|Adverse Event|1|||
125492688|NCT04018495|451437734|FG000|Overall Study|Physician Decision|1|||
125492689|NCT04059406|451437735|FG000|Overall Study|Early Treatment Termination|5|||
125492690|NCT04059406|451437736|FG001|Overall Study|Early Treatment Termination|5|||
125492691|NCT04059406|451437737|FG002|Overall Study|Early Treatment Termination|15|||
125492692|NCT05601882|451437738|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
125492693|NCT05601882|451437739|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
125492694|NCT05601882|451437740|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
125492695|NCT05601882|451437741|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
125492696|NCT05601882|451437738|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
125492697|NCT05601882|451437739|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
125492698|NCT05601882|451437740|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
125492699|NCT05601882|451437741|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
125492700|NCT05601882|451437738|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
125492701|NCT05601882|451437739|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
125492702|NCT05601882|451437740|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
125492703|NCT05601882|451437741|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
125492704|NCT05601882|451437738|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
125492705|NCT05601882|451437739|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
125492706|NCT05601882|451437740|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
125303632|NCT01959841|450739480|FG001|Overall Study|Platelet count below on day1 or 4|15|||
125303633|NCT01959841|450739481|FG002|Overall Study|Platelet count below on day1 or 4|11|||
125303634|NCT00780416|450739482|FG000|Overall Study|Physician Decision|3|||
125303635|NCT00780416|450739483|FG001|Overall Study|Physician Decision|3|||
125303636|NCT00780416|450739482|FG000|Overall Study|Protocol Violation|1|||
125303637|NCT00780416|450739483|FG001|Overall Study|Protocol Violation|0|||
125303638|NCT00780416|450739482|FG000|Overall Study|Withdrawal by Subject|8|||
125303639|NCT00780416|450739483|FG001|Overall Study|Withdrawal by Subject|6|||
125303640|NCT00666224|450739486|FG000|Double-Blind|Adverse Event|15|||
125303641|NCT00666224|450739487|FG001|Double-Blind|Adverse Event|5|||
125303642|NCT00666224|450739486|FG000|Double-Blind|Lost to Follow-up|2|||
125303643|NCT00666224|450739487|FG001|Double-Blind|Lost to Follow-up|2|||
125303644|NCT00666224|450739486|FG000|Double-Blind|Withdrawal by Subject|18|||
125303645|NCT00666224|450739487|FG001|Double-Blind|Withdrawal by Subject|14|||
125303646|NCT00666224|450739486|FG000|Double-Blind|Physician Decision|0|||
125303647|NCT00666224|450739487|FG001|Double-Blind|Physician Decision|3|||
125303648|NCT00666224|450739486|FG000|Double-Blind|Sponsor decision|1|||
125303649|NCT00666224|450739487|FG001|Double-Blind|Sponsor decision|0|||
125303650|NCT00666224|450739486|FG000|Double-Blind|Pregnancy|3|||
125303651|NCT00666224|450739487|FG001|Double-Blind|Pregnancy|2|||
125303652|NCT00666224|450739486|FG000|Double-Blind|Noncompliance|1|||
125303653|NCT00666224|450739487|FG001|Double-Blind|Noncompliance|0|||
125303654|NCT00666224|450739486|FG000|Double-Blind|Death|1|||
125303655|NCT00666224|450739487|FG001|Double-Blind|Death|0|||
125492707|NCT05601882|451437741|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
125492708|NCT05601882|451437738|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
125492709|NCT05601882|451437739|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
125492710|NCT05601882|451437740|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
125492711|NCT05601882|451437741|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
125492712|NCT05601882|451437738|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
125492713|NCT05601882|451437739|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
125492714|NCT05601882|451437740|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
125492715|NCT05601882|451437741|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
125492716|NCT04121741|451437742|FG000|Overall Study|Protocol Violation|1|||
125492717|NCT04121741|451437743|FG001|Overall Study|Protocol Violation|0|||
125492718|NCT04121741|451437744|FG002|Overall Study|Protocol Violation|0|||
125492719|NCT04121741|451437745|FG003|Overall Study|Protocol Violation|0|||
125492720|NCT04121741|451437746|FG004|Overall Study|Protocol Violation|0|||
125492721|NCT04121741|451437747|FG005|Overall Study|Protocol Violation|0|||
125492722|NCT03473223|451437748|FG000|Overall Study|Lost to Follow-up|1|||
125492723|NCT03473223|451437749|FG001|Overall Study|Lost to Follow-up|1|||
125492724|NCT03473223|451437748|FG000|Overall Study|Withdrawal by Subject|47|||
125492725|NCT03473223|451437749|FG001|Overall Study|Withdrawal by Subject|42|||
125492726|NCT03473223|451437748|FG000|Overall Study|Indirect contact|32|||
125492727|NCT03473223|451437749|FG001|Overall Study|Indirect contact|29|||
125492728|NCT03473223|451437748|FG000|Overall Study|Other (Not specified)|32|||
125492729|NCT03473223|451437749|FG001|Overall Study|Other (Not specified)|20|||
125492730|NCT03524092|451437750|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
125492731|NCT03524092|451437751|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
125492732|NCT03524092|451437752|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
125492733|NCT03524092|451437753|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
125492734|NCT03524092|451437754|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
125492735|NCT03524092|451437755|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
125492736|NCT03524092|451437750|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
125492737|NCT03524092|451437751|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
125492738|NCT03524092|451437752|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
125492739|NCT03524092|451437753|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
125492740|NCT03524092|451437754|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
125492741|NCT03524092|451437755|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
125492742|NCT03524092|451437750|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
125492743|NCT03524092|451437751|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
125492744|NCT03524092|451437752|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
125492745|NCT03524092|451437753|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
125492746|NCT03524092|451437754|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
125492747|NCT03524092|451437755|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
125492748|NCT03524092|451437750|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
125492749|NCT03524092|451437751|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
125492750|NCT03524092|451437752|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
125492751|NCT03524092|451437753|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
125492752|NCT03524092|451437754|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
125492753|NCT03524092|451437755|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
125492754|NCT03524092|451437750|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
125492755|NCT03524092|451437751|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
125492756|NCT03524092|451437752|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
125492757|NCT03524092|451437753|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
125492758|NCT03524092|451437754|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
125492759|NCT03524092|451437755|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
125492760|NCT03524092|451437750|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
125492761|NCT03524092|451437751|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
125492762|NCT03524092|451437752|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
125492763|NCT03524092|451437753|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
125492764|NCT03524092|451437754|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
125492765|NCT03524092|451437755|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
125492766|NCT03524092|451437750|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
125492767|NCT03524092|451437751|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
125492768|NCT03524092|451437752|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
125492769|NCT03524092|451437753|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
125492770|NCT03524092|451437754|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
125492771|NCT03524092|451437755|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
125492772|NCT03524092|451437750|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
125492773|NCT03524092|451437751|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
125492774|NCT03524092|451437752|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
125492775|NCT03524092|451437753|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
125492776|NCT03524092|451437754|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
125492777|NCT03524092|451437755|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
125492778|NCT03524092|451437750|FG000|Loss of Response Rescue Period|Adverse Event|0|||
125492779|NCT03524092|451437751|FG001|Loss of Response Rescue Period|Adverse Event|0|||
125303656|NCT00666224|450739486|FG000|Double-Blind|Undefined/Unknown|4|||
125492780|NCT03524092|451437752|FG002|Loss of Response Rescue Period|Adverse Event|0|||
125492781|NCT03524092|451437753|FG003|Loss of Response Rescue Period|Adverse Event|2|||
125492782|NCT03524092|451437754|FG004|Loss of Response Rescue Period|Adverse Event|0|||
125492783|NCT03524092|451437755|FG005|Loss of Response Rescue Period|Adverse Event|0|||
125492784|NCT03524092|451437750|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
125492785|NCT03524092|451437751|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
125492786|NCT03524092|451437752|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
125492787|NCT03524092|451437753|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
125492788|NCT03524092|451437754|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
125492789|NCT03524092|451437755|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
125492790|NCT03524092|451437750|FG000|Loss of Response Rescue Period|Pregnancy|0|||
125492791|NCT03524092|451437751|FG001|Loss of Response Rescue Period|Pregnancy|0|||
125492792|NCT03524092|451437752|FG002|Loss of Response Rescue Period|Pregnancy|0|||
125492793|NCT03524092|451437753|FG003|Loss of Response Rescue Period|Pregnancy|1|||
125492794|NCT03524092|451437754|FG004|Loss of Response Rescue Period|Pregnancy|0|||
125492795|NCT03524092|451437755|FG005|Loss of Response Rescue Period|Pregnancy|0|||
125492796|NCT03524092|451437750|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
125492797|NCT03524092|451437751|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
125492798|NCT03524092|451437752|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
125492799|NCT03524092|451437753|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
125492800|NCT03524092|451437754|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
125492801|NCT03524092|451437755|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
125492802|NCT03524092|451437750|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
125492803|NCT03524092|451437751|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
125492804|NCT03524092|451437752|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
125492805|NCT03524092|451437753|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
125492806|NCT03524092|451437754|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
125492807|NCT03524092|451437755|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
125492808|NCT03524092|451437750|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
125492809|NCT03524092|451437751|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
125492810|NCT03524092|451437752|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
125492811|NCT03524092|451437753|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
125492812|NCT03524092|451437754|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
125492813|NCT03524092|451437755|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
125492814|NCT03524092|451437750|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
125492815|NCT03524092|451437751|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
125492816|NCT03524092|451437752|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
125492817|NCT03524092|451437753|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
125492818|NCT03524092|451437754|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
125492819|NCT03524092|451437755|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
125492820|NCT03524092|451437750|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
125492821|NCT03524092|451437751|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
125492822|NCT03524092|451437752|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
125492823|NCT03524092|451437753|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
125492824|NCT03524092|451437754|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
125492825|NCT03524092|451437755|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
125492826|NCT03524092|451437750|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
125492827|NCT03524092|451437751|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
125492828|NCT03524092|451437752|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
125492829|NCT03524092|451437753|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
125492830|NCT03524092|451437754|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
125492831|NCT03524092|451437755|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
125492832|NCT03524092|451437750|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
125492833|NCT03524092|451437751|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
125492834|NCT03524092|451437752|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
125492835|NCT03524092|451437753|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
125492836|NCT03524092|451437754|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
125492837|NCT03524092|451437755|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
125492838|NCT03524092|451437750|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
125492839|NCT03524092|451437751|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
125492840|NCT03524092|451437752|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
125492841|NCT03524092|451437753|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
125492842|NCT03524092|451437754|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
125492843|NCT03524092|451437755|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
125492844|NCT03524092|451437750|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
125303657|NCT00666224|450739487|FG001|Double-Blind|Undefined/Unknown|1|||
125492845|NCT03524092|451437751|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
125492846|NCT03524092|451437752|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
125492847|NCT03524092|451437753|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
125492848|NCT03524092|451437754|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
125492849|NCT03524092|451437755|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
125492850|NCT03524092|451437750|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
125492851|NCT03524092|451437751|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
125492852|NCT03524092|451437752|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
125492853|NCT03524092|451437753|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
125492854|NCT03524092|451437754|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
125492855|NCT03524092|451437755|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
125303658|NCT00666224|450739486|FG000|Open-Label|Adverse Event|8|||
125303659|NCT00666224|450739487|FG001|Open-Label|Adverse Event|43|||
125303660|NCT00666224|450739486|FG000|Open-Label|Lost to Follow-up|4|||
125303661|NCT00666224|450739487|FG001|Open-Label|Lost to Follow-up|5|||
125303662|NCT00666224|450739486|FG000|Open-Label|Withdrawal by Subject|12|||
125303663|NCT00666224|450739487|FG001|Open-Label|Withdrawal by Subject|25|||
125303664|NCT00666224|450739486|FG000|Open-Label|Physician Decision|7|||
125303665|NCT00666224|450739487|FG001|Open-Label|Physician Decision|5|||
125303666|NCT00666224|450739486|FG000|Open-Label|Pregnancy|1|||
125303667|NCT00666224|450739487|FG001|Open-Label|Pregnancy|5|||
125303668|NCT00666224|450739486|FG000|Open-Label|Noncompliance|2|||
125303669|NCT00666224|450739487|FG001|Open-Label|Noncompliance|1|||
125303670|NCT00666224|450739486|FG000|Open-Label|Undefined/Unknown|1|||
125303671|NCT00666224|450739487|FG001|Open-Label|Undefined/Unknown|1|||
125303672|NCT00871338|450739491|FG000|Prior to Booster|Withdrawal by Subject|1|||
125303673|NCT00871338|450739492|FG001|Prior to Booster|Withdrawal by Subject|3|||
125303674|NCT00871338|450739491|FG000|Prior to Booster|Lost to Follow-up|1|||
125303675|NCT00871338|450739492|FG001|Prior to Booster|Lost to Follow-up|0|||
125303676|NCT01959139|450739500|FG000|Phase II|Disease progression|0|||
125303677|NCT01959139|450739501|FG001|Phase II|Disease progression|0|||
125303678|NCT01959139|450739502|FG002|Phase II|Disease progression|26|||
125303679|NCT01959139|450739503|FG003|Phase II|Disease progression|34|||
125303680|NCT01959139|450739500|FG000|Phase II|Adverse Event|0|||
125303681|NCT01959139|450739501|FG001|Phase II|Adverse Event|0|||
125303682|NCT01959139|450739502|FG002|Phase II|Adverse Event|10|||
125303683|NCT01959139|450739503|FG003|Phase II|Adverse Event|11|||
125303684|NCT01959139|450739500|FG000|Phase II|Patient Refusal|0|||
125303685|NCT01959139|450739501|FG001|Phase II|Patient Refusal|0|||
125303686|NCT01959139|450739502|FG002|Phase II|Patient Refusal|5|||
125303687|NCT01959139|450739503|FG003|Phase II|Patient Refusal|4|||
125303688|NCT01959139|450739500|FG000|Phase II|Death|0|||
125303689|NCT01959139|450739501|FG001|Phase II|Death|0|||
125303690|NCT01959139|450739502|FG002|Phase II|Death|3|||
125303691|NCT01959139|450739503|FG003|Phase II|Death|1|||
125303692|NCT01959139|450739500|FG000|Phase II|Other/Unknown|0|||
125303693|NCT01959139|450739501|FG001|Phase II|Other/Unknown|0|||
125303694|NCT01959139|450739502|FG002|Phase II|Other/Unknown|8|||
125303695|NCT01959139|450739503|FG003|Phase II|Other/Unknown|5|||
125303696|NCT01959139|450739500|FG000|Phase II|On treatment|0|||
125303697|NCT01959139|450739501|FG001|Phase II|On treatment|0|||
125303698|NCT01959139|450739502|FG002|Phase II|On treatment|4|||
125303699|NCT01959139|450739503|FG003|Phase II|On treatment|0|||
125303700|NCT01964963|450739506|FG000|Overall Study|Case Report Forms Uncollected|888|||
125303701|NCT01964963|450739506|FG000|Overall Study|Protocol Deviation|50|||
125303702|NCT01964963|450739506|FG000|Overall Study|Data Reliability was not Assured|5|||
125303703|NCT01235234|450739507|FG000|Overall Study|Adverse Event|2|||
125303704|NCT01235234|450739508|FG001|Overall Study|Adverse Event|2|||
125303705|NCT01235234|450739509|FG002|Overall Study|Adverse Event|1|||
125303706|NCT02352753|450739510|FG000|6-Month Dosing Period|Decision by sponsor|2|||
125303707|NCT02352753|450739510|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
125303708|NCT02352753|450739510|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
125303709|NCT02352753|450739510|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
125303710|NCT02352753|450739510|FG000|3-Month Dosing Period|Decision by sponsor|14|||
125303711|NCT02352753|450739510|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
125492856|NCT03524092|451437750|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
125492857|NCT03524092|451437751|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
125303712|NCT00711971|450739513|FG000|Overall Study|Lost to Follow-up|3|||
125303713|NCT00711971|450739514|FG001|Overall Study|Lost to Follow-up|4|||
125303714|NCT00711971|450739515|FG002|Overall Study|Lost to Follow-up|1|||
125303715|NCT00536471|450739520|FG000|Overall Study|Lost to Follow-up|48|||
125303716|NCT00536471|450739521|FG001|Overall Study|Lost to Follow-up|23|||
125303717|NCT00536471|450739522|FG002|Overall Study|Lost to Follow-up|48|||
125303718|NCT00536471|450739523|FG003|Overall Study|Lost to Follow-up|22|||
125303719|NCT00536471|450739520|FG000|Overall Study|Adverse Event|32|||
125303720|NCT00536471|450739521|FG001|Overall Study|Adverse Event|16|||
125303721|NCT00536471|450739522|FG002|Overall Study|Adverse Event|28|||
125303722|NCT00536471|450739523|FG003|Overall Study|Adverse Event|13|||
125492858|NCT03524092|451437752|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
125492859|NCT03524092|451437753|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
125492860|NCT03524092|451437754|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
125492861|NCT03524092|451437755|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
125492862|NCT03524092|451437750|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
125492863|NCT03524092|451437751|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
125492864|NCT03524092|451437752|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
125492865|NCT03524092|451437753|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
125492866|NCT03524092|451437754|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
125492867|NCT03524092|451437755|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
125492868|NCT03834740|451437756|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
125492869|NCT03834740|451437757|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
125492870|NCT03834740|451437758|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
125492871|NCT00115934|451437759|FG000|Overall Study|Lost to Follow-up|1|||
125492872|NCT00115934|451437760|FG001|Overall Study|Lost to Follow-up|0|||
125492873|NCT00115934|451437759|FG000|Overall Study|Did not receive intervention|3|||
125492874|NCT00115934|451437760|FG001|Overall Study|Did not receive intervention|2|||
125492875|NCT03997474|451437761|FG000|Overall Study|Death|6|||
125492876|NCT03997474|451437762|FG001|Overall Study|Death|2|||
125492877|NCT03997474|451437763|FG002|Overall Study|Death|1|||
125492878|NCT03997474|451437761|FG000|Overall Study|Physician Decision|2|||
125492879|NCT03997474|451437762|FG001|Overall Study|Physician Decision|0|||
125492880|NCT03997474|451437763|FG002|Overall Study|Physician Decision|0|||
125492881|NCT03997474|451437761|FG000|Overall Study|study terminated by sponsor|1|||
125492882|NCT03997474|451437762|FG001|Overall Study|study terminated by sponsor|0|||
125492883|NCT03997474|451437763|FG002|Overall Study|study terminated by sponsor|1|||
125492884|NCT02325466|451438707|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
125492885|NCT02325466|451438708|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
125492886|NCT02325466|451438709|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
125492887|NCT02325466|451438707|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
125492888|NCT02325466|451438708|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
125492889|NCT02325466|451438709|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
125492890|NCT02325466|451438707|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
125492891|NCT02325466|451438708|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
125492892|NCT02325466|451438709|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
125492893|NCT02325466|451438707|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
125492894|NCT02325466|451438708|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
125492895|NCT02325466|451438709|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
125492896|NCT02325466|451438707|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
125492897|NCT02325466|451438708|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
125492898|NCT02325466|451438709|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
125492899|NCT02325466|451438707|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
125492900|NCT02325466|451438708|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
125492901|NCT02325466|451438709|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
125492902|NCT02325466|451438707|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
125492903|NCT02325466|451438708|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
125492904|NCT02325466|451438709|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
125492905|NCT02325466|451438707|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
125492906|NCT02325466|451438708|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
125492907|NCT02325466|451438709|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
125492908|NCT02325466|451438707|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
125492909|NCT02325466|451438708|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
125492910|NCT02325466|451438709|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
125492911|NCT03183050|451438710|FG000|Overall Study|Lost to Follow-up|23|||
125492912|NCT00754065|451438711|FG000|Overall Study|Never received treatment|12|||
125492913|NCT00754065|451438712|FG001|Overall Study|Never received treatment|2|||
125492914|NCT00754065|451438711|FG000|Overall Study|Adverse Event|19|||
125492915|NCT00754065|451438712|FG001|Overall Study|Adverse Event|25|||
125492916|NCT00754065|451438711|FG000|Overall Study|Lost to Follow-up|7|||
125492917|NCT00754065|451438712|FG001|Overall Study|Lost to Follow-up|11|||
125303723|NCT00536471|450739520|FG000|Overall Study|Withdrawal by Subject|40|||
125303724|NCT00536471|450739521|FG001|Overall Study|Withdrawal by Subject|24|||
125492918|NCT00754065|451438711|FG000|Overall Study|Protocol Violation|12|||
125492919|NCT00754065|451438712|FG001|Overall Study|Protocol Violation|10|||
125492920|NCT00754065|451438711|FG000|Overall Study|Withdrawal by Subject|4|||
125492921|NCT00754065|451438712|FG001|Overall Study|Withdrawal by Subject|5|||
125492922|NCT00754065|451438711|FG000|Overall Study|Pregnancy|6|||
125492923|NCT00754065|451438712|FG001|Overall Study|Pregnancy|0|||
125492924|NCT00754065|451438711|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
125492925|NCT00754065|451438712|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
125492926|NCT01171976|451438715|FG000|Overall Study|Protocol Violation|0|||
125492927|NCT01171976|451438716|FG001|Overall Study|Protocol Violation|0|||
125492928|NCT01171976|451438717|FG002|Overall Study|Protocol Violation|1|||
125492929|NCT01171976|451438715|FG000|Overall Study|Death|2|||
125492930|NCT01171976|451438716|FG001|Overall Study|Death|4|||
125492931|NCT01171976|451438717|FG002|Overall Study|Death|1|||
125492932|NCT01171976|451438715|FG000|Overall Study|Lost to Follow-up|4|||
125492933|NCT01171976|451438716|FG001|Overall Study|Lost to Follow-up|0|||
125492934|NCT01171976|451438717|FG002|Overall Study|Lost to Follow-up|2|||
125492935|NCT01171976|451438715|FG000|Overall Study|Withdrawal by Subject|1|||
125492936|NCT01171976|451438716|FG001|Overall Study|Withdrawal by Subject|5|||
125492937|NCT01171976|451438717|FG002|Overall Study|Withdrawal by Subject|6|||
125492938|NCT01171976|451438715|FG000|Overall Study|Abnormal test result|1|||
125492939|NCT01171976|451438716|FG001|Overall Study|Abnormal test result|0|||
125492940|NCT01171976|451438717|FG002|Overall Study|Abnormal test result|0|||
125492941|NCT01171976|451438715|FG000|Overall Study|Adverse Event|6|||
125492942|NCT01171976|451438716|FG001|Overall Study|Adverse Event|2|||
125492943|NCT01171976|451438717|FG002|Overall Study|Adverse Event|5|||
125492944|NCT03222609|451438720|FG000|Overall Study|Withdrew consent|2|||
125492945|NCT03222609|451438721|FG001|Overall Study|Withdrew consent|3|||
125492946|NCT03222609|451438722|FG002|Overall Study|Withdrew consent|4|||
125492947|NCT03222609|451438723|FG003|Overall Study|Withdrew consent|2|||
125492948|NCT03222609|451438720|FG000|Overall Study|Lost to Follow-up|1|||
125492949|NCT03222609|451438721|FG001|Overall Study|Lost to Follow-up|0|||
125492950|NCT03222609|451438722|FG002|Overall Study|Lost to Follow-up|0|||
125492951|NCT03222609|451438723|FG003|Overall Study|Lost to Follow-up|0|||
125492952|NCT03222609|451438720|FG000|Overall Study|Death|16|||
125492953|NCT03222609|451438721|FG001|Overall Study|Death|13|||
125492954|NCT03222609|451438722|FG002|Overall Study|Death|9|||
125492955|NCT03222609|451438723|FG003|Overall Study|Death|6|||
125492956|NCT03222609|451438720|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
125492957|NCT03222609|451438721|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
125492958|NCT03222609|451438722|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
125492959|NCT03222609|451438723|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
125492960|NCT01084863|451438724|FG000|Main Study Treatment Period|Disease progression|11|||
125492961|NCT01084863|451438725|FG001|Main Study Treatment Period|Disease progression|7|||
125492962|NCT01084863|451438724|FG000|Main Study Treatment Period|Adverse Event|5|||
125492963|NCT01084863|451438725|FG001|Main Study Treatment Period|Adverse Event|3|||
125492964|NCT01084863|451438724|FG000|Main Study Treatment Period|Other Reason|0|||
125492965|NCT01084863|451438725|FG001|Main Study Treatment Period|Other Reason|1|||
125492966|NCT01084863|451438724|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
125492967|NCT01084863|451438725|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
125492968|NCT01084863|451438724|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
125492969|NCT01084863|451438725|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
125492970|NCT01084863|451438724|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
125492971|NCT01084863|451438725|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
125492972|NCT01084863|451438724|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
125492973|NCT01084863|451438725|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
125492974|NCT01084863|451438724|FG000|Treatment Period Beyond Cycle 8|Other|0|||
125492975|NCT01084863|451438725|FG001|Treatment Period Beyond Cycle 8|Other|1|||
125492976|NCT01084863|451438724|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
125492977|NCT01084863|451438725|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
125492978|NCT04305327|451438726|FG000|Overall Study|Study early termination|2|||
125492979|NCT04305327|451438727|FG001|Overall Study|Study early termination|5|||
125492980|NCT04305327|451438728|FG002|Overall Study|Study early termination|2|||
125492981|NCT04305327|451438729|FG003|Overall Study|Study early termination|2|||
125492982|NCT04305327|451438726|FG000|Overall Study|Withdrawal by Subject|0|||
125492983|NCT04305327|451438727|FG001|Overall Study|Withdrawal by Subject|1|||
125492984|NCT04305327|451438728|FG002|Overall Study|Withdrawal by Subject|0|||
125492985|NCT04305327|451438729|FG003|Overall Study|Withdrawal by Subject|0|||
125492986|NCT03275285|451438732|FG000|Overall Study|Ongoing|45|||
125492987|NCT03275285|451438733|FG001|Overall Study|Ongoing|69|||
125303725|NCT00536471|450739522|FG002|Overall Study|Withdrawal by Subject|43|||
125303726|NCT00536471|450739523|FG003|Overall Study|Withdrawal by Subject|21|||
125492988|NCT06191679|451438734|FG000|Baseline|Lost to Follow-up|1|||
125492989|NCT06191679|451438735|FG001|Baseline|Lost to Follow-up|0|||
125492990|NCT06191679|451438736|FG002|Baseline|Lost to Follow-up|1|||
125492991|NCT06191679|451438737|FG003|Baseline|Lost to Follow-up|0|||
125492992|NCT06191679|451438734|FG000|Allocation to Group|Withdrawal by Subject|0|||
125492993|NCT06191679|451438735|FG001|Allocation to Group|Withdrawal by Subject|1|||
125492994|NCT06191679|451438736|FG002|Allocation to Group|Withdrawal by Subject|2|||
125492995|NCT06191679|451438737|FG003|Allocation to Group|Withdrawal by Subject|0|||
125303727|NCT00536471|450739520|FG000|Overall Study|Lack of Efficacy|17|||
125303728|NCT00536471|450739521|FG001|Overall Study|Lack of Efficacy|18|||
125492996|NCT06191679|451438734|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
125492997|NCT06191679|451438735|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
125492998|NCT06191679|451438736|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
125492999|NCT06191679|451438737|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
125493000|NCT06191679|451438734|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
125493001|NCT06191679|451438735|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
125493002|NCT06191679|451438736|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
125493003|NCT06191679|451438737|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
125493004|NCT06191679|451438734|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
125493005|NCT06191679|451438735|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
125493006|NCT06191679|451438736|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
125493007|NCT06191679|451438737|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
125493008|NCT03656718|451438738|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
125493009|NCT03656718|451438739|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
125493010|NCT03656718|451438740|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
125493011|NCT03656718|451438741|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
125493012|NCT03656718|451438742|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
125493013|NCT03656718|451438743|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
125493014|NCT03656718|451438744|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
125493015|NCT03656718|451438738|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
125493016|NCT03656718|451438739|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
125493017|NCT03656718|451438740|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
125493018|NCT03656718|451438741|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
125493019|NCT03656718|451438742|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
125493020|NCT03656718|451438743|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
125493021|NCT03656718|451438744|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
125493022|NCT03656718|451438738|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
125493023|NCT03656718|451438739|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
125493024|NCT03656718|451438740|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
125493025|NCT03656718|451438741|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
125493026|NCT03656718|451438742|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
125493027|NCT03656718|451438743|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
125493028|NCT03656718|451438744|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
125493029|NCT03656718|451438738|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
125493030|NCT03656718|451438739|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
125493031|NCT03656718|451438740|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
125493032|NCT03656718|451438741|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
125493033|NCT03656718|451438742|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
125493034|NCT03656718|451438743|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
125493035|NCT03656718|451438744|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
125493036|NCT03656718|451438738|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
125493037|NCT03656718|451438739|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
125493038|NCT03656718|451438740|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
125493039|NCT03656718|451438741|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
125493040|NCT03656718|451438742|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
125493041|NCT03656718|451438743|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
125493042|NCT03656718|451438744|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
125493043|NCT03656718|451438738|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
125493044|NCT03656718|451438739|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
125493045|NCT03656718|451438740|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
125493046|NCT03656718|451438741|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
125493047|NCT03656718|451438742|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
125493048|NCT03656718|451438743|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
125493049|NCT03656718|451438744|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
125493050|NCT03656718|451438738|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
125493051|NCT03656718|451438739|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
125493052|NCT03656718|451438740|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
125493053|NCT03656718|451438741|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
125493054|NCT03656718|451438742|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
125303729|NCT00536471|450739522|FG002|Overall Study|Lack of Efficacy|11|||
125303730|NCT00536471|450739523|FG003|Overall Study|Lack of Efficacy|9|||
125303731|NCT00536471|450739520|FG000|Overall Study|Protocol Violation|8|||
125303732|NCT00536471|450739521|FG001|Overall Study|Protocol Violation|1|||
125493055|NCT03656718|451438743|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
125493056|NCT03656718|451438744|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
125493057|NCT03656718|451438738|FG000|Treatment Period Part C|Disease progression|0|||
125493058|NCT03656718|451438739|FG001|Treatment Period Part C|Disease progression|0|||
125493059|NCT03656718|451438740|FG002|Treatment Period Part C|Disease progression|0|||
125493060|NCT03656718|451438741|FG003|Treatment Period Part C|Disease progression|0|||
125493061|NCT03656718|451438742|FG004|Treatment Period Part C|Disease progression|12|||
125493062|NCT03656718|451438743|FG005|Treatment Period Part C|Disease progression|0|||
125493063|NCT03656718|451438744|FG006|Treatment Period Part C|Disease progression|0|||
125493064|NCT03656718|451438738|FG000|Treatment Period Part C|Death|0|||
125493065|NCT03656718|451438739|FG001|Treatment Period Part C|Death|0|||
125493066|NCT03656718|451438740|FG002|Treatment Period Part C|Death|0|||
125493067|NCT03656718|451438741|FG003|Treatment Period Part C|Death|0|||
125493068|NCT03656718|451438742|FG004|Treatment Period Part C|Death|1|||
125493069|NCT03656718|451438743|FG005|Treatment Period Part C|Death|0|||
125493070|NCT03656718|451438744|FG006|Treatment Period Part C|Death|0|||
125493071|NCT03656718|451438738|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
125493072|NCT03656718|451438739|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
125493073|NCT03656718|451438740|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
125493074|NCT03656718|451438741|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
125493075|NCT03656718|451438742|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
125493076|NCT03656718|451438743|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
125493077|NCT03656718|451438744|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
125493078|NCT03656718|451438738|FG000|Treatment Period Part C|Other reasons|0|||
125493079|NCT03656718|451438739|FG001|Treatment Period Part C|Other reasons|0|||
125493080|NCT03656718|451438740|FG002|Treatment Period Part C|Other reasons|0|||
125493081|NCT03656718|451438741|FG003|Treatment Period Part C|Other reasons|0|||
125493082|NCT03656718|451438742|FG004|Treatment Period Part C|Other reasons|1|||
125493083|NCT03656718|451438743|FG005|Treatment Period Part C|Other reasons|0|||
125493084|NCT03656718|451438744|FG006|Treatment Period Part C|Other reasons|0|||
125493085|NCT03656718|451438738|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
125493086|NCT03656718|451438739|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
125493087|NCT03656718|451438740|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
125493088|NCT03656718|451438741|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
125493089|NCT03656718|451438742|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
125493090|NCT03656718|451438743|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
125493091|NCT03656718|451438744|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
125493092|NCT03211247|451438745|FG000|Overall Study|Adverse Event|8|||
125493093|NCT03211247|451438746|FG001|Overall Study|Adverse Event|0|||
125493094|NCT03211247|451438747|FG002|Overall Study|Adverse Event|1|||
125493095|NCT03211247|451438748|FG003|Overall Study|Adverse Event|0|||
125493096|NCT03211247|451438749|FG004|Overall Study|Adverse Event|0|||
125493097|NCT03211247|451438745|FG000|Overall Study|Lost to Follow-up|2|||
125493098|NCT03211247|451438746|FG001|Overall Study|Lost to Follow-up|1|||
125493099|NCT03211247|451438747|FG002|Overall Study|Lost to Follow-up|0|||
125493100|NCT03211247|451438748|FG003|Overall Study|Lost to Follow-up|0|||
125493101|NCT03211247|451438749|FG004|Overall Study|Lost to Follow-up|0|||
125493102|NCT03211247|451438745|FG000|Overall Study|Physician Decision|1|||
125493103|NCT03211247|451438746|FG001|Overall Study|Physician Decision|2|||
125493104|NCT03211247|451438747|FG002|Overall Study|Physician Decision|0|||
125493105|NCT03211247|451438748|FG003|Overall Study|Physician Decision|0|||
125493106|NCT03211247|451438749|FG004|Overall Study|Physician Decision|0|||
125493107|NCT03211247|451438745|FG000|Overall Study|Non-compliance with study drug|2|||
125493108|NCT03211247|451438746|FG001|Overall Study|Non-compliance with study drug|0|||
125493109|NCT03211247|451438747|FG002|Overall Study|Non-compliance with study drug|0|||
125493110|NCT03211247|451438748|FG003|Overall Study|Non-compliance with study drug|0|||
125493111|NCT03211247|451438749|FG004|Overall Study|Non-compliance with study drug|0|||
125493112|NCT03211247|451438745|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
125493113|NCT03211247|451438746|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
125493114|NCT03211247|451438747|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
125493115|NCT03211247|451438748|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
125493116|NCT03211247|451438749|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
125493117|NCT03211247|451438745|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
125493118|NCT03211247|451438746|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
125493119|NCT03211247|451438747|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
125493120|NCT03211247|451438748|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
125493121|NCT03211247|451438749|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
125493122|NCT03211247|451438745|FG000|Overall Study|Protocol Violation|0|||
125493123|NCT03211247|451438746|FG001|Overall Study|Protocol Violation|1|||
125493124|NCT03211247|451438747|FG002|Overall Study|Protocol Violation|0|||
125493125|NCT03211247|451438748|FG003|Overall Study|Protocol Violation|0|||
125493126|NCT03211247|451438749|FG004|Overall Study|Protocol Violation|0|||
125493127|NCT02039401|451438750|FG000|Overall Study|Adverse Event|0|||
125493128|NCT02039401|451438751|FG001|Overall Study|Adverse Event|1|||
125493129|NCT05827068|451438755|FG000|Overall Study|Lost to Follow-up|1|||
125303733|NCT00536471|450739522|FG002|Overall Study|Protocol Violation|2|||
125303734|NCT00536471|450739523|FG003|Overall Study|Protocol Violation|3|||
125303735|NCT00536471|450739520|FG000|Overall Study|Physician Decision|11|||
125303736|NCT00536471|450739521|FG001|Overall Study|Physician Decision|1|||
125303737|NCT00536471|450739522|FG002|Overall Study|Physician Decision|3|||
125303738|NCT00536471|450739523|FG003|Overall Study|Physician Decision|2|||
125303739|NCT00536471|450739520|FG000|Overall Study|Death|0|||
125303740|NCT00536471|450739521|FG001|Overall Study|Death|0|||
125303741|NCT00536471|450739522|FG002|Overall Study|Death|1|||
125303742|NCT00536471|450739523|FG003|Overall Study|Death|2|||
125303743|NCT00536471|450739520|FG000|Overall Study|Sponsor Decision|0|||
125303744|NCT00536471|450739521|FG001|Overall Study|Sponsor Decision|1|||
125303745|NCT00536471|450739522|FG002|Overall Study|Sponsor Decision|3|||
125303746|NCT00536471|450739523|FG003|Overall Study|Sponsor Decision|2|||
125303747|NCT01440816|450739528|FG000|Overall Study|Disease Progression|0|||
125303748|NCT01440816|450739529|FG001|Overall Study|Disease Progression|9|||
125303749|NCT01440816|450739528|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
125303750|NCT01440816|450739529|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
125303751|NCT01687101|450739530|FG000|Overall Study|Lost to Follow-up|7|||
125303752|NCT03250182|450739533|FG000|Overall Study|Withdrawal by Subject|1|||
125303753|NCT01858740|450739534|FG000|Overall Study|Death|4|||
125303754|NCT00894361|450739541|FG000|Overall Study|deaths and less than 2 years followup|24|||
125303755|NCT00894361|450739542|FG001|Overall Study|deaths and less than 2 years followup|64|||
125303756|NCT04207060|450739547|FG000|Overall Study|Lost to Follow-up|2|||
125303757|NCT04207060|450739548|FG001|Overall Study|Lost to Follow-up|0|||
125303758|NCT02718716|450739550|FG000|Overall Study|Lack of Efficacy|1|||
125303759|NCT02718716|450739551|FG001|Overall Study|Lack of Efficacy|0|||
125303760|NCT02718716|450739552|FG002|Overall Study|Lack of Efficacy|0|||
125303761|NCT02718716|450739553|FG003|Overall Study|Lack of Efficacy|0|||
125303762|NCT02718716|450739554|FG004|Overall Study|Lack of Efficacy|0|||
125303763|NCT00296140|450739555|FG000|Overall Study|Lost to Follow-up|1|||
125303764|NCT00296140|450739556|FG001|Overall Study|Lost to Follow-up|0|||
125303765|NCT00296140|450739555|FG000|Overall Study|Withdrawal by Subject|1|||
125303766|NCT00296140|450739556|FG001|Overall Study|Withdrawal by Subject|0|||
125303767|NCT00296140|450739555|FG000|Overall Study|Discharge to Nursing Home|1|||
125303768|NCT00296140|450739556|FG001|Overall Study|Discharge to Nursing Home|0|||
125303769|NCT01856582|450739560|FG000|Overall Study|Died prior to Boost infusion|1|||
125303770|NCT03245398|450739565|FG000|Overall Study|Travelled to another island|1|||
125303771|NCT03245398|450739566|FG001|Overall Study|Travelled to another island|0|||
125303772|NCT00596830|450739567|FG000|Overall Study|Death|258|||
125303773|NCT00596830|450739568|FG001|Overall Study|Death|247|||
125303774|NCT00596830|450739567|FG000|Overall Study|Lost to Follow-up|7|||
125303775|NCT00596830|450739568|FG001|Overall Study|Lost to Follow-up|11|||
125303776|NCT00596830|450739567|FG000|Overall Study|Withdrawal by Subject|22|||
125303777|NCT00596830|450739568|FG001|Overall Study|Withdrawal by Subject|12|||
125303778|NCT00596830|450739567|FG000|Overall Study|Study terminated by sponsor|51|||
125303779|NCT00596830|450739568|FG001|Overall Study|Study terminated by sponsor|62|||
125303780|NCT00596830|450739567|FG000|Overall Study|Follow-up was discontinued|1|||
125303781|NCT00596830|450739568|FG001|Overall Study|Follow-up was discontinued|0|||
125303782|NCT00596830|450739567|FG000|Overall Study|Randomized but not treated|3|||
125303783|NCT00596830|450739568|FG001|Overall Study|Randomized but not treated|7|||
125303784|NCT00887926|450739571|FG000|Overall Study|Withdrawal by Subject|0|||
125303785|NCT00887926|450739572|FG001|Overall Study|Withdrawal by Subject|1|||
125303786|NCT00887926|450739573|FG002|Overall Study|Withdrawal by Subject|0|||
125303787|NCT00887926|450739574|FG003|Overall Study|Withdrawal by Subject|0|||
125303788|NCT00880191|450739575|FG000|Overall Study|Refused further treatment|4|||
125493130|NCT05827068|451438756|FG001|Overall Study|Lost to Follow-up|4|||
125493131|NCT05827068|451438757|FG002|Overall Study|Lost to Follow-up|1|||
125493132|NCT05827068|451438758|FG003|Overall Study|Lost to Follow-up|1|||
125303789|NCT00880191|450739576|FG001|Overall Study|Refused further treatment|1|||
125303790|NCT00880191|450739575|FG000|Overall Study|Adverse Event|8|||
125303791|NCT00880191|450739576|FG001|Overall Study|Adverse Event|6|||
125303792|NCT00880191|450739575|FG000|Overall Study|Hospitalization/efficacy|1|||
125303793|NCT00880191|450739576|FG001|Overall Study|Hospitalization/efficacy|1|||
125493133|NCT05827068|451438759|FG004|Overall Study|Lost to Follow-up|2|||
125493134|NCT05827068|451438760|FG005|Overall Study|Lost to Follow-up|4|||
125493135|NCT05827068|451438761|FG006|Overall Study|Lost to Follow-up|1|||
125303794|NCT02097030|450739577|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
125303795|NCT02097030|450739578|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
125493136|NCT05827068|451438755|FG000|Overall Study|Withdrawal by Subject|4|||
125303796|NCT02097030|450739577|FG000|First Intervention (3 Days)|Visual Acuity|0|||
125303797|NCT02097030|450739578|FG001|First Intervention (3 Days)|Visual Acuity|1|||
125303798|NCT01919801|450739579|FG000|Overall Study|Withdrawal by Subject|1|||
125493137|NCT05827068|451438756|FG001|Overall Study|Withdrawal by Subject|0|||
125493138|NCT05827068|451438757|FG002|Overall Study|Withdrawal by Subject|1|||
125493139|NCT05827068|451438758|FG003|Overall Study|Withdrawal by Subject|2|||
125493140|NCT05827068|451438759|FG004|Overall Study|Withdrawal by Subject|3|||
125493141|NCT05827068|451438760|FG005|Overall Study|Withdrawal by Subject|0|||
125493142|NCT05827068|451438761|FG006|Overall Study|Withdrawal by Subject|1|||
125493143|NCT05827068|451438755|FG000|Overall Study|Physician Decision|0|||
125493144|NCT05827068|451438756|FG001|Overall Study|Physician Decision|0|||
125493145|NCT05827068|451438757|FG002|Overall Study|Physician Decision|0|||
125493146|NCT05827068|451438758|FG003|Overall Study|Physician Decision|0|||
125493147|NCT05827068|451438759|FG004|Overall Study|Physician Decision|1|||
125493148|NCT05827068|451438760|FG005|Overall Study|Physician Decision|0|||
125493149|NCT05827068|451438761|FG006|Overall Study|Physician Decision|1|||
125493150|NCT05827068|451438755|FG000|Overall Study|Other Than Specified|0|||
125493151|NCT05827068|451438756|FG001|Overall Study|Other Than Specified|1|||
125493152|NCT05827068|451438757|FG002|Overall Study|Other Than Specified|0|||
125493153|NCT05827068|451438758|FG003|Overall Study|Other Than Specified|0|||
125493154|NCT05827068|451438759|FG004|Overall Study|Other Than Specified|0|||
125493155|NCT05827068|451438760|FG005|Overall Study|Other Than Specified|0|||
125493156|NCT05827068|451438761|FG006|Overall Study|Other Than Specified|0|||
125493157|NCT04039113|451438762|FG000|Overall Study|Withdrawal by Subject|8|||
125493158|NCT04039113|451438763|FG001|Overall Study|Withdrawal by Subject|11|||
125493159|NCT04039113|451438762|FG000|Overall Study|Lost to Follow-up|1|||
125303799|NCT01919801|450739580|FG001|Overall Study|Withdrawal by Subject|0|||
125303800|NCT01919801|450739579|FG000|Overall Study|Physician Decision|0|||
125303801|NCT01919801|450739580|FG001|Overall Study|Physician Decision|1|||
125303802|NCT01919801|450739579|FG000|Overall Study|Lost to Follow-up|0|||
125303803|NCT01919801|450739580|FG001|Overall Study|Lost to Follow-up|1|||
125303804|NCT01919801|450739579|FG000|Overall Study|Other|0|||
125303805|NCT01919801|450739580|FG001|Overall Study|Other|1|||
125303806|NCT01843062|450739581|FG000|Overall Study|Protocol Violation|1|||
125303807|NCT01843062|450739582|FG001|Overall Study|Protocol Violation|0|||
125303808|NCT01843062|450739581|FG000|Overall Study|New treatment following progression|2|||
125303809|NCT01843062|450739582|FG001|Overall Study|New treatment following progression|0|||
125303810|NCT01843062|450739581|FG000|Overall Study|Pregnancy|1|||
125303811|NCT01843062|450739582|FG001|Overall Study|Pregnancy|0|||
125303812|NCT01843062|450739581|FG000|Overall Study|Adverse Event|2|||
125303813|NCT01843062|450739582|FG001|Overall Study|Adverse Event|0|||
125303814|NCT01843062|450739581|FG000|Overall Study|Incorrect randomisation|1|||
125303815|NCT01843062|450739582|FG001|Overall Study|Incorrect randomisation|0|||
125303816|NCT01843062|450739581|FG000|Overall Study|Withdrawal by Subject|12|||
125303817|NCT01843062|450739582|FG001|Overall Study|Withdrawal by Subject|3|||
125303818|NCT01843062|450739581|FG000|Overall Study|Death|1|||
125303819|NCT01843062|450739582|FG001|Overall Study|Death|2|||
125303820|NCT01843062|450739581|FG000|Overall Study|Lost to Follow-up|2|||
125303821|NCT01843062|450739582|FG001|Overall Study|Lost to Follow-up|4|||
125303822|NCT01677858|450739583|FG000|Overall Study|Adverse Event|0|||
125303823|NCT01677858|450739584|FG001|Overall Study|Adverse Event|0|||
125303824|NCT01677858|450739585|FG002|Overall Study|Adverse Event|2|||
125303825|NCT01677858|450739586|FG003|Overall Study|Adverse Event|3|||
125303826|NCT01677858|450739587|FG004|Overall Study|Adverse Event|13|||
125303827|NCT01677858|450739583|FG000|Overall Study|Death|0|||
125303828|NCT01677858|450739584|FG001|Overall Study|Death|0|||
125303829|NCT01677858|450739585|FG002|Overall Study|Death|0|||
125303830|NCT01677858|450739586|FG003|Overall Study|Death|0|||
125493160|NCT04039113|451438763|FG001|Overall Study|Lost to Follow-up|1|||
125493161|NCT04039113|451438762|FG000|Overall Study|Adverse Event|2|||
125493162|NCT04039113|451438763|FG001|Overall Study|Adverse Event|2|||
125493163|NCT04039113|451438762|FG000|Overall Study|Death|2|||
125493164|NCT04039113|451438763|FG001|Overall Study|Death|4|||
125493165|NCT04039113|451438762|FG000|Overall Study|Site Closure|6|||
125493166|NCT04039113|451438763|FG001|Overall Study|Site Closure|0|||
125493167|NCT04039113|451438762|FG000|Overall Study|Failure to meet randomisation criteria|4|||
125493168|NCT04039113|451438763|FG001|Overall Study|Failure to meet randomisation criteria|0|||
125493169|NCT00353496|451438764|FG000|Overall Study|Adverse Event|1|||
125303831|NCT01677858|450739587|FG004|Overall Study|Death|1|||
125303832|NCT01677858|450739583|FG000|Overall Study|Physician Decision|1|||
125303833|NCT01677858|450739584|FG001|Overall Study|Physician Decision|0|||
125303834|NCT01677858|450739585|FG002|Overall Study|Physician Decision|2|||
125303835|NCT01677858|450739586|FG003|Overall Study|Physician Decision|0|||
125303836|NCT01677858|450739587|FG004|Overall Study|Physician Decision|12|||
125303837|NCT01677858|450739583|FG000|Overall Study|Progressive Disease|2|||
125303838|NCT01677858|450739584|FG001|Overall Study|Progressive Disease|1|||
125303839|NCT01677858|450739585|FG002|Overall Study|Progressive Disease|9|||
125303840|NCT01677858|450739586|FG003|Overall Study|Progressive Disease|3|||
125493170|NCT00353496|451438765|FG001|Overall Study|Adverse Event|0|||
125493171|NCT00353496|451438764|FG000|Overall Study|Protocol Violation|2|||
125303841|NCT01677858|450739587|FG004|Overall Study|Progressive Disease|43|||
125493172|NCT00353496|451438765|FG001|Overall Study|Protocol Violation|2|||
125493173|NCT00353496|451438764|FG000|Overall Study|Withdrawal by Subject|3|||
125493174|NCT00353496|451438765|FG001|Overall Study|Withdrawal by Subject|4|||
125493175|NCT00353496|451438764|FG000|Overall Study|Physician Decision|6|||
125493176|NCT00353496|451438765|FG001|Overall Study|Physician Decision|9|||
125493177|NCT00353496|451438764|FG000|Overall Study|Not otherwise specified|4|||
125493178|NCT00353496|451438765|FG001|Overall Study|Not otherwise specified|2|||
125493179|NCT04980300|451438766|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
125493180|NCT04980300|451438767|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
125493181|NCT04980300|451438766|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
125493182|NCT04980300|451438767|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
125493183|NCT04980300|451438766|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
125493184|NCT04980300|451438767|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
125493185|NCT04980300|451438766|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
125493186|NCT04980300|451438767|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
125493187|NCT01470144|451438773|FG000|Overall Study|Adverse Event|2|||
125493188|NCT01470144|451438773|FG000|Overall Study|Death|1|||
125493189|NCT01470144|451438773|FG000|Overall Study|Lung transplant|6|||
125493190|NCT01470144|451438773|FG000|Overall Study|Patient's and investigator's decision|1|||
125493191|NCT03459196|451439430|FG000|Overall Study|Subject didn't receive study catheter|2|||
125493192|NCT01074294|451439431|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
125493193|NCT01074294|451439432|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
125493194|NCT01074294|451439433|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
125493195|NCT01074294|451439434|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
125493196|NCT01074294|451439431|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
125493197|NCT01074294|451439432|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
125493198|NCT01074294|451439433|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
125493199|NCT01074294|451439434|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
125493200|NCT01074294|451439431|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
125493201|NCT01074294|451439432|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
125493202|NCT01074294|451439433|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
125493203|NCT01074294|451439434|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
125303842|NCT01677858|450739583|FG000|Overall Study|Withdrawal by Subject|0|||
125303843|NCT01677858|450739584|FG001|Overall Study|Withdrawal by Subject|1|||
125303844|NCT01677858|450739585|FG002|Overall Study|Withdrawal by Subject|1|||
125303845|NCT01677858|450739586|FG003|Overall Study|Withdrawal by Subject|0|||
125303846|NCT01677858|450739587|FG004|Overall Study|Withdrawal by Subject|15|||
125303847|NCT01677858|450739583|FG000|Overall Study|Lost to Follow-up|0|||
125303848|NCT01677858|450739584|FG001|Overall Study|Lost to Follow-up|0|||
125303849|NCT01677858|450739585|FG002|Overall Study|Lost to Follow-up|0|||
125303850|NCT01677858|450739586|FG003|Overall Study|Lost to Follow-up|0|||
125303851|NCT01677858|450739587|FG004|Overall Study|Lost to Follow-up|1|||
125303852|NCT00773747|450739588|FG000|Overall Study|Lack of Efficacy|112|||
125303853|NCT00773747|450739589|FG001|Overall Study|Lack of Efficacy|144|||
125303854|NCT00773747|450739588|FG000|Overall Study|Physician Decision|26|||
125303855|NCT00773747|450739589|FG001|Overall Study|Physician Decision|18|||
125303856|NCT00773747|450739588|FG000|Overall Study|Lost to Follow-up|0|||
125303857|NCT00773747|450739589|FG001|Overall Study|Lost to Follow-up|1|||
125303858|NCT00773747|450739588|FG000|Overall Study|Protocol Violation|2|||
125303859|NCT00773747|450739589|FG001|Overall Study|Protocol Violation|2|||
125303860|NCT00773747|450739588|FG000|Overall Study|Withdrawal by Subject|89|||
125303861|NCT00773747|450739589|FG001|Overall Study|Withdrawal by Subject|61|||
125303862|NCT00773747|450739588|FG000|Overall Study|Adverse Event|61|||
125303863|NCT00773747|450739589|FG001|Overall Study|Adverse Event|62|||
125303864|NCT00773747|450739588|FG000|Overall Study|Death|5|||
125303865|NCT00773747|450739589|FG001|Overall Study|Death|8|||
125303866|NCT00773747|450739588|FG000|Overall Study|Not Treated|2|||
125303867|NCT00773747|450739589|FG001|Overall Study|Not Treated|0|||
125303868|NCT02669212|450739592|FG000|Overall Study|Lost to Follow-up|1|||
125303869|NCT02669212|450739593|FG001|Overall Study|Lost to Follow-up|0|||
125303870|NCT02669212|450739592|FG000|Overall Study|Medical Condition|3|||
125303871|NCT02669212|450739593|FG001|Overall Study|Medical Condition|4|||
125303872|NCT02669212|450739592|FG000|Overall Study|Withdrawal by Subject|0|||
125303873|NCT02669212|450739593|FG001|Overall Study|Withdrawal by Subject|2|||
125303874|NCT02669212|450739592|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
125493204|NCT01074294|451439431|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
125303875|NCT02669212|450739593|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
125493205|NCT01074294|451439432|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
125493206|NCT01074294|451439433|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
125493207|NCT01074294|451439434|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
125303876|NCT03549104|450739594|FG000|Overall Study|Withdrawal by Subject|5|||
125303877|NCT03549104|450739595|FG001|Overall Study|Withdrawal by Subject|2|||
125303878|NCT03549104|450739594|FG000|Overall Study|Covid shelter in place|1|||
125303879|NCT03549104|450739595|FG001|Overall Study|Covid shelter in place|2|||
125303880|NCT04869358|450739596|FG000|Overall Study|Wish to have children.|1|||
125303881|NCT04869358|450739597|FG001|Overall Study|Wish to have children.|0|||
125493208|NCT01074294|451439431|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
125493209|NCT01074294|451439432|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
125493210|NCT01074294|451439433|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
125493211|NCT01074294|451439434|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
125493212|NCT01074294|451439431|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
125493213|NCT01074294|451439432|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
125493214|NCT01074294|451439433|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
125493215|NCT01074294|451439434|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
125493216|NCT01074294|451439431|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
125493217|NCT01074294|451439432|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
125493218|NCT01074294|451439433|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
125493219|NCT01074294|451439434|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
125493220|NCT01074294|451439431|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
125493221|NCT01074294|451439432|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
125493222|NCT01074294|451439433|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
125493223|NCT01074294|451439434|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
125493224|NCT01074294|451439431|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
125493225|NCT01074294|451439432|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
125493226|NCT01074294|451439433|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
125493227|NCT01074294|451439434|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
125493228|NCT01074294|451439431|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
125493229|NCT01074294|451439432|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
125493230|NCT01074294|451439433|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
125493231|NCT01074294|451439434|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
125493232|NCT01074294|451439431|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
125493233|NCT01074294|451439432|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
125493234|NCT01074294|451439433|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
125493235|NCT01074294|451439434|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
125493236|NCT01074294|451439431|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
125493237|NCT01074294|451439432|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
125493238|NCT01074294|451439433|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
125493239|NCT01074294|451439434|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
125493240|NCT01074294|451439431|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
125493241|NCT01074294|451439432|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
125493242|NCT01074294|451439433|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
125493243|NCT01074294|451439434|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
125493244|NCT02284113|451439436|FG000|Overall Study|Adverse Event|1|||
125493245|NCT02284113|451439437|FG001|Overall Study|Adverse Event|0|||
125493246|NCT02284113|451439436|FG000|Overall Study|non-compliance|0|||
125493247|NCT02284113|451439437|FG001|Overall Study|non-compliance|1|||
125493248|NCT02284113|451439436|FG000|Overall Study|Withdrawal by Subject|0|||
125493249|NCT02284113|451439437|FG001|Overall Study|Withdrawal by Subject|1|||
125493250|NCT02284113|451439436|FG000|Overall Study|not provided|0|||
125493251|NCT02284113|451439437|FG001|Overall Study|not provided|1|||
125493252|NCT02284113|451439436|FG000|Overall Study|surgery cancelled|2|||
125493253|NCT02284113|451439437|FG001|Overall Study|surgery cancelled|0|||
125493254|NCT03885232|451439438|FG000|Overall Study|Lost to Follow-up|74|||
125493255|NCT03885232|451439439|FG001|Overall Study|Lost to Follow-up|32|||
125493256|NCT03885232|451439438|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
125493257|NCT03885232|451439439|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
125493258|NCT01315132|451439440|FG000|Overall Study|not treated due to disease progression|1|||
125493259|NCT03840902|451439443|FG000|Overall Study|Randomized but not treated|1|||
125493260|NCT03840902|451439444|FG001|Overall Study|Randomized but not treated|1|||
125493261|NCT03660930|451439445|FG000|Overall Study|Adverse Event|0|||
125493262|NCT03660930|451439446|FG001|Overall Study|Adverse Event|0|||
125493263|NCT03660930|451439447|FG002|Overall Study|Adverse Event|0|||
125493264|NCT03660930|451439448|FG003|Overall Study|Adverse Event|2|||
125493265|NCT03660930|451439449|FG004|Overall Study|Adverse Event|0|||
125493266|NCT03660930|451439450|FG005|Overall Study|Adverse Event|1|||
125493267|NCT03660930|451439451|FG006|Overall Study|Adverse Event|0|||
125493268|NCT03660930|451439452|FG007|Overall Study|Adverse Event|0|||
125493269|NCT03660930|451439445|FG000|Overall Study|Withdrawal by Subject|0|||
125493270|NCT03660930|451439446|FG001|Overall Study|Withdrawal by Subject|0|||
125303882|NCT04869358|450739598|FG002|Overall Study|Wish to have children.|0|||
125303883|NCT04869358|450739599|FG003|Overall Study|Wish to have children.|0|||
125303884|NCT04164732|450739600|FG000|Treatment run-in Period|Adverse Event|4|||
125303885|NCT04164732|450739601|FG001|Treatment run-in Period|Adverse Event|0|||
125303886|NCT04164732|450739602|FG002|Treatment run-in Period|Adverse Event|0|||
125303887|NCT04164732|450739600|FG000|Treatment run-in Period|Physician Decision|1|||
125303888|NCT04164732|450739601|FG001|Treatment run-in Period|Physician Decision|0|||
125493271|NCT03660930|451439447|FG002|Overall Study|Withdrawal by Subject|0|||
125493272|NCT03660930|451439448|FG003|Overall Study|Withdrawal by Subject|0|||
125493273|NCT03660930|451439449|FG004|Overall Study|Withdrawal by Subject|0|||
125493274|NCT03660930|451439450|FG005|Overall Study|Withdrawal by Subject|1|||
125493275|NCT03660930|451439451|FG006|Overall Study|Withdrawal by Subject|0|||
125493276|NCT03660930|451439452|FG007|Overall Study|Withdrawal by Subject|0|||
125493277|NCT03509909|451439453|FG000|Overall Study|Withdrawal by Subject|16|||
125493278|NCT03509909|451439454|FG001|Overall Study|Withdrawal by Subject|9|||
125493279|NCT03509909|451439453|FG000|Overall Study|Lost to Follow-up|3|||
125493280|NCT03509909|451439454|FG001|Overall Study|Lost to Follow-up|4|||
125493281|NCT03509909|451439453|FG000|Overall Study|Adverse Event|2|||
125493282|NCT03509909|451439454|FG001|Overall Study|Adverse Event|0|||
125493283|NCT03357952|451439460|FG000|Overall Study|Withdrawal by Subject|0|||
125493284|NCT03357952|451439461|FG001|Overall Study|Withdrawal by Subject|1|||
125493285|NCT03357952|451439460|FG000|Overall Study|Sponsor Decision|9|||
125493286|NCT03357952|451439461|FG001|Overall Study|Sponsor Decision|0|||
125493287|NCT01371994|451439462|FG000|Overall Study|Adverse Event|3|||
125493288|NCT01371994|451439463|FG001|Overall Study|Adverse Event|6|||
125493289|NCT01371994|451439462|FG000|Overall Study|Lack of Efficacy|3|||
125493290|NCT01371994|451439463|FG001|Overall Study|Lack of Efficacy|0|||
125493291|NCT01371994|451439462|FG000|Overall Study|Withdrawal by Subject|13|||
125493292|NCT01371994|451439463|FG001|Overall Study|Withdrawal by Subject|7|||
125493293|NCT01371994|451439462|FG000|Overall Study|Lost to Follow-up|1|||
125493294|NCT01371994|451439463|FG001|Overall Study|Lost to Follow-up|1|||
125493295|NCT01371994|451439462|FG000|Overall Study|Protocol Violation|24|||
125493296|NCT01371994|451439463|FG001|Overall Study|Protocol Violation|17|||
125493297|NCT01371994|451439462|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
125493298|NCT01371994|451439463|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
125493299|NCT01371994|451439462|FG000|Overall Study|Physician Decision|1|||
125493300|NCT01371994|451439463|FG001|Overall Study|Physician Decision|1|||
125493301|NCT01371994|451439462|FG000|Overall Study|Miscellaneous Reasons|6|||
125493302|NCT01371994|451439463|FG001|Overall Study|Miscellaneous Reasons|4|||
125493303|NCT03280030|451439464|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
125493304|NCT03280030|451439465|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
125493305|NCT03280030|451439466|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
125493306|NCT03280030|451439464|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
125493307|NCT03280030|451439465|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
125493308|NCT03280030|451439466|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
125493309|NCT03280030|451439464|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
125493310|NCT03280030|451439465|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
125493311|NCT03280030|451439466|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
125493312|NCT03280030|451439464|FG000|Part 2 - Efficacy|Adverse Event|0|||
125493313|NCT03280030|451439465|FG001|Part 2 - Efficacy|Adverse Event|4|||
125493314|NCT03280030|451439466|FG002|Part 2 - Efficacy|Adverse Event|6|||
125493315|NCT03280030|451439464|FG000|Part 2 - Efficacy|Death|0|||
125493316|NCT03280030|451439465|FG001|Part 2 - Efficacy|Death|3|||
125493317|NCT03280030|451439466|FG002|Part 2 - Efficacy|Death|0|||
125493318|NCT03280030|451439464|FG000|Part 2 - Efficacy|Physician Decision|0|||
125493319|NCT03280030|451439465|FG001|Part 2 - Efficacy|Physician Decision|10|||
125493320|NCT03280030|451439466|FG002|Part 2 - Efficacy|Physician Decision|16|||
125493321|NCT03280030|451439464|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
125493322|NCT03280030|451439465|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
125493323|NCT03280030|451439466|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
125493324|NCT03280030|451439464|FG000|Part 2 - Efficacy|Progressive disease|0|||
125493325|NCT03280030|451439465|FG001|Part 2 - Efficacy|Progressive disease|7|||
125493326|NCT03280030|451439466|FG002|Part 2 - Efficacy|Progressive disease|5|||
125493327|NCT05139992|451439469|FG000|Overall Study|Withdrawal by Subject|12|||
125303889|NCT04164732|450739602|FG002|Treatment run-in Period|Physician Decision|0|||
125303890|NCT04164732|450739600|FG000|Treatment run-in Period|Screen Failure|1|||
125303891|NCT04164732|450739601|FG001|Treatment run-in Period|Screen Failure|0|||
125493328|NCT05139992|451439469|FG000|Overall Study|Lost to Follow-up|6|||
125493329|NCT01208974|451439470|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
125493330|NCT01208974|451439471|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
125493331|NCT01208974|451439472|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
125303892|NCT04164732|450739602|FG002|Treatment run-in Period|Screen Failure|0|||
125303893|NCT04164732|450739600|FG000|Randomized Treatment Period|Adverse Event|0|||
125303894|NCT04164732|450739601|FG001|Randomized Treatment Period|Adverse Event|1|||
125493332|NCT01208974|451439473|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
125493333|NCT01208974|451439470|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
125493334|NCT01208974|451439471|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
125493335|NCT01208974|451439472|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
125493336|NCT01208974|451439473|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
125493337|NCT01208974|451439470|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
125493338|NCT01208974|451439471|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
125493339|NCT01208974|451439472|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
125493340|NCT01208974|451439473|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
125493341|NCT05521516|451439474|FG000|Overall Study|Withdrawal by Subject|1|||
125493342|NCT05521516|451439475|FG001|Overall Study|Withdrawal by Subject|1|||
125493343|NCT03777657|451439476|FG000|Overall Study|Death|397|||
125493344|NCT03777657|451439477|FG001|Overall Study|Death|431|||
125493345|NCT03777657|451439476|FG000|Overall Study|Study Closed by Sponsor|77|||
125493346|NCT03777657|451439477|FG001|Overall Study|Study Closed by Sponsor|38|||
125493347|NCT03777657|451439476|FG000|Overall Study|Withdrawal by Subject|20|||
125493348|NCT03777657|451439477|FG001|Overall Study|Withdrawal by Subject|17|||
125493349|NCT03777657|451439476|FG000|Overall Study|Lost to Follow-up|6|||
125493350|NCT03777657|451439477|FG001|Overall Study|Lost to Follow-up|10|||
125493351|NCT02500576|451439478|FG000|Overall Study|Adverse Event|0|||
125493352|NCT02500576|451439479|FG001|Overall Study|Adverse Event|1|||
125493353|NCT02500576|451439478|FG000|Overall Study|Death|2|||
125493354|NCT02500576|451439479|FG001|Overall Study|Death|1|||
125493355|NCT02500576|451439478|FG000|Overall Study|Lack of Efficacy|5|||
125493356|NCT02500576|451439479|FG001|Overall Study|Lack of Efficacy|5|||
125493357|NCT02500576|451439478|FG000|Overall Study|Withdrawal by Subject|1|||
125493358|NCT02500576|451439479|FG001|Overall Study|Withdrawal by Subject|1|||
125493359|NCT03691493|451439485|FG000|Overall Study|Withdrawal by Subject|1|||
125493360|NCT03867201|451439486|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
125493361|NCT03867201|451439487|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
125493362|NCT03867201|451439486|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
125493363|NCT03867201|451439487|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
125493364|NCT03867201|451439486|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
125303895|NCT04164732|450739602|FG002|Randomized Treatment Period|Adverse Event|0|||
125303896|NCT04164732|450739600|FG000|Randomized Treatment Period|Protocol Deviation|0|||
125303897|NCT04164732|450739601|FG001|Randomized Treatment Period|Protocol Deviation|1|||
125303898|NCT04164732|450739602|FG002|Randomized Treatment Period|Protocol Deviation|1|||
125303899|NCT04164732|450739600|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
125303900|NCT04164732|450739601|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
125303901|NCT04164732|450739602|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
125303902|NCT01844778|450739608|FG000|Overall Study|Protocol deviation|0|||
125303903|NCT01844778|450739609|FG001|Overall Study|Protocol deviation|1|||
125303904|NCT01844778|450739610|FG002|Overall Study|Protocol deviation|2|||
125303905|NCT01844778|450739608|FG000|Overall Study|Withdrawal by Subject|2|||
125303906|NCT01844778|450739609|FG001|Overall Study|Withdrawal by Subject|0|||
125303907|NCT01844778|450739610|FG002|Overall Study|Withdrawal by Subject|0|||
125303908|NCT01844778|450739608|FG000|Overall Study|Adverse Event|0|||
125303909|NCT01844778|450739609|FG001|Overall Study|Adverse Event|2|||
125303910|NCT01844778|450739610|FG002|Overall Study|Adverse Event|2|||
125303911|NCT02951429|450739616|FG000|Overall Study|Adverse Event|3|||
125303912|NCT02951429|450739617|FG001|Overall Study|Adverse Event|7|||
125303913|NCT02951429|450739616|FG000|Overall Study|Death|28|||
125303914|NCT02951429|450739617|FG001|Overall Study|Death|36|||
125303915|NCT02951429|450739616|FG000|Overall Study|Lack of Efficacy|0|||
125303916|NCT02951429|450739617|FG001|Overall Study|Lack of Efficacy|1|||
125303917|NCT02951429|450739616|FG000|Overall Study|Lost to Follow-up|0|||
125303918|NCT02951429|450739617|FG001|Overall Study|Lost to Follow-up|1|||
125303919|NCT02951429|450739616|FG000|Overall Study|Lung Transplantation|9|||
125303920|NCT02951429|450739617|FG001|Overall Study|Lung Transplantation|6|||
125303921|NCT02951429|450739616|FG000|Overall Study|Other|1|||
125303922|NCT02951429|450739617|FG001|Overall Study|Other|3|||
125303923|NCT02951429|450739616|FG000|Overall Study|Progressive Disease|1|||
125303924|NCT02951429|450739617|FG001|Overall Study|Progressive Disease|1|||
125303925|NCT02951429|450739616|FG000|Overall Study|Withdrawal by Subject|7|||
125303926|NCT02951429|450739617|FG001|Overall Study|Withdrawal by Subject|11|||
125303927|NCT02951429|450739616|FG000|Overall Study|Participant ongoing in the study|23|||
125303928|NCT02951429|450739617|FG001|Overall Study|Participant ongoing in the study|17|||
125303929|NCT01620528|450739618|FG000|Treatment Period|Did Not Receive Study Drug|0|||
125493365|NCT03867201|451439487|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
125493366|NCT03867201|451439486|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
125493367|NCT03867201|451439487|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
125493368|NCT03867201|451439486|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
125493369|NCT03867201|451439487|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
125493370|NCT03867201|451439486|FG000|Open-Label Period From Week 12|Adverse Event|5|||
125493371|NCT03867201|451439487|FG001|Open-Label Period From Week 12|Adverse Event|11|||
125493372|NCT03867201|451439486|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
125493373|NCT03867201|451439487|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
125303930|NCT01620528|450739619|FG001|Treatment Period|Did Not Receive Study Drug|0|||
125303931|NCT01620528|450739620|FG002|Treatment Period|Did Not Receive Study Drug|1|||
125303932|NCT01620528|450739618|FG000|Treatment Period|Withdrawal by Subject|35|||
125303933|NCT01620528|450739619|FG001|Treatment Period|Withdrawal by Subject|21|||
125303934|NCT01620528|450739620|FG002|Treatment Period|Withdrawal by Subject|16|||
125493374|NCT03867201|451439486|FG000|Open-Label Period From Week 12|Physician Decision|6|||
125493375|NCT03867201|451439487|FG001|Open-Label Period From Week 12|Physician Decision|3|||
125493376|NCT03867201|451439486|FG000|Open-Label Period From Week 12|Pregnancy|2|||
125493377|NCT03867201|451439487|FG001|Open-Label Period From Week 12|Pregnancy|2|||
125493378|NCT03867201|451439486|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
125493379|NCT03867201|451439487|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
125493380|NCT03867201|451439486|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
125493381|NCT03867201|451439487|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
125493382|NCT03867201|451439486|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
125493383|NCT03867201|451439487|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
125493384|NCT03867201|451439486|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
125493385|NCT03867201|451439487|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
125493386|NCT01983683|451439488|FG000|Overall Study|Withdrawal by Subject|14|||
125493387|NCT01983683|451439489|FG001|Overall Study|Withdrawal by Subject|18|||
125493388|NCT01983683|451439488|FG000|Overall Study|Death|11|||
125493389|NCT01983683|451439489|FG001|Overall Study|Death|15|||
125493390|NCT01983683|451439488|FG000|Overall Study|Physician Decision|8|||
125493391|NCT01983683|451439489|FG001|Overall Study|Physician Decision|9|||
125493392|NCT01983683|451439488|FG000|Overall Study|Lost to Follow-up|4|||
125493393|NCT01983683|451439489|FG001|Overall Study|Lost to Follow-up|8|||
125493394|NCT01983683|451439488|FG000|Overall Study|Sponsor Decision|1|||
125493395|NCT01983683|451439489|FG001|Overall Study|Sponsor Decision|1|||
125493396|NCT05464732|451439492|FG000|Overall Study|Lost to Follow-up|0|||
125493397|NCT05464732|451439493|FG001|Overall Study|Lost to Follow-up|1|||
125493398|NCT05464732|451439492|FG000|Overall Study|Adverse Event|1|||
125493399|NCT05464732|451439493|FG001|Overall Study|Adverse Event|0|||
125493400|NCT05786612|451439500|FG000|Overall Study|Adverse Event|1|||
125493401|NCT05786612|451439501|FG001|Overall Study|Adverse Event|2|||
125493402|NCT05786612|451439500|FG000|Overall Study|one screening failure|0|||
125493403|NCT05786612|451439501|FG001|Overall Study|one screening failure|2|||
125493404|NCT04926740|451439502|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
125493405|NCT04926740|451439503|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
125493406|NCT04926740|451439502|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
125493407|NCT04926740|451439503|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
125493408|NCT00655499|451440336|FG000|Overall Study|not eligible|4|||
125493409|NCT03140670|451440342|FG000|Overall Study|Withdrawal by Subject|2|||
125493410|NCT03140670|451440342|FG000|Overall Study|Lost to Follow-up|1|||
125493411|NCT03140670|451440342|FG000|Overall Study|Physician Decision|1|||
125493412|NCT00220805|451440343|FG000|Overall Study|Adverse Event|1|||
125493413|NCT00220805|451440344|FG001|Overall Study|Adverse Event|3|||
125493414|NCT00220805|451440343|FG000|Overall Study|Withdrawal by Subject|3|||
125493415|NCT00220805|451440344|FG001|Overall Study|Withdrawal by Subject|0|||
125493416|NCT00220805|451440343|FG000|Overall Study|Lack of Efficacy|1|||
125493417|NCT00220805|451440344|FG001|Overall Study|Lack of Efficacy|0|||
125493418|NCT00220805|451440343|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
125493419|NCT00220805|451440344|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
125493420|NCT00146172|451440345|FG000|Overall Study|Adverse Event|0|||
125493421|NCT00146172|451440346|FG001|Overall Study|Adverse Event|0|||
125493422|NCT00146172|451440347|FG002|Overall Study|Adverse Event|1|||
125493423|NCT00146172|451440348|FG003|Overall Study|Adverse Event|1|||
125493424|NCT00146172|451440349|FG004|Overall Study|Adverse Event|0|||
125493425|NCT00146172|451440350|FG005|Overall Study|Adverse Event|2|||
125493426|NCT00146172|451440351|FG006|Overall Study|Adverse Event|3|||
125493427|NCT00146172|451440352|FG007|Overall Study|Adverse Event|10|||
125493428|NCT00146172|451440345|FG000|Overall Study|Lost to Follow-up|0|||
125493429|NCT00146172|451440346|FG001|Overall Study|Lost to Follow-up|0|||
125493430|NCT00146172|451440347|FG002|Overall Study|Lost to Follow-up|0|||
125493431|NCT00146172|451440348|FG003|Overall Study|Lost to Follow-up|0|||
125493432|NCT00146172|451440349|FG004|Overall Study|Lost to Follow-up|0|||
125493433|NCT00146172|451440350|FG005|Overall Study|Lost to Follow-up|0|||
125493434|NCT00146172|451440351|FG006|Overall Study|Lost to Follow-up|0|||
125493435|NCT00146172|451440352|FG007|Overall Study|Lost to Follow-up|1|||
125493436|NCT00146172|451440345|FG000|Overall Study|Disease Progression|2|||
125493437|NCT00146172|451440346|FG001|Overall Study|Disease Progression|4|||
125493438|NCT00146172|451440347|FG002|Overall Study|Disease Progression|2|||
125493439|NCT00146172|451440348|FG003|Overall Study|Disease Progression|5|||
125493440|NCT00146172|451440349|FG004|Overall Study|Disease Progression|2|||
125493441|NCT00146172|451440350|FG005|Overall Study|Disease Progression|2|||
125493442|NCT00146172|451440351|FG006|Overall Study|Disease Progression|1|||
125493443|NCT00146172|451440352|FG007|Overall Study|Disease Progression|22|||
125493444|NCT00146172|451440345|FG000|Overall Study|Death|0|||
125493445|NCT00146172|451440346|FG001|Overall Study|Death|0|||
125493446|NCT00146172|451440347|FG002|Overall Study|Death|0|||
125493447|NCT00146172|451440348|FG003|Overall Study|Death|0|||
125493448|NCT00146172|451440349|FG004|Overall Study|Death|0|||
125493449|NCT00146172|451440350|FG005|Overall Study|Death|0|||
125493450|NCT00146172|451440351|FG006|Overall Study|Death|1|||
125493451|NCT00146172|451440352|FG007|Overall Study|Death|0|||
125493452|NCT00146172|451440345|FG000|Overall Study|Physician Decision|0|||
125493453|NCT00146172|451440346|FG001|Overall Study|Physician Decision|0|||
125493454|NCT00146172|451440347|FG002|Overall Study|Physician Decision|0|||
125493455|NCT00146172|451440348|FG003|Overall Study|Physician Decision|0|||
125493456|NCT00146172|451440349|FG004|Overall Study|Physician Decision|0|||
125493457|NCT00146172|451440350|FG005|Overall Study|Physician Decision|0|||
125493458|NCT00146172|451440351|FG006|Overall Study|Physician Decision|0|||
125493459|NCT00146172|451440352|FG007|Overall Study|Physician Decision|1|||
125493460|NCT00146172|451440345|FG000|Overall Study|Withdrawal by Subject|0|||
125493461|NCT00146172|451440346|FG001|Overall Study|Withdrawal by Subject|0|||
125493462|NCT00146172|451440347|FG002|Overall Study|Withdrawal by Subject|0|||
125493463|NCT00146172|451440348|FG003|Overall Study|Withdrawal by Subject|0|||
125493464|NCT00146172|451440349|FG004|Overall Study|Withdrawal by Subject|0|||
125493465|NCT00146172|451440350|FG005|Overall Study|Withdrawal by Subject|1|||
125493466|NCT00146172|451440351|FG006|Overall Study|Withdrawal by Subject|1|||
125493467|NCT00146172|451440352|FG007|Overall Study|Withdrawal by Subject|4|||
125493468|NCT00146172|451440345|FG000|Overall Study|Symptomatic Deterioration|1|||
125493469|NCT00146172|451440346|FG001|Overall Study|Symptomatic Deterioration|0|||
125493470|NCT00146172|451440347|FG002|Overall Study|Symptomatic Deterioration|1|||
125493471|NCT00146172|451440348|FG003|Overall Study|Symptomatic Deterioration|0|||
125493472|NCT00146172|451440349|FG004|Overall Study|Symptomatic Deterioration|1|||
125493473|NCT00146172|451440350|FG005|Overall Study|Symptomatic Deterioration|2|||
125493474|NCT00146172|451440351|FG006|Overall Study|Symptomatic Deterioration|0|||
125493475|NCT00146172|451440352|FG007|Overall Study|Symptomatic Deterioration|2|||
125493476|NCT01288443|451440355|FG000|Overall Study|Adverse Event|0|||
125493477|NCT01288443|451440356|FG001|Overall Study|Adverse Event|0|||
125493478|NCT01288443|451440357|FG002|Overall Study|Adverse Event|1|||
125493479|NCT01288443|451440358|FG003|Overall Study|Adverse Event|1|||
125493480|NCT01288443|451440359|FG004|Overall Study|Adverse Event|3|||
125493481|NCT01288443|451440360|FG005|Overall Study|Adverse Event|1|||
125493482|NCT01288443|451440355|FG000|Overall Study|Poor compliance to protocol|0|||
125493483|NCT01288443|451440356|FG001|Overall Study|Poor compliance to protocol|0|||
125493484|NCT01288443|451440357|FG002|Overall Study|Poor compliance to protocol|0|||
125493485|NCT01288443|451440358|FG003|Overall Study|Poor compliance to protocol|0|||
125493486|NCT01288443|451440359|FG004|Overall Study|Poor compliance to protocol|0|||
125493487|NCT01288443|451440360|FG005|Overall Study|Poor compliance to protocol|1|||
125493488|NCT01288443|451440355|FG000|Overall Study|Participant Moved|0|||
125493489|NCT01288443|451440356|FG001|Overall Study|Participant Moved|0|||
125493490|NCT01288443|451440357|FG002|Overall Study|Participant Moved|0|||
125493491|NCT01288443|451440358|FG003|Overall Study|Participant Moved|1|||
125493492|NCT01288443|451440359|FG004|Overall Study|Participant Moved|2|||
125493493|NCT01288443|451440360|FG005|Overall Study|Participant Moved|1|||
125493494|NCT01288443|451440355|FG000|Overall Study|Consent withdrawn by Participant|0|||
125493495|NCT01288443|451440356|FG001|Overall Study|Consent withdrawn by Participant|0|||
125493496|NCT01288443|451440357|FG002|Overall Study|Consent withdrawn by Participant|0|||
125493497|NCT01288443|451440358|FG003|Overall Study|Consent withdrawn by Participant|0|||
125493498|NCT01288443|451440359|FG004|Overall Study|Consent withdrawn by Participant|0|||
125493499|NCT01288443|451440360|FG005|Overall Study|Consent withdrawn by Participant|1|||
125493500|NCT01288443|451440355|FG000|Overall Study|Lost to Follow-up|0|||
125493501|NCT01288443|451440356|FG001|Overall Study|Lost to Follow-up|1|||
125493502|NCT01288443|451440357|FG002|Overall Study|Lost to Follow-up|0|||
125493503|NCT01288443|451440358|FG003|Overall Study|Lost to Follow-up|0|||
125493504|NCT01288443|451440359|FG004|Overall Study|Lost to Follow-up|0|||
125493505|NCT01288443|451440360|FG005|Overall Study|Lost to Follow-up|0|||
125493506|NCT01288443|451440355|FG000|Overall Study|Study drug auto-injector administration|0|||
125493507|NCT01288443|451440356|FG001|Overall Study|Study drug auto-injector administration|0|||
125493508|NCT01288443|451440357|FG002|Overall Study|Study drug auto-injector administration|0|||
125493509|NCT01288443|451440358|FG003|Overall Study|Study drug auto-injector administration|0|||
125493510|NCT01288443|451440359|FG004|Overall Study|Study drug auto-injector administration|1|||
125493511|NCT01288443|451440360|FG005|Overall Study|Study drug auto-injector administration|1|||
125493512|NCT01288443|451440355|FG000|Overall Study|Other than above|0|||
125493513|NCT01288443|451440356|FG001|Overall Study|Other than above|0|||
125493514|NCT01288443|451440357|FG002|Overall Study|Other than above|0|||
125493515|NCT01288443|451440358|FG003|Overall Study|Other than above|2|||
125493516|NCT01288443|451440359|FG004|Overall Study|Other than above|1|||
125493517|NCT01288443|451440360|FG005|Overall Study|Other than above|0|||
125493518|NCT01596972|451440361|FG000|Overall Study|Physician Decision|1|||
125303935|NCT01620528|450739618|FG000|Treatment Period|Adverse Event|17|||
125493519|NCT01596972|451440362|FG001|Overall Study|Physician Decision|9|||
125493520|NCT01596972|451440361|FG000|Overall Study|Lost to Follow-up|0|||
125493521|NCT01596972|451440362|FG001|Overall Study|Lost to Follow-up|4|||
125493522|NCT01596972|451440361|FG000|Overall Study|Withdrawal by Subject|0|||
125493523|NCT01596972|451440362|FG001|Overall Study|Withdrawal by Subject|1|||
125493524|NCT01964300|451440365|FG000|Overall Study|Ineligible after enrollment|0|||
125493525|NCT01964300|451440366|FG001|Overall Study|Ineligible after enrollment|1|||
125493526|NCT01964300|451440365|FG000|Overall Study|Adverse Event|1|||
125493527|NCT01964300|451440366|FG001|Overall Study|Adverse Event|1|||
125493528|NCT01964300|451440365|FG000|Overall Study|Lack of Efficacy|3|||
125493529|NCT01964300|451440366|FG001|Overall Study|Lack of Efficacy|5|||
125493530|NCT01964300|451440365|FG000|Overall Study|Withdrawal by Subject|0|||
125493531|NCT01964300|451440366|FG001|Overall Study|Withdrawal by Subject|1|||
125493532|NCT01964300|451440365|FG000|Overall Study|To receive alternative therapy|1|||
125493533|NCT01964300|451440366|FG001|Overall Study|To receive alternative therapy|2|||
125493534|NCT01964300|451440365|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
125493535|NCT01964300|451440366|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
125493536|NCT01964300|451440365|FG000|Overall Study|Weight criteria not met|0|||
125493537|NCT01964300|451440366|FG001|Overall Study|Weight criteria not met|1|||
125493538|NCT00557492|451440367|FG000|Overall Study|Change in health insurance|1|||
125493539|NCT02438137|451440368|FG000|Overall Study|Lost to Follow-up|3|||
125493540|NCT02438137|451440369|FG001|Overall Study|Lost to Follow-up|2|||
125493541|NCT02438137|451440368|FG000|Overall Study|Adverse Event|1|||
125493542|NCT02438137|451440369|FG001|Overall Study|Adverse Event|0|||
125493543|NCT02438137|451440368|FG000|Overall Study|Withdrawal by Subject|4|||
125493544|NCT02438137|451440369|FG001|Overall Study|Withdrawal by Subject|3|||
125493545|NCT02438137|451440368|FG000|Overall Study|Physician Decision|0|||
125493546|NCT02438137|451440369|FG001|Overall Study|Physician Decision|1|||
125493547|NCT02285270|451440370|FG000|Overall Study|Lost to Follow-up|1|||
125493548|NCT02285270|451440370|FG000|Overall Study|Physician Decision|3|||
125493549|NCT02285270|451440370|FG000|Overall Study|Determined to be ineligible|1|||
125493550|NCT04868617|451440371|FG000|Overall Study|Death|1|||
125493551|NCT04868617|451440372|FG001|Overall Study|Death|0|||
125493552|NCT04868617|451440371|FG000|Overall Study|Adverse Event|1|||
125493553|NCT04868617|451440372|FG001|Overall Study|Adverse Event|0|||
125493554|NCT04868617|451440371|FG000|Overall Study|Withdrawal by Subject|1|||
125493555|NCT04868617|451440372|FG001|Overall Study|Withdrawal by Subject|0|||
125493556|NCT04868617|451440371|FG000|Overall Study|Device deficiency|1|||
125493557|NCT04868617|451440372|FG001|Overall Study|Device deficiency|0|||
125493558|NCT01579318|451440375|FG000|Overall Study|Disease Progression|1|||
125493559|NCT02347332|451440376|FG000|Overall Study|Not treated|5|||
125493560|NCT02347332|451440377|FG001|Overall Study|Not treated|2|||
125493561|NCT02347332|451440376|FG000|Overall Study|Progressive disease|141|||
125493562|NCT02347332|451440377|FG001|Overall Study|Progressive disease|159|||
125493563|NCT02347332|451440376|FG000|Overall Study|Adverse Event|50|||
125493564|NCT02347332|451440377|FG001|Overall Study|Adverse Event|41|||
125493565|NCT02347332|451440376|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
125493566|NCT02347332|451440377|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
125493567|NCT02347332|451440376|FG000|Overall Study|Protocol Violation|1|||
125493568|NCT02347332|451440377|FG001|Overall Study|Protocol Violation|1|||
125493569|NCT02347332|451440376|FG000|Overall Study|Lost to Follow-up|2|||
125493570|NCT02347332|451440377|FG001|Overall Study|Lost to Follow-up|1|||
125493571|NCT02347332|451440376|FG000|Overall Study|Physician Decision|4|||
125493572|NCT02347332|451440377|FG001|Overall Study|Physician Decision|3|||
125493573|NCT02347332|451440376|FG000|Overall Study|Withdrawal by Subject|20|||
125493574|NCT02347332|451440377|FG001|Overall Study|Withdrawal by Subject|14|||
125493575|NCT02347332|451440376|FG000|Overall Study|Protocol requirement|1|||
125493576|NCT02347332|451440377|FG001|Overall Study|Protocol requirement|1|||
125493577|NCT02347332|451440376|FG000|Overall Study|Switch Post-Trial program|0|||
125493578|NCT02347332|451440377|FG001|Overall Study|Switch Post-Trial program|1|||
125493579|NCT00623194|451440378|FG000|Overall Study|Lack of Efficacy|1|||
125493580|NCT00623194|451440378|FG000|Overall Study|Protocol Violation|3|||
125493581|NCT00623194|451440378|FG000|Overall Study|Unclassified|1|||
125493582|NCT01260896|451440379|FG000|First Intervention|Withdrawn Due to Emesis|2|||
125493583|NCT01260896|451440380|FG001|First Intervention|Withdrawn Due to Emesis|0|||
125493584|NCT00312208|451440381|FG000|Overall Study|Adverse Event|97|||
125493585|NCT00312208|451440382|FG001|Overall Study|Adverse Event|61|||
125493586|NCT00312208|451440381|FG000|Overall Study|Protocol Violation|5|||
125493587|NCT00312208|451440382|FG001|Overall Study|Protocol Violation|3|||
125303936|NCT01620528|450739619|FG001|Treatment Period|Adverse Event|13|||
125493588|NCT00312208|451440381|FG000|Overall Study|Death|2|||
125493589|NCT00312208|451440382|FG001|Overall Study|Death|1|||
125493590|NCT00312208|451440381|FG000|Overall Study|Lack of Efficacy|7|||
125493591|NCT00312208|451440382|FG001|Overall Study|Lack of Efficacy|4|||
125493592|NCT00312208|451440381|FG000|Overall Study|Lost to Follow-up|3|||
125493593|NCT00312208|451440382|FG001|Overall Study|Lost to Follow-up|5|||
125303937|NCT01620528|450739620|FG002|Treatment Period|Adverse Event|21|||
125303938|NCT01620528|450739618|FG000|Treatment Period|Lost to Follow-up|16|||
125303939|NCT01620528|450739619|FG001|Treatment Period|Lost to Follow-up|8|||
125493594|NCT00312208|451440381|FG000|Overall Study|Withdrawal by Subject|53|||
125493595|NCT00312208|451440382|FG001|Overall Study|Withdrawal by Subject|42|||
125493596|NCT00312208|451440381|FG000|Overall Study|Other|5|||
125493597|NCT00312208|451440382|FG001|Overall Study|Other|7|||
125493598|NCT00982644|451440385|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
125303940|NCT01620528|450739620|FG002|Treatment Period|Lost to Follow-up|14|||
125493599|NCT00982644|451440386|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
125493600|NCT00982644|451440385|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
125493601|NCT00982644|451440386|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
125493602|NCT00982644|451440385|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
125493603|NCT00982644|451440386|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
125493604|NCT00982644|451440385|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
125493605|NCT00982644|451440386|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
125493606|NCT00982644|451440385|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
125493607|NCT00982644|451440386|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
125493608|NCT00982644|451440385|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
125493609|NCT00982644|451440386|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
125493610|NCT00982644|451440385|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
125493611|NCT00982644|451440386|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
125493612|NCT00982644|451440385|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
125493613|NCT00982644|451440386|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
125493614|NCT00982644|451440385|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
125493615|NCT00982644|451440386|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
125493616|NCT00982644|451440385|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
125493617|NCT00982644|451440386|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
125493618|NCT00943917|451440389|FG000|Stage I|Adverse Event|1|||
125493619|NCT00943917|451440390|FG001|Stage I|Adverse Event|2|||
125493620|NCT00943917|451440391|FG002|Stage I|Adverse Event|2|||
125493621|NCT00943917|451440392|FG003|Stage I|Adverse Event|0|||
125493622|NCT00943917|451440393|FG004|Stage I|Adverse Event|0|||
125493623|NCT00943917|451440394|FG005|Stage I|Adverse Event|0|||
125493624|NCT00943917|451440395|FG006|Stage I|Adverse Event|0|||
125493625|NCT00943917|451440396|FG007|Stage I|Adverse Event|0|||
125493626|NCT00943917|451440397|FG008|Stage I|Adverse Event|0|||
125493627|NCT00943917|451440398|FG009|Stage I|Adverse Event|0|||
125493628|NCT00943917|451440399|FG010|Stage I|Adverse Event|0|||
125493629|NCT00943917|451440400|FG011|Stage I|Adverse Event|0|||
125493630|NCT00943917|451440401|FG012|Stage I|Adverse Event|0|||
125493631|NCT00943917|451440402|FG013|Stage I|Adverse Event|0|||
125493632|NCT00943917|451440403|FG014|Stage I|Adverse Event|0|||
125493633|NCT00943917|451440389|FG000|Stage I|Lost to Follow-up|0|||
125493634|NCT00943917|451440390|FG001|Stage I|Lost to Follow-up|0|||
125493635|NCT00943917|451440391|FG002|Stage I|Lost to Follow-up|1|||
125493636|NCT00943917|451440392|FG003|Stage I|Lost to Follow-up|0|||
125493637|NCT00943917|451440393|FG004|Stage I|Lost to Follow-up|0|||
125493638|NCT00943917|451440394|FG005|Stage I|Lost to Follow-up|0|||
125493639|NCT00943917|451440395|FG006|Stage I|Lost to Follow-up|0|||
125493640|NCT00943917|451440396|FG007|Stage I|Lost to Follow-up|0|||
125493641|NCT00943917|451440397|FG008|Stage I|Lost to Follow-up|0|||
125493642|NCT00943917|451440398|FG009|Stage I|Lost to Follow-up|0|||
125493643|NCT00943917|451440399|FG010|Stage I|Lost to Follow-up|0|||
125493644|NCT00943917|451440400|FG011|Stage I|Lost to Follow-up|0|||
125493645|NCT00943917|451440401|FG012|Stage I|Lost to Follow-up|0|||
125493646|NCT00943917|451440402|FG013|Stage I|Lost to Follow-up|0|||
125493647|NCT00943917|451440403|FG014|Stage I|Lost to Follow-up|0|||
125493648|NCT00943917|451440389|FG000|Stage I|hyperglycemia|0|||
125493649|NCT00943917|451440390|FG001|Stage I|hyperglycemia|0|||
125493650|NCT00943917|451440391|FG002|Stage I|hyperglycemia|1|||
125493651|NCT00943917|451440392|FG003|Stage I|hyperglycemia|0|||
125493652|NCT00943917|451440393|FG004|Stage I|hyperglycemia|0|||
125493653|NCT00943917|451440394|FG005|Stage I|hyperglycemia|0|||
125493654|NCT00943917|451440395|FG006|Stage I|hyperglycemia|0|||
125493655|NCT00943917|451440396|FG007|Stage I|hyperglycemia|0|||
125493656|NCT00943917|451440397|FG008|Stage I|hyperglycemia|0|||
125493657|NCT00943917|451440398|FG009|Stage I|hyperglycemia|0|||
125493658|NCT00943917|451440399|FG010|Stage I|hyperglycemia|0|||
125493659|NCT00943917|451440400|FG011|Stage I|hyperglycemia|0|||
125493660|NCT00943917|451440401|FG012|Stage I|hyperglycemia|0|||
125493661|NCT00943917|451440402|FG013|Stage I|hyperglycemia|0|||
125493662|NCT00943917|451440403|FG014|Stage I|hyperglycemia|0|||
125493663|NCT00943917|451440389|FG000|Stage I|A1C elevation|1|||
125493664|NCT00943917|451440390|FG001|Stage I|A1C elevation|0|||
125493665|NCT00943917|451440391|FG002|Stage I|A1C elevation|0|||
125493666|NCT00943917|451440392|FG003|Stage I|A1C elevation|0|||
125493667|NCT00943917|451440393|FG004|Stage I|A1C elevation|0|||
125493668|NCT00943917|451440394|FG005|Stage I|A1C elevation|0|||
125493669|NCT00943917|451440395|FG006|Stage I|A1C elevation|0|||
125493670|NCT00943917|451440396|FG007|Stage I|A1C elevation|0|||
125493671|NCT00943917|451440397|FG008|Stage I|A1C elevation|0|||
125493672|NCT00943917|451440398|FG009|Stage I|A1C elevation|0|||
125493673|NCT00943917|451440399|FG010|Stage I|A1C elevation|0|||
125493674|NCT00943917|451440400|FG011|Stage I|A1C elevation|0|||
125493675|NCT00943917|451440401|FG012|Stage I|A1C elevation|0|||
125493676|NCT00943917|451440402|FG013|Stage I|A1C elevation|0|||
125493677|NCT00943917|451440403|FG014|Stage I|A1C elevation|0|||
125493678|NCT00943917|451440389|FG000|Stage I|Withdrawal by Subject|2|||
125493679|NCT00943917|451440390|FG001|Stage I|Withdrawal by Subject|1|||
125493680|NCT00943917|451440391|FG002|Stage I|Withdrawal by Subject|2|||
125493681|NCT00943917|451440392|FG003|Stage I|Withdrawal by Subject|0|||
125493682|NCT00943917|451440393|FG004|Stage I|Withdrawal by Subject|0|||
125493683|NCT00943917|451440394|FG005|Stage I|Withdrawal by Subject|0|||
125493684|NCT00943917|451440395|FG006|Stage I|Withdrawal by Subject|0|||
125493685|NCT00943917|451440396|FG007|Stage I|Withdrawal by Subject|0|||
125493686|NCT00943917|451440397|FG008|Stage I|Withdrawal by Subject|0|||
125493687|NCT00943917|451440398|FG009|Stage I|Withdrawal by Subject|0|||
125493688|NCT00943917|451440399|FG010|Stage I|Withdrawal by Subject|0|||
125493689|NCT00943917|451440400|FG011|Stage I|Withdrawal by Subject|0|||
125493690|NCT00943917|451440401|FG012|Stage I|Withdrawal by Subject|0|||
125493691|NCT00943917|451440402|FG013|Stage I|Withdrawal by Subject|0|||
125493692|NCT00943917|451440403|FG014|Stage I|Withdrawal by Subject|0|||
125493693|NCT00943917|451440389|FG000|Stage II|Adverse Event|0|||
125493694|NCT00943917|451440390|FG001|Stage II|Adverse Event|0|||
125493695|NCT00943917|451440391|FG002|Stage II|Adverse Event|0|||
125493696|NCT00943917|451440392|FG003|Stage II|Adverse Event|0|||
125493697|NCT00943917|451440393|FG004|Stage II|Adverse Event|0|||
125493698|NCT00943917|451440394|FG005|Stage II|Adverse Event|1|||
125493699|NCT00943917|451440395|FG006|Stage II|Adverse Event|3|||
125493700|NCT00943917|451440396|FG007|Stage II|Adverse Event|0|||
125493701|NCT00943917|451440397|FG008|Stage II|Adverse Event|1|||
125493702|NCT00943917|451440398|FG009|Stage II|Adverse Event|0|||
125493703|NCT00943917|451440399|FG010|Stage II|Adverse Event|0|||
125493704|NCT00943917|451440400|FG011|Stage II|Adverse Event|0|||
125493705|NCT00943917|451440401|FG012|Stage II|Adverse Event|0|||
125493706|NCT00943917|451440402|FG013|Stage II|Adverse Event|0|||
125493707|NCT00943917|451440403|FG014|Stage II|Adverse Event|0|||
125493708|NCT00943917|451440389|FG000|Stage II|Withdrawal by Subject|0|||
125493709|NCT00943917|451440390|FG001|Stage II|Withdrawal by Subject|0|||
125493710|NCT00943917|451440391|FG002|Stage II|Withdrawal by Subject|0|||
125493711|NCT00943917|451440392|FG003|Stage II|Withdrawal by Subject|0|||
125493712|NCT00943917|451440393|FG004|Stage II|Withdrawal by Subject|0|||
125493713|NCT00943917|451440394|FG005|Stage II|Withdrawal by Subject|1|||
125493714|NCT00943917|451440395|FG006|Stage II|Withdrawal by Subject|0|||
125493715|NCT00943917|451440396|FG007|Stage II|Withdrawal by Subject|0|||
125493716|NCT00943917|451440397|FG008|Stage II|Withdrawal by Subject|0|||
125493717|NCT00943917|451440398|FG009|Stage II|Withdrawal by Subject|0|||
125493718|NCT00943917|451440399|FG010|Stage II|Withdrawal by Subject|0|||
125493719|NCT00943917|451440400|FG011|Stage II|Withdrawal by Subject|0|||
125493720|NCT00943917|451440401|FG012|Stage II|Withdrawal by Subject|0|||
125493721|NCT00943917|451440402|FG013|Stage II|Withdrawal by Subject|0|||
125493722|NCT00943917|451440403|FG014|Stage II|Withdrawal by Subject|0|||
125493723|NCT00943917|451440389|FG000|Stage II|Pregnancy|0|||
125493724|NCT00943917|451440390|FG001|Stage II|Pregnancy|0|||
125493725|NCT00943917|451440391|FG002|Stage II|Pregnancy|0|||
125493726|NCT00943917|451440392|FG003|Stage II|Pregnancy|0|||
125493727|NCT00943917|451440393|FG004|Stage II|Pregnancy|0|||
125493728|NCT00943917|451440394|FG005|Stage II|Pregnancy|1|||
125493729|NCT00943917|451440395|FG006|Stage II|Pregnancy|0|||
125493730|NCT00943917|451440396|FG007|Stage II|Pregnancy|0|||
125493731|NCT00943917|451440397|FG008|Stage II|Pregnancy|0|||
125493732|NCT00943917|451440398|FG009|Stage II|Pregnancy|0|||
125493733|NCT00943917|451440399|FG010|Stage II|Pregnancy|0|||
125493734|NCT00943917|451440400|FG011|Stage II|Pregnancy|0|||
125493735|NCT00943917|451440401|FG012|Stage II|Pregnancy|0|||
125493736|NCT00943917|451440402|FG013|Stage II|Pregnancy|0|||
125493737|NCT00943917|451440403|FG014|Stage II|Pregnancy|0|||
125493738|NCT00943917|451440389|FG000|Stage II Continuation|Adverse Event|0|||
125493739|NCT00943917|451440390|FG001|Stage II Continuation|Adverse Event|0|||
125303941|NCT01620528|450739618|FG000|Treatment Period|Other|9|||
125303942|NCT01620528|450739619|FG001|Treatment Period|Other|5|||
125303943|NCT01620528|450739620|FG002|Treatment Period|Other|7|||
125303944|NCT01620528|450739618|FG000|Treatment Period|Subject Noncompliant|11|||
125303945|NCT01620528|450739619|FG001|Treatment Period|Subject Noncompliant|2|||
125303946|NCT01620528|450739620|FG002|Treatment Period|Subject Noncompliant|2|||
125303947|NCT01620528|450739618|FG000|Treatment Period|Pregnancy|7|||
125303948|NCT01620528|450739619|FG001|Treatment Period|Pregnancy|2|||
125303949|NCT01620528|450739620|FG002|Treatment Period|Pregnancy|2|||
125493740|NCT00943917|451440391|FG002|Stage II Continuation|Adverse Event|0|||
125493741|NCT00943917|451440392|FG003|Stage II Continuation|Adverse Event|0|||
125493742|NCT00943917|451440393|FG004|Stage II Continuation|Adverse Event|0|||
125493743|NCT00943917|451440394|FG005|Stage II Continuation|Adverse Event|0|||
125493744|NCT00943917|451440395|FG006|Stage II Continuation|Adverse Event|0|||
125493745|NCT00943917|451440396|FG007|Stage II Continuation|Adverse Event|0|||
125493746|NCT00943917|451440397|FG008|Stage II Continuation|Adverse Event|0|||
125493747|NCT00943917|451440398|FG009|Stage II Continuation|Adverse Event|0|||
125493748|NCT00943917|451440399|FG010|Stage II Continuation|Adverse Event|0|||
125493749|NCT00943917|451440400|FG011|Stage II Continuation|Adverse Event|1|||
125303950|NCT01620528|450739618|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
125303951|NCT01620528|450739619|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
125493750|NCT00943917|451440401|FG012|Stage II Continuation|Adverse Event|2|||
125493751|NCT00943917|451440402|FG013|Stage II Continuation|Adverse Event|1|||
125493752|NCT00943917|451440403|FG014|Stage II Continuation|Adverse Event|1|||
125493753|NCT00943917|451440389|FG000|Stage II Continuation|Withdrawal by Subject|0|||
125493754|NCT00943917|451440390|FG001|Stage II Continuation|Withdrawal by Subject|0|||
125493755|NCT00943917|451440391|FG002|Stage II Continuation|Withdrawal by Subject|0|||
125493756|NCT00943917|451440392|FG003|Stage II Continuation|Withdrawal by Subject|0|||
125493757|NCT00943917|451440393|FG004|Stage II Continuation|Withdrawal by Subject|0|||
125493758|NCT00943917|451440394|FG005|Stage II Continuation|Withdrawal by Subject|0|||
125493759|NCT00943917|451440395|FG006|Stage II Continuation|Withdrawal by Subject|0|||
125493760|NCT00943917|451440396|FG007|Stage II Continuation|Withdrawal by Subject|0|||
125493761|NCT00943917|451440397|FG008|Stage II Continuation|Withdrawal by Subject|0|||
125493762|NCT00943917|451440398|FG009|Stage II Continuation|Withdrawal by Subject|0|||
125493763|NCT00943917|451440399|FG010|Stage II Continuation|Withdrawal by Subject|0|||
125493764|NCT00943917|451440400|FG011|Stage II Continuation|Withdrawal by Subject|0|||
125493765|NCT00943917|451440401|FG012|Stage II Continuation|Withdrawal by Subject|0|||
125493766|NCT00943917|451440402|FG013|Stage II Continuation|Withdrawal by Subject|1|||
125493767|NCT00943917|451440403|FG014|Stage II Continuation|Withdrawal by Subject|3|||
125493768|NCT00943917|451440389|FG000|Stage II Continuation|Protocol Violation|0|||
125493769|NCT00943917|451440390|FG001|Stage II Continuation|Protocol Violation|0|||
125493770|NCT00943917|451440391|FG002|Stage II Continuation|Protocol Violation|0|||
125493771|NCT00943917|451440392|FG003|Stage II Continuation|Protocol Violation|0|||
125493772|NCT00943917|451440393|FG004|Stage II Continuation|Protocol Violation|0|||
125493773|NCT00943917|451440394|FG005|Stage II Continuation|Protocol Violation|0|||
125493774|NCT00943917|451440395|FG006|Stage II Continuation|Protocol Violation|0|||
125493775|NCT00943917|451440396|FG007|Stage II Continuation|Protocol Violation|0|||
125493776|NCT00943917|451440397|FG008|Stage II Continuation|Protocol Violation|0|||
125493777|NCT00943917|451440398|FG009|Stage II Continuation|Protocol Violation|1|||
125493778|NCT00943917|451440399|FG010|Stage II Continuation|Protocol Violation|0|||
125493779|NCT00943917|451440400|FG011|Stage II Continuation|Protocol Violation|1|||
125493780|NCT00943917|451440401|FG012|Stage II Continuation|Protocol Violation|0|||
125493781|NCT00943917|451440402|FG013|Stage II Continuation|Protocol Violation|0|||
125493782|NCT00943917|451440403|FG014|Stage II Continuation|Protocol Violation|0|||
125493783|NCT00943917|451440389|FG000|Stage II Continuation|hypoglycemia|0|||
125493784|NCT00943917|451440390|FG001|Stage II Continuation|hypoglycemia|0|||
125303952|NCT01620528|450739620|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
125303953|NCT01620528|450739618|FG000|Treatment Period|Exclusionary Medication Received|0|||
125303954|NCT01620528|450739619|FG001|Treatment Period|Exclusionary Medication Received|1|||
125303955|NCT01620528|450739620|FG002|Treatment Period|Exclusionary Medication Received|0|||
125303956|NCT01620528|450739618|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
125303957|NCT01620528|450739619|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
125303958|NCT01620528|450739620|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
125303959|NCT01620528|450739618|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
125303960|NCT01620528|450739619|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
125303961|NCT01620528|450739620|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
125303962|NCT01620528|450739618|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
125303963|NCT01620528|450739619|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
125303964|NCT01620528|450739620|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
125303965|NCT01620528|450739618|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
125303966|NCT01620528|450739619|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
125303967|NCT01620528|450739620|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
125303968|NCT01620528|450739618|FG000|Post-Treatment Follow-Up Period|Other|6|||
125303969|NCT01620528|450739619|FG001|Post-Treatment Follow-Up Period|Other|4|||
125303970|NCT01620528|450739620|FG002|Post-Treatment Follow-Up Period|Other|2|||
125303971|NCT01457846|450739621|FG000|Overall Study|Death before treatment|1|||
125303972|NCT01457846|450739622|FG001|Overall Study|Death before treatment|2|||
125303973|NCT01457846|450739621|FG000|Overall Study|Did not receive treatment|0|||
125303974|NCT01457846|450739622|FG001|Overall Study|Did not receive treatment|1|||
125303975|NCT01457846|450739621|FG000|Overall Study|Death|27|||
125303976|NCT01457846|450739622|FG001|Overall Study|Death|16|||
125303977|NCT01457846|450739621|FG000|Overall Study|Unclassified reason for not completed|11|||
125303978|NCT01457846|450739622|FG001|Overall Study|Unclassified reason for not completed|10|||
125303979|NCT01457846|450739621|FG000|Overall Study|Withdrawal by Subject|1|||
125303980|NCT01457846|450739622|FG001|Overall Study|Withdrawal by Subject|1|||
125303981|NCT01457846|450739621|FG000|Overall Study|Lost to Follow-up|1|||
125303982|NCT01457846|450739622|FG001|Overall Study|Lost to Follow-up|0|||
125303983|NCT01743040|450739623|FG000|Overall Study|Death|1|||
125303984|NCT01743040|450739623|FG000|Overall Study|Lost to Follow-up|66|||
125303985|NCT01743040|450739623|FG000|Overall Study|Physician Decision|40|||
125303986|NCT01743040|450739623|FG000|Overall Study|Protocol Violation|1|||
125303987|NCT01743040|450739623|FG000|Overall Study|Withdrawal by Subject|121|||
125303988|NCT02974842|450739624|FG000|Overall Study|Withdrawal by Subject|4|||
125303989|NCT02974842|450739624|FG000|Overall Study|Screen failures|4|||
125303990|NCT03824587|450739625|FG000|Run-in Period|Screen Failure|0|||
125303991|NCT03824587|450739626|FG001|Run-in Period|Screen Failure|275|||
125493785|NCT00943917|451440391|FG002|Stage II Continuation|hypoglycemia|0|||
125493786|NCT00943917|451440392|FG003|Stage II Continuation|hypoglycemia|0|||
125493787|NCT00943917|451440393|FG004|Stage II Continuation|hypoglycemia|0|||
125493788|NCT00943917|451440394|FG005|Stage II Continuation|hypoglycemia|0|||
125493789|NCT00943917|451440395|FG006|Stage II Continuation|hypoglycemia|0|||
125493790|NCT00943917|451440396|FG007|Stage II Continuation|hypoglycemia|0|||
125493791|NCT00943917|451440397|FG008|Stage II Continuation|hypoglycemia|0|||
125493792|NCT00943917|451440398|FG009|Stage II Continuation|hypoglycemia|0|||
125493793|NCT00943917|451440399|FG010|Stage II Continuation|hypoglycemia|0|||
125493794|NCT00943917|451440400|FG011|Stage II Continuation|hypoglycemia|0|||
125493795|NCT00943917|451440401|FG012|Stage II Continuation|hypoglycemia|1|||
125493796|NCT00943917|451440402|FG013|Stage II Continuation|hypoglycemia|0|||
125493797|NCT00943917|451440403|FG014|Stage II Continuation|hypoglycemia|0|||
125493798|NCT00943917|451440389|FG000|Stage II Continuation|A1C elevation|0|||
125493799|NCT00943917|451440390|FG001|Stage II Continuation|A1C elevation|0|||
125493800|NCT00943917|451440391|FG002|Stage II Continuation|A1C elevation|0|||
125493801|NCT00943917|451440392|FG003|Stage II Continuation|A1C elevation|0|||
125493802|NCT00943917|451440393|FG004|Stage II Continuation|A1C elevation|0|||
125493803|NCT00943917|451440394|FG005|Stage II Continuation|A1C elevation|0|||
125493804|NCT00943917|451440395|FG006|Stage II Continuation|A1C elevation|0|||
125493805|NCT00943917|451440396|FG007|Stage II Continuation|A1C elevation|0|||
125493806|NCT00943917|451440397|FG008|Stage II Continuation|A1C elevation|0|||
125493807|NCT00943917|451440398|FG009|Stage II Continuation|A1C elevation|0|||
125493808|NCT00943917|451440399|FG010|Stage II Continuation|A1C elevation|0|||
125493809|NCT00943917|451440400|FG011|Stage II Continuation|A1C elevation|0|||
125493810|NCT00943917|451440401|FG012|Stage II Continuation|A1C elevation|0|||
125493811|NCT00943917|451440402|FG013|Stage II Continuation|A1C elevation|1|||
125493812|NCT00943917|451440403|FG014|Stage II Continuation|A1C elevation|0|||
125493813|NCT02844439|451440404|FG000|Overall Study|Withdrawal by Subject|1|||
125493814|NCT02844439|451440404|FG000|Overall Study|Lost to Follow-up|2|||
125493815|NCT02844439|451440404|FG000|Overall Study|Termination by Sponsor|4|||
125493816|NCT02844439|451440404|FG000|Overall Study|Death|28|||
125493817|NCT02844439|451440404|FG000|Overall Study|Other|5|||
125493818|NCT03170648|451440409|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
125493819|NCT03170648|451440409|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
125493820|NCT03500549|451440410|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
125493821|NCT03500549|451440411|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
125493822|NCT03500549|451440410|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
125493823|NCT03500549|451440411|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
125493824|NCT02754596|451440412|FG000|Overall Study|Withdrawal by Subject|3|||
125493825|NCT02754596|451440413|FG001|Overall Study|Withdrawal by Subject|4|||
125493826|NCT02754596|451440414|FG002|Overall Study|Withdrawal by Subject|0|||
125493827|NCT02754596|451440412|FG000|Overall Study|Physician Decision|1|||
125493828|NCT02754596|451440413|FG001|Overall Study|Physician Decision|1|||
125493829|NCT02754596|451440414|FG002|Overall Study|Physician Decision|1|||
125493830|NCT02754596|451440412|FG000|Overall Study|Lost to Follow-up|1|||
125493831|NCT02754596|451440413|FG001|Overall Study|Lost to Follow-up|1|||
125493832|NCT02754596|451440414|FG002|Overall Study|Lost to Follow-up|2|||
125493833|NCT02754596|451440412|FG000|Overall Study|Death|0|||
125493834|NCT02754596|451440413|FG001|Overall Study|Death|2|||
125493835|NCT02754596|451440414|FG002|Overall Study|Death|0|||
125493836|NCT02754596|451440412|FG000|Overall Study|Adverse Event|1|||
125493837|NCT02754596|451440413|FG001|Overall Study|Adverse Event|0|||
125493838|NCT02754596|451440414|FG002|Overall Study|Adverse Event|1|||
125493839|NCT02754596|451440412|FG000|Overall Study|Other|1|||
125493840|NCT02754596|451440413|FG001|Overall Study|Other|0|||
125493841|NCT02754596|451440414|FG002|Overall Study|Other|0|||
125493842|NCT02107261|451440415|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
125493843|NCT02107261|451440416|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
125493844|NCT02107261|451440415|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
125493845|NCT02107261|451440416|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
125493846|NCT04337931|451440417|FG000|Overall Study|Death|4|||
125493847|NCT04337931|451440418|FG001|Overall Study|Death|1|||
125493848|NCT04337931|451440419|FG002|Overall Study|Death|7|||
125493849|NCT04337931|451440417|FG000|Overall Study|Withdrawal by Subject|0|||
125493850|NCT04337931|451440418|FG001|Overall Study|Withdrawal by Subject|1|||
125493851|NCT04337931|451440419|FG002|Overall Study|Withdrawal by Subject|0|||
125493852|NCT04337931|451440417|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
125493853|NCT04337931|451440418|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
125493854|NCT04337931|451440419|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
125493855|NCT04337931|451440417|FG000|Overall Study|Study terminated by sponsor|3|||
125493856|NCT04337931|451440418|FG001|Overall Study|Study terminated by sponsor|6|||
125493857|NCT04337931|451440419|FG002|Overall Study|Study terminated by sponsor|2|||
125493858|NCT04337931|451440417|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
125493859|NCT04337931|451440418|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
125493860|NCT04337931|451440419|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
125493861|NCT04337931|451440417|FG000|Overall Study|Colorectal cancer treatment|1|||
125493862|NCT04337931|451440418|FG001|Overall Study|Colorectal cancer treatment|0|||
125493863|NCT04337931|451440419|FG002|Overall Study|Colorectal cancer treatment|0|||
125493864|NCT04337931|451440417|FG000|Overall Study|Participant decision|0|||
125493865|NCT04337931|451440418|FG001|Overall Study|Participant decision|1|||
125493866|NCT04337931|451440419|FG002|Overall Study|Participant decision|0|||
125493867|NCT04436289|451440421|FG000|Overall Study|Death prior to hospital discharge|8|||
125493868|NCT04436289|451440422|FG001|Overall Study|Death prior to hospital discharge|5|||
125493869|NCT04436289|451440423|FG002|Overall Study|Death prior to hospital discharge|0|||
125493870|NCT04436289|451440424|FG003|Overall Study|Death prior to hospital discharge|1|||
125493871|NCT04436289|451440421|FG000|Overall Study|Withdrawal by Subject|0|||
125493872|NCT04436289|451440422|FG001|Overall Study|Withdrawal by Subject|1|||
125493873|NCT04436289|451440423|FG002|Overall Study|Withdrawal by Subject|4|||
125493874|NCT04436289|451440424|FG003|Overall Study|Withdrawal by Subject|0|||
125493875|NCT04436289|451440421|FG000|Overall Study|Extended hospital stay|0|||
125493876|NCT04436289|451440422|FG001|Overall Study|Extended hospital stay|1|||
125493877|NCT04436289|451440423|FG002|Overall Study|Extended hospital stay|0|||
125493878|NCT04436289|451440424|FG003|Overall Study|Extended hospital stay|0|||
125493879|NCT04436289|451440421|FG000|Overall Study|Lost to Follow-up|0|||
125493880|NCT04436289|451440422|FG001|Overall Study|Lost to Follow-up|4|||
125493881|NCT04436289|451440423|FG002|Overall Study|Lost to Follow-up|1|||
125493882|NCT04436289|451440424|FG003|Overall Study|Lost to Follow-up|3|||
125493883|NCT00747565|451440425|FG000|Overall Study|Withdrawal by Subject|10|||
125493884|NCT00747565|451440426|FG001|Overall Study|Withdrawal by Subject|6|||
125493885|NCT00747565|451440425|FG000|Overall Study|Lost to Follow-up|4|||
125493886|NCT00747565|451440426|FG001|Overall Study|Lost to Follow-up|1|||
125493887|NCT00319020|451440429|FG000|Overall Study|Death|2|||
125493888|NCT00319020|451440430|FG001|Overall Study|Death|2|||
125493889|NCT00319020|451440429|FG000|Overall Study|Withdrawal by Subject|4|||
125493890|NCT00319020|451440430|FG001|Overall Study|Withdrawal by Subject|1|||
125493891|NCT00319020|451440429|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
125493892|NCT00319020|451440430|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
125493893|NCT00319020|451440429|FG000|Overall Study|Administrative reason|0|||
125493894|NCT00319020|451440430|FG001|Overall Study|Administrative reason|5|||
125493895|NCT00319020|451440429|FG000|Overall Study|Disease progression|0|||
125493896|NCT00319020|451440430|FG001|Overall Study|Disease progression|2|||
125493897|NCT00319020|451440429|FG000|Overall Study|Transplant|0|||
125493898|NCT00319020|451440430|FG001|Overall Study|Transplant|1|||
125493899|NCT00319020|451440429|FG000|Overall Study|Treatment failure|0|||
125493900|NCT00319020|451440430|FG001|Overall Study|Treatment failure|1|||
125493901|NCT00319020|451440429|FG000|Overall Study|Adverse Event|0|||
125493902|NCT00319020|451440430|FG001|Overall Study|Adverse Event|1|||
125493903|NCT00227266|451440431|FG000|Overall Study|Withdrawal by Subject|0|||
125493904|NCT00227266|451440432|FG001|Overall Study|Withdrawal by Subject|0|||
125493905|NCT00227266|451440433|FG002|Overall Study|Withdrawal by Subject|1|||
125493906|NCT00227266|451440431|FG000|Overall Study|Protocol Violation|1|||
125493907|NCT00227266|451440432|FG001|Overall Study|Protocol Violation|0|||
125493908|NCT00227266|451440433|FG002|Overall Study|Protocol Violation|1|||
125493909|NCT00227266|451440431|FG000|Overall Study|Excessive weight gain|0|||
125493910|NCT00227266|451440432|FG001|Overall Study|Excessive weight gain|0|||
125493911|NCT00227266|451440433|FG002|Overall Study|Excessive weight gain|2|||
125493912|NCT04153890|451440434|FG000|Overall Study|Lost to Follow-up|9|||
125493913|NCT04153890|451440435|FG001|Overall Study|Lost to Follow-up|0|||
125493914|NCT04153890|451440436|FG002|Overall Study|Lost to Follow-up|9|||
125303992|NCT03824587|450739625|FG000|Treatment Period|Adverse Event|4|||
125303993|NCT03824587|450739626|FG001|Treatment Period|Adverse Event|1|||
125303994|NCT03824587|450739625|FG000|Treatment Period|Withdrawal by Subject|0|||
125303995|NCT03824587|450739626|FG001|Treatment Period|Withdrawal by Subject|1|||
125303996|NCT03824587|450739625|FG000|Treatment Period|Kidney Transplant|1|||
125303997|NCT03824587|450739626|FG001|Treatment Period|Kidney Transplant|1|||
125303998|NCT00986362|450739627|FG000|Overall Study|Death|2|||
125493915|NCT04153890|451440437|FG003|Overall Study|Lost to Follow-up|0|||
125493916|NCT04153890|451440434|FG000|Overall Study|Death|0|||
125493917|NCT04153890|451440435|FG001|Overall Study|Death|2|||
125493918|NCT04153890|451440436|FG002|Overall Study|Death|0|||
125493919|NCT04153890|451440437|FG003|Overall Study|Death|0|||
125493920|NCT04153890|451440434|FG000|Overall Study|Withdrawal by Subject|0|||
125493921|NCT04153890|451440435|FG001|Overall Study|Withdrawal by Subject|0|||
125493922|NCT04153890|451440436|FG002|Overall Study|Withdrawal by Subject|0|||
125493923|NCT04153890|451440437|FG003|Overall Study|Withdrawal by Subject|2|||
125493924|NCT03959423|451440438|FG000|Overall Study|Withdrawal by Subject|2|||
125493925|NCT03959423|451440439|FG001|Overall Study|Withdrawal by Subject|3|||
125493926|NCT03959423|451440438|FG000|Overall Study|Physician Decision|0|||
125493927|NCT03959423|451440439|FG001|Overall Study|Physician Decision|1|||
125493928|NCT03959423|451440438|FG000|Overall Study|Lost to Follow-up|1|||
125493929|NCT03959423|451440439|FG001|Overall Study|Lost to Follow-up|0|||
125493930|NCT03959423|451440438|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
125493931|NCT03959423|451440439|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125493932|NCT00593840|451440440|FG000|Overall Study|Withdrawal by Subject|1|||
125493933|NCT04530487|451441758|FG000|Overall Study|Death|1|||
125493934|NCT03876457|451441759|FG000|Overall Study|Lost to Follow-up|1|||
125493935|NCT03876457|451441760|FG001|Overall Study|Lost to Follow-up|3|||
125493936|NCT01184326|451441761|FG000|Overall Study|Adverse Event|1|||
125493937|NCT01184326|451441762|FG001|Overall Study|Adverse Event|2|||
125493938|NCT01184326|451441763|FG002|Overall Study|Adverse Event|0|||
125493939|NCT01184326|451441761|FG000|Overall Study|Death|0|||
125493940|NCT01184326|451441762|FG001|Overall Study|Death|0|||
125493941|NCT01184326|451441763|FG002|Overall Study|Death|1|||
125493942|NCT01184326|451441761|FG000|Overall Study|Withdrawal by Subject|0|||
125493943|NCT01184326|451441762|FG001|Overall Study|Withdrawal by Subject|0|||
125493944|NCT01184326|451441763|FG002|Overall Study|Withdrawal by Subject|1|||
125493945|NCT01184326|451441761|FG000|Overall Study|Physician Decision|1|||
125493946|NCT01184326|451441762|FG001|Overall Study|Physician Decision|1|||
125493947|NCT01184326|451441763|FG002|Overall Study|Physician Decision|0|||
125493948|NCT01184326|451441761|FG000|Overall Study|Disease Progression|1|||
125493949|NCT01184326|451441762|FG001|Overall Study|Disease Progression|3|||
125493950|NCT01184326|451441763|FG002|Overall Study|Disease Progression|12|||
125493951|NCT01036724|451441764|FG000|Overall Study|Adverse Event|1|||
125493952|NCT01036724|451441765|FG001|Overall Study|Adverse Event|2|||
125493953|NCT01036724|451441764|FG000|Overall Study|Lack of Efficacy|1|||
125493954|NCT01036724|451441765|FG001|Overall Study|Lack of Efficacy|1|||
125493955|NCT01036724|451441764|FG000|Overall Study|Protocol Violation|4|||
125493956|NCT01036724|451441765|FG001|Overall Study|Protocol Violation|5|||
125493957|NCT04213807|451441773|FG000|Overall Study|Physician Decision|0|||
125493958|NCT04213807|451441774|FG001|Overall Study|Physician Decision|0|||
125493959|NCT04213807|451441775|FG002|Overall Study|Physician Decision|1|||
125493960|NCT01574716|451441776|FG000|Part 1|Death|3|||
125493961|NCT01574716|451441777|FG001|Part 1|Death|1|||
125493962|NCT01574716|451441778|FG002|Part 1|Death|8|||
125493963|NCT01574716|451441779|FG003|Part 1|Death|0|||
125493964|NCT01574716|451441780|FG004|Part 1|Death|0|||
125493965|NCT01574716|451441776|FG000|Part 1|Discontinuation of study by sponsor|0|||
125493966|NCT01574716|451441777|FG001|Part 1|Discontinuation of study by sponsor|0|||
125493967|NCT01574716|451441778|FG002|Part 1|Discontinuation of study by sponsor|1|||
125493968|NCT01574716|451441779|FG003|Part 1|Discontinuation of study by sponsor|0|||
125493969|NCT01574716|451441780|FG004|Part 1|Discontinuation of study by sponsor|0|||
125493970|NCT01574716|451441776|FG000|Part 1|Withdrawal by Subject|0|||
125493971|NCT01574716|451441777|FG001|Part 1|Withdrawal by Subject|2|||
125493972|NCT01574716|451441778|FG002|Part 1|Withdrawal by Subject|0|||
125493973|NCT01574716|451441779|FG003|Part 1|Withdrawal by Subject|0|||
125493974|NCT01574716|451441780|FG004|Part 1|Withdrawal by Subject|0|||
125493975|NCT01574716|451441776|FG000|Part 1|Lost to Follow-up|0|||
125493976|NCT01574716|451441777|FG001|Part 1|Lost to Follow-up|1|||
125493977|NCT01574716|451441778|FG002|Part 1|Lost to Follow-up|0|||
125493978|NCT01574716|451441779|FG003|Part 1|Lost to Follow-up|0|||
125493979|NCT01574716|451441780|FG004|Part 1|Lost to Follow-up|0|||
125493980|NCT01574716|451441776|FG000|Part 2|Progressive disease|0|||
125493981|NCT01574716|451441777|FG001|Part 2|Progressive disease|0|||
125493982|NCT01574716|451441778|FG002|Part 2|Progressive disease|0|||
125493983|NCT01574716|451441779|FG003|Part 2|Progressive disease|1|||
125493984|NCT01574716|451441780|FG004|Part 2|Progressive disease|0|||
125493985|NCT01574716|451441776|FG000|Part 2|Death|0|||
125493986|NCT01574716|451441777|FG001|Part 2|Death|0|||
125493987|NCT01574716|451441778|FG002|Part 2|Death|0|||
125493988|NCT01574716|451441779|FG003|Part 2|Death|76|||
125303999|NCT00986362|450739628|FG001|Overall Study|Death|0|||
125304000|NCT00986362|450739627|FG000|Overall Study|Lost to Follow-up|0|||
125304001|NCT00986362|450739628|FG001|Overall Study|Lost to Follow-up|1|||
125304002|NCT00384332|450739629|FG000|Overall Study|Lost to Follow-up|4|||
125493989|NCT01574716|451441780|FG004|Part 2|Death|35|||
125493990|NCT01574716|451441776|FG000|Part 2|Discontinuation of study by sponsor|0|||
125493991|NCT01574716|451441777|FG001|Part 2|Discontinuation of study by sponsor|0|||
125493992|NCT01574716|451441778|FG002|Part 2|Discontinuation of study by sponsor|0|||
125493993|NCT01574716|451441779|FG003|Part 2|Discontinuation of study by sponsor|51|||
125493994|NCT01574716|451441780|FG004|Part 2|Discontinuation of study by sponsor|31|||
125493995|NCT01574716|451441776|FG000|Part 2|Withdrawal by Subject|0|||
125493996|NCT01574716|451441777|FG001|Part 2|Withdrawal by Subject|0|||
125493997|NCT01574716|451441778|FG002|Part 2|Withdrawal by Subject|0|||
125493998|NCT01574716|451441779|FG003|Part 2|Withdrawal by Subject|5|||
125493999|NCT01574716|451441780|FG004|Part 2|Withdrawal by Subject|4|||
125494000|NCT01574716|451441776|FG000|Part 2|Brain metastases|0|||
125304003|NCT00384332|450739630|FG001|Overall Study|Lost to Follow-up|0|||
125494001|NCT01574716|451441777|FG001|Part 2|Brain metastases|0|||
125494002|NCT01574716|451441778|FG002|Part 2|Brain metastases|0|||
125494003|NCT01574716|451441779|FG003|Part 2|Brain metastases|1|||
125494004|NCT01574716|451441780|FG004|Part 2|Brain metastases|0|||
125494005|NCT01574716|451441776|FG000|Part 2|Lost to Follow-up|0|||
125494006|NCT01574716|451441777|FG001|Part 2|Lost to Follow-up|0|||
125494007|NCT01574716|451441778|FG002|Part 2|Lost to Follow-up|0|||
125494008|NCT01574716|451441779|FG003|Part 2|Lost to Follow-up|3|||
125494009|NCT01574716|451441780|FG004|Part 2|Lost to Follow-up|0|||
125494010|NCT01637402|451441782|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
125494011|NCT01637402|451441783|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
125494012|NCT01637402|451441782|FG000|Standard Dose Regimen|Adverse Event|1|||
125494013|NCT01637402|451441783|FG001|Standard Dose Regimen|Adverse Event|0|||
125494014|NCT01637402|451441782|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
125494015|NCT01637402|451441783|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
125494016|NCT01637402|451441782|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
125304004|NCT02006979|450739631|FG000|Overall Study|Withdrawal by Subject|1|||
125304005|NCT02006979|450739632|FG001|Overall Study|Withdrawal by Subject|1|||
125304006|NCT02006979|450739631|FG000|Overall Study|Protocol Violation|0|||
125304007|NCT02006979|450739632|FG001|Overall Study|Protocol Violation|1|||
125304008|NCT03170193|450739633|FG000|Overall Study|Withdrawal by Subject|0|||
125304009|NCT03170193|450739634|FG001|Overall Study|Withdrawal by Subject|0|||
125304010|NCT03170193|450739635|FG002|Overall Study|Withdrawal by Subject|0|||
125304011|NCT03170193|450739636|FG003|Overall Study|Withdrawal by Subject|1|||
125304012|NCT03170193|450739637|FG004|Overall Study|Withdrawal by Subject|0|||
125304013|NCT03170193|450739638|FG005|Overall Study|Withdrawal by Subject|0|||
125304014|NCT03170193|450739639|FG006|Overall Study|Withdrawal by Subject|0|||
125304015|NCT03170193|450739633|FG000|Overall Study|Lost to Follow-up|1|||
125304016|NCT03170193|450739634|FG001|Overall Study|Lost to Follow-up|1|||
125304017|NCT03170193|450739635|FG002|Overall Study|Lost to Follow-up|0|||
125304018|NCT03170193|450739636|FG003|Overall Study|Lost to Follow-up|0|||
125304019|NCT03170193|450739637|FG004|Overall Study|Lost to Follow-up|0|||
125304020|NCT03170193|450739638|FG005|Overall Study|Lost to Follow-up|0|||
125304021|NCT03170193|450739639|FG006|Overall Study|Lost to Follow-up|0|||
125304022|NCT02560012|450739640|FG000|Overall Study|Study Terminated|2|||
125304023|NCT01007838|450739641|FG000|Overall Study|Withdrawal by Subject|1|||
125304024|NCT01007838|450739642|FG001|Overall Study|Withdrawal by Subject|0|||
125304025|NCT01007838|450739643|FG002|Overall Study|Withdrawal by Subject|0|||
125304026|NCT01007838|450739644|FG003|Overall Study|Withdrawal by Subject|0|||
125304027|NCT01007838|450739641|FG000|Overall Study|Physician Decision|1|||
125304028|NCT01007838|450739642|FG001|Overall Study|Physician Decision|0|||
125304029|NCT01007838|450739643|FG002|Overall Study|Physician Decision|0|||
125304030|NCT01007838|450739644|FG003|Overall Study|Physician Decision|0|||
125304031|NCT01007838|450739641|FG000|Overall Study|Started home haemodialysis|1|||
125304032|NCT01007838|450739642|FG001|Overall Study|Started home haemodialysis|0|||
125304033|NCT01007838|450739643|FG002|Overall Study|Started home haemodialysis|0|||
125304034|NCT01007838|450739644|FG003|Overall Study|Started home haemodialysis|0|||
125304035|NCT04167137|450739645|FG000|Overall Study|Disease progression|1|||
125304036|NCT04167137|450739646|FG001|Overall Study|Disease progression|1|||
125304037|NCT04167137|450739647|FG002|Overall Study|Disease progression|3|||
125304038|NCT04167137|450739648|FG003|Overall Study|Disease progression|3|||
125304039|NCT04167137|450739649|FG004|Overall Study|Disease progression|2|||
125304040|NCT04167137|450739650|FG005|Overall Study|Disease progression|3|||
125304041|NCT04167137|450739651|FG006|Overall Study|Disease progression|2|||
125304042|NCT04167137|450739652|FG007|Overall Study|Disease progression|2|||
125304043|NCT04167137|450739645|FG000|Overall Study|Withdrawal by Subject|1|||
125304044|NCT04167137|450739646|FG001|Overall Study|Withdrawal by Subject|0|||
125304045|NCT04167137|450739647|FG002|Overall Study|Withdrawal by Subject|0|||
125304046|NCT04167137|450739648|FG003|Overall Study|Withdrawal by Subject|1|||
125304047|NCT04167137|450739649|FG004|Overall Study|Withdrawal by Subject|0|||
125304048|NCT04167137|450739650|FG005|Overall Study|Withdrawal by Subject|2|||
125304049|NCT04167137|450739651|FG006|Overall Study|Withdrawal by Subject|1|||
125304050|NCT04167137|450739652|FG007|Overall Study|Withdrawal by Subject|0|||
125304051|NCT04167137|450739645|FG000|Overall Study|Adverse Event|0|||
125304052|NCT04167137|450739646|FG001|Overall Study|Adverse Event|0|||
125304053|NCT04167137|450739647|FG002|Overall Study|Adverse Event|0|||
125304054|NCT04167137|450739648|FG003|Overall Study|Adverse Event|0|||
125304055|NCT04167137|450739649|FG004|Overall Study|Adverse Event|0|||
125304056|NCT04167137|450739650|FG005|Overall Study|Adverse Event|1|||
125494017|NCT01637402|451441783|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
125304057|NCT04167137|450739651|FG006|Overall Study|Adverse Event|0|||
125304058|NCT04167137|450739652|FG007|Overall Study|Adverse Event|1|||
125304059|NCT04167137|450739645|FG000|Overall Study|Physician Decision|0|||
125304060|NCT04167137|450739646|FG001|Overall Study|Physician Decision|0|||
125304061|NCT04167137|450739647|FG002|Overall Study|Physician Decision|0|||
125304062|NCT04167137|450739648|FG003|Overall Study|Physician Decision|1|||
125304063|NCT04167137|450739649|FG004|Overall Study|Physician Decision|0|||
125304064|NCT04167137|450739650|FG005|Overall Study|Physician Decision|0|||
125494018|NCT01637402|451441782|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
125304065|NCT04167137|450739651|FG006|Overall Study|Physician Decision|1|||
125304066|NCT04167137|450739652|FG007|Overall Study|Physician Decision|0|||
125304067|NCT04167137|450739645|FG000|Overall Study|Death|0|||
125304068|NCT04167137|450739646|FG001|Overall Study|Death|1|||
125304069|NCT04167137|450739647|FG002|Overall Study|Death|0|||
125494019|NCT01637402|451441783|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
125494020|NCT01637402|451441782|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
125494021|NCT01637402|451441783|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
125494022|NCT02111096|451441784|FG000|Overall Study|Adverse Event|4|||
125494023|NCT02111096|451441785|FG001|Overall Study|Adverse Event|1|||
125494024|NCT02111096|451441786|FG002|Overall Study|Adverse Event|2|||
125494025|NCT02111096|451441784|FG000|Overall Study|Non-Compliance with Study Drug|1|||
125494026|NCT02111096|451441785|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125494027|NCT02111096|451441786|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125494028|NCT02111096|451441784|FG000|Overall Study|Lost to Follow Up|1|||
125494029|NCT02111096|451441785|FG001|Overall Study|Lost to Follow Up|1|||
125494030|NCT02111096|451441786|FG002|Overall Study|Lost to Follow Up|1|||
125494031|NCT02111096|451441784|FG000|Overall Study|Physician Decision|0|||
125494032|NCT02111096|451441785|FG001|Overall Study|Physician Decision|1|||
125494033|NCT02111096|451441786|FG002|Overall Study|Physician Decision|0|||
125494034|NCT02111096|451441784|FG000|Overall Study|Protocol Violation|1|||
125494035|NCT02111096|451441785|FG001|Overall Study|Protocol Violation|0|||
125494036|NCT02111096|451441786|FG002|Overall Study|Protocol Violation|1|||
125494037|NCT02111096|451441784|FG000|Overall Study|Terminated by Sponsor|53|||
125494038|NCT02111096|451441785|FG001|Overall Study|Terminated by Sponsor|35|||
125494039|NCT02111096|451441786|FG002|Overall Study|Terminated by Sponsor|54|||
125494040|NCT02111096|451441784|FG000|Overall Study|Withdrawal by Subject|4|||
125494041|NCT02111096|451441785|FG001|Overall Study|Withdrawal by Subject|2|||
125494042|NCT02111096|451441786|FG002|Overall Study|Withdrawal by Subject|8|||
125494043|NCT03709706|451441787|FG000|Overall Study|Adverse Event|0|||
125494044|NCT03709706|451441788|FG001|Overall Study|Adverse Event|1|||
125494045|NCT03709706|451441787|FG000|Overall Study|Physician Decision|14|||
125494046|NCT03709706|451441788|FG001|Overall Study|Physician Decision|8|||
125494047|NCT03709706|451441787|FG000|Overall Study|Withdrawal by Subject|2|||
125494048|NCT03709706|451441788|FG001|Overall Study|Withdrawal by Subject|1|||
125494049|NCT03709706|451441787|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
125494050|NCT03709706|451441788|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
125494051|NCT00609869|451441789|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
125494052|NCT00609869|451441789|FG000|Overall Study|Severe hematologic toxicity|1|||
125494053|NCT00609869|451441789|FG000|Overall Study|Withdrawal by Subject|1|||
125494054|NCT00609869|451441789|FG000|Overall Study|Seizures|1|||
125494055|NCT00609869|451441789|FG000|Overall Study|Severe tumor flare reaction|1|||
125494056|NCT00609869|451441789|FG000|Overall Study|Hepatitis B infection|1|||
125494057|NCT00609869|451441789|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
125494058|NCT00609869|451441789|FG000|Overall Study|Mantle cell: not evaluable|4|||
125494059|NCT01627561|451441790|FG000|Overall Study|Lost to Follow-up|1|||
125494060|NCT01627561|451441791|FG001|Overall Study|Lost to Follow-up|0|||
125494061|NCT01627561|451441790|FG000|Overall Study|Withdrawal by Subject|0|||
125494062|NCT01627561|451441791|FG001|Overall Study|Withdrawal by Subject|1|||
125494063|NCT01627561|451441790|FG000|Overall Study|Migrated/moved from study area|0|||
125494064|NCT01627561|451441791|FG001|Overall Study|Migrated/moved from study area|2|||
125494065|NCT00890591|451441793|FG000|Overall Study|Lack of Efficacy|20|||
125494066|NCT02797132|451441794|FG000|Part A (15 Days)|Adverse Event|1|||
125494067|NCT02797132|451441794|FG000|Part B (24 Weeks)|Adverse Event|3|||
125494068|NCT01970007|451441795|FG000|Overall Study|Death|5|||
125494069|NCT01970007|451441795|FG000|Overall Study|Withdrawal by Subject|23|||
125494070|NCT01970007|451441795|FG000|Overall Study|Lost to Follow-up|24|||
125494071|NCT01970007|451441795|FG000|Overall Study|"Other endpoint"|3|||
125494072|NCT00112359|451441799|FG000|Overall Study|Unrelated adverse event|16|||
125494073|NCT00112359|451441800|FG001|Overall Study|Unrelated adverse event|8|||
125494074|NCT00112359|451441799|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
125494075|NCT00112359|451441800|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
125494076|NCT00112359|451441799|FG000|Overall Study|Related adverse event|5|||
125494077|NCT00112359|451441800|FG001|Overall Study|Related adverse event|3|||
125494078|NCT00112359|451441799|FG000|Overall Study|Lost to Follow-up|0|||
125494079|NCT00112359|451441800|FG001|Overall Study|Lost to Follow-up|1|||
125304070|NCT04167137|450739648|FG003|Overall Study|Death|0|||
125304071|NCT04167137|450739649|FG004|Overall Study|Death|0|||
125494080|NCT00112359|451441799|FG000|Overall Study|Personal/administrative|1|||
125494081|NCT00112359|451441800|FG001|Overall Study|Personal/administrative|1|||
125494082|NCT00112359|451441799|FG000|Overall Study|Other|3|||
125494083|NCT00112359|451441800|FG001|Overall Study|Other|0|||
125494084|NCT01961609|451441801|FG000|Initiation|Missing|3|||
125494085|NCT01961609|451441802|FG001|Initiation|Missing|2|||
125494086|NCT01961609|451441803|FG002|Initiation|Missing|0|||
125494087|NCT01961609|451441804|FG003|Initiation|Missing|0|||
125494088|NCT01961609|451441801|FG000|Initiation|Protocol deviation|1|||
125494089|NCT01961609|451441802|FG001|Initiation|Protocol deviation|0|||
125494090|NCT01961609|451441803|FG002|Initiation|Protocol deviation|0|||
125494091|NCT01961609|451441804|FG003|Initiation|Protocol deviation|0|||
125494092|NCT01961609|451441801|FG000|Initiation|Death|0|||
125494093|NCT01961609|451441802|FG001|Initiation|Death|1|||
125494094|NCT01961609|451441803|FG002|Initiation|Death|0|||
125420837|NCT01260350|451166154|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420838|NCT01260350|451166155|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420839|NCT01260350|451166156|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420840|NCT01260350|451166157|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420841|NCT01260350|451166158|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420842|NCT01260350|451166159|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420843|NCT01260350|451166160|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420844|NCT01260350|451166161|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420845|NCT01260350|451166162|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420846|NCT01260350|451166163|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420847|NCT01260350|451166164|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420848|NCT01260350|451166165|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
125420849|NCT04402866|451166166|FG000|Overall Study|Discontinued Prior to Treatment|0|||
125420850|NCT04402866|451166167|FG001|Overall Study|Discontinued Prior to Treatment|0|||
125420851|NCT04402866|451166168|FG002|Overall Study|Discontinued Prior to Treatment|0|||
125420852|NCT04402866|451166169|FG003|Overall Study|Discontinued Prior to Treatment|0|||
125420853|NCT04402866|451166170|FG004|Overall Study|Discontinued Prior to Treatment|2|||
125420854|NCT04402866|451166171|FG005|Overall Study|Discontinued Prior to Treatment|3|||
125420855|NCT04402866|451166166|FG000|Overall Study|Adverse Event|2|||
125420856|NCT04402866|451166167|FG001|Overall Study|Adverse Event|1|||
125420857|NCT04402866|451166168|FG002|Overall Study|Adverse Event|0|||
125420858|NCT04402866|451166169|FG003|Overall Study|Adverse Event|0|||
125420859|NCT04402866|451166170|FG004|Overall Study|Adverse Event|13|||
125420860|NCT04402866|451166171|FG005|Overall Study|Adverse Event|8|||
125420861|NCT04402866|451166166|FG000|Overall Study|Miscellaneous|0|||
125420862|NCT04402866|451166167|FG001|Overall Study|Miscellaneous|0|||
125420863|NCT04402866|451166168|FG002|Overall Study|Miscellaneous|1|||
125420864|NCT04402866|451166169|FG003|Overall Study|Miscellaneous|0|||
125420865|NCT04402866|451166170|FG004|Overall Study|Miscellaneous|0|||
125420866|NCT04402866|451166171|FG005|Overall Study|Miscellaneous|0|||
125420867|NCT04402866|451166166|FG000|Overall Study|Lost to Follow-up|0|||
125420868|NCT04402866|451166167|FG001|Overall Study|Lost to Follow-up|0|||
125420869|NCT04402866|451166168|FG002|Overall Study|Lost to Follow-up|0|||
125420870|NCT04402866|451166169|FG003|Overall Study|Lost to Follow-up|0|||
125420871|NCT04402866|451166170|FG004|Overall Study|Lost to Follow-up|0|||
125420872|NCT04402866|451166171|FG005|Overall Study|Lost to Follow-up|1|||
125420873|NCT04402866|451166166|FG000|Overall Study|Withdrawal by Subject|0|||
125420874|NCT04402866|451166167|FG001|Overall Study|Withdrawal by Subject|0|||
125420875|NCT04402866|451166168|FG002|Overall Study|Withdrawal by Subject|0|||
125420876|NCT04402866|451166169|FG003|Overall Study|Withdrawal by Subject|0|||
125420877|NCT04402866|451166170|FG004|Overall Study|Withdrawal by Subject|0|||
125420878|NCT04402866|451166171|FG005|Overall Study|Withdrawal by Subject|2|||
125420879|NCT01814371|451166172|FG000|Overall Study|Lost to Follow-up|30|||
125420880|NCT01814371|451166173|FG001|Overall Study|Lost to Follow-up|27|||
125420881|NCT02794285|451166174|FG000|Overall Study|Adverse Event|11|||
125420882|NCT02794285|451166175|FG001|Overall Study|Adverse Event|4|||
125420883|NCT02794285|451166176|FG002|Overall Study|Adverse Event|5|||
125420884|NCT02794285|451166177|FG003|Overall Study|Adverse Event|8|||
125420885|NCT02794285|451166174|FG000|Overall Study|Condition Under Investigation Improved|1|||
125420886|NCT02794285|451166175|FG001|Overall Study|Condition Under Investigation Improved|0|||
125420887|NCT02794285|451166176|FG002|Overall Study|Condition Under Investigation Improved|0|||
125420888|NCT02794285|451166177|FG003|Overall Study|Condition Under Investigation Improved|0|||
125420889|NCT02794285|451166174|FG000|Overall Study|Condition Under Investigation Worsened|0|||
125420890|NCT02794285|451166175|FG001|Overall Study|Condition Under Investigation Worsened|2|||
125420891|NCT02794285|451166176|FG002|Overall Study|Condition Under Investigation Worsened|1|||
125420892|NCT02794285|451166177|FG003|Overall Study|Condition Under Investigation Worsened|0|||
125420893|NCT02794285|451166174|FG000|Overall Study|Death|2|||
125420894|NCT02794285|451166175|FG001|Overall Study|Death|1|||
125420895|NCT02794285|451166176|FG002|Overall Study|Death|2|||
125420896|NCT02794285|451166177|FG003|Overall Study|Death|0|||
125420897|NCT02794285|451166174|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
125420898|NCT02794285|451166175|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
125420899|NCT02794285|451166176|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
125420900|NCT02794285|451166177|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
125420901|NCT02794285|451166174|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
125420902|NCT02794285|451166175|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
125420903|NCT02794285|451166176|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
125420904|NCT02794285|451166177|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
125420905|NCT02794285|451166174|FG000|Overall Study|Lack of Efficacy|10|||
125420906|NCT02794285|451166175|FG001|Overall Study|Lack of Efficacy|6|||
125420907|NCT02794285|451166176|FG002|Overall Study|Lack of Efficacy|3|||
125420908|NCT02794285|451166177|FG003|Overall Study|Lack of Efficacy|3|||
125420909|NCT02794285|451166174|FG000|Overall Study|Lost to Follow-up|5|||
125420910|NCT02794285|451166175|FG001|Overall Study|Lost to Follow-up|6|||
125494095|NCT01961609|451441804|FG003|Initiation|Death|0|||
125494096|NCT01961609|451441801|FG000|Initiation|Administrative problems|1|||
125494097|NCT01961609|451441802|FG001|Initiation|Administrative problems|0|||
125494098|NCT01961609|451441803|FG002|Initiation|Administrative problems|0|||
125494099|NCT01961609|451441804|FG003|Initiation|Administrative problems|0|||
125494100|NCT01961609|451441801|FG000|Initiation|Withdrawal by Subject|1|||
125494101|NCT01961609|451441802|FG001|Initiation|Withdrawal by Subject|2|||
125494102|NCT01961609|451441803|FG002|Initiation|Withdrawal by Subject|0|||
125494103|NCT01961609|451441804|FG003|Initiation|Withdrawal by Subject|0|||
125494104|NCT01961609|451441801|FG000|Initiation|Lack of Efficacy|2|||
125494105|NCT01961609|451441802|FG001|Initiation|Lack of Efficacy|1|||
125494106|NCT01961609|451441803|FG002|Initiation|Lack of Efficacy|0|||
125494107|NCT01961609|451441804|FG003|Initiation|Lack of Efficacy|0|||
125494108|NCT01961609|451441801|FG000|Initiation|Abnormal lab values|0|||
125494109|NCT01961609|451441802|FG001|Initiation|Abnormal lab values|1|||
125494110|NCT01961609|451441803|FG002|Initiation|Abnormal lab values|0|||
125494111|NCT01961609|451441804|FG003|Initiation|Abnormal lab values|0|||
125494112|NCT01961609|451441801|FG000|Initiation|Adverse Event|3|||
125494113|NCT01961609|451441802|FG001|Initiation|Adverse Event|5|||
125494114|NCT01961609|451441803|FG002|Initiation|Adverse Event|0|||
125494115|NCT01961609|451441804|FG003|Initiation|Adverse Event|0|||
125494116|NCT01961609|451441801|FG000|Initiation|Randomized but not treated|1|||
125494117|NCT01961609|451441802|FG001|Initiation|Randomized but not treated|1|||
125494118|NCT01961609|451441803|FG002|Initiation|Randomized but not treated|0|||
125494119|NCT01961609|451441804|FG003|Initiation|Randomized but not treated|0|||
125494120|NCT01961609|451441801|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
125494121|NCT01961609|451441802|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
125494122|NCT01961609|451441803|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
125494123|NCT01961609|451441804|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
125494124|NCT01961609|451441801|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
125494125|NCT01961609|451441802|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
125494126|NCT01961609|451441803|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
125494127|NCT01961609|451441804|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
125494128|NCT01961609|451441801|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
125494129|NCT01961609|451441802|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
125494130|NCT01961609|451441803|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
125494131|NCT01961609|451441804|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
125494132|NCT01961609|451441801|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
125494133|NCT01961609|451441802|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
125494134|NCT01961609|451441803|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
125494135|NCT01961609|451441804|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
125494136|NCT01961609|451441801|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
125494137|NCT01961609|451441802|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
125494138|NCT01961609|451441803|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
125494139|NCT01961609|451441804|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
125494140|NCT01961609|451441801|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
125494141|NCT01961609|451441802|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
125494142|NCT01961609|451441803|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
125494143|NCT01961609|451441804|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
125494144|NCT01961609|451441801|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
125494145|NCT01961609|451441802|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
125494146|NCT01961609|451441803|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
125494147|NCT01961609|451441804|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
125494148|NCT01961609|451441801|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
125494149|NCT01961609|451441802|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
125494150|NCT01961609|451441803|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
125494151|NCT01961609|451441804|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
125494152|NCT01961609|451441801|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
125494153|NCT01961609|451441802|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
125494154|NCT01961609|451441803|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
125494155|NCT01961609|451441804|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
125494156|NCT01961609|451441801|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
125494157|NCT01961609|451441802|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
125494158|NCT01961609|451441803|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
125494159|NCT01961609|451441804|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
125494160|NCT01961609|451441801|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
125494161|NCT01961609|451441802|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
125494162|NCT01961609|451441803|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
125494163|NCT01961609|451441804|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
125494164|NCT01961609|451441801|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
125494165|NCT01961609|451441802|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
125494166|NCT01961609|451441803|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
125494167|NCT01961609|451441804|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
125494168|NCT01988402|451441805|FG000|Overall Study|Adverse Event|1|||
125494169|NCT01988402|451441806|FG001|Overall Study|Adverse Event|2|||
125494170|NCT01988402|451441805|FG000|Overall Study|Withdrawal by Subject|1|||
125494171|NCT01988402|451441806|FG001|Overall Study|Withdrawal by Subject|0|||
125494172|NCT00582972|451441808|FG000|Overall Study|Protocol Violation|2|||
125494173|NCT01566890|451441811|FG000|Overall Study|Adverse Event|1|||
125494174|NCT01566890|451441812|FG001|Overall Study|Adverse Event|0|||
125494175|NCT01566890|451441813|FG002|Overall Study|Adverse Event|0|||
125494176|NCT01566890|451441814|FG003|Overall Study|Adverse Event|0|||
125494177|NCT01566890|451441815|FG004|Overall Study|Adverse Event|0|||
125494178|NCT01566890|451441811|FG000|Overall Study|Withdrawal by Subject|3|||
125494179|NCT01566890|451441812|FG001|Overall Study|Withdrawal by Subject|1|||
125494180|NCT01566890|451441813|FG002|Overall Study|Withdrawal by Subject|1|||
125494181|NCT01566890|451441814|FG003|Overall Study|Withdrawal by Subject|1|||
125494182|NCT01566890|451441815|FG004|Overall Study|Withdrawal by Subject|0|||
125494183|NCT01566890|451441811|FG000|Overall Study|Screen failure|6|||
125494184|NCT01566890|451441812|FG001|Overall Study|Screen failure|0|||
125494185|NCT01566890|451441813|FG002|Overall Study|Screen failure|1|||
125494186|NCT01566890|451441814|FG003|Overall Study|Screen failure|1|||
125494187|NCT01566890|451441815|FG004|Overall Study|Screen failure|0|||
125494188|NCT01566890|451441811|FG000|Overall Study|Incomplete CEU data|1|||
125494189|NCT01566890|451441812|FG001|Overall Study|Incomplete CEU data|3|||
125494190|NCT01566890|451441813|FG002|Overall Study|Incomplete CEU data|5|||
125494191|NCT01566890|451441814|FG003|Overall Study|Incomplete CEU data|8|||
125494192|NCT01566890|451441815|FG004|Overall Study|Incomplete CEU data|0|||
125494193|NCT01566890|451441811|FG000|Overall Study|Lost to Follow-up|0|||
125494194|NCT01566890|451441812|FG001|Overall Study|Lost to Follow-up|0|||
125494195|NCT01566890|451441813|FG002|Overall Study|Lost to Follow-up|4|||
125494196|NCT01566890|451441814|FG003|Overall Study|Lost to Follow-up|4|||
125494197|NCT01566890|451441815|FG004|Overall Study|Lost to Follow-up|0|||
125494198|NCT01566890|451441811|FG000|Overall Study|Other|0|||
125494199|NCT01566890|451441812|FG001|Overall Study|Other|0|||
125494200|NCT01566890|451441813|FG002|Overall Study|Other|0|||
125494201|NCT01566890|451441814|FG003|Overall Study|Other|0|||
125494202|NCT01566890|451441815|FG004|Overall Study|Other|7|||
125494203|NCT01211184|451441825|FG000|Overall Study|Withdrawal by Subject|0|||
125494204|NCT01211184|451441826|FG001|Overall Study|Withdrawal by Subject|2|||
125494205|NCT01211184|451441827|FG002|Overall Study|Withdrawal by Subject|1|||
125494206|NCT00822120|451441828|FG000|Initial Registration|Adverse Event|1|||
125494207|NCT00822120|451441829|FG001|Initial Registration|Adverse Event|0|||
125494208|NCT00822120|451441830|FG002|Initial Registration|Adverse Event|0|||
125494209|NCT00822120|451441831|FG003|Initial Registration|Adverse Event|0|||
125494210|NCT00822120|451441832|FG004|Initial Registration|Adverse Event|0|||
125494211|NCT00822120|451441833|FG005|Initial Registration|Adverse Event|0|||
125494212|NCT00822120|451441828|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
125494213|NCT00822120|451441829|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
125494214|NCT00822120|451441830|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
125494215|NCT00822120|451441831|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
125494216|NCT00822120|451441832|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
125494217|NCT00822120|451441833|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
125494218|NCT00822120|451441828|FG000|Initial Registration|Reasons not Protocol Specified|2|||
125494219|NCT00822120|451441829|FG001|Initial Registration|Reasons not Protocol Specified|0|||
125494220|NCT00822120|451441830|FG002|Initial Registration|Reasons not Protocol Specified|0|||
125494221|NCT00822120|451441831|FG003|Initial Registration|Reasons not Protocol Specified|0|||
125494222|NCT00822120|451441832|FG004|Initial Registration|Reasons not Protocol Specified|0|||
125304072|NCT04167137|450739650|FG005|Overall Study|Death|0|||
125494223|NCT00822120|451441833|FG005|Initial Registration|Reasons not Protocol Specified|0|||
125494224|NCT00822120|451441828|FG000|Initial Registration|Ineligible|22|||
125494225|NCT00822120|451441829|FG001|Initial Registration|Ineligible|1|||
125494226|NCT00822120|451441830|FG002|Initial Registration|Ineligible|0|||
125494227|NCT00822120|451441831|FG003|Initial Registration|Ineligible|0|||
125494228|NCT00822120|451441832|FG004|Initial Registration|Ineligible|0|||
125494229|NCT00822120|451441833|FG005|Initial Registration|Ineligible|0|||
125494230|NCT00822120|451441828|FG000|PET-directed Therapy|Adverse Event|0|||
125494231|NCT00822120|451441829|FG001|PET-directed Therapy|Adverse Event|0|||
125494232|NCT00822120|451441830|FG002|PET-directed Therapy|Adverse Event|0|||
125494233|NCT00822120|451441831|FG003|PET-directed Therapy|Adverse Event|1|||
125494234|NCT00822120|451441832|FG004|PET-directed Therapy|Adverse Event|0|||
125494235|NCT00822120|451441833|FG005|PET-directed Therapy|Adverse Event|0|||
125494236|NCT00822120|451441828|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
125494237|NCT00822120|451441829|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
125494238|NCT00822120|451441830|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
125494239|NCT00822120|451441831|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
125304073|NCT04167137|450739651|FG006|Overall Study|Death|0|||
125494240|NCT00822120|451441832|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
125494241|NCT00822120|451441833|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
125494242|NCT00822120|451441828|FG000|PET-directed Therapy|Death|0|||
125494243|NCT00822120|451441829|FG001|PET-directed Therapy|Death|0|||
125494244|NCT00822120|451441830|FG002|PET-directed Therapy|Death|0|||
125494245|NCT00822120|451441831|FG003|PET-directed Therapy|Death|2|||
125494246|NCT00822120|451441832|FG004|PET-directed Therapy|Death|0|||
125494247|NCT00822120|451441833|FG005|PET-directed Therapy|Death|0|||
125494248|NCT00822120|451441828|FG000|PET-directed Therapy|Protocol Violation|0|||
125494249|NCT00822120|451441829|FG001|PET-directed Therapy|Protocol Violation|0|||
125494250|NCT00822120|451441830|FG002|PET-directed Therapy|Protocol Violation|0|||
125494251|NCT00822120|451441831|FG003|PET-directed Therapy|Protocol Violation|6|||
125494252|NCT00822120|451441832|FG004|PET-directed Therapy|Protocol Violation|0|||
125494253|NCT00822120|451441833|FG005|PET-directed Therapy|Protocol Violation|0|||
125494254|NCT01324310|451441834|FG000|Overall Study|Adverse Event|1|||
125494255|NCT01324310|451441834|FG000|Overall Study|Disease Progression|1|||
125494256|NCT04060212|451441836|FG000|Overall Study|Withdrawal by Subject|7|||
125494257|NCT02787005|451441857|FG000|Overall Study|Adverse Event|24|||
125494258|NCT02787005|451441858|FG001|Overall Study|Adverse Event|9|||
125494259|NCT02787005|451441859|FG002|Overall Study|Adverse Event|9|||
125494260|NCT02787005|451441860|FG003|Overall Study|Adverse Event|7|||
125494261|NCT02787005|451441861|FG004|Overall Study|Adverse Event|2|||
125494262|NCT02787005|451441857|FG000|Overall Study|Death|100|||
125494263|NCT02787005|451441858|FG001|Overall Study|Death|53|||
125494264|NCT02787005|451441859|FG002|Overall Study|Death|48|||
125494265|NCT02787005|451441860|FG003|Overall Study|Death|69|||
125494266|NCT02787005|451441861|FG004|Overall Study|Death|38|||
125494267|NCT02787005|451441857|FG000|Overall Study|Sponsor Decision|7|||
125494268|NCT02787005|451441858|FG001|Overall Study|Sponsor Decision|4|||
125494269|NCT02787005|451441859|FG002|Overall Study|Sponsor Decision|0|||
125494270|NCT02787005|451441860|FG003|Overall Study|Sponsor Decision|4|||
125494271|NCT02787005|451441861|FG004|Overall Study|Sponsor Decision|5|||
125494272|NCT02787005|451441857|FG000|Overall Study|Withdrawal by Subject|2|||
125494273|NCT02787005|451441858|FG001|Overall Study|Withdrawal by Subject|1|||
125494274|NCT02787005|451441859|FG002|Overall Study|Withdrawal by Subject|1|||
125494275|NCT02787005|451441860|FG003|Overall Study|Withdrawal by Subject|0|||
125494276|NCT02787005|451441861|FG004|Overall Study|Withdrawal by Subject|1|||
125494277|NCT02787005|451441857|FG000|Overall Study|Screen Failure|0|||
125494278|NCT02787005|451441858|FG001|Overall Study|Screen Failure|2|||
125494279|NCT02787005|451441859|FG002|Overall Study|Screen Failure|0|||
125494280|NCT02787005|451441860|FG003|Overall Study|Screen Failure|0|||
125494281|NCT02787005|451441861|FG004|Overall Study|Screen Failure|1|||
125494282|NCT02787005|451441857|FG000|Overall Study|Lost to Follow-up|0|||
125494283|NCT02787005|451441858|FG001|Overall Study|Lost to Follow-up|0|||
125494284|NCT02787005|451441859|FG002|Overall Study|Lost to Follow-up|0|||
125494285|NCT02787005|451441860|FG003|Overall Study|Lost to Follow-up|1|||
125494286|NCT02787005|451441861|FG004|Overall Study|Lost to Follow-up|0|||
125494287|NCT02016872|451441865|FG000|Overall Study|Withdrawal by Subject|10|||
125494288|NCT02016872|451441865|FG000|Overall Study|Death Progression|2|||
125494289|NCT02016872|451441865|FG000|Overall Study|No FMISO scan|1|||
125494290|NCT02016872|451441865|FG000|Overall Study|Ineligible|2|||
125494291|NCT03477175|451441868|FG000|Overall Study|Unable to travel due to COVID-19|0|||
125494292|NCT03477175|451441869|FG001|Overall Study|Unable to travel due to COVID-19|1|||
125494293|NCT03477175|451441868|FG000|Overall Study|Physician Decision|1|||
125494294|NCT03477175|451441869|FG001|Overall Study|Physician Decision|0|||
125494295|NCT03477175|451441868|FG000|Overall Study|Transitioned to commercial drug|6|||
125494296|NCT03477175|451441869|FG001|Overall Study|Transitioned to commercial drug|6|||
125494297|NCT03477175|451441868|FG000|Overall Study|Lost to Follow-up|1|||
125494298|NCT03477175|451441869|FG001|Overall Study|Lost to Follow-up|1|||
125494299|NCT03477175|451441868|FG000|Overall Study|Withdrawal by Subject|3|||
125494300|NCT03477175|451441869|FG001|Overall Study|Withdrawal by Subject|1|||
125494301|NCT03477175|451441868|FG000|Overall Study|Adverse Event|1|||
125494302|NCT03477175|451441869|FG001|Overall Study|Adverse Event|5|||
125494303|NCT03477175|451441868|FG000|Overall Study|Disease Progression|7|||
125494304|NCT03477175|451441869|FG001|Overall Study|Disease Progression|7|||
125494305|NCT03593226|451441870|FG000|Overall Study|Disease progression|6|||
125494306|NCT03593226|451441871|FG001|Overall Study|Disease progression|13|||
125494307|NCT03593226|451441872|FG002|Overall Study|Disease progression|5|||
125494308|NCT03593226|451441873|FG003|Overall Study|Disease progression|6|||
125494309|NCT03593226|451441870|FG000|Overall Study|Adverse Event|0|||
125494310|NCT03593226|451441871|FG001|Overall Study|Adverse Event|1|||
125494311|NCT03593226|451441872|FG002|Overall Study|Adverse Event|0|||
125494312|NCT03593226|451441873|FG003|Overall Study|Adverse Event|0|||
125494313|NCT03593226|451441870|FG000|Overall Study|Withdrawal by Subject|0|||
125494314|NCT03593226|451441871|FG001|Overall Study|Withdrawal by Subject|4|||
125494315|NCT03593226|451441872|FG002|Overall Study|Withdrawal by Subject|1|||
125494316|NCT03593226|451441873|FG003|Overall Study|Withdrawal by Subject|0|||
125494317|NCT03593226|451441870|FG000|Overall Study|Physician Decision|0|||
125494318|NCT03593226|451441871|FG001|Overall Study|Physician Decision|1|||
125494319|NCT03593226|451441872|FG002|Overall Study|Physician Decision|0|||
125494320|NCT03593226|451441873|FG003|Overall Study|Physician Decision|0|||
125494321|NCT03593226|451441870|FG000|Overall Study|Clinical disease progression|0|||
125494322|NCT03593226|451441871|FG001|Overall Study|Clinical disease progression|0|||
125494323|NCT03593226|451441872|FG002|Overall Study|Clinical disease progression|1|||
125494324|NCT03593226|451441873|FG003|Overall Study|Clinical disease progression|0|||
125494325|NCT00545545|451441874|FG000|Overall Study|Progressive Neoplastic Disease|1|||
125494326|NCT00545545|451441875|FG001|Overall Study|Progressive Neoplastic Disease|5|||
125494327|NCT00545545|451441876|FG002|Overall Study|Progressive Neoplastic Disease|0|||
125494328|NCT00545545|451441877|FG003|Overall Study|Progressive Neoplastic Disease|4|||
125494329|NCT00545545|451441878|FG004|Overall Study|Progressive Neoplastic Disease|8|||
125494330|NCT00545545|451441879|FG005|Overall Study|Progressive Neoplastic Disease|7|||
125494331|NCT00545545|451441874|FG000|Overall Study|Withdrawal by Subject|0|||
125494332|NCT00545545|451441875|FG001|Overall Study|Withdrawal by Subject|1|||
125494333|NCT00545545|451441876|FG002|Overall Study|Withdrawal by Subject|0|||
125494334|NCT00545545|451441877|FG003|Overall Study|Withdrawal by Subject|0|||
125494335|NCT00545545|451441878|FG004|Overall Study|Withdrawal by Subject|0|||
125494336|NCT00545545|451441879|FG005|Overall Study|Withdrawal by Subject|0|||
125494337|NCT00545545|451441874|FG000|Overall Study|Physician Decision|1|||
125494338|NCT00545545|451441875|FG001|Overall Study|Physician Decision|0|||
125494339|NCT00545545|451441876|FG002|Overall Study|Physician Decision|0|||
125494340|NCT00545545|451441877|FG003|Overall Study|Physician Decision|0|||
125494341|NCT00545545|451441878|FG004|Overall Study|Physician Decision|0|||
125494342|NCT00545545|451441879|FG005|Overall Study|Physician Decision|1|||
125494343|NCT00545545|451441874|FG000|Overall Study|Irinotecan intolerance|1|||
125494344|NCT00545545|451441875|FG001|Overall Study|Irinotecan intolerance|1|||
125494345|NCT00545545|451441876|FG002|Overall Study|Irinotecan intolerance|0|||
125494346|NCT00545545|451441877|FG003|Overall Study|Irinotecan intolerance|0|||
125494347|NCT00545545|451441878|FG004|Overall Study|Irinotecan intolerance|0|||
125494348|NCT00545545|451441879|FG005|Overall Study|Irinotecan intolerance|0|||
125494349|NCT00545545|451441874|FG000|Overall Study|No target lesions to track post surgery|0|||
125494350|NCT00545545|451441875|FG001|Overall Study|No target lesions to track post surgery|0|||
125494351|NCT00545545|451441876|FG002|Overall Study|No target lesions to track post surgery|0|||
125494352|NCT00545545|451441877|FG003|Overall Study|No target lesions to track post surgery|0|||
125494353|NCT00545545|451441878|FG004|Overall Study|No target lesions to track post surgery|1|||
125494354|NCT00545545|451441879|FG005|Overall Study|No target lesions to track post surgery|1|||
125494355|NCT03978637|451441892|FG000|Overall Study|Death|0|||
125494356|NCT03978637|451441893|FG001|Overall Study|Death|2|||
125494357|NCT03978637|451441894|FG002|Overall Study|Death|2|||
125494358|NCT03978637|451441895|FG003|Overall Study|Death|0|||
125494359|NCT03978637|451441892|FG000|Overall Study|Withdrawal by Subject|0|||
125494360|NCT03978637|451441893|FG001|Overall Study|Withdrawal by Subject|0|||
125494361|NCT03978637|451441894|FG002|Overall Study|Withdrawal by Subject|1|||
125494362|NCT03978637|451441895|FG003|Overall Study|Withdrawal by Subject|0|||
125494363|NCT03978637|451441892|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
125494364|NCT03978637|451441893|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
125494365|NCT03978637|451441894|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
125494366|NCT03978637|451441895|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
125494367|NCT02549352|451441896|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
125494368|NCT02549352|451441897|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
125494369|NCT02549352|451441896|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
125494370|NCT02549352|451441897|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
125494371|NCT02549352|451441896|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
125494372|NCT02549352|451441897|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
125494373|NCT02549352|451441896|FG000|12-month Follow-up|Withdrawal by Subject|4|||
125494374|NCT02549352|451441897|FG001|12-month Follow-up|Withdrawal by Subject|5|||
125494375|NCT02549352|451441896|FG000|12-month Follow-up|Lost to Follow-up|3|||
125494376|NCT02549352|451441897|FG001|12-month Follow-up|Lost to Follow-up|2|||
125494377|NCT02549352|451441896|FG000|12-month Follow-up|Death|0|||
125494378|NCT02549352|451441897|FG001|12-month Follow-up|Death|1|||
125494379|NCT02549352|451441896|FG000|12-month Follow-up|Protocol Violation|0|||
125494380|NCT02549352|451441897|FG001|12-month Follow-up|Protocol Violation|1|||
125494381|NCT02549352|451441896|FG000|12-month Follow-up|Other|1|||
125494382|NCT02549352|451441897|FG001|12-month Follow-up|Other|3|||
125494383|NCT00692913|451443132|FG000|Overall Study|Adverse Event|8|||
125494384|NCT00692913|451443133|FG001|Overall Study|Adverse Event|4|||
125304074|NCT04167137|450739652|FG007|Overall Study|Death|0|||
125304075|NCT04167137|450739645|FG000|Overall Study|Study terminated by Sponsor|0|||
125304076|NCT04167137|450739646|FG001|Overall Study|Study terminated by Sponsor|0|||
125494385|NCT00692913|451443132|FG000|Overall Study|Lost to Follow-up|3|||
125494386|NCT00692913|451443133|FG001|Overall Study|Lost to Follow-up|5|||
125304077|NCT04167137|450739647|FG002|Overall Study|Study terminated by Sponsor|0|||
125304078|NCT04167137|450739648|FG003|Overall Study|Study terminated by Sponsor|0|||
125494387|NCT00692913|451443132|FG000|Overall Study|Physician Decision|2|||
125494388|NCT00692913|451443133|FG001|Overall Study|Physician Decision|0|||
125494389|NCT00692913|451443132|FG000|Overall Study|Protocol Violation|1|||
125494390|NCT00692913|451443133|FG001|Overall Study|Protocol Violation|1|||
125494391|NCT00692913|451443132|FG000|Overall Study|Withdrawal by Subject|15|||
125494392|NCT00692913|451443133|FG001|Overall Study|Withdrawal by Subject|20|||
125494393|NCT03801148|451443134|FG000|Period 1 (2 Days)|Adverse Event|1|||
125494394|NCT03801148|451443135|FG001|Period 1 (2 Days)|Adverse Event|1|||
125494395|NCT03801148|451443136|FG002|Period 1 (2 Days)|Adverse Event|0|||
125494396|NCT03801148|451443137|FG003|Period 1 (2 Days)|Adverse Event|0|||
125494397|NCT03801148|451443134|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
125494398|NCT03801148|451443135|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
125494399|NCT03801148|451443136|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
125494400|NCT03801148|451443137|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
125494401|NCT03801148|451443134|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125494402|NCT03801148|451443135|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125494403|NCT03801148|451443136|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
125494404|NCT03801148|451443137|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
125494405|NCT03801148|451443134|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
125494406|NCT03801148|451443135|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
125494407|NCT03801148|451443136|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
125494408|NCT03801148|451443137|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
125494409|NCT01268306|451443138|FG000|Overall Study|Lost to Follow-up|1|||
125494410|NCT04334317|451443139|FG000|Overall Study|Adverse Event|1|||
125494411|NCT04334317|451443140|FG001|Overall Study|Adverse Event|2|||
125494412|NCT04334317|451443141|FG002|Overall Study|Adverse Event|0|||
125494413|NCT04334317|451443142|FG003|Overall Study|Adverse Event|0|||
125494414|NCT04334317|451443139|FG000|Overall Study|Protocol Deviation|0|||
125494415|NCT04334317|451443140|FG001|Overall Study|Protocol Deviation|1|||
125494416|NCT04334317|451443141|FG002|Overall Study|Protocol Deviation|0|||
125494417|NCT04334317|451443142|FG003|Overall Study|Protocol Deviation|0|||
125494418|NCT04334317|451443139|FG000|Overall Study|Withdrawal by Subject|2|||
125494419|NCT04334317|451443140|FG001|Overall Study|Withdrawal by Subject|2|||
125494420|NCT04334317|451443141|FG002|Overall Study|Withdrawal by Subject|0|||
125494421|NCT04334317|451443142|FG003|Overall Study|Withdrawal by Subject|0|||
125494422|NCT03621735|451443143|FG000|Overall Study|Withdrawal by Subject|13|||
125494423|NCT03621735|451443144|FG001|Overall Study|Withdrawal by Subject|13|||
125494424|NCT01128595|451443147|FG000|Treatment Period 3|Withdrawal by Subject|0|||
125494425|NCT01128595|451443148|FG001|Treatment Period 3|Withdrawal by Subject|1|||
125494426|NCT01128595|451443149|FG002|Treatment Period 3|Withdrawal by Subject|0|||
125494427|NCT01128595|451443150|FG003|Treatment Period 3|Withdrawal by Subject|0|||
125494428|NCT00605306|451443151|FG000|Overall Study|Adverse Event|0|||
125494429|NCT00605306|451443152|FG001|Overall Study|Adverse Event|1|||
125494430|NCT00372775|451443153|FG000|Overall Study|Adverse Event|8|||
125494431|NCT00372775|451443153|FG000|Overall Study|Death|15|||
125494432|NCT00372775|451443153|FG000|Overall Study|Objective progression or relapse|30|||
125494433|NCT00372775|451443153|FG000|Overall Study|Global deterioration of health status|6|||
125494434|NCT00372775|451443153|FG000|Overall Study|Withdrawal by Subject|1|||
125494435|NCT00372775|451443153|FG000|Overall Study|Other|1|||
125494436|NCT00372775|451443153|FG000|Overall Study|Not Treated|2|||
125494437|NCT00336505|451443159|FG000|Overall Study|Adverse Event|10|||
125494438|NCT00336505|451443160|FG001|Overall Study|Adverse Event|9|||
125494439|NCT00336505|451443159|FG000|Overall Study|Lack of Efficacy|8|||
125494440|NCT00336505|451443160|FG001|Overall Study|Lack of Efficacy|4|||
125494441|NCT00336505|451443159|FG000|Overall Study|Lost to Follow-up|7|||
125494442|NCT00336505|451443160|FG001|Overall Study|Lost to Follow-up|4|||
125494443|NCT00336505|451443159|FG000|Overall Study|Withdrawal by Subject|5|||
125494444|NCT00336505|451443160|FG001|Overall Study|Withdrawal by Subject|3|||
125494445|NCT00336505|451443159|FG000|Overall Study|Other|7|||
125494446|NCT00336505|451443160|FG001|Overall Study|Other|7|||
125494447|NCT01561300|451443161|FG000|Run in on Placebo|Adverse Event|1|||
125494448|NCT01561300|451443162|FG001|Run in on Placebo|Adverse Event|0|||
125494449|NCT00724126|451443165|FG000|Overall Study|Adverse Event|2|||
125494450|NCT00724126|451443166|FG001|Overall Study|Adverse Event|0|||
125494451|NCT00724126|451443165|FG000|Overall Study|Withdrawal by Subject|8|||
125494452|NCT00724126|451443166|FG001|Overall Study|Withdrawal by Subject|6|||
125494453|NCT00724126|451443165|FG000|Overall Study|Lost to Follow-up|6|||
125494454|NCT00724126|451443166|FG001|Overall Study|Lost to Follow-up|6|||
125494455|NCT00724126|451443165|FG000|Overall Study|Noncompliance|2|||
125494456|NCT00724126|451443166|FG001|Overall Study|Noncompliance|1|||
125494457|NCT00724126|451443165|FG000|Overall Study|Subject randomized although ineligible|1|||
125494458|NCT00724126|451443166|FG001|Overall Study|Subject randomized although ineligible|1|||
125494459|NCT00724126|451443165|FG000|Overall Study|Subject had to leave vicinity of site|0|||
125494460|NCT00724126|451443166|FG001|Overall Study|Subject had to leave vicinity of site|1|||
125494461|NCT02502526|451443168|FG000|Overall Study|Lost to Follow-up|2|||
125494462|NCT02502526|451443169|FG001|Overall Study|Lost to Follow-up|2|||
125494463|NCT02502526|451443170|FG002|Overall Study|Lost to Follow-up|3|||
125494464|NCT02502526|451443168|FG000|Overall Study|Withdrawal by Subject|0|||
125494465|NCT02502526|451443169|FG001|Overall Study|Withdrawal by Subject|1|||
125494466|NCT02502526|451443170|FG002|Overall Study|Withdrawal by Subject|1|||
125494467|NCT02502526|451443168|FG000|Overall Study|Disqualified due to cataract grading|0|||
125494468|NCT02502526|451443169|FG001|Overall Study|Disqualified due to cataract grading|0|||
125494469|NCT02502526|451443170|FG002|Overall Study|Disqualified due to cataract grading|1|||
125494470|NCT02502526|451443168|FG000|Overall Study|Enrollment suspension|4|||
125494471|NCT02502526|451443169|FG001|Overall Study|Enrollment suspension|1|||
125494472|NCT02502526|451443170|FG002|Overall Study|Enrollment suspension|1|||
125494473|NCT01952366|451443171|FG000|Overall Study|Death|22|||
125494474|NCT01952366|451443171|FG000|Overall Study|Withdrawal by Subject|9|||
125494475|NCT00571649|451443172|FG000|Treatment Period|Adverse Event|438|||
125494476|NCT00571649|451443173|FG001|Treatment Period|Adverse Event|385|||
125494477|NCT00571649|451443172|FG000|Treatment Period|Clinical endpoint reached|50|||
125494478|NCT00571649|451443173|FG001|Treatment Period|Clinical endpoint reached|56|||
125494479|NCT00571649|451443172|FG000|Treatment Period|Withdrawal by Subject|285|||
125494480|NCT00571649|451443173|FG001|Treatment Period|Withdrawal by Subject|255|||
125494481|NCT00571649|451443172|FG000|Treatment Period|Death|76|||
125494482|NCT00571649|451443173|FG001|Treatment Period|Death|59|||
125494483|NCT00571649|451443172|FG000|Treatment Period|Physician Decision|8|||
125494484|NCT00571649|451443173|FG001|Treatment Period|Physician Decision|9|||
125494485|NCT00571649|451443172|FG000|Treatment Period|Lost to Follow-up|43|||
125494486|NCT00571649|451443173|FG001|Treatment Period|Lost to Follow-up|41|||
125494487|NCT00571649|451443172|FG000|Treatment Period|Non-compliant with study medication|88|||
125494488|NCT00571649|451443173|FG001|Treatment Period|Non-compliant with study medication|89|||
125494489|NCT00571649|451443172|FG000|Treatment Period|Patient convenience|11|||
125494490|NCT00571649|451443173|FG001|Treatment Period|Patient convenience|13|||
125494491|NCT00571649|451443172|FG000|Treatment Period|Protocol Violation|90|||
125494492|NCT00571649|451443173|FG001|Treatment Period|Protocol Violation|92|||
125494493|NCT00571649|451443172|FG000|Treatment Period|Technical problems|3|||
125494494|NCT00571649|451443173|FG001|Treatment Period|Technical problems|5|||
125494495|NCT00571649|451443172|FG000|Follow-up Period|Adverse Event|46|||
125494496|NCT00571649|451443173|FG001|Follow-up Period|Adverse Event|40|||
125494497|NCT00571649|451443172|FG000|Follow-up Period|Clinical endpoint reached|5|||
125494498|NCT00571649|451443173|FG001|Follow-up Period|Clinical endpoint reached|2|||
125494499|NCT00571649|451443172|FG000|Follow-up Period|Withdrawal by Subject|119|||
125494500|NCT00571649|451443173|FG001|Follow-up Period|Withdrawal by Subject|115|||
125494501|NCT00571649|451443172|FG000|Follow-up Period|Death|132|||
125494502|NCT00571649|451443173|FG001|Follow-up Period|Death|133|||
125494503|NCT00571649|451443172|FG000|Follow-up Period|Physician Decision|7|||
125494504|NCT00571649|451443173|FG001|Follow-up Period|Physician Decision|13|||
125494505|NCT00571649|451443172|FG000|Follow-up Period|Lost to Follow-up|95|||
125494506|NCT00571649|451443173|FG001|Follow-up Period|Lost to Follow-up|92|||
125494507|NCT00571649|451443172|FG000|Follow-up Period|Patient convenience|136|||
125494508|NCT00571649|451443173|FG001|Follow-up Period|Patient convenience|121|||
125494509|NCT00571649|451443172|FG000|Follow-up Period|Protocol Violation|5|||
125494510|NCT00571649|451443173|FG001|Follow-up Period|Protocol Violation|12|||
125494511|NCT01421667|451443174|FG000|Overall Study|Withdrawal by Subject|0|||
125494512|NCT01421667|451443175|FG001|Overall Study|Withdrawal by Subject|1|||
125494513|NCT01421667|451443176|FG002|Overall Study|Withdrawal by Subject|2|||
125494514|NCT01421667|451443177|FG003|Overall Study|Withdrawal by Subject|1|||
125494515|NCT01421667|451443174|FG000|Overall Study|Lost to Follow-up|0|||
125494516|NCT01421667|451443175|FG001|Overall Study|Lost to Follow-up|1|||
125494517|NCT01421667|451443176|FG002|Overall Study|Lost to Follow-up|0|||
125494518|NCT01421667|451443177|FG003|Overall Study|Lost to Follow-up|0|||
125494519|NCT00503906|451443178|FG000|Overall Study|Withdrawal by Subject|1|||
125494520|NCT01387516|451443179|FG000|Overall Study|Lost to Follow-up|4|||
125494521|NCT01387516|451443180|FG001|Overall Study|Lost to Follow-up|4|||
125494522|NCT01387516|451443181|FG002|Overall Study|Lost to Follow-up|2|||
125494523|NCT01387516|451443182|FG003|Overall Study|Lost to Follow-up|3|||
125494524|NCT01387516|451443179|FG000|Overall Study|Withdrawal by Subject|1|||
125494525|NCT01387516|451443180|FG001|Overall Study|Withdrawal by Subject|1|||
125494526|NCT01387516|451443181|FG002|Overall Study|Withdrawal by Subject|2|||
125494527|NCT01387516|451443182|FG003|Overall Study|Withdrawal by Subject|0|||
125494528|NCT01387516|451443179|FG000|Overall Study|Death|0|||
125494529|NCT01387516|451443180|FG001|Overall Study|Death|0|||
125494530|NCT01387516|451443181|FG002|Overall Study|Death|0|||
125304079|NCT04167137|450739649|FG004|Overall Study|Study terminated by Sponsor|0|||
125304080|NCT04167137|450739650|FG005|Overall Study|Study terminated by Sponsor|0|||
125304081|NCT04167137|450739651|FG006|Overall Study|Study terminated by Sponsor|0|||
125304082|NCT04167137|450739652|FG007|Overall Study|Study terminated by Sponsor|1|||
125304083|NCT02147288|450739653|FG000|Overall Study|post-operative hematoma|1|||
125304084|NCT02147288|450739654|FG001|Overall Study|post-operative hematoma|1|||
125304085|NCT02147288|450739655|FG002|Overall Study|post-operative hematoma|0|||
125494531|NCT01387516|451443182|FG003|Overall Study|Death|1|||
125494532|NCT01738438|451443184|FG000|Overall Study|Disease Progression|32|||
125494533|NCT01738438|451443184|FG000|Overall Study|Adverse Event|3|||
125494534|NCT02928172|451443185|FG000|Overall Study|Device did not record data|1|||
125494535|NCT04066075|451443186|FG000|Overall Study|Lost to Follow-up|3|||
125494536|NCT04066075|451443187|FG001|Overall Study|Lost to Follow-up|3|||
125494537|NCT04066075|451443186|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
125494538|NCT04066075|451443187|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
125494539|NCT04066075|451443186|FG000|Overall Study|Withdrawal by Subject|2|||
125494540|NCT04066075|451443187|FG001|Overall Study|Withdrawal by Subject|2|||
125494541|NCT00309166|451443188|FG000|Overall Study|Adverse event, non-fatal|1|||
125494542|NCT00309166|451443189|FG001|Overall Study|Adverse event, non-fatal|0|||
125494543|NCT00309166|451443188|FG000|Overall Study|Withdrawal by Subject|4|||
125494544|NCT00309166|451443189|FG001|Overall Study|Withdrawal by Subject|3|||
125494545|NCT04517435|451443210|FG000|Overall Study|Withdrawal by Subject|0|||
125494546|NCT04517435|451443211|FG001|Overall Study|Withdrawal by Subject|0|||
125494547|NCT04517435|451443212|FG002|Overall Study|Withdrawal by Subject|1|||
125494548|NCT04517435|451443210|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
125494549|NCT04517435|451443211|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
125494550|NCT04517435|451443212|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
125494551|NCT02415127|451443213|FG000|Overall Study|Adverse Event|1|||
125494552|NCT02415127|451443214|FG001|Overall Study|Adverse Event|0|||
125494553|NCT04882917|451443218|FG000|Overall Study|Adverse Event|0|||
125494554|NCT04882917|451443219|FG001|Overall Study|Adverse Event|1|||
125494555|NCT04882917|451443220|FG002|Overall Study|Adverse Event|2|||
125494556|NCT04882917|451443221|FG003|Overall Study|Adverse Event|2|||
125494557|NCT04882917|451443218|FG000|Overall Study|Withdrawal by Subject|1|||
125494558|NCT04882917|451443219|FG001|Overall Study|Withdrawal by Subject|0|||
125494559|NCT04882917|451443220|FG002|Overall Study|Withdrawal by Subject|2|||
125494560|NCT04882917|451443221|FG003|Overall Study|Withdrawal by Subject|1|||
125494561|NCT04882917|451443218|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
125494562|NCT04882917|451443219|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
125494563|NCT04882917|451443220|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
125494564|NCT04882917|451443221|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
125494565|NCT02678689|451443222|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
125494566|NCT02678689|451443223|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
125494567|NCT03160885|451443224|FG000|Initial Treatment Period|Not dosed|2|||
125494568|NCT03160885|451443225|FG001|Initial Treatment Period|Not dosed|0|||
125494569|NCT03160885|451443226|FG002|Initial Treatment Period|Not dosed|0|||
125494570|NCT03160885|451443227|FG003|Initial Treatment Period|Not dosed|0|||
125494571|NCT03160885|451443228|FG004|Initial Treatment Period|Not dosed|0|||
125494572|NCT03160885|451443229|FG005|Initial Treatment Period|Not dosed|0|||
125494573|NCT03160885|451443230|FG006|Initial Treatment Period|Not dosed|0|||
125494574|NCT03160885|451443224|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
125494575|NCT03160885|451443225|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
125494576|NCT03160885|451443226|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
125494577|NCT03160885|451443227|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
125494578|NCT03160885|451443228|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
125494579|NCT03160885|451443229|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
125494580|NCT03160885|451443230|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
125494581|NCT03160885|451443224|FG000|Open-label Treatment|Not dosed|0|||
125494582|NCT03160885|451443225|FG001|Open-label Treatment|Not dosed|0|||
125494583|NCT03160885|451443226|FG002|Open-label Treatment|Not dosed|0|||
125494584|NCT03160885|451443227|FG003|Open-label Treatment|Not dosed|0|||
125494585|NCT03160885|451443228|FG004|Open-label Treatment|Not dosed|0|||
125494586|NCT03160885|451443229|FG005|Open-label Treatment|Not dosed|0|||
125494587|NCT03160885|451443230|FG006|Open-label Treatment|Not dosed|2|||
125494588|NCT03160885|451443224|FG000|Open-label Treatment|Discontinued IMP|0|||
125494589|NCT03160885|451443225|FG001|Open-label Treatment|Discontinued IMP|0|||
125494590|NCT03160885|451443226|FG002|Open-label Treatment|Discontinued IMP|0|||
125494591|NCT03160885|451443227|FG003|Open-label Treatment|Discontinued IMP|0|||
125494592|NCT03160885|451443228|FG004|Open-label Treatment|Discontinued IMP|0|||
125494593|NCT03160885|451443229|FG005|Open-label Treatment|Discontinued IMP|0|||
125494594|NCT03160885|451443230|FG006|Open-label Treatment|Discontinued IMP|131|||
125494595|NCT03160885|451443224|FG000|Open-label Treatment|Completed Week 50|0|||
125494596|NCT03160885|451443225|FG001|Open-label Treatment|Completed Week 50|0|||
125494597|NCT03160885|451443226|FG002|Open-label Treatment|Completed Week 50|0|||
125494598|NCT03160885|451443227|FG003|Open-label Treatment|Completed Week 50|0|||
125304086|NCT02147288|450739656|FG003|Overall Study|post-operative hematoma|0|||
125494599|NCT03160885|451443228|FG004|Open-label Treatment|Completed Week 50|0|||
125494600|NCT03160885|451443229|FG005|Open-label Treatment|Completed Week 50|0|||
125494601|NCT03160885|451443230|FG006|Open-label Treatment|Completed Week 50|4|||
125304087|NCT02147288|450739657|FG004|Overall Study|post-operative hematoma|0|||
125494602|NCT03160885|451443224|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
125494603|NCT03160885|451443225|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
125494604|NCT03160885|451443226|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
125494605|NCT03160885|451443227|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
125494606|NCT03160885|451443228|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
125494607|NCT03160885|451443229|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
125494608|NCT03160885|451443230|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
125494609|NCT03160885|451443224|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
125494610|NCT03160885|451443225|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
125494611|NCT03160885|451443226|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
125494612|NCT03160885|451443227|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
125494613|NCT03160885|451443228|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
125494614|NCT03160885|451443229|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
125494615|NCT03160885|451443230|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
125494616|NCT03160885|451443224|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
125494617|NCT03160885|451443225|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
125494618|NCT03160885|451443226|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
125494619|NCT03160885|451443227|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
125494620|NCT03160885|451443228|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
125494621|NCT03160885|451443229|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
125494622|NCT03160885|451443230|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
125494623|NCT03160885|451443224|FG000|Maintenance Treatment Period|Completed Week 50|0|||
125494624|NCT03160885|451443225|FG001|Maintenance Treatment Period|Completed Week 50|0|||
125494625|NCT03160885|451443226|FG002|Maintenance Treatment Period|Completed Week 50|1|||
125494626|NCT03160885|451443227|FG003|Maintenance Treatment Period|Completed Week 50|0|||
125494627|NCT03160885|451443228|FG004|Maintenance Treatment Period|Completed Week 50|0|||
125494628|NCT03160885|451443229|FG005|Maintenance Treatment Period|Completed Week 50|0|||
125494629|NCT03160885|451443230|FG006|Maintenance Treatment Period|Completed Week 50|0|||
125494630|NCT02761187|451443231|FG000|Overall Study|Too ill to Participate|13|||
125494631|NCT02761187|451443232|FG001|Overall Study|Too ill to Participate|8|||
125494632|NCT02761187|451443231|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
125494633|NCT02761187|451443232|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
125494634|NCT02761187|451443231|FG000|Overall Study|Patient withdrew consent|64|||
125494635|NCT02761187|451443232|FG001|Overall Study|Patient withdrew consent|58|||
125494636|NCT02761187|451443231|FG000|Overall Study|Physician discretion|4|||
125494637|NCT02761187|451443232|FG001|Overall Study|Physician discretion|8|||
125494638|NCT02761187|451443231|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
125494639|NCT02761187|451443232|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
125494640|NCT02761187|451443231|FG000|Overall Study|On Hospice|20|||
125494641|NCT02761187|451443232|FG001|Overall Study|On Hospice|26|||
125494642|NCT02761187|451443231|FG000|Overall Study|Deceased|474|||
125494643|NCT02761187|451443232|FG001|Overall Study|Deceased|642|||
125494644|NCT02761187|451443231|FG000|Overall Study|Lost to Follow-up|73|||
125494645|NCT02761187|451443232|FG001|Overall Study|Lost to Follow-up|63|||
125494646|NCT02761187|451443231|FG000|Overall Study|Due to study discontinued at site|100|||
125494647|NCT02761187|451443232|FG001|Overall Study|Due to study discontinued at site|85|||
125494648|NCT02761187|451443231|FG000|Overall Study|Reason not Specified|1484|||
125494649|NCT02761187|451443232|FG001|Overall Study|Reason not Specified|937|||
125494650|NCT02307682|451443233|FG000|Overall Study|Adverse Event|9|||
125494651|NCT02307682|451443234|FG001|Overall Study|Adverse Event|8|||
125494652|NCT02307682|451443235|FG002|Overall Study|Adverse Event|12|||
125494653|NCT02307682|451443233|FG000|Overall Study|Lack of Efficacy|1|||
125494654|NCT02307682|451443234|FG001|Overall Study|Lack of Efficacy|0|||
125494655|NCT02307682|451443235|FG002|Overall Study|Lack of Efficacy|1|||
125494656|NCT02307682|451443233|FG000|Overall Study|Physician Decision|2|||
125494657|NCT02307682|451443234|FG001|Overall Study|Physician Decision|2|||
125494658|NCT02307682|451443235|FG002|Overall Study|Physician Decision|8|||
125494659|NCT02307682|451443233|FG000|Overall Study|Progressive Disease|1|||
125494660|NCT02307682|451443234|FG001|Overall Study|Progressive Disease|0|||
125494661|NCT02307682|451443235|FG002|Overall Study|Progressive Disease|0|||
125494662|NCT02307682|451443233|FG000|Overall Study|Withdrawal by Subject|26|||
125494663|NCT02307682|451443234|FG001|Overall Study|Withdrawal by Subject|34|||
125494664|NCT02307682|451443235|FG002|Overall Study|Withdrawal by Subject|23|||
125494665|NCT02307682|451443233|FG000|Overall Study|Death|9|||
125494666|NCT02307682|451443234|FG001|Overall Study|Death|7|||
125494667|NCT02307682|451443235|FG002|Overall Study|Death|12|||
125494668|NCT02307682|451443233|FG000|Overall Study|Lost to Follow-up|1|||
125494669|NCT02307682|451443234|FG001|Overall Study|Lost to Follow-up|5|||
125494670|NCT02307682|451443235|FG002|Overall Study|Lost to Follow-up|6|||
125494671|NCT02307682|451443233|FG000|Overall Study|Protocol Deviation|0|||
125494672|NCT02307682|451443234|FG001|Overall Study|Protocol Deviation|0|||
125494673|NCT02307682|451443235|FG002|Overall Study|Protocol Deviation|2|||
125494674|NCT02307682|451443233|FG000|Overall Study|Other|1|||
125494675|NCT02307682|451443234|FG001|Overall Study|Other|1|||
125494676|NCT02307682|451443235|FG002|Overall Study|Other|0|||
125494677|NCT05630833|451443236|FG000|Overall Study|Adverse Event|3|||
125494678|NCT05630833|451443237|FG001|Overall Study|Adverse Event|0|||
125494679|NCT05630833|451443236|FG000|Overall Study|Lack of Efficacy|0|||
125494680|NCT05630833|451443237|FG001|Overall Study|Lack of Efficacy|1|||
125494681|NCT05630833|451443236|FG000|Overall Study|Lost to Follow-up|1|||
125494682|NCT05630833|451443237|FG001|Overall Study|Lost to Follow-up|0|||
125494683|NCT05630833|451443236|FG000|Overall Study|Withdrawal by Subject|3|||
125494684|NCT05630833|451443237|FG001|Overall Study|Withdrawal by Subject|1|||
125494685|NCT03170349|451443239|FG000|From Implant to the 30-Day Visit|Death|1|||
125494686|NCT03170349|451443239|FG000|From 30-Day to 6-Month Visit|Death|3|||
125494687|NCT03170349|451443239|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
125494688|NCT03170349|451443239|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
125494689|NCT03170349|451443239|FG000|From 6-Month to 1-Year Visit|Death|6|||
125494690|NCT03170349|451443239|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
125494691|NCT03170349|451443239|FG000|From 1-Year to 2-Year Visit|Death|13|||
125494692|NCT03170349|451443239|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
125494693|NCT03170349|451443239|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
125494694|NCT03170349|451443239|FG000|From 2-Year to 3-Year Visit|Death|10|||
125494695|NCT03170349|451443239|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
125494696|NCT03170349|451443239|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
125494697|NCT03170349|451443239|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
125494698|NCT04551066|451443240|FG000|Overall Study|Death|5|||
125494699|NCT04551066|451443241|FG001|Overall Study|Death|3|||
125494700|NCT04551066|451443240|FG000|Overall Study|Lost to Follow-up|1|||
125494701|NCT04551066|451443241|FG001|Overall Study|Lost to Follow-up|0|||
125494702|NCT04551066|451443240|FG000|Overall Study|Sponsor Decision|103|||
125494703|NCT04551066|451443241|FG001|Overall Study|Sponsor Decision|117|||
125494704|NCT04551066|451443240|FG000|Overall Study|Withdrawal by Subject|8|||
125494705|NCT04551066|451443241|FG001|Overall Study|Withdrawal by Subject|2|||
125494706|NCT04551066|451443240|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
125494707|NCT04551066|451443241|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
125494708|NCT04551066|451443240|FG000|Overall Study|Adverse Event|2|||
125494709|NCT04551066|451443241|FG001|Overall Study|Adverse Event|0|||
125494710|NCT04551066|451443240|FG000|Overall Study|Physician Decision|2|||
125494711|NCT04551066|451443241|FG001|Overall Study|Physician Decision|0|||
125494712|NCT04551066|451443240|FG000|Overall Study|Protocol Violation|1|||
125494713|NCT04551066|451443241|FG001|Overall Study|Protocol Violation|0|||
125494714|NCT04551066|451443240|FG000|Overall Study|Lack of Efficacy|0|||
125494715|NCT04551066|451443241|FG001|Overall Study|Lack of Efficacy|1|||
125494716|NCT04551066|451443240|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
125494717|NCT04551066|451443241|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
125494718|NCT05529992|451443242|FG000|Overall Study|Withdrawal by Subject|1|||
125494719|NCT00536120|451444220|FG000|Overall Study|Lost to Follow-up|1|||
125494720|NCT00536120|451444221|FG001|Overall Study|Lost to Follow-up|0|||
125494721|NCT00536120|451444220|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
125494722|NCT00536120|451444221|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
125494723|NCT00536120|451444220|FG000|Overall Study|Non-compliance|1|||
125494724|NCT00536120|451444221|FG001|Overall Study|Non-compliance|0|||
125494725|NCT00536120|451444220|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
125494726|NCT00536120|451444221|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
125494727|NCT00536120|451444220|FG000|Overall Study|Steroid Use|0|||
125494728|NCT00536120|451444221|FG001|Overall Study|Steroid Use|2|||
125494729|NCT00536120|451444220|FG000|Overall Study|Missed Study Visit|0|||
125494730|NCT00536120|451444221|FG001|Overall Study|Missed Study Visit|1|||
125494731|NCT02760654|451444222|FG000|Overall Study|Lost to Follow-up|3|||
125494732|NCT02760654|451444223|FG001|Overall Study|Lost to Follow-up|3|||
125494733|NCT02760654|451444222|FG000|Overall Study|Withdrawal by Subject|4|||
125494734|NCT02760654|451444223|FG001|Overall Study|Withdrawal by Subject|3|||
125494735|NCT01084694|451444225|FG000|Overall Study|Withdrawal by Subject|2|||
125494736|NCT01084694|451444226|FG001|Overall Study|Withdrawal by Subject|1|||
125494737|NCT01084694|451444225|FG000|Overall Study|Death|2|||
125494738|NCT01084694|451444226|FG001|Overall Study|Death|12|||
125494739|NCT01084694|451444225|FG000|Overall Study|eligibility not maintained|2|||
125494740|NCT01084694|451444226|FG001|Overall Study|eligibility not maintained|7|||
125494741|NCT00945321|451444229|FG000|Period 1|Adverse Event|0|||
125494742|NCT00945321|451444230|FG001|Period 1|Adverse Event|0|||
125494743|NCT00945321|451444231|FG002|Period 1|Adverse Event|0|||
125494744|NCT00945321|451444232|FG003|Period 1|Adverse Event|0|||
125494745|NCT00945321|451444233|FG004|Period 1|Adverse Event|1|||
125494746|NCT00945321|451444234|FG005|Period 1|Adverse Event|0|||
125494747|NCT00945321|451444229|FG000|Period 4|Lost to Follow-up|0|||
125304088|NCT02147288|450739658|FG005|Overall Study|post-operative hematoma|0|||
125494748|NCT00945321|451444230|FG001|Period 4|Lost to Follow-up|0|||
125494749|NCT00945321|451444231|FG002|Period 4|Lost to Follow-up|0|||
125494750|NCT00945321|451444232|FG003|Period 4|Lost to Follow-up|0|||
125494751|NCT00945321|451444233|FG004|Period 4|Lost to Follow-up|0|||
125494752|NCT00945321|451444234|FG005|Period 4|Lost to Follow-up|1|||
125494753|NCT02633215|451444235|FG000|Overall Study|Lost to Follow-up|2|||
125494754|NCT02633215|451444236|FG001|Overall Study|Lost to Follow-up|3|||
125494755|NCT04017611|451444237|FG000|Overall Study|Withdrawn prior to completion|1|||
125494756|NCT02291913|451444238|FG000|Overall Study|Progressive Disease|32|||
125494757|NCT02291913|451444238|FG000|Overall Study|Adverse Event|11|||
125494758|NCT02291913|451444238|FG000|Overall Study|Death|2|||
125494759|NCT02291913|451444238|FG000|Overall Study|Physician Decision|1|||
125494760|NCT02291913|451444238|FG000|Overall Study|Withdrawal by Subject|1|||
125494761|NCT02291913|451444238|FG000|Overall Study|Protocol Violation|1|||
125494762|NCT04876417|451444249|FG000|Overall Study|Lost to Follow-up|5|||
125494763|NCT04876417|451444250|FG001|Overall Study|Lost to Follow-up|8|||
125494764|NCT04876417|451444251|FG002|Overall Study|Lost to Follow-up|0|||
125494765|NCT04876417|451444252|FG003|Overall Study|Lost to Follow-up|0|||
125494766|NCT02866942|451444253|FG000|Overall Study|Invalid consent|1|||
125494767|NCT00439270|451444254|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
125494768|NCT00439270|451444255|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
125494769|NCT00439270|451444256|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
125494770|NCT00439270|451444257|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
125494771|NCT00439270|451444258|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
125494772|NCT00439270|451444254|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
125494773|NCT00439270|451444255|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
125494774|NCT00439270|451444256|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
125494775|NCT00439270|451444257|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
125494776|NCT00439270|451444258|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
125494777|NCT00439270|451444254|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
125494778|NCT00439270|451444255|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
125494779|NCT00439270|451444256|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
125494780|NCT00439270|451444257|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
125494781|NCT00439270|451444258|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
125494782|NCT00439270|451444254|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
125494783|NCT00439270|451444255|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
125494784|NCT00439270|451444256|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
125494785|NCT00439270|451444257|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
125494786|NCT00439270|451444258|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
125494787|NCT00439270|451444254|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
125494788|NCT00439270|451444255|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
125494789|NCT00439270|451444256|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
125494790|NCT00439270|451444257|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
125494791|NCT00439270|451444258|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
125494792|NCT00439270|451444254|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
125494793|NCT00439270|451444255|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
125494794|NCT00439270|451444256|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
125494795|NCT00439270|451444257|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
125494796|NCT00439270|451444258|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
125494797|NCT00439270|451444254|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
125494798|NCT00439270|451444255|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
125494799|NCT00439270|451444256|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
125494800|NCT00439270|451444257|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
125494801|NCT00439270|451444258|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
125494802|NCT00439270|451444254|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
125494803|NCT00439270|451444255|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
125494804|NCT00439270|451444256|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
125494805|NCT00439270|451444257|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
125494806|NCT00439270|451444258|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
125494807|NCT00439270|451444254|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
125494808|NCT00439270|451444255|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
125494809|NCT00439270|451444256|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
125494810|NCT00439270|451444257|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
125494811|NCT00439270|451444258|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
125494812|NCT00439270|451444254|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
125494813|NCT00439270|451444255|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
125494814|NCT00439270|451444256|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
125494815|NCT00439270|451444257|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
125494816|NCT00439270|451444258|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
125494817|NCT02568215|451444260|FG000|Overall Study|Death|1|||
125494818|NCT02568215|451444261|FG001|Overall Study|Death|2|||
125494819|NCT02568215|451444262|FG002|Overall Study|Death|0|||
125494820|NCT02568215|451444260|FG000|Overall Study|Physician Decision|2|||
125494821|NCT02568215|451444261|FG001|Overall Study|Physician Decision|2|||
125494822|NCT02568215|451444262|FG002|Overall Study|Physician Decision|2|||
125494823|NCT02568215|451444260|FG000|Overall Study|Lost to Follow-up|29|||
125494824|NCT02568215|451444261|FG001|Overall Study|Lost to Follow-up|32|||
125494825|NCT02568215|451444262|FG002|Overall Study|Lost to Follow-up|41|||
125494826|NCT02568215|451444260|FG000|Overall Study|Withdrawal by Subject|21|||
125494827|NCT02568215|451444261|FG001|Overall Study|Withdrawal by Subject|19|||
125494828|NCT02568215|451444262|FG002|Overall Study|Withdrawal by Subject|22|||
125494829|NCT02568215|451444260|FG000|Overall Study|Protocol Violation|1|||
125494830|NCT02568215|451444261|FG001|Overall Study|Protocol Violation|1|||
125494831|NCT02568215|451444262|FG002|Overall Study|Protocol Violation|0|||
125494832|NCT02568215|451444260|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
125494833|NCT02568215|451444261|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
125494834|NCT02568215|451444262|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
125494835|NCT02568215|451444260|FG000|Overall Study|Other|0|||
125494836|NCT02568215|451444261|FG001|Overall Study|Other|1|||
125494837|NCT02568215|451444262|FG002|Overall Study|Other|4|||
125304089|NCT02147288|450739659|FG006|Overall Study|post-operative hematoma|0|||
125304090|NCT02147288|450739660|FG007|Overall Study|post-operative hematoma|0|||
125304091|NCT02147288|450739661|FG008|Overall Study|post-operative hematoma|0|||
125304092|NCT02147288|450739662|FG009|Overall Study|post-operative hematoma|0|||
125304093|NCT02147288|450739653|FG000|Overall Study|complications from concurrent hernia rep|0|||
125420911|NCT02794285|451166176|FG002|Overall Study|Lost to Follow-up|3|||
125420912|NCT02794285|451166177|FG003|Overall Study|Lost to Follow-up|1|||
125420913|NCT02794285|451166174|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
125420914|NCT02794285|451166175|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
125420915|NCT02794285|451166176|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
125420916|NCT02794285|451166177|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
125420917|NCT02794285|451166174|FG000|Overall Study|Withdrawal by Subject|38|||
125420918|NCT02794285|451166175|FG001|Overall Study|Withdrawal by Subject|29|||
125420919|NCT02794285|451166176|FG002|Overall Study|Withdrawal by Subject|20|||
125420920|NCT02794285|451166177|FG003|Overall Study|Withdrawal by Subject|12|||
125420921|NCT02794285|451166174|FG000|Overall Study|Missing|1|||
125420922|NCT02794285|451166175|FG001|Overall Study|Missing|0|||
125420923|NCT02794285|451166176|FG002|Overall Study|Missing|0|||
125420924|NCT02794285|451166177|FG003|Overall Study|Missing|0|||
125420925|NCT02794285|451166174|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
125420926|NCT02794285|451166175|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
125420927|NCT02794285|451166176|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
125420928|NCT02794285|451166177|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
125420929|NCT02794285|451166174|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
125420930|NCT02794285|451166175|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
125420931|NCT02794285|451166176|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
125420932|NCT02794285|451166177|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
125420933|NCT00423176|451166178|FG000|Overall Study|Adverse Event|4|||
125420934|NCT00423176|451166179|FG001|Overall Study|Adverse Event|6|||
125420935|NCT00423176|451166178|FG000|Overall Study|Treatment Failure|1|||
125420936|NCT00423176|451166179|FG001|Overall Study|Treatment Failure|6|||
125420937|NCT00423176|451166178|FG000|Overall Study|Lost to Follow-up|4|||
125420938|NCT00423176|451166179|FG001|Overall Study|Lost to Follow-up|7|||
125420939|NCT00423176|451166178|FG000|Overall Study|Withdrawal by Subject|4|||
125420940|NCT00423176|451166179|FG001|Overall Study|Withdrawal by Subject|3|||
125420941|NCT00423176|451166178|FG000|Overall Study|Protocol Violation|1|||
125420942|NCT00423176|451166179|FG001|Overall Study|Protocol Violation|3|||
125420943|NCT00423176|451166178|FG000|Overall Study|Did not meet protocol eligibility|2|||
125420944|NCT00423176|451166179|FG001|Overall Study|Did not meet protocol eligibility|4|||
125420945|NCT05072080|451166182|FG000|Overall Study|Death|0|||
125420946|NCT05072080|451166183|FG001|Overall Study|Death|0|||
125420947|NCT05072080|451166184|FG002|Overall Study|Death|1|||
125420948|NCT05072080|451166185|FG003|Overall Study|Death|0|||
125420949|NCT05072080|451166182|FG000|Overall Study|Lost to Follow-up|65|||
125420950|NCT05072080|451166183|FG001|Overall Study|Lost to Follow-up|70|||
125420951|NCT05072080|451166184|FG002|Overall Study|Lost to Follow-up|58|||
125420952|NCT05072080|451166185|FG003|Overall Study|Lost to Follow-up|23|||
125420953|NCT05072080|451166182|FG000|Overall Study|Physician Decision|2|||
125420954|NCT05072080|451166183|FG001|Overall Study|Physician Decision|1|||
125420955|NCT05072080|451166184|FG002|Overall Study|Physician Decision|1|||
125420956|NCT05072080|451166185|FG003|Overall Study|Physician Decision|0|||
125420957|NCT05072080|451166182|FG000|Overall Study|Withdrawal by Subject|45|||
125420958|NCT05072080|451166183|FG001|Overall Study|Withdrawal by Subject|30|||
125420959|NCT05072080|451166184|FG002|Overall Study|Withdrawal by Subject|27|||
125420960|NCT05072080|451166185|FG003|Overall Study|Withdrawal by Subject|7|||
125420961|NCT05072080|451166182|FG000|Overall Study|Sponsor Decision|0|||
125420962|NCT05072080|451166183|FG001|Overall Study|Sponsor Decision|1|||
125420963|NCT05072080|451166184|FG002|Overall Study|Sponsor Decision|0|||
125420964|NCT05072080|451166185|FG003|Overall Study|Sponsor Decision|0|||
125420965|NCT05072080|451166182|FG000|Overall Study|Subject moved|1|||
125420966|NCT05072080|451166183|FG001|Overall Study|Subject moved|3|||
125420967|NCT05072080|451166184|FG002|Overall Study|Subject moved|5|||
125420968|NCT05072080|451166185|FG003|Overall Study|Subject moved|2|||
125420969|NCT05072080|451166182|FG000|Overall Study|Withdrawal by parent|0|||
125494838|NCT00246805|451444263|FG000|Phase 1|Lost to Follow-up|1|||
125494839|NCT00246805|451444264|FG001|Phase 1|Lost to Follow-up|0|||
125494840|NCT02964741|451444265|FG000|Overall Study|Protocol Violation|1|||
125494841|NCT02964741|451444266|FG001|Overall Study|Protocol Violation|0|||
125494842|NCT02964741|451444267|FG002|Overall Study|Protocol Violation|0|||
125494843|NCT02964741|451444265|FG000|Overall Study|Withdrawal by Subject|0|||
125494844|NCT02964741|451444266|FG001|Overall Study|Withdrawal by Subject|1|||
125494845|NCT02964741|451444267|FG002|Overall Study|Withdrawal by Subject|0|||
125494846|NCT02964741|451444265|FG000|Overall Study|claustrophobia|1|||
125494847|NCT02964741|451444266|FG001|Overall Study|claustrophobia|0|||
125494848|NCT02964741|451444267|FG002|Overall Study|claustrophobia|0|||
125494849|NCT01500200|451444268|FG000|Stage 1|Adverse Event|1|||
125494850|NCT01500200|451444269|FG001|Stage 1|Adverse Event|4|||
125494851|NCT01500200|451444270|FG002|Stage 1|Adverse Event|5|||
125494852|NCT01500200|451444271|FG003|Stage 1|Adverse Event|0|||
125494853|NCT01500200|451444272|FG004|Stage 1|Adverse Event|0|||
125494854|NCT01500200|451444273|FG005|Stage 1|Adverse Event|0|||
125494855|NCT01500200|451444268|FG000|Stage 1|Lost to Follow-up|2|||
125494856|NCT01500200|451444269|FG001|Stage 1|Lost to Follow-up|2|||
125494857|NCT01500200|451444270|FG002|Stage 1|Lost to Follow-up|1|||
125494858|NCT01500200|451444271|FG003|Stage 1|Lost to Follow-up|0|||
125494859|NCT01500200|451444272|FG004|Stage 1|Lost to Follow-up|0|||
125494860|NCT01500200|451444273|FG005|Stage 1|Lost to Follow-up|0|||
125494861|NCT01500200|451444268|FG000|Stage 1|Withdrawal by Subject|3|||
125494862|NCT01500200|451444269|FG001|Stage 1|Withdrawal by Subject|0|||
125494863|NCT01500200|451444270|FG002|Stage 1|Withdrawal by Subject|0|||
125494864|NCT01500200|451444271|FG003|Stage 1|Withdrawal by Subject|0|||
125494865|NCT01500200|451444272|FG004|Stage 1|Withdrawal by Subject|0|||
125494866|NCT01500200|451444273|FG005|Stage 1|Withdrawal by Subject|0|||
125494867|NCT01500200|451444268|FG000|Stage 1|Noncompliance with Study Drug|1|||
125494868|NCT01500200|451444269|FG001|Stage 1|Noncompliance with Study Drug|0|||
125494869|NCT01500200|451444270|FG002|Stage 1|Noncompliance with Study Drug|0|||
125494870|NCT01500200|451444271|FG003|Stage 1|Noncompliance with Study Drug|0|||
125494871|NCT01500200|451444272|FG004|Stage 1|Noncompliance with Study Drug|0|||
125494872|NCT01500200|451444273|FG005|Stage 1|Noncompliance with Study Drug|0|||
125494873|NCT01500200|451444268|FG000|Stage 1|Physician Decision|1|||
125494874|NCT01500200|451444269|FG001|Stage 1|Physician Decision|0|||
125494875|NCT01500200|451444270|FG002|Stage 1|Physician Decision|0|||
125494876|NCT01500200|451444271|FG003|Stage 1|Physician Decision|0|||
125494877|NCT01500200|451444272|FG004|Stage 1|Physician Decision|0|||
125494878|NCT01500200|451444273|FG005|Stage 1|Physician Decision|0|||
125494879|NCT01500200|451444268|FG000|Stage 2|Adverse Event|0|||
125494880|NCT01500200|451444269|FG001|Stage 2|Adverse Event|0|||
125494881|NCT01500200|451444270|FG002|Stage 2|Adverse Event|0|||
125494882|NCT01500200|451444271|FG003|Stage 2|Adverse Event|0|||
125494883|NCT01500200|451444272|FG004|Stage 2|Adverse Event|5|||
125494884|NCT01500200|451444273|FG005|Stage 2|Adverse Event|4|||
125494885|NCT01212744|451444280|FG000|Overall Study|Withdrawal by Subject|1|||
125494886|NCT02167451|451444281|FG000|Overall Study|Withdrawal by Subject|1|||
125494887|NCT00293397|451444283|FG000|Overall Study|Death|2|||
125494888|NCT01218009|451444284|FG000|Overall Study|Protocol Violation|2|||
125494889|NCT01218009|451444285|FG001|Overall Study|Protocol Violation|1|||
125494890|NCT01218009|451444284|FG000|Overall Study|Withdrawal by Subject|3|||
125494891|NCT01218009|451444285|FG001|Overall Study|Withdrawal by Subject|1|||
125494892|NCT01218009|451444284|FG000|Overall Study|Sponsor terminated study|161|||
125494893|NCT01218009|451444285|FG001|Overall Study|Sponsor terminated study|163|||
125494894|NCT00174252|451444286|FG000|Overall Study|Protocol Violation|2|||
125494895|NCT03170882|451444287|FG000|Overall Study|Death|17|||
125494896|NCT03170882|451444288|FG001|Overall Study|Death|29|||
125494897|NCT03170882|451444287|FG000|Overall Study|Lost to Follow-up|0|||
125494898|NCT03170882|451444288|FG001|Overall Study|Lost to Follow-up|1|||
125494899|NCT03170882|451444287|FG000|Overall Study|Withdrawal by Subject|4|||
125494900|NCT03170882|451444288|FG001|Overall Study|Withdrawal by Subject|7|||
125304094|NCT02147288|450739654|FG001|Overall Study|complications from concurrent hernia rep|1|||
125304095|NCT02147288|450739655|FG002|Overall Study|complications from concurrent hernia rep|0|||
125494901|NCT03170882|451444287|FG000|Overall Study|Reason not Specified|28|||
125494902|NCT03170882|451444288|FG001|Overall Study|Reason not Specified|36|||
125494903|NCT03802994|451444289|FG000|Overall Study|Lost to Follow-up|0|||
125494904|NCT03802994|451444290|FG001|Overall Study|Lost to Follow-up|2|||
125304096|NCT02147288|450739656|FG003|Overall Study|complications from concurrent hernia rep|0|||
125494905|NCT03802994|451444291|FG002|Overall Study|Lost to Follow-up|3|||
125494906|NCT03802994|451444292|FG003|Overall Study|Lost to Follow-up|2|||
125494907|NCT03802994|451444293|FG004|Overall Study|Lost to Follow-up|2|||
125494908|NCT01753999|451444296|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
125494909|NCT01753999|451444297|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
125494910|NCT01753999|451444296|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
125494911|NCT01753999|451444297|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
125494912|NCT01753999|451444296|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
125494913|NCT01753999|451444297|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
125494914|NCT01753999|451444296|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
125494915|NCT01753999|451444297|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
125494916|NCT01753999|451444296|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
125494917|NCT01753999|451444297|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
125494918|NCT01753999|451444296|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
125494919|NCT01753999|451444297|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
125494920|NCT02392234|451444298|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
125494921|NCT02392234|451444299|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
125494922|NCT02392234|451444300|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
125494923|NCT02392234|451444301|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
125494924|NCT02392234|451444302|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
125494925|NCT02392234|451444303|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
125494926|NCT02392234|451444298|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
125494927|NCT02392234|451444299|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
125494928|NCT02392234|451444300|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
125494929|NCT02392234|451444301|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
125494930|NCT02392234|451444302|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
125494931|NCT02392234|451444303|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
125494932|NCT02392234|451444298|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
125494933|NCT02392234|451444299|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
125494934|NCT02392234|451444300|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
125494935|NCT02392234|451444301|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
125494936|NCT02392234|451444302|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
125494937|NCT02392234|451444303|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
125494938|NCT02392234|451444298|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
125494939|NCT02392234|451444299|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
125494940|NCT02392234|451444300|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
125494941|NCT02392234|451444301|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
125494942|NCT02392234|451444302|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
125494943|NCT02392234|451444303|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
125494944|NCT02392234|451444298|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
125494945|NCT02392234|451444299|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
125494946|NCT02392234|451444300|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
125494947|NCT02392234|451444301|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
125494948|NCT02392234|451444302|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
125494949|NCT02392234|451444303|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
125494950|NCT02392234|451444298|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
125494951|NCT02392234|451444299|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
125494952|NCT02392234|451444300|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
125494953|NCT02392234|451444301|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
125494954|NCT02392234|451444302|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
125494955|NCT02392234|451444303|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
125494956|NCT02392234|451444298|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
125494957|NCT02392234|451444299|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
125494958|NCT02392234|451444300|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
125494959|NCT02392234|451444301|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
125494960|NCT02392234|451444302|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
125494961|NCT02392234|451444303|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
125494962|NCT02392234|451444298|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
125494963|NCT02392234|451444299|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
125494964|NCT02392234|451444300|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
125494965|NCT02392234|451444301|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
125494966|NCT02392234|451444302|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
125494967|NCT02392234|451444303|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
125494968|NCT02029235|451444304|FG000|Overall Study|Non-compliance with study meds or diary|4|||
125494969|NCT02029235|451444305|FG001|Overall Study|Non-compliance with study meds or diary|1|||
125494970|NCT00701701|451444306|FG000|Overall Study|Withdrawal by Subject|0|||
125494971|NCT00701701|451444307|FG001|Overall Study|Withdrawal by Subject|1|||
125494972|NCT00701701|451444306|FG000|Overall Study|Adverse Event|0|||
125494973|NCT00701701|451444307|FG001|Overall Study|Adverse Event|1|||
125494974|NCT03789110|451444308|FG000|Overall Study|Adverse Event|2|||
125494975|NCT03789110|451444308|FG000|Overall Study|Physician Decision|1|||
125494976|NCT03789110|451444308|FG000|Overall Study|Withdrawal by Subject|2|||
125494977|NCT03789110|451444308|FG000|Overall Study|Lack of Efficacy|22|||
125494978|NCT03789110|451444308|FG000|Overall Study|still on treatment|3|||
125494979|NCT01855750|451444309|FG000|Overall Study|Death|78|||
125494980|NCT01855750|451444310|FG001|Overall Study|Death|78|||
125494981|NCT01855750|451444309|FG000|Overall Study|Lost to Follow-up|9|||
125494982|NCT01855750|451444310|FG001|Overall Study|Lost to Follow-up|23|||
125494983|NCT01855750|451444309|FG000|Overall Study|Withdrawal by Subject|35|||
125494984|NCT01855750|451444310|FG001|Overall Study|Withdrawal by Subject|28|||
125494985|NCT01855750|451444309|FG000|Overall Study|Sponsor ends the study|297|||
125494986|NCT01855750|451444310|FG001|Overall Study|Sponsor ends the study|290|||
125494987|NCT04300023|451444311|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
125494988|NCT04300023|451444312|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
125494989|NCT05525572|451444313|FG000|Overall Study|Lost to Follow-up|2|||
125494990|NCT04057131|451444314|FG000|Overall Study|Protocol Violation|24|||
125494991|NCT03425682|451444315|FG000|Overall Study|Lost to Follow-up|2|||
125494992|NCT03425682|451444316|FG001|Overall Study|Lost to Follow-up|4|||
125494993|NCT03425682|451444315|FG000|Overall Study|Withdrawal by Subject|0|||
125494994|NCT03425682|451444316|FG001|Overall Study|Withdrawal by Subject|3|||
125494995|NCT03425682|451444315|FG000|Overall Study|Subject did not meet I/E|4|||
125494996|NCT03425682|451444316|FG001|Overall Study|Subject did not meet I/E|10|||
125494997|NCT03277989|451444320|FG000|Overall Study|Lost to Follow-up|6|||
125494998|NCT03277989|451444320|FG000|Overall Study|Adverse Event|6|||
125494999|NCT03277989|451444320|FG000|Overall Study|Withdrawal by Subject|3|||
125495000|NCT03277989|451444320|FG000|Overall Study|Didn't Receive Study Device|7|||
125495001|NCT03277989|451444320|FG000|Overall Study|Site Closure|26|||
125495002|NCT03277989|451444320|FG000|Overall Study|Sponsor Closure|107|||
125495003|NCT05704725|451444323|FG000|Overall Study|Lost to Follow-up|0|||
125495004|NCT05704725|451444324|FG001|Overall Study|Lost to Follow-up|1|||
125495005|NCT05704725|451444323|FG000|Overall Study|Withdrawal by Subject|1|||
125495006|NCT05704725|451444324|FG001|Overall Study|Withdrawal by Subject|0|||
125495007|NCT03227861|451444325|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
125495008|NCT03227861|451444325|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
125495009|NCT03227861|451444325|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
125495010|NCT03227861|451444325|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
125495011|NCT03227861|451444325|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
125495012|NCT03227861|451444325|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
125495013|NCT03227861|451444325|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
125495014|NCT03227861|451444325|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
125495015|NCT03227861|451444325|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
125495016|NCT03227861|451444325|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
125495017|NCT03516942|451444326|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
125495018|NCT03516942|451444326|FG000|Registration Through Baseline Survey Com|Death|8|||
125495019|NCT03516942|451444326|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
125495020|NCT03516942|451444326|FG000|T0: Baseline|LOST|13|||
125495021|NCT03516942|451444326|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
125495022|NCT03516942|451444326|FG000|T1: 3 Months Survey|Death|10|||
125495023|NCT03516942|451444326|FG000|T1: 3 Months Survey|Lost|163|||
125495024|NCT03516942|451444326|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
125495025|NCT03516942|451444326|FG000|T2: 6 Month Survey|Death|14|||
125495026|NCT03516942|451444326|FG000|T2: 6 Month Survey|Lost|180|||
125495027|NCT03516942|451444326|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
125495028|NCT03516942|451444326|FG000|T3: 12 Month Survey|Death|19|||
125495029|NCT03516942|451444326|FG000|T3: 12 Month Survey|Lost|209|||
125495030|NCT00490139|451444328|FG000|Overall Study|Lost to Follow-up|249|||
125495031|NCT00490139|451444329|FG001|Overall Study|Lost to Follow-up|216|||
125495032|NCT00490139|451444330|FG002|Overall Study|Lost to Follow-up|205|||
125495033|NCT00490139|451444331|FG003|Overall Study|Lost to Follow-up|229|||
125495034|NCT00490139|451444328|FG000|Overall Study|Withdrawal by Subject|333|||
125495035|NCT00490139|451444329|FG001|Overall Study|Withdrawal by Subject|322|||
125495036|NCT00490139|451444330|FG002|Overall Study|Withdrawal by Subject|396|||
125495037|NCT00490139|451444331|FG003|Overall Study|Withdrawal by Subject|295|||
125495038|NCT00490139|451444328|FG000|Overall Study|Patient did not sign ICF 12|169|||
125495039|NCT00490139|451444329|FG001|Overall Study|Patient did not sign ICF 12|176|||
125495040|NCT00490139|451444330|FG002|Overall Study|Patient did not sign ICF 12|139|||
125495041|NCT00490139|451444331|FG003|Overall Study|Patient did not sign ICF 12|167|||
125495042|NCT00490139|451444328|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
125495043|NCT00490139|451444329|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
125304097|NCT02147288|450739657|FG004|Overall Study|complications from concurrent hernia rep|0|||
125309881|NCT00511238|450760204|FG000|Overall Study|Adverse Event|13|||
125495044|NCT00490139|451444330|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
125495045|NCT00490139|451444331|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
125495046|NCT00490139|451444328|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
125495047|NCT00490139|451444329|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
125495048|NCT00490139|451444330|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
125495049|NCT00490139|451444331|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
125495050|NCT00490139|451444328|FG000|Overall Study|Other reasons as defined per protocol|98|||
125495051|NCT00490139|451444329|FG001|Overall Study|Other reasons as defined per protocol|84|||
125495052|NCT00490139|451444330|FG002|Overall Study|Other reasons as defined per protocol|82|||
125495053|NCT00490139|451444331|FG003|Overall Study|Other reasons as defined per protocol|105|||
125495054|NCT02798471|451444334|FG000|Overall Study|Adverse Event|7|||
125495055|NCT02798471|451444335|FG001|Overall Study|Adverse Event|2|||
125495056|NCT02798471|451444334|FG000|Overall Study|Physician Decision|3|||
125495057|NCT02798471|451444335|FG001|Overall Study|Physician Decision|7|||
125495058|NCT02798471|451444334|FG000|Overall Study|Death|2|||
125495059|NCT02798471|451444335|FG001|Overall Study|Death|3|||
125495060|NCT02798471|451444334|FG000|Overall Study|Lost to Follow-up|0|||
125495061|NCT02798471|451444335|FG001|Overall Study|Lost to Follow-up|1|||
125495062|NCT02798471|451444334|FG000|Overall Study|Other|5|||
125495063|NCT02798471|451444335|FG001|Overall Study|Other|3|||
125495064|NCT02798471|451444334|FG000|Overall Study|Subject withdrew consent|0|||
125495065|NCT02798471|451444335|FG001|Overall Study|Subject withdrew consent|6|||
125495066|NCT02798471|451444334|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
125495067|NCT02798471|451444335|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
125495068|NCT02798471|451444334|FG000|Overall Study|Randomized, but not treated|0|||
125495069|NCT02798471|451444335|FG001|Overall Study|Randomized, but not treated|2|||
125495070|NCT05293717|451444336|FG000|Overall Study|Physician Decision|1|||
125495071|NCT03762850|451445622|FG000|Overall Study|Death|0|||
125495072|NCT03762850|451445623|FG001|Overall Study|Death|1|||
125495073|NCT03762850|451445622|FG000|Overall Study|Lost to Follow-up|0|||
125495074|NCT03762850|451445623|FG001|Overall Study|Lost to Follow-up|1|||
125495075|NCT03762850|451445622|FG000|Overall Study|Physician Decision|0|||
125495076|NCT03762850|451445623|FG001|Overall Study|Physician Decision|1|||
125495077|NCT03762850|451445622|FG000|Overall Study|Withdrawal by Subject|4|||
125495078|NCT03762850|451445623|FG001|Overall Study|Withdrawal by Subject|9|||
125495079|NCT03083366|451445624|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
125495080|NCT03083366|451445625|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
125495081|NCT03083366|451445624|FG000|Enrollment Period|Lack of Efficacy|1|||
125495082|NCT03083366|451445625|FG001|Enrollment Period|Lack of Efficacy|0|||
125495083|NCT04989816|451445630|FG000|Overall Study|Death|77|||
125495084|NCT04989816|451445630|FG000|Overall Study|Lost to Follow-up|3|||
125495085|NCT01982682|451445631|FG000|Overall Study|Physician Decision|1|||
125495086|NCT00210106|451445632|FG000|Overall Study|Death|1|||
125495087|NCT00210106|451445632|FG000|Overall Study|Protocol Violation|13|||
125495088|NCT00065182|451445641|FG000|Overall Study|Adverse Event|24|||
125495089|NCT00065182|451445642|FG001|Overall Study|Adverse Event|17|||
125495090|NCT00065182|451445641|FG000|Overall Study|Lost to Follow-up|0|||
125495091|NCT00065182|451445642|FG001|Overall Study|Lost to Follow-up|4|||
125495092|NCT00065182|451445641|FG000|Overall Study|Protocol Violation|3|||
125495093|NCT00065182|451445642|FG001|Overall Study|Protocol Violation|4|||
125495094|NCT00065182|451445641|FG000|Overall Study|Serious adverse events (SAE)|1|||
125495095|NCT00065182|451445642|FG001|Overall Study|Serious adverse events (SAE)|0|||
125495096|NCT00065182|451445641|FG000|Overall Study|Sponsor Decision|11|||
125495097|NCT00065182|451445642|FG001|Overall Study|Sponsor Decision|7|||
125495098|NCT00065182|451445641|FG000|Overall Study|Withdrawal by Subject|8|||
125495099|NCT00065182|451445642|FG001|Overall Study|Withdrawal by Subject|3|||
125495100|NCT00065182|451445641|FG000|Overall Study|No clinical benefit|1|||
125495101|NCT00065182|451445642|FG001|Overall Study|No clinical benefit|0|||
125495102|NCT00065182|451445641|FG000|Overall Study|Death|0|||
125495103|NCT00065182|451445642|FG001|Overall Study|Death|1|||
125495104|NCT00065182|451445641|FG000|Overall Study|Decline in Status|0|||
125495105|NCT00065182|451445642|FG001|Overall Study|Decline in Status|1|||
125495106|NCT00754325|451445643|FG000|Initial Treatment|Continuing Active Treatment|4|||
125495107|NCT00754325|451445644|FG001|Initial Treatment|Continuing Active Treatment|5|||
125495108|NCT00754325|451445643|FG000|Initial Treatment|Adverse Event|7|||
125495109|NCT00754325|451445644|FG001|Initial Treatment|Adverse Event|6|||
125495110|NCT00754325|451445643|FG000|Initial Treatment|Withdrawal by Subject|2|||
125495111|NCT00754325|451445644|FG001|Initial Treatment|Withdrawal by Subject|2|||
125495112|NCT00754325|451445643|FG000|Initial Treatment|Physician Decision|2|||
125495113|NCT00754325|451445644|FG001|Initial Treatment|Physician Decision|0|||
125495114|NCT00754325|451445643|FG000|Initial Treatment|Sponsor Request|0|||
125495115|NCT00754325|451445644|FG001|Initial Treatment|Sponsor Request|1|||
125495116|NCT00754325|451445643|FG000|Initial Treatment|Disease Progression|35|||
125495117|NCT00754325|451445644|FG001|Initial Treatment|Disease Progression|35|||
125495118|NCT01750684|451445649|FG000|Overall Study|Death|1|||
125495119|NCT01750684|451445650|FG001|Overall Study|Death|0|||
125495120|NCT01750684|451445649|FG000|Overall Study|Non-compliance with Study Drug|0|||
125495121|NCT01750684|451445650|FG001|Overall Study|Non-compliance with Study Drug|1|||
125304098|NCT02147288|450739658|FG005|Overall Study|complications from concurrent hernia rep|0|||
125495122|NCT01750684|451445649|FG000|Overall Study|Withdrawn by Sponsor|0|||
125495123|NCT01750684|451445650|FG001|Overall Study|Withdrawn by Sponsor|1|||
125495124|NCT01750684|451445649|FG000|Overall Study|Protocol Violation|1|||
125495125|NCT01750684|451445650|FG001|Overall Study|Protocol Violation|0|||
125495126|NCT02185794|451445652|FG000|Overall Study|Enrolled but Never Dosed|1|||
125495127|NCT02185794|451445653|FG001|Overall Study|Enrolled but Never Dosed|6|||
125495128|NCT02185794|451445654|FG002|Overall Study|Enrolled but Never Dosed|3|||
125304099|NCT02147288|450739659|FG006|Overall Study|complications from concurrent hernia rep|0|||
125495129|NCT02185794|451445655|FG003|Overall Study|Enrolled but Never Dosed|1|||
125495130|NCT02185794|451445656|FG004|Overall Study|Enrolled but Never Dosed|1|||
125495131|NCT02185794|451445657|FG005|Overall Study|Enrolled but Never Dosed|0|||
125495132|NCT02185794|451445652|FG000|Overall Study|Investigator's Discretion|1|||
125495133|NCT02185794|451445653|FG001|Overall Study|Investigator's Discretion|0|||
125495134|NCT02185794|451445654|FG002|Overall Study|Investigator's Discretion|1|||
125495135|NCT02185794|451445655|FG003|Overall Study|Investigator's Discretion|2|||
125495136|NCT02185794|451445656|FG004|Overall Study|Investigator's Discretion|2|||
125495137|NCT02185794|451445657|FG005|Overall Study|Investigator's Discretion|15|||
125495138|NCT02185794|451445652|FG000|Overall Study|Withdrew Consent|2|||
125495139|NCT02185794|451445653|FG001|Overall Study|Withdrew Consent|5|||
125495140|NCT02185794|451445654|FG002|Overall Study|Withdrew Consent|10|||
125495141|NCT02185794|451445655|FG003|Overall Study|Withdrew Consent|2|||
125495142|NCT02185794|451445656|FG004|Overall Study|Withdrew Consent|0|||
125495143|NCT02185794|451445657|FG005|Overall Study|Withdrew Consent|0|||
125495144|NCT02185794|451445652|FG000|Overall Study|Lost to Follow-up|1|||
125495145|NCT02185794|451445653|FG001|Overall Study|Lost to Follow-up|2|||
125495146|NCT02185794|451445654|FG002|Overall Study|Lost to Follow-up|2|||
125495147|NCT02185794|451445655|FG003|Overall Study|Lost to Follow-up|3|||
125495148|NCT02185794|451445656|FG004|Overall Study|Lost to Follow-up|0|||
125495149|NCT02185794|451445657|FG005|Overall Study|Lost to Follow-up|1|||
125495150|NCT01092416|451445658|FG000|Enrollment|Atherectomy device not inserted|3|||
125495151|NCT01092416|451445658|FG000|30-Day Follow-up|Death|2|||
125495152|NCT01092416|451445658|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
125495153|NCT01092416|451445658|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
125495154|NCT01092416|451445658|FG000|12-Month Follow-up|Death|16|||
125495155|NCT01092416|451445658|FG000|12-Month Follow-up|Lost to Follow-up|4|||
125495156|NCT01092416|451445658|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
125495157|NCT01092416|451445658|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
125495158|NCT01092416|451445658|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
125495159|NCT00366249|451445659|FG000|Overall Study|Adverse Event|53|||
125495160|NCT00366249|451445660|FG001|Overall Study|Adverse Event|28|||
125495161|NCT00366249|451445659|FG000|Overall Study|Death|0|||
125495162|NCT00366249|451445660|FG001|Overall Study|Death|1|||
125495163|NCT00366249|451445659|FG000|Overall Study|Physician Decision|5|||
125495164|NCT00366249|451445660|FG001|Overall Study|Physician Decision|2|||
125495165|NCT00366249|451445659|FG000|Overall Study|Lost to Follow-up|2|||
125495166|NCT00366249|451445660|FG001|Overall Study|Lost to Follow-up|0|||
125495167|NCT00366249|451445659|FG000|Overall Study|Protocol Violation|1|||
125495168|NCT00366249|451445660|FG001|Overall Study|Protocol Violation|2|||
125495169|NCT00366249|451445659|FG000|Overall Study|Withdrawal by Subject|18|||
125495170|NCT00366249|451445660|FG001|Overall Study|Withdrawal by Subject|4|||
125495171|NCT00366249|451445659|FG000|Overall Study|Lack of Efficacy|21|||
125495172|NCT00366249|451445660|FG001|Overall Study|Lack of Efficacy|21|||
125495173|NCT00366249|451445659|FG000|Overall Study|Most due to osteomylitis status|31|||
125495174|NCT00366249|451445660|FG001|Overall Study|Most due to osteomylitis status|20|||
125495175|NCT00777049|451445661|FG000|Overall Study|Withdrawal by Subject|1|||
125495176|NCT00777049|451445662|FG001|Overall Study|Withdrawal by Subject|0|||
125495177|NCT00777049|451445661|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
125495178|NCT00777049|451445662|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
125495179|NCT03478969|451445663|FG000|Overall Study|Withdrawal by Subject|4|||
125495180|NCT03478969|451445664|FG001|Overall Study|Withdrawal by Subject|7|||
125495181|NCT03478969|451445665|FG002|Overall Study|Withdrawal by Subject|6|||
125495182|NCT03478969|451445663|FG000|Overall Study|Adverse Event|2|||
125495183|NCT03478969|451445664|FG001|Overall Study|Adverse Event|0|||
125495184|NCT03478969|451445665|FG002|Overall Study|Adverse Event|1|||
125495185|NCT03478969|451445663|FG000|Overall Study|Pregnancy|1|||
125495186|NCT03478969|451445664|FG001|Overall Study|Pregnancy|0|||
125495187|NCT03478969|451445665|FG002|Overall Study|Pregnancy|0|||
125495188|NCT03478969|451445663|FG000|Overall Study|Personal Reasons|1|||
125495189|NCT03478969|451445664|FG001|Overall Study|Personal Reasons|0|||
125495190|NCT03478969|451445665|FG002|Overall Study|Personal Reasons|1|||
125495191|NCT03478969|451445663|FG000|Overall Study|Covid-19|1|||
125495192|NCT03478969|451445664|FG001|Overall Study|Covid-19|4|||
125495193|NCT03478969|451445665|FG002|Overall Study|Covid-19|3|||
125495194|NCT03478969|451445663|FG000|Overall Study|Multiple Reasons|0|||
125304100|NCT02147288|450739660|FG007|Overall Study|complications from concurrent hernia rep|0|||
125304101|NCT02147288|450739661|FG008|Overall Study|complications from concurrent hernia rep|0|||
125304102|NCT02147288|450739662|FG009|Overall Study|complications from concurrent hernia rep|0|||
125304103|NCT02467582|450741192|FG000|Allocation|Withdrawal by Subject|1|||
125304104|NCT02467582|450741193|FG001|Allocation|Withdrawal by Subject|0|||
125304105|NCT02467582|450741192|FG000|Follow-up|Death|5|||
125495195|NCT03478969|451445664|FG001|Overall Study|Multiple Reasons|1|||
125495196|NCT03478969|451445665|FG002|Overall Study|Multiple Reasons|1|||
125495197|NCT03478969|451445663|FG000|Overall Study|Eligibility Criteria|0|||
125304106|NCT02467582|450741193|FG001|Follow-up|Death|4|||
125495198|NCT03478969|451445664|FG001|Overall Study|Eligibility Criteria|0|||
125495199|NCT03478969|451445665|FG002|Overall Study|Eligibility Criteria|5|||
125495200|NCT03478969|451445663|FG000|Overall Study|Lost to Follow-up|0|||
125495201|NCT03478969|451445664|FG001|Overall Study|Lost to Follow-up|0|||
125495202|NCT03478969|451445665|FG002|Overall Study|Lost to Follow-up|1|||
125495203|NCT01185600|451445666|FG000|Overall Study|Adverse Event|1|||
125495204|NCT01185600|451445667|FG001|Overall Study|Adverse Event|1|||
125495205|NCT01185600|451445666|FG000|Overall Study|Death|0|||
125495206|NCT01185600|451445667|FG001|Overall Study|Death|1|||
125495207|NCT01185600|451445666|FG000|Overall Study|Lost to Follow-up|0|||
125495208|NCT01185600|451445667|FG001|Overall Study|Lost to Follow-up|5|||
125495209|NCT01185600|451445666|FG000|Overall Study|Physician Decision|29|||
125495210|NCT01185600|451445667|FG001|Overall Study|Physician Decision|35|||
125495211|NCT01185600|451445666|FG000|Overall Study|Withdrawal by Subject|1|||
125495212|NCT01185600|451445667|FG001|Overall Study|Withdrawal by Subject|1|||
125495213|NCT01185600|451445666|FG000|Overall Study|Hold by DSMB|1|||
125495214|NCT01185600|451445667|FG001|Overall Study|Hold by DSMB|2|||
125495215|NCT02941549|451445668|FG000|Overall Study|Adverse Event|1|||
125495216|NCT02941549|451445669|FG001|Overall Study|Adverse Event|0|||
125495217|NCT02941549|451445670|FG002|Overall Study|Adverse Event|0|||
125495218|NCT02941549|451445668|FG000|Overall Study|Withdrawal by Subject|2|||
125495219|NCT02941549|451445669|FG001|Overall Study|Withdrawal by Subject|1|||
125495220|NCT02941549|451445670|FG002|Overall Study|Withdrawal by Subject|2|||
125495221|NCT01436175|451445671|FG000|Overall Study|Adverse Event|111|||
125495222|NCT01436175|451445671|FG000|Overall Study|Protocol Violation|49|||
125495223|NCT01436175|451445671|FG000|Overall Study|Withdrawal by Subject|108|||
125495224|NCT01436175|451445671|FG000|Overall Study|Lost to Follow-up|89|||
125495225|NCT01436175|451445671|FG000|Overall Study|Lack of Efficacy|24|||
125495226|NCT01436175|451445671|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
125495227|NCT01436175|451445671|FG000|Overall Study|Other|826|||
125495228|NCT05405244|451445673|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
125495229|NCT05405244|451445674|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
125495230|NCT05405244|451445673|FG000|Washout (2 Weeks)|Adverse Event|2|||
125495231|NCT05405244|451445674|FG001|Washout (2 Weeks)|Adverse Event|0|||
125495232|NCT05405244|451445673|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
125495233|NCT05405244|451445674|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
125495234|NCT00739934|451445677|FG000|Voriconazole IV|Adverse Event|6|||
125495235|NCT00739934|451445677|FG000|Voriconazole Oral|Other|3|||
125495236|NCT03418922|451445678|FG000|Overall Study|Withdrawal by Subject|0|||
125495237|NCT03418922|451445679|FG001|Overall Study|Withdrawal by Subject|2|||
125495238|NCT03418922|451445678|FG000|Overall Study|Adverse Event|2|||
125495239|NCT03418922|451445679|FG001|Overall Study|Adverse Event|2|||
125495240|NCT03418922|451445678|FG000|Overall Study|Death|0|||
125495241|NCT03418922|451445679|FG001|Overall Study|Death|1|||
125495242|NCT03418922|451445678|FG000|Overall Study|Physician Decision|0|||
125495243|NCT03418922|451445679|FG001|Overall Study|Physician Decision|1|||
125495244|NCT03577106|451445680|FG000|Overall Study|Withdrawal by Subject|3|||
125495245|NCT03451422|451445681|FG000|Overall Study|Lost to Follow-up|0|||
125495246|NCT03451422|451445682|FG001|Overall Study|Lost to Follow-up|0|||
125495247|NCT03451422|451445683|FG002|Overall Study|Lost to Follow-up|0|||
125495248|NCT03451422|451445684|FG003|Overall Study|Lost to Follow-up|0|||
125495249|NCT03451422|451445685|FG004|Overall Study|Lost to Follow-up|0|||
125495250|NCT03451422|451445686|FG005|Overall Study|Lost to Follow-up|1|||
125495251|NCT03451422|451445681|FG000|Overall Study|Decision by sponsor|1|||
125495252|NCT03451422|451445682|FG001|Overall Study|Decision by sponsor|0|||
125495253|NCT03451422|451445683|FG002|Overall Study|Decision by sponsor|1|||
125495254|NCT03451422|451445684|FG003|Overall Study|Decision by sponsor|0|||
125495255|NCT03451422|451445685|FG004|Overall Study|Decision by sponsor|0|||
125495256|NCT03451422|451445686|FG005|Overall Study|Decision by sponsor|0|||
125495257|NCT03451422|451445681|FG000|Overall Study|Withdrawal by Subject|0|||
125495258|NCT03451422|451445682|FG001|Overall Study|Withdrawal by Subject|0|||
125495259|NCT03451422|451445683|FG002|Overall Study|Withdrawal by Subject|2|||
125495260|NCT03451422|451445684|FG003|Overall Study|Withdrawal by Subject|3|||
125304107|NCT02467582|450741192|FG000|Follow-up|Lost to Follow-up|6|||
125304108|NCT02467582|450741193|FG001|Follow-up|Lost to Follow-up|5|||
125495261|NCT03451422|451445685|FG004|Overall Study|Withdrawal by Subject|2|||
125495262|NCT03451422|451445686|FG005|Overall Study|Withdrawal by Subject|1|||
125495263|NCT03601715|451445689|FG000|Second Intervention|Lost to Follow-up|1|||
125495264|NCT03601715|451445690|FG001|Second Intervention|Lost to Follow-up|1|||
125495265|NCT03601715|451445691|FG002|Second Intervention|Lost to Follow-up|0|||
125495266|NCT00918333|451445694|FG000|Overall Study|Drug not taken per protocol|1|||
125495267|NCT00918333|451445695|FG001|Overall Study|Drug not taken per protocol|0|||
125495268|NCT00918333|451445694|FG000|Overall Study|Inadequate amount of drugs provided|1|||
125495269|NCT00918333|451445695|FG001|Overall Study|Inadequate amount of drugs provided|4|||
125495270|NCT00918333|451445694|FG000|Overall Study|Ineligible|1|||
125495271|NCT00918333|451445695|FG001|Overall Study|Ineligible|0|||
125495272|NCT00918333|451445694|FG000|Overall Study|Withdrawal by Subject|0|||
125495273|NCT00918333|451445695|FG001|Overall Study|Withdrawal by Subject|1|||
125304109|NCT01370265|450741194|FG000|First Intervention|Adverse Event|1|||
125495274|NCT01313884|451445697|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
125495275|NCT00263757|451445698|FG000|Overall Study|Withdrawal by Subject|5|||
125495276|NCT00263757|451445699|FG001|Overall Study|Withdrawal by Subject|4|||
125495277|NCT00263757|451445698|FG000|Overall Study|Screen failure|0|||
125495278|NCT00263757|451445699|FG001|Overall Study|Screen failure|1|||
125495279|NCT00263757|451445698|FG000|Overall Study|Adverse Event|3|||
125495280|NCT00263757|451445699|FG001|Overall Study|Adverse Event|3|||
125495281|NCT01342367|451445700|FG000|Overall Study|Death|1|||
125495282|NCT01342367|451445701|FG001|Overall Study|Death|0|||
125495283|NCT01342367|451445700|FG000|Overall Study|Withdrawal by Subject|1|||
125495284|NCT01342367|451445701|FG001|Overall Study|Withdrawal by Subject|2|||
125495285|NCT00640159|451445702|FG000|Overall Study|Lost to Follow-up|2|||
125495286|NCT04860505|451445709|FG000|Overall Study|Lost to Follow-up|2|||
125495287|NCT01218659|451445712|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
125495288|NCT01218659|451445713|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
125495289|NCT01218659|451445714|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
125495290|NCT01218659|451445712|FG000|18-Month Randomized Period|Did not receive study drug|0|||
125495291|NCT01218659|451445713|FG001|18-Month Randomized Period|Did not receive study drug|3|||
125495292|NCT01218659|451445714|FG002|18-Month Randomized Period|Did not receive study drug|0|||
125495293|NCT01218659|451445712|FG000|12-Month OLE|Withdrawal by Subject|0|||
125495294|NCT01218659|451445713|FG001|12-Month OLE|Withdrawal by Subject|0|||
125495295|NCT01218659|451445714|FG002|12-Month OLE|Withdrawal by Subject|2|||
125495296|NCT01218659|451445712|FG000|12-Month OLE|Physician Decision|0|||
125495297|NCT01218659|451445713|FG001|12-Month OLE|Physician Decision|0|||
125495298|NCT01218659|451445714|FG002|12-Month OLE|Physician Decision|1|||
125495299|NCT01218659|451445712|FG000|12-Month OLE|Lost to Follow-up|0|||
125495300|NCT01218659|451445713|FG001|12-Month OLE|Lost to Follow-up|0|||
125495301|NCT01218659|451445714|FG002|12-Month OLE|Lost to Follow-up|1|||
125495302|NCT01218659|451445712|FG000|12-Month OLE|Pregnancy|0|||
125495303|NCT01218659|451445713|FG001|12-Month OLE|Pregnancy|0|||
125495304|NCT01218659|451445714|FG002|12-Month OLE|Pregnancy|1|||
125495305|NCT01218659|451445712|FG000|12-Month OLE|Lack of Efficacy|0|||
125495306|NCT01218659|451445713|FG001|12-Month OLE|Lack of Efficacy|0|||
125495307|NCT01218659|451445714|FG002|12-Month OLE|Lack of Efficacy|1|||
125495308|NCT01218659|451445712|FG000|12-Month OLE|Declined to participate in the OLE|0|||
125495309|NCT01218659|451445713|FG001|12-Month OLE|Declined to participate in the OLE|0|||
125495310|NCT01218659|451445714|FG002|12-Month OLE|Declined to participate in the OLE|4|||
125495311|NCT03066609|451445719|FG000|INDUCTION|Pregnancy|0|||
125495312|NCT03066609|451445720|FG001|INDUCTION|Pregnancy|0|||
125495313|NCT03066609|451445721|FG002|INDUCTION|Pregnancy|1|||
125495314|NCT03066609|451445722|FG003|INDUCTION|Pregnancy|0|||
125495315|NCT03066609|451445719|FG000|INDUCTION|Lack of Efficacy|0|||
125495316|NCT03066609|451445720|FG001|INDUCTION|Lack of Efficacy|0|||
125495317|NCT03066609|451445721|FG002|INDUCTION|Lack of Efficacy|1|||
125495318|NCT03066609|451445722|FG003|INDUCTION|Lack of Efficacy|0|||
125495319|NCT03066609|451445719|FG000|INDUCTION|Adverse Event|2|||
125495320|NCT03066609|451445720|FG001|INDUCTION|Adverse Event|2|||
125495321|NCT03066609|451445721|FG002|INDUCTION|Adverse Event|0|||
125495322|NCT03066609|451445722|FG003|INDUCTION|Adverse Event|0|||
125495323|NCT03066609|451445719|FG000|MAINTENANCE|Adverse Event|0|||
125495324|NCT03066609|451445720|FG001|MAINTENANCE|Adverse Event|0|||
125495325|NCT03066609|451445721|FG002|MAINTENANCE|Adverse Event|0|||
125495326|NCT03066609|451445722|FG003|MAINTENANCE|Adverse Event|1|||
125495327|NCT03066609|451445719|FG000|MAINTENANCE|Withdrawal by Subject|4|||
125495328|NCT03066609|451445720|FG001|MAINTENANCE|Withdrawal by Subject|2|||
125495329|NCT03066609|451445721|FG002|MAINTENANCE|Withdrawal by Subject|1|||
125495330|NCT03066609|451445722|FG003|MAINTENANCE|Withdrawal by Subject|1|||
125495331|NCT03066609|451445719|FG000|MAINTENANCE|Lost to Follow-up|0|||
125495332|NCT03066609|451445720|FG001|MAINTENANCE|Lost to Follow-up|1|||
125495333|NCT03066609|451445721|FG002|MAINTENANCE|Lost to Follow-up|1|||
125495334|NCT03066609|451445722|FG003|MAINTENANCE|Lost to Follow-up|0|||
125495335|NCT03066609|451445719|FG000|MAINTENANCE|Pregnancy|1|||
125495336|NCT03066609|451445720|FG001|MAINTENANCE|Pregnancy|0|||
125495337|NCT03066609|451445721|FG002|MAINTENANCE|Pregnancy|0|||
125495338|NCT03066609|451445722|FG003|MAINTENANCE|Pregnancy|0|||
125304110|NCT01370265|450741195|FG001|First Intervention|Adverse Event|1|||
125304111|NCT02611817|450741196|FG000|Open-label Induction Phase|Reason not Specified|9|||
125304112|NCT02611817|450741197|FG001|Open-label Induction Phase|Reason not Specified|0|||
125495339|NCT03066609|451445719|FG000|MAINTENANCE|Lack of Efficacy|2|||
125304113|NCT02611817|450741198|FG002|Open-label Induction Phase|Reason not Specified|0|||
125495340|NCT03066609|451445720|FG001|MAINTENANCE|Lack of Efficacy|1|||
125495341|NCT03066609|451445721|FG002|MAINTENANCE|Lack of Efficacy|0|||
125495342|NCT03066609|451445722|FG003|MAINTENANCE|Lack of Efficacy|1|||
125495343|NCT03066609|451445719|FG000|OVERALL STUDY|Adverse Event|2|||
125495344|NCT03066609|451445720|FG001|OVERALL STUDY|Adverse Event|2|||
125495345|NCT03066609|451445721|FG002|OVERALL STUDY|Adverse Event|0|||
125495346|NCT03066609|451445722|FG003|OVERALL STUDY|Adverse Event|1|||
125495347|NCT03066609|451445719|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
125495348|NCT03066609|451445720|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
125495349|NCT03066609|451445721|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
125495350|NCT03066609|451445722|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
125495351|NCT03066609|451445719|FG000|OVERALL STUDY|Lost to Follow-up|1|||
125495352|NCT03066609|451445720|FG001|OVERALL STUDY|Lost to Follow-up|1|||
125495353|NCT03066609|451445721|FG002|OVERALL STUDY|Lost to Follow-up|1|||
125495354|NCT03066609|451445722|FG003|OVERALL STUDY|Lost to Follow-up|1|||
125495355|NCT03066609|451445719|FG000|OVERALL STUDY|Pregnancy|1|||
125495356|NCT03066609|451445720|FG001|OVERALL STUDY|Pregnancy|0|||
125495357|NCT03066609|451445721|FG002|OVERALL STUDY|Pregnancy|1|||
125495358|NCT03066609|451445722|FG003|OVERALL STUDY|Pregnancy|0|||
125495359|NCT03066609|451445719|FG000|OVERALL STUDY|Lack of Efficacy|2|||
125495360|NCT03066609|451445720|FG001|OVERALL STUDY|Lack of Efficacy|1|||
125495361|NCT03066609|451445721|FG002|OVERALL STUDY|Lack of Efficacy|1|||
125495362|NCT03066609|451445722|FG003|OVERALL STUDY|Lack of Efficacy|1|||
125495363|NCT03066609|451445719|FG000|OVERALL STUDY|discontinued follow up|0|||
125495364|NCT03066609|451445720|FG001|OVERALL STUDY|discontinued follow up|2|||
125495365|NCT03066609|451445721|FG002|OVERALL STUDY|discontinued follow up|0|||
125495366|NCT03066609|451445722|FG003|OVERALL STUDY|discontinued follow up|0|||
125495367|NCT00523419|451445726|FG000|Overall Study|Adverse Event|1|||
125495368|NCT00523419|451445726|FG000|Overall Study|Withdrawal by Subject|1|||
125495369|NCT00523419|451445726|FG000|Overall Study|Physician Decision|2|||
125495370|NCT00523419|451445726|FG000|Overall Study|Progressive Disease|22|||
125495371|NCT00523419|451445726|FG000|Overall Study|Death due to Study Disease|4|||
125495372|NCT00523419|451445726|FG000|Overall Study|Death due to Adverse Event|2|||
125495373|NCT01437319|451445729|FG000|Phase I|Lost to Follow-up|2|||
125495374|NCT01437319|451445730|FG001|Phase I|Lost to Follow-up|0|||
125495375|NCT01437319|451445731|FG002|Phase I|Lost to Follow-up|0|||
125495376|NCT01437319|451445729|FG000|Phase I|Protocol Violation|1|||
125495377|NCT01437319|451445730|FG001|Phase I|Protocol Violation|0|||
125495378|NCT01437319|451445731|FG002|Phase I|Protocol Violation|0|||
125495379|NCT01437319|451445729|FG000|Phase I|Study related symptoms/complaints|27|||
125495380|NCT01437319|451445730|FG001|Phase I|Study related symptoms/complaints|0|||
125495381|NCT01437319|451445731|FG002|Phase I|Study related symptoms/complaints|0|||
125495382|NCT01437319|451445729|FG000|Phase I|Withdrawal by Subject|25|||
125495383|NCT01437319|451445730|FG001|Phase I|Withdrawal by Subject|0|||
125495384|NCT01437319|451445731|FG002|Phase I|Withdrawal by Subject|0|||
125495385|NCT01437319|451445729|FG000|Phase II|Withdrawal by Subject|0|||
125495386|NCT01437319|451445730|FG001|Phase II|Withdrawal by Subject|8|||
125495387|NCT01437319|451445731|FG002|Phase II|Withdrawal by Subject|16|||
125495388|NCT01437319|451445729|FG000|Phase II|Lost to Follow-up|0|||
125495389|NCT01437319|451445730|FG001|Phase II|Lost to Follow-up|7|||
125495390|NCT01437319|451445731|FG002|Phase II|Lost to Follow-up|2|||
125495391|NCT01437319|451445729|FG000|Phase II|Study related symptoms/complaints|0|||
125495392|NCT01437319|451445730|FG001|Phase II|Study related symptoms/complaints|28|||
125495393|NCT01437319|451445731|FG002|Phase II|Study related symptoms/complaints|19|||
125495394|NCT01437319|451445729|FG000|Phase II|Protocol Violation|0|||
125495395|NCT01437319|451445730|FG001|Phase II|Protocol Violation|1|||
125495396|NCT01437319|451445731|FG002|Phase II|Protocol Violation|0|||
125495397|NCT01499849|451445732|FG000|Overall Study|Adverse Event|28|||
125495398|NCT01499849|451445733|FG001|Overall Study|Adverse Event|32|||
125495399|NCT01499849|451445732|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
125495400|NCT01499849|451445733|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
125495401|NCT01499849|451445732|FG000|Overall Study|Withdrawal by Subject|43|||
125495402|NCT01499849|451445733|FG001|Overall Study|Withdrawal by Subject|43|||
125495403|NCT01499849|451445732|FG000|Overall Study|Death|5|||
125495404|NCT01499849|451445733|FG001|Overall Study|Death|7|||
125495405|NCT01499849|451445732|FG000|Overall Study|Disease Progression|11|||
125495406|NCT01499849|451445733|FG001|Overall Study|Disease Progression|10|||
125495407|NCT01499849|451445732|FG000|Overall Study|Protocol Violation|11|||
125495408|NCT01499849|451445733|FG001|Overall Study|Protocol Violation|11|||
125495409|NCT01499849|451445732|FG000|Overall Study|Physician Decision|20|||
125495410|NCT01499849|451445733|FG001|Overall Study|Physician Decision|19|||
125495411|NCT01499849|451445732|FG000|Overall Study|Lack of Efficacy|3|||
125495412|NCT01499849|451445733|FG001|Overall Study|Lack of Efficacy|4|||
125495413|NCT01499849|451445732|FG000|Overall Study|Lost to Follow-up|6|||
125495414|NCT01499849|451445733|FG001|Overall Study|Lost to Follow-up|3|||
125495415|NCT01499849|451445732|FG000|Overall Study|Other Reasons|27|||
125495416|NCT01499849|451445733|FG001|Overall Study|Other Reasons|30|||
125495417|NCT00811941|451445734|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
125495418|NCT00811941|451445735|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
125495419|NCT00811941|451445734|FG000|All Treated Patients|Adverse Event|2|||
125495420|NCT00811941|451445735|FG001|All Treated Patients|Adverse Event|43|||
125495421|NCT00811941|451445734|FG000|All Treated Patients|Lack of Efficacy|2|||
125495422|NCT00811941|451445735|FG001|All Treated Patients|Lack of Efficacy|3|||
125495423|NCT00811941|451445734|FG000|All Treated Patients|Non-compliance|1|||
125495424|NCT00811941|451445735|FG001|All Treated Patients|Non-compliance|8|||
125495425|NCT00811941|451445734|FG000|All Treated Patients|Protocol Violation|5|||
125495426|NCT00811941|451445735|FG001|All Treated Patients|Protocol Violation|17|||
125495427|NCT00811941|451445734|FG000|All Treated Patients|Withdrawal by Subject|35|||
125495428|NCT00811941|451445735|FG001|All Treated Patients|Withdrawal by Subject|94|||
125495429|NCT00811941|451445734|FG000|All Treated Patients|Lost to Follow-up|3|||
125495430|NCT00811941|451445735|FG001|All Treated Patients|Lost to Follow-up|12|||
125495431|NCT00811941|451445734|FG000|All Treated Patients|Other Reason|4|||
125495432|NCT00811941|451445735|FG001|All Treated Patients|Other Reason|14|||
125495433|NCT00622700|451445738|FG000|Core Treatment Period|Randomized but Not Treated|0|||
125495434|NCT00622700|451445739|FG001|Core Treatment Period|Randomized but Not Treated|2|||
125495435|NCT00622700|451445740|FG002|Core Treatment Period|Randomized but Not Treated|2|||
125495436|NCT00622700|451445741|FG003|Core Treatment Period|Randomized but Not Treated|0|||
125495437|NCT00622700|451445742|FG004|Core Treatment Period|Randomized but Not Treated|0|||
125495438|NCT00622700|451445743|FG005|Core Treatment Period|Randomized but Not Treated|0|||
125495439|NCT00622700|451445744|FG006|Core Treatment Period|Randomized but Not Treated|0|||
125495440|NCT00622700|451445738|FG000|Core Treatment Period|Adverse Event|18|||
125495441|NCT00622700|451445739|FG001|Core Treatment Period|Adverse Event|25|||
125495442|NCT00622700|451445740|FG002|Core Treatment Period|Adverse Event|18|||
125495443|NCT00622700|451445741|FG003|Core Treatment Period|Adverse Event|0|||
125495444|NCT00622700|451445742|FG004|Core Treatment Period|Adverse Event|0|||
125495445|NCT00622700|451445743|FG005|Core Treatment Period|Adverse Event|0|||
125495446|NCT00622700|451445744|FG006|Core Treatment Period|Adverse Event|0|||
125495447|NCT00622700|451445738|FG000|Core Treatment Period|Lack of Efficacy|19|||
125495448|NCT00622700|451445739|FG001|Core Treatment Period|Lack of Efficacy|6|||
125495449|NCT00622700|451445740|FG002|Core Treatment Period|Lack of Efficacy|12|||
125495450|NCT00622700|451445741|FG003|Core Treatment Period|Lack of Efficacy|0|||
125495451|NCT00622700|451445742|FG004|Core Treatment Period|Lack of Efficacy|0|||
125495452|NCT00622700|451445743|FG005|Core Treatment Period|Lack of Efficacy|0|||
125495453|NCT00622700|451445744|FG006|Core Treatment Period|Lack of Efficacy|0|||
125495454|NCT00622700|451445738|FG000|Core Treatment Period|Lost to Follow-up|1|||
125495455|NCT00622700|451445739|FG001|Core Treatment Period|Lost to Follow-up|1|||
125495456|NCT00622700|451445740|FG002|Core Treatment Period|Lost to Follow-up|1|||
125495457|NCT00622700|451445741|FG003|Core Treatment Period|Lost to Follow-up|0|||
125495458|NCT00622700|451445742|FG004|Core Treatment Period|Lost to Follow-up|0|||
125495459|NCT00622700|451445743|FG005|Core Treatment Period|Lost to Follow-up|0|||
125495460|NCT00622700|451445744|FG006|Core Treatment Period|Lost to Follow-up|0|||
125495461|NCT00622700|451445738|FG000|Core Treatment Period|Death|1|||
125495462|NCT00622700|451445739|FG001|Core Treatment Period|Death|0|||
125495463|NCT00622700|451445740|FG002|Core Treatment Period|Death|0|||
125495464|NCT00622700|451445741|FG003|Core Treatment Period|Death|0|||
125495465|NCT00622700|451445742|FG004|Core Treatment Period|Death|0|||
125495466|NCT00622700|451445743|FG005|Core Treatment Period|Death|0|||
125495467|NCT00622700|451445744|FG006|Core Treatment Period|Death|0|||
125495468|NCT00622700|451445738|FG000|Core Treatment Period|Progressive Disease|3|||
125495469|NCT00622700|451445739|FG001|Core Treatment Period|Progressive Disease|1|||
125495470|NCT00622700|451445740|FG002|Core Treatment Period|Progressive Disease|0|||
125495471|NCT00622700|451445741|FG003|Core Treatment Period|Progressive Disease|0|||
125495472|NCT00622700|451445742|FG004|Core Treatment Period|Progressive Disease|0|||
125495473|NCT00622700|451445743|FG005|Core Treatment Period|Progressive Disease|0|||
125495474|NCT00622700|451445744|FG006|Core Treatment Period|Progressive Disease|0|||
125495475|NCT00622700|451445738|FG000|Core Treatment Period|Withdrawal by Subject|12|||
125495476|NCT00622700|451445739|FG001|Core Treatment Period|Withdrawal by Subject|18|||
125495477|NCT00622700|451445740|FG002|Core Treatment Period|Withdrawal by Subject|15|||
125495478|NCT00622700|451445741|FG003|Core Treatment Period|Withdrawal by Subject|0|||
125495479|NCT00622700|451445742|FG004|Core Treatment Period|Withdrawal by Subject|0|||
125495480|NCT00622700|451445743|FG005|Core Treatment Period|Withdrawal by Subject|0|||
125495481|NCT00622700|451445744|FG006|Core Treatment Period|Withdrawal by Subject|0|||
125495482|NCT00622700|451445738|FG000|Core Treatment Period|Other than specified above|2|||
125495483|NCT00622700|451445739|FG001|Core Treatment Period|Other than specified above|2|||
125495484|NCT00622700|451445740|FG002|Core Treatment Period|Other than specified above|5|||
125495485|NCT00622700|451445741|FG003|Core Treatment Period|Other than specified above|0|||
125495486|NCT00622700|451445742|FG004|Core Treatment Period|Other than specified above|0|||
125495487|NCT00622700|451445743|FG005|Core Treatment Period|Other than specified above|0|||
125495488|NCT00622700|451445744|FG006|Core Treatment Period|Other than specified above|0|||
125495489|NCT00622700|451445738|FG000|Extension Treatment Period|Adverse Event|0|||
125495490|NCT00622700|451445739|FG001|Extension Treatment Period|Adverse Event|0|||
125495491|NCT00622700|451445740|FG002|Extension Treatment Period|Adverse Event|0|||
125495492|NCT00622700|451445741|FG003|Extension Treatment Period|Adverse Event|5|||
125495493|NCT00622700|451445742|FG004|Extension Treatment Period|Adverse Event|9|||
125495494|NCT00622700|451445743|FG005|Extension Treatment Period|Adverse Event|6|||
125495495|NCT00622700|451445744|FG006|Extension Treatment Period|Adverse Event|8|||
125495496|NCT00622700|451445738|FG000|Extension Treatment Period|Lack of Efficacy|0|||
125495497|NCT00622700|451445739|FG001|Extension Treatment Period|Lack of Efficacy|0|||
125495498|NCT00622700|451445740|FG002|Extension Treatment Period|Lack of Efficacy|0|||
125495499|NCT00622700|451445741|FG003|Extension Treatment Period|Lack of Efficacy|2|||
125495500|NCT00622700|451445742|FG004|Extension Treatment Period|Lack of Efficacy|8|||
125495501|NCT00622700|451445743|FG005|Extension Treatment Period|Lack of Efficacy|1|||
125495502|NCT00622700|451445744|FG006|Extension Treatment Period|Lack of Efficacy|9|||
125495503|NCT00622700|451445738|FG000|Extension Treatment Period|Protocol Violation|0|||
125495504|NCT00622700|451445739|FG001|Extension Treatment Period|Protocol Violation|0|||
125495505|NCT00622700|451445740|FG002|Extension Treatment Period|Protocol Violation|0|||
125495506|NCT00622700|451445741|FG003|Extension Treatment Period|Protocol Violation|0|||
125495507|NCT00622700|451445742|FG004|Extension Treatment Period|Protocol Violation|0|||
125495508|NCT00622700|451445743|FG005|Extension Treatment Period|Protocol Violation|2|||
125495509|NCT00622700|451445744|FG006|Extension Treatment Period|Protocol Violation|0|||
125495510|NCT00622700|451445738|FG000|Extension Treatment Period|Lost to Follow-up|0|||
125495511|NCT00622700|451445739|FG001|Extension Treatment Period|Lost to Follow-up|0|||
125495512|NCT00622700|451445740|FG002|Extension Treatment Period|Lost to Follow-up|0|||
125495513|NCT00622700|451445741|FG003|Extension Treatment Period|Lost to Follow-up|0|||
125495514|NCT00622700|451445742|FG004|Extension Treatment Period|Lost to Follow-up|1|||
125495515|NCT00622700|451445743|FG005|Extension Treatment Period|Lost to Follow-up|0|||
125495516|NCT00622700|451445744|FG006|Extension Treatment Period|Lost to Follow-up|0|||
125495517|NCT00622700|451445738|FG000|Extension Treatment Period|Progressive Disease|0|||
125495518|NCT00622700|451445739|FG001|Extension Treatment Period|Progressive Disease|0|||
125495519|NCT00622700|451445740|FG002|Extension Treatment Period|Progressive Disease|0|||
125495520|NCT00622700|451445741|FG003|Extension Treatment Period|Progressive Disease|1|||
125495521|NCT00622700|451445742|FG004|Extension Treatment Period|Progressive Disease|2|||
125495522|NCT00622700|451445743|FG005|Extension Treatment Period|Progressive Disease|0|||
125495523|NCT00622700|451445744|FG006|Extension Treatment Period|Progressive Disease|2|||
125495524|NCT00622700|451445738|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
125495525|NCT00622700|451445739|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
125495526|NCT00622700|451445740|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
125495527|NCT00622700|451445741|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
125495528|NCT00622700|451445742|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
125495529|NCT00622700|451445743|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
125495530|NCT00622700|451445744|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
125495531|NCT00622700|451445738|FG000|Extension Treatment Period|Missing|0|||
125495532|NCT00622700|451445739|FG001|Extension Treatment Period|Missing|0|||
125495533|NCT00622700|451445740|FG002|Extension Treatment Period|Missing|0|||
125495534|NCT00622700|451445741|FG003|Extension Treatment Period|Missing|2|||
125495535|NCT00622700|451445742|FG004|Extension Treatment Period|Missing|3|||
125495536|NCT00622700|451445743|FG005|Extension Treatment Period|Missing|1|||
125495537|NCT00622700|451445744|FG006|Extension Treatment Period|Missing|0|||
125495538|NCT00622700|451445738|FG000|Extension Treatment Period|Other than specified above|0|||
125495539|NCT00622700|451445739|FG001|Extension Treatment Period|Other than specified above|0|||
125495540|NCT00622700|451445740|FG002|Extension Treatment Period|Other than specified above|0|||
125495541|NCT00622700|451445741|FG003|Extension Treatment Period|Other than specified above|0|||
125495542|NCT00622700|451445742|FG004|Extension Treatment Period|Other than specified above|0|||
125495543|NCT00622700|451445743|FG005|Extension Treatment Period|Other than specified above|1|||
125495544|NCT00622700|451445744|FG006|Extension Treatment Period|Other than specified above|1|||
125495545|NCT03611556|451445745|FG000|Overall Study|Death|7|||
125495546|NCT03611556|451445746|FG001|Overall Study|Death|7|||
125495547|NCT03611556|451445747|FG002|Overall Study|Death|3|||
125495548|NCT03611556|451445748|FG003|Overall Study|Death|8|||
125495549|NCT03611556|451445749|FG004|Overall Study|Death|47|||
125495550|NCT03611556|451445750|FG005|Overall Study|Death|32|||
125495551|NCT03611556|451445751|FG006|Overall Study|Death|53|||
125495552|NCT03611556|451445745|FG000|Overall Study|Withdrawal by Subject|0|||
125495553|NCT03611556|451445746|FG001|Overall Study|Withdrawal by Subject|0|||
125495554|NCT03611556|451445747|FG002|Overall Study|Withdrawal by Subject|0|||
125495555|NCT03611556|451445748|FG003|Overall Study|Withdrawal by Subject|0|||
125495556|NCT03611556|451445749|FG004|Overall Study|Withdrawal by Subject|4|||
125495557|NCT03611556|451445750|FG005|Overall Study|Withdrawal by Subject|2|||
125495558|NCT03611556|451445751|FG006|Overall Study|Withdrawal by Subject|4|||
125495559|NCT03611556|451445745|FG000|Overall Study|Sponsor decision|0|||
125495560|NCT03611556|451445746|FG001|Overall Study|Sponsor decision|0|||
125495561|NCT03611556|451445747|FG002|Overall Study|Sponsor decision|0|||
125495562|NCT03611556|451445748|FG003|Overall Study|Sponsor decision|0|||
125495563|NCT03611556|451445749|FG004|Overall Study|Sponsor decision|9|||
125495564|NCT03611556|451445750|FG005|Overall Study|Sponsor decision|4|||
125495565|NCT03611556|451445751|FG006|Overall Study|Sponsor decision|12|||
125495566|NCT03611556|451445745|FG000|Overall Study|Reasons|0|||
125495567|NCT03611556|451445746|FG001|Overall Study|Reasons|0|||
125495568|NCT03611556|451445747|FG002|Overall Study|Reasons|0|||
125495569|NCT03611556|451445748|FG003|Overall Study|Reasons|0|||
125495570|NCT03611556|451445749|FG004|Overall Study|Reasons|2|||
125495571|NCT03611556|451445750|FG005|Overall Study|Reasons|0|||
125495572|NCT03611556|451445751|FG006|Overall Study|Reasons|1|||
125495573|NCT02078648|451445761|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
125495574|NCT02078648|451445762|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
125495575|NCT02078648|451445761|FG000|Overall Study|Adverse Event|0|||
125495576|NCT02078648|451445762|FG001|Overall Study|Adverse Event|1|||
125495577|NCT02078648|451445761|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
125532346|NCT00588692|451580090|FG000|Overall Study|Withdrawal by Subject|4|||
125495578|NCT02078648|451445762|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
125495579|NCT02078648|451445761|FG000|Overall Study|Withdrawal by Subject|3|||
125495580|NCT02078648|451445762|FG001|Overall Study|Withdrawal by Subject|1|||
125495581|NCT02078648|451445761|FG000|Overall Study|Investigator Decision|5|||
125495582|NCT02078648|451445762|FG001|Overall Study|Investigator Decision|7|||
125495583|NCT02078648|451445761|FG000|Overall Study|Death|1|||
125495584|NCT02078648|451445762|FG001|Overall Study|Death|1|||
125495585|NCT02078648|451445761|FG000|Overall Study|Undefined|0|||
125495586|NCT02078648|451445762|FG001|Overall Study|Undefined|1|||
125495587|NCT04088227|451445763|FG000|Overall Study|Withdrawal by Subject|1|||
125495588|NCT04088227|451445764|FG001|Overall Study|Withdrawal by Subject|0|||
125495589|NCT04088227|451445763|FG000|Overall Study|Surgery postponed >5weeks|1|||
125495590|NCT04088227|451445764|FG001|Overall Study|Surgery postponed >5weeks|0|||
125495591|NCT01675492|451445765|FG000|Overall Study|study completed early - product approval|42|||
125495592|NCT02036970|451447559|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
125495593|NCT02036970|451447560|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
125495594|NCT02036970|451447561|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
125495595|NCT02036970|451447562|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
125495596|NCT02036970|451447563|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
125495597|NCT02036970|451447564|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
125495598|NCT02036970|451447565|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
125495599|NCT02036970|451447566|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
125495600|NCT02036970|451447567|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
125495601|NCT02036970|451447568|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
125495602|NCT02036970|451447559|FG000|Part 1: Day 1 Through Week 16|Death|0|||
125495603|NCT02036970|451447560|FG001|Part 1: Day 1 Through Week 16|Death|0|||
125495604|NCT02036970|451447561|FG002|Part 1: Day 1 Through Week 16|Death|0|||
125495605|NCT02036970|451447562|FG003|Part 1: Day 1 Through Week 16|Death|0|||
125495606|NCT02036970|451447563|FG004|Part 1: Day 1 Through Week 16|Death|0|||
125495607|NCT02036970|451447564|FG005|Part 1: Day 1 Through Week 16|Death|0|||
125495608|NCT02036970|451447565|FG006|Part 1: Day 1 Through Week 16|Death|0|||
125495609|NCT02036970|451447566|FG007|Part 1: Day 1 Through Week 16|Death|0|||
125495610|NCT02036970|451447567|FG008|Part 1: Day 1 Through Week 16|Death|1|||
125495611|NCT02036970|451447568|FG009|Part 1: Day 1 Through Week 16|Death|0|||
125495612|NCT02036970|451447559|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
125495613|NCT02036970|451447560|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
125495614|NCT02036970|451447561|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
125495615|NCT02036970|451447562|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
125495616|NCT02036970|451447563|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
125495617|NCT02036970|451447564|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
125495618|NCT02036970|451447565|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
125495619|NCT02036970|451447566|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
125495620|NCT02036970|451447567|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
125495621|NCT02036970|451447568|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
125495622|NCT02036970|451447559|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
125495623|NCT02036970|451447560|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
125495624|NCT02036970|451447561|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
125495625|NCT02036970|451447562|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
125495626|NCT02036970|451447563|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
125495627|NCT02036970|451447564|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
125495628|NCT02036970|451447565|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
125495629|NCT02036970|451447566|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
125495630|NCT02036970|451447567|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
125495631|NCT02036970|451447568|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
125495632|NCT02036970|451447559|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
125495633|NCT02036970|451447560|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
125495634|NCT02036970|451447561|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
125495635|NCT02036970|451447562|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
125495636|NCT02036970|451447563|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
125495637|NCT02036970|451447564|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
125495638|NCT02036970|451447565|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
125495639|NCT02036970|451447566|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
125495640|NCT02036970|451447567|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
125495641|NCT02036970|451447568|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
125495642|NCT02036970|451447559|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
125495643|NCT02036970|451447560|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
125495644|NCT02036970|451447561|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
125495645|NCT02036970|451447562|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
125495646|NCT02036970|451447563|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
125495647|NCT02036970|451447564|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
125495648|NCT02036970|451447565|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
125495649|NCT02036970|451447566|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
125495650|NCT02036970|451447567|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
125495651|NCT02036970|451447568|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
125495652|NCT02036970|451447559|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
125495653|NCT02036970|451447560|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
125495654|NCT02036970|451447561|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
125495655|NCT02036970|451447562|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
125495656|NCT02036970|451447563|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
125495657|NCT02036970|451447564|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
125495658|NCT02036970|451447565|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
125495659|NCT02036970|451447566|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
125495660|NCT02036970|451447567|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
125495661|NCT02036970|451447568|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
125495662|NCT02036970|451447559|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
125495663|NCT02036970|451447560|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
125495664|NCT02036970|451447561|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
125495665|NCT02036970|451447562|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
125495666|NCT02036970|451447563|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
125495667|NCT02036970|451447564|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
125495668|NCT02036970|451447565|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
125495669|NCT02036970|451447566|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
125495670|NCT02036970|451447567|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
125495671|NCT02036970|451447568|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
125495672|NCT02036970|451447559|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
125495673|NCT02036970|451447560|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
125495674|NCT02036970|451447561|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
125495675|NCT02036970|451447562|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
125495676|NCT02036970|451447563|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
125495677|NCT02036970|451447564|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
125495678|NCT02036970|451447565|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
125495679|NCT02036970|451447566|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
125495680|NCT02036970|451447567|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
125495681|NCT02036970|451447568|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
125495682|NCT02386098|451447571|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
125495683|NCT02386098|451447572|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
125495684|NCT02386098|451447573|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
125495685|NCT02386098|451447574|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
125495686|NCT02386098|451447575|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
125495687|NCT02386098|451447571|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
125495688|NCT02386098|451447572|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
125495689|NCT02386098|451447573|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
125495690|NCT02386098|451447574|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
125495691|NCT02386098|451447575|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
125495692|NCT02386098|451447571|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
125495693|NCT02386098|451447572|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
125495694|NCT02386098|451447573|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
125495695|NCT02386098|451447574|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
125495696|NCT02386098|451447575|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
125495697|NCT02386098|451447571|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
125495698|NCT02386098|451447572|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
125495699|NCT02386098|451447573|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
125495700|NCT02386098|451447574|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
125495701|NCT02386098|451447575|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
125495702|NCT02386098|451447571|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
125495703|NCT02386098|451447572|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
125495704|NCT02386098|451447573|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
125495705|NCT02386098|451447574|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
125495706|NCT02386098|451447575|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
125495707|NCT02386098|451447571|FG000|Stage 1 (96 Weeks)|Other|1|||
125495708|NCT02386098|451447572|FG001|Stage 1 (96 Weeks)|Other|0|||
125495709|NCT02386098|451447573|FG002|Stage 1 (96 Weeks)|Other|0|||
125304114|NCT02611817|450741196|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
125304115|NCT02611817|450741197|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
125304116|NCT02611817|450741198|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
125304117|NCT02611817|450741196|FG000|Open-label Induction Phase|Pregnancy|1|||
125495710|NCT02386098|451447574|FG003|Stage 1 (96 Weeks)|Other|0|||
125495711|NCT02386098|451447575|FG004|Stage 1 (96 Weeks)|Other|0|||
125495712|NCT02386098|451447571|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
125495713|NCT02386098|451447572|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
125495714|NCT02386098|451447573|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
125495715|NCT02386098|451447574|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
125495716|NCT02386098|451447575|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
125495717|NCT04503681|451447578|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
125495718|NCT04503681|451447579|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
125495719|NCT03352713|451447580|FG000|Overall Study|Lost to Follow-up|8|||
125304118|NCT02611817|450741197|FG001|Open-label Induction Phase|Pregnancy|0|||
125304119|NCT02611817|450741198|FG002|Open-label Induction Phase|Pregnancy|0|||
125304120|NCT02611817|450741196|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
125304121|NCT02611817|450741197|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
125304122|NCT02611817|450741198|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
125304123|NCT02611817|450741196|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
125304124|NCT02611817|450741197|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
125304125|NCT02611817|450741198|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
125304126|NCT02611817|450741196|FG000|Open-label Induction Phase|Protocol Violation|5|||
125304127|NCT02611817|450741197|FG001|Open-label Induction Phase|Protocol Violation|0|||
125304128|NCT02611817|450741198|FG002|Open-label Induction Phase|Protocol Violation|0|||
125304129|NCT02611817|450741196|FG000|Open-label Induction Phase|Adverse Event|16|||
125304130|NCT02611817|450741197|FG001|Open-label Induction Phase|Adverse Event|0|||
125304131|NCT02611817|450741198|FG002|Open-label Induction Phase|Adverse Event|0|||
125304132|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
125304133|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
125304134|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
125304135|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
125304136|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
125304137|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
125304138|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
125304139|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
125304140|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
125304141|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
125304142|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
125304143|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
125304144|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
125304145|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
125304146|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
125304147|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
125304148|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
125304149|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
125304150|NCT02611817|450741196|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
125304151|NCT02611817|450741197|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
125304152|NCT02611817|450741198|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
125304153|NCT00265317|450741199|FG000|Lead-In|Objective progression or relapse|6|||
125304154|NCT00265317|450741200|FG001|Lead-In|Objective progression or relapse|11|||
125304155|NCT00265317|450741201|FG002|Lead-In|Objective progression or relapse|0|||
125304156|NCT00265317|450741202|FG003|Lead-In|Objective progression or relapse|0|||
125304157|NCT00265317|450741199|FG000|Lead-In|Adverse Event|2|||
125304158|NCT00265317|450741200|FG001|Lead-In|Adverse Event|1|||
125304159|NCT00265317|450741201|FG002|Lead-In|Adverse Event|0|||
125304160|NCT00265317|450741202|FG003|Lead-In|Adverse Event|0|||
125304161|NCT00265317|450741199|FG000|Lead-In|Death|3|||
125304162|NCT00265317|450741200|FG001|Lead-In|Death|5|||
125304163|NCT00265317|450741201|FG002|Lead-In|Death|0|||
125304164|NCT00265317|450741202|FG003|Lead-In|Death|0|||
125304165|NCT00265317|450741199|FG000|Lead-In|Withdrawal/other than adverse event|1|||
125304166|NCT00265317|450741200|FG001|Lead-In|Withdrawal/other than adverse event|0|||
125304167|NCT00265317|450741201|FG002|Lead-In|Withdrawal/other than adverse event|0|||
125304168|NCT00265317|450741202|FG003|Lead-In|Withdrawal/other than adverse event|0|||
125304169|NCT00265317|450741199|FG000|Phase 2|Objective progression or relapse|0|||
125495720|NCT03352713|451447580|FG000|Overall Study|Withdrawn by investigator|5|||
125495721|NCT03352713|451447580|FG000|Overall Study|Completed 0 EMAs|8|||
125495722|NCT03352713|451447580|FG000|Overall Study|Device incompatible/stolen|5|||
125495723|NCT01812759|451447581|FG000|Overall Study|Physician Decision|0|||
125495724|NCT01812759|451447582|FG001|Overall Study|Physician Decision|0|||
125495725|NCT01812759|451447583|FG002|Overall Study|Physician Decision|1|||
125495726|NCT00360269|451447584|FG000|Overall Study|Lost to Follow-up|7|||
125495727|NCT00360269|451447585|FG001|Overall Study|Lost to Follow-up|9|||
125495728|NCT00360269|451447584|FG000|Overall Study|Physician Decision|1|||
125495729|NCT00360269|451447585|FG001|Overall Study|Physician Decision|2|||
125304170|NCT00265317|450741200|FG001|Phase 2|Objective progression or relapse|0|||
125304171|NCT00265317|450741201|FG002|Phase 2|Objective progression or relapse|37|||
125304172|NCT00265317|450741202|FG003|Phase 2|Objective progression or relapse|38|||
125304173|NCT00265317|450741199|FG000|Phase 2|Global deterioration of health status|0|||
125304174|NCT00265317|450741200|FG001|Phase 2|Global deterioration of health status|0|||
125304175|NCT00265317|450741201|FG002|Phase 2|Global deterioration of health status|3|||
125304176|NCT00265317|450741202|FG003|Phase 2|Global deterioration of health status|0|||
125495730|NCT00360269|451447584|FG000|Overall Study|Adverse Event|1|||
125495731|NCT00360269|451447585|FG001|Overall Study|Adverse Event|0|||
125495732|NCT00360269|451447584|FG000|Overall Study|Withdrawal by Subject|1|||
125495733|NCT00360269|451447585|FG001|Overall Study|Withdrawal by Subject|1|||
125495734|NCT03437733|451447591|FG000|Overall Study|Eligibility criteria not met|0|||
125495735|NCT03437733|451447592|FG001|Overall Study|Eligibility criteria not met|3|||
125495736|NCT03355573|451447593|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
125495737|NCT03355573|451447593|FG000|Overall Study|Sponsor's decision|1|||
125495738|NCT03355573|451447593|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
125495739|NCT03355573|451447593|FG000|Overall Study|PI's decision|2|||
125495740|NCT03355573|451447593|FG000|Overall Study|Withdrawal by Subject|23|||
125495741|NCT03355573|451447593|FG000|Overall Study|Lost to Follow-up|4|||
125495742|NCT03355573|451447593|FG000|Overall Study|Lack of Efficacy|2|||
125495743|NCT03355573|451447593|FG000|Overall Study|Adverse Event, non-fatal|17|||
125495744|NCT03355573|451447593|FG000|Overall Study|Adverse Event, serious fatal|2|||
125495745|NCT04191824|451447598|FG000|Overall Study|Death|13|||
125495746|NCT04191824|451447599|FG001|Overall Study|Death|12|||
125495747|NCT04191824|451447598|FG000|Overall Study|Lost to Follow-up|456|||
125495748|NCT04191824|451447599|FG001|Overall Study|Lost to Follow-up|435|||
125495749|NCT04191824|451447598|FG000|Overall Study|Physician Decision|2|||
125495750|NCT04191824|451447599|FG001|Overall Study|Physician Decision|1|||
125495751|NCT04191824|451447598|FG000|Overall Study|Protocol Violation|0|||
125495752|NCT04191824|451447599|FG001|Overall Study|Protocol Violation|2|||
125495753|NCT04191824|451447598|FG000|Overall Study|Withdrawal by Subject|16|||
125495754|NCT04191824|451447599|FG001|Overall Study|Withdrawal by Subject|18|||
125495755|NCT04191824|451447598|FG000|Overall Study|Early site closure|24|||
125495756|NCT04191824|451447599|FG001|Overall Study|Early site closure|22|||
125495757|NCT03631407|451447600|FG000|Overall Study|Withdrawal by Subject|3|||
125495758|NCT03631407|451447601|FG001|Overall Study|Withdrawal by Subject|2|||
125495759|NCT03631407|451447600|FG000|Overall Study|Sponsor Decision|0|||
125495760|NCT03631407|451447601|FG001|Overall Study|Sponsor Decision|2|||
125495761|NCT03631407|451447600|FG000|Overall Study|Death|16|||
125495762|NCT03631407|451447601|FG001|Overall Study|Death|16|||
125495763|NCT03631407|451447600|FG000|Overall Study|Randomized by mistake without study treatment|1|||
125495764|NCT03631407|451447601|FG001|Overall Study|Randomized by mistake without study treatment|0|||
125495765|NCT02646618|451447606|FG000|Overall Study|Lost to Follow-up|10|||
125495766|NCT02646618|451447607|FG001|Overall Study|Lost to Follow-up|14|||
125495767|NCT00390884|451447608|FG000|Overall Study|Withdrawal by Subject|2|||
125495768|NCT00390884|451447609|FG001|Overall Study|Withdrawal by Subject|2|||
125495769|NCT04035447|451447610|FG000|Treatment Period|Lost to Follow-up|6|||
125495770|NCT04035447|451447611|FG001|Treatment Period|Lost to Follow-up|5|||
125495771|NCT04035447|451447610|FG000|Treatment Period|Physician Decision|0|||
125495772|NCT04035447|451447611|FG001|Treatment Period|Physician Decision|2|||
125495773|NCT03304587|451447612|FG000|Overall Study|Headache after intervention|0|||
125495774|NCT03304587|451447613|FG001|Overall Study|Headache after intervention|1|||
125495775|NCT03304587|451447612|FG000|Overall Study|Withdrawal by Subject|1|||
125495776|NCT03304587|451447613|FG001|Overall Study|Withdrawal by Subject|0|||
125495777|NCT01458366|451447615|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
125495778|NCT01458366|451447616|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
125495779|NCT01458366|451447617|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
125495780|NCT01458366|451447618|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
125495781|NCT01458366|451447619|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
125495782|NCT01458366|451447615|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
125495783|NCT01458366|451447616|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
125495784|NCT01458366|451447617|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
125495785|NCT01458366|451447618|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
125495786|NCT01458366|451447619|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
125495787|NCT02397096|451447620|FG000|Day 1 to Week 24|Adverse Event|7|||
125495788|NCT02397096|451447621|FG001|Day 1 to Week 24|Adverse Event|1|||
125495789|NCT02397096|451447620|FG000|Day 1 to Week 24|Death|1|||
125495790|NCT02397096|451447621|FG001|Day 1 to Week 24|Death|0|||
125495791|NCT02397096|451447620|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
125495792|NCT02397096|451447621|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
125495793|NCT02397096|451447620|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
125495794|NCT02397096|451447621|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
125495795|NCT02397096|451447620|FG000|Day 1 to Week 24|Physician Decision|2|||
125495796|NCT02397096|451447621|FG001|Day 1 to Week 24|Physician Decision|3|||
125495797|NCT02397096|451447620|FG000|Day 1 to Week 24|Protocol Violation|1|||
125495798|NCT02397096|451447621|FG001|Day 1 to Week 24|Protocol Violation|4|||
125495799|NCT02397096|451447620|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
125495800|NCT02397096|451447621|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
125495801|NCT02397096|451447620|FG000|Day 1 to Week 24|Randomized, not treated|3|||
125495802|NCT02397096|451447621|FG001|Day 1 to Week 24|Randomized, not treated|0|||
125495803|NCT02397096|451447620|FG000|Week 24 to Week 48|Adverse Event|6|||
125495804|NCT02397096|451447621|FG001|Week 24 to Week 48|Adverse Event|2|||
125495805|NCT02397096|451447620|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
125495806|NCT02397096|451447621|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
125495807|NCT02397096|451447620|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
125495808|NCT02397096|451447621|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
125495809|NCT02397096|451447620|FG000|Week 24 to Week 48|Physician Decision|2|||
125495810|NCT02397096|451447621|FG001|Week 24 to Week 48|Physician Decision|1|||
125495811|NCT02397096|451447620|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
125495812|NCT02397096|451447621|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
125495813|NCT02397096|451447620|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
125495814|NCT02397096|451447621|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
125495815|NCT02397096|451447620|FG000|Study Extension 1|Adverse Event|7|||
125495816|NCT02397096|451447621|FG001|Study Extension 1|Adverse Event|5|||
125495817|NCT02397096|451447620|FG000|Study Extension 1|Death|1|||
125495818|NCT02397096|451447621|FG001|Study Extension 1|Death|0|||
125495819|NCT02397096|451447620|FG000|Study Extension 1|Lack of Efficacy|2|||
125495820|NCT02397096|451447621|FG001|Study Extension 1|Lack of Efficacy|5|||
125495821|NCT02397096|451447620|FG000|Study Extension 1|Lost to Follow-up|2|||
125495822|NCT02397096|451447621|FG001|Study Extension 1|Lost to Follow-up|3|||
125495823|NCT02397096|451447620|FG000|Study Extension 1|Non-compliance with study drug|3|||
125495824|NCT02397096|451447621|FG001|Study Extension 1|Non-compliance with study drug|0|||
125495825|NCT02397096|451447620|FG000|Study Extension 1|Physician Decision|4|||
125495826|NCT02397096|451447621|FG001|Study Extension 1|Physician Decision|2|||
125495827|NCT02397096|451447620|FG000|Study Extension 1|Pregnancy|1|||
125495828|NCT02397096|451447621|FG001|Study Extension 1|Pregnancy|0|||
125495829|NCT02397096|451447620|FG000|Study Extension 1|Protocol Violation|0|||
125495830|NCT02397096|451447621|FG001|Study Extension 1|Protocol Violation|1|||
125495831|NCT02397096|451447620|FG000|Study Extension 1|Withdrawal by Subject|21|||
125495832|NCT02397096|451447621|FG001|Study Extension 1|Withdrawal by Subject|7|||
125495833|NCT02397096|451447620|FG000|Study Extension 2|Adverse Event|3|||
125495834|NCT02397096|451447621|FG001|Study Extension 2|Adverse Event|3|||
125495835|NCT02397096|451447620|FG000|Study Extension 2|Availability of study medication locally|152|||
125495836|NCT02397096|451447621|FG001|Study Extension 2|Availability of study medication locally|64|||
125495837|NCT02397096|451447620|FG000|Study Extension 2|Death|2|||
125495838|NCT02397096|451447621|FG001|Study Extension 2|Death|0|||
125495839|NCT02397096|451447620|FG000|Study Extension 2|Lack of Efficacy|1|||
125495840|NCT02397096|451447621|FG001|Study Extension 2|Lack of Efficacy|0|||
125495841|NCT02397096|451447620|FG000|Study Extension 2|Lost to Follow-up|2|||
125495842|NCT02397096|451447621|FG001|Study Extension 2|Lost to Follow-up|1|||
125495843|NCT02397096|451447620|FG000|Study Extension 2|Non-compliance with study drug|1|||
125495844|NCT02397096|451447621|FG001|Study Extension 2|Non-compliance with study drug|0|||
125495845|NCT02397096|451447620|FG000|Study Extension 2|Physician Decision|2|||
125495846|NCT02397096|451447621|FG001|Study Extension 2|Physician Decision|5|||
125495847|NCT02397096|451447620|FG000|Study Extension 2|Pregnancy|1|||
125495848|NCT02397096|451447621|FG001|Study Extension 2|Pregnancy|0|||
125495849|NCT02397096|451447620|FG000|Study Extension 2|Withdrawal by Subject|10|||
125495850|NCT02397096|451447621|FG001|Study Extension 2|Withdrawal by Subject|3|||
125495851|NCT02397096|451447620|FG000|Study Extension 3|Adverse Event|1|||
125495852|NCT02397096|451447621|FG001|Study Extension 3|Adverse Event|0|||
125495853|NCT02397096|451447620|FG000|Study Extension 3|Availability of study medication locally|11|||
125495854|NCT02397096|451447621|FG001|Study Extension 3|Availability of study medication locally|3|||
125495855|NCT02397096|451447620|FG000|Study Extension 3|Lost to Follow-up|1|||
125495856|NCT02397096|451447621|FG001|Study Extension 3|Lost to Follow-up|0|||
125495857|NCT02397096|451447620|FG000|Study Extension 3|Withdrawal by Subject|2|||
125495858|NCT02397096|451447621|FG001|Study Extension 3|Withdrawal by Subject|1|||
125495859|NCT05580003|451447622|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495860|NCT05580003|451447623|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495861|NCT05580003|451447624|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495862|NCT05580003|451447625|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495863|NCT05580003|451447626|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495864|NCT05580003|451447627|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495865|NCT05580003|451447628|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
125495866|NCT05580003|451447629|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495867|NCT05580003|451447630|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495868|NCT05580003|451447631|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495869|NCT05580003|451447632|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495870|NCT05580003|451447633|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495871|NCT05580003|451447634|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495872|NCT05580003|451447635|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495873|NCT05580003|451447636|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495874|NCT05580003|451447637|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495875|NCT05580003|451447638|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495876|NCT05580003|451447639|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495877|NCT05580003|451447640|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495878|NCT05580003|451447641|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495879|NCT05580003|451447642|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495880|NCT05580003|451447643|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495881|NCT05580003|451447644|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495882|NCT05580003|451447645|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495883|NCT05580003|451447646|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495884|NCT05580003|451447647|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495885|NCT05580003|451447648|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495886|NCT05580003|451447649|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
125495887|NCT05580003|451447622|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495888|NCT05580003|451447623|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495889|NCT05580003|451447624|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495890|NCT05580003|451447625|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495891|NCT05580003|451447626|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495892|NCT05580003|451447627|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
125495893|NCT05580003|451447628|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495894|NCT05580003|451447629|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495895|NCT05580003|451447630|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495896|NCT05580003|451447631|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495897|NCT05580003|451447632|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495898|NCT05580003|451447633|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495899|NCT05580003|451447634|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495900|NCT05580003|451447635|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495901|NCT05580003|451447636|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495902|NCT05580003|451447637|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495903|NCT05580003|451447638|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495904|NCT05580003|451447639|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495905|NCT05580003|451447640|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495906|NCT05580003|451447641|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495907|NCT05580003|451447642|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495908|NCT05580003|451447643|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495909|NCT05580003|451447644|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495910|NCT05580003|451447645|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495911|NCT05580003|451447646|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495912|NCT05580003|451447647|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495913|NCT05580003|451447648|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495914|NCT05580003|451447649|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
125495915|NCT05580003|451447622|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495916|NCT05580003|451447623|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495917|NCT05580003|451447624|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495918|NCT05580003|451447625|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
125495919|NCT05580003|451447626|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495920|NCT05580003|451447627|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495921|NCT05580003|451447628|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495922|NCT05580003|451447629|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495923|NCT05580003|451447630|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495924|NCT05580003|451447631|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495925|NCT05580003|451447632|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495926|NCT05580003|451447633|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495927|NCT05580003|451447634|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495928|NCT05580003|451447635|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495929|NCT05580003|451447636|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495930|NCT05580003|451447637|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495931|NCT05580003|451447638|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495932|NCT05580003|451447639|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495933|NCT05580003|451447640|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495934|NCT05580003|451447641|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495935|NCT05580003|451447642|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495936|NCT05580003|451447643|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495937|NCT05580003|451447644|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495938|NCT05580003|451447645|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495939|NCT05580003|451447646|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495940|NCT05580003|451447647|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495941|NCT05580003|451447648|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495942|NCT05580003|451447649|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
125495943|NCT05580003|451447622|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495944|NCT05580003|451447623|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
125495945|NCT05580003|451447624|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495946|NCT05580003|451447625|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495947|NCT05580003|451447626|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495948|NCT05580003|451447627|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495949|NCT05580003|451447628|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495950|NCT05580003|451447629|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495951|NCT05580003|451447630|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495952|NCT05580003|451447631|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495953|NCT05580003|451447632|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495954|NCT05580003|451447633|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495955|NCT05580003|451447634|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495956|NCT05580003|451447635|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495957|NCT05580003|451447636|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495958|NCT05580003|451447637|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495959|NCT05580003|451447638|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495960|NCT05580003|451447639|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495961|NCT05580003|451447640|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125304177|NCT00265317|450741199|FG000|Phase 2|Adverse Event|0|||
125304178|NCT00265317|450741200|FG001|Phase 2|Adverse Event|0|||
125304179|NCT00265317|450741201|FG002|Phase 2|Adverse Event|7|||
125304180|NCT00265317|450741202|FG003|Phase 2|Adverse Event|5|||
125304181|NCT00265317|450741199|FG000|Phase 2|Death|0|||
125304182|NCT00265317|450741200|FG001|Phase 2|Death|0|||
125304183|NCT00265317|450741201|FG002|Phase 2|Death|12|||
125304184|NCT00265317|450741202|FG003|Phase 2|Death|15|||
125304185|NCT00265317|450741199|FG000|Phase 2|Protocol Violation|0|||
125304186|NCT00265317|450741200|FG001|Phase 2|Protocol Violation|0|||
125304187|NCT00265317|450741201|FG002|Phase 2|Protocol Violation|1|||
125304188|NCT00265317|450741202|FG003|Phase 2|Protocol Violation|4|||
125304189|NCT00265317|450741199|FG000|Phase 2|Lost to Follow-up|0|||
125304190|NCT00265317|450741200|FG001|Phase 2|Lost to Follow-up|0|||
125304191|NCT00265317|450741201|FG002|Phase 2|Lost to Follow-up|0|||
125304192|NCT00265317|450741202|FG003|Phase 2|Lost to Follow-up|1|||
125304193|NCT00265317|450741199|FG000|Phase 2|Withdrawal/other than adverse event|0|||
125304194|NCT00265317|450741200|FG001|Phase 2|Withdrawal/other than adverse event|0|||
125304195|NCT00265317|450741201|FG002|Phase 2|Withdrawal/other than adverse event|2|||
125304196|NCT00265317|450741202|FG003|Phase 2|Withdrawal/other than adverse event|1|||
125304197|NCT00265317|450741199|FG000|Phase 2|Study terminated by sponsor|0|||
125304198|NCT00265317|450741200|FG001|Phase 2|Study terminated by sponsor|0|||
125304199|NCT00265317|450741201|FG002|Phase 2|Study terminated by sponsor|1|||
125304200|NCT00265317|450741202|FG003|Phase 2|Study terminated by sponsor|0|||
125304201|NCT00265317|450741199|FG000|Phase 2|Other|0|||
125304202|NCT00265317|450741200|FG001|Phase 2|Other|0|||
125304203|NCT00265317|450741201|FG002|Phase 2|Other|1|||
125304204|NCT00265317|450741202|FG003|Phase 2|Other|1|||
125304205|NCT02510001|450741203|FG000|Overall Study|Early disease progression|0|||
125304206|NCT02510001|450741204|FG001|Overall Study|Early disease progression|0|||
125304207|NCT02510001|450741205|FG002|Overall Study|Early disease progression|0|||
125304208|NCT02510001|450741206|FG003|Overall Study|Early disease progression|1|||
125304209|NCT02510001|450741207|FG004|Overall Study|Early disease progression|1|||
125304210|NCT02510001|450741208|FG005|Overall Study|Early disease progression|1|||
125304211|NCT02510001|450741209|FG006|Overall Study|Early disease progression|0|||
125304212|NCT02510001|450741210|FG007|Overall Study|Early disease progression|0|||
125304213|NCT02510001|450741203|FG000|Overall Study|Adverse Event|0|||
125304214|NCT02510001|450741204|FG001|Overall Study|Adverse Event|0|||
125304215|NCT02510001|450741205|FG002|Overall Study|Adverse Event|0|||
125304216|NCT02510001|450741206|FG003|Overall Study|Adverse Event|1|||
125304217|NCT02510001|450741207|FG004|Overall Study|Adverse Event|2|||
125304218|NCT02510001|450741208|FG005|Overall Study|Adverse Event|1|||
125304219|NCT02510001|450741209|FG006|Overall Study|Adverse Event|2|||
125304220|NCT02510001|450741210|FG007|Overall Study|Adverse Event|5|||
125304221|NCT02510001|450741203|FG000|Overall Study|Physician Decision|0|||
125495962|NCT05580003|451447641|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495963|NCT05580003|451447642|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495964|NCT05580003|451447643|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125304222|NCT02510001|450741204|FG001|Overall Study|Physician Decision|0|||
125304223|NCT02510001|450741205|FG002|Overall Study|Physician Decision|0|||
125304224|NCT02510001|450741206|FG003|Overall Study|Physician Decision|0|||
125304225|NCT02510001|450741207|FG004|Overall Study|Physician Decision|1|||
125304226|NCT02510001|450741208|FG005|Overall Study|Physician Decision|0|||
125304227|NCT02510001|450741209|FG006|Overall Study|Physician Decision|0|||
125304228|NCT02510001|450741210|FG007|Overall Study|Physician Decision|0|||
125304229|NCT02510001|450741203|FG000|Overall Study|Withdrawal by Subject|0|||
125304230|NCT02510001|450741204|FG001|Overall Study|Withdrawal by Subject|0|||
125304231|NCT02510001|450741205|FG002|Overall Study|Withdrawal by Subject|0|||
125304232|NCT02510001|450741206|FG003|Overall Study|Withdrawal by Subject|0|||
125495965|NCT05580003|451447644|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495966|NCT05580003|451447645|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495967|NCT05580003|451447646|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495968|NCT05580003|451447647|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495969|NCT05580003|451447648|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495970|NCT05580003|451447649|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
125495971|NCT05580003|451447622|FG000|Part 2 (up to 10 Days)|Other|0|||
125495972|NCT05580003|451447623|FG001|Part 2 (up to 10 Days)|Other|0|||
125495973|NCT05580003|451447624|FG002|Part 2 (up to 10 Days)|Other|0|||
125495974|NCT05580003|451447625|FG003|Part 2 (up to 10 Days)|Other|0|||
125495975|NCT05580003|451447626|FG004|Part 2 (up to 10 Days)|Other|0|||
125495976|NCT05580003|451447627|FG005|Part 2 (up to 10 Days)|Other|0|||
125495977|NCT05580003|451447628|FG006|Part 2 (up to 10 Days)|Other|0|||
125495978|NCT05580003|451447629|FG007|Part 2 (up to 10 Days)|Other|0|||
125495979|NCT05580003|451447630|FG008|Part 2 (up to 10 Days)|Other|0|||
125495980|NCT05580003|451447631|FG009|Part 2 (up to 10 Days)|Other|1|||
125495981|NCT05580003|451447632|FG010|Part 2 (up to 10 Days)|Other|0|||
125495982|NCT05580003|451447633|FG011|Part 2 (up to 10 Days)|Other|0|||
125495983|NCT05580003|451447634|FG012|Part 2 (up to 10 Days)|Other|0|||
125495984|NCT05580003|451447635|FG013|Part 2 (up to 10 Days)|Other|0|||
125495985|NCT05580003|451447636|FG014|Part 2 (up to 10 Days)|Other|0|||
125495986|NCT05580003|451447637|FG015|Part 2 (up to 10 Days)|Other|0|||
125495987|NCT05580003|451447638|FG016|Part 2 (up to 10 Days)|Other|0|||
125495988|NCT05580003|451447639|FG017|Part 2 (up to 10 Days)|Other|0|||
125495989|NCT05580003|451447640|FG018|Part 2 (up to 10 Days)|Other|0|||
125495990|NCT05580003|451447641|FG019|Part 2 (up to 10 Days)|Other|0|||
125495991|NCT05580003|451447642|FG020|Part 2 (up to 10 Days)|Other|0|||
125495992|NCT05580003|451447643|FG021|Part 2 (up to 10 Days)|Other|0|||
125495993|NCT05580003|451447644|FG022|Part 2 (up to 10 Days)|Other|0|||
125495994|NCT05580003|451447645|FG023|Part 2 (up to 10 Days)|Other|0|||
125495995|NCT05580003|451447646|FG024|Part 2 (up to 10 Days)|Other|0|||
125495996|NCT05580003|451447647|FG025|Part 2 (up to 10 Days)|Other|0|||
125495997|NCT05580003|451447648|FG026|Part 2 (up to 10 Days)|Other|0|||
125495998|NCT05580003|451447649|FG027|Part 2 (up to 10 Days)|Other|0|||
125495999|NCT05580003|451447622|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496000|NCT05580003|451447623|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496001|NCT05580003|451447624|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496002|NCT05580003|451447625|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496003|NCT05580003|451447626|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496004|NCT05580003|451447627|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496005|NCT05580003|451447628|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496006|NCT05580003|451447629|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496007|NCT05580003|451447630|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496008|NCT05580003|451447631|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496009|NCT05580003|451447632|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496010|NCT05580003|451447633|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496011|NCT05580003|451447634|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496012|NCT05580003|451447635|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496013|NCT05580003|451447636|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496014|NCT05580003|451447637|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496015|NCT05580003|451447638|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496016|NCT05580003|451447639|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496017|NCT05580003|451447640|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496018|NCT05580003|451447641|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
125496019|NCT05580003|451447642|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496020|NCT05580003|451447643|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496021|NCT05580003|451447644|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496022|NCT05580003|451447645|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496023|NCT05580003|451447646|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496024|NCT05580003|451447647|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496025|NCT05580003|451447648|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496026|NCT05580003|451447649|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
125496027|NCT05580003|451447622|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496028|NCT05580003|451447623|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496029|NCT05580003|451447624|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496030|NCT05580003|451447625|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496031|NCT05580003|451447626|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496032|NCT05580003|451447627|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496033|NCT05580003|451447628|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496034|NCT05580003|451447629|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496035|NCT05580003|451447630|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496036|NCT05580003|451447631|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496037|NCT05580003|451447632|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496038|NCT05580003|451447633|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496039|NCT05580003|451447634|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496040|NCT05580003|451447635|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496041|NCT05580003|451447636|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496042|NCT05580003|451447637|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496043|NCT05580003|451447638|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496044|NCT05580003|451447639|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496045|NCT05580003|451447640|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496046|NCT05580003|451447641|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496047|NCT05580003|451447642|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
125496048|NCT05580003|451447643|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496049|NCT05580003|451447644|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496050|NCT05580003|451447645|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496051|NCT05580003|451447646|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496052|NCT05580003|451447647|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496053|NCT05580003|451447648|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496054|NCT05580003|451447649|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
125496055|NCT05580003|451447622|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496056|NCT05580003|451447623|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496057|NCT05580003|451447624|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496058|NCT05580003|451447625|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496059|NCT05580003|451447626|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496060|NCT05580003|451447627|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496061|NCT05580003|451447628|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496062|NCT05580003|451447629|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496063|NCT05580003|451447630|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496064|NCT05580003|451447631|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496065|NCT05580003|451447632|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496066|NCT05580003|451447633|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496067|NCT05580003|451447634|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496068|NCT05580003|451447635|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496069|NCT05580003|451447636|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496070|NCT05580003|451447637|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496071|NCT05580003|451447638|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496072|NCT05580003|451447639|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496073|NCT05580003|451447640|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496074|NCT05580003|451447641|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125304233|NCT02510001|450741207|FG004|Overall Study|Withdrawal by Subject|0|||
125304234|NCT02510001|450741208|FG005|Overall Study|Withdrawal by Subject|0|||
125304235|NCT02510001|450741209|FG006|Overall Study|Withdrawal by Subject|0|||
125304236|NCT02510001|450741210|FG007|Overall Study|Withdrawal by Subject|2|||
125304237|NCT00303485|450741214|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
125304238|NCT00303485|450741215|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
125304239|NCT00303485|450741214|FG000|Overall Study|Failure to return|0|||
125304240|NCT00303485|450741215|FG001|Overall Study|Failure to return|1|||
125304241|NCT00303485|450741214|FG000|Overall Study|Withdrawal by Subject|1|||
125304242|NCT00303485|450741215|FG001|Overall Study|Withdrawal by Subject|0|||
125304243|NCT01363908|450741224|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
125304244|NCT01363908|450741225|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
125304245|NCT01363908|450741224|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
125304246|NCT01363908|450741225|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
125304247|NCT01363908|450741224|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
125304248|NCT01363908|450741225|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
125304249|NCT01363908|450741224|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
125304250|NCT01363908|450741225|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
125304251|NCT02644343|450741226|FG000|Overall Study|Withdrawal by Subject|1|||
125304252|NCT03437577|450741227|FG000|Pre-Randomization|Withdrawal by Subject|0|||
125304253|NCT03437577|450741228|FG001|Pre-Randomization|Withdrawal by Subject|0|||
125304254|NCT03437577|450741229|FG002|Pre-Randomization|Withdrawal by Subject|10|||
125304255|NCT03437577|450741227|FG000|Post-Randomization|Physician Decision|0|||
125304256|NCT03437577|450741228|FG001|Post-Randomization|Physician Decision|2|||
125304257|NCT03437577|450741229|FG002|Post-Randomization|Physician Decision|0|||
125304258|NCT04774926|450741236|FG000|Overall Study|Adverse Event|15|||
125304259|NCT04774926|450741236|FG000|Overall Study|Lost to Follow-up|3|||
125304260|NCT04774926|450741236|FG000|Overall Study|Physician Decision|6|||
125496075|NCT05580003|451447642|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496076|NCT05580003|451447643|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
125304261|NCT04774926|450741236|FG000|Overall Study|Withdrawal by Subject|3|||
125304262|NCT04774926|450741236|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
125304263|NCT03078855|450741237|FG000|Overall Study|Lack of Efficacy|62|||
125496077|NCT05580003|451447644|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496078|NCT05580003|451447645|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496079|NCT05580003|451447646|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496080|NCT05580003|451447647|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496081|NCT05580003|451447648|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496082|NCT05580003|451447649|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
125496083|NCT05580003|451447622|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496084|NCT05580003|451447623|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496085|NCT05580003|451447624|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496086|NCT05580003|451447625|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496087|NCT05580003|451447626|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496088|NCT05580003|451447627|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496089|NCT05580003|451447628|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496090|NCT05580003|451447629|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496091|NCT05580003|451447630|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496092|NCT05580003|451447631|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496093|NCT05580003|451447632|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496094|NCT05580003|451447633|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496095|NCT05580003|451447634|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496096|NCT05580003|451447635|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496097|NCT05580003|451447636|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496098|NCT05580003|451447637|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496099|NCT05580003|451447638|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496100|NCT05580003|451447639|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496101|NCT05580003|451447640|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496102|NCT05580003|451447641|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496103|NCT05580003|451447642|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496104|NCT05580003|451447643|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496105|NCT05580003|451447644|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496106|NCT05580003|451447645|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496107|NCT05580003|451447646|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496108|NCT05580003|451447647|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496109|NCT05580003|451447648|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
125496110|NCT05580003|451447649|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
125496111|NCT05580003|451447622|FG000|Part 6 Period 2 (Day 1)|Other|0|||
125496112|NCT05580003|451447623|FG001|Part 6 Period 2 (Day 1)|Other|0|||
125496113|NCT05580003|451447624|FG002|Part 6 Period 2 (Day 1)|Other|0|||
125496114|NCT05580003|451447625|FG003|Part 6 Period 2 (Day 1)|Other|0|||
125496115|NCT05580003|451447626|FG004|Part 6 Period 2 (Day 1)|Other|0|||
125496116|NCT05580003|451447627|FG005|Part 6 Period 2 (Day 1)|Other|0|||
125496117|NCT05580003|451447628|FG006|Part 6 Period 2 (Day 1)|Other|0|||
125496118|NCT05580003|451447629|FG007|Part 6 Period 2 (Day 1)|Other|0|||
125496119|NCT05580003|451447630|FG008|Part 6 Period 2 (Day 1)|Other|0|||
125496120|NCT05580003|451447631|FG009|Part 6 Period 2 (Day 1)|Other|0|||
125496121|NCT05580003|451447632|FG010|Part 6 Period 2 (Day 1)|Other|0|||
125496122|NCT05580003|451447633|FG011|Part 6 Period 2 (Day 1)|Other|0|||
125496123|NCT05580003|451447634|FG012|Part 6 Period 2 (Day 1)|Other|0|||
125496124|NCT05580003|451447635|FG013|Part 6 Period 2 (Day 1)|Other|0|||
125496125|NCT05580003|451447636|FG014|Part 6 Period 2 (Day 1)|Other|0|||
125496126|NCT05580003|451447637|FG015|Part 6 Period 2 (Day 1)|Other|0|||
125496127|NCT05580003|451447638|FG016|Part 6 Period 2 (Day 1)|Other|0|||
125496128|NCT05580003|451447639|FG017|Part 6 Period 2 (Day 1)|Other|0|||
125496129|NCT05580003|451447640|FG018|Part 6 Period 2 (Day 1)|Other|0|||
125496130|NCT05580003|451447641|FG019|Part 6 Period 2 (Day 1)|Other|0|||
125496131|NCT05580003|451447642|FG020|Part 6 Period 2 (Day 1)|Other|0|||
125496132|NCT05580003|451447643|FG021|Part 6 Period 2 (Day 1)|Other|0|||
125496133|NCT05580003|451447644|FG022|Part 6 Period 2 (Day 1)|Other|0|||
125496134|NCT05580003|451447645|FG023|Part 6 Period 2 (Day 1)|Other|0|||
125496135|NCT05580003|451447646|FG024|Part 6 Period 2 (Day 1)|Other|1|||
125496136|NCT05580003|451447647|FG025|Part 6 Period 2 (Day 1)|Other|0|||
125304264|NCT03078855|450741238|FG001|Overall Study|Lack of Efficacy|31|||
125304265|NCT03078855|450741237|FG000|Overall Study|Death|1|||
125496137|NCT05580003|451447648|FG026|Part 6 Period 2 (Day 1)|Other|0|||
125496138|NCT05580003|451447649|FG027|Part 6 Period 2 (Day 1)|Other|0|||
125496139|NCT04795167|451447650|FG000|Overall Study|Death|1|||
125496140|NCT04795167|451447651|FG001|Overall Study|Death|18|||
125496141|NCT04795167|451447652|FG002|Overall Study|Death|1|||
125496142|NCT04795167|451447650|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
125496143|NCT04795167|451447651|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
125496144|NCT04795167|451447652|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
125496145|NCT02052440|451447654|FG000|Overall Study|Withdrawal by Subject|0|||
125496146|NCT02052440|451447655|FG001|Overall Study|Withdrawal by Subject|1|||
125496147|NCT02130557|451447658|FG000|Overall Study|Withdrawal by Subject|12|||
125496148|NCT02130557|451447659|FG001|Overall Study|Withdrawal by Subject|12|||
125496149|NCT02130557|451447658|FG000|Overall Study|Investigator Request|0|||
125496150|NCT02130557|451447659|FG001|Overall Study|Investigator Request|2|||
125496151|NCT02130557|451447658|FG000|Overall Study|Deceased|14|||
125496152|NCT02130557|451447659|FG001|Overall Study|Deceased|14|||
125496153|NCT02130557|451447658|FG000|Overall Study|Lost to Follow-up|6|||
125496154|NCT02130557|451447659|FG001|Overall Study|Lost to Follow-up|7|||
125496155|NCT02130557|451447658|FG000|Overall Study|Other|2|||
125496156|NCT02130557|451447659|FG001|Overall Study|Other|1|||
125496157|NCT02130557|451447658|FG000|Overall Study|Missing|2|||
125496158|NCT02130557|451447659|FG001|Overall Study|Missing|1|||
125496159|NCT02408887|451447660|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
125496160|NCT02408887|451447661|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
125496161|NCT02408887|451447660|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
125496162|NCT02408887|451447661|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
125496163|NCT03333109|451447663|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
125496164|NCT03333109|451447664|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
125496165|NCT03333109|451447665|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
125496166|NCT03333109|451447663|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125496167|NCT03333109|451447664|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
125496168|NCT03333109|451447665|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
125496169|NCT03333109|451447663|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
125496170|NCT03333109|451447664|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
125496171|NCT03333109|451447665|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
125496172|NCT03333109|451447663|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
125496173|NCT03333109|451447664|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
125496174|NCT03333109|451447665|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
125496175|NCT03333109|451447663|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
125496176|NCT03333109|451447664|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
125496177|NCT03333109|451447665|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
125496178|NCT03333109|451447663|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
125496179|NCT03333109|451447664|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
125496180|NCT03333109|451447665|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
125496181|NCT03333109|451447663|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
125496182|NCT03333109|451447664|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
125496183|NCT03333109|451447665|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
125496184|NCT03333109|451447663|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
125496185|NCT03333109|451447664|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
125496186|NCT03333109|451447665|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
125496187|NCT00918203|451447666|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
125496188|NCT00918203|451447667|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
125496189|NCT00918203|451447668|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
125496190|NCT00918203|451447666|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
125496191|NCT00918203|451447667|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
125496192|NCT00918203|451447668|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
125496193|NCT00918203|451447666|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
125496194|NCT00918203|451447667|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
125496195|NCT00918203|451447668|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
125496196|NCT00918203|451447666|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
125496197|NCT00918203|451447667|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
125496198|NCT00918203|451447668|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
125496199|NCT00589875|451447673|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
125496200|NCT00589875|451447673|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
125496201|NCT03488719|451447676|FG000|Overall Study|Adverse Event|0|||
125496202|NCT03488719|451447677|FG001|Overall Study|Adverse Event|4|||
125496203|NCT03488719|451447678|FG002|Overall Study|Adverse Event|2|||
125496204|NCT03488719|451447676|FG000|Overall Study|Other|0|||
125496205|NCT03488719|451447677|FG001|Overall Study|Other|0|||
125496206|NCT03488719|451447678|FG002|Overall Study|Other|5|||
125496207|NCT05025384|451447679|FG000|Overall Study|Physician Decision|5|||
125496208|NCT05025384|451447680|FG001|Overall Study|Physician Decision|6|||
125496209|NCT03610581|451447681|FG000|Overall Study|Study terminated by sponsor|2|||
125496210|NCT03610581|451447682|FG001|Overall Study|Study terminated by sponsor|0|||
125496211|NCT03610581|451447681|FG000|Overall Study|Other|0|||
125496212|NCT03610581|451447682|FG001|Overall Study|Other|1|||
125496213|NCT03610581|451447681|FG000|Overall Study|Withdrawal by Subject|1|||
125496214|NCT03610581|451447682|FG001|Overall Study|Withdrawal by Subject|0|||
125496215|NCT05485805|451447691|FG000|Overall Study|Withdrawal by Subject|1|||
125496216|NCT05485805|451447692|FG001|Overall Study|Withdrawal by Subject|2|||
125496217|NCT05485805|451447693|FG002|Overall Study|Withdrawal by Subject|2|||
125496218|NCT05485805|451447694|FG003|Overall Study|Withdrawal by Subject|0|||
125496219|NCT05485805|451447695|FG004|Overall Study|Withdrawal by Subject|2|||
125496220|NCT05485805|451447691|FG000|Overall Study|Adverse Event|0|||
125496221|NCT05485805|451447692|FG001|Overall Study|Adverse Event|1|||
125496222|NCT05485805|451447693|FG002|Overall Study|Adverse Event|0|||
125496223|NCT05485805|451447694|FG003|Overall Study|Adverse Event|0|||
125496224|NCT05485805|451447695|FG004|Overall Study|Adverse Event|0|||
125496225|NCT05485805|451447691|FG000|Overall Study|Lost to Follow-up|1|||
125496226|NCT05485805|451447692|FG001|Overall Study|Lost to Follow-up|1|||
125496227|NCT05485805|451447693|FG002|Overall Study|Lost to Follow-up|3|||
125496228|NCT05485805|451447694|FG003|Overall Study|Lost to Follow-up|1|||
125496229|NCT05485805|451447695|FG004|Overall Study|Lost to Follow-up|0|||
125496230|NCT04218357|451447697|FG000|1st Allocation|Withdrawal by Subject|1|||
125496231|NCT04218357|451447698|FG001|1st Allocation|Withdrawal by Subject|0|||
125496232|NCT05349838|451447699|FG000|Overall Study|Virological Failure|1|||
125496233|NCT05349838|451447700|FG001|Overall Study|Virological Failure|2|||
125496234|NCT05349838|451447699|FG000|Overall Study|Withdrawal by Subject|2|||
125496235|NCT05349838|451447700|FG001|Overall Study|Withdrawal by Subject|3|||
125496236|NCT05349838|451447699|FG000|Overall Study|Adverse Event|3|||
125496237|NCT05349838|451447700|FG001|Overall Study|Adverse Event|1|||
125496238|NCT05349838|451447699|FG000|Overall Study|Lost to Follow-up|1|||
125496239|NCT05349838|451447700|FG001|Overall Study|Lost to Follow-up|2|||
125496240|NCT05349838|451447699|FG000|Overall Study|Other reasons|5|||
125496241|NCT05349838|451447700|FG001|Overall Study|Other reasons|1|||
125496242|NCT04484623|451447703|FG000|Overall Study|Lost to Follow-up|0|||
125496243|NCT04484623|451447704|FG001|Overall Study|Lost to Follow-up|1|||
125496244|NCT04484623|451447703|FG000|Overall Study|Protocol Deviation|1|||
125496245|NCT04484623|451447704|FG001|Overall Study|Protocol Deviation|0|||
125496246|NCT04484623|451447703|FG000|Overall Study|Physician Decision|1|||
125496247|NCT04484623|451447704|FG001|Overall Study|Physician Decision|0|||
125496248|NCT04484623|451447703|FG000|Overall Study|Withdrawal by Subject|11|||
125496249|NCT04484623|451447704|FG001|Overall Study|Withdrawal by Subject|8|||
125496250|NCT04484623|451447703|FG000|Overall Study|Ongoing|94|||
125496251|NCT04484623|451447704|FG001|Overall Study|Ongoing|84|||
125496252|NCT02488408|451447705|FG000|Part A|Adverse Event|2|||
125496253|NCT02488408|451447706|FG001|Part A|Adverse Event|0|||
125496254|NCT02488408|451447707|FG002|Part A|Adverse Event|0|||
125496255|NCT02488408|451447708|FG003|Part A|Adverse Event|0|||
125496256|NCT02488408|451447709|FG004|Part A|Adverse Event|0|||
125496257|NCT02488408|451447710|FG005|Part A|Adverse Event|0|||
125496258|NCT02488408|451447711|FG006|Part A|Adverse Event|0|||
125496259|NCT02488408|451447712|FG007|Part A|Adverse Event|0|||
125496260|NCT02488408|451447713|FG008|Part A|Adverse Event|0|||
125496261|NCT02488408|451447714|FG009|Part A|Adverse Event|0|||
125496262|NCT02488408|451447705|FG000|Part A|Death|1|||
125496263|NCT02488408|451447706|FG001|Part A|Death|5|||
125496264|NCT02488408|451447707|FG002|Part A|Death|0|||
125496265|NCT02488408|451447708|FG003|Part A|Death|0|||
125496266|NCT02488408|451447709|FG004|Part A|Death|3|||
125496267|NCT02488408|451447710|FG005|Part A|Death|0|||
125496268|NCT02488408|451447711|FG006|Part A|Death|0|||
125496269|NCT02488408|451447712|FG007|Part A|Death|0|||
125496270|NCT02488408|451447713|FG008|Part A|Death|0|||
125496271|NCT02488408|451447714|FG009|Part A|Death|0|||
125496272|NCT02488408|451447705|FG000|Part A|Disease Progression|2|||
125496273|NCT02488408|451447706|FG001|Part A|Disease Progression|8|||
125496274|NCT02488408|451447707|FG002|Part A|Disease Progression|2|||
125496275|NCT02488408|451447708|FG003|Part A|Disease Progression|3|||
125496276|NCT02488408|451447709|FG004|Part A|Disease Progression|4|||
125496277|NCT02488408|451447710|FG005|Part A|Disease Progression|0|||
125496278|NCT02488408|451447711|FG006|Part A|Disease Progression|0|||
125496279|NCT02488408|451447712|FG007|Part A|Disease Progression|0|||
125496280|NCT02488408|451447713|FG008|Part A|Disease Progression|0|||
125496281|NCT02488408|451447714|FG009|Part A|Disease Progression|0|||
125496282|NCT02488408|451447705|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
125496283|NCT02488408|451447706|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
125496284|NCT02488408|451447707|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
125496285|NCT02488408|451447708|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
125496286|NCT02488408|451447709|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
125496287|NCT02488408|451447710|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
125496288|NCT02488408|451447711|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
125496289|NCT02488408|451447712|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
125496290|NCT02488408|451447713|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
125496291|NCT02488408|451447714|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
125496292|NCT02488408|451447705|FG000|Part A|Investigator Decision|0|||
125496293|NCT02488408|451447706|FG001|Part A|Investigator Decision|1|||
125496294|NCT02488408|451447707|FG002|Part A|Investigator Decision|1|||
125496295|NCT02488408|451447708|FG003|Part A|Investigator Decision|0|||
125496296|NCT02488408|451447709|FG004|Part A|Investigator Decision|0|||
125496297|NCT02488408|451447710|FG005|Part A|Investigator Decision|0|||
125496298|NCT02488408|451447711|FG006|Part A|Investigator Decision|0|||
125496299|NCT02488408|451447712|FG007|Part A|Investigator Decision|0|||
125496300|NCT02488408|451447713|FG008|Part A|Investigator Decision|0|||
125496301|NCT02488408|451447714|FG009|Part A|Investigator Decision|0|||
125496302|NCT02488408|451447705|FG000|Part A|Withdrawal by Subject|0|||
125496303|NCT02488408|451447706|FG001|Part A|Withdrawal by Subject|0|||
125496304|NCT02488408|451447707|FG002|Part A|Withdrawal by Subject|2|||
125496305|NCT02488408|451447708|FG003|Part A|Withdrawal by Subject|0|||
125496306|NCT02488408|451447709|FG004|Part A|Withdrawal by Subject|0|||
125496307|NCT02488408|451447710|FG005|Part A|Withdrawal by Subject|0|||
125496308|NCT02488408|451447711|FG006|Part A|Withdrawal by Subject|0|||
125496309|NCT02488408|451447712|FG007|Part A|Withdrawal by Subject|0|||
125496310|NCT02488408|451447713|FG008|Part A|Withdrawal by Subject|0|||
125496311|NCT02488408|451447714|FG009|Part A|Withdrawal by Subject|0|||
125496312|NCT02488408|451447705|FG000|Part A|Other|1|||
125496313|NCT02488408|451447706|FG001|Part A|Other|0|||
125496314|NCT02488408|451447707|FG002|Part A|Other|0|||
125496315|NCT02488408|451447708|FG003|Part A|Other|0|||
125496316|NCT02488408|451447709|FG004|Part A|Other|0|||
125496317|NCT02488408|451447710|FG005|Part A|Other|0|||
125496318|NCT02488408|451447711|FG006|Part A|Other|0|||
125496319|NCT02488408|451447712|FG007|Part A|Other|0|||
125496320|NCT02488408|451447713|FG008|Part A|Other|0|||
125496321|NCT02488408|451447714|FG009|Part A|Other|0|||
125496322|NCT02488408|451447705|FG000|Part B|Adverse Event|0|||
125496323|NCT02488408|451447706|FG001|Part B|Adverse Event|0|||
125496324|NCT02488408|451447707|FG002|Part B|Adverse Event|0|||
125496325|NCT02488408|451447708|FG003|Part B|Adverse Event|0|||
125496326|NCT02488408|451447709|FG004|Part B|Adverse Event|0|||
125496327|NCT02488408|451447710|FG005|Part B|Adverse Event|2|||
125496328|NCT02488408|451447711|FG006|Part B|Adverse Event|2|||
125496329|NCT02488408|451447712|FG007|Part B|Adverse Event|7|||
125496330|NCT02488408|451447713|FG008|Part B|Adverse Event|2|||
125496331|NCT02488408|451447714|FG009|Part B|Adverse Event|2|||
125496332|NCT02488408|451447705|FG000|Part B|Death|0|||
125496333|NCT02488408|451447706|FG001|Part B|Death|0|||
125496334|NCT02488408|451447707|FG002|Part B|Death|0|||
125496335|NCT02488408|451447708|FG003|Part B|Death|0|||
125496336|NCT02488408|451447709|FG004|Part B|Death|0|||
125496337|NCT02488408|451447710|FG005|Part B|Death|3|||
125496338|NCT02488408|451447711|FG006|Part B|Death|1|||
125496339|NCT02488408|451447712|FG007|Part B|Death|2|||
125496340|NCT02488408|451447713|FG008|Part B|Death|2|||
125496341|NCT02488408|451447714|FG009|Part B|Death|2|||
125496342|NCT02488408|451447705|FG000|Part B|Death due to Disease Progression|0|||
125496343|NCT02488408|451447706|FG001|Part B|Death due to Disease Progression|0|||
125496344|NCT02488408|451447707|FG002|Part B|Death due to Disease Progression|0|||
125496345|NCT02488408|451447708|FG003|Part B|Death due to Disease Progression|0|||
125496346|NCT02488408|451447709|FG004|Part B|Death due to Disease Progression|0|||
125496347|NCT02488408|451447710|FG005|Part B|Death due to Disease Progression|2|||
125496348|NCT02488408|451447711|FG006|Part B|Death due to Disease Progression|2|||
125496349|NCT02488408|451447712|FG007|Part B|Death due to Disease Progression|1|||
125496350|NCT02488408|451447713|FG008|Part B|Death due to Disease Progression|1|||
125496351|NCT02488408|451447714|FG009|Part B|Death due to Disease Progression|1|||
125496352|NCT02488408|451447705|FG000|Part B|Disease Progression|0|||
125496353|NCT02488408|451447706|FG001|Part B|Disease Progression|0|||
125496354|NCT02488408|451447707|FG002|Part B|Disease Progression|0|||
125496355|NCT02488408|451447708|FG003|Part B|Disease Progression|0|||
125496356|NCT02488408|451447709|FG004|Part B|Disease Progression|0|||
125496357|NCT02488408|451447710|FG005|Part B|Disease Progression|6|||
125496358|NCT02488408|451447711|FG006|Part B|Disease Progression|9|||
125496359|NCT02488408|451447712|FG007|Part B|Disease Progression|7|||
125496360|NCT02488408|451447713|FG008|Part B|Disease Progression|9|||
125496361|NCT02488408|451447714|FG009|Part B|Disease Progression|11|||
125496362|NCT02488408|451447705|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
125496363|NCT02488408|451447706|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
125496364|NCT02488408|451447707|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
125496365|NCT02488408|451447708|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
125304266|NCT03078855|450741238|FG001|Overall Study|Death|0|||
125304267|NCT03078855|450741237|FG000|Overall Study|Withdrawal by Subject|12|||
125304268|NCT03078855|450741238|FG001|Overall Study|Withdrawal by Subject|6|||
125304269|NCT03078855|450741237|FG000|Overall Study|Physician Decision|3|||
125496366|NCT02488408|451447709|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
125304270|NCT03078855|450741238|FG001|Overall Study|Physician Decision|2|||
125496367|NCT02488408|451447710|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
125496368|NCT02488408|451447711|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
125496369|NCT02488408|451447712|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
125496370|NCT02488408|451447713|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
125496371|NCT02488408|451447714|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
125304271|NCT03078855|450741237|FG000|Overall Study|Second Malignancy|4|||
125304272|NCT03078855|450741238|FG001|Overall Study|Second Malignancy|0|||
125496372|NCT02488408|451447705|FG000|Part B|Investigator Decision|0|||
125496373|NCT02488408|451447706|FG001|Part B|Investigator Decision|0|||
125496374|NCT02488408|451447707|FG002|Part B|Investigator Decision|0|||
125496375|NCT02488408|451447708|FG003|Part B|Investigator Decision|0|||
125496376|NCT02488408|451447709|FG004|Part B|Investigator Decision|0|||
125496377|NCT02488408|451447710|FG005|Part B|Investigator Decision|0|||
125496378|NCT02488408|451447711|FG006|Part B|Investigator Decision|1|||
125496379|NCT02488408|451447712|FG007|Part B|Investigator Decision|0|||
125496380|NCT02488408|451447713|FG008|Part B|Investigator Decision|2|||
125420970|NCT05072080|451166183|FG001|Overall Study|Withdrawal by parent|0|||
125420971|NCT05072080|451166184|FG002|Overall Study|Withdrawal by parent|1|||
125420972|NCT05072080|451166185|FG003|Overall Study|Withdrawal by parent|0|||
125420973|NCT05072080|451166182|FG000|Overall Study|Subject was deployed|0|||
125420974|NCT05072080|451166183|FG001|Overall Study|Subject was deployed|1|||
125420975|NCT05072080|451166184|FG002|Overall Study|Subject was deployed|0|||
125420976|NCT05072080|451166185|FG003|Overall Study|Subject was deployed|0|||
125420977|NCT05072080|451166182|FG000|Overall Study|Subject left site without receiving dose|0|||
125420978|NCT05072080|451166183|FG001|Overall Study|Subject left site without receiving dose|1|||
125420979|NCT05072080|451166184|FG002|Overall Study|Subject left site without receiving dose|0|||
125420980|NCT05072080|451166185|FG003|Overall Study|Subject left site without receiving dose|0|||
125420981|NCT05072080|451166182|FG000|Overall Study|Subject incarcerated|0|||
125420982|NCT05072080|451166183|FG001|Overall Study|Subject incarcerated|1|||
125420983|NCT05072080|451166184|FG002|Overall Study|Subject incarcerated|0|||
125420984|NCT05072080|451166185|FG003|Overall Study|Subject incarcerated|1|||
125420985|NCT05072080|451166182|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
125420986|NCT05072080|451166183|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
125420987|NCT05072080|451166184|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
125420988|NCT05072080|451166185|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
125420989|NCT05072080|451166182|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
125420990|NCT05072080|451166183|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
125420991|NCT05072080|451166184|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
125420992|NCT05072080|451166185|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
125420993|NCT05554237|451166186|FG000|Part 2 (7 Days)|Adverse Event|0|||
125420994|NCT05554237|451166187|FG001|Part 2 (7 Days)|Adverse Event|0|||
125420995|NCT05554237|451166188|FG002|Part 2 (7 Days)|Adverse Event|0|||
125420996|NCT05554237|451166189|FG003|Part 2 (7 Days)|Adverse Event|0|||
125420997|NCT05554237|451166190|FG004|Part 2 (7 Days)|Adverse Event|2|||
125420998|NCT05554237|451166191|FG005|Part 2 (7 Days)|Adverse Event|0|||
125420999|NCT05554237|451166192|FG006|Part 2 (7 Days)|Adverse Event|0|||
125421000|NCT05554237|451166193|FG007|Part 2 (7 Days)|Adverse Event|0|||
125421001|NCT05554237|451166194|FG008|Part 2 (7 Days)|Adverse Event|0|||
125421002|NCT05554237|451166195|FG009|Part 2 (7 Days)|Adverse Event|1|||
125421003|NCT05554237|451166196|FG010|Part 2 (7 Days)|Adverse Event|0|||
125421004|NCT05554237|451166197|FG011|Part 2 (7 Days)|Adverse Event|0|||
125421005|NCT05554237|451166198|FG012|Part 2 (7 Days)|Adverse Event|1|||
125421006|NCT05554237|451166199|FG013|Part 2 (7 Days)|Adverse Event|0|||
125421007|NCT02395042|451166200|FG000|Treatment 1 Period|Adverse Event|1|||
125421008|NCT02395042|451166201|FG001|Treatment 1 Period|Adverse Event|3|||
125421009|NCT02395042|451166202|FG002|Treatment 1 Period|Adverse Event|1|||
125421010|NCT02395042|451166200|FG000|Treatment 1 Period|Lack of Efficacy|1|||
125421011|NCT02395042|451166201|FG001|Treatment 1 Period|Lack of Efficacy|1|||
125421012|NCT02395042|451166202|FG002|Treatment 1 Period|Lack of Efficacy|0|||
125421013|NCT02395042|451166200|FG000|Treatment 1 Period|Lost to Follow-up|1|||
125421014|NCT02395042|451166201|FG001|Treatment 1 Period|Lost to Follow-up|0|||
125421015|NCT02395042|451166202|FG002|Treatment 1 Period|Lost to Follow-up|0|||
125421016|NCT02395042|451166200|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
125421017|NCT02395042|451166201|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
125421018|NCT02395042|451166202|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
125421019|NCT02395042|451166200|FG000|Treatment 2 Period|Lack of Efficacy|1|||
125421020|NCT02395042|451166201|FG001|Treatment 2 Period|Lack of Efficacy|1|||
125421021|NCT02395042|451166202|FG002|Treatment 2 Period|Lack of Efficacy|0|||
125421022|NCT03996473|451166203|FG000|Treatment Assignment|Withdrawal by Subject|1|||
125421023|NCT03996473|451166203|FG000|Treatment Assignment|Progressive disease|6|||
125421024|NCT03996473|451166203|FG000|Treatment Assignment|Study drug never administered|1|||
125421025|NCT03996473|451166203|FG000|Active Follow-up|Death|1|||
125421026|NCT03996473|451166203|FG000|Long-term Follow-up|Death|5|||
125421027|NCT06116591|451166204|FG000|Overall Study|No longer met eligibility criteria|0|||
125421028|NCT06116591|451166205|FG001|Overall Study|No longer met eligibility criteria|1|||
125421029|NCT06116591|451166204|FG000|Overall Study|Other: Change in life situation|0|||
125421030|NCT06116591|451166205|FG001|Overall Study|Other: Change in life situation|1|||
125421031|NCT01972841|451166206|FG000|Overall Study|Randomized but Never Received Treatment|2|||
125421032|NCT01972841|451166207|FG001|Overall Study|Randomized but Never Received Treatment|5|||
125421033|NCT01972841|451166208|FG002|Overall Study|Randomized but Never Received Treatment|4|||
125421034|NCT01972841|451166209|FG003|Overall Study|Randomized but Never Received Treatment|2|||
125421035|NCT01972841|451166210|FG004|Overall Study|Randomized but Never Received Treatment|6|||
125421036|NCT01972841|451166211|FG005|Overall Study|Randomized but Never Received Treatment|13|||
125421037|NCT01972841|451166206|FG000|Overall Study|Adverse Event|13|||
125421038|NCT01972841|451166207|FG001|Overall Study|Adverse Event|8|||
125421039|NCT01972841|451166208|FG002|Overall Study|Adverse Event|12|||
125421040|NCT01972841|451166209|FG003|Overall Study|Adverse Event|9|||
125421041|NCT01972841|451166210|FG004|Overall Study|Adverse Event|21|||
125421042|NCT01972841|451166211|FG005|Overall Study|Adverse Event|26|||
125421043|NCT01972841|451166206|FG000|Overall Study|Lack of Efficacy|1|||
125496381|NCT02488408|451447714|FG009|Part B|Investigator Decision|1|||
125496382|NCT03664804|451447718|FG000|Overall Study|Withdrawal by Subject|7|||
125496383|NCT04701203|451447719|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
125496384|NCT04701203|451447720|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
125496385|NCT04701203|451447721|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
125496386|NCT04701203|451447719|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
125496387|NCT04701203|451447720|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
125496388|NCT04701203|451447721|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
125496389|NCT04701203|451447719|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
125496390|NCT04701203|451447720|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
125496391|NCT04701203|451447721|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
125496392|NCT04701203|451447719|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
125496393|NCT04701203|451447720|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
125496394|NCT04701203|451447721|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
125496395|NCT06140290|451447722|FG000|Period 1|Adverse Event|1|||
125496396|NCT06140290|451447723|FG001|Period 1|Adverse Event|0|||
125496397|NCT06140290|451447722|FG000|Period 2|Assigned but not treated|0|||
125496398|NCT06140290|451447723|FG001|Period 2|Assigned but not treated|1|||
125496399|NCT06140290|451447722|FG000|Period 2|Withdrawal by Subject|0|||
125496400|NCT06140290|451447723|FG001|Period 2|Withdrawal by Subject|1|||
125496401|NCT03752684|451448900|FG000|Overall Study|Lost to Follow-up|4|||
125496402|NCT02722434|451448903|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
125496403|NCT02722434|451448904|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
125496404|NCT02722434|451448903|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
125496405|NCT02722434|451448904|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
125496406|NCT02200705|451448905|FG000|Overall Study|Excluded|12|||
125496407|NCT02200705|451448905|FG000|Overall Study|Death|21|||
125496408|NCT02200705|451448905|FG000|Overall Study|Withdrawal by Subject|22|||
125496409|NCT02200705|451448905|FG000|Overall Study|Lost to Follow-up|13|||
125496410|NCT02200705|451448905|FG000|Overall Study|Physician Decision|5|||
125496411|NCT02200705|451448905|FG000|Overall Study|Adverse Event|2|||
125496412|NCT00786864|451448906|FG000|Overall Study|Lost to Follow-up|0|||
125496413|NCT00786864|451448907|FG001|Overall Study|Lost to Follow-up|1|||
125496414|NCT00786864|451448906|FG000|Overall Study|Sustained serious back injury|1|||
125496415|NCT00786864|451448907|FG001|Overall Study|Sustained serious back injury|0|||
125496416|NCT03442777|451448911|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
125496417|NCT03442777|451448912|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
125496418|NCT03442777|451448913|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
125496419|NCT00442104|451448915|FG000|Overall Study|Adverse Event|5|||
125496420|NCT00442104|451448915|FG000|Overall Study|Death|2|||
125496421|NCT00442104|451448915|FG000|Overall Study|Lost to Follow-up|3|||
125496422|NCT00442104|451448915|FG000|Overall Study|Withdrawal by Subject|5|||
125496423|NCT00442104|451448915|FG000|Overall Study|Insufficient Clinical Response|10|||
125496424|NCT00442104|451448915|FG000|Overall Study|Other|21|||
125496425|NCT00442104|451448915|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
125496426|NCT00463229|451448921|FG000|Overall Study|Lost to Follow-up|5|||
125496427|NCT00463229|451448922|FG001|Overall Study|Lost to Follow-up|7|||
125496428|NCT00463229|451448921|FG000|Overall Study|Death|4|||
125496429|NCT00463229|451448922|FG001|Overall Study|Death|3|||
125496430|NCT01932970|451448923|FG000|Overall Study|Withdrawal by Subject|5|||
125496431|NCT01932970|451448923|FG000|Overall Study|Death|1|||
125496432|NCT01932970|451448923|FG000|Overall Study|Lost to Follow-up|2|||
125496433|NCT01932970|451448923|FG000|Overall Study|Protocol Specified Criteria|10|||
125496434|NCT01767467|451448924|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
125496435|NCT01767467|451448925|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
125496436|NCT01767467|451448924|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
125304273|NCT03078855|450741237|FG000|Overall Study|Ineligible|2|||
125304274|NCT03078855|450741238|FG001|Overall Study|Ineligible|0|||
125304275|NCT03078855|450741237|FG000|Overall Study|Withdrew before day 1 treatment|2|||
125496437|NCT01767467|451448925|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
125496438|NCT01767467|451448924|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
125496439|NCT01767467|451448925|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
125496440|NCT01767467|451448924|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
125496441|NCT01767467|451448925|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
125496442|NCT01767467|451448924|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
125496443|NCT01767467|451448925|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
125496444|NCT01767467|451448924|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
125496445|NCT01767467|451448925|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
125496446|NCT01767467|451448924|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
125496447|NCT01767467|451448925|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
125496448|NCT01767467|451448924|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
125496449|NCT01767467|451448925|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
125496450|NCT01767467|451448924|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
125496451|NCT01767467|451448925|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
125496452|NCT01767467|451448924|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
125496453|NCT01767467|451448925|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
125304276|NCT03078855|450741238|FG001|Overall Study|Withdrew before day 1 treatment|1|||
125304277|NCT00391027|450741240|FG000|Overall Study|Adverse Event|8|||
125304278|NCT00391027|450741241|FG001|Overall Study|Adverse Event|8|||
125304279|NCT00391027|450741240|FG000|Overall Study|Lack of Efficacy|3|||
125304280|NCT00391027|450741241|FG001|Overall Study|Lack of Efficacy|0|||
125304281|NCT00391027|450741240|FG000|Overall Study|Withdrawal by Subject|10|||
125304282|NCT00391027|450741241|FG001|Overall Study|Withdrawal by Subject|1|||
125304283|NCT00391027|450741240|FG000|Overall Study|Other|4|||
125304284|NCT00391027|450741241|FG001|Overall Study|Other|3|||
125304285|NCT04124705|450741244|FG000|Titration Period|Adverse Event|9|||
125304286|NCT04124705|450741245|FG001|Titration Period|Adverse Event|5|||
125304287|NCT04124705|450741244|FG000|Titration Period|Withdrawal by Subject|6|||
125304288|NCT04124705|450741245|FG001|Titration Period|Withdrawal by Subject|3|||
125304289|NCT04124705|450741244|FG000|Titration Period|Lost to Follow-up|0|||
125304290|NCT04124705|450741245|FG001|Titration Period|Lost to Follow-up|1|||
125304291|NCT04124705|450741244|FG000|Titration Period|Death|1|||
125304292|NCT04124705|450741245|FG001|Titration Period|Death|1|||
125304293|NCT04124705|450741244|FG000|Titration Period|Lack of Efficacy|2|||
125304294|NCT04124705|450741245|FG001|Titration Period|Lack of Efficacy|0|||
125304295|NCT04124705|450741244|FG000|Titration Period|Physician Decision|2|||
125304296|NCT04124705|450741245|FG001|Titration Period|Physician Decision|0|||
125304297|NCT04124705|450741244|FG000|Titration Period|Non-compliance with Study Drug|2|||
125304298|NCT04124705|450741245|FG001|Titration Period|Non-compliance with Study Drug|0|||
125304299|NCT04124705|450741244|FG000|Titration Period|Other|4|||
125304300|NCT04124705|450741245|FG001|Titration Period|Other|9|||
125304301|NCT04124705|450741244|FG000|Stabilization Period|Adverse Event|4|||
125304302|NCT04124705|450741245|FG001|Stabilization Period|Adverse Event|2|||
125304303|NCT04124705|450741244|FG000|Stabilization Period|Withdrawal by Subject|1|||
125304304|NCT04124705|450741245|FG001|Stabilization Period|Withdrawal by Subject|1|||
125304305|NCT04124705|450741244|FG000|Stabilization Period|Lost to Follow-up|0|||
125304306|NCT04124705|450741245|FG001|Stabilization Period|Lost to Follow-up|1|||
125304307|NCT04124705|450741244|FG000|Stabilization Period|Lack of Efficacy|4|||
125304308|NCT04124705|450741245|FG001|Stabilization Period|Lack of Efficacy|2|||
125304309|NCT04124705|450741244|FG000|Stabilization Period|Protocol Deviation|0|||
125304310|NCT04124705|450741245|FG001|Stabilization Period|Protocol Deviation|2|||
125304311|NCT04124705|450741244|FG000|Stabilization Period|Other|2|||
125304312|NCT04124705|450741245|FG001|Stabilization Period|Other|2|||
125304313|NCT01973998|450741246|FG000|Overall Study|Death|2|||
125304314|NCT01973998|450741247|FG001|Overall Study|Death|2|||
125304315|NCT04302545|450741250|FG000|Overall Study|Lost to Follow-up|3|||
125304316|NCT04302545|450741251|FG001|Overall Study|Lost to Follow-up|4|||
125304317|NCT01636986|450741255|FG000|Overall Study|Withdrawal by Subject|0|||
125304318|NCT01636986|450741256|FG001|Overall Study|Withdrawal by Subject|1|||
125304319|NCT01636986|450741255|FG000|Overall Study|Corneal Staining|0|||
125304320|NCT01636986|450741256|FG001|Overall Study|Corneal Staining|1|||
125304321|NCT02106403|450741261|FG000|Follow-Up Visit 3|Other Reason|0|||
125304322|NCT02106403|450741262|FG001|Follow-Up Visit 3|Other Reason|0|||
125304323|NCT02106403|450741263|FG002|Follow-Up Visit 3|Other Reason|0|||
125304324|NCT02106403|450741264|FG003|Follow-Up Visit 3|Other Reason|0|||
125304325|NCT02106403|450741265|FG004|Follow-Up Visit 3|Other Reason|0|||
125304326|NCT02106403|450741266|FG005|Follow-Up Visit 3|Other Reason|1|||
125304327|NCT04038567|450741268|FG000|Overall Study|Lost to Follow-up|6|||
125304328|NCT04038567|450741269|FG001|Overall Study|Lost to Follow-up|4|||
125304329|NCT04038567|450741270|FG002|Overall Study|Lost to Follow-up|5|||
125304330|NCT04038567|450741271|FG003|Overall Study|Lost to Follow-up|4|||
125304331|NCT04038567|450741272|FG004|Overall Study|Lost to Follow-up|6|||
125304332|NCT04038567|450741273|FG005|Overall Study|Lost to Follow-up|4|||
125304333|NCT04038567|450741274|FG006|Overall Study|Lost to Follow-up|4|||
125304334|NCT04038567|450741275|FG007|Overall Study|Lost to Follow-up|1|||
125304335|NCT04038567|450741268|FG000|Overall Study|Withdrawal by Subject|2|||
125304336|NCT04038567|450741269|FG001|Overall Study|Withdrawal by Subject|1|||
125304337|NCT04038567|450741270|FG002|Overall Study|Withdrawal by Subject|1|||
125304338|NCT04038567|450741271|FG003|Overall Study|Withdrawal by Subject|1|||
125304339|NCT04038567|450741272|FG004|Overall Study|Withdrawal by Subject|4|||
125304340|NCT04038567|450741273|FG005|Overall Study|Withdrawal by Subject|1|||
125304341|NCT04038567|450741274|FG006|Overall Study|Withdrawal by Subject|1|||
125304342|NCT04038567|450741275|FG007|Overall Study|Withdrawal by Subject|1|||
125304343|NCT04038567|450741268|FG000|Overall Study|missed survey window|1|||
125304344|NCT04038567|450741269|FG001|Overall Study|missed survey window|2|||
125304345|NCT04038567|450741270|FG002|Overall Study|missed survey window|0|||
125304346|NCT04038567|450741271|FG003|Overall Study|missed survey window|0|||
125304347|NCT04038567|450741272|FG004|Overall Study|missed survey window|1|||
125304348|NCT04038567|450741273|FG005|Overall Study|missed survey window|1|||
125496454|NCT01767467|451448924|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
125496455|NCT01767467|451448925|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
125496456|NCT01767467|451448924|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
125496457|NCT01767467|451448925|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
125496458|NCT01767467|451448924|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
125496459|NCT01767467|451448925|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
125496460|NCT01767467|451448924|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
125496461|NCT01767467|451448925|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
125496462|NCT01787032|451448930|FG000|Overall Study|Protocol Violation|0|||
125496463|NCT01787032|451448931|FG001|Overall Study|Protocol Violation|0|||
125496464|NCT01787032|451448932|FG002|Overall Study|Protocol Violation|0|||
125496465|NCT01787032|451448933|FG003|Overall Study|Protocol Violation|0|||
125496466|NCT01787032|451448934|FG004|Overall Study|Protocol Violation|1|||
125496467|NCT01787032|451448935|FG005|Overall Study|Protocol Violation|1|||
125496468|NCT00776009|451448938|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
125496469|NCT00776009|451448939|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
125496470|NCT00776009|451448940|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
125496471|NCT00776009|451448941|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
125496472|NCT00776009|451448942|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
125496473|NCT00776009|451448943|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
125496474|NCT00776009|451448938|FG000|Period 1: First Intervention|Protocol Violation|0|||
125496475|NCT00776009|451448939|FG001|Period 1: First Intervention|Protocol Violation|1|||
125496476|NCT00776009|451448940|FG002|Period 1: First Intervention|Protocol Violation|0|||
125496477|NCT00776009|451448941|FG003|Period 1: First Intervention|Protocol Violation|0|||
125496478|NCT00776009|451448942|FG004|Period 1: First Intervention|Protocol Violation|1|||
125496479|NCT00776009|451448943|FG005|Period 1: First Intervention|Protocol Violation|0|||
125496480|NCT00776009|451448938|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
125496481|NCT00776009|451448939|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
125496482|NCT00776009|451448940|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
125496483|NCT00776009|451448941|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
125496484|NCT00776009|451448942|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
125496485|NCT00776009|451448943|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
125496486|NCT00776009|451448938|FG000|Period 2: Second Intervention|Protocol Violation|1|||
125496487|NCT00776009|451448939|FG001|Period 2: Second Intervention|Protocol Violation|0|||
125496488|NCT00776009|451448940|FG002|Period 2: Second Intervention|Protocol Violation|1|||
125496489|NCT00776009|451448941|FG003|Period 2: Second Intervention|Protocol Violation|0|||
125496490|NCT00776009|451448942|FG004|Period 2: Second Intervention|Protocol Violation|0|||
125496491|NCT00776009|451448943|FG005|Period 2: Second Intervention|Protocol Violation|0|||
125496492|NCT00776009|451448938|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
125496493|NCT00776009|451448939|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
125496494|NCT00776009|451448940|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
125496495|NCT00776009|451448941|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
125496496|NCT00776009|451448942|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
125496497|NCT00776009|451448943|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
125496498|NCT01640951|451448944|FG000|Overall Study|Adverse Event|8|||
125496499|NCT01640951|451448945|FG001|Overall Study|Adverse Event|3|||
125496500|NCT01640951|451448946|FG002|Overall Study|Adverse Event|10|||
125496501|NCT01640951|451448947|FG003|Overall Study|Adverse Event|6|||
125496502|NCT01640951|451448948|FG004|Overall Study|Adverse Event|1|||
125496503|NCT01640951|451448949|FG005|Overall Study|Adverse Event|11|||
125496504|NCT01640951|451448950|FG006|Overall Study|Adverse Event|1|||
125496505|NCT01640951|451448951|FG007|Overall Study|Adverse Event|3|||
125496506|NCT01640951|451448944|FG000|Overall Study|Lack of Efficacy|20|||
125496507|NCT01640951|451448945|FG001|Overall Study|Lack of Efficacy|1|||
125496508|NCT01640951|451448946|FG002|Overall Study|Lack of Efficacy|7|||
125496509|NCT01640951|451448947|FG003|Overall Study|Lack of Efficacy|14|||
125496510|NCT01640951|451448948|FG004|Overall Study|Lack of Efficacy|0|||
125496511|NCT01640951|451448949|FG005|Overall Study|Lack of Efficacy|6|||
125496512|NCT01640951|451448950|FG006|Overall Study|Lack of Efficacy|5|||
125496513|NCT01640951|451448951|FG007|Overall Study|Lack of Efficacy|6|||
125496514|NCT01640951|451448944|FG000|Overall Study|Lost to Follow-up|1|||
125496515|NCT01640951|451448945|FG001|Overall Study|Lost to Follow-up|0|||
125496516|NCT01640951|451448946|FG002|Overall Study|Lost to Follow-up|6|||
125496517|NCT01640951|451448947|FG003|Overall Study|Lost to Follow-up|2|||
125496518|NCT01640951|451448948|FG004|Overall Study|Lost to Follow-up|2|||
125496519|NCT01640951|451448949|FG005|Overall Study|Lost to Follow-up|3|||
125304349|NCT04038567|450741274|FG006|Overall Study|missed survey window|2|||
125304350|NCT04038567|450741275|FG007|Overall Study|missed survey window|2|||
125304351|NCT04038567|450741268|FG000|Overall Study|technical issues|0|||
125496520|NCT01640951|451448950|FG006|Overall Study|Lost to Follow-up|1|||
125496521|NCT01640951|451448951|FG007|Overall Study|Lost to Follow-up|1|||
125496522|NCT01640951|451448944|FG000|Overall Study|Non-compliance with study treatment|0|||
125496523|NCT01640951|451448945|FG001|Overall Study|Non-compliance with study treatment|0|||
125496524|NCT01640951|451448946|FG002|Overall Study|Non-compliance with study treatment|1|||
125496525|NCT01640951|451448947|FG003|Overall Study|Non-compliance with study treatment|1|||
125496526|NCT01640951|451448948|FG004|Overall Study|Non-compliance with study treatment|1|||
125496527|NCT01640951|451448949|FG005|Overall Study|Non-compliance with study treatment|4|||
125496528|NCT01640951|451448950|FG006|Overall Study|Non-compliance with study treatment|1|||
125496529|NCT01640951|451448951|FG007|Overall Study|Non-compliance with study treatment|0|||
125496530|NCT01640951|451448944|FG000|Overall Study|Physician Decision|2|||
125496531|NCT01640951|451448945|FG001|Overall Study|Physician Decision|5|||
125496532|NCT01640951|451448946|FG002|Overall Study|Physician Decision|2|||
125496533|NCT01640951|451448947|FG003|Overall Study|Physician Decision|2|||
125496534|NCT01640951|451448948|FG004|Overall Study|Physician Decision|2|||
125496535|NCT01640951|451448949|FG005|Overall Study|Physician Decision|3|||
125496536|NCT01640951|451448950|FG006|Overall Study|Physician Decision|3|||
125496537|NCT01640951|451448951|FG007|Overall Study|Physician Decision|0|||
125496538|NCT01640951|451448944|FG000|Overall Study|Pregnancy|3|||
125496539|NCT01640951|451448945|FG001|Overall Study|Pregnancy|0|||
125496540|NCT01640951|451448946|FG002|Overall Study|Pregnancy|0|||
125496541|NCT01640951|451448947|FG003|Overall Study|Pregnancy|4|||
125496542|NCT01640951|451448948|FG004|Overall Study|Pregnancy|0|||
125496543|NCT01640951|451448949|FG005|Overall Study|Pregnancy|0|||
125496544|NCT01640951|451448950|FG006|Overall Study|Pregnancy|2|||
125496545|NCT01640951|451448951|FG007|Overall Study|Pregnancy|0|||
125496546|NCT01640951|451448944|FG000|Overall Study|Protocol Deviation|0|||
125496547|NCT01640951|451448945|FG001|Overall Study|Protocol Deviation|1|||
125496548|NCT01640951|451448946|FG002|Overall Study|Protocol Deviation|2|||
125496549|NCT01640951|451448947|FG003|Overall Study|Protocol Deviation|1|||
125496550|NCT01640951|451448948|FG004|Overall Study|Protocol Deviation|0|||
125496551|NCT01640951|451448949|FG005|Overall Study|Protocol Deviation|1|||
125496552|NCT01640951|451448950|FG006|Overall Study|Protocol Deviation|0|||
125496553|NCT01640951|451448951|FG007|Overall Study|Protocol Deviation|0|||
125496554|NCT01640951|451448944|FG000|Overall Study|Subject/Guardian decision|12|||
125496555|NCT01640951|451448945|FG001|Overall Study|Subject/Guardian decision|4|||
125496556|NCT01640951|451448946|FG002|Overall Study|Subject/Guardian decision|13|||
125496557|NCT01640951|451448947|FG003|Overall Study|Subject/Guardian decision|15|||
125496558|NCT01640951|451448948|FG004|Overall Study|Subject/Guardian decision|7|||
125496559|NCT01640951|451448949|FG005|Overall Study|Subject/Guardian decision|19|||
125496560|NCT01640951|451448950|FG006|Overall Study|Subject/Guardian decision|5|||
125496561|NCT01640951|451448951|FG007|Overall Study|Subject/Guardian decision|4|||
125496562|NCT01640951|451448944|FG000|Overall Study|Death|0|||
125496563|NCT01640951|451448945|FG001|Overall Study|Death|1|||
125496564|NCT01640951|451448946|FG002|Overall Study|Death|1|||
125496565|NCT01640951|451448947|FG003|Overall Study|Death|0|||
125496566|NCT01640951|451448948|FG004|Overall Study|Death|0|||
125496567|NCT01640951|451448949|FG005|Overall Study|Death|0|||
125496568|NCT01640951|451448950|FG006|Overall Study|Death|0|||
125496569|NCT01640951|451448951|FG007|Overall Study|Death|2|||
125496570|NCT02406092|451448952|FG000|Overall Study|Screen failure|10|||
125496571|NCT02406092|451448953|FG001|Overall Study|Screen failure|7|||
125496572|NCT02406092|451448952|FG000|Overall Study|Death|22|||
125496573|NCT02406092|451448953|FG001|Overall Study|Death|5|||
125496574|NCT02406092|451448952|FG000|Overall Study|Lost to Follow-up|4|||
125496575|NCT02406092|451448953|FG001|Overall Study|Lost to Follow-up|1|||
125496576|NCT02406092|451448952|FG000|Overall Study|Adverse Event|1|||
125496577|NCT02406092|451448953|FG001|Overall Study|Adverse Event|0|||
125496578|NCT02406092|451448952|FG000|Overall Study|Withdrawal by Subject|1|||
125496579|NCT02406092|451448953|FG001|Overall Study|Withdrawal by Subject|0|||
125496580|NCT03041233|451448956|FG000|Overall Study|Death|5|||
125496581|NCT03041233|451448956|FG000|Overall Study|Physician Decision|1|||
125496582|NCT03041233|451448956|FG000|Overall Study|Lost to Follow-up|16|||
125496583|NCT03041233|451448956|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
125496584|NCT03041233|451448956|FG000|Overall Study|Sponsor Request|1|||
125496585|NCT03041233|451448956|FG000|Overall Study|Duplicate subject|1|||
125496586|NCT03041233|451448956|FG000|Overall Study|Re-ablation|1|||
125496587|NCT00942266|451448957|FG000|Overall Study|Withdrawal by Subject|1|||
125496588|NCT00942266|451448958|FG001|Overall Study|Withdrawal by Subject|0|||
125496589|NCT00942266|451448957|FG000|Overall Study|Adverse Event|2|||
125496590|NCT00942266|451448958|FG001|Overall Study|Adverse Event|1|||
125496591|NCT00942266|451448957|FG000|Overall Study|Disease Progression|38|||
125496592|NCT00942266|451448958|FG001|Overall Study|Disease Progression|11|||
125496593|NCT00942266|451448957|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
125496594|NCT00942266|451448958|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
125496595|NCT00942266|451448957|FG000|Overall Study|Intercurrent illness|0|||
125496596|NCT00942266|451448958|FG001|Overall Study|Intercurrent illness|1|||
125496597|NCT00942266|451448957|FG000|Overall Study|Physician Decision|2|||
125496598|NCT00942266|451448958|FG001|Overall Study|Physician Decision|0|||
125496599|NCT00942266|451448957|FG000|Overall Study|medical deterioration (pneumonia)|0|||
125496600|NCT00942266|451448958|FG001|Overall Study|medical deterioration (pneumonia)|1|||
125496601|NCT00756574|451448962|FG000|Overall Study|Withdrawal by Subject|9|||
125496602|NCT00756574|451448963|FG001|Overall Study|Withdrawal by Subject|7|||
125496603|NCT00756574|451448962|FG000|Overall Study|Lost to Follow-up|4|||
125496604|NCT00756574|451448963|FG001|Overall Study|Lost to Follow-up|4|||
125496605|NCT02816398|451448968|FG000|Overall Study|Death|5|||
125496606|NCT02816398|451448968|FG000|Overall Study|Lack of Efficacy|8|||
125496607|NCT02816398|451448968|FG000|Overall Study|Lost to Follow-up|1|||
125496608|NCT01588951|451448970|FG000|Overall Study|Ineligible in retrospect|0|||
125496609|NCT01588951|451448971|FG001|Overall Study|Ineligible in retrospect|0|||
125496610|NCT01588951|451448972|FG002|Overall Study|Ineligible in retrospect|1|||
125496611|NCT02517268|451448981|FG000|Overall Study|Withdrawal by Subject|1|||
125496612|NCT02517268|451448982|FG001|Overall Study|Withdrawal by Subject|0|||
125496613|NCT05613907|451448992|FG000|Overall Study|Lost to Follow-up|5|||
125496614|NCT05613907|451448992|FG000|Overall Study|Death|3|||
125496615|NCT05613907|451448992|FG000|Overall Study|Withdrawal by Subject|2|||
125496616|NCT04912856|451448993|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
125496617|NCT04912856|451448994|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
125496618|NCT04912856|451448993|FG000|Overall Study|Not reported in synoptic CSR.|0|||
125496619|NCT04912856|451448994|FG001|Overall Study|Not reported in synoptic CSR.|1|||
125496620|NCT00748709|451448997|FG000|Overall Study|Progressive disease|15|||
125496621|NCT00748709|451448997|FG000|Overall Study|Drug reducing Toxity|2|||
125496622|NCT00748709|451448997|FG000|Overall Study|Other Adverse Event|1|||
125496623|NCT00748709|451448997|FG000|Overall Study|Withdrawal by Subject|1|||
125496624|NCT00748709|451448997|FG000|Overall Study|Other Reasons|1|||
125496625|NCT02751528|451449002|FG000|Overall Study|Withdrawal by Subject|1|||
125496626|NCT02751528|451449002|FG000|Overall Study|Adverse Event|1|||
125496627|NCT05071430|451449003|FG000|Overall Study|Adverse Event|1|||
125496628|NCT05071430|451449004|FG001|Overall Study|Adverse Event|2|||
125496629|NCT05071430|451449003|FG000|Overall Study|Lost to Follow-up|4|||
125496630|NCT05071430|451449004|FG001|Overall Study|Lost to Follow-up|4|||
125496631|NCT05071430|451449003|FG000|Overall Study|Protocol Violation|1|||
125496632|NCT05071430|451449004|FG001|Overall Study|Protocol Violation|0|||
125496633|NCT05071430|451449003|FG000|Overall Study|Withdrawal by Subject|3|||
125496634|NCT05071430|451449004|FG001|Overall Study|Withdrawal by Subject|2|||
125496635|NCT05071430|451449003|FG000|Overall Study|Other|1|||
125496636|NCT05071430|451449004|FG001|Overall Study|Other|1|||
125496637|NCT01958021|451449005|FG000|Treatment|Progressive disease|206|||
125496638|NCT01958021|451449006|FG001|Treatment|Progressive disease|265|||
125496639|NCT01958021|451449005|FG000|Treatment|Adverse Event|38|||
125496640|NCT01958021|451449006|FG001|Treatment|Adverse Event|10|||
125496641|NCT01958021|451449005|FG000|Treatment|Subject/guardian decision|29|||
125496642|NCT01958021|451449006|FG001|Treatment|Subject/guardian decision|25|||
125496643|NCT01958021|451449005|FG000|Treatment|Physician Decision|28|||
125496644|NCT01958021|451449006|FG001|Treatment|Physician Decision|21|||
125496645|NCT01958021|451449005|FG000|Treatment|Death|6|||
125496646|NCT01958021|451449006|FG001|Treatment|Death|1|||
125496647|NCT01958021|451449005|FG000|Treatment|Protocol deviation|3|||
125496648|NCT01958021|451449006|FG001|Treatment|Protocol deviation|1|||
125496649|NCT01958021|451449005|FG000|Treatment|Sponsor decision|24|||
125496650|NCT01958021|451449006|FG001|Treatment|Sponsor decision|11|||
125496651|NCT01958021|451449005|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
125496652|NCT01958021|451449006|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
125496653|NCT01958021|451449005|FG000|Post-treatment Efficacy Follow-up|Death|1|||
125496654|NCT01958021|451449006|FG001|Post-treatment Efficacy Follow-up|Death|0|||
125496655|NCT01958021|451449005|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
125496656|NCT01958021|451449006|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
125496657|NCT01958021|451449005|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
125496658|NCT01958021|451449006|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
125496659|NCT01958021|451449005|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
125496660|NCT01958021|451449006|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
125496661|NCT01958021|451449005|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
125496662|NCT01958021|451449006|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
125496663|NCT01958021|451449005|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
125304352|NCT04038567|450741269|FG001|Overall Study|technical issues|0|||
125304353|NCT04038567|450741270|FG002|Overall Study|technical issues|0|||
125304354|NCT04038567|450741271|FG003|Overall Study|technical issues|0|||
125496664|NCT01958021|451449006|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
125496665|NCT04649047|451449007|FG000|Overall Study|Withdrawal by Subject|3|||
125496666|NCT00719888|451449008|FG000|Overall Study|Death|24|||
125496667|NCT00719888|451449009|FG001|Overall Study|Death|9|||
125496668|NCT00719888|451449008|FG000|Overall Study|Relapse|8|||
125304355|NCT04038567|450741272|FG004|Overall Study|technical issues|0|||
125496669|NCT00719888|451449009|FG001|Overall Study|Relapse|3|||
125496670|NCT00719888|451449008|FG000|Overall Study|Physician Decision|1|||
125496671|NCT00719888|451449009|FG001|Overall Study|Physician Decision|0|||
125496672|NCT00719888|451449008|FG000|Overall Study|Withdrawal by Subject|1|||
125496673|NCT00719888|451449009|FG001|Overall Study|Withdrawal by Subject|0|||
125304356|NCT04038567|450741273|FG005|Overall Study|technical issues|0|||
125496674|NCT05037513|451449010|FG000|Intervention Period|Lost to Follow-up|1|||
125496675|NCT05037513|451449011|FG001|Intervention Period|Lost to Follow-up|2|||
125496676|NCT05037513|451449010|FG000|Follow Up Period|Lost to Follow-up|16|||
125496677|NCT05037513|451449011|FG001|Follow Up Period|Lost to Follow-up|21|||
125496678|NCT05037513|451449010|FG000|Follow Up Period|Death|0|||
125496679|NCT05037513|451449011|FG001|Follow Up Period|Death|1|||
125496680|NCT05037513|451449010|FG000|Follow Up Period|Incarcerated|4|||
125496681|NCT05037513|451449011|FG001|Follow Up Period|Incarcerated|2|||
125496682|NCT05886777|451449012|FG000|Overall Study|Lost to Follow-up|1|||
125496683|NCT05886777|451449013|FG001|Overall Study|Lost to Follow-up|0|||
125496684|NCT05886777|451449014|FG002|Overall Study|Lost to Follow-up|2|||
125496685|NCT05886777|451449015|FG003|Overall Study|Lost to Follow-up|1|||
125496686|NCT05886777|451449016|FG004|Overall Study|Lost to Follow-up|0|||
125496687|NCT05886777|451449017|FG005|Overall Study|Lost to Follow-up|2|||
125496688|NCT05886777|451449018|FG006|Overall Study|Lost to Follow-up|0|||
125496689|NCT05886777|451449012|FG000|Overall Study|Other|0|||
125496690|NCT05886777|451449013|FG001|Overall Study|Other|2|||
125496691|NCT05886777|451449014|FG002|Overall Study|Other|1|||
125496692|NCT05886777|451449015|FG003|Overall Study|Other|0|||
125496693|NCT05886777|451449016|FG004|Overall Study|Other|0|||
125496694|NCT05886777|451449017|FG005|Overall Study|Other|0|||
125496695|NCT05886777|451449018|FG006|Overall Study|Other|0|||
125496696|NCT05886777|451449012|FG000|Overall Study|Withdrawal by Subject|1|||
125496697|NCT05886777|451449013|FG001|Overall Study|Withdrawal by Subject|0|||
125496698|NCT05886777|451449014|FG002|Overall Study|Withdrawal by Subject|1|||
125496699|NCT05886777|451449015|FG003|Overall Study|Withdrawal by Subject|4|||
125496700|NCT05886777|451449016|FG004|Overall Study|Withdrawal by Subject|3|||
125496701|NCT05886777|451449017|FG005|Overall Study|Withdrawal by Subject|1|||
125496702|NCT05886777|451449018|FG006|Overall Study|Withdrawal by Subject|1|||
125496703|NCT05886777|451449012|FG000|Overall Study|Protocol Violation|0|||
125496704|NCT05886777|451449013|FG001|Overall Study|Protocol Violation|0|||
125496705|NCT05886777|451449014|FG002|Overall Study|Protocol Violation|1|||
125496706|NCT05886777|451449015|FG003|Overall Study|Protocol Violation|0|||
125496707|NCT05886777|451449016|FG004|Overall Study|Protocol Violation|0|||
125496708|NCT05886777|451449017|FG005|Overall Study|Protocol Violation|0|||
125496709|NCT05886777|451449018|FG006|Overall Study|Protocol Violation|0|||
125496710|NCT05886777|451449012|FG000|Overall Study|No longer met eligibility criteria|0|||
125496711|NCT05886777|451449013|FG001|Overall Study|No longer met eligibility criteria|1|||
125496712|NCT05886777|451449014|FG002|Overall Study|No longer met eligibility criteria|0|||
125496713|NCT05886777|451449015|FG003|Overall Study|No longer met eligibility criteria|0|||
125496714|NCT05886777|451449016|FG004|Overall Study|No longer met eligibility criteria|0|||
125496715|NCT05886777|451449017|FG005|Overall Study|No longer met eligibility criteria|0|||
125496716|NCT05886777|451449018|FG006|Overall Study|No longer met eligibility criteria|0|||
125496717|NCT03002194|451450552|FG000|Overall Study|Lost to Follow-up|6|||
125496718|NCT03002194|451450552|FG000|Overall Study|Adverse Event|1|||
125496719|NCT03002194|451450552|FG000|Overall Study|Lack of Efficacy|1|||
125496720|NCT03002194|451450552|FG000|Overall Study|Withdrawal by Subject|2|||
125496721|NCT00048932|451450553|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
125496722|NCT00048932|451450554|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
125496723|NCT00048932|451450555|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
125496724|NCT00048932|451450553|FG000|Double Blind Period (DB)|Adverse Event|51|||
125496725|NCT00048932|451450554|FG001|Double Blind Period (DB)|Adverse Event|19|||
125496726|NCT00048932|451450555|FG002|Double Blind Period (DB)|Adverse Event|0|||
125496727|NCT00048932|451450553|FG000|Double Blind Period (DB)|Death|5|||
125496728|NCT00048932|451450554|FG001|Double Blind Period (DB)|Death|3|||
125496729|NCT00048932|451450555|FG002|Double Blind Period (DB)|Death|0|||
125496730|NCT00048932|451450553|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
125496731|NCT00048932|451450554|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
125496732|NCT00048932|451450555|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
125496733|NCT00048932|451450553|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
125496734|NCT00048932|451450554|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
125496735|NCT00048932|451450555|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
125496736|NCT00048932|451450553|FG000|Double Blind Period (DB)|Relocation|1|||
125496737|NCT00048932|451450554|FG001|Double Blind Period (DB)|Relocation|0|||
125496738|NCT00048932|451450555|FG002|Double Blind Period (DB)|Relocation|0|||
125496739|NCT00048932|451450553|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
125496740|NCT00048932|451450554|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
125496741|NCT00048932|451450555|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
125496742|NCT00048932|451450553|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
125496743|NCT00048932|451450554|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
125496744|NCT00048932|451450555|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
125496745|NCT00048932|451450553|FG000|Double Blind Period (DB)|Pregnancy|1|||
125496746|NCT00048932|451450554|FG001|Double Blind Period (DB)|Pregnancy|0|||
125496747|NCT00048932|451450555|FG002|Double Blind Period (DB)|Pregnancy|0|||
125496748|NCT00048932|451450553|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
125496749|NCT00048932|451450554|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
125496750|NCT00048932|451450555|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
125496751|NCT00048932|451450553|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
125496752|NCT00048932|451450554|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
125496753|NCT00048932|451450555|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
125496754|NCT00048932|451450553|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
125496755|NCT00048932|451450554|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
125496756|NCT00048932|451450555|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
125496757|NCT00048932|451450553|FG000|Open Label Period (OL)|Death|0|||
125496758|NCT00048932|451450554|FG001|Open Label Period (OL)|Death|0|||
125496759|NCT00048932|451450555|FG002|Open Label Period (OL)|Death|25|||
125496760|NCT00048932|451450553|FG000|Open Label Period (OL)|Adverse Event|0|||
125496761|NCT00048932|451450554|FG001|Open Label Period (OL)|Adverse Event|0|||
125496762|NCT00048932|451450555|FG002|Open Label Period (OL)|Adverse Event|103|||
125496763|NCT00048932|451450553|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
125496764|NCT00048932|451450554|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
125496765|NCT00048932|451450555|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
125496766|NCT00048932|451450553|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
125496767|NCT00048932|451450554|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
125496768|NCT00048932|451450555|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
125496769|NCT00048932|451450553|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
125496770|NCT00048932|451450554|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
125496771|NCT00048932|451450555|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
125496772|NCT00048932|451450553|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
125496773|NCT00048932|451450554|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
125496774|NCT00048932|451450555|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
125496775|NCT00048932|451450553|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
125496776|NCT00048932|451450554|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
125496777|NCT00048932|451450555|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
125496778|NCT00048932|451450553|FG000|Open Label Period (OL)|Pregnancy|0|||
125496779|NCT00048932|451450554|FG001|Open Label Period (OL)|Pregnancy|0|||
125496780|NCT00048932|451450555|FG002|Open Label Period (OL)|Pregnancy|6|||
125496781|NCT00048932|451450553|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
125496782|NCT00048932|451450554|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
125496783|NCT00048932|451450555|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
125496784|NCT00048932|451450553|FG000|Open Label Period (OL)|Investigator Retiring|0|||
125496785|NCT00048932|451450554|FG001|Open Label Period (OL)|Investigator Retiring|0|||
125496786|NCT00048932|451450555|FG002|Open Label Period (OL)|Investigator Retiring|2|||
125496787|NCT00048932|451450553|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
125496788|NCT00048932|451450554|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
125496789|NCT00048932|451450555|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
125496790|NCT00048932|451450553|FG000|Open Label Period (OL)|Participant Relocated|0|||
125496791|NCT00048932|451450554|FG001|Open Label Period (OL)|Participant Relocated|0|||
125496792|NCT00048932|451450555|FG002|Open Label Period (OL)|Participant Relocated|6|||
125496793|NCT00048932|451450553|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
125496794|NCT00048932|451450554|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
125496795|NCT00048932|451450555|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
125496796|NCT00048932|451450553|FG000|Open Label Period (OL)|Site Closure|0|||
125496797|NCT00048932|451450554|FG001|Open Label Period (OL)|Site Closure|0|||
125496798|NCT00048932|451450555|FG002|Open Label Period (OL)|Site Closure|3|||
125496799|NCT00048932|451450553|FG000|Open Label Period (OL)|Trial Terminated|0|||
125496800|NCT00048932|451450554|FG001|Open Label Period (OL)|Trial Terminated|0|||
125496801|NCT00048932|451450555|FG002|Open Label Period (OL)|Trial Terminated|1|||
125496802|NCT00048932|451450553|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
125496803|NCT00048932|451450554|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
125496804|NCT00048932|451450555|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
125496805|NCT00048932|451450553|FG000|Open Label Period (OL)|Patient Decision|0|||
125496806|NCT00048932|451450554|FG001|Open Label Period (OL)|Patient Decision|0|||
125496807|NCT00048932|451450555|FG002|Open Label Period (OL)|Patient Decision|4|||
125496808|NCT00048932|451450553|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
125496809|NCT00048932|451450554|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
125496810|NCT00048932|451450555|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
125496811|NCT00048932|451450553|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
125496812|NCT00048932|451450554|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
125496813|NCT00048932|451450555|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
125496814|NCT00048932|451450553|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
125496815|NCT00048932|451450554|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
125496816|NCT00048932|451450555|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
125496817|NCT00048932|451450553|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
125496818|NCT00048932|451450554|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
125496819|NCT00048932|451450555|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
125496820|NCT00048932|451450553|FG000|Open Label Period (OL)|Investigator Decision|0|||
125496821|NCT00048932|451450554|FG001|Open Label Period (OL)|Investigator Decision|0|||
125496822|NCT00048932|451450555|FG002|Open Label Period (OL)|Investigator Decision|4|||
125496823|NCT00048932|451450553|FG000|Open Label Period (OL)|Site Staff Issues|0|||
125496824|NCT00048932|451450554|FG001|Open Label Period (OL)|Site Staff Issues|0|||
125496825|NCT00048932|451450555|FG002|Open Label Period (OL)|Site Staff Issues|2|||
125496826|NCT00048932|451450553|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
125496827|NCT00048932|451450554|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
125496828|NCT00048932|451450555|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
125496829|NCT00048932|451450553|FG000|Open Label Period (OL)|Participant Surgery|0|||
125496830|NCT00048932|451450554|FG001|Open Label Period (OL)|Participant Surgery|0|||
125496831|NCT00048932|451450555|FG002|Open Label Period (OL)|Participant Surgery|1|||
125496832|NCT02232737|451450556|FG000|Overall Study|Lost to Follow-up|18|||
125496833|NCT02232737|451450557|FG001|Overall Study|Lost to Follow-up|28|||
125496834|NCT02232737|451450558|FG002|Overall Study|Lost to Follow-up|33|||
125496835|NCT02232737|451450556|FG000|Overall Study|Personal reasons|7|||
125496836|NCT02232737|451450557|FG001|Overall Study|Personal reasons|8|||
125496837|NCT02232737|451450558|FG002|Overall Study|Personal reasons|14|||
125496838|NCT02232737|451450556|FG000|Overall Study|Adverse Event|6|||
125496839|NCT02232737|451450557|FG001|Overall Study|Adverse Event|3|||
125496840|NCT02232737|451450558|FG002|Overall Study|Adverse Event|8|||
125496841|NCT02232737|451450556|FG000|Overall Study|Incarcerated|2|||
125496842|NCT02232737|451450557|FG001|Overall Study|Incarcerated|1|||
125496843|NCT02232737|451450558|FG002|Overall Study|Incarcerated|2|||
125496844|NCT02232737|451450556|FG000|Overall Study|Withdrawal by Subject|0|||
125496845|NCT02232737|451450557|FG001|Overall Study|Withdrawal by Subject|1|||
125496846|NCT02232737|451450558|FG002|Overall Study|Withdrawal by Subject|2|||
125496847|NCT02232737|451450556|FG000|Overall Study|Death|0|||
125496848|NCT02232737|451450557|FG001|Overall Study|Death|1|||
125496849|NCT02232737|451450558|FG002|Overall Study|Death|1|||
125496850|NCT02232737|451450556|FG000|Overall Study|Physician Decision|1|||
125496851|NCT02232737|451450557|FG001|Overall Study|Physician Decision|3|||
125496852|NCT02232737|451450558|FG002|Overall Study|Physician Decision|1|||
125496853|NCT02232737|451450556|FG000|Overall Study|Protocol Violation|1|||
125496854|NCT02232737|451450557|FG001|Overall Study|Protocol Violation|0|||
125496855|NCT02232737|451450558|FG002|Overall Study|Protocol Violation|1|||
125496856|NCT02232737|451450556|FG000|Overall Study|Reason unknown|1|||
125496857|NCT02232737|451450557|FG001|Overall Study|Reason unknown|0|||
125496858|NCT02232737|451450558|FG002|Overall Study|Reason unknown|0|||
125496859|NCT04559698|451450559|FG000|Overall Study|Lost to Follow-up|14|||
125496860|NCT04559698|451450560|FG001|Overall Study|Lost to Follow-up|15|||
125496861|NCT04559698|451450559|FG000|Overall Study|Withdrawal by Subject|0|||
125496862|NCT04559698|451450560|FG001|Overall Study|Withdrawal by Subject|1|||
125496863|NCT01641900|451450574|FG000|Overall Study|Withdrawal by Subject|2|||
125496864|NCT01641900|451450575|FG001|Overall Study|Withdrawal by Subject|2|||
125496865|NCT03220724|451450581|FG000|Overall Study|Lost to Follow-up|2|||
125496866|NCT03220724|451450582|FG001|Overall Study|Lost to Follow-up|2|||
125496867|NCT03220724|451450583|FG002|Overall Study|Lost to Follow-up|0|||
125496868|NCT03220724|451450584|FG003|Overall Study|Lost to Follow-up|3|||
125496869|NCT03220724|451450585|FG004|Overall Study|Lost to Follow-up|1|||
125496870|NCT03220724|451450586|FG005|Overall Study|Lost to Follow-up|0|||
125496871|NCT03220724|451450587|FG006|Overall Study|Lost to Follow-up|2|||
125496872|NCT03220724|451450588|FG007|Overall Study|Lost to Follow-up|1|||
125496873|NCT03220724|451450589|FG008|Overall Study|Lost to Follow-up|0|||
125496874|NCT03220724|451450581|FG000|Overall Study|Withdrawal by Subject|1|||
125496875|NCT03220724|451450582|FG001|Overall Study|Withdrawal by Subject|0|||
125496876|NCT03220724|451450583|FG002|Overall Study|Withdrawal by Subject|1|||
125496877|NCT03220724|451450584|FG003|Overall Study|Withdrawal by Subject|0|||
125304357|NCT04038567|450741274|FG006|Overall Study|technical issues|1|||
125304358|NCT04038567|450741275|FG007|Overall Study|technical issues|0|||
125496878|NCT03220724|451450585|FG004|Overall Study|Withdrawal by Subject|0|||
125496879|NCT03220724|451450586|FG005|Overall Study|Withdrawal by Subject|0|||
125496880|NCT03220724|451450587|FG006|Overall Study|Withdrawal by Subject|0|||
125496881|NCT03220724|451450588|FG007|Overall Study|Withdrawal by Subject|0|||
125496882|NCT03220724|451450589|FG008|Overall Study|Withdrawal by Subject|0|||
125496883|NCT01478594|451450594|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
125496884|NCT01478594|451450595|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
125496885|NCT01478594|451450594|FG000|Overall Study|Death|45|||
125496886|NCT01478594|451450595|FG001|Overall Study|Death|18|||
125496887|NCT01478594|451450594|FG000|Overall Study|Lost to Follow-up|3|||
125496888|NCT01478594|451450595|FG001|Overall Study|Lost to Follow-up|1|||
125304359|NCT04038567|450741268|FG000|Overall Study|Medical issues (i.e., illness)|0|||
125496889|NCT01478594|451450594|FG000|Overall Study|Withdrawal by Subject|9|||
125496890|NCT01478594|451450595|FG001|Overall Study|Withdrawal by Subject|3|||
125496891|NCT01478594|451450594|FG000|Overall Study|Study Closed by Sponsor|8|||
125496892|NCT01478594|451450595|FG001|Overall Study|Study Closed by Sponsor|5|||
125496893|NCT02463448|451450602|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
125496894|NCT02463448|451450602|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
125496895|NCT02463448|451450602|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
125496896|NCT02463448|451450602|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
125496897|NCT01359150|451450603|FG000|Overall Study|Lack of Efficacy|1|||
125496898|NCT01359150|451450604|FG001|Overall Study|Lack of Efficacy|1|||
125496899|NCT01359150|451450603|FG000|Overall Study|Withdrawal by Subject|1|||
125496900|NCT01359150|451450604|FG001|Overall Study|Withdrawal by Subject|1|||
125496901|NCT01359150|451450603|FG000|Overall Study|Adverse Event|4|||
125496902|NCT01359150|451450604|FG001|Overall Study|Adverse Event|3|||
125496903|NCT01359150|451450603|FG000|Overall Study|Other|1|||
125496904|NCT01359150|451450604|FG001|Overall Study|Other|0|||
125496905|NCT00857766|451450605|FG000|Overall Study|Adverse Event|13|||
125496906|NCT00857766|451450606|FG001|Overall Study|Adverse Event|12|||
125496907|NCT00857766|451450605|FG000|Overall Study|Protocol Violation|11|||
125496908|NCT00857766|451450606|FG001|Overall Study|Protocol Violation|11|||
125496909|NCT00857766|451450605|FG000|Overall Study|Lost to Follow-up|1|||
125496910|NCT00857766|451450606|FG001|Overall Study|Lost to Follow-up|0|||
125496911|NCT00857766|451450605|FG000|Overall Study|Investigator Discretion|2|||
125496912|NCT00857766|451450606|FG001|Overall Study|Investigator Discretion|3|||
125496913|NCT00857766|451450605|FG000|Overall Study|Participant Withdrew Consent|4|||
125496914|NCT00857766|451450606|FG001|Overall Study|Participant Withdrew Consent|4|||
125496915|NCT03113409|451450607|FG000|Overall Study|Withdrawal by Subject|5|||
125496916|NCT03113409|451450608|FG001|Overall Study|Withdrawal by Subject|0|||
125496917|NCT03113409|451450609|FG002|Overall Study|Withdrawal by Subject|0|||
125496918|NCT02040870|451450610|FG000|Overall Study|Completed treatment phase|6|||
125496919|NCT02040870|451450610|FG000|Overall Study|Adverse Event|7|||
125496920|NCT02040870|451450610|FG000|Overall Study|Progressive disease|58|||
125496921|NCT02040870|451450610|FG000|Overall Study|Physician Decision|6|||
125496922|NCT02040870|451450610|FG000|Overall Study|Subject/guardian decision|10|||
125496923|NCT02040870|451450610|FG000|Overall Study|Lost to Follow-up|3|||
125496924|NCT02040870|451450610|FG000|Overall Study|Death|13|||
125496925|NCT01536093|451450611|FG000|Overall Study|Death|1|||
125496926|NCT01536093|451450612|FG001|Overall Study|Death|2|||
125496927|NCT01536093|451450611|FG000|Overall Study|absence of maternal colostrum|2|||
125496928|NCT01536093|451450612|FG001|Overall Study|absence of maternal colostrum|0|||
125496929|NCT01536093|451450611|FG000|Overall Study|Withdrawal by Subject|0|||
125496930|NCT01536093|451450612|FG001|Overall Study|Withdrawal by Subject|1|||
125496931|NCT04971733|451450613|FG000|Overall Study|Adverse Event|1|||
125496932|NCT04971733|451450614|FG001|Overall Study|Adverse Event|1|||
125496933|NCT04971733|451450613|FG000|Overall Study|Subject choice|2|||
125496934|NCT04971733|451450614|FG001|Overall Study|Subject choice|0|||
125496935|NCT04971733|451450613|FG000|Overall Study|Withdrawal by Subject|1|||
125496936|NCT04971733|451450614|FG001|Overall Study|Withdrawal by Subject|0|||
125496937|NCT04971733|451450613|FG000|Overall Study|Other|1|||
125496938|NCT04971733|451450614|FG001|Overall Study|Other|0|||
125496939|NCT02275611|451450617|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
125496940|NCT02275611|451450618|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
125496941|NCT02275611|451450619|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
125496942|NCT02275611|451450620|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
125496943|NCT01759862|451450624|FG000|Overall Study|Physician Decision|3|||
125496944|NCT01759862|451450625|FG001|Overall Study|Physician Decision|1|||
125496945|NCT01759862|451450624|FG000|Overall Study|Adverse Event|0|||
125496946|NCT01759862|451450625|FG001|Overall Study|Adverse Event|1|||
125496947|NCT03890289|451450628|FG000|Overall Study|Adverse Event|1|||
125496948|NCT03890289|451450628|FG000|Overall Study|Physician Decision|1|||
125496949|NCT03890289|451450628|FG000|Overall Study|Lack of Efficacy|2|||
125496950|NCT00274261|451450631|FG000|Overall Study|Adverse Event|19|||
125496951|NCT00274261|451450632|FG001|Overall Study|Adverse Event|11|||
125496952|NCT00274261|451450631|FG000|Overall Study|Pregnancy|114|||
125496953|NCT00274261|451450632|FG001|Overall Study|Pregnancy|83|||
125496954|NCT00274261|451450631|FG000|Overall Study|Withdrawal by Subject|179|||
125304360|NCT04038567|450741269|FG001|Overall Study|Medical issues (i.e., illness)|1|||
125496955|NCT00274261|451450632|FG001|Overall Study|Withdrawal by Subject|126|||
125496956|NCT00274261|451450631|FG000|Overall Study|Protocol Violation|71|||
125496957|NCT00274261|451450632|FG001|Overall Study|Protocol Violation|42|||
125496958|NCT00274261|451450631|FG000|Overall Study|Lost to Follow-up|106|||
125304361|NCT04038567|450741270|FG002|Overall Study|Medical issues (i.e., illness)|2|||
125496959|NCT00274261|451450632|FG001|Overall Study|Lost to Follow-up|75|||
125496960|NCT01367236|451450637|FG000|Overall Study|Withdrawal by Subject|3|||
125496961|NCT01367236|451450638|FG001|Overall Study|Withdrawal by Subject|1|||
125496962|NCT02628626|451450639|FG000|Overall Study|Withdrawal by Subject|2|||
125496963|NCT02628626|451450640|FG001|Overall Study|Withdrawal by Subject|2|||
125496964|NCT01593020|451450641|FG000|Overall Study|Adverse Event|1|||
125496965|NCT01593020|451450642|FG001|Overall Study|Adverse Event|1|||
125304362|NCT04038567|450741271|FG003|Overall Study|Medical issues (i.e., illness)|1|||
125496966|NCT01593020|451450641|FG000|Overall Study|Death|0|||
125496967|NCT01593020|451450642|FG001|Overall Study|Death|1|||
125496968|NCT01593020|451450641|FG000|Overall Study|Ineligible|1|||
125496969|NCT01593020|451450642|FG001|Overall Study|Ineligible|0|||
125496970|NCT02972359|451450643|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
125496971|NCT02972359|451450643|FG000|Overall Study|Lack of Efficacy|1|||
125496972|NCT02972359|451450643|FG000|Overall Study|Adverse Event|4|||
125496973|NCT02972359|451450643|FG000|Overall Study|Death|1|||
125496974|NCT02972359|451450643|FG000|Overall Study|Withdrawal by Subject|30|||
125496975|NCT02972359|451450643|FG000|Overall Study|Protocol Violation|1|||
125496976|NCT02972359|451450643|FG000|Overall Study|Lost to Follow-up|26|||
125496977|NCT02972359|451450643|FG000|Overall Study|Other reasons|5|||
125496978|NCT02972359|451450643|FG000|Overall Study|Missing|1|||
125496979|NCT02063659|451450644|FG000|Double-Blind Treatment Period|Adverse Event|1|||
125496980|NCT02063659|451450645|FG001|Double-Blind Treatment Period|Adverse Event|2|||
125496981|NCT02063659|451450646|FG002|Double-Blind Treatment Period|Adverse Event|0|||
125496982|NCT02063659|451450647|FG003|Double-Blind Treatment Period|Adverse Event|0|||
125496983|NCT02063659|451450644|FG000|Double-Blind Treatment Period|Physician Decision|1|||
125496984|NCT02063659|451450645|FG001|Double-Blind Treatment Period|Physician Decision|0|||
125496985|NCT02063659|451450646|FG002|Double-Blind Treatment Period|Physician Decision|0|||
125496986|NCT02063659|451450647|FG003|Double-Blind Treatment Period|Physician Decision|0|||
125496987|NCT02063659|451450644|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
125496988|NCT02063659|451450645|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
125496989|NCT02063659|451450646|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
125496990|NCT02063659|451450647|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
125496991|NCT02063659|451450644|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
125496992|NCT02063659|451450645|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
125496993|NCT02063659|451450646|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
125496994|NCT02063659|451450647|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
125496995|NCT02063659|451450644|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
125496996|NCT02063659|451450645|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
125496997|NCT02063659|451450646|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
125496998|NCT02063659|451450647|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
125496999|NCT02063659|451450644|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
125497000|NCT02063659|451450645|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
125497001|NCT02063659|451450646|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
125497002|NCT02063659|451450647|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
125497003|NCT02063659|451450644|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
125497004|NCT02063659|451450645|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
125497005|NCT02063659|451450646|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
125497006|NCT02063659|451450647|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
125497007|NCT02063659|451450644|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
125497008|NCT02063659|451450645|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
125497009|NCT02063659|451450646|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
125497010|NCT02063659|451450647|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
125497011|NCT01532999|451450648|FG000|Overall Study|Lost to Follow-up|14|||
125497012|NCT01532999|451450649|FG001|Overall Study|Lost to Follow-up|8|||
125497013|NCT01532999|451450648|FG000|Overall Study|Physician Decision|1|||
125497014|NCT01532999|451450649|FG001|Overall Study|Physician Decision|2|||
125497015|NCT01532999|451450648|FG000|Overall Study|Withdrawal by Subject|5|||
125497016|NCT01532999|451450649|FG001|Overall Study|Withdrawal by Subject|0|||
125497017|NCT01532999|451450648|FG000|Overall Study|Relocated|2|||
125497018|NCT01532999|451450649|FG001|Overall Study|Relocated|0|||
125497019|NCT01532999|451450648|FG000|Overall Study|should not have been randomized|1|||
125497020|NCT01532999|451450649|FG001|Overall Study|should not have been randomized|0|||
125497021|NCT01532999|451450648|FG000|Overall Study|substantial noncompliance|2|||
125497022|NCT01532999|451450649|FG001|Overall Study|substantial noncompliance|0|||
125497023|NCT01532999|451450648|FG000|Overall Study|no show for week 9 assessments|6|||
125497024|NCT01532999|451450649|FG001|Overall Study|no show for week 9 assessments|4|||
125497025|NCT01532999|451450648|FG000|Overall Study|Adverse Event|0|||
125497026|NCT01532999|451450649|FG001|Overall Study|Adverse Event|1|||
125497027|NCT01532999|451450648|FG000|Overall Study|incarcerated|0|||
125497028|NCT01532999|451450649|FG001|Overall Study|incarcerated|1|||
125497029|NCT01532999|451450648|FG000|Overall Study|New job|0|||
125497030|NCT01532999|451450649|FG001|Overall Study|New job|2|||
125497031|NCT00914966|451450650|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
125497032|NCT00914966|451450650|FG000|Step 1: 1500 Units|Physician Decision|1|||
125497033|NCT00914966|451450650|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
125497034|NCT03598907|451450657|FG000|Overall Study|Physician Decision|14|||
125497035|NCT03598907|451450658|FG001|Overall Study|Physician Decision|19|||
125497036|NCT04021862|451450659|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
125497037|NCT04021862|451450660|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
125497038|NCT04021862|451450661|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
125497039|NCT04021862|451450662|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
125497040|NCT04021862|451450663|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
125304363|NCT04038567|450741272|FG004|Overall Study|Medical issues (i.e., illness)|1|||
125304364|NCT04038567|450741273|FG005|Overall Study|Medical issues (i.e., illness)|1|||
125304365|NCT04038567|450741274|FG006|Overall Study|Medical issues (i.e., illness)|0|||
125304366|NCT04038567|450741275|FG007|Overall Study|Medical issues (i.e., illness)|0|||
125304367|NCT04038567|450741268|FG000|Overall Study|Death|0|||
125304368|NCT04038567|450741269|FG001|Overall Study|Death|0|||
125304369|NCT04038567|450741270|FG002|Overall Study|Death|0|||
125304370|NCT04038567|450741271|FG003|Overall Study|Death|1|||
125304371|NCT04038567|450741272|FG004|Overall Study|Death|1|||
125304372|NCT04038567|450741273|FG005|Overall Study|Death|0|||
125304373|NCT04038567|450741274|FG006|Overall Study|Death|0|||
125304374|NCT04038567|450741275|FG007|Overall Study|Death|1|||
125304375|NCT01496846|450741279|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
125304376|NCT01496846|450741280|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
125304377|NCT01496846|450741281|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
125304378|NCT01496846|450741282|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
125304379|NCT01496846|450741283|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
125304380|NCT01496846|450741284|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
125304381|NCT01772576|450741285|FG000|Overall Study|Death|15|||
125304382|NCT01772576|450741285|FG000|Overall Study|Protocol Violation|1|||
125304383|NCT01772576|450741285|FG000|Overall Study|Lost to Follow-up|3|||
125304384|NCT01772576|450741285|FG000|Overall Study|Study device not used|3|||
125304385|NCT01772576|450741285|FG000|Overall Study|Adverse Event|6|||
125304386|NCT01772576|450741285|FG000|Overall Study|Withdrawal by Subject|6|||
125304387|NCT00923845|450741288|FG000|Induction Therapy|Poor performance status|0|||
125304388|NCT00923845|450741289|FG001|Induction Therapy|Poor performance status|2|||
125304389|NCT04356352|450741296|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
125304390|NCT04356352|450741297|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
125304391|NCT04356352|450741298|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
125304392|NCT04356352|450741296|FG000|Overall Study|Protocol Violation|0|||
125304393|NCT04356352|450741297|FG001|Overall Study|Protocol Violation|3|||
125304394|NCT04356352|450741298|FG002|Overall Study|Protocol Violation|1|||
125304395|NCT01371734|450741301|FG000|Overall Study|Other|2|||
125304396|NCT01371734|450741302|FG001|Overall Study|Other|1|||
125304397|NCT01371734|450741303|FG002|Overall Study|Other|2|||
125304398|NCT01371734|450741301|FG000|Overall Study|Withdrawal by Subject|3|||
125304399|NCT01371734|450741302|FG001|Overall Study|Withdrawal by Subject|4|||
125304400|NCT01371734|450741303|FG002|Overall Study|Withdrawal by Subject|9|||
125304401|NCT01371734|450741301|FG000|Overall Study|Lost to Follow-up|5|||
125304402|NCT01371734|450741302|FG001|Overall Study|Lost to Follow-up|3|||
125304403|NCT01371734|450741303|FG002|Overall Study|Lost to Follow-up|1|||
125304404|NCT01371734|450741301|FG000|Overall Study|Protocol Violation|3|||
125304405|NCT01371734|450741302|FG001|Overall Study|Protocol Violation|1|||
125304406|NCT01371734|450741303|FG002|Overall Study|Protocol Violation|2|||
125304407|NCT01371734|450741301|FG000|Overall Study|Adverse Event|8|||
125304408|NCT01371734|450741302|FG001|Overall Study|Adverse Event|8|||
125304409|NCT01371734|450741303|FG002|Overall Study|Adverse Event|3|||
125304410|NCT01371734|450741301|FG000|Overall Study|Lack of Efficacy|2|||
125304411|NCT01371734|450741302|FG001|Overall Study|Lack of Efficacy|2|||
125304412|NCT01371734|450741303|FG002|Overall Study|Lack of Efficacy|0|||
125304413|NCT03565237|450741304|FG000|Overall Study|Non-compliance of Investigational Product|1|||
125304414|NCT03565237|450741304|FG000|Overall Study|Physician Decision|1|||
125304415|NCT00828750|450741305|FG000|Overall Study|Lack of Efficacy|3|||
125304416|NCT00828750|450741305|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
125304417|NCT04006392|450741306|FG000|Overall Study|Lost to Follow-up|0|||
125304418|NCT04006392|450741307|FG001|Overall Study|Lost to Follow-up|1|||
125304419|NCT01832532|450741308|FG000|Overall Study|Withdrawal by Subject|5|||
125304420|NCT01832532|450741309|FG001|Overall Study|Withdrawal by Subject|2|||
125304421|NCT01534195|450741310|FG000|Overall Study|Withdrawal by Subject|1|||
125304422|NCT01534195|450741311|FG001|Overall Study|Withdrawal by Subject|1|||
125304423|NCT01368081|450741312|FG000|Overall Study|Adverse Event|4|||
125304424|NCT01368081|450741313|FG001|Overall Study|Adverse Event|4|||
125304425|NCT01368081|450741314|FG002|Overall Study|Adverse Event|3|||
125304426|NCT01368081|450741315|FG003|Overall Study|Adverse Event|2|||
125304427|NCT01368081|450741316|FG004|Overall Study|Adverse Event|2|||
125304428|NCT01368081|450741317|FG005|Overall Study|Adverse Event|5|||
125304429|NCT01368081|450741318|FG006|Overall Study|Adverse Event|6|||
125304430|NCT01368081|450741319|FG007|Overall Study|Adverse Event|2|||
125304431|NCT01368081|450741320|FG008|Overall Study|Adverse Event|3|||
125304432|NCT01368081|450741321|FG009|Overall Study|Adverse Event|5|||
125304433|NCT01368081|450741322|FG010|Overall Study|Adverse Event|6|||
125304434|NCT01368081|450741323|FG011|Overall Study|Adverse Event|1|||
125304435|NCT01368081|450741324|FG012|Overall Study|Adverse Event|3|||
125304436|NCT01368081|450741312|FG000|Overall Study|Lack of Efficacy|0|||
125304437|NCT01368081|450741313|FG001|Overall Study|Lack of Efficacy|1|||
125304438|NCT01368081|450741314|FG002|Overall Study|Lack of Efficacy|0|||
125304439|NCT01368081|450741315|FG003|Overall Study|Lack of Efficacy|1|||
125497041|NCT04021862|451450664|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
125497042|NCT04021862|451450659|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
125497043|NCT04021862|451450660|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
125497044|NCT04021862|451450661|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
125497045|NCT04021862|451450662|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
125497046|NCT04021862|451450663|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
125497047|NCT04021862|451450664|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
125497048|NCT04021862|451450659|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
125497049|NCT04021862|451450660|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
125497050|NCT04021862|451450661|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
125497051|NCT04021862|451450662|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
125497052|NCT04021862|451450663|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
125497053|NCT04021862|451450664|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
125497054|NCT04021862|451450659|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
125497055|NCT04021862|451450660|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
125497056|NCT04021862|451450661|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
125497057|NCT04021862|451450662|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
125497058|NCT04021862|451450663|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
125304440|NCT01368081|450741316|FG004|Overall Study|Lack of Efficacy|0|||
125304441|NCT01368081|450741317|FG005|Overall Study|Lack of Efficacy|0|||
125304442|NCT01368081|450741318|FG006|Overall Study|Lack of Efficacy|0|||
125304443|NCT01368081|450741319|FG007|Overall Study|Lack of Efficacy|2|||
125304444|NCT01368081|450741320|FG008|Overall Study|Lack of Efficacy|0|||
125304445|NCT01368081|450741321|FG009|Overall Study|Lack of Efficacy|0|||
125304446|NCT01368081|450741322|FG010|Overall Study|Lack of Efficacy|0|||
125304447|NCT01368081|450741323|FG011|Overall Study|Lack of Efficacy|0|||
125304448|NCT01368081|450741324|FG012|Overall Study|Lack of Efficacy|0|||
125304449|NCT01368081|450741312|FG000|Overall Study|Protocol Violation|0|||
125304450|NCT01368081|450741313|FG001|Overall Study|Protocol Violation|0|||
125304451|NCT01368081|450741314|FG002|Overall Study|Protocol Violation|0|||
125304452|NCT01368081|450741315|FG003|Overall Study|Protocol Violation|0|||
125304453|NCT01368081|450741316|FG004|Overall Study|Protocol Violation|0|||
125304454|NCT01368081|450741317|FG005|Overall Study|Protocol Violation|1|||
125304455|NCT01368081|450741318|FG006|Overall Study|Protocol Violation|0|||
125304456|NCT01368081|450741319|FG007|Overall Study|Protocol Violation|1|||
125304457|NCT01368081|450741320|FG008|Overall Study|Protocol Violation|0|||
125304458|NCT01368081|450741321|FG009|Overall Study|Protocol Violation|0|||
125304459|NCT01368081|450741322|FG010|Overall Study|Protocol Violation|0|||
125304460|NCT01368081|450741323|FG011|Overall Study|Protocol Violation|0|||
125304461|NCT01368081|450741324|FG012|Overall Study|Protocol Violation|0|||
125304462|NCT01368081|450741312|FG000|Overall Study|Lost to Follow-up|0|||
125304463|NCT01368081|450741313|FG001|Overall Study|Lost to Follow-up|0|||
125304464|NCT01368081|450741314|FG002|Overall Study|Lost to Follow-up|0|||
125304465|NCT01368081|450741315|FG003|Overall Study|Lost to Follow-up|0|||
125304466|NCT01368081|450741316|FG004|Overall Study|Lost to Follow-up|0|||
125304467|NCT01368081|450741317|FG005|Overall Study|Lost to Follow-up|0|||
125304468|NCT01368081|450741318|FG006|Overall Study|Lost to Follow-up|0|||
125304469|NCT01368081|450741319|FG007|Overall Study|Lost to Follow-up|0|||
125304470|NCT01368081|450741320|FG008|Overall Study|Lost to Follow-up|0|||
125304471|NCT01368081|450741321|FG009|Overall Study|Lost to Follow-up|0|||
125304472|NCT01368081|450741322|FG010|Overall Study|Lost to Follow-up|0|||
125304473|NCT01368081|450741323|FG011|Overall Study|Lost to Follow-up|0|||
125304474|NCT01368081|450741324|FG012|Overall Study|Lost to Follow-up|1|||
125304475|NCT01368081|450741312|FG000|Overall Study|Withdrawal by Subject|4|||
125304476|NCT01368081|450741313|FG001|Overall Study|Withdrawal by Subject|4|||
125304477|NCT01368081|450741314|FG002|Overall Study|Withdrawal by Subject|1|||
125304478|NCT01368081|450741315|FG003|Overall Study|Withdrawal by Subject|1|||
125304479|NCT01368081|450741316|FG004|Overall Study|Withdrawal by Subject|0|||
125304480|NCT01368081|450741317|FG005|Overall Study|Withdrawal by Subject|3|||
125304481|NCT01368081|450741318|FG006|Overall Study|Withdrawal by Subject|4|||
125304482|NCT01368081|450741319|FG007|Overall Study|Withdrawal by Subject|2|||
125304483|NCT01368081|450741320|FG008|Overall Study|Withdrawal by Subject|5|||
125304484|NCT01368081|450741321|FG009|Overall Study|Withdrawal by Subject|4|||
125304485|NCT01368081|450741322|FG010|Overall Study|Withdrawal by Subject|3|||
125304486|NCT01368081|450741323|FG011|Overall Study|Withdrawal by Subject|2|||
125304487|NCT01368081|450741324|FG012|Overall Study|Withdrawal by Subject|0|||
125304488|NCT01368081|450741312|FG000|Overall Study|Other reason not defined above|2|||
125304489|NCT01368081|450741313|FG001|Overall Study|Other reason not defined above|0|||
125304490|NCT01368081|450741314|FG002|Overall Study|Other reason not defined above|0|||
125304491|NCT01368081|450741315|FG003|Overall Study|Other reason not defined above|1|||
125304492|NCT01368081|450741316|FG004|Overall Study|Other reason not defined above|0|||
125304493|NCT01368081|450741317|FG005|Overall Study|Other reason not defined above|1|||
125304494|NCT01368081|450741318|FG006|Overall Study|Other reason not defined above|2|||
125304495|NCT01368081|450741319|FG007|Overall Study|Other reason not defined above|0|||
125304496|NCT01368081|450741320|FG008|Overall Study|Other reason not defined above|0|||
125421044|NCT01972841|451166207|FG001|Overall Study|Lack of Efficacy|0|||
125421045|NCT01972841|451166208|FG002|Overall Study|Lack of Efficacy|0|||
125421046|NCT01972841|451166209|FG003|Overall Study|Lack of Efficacy|2|||
125421047|NCT01972841|451166210|FG004|Overall Study|Lack of Efficacy|4|||
125421048|NCT01972841|451166211|FG005|Overall Study|Lack of Efficacy|1|||
125421049|NCT01972841|451166206|FG000|Overall Study|Lost to Follow-up|4|||
125421050|NCT01972841|451166207|FG001|Overall Study|Lost to Follow-up|2|||
125421051|NCT01972841|451166208|FG002|Overall Study|Lost to Follow-up|4|||
125421052|NCT01972841|451166209|FG003|Overall Study|Lost to Follow-up|2|||
125421053|NCT01972841|451166210|FG004|Overall Study|Lost to Follow-up|9|||
125421054|NCT01972841|451166211|FG005|Overall Study|Lost to Follow-up|3|||
125421055|NCT01972841|451166206|FG000|Overall Study|Protocol Violation|2|||
125421056|NCT01972841|451166207|FG001|Overall Study|Protocol Violation|2|||
125421057|NCT01972841|451166208|FG002|Overall Study|Protocol Violation|3|||
125421058|NCT01972841|451166209|FG003|Overall Study|Protocol Violation|5|||
125421059|NCT01972841|451166210|FG004|Overall Study|Protocol Violation|9|||
125421060|NCT01972841|451166211|FG005|Overall Study|Protocol Violation|4|||
125421061|NCT01972841|451166206|FG000|Overall Study|Withdrawal by participants|21|||
125421062|NCT01972841|451166207|FG001|Overall Study|Withdrawal by participants|27|||
125421063|NCT01972841|451166208|FG002|Overall Study|Withdrawal by participants|23|||
125421064|NCT01972841|451166209|FG003|Overall Study|Withdrawal by participants|16|||
125421065|NCT01972841|451166210|FG004|Overall Study|Withdrawal by participants|33|||
125421066|NCT01972841|451166211|FG005|Overall Study|Withdrawal by participants|34|||
125421067|NCT01972841|451166206|FG000|Overall Study|Miscellaneous|0|||
125421068|NCT01972841|451166207|FG001|Overall Study|Miscellaneous|0|||
125421069|NCT01972841|451166208|FG002|Overall Study|Miscellaneous|4|||
125421070|NCT01972841|451166209|FG003|Overall Study|Miscellaneous|1|||
125421071|NCT01972841|451166210|FG004|Overall Study|Miscellaneous|0|||
125421072|NCT01972841|451166211|FG005|Overall Study|Miscellaneous|4|||
125421073|NCT01972841|451166206|FG000|Overall Study|Did not have end of treatment page|0|||
125421074|NCT01972841|451166207|FG001|Overall Study|Did not have end of treatment page|0|||
125421075|NCT01972841|451166208|FG002|Overall Study|Did not have end of treatment page|0|||
125421076|NCT01972841|451166209|FG003|Overall Study|Did not have end of treatment page|0|||
125421077|NCT01972841|451166210|FG004|Overall Study|Did not have end of treatment page|1|||
125421078|NCT01972841|451166211|FG005|Overall Study|Did not have end of treatment page|0|||
125421079|NCT04969198|451166214|FG000|Overall Study|Withdrawal by Subject|20|||
125421080|NCT04969198|451166214|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
125421081|NCT04969198|451166214|FG000|Overall Study|Lost to Follow-up|20|||
125421082|NCT05553808|451166218|FG000|Overall Study|Death|25|||
125421083|NCT05553808|451166219|FG001|Overall Study|Death|62|||
125421084|NCT05553808|451166218|FG000|Overall Study|Site Closed|6|||
125421085|NCT05553808|451166219|FG001|Overall Study|Site Closed|6|||
125421086|NCT05553808|451166218|FG000|Overall Study|Lost to Follow-up|1|||
125421087|NCT05553808|451166219|FG001|Overall Study|Lost to Follow-up|0|||
125421088|NCT05553808|451166218|FG000|Overall Study|Withdrawal by Subject|3|||
125421089|NCT05553808|451166219|FG001|Overall Study|Withdrawal by Subject|2|||
125421090|NCT02308748|451166227|FG000|Period 1|Withdrawal by Subject|0|||
125421091|NCT02308748|451166228|FG001|Period 1|Withdrawal by Subject|0|||
125421092|NCT02308748|451166229|FG002|Period 1|Withdrawal by Subject|1|||
125421093|NCT02308748|451166230|FG003|Period 1|Withdrawal by Subject|0|||
125421094|NCT02308748|451166231|FG004|Period 1|Withdrawal by Subject|0|||
125421095|NCT02308748|451166232|FG005|Period 1|Withdrawal by Subject|0|||
125421096|NCT02308748|451166233|FG006|Period 1|Withdrawal by Subject|0|||
125421097|NCT02308748|451166234|FG007|Period 1|Withdrawal by Subject|0|||
125421098|NCT02308748|451166235|FG008|Period 1|Withdrawal by Subject|0|||
125421099|NCT02308748|451166236|FG009|Period 1|Withdrawal by Subject|0|||
125421100|NCT02308748|451166227|FG000|Period 2|Adverse Event|0|||
125421101|NCT02308748|451166228|FG001|Period 2|Adverse Event|0|||
125421102|NCT02308748|451166229|FG002|Period 2|Adverse Event|0|||
125421103|NCT02308748|451166230|FG003|Period 2|Adverse Event|0|||
125421104|NCT02308748|451166231|FG004|Period 2|Adverse Event|0|||
125421105|NCT02308748|451166232|FG005|Period 2|Adverse Event|0|||
125421106|NCT02308748|451166233|FG006|Period 2|Adverse Event|0|||
125421107|NCT02308748|451166234|FG007|Period 2|Adverse Event|1|||
125421108|NCT02308748|451166235|FG008|Period 2|Adverse Event|0|||
125421109|NCT02308748|451166236|FG009|Period 2|Adverse Event|0|||
125421110|NCT02308748|451166227|FG000|Period 3|Protocol Violation|0|||
125421111|NCT02308748|451166228|FG001|Period 3|Protocol Violation|0|||
125421112|NCT02308748|451166229|FG002|Period 3|Protocol Violation|0|||
125421113|NCT02308748|451166230|FG003|Period 3|Protocol Violation|0|||
125421114|NCT02308748|451166231|FG004|Period 3|Protocol Violation|0|||
125421115|NCT02308748|451166232|FG005|Period 3|Protocol Violation|0|||
125421116|NCT02308748|451166233|FG006|Period 3|Protocol Violation|0|||
125421117|NCT02308748|451166234|FG007|Period 3|Protocol Violation|0|||
125421118|NCT02308748|451166235|FG008|Period 3|Protocol Violation|0|||
125421119|NCT02308748|451166236|FG009|Period 3|Protocol Violation|1|||
125421120|NCT02308748|451166227|FG000|Period 5|Adverse Event|1|||
125421121|NCT02308748|451166228|FG001|Period 5|Adverse Event|0|||
125421122|NCT02308748|451166229|FG002|Period 5|Adverse Event|0|||
125421123|NCT02308748|451166230|FG003|Period 5|Adverse Event|0|||
125421124|NCT02308748|451166231|FG004|Period 5|Adverse Event|0|||
125497059|NCT04021862|451450664|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
125497060|NCT04021862|451450659|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
125497061|NCT04021862|451450660|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
125497062|NCT04021862|451450661|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
125497063|NCT04021862|451450662|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
125497064|NCT04021862|451450663|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
125497065|NCT04021862|451450664|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
125497066|NCT05251363|451450665|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
125497067|NCT05251363|451450665|FG000|Overall Study After Implant Period|Death|9|||
125497068|NCT05251363|451450665|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
125497069|NCT05251363|451450665|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
125497070|NCT05251363|451450665|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
125497071|NCT05251363|451450665|FG000|Overall Study After Implant Period|Physician Decision|1|||
125497072|NCT05251363|451450665|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
125497073|NCT03835754|451450668|FG000|Overall Study|Death|4|||
125497074|NCT02830204|451450669|FG000|Overall Study|Death|9|||
125497075|NCT02830204|451450669|FG000|Overall Study|Withdrawal by Subject|1|||
125497076|NCT01690624|451450672|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
125497077|NCT01690624|451450673|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
125497078|NCT01690624|451450674|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
125497079|NCT01690624|451450675|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
125497080|NCT01690624|451450672|FG000|Overall Study|Adverse event (other than DLT)|3|||
125497081|NCT01690624|451450673|FG001|Overall Study|Adverse event (other than DLT)|1|||
125497082|NCT01690624|451450674|FG002|Overall Study|Adverse event (other than DLT)|1|||
125497083|NCT01690624|451450675|FG003|Overall Study|Adverse event (other than DLT)|1|||
125497084|NCT01690624|451450672|FG000|Overall Study|Withdrawal by Subject|0|||
125497085|NCT01690624|451450673|FG001|Overall Study|Withdrawal by Subject|0|||
125497086|NCT01690624|451450674|FG002|Overall Study|Withdrawal by Subject|1|||
125497087|NCT01690624|451450675|FG003|Overall Study|Withdrawal by Subject|0|||
125497088|NCT01690624|451450672|FG000|Overall Study|Sponsor is ending trial|0|||
125497089|NCT01690624|451450673|FG001|Overall Study|Sponsor is ending trial|0|||
125497090|NCT01690624|451450674|FG002|Overall Study|Sponsor is ending trial|0|||
125497091|NCT01690624|451450675|FG003|Overall Study|Sponsor is ending trial|1|||
125497092|NCT01690624|451450672|FG000|Overall Study|Physician Decision|0|||
125497093|NCT01690624|451450673|FG001|Overall Study|Physician Decision|0|||
125497094|NCT01690624|451450674|FG002|Overall Study|Physician Decision|0|||
125497095|NCT01690624|451450675|FG003|Overall Study|Physician Decision|1|||
125497096|NCT01690624|451450672|FG000|Overall Study|Withdrawal by Subject|0|||
125497097|NCT01690624|451450673|FG001|Overall Study|Withdrawal by Subject|1|||
125497098|NCT01690624|451450674|FG002|Overall Study|Withdrawal by Subject|0|||
125497099|NCT01690624|451450675|FG003|Overall Study|Withdrawal by Subject|0|||
125497100|NCT01690624|451450672|FG000|Overall Study|Lack of Efficacy|1|||
125497101|NCT01690624|451450673|FG001|Overall Study|Lack of Efficacy|1|||
125497102|NCT01690624|451450674|FG002|Overall Study|Lack of Efficacy|3|||
125497103|NCT01690624|451450675|FG003|Overall Study|Lack of Efficacy|0|||
125497104|NCT04686266|451450677|FG000|Overall Study|Withdrawal by Subject|0|||
125497105|NCT04686266|451450678|FG001|Overall Study|Withdrawal by Subject|1|||
125497106|NCT04306367|451450679|FG000|Overall Study|Progression of Disease|9|||
125497107|NCT04306367|451450679|FG000|Overall Study|Adverse Event|3|||
125497108|NCT04306367|451450679|FG000|Overall Study|Withdrawal by Subject|1|||
125497109|NCT02401815|451450680|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
125497110|NCT02401815|451450681|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
125497111|NCT02401815|451450682|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
125497112|NCT02401815|451450683|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
125497113|NCT02401815|451450684|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
125497114|NCT02401815|451450685|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
125497115|NCT02401815|451450686|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
125497116|NCT02401815|451450687|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
125497117|NCT02401815|451450688|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
125497118|NCT02401815|451450689|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
125497119|NCT02401815|451450680|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
125497120|NCT02401815|451450681|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
125497121|NCT02401815|451450682|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
125497122|NCT02401815|451450683|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
125497123|NCT02401815|451450684|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
125497124|NCT02401815|451450685|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
125497125|NCT02401815|451450686|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
125497126|NCT02401815|451450687|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
125497127|NCT02401815|451450688|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
125309882|NCT00511238|450760205|FG001|Overall Study|Adverse Event|33|||
125497128|NCT02401815|451450689|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
125497129|NCT02401815|451450680|FG000|Dose Escalation (up to 670 Days)|Death|1|||
125497130|NCT02401815|451450681|FG001|Dose Escalation (up to 670 Days)|Death|2|||
125497131|NCT02401815|451450682|FG002|Dose Escalation (up to 670 Days)|Death|3|||
125497132|NCT02401815|451450683|FG003|Dose Escalation (up to 670 Days)|Death|5|||
125497133|NCT02401815|451450684|FG004|Dose Escalation (up to 670 Days)|Death|4|||
125497134|NCT02401815|451450685|FG005|Dose Escalation (up to 670 Days)|Death|0|||
125497135|NCT02401815|451450686|FG006|Dose Escalation (up to 670 Days)|Death|0|||
125497136|NCT02401815|451450687|FG007|Dose Escalation (up to 670 Days)|Death|0|||
125497137|NCT02401815|451450688|FG008|Dose Escalation (up to 670 Days)|Death|0|||
125497138|NCT02401815|451450689|FG009|Dose Escalation (up to 670 Days)|Death|0|||
125497139|NCT02401815|451450680|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
125497140|NCT02401815|451450681|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
125497141|NCT02401815|451450682|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
125497142|NCT02401815|451450683|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
125497143|NCT02401815|451450684|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
125497144|NCT02401815|451450685|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
125497145|NCT02401815|451450686|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
125497146|NCT02401815|451450687|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
125497147|NCT02401815|451450688|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
125497148|NCT02401815|451450689|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
125497149|NCT02401815|451450680|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
125497150|NCT02401815|451450681|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
125497151|NCT02401815|451450682|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
125497152|NCT02401815|451450683|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
125497153|NCT02401815|451450684|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
125497154|NCT02401815|451450685|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
125497155|NCT02401815|451450686|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
125497156|NCT02401815|451450687|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
125497157|NCT02401815|451450688|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
125497158|NCT02401815|451450689|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
125497159|NCT02401815|451450680|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
125497160|NCT02401815|451450681|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
125497161|NCT02401815|451450682|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
125497162|NCT02401815|451450683|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
125497163|NCT02401815|451450684|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
125497164|NCT02401815|451450685|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
125497165|NCT02401815|451450686|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
125497166|NCT02401815|451450687|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
125497167|NCT02401815|451450688|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
125497168|NCT02401815|451450689|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
125497169|NCT02401815|451450680|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497170|NCT02401815|451450681|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497171|NCT02401815|451450682|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497172|NCT02401815|451450683|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497173|NCT02401815|451450684|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497174|NCT02401815|451450685|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497175|NCT02401815|451450686|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
125497176|NCT02401815|451450687|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497177|NCT02401815|451450688|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497178|NCT02401815|451450689|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497179|NCT02401815|451450680|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
125497180|NCT02401815|451450681|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
125497181|NCT02401815|451450682|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
125497182|NCT02401815|451450683|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
125497183|NCT02401815|451450684|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
125497184|NCT02401815|451450685|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
125497185|NCT02401815|451450686|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
125497186|NCT02401815|451450687|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
125497187|NCT02401815|451450688|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
125497188|NCT02401815|451450689|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
125497189|NCT02401815|451450680|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
125497190|NCT02401815|451450681|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
125497191|NCT02401815|451450682|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
125497192|NCT02401815|451450683|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
125497193|NCT02401815|451450684|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
125497194|NCT02401815|451450685|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
125497195|NCT02401815|451450686|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
125497196|NCT02401815|451450687|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
125497197|NCT02401815|451450688|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
125497198|NCT02401815|451450689|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
125497199|NCT02401815|451450680|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
125497200|NCT02401815|451450681|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
125497201|NCT02401815|451450682|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
125497202|NCT02401815|451450683|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
125497203|NCT02401815|451450684|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
125497204|NCT02401815|451450685|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
125497205|NCT02401815|451450686|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
125497206|NCT02401815|451450687|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
125497207|NCT02401815|451450688|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
125497208|NCT02401815|451450689|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
125497209|NCT02401815|451450680|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497210|NCT02401815|451450681|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497211|NCT02401815|451450682|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497212|NCT02401815|451450683|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497213|NCT02401815|451450684|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497214|NCT02401815|451450685|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497215|NCT02401815|451450686|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497216|NCT02401815|451450687|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
125497217|NCT02401815|451450688|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
125497218|NCT02401815|451450689|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
125497219|NCT02401815|451450680|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
125497220|NCT02401815|451450681|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
125497221|NCT02401815|451450682|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
125497222|NCT02401815|451450683|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
125497223|NCT02401815|451450684|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
125497224|NCT02401815|451450685|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
125497225|NCT02401815|451450686|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
125497226|NCT02401815|451450687|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
125497227|NCT02401815|451450688|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
125497228|NCT02401815|451450689|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
125497229|NCT02401815|451450680|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
125497230|NCT02401815|451450681|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
125497231|NCT02401815|451450682|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
125497232|NCT02401815|451450683|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
125497233|NCT02401815|451450684|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
125497234|NCT02401815|451450685|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
125497235|NCT02401815|451450686|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
125497236|NCT02401815|451450687|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
125497237|NCT02401815|451450688|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
125497238|NCT02401815|451450689|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
125497239|NCT02401815|451450680|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
125497240|NCT02401815|451450681|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
125497241|NCT02401815|451450682|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
125497242|NCT02401815|451450683|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
125497243|NCT02401815|451450684|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
125497244|NCT02401815|451450685|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
125497245|NCT02401815|451450686|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
125497246|NCT02401815|451450687|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
125497247|NCT02401815|451450688|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
125497248|NCT02401815|451450689|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
125497249|NCT03773107|451450703|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
125497250|NCT03773107|451450704|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
125497251|NCT03773107|451450705|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
125497252|NCT03773107|451450706|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
125497253|NCT01563185|451450709|FG000|Overall Study|Withdrawal by Subject|1|||
125497254|NCT01563185|451450709|FG000|Overall Study|Non-Compliance with study drug|1|||
125497255|NCT05864209|451452365|FG000|Overall Study|Lost to Follow-up|2|||
125497256|NCT05864209|451452366|FG001|Overall Study|Lost to Follow-up|3|||
125497257|NCT00092534|451452369|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
125497258|NCT00092534|451452370|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
125497259|NCT00092534|451452371|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
125497260|NCT00092534|451452372|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
125497261|NCT00092534|451452373|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
125497262|NCT00092534|451452369|FG000|Base Study Vaccination Period|Adverse Event|3|||
125497263|NCT00092534|451452370|FG001|Base Study Vaccination Period|Adverse Event|1|||
125497264|NCT00092534|451452371|FG002|Base Study Vaccination Period|Adverse Event|0|||
125497265|NCT00092534|451452372|FG003|Base Study Vaccination Period|Adverse Event|0|||
125497266|NCT00092534|451452373|FG004|Base Study Vaccination Period|Adverse Event|0|||
125497267|NCT00092534|451452369|FG000|Base Study Vaccination Period|Death|5|||
125497268|NCT00092534|451452370|FG001|Base Study Vaccination Period|Death|4|||
125497269|NCT00092534|451452371|FG002|Base Study Vaccination Period|Death|0|||
125497270|NCT00092534|451452372|FG003|Base Study Vaccination Period|Death|0|||
125497271|NCT00092534|451452373|FG004|Base Study Vaccination Period|Death|0|||
125497272|NCT00092534|451452369|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
125497273|NCT00092534|451452370|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
125497274|NCT00092534|451452371|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
125497275|NCT00092534|451452372|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
125497276|NCT00092534|451452373|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
125497277|NCT00092534|451452369|FG000|Base Study Vaccination Period|Physician Decision|1|||
125497278|NCT00092534|451452370|FG001|Base Study Vaccination Period|Physician Decision|0|||
125497279|NCT00092534|451452371|FG002|Base Study Vaccination Period|Physician Decision|0|||
125497280|NCT00092534|451452372|FG003|Base Study Vaccination Period|Physician Decision|0|||
125497281|NCT00092534|451452373|FG004|Base Study Vaccination Period|Physician Decision|0|||
125497282|NCT00092534|451452369|FG000|Base Study Vaccination Period|Pregnancy|9|||
125497283|NCT00092534|451452370|FG001|Base Study Vaccination Period|Pregnancy|7|||
125497284|NCT00092534|451452371|FG002|Base Study Vaccination Period|Pregnancy|0|||
125497285|NCT00092534|451452372|FG003|Base Study Vaccination Period|Pregnancy|0|||
125497286|NCT00092534|451452373|FG004|Base Study Vaccination Period|Pregnancy|0|||
125497287|NCT00092534|451452369|FG000|Base Study Vaccination Period|Protocol Violation|2|||
125497288|NCT00092534|451452370|FG001|Base Study Vaccination Period|Protocol Violation|1|||
125497289|NCT00092534|451452371|FG002|Base Study Vaccination Period|Protocol Violation|0|||
125497290|NCT00092534|451452372|FG003|Base Study Vaccination Period|Protocol Violation|0|||
125497291|NCT00092534|451452373|FG004|Base Study Vaccination Period|Protocol Violation|0|||
125497292|NCT00092534|451452369|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
125497293|NCT00092534|451452370|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
125497294|NCT00092534|451452371|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
125497295|NCT00092534|451452372|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
125497296|NCT00092534|451452373|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
125497297|NCT00092534|451452369|FG000|Base Study Vaccination Period|Moved|14|||
125497298|NCT00092534|451452370|FG001|Base Study Vaccination Period|Moved|12|||
125497299|NCT00092534|451452371|FG002|Base Study Vaccination Period|Moved|0|||
125497300|NCT00092534|451452372|FG003|Base Study Vaccination Period|Moved|0|||
125497301|NCT00092534|451452373|FG004|Base Study Vaccination Period|Moved|0|||
125497302|NCT00092534|451452369|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
125497303|NCT00092534|451452370|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
125497304|NCT00092534|451452371|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
125497305|NCT00092534|451452372|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
125497306|NCT00092534|451452373|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
125497307|NCT00092534|451452369|FG000|Base Study Vaccination Period|Travel|1|||
125497308|NCT00092534|451452370|FG001|Base Study Vaccination Period|Travel|0|||
125497309|NCT00092534|451452371|FG002|Base Study Vaccination Period|Travel|0|||
125497310|NCT00092534|451452372|FG003|Base Study Vaccination Period|Travel|0|||
125497311|NCT00092534|451452373|FG004|Base Study Vaccination Period|Travel|0|||
125497312|NCT00092534|451452369|FG000|Base Study Vaccination Period|Site Closed|0|||
125497313|NCT00092534|451452370|FG001|Base Study Vaccination Period|Site Closed|1|||
125497314|NCT00092534|451452371|FG002|Base Study Vaccination Period|Site Closed|0|||
125497315|NCT00092534|451452372|FG003|Base Study Vaccination Period|Site Closed|0|||
125497316|NCT00092534|451452373|FG004|Base Study Vaccination Period|Site Closed|0|||
125497317|NCT00092534|451452369|FG000|Base Study Follow-Up Period|Adverse Event|2|||
125497318|NCT00092534|451452370|FG001|Base Study Follow-Up Period|Adverse Event|4|||
125497319|NCT00092534|451452371|FG002|Base Study Follow-Up Period|Adverse Event|0|||
125497320|NCT00092534|451452372|FG003|Base Study Follow-Up Period|Adverse Event|0|||
125497321|NCT00092534|451452373|FG004|Base Study Follow-Up Period|Adverse Event|0|||
125497322|NCT00092534|451452369|FG000|Base Study Follow-Up Period|Death|2|||
125497323|NCT00092534|451452370|FG001|Base Study Follow-Up Period|Death|1|||
125497324|NCT00092534|451452371|FG002|Base Study Follow-Up Period|Death|0|||
125497325|NCT00092534|451452372|FG003|Base Study Follow-Up Period|Death|0|||
125497326|NCT00092534|451452373|FG004|Base Study Follow-Up Period|Death|0|||
125497327|NCT00092534|451452369|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
125497328|NCT00092534|451452370|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
125497329|NCT00092534|451452371|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
125497330|NCT00092534|451452372|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
125497331|NCT00092534|451452373|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
125497332|NCT00092534|451452369|FG000|Base Study Follow-Up Period|Pregnancy|6|||
125497333|NCT00092534|451452370|FG001|Base Study Follow-Up Period|Pregnancy|10|||
125497334|NCT00092534|451452371|FG002|Base Study Follow-Up Period|Pregnancy|0|||
125497335|NCT00092534|451452372|FG003|Base Study Follow-Up Period|Pregnancy|0|||
125497336|NCT00092534|451452373|FG004|Base Study Follow-Up Period|Pregnancy|0|||
125497337|NCT00092534|451452369|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
125497338|NCT00092534|451452370|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
125497339|NCT00092534|451452371|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
125497340|NCT00092534|451452372|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
125497341|NCT00092534|451452373|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
125497342|NCT00092534|451452369|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
125497343|NCT00092534|451452370|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
125497344|NCT00092534|451452371|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
125497345|NCT00092534|451452372|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
125497346|NCT00092534|451452373|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
125497347|NCT00092534|451452369|FG000|Base Study Follow-Up Period|Moved|62|||
125497348|NCT00092534|451452370|FG001|Base Study Follow-Up Period|Moved|58|||
125497349|NCT00092534|451452371|FG002|Base Study Follow-Up Period|Moved|0|||
125497350|NCT00092534|451452372|FG003|Base Study Follow-Up Period|Moved|0|||
125497351|NCT00092534|451452373|FG004|Base Study Follow-Up Period|Moved|0|||
125497352|NCT00092534|451452369|FG000|Base Study Follow-Up Period|Travel|10|||
125497353|NCT00092534|451452370|FG001|Base Study Follow-Up Period|Travel|7|||
125497354|NCT00092534|451452371|FG002|Base Study Follow-Up Period|Travel|0|||
125497355|NCT00092534|451452372|FG003|Base Study Follow-Up Period|Travel|0|||
125497356|NCT00092534|451452373|FG004|Base Study Follow-Up Period|Travel|0|||
125497357|NCT00092534|451452369|FG000|Base Study Follow-Up Period|Site Closed|0|||
125497358|NCT00092534|451452370|FG001|Base Study Follow-Up Period|Site Closed|2|||
125497359|NCT00092534|451452371|FG002|Base Study Follow-Up Period|Site Closed|0|||
125497360|NCT00092534|451452372|FG003|Base Study Follow-Up Period|Site Closed|0|||
125497361|NCT00092534|451452373|FG004|Base Study Follow-Up Period|Site Closed|0|||
125497362|NCT00092534|451452369|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
125497363|NCT00092534|451452370|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
125497364|NCT00092534|451452371|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
125497365|NCT00092534|451452372|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
125497366|NCT00092534|451452373|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
125497367|NCT00092534|451452369|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
125497368|NCT00092534|451452370|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
125497369|NCT00092534|451452371|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
125497370|NCT00092534|451452372|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
125497371|NCT00092534|451452373|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
125497372|NCT00092534|451452369|FG000|Base Study EXT|Lost to Follow-up|0|||
125497373|NCT00092534|451452370|FG001|Base Study EXT|Lost to Follow-up|0|||
125497374|NCT00092534|451452371|FG002|Base Study EXT|Lost to Follow-up|41|||
125497375|NCT00092534|451452372|FG003|Base Study EXT|Lost to Follow-up|0|||
125497376|NCT00092534|451452373|FG004|Base Study EXT|Lost to Follow-up|0|||
125497377|NCT00092534|451452369|FG000|Base Study EXT|Physician Decision|0|||
125497378|NCT00092534|451452370|FG001|Base Study EXT|Physician Decision|0|||
125497379|NCT00092534|451452371|FG002|Base Study EXT|Physician Decision|1|||
125497380|NCT00092534|451452372|FG003|Base Study EXT|Physician Decision|0|||
125497381|NCT00092534|451452373|FG004|Base Study EXT|Physician Decision|0|||
125497382|NCT00092534|451452369|FG000|Base Study EXT|Pregnancy|0|||
125497383|NCT00092534|451452370|FG001|Base Study EXT|Pregnancy|0|||
125497384|NCT00092534|451452371|FG002|Base Study EXT|Pregnancy|12|||
125497385|NCT00092534|451452372|FG003|Base Study EXT|Pregnancy|0|||
125497386|NCT00092534|451452373|FG004|Base Study EXT|Pregnancy|0|||
125497387|NCT00092534|451452369|FG000|Base Study EXT|Withdrawal by Subject|0|||
125497388|NCT00092534|451452370|FG001|Base Study EXT|Withdrawal by Subject|0|||
125497389|NCT00092534|451452371|FG002|Base Study EXT|Withdrawal by Subject|18|||
125497390|NCT00092534|451452372|FG003|Base Study EXT|Withdrawal by Subject|0|||
125497391|NCT00092534|451452373|FG004|Base Study EXT|Withdrawal by Subject|0|||
125497392|NCT00092534|451452369|FG000|Base Study EXT|Participant moved|0|||
125497393|NCT00092534|451452370|FG001|Base Study EXT|Participant moved|0|||
125497394|NCT00092534|451452371|FG002|Base Study EXT|Participant moved|6|||
125497395|NCT00092534|451452372|FG003|Base Study EXT|Participant moved|0|||
125497396|NCT00092534|451452373|FG004|Base Study EXT|Participant moved|0|||
125497397|NCT00092534|451452369|FG000|Base Study EXT|Travel|0|||
125497398|NCT00092534|451452370|FG001|Base Study EXT|Travel|0|||
125497399|NCT00092534|451452371|FG002|Base Study EXT|Travel|2|||
125497400|NCT00092534|451452372|FG003|Base Study EXT|Travel|0|||
125497401|NCT00092534|451452373|FG004|Base Study EXT|Travel|0|||
125497402|NCT00092534|451452369|FG000|Base Study EXT|Site closed|0|||
125497403|NCT00092534|451452370|FG001|Base Study EXT|Site closed|0|||
125497404|NCT00092534|451452371|FG002|Base Study EXT|Site closed|21|||
125497405|NCT00092534|451452372|FG003|Base Study EXT|Site closed|0|||
125497406|NCT00092534|451452373|FG004|Base Study EXT|Site closed|0|||
125497407|NCT00092534|451452369|FG000|Base Study EXT|Study ended|0|||
125497408|NCT00092534|451452370|FG001|Base Study EXT|Study ended|0|||
125497409|NCT00092534|451452371|FG002|Base Study EXT|Study ended|29|||
125497410|NCT00092534|451452372|FG003|Base Study EXT|Study ended|0|||
125497411|NCT00092534|451452373|FG004|Base Study EXT|Study ended|0|||
125497412|NCT00092534|451452369|FG000|Base Study EXT|Protocol Violation|0|||
125497413|NCT00092534|451452370|FG001|Base Study EXT|Protocol Violation|0|||
125497414|NCT00092534|451452371|FG002|Base Study EXT|Protocol Violation|15|||
125497415|NCT00092534|451452372|FG003|Base Study EXT|Protocol Violation|0|||
125497416|NCT00092534|451452373|FG004|Base Study EXT|Protocol Violation|0|||
125497417|NCT00092534|451452369|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
125497418|NCT00092534|451452370|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
125497419|NCT00092534|451452371|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
125497420|NCT00092534|451452372|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
125497421|NCT00092534|451452373|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
125497422|NCT05029284|451452374|FG000|Overall Study|Lost to Follow-up|1|||
125497423|NCT04001829|451452375|FG000|Overall Study|Never start protocol therapy|5|||
125497424|NCT04001829|451452376|FG001|Overall Study|Never start protocol therapy|5|||
125497425|NCT04001829|451452375|FG000|Overall Study|Adverse Event|11|||
125497426|NCT04001829|451452376|FG001|Overall Study|Adverse Event|7|||
125497427|NCT04001829|451452375|FG000|Overall Study|Alternative therapy|1|||
125497428|NCT04001829|451452376|FG001|Overall Study|Alternative therapy|2|||
125497429|NCT04001829|451452375|FG000|Overall Study|Disease progression/relapse|2|||
125497430|NCT04001829|451452376|FG001|Overall Study|Disease progression/relapse|1|||
125497431|NCT04001829|451452375|FG000|Overall Study|Other complicating disease|1|||
125497432|NCT04001829|451452376|FG001|Overall Study|Other complicating disease|0|||
125497433|NCT04001829|451452375|FG000|Overall Study|Withdrawal by Subject|1|||
125497434|NCT04001829|451452376|FG001|Overall Study|Withdrawal by Subject|4|||
125497435|NCT04001829|451452375|FG000|Overall Study|Ineligible|2|||
125497436|NCT04001829|451452376|FG001|Overall Study|Ineligible|2|||
125497437|NCT04001829|451452375|FG000|Overall Study|Reason missing due to delinquent data|1|||
125497438|NCT04001829|451452376|FG001|Overall Study|Reason missing due to delinquent data|0|||
125497439|NCT03678688|451452377|FG000|Overall Study|Reason not Specified|0|||
125497440|NCT03678688|451452378|FG001|Overall Study|Reason not Specified|0|||
125497441|NCT03678688|451452379|FG002|Overall Study|Reason not Specified|3|||
125497442|NCT03678688|451452380|FG003|Overall Study|Reason not Specified|0|||
125497443|NCT03678688|451452381|FG004|Overall Study|Reason not Specified|1|||
125497444|NCT03678688|451452382|FG005|Overall Study|Reason not Specified|0|||
125497445|NCT03678688|451452383|FG006|Overall Study|Reason not Specified|0|||
125497446|NCT03678688|451452384|FG007|Overall Study|Reason not Specified|0|||
125497447|NCT03678688|451452385|FG008|Overall Study|Reason not Specified|0|||
125497448|NCT03678688|451452377|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
125497449|NCT03678688|451452378|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
125497450|NCT03678688|451452379|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
125497451|NCT03678688|451452380|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
125497452|NCT03678688|451452381|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
125497453|NCT03678688|451452382|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
125497454|NCT03678688|451452383|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
125497455|NCT03678688|451452384|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
125497456|NCT03678688|451452385|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
125497457|NCT03678688|451452377|FG000|Overall Study|Covid Related Adverse Event|0|||
125497458|NCT03678688|451452378|FG001|Overall Study|Covid Related Adverse Event|0|||
125497459|NCT03678688|451452379|FG002|Overall Study|Covid Related Adverse Event|0|||
125497460|NCT03678688|451452380|FG003|Overall Study|Covid Related Adverse Event|0|||
125304497|NCT01368081|450741321|FG009|Overall Study|Other reason not defined above|1|||
125304498|NCT01368081|450741322|FG010|Overall Study|Other reason not defined above|0|||
125304499|NCT01368081|450741323|FG011|Overall Study|Other reason not defined above|0|||
125304500|NCT01368081|450741324|FG012|Overall Study|Other reason not defined above|3|||
125304501|NCT01736618|450741327|FG000|Overall Study|Death|294|||
125304502|NCT01736618|450741327|FG000|Overall Study|Lost to Follow-up|193|||
125304503|NCT01736618|450741327|FG000|Overall Study|Withdrawal by Subject|54|||
125304504|NCT01736618|450741327|FG000|Overall Study|Subject unable to be followed at study location|223|||
125304505|NCT01736618|450741327|FG000|Overall Study|Physician Decision|33|||
125304506|NCT01736618|450741327|FG000|Overall Study|Transplant or removal of target organ|19|||
125304507|NCT01736618|450741327|FG000|Overall Study|Change in indication or condition|78|||
125497461|NCT03678688|451452381|FG004|Overall Study|Covid Related Adverse Event|0|||
125497462|NCT03678688|451452382|FG005|Overall Study|Covid Related Adverse Event|3|||
125497463|NCT03678688|451452383|FG006|Overall Study|Covid Related Adverse Event|1|||
125497464|NCT03678688|451452384|FG007|Overall Study|Covid Related Adverse Event|1|||
125497465|NCT03678688|451452385|FG008|Overall Study|Covid Related Adverse Event|0|||
125497466|NCT03678688|451452377|FG000|Overall Study|Physician Decision|0|||
125497467|NCT03678688|451452378|FG001|Overall Study|Physician Decision|0|||
125497468|NCT03678688|451452379|FG002|Overall Study|Physician Decision|0|||
125497469|NCT03678688|451452380|FG003|Overall Study|Physician Decision|0|||
125497470|NCT03678688|451452381|FG004|Overall Study|Physician Decision|0|||
125497471|NCT03678688|451452382|FG005|Overall Study|Physician Decision|1|||
125497472|NCT03678688|451452383|FG006|Overall Study|Physician Decision|0|||
125497473|NCT03678688|451452384|FG007|Overall Study|Physician Decision|0|||
125497474|NCT03678688|451452385|FG008|Overall Study|Physician Decision|0|||
125497475|NCT03678688|451452377|FG000|Overall Study|Withdrawal by Subject|0|||
125497476|NCT03678688|451452378|FG001|Overall Study|Withdrawal by Subject|0|||
125497477|NCT03678688|451452379|FG002|Overall Study|Withdrawal by Subject|0|||
125497478|NCT03678688|451452380|FG003|Overall Study|Withdrawal by Subject|0|||
125497479|NCT03678688|451452381|FG004|Overall Study|Withdrawal by Subject|0|||
125497480|NCT03678688|451452382|FG005|Overall Study|Withdrawal by Subject|0|||
125497481|NCT03678688|451452383|FG006|Overall Study|Withdrawal by Subject|2|||
125497482|NCT03678688|451452384|FG007|Overall Study|Withdrawal by Subject|1|||
125497483|NCT03678688|451452385|FG008|Overall Study|Withdrawal by Subject|0|||
125497484|NCT00985088|451452391|FG000|Overall Study|Serious Adverse Event|1|||
125497485|NCT00985088|451452392|FG001|Overall Study|Serious Adverse Event|1|||
125497486|NCT00985088|451452393|FG002|Overall Study|Serious Adverse Event|0|||
125497487|NCT00985088|451452394|FG003|Overall Study|Serious Adverse Event|0|||
125497488|NCT00985088|451452395|FG004|Overall Study|Serious Adverse Event|0|||
125497489|NCT00985088|451452396|FG005|Overall Study|Serious Adverse Event|0|||
125497490|NCT00985088|451452397|FG006|Overall Study|Serious Adverse Event|0|||
125497491|NCT00985088|451452398|FG007|Overall Study|Serious Adverse Event|1|||
125497492|NCT00985088|451452391|FG000|Overall Study|Adverse Event|0|||
125497493|NCT00985088|451452392|FG001|Overall Study|Adverse Event|0|||
125497494|NCT00985088|451452393|FG002|Overall Study|Adverse Event|1|||
125497495|NCT00985088|451452394|FG003|Overall Study|Adverse Event|0|||
125497496|NCT00985088|451452395|FG004|Overall Study|Adverse Event|0|||
125497497|NCT00985088|451452396|FG005|Overall Study|Adverse Event|0|||
125497498|NCT00985088|451452397|FG006|Overall Study|Adverse Event|0|||
125497499|NCT00985088|451452398|FG007|Overall Study|Adverse Event|0|||
125497500|NCT00985088|451452391|FG000|Overall Study|Withdrawal by Subject|4|||
125497501|NCT00985088|451452392|FG001|Overall Study|Withdrawal by Subject|0|||
125497502|NCT00985088|451452393|FG002|Overall Study|Withdrawal by Subject|0|||
125497503|NCT00985088|451452394|FG003|Overall Study|Withdrawal by Subject|1|||
125497504|NCT00985088|451452395|FG004|Overall Study|Withdrawal by Subject|3|||
125497505|NCT00985088|451452396|FG005|Overall Study|Withdrawal by Subject|2|||
125497506|NCT00985088|451452397|FG006|Overall Study|Withdrawal by Subject|1|||
125497507|NCT00985088|451452398|FG007|Overall Study|Withdrawal by Subject|2|||
125497508|NCT00985088|451452391|FG000|Overall Study|Migrated/moved from study area|0|||
125497509|NCT00985088|451452392|FG001|Overall Study|Migrated/moved from study area|0|||
125497510|NCT00985088|451452393|FG002|Overall Study|Migrated/moved from study area|1|||
125497511|NCT00985088|451452394|FG003|Overall Study|Migrated/moved from study area|0|||
125497512|NCT00985088|451452395|FG004|Overall Study|Migrated/moved from study area|0|||
125497513|NCT00985088|451452396|FG005|Overall Study|Migrated/moved from study area|0|||
125497514|NCT00985088|451452397|FG006|Overall Study|Migrated/moved from study area|0|||
125497515|NCT00985088|451452398|FG007|Overall Study|Migrated/moved from study area|1|||
125497516|NCT00985088|451452391|FG000|Overall Study|Lost to Follow-up|6|||
125497517|NCT00985088|451452392|FG001|Overall Study|Lost to Follow-up|1|||
125497518|NCT00985088|451452393|FG002|Overall Study|Lost to Follow-up|2|||
125497519|NCT00985088|451452394|FG003|Overall Study|Lost to Follow-up|6|||
125497520|NCT00985088|451452395|FG004|Overall Study|Lost to Follow-up|6|||
125497521|NCT00985088|451452396|FG005|Overall Study|Lost to Follow-up|5|||
125497522|NCT00985088|451452397|FG006|Overall Study|Lost to Follow-up|3|||
125497523|NCT00985088|451452398|FG007|Overall Study|Lost to Follow-up|2|||
125497524|NCT01278030|451452401|FG000|Overall Study|Withdrawal by Subject|8|||
125497525|NCT01278030|451452402|FG001|Overall Study|Withdrawal by Subject|4|||
125497526|NCT00458783|451452404|FG000|Overall Study|Protocol Violation|1228|||
125497527|NCT00458783|451452405|FG001|Overall Study|Protocol Violation|1220|||
125497528|NCT01737398|451452406|FG000|Overall Study|Adverse event or SAE|16|||
125497529|NCT01737398|451452407|FG001|Overall Study|Adverse event or SAE|1|||
125497530|NCT01737398|451452406|FG000|Overall Study|Stopping rule met|2|||
125497531|NCT01737398|451452407|FG001|Overall Study|Stopping rule met|1|||
125497532|NCT01737398|451452406|FG000|Overall Study|Voluntary withdrawal|2|||
125497533|NCT01737398|451452407|FG001|Overall Study|Voluntary withdrawal|3|||
125497534|NCT01737398|451452406|FG000|Overall Study|Ineligibility|1|||
125497535|NCT01737398|451452407|FG001|Overall Study|Ineligibility|0|||
125497536|NCT01737398|451452406|FG000|Overall Study|Liver transplant|1|||
125497537|NCT01737398|451452407|FG001|Overall Study|Liver transplant|0|||
125497538|NCT01737398|451452406|FG000|Overall Study|Disease progression|2|||
125497539|NCT01737398|451452407|FG001|Overall Study|Disease progression|3|||
125497540|NCT01737398|451452406|FG000|Overall Study|Sponsor's decision|2|||
125497541|NCT01737398|451452407|FG001|Overall Study|Sponsor's decision|0|||
125497542|NCT02962284|451452409|FG000|Overall Study|Death|2|||
125497543|NCT02962284|451452410|FG001|Overall Study|Death|0|||
125497544|NCT02962284|451452409|FG000|Overall Study|Progressive disease|2|||
125497545|NCT02962284|451452410|FG001|Overall Study|Progressive disease|3|||
125497546|NCT02962284|451452409|FG000|Overall Study|Withdrawal by Subject|1|||
125497547|NCT02962284|451452410|FG001|Overall Study|Withdrawal by Subject|0|||
125497548|NCT00357994|451452413|FG000|Overall Study|Adverse Event|1|||
125497549|NCT00357994|451452414|FG001|Overall Study|Adverse Event|2|||
125497550|NCT00357994|451452413|FG000|Overall Study|Lack of Efficacy|0|||
125497551|NCT00357994|451452414|FG001|Overall Study|Lack of Efficacy|1|||
125497552|NCT00357994|451452413|FG000|Overall Study|Protocol Violation|1|||
125497553|NCT00357994|451452414|FG001|Overall Study|Protocol Violation|0|||
125497554|NCT04162210|451452419|FG000|Overall Study|Lost to Follow-up|4|||
125497555|NCT04162210|451452420|FG001|Overall Study|Lost to Follow-up|1|||
125497556|NCT04162210|451452419|FG000|Overall Study|Withdrawal by Subject|17|||
125497557|NCT04162210|451452420|FG001|Overall Study|Withdrawal by Subject|9|||
125497558|NCT04162210|451452419|FG000|Overall Study|Ongoing|113|||
125497559|NCT04162210|451452420|FG001|Overall Study|Ongoing|59|||
125497560|NCT03244800|451452421|FG000|Overall Study|Adverse Event|0|||
125497561|NCT03244800|451452422|FG001|Overall Study|Adverse Event|1|||
125497562|NCT03244800|451452423|FG002|Overall Study|Adverse Event|0|||
125497563|NCT03244800|451452424|FG003|Overall Study|Adverse Event|1|||
125497564|NCT03244800|451452421|FG000|Overall Study|Withdrew treatment|0|||
125497565|NCT03244800|451452422|FG001|Overall Study|Withdrew treatment|0|||
125497566|NCT03244800|451452423|FG002|Overall Study|Withdrew treatment|0|||
125497567|NCT03244800|451452424|FG003|Overall Study|Withdrew treatment|1|||
125497568|NCT00371345|451452427|FG000|Overall Study|Disease Progression|21|||
125497569|NCT00371345|451452428|FG001|Overall Study|Disease Progression|35|||
125497570|NCT00371345|451452427|FG000|Overall Study|Study Drug Toxicity|1|||
125497571|NCT00371345|451452428|FG001|Overall Study|Study Drug Toxicity|7|||
125497572|NCT00371345|451452427|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
125497573|NCT00371345|451452428|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
125497574|NCT00371345|451452427|FG000|Overall Study|Participant Request|1|||
125497575|NCT00371345|451452428|FG001|Overall Study|Participant Request|1|||
125497576|NCT00371345|451452427|FG000|Overall Study|Participant Withdrew Consent|0|||
125497577|NCT00371345|451452428|FG001|Overall Study|Participant Withdrew Consent|1|||
125497578|NCT00713596|451452429|FG000|Overall Study|Study was terminated|2|||
125497579|NCT00713596|451452430|FG001|Overall Study|Study was terminated|3|||
125497580|NCT00713596|451452431|FG002|Overall Study|Study was terminated|2|||
125497581|NCT04545619|451452432|FG000|Overall Study|due to equipment challenges|1|||
125497582|NCT03712371|451452433|FG000|Overall Study|Lack of Efficacy|0|||
125497583|NCT03712371|451452434|FG001|Overall Study|Lack of Efficacy|0|||
125497584|NCT03712371|451452435|FG002|Overall Study|Lack of Efficacy|0|||
125497585|NCT03712371|451452436|FG003|Overall Study|Lack of Efficacy|1|||
125497586|NCT02788981|451452437|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
125497587|NCT02788981|451452438|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
125421125|NCT02308748|451166232|FG005|Period 5|Adverse Event|0|||
125421126|NCT02308748|451166233|FG006|Period 5|Adverse Event|0|||
125421127|NCT02308748|451166234|FG007|Period 5|Adverse Event|0|||
125421128|NCT02308748|451166235|FG008|Period 5|Adverse Event|1|||
125421129|NCT02308748|451166236|FG009|Period 5|Adverse Event|0|||
125421130|NCT05207813|451166239|FG000|Overall Study|Lost to Follow-up|2|||
125421131|NCT04988308|451166243|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
125421132|NCT04988308|451166244|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
125421133|NCT04988308|451166245|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
125421134|NCT04988308|451166246|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
125421135|NCT04988308|451166247|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
125421136|NCT04988308|451166248|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
125421137|NCT04988308|451166243|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
125421138|NCT04988308|451166244|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
125421139|NCT04988308|451166245|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
125421140|NCT04988308|451166246|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
125421141|NCT04988308|451166247|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
125421142|NCT04988308|451166248|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
125421143|NCT04988308|451166243|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
125421144|NCT04988308|451166244|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
125421145|NCT04988308|451166245|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
125421146|NCT04988308|451166246|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
125421147|NCT04988308|451166247|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
125421148|NCT04988308|451166248|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
125421149|NCT04988308|451166243|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
125421150|NCT04988308|451166244|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
125421151|NCT04988308|451166245|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
125421152|NCT04988308|451166246|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
125497588|NCT00229658|451452439|FG000|Overall Study|Administrative|2|||
125497589|NCT00229658|451452440|FG001|Overall Study|Administrative|1|||
125497590|NCT00229658|451452439|FG000|Overall Study|Investigator decision|13|||
125497591|NCT00229658|451452440|FG001|Overall Study|Investigator decision|10|||
125497592|NCT00229658|451452439|FG000|Overall Study|Other|80|||
125497593|NCT00229658|451452440|FG001|Overall Study|Other|60|||
125497594|NCT00229658|451452439|FG000|Overall Study|Lost to Follow-up|82|||
125497595|NCT00229658|451452440|FG001|Overall Study|Lost to Follow-up|55|||
125497596|NCT00229658|451452439|FG000|Overall Study|Serious Adverse Event|2|||
125497597|NCT00229658|451452440|FG001|Overall Study|Serious Adverse Event|2|||
125497598|NCT00229658|451452439|FG000|Overall Study|Withdrawal of consent|46|||
125497599|NCT00229658|451452440|FG001|Overall Study|Withdrawal of consent|39|||
125497600|NCT00249769|451452441|FG000|Overall Study|Withdrawal by Subject|1|||
125497601|NCT00249769|451452442|FG001|Overall Study|Withdrawal by Subject|10|||
125497602|NCT00249769|451452443|FG002|Overall Study|Withdrawal by Subject|6|||
125497603|NCT00249769|451452441|FG000|Overall Study|Migration from Study Area|1|||
125497604|NCT00249769|451452442|FG001|Overall Study|Migration from Study Area|3|||
125497605|NCT00249769|451452443|FG002|Overall Study|Migration from Study Area|14|||
125497606|NCT00249769|451452441|FG000|Overall Study|Miscellaneous|0|||
125497607|NCT00249769|451452442|FG001|Overall Study|Miscellaneous|2|||
125497608|NCT00249769|451452443|FG002|Overall Study|Miscellaneous|2|||
125497609|NCT00249769|451452441|FG000|Overall Study|Adverse Event|0|||
125497610|NCT00249769|451452442|FG001|Overall Study|Adverse Event|0|||
125497611|NCT00249769|451452443|FG002|Overall Study|Adverse Event|1|||
125497612|NCT00249769|451452441|FG000|Overall Study|Physician Decision|0|||
125497613|NCT00249769|451452442|FG001|Overall Study|Physician Decision|0|||
125497614|NCT00249769|451452443|FG002|Overall Study|Physician Decision|2|||
125497615|NCT00249769|451452441|FG000|Overall Study|Lost to Follow-up|0|||
125497616|NCT00249769|451452442|FG001|Overall Study|Lost to Follow-up|0|||
125497617|NCT00249769|451452443|FG002|Overall Study|Lost to Follow-up|3|||
125497618|NCT01953224|451452444|FG000|Overall Study|Lost to Follow-up|1|||
125497619|NCT01953224|451452445|FG001|Overall Study|Lost to Follow-up|1|||
125497620|NCT01953224|451452444|FG000|Overall Study|Withdrawal by Subject|1|||
125497621|NCT01953224|451452445|FG001|Overall Study|Withdrawal by Subject|2|||
125497622|NCT03229408|451452452|FG000|Overall Study|Withdrawal by Subject|4|||
125497623|NCT03229408|451452453|FG001|Overall Study|Withdrawal by Subject|1|||
125497624|NCT03229408|451452452|FG000|Overall Study|Adverse Event|2|||
125497625|NCT03229408|451452453|FG001|Overall Study|Adverse Event|0|||
125497626|NCT03229408|451452452|FG000|Overall Study|Pregnancy|0|||
125497627|NCT03229408|451452453|FG001|Overall Study|Pregnancy|1|||
125497628|NCT03229408|451452452|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
125497629|NCT03229408|451452453|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
125497630|NCT04541589|451452454|FG000|Treatment Period|Adverse Event|8|||
125497631|NCT04541589|451452455|FG001|Treatment Period|Adverse Event|2|||
125497632|NCT04541589|451452454|FG000|Treatment Period|Physician Decision|3|||
125497633|NCT04541589|451452455|FG001|Treatment Period|Physician Decision|1|||
125497634|NCT04541589|451452454|FG000|Treatment Period|Subject decision|7|||
125497635|NCT04541589|451452455|FG001|Treatment Period|Subject decision|4|||
125497636|NCT04541589|451452454|FG000|Treatment Period|Withdrawal by Subject|1|||
125497637|NCT04541589|451452455|FG001|Treatment Period|Withdrawal by Subject|0|||
125497638|NCT04541589|451452454|FG000|Safety Follow-up Period|Adverse Event|2|||
125497639|NCT04541589|451452455|FG001|Safety Follow-up Period|Adverse Event|1|||
125497640|NCT04541589|451452454|FG000|Safety Follow-up Period|Physician Decision|1|||
125497641|NCT04541589|451452455|FG001|Safety Follow-up Period|Physician Decision|0|||
125497642|NCT04541589|451452454|FG000|Safety Follow-up Period|Subject decision|5|||
125497643|NCT04541589|451452455|FG001|Safety Follow-up Period|Subject decision|3|||
125497644|NCT04541589|451452454|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
125497645|NCT04541589|451452455|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
125497646|NCT02426138|451452456|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
125497647|NCT02426138|451452457|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
125497648|NCT03362190|451452464|FG000|Overall Study|Adverse Event|0|||
125497649|NCT03362190|451452465|FG001|Overall Study|Adverse Event|0|||
125497650|NCT03362190|451452466|FG002|Overall Study|Adverse Event|0|||
125497651|NCT03362190|451452467|FG003|Overall Study|Adverse Event|1|||
125497652|NCT03362190|451452464|FG000|Overall Study|Withdrawal by Subject|0|||
125497653|NCT03362190|451452465|FG001|Overall Study|Withdrawal by Subject|0|||
125497654|NCT03362190|451452466|FG002|Overall Study|Withdrawal by Subject|0|||
125497655|NCT03362190|451452467|FG003|Overall Study|Withdrawal by Subject|1|||
125497656|NCT00687219|451452468|FG000|Overall Study|Adverse Event|8|||
125497657|NCT00687219|451452468|FG000|Overall Study|Discontinuance criteria met|7|||
125497658|NCT00687219|451452468|FG000|Overall Study|HCV-RNA positive conversion|34|||
125497659|NCT00687219|451452468|FG000|Overall Study|Withdrawal by Subject|1|||
125497660|NCT00687219|451452468|FG000|Overall Study|Lack of Efficacy|1|||
125497661|NCT02350634|451452471|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
125497662|NCT01400958|451452480|FG000|Overall Study|Physician Decision|0|||
125497663|NCT01400958|451452481|FG001|Overall Study|Physician Decision|1|||
125497664|NCT01400958|451452480|FG000|Overall Study|Withdrawal by Subject|0|||
125497665|NCT01400958|451452481|FG001|Overall Study|Withdrawal by Subject|1|||
125497666|NCT01400958|451452480|FG000|Overall Study|Adverse Event|1|||
125497667|NCT01400958|451452481|FG001|Overall Study|Adverse Event|0|||
125497668|NCT04445831|451452485|FG000|Overall Study|Withdrawal by Subject|2|||
125497669|NCT04445831|451452486|FG001|Overall Study|Withdrawal by Subject|1|||
125497670|NCT04445831|451452487|FG002|Overall Study|Withdrawal by Subject|1|||
125497671|NCT04445831|451452488|FG003|Overall Study|Withdrawal by Subject|0|||
125497672|NCT04445831|451452489|FG004|Overall Study|Withdrawal by Subject|0|||
125497673|NCT04445831|451452490|FG005|Overall Study|Withdrawal by Subject|0|||
125497674|NCT04445831|451452491|FG006|Overall Study|Withdrawal by Subject|0|||
125497675|NCT04445831|451452485|FG000|Overall Study|Subject withdrawal by caregiver|0|||
125497676|NCT04445831|451452486|FG001|Overall Study|Subject withdrawal by caregiver|1|||
125497677|NCT04445831|451452487|FG002|Overall Study|Subject withdrawal by caregiver|0|||
125497678|NCT04445831|451452488|FG003|Overall Study|Subject withdrawal by caregiver|0|||
125497679|NCT04445831|451452489|FG004|Overall Study|Subject withdrawal by caregiver|0|||
125497680|NCT04445831|451452490|FG005|Overall Study|Subject withdrawal by caregiver|0|||
125497681|NCT04445831|451452491|FG006|Overall Study|Subject withdrawal by caregiver|0|||
125497682|NCT05810285|451452492|FG000|Overall Study|Death|4|||
125497683|NCT05810285|451452493|FG001|Overall Study|Death|21|||
125497684|NCT05810285|451452492|FG000|Overall Study|Adverse Event|18|||
125497685|NCT05810285|451452493|FG001|Overall Study|Adverse Event|16|||
125497686|NCT05470114|451452494|FG000|Overall Study|Withdrawal by Subject|1|||
125497687|NCT05470114|451452495|FG001|Overall Study|Withdrawal by Subject|0|||
125497688|NCT05470114|451452494|FG000|Overall Study|Lost to Follow-up|1|||
125497689|NCT05470114|451452495|FG001|Overall Study|Lost to Follow-up|0|||
125497690|NCT05325294|451452496|FG000|Overall Study|Adverse Event|3|||
125497691|NCT05325294|451452497|FG001|Overall Study|Adverse Event|3|||
125497692|NCT05325294|451452496|FG000|Overall Study|Physician Decision|0|||
125497693|NCT05325294|451452497|FG001|Overall Study|Physician Decision|1|||
125497694|NCT05325294|451452496|FG000|Overall Study|Withdrawal by Subject|0|||
125497695|NCT05325294|451452497|FG001|Overall Study|Withdrawal by Subject|3|||
125497696|NCT05325294|451452496|FG000|Overall Study|Lost to Follow-up|1|||
125497697|NCT05325294|451452497|FG001|Overall Study|Lost to Follow-up|0|||
125497698|NCT05325294|451452496|FG000|Overall Study|Sponsor Request|0|||
125497699|NCT05325294|451452497|FG001|Overall Study|Sponsor Request|2|||
125497700|NCT04577651|451452499|FG000|Overall Study|Screen Failure|7|||
125497701|NCT04577651|451452499|FG000|Overall Study|Adverse Event|1|||
125497702|NCT04577651|451452499|FG000|Overall Study|Death|1|||
125497703|NCT04577651|451452499|FG000|Overall Study|Physician Decision|1|||
125497704|NCT04577651|451452499|FG000|Overall Study|Withdrawal by Subject|3|||
125497705|NCT03214081|451453639|FG000|Overall Study|Case Report Forms Uncollected|9|||
125497706|NCT03214081|451453639|FG000|Overall Study|Protocol Deviation|54|||
125497707|NCT01372085|451453642|FG000|Washout Period 2|Physician Decision|0|||
125497708|NCT01372085|451453643|FG001|Washout Period 2|Physician Decision|0|||
125497709|NCT01372085|451453644|FG002|Washout Period 2|Physician Decision|0|||
125497710|NCT01372085|451453645|FG003|Washout Period 2|Physician Decision|0|||
125497711|NCT01372085|451453646|FG004|Washout Period 2|Physician Decision|1|||
125497712|NCT01372085|451453647|FG005|Washout Period 2|Physician Decision|0|||
125497713|NCT01372085|451453648|FG006|Washout Period 2|Physician Decision|0|||
125497714|NCT01372085|451453649|FG007|Washout Period 2|Physician Decision|0|||
125497715|NCT01372085|451453650|FG008|Washout Period 2|Physician Decision|0|||
125497716|NCT01372085|451453651|FG009|Washout Period 2|Physician Decision|0|||
125497717|NCT01372085|451453642|FG000|Washout Period 3|Withdrawal by Subject|0|||
125497718|NCT01372085|451453643|FG001|Washout Period 3|Withdrawal by Subject|0|||
125497719|NCT01372085|451453644|FG002|Washout Period 3|Withdrawal by Subject|0|||
125497720|NCT01372085|451453645|FG003|Washout Period 3|Withdrawal by Subject|0|||
125497721|NCT01372085|451453646|FG004|Washout Period 3|Withdrawal by Subject|0|||
125497722|NCT01372085|451453647|FG005|Washout Period 3|Withdrawal by Subject|2|||
125497723|NCT01372085|451453648|FG006|Washout Period 3|Withdrawal by Subject|0|||
125497724|NCT01372085|451453649|FG007|Washout Period 3|Withdrawal by Subject|0|||
125497725|NCT01372085|451453650|FG008|Washout Period 3|Withdrawal by Subject|0|||
125497726|NCT01372085|451453651|FG009|Washout Period 3|Withdrawal by Subject|0|||
125497727|NCT00790569|451453652|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
125497728|NCT00790569|451453653|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
125497729|NCT00790569|451453654|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
125497730|NCT00790569|451453652|FG000|End of Treatment (6 Month Interview)|Death|0|||
125497731|NCT00790569|451453653|FG001|End of Treatment (6 Month Interview)|Death|2|||
125497732|NCT00790569|451453654|FG002|End of Treatment (6 Month Interview)|Death|1|||
125497733|NCT00790569|451453652|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
125497734|NCT00790569|451453653|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
125497735|NCT00790569|451453654|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
125497736|NCT00790569|451453652|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
125497737|NCT00790569|451453653|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
125497738|NCT00790569|451453654|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
125497739|NCT00790569|451453652|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
125497740|NCT00790569|451453653|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
125497741|NCT00790569|451453654|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
125497742|NCT00790569|451453652|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
125497743|NCT00790569|451453653|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
125497744|NCT00790569|451453654|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
125497745|NCT00512252|451453658|FG000|Overall Study|Lost to Follow-up|0|||
125497746|NCT00512252|451453659|FG001|Overall Study|Lost to Follow-up|0|||
125497747|NCT00512252|451453660|FG002|Overall Study|Lost to Follow-up|1|||
125497748|NCT00512252|451453658|FG000|Overall Study|Protocol Violation|0|||
125497749|NCT00512252|451453659|FG001|Overall Study|Protocol Violation|0|||
125497750|NCT00512252|451453660|FG002|Overall Study|Protocol Violation|1|||
125497751|NCT00512252|451453658|FG000|Overall Study|Death|0|||
125497752|NCT00512252|451453659|FG001|Overall Study|Death|0|||
125497753|NCT00512252|451453660|FG002|Overall Study|Death|1|||
125497754|NCT00705406|451453663|FG000|Overall Study|Lost to Follow-up|3|||
125497755|NCT00705406|451453664|FG001|Overall Study|Lost to Follow-up|3|||
125497756|NCT00705406|451453663|FG000|Overall Study|Did not receive study drug|1|||
125497757|NCT00705406|451453664|FG001|Overall Study|Did not receive study drug|2|||
125497758|NCT02357966|451453665|FG000|Overall Study|Death|0|||
125497759|NCT02357966|451453666|FG001|Overall Study|Death|0|||
125497760|NCT02357966|451453667|FG002|Overall Study|Death|1|||
125497761|NCT02357966|451453668|FG003|Overall Study|Death|0|||
125497762|NCT02357966|451453669|FG004|Overall Study|Death|2|||
125497763|NCT02357966|451453670|FG005|Overall Study|Death|0|||
125497764|NCT02357966|451453665|FG000|Overall Study|Physician Decision|1|||
125497765|NCT02357966|451453666|FG001|Overall Study|Physician Decision|0|||
125497766|NCT02357966|451453667|FG002|Overall Study|Physician Decision|0|||
125497767|NCT02357966|451453668|FG003|Overall Study|Physician Decision|0|||
125497768|NCT02357966|451453669|FG004|Overall Study|Physician Decision|1|||
125497769|NCT02357966|451453670|FG005|Overall Study|Physician Decision|0|||
125497770|NCT01079806|451453671|FG000|Day 1 to Week 96|Adverse Event|0|||
125497771|NCT01079806|451453672|FG001|Day 1 to Week 96|Adverse Event|3|||
125497772|NCT01079806|451453671|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
125497773|NCT01079806|451453672|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
125497774|NCT01079806|451453671|FG000|Day 1 to Week 96|Pregnancy|0|||
125497775|NCT01079806|451453672|FG001|Day 1 to Week 96|Pregnancy|1|||
125497776|NCT01079806|451453671|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
125497777|NCT01079806|451453672|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
125497778|NCT01079806|451453671|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
125497779|NCT01079806|451453672|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
125497780|NCT01079806|451453671|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
125497781|NCT01079806|451453672|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
125497782|NCT01079806|451453671|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
125497783|NCT01079806|451453672|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
125497784|NCT01079806|451453671|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
125497785|NCT01079806|451453672|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
125497786|NCT01079806|451453671|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
125497787|NCT01079806|451453672|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
125497788|NCT01079806|451453671|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
125497789|NCT01079806|451453672|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
125497790|NCT03732807|451453673|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
125497791|NCT03732807|451453674|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
125497792|NCT03732807|451453675|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
125497793|NCT03732807|451453676|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
125497794|NCT03732807|451453677|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
125497795|NCT03732807|451453678|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
125497796|NCT03732807|451453679|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
125497797|NCT03732807|451453673|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
125497798|NCT03732807|451453674|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
125497799|NCT03732807|451453675|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
125497800|NCT03732807|451453676|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
125497801|NCT03732807|451453677|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
125497802|NCT03732807|451453678|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
125497803|NCT03732807|451453679|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
125497804|NCT03732807|451453673|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
125497805|NCT03732807|451453674|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
125497806|NCT03732807|451453675|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
125497807|NCT03732807|451453676|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
125497808|NCT03732807|451453677|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
125497809|NCT03732807|451453678|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
125497810|NCT03732807|451453679|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
125497811|NCT03732807|451453673|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
125497812|NCT03732807|451453674|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
125497813|NCT03732807|451453675|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
125497814|NCT03732807|451453676|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
125497815|NCT03732807|451453677|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
125497816|NCT03732807|451453678|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
125497817|NCT03732807|451453679|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
125497818|NCT03732807|451453673|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
125497819|NCT03732807|451453674|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
125497820|NCT03732807|451453675|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
125497821|NCT03732807|451453676|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
125497822|NCT03732807|451453677|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
125497823|NCT03732807|451453678|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
125497824|NCT03732807|451453679|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
125497825|NCT03732807|451453673|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
125497826|NCT03732807|451453674|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
125497827|NCT03732807|451453675|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
125497828|NCT03732807|451453676|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
125497829|NCT03732807|451453677|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
125497830|NCT03732807|451453678|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
125497831|NCT03732807|451453679|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
125497832|NCT03732807|451453673|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
125497833|NCT03732807|451453674|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
125497834|NCT03732807|451453675|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
125497835|NCT03732807|451453676|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
125497836|NCT03732807|451453677|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
125497837|NCT03732807|451453678|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
125497838|NCT03732807|451453679|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
125497839|NCT03732807|451453673|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
125497840|NCT03732807|451453674|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
125497841|NCT03732807|451453675|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
125497842|NCT03732807|451453676|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
125497843|NCT03732807|451453677|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
125497844|NCT03732807|451453678|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
125497845|NCT03732807|451453679|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
125497846|NCT03732807|451453673|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
125497847|NCT03732807|451453674|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
125497848|NCT03732807|451453675|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
125497849|NCT03732807|451453676|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
125497850|NCT03732807|451453677|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
125497851|NCT03732807|451453678|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
125497852|NCT03732807|451453679|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
125497853|NCT03732807|451453673|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
125497854|NCT03732807|451453674|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
125497855|NCT03732807|451453675|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
125497856|NCT03732807|451453676|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
125497857|NCT03732807|451453677|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
125497858|NCT03732807|451453678|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
125497859|NCT03732807|451453679|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
125497860|NCT03732807|451453673|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
125497861|NCT03732807|451453674|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
125497862|NCT03732807|451453675|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
125497863|NCT03732807|451453676|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
125497864|NCT03732807|451453677|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
125497865|NCT03732807|451453678|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
125497866|NCT03732807|451453679|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
125497867|NCT03732807|451453673|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
125497868|NCT03732807|451453674|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
125497869|NCT03732807|451453675|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
125497870|NCT03732807|451453676|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
125497871|NCT03732807|451453677|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
125497872|NCT03732807|451453678|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
125304508|NCT01736618|450741327|FG000|Overall Study|Study device explant|103|||
125304509|NCT01736618|450741327|FG000|Overall Study|Unable to complete implant|2|||
125304510|NCT00400569|450741332|FG000|Overall Study|Death|1|||
125497873|NCT03732807|451453679|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
125304511|NCT00620113|450741335|FG000|Overall Study|Adverse Event|3|||
125497874|NCT03732807|451453673|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
125497875|NCT03732807|451453674|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
125497876|NCT03732807|451453675|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
125497877|NCT03732807|451453676|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
125497878|NCT03732807|451453677|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
125497879|NCT03732807|451453678|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
125497880|NCT03732807|451453679|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
125497881|NCT03732807|451453673|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
125497882|NCT03732807|451453674|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
125497883|NCT03732807|451453675|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
125497884|NCT03732807|451453676|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
125497885|NCT03732807|451453677|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
125497886|NCT03732807|451453678|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
125497887|NCT03732807|451453679|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
125497888|NCT01779700|451453680|FG000|Overall Study|Adverse Event|4|||
125497889|NCT01779700|451453681|FG001|Overall Study|Adverse Event|3|||
125497890|NCT01779700|451453680|FG000|Overall Study|Withdrawal by Subject|0|||
125497891|NCT01779700|451453681|FG001|Overall Study|Withdrawal by Subject|2|||
125497892|NCT00019604|451453682|FG000|Overall Study|Death|1|||
125497893|NCT00019604|451453682|FG000|Overall Study|Progressive disease|23|||
125497894|NCT00019604|451453682|FG000|Overall Study|Refused treatment|1|||
125497895|NCT00019604|451453682|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
125497896|NCT00019604|451453682|FG000|Overall Study|Going to have liver transplant|1|||
125497897|NCT00019604|451453682|FG000|Overall Study|Move to a different study|1|||
125497898|NCT00019604|451453682|FG000|Overall Study|Non compliant on systemic CH|1|||
125497899|NCT00019604|451453682|FG000|Overall Study|Non compliant|1|||
125497900|NCT00019604|451453682|FG000|Overall Study|Resectable disease|1|||
125497901|NCT00019604|451453682|FG000|Overall Study|Started new chemo regimen|1|||
125497902|NCT00019604|451453682|FG000|Overall Study|Pt going to immunotherapy study|1|||
125497903|NCT00019604|451453682|FG000|Overall Study|Too much disease|1|||
125497904|NCT00019604|451453682|FG000|Overall Study|Unable to evaluate|1|||
125497905|NCT00019604|451453682|FG000|Overall Study|Details for other not available|4|||
125497906|NCT00975585|451453684|FG000|Overall Study|Adverse Event|0|||
125497907|NCT00975585|451453685|FG001|Overall Study|Adverse Event|4|||
125497908|NCT00975585|451453684|FG000|Overall Study|Lost to Follow-up|3|||
125497909|NCT00975585|451453685|FG001|Overall Study|Lost to Follow-up|5|||
125497910|NCT00975585|451453684|FG000|Overall Study|Withdrawal by Subject|2|||
125497911|NCT00975585|451453685|FG001|Overall Study|Withdrawal by Subject|1|||
125497912|NCT00975585|451453684|FG000|Overall Study|Lens issue|2|||
125497913|NCT00975585|451453685|FG001|Overall Study|Lens issue|2|||
125497914|NCT00683800|451453687|FG000|Overall Study|Adverse Event|195|||
125497915|NCT00683800|451453688|FG001|Overall Study|Adverse Event|102|||
125497916|NCT00683800|451453687|FG000|Overall Study|Death|0|||
125497917|NCT00683800|451453688|FG001|Overall Study|Death|1|||
125497918|NCT00683800|451453687|FG000|Overall Study|Lost to Follow-up|57|||
125497919|NCT00683800|451453688|FG001|Overall Study|Lost to Follow-up|44|||
125497920|NCT00683800|451453687|FG000|Overall Study|Other|5|||
125497921|NCT00683800|451453688|FG001|Overall Study|Other|2|||
125497922|NCT00683800|451453687|FG000|Overall Study|Protocol Violation|13|||
125497923|NCT00683800|451453688|FG001|Overall Study|Protocol Violation|16|||
125497924|NCT00683800|451453687|FG000|Overall Study|Withdrawal by Subject|66|||
125497925|NCT00683800|451453688|FG001|Overall Study|Withdrawal by Subject|64|||
125497926|NCT00683800|451453687|FG000|Overall Study|Lack of Efficacy|61|||
125497927|NCT00683800|451453688|FG001|Overall Study|Lack of Efficacy|104|||
125497928|NCT00683800|451453687|FG000|Overall Study|Randomized, not treated|35|||
125497929|NCT00683800|451453688|FG001|Overall Study|Randomized, not treated|33|||
125497930|NCT00205179|451453691|FG000|Overall Study|Death|0|||
125497931|NCT00205179|451453692|FG001|Overall Study|Death|2|||
125497932|NCT00205179|451453691|FG000|Overall Study|Physician Decision|1|||
125497933|NCT00205179|451453692|FG001|Overall Study|Physician Decision|1|||
125497934|NCT00205179|451453691|FG000|Overall Study|Adverse Event|1|||
125497935|NCT00205179|451453692|FG001|Overall Study|Adverse Event|1|||
125497936|NCT00586313|451453693|FG000|Overall Study|Lack of Efficacy|2|||
125497937|NCT01700205|451453697|FG000|Overall Study|Withdrawal by Subject|13|||
125497938|NCT01700205|451453698|FG001|Overall Study|Withdrawal by Subject|13|||
125497939|NCT01700205|451453697|FG000|Overall Study|Protocol Violation|2|||
125497940|NCT01700205|451453698|FG001|Overall Study|Protocol Violation|2|||
125497941|NCT02251652|451453699|FG000|Overall Study|Withdrawal by Subject|1|||
125497942|NCT00983294|451453703|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
125497943|NCT00983294|451453703|FG000|Colchicine With Azithromycin|Adverse Event|1|||
125497944|NCT04200664|451453707|FG000|Overall Study|Withdrawal by Subject|1|||
125497945|NCT04200664|451453708|FG001|Overall Study|Withdrawal by Subject|0|||
125497946|NCT04200664|451453709|FG002|Overall Study|Withdrawal by Subject|0|||
125497947|NCT03582475|451453715|FG000|Treatment Period|Withdrawal by Subject|0|||
125497948|NCT03582475|451453716|FG001|Treatment Period|Withdrawal by Subject|1|||
125304512|NCT00620113|450741336|FG001|Overall Study|Adverse Event|2|||
125497949|NCT03582475|451453715|FG000|Follow-up Period|Withdrawal by Subject|0|||
125497950|NCT03582475|451453716|FG001|Follow-up Period|Withdrawal by Subject|1|||
125497951|NCT01706159|451453717|FG000|Overall Study|Withdrawal Criteria|2|||
125497952|NCT01706159|451453718|FG001|Overall Study|Withdrawal Criteria|1|||
125497953|NCT01706159|451453717|FG000|Overall Study|Unclassified|6|||
125497954|NCT01706159|451453718|FG001|Overall Study|Unclassified|1|||
125497955|NCT03775486|451453723|FG000|Initial Therapy Phase|Other reason provided|0|||
125497956|NCT03775486|451453724|FG001|Initial Therapy Phase|Other reason provided|15|||
125497957|NCT03775486|451453723|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
125497958|NCT03775486|451453724|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
125497959|NCT03775486|451453723|FG000|Initial Therapy Phase|Protocol Violation|0|||
125497960|NCT03775486|451453724|FG001|Initial Therapy Phase|Protocol Violation|2|||
125497961|NCT03775486|451453723|FG000|Initial Therapy Phase|Adverse Event|0|||
125497962|NCT03775486|451453724|FG001|Initial Therapy Phase|Adverse Event|34|||
125497963|NCT03775486|451453723|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
125497964|NCT03775486|451453724|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
125497965|NCT03775486|451453723|FG000|Maintenance Phase|Withdrawal by Subject|13|||
125497966|NCT03775486|451453724|FG001|Maintenance Phase|Withdrawal by Subject|12|||
125497967|NCT03775486|451453723|FG000|Maintenance Phase|Death|44|||
125497968|NCT03775486|451453724|FG001|Maintenance Phase|Death|45|||
125497969|NCT02744066|451453730|FG000|Overall Study|Withdrawal by parent|0|||
125497970|NCT02744066|451453731|FG001|Overall Study|Withdrawal by parent|1|||
125497971|NCT02744066|451453730|FG000|Overall Study|Discharged from NICU prior to completion|0|||
125497972|NCT02744066|451453731|FG001|Overall Study|Discharged from NICU prior to completion|4|||
125497973|NCT02454959|451453732|FG000|Overall Study|Protocol-Specified Criteria|3|||
125497974|NCT02454959|451453732|FG000|Overall Study|Physician Decision|1|||
125497975|NCT02454959|451453732|FG000|Overall Study|Withdrawal by Subject|3|||
125497976|NCT02454959|451453732|FG000|Overall Study|Adverse Event|2|||
125497977|NCT00647387|451453743|FG000|Overall Study|Lost to Follow-up|6|||
125497978|NCT00647387|451453743|FG000|Overall Study|Unsuccessful implant|5|||
125497979|NCT00647387|451453743|FG000|Overall Study|Device explanted|3|||
125497980|NCT00647387|451453743|FG000|Overall Study|Other Reason|3|||
125497981|NCT00647387|451453743|FG000|Overall Study|Death|2|||
125497982|NCT02969356|451453745|FG000|Overall Study|Adverse Event|7|||
125497983|NCT02969356|451453745|FG000|Overall Study|Consent withdrawn|2|||
125497984|NCT02969356|451453745|FG000|Overall Study|Lost to Follow-up|3|||
125497985|NCT02969356|451453745|FG000|Overall Study|Did not need to be reinjected|6|||
125497986|NCT02969356|451453745|FG000|Overall Study|Personal reasons|5|||
125497987|NCT04172675|451455543|FG000|Overall Study|Withdrawal by Subject|7|||
125497988|NCT04172675|451455544|FG001|Overall Study|Withdrawal by Subject|5|||
125497989|NCT04172675|451455545|FG002|Overall Study|Withdrawal by Subject|1|||
125497990|NCT04172675|451455546|FG003|Overall Study|Withdrawal by Subject|4|||
125497991|NCT03945773|451455547|FG000|Overall Study|Consent Withdrawn|1|||
125497992|NCT03945773|451455548|FG001|Overall Study|Consent Withdrawn|1|||
125497993|NCT03945773|451455547|FG000|Overall Study|Lost to Follow-up|1|||
125497994|NCT03945773|451455548|FG001|Overall Study|Lost to Follow-up|0|||
125497995|NCT03945773|451455547|FG000|Overall Study|Death|46|||
125497996|NCT03945773|451455548|FG001|Overall Study|Death|22|||
125497997|NCT03945773|451455547|FG000|Overall Study|Physician Decision|1|||
125497998|NCT03945773|451455548|FG001|Overall Study|Physician Decision|0|||
125497999|NCT03945773|451455547|FG000|Overall Study|Other|1|||
125498000|NCT03945773|451455548|FG001|Overall Study|Other|0|||
125498001|NCT03945773|451455547|FG000|Overall Study|Ongoing at the time of DCO|4|||
125498002|NCT03945773|451455548|FG001|Overall Study|Ongoing at the time of DCO|3|||
125498003|NCT05349721|451455549|FG000|Part A (24 Weeks)|Adverse Event|9|||
125498004|NCT05349721|451455550|FG001|Part A (24 Weeks)|Adverse Event|2|||
125498005|NCT05349721|451455549|FG000|Part A (24 Weeks)|Death|8|||
125498006|NCT05349721|451455550|FG001|Part A (24 Weeks)|Death|3|||
125498007|NCT05349721|451455549|FG000|Part A (24 Weeks)|Disease Progression|1|||
125498008|NCT05349721|451455550|FG001|Part A (24 Weeks)|Disease Progression|1|||
125498009|NCT05349721|451455549|FG000|Part A (24 Weeks)|Screen Failure|2|||
125498010|NCT05349721|451455550|FG001|Part A (24 Weeks)|Screen Failure|0|||
125498011|NCT05349721|451455549|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
125498012|NCT05349721|451455550|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
125498013|NCT05349721|451455549|FG000|Part A (24 Weeks)|Other Than Specified|5|||
125498014|NCT05349721|451455550|FG001|Part A (24 Weeks)|Other Than Specified|1|||
125498015|NCT05349721|451455549|FG000|Part B (28 Weeks)|Adverse Event|3|||
125498016|NCT05349721|451455550|FG001|Part B (28 Weeks)|Adverse Event|0|||
125498017|NCT05349721|451455549|FG000|Part B (28 Weeks)|Death|21|||
125498018|NCT05349721|451455550|FG001|Part B (28 Weeks)|Death|11|||
125498019|NCT05349721|451455549|FG000|Part B (28 Weeks)|Disease Progression|2|||
125498020|NCT05349721|451455550|FG001|Part B (28 Weeks)|Disease Progression|1|||
125498021|NCT05349721|451455549|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
125498022|NCT05349721|451455550|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
125498023|NCT05349721|451455549|FG000|Part B (28 Weeks)|Physician Decision|1|||
125498024|NCT05349721|451455550|FG001|Part B (28 Weeks)|Physician Decision|0|||
125498025|NCT05349721|451455549|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
125498026|NCT05349721|451455550|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
125498027|NCT05349721|451455549|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
125498028|NCT05349721|451455550|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
125498029|NCT05349721|451455549|FG000|Part B (28 Weeks)|Other Than Specified|4|||
125498030|NCT05349721|451455550|FG001|Part B (28 Weeks)|Other Than Specified|2|||
125498031|NCT05349721|451455549|FG000|Part C (108 Weeks)|Death|0|||
125498032|NCT05349721|451455550|FG001|Part C (108 Weeks)|Death|1|||
125498033|NCT05349721|451455549|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
125498034|NCT05349721|451455550|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
125498035|NCT05349721|451455549|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
125498036|NCT05349721|451455550|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
125498037|NCT05349721|451455549|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
125498038|NCT05349721|451455550|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
125498039|NCT03070392|451455551|FG000|Overall Study|Not Treated|7|||
125498040|NCT03070392|451455552|FG001|Overall Study|Not Treated|0|||
125498041|NCT03070392|451455553|FG002|Overall Study|Not Treated|3|||
125498042|NCT03070392|451455554|FG003|Overall Study|Not Treated|12|||
125498043|NCT03070392|451455551|FG000|Overall Study|Death|3|||
125498044|NCT03070392|451455552|FG001|Overall Study|Death|0|||
125498045|NCT03070392|451455553|FG002|Overall Study|Death|0|||
125498046|NCT03070392|451455554|FG003|Overall Study|Death|1|||
125498047|NCT03070392|451455551|FG000|Overall Study|Withdrawal by Subject|7|||
125498048|NCT03070392|451455552|FG001|Overall Study|Withdrawal by Subject|0|||
125498049|NCT03070392|451455553|FG002|Overall Study|Withdrawal by Subject|0|||
125498050|NCT03070392|451455554|FG003|Overall Study|Withdrawal by Subject|3|||
125498051|NCT03070392|451455551|FG000|Overall Study|Physician Decision|1|||
125498052|NCT03070392|451455552|FG001|Overall Study|Physician Decision|0|||
125498053|NCT03070392|451455553|FG002|Overall Study|Physician Decision|0|||
125498054|NCT03070392|451455554|FG003|Overall Study|Physician Decision|2|||
125498055|NCT03070392|451455551|FG000|Overall Study|Progressive Disease|154|||
125498056|NCT03070392|451455552|FG001|Overall Study|Progressive Disease|6|||
125498057|NCT03070392|451455553|FG002|Overall Study|Progressive Disease|2|||
125498058|NCT03070392|451455554|FG003|Overall Study|Progressive Disease|70|||
125498059|NCT03070392|451455551|FG000|Overall Study|Adverse Event|6|||
125498060|NCT03070392|451455552|FG001|Overall Study|Adverse Event|1|||
125498061|NCT03070392|451455553|FG002|Overall Study|Adverse Event|1|||
125498062|NCT03070392|451455554|FG003|Overall Study|Adverse Event|3|||
125498063|NCT03070392|451455551|FG000|Overall Study|Alternate anticancer treatment|1|||
125498064|NCT03070392|451455552|FG001|Overall Study|Alternate anticancer treatment|0|||
125498065|NCT03070392|451455553|FG002|Overall Study|Alternate anticancer treatment|0|||
125498066|NCT03070392|451455554|FG003|Overall Study|Alternate anticancer treatment|1|||
125498067|NCT03070392|451455551|FG000|Overall Study|Ongoing|73|||
125498068|NCT03070392|451455552|FG001|Overall Study|Ongoing|0|||
125498069|NCT03070392|451455553|FG002|Overall Study|Ongoing|0|||
125498070|NCT03070392|451455554|FG003|Overall Study|Ongoing|11|||
125498071|NCT02972034|451455555|FG000|Overall Study|Death|11|||
125498072|NCT02972034|451455556|FG001|Overall Study|Death|1|||
125498073|NCT02972034|451455557|FG002|Overall Study|Death|3|||
125498074|NCT02972034|451455558|FG003|Overall Study|Death|3|||
125498075|NCT02972034|451455559|FG004|Overall Study|Death|2|||
125498076|NCT02972034|451455560|FG005|Overall Study|Death|2|||
125498077|NCT02972034|451455561|FG006|Overall Study|Death|3|||
125498078|NCT02972034|451455562|FG007|Overall Study|Death|4|||
125498079|NCT02972034|451455563|FG008|Overall Study|Death|8|||
125498080|NCT02972034|451455564|FG009|Overall Study|Death|11|||
125498081|NCT02972034|451455565|FG010|Overall Study|Death|3|||
125304513|NCT00620113|450741337|FG002|Overall Study|Adverse Event|2|||
125304514|NCT00620113|450741338|FG003|Overall Study|Adverse Event|1|||
125304515|NCT00620113|450741335|FG000|Overall Study|Lack of Efficacy|2|||
125304516|NCT00620113|450741336|FG001|Overall Study|Lack of Efficacy|3|||
125498082|NCT02972034|451455566|FG011|Overall Study|Death|2|||
125498083|NCT02972034|451455567|FG012|Overall Study|Death|11|||
125498084|NCT02972034|451455568|FG013|Overall Study|Death|10|||
125498085|NCT02972034|451455569|FG014|Overall Study|Death|9|||
125498086|NCT02972034|451455555|FG000|Overall Study|Lost to Follow-up|0|||
125498087|NCT02972034|451455556|FG001|Overall Study|Lost to Follow-up|0|||
125498088|NCT02972034|451455557|FG002|Overall Study|Lost to Follow-up|0|||
125498089|NCT02972034|451455558|FG003|Overall Study|Lost to Follow-up|0|||
125498090|NCT02972034|451455559|FG004|Overall Study|Lost to Follow-up|1|||
125498091|NCT02972034|451455560|FG005|Overall Study|Lost to Follow-up|0|||
125498092|NCT02972034|451455561|FG006|Overall Study|Lost to Follow-up|0|||
125498093|NCT02972034|451455562|FG007|Overall Study|Lost to Follow-up|1|||
125498094|NCT02972034|451455563|FG008|Overall Study|Lost to Follow-up|0|||
125498095|NCT02972034|451455564|FG009|Overall Study|Lost to Follow-up|0|||
125304517|NCT00620113|450741337|FG002|Overall Study|Lack of Efficacy|0|||
125498096|NCT02972034|451455565|FG010|Overall Study|Lost to Follow-up|0|||
125498097|NCT02972034|451455566|FG011|Overall Study|Lost to Follow-up|0|||
125498098|NCT02972034|451455567|FG012|Overall Study|Lost to Follow-up|0|||
125498099|NCT02972034|451455568|FG013|Overall Study|Lost to Follow-up|0|||
125304518|NCT00620113|450741338|FG003|Overall Study|Lack of Efficacy|2|||
125498100|NCT02972034|451455569|FG014|Overall Study|Lost to Follow-up|1|||
125498101|NCT02972034|451455555|FG000|Overall Study|Physician Decision|0|||
125498102|NCT02972034|451455556|FG001|Overall Study|Physician Decision|0|||
125498103|NCT02972034|451455557|FG002|Overall Study|Physician Decision|0|||
125498104|NCT02972034|451455558|FG003|Overall Study|Physician Decision|0|||
125498105|NCT02972034|451455559|FG004|Overall Study|Physician Decision|0|||
125498106|NCT02972034|451455560|FG005|Overall Study|Physician Decision|0|||
125498107|NCT02972034|451455561|FG006|Overall Study|Physician Decision|0|||
125498108|NCT02972034|451455562|FG007|Overall Study|Physician Decision|1|||
125498109|NCT02972034|451455563|FG008|Overall Study|Physician Decision|0|||
125498110|NCT02972034|451455564|FG009|Overall Study|Physician Decision|0|||
125498111|NCT02972034|451455565|FG010|Overall Study|Physician Decision|1|||
125498112|NCT02972034|451455566|FG011|Overall Study|Physician Decision|0|||
125498113|NCT02972034|451455567|FG012|Overall Study|Physician Decision|0|||
125498114|NCT02972034|451455568|FG013|Overall Study|Physician Decision|0|||
125498115|NCT02972034|451455569|FG014|Overall Study|Physician Decision|0|||
125498116|NCT02972034|451455555|FG000|Overall Study|Sponsor Decision|0|||
125498117|NCT02972034|451455556|FG001|Overall Study|Sponsor Decision|0|||
125498118|NCT02972034|451455557|FG002|Overall Study|Sponsor Decision|0|||
125498119|NCT02972034|451455558|FG003|Overall Study|Sponsor Decision|1|||
125498120|NCT02972034|451455559|FG004|Overall Study|Sponsor Decision|0|||
125498121|NCT02972034|451455560|FG005|Overall Study|Sponsor Decision|0|||
125498122|NCT02972034|451455561|FG006|Overall Study|Sponsor Decision|1|||
125498123|NCT02972034|451455562|FG007|Overall Study|Sponsor Decision|1|||
125498124|NCT02972034|451455563|FG008|Overall Study|Sponsor Decision|1|||
125498125|NCT02972034|451455564|FG009|Overall Study|Sponsor Decision|2|||
125498126|NCT02972034|451455565|FG010|Overall Study|Sponsor Decision|2|||
125498127|NCT02972034|451455566|FG011|Overall Study|Sponsor Decision|0|||
125498128|NCT02972034|451455567|FG012|Overall Study|Sponsor Decision|1|||
125498129|NCT02972034|451455568|FG013|Overall Study|Sponsor Decision|0|||
125498130|NCT02972034|451455569|FG014|Overall Study|Sponsor Decision|1|||
125498131|NCT02972034|451455555|FG000|Overall Study|Withdrawal by Subject|3|||
125498132|NCT02972034|451455556|FG001|Overall Study|Withdrawal by Subject|0|||
125498133|NCT02972034|451455557|FG002|Overall Study|Withdrawal by Subject|0|||
125498134|NCT02972034|451455558|FG003|Overall Study|Withdrawal by Subject|0|||
125498135|NCT02972034|451455559|FG004|Overall Study|Withdrawal by Subject|1|||
125498136|NCT02972034|451455560|FG005|Overall Study|Withdrawal by Subject|1|||
125498137|NCT02972034|451455561|FG006|Overall Study|Withdrawal by Subject|0|||
125498138|NCT02972034|451455562|FG007|Overall Study|Withdrawal by Subject|0|||
125498139|NCT02972034|451455563|FG008|Overall Study|Withdrawal by Subject|1|||
125498140|NCT02972034|451455564|FG009|Overall Study|Withdrawal by Subject|1|||
125498141|NCT02972034|451455565|FG010|Overall Study|Withdrawal by Subject|2|||
125498142|NCT02972034|451455566|FG011|Overall Study|Withdrawal by Subject|1|||
125498143|NCT02972034|451455567|FG012|Overall Study|Withdrawal by Subject|1|||
125498144|NCT02972034|451455568|FG013|Overall Study|Withdrawal by Subject|1|||
125498145|NCT02972034|451455569|FG014|Overall Study|Withdrawal by Subject|0|||
125498146|NCT02972034|451455555|FG000|Overall Study|Screen Failure|0|||
125498147|NCT02972034|451455556|FG001|Overall Study|Screen Failure|0|||
125498148|NCT02972034|451455557|FG002|Overall Study|Screen Failure|0|||
125498149|NCT02972034|451455558|FG003|Overall Study|Screen Failure|0|||
125498150|NCT02972034|451455559|FG004|Overall Study|Screen Failure|0|||
125498151|NCT02972034|451455560|FG005|Overall Study|Screen Failure|0|||
125498152|NCT02972034|451455561|FG006|Overall Study|Screen Failure|0|||
125498153|NCT02972034|451455562|FG007|Overall Study|Screen Failure|0|||
125498154|NCT02972034|451455563|FG008|Overall Study|Screen Failure|0|||
125498155|NCT02972034|451455564|FG009|Overall Study|Screen Failure|0|||
125498156|NCT02972034|451455565|FG010|Overall Study|Screen Failure|0|||
125498157|NCT02972034|451455566|FG011|Overall Study|Screen Failure|0|||
125498158|NCT02972034|451455567|FG012|Overall Study|Screen Failure|1|||
125498159|NCT02972034|451455568|FG013|Overall Study|Screen Failure|0|||
125498160|NCT02972034|451455569|FG014|Overall Study|Screen Failure|0|||
125498161|NCT03861052|451455570|FG000|Overall Study|Adverse Event|1|||
125498162|NCT03861052|451455571|FG001|Overall Study|Adverse Event|1|||
125498163|NCT03861052|451455572|FG002|Overall Study|Adverse Event|2|||
125498164|NCT03861052|451455573|FG003|Overall Study|Adverse Event|4|||
125304519|NCT00620113|450741335|FG000|Overall Study|Physician Decision|1|||
125304520|NCT00620113|450741336|FG001|Overall Study|Physician Decision|0|||
125304521|NCT00620113|450741337|FG002|Overall Study|Physician Decision|0|||
125304522|NCT00620113|450741338|FG003|Overall Study|Physician Decision|2|||
125304523|NCT00620113|450741335|FG000|Overall Study|Protocol Violation|2|||
125304524|NCT00620113|450741336|FG001|Overall Study|Protocol Violation|1|||
125304525|NCT00620113|450741337|FG002|Overall Study|Protocol Violation|0|||
125304526|NCT00620113|450741338|FG003|Overall Study|Protocol Violation|0|||
125498165|NCT03861052|451455570|FG000|Overall Study|Lost to Follow-up|0|||
125498166|NCT03861052|451455571|FG001|Overall Study|Lost to Follow-up|0|||
125304527|NCT00620113|450741335|FG000|Overall Study|Withdrawal by Subject|5|||
125304528|NCT00620113|450741336|FG001|Overall Study|Withdrawal by Subject|1|||
125498167|NCT03861052|451455572|FG002|Overall Study|Lost to Follow-up|0|||
125498168|NCT03861052|451455573|FG003|Overall Study|Lost to Follow-up|1|||
125498169|NCT03861052|451455570|FG000|Overall Study|Physician Decision|0|||
125498170|NCT03861052|451455571|FG001|Overall Study|Physician Decision|1|||
125498171|NCT03861052|451455572|FG002|Overall Study|Physician Decision|0|||
125498172|NCT03861052|451455573|FG003|Overall Study|Physician Decision|0|||
125498173|NCT03861052|451455570|FG000|Overall Study|Withdrawal by Subject|2|||
125498174|NCT03861052|451455571|FG001|Overall Study|Withdrawal by Subject|5|||
125498175|NCT03861052|451455572|FG002|Overall Study|Withdrawal by Subject|3|||
125498176|NCT03861052|451455573|FG003|Overall Study|Withdrawal by Subject|0|||
125498177|NCT03861052|451455570|FG000|Overall Study|Relocation to other city|1|||
125498178|NCT03861052|451455571|FG001|Overall Study|Relocation to other city|0|||
125498179|NCT03861052|451455572|FG002|Overall Study|Relocation to other city|0|||
125498180|NCT03861052|451455573|FG003|Overall Study|Relocation to other city|0|||
125498181|NCT03823703|451455574|FG000|Overall Study|Sponsor request|0|||
125498182|NCT03823703|451455575|FG001|Overall Study|Sponsor request|3|||
125498183|NCT03823703|451455576|FG002|Overall Study|Sponsor request|4|||
125498184|NCT03823703|451455574|FG000|Overall Study|Adverse Event|3|||
125498185|NCT03823703|451455575|FG001|Overall Study|Adverse Event|1|||
125498186|NCT03823703|451455576|FG002|Overall Study|Adverse Event|0|||
125498187|NCT03823703|451455574|FG000|Overall Study|Withdrawal by Subject|0|||
125498188|NCT03823703|451455575|FG001|Overall Study|Withdrawal by Subject|1|||
125498189|NCT03823703|451455576|FG002|Overall Study|Withdrawal by Subject|0|||
125498190|NCT03137459|451455577|FG000|2-month Assessment|Withdrawal by Subject|13|||
125498191|NCT03137459|451455578|FG001|2-month Assessment|Withdrawal by Subject|3|||
125498192|NCT03137459|451455577|FG000|2-month Assessment|Unable to reach|42|||
125498193|NCT03137459|451455578|FG001|2-month Assessment|Unable to reach|32|||
125498194|NCT03137459|451455577|FG000|2-month Assessment|Refused assessment|7|||
125498195|NCT03137459|451455578|FG001|2-month Assessment|Refused assessment|5|||
125498196|NCT03137459|451455577|FG000|2-month Assessment|Acutely ill|6|||
125498197|NCT03137459|451455578|FG001|2-month Assessment|Acutely ill|2|||
125498198|NCT03137459|451455577|FG000|4-month Assessment|Death|4|||
125498199|NCT03137459|451455578|FG001|4-month Assessment|Death|2|||
125498200|NCT03137459|451455577|FG000|4-month Assessment|Withdrawal by Subject|4|||
125498201|NCT03137459|451455578|FG001|4-month Assessment|Withdrawal by Subject|2|||
125498202|NCT03137459|451455577|FG000|4-month Assessment|Unable to reach|44|||
125498203|NCT03137459|451455578|FG001|4-month Assessment|Unable to reach|29|||
125498204|NCT03137459|451455577|FG000|4-month Assessment|Refused assessment|24|||
125498205|NCT03137459|451455578|FG001|4-month Assessment|Refused assessment|10|||
125498206|NCT03137459|451455577|FG000|4-month Assessment|Acutely ill|2|||
125498207|NCT03137459|451455578|FG001|4-month Assessment|Acutely ill|3|||
125498208|NCT03137459|451455577|FG000|6-months|Lost to Follow-up|14|||
125498209|NCT03137459|451455578|FG001|6-months|Lost to Follow-up|11|||
125498210|NCT03137459|451455577|FG000|6-months|Death|0|||
125498211|NCT03137459|451455578|FG001|6-months|Death|2|||
125498212|NCT03137459|451455577|FG000|6-months|Refused assessment|6|||
125498213|NCT03137459|451455578|FG001|6-months|Refused assessment|3|||
125498214|NCT03137459|451455577|FG000|6-months|Acutely ill|1|||
125498215|NCT03137459|451455578|FG001|6-months|Acutely ill|1|||
125498216|NCT01970878|451455579|FG000|Overall Study|Withdrawal by Subject|11|||
125498217|NCT01970878|451455580|FG001|Overall Study|Withdrawal by Subject|10|||
125498218|NCT01970878|451455581|FG002|Overall Study|Withdrawal by Subject|14|||
125498219|NCT01970878|451455582|FG003|Overall Study|Withdrawal by Subject|7|||
125498220|NCT01970878|451455579|FG000|Overall Study|Lost to Follow-up|1|||
125498221|NCT01970878|451455580|FG001|Overall Study|Lost to Follow-up|3|||
125498222|NCT01970878|451455581|FG002|Overall Study|Lost to Follow-up|2|||
125498223|NCT01970878|451455582|FG003|Overall Study|Lost to Follow-up|4|||
125498224|NCT01970878|451455579|FG000|Overall Study|Administrative Reasons|1|||
125498225|NCT01970878|451455580|FG001|Overall Study|Administrative Reasons|0|||
125498226|NCT01970878|451455581|FG002|Overall Study|Administrative Reasons|0|||
125498227|NCT01970878|451455582|FG003|Overall Study|Administrative Reasons|4|||
125498228|NCT01970878|451455579|FG000|Overall Study|Lack of Efficacy|2|||
125498229|NCT01970878|451455580|FG001|Overall Study|Lack of Efficacy|1|||
125304529|NCT00620113|450741337|FG002|Overall Study|Withdrawal by Subject|3|||
125304530|NCT00620113|450741338|FG003|Overall Study|Withdrawal by Subject|5|||
125304531|NCT02461745|450741341|FG000|Overall Study|Lack of Efficacy|9|||
125498230|NCT01970878|451455581|FG002|Overall Study|Lack of Efficacy|2|||
125498231|NCT01970878|451455582|FG003|Overall Study|Lack of Efficacy|0|||
125498232|NCT01970878|451455579|FG000|Overall Study|Adverse Event|12|||
125498233|NCT01970878|451455580|FG001|Overall Study|Adverse Event|7|||
125498234|NCT01970878|451455581|FG002|Overall Study|Adverse Event|4|||
125498235|NCT01970878|451455582|FG003|Overall Study|Adverse Event|3|||
125498236|NCT01970878|451455579|FG000|Overall Study|Protocol Specified Criteria|10|||
125498237|NCT01970878|451455580|FG001|Overall Study|Protocol Specified Criteria|4|||
125498238|NCT01970878|451455581|FG002|Overall Study|Protocol Specified Criteria|3|||
125498239|NCT01970878|451455582|FG003|Overall Study|Protocol Specified Criteria|6|||
125498240|NCT01970878|451455579|FG000|Overall Study|Physician Decision|0|||
125498241|NCT01970878|451455580|FG001|Overall Study|Physician Decision|1|||
125498242|NCT01970878|451455581|FG002|Overall Study|Physician Decision|1|||
125498243|NCT01970878|451455582|FG003|Overall Study|Physician Decision|0|||
125498244|NCT01970878|451455579|FG000|Overall Study|No Completion Status|0|||
125498245|NCT01970878|451455580|FG001|Overall Study|No Completion Status|1|||
125498246|NCT01970878|451455581|FG002|Overall Study|No Completion Status|0|||
125498247|NCT01970878|451455582|FG003|Overall Study|No Completion Status|0|||
125498248|NCT00925548|451455584|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
125498249|NCT00925548|451455585|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
125498250|NCT04921358|451455586|FG000|Overall Study|Withdrawal by Subject|6|||
125498251|NCT04921358|451455587|FG001|Overall Study|Withdrawal by Subject|13|||
125498252|NCT04921358|451455586|FG000|Overall Study|Lost to Follow-up|3|||
125498253|NCT04921358|451455587|FG001|Overall Study|Lost to Follow-up|6|||
125498254|NCT04921358|451455586|FG000|Overall Study|Study Terminated by Sponsor|86|||
125498255|NCT04921358|451455587|FG001|Overall Study|Study Terminated by Sponsor|89|||
125498256|NCT04921358|451455586|FG000|Overall Study|Death|92|||
125498257|NCT04921358|451455587|FG001|Overall Study|Death|82|||
125498258|NCT02278796|451455588|FG000|Overall Study|Death|2|||
125498259|NCT02278796|451455589|FG001|Overall Study|Death|3|||
125498260|NCT04926857|451455590|FG000|Overall Study|Withdrawal by Subject|40|||
125498261|NCT04926857|451455590|FG000|Overall Study|Death|9|||
125498262|NCT04926857|451455590|FG000|Overall Study|Study product no longer in use|44|||
125498263|NCT04926857|451455590|FG000|Overall Study|Inadequate data to address primary objective|16|||
125498264|NCT02372799|451455595|FG000|Treatment Period|Adverse Event|3|||
125498265|NCT02372799|451455596|FG001|Treatment Period|Adverse Event|10|||
125498266|NCT02372799|451455597|FG002|Treatment Period|Adverse Event|6|||
125498267|NCT02372799|451455595|FG000|Treatment Period|Insufficient therapeutic response|2|||
125498268|NCT02372799|451455596|FG001|Treatment Period|Insufficient therapeutic response|2|||
125498269|NCT02372799|451455597|FG002|Treatment Period|Insufficient therapeutic response|0|||
125498270|NCT02372799|451455595|FG000|Treatment Period|Withdrawal by Subject|10|||
125498271|NCT02372799|451455596|FG001|Treatment Period|Withdrawal by Subject|10|||
125498272|NCT02372799|451455597|FG002|Treatment Period|Withdrawal by Subject|2|||
125498273|NCT02372799|451455595|FG000|Treatment Period|Lost to Follow-up|11|||
125498274|NCT02372799|451455596|FG001|Treatment Period|Lost to Follow-up|5|||
125498275|NCT02372799|451455597|FG002|Treatment Period|Lost to Follow-up|3|||
125498276|NCT02372799|451455595|FG000|Treatment Period|Protocol Violation|3|||
125498277|NCT02372799|451455596|FG001|Treatment Period|Protocol Violation|0|||
125498278|NCT02372799|451455597|FG002|Treatment Period|Protocol Violation|0|||
125498279|NCT02372799|451455595|FG000|Treatment Period|Non-compliance with study drug|4|||
125498280|NCT02372799|451455596|FG001|Treatment Period|Non-compliance with study drug|4|||
125498281|NCT02372799|451455597|FG002|Treatment Period|Non-compliance with study drug|4|||
125498282|NCT02372799|451455595|FG000|Treatment Period|Miscellaneous Reasons|1|||
125498283|NCT02372799|451455596|FG001|Treatment Period|Miscellaneous Reasons|1|||
125498284|NCT02372799|451455597|FG002|Treatment Period|Miscellaneous Reasons|0|||
125498285|NCT02372799|451455595|FG000|Down-taper Period|Lost to Follow-up|1|||
125498286|NCT02372799|451455596|FG001|Down-taper Period|Lost to Follow-up|2|||
125498287|NCT02372799|451455597|FG002|Down-taper Period|Lost to Follow-up|2|||
125498288|NCT02637063|451455599|FG000|Overall Study|Lost to Follow-up|3|||
125498289|NCT02637063|451455600|FG001|Overall Study|Lost to Follow-up|2|||
125498290|NCT02637063|451455601|FG002|Overall Study|Lost to Follow-up|3|||
125498291|NCT02637063|451455599|FG000|Overall Study|Withdrawal by Subject|2|||
125498292|NCT02637063|451455600|FG001|Overall Study|Withdrawal by Subject|2|||
125498293|NCT02637063|451455601|FG002|Overall Study|Withdrawal by Subject|3|||
125498294|NCT00491400|451455602|FG000|Overall Study|Withdrawal by Subject|5|||
125498295|NCT00491400|451455603|FG001|Overall Study|Withdrawal by Subject|4|||
125498296|NCT00747006|451455604|FG000|Overall Study|Adverse Event|1|||
125498297|NCT00747006|451455605|FG001|Overall Study|Adverse Event|0|||
125498298|NCT00747006|451455606|FG002|Overall Study|Adverse Event|0|||
125498299|NCT00747006|451455604|FG000|Overall Study|Lost to Follow-up|0|||
125498300|NCT00747006|451455605|FG001|Overall Study|Lost to Follow-up|1|||
125498301|NCT00747006|451455606|FG002|Overall Study|Lost to Follow-up|0|||
125498302|NCT00747006|451455604|FG000|Overall Study|Physician Decision|2|||
125498303|NCT00747006|451455605|FG001|Overall Study|Physician Decision|0|||
125498304|NCT00747006|451455606|FG002|Overall Study|Physician Decision|1|||
125498305|NCT00345046|451455611|FG000|Overall Study|Protocol Violation|1|||
125498306|NCT00345046|451455612|FG001|Overall Study|Protocol Violation|1|||
125498307|NCT00345046|451455613|FG002|Overall Study|Protocol Violation|2|||
125498308|NCT02824198|451455614|FG000|Overall Study|Non-compliance with the protocol|5|||
125498309|NCT02824198|451455615|FG001|Overall Study|Non-compliance with the protocol|1|||
125498310|NCT02824198|451455614|FG000|Overall Study|Lost to Follow-up|5|||
125498311|NCT02824198|451455615|FG001|Overall Study|Lost to Follow-up|2|||
125498312|NCT02824198|451455614|FG000|Overall Study|Withdrawal by Subject|5|||
125498313|NCT02824198|451455615|FG001|Overall Study|Withdrawal by Subject|0|||
125498314|NCT00562094|451455616|FG000|Overall Study|Lost to Follow-up|62|||
125498315|NCT03689946|451455619|FG000|Overall Study|Withdrawal by Subject|3|||
125498316|NCT03689946|451455619|FG000|Overall Study|Lost to Follow-up|3|||
125498317|NCT03689946|451455619|FG000|Overall Study|Data corruption|2|||
125498318|NCT01555138|451455620|FG000|Overall Study|Death|0|||
125498319|NCT01555138|451455621|FG001|Overall Study|Death|1|||
125498320|NCT01555138|451455620|FG000|Overall Study|Lost to Follow-up|1|||
125498321|NCT01555138|451455621|FG001|Overall Study|Lost to Follow-up|0|||
125498322|NCT01555138|451455620|FG000|Overall Study|Abnormal Lab reults|1|||
125498323|NCT01555138|451455621|FG001|Overall Study|Abnormal Lab reults|3|||
125498324|NCT01555138|451455620|FG000|Overall Study|Lack of Efficacy|2|||
125498325|NCT01555138|451455621|FG001|Overall Study|Lack of Efficacy|2|||
125498326|NCT01555138|451455620|FG000|Overall Study|Protocol Violation|5|||
125498327|NCT01555138|451455621|FG001|Overall Study|Protocol Violation|3|||
125498328|NCT01555138|451455620|FG000|Overall Study|Administrative problems|8|||
125498329|NCT01555138|451455621|FG001|Overall Study|Administrative problems|0|||
125498330|NCT01555138|451455620|FG000|Overall Study|Withdrawal by Subject|16|||
125498331|NCT01555138|451455621|FG001|Overall Study|Withdrawal by Subject|15|||
125498332|NCT01555138|451455620|FG000|Overall Study|Adverse Event|14|||
125498333|NCT01555138|451455621|FG001|Overall Study|Adverse Event|14|||
125498334|NCT01613417|451455622|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
125498335|NCT01613417|451455623|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
125498336|NCT04608409|451455624|FG000|Overall Study|Physician Decision|1|||
125498337|NCT04608409|451455625|FG001|Overall Study|Physician Decision|1|||
125498338|NCT04608409|451455626|FG002|Overall Study|Physician Decision|2|||
125498339|NCT00599196|451455627|FG000|Overall Study|Lack of Efficacy|22|||
125498340|NCT00599196|451455627|FG000|Overall Study|Adverse Event|93|||
125498341|NCT00599196|451455627|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
125498342|NCT00599196|451455627|FG000|Overall Study|Subject withdrew consent|43|||
125498343|NCT00599196|451455627|FG000|Overall Study|Study ended per sponsor|197|||
125498344|NCT00599196|451455627|FG000|Overall Study|Lost to Follow-up|17|||
125498345|NCT00599196|451455627|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
125498346|NCT00599196|451455627|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
125498347|NCT00599196|451455627|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
125498348|NCT00599196|451455627|FG000|Overall Study|Other: Pt Moved To Australia|1|||
125498349|NCT00599196|451455627|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
125498350|NCT00599196|451455627|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
125498351|NCT04497415|451455645|FG000|Overall Study|Lost to Follow-up|43|||
125498352|NCT04497415|451455646|FG001|Overall Study|Lost to Follow-up|27|||
125498353|NCT00734578|451455649|FG000|Overall Study|Adverse Event|4|||
125498354|NCT00734578|451455650|FG001|Overall Study|Adverse Event|6|||
125498355|NCT00734578|451455651|FG002|Overall Study|Adverse Event|1|||
125498356|NCT00734578|451455649|FG000|Overall Study|Protocol Violation|8|||
125498357|NCT00734578|451455650|FG001|Overall Study|Protocol Violation|6|||
125498358|NCT00734578|451455651|FG002|Overall Study|Protocol Violation|3|||
125498359|NCT00734578|451455649|FG000|Overall Study|Withdrawal by Subject|7|||
125498360|NCT00734578|451455650|FG001|Overall Study|Withdrawal by Subject|8|||
125498361|NCT00734578|451455651|FG002|Overall Study|Withdrawal by Subject|11|||
125498362|NCT00734578|451455649|FG000|Overall Study|Lost to Follow-up|9|||
125498363|NCT00734578|451455650|FG001|Overall Study|Lost to Follow-up|3|||
125498364|NCT00734578|451455651|FG002|Overall Study|Lost to Follow-up|5|||
125498365|NCT00734578|451455649|FG000|Overall Study|Lack of Efficacy|3|||
125498366|NCT00734578|451455650|FG001|Overall Study|Lack of Efficacy|2|||
125498367|NCT00734578|451455651|FG002|Overall Study|Lack of Efficacy|5|||
125498368|NCT00734578|451455649|FG000|Overall Study|Randomized in error|1|||
125498369|NCT00734578|451455650|FG001|Overall Study|Randomized in error|0|||
125498370|NCT00734578|451455651|FG002|Overall Study|Randomized in error|0|||
125498371|NCT00734578|451455649|FG000|Overall Study|Exclusion criteria|1|||
125498372|NCT00734578|451455650|FG001|Overall Study|Exclusion criteria|0|||
125498373|NCT00734578|451455651|FG002|Overall Study|Exclusion criteria|0|||
125498374|NCT02085941|451455655|FG000|Overall Study|Lack of Efficacy|1|||
125498375|NCT02085941|451455656|FG001|Overall Study|Lack of Efficacy|0|||
125498376|NCT02085941|451455655|FG000|Overall Study|Death|6|||
125498377|NCT02085941|451455656|FG001|Overall Study|Death|1|||
125498378|NCT02085941|451455655|FG000|Overall Study|Lost to Follow-up|1|||
125498379|NCT02085941|451455656|FG001|Overall Study|Lost to Follow-up|0|||
125498380|NCT02085941|451455655|FG000|Overall Study|Physician Decision|0|||
125498381|NCT02085941|451455656|FG001|Overall Study|Physician Decision|2|||
125498382|NCT04652726|451455661|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
125498383|NCT04652726|451455662|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
125498384|NCT04652726|451455663|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
125498385|NCT04652726|451455661|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
125498386|NCT04652726|451455662|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
125498387|NCT04652726|451455663|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
125498388|NCT02157116|451455664|FG000|Overall Study|Withdrawal by Subject|4|||
125498389|NCT02157116|451455664|FG000|Overall Study|Physician Decision|3|||
125498390|NCT02157116|451455664|FG000|Overall Study|Failed Screening|2|||
125498391|NCT00093496|451455665|FG000|Overall Study|Protocol Violation|1|||
125498392|NCT00093496|451455666|FG001|Overall Study|Protocol Violation|3|||
125498393|NCT03274076|451455668|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
125498394|NCT03274076|451455669|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
125498395|NCT03274076|451455670|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
125498396|NCT03274076|451455671|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
125498397|NCT03274076|451455668|FG000|24 Weeks Open Label|Adverse Event|0|||
125498398|NCT03274076|451455669|FG001|24 Weeks Open Label|Adverse Event|0|||
125498399|NCT03274076|451455670|FG002|24 Weeks Open Label|Adverse Event|2|||
125498400|NCT03274076|451455671|FG003|24 Weeks Open Label|Adverse Event|0|||
125498401|NCT03274076|451455668|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
125498402|NCT03274076|451455669|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
125498403|NCT03274076|451455670|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
125498404|NCT03274076|451455671|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
125498405|NCT00795184|451455672|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
125498406|NCT00795184|451455673|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
125498407|NCT02079649|451455676|FG000|Overall Study|Lost to Follow-up|0|||
125498408|NCT02079649|451455677|FG001|Overall Study|Lost to Follow-up|0|||
125498409|NCT02079649|451455678|FG002|Overall Study|Lost to Follow-up|0|||
125498410|NCT02079649|451455679|FG003|Overall Study|Lost to Follow-up|1|||
125498411|NCT02079649|451455676|FG000|Overall Study|Withdrawal by Subject|0|||
125498412|NCT02079649|451455677|FG001|Overall Study|Withdrawal by Subject|0|||
125498413|NCT02079649|451455678|FG002|Overall Study|Withdrawal by Subject|0|||
125498414|NCT02079649|451455679|FG003|Overall Study|Withdrawal by Subject|1|||
125498415|NCT02079649|451455676|FG000|Overall Study|Randomization error (prior to treatment)|1|||
125304532|NCT02461745|450741342|FG001|Overall Study|Lack of Efficacy|1|||
125304533|NCT02461745|450741341|FG000|Overall Study|Lost to Follow-up|2|||
125304534|NCT02461745|450741342|FG001|Overall Study|Lost to Follow-up|2|||
125304535|NCT02461745|450741341|FG000|Overall Study|Withdrawal by Subject|3|||
125304536|NCT02461745|450741342|FG001|Overall Study|Withdrawal by Subject|1|||
125304537|NCT00211887|450741345|FG000|Overall Study|Adverse Event|8|||
125304538|NCT00211887|450741346|FG001|Overall Study|Adverse Event|4|||
125304539|NCT00211887|450741347|FG002|Overall Study|Adverse Event|6|||
125304540|NCT00211887|450741345|FG000|Overall Study|Death|1|||
125304541|NCT00211887|450741346|FG001|Overall Study|Death|1|||
125304542|NCT00211887|450741347|FG002|Overall Study|Death|1|||
125304543|NCT00211887|450741345|FG000|Overall Study|Lost to Follow-up|28|||
125304544|NCT00211887|450741346|FG001|Overall Study|Lost to Follow-up|13|||
125304545|NCT00211887|450741347|FG002|Overall Study|Lost to Follow-up|9|||
125304546|NCT00211887|450741345|FG000|Overall Study|Non-medical reason|31|||
125304547|NCT00211887|450741346|FG001|Overall Study|Non-medical reason|14|||
125304548|NCT00211887|450741347|FG002|Overall Study|Non-medical reason|8|||
125304549|NCT00211887|450741345|FG000|Overall Study|Other medical reason|15|||
125304550|NCT00211887|450741346|FG001|Overall Study|Other medical reason|11|||
125304551|NCT00211887|450741347|FG002|Overall Study|Other medical reason|7|||
125304552|NCT00211887|450741345|FG000|Overall Study|Side effects|19|||
125498416|NCT02079649|451455677|FG001|Overall Study|Randomization error (prior to treatment)|0|||
125498417|NCT02079649|451455678|FG002|Overall Study|Randomization error (prior to treatment)|1|||
125498418|NCT02079649|451455679|FG003|Overall Study|Randomization error (prior to treatment)|0|||
125498419|NCT00853580|451455699|FG000|Overall Study|Lost to Follow-up|3|||
125498420|NCT00853580|451455700|FG001|Overall Study|Lost to Follow-up|5|||
125498421|NCT00853580|451455699|FG000|Overall Study|Protocol Violation|2|||
125498422|NCT00853580|451455700|FG001|Overall Study|Protocol Violation|1|||
125498423|NCT00853580|451455699|FG000|Overall Study|Withdrawal by Subject|2|||
125498424|NCT00853580|451455700|FG001|Overall Study|Withdrawal by Subject|8|||
125498425|NCT00853580|451455699|FG000|Overall Study|Commenced contraindicated therapy|0|||
125498426|NCT00853580|451455700|FG001|Overall Study|Commenced contraindicated therapy|2|||
125498427|NCT01968967|451455703|FG000|Treatment Period|Other|22|||
125498428|NCT01968967|451455704|FG001|Treatment Period|Other|22|||
125498429|NCT01968967|451455705|FG002|Treatment Period|Other|0|||
125498430|NCT01968967|451455706|FG003|Treatment Period|Other|0|||
125498431|NCT01968967|451455707|FG004|Treatment Period|Other|0|||
125498432|NCT01968967|451455703|FG000|Treatment Period|Withdrawal by Subject|71|||
125498433|NCT01968967|451455704|FG001|Treatment Period|Withdrawal by Subject|61|||
125498434|NCT01968967|451455705|FG002|Treatment Period|Withdrawal by Subject|0|||
125498435|NCT01968967|451455706|FG003|Treatment Period|Withdrawal by Subject|0|||
125498436|NCT01968967|451455707|FG004|Treatment Period|Withdrawal by Subject|0|||
125498437|NCT01968967|451455703|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
125498438|NCT01968967|451455704|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
125498439|NCT01968967|451455705|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
125498440|NCT01968967|451455706|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
125498441|NCT01968967|451455707|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
125498442|NCT01968967|451455703|FG000|Treatment Period|Lost to Follow-up|26|||
125498443|NCT01968967|451455704|FG001|Treatment Period|Lost to Follow-up|31|||
125498444|NCT01968967|451455705|FG002|Treatment Period|Lost to Follow-up|0|||
125498445|NCT01968967|451455706|FG003|Treatment Period|Lost to Follow-up|0|||
125498446|NCT01968967|451455707|FG004|Treatment Period|Lost to Follow-up|0|||
125304553|NCT00211887|450741346|FG001|Overall Study|Side effects|13|||
125304554|NCT00211887|450741347|FG002|Overall Study|Side effects|5|||
125304555|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Adverse Event|33|||
125304556|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
125304557|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
125304558|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
125498447|NCT01968967|451455703|FG000|Treatment Period|Protocol Violation|1|||
125498448|NCT01968967|451455704|FG001|Treatment Period|Protocol Violation|2|||
125498449|NCT01968967|451455705|FG002|Treatment Period|Protocol Violation|0|||
125498450|NCT01968967|451455706|FG003|Treatment Period|Protocol Violation|0|||
125498451|NCT01968967|451455707|FG004|Treatment Period|Protocol Violation|0|||
125498452|NCT01968967|451455703|FG000|Treatment Period|Adverse Event|9|||
125498453|NCT01968967|451455704|FG001|Treatment Period|Adverse Event|8|||
125498454|NCT01968967|451455705|FG002|Treatment Period|Adverse Event|0|||
125498455|NCT01968967|451455706|FG003|Treatment Period|Adverse Event|0|||
125498456|NCT01968967|451455707|FG004|Treatment Period|Adverse Event|0|||
125498457|NCT01968967|451455703|FG000|Treatment Period|Death|9|||
125498458|NCT01968967|451455704|FG001|Treatment Period|Death|2|||
125498459|NCT01968967|451455705|FG002|Treatment Period|Death|0|||
125498460|NCT01968967|451455706|FG003|Treatment Period|Death|0|||
125498461|NCT01968967|451455707|FG004|Treatment Period|Death|0|||
125498462|NCT01968967|451455703|FG000|Treatment Period|Randomized Not Treated|6|||
125498463|NCT01968967|451455704|FG001|Treatment Period|Randomized Not Treated|5|||
125498464|NCT01968967|451455705|FG002|Treatment Period|Randomized Not Treated|0|||
125498465|NCT01968967|451455706|FG003|Treatment Period|Randomized Not Treated|0|||
125498466|NCT01968967|451455707|FG004|Treatment Period|Randomized Not Treated|0|||
125498467|NCT01968967|451455703|FG000|Extension Period|Withdrew Consent|0|||
125498468|NCT01968967|451455704|FG001|Extension Period|Withdrew Consent|0|||
125498469|NCT01968967|451455705|FG002|Extension Period|Withdrew Consent|2|||
125498470|NCT01968967|451455706|FG003|Extension Period|Withdrew Consent|0|||
125498471|NCT01968967|451455707|FG004|Extension Period|Withdrew Consent|5|||
125498472|NCT01170208|451455708|FG000|Overall Study|Withdrawal by Subject|5|||
125498473|NCT01170208|451455709|FG001|Overall Study|Withdrawal by Subject|0|||
125498474|NCT01170208|451455710|FG002|Overall Study|Withdrawal by Subject|1|||
125498475|NCT01170208|451455708|FG000|Overall Study|Protocol Violation|1|||
125498476|NCT01170208|451455709|FG001|Overall Study|Protocol Violation|0|||
125498477|NCT01170208|451455710|FG002|Overall Study|Protocol Violation|1|||
125498478|NCT01160354|451455725|FG000|Overall Study|Death|0|||
125498479|NCT01160354|451455726|FG001|Overall Study|Death|1|||
125498480|NCT01160354|451455727|FG002|Overall Study|Death|1|||
125498481|NCT00853593|451455735|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
125498482|NCT00853593|451455735|FG000|Overall Study|Model 4396 lead not attempted|29|||
125498483|NCT00853593|451455735|FG000|Overall Study|Implant not attempted|4|||
125498484|NCT00600353|451455739|FG000|Overall Study|history of malignancy within 5 years|1|||
125498485|NCT00600353|451455740|FG001|Overall Study|history of malignancy within 5 years|0|||
125498486|NCT00600353|451455739|FG000|Overall Study|History of prepartive regimen|0|||
125498487|NCT00600353|451455740|FG001|Overall Study|History of prepartive regimen|1|||
125498488|NCT05966155|451455741|FG000|Overall Study|Death|1|||
125498489|NCT05966155|451455742|FG001|Overall Study|Death|2|||
125498490|NCT05966155|451455741|FG000|Overall Study|Lost to Follow-up|63|||
125498491|NCT05966155|451455742|FG001|Overall Study|Lost to Follow-up|67|||
125498492|NCT05966155|451455741|FG000|Overall Study|Protocol Violation|1|||
125498493|NCT05966155|451455742|FG001|Overall Study|Protocol Violation|0|||
125498494|NCT05966155|451455741|FG000|Overall Study|Withdrawal by Subject|8|||
125498495|NCT05966155|451455742|FG001|Overall Study|Withdrawal by Subject|9|||
125498496|NCT05966155|451455741|FG000|Overall Study|Enrolled Erroneously|0|||
125498497|NCT05966155|451455742|FG001|Overall Study|Enrolled Erroneously|1|||
125498498|NCT05966155|451455741|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
125498499|NCT05966155|451455742|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
125498500|NCT02743819|451455743|FG000|Overall Study|Lack of Efficacy|5|||
125498501|NCT02743819|451455743|FG000|Overall Study|Death|2|||
125498502|NCT02743819|451455743|FG000|Overall Study|Adverse Event|1|||
125498503|NCT00553332|451455750|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
125498504|NCT02235298|451455752|FG000|Overall Study|Lost to Follow-up|6|||
125498505|NCT02235298|451455753|FG001|Overall Study|Lost to Follow-up|5|||
125498506|NCT02235298|451455752|FG000|Overall Study|Adverse Event|2|||
125498507|NCT02235298|451455753|FG001|Overall Study|Adverse Event|2|||
125498508|NCT02235298|451455752|FG000|Overall Study|Withdrawal by Subject|0|||
125304559|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Physician Decision|6|||
125304560|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
125304561|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
125304562|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
125304563|NCT00965419|450741351|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
125304564|NCT00965419|450741351|FG000|Follow-up Phase|Adverse Event|9|||
125304565|NCT00965419|450741351|FG000|Follow-up Phase|Protocol Violation|4|||
125304566|NCT00965419|450741351|FG000|Follow-up Phase|Withdrawal by Subject|8|||
125498509|NCT02235298|451455753|FG001|Overall Study|Withdrawal by Subject|1|||
125498510|NCT03683576|451455756|FG000|Overall Study|Withdrawal by Subject|2|||
125304567|NCT00965419|450741351|FG000|Follow-up Phase|Physician Decision|4|||
125498511|NCT03683576|451455757|FG001|Overall Study|Withdrawal by Subject|0|||
125498512|NCT03683576|451455758|FG002|Overall Study|Withdrawal by Subject|8|||
125498513|NCT03683576|451455759|FG003|Overall Study|Withdrawal by Subject|3|||
125498514|NCT03683576|451455756|FG000|Overall Study|Adverse Event|3|||
125498515|NCT03683576|451455757|FG001|Overall Study|Adverse Event|0|||
125498516|NCT03683576|451455758|FG002|Overall Study|Adverse Event|0|||
125498517|NCT03683576|451455759|FG003|Overall Study|Adverse Event|4|||
125498518|NCT03683576|451455756|FG000|Overall Study|Lack of Efficacy|1|||
125498519|NCT03683576|451455757|FG001|Overall Study|Lack of Efficacy|0|||
125498520|NCT03683576|451455758|FG002|Overall Study|Lack of Efficacy|1|||
125498521|NCT03683576|451455759|FG003|Overall Study|Lack of Efficacy|1|||
125498522|NCT03683576|451455756|FG000|Overall Study|Lost to Follow-up|0|||
125498523|NCT03683576|451455757|FG001|Overall Study|Lost to Follow-up|1|||
125498524|NCT03683576|451455758|FG002|Overall Study|Lost to Follow-up|2|||
125498525|NCT03683576|451455759|FG003|Overall Study|Lost to Follow-up|0|||
125498526|NCT03683576|451455756|FG000|Overall Study|Other, Not Specified|0|||
125498527|NCT03683576|451455757|FG001|Overall Study|Other, Not Specified|2|||
125498528|NCT03683576|451455758|FG002|Overall Study|Other, Not Specified|0|||
125498529|NCT03683576|451455759|FG003|Overall Study|Other, Not Specified|0|||
125498530|NCT03683576|451455756|FG000|Overall Study|Protocol Violation|0|||
125498531|NCT03683576|451455757|FG001|Overall Study|Protocol Violation|1|||
125498532|NCT03683576|451455758|FG002|Overall Study|Protocol Violation|1|||
125498533|NCT03683576|451455759|FG003|Overall Study|Protocol Violation|0|||
125498534|NCT01827839|451455760|FG000|Overall Study|Adverse Event|1|||
125498535|NCT01827839|451455760|FG000|Overall Study|Consent Withdrawal|2|||
125498536|NCT00491894|451455761|FG000|Overall Study|Adverse Event|14|||
125498537|NCT00491894|451455761|FG000|Overall Study|Withdrawal by Subject|5|||
125498538|NCT00491894|451455761|FG000|Overall Study|Death|3|||
125498539|NCT00491894|451455761|FG000|Overall Study|Lost to Follow-up|3|||
125498540|NCT00491894|451455761|FG000|Overall Study|Lack of Efficacy|2|||
125498541|NCT00491894|451455761|FG000|Overall Study|Other-Failed to meet any criteria|2|||
125498542|NCT00491894|451455761|FG000|Overall Study|Physician Decision|2|||
125498543|NCT00491894|451455761|FG000|Overall Study|Protocol Violation|2|||
125498544|NCT00491894|451455761|FG000|Overall Study|Other-Intake of prohibited medication|1|||
125498545|NCT03499964|451457576|FG000|Overall Study|Lack of Efficacy|6|||
125498546|NCT03499964|451457577|FG001|Overall Study|Lack of Efficacy|26|||
125498547|NCT03499964|451457576|FG000|Overall Study|Adverse Event|1|||
125498548|NCT03499964|451457577|FG001|Overall Study|Adverse Event|0|||
125498549|NCT03499964|451457576|FG000|Overall Study|Death|1|||
125498550|NCT03499964|451457577|FG001|Overall Study|Death|0|||
125498551|NCT03499964|451457576|FG000|Overall Study|Withdrawal by Subject|2|||
125498552|NCT03499964|451457577|FG001|Overall Study|Withdrawal by Subject|1|||
125498553|NCT03499964|451457576|FG000|Overall Study|Lost to Follow-up|1|||
125498554|NCT03499964|451457577|FG001|Overall Study|Lost to Follow-up|0|||
125498555|NCT03739866|451457581|FG000|Overall Study|Lost to Follow-up|0|||
125498556|NCT03739866|451457582|FG001|Overall Study|Lost to Follow-up|0|||
125498557|NCT03739866|451457583|FG002|Overall Study|Lost to Follow-up|0|||
125498558|NCT03739866|451457584|FG003|Overall Study|Lost to Follow-up|1|||
125498559|NCT03739866|451457585|FG004|Overall Study|Lost to Follow-up|0|||
125498560|NCT03739866|451457586|FG005|Overall Study|Lost to Follow-up|0|||
125498561|NCT03739866|451457587|FG006|Overall Study|Lost to Follow-up|0|||
125498562|NCT03739866|451457588|FG007|Overall Study|Lost to Follow-up|0|||
125498563|NCT03739866|451457581|FG000|Overall Study|Enrolled but not treated|0|||
125498564|NCT03739866|451457582|FG001|Overall Study|Enrolled but not treated|0|||
125498565|NCT03739866|451457583|FG002|Overall Study|Enrolled but not treated|1|||
125498566|NCT03739866|451457584|FG003|Overall Study|Enrolled but not treated|0|||
125498567|NCT03739866|451457585|FG004|Overall Study|Enrolled but not treated|1|||
125498568|NCT03739866|451457586|FG005|Overall Study|Enrolled but not treated|0|||
125498569|NCT03739866|451457587|FG006|Overall Study|Enrolled but not treated|0|||
125498570|NCT03739866|451457588|FG007|Overall Study|Enrolled but not treated|0|||
125498571|NCT01728324|451457589|FG000|Termination of DBV|Adverse Event|14|||
125498572|NCT01728324|451457590|FG001|Termination of DBV|Adverse Event|13|||
125498573|NCT01728324|451457591|FG002|Termination of DBV|Adverse Event|4|||
125498574|NCT01728324|451457589|FG000|Termination of DBV|Lack of Efficacy|14|||
125498575|NCT01728324|451457590|FG001|Termination of DBV|Lack of Efficacy|12|||
125498576|NCT01728324|451457591|FG002|Termination of DBV|Lack of Efficacy|8|||
125498577|NCT01728324|451457589|FG000|Termination of DBV|Withdrawal by Subject|9|||
125498578|NCT01728324|451457590|FG001|Termination of DBV|Withdrawal by Subject|6|||
125498579|NCT01728324|451457591|FG002|Termination of DBV|Withdrawal by Subject|2|||
125498580|NCT01728324|451457589|FG000|Termination of DBV|Other than stated|1|||
125498581|NCT01728324|451457590|FG001|Termination of DBV|Other than stated|3|||
125498582|NCT01728324|451457591|FG002|Termination of DBV|Other than stated|0|||
125498583|NCT01728324|451457589|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
125498584|NCT01728324|451457590|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
125498585|NCT01728324|451457591|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
125498586|NCT01728324|451457589|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
125498587|NCT01728324|451457590|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
125498588|NCT01728324|451457591|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
125498589|NCT01728324|451457589|FG000|Termination of FDV|Adverse Event|14|||
125498590|NCT01728324|451457590|FG001|Termination of FDV|Adverse Event|13|||
125498591|NCT01728324|451457591|FG002|Termination of FDV|Adverse Event|4|||
125498592|NCT01728324|451457589|FG000|Termination of FDV|Lack of Efficacy|14|||
125498593|NCT01728324|451457590|FG001|Termination of FDV|Lack of Efficacy|12|||
125498594|NCT01728324|451457591|FG002|Termination of FDV|Lack of Efficacy|8|||
125498595|NCT01728324|451457589|FG000|Termination of FDV|Withdrawal by Subject|9|||
125498596|NCT01728324|451457590|FG001|Termination of FDV|Withdrawal by Subject|6|||
125498597|NCT01728324|451457591|FG002|Termination of FDV|Withdrawal by Subject|2|||
125498598|NCT01728324|451457589|FG000|Termination of FDV|Other than stated|1|||
125498599|NCT01728324|451457590|FG001|Termination of FDV|Other than stated|3|||
125498600|NCT01728324|451457591|FG002|Termination of FDV|Other than stated|0|||
125498601|NCT01728324|451457589|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
125498602|NCT01728324|451457590|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
125498603|NCT01728324|451457591|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
125498604|NCT01728324|451457589|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
125498605|NCT01728324|451457590|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
125498606|NCT01728324|451457591|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
125498607|NCT01728324|451457589|FG000|Termination of RBV|Adverse Event|15|||
125498608|NCT01728324|451457590|FG001|Termination of RBV|Adverse Event|16|||
125498609|NCT01728324|451457591|FG002|Termination of RBV|Adverse Event|5|||
125498610|NCT01728324|451457589|FG000|Termination of RBV|Lack of Efficacy|14|||
125498611|NCT01728324|451457590|FG001|Termination of RBV|Lack of Efficacy|11|||
125498612|NCT01728324|451457591|FG002|Termination of RBV|Lack of Efficacy|7|||
125498613|NCT01728324|451457589|FG000|Termination of RBV|Withdrawal by Subject|9|||
125498614|NCT01728324|451457590|FG001|Termination of RBV|Withdrawal by Subject|5|||
125498615|NCT01728324|451457591|FG002|Termination of RBV|Withdrawal by Subject|2|||
125498616|NCT01728324|451457589|FG000|Termination of RBV|Other than stated|1|||
125498617|NCT01728324|451457590|FG001|Termination of RBV|Other than stated|3|||
125498618|NCT01728324|451457591|FG002|Termination of RBV|Other than stated|1|||
125498619|NCT01728324|451457589|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
125498620|NCT01728324|451457590|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
125498621|NCT01728324|451457591|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
125498622|NCT01728324|451457589|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
125498623|NCT01728324|451457590|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
125498624|NCT01728324|451457591|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
125498625|NCT03057600|451457594|FG000|Overall Study|Adverse Event|0|||
125498626|NCT03057600|451457595|FG001|Overall Study|Adverse Event|0|||
125498627|NCT03057600|451457596|FG002|Overall Study|Adverse Event|4|||
125498628|NCT03057600|451457597|FG003|Overall Study|Adverse Event|0|||
125498629|NCT03057600|451457594|FG000|Overall Study|Radiologic Disease Progression|8|||
125498630|NCT03057600|451457595|FG001|Overall Study|Radiologic Disease Progression|7|||
125498631|NCT03057600|451457596|FG002|Overall Study|Radiologic Disease Progression|13|||
125498632|NCT03057600|451457597|FG003|Overall Study|Radiologic Disease Progression|10|||
125498633|NCT03057600|451457594|FG000|Overall Study|Symptomatic Deterioration|0|||
125498634|NCT03057600|451457595|FG001|Overall Study|Symptomatic Deterioration|1|||
125498635|NCT03057600|451457596|FG002|Overall Study|Symptomatic Deterioration|1|||
125498636|NCT03057600|451457597|FG003|Overall Study|Symptomatic Deterioration|0|||
125498637|NCT03057600|451457594|FG000|Overall Study|Investigator Decision|0|||
125498638|NCT03057600|451457595|FG001|Overall Study|Investigator Decision|0|||
125498639|NCT03057600|451457596|FG002|Overall Study|Investigator Decision|1|||
125498640|NCT03057600|451457597|FG003|Overall Study|Investigator Decision|0|||
125498641|NCT03057600|451457594|FG000|Overall Study|Study Termination by Sponsor|0|||
125498642|NCT03057600|451457595|FG001|Overall Study|Study Termination by Sponsor|0|||
125498643|NCT03057600|451457596|FG002|Overall Study|Study Termination by Sponsor|0|||
125498644|NCT03057600|451457597|FG003|Overall Study|Study Termination by Sponsor|2|||
125498645|NCT03057600|451457594|FG000|Overall Study|Withdrawal by Subject|0|||
125498646|NCT03057600|451457595|FG001|Overall Study|Withdrawal by Subject|1|||
125498647|NCT03057600|451457596|FG002|Overall Study|Withdrawal by Subject|0|||
125498648|NCT03057600|451457597|FG003|Overall Study|Withdrawal by Subject|0|||
125498649|NCT03057600|451457594|FG000|Overall Study|Other, Not Specified|1|||
125498650|NCT03057600|451457595|FG001|Overall Study|Other, Not Specified|1|||
125498651|NCT03057600|451457596|FG002|Overall Study|Other, Not Specified|1|||
125498652|NCT03057600|451457597|FG003|Overall Study|Other, Not Specified|1|||
125498653|NCT03489369|451457598|FG000|Overall Study|Documented Progressive Disease|3|||
125498654|NCT03489369|451457599|FG001|Overall Study|Documented Progressive Disease|2|||
125498655|NCT03489369|451457600|FG002|Overall Study|Documented Progressive Disease|3|||
125498656|NCT03489369|451457601|FG003|Overall Study|Documented Progressive Disease|6|||
125498657|NCT03489369|451457598|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
125498658|NCT03489369|451457599|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
125498659|NCT03489369|451457600|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
125498660|NCT03489369|451457601|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
125498661|NCT03335488|451457602|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
125498662|NCT03335488|451457603|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
125498663|NCT03335488|451457602|FG000|Safety Extension Period|Adverse Event|1|||
125498664|NCT03335488|451457603|FG001|Safety Extension Period|Adverse Event|0|||
125498665|NCT03335488|451457602|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
125498666|NCT03335488|451457603|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
125498667|NCT00388726|451457604|FG000|Overall Study|Adverse Event|50|||
125498668|NCT00388726|451457605|FG001|Overall Study|Adverse Event|24|||
125498669|NCT00388726|451457604|FG000|Overall Study|Progressive Disease|336|||
125498670|NCT00388726|451457605|FG001|Overall Study|Progressive Disease|153|||
125498671|NCT00388726|451457604|FG000|Overall Study|Clinical Progression|61|||
125498672|NCT00388726|451457605|FG001|Overall Study|Clinical Progression|36|||
125498673|NCT00388726|451457604|FG000|Overall Study|Withdrawal by Subject|10|||
125498674|NCT00388726|451457605|FG001|Overall Study|Withdrawal by Subject|7|||
125498675|NCT00388726|451457604|FG000|Overall Study|Administrative|6|||
125498676|NCT00388726|451457605|FG001|Overall Study|Administrative|9|||
125498677|NCT00388726|451457604|FG000|Overall Study|Physician Decision|18|||
125498678|NCT00388726|451457605|FG001|Overall Study|Physician Decision|13|||
125498679|NCT00388726|451457604|FG000|Overall Study|Death|3|||
125498680|NCT00388726|451457605|FG001|Overall Study|Death|2|||
125498681|NCT01953692|451457606|FG000|Overall Study|Adverse Event|5|||
125498682|NCT01953692|451457607|FG001|Overall Study|Adverse Event|2|||
125498683|NCT01953692|451457608|FG002|Overall Study|Adverse Event|4|||
125498684|NCT01953692|451457609|FG003|Overall Study|Adverse Event|2|||
125498685|NCT01953692|451457610|FG004|Overall Study|Adverse Event|1|||
125498686|NCT01953692|451457611|FG005|Overall Study|Adverse Event|2|||
125498687|NCT01953692|451457612|FG006|Overall Study|Adverse Event|0|||
125498688|NCT01953692|451457613|FG007|Overall Study|Adverse Event|0|||
125498689|NCT01953692|451457614|FG008|Overall Study|Adverse Event|0|||
125498690|NCT01953692|451457606|FG000|Overall Study|Clinical Progression|0|||
125498691|NCT01953692|451457607|FG001|Overall Study|Clinical Progression|15|||
125498692|NCT01953692|451457608|FG002|Overall Study|Clinical Progression|7|||
125498693|NCT01953692|451457609|FG003|Overall Study|Clinical Progression|5|||
125498694|NCT01953692|451457610|FG004|Overall Study|Clinical Progression|0|||
125498695|NCT01953692|451457611|FG005|Overall Study|Clinical Progression|7|||
125498696|NCT01953692|451457612|FG006|Overall Study|Clinical Progression|20|||
125498697|NCT01953692|451457613|FG007|Overall Study|Clinical Progression|3|||
125498698|NCT01953692|451457614|FG008|Overall Study|Clinical Progression|3|||
125498699|NCT01953692|451457606|FG000|Overall Study|Death|5|||
125498700|NCT01953692|451457607|FG001|Overall Study|Death|0|||
125498701|NCT01953692|451457608|FG002|Overall Study|Death|2|||
125498702|NCT01953692|451457609|FG003|Overall Study|Death|2|||
125498703|NCT01953692|451457610|FG004|Overall Study|Death|1|||
125498704|NCT01953692|451457611|FG005|Overall Study|Death|3|||
125498705|NCT01953692|451457612|FG006|Overall Study|Death|6|||
125498706|NCT01953692|451457613|FG007|Overall Study|Death|2|||
125498707|NCT01953692|451457614|FG008|Overall Study|Death|1|||
125498708|NCT01953692|451457606|FG000|Overall Study|Excluded Medication|1|||
125498709|NCT01953692|451457607|FG001|Overall Study|Excluded Medication|0|||
125498710|NCT01953692|451457608|FG002|Overall Study|Excluded Medication|0|||
125498711|NCT01953692|451457609|FG003|Overall Study|Excluded Medication|0|||
125498712|NCT01953692|451457610|FG004|Overall Study|Excluded Medication|0|||
125498713|NCT01953692|451457611|FG005|Overall Study|Excluded Medication|0|||
125498714|NCT01953692|451457612|FG006|Overall Study|Excluded Medication|0|||
125498715|NCT01953692|451457613|FG007|Overall Study|Excluded Medication|0|||
125498716|NCT01953692|451457614|FG008|Overall Study|Excluded Medication|0|||
125498717|NCT01953692|451457606|FG000|Overall Study|Lost to Follow-up|1|||
125498718|NCT01953692|451457607|FG001|Overall Study|Lost to Follow-up|0|||
125498719|NCT01953692|451457608|FG002|Overall Study|Lost to Follow-up|3|||
125498720|NCT01953692|451457609|FG003|Overall Study|Lost to Follow-up|1|||
125498721|NCT01953692|451457610|FG004|Overall Study|Lost to Follow-up|0|||
125498722|NCT01953692|451457611|FG005|Overall Study|Lost to Follow-up|1|||
125498723|NCT01953692|451457612|FG006|Overall Study|Lost to Follow-up|0|||
125498724|NCT01953692|451457613|FG007|Overall Study|Lost to Follow-up|0|||
125498725|NCT01953692|451457614|FG008|Overall Study|Lost to Follow-up|0|||
125498726|NCT01953692|451457606|FG000|Overall Study|Physician Decision|11|||
125498727|NCT01953692|451457607|FG001|Overall Study|Physician Decision|4|||
125498728|NCT01953692|451457608|FG002|Overall Study|Physician Decision|2|||
125498729|NCT01953692|451457609|FG003|Overall Study|Physician Decision|2|||
125498730|NCT01953692|451457610|FG004|Overall Study|Physician Decision|1|||
125498731|NCT01953692|451457611|FG005|Overall Study|Physician Decision|2|||
125498732|NCT01953692|451457612|FG006|Overall Study|Physician Decision|4|||
125498733|NCT01953692|451457613|FG007|Overall Study|Physician Decision|1|||
125498734|NCT01953692|451457614|FG008|Overall Study|Physician Decision|0|||
125498735|NCT01953692|451457606|FG000|Overall Study|Protocol Violation|0|||
125498736|NCT01953692|451457607|FG001|Overall Study|Protocol Violation|2|||
125498737|NCT01953692|451457608|FG002|Overall Study|Protocol Violation|1|||
125498738|NCT01953692|451457609|FG003|Overall Study|Protocol Violation|0|||
125498739|NCT01953692|451457610|FG004|Overall Study|Protocol Violation|0|||
125498740|NCT01953692|451457611|FG005|Overall Study|Protocol Violation|0|||
125498741|NCT01953692|451457612|FG006|Overall Study|Protocol Violation|0|||
125498742|NCT01953692|451457613|FG007|Overall Study|Protocol Violation|1|||
125498743|NCT01953692|451457614|FG008|Overall Study|Protocol Violation|0|||
125498744|NCT01953692|451457606|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
125498745|NCT01953692|451457607|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
125498746|NCT01953692|451457608|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
125498747|NCT01953692|451457609|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
125498748|NCT01953692|451457610|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
125498749|NCT01953692|451457611|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
125498750|NCT01953692|451457612|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
125498751|NCT01953692|451457613|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
125498752|NCT01953692|451457614|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
125498753|NCT01953692|451457606|FG000|Overall Study|Withdrawal by Subject|4|||
125498754|NCT01953692|451457607|FG001|Overall Study|Withdrawal by Subject|2|||
125498755|NCT01953692|451457608|FG002|Overall Study|Withdrawal by Subject|1|||
125498756|NCT01953692|451457609|FG003|Overall Study|Withdrawal by Subject|2|||
125498757|NCT01953692|451457610|FG004|Overall Study|Withdrawal by Subject|0|||
125498758|NCT01953692|451457611|FG005|Overall Study|Withdrawal by Subject|3|||
125498759|NCT01953692|451457612|FG006|Overall Study|Withdrawal by Subject|2|||
125498760|NCT01953692|451457613|FG007|Overall Study|Withdrawal by Subject|1|||
125498761|NCT01953692|451457614|FG008|Overall Study|Withdrawal by Subject|1|||
125498762|NCT04638816|451457615|FG000|Overall Study|Withdrawal by Subject|0|||
125498763|NCT04638816|451457616|FG001|Overall Study|Withdrawal by Subject|1|||
125498764|NCT04638816|451457615|FG000|Overall Study|Lost to Follow-up|0|||
125498765|NCT04638816|451457616|FG001|Overall Study|Lost to Follow-up|1|||
125498766|NCT00109031|451457619|FG000|Overall Study|Adverse Event|0|||
125498767|NCT00109031|451457620|FG001|Overall Study|Adverse Event|0|||
125498768|NCT00109031|451457621|FG002|Overall Study|Adverse Event|1|||
125498769|NCT00109031|451457622|FG003|Overall Study|Adverse Event|0|||
125498770|NCT00109031|451457619|FG000|Overall Study|Withdrawal by Subject|0|||
125498771|NCT00109031|451457620|FG001|Overall Study|Withdrawal by Subject|1|||
125498772|NCT00109031|451457621|FG002|Overall Study|Withdrawal by Subject|0|||
125498773|NCT00109031|451457622|FG003|Overall Study|Withdrawal by Subject|0|||
125498774|NCT00109031|451457619|FG000|Overall Study|Physician Decision|0|||
125498775|NCT00109031|451457620|FG001|Overall Study|Physician Decision|1|||
125498776|NCT00109031|451457621|FG002|Overall Study|Physician Decision|0|||
125498777|NCT00109031|451457622|FG003|Overall Study|Physician Decision|0|||
125498778|NCT00109031|451457619|FG000|Overall Study|Protocol Violation|0|||
125498779|NCT00109031|451457620|FG001|Overall Study|Protocol Violation|0|||
125498780|NCT00109031|451457621|FG002|Overall Study|Protocol Violation|1|||
125498781|NCT00109031|451457622|FG003|Overall Study|Protocol Violation|0|||
125498782|NCT01822756|451457623|FG000|Overall Study|Adverse Event|0|||
125498783|NCT01822756|451457624|FG001|Overall Study|Adverse Event|0|||
125498784|NCT01822756|451457625|FG002|Overall Study|Adverse Event|0|||
125498785|NCT01822756|451457626|FG003|Overall Study|Adverse Event|2|||
125498786|NCT01822756|451457627|FG004|Overall Study|Adverse Event|0|||
125498787|NCT01822756|451457623|FG000|Overall Study|Disease progression|11|||
125498788|NCT01822756|451457624|FG001|Overall Study|Disease progression|1|||
125498789|NCT01822756|451457625|FG002|Overall Study|Disease progression|7|||
125498790|NCT01822756|451457626|FG003|Overall Study|Disease progression|2|||
125498791|NCT01822756|451457627|FG004|Overall Study|Disease progression|6|||
125498792|NCT01822756|451457623|FG000|Overall Study|Death|2|||
125498793|NCT01822756|451457624|FG001|Overall Study|Death|2|||
125498794|NCT01822756|451457625|FG002|Overall Study|Death|1|||
125498795|NCT01822756|451457626|FG003|Overall Study|Death|0|||
125498796|NCT01822756|451457627|FG004|Overall Study|Death|0|||
125498797|NCT01822756|451457623|FG000|Overall Study|Lost to Follow-up|1|||
125498798|NCT01822756|451457624|FG001|Overall Study|Lost to Follow-up|0|||
125498799|NCT01822756|451457625|FG002|Overall Study|Lost to Follow-up|1|||
125498800|NCT01822756|451457626|FG003|Overall Study|Lost to Follow-up|0|||
125498801|NCT01822756|451457627|FG004|Overall Study|Lost to Follow-up|1|||
125498802|NCT01822756|451457623|FG000|Overall Study|Physician Decision|0|||
125498803|NCT01822756|451457624|FG001|Overall Study|Physician Decision|1|||
125498804|NCT01822756|451457625|FG002|Overall Study|Physician Decision|0|||
125498805|NCT01822756|451457626|FG003|Overall Study|Physician Decision|0|||
125498806|NCT01822756|451457627|FG004|Overall Study|Physician Decision|0|||
125498807|NCT01822756|451457623|FG000|Overall Study|disease progression & patient preference|2|||
125498808|NCT01822756|451457624|FG001|Overall Study|disease progression & patient preference|0|||
125304568|NCT00965419|450741351|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
125304569|NCT00965419|450741351|FG000|Follow-up Phase|Lack of Efficacy|28|||
125498809|NCT01822756|451457625|FG002|Overall Study|disease progression & patient preference|1|||
125304570|NCT02927938|450741352|FG000|Overall Study|Death|0|||
125304571|NCT02927938|450741353|FG001|Overall Study|Death|1|||
125498810|NCT01822756|451457626|FG003|Overall Study|disease progression & patient preference|0|||
125498811|NCT01822756|451457627|FG004|Overall Study|disease progression & patient preference|0|||
125498812|NCT01328496|451457633|FG000|Overall Study|Significant Change in Health Status|1|||
125498813|NCT01328496|451457634|FG001|Overall Study|Significant Change in Health Status|0|||
125498814|NCT02309294|451457637|FG000|Overall Study|Withdrawal by Subject|2|||
125498815|NCT03520036|451457638|FG000|Overall Study|Adverse Event|1|||
125498816|NCT03520036|451457639|FG001|Overall Study|Adverse Event|2|||
125498817|NCT03520036|451457640|FG002|Overall Study|Adverse Event|0|||
125498818|NCT03520036|451457638|FG000|Overall Study|Protocol Violation|1|||
125498819|NCT03520036|451457639|FG001|Overall Study|Protocol Violation|0|||
125498820|NCT03520036|451457640|FG002|Overall Study|Protocol Violation|0|||
125498821|NCT03520036|451457638|FG000|Overall Study|Withdrawal by Subject|0|||
125498822|NCT03520036|451457639|FG001|Overall Study|Withdrawal by Subject|1|||
125498823|NCT03520036|451457640|FG002|Overall Study|Withdrawal by Subject|4|||
125498824|NCT03520036|451457638|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
125498825|NCT03520036|451457639|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
125498826|NCT03520036|451457640|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
125498827|NCT05426109|451457645|FG000|Overall Study|Withdrawal by Subject|0|||
125498828|NCT05426109|451457646|FG001|Overall Study|Withdrawal by Subject|1|||
125498829|NCT03102034|451457647|FG000|Overall Study|Withdrawal by Subject|1|||
125498830|NCT03102034|451457648|FG001|Overall Study|Withdrawal by Subject|0|||
125498831|NCT02222493|451457649|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
125498832|NCT02222493|451457650|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
125498833|NCT02222493|451457649|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
125498834|NCT02222493|451457650|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
125498835|NCT02222493|451457649|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
125498836|NCT02222493|451457650|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
125498837|NCT02222493|451457649|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
125498838|NCT02222493|451457650|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
125498839|NCT02222493|451457649|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
125498840|NCT02222493|451457650|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
125498841|NCT02222493|451457649|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
125498842|NCT02222493|451457650|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
125498843|NCT02222493|451457649|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
125498844|NCT02222493|451457650|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
125498845|NCT02222493|451457649|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
125498846|NCT02222493|451457650|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
125498847|NCT02222493|451457649|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
125498848|NCT02222493|451457650|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
125498849|NCT02222493|451457649|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
125498850|NCT02222493|451457650|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
125498851|NCT02222493|451457649|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
125498852|NCT02222493|451457650|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
125498853|NCT02222493|451457649|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
125498854|NCT02222493|451457650|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
125498855|NCT02222493|451457649|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
125498856|NCT02222493|451457650|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
125498857|NCT02222493|451457649|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
125498858|NCT02222493|451457650|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
125498859|NCT02222493|451457649|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
125498860|NCT02222493|451457650|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
125498861|NCT02222493|451457649|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
125498862|NCT02222493|451457650|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
125498863|NCT02222493|451457649|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
125498864|NCT02222493|451457650|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
125498865|NCT02222493|451457649|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
125498866|NCT02222493|451457650|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
125498867|NCT02222493|451457649|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
125498868|NCT02222493|451457650|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
125498869|NCT02222493|451457649|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
125498870|NCT02222493|451457650|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
125498871|NCT02222493|451457649|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
125498872|NCT02222493|451457650|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
125498873|NCT02222493|451457649|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
125498874|NCT02222493|451457650|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
125498875|NCT03611075|451457653|FG000|Overall Study|Physician Decision|0|||
125498876|NCT03611075|451457654|FG001|Overall Study|Physician Decision|1|||
125498877|NCT03611075|451457655|FG002|Overall Study|Physician Decision|1|||
125498878|NCT03611075|451457656|FG003|Overall Study|Physician Decision|0|||
125498879|NCT03611075|451457657|FG004|Overall Study|Physician Decision|0|||
125498880|NCT03611075|451457658|FG005|Overall Study|Physician Decision|0|||
125498881|NCT03611075|451457659|FG006|Overall Study|Physician Decision|0|||
125498882|NCT03611075|451457660|FG007|Overall Study|Physician Decision|0|||
125498883|NCT03611075|451457661|FG008|Overall Study|Physician Decision|0|||
125498884|NCT03611075|451457653|FG000|Overall Study|Lost to Follow-up|1|||
125498885|NCT03611075|451457654|FG001|Overall Study|Lost to Follow-up|0|||
125498886|NCT03611075|451457655|FG002|Overall Study|Lost to Follow-up|0|||
125498887|NCT03611075|451457656|FG003|Overall Study|Lost to Follow-up|2|||
125498888|NCT03611075|451457657|FG004|Overall Study|Lost to Follow-up|0|||
125498889|NCT03611075|451457658|FG005|Overall Study|Lost to Follow-up|0|||
125498890|NCT03611075|451457659|FG006|Overall Study|Lost to Follow-up|0|||
125498891|NCT03611075|451457660|FG007|Overall Study|Lost to Follow-up|0|||
125498892|NCT03611075|451457661|FG008|Overall Study|Lost to Follow-up|0|||
125498893|NCT03611075|451457653|FG000|Overall Study|Withdrawal by Subject|0|||
125498894|NCT03611075|451457654|FG001|Overall Study|Withdrawal by Subject|1|||
125498895|NCT03611075|451457655|FG002|Overall Study|Withdrawal by Subject|1|||
125498896|NCT03611075|451457656|FG003|Overall Study|Withdrawal by Subject|1|||
125498897|NCT03611075|451457657|FG004|Overall Study|Withdrawal by Subject|0|||
125498898|NCT03611075|451457658|FG005|Overall Study|Withdrawal by Subject|0|||
125498899|NCT03611075|451457659|FG006|Overall Study|Withdrawal by Subject|1|||
125498900|NCT03611075|451457660|FG007|Overall Study|Withdrawal by Subject|0|||
125498901|NCT03611075|451457661|FG008|Overall Study|Withdrawal by Subject|0|||
125498902|NCT03611075|451457653|FG000|Overall Study|Reason unknown|0|||
125498903|NCT03611075|451457654|FG001|Overall Study|Reason unknown|0|||
125498904|NCT03611075|451457655|FG002|Overall Study|Reason unknown|0|||
125498905|NCT03611075|451457656|FG003|Overall Study|Reason unknown|1|||
125498906|NCT03611075|451457657|FG004|Overall Study|Reason unknown|0|||
125498907|NCT03611075|451457658|FG005|Overall Study|Reason unknown|0|||
125498908|NCT03611075|451457659|FG006|Overall Study|Reason unknown|1|||
125498909|NCT03611075|451457660|FG007|Overall Study|Reason unknown|0|||
125498910|NCT03611075|451457661|FG008|Overall Study|Reason unknown|0|||
125498911|NCT00676091|451457662|FG000|Infant Series|Parent or legal guardian request|10|||
125498912|NCT00676091|451457663|FG001|Infant Series|Parent or legal guardian request|8|||
125498913|NCT00676091|451457662|FG000|Infant Series|Protocol Violation|6|||
125498914|NCT00676091|451457663|FG001|Infant Series|Protocol Violation|3|||
125498915|NCT00676091|451457662|FG000|Infant Series|Adverse Event|2|||
125498916|NCT00676091|451457663|FG001|Infant Series|Adverse Event|3|||
125498917|NCT00676091|451457662|FG000|Infant Series|Failed to return|1|||
125498918|NCT00676091|451457663|FG001|Infant Series|Failed to return|3|||
125498919|NCT00676091|451457662|FG000|Infant Series|Lost to Follow-up|1|||
125498920|NCT00676091|451457663|FG001|Infant Series|Lost to Follow-up|0|||
125498921|NCT00676091|451457662|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
125498922|NCT00676091|451457663|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
125498923|NCT00676091|451457662|FG000|After Infant Series|Adverse Event|0|||
125498924|NCT00676091|451457663|FG001|After Infant Series|Adverse Event|1|||
125498925|NCT00676091|451457662|FG000|After Infant Series|Protocol Violation|0|||
125498926|NCT00676091|451457663|FG001|After Infant Series|Protocol Violation|1|||
125498927|NCT00676091|451457662|FG000|After Infant Series|Failed to return|1|||
125498928|NCT00676091|451457663|FG001|After Infant Series|Failed to return|1|||
125498929|NCT00676091|451457662|FG000|Toddler Dose|Failed to return|2|||
125498930|NCT00676091|451457663|FG001|Toddler Dose|Failed to return|0|||
125498931|NCT00676091|451457662|FG000|Toddler Dose|Parent or legal guardian request|1|||
125498932|NCT00676091|451457663|FG001|Toddler Dose|Parent or legal guardian request|0|||
125498933|NCT01701401|451457667|FG000|Overall Study|Randomized But Not Treated|3|||
125498934|NCT01701401|451457668|FG001|Overall Study|Randomized But Not Treated|1|||
125498935|NCT01701401|451457669|FG002|Overall Study|Randomized But Not Treated|0|||
125498936|NCT01701401|451457670|FG003|Overall Study|Randomized But Not Treated|1|||
125498937|NCT01701401|451457667|FG000|Overall Study|Lost to Follow-up|5|||
125498938|NCT01701401|451457668|FG001|Overall Study|Lost to Follow-up|5|||
125498939|NCT01701401|451457669|FG002|Overall Study|Lost to Follow-up|1|||
125498940|NCT01701401|451457670|FG003|Overall Study|Lost to Follow-up|3|||
125498941|NCT01701401|451457667|FG000|Overall Study|Withdrew Consent|0|||
125498942|NCT01701401|451457668|FG001|Overall Study|Withdrew Consent|3|||
125498943|NCT01701401|451457669|FG002|Overall Study|Withdrew Consent|1|||
125498944|NCT01701401|451457670|FG003|Overall Study|Withdrew Consent|2|||
125498945|NCT01701401|451457667|FG000|Overall Study|Lack of Efficacy|1|||
125498946|NCT01701401|451457668|FG001|Overall Study|Lack of Efficacy|0|||
125498947|NCT01701401|451457669|FG002|Overall Study|Lack of Efficacy|2|||
125498948|NCT01701401|451457670|FG003|Overall Study|Lack of Efficacy|0|||
125498949|NCT01701401|451457667|FG000|Overall Study|Adverse Event|1|||
125498950|NCT01701401|451457668|FG001|Overall Study|Adverse Event|0|||
125498951|NCT01701401|451457669|FG002|Overall Study|Adverse Event|0|||
125498952|NCT01701401|451457670|FG003|Overall Study|Adverse Event|0|||
125498953|NCT01701401|451457667|FG000|Overall Study|Protocol Violation|0|||
125498954|NCT01701401|451457668|FG001|Overall Study|Protocol Violation|0|||
125498955|NCT01701401|451457669|FG002|Overall Study|Protocol Violation|1|||
125498956|NCT01701401|451457670|FG003|Overall Study|Protocol Violation|0|||
125498957|NCT00933270|451457671|FG000|Overall Study|Withdrawal by Subject|26|||
125498958|NCT00933270|451457671|FG000|Overall Study|Insufficient Follow-up|10|||
125498959|NCT00933270|451457671|FG000|Overall Study|Lost to Follow-up|14|||
125304572|NCT02927938|450741354|FG002|Overall Study|Death|0|||
125498960|NCT00933270|451457671|FG000|Overall Study|Adverse Event|1|||
125498961|NCT00933270|451457671|FG000|Overall Study|Missed Visit|2|||
125498962|NCT00933270|451457671|FG000|Overall Study|Death|24|||
125498963|NCT00933270|451457671|FG000|Overall Study|Moved or would not return|10|||
125498964|NCT01000805|451457672|FG000|Overall Study|Adverse Event|21|||
125498965|NCT01000805|451457673|FG001|Overall Study|Adverse Event|9|||
125498966|NCT01000805|451457672|FG000|Overall Study|Lack of Efficacy|5|||
125498967|NCT01000805|451457673|FG001|Overall Study|Lack of Efficacy|16|||
125498968|NCT01000805|451457672|FG000|Overall Study|Lost to Follow-up|16|||
125498969|NCT01000805|451457673|FG001|Overall Study|Lost to Follow-up|21|||
125498970|NCT01000805|451457672|FG000|Overall Study|Physician Decision|0|||
125498971|NCT01000805|451457673|FG001|Overall Study|Physician Decision|1|||
125498972|NCT01000805|451457672|FG000|Overall Study|Protocol Violation|12|||
125498973|NCT01000805|451457673|FG001|Overall Study|Protocol Violation|8|||
125498974|NCT01000805|451457672|FG000|Overall Study|Withdrawal by Subject|16|||
125498975|NCT01000805|451457673|FG001|Overall Study|Withdrawal by Subject|6|||
125498976|NCT01000805|451457672|FG000|Overall Study|Sponsor Decision|0|||
125498977|NCT01000805|451457673|FG001|Overall Study|Sponsor Decision|1|||
125498978|NCT00989196|451457674|FG000|Treatment Period|Lost to Follow-up|1|||
125498979|NCT00989196|451457675|FG001|Treatment Period|Lost to Follow-up|0|||
125498980|NCT03476798|451457678|FG000|Overall Study|Death|1|||
125498981|NCT03476798|451457678|FG000|Overall Study|Withdrawal by Subject|2|||
125498982|NCT03476798|451457678|FG000|Overall Study|Protocol Violation|2|||
125498983|NCT02409680|451457683|FG000|Overall Study|Lost to Follow-up|15|||
125498984|NCT02409680|451457684|FG001|Overall Study|Lost to Follow-up|30|||
125498985|NCT03343704|451457688|FG000|Overall Study|Refused to complete follow up|0|||
125498986|NCT03343704|451457689|FG001|Overall Study|Refused to complete follow up|1|||
125498987|NCT03343704|451457688|FG000|Overall Study|Death|0|||
125498988|NCT03343704|451457689|FG001|Overall Study|Death|1|||
125498989|NCT03343704|451457688|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
125498990|NCT03343704|451457689|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
125498991|NCT03789656|451457694|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
125498992|NCT03789656|451457695|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
125498993|NCT03789656|451457696|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
125498994|NCT03789656|451457697|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
125498995|NCT03789656|451457698|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
125498996|NCT03789656|451457694|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
125498997|NCT03789656|451457695|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
125498998|NCT03789656|451457696|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
125498999|NCT03789656|451457697|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
125499000|NCT03789656|451457698|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
125499001|NCT03789656|451457694|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
125499002|NCT03789656|451457695|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
125499003|NCT03789656|451457696|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
125499004|NCT03789656|451457697|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
125499005|NCT03789656|451457698|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
125499006|NCT03789656|451457694|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
125499007|NCT03789656|451457695|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
125499008|NCT03789656|451457696|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
125499009|NCT03789656|451457697|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
125499010|NCT03789656|451457698|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
125499011|NCT02434328|451457706|FG000|Overall Study|Adverse Event|9|||
125499012|NCT02434328|451457707|FG001|Overall Study|Adverse Event|4|||
125499013|NCT02434328|451457706|FG000|Overall Study|Lack of Efficacy|0|||
125499014|NCT02434328|451457707|FG001|Overall Study|Lack of Efficacy|2|||
125499015|NCT02434328|451457706|FG000|Overall Study|Physician Decision|0|||
125499016|NCT02434328|451457707|FG001|Overall Study|Physician Decision|1|||
125499017|NCT02434328|451457706|FG000|Overall Study|Withdrawal by Subject|12|||
125499018|NCT02434328|451457707|FG001|Overall Study|Withdrawal by Subject|21|||
125499019|NCT02434328|451457706|FG000|Overall Study|Death|4|||
125499020|NCT02434328|451457707|FG001|Overall Study|Death|7|||
125499021|NCT02434328|451457706|FG000|Overall Study|Lost to Follow-up|1|||
125499022|NCT02434328|451457707|FG001|Overall Study|Lost to Follow-up|6|||
125499023|NCT02434328|451457706|FG000|Overall Study|Other|4|||
125499024|NCT02434328|451457707|FG001|Overall Study|Other|1|||
125499025|NCT00302211|451457714|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
125499026|NCT00302211|451457715|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
125499027|NCT00302211|451457716|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
125499028|NCT00302211|451457717|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
125499029|NCT00302211|451457718|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
125499030|NCT00302211|451457714|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
125499031|NCT00302211|451457715|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
125499032|NCT00302211|451457716|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
125499033|NCT00302211|451457717|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
125499034|NCT00302211|451457718|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
125499035|NCT00302211|451457714|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
125499036|NCT00302211|451457715|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
125499037|NCT00302211|451457716|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
125499038|NCT00302211|451457717|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
125499039|NCT00302211|451457718|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
125499040|NCT00302211|451457714|FG000|Double Blind Period (New Patients)|Disease progression|0|||
125499041|NCT00302211|451457715|FG001|Double Blind Period (New Patients)|Disease progression|1|||
125499042|NCT00302211|451457716|FG002|Double Blind Period (New Patients)|Disease progression|1|||
125499043|NCT00302211|451457717|FG003|Double Blind Period (New Patients)|Disease progression|0|||
125499044|NCT00302211|451457718|FG004|Double Blind Period (New Patients)|Disease progression|0|||
125499045|NCT00302211|451457714|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
125499046|NCT00302211|451457715|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
125499047|NCT00302211|451457716|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
125499048|NCT00302211|451457717|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
125499049|NCT00302211|451457718|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
125499050|NCT00302211|451457714|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
125499051|NCT00302211|451457715|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
125499052|NCT00302211|451457716|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
125499053|NCT00302211|451457717|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
125499054|NCT00302211|451457718|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
125499055|NCT00302211|451457714|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
125499056|NCT00302211|451457715|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
125499057|NCT00302211|451457716|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
125499058|NCT00302211|451457717|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
125499059|NCT00302211|451457718|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
125499060|NCT00302211|451457714|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
125499061|NCT00302211|451457715|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
125499062|NCT00302211|451457716|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
125499063|NCT00302211|451457717|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
125499064|NCT00302211|451457718|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
125499065|NCT00302211|451457714|FG000|Open Label-Patients From Double-Blind|Death|0|||
125499066|NCT00302211|451457715|FG001|Open Label-Patients From Double-Blind|Death|0|||
125499067|NCT00302211|451457716|FG002|Open Label-Patients From Double-Blind|Death|0|||
125499068|NCT00302211|451457717|FG003|Open Label-Patients From Double-Blind|Death|1|||
125499069|NCT00302211|451457718|FG004|Open Label-Patients From Double-Blind|Death|1|||
125499070|NCT00302211|451457714|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
125499071|NCT00302211|451457715|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
125499072|NCT00302211|451457716|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
125499073|NCT00302211|451457717|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
125499074|NCT00302211|451457718|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
125499075|NCT00302211|451457714|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
125499076|NCT00302211|451457715|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
125499077|NCT00302211|451457716|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
125499078|NCT00302211|451457717|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
125499079|NCT00302211|451457718|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
125499080|NCT00302211|451457714|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
125499081|NCT00302211|451457715|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
125499082|NCT00302211|451457716|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
125499083|NCT00302211|451457717|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
125499084|NCT00302211|451457718|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
125499085|NCT02294461|451457719|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
125499086|NCT02294461|451457720|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
125499087|NCT02294461|451457721|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
125499088|NCT02294461|451457719|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
125499089|NCT02294461|451457720|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
125499090|NCT02294461|451457721|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
125499091|NCT02294461|451457719|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
125499092|NCT02294461|451457720|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
125499093|NCT02294461|451457721|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
125499094|NCT02294461|451457719|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
125499095|NCT02294461|451457720|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
125499096|NCT02294461|451457721|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
125499097|NCT02294461|451457719|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
125499098|NCT02294461|451457720|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
125499099|NCT02294461|451457721|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
125499100|NCT02294461|451457719|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
125304573|NCT02927938|450741355|FG003|Overall Study|Death|4|||
125499101|NCT02294461|451457720|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
125499102|NCT02294461|451457721|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
125499103|NCT02294461|451457719|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
125499104|NCT02294461|451457720|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
125499105|NCT02294461|451457721|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
125499106|NCT02294461|451457719|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
125499107|NCT02294461|451457720|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
125499108|NCT02294461|451457721|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
125499109|NCT02294461|451457719|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
125499110|NCT02294461|451457720|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
125499111|NCT02294461|451457721|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
125499112|NCT02294461|451457719|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
125499113|NCT02294461|451457720|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
125499114|NCT02294461|451457721|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
125499115|NCT02294461|451457719|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
125499116|NCT02294461|451457720|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
125499117|NCT02294461|451457721|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
125499118|NCT02294461|451457719|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
125499119|NCT02294461|451457720|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
125499120|NCT02294461|451457721|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
125499121|NCT02294461|451457719|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
125499122|NCT02294461|451457720|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
125499123|NCT02294461|451457721|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
125499124|NCT02294461|451457719|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
125499125|NCT02294461|451457720|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
125499126|NCT02294461|451457721|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
125499127|NCT05432986|451457722|FG000|Overall Study|Withdrawal by Subject|2|||
125499128|NCT05432986|451457722|FG000|Overall Study|incomplete measurement|7|||
125499129|NCT03009344|451458861|FG000|Overall Study|Lack of Efficacy|5|||
125499130|NCT03009344|451458861|FG000|Overall Study|Withdrawal by Subject|1|||
125499131|NCT03009344|451458861|FG000|Overall Study|Adverse Event|1|||
125499132|NCT00378898|451458862|FG000|Overall Study|Withdrawal by Subject|10|||
125499133|NCT00378898|451458863|FG001|Overall Study|Withdrawal by Subject|5|||
125499134|NCT00378898|451458862|FG000|Overall Study|Protocol Violation|1|||
125499135|NCT00378898|451458863|FG001|Overall Study|Protocol Violation|1|||
125499136|NCT02534233|451458866|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
125499137|NCT00551421|451458867|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
125499138|NCT03136159|451458869|FG000|Overall Study|chorioamnionitis|2|||
125499139|NCT03136159|451458870|FG001|Overall Study|chorioamnionitis|0|||
125499140|NCT03136159|451458869|FG000|Overall Study|vertical skin incision|1|||
125499141|NCT03136159|451458870|FG001|Overall Study|vertical skin incision|0|||
125499142|NCT03136159|451458869|FG000|Overall Study|additional dressing|1|||
125499143|NCT03136159|451458870|FG001|Overall Study|additional dressing|0|||
125499144|NCT03136159|451458869|FG000|Overall Study|never got dressing placed|1|||
125499145|NCT03136159|451458870|FG001|Overall Study|never got dressing placed|0|||
125499146|NCT01732757|451458872|FG000|Overall Study|Lost to Follow-up|1|||
125499147|NCT01732757|451458873|FG001|Overall Study|Lost to Follow-up|0|||
125499148|NCT01732757|451458874|FG002|Overall Study|Lost to Follow-up|0|||
125499149|NCT00089609|451458880|FG000|Overall Study|Withdrawal by Subject|3|||
125499150|NCT00089609|451458881|FG001|Overall Study|Withdrawal by Subject|1|||
125499151|NCT03116464|451458882|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
125499152|NCT00597376|451458883|FG000|Overall Study|Withdrawal by Subject|4|||
125499153|NCT00597376|451458884|FG001|Overall Study|Withdrawal by Subject|3|||
125499154|NCT00597376|451458883|FG000|Overall Study|Adverse Event|4|||
125499155|NCT00597376|451458884|FG001|Overall Study|Adverse Event|1|||
125499156|NCT04693637|451458889|FG000|Overall Study|Death|4|||
125499157|NCT04693637|451458889|FG000|Overall Study|Withdrawal by Subject|3|||
125499158|NCT04693637|451458889|FG000|Overall Study|Physician Decision|2|||
125499159|NCT04693637|451458889|FG000|Overall Study|Lost to Follow-up|1|||
125499160|NCT04237792|451458890|FG000|Treatment (Day 1)|Adverse Event|1|||
125499161|NCT04237792|451458891|FG001|Treatment (Day 1)|Adverse Event|0|||
125499162|NCT04237792|451458892|FG002|Treatment (Day 1)|Adverse Event|0|||
125499163|NCT04237792|451458893|FG003|Treatment (Day 1)|Adverse Event|0|||
125499164|NCT04237792|451458894|FG004|Treatment (Day 1)|Adverse Event|1|||
125499165|NCT04237792|451458895|FG005|Treatment (Day 1)|Adverse Event|1|||
125499166|NCT04237792|451458890|FG000|Treatment (Day 1)|Other|0|||
125499167|NCT04237792|451458891|FG001|Treatment (Day 1)|Other|0|||
125499168|NCT04237792|451458892|FG002|Treatment (Day 1)|Other|1|||
125499169|NCT04237792|451458893|FG003|Treatment (Day 1)|Other|0|||
125499170|NCT04237792|451458894|FG004|Treatment (Day 1)|Other|0|||
125499171|NCT04237792|451458895|FG005|Treatment (Day 1)|Other|1|||
125499172|NCT04237792|451458890|FG000|Treatment (Day 1)|Not treated|1|||
125499173|NCT04237792|451458891|FG001|Treatment (Day 1)|Not treated|1|||
125499174|NCT04237792|451458892|FG002|Treatment (Day 1)|Not treated|2|||
125499175|NCT04237792|451458893|FG003|Treatment (Day 1)|Not treated|1|||
125499176|NCT04237792|451458894|FG004|Treatment (Day 1)|Not treated|0|||
125499177|NCT04237792|451458895|FG005|Treatment (Day 1)|Not treated|1|||
125499178|NCT03205566|451458898|FG000|Phase 1|Protocol Violation|1|||
125499179|NCT03205566|451458899|FG001|Phase 1|Protocol Violation|1|||
125499180|NCT02022670|451458900|FG000|Overall Study|Adverse Event|1|||
125499181|NCT02022670|451458901|FG001|Overall Study|Adverse Event|0|||
125499182|NCT02022670|451458902|FG002|Overall Study|Adverse Event|1|||
125499183|NCT02113449|451458903|FG000|Overall Study|Adverse Event|4|||
125499184|NCT01074242|451458906|FG000|Overall Study|Case report before date of contract|40|||
125499185|NCT01074242|451458906|FG000|Overall Study|Lost to Follow-up|1|||
125499186|NCT01074242|451458906|FG000|Overall Study|Case report unclear|6|||
125499187|NCT01074242|451458906|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
125499188|NCT01074242|451458906|FG000|Overall Study|Duplicate Case Report Form|5|||
125499189|NCT01957163|451458907|FG000|Overall Study|Adverse Event|5|||
125499190|NCT01957163|451458908|FG001|Overall Study|Adverse Event|2|||
125499191|NCT01957163|451458909|FG002|Overall Study|Adverse Event|4|||
125499192|NCT01957163|451458907|FG000|Overall Study|Lack of Efficacy|5|||
125499193|NCT01957163|451458908|FG001|Overall Study|Lack of Efficacy|4|||
125499194|NCT01957163|451458909|FG002|Overall Study|Lack of Efficacy|9|||
125499195|NCT01957163|451458907|FG000|Overall Study|Protocol Violation|1|||
125499196|NCT01957163|451458908|FG001|Overall Study|Protocol Violation|2|||
125499197|NCT01957163|451458909|FG002|Overall Study|Protocol Violation|0|||
125499198|NCT01957163|451458907|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
125499199|NCT01957163|451458908|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
125499200|NCT01957163|451458909|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
125499201|NCT01957163|451458907|FG000|Overall Study|Lost to Follow-up|0|||
125499202|NCT01957163|451458908|FG001|Overall Study|Lost to Follow-up|1|||
125499203|NCT01957163|451458909|FG002|Overall Study|Lost to Follow-up|0|||
125499204|NCT01957163|451458907|FG000|Overall Study|Withdrawal by Subject|4|||
125499205|NCT01957163|451458908|FG001|Overall Study|Withdrawal by Subject|2|||
125499206|NCT01957163|451458909|FG002|Overall Study|Withdrawal by Subject|4|||
125499207|NCT03697603|451458910|FG000|Overall Study|Adverse Event|3|||
125499208|NCT03697603|451458911|FG001|Overall Study|Adverse Event|18|||
125499209|NCT03697603|451458912|FG002|Overall Study|Adverse Event|3|||
125499210|NCT03697603|451458910|FG000|Overall Study|Physician Decision|1|||
125499211|NCT03697603|451458911|FG001|Overall Study|Physician Decision|0|||
125499212|NCT03697603|451458912|FG002|Overall Study|Physician Decision|2|||
125499213|NCT03697603|451458910|FG000|Overall Study|Protocol Violation|3|||
125499214|NCT03697603|451458911|FG001|Overall Study|Protocol Violation|8|||
125499215|NCT03697603|451458912|FG002|Overall Study|Protocol Violation|5|||
125499216|NCT03697603|451458910|FG000|Overall Study|Withdrawal by Subject|5|||
125499217|NCT03697603|451458911|FG001|Overall Study|Withdrawal by Subject|1|||
125499218|NCT03697603|451458912|FG002|Overall Study|Withdrawal by Subject|1|||
125499219|NCT03697603|451458910|FG000|Overall Study|Protocol Violation|0|||
125499220|NCT03697603|451458911|FG001|Overall Study|Protocol Violation|0|||
125499221|NCT03697603|451458912|FG002|Overall Study|Protocol Violation|1|||
125499222|NCT02686658|451458913|FG000|Overall Study|Adverse Event|0|||
125499223|NCT02686658|451458914|FG001|Overall Study|Adverse Event|0|||
125499224|NCT02686658|451458915|FG002|Overall Study|Adverse Event|1|||
125499225|NCT02686658|451458916|FG003|Overall Study|Adverse Event|1|||
125499226|NCT02686658|451458917|FG004|Overall Study|Adverse Event|2|||
125499227|NCT02686658|451458918|FG005|Overall Study|Adverse Event|1|||
125499228|NCT02686658|451458913|FG000|Overall Study|Investigator decision|0|||
125499229|NCT02686658|451458914|FG001|Overall Study|Investigator decision|0|||
125499230|NCT02686658|451458915|FG002|Overall Study|Investigator decision|0|||
125499231|NCT02686658|451458916|FG003|Overall Study|Investigator decision|1|||
125499232|NCT02686658|451458917|FG004|Overall Study|Investigator decision|2|||
125499233|NCT02686658|451458918|FG005|Overall Study|Investigator decision|1|||
125499234|NCT02686658|451458913|FG000|Overall Study|Sponsor decision|1|||
125499235|NCT02686658|451458914|FG001|Overall Study|Sponsor decision|2|||
125499236|NCT02686658|451458915|FG002|Overall Study|Sponsor decision|1|||
125499237|NCT02686658|451458916|FG003|Overall Study|Sponsor decision|5|||
125499238|NCT02686658|451458917|FG004|Overall Study|Sponsor decision|13|||
125499239|NCT02686658|451458918|FG005|Overall Study|Sponsor decision|2|||
125304574|NCT02927938|450741352|FG000|Overall Study|Early Study Termination|1|||
125499240|NCT02686658|451458913|FG000|Overall Study|Lost to Follow-up|0|||
125304575|NCT02927938|450741353|FG001|Overall Study|Early Study Termination|5|||
125499241|NCT02686658|451458914|FG001|Overall Study|Lost to Follow-up|0|||
125499242|NCT02686658|451458915|FG002|Overall Study|Lost to Follow-up|2|||
125499243|NCT02686658|451458916|FG003|Overall Study|Lost to Follow-up|0|||
125304576|NCT02927938|450741354|FG002|Overall Study|Early Study Termination|4|||
125499244|NCT02686658|451458917|FG004|Overall Study|Lost to Follow-up|0|||
125499245|NCT02686658|451458918|FG005|Overall Study|Lost to Follow-up|1|||
125499246|NCT02686658|451458913|FG000|Overall Study|Death|1|||
125499247|NCT02686658|451458914|FG001|Overall Study|Death|0|||
125499248|NCT02686658|451458915|FG002|Overall Study|Death|0|||
125499249|NCT02686658|451458916|FG003|Overall Study|Death|1|||
125499250|NCT02686658|451458917|FG004|Overall Study|Death|1|||
125499251|NCT02686658|451458918|FG005|Overall Study|Death|1|||
125499252|NCT02686658|451458913|FG000|Overall Study|Withdrawal by Subject|2|||
125499253|NCT02686658|451458914|FG001|Overall Study|Withdrawal by Subject|5|||
125499254|NCT02686658|451458915|FG002|Overall Study|Withdrawal by Subject|4|||
125499255|NCT02686658|451458916|FG003|Overall Study|Withdrawal by Subject|4|||
125499256|NCT02686658|451458917|FG004|Overall Study|Withdrawal by Subject|17|||
125499257|NCT02686658|451458918|FG005|Overall Study|Withdrawal by Subject|8|||
125499258|NCT02686658|451458913|FG000|Overall Study|Placed in hospice care|0|||
125499259|NCT02686658|451458914|FG001|Overall Study|Placed in hospice care|0|||
125499260|NCT02686658|451458915|FG002|Overall Study|Placed in hospice care|1|||
125499261|NCT02686658|451458916|FG003|Overall Study|Placed in hospice care|0|||
125499262|NCT02686658|451458917|FG004|Overall Study|Placed in hospice care|0|||
125499263|NCT02686658|451458918|FG005|Overall Study|Placed in hospice care|0|||
125499264|NCT02686658|451458913|FG000|Overall Study|Participant non-compliance|0|||
125499265|NCT02686658|451458914|FG001|Overall Study|Participant non-compliance|0|||
125499266|NCT02686658|451458915|FG002|Overall Study|Participant non-compliance|0|||
125499267|NCT02686658|451458916|FG003|Overall Study|Participant non-compliance|0|||
125499268|NCT02686658|451458917|FG004|Overall Study|Participant non-compliance|0|||
125499269|NCT02686658|451458918|FG005|Overall Study|Participant non-compliance|1|||
125499270|NCT02686658|451458913|FG000|Overall Study|Concern over coronavirus disease care|0|||
125499271|NCT02686658|451458914|FG001|Overall Study|Concern over coronavirus disease care|0|||
125499272|NCT02686658|451458915|FG002|Overall Study|Concern over coronavirus disease care|0|||
125499273|NCT02686658|451458916|FG003|Overall Study|Concern over coronavirus disease care|0|||
125499274|NCT02686658|451458917|FG004|Overall Study|Concern over coronavirus disease care|2|||
125499275|NCT02686658|451458918|FG005|Overall Study|Concern over coronavirus disease care|1|||
125499276|NCT00467272|451458919|FG000|Overall Study|Pneumonia|2|||
125499277|NCT00467272|451458919|FG000|Overall Study|Thrombophlebitis|1|||
125499278|NCT00570505|451458920|FG000|Overall Study|Adverse Event|7|||
125499279|NCT00570505|451458920|FG000|Overall Study|Withdrawal by Subject|7|||
125499280|NCT00570505|451458920|FG000|Overall Study|Lost to Follow-up|23|||
125499281|NCT00570505|451458920|FG000|Overall Study|Other loss to follow-up|4|||
125499282|NCT00614614|451458923|FG000|Primary Vaccination Phase|Adverse Event|6|||
125499283|NCT00614614|451458924|FG001|Primary Vaccination Phase|Adverse Event|0|||
125499284|NCT00614614|451458925|FG002|Primary Vaccination Phase|Adverse Event|0|||
125499285|NCT00614614|451458926|FG003|Primary Vaccination Phase|Adverse Event|0|||
125499286|NCT00614614|451458927|FG004|Primary Vaccination Phase|Adverse Event|0|||
125499287|NCT00614614|451458923|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
125499288|NCT00614614|451458924|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
125499289|NCT00614614|451458925|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
125499290|NCT00614614|451458926|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
125499291|NCT00614614|451458927|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
125499292|NCT00614614|451458923|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
125499293|NCT00614614|451458924|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
125499294|NCT00614614|451458925|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
125499295|NCT00614614|451458926|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
125499296|NCT00614614|451458927|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
125499297|NCT00614614|451458923|FG000|Primary Vaccination Phase|Protocol Violation|9|||
125499298|NCT00614614|451458924|FG001|Primary Vaccination Phase|Protocol Violation|3|||
125499299|NCT00614614|451458925|FG002|Primary Vaccination Phase|Protocol Violation|0|||
125499300|NCT00614614|451458926|FG003|Primary Vaccination Phase|Protocol Violation|0|||
125499301|NCT00614614|451458927|FG004|Primary Vaccination Phase|Protocol Violation|0|||
125499302|NCT00614614|451458923|FG000|Primary Vaccination Phase|Other|4|||
125499303|NCT00614614|451458924|FG001|Primary Vaccination Phase|Other|0|||
125499304|NCT00614614|451458925|FG002|Primary Vaccination Phase|Other|0|||
125499305|NCT00614614|451458926|FG003|Primary Vaccination Phase|Other|0|||
125499306|NCT00614614|451458927|FG004|Primary Vaccination Phase|Other|0|||
125499307|NCT00614614|451458923|FG000|Booster Vaccination Phase|Adverse Event|0|||
125499308|NCT00614614|451458924|FG001|Booster Vaccination Phase|Adverse Event|0|||
125499309|NCT00614614|451458925|FG002|Booster Vaccination Phase|Adverse Event|1|||
125499310|NCT00614614|451458926|FG003|Booster Vaccination Phase|Adverse Event|1|||
125499311|NCT00614614|451458927|FG004|Booster Vaccination Phase|Adverse Event|0|||
125499312|NCT00614614|451458923|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
125304577|NCT02927938|450741355|FG003|Overall Study|Early Study Termination|3|||
125499313|NCT00614614|451458924|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
125499314|NCT00614614|451458925|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
125499315|NCT00614614|451458926|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
125499316|NCT00614614|451458927|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
125499317|NCT00614614|451458923|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
125499318|NCT00614614|451458924|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
125499319|NCT00614614|451458925|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
125499320|NCT00614614|451458926|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
125499321|NCT00614614|451458927|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
125499322|NCT00614614|451458923|FG000|Booster Vaccination Phase|Protocol Violation|0|||
125499323|NCT00614614|451458924|FG001|Booster Vaccination Phase|Protocol Violation|0|||
125499324|NCT00614614|451458925|FG002|Booster Vaccination Phase|Protocol Violation|2|||
125499325|NCT00614614|451458926|FG003|Booster Vaccination Phase|Protocol Violation|3|||
125499326|NCT00614614|451458927|FG004|Booster Vaccination Phase|Protocol Violation|0|||
125499327|NCT00614614|451458923|FG000|Booster Vaccination Phase|Other|0|||
125499328|NCT00614614|451458924|FG001|Booster Vaccination Phase|Other|1|||
125499329|NCT00614614|451458925|FG002|Booster Vaccination Phase|Other|3|||
125499330|NCT00614614|451458926|FG003|Booster Vaccination Phase|Other|2|||
125499331|NCT00614614|451458927|FG004|Booster Vaccination Phase|Other|1|||
125499332|NCT05212285|451458928|FG000|Overall Study|Lack of Efficacy|12|||
125499333|NCT05212285|451458929|FG001|Overall Study|Lack of Efficacy|8|||
125499334|NCT05212285|451458928|FG000|Overall Study|Withdrawal by Subject|8|||
125499335|NCT05212285|451458929|FG001|Overall Study|Withdrawal by Subject|1|||
125499336|NCT05212285|451458928|FG000|Overall Study|Lost to Follow-up|13|||
125499337|NCT05212285|451458929|FG001|Overall Study|Lost to Follow-up|1|||
125499338|NCT05212285|451458928|FG000|Overall Study|miss data|21|||
125499339|NCT05212285|451458929|FG001|Overall Study|miss data|2|||
125499340|NCT03924869|451458933|FG000|Overall Study|Death|66|||
125499341|NCT03924869|451458934|FG001|Overall Study|Death|53|||
125499342|NCT03924869|451458933|FG000|Overall Study|Lost to Follow-up|2|||
125499343|NCT03924869|451458934|FG001|Overall Study|Lost to Follow-up|0|||
125499344|NCT03924869|451458933|FG000|Overall Study|Physician Decision|0|||
125499345|NCT03924869|451458934|FG001|Overall Study|Physician Decision|3|||
125499346|NCT03924869|451458933|FG000|Overall Study|Withdrawal by Subject|5|||
125499347|NCT03924869|451458934|FG001|Overall Study|Withdrawal by Subject|1|||
125499348|NCT03924869|451458933|FG000|Overall Study|Participants Ongoing|154|||
125499349|NCT03924869|451458934|FG001|Overall Study|Participants Ongoing|164|||
125499350|NCT02542943|451458935|FG000|Overall Study|Lost to Follow-up|1|||
125499351|NCT02542943|451458936|FG001|Overall Study|Lost to Follow-up|0|||
125499352|NCT02542943|451458937|FG002|Overall Study|Lost to Follow-up|0|||
125499353|NCT02542943|451458935|FG000|Overall Study|Withdrawal by Subject|0|||
125499354|NCT02542943|451458936|FG001|Overall Study|Withdrawal by Subject|1|||
125499355|NCT02542943|451458937|FG002|Overall Study|Withdrawal by Subject|0|||
125499356|NCT05824559|451458941|FG000|Overall Study|Adverse Event|2|||
125499357|NCT05824559|451458941|FG000|Overall Study|Physician Decision|2|||
125499358|NCT05824559|451458941|FG000|Overall Study|Progressive Disease|16|||
125499359|NCT05824559|451458941|FG000|Overall Study|Study Terminated by Sponsor|1|||
125499360|NCT05824559|451458941|FG000|Overall Study|Withdrawal by Subject|2|||
125499361|NCT04602728|451458947|FG000|Overall Study|Lost to Follow-up|4|||
125499362|NCT04602728|451458948|FG001|Overall Study|Lost to Follow-up|4|||
125499363|NCT05865392|451458949|FG000|Overall Study|Withdrawal by Subject|4|||
125499364|NCT05865392|451458950|FG001|Overall Study|Withdrawal by Subject|0|||
125499365|NCT05865392|451458949|FG000|Overall Study|Didn't meet inclusion criteria|4|||
125499366|NCT05865392|451458950|FG001|Overall Study|Didn't meet inclusion criteria|0|||
125499367|NCT05366751|451458953|FG000|Overall Study|Adverse Event|25|||
125499368|NCT05366751|451458953|FG000|Overall Study|Physician Decision|3|||
125499369|NCT05366751|451458953|FG000|Overall Study|Lost to Follow-up|2|||
125499370|NCT05366751|451458953|FG000|Overall Study|Withdrawal by Subject|14|||
125499371|NCT05366751|451458953|FG000|Overall Study|Study Terminated by Sponsor|50|||
125499372|NCT05366751|451458953|FG000|Overall Study|Site Terminated by Sponsor|3|||
125499373|NCT02831049|451458954|FG000|Overall Study|Lost to Follow-up|0|||
125499374|NCT02831049|451458955|FG001|Overall Study|Lost to Follow-up|0|||
125499375|NCT02831049|451458956|FG002|Overall Study|Lost to Follow-up|1|||
125499376|NCT02831049|451458954|FG000|Overall Study|Withdrawal by Subject|0|||
125499377|NCT02831049|451458955|FG001|Overall Study|Withdrawal by Subject|1|||
125499378|NCT02831049|451458956|FG002|Overall Study|Withdrawal by Subject|1|||
125499379|NCT02831049|451458954|FG000|Overall Study|Pandemic shutdown|1|||
125499380|NCT02831049|451458955|FG001|Overall Study|Pandemic shutdown|0|||
125499381|NCT02831049|451458956|FG002|Overall Study|Pandemic shutdown|0|||
125499382|NCT02609048|451458957|FG000|Overall Study|Adverse Event|3|||
125499383|NCT02609048|451458958|FG001|Overall Study|Adverse Event|0|||
125499384|NCT02609048|451458959|FG002|Overall Study|Adverse Event|0|||
125499385|NCT02609048|451458957|FG000|Overall Study|Randomized but never treated|1|||
125499386|NCT02609048|451458958|FG001|Overall Study|Randomized but never treated|1|||
125499387|NCT02609048|451458959|FG002|Overall Study|Randomized but never treated|1|||
125499388|NCT02609048|451458957|FG000|Overall Study|Withdrawal of informed consent|1|||
125499389|NCT02609048|451458958|FG001|Overall Study|Withdrawal of informed consent|0|||
125499390|NCT02609048|451458959|FG002|Overall Study|Withdrawal of informed consent|0|||
125499391|NCT02609048|451458957|FG000|Overall Study|Reason not specified|6|||
125499392|NCT02609048|451458958|FG001|Overall Study|Reason not specified|9|||
125499393|NCT02609048|451458959|FG002|Overall Study|Reason not specified|9|||
125499394|NCT02485925|451458960|FG000|Overall Study|Withdrawal by Subject|3|||
125499395|NCT02485925|451458960|FG000|Overall Study|Death|1|||
125499396|NCT02485925|451458960|FG000|Overall Study|Lost to Follow-up|11|||
125499397|NCT04937504|451458961|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
125499398|NCT04937504|451458962|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
125499399|NCT04937504|451458961|FG000|9 Months Assessment|Lost to Follow-up|3|||
125499400|NCT04937504|451458962|FG001|9 Months Assessment|Lost to Follow-up|2|||
125499401|NCT04118894|451458963|FG000|Overall Study|Lost to Follow-up|21|||
125499402|NCT04118894|451458963|FG000|Overall Study|Withdrawal by Subject|10|||
125499403|NCT04118894|451458963|FG000|Overall Study|Adverse Event|4|||
125499404|NCT02634307|451460254|FG000|Overall Study|Adverse Event|50|||
125499405|NCT02634307|451460255|FG001|Overall Study|Adverse Event|24|||
125499406|NCT02634307|451460256|FG002|Overall Study|Adverse Event|14|||
125499407|NCT02634307|451460254|FG000|Overall Study|Lost to Follow-up|21|||
125499408|NCT02634307|451460255|FG001|Overall Study|Lost to Follow-up|5|||
125499409|NCT02634307|451460256|FG002|Overall Study|Lost to Follow-up|6|||
125499410|NCT02634307|451460254|FG000|Overall Study|Pregnancy|5|||
125499411|NCT02634307|451460255|FG001|Overall Study|Pregnancy|1|||
125499412|NCT02634307|451460256|FG002|Overall Study|Pregnancy|3|||
125499413|NCT02634307|451460254|FG000|Overall Study|Withdrawal by Subject|38|||
125499414|NCT02634307|451460255|FG001|Overall Study|Withdrawal by Subject|24|||
125499415|NCT02634307|451460256|FG002|Overall Study|Withdrawal by Subject|18|||
125499416|NCT02634307|451460254|FG000|Overall Study|Non-Compliance with Study Drug|0|||
125499417|NCT02634307|451460255|FG001|Overall Study|Non-Compliance with Study Drug|2|||
125499418|NCT02634307|451460256|FG002|Overall Study|Non-Compliance with Study Drug|2|||
125499419|NCT02634307|451460254|FG000|Overall Study|Lack of Efficacy|1|||
125499420|NCT02634307|451460255|FG001|Overall Study|Lack of Efficacy|5|||
125499421|NCT02634307|451460256|FG002|Overall Study|Lack of Efficacy|3|||
125499422|NCT02634307|451460254|FG000|Overall Study|Physician Decision|7|||
125499423|NCT02634307|451460255|FG001|Overall Study|Physician Decision|5|||
125499424|NCT02634307|451460256|FG002|Overall Study|Physician Decision|5|||
125499425|NCT02634307|451460254|FG000|Overall Study|Reason not Specified|3|||
125499426|NCT02634307|451460255|FG001|Overall Study|Reason not Specified|5|||
125499427|NCT02634307|451460256|FG002|Overall Study|Reason not Specified|10|||
125499428|NCT02698475|451460257|FG000|Main Study Period|Lack of Efficacy|1|||
125499429|NCT02698475|451460257|FG000|Main Study Period|Protocol Violation|2|||
125499430|NCT02698475|451460257|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
125499431|NCT02698475|451460257|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
125499432|NCT02698475|451460257|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
125499433|NCT02698475|451460257|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
125499434|NCT02698475|451460257|FG000|Long-Term Extension Period|Other|1|||
125499435|NCT02132949|451460258|FG000|Overall Study|Death|7|||
125499436|NCT02132949|451460259|FG001|Overall Study|Death|13|||
125499437|NCT02132949|451460258|FG000|Overall Study|Lost to Follow-up|14|||
125499438|NCT02132949|451460259|FG001|Overall Study|Lost to Follow-up|4|||
125499439|NCT02132949|451460258|FG000|Overall Study|Withdrawal by Subject|6|||
125499440|NCT02132949|451460259|FG001|Overall Study|Withdrawal by Subject|5|||
125499441|NCT02132949|451460258|FG000|Overall Study|Noncompliance|5|||
125499442|NCT02132949|451460259|FG001|Overall Study|Noncompliance|1|||
125499443|NCT02132949|451460258|FG000|Overall Study|Physician Decision|3|||
125499444|NCT02132949|451460259|FG001|Overall Study|Physician Decision|1|||
125499445|NCT02132949|451460258|FG000|Overall Study|Disease Progression|3|||
125499446|NCT02132949|451460259|FG001|Overall Study|Disease Progression|0|||
125499447|NCT02132949|451460258|FG000|Overall Study|Adverse Event|2|||
125499448|NCT02132949|451460259|FG001|Overall Study|Adverse Event|1|||
125499449|NCT02132949|451460258|FG000|Overall Study|Withdrew Prior to Treatment|1|||
125499450|NCT02132949|451460259|FG001|Overall Study|Withdrew Prior to Treatment|2|||
125499451|NCT02132949|451460258|FG000|Overall Study|Reason Unspecified|0|||
125499452|NCT02132949|451460259|FG001|Overall Study|Reason Unspecified|1|||
125499453|NCT01823224|451460260|FG000|Overall Study|Lost to Follow-up|5|||
125499454|NCT01823224|451460261|FG001|Overall Study|Lost to Follow-up|6|||
125499455|NCT01823224|451460260|FG000|Overall Study|didn't qualify|1|||
125499456|NCT01823224|451460261|FG001|Overall Study|didn't qualify|2|||
125499457|NCT01823224|451460260|FG000|Overall Study|pharmacy error|0|||
125499458|NCT01823224|451460261|FG001|Overall Study|pharmacy error|1|||
125499459|NCT01823224|451460260|FG000|Overall Study|missed med dose|0|||
125499460|NCT01823224|451460261|FG001|Overall Study|missed med dose|1|||
125499461|NCT01823224|451460260|FG000|Overall Study|Withdrawal by Subject|0|||
125499462|NCT01823224|451460261|FG001|Overall Study|Withdrawal by Subject|1|||
125499463|NCT00745875|451460269|FG000|Overall Study|Continuing study treatment|4|||
125499464|NCT00745875|451460270|FG001|Overall Study|Continuing study treatment|4|||
125499465|NCT01532648|451460271|FG000|Overall Study|Lost to Follow-up|3|||
125499466|NCT01532648|451460272|FG001|Overall Study|Lost to Follow-up|4|||
125499467|NCT01532648|451460271|FG000|Overall Study|Lack of Efficacy|4|||
125499468|NCT01532648|451460272|FG001|Overall Study|Lack of Efficacy|1|||
125499469|NCT01532648|451460271|FG000|Overall Study|Protocol Violation|1|||
125499470|NCT01532648|451460272|FG001|Overall Study|Protocol Violation|1|||
125499471|NCT01532648|451460271|FG000|Overall Study|Adverse Event|12|||
125304578|NCT00082407|450742689|FG000|Overall Study|Adverse Event|20|||
125499472|NCT01532648|451460272|FG001|Overall Study|Adverse Event|9|||
125499473|NCT01532648|451460271|FG000|Overall Study|Withdrawal by Subject|16|||
125499474|NCT01532648|451460272|FG001|Overall Study|Withdrawal by Subject|2|||
125304579|NCT00082407|450742690|FG001|Overall Study|Adverse Event|0|||
125499475|NCT02148705|451460273|FG000|Overall Study|Death|2|||
125499476|NCT02148705|451460274|FG001|Overall Study|Death|0|||
125499477|NCT02148705|451460275|FG002|Overall Study|Death|0|||
125499478|NCT02148705|451460273|FG000|Overall Study|Lost to Follow-up|13|||
125499479|NCT02148705|451460274|FG001|Overall Study|Lost to Follow-up|4|||
125499480|NCT02148705|451460275|FG002|Overall Study|Lost to Follow-up|10|||
125499481|NCT02148705|451460273|FG000|Overall Study|Withdrawal by Subject|3|||
125499482|NCT02148705|451460274|FG001|Overall Study|Withdrawal by Subject|0|||
125499483|NCT02148705|451460275|FG002|Overall Study|Withdrawal by Subject|2|||
125499484|NCT02148705|451460273|FG000|Overall Study|Not Treated|0|||
125499485|NCT02148705|451460274|FG001|Overall Study|Not Treated|1|||
125499486|NCT02148705|451460275|FG002|Overall Study|Not Treated|5|||
125499487|NCT01583166|451460276|FG000|Overall Study|Withdrawal by Subject|4|||
125499488|NCT01583166|451460277|FG001|Overall Study|Withdrawal by Subject|6|||
125499489|NCT01737021|451460278|FG000|Overall Study|Lost to Follow-up|5|||
125499490|NCT01737021|451460279|FG001|Overall Study|Lost to Follow-up|3|||
125499491|NCT02310581|451460280|FG000|Overall Study|Adverse Event|1|||
125499492|NCT02310581|451460281|FG001|Overall Study|Adverse Event|1|||
125499493|NCT02310581|451460282|FG002|Overall Study|Adverse Event|1|||
125499494|NCT02310581|451460283|FG003|Overall Study|Adverse Event|0|||
125499495|NCT02310581|451460280|FG000|Overall Study|Withdrawal by Subject|2|||
125499496|NCT02310581|451460281|FG001|Overall Study|Withdrawal by Subject|1|||
125499497|NCT02310581|451460282|FG002|Overall Study|Withdrawal by Subject|0|||
125499498|NCT02310581|451460283|FG003|Overall Study|Withdrawal by Subject|1|||
125499499|NCT04652869|451460284|FG000|Overall Study|Withdrawal by Subject|0|||
125499500|NCT04652869|451460285|FG001|Overall Study|Withdrawal by Subject|2|||
125499501|NCT04652869|451460286|FG002|Overall Study|Withdrawal by Subject|0|||
125499502|NCT01833455|451460287|FG000|Overall Study|Withdrawal by Subject|1|||
125499503|NCT01833455|451460288|FG001|Overall Study|Withdrawal by Subject|0|||
125499504|NCT00887224|451460289|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
125499505|NCT00887224|451460290|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
125499506|NCT00887224|451460291|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
125499507|NCT00887224|451460289|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
125499508|NCT00887224|451460290|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
125499509|NCT00887224|451460291|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
125499510|NCT00887224|451460289|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
125499511|NCT00887224|451460290|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
125499512|NCT00887224|451460291|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
125499513|NCT00887224|451460289|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
125499514|NCT00887224|451460290|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
125499515|NCT00887224|451460291|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
125499516|NCT00887224|451460289|FG000|Open-label Response (OLR) Phase|Other|1|||
125499517|NCT00887224|451460290|FG001|Open-label Response (OLR) Phase|Other|0|||
125499518|NCT00887224|451460291|FG002|Open-label Response (OLR) Phase|Other|0|||
125499519|NCT00887224|451460289|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
125499520|NCT00887224|451460290|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
125499521|NCT00887224|451460291|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
125499522|NCT00887224|451460289|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
125499523|NCT00887224|451460290|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
125499524|NCT00887224|451460291|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
125499525|NCT00887224|451460289|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
125499526|NCT00887224|451460290|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
125499527|NCT00887224|451460291|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
125499528|NCT00887224|451460289|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
125499529|NCT00887224|451460290|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
125499530|NCT00887224|451460291|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
125499531|NCT00887224|451460289|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
125499532|NCT00887224|451460290|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
125499533|NCT00887224|451460291|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
125499534|NCT00887224|451460289|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
125499535|NCT00887224|451460290|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
125499536|NCT00887224|451460291|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
125499537|NCT00887224|451460289|FG000|Open-label Stability (OLS) Phase|Other|1|||
125499538|NCT00887224|451460290|FG001|Open-label Stability (OLS) Phase|Other|0|||
125499539|NCT00887224|451460291|FG002|Open-label Stability (OLS) Phase|Other|0|||
125499540|NCT00887224|451460289|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
125499541|NCT00887224|451460290|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
125499542|NCT00887224|451460291|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
125499543|NCT00887224|451460289|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
125499544|NCT00887224|451460290|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
125499545|NCT00887224|451460291|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
125499546|NCT00887224|451460289|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
125499547|NCT00887224|451460290|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
125499548|NCT00887224|451460291|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
125499549|NCT00887224|451460289|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
125499550|NCT00887224|451460290|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
125499551|NCT00887224|451460291|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
125499552|NCT00887224|451460289|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
125499553|NCT00887224|451460290|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
125499554|NCT00887224|451460291|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
125499555|NCT00887224|451460289|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
125499556|NCT00887224|451460290|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
125499557|NCT00887224|451460291|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
125499558|NCT00887224|451460289|FG000|OL Taper Phase / OL Follow Up|Other|30|||
125499559|NCT00887224|451460290|FG001|OL Taper Phase / OL Follow Up|Other|0|||
125499560|NCT00887224|451460291|FG002|OL Taper Phase / OL Follow Up|Other|0|||
125499561|NCT00887224|451460289|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
125499562|NCT00887224|451460290|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
125499563|NCT00887224|451460291|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
125499564|NCT00887224|451460289|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
125499565|NCT00887224|451460290|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
125499566|NCT00887224|451460291|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
125499567|NCT00887224|451460289|FG000|Double-blind (DB) Phase|Adverse Event|0|||
125499568|NCT00887224|451460290|FG001|Double-blind (DB) Phase|Adverse Event|7|||
125499569|NCT00887224|451460291|FG002|Double-blind (DB) Phase|Adverse Event|2|||
125499570|NCT00887224|451460289|FG000|Double-blind (DB) Phase|Failed to return|0|||
125499571|NCT00887224|451460290|FG001|Double-blind (DB) Phase|Failed to return|2|||
125499572|NCT00887224|451460291|FG002|Double-blind (DB) Phase|Failed to return|2|||
125499573|NCT00887224|451460289|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
125499574|NCT00887224|451460290|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
125499575|NCT00887224|451460291|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
125499576|NCT00887224|451460289|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
125499577|NCT00887224|451460290|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
125499578|NCT00887224|451460291|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
125499579|NCT00887224|451460289|FG000|Double-blind (DB) Phase|Other|0|||
125499580|NCT00887224|451460290|FG001|Double-blind (DB) Phase|Other|2|||
125499581|NCT00887224|451460291|FG002|Double-blind (DB) Phase|Other|0|||
125499582|NCT00887224|451460289|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
125499583|NCT00887224|451460290|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
125499584|NCT00887224|451460291|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
125499585|NCT00887224|451460289|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
125499586|NCT00887224|451460290|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
125499587|NCT00887224|451460291|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
125499588|NCT00887224|451460289|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
125499589|NCT00887224|451460290|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
125499590|NCT00887224|451460291|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
125499591|NCT00887224|451460289|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
125499592|NCT00887224|451460290|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
125499593|NCT00887224|451460291|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
125499594|NCT00887224|451460289|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
125499595|NCT00887224|451460290|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
125499596|NCT00887224|451460291|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
125499597|NCT00887224|451460289|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
125499598|NCT00887224|451460290|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
125499599|NCT00887224|451460291|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
125499600|NCT00887224|451460289|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
125499601|NCT00887224|451460290|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
125499602|NCT00887224|451460291|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
125499603|NCT00887224|451460289|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
125499604|NCT00887224|451460290|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
125499605|NCT00887224|451460291|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
125499606|NCT00887224|451460289|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
125499607|NCT00887224|451460290|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
125304580|NCT00082407|450742689|FG000|Overall Study|Protocol Violation|14|||
125304581|NCT00082407|450742690|FG001|Overall Study|Protocol Violation|12|||
125499608|NCT00887224|451460291|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
125499609|NCT03883828|451460292|FG000|Overall Study|Did not start radiotherapy|1|||
125499610|NCT03883828|451460293|FG001|Overall Study|Did not start radiotherapy|2|||
125499611|NCT01256359|451460294|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
125499612|NCT01256359|451460295|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
125499613|NCT01256359|451460294|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
125304582|NCT00082407|450742689|FG000|Overall Study|Patient Decision|13|||
125499614|NCT01256359|451460295|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
125499615|NCT02000752|451460298|FG000|Overall Study|Dystocic delivery|19|||
125499616|NCT02000752|451460299|FG001|Overall Study|Dystocic delivery|8|||
125499617|NCT02000752|451460298|FG000|Overall Study|Shift Changes|12|||
125499618|NCT02000752|451460299|FG001|Overall Study|Shift Changes|5|||
125499619|NCT04658784|451460305|FG000|6-month Follow-up|Lost to Follow-up|2|||
125499620|NCT04658784|451460306|FG001|6-month Follow-up|Lost to Follow-up|5|||
125499621|NCT02095145|451460308|FG000|Overall Study|Withdrawal by Subject|1|||
125499622|NCT02095145|451460309|FG001|Overall Study|Withdrawal by Subject|0|||
125499623|NCT02630186|451460310|FG000|Overall Study|Withdrawal by Subject|1|||
125499624|NCT00670488|451460312|FG000|Overall Study|Adverse Event|0|||
125499625|NCT00670488|451460313|FG001|Overall Study|Adverse Event|7|||
125499626|NCT00670488|451460314|FG002|Overall Study|Adverse Event|0|||
125499627|NCT00670488|451460315|FG003|Overall Study|Adverse Event|3|||
125499628|NCT00670488|451460316|FG004|Overall Study|Adverse Event|1|||
125499629|NCT00670488|451460317|FG005|Overall Study|Adverse Event|1|||
125499630|NCT00670488|451460318|FG006|Overall Study|Adverse Event|5|||
125499631|NCT00670488|451460319|FG007|Overall Study|Adverse Event|1|||
125499632|NCT00670488|451460320|FG008|Overall Study|Adverse Event|0|||
125499633|NCT00670488|451460321|FG009|Overall Study|Adverse Event|1|||
125499634|NCT00670488|451460312|FG000|Overall Study|Physician Decision|1|||
125499635|NCT00670488|451460313|FG001|Overall Study|Physician Decision|9|||
125499636|NCT00670488|451460314|FG002|Overall Study|Physician Decision|0|||
125499637|NCT00670488|451460315|FG003|Overall Study|Physician Decision|1|||
125499638|NCT00670488|451460316|FG004|Overall Study|Physician Decision|0|||
125499639|NCT00670488|451460317|FG005|Overall Study|Physician Decision|0|||
125499640|NCT00670488|451460318|FG006|Overall Study|Physician Decision|0|||
125499641|NCT00670488|451460319|FG007|Overall Study|Physician Decision|0|||
125499642|NCT00670488|451460320|FG008|Overall Study|Physician Decision|0|||
125499643|NCT00670488|451460321|FG009|Overall Study|Physician Decision|0|||
125499644|NCT00670488|451460312|FG000|Overall Study|Progressive Disease|2|||
125499645|NCT00670488|451460313|FG001|Overall Study|Progressive Disease|41|||
125499646|NCT00670488|451460314|FG002|Overall Study|Progressive Disease|3|||
125499647|NCT00670488|451460315|FG003|Overall Study|Progressive Disease|2|||
125499648|NCT00670488|451460316|FG004|Overall Study|Progressive Disease|2|||
125499649|NCT00670488|451460317|FG005|Overall Study|Progressive Disease|4|||
125499650|NCT00670488|451460318|FG006|Overall Study|Progressive Disease|11|||
125499651|NCT00670488|451460319|FG007|Overall Study|Progressive Disease|2|||
125499652|NCT00670488|451460320|FG008|Overall Study|Progressive Disease|2|||
125499653|NCT00670488|451460321|FG009|Overall Study|Progressive Disease|1|||
125499654|NCT00670488|451460312|FG000|Overall Study|Withdrawal by Subject|0|||
125499655|NCT00670488|451460313|FG001|Overall Study|Withdrawal by Subject|1|||
125499656|NCT00670488|451460314|FG002|Overall Study|Withdrawal by Subject|0|||
125499657|NCT00670488|451460315|FG003|Overall Study|Withdrawal by Subject|1|||
125499658|NCT00670488|451460316|FG004|Overall Study|Withdrawal by Subject|0|||
125499659|NCT00670488|451460317|FG005|Overall Study|Withdrawal by Subject|0|||
125499660|NCT00670488|451460318|FG006|Overall Study|Withdrawal by Subject|1|||
125499661|NCT00670488|451460319|FG007|Overall Study|Withdrawal by Subject|0|||
125499662|NCT00670488|451460320|FG008|Overall Study|Withdrawal by Subject|1|||
125499663|NCT00670488|451460321|FG009|Overall Study|Withdrawal by Subject|0|||
125499664|NCT01034306|451460329|FG000|Overall Study|Adverse Event|1|||
125499665|NCT01034306|451460330|FG001|Overall Study|Adverse Event|0|||
125499666|NCT01034306|451460329|FG000|Overall Study|Lost to Follow-up|0|||
125499667|NCT01034306|451460330|FG001|Overall Study|Lost to Follow-up|1|||
125499668|NCT01034306|451460329|FG000|Overall Study|Withdrawal by Subject|2|||
125499669|NCT01034306|451460330|FG001|Overall Study|Withdrawal by Subject|2|||
125499670|NCT01034306|451460329|FG000|Overall Study|hospitalized and decided to stop|1|||
125499671|NCT01034306|451460330|FG001|Overall Study|hospitalized and decided to stop|0|||
125499672|NCT01034306|451460329|FG000|Overall Study|Noncomplience|1|||
125499673|NCT01034306|451460330|FG001|Overall Study|Noncomplience|0|||
125499674|NCT00836498|451460331|FG000|Overall Study|Adverse Event|1|||
125499675|NCT00836498|451460332|FG001|Overall Study|Adverse Event|0|||
125499676|NCT00836498|451460331|FG000|Overall Study|Lost to Follow-up|1|||
125499677|NCT00836498|451460332|FG001|Overall Study|Lost to Follow-up|0|||
125499678|NCT00836498|451460331|FG000|Overall Study|Withdrawal by Subject|2|||
125499679|NCT00836498|451460332|FG001|Overall Study|Withdrawal by Subject|1|||
125499680|NCT01619059|451460333|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
125499681|NCT01619059|451460334|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
125499682|NCT01619059|451460333|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
125499683|NCT01619059|451460334|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
125499684|NCT01619059|451460333|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
125499685|NCT01619059|451460334|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
125499686|NCT01619059|451460333|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
125499687|NCT01619059|451460334|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
125499688|NCT01619059|451460333|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
125499689|NCT01619059|451460334|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
125499690|NCT01619059|451460333|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
125499691|NCT01619059|451460334|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
125499692|NCT01619059|451460333|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
125499693|NCT01619059|451460334|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
125499694|NCT01619059|451460333|FG000|Long-Term (LT) Treatment Period|Death|1|||
125499695|NCT01619059|451460334|FG001|Long-Term (LT) Treatment Period|Death|0|||
125499696|NCT01619059|451460333|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
125499697|NCT01619059|451460334|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
125499698|NCT01619059|451460333|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
125499699|NCT01619059|451460334|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
125499700|NCT03418545|451460335|FG000|Overall Study|Withdrawal by Participant|2|||
125499701|NCT03418545|451460336|FG001|Overall Study|Withdrawal by Participant|4|||
125499702|NCT03418545|451460335|FG000|Overall Study|Lost to Follow-up|3|||
125499703|NCT03418545|451460336|FG001|Overall Study|Lost to Follow-up|5|||
125499704|NCT03418545|451460335|FG000|Overall Study|Reason Not Specified|0|||
125499705|NCT03418545|451460336|FG001|Overall Study|Reason Not Specified|1|||
125499706|NCT03418545|451460335|FG000|Overall Study|Missing Completion Status|0|||
125499707|NCT03418545|451460336|FG001|Overall Study|Missing Completion Status|1|||
125499708|NCT02384382|451460344|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
125499709|NCT02384382|451460344|FG000|Overall Study|Death|1|||
125499710|NCT02384382|451460344|FG000|Overall Study|Adverse Event|1|||
125499711|NCT02384382|451460344|FG000|Overall Study|Disease progression|16|||
125499712|NCT03567616|451460353|FG000|Overall Study|Disease progression|4|||
125499713|NCT03567616|451460353|FG000|Overall Study|Withdrawal by Subject|1|||
125499714|NCT03567616|451460353|FG000|Overall Study|Physician Decision|1|||
125499715|NCT03567616|451460353|FG000|Overall Study|Death|1|||
125499716|NCT03567616|451460353|FG000|Overall Study|Adverse Event|1|||
125499717|NCT04447027|451460368|FG000|Dose Escalation|Withdrawal by Subject|1|||
125499718|NCT04447027|451460369|FG001|Dose Escalation|Withdrawal by Subject|4|||
125499719|NCT04447027|451460370|FG002|Dose Escalation|Withdrawal by Subject|3|||
125499720|NCT04447027|451460371|FG003|Dose Escalation|Withdrawal by Subject|3|||
125499721|NCT04447027|451460372|FG004|Dose Escalation|Withdrawal by Subject|1|||
125499722|NCT04447027|451460373|FG005|Dose Escalation|Withdrawal by Subject|0|||
125499723|NCT04447027|451460374|FG006|Dose Escalation|Withdrawal by Subject|0|||
125499724|NCT04447027|451460375|FG007|Dose Escalation|Withdrawal by Subject|0|||
125499725|NCT04447027|451460376|FG008|Dose Escalation|Withdrawal by Subject|0|||
125499726|NCT04447027|451460368|FG000|Dose Escalation|Refused further treatment|0|||
125499727|NCT04447027|451460369|FG001|Dose Escalation|Refused further treatment|1|||
125499728|NCT04447027|451460370|FG002|Dose Escalation|Refused further treatment|1|||
125499729|NCT04447027|451460371|FG003|Dose Escalation|Refused further treatment|0|||
125499730|NCT04447027|451460372|FG004|Dose Escalation|Refused further treatment|0|||
125499731|NCT04447027|451460373|FG005|Dose Escalation|Refused further treatment|0|||
125499732|NCT04447027|451460374|FG006|Dose Escalation|Refused further treatment|0|||
125499733|NCT04447027|451460375|FG007|Dose Escalation|Refused further treatment|0|||
125499734|NCT04447027|451460376|FG008|Dose Escalation|Refused further treatment|0|||
125499735|NCT04447027|451460368|FG000|Dose Expansion|Withdrawal by Subject|0|||
125499736|NCT04447027|451460369|FG001|Dose Expansion|Withdrawal by Subject|0|||
125499737|NCT04447027|451460370|FG002|Dose Expansion|Withdrawal by Subject|0|||
125499738|NCT04447027|451460371|FG003|Dose Expansion|Withdrawal by Subject|0|||
125499739|NCT04447027|451460372|FG004|Dose Expansion|Withdrawal by Subject|0|||
125499740|NCT04447027|451460373|FG005|Dose Expansion|Withdrawal by Subject|2|||
125499741|NCT04447027|451460374|FG006|Dose Expansion|Withdrawal by Subject|0|||
125499742|NCT04447027|451460375|FG007|Dose Expansion|Withdrawal by Subject|2|||
125499743|NCT04447027|451460376|FG008|Dose Expansion|Withdrawal by Subject|0|||
125499744|NCT04224272|451460377|FG000|Part 1 - Dose Finding|Death|4|||
125499745|NCT04224272|451460377|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
125499746|NCT04224272|451460377|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
125499747|NCT04224272|451460377|FG000|Part 2 - Dose Expansion|Death|10|||
125499748|NCT04224272|451460377|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
125499749|NCT05995977|451460378|FG000|Overall Study|Withdrawal by Subject|1|||
125499750|NCT05995977|451460379|FG001|Overall Study|Withdrawal by Subject|4|||
125499751|NCT05995977|451460378|FG000|Overall Study|Lost to Follow-up|2|||
125499752|NCT05995977|451460379|FG001|Overall Study|Lost to Follow-up|0|||
125499753|NCT04181788|451460380|FG000|TREATMENT|Adverse Event|0|||
125499754|NCT04181788|451460381|FG001|TREATMENT|Adverse Event|2|||
125499755|NCT04181788|451460382|FG002|TREATMENT|Adverse Event|1|||
125499756|NCT04181788|451460383|FG003|TREATMENT|Adverse Event|0|||
125499757|NCT04181788|451460384|FG004|TREATMENT|Adverse Event|1|||
125499758|NCT04181788|451460385|FG005|TREATMENT|Adverse Event|3|||
125499759|NCT04181788|451460380|FG000|TREATMENT|Death|0|||
125499760|NCT04181788|451460381|FG001|TREATMENT|Death|0|||
125499761|NCT04181788|451460382|FG002|TREATMENT|Death|0|||
125499762|NCT04181788|451460383|FG003|TREATMENT|Death|0|||
125499763|NCT04181788|451460384|FG004|TREATMENT|Death|8|||
125499764|NCT04181788|451460385|FG005|TREATMENT|Death|8|||
125499765|NCT04181788|451460380|FG000|TREATMENT|Physician Decision|0|||
125499766|NCT04181788|451460381|FG001|TREATMENT|Physician Decision|0|||
125499767|NCT04181788|451460382|FG002|TREATMENT|Physician Decision|0|||
125499768|NCT04181788|451460383|FG003|TREATMENT|Physician Decision|0|||
125499769|NCT04181788|451460384|FG004|TREATMENT|Physician Decision|0|||
125499770|NCT04181788|451460385|FG005|TREATMENT|Physician Decision|1|||
125499771|NCT04181788|451460380|FG000|TREATMENT|Progressive disease|3|||
125499772|NCT04181788|451460381|FG001|TREATMENT|Progressive disease|3|||
125499773|NCT04181788|451460382|FG002|TREATMENT|Progressive disease|5|||
125499774|NCT04181788|451460383|FG003|TREATMENT|Progressive disease|7|||
125499775|NCT04181788|451460384|FG004|TREATMENT|Progressive disease|20|||
125499776|NCT04181788|451460385|FG005|TREATMENT|Progressive disease|38|||
125499777|NCT04181788|451460380|FG000|TREATMENT|Global deterioration of health status|0|||
125499778|NCT04181788|451460381|FG001|TREATMENT|Global deterioration of health status|2|||
125499779|NCT04181788|451460382|FG002|TREATMENT|Global deterioration of health status|0|||
125499780|NCT04181788|451460383|FG003|TREATMENT|Global deterioration of health status|0|||
125499781|NCT04181788|451460384|FG004|TREATMENT|Global deterioration of health status|2|||
125499782|NCT04181788|451460385|FG005|TREATMENT|Global deterioration of health status|8|||
125499783|NCT04181788|451460380|FG000|TREATMENT|Withdrawal by Subject|1|||
125499784|NCT04181788|451460381|FG001|TREATMENT|Withdrawal by Subject|2|||
125499785|NCT04181788|451460382|FG002|TREATMENT|Withdrawal by Subject|0|||
125499786|NCT04181788|451460383|FG003|TREATMENT|Withdrawal by Subject|0|||
125499787|NCT04181788|451460384|FG004|TREATMENT|Withdrawal by Subject|3|||
125499788|NCT04181788|451460385|FG005|TREATMENT|Withdrawal by Subject|5|||
125499789|NCT04181788|451460380|FG000|TREATMENT|Other unspecified|0|||
125499790|NCT04181788|451460381|FG001|TREATMENT|Other unspecified|0|||
125499791|NCT04181788|451460382|FG002|TREATMENT|Other unspecified|0|||
125499792|NCT04181788|451460383|FG003|TREATMENT|Other unspecified|0|||
125499793|NCT04181788|451460384|FG004|TREATMENT|Other unspecified|0|||
125499794|NCT04181788|451460385|FG005|TREATMENT|Other unspecified|2|||
125499795|NCT04181788|451460380|FG000|TREATMENT|Ongoing|0|||
125499796|NCT04181788|451460381|FG001|TREATMENT|Ongoing|3|||
125499797|NCT04181788|451460382|FG002|TREATMENT|Ongoing|0|||
125499798|NCT04181788|451460383|FG003|TREATMENT|Ongoing|5|||
125499799|NCT04181788|451460384|FG004|TREATMENT|Ongoing|7|||
125499800|NCT04181788|451460385|FG005|TREATMENT|Ongoing|15|||
125499801|NCT04181788|451460380|FG000|FOLLOW-UP|Death|0|||
125499802|NCT04181788|451460381|FG001|FOLLOW-UP|Death|0|||
125499803|NCT04181788|451460382|FG002|FOLLOW-UP|Death|1|||
125499804|NCT04181788|451460383|FG003|FOLLOW-UP|Death|2|||
125499805|NCT04181788|451460384|FG004|FOLLOW-UP|Death|8|||
125499806|NCT04181788|451460385|FG005|FOLLOW-UP|Death|20|||
125499807|NCT04181788|451460380|FG000|FOLLOW-UP|Lost to Follow-up|0|||
125499808|NCT04181788|451460381|FG001|FOLLOW-UP|Lost to Follow-up|0|||
125499809|NCT04181788|451460382|FG002|FOLLOW-UP|Lost to Follow-up|0|||
125499810|NCT04181788|451460383|FG003|FOLLOW-UP|Lost to Follow-up|0|||
125499811|NCT04181788|451460384|FG004|FOLLOW-UP|Lost to Follow-up|0|||
125499812|NCT04181788|451460385|FG005|FOLLOW-UP|Lost to Follow-up|2|||
125499813|NCT04181788|451460380|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
125499814|NCT04181788|451460381|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
125499815|NCT04181788|451460382|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
125499816|NCT04181788|451460383|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
125499817|NCT04181788|451460384|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
125499818|NCT04181788|451460385|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
125499819|NCT04181788|451460380|FG000|FOLLOW-UP|Other unspecified|0|||
125499820|NCT04181788|451460381|FG001|FOLLOW-UP|Other unspecified|1|||
125499821|NCT04181788|451460382|FG002|FOLLOW-UP|Other unspecified|0|||
125499822|NCT04181788|451460383|FG003|FOLLOW-UP|Other unspecified|0|||
125499823|NCT04181788|451460384|FG004|FOLLOW-UP|Other unspecified|0|||
125499824|NCT04181788|451460385|FG005|FOLLOW-UP|Other unspecified|3|||
125499825|NCT04181788|451460380|FG000|FOLLOW-UP|Ongoing|0|||
125499826|NCT04181788|451460381|FG001|FOLLOW-UP|Ongoing|0|||
125499827|NCT04181788|451460382|FG002|FOLLOW-UP|Ongoing|1|||
125499828|NCT04181788|451460383|FG003|FOLLOW-UP|Ongoing|3|||
125499829|NCT04181788|451460384|FG004|FOLLOW-UP|Ongoing|2|||
125499830|NCT04181788|451460385|FG005|FOLLOW-UP|Ongoing|2|||
125499831|NCT04535414|451460386|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
125499832|NCT04535414|451460387|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
125499833|NCT04535414|451460386|FG000|Overall Study|Cancelled appointment|1|||
125499834|NCT04535414|451460387|FG001|Overall Study|Cancelled appointment|0|||
125499835|NCT04535414|451460386|FG000|Overall Study|cancelled - food in stomach|2|||
125499836|NCT04535414|451460387|FG001|Overall Study|cancelled - food in stomach|0|||
125499837|NCT04535414|451460386|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
125499838|NCT04535414|451460387|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
125499839|NCT04535414|451460386|FG000|Overall Study|Withdrawal by Subject|0|||
125499840|NCT04535414|451460387|FG001|Overall Study|Withdrawal by Subject|1|||
125499841|NCT03662659|451460388|FG000|Pre-treatment|Participant no longer met study criteria|1|||
125499842|NCT03662659|451460389|FG001|Pre-treatment|Participant no longer met study criteria|1|||
125499843|NCT03662659|451460388|FG000|Pre-treatment|Other reasons|1|||
125499844|NCT03662659|451460389|FG001|Pre-treatment|Other reasons|0|||
125499845|NCT03662659|451460388|FG000|Treatment|Completed Treatment|0|||
125304583|NCT00082407|450742690|FG001|Overall Study|Patient Decision|6|||
125499846|NCT03662659|451460389|FG001|Treatment|Completed Treatment|2|||
125499847|NCT03662659|451460388|FG000|Treatment|Disease Progression|85|||
125499848|NCT03662659|451460389|FG001|Treatment|Disease Progression|97|||
125499849|NCT03662659|451460388|FG000|Treatment|Study Drug Toxicity|19|||
125499850|NCT03662659|451460389|FG001|Treatment|Study Drug Toxicity|9|||
125499851|NCT03662659|451460388|FG000|Treatment|Death|11|||
125499852|NCT03662659|451460389|FG001|Treatment|Death|9|||
125499853|NCT03662659|451460388|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
125499854|NCT03662659|451460389|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
125499855|NCT03662659|451460388|FG000|Treatment|Withdrawal by Subject|1|||
125499856|NCT03662659|451460389|FG001|Treatment|Withdrawal by Subject|1|||
125499857|NCT03662659|451460388|FG000|Treatment|Poor/Non-compliance|1|||
125499858|NCT03662659|451460389|FG001|Treatment|Poor/Non-compliance|0|||
125499859|NCT03662659|451460388|FG000|Treatment|Participant no longer meets study criteria|1|||
125499860|NCT03662659|451460389|FG001|Treatment|Participant no longer meets study criteria|0|||
125499861|NCT03662659|451460388|FG000|Treatment|Other reasons|10|||
125499862|NCT03662659|451460389|FG001|Treatment|Other reasons|8|||
125499863|NCT03662659|451460388|FG000|Treatment|Administrative reasons by sponsor|1|||
125499864|NCT03662659|451460389|FG001|Treatment|Administrative reasons by sponsor|0|||
125499865|NCT03662659|451460388|FG000|Treatment|maximum clinical benefit|0|||
125499866|NCT03662659|451460389|FG001|Treatment|maximum clinical benefit|2|||
125499867|NCT02556918|451462254|FG000|Overall Study|Protocol Violation|5|||
125499868|NCT02556918|451462255|FG001|Overall Study|Protocol Violation|6|||
125499869|NCT02556918|451462254|FG000|Overall Study|Withdrawal by Subject|4|||
125499870|NCT02556918|451462255|FG001|Overall Study|Withdrawal by Subject|4|||
125499871|NCT01673594|451462270|FG000|Overall Study|Adverse Event|3|||
125499872|NCT01673594|451462271|FG001|Overall Study|Adverse Event|1|||
125499873|NCT01673594|451462270|FG000|Overall Study|Lost to Follow-up|1|||
125499874|NCT01673594|451462271|FG001|Overall Study|Lost to Follow-up|0|||
125499875|NCT01673594|451462270|FG000|Overall Study|Physician Decision|2|||
125499876|NCT01673594|451462271|FG001|Overall Study|Physician Decision|4|||
125499877|NCT01673594|451462270|FG000|Overall Study|Withdrawal by Subject|0|||
125499878|NCT01673594|451462271|FG001|Overall Study|Withdrawal by Subject|1|||
125499879|NCT04938453|451462276|FG000|Washout Period 1|Adverse Event|1|||
125499880|NCT04938453|451462277|FG001|Washout Period 1|Adverse Event|0|||
125499881|NCT04938453|451462276|FG000|Washout Period 1|Physician Decision|0|||
125499882|NCT04938453|451462277|FG001|Washout Period 1|Physician Decision|1|||
125499883|NCT00273052|451462281|FG000|Overall Study|Withdrawal by Subject|16|||
125499884|NCT00273052|451462282|FG001|Overall Study|Withdrawal by Subject|19|||
125499885|NCT00273052|451462281|FG000|Overall Study|Adverse Event|21|||
125499886|NCT00273052|451462282|FG001|Overall Study|Adverse Event|19|||
125499887|NCT00273052|451462281|FG000|Overall Study|Protocol Violation|14|||
125499888|NCT00273052|451462282|FG001|Overall Study|Protocol Violation|18|||
125499889|NCT00273052|451462281|FG000|Overall Study|Lost to Follow-up|7|||
125499890|NCT00273052|451462282|FG001|Overall Study|Lost to Follow-up|25|||
125499891|NCT00273052|451462281|FG000|Overall Study|Lack of Efficacy|6|||
125499892|NCT00273052|451462282|FG001|Overall Study|Lack of Efficacy|4|||
125499893|NCT00273052|451462281|FG000|Overall Study|Non-Compliance|3|||
125499894|NCT00273052|451462282|FG001|Overall Study|Non-Compliance|1|||
125499895|NCT00273052|451462281|FG000|Overall Study|Other|2|||
125499896|NCT00273052|451462282|FG001|Overall Study|Other|0|||
125499897|NCT00273052|451462281|FG000|Overall Study|Worsening serum lipid levels|0|||
125499898|NCT00273052|451462282|FG001|Overall Study|Worsening serum lipid levels|2|||
125499899|NCT00454194|451462284|FG000|Overall Study|Adverse Event|7|||
125499900|NCT00454194|451462285|FG001|Overall Study|Adverse Event|2|||
125499901|NCT00454194|451462284|FG000|Overall Study|Withdrawal by Subject|12|||
125499902|NCT00454194|451462285|FG001|Overall Study|Withdrawal by Subject|8|||
125499903|NCT00454194|451462284|FG000|Overall Study|Other Medical Problems|1|||
125499904|NCT00454194|451462285|FG001|Overall Study|Other Medical Problems|2|||
125499905|NCT00454194|451462284|FG000|Overall Study|Other Unspecified Reason|2|||
125499906|NCT00454194|451462285|FG001|Overall Study|Other Unspecified Reason|2|||
125499907|NCT02827201|451462286|FG000|Overall Study|Death|1|||
125499908|NCT02827201|451462287|FG001|Overall Study|Death|2|||
125499909|NCT02827201|451462286|FG000|Overall Study|Patients not treated|1|||
125499910|NCT02827201|451462287|FG001|Overall Study|Patients not treated|1|||
125499911|NCT00620854|451462288|FG000|Washout 1|Withdrawal by Subject|0|||
125499912|NCT00620854|451462289|FG001|Washout 1|Withdrawal by Subject|0|||
125499913|NCT00620854|451462290|FG002|Washout 1|Withdrawal by Subject|1|||
125304584|NCT00082407|450742689|FG000|Overall Study|Physician Decision|5|||
125499914|NCT00620854|451462291|FG003|Washout 1|Withdrawal by Subject|1|||
125499915|NCT00620854|451462292|FG004|Washout 1|Withdrawal by Subject|0|||
125499916|NCT00620854|451462293|FG005|Washout 1|Withdrawal by Subject|0|||
125304585|NCT00082407|450742690|FG001|Overall Study|Physician Decision|3|||
125304586|NCT00082407|450742689|FG000|Overall Study|Loss of Glucose Control|2|||
125304587|NCT00082407|450742690|FG001|Overall Study|Loss of Glucose Control|2|||
125499917|NCT03345979|451462294|FG000|Overall Study|Withdrawal by Subject|20|||
125499918|NCT03345979|451462295|FG001|Overall Study|Withdrawal by Subject|31|||
125499919|NCT03345979|451462294|FG000|Overall Study|Adverse Event|10|||
125499920|NCT03345979|451462295|FG001|Overall Study|Adverse Event|11|||
125499921|NCT03345979|451462294|FG000|Overall Study|Lost to Follow-up|8|||
125304588|NCT00082407|450742689|FG000|Overall Study|Death|2|||
125304589|NCT00082407|450742690|FG001|Overall Study|Death|1|||
125304590|NCT00082407|450742689|FG000|Overall Study|Lost to Follow-up|0|||
125304591|NCT00082407|450742690|FG001|Overall Study|Lost to Follow-up|3|||
125304592|NCT00891228|450742692|FG000|Overall Study|Adverse Event|0|||
125304593|NCT00891228|450742693|FG001|Overall Study|Adverse Event|2|||
125304594|NCT00891228|450742694|FG002|Overall Study|Adverse Event|3|||
125304595|NCT00891228|450742692|FG000|Overall Study|Withdrawal by Subject|2|||
125304596|NCT00891228|450742693|FG001|Overall Study|Withdrawal by Subject|4|||
125304597|NCT00891228|450742694|FG002|Overall Study|Withdrawal by Subject|5|||
125304598|NCT00891228|450742692|FG000|Overall Study|Protocol Violation|3|||
125304599|NCT00891228|450742693|FG001|Overall Study|Protocol Violation|1|||
125304600|NCT00891228|450742694|FG002|Overall Study|Protocol Violation|2|||
125304601|NCT00891228|450742692|FG000|Overall Study|Physician Decision|2|||
125304602|NCT00891228|450742693|FG001|Overall Study|Physician Decision|1|||
125304603|NCT00891228|450742694|FG002|Overall Study|Physician Decision|0|||
125304604|NCT00891228|450742692|FG000|Overall Study|Lost to Follow-up|4|||
125304605|NCT00891228|450742693|FG001|Overall Study|Lost to Follow-up|4|||
125304606|NCT00891228|450742694|FG002|Overall Study|Lost to Follow-up|5|||
125304607|NCT00891228|450742692|FG000|Overall Study|Pregnancy|0|||
125304608|NCT00891228|450742693|FG001|Overall Study|Pregnancy|1|||
125304609|NCT00891228|450742694|FG002|Overall Study|Pregnancy|0|||
125304610|NCT02688985|450742697|FG000|Overall Study|Adverse Event|1|||
125304611|NCT02688985|450742698|FG001|Overall Study|Adverse Event|2|||
125304612|NCT02688985|450742699|FG002|Overall Study|Adverse Event|2|||
125304613|NCT02688985|450742700|FG003|Overall Study|Adverse Event|0|||
125304614|NCT02688985|450742701|FG004|Overall Study|Adverse Event|0|||
125304615|NCT02688985|450742697|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
125304616|NCT02688985|450742698|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
125304617|NCT02688985|450742699|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
125304618|NCT02688985|450742700|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
125304619|NCT02688985|450742701|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
125304620|NCT02688985|450742697|FG000|Overall Study|Death|0|||
125304621|NCT02688985|450742698|FG001|Overall Study|Death|0|||
125304622|NCT02688985|450742699|FG002|Overall Study|Death|0|||
125304623|NCT02688985|450742700|FG003|Overall Study|Death|0|||
125304624|NCT02688985|450742701|FG004|Overall Study|Death|1|||
125304625|NCT02688985|450742697|FG000|Overall Study|Lack of Efficacy|0|||
125304626|NCT02688985|450742698|FG001|Overall Study|Lack of Efficacy|0|||
125304627|NCT02688985|450742699|FG002|Overall Study|Lack of Efficacy|0|||
125304628|NCT02688985|450742700|FG003|Overall Study|Lack of Efficacy|0|||
125304629|NCT02688985|450742701|FG004|Overall Study|Lack of Efficacy|1|||
125304630|NCT02688985|450742697|FG000|Overall Study|Lost to Follow-up|2|||
125304631|NCT02688985|450742698|FG001|Overall Study|Lost to Follow-up|0|||
125304632|NCT02688985|450742699|FG002|Overall Study|Lost to Follow-up|1|||
125304633|NCT02688985|450742700|FG003|Overall Study|Lost to Follow-up|1|||
125304634|NCT02688985|450742701|FG004|Overall Study|Lost to Follow-up|1|||
125304635|NCT02688985|450742697|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125304636|NCT02688985|450742698|FG001|Overall Study|Non-Compliance With Study Drug|3|||
125304637|NCT02688985|450742699|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125304638|NCT02688985|450742700|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125304639|NCT02688985|450742701|FG004|Overall Study|Non-Compliance With Study Drug|1|||
125304640|NCT02688985|450742697|FG000|Overall Study|Other|3|||
125304641|NCT02688985|450742698|FG001|Overall Study|Other|4|||
125304642|NCT02688985|450742699|FG002|Overall Study|Other|1|||
125304643|NCT02688985|450742700|FG003|Overall Study|Other|0|||
125304644|NCT02688985|450742701|FG004|Overall Study|Other|0|||
125304645|NCT02688985|450742697|FG000|Overall Study|Physician Decision|2|||
125304646|NCT02688985|450742698|FG001|Overall Study|Physician Decision|2|||
125304647|NCT02688985|450742699|FG002|Overall Study|Physician Decision|0|||
125304648|NCT02688985|450742700|FG003|Overall Study|Physician Decision|0|||
125304649|NCT02688985|450742701|FG004|Overall Study|Physician Decision|1|||
125304650|NCT02688985|450742697|FG000|Overall Study|Pregnancy|0|||
125304651|NCT02688985|450742698|FG001|Overall Study|Pregnancy|0|||
125304652|NCT02688985|450742699|FG002|Overall Study|Pregnancy|2|||
125304653|NCT02688985|450742700|FG003|Overall Study|Pregnancy|1|||
125304654|NCT02688985|450742701|FG004|Overall Study|Pregnancy|0|||
125304655|NCT02688985|450742697|FG000|Overall Study|Study Terminated By Sponsor|0|||
125304656|NCT02688985|450742698|FG001|Overall Study|Study Terminated By Sponsor|0|||
125304657|NCT02688985|450742699|FG002|Overall Study|Study Terminated By Sponsor|0|||
125304658|NCT02688985|450742700|FG003|Overall Study|Study Terminated By Sponsor|1|||
125304659|NCT02688985|450742701|FG004|Overall Study|Study Terminated By Sponsor|0|||
125304660|NCT02688985|450742697|FG000|Overall Study|Withdrawal by Subject|2|||
125304661|NCT02688985|450742698|FG001|Overall Study|Withdrawal by Subject|8|||
125304662|NCT02688985|450742699|FG002|Overall Study|Withdrawal by Subject|7|||
125304663|NCT02688985|450742700|FG003|Overall Study|Withdrawal by Subject|1|||
125499922|NCT03345979|451462295|FG001|Overall Study|Lost to Follow-up|9|||
125304664|NCT02688985|450742701|FG004|Overall Study|Withdrawal by Subject|4|||
125304665|NCT01726582|450742702|FG000|Overall Study|Physician Decision|99|||
125304666|NCT01726582|450742702|FG000|Overall Study|Death|85|||
125304667|NCT03704688|450742707|FG000|Overall Study|Adverse Event|0|||
125304668|NCT03704688|450742708|FG001|Overall Study|Adverse Event|0|||
125304669|NCT03704688|450742709|FG002|Overall Study|Adverse Event|0|||
125304670|NCT03704688|450742710|FG003|Overall Study|Adverse Event|4|||
125304671|NCT03704688|450742711|FG004|Overall Study|Adverse Event|1|||
125304672|NCT03704688|450742712|FG005|Overall Study|Adverse Event|0|||
125304673|NCT03704688|450742707|FG000|Overall Study|Disease Progression|0|||
125304674|NCT03704688|450742708|FG001|Overall Study|Disease Progression|0|||
125304675|NCT03704688|450742709|FG002|Overall Study|Disease Progression|0|||
125304676|NCT03704688|450742710|FG003|Overall Study|Disease Progression|3|||
125304677|NCT03704688|450742711|FG004|Overall Study|Disease Progression|1|||
125304678|NCT03704688|450742712|FG005|Overall Study|Disease Progression|0|||
125304679|NCT03704688|450742707|FG000|Overall Study|Death|0|||
125304680|NCT03704688|450742708|FG001|Overall Study|Death|0|||
125304681|NCT03704688|450742709|FG002|Overall Study|Death|0|||
125304682|NCT03704688|450742710|FG003|Overall Study|Death|0|||
125304683|NCT03704688|450742711|FG004|Overall Study|Death|3|||
125304684|NCT03704688|450742712|FG005|Overall Study|Death|0|||
125304685|NCT04878211|450742714|FG000|Overall Study|Lost to Follow-up|0|||
125304686|NCT04878211|450742715|FG001|Overall Study|Lost to Follow-up|0|||
125304687|NCT04878211|450742716|FG002|Overall Study|Lost to Follow-up|0|||
125304688|NCT04878211|450742717|FG003|Overall Study|Lost to Follow-up|1|||
125304689|NCT04878211|450742718|FG004|Overall Study|Lost to Follow-up|0|||
125304690|NCT04878211|450742719|FG005|Overall Study|Lost to Follow-up|1|||
125304691|NCT04878211|450742714|FG000|Overall Study|Protocol deviation|1|||
125304692|NCT04878211|450742715|FG001|Overall Study|Protocol deviation|0|||
125304693|NCT04878211|450742716|FG002|Overall Study|Protocol deviation|0|||
125304694|NCT04878211|450742717|FG003|Overall Study|Protocol deviation|0|||
125304695|NCT04878211|450742718|FG004|Overall Study|Protocol deviation|0|||
125304696|NCT04878211|450742719|FG005|Overall Study|Protocol deviation|0|||
125304697|NCT04878211|450742714|FG000|Overall Study|Study terminated by sponsor|0|||
125304698|NCT04878211|450742715|FG001|Overall Study|Study terminated by sponsor|0|||
125304699|NCT04878211|450742716|FG002|Overall Study|Study terminated by sponsor|0|||
125304700|NCT04878211|450742717|FG003|Overall Study|Study terminated by sponsor|0|||
125499923|NCT03345979|451462294|FG000|Overall Study|Lack of Efficacy|4|||
125499924|NCT03345979|451462295|FG001|Overall Study|Lack of Efficacy|2|||
125499925|NCT03345979|451462294|FG000|Overall Study|Protocol Violation|1|||
125499926|NCT03345979|451462295|FG001|Overall Study|Protocol Violation|3|||
125499927|NCT03345979|451462294|FG000|Overall Study|Physician Decision|0|||
125499928|NCT03345979|451462295|FG001|Overall Study|Physician Decision|2|||
125499929|NCT00999596|451462296|FG000|Overall Study|Statistical population not required|101|||
125499930|NCT00439218|451462299|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
125499931|NCT03176407|451462300|FG000|Overall Study|Protocol Violation|1|||
125499932|NCT03176407|451462300|FG000|Overall Study|human failure|1|||
125499933|NCT03176407|451462300|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
125499934|NCT01428583|451462303|FG000|Overall Study|Adverse Event|75|||
125499935|NCT01428583|451462303|FG000|Overall Study|Withdrawal by Subject|51|||
125499936|NCT01428583|451462303|FG000|Overall Study|Lack of Efficacy|37|||
125499937|NCT01428583|451462303|FG000|Overall Study|Lost to Follow-up|17|||
125499938|NCT01428583|451462303|FG000|Overall Study|Death|1|||
125499939|NCT01428583|451462303|FG000|Overall Study|Pregnancy|1|||
125499940|NCT01428583|451462303|FG000|Overall Study|Protocol Violation|1|||
125499941|NCT01428583|451462303|FG000|Overall Study|Physician Decision|12|||
125499942|NCT01428583|451462303|FG000|Overall Study|Non-compliant|25|||
125499943|NCT01428583|451462303|FG000|Overall Study|Confirmed positive urine drug test|8|||
125499944|NCT01428583|451462303|FG000|Overall Study|Sponsor's request|3|||
125499945|NCT01428583|451462303|FG000|Overall Study|Other|6|||
125499946|NCT01124045|451462306|FG000|Overall Study|Lost to Follow-up|0|||
125499947|NCT01124045|451462307|FG001|Overall Study|Lost to Follow-up|1|||
125499948|NCT01124045|451462306|FG000|Overall Study|Physician Decision|0|||
125499949|NCT01124045|451462307|FG001|Overall Study|Physician Decision|2|||
125499950|NCT03298087|451462308|FG000|Overall Study|Withdrawal by Subject|4|||
125499951|NCT05553366|451462311|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
125304701|NCT04878211|450742718|FG004|Overall Study|Study terminated by sponsor|9|||
125304702|NCT04878211|450742719|FG005|Overall Study|Study terminated by sponsor|4|||
125304703|NCT04878211|450742714|FG000|Overall Study|Subject decision|0|||
125304704|NCT04878211|450742715|FG001|Overall Study|Subject decision|0|||
125304705|NCT04878211|450742716|FG002|Overall Study|Subject decision|0|||
125304706|NCT04878211|450742717|FG003|Overall Study|Subject decision|0|||
125499952|NCT05553366|451462312|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
125499953|NCT05553366|451462313|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
125499954|NCT05553366|451462311|FG000|Overall Study|Lost to Follow-up|3|||
125499955|NCT05553366|451462312|FG001|Overall Study|Lost to Follow-up|3|||
125304707|NCT04878211|450742718|FG004|Overall Study|Subject decision|1|||
125304708|NCT04878211|450742719|FG005|Overall Study|Subject decision|0|||
125304709|NCT02783599|450742720|FG000|Overall Study|Progressive disease|23|||
125304710|NCT02783599|450742720|FG000|Overall Study|Surgical Resection|10|||
125304711|NCT02783599|450742720|FG000|Overall Study|Adverse Event|4|||
125304712|NCT02783599|450742720|FG000|Overall Study|Physician Decision|2|||
125499956|NCT05553366|451462313|FG002|Overall Study|Lost to Follow-up|3|||
125499957|NCT05553366|451462311|FG000|Overall Study|Other non-compliance|1|||
125499958|NCT05553366|451462312|FG001|Overall Study|Other non-compliance|1|||
125499959|NCT05553366|451462313|FG002|Overall Study|Other non-compliance|0|||
125499960|NCT05553366|451462311|FG000|Overall Study|Randomized but not dosed|0|||
125499961|NCT05553366|451462312|FG001|Overall Study|Randomized but not dosed|0|||
125499962|NCT05553366|451462313|FG002|Overall Study|Randomized but not dosed|2|||
125499963|NCT02022657|451462314|FG000|Overall Study|Withdrawal by Subject|2|||
125499964|NCT02022657|451462315|FG001|Overall Study|Withdrawal by Subject|0|||
125499965|NCT02022657|451462316|FG002|Overall Study|Withdrawal by Subject|1|||
125499966|NCT02022657|451462317|FG003|Overall Study|Withdrawal by Subject|0|||
125499967|NCT02022657|451462318|FG004|Overall Study|Withdrawal by Subject|0|||
125499968|NCT02022657|451462319|FG005|Overall Study|Withdrawal by Subject|0|||
125499969|NCT02022657|451462314|FG000|Overall Study|Physician Decision|0|||
125499970|NCT02022657|451462315|FG001|Overall Study|Physician Decision|0|||
125499971|NCT02022657|451462316|FG002|Overall Study|Physician Decision|0|||
125499972|NCT02022657|451462317|FG003|Overall Study|Physician Decision|0|||
125499973|NCT02022657|451462318|FG004|Overall Study|Physician Decision|0|||
125499974|NCT02022657|451462319|FG005|Overall Study|Physician Decision|1|||
125499975|NCT01530334|451462320|FG000|Overall Study|Adverse Event|3|||
125499976|NCT01530334|451462320|FG000|Overall Study|unknown reason|1|||
125499977|NCT01530334|451462320|FG000|Overall Study|Progressive disease|47|||
125499978|NCT01485887|451462322|FG000|Overall Study|Withdrawal by Subject|2|||
125499979|NCT01485887|451462322|FG000|Overall Study|Adverse Event|8|||
125499980|NCT01485887|451462322|FG000|Overall Study|Deterioration of primary disease|1|||
125499981|NCT01485887|451462322|FG000|Overall Study|Primary disease markedly improved|1|||
125499982|NCT03184987|451462326|FG000|Overall Study|Withdrawal by Subject|0|||
125499983|NCT03184987|451462327|FG001|Overall Study|Withdrawal by Subject|1|||
125499984|NCT03184987|451462328|FG002|Overall Study|Withdrawal by Subject|2|||
125499985|NCT03184987|451462326|FG000|Overall Study|Physician Decision|0|||
125499986|NCT03184987|451462327|FG001|Overall Study|Physician Decision|0|||
125499987|NCT03184987|451462328|FG002|Overall Study|Physician Decision|1|||
125499988|NCT03184987|451462326|FG000|Overall Study|Adverse Event|1|||
125499989|NCT03184987|451462327|FG001|Overall Study|Adverse Event|0|||
125499990|NCT03184987|451462328|FG002|Overall Study|Adverse Event|1|||
125499991|NCT00659373|451462331|FG000|Overall Study|Withdrawal by Subject|3|||
125499992|NCT00659373|451462332|FG001|Overall Study|Withdrawal by Subject|5|||
125499993|NCT00659373|451462331|FG000|Overall Study|Assessment Missed|2|||
125499994|NCT00659373|451462332|FG001|Overall Study|Assessment Missed|2|||
125499995|NCT02382640|451462333|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
125499996|NCT02382640|451462334|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
125499997|NCT02382640|451462335|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
125499998|NCT02382640|451462336|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
125499999|NCT03162614|451462339|FG000|Overall Study|Lost to Follow-up|2|||
125500000|NCT03162614|451462340|FG001|Overall Study|Lost to Follow-up|1|||
125500001|NCT03162614|451462341|FG002|Overall Study|Lost to Follow-up|1|||
125500002|NCT03162614|451462342|FG003|Overall Study|Lost to Follow-up|1|||
125500003|NCT03162614|451462343|FG004|Overall Study|Lost to Follow-up|2|||
125500004|NCT03162614|451462344|FG005|Overall Study|Lost to Follow-up|0|||
125500005|NCT03162614|451462339|FG000|Overall Study|Protocol Violation|0|||
125500006|NCT03162614|451462340|FG001|Overall Study|Protocol Violation|1|||
125500007|NCT03162614|451462341|FG002|Overall Study|Protocol Violation|0|||
125500008|NCT03162614|451462342|FG003|Overall Study|Protocol Violation|1|||
125500009|NCT03162614|451462343|FG004|Overall Study|Protocol Violation|0|||
125500010|NCT03162614|451462344|FG005|Overall Study|Protocol Violation|0|||
125500011|NCT03162614|451462339|FG000|Overall Study|Withdrawal by Subject|2|||
125500012|NCT03162614|451462340|FG001|Overall Study|Withdrawal by Subject|1|||
125500013|NCT03162614|451462341|FG002|Overall Study|Withdrawal by Subject|1|||
125500014|NCT03162614|451462342|FG003|Overall Study|Withdrawal by Subject|1|||
125500015|NCT03162614|451462343|FG004|Overall Study|Withdrawal by Subject|0|||
125500016|NCT03162614|451462344|FG005|Overall Study|Withdrawal by Subject|0|||
125500017|NCT03162614|451462339|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
125500018|NCT03162614|451462340|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
125500019|NCT03162614|451462341|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
125500020|NCT03162614|451462342|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
125500021|NCT03162614|451462343|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
125304713|NCT02783599|450742720|FG000|Overall Study|Death|1|||
125500022|NCT03162614|451462344|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
125304714|NCT00856544|450742721|FG000|Overall Study|Randomized but not treated|3|||
125304715|NCT00856544|450742722|FG001|Overall Study|Randomized but not treated|0|||
125500023|NCT00380250|451462345|FG000|Overall Study|Withdrawal by Subject|39|||
125500024|NCT00380250|451462346|FG001|Overall Study|Withdrawal by Subject|28|||
125500025|NCT00380250|451462345|FG000|Overall Study|Adverse Event|20|||
125500026|NCT00380250|451462346|FG001|Overall Study|Adverse Event|9|||
125500027|NCT00380250|451462345|FG000|Overall Study|Lack of Efficacy|10|||
125500028|NCT00380250|451462346|FG001|Overall Study|Lack of Efficacy|8|||
125500029|NCT00380250|451462345|FG000|Overall Study|Protocol Violation|15|||
125500030|NCT00380250|451462346|FG001|Overall Study|Protocol Violation|5|||
125500031|NCT00380250|451462345|FG000|Overall Study|Lost to Follow-up|14|||
125500032|NCT00380250|451462346|FG001|Overall Study|Lost to Follow-up|5|||
125500033|NCT00380250|451462345|FG000|Overall Study|Physician Decision|1|||
125500034|NCT00380250|451462346|FG001|Overall Study|Physician Decision|0|||
125500035|NCT02630966|451462347|FG000|Overall Study|Adverse Event|1|||
125500036|NCT02630966|451462348|FG001|Overall Study|Adverse Event|3|||
125500037|NCT02630966|451462347|FG000|Overall Study|Significant Protocol Deviation|0|||
125500038|NCT02630966|451462348|FG001|Overall Study|Significant Protocol Deviation|2|||
125500039|NCT02630966|451462347|FG000|Overall Study|Voluntary Withdrawal|1|||
125500040|NCT02630966|451462348|FG001|Overall Study|Voluntary Withdrawal|1|||
125500041|NCT02630966|451462347|FG000|Overall Study|Lack of Efficacy|0|||
125500042|NCT02630966|451462348|FG001|Overall Study|Lack of Efficacy|2|||
125500043|NCT00641537|451462349|FG000|96-week Period|Adverse Event|0|||
125500044|NCT00641537|451462350|FG001|96-week Period|Adverse Event|1|||
125500045|NCT00641537|451462351|FG002|96-week Period|Adverse Event|3|||
125500046|NCT00641537|451462352|FG003|96-week Period|Adverse Event|0|||
125500047|NCT00641537|451462353|FG004|96-week Period|Adverse Event|2|||
125500048|NCT00641537|451462354|FG005|96-week Period|Adverse Event|0|||
125500049|NCT00641537|451462355|FG006|96-week Period|Adverse Event|0|||
125500050|NCT00641537|451462356|FG007|96-week Period|Adverse Event|0|||
125500051|NCT00641537|451462349|FG000|96-week Period|Lost to Follow-up|3|||
125500052|NCT00641537|451462350|FG001|96-week Period|Lost to Follow-up|1|||
125500053|NCT00641537|451462351|FG002|96-week Period|Lost to Follow-up|2|||
125500054|NCT00641537|451462352|FG003|96-week Period|Lost to Follow-up|2|||
125500055|NCT00641537|451462353|FG004|96-week Period|Lost to Follow-up|4|||
125500056|NCT00641537|451462354|FG005|96-week Period|Lost to Follow-up|0|||
125500057|NCT00641537|451462355|FG006|96-week Period|Lost to Follow-up|1|||
125500058|NCT00641537|451462356|FG007|96-week Period|Lost to Follow-up|0|||
125500059|NCT00641537|451462349|FG000|96-week Period|Protocol Violation|0|||
125500060|NCT00641537|451462350|FG001|96-week Period|Protocol Violation|1|||
125500061|NCT00641537|451462351|FG002|96-week Period|Protocol Violation|0|||
125500062|NCT00641537|451462352|FG003|96-week Period|Protocol Violation|1|||
125500063|NCT00641537|451462353|FG004|96-week Period|Protocol Violation|0|||
125500064|NCT00641537|451462354|FG005|96-week Period|Protocol Violation|1|||
125500065|NCT00641537|451462355|FG006|96-week Period|Protocol Violation|0|||
125500066|NCT00641537|451462356|FG007|96-week Period|Protocol Violation|0|||
125500067|NCT00641537|451462349|FG000|96-week Period|Death|2|||
125500068|NCT00641537|451462350|FG001|96-week Period|Death|0|||
125500069|NCT00641537|451462351|FG002|96-week Period|Death|1|||
125500070|NCT00641537|451462352|FG003|96-week Period|Death|0|||
125500071|NCT00641537|451462353|FG004|96-week Period|Death|0|||
125500072|NCT00641537|451462354|FG005|96-week Period|Death|0|||
125500073|NCT00641537|451462355|FG006|96-week Period|Death|0|||
125500074|NCT00641537|451462356|FG007|96-week Period|Death|0|||
125500075|NCT00641537|451462349|FG000|96-week Period|Other|4|||
125500076|NCT00641537|451462350|FG001|96-week Period|Other|7|||
125500077|NCT00641537|451462351|FG002|96-week Period|Other|14|||
125500078|NCT00641537|451462352|FG003|96-week Period|Other|9|||
125500079|NCT00641537|451462353|FG004|96-week Period|Other|11|||
125500080|NCT00641537|451462354|FG005|96-week Period|Other|6|||
125500081|NCT00641537|451462355|FG006|96-week Period|Other|4|||
125500082|NCT00641537|451462356|FG007|96-week Period|Other|6|||
125500083|NCT00641537|451462349|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
125500084|NCT00641537|451462350|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
125500085|NCT00641537|451462351|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
125500086|NCT00641537|451462352|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
125500087|NCT00641537|451462353|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
125500088|NCT00641537|451462354|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
125500089|NCT00641537|451462355|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
125304716|NCT00856544|450742723|FG002|Overall Study|Randomized but not treated|0|||
125304717|NCT00856544|450742724|FG003|Overall Study|Randomized but not treated|0|||
125500090|NCT00641537|451462356|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
125500091|NCT00641537|451462349|FG000|24-Week Supplemental Follow-up Period|Other|0|||
125500092|NCT00641537|451462350|FG001|24-Week Supplemental Follow-up Period|Other|2|||
125500093|NCT00641537|451462351|FG002|24-Week Supplemental Follow-up Period|Other|2|||
125500094|NCT00641537|451462352|FG003|24-Week Supplemental Follow-up Period|Other|1|||
125500095|NCT00641537|451462353|FG004|24-Week Supplemental Follow-up Period|Other|3|||
125500096|NCT00641537|451462354|FG005|24-Week Supplemental Follow-up Period|Other|0|||
125500097|NCT00641537|451462355|FG006|24-Week Supplemental Follow-up Period|Other|1|||
125500098|NCT00641537|451462356|FG007|24-Week Supplemental Follow-up Period|Other|1|||
125500099|NCT01801007|451462357|FG000|Overall Study|Adverse Event|2|||
125500100|NCT01801007|451462357|FG000|Overall Study|Lost to Follow-up|4|||
125500101|NCT01801007|451462357|FG000|Overall Study|Withdrawal by Subject|5|||
125500102|NCT00665392|451462358|FG000|Overall Study|not treated|1|||
125500103|NCT00243867|451462359|FG000|Overall Study|Adverse Event|24|||
125500104|NCT00243867|451462360|FG001|Overall Study|Adverse Event|34|||
125500105|NCT00243867|451462359|FG000|Overall Study|Lack of Efficacy|115|||
125500106|NCT00243867|451462360|FG001|Overall Study|Lack of Efficacy|78|||
125500107|NCT00243867|451462359|FG000|Overall Study|Withdrawal by Subject|11|||
125500108|NCT00243867|451462360|FG001|Overall Study|Withdrawal by Subject|23|||
125500109|NCT00243867|451462359|FG000|Overall Study|Lost to Follow-up|2|||
125500110|NCT00243867|451462360|FG001|Overall Study|Lost to Follow-up|1|||
125500111|NCT00243867|451462359|FG000|Overall Study|Physician Decision|2|||
125500112|NCT00243867|451462360|FG001|Overall Study|Physician Decision|7|||
125500113|NCT00243867|451462359|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
125500114|NCT00243867|451462360|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
125500115|NCT01321073|451462365|FG000|Overall Study|Did not attempt implant|4|||
125500116|NCT01321073|451462365|FG000|Overall Study|Death|3|||
125500117|NCT01638000|451462372|FG000|Overall Study|Randomized but Never Received Drug|7|||
125500118|NCT01638000|451462373|FG001|Overall Study|Randomized but Never Received Drug|10|||
125500119|NCT01638000|451462372|FG000|Overall Study|Adverse Event|14|||
125500120|NCT01638000|451462373|FG001|Overall Study|Adverse Event|16|||
125500121|NCT01638000|451462372|FG000|Overall Study|Lack of Efficacy|5|||
125500122|NCT01638000|451462373|FG001|Overall Study|Lack of Efficacy|6|||
125500123|NCT01638000|451462372|FG000|Overall Study|Protocol Violation|11|||
125500124|NCT01638000|451462373|FG001|Overall Study|Protocol Violation|13|||
125500125|NCT01638000|451462372|FG000|Overall Study|Withdrawal by Subject|21|||
125500126|NCT01638000|451462373|FG001|Overall Study|Withdrawal by Subject|24|||
125500127|NCT01638000|451462372|FG000|Overall Study|Miscellaneous|2|||
125500128|NCT01638000|451462373|FG001|Overall Study|Miscellaneous|2|||
125500129|NCT05352230|451462374|FG000|First Intervention (3 Months)|study terminated|2|||
125500130|NCT05352230|451462375|FG001|First Intervention (3 Months)|study terminated|2|||
125500131|NCT01683409|451462376|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
125500132|NCT01683409|451462377|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
125500133|NCT01683409|451462378|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
125500134|NCT01683409|451462379|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
125500135|NCT01683409|451462380|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
125500136|NCT01683409|451462376|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
125500137|NCT01683409|451462377|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
125500138|NCT01683409|451462378|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
125500139|NCT01683409|451462379|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
125500140|NCT01683409|451462380|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
125500141|NCT01683409|451462376|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
125500142|NCT01683409|451462377|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
125500143|NCT01683409|451462378|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
125500144|NCT01683409|451462379|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
125500145|NCT01683409|451462380|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
125500146|NCT01683409|451462376|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
125500147|NCT01683409|451462377|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
125500148|NCT01683409|451462378|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
125500149|NCT01683409|451462379|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
125500150|NCT01683409|451462380|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
125500151|NCT01683409|451462376|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
125500152|NCT01683409|451462377|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
125500153|NCT01683409|451462378|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
125500154|NCT01683409|451462379|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
125500155|NCT01683409|451462380|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
125500156|NCT01683409|451462376|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
125500157|NCT01683409|451462377|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
125500158|NCT01683409|451462378|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
125500159|NCT01683409|451462379|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
125500160|NCT01683409|451462380|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
125500161|NCT01683409|451462376|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
125500162|NCT01683409|451462377|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
125500163|NCT01683409|451462378|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
125500164|NCT01683409|451462379|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
125500165|NCT01683409|451462380|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
125500166|NCT01683409|451462376|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
125500167|NCT01683409|451462377|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
125500168|NCT01683409|451462378|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
125304718|NCT00856544|450742721|FG000|Overall Study|Death|0|||
125304719|NCT00856544|450742722|FG001|Overall Study|Death|2|||
125304720|NCT00856544|450742723|FG002|Overall Study|Death|0|||
125500169|NCT01683409|451462379|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
125500170|NCT01683409|451462380|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
125500171|NCT01683409|451462376|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
125500172|NCT01683409|451462377|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
125304721|NCT00856544|450742724|FG003|Overall Study|Death|0|||
125500173|NCT01683409|451462378|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
125500174|NCT01683409|451462379|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
125500175|NCT01683409|451462380|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
125500176|NCT01683409|451462376|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
125500177|NCT01683409|451462377|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
125500178|NCT01683409|451462378|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
125500179|NCT01683409|451462379|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
125500180|NCT01683409|451462380|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
125500181|NCT01683409|451462376|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
125500182|NCT01683409|451462377|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
125500183|NCT01683409|451462378|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
125500184|NCT01683409|451462379|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
125500185|NCT01683409|451462380|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
125500186|NCT04218864|451462381|FG000|Overall Study|Lost to Follow-up|8|||
125500187|NCT04218864|451462382|FG001|Overall Study|Lost to Follow-up|4|||
125500188|NCT04218864|451462381|FG000|Overall Study|Withdrawal by Subject|1|||
125500189|NCT04218864|451462382|FG001|Overall Study|Withdrawal by Subject|3|||
125500190|NCT01227421|451462383|FG000|Overall Study|Lost to Follow-up|6|||
125500191|NCT01227421|451462384|FG001|Overall Study|Lost to Follow-up|7|||
125500192|NCT01227421|451462385|FG002|Overall Study|Lost to Follow-up|5|||
125500193|NCT01227421|451462383|FG000|Overall Study|Adverse Event|2|||
125500194|NCT01227421|451462384|FG001|Overall Study|Adverse Event|7|||
125500195|NCT01227421|451462385|FG002|Overall Study|Adverse Event|2|||
125500196|NCT01227421|451462383|FG000|Overall Study|Withdrawal by Subject|1|||
125500197|NCT01227421|451462384|FG001|Overall Study|Withdrawal by Subject|2|||
125500198|NCT01227421|451462385|FG002|Overall Study|Withdrawal by Subject|1|||
125500199|NCT01227421|451462383|FG000|Overall Study|Protocol Violation|1|||
125500200|NCT01227421|451462384|FG001|Overall Study|Protocol Violation|1|||
125500201|NCT01227421|451462385|FG002|Overall Study|Protocol Violation|2|||
125500202|NCT01227421|451462383|FG000|Overall Study|Randomized in error|1|||
125500203|NCT01227421|451462384|FG001|Overall Study|Randomized in error|1|||
125500204|NCT01227421|451462385|FG002|Overall Study|Randomized in error|0|||
125500205|NCT02499328|451462386|FG000|Overall Study|Withdrawal by Subject|1|||
125500206|NCT02499328|451462387|FG001|Overall Study|Withdrawal by Subject|1|||
125500207|NCT02499328|451462388|FG002|Overall Study|Withdrawal by Subject|5|||
125500208|NCT02499328|451462389|FG003|Overall Study|Withdrawal by Subject|3|||
125500209|NCT02499328|451462390|FG004|Overall Study|Withdrawal by Subject|5|||
125500210|NCT02499328|451462391|FG005|Overall Study|Withdrawal by Subject|0|||
125500211|NCT02499328|451462392|FG006|Overall Study|Withdrawal by Subject|0|||
125500212|NCT02499328|451462393|FG007|Overall Study|Withdrawal by Subject|0|||
125500213|NCT02499328|451462394|FG008|Overall Study|Withdrawal by Subject|2|||
125500214|NCT02499328|451462395|FG009|Overall Study|Withdrawal by Subject|2|||
125500215|NCT02499328|451462396|FG010|Overall Study|Withdrawal by Subject|0|||
125500216|NCT02499328|451462397|FG011|Overall Study|Withdrawal by Subject|3|||
125500217|NCT02499328|451462398|FG012|Overall Study|Withdrawal by Subject|7|||
125500218|NCT02499328|451462399|FG013|Overall Study|Withdrawal by Subject|3|||
125500219|NCT02499328|451462400|FG014|Overall Study|Withdrawal by Subject|1|||
125500220|NCT02499328|451462401|FG015|Overall Study|Withdrawal by Subject|0|||
125500221|NCT02499328|451462402|FG016|Overall Study|Withdrawal by Subject|0|||
125500222|NCT02499328|451462403|FG017|Overall Study|Withdrawal by Subject|3|||
125500223|NCT02499328|451462404|FG018|Overall Study|Withdrawal by Subject|0|||
125500224|NCT02499328|451462386|FG000|Overall Study|Lost to Follow-up|0|||
125500225|NCT02499328|451462387|FG001|Overall Study|Lost to Follow-up|1|||
125500226|NCT02499328|451462388|FG002|Overall Study|Lost to Follow-up|1|||
125500227|NCT02499328|451462389|FG003|Overall Study|Lost to Follow-up|2|||
125500228|NCT02499328|451462390|FG004|Overall Study|Lost to Follow-up|0|||
125500229|NCT02499328|451462391|FG005|Overall Study|Lost to Follow-up|0|||
125500230|NCT02499328|451462392|FG006|Overall Study|Lost to Follow-up|0|||
125500231|NCT02499328|451462393|FG007|Overall Study|Lost to Follow-up|2|||
125500232|NCT02499328|451462394|FG008|Overall Study|Lost to Follow-up|3|||
125500233|NCT02499328|451462395|FG009|Overall Study|Lost to Follow-up|0|||
125500234|NCT02499328|451462396|FG010|Overall Study|Lost to Follow-up|0|||
125500235|NCT02499328|451462397|FG011|Overall Study|Lost to Follow-up|0|||
125500236|NCT02499328|451462398|FG012|Overall Study|Lost to Follow-up|0|||
125500237|NCT02499328|451462399|FG013|Overall Study|Lost to Follow-up|0|||
125500238|NCT02499328|451462400|FG014|Overall Study|Lost to Follow-up|0|||
125500239|NCT02499328|451462401|FG015|Overall Study|Lost to Follow-up|0|||
125500240|NCT02499328|451462402|FG016|Overall Study|Lost to Follow-up|0|||
125500241|NCT02499328|451462403|FG017|Overall Study|Lost to Follow-up|0|||
125500242|NCT02499328|451462404|FG018|Overall Study|Lost to Follow-up|1|||
125500243|NCT02499328|451462386|FG000|Overall Study|Death|0|||
125500244|NCT02499328|451462387|FG001|Overall Study|Death|3|||
125500245|NCT02499328|451462388|FG002|Overall Study|Death|3|||
125500246|NCT02499328|451462389|FG003|Overall Study|Death|2|||
125500247|NCT02499328|451462390|FG004|Overall Study|Death|4|||
125500248|NCT02499328|451462391|FG005|Overall Study|Death|7|||
125500249|NCT02499328|451462392|FG006|Overall Study|Death|3|||
125500250|NCT02499328|451462393|FG007|Overall Study|Death|0|||
125500251|NCT02499328|451462394|FG008|Overall Study|Death|2|||
125500252|NCT02499328|451462395|FG009|Overall Study|Death|6|||
125500253|NCT02499328|451462396|FG010|Overall Study|Death|6|||
125500254|NCT02499328|451462397|FG011|Overall Study|Death|20|||
125500255|NCT02499328|451462398|FG012|Overall Study|Death|9|||
125500256|NCT02499328|451462399|FG013|Overall Study|Death|7|||
125500257|NCT02499328|451462400|FG014|Overall Study|Death|3|||
125500258|NCT02499328|451462401|FG015|Overall Study|Death|1|||
125500259|NCT02499328|451462402|FG016|Overall Study|Death|1|||
125500260|NCT02499328|451462403|FG017|Overall Study|Death|16|||
125500261|NCT02499328|451462404|FG018|Overall Study|Death|5|||
125500262|NCT02499328|451462386|FG000|Overall Study|"Other"|2|||
125500263|NCT02499328|451462387|FG001|Overall Study|"Other"|2|||
125500264|NCT02499328|451462388|FG002|Overall Study|"Other"|1|||
125500265|NCT02499328|451462389|FG003|Overall Study|"Other"|3|||
125500266|NCT02499328|451462390|FG004|Overall Study|"Other"|6|||
125500267|NCT02499328|451462391|FG005|Overall Study|"Other"|2|||
125500268|NCT02499328|451462392|FG006|Overall Study|"Other"|3|||
125500269|NCT02499328|451462393|FG007|Overall Study|"Other"|4|||
125500270|NCT02499328|451462394|FG008|Overall Study|"Other"|6|||
125500271|NCT02499328|451462395|FG009|Overall Study|"Other"|16|||
125500272|NCT02499328|451462396|FG010|Overall Study|"Other"|13|||
125500273|NCT02499328|451462397|FG011|Overall Study|"Other"|31|||
125500274|NCT02499328|451462398|FG012|Overall Study|"Other"|8|||
125500275|NCT02499328|451462399|FG013|Overall Study|"Other"|7|||
125500276|NCT02499328|451462400|FG014|Overall Study|"Other"|6|||
125500277|NCT02499328|451462401|FG015|Overall Study|"Other"|0|||
125500278|NCT02499328|451462402|FG016|Overall Study|"Other"|0|||
125500279|NCT02499328|451462403|FG017|Overall Study|"Other"|34|||
125500280|NCT02499328|451462404|FG018|Overall Study|"Other"|43|||
125500281|NCT02499328|451462386|FG000|Overall Study|Disease Progression|0|||
125500282|NCT02499328|451462387|FG001|Overall Study|Disease Progression|0|||
125500283|NCT02499328|451462388|FG002|Overall Study|Disease Progression|0|||
125500284|NCT02499328|451462389|FG003|Overall Study|Disease Progression|0|||
125500285|NCT02499328|451462390|FG004|Overall Study|Disease Progression|0|||
125500286|NCT02499328|451462391|FG005|Overall Study|Disease Progression|0|||
125500287|NCT02499328|451462392|FG006|Overall Study|Disease Progression|1|||
125500288|NCT02499328|451462393|FG007|Overall Study|Disease Progression|0|||
125500289|NCT02499328|451462394|FG008|Overall Study|Disease Progression|1|||
125500290|NCT02499328|451462395|FG009|Overall Study|Disease Progression|0|||
125500291|NCT02499328|451462396|FG010|Overall Study|Disease Progression|1|||
125500292|NCT02499328|451462397|FG011|Overall Study|Disease Progression|0|||
125500293|NCT02499328|451462398|FG012|Overall Study|Disease Progression|0|||
125500294|NCT02499328|451462399|FG013|Overall Study|Disease Progression|0|||
125500295|NCT02499328|451462400|FG014|Overall Study|Disease Progression|0|||
125500296|NCT02499328|451462401|FG015|Overall Study|Disease Progression|0|||
125500297|NCT02499328|451462402|FG016|Overall Study|Disease Progression|0|||
125500298|NCT02499328|451462403|FG017|Overall Study|Disease Progression|2|||
125500299|NCT02499328|451462404|FG018|Overall Study|Disease Progression|0|||
125500300|NCT02499328|451462386|FG000|Overall Study|Adverse Event|1|||
125500301|NCT02499328|451462387|FG001|Overall Study|Adverse Event|0|||
125500302|NCT02499328|451462388|FG002|Overall Study|Adverse Event|0|||
125500303|NCT02499328|451462389|FG003|Overall Study|Adverse Event|1|||
125500304|NCT02499328|451462390|FG004|Overall Study|Adverse Event|0|||
125500305|NCT02499328|451462391|FG005|Overall Study|Adverse Event|0|||
125500306|NCT02499328|451462392|FG006|Overall Study|Adverse Event|0|||
125500307|NCT02499328|451462393|FG007|Overall Study|Adverse Event|0|||
125500308|NCT02499328|451462394|FG008|Overall Study|Adverse Event|0|||
125500309|NCT02499328|451462395|FG009|Overall Study|Adverse Event|0|||
125500310|NCT02499328|451462396|FG010|Overall Study|Adverse Event|0|||
125500311|NCT02499328|451462397|FG011|Overall Study|Adverse Event|0|||
125500312|NCT02499328|451462398|FG012|Overall Study|Adverse Event|1|||
125500313|NCT02499328|451462399|FG013|Overall Study|Adverse Event|0|||
125500314|NCT02499328|451462400|FG014|Overall Study|Adverse Event|0|||
125500315|NCT02499328|451462401|FG015|Overall Study|Adverse Event|0|||
125500316|NCT02499328|451462402|FG016|Overall Study|Adverse Event|0|||
125500317|NCT02499328|451462403|FG017|Overall Study|Adverse Event|0|||
125500318|NCT02499328|451462404|FG018|Overall Study|Adverse Event|0|||
125500319|NCT00145470|451462405|FG000|Overall Study|Adverse Event|19|||
125500320|NCT00145470|451462406|FG001|Overall Study|Adverse Event|25|||
125500321|NCT00145470|451462405|FG000|Overall Study|Lack of Efficacy|27|||
125500322|NCT00145470|451462406|FG001|Overall Study|Lack of Efficacy|13|||
125500323|NCT00145470|451462405|FG000|Overall Study|Withdrawal by Subject|36|||
125500324|NCT00145470|451462406|FG001|Overall Study|Withdrawal by Subject|34|||
125500325|NCT00145470|451462405|FG000|Overall Study|Lost to Follow-up|21|||
125500326|NCT00145470|451462406|FG001|Overall Study|Lost to Follow-up|17|||
125500327|NCT00145470|451462405|FG000|Overall Study|Reason Not Reported|9|||
125500328|NCT00145470|451462406|FG001|Overall Study|Reason Not Reported|9|||
125500329|NCT06269003|451462408|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
125500330|NCT06269003|451462409|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
125500331|NCT06269003|451462410|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
125500332|NCT06269003|451462411|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
125500333|NCT04186247|451462412|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
125500334|NCT04186247|451462413|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
125500335|NCT04186247|451462414|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
125500336|NCT04186247|451462415|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
125500337|NCT04186247|451462416|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
125500338|NCT04323800|451464008|FG000|Overall Study|Withdrawal by Subject|4|||
125500339|NCT04323800|451464009|FG001|Overall Study|Withdrawal by Subject|4|||
125500340|NCT04323800|451464008|FG000|Overall Study|Incomplete transfusion|1|||
125500341|NCT04323800|451464009|FG001|Overall Study|Incomplete transfusion|0|||
125500342|NCT04323800|451464008|FG000|Overall Study|Other|0|||
125500343|NCT04323800|451464009|FG001|Overall Study|Other|1|||
125500344|NCT04323800|451464008|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
125500345|NCT04323800|451464009|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
125500346|NCT00489554|451464010|FG000|Overall Study|Adverse Event|2|||
125500347|NCT00489554|451464010|FG000|Overall Study|Withdrawal by Subject|1|||
125500348|NCT00489554|451464010|FG000|Overall Study|Lost to Follow-up|1|||
125500349|NCT06571695|451464011|FG000|Overall Study|Lost to Follow-up|1|||
125500350|NCT06571695|451464012|FG001|Overall Study|Lost to Follow-up|6|||
125500351|NCT01380145|451464013|FG000|Overall Study|Progressive disease|4|||
125500352|NCT02038049|451464018|FG000|Overall Study|Lost to Follow-up|1|||
125500353|NCT02038049|451464019|FG001|Overall Study|Lost to Follow-up|0|||
125500354|NCT01808534|451464020|FG000|Overall Study|Disease progression|3|||
125500355|NCT01808534|451464020|FG000|Overall Study|Physician Decision|1|||
125500356|NCT02660086|451464021|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
125500357|NCT02660086|451464022|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
125500358|NCT02660086|451464021|FG000|Overall Study- 12-month|Left full-time employment|12|||
125500359|NCT02660086|451464022|FG001|Overall Study- 12-month|Left full-time employment|20|||
125500360|NCT02660086|451464021|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
125500361|NCT02660086|451464022|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
125500362|NCT02660086|451464021|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
125500363|NCT02660086|451464022|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
125500364|NCT02660086|451464021|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
125500365|NCT02660086|451464022|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
125500366|NCT02660086|451464021|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
125500367|NCT02660086|451464022|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
125500368|NCT00667017|451464025|FG000|Overall Study|Withdrawal by Subject|1|||
125500369|NCT02605174|451464032|FG000|Overall Study|Adverse Event|0|||
125500370|NCT02605174|451464033|FG001|Overall Study|Adverse Event|0|||
125500371|NCT02605174|451464034|FG002|Overall Study|Adverse Event|1|||
125500372|NCT02605174|451464035|FG003|Overall Study|Adverse Event|0|||
125500373|NCT02605174|451464036|FG004|Overall Study|Adverse Event|4|||
125500374|NCT02605174|451464037|FG005|Overall Study|Adverse Event|0|||
125500375|NCT02605174|451464038|FG006|Overall Study|Adverse Event|0|||
125500376|NCT02605174|451464032|FG000|Overall Study|Lost to Follow-up|20|||
125500377|NCT02605174|451464033|FG001|Overall Study|Lost to Follow-up|7|||
125500378|NCT02605174|451464034|FG002|Overall Study|Lost to Follow-up|27|||
125500379|NCT02605174|451464035|FG003|Overall Study|Lost to Follow-up|10|||
125500380|NCT02605174|451464036|FG004|Overall Study|Lost to Follow-up|20|||
125500381|NCT02605174|451464037|FG005|Overall Study|Lost to Follow-up|10|||
125500382|NCT02605174|451464038|FG006|Overall Study|Lost to Follow-up|29|||
125500383|NCT02605174|451464032|FG000|Overall Study|Protocol Violation|10|||
125500384|NCT02605174|451464033|FG001|Overall Study|Protocol Violation|4|||
125500385|NCT02605174|451464034|FG002|Overall Study|Protocol Violation|14|||
125500386|NCT02605174|451464035|FG003|Overall Study|Protocol Violation|6|||
125500387|NCT02605174|451464036|FG004|Overall Study|Protocol Violation|7|||
125500388|NCT02605174|451464037|FG005|Overall Study|Protocol Violation|7|||
125500389|NCT02605174|451464038|FG006|Overall Study|Protocol Violation|12|||
125500390|NCT02605174|451464032|FG000|Overall Study|Pregnancy|1|||
125500391|NCT02605174|451464033|FG001|Overall Study|Pregnancy|0|||
125304722|NCT00856544|450742721|FG000|Overall Study|Adverse Event|20|||
125500392|NCT02605174|451464034|FG002|Overall Study|Pregnancy|0|||
125304723|NCT00856544|450742722|FG001|Overall Study|Adverse Event|29|||
125500393|NCT02605174|451464035|FG003|Overall Study|Pregnancy|2|||
125500394|NCT02605174|451464036|FG004|Overall Study|Pregnancy|0|||
125500395|NCT02605174|451464037|FG005|Overall Study|Pregnancy|0|||
125500396|NCT02605174|451464038|FG006|Overall Study|Pregnancy|0|||
125500397|NCT02605174|451464032|FG000|Overall Study|Withdrawal by Subject|9|||
125500398|NCT02605174|451464033|FG001|Overall Study|Withdrawal by Subject|6|||
125500399|NCT02605174|451464034|FG002|Overall Study|Withdrawal by Subject|14|||
125500400|NCT02605174|451464035|FG003|Overall Study|Withdrawal by Subject|11|||
125500401|NCT02605174|451464036|FG004|Overall Study|Withdrawal by Subject|6|||
125500402|NCT02605174|451464037|FG005|Overall Study|Withdrawal by Subject|4|||
125500403|NCT02605174|451464038|FG006|Overall Study|Withdrawal by Subject|15|||
125500404|NCT02605174|451464032|FG000|Overall Study|Physician Decision|2|||
125500405|NCT02605174|451464033|FG001|Overall Study|Physician Decision|0|||
125500406|NCT02605174|451464034|FG002|Overall Study|Physician Decision|0|||
125500407|NCT02605174|451464035|FG003|Overall Study|Physician Decision|0|||
125500408|NCT02605174|451464036|FG004|Overall Study|Physician Decision|0|||
125500409|NCT02605174|451464037|FG005|Overall Study|Physician Decision|0|||
125500410|NCT02605174|451464038|FG006|Overall Study|Physician Decision|3|||
125500411|NCT02605174|451464032|FG000|Overall Study|Randomization Failure|22|||
125500412|NCT02605174|451464033|FG001|Overall Study|Randomization Failure|6|||
125500413|NCT02605174|451464034|FG002|Overall Study|Randomization Failure|20|||
125500414|NCT02605174|451464035|FG003|Overall Study|Randomization Failure|7|||
125500415|NCT02605174|451464036|FG004|Overall Study|Randomization Failure|16|||
125500416|NCT02605174|451464037|FG005|Overall Study|Randomization Failure|11|||
125500417|NCT02605174|451464038|FG006|Overall Study|Randomization Failure|30|||
125500418|NCT03737110|451464040|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
125500419|NCT03737110|451464041|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
125500420|NCT03737110|451464042|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
125500421|NCT03737110|451464043|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
125500422|NCT03737110|451464044|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
125500423|NCT03737110|451464045|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
125500424|NCT03737110|451464040|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
125500425|NCT03737110|451464041|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
125500426|NCT03737110|451464042|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
125500427|NCT03737110|451464043|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
125500428|NCT03737110|451464044|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
125500429|NCT03737110|451464045|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
125500430|NCT03737110|451464040|FG000|Run-in (RI) Period|Adverse Event|4|||
125500431|NCT03737110|451464041|FG001|Run-in (RI) Period|Adverse Event|0|||
125500432|NCT03737110|451464042|FG002|Run-in (RI) Period|Adverse Event|0|||
125500433|NCT03737110|451464043|FG003|Run-in (RI) Period|Adverse Event|0|||
125500434|NCT03737110|451464044|FG004|Run-in (RI) Period|Adverse Event|0|||
125500435|NCT03737110|451464045|FG005|Run-in (RI) Period|Adverse Event|0|||
125500436|NCT03737110|451464040|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
125500437|NCT03737110|451464041|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
125500438|NCT03737110|451464042|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
125500439|NCT03737110|451464043|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
125500440|NCT03737110|451464044|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
125500441|NCT03737110|451464045|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
125500442|NCT03737110|451464040|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
125500443|NCT03737110|451464041|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
125500444|NCT03737110|451464042|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
125500445|NCT03737110|451464043|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
125500446|NCT03737110|451464044|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
125500447|NCT03737110|451464045|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
125500448|NCT03737110|451464040|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
125500449|NCT03737110|451464041|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
125500450|NCT03737110|451464042|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
125500451|NCT03737110|451464043|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
125500452|NCT03737110|451464044|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
125500453|NCT03737110|451464045|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
125500454|NCT03737110|451464040|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
125500455|NCT03737110|451464041|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
125500456|NCT03737110|451464042|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
125500457|NCT03737110|451464043|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
125500458|NCT03737110|451464044|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
125500459|NCT03737110|451464045|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
125500460|NCT03737110|451464040|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
125500461|NCT03737110|451464041|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
125500462|NCT03737110|451464042|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
125500463|NCT03737110|451464043|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
125500464|NCT03737110|451464044|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
125500465|NCT03737110|451464045|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
125500466|NCT02575365|451464046|FG000|Overall Study|Lost to Follow-up|4|||
125500467|NCT03865732|451464051|FG000|Overall Study|Adverse Event|0|||
125500468|NCT03865732|451464052|FG001|Overall Study|Adverse Event|1|||
125500469|NCT03392194|451464053|FG000|Overall Study|Withdrawal by Subject|1|||
125500470|NCT03392194|451464054|FG001|Overall Study|Withdrawal by Subject|2|||
125500471|NCT03392194|451464053|FG000|Overall Study|Conflicts with personal schedule|1|||
125500472|NCT03392194|451464054|FG001|Overall Study|Conflicts with personal schedule|0|||
125500473|NCT01951703|451464065|FG000|First Intervention|Withdrawal by Subject|1|||
125500474|NCT01951703|451464066|FG001|First Intervention|Withdrawal by Subject|0|||
125500475|NCT01951703|451464065|FG000|First Intervention|Subject was not compliant|1|||
125500476|NCT01951703|451464066|FG001|First Intervention|Subject was not compliant|1|||
125500477|NCT01951703|451464065|FG000|First Intervention|Physician Decision|1|||
125500478|NCT01951703|451464066|FG001|First Intervention|Physician Decision|0|||
125500479|NCT01951703|451464065|FG000|Second Intervention|Protocol Violation|0|||
125500480|NCT01951703|451464066|FG001|Second Intervention|Protocol Violation|1|||
125500481|NCT01951703|451464065|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
125500482|NCT01951703|451464066|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
125500483|NCT01009645|451464067|FG000|Overall Study|Lost to Follow-up|2|||
125500484|NCT01009645|451464068|FG001|Overall Study|Lost to Follow-up|8|||
125500485|NCT01009645|451464069|FG002|Overall Study|Lost to Follow-up|4|||
125500486|NCT01009645|451464070|FG003|Overall Study|Lost to Follow-up|5|||
125500487|NCT00487240|451464071|FG000|Overall Study|Withdrawal by Subject|12|||
125500488|NCT00487240|451464072|FG001|Overall Study|Withdrawal by Subject|6|||
125500489|NCT00487240|451464071|FG000|Overall Study|Lost to Follow-up|7|||
125500490|NCT00487240|451464072|FG001|Overall Study|Lost to Follow-up|6|||
125500491|NCT00487240|451464071|FG000|Overall Study|Adverse Event|0|||
125500492|NCT00487240|451464072|FG001|Overall Study|Adverse Event|4|||
125500493|NCT00487240|451464071|FG000|Overall Study|Protocol Violation|5|||
125500494|NCT00487240|451464072|FG001|Overall Study|Protocol Violation|5|||
125500495|NCT00487240|451464071|FG000|Overall Study|Entry Criteria Not Met|3|||
125500496|NCT00487240|451464072|FG001|Overall Study|Entry Criteria Not Met|4|||
125500497|NCT00487240|451464071|FG000|Overall Study|Sponsor Decision|2|||
125500498|NCT00487240|451464072|FG001|Overall Study|Sponsor Decision|1|||
125500499|NCT00487240|451464071|FG000|Overall Study|Physician Decision|2|||
125500500|NCT00487240|451464072|FG001|Overall Study|Physician Decision|0|||
125500501|NCT01019135|451464075|FG000|Overall Study|Did not receive allocated intervention|12|||
125500502|NCT01019135|451464076|FG001|Overall Study|Did not receive allocated intervention|6|||
125500503|NCT01019135|451464077|FG002|Overall Study|Did not receive allocated intervention|25|||
125500504|NCT01019135|451464075|FG000|Overall Study|Did not attend CR|8|||
125500505|NCT01019135|451464076|FG001|Overall Study|Did not attend CR|13|||
125500506|NCT01019135|451464077|FG002|Overall Study|Did not attend CR|6|||
125500507|NCT05124210|451464078|FG000|Overall Study|Lost to Follow-up|1|||
125500508|NCT05124210|451464079|FG001|Overall Study|Lost to Follow-up|0|||
125500509|NCT05124210|451464078|FG000|Overall Study|Withdrawal by Subject|1|||
125500510|NCT05124210|451464079|FG001|Overall Study|Withdrawal by Subject|0|||
125500511|NCT00768755|451464082|FG000|Phase 1|Death|6|||
125500512|NCT00768755|451464083|FG001|Phase 1|Death|0|||
125500513|NCT00768755|451464084|FG002|Phase 1|Death|0|||
125500514|NCT00768755|451464085|FG003|Phase 1|Death|0|||
125500515|NCT00768755|451464082|FG000|Phase 1|Other|4|||
125500516|NCT00768755|451464083|FG001|Phase 1|Other|0|||
125500517|NCT00768755|451464084|FG002|Phase 1|Other|0|||
125500518|NCT00768755|451464085|FG003|Phase 1|Other|0|||
125500519|NCT00768755|451464082|FG000|Phase 2|Death|0|||
125500520|NCT00768755|451464083|FG001|Phase 2|Death|37|||
125500521|NCT00768755|451464084|FG002|Phase 2|Death|48|||
125500522|NCT00768755|451464085|FG003|Phase 2|Death|31|||
125500523|NCT00768755|451464082|FG000|Phase 2|Protocol Violation|0|||
125500524|NCT00768755|451464083|FG001|Phase 2|Protocol Violation|2|||
125500525|NCT00768755|451464084|FG002|Phase 2|Protocol Violation|0|||
125500526|NCT00768755|451464085|FG003|Phase 2|Protocol Violation|1|||
125500527|NCT00768755|451464082|FG000|Phase 2|Lost to Follow-up|0|||
125500528|NCT00768755|451464083|FG001|Phase 2|Lost to Follow-up|1|||
125500529|NCT00768755|451464084|FG002|Phase 2|Lost to Follow-up|1|||
125500530|NCT00768755|451464085|FG003|Phase 2|Lost to Follow-up|4|||
125500531|NCT00768755|451464082|FG000|Phase 2|Withdrawal by Subject|0|||
125500532|NCT00768755|451464083|FG001|Phase 2|Withdrawal by Subject|1|||
125500533|NCT00768755|451464084|FG002|Phase 2|Withdrawal by Subject|0|||
125500534|NCT00768755|451464085|FG003|Phase 2|Withdrawal by Subject|1|||
125500535|NCT00768755|451464082|FG000|Phase 2|Other|0|||
125500536|NCT00768755|451464083|FG001|Phase 2|Other|1|||
125304724|NCT00856544|450742723|FG002|Overall Study|Adverse Event|2|||
125304725|NCT00856544|450742724|FG003|Overall Study|Adverse Event|3|||
125304726|NCT00856544|450742721|FG000|Overall Study|Lack of Efficacy|16|||
125500537|NCT00768755|451464084|FG002|Phase 2|Other|2|||
125500538|NCT00768755|451464085|FG003|Phase 2|Other|4|||
125500539|NCT00768755|451464082|FG000|Phase 2|Study Terminated by Sponsor|0|||
125500540|NCT00768755|451464083|FG001|Phase 2|Study Terminated by Sponsor|13|||
125500541|NCT00768755|451464084|FG002|Phase 2|Study Terminated by Sponsor|7|||
125500542|NCT00768755|451464085|FG003|Phase 2|Study Terminated by Sponsor|14|||
125500543|NCT00768755|451464082|FG000|Phase 2|Randomized but not treated|0|||
125500544|NCT00768755|451464083|FG001|Phase 2|Randomized but not treated|0|||
125500545|NCT00768755|451464084|FG002|Phase 2|Randomized but not treated|0|||
125500546|NCT00768755|451464085|FG003|Phase 2|Randomized but not treated|2|||
125500547|NCT02095678|451464090|FG000|Overall Study|Withdrawal by Subject|0|||
125500548|NCT02095678|451464091|FG001|Overall Study|Withdrawal by Subject|1|||
125500549|NCT02095678|451464090|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
125304727|NCT00856544|450742722|FG001|Overall Study|Lack of Efficacy|12|||
125500550|NCT02095678|451464091|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
125500551|NCT02095678|451464090|FG000|Overall Study|lesion impacted by previous treatment|1|||
125500552|NCT02095678|451464091|FG001|Overall Study|lesion impacted by previous treatment|1|||
125500553|NCT02095678|451464090|FG000|Overall Study|No Confirmed Diagnosis|0|||
125500554|NCT02095678|451464091|FG001|Overall Study|No Confirmed Diagnosis|3|||
125500555|NCT02095678|451464090|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
125500556|NCT02095678|451464091|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
125500557|NCT02095678|451464090|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
125500558|NCT02095678|451464091|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
125500559|NCT02203799|451464092|FG000|Overall Study|Withdrawal by Subject|3|||
125500560|NCT00681109|451464093|FG000|Overall Study|Lost to Follow-up|2|||
125500561|NCT00681109|451464094|FG001|Overall Study|Lost to Follow-up|6|||
125500562|NCT00681109|451464095|FG002|Overall Study|Lost to Follow-up|0|||
125500563|NCT04660799|451464096|FG000|Overall Study|Progressive Disease|1|||
125500564|NCT04660799|451464097|FG001|Overall Study|Progressive Disease|1|||
125500565|NCT04660799|451464096|FG000|Overall Study|Death|2|||
125500566|NCT04660799|451464097|FG001|Overall Study|Death|1|||
125500567|NCT04660799|451464096|FG000|Overall Study|Adverse Event|2|||
125500568|NCT04660799|451464097|FG001|Overall Study|Adverse Event|1|||
125500569|NCT04660799|451464096|FG000|Overall Study|Withdrawal by Subject|2|||
125500570|NCT04660799|451464097|FG001|Overall Study|Withdrawal by Subject|5|||
125500571|NCT01220999|451464100|FG000|Overall Study|Progressive disease|0|||
125500572|NCT01220999|451464101|FG001|Overall Study|Progressive disease|0|||
125500573|NCT01220999|451464102|FG002|Overall Study|Progressive disease|1|||
125500574|NCT01220999|451464103|FG003|Overall Study|Progressive disease|0|||
125500575|NCT01220999|451464104|FG004|Overall Study|Progressive disease|0|||
125500576|NCT01560429|451464105|FG000|Overall Study|Protocol Violation|3|||
125500577|NCT01560429|451464106|FG001|Overall Study|Protocol Violation|6|||
125500578|NCT00391170|451464117|FG000|Overall Study|Withdrawal by Subject|1|||
125500579|NCT00391170|451464118|FG001|Overall Study|Withdrawal by Subject|0|||
125500580|NCT00391170|451464117|FG000|Overall Study|Adverse Event|3|||
125500581|NCT00391170|451464118|FG001|Overall Study|Adverse Event|2|||
125500582|NCT00391170|451464117|FG000|Overall Study|Physician Decision|2|||
125500583|NCT00391170|451464118|FG001|Overall Study|Physician Decision|2|||
125500584|NCT03026166|451464123|FG000|Overall Study|Death|22|||
125500585|NCT03026166|451464124|FG001|Overall Study|Death|7|||
125500586|NCT03026166|451464123|FG000|Overall Study|Physician Decision|2|||
125500587|NCT03026166|451464124|FG001|Overall Study|Physician Decision|0|||
125500588|NCT03026166|451464123|FG000|Overall Study|Withdrawal by Subject|1|||
125500589|NCT03026166|451464124|FG001|Overall Study|Withdrawal by Subject|2|||
125500590|NCT03026166|451464123|FG000|Overall Study|Lost to Follow-up|1|||
125500591|NCT03026166|451464124|FG001|Overall Study|Lost to Follow-up|0|||
125500592|NCT03026166|451464123|FG000|Overall Study|Study Terminated by Sponsor|3|||
125500593|NCT03026166|451464124|FG001|Overall Study|Study Terminated by Sponsor|3|||
125500594|NCT03026166|451464123|FG000|Overall Study|Other|1|||
125500595|NCT03026166|451464124|FG001|Overall Study|Other|0|||
125500596|NCT03035942|451464125|FG000|Overall Study|Adverse Event|8|||
125500597|NCT03035942|451464126|FG001|Overall Study|Adverse Event|4|||
125500598|NCT03035942|451464127|FG002|Overall Study|Adverse Event|5|||
125500599|NCT05270460|451464128|FG000|Overall Study|Adverse Event|0|||
125500600|NCT05270460|451464129|FG001|Overall Study|Adverse Event|1|||
125500601|NCT05270460|451464130|FG002|Overall Study|Adverse Event|0|||
125500602|NCT05270460|451464128|FG000|Overall Study|Early Termination|0|||
125500603|NCT05270460|451464129|FG001|Overall Study|Early Termination|1|||
125500604|NCT05270460|451464130|FG002|Overall Study|Early Termination|0|||
125500605|NCT02091752|451464131|FG000|Overall Study|Study terminated by Sponsor|2|||
125500606|NCT02091752|451464131|FG000|Overall Study|Adverse Event|1|||
125500607|NCT01989104|451464132|FG000|Overall Study|Withdrawal by Subject|3|||
125500608|NCT01989104|451464133|FG001|Overall Study|Withdrawal by Subject|0|||
125500609|NCT01989104|451464134|FG002|Overall Study|Withdrawal by Subject|0|||
125500610|NCT01989104|451464135|FG003|Overall Study|Withdrawal by Subject|0|||
125304728|NCT00856544|450742723|FG002|Overall Study|Lack of Efficacy|3|||
125304729|NCT00856544|450742724|FG003|Overall Study|Lack of Efficacy|3|||
125304730|NCT00856544|450742721|FG000|Overall Study|Other|9|||
125304731|NCT00856544|450742722|FG001|Overall Study|Other|16|||
125304732|NCT00856544|450742723|FG002|Overall Study|Other|1|||
125500611|NCT01989104|451464136|FG004|Overall Study|Withdrawal by Subject|0|||
125500612|NCT04029090|451464138|FG000|Overall Study|Protocol Violation|1|||
125500613|NCT04029090|451464139|FG001|Overall Study|Protocol Violation|0|||
125500614|NCT04029090|451464140|FG002|Overall Study|Protocol Violation|0|||
125500615|NCT04029090|451464138|FG000|Overall Study|Withdrawal by Subject|0|||
125500616|NCT04029090|451464139|FG001|Overall Study|Withdrawal by Subject|1|||
125500617|NCT04029090|451464140|FG002|Overall Study|Withdrawal by Subject|0|||
125500618|NCT01065779|451464144|FG000|Overall Study|Duplicate Investigation|1|||
125500619|NCT01065779|451464144|FG000|Overall Study|Investigation Before Contract Date|37|||
125500620|NCT01065779|451464144|FG000|Overall Study|Non-enrollment Period Administration|10|||
125500621|NCT01065779|451464144|FG000|Overall Study|Not Administered With Study Drug|17|||
125500622|NCT01065779|451464144|FG000|Overall Study|Failed to Follow-up|10|||
125500623|NCT01065779|451464144|FG000|Overall Study|Inclusion Criteria Violation|7|||
125500624|NCT02157948|451464145|FG000|Overall Study|Withdrawal by Subject|4|||
125500625|NCT02157948|451464146|FG001|Overall Study|Withdrawal by Subject|5|||
125500626|NCT02157948|451464145|FG000|Overall Study|Lost to Follow-up|3|||
125500627|NCT02157948|451464146|FG001|Overall Study|Lost to Follow-up|2|||
125500628|NCT02157948|451464145|FG000|Overall Study|Protocol Specified Criteria|2|||
125500629|NCT02157948|451464146|FG001|Overall Study|Protocol Specified Criteria|1|||
125500630|NCT02157948|451464145|FG000|Overall Study|Decision by Sponsor|0|||
125500631|NCT02157948|451464146|FG001|Overall Study|Decision by Sponsor|1|||
125500632|NCT01604824|451464147|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
125500633|NCT01604824|451464148|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
125500634|NCT01604824|451464149|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
125500635|NCT01604824|451464150|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
125500636|NCT01604824|451464151|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
125500637|NCT01604824|451464152|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
125500638|NCT01604824|451464147|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
125500639|NCT01604824|451464148|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
125500640|NCT01604824|451464149|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
125500641|NCT01604824|451464150|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
125500642|NCT01604824|451464151|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
125500643|NCT01604824|451464152|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
125500644|NCT03775213|451464159|FG000|Overall Study|Withdrawal by Subject|51|||
125500645|NCT03775213|451464160|FG001|Overall Study|Withdrawal by Subject|53|||
125500646|NCT03775213|451464159|FG000|Overall Study|Incomplete Survey|7|||
125500647|NCT03775213|451464160|FG001|Overall Study|Incomplete Survey|7|||
125500648|NCT04821271|451464161|FG000|Period 1|Withdrawal by Subject|2|||
125500649|NCT04821271|451464162|FG001|Period 1|Withdrawal by Subject|0|||
125500650|NCT01567852|451465056|FG000|Overall Study|Withdrawal by Subject|3|||
125500651|NCT01567852|451465057|FG001|Overall Study|Withdrawal by Subject|6|||
125500652|NCT01567852|451465056|FG000|Overall Study|ECT discontinued|1|||
125500653|NCT01567852|451465057|FG001|Overall Study|ECT discontinued|1|||
125500654|NCT04809623|451465058|FG000|Overall Study|Study Terminated by Sponsor|1|||
125500655|NCT04809623|451465059|FG001|Overall Study|Study Terminated by Sponsor|0|||
125500656|NCT02202317|451465060|FG000|Overall Study|Lost to Follow-up|1|||
125500657|NCT01450007|451465066|FG000|Overall Study|Late exclusion before treatment|2|||
125500658|NCT01450007|451465067|FG001|Overall Study|Late exclusion before treatment|3|||
125500659|NCT01450007|451465068|FG002|Overall Study|Late exclusion before treatment|2|||
125500660|NCT01450007|451465066|FG000|Overall Study|Protocol Violation|0|||
125500661|NCT01450007|451465067|FG001|Overall Study|Protocol Violation|1|||
125500662|NCT01450007|451465068|FG002|Overall Study|Protocol Violation|1|||
125500663|NCT01450007|451465066|FG000|Overall Study|Adverse Event|0|||
125500664|NCT01450007|451465067|FG001|Overall Study|Adverse Event|1|||
125500665|NCT01450007|451465068|FG002|Overall Study|Adverse Event|0|||
125500666|NCT01852045|451465075|FG000|Overall Study|Adverse Event|1|||
125500667|NCT01852045|451465076|FG001|Overall Study|Adverse Event|0|||
125500668|NCT01852045|451465077|FG002|Overall Study|Adverse Event|0|||
125500669|NCT01852045|451465075|FG000|Overall Study|Lack of Efficacy|3|||
125500670|NCT01852045|451465076|FG001|Overall Study|Lack of Efficacy|0|||
125500671|NCT01852045|451465077|FG002|Overall Study|Lack of Efficacy|0|||
125500672|NCT01852045|451465075|FG000|Overall Study|Lost to Follow-up|0|||
125500673|NCT01852045|451465076|FG001|Overall Study|Lost to Follow-up|1|||
125500674|NCT01852045|451465077|FG002|Overall Study|Lost to Follow-up|1|||
125500675|NCT01852045|451465075|FG000|Overall Study|Withdrawal by Subject|1|||
125500676|NCT01852045|451465076|FG001|Overall Study|Withdrawal by Subject|0|||
125500677|NCT01852045|451465077|FG002|Overall Study|Withdrawal by Subject|1|||
125500678|NCT01852045|451465075|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125500679|NCT01852045|451465076|FG001|Overall Study|Other Miscellaneous Reasons|3|||
125500680|NCT01852045|451465077|FG002|Overall Study|Other Miscellaneous Reasons|2|||
125500681|NCT01698918|451465078|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
125500682|NCT01698918|451465078|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
125500683|NCT01698918|451465078|FG000|First Line Treatment (Core+Extension)|Death|2|||
125500684|NCT01698918|451465078|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
125500685|NCT01698918|451465078|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
125500686|NCT01698918|451465078|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
125500687|NCT01698918|451465078|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
125500688|NCT01698918|451465078|FG000|Second Line Treatment (Core+Extension)|Death|1|||
125500689|NCT01698918|451465078|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
125500690|NCT01698918|451465078|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
125500691|NCT00822900|451465079|FG000|Overall Study|Withdrawal by Subject|14|||
125500692|NCT00822900|451465080|FG001|Overall Study|Withdrawal by Subject|14|||
125500693|NCT00822900|451465079|FG000|Overall Study|Lost to Follow-up|9|||
125500694|NCT00822900|451465080|FG001|Overall Study|Lost to Follow-up|9|||
125500695|NCT00822900|451465079|FG000|Overall Study|Death|83|||
125500696|NCT00822900|451465080|FG001|Overall Study|Death|69|||
125500697|NCT00822900|451465079|FG000|Overall Study|Became a ward of the state|2|||
125500698|NCT00822900|451465080|FG001|Overall Study|Became a ward of the state|1|||
125500699|NCT02234141|451465081|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
125500700|NCT02234141|451465082|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
125500701|NCT02234141|451465083|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
125500702|NCT02234141|451465084|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
125500703|NCT02234141|451465085|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
125500704|NCT02234141|451465086|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
125500705|NCT02234141|451465087|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
125500706|NCT02234141|451465081|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
125500707|NCT02234141|451465082|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
125500708|NCT02234141|451465083|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
125500709|NCT02234141|451465084|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
125500710|NCT02234141|451465085|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
125500711|NCT02234141|451465086|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
125500712|NCT02234141|451465087|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
125500713|NCT02234141|451465081|FG000|Treatment Period (24 Weeks)|Death|1|||
125500714|NCT02234141|451465082|FG001|Treatment Period (24 Weeks)|Death|2|||
125500715|NCT02234141|451465083|FG002|Treatment Period (24 Weeks)|Death|0|||
125500716|NCT02234141|451465084|FG003|Treatment Period (24 Weeks)|Death|1|||
125500717|NCT02234141|451465085|FG004|Treatment Period (24 Weeks)|Death|0|||
125500718|NCT02234141|451465086|FG005|Treatment Period (24 Weeks)|Death|0|||
125500719|NCT02234141|451465087|FG006|Treatment Period (24 Weeks)|Death|0|||
125500720|NCT02234141|451465081|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
125500721|NCT02234141|451465082|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
125500722|NCT02234141|451465083|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
125500723|NCT02234141|451465084|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
125500724|NCT02234141|451465085|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
125500725|NCT02234141|451465086|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
125500726|NCT02234141|451465087|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
125500727|NCT02234141|451465081|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
125500728|NCT02234141|451465082|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
125500729|NCT02234141|451465083|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
125500730|NCT02234141|451465084|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
125500731|NCT02234141|451465085|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
125500732|NCT02234141|451465086|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
125500733|NCT02234141|451465087|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
125500734|NCT02234141|451465081|FG000|Long-Term Treatment Period|Death|0|||
125500735|NCT02234141|451465082|FG001|Long-Term Treatment Period|Death|0|||
125500736|NCT02234141|451465083|FG002|Long-Term Treatment Period|Death|0|||
125500737|NCT02234141|451465084|FG003|Long-Term Treatment Period|Death|0|||
125500738|NCT02234141|451465085|FG004|Long-Term Treatment Period|Death|0|||
125500739|NCT02234141|451465086|FG005|Long-Term Treatment Period|Death|1|||
125500740|NCT02234141|451465087|FG006|Long-Term Treatment Period|Death|0|||
125500741|NCT02234141|451465081|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
125500742|NCT02234141|451465082|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
125500743|NCT02234141|451465083|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
125500744|NCT02234141|451465084|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
125500745|NCT02234141|451465085|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
125500746|NCT02234141|451465086|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
125500747|NCT02234141|451465087|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
125500748|NCT02234141|451465081|FG000|Long-Term Treatment Period|Adverse Event|4|||
125500749|NCT02234141|451465082|FG001|Long-Term Treatment Period|Adverse Event|0|||
125500750|NCT02234141|451465083|FG002|Long-Term Treatment Period|Adverse Event|5|||
125500751|NCT02234141|451465084|FG003|Long-Term Treatment Period|Adverse Event|0|||
125500752|NCT02234141|451465085|FG004|Long-Term Treatment Period|Adverse Event|1|||
125500753|NCT02234141|451465086|FG005|Long-Term Treatment Period|Adverse Event|1|||
125500754|NCT02234141|451465087|FG006|Long-Term Treatment Period|Adverse Event|1|||
125500755|NCT02234141|451465081|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
125500756|NCT02234141|451465082|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
125500757|NCT02234141|451465083|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
125500758|NCT02234141|451465084|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
125500759|NCT02234141|451465085|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
125500760|NCT02234141|451465086|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
125500761|NCT02234141|451465087|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
125500762|NCT02234141|451465081|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
125500763|NCT02234141|451465082|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
125500764|NCT02234141|451465083|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
125500765|NCT02234141|451465084|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
125500766|NCT02234141|451465085|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
125500767|NCT02234141|451465086|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
125500768|NCT02234141|451465087|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
125500769|NCT00701415|451465088|FG000|Overall Study|Adverse Event|0|||
125500770|NCT00701415|451465089|FG001|Overall Study|Adverse Event|1|||
125500771|NCT00701415|451465088|FG000|Overall Study|Social/family issues and needle phobia|1|||
125500772|NCT00701415|451465089|FG001|Overall Study|Social/family issues and needle phobia|0|||
125500773|NCT02106884|451465092|FG000|Overall Study|Change of diagnosis/exclusion|0|||
125500774|NCT02106884|451465093|FG001|Overall Study|Change of diagnosis/exclusion|1|||
125500775|NCT02161458|451465094|FG000|Overall Study|Withdrawal by Subject|0|||
125500776|NCT02161458|451465095|FG001|Overall Study|Withdrawal by Subject|4|||
125500777|NCT02161458|451465096|FG002|Overall Study|Withdrawal by Subject|4|||
125500778|NCT02161458|451465097|FG003|Overall Study|Withdrawal by Subject|0|||
125500779|NCT02161458|451465094|FG000|Overall Study|Lost to Follow-up|0|||
125500780|NCT02161458|451465095|FG001|Overall Study|Lost to Follow-up|2|||
125500781|NCT02161458|451465096|FG002|Overall Study|Lost to Follow-up|1|||
125500782|NCT02161458|451465097|FG003|Overall Study|Lost to Follow-up|0|||
125500783|NCT03042767|451465098|FG000|Overall Study|Lost to Follow-up|1|||
125500784|NCT03042767|451465099|FG001|Overall Study|Lost to Follow-up|2|||
125500785|NCT02037568|451465102|FG000|Overall Study|Withdrawal by Subject|17|||
125500786|NCT02037568|451465103|FG001|Overall Study|Withdrawal by Subject|24|||
125500787|NCT02037568|451465102|FG000|Overall Study|Lost to Follow-up|16|||
125500788|NCT02037568|451465103|FG001|Overall Study|Lost to Follow-up|13|||
125500789|NCT02037568|451465102|FG000|Overall Study|Screen Failure|3|||
125500790|NCT02037568|451465103|FG001|Overall Study|Screen Failure|1|||
125500791|NCT02037568|451465102|FG000|Overall Study|Patient did not receive transplant|0|||
125500792|NCT02037568|451465103|FG001|Overall Study|Patient did not receive transplant|1|||
125500793|NCT03861234|451465104|FG000|Overall Study|Not treated|0|||
125500794|NCT03861234|451465105|FG001|Overall Study|Not treated|0|||
125500795|NCT03861234|451465106|FG002|Overall Study|Not treated|0|||
125500796|NCT03861234|451465107|FG003|Overall Study|Not treated|0|||
125500797|NCT03861234|451465108|FG004|Overall Study|Not treated|0|||
125500798|NCT03861234|451465109|FG005|Overall Study|Not treated|1|||
125500799|NCT03861234|451465110|FG006|Overall Study|Not treated|0|||
125500800|NCT03861234|451465111|FG007|Overall Study|Not treated|0|||
125500801|NCT03861234|451465104|FG000|Overall Study|Adverse Event|0|||
125500802|NCT03861234|451465105|FG001|Overall Study|Adverse Event|0|||
125500803|NCT03861234|451465106|FG002|Overall Study|Adverse Event|0|||
125500804|NCT03861234|451465107|FG003|Overall Study|Adverse Event|0|||
125500805|NCT03861234|451465108|FG004|Overall Study|Adverse Event|0|||
125500806|NCT03861234|451465109|FG005|Overall Study|Adverse Event|1|||
125500807|NCT03861234|451465110|FG006|Overall Study|Adverse Event|0|||
125500808|NCT03861234|451465111|FG007|Overall Study|Adverse Event|0|||
125500809|NCT03861234|451465104|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
125500810|NCT03861234|451465105|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
125500811|NCT03861234|451465106|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
125500812|NCT03861234|451465107|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
125500813|NCT03861234|451465108|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
125500814|NCT03861234|451465109|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
125500815|NCT03861234|451465110|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
125500816|NCT03861234|451465111|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
125500817|NCT03861234|451465104|FG000|Overall Study|As per sponsor decision|0|||
125500818|NCT03861234|451465105|FG001|Overall Study|As per sponsor decision|0|||
125500819|NCT03861234|451465106|FG002|Overall Study|As per sponsor decision|0|||
125500820|NCT03861234|451465107|FG003|Overall Study|As per sponsor decision|0|||
125500821|NCT03861234|451465108|FG004|Overall Study|As per sponsor decision|0|||
125500822|NCT03861234|451465109|FG005|Overall Study|As per sponsor decision|0|||
125500823|NCT03861234|451465110|FG006|Overall Study|As per sponsor decision|1|||
125500824|NCT03861234|451465111|FG007|Overall Study|As per sponsor decision|0|||
125500825|NCT03861234|451465104|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
125500826|NCT03861234|451465105|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
125500827|NCT03861234|451465106|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
125500828|NCT03861234|451465107|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
125500829|NCT03861234|451465108|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
125500830|NCT03861234|451465109|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
125500831|NCT03861234|451465110|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
125500832|NCT03861234|451465111|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
125500833|NCT00621842|451465112|FG000|Overall Study|Adverse Event|6|||
125500834|NCT00621842|451465112|FG000|Overall Study|Withdrawal by Subject|7|||
125500835|NCT00621842|451465112|FG000|Overall Study|Protocol Violation|4|||
125500836|NCT00621842|451465112|FG000|Overall Study|Lack of Efficacy|2|||
125500837|NCT02066636|451465113|FG000|Overall Study|Disease progression|51|||
125500838|NCT02066636|451465114|FG001|Overall Study|Disease progression|60|||
125500839|NCT02066636|451465115|FG002|Overall Study|Disease progression|700|||
125500840|NCT02066636|451465113|FG000|Overall Study|Study drug toxicity|13|||
125500841|NCT02066636|451465114|FG001|Overall Study|Study drug toxicity|2|||
125500842|NCT02066636|451465115|FG002|Overall Study|Study drug toxicity|58|||
125500843|NCT02066636|451465113|FG000|Overall Study|Death|4|||
125500844|NCT02066636|451465114|FG001|Overall Study|Death|2|||
125500845|NCT02066636|451465115|FG002|Overall Study|Death|158|||
125500846|NCT02066636|451465113|FG000|Overall Study|Adverse event unrelated to study drug|6|||
125500847|NCT02066636|451465114|FG001|Overall Study|Adverse event unrelated to study drug|4|||
125500848|NCT02066636|451465115|FG002|Overall Study|Adverse event unrelated to study drug|45|||
125500849|NCT02066636|451465113|FG000|Overall Study|Participant request to discontinue treatment|12|||
125500850|NCT02066636|451465114|FG001|Overall Study|Participant request to discontinue treatment|12|||
125500851|NCT02066636|451465115|FG002|Overall Study|Participant request to discontinue treatment|70|||
125500852|NCT02066636|451465113|FG000|Overall Study|Participant withdrew consent|10|||
125500853|NCT02066636|451465114|FG001|Overall Study|Participant withdrew consent|18|||
125500854|NCT02066636|451465115|FG002|Overall Study|Participant withdrew consent|61|||
125500855|NCT02066636|451465113|FG000|Overall Study|Lost to Follow-up|0|||
125500856|NCT02066636|451465114|FG001|Overall Study|Lost to Follow-up|2|||
125500857|NCT02066636|451465115|FG002|Overall Study|Lost to Follow-up|2|||
125500858|NCT02066636|451465113|FG000|Overall Study|Maximum clinical benefit|2|||
125500859|NCT02066636|451465114|FG001|Overall Study|Maximum clinical benefit|2|||
125500860|NCT02066636|451465115|FG002|Overall Study|Maximum clinical benefit|3|||
125500861|NCT02066636|451465113|FG000|Overall Study|Poor/non-compliance|2|||
125500862|NCT02066636|451465114|FG001|Overall Study|Poor/non-compliance|1|||
125500863|NCT02066636|451465115|FG002|Overall Study|Poor/non-compliance|1|||
125500864|NCT02066636|451465113|FG000|Overall Study|Participant no loner meets study criteria|3|||
125500865|NCT02066636|451465114|FG001|Overall Study|Participant no loner meets study criteria|2|||
125500866|NCT02066636|451465115|FG002|Overall Study|Participant no loner meets study criteria|28|||
125500867|NCT02066636|451465113|FG000|Overall Study|Administrative reasons by sponsor|8|||
125500868|NCT02066636|451465114|FG001|Overall Study|Administrative reasons by sponsor|5|||
125500869|NCT02066636|451465115|FG002|Overall Study|Administrative reasons by sponsor|0|||
125500870|NCT02066636|451465113|FG000|Overall Study|Other reasons|16|||
125500871|NCT02066636|451465114|FG001|Overall Study|Other reasons|15|||
125500872|NCT02066636|451465115|FG002|Overall Study|Other reasons|50|||
125500873|NCT00705159|451465119|FG000|Overall Study|Withdrawal by Subject|0|||
125500874|NCT00705159|451465120|FG001|Overall Study|Withdrawal by Subject|1|||
125500875|NCT00705159|451465121|FG002|Overall Study|Withdrawal by Subject|1|||
125500876|NCT00705159|451465122|FG003|Overall Study|Withdrawal by Subject|1|||
125500877|NCT00705159|451465119|FG000|Overall Study|Protocol Violation|0|||
125500878|NCT00705159|451465120|FG001|Overall Study|Protocol Violation|1|||
125500879|NCT00705159|451465121|FG002|Overall Study|Protocol Violation|0|||
125500880|NCT00705159|451465122|FG003|Overall Study|Protocol Violation|0|||
125500881|NCT00705159|451465119|FG000|Overall Study|Adverse Event|0|||
125500882|NCT00705159|451465120|FG001|Overall Study|Adverse Event|0|||
125500883|NCT00705159|451465121|FG002|Overall Study|Adverse Event|1|||
125500884|NCT00705159|451465122|FG003|Overall Study|Adverse Event|0|||
125500885|NCT00705159|451465119|FG000|Overall Study|Lost to Follow-up|0|||
125500886|NCT00705159|451465120|FG001|Overall Study|Lost to Follow-up|0|||
125500887|NCT00705159|451465121|FG002|Overall Study|Lost to Follow-up|3|||
125500888|NCT00705159|451465122|FG003|Overall Study|Lost to Follow-up|2|||
125500889|NCT00705159|451465119|FG000|Overall Study|Screen Failure|0|||
125500890|NCT00705159|451465120|FG001|Overall Study|Screen Failure|0|||
125500891|NCT00705159|451465121|FG002|Overall Study|Screen Failure|0|||
125500892|NCT00705159|451465122|FG003|Overall Study|Screen Failure|1|||
125500893|NCT04076059|451465128|FG000|Double Blind Phase|Progressive disease|22|||
125500894|NCT04076059|451465129|FG001|Double Blind Phase|Progressive disease|26|||
125500895|NCT04076059|451465130|FG002|Double Blind Phase|Progressive disease|0|||
125500896|NCT04076059|451465128|FG000|Double Blind Phase|Withdrawal by Subject|4|||
125500897|NCT04076059|451465129|FG001|Double Blind Phase|Withdrawal by Subject|11|||
125500898|NCT04076059|451465130|FG002|Double Blind Phase|Withdrawal by Subject|0|||
125500899|NCT04076059|451465128|FG000|Double Blind Phase|Death|1|||
125500900|NCT04076059|451465129|FG001|Double Blind Phase|Death|1|||
125500901|NCT04076059|451465130|FG002|Double Blind Phase|Death|0|||
125500902|NCT04076059|451465128|FG000|Double Blind Phase|Lost to Follow-up|1|||
125500903|NCT04076059|451465129|FG001|Double Blind Phase|Lost to Follow-up|0|||
125500904|NCT04076059|451465130|FG002|Double Blind Phase|Lost to Follow-up|0|||
125500905|NCT04076059|451465128|FG000|Double Blind Phase|Adverse Event|5|||
125500906|NCT04076059|451465129|FG001|Double Blind Phase|Adverse Event|1|||
125500907|NCT04076059|451465130|FG002|Double Blind Phase|Adverse Event|0|||
125500908|NCT04076059|451465128|FG000|Double Blind Phase|Ongoing Participants|82|||
125500909|NCT04076059|451465129|FG001|Double Blind Phase|Ongoing Participants|18|||
125500910|NCT04076059|451465130|FG002|Double Blind Phase|Ongoing Participants|0|||
125500911|NCT04076059|451465128|FG000|Double Blind Phase|Miscellaneous|3|||
125500912|NCT04076059|451465129|FG001|Double Blind Phase|Miscellaneous|1|||
125500913|NCT04076059|451465130|FG002|Double Blind Phase|Miscellaneous|0|||
125500914|NCT04076059|451465128|FG000|Double Blind Phase|Protocol Deviation|1|||
125500915|NCT04076059|451465129|FG001|Double Blind Phase|Protocol Deviation|1|||
125500916|NCT04076059|451465130|FG002|Double Blind Phase|Protocol Deviation|0|||
125500917|NCT04076059|451465128|FG000|Double Blind Phase|Did not take study drug|1|||
125500918|NCT04076059|451465129|FG001|Double Blind Phase|Did not take study drug|1|||
125500919|NCT04076059|451465130|FG002|Double Blind Phase|Did not take study drug|0|||
125500920|NCT04076059|451465128|FG000|Open Label Phase|Progressive disease|0|||
125500921|NCT04076059|451465129|FG001|Open Label Phase|Progressive disease|0|||
125500922|NCT04076059|451465130|FG002|Open Label Phase|Progressive disease|7|||
125500923|NCT04076059|451465128|FG000|Open Label Phase|Withdrawal by Subject|0|||
125500924|NCT04076059|451465129|FG001|Open Label Phase|Withdrawal by Subject|0|||
125500925|NCT04076059|451465130|FG002|Open Label Phase|Withdrawal by Subject|3|||
125500926|NCT04076059|451465128|FG000|Open Label Phase|Death|0|||
125500927|NCT04076059|451465129|FG001|Open Label Phase|Death|0|||
125500928|NCT04076059|451465130|FG002|Open Label Phase|Death|2|||
125500929|NCT04076059|451465128|FG000|Open Label Phase|Ongoing Participants|0|||
125500930|NCT04076059|451465129|FG001|Open Label Phase|Ongoing Participants|0|||
125500931|NCT04076059|451465130|FG002|Open Label Phase|Ongoing Participants|11|||
125500932|NCT02521493|451465131|FG000|Overall Study|Death|3|||
125500933|NCT02521493|451465132|FG001|Overall Study|Death|4|||
125500934|NCT02521493|451465133|FG002|Overall Study|Death|1|||
125500935|NCT02521493|451465131|FG000|Overall Study|Physician Decision|19|||
125500936|NCT02521493|451465132|FG001|Overall Study|Physician Decision|1|||
125500937|NCT02521493|451465133|FG002|Overall Study|Physician Decision|2|||
125500938|NCT02521493|451465131|FG000|Overall Study|Withdrawal by Subject|3|||
125500939|NCT02521493|451465132|FG001|Overall Study|Withdrawal by Subject|0|||
125500940|NCT02521493|451465133|FG002|Overall Study|Withdrawal by Subject|0|||
125500941|NCT02521493|451465131|FG000|Overall Study|Ineligible|0|||
125500942|NCT02521493|451465132|FG001|Overall Study|Ineligible|1|||
125500943|NCT02521493|451465133|FG002|Overall Study|Ineligible|0|||
125500944|NCT02521493|451465131|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
125500945|NCT02521493|451465132|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
125500946|NCT02521493|451465133|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
125500947|NCT02521493|451465131|FG000|Overall Study|No MRD result|0|||
125500948|NCT02521493|451465132|FG001|Overall Study|No MRD result|0|||
125500949|NCT02521493|451465133|FG002|Overall Study|No MRD result|4|||
125500950|NCT01218594|451465135|FG000|Overall Study|Death|1|||
125500951|NCT01218594|451465135|FG000|Overall Study|Withdrawal by Subject|3|||
125500952|NCT01218594|451465135|FG000|Overall Study|Adverse Event|2|||
125500953|NCT01218594|451465135|FG000|Overall Study|Physician Decision|6|||
125500954|NCT00452114|451465136|FG000|Overall Study|Physician Decision|3|||
125500955|NCT00452114|451465137|FG001|Overall Study|Physician Decision|3|||
125500956|NCT00949117|451466693|FG000|Overall Study|Lack of Efficacy|2|||
125500957|NCT00949117|451466694|FG001|Overall Study|Lack of Efficacy|3|||
125500958|NCT00949117|451466693|FG000|Overall Study|Protocol Violation|1|||
125500959|NCT00949117|451466694|FG001|Overall Study|Protocol Violation|1|||
125500960|NCT00949117|451466693|FG000|Overall Study|Adverse Event|0|||
125500961|NCT00949117|451466694|FG001|Overall Study|Adverse Event|1|||
125500962|NCT03964974|451466695|FG000|Overall Study|Lost to Follow-up|3|||
125500963|NCT03964974|451466696|FG001|Overall Study|Lost to Follow-up|2|||
125500964|NCT03964974|451466695|FG000|Overall Study|Withdrawal by Subject|0|||
125500965|NCT03964974|451466696|FG001|Overall Study|Withdrawal by Subject|3|||
125500966|NCT01214200|451466697|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
125500967|NCT01214200|451466697|FG000|Overall Study|Withdrawal by Subject|2|||
125500968|NCT01719172|451466698|FG000|Overall Study|Lost to Follow-up|1|||
125500969|NCT01719172|451466698|FG000|Overall Study|Death|1|||
125500970|NCT04250636|451466701|FG000|Overall Study|Lost to Follow-up|2|||
125500971|NCT03041090|451466702|FG000|Overall Study|technical error|0|||
125500972|NCT03041090|451466703|FG001|Overall Study|technical error|3|||
125500973|NCT01779050|451466704|FG000|Overall Study|Withdrawal by Subject|1|||
125500974|NCT01779050|451466705|FG001|Overall Study|Withdrawal by Subject|0|||
125500975|NCT01353274|451466706|FG000|Overall Study|No case report form (CRF) collected|28|||
125500976|NCT01409837|451466707|FG000|Overall Study|Withdrawal by Subject|2|||
125500977|NCT01409837|451466708|FG001|Overall Study|Withdrawal by Subject|1|||
125500978|NCT01409837|451466707|FG000|Overall Study|Lost to Follow-up|1|||
125500979|NCT01409837|451466708|FG001|Overall Study|Lost to Follow-up|0|||
125500980|NCT01409837|451466707|FG000|Overall Study|Physician Decision|0|||
125500981|NCT01409837|451466708|FG001|Overall Study|Physician Decision|1|||
125500982|NCT03960645|451466709|FG000|Overall Study|Protocol Violation|1|||
125500983|NCT03960645|451466710|FG001|Overall Study|Protocol Violation|0|||
125500984|NCT03292406|451466712|FG000|Overall Study|Progressive Disease|6|||
125500985|NCT03292406|451466713|FG001|Overall Study|Progressive Disease|3|||
125500986|NCT03292406|451466714|FG002|Overall Study|Progressive Disease|4|||
125500987|NCT03292406|451466712|FG000|Overall Study|Adverse Event|7|||
125500988|NCT03292406|451466713|FG001|Overall Study|Adverse Event|1|||
125500989|NCT03292406|451466714|FG002|Overall Study|Adverse Event|4|||
125500990|NCT03292406|451466712|FG000|Overall Study|Withdrawal by Subject|0|||
125500991|NCT03292406|451466713|FG001|Overall Study|Withdrawal by Subject|7|||
125500992|NCT03292406|451466714|FG002|Overall Study|Withdrawal by Subject|2|||
125500993|NCT03292406|451466712|FG000|Overall Study|Protocol Violation|0|||
125500994|NCT03292406|451466713|FG001|Overall Study|Protocol Violation|1|||
125304733|NCT00856544|450742724|FG003|Overall Study|Other|6|||
125500995|NCT03292406|451466714|FG002|Overall Study|Protocol Violation|1|||
125500996|NCT03292406|451466712|FG000|Overall Study|Other|0|||
125500997|NCT03292406|451466713|FG001|Overall Study|Other|1|||
125500998|NCT03292406|451466714|FG002|Overall Study|Other|2|||
125500999|NCT00022672|451466716|FG000|Main Phase: 24 Months|Adverse Event|6|||
125501000|NCT00022672|451466717|FG001|Main Phase: 24 Months|Adverse Event|0|||
125501001|NCT00022672|451466716|FG000|Main Phase: 24 Months|Death|0|||
125501002|NCT00022672|451466717|FG001|Main Phase: 24 Months|Death|3|||
125501003|NCT00022672|451466716|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
125501004|NCT00022672|451466717|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
125501005|NCT00022672|451466716|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
125501006|NCT00022672|451466717|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
125501007|NCT00022672|451466716|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
125501008|NCT00022672|451466717|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
125501009|NCT00022672|451466716|FG000|Main Phase: 24 Months|Refused Treatment|3|||
125501010|NCT00022672|451466717|FG001|Main Phase: 24 Months|Refused Treatment|4|||
125501011|NCT00022672|451466716|FG000|Main Phase: 24 Months|Failure to Return|1|||
125501012|NCT00022672|451466717|FG001|Main Phase: 24 Months|Failure to Return|1|||
125501013|NCT00022672|451466716|FG000|Main Phase: 24 Months|Other|1|||
125501014|NCT00022672|451466717|FG001|Main Phase: 24 Months|Other|0|||
125501015|NCT00022672|451466716|FG000|Extension Phase|Adverse Event|1|||
125501016|NCT00022672|451466717|FG001|Extension Phase|Adverse Event|3|||
125501017|NCT00022672|451466716|FG000|Extension Phase|Death|0|||
125501018|NCT00022672|451466717|FG001|Extension Phase|Death|1|||
125501019|NCT00022672|451466716|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
125501020|NCT00022672|451466717|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
125501021|NCT00022672|451466716|FG000|Extension Phase|Refused Treatment|0|||
125501022|NCT00022672|451466717|FG001|Extension Phase|Refused Treatment|2|||
125501023|NCT00022672|451466716|FG000|Extension Phase|Other|1|||
125501024|NCT00022672|451466717|FG001|Extension Phase|Other|1|||
125501025|NCT00403494|451466718|FG000|Overall Study|Adverse Event|10|||
125501026|NCT00403494|451466719|FG001|Overall Study|Adverse Event|8|||
125501027|NCT00403494|451466718|FG000|Overall Study|Withdrew Consent|3|||
125501028|NCT00403494|451466719|FG001|Overall Study|Withdrew Consent|2|||
125501029|NCT00403494|451466718|FG000|Overall Study|Inappropriately enrolled|0|||
125501030|NCT00403494|451466719|FG001|Overall Study|Inappropriately enrolled|1|||
125501031|NCT00403494|451466718|FG000|Overall Study|Lost to Follow-up|0|||
125501032|NCT00403494|451466719|FG001|Overall Study|Lost to Follow-up|2|||
125501033|NCT00403494|451466718|FG000|Overall Study|Protocol noncompliance|0|||
125501034|NCT00403494|451466719|FG001|Overall Study|Protocol noncompliance|1|||
125501035|NCT00403494|451466718|FG000|Overall Study|Death|1|||
125501036|NCT00403494|451466719|FG001|Overall Study|Death|0|||
125501037|NCT00403494|451466718|FG000|Overall Study|Sponsor Request|1|||
125501038|NCT00403494|451466719|FG001|Overall Study|Sponsor Request|0|||
125501039|NCT03851094|451466721|FG000|Overall Study|Withdrawal by Subject|0|||
125501040|NCT03851094|451466722|FG001|Overall Study|Withdrawal by Subject|1|||
125501041|NCT03851094|451466721|FG000|Overall Study|Participant lost device|0|||
125501042|NCT03851094|451466722|FG001|Overall Study|Participant lost device|1|||
125501043|NCT03851094|451466721|FG000|Overall Study|Participant returned device|0|||
125501044|NCT03851094|451466722|FG001|Overall Study|Participant returned device|2|||
125501045|NCT01332266|451466723|FG000|Phase 1b|Death|3|||
125501046|NCT01332266|451466724|FG001|Phase 1b|Death|3|||
125501047|NCT01332266|451466725|FG002|Phase 1b|Death|2|||
125501048|NCT01332266|451466726|FG003|Phase 1b|Death|0|||
125501049|NCT01332266|451466727|FG004|Phase 1b|Death|0|||
125501050|NCT01332266|451466723|FG000|Phase 1b|Lost to Follow-up|0|||
125501051|NCT01332266|451466724|FG001|Phase 1b|Lost to Follow-up|1|||
125501052|NCT01332266|451466725|FG002|Phase 1b|Lost to Follow-up|0|||
125501053|NCT01332266|451466726|FG003|Phase 1b|Lost to Follow-up|0|||
125501054|NCT01332266|451466727|FG004|Phase 1b|Lost to Follow-up|0|||
125501055|NCT01332266|451466723|FG000|Phase 1b|Withdrawal by Subject|1|||
125501056|NCT01332266|451466724|FG001|Phase 1b|Withdrawal by Subject|1|||
125501057|NCT01332266|451466725|FG002|Phase 1b|Withdrawal by Subject|1|||
125501058|NCT01332266|451466726|FG003|Phase 1b|Withdrawal by Subject|0|||
125501059|NCT01332266|451466727|FG004|Phase 1b|Withdrawal by Subject|0|||
125501060|NCT01332266|451466723|FG000|Phase 2|Death|0|||
125501061|NCT01332266|451466724|FG001|Phase 2|Death|0|||
125501062|NCT01332266|451466725|FG002|Phase 2|Death|0|||
125501063|NCT01332266|451466726|FG003|Phase 2|Death|33|||
125501064|NCT01332266|451466727|FG004|Phase 2|Death|36|||
125501065|NCT01332266|451466723|FG000|Phase 2|Lost to Follow-up|0|||
125501066|NCT01332266|451466724|FG001|Phase 2|Lost to Follow-up|0|||
125501067|NCT01332266|451466725|FG002|Phase 2|Lost to Follow-up|0|||
125501068|NCT01332266|451466726|FG003|Phase 2|Lost to Follow-up|2|||
125501069|NCT01332266|451466727|FG004|Phase 2|Lost to Follow-up|0|||
125501070|NCT01332266|451466723|FG000|Phase 2|Physician Decision|0|||
125501071|NCT01332266|451466724|FG001|Phase 2|Physician Decision|0|||
125501072|NCT01332266|451466725|FG002|Phase 2|Physician Decision|0|||
125501073|NCT01332266|451466726|FG003|Phase 2|Physician Decision|3|||
125501074|NCT01332266|451466727|FG004|Phase 2|Physician Decision|1|||
125501075|NCT01332266|451466723|FG000|Phase 2|Symptomatic deterioration|0|||
125501076|NCT01332266|451466724|FG001|Phase 2|Symptomatic deterioration|0|||
125501077|NCT01332266|451466725|FG002|Phase 2|Symptomatic deterioration|0|||
125501078|NCT01332266|451466726|FG003|Phase 2|Symptomatic deterioration|0|||
125501079|NCT01332266|451466727|FG004|Phase 2|Symptomatic deterioration|1|||
125501080|NCT01332266|451466723|FG000|Phase 2|Progression Disease|0|||
125501081|NCT01332266|451466724|FG001|Phase 2|Progression Disease|0|||
125501082|NCT01332266|451466725|FG002|Phase 2|Progression Disease|0|||
125501083|NCT01332266|451466726|FG003|Phase 2|Progression Disease|2|||
125501084|NCT01332266|451466727|FG004|Phase 2|Progression Disease|1|||
125501085|NCT01332266|451466723|FG000|Phase 2|Withdrawal by Subject|0|||
125501086|NCT01332266|451466724|FG001|Phase 2|Withdrawal by Subject|0|||
125501087|NCT01332266|451466725|FG002|Phase 2|Withdrawal by Subject|0|||
125501088|NCT01332266|451466726|FG003|Phase 2|Withdrawal by Subject|2|||
125501089|NCT01332266|451466727|FG004|Phase 2|Withdrawal by Subject|2|||
125501090|NCT01536704|451466730|FG000|Washout Period 1|Withdrawal by Subject|1|||
125501091|NCT01536704|451466731|FG001|Washout Period 1|Withdrawal by Subject|2|||
125501092|NCT01536704|451466732|FG002|Washout Period 1|Withdrawal by Subject|0|||
125501093|NCT01536704|451466733|FG003|Washout Period 1|Withdrawal by Subject|0|||
125501094|NCT01536704|451466730|FG000|Washout Period 2|Adverse Event|1|||
125501095|NCT01536704|451466731|FG001|Washout Period 2|Adverse Event|0|||
125501096|NCT01536704|451466732|FG002|Washout Period 2|Adverse Event|0|||
125501097|NCT01536704|451466733|FG003|Washout Period 2|Adverse Event|0|||
125501098|NCT01536704|451466730|FG000|Washout Period 2|Withdrawal by Subject|0|||
125501099|NCT01536704|451466731|FG001|Washout Period 2|Withdrawal by Subject|0|||
125501100|NCT01536704|451466732|FG002|Washout Period 2|Withdrawal by Subject|0|||
125501101|NCT01536704|451466733|FG003|Washout Period 2|Withdrawal by Subject|1|||
125501102|NCT01536704|451466730|FG000|Period 3|Adverse Event|0|||
125501103|NCT01536704|451466731|FG001|Period 3|Adverse Event|0|||
125501104|NCT01536704|451466732|FG002|Period 3|Adverse Event|0|||
125501105|NCT01536704|451466733|FG003|Period 3|Adverse Event|1|||
125501106|NCT01536704|451466730|FG000|Washout Period 3|Adverse Event|0|||
125501107|NCT01536704|451466731|FG001|Washout Period 3|Adverse Event|0|||
125501108|NCT01536704|451466732|FG002|Washout Period 3|Adverse Event|1|||
125501109|NCT01536704|451466733|FG003|Washout Period 3|Adverse Event|0|||
125501110|NCT00047385|451466734|FG000|Overall Study|Death before any screening|2|||
125501111|NCT00047385|451466735|FG001|Overall Study|Death before any screening|5|||
125501112|NCT00047385|451466734|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
125501113|NCT00047385|451466735|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
125501114|NCT00047385|451466734|FG000|Overall Study|Eligible for screening but had no screen|260|||
125501115|NCT00047385|451466735|FG001|Overall Study|Eligible for screening but had no screen|492|||
125501116|NCT03490032|451466736|FG000|Overall Study|family issue (child custody)|1|||
125501117|NCT03490032|451466737|FG001|Overall Study|family issue (child custody)|0|||
125501118|NCT03490032|451466738|FG002|Overall Study|family issue (child custody)|0|||
125501119|NCT00310037|451466741|FG000|Overall Study|Adverse Event|7|||
125501120|NCT00310037|451466742|FG001|Overall Study|Adverse Event|14|||
125501121|NCT00310037|451466741|FG000|Overall Study|Withdrawal by Subject|4|||
125501122|NCT00310037|451466742|FG001|Overall Study|Withdrawal by Subject|3|||
125501123|NCT00310037|451466741|FG000|Overall Study|Progression|6|||
125501124|NCT00310037|451466742|FG001|Overall Study|Progression|0|||
125501125|NCT00310037|451466741|FG000|Overall Study|Non-protocol treatment|1|||
125501126|NCT00310037|451466742|FG001|Overall Study|Non-protocol treatment|0|||
125304734|NCT00856544|450742721|FG000|Overall Study|Lost to Follow-up|1|||
125304735|NCT00856544|450742722|FG001|Overall Study|Lost to Follow-up|2|||
125304736|NCT00856544|450742723|FG002|Overall Study|Lost to Follow-up|2|||
125304737|NCT00856544|450742724|FG003|Overall Study|Lost to Follow-up|0|||
125304738|NCT00856544|450742721|FG000|Overall Study|Withdrawal by Subject|8|||
125304739|NCT00856544|450742722|FG001|Overall Study|Withdrawal by Subject|5|||
125304740|NCT00856544|450742723|FG002|Overall Study|Withdrawal by Subject|0|||
125304741|NCT00856544|450742724|FG003|Overall Study|Withdrawal by Subject|1|||
125304742|NCT00787189|450742725|FG000|Overall Study|Lost to Follow-up|2|||
125304743|NCT00787189|450742726|FG001|Overall Study|Lost to Follow-up|2|||
125304744|NCT00847886|450742727|FG000|Overall Study|Adverse Event|0|||
125304745|NCT00847886|450742728|FG001|Overall Study|Adverse Event|1|||
125304746|NCT03920254|450742733|FG000|Overall Study|Adverse Event|1|||
125304747|NCT03920254|450742734|FG001|Overall Study|Adverse Event|0|||
125304748|NCT03920254|450742735|FG002|Overall Study|Adverse Event|0|||
125304749|NCT03920254|450742733|FG000|Overall Study|Physician Decision|0|||
125304750|NCT03920254|450742734|FG001|Overall Study|Physician Decision|1|||
125501127|NCT02128269|451466747|FG000|Treatment Period|Adverse Event|1|||
125501128|NCT02128269|451466747|FG000|Treatment Period|Physician Decision|1|||
125501129|NCT00878189|451466748|FG000|Overall Study|Death|0|||
125304751|NCT03920254|450742735|FG002|Overall Study|Physician Decision|2|||
125304752|NCT03920254|450742733|FG000|Overall Study|Study Terminated By Sponsor|12|||
125304753|NCT03920254|450742734|FG001|Overall Study|Study Terminated By Sponsor|17|||
125304754|NCT03920254|450742735|FG002|Overall Study|Study Terminated By Sponsor|12|||
125304755|NCT03920254|450742733|FG000|Overall Study|Withdrawal by Subject|0|||
125304756|NCT03920254|450742734|FG001|Overall Study|Withdrawal by Subject|0|||
125501130|NCT00878189|451466749|FG001|Overall Study|Death|1|||
125501131|NCT00878189|451466750|FG002|Overall Study|Death|0|||
125304757|NCT03920254|450742735|FG002|Overall Study|Withdrawal by Subject|1|||
125304758|NCT05274269|450742736|FG000|Overall Study|Adverse Event|0|||
125304759|NCT05274269|450742737|FG001|Overall Study|Adverse Event|3|||
125304760|NCT05274269|450742736|FG000|Overall Study|Death|0|||
125304761|NCT05274269|450742737|FG001|Overall Study|Death|1|||
125304762|NCT05274269|450742736|FG000|Overall Study|Other|0|||
125304763|NCT05274269|450742737|FG001|Overall Study|Other|2|||
125304764|NCT05274269|450742736|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
125304765|NCT05274269|450742737|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
125304766|NCT02206035|450742738|FG000|Overall Study|Physician Decision|10|||
125304767|NCT02206035|450742739|FG001|Overall Study|Physician Decision|0|||
125304768|NCT02206035|450742740|FG002|Overall Study|Physician Decision|175|||
125304769|NCT05173012|450742742|FG000|Overall Study|Adverse Event|2|||
125304770|NCT05173012|450742743|FG001|Overall Study|Adverse Event|3|||
125304771|NCT05173012|450742744|FG002|Overall Study|Adverse Event|4|||
125304772|NCT05173012|450742745|FG003|Overall Study|Adverse Event|13|||
125304773|NCT05173012|450742746|FG004|Overall Study|Adverse Event|0|||
125304774|NCT05173012|450742747|FG005|Overall Study|Adverse Event|0|||
125304775|NCT05173012|450742748|FG006|Overall Study|Adverse Event|2|||
125304776|NCT05173012|450742749|FG007|Overall Study|Adverse Event|4|||
125304777|NCT05173012|450742742|FG000|Overall Study|Lost to Follow-up|0|||
125304778|NCT05173012|450742743|FG001|Overall Study|Lost to Follow-up|0|||
125304779|NCT05173012|450742744|FG002|Overall Study|Lost to Follow-up|0|||
125304780|NCT05173012|450742745|FG003|Overall Study|Lost to Follow-up|1|||
125304781|NCT05173012|450742746|FG004|Overall Study|Lost to Follow-up|0|||
125304782|NCT05173012|450742747|FG005|Overall Study|Lost to Follow-up|0|||
125304783|NCT05173012|450742748|FG006|Overall Study|Lost to Follow-up|0|||
125304784|NCT05173012|450742749|FG007|Overall Study|Lost to Follow-up|0|||
125304785|NCT05173012|450742742|FG000|Overall Study|Withdrawal by Subject|1|||
125304786|NCT05173012|450742743|FG001|Overall Study|Withdrawal by Subject|0|||
125304787|NCT05173012|450742744|FG002|Overall Study|Withdrawal by Subject|1|||
125304788|NCT05173012|450742745|FG003|Overall Study|Withdrawal by Subject|3|||
125304789|NCT05173012|450742746|FG004|Overall Study|Withdrawal by Subject|1|||
125304790|NCT05173012|450742747|FG005|Overall Study|Withdrawal by Subject|0|||
125304791|NCT05173012|450742748|FG006|Overall Study|Withdrawal by Subject|1|||
125304792|NCT05173012|450742749|FG007|Overall Study|Withdrawal by Subject|0|||
125304793|NCT05173012|450742742|FG000|Overall Study|Protocol Deviation|0|||
125304794|NCT05173012|450742743|FG001|Overall Study|Protocol Deviation|0|||
125304795|NCT05173012|450742744|FG002|Overall Study|Protocol Deviation|0|||
125304796|NCT05173012|450742745|FG003|Overall Study|Protocol Deviation|1|||
125304797|NCT05173012|450742746|FG004|Overall Study|Protocol Deviation|0|||
125304798|NCT05173012|450742747|FG005|Overall Study|Protocol Deviation|0|||
125304799|NCT05173012|450742748|FG006|Overall Study|Protocol Deviation|0|||
125304800|NCT05173012|450742749|FG007|Overall Study|Protocol Deviation|0|||
125304801|NCT05173012|450742742|FG000|Overall Study|Other|0|||
125304802|NCT05173012|450742743|FG001|Overall Study|Other|0|||
125304803|NCT05173012|450742744|FG002|Overall Study|Other|0|||
125304804|NCT05173012|450742745|FG003|Overall Study|Other|2|||
125304805|NCT05173012|450742746|FG004|Overall Study|Other|0|||
125304806|NCT05173012|450742747|FG005|Overall Study|Other|0|||
125304807|NCT05173012|450742748|FG006|Overall Study|Other|0|||
125304808|NCT05173012|450742749|FG007|Overall Study|Other|0|||
125304809|NCT03668613|450742750|FG000|Overall Study|Adverse Event|1|||
125304810|NCT03668613|450742751|FG001|Overall Study|Adverse Event|2|||
125304811|NCT03668613|450742750|FG000|Overall Study|Lack of Efficacy|5|||
125304812|NCT03668613|450742751|FG001|Overall Study|Lack of Efficacy|1|||
125304813|NCT03668613|450742750|FG000|Overall Study|Pregnancy|0|||
125304814|NCT03668613|450742751|FG001|Overall Study|Pregnancy|2|||
125304815|NCT03668613|450742750|FG000|Overall Study|Protocol Violation|1|||
125304816|NCT03668613|450742751|FG001|Overall Study|Protocol Violation|0|||
125304817|NCT03668613|450742750|FG000|Overall Study|Physician Decision|1|||
125304818|NCT03668613|450742751|FG001|Overall Study|Physician Decision|0|||
125304819|NCT03668613|450742750|FG000|Overall Study|Withdrawal by Subject|2|||
125304820|NCT03668613|450742751|FG001|Overall Study|Withdrawal by Subject|1|||
125304821|NCT03668613|450742750|FG000|Overall Study|Guardian decision|1|||
125304822|NCT03668613|450742751|FG001|Overall Study|Guardian decision|0|||
125304823|NCT01068769|450742754|FG000|Overall Study|Ineligible|1|||
125304824|NCT00709618|450742755|FG000|Overall Study|Withdrawal by Subject|4|||
125304825|NCT00709618|450742755|FG000|Overall Study|Lost to Follow-up|1|||
125304826|NCT00709618|450742755|FG000|Overall Study|Study Closed/Terminated|25|||
125304827|NCT01948063|450742758|FG000|Overall Study|Boston MCI halted research protocol|0|||
125304828|NCT01948063|450742759|FG001|Overall Study|Boston MCI halted research protocol|1|||
125304829|NCT01948063|450742758|FG000|Overall Study|Discovered an enrollment in other study|0|||
125304830|NCT01948063|450742759|FG001|Overall Study|Discovered an enrollment in other study|1|||
125304831|NCT01948063|450742758|FG000|Overall Study|Blood samples were accidentally thawed|1|||
125304832|NCT01948063|450742759|FG001|Overall Study|Blood samples were accidentally thawed|0|||
125304833|NCT03781414|450742762|FG000|Overall Study|Study terminated by sponsor|39|||
125304834|NCT03781414|450742763|FG001|Overall Study|Study terminated by sponsor|34|||
125304835|NCT03781414|450742764|FG002|Overall Study|Study terminated by sponsor|25|||
125304836|NCT03781414|450742762|FG000|Overall Study|Adverse Event|3|||
125304837|NCT03781414|450742763|FG001|Overall Study|Adverse Event|6|||
125304838|NCT03781414|450742764|FG002|Overall Study|Adverse Event|3|||
125304839|NCT03781414|450742762|FG000|Overall Study|Physician Decision|2|||
125304840|NCT03781414|450742763|FG001|Overall Study|Physician Decision|0|||
125304841|NCT03781414|450742764|FG002|Overall Study|Physician Decision|1|||
125304842|NCT03781414|450742762|FG000|Overall Study|Withdrawal by Subject|2|||
125304843|NCT03781414|450742763|FG001|Overall Study|Withdrawal by Subject|3|||
125304844|NCT03781414|450742764|FG002|Overall Study|Withdrawal by Subject|3|||
125304845|NCT03781414|450742762|FG000|Overall Study|Death|1|||
125304846|NCT03781414|450742763|FG001|Overall Study|Death|4|||
125304847|NCT03781414|450742764|FG002|Overall Study|Death|0|||
125304848|NCT03781414|450742762|FG000|Overall Study|Lost to Follow-up|1|||
125304849|NCT03781414|450742763|FG001|Overall Study|Lost to Follow-up|1|||
125304850|NCT03781414|450742764|FG002|Overall Study|Lost to Follow-up|0|||
125304851|NCT04752358|450742765|FG000|Overall Study|Death|2|||
125304852|NCT04752358|450742766|FG001|Overall Study|Death|1|||
125304853|NCT00719355|450742767|FG000|Overall Study|Death|0|||
125501132|NCT00878189|451466751|FG003|Overall Study|Death|1|||
125501133|NCT00878189|451466752|FG004|Overall Study|Death|0|||
125501134|NCT00878189|451466753|FG005|Overall Study|Death|0|||
125501135|NCT00878189|451466754|FG006|Overall Study|Death|0|||
125501136|NCT00878189|451466755|FG007|Overall Study|Death|0|||
125501137|NCT00878189|451466756|FG008|Overall Study|Death|1|||
125501138|NCT00878189|451466748|FG000|Overall Study|Participant Refused to Follow-up|0|||
125501139|NCT00878189|451466749|FG001|Overall Study|Participant Refused to Follow-up|0|||
125501140|NCT00878189|451466750|FG002|Overall Study|Participant Refused to Follow-up|0|||
125501141|NCT00878189|451466751|FG003|Overall Study|Participant Refused to Follow-up|0|||
125501142|NCT00878189|451466752|FG004|Overall Study|Participant Refused to Follow-up|0|||
125501143|NCT00878189|451466753|FG005|Overall Study|Participant Refused to Follow-up|4|||
125501144|NCT00878189|451466754|FG006|Overall Study|Participant Refused to Follow-up|0|||
125501145|NCT00878189|451466755|FG007|Overall Study|Participant Refused to Follow-up|0|||
125501146|NCT00878189|451466756|FG008|Overall Study|Participant Refused to Follow-up|0|||
125501147|NCT00878189|451466748|FG000|Overall Study|Other|3|||
125501148|NCT00878189|451466749|FG001|Overall Study|Other|2|||
125501149|NCT00878189|451466750|FG002|Overall Study|Other|4|||
125501150|NCT00878189|451466751|FG003|Overall Study|Other|7|||
125501151|NCT00878189|451466752|FG004|Overall Study|Other|4|||
125501152|NCT00878189|451466753|FG005|Overall Study|Other|18|||
125501153|NCT00878189|451466754|FG006|Overall Study|Other|15|||
125501154|NCT00878189|451466755|FG007|Overall Study|Other|3|||
125501155|NCT00878189|451466756|FG008|Overall Study|Other|4|||
125501156|NCT00878189|451466748|FG000|Overall Study|Lost to Follow-up|0|||
125501157|NCT00878189|451466749|FG001|Overall Study|Lost to Follow-up|0|||
125501158|NCT00878189|451466750|FG002|Overall Study|Lost to Follow-up|0|||
125501159|NCT00878189|451466751|FG003|Overall Study|Lost to Follow-up|0|||
125501160|NCT00878189|451466752|FG004|Overall Study|Lost to Follow-up|0|||
125501161|NCT00878189|451466753|FG005|Overall Study|Lost to Follow-up|1|||
125501162|NCT00878189|451466754|FG006|Overall Study|Lost to Follow-up|1|||
125501163|NCT00878189|451466755|FG007|Overall Study|Lost to Follow-up|0|||
125501164|NCT00878189|451466756|FG008|Overall Study|Lost to Follow-up|0|||
125501165|NCT00878189|451466748|FG000|Overall Study|Objection Progression or Relapse|0|||
125501166|NCT00878189|451466749|FG001|Overall Study|Objection Progression or Relapse|0|||
125501167|NCT00878189|451466750|FG002|Overall Study|Objection Progression or Relapse|0|||
125501168|NCT00878189|451466751|FG003|Overall Study|Objection Progression or Relapse|0|||
125501169|NCT00878189|451466752|FG004|Overall Study|Objection Progression or Relapse|0|||
125501170|NCT00878189|451466753|FG005|Overall Study|Objection Progression or Relapse|0|||
125501171|NCT00878189|451466754|FG006|Overall Study|Objection Progression or Relapse|0|||
125501172|NCT00878189|451466755|FG007|Overall Study|Objection Progression or Relapse|0|||
125304854|NCT00719355|450742768|FG001|Overall Study|Death|1|||
125304855|NCT00719355|450742767|FG000|Overall Study|Medical|14|||
125304856|NCT00719355|450742768|FG001|Overall Study|Medical|5|||
125501173|NCT00878189|451466756|FG008|Overall Study|Objection Progression or Relapse|3|||
125501174|NCT00703092|451466757|FG000|Overall Study|Withdrawal by Subject|2|||
125501175|NCT02007070|451466758|FG000|Overall Study|Adverse Event|4|||
125501176|NCT02007070|451466758|FG000|Overall Study|Clinical Progression|4|||
125501177|NCT02007070|451466758|FG000|Overall Study|Death|1|||
125501178|NCT02007070|451466758|FG000|Overall Study|Protocol Violation|2|||
125304857|NCT00719355|450742767|FG000|Overall Study|Compliance|4|||
125304858|NCT00719355|450742768|FG001|Overall Study|Compliance|6|||
125304859|NCT00719355|450742767|FG000|Overall Study|Moved|0|||
125304860|NCT00719355|450742768|FG001|Overall Study|Moved|1|||
125304861|NCT03364738|450742770|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
125501179|NCT02007070|451466758|FG000|Overall Study|Physician Decision|1|||
125501180|NCT02007070|451466758|FG000|Overall Study|Progressive Disease|21|||
125501181|NCT02708498|451466759|FG000|Overall Study|Death|20|||
125304862|NCT03364738|450742770|FG000|Overall Study|Withdrawal by Subject|1|||
125501182|NCT02708498|451466760|FG001|Overall Study|Death|19|||
125501183|NCT02708498|451466761|FG002|Overall Study|Death|0|||
125501184|NCT02708498|451466762|FG003|Overall Study|Death|0|||
125501185|NCT02708498|451466763|FG004|Overall Study|Death|1|||
125501186|NCT02708498|451466764|FG005|Overall Study|Death|0|||
125501187|NCT02708498|451466765|FG006|Overall Study|Death|0|||
125501188|NCT02708498|451466766|FG007|Overall Study|Death|0|||
125501189|NCT02708498|451466759|FG000|Overall Study|Unknown reason, missing data|0|||
125501190|NCT02708498|451466760|FG001|Overall Study|Unknown reason, missing data|0|||
125501191|NCT02708498|451466761|FG002|Overall Study|Unknown reason, missing data|62|||
125501192|NCT02708498|451466762|FG003|Overall Study|Unknown reason, missing data|51|||
125501193|NCT02708498|451466763|FG004|Overall Study|Unknown reason, missing data|195|||
125501194|NCT02708498|451466764|FG005|Overall Study|Unknown reason, missing data|132|||
125501195|NCT02708498|451466765|FG006|Overall Study|Unknown reason, missing data|0|||
125501196|NCT02708498|451466766|FG007|Overall Study|Unknown reason, missing data|0|||
125501197|NCT01021748|451466768|FG000|Overall Study|Adverse Event|2|||
125501198|NCT01021748|451466769|FG001|Overall Study|Adverse Event|1|||
125501199|NCT01021748|451466770|FG002|Overall Study|Adverse Event|2|||
125501200|NCT01021748|451466771|FG003|Overall Study|Adverse Event|0|||
125501201|NCT01021748|451466772|FG004|Overall Study|Adverse Event|2|||
125501202|NCT01021748|451466773|FG005|Overall Study|Adverse Event|0|||
125501203|NCT01021748|451466774|FG006|Overall Study|Adverse Event|1|||
125501204|NCT01021748|451466775|FG007|Overall Study|Adverse Event|0|||
125501205|NCT01021748|451466776|FG008|Overall Study|Adverse Event|7|||
125501206|NCT01021748|451466768|FG000|Overall Study|Physician Decision|1|||
125501207|NCT01021748|451466769|FG001|Overall Study|Physician Decision|0|||
125501208|NCT01021748|451466770|FG002|Overall Study|Physician Decision|1|||
125501209|NCT01021748|451466771|FG003|Overall Study|Physician Decision|1|||
125501210|NCT01021748|451466772|FG004|Overall Study|Physician Decision|0|||
125501211|NCT01021748|451466773|FG005|Overall Study|Physician Decision|0|||
125501212|NCT01021748|451466774|FG006|Overall Study|Physician Decision|1|||
125501213|NCT01021748|451466775|FG007|Overall Study|Physician Decision|1|||
125501214|NCT01021748|451466776|FG008|Overall Study|Physician Decision|2|||
125501215|NCT01021748|451466768|FG000|Overall Study|Progressive Disease|3|||
125501216|NCT01021748|451466769|FG001|Overall Study|Progressive Disease|3|||
125501217|NCT01021748|451466770|FG002|Overall Study|Progressive Disease|4|||
125501218|NCT01021748|451466771|FG003|Overall Study|Progressive Disease|6|||
125501219|NCT01021748|451466772|FG004|Overall Study|Progressive Disease|7|||
125501220|NCT01021748|451466773|FG005|Overall Study|Progressive Disease|3|||
125501221|NCT01021748|451466774|FG006|Overall Study|Progressive Disease|0|||
125501222|NCT01021748|451466775|FG007|Overall Study|Progressive Disease|5|||
125501223|NCT01021748|451466776|FG008|Overall Study|Progressive Disease|6|||
125501224|NCT01021748|451466768|FG000|Overall Study|Withdrawal by Subject|0|||
125501225|NCT01021748|451466769|FG001|Overall Study|Withdrawal by Subject|0|||
125501226|NCT01021748|451466770|FG002|Overall Study|Withdrawal by Subject|0|||
125501227|NCT01021748|451466771|FG003|Overall Study|Withdrawal by Subject|0|||
125501228|NCT01021748|451466772|FG004|Overall Study|Withdrawal by Subject|0|||
125501229|NCT01021748|451466773|FG005|Overall Study|Withdrawal by Subject|0|||
125501230|NCT01021748|451466774|FG006|Overall Study|Withdrawal by Subject|1|||
125501231|NCT01021748|451466775|FG007|Overall Study|Withdrawal by Subject|0|||
125501232|NCT01021748|451466776|FG008|Overall Study|Withdrawal by Subject|1|||
125501233|NCT01021748|451466768|FG000|Overall Study|Not Treated|0|||
125501234|NCT01021748|451466769|FG001|Overall Study|Not Treated|1|||
125501235|NCT01021748|451466770|FG002|Overall Study|Not Treated|0|||
125501236|NCT01021748|451466771|FG003|Overall Study|Not Treated|0|||
125501237|NCT01021748|451466772|FG004|Overall Study|Not Treated|0|||
125501238|NCT01021748|451466773|FG005|Overall Study|Not Treated|0|||
125501239|NCT01021748|451466774|FG006|Overall Study|Not Treated|0|||
125501240|NCT01021748|451466775|FG007|Overall Study|Not Treated|0|||
125501241|NCT01021748|451466776|FG008|Overall Study|Not Treated|0|||
125501242|NCT03316170|451466783|FG000|Overall Study|Death|1|||
125501243|NCT03316170|451466784|FG001|Overall Study|Death|0|||
125501244|NCT03316170|451466783|FG000|Overall Study|Lost to Follow-up|6|||
125304863|NCT03364738|450742770|FG000|Overall Study|Adverse Event|1|||
125501245|NCT03316170|451466784|FG001|Overall Study|Lost to Follow-up|7|||
125501246|NCT03052517|451466785|FG000|Overall Study|Study Terminated By Sponsor|928|||
125501247|NCT03052517|451466786|FG001|Overall Study|Study Terminated By Sponsor|938|||
125501248|NCT03052517|451466787|FG002|Overall Study|Study Terminated By Sponsor|296|||
125501249|NCT03052517|451466785|FG000|Overall Study|Subject/Guardian Decision|50|||
125501250|NCT03052517|451466786|FG001|Overall Study|Subject/Guardian Decision|45|||
125501251|NCT03052517|451466787|FG002|Overall Study|Subject/Guardian Decision|22|||
125501252|NCT03052517|451466785|FG000|Overall Study|Lack of Efficacy|23|||
125501253|NCT03052517|451466786|FG001|Overall Study|Lack of Efficacy|14|||
125501254|NCT03052517|451466787|FG002|Overall Study|Lack of Efficacy|7|||
125501255|NCT03052517|451466785|FG000|Overall Study|Adverse Event|6|||
125501256|NCT03052517|451466786|FG001|Overall Study|Adverse Event|5|||
125501257|NCT03052517|451466787|FG002|Overall Study|Adverse Event|0|||
125501258|NCT03052517|451466785|FG000|Overall Study|Physician Decision|4|||
125501259|NCT03052517|451466786|FG001|Overall Study|Physician Decision|5|||
125501260|NCT03052517|451466787|FG002|Overall Study|Physician Decision|1|||
125501261|NCT03052517|451466785|FG000|Overall Study|Death|3|||
125501262|NCT03052517|451466786|FG001|Overall Study|Death|0|||
125501263|NCT03052517|451466787|FG002|Overall Study|Death|1|||
125501264|NCT03052517|451466785|FG000|Overall Study|Lost to Follow-up|2|||
125501265|NCT03052517|451466786|FG001|Overall Study|Lost to Follow-up|4|||
125501266|NCT03052517|451466787|FG002|Overall Study|Lost to Follow-up|0|||
125501267|NCT03052517|451466785|FG000|Overall Study|Pregnancy|1|||
125501268|NCT03052517|451466786|FG001|Overall Study|Pregnancy|0|||
125501269|NCT03052517|451466787|FG002|Overall Study|Pregnancy|1|||
125501270|NCT03052517|451466785|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
125501271|NCT03052517|451466786|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
125501272|NCT03052517|451466787|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
125501273|NCT03052517|451466785|FG000|Overall Study|Technical Problems|0|||
125501274|NCT03052517|451466786|FG001|Overall Study|Technical Problems|1|||
125501275|NCT03052517|451466787|FG002|Overall Study|Technical Problems|0|||
125501276|NCT01640288|451466788|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
125501277|NCT01640288|451466789|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
125501278|NCT01640288|451466788|FG000|Overall Study|Screen Failure|20|||
125501279|NCT01640288|451466789|FG001|Overall Study|Screen Failure|18|||
125501280|NCT01640288|451466788|FG000|Overall Study|Withdrawn by PI|5|||
125501281|NCT01640288|451466789|FG001|Overall Study|Withdrawn by PI|0|||
125501282|NCT01640288|451466788|FG000|Overall Study|Withdrawal by Subject|1|||
125501283|NCT01640288|451466789|FG001|Overall Study|Withdrawal by Subject|0|||
125501284|NCT04803734|451466790|FG000|Overall Study|Withdrawal by Subject|0|||
125501285|NCT04803734|451466791|FG001|Overall Study|Withdrawal by Subject|1|||
125501286|NCT04803734|451466790|FG000|Overall Study|Protocol Violation|0|||
125501287|NCT04803734|451466791|FG001|Overall Study|Protocol Violation|1|||
125501288|NCT02309515|451466792|FG000|Overall Study|Withdrawal by Subject|0|||
125501289|NCT02309515|451466793|FG001|Overall Study|Withdrawal by Subject|1|||
125501290|NCT00195819|451466801|FG000|Double-Blind|Withdrawal by Subject|1|||
125501291|NCT00195819|451466802|FG001|Double-Blind|Withdrawal by Subject|0|||
125501292|NCT00195819|451466801|FG000|Double-Blind|Moved|1|||
125501293|NCT00195819|451466802|FG001|Double-Blind|Moved|0|||
125501294|NCT00195819|451466801|FG000|Open-label|Adverse Event|0|||
125501295|NCT00195819|451466802|FG001|Open-label|Adverse Event|9|||
125501296|NCT00195819|451466801|FG000|Open-label|Lack of Efficacy|0|||
125501297|NCT00195819|451466802|FG001|Open-label|Lack of Efficacy|2|||
125501298|NCT00195819|451466801|FG000|Open-label|Pregnancy|0|||
125501299|NCT00195819|451466802|FG001|Open-label|Pregnancy|1|||
125501300|NCT00195819|451466801|FG000|Open-label|Protocol Violation|0|||
125501301|NCT00195819|451466802|FG001|Open-label|Protocol Violation|2|||
125501302|NCT00195819|451466801|FG000|Open-label|Moved|0|||
125501303|NCT00195819|451466802|FG001|Open-label|Moved|1|||
125501304|NCT00195819|451466801|FG000|Open-label|Withdrawal by Subject|0|||
125501305|NCT00195819|451466802|FG001|Open-label|Withdrawal by Subject|5|||
125501306|NCT03781375|451466805|FG000|Double-blind Phase|Adverse Event|0|||
125501307|NCT03781375|451466806|FG001|Double-blind Phase|Adverse Event|1|||
125501308|NCT03781375|451466805|FG000|Double-blind Phase|Lack of Response|6|||
125501309|NCT03781375|451466806|FG001|Double-blind Phase|Lack of Response|2|||
125501310|NCT03781375|451466805|FG000|Double-blind Phase|Other|1|||
125501311|NCT03781375|451466806|FG001|Double-blind Phase|Other|3|||
125501312|NCT03781375|451466805|FG000|Open-label Phase|Protocol Issues|0|||
125501313|NCT03781375|451466806|FG001|Open-label Phase|Protocol Issues|1|||
125501314|NCT03781375|451466805|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
125501315|NCT03781375|451466806|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
125501316|NCT03781375|451466805|FG000|Open-label Phase|Other|2|||
125501317|NCT03781375|451466806|FG001|Open-label Phase|Other|2|||
125501318|NCT01629589|451466807|FG000|Overall Study|Protocol Violation|4|||
125501319|NCT01629589|451466808|FG001|Overall Study|Protocol Violation|2|||
125501320|NCT01629589|451466807|FG000|Overall Study|Lost to Follow-up|2|||
125501321|NCT01629589|451466808|FG001|Overall Study|Lost to Follow-up|1|||
125501322|NCT01629589|451466807|FG000|Overall Study|Withdrawal by Subject|2|||
125501323|NCT01629589|451466808|FG001|Overall Study|Withdrawal by Subject|3|||
125304864|NCT00988091|450742777|FG000|Double-blind Period|Withdrawal by Subject|15|||
125304865|NCT00988091|450742778|FG001|Double-blind Period|Withdrawal by Subject|13|||
125304866|NCT00988091|450742777|FG000|Double-blind Period|Lost to Follow-up|12|||
125501324|NCT01629589|451466807|FG000|Overall Study|Did not receive study vaccine|0|||
125501325|NCT01629589|451466808|FG001|Overall Study|Did not receive study vaccine|1|||
125501326|NCT01303510|451466811|FG000|Overall Study|Lost to Follow-up|1|||
125501327|NCT01303510|451466812|FG001|Overall Study|Lost to Follow-up|0|||
125501328|NCT02404441|451466813|FG000|Phase 1 Part|Adverse Event|1|||
125501329|NCT02404441|451466814|FG001|Phase 1 Part|Adverse Event|0|||
125501330|NCT02404441|451466815|FG002|Phase 1 Part|Adverse Event|0|||
125501331|NCT02404441|451466816|FG003|Phase 1 Part|Adverse Event|0|||
125501332|NCT02404441|451466817|FG004|Phase 1 Part|Adverse Event|0|||
125501333|NCT02404441|451466818|FG005|Phase 1 Part|Adverse Event|0|||
125501334|NCT02404441|451466819|FG006|Phase 1 Part|Adverse Event|0|||
125501335|NCT02404441|451466820|FG007|Phase 1 Part|Adverse Event|0|||
125501336|NCT02404441|451466821|FG008|Phase 1 Part|Adverse Event|0|||
125501337|NCT02404441|451466822|FG009|Phase 1 Part|Adverse Event|0|||
125501338|NCT02404441|451466813|FG000|Phase 1 Part|Physician Decision|0|||
125501339|NCT02404441|451466814|FG001|Phase 1 Part|Physician Decision|1|||
125501340|NCT02404441|451466815|FG002|Phase 1 Part|Physician Decision|0|||
125501341|NCT02404441|451466816|FG003|Phase 1 Part|Physician Decision|0|||
125501342|NCT02404441|451466817|FG004|Phase 1 Part|Physician Decision|0|||
125501343|NCT02404441|451466818|FG005|Phase 1 Part|Physician Decision|0|||
125501344|NCT02404441|451466819|FG006|Phase 1 Part|Physician Decision|0|||
125501345|NCT02404441|451466820|FG007|Phase 1 Part|Physician Decision|0|||
125501346|NCT02404441|451466821|FG008|Phase 1 Part|Physician Decision|0|||
125501347|NCT02404441|451466822|FG009|Phase 1 Part|Physician Decision|0|||
125501348|NCT02404441|451466813|FG000|Phase 1 Part|Progressive Disease|14|||
125501349|NCT02404441|451466814|FG001|Phase 1 Part|Progressive Disease|11|||
125501350|NCT02404441|451466815|FG002|Phase 1 Part|Progressive Disease|7|||
125501351|NCT02404441|451466816|FG003|Phase 1 Part|Progressive Disease|6|||
125501352|NCT02404441|451466817|FG004|Phase 1 Part|Progressive Disease|9|||
125501353|NCT02404441|451466818|FG005|Phase 1 Part|Progressive Disease|0|||
125501354|NCT02404441|451466819|FG006|Phase 1 Part|Progressive Disease|0|||
125501355|NCT02404441|451466820|FG007|Phase 1 Part|Progressive Disease|0|||
125501356|NCT02404441|451466821|FG008|Phase 1 Part|Progressive Disease|0|||
125501357|NCT02404441|451466822|FG009|Phase 1 Part|Progressive Disease|0|||
125501358|NCT02404441|451466813|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
125501359|NCT02404441|451466814|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
125501360|NCT02404441|451466815|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
125501361|NCT02404441|451466816|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
125501362|NCT02404441|451466817|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
125501363|NCT02404441|451466818|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
125501364|NCT02404441|451466819|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
125501365|NCT02404441|451466820|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
125501366|NCT02404441|451466821|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
125501367|NCT02404441|451466822|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
125501368|NCT02404441|451466813|FG000|Phase 1 Part|Death|1|||
125501369|NCT02404441|451466814|FG001|Phase 1 Part|Death|1|||
125501370|NCT02404441|451466815|FG002|Phase 1 Part|Death|1|||
125501371|NCT02404441|451466816|FG003|Phase 1 Part|Death|0|||
125501372|NCT02404441|451466817|FG004|Phase 1 Part|Death|1|||
125501373|NCT02404441|451466818|FG005|Phase 1 Part|Death|0|||
125501374|NCT02404441|451466819|FG006|Phase 1 Part|Death|0|||
125501375|NCT02404441|451466820|FG007|Phase 1 Part|Death|0|||
125501376|NCT02404441|451466821|FG008|Phase 1 Part|Death|0|||
125501377|NCT02404441|451466822|FG009|Phase 1 Part|Death|0|||
125501378|NCT02404441|451466813|FG000|Phase 2 Part|Adverse Event|0|||
125501379|NCT02404441|451466814|FG001|Phase 2 Part|Adverse Event|0|||
125501380|NCT02404441|451466815|FG002|Phase 2 Part|Adverse Event|0|||
125501381|NCT02404441|451466816|FG003|Phase 2 Part|Adverse Event|0|||
125501382|NCT02404441|451466817|FG004|Phase 2 Part|Adverse Event|0|||
125501383|NCT02404441|451466818|FG005|Phase 2 Part|Adverse Event|2|||
125501384|NCT02404441|451466819|FG006|Phase 2 Part|Adverse Event|3|||
125501385|NCT02404441|451466820|FG007|Phase 2 Part|Adverse Event|3|||
125501386|NCT02404441|451466821|FG008|Phase 2 Part|Adverse Event|6|||
125501387|NCT02404441|451466822|FG009|Phase 2 Part|Adverse Event|1|||
125501388|NCT02404441|451466813|FG000|Phase 2 Part|Physician Decision|0|||
125501389|NCT02404441|451466814|FG001|Phase 2 Part|Physician Decision|0|||
125501390|NCT02404441|451466815|FG002|Phase 2 Part|Physician Decision|0|||
125501391|NCT02404441|451466816|FG003|Phase 2 Part|Physician Decision|0|||
125501392|NCT02404441|451466817|FG004|Phase 2 Part|Physician Decision|0|||
125501393|NCT02404441|451466818|FG005|Phase 2 Part|Physician Decision|7|||
125501394|NCT02404441|451466819|FG006|Phase 2 Part|Physician Decision|9|||
125501395|NCT02404441|451466820|FG007|Phase 2 Part|Physician Decision|2|||
125501396|NCT02404441|451466821|FG008|Phase 2 Part|Physician Decision|1|||
125501397|NCT02404441|451466822|FG009|Phase 2 Part|Physician Decision|3|||
125501398|NCT02404441|451466813|FG000|Phase 2 Part|Progressive disease|0|||
125501399|NCT02404441|451466814|FG001|Phase 2 Part|Progressive disease|0|||
125501400|NCT02404441|451466815|FG002|Phase 2 Part|Progressive disease|0|||
125501401|NCT02404441|451466816|FG003|Phase 2 Part|Progressive disease|0|||
125501402|NCT02404441|451466817|FG004|Phase 2 Part|Progressive disease|0|||
125501403|NCT02404441|451466818|FG005|Phase 2 Part|Progressive disease|43|||
125304867|NCT00988091|450742778|FG001|Double-blind Period|Lost to Follow-up|14|||
125501404|NCT02404441|451466819|FG006|Phase 2 Part|Progressive disease|32|||
125501405|NCT02404441|451466820|FG007|Phase 2 Part|Progressive disease|31|||
125501406|NCT02404441|451466821|FG008|Phase 2 Part|Progressive disease|39|||
125501407|NCT02404441|451466822|FG009|Phase 2 Part|Progressive disease|27|||
125501408|NCT02404441|451466813|FG000|Phase 2 Part|Subject/guardian decision|0|||
125501409|NCT02404441|451466814|FG001|Phase 2 Part|Subject/guardian decision|0|||
125501410|NCT02404441|451466815|FG002|Phase 2 Part|Subject/guardian decision|0|||
125501411|NCT02404441|451466816|FG003|Phase 2 Part|Subject/guardian decision|0|||
125501412|NCT02404441|451466817|FG004|Phase 2 Part|Subject/guardian decision|0|||
125501413|NCT02404441|451466818|FG005|Phase 2 Part|Subject/guardian decision|3|||
125501414|NCT02404441|451466819|FG006|Phase 2 Part|Subject/guardian decision|9|||
125304868|NCT00988091|450742777|FG000|Double-blind Period|Other|8|||
125501415|NCT02404441|451466820|FG007|Phase 2 Part|Subject/guardian decision|0|||
125501416|NCT02404441|451466821|FG008|Phase 2 Part|Subject/guardian decision|3|||
125501417|NCT02404441|451466822|FG009|Phase 2 Part|Subject/guardian decision|2|||
125501418|NCT02404441|451466813|FG000|Phase 2 Part|Death|0|||
125501419|NCT02404441|451466814|FG001|Phase 2 Part|Death|0|||
125501420|NCT02404441|451466815|FG002|Phase 2 Part|Death|0|||
125501421|NCT02404441|451466816|FG003|Phase 2 Part|Death|0|||
125501422|NCT02404441|451466817|FG004|Phase 2 Part|Death|0|||
125501423|NCT02404441|451466818|FG005|Phase 2 Part|Death|4|||
125501424|NCT02404441|451466819|FG006|Phase 2 Part|Death|8|||
125501425|NCT02404441|451466820|FG007|Phase 2 Part|Death|4|||
125501426|NCT02404441|451466821|FG008|Phase 2 Part|Death|10|||
125501427|NCT02404441|451466822|FG009|Phase 2 Part|Death|9|||
125501428|NCT04679675|451466823|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
125501429|NCT04679675|451466824|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
125501430|NCT04679675|451466825|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
125501431|NCT04679675|451466826|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
125501432|NCT04679675|451466823|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
125501433|NCT04679675|451466824|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
125501434|NCT04679675|451466825|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
125501435|NCT04679675|451466826|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
125501436|NCT00526994|451466827|FG000|Overall Study|Lost to Follow-up|98|||
125501437|NCT00526994|451466828|FG001|Overall Study|Lost to Follow-up|108|||
125501438|NCT00526994|451466829|FG002|Overall Study|Lost to Follow-up|96|||
125501439|NCT00526994|451466827|FG000|Overall Study|Death|4|||
125501440|NCT00526994|451466828|FG001|Overall Study|Death|3|||
125501441|NCT00526994|451466829|FG002|Overall Study|Death|3|||
125501442|NCT00526994|451466827|FG000|Overall Study|Withdrawal by Subject|2|||
125501443|NCT00526994|451466828|FG001|Overall Study|Withdrawal by Subject|7|||
125501444|NCT00526994|451466829|FG002|Overall Study|Withdrawal by Subject|5|||
125501445|NCT00526994|451466827|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
125501446|NCT00526994|451466828|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
125501447|NCT00526994|451466829|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
125501448|NCT02833948|451466835|FG000|Overall Study|Death|2|||
125501449|NCT02833948|451466836|FG001|Overall Study|Death|3|||
125501450|NCT02833948|451466835|FG000|Overall Study|were not scanned|8|||
125501451|NCT02833948|451466836|FG001|Overall Study|were not scanned|13|||
125501452|NCT02833948|451466835|FG000|Overall Study|scans could not be evaluated|5|||
125501453|NCT02833948|451466836|FG001|Overall Study|scans could not be evaluated|2|||
125501454|NCT02644122|451466837|FG000|Overall Study|Withdrawal by Subject|1|||
125501455|NCT03182244|451466838|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
125501456|NCT03182244|451466839|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
125501457|NCT03182244|451466838|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
125501458|NCT03182244|451466839|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
125501459|NCT03182244|451466838|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
125501460|NCT03182244|451466839|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
125501461|NCT03182244|451466838|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
125501462|NCT03182244|451466839|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
125501463|NCT03182244|451466838|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
125501464|NCT03182244|451466839|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
125501465|NCT03182244|451466838|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
125501466|NCT03182244|451466839|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
125501467|NCT03182244|451466838|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
125501468|NCT03182244|451466839|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
125501469|NCT03182244|451466838|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
125501470|NCT03182244|451466839|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
125501471|NCT03182244|451466838|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
125501472|NCT03182244|451466839|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
125501473|NCT03182244|451466838|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
125501474|NCT03182244|451466839|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
125501475|NCT03182244|451466838|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
125501476|NCT03182244|451466839|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
125501477|NCT03182244|451466838|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
125501478|NCT03182244|451466839|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
125501479|NCT03182244|451466838|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
125501480|NCT03182244|451466839|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
125501481|NCT02852824|451466842|FG000|Overall Study|Withdrawal by Subject|1|||
125501482|NCT02852824|451466843|FG001|Overall Study|Withdrawal by Subject|0|||
125501483|NCT02852824|451466844|FG002|Overall Study|Withdrawal by Subject|0|||
125501484|NCT02852824|451466845|FG003|Overall Study|Withdrawal by Subject|0|||
125501485|NCT02852824|451466846|FG004|Overall Study|Withdrawal by Subject|0|||
125501486|NCT02852824|451466847|FG005|Overall Study|Withdrawal by Subject|0|||
125501487|NCT02852824|451466848|FG006|Overall Study|Withdrawal by Subject|0|||
125304869|NCT00988091|450742778|FG001|Double-blind Period|Other|8|||
125304870|NCT00988091|450742777|FG000|Double-blind Period|Adverse Event|6|||
125304871|NCT00988091|450742778|FG001|Double-blind Period|Adverse Event|9|||
125501488|NCT02852824|451466842|FG000|Overall Study|Adverse Event|0|||
125501489|NCT02852824|451466843|FG001|Overall Study|Adverse Event|0|||
125501490|NCT02852824|451466844|FG002|Overall Study|Adverse Event|0|||
125501491|NCT02852824|451466845|FG003|Overall Study|Adverse Event|0|||
125501492|NCT02852824|451466846|FG004|Overall Study|Adverse Event|2|||
125501493|NCT02852824|451466847|FG005|Overall Study|Adverse Event|0|||
125501494|NCT02852824|451466848|FG006|Overall Study|Adverse Event|0|||
125501495|NCT00680771|451466849|FG000|Overall Study|Withdrawal by Subject|1|||
125501496|NCT00680771|451466850|FG001|Overall Study|Withdrawal by Subject|0|||
125501497|NCT00680771|451466849|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
125501498|NCT00680771|451466850|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
125501499|NCT00680771|451466849|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
125501500|NCT00680771|451466850|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
125501501|NCT04748341|451466851|FG000|Overall Study|Lost to Follow-up|1|||
125501502|NCT04748341|451466852|FG001|Overall Study|Lost to Follow-up|1|||
125501503|NCT03769090|451468518|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
125501504|NCT03769090|451468519|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
125501505|NCT03769090|451468520|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
125501506|NCT03769090|451468518|FG000|Overall Study|Withdrawal by Subject|52|||
125501507|NCT03769090|451468519|FG001|Overall Study|Withdrawal by Subject|62|||
125501508|NCT03769090|451468520|FG002|Overall Study|Withdrawal by Subject|74|||
125501509|NCT03769090|451468518|FG000|Overall Study|Death|4|||
125501510|NCT03769090|451468519|FG001|Overall Study|Death|2|||
125501511|NCT03769090|451468520|FG002|Overall Study|Death|2|||
125501512|NCT03769090|451468518|FG000|Overall Study|Adverse Event|7|||
125501513|NCT03769090|451468519|FG001|Overall Study|Adverse Event|7|||
125501514|NCT03769090|451468520|FG002|Overall Study|Adverse Event|8|||
125501515|NCT03769090|451468518|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
125501516|NCT03769090|451468519|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
125501517|NCT03769090|451468520|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
125501518|NCT03769090|451468518|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
125501519|NCT03769090|451468519|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
125501520|NCT03769090|451468520|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
125501521|NCT03769090|451468518|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
125304872|NCT00988091|450742777|FG000|Double-blind Period|Use of exclusionary medication|2|||
125304873|NCT00988091|450742778|FG001|Double-blind Period|Use of exclusionary medication|3|||
125304874|NCT00988091|450742777|FG000|Open-label Period|Adverse Event|4|||
125304875|NCT00988091|450742778|FG001|Open-label Period|Adverse Event|7|||
125304876|NCT00988091|450742777|FG000|Open-label Period|Use of exclusionary medication|1|||
125304877|NCT00988091|450742778|FG001|Open-label Period|Use of exclusionary medication|1|||
125304878|NCT00988091|450742777|FG000|Open-label Period|Protocol Violation|1|||
125304879|NCT00988091|450742778|FG001|Open-label Period|Protocol Violation|1|||
125304880|NCT00988091|450742777|FG000|Open-label Period|Withdrawal by Subject|10|||
125304881|NCT00988091|450742778|FG001|Open-label Period|Withdrawal by Subject|16|||
125304882|NCT00988091|450742777|FG000|Open-label Period|Lost to Follow-up|3|||
125304883|NCT00988091|450742778|FG001|Open-label Period|Lost to Follow-up|5|||
125304884|NCT00988091|450742777|FG000|Open-label Period|Other|2|||
125304885|NCT00988091|450742778|FG001|Open-label Period|Other|3|||
125501522|NCT03769090|451468519|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
125501523|NCT03769090|451468520|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
125501524|NCT03769090|451468518|FG000|Overall Study|Protocol Violation|5|||
125501525|NCT03769090|451468519|FG001|Overall Study|Protocol Violation|6|||
125501526|NCT03769090|451468520|FG002|Overall Study|Protocol Violation|8|||
125501527|NCT03769090|451468518|FG000|Overall Study|Pregnancy|1|||
125304886|NCT00994422|450742779|FG000|Overall Study|Lost to Follow-up|7|||
125501528|NCT03769090|451468519|FG001|Overall Study|Pregnancy|0|||
125501529|NCT03769090|451468520|FG002|Overall Study|Pregnancy|3|||
125501530|NCT03769090|451468518|FG000|Overall Study|Lost to Follow-up|19|||
125501531|NCT03769090|451468519|FG001|Overall Study|Lost to Follow-up|25|||
125501532|NCT03769090|451468520|FG002|Overall Study|Lost to Follow-up|21|||
125501533|NCT03769090|451468518|FG000|Overall Study|Condition under investigation worsened|2|||
125304887|NCT00994422|450742780|FG001|Overall Study|Lost to Follow-up|1|||
125304888|NCT01846741|450742782|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
125304889|NCT03664765|450742783|FG000|Overall Study|Withdrawal by Subject|4|||
125304890|NCT03664765|450742784|FG001|Overall Study|Withdrawal by Subject|1|||
125304891|NCT03664765|450742783|FG000|Overall Study|Lost to Follow-up|0|||
125304892|NCT03664765|450742784|FG001|Overall Study|Lost to Follow-up|1|||
125501534|NCT03769090|451468519|FG001|Overall Study|Condition under investigation worsened|0|||
125501535|NCT03769090|451468520|FG002|Overall Study|Condition under investigation worsened|1|||
125304893|NCT01153698|450742785|FG000|Overall Study|Adverse Event|12|||
125501536|NCT03769090|451468518|FG000|Overall Study|Lack of Efficacy|1|||
125501537|NCT03769090|451468519|FG001|Overall Study|Lack of Efficacy|2|||
125304894|NCT01153698|450742785|FG000|Overall Study|Lost to Follow-up|4|||
125304895|NCT01153698|450742785|FG000|Overall Study|Withdrawal by Subject|2|||
125501538|NCT03769090|451468520|FG002|Overall Study|Lack of Efficacy|2|||
125501539|NCT03769090|451468518|FG000|Overall Study|Other reasons|8|||
125501540|NCT03769090|451468519|FG001|Overall Study|Other reasons|12|||
125501541|NCT03769090|451468520|FG002|Overall Study|Other reasons|15|||
125501542|NCT00799409|451468521|FG000|Overall Study|Withdrawal by Subject|1|||
125501543|NCT00799409|451468522|FG001|Overall Study|Withdrawal by Subject|0|||
125501544|NCT00799409|451468523|FG002|Overall Study|Withdrawal by Subject|0|||
125501545|NCT00799409|451468521|FG000|Overall Study|Lost to Follow-up|1|||
125501546|NCT00799409|451468522|FG001|Overall Study|Lost to Follow-up|0|||
125501547|NCT00799409|451468523|FG002|Overall Study|Lost to Follow-up|0|||
125501548|NCT00799409|451468521|FG000|Overall Study|Optimal Dose Not Achieved|2|||
125501549|NCT00799409|451468522|FG001|Overall Study|Optimal Dose Not Achieved|0|||
125501550|NCT00799409|451468523|FG002|Overall Study|Optimal Dose Not Achieved|0|||
125501551|NCT00799409|451468521|FG000|Overall Study|Failure to follow study protocol)|1|||
125501552|NCT00799409|451468522|FG001|Overall Study|Failure to follow study protocol)|0|||
125501553|NCT00799409|451468523|FG002|Overall Study|Failure to follow study protocol)|0|||
125501554|NCT00799409|451468521|FG000|Overall Study|Did not attend lab school day 1|1|||
125501555|NCT00799409|451468522|FG001|Overall Study|Did not attend lab school day 1|0|||
125501556|NCT00799409|451468523|FG002|Overall Study|Did not attend lab school day 1|0|||
125501557|NCT00799409|451468521|FG000|Overall Study|medication compliance|1|||
125501558|NCT00799409|451468522|FG001|Overall Study|medication compliance|0|||
125501559|NCT00799409|451468523|FG002|Overall Study|medication compliance|0|||
125501560|NCT00443820|451468524|FG000|Overall Study|Adverse Event|1|||
125501561|NCT00443820|451468525|FG001|Overall Study|Adverse Event|1|||
125501562|NCT00443820|451468526|FG002|Overall Study|Adverse Event|0|||
125501563|NCT00443820|451468527|FG003|Overall Study|Adverse Event|0|||
125501564|NCT00443820|451468524|FG000|Overall Study|Lack of Efficacy|3|||
125501565|NCT00443820|451468525|FG001|Overall Study|Lack of Efficacy|2|||
125501566|NCT00443820|451468526|FG002|Overall Study|Lack of Efficacy|1|||
125501567|NCT00443820|451468527|FG003|Overall Study|Lack of Efficacy|1|||
125501568|NCT00443820|451468524|FG000|Overall Study|Protocol Violation|2|||
125501569|NCT00443820|451468525|FG001|Overall Study|Protocol Violation|1|||
125501570|NCT00443820|451468526|FG002|Overall Study|Protocol Violation|2|||
125501571|NCT00443820|451468527|FG003|Overall Study|Protocol Violation|1|||
125501572|NCT00443820|451468524|FG000|Overall Study|Withdrawal by Subject|6|||
125501573|NCT00443820|451468525|FG001|Overall Study|Withdrawal by Subject|7|||
125501574|NCT00443820|451468526|FG002|Overall Study|Withdrawal by Subject|8|||
125501575|NCT00443820|451468527|FG003|Overall Study|Withdrawal by Subject|9|||
125501576|NCT00443820|451468524|FG000|Overall Study|Lost to Follow-up|9|||
125501577|NCT00443820|451468525|FG001|Overall Study|Lost to Follow-up|8|||
125501578|NCT00443820|451468526|FG002|Overall Study|Lost to Follow-up|6|||
125501579|NCT00443820|451468527|FG003|Overall Study|Lost to Follow-up|5|||
125501580|NCT00443820|451468524|FG000|Overall Study|Administrative problems|0|||
125501581|NCT00443820|451468525|FG001|Overall Study|Administrative problems|0|||
125501582|NCT00443820|451468526|FG002|Overall Study|Administrative problems|0|||
125501583|NCT00443820|451468527|FG003|Overall Study|Administrative problems|1|||
125501584|NCT00443820|451468524|FG000|Overall Study|Death|0|||
125501585|NCT00443820|451468525|FG001|Overall Study|Death|0|||
125501586|NCT00443820|451468526|FG002|Overall Study|Death|1|||
125501587|NCT00443820|451468527|FG003|Overall Study|Death|0|||
125501588|NCT04633200|451468528|FG000|Overall Study|Lost to Follow-up|3|||
125501589|NCT04633200|451468529|FG001|Overall Study|Lost to Follow-up|5|||
125501590|NCT02713594|451468530|FG000|Overall Study|Withdrawal by Subject|32|||
125501591|NCT02713594|451468531|FG001|Overall Study|Withdrawal by Subject|22|||
125501592|NCT02713594|451468530|FG000|Overall Study|Lost to Follow-up|358|||
125501593|NCT02713594|451468531|FG001|Overall Study|Lost to Follow-up|374|||
125501594|NCT00670449|451468532|FG000|Overall Study|Adverse Event|6|||
125501595|NCT00670449|451468533|FG001|Overall Study|Adverse Event|2|||
125501596|NCT00670449|451468534|FG002|Overall Study|Adverse Event|8|||
125501597|NCT00670449|451468535|FG003|Overall Study|Adverse Event|5|||
125501598|NCT00670449|451468532|FG000|Overall Study|Protocol Deviation|1|||
125304896|NCT01153698|450742785|FG000|Overall Study|Switch to other anticoagulants|4|||
125304897|NCT01153698|450742785|FG000|Overall Study|Other|2|||
125501599|NCT00670449|451468533|FG001|Overall Study|Protocol Deviation|2|||
125501600|NCT00670449|451468534|FG002|Overall Study|Protocol Deviation|0|||
125501601|NCT00670449|451468535|FG003|Overall Study|Protocol Deviation|1|||
125501602|NCT00670449|451468532|FG000|Overall Study|Administrative Problems|0|||
125501603|NCT00670449|451468533|FG001|Overall Study|Administrative Problems|2|||
125501604|NCT00670449|451468534|FG002|Overall Study|Administrative Problems|0|||
125501605|NCT00670449|451468535|FG003|Overall Study|Administrative Problems|1|||
125501606|NCT00670449|451468532|FG000|Overall Study|Subject Withdrew Consent|0|||
125501607|NCT00670449|451468533|FG001|Overall Study|Subject Withdrew Consent|2|||
125501608|NCT00670449|451468534|FG002|Overall Study|Subject Withdrew Consent|0|||
125501609|NCT00670449|451468535|FG003|Overall Study|Subject Withdrew Consent|1|||
125501610|NCT00670449|451468532|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
125501611|NCT00670449|451468533|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125501612|NCT00670449|451468534|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
125501613|NCT00670449|451468535|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
125501614|NCT00670449|451468532|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
125501615|NCT00670449|451468533|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
125501616|NCT00670449|451468534|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
125501617|NCT00670449|451468535|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
125501618|NCT02771366|451468536|FG000|Period 1|Withdrawal by Subject|0|||
125501619|NCT02771366|451468537|FG001|Period 1|Withdrawal by Subject|2|||
125501620|NCT02771366|451468536|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
125501621|NCT02771366|451468537|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
125501622|NCT00671853|451468540|FG000|Overall Study|Lack of Efficacy|3|||
125501623|NCT00671853|451468541|FG001|Overall Study|Lack of Efficacy|7|||
125501624|NCT00671853|451468540|FG000|Overall Study|Adverse Event|7|||
125501625|NCT00671853|451468541|FG001|Overall Study|Adverse Event|1|||
125501626|NCT00671853|451468540|FG000|Overall Study|Withdrawal by Subject|1|||
125501627|NCT00671853|451468541|FG001|Overall Study|Withdrawal by Subject|5|||
125501628|NCT00671853|451468540|FG000|Overall Study|Lost to Follow-up|8|||
125501629|NCT00671853|451468541|FG001|Overall Study|Lost to Follow-up|8|||
125501630|NCT00671853|451468540|FG000|Overall Study|Physician Decision|0|||
125501631|NCT00671853|451468541|FG001|Overall Study|Physician Decision|2|||
125501632|NCT00671853|451468540|FG000|Overall Study|Non-adherence with study procedures|1|||
125501633|NCT00671853|451468541|FG001|Overall Study|Non-adherence with study procedures|4|||
125501634|NCT00587171|451468543|FG000|Overall Study|Lost to Follow-up|1|||
125501635|NCT00587171|451468544|FG001|Overall Study|Lost to Follow-up|1|||
125501636|NCT01848483|451468545|FG000|Overall Study|Death|2|||
125501637|NCT01848483|451468546|FG001|Overall Study|Death|1|||
125501638|NCT01848483|451468545|FG000|Overall Study|Lost to Follow-up|6|||
125501639|NCT01848483|451468546|FG001|Overall Study|Lost to Follow-up|8|||
125501640|NCT01848483|451468545|FG000|Overall Study|Withdrawal by Subject|1|||
125501641|NCT01848483|451468546|FG001|Overall Study|Withdrawal by Subject|0|||
125501642|NCT01848483|451468545|FG000|Overall Study|Incarceration|2|||
125501643|NCT01848483|451468546|FG001|Overall Study|Incarceration|2|||
125501644|NCT01148017|451468547|FG000|Overall Study|Withdrawal by Subject|31|||
125501645|NCT01148017|451468548|FG001|Overall Study|Withdrawal by Subject|14|||
125501646|NCT01148017|451468549|FG002|Overall Study|Withdrawal by Subject|0|||
125501647|NCT01148017|451468550|FG003|Overall Study|Withdrawal by Subject|0|||
125501648|NCT01148017|451468547|FG000|Overall Study|Lost to Follow-up|23|||
125501649|NCT01148017|451468548|FG001|Overall Study|Lost to Follow-up|10|||
125501650|NCT01148017|451468549|FG002|Overall Study|Lost to Follow-up|0|||
125501651|NCT01148017|451468550|FG003|Overall Study|Lost to Follow-up|0|||
125501652|NCT01148017|451468547|FG000|Overall Study|Inappropriate enrollment|1|||
125501653|NCT01148017|451468548|FG001|Overall Study|Inappropriate enrollment|0|||
125501654|NCT01148017|451468549|FG002|Overall Study|Inappropriate enrollment|0|||
125501655|NCT01148017|451468550|FG003|Overall Study|Inappropriate enrollment|0|||
125501656|NCT01148017|451468547|FG000|Overall Study|Administrative reason|22|||
125501657|NCT01148017|451468548|FG001|Overall Study|Administrative reason|9|||
125501658|NCT01148017|451468549|FG002|Overall Study|Administrative reason|0|||
125501659|NCT01148017|451468550|FG003|Overall Study|Administrative reason|0|||
125501660|NCT01148017|451468547|FG000|Overall Study|Unable to classify|3|||
125501661|NCT01148017|451468548|FG001|Overall Study|Unable to classify|1|||
125501662|NCT01148017|451468549|FG002|Overall Study|Unable to classify|0|||
125501663|NCT01148017|451468550|FG003|Overall Study|Unable to classify|0|||
125501664|NCT03928743|451468551|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
125501665|NCT03928743|451468552|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
125501666|NCT03928743|451468553|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
125501667|NCT03928743|451468551|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
125501668|NCT03928743|451468552|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
125501669|NCT03928743|451468553|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
125501670|NCT03928743|451468551|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
125501671|NCT03928743|451468552|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
125501672|NCT03928743|451468553|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
125501673|NCT03928743|451468551|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
125501674|NCT03928743|451468552|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
125501675|NCT03928743|451468553|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
125501676|NCT03928743|451468551|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
125501677|NCT03928743|451468552|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
125501678|NCT03928743|451468553|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
125501679|NCT03928743|451468551|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
125304898|NCT01153698|450742785|FG000|Overall Study|Not treated with Pradaxa|5|||
125304899|NCT01090063|450742786|FG000|Screen|Screen Failed|4|||
125501680|NCT03928743|451468552|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
125501681|NCT03928743|451468553|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
125501682|NCT03928743|451468551|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
125501683|NCT03928743|451468552|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
125501684|NCT03928743|451468553|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
125501685|NCT03928743|451468551|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
125501686|NCT03928743|451468552|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
125501687|NCT03928743|451468553|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
125501688|NCT03928743|451468551|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
125501689|NCT03928743|451468552|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
125501690|NCT03928743|451468553|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
125501691|NCT03928743|451468551|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
125501692|NCT03928743|451468552|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
125501693|NCT03928743|451468553|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
125501694|NCT03928743|451468551|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
125501695|NCT03928743|451468552|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
125501696|NCT03928743|451468553|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
125501697|NCT02392507|451468554|FG000|Induction Regimen|Death|3|||
125501698|NCT02392507|451468554|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
125501699|NCT02392507|451468554|FG000|Induction Regimen|Physician Decision|1|||
125501700|NCT02392507|451468554|FG000|Induction Regimen|Withdrawal by Subject|2|||
125501701|NCT02392507|451468554|FG000|Maintenance Regimen|Death|1|||
125501702|NCT02392507|451468554|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
125501703|NCT02224755|451468555|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
125501704|NCT02224755|451468556|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
125501705|NCT02224755|451468555|FG000|Two Year Follow up Post-implant|Death|103|||
125501706|NCT02224755|451468556|FG001|Two Year Follow up Post-implant|Death|98|||
125501707|NCT02224755|451468555|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
125501708|NCT02224755|451468556|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
125501709|NCT02224755|451468555|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
125501710|NCT02224755|451468556|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
125501711|NCT02224755|451468555|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
125501712|NCT02224755|451468556|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
125501713|NCT01829711|451468557|FG000|Overall Study|Lost to Follow-up|2|||
125501714|NCT01829711|451468557|FG000|Overall Study|Withdrawal by Subject|3|||
125501715|NCT01829711|451468557|FG000|Overall Study|Death|4|||
125501716|NCT01829711|451468557|FG000|Overall Study|Started new therapies|17|||
125501717|NCT01829711|451468557|FG000|Overall Study|Adverse Event|3|||
125501718|NCT01829711|451468557|FG000|Overall Study|Due to progression of disease|13|||
125501719|NCT01829711|451468557|FG000|Overall Study|Due to lack of response|1|||
125501720|NCT01480258|451468560|FG000|Infant Series|Protocol Violation|2|||
125501721|NCT01480258|451468561|FG001|Infant Series|Protocol Violation|0|||
125501722|NCT01480258|451468560|FG000|Infant Series|Physician Decision|0|||
125501723|NCT01480258|451468561|FG001|Infant Series|Physician Decision|1|||
125501724|NCT01480258|451468560|FG000|Infant Series|Not Vaccinated|3|||
125501725|NCT01480258|451468561|FG001|Infant Series|Not Vaccinated|0|||
125501726|NCT01480258|451468560|FG000|Infant Series|Adverse Event|1|||
125501727|NCT01480258|451468561|FG001|Infant Series|Adverse Event|1|||
125501728|NCT01480258|451468560|FG000|Infant Series|Withdrawal by Subject|1|||
125501729|NCT01480258|451468561|FG001|Infant Series|Withdrawal by Subject|6|||
125501730|NCT01480258|451468560|FG000|Interim Period|Lost to Follow-up|0|||
125501731|NCT01480258|451468561|FG001|Interim Period|Lost to Follow-up|2|||
125501732|NCT01480258|451468560|FG000|Interim Period|Physician Decision|1|||
125501733|NCT01480258|451468561|FG001|Interim Period|Physician Decision|0|||
125501734|NCT01480258|451468560|FG000|Interim Period|Protocol Violation|0|||
125501735|NCT01480258|451468561|FG001|Interim Period|Protocol Violation|1|||
125501736|NCT01480258|451468560|FG000|Interim Period|Withdrawal by Subject|9|||
125501737|NCT01480258|451468561|FG001|Interim Period|Withdrawal by Subject|6|||
125501738|NCT02169414|451468562|FG000|Overall Study|Withdrawal by Subject|1|||
125501739|NCT02169414|451468563|FG001|Overall Study|Withdrawal by Subject|0|||
125501740|NCT02169414|451468564|FG002|Overall Study|Withdrawal by Subject|0|||
125501741|NCT02169414|451468565|FG003|Overall Study|Withdrawal by Subject|0|||
125501742|NCT02169414|451468562|FG000|Overall Study|Adverse Event|0|||
125501743|NCT02169414|451468563|FG001|Overall Study|Adverse Event|1|||
125501744|NCT02169414|451468564|FG002|Overall Study|Adverse Event|0|||
125501745|NCT02169414|451468565|FG003|Overall Study|Adverse Event|0|||
125501746|NCT03374254|451468566|FG000|Overall Study|Death|5|||
125501747|NCT03374254|451468567|FG001|Overall Study|Death|16|||
125501748|NCT03374254|451468568|FG002|Overall Study|Death|13|||
125501749|NCT03374254|451468569|FG003|Overall Study|Death|11|||
125501750|NCT03374254|451468570|FG004|Overall Study|Death|9|||
125501751|NCT03374254|451468571|FG005|Overall Study|Death|12|||
125501752|NCT03374254|451468572|FG006|Overall Study|Death|11|||
125501753|NCT03374254|451468573|FG007|Overall Study|Death|6|||
125501754|NCT03374254|451468574|FG008|Overall Study|Death|7|||
125501755|NCT03374254|451468566|FG000|Overall Study|Lost to Follow-up|0|||
125501756|NCT03374254|451468567|FG001|Overall Study|Lost to Follow-up|0|||
125501757|NCT03374254|451468568|FG002|Overall Study|Lost to Follow-up|0|||
125501758|NCT03374254|451468569|FG003|Overall Study|Lost to Follow-up|0|||
125501759|NCT03374254|451468570|FG004|Overall Study|Lost to Follow-up|0|||
125501760|NCT03374254|451468571|FG005|Overall Study|Lost to Follow-up|0|||
125501761|NCT03374254|451468572|FG006|Overall Study|Lost to Follow-up|2|||
125501762|NCT03374254|451468573|FG007|Overall Study|Lost to Follow-up|0|||
125501763|NCT03374254|451468574|FG008|Overall Study|Lost to Follow-up|0|||
125501764|NCT03374254|451468566|FG000|Overall Study|Sponsor Decision|1|||
125501765|NCT03374254|451468567|FG001|Overall Study|Sponsor Decision|0|||
125501766|NCT03374254|451468568|FG002|Overall Study|Sponsor Decision|2|||
125501767|NCT03374254|451468569|FG003|Overall Study|Sponsor Decision|3|||
125501768|NCT03374254|451468570|FG004|Overall Study|Sponsor Decision|2|||
125501769|NCT03374254|451468571|FG005|Overall Study|Sponsor Decision|3|||
125501770|NCT03374254|451468572|FG006|Overall Study|Sponsor Decision|3|||
125501771|NCT03374254|451468573|FG007|Overall Study|Sponsor Decision|3|||
125501772|NCT03374254|451468574|FG008|Overall Study|Sponsor Decision|4|||
125501773|NCT03374254|451468566|FG000|Overall Study|Withdrawal by Subject|0|||
125501774|NCT03374254|451468567|FG001|Overall Study|Withdrawal by Subject|0|||
125501775|NCT03374254|451468568|FG002|Overall Study|Withdrawal by Subject|0|||
125501776|NCT03374254|451468569|FG003|Overall Study|Withdrawal by Subject|2|||
125501777|NCT03374254|451468570|FG004|Overall Study|Withdrawal by Subject|0|||
125501778|NCT03374254|451468571|FG005|Overall Study|Withdrawal by Subject|1|||
125501779|NCT03374254|451468572|FG006|Overall Study|Withdrawal by Subject|0|||
125501780|NCT03374254|451468573|FG007|Overall Study|Withdrawal by Subject|0|||
125501781|NCT03374254|451468574|FG008|Overall Study|Withdrawal by Subject|0|||
125501782|NCT00624377|451468578|FG000|Overall Study|Lost to Follow-up|355|||
125501783|NCT00624377|451468578|FG000|Overall Study|Withdrawal by Subject|100|||
125501784|NCT00624377|451468578|FG000|Overall Study|Adverse Event|14|||
125501785|NCT00624377|451468578|FG000|Overall Study|Other|91|||
125501786|NCT00624377|451468578|FG000|Overall Study|Non-evaluable population|84|||
125501787|NCT05260437|451468579|FG000|Overall Study|Lost to Follow-up|5|||
125501788|NCT05260437|451468580|FG001|Overall Study|Lost to Follow-up|2|||
125501789|NCT05260437|451468581|FG002|Overall Study|Lost to Follow-up|1|||
125501790|NCT05260437|451468582|FG003|Overall Study|Lost to Follow-up|2|||
125501791|NCT05260437|451468583|FG004|Overall Study|Lost to Follow-up|2|||
125501792|NCT05260437|451468579|FG000|Overall Study|Withdrawal by Subject|3|||
125501793|NCT05260437|451468580|FG001|Overall Study|Withdrawal by Subject|0|||
125501794|NCT05260437|451468581|FG002|Overall Study|Withdrawal by Subject|4|||
125501795|NCT05260437|451468582|FG003|Overall Study|Withdrawal by Subject|5|||
125501796|NCT05260437|451468583|FG004|Overall Study|Withdrawal by Subject|0|||
125501797|NCT05260437|451468579|FG000|Overall Study|Vaccine Not Administered|0|||
125501798|NCT05260437|451468580|FG001|Overall Study|Vaccine Not Administered|1|||
125501799|NCT05260437|451468581|FG002|Overall Study|Vaccine Not Administered|0|||
125501800|NCT05260437|451468582|FG003|Overall Study|Vaccine Not Administered|0|||
125501801|NCT05260437|451468583|FG004|Overall Study|Vaccine Not Administered|0|||
125501802|NCT00910962|451468584|FG000|Overall Study|Adverse Event|5|||
125501803|NCT00910962|451468585|FG001|Overall Study|Adverse Event|20|||
125501804|NCT00910962|451468586|FG002|Overall Study|Adverse Event|17|||
125501805|NCT00910962|451468584|FG000|Overall Study|Protocol Violation|1|||
125501806|NCT00910962|451468585|FG001|Overall Study|Protocol Violation|3|||
125501807|NCT00910962|451468586|FG002|Overall Study|Protocol Violation|3|||
125501808|NCT00910962|451468584|FG000|Overall Study|Lost to Follow-up|0|||
125501809|NCT00910962|451468585|FG001|Overall Study|Lost to Follow-up|3|||
125501810|NCT00910962|451468586|FG002|Overall Study|Lost to Follow-up|1|||
125501811|NCT00910962|451468584|FG000|Overall Study|Physician Decision|0|||
125501812|NCT00910962|451468585|FG001|Overall Study|Physician Decision|6|||
125501813|NCT00910962|451468586|FG002|Overall Study|Physician Decision|6|||
125501814|NCT00910962|451468584|FG000|Overall Study|Withdrawal by Subject|25|||
125501815|NCT00910962|451468585|FG001|Overall Study|Withdrawal by Subject|32|||
125501816|NCT00910962|451468586|FG002|Overall Study|Withdrawal by Subject|32|||
125501817|NCT00910962|451468584|FG000|Overall Study|Reached defined stopping criteria|12|||
125501818|NCT00910962|451468585|FG001|Overall Study|Reached defined stopping criteria|14|||
125501819|NCT00910962|451468586|FG002|Overall Study|Reached defined stopping criteria|17|||
125501820|NCT00923078|451468587|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
125501821|NCT00923078|451468588|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
125501822|NCT00923078|451468589|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
125501823|NCT00923078|451468587|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
125501824|NCT00923078|451468588|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
125501825|NCT00923078|451468589|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
125501826|NCT01858688|451468590|FG000|Overall Study|Withdrawal by Subject|8|||
125501827|NCT01858688|451468590|FG000|Overall Study|Participant began another therapy|3|||
125501828|NCT01858688|451468590|FG000|Overall Study|Physician Decision|2|||
125501829|NCT01858688|451468590|FG000|Overall Study|Progressive Disease|2|||
125501830|NCT01858688|451468590|FG000|Overall Study|Reason not reproted|5|||
125501831|NCT01999335|451468591|FG000|Overall Study|Discontinued before receiving treatment|0|||
125501832|NCT01999335|451468592|FG001|Overall Study|Discontinued before receiving treatment|0|||
125501833|NCT01999335|451468593|FG002|Overall Study|Discontinued before receiving treatment|0|||
125501834|NCT01999335|451468594|FG003|Overall Study|Discontinued before receiving treatment|0|||
125501835|NCT01999335|451468595|FG004|Overall Study|Discontinued before receiving treatment|2|||
125501836|NCT00787176|451468596|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
125501837|NCT00787176|451468597|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
125501838|NCT00787176|451468598|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
125501839|NCT00787176|451468599|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
125501840|NCT02449902|451468604|FG000|Overall Study|Adverse Event|0|||
125501841|NCT02449902|451468605|FG001|Overall Study|Adverse Event|1|||
125501842|NCT02449902|451468604|FG000|Overall Study|Withdrawal by Subject|0|||
125501843|NCT02449902|451468605|FG001|Overall Study|Withdrawal by Subject|1|||
125501844|NCT02362789|451468606|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
125501845|NCT02362789|451468607|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
125501846|NCT02362789|451468608|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
125501847|NCT02362789|451468606|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
125501848|NCT02362789|451468607|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
125501849|NCT02362789|451468608|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
125501850|NCT02362789|451468606|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
125501851|NCT02362789|451468607|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
125501852|NCT02362789|451468608|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
125501853|NCT02362789|451468606|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
125501854|NCT02362789|451468607|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
125501855|NCT02362789|451468608|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
125501856|NCT02362789|451468606|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
125501857|NCT02362789|451468607|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
125501858|NCT02362789|451468608|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
125501859|NCT03326856|451468609|FG000|Overall Study|Lost to Follow-up|1|||
125501860|NCT03326856|451468610|FG001|Overall Study|Lost to Follow-up|1|||
125501861|NCT03326856|451468611|FG002|Overall Study|Lost to Follow-up|0|||
125501862|NCT03326856|451468612|FG003|Overall Study|Lost to Follow-up|0|||
125501863|NCT03326856|451468613|FG004|Overall Study|Lost to Follow-up|0|||
125501864|NCT03692871|451468614|FG000|Overall Study|Death|1|||
125501865|NCT03692871|451468615|FG001|Overall Study|Death|1|||
125501866|NCT03692871|451468614|FG000|Overall Study|Lost to Follow-up|24|||
125501867|NCT03692871|451468615|FG001|Overall Study|Lost to Follow-up|9|||
125501868|NCT03692871|451468614|FG000|Overall Study|Physician Decision|22|||
125501869|NCT03692871|451468615|FG001|Overall Study|Physician Decision|7|||
125501870|NCT03692871|451468614|FG000|Overall Study|Protocol Deviation|1|||
125501871|NCT03692871|451468615|FG001|Overall Study|Protocol Deviation|0|||
125501872|NCT03692871|451468614|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
125501873|NCT03692871|451468615|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
125501874|NCT01316913|451468618|FG000|Overall Study|Adverse Event|17|||
125501875|NCT01316913|451468619|FG001|Overall Study|Adverse Event|20|||
125501876|NCT01316913|451468620|FG002|Overall Study|Adverse Event|15|||
125501877|NCT01316913|451468621|FG003|Overall Study|Adverse Event|11|||
125501878|NCT01316913|451468618|FG000|Overall Study|Lack of Efficacy|22|||
125501879|NCT01316913|451468619|FG001|Overall Study|Lack of Efficacy|12|||
125501880|NCT01316913|451468620|FG002|Overall Study|Lack of Efficacy|9|||
125501881|NCT01316913|451468621|FG003|Overall Study|Lack of Efficacy|13|||
125501882|NCT01316913|451468618|FG000|Overall Study|Protocol Violation|1|||
125501883|NCT01316913|451468619|FG001|Overall Study|Protocol Violation|4|||
125501884|NCT01316913|451468620|FG002|Overall Study|Protocol Violation|4|||
125501885|NCT01316913|451468621|FG003|Overall Study|Protocol Violation|1|||
125501886|NCT01316913|451468618|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
125501887|NCT01316913|451468619|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
125501888|NCT01316913|451468620|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
125501889|NCT01316913|451468621|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
125501890|NCT01316913|451468618|FG000|Overall Study|Lost to Follow-up|0|||
125501891|NCT01316913|451468619|FG001|Overall Study|Lost to Follow-up|1|||
125501892|NCT01316913|451468620|FG002|Overall Study|Lost to Follow-up|0|||
125501893|NCT01316913|451468621|FG003|Overall Study|Lost to Follow-up|2|||
125501894|NCT01316913|451468618|FG000|Overall Study|Withdrawal by Subject|10|||
125501895|NCT01316913|451468619|FG001|Overall Study|Withdrawal by Subject|9|||
125501896|NCT01316913|451468620|FG002|Overall Study|Withdrawal by Subject|10|||
125501897|NCT01316913|451468621|FG003|Overall Study|Withdrawal by Subject|6|||
125501898|NCT02691702|451468622|FG000|Overall Study|Adverse Event|1|||
125501899|NCT02691702|451468623|FG001|Overall Study|Adverse Event|0|||
125501900|NCT02691702|451468624|FG002|Overall Study|Adverse Event|0|||
125501901|NCT02691702|451468625|FG003|Overall Study|Adverse Event|0|||
125501902|NCT02691702|451468626|FG004|Overall Study|Adverse Event|0|||
125501903|NCT02691702|451468627|FG005|Overall Study|Adverse Event|0|||
125501904|NCT02691702|451468628|FG006|Overall Study|Adverse Event|0|||
125501905|NCT02691702|451468629|FG007|Overall Study|Adverse Event|0|||
125501906|NCT02691702|451468630|FG008|Overall Study|Adverse Event|1|||
125501907|NCT02691702|451468631|FG009|Overall Study|Adverse Event|0|||
125501908|NCT02691702|451468632|FG010|Overall Study|Adverse Event|1|||
125501909|NCT02691702|451468622|FG000|Overall Study|Lost to Follow-up|0|||
125501910|NCT02691702|451468623|FG001|Overall Study|Lost to Follow-up|0|||
125501911|NCT02691702|451468624|FG002|Overall Study|Lost to Follow-up|1|||
125501912|NCT02691702|451468625|FG003|Overall Study|Lost to Follow-up|0|||
125501913|NCT02691702|451468626|FG004|Overall Study|Lost to Follow-up|0|||
125501914|NCT02691702|451468627|FG005|Overall Study|Lost to Follow-up|2|||
125501915|NCT02691702|451468628|FG006|Overall Study|Lost to Follow-up|0|||
125501916|NCT02691702|451468629|FG007|Overall Study|Lost to Follow-up|0|||
125501917|NCT02691702|451468630|FG008|Overall Study|Lost to Follow-up|0|||
125501918|NCT02691702|451468631|FG009|Overall Study|Lost to Follow-up|0|||
125501919|NCT02691702|451468632|FG010|Overall Study|Lost to Follow-up|1|||
125501920|NCT02691702|451468622|FG000|Overall Study|Withdrawal by Subject|1|||
125501921|NCT02691702|451468623|FG001|Overall Study|Withdrawal by Subject|1|||
125501922|NCT02691702|451468624|FG002|Overall Study|Withdrawal by Subject|0|||
125501923|NCT02691702|451468625|FG003|Overall Study|Withdrawal by Subject|0|||
125501924|NCT02691702|451468626|FG004|Overall Study|Withdrawal by Subject|0|||
125501925|NCT02691702|451468627|FG005|Overall Study|Withdrawal by Subject|1|||
125501926|NCT02691702|451468628|FG006|Overall Study|Withdrawal by Subject|2|||
125501927|NCT02691702|451468629|FG007|Overall Study|Withdrawal by Subject|0|||
125501928|NCT02691702|451468630|FG008|Overall Study|Withdrawal by Subject|0|||
125501929|NCT02691702|451468631|FG009|Overall Study|Withdrawal by Subject|0|||
125501930|NCT02691702|451468632|FG010|Overall Study|Withdrawal by Subject|0|||
125501931|NCT02691702|451468622|FG000|Overall Study|Other|0|||
125501932|NCT02691702|451468623|FG001|Overall Study|Other|0|||
125501933|NCT02691702|451468624|FG002|Overall Study|Other|0|||
125501934|NCT02691702|451468625|FG003|Overall Study|Other|0|||
125501935|NCT02691702|451468626|FG004|Overall Study|Other|0|||
125501936|NCT02691702|451468627|FG005|Overall Study|Other|0|||
125501937|NCT02691702|451468628|FG006|Overall Study|Other|1|||
125501938|NCT02691702|451468629|FG007|Overall Study|Other|0|||
125501939|NCT02691702|451468630|FG008|Overall Study|Other|1|||
125501940|NCT02691702|451468631|FG009|Overall Study|Other|0|||
125501941|NCT02691702|451468632|FG010|Overall Study|Other|0|||
125501942|NCT02691702|451468622|FG000|Overall Study|Protocol Violation|0|||
125501943|NCT02691702|451468623|FG001|Overall Study|Protocol Violation|0|||
125501944|NCT02691702|451468624|FG002|Overall Study|Protocol Violation|0|||
125501945|NCT02691702|451468625|FG003|Overall Study|Protocol Violation|0|||
125501946|NCT02691702|451468626|FG004|Overall Study|Protocol Violation|0|||
125501947|NCT02691702|451468627|FG005|Overall Study|Protocol Violation|0|||
125501948|NCT02691702|451468628|FG006|Overall Study|Protocol Violation|0|||
125501949|NCT02691702|451468629|FG007|Overall Study|Protocol Violation|0|||
125501950|NCT02691702|451468630|FG008|Overall Study|Protocol Violation|0|||
125501951|NCT02691702|451468631|FG009|Overall Study|Protocol Violation|2|||
125501952|NCT02691702|451468632|FG010|Overall Study|Protocol Violation|0|||
125501953|NCT05169684|451468633|FG000|Overall Study|Adverse Event|1|||
125501954|NCT05169684|451468634|FG001|Overall Study|Adverse Event|3|||
125501955|NCT05169684|451468633|FG000|Overall Study|Physician Decision|0|||
125501956|NCT05169684|451468634|FG001|Overall Study|Physician Decision|1|||
125501957|NCT05169684|451468633|FG000|Overall Study|Progressive Disease|1|||
125501958|NCT05169684|451468634|FG001|Overall Study|Progressive Disease|1|||
125501959|NCT05169684|451468633|FG000|Overall Study|Participant request to discontinue treatment|0|||
125501960|NCT05169684|451468634|FG001|Overall Study|Participant request to discontinue treatment|1|||
125501961|NCT05169684|451468633|FG000|Overall Study|Other Reason|0|||
125501962|NCT05169684|451468634|FG001|Overall Study|Other Reason|1|||
125501963|NCT01668719|451468635|FG000|Phase I|On treatment|1|||
125501964|NCT01668719|451468636|FG001|Phase I|On treatment|0|||
125501965|NCT01668719|451468637|FG002|Phase I|On treatment|0|||
125501966|NCT01668719|451468635|FG000|Phase I|Adverse Event|2|||
125501967|NCT01668719|451468636|FG001|Phase I|Adverse Event|0|||
125501968|NCT01668719|451468637|FG002|Phase I|Adverse Event|0|||
125501969|NCT01668719|451468635|FG000|Phase I|Progression/relapse|1|||
125501970|NCT01668719|451468636|FG001|Phase I|Progression/relapse|0|||
125501971|NCT01668719|451468637|FG002|Phase I|Progression/relapse|0|||
125501972|NCT01668719|451468635|FG000|Phase I|not protocol specified|2|||
125501973|NCT01668719|451468636|FG001|Phase I|not protocol specified|0|||
125501974|NCT01668719|451468637|FG002|Phase I|not protocol specified|0|||
125501975|NCT01668719|451468635|FG000|Phase II|On treatment|0|||
125501976|NCT01668719|451468636|FG001|Phase II|On treatment|4|||
125501977|NCT01668719|451468637|FG002|Phase II|On treatment|3|||
125501978|NCT01668719|451468635|FG000|Phase II|Adverse Event|0|||
125501979|NCT01668719|451468636|FG001|Phase II|Adverse Event|18|||
125501980|NCT01668719|451468637|FG002|Phase II|Adverse Event|18|||
125501981|NCT01668719|451468635|FG000|Phase II|Refusal unrelated to adverse event|0|||
125501982|NCT01668719|451468636|FG001|Phase II|Refusal unrelated to adverse event|4|||
125501983|NCT01668719|451468637|FG002|Phase II|Refusal unrelated to adverse event|1|||
125501984|NCT01668719|451468635|FG000|Phase II|Progression/relapse|0|||
125501985|NCT01668719|451468636|FG001|Phase II|Progression/relapse|13|||
125501986|NCT01668719|451468637|FG002|Phase II|Progression/relapse|17|||
125501987|NCT01668719|451468635|FG000|Phase II|Death|0|||
125501988|NCT01668719|451468636|FG001|Phase II|Death|0|||
125501989|NCT01668719|451468637|FG002|Phase II|Death|2|||
125501990|NCT01668719|451468635|FG000|Phase II|not protocol specified|0|||
125501991|NCT01668719|451468636|FG001|Phase II|not protocol specified|13|||
125501992|NCT01668719|451468637|FG002|Phase II|not protocol specified|7|||
125501993|NCT03539055|451468638|FG000|Overall Study|Death|4|||
125501994|NCT03539055|451468638|FG000|Overall Study|Lost to Follow-up|1|||
125501995|NCT03539055|451468638|FG000|Overall Study|Withdrawal by Subject|2|||
125501996|NCT03539055|451468638|FG000|Overall Study|Screen Fail|7|||
125501997|NCT03539055|451468638|FG000|Overall Study|Drug Intolerance|2|||
125501998|NCT02060487|451468639|FG000|Overall Study|Other|1|||
125501999|NCT02060487|451468640|FG001|Overall Study|Other|2|||
125502000|NCT02060487|451468641|FG002|Overall Study|Other|1|||
125502001|NCT02060487|451468639|FG000|Overall Study|Lack of Efficacy|0|||
125502002|NCT02060487|451468640|FG001|Overall Study|Lack of Efficacy|1|||
125502003|NCT02060487|451468641|FG002|Overall Study|Lack of Efficacy|0|||
125502004|NCT02060487|451468639|FG000|Overall Study|Withdrawal by Subject|3|||
125502005|NCT02060487|451468640|FG001|Overall Study|Withdrawal by Subject|10|||
125502006|NCT02060487|451468641|FG002|Overall Study|Withdrawal by Subject|4|||
125502007|NCT02060487|451468639|FG000|Overall Study|Study Terminated By Sponsor|87|||
125502008|NCT02060487|451468640|FG001|Overall Study|Study Terminated By Sponsor|89|||
125502009|NCT02060487|451468641|FG002|Overall Study|Study Terminated By Sponsor|100|||
125502010|NCT02060487|451468639|FG000|Overall Study|Randomized in error|1|||
125502011|NCT02060487|451468640|FG001|Overall Study|Randomized in error|0|||
125502012|NCT02060487|451468641|FG002|Overall Study|Randomized in error|0|||
125502013|NCT02060487|451468639|FG000|Overall Study|Protocol Violation|0|||
125502014|NCT02060487|451468640|FG001|Overall Study|Protocol Violation|1|||
125502015|NCT02060487|451468641|FG002|Overall Study|Protocol Violation|1|||
125502016|NCT02060487|451468639|FG000|Overall Study|Lost to Follow-up|3|||
125502017|NCT02060487|451468640|FG001|Overall Study|Lost to Follow-up|0|||
125502018|NCT02060487|451468641|FG002|Overall Study|Lost to Follow-up|2|||
125502019|NCT02060487|451468639|FG000|Overall Study|Death|34|||
125502020|NCT02060487|451468640|FG001|Overall Study|Death|25|||
125502021|NCT02060487|451468641|FG002|Overall Study|Death|19|||
125502022|NCT02060487|451468639|FG000|Overall Study|Adverse Event|0|||
125502023|NCT02060487|451468640|FG001|Overall Study|Adverse Event|0|||
125502024|NCT02060487|451468641|FG002|Overall Study|Adverse Event|1|||
125502025|NCT05484661|451468642|FG000|Overall Study|Withdrawal by Subject|1|||
125502026|NCT05484661|451468643|FG001|Overall Study|Withdrawal by Subject|0|||
125502027|NCT01856569|451468644|FG000|Overall Study|Other|1|||
125502028|NCT01856569|451468644|FG000|Overall Study|Changed Site/Structure|1|||
125502029|NCT01856569|451468644|FG000|Overall Study|Lost to Follow-up|3|||
125502030|NCT01856569|451468644|FG000|Overall Study|Did not met inclusion criteria|8|||
125502031|NCT01860079|451468645|FG000|Overall Study|Physician Decision|14|||
125502032|NCT01860079|451468646|FG001|Overall Study|Physician Decision|22|||
125502033|NCT02950961|451468654|FG000|Overall Study|Study had to stop due to COVID.|7|||
125502034|NCT02241785|451468657|FG000|Overall Study|Sponsor Termination|43|||
125502035|NCT02241785|451468657|FG000|Overall Study|Withdrawal by Subject|1|||
125502036|NCT02241785|451468657|FG000|Overall Study|Lost to Follow-up|2|||
125502037|NCT02241785|451468657|FG000|Overall Study|Adverse Event|1|||
125502038|NCT03055988|451468658|FG000|Period 1|Adverse Event|0|||
125502039|NCT03055988|451468659|FG001|Period 1|Adverse Event|1|||
125502040|NCT03055988|451468658|FG000|Period 1|Lost to Follow-up|1|||
125502041|NCT03055988|451468659|FG001|Period 1|Lost to Follow-up|0|||
125502042|NCT03055988|451468658|FG000|Period 1|Withdrawal by Subject|0|||
125502043|NCT03055988|451468659|FG001|Period 1|Withdrawal by Subject|4|||
125502044|NCT03055988|451468658|FG000|Period 2|Adverse Event|0|||
125502045|NCT03055988|451468659|FG001|Period 2|Adverse Event|1|||
125502046|NCT03055988|451468658|FG000|Period 2|Other than listed|1|||
125502047|NCT03055988|451468659|FG001|Period 2|Other than listed|1|||
125502048|NCT00845520|451468660|FG000|Overall Study|Death|1|||
125502049|NCT00845520|451468661|FG001|Overall Study|Death|2|||
125502050|NCT00845520|451468662|FG002|Overall Study|Death|0|||
125502051|NCT00845520|451468660|FG000|Overall Study|Lost to Follow-up|1|||
125502052|NCT00845520|451468661|FG001|Overall Study|Lost to Follow-up|0|||
125502053|NCT00845520|451468662|FG002|Overall Study|Lost to Follow-up|0|||
125502054|NCT00845520|451468660|FG000|Overall Study|Adverse Event|0|||
125502055|NCT00845520|451468661|FG001|Overall Study|Adverse Event|0|||
125502056|NCT00845520|451468662|FG002|Overall Study|Adverse Event|1|||
125502057|NCT01736475|451468663|FG000|Overall Study|Adverse Event|4|||
125502058|NCT01736475|451468664|FG001|Overall Study|Adverse Event|0|||
125502059|NCT01736475|451468663|FG000|Overall Study|Withdrawal by Subject|2|||
125502060|NCT01736475|451468664|FG001|Overall Study|Withdrawal by Subject|0|||
125502061|NCT01736475|451468663|FG000|Overall Study|Protocol Violation|4|||
125502062|NCT01736475|451468664|FG001|Overall Study|Protocol Violation|0|||
125502063|NCT01736475|451468663|FG000|Overall Study|Other - Screen failure|1|||
125502064|NCT01736475|451468664|FG001|Overall Study|Other - Screen failure|0|||
125502065|NCT01736475|451468663|FG000|Overall Study|Other - Surgical procedure|1|||
125502066|NCT01736475|451468664|FG001|Overall Study|Other - Surgical procedure|0|||
125502067|NCT02807857|451468665|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
125502068|NCT02807857|451468665|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
125502069|NCT02807857|451468665|FG000|Follow-Up Set|Withdrawal by Subject|8|||
125502070|NCT02807857|451468665|FG000|Follow-Up Set|Lost to Follow-up|7|||
125502071|NCT02807857|451468665|FG000|Follow-Up Set|Physician Decision|6|||
125502072|NCT02807857|451468665|FG000|Follow-Up Set|Adverse Event|3|||
125502073|NCT02807857|451468665|FG000|Follow-Up Set|Death|27|||
125502074|NCT02807857|451468665|FG000|Follow-Up Set|Relocation|2|||
125502075|NCT03905642|451468669|FG000|Overall Study|Withdrawal by Subject|3|||
125502076|NCT03905642|451468669|FG000|Overall Study|Pregnancy|1|||
125502077|NCT03905642|451468669|FG000|Overall Study|Adverse Event|1|||
125502078|NCT03905642|451468669|FG000|Overall Study|Lack of Efficacy|1|||
125502079|NCT03905642|451468669|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
125502080|NCT02014402|451470204|FG000|Overall Study|Adverse Event|1|||
125502081|NCT02014402|451470205|FG001|Overall Study|Adverse Event|0|||
125502082|NCT02014402|451470206|FG002|Overall Study|Adverse Event|0|||
125502083|NCT02014402|451470207|FG003|Overall Study|Adverse Event|0|||
125502084|NCT02014402|451470204|FG000|Overall Study|Withdrawal by Subject|1|||
125502085|NCT02014402|451470205|FG001|Overall Study|Withdrawal by Subject|2|||
125502086|NCT02014402|451470206|FG002|Overall Study|Withdrawal by Subject|2|||
125502087|NCT02014402|451470207|FG003|Overall Study|Withdrawal by Subject|1|||
125502088|NCT02014402|451470204|FG000|Overall Study|Subject did not have transportation|0|||
125502089|NCT02014402|451470205|FG001|Overall Study|Subject did not have transportation|1|||
125502090|NCT02014402|451470206|FG002|Overall Study|Subject did not have transportation|0|||
125502091|NCT02014402|451470207|FG003|Overall Study|Subject did not have transportation|0|||
125502092|NCT02014402|451470204|FG000|Overall Study|Lost to Follow-up|0|||
125502093|NCT02014402|451470205|FG001|Overall Study|Lost to Follow-up|0|||
125502094|NCT02014402|451470206|FG002|Overall Study|Lost to Follow-up|1|||
125502095|NCT02014402|451470207|FG003|Overall Study|Lost to Follow-up|2|||
125502096|NCT01190124|451470209|FG000|Overall Study|Death|3|||
125502097|NCT01190124|451470210|FG001|Overall Study|Death|0|||
125502098|NCT01190124|451470211|FG002|Overall Study|Death|0|||
125502099|NCT01190124|451470209|FG000|Overall Study|Therapeutic Failure|12|||
125502100|NCT01190124|451470210|FG001|Overall Study|Therapeutic Failure|0|||
125502101|NCT01190124|451470211|FG002|Overall Study|Therapeutic Failure|1|||
125502102|NCT01190124|451470209|FG000|Overall Study|Lost to Follow-up|2|||
125502103|NCT01190124|451470210|FG001|Overall Study|Lost to Follow-up|0|||
125502104|NCT01190124|451470211|FG002|Overall Study|Lost to Follow-up|0|||
125502105|NCT03493282|451470212|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
125502106|NCT03493282|451470213|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
125502107|NCT03493282|451470214|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
125502108|NCT03493282|451470212|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
125502109|NCT03493282|451470213|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
125502110|NCT03493282|451470214|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
125502111|NCT00070707|451470215|FG000|Overall Study|Adverse Event|1|||
125502112|NCT00070707|451470216|FG001|Overall Study|Adverse Event|2|||
125502113|NCT00070707|451470215|FG000|Overall Study|Lack of Efficacy|4|||
125502114|NCT00070707|451470216|FG001|Overall Study|Lack of Efficacy|1|||
125502115|NCT00070707|451470215|FG000|Overall Study|Protocol Violation|8|||
125502116|NCT00070707|451470216|FG001|Overall Study|Protocol Violation|4|||
125502117|NCT00070707|451470215|FG000|Overall Study|Unrelated to Study Medication|1|||
125502118|NCT00070707|451470216|FG001|Overall Study|Unrelated to Study Medication|0|||
125502119|NCT01128959|451470217|FG000|Lead in Period|Adverse Event|3|||
125502120|NCT01128959|451470217|FG000|Treatment Period|Adverse Event|3|||
125502121|NCT01128959|451470217|FG000|Treatment Period|Withdrawal by Subject|1|||
125502122|NCT02338999|451470218|FG000|First Intervention|Withdrawal by Subject|3|||
125502123|NCT02338999|451470219|FG001|First Intervention|Withdrawal by Subject|1|||
125502124|NCT02338999|451470218|FG000|Washout Period|Withdrawal by Subject|0|||
125502125|NCT02338999|451470219|FG001|Washout Period|Withdrawal by Subject|2|||
125502126|NCT02338999|451470218|FG000|Second Intervention|Withdrawal by Subject|0|||
125502127|NCT02338999|451470219|FG001|Second Intervention|Withdrawal by Subject|2|||
125502128|NCT02958553|451470220|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
125502129|NCT02958553|451470220|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
125502130|NCT00308308|451470221|FG000|Overall Study|Adverse Event|17|||
125502131|NCT00308308|451470222|FG001|Overall Study|Adverse Event|2|||
125502132|NCT00308308|451470221|FG000|Overall Study|Lost to Follow-up|5|||
125502133|NCT00308308|451470222|FG001|Overall Study|Lost to Follow-up|5|||
125502134|NCT00308308|451470221|FG000|Overall Study|Physician Decision|15|||
125502135|NCT00308308|451470222|FG001|Overall Study|Physician Decision|7|||
125502136|NCT00308308|451470221|FG000|Overall Study|Protocol Violation|3|||
125502137|NCT00308308|451470222|FG001|Overall Study|Protocol Violation|14|||
125502138|NCT00308308|451470221|FG000|Overall Study|Withdrawal by Subject|47|||
125502139|NCT00308308|451470222|FG001|Overall Study|Withdrawal by Subject|19|||
125502140|NCT00308308|451470221|FG000|Overall Study|Various|7|||
125502141|NCT00308308|451470222|FG001|Overall Study|Various|5|||
125502142|NCT00308308|451470221|FG000|Overall Study|Randomized but not dosed|8|||
125502143|NCT00308308|451470222|FG001|Overall Study|Randomized but not dosed|16|||
125502144|NCT00308308|451470221|FG000|Overall Study|Other|1|||
125502145|NCT00308308|451470222|FG001|Overall Study|Other|0|||
125502146|NCT01686152|451470223|FG000|Overall Study|Withdrawal by Subject|11|||
125502147|NCT01686152|451470224|FG001|Overall Study|Withdrawal by Subject|11|||
125502148|NCT01686152|451470225|FG002|Overall Study|Withdrawal by Subject|3|||
125502149|NCT01686152|451470223|FG000|Overall Study|Drug Code Unblinded|0|||
125502150|NCT01686152|451470224|FG001|Overall Study|Drug Code Unblinded|1|||
125502151|NCT01686152|451470225|FG002|Overall Study|Drug Code Unblinded|0|||
125502152|NCT01686152|451470223|FG000|Overall Study|Protocol Violation|6|||
125502153|NCT01686152|451470224|FG001|Overall Study|Protocol Violation|1|||
125502154|NCT01686152|451470225|FG002|Overall Study|Protocol Violation|0|||
125502155|NCT01686152|451470223|FG000|Overall Study|Adverse Event|12|||
125502156|NCT01686152|451470224|FG001|Overall Study|Adverse Event|11|||
125502157|NCT01686152|451470225|FG002|Overall Study|Adverse Event|0|||
125502158|NCT01686152|451470223|FG000|Overall Study|Lack of Efficacy|0|||
125502159|NCT01686152|451470224|FG001|Overall Study|Lack of Efficacy|0|||
125502160|NCT01686152|451470225|FG002|Overall Study|Lack of Efficacy|1|||
125502161|NCT01686152|451470223|FG000|Overall Study|IP Non-compliance|5|||
125502162|NCT01686152|451470224|FG001|Overall Study|IP Non-compliance|5|||
125502163|NCT01686152|451470225|FG002|Overall Study|IP Non-compliance|0|||
125502164|NCT01686152|451470223|FG000|Overall Study|Lost to Follow-up|7|||
125502165|NCT01686152|451470224|FG001|Overall Study|Lost to Follow-up|6|||
125502166|NCT01686152|451470225|FG002|Overall Study|Lost to Follow-up|5|||
125502167|NCT01802333|451470226|FG000|Overall Study|Ineligible|2|||
125502168|NCT01802333|451470227|FG001|Overall Study|Ineligible|6|||
125502169|NCT01802333|451470228|FG002|Overall Study|Ineligible|8|||
125502170|NCT01802333|451470226|FG000|Overall Study|Adverse Event|1|||
125502171|NCT01802333|451470227|FG001|Overall Study|Adverse Event|8|||
125502172|NCT01802333|451470228|FG002|Overall Study|Adverse Event|8|||
125502173|NCT01802333|451470226|FG000|Overall Study|Withdrawal by Subject|6|||
125502174|NCT01802333|451470227|FG001|Overall Study|Withdrawal by Subject|6|||
125502175|NCT01802333|451470228|FG002|Overall Study|Withdrawal by Subject|5|||
125502176|NCT01802333|451470226|FG000|Overall Study|Progression/relapse|1|||
125502177|NCT01802333|451470227|FG001|Overall Study|Progression/relapse|3|||
125502178|NCT01802333|451470228|FG002|Overall Study|Progression/relapse|0|||
125502179|NCT01802333|451470226|FG000|Overall Study|Death|7|||
125502180|NCT01802333|451470227|FG001|Overall Study|Death|14|||
125502181|NCT01802333|451470228|FG002|Overall Study|Death|13|||
125502182|NCT01802333|451470226|FG000|Overall Study|Other - not protocol specified|32|||
125502183|NCT01802333|451470227|FG001|Overall Study|Other - not protocol specified|22|||
125502184|NCT01802333|451470228|FG002|Overall Study|Other - not protocol specified|24|||
125502185|NCT01802333|451470226|FG000|Overall Study|Did not start treatment|0|||
125502186|NCT01802333|451470227|FG001|Overall Study|Did not start treatment|2|||
125502187|NCT01802333|451470228|FG002|Overall Study|Did not start treatment|5|||
125502188|NCT01947491|451470230|FG000|Overall Study|Lost to Follow-up|5|||
125502189|NCT01947491|451470231|FG001|Overall Study|Lost to Follow-up|3|||
125502190|NCT01947491|451470232|FG002|Overall Study|Lost to Follow-up|1|||
125502191|NCT01947491|451470233|FG003|Overall Study|Lost to Follow-up|2|||
125502192|NCT01947491|451470230|FG000|Overall Study|Lack of Efficacy|1|||
125502193|NCT01947491|451470231|FG001|Overall Study|Lack of Efficacy|0|||
125502194|NCT01947491|451470232|FG002|Overall Study|Lack of Efficacy|0|||
125502195|NCT01947491|451470233|FG003|Overall Study|Lack of Efficacy|1|||
125502196|NCT01947491|451470230|FG000|Overall Study|Protocol Violation|1|||
125502197|NCT01947491|451470231|FG001|Overall Study|Protocol Violation|0|||
125502198|NCT01947491|451470232|FG002|Overall Study|Protocol Violation|0|||
125502199|NCT01947491|451470233|FG003|Overall Study|Protocol Violation|0|||
125502200|NCT01947491|451470230|FG000|Overall Study|Withdrawal by Subject|1|||
125502201|NCT01947491|451470231|FG001|Overall Study|Withdrawal by Subject|1|||
125502202|NCT01947491|451470232|FG002|Overall Study|Withdrawal by Subject|1|||
125502203|NCT01947491|451470233|FG003|Overall Study|Withdrawal by Subject|0|||
125502204|NCT01947491|451470230|FG000|Overall Study|Worsening of condition|0|||
125502205|NCT01947491|451470231|FG001|Overall Study|Worsening of condition|1|||
125502206|NCT01947491|451470232|FG002|Overall Study|Worsening of condition|0|||
125502207|NCT01947491|451470233|FG003|Overall Study|Worsening of condition|0|||
125502208|NCT01947491|451470230|FG000|Overall Study|Adverse Event|0|||
125502209|NCT01947491|451470231|FG001|Overall Study|Adverse Event|1|||
125502210|NCT01947491|451470232|FG002|Overall Study|Adverse Event|0|||
125502211|NCT01947491|451470233|FG003|Overall Study|Adverse Event|2|||
125304900|NCT01090063|450742786|FG000|Treatment|Withdrawal by Subject|4|||
125502212|NCT02067663|451470234|FG000|Overall Study|Lost to Follow-up|13|||
125502213|NCT02067663|451470235|FG001|Overall Study|Lost to Follow-up|14|||
125502214|NCT00704340|451470236|FG000|Overall Study|Lost to Follow-up|2|||
125502215|NCT00704340|451470237|FG001|Overall Study|Lost to Follow-up|1|||
125502216|NCT00704340|451470236|FG000|Overall Study|Death|0|||
125502217|NCT00704340|451470237|FG001|Overall Study|Death|1|||
125502218|NCT03137784|451470238|FG000|Overall Study|Adverse Event|1|||
125502219|NCT03137784|451470239|FG001|Overall Study|Adverse Event|1|||
125502220|NCT03137784|451470240|FG002|Overall Study|Adverse Event|0|||
125502221|NCT03137784|451470241|FG003|Overall Study|Adverse Event|0|||
125502222|NCT03137784|451470242|FG004|Overall Study|Adverse Event|0|||
125502223|NCT03137784|451470243|FG005|Overall Study|Adverse Event|0|||
125502224|NCT03137784|451470238|FG000|Overall Study|Subject/guardian decision|1|||
125502225|NCT03137784|451470239|FG001|Overall Study|Subject/guardian decision|0|||
125502226|NCT03137784|451470240|FG002|Overall Study|Subject/guardian decision|0|||
125502227|NCT03137784|451470241|FG003|Overall Study|Subject/guardian decision|0|||
125502228|NCT03137784|451470242|FG004|Overall Study|Subject/guardian decision|0|||
125502229|NCT03137784|451470243|FG005|Overall Study|Subject/guardian decision|0|||
125502230|NCT03137784|451470238|FG000|Overall Study|Non-compliance with study treatment|0|||
125502231|NCT03137784|451470239|FG001|Overall Study|Non-compliance with study treatment|0|||
125502232|NCT03137784|451470240|FG002|Overall Study|Non-compliance with study treatment|0|||
125502233|NCT03137784|451470241|FG003|Overall Study|Non-compliance with study treatment|0|||
125502234|NCT03137784|451470242|FG004|Overall Study|Non-compliance with study treatment|1|||
125502235|NCT03137784|451470243|FG005|Overall Study|Non-compliance with study treatment|0|||
125502236|NCT02736188|451470244|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
125502237|NCT02736188|451470244|FG000|Overall Study|Adverse Event|1|||
125502238|NCT02736188|451470244|FG000|Overall Study|Withdrawal by Subject|1|||
125502239|NCT02736188|451470244|FG000|Overall Study|Other|6|||
125502240|NCT00240994|451470245|FG000|Overall Study|Lost to Follow-up|1|||
125502241|NCT00240994|451470245|FG000|Overall Study|Protocol Violation|1|||
125502242|NCT00240994|451470245|FG000|Overall Study|Graft failure|1|||
125502243|NCT01437540|451470246|FG000|Overall Study|Not listed below|7|||
125502244|NCT01437540|451470247|FG001|Overall Study|Not listed below|6|||
125502245|NCT01437540|451470246|FG000|Overall Study|COPD exacerbation|13|||
125502246|NCT01437540|451470247|FG001|Overall Study|COPD exacerbation|3|||
125502247|NCT01437540|451470246|FG000|Overall Study|Lost to Follow-up|3|||
125502248|NCT01437540|451470247|FG001|Overall Study|Lost to Follow-up|5|||
125502249|NCT01437540|451470246|FG000|Overall Study|Lack of Efficacy|23|||
125502250|NCT01437540|451470247|FG001|Overall Study|Lack of Efficacy|11|||
125502251|NCT01437540|451470246|FG000|Overall Study|Protocol Violation|24|||
125502252|NCT01437540|451470247|FG001|Overall Study|Protocol Violation|12|||
125502253|NCT01437540|451470246|FG000|Overall Study|Adverse Event|26|||
125502254|NCT01437540|451470247|FG001|Overall Study|Adverse Event|13|||
125502255|NCT01437540|451470246|FG000|Overall Study|Withdrawal by Subject|31|||
125502256|NCT01437540|451470247|FG001|Overall Study|Withdrawal by Subject|15|||
125502257|NCT03142932|451470248|FG000|Overall Study|Lost to Follow-up|2|||
125502258|NCT03142932|451470249|FG001|Overall Study|Lost to Follow-up|11|||
125502259|NCT04070105|451470250|FG000|Overall Study|Lost to Follow-up|0|||
125502260|NCT04070105|451470251|FG001|Overall Study|Lost to Follow-up|0|||
125502261|NCT04070105|451470252|FG002|Overall Study|Lost to Follow-up|0|||
125502262|NCT04070105|451470253|FG003|Overall Study|Lost to Follow-up|0|||
125502263|NCT04070105|451470254|FG004|Overall Study|Lost to Follow-up|0|||
125502264|NCT04070105|451470255|FG005|Overall Study|Lost to Follow-up|1|||
125502265|NCT00749944|451470260|FG000|Overall Study|Lost to Follow-up|2|||
125502266|NCT00749944|451470261|FG001|Overall Study|Lost to Follow-up|1|||
125502267|NCT00749944|451470260|FG000|Overall Study|Other|1|||
125502268|NCT00749944|451470261|FG001|Overall Study|Other|0|||
125502269|NCT00749944|451470260|FG000|Overall Study|Withdrawal by Subject|2|||
125502270|NCT00749944|451470261|FG001|Overall Study|Withdrawal by Subject|0|||
125502271|NCT03547154|451470275|FG000|Overall Study|Disease Progression/Recurrence|6|||
125502272|NCT03547154|451470276|FG001|Overall Study|Disease Progression/Recurrence|14|||
125502273|NCT03547154|451470275|FG000|Overall Study|Adverse Event|26|||
125502274|NCT03547154|451470276|FG001|Overall Study|Adverse Event|31|||
125502275|NCT03547154|451470275|FG000|Overall Study|Protocol Violation|6|||
125502276|NCT03547154|451470276|FG001|Overall Study|Protocol Violation|1|||
125502277|NCT03547154|451470275|FG000|Overall Study|Physician Decision|4|||
125502278|NCT03547154|451470276|FG001|Overall Study|Physician Decision|3|||
125502279|NCT03547154|451470275|FG000|Overall Study|Insufficient Therapeutic Response|13|||
125502280|NCT03547154|451470276|FG001|Overall Study|Insufficient Therapeutic Response|10|||
125502281|NCT03547154|451470275|FG000|Overall Study|Withdrawal by Subject|10|||
125502282|NCT03547154|451470276|FG001|Overall Study|Withdrawal by Subject|6|||
125502283|NCT03547154|451470275|FG000|Overall Study|Not Selected|0|||
125502284|NCT03547154|451470276|FG001|Overall Study|Not Selected|1|||
125502285|NCT03547154|451470275|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
125502286|NCT03547154|451470276|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
125502287|NCT00895245|451470277|FG000|Overall Study|Lack of Efficacy|6|||
125502288|NCT02706483|451470278|FG000|Overall Study|Adverse Event|97|||
125502289|NCT02706483|451470278|FG000|Overall Study|Death|1|||
125502290|NCT02706483|451470278|FG000|Overall Study|Lack of Efficacy|39|||
125502291|NCT02706483|451470278|FG000|Overall Study|Lost to Follow-up|101|||
125502292|NCT02706483|451470278|FG000|Overall Study|Non-compliance with study drug|15|||
125502293|NCT02706483|451470278|FG000|Overall Study|Physician Decision|6|||
125502294|NCT02706483|451470278|FG000|Overall Study|Pregnancy|6|||
125502295|NCT02706483|451470278|FG000|Overall Study|Protocol Violation|18|||
125502296|NCT02706483|451470278|FG000|Overall Study|Withdrawal by Subject|136|||
125502297|NCT02706483|451470278|FG000|Overall Study|Non-compliance with visits|6|||
125502298|NCT02706483|451470278|FG000|Overall Study|Site closure|4|||
125502299|NCT02706483|451470278|FG000|Overall Study|Subject moved|1|||
125502300|NCT01972776|451470279|FG000|Part 1|Withdrawal by Subject|0|||
125502301|NCT01972776|451470280|FG001|Part 1|Withdrawal by Subject|0|||
125502302|NCT01972776|451470281|FG002|Part 1|Withdrawal by Subject|1|||
125502303|NCT01972776|451470282|FG003|Part 1|Withdrawal by Subject|0|||
125502304|NCT01972776|451470283|FG004|Part 1|Withdrawal by Subject|0|||
125502305|NCT01972776|451470284|FG005|Part 1|Withdrawal by Subject|0|||
125502306|NCT01972776|451470279|FG000|Part 1|Adverse Event|0|||
125502307|NCT01972776|451470280|FG001|Part 1|Adverse Event|0|||
125502308|NCT01972776|451470281|FG002|Part 1|Adverse Event|1|||
125502309|NCT01972776|451470282|FG003|Part 1|Adverse Event|1|||
125502310|NCT01972776|451470283|FG004|Part 1|Adverse Event|0|||
125502311|NCT01972776|451470284|FG005|Part 1|Adverse Event|0|||
125502312|NCT01972776|451470279|FG000|Part 2|Adverse Event|0|||
125502313|NCT01972776|451470280|FG001|Part 2|Adverse Event|0|||
125502314|NCT01972776|451470281|FG002|Part 2|Adverse Event|0|||
125502315|NCT01972776|451470282|FG003|Part 2|Adverse Event|0|||
125304901|NCT01817959|450742787|FG000|Overall Study|Graft loss|1|||
125304902|NCT01817959|450742788|FG001|Overall Study|Graft loss|1|||
125304903|NCT01817959|450742787|FG000|Overall Study|forbidden medication|1|||
125304904|NCT01817959|450742788|FG001|Overall Study|forbidden medication|1|||
125304905|NCT01817959|450742787|FG000|Overall Study|Adverse Event|1|||
125304906|NCT01817959|450742788|FG001|Overall Study|Adverse Event|0|||
125304907|NCT01817959|450742787|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
125304908|NCT01817959|450742788|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
125304909|NCT00330681|450742794|FG000|Overall Study|Adverse Event|3|||
125304910|NCT00330681|450742795|FG001|Overall Study|Adverse Event|6|||
125304911|NCT00330681|450742794|FG000|Overall Study|Protocol Violation|0|||
125304912|NCT00330681|450742795|FG001|Overall Study|Protocol Violation|1|||
125304913|NCT00330681|450742794|FG000|Overall Study|Withdrawal by Subject|5|||
125304914|NCT00330681|450742795|FG001|Overall Study|Withdrawal by Subject|5|||
125304915|NCT00330681|450742794|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
125304916|NCT00330681|450742795|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
125304917|NCT02578186|450742796|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
125304918|NCT02578186|450742797|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
125304919|NCT02578186|450742796|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
125304920|NCT02578186|450742797|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
125304921|NCT01140061|450742798|FG000|Part I|Adverse Event|1|||
125304922|NCT01140061|450742799|FG001|Part I|Adverse Event|0|||
125304923|NCT01140061|450742800|FG002|Part I|Adverse Event|0|||
125304924|NCT01140061|450742801|FG003|Part I|Adverse Event|0|||
125304925|NCT01140061|450742802|FG004|Part I|Adverse Event|0|||
125304926|NCT01140061|450742803|FG005|Part I|Adverse Event|0|||
125304927|NCT01140061|450742804|FG006|Part I|Adverse Event|0|||
125304928|NCT01140061|450742805|FG007|Part I|Adverse Event|0|||
125304929|NCT01140061|450742806|FG008|Part I|Adverse Event|0|||
125304930|NCT01140061|450742807|FG009|Part I|Adverse Event|0|||
125304931|NCT01140061|450742798|FG000|Extension|Laboratory Adverse Event|0|||
125304932|NCT01140061|450742799|FG001|Extension|Laboratory Adverse Event|0|||
125304933|NCT01140061|450742800|FG002|Extension|Laboratory Adverse Event|0|||
125304934|NCT01140061|450742801|FG003|Extension|Laboratory Adverse Event|0|||
125304935|NCT01140061|450742802|FG004|Extension|Laboratory Adverse Event|0|||
125304936|NCT01140061|450742803|FG005|Extension|Laboratory Adverse Event|0|||
125304937|NCT01140061|450742804|FG006|Extension|Laboratory Adverse Event|0|||
125304938|NCT01140061|450742805|FG007|Extension|Laboratory Adverse Event|0|||
125304939|NCT01140061|450742806|FG008|Extension|Laboratory Adverse Event|0|||
125304940|NCT01140061|450742807|FG009|Extension|Laboratory Adverse Event|1|||
125304941|NCT00428389|450742808|FG000|Core Phase|Adverse Event|6|||
125304942|NCT00428389|450742809|FG001|Core Phase|Adverse Event|4|||
125304943|NCT00428389|450742808|FG000|Core Phase|Lack of Efficacy|2|||
125304944|NCT00428389|450742809|FG001|Core Phase|Lack of Efficacy|0|||
125304945|NCT00428389|450742808|FG000|Core Phase|Abnormal test procedure result(s)|0|||
125304946|NCT00428389|450742809|FG001|Core Phase|Abnormal test procedure result(s)|1|||
125304947|NCT00428389|450742808|FG000|Core Phase|Withdrawal by Subject|3|||
125304948|NCT00428389|450742809|FG001|Core Phase|Withdrawal by Subject|4|||
125304949|NCT00428389|450742808|FG000|Core Phase|Protocol deviation|0|||
125304950|NCT00428389|450742809|FG001|Core Phase|Protocol deviation|2|||
125304951|NCT00428389|450742808|FG000|Extension Phase|Adverse Event|17|||
125304952|NCT00428389|450742809|FG001|Extension Phase|Adverse Event|11|||
125304953|NCT00428389|450742808|FG000|Extension Phase|Lack of Efficacy|4|||
125304954|NCT00428389|450742809|FG001|Extension Phase|Lack of Efficacy|3|||
125304955|NCT00428389|450742808|FG000|Extension Phase|Withdrawal by Subject|6|||
125304956|NCT00428389|450742809|FG001|Extension Phase|Withdrawal by Subject|6|||
125304957|NCT00428389|450742808|FG000|Extension Phase|Lost to Follow-up|0|||
125304958|NCT00428389|450742809|FG001|Extension Phase|Lost to Follow-up|3|||
125304959|NCT00428389|450742808|FG000|Extension Phase|Death|1|||
125304960|NCT00428389|450742809|FG001|Extension Phase|Death|0|||
125304961|NCT00428389|450742808|FG000|Extension Phase|Protocol Violation|3|||
125304962|NCT00428389|450742809|FG001|Extension Phase|Protocol Violation|2|||
125304963|NCT00428389|450742808|FG000|Extension Phase|Administrative problems|1|||
125304964|NCT00428389|450742809|FG001|Extension Phase|Administrative problems|1|||
125502316|NCT01972776|451470283|FG004|Part 2|Adverse Event|3|||
125304965|NCT03216746|450742810|FG000|Overall Study|Lost to Follow-up|6|||
125304966|NCT03216746|450742811|FG001|Overall Study|Lost to Follow-up|8|||
125304967|NCT03216746|450742812|FG002|Overall Study|Lost to Follow-up|5|||
125304968|NCT03216746|450742813|FG003|Overall Study|Lost to Follow-up|6|||
125502317|NCT01972776|451470284|FG005|Part 2|Adverse Event|0|||
125502318|NCT01972776|451470279|FG000|Part 2|Administrative problems|0|||
125502319|NCT01972776|451470280|FG001|Part 2|Administrative problems|0|||
125502320|NCT01972776|451470281|FG002|Part 2|Administrative problems|0|||
125502321|NCT01972776|451470282|FG003|Part 2|Administrative problems|0|||
125502322|NCT01972776|451470283|FG004|Part 2|Administrative problems|10|||
125502323|NCT01972776|451470284|FG005|Part 2|Administrative problems|7|||
125502324|NCT01543204|451470285|FG000|Overall Study|Non-compliance|1|||
125502325|NCT01543204|451470285|FG000|Overall Study|Adverse Event|1|||
125502326|NCT01543204|451470285|FG000|Overall Study|Withdrawal by Subject|4|||
125502327|NCT01543204|451470285|FG000|Overall Study|Requirement for Alternative Therapy|1|||
125502328|NCT01543204|451470285|FG000|Overall Study|Lost to Follow-up|1|||
125502329|NCT03938272|451470293|FG000|Overall Study|Withdrawal by Subject|1|||
125502330|NCT03938272|451470294|FG001|Overall Study|Withdrawal by Subject|0|||
125502331|NCT03938272|451470293|FG000|Overall Study|Physician Decision|0|||
125502332|NCT03938272|451470294|FG001|Overall Study|Physician Decision|2|||
125502333|NCT03938272|451470293|FG000|Overall Study|Study termination by sponsor|10|||
125502334|NCT03938272|451470294|FG001|Overall Study|Study termination by sponsor|8|||
125502335|NCT00068107|451470297|FG000|Overall Study|end-stage renal disease|6|||
125502336|NCT00068107|451470297|FG000|Overall Study|Death|2|||
125502337|NCT00068107|451470297|FG000|Overall Study|Withdrawal by Subject|1|||
125502338|NCT03288506|451470298|FG000|Overall Study|Withdrawal by Subject|52|||
125502339|NCT01419184|451470301|FG000|Overall Study|Site data not available|3|||
125502340|NCT01419184|451470302|FG001|Overall Study|Site data not available|2|||
125502341|NCT01419184|451470301|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
125502342|NCT01419184|451470302|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
125502343|NCT01419184|451470301|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
125502344|NCT01419184|451470302|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
125502345|NCT01419184|451470301|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
125502346|NCT01419184|451470302|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
125502347|NCT01419184|451470301|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
125502348|NCT01419184|451470302|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
125502349|NCT01419184|451470301|FG000|Overall Study|Participant randomized, not treated|1|||
125502350|NCT01419184|451470302|FG001|Overall Study|Participant randomized, not treated|0|||
125502351|NCT00875706|451470303|FG000|Overall Study|Withdrawal by Subject|1|||
125502352|NCT00875706|451470304|FG001|Overall Study|Withdrawal by Subject|0|||
125502353|NCT00875706|451470305|FG002|Overall Study|Withdrawal by Subject|0|||
125502354|NCT00786188|451470306|FG000|Overall Study|Adverse Event|3|||
125502355|NCT00786188|451470307|FG001|Overall Study|Adverse Event|1|||
125502356|NCT00786188|451470306|FG000|Overall Study|Withdrawal by Subject|2|||
125502357|NCT00786188|451470307|FG001|Overall Study|Withdrawal by Subject|0|||
125502358|NCT02279732|451470309|FG000|Overall Study|Death|23|||
125502359|NCT02279732|451470310|FG001|Overall Study|Death|20|||
125502360|NCT02279732|451470309|FG000|Overall Study|Disease Progression|13|||
125502361|NCT02279732|451470310|FG001|Overall Study|Disease Progression|3|||
125502362|NCT02279732|451470309|FG000|Overall Study|Withdrawal by Subject|2|||
125502363|NCT02279732|451470310|FG001|Overall Study|Withdrawal by Subject|7|||
125502364|NCT02279732|451470309|FG000|Overall Study|Adverse Event|1|||
125502365|NCT02279732|451470310|FG001|Overall Study|Adverse Event|2|||
125502366|NCT02279732|451470309|FG000|Overall Study|Administrative Reason By Sponsor|0|||
125502367|NCT02279732|451470310|FG001|Overall Study|Administrative Reason By Sponsor|2|||
125502368|NCT02279732|451470309|FG000|Overall Study|Study Drug Toxicity|2|||
125502369|NCT02279732|451470310|FG001|Overall Study|Study Drug Toxicity|0|||
125502370|NCT02279732|451470309|FG000|Overall Study|Lost to Follow-up|0|||
125502371|NCT02279732|451470310|FG001|Overall Study|Lost to Follow-up|1|||
125502372|NCT02279732|451470309|FG000|Overall Study|Maximum Clinical Benefit|1|||
125502373|NCT02279732|451470310|FG001|Overall Study|Maximum Clinical Benefit|0|||
125502374|NCT02279732|451470309|FG000|Overall Study|Subject Requested to Discontinue|0|||
125502375|NCT02279732|451470310|FG001|Overall Study|Subject Requested to Discontinue|1|||
125502376|NCT02279732|451470309|FG000|Overall Study|Other|53|||
125502377|NCT02279732|451470310|FG001|Overall Study|Other|67|||
125502378|NCT02279732|451470309|FG000|Overall Study|Other|3|||
125502379|NCT02279732|451470310|FG001|Overall Study|Other|3|||
125502380|NCT02970318|451470311|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
125502381|NCT02970318|451470312|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
125502382|NCT02970318|451470313|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
125502383|NCT02970318|451470314|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
125502384|NCT02970318|451470311|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
125502385|NCT02970318|451470312|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
125502386|NCT02970318|451470313|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
125502387|NCT02970318|451470314|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
125502388|NCT02970318|451470311|FG000|Overall for Arm A & Main for Arm B|Death|41|||
125502389|NCT02970318|451470312|FG001|Overall for Arm A & Main for Arm B|Death|33|||
125502390|NCT02970318|451470313|FG002|Overall for Arm A & Main for Arm B|Death|0|||
125502391|NCT02970318|451470314|FG003|Overall for Arm A & Main for Arm B|Death|0|||
125502392|NCT02970318|451470311|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
125502393|NCT02970318|451470312|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
125502394|NCT02970318|451470313|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
125502395|NCT02970318|451470314|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
125502396|NCT02970318|451470311|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
125502397|NCT02970318|451470312|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
125502398|NCT02970318|451470313|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
125502399|NCT02970318|451470314|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
125502400|NCT02970318|451470311|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
125502401|NCT02970318|451470312|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
125502402|NCT02970318|451470313|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
125502403|NCT02970318|451470314|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
125502404|NCT02970318|451470311|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
125502405|NCT02970318|451470312|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
125502406|NCT02970318|451470313|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
125502407|NCT02970318|451470314|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
125502408|NCT00824408|451470315|FG000|Run-in Phase|Progressive disease|4|||
125502409|NCT00824408|451470316|FG001|Run-in Phase|Progressive disease|4|||
125502410|NCT00824408|451470317|FG002|Run-in Phase|Progressive disease|0|||
125502411|NCT00824408|451470318|FG003|Run-in Phase|Progressive disease|0|||
125502412|NCT00824408|451470319|FG004|Run-in Phase|Progressive disease|0|||
125502413|NCT00824408|451470315|FG000|Run-in Phase|Adverse Event|1|||
125502414|NCT00824408|451470316|FG001|Run-in Phase|Adverse Event|1|||
125502415|NCT00824408|451470317|FG002|Run-in Phase|Adverse Event|0|||
125502416|NCT00824408|451470318|FG003|Run-in Phase|Adverse Event|0|||
125502417|NCT00824408|451470319|FG004|Run-in Phase|Adverse Event|0|||
125502418|NCT00824408|451470315|FG000|Run-in Phase|Refused to continue medication|1|||
125502419|NCT00824408|451470316|FG001|Run-in Phase|Refused to continue medication|0|||
125502420|NCT00824408|451470317|FG002|Run-in Phase|Refused to continue medication|0|||
125502421|NCT00824408|451470318|FG003|Run-in Phase|Refused to continue medication|0|||
125502422|NCT00824408|451470319|FG004|Run-in Phase|Refused to continue medication|0|||
125502423|NCT00824408|451470315|FG000|Run-in Phase|Other reason not defined above|0|||
125502424|NCT00824408|451470316|FG001|Run-in Phase|Other reason not defined above|1|||
125502425|NCT00824408|451470317|FG002|Run-in Phase|Other reason not defined above|0|||
125502426|NCT00824408|451470318|FG003|Run-in Phase|Other reason not defined above|0|||
125502427|NCT00824408|451470319|FG004|Run-in Phase|Other reason not defined above|0|||
125502428|NCT00824408|451470315|FG000|Randomized Phase|Not treated|0|||
125502429|NCT00824408|451470316|FG001|Randomized Phase|Not treated|0|||
125502430|NCT00824408|451470317|FG002|Randomized Phase|Not treated|1|||
125502431|NCT00824408|451470318|FG003|Randomized Phase|Not treated|1|||
125502432|NCT00824408|451470319|FG004|Randomized Phase|Not treated|1|||
125502433|NCT00824408|451470315|FG000|Randomized Phase|Progressive disease|0|||
125502434|NCT00824408|451470316|FG001|Randomized Phase|Progressive disease|0|||
125502435|NCT00824408|451470317|FG002|Randomized Phase|Progressive disease|25|||
125502436|NCT00824408|451470318|FG003|Randomized Phase|Progressive disease|36|||
125502437|NCT00824408|451470319|FG004|Randomized Phase|Progressive disease|34|||
125502438|NCT00824408|451470315|FG000|Randomized Phase|Adverse Event|0|||
125502439|NCT00824408|451470316|FG001|Randomized Phase|Adverse Event|0|||
125502440|NCT00824408|451470317|FG002|Randomized Phase|Adverse Event|4|||
125502441|NCT00824408|451470318|FG003|Randomized Phase|Adverse Event|5|||
125502442|NCT00824408|451470319|FG004|Randomized Phase|Adverse Event|5|||
125502443|NCT00824408|451470315|FG000|Randomized Phase|Refused to continue medication|0|||
125502444|NCT00824408|451470316|FG001|Randomized Phase|Refused to continue medication|0|||
125502445|NCT00824408|451470317|FG002|Randomized Phase|Refused to continue medication|2|||
125502446|NCT00824408|451470318|FG003|Randomized Phase|Refused to continue medication|2|||
125502447|NCT00824408|451470319|FG004|Randomized Phase|Refused to continue medication|2|||
125502448|NCT00824408|451470315|FG000|Randomized Phase|Other reason not defined above|0|||
125502449|NCT00824408|451470316|FG001|Randomized Phase|Other reason not defined above|0|||
125502450|NCT00824408|451470317|FG002|Randomized Phase|Other reason not defined above|4|||
125502451|NCT00824408|451470318|FG003|Randomized Phase|Other reason not defined above|2|||
125502452|NCT00824408|451470319|FG004|Randomized Phase|Other reason not defined above|4|||
125502453|NCT01880736|451470320|FG000|Overall Study|Adverse Event|0|||
125502454|NCT01880736|451470321|FG001|Overall Study|Adverse Event|0|||
125502455|NCT01880736|451470322|FG002|Overall Study|Adverse Event|0|||
125502456|NCT01880736|451470323|FG003|Overall Study|Adverse Event|1|||
125502457|NCT01880736|451470320|FG000|Overall Study|Withdrawal Criteria|1|||
125502458|NCT01880736|451470321|FG001|Overall Study|Withdrawal Criteria|2|||
125502459|NCT01880736|451470322|FG002|Overall Study|Withdrawal Criteria|1|||
125502460|NCT01880736|451470323|FG003|Overall Study|Withdrawal Criteria|5|||
125502461|NCT00266656|451470327|FG000|Overall Study|Death|1|||
125502462|NCT00266656|451470328|FG001|Overall Study|Death|0|||
125502463|NCT00266656|451470327|FG000|Overall Study|Lost to Follow-up|4|||
125502464|NCT00266656|451470328|FG001|Overall Study|Lost to Follow-up|1|||
125502465|NCT00266656|451470327|FG000|Overall Study|Withdrawal by Subject|4|||
125502466|NCT00266656|451470328|FG001|Overall Study|Withdrawal by Subject|2|||
125502467|NCT00266656|451470327|FG000|Overall Study|Did Not Reach Final Height|4|||
125502468|NCT00266656|451470328|FG001|Overall Study|Did Not Reach Final Height|8|||
125502469|NCT00266656|451470327|FG000|Overall Study|Parent/Caregiver Decision|1|||
125502470|NCT00266656|451470328|FG001|Overall Study|Parent/Caregiver Decision|2|||
125502471|NCT02915783|451470329|FG000|Overall Study|Death|21|||
125502472|NCT02915783|451470329|FG000|Overall Study|Lost to Follow-up|1|||
125502473|NCT02915783|451470329|FG000|Overall Study|Withdrawal by Subject|2|||
125502474|NCT02203032|451470330|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
125502475|NCT02203032|451470331|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
125502476|NCT02203032|451470332|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
125502477|NCT02203032|451470333|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
125502478|NCT02203032|451470330|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
125502479|NCT02203032|451470331|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
125502480|NCT02203032|451470332|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
125502481|NCT02203032|451470333|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
125502482|NCT02203032|451470330|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
125502483|NCT02203032|451470331|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
125502484|NCT02203032|451470332|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
125502485|NCT02203032|451470333|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
125502486|NCT02203032|451470330|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
125502487|NCT02203032|451470331|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
125502488|NCT02203032|451470332|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
125502489|NCT02203032|451470333|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
125502490|NCT02203032|451470330|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
125502491|NCT02203032|451470331|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
125502492|NCT02203032|451470332|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
125502493|NCT02203032|451470333|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
125502494|NCT02203032|451470330|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
125502495|NCT02203032|451470331|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
125502496|NCT02203032|451470332|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
125502497|NCT02203032|451470333|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
125502498|NCT02203032|451470330|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
125502499|NCT02203032|451470331|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
125502500|NCT02203032|451470332|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
125502501|NCT02203032|451470333|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
125502502|NCT02203032|451470330|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
125502503|NCT02203032|451470331|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
125502504|NCT02203032|451470332|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
125502505|NCT02203032|451470333|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
125502506|NCT02203032|451470330|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
125502507|NCT02203032|451470331|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
125502508|NCT02203032|451470332|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
125502509|NCT02203032|451470333|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
125502510|NCT02203032|451470330|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
125502511|NCT02203032|451470331|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
125502512|NCT02203032|451470332|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
125502513|NCT02203032|451470333|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
125502514|NCT02203032|451470330|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
125502515|NCT02203032|451470331|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
125502516|NCT02203032|451470332|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
125502517|NCT02203032|451470333|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
125502518|NCT02203032|451470330|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
125502519|NCT02203032|451470331|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
125502520|NCT02203032|451470332|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
125502521|NCT02203032|451470333|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
125502522|NCT01915914|451470334|FG000|Acute Phase|Withdrawal by Subject|4|||
125502523|NCT01915914|451470335|FG001|Acute Phase|Withdrawal by Subject|0|||
125502524|NCT01915914|451470336|FG002|Acute Phase|Withdrawal by Subject|0|||
125502525|NCT01915914|451470337|FG003|Acute Phase|Withdrawal by Subject|0|||
125502526|NCT01915914|451470334|FG000|Acute Phase|Lost to Follow-up|4|||
125502527|NCT01915914|451470335|FG001|Acute Phase|Lost to Follow-up|0|||
125502528|NCT01915914|451470336|FG002|Acute Phase|Lost to Follow-up|0|||
125502529|NCT01915914|451470337|FG003|Acute Phase|Lost to Follow-up|0|||
125502530|NCT01915914|451470334|FG000|Acute Phase|Physician Decision|1|||
125502531|NCT01915914|451470335|FG001|Acute Phase|Physician Decision|0|||
125502532|NCT01915914|451470336|FG002|Acute Phase|Physician Decision|0|||
125502533|NCT01915914|451470337|FG003|Acute Phase|Physician Decision|0|||
125502534|NCT01915914|451470334|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
125502535|NCT01915914|451470335|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
125502536|NCT01915914|451470336|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
125502537|NCT01915914|451470337|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
125502538|NCT01915914|451470334|FG000|Acute Phase|"Not Achieved treatment success"|1|||
125502539|NCT01915914|451470335|FG001|Acute Phase|"Not Achieved treatment success"|0|||
125502540|NCT01915914|451470336|FG002|Acute Phase|"Not Achieved treatment success"|0|||
125502541|NCT01915914|451470337|FG003|Acute Phase|"Not Achieved treatment success"|0|||
125502542|NCT01915914|451470334|FG000|Acute Phase|Missing|1|||
125502543|NCT01915914|451470335|FG001|Acute Phase|Missing|0|||
125502544|NCT01915914|451470336|FG002|Acute Phase|Missing|0|||
125502545|NCT01915914|451470337|FG003|Acute Phase|Missing|0|||
125502546|NCT01915914|451470334|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125502547|NCT01915914|451470335|FG001|Maintenance Phase|Withdrawal by Subject|1|||
125502548|NCT01915914|451470336|FG002|Maintenance Phase|Withdrawal by Subject|1|||
125502549|NCT01915914|451470337|FG003|Maintenance Phase|Withdrawal by Subject|0|||
125502550|NCT01915914|451470334|FG000|Maintenance Phase|Lost to Follow-up|0|||
125502551|NCT01915914|451470335|FG001|Maintenance Phase|Lost to Follow-up|4|||
125502552|NCT01915914|451470336|FG002|Maintenance Phase|Lost to Follow-up|1|||
125502553|NCT01915914|451470337|FG003|Maintenance Phase|Lost to Follow-up|0|||
125502554|NCT01915914|451470334|FG000|Maintenance Phase|Missing|0|||
125502555|NCT01915914|451470335|FG001|Maintenance Phase|Missing|1|||
125502556|NCT01915914|451470336|FG002|Maintenance Phase|Missing|0|||
125502557|NCT01915914|451470337|FG003|Maintenance Phase|Missing|0|||
125502558|NCT01915914|451470334|FG000|Follow-up Phase|Withdrawal by Subject|0|||
125502559|NCT01915914|451470335|FG001|Follow-up Phase|Withdrawal by Subject|0|||
125502560|NCT01915914|451470336|FG002|Follow-up Phase|Withdrawal by Subject|0|||
125502561|NCT01915914|451470337|FG003|Follow-up Phase|Withdrawal by Subject|1|||
125502562|NCT01915914|451470334|FG000|Follow-up Phase|Physician Decision|0|||
125502563|NCT01915914|451470335|FG001|Follow-up Phase|Physician Decision|0|||
125502564|NCT01915914|451470336|FG002|Follow-up Phase|Physician Decision|0|||
125502565|NCT01915914|451470337|FG003|Follow-up Phase|Physician Decision|1|||
125502566|NCT00116649|451470338|FG000|Overall Study|Adverse Event|20|||
125502567|NCT00116649|451470338|FG000|Overall Study|Lack of Efficacy|1|||
125502568|NCT00116649|451470338|FG000|Overall Study|Lost to Follow-up|32|||
125502569|NCT00116649|451470338|FG000|Overall Study|Withdrawal by Subject|68|||
125502570|NCT00116649|451470338|FG000|Overall Study|Local Skin Reaction|9|||
125502571|NCT00116649|451470338|FG000|Overall Study|Various Reasons|18|||
125502572|NCT00116649|451470338|FG000|Overall Study|Protocol Specified|7|||
125502573|NCT02114515|451470339|FG000|Overall Study|Lost to Follow-up|52|||
125502574|NCT02114515|451470340|FG001|Overall Study|Lost to Follow-up|55|||
125502575|NCT02114515|451470339|FG000|Overall Study|Death|12|||
125502576|NCT02114515|451470340|FG001|Overall Study|Death|12|||
125502577|NCT02114515|451470339|FG000|Overall Study|Withdrawal by Subject|4|||
125502578|NCT02114515|451470340|FG001|Overall Study|Withdrawal by Subject|22|||
125502579|NCT02114515|451470339|FG000|Overall Study|Other|65|||
125502580|NCT02114515|451470340|FG001|Overall Study|Other|61|||
125502581|NCT02659540|451470341|FG000|Overall Study|Adverse Event|3|||
125502582|NCT02659540|451470342|FG001|Overall Study|Adverse Event|2|||
125502583|NCT02659540|451470341|FG000|Overall Study|Death|1|||
125502584|NCT02659540|451470342|FG001|Overall Study|Death|0|||
125502585|NCT02659540|451470341|FG000|Overall Study|Progressive disease|2|||
125502586|NCT02659540|451470342|FG001|Overall Study|Progressive disease|6|||
125502587|NCT01075152|451470347|FG000|Overall Study|Withdrawal by Subject|1|||
125502588|NCT01075152|451470348|FG001|Overall Study|Withdrawal by Subject|0|||
125502589|NCT04820491|451470349|FG000|Overall Study|Withdrawal by Subject|1|||
125502590|NCT04820491|451470350|FG001|Overall Study|Withdrawal by Subject|0|||
125502591|NCT02334215|451470351|FG000|Overall Study|Death|1|||
125502592|NCT02334215|451470352|FG001|Overall Study|Death|1|||
125502593|NCT02334215|451470353|FG002|Overall Study|Death|0|||
125502594|NCT02334215|451470351|FG000|Overall Study|Lost to Follow-up|1|||
125502595|NCT02334215|451470352|FG001|Overall Study|Lost to Follow-up|0|||
125502596|NCT02334215|451470353|FG002|Overall Study|Lost to Follow-up|4|||
125502597|NCT02334215|451470351|FG000|Overall Study|Withdrawal by Subject|2|||
125502598|NCT02334215|451470352|FG001|Overall Study|Withdrawal by Subject|2|||
125502599|NCT02334215|451470353|FG002|Overall Study|Withdrawal by Subject|1|||
125502600|NCT02334215|451470351|FG000|Overall Study|Not released from incarceration on time|3|||
125304969|NCT04384523|450742814|FG000|Overall Study|Lost to Follow-up|0|||
125304970|NCT04384523|450742815|FG001|Overall Study|Lost to Follow-up|0|||
125502601|NCT02334215|451470352|FG001|Overall Study|Not released from incarceration on time|3|||
125502602|NCT02334215|451470353|FG002|Overall Study|Not released from incarceration on time|3|||
125502603|NCT02334215|451470351|FG000|Overall Study|Incarcerated|0|||
125502604|NCT02334215|451470352|FG001|Overall Study|Incarcerated|0|||
125502605|NCT02334215|451470353|FG002|Overall Study|Incarcerated|7|||
125502606|NCT03976323|451470356|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
125502607|NCT03976323|451470357|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
125502608|NCT03976323|451470358|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
125502609|NCT03976323|451470356|FG000|Induction Phase|Death|80|||
125502610|NCT03976323|451470357|FG001|Induction Phase|Death|0|||
125502611|NCT03976323|451470358|FG002|Induction Phase|Death|0|||
125502612|NCT03976323|451470356|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
125502613|NCT03976323|451470357|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
125502614|NCT03976323|451470358|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
125502615|NCT03976323|451470356|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125502616|NCT03976323|451470357|FG001|Maintenance Phase|Withdrawal by Subject|9|||
125502617|NCT03976323|451470358|FG002|Maintenance Phase|Withdrawal by Subject|3|||
125502618|NCT03976323|451470356|FG000|Maintenance Phase|Physician Decision|0|||
125502619|NCT03976323|451470357|FG001|Maintenance Phase|Physician Decision|0|||
125502620|NCT03976323|451470358|FG002|Maintenance Phase|Physician Decision|1|||
125502621|NCT03976323|451470356|FG000|Maintenance Phase|Death|0|||
125502622|NCT03976323|451470357|FG001|Maintenance Phase|Death|228|||
125502623|NCT03976323|451470358|FG002|Maintenance Phase|Death|234|||
125502624|NCT00535626|451472147|FG000|Overall Study|Death|15|||
125502625|NCT00535626|451472147|FG000|Overall Study|Lost to Follow-up|29|||
125502626|NCT00535626|451472147|FG000|Overall Study|Withdrawal by Subject|20|||
125502627|NCT00535626|451472147|FG000|Overall Study|Removal/revision of study component|8|||
125502628|NCT00535626|451472147|FG000|Overall Study|Subject terminated|31|||
125502629|NCT00535626|451472147|FG000|Overall Study|Unable to return|2|||
125502630|NCT02710669|451472148|FG000|Overall Study|Physician Decision|2|||
125502631|NCT02710669|451472149|FG001|Overall Study|Physician Decision|1|||
125502632|NCT02710669|451472150|FG002|Overall Study|Physician Decision|0|||
125502633|NCT02710669|451472148|FG000|Overall Study|Institutional delays (including COVID)|2|||
125502634|NCT02710669|451472149|FG001|Overall Study|Institutional delays (including COVID)|2|||
125502635|NCT02710669|451472150|FG002|Overall Study|Institutional delays (including COVID)|0|||
125502636|NCT02710669|451472148|FG000|Overall Study|arrived in afib/aflutter|10|||
125502637|NCT02710669|451472149|FG001|Overall Study|arrived in afib/aflutter|8|||
125502638|NCT02710669|451472150|FG002|Overall Study|arrived in afib/aflutter|2|||
125502639|NCT01523392|451472151|FG000|Treatment Period 1|Withdrawal by Subject|2|||
125502640|NCT01523392|451472152|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125502641|NCT01523392|451472151|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
125502642|NCT01523392|451472152|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
125502643|NCT01523392|451472151|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
125502644|NCT01523392|451472152|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
125502645|NCT02002689|451472154|FG000|Overall Study|Disease Progression|7|||
125502646|NCT02002689|451472154|FG000|Overall Study|Adverse Event|3|||
125502647|NCT01377844|451472155|FG000|Overall Study|Withdrawal by Subject|25|||
125502648|NCT01377844|451472156|FG001|Overall Study|Withdrawal by Subject|28|||
125502649|NCT01377844|451472155|FG000|Overall Study|Protocol Violation|2|||
125502650|NCT01377844|451472156|FG001|Overall Study|Protocol Violation|3|||
125502651|NCT01377844|451472155|FG000|Overall Study|Adverse Event|3|||
125502652|NCT01377844|451472156|FG001|Overall Study|Adverse Event|0|||
125502653|NCT01377844|451472155|FG000|Overall Study|Physician Decision|6|||
125502654|NCT01377844|451472156|FG001|Overall Study|Physician Decision|3|||
125502655|NCT01377844|451472155|FG000|Overall Study|Study terminated by Sponsor|0|||
125502656|NCT01377844|451472156|FG001|Overall Study|Study terminated by Sponsor|1|||
125502657|NCT02236611|451472158|FG000|Overall Study|Adverse Event|10|||
125502658|NCT02236611|451472159|FG001|Overall Study|Adverse Event|16|||
125502659|NCT02236611|451472158|FG000|Overall Study|Lack of Efficacy|4|||
125502660|NCT02236611|451472159|FG001|Overall Study|Lack of Efficacy|7|||
125502661|NCT02236611|451472158|FG000|Overall Study|Lost to Follow-up|0|||
125502662|NCT02236611|451472159|FG001|Overall Study|Lost to Follow-up|2|||
125502663|NCT02236611|451472158|FG000|Overall Study|Protocol deviation|3|||
125502664|NCT02236611|451472159|FG001|Overall Study|Protocol deviation|5|||
125502665|NCT02236611|451472158|FG000|Overall Study|Withdrew consent|9|||
125502666|NCT02236611|451472159|FG001|Overall Study|Withdrew consent|4|||
125502667|NCT03403036|451472163|FG000|Overall Study|Lack of Efficacy|5|||
125502668|NCT02701296|451472166|FG000|Overall Study|Incomplete Data|0|||
125502669|NCT02701296|451472167|FG001|Overall Study|Incomplete Data|2|||
125502670|NCT02547974|451472168|FG000|Overall Study|Withdrawal by Subject|1|||
125502671|NCT02547974|451472169|FG001|Overall Study|Withdrawal by Subject|0|||
125502672|NCT02547974|451472170|FG002|Overall Study|Withdrawal by Subject|0|||
125502673|NCT02547974|451472171|FG003|Overall Study|Withdrawal by Subject|0|||
125502674|NCT01393600|451472175|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
125502675|NCT01393600|451472176|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
125502676|NCT01393600|451472177|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
125502677|NCT01393600|451472178|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
125502678|NCT01393600|451472175|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
125502679|NCT01393600|451472176|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
125502680|NCT01393600|451472177|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
125502681|NCT01393600|451472178|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
125502682|NCT01393600|451472175|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
125502683|NCT01393600|451472176|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
125502684|NCT01393600|451472177|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
125502685|NCT01393600|451472178|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
125502686|NCT01393600|451472175|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
125502687|NCT01393600|451472176|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
125502688|NCT01393600|451472177|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
125502689|NCT01393600|451472178|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
125502690|NCT01393600|451472175|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
125502691|NCT01393600|451472176|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
125502692|NCT01393600|451472177|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
125502693|NCT01393600|451472178|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
125502694|NCT01393600|451472175|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
125502695|NCT01393600|451472176|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
125502696|NCT01393600|451472177|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
125502697|NCT01393600|451472178|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
125502698|NCT01393600|451472175|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
125502699|NCT01393600|451472176|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
125502700|NCT01393600|451472177|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
125502701|NCT01393600|451472178|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
125502702|NCT00603798|451472179|FG000|Overall Study|Adverse Event|4|||
125502703|NCT00603798|451472180|FG001|Overall Study|Adverse Event|2|||
125502704|NCT00603798|451472181|FG002|Overall Study|Adverse Event|1|||
125502705|NCT00603798|451472179|FG000|Overall Study|Withdrawal by Subject|4|||
125502706|NCT00603798|451472180|FG001|Overall Study|Withdrawal by Subject|3|||
125502707|NCT00603798|451472181|FG002|Overall Study|Withdrawal by Subject|4|||
125502708|NCT00603798|451472179|FG000|Overall Study|Lost to Follow-up|1|||
125502709|NCT00603798|451472180|FG001|Overall Study|Lost to Follow-up|0|||
125502710|NCT00603798|451472181|FG002|Overall Study|Lost to Follow-up|1|||
125502711|NCT00603798|451472179|FG000|Overall Study|Non-compliance with study procedures|0|||
125502712|NCT00603798|451472180|FG001|Overall Study|Non-compliance with study procedures|1|||
125502713|NCT00603798|451472181|FG002|Overall Study|Non-compliance with study procedures|0|||
125502714|NCT00603798|451472179|FG000|Overall Study|Not due to AE|1|||
125502715|NCT00603798|451472180|FG001|Overall Study|Not due to AE|1|||
125502716|NCT00603798|451472181|FG002|Overall Study|Not due to AE|4|||
125502717|NCT04766996|451472182|FG000|Overall Study|Withdrawal by Subject|1|||
125502718|NCT04766996|451472183|FG001|Overall Study|Withdrawal by Subject|0|||
125502719|NCT04766996|451472184|FG002|Overall Study|Withdrawal by Subject|13|||
125502720|NCT02988713|451472187|FG000|Overall Study|Withdrawal by Subject|1|||
125502721|NCT02988713|451472187|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
125502722|NCT04248868|451472191|FG000|Overall Study|Death|1|||
125502723|NCT04248868|451472191|FG000|Overall Study|Lost to Follow-up|3|||
125502724|NCT04248868|451472191|FG000|Overall Study|Protocol Violation|2|||
125502725|NCT03131713|451472194|FG000|Overall Study|Lost to Follow-up|5|||
125502726|NCT03131713|451472195|FG001|Overall Study|Lost to Follow-up|0|||
125502727|NCT02208843|451472196|FG000|Overall Study|Clinical symptoms of progression|2|||
125502728|NCT02208843|451472196|FG000|Overall Study|Progression disease according to RECIST|24|||
125502729|NCT02208843|451472196|FG000|Overall Study|Adverse Event|12|||
125502730|NCT02208843|451472196|FG000|Overall Study|Protocol Violation|1|||
125502731|NCT02208843|451472196|FG000|Overall Study|Withdrawal by Subject|1|||
125502732|NCT02208843|451472196|FG000|Overall Study|Switched to commercial afatinib|20|||
125502733|NCT01976507|451472197|FG000|Overall Study|Adverse Event|6|||
125502734|NCT01976507|451472197|FG000|Overall Study|ablation not done, drug not given|1|||
125502735|NCT01794299|451472207|FG000|Overall Study|ATIR manufacturing not possible|1|||
125502736|NCT01794299|451472207|FG000|Overall Study|Death|14|||
125502737|NCT01794299|451472207|FG000|Overall Study|Graft failure|1|||
125502738|NCT01794299|451472207|FG000|Overall Study|ATIR batch rejected|2|||
125502739|NCT01794299|451472207|FG000|Overall Study|Relapse|2|||
125502740|NCT01794299|451472207|FG000|Overall Study|Discontinued from active follow-up|1|||
125502741|NCT01794299|451472207|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
125502742|NCT01029704|451472208|FG000|Overall Study|Adverse Event|0|||
125502743|NCT01029704|451472209|FG001|Overall Study|Adverse Event|0|||
125502744|NCT01029704|451472210|FG002|Overall Study|Adverse Event|0|||
125502745|NCT01029704|451472211|FG003|Overall Study|Adverse Event|0|||
125502746|NCT01029704|451472212|FG004|Overall Study|Adverse Event|0|||
125502747|NCT01029704|451472213|FG005|Overall Study|Adverse Event|0|||
125502748|NCT01029704|451472214|FG006|Overall Study|Adverse Event|1|||
125502749|NCT01029704|451472215|FG007|Overall Study|Adverse Event|1|||
125502750|NCT01029704|451472216|FG008|Overall Study|Adverse Event|0|||
125502751|NCT01029704|451472208|FG000|Overall Study|Withdrawal by Subject|0|||
125304971|NCT04384523|450742816|FG002|Overall Study|Lost to Follow-up|0|||
125502752|NCT01029704|451472209|FG001|Overall Study|Withdrawal by Subject|0|||
125502753|NCT01029704|451472210|FG002|Overall Study|Withdrawal by Subject|0|||
125502754|NCT01029704|451472211|FG003|Overall Study|Withdrawal by Subject|0|||
125502755|NCT01029704|451472212|FG004|Overall Study|Withdrawal by Subject|2|||
125502756|NCT01029704|451472213|FG005|Overall Study|Withdrawal by Subject|1|||
125502757|NCT01029704|451472214|FG006|Overall Study|Withdrawal by Subject|1|||
125502758|NCT01029704|451472215|FG007|Overall Study|Withdrawal by Subject|1|||
125502759|NCT01029704|451472216|FG008|Overall Study|Withdrawal by Subject|0|||
125502760|NCT01029704|451472208|FG000|Overall Study|Lost to Follow-up|0|||
125502761|NCT01029704|451472209|FG001|Overall Study|Lost to Follow-up|0|||
125502762|NCT01029704|451472210|FG002|Overall Study|Lost to Follow-up|0|||
125502763|NCT01029704|451472211|FG003|Overall Study|Lost to Follow-up|0|||
125502764|NCT01029704|451472212|FG004|Overall Study|Lost to Follow-up|0|||
125502765|NCT01029704|451472213|FG005|Overall Study|Lost to Follow-up|0|||
125502766|NCT01029704|451472214|FG006|Overall Study|Lost to Follow-up|1|||
125502767|NCT01029704|451472215|FG007|Overall Study|Lost to Follow-up|1|||
125502768|NCT01029704|451472216|FG008|Overall Study|Lost to Follow-up|1|||
125502769|NCT01029704|451472208|FG000|Overall Study|Lack of Efficacy|0|||
125502770|NCT01029704|451472209|FG001|Overall Study|Lack of Efficacy|0|||
125502771|NCT01029704|451472210|FG002|Overall Study|Lack of Efficacy|0|||
125502772|NCT01029704|451472211|FG003|Overall Study|Lack of Efficacy|0|||
125502773|NCT01029704|451472212|FG004|Overall Study|Lack of Efficacy|2|||
125502774|NCT01029704|451472213|FG005|Overall Study|Lack of Efficacy|3|||
125502775|NCT01029704|451472214|FG006|Overall Study|Lack of Efficacy|1|||
125502776|NCT01029704|451472215|FG007|Overall Study|Lack of Efficacy|2|||
125502777|NCT01029704|451472216|FG008|Overall Study|Lack of Efficacy|0|||
125502778|NCT01029704|451472208|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
125502779|NCT01029704|451472209|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
125502780|NCT01029704|451472210|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
125502781|NCT01029704|451472211|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
125502782|NCT01029704|451472212|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
125502783|NCT01029704|451472213|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
125502784|NCT01029704|451472214|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
125502785|NCT01029704|451472215|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
125502786|NCT01029704|451472216|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
125502787|NCT00089791|451472220|FG000|Overall Study|Physician Decision|6|||
125502788|NCT00089791|451472221|FG001|Overall Study|Physician Decision|3|||
125502789|NCT00089791|451472220|FG000|Overall Study|Adverse Event|81|||
125502790|NCT00089791|451472221|FG001|Overall Study|Adverse Event|93|||
125502791|NCT00089791|451472220|FG000|Overall Study|Withdrawal by Subject|403|||
125502792|NCT00089791|451472221|FG001|Overall Study|Withdrawal by Subject|344|||
125502793|NCT00089791|451472220|FG000|Overall Study|Death|78|||
125502794|NCT00089791|451472221|FG001|Overall Study|Death|62|||
125502795|NCT00089791|451472220|FG000|Overall Study|Disease progression|7|||
125502796|NCT00089791|451472221|FG001|Overall Study|Disease progression|3|||
125502797|NCT00089791|451472220|FG000|Overall Study|Ineligibility determined|12|||
125502798|NCT00089791|451472221|FG001|Overall Study|Ineligibility determined|9|||
125502799|NCT00089791|451472220|FG000|Overall Study|Lost to Follow-up|57|||
125502800|NCT00089791|451472221|FG001|Overall Study|Lost to Follow-up|57|||
125502801|NCT00089791|451472220|FG000|Overall Study|Noncompliance|17|||
125502802|NCT00089791|451472221|FG001|Overall Study|Noncompliance|13|||
125502803|NCT00089791|451472220|FG000|Overall Study|Other|20|||
125502804|NCT00089791|451472221|FG001|Overall Study|Other|32|||
125502805|NCT00089791|451472220|FG000|Overall Study|Protocol deviation|12|||
125502806|NCT00089791|451472221|FG001|Overall Study|Protocol deviation|10|||
125502807|NCT00089791|451472220|FG000|Overall Study|Requirement for alternative therapy|7|||
125502808|NCT00089791|451472221|FG001|Overall Study|Requirement for alternative therapy|4|||
125502809|NCT00148122|451472222|FG000|Overall Study|Withdrawal by Subject|2|||
125502810|NCT05376397|451472225|FG000|Overall Study|Lost to Follow-up|1|||
125502811|NCT01137682|451472226|FG000|Overall Study|Adverse Event-CORE|2|||
125502812|NCT01137682|451472227|FG001|Overall Study|Adverse Event-CORE|4|||
125502813|NCT01137682|451472228|FG002|Overall Study|Adverse Event-CORE|0|||
125502814|NCT01137682|451472226|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
125502815|NCT01137682|451472227|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
125304972|NCT04384523|450742817|FG003|Overall Study|Lost to Follow-up|0|||
125304973|NCT04384523|450742818|FG004|Overall Study|Lost to Follow-up|0|||
125304974|NCT04384523|450742819|FG005|Overall Study|Lost to Follow-up|1|||
125304975|NCT04384523|450742814|FG000|Overall Study|Protocol Violation|0|||
125304976|NCT04384523|450742815|FG001|Overall Study|Protocol Violation|1|||
125304977|NCT04384523|450742816|FG002|Overall Study|Protocol Violation|0|||
125304978|NCT04384523|450742817|FG003|Overall Study|Protocol Violation|0|||
125304979|NCT04384523|450742818|FG004|Overall Study|Protocol Violation|0|||
125304980|NCT04384523|450742819|FG005|Overall Study|Protocol Violation|0|||
125304981|NCT04384523|450742814|FG000|Overall Study|Withdrawal by Subject|1|||
125304982|NCT04384523|450742815|FG001|Overall Study|Withdrawal by Subject|0|||
125304983|NCT04384523|450742816|FG002|Overall Study|Withdrawal by Subject|0|||
125304984|NCT04384523|450742817|FG003|Overall Study|Withdrawal by Subject|0|||
125502816|NCT01137682|451472228|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
125502817|NCT01137682|451472226|FG000|Overall Study|Administrative problems-CORE|2|||
125502818|NCT01137682|451472227|FG001|Overall Study|Administrative problems-CORE|1|||
125502819|NCT01137682|451472228|FG002|Overall Study|Administrative problems-CORE|0|||
125502820|NCT01137682|451472226|FG000|Overall Study|Protocol Violation-CORE|0|||
125502821|NCT01137682|451472227|FG001|Overall Study|Protocol Violation-CORE|1|||
125502822|NCT01137682|451472228|FG002|Overall Study|Protocol Violation-CORE|1|||
125502823|NCT01137682|451472226|FG000|Overall Study|Adverse Event-Extension|4|||
125502824|NCT01137682|451472227|FG001|Overall Study|Adverse Event-Extension|8|||
125502825|NCT01137682|451472228|FG002|Overall Study|Adverse Event-Extension|7|||
125502826|NCT01137682|451472226|FG000|Overall Study|Lack of Efficacy-Extension|15|||
125502827|NCT01137682|451472227|FG001|Overall Study|Lack of Efficacy-Extension|9|||
125502828|NCT01137682|451472228|FG002|Overall Study|Lack of Efficacy-Extension|13|||
125502829|NCT01137682|451472226|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
125502830|NCT01137682|451472227|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
125502831|NCT01137682|451472228|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
125502832|NCT01137682|451472226|FG000|Overall Study|Lost to Follow Up-Extension|0|||
125502833|NCT01137682|451472227|FG001|Overall Study|Lost to Follow Up-Extension|1|||
125502834|NCT01137682|451472228|FG002|Overall Study|Lost to Follow Up-Extension|0|||
125502835|NCT01137682|451472226|FG000|Overall Study|Administrative problems-Extension|0|||
125502836|NCT01137682|451472227|FG001|Overall Study|Administrative problems-Extension|2|||
125502837|NCT01137682|451472228|FG002|Overall Study|Administrative problems-Extension|0|||
125502838|NCT01137682|451472226|FG000|Overall Study|Death-Extension|2|||
125502839|NCT01137682|451472227|FG001|Overall Study|Death-Extension|0|||
125502840|NCT01137682|451472228|FG002|Overall Study|Death-Extension|0|||
125502841|NCT01137682|451472226|FG000|Overall Study|Protocol Violation-Extension|2|||
125502842|NCT01137682|451472227|FG001|Overall Study|Protocol Violation-Extension|1|||
125502843|NCT01137682|451472228|FG002|Overall Study|Protocol Violation-Extension|0|||
125502844|NCT01137682|451472226|FG000|Overall Study|Did not enter extension|2|||
125502845|NCT01137682|451472227|FG001|Overall Study|Did not enter extension|3|||
125502846|NCT01137682|451472228|FG002|Overall Study|Did not enter extension|2|||
125502847|NCT01137682|451472226|FG000|Overall Study|Did not receive treatment in extension|0|||
125502848|NCT01137682|451472227|FG001|Overall Study|Did not receive treatment in extension|0|||
125502849|NCT01137682|451472228|FG002|Overall Study|Did not receive treatment in extension|1|||
125502850|NCT01365546|451472229|FG000|Overall Study|Withdrawal by Subject|1|||
125502851|NCT01365546|451472229|FG000|Overall Study|Screen failure|9|||
125502852|NCT01365546|451472229|FG000|Overall Study|Study termination|1|||
125502853|NCT00721734|451472230|FG000|Overall Study|Progressive Disease|3|||
125502854|NCT00721734|451472231|FG001|Overall Study|Progressive Disease|10|||
125502855|NCT00721734|451472232|FG002|Overall Study|Progressive Disease|4|||
125502856|NCT00721734|451472233|FG003|Overall Study|Progressive Disease|5|||
125502857|NCT00721734|451472234|FG004|Overall Study|Progressive Disease|2|||
125502858|NCT00721734|451472230|FG000|Overall Study|Adverse Event|3|||
125502859|NCT00721734|451472231|FG001|Overall Study|Adverse Event|1|||
125502860|NCT00721734|451472232|FG002|Overall Study|Adverse Event|4|||
125502861|NCT00721734|451472233|FG003|Overall Study|Adverse Event|0|||
125502862|NCT00721734|451472234|FG004|Overall Study|Adverse Event|3|||
125502863|NCT00721734|451472230|FG000|Overall Study|Withdrawal by Subject|2|||
125502864|NCT00721734|451472231|FG001|Overall Study|Withdrawal by Subject|1|||
125502865|NCT00721734|451472232|FG002|Overall Study|Withdrawal by Subject|0|||
125502866|NCT00721734|451472233|FG003|Overall Study|Withdrawal by Subject|0|||
125502867|NCT00721734|451472234|FG004|Overall Study|Withdrawal by Subject|1|||
125502868|NCT00721734|451472230|FG000|Overall Study|Other|0|||
125502869|NCT00721734|451472231|FG001|Overall Study|Other|0|||
125502870|NCT00721734|451472232|FG002|Overall Study|Other|0|||
125502871|NCT00721734|451472233|FG003|Overall Study|Other|1|||
125502872|NCT00721734|451472234|FG004|Overall Study|Other|0|||
125502873|NCT00472082|451472235|FG000|Overall Study|Study prematurely terminated|5|||
125502874|NCT04617847|451472236|FG000|Overall Study|Withdrawal by Subject|1|||
125502875|NCT04617847|451472237|FG001|Overall Study|Withdrawal by Subject|0|||
125502876|NCT04617847|451472236|FG000|Overall Study|Adverse Event|0|||
125502877|NCT04617847|451472237|FG001|Overall Study|Adverse Event|2|||
125502878|NCT04617847|451472236|FG000|Overall Study|Death|0|||
125502879|NCT04617847|451472237|FG001|Overall Study|Death|1|||
125502880|NCT04617847|451472236|FG000|Overall Study|Termination of Study by Sponsor|2|||
125502881|NCT04617847|451472237|FG001|Overall Study|Termination of Study by Sponsor|21|||
125502882|NCT01989689|451472238|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
125502883|NCT01989689|451472239|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
125502884|NCT01989689|451472238|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
125502885|NCT01989689|451472239|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
125502886|NCT00761267|451472240|FG000|Overall Study|Death|1|||
125502887|NCT00761267|451472241|FG001|Overall Study|Death|2|||
125502888|NCT00761267|451472242|FG002|Overall Study|Death|5|||
125502889|NCT00761267|451472240|FG000|Overall Study|Lost to Follow-up|0|||
125502890|NCT00761267|451472241|FG001|Overall Study|Lost to Follow-up|0|||
125502891|NCT00761267|451472242|FG002|Overall Study|Lost to Follow-up|1|||
125502892|NCT00761267|451472240|FG000|Overall Study|Randomized but not treated|1|||
125502893|NCT00761267|451472241|FG001|Overall Study|Randomized but not treated|1|||
125502894|NCT00761267|451472242|FG002|Overall Study|Randomized but not treated|0|||
125502895|NCT00761267|451472240|FG000|Overall Study|Withdrawal by Subject|0|||
125502896|NCT00761267|451472241|FG001|Overall Study|Withdrawal by Subject|1|||
125502897|NCT00761267|451472242|FG002|Overall Study|Withdrawal by Subject|0|||
125502898|NCT04492475|451472243|FG000|Overall Study|Enrolled but not treated|8|||
125502899|NCT04492475|451472244|FG001|Overall Study|Enrolled but not treated|8|||
125502900|NCT04492475|451472243|FG000|Overall Study|Withdrawal by Subject|4|||
125502901|NCT04492475|451472244|FG001|Overall Study|Withdrawal by Subject|0|||
125502902|NCT04492475|451472243|FG000|Overall Study|Became ineligible after enrollment|2|||
125502903|NCT04492475|451472244|FG001|Overall Study|Became ineligible after enrollment|0|||
125502904|NCT03989232|451472245|FG000|Overall Study|Lost to Follow-up|3|||
125502905|NCT03989232|451472246|FG001|Overall Study|Lost to Follow-up|10|||
125502906|NCT03989232|451472245|FG000|Overall Study|Withdrawal by Subject|6|||
125502907|NCT03989232|451472246|FG001|Overall Study|Withdrawal by Subject|6|||
125502908|NCT03989232|451472245|FG000|Overall Study|Death|1|||
125502909|NCT03989232|451472246|FG001|Overall Study|Death|2|||
125502910|NCT03652610|451472259|FG000|Overall Study|Lost to Follow-up|1|||
125502911|NCT03652610|451472260|FG001|Overall Study|Lost to Follow-up|0|||
125502912|NCT03652610|451472259|FG000|Overall Study|Withdrawal by Subject|3|||
125502913|NCT03652610|451472260|FG001|Overall Study|Withdrawal by Subject|5|||
125502914|NCT00326183|451472261|FG000|Overall Study|Lost to Follow-up|104|||
125502915|NCT00326183|451472262|FG001|Overall Study|Lost to Follow-up|56|||
125502916|NCT00326183|451472261|FG000|Overall Study|Protocol Violation|6|||
125502917|NCT00326183|451472262|FG001|Overall Study|Protocol Violation|3|||
125502918|NCT00326183|451472261|FG000|Overall Study|Withdrawal by Subject|35|||
125502919|NCT00326183|451472262|FG001|Overall Study|Withdrawal by Subject|7|||
125502920|NCT00326183|451472261|FG000|Overall Study|Subject Moved|7|||
125502921|NCT00326183|451472262|FG001|Overall Study|Subject Moved|4|||
125502922|NCT00326183|451472261|FG000|Overall Study|Other|47|||
125502923|NCT00326183|451472262|FG001|Overall Study|Other|13|||
125502924|NCT00326183|451472261|FG000|Overall Study|Adverse Event|1|||
125502925|NCT00326183|451472262|FG001|Overall Study|Adverse Event|0|||
125502926|NCT01323790|451472265|FG000|Overall Study|Other|3|||
125502927|NCT01323790|451472266|FG001|Overall Study|Other|2|||
125502928|NCT01323790|451472267|FG002|Overall Study|Other|1|||
125502929|NCT01323790|451472265|FG000|Overall Study|Lost to Follow-up|11|||
125502930|NCT01323790|451472266|FG001|Overall Study|Lost to Follow-up|9|||
125502931|NCT01323790|451472267|FG002|Overall Study|Lost to Follow-up|9|||
125502932|NCT01323790|451472265|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
125502933|NCT01323790|451472266|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
125502934|NCT01323790|451472267|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
125502935|NCT01323790|451472265|FG000|Overall Study|Lack of Efficacy|3|||
125502936|NCT01323790|451472266|FG001|Overall Study|Lack of Efficacy|0|||
125502937|NCT01323790|451472267|FG002|Overall Study|Lack of Efficacy|3|||
125502938|NCT01323790|451472265|FG000|Overall Study|Adverse Event|11|||
125502939|NCT01323790|451472266|FG001|Overall Study|Adverse Event|24|||
125502940|NCT01323790|451472267|FG002|Overall Study|Adverse Event|12|||
125502941|NCT01323790|451472265|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
125502942|NCT01323790|451472266|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
125502943|NCT01323790|451472267|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
125502944|NCT01323790|451472265|FG000|Overall Study|Withdrawal by Subject|23|||
125502945|NCT01323790|451472266|FG001|Overall Study|Withdrawal by Subject|20|||
125502946|NCT01323790|451472267|FG002|Overall Study|Withdrawal by Subject|13|||
125502947|NCT01323790|451472265|FG000|Overall Study|Did Not Receive Treatment|2|||
125502948|NCT01323790|451472266|FG001|Overall Study|Did Not Receive Treatment|0|||
125502949|NCT01323790|451472267|FG002|Overall Study|Did Not Receive Treatment|1|||
125502950|NCT01323790|451472265|FG000|Overall Study|Severe non-compliance with protocol|2|||
125502951|NCT01323790|451472266|FG001|Overall Study|Severe non-compliance with protocol|2|||
125502952|NCT01323790|451472267|FG002|Overall Study|Severe non-compliance with protocol|2|||
125502953|NCT01263496|451472268|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
125502954|NCT01263496|451472269|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
125502955|NCT01263496|451472270|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
125502956|NCT01263496|451472271|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
125502957|NCT01263496|451472272|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
125502958|NCT01263496|451472273|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
125502959|NCT01263496|451472274|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
125502960|NCT01263496|451472275|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
125502961|NCT01263496|451472276|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
125304985|NCT04384523|450742818|FG004|Overall Study|Withdrawal by Subject|0|||
125502962|NCT01263496|451472268|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125502963|NCT01263496|451472269|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125502964|NCT01263496|451472270|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125502965|NCT01263496|451472271|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
125502966|NCT01263496|451472272|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
125502967|NCT01263496|451472273|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125502968|NCT01263496|451472274|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125502969|NCT01263496|451472275|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125502970|NCT01263496|451472276|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
125502971|NCT01263496|451472268|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
125502972|NCT01263496|451472269|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
125502973|NCT01263496|451472270|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
125502974|NCT01263496|451472271|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
125502975|NCT01263496|451472272|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
125502976|NCT01263496|451472273|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
125502977|NCT01263496|451472274|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
125502978|NCT01263496|451472275|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
125502979|NCT01263496|451472276|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
125502980|NCT01263496|451472268|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125502981|NCT01263496|451472269|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
125502982|NCT01263496|451472270|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125502983|NCT01263496|451472271|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125502984|NCT01263496|451472272|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125502985|NCT01263496|451472273|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125502986|NCT01263496|451472274|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125502987|NCT01263496|451472275|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125502988|NCT01263496|451472276|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
125502989|NCT01263496|451472268|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
125502990|NCT01263496|451472269|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
125502991|NCT01263496|451472270|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
125502992|NCT01263496|451472271|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
125502993|NCT01263496|451472272|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
125502994|NCT01263496|451472273|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
125502995|NCT01263496|451472274|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
125502996|NCT01263496|451472275|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
125502997|NCT01263496|451472276|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
125502998|NCT01263496|451472268|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
125502999|NCT01263496|451472269|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
125503000|NCT01263496|451472270|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
125503001|NCT01263496|451472271|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
125503002|NCT01263496|451472272|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
125503003|NCT01263496|451472273|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
125503004|NCT01263496|451472274|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
125503005|NCT01263496|451472275|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
125503006|NCT01263496|451472276|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
125503007|NCT01263496|451472268|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
125503008|NCT01263496|451472269|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
125503009|NCT01263496|451472270|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
125503010|NCT01263496|451472271|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
125503011|NCT01263496|451472272|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
125503012|NCT01263496|451472273|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
125503013|NCT01263496|451472274|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
125503014|NCT01263496|451472275|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
125503015|NCT01263496|451472276|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
125503016|NCT02432274|451472277|FG000|Overall Study|Death|2|||
125503017|NCT02432274|451472278|FG001|Overall Study|Death|6|||
125503018|NCT02432274|451472279|FG002|Overall Study|Death|7|||
125503019|NCT02432274|451472280|FG003|Overall Study|Death|0|||
125503020|NCT02432274|451472281|FG004|Overall Study|Death|27|||
125503021|NCT02432274|451472282|FG005|Overall Study|Death|7|||
125503022|NCT02432274|451472283|FG006|Overall Study|Death|9|||
125503023|NCT02432274|451472284|FG007|Overall Study|Death|14|||
125503024|NCT02432274|451472277|FG000|Overall Study|Withdrawal of Consent|0|||
125503025|NCT02432274|451472278|FG001|Overall Study|Withdrawal of Consent|0|||
125503026|NCT02432274|451472279|FG002|Overall Study|Withdrawal of Consent|0|||
125503027|NCT02432274|451472280|FG003|Overall Study|Withdrawal of Consent|0|||
125503028|NCT02432274|451472281|FG004|Overall Study|Withdrawal of Consent|2|||
125503029|NCT02432274|451472282|FG005|Overall Study|Withdrawal of Consent|0|||
125503030|NCT02432274|451472283|FG006|Overall Study|Withdrawal of Consent|1|||
125503031|NCT02432274|451472284|FG007|Overall Study|Withdrawal of Consent|2|||
125503032|NCT00513071|451472287|FG000|Overall Study|Adverse Event|1|||
125503033|NCT00513071|451472287|FG000|Overall Study|Withdrawal by Subject|1|||
125503034|NCT00513071|451472287|FG000|Overall Study|Physician Decision|3|||
125503035|NCT00667732|451472290|FG000|Run -In (8 Weeks)|Adverse Event|4|||
125503036|NCT00667732|451472291|FG001|Run -In (8 Weeks)|Adverse Event|0|||
125503037|NCT00667732|451472292|FG002|Run -In (8 Weeks)|Adverse Event|0|||
125503038|NCT00667732|451472290|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
125503039|NCT00667732|451472291|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
125503040|NCT00667732|451472292|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
125503041|NCT00667732|451472290|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
125503042|NCT00667732|451472291|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
125304986|NCT04384523|450742819|FG005|Overall Study|Withdrawal by Subject|0|||
125304987|NCT04405076|450742820|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
125421153|NCT04988308|451166247|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
125421154|NCT04988308|451166248|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
125421155|NCT04988308|451166243|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
125421156|NCT04988308|451166244|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
125421157|NCT04988308|451166245|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
125421158|NCT04988308|451166246|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
125421159|NCT04988308|451166247|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
125421160|NCT04988308|451166248|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
125421161|NCT04988308|451166243|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
125421162|NCT04988308|451166244|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
125421163|NCT04988308|451166245|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
125421164|NCT04988308|451166246|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
125421165|NCT04988308|451166247|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
125421166|NCT04988308|451166248|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
125421167|NCT04988308|451166243|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
125421168|NCT04988308|451166244|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
125421169|NCT04988308|451166245|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
125421170|NCT04988308|451166246|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
125421171|NCT04988308|451166247|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
125421172|NCT04988308|451166248|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
125421173|NCT04988308|451166243|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125421174|NCT04988308|451166244|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125421175|NCT04988308|451166245|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
125421176|NCT04988308|451166246|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
125421177|NCT04988308|451166247|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
125421178|NCT04988308|451166248|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
125421179|NCT04988308|451166243|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
125421180|NCT04988308|451166244|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
125421181|NCT04988308|451166245|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
125421182|NCT04988308|451166246|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
125421183|NCT04988308|451166247|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
125421184|NCT04988308|451166248|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
125421185|NCT02625623|451166250|FG000|Overall Study|Participants randomized but not treated|9|||
125421186|NCT02625623|451166251|FG001|Overall Study|Participants randomized but not treated|1|||
125421187|NCT00808808|451166252|FG000|Overall Study|Vaccinated; survey not completed|131|||
125421188|NCT00808808|451166253|FG001|Overall Study|Vaccinated; survey not completed|169|||
125421189|NCT00808808|451166254|FG002|Overall Study|Vaccinated; survey not completed|302|||
125421190|NCT00808808|451166252|FG000|Overall Study|Employee was not vaccinated.|2686|||
125421191|NCT00808808|451166253|FG001|Overall Study|Employee was not vaccinated.|2268|||
125421192|NCT00808808|451166254|FG002|Overall Study|Employee was not vaccinated.|2255|||
125421193|NCT02352948|451166256|FG000|Overall Study|Death|47|||
125421194|NCT02352948|451166257|FG001|Overall Study|Death|48|||
125421195|NCT02352948|451166258|FG002|Overall Study|Death|114|||
125421196|NCT02352948|451166259|FG003|Overall Study|Death|74|||
125421197|NCT02352948|451166260|FG004|Overall Study|Death|77|||
125421198|NCT02352948|451166261|FG005|Overall Study|Death|44|||
125421199|NCT02352948|451166256|FG000|Overall Study|Lost to Follow-up|1|||
125421200|NCT02352948|451166257|FG001|Overall Study|Lost to Follow-up|0|||
125421201|NCT02352948|451166258|FG002|Overall Study|Lost to Follow-up|2|||
125421202|NCT02352948|451166259|FG003|Overall Study|Lost to Follow-up|1|||
125421203|NCT02352948|451166260|FG004|Overall Study|Lost to Follow-up|2|||
125421204|NCT02352948|451166261|FG005|Overall Study|Lost to Follow-up|1|||
125421205|NCT02352948|451166256|FG000|Overall Study|Withdrawal by Subject|1|||
125421206|NCT02352948|451166257|FG001|Overall Study|Withdrawal by Subject|10|||
125421207|NCT02352948|451166258|FG002|Overall Study|Withdrawal by Subject|11|||
125421208|NCT02352948|451166259|FG003|Overall Study|Withdrawal by Subject|23|||
125421209|NCT02352948|451166260|FG004|Overall Study|Withdrawal by Subject|9|||
125421210|NCT02352948|451166261|FG005|Overall Study|Withdrawal by Subject|4|||
125421211|NCT02352948|451166256|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125421212|NCT02352948|451166257|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
125421213|NCT02352948|451166258|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
125421214|NCT02352948|451166259|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
125421215|NCT02352948|451166260|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
125421216|NCT02352948|451166261|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
125421217|NCT02352948|451166256|FG000|Overall Study|Other|0|||
125421218|NCT02352948|451166257|FG001|Overall Study|Other|0|||
125421219|NCT02352948|451166258|FG002|Overall Study|Other|2|||
125304988|NCT04405076|450742821|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
125304989|NCT04405076|450742822|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
125304990|NCT04405076|450742823|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
125304991|NCT04405076|450742824|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
125304992|NCT04405076|450742825|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
125304993|NCT04405076|450742826|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
125421220|NCT02352948|451166259|FG003|Overall Study|Other|0|||
125421221|NCT02352948|451166260|FG004|Overall Study|Other|0|||
125421222|NCT02352948|451166261|FG005|Overall Study|Other|0|||
125421223|NCT00490646|451166262|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
125421224|NCT00490646|451166263|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
125421225|NCT00490646|451166262|FG000|Overall Study|Never Treated (had an adverse event)|1|||
125421226|NCT00490646|451166263|FG001|Overall Study|Never Treated (had an adverse event)|0|||
125421227|NCT00490646|451166262|FG000|Overall Study|Never Treated (withdrew consent)|0|||
125421228|NCT00490646|451166263|FG001|Overall Study|Never Treated (withdrew consent)|1|||
125421229|NCT01178086|451166264|FG000|Overall Study|Participant refusal|7|||
125421230|NCT01178086|451166264|FG000|Overall Study|Physician Decision|44|||
125421231|NCT01178086|451166264|FG000|Overall Study|Switch to other CLL therapy|113|||
125421232|NCT01178086|451166264|FG000|Overall Study|Death|59|||
125421233|NCT01178086|451166264|FG000|Overall Study|Other unspecified|89|||
125421234|NCT01178086|451166264|FG000|Overall Study|Excluded from EAS|20|||
125421235|NCT02313428|451166265|FG000|Overall Study|Lost to Follow-up|1|||
125421236|NCT02313428|451166266|FG001|Overall Study|Lost to Follow-up|1|||
125503043|NCT00667732|451472292|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
125503044|NCT01240590|451472293|FG000|Phase I|Refused further treatment|0|||
125503045|NCT01240590|451472294|FG001|Phase I|Refused further treatment|0|||
125503046|NCT01240590|451472295|FG002|Phase I|Refused further treatment|3|||
125503047|NCT01240590|451472296|FG003|Phase I|Refused further treatment|0|||
125503048|NCT01240590|451472297|FG004|Phase I|Refused further treatment|0|||
125503049|NCT01240590|451472293|FG000|Phase II|Refused further treatment|0|||
125503050|NCT01240590|451472294|FG001|Phase II|Refused further treatment|0|||
125503051|NCT01240590|451472295|FG002|Phase II|Refused further treatment|0|||
125503052|NCT01240590|451472296|FG003|Phase II|Refused further treatment|2|||
125503053|NCT01240590|451472297|FG004|Phase II|Refused further treatment|1|||
125503054|NCT03890484|451472298|FG000|Overall Study|Lost to Follow-up|1|||
125503055|NCT03890484|451472299|FG001|Overall Study|Lost to Follow-up|1|||
125503056|NCT02106325|451472300|FG000|Phase 1|Lost to Follow-up|2|||
125503057|NCT02106325|451472301|FG001|Phase 1|Lost to Follow-up|2|||
125503058|NCT02106325|451472300|FG000|Phase 2|Lost to Follow-up|2|||
125503059|NCT02106325|451472301|FG001|Phase 2|Lost to Follow-up|3|||
125503060|NCT02106325|451472300|FG000|Phase 3|Lost to Follow-up|2|||
125503061|NCT02106325|451472301|FG001|Phase 3|Lost to Follow-up|1|||
125503062|NCT00824850|451472303|FG000|Overall Study|Withdrawal by Subject|0|||
125503063|NCT00824850|451472304|FG001|Overall Study|Withdrawal by Subject|1|||
125503064|NCT05184062|451472305|FG000|Overall Study|Lost to Follow-up|5|||
125503065|NCT05184062|451472306|FG001|Overall Study|Lost to Follow-up|1|||
125503066|NCT05184062|451472305|FG000|Overall Study|Withdrawal by Subject|1|||
125503067|NCT05184062|451472306|FG001|Overall Study|Withdrawal by Subject|0|||
125503068|NCT02830893|451473888|FG000|Overall Study|Relocation to out of the country|1|||
125503069|NCT02830893|451473889|FG001|Overall Study|Relocation to out of the country|0|||
125503070|NCT02830893|451473888|FG000|Overall Study|Lost to Follow-up|0|||
125503071|NCT02830893|451473889|FG001|Overall Study|Lost to Follow-up|2|||
125503072|NCT02830893|451473888|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
125503073|NCT02830893|451473889|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
125503074|NCT01277302|451473890|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
125503075|NCT01277302|451473891|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
125503076|NCT01277302|451473892|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
125503077|NCT01277302|451473890|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
125503078|NCT01277302|451473891|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
125503079|NCT01277302|451473892|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
125503080|NCT01277302|451473890|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
125503081|NCT01277302|451473891|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
125503082|NCT01277302|451473892|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
125503083|NCT01277302|451473890|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
125503084|NCT01277302|451473891|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
125503085|NCT01277302|451473892|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
125503086|NCT01277302|451473890|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
125503087|NCT01277302|451473891|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
125503088|NCT01277302|451473892|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
125503089|NCT01277302|451473890|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
125503090|NCT01277302|451473891|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
125503091|NCT01277302|451473892|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
125503092|NCT01277302|451473890|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
125503093|NCT01277302|451473891|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
125503094|NCT01277302|451473892|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
125503095|NCT01277302|451473890|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
125503096|NCT01277302|451473891|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
125503097|NCT01277302|451473892|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
125503098|NCT01277302|451473890|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
125503099|NCT01277302|451473891|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
125503100|NCT01277302|451473892|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
125503101|NCT00731692|451473893|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
125503102|NCT00731692|451473894|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
125503103|NCT00731692|451473895|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
125503104|NCT00731692|451473893|FG000|Core Study (36 Months)|Physician Decision|1|||
125503105|NCT00731692|451473894|FG001|Core Study (36 Months)|Physician Decision|0|||
125503106|NCT00731692|451473895|FG002|Core Study (36 Months)|Physician Decision|2|||
125503107|NCT00731692|451473893|FG000|Core Study (36 Months)|Death|2|||
125503108|NCT00731692|451473894|FG001|Core Study (36 Months)|Death|1|||
125503109|NCT00731692|451473895|FG002|Core Study (36 Months)|Death|2|||
125503110|NCT00731692|451473893|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
125503111|NCT00731692|451473894|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
125503112|NCT00731692|451473895|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
125503113|NCT00731692|451473893|FG000|Core Study (36 Months)|Administrative|2|||
125503114|NCT00731692|451473894|FG001|Core Study (36 Months)|Administrative|2|||
125503115|NCT00731692|451473895|FG002|Core Study (36 Months)|Administrative|6|||
125503116|NCT00731692|451473893|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
125503117|NCT00731692|451473894|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
125503118|NCT00731692|451473895|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
125503119|NCT00731692|451473893|FG000|Core Study (36 Months)|Protocol Violation|4|||
125503120|NCT00731692|451473894|FG001|Core Study (36 Months)|Protocol Violation|5|||
125503121|NCT00731692|451473895|FG002|Core Study (36 Months)|Protocol Violation|8|||
125503122|NCT00731692|451473893|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
125503123|NCT00731692|451473894|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
125503124|NCT00731692|451473895|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
125503125|NCT00731692|451473893|FG000|Core Study (36 Months)|Adverse Event|25|||
125503126|NCT00731692|451473894|FG001|Core Study (36 Months)|Adverse Event|28|||
125503127|NCT00731692|451473895|FG002|Core Study (36 Months)|Adverse Event|29|||
125503128|NCT00731692|451473893|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
125503129|NCT00731692|451473894|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
125503130|NCT00731692|451473895|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
125503131|NCT00731692|451473893|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
125503132|NCT00731692|451473894|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
125503133|NCT00731692|451473895|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
125503134|NCT00731692|451473893|FG000|Extension Phase|Abnormal test procedure|0|||
125503135|NCT00731692|451473894|FG001|Extension Phase|Abnormal test procedure|0|||
125503136|NCT00731692|451473895|FG002|Extension Phase|Abnormal test procedure|1|||
125503137|NCT00731692|451473893|FG000|Extension Phase|Abnormal lab values|0|||
125503138|NCT00731692|451473894|FG001|Extension Phase|Abnormal lab values|0|||
125503139|NCT00731692|451473895|FG002|Extension Phase|Abnormal lab values|1|||
125503140|NCT00731692|451473893|FG000|Extension Phase|Lost to Follow-up|0|||
125503141|NCT00731692|451473894|FG001|Extension Phase|Lost to Follow-up|1|||
125503142|NCT00731692|451473895|FG002|Extension Phase|Lost to Follow-up|4|||
125503143|NCT00731692|451473893|FG000|Extension Phase|Withdrawal by Subject|4|||
125503144|NCT00731692|451473894|FG001|Extension Phase|Withdrawal by Subject|5|||
125503145|NCT00731692|451473895|FG002|Extension Phase|Withdrawal by Subject|3|||
125503146|NCT00731692|451473893|FG000|Extension Phase|Adverse Event|1|||
125503147|NCT00731692|451473894|FG001|Extension Phase|Adverse Event|1|||
125503148|NCT00731692|451473895|FG002|Extension Phase|Adverse Event|15|||
125503149|NCT03332589|451473896|FG000|Overall Study|Lack of Efficacy|2|||
125503150|NCT03332589|451473897|FG001|Overall Study|Lack of Efficacy|0|||
125503151|NCT03332589|451473898|FG002|Overall Study|Lack of Efficacy|0|||
125503152|NCT03332589|451473896|FG000|Overall Study|Adverse Event|1|||
125503153|NCT03332589|451473897|FG001|Overall Study|Adverse Event|0|||
125503154|NCT03332589|451473898|FG002|Overall Study|Adverse Event|0|||
125503155|NCT03332589|451473896|FG000|Overall Study|Death|1|||
125503156|NCT03332589|451473897|FG001|Overall Study|Death|0|||
125503157|NCT03332589|451473898|FG002|Overall Study|Death|0|||
125503158|NCT00108355|451473902|FG000|Overall Study|Peritonitis at index paracentesis|1|||
125503159|NCT00108355|451473903|FG001|Overall Study|Peritonitis at index paracentesis|1|||
125503160|NCT00108355|451473902|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
125503161|NCT00108355|451473903|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
125503162|NCT01185340|451473910|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
125503163|NCT01185340|451473911|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125503164|NCT01185340|451473912|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125503165|NCT01185340|451473913|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125503166|NCT01185340|451473910|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
125503167|NCT01185340|451473911|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125503168|NCT01185340|451473912|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125503169|NCT01185340|451473913|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125503170|NCT01185340|451473910|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
125503171|NCT01185340|451473911|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125503172|NCT01185340|451473912|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125503173|NCT01185340|451473913|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125503174|NCT01185340|451473910|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
125503175|NCT01185340|451473911|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125503176|NCT01185340|451473912|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125503177|NCT01185340|451473913|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125503178|NCT01185340|451473910|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
125503179|NCT01185340|451473911|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125503180|NCT01185340|451473912|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125503181|NCT01185340|451473913|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125503182|NCT01185340|451473910|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
125503183|NCT01185340|451473911|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125503184|NCT01185340|451473912|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125503185|NCT01185340|451473913|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125503186|NCT01185340|451473910|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
125503187|NCT01185340|451473911|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125503188|NCT01185340|451473912|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125503189|NCT01185340|451473913|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125503190|NCT01185340|451473910|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
125503191|NCT01185340|451473911|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
125503192|NCT01185340|451473912|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
125503193|NCT01185340|451473913|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
125503194|NCT01185340|451473910|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
125503195|NCT01185340|451473911|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
125503196|NCT01185340|451473912|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
125503197|NCT01185340|451473913|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
125503198|NCT01185340|451473910|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
125503199|NCT01185340|451473911|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
125503200|NCT01185340|451473912|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
125503201|NCT01185340|451473913|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
125503202|NCT01185340|451473910|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
125503203|NCT01185340|451473911|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
125503204|NCT01185340|451473912|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
125503205|NCT01185340|451473913|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
125503206|NCT01185340|451473910|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
125503207|NCT01185340|451473911|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
125503208|NCT01185340|451473912|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
125503209|NCT01185340|451473913|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
125503210|NCT01185340|451473910|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
125503211|NCT01185340|451473911|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
125503212|NCT01185340|451473912|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
125503213|NCT01185340|451473913|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
125503214|NCT01185340|451473910|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
125503215|NCT01185340|451473911|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
125503216|NCT01185340|451473912|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
125503217|NCT01185340|451473913|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
125503218|NCT00087516|451473914|FG000|Overall Study|Adverse Event|10|||
125503219|NCT00087516|451473915|FG001|Overall Study|Adverse Event|10|||
125503220|NCT00087516|451473916|FG002|Overall Study|Adverse Event|3|||
125503221|NCT00087516|451473917|FG003|Overall Study|Adverse Event|6|||
125304994|NCT04405076|450742827|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
125304995|NCT04405076|450742828|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
125304996|NCT04405076|450742820|FG000|Part A (Blinded Phase)|Physician Decision|1|||
125304997|NCT04405076|450742821|FG001|Part A (Blinded Phase)|Physician Decision|2|||
125304998|NCT04405076|450742822|FG002|Part A (Blinded Phase)|Physician Decision|0|||
125304999|NCT04405076|450742823|FG003|Part A (Blinded Phase)|Physician Decision|0|||
125503222|NCT00087516|451473914|FG000|Overall Study|Lack of Efficacy|82|||
125503223|NCT00087516|451473915|FG001|Overall Study|Lack of Efficacy|80|||
125503224|NCT00087516|451473916|FG002|Overall Study|Lack of Efficacy|39|||
125305000|NCT04405076|450742824|FG004|Part A (Blinded Phase)|Physician Decision|0|||
125305001|NCT04405076|450742825|FG005|Part A (Blinded Phase)|Physician Decision|0|||
125503225|NCT00087516|451473917|FG003|Overall Study|Lack of Efficacy|29|||
125503226|NCT00087516|451473914|FG000|Overall Study|Lost to Follow-up|8|||
125503227|NCT00087516|451473915|FG001|Overall Study|Lost to Follow-up|6|||
125503228|NCT00087516|451473916|FG002|Overall Study|Lost to Follow-up|5|||
125503229|NCT00087516|451473917|FG003|Overall Study|Lost to Follow-up|5|||
125503230|NCT00087516|451473914|FG000|Overall Study|Protocol Violation|4|||
125503231|NCT00087516|451473915|FG001|Overall Study|Protocol Violation|8|||
125503232|NCT00087516|451473916|FG002|Overall Study|Protocol Violation|3|||
125503233|NCT00087516|451473917|FG003|Overall Study|Protocol Violation|6|||
125503234|NCT00087516|451473914|FG000|Overall Study|Withdrawal by Subject|16|||
125503235|NCT00087516|451473915|FG001|Overall Study|Withdrawal by Subject|27|||
125503236|NCT00087516|451473916|FG002|Overall Study|Withdrawal by Subject|11|||
125503237|NCT00087516|451473917|FG003|Overall Study|Withdrawal by Subject|12|||
125503238|NCT00087516|451473914|FG000|Overall Study|Site terminated|0|||
125503239|NCT00087516|451473915|FG001|Overall Study|Site terminated|2|||
125503240|NCT00087516|451473916|FG002|Overall Study|Site terminated|1|||
125503241|NCT00087516|451473917|FG003|Overall Study|Site terminated|0|||
125503242|NCT00087516|451473914|FG000|Overall Study|Protocol specified discontinuation|35|||
125503243|NCT00087516|451473915|FG001|Overall Study|Protocol specified discontinuation|33|||
125503244|NCT00087516|451473916|FG002|Overall Study|Protocol specified discontinuation|33|||
125503245|NCT00087516|451473917|FG003|Overall Study|Protocol specified discontinuation|26|||
125503246|NCT00087516|451473914|FG000|Overall Study|Patient moved|3|||
125503247|NCT00087516|451473915|FG001|Overall Study|Patient moved|2|||
125503248|NCT00087516|451473916|FG002|Overall Study|Patient moved|1|||
125503249|NCT00087516|451473917|FG003|Overall Study|Patient moved|0|||
125503250|NCT00087516|451473914|FG000|Overall Study|Patient was non-compliant|3|||
125503251|NCT00087516|451473915|FG001|Overall Study|Patient was non-compliant|1|||
125503252|NCT00087516|451473916|FG002|Overall Study|Patient was non-compliant|0|||
125503253|NCT00087516|451473917|FG003|Overall Study|Patient was non-compliant|0|||
125503254|NCT00087516|451473914|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
125503255|NCT00087516|451473915|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
125503256|NCT00087516|451473916|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
125503257|NCT00087516|451473917|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
125503258|NCT00087516|451473914|FG000|Overall Study|Other|0|||
125503259|NCT00087516|451473915|FG001|Overall Study|Other|0|||
125503260|NCT00087516|451473916|FG002|Overall Study|Other|1|||
125503261|NCT00087516|451473917|FG003|Overall Study|Other|0|||
125503262|NCT02065895|451473918|FG000|Overall Study|Protocol Violation|1|||
125503263|NCT02065895|451473919|FG001|Overall Study|Protocol Violation|0|||
125503264|NCT02065895|451473920|FG002|Overall Study|Protocol Violation|0|||
125503265|NCT02065895|451473921|FG003|Overall Study|Protocol Violation|1|||
125503266|NCT02065895|451473922|FG004|Overall Study|Protocol Violation|0|||
125503267|NCT02065895|451473923|FG005|Overall Study|Protocol Violation|0|||
125503268|NCT02065895|451473918|FG000|Overall Study|Scheduling conflicts|0|||
125503269|NCT02065895|451473919|FG001|Overall Study|Scheduling conflicts|1|||
125503270|NCT02065895|451473920|FG002|Overall Study|Scheduling conflicts|0|||
125503271|NCT02065895|451473921|FG003|Overall Study|Scheduling conflicts|0|||
125503272|NCT02065895|451473922|FG004|Overall Study|Scheduling conflicts|0|||
125503273|NCT02065895|451473923|FG005|Overall Study|Scheduling conflicts|0|||
125503274|NCT00569166|451473928|FG000|Overall Study|Withdrawal by Subject|7|||
125503275|NCT00569166|451473929|FG001|Overall Study|Withdrawal by Subject|5|||
125503276|NCT00569166|451473930|FG002|Overall Study|Withdrawal by Subject|3|||
125503277|NCT00569166|451473928|FG000|Overall Study|Lost to Follow-up|2|||
125503278|NCT00569166|451473929|FG001|Overall Study|Lost to Follow-up|1|||
125503279|NCT00569166|451473930|FG002|Overall Study|Lost to Follow-up|1|||
125503280|NCT05005247|451473931|FG000|Overall Study|Withdrawal by Subject|0|||
125503281|NCT05005247|451473932|FG001|Overall Study|Withdrawal by Subject|1|||
125503282|NCT05005247|451473933|FG002|Overall Study|Withdrawal by Subject|0|||
125503283|NCT00484198|451473934|FG000|Overall Study|Participant Withdrew Consent|12|||
125503284|NCT00484198|451473935|FG001|Overall Study|Participant Withdrew Consent|21|||
125503285|NCT00484198|451473936|FG002|Overall Study|Participant Withdrew Consent|47|||
125503286|NCT00484198|451473937|FG003|Overall Study|Participant Withdrew Consent|59|||
125503287|NCT00484198|451473934|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
125503288|NCT00484198|451473935|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
125503289|NCT00484198|451473936|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
125503290|NCT00484198|451473937|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
125503291|NCT00484198|451473934|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
125503292|NCT00484198|451473935|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
125503293|NCT00484198|451473936|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
125503294|NCT00484198|451473937|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
125503295|NCT00484198|451473934|FG000|Overall Study|Adverse Event|3|||
125503296|NCT00484198|451473935|FG001|Overall Study|Adverse Event|11|||
125503297|NCT00484198|451473936|FG002|Overall Study|Adverse Event|32|||
125503298|NCT00484198|451473937|FG003|Overall Study|Adverse Event|31|||
125503299|NCT00484198|451473934|FG000|Overall Study|Protocol Violation|0|||
125503300|NCT00484198|451473935|FG001|Overall Study|Protocol Violation|5|||
125503301|NCT00484198|451473936|FG002|Overall Study|Protocol Violation|6|||
125503302|NCT00484198|451473937|FG003|Overall Study|Protocol Violation|8|||
125503303|NCT00484198|451473934|FG000|Overall Study|Other|7|||
125503304|NCT00484198|451473935|FG001|Overall Study|Other|10|||
125503305|NCT00484198|451473936|FG002|Overall Study|Other|31|||
125503306|NCT00484198|451473937|FG003|Overall Study|Other|28|||
125503307|NCT00486954|451473939|FG000|Pilot Part|Adverse Event|4|||
125503308|NCT00486954|451473940|FG001|Pilot Part|Adverse Event|0|||
125503309|NCT00486954|451473941|FG002|Pilot Part|Adverse Event|5|||
125503310|NCT00486954|451473942|FG003|Pilot Part|Adverse Event|0|||
125503311|NCT00486954|451473943|FG004|Pilot Part|Adverse Event|0|||
125503312|NCT00486954|451473939|FG000|Pilot Part|Disease Progression|2|||
125503313|NCT00486954|451473940|FG001|Pilot Part|Disease Progression|0|||
125503314|NCT00486954|451473941|FG002|Pilot Part|Disease Progression|1|||
125503315|NCT00486954|451473942|FG003|Pilot Part|Disease Progression|0|||
125503316|NCT00486954|451473943|FG004|Pilot Part|Disease Progression|0|||
125503317|NCT00486954|451473939|FG000|Randomized Part|Lost to Follow-up|0|||
125503318|NCT00486954|451473940|FG001|Randomized Part|Lost to Follow-up|0|||
125503319|NCT00486954|451473941|FG002|Randomized Part|Lost to Follow-up|0|||
125503320|NCT00486954|451473942|FG003|Randomized Part|Lost to Follow-up|0|||
125503321|NCT00486954|451473943|FG004|Randomized Part|Lost to Follow-up|1|||
125503322|NCT00486954|451473939|FG000|Randomized Part|Withdrawal by Subject|0|||
125503323|NCT00486954|451473940|FG001|Randomized Part|Withdrawal by Subject|0|||
125503324|NCT00486954|451473941|FG002|Randomized Part|Withdrawal by Subject|0|||
125503325|NCT00486954|451473942|FG003|Randomized Part|Withdrawal by Subject|1|||
125503326|NCT00486954|451473943|FG004|Randomized Part|Withdrawal by Subject|0|||
125503327|NCT00486954|451473939|FG000|Randomized Part|Sponsor Terminated Study|0|||
125503328|NCT00486954|451473940|FG001|Randomized Part|Sponsor Terminated Study|0|||
125503329|NCT00486954|451473941|FG002|Randomized Part|Sponsor Terminated Study|0|||
125503330|NCT00486954|451473942|FG003|Randomized Part|Sponsor Terminated Study|19|||
125503331|NCT00486954|451473943|FG004|Randomized Part|Sponsor Terminated Study|13|||
125503332|NCT00929526|451473944|FG000|Overall Study|Withdrawal by Subject|1|||
125503333|NCT00929526|451473945|FG001|Overall Study|Withdrawal by Subject|11|||
125503334|NCT00929526|451473944|FG000|Overall Study|Lost to Follow-up|8|||
125503335|NCT00929526|451473945|FG001|Overall Study|Lost to Follow-up|12|||
125503336|NCT00929526|451473944|FG000|Overall Study|Other|8|||
125503337|NCT00929526|451473945|FG001|Overall Study|Other|6|||
125503338|NCT01836523|451473946|FG000|Overall Study|Adverse Event|15|||
125503339|NCT01836523|451473947|FG001|Overall Study|Adverse Event|41|||
125503340|NCT01836523|451473948|FG002|Overall Study|Adverse Event|49|||
125503341|NCT01836523|451473949|FG003|Overall Study|Adverse Event|14|||
125503342|NCT01836523|451473946|FG000|Overall Study|Protocol Violation|6|||
125503343|NCT01836523|451473947|FG001|Overall Study|Protocol Violation|3|||
125503344|NCT01836523|451473948|FG002|Overall Study|Protocol Violation|2|||
125503345|NCT01836523|451473949|FG003|Overall Study|Protocol Violation|4|||
125503346|NCT01836523|451473946|FG000|Overall Study|Met Withdrawal Criteria|13|||
125503347|NCT01836523|451473947|FG001|Overall Study|Met Withdrawal Criteria|13|||
125503348|NCT01836523|451473948|FG002|Overall Study|Met Withdrawal Criteria|21|||
125503349|NCT01836523|451473949|FG003|Overall Study|Met Withdrawal Criteria|27|||
125503350|NCT01836523|451473946|FG000|Overall Study|Unclassified|17|||
125503351|NCT01836523|451473947|FG001|Overall Study|Unclassified|28|||
125503352|NCT01836523|451473948|FG002|Overall Study|Unclassified|19|||
125503353|NCT01836523|451473949|FG003|Overall Study|Unclassified|29|||
125503354|NCT00813709|451473952|FG000|Double Blind Period|Adverse Event|4|||
125503355|NCT00813709|451473953|FG001|Double Blind Period|Adverse Event|1|||
125503356|NCT00813709|451473954|FG002|Double Blind Period|Adverse Event|4|||
125503357|NCT00813709|451473955|FG003|Double Blind Period|Adverse Event|0|||
125503358|NCT00813709|451473956|FG004|Double Blind Period|Adverse Event|0|||
125503359|NCT00813709|451473957|FG005|Double Blind Period|Adverse Event|0|||
125503360|NCT00813709|451473952|FG000|Double Blind Period|Lost to Follow-up|3|||
125503361|NCT00813709|451473953|FG001|Double Blind Period|Lost to Follow-up|2|||
125503362|NCT00813709|451473954|FG002|Double Blind Period|Lost to Follow-up|2|||
125503363|NCT00813709|451473955|FG003|Double Blind Period|Lost to Follow-up|0|||
125503364|NCT00813709|451473956|FG004|Double Blind Period|Lost to Follow-up|0|||
125503365|NCT00813709|451473957|FG005|Double Blind Period|Lost to Follow-up|0|||
125503366|NCT00813709|451473952|FG000|Double Blind Period|Switched to open label phase|9|||
125503367|NCT00813709|451473953|FG001|Double Blind Period|Switched to open label phase|26|||
125503368|NCT00813709|451473954|FG002|Double Blind Period|Switched to open label phase|18|||
125503369|NCT00813709|451473955|FG003|Double Blind Period|Switched to open label phase|0|||
125503370|NCT00813709|451473956|FG004|Double Blind Period|Switched to open label phase|0|||
125503371|NCT00813709|451473957|FG005|Double Blind Period|Switched to open label phase|0|||
125503372|NCT00813709|451473952|FG000|Double Blind Period|Randomized but not treated|1|||
125503373|NCT00813709|451473953|FG001|Double Blind Period|Randomized but not treated|3|||
125503374|NCT00813709|451473954|FG002|Double Blind Period|Randomized but not treated|1|||
125503375|NCT00813709|451473955|FG003|Double Blind Period|Randomized but not treated|0|||
125503376|NCT00813709|451473956|FG004|Double Blind Period|Randomized but not treated|0|||
125503377|NCT00813709|451473957|FG005|Double Blind Period|Randomized but not treated|0|||
125503378|NCT00813709|451473952|FG000|Double Blind Period|Other|14|||
125503379|NCT00813709|451473953|FG001|Double Blind Period|Other|9|||
125503380|NCT00813709|451473954|FG002|Double Blind Period|Other|6|||
125503381|NCT00813709|451473955|FG003|Double Blind Period|Other|0|||
125503382|NCT00813709|451473956|FG004|Double Blind Period|Other|0|||
125503383|NCT00813709|451473957|FG005|Double Blind Period|Other|0|||
125503384|NCT00813709|451473952|FG000|Open Label Period|Adverse Event|0|||
125503385|NCT00813709|451473953|FG001|Open Label Period|Adverse Event|0|||
125503386|NCT00813709|451473954|FG002|Open Label Period|Adverse Event|0|||
125503387|NCT00813709|451473955|FG003|Open Label Period|Adverse Event|5|||
125503388|NCT00813709|451473956|FG004|Open Label Period|Adverse Event|4|||
125503389|NCT00813709|451473957|FG005|Open Label Period|Adverse Event|3|||
125503390|NCT00813709|451473952|FG000|Open Label Period|Lack of Efficacy|0|||
125503391|NCT00813709|451473953|FG001|Open Label Period|Lack of Efficacy|0|||
125503392|NCT00813709|451473954|FG002|Open Label Period|Lack of Efficacy|0|||
125503393|NCT00813709|451473955|FG003|Open Label Period|Lack of Efficacy|3|||
125503394|NCT00813709|451473956|FG004|Open Label Period|Lack of Efficacy|1|||
125503395|NCT00813709|451473957|FG005|Open Label Period|Lack of Efficacy|1|||
125503396|NCT00813709|451473952|FG000|Open Label Period|Randomized but not treated|0|||
125503397|NCT00813709|451473953|FG001|Open Label Period|Randomized but not treated|0|||
125503398|NCT00813709|451473954|FG002|Open Label Period|Randomized but not treated|0|||
125503399|NCT00813709|451473955|FG003|Open Label Period|Randomized but not treated|1|||
125503400|NCT00813709|451473956|FG004|Open Label Period|Randomized but not treated|0|||
125503401|NCT00813709|451473957|FG005|Open Label Period|Randomized but not treated|1|||
125503402|NCT00813709|451473952|FG000|Open Label Period|Other|0|||
125503403|NCT00813709|451473953|FG001|Open Label Period|Other|0|||
125503404|NCT00813709|451473954|FG002|Open Label Period|Other|0|||
125503405|NCT00813709|451473955|FG003|Open Label Period|Other|11|||
125503406|NCT00813709|451473956|FG004|Open Label Period|Other|5|||
125503407|NCT00813709|451473957|FG005|Open Label Period|Other|6|||
125503408|NCT02753075|451473958|FG000|Overall Study|Adverse Event|2|||
125503409|NCT02753075|451473959|FG001|Overall Study|Adverse Event|1|||
125503410|NCT02753075|451473960|FG002|Overall Study|Adverse Event|0|||
125503411|NCT02753075|451473958|FG000|Overall Study|Lost to Follow-up|2|||
125503412|NCT02753075|451473959|FG001|Overall Study|Lost to Follow-up|0|||
125503413|NCT02753075|451473960|FG002|Overall Study|Lost to Follow-up|0|||
125503414|NCT02753075|451473958|FG000|Overall Study|Withdrawal of Consent|1|||
125503415|NCT02753075|451473959|FG001|Overall Study|Withdrawal of Consent|1|||
125503416|NCT02753075|451473960|FG002|Overall Study|Withdrawal of Consent|3|||
125503417|NCT02753075|451473958|FG000|Overall Study|Physician Decision|3|||
125503418|NCT02753075|451473959|FG001|Overall Study|Physician Decision|1|||
125503419|NCT02753075|451473960|FG002|Overall Study|Physician Decision|0|||
125503420|NCT02245620|451473961|FG000|Overall Study|Physician Decision|1|||
125503421|NCT02245620|451473962|FG001|Overall Study|Physician Decision|1|||
125503422|NCT01102426|451473963|FG000|Overall Study|Randomized but not treated|4|||
125503423|NCT01102426|451473964|FG001|Overall Study|Randomized but not treated|1|||
125503424|NCT01102426|451473963|FG000|Overall Study|Adverse Events (treatment-related)|15|||
125503425|NCT01102426|451473964|FG001|Overall Study|Adverse Events (treatment-related)|8|||
125503426|NCT01102426|451473963|FG000|Overall Study|Physician Decision|9|||
125503427|NCT01102426|451473964|FG001|Overall Study|Physician Decision|6|||
125503428|NCT01102426|451473963|FG000|Overall Study|Progressive Disease|85|||
125503429|NCT01102426|451473964|FG001|Overall Study|Progressive Disease|44|||
125503430|NCT01102426|451473963|FG000|Overall Study|Adverse Events (unrelated to|9|||
125503431|NCT01102426|451473964|FG001|Overall Study|Adverse Events (unrelated to|1|||
125503432|NCT01102426|451473963|FG000|Overall Study|Patient Refusal|24|||
125503433|NCT01102426|451473964|FG001|Overall Study|Patient Refusal|12|||
125503434|NCT01102426|451473963|FG000|Overall Study|Death (due to adverse events|0|||
125503435|NCT01102426|451473964|FG001|Overall Study|Death (due to adverse events|1|||
125503436|NCT01102426|451473963|FG000|Overall Study|Death (non-related to the study|19|||
125503437|NCT01102426|451473964|FG001|Overall Study|Death (non-related to the study|8|||
125503438|NCT00889863|451473965|FG000|Part I: Open Label|Death|1|||
125503439|NCT00889863|451473966|FG001|Part I: Open Label|Death|0|||
125503440|NCT00889863|451473965|FG000|Part I: Open Label|Adverse Event|4|||
125503441|NCT00889863|451473966|FG001|Part I: Open Label|Adverse Event|0|||
125503442|NCT00889863|451473965|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
125503443|NCT00889863|451473966|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
125503444|NCT00889863|451473965|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
125503445|NCT00889863|451473966|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
125503446|NCT00889863|451473965|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
125503447|NCT00889863|451473966|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
125503448|NCT00889863|451473965|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
125503449|NCT00889863|451473966|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
125503450|NCT00889863|451473965|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
125503451|NCT00889863|451473966|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
125503452|NCT00930644|451473967|FG000|Overall Study|Withdrawal by Subject|4|||
125503453|NCT00930644|451473967|FG000|Overall Study|Physician Decision|2|||
125503454|NCT00930644|451473967|FG000|Overall Study|Death|1|||
125503455|NCT00930644|451473967|FG000|Overall Study|Adverse Event|16|||
125503456|NCT04361617|451473968|FG000|Overall Study|Withdrawal by Subject|0|||
125503457|NCT04361617|451473969|FG001|Overall Study|Withdrawal by Subject|1|||
125503458|NCT01918033|451473971|FG000|Overall Study|Adverse Event|1|||
125503459|NCT01918033|451473972|FG001|Overall Study|Adverse Event|0|||
125503460|NCT01918033|451473973|FG002|Overall Study|Adverse Event|2|||
125503461|NCT01918033|451473971|FG000|Overall Study|Lost to Follow-up|0|||
125503462|NCT01918033|451473972|FG001|Overall Study|Lost to Follow-up|1|||
125503463|NCT01918033|451473973|FG002|Overall Study|Lost to Follow-up|0|||
125503464|NCT01918033|451473971|FG000|Overall Study|Protocol Violation|2|||
125503465|NCT01918033|451473972|FG001|Overall Study|Protocol Violation|0|||
125503466|NCT01918033|451473973|FG002|Overall Study|Protocol Violation|1|||
125503467|NCT01918033|451473971|FG000|Overall Study|Withdrawal by Subject|2|||
125503468|NCT01918033|451473972|FG001|Overall Study|Withdrawal by Subject|1|||
125503469|NCT01918033|451473973|FG002|Overall Study|Withdrawal by Subject|0|||
125503470|NCT03259568|451473981|FG000|Overall Study|Participant performance was low|3|||
125503471|NCT03006393|451473982|FG000|Overall Study|Withdrawal by Subject|1|||
125503472|NCT03006393|451473983|FG001|Overall Study|Withdrawal by Subject|1|||
125503473|NCT03006393|451473982|FG000|Overall Study|Pregnancy|0|||
125503474|NCT03006393|451473983|FG001|Overall Study|Pregnancy|1|||
125503475|NCT03006393|451473982|FG000|Overall Study|Lost to Follow-up|0|||
125503476|NCT03006393|451473983|FG001|Overall Study|Lost to Follow-up|1|||
125503477|NCT03136861|451473984|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
125503478|NCT03136861|451473985|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
125503479|NCT03136861|451473986|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
125503480|NCT03136861|451473987|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
125503481|NCT03136861|451473988|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
125503482|NCT03136861|451473989|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
125503483|NCT03136861|451473990|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
125503484|NCT03136861|451473984|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
125503485|NCT03136861|451473985|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
125503486|NCT03136861|451473986|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
125503487|NCT03136861|451473987|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
125503488|NCT03136861|451473988|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
125503489|NCT03136861|451473989|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
125503490|NCT03136861|451473990|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
125503491|NCT03136861|451473984|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
125503492|NCT03136861|451473985|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
125503493|NCT03136861|451473986|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
125503494|NCT03136861|451473987|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
125503495|NCT03136861|451473988|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
125503496|NCT03136861|451473989|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
125503497|NCT03136861|451473990|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
125503498|NCT03136861|451473984|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
125503499|NCT03136861|451473985|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
125503500|NCT03136861|451473986|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
125503501|NCT03136861|451473987|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
125503502|NCT03136861|451473988|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
125503503|NCT03136861|451473989|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
125503504|NCT03136861|451473990|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
125503505|NCT03136861|451473984|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
125503506|NCT03136861|451473985|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
125503507|NCT03136861|451473986|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
125503508|NCT03136861|451473987|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
125503509|NCT03136861|451473988|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
125503510|NCT03136861|451473989|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
125503511|NCT03136861|451473990|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
125503512|NCT03136861|451473984|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
125503513|NCT03136861|451473985|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
125503514|NCT03136861|451473986|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
125503515|NCT03136861|451473987|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
125503516|NCT03136861|451473988|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
125503517|NCT03136861|451473989|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
125503518|NCT03136861|451473990|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
125503519|NCT03136861|451473984|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
125503520|NCT03136861|451473985|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
125305002|NCT04405076|450742826|FG006|Part A (Blinded Phase)|Physician Decision|0|||
125503521|NCT03136861|451473986|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
125503522|NCT03136861|451473987|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
125503523|NCT03136861|451473988|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
125503524|NCT03136861|451473989|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
125503525|NCT03136861|451473990|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
125503526|NCT03136861|451473984|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
125503527|NCT03136861|451473985|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
125503528|NCT03136861|451473986|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
125503529|NCT03136861|451473987|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
125503530|NCT03136861|451473988|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
125503531|NCT03136861|451473989|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
125503532|NCT03136861|451473990|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
125503533|NCT01584648|451473991|FG000|Overall Study|Death|136|||
125503534|NCT01584648|451473992|FG001|Overall Study|Death|146|||
125503535|NCT01584648|451473991|FG000|Overall Study|Lost to Follow-up|9|||
125503536|NCT01584648|451473992|FG001|Overall Study|Lost to Follow-up|9|||
125503537|NCT01584648|451473991|FG000|Overall Study|Investigator discretion|3|||
125503538|NCT01584648|451473992|FG001|Overall Study|Investigator discretion|2|||
125503539|NCT01584648|451473991|FG000|Overall Study|Withdrew consent|13|||
125503540|NCT01584648|451473992|FG001|Overall Study|Withdrew consent|4|||
125503541|NCT01584648|451473991|FG000|Overall Study|Study closed/terminated|50|||
125503542|NCT01584648|451473992|FG001|Overall Study|Study closed/terminated|23|||
125503543|NCT01584648|451473991|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
125503544|NCT01584648|451473992|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
125503545|NCT01328756|451473993|FG000|Overall Study|Protocol Violation|4|||
125503546|NCT01328756|451473993|FG000|Overall Study|Adverse Event|39|||
125503547|NCT01328756|451473993|FG000|Overall Study|Lack of Efficacy|5|||
125503548|NCT01328756|451473993|FG000|Overall Study|Withdrawal by Subject|41|||
125503549|NCT01328756|451473993|FG000|Overall Study|Lost to Follow-up|5|||
125503550|NCT01328756|451473993|FG000|Overall Study|Other|29|||
125503551|NCT03200574|451474009|FG000|Overall Study|Death|4|||
125503552|NCT03200574|451474009|FG000|Overall Study|Withdrawal by Subject|8|||
125503553|NCT03200574|451474009|FG000|Overall Study|Long-Term need for anticoagulation|1|||
125503554|NCT03200574|451474009|FG000|Overall Study|Relocation|2|||
125503555|NCT03200574|451474009|FG000|Overall Study|Lost to Follow-up|2|||
125503556|NCT04183491|451474010|FG000|Overall Study|Withdrawal by Subject|0|||
125503557|NCT04183491|451474011|FG001|Overall Study|Withdrawal by Subject|0|||
125503558|NCT04183491|451474012|FG002|Overall Study|Withdrawal by Subject|1|||
125503559|NCT04183491|451474013|FG003|Overall Study|Withdrawal by Subject|0|||
125503560|NCT04183491|451474014|FG004|Overall Study|Withdrawal by Subject|0|||
125503561|NCT04183491|451474015|FG005|Overall Study|Withdrawal by Subject|1|||
125503562|NCT04183491|451474016|FG006|Overall Study|Withdrawal by Subject|0|||
125305003|NCT04405076|450742827|FG007|Part A (Blinded Phase)|Physician Decision|0|||
125305004|NCT04405076|450742828|FG008|Part A (Blinded Phase)|Physician Decision|0|||
125305005|NCT04405076|450742820|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
125305006|NCT04405076|450742821|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
125305007|NCT04405076|450742822|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
125305008|NCT04405076|450742823|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
125305009|NCT04405076|450742824|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
125305010|NCT04405076|450742825|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
125305011|NCT04405076|450742826|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
125305012|NCT04405076|450742827|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
125305013|NCT04405076|450742828|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
125305014|NCT04405076|450742820|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
125305015|NCT04405076|450742821|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305016|NCT04405076|450742822|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305017|NCT04405076|450742823|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305018|NCT04405076|450742824|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305019|NCT04405076|450742825|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305020|NCT04405076|450742826|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305021|NCT04405076|450742827|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305022|NCT04405076|450742828|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
125305023|NCT04405076|450742820|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
125305024|NCT04405076|450742821|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
125305025|NCT04405076|450742822|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
125305026|NCT04405076|450742823|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
125305027|NCT04405076|450742824|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
125305028|NCT04405076|450742825|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
125305029|NCT04405076|450742826|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
125503563|NCT01262456|451474017|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
125503564|NCT01262456|451474018|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
125503565|NCT01262456|451474019|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
125503566|NCT01262456|451474017|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
125503567|NCT01262456|451474018|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
125503568|NCT01262456|451474019|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
125503569|NCT01262456|451474017|FG000|3-Month Double-Blind Period|Adverse Event|6|||
125503570|NCT01262456|451474018|FG001|3-Month Double-Blind Period|Adverse Event|4|||
125503571|NCT01262456|451474019|FG002|3-Month Double-Blind Period|Adverse Event|8|||
125503572|NCT01262456|451474017|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
125503573|NCT01262456|451474018|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
125503574|NCT01262456|451474019|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
125503575|NCT01262456|451474017|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
125503576|NCT01262456|451474018|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
125503577|NCT01262456|451474019|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
125503578|NCT01262456|451474017|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
125503579|NCT01262456|451474018|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
125503580|NCT01262456|451474019|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
125503581|NCT01262456|451474017|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
125503582|NCT01262456|451474018|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
125503583|NCT01262456|451474019|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
125503584|NCT01262456|451474017|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
125503585|NCT01262456|451474018|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
125503586|NCT01262456|451474019|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
125503587|NCT01262456|451474017|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
125503588|NCT01262456|451474018|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
125503589|NCT01262456|451474019|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
125503590|NCT02538094|451474020|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
125503591|NCT02538094|451474021|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
125503592|NCT02538094|451474020|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
125503593|NCT02538094|451474021|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
125503594|NCT01528605|451474030|FG000|Overall Study|Lost to Follow-up|1|||
125503595|NCT01528605|451474031|FG001|Overall Study|Lost to Follow-up|0|||
125503596|NCT01528605|451474032|FG002|Overall Study|Lost to Follow-up|1|||
125503597|NCT01528605|451474033|FG003|Overall Study|Lost to Follow-up|1|||
125503598|NCT01528605|451474034|FG004|Overall Study|Lost to Follow-up|0|||
125503599|NCT01528605|451474035|FG005|Overall Study|Lost to Follow-up|0|||
125503600|NCT01528605|451474030|FG000|Overall Study|Death|1|||
125503601|NCT01528605|451474031|FG001|Overall Study|Death|0|||
125503602|NCT01528605|451474032|FG002|Overall Study|Death|0|||
125503603|NCT01528605|451474033|FG003|Overall Study|Death|0|||
125503604|NCT01528605|451474034|FG004|Overall Study|Death|0|||
125503605|NCT01528605|451474035|FG005|Overall Study|Death|0|||
125503606|NCT01156675|451474036|FG000|Overall Study|Death|5|||
125503607|NCT01156675|451474037|FG001|Overall Study|Death|3|||
125503608|NCT01156675|451474038|FG002|Overall Study|Death|0|||
125503609|NCT01156675|451474036|FG000|Overall Study|No data|29|||
125503610|NCT01156675|451474037|FG001|Overall Study|No data|22|||
125503611|NCT01156675|451474038|FG002|Overall Study|No data|2|||
125503612|NCT02326220|451474039|FG000|Double-blind Treatment Period|Adverse Event|1|||
125503613|NCT02326220|451474040|FG001|Double-blind Treatment Period|Adverse Event|2|||
125503614|NCT02326220|451474041|FG002|Double-blind Treatment Period|Adverse Event|0|||
125503615|NCT02326220|451474039|FG000|Double-blind Treatment Period|Protocol Violation|0|||
125503616|NCT02326220|451474040|FG001|Double-blind Treatment Period|Protocol Violation|1|||
125503617|NCT02326220|451474041|FG002|Double-blind Treatment Period|Protocol Violation|0|||
125503618|NCT02326220|451474039|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
125503619|NCT02326220|451474040|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
125503620|NCT02326220|451474041|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125503621|NCT02326220|451474039|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
125503622|NCT02326220|451474040|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
125503623|NCT02326220|451474041|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
125503624|NCT02326220|451474039|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
125503625|NCT02326220|451474040|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
125503626|NCT02326220|451474041|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
125503627|NCT02699099|451474042|FG000|Overall Study|Adverse Event|1|||
125503628|NCT02699099|451474043|FG001|Overall Study|Adverse Event|0|||
125503629|NCT02699099|451474044|FG002|Overall Study|Adverse Event|2|||
125503630|NCT02699099|451474042|FG000|Overall Study|Lost to Follow-up|0|||
125503631|NCT02699099|451474043|FG001|Overall Study|Lost to Follow-up|1|||
125503632|NCT02699099|451474044|FG002|Overall Study|Lost to Follow-up|0|||
125503633|NCT02699099|451474042|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
125503634|NCT02699099|451474043|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
125503635|NCT02699099|451474044|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
125503636|NCT03659136|451474050|FG000|Overall Study|Not treated|2|||
125503637|NCT03659136|451474051|FG001|Overall Study|Not treated|0|||
125503638|NCT03659136|451474050|FG000|Overall Study|Covid-19 related|1|||
125503639|NCT03659136|451474051|FG001|Overall Study|Covid-19 related|1|||
125503640|NCT03659136|451474050|FG000|Overall Study|Withdrawal by Subject|1|||
125503641|NCT03659136|451474051|FG001|Overall Study|Withdrawal by Subject|6|||
125503642|NCT03659136|451474050|FG000|Overall Study|Adverse Event|4|||
125503643|NCT03659136|451474051|FG001|Overall Study|Adverse Event|6|||
125503644|NCT03659136|451474050|FG000|Overall Study|Progressive disease|37|||
125503645|NCT03659136|451474051|FG001|Overall Study|Progressive disease|31|||
125503646|NCT03659136|451474050|FG000|Overall Study|Study closure|2|||
125503647|NCT03659136|451474051|FG001|Overall Study|Study closure|2|||
125503648|NCT03659136|451474050|FG000|Overall Study|Sponsor decision/recommendation|3|||
125503649|NCT03659136|451474051|FG001|Overall Study|Sponsor decision/recommendation|2|||
125503650|NCT03659136|451474050|FG000|Overall Study|Switched to other drug/therapy|2|||
125503651|NCT03659136|451474051|FG001|Overall Study|Switched to other drug/therapy|2|||
125503652|NCT03659136|451474050|FG000|Overall Study|Lack of clinical benefit|0|||
125503653|NCT03659136|451474051|FG001|Overall Study|Lack of clinical benefit|1|||
125503654|NCT00647699|451475852|FG000|Overall Study|Lost to Follow-up|5|||
125503655|NCT00647699|451475853|FG001|Overall Study|Lost to Follow-up|4|||
125503656|NCT00647699|451475852|FG000|Overall Study|Withdrawal by Subject|3|||
125503657|NCT00647699|451475853|FG001|Overall Study|Withdrawal by Subject|8|||
125503658|NCT00413283|451475854|FG000|Overall Study|Withdrawal by Subject|1|||
125503659|NCT00413283|451475855|FG001|Overall Study|Withdrawal by Subject|0|||
125503660|NCT00413283|451475856|FG002|Overall Study|Withdrawal by Subject|0|||
125503661|NCT00413283|451475857|FG003|Overall Study|Withdrawal by Subject|1|||
125503662|NCT00413283|451475854|FG000|Overall Study|Death|0|||
125503663|NCT00413283|451475855|FG001|Overall Study|Death|0|||
125503664|NCT00413283|451475856|FG002|Overall Study|Death|1|||
125503665|NCT00413283|451475857|FG003|Overall Study|Death|1|||
125503666|NCT00413283|451475854|FG000|Overall Study|Adverse Event|0|||
125503667|NCT00413283|451475855|FG001|Overall Study|Adverse Event|0|||
125503668|NCT00413283|451475856|FG002|Overall Study|Adverse Event|0|||
125503669|NCT00413283|451475857|FG003|Overall Study|Adverse Event|1|||
125503670|NCT00413283|451475854|FG000|Overall Study|Ineligibility determined|0|||
125503671|NCT00413283|451475855|FG001|Overall Study|Ineligibility determined|0|||
125503672|NCT00413283|451475856|FG002|Overall Study|Ineligibility determined|0|||
125503673|NCT00413283|451475857|FG003|Overall Study|Ineligibility determined|1|||
125503674|NCT00413283|451475854|FG000|Overall Study|Protocol deviation|0|||
125503675|NCT00413283|451475855|FG001|Overall Study|Protocol deviation|1|||
125503676|NCT00413283|451475856|FG002|Overall Study|Protocol deviation|0|||
125503677|NCT00413283|451475857|FG003|Overall Study|Protocol deviation|0|||
125503678|NCT00413283|451475854|FG000|Overall Study|Requirement for alternative therapy|0|||
125503679|NCT00413283|451475855|FG001|Overall Study|Requirement for alternative therapy|2|||
125503680|NCT00413283|451475856|FG002|Overall Study|Requirement for alternative therapy|0|||
125503681|NCT00413283|451475857|FG003|Overall Study|Requirement for alternative therapy|0|||
125503682|NCT00413283|451475854|FG000|Overall Study|Other|0|||
125503683|NCT00413283|451475855|FG001|Overall Study|Other|0|||
125503684|NCT00413283|451475856|FG002|Overall Study|Other|1|||
125503685|NCT00413283|451475857|FG003|Overall Study|Other|0|||
125503686|NCT02354417|451475858|FG000|Overall Study|Physician Decision|1|||
125503687|NCT00246129|451475859|FG000|Overall Study|Lost to Follow-up|1|||
125503688|NCT00246129|451475860|FG001|Overall Study|Lost to Follow-up|0|||
125503689|NCT00246129|451475859|FG000|Overall Study|Death|2|||
125503690|NCT00246129|451475860|FG001|Overall Study|Death|1|||
125503691|NCT00246129|451475859|FG000|Overall Study|suffered primary non-function|1|||
125503692|NCT00246129|451475860|FG001|Overall Study|suffered primary non-function|0|||
125503693|NCT00246129|451475859|FG000|Overall Study|grafts failed|3|||
125503694|NCT00246129|451475860|FG001|Overall Study|grafts failed|1|||
125503695|NCT03469258|451475861|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
125503696|NCT03340961|451475865|FG000|Overall Study|Adverse Event|1|||
125503697|NCT03340961|451475866|FG001|Overall Study|Adverse Event|3|||
125503698|NCT03340961|451475867|FG002|Overall Study|Adverse Event|2|||
125503699|NCT03340961|451475868|FG003|Overall Study|Adverse Event|4|||
125503700|NCT03340961|451475865|FG000|Overall Study|Lost to Follow-up|0|||
125503701|NCT03340961|451475866|FG001|Overall Study|Lost to Follow-up|1|||
125503702|NCT03340961|451475867|FG002|Overall Study|Lost to Follow-up|0|||
125503703|NCT03340961|451475868|FG003|Overall Study|Lost to Follow-up|1|||
125503704|NCT03340961|451475865|FG000|Overall Study|Withdrawal by Subject|3|||
125503705|NCT03340961|451475866|FG001|Overall Study|Withdrawal by Subject|2|||
125503706|NCT03340961|451475867|FG002|Overall Study|Withdrawal by Subject|4|||
125503707|NCT03340961|451475868|FG003|Overall Study|Withdrawal by Subject|7|||
125503708|NCT03340961|451475865|FG000|Overall Study|Use of prohibited treatment|0|||
125503709|NCT03340961|451475866|FG001|Overall Study|Use of prohibited treatment|3|||
125503710|NCT03340961|451475867|FG002|Overall Study|Use of prohibited treatment|2|||
125503711|NCT03340961|451475868|FG003|Overall Study|Use of prohibited treatment|4|||
125503712|NCT03340961|451475865|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
125503713|NCT03340961|451475866|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
125503714|NCT03340961|451475867|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
125503715|NCT03340961|451475868|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
125503716|NCT03340961|451475865|FG000|Overall Study|Subject developed an exclusion criterion|0|||
125503717|NCT03340961|451475866|FG001|Overall Study|Subject developed an exclusion criterion|1|||
125503718|NCT03340961|451475867|FG002|Overall Study|Subject developed an exclusion criterion|0|||
125503719|NCT03340961|451475868|FG003|Overall Study|Subject developed an exclusion criterion|0|||
125503720|NCT03340961|451475865|FG000|Overall Study|Protocol Violation|1|||
125503721|NCT03340961|451475866|FG001|Overall Study|Protocol Violation|0|||
125503722|NCT03340961|451475867|FG002|Overall Study|Protocol Violation|1|||
125503723|NCT03340961|451475868|FG003|Overall Study|Protocol Violation|0|||
125503724|NCT03340961|451475865|FG000|Overall Study|Adverse Event|1|||
125503725|NCT03340961|451475866|FG001|Overall Study|Adverse Event|1|||
125503726|NCT03340961|451475867|FG002|Overall Study|Adverse Event|0|||
125503727|NCT03340961|451475868|FG003|Overall Study|Adverse Event|0|||
125503728|NCT03340961|451475865|FG000|Overall Study|Lack of Efficacy|0|||
125503729|NCT03340961|451475866|FG001|Overall Study|Lack of Efficacy|0|||
125503730|NCT03340961|451475867|FG002|Overall Study|Lack of Efficacy|0|||
125503731|NCT03340961|451475868|FG003|Overall Study|Lack of Efficacy|1|||
125503732|NCT01853384|451475869|FG000|Randomized|Adverse Event|5|||
125503733|NCT01853384|451475870|FG001|Randomized|Adverse Event|3|||
125503734|NCT01853384|451475869|FG000|Randomized|Death|1|||
125503735|NCT01853384|451475870|FG001|Randomized|Death|2|||
125503736|NCT01853384|451475869|FG000|Randomized|Lost to Follow-up|1|||
125503737|NCT01853384|451475870|FG001|Randomized|Lost to Follow-up|1|||
125503738|NCT01853384|451475869|FG000|Randomized|Withdrawal by Subject|5|||
125503739|NCT01853384|451475870|FG001|Randomized|Withdrawal by Subject|3|||
125503740|NCT01853384|451475869|FG000|Randomized|Sponsor Decision|47|||
125503741|NCT01853384|451475870|FG001|Randomized|Sponsor Decision|34|||
125503742|NCT01853384|451475869|FG000|Randomized|Other|3|||
125503743|NCT01853384|451475870|FG001|Randomized|Other|3|||
125503744|NCT01853384|451475869|FG000|Completed Follow up Visit 1|Early Termination|13|||
125503745|NCT01853384|451475870|FG001|Completed Follow up Visit 1|Early Termination|9|||
125503746|NCT01853384|451475869|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
125503747|NCT01853384|451475870|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
125503748|NCT01853384|451475869|FG000|Completed Follow up Visit 2|Adverse Event|1|||
125503749|NCT01853384|451475870|FG001|Completed Follow up Visit 2|Adverse Event|0|||
125503750|NCT01853384|451475869|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
125503751|NCT01853384|451475870|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
125503752|NCT01853384|451475869|FG000|Completed Follow up Visit 2|Death|1|||
125503753|NCT01853384|451475870|FG001|Completed Follow up Visit 2|Death|0|||
125503754|NCT01853384|451475869|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
125503755|NCT01853384|451475870|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
125503756|NCT04311983|451475871|FG000|Overall Study|Lost to Follow-up|421|||
125503757|NCT04311983|451475872|FG001|Overall Study|Lost to Follow-up|456|||
125503758|NCT04311983|451475871|FG000|Overall Study|Incomplete survey|7|||
125503759|NCT04311983|451475872|FG001|Overall Study|Incomplete survey|9|||
125503760|NCT04311983|451475871|FG000|Overall Study|Death|1|||
125503761|NCT04311983|451475872|FG001|Overall Study|Death|0|||
125503762|NCT01205126|451475876|FG000|Titration Phase|Adverse Event|5|||
125503763|NCT01205126|451475877|FG001|Titration Phase|Adverse Event|3|||
125503764|NCT01205126|451475876|FG000|Titration Phase|Withdrawal by Subject|5|||
125503765|NCT01205126|451475877|FG001|Titration Phase|Withdrawal by Subject|5|||
125503766|NCT01205126|451475876|FG000|Titration Phase|Lost to Follow-up|2|||
125503767|NCT01205126|451475877|FG001|Titration Phase|Lost to Follow-up|2|||
125503768|NCT01205126|451475876|FG000|Titration Phase|No stable titration dose|1|||
125503769|NCT01205126|451475877|FG001|Titration Phase|No stable titration dose|0|||
125503770|NCT01205126|451475876|FG000|Titration Phase|More than maximum dosage required|2|||
125503771|NCT01205126|451475877|FG001|Titration Phase|More than maximum dosage required|3|||
125503772|NCT01205126|451475876|FG000|Titration Phase|Other|8|||
125503773|NCT01205126|451475877|FG001|Titration Phase|Other|6|||
125503774|NCT01205126|451475876|FG000|Between Titration & Maintenance Phase|Other|0|||
125503775|NCT01205126|451475877|FG001|Between Titration & Maintenance Phase|Other|4|||
125503776|NCT01205126|451475876|FG000|Maintenance Phase|Adverse Event|3|||
125503777|NCT01205126|451475877|FG001|Maintenance Phase|Adverse Event|7|||
125503778|NCT01205126|451475876|FG000|Maintenance Phase|Death|4|||
125503779|NCT01205126|451475877|FG001|Maintenance Phase|Death|4|||
125503780|NCT01205126|451475876|FG000|Maintenance Phase|More than the maximum dosage required|5|||
125503781|NCT01205126|451475877|FG001|Maintenance Phase|More than the maximum dosage required|5|||
125503782|NCT01205126|451475876|FG000|Maintenance Phase|Prohibited drugs used|1|||
125503783|NCT01205126|451475877|FG001|Maintenance Phase|Prohibited drugs used|0|||
125503784|NCT01205126|451475876|FG000|Maintenance Phase|Other|11|||
125503785|NCT01205126|451475877|FG001|Maintenance Phase|Other|8|||
125503786|NCT01205126|451475876|FG000|Maintenance Phase|Lost to Follow-up|5|||
125503787|NCT01205126|451475877|FG001|Maintenance Phase|Lost to Follow-up|5|||
125503788|NCT01205126|451475876|FG000|Maintenance Phase|Withdrawal by Subject|8|||
125503789|NCT01205126|451475877|FG001|Maintenance Phase|Withdrawal by Subject|11|||
125503790|NCT00638456|451475880|FG000|Overall Study|Withdrawal by Subject|6|||
125503791|NCT00638456|451475881|FG001|Overall Study|Withdrawal by Subject|2|||
125503792|NCT03236779|451475882|FG000|Overall Study|Lost to Follow-up|13|||
125503793|NCT03236779|451475883|FG001|Overall Study|Lost to Follow-up|21|||
125503794|NCT00805792|451475884|FG000|Overall Study|Death|3|||
125503795|NCT00805792|451475884|FG000|Overall Study|Lost to Follow-up|2|||
125503796|NCT01393964|451475889|FG000|Overall Study|Disease Progression|4|||
125503797|NCT01393964|451475890|FG001|Overall Study|Disease Progression|3|||
125503798|NCT01393964|451475891|FG002|Overall Study|Disease Progression|5|||
125503799|NCT01393964|451475889|FG000|Overall Study|Study drug toxicity|1|||
125503800|NCT01393964|451475890|FG001|Overall Study|Study drug toxicity|0|||
125503801|NCT01393964|451475891|FG002|Overall Study|Study drug toxicity|0|||
125503802|NCT01393964|451475889|FG000|Overall Study|Withdrawal by Subject|0|||
125503803|NCT01393964|451475890|FG001|Overall Study|Withdrawal by Subject|0|||
125503804|NCT01393964|451475891|FG002|Overall Study|Withdrawal by Subject|1|||
125503805|NCT01393964|451475889|FG000|Overall Study|Adverse event unrelated to study drug|0|||
125503806|NCT01393964|451475890|FG001|Overall Study|Adverse event unrelated to study drug|3|||
125503807|NCT01393964|451475891|FG002|Overall Study|Adverse event unrelated to study drug|0|||
125503808|NCT01393964|451475889|FG000|Overall Study|Subject request stop study treatment|0|||
125503809|NCT01393964|451475890|FG001|Overall Study|Subject request stop study treatment|1|||
125503810|NCT01393964|451475891|FG002|Overall Study|Subject request stop study treatment|0|||
125503811|NCT01393964|451475889|FG000|Overall Study|Subject decided to move to transplant|1|||
125503812|NCT01393964|451475890|FG001|Overall Study|Subject decided to move to transplant|0|||
125503813|NCT01393964|451475891|FG002|Overall Study|Subject decided to move to transplant|0|||
125503814|NCT01393964|451475889|FG000|Overall Study|Subject switched to commercial supply|1|||
125503815|NCT01393964|451475890|FG001|Overall Study|Subject switched to commercial supply|0|||
125503816|NCT01393964|451475891|FG002|Overall Study|Subject switched to commercial supply|2|||
125503817|NCT01393964|451475889|FG000|Overall Study|Subject plateaued in terms of effect|1|||
125503818|NCT01393964|451475890|FG001|Overall Study|Subject plateaued in terms of effect|0|||
125503819|NCT01393964|451475891|FG002|Overall Study|Subject plateaued in terms of effect|0|||
125503820|NCT01393964|451475889|FG000|Overall Study|Investigator removed subject from study|0|||
125503821|NCT01393964|451475890|FG001|Overall Study|Investigator removed subject from study|1|||
125503822|NCT01393964|451475891|FG002|Overall Study|Investigator removed subject from study|0|||
125503823|NCT01393964|451475889|FG000|Overall Study|Subject converted to roll-over study|0|||
125503824|NCT01393964|451475890|FG001|Overall Study|Subject converted to roll-over study|1|||
125503825|NCT01393964|451475891|FG002|Overall Study|Subject converted to roll-over study|0|||
125503826|NCT01393964|451475889|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
125503827|NCT01393964|451475890|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
125503828|NCT01393964|451475891|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
125503829|NCT03265132|451475898|FG000|Overall Study|Adverse Event|0|||
125503830|NCT03265132|451475899|FG001|Overall Study|Adverse Event|1|||
125503831|NCT03265132|451475898|FG000|Overall Study|Lack of Efficacy|0|||
125503832|NCT03265132|451475899|FG001|Overall Study|Lack of Efficacy|2|||
125503833|NCT03265132|451475898|FG000|Overall Study|Progressive disease|0|||
125503834|NCT03265132|451475899|FG001|Overall Study|Progressive disease|2|||
125503835|NCT03265132|451475898|FG000|Overall Study|Withdrawal by Subject|0|||
125503836|NCT03265132|451475899|FG001|Overall Study|Withdrawal by Subject|1|||
125503837|NCT00687297|451475900|FG000|Randomization|Withdrawal by Subject|2|||
125503838|NCT00687297|451475901|FG001|Randomization|Withdrawal by Subject|0|||
125503839|NCT00687297|451475900|FG000|Randomization|Withdrew before treatment, ineligible|1|||
125503840|NCT00687297|451475901|FG001|Randomization|Withdrew before treatment, ineligible|1|||
125503841|NCT00687297|451475900|FG000|Induction|Withdrawal by Subject|4|||
125503842|NCT00687297|451475901|FG001|Induction|Withdrawal by Subject|4|||
125503843|NCT00687297|451475900|FG000|Induction|Adverse Event|16|||
125503844|NCT00687297|451475901|FG001|Induction|Adverse Event|15|||
125503845|NCT00687297|451475900|FG000|Induction|Death|7|||
125503846|NCT00687297|451475901|FG001|Induction|Death|11|||
125503847|NCT00687297|451475900|FG000|Induction|Lack of Efficacy|17|||
125503848|NCT00687297|451475901|FG001|Induction|Lack of Efficacy|21|||
125503849|NCT00687297|451475900|FG000|Induction|Ineligible|0|||
125503850|NCT00687297|451475901|FG001|Induction|Ineligible|1|||
125503851|NCT00687297|451475900|FG000|Induction|Patient Noncompliance|1|||
125503852|NCT00687297|451475901|FG001|Induction|Patient Noncompliance|0|||
125503853|NCT00687297|451475900|FG000|Induction|Physician Decision|0|||
125503854|NCT00687297|451475901|FG001|Induction|Physician Decision|2|||
125503855|NCT00687297|451475900|FG000|Induction|Other|0|||
125503856|NCT00687297|451475901|FG001|Induction|Other|1|||
125503857|NCT00244751|451475906|FG000|Overall Study|Adverse Event|7|||
125503858|NCT00244751|451475907|FG001|Overall Study|Adverse Event|7|||
125503859|NCT00244751|451475908|FG002|Overall Study|Adverse Event|5|||
125503860|NCT00244751|451475906|FG000|Overall Study|Lost to Follow-up|0|||
125503861|NCT00244751|451475907|FG001|Overall Study|Lost to Follow-up|1|||
125503862|NCT00244751|451475908|FG002|Overall Study|Lost to Follow-up|0|||
125503863|NCT00244751|451475906|FG000|Overall Study|Protocol Violation|1|||
125503864|NCT00244751|451475907|FG001|Overall Study|Protocol Violation|0|||
125503865|NCT00244751|451475908|FG002|Overall Study|Protocol Violation|1|||
125503866|NCT00244751|451475906|FG000|Overall Study|Withdrawal by Subject|7|||
125503867|NCT00244751|451475907|FG001|Overall Study|Withdrawal by Subject|5|||
125503868|NCT00244751|451475908|FG002|Overall Study|Withdrawal by Subject|3|||
125503869|NCT00244751|451475906|FG000|Overall Study|Elevated liver enzymes|1|||
125503870|NCT00244751|451475907|FG001|Overall Study|Elevated liver enzymes|0|||
125503871|NCT00244751|451475908|FG002|Overall Study|Elevated liver enzymes|0|||
125503872|NCT00244751|451475906|FG000|Overall Study|Lack of compliance with protocol|0|||
125503873|NCT00244751|451475907|FG001|Overall Study|Lack of compliance with protocol|1|||
125503874|NCT00244751|451475908|FG002|Overall Study|Lack of compliance with protocol|0|||
125503875|NCT00244751|451475906|FG000|Overall Study|Safety reasons|0|||
125503876|NCT00244751|451475907|FG001|Overall Study|Safety reasons|1|||
125503877|NCT00244751|451475908|FG002|Overall Study|Safety reasons|0|||
125503878|NCT00244751|451475906|FG000|Overall Study|Participant randomized by mistake|0|||
125503879|NCT00244751|451475907|FG001|Overall Study|Participant randomized by mistake|0|||
125503880|NCT00244751|451475908|FG002|Overall Study|Participant randomized by mistake|1|||
125503881|NCT02206607|451475909|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
125503882|NCT02206607|451475910|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
125503883|NCT02206607|451475911|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
125503884|NCT02206607|451475912|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
125503885|NCT02206607|451475913|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
125503886|NCT02206607|451475909|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
125503887|NCT02206607|451475910|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
125503888|NCT02206607|451475911|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
125503889|NCT02206607|451475912|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
125503890|NCT02206607|451475913|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
125503891|NCT00879710|451475914|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
125503892|NCT00879710|451475915|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
125503893|NCT00879710|451475916|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
125503894|NCT00879710|451475917|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
125503895|NCT00879710|451475914|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
125503896|NCT00879710|451475915|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
125503897|NCT00879710|451475916|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
125503898|NCT00879710|451475917|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
125503899|NCT04085614|451475918|FG000|Overall Study|Protocol Violation|9|||
125503900|NCT04085614|451475919|FG001|Overall Study|Protocol Violation|6|||
125503901|NCT02399449|451475920|FG000|Overall Study|Withdrawal by Subject|3|||
125503902|NCT02399449|451475921|FG001|Overall Study|Withdrawal by Subject|9|||
125503903|NCT02399449|451475920|FG000|Overall Study|Physician Decision|0|||
125503904|NCT02399449|451475921|FG001|Overall Study|Physician Decision|1|||
125503905|NCT02516202|451475922|FG000|Overall Study|Withdrawal by Subject|1|||
125503906|NCT02516202|451475923|FG001|Overall Study|Withdrawal by Subject|0|||
125503907|NCT02516202|451475924|FG002|Overall Study|Withdrawal by Subject|1|||
125503908|NCT02516202|451475922|FG000|Overall Study|Lost to Follow-up|1|||
125503909|NCT02516202|451475923|FG001|Overall Study|Lost to Follow-up|1|||
125503910|NCT02516202|451475924|FG002|Overall Study|Lost to Follow-up|1|||
125503911|NCT02516202|451475922|FG000|Overall Study|Stopped Follow-up|0|||
125503912|NCT02516202|451475923|FG001|Overall Study|Stopped Follow-up|0|||
125503913|NCT02516202|451475924|FG002|Overall Study|Stopped Follow-up|1|||
125503914|NCT00337610|451475925|FG000|Overall Study|Adverse Event|2|||
125503915|NCT00337610|451475926|FG001|Overall Study|Adverse Event|2|||
125503916|NCT00337610|451475925|FG000|Overall Study|Death|0|||
125503917|NCT00337610|451475926|FG001|Overall Study|Death|1|||
125503918|NCT00337610|451475925|FG000|Overall Study|Lack of Efficacy|6|||
125503919|NCT00337610|451475926|FG001|Overall Study|Lack of Efficacy|3|||
125503920|NCT00337610|451475925|FG000|Overall Study|Lost to Follow-up|3|||
125503921|NCT00337610|451475926|FG001|Overall Study|Lost to Follow-up|3|||
125503922|NCT00337610|451475925|FG000|Overall Study|Withdrawal by Subject|6|||
125503923|NCT00337610|451475926|FG001|Overall Study|Withdrawal by Subject|5|||
125503924|NCT03541369|451475927|FG000|Overall Study|Death|0|||
125503925|NCT03541369|451475928|FG001|Overall Study|Death|0|||
125503926|NCT03541369|451475929|FG002|Overall Study|Death|0|||
125503927|NCT03541369|451475930|FG003|Overall Study|Death|0|||
125503928|NCT03541369|451475931|FG004|Overall Study|Death|1|||
125503929|NCT03541369|451475932|FG005|Overall Study|Death|1|||
125503930|NCT03541369|451475933|FG006|Overall Study|Death|0|||
125503931|NCT03541369|451475934|FG007|Overall Study|Death|2|||
125503932|NCT03541369|451475935|FG008|Overall Study|Death|1|||
125503933|NCT03541369|451475936|FG009|Overall Study|Death|2|||
125503934|NCT03541369|451475937|FG010|Overall Study|Death|1|||
125503935|NCT03541369|451475938|FG011|Overall Study|Death|0|||
125503936|NCT03541369|451475939|FG012|Overall Study|Death|2|||
125503937|NCT03541369|451475940|FG013|Overall Study|Death|1|||
125503938|NCT03541369|451475941|FG014|Overall Study|Death|1|||
125503939|NCT03541369|451475942|FG015|Overall Study|Death|1|||
125503940|NCT03541369|451475943|FG016|Overall Study|Death|0|||
125503941|NCT03541369|451475944|FG017|Overall Study|Death|1|||
125503942|NCT03541369|451475927|FG000|Overall Study|Decision by sponsor|0|||
125503943|NCT03541369|451475928|FG001|Overall Study|Decision by sponsor|0|||
125503944|NCT03541369|451475929|FG002|Overall Study|Decision by sponsor|0|||
125503945|NCT03541369|451475930|FG003|Overall Study|Decision by sponsor|1|||
125503946|NCT03541369|451475931|FG004|Overall Study|Decision by sponsor|0|||
125503947|NCT03541369|451475932|FG005|Overall Study|Decision by sponsor|2|||
125503948|NCT03541369|451475933|FG006|Overall Study|Decision by sponsor|0|||
125503949|NCT03541369|451475934|FG007|Overall Study|Decision by sponsor|1|||
125503950|NCT03541369|451475935|FG008|Overall Study|Decision by sponsor|2|||
125503951|NCT03541369|451475936|FG009|Overall Study|Decision by sponsor|0|||
125503952|NCT03541369|451475937|FG010|Overall Study|Decision by sponsor|0|||
125503953|NCT03541369|451475938|FG011|Overall Study|Decision by sponsor|0|||
125503954|NCT03541369|451475939|FG012|Overall Study|Decision by sponsor|2|||
125503955|NCT03541369|451475940|FG013|Overall Study|Decision by sponsor|2|||
125503956|NCT03541369|451475941|FG014|Overall Study|Decision by sponsor|0|||
125503957|NCT03541369|451475942|FG015|Overall Study|Decision by sponsor|1|||
125503958|NCT03541369|451475943|FG016|Overall Study|Decision by sponsor|1|||
125503959|NCT03541369|451475944|FG017|Overall Study|Decision by sponsor|1|||
125503960|NCT03541369|451475927|FG000|Overall Study|Withdrawal by Subject|0|||
125503961|NCT03541369|451475928|FG001|Overall Study|Withdrawal by Subject|0|||
125503962|NCT03541369|451475929|FG002|Overall Study|Withdrawal by Subject|0|||
125503963|NCT03541369|451475930|FG003|Overall Study|Withdrawal by Subject|0|||
125503964|NCT03541369|451475931|FG004|Overall Study|Withdrawal by Subject|0|||
125503965|NCT03541369|451475932|FG005|Overall Study|Withdrawal by Subject|0|||
125503966|NCT03541369|451475933|FG006|Overall Study|Withdrawal by Subject|1|||
125503967|NCT03541369|451475934|FG007|Overall Study|Withdrawal by Subject|0|||
125503968|NCT03541369|451475935|FG008|Overall Study|Withdrawal by Subject|0|||
125503969|NCT03541369|451475936|FG009|Overall Study|Withdrawal by Subject|0|||
125503970|NCT03541369|451475937|FG010|Overall Study|Withdrawal by Subject|0|||
125503971|NCT03541369|451475938|FG011|Overall Study|Withdrawal by Subject|1|||
125503972|NCT03541369|451475939|FG012|Overall Study|Withdrawal by Subject|0|||
125503973|NCT03541369|451475940|FG013|Overall Study|Withdrawal by Subject|0|||
125503974|NCT03541369|451475941|FG014|Overall Study|Withdrawal by Subject|3|||
125503975|NCT03541369|451475942|FG015|Overall Study|Withdrawal by Subject|0|||
125503976|NCT03541369|451475943|FG016|Overall Study|Withdrawal by Subject|4|||
125503977|NCT03541369|451475944|FG017|Overall Study|Withdrawal by Subject|2|||
125503978|NCT03541369|451475927|FG000|Overall Study|Lost to Follow-up|0|||
125503979|NCT03541369|451475928|FG001|Overall Study|Lost to Follow-up|0|||
125503980|NCT03541369|451475929|FG002|Overall Study|Lost to Follow-up|0|||
125503981|NCT03541369|451475930|FG003|Overall Study|Lost to Follow-up|0|||
125503982|NCT03541369|451475931|FG004|Overall Study|Lost to Follow-up|1|||
125503983|NCT03541369|451475932|FG005|Overall Study|Lost to Follow-up|0|||
125503984|NCT03541369|451475933|FG006|Overall Study|Lost to Follow-up|0|||
125503985|NCT03541369|451475934|FG007|Overall Study|Lost to Follow-up|0|||
125503986|NCT03541369|451475935|FG008|Overall Study|Lost to Follow-up|1|||
125503987|NCT03541369|451475936|FG009|Overall Study|Lost to Follow-up|0|||
125503988|NCT03541369|451475937|FG010|Overall Study|Lost to Follow-up|0|||
125503989|NCT03541369|451475938|FG011|Overall Study|Lost to Follow-up|0|||
125503990|NCT03541369|451475939|FG012|Overall Study|Lost to Follow-up|1|||
125503991|NCT03541369|451475940|FG013|Overall Study|Lost to Follow-up|0|||
125503992|NCT03541369|451475941|FG014|Overall Study|Lost to Follow-up|0|||
125503993|NCT03541369|451475942|FG015|Overall Study|Lost to Follow-up|0|||
125503994|NCT03541369|451475943|FG016|Overall Study|Lost to Follow-up|0|||
125503995|NCT03541369|451475944|FG017|Overall Study|Lost to Follow-up|0|||
125503996|NCT03205488|451475947|FG000|Overall Study|Adverse Event|1|||
125503997|NCT03205488|451475948|FG001|Overall Study|Adverse Event|2|||
125503998|NCT03205488|451475949|FG002|Overall Study|Adverse Event|4|||
125503999|NCT03205488|451475947|FG000|Overall Study|Protocol Violation|0|||
125504000|NCT03205488|451475948|FG001|Overall Study|Protocol Violation|0|||
125504001|NCT03205488|451475949|FG002|Overall Study|Protocol Violation|1|||
125504002|NCT04867382|451475950|FG000|Overall Study|Did not complete the survey|2|||
125504003|NCT04867382|451475951|FG001|Overall Study|Did not complete the survey|1|||
125504004|NCT05445557|451475959|FG000|Double Blind Part|Lost to Follow-up|1|||
125504005|NCT02008916|451475960|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
125305030|NCT04405076|450742827|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
125305031|NCT04405076|450742828|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
125305032|NCT04405076|450742820|FG000|Part A (Blinded Phase)|Other than Specified|0|||
125305033|NCT04405076|450742821|FG001|Part A (Blinded Phase)|Other than Specified|0|||
125305034|NCT04405076|450742822|FG002|Part A (Blinded Phase)|Other than Specified|3|||
125305035|NCT04405076|450742823|FG003|Part A (Blinded Phase)|Other than Specified|0|||
125305036|NCT04405076|450742824|FG004|Part A (Blinded Phase)|Other than Specified|0|||
125504006|NCT02008916|451475961|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
125504007|NCT02008916|451475962|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
125504008|NCT02008916|451475960|FG000|Week 16 - 156|Adverse Event|4|||
125504009|NCT02008916|451475961|FG001|Week 16 - 156|Adverse Event|2|||
125504010|NCT02008916|451475962|FG002|Week 16 - 156|Adverse Event|3|||
125504011|NCT02008916|451475960|FG000|Week 16 - 156|Withdrawal by Subject|7|||
125504012|NCT02008916|451475961|FG001|Week 16 - 156|Withdrawal by Subject|3|||
125504013|NCT02008916|451475962|FG002|Week 16 - 156|Withdrawal by Subject|5|||
125504014|NCT02008916|451475960|FG000|Week 16 - 156|No longer requires treatment|0|||
125504015|NCT02008916|451475961|FG001|Week 16 - 156|No longer requires treatment|1|||
125504016|NCT02008916|451475962|FG002|Week 16 - 156|No longer requires treatment|0|||
125504017|NCT02008916|451475960|FG000|Week 16 - 156|Lost to Follow-up|5|||
125504018|NCT02008916|451475961|FG001|Week 16 - 156|Lost to Follow-up|0|||
125504019|NCT02008916|451475962|FG002|Week 16 - 156|Lost to Follow-up|0|||
125504020|NCT02008916|451475960|FG000|Week 16 - 156|Lack of Efficacy|3|||
125504021|NCT02008916|451475961|FG001|Week 16 - 156|Lack of Efficacy|5|||
125504022|NCT02008916|451475962|FG002|Week 16 - 156|Lack of Efficacy|2|||
125504023|NCT02008916|451475960|FG000|Week 16 - 156|Pregnancy|0|||
125504024|NCT02008916|451475961|FG001|Week 16 - 156|Pregnancy|1|||
125504025|NCT02008916|451475962|FG002|Week 16 - 156|Pregnancy|0|||
125504026|NCT02008916|451475960|FG000|Week 16 - 156|Physician Decision|0|||
125504027|NCT02008916|451475961|FG001|Week 16 - 156|Physician Decision|1|||
125504028|NCT02008916|451475962|FG002|Week 16 - 156|Physician Decision|0|||
125504029|NCT03803475|451475963|FG000|Overall Study|Physician Decision|1|||
125504030|NCT00392197|451475966|FG000|Overall Study|Adverse Event|4|||
125504031|NCT00392197|451475967|FG001|Overall Study|Adverse Event|12|||
125504032|NCT00392197|451475966|FG000|Overall Study|Lack of Efficacy|3|||
125504033|NCT00392197|451475967|FG001|Overall Study|Lack of Efficacy|4|||
125504034|NCT00392197|451475966|FG000|Overall Study|Lost to Follow-up|0|||
125504035|NCT00392197|451475967|FG001|Overall Study|Lost to Follow-up|1|||
125504036|NCT00392197|451475966|FG000|Overall Study|Physician Decision|3|||
125504037|NCT00392197|451475967|FG001|Overall Study|Physician Decision|2|||
125504038|NCT00392197|451475966|FG000|Overall Study|Protocol Violation|7|||
125504039|NCT00392197|451475967|FG001|Overall Study|Protocol Violation|5|||
125504040|NCT00392197|451475966|FG000|Overall Study|Withdrawal by Subject|4|||
125504041|NCT00392197|451475967|FG001|Overall Study|Withdrawal by Subject|6|||
125504042|NCT00428714|451475969|FG000|Overall Study|Progressive Disease|28|||
125504043|NCT00428714|451475970|FG001|Overall Study|Progressive Disease|36|||
125504044|NCT00428714|451475969|FG000|Overall Study|Withdrawal by Subject|0|||
125504045|NCT00428714|451475970|FG001|Overall Study|Withdrawal by Subject|3|||
125504046|NCT00428714|451475969|FG000|Overall Study|Adverse Event|0|||
125504047|NCT00428714|451475970|FG001|Overall Study|Adverse Event|2|||
125504048|NCT00428714|451475969|FG000|Overall Study|Physician Decision|1|||
125504049|NCT00428714|451475970|FG001|Overall Study|Physician Decision|1|||
125504050|NCT00428714|451475969|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
125504051|NCT00428714|451475970|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
125504052|NCT00428714|451475969|FG000|Overall Study|Death due to other then PD|1|||
125504053|NCT00428714|451475970|FG001|Overall Study|Death due to other then PD|0|||
125504054|NCT01681511|451475971|FG000|Overall Study|No Treatment Received|1|||
125504055|NCT01681511|451475972|FG001|Overall Study|No Treatment Received|3|||
125504056|NCT01681511|451475971|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
125504057|NCT01681511|451475972|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
125504058|NCT01681511|451475971|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
125504059|NCT01681511|451475972|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
125504060|NCT01681511|451475971|FG000|Overall Study|No Daily Urine Sample Collected|0|||
125504061|NCT01681511|451475972|FG001|Overall Study|No Daily Urine Sample Collected|1|||
125504062|NCT01681511|451475971|FG000|Overall Study|No post-catheter sample collected|11|||
125504063|NCT01681511|451475972|FG001|Overall Study|No post-catheter sample collected|4|||
125504064|NCT00090519|451475986|FG000|Overall Study|Adverse Event|5|||
125504065|NCT00090519|451475987|FG001|Overall Study|Adverse Event|4|||
125504066|NCT00090519|451475986|FG000|Overall Study|Death|9|||
125504067|NCT00090519|451475987|FG001|Overall Study|Death|9|||
125504068|NCT00090519|451475986|FG000|Overall Study|Lost to Follow-up|26|||
125504069|NCT00090519|451475987|FG001|Overall Study|Lost to Follow-up|29|||
125504070|NCT00090519|451475986|FG000|Overall Study|Withdrawal by Subject|28|||
125504071|NCT00090519|451475987|FG001|Overall Study|Withdrawal by Subject|29|||
125504072|NCT00090519|451475986|FG000|Overall Study|Physician Decision|2|||
125504073|NCT00090519|451475987|FG001|Overall Study|Physician Decision|3|||
125504074|NCT00090519|451475986|FG000|Overall Study|Sponsor Decision|3|||
125504075|NCT00090519|451475987|FG001|Overall Study|Sponsor Decision|1|||
125504076|NCT02161146|451475988|FG000|Overall Study|Adverse Event|1|||
125504077|NCT02161146|451475989|FG001|Overall Study|Adverse Event|1|||
125504078|NCT02161146|451475990|FG002|Overall Study|Adverse Event|0|||
125504079|NCT02161146|451475991|FG003|Overall Study|Adverse Event|1|||
125504080|NCT02161146|451475992|FG004|Overall Study|Adverse Event|0|||
125504081|NCT02161146|451475988|FG000|Overall Study|Lost to Follow-up|0|||
125504082|NCT02161146|451475989|FG001|Overall Study|Lost to Follow-up|1|||
125504083|NCT02161146|451475990|FG002|Overall Study|Lost to Follow-up|0|||
125504084|NCT02161146|451475991|FG003|Overall Study|Lost to Follow-up|0|||
125504085|NCT02161146|451475992|FG004|Overall Study|Lost to Follow-up|0|||
125504086|NCT02161146|451475988|FG000|Overall Study|Personal Reasons|0|||
125504087|NCT02161146|451475989|FG001|Overall Study|Personal Reasons|1|||
125504088|NCT02161146|451475990|FG002|Overall Study|Personal Reasons|0|||
125504089|NCT02161146|451475991|FG003|Overall Study|Personal Reasons|2|||
125504090|NCT02161146|451475992|FG004|Overall Study|Personal Reasons|1|||
125504091|NCT02161146|451475988|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125504092|NCT02161146|451475989|FG001|Overall Study|Other Miscellaneous Reasons|1|||
125504093|NCT02161146|451475990|FG002|Overall Study|Other Miscellaneous Reasons|0|||
125504094|NCT02161146|451475991|FG003|Overall Study|Other Miscellaneous Reasons|0|||
125504095|NCT02161146|451475992|FG004|Overall Study|Other Miscellaneous Reasons|0|||
125504096|NCT02613403|451475995|FG000|Overall Study|Lost to Follow-up|0|||
125504097|NCT02613403|451475996|FG001|Overall Study|Lost to Follow-up|1|||
125504098|NCT02613403|451475997|FG002|Overall Study|Lost to Follow-up|0|||
125504099|NCT02613403|451475998|FG003|Overall Study|Lost to Follow-up|0|||
125504100|NCT02613403|451475999|FG004|Overall Study|Lost to Follow-up|0|||
125504101|NCT02613403|451475995|FG000|Overall Study|Withdrawal by Subject|2|||
125504102|NCT02613403|451475996|FG001|Overall Study|Withdrawal by Subject|0|||
125504103|NCT02613403|451475997|FG002|Overall Study|Withdrawal by Subject|0|||
125504104|NCT02613403|451475998|FG003|Overall Study|Withdrawal by Subject|0|||
125504105|NCT02613403|451475999|FG004|Overall Study|Withdrawal by Subject|0|||
125504106|NCT02189759|451476000|FG000|Overall Study|Lost to Follow-up|0|||
125504107|NCT02189759|451476001|FG001|Overall Study|Lost to Follow-up|0|||
125504108|NCT02189759|451476002|FG002|Overall Study|Lost to Follow-up|2|||
125504109|NCT02189759|451476003|FG003|Overall Study|Lost to Follow-up|5|||
125504110|NCT00800176|451476006|FG000|Overall Study|Adverse Event|2|||
125504111|NCT00800176|451476007|FG001|Overall Study|Adverse Event|1|||
125504112|NCT00800176|451476008|FG002|Overall Study|Adverse Event|0|||
125504113|NCT00800176|451476009|FG003|Overall Study|Adverse Event|2|||
125504114|NCT00800176|451476010|FG004|Overall Study|Adverse Event|1|||
125504115|NCT00800176|451476011|FG005|Overall Study|Adverse Event|1|||
125504116|NCT00800176|451476006|FG000|Overall Study|Refused treatment|3|||
125504117|NCT00800176|451476007|FG001|Overall Study|Refused treatment|2|||
125504118|NCT00800176|451476008|FG002|Overall Study|Refused treatment|0|||
125504119|NCT00800176|451476009|FG003|Overall Study|Refused treatment|0|||
125504120|NCT00800176|451476010|FG004|Overall Study|Refused treatment|1|||
125504121|NCT00800176|451476011|FG005|Overall Study|Refused treatment|4|||
125504122|NCT00800176|451476006|FG000|Overall Study|Failure to return|3|||
125504123|NCT00800176|451476007|FG001|Overall Study|Failure to return|3|||
125504124|NCT00800176|451476008|FG002|Overall Study|Failure to return|0|||
125504125|NCT00800176|451476009|FG003|Overall Study|Failure to return|2|||
125504126|NCT00800176|451476010|FG004|Overall Study|Failure to return|0|||
125504127|NCT00800176|451476011|FG005|Overall Study|Failure to return|0|||
125504128|NCT00800176|451476006|FG000|Overall Study|Other|1|||
125504129|NCT00800176|451476007|FG001|Overall Study|Other|0|||
125504130|NCT00800176|451476008|FG002|Overall Study|Other|0|||
125504131|NCT00800176|451476009|FG003|Overall Study|Other|0|||
125504132|NCT00800176|451476010|FG004|Overall Study|Other|2|||
125504133|NCT00800176|451476011|FG005|Overall Study|Other|0|||
125504134|NCT02548585|451476014|FG000|Overall Study|Withdrawal by Subject|0|||
125504135|NCT02548585|451476015|FG001|Overall Study|Withdrawal by Subject|0|||
125504136|NCT02548585|451476016|FG002|Overall Study|Withdrawal by Subject|0|||
125504137|NCT02548585|451476017|FG003|Overall Study|Withdrawal by Subject|0|||
125504138|NCT02548585|451476018|FG004|Overall Study|Withdrawal by Subject|0|||
125504139|NCT02548585|451476019|FG005|Overall Study|Withdrawal by Subject|1|||
125305037|NCT04405076|450742825|FG005|Part A (Blinded Phase)|Other than Specified|0|||
125305038|NCT04405076|450742826|FG006|Part A (Blinded Phase)|Other than Specified|0|||
125305039|NCT04405076|450742827|FG007|Part A (Blinded Phase)|Other than Specified|0|||
125305040|NCT04405076|450742828|FG008|Part A (Blinded Phase)|Other than Specified|0|||
125305041|NCT04405076|450742820|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
125305042|NCT04405076|450742821|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
125305043|NCT04405076|450742822|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
125305044|NCT04405076|450742823|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
125305045|NCT04405076|450742824|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
125305046|NCT04405076|450742825|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
125305047|NCT04405076|450742826|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
125305048|NCT04405076|450742827|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
125305049|NCT04405076|450742828|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
125305050|NCT04405076|450742820|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305051|NCT04405076|450742821|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305052|NCT04405076|450742822|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305053|NCT04405076|450742823|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305054|NCT04405076|450742824|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
125504140|NCT02548585|451476020|FG006|Overall Study|Withdrawal by Subject|0|||
125504141|NCT02548585|451476014|FG000|Overall Study|Lost to Follow-up|1|||
125504142|NCT02548585|451476015|FG001|Overall Study|Lost to Follow-up|0|||
125504143|NCT02548585|451476016|FG002|Overall Study|Lost to Follow-up|0|||
125504144|NCT02548585|451476017|FG003|Overall Study|Lost to Follow-up|0|||
125504145|NCT02548585|451476018|FG004|Overall Study|Lost to Follow-up|0|||
125504146|NCT02548585|451476019|FG005|Overall Study|Lost to Follow-up|0|||
125504147|NCT02548585|451476020|FG006|Overall Study|Lost to Follow-up|0|||
125504148|NCT02548585|451476014|FG000|Overall Study|Other|1|||
125504149|NCT02548585|451476015|FG001|Overall Study|Other|0|||
125504150|NCT02548585|451476016|FG002|Overall Study|Other|0|||
125504151|NCT02548585|451476017|FG003|Overall Study|Other|2|||
125504152|NCT02548585|451476018|FG004|Overall Study|Other|3|||
125504153|NCT02548585|451476019|FG005|Overall Study|Other|0|||
125504154|NCT02548585|451476020|FG006|Overall Study|Other|1|||
125504155|NCT02548585|451476014|FG000|Overall Study|Randomized but not treated|0|||
125504156|NCT02548585|451476015|FG001|Overall Study|Randomized but not treated|0|||
125504157|NCT02548585|451476016|FG002|Overall Study|Randomized but not treated|0|||
125504158|NCT02548585|451476017|FG003|Overall Study|Randomized but not treated|0|||
125504159|NCT02548585|451476018|FG004|Overall Study|Randomized but not treated|0|||
125504160|NCT02548585|451476019|FG005|Overall Study|Randomized but not treated|1|||
125504161|NCT02548585|451476020|FG006|Overall Study|Randomized but not treated|0|||
125504162|NCT03242863|451476024|FG000|Study Week 1|Withdrawal by Subject|0|||
125504163|NCT03242863|451476025|FG001|Study Week 1|Withdrawal by Subject|1|||
125504164|NCT03242863|451476026|FG002|Study Week 1|Withdrawal by Subject|0|||
125504165|NCT03242863|451476027|FG003|Study Week 1|Withdrawal by Subject|0|||
125504166|NCT03242863|451476028|FG004|Study Week 1|Withdrawal by Subject|3|||
125504167|NCT03242863|451476029|FG005|Study Week 1|Withdrawal by Subject|0|||
125504168|NCT01079949|451476033|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
125504169|NCT01079949|451476034|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
125504170|NCT01079949|451476033|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
125504171|NCT01079949|451476034|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
125504172|NCT01079949|451476033|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
125504173|NCT01079949|451476034|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
125504174|NCT01079949|451476033|FG000|Overall Study|Randomized but not treated|1|||
125504175|NCT01079949|451476034|FG001|Overall Study|Randomized but not treated|0|||
125504176|NCT02144285|451476035|FG000|Overall Study|Withdrawal by Subject|0|||
125504177|NCT02144285|451476036|FG001|Overall Study|Withdrawal by Subject|0|||
125504178|NCT02144285|451476037|FG002|Overall Study|Withdrawal by Subject|0|||
125504179|NCT02144285|451476038|FG003|Overall Study|Withdrawal by Subject|0|||
125504180|NCT02144285|451476039|FG004|Overall Study|Withdrawal by Subject|1|||
125504181|NCT02144285|451476040|FG005|Overall Study|Withdrawal by Subject|0|||
125504182|NCT02144285|451476041|FG006|Overall Study|Withdrawal by Subject|0|||
125305055|NCT04405076|450742825|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305056|NCT04405076|450742826|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305057|NCT04405076|450742827|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305058|NCT04405076|450742828|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
125305059|NCT04405076|450742820|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
125305060|NCT04405076|450742821|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
125305061|NCT04405076|450742822|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
125305062|NCT04405076|450742823|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
125305063|NCT04405076|450742824|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
125305064|NCT04405076|450742825|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
125305065|NCT04405076|450742826|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
125305066|NCT04405076|450742827|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
125305067|NCT04405076|450742828|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
125305068|NCT04405076|450742820|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305069|NCT04405076|450742821|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305070|NCT04405076|450742822|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305071|NCT04405076|450742823|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305072|NCT04405076|450742824|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305073|NCT04405076|450742825|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305074|NCT04405076|450742826|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
125305075|NCT04405076|450742827|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
125305076|NCT04405076|450742828|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
125305077|NCT04405076|450742820|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305078|NCT04405076|450742821|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305079|NCT04405076|450742822|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305080|NCT04405076|450742823|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305081|NCT04405076|450742824|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305082|NCT04405076|450742825|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305083|NCT04405076|450742826|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
125305084|NCT04405076|450742827|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305085|NCT04405076|450742828|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
125305086|NCT00392990|450742829|FG000|Treatment on Study|Adverse Event|3|||
125305087|NCT00392990|450742830|FG001|Treatment on Study|Adverse Event|1|||
125504183|NCT02144285|451476042|FG007|Overall Study|Withdrawal by Subject|0|||
125504184|NCT02144285|451476043|FG008|Overall Study|Withdrawal by Subject|0|||
125504185|NCT02144285|451476044|FG009|Overall Study|Withdrawal by Subject|0|||
125504186|NCT01529632|451476045|FG000|Overall Study|Administrative problem|2|||
125504187|NCT01529632|451476046|FG001|Overall Study|Administrative problem|1|||
125504188|NCT01529632|451476045|FG000|Overall Study|Protocol Violation|0|||
125305088|NCT00392990|450742829|FG000|Follow up for 2 Years|Death|4|||
125305089|NCT00392990|450742830|FG001|Follow up for 2 Years|Death|0|||
125305090|NCT02980133|450742831|FG000|Overall Study|Other than specified|1|||
125305091|NCT02980133|450742832|FG001|Overall Study|Other than specified|1|||
125305092|NCT02980133|450742833|FG002|Overall Study|Other than specified|2|||
125305093|NCT02980133|450742834|FG003|Overall Study|Other than specified|2|||
125305094|NCT02980133|450742831|FG000|Overall Study|Lost to Follow-up|0|||
125305095|NCT02980133|450742832|FG001|Overall Study|Lost to Follow-up|0|||
125305096|NCT02980133|450742833|FG002|Overall Study|Lost to Follow-up|1|||
125305097|NCT02980133|450742834|FG003|Overall Study|Lost to Follow-up|3|||
125305098|NCT02980133|450742831|FG000|Overall Study|Protocol Violation|0|||
125305099|NCT02980133|450742832|FG001|Overall Study|Protocol Violation|1|||
125305100|NCT02980133|450742833|FG002|Overall Study|Protocol Violation|0|||
125305101|NCT02980133|450742834|FG003|Overall Study|Protocol Violation|0|||
125305102|NCT02980133|450742831|FG000|Overall Study|Withdrawal by parent/guardian|6|||
125305103|NCT02980133|450742832|FG001|Overall Study|Withdrawal by parent/guardian|3|||
125305104|NCT02980133|450742833|FG002|Overall Study|Withdrawal by parent/guardian|3|||
125305105|NCT02980133|450742834|FG003|Overall Study|Withdrawal by parent/guardian|1|||
125305106|NCT02980133|450742831|FG000|Overall Study|Withdrawal by Subject|0|||
125305107|NCT02980133|450742832|FG001|Overall Study|Withdrawal by Subject|0|||
125305108|NCT02980133|450742833|FG002|Overall Study|Withdrawal by Subject|1|||
125305109|NCT02980133|450742834|FG003|Overall Study|Withdrawal by Subject|0|||
125305110|NCT00172042|450742835|FG000|Overall Study|Adverse Event|27|||
125305111|NCT00172042|450742836|FG001|Overall Study|Adverse Event|13|||
125305112|NCT00172042|450742835|FG000|Overall Study|Abnormal laboratory value(s)|5|||
125305113|NCT00172042|450742836|FG001|Overall Study|Abnormal laboratory value(s)|1|||
125305114|NCT00172042|450742835|FG000|Overall Study|Abnormal test procedure(s)|0|||
125305115|NCT00172042|450742836|FG001|Overall Study|Abnormal test procedure(s)|3|||
125305116|NCT00172042|450742835|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
125305117|NCT00172042|450742836|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
125305118|NCT00172042|450742835|FG000|Overall Study|Patient no longer requires study drug|10|||
125305119|NCT00172042|450742836|FG001|Overall Study|Patient no longer requires study drug|8|||
125305120|NCT00172042|450742835|FG000|Overall Study|Protocol Violation|8|||
125305121|NCT00172042|450742836|FG001|Overall Study|Protocol Violation|7|||
125305122|NCT00172042|450742835|FG000|Overall Study|Withdrawal by Subject|37|||
125305123|NCT00172042|450742836|FG001|Overall Study|Withdrawal by Subject|25|||
125305124|NCT00172042|450742835|FG000|Overall Study|Lost to Follow-up|3|||
125305125|NCT00172042|450742836|FG001|Overall Study|Lost to Follow-up|5|||
125305126|NCT00172042|450742835|FG000|Overall Study|Administrative problems|13|||
125305127|NCT00172042|450742836|FG001|Overall Study|Administrative problems|10|||
125305128|NCT00172042|450742835|FG000|Overall Study|Death|42|||
125305129|NCT00172042|450742836|FG001|Overall Study|Death|42|||
125305130|NCT03052816|450742837|FG000|Overall Study|Withdrawal by Subject|1|||
125305131|NCT03052816|450742838|FG001|Overall Study|Withdrawal by Subject|0|||
125305132|NCT03052816|450742837|FG000|Overall Study|Desired opioids|2|||
125305133|NCT03052816|450742838|FG001|Overall Study|Desired opioids|0|||
125305134|NCT00408434|450742839|FG000|Overall Study|Adverse Event|0|||
125305135|NCT00408434|450742840|FG001|Overall Study|Adverse Event|0|||
125305136|NCT00408434|450742841|FG002|Overall Study|Adverse Event|1|||
125305137|NCT00408434|450742842|FG003|Overall Study|Adverse Event|0|||
125305138|NCT00408434|450742843|FG004|Overall Study|Adverse Event|0|||
125305139|NCT00408434|450742844|FG005|Overall Study|Adverse Event|0|||
125305140|NCT00408434|450742845|FG006|Overall Study|Adverse Event|0|||
125305141|NCT00408434|450742839|FG000|Overall Study|Progressive disease|6|||
125305142|NCT00408434|450742840|FG001|Overall Study|Progressive disease|3|||
125305143|NCT00408434|450742841|FG002|Overall Study|Progressive disease|4|||
125305144|NCT00408434|450742842|FG003|Overall Study|Progressive disease|3|||
125305145|NCT00408434|450742843|FG004|Overall Study|Progressive disease|3|||
125305146|NCT00408434|450742844|FG005|Overall Study|Progressive disease|1|||
125305147|NCT00408434|450742845|FG006|Overall Study|Progressive disease|4|||
125305148|NCT00408434|450742839|FG000|Overall Study|Other|0|||
125305149|NCT00408434|450742840|FG001|Overall Study|Other|0|||
125305150|NCT00408434|450742841|FG002|Overall Study|Other|1|||
125305151|NCT00408434|450742842|FG003|Overall Study|Other|0|||
125305152|NCT00408434|450742843|FG004|Overall Study|Other|2|||
125305153|NCT00408434|450742844|FG005|Overall Study|Other|1|||
125305154|NCT00408434|450742845|FG006|Overall Study|Other|0|||
125305155|NCT00408434|450742839|FG000|Overall Study|Terminated by Investigator|0|||
125305156|NCT00408434|450742840|FG001|Overall Study|Terminated by Investigator|0|||
125305157|NCT00408434|450742841|FG002|Overall Study|Terminated by Investigator|0|||
125305158|NCT00408434|450742842|FG003|Overall Study|Terminated by Investigator|0|||
125305159|NCT00408434|450742843|FG004|Overall Study|Terminated by Investigator|1|||
125305160|NCT00408434|450742844|FG005|Overall Study|Terminated by Investigator|1|||
125305161|NCT00408434|450742845|FG006|Overall Study|Terminated by Investigator|0|||
125305162|NCT01278797|450742846|FG000|Period 1|Adverse Event|0|||
125305163|NCT01278797|450742847|FG001|Period 1|Adverse Event|1|||
125305164|NCT01278797|450742846|FG000|Period 1|Protocol Violation|1|||
125305165|NCT01278797|450742847|FG001|Period 1|Protocol Violation|0|||
125305166|NCT00895453|450742848|FG000|Overall Study|Lost to Follow-up|25|||
125305167|NCT00895453|450742849|FG001|Overall Study|Lost to Follow-up|25|||
125305168|NCT00895453|450742850|FG002|Overall Study|Lost to Follow-up|23|||
125305169|NCT03188510|450742852|FG000|Overall Study|Inappropriate behavior with site staff|0|||
125305170|NCT03188510|450742853|FG001|Overall Study|Inappropriate behavior with site staff|1|||
125305171|NCT03188510|450742854|FG002|Overall Study|Inappropriate behavior with site staff|0|||
125305172|NCT03052049|450742856|FG000|Overall Study|Withdrawal by Subject|2|||
125305173|NCT03343626|450744993|FG000|Overall Study|Lost to Follow-up|4|||
125305174|NCT03343626|450744994|FG001|Overall Study|Lost to Follow-up|3|||
125305175|NCT03343626|450744995|FG002|Overall Study|Lost to Follow-up|2|||
125305176|NCT03343626|450744996|FG003|Overall Study|Lost to Follow-up|5|||
125305177|NCT03343626|450744997|FG004|Overall Study|Lost to Follow-up|4|||
125305178|NCT03343626|450744998|FG005|Overall Study|Lost to Follow-up|4|||
125305179|NCT03343626|450744999|FG006|Overall Study|Lost to Follow-up|4|||
125305180|NCT03343626|450745000|FG007|Overall Study|Lost to Follow-up|7|||
125305181|NCT03343626|450744993|FG000|Overall Study|Withdrawal of Consent|2|||
125305182|NCT03343626|450744994|FG001|Overall Study|Withdrawal of Consent|1|||
125305183|NCT03343626|450744995|FG002|Overall Study|Withdrawal of Consent|0|||
125305184|NCT03343626|450744996|FG003|Overall Study|Withdrawal of Consent|3|||
125305185|NCT03343626|450744997|FG004|Overall Study|Withdrawal of Consent|3|||
125305186|NCT03343626|450744998|FG005|Overall Study|Withdrawal of Consent|1|||
125305187|NCT03343626|450744999|FG006|Overall Study|Withdrawal of Consent|1|||
125305188|NCT03343626|450745000|FG007|Overall Study|Withdrawal of Consent|2|||
125305189|NCT03343626|450744993|FG000|Overall Study|Reason not Specified|0|||
125305190|NCT03343626|450744994|FG001|Overall Study|Reason not Specified|1|||
125305191|NCT03343626|450744995|FG002|Overall Study|Reason not Specified|0|||
125305192|NCT03343626|450744996|FG003|Overall Study|Reason not Specified|0|||
125305193|NCT03343626|450744997|FG004|Overall Study|Reason not Specified|0|||
125305194|NCT03343626|450744998|FG005|Overall Study|Reason not Specified|0|||
125305195|NCT03343626|450744999|FG006|Overall Study|Reason not Specified|0|||
125305196|NCT03343626|450745000|FG007|Overall Study|Reason not Specified|1|||
125305197|NCT03343626|450744993|FG000|Overall Study|Data Entry Error|0|||
125305198|NCT03343626|450744994|FG001|Overall Study|Data Entry Error|0|||
125305199|NCT03343626|450744995|FG002|Overall Study|Data Entry Error|0|||
125305200|NCT03343626|450744996|FG003|Overall Study|Data Entry Error|0|||
125305201|NCT03343626|450744997|FG004|Overall Study|Data Entry Error|0|||
125305202|NCT03343626|450744998|FG005|Overall Study|Data Entry Error|0|||
125305203|NCT03343626|450744999|FG006|Overall Study|Data Entry Error|0|||
125305204|NCT03343626|450745000|FG007|Overall Study|Data Entry Error|1|||
125305205|NCT02475278|450745008|FG000|Overall Study|Lost to Follow-up|1|||
125305206|NCT02475278|450745008|FG000|Overall Study|Reason Not Specified|1|||
125305207|NCT00826618|450745009|FG000|Overall Study|Withdrawal by Subject|1|||
125305208|NCT03712787|450745010|FG000|Overall Study|Adverse Event|2|||
125305209|NCT03712787|450745011|FG001|Overall Study|Adverse Event|3|||
125305210|NCT03712787|450745012|FG002|Overall Study|Adverse Event|0|||
125305211|NCT03712787|450745013|FG003|Overall Study|Adverse Event|4|||
125305212|NCT03712787|450745010|FG000|Overall Study|Withdrawal by Subject|4|||
125305213|NCT03712787|450745011|FG001|Overall Study|Withdrawal by Subject|14|||
125305214|NCT03712787|450745012|FG002|Overall Study|Withdrawal by Subject|12|||
125504189|NCT01529632|451476046|FG001|Overall Study|Protocol Violation|1|||
125504190|NCT01529632|451476045|FG000|Overall Study|Adverse Event|1|||
125504191|NCT01529632|451476046|FG001|Overall Study|Adverse Event|1|||
125504192|NCT01276509|451477735|FG000|Overall Study|Adverse Event|9|||
125504193|NCT01276509|451477736|FG001|Overall Study|Adverse Event|8|||
125504194|NCT01276509|451477737|FG002|Overall Study|Adverse Event|4|||
125504195|NCT01276509|451477738|FG003|Overall Study|Adverse Event|3|||
125504196|NCT01276509|451477735|FG000|Overall Study|Lack of Efficacy|2|||
125305215|NCT03712787|450745013|FG003|Overall Study|Withdrawal by Subject|8|||
125305216|NCT03712787|450745010|FG000|Overall Study|Lost to Follow-up|1|||
125305217|NCT03712787|450745011|FG001|Overall Study|Lost to Follow-up|1|||
125305218|NCT03712787|450745012|FG002|Overall Study|Lost to Follow-up|2|||
125305219|NCT03712787|450745013|FG003|Overall Study|Lost to Follow-up|1|||
125305220|NCT03712787|450745010|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
125305221|NCT03712787|450745011|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
125504197|NCT01276509|451477736|FG001|Overall Study|Lack of Efficacy|1|||
125305222|NCT03712787|450745012|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
125305223|NCT03712787|450745013|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
125305224|NCT03712787|450745010|FG000|Overall Study|COVID-19 Infection|0|||
125305225|NCT03712787|450745011|FG001|Overall Study|COVID-19 Infection|1|||
125305226|NCT03712787|450745012|FG002|Overall Study|COVID-19 Infection|0|||
125305227|NCT03712787|450745013|FG003|Overall Study|COVID-19 Infection|0|||
125305228|NCT03712787|450745010|FG000|Overall Study|Other, Not Specified|79|||
125305229|NCT03712787|450745011|FG001|Overall Study|Other, Not Specified|77|||
125305230|NCT03712787|450745012|FG002|Overall Study|Other, Not Specified|74|||
125504198|NCT01276509|451477737|FG002|Overall Study|Lack of Efficacy|1|||
125305231|NCT03712787|450745013|FG003|Overall Study|Other, Not Specified|78|||
125305232|NCT00931606|450745015|FG000|Overall Study|Death|1|||
125504199|NCT01276509|451477738|FG003|Overall Study|Lack of Efficacy|2|||
125504200|NCT01276509|451477735|FG000|Overall Study|Pregnancy|1|||
125504201|NCT01276509|451477736|FG001|Overall Study|Pregnancy|0|||
125504202|NCT01276509|451477737|FG002|Overall Study|Pregnancy|0|||
125504203|NCT01276509|451477738|FG003|Overall Study|Pregnancy|0|||
125504204|NCT01276509|451477735|FG000|Overall Study|Withdrawal by Subject|1|||
125504205|NCT01276509|451477736|FG001|Overall Study|Withdrawal by Subject|2|||
125504206|NCT01276509|451477737|FG002|Overall Study|Withdrawal by Subject|0|||
125504207|NCT01276509|451477738|FG003|Overall Study|Withdrawal by Subject|0|||
125504208|NCT01276509|451477735|FG000|Overall Study|Other|0|||
125504209|NCT01276509|451477736|FG001|Overall Study|Other|1|||
125504210|NCT01276509|451477737|FG002|Overall Study|Other|0|||
125504211|NCT01276509|451477738|FG003|Overall Study|Other|0|||
125504212|NCT02196259|451477744|FG000|Overall Study|Researcher choice|0|||
125504213|NCT02196259|451477745|FG001|Overall Study|Researcher choice|0|||
125504214|NCT02196259|451477746|FG002|Overall Study|Researcher choice|1|||
125504215|NCT02196259|451477744|FG000|Overall Study|Partial data analysis|0|||
125504216|NCT02196259|451477745|FG001|Overall Study|Partial data analysis|3|||
125504217|NCT02196259|451477746|FG002|Overall Study|Partial data analysis|0|||
125504218|NCT01668355|451477747|FG000|Overall Study|Death|3|||
125504219|NCT01668355|451477748|FG001|Overall Study|Death|1|||
125504220|NCT01668355|451477747|FG000|Overall Study|Withdrawal by Subject|6|||
125504221|NCT01668355|451477748|FG001|Overall Study|Withdrawal by Subject|1|||
125504222|NCT00215943|451477749|FG000|Overall Study|Disease Progression|3|||
125504223|NCT00215943|451477750|FG001|Overall Study|Disease Progression|5|||
125504224|NCT00215943|451477749|FG000|Overall Study|Alternate therapy|0|||
125504225|NCT00215943|451477750|FG001|Overall Study|Alternate therapy|1|||
125504226|NCT00215943|451477749|FG000|Overall Study|Adverse Event|3|||
125504227|NCT00215943|451477750|FG001|Overall Study|Adverse Event|6|||
125504228|NCT00215943|451477749|FG000|Overall Study|Other disease|0|||
125504229|NCT00215943|451477750|FG001|Overall Study|Other disease|1|||
125504230|NCT00215943|451477749|FG000|Overall Study|Other complications|3|||
125504231|NCT00215943|451477750|FG001|Overall Study|Other complications|1|||
125504232|NCT00403845|451477757|FG000|Treatment Period 1|Subject withdrew consent|1|||
125504233|NCT00403845|451477758|FG001|Treatment Period 1|Subject withdrew consent|0|||
125504234|NCT00403845|451477759|FG002|Treatment Period 1|Subject withdrew consent|0|||
125504235|NCT00403845|451477760|FG003|Treatment Period 1|Subject withdrew consent|0|||
125504236|NCT00403845|451477757|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
125504237|NCT00403845|451477758|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
125504238|NCT00403845|451477759|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
125504239|NCT00403845|451477760|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
125504240|NCT00403845|451477757|FG000|Treatment Period 2|Subject withdrew consent|1|||
125504241|NCT00403845|451477758|FG001|Treatment Period 2|Subject withdrew consent|0|||
125504242|NCT00403845|451477759|FG002|Treatment Period 2|Subject withdrew consent|0|||
125504243|NCT00403845|451477760|FG003|Treatment Period 2|Subject withdrew consent|0|||
125504244|NCT00403845|451477757|FG000|Treatment Period 3|Subject withdrew consent|0|||
125504245|NCT00403845|451477758|FG001|Treatment Period 3|Subject withdrew consent|0|||
125504246|NCT00403845|451477759|FG002|Treatment Period 3|Subject withdrew consent|0|||
125504247|NCT00403845|451477760|FG003|Treatment Period 3|Subject withdrew consent|1|||
125504248|NCT00403845|451477757|FG000|Treatment Period 3|Adverse Event|0|||
125504249|NCT00403845|451477758|FG001|Treatment Period 3|Adverse Event|0|||
125504250|NCT00403845|451477759|FG002|Treatment Period 3|Adverse Event|0|||
125504251|NCT00403845|451477760|FG003|Treatment Period 3|Adverse Event|1|||
125504252|NCT02152384|451477761|FG000|Period 1|Withdrawal by Subject|0|||
125504253|NCT02152384|451477762|FG001|Period 1|Withdrawal by Subject|1|||
125504254|NCT02152384|451477761|FG000|Period 1|Adverse Event|1|||
125504255|NCT02152384|451477762|FG001|Period 1|Adverse Event|1|||
125504256|NCT00088166|451477764|FG000|Overall Study|Adverse Event|11|||
125504257|NCT00088166|451477765|FG001|Overall Study|Adverse Event|9|||
125504258|NCT00088166|451477764|FG000|Overall Study|Death|3|||
125504259|NCT00088166|451477765|FG001|Overall Study|Death|1|||
125504260|NCT00088166|451477764|FG000|Overall Study|Lost to Follow-up|0|||
125504261|NCT00088166|451477765|FG001|Overall Study|Lost to Follow-up|1|||
125504262|NCT00088166|451477764|FG000|Overall Study|Physician Decision|4|||
125504263|NCT00088166|451477765|FG001|Overall Study|Physician Decision|1|||
125504264|NCT00088166|451477764|FG000|Overall Study|Protocol Violation|1|||
125504265|NCT00088166|451477765|FG001|Overall Study|Protocol Violation|5|||
125504266|NCT00088166|451477764|FG000|Overall Study|Patient deterioration|29|||
125504267|NCT00088166|451477765|FG001|Overall Study|Patient deterioration|39|||
125504268|NCT00088166|451477764|FG000|Overall Study|Withdrawal by Subject|5|||
125504269|NCT00088166|451477765|FG001|Overall Study|Withdrawal by Subject|5|||
125504270|NCT02671266|451477766|FG000|Overall Study|Withdrawal by Subject|1|||
125504271|NCT02671266|451477767|FG001|Overall Study|Withdrawal by Subject|1|||
125504272|NCT00666705|451477768|FG000|Overall Study|Withdrawal by Subject|1|||
125504273|NCT01228734|451477769|FG000|Overall Study|Randomized, but not treated|0|||
125504274|NCT01228734|451477770|FG001|Overall Study|Randomized, but not treated|4|||
125504275|NCT01109979|451477771|FG000|Overall Study|Physician Decision|2|||
125504276|NCT01109979|451477772|FG001|Overall Study|Physician Decision|0|||
125504277|NCT01109979|451477771|FG000|Overall Study|Withdrawal by Subject|0|||
125504278|NCT01109979|451477772|FG001|Overall Study|Withdrawal by Subject|1|||
125504279|NCT03128099|451477776|FG000|Overall Study|High dose task was too long|0|||
125504280|NCT03128099|451477777|FG001|Overall Study|High dose task was too long|4|||
125504281|NCT03128099|451477778|FG002|Overall Study|High dose task was too long|0|||
125504282|NCT03128099|451477776|FG000|Overall Study|Participant got a full time job.|1|||
125504283|NCT03128099|451477777|FG001|Overall Study|Participant got a full time job.|0|||
125504284|NCT03128099|451477778|FG002|Overall Study|Participant got a full time job.|0|||
125504285|NCT03128099|451477776|FG000|Overall Study|Became homeless and lost contact|1|||
125504286|NCT03128099|451477777|FG001|Overall Study|Became homeless and lost contact|0|||
125504287|NCT03128099|451477778|FG002|Overall Study|Became homeless and lost contact|0|||
125504288|NCT03128099|451477776|FG000|Overall Study|Did not complete all the assessments|0|||
125504289|NCT03128099|451477777|FG001|Overall Study|Did not complete all the assessments|0|||
125504290|NCT03128099|451477778|FG002|Overall Study|Did not complete all the assessments|1|||
125504291|NCT03456856|451477779|FG000|Overall Study|Lost to Follow-up|2|||
125504292|NCT03456856|451477779|FG000|Overall Study|Withdrawal by Subject|1|||
125504293|NCT02542696|451477784|FG000|Overall Study|Adverse Event|167|||
125504294|NCT02542696|451477784|FG000|Overall Study|Lack of Efficacy|26|||
125504295|NCT02542696|451477784|FG000|Overall Study|Lost to Follow-up|6|||
125504296|NCT02542696|451477784|FG000|Overall Study|Withdrawal by Subject|104|||
125504297|NCT02542696|451477784|FG000|Overall Study|Protocol Violation|5|||
125504298|NCT02542696|451477784|FG000|Overall Study|Death|8|||
125504299|NCT02542696|451477784|FG000|Overall Study|DECREASED OFF TIME|1|||
125504300|NCT02542696|451477784|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
125504301|NCT02542696|451477784|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
125504302|NCT02542696|451477784|FG000|Overall Study|MEDICAL HISTORY|1|||
125504303|NCT02542696|451477784|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
125504304|NCT02542696|451477784|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
125504305|NCT02542696|451477784|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
125504306|NCT02542696|451477784|FG000|Overall Study|SPONSOR DECISION|3|||
125504307|NCT02542696|451477784|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
125504308|NCT02542696|451477784|FG000|Overall Study|SUBJECT DECISION|2|||
125504309|NCT02410278|451477785|FG000|Run-in Period|Adverse Event|5|||
125504310|NCT02410278|451477786|FG001|Run-in Period|Adverse Event|0|||
125504311|NCT02410278|451477787|FG002|Run-in Period|Adverse Event|0|||
125504312|NCT02410278|451477785|FG000|Run-in Period|GSRS Threshold Not Met|30|||
125504313|NCT02410278|451477786|FG001|Run-in Period|GSRS Threshold Not Met|0|||
125504314|NCT02410278|451477787|FG002|Run-in Period|GSRS Threshold Not Met|0|||
125504315|NCT02410278|451477785|FG000|Run-in Period|Lost to Follow-up|1|||
125504316|NCT02410278|451477786|FG001|Run-in Period|Lost to Follow-up|0|||
125504317|NCT02410278|451477787|FG002|Run-in Period|Lost to Follow-up|0|||
125504318|NCT02410278|451477785|FG000|Run-in Period|Withdrawal by Subject|1|||
125504319|NCT02410278|451477786|FG001|Run-in Period|Withdrawal by Subject|0|||
125504320|NCT02410278|451477787|FG002|Run-in Period|Withdrawal by Subject|0|||
125504321|NCT02410278|451477785|FG000|Run-in Period|Pregnancy|1|||
125504322|NCT02410278|451477786|FG001|Run-in Period|Pregnancy|0|||
125504323|NCT02410278|451477787|FG002|Run-in Period|Pregnancy|0|||
125504324|NCT02410278|451477785|FG000|Study Treatment Period|Adverse Event|0|||
125504325|NCT02410278|451477786|FG001|Study Treatment Period|Adverse Event|6|||
125504326|NCT02410278|451477787|FG002|Study Treatment Period|Adverse Event|3|||
125504327|NCT02410278|451477785|FG000|Study Treatment Period|Physician Decision|0|||
125504328|NCT02410278|451477786|FG001|Study Treatment Period|Physician Decision|0|||
125504329|NCT02410278|451477787|FG002|Study Treatment Period|Physician Decision|1|||
125504330|NCT02410278|451477785|FG000|Study Treatment Period|Withdrawal by Subject|0|||
125504331|NCT02410278|451477786|FG001|Study Treatment Period|Withdrawal by Subject|1|||
125305233|NCT00931606|450745016|FG001|Overall Study|Death|3|||
125305234|NCT00931606|450745017|FG002|Overall Study|Death|2|||
125305235|NCT00931606|450745018|FG003|Overall Study|Death|0|||
125305236|NCT00931606|450745015|FG000|Overall Study|Lost to Follow-up|0|||
125305237|NCT00931606|450745016|FG001|Overall Study|Lost to Follow-up|1|||
125305238|NCT00931606|450745017|FG002|Overall Study|Lost to Follow-up|0|||
125305239|NCT00931606|450745018|FG003|Overall Study|Lost to Follow-up|0|||
125305240|NCT00931606|450745015|FG000|Overall Study|Physician Decision|0|||
125305241|NCT00931606|450745016|FG001|Overall Study|Physician Decision|0|||
125305242|NCT00931606|450745017|FG002|Overall Study|Physician Decision|3|||
125305243|NCT00931606|450745018|FG003|Overall Study|Physician Decision|0|||
125305244|NCT00931606|450745015|FG000|Overall Study|Sponsor Decision|1|||
125305245|NCT00931606|450745016|FG001|Overall Study|Sponsor Decision|4|||
125305246|NCT00931606|450745017|FG002|Overall Study|Sponsor Decision|0|||
125305247|NCT00931606|450745018|FG003|Overall Study|Sponsor Decision|2|||
125504332|NCT02410278|451477787|FG002|Study Treatment Period|Withdrawal by Subject|0|||
125504333|NCT02410278|451477785|FG000|Study Treatment Period|Other|0|||
125504334|NCT02410278|451477786|FG001|Study Treatment Period|Other|3|||
125504335|NCT02410278|451477787|FG002|Study Treatment Period|Other|0|||
125504336|NCT02410278|451477785|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
125504337|NCT02410278|451477786|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
125504338|NCT02410278|451477787|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
125504339|NCT03695185|451477788|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
125504340|NCT03695185|451477788|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
125504341|NCT03695185|451477788|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
125504342|NCT03695185|451477788|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
125504343|NCT03695185|451477788|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
125504344|NCT03695185|451477788|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
125504345|NCT02584257|451477792|FG000|Period 1|Withdrawal by Subject|0|||
125504346|NCT02584257|451477793|FG001|Period 1|Withdrawal by Subject|0|||
125504347|NCT02584257|451477794|FG002|Period 1|Withdrawal by Subject|0|||
125504348|NCT02584257|451477795|FG003|Period 1|Withdrawal by Subject|0|||
125504349|NCT02584257|451477796|FG004|Period 1|Withdrawal by Subject|0|||
125504350|NCT02584257|451477797|FG005|Period 1|Withdrawal by Subject|0|||
125504351|NCT02584257|451477798|FG006|Period 1|Withdrawal by Subject|1|||
125504352|NCT02584257|451477799|FG007|Period 1|Withdrawal by Subject|0|||
125504353|NCT02584257|451477800|FG008|Period 1|Withdrawal by Subject|0|||
125504354|NCT02584257|451477792|FG000|Period 2|Physician Decision|1|||
125504355|NCT02584257|451477793|FG001|Period 2|Physician Decision|0|||
125504356|NCT02584257|451477794|FG002|Period 2|Physician Decision|0|||
125504357|NCT02584257|451477795|FG003|Period 2|Physician Decision|0|||
125305248|NCT00931606|450745015|FG000|Overall Study|Withdrawal by Subject|3|||
125305249|NCT00931606|450745016|FG001|Overall Study|Withdrawal by Subject|1|||
125305250|NCT00931606|450745017|FG002|Overall Study|Withdrawal by Subject|1|||
125305251|NCT00931606|450745018|FG003|Overall Study|Withdrawal by Subject|1|||
125305252|NCT03412812|450745026|FG000|Level 1|Death|3|||
125305253|NCT03412812|450745027|FG001|Level 1|Death|0|||
125305254|NCT03412812|450745026|FG000|Level 1|Adverse Event|0|||
125305255|NCT03412812|450745027|FG001|Level 1|Adverse Event|1|||
125305256|NCT02391363|450745033|FG000|Overall Study|Lost to Follow-up|5|||
125305257|NCT02391363|450745034|FG001|Overall Study|Lost to Follow-up|5|||
125305258|NCT02391363|450745033|FG000|Overall Study|Withdrawal by Subject|6|||
125305259|NCT02391363|450745034|FG001|Overall Study|Withdrawal by Subject|3|||
125305260|NCT03828617|450745035|FG000|Overall Study|Lost to Follow-up|22|||
125305261|NCT03828617|450745036|FG001|Overall Study|Lost to Follow-up|12|||
125305262|NCT03828617|450745037|FG002|Overall Study|Lost to Follow-up|23|||
125305263|NCT03828617|450745038|FG003|Overall Study|Lost to Follow-up|7|||
125305264|NCT03828617|450745035|FG000|Overall Study|No longer met eligibility criteria|0|||
125305265|NCT03828617|450745036|FG001|Overall Study|No longer met eligibility criteria|1|||
125305266|NCT03828617|450745037|FG002|Overall Study|No longer met eligibility criteria|1|||
125305267|NCT03828617|450745038|FG003|Overall Study|No longer met eligibility criteria|3|||
125305268|NCT03828617|450745035|FG000|Overall Study|Protocol Violation|0|||
125305269|NCT03828617|450745036|FG001|Overall Study|Protocol Violation|2|||
125305270|NCT03828617|450745037|FG002|Overall Study|Protocol Violation|0|||
125305271|NCT03828617|450745038|FG003|Overall Study|Protocol Violation|0|||
125305272|NCT03828617|450745035|FG000|Overall Study|Withdrawal by Subject|2|||
125305273|NCT03828617|450745036|FG001|Overall Study|Withdrawal by Subject|0|||
125305274|NCT03828617|450745037|FG002|Overall Study|Withdrawal by Subject|2|||
125305275|NCT03828617|450745038|FG003|Overall Study|Withdrawal by Subject|0|||
125305276|NCT04794270|450745039|FG000|Period 1|Non Compliance|1|||
125305277|NCT04794270|450745040|FG001|Period 1|Non Compliance|0|||
125305278|NCT04794270|450745039|FG000|Period 1|Adverse Event|1|||
125305279|NCT04794270|450745040|FG001|Period 1|Adverse Event|0|||
125305280|NCT04794270|450745039|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
125305281|NCT04794270|450745040|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
125305282|NCT00732875|450745045|FG000|Overall Study|Adverse Event|16|||
125305283|NCT00732875|450745045|FG000|Overall Study|Withdrawal by Subject|6|||
125305284|NCT00732875|450745045|FG000|Overall Study|Lack of Efficacy|13|||
125305285|NCT03826186|450745046|FG000|Overall Study|Protocol Violation|2|||
125305286|NCT03826186|450745047|FG001|Overall Study|Protocol Violation|0|||
125305287|NCT03826186|450745046|FG000|Overall Study|Withdrawal by Subject|1|||
125305288|NCT03826186|450745047|FG001|Overall Study|Withdrawal by Subject|0|||
125305289|NCT03688074|450745049|FG000|Overall Study|Adverse Event|0|||
125305290|NCT03688074|450745050|FG001|Overall Study|Adverse Event|1|||
125504358|NCT02584257|451477796|FG004|Period 2|Physician Decision|0|||
125504359|NCT02584257|451477797|FG005|Period 2|Physician Decision|0|||
125305291|NCT03688074|450745049|FG000|Overall Study|Other|1|||
125305292|NCT03688074|450745050|FG001|Overall Study|Other|0|||
125305293|NCT03056339|450745064|FG000|Overall Study|Failed Requirements|0|||
125305294|NCT03056339|450745065|FG001|Overall Study|Failed Requirements|2|||
125305295|NCT03056339|450745066|FG002|Overall Study|Failed Requirements|7|||
125305296|NCT03056339|450745067|FG003|Overall Study|Failed Requirements|1|||
125305297|NCT01128244|450745073|FG000|Overall Study|Adverse Event|1|||
125305298|NCT01128244|450745073|FG000|Overall Study|Scheduling conflict|2|||
125305299|NCT02219334|450745076|FG000|Overall Study|Withdrawal by Subject|1|||
125305300|NCT02219334|450745077|FG001|Overall Study|Withdrawal by Subject|0|||
125305301|NCT02219334|450745076|FG000|Overall Study|Protocol Violation|7|||
125305302|NCT02219334|450745077|FG001|Overall Study|Protocol Violation|3|||
125504360|NCT02584257|451477798|FG006|Period 2|Physician Decision|0|||
125504361|NCT02584257|451477799|FG007|Period 2|Physician Decision|0|||
125504362|NCT02584257|451477800|FG008|Period 2|Physician Decision|0|||
125504363|NCT02584257|451477792|FG000|Period 2|Adverse Event|0|||
125504364|NCT02584257|451477793|FG001|Period 2|Adverse Event|1|||
125504365|NCT02584257|451477794|FG002|Period 2|Adverse Event|0|||
125504366|NCT02584257|451477795|FG003|Period 2|Adverse Event|0|||
125504367|NCT02584257|451477796|FG004|Period 2|Adverse Event|0|||
125504368|NCT02584257|451477797|FG005|Period 2|Adverse Event|0|||
125504369|NCT02584257|451477798|FG006|Period 2|Adverse Event|0|||
125504370|NCT02584257|451477799|FG007|Period 2|Adverse Event|0|||
125504371|NCT02584257|451477800|FG008|Period 2|Adverse Event|0|||
125504372|NCT02137785|451477801|FG000|Overall Study|Lost to Follow-up|1|||
125504373|NCT02137785|451477802|FG001|Overall Study|Lost to Follow-up|0|||
125504374|NCT02137785|451477801|FG000|Overall Study|Withdrawal by Subject|1|||
125504375|NCT02137785|451477802|FG001|Overall Study|Withdrawal by Subject|4|||
125504376|NCT02137785|451477801|FG000|Overall Study|subject moved out of state|1|||
125504377|NCT02137785|451477802|FG001|Overall Study|subject moved out of state|0|||
125504378|NCT01670877|451477803|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
125504379|NCT01670877|451477804|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
125504380|NCT01670877|451477805|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
125504381|NCT01670877|451477806|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
125504382|NCT01670877|451477807|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
125504383|NCT01670877|451477808|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
125504384|NCT01670877|451477803|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
125504385|NCT01670877|451477804|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
125504386|NCT01670877|451477805|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
125504387|NCT01670877|451477806|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
125504388|NCT01670877|451477807|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
125504389|NCT01670877|451477808|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
125504390|NCT01670877|451477803|FG000|Part I and Part 2|Grade 2 vomiting|0|||
125504391|NCT01670877|451477804|FG001|Part I and Part 2|Grade 2 vomiting|0|||
125504392|NCT01670877|451477805|FG002|Part I and Part 2|Grade 2 vomiting|0|||
125504393|NCT01670877|451477806|FG003|Part I and Part 2|Grade 2 vomiting|1|||
125504394|NCT01670877|451477807|FG004|Part I and Part 2|Grade 2 vomiting|0|||
125504395|NCT01670877|451477808|FG005|Part I and Part 2|Grade 2 vomiting|0|||
125504396|NCT01670877|451477803|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
125504397|NCT01670877|451477804|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
125504398|NCT01670877|451477805|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
125504399|NCT01670877|451477806|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
125504400|NCT01670877|451477807|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
125504401|NCT01670877|451477808|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
125504402|NCT01670877|451477803|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
125504403|NCT01670877|451477804|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
125504404|NCT01670877|451477805|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
125504405|NCT01670877|451477806|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
125504406|NCT01670877|451477807|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
125504407|NCT01670877|451477808|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
125504408|NCT03390166|451477809|FG000|Overall Study|Death|0|||
125504409|NCT03390166|451477810|FG001|Overall Study|Death|1|||
125305303|NCT04171219|450745078|FG000|Overall Study|Adverse Event|1|||
125305304|NCT04171219|450745079|FG001|Overall Study|Adverse Event|0|||
125305305|NCT04171219|450745078|FG000|Overall Study|Death|0|||
125305306|NCT04171219|450745079|FG001|Overall Study|Death|1|||
125305307|NCT04171219|450745078|FG000|Overall Study|Lack of Efficacy|9|||
125305308|NCT04171219|450745079|FG001|Overall Study|Lack of Efficacy|13|||
125305309|NCT04171219|450745078|FG000|Overall Study|Withdrawal by Subject|1|||
125305310|NCT04171219|450745079|FG001|Overall Study|Withdrawal by Subject|2|||
125305311|NCT04171219|450745078|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
125305312|NCT04171219|450745079|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
125305313|NCT04171219|450745078|FG000|Overall Study|Clinical PD/Patient choice|1|||
125305314|NCT04171219|450745079|FG001|Overall Study|Clinical PD/Patient choice|0|||
125305315|NCT04171219|450745078|FG000|Overall Study|Toxicity/ Patient choice|1|||
125305316|NCT04171219|450745079|FG001|Overall Study|Toxicity/ Patient choice|0|||
125305317|NCT04838626|450745080|FG000|Overall Study|Adverse Event|2|||
125305318|NCT04838626|450745080|FG000|Overall Study|Physician Decision|6|||
125305319|NCT04838626|450745080|FG000|Overall Study|Protocol Violation|3|||
125305320|NCT04838626|450745080|FG000|Overall Study|Withdrawal by Subject|9|||
125504410|NCT03390166|451477809|FG000|Overall Study|Lost to Follow-up|6|||
125504411|NCT03390166|451477810|FG001|Overall Study|Lost to Follow-up|4|||
125504412|NCT03390166|451477809|FG000|Overall Study|Physician Decision|2|||
125504413|NCT03390166|451477810|FG001|Overall Study|Physician Decision|1|||
125504414|NCT03390166|451477809|FG000|Overall Study|Move from study area|3|||
125504415|NCT03390166|451477810|FG001|Overall Study|Move from study area|2|||
125305321|NCT04838626|450745080|FG000|Overall Study|Technical Problems|2|||
125504416|NCT03390166|451477809|FG000|Overall Study|To militarycamp for conscript|1|||
125504417|NCT03390166|451477810|FG001|Overall Study|To militarycamp for conscript|0|||
125504418|NCT03390166|451477809|FG000|Overall Study|To drug therapy course|0|||
125504419|NCT03390166|451477810|FG001|Overall Study|To drug therapy course|1|||
125504420|NCT03390166|451477809|FG000|Overall Study|Move to work oversea|0|||
125504421|NCT03390166|451477810|FG001|Overall Study|Move to work oversea|1|||
125504422|NCT03693989|451477813|FG000|Overall Study|Protocol Violation|3|||
125504423|NCT03693989|451477814|FG001|Overall Study|Protocol Violation|4|||
125504424|NCT00113529|451477815|FG000|Overall Study|Adverse Event|4|||
125504425|NCT00113529|451477815|FG000|Overall Study|Lack of Efficacy|20|||
125504426|NCT00113529|451477815|FG000|Overall Study|Decision of sponsor|6|||
125504427|NCT00113529|451477815|FG000|Overall Study|Withdrawal by Subject|4|||
125504428|NCT02825550|451477817|FG000|Overall Study|Physician Decision|1|||
125504429|NCT00042939|451477818|FG000|Overall Study|Adverse Event|6|||
125504430|NCT00042939|451477819|FG001|Overall Study|Adverse Event|7|||
125504431|NCT00042939|451477818|FG000|Overall Study|Death|3|||
125504432|NCT00042939|451477819|FG001|Overall Study|Death|2|||
125504433|NCT00042939|451477818|FG000|Overall Study|Withdrawal by Subject|3|||
125504434|NCT00042939|451477819|FG001|Overall Study|Withdrawal by Subject|4|||
125504435|NCT00042939|451477818|FG000|Overall Study|Other disease|1|||
125504436|NCT00042939|451477819|FG001|Overall Study|Other disease|0|||
125504437|NCT00042939|451477818|FG000|Overall Study|Ineligible|2|||
125504438|NCT00042939|451477819|FG001|Overall Study|Ineligible|2|||
125504439|NCT00042939|451477818|FG000|Overall Study|Deterioration of health|3|||
125504440|NCT00042939|451477819|FG001|Overall Study|Deterioration of health|4|||
125504441|NCT00042939|451477818|FG000|Overall Study|QOL diminished|1|||
125504442|NCT00042939|451477819|FG001|Overall Study|QOL diminished|0|||
125504443|NCT00042939|451477818|FG000|Overall Study|Rising ca 19-9|1|||
125504444|NCT00042939|451477819|FG001|Overall Study|Rising ca 19-9|0|||
125504445|NCT00042939|451477818|FG000|Overall Study|Patient non-compliance|1|||
125504446|NCT00042939|451477819|FG001|Overall Study|Patient non-compliance|0|||
125504447|NCT00042939|451477818|FG000|Overall Study|Still on treatment|1|||
125504448|NCT00042939|451477819|FG001|Overall Study|Still on treatment|0|||
125504449|NCT00042939|451477818|FG000|Overall Study|Treatment break > 4 weeks|0|||
125504450|NCT00042939|451477819|FG001|Overall Study|Treatment break > 4 weeks|1|||
125504451|NCT00042939|451477818|FG000|Overall Study|Did not start treatment|2|||
125504452|NCT00042939|451477819|FG001|Overall Study|Did not start treatment|1|||
125504453|NCT00795639|451477820|FG000|Overall Study|Death|1|||
125504454|NCT00795639|451477821|FG001|Overall Study|Death|6|||
125504455|NCT00795639|451477820|FG000|Overall Study|Withdrawal by Subject|1|||
125504456|NCT00795639|451477821|FG001|Overall Study|Withdrawal by Subject|3|||
125504457|NCT00795639|451477820|FG000|Overall Study|Pregnancy|1|||
125504458|NCT00795639|451477821|FG001|Overall Study|Pregnancy|0|||
125504459|NCT00795639|451477820|FG000|Overall Study|Adverse Event|5|||
125504460|NCT00795639|451477821|FG001|Overall Study|Adverse Event|2|||
125504461|NCT00795639|451477820|FG000|Overall Study|Other|0|||
125504462|NCT00795639|451477821|FG001|Overall Study|Other|2|||
125504463|NCT00795639|451477820|FG000|Overall Study|Terminated by sponsor|13|||
125504464|NCT00795639|451477821|FG001|Overall Study|Terminated by sponsor|12|||
125504465|NCT00795639|451477820|FG000|Overall Study|Randomized and not treated|0|||
125504466|NCT00795639|451477821|FG001|Overall Study|Randomized and not treated|1|||
125504467|NCT02525744|451477822|FG000|Period 1|Physician Decision|0|||
125504468|NCT02525744|451477823|FG001|Period 1|Physician Decision|0|||
125504469|NCT02525744|451477824|FG002|Period 1|Physician Decision|1|||
125504470|NCT02525744|451477825|FG003|Period 1|Physician Decision|0|||
125504471|NCT02525744|451477822|FG000|Period 3|Adverse Event|0|||
125504472|NCT02525744|451477823|FG001|Period 3|Adverse Event|1|||
125504473|NCT02525744|451477824|FG002|Period 3|Adverse Event|0|||
125504474|NCT02525744|451477825|FG003|Period 3|Adverse Event|0|||
125504475|NCT02525744|451477822|FG000|Period 4|Withdrawal by Subject|1|||
125504476|NCT02525744|451477823|FG001|Period 4|Withdrawal by Subject|0|||
125504477|NCT02525744|451477824|FG002|Period 4|Withdrawal by Subject|0|||
125504478|NCT02525744|451477825|FG003|Period 4|Withdrawal by Subject|0|||
125305322|NCT01934010|450745085|FG000|Overall Study|Adverse Event|1|||
125305323|NCT01934010|450745086|FG001|Overall Study|Adverse Event|1|||
125504479|NCT02525744|451477822|FG000|Period 5|Physician Decision|1|||
125504480|NCT02525744|451477823|FG001|Period 5|Physician Decision|0|||
125504481|NCT02525744|451477824|FG002|Period 5|Physician Decision|0|||
125504482|NCT02525744|451477825|FG003|Period 5|Physician Decision|0|||
125504483|NCT01138657|451477828|FG000|Overall Study|Adverse Event|3|||
125504484|NCT01138657|451477829|FG001|Overall Study|Adverse Event|10|||
125504485|NCT01138657|451477828|FG000|Overall Study|Lack of Efficacy|2|||
125504486|NCT01138657|451477829|FG001|Overall Study|Lack of Efficacy|1|||
125504487|NCT01138657|451477828|FG000|Overall Study|Lost to Follow-up|0|||
125504488|NCT01138657|451477829|FG001|Overall Study|Lost to Follow-up|3|||
125305324|NCT01934010|450745087|FG002|Overall Study|Adverse Event|0|||
125504489|NCT01138657|451477828|FG000|Overall Study|Miscellaneous Reasons|3|||
125504490|NCT01138657|451477829|FG001|Overall Study|Miscellaneous Reasons|4|||
125504491|NCT03150589|451477830|FG000|Overall Study|Withdrawal by Subject|16|||
125504492|NCT03150589|451477831|FG001|Overall Study|Withdrawal by Subject|9|||
125504493|NCT03150589|451477830|FG000|Overall Study|Adverse Event|7|||
125504494|NCT03150589|451477831|FG001|Overall Study|Adverse Event|6|||
125504495|NCT03150589|451477830|FG000|Overall Study|Protocol Violation|4|||
125504496|NCT03150589|451477831|FG001|Overall Study|Protocol Violation|3|||
125504497|NCT03150589|451477830|FG000|Overall Study|Lost to Follow-up|3|||
125504498|NCT03150589|451477831|FG001|Overall Study|Lost to Follow-up|3|||
125504499|NCT03150589|451477830|FG000|Overall Study|Death|2|||
125504500|NCT03150589|451477831|FG001|Overall Study|Death|3|||
125504501|NCT03150589|451477830|FG000|Overall Study|IP non-compliance and other reasons|12|||
125504502|NCT03150589|451477831|FG001|Overall Study|IP non-compliance and other reasons|3|||
125504503|NCT01000649|451477834|FG000|Overall Study|Adverse Event|5|||
125504504|NCT01000649|451477835|FG001|Overall Study|Adverse Event|1|||
125504505|NCT01000649|451477836|FG002|Overall Study|Adverse Event|2|||
125504506|NCT01000649|451477837|FG003|Overall Study|Adverse Event|4|||
125504507|NCT01000649|451477834|FG000|Overall Study|Lost to Follow-up|0|||
125504508|NCT01000649|451477835|FG001|Overall Study|Lost to Follow-up|2|||
125504509|NCT01000649|451477836|FG002|Overall Study|Lost to Follow-up|0|||
125504510|NCT01000649|451477837|FG003|Overall Study|Lost to Follow-up|2|||
125504511|NCT00346398|451477838|FG000|Overall Study|Lost to Follow-up|3|||
125504512|NCT00346398|451477839|FG001|Overall Study|Lost to Follow-up|0|||
125504513|NCT00346398|451477838|FG000|Overall Study|Withdrawal by Subject|0|||
125504514|NCT00346398|451477839|FG001|Overall Study|Withdrawal by Subject|2|||
125504515|NCT03979040|451477840|FG000|Overall Study|Withdrawal by Subject|24|||
125504516|NCT03979040|451477841|FG001|Overall Study|Withdrawal by Subject|32|||
125504517|NCT03979040|451477840|FG000|Overall Study|randomized but never started treatment|32|||
125504518|NCT03979040|451477841|FG001|Overall Study|randomized but never started treatment|39|||
125504519|NCT03979040|451477840|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
125504520|NCT03979040|451477841|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
125504521|NCT02607956|451477842|FG000|Double-Blinded Phase|Withdrew Consent|17|||
125504522|NCT02607956|451477843|FG001|Double-Blinded Phase|Withdrew Consent|19|||
125504523|NCT02607956|451477844|FG002|Double-Blinded Phase|Withdrew Consent|0|||
125504524|NCT02607956|451477845|FG003|Double-Blinded Phase|Withdrew Consent|0|||
125504525|NCT02607956|451477842|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
125504526|NCT02607956|451477843|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
125504527|NCT02607956|451477844|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
125504528|NCT02607956|451477845|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
125504529|NCT02607956|451477842|FG000|Double-Blinded Phase|Randomized but never treated|7|||
125504530|NCT02607956|451477843|FG001|Double-Blinded Phase|Randomized but never treated|5|||
125504531|NCT02607956|451477844|FG002|Double-Blinded Phase|Randomized but never treated|0|||
125504532|NCT02607956|451477845|FG003|Double-Blinded Phase|Randomized but never treated|0|||
125504533|NCT02607956|451477842|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
125504534|NCT02607956|451477843|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
125504535|NCT02607956|451477844|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
125504536|NCT02607956|451477845|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
125504537|NCT02607956|451477842|FG000|Double-Blinded Phase|Death|4|||
125504538|NCT02607956|451477843|FG001|Double-Blinded Phase|Death|4|||
125504539|NCT02607956|451477844|FG002|Double-Blinded Phase|Death|0|||
125504540|NCT02607956|451477845|FG003|Double-Blinded Phase|Death|0|||
125504541|NCT02607956|451477842|FG000|Double-Blinded Phase|Adverse Event|4|||
125504542|NCT02607956|451477843|FG001|Double-Blinded Phase|Adverse Event|3|||
125504543|NCT02607956|451477844|FG002|Double-Blinded Phase|Adverse Event|0|||
125504544|NCT02607956|451477845|FG003|Double-Blinded Phase|Adverse Event|0|||
125504545|NCT02607956|451477842|FG000|Double-Blinded Phase|Protocol Violation|3|||
125504546|NCT02607956|451477843|FG001|Double-Blinded Phase|Protocol Violation|1|||
125504547|NCT02607956|451477844|FG002|Double-Blinded Phase|Protocol Violation|0|||
125504548|NCT02607956|451477845|FG003|Double-Blinded Phase|Protocol Violation|0|||
125504549|NCT02607956|451477842|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
125504550|NCT02607956|451477843|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
125504551|NCT02607956|451477844|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
125504552|NCT02607956|451477845|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
125504553|NCT02607956|451477842|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
125504554|NCT02607956|451477843|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
125504555|NCT02607956|451477844|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
125504556|NCT02607956|451477845|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
125504557|NCT02607956|451477842|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
125504558|NCT02607956|451477843|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
125504559|NCT02607956|451477844|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
125504560|NCT02607956|451477845|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
125504561|NCT02607956|451477842|FG000|Open-Label Extension Phase|Death|0|||
125504562|NCT02607956|451477843|FG001|Open-Label Extension Phase|Death|0|||
125504563|NCT02607956|451477844|FG002|Open-Label Extension Phase|Death|1|||
125504564|NCT02607956|451477845|FG003|Open-Label Extension Phase|Death|3|||
125504565|NCT02607956|451477842|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
125504566|NCT02607956|451477843|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
125504567|NCT02607956|451477844|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
125504568|NCT02607956|451477845|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
125504569|NCT02607956|451477842|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
125504570|NCT02607956|451477843|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
125504571|NCT02607956|451477844|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
125504572|NCT02607956|451477845|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
125504573|NCT02607956|451477842|FG000|Open-Label Extension Phase|Protocol Violation|0|||
125504574|NCT02607956|451477843|FG001|Open-Label Extension Phase|Protocol Violation|0|||
125504575|NCT02607956|451477844|FG002|Open-Label Extension Phase|Protocol Violation|0|||
125504576|NCT02607956|451477845|FG003|Open-Label Extension Phase|Protocol Violation|2|||
125504577|NCT02607956|451477842|FG000|Open-Label Extension Phase|Pregnancy|0|||
125504578|NCT02607956|451477843|FG001|Open-Label Extension Phase|Pregnancy|0|||
125504579|NCT02607956|451477844|FG002|Open-Label Extension Phase|Pregnancy|0|||
125504580|NCT02607956|451477845|FG003|Open-Label Extension Phase|Pregnancy|1|||
125504581|NCT01005914|451477846|FG000|Overall Study|Adverse Event|4|||
125504582|NCT01005914|451477846|FG000|Overall Study|Death|4|||
125504583|NCT01005914|451477846|FG000|Overall Study|Lack of Efficacy|1|||
125504584|NCT01005914|451477846|FG000|Overall Study|Withdrawal by Subject|1|||
125504585|NCT01240785|451477848|FG000|Overall Study|Lost to Follow-up|1|||
125504586|NCT01240785|451477849|FG001|Overall Study|Lost to Follow-up|0|||
125504587|NCT01240785|451477848|FG000|Overall Study|Protocol Violation|0|||
125504588|NCT01240785|451477849|FG001|Overall Study|Protocol Violation|3|||
125504589|NCT00696241|451477850|FG000|Overall Study|Adverse Event|11|||
125504590|NCT00696241|451477851|FG001|Overall Study|Adverse Event|3|||
125504591|NCT00696241|451477852|FG002|Overall Study|Adverse Event|6|||
125504592|NCT00696241|451477853|FG003|Overall Study|Adverse Event|4|||
125504593|NCT00696241|451477854|FG004|Overall Study|Adverse Event|5|||
125504594|NCT00696241|451477850|FG000|Overall Study|Protocol Violation|1|||
125504595|NCT00696241|451477851|FG001|Overall Study|Protocol Violation|1|||
125504596|NCT00696241|451477852|FG002|Overall Study|Protocol Violation|2|||
125504597|NCT00696241|451477853|FG003|Overall Study|Protocol Violation|0|||
125504598|NCT00696241|451477854|FG004|Overall Study|Protocol Violation|3|||
125504599|NCT00696241|451477850|FG000|Overall Study|Lost to Follow-up|1|||
125504600|NCT00696241|451477851|FG001|Overall Study|Lost to Follow-up|4|||
125504601|NCT00696241|451477852|FG002|Overall Study|Lost to Follow-up|1|||
125504602|NCT00696241|451477853|FG003|Overall Study|Lost to Follow-up|2|||
125504603|NCT00696241|451477854|FG004|Overall Study|Lost to Follow-up|0|||
125504604|NCT00696241|451477850|FG000|Overall Study|Withdrawal by Subject|4|||
125504605|NCT00696241|451477851|FG001|Overall Study|Withdrawal by Subject|8|||
125504606|NCT00696241|451477852|FG002|Overall Study|Withdrawal by Subject|6|||
125504607|NCT00696241|451477853|FG003|Overall Study|Withdrawal by Subject|1|||
125504608|NCT00696241|451477854|FG004|Overall Study|Withdrawal by Subject|0|||
125504609|NCT00696241|451477850|FG000|Overall Study|Lack of Efficacy|1|||
125504610|NCT00696241|451477851|FG001|Overall Study|Lack of Efficacy|5|||
125504611|NCT00696241|451477852|FG002|Overall Study|Lack of Efficacy|4|||
125504612|NCT00696241|451477853|FG003|Overall Study|Lack of Efficacy|5|||
125504613|NCT00696241|451477854|FG004|Overall Study|Lack of Efficacy|3|||
125504614|NCT00696241|451477850|FG000|Overall Study|Other|6|||
125504615|NCT00696241|451477851|FG001|Overall Study|Other|1|||
125504616|NCT00696241|451477852|FG002|Overall Study|Other|5|||
125504617|NCT00696241|451477853|FG003|Overall Study|Other|2|||
125504618|NCT00696241|451477854|FG004|Overall Study|Other|1|||
125504619|NCT03347396|451477857|FG000|Part A (26 Weeks)|Adverse Event|1|||
125504620|NCT03347396|451477858|FG001|Part A (26 Weeks)|Adverse Event|0|||
125504621|NCT03347396|451477857|FG000|Part A (26 Weeks)|Death|0|||
125504622|NCT03347396|451477858|FG001|Part A (26 Weeks)|Death|1|||
125504623|NCT03347396|451477857|FG000|Part B (149 Weeks)|Adverse Event|1|||
125504624|NCT03347396|451477858|FG001|Part B (149 Weeks)|Adverse Event|1|||
125504625|NCT03347396|451477857|FG000|Part B (149 Weeks)|Death|1|||
125504626|NCT03347396|451477858|FG001|Part B (149 Weeks)|Death|0|||
125504627|NCT03060525|451477859|FG000|Overall Study|moved out of state|1|||
125504628|NCT03060525|451477860|FG001|Overall Study|moved out of state|1|||
125504629|NCT03060525|451477861|FG002|Overall Study|moved out of state|1|||
125504630|NCT03060525|451477862|FG003|Overall Study|moved out of state|1|||
125504631|NCT03060525|451477859|FG000|Overall Study|unable to meet time commitment required of study|2|||
125504632|NCT03060525|451477860|FG001|Overall Study|unable to meet time commitment required of study|3|||
125504633|NCT03060525|451477861|FG002|Overall Study|unable to meet time commitment required of study|3|||
125504634|NCT03060525|451477862|FG003|Overall Study|unable to meet time commitment required of study|1|||
125504635|NCT03060525|451477859|FG000|Overall Study|no longer interested in doing intervention|0|||
125504636|NCT03060525|451477860|FG001|Overall Study|no longer interested in doing intervention|0|||
125504637|NCT03060525|451477861|FG002|Overall Study|no longer interested in doing intervention|0|||
125504638|NCT03060525|451477862|FG003|Overall Study|no longer interested in doing intervention|1|||
125504639|NCT01294644|451477868|FG000|Overall Study|Adverse Event|2|||
125504640|NCT01294644|451477869|FG001|Overall Study|Adverse Event|0|||
125504641|NCT01294644|451477870|FG002|Overall Study|Adverse Event|1|||
125504642|NCT01294644|451477868|FG000|Overall Study|Withdrawal by Subject|3|||
125504643|NCT01294644|451477869|FG001|Overall Study|Withdrawal by Subject|7|||
125504644|NCT01294644|451477870|FG002|Overall Study|Withdrawal by Subject|4|||
125504645|NCT01294644|451477868|FG000|Overall Study|Lost to Follow-up|3|||
125504646|NCT01294644|451477869|FG001|Overall Study|Lost to Follow-up|2|||
125504647|NCT01294644|451477870|FG002|Overall Study|Lost to Follow-up|5|||
125504648|NCT01294644|451477868|FG000|Overall Study|Miscellaneous Reason|2|||
125504649|NCT01294644|451477869|FG001|Overall Study|Miscellaneous Reason|1|||
125504650|NCT01294644|451477870|FG002|Overall Study|Miscellaneous Reason|4|||
125504651|NCT02188459|451477871|FG000|Overall Study|Lost to Follow-up|3|||
125504652|NCT02188459|451477872|FG001|Overall Study|Lost to Follow-up|4|||
125504653|NCT02188459|451477871|FG000|Overall Study|Early Termination|0|||
125504654|NCT02188459|451477872|FG001|Overall Study|Early Termination|3|||
125504655|NCT01986348|451477873|FG000|Overall Study|Death|8|||
125504656|NCT01986348|451477874|FG001|Overall Study|Death|22|||
125504657|NCT01986348|451477875|FG002|Overall Study|Death|10|||
125504658|NCT01986348|451477876|FG003|Overall Study|Death|21|||
125504659|NCT01986348|451477873|FG000|Overall Study|Lost to Follow-up|0|||
125504660|NCT01986348|451477874|FG001|Overall Study|Lost to Follow-up|0|||
125504661|NCT01986348|451477875|FG002|Overall Study|Lost to Follow-up|0|||
125504662|NCT01986348|451477876|FG003|Overall Study|Lost to Follow-up|2|||
125504663|NCT01986348|451477873|FG000|Overall Study|Physician Decision|0|||
125504664|NCT01986348|451477874|FG001|Overall Study|Physician Decision|0|||
125504665|NCT01986348|451477875|FG002|Overall Study|Physician Decision|0|||
125504666|NCT01986348|451477876|FG003|Overall Study|Physician Decision|1|||
125504667|NCT01986348|451477873|FG000|Overall Study|Progressive Disease|0|||
125504668|NCT01986348|451477874|FG001|Overall Study|Progressive Disease|0|||
125504669|NCT01986348|451477875|FG002|Overall Study|Progressive Disease|2|||
125504670|NCT01986348|451477876|FG003|Overall Study|Progressive Disease|0|||
125504671|NCT01986348|451477873|FG000|Overall Study|Withdrawal by Participant|0|||
125504672|NCT01986348|451477874|FG001|Overall Study|Withdrawal by Participant|1|||
125504673|NCT01986348|451477875|FG002|Overall Study|Withdrawal by Participant|2|||
125504674|NCT01986348|451477876|FG003|Overall Study|Withdrawal by Participant|1|||
125504675|NCT01986348|451477873|FG000|Overall Study|Study Terminated by Sponsor|0|||
125504676|NCT01986348|451477874|FG001|Overall Study|Study Terminated by Sponsor|0|||
125504677|NCT01986348|451477875|FG002|Overall Study|Study Terminated by Sponsor|0|||
125504678|NCT01986348|451477876|FG003|Overall Study|Study Terminated by Sponsor|3|||
125504679|NCT01986348|451477873|FG000|Overall Study|Other-unspecified|0|||
125504680|NCT01986348|451477874|FG001|Overall Study|Other-unspecified|1|||
125504681|NCT01986348|451477875|FG002|Overall Study|Other-unspecified|0|||
125504682|NCT01986348|451477876|FG003|Overall Study|Other-unspecified|2|||
125504683|NCT02935894|451477877|FG000|Overall Study|Subject dismissed|1|||
125504684|NCT00853957|451477878|FG000|Overall Study|Adverse Event|9|||
125504685|NCT00853957|451477879|FG001|Overall Study|Adverse Event|3|||
125504686|NCT00853957|451477878|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125504687|NCT00853957|451477879|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125504688|NCT00853957|451477878|FG000|Overall Study|Subject withdrew consent|4|||
125504689|NCT00853957|451477879|FG001|Overall Study|Subject withdrew consent|5|||
125504690|NCT00853957|451477878|FG000|Overall Study|Lost to Follow-up|1|||
125504691|NCT00853957|451477879|FG001|Overall Study|Lost to Follow-up|6|||
125504692|NCT00853957|451477878|FG000|Overall Study|Protocol deviation|0|||
125504693|NCT00853957|451477879|FG001|Overall Study|Protocol deviation|3|||
125504694|NCT04919499|451477880|FG000|Overall Study|Adverse Event|0|||
125504695|NCT04919499|451477881|FG001|Overall Study|Adverse Event|0|||
125504696|NCT04919499|451477882|FG002|Overall Study|Adverse Event|0|||
125504697|NCT04919499|451477883|FG003|Overall Study|Adverse Event|0|||
125504698|NCT04919499|451477884|FG004|Overall Study|Adverse Event|2|||
125504699|NCT04919499|451477880|FG000|Overall Study|Not treated|0|||
125504700|NCT04919499|451477881|FG001|Overall Study|Not treated|0|||
125504701|NCT04919499|451477882|FG002|Overall Study|Not treated|0|||
125504702|NCT04919499|451477883|FG003|Overall Study|Not treated|1|||
125504703|NCT04919499|451477884|FG004|Overall Study|Not treated|0|||
125504704|NCT04520256|451477888|FG000|Overall Study|Lost to Follow-up|6|||
125504705|NCT04520256|451477889|FG001|Overall Study|Lost to Follow-up|4|||
125504706|NCT04520256|451477890|FG002|Overall Study|Lost to Follow-up|2|||
125504707|NCT04520256|451477891|FG003|Overall Study|Lost to Follow-up|3|||
125504708|NCT04520256|451477892|FG004|Overall Study|Lost to Follow-up|6|||
125504709|NCT04520256|451477893|FG005|Overall Study|Lost to Follow-up|6|||
125504710|NCT04520256|451477894|FG006|Overall Study|Lost to Follow-up|4|||
125504711|NCT04520256|451477895|FG007|Overall Study|Lost to Follow-up|6|||
125504712|NCT04520256|451477896|FG008|Overall Study|Lost to Follow-up|1|||
125504713|NCT04520256|451477897|FG009|Overall Study|Lost to Follow-up|3|||
125504714|NCT04520256|451477898|FG010|Overall Study|Lost to Follow-up|3|||
125504715|NCT04520256|451477899|FG011|Overall Study|Lost to Follow-up|2|||
125504716|NCT04520256|451477900|FG012|Overall Study|Lost to Follow-up|5|||
125504717|NCT04520256|451477901|FG013|Overall Study|Lost to Follow-up|3|||
125504718|NCT04520256|451477902|FG014|Overall Study|Lost to Follow-up|3|||
125504719|NCT04520256|451477903|FG015|Overall Study|Lost to Follow-up|6|||
125504720|NCT04520256|451477904|FG016|Overall Study|Lost to Follow-up|6|||
125504721|NCT04520256|451477905|FG017|Overall Study|Lost to Follow-up|4|||
125504722|NCT04520256|451477906|FG018|Overall Study|Lost to Follow-up|3|||
125504723|NCT04520256|451477907|FG019|Overall Study|Lost to Follow-up|3|||
125504724|NCT04520256|451477908|FG020|Overall Study|Lost to Follow-up|7|||
125504725|NCT04520256|451477909|FG021|Overall Study|Lost to Follow-up|3|||
125504726|NCT04520256|451477910|FG022|Overall Study|Lost to Follow-up|3|||
125504727|NCT04520256|451477911|FG023|Overall Study|Lost to Follow-up|8|||
125504728|NCT04520256|451477912|FG024|Overall Study|Lost to Follow-up|5|||
125504729|NCT04520256|451477913|FG025|Overall Study|Lost to Follow-up|4|||
125504730|NCT04520256|451477914|FG026|Overall Study|Lost to Follow-up|3|||
125504731|NCT04520256|451477915|FG027|Overall Study|Lost to Follow-up|4|||
125504732|NCT04520256|451477916|FG028|Overall Study|Lost to Follow-up|3|||
125504733|NCT04520256|451477917|FG029|Overall Study|Lost to Follow-up|4|||
125504734|NCT04520256|451477918|FG030|Overall Study|Lost to Follow-up|4|||
125504735|NCT04520256|451477919|FG031|Overall Study|Lost to Follow-up|4|||
125504736|NCT03786471|451477920|FG000|Overall Study|Death|254|||
125504737|NCT03786471|451477921|FG001|Overall Study|Death|223|||
125504738|NCT03786471|451477922|FG002|Overall Study|Death|37|||
125504739|NCT03786471|451477920|FG000|Overall Study|Lost to Follow-up|63|||
125504740|NCT03786471|451477921|FG001|Overall Study|Lost to Follow-up|50|||
125504741|NCT03786471|451477922|FG002|Overall Study|Lost to Follow-up|15|||
125504742|NCT03786471|451477920|FG000|Overall Study|Withdrawal by Subject|99|||
125504743|NCT03786471|451477921|FG001|Overall Study|Withdrawal by Subject|81|||
125504744|NCT03786471|451477922|FG002|Overall Study|Withdrawal by Subject|11|||
125504745|NCT00747149|451479481|FG000|Overall Study|Adverse Event|0|||
125504746|NCT00747149|451479482|FG001|Overall Study|Adverse Event|15|||
125504747|NCT00747149|451479481|FG000|Overall Study|Lost to Follow-up|0|||
125504748|NCT00747149|451479482|FG001|Overall Study|Lost to Follow-up|10|||
125504749|NCT00747149|451479481|FG000|Overall Study|Withdrawal by Subject|0|||
125504750|NCT00747149|451479482|FG001|Overall Study|Withdrawal by Subject|6|||
125504751|NCT00747149|451479481|FG000|Overall Study|Did not receive treatment|0|||
125504752|NCT00747149|451479482|FG001|Overall Study|Did not receive treatment|1|||
125504753|NCT00747149|451479481|FG000|Overall Study|Incorrect enrollment|0|||
125504754|NCT00747149|451479482|FG001|Overall Study|Incorrect enrollment|6|||
125504755|NCT00747149|451479481|FG000|Overall Study|Severe non-compliance to protocol|0|||
125504756|NCT00747149|451479482|FG001|Overall Study|Severe non-compliance to protocol|1|||
125504757|NCT00747149|451479481|FG000|Overall Study|Not reported|1|||
125504758|NCT00747149|451479482|FG001|Overall Study|Not reported|4|||
125504759|NCT05522777|451479483|FG000|Overall Study|Lack of Efficacy|1|||
125504760|NCT05522777|451479483|FG000|Overall Study|Withdrawal by Subject|1|||
125504761|NCT05006703|451479484|FG000|Overall Study|Withdrawal by Subject|1|||
125504762|NCT05006703|451479485|FG001|Overall Study|Withdrawal by Subject|0|||
125504763|NCT05006703|451479484|FG000|Overall Study|Lost to Follow-up|13|||
125504764|NCT05006703|451479485|FG001|Overall Study|Lost to Follow-up|5|||
125504765|NCT01381549|451479486|FG000|Overall Study|Ineligible: No organisms isolated|0|||
125504766|NCT01381549|451479487|FG001|Overall Study|Ineligible: No organisms isolated|0|||
125504767|NCT01381549|451479488|FG002|Overall Study|Ineligible: No organisms isolated|1|||
125504768|NCT01416285|451479489|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
125504769|NCT01416285|451479490|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
125504770|NCT00578344|451479491|FG000|Overall Study|Insurance problems|1|||
125504771|NCT00578344|451479491|FG000|Overall Study|Graft failure|1|||
125504772|NCT02935673|451479492|FG000|Overall Study|Adverse Event|0|||
125504773|NCT02935673|451479493|FG001|Overall Study|Adverse Event|1|||
125504774|NCT02935673|451479494|FG002|Overall Study|Adverse Event|0|||
125504775|NCT02935673|451479492|FG000|Overall Study|Withdrawal by Subject|1|||
125504776|NCT02935673|451479493|FG001|Overall Study|Withdrawal by Subject|2|||
125504777|NCT02935673|451479494|FG002|Overall Study|Withdrawal by Subject|0|||
125504778|NCT04328467|451479495|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
125504779|NCT04328467|451479496|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
125504780|NCT04328467|451479497|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
125504781|NCT00990184|451479498|FG000|Overall Study|Physician Decision|1|||
125504782|NCT01090739|451479501|FG000|Enrollment|Withdrawal by Subject|24|||
125504783|NCT01090739|451479501|FG000|Enrollment|Protocol Violation|14|||
125504784|NCT01090739|451479501|FG000|Enrollment|Lost to Follow-up|5|||
125504785|NCT01090739|451479501|FG000|Enrollment|Physician Decision|5|||
125504786|NCT01090739|451479501|FG000|Enrollment|Sponsor termination of site|4|||
125504787|NCT01090739|451479501|FG000|Enrollment|Study implant limit reached|2|||
125504788|NCT01090739|451479501|FG000|Enrollment|Adverse Event|1|||
125504789|NCT01090739|451479501|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
125504790|NCT01090739|451479501|FG000|12 Month Follow-up|Lost to Follow-up|1|||
125504791|NCT01090739|451479501|FG000|12 Month Follow-up|Physician Decision|1|||
125504792|NCT01090739|451479501|FG000|12 Month Follow-up|Death|1|||
125504793|NCT01090739|451479501|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
125504794|NCT01090739|451479501|FG000|24 Month Follow-up|Lost to Follow-up|1|||
125504795|NCT01090739|451479501|FG000|24 Month Follow-up|Death|1|||
125504796|NCT01090739|451479501|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
125504797|NCT01090739|451479501|FG000|36 Month Follow-up|Visit still pending|17|||
125504798|NCT00441168|451479502|FG000|Treatment Period|Death|3|||
125504799|NCT00441168|451479503|FG001|Treatment Period|Death|0|||
125504800|NCT00441168|451479502|FG000|Treatment Period|Adverse Event|1|||
125504801|NCT00441168|451479503|FG001|Treatment Period|Adverse Event|2|||
125504802|NCT00441168|451479502|FG000|Treatment Period|Progressive Disease|0|||
125504803|NCT00441168|451479503|FG001|Treatment Period|Progressive Disease|2|||
125504804|NCT00441168|451479502|FG000|Treatment Period|Protocol Violation|0|||
125504805|NCT00441168|451479503|FG001|Treatment Period|Protocol Violation|1|||
125504806|NCT00441168|451479502|FG000|Treatment Period|Lost to Follow-up|0|||
125504807|NCT00441168|451479503|FG001|Treatment Period|Lost to Follow-up|1|||
125504808|NCT00441168|451479502|FG000|Treatment Period|Withdrawal by Subject|3|||
125504809|NCT00441168|451479503|FG001|Treatment Period|Withdrawal by Subject|0|||
125504810|NCT00441168|451479502|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
125504811|NCT00441168|451479503|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
125504812|NCT00441168|451479502|FG000|Treatment Period|refractory disease|1|||
125504813|NCT00441168|451479503|FG001|Treatment Period|refractory disease|0|||
125504814|NCT00441168|451479502|FG000|Follow-up Period|Death|3|||
125504815|NCT00441168|451479503|FG001|Follow-up Period|Death|0|||
125504816|NCT00441168|451479502|FG000|Follow-up Period|Lost to Follow-up|5|||
125504817|NCT00441168|451479503|FG001|Follow-up Period|Lost to Follow-up|6|||
125504818|NCT00441168|451479502|FG000|Follow-up Period|Withdrawal by Subject|3|||
125504819|NCT00441168|451479503|FG001|Follow-up Period|Withdrawal by Subject|0|||
125504820|NCT00441168|451479502|FG000|Follow-up Period|Other|1|||
125504821|NCT00441168|451479503|FG001|Follow-up Period|Other|3|||
125504822|NCT03909100|451479504|FG000|Overall Study|Protocol Deviation|2|||
125504823|NCT03909100|451479504|FG000|Overall Study|Technical Problems|4|||
125504824|NCT03909100|451479504|FG000|Overall Study|Withdrawal by Subject|4|||
125504825|NCT03909100|451479504|FG000|Overall Study|Lost to Follow-up|1|||
125504826|NCT03909100|451479504|FG000|Overall Study|Reason not Specified|4|||
125504827|NCT00807599|451479505|FG000|Overall Study|Not treated on protocol study|0|||
125504828|NCT00807599|451479506|FG001|Overall Study|Not treated on protocol study|0|||
125504829|NCT00807599|451479507|FG002|Overall Study|Not treated on protocol study|2|||
125504830|NCT00807599|451479505|FG000|Overall Study|Adverse Event|0|||
125504831|NCT00807599|451479506|FG001|Overall Study|Adverse Event|0|||
125504832|NCT00807599|451479507|FG002|Overall Study|Adverse Event|5|||
125504833|NCT00807599|451479505|FG000|Overall Study|Inadequate response to induction|0|||
125504834|NCT00807599|451479506|FG001|Overall Study|Inadequate response to induction|0|||
125504835|NCT00807599|451479507|FG002|Overall Study|Inadequate response to induction|9|||
125504836|NCT00807599|451479505|FG000|Overall Study|Withdrawal by Subject|0|||
125504837|NCT00807599|451479506|FG001|Overall Study|Withdrawal by Subject|0|||
125504838|NCT00807599|451479507|FG002|Overall Study|Withdrawal by Subject|1|||
125504839|NCT03349476|451479511|FG000|Overall Study|Physician Decision|3|||
125504840|NCT00274287|451479518|FG000|Overall Study|Withdrawal by Subject|1|||
125504841|NCT00274287|451479518|FG000|Overall Study|subject non-compliance|1|||
125504842|NCT04421456|451479519|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
125504843|NCT04421456|451479520|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
125504844|NCT04421456|451479521|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
125504845|NCT04421456|451479519|FG000|Randomized Treatment Period|Adverse Event|0|||
125504846|NCT04421456|451479520|FG001|Randomized Treatment Period|Adverse Event|1|||
125504847|NCT04421456|451479521|FG002|Randomized Treatment Period|Adverse Event|0|||
125504848|NCT04421456|451479519|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
125504849|NCT04421456|451479520|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
125504850|NCT04421456|451479521|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
125504851|NCT04421456|451479519|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
125504852|NCT04421456|451479520|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
125504853|NCT04421456|451479521|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
125504854|NCT04421456|451479519|FG000|Randomized Treatment Period|Participant non-compliance|1|||
125504855|NCT04421456|451479520|FG001|Randomized Treatment Period|Participant non-compliance|1|||
125504856|NCT04421456|451479521|FG002|Randomized Treatment Period|Participant non-compliance|2|||
125504857|NCT04421456|451479519|FG000|Randomized Treatment Period|Other|0|||
125504858|NCT04421456|451479520|FG001|Randomized Treatment Period|Other|1|||
125504859|NCT04421456|451479521|FG002|Randomized Treatment Period|Other|3|||
125504860|NCT01777932|451479524|FG000|Overall Study|Disease progression|136|||
125305325|NCT01934010|450745085|FG000|Overall Study|Withdrawal by Subject|15|||
125504861|NCT01777932|451479524|FG000|Overall Study|Death|3|||
125504862|NCT01777932|451479524|FG000|Overall Study|Adverse Event|34|||
125504863|NCT01777932|451479524|FG000|Overall Study|Lost to Follow-up|3|||
125504864|NCT01777932|451479524|FG000|Overall Study|Investigator decision|10|||
125504865|NCT01777932|451479524|FG000|Overall Study|Reimbursement limit|9|||
125504866|NCT01777932|451479524|FG000|Overall Study|Patient refused further treatment|10|||
125305326|NCT01934010|450745086|FG001|Overall Study|Withdrawal by Subject|6|||
125504867|NCT03031782|451479532|FG000|Treatment Period 1|Lack of Efficacy|3|||
125504868|NCT03031782|451479533|FG001|Treatment Period 1|Lack of Efficacy|0|||
125504869|NCT03031782|451479534|FG002|Treatment Period 1|Lack of Efficacy|0|||
125504870|NCT03031782|451479535|FG003|Treatment Period 1|Lack of Efficacy|0|||
125504871|NCT03031782|451479536|FG004|Treatment Period 1|Lack of Efficacy|0|||
125504872|NCT03031782|451479532|FG000|Treatment Period 2|Physician Decision|0|||
125504873|NCT03031782|451479533|FG001|Treatment Period 2|Physician Decision|1|||
125504874|NCT03031782|451479534|FG002|Treatment Period 2|Physician Decision|0|||
125504875|NCT03031782|451479535|FG003|Treatment Period 2|Physician Decision|0|||
125504876|NCT03031782|451479536|FG004|Treatment Period 2|Physician Decision|3|||
125504877|NCT03031782|451479532|FG000|Treatment Period 2|Lack of Efficacy|0|||
125504878|NCT03031782|451479533|FG001|Treatment Period 2|Lack of Efficacy|1|||
125504879|NCT03031782|451479534|FG002|Treatment Period 2|Lack of Efficacy|0|||
125504880|NCT03031782|451479535|FG003|Treatment Period 2|Lack of Efficacy|0|||
125504881|NCT03031782|451479536|FG004|Treatment Period 2|Lack of Efficacy|1|||
125504882|NCT03031782|451479532|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125504883|NCT03031782|451479533|FG001|Treatment Period 2|Withdrawal by Subject|3|||
125504884|NCT03031782|451479534|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125504885|NCT03031782|451479535|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125504886|NCT03031782|451479536|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125504887|NCT03031782|451479532|FG000|Treatment Period 2|Adverse Event|0|||
125504888|NCT03031782|451479533|FG001|Treatment Period 2|Adverse Event|1|||
125504889|NCT03031782|451479534|FG002|Treatment Period 2|Adverse Event|2|||
125504890|NCT03031782|451479535|FG003|Treatment Period 2|Adverse Event|0|||
125504891|NCT03031782|451479536|FG004|Treatment Period 2|Adverse Event|0|||
125504892|NCT03031782|451479532|FG000|Treatment Period 3|Withdrawal by Subject|0|||
125504893|NCT03031782|451479533|FG001|Treatment Period 3|Withdrawal by Subject|0|||
125504894|NCT03031782|451479534|FG002|Treatment Period 3|Withdrawal by Subject|0|||
125504895|NCT03031782|451479535|FG003|Treatment Period 3|Withdrawal by Subject|1|||
125504896|NCT03031782|451479536|FG004|Treatment Period 3|Withdrawal by Subject|0|||
125504897|NCT01930188|451479537|FG000|Overall Study|unclassified|4|||
125504898|NCT01930188|451479538|FG001|Overall Study|unclassified|5|||
125504899|NCT01930188|451479539|FG002|Overall Study|unclassified|3|||
125504900|NCT01930188|451479537|FG000|Overall Study|Missing follow-up information|2|||
125504901|NCT01930188|451479538|FG001|Overall Study|Missing follow-up information|2|||
125504902|NCT01930188|451479539|FG002|Overall Study|Missing follow-up information|3|||
125504903|NCT01930188|451479537|FG000|Overall Study|Lost to Follow-up|5|||
125504904|NCT01930188|451479538|FG001|Overall Study|Lost to Follow-up|2|||
125504905|NCT01930188|451479539|FG002|Overall Study|Lost to Follow-up|2|||
125504906|NCT01930188|451479537|FG000|Overall Study|Death|2|||
125504907|NCT01930188|451479538|FG001|Overall Study|Death|1|||
125504908|NCT01930188|451479539|FG002|Overall Study|Death|3|||
125504909|NCT01930188|451479537|FG000|Overall Study|Withdrawal by Subject|9|||
125504910|NCT01930188|451479538|FG001|Overall Study|Withdrawal by Subject|11|||
125504911|NCT01930188|451479539|FG002|Overall Study|Withdrawal by Subject|8|||
125504912|NCT02514824|451479540|FG000|Overall Study|Withdrawal by Subject|1|||
125504913|NCT02514824|451479541|FG001|Overall Study|Withdrawal by Subject|0|||
125504914|NCT02514824|451479542|FG002|Overall Study|Withdrawal by Subject|0|||
125504915|NCT02514824|451479543|FG003|Overall Study|Withdrawal by Subject|0|||
125504916|NCT02514824|451479540|FG000|Overall Study|Dose-Limiting Toxicity|0|||
125504917|NCT02514824|451479541|FG001|Overall Study|Dose-Limiting Toxicity|1|||
125504918|NCT02514824|451479542|FG002|Overall Study|Dose-Limiting Toxicity|0|||
125504919|NCT02514824|451479543|FG003|Overall Study|Dose-Limiting Toxicity|0|||
125504920|NCT02170207|451479546|FG000|Overall Study|Case report forms unavailable|5|||
125504921|NCT00886834|451479547|FG000|Overall Study|Protocol Violation|0|||
125504922|NCT00886834|451479548|FG001|Overall Study|Protocol Violation|3|||
125504923|NCT03122860|451479549|FG000|Overall Study|Discontinued Before Treatment|1|||
125504924|NCT03122860|451479550|FG001|Overall Study|Discontinued Before Treatment|1|||
125504925|NCT03122860|451479551|FG002|Overall Study|Discontinued Before Treatment|2|||
125504926|NCT03122860|451479552|FG003|Overall Study|Discontinued Before Treatment|0|||
125504927|NCT03122860|451479553|FG004|Overall Study|Discontinued Before Treatment|1|||
125504928|NCT03122860|451479554|FG005|Overall Study|Discontinued Before Treatment|0|||
125504929|NCT03122860|451479549|FG000|Overall Study|Adverse Event|1|||
125504930|NCT03122860|451479550|FG001|Overall Study|Adverse Event|0|||
125504931|NCT03122860|451479551|FG002|Overall Study|Adverse Event|1|||
125504932|NCT03122860|451479552|FG003|Overall Study|Adverse Event|1|||
125504933|NCT03122860|451479553|FG004|Overall Study|Adverse Event|0|||
125305327|NCT01934010|450745087|FG002|Overall Study|Withdrawal by Subject|2|||
125504934|NCT03122860|451479554|FG005|Overall Study|Adverse Event|0|||
125504935|NCT03122860|451479549|FG000|Overall Study|Lost to Follow-up|5|||
125504936|NCT03122860|451479550|FG001|Overall Study|Lost to Follow-up|2|||
125504937|NCT03122860|451479551|FG002|Overall Study|Lost to Follow-up|3|||
125504938|NCT03122860|451479552|FG003|Overall Study|Lost to Follow-up|3|||
125504939|NCT03122860|451479553|FG004|Overall Study|Lost to Follow-up|5|||
125504940|NCT03122860|451479554|FG005|Overall Study|Lost to Follow-up|4|||
125504941|NCT03122860|451479549|FG000|Overall Study|Subject Non-Compliance|0|||
125504942|NCT03122860|451479550|FG001|Overall Study|Subject Non-Compliance|0|||
125504943|NCT03122860|451479551|FG002|Overall Study|Subject Non-Compliance|1|||
125504944|NCT03122860|451479552|FG003|Overall Study|Subject Non-Compliance|0|||
125305328|NCT01934010|450745085|FG000|Overall Study|Lost to Follow-up|7|||
125305329|NCT01934010|450745086|FG001|Overall Study|Lost to Follow-up|4|||
125504945|NCT03122860|451479553|FG004|Overall Study|Subject Non-Compliance|0|||
125504946|NCT03122860|451479554|FG005|Overall Study|Subject Non-Compliance|0|||
125504947|NCT03122860|451479549|FG000|Overall Study|Withdrawal by Subject|3|||
125504948|NCT03122860|451479550|FG001|Overall Study|Withdrawal by Subject|2|||
125504949|NCT03122860|451479551|FG002|Overall Study|Withdrawal by Subject|5|||
125504950|NCT03122860|451479552|FG003|Overall Study|Withdrawal by Subject|7|||
125504951|NCT03122860|451479553|FG004|Overall Study|Withdrawal by Subject|9|||
125504952|NCT03122860|451479554|FG005|Overall Study|Withdrawal by Subject|8|||
125504953|NCT00529529|451479555|FG000|Overall Study|Adverse Event|12|||
125504954|NCT00529529|451479556|FG001|Overall Study|Adverse Event|17|||
125504955|NCT00529529|451479557|FG002|Overall Study|Adverse Event|8|||
125504956|NCT00529529|451479555|FG000|Overall Study|Subject withdrew consent|12|||
125504957|NCT00529529|451479556|FG001|Overall Study|Subject withdrew consent|9|||
125504958|NCT00529529|451479557|FG002|Overall Study|Subject withdrew consent|12|||
125504959|NCT00529529|451479555|FG000|Overall Study|Protocol deviation|8|||
125504960|NCT00529529|451479556|FG001|Overall Study|Protocol deviation|12|||
125504961|NCT00529529|451479557|FG002|Overall Study|Protocol deviation|5|||
125504962|NCT00529529|451479555|FG000|Overall Study|Lost to Follow-up|5|||
125504963|NCT00529529|451479556|FG001|Overall Study|Lost to Follow-up|3|||
125504964|NCT00529529|451479557|FG002|Overall Study|Lost to Follow-up|1|||
125504965|NCT00529529|451479555|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
125504966|NCT00529529|451479556|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125504967|NCT00529529|451479557|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
125504968|NCT00529529|451479555|FG000|Overall Study|Death|2|||
125504969|NCT00529529|451479556|FG001|Overall Study|Death|0|||
125504970|NCT00529529|451479557|FG002|Overall Study|Death|0|||
125504971|NCT00529529|451479555|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125504972|NCT00529529|451479556|FG001|Overall Study|Abnormal test procedure result(s)|0|||
125504973|NCT00529529|451479557|FG002|Overall Study|Abnormal test procedure result(s)|0|||
125504974|NCT00529529|451479555|FG000|Overall Study|Administrative problems|1|||
125504975|NCT00529529|451479556|FG001|Overall Study|Administrative problems|0|||
125504976|NCT00529529|451479557|FG002|Overall Study|Administrative problems|3|||
125504977|NCT01020435|451479558|FG000|Overall Study|Lost to Follow-up|0|||
125504978|NCT01020435|451479559|FG001|Overall Study|Lost to Follow-up|1|||
125504979|NCT00103857|451479560|FG000|54-Week Base Study|Adverse Event|12|||
125504980|NCT00103857|451479561|FG001|54-Week Base Study|Adverse Event|9|||
125504981|NCT00103857|451479562|FG002|54-Week Base Study|Adverse Event|11|||
125504982|NCT00103857|451479563|FG003|54-Week Base Study|Adverse Event|6|||
125504983|NCT00103857|451479564|FG004|54-Week Base Study|Adverse Event|5|||
125504984|NCT00103857|451479565|FG005|54-Week Base Study|Adverse Event|11|||
125504985|NCT00103857|451479566|FG006|54-Week Base Study|Adverse Event|3|||
125504986|NCT00103857|451479560|FG000|54-Week Base Study|Death|0|||
125504987|NCT00103857|451479561|FG001|54-Week Base Study|Death|0|||
125504988|NCT00103857|451479562|FG002|54-Week Base Study|Death|0|||
125504989|NCT00103857|451479563|FG003|54-Week Base Study|Death|0|||
125504990|NCT00103857|451479564|FG004|54-Week Base Study|Death|1|||
125504991|NCT00103857|451479565|FG005|54-Week Base Study|Death|1|||
125504992|NCT00103857|451479566|FG006|54-Week Base Study|Death|0|||
125504993|NCT00103857|451479560|FG000|54-Week Base Study|Lack of Efficacy|11|||
125504994|NCT00103857|451479561|FG001|54-Week Base Study|Lack of Efficacy|14|||
125504995|NCT00103857|451479562|FG002|54-Week Base Study|Lack of Efficacy|8|||
125504996|NCT00103857|451479563|FG003|54-Week Base Study|Lack of Efficacy|4|||
125504997|NCT00103857|451479564|FG004|54-Week Base Study|Lack of Efficacy|3|||
125504998|NCT00103857|451479565|FG005|54-Week Base Study|Lack of Efficacy|14|||
125504999|NCT00103857|451479566|FG006|54-Week Base Study|Lack of Efficacy|19|||
125505000|NCT00103857|451479560|FG000|54-Week Base Study|Lost to Follow-up|5|||
125505001|NCT00103857|451479561|FG001|54-Week Base Study|Lost to Follow-up|4|||
125505002|NCT00103857|451479562|FG002|54-Week Base Study|Lost to Follow-up|7|||
125505003|NCT00103857|451479563|FG003|54-Week Base Study|Lost to Follow-up|5|||
125505004|NCT00103857|451479564|FG004|54-Week Base Study|Lost to Follow-up|10|||
125505005|NCT00103857|451479565|FG005|54-Week Base Study|Lost to Follow-up|9|||
125505006|NCT00103857|451479566|FG006|54-Week Base Study|Lost to Follow-up|3|||
125505007|NCT00103857|451479560|FG000|54-Week Base Study|Physician Decision|1|||
125505008|NCT00103857|451479561|FG001|54-Week Base Study|Physician Decision|1|||
125505009|NCT00103857|451479562|FG002|54-Week Base Study|Physician Decision|0|||
125505010|NCT00103857|451479563|FG003|54-Week Base Study|Physician Decision|0|||
125505011|NCT00103857|451479564|FG004|54-Week Base Study|Physician Decision|1|||
125505012|NCT00103857|451479565|FG005|54-Week Base Study|Physician Decision|0|||
125505013|NCT00103857|451479566|FG006|54-Week Base Study|Physician Decision|0|||
125505014|NCT00103857|451479560|FG000|54-Week Base Study|Pregnancy|1|||
125505015|NCT00103857|451479561|FG001|54-Week Base Study|Pregnancy|0|||
125505016|NCT00103857|451479562|FG002|54-Week Base Study|Pregnancy|0|||
125505017|NCT00103857|451479563|FG003|54-Week Base Study|Pregnancy|0|||
125505018|NCT00103857|451479564|FG004|54-Week Base Study|Pregnancy|1|||
125505019|NCT00103857|451479565|FG005|54-Week Base Study|Pregnancy|0|||
125505020|NCT00103857|451479566|FG006|54-Week Base Study|Pregnancy|1|||
125505021|NCT00103857|451479560|FG000|54-Week Base Study|Protocol Violation|6|||
125505022|NCT00103857|451479561|FG001|54-Week Base Study|Protocol Violation|4|||
125505023|NCT00103857|451479562|FG002|54-Week Base Study|Protocol Violation|2|||
125505024|NCT00103857|451479563|FG003|54-Week Base Study|Protocol Violation|4|||
125505025|NCT00103857|451479564|FG004|54-Week Base Study|Protocol Violation|0|||
125505026|NCT00103857|451479565|FG005|54-Week Base Study|Protocol Violation|3|||
125505027|NCT00103857|451479566|FG006|54-Week Base Study|Protocol Violation|3|||
125505028|NCT00103857|451479560|FG000|54-Week Base Study|Withdrawal by Subject|17|||
125505029|NCT00103857|451479561|FG001|54-Week Base Study|Withdrawal by Subject|16|||
125505030|NCT00103857|451479562|FG002|54-Week Base Study|Withdrawal by Subject|16|||
125505031|NCT00103857|451479563|FG003|54-Week Base Study|Withdrawal by Subject|15|||
125505032|NCT00103857|451479564|FG004|54-Week Base Study|Withdrawal by Subject|10|||
125505033|NCT00103857|451479565|FG005|54-Week Base Study|Withdrawal by Subject|15|||
125505034|NCT00103857|451479566|FG006|54-Week Base Study|Withdrawal by Subject|4|||
125505035|NCT00103857|451479560|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
125305330|NCT01934010|450745087|FG002|Overall Study|Lost to Follow-up|0|||
125305331|NCT01393821|450745088|FG000|Overall Study|Cancel|1|||
125505036|NCT00103857|451479561|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
125505037|NCT00103857|451479562|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
125505038|NCT00103857|451479563|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
125505039|NCT00103857|451479564|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
125505040|NCT00103857|451479565|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
125505041|NCT00103857|451479566|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
125505042|NCT00103857|451479560|FG000|54-Week Base Study|patient moved|0|||
125505043|NCT00103857|451479561|FG001|54-Week Base Study|patient moved|1|||
125505044|NCT00103857|451479562|FG002|54-Week Base Study|patient moved|1|||
125505045|NCT00103857|451479563|FG003|54-Week Base Study|patient moved|2|||
125505046|NCT00103857|451479564|FG004|54-Week Base Study|patient moved|3|||
125505047|NCT00103857|451479565|FG005|54-Week Base Study|patient moved|1|||
125505048|NCT00103857|451479566|FG006|54-Week Base Study|patient moved|0|||
125505049|NCT00103857|451479560|FG000|54-Week Base Study|non-compliance with study procedures|1|||
125505050|NCT00103857|451479561|FG001|54-Week Base Study|non-compliance with study procedures|2|||
125505051|NCT00103857|451479562|FG002|54-Week Base Study|non-compliance with study procedures|0|||
125505052|NCT00103857|451479563|FG003|54-Week Base Study|non-compliance with study procedures|0|||
125505053|NCT00103857|451479564|FG004|54-Week Base Study|non-compliance with study procedures|0|||
125505054|NCT00103857|451479565|FG005|54-Week Base Study|non-compliance with study procedures|2|||
125505055|NCT00103857|451479566|FG006|54-Week Base Study|non-compliance with study procedures|0|||
125505056|NCT00103857|451479560|FG000|54-Week Base Study|patient incarcerated|0|||
125505057|NCT00103857|451479561|FG001|54-Week Base Study|patient incarcerated|0|||
125505058|NCT00103857|451479562|FG002|54-Week Base Study|patient incarcerated|0|||
125505059|NCT00103857|451479563|FG003|54-Week Base Study|patient incarcerated|0|||
125505060|NCT00103857|451479564|FG004|54-Week Base Study|patient incarcerated|1|||
125505061|NCT00103857|451479565|FG005|54-Week Base Study|patient incarcerated|1|||
125505062|NCT00103857|451479566|FG006|54-Week Base Study|patient incarcerated|0|||
125505063|NCT00103857|451479560|FG000|54-Week Base Study|laboratory reporting error|0|||
125505064|NCT00103857|451479561|FG001|54-Week Base Study|laboratory reporting error|0|||
125505065|NCT00103857|451479562|FG002|54-Week Base Study|laboratory reporting error|0|||
125505066|NCT00103857|451479563|FG003|54-Week Base Study|laboratory reporting error|0|||
125505067|NCT00103857|451479564|FG004|54-Week Base Study|laboratory reporting error|1|||
125505068|NCT00103857|451479565|FG005|54-Week Base Study|laboratory reporting error|0|||
125505069|NCT00103857|451479566|FG006|54-Week Base Study|laboratory reporting error|0|||
125505070|NCT00103857|451479560|FG000|54-Week Base Study|site error|0|||
125505071|NCT00103857|451479561|FG001|54-Week Base Study|site error|0|||
125505072|NCT00103857|451479562|FG002|54-Week Base Study|site error|0|||
125505073|NCT00103857|451479563|FG003|54-Week Base Study|site error|0|||
125505074|NCT00103857|451479564|FG004|54-Week Base Study|site error|0|||
125505075|NCT00103857|451479565|FG005|54-Week Base Study|site error|1|||
125505076|NCT00103857|451479566|FG006|54-Week Base Study|site error|0|||
125505077|NCT00103857|451479560|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
125505078|NCT00103857|451479561|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
125505079|NCT00103857|451479562|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
125505080|NCT00103857|451479563|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
125505081|NCT00103857|451479564|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
125505082|NCT00103857|451479565|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
125505083|NCT00103857|451479566|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
125505084|NCT00103857|451479560|FG000|50-Week Extension Study|Adverse Event|2|||
125505085|NCT00103857|451479561|FG001|50-Week Extension Study|Adverse Event|3|||
125505086|NCT00103857|451479562|FG002|50-Week Extension Study|Adverse Event|2|||
125505087|NCT00103857|451479563|FG003|50-Week Extension Study|Adverse Event|0|||
125305332|NCT01393821|450745089|FG001|Overall Study|Cancel|1|||
125505088|NCT00103857|451479564|FG004|50-Week Extension Study|Adverse Event|1|||
125505089|NCT00103857|451479565|FG005|50-Week Extension Study|Adverse Event|1|||
125505090|NCT00103857|451479566|FG006|50-Week Extension Study|Adverse Event|0|||
125505091|NCT00103857|451479560|FG000|50-Week Extension Study|Death|0|||
125505092|NCT00103857|451479561|FG001|50-Week Extension Study|Death|0|||
125505093|NCT00103857|451479562|FG002|50-Week Extension Study|Death|0|||
125505094|NCT00103857|451479563|FG003|50-Week Extension Study|Death|1|||
125505095|NCT00103857|451479564|FG004|50-Week Extension Study|Death|0|||
125505096|NCT00103857|451479565|FG005|50-Week Extension Study|Death|1|||
125505097|NCT00103857|451479566|FG006|50-Week Extension Study|Death|0|||
125505098|NCT00103857|451479560|FG000|50-Week Extension Study|Lack of Efficacy|26|||
125505099|NCT00103857|451479561|FG001|50-Week Extension Study|Lack of Efficacy|15|||
125505100|NCT00103857|451479562|FG002|50-Week Extension Study|Lack of Efficacy|13|||
125505101|NCT00103857|451479563|FG003|50-Week Extension Study|Lack of Efficacy|16|||
125505102|NCT00103857|451479564|FG004|50-Week Extension Study|Lack of Efficacy|8|||
125505103|NCT00103857|451479565|FG005|50-Week Extension Study|Lack of Efficacy|8|||
125505104|NCT00103857|451479566|FG006|50-Week Extension Study|Lack of Efficacy|0|||
125505105|NCT00103857|451479560|FG000|50-Week Extension Study|Lost to Follow-up|4|||
125505106|NCT00103857|451479561|FG001|50-Week Extension Study|Lost to Follow-up|0|||
125505107|NCT00103857|451479562|FG002|50-Week Extension Study|Lost to Follow-up|1|||
125505108|NCT00103857|451479563|FG003|50-Week Extension Study|Lost to Follow-up|4|||
125505109|NCT00103857|451479564|FG004|50-Week Extension Study|Lost to Follow-up|3|||
125505110|NCT00103857|451479565|FG005|50-Week Extension Study|Lost to Follow-up|3|||
125505111|NCT00103857|451479566|FG006|50-Week Extension Study|Lost to Follow-up|0|||
125505112|NCT00103857|451479560|FG000|50-Week Extension Study|Physician Decision|0|||
125505113|NCT00103857|451479561|FG001|50-Week Extension Study|Physician Decision|1|||
125505114|NCT00103857|451479562|FG002|50-Week Extension Study|Physician Decision|1|||
125505115|NCT00103857|451479563|FG003|50-Week Extension Study|Physician Decision|0|||
125505116|NCT00103857|451479564|FG004|50-Week Extension Study|Physician Decision|0|||
125505117|NCT00103857|451479565|FG005|50-Week Extension Study|Physician Decision|0|||
125505118|NCT00103857|451479566|FG006|50-Week Extension Study|Physician Decision|0|||
125505119|NCT00103857|451479560|FG000|50-Week Extension Study|Pregnancy|0|||
125505120|NCT00103857|451479561|FG001|50-Week Extension Study|Pregnancy|0|||
125505121|NCT00103857|451479562|FG002|50-Week Extension Study|Pregnancy|1|||
125505122|NCT00103857|451479563|FG003|50-Week Extension Study|Pregnancy|0|||
125505123|NCT00103857|451479564|FG004|50-Week Extension Study|Pregnancy|1|||
125505124|NCT00103857|451479565|FG005|50-Week Extension Study|Pregnancy|0|||
125505125|NCT00103857|451479566|FG006|50-Week Extension Study|Pregnancy|0|||
125505126|NCT00103857|451479560|FG000|50-Week Extension Study|Protocol Violation|1|||
125505127|NCT00103857|451479561|FG001|50-Week Extension Study|Protocol Violation|1|||
125505128|NCT00103857|451479562|FG002|50-Week Extension Study|Protocol Violation|1|||
125505129|NCT00103857|451479563|FG003|50-Week Extension Study|Protocol Violation|2|||
125505130|NCT00103857|451479564|FG004|50-Week Extension Study|Protocol Violation|0|||
125505131|NCT00103857|451479565|FG005|50-Week Extension Study|Protocol Violation|1|||
125505132|NCT00103857|451479566|FG006|50-Week Extension Study|Protocol Violation|0|||
125505133|NCT00103857|451479560|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
125505134|NCT00103857|451479561|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
125505135|NCT00103857|451479562|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
125505136|NCT00103857|451479563|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
125505137|NCT00103857|451479564|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
125505138|NCT00103857|451479565|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
125505139|NCT00103857|451479566|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
125505140|NCT00103857|451479560|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
125505141|NCT00103857|451479561|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
125505142|NCT00103857|451479562|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
125505143|NCT00103857|451479563|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
125505144|NCT00103857|451479564|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
125505145|NCT00103857|451479565|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
125505146|NCT00103857|451479566|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
125505147|NCT00103857|451479560|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
125505148|NCT00103857|451479561|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
125505149|NCT00103857|451479562|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
125505150|NCT00103857|451479563|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
125505151|NCT00103857|451479564|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
125505152|NCT00103857|451479565|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
125505153|NCT00103857|451479566|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
125505154|NCT00103857|451479560|FG000|50-Week Extension Study|patient moved|0|||
125505155|NCT00103857|451479561|FG001|50-Week Extension Study|patient moved|0|||
125505156|NCT00103857|451479562|FG002|50-Week Extension Study|patient moved|1|||
125505157|NCT00103857|451479563|FG003|50-Week Extension Study|patient moved|2|||
125505158|NCT00103857|451479564|FG004|50-Week Extension Study|patient moved|0|||
125505159|NCT00103857|451479565|FG005|50-Week Extension Study|patient moved|0|||
125505160|NCT00103857|451479566|FG006|50-Week Extension Study|patient moved|0|||
125505161|NCT00103857|451479560|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
125505162|NCT00103857|451479561|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
125505163|NCT00103857|451479562|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
125505164|NCT00103857|451479563|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
125505165|NCT00103857|451479564|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
125505166|NCT00103857|451479565|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
125505167|NCT00103857|451479566|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
125505168|NCT00103857|451479560|FG000|50-Week Extension Study|reason unspecified|0|||
125505169|NCT00103857|451479561|FG001|50-Week Extension Study|reason unspecified|0|||
125505170|NCT00103857|451479562|FG002|50-Week Extension Study|reason unspecified|0|||
125505171|NCT00103857|451479563|FG003|50-Week Extension Study|reason unspecified|0|||
125505172|NCT00103857|451479564|FG004|50-Week Extension Study|reason unspecified|1|||
125505173|NCT00103857|451479565|FG005|50-Week Extension Study|reason unspecified|0|||
125505174|NCT00103857|451479566|FG006|50-Week Extension Study|reason unspecified|0|||
125505175|NCT02132195|451479569|FG000|Initial Assignment|Relapsed|14|||
125505176|NCT02132195|451479570|FG001|Initial Assignment|Relapsed|0|||
125505177|NCT02132195|451479571|FG002|Initial Assignment|Relapsed|0|||
125505178|NCT02132195|451479569|FG000|Rescue Therapy|Relapsed|0|||
125505179|NCT02132195|451479570|FG001|Rescue Therapy|Relapsed|0|||
125505180|NCT02132195|451479571|FG002|Rescue Therapy|Relapsed|7|||
125505181|NCT02132195|451479569|FG000|Rescue Therapy|Physician Decision|0|||
125505182|NCT02132195|451479570|FG001|Rescue Therapy|Physician Decision|0|||
125505183|NCT02132195|451479571|FG002|Rescue Therapy|Physician Decision|1|||
125505184|NCT02132195|451479569|FG000|Rescue Therapy|Withdrawal by Subject|0|||
125505185|NCT02132195|451479570|FG001|Rescue Therapy|Withdrawal by Subject|0|||
125505186|NCT02132195|451479571|FG002|Rescue Therapy|Withdrawal by Subject|1|||
125505187|NCT02132195|451479569|FG000|Rescue Therapy|Adverse Event|0|||
125505188|NCT02132195|451479570|FG001|Rescue Therapy|Adverse Event|0|||
125505189|NCT02132195|451479571|FG002|Rescue Therapy|Adverse Event|2|||
125505190|NCT03065400|451479574|FG000|Overall Study|Adverse Event|1|||
125505191|NCT03065400|451479574|FG000|Overall Study|Physician Decision|3|||
125505192|NCT03065400|451479574|FG000|Overall Study|Withdrawal by Subject|1|||
125505193|NCT03065400|451479574|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
125505194|NCT02102724|451479575|FG000|Overall Study|Lost to Follow-up|1|||
125505195|NCT02102724|451479576|FG001|Overall Study|Lost to Follow-up|0|||
125505196|NCT02102724|451479575|FG000|Overall Study|surgery for brain aneurysm|1|||
125505197|NCT02102724|451479576|FG001|Overall Study|surgery for brain aneurysm|1|||
125505198|NCT03072862|451479577|FG000|Overall Study|Withdrawal by Subject|4|||
125505199|NCT03072862|451479577|FG000|Overall Study|Lost to Follow-up|6|||
125505200|NCT03072862|451479577|FG000|Overall Study|Protocol Violation|4|||
125505201|NCT03072862|451479577|FG000|Overall Study|Physician Decision|2|||
125505202|NCT03072862|451479577|FG000|Overall Study|Death|1|||
125505203|NCT03072862|451479577|FG000|Overall Study|Adverse Event|1|||
125505204|NCT02203513|451479578|FG000|Overall Study|Refused further treatment|2|||
125505205|NCT02203513|451479579|FG001|Overall Study|Refused further treatment|0|||
125505206|NCT02203513|451479580|FG002|Overall Study|Refused further treatment|1|||
125505207|NCT02203513|451479581|FG003|Overall Study|Refused further treatment|0|||
125505208|NCT02203513|451479582|FG004|Overall Study|Refused further treatment|0|||
125505209|NCT02203513|451479578|FG000|Overall Study|Switched to alternative treatment|3|||
125505210|NCT02203513|451479579|FG001|Overall Study|Switched to alternative treatment|4|||
125505211|NCT02203513|451479580|FG002|Overall Study|Switched to alternative treatment|0|||
125505212|NCT02203513|451479581|FG003|Overall Study|Switched to alternative treatment|0|||
125505213|NCT02203513|451479582|FG004|Overall Study|Switched to alternative treatment|4|||
125505214|NCT02203513|451479578|FG000|Overall Study|Did not receive investigational product (IP)|0|||
125505215|NCT02203513|451479579|FG001|Overall Study|Did not receive investigational product (IP)|1|||
125505216|NCT02203513|451479580|FG002|Overall Study|Did not receive investigational product (IP)|0|||
125505217|NCT02203513|451479581|FG003|Overall Study|Did not receive investigational product (IP)|0|||
125505218|NCT02203513|451479582|FG004|Overall Study|Did not receive investigational product (IP)|0|||
125505219|NCT02203513|451479578|FG000|Overall Study|Death (unrelated to study therapy)|1|||
125505220|NCT02203513|451479579|FG001|Overall Study|Death (unrelated to study therapy)|3|||
125505221|NCT02203513|451479580|FG002|Overall Study|Death (unrelated to study therapy)|1|||
125505222|NCT02203513|451479581|FG003|Overall Study|Death (unrelated to study therapy)|0|||
125505223|NCT02203513|451479582|FG004|Overall Study|Death (unrelated to study therapy)|2|||
125505224|NCT02203513|451479578|FG000|Overall Study|Lost to Follow-up|0|||
125505225|NCT02203513|451479579|FG001|Overall Study|Lost to Follow-up|0|||
125505226|NCT02203513|451479580|FG002|Overall Study|Lost to Follow-up|1|||
125505227|NCT02203513|451479581|FG003|Overall Study|Lost to Follow-up|1|||
125505228|NCT02203513|451479582|FG004|Overall Study|Lost to Follow-up|0|||
125505229|NCT02513667|451479583|FG000|Overall Study|Withdrawal by Subject|0|||
125505230|NCT02513667|451479584|FG001|Overall Study|Withdrawal by Subject|1|||
125505231|NCT01964547|451479595|FG000|Overall Study|Adverse Event|8|||
125505232|NCT01964547|451479596|FG001|Overall Study|Adverse Event|2|||
125505233|NCT01964547|451479595|FG000|Overall Study|Withdrawal by Subject|4|||
125505234|NCT01964547|451479596|FG001|Overall Study|Withdrawal by Subject|7|||
125505235|NCT01964547|451479595|FG000|Overall Study|Lost to Follow-up|0|||
125505236|NCT01964547|451479596|FG001|Overall Study|Lost to Follow-up|1|||
125505237|NCT01964547|451479595|FG000|Overall Study|Withdrawal by Investigator|0|||
125505238|NCT01964547|451479596|FG001|Overall Study|Withdrawal by Investigator|1|||
125505239|NCT00912964|451479597|FG000|Overall Study|Eligibility criterion not met|1|||
125505240|NCT00912964|451479598|FG001|Overall Study|Eligibility criterion not met|1|||
125505241|NCT00912964|451479599|FG002|Overall Study|Eligibility criterion not met|0|||
125505242|NCT00912964|451479597|FG000|Overall Study|Adverse Event|15|||
125505243|NCT00912964|451479598|FG001|Overall Study|Adverse Event|18|||
125505244|NCT00912964|451479599|FG002|Overall Study|Adverse Event|12|||
125505245|NCT00912964|451479597|FG000|Overall Study|Lack of Efficacy|11|||
125505246|NCT00912964|451479598|FG001|Overall Study|Lack of Efficacy|4|||
125505247|NCT00912964|451479599|FG002|Overall Study|Lack of Efficacy|3|||
125505248|NCT00912964|451479597|FG000|Overall Study|Withdrawal by Subject|20|||
125505249|NCT00912964|451479598|FG001|Overall Study|Withdrawal by Subject|12|||
125505250|NCT00912964|451479599|FG002|Overall Study|Withdrawal by Subject|18|||
125505251|NCT00912964|451479597|FG000|Overall Study|Lost to Follow-up|4|||
125505252|NCT00912964|451479598|FG001|Overall Study|Lost to Follow-up|3|||
125505253|NCT00912964|451479599|FG002|Overall Study|Lost to Follow-up|3|||
125505254|NCT00912964|451479597|FG000|Overall Study|Protocol Violation|5|||
125505255|NCT00912964|451479598|FG001|Overall Study|Protocol Violation|3|||
125505256|NCT00912964|451479599|FG002|Overall Study|Protocol Violation|8|||
125505257|NCT00912964|451479597|FG000|Overall Study|Taking exclusionary medications|7|||
125505258|NCT00912964|451479598|FG001|Overall Study|Taking exclusionary medications|4|||
125505259|NCT00912964|451479599|FG002|Overall Study|Taking exclusionary medications|8|||
125505260|NCT00912964|451479597|FG000|Overall Study|Medical History|1|||
125505261|NCT00912964|451479598|FG001|Overall Study|Medical History|0|||
125505262|NCT00912964|451479599|FG002|Overall Study|Medical History|0|||
125505263|NCT00912964|451479597|FG000|Overall Study|Non-compliance with study procedures|2|||
125505264|NCT00912964|451479598|FG001|Overall Study|Non-compliance with study procedures|0|||
125305333|NCT01393821|450745088|FG000|Overall Study|not evaluable for primary endpoint|4|||
125305334|NCT01393821|450745089|FG001|Overall Study|not evaluable for primary endpoint|2|||
125305335|NCT03422536|450745090|FG000|Randomized|Physician Decision|1|||
125305336|NCT03422536|450745091|FG001|Randomized|Physician Decision|1|||
125305337|NCT03422536|450745090|FG000|Allocation - Received Intervention|Disease progression|19|||
125305338|NCT03422536|450745091|FG001|Allocation - Received Intervention|Disease progression|25|||
125305339|NCT03422536|450745090|FG000|Allocation - Received Intervention|Death|1|||
125305340|NCT03422536|450745091|FG001|Allocation - Received Intervention|Death|3|||
125305341|NCT03422536|450745090|FG000|Allocation - Received Intervention|Adverse Event|1|||
125305342|NCT03422536|450745091|FG001|Allocation - Received Intervention|Adverse Event|0|||
125305343|NCT03422536|450745090|FG000|Allocation - Received Intervention|Physician Decision|1|||
125305344|NCT03422536|450745091|FG001|Allocation - Received Intervention|Physician Decision|1|||
125305345|NCT03422536|450745090|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
125305346|NCT03422536|450745091|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
125305347|NCT03422536|450745090|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
125305348|NCT03422536|450745091|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
125305349|NCT04929249|450745092|FG000|Overall Study|Adverse Event|2|||
125305350|NCT04929249|450745093|FG001|Overall Study|Adverse Event|1|||
125305351|NCT04929249|450745092|FG000|Overall Study|Death|2|||
125305352|NCT04929249|450745093|FG001|Overall Study|Death|1|||
125305353|NCT04929249|450745092|FG000|Overall Study|Lost to Follow-up|3|||
125305354|NCT04929249|450745093|FG001|Overall Study|Lost to Follow-up|11|||
125305355|NCT04929249|450745092|FG000|Overall Study|Technical problems|0|||
125305356|NCT04929249|450745093|FG001|Overall Study|Technical problems|1|||
125305357|NCT04929249|450745092|FG000|Overall Study|Subject decision|6|||
125305358|NCT04929249|450745093|FG001|Overall Study|Subject decision|8|||
125305359|NCT04929249|450745092|FG000|Overall Study|Withdrew consent|0|||
125305360|NCT04929249|450745093|FG001|Overall Study|Withdrew consent|8|||
125305361|NCT00395850|450745104|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
125305362|NCT00395850|450745105|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
125305363|NCT00395850|450745106|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
125305364|NCT00395850|450745107|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
125305365|NCT00395850|450745104|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
125305366|NCT00395850|450745105|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
125305367|NCT00395850|450745106|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
125305368|NCT00395850|450745107|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
125305369|NCT00395850|450745104|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
125305370|NCT00395850|450745105|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
125305371|NCT00395850|450745106|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
125305372|NCT00395850|450745107|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
125305373|NCT00395850|450745104|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
125305374|NCT00395850|450745105|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
125305375|NCT00395850|450745106|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
125305376|NCT00395850|450745107|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
125305377|NCT00395850|450745104|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
125305378|NCT00395850|450745105|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
125305379|NCT00395850|450745106|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
125305380|NCT00395850|450745107|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
125305381|NCT00395850|450745104|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
125305382|NCT00395850|450745105|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
125305383|NCT00395850|450745106|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
125305384|NCT00395850|450745107|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
125305385|NCT00395850|450745104|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
125305386|NCT00395850|450745105|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
125305387|NCT00395850|450745106|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
125305388|NCT00395850|450745107|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
125305389|NCT01620762|450745109|FG000|Overall Study|Protocol Violation|1|||
125305390|NCT01620762|450745110|FG001|Overall Study|Protocol Violation|1|||
125305391|NCT01620762|450745111|FG002|Overall Study|Protocol Violation|1|||
125305392|NCT01620762|450745109|FG000|Overall Study|Adverse Event|9|||
125305393|NCT01620762|450745110|FG001|Overall Study|Adverse Event|5|||
125305394|NCT01620762|450745111|FG002|Overall Study|Adverse Event|2|||
125505265|NCT00912964|451479599|FG002|Overall Study|Non-compliance with study procedures|0|||
125505266|NCT00912964|451479597|FG000|Overall Study|Violation of exclusion criterion|0|||
125505267|NCT00912964|451479598|FG001|Overall Study|Violation of exclusion criterion|0|||
125505268|NCT00912964|451479599|FG002|Overall Study|Violation of exclusion criterion|2|||
125505269|NCT00912964|451479597|FG000|Overall Study|Randomized but never received study drug|0|||
125505270|NCT00912964|451479598|FG001|Overall Study|Randomized but never received study drug|1|||
125505271|NCT00912964|451479599|FG002|Overall Study|Randomized but never received study drug|0|||
125505272|NCT02978716|451479600|FG000|Overall Study|Death|25|||
125505273|NCT02978716|451479601|FG001|Overall Study|Death|13|||
125505274|NCT02978716|451479602|FG002|Overall Study|Death|20|||
125505275|NCT02978716|451479600|FG000|Overall Study|Lost to Follow-up|0|||
125505276|NCT02978716|451479601|FG001|Overall Study|Lost to Follow-up|0|||
125505277|NCT02978716|451479602|FG002|Overall Study|Lost to Follow-up|1|||
125505278|NCT02978716|451479600|FG000|Overall Study|Withdrawal by Subject|6|||
125505279|NCT02978716|451479601|FG001|Overall Study|Withdrawal by Subject|4|||
125505280|NCT02978716|451479602|FG002|Overall Study|Withdrawal by Subject|5|||
125505281|NCT02978716|451479600|FG000|Overall Study|Sponsor terminated|2|||
125505282|NCT02978716|451479601|FG001|Overall Study|Sponsor terminated|13|||
125505283|NCT02978716|451479602|FG002|Overall Study|Sponsor terminated|9|||
125505284|NCT02978716|451479600|FG000|Overall Study|Other|1|||
125505285|NCT02978716|451479601|FG001|Overall Study|Other|3|||
125505286|NCT02978716|451479602|FG002|Overall Study|Other|0|||
125505287|NCT00960206|451479603|FG000|Overall Study|Death|7|||
125505288|NCT00960206|451479604|FG001|Overall Study|Death|4|||
125505289|NCT00960206|451479605|FG002|Overall Study|Death|1|||
125505290|NCT00960206|451479603|FG000|Overall Study|Unwilling/Unable to return|1|||
125505291|NCT00960206|451479604|FG001|Overall Study|Unwilling/Unable to return|2|||
125505292|NCT00960206|451479605|FG002|Overall Study|Unwilling/Unable to return|0|||
125505293|NCT00960206|451479603|FG000|Overall Study|Lost to Follow-up|8|||
125505294|NCT00960206|451479604|FG001|Overall Study|Lost to Follow-up|14|||
125505295|NCT00960206|451479605|FG002|Overall Study|Lost to Follow-up|8|||
125505296|NCT00960206|451479603|FG000|Overall Study|Withdrawal by Subject|2|||
125505297|NCT00960206|451479604|FG001|Overall Study|Withdrawal by Subject|4|||
125505298|NCT00960206|451479605|FG002|Overall Study|Withdrawal by Subject|0|||
125505299|NCT00960206|451479603|FG000|Overall Study|Revision of study component|2|||
125505300|NCT00960206|451479604|FG001|Overall Study|Revision of study component|2|||
125505301|NCT00960206|451479605|FG002|Overall Study|Revision of study component|2|||
125505302|NCT00960206|451479603|FG000|Overall Study|Missing 10 year data|20|||
125505303|NCT00960206|451479604|FG001|Overall Study|Missing 10 year data|1|||
125505304|NCT00960206|451479605|FG002|Overall Study|Missing 10 year data|1|||
125505305|NCT02470806|451479606|FG000|Overall Study|Lost to Follow-up|1|||
125505306|NCT02470806|451479607|FG001|Overall Study|Lost to Follow-up|1|||
125505307|NCT02470806|451479606|FG000|Overall Study|Adverse Event|5|||
125505308|NCT02470806|451479607|FG001|Overall Study|Adverse Event|2|||
125505309|NCT02470806|451479606|FG000|Overall Study|Protocol Violation|4|||
125505310|NCT02470806|451479607|FG001|Overall Study|Protocol Violation|11|||
125505311|NCT02470806|451479606|FG000|Overall Study|Physician Decision|0|||
125505312|NCT02470806|451479607|FG001|Overall Study|Physician Decision|3|||
125505313|NCT02470806|451479606|FG000|Overall Study|Withdrawal by Subject|3|||
125505314|NCT02470806|451479607|FG001|Overall Study|Withdrawal by Subject|10|||
125505315|NCT02470806|451479606|FG000|Overall Study|Lack of Efficacy|5|||
125505316|NCT02470806|451479607|FG001|Overall Study|Lack of Efficacy|15|||
125505317|NCT01147471|451479608|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
125505318|NCT01147471|451479609|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
125505319|NCT01147471|451479608|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
125505320|NCT01147471|451479609|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
125505321|NCT01147471|451479608|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
125505322|NCT01147471|451479609|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
125505323|NCT01147471|451479608|FG000|3 Month Follow Up|Lost to Follow-up|1|||
125505324|NCT01147471|451479609|FG001|3 Month Follow Up|Lost to Follow-up|1|||
125505325|NCT01147471|451479608|FG000|3 Month Follow Up|Physician Decision|0|||
125505326|NCT01147471|451479609|FG001|3 Month Follow Up|Physician Decision|1|||
125505327|NCT01147471|451479608|FG000|6 Month Follow Up|Lost to Follow-up|4|||
125505328|NCT01147471|451479609|FG001|6 Month Follow Up|Lost to Follow-up|2|||
125505329|NCT03075878|451479614|FG000|Overall Study|Physician Decision|1|||
125505330|NCT02158806|451479619|FG000|Overall Study|Death|2|||
125505331|NCT02158806|451479620|FG001|Overall Study|Death|0|||
125505332|NCT02158806|451479619|FG000|Overall Study|Withdrawal by Subject|2|||
125505333|NCT02158806|451479620|FG001|Overall Study|Withdrawal by Subject|0|||
125505334|NCT02158806|451479619|FG000|Overall Study|Lost to Follow-up|0|||
125305395|NCT01620762|450745109|FG000|Overall Study|Withdrawal by Subject|23|||
125505335|NCT02158806|451479620|FG001|Overall Study|Lost to Follow-up|3|||
125305396|NCT01620762|450745110|FG001|Overall Study|Withdrawal by Subject|26|||
125505336|NCT02158806|451479619|FG000|Overall Study|Moved out of area|0|||
125505337|NCT02158806|451479620|FG001|Overall Study|Moved out of area|1|||
125505338|NCT02158806|451479619|FG000|Overall Study|Transferred to palliative care|0|||
125505339|NCT02158806|451479620|FG001|Overall Study|Transferred to palliative care|1|||
125505340|NCT01898299|451479621|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
125505341|NCT01898299|451479622|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
125505342|NCT04895085|451479626|FG000|Overall Study|Death|1|||
125505343|NCT04895085|451479626|FG000|Overall Study|Withdrawal by Subject|1|||
125505344|NCT04895085|451479626|FG000|Overall Study|No longer eligible: Moved from area|1|||
125505345|NCT04369664|451481327|FG000|Overall Study|Physician Decision|1|||
125505346|NCT04369664|451481328|FG001|Overall Study|Physician Decision|0|||
125505347|NCT03840200|451481329|FG000|Overall Study|Death|6|||
125505348|NCT03840200|451481330|FG001|Overall Study|Death|3|||
125505349|NCT03840200|451481331|FG002|Overall Study|Death|6|||
125505350|NCT03840200|451481332|FG003|Overall Study|Death|10|||
125505351|NCT03840200|451481329|FG000|Overall Study|Reason Not Specified|2|||
125505352|NCT03840200|451481330|FG001|Overall Study|Reason Not Specified|2|||
125505353|NCT03840200|451481331|FG002|Overall Study|Reason Not Specified|1|||
125505354|NCT03840200|451481332|FG003|Overall Study|Reason Not Specified|15|||
125505355|NCT03840200|451481329|FG000|Overall Study|Physician Decision|0|||
125505356|NCT03840200|451481330|FG001|Overall Study|Physician Decision|0|||
125505357|NCT03840200|451481331|FG002|Overall Study|Physician Decision|0|||
125505358|NCT03840200|451481332|FG003|Overall Study|Physician Decision|2|||
125505359|NCT03840200|451481329|FG000|Overall Study|Progressive Disease|0|||
125505360|NCT03840200|451481330|FG001|Overall Study|Progressive Disease|0|||
125505361|NCT03840200|451481331|FG002|Overall Study|Progressive Disease|0|||
125505362|NCT03840200|451481332|FG003|Overall Study|Progressive Disease|1|||
125505363|NCT03840200|451481329|FG000|Overall Study|Withdrawal by Subject|0|||
125505364|NCT03840200|451481330|FG001|Overall Study|Withdrawal by Subject|1|||
125505365|NCT03840200|451481331|FG002|Overall Study|Withdrawal by Subject|0|||
125505366|NCT03840200|451481332|FG003|Overall Study|Withdrawal by Subject|2|||
125505367|NCT05487300|451481337|FG000|Overall Study|Withdrawal by Subject|1|||
125505368|NCT05487300|451481338|FG001|Overall Study|Withdrawal by Subject|0|||
125505369|NCT02880293|451481341|FG000|Overall Study|Inevaluable|5|||
125505370|NCT00264576|451481342|FG000|Overall Study|Lost to Follow-up|1|||
125505371|NCT00264576|451481343|FG001|Overall Study|Lost to Follow-up|1|||
125505372|NCT03976102|451481348|FG000|Overall Study|Withdrawal by Subject|4|||
125505373|NCT03976102|451481349|FG001|Overall Study|Withdrawal by Subject|4|||
125505374|NCT03976102|451481348|FG000|Overall Study|Adverse Event|2|||
125505375|NCT03976102|451481349|FG001|Overall Study|Adverse Event|4|||
125505376|NCT03976102|451481348|FG000|Overall Study|Not related to Covid-19|9|||
125505377|NCT03976102|451481349|FG001|Overall Study|Not related to Covid-19|13|||
125505378|NCT03976102|451481348|FG000|Overall Study|Lost to Follow-up|0|||
125505379|NCT03976102|451481349|FG001|Overall Study|Lost to Follow-up|2|||
125505380|NCT03976102|451481348|FG000|Overall Study|Death|3|||
125505381|NCT03976102|451481349|FG001|Overall Study|Death|2|||
125505382|NCT03976102|451481348|FG000|Overall Study|Physician Decision|1|||
125505383|NCT03976102|451481349|FG001|Overall Study|Physician Decision|1|||
125505384|NCT00092456|451481353|FG000|Overall Study|Adverse Event|0|||
125505385|NCT00092456|451481354|FG001|Overall Study|Adverse Event|0|||
125505386|NCT00092456|451481355|FG002|Overall Study|Adverse Event|1|||
125505387|NCT00092456|451481356|FG003|Overall Study|Adverse Event|1|||
125505388|NCT00092456|451481353|FG000|Overall Study|Lost to Follow-up|2|||
125505389|NCT00092456|451481354|FG001|Overall Study|Lost to Follow-up|2|||
125505390|NCT00092456|451481355|FG002|Overall Study|Lost to Follow-up|1|||
125505391|NCT00092456|451481356|FG003|Overall Study|Lost to Follow-up|2|||
125305397|NCT01620762|450745111|FG002|Overall Study|Withdrawal by Subject|27|||
125305398|NCT01620762|450745109|FG000|Overall Study|Lost to Follow-up|11|||
125305399|NCT01620762|450745110|FG001|Overall Study|Lost to Follow-up|17|||
125305400|NCT01620762|450745111|FG002|Overall Study|Lost to Follow-up|10|||
125305401|NCT01620762|450745109|FG000|Overall Study|Protocol deviation|1|||
125305402|NCT01620762|450745110|FG001|Overall Study|Protocol deviation|1|||
125305403|NCT01620762|450745111|FG002|Overall Study|Protocol deviation|6|||
125305404|NCT01620762|450745109|FG000|Overall Study|Subject deterioration|0|||
125305405|NCT01620762|450745110|FG001|Overall Study|Subject deterioration|1|||
125505392|NCT00092456|451481353|FG000|Overall Study|Protocol Violation|5|||
125505393|NCT00092456|451481354|FG001|Overall Study|Protocol Violation|7|||
125505394|NCT00092456|451481355|FG002|Overall Study|Protocol Violation|8|||
125505395|NCT00092456|451481356|FG003|Overall Study|Protocol Violation|6|||
125505396|NCT00092456|451481353|FG000|Overall Study|Withdrawal by Subject|13|||
125505397|NCT00092456|451481354|FG001|Overall Study|Withdrawal by Subject|5|||
125505398|NCT00092456|451481355|FG002|Overall Study|Withdrawal by Subject|16|||
125505399|NCT00092456|451481356|FG003|Overall Study|Withdrawal by Subject|6|||
125505400|NCT00092456|451481353|FG000|Overall Study|Moved|1|||
125505401|NCT00092456|451481354|FG001|Overall Study|Moved|1|||
125505402|NCT00092456|451481355|FG002|Overall Study|Moved|0|||
125505403|NCT00092456|451481356|FG003|Overall Study|Moved|1|||
125505404|NCT00092456|451481353|FG000|Overall Study|Other|4|||
125505405|NCT00092456|451481354|FG001|Overall Study|Other|2|||
125505406|NCT00092456|451481355|FG002|Overall Study|Other|3|||
125305406|NCT01620762|450745111|FG002|Overall Study|Subject deterioration|1|||
125505407|NCT00092456|451481356|FG003|Overall Study|Other|0|||
125305407|NCT01620762|450745109|FG000|Overall Study|Non-specified|3|||
125505408|NCT04783389|451481359|FG000|Overall Study|Withdrawal by Subject|2|||
125505409|NCT04783389|451481360|FG001|Overall Study|Withdrawal by Subject|0|||
125505410|NCT04783389|451481361|FG002|Overall Study|Withdrawal by Subject|0|||
125505411|NCT04783389|451481359|FG000|Overall Study|Termination of Study by Sponsor|10|||
125505412|NCT04783389|451481360|FG001|Overall Study|Termination of Study by Sponsor|12|||
125505413|NCT04783389|451481361|FG002|Overall Study|Termination of Study by Sponsor|14|||
125505414|NCT00451906|451481362|FG000|Overall Study|Adverse Event|515|||
125505415|NCT00451906|451481362|FG000|Overall Study|Lost to Follow-up|31|||
125505416|NCT00451906|451481362|FG000|Overall Study|Withdrawal by Subject|111|||
125505417|NCT00451906|451481362|FG000|Overall Study|Protocol Violation|21|||
125505418|NCT00451906|451481362|FG000|Overall Study|Progressive disease|1328|||
125505419|NCT00451906|451481362|FG000|Overall Study|Termination of the study|108|||
125505420|NCT00451906|451481362|FG000|Overall Study|Other Reasons|121|||
125505421|NCT00451906|451481362|FG000|Overall Study|Did not complete final visit|4|||
125505422|NCT02121808|451481364|FG000|Overall Study|Technical problem|3|||
125505423|NCT04820023|451481369|FG000|Overall Study|Death|0|||
125505424|NCT04820023|451481370|FG001|Overall Study|Death|0|||
125505425|NCT04820023|451481371|FG002|Overall Study|Death|0|||
125505426|NCT04820023|451481372|FG003|Overall Study|Death|0|||
125505427|NCT04820023|451481373|FG004|Overall Study|Death|0|||
125505428|NCT04820023|451481374|FG005|Overall Study|Death|0|||
125505429|NCT04820023|451481375|FG006|Overall Study|Death|1|||
125505430|NCT04820023|451481376|FG007|Overall Study|Death|0|||
125505431|NCT04820023|451481377|FG008|Overall Study|Death|1|||
125505432|NCT04820023|451481369|FG000|Overall Study|Withdrawal by Subject|1|||
125505433|NCT04820023|451481370|FG001|Overall Study|Withdrawal by Subject|2|||
125505434|NCT04820023|451481371|FG002|Overall Study|Withdrawal by Subject|2|||
125505435|NCT04820023|451481372|FG003|Overall Study|Withdrawal by Subject|1|||
125505436|NCT04820023|451481373|FG004|Overall Study|Withdrawal by Subject|4|||
125505437|NCT04820023|451481374|FG005|Overall Study|Withdrawal by Subject|3|||
125505438|NCT04820023|451481375|FG006|Overall Study|Withdrawal by Subject|3|||
125505439|NCT04820023|451481376|FG007|Overall Study|Withdrawal by Subject|6|||
125505440|NCT04820023|451481377|FG008|Overall Study|Withdrawal by Subject|5|||
125505441|NCT04820023|451481369|FG000|Overall Study|Progressive Disease|3|||
125505442|NCT04820023|451481370|FG001|Overall Study|Progressive Disease|0|||
125505443|NCT04820023|451481371|FG002|Overall Study|Progressive Disease|2|||
125505444|NCT04820023|451481372|FG003|Overall Study|Progressive Disease|2|||
125505445|NCT04820023|451481373|FG004|Overall Study|Progressive Disease|2|||
125505446|NCT04820023|451481374|FG005|Overall Study|Progressive Disease|0|||
125505447|NCT04820023|451481375|FG006|Overall Study|Progressive Disease|1|||
125505448|NCT04820023|451481376|FG007|Overall Study|Progressive Disease|1|||
125505449|NCT04820023|451481377|FG008|Overall Study|Progressive Disease|0|||
125505450|NCT04820023|451481369|FG000|Overall Study|New anti-cancer therapy|0|||
125505451|NCT04820023|451481370|FG001|Overall Study|New anti-cancer therapy|0|||
125505452|NCT04820023|451481371|FG002|Overall Study|New anti-cancer therapy|0|||
125505453|NCT04820023|451481372|FG003|Overall Study|New anti-cancer therapy|0|||
125505454|NCT04820023|451481373|FG004|Overall Study|New anti-cancer therapy|2|||
125505455|NCT04820023|451481374|FG005|Overall Study|New anti-cancer therapy|0|||
125505456|NCT04820023|451481375|FG006|Overall Study|New anti-cancer therapy|0|||
125505457|NCT04820023|451481376|FG007|Overall Study|New anti-cancer therapy|0|||
125505458|NCT04820023|451481377|FG008|Overall Study|New anti-cancer therapy|0|||
125505459|NCT04820023|451481369|FG000|Overall Study|Other|0|||
125505460|NCT04820023|451481370|FG001|Overall Study|Other|1|||
125505461|NCT04820023|451481371|FG002|Overall Study|Other|0|||
125505462|NCT04820023|451481372|FG003|Overall Study|Other|0|||
125505463|NCT04820023|451481373|FG004|Overall Study|Other|0|||
125505464|NCT04820023|451481374|FG005|Overall Study|Other|0|||
125505465|NCT04820023|451481375|FG006|Overall Study|Other|0|||
125505466|NCT04820023|451481376|FG007|Overall Study|Other|2|||
125505467|NCT04820023|451481377|FG008|Overall Study|Other|0|||
125305408|NCT01620762|450745110|FG001|Overall Study|Non-specified|6|||
125305409|NCT01620762|450745111|FG002|Overall Study|Non-specified|5|||
125305410|NCT01620762|450745109|FG000|Overall Study|Use of prohibted therapies|0|||
125305411|NCT01620762|450745110|FG001|Overall Study|Use of prohibted therapies|1|||
125505468|NCT05066230|451481378|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
125505469|NCT05066230|451481379|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
125505470|NCT05066230|451481378|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
125505471|NCT05066230|451481379|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
125505472|NCT05066230|451481378|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
125505473|NCT05066230|451481379|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
125505474|NCT05066230|451481378|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
125505475|NCT05066230|451481379|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
125505476|NCT05066230|451481378|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
125505477|NCT05066230|451481379|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
125505478|NCT05066230|451481378|FG000|After Week 48|Adverse Event|1|||
125505479|NCT05066230|451481379|FG001|After Week 48|Adverse Event|0|||
125505480|NCT05066230|451481378|FG000|After Week 48|Non-compliance with study schedule|1|||
125505481|NCT05066230|451481379|FG001|After Week 48|Non-compliance with study schedule|0|||
125505482|NCT05066230|451481378|FG000|After Week 48|Withdrawal by Subject|0|||
125305412|NCT01620762|450745111|FG002|Overall Study|Use of prohibted therapies|1|||
125505483|NCT05066230|451481379|FG001|After Week 48|Withdrawal by Subject|1|||
125505484|NCT05066230|451481378|FG000|After Week 48|Lost to Follow-up|3|||
125505485|NCT05066230|451481379|FG001|After Week 48|Lost to Follow-up|3|||
125505486|NCT05066230|451481378|FG000|After Week 48|Sponsor Request|115|||
125505487|NCT05066230|451481379|FG001|After Week 48|Sponsor Request|111|||
125505488|NCT02164578|451481380|FG000|Treatment Period|Withdrawal by Subject|3|||
125505489|NCT02164578|451481381|FG001|Treatment Period|Withdrawal by Subject|3|||
125505490|NCT02164578|451481380|FG000|Treatment Period|Adverse Event|13|||
125505491|NCT02164578|451481381|FG001|Treatment Period|Adverse Event|6|||
125505492|NCT02164578|451481380|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
125505493|NCT02164578|451481381|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
125505494|NCT02164578|451481380|FG000|Treatment Period|Protocol Violation|0|||
125505495|NCT02164578|451481381|FG001|Treatment Period|Protocol Violation|2|||
125505496|NCT02164578|451481380|FG000|Extension Period|Withdrawal by Subject|2|||
125505497|NCT02164578|451481381|FG001|Extension Period|Withdrawal by Subject|0|||
125505498|NCT02164578|451481380|FG000|Extension Period|Adverse Event|4|||
125505499|NCT02164578|451481381|FG001|Extension Period|Adverse Event|0|||
125505500|NCT02164578|451481380|FG000|Extension Period|Expiry of study medication|1|||
125505501|NCT02164578|451481381|FG001|Extension Period|Expiry of study medication|0|||
125505502|NCT02164578|451481380|FG000|Extension Period|Protocol Violation|0|||
125505503|NCT02164578|451481381|FG001|Extension Period|Protocol Violation|1|||
125505504|NCT02507297|451481382|FG000|Overall Study|Withdrawal by Subject|1|||
125505505|NCT02507297|451481383|FG001|Overall Study|Withdrawal by Subject|0|||
125505506|NCT02507297|451481382|FG000|Overall Study|Lost to Follow-up|0|||
125505507|NCT02507297|451481383|FG001|Overall Study|Lost to Follow-up|1|||
125505508|NCT01018992|451481384|FG000|Overall Study|Adverse Event|8|||
125505509|NCT01018992|451481385|FG001|Overall Study|Adverse Event|3|||
125505510|NCT01018992|451481384|FG000|Overall Study|Withdrawal by Subject|3|||
125505511|NCT01018992|451481385|FG001|Overall Study|Withdrawal by Subject|8|||
125505512|NCT01018992|451481384|FG000|Overall Study|Protocol Violation|0|||
125505513|NCT01018992|451481385|FG001|Overall Study|Protocol Violation|4|||
125505514|NCT01018992|451481384|FG000|Overall Study|Lost to Follow-up|5|||
125505515|NCT01018992|451481385|FG001|Overall Study|Lost to Follow-up|1|||
125505516|NCT03029585|451481386|FG000|Overall Study|Death|1|||
125505517|NCT03029585|451481387|FG001|Overall Study|Death|1|||
125505518|NCT03029585|451481386|FG000|Overall Study|Withdrawal by Subject|1|||
125505519|NCT03029585|451481387|FG001|Overall Study|Withdrawal by Subject|0|||
125505520|NCT02092285|451481388|FG000|Induction Phase|Adverse Event|7|||
125505521|NCT02092285|451481388|FG000|Induction Phase|Physician Decision|4|||
125505522|NCT02092285|451481388|FG000|Induction Phase|Pregnancy|1|||
125505523|NCT02092285|451481388|FG000|Induction Phase|Relapse/Recurrence|7|||
125505524|NCT02092285|451481388|FG000|Induction Phase|Withdrawal by Subject|2|||
125505525|NCT02092285|451481388|FG000|Induction Phase|Lack of Efficacy|14|||
125505526|NCT02092285|451481388|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
125505527|NCT02092285|451481388|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
125505528|NCT02092285|451481388|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
125505529|NCT02092285|451481388|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
125505530|NCT02092285|451481388|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
125505531|NCT02092285|451481388|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
125505532|NCT02092285|451481388|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
125505533|NCT02092285|451481388|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
125505534|NCT02092285|451481388|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
125505535|NCT01825785|451481389|FG000|Overall Study|Adverse Event|0|||
125505536|NCT01825785|451481390|FG001|Overall Study|Adverse Event|0|||
125505537|NCT01825785|451481391|FG002|Overall Study|Adverse Event|0|||
125505538|NCT01825785|451481392|FG003|Overall Study|Adverse Event|0|||
125505539|NCT01825785|451481393|FG004|Overall Study|Adverse Event|1|||
125505540|NCT01825785|451481394|FG005|Overall Study|Adverse Event|0|||
125505541|NCT01825785|451481395|FG006|Overall Study|Adverse Event|0|||
125505542|NCT01825785|451481389|FG000|Overall Study|Withdrawal by Subject|0|||
125505543|NCT01825785|451481390|FG001|Overall Study|Withdrawal by Subject|0|||
125505544|NCT01825785|451481391|FG002|Overall Study|Withdrawal by Subject|0|||
125505545|NCT01825785|451481392|FG003|Overall Study|Withdrawal by Subject|0|||
125505546|NCT01825785|451481393|FG004|Overall Study|Withdrawal by Subject|1|||
125505547|NCT01825785|451481394|FG005|Overall Study|Withdrawal by Subject|1|||
125505548|NCT01825785|451481395|FG006|Overall Study|Withdrawal by Subject|0|||
125505549|NCT01304940|451481397|FG000|Overall Study|not meet symptom severity requirement|3|||
125505550|NCT01304940|451481398|FG001|Overall Study|not meet symptom severity requirement|0|||
125505551|NCT00278395|451481399|FG000|Overall Study|Adverse Event|2|||
125505552|NCT00278395|451481399|FG000|Overall Study|Nonevaluable|1|||
125505553|NCT03740737|451481402|FG000|Overall Study|Protocol deviation|13|||
125505554|NCT03740737|451481403|FG001|Overall Study|Protocol deviation|0|||
125505555|NCT03740737|451481402|FG000|Overall Study|Adverse Event|2|||
125505556|NCT03740737|451481403|FG001|Overall Study|Adverse Event|0|||
125305413|NCT00705146|450745116|FG000|Overall Study|Lost to Follow-up|1|||
125505557|NCT03740737|451481402|FG000|Overall Study|Lost to Follow-up|1|||
125505558|NCT03740737|451481403|FG001|Overall Study|Lost to Follow-up|0|||
125505559|NCT03740737|451481402|FG000|Overall Study|Randomization failure|1|||
125505560|NCT03740737|451481403|FG001|Overall Study|Randomization failure|0|||
125505561|NCT03740737|451481402|FG000|Overall Study|Participant withdrew consent|1|||
125505562|NCT03740737|451481403|FG001|Overall Study|Participant withdrew consent|0|||
125505563|NCT03740737|451481402|FG000|Overall Study|Participant withdrew from trial|2|||
125505564|NCT03740737|451481403|FG001|Overall Study|Participant withdrew from trial|1|||
125505565|NCT01286311|451481405|FG000|Overall Study|Physician did not want outreach sent|14|||
125505566|NCT01286311|451481406|FG001|Overall Study|Physician did not want outreach sent|0|||
125505567|NCT02981953|451481412|FG000|Overall Study|Death|9|||
125505568|NCT02981953|451481412|FG000|Overall Study|Withdrawal by Subject|1|||
125505569|NCT02981953|451481412|FG000|Overall Study|Withdrawal to non-compliance|1|||
125505570|NCT02889900|451481413|FG000|Overall Study|Adverse Event|11|||
125505571|NCT02889900|451481413|FG000|Overall Study|Condition under investigation worsened|32|||
125505572|NCT02889900|451481413|FG000|Overall Study|Other|5|||
125505573|NCT02889900|451481413|FG000|Overall Study|Withdrawal by Subject|7|||
125505574|NCT02889900|451481413|FG000|Overall Study|Not treated|2|||
125505575|NCT03146845|451481418|FG000|Overall Study|Reference ulcer healed|1|||
125505576|NCT03146845|451481419|FG001|Overall Study|Reference ulcer healed|0|||
125505577|NCT03146845|451481418|FG000|Overall Study|Physician Decision|1|||
125505578|NCT03146845|451481419|FG001|Overall Study|Physician Decision|0|||
125505579|NCT03146845|451481418|FG000|Overall Study|Adverse Event|1|||
125505580|NCT03146845|451481419|FG001|Overall Study|Adverse Event|0|||
125505581|NCT03146845|451481418|FG000|Overall Study|Withdrawal by Subject|2|||
125505582|NCT03146845|451481419|FG001|Overall Study|Withdrawal by Subject|0|||
125505583|NCT03146845|451481418|FG000|Overall Study|Noncompliance|0|||
125505584|NCT03146845|451481419|FG001|Overall Study|Noncompliance|1|||
125505585|NCT03146845|451481418|FG000|Overall Study|Protocol Violation|0|||
125505586|NCT03146845|451481419|FG001|Overall Study|Protocol Violation|2|||
125505587|NCT03146845|451481418|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
125505588|NCT03146845|451481419|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
125505589|NCT01535261|451481426|FG000|Overall Study|Physician Decision|8|||
125505590|NCT01535261|451481426|FG000|Overall Study|Protocol Violation|3|||
125505591|NCT01535261|451481426|FG000|Overall Study|Death|5|||
125505592|NCT01535261|451481426|FG000|Overall Study|Lost to Follow-up|8|||
125505593|NCT01535261|451481426|FG000|Overall Study|Withdrawal by Subject|14|||
125505594|NCT01535261|451481426|FG000|Overall Study|Adverse Event|12|||
125505595|NCT01757288|451481430|FG000|Overall Study|Consent withdrawal|0|||
125505596|NCT01757288|451481431|FG001|Overall Study|Consent withdrawal|4|||
125505597|NCT01757288|451481432|FG002|Overall Study|Consent withdrawal|4|||
125505598|NCT01757288|451481430|FG000|Overall Study|Patient off study, IRB hold.|0|||
125505599|NCT01757288|451481431|FG001|Overall Study|Patient off study, IRB hold.|0|||
125505600|NCT01757288|451481432|FG002|Overall Study|Patient off study, IRB hold.|1|||
125505601|NCT01757288|451481430|FG000|Overall Study|Patient death prior to starting treatment|0|||
125505602|NCT01757288|451481431|FG001|Overall Study|Patient death prior to starting treatment|0|||
125505603|NCT01757288|451481432|FG002|Overall Study|Patient death prior to starting treatment|1|||
125505604|NCT01757288|451481430|FG000|Overall Study|Wrong medication administered|0|||
125505605|NCT01757288|451481431|FG001|Overall Study|Wrong medication administered|1|||
125505606|NCT01757288|451481432|FG002|Overall Study|Wrong medication administered|0|||
125505607|NCT01757288|451481430|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
125505608|NCT01757288|451481431|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
125505609|NCT01757288|451481432|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
125505610|NCT01757288|451481430|FG000|Overall Study|Not meeting protocol constraints|0|||
125505611|NCT01757288|451481431|FG001|Overall Study|Not meeting protocol constraints|1|||
125505612|NCT01757288|451481432|FG002|Overall Study|Not meeting protocol constraints|1|||
125505613|NCT01757288|451481430|FG000|Overall Study|Multiple missed appointments|0|||
125505614|NCT01757288|451481431|FG001|Overall Study|Multiple missed appointments|1|||
125505615|NCT01757288|451481432|FG002|Overall Study|Multiple missed appointments|0|||
125305414|NCT00705146|450745117|FG001|Overall Study|Lost to Follow-up|1|||
125505616|NCT01757288|451481430|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
125505617|NCT01757288|451481431|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
125505618|NCT01757288|451481432|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
125505619|NCT01757288|451481430|FG000|Overall Study|>2 weeks treatment break|0|||
125505620|NCT01757288|451481431|FG001|Overall Study|>2 weeks treatment break|0|||
125505621|NCT01757288|451481432|FG002|Overall Study|>2 weeks treatment break|1|||
125305415|NCT02669121|450745120|FG000|Overall Study|Adverse Event|4|||
125305416|NCT02669121|450745121|FG001|Overall Study|Adverse Event|5|||
125305417|NCT02669121|450745120|FG000|Overall Study|Lost to Follow-up|15|||
125305418|NCT02669121|450745121|FG001|Overall Study|Lost to Follow-up|27|||
125505622|NCT03875729|451481435|FG000|Overall Study|Adverse Event|0|||
125505623|NCT03875729|451481436|FG001|Overall Study|Adverse Event|5|||
125505624|NCT03875729|451481435|FG000|Overall Study|Withdrawal by Subject|8|||
125505625|NCT03875729|451481436|FG001|Overall Study|Withdrawal by Subject|11|||
125505626|NCT03875729|451481435|FG000|Overall Study|Pregnancy|0|||
125505627|NCT03875729|451481436|FG001|Overall Study|Pregnancy|1|||
125505628|NCT03875729|451481435|FG000|Overall Study|Lost to Follow-up|0|||
125505629|NCT03875729|451481436|FG001|Overall Study|Lost to Follow-up|5|||
125505630|NCT03875729|451481435|FG000|Overall Study|Personal reasons|2|||
125505631|NCT03875729|451481436|FG001|Overall Study|Personal reasons|0|||
125505632|NCT02764320|451481437|FG000|Overall Study|Withdrawal by Subject|35|||
125505633|NCT02764320|451481438|FG001|Overall Study|Withdrawal by Subject|38|||
125505634|NCT02764320|451481437|FG000|Overall Study|Protocol Violation|11|||
125505635|NCT02764320|451481438|FG001|Overall Study|Protocol Violation|6|||
125505636|NCT02764320|451481437|FG000|Overall Study|Adverse Event|2|||
125505637|NCT02764320|451481438|FG001|Overall Study|Adverse Event|0|||
125505638|NCT02764320|451481437|FG000|Overall Study|Health Issues unable to continue|2|||
125505639|NCT02764320|451481438|FG001|Overall Study|Health Issues unable to continue|0|||
125505640|NCT02764320|451481437|FG000|Overall Study|Did not meet inclusion criteria|1|||
125505641|NCT02764320|451481438|FG001|Overall Study|Did not meet inclusion criteria|0|||
125505642|NCT02764320|451481437|FG000|Overall Study|Subject moved|0|||
125505643|NCT02764320|451481438|FG001|Overall Study|Subject moved|2|||
125505644|NCT02764320|451481437|FG000|Overall Study|Overused medication unavailable|0|||
125505645|NCT02764320|451481438|FG001|Overall Study|Overused medication unavailable|1|||
125505646|NCT02764320|451481437|FG000|Overall Study|Seeking care outside site|0|||
125505647|NCT02764320|451481438|FG001|Overall Study|Seeking care outside site|1|||
125505648|NCT02764320|451481437|FG000|Overall Study|Technology barriers|0|||
125505649|NCT02764320|451481438|FG001|Overall Study|Technology barriers|1|||
125505650|NCT01405508|451481441|FG000|Overall Study|AE, non-serious non-fatal|1|||
125505651|NCT01405508|451481442|FG001|Overall Study|AE, non-serious non-fatal|1|||
125505652|NCT01405508|451481443|FG002|Overall Study|AE, non-serious non-fatal|0|||
125505653|NCT01405508|451481444|FG003|Overall Study|AE, non-serious non-fatal|0|||
125505654|NCT00476957|451481445|FG000|Overall Study|Lost to Follow-up|176|||
125505655|NCT00476957|451481446|FG001|Overall Study|Lost to Follow-up|193|||
125505656|NCT02159352|451481451|FG000|Overall Study|Adverse Event|3|||
125505657|NCT02159352|451481452|FG001|Overall Study|Adverse Event|1|||
125505658|NCT02159352|451481451|FG000|Overall Study|Withdrawal by Subject|0|||
125505659|NCT02159352|451481452|FG001|Overall Study|Withdrawal by Subject|1|||
125505660|NCT03246724|451481457|FG000|Overall Study|Withdrawal by Subject|5|||
125505661|NCT03246724|451481458|FG001|Overall Study|Withdrawal by Subject|2|||
125505662|NCT03246724|451481459|FG002|Overall Study|Withdrawal by Subject|4|||
125505663|NCT03246724|451481460|FG003|Overall Study|Withdrawal by Subject|2|||
125505664|NCT03246724|451481457|FG000|Overall Study|Ineligible on day of surgery|7|||
125505665|NCT03246724|451481458|FG001|Overall Study|Ineligible on day of surgery|2|||
125505666|NCT03246724|451481459|FG002|Overall Study|Ineligible on day of surgery|0|||
125505667|NCT03246724|451481460|FG003|Overall Study|Ineligible on day of surgery|3|||
125505668|NCT03246724|451481457|FG000|Overall Study|Study completed before surgical date|2|||
125505669|NCT03246724|451481458|FG001|Overall Study|Study completed before surgical date|1|||
125505670|NCT03246724|451481459|FG002|Overall Study|Study completed before surgical date|8|||
125505671|NCT03246724|451481460|FG003|Overall Study|Study completed before surgical date|1|||
125505672|NCT03246724|451481457|FG000|Overall Study|Transferred to other arm|0|||
125505673|NCT03246724|451481458|FG001|Overall Study|Transferred to other arm|0|||
125505674|NCT03246724|451481459|FG002|Overall Study|Transferred to other arm|1|||
125505675|NCT03246724|451481460|FG003|Overall Study|Transferred to other arm|0|||
125505676|NCT03246724|451481457|FG000|Overall Study|Unable to obtain medication timely|0|||
125505677|NCT03246724|451481458|FG001|Overall Study|Unable to obtain medication timely|2|||
125505678|NCT03246724|451481459|FG002|Overall Study|Unable to obtain medication timely|2|||
125505679|NCT03246724|451481460|FG003|Overall Study|Unable to obtain medication timely|1|||
125505680|NCT03246724|451481457|FG000|Overall Study|Re-consented to participate|0|||
125505681|NCT03246724|451481458|FG001|Overall Study|Re-consented to participate|0|||
125505682|NCT03246724|451481459|FG002|Overall Study|Re-consented to participate|0|||
125305419|NCT02669121|450745120|FG000|Overall Study|Withdrawal by Subject|132|||
125305420|NCT02669121|450745121|FG001|Overall Study|Withdrawal by Subject|140|||
125305421|NCT02669121|450745120|FG000|Overall Study|Pregnancy|0|||
125305422|NCT02669121|450745121|FG001|Overall Study|Pregnancy|1|||
125305423|NCT02669121|450745120|FG000|Overall Study|Discharged from US Military Active Service|117|||
125305424|NCT02669121|450745121|FG001|Overall Study|Discharged from US Military Active Service|91|||
125305425|NCT02669121|450745120|FG000|Overall Study|Reason not Specified|22|||
125305426|NCT02669121|450745121|FG001|Overall Study|Reason not Specified|18|||
125305427|NCT00825812|450745128|FG000|Overall Study|Never entered follow up|0|||
125505683|NCT03246724|451481460|FG003|Overall Study|Re-consented to participate|1|||
125505684|NCT02255474|451481462|FG000|Overall Study|Lost to Follow-up|1|||
125505685|NCT02255474|451481463|FG001|Overall Study|Lost to Follow-up|1|||
125305428|NCT00825812|450745129|FG001|Overall Study|Never entered follow up|0|||
125305429|NCT00825812|450745130|FG002|Overall Study|Never entered follow up|0|||
125505686|NCT02255474|451481464|FG002|Overall Study|Lost to Follow-up|3|||
125505687|NCT02255474|451481462|FG000|Overall Study|Withdrawal by Subject|1|||
125505688|NCT02255474|451481463|FG001|Overall Study|Withdrawal by Subject|1|||
125505689|NCT02255474|451481464|FG002|Overall Study|Withdrawal by Subject|0|||
125505690|NCT02010684|451481468|FG000|Overall Study|Lost to Follow-up|8|||
125505691|NCT02010684|451481469|FG001|Overall Study|Lost to Follow-up|18|||
125505692|NCT02010684|451481468|FG000|Overall Study|Withdrawal by Subject|4|||
125505693|NCT02010684|451481469|FG001|Overall Study|Withdrawal by Subject|5|||
125505694|NCT02612285|451481470|FG000|Overall Study|Withdrawal by Subject|1|||
125505695|NCT00805441|451481471|FG000|Overall Study|Adverse Event|5|||
125505696|NCT00805441|451481472|FG001|Overall Study|Adverse Event|2|||
125505697|NCT00805441|451481471|FG000|Overall Study|Lack of Efficacy|0|||
125505698|NCT00805441|451481472|FG001|Overall Study|Lack of Efficacy|2|||
125505699|NCT00805441|451481471|FG000|Overall Study|Protocol Violation|4|||
125505700|NCT00805441|451481472|FG001|Overall Study|Protocol Violation|8|||
125505701|NCT00805441|451481471|FG000|Overall Study|Lost to Follow-up|10|||
125505702|NCT00805441|451481472|FG001|Overall Study|Lost to Follow-up|13|||
125505703|NCT00805441|451481471|FG000|Overall Study|Withdrawal by Subject|15|||
125505704|NCT00805441|451481472|FG001|Overall Study|Withdrawal by Subject|9|||
125505705|NCT00805441|451481471|FG000|Overall Study|Physician Decision|0|||
125505706|NCT00805441|451481472|FG001|Overall Study|Physician Decision|1|||
125505707|NCT00805441|451481471|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
125505708|NCT00805441|451481472|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
125505709|NCT01884571|451481477|FG000|Overall Study|Adverse Event|1|||
125505710|NCT01884571|451481477|FG000|Overall Study|Death|2|||
125505711|NCT01884571|451481477|FG000|Overall Study|Withdrawal by Subject|2|||
125505712|NCT01884571|451481477|FG000|Overall Study|Disease progression|3|||
125505713|NCT00091572|451481478|FG000|Overall Study|Lost to Follow-up|1|||
125505714|NCT00091572|451481479|FG001|Overall Study|Lost to Follow-up|1|||
125505715|NCT00091572|451481478|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
125505716|NCT00091572|451481479|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
125505717|NCT00091572|451481478|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
125505718|NCT00091572|451481479|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
125505719|NCT00091572|451481478|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
125505720|NCT00091572|451481479|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
125505721|NCT00091572|451481478|FG000|Overall Study|Other Reason|6|||
125505722|NCT00091572|451481479|FG001|Overall Study|Other Reason|13|||
125505723|NCT00091572|451481478|FG000|Overall Study|Ongoing (still on treatment)|8|||
125505724|NCT00091572|451481479|FG001|Overall Study|Ongoing (still on treatment)|12|||
125505725|NCT00091572|451481478|FG000|Overall Study|Major Protocol Violation|2|||
125505726|NCT00091572|451481479|FG001|Overall Study|Major Protocol Violation|0|||
125505727|NCT00091572|451481478|FG000|Overall Study|Toxicity (Related AE)|53|||
125505728|NCT00091572|451481479|FG001|Overall Study|Toxicity (Related AE)|9|||
125505729|NCT02340806|451481483|FG000|Overall Study|Protocol Violation|2|||
125505730|NCT02340806|451481484|FG001|Overall Study|Protocol Violation|0|||
125505731|NCT02340806|451481483|FG000|Overall Study|epidural catheter replaced|2|||
125505732|NCT02340806|451481484|FG001|Overall Study|epidural catheter replaced|1|||
125505733|NCT02340806|451481483|FG000|Overall Study|history of chronic pain medication|1|||
125505734|NCT02340806|451481484|FG001|Overall Study|history of chronic pain medication|0|||
125505735|NCT02340806|451481483|FG000|Overall Study|re-dose < 90 min of CSE|1|||
125505736|NCT02340806|451481484|FG001|Overall Study|re-dose < 90 min of CSE|3|||
125505737|NCT00452452|451481485|FG000|Overall Study|Protocol Violation|0|||
125505738|NCT00452452|451481486|FG001|Overall Study|Protocol Violation|0|||
125505739|NCT00452452|451481487|FG002|Overall Study|Protocol Violation|1|||
125505740|NCT00452452|451481485|FG000|Overall Study|Withdrawal by Subject|1|||
125505741|NCT00452452|451481486|FG001|Overall Study|Withdrawal by Subject|0|||
125505742|NCT00452452|451481487|FG002|Overall Study|Withdrawal by Subject|0|||
125505743|NCT00452452|451481485|FG000|Overall Study|Lost to Follow-up|1|||
125505744|NCT00452452|451481486|FG001|Overall Study|Lost to Follow-up|0|||
125505745|NCT00452452|451481487|FG002|Overall Study|Lost to Follow-up|0|||
125505746|NCT04097535|451481492|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
125505747|NCT03070301|451481493|FG000|Overall Study|Progression of disease|16|||
125505748|NCT03070301|451481493|FG000|Overall Study|Physician Decision|3|||
125505749|NCT03070301|451481493|FG000|Overall Study|Withdrawal by Subject|1|||
125505750|NCT04620733|451483215|FG000|Overall Study|Adverse Event|4|||
125505751|NCT04620733|451483216|FG001|Overall Study|Adverse Event|3|||
125505752|NCT04620733|451483215|FG000|Overall Study|Withdrawal by Subject|2|||
125505753|NCT04620733|451483216|FG001|Overall Study|Withdrawal by Subject|5|||
125505754|NCT04620733|451483215|FG000|Overall Study|Lost to Follow-up|1|||
125505755|NCT04620733|451483216|FG001|Overall Study|Lost to Follow-up|1|||
125505756|NCT04620733|451483215|FG000|Overall Study|Protocol Deviation|1|||
125505757|NCT04620733|451483216|FG001|Overall Study|Protocol Deviation|1|||
125505758|NCT04620733|451483215|FG000|Overall Study|Reason Not Specified|0|||
125505759|NCT04620733|451483216|FG001|Overall Study|Reason Not Specified|1|||
125505760|NCT02659059|451483223|FG000|Overall Study|Other reasons|6|||
125505761|NCT02659059|451483224|FG001|Overall Study|Other reasons|1|||
125505762|NCT02659059|451483223|FG000|Overall Study|Disease Progression|143|||
125505763|NCT02659059|451483224|FG001|Overall Study|Disease Progression|16|||
125505764|NCT02659059|451483223|FG000|Overall Study|Study Drug toxicity|56|||
125505765|NCT02659059|451483224|FG001|Overall Study|Study Drug toxicity|9|||
125505766|NCT02659059|451483223|FG000|Overall Study|Death|3|||
125505767|NCT02659059|451483224|FG001|Overall Study|Death|1|||
125505768|NCT02659059|451483223|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
125505769|NCT02659059|451483224|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
125505770|NCT02659059|451483223|FG000|Overall Study|Participant request to discontinue study treatment|5|||
125505771|NCT02659059|451483224|FG001|Overall Study|Participant request to discontinue study treatment|0|||
125505772|NCT02659059|451483223|FG000|Overall Study|Participant withdrew consent|6|||
125505773|NCT02659059|451483224|FG001|Overall Study|Participant withdrew consent|1|||
125505774|NCT03072238|451483227|FG000|Overall Study|Withdrawal by Subject|44|||
125505775|NCT03072238|451483228|FG001|Overall Study|Withdrawal by Subject|64|||
125505776|NCT03072238|451483227|FG000|Overall Study|Lost to Follow-up|14|||
125505777|NCT03072238|451483228|FG001|Overall Study|Lost to Follow-up|5|||
125505778|NCT03072238|451483227|FG000|Overall Study|Physician Decision|4|||
125505779|NCT03072238|451483228|FG001|Overall Study|Physician Decision|6|||
125505780|NCT03072238|451483227|FG000|Overall Study|Death|351|||
125505781|NCT03072238|451483228|FG001|Overall Study|Death|318|||
125505782|NCT03072238|451483227|FG000|Overall Study|Progressive Disease|3|||
125505783|NCT03072238|451483228|FG001|Overall Study|Progressive Disease|4|||
125505784|NCT03072238|451483227|FG000|Overall Study|Reason Not Specified|138|||
125505785|NCT03072238|451483228|FG001|Overall Study|Reason Not Specified|150|||
125505786|NCT03924193|451483234|FG000|Overall Study|Adverse Event|10|||
125505787|NCT03924193|451483235|FG001|Overall Study|Adverse Event|0|||
125505788|NCT03924193|451483236|FG002|Overall Study|Adverse Event|10|||
125505789|NCT03924193|451483234|FG000|Overall Study|Withdrawal by Subject|5|||
125505790|NCT03924193|451483235|FG001|Overall Study|Withdrawal by Subject|10|||
125505791|NCT03924193|451483236|FG002|Overall Study|Withdrawal by Subject|2|||
125505792|NCT02489799|451483237|FG000|Overall Study|Lost to Follow-up|4|||
125505793|NCT02489799|451483238|FG001|Overall Study|Lost to Follow-up|1|||
125505794|NCT02489799|451483237|FG000|Overall Study|Failure to Maintain Eligibility|4|||
125505795|NCT02489799|451483238|FG001|Overall Study|Failure to Maintain Eligibility|6|||
125505796|NCT02489799|451483237|FG000|Overall Study|Withdrawal by Subject|1|||
125505797|NCT02489799|451483238|FG001|Overall Study|Withdrawal by Subject|1|||
125505798|NCT02489799|451483237|FG000|Overall Study|Death|0|||
125505799|NCT02489799|451483238|FG001|Overall Study|Death|1|||
125505800|NCT04909593|451483239|FG000|Overall Study|Withdrawal by Subject|1|||
125505801|NCT01241448|451483240|FG000|Overall Study|Adverse Event|1|||
125505802|NCT01241448|451483241|FG001|Overall Study|Adverse Event|0|||
125505803|NCT01241448|451483242|FG002|Overall Study|Adverse Event|2|||
125505804|NCT01241448|451483243|FG003|Overall Study|Adverse Event|2|||
125505805|NCT01241448|451483240|FG000|Overall Study|Lost to Follow-up|2|||
125505806|NCT01241448|451483241|FG001|Overall Study|Lost to Follow-up|1|||
125505807|NCT01241448|451483242|FG002|Overall Study|Lost to Follow-up|1|||
125505808|NCT01241448|451483243|FG003|Overall Study|Lost to Follow-up|1|||
125505809|NCT01241448|451483240|FG000|Overall Study|Physician Decision|0|||
125505810|NCT01241448|451483241|FG001|Overall Study|Physician Decision|2|||
125505811|NCT01241448|451483242|FG002|Overall Study|Physician Decision|0|||
125505812|NCT01241448|451483243|FG003|Overall Study|Physician Decision|0|||
125505813|NCT01241448|451483240|FG000|Overall Study|Protocol Violation|10|||
125505814|NCT01241448|451483241|FG001|Overall Study|Protocol Violation|5|||
125505815|NCT01241448|451483242|FG002|Overall Study|Protocol Violation|3|||
125505816|NCT01241448|451483243|FG003|Overall Study|Protocol Violation|6|||
125505817|NCT01241448|451483240|FG000|Overall Study|Sponsor Decision|17|||
125505818|NCT01241448|451483241|FG001|Overall Study|Sponsor Decision|14|||
125505819|NCT01241448|451483242|FG002|Overall Study|Sponsor Decision|12|||
125505820|NCT01241448|451483243|FG003|Overall Study|Sponsor Decision|6|||
125505821|NCT01241448|451483240|FG000|Overall Study|Withdrawal by Subject|4|||
125505822|NCT01241448|451483241|FG001|Overall Study|Withdrawal by Subject|5|||
125505823|NCT01241448|451483242|FG002|Overall Study|Withdrawal by Subject|3|||
125505824|NCT01241448|451483243|FG003|Overall Study|Withdrawal by Subject|6|||
125505825|NCT01241448|451483240|FG000|Overall Study|Excluded due to data integrity issues|3|||
125505826|NCT01241448|451483241|FG001|Overall Study|Excluded due to data integrity issues|2|||
125505827|NCT01241448|451483242|FG002|Overall Study|Excluded due to data integrity issues|2|||
125505828|NCT01241448|451483243|FG003|Overall Study|Excluded due to data integrity issues|2|||
125505829|NCT02165202|451483251|FG000|Oral Phase|Refused further participation|5|||
125505830|NCT02165202|451483252|FG001|Oral Phase|Refused further participation|1|||
125505831|NCT02165202|451483251|FG000|Oral Phase|Study product Related Toxicity|1|||
125505832|NCT02165202|451483252|FG001|Oral Phase|Study product Related Toxicity|0|||
125505833|NCT02165202|451483251|FG000|Oral Phase|Unable to contact Participant|1|||
125505834|NCT02165202|451483252|FG001|Oral Phase|Unable to contact Participant|1|||
125505835|NCT02165202|451483251|FG000|Oral Phase|Clinical reasons|1|||
125505836|NCT02165202|451483252|FG001|Oral Phase|Clinical reasons|0|||
125505837|NCT02165202|451483251|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
125505838|NCT02165202|451483252|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
125505839|NCT02165202|451483251|FG000|Oral Phase|CMC advised termination|1|||
125505840|NCT02165202|451483252|FG001|Oral Phase|CMC advised termination|0|||
125505841|NCT02165202|451483251|FG000|Oral Phase|Relocated, no follow-up planned|1|||
125505842|NCT02165202|451483252|FG001|Oral Phase|Relocated, no follow-up planned|0|||
125505843|NCT02165202|451483251|FG000|Oral Phase|Abnormal EKG|0|||
125505844|NCT02165202|451483252|FG001|Oral Phase|Abnormal EKG|1|||
125505845|NCT02165202|451483251|FG000|Injection Phase|Abnormal Lab Value|5|||
125505846|NCT02165202|451483252|FG001|Injection Phase|Abnormal Lab Value|1|||
125505847|NCT02165202|451483251|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
125505848|NCT02165202|451483252|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
125505849|NCT02165202|451483251|FG000|Injection Phase|Unable to attend within Visit Window|1|||
125505850|NCT02165202|451483252|FG001|Injection Phase|Unable to attend within Visit Window|0|||
125505851|NCT02165202|451483251|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
125505852|NCT02165202|451483252|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
125505853|NCT02165202|451483251|FG000|Injection Phase|End of Study|2|||
125505854|NCT02165202|451483252|FG001|Injection Phase|End of Study|1|||
125505855|NCT02165202|451483251|FG000|Injection Phase|Study Product related Toxicity|1|||
125505856|NCT02165202|451483252|FG001|Injection Phase|Study Product related Toxicity|0|||
125505857|NCT02165202|451483251|FG000|Injection Phase|No longer interested|0|||
125505858|NCT02165202|451483252|FG001|Injection Phase|No longer interested|1|||
125505859|NCT02165202|451483251|FG000|Injection Phase|Participant unwilling to comply|1|||
125505860|NCT02165202|451483252|FG001|Injection Phase|Participant unwilling to comply|0|||
125505861|NCT01975701|451483261|FG000|Overall Study|Lost to Follow-up|1|||
125505862|NCT01975701|451483261|FG000|Overall Study|Death|23|||
125505863|NCT01975701|451483261|FG000|Overall Study|Physician Decision|1|||
125505864|NCT01655498|451483262|FG000|Overall Study|Unrelated health issue|2|||
125505865|NCT01655498|451483262|FG000|Overall Study|Protocol Violation|2|||
125505866|NCT01655498|451483262|FG000|Overall Study|Withdrawal by Subject|1|||
125505867|NCT01072149|451483267|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505868|NCT01072149|451483268|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505869|NCT01072149|451483269|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
125505870|NCT01072149|451483270|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505871|NCT01072149|451483271|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505872|NCT01072149|451483272|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505873|NCT01072149|451483273|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505874|NCT01072149|451483274|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505875|NCT01072149|451483275|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505876|NCT01072149|451483276|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505877|NCT01072149|451483277|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505878|NCT01072149|451483278|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505879|NCT01072149|451483279|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505880|NCT01072149|451483280|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505881|NCT01072149|451483281|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505882|NCT01072149|451483282|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505883|NCT01072149|451483283|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505884|NCT01072149|451483284|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
125505885|NCT01072149|451483267|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505886|NCT01072149|451483268|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505887|NCT01072149|451483269|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505888|NCT01072149|451483270|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505889|NCT01072149|451483271|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505890|NCT01072149|451483272|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505891|NCT01072149|451483273|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505892|NCT01072149|451483274|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505893|NCT01072149|451483275|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505894|NCT01072149|451483276|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505895|NCT01072149|451483277|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505896|NCT01072149|451483278|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505897|NCT01072149|451483279|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505898|NCT01072149|451483280|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505899|NCT01072149|451483281|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505900|NCT01072149|451483282|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505901|NCT01072149|451483283|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
125505902|NCT01072149|451483284|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
125505903|NCT01072149|451483267|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505904|NCT01072149|451483268|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505905|NCT01072149|451483269|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505906|NCT01072149|451483270|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505907|NCT01072149|451483271|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505908|NCT01072149|451483272|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505909|NCT01072149|451483273|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505910|NCT01072149|451483274|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505911|NCT01072149|451483275|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505912|NCT01072149|451483276|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505913|NCT01072149|451483277|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
125505914|NCT01072149|451483278|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505915|NCT01072149|451483279|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505916|NCT01072149|451483280|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505917|NCT01072149|451483281|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505918|NCT01072149|451483282|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505919|NCT01072149|451483283|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505920|NCT01072149|451483284|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
125505921|NCT01072149|451483267|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505922|NCT01072149|451483268|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
125505923|NCT01072149|451483269|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505924|NCT01072149|451483270|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505925|NCT01072149|451483271|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505926|NCT01072149|451483272|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505927|NCT01072149|451483273|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505928|NCT01072149|451483274|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505929|NCT01072149|451483275|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505930|NCT01072149|451483276|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505931|NCT01072149|451483277|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505932|NCT01072149|451483278|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505933|NCT01072149|451483279|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505934|NCT01072149|451483280|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505935|NCT01072149|451483281|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505936|NCT01072149|451483282|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505937|NCT01072149|451483283|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505938|NCT01072149|451483284|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
125505939|NCT01072149|451483267|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505940|NCT01072149|451483268|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505941|NCT01072149|451483269|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
125505942|NCT01072149|451483270|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505943|NCT01072149|451483271|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505944|NCT01072149|451483272|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505945|NCT01072149|451483273|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505946|NCT01072149|451483274|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505947|NCT01072149|451483275|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505948|NCT01072149|451483276|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505949|NCT01072149|451483277|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505950|NCT01072149|451483278|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505951|NCT01072149|451483279|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505952|NCT01072149|451483280|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505953|NCT01072149|451483281|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505954|NCT01072149|451483282|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505955|NCT01072149|451483283|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505956|NCT01072149|451483284|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
125505957|NCT01072149|451483267|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505958|NCT01072149|451483268|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505959|NCT01072149|451483269|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505960|NCT01072149|451483270|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505961|NCT01072149|451483271|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505962|NCT01072149|451483272|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505963|NCT01072149|451483273|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505964|NCT01072149|451483274|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
125505965|NCT01072149|451483275|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505966|NCT01072149|451483276|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505967|NCT01072149|451483277|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505968|NCT01072149|451483278|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505969|NCT01072149|451483279|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505970|NCT01072149|451483280|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505971|NCT01072149|451483281|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505972|NCT01072149|451483282|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505973|NCT01072149|451483283|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505974|NCT01072149|451483284|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
125505975|NCT01072149|451483267|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
125505976|NCT01072149|451483268|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
125505977|NCT01072149|451483269|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
125505978|NCT01072149|451483270|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
125505979|NCT01072149|451483271|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
125505980|NCT01072149|451483272|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
125505981|NCT01072149|451483273|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
125505982|NCT01072149|451483274|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
125505983|NCT01072149|451483275|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
125505984|NCT01072149|451483276|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
125505985|NCT01072149|451483277|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
125505986|NCT01072149|451483278|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
125505987|NCT01072149|451483279|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
125505988|NCT01072149|451483280|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
125505989|NCT01072149|451483281|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
125505990|NCT01072149|451483282|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
125505991|NCT01072149|451483283|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
125505992|NCT01072149|451483284|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
125505993|NCT01072149|451483267|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125505994|NCT01072149|451483268|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125505995|NCT01072149|451483269|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125505996|NCT01072149|451483270|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125505997|NCT01072149|451483271|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125505998|NCT01072149|451483272|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125505999|NCT01072149|451483273|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125506000|NCT01072149|451483274|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125506001|NCT01072149|451483275|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125506002|NCT01072149|451483276|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125506003|NCT01072149|451483277|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125506004|NCT01072149|451483278|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125506005|NCT01072149|451483279|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125506006|NCT01072149|451483280|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125506007|NCT01072149|451483281|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125506008|NCT01072149|451483282|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
125506009|NCT01072149|451483283|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125506010|NCT01072149|451483284|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
125506011|NCT01072149|451483267|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
125506012|NCT01072149|451483268|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
125506013|NCT01072149|451483269|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
125506014|NCT01072149|451483270|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
125506015|NCT01072149|451483271|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
125506016|NCT01072149|451483272|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
125506017|NCT01072149|451483273|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
125506018|NCT01072149|451483274|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
125506019|NCT01072149|451483275|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
125506020|NCT01072149|451483276|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
125506021|NCT01072149|451483277|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
125506022|NCT01072149|451483278|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
125506023|NCT01072149|451483279|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
125506024|NCT01072149|451483280|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
125506025|NCT01072149|451483281|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
125506026|NCT01072149|451483282|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
125506027|NCT01072149|451483283|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
125506028|NCT01072149|451483284|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
125506029|NCT01072149|451483267|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506030|NCT01072149|451483268|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506031|NCT01072149|451483269|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506032|NCT01072149|451483270|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506033|NCT01072149|451483271|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506034|NCT01072149|451483272|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506035|NCT01072149|451483273|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506036|NCT01072149|451483274|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506037|NCT01072149|451483275|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125305430|NCT00825812|450745131|FG003|Overall Study|Never entered follow up|1|||
125305431|NCT00825812|450745128|FG000|Overall Study|Adverse Event|0|||
125305432|NCT00825812|450745129|FG001|Overall Study|Adverse Event|0|||
125305433|NCT00825812|450745130|FG002|Overall Study|Adverse Event|0|||
125305434|NCT00825812|450745131|FG003|Overall Study|Adverse Event|1|||
125305435|NCT00825812|450745128|FG000|Overall Study|Subject withdrew consent|0|||
125305436|NCT00825812|450745129|FG001|Overall Study|Subject withdrew consent|0|||
125305437|NCT00825812|450745130|FG002|Overall Study|Subject withdrew consent|3|||
125305438|NCT00825812|450745131|FG003|Overall Study|Subject withdrew consent|2|||
125506038|NCT01072149|451483276|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506039|NCT01072149|451483277|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506040|NCT01072149|451483278|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506041|NCT01072149|451483279|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
125305439|NCT00825812|450745128|FG000|Overall Study|Non-compliance with protocol|0|||
125305440|NCT00825812|450745129|FG001|Overall Study|Non-compliance with protocol|0|||
125305441|NCT00825812|450745130|FG002|Overall Study|Non-compliance with protocol|0|||
125305442|NCT00825812|450745131|FG003|Overall Study|Non-compliance with protocol|1|||
125305443|NCT00825812|450745128|FG000|Overall Study|Administrative|0|||
125305444|NCT00825812|450745129|FG001|Overall Study|Administrative|1|||
125305445|NCT00825812|450745130|FG002|Overall Study|Administrative|3|||
125305446|NCT00825812|450745131|FG003|Overall Study|Administrative|5|||
125305447|NCT00483938|450745132|FG000|Overall Study|Protocol Violation|0|||
125305448|NCT00483938|450745133|FG001|Overall Study|Protocol Violation|0|||
125305449|NCT00483938|450745134|FG002|Overall Study|Protocol Violation|0|||
125305450|NCT00483938|450745135|FG003|Overall Study|Protocol Violation|0|||
125305451|NCT00483938|450745136|FG004|Overall Study|Protocol Violation|0|||
125305452|NCT00483938|450745137|FG005|Overall Study|Protocol Violation|0|||
125305453|NCT00483938|450745138|FG006|Overall Study|Protocol Violation|3|||
125506042|NCT01072149|451483280|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506043|NCT01072149|451483281|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506044|NCT01072149|451483282|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506045|NCT01072149|451483283|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506046|NCT01072149|451483284|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
125506047|NCT01072149|451483267|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506048|NCT01072149|451483268|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506049|NCT01072149|451483269|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
125506050|NCT01072149|451483270|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506051|NCT01072149|451483271|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506052|NCT01072149|451483272|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506053|NCT01072149|451483273|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506054|NCT01072149|451483274|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506055|NCT01072149|451483275|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506056|NCT01072149|451483276|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506057|NCT01072149|451483277|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506058|NCT01072149|451483278|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506059|NCT01072149|451483279|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506060|NCT01072149|451483280|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
125506061|NCT01072149|451483281|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506062|NCT01072149|451483282|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506063|NCT01072149|451483283|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506064|NCT01072149|451483284|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
125506065|NCT02784834|451483287|FG000|Overall Study|Lack of Efficacy|1|||
125506066|NCT02143713|451483288|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
125506067|NCT02143713|451483289|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
125506068|NCT02143713|451483290|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
125506069|NCT02143713|451483291|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
125506070|NCT02143713|451483288|FG000|Treatment Period (6 Months)|Adverse Event|7|||
125506071|NCT02143713|451483289|FG001|Treatment Period (6 Months)|Adverse Event|8|||
125506072|NCT02143713|451483290|FG002|Treatment Period (6 Months)|Adverse Event|8|||
125506073|NCT02143713|451483291|FG003|Treatment Period (6 Months)|Adverse Event|9|||
125506074|NCT02143713|451483288|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
125506075|NCT02143713|451483289|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
125506076|NCT02143713|451483290|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
125506077|NCT02143713|451483291|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
125506078|NCT02143713|451483288|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
125506079|NCT02143713|451483289|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
125506080|NCT02143713|451483290|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
125506081|NCT02143713|451483291|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
125506082|NCT02143713|451483288|FG000|Treatment Period (6 Months)|Pregnancy|0|||
125506083|NCT02143713|451483289|FG001|Treatment Period (6 Months)|Pregnancy|2|||
125506084|NCT02143713|451483290|FG002|Treatment Period (6 Months)|Pregnancy|2|||
125506085|NCT02143713|451483291|FG003|Treatment Period (6 Months)|Pregnancy|0|||
125506086|NCT02143713|451483288|FG000|Treatment Period (6 Months)|Non-compliance|1|||
125506087|NCT02143713|451483289|FG001|Treatment Period (6 Months)|Non-compliance|0|||
125506088|NCT02143713|451483290|FG002|Treatment Period (6 Months)|Non-compliance|0|||
125506089|NCT02143713|451483291|FG003|Treatment Period (6 Months)|Non-compliance|3|||
125506090|NCT02143713|451483288|FG000|Treatment Period (6 Months)|Other|3|||
125506091|NCT02143713|451483289|FG001|Treatment Period (6 Months)|Other|0|||
125506092|NCT02143713|451483290|FG002|Treatment Period (6 Months)|Other|3|||
125506093|NCT02143713|451483291|FG003|Treatment Period (6 Months)|Other|2|||
125506094|NCT02143713|451483288|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
125506095|NCT02143713|451483289|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
125305454|NCT00483938|450745132|FG000|Overall Study|Withdrawal by Subject|1|||
125305455|NCT00483938|450745133|FG001|Overall Study|Withdrawal by Subject|6|||
125305456|NCT00483938|450745134|FG002|Overall Study|Withdrawal by Subject|0|||
125305457|NCT00483938|450745135|FG003|Overall Study|Withdrawal by Subject|0|||
125506096|NCT02143713|451483290|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
125506097|NCT02143713|451483291|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
125506098|NCT02143713|451483288|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
125506099|NCT02143713|451483289|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
125506100|NCT02143713|451483290|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
125506101|NCT02143713|451483291|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
125506102|NCT02143713|451483288|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
125506103|NCT02143713|451483289|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
125506104|NCT02143713|451483290|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
125506105|NCT02143713|451483291|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
125506106|NCT02143713|451483288|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
125506107|NCT02143713|451483289|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
125506108|NCT02143713|451483290|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
125506109|NCT02143713|451483291|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
125506110|NCT02143713|451483288|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
125506111|NCT02143713|451483289|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
125506112|NCT02143713|451483290|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
125506113|NCT02143713|451483291|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
125506114|NCT02143713|451483288|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
125506115|NCT02143713|451483289|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
125506116|NCT02143713|451483290|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
125506117|NCT02143713|451483291|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
125506118|NCT02143713|451483288|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
125506119|NCT02143713|451483289|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
125506120|NCT02143713|451483290|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
125506121|NCT02143713|451483291|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
125506122|NCT02143713|451483288|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
125506123|NCT02143713|451483289|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
125506124|NCT02143713|451483290|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
125506125|NCT02143713|451483291|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
125506126|NCT02143713|451483288|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
125506127|NCT02143713|451483289|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
125506128|NCT02143713|451483290|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
125506129|NCT02143713|451483291|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
125506130|NCT01768572|451483292|FG000|Overall Study|Adverse Event|7|||
125506131|NCT01768572|451483293|FG001|Overall Study|Adverse Event|8|||
125506132|NCT01768572|451483294|FG002|Overall Study|Adverse Event|4|||
125506133|NCT01768572|451483292|FG000|Overall Study|Lack of Efficacy|1|||
125506134|NCT01768572|451483293|FG001|Overall Study|Lack of Efficacy|3|||
125506135|NCT01768572|451483294|FG002|Overall Study|Lack of Efficacy|1|||
125506136|NCT01768572|451483292|FG000|Overall Study|Other, Not due to an adverse event|1|||
125506137|NCT01768572|451483293|FG001|Overall Study|Other, Not due to an adverse event|1|||
125506138|NCT01768572|451483294|FG002|Overall Study|Other, Not due to an adverse event|1|||
125506139|NCT00080119|451483297|FG000|Overall Study|Discontinued because of study closure|0|||
125506140|NCT00080119|451483298|FG001|Overall Study|Discontinued because of study closure|0|||
125506141|NCT00080119|451483299|FG002|Overall Study|Discontinued because of study closure|130|||
125506142|NCT00080119|451483300|FG003|Overall Study|Discontinued because of study closure|141|||
125506143|NCT00080119|451483297|FG000|Overall Study|Unable to get to clinic|24|||
125506144|NCT00080119|451483298|FG001|Overall Study|Unable to get to clinic|24|||
125506145|NCT00080119|451483299|FG002|Overall Study|Unable to get to clinic|7|||
125506146|NCT00080119|451483300|FG003|Overall Study|Unable to get to clinic|1|||
125506147|NCT00080119|451483297|FG000|Overall Study|Consent withdrawn|13|||
125506148|NCT00080119|451483298|FG001|Overall Study|Consent withdrawn|17|||
125506149|NCT00080119|451483299|FG002|Overall Study|Consent withdrawn|4|||
125506150|NCT00080119|451483300|FG003|Overall Study|Consent withdrawn|6|||
125506151|NCT00080119|451483297|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
125506152|NCT00080119|451483298|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
125506153|NCT00080119|451483299|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
125506154|NCT00080119|451483300|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
125506155|NCT00080119|451483297|FG000|Overall Study|Lost to Follow-up|16|||
125506156|NCT00080119|451483298|FG001|Overall Study|Lost to Follow-up|19|||
125506157|NCT00080119|451483299|FG002|Overall Study|Lost to Follow-up|19|||
125506158|NCT00080119|451483300|FG003|Overall Study|Lost to Follow-up|14|||
125506159|NCT01919489|451483302|FG000|Overall Study|Rejected the need of injections|4|||
125506160|NCT01919489|451483303|FG001|Overall Study|Rejected the need of injections|7|||
125506161|NCT01919489|451483302|FG000|Overall Study|Adverse Event|10|||
125506162|NCT01919489|451483303|FG001|Overall Study|Adverse Event|0|||
125506163|NCT01919489|451483302|FG000|Overall Study|Hospital readmission|2|||
125506164|NCT01919489|451483303|FG001|Overall Study|Hospital readmission|9|||
125506165|NCT01919489|451483302|FG000|Overall Study|Death|2|||
125506166|NCT01919489|451483303|FG001|Overall Study|Death|1|||
125506167|NCT01919489|451483302|FG000|Overall Study|Lost to Follow-up|38|||
125506168|NCT01919489|451483303|FG001|Overall Study|Lost to Follow-up|27|||
125506169|NCT01322386|451483304|FG000|Overall Study|Protocol Violation|0|||
125506170|NCT01322386|451483305|FG001|Overall Study|Protocol Violation|1|||
125506171|NCT01322386|451483304|FG000|Overall Study|Physician Decision|0|||
125506172|NCT01322386|451483305|FG001|Overall Study|Physician Decision|1|||
125506173|NCT00871494|451483310|FG000|Overall Study|Protocol Violation|5|||
125506174|NCT00871494|451483310|FG000|Overall Study|Lack of Efficacy|4|||
125506175|NCT00871494|451483310|FG000|Overall Study|Adverse Event|4|||
125506176|NCT00871494|451483310|FG000|Overall Study|Lost to Follow-up|1|||
125506177|NCT02291861|451483311|FG000|Overall Study|Adverse Event|2|||
125506178|NCT02291861|451483312|FG001|Overall Study|Adverse Event|4|||
125506179|NCT02291861|451483313|FG002|Overall Study|Adverse Event|1|||
125506180|NCT02291861|451483314|FG003|Overall Study|Adverse Event|2|||
125506181|NCT02291861|451483311|FG000|Overall Study|Death|0|||
125506182|NCT02291861|451483312|FG001|Overall Study|Death|0|||
125506183|NCT02291861|451483313|FG002|Overall Study|Death|1|||
125506184|NCT02291861|451483314|FG003|Overall Study|Death|1|||
125506185|NCT02291861|451483311|FG000|Overall Study|Protocol Violation|1|||
125506186|NCT02291861|451483312|FG001|Overall Study|Protocol Violation|0|||
125506187|NCT02291861|451483313|FG002|Overall Study|Protocol Violation|0|||
125506188|NCT02291861|451483314|FG003|Overall Study|Protocol Violation|1|||
125506189|NCT02291861|451483311|FG000|Overall Study|Withdrawal by Subject|1|||
125506190|NCT02291861|451483312|FG001|Overall Study|Withdrawal by Subject|2|||
125506191|NCT02291861|451483313|FG002|Overall Study|Withdrawal by Subject|1|||
125506192|NCT02291861|451483314|FG003|Overall Study|Withdrawal by Subject|4|||
125506193|NCT02291861|451483311|FG000|Overall Study|Noncompliance|1|||
125506194|NCT02291861|451483312|FG001|Overall Study|Noncompliance|1|||
125506195|NCT02291861|451483313|FG002|Overall Study|Noncompliance|2|||
125506196|NCT02291861|451483314|FG003|Overall Study|Noncompliance|1|||
125506197|NCT02291861|451483311|FG000|Overall Study|Lost to Follow-up|2|||
125506198|NCT02291861|451483312|FG001|Overall Study|Lost to Follow-up|1|||
125506199|NCT02291861|451483313|FG002|Overall Study|Lost to Follow-up|4|||
125506200|NCT02291861|451483314|FG003|Overall Study|Lost to Follow-up|0|||
125506201|NCT02291861|451483311|FG000|Overall Study|Other|0|||
125506202|NCT02291861|451483312|FG001|Overall Study|Other|0|||
125506203|NCT02291861|451483313|FG002|Overall Study|Other|0|||
125506204|NCT02291861|451483314|FG003|Overall Study|Other|1|||
125506205|NCT00963924|451483315|FG000|Overall Study|Adverse Event|1|||
125506206|NCT00963924|451483316|FG001|Overall Study|Adverse Event|0|||
125506207|NCT00963924|451483315|FG000|Overall Study|Withdrawal by Subject|0|||
125506208|NCT00963924|451483316|FG001|Overall Study|Withdrawal by Subject|1|||
125506209|NCT00963924|451483315|FG000|Overall Study|Changed antipsychotic|0|||
125506210|NCT00963924|451483316|FG001|Overall Study|Changed antipsychotic|1|||
125506211|NCT00963924|451483315|FG000|Overall Study|Lost to Follow-up|0|||
125506212|NCT00963924|451483316|FG001|Overall Study|Lost to Follow-up|1|||
125506213|NCT00237809|451483317|FG000|Overall Study|Lost to Follow-up|11|||
125506214|NCT00237809|451483318|FG001|Overall Study|Lost to Follow-up|10|||
125506215|NCT00237809|451483319|FG002|Overall Study|Lost to Follow-up|9|||
125506216|NCT00237809|451483320|FG003|Overall Study|Lost to Follow-up|9|||
125506217|NCT00871715|451483323|FG000|Overall Study|Withdrawal by Subject|6|||
125506218|NCT00871715|451483324|FG001|Overall Study|Withdrawal by Subject|10|||
125506219|NCT00871715|451483325|FG002|Overall Study|Withdrawal by Subject|15|||
125506220|NCT00871715|451483323|FG000|Overall Study|Physician Decision|6|||
125506221|NCT00871715|451483324|FG001|Overall Study|Physician Decision|0|||
125506222|NCT00871715|451483325|FG002|Overall Study|Physician Decision|2|||
125506223|NCT00871715|451483323|FG000|Overall Study|Lost to Follow-up|3|||
125506224|NCT00871715|451483324|FG001|Overall Study|Lost to Follow-up|6|||
125506225|NCT00871715|451483325|FG002|Overall Study|Lost to Follow-up|9|||
125506226|NCT03015220|451483329|FG000|Overall Study|Withdrawal by Subject|3|||
125506227|NCT03015220|451483330|FG001|Overall Study|Withdrawal by Subject|2|||
125506228|NCT03015220|451483331|FG002|Overall Study|Withdrawal by Subject|2|||
125506229|NCT03015220|451483332|FG003|Overall Study|Withdrawal by Subject|2|||
125305458|NCT00483938|450745136|FG004|Overall Study|Withdrawal by Subject|1|||
125506230|NCT03015220|451483329|FG000|Overall Study|Lost to Follow-up|0|||
125506231|NCT03015220|451483330|FG001|Overall Study|Lost to Follow-up|0|||
125506232|NCT03015220|451483331|FG002|Overall Study|Lost to Follow-up|1|||
125506233|NCT03015220|451483332|FG003|Overall Study|Lost to Follow-up|0|||
125506234|NCT01670526|451483333|FG000|Overall Study|Withdrawal by Subject|3|||
125506235|NCT01670526|451483334|FG001|Overall Study|Withdrawal by Subject|1|||
125506236|NCT01670526|451483333|FG000|Overall Study|Lost to Follow-up|9|||
125305459|NCT00483938|450745137|FG005|Overall Study|Withdrawal by Subject|3|||
125305460|NCT00483938|450745138|FG006|Overall Study|Withdrawal by Subject|2|||
125506237|NCT01670526|451483334|FG001|Overall Study|Lost to Follow-up|5|||
125506238|NCT02291549|451483335|FG000|Overall Study|Lost to Follow-up|1|||
125506239|NCT02291549|451483336|FG001|Overall Study|Lost to Follow-up|0|||
125305461|NCT00483938|450745132|FG000|Overall Study|Lost to Follow-up|1|||
125506240|NCT02291549|451483335|FG000|Overall Study|Withdrawal by Subject|0|||
125506241|NCT02291549|451483336|FG001|Overall Study|Withdrawal by Subject|1|||
125506242|NCT01970527|451483338|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
125506243|NCT01970527|451483339|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
125506244|NCT01970527|451483338|FG000|Treatment|Disease progression|0|||
125506245|NCT01970527|451483339|FG001|Treatment|Disease progression|1|||
125506246|NCT01970527|451483338|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
125506247|NCT01970527|451483339|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
125506248|NCT01970527|451483338|FG000|Treatment|Death|0|||
125506249|NCT01970527|451483339|FG001|Treatment|Death|1|||
125506250|NCT01970527|451483338|FG000|Follow-up Clinic Visit|Disease progression|1|||
125506251|NCT01970527|451483339|FG001|Follow-up Clinic Visit|Disease progression|1|||
125506252|NCT01970527|451483338|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
125506253|NCT01970527|451483339|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
125506254|NCT01970527|451483338|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
125506255|NCT01970527|451483339|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
125506256|NCT01115309|451483340|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
125506257|NCT01115309|451483340|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
125506258|NCT01115309|451483340|FG000|Long-term Follow-up|Lost to Follow-up|6|||
125506259|NCT04447287|451483341|FG000|Period 1: Run-in Period|Adverse Event|3|||
125506260|NCT04447287|451483342|FG001|Period 1: Run-in Period|Adverse Event|0|||
125506261|NCT04447287|451483343|FG002|Period 1: Run-in Period|Adverse Event|0|||
125506262|NCT04447287|451483341|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
125506263|NCT04447287|451483342|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
125506264|NCT04447287|451483343|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
125506265|NCT04447287|451483341|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
125506266|NCT04447287|451483342|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
125506267|NCT04447287|451483343|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
125506268|NCT05700851|451483344|FG000|Overall Study|Received a kidney transplant|1|||
125506269|NCT05700851|451483344|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
125506270|NCT05700851|451483344|FG000|Overall Study|Withdrawal by Subject|1|||
125506271|NCT02147093|451483347|FG000|Period 1|Lost to Follow-up|0|||
125506272|NCT02147093|451483348|FG001|Period 1|Lost to Follow-up|1|||
125506273|NCT02147093|451483347|FG000|Period 2|Protocol Violation|2|||
125506274|NCT02147093|451483348|FG001|Period 2|Protocol Violation|0|||
125506275|NCT00655824|451483349|FG000|Overall Study|Adverse Event|3|||
125506276|NCT00655824|451483349|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
125506277|NCT00655824|451483349|FG000|Overall Study|Protocol Violation|1|||
125506278|NCT00655824|451483349|FG000|Overall Study|Withdrawal by Subject|4|||
125506279|NCT00655824|451483349|FG000|Overall Study|Deterioration of Trial Disease|2|||
125506280|NCT00589628|451483350|FG000|Overall Study|Lost to Follow-up|0|||
125506281|NCT00589628|451483351|FG001|Overall Study|Lost to Follow-up|1|||
125506282|NCT03032198|451483359|FG000|Overall Study|Screen Fail|1|||
125506283|NCT01307800|451483360|FG000|Overall Study|Adverse Event|9|||
125506284|NCT01307800|451483361|FG001|Overall Study|Adverse Event|8|||
125506285|NCT01307800|451483362|FG002|Overall Study|Adverse Event|10|||
125506286|NCT01307800|451483363|FG003|Overall Study|Adverse Event|14|||
125506287|NCT01307800|451483360|FG000|Overall Study|Entry Criteria Not Met|0|||
125506288|NCT01307800|451483361|FG001|Overall Study|Entry Criteria Not Met|0|||
125506289|NCT01307800|451483362|FG002|Overall Study|Entry Criteria Not Met|0|||
125506290|NCT01307800|451483363|FG003|Overall Study|Entry Criteria Not Met|2|||
125506291|NCT01307800|451483360|FG000|Overall Study|Lost to Follow-up|5|||
125506292|NCT01307800|451483361|FG001|Overall Study|Lost to Follow-up|6|||
125506293|NCT01307800|451483362|FG002|Overall Study|Lost to Follow-up|2|||
125506294|NCT01307800|451483363|FG003|Overall Study|Lost to Follow-up|8|||
125506295|NCT01307800|451483360|FG000|Overall Study|Perceived Lack of Efficacy|24|||
125506296|NCT01307800|451483361|FG001|Overall Study|Perceived Lack of Efficacy|23|||
125506297|NCT01307800|451483362|FG002|Overall Study|Perceived Lack of Efficacy|20|||
125506298|NCT01307800|451483363|FG003|Overall Study|Perceived Lack of Efficacy|33|||
125506299|NCT01307800|451483360|FG000|Overall Study|Protocol Violation|0|||
125506300|NCT01307800|451483361|FG001|Overall Study|Protocol Violation|3|||
125506301|NCT01307800|451483362|FG002|Overall Study|Protocol Violation|4|||
125506302|NCT01307800|451483363|FG003|Overall Study|Protocol Violation|5|||
125506303|NCT01307800|451483360|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
125506304|NCT01307800|451483361|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
125305462|NCT00483938|450745133|FG001|Overall Study|Lost to Follow-up|2|||
125305463|NCT00483938|450745134|FG002|Overall Study|Lost to Follow-up|0|||
125506305|NCT01307800|451483362|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
125506306|NCT01307800|451483363|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
125506307|NCT01307800|451483360|FG000|Overall Study|Sponsor Decision|6|||
125305464|NCT00483938|450745135|FG003|Overall Study|Lost to Follow-up|2|||
125305465|NCT00483938|450745136|FG004|Overall Study|Lost to Follow-up|1|||
125506308|NCT01307800|451483361|FG001|Overall Study|Sponsor Decision|9|||
125305466|NCT00483938|450745137|FG005|Overall Study|Lost to Follow-up|1|||
125506309|NCT01307800|451483362|FG002|Overall Study|Sponsor Decision|12|||
125506310|NCT01307800|451483363|FG003|Overall Study|Sponsor Decision|28|||
125506311|NCT01307800|451483360|FG000|Overall Study|Withdrawal by Subject|10|||
125506312|NCT01307800|451483361|FG001|Overall Study|Withdrawal by Subject|11|||
125506313|NCT01307800|451483362|FG002|Overall Study|Withdrawal by Subject|8|||
125506314|NCT01307800|451483363|FG003|Overall Study|Withdrawal by Subject|15|||
125506315|NCT01307800|451483360|FG000|Overall Study|Participant Moved|0|||
125506316|NCT01307800|451483361|FG001|Overall Study|Participant Moved|2|||
125506317|NCT01307800|451483362|FG002|Overall Study|Participant Moved|1|||
125506318|NCT01307800|451483363|FG003|Overall Study|Participant Moved|3|||
125506319|NCT02892019|451483364|FG000|Overall Study|randomized but not treated|0|||
125506320|NCT02892019|451483365|FG001|Overall Study|randomized but not treated|1|||
125506321|NCT02892019|451483364|FG000|Overall Study|Withdrawal by Subject|0|||
125506322|NCT02892019|451483365|FG001|Overall Study|Withdrawal by Subject|1|||
125506323|NCT02892019|451483364|FG000|Overall Study|Adverse Event|1|||
125506324|NCT02892019|451483365|FG001|Overall Study|Adverse Event|1|||
125506325|NCT00689351|451483366|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
125506326|NCT00689351|451483367|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
125506327|NCT00689351|451483366|FG000|Infant Series of Dosing|Adverse Event|1|||
125506328|NCT00689351|451483367|FG001|Infant Series of Dosing|Adverse Event|0|||
125506329|NCT00689351|451483366|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
125506330|NCT00689351|451483367|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
125506331|NCT00689351|451483366|FG000|After Infant Series|Parent/legal guardian request|1|||
125506332|NCT00689351|451483367|FG001|After Infant Series|Parent/legal guardian request|0|||
125506333|NCT01766206|451483368|FG000|Overall Study|Withdrawal by Subject|22|||
125506334|NCT01766206|451483368|FG000|Overall Study|Lost to Follow-up|10|||
125506335|NCT01766206|451483368|FG000|Overall Study|Inappropriate enrollment|18|||
125506336|NCT01766206|451483368|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
125506337|NCT01662505|451483369|FG000|Overall Study|Progressive disease|6|||
125506338|NCT01662505|451483370|FG001|Overall Study|Progressive disease|1|||
125506339|NCT01662505|451483371|FG002|Overall Study|Progressive disease|5|||
125506340|NCT01662505|451483369|FG000|Overall Study|Refused cont. medication|0|||
125506341|NCT01662505|451483370|FG001|Overall Study|Refused cont. medication|0|||
125506342|NCT01662505|451483371|FG002|Overall Study|Refused cont. medication|1|||
125506343|NCT01662505|451483369|FG000|Overall Study|Not specified above|1|||
125506344|NCT01662505|451483370|FG001|Overall Study|Not specified above|3|||
125506345|NCT01662505|451483371|FG002|Overall Study|Not specified above|2|||
125506346|NCT01313663|451483372|FG000|Overall Study|Study Closed/Terminated|2|||
125506347|NCT01313663|451483373|FG001|Overall Study|Study Closed/Terminated|4|||
125506348|NCT01313663|451483372|FG000|Overall Study|Lost to Follow-up|0|||
125506349|NCT01313663|451483373|FG001|Overall Study|Lost to Follow-up|1|||
125506350|NCT01313663|451483372|FG000|Overall Study|Physician Decision|0|||
125506351|NCT01313663|451483373|FG001|Overall Study|Physician Decision|2|||
125506352|NCT01313663|451483372|FG000|Overall Study|Withdrawal by Subject|2|||
125506353|NCT01313663|451483373|FG001|Overall Study|Withdrawal by Subject|1|||
125506354|NCT01229176|451483374|FG000|Overall Study|Withdrawal by Subject|0|||
125506355|NCT01229176|451483375|FG001|Overall Study|Withdrawal by Subject|0|||
125506356|NCT01229176|451483376|FG002|Overall Study|Withdrawal by Subject|0|||
125506357|NCT01229176|451483377|FG003|Overall Study|Withdrawal by Subject|1|||
125506358|NCT01229176|451483378|FG004|Overall Study|Withdrawal by Subject|1|||
125506359|NCT01229176|451483379|FG005|Overall Study|Withdrawal by Subject|1|||
125506360|NCT01229176|451483380|FG006|Overall Study|Withdrawal by Subject|0|||
125506361|NCT01229176|451483381|FG007|Overall Study|Withdrawal by Subject|1|||
125506362|NCT01229176|451483374|FG000|Overall Study|Lost to Follow-up|0|||
125506363|NCT01229176|451483375|FG001|Overall Study|Lost to Follow-up|3|||
125506364|NCT01229176|451483376|FG002|Overall Study|Lost to Follow-up|0|||
125506365|NCT01229176|451483377|FG003|Overall Study|Lost to Follow-up|0|||
125506366|NCT01229176|451483378|FG004|Overall Study|Lost to Follow-up|1|||
125506367|NCT01229176|451483379|FG005|Overall Study|Lost to Follow-up|1|||
125506368|NCT01229176|451483380|FG006|Overall Study|Lost to Follow-up|0|||
125506369|NCT01229176|451483381|FG007|Overall Study|Lost to Follow-up|2|||
125506370|NCT02367794|451483389|FG000|Overall Study|Death|252|||
125506371|NCT02367794|451483390|FG001|Overall Study|Death|245|||
125506372|NCT02367794|451483391|FG002|Overall Study|Death|243|||
125506373|NCT02367794|451483389|FG000|Overall Study|Lost to Follow-up|1|||
125305467|NCT00483938|450745138|FG006|Overall Study|Lost to Follow-up|3|||
125305468|NCT00483938|450745132|FG000|Overall Study|Death|0|||
125506374|NCT02367794|451483390|FG001|Overall Study|Lost to Follow-up|2|||
125506375|NCT02367794|451483391|FG002|Overall Study|Lost to Follow-up|2|||
125305469|NCT00483938|450745133|FG001|Overall Study|Death|2|||
125305470|NCT00483938|450745134|FG002|Overall Study|Death|0|||
125305471|NCT00483938|450745135|FG003|Overall Study|Death|0|||
125506376|NCT02367794|451483389|FG000|Overall Study|Physician Decision|0|||
125506377|NCT02367794|451483390|FG001|Overall Study|Physician Decision|5|||
125506378|NCT02367794|451483391|FG002|Overall Study|Physician Decision|3|||
125506379|NCT02367794|451483389|FG000|Overall Study|Protocol Violation|1|||
125506380|NCT02367794|451483390|FG001|Overall Study|Protocol Violation|0|||
125506381|NCT02367794|451483391|FG002|Overall Study|Protocol Violation|1|||
125506382|NCT02367794|451483389|FG000|Overall Study|Withdrawal by Subject|25|||
125506383|NCT02367794|451483390|FG001|Overall Study|Withdrawal by Subject|12|||
125506384|NCT02367794|451483391|FG002|Overall Study|Withdrawal by Subject|20|||
125506385|NCT02367794|451483389|FG000|Overall Study|Brain metastasis|1|||
125506386|NCT02367794|451483390|FG001|Overall Study|Brain metastasis|0|||
125506387|NCT02367794|451483391|FG002|Overall Study|Brain metastasis|0|||
125506388|NCT02367794|451483389|FG000|Overall Study|Randomized in error|0|||
125506389|NCT02367794|451483390|FG001|Overall Study|Randomized in error|0|||
125506390|NCT02367794|451483391|FG002|Overall Study|Randomized in error|1|||
125506391|NCT02367794|451483389|FG000|Overall Study|Patient unable to receive carboplatin|0|||
125506392|NCT02367794|451483390|FG001|Overall Study|Patient unable to receive carboplatin|0|||
125506393|NCT02367794|451483391|FG002|Overall Study|Patient unable to receive carboplatin|1|||
125506394|NCT02367794|451483389|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
125506395|NCT02367794|451483390|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
125506396|NCT02367794|451483391|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
125506397|NCT02367794|451483389|FG000|Overall Study|Adverse Event|0|||
125506398|NCT02367794|451483390|FG001|Overall Study|Adverse Event|0|||
125506399|NCT02367794|451483391|FG002|Overall Study|Adverse Event|2|||
125506400|NCT02367794|451483389|FG000|Overall Study|Study Terminated By Sponsor|0|||
125506401|NCT02367794|451483390|FG001|Overall Study|Study Terminated By Sponsor|1|||
125506402|NCT02367794|451483391|FG002|Overall Study|Study Terminated By Sponsor|1|||
125506403|NCT02367794|451483389|FG000|Overall Study|Moved to Roll-Over Study|0|||
125506404|NCT02367794|451483390|FG001|Overall Study|Moved to Roll-Over Study|15|||
125506405|NCT02367794|451483391|FG002|Overall Study|Moved to Roll-Over Study|13|||
125506406|NCT02367794|451483389|FG000|Overall Study|Sponsor Request|60|||
125506407|NCT02367794|451483390|FG001|Overall Study|Sponsor Request|57|||
125506408|NCT02367794|451483391|FG002|Overall Study|Sponsor Request|45|||
125506409|NCT02367794|451483389|FG000|Overall Study|Moved into PTAP Study|0|||
125506410|NCT02367794|451483390|FG001|Overall Study|Moved into PTAP Study|2|||
125506411|NCT02367794|451483391|FG002|Overall Study|Moved into PTAP Study|3|||
125506412|NCT02367794|451483389|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
125506413|NCT02367794|451483390|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
125506414|NCT02367794|451483391|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
125506415|NCT02367794|451483389|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
125506416|NCT02367794|451483390|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
125506417|NCT02367794|451483391|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
125506418|NCT02367794|451483389|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
125506419|NCT02367794|451483390|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
125506420|NCT02367794|451483391|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
125506421|NCT02367794|451483389|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
125506422|NCT02367794|451483390|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
125506423|NCT02367794|451483391|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
125506424|NCT00882050|451483392|FG000|Overall Study|Physician Decision|1|||
125506425|NCT00882050|451483393|FG001|Overall Study|Physician Decision|0|||
125506426|NCT00882050|451483394|FG002|Overall Study|Physician Decision|0|||
125506427|NCT02942771|451483396|FG000|Overall Study|Adverse Event|1|||
125506428|NCT02942771|451483397|FG001|Overall Study|Adverse Event|0|||
125506429|NCT02942771|451483398|FG002|Overall Study|Adverse Event|0|||
125506430|NCT02942771|451483399|FG003|Overall Study|Adverse Event|0|||
125506431|NCT02942771|451483400|FG004|Overall Study|Adverse Event|2|||
125506432|NCT02942771|451483396|FG000|Overall Study|Lost to Follow-up|1|||
125506433|NCT02942771|451483397|FG001|Overall Study|Lost to Follow-up|0|||
125506434|NCT02942771|451483398|FG002|Overall Study|Lost to Follow-up|0|||
125506435|NCT02942771|451483399|FG003|Overall Study|Lost to Follow-up|0|||
125506436|NCT02942771|451483400|FG004|Overall Study|Lost to Follow-up|0|||
125506437|NCT02942771|451483396|FG000|Overall Study|Withdrawal by Subject|1|||
125506438|NCT02942771|451483397|FG001|Overall Study|Withdrawal by Subject|0|||
125506439|NCT02942771|451483398|FG002|Overall Study|Withdrawal by Subject|0|||
125506440|NCT02942771|451483399|FG003|Overall Study|Withdrawal by Subject|0|||
125506441|NCT02942771|451483400|FG004|Overall Study|Withdrawal by Subject|2|||
125506442|NCT01186809|451483401|FG000|Overall Study|Death|30|||
125506443|NCT01159600|451483403|FG000|Overall Study|Not treated|0|||
125506444|NCT01159600|451483404|FG001|Overall Study|Not treated|0|||
125506445|NCT01159600|451483405|FG002|Overall Study|Not treated|1|||
125506446|NCT01159600|451483406|FG003|Overall Study|Not treated|0|||
125506447|NCT01159600|451483407|FG004|Overall Study|Not treated|0|||
125506448|NCT01159600|451483408|FG005|Overall Study|Not treated|1|||
125506449|NCT01159600|451483409|FG006|Overall Study|Not treated|2|||
125506450|NCT01159600|451483410|FG007|Overall Study|Not treated|2|||
125506451|NCT01159600|451483403|FG000|Overall Study|Adverse Event|7|||
125506452|NCT01159600|451483404|FG001|Overall Study|Adverse Event|2|||
125506453|NCT01159600|451483405|FG002|Overall Study|Adverse Event|5|||
125506454|NCT01159600|451483406|FG003|Overall Study|Adverse Event|1|||
125506455|NCT01159600|451483407|FG004|Overall Study|Adverse Event|8|||
125506456|NCT01159600|451483408|FG005|Overall Study|Adverse Event|6|||
125506457|NCT01159600|451483409|FG006|Overall Study|Adverse Event|7|||
125506458|NCT01159600|451483410|FG007|Overall Study|Adverse Event|5|||
125506459|NCT01159600|451483403|FG000|Overall Study|Lack of Efficacy|0|||
125506460|NCT01159600|451483404|FG001|Overall Study|Lack of Efficacy|0|||
125506461|NCT01159600|451483405|FG002|Overall Study|Lack of Efficacy|0|||
125506462|NCT01159600|451483406|FG003|Overall Study|Lack of Efficacy|0|||
125506463|NCT01159600|451483407|FG004|Overall Study|Lack of Efficacy|2|||
125506464|NCT01159600|451483408|FG005|Overall Study|Lack of Efficacy|0|||
125506465|NCT01159600|451483409|FG006|Overall Study|Lack of Efficacy|0|||
125506466|NCT01159600|451483410|FG007|Overall Study|Lack of Efficacy|1|||
125506467|NCT01159600|451483403|FG000|Overall Study|Non compliant with protocol|2|||
125506468|NCT01159600|451483404|FG001|Overall Study|Non compliant with protocol|1|||
125506469|NCT01159600|451483405|FG002|Overall Study|Non compliant with protocol|0|||
125506470|NCT01159600|451483406|FG003|Overall Study|Non compliant with protocol|0|||
125506471|NCT01159600|451483407|FG004|Overall Study|Non compliant with protocol|2|||
125506472|NCT01159600|451483408|FG005|Overall Study|Non compliant with protocol|0|||
125506473|NCT01159600|451483409|FG006|Overall Study|Non compliant with protocol|2|||
125506474|NCT01159600|451483410|FG007|Overall Study|Non compliant with protocol|0|||
125506475|NCT01159600|451483403|FG000|Overall Study|Lost to Follow-up|2|||
125506476|NCT01159600|451483404|FG001|Overall Study|Lost to Follow-up|3|||
125506477|NCT01159600|451483405|FG002|Overall Study|Lost to Follow-up|4|||
125506478|NCT01159600|451483406|FG003|Overall Study|Lost to Follow-up|3|||
125506479|NCT01159600|451483407|FG004|Overall Study|Lost to Follow-up|3|||
125506480|NCT01159600|451483408|FG005|Overall Study|Lost to Follow-up|0|||
125506481|NCT01159600|451483409|FG006|Overall Study|Lost to Follow-up|3|||
125506482|NCT01159600|451483410|FG007|Overall Study|Lost to Follow-up|2|||
125506483|NCT01159600|451483403|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
125506484|NCT01159600|451483404|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
125506485|NCT01159600|451483405|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
125506486|NCT01159600|451483406|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
125506487|NCT01159600|451483407|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
125506488|NCT01159600|451483408|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
125506489|NCT01159600|451483409|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
125506490|NCT01159600|451483410|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
125506491|NCT01159600|451483403|FG000|Overall Study|Other reason not defined above|3|||
125506492|NCT01159600|451483404|FG001|Overall Study|Other reason not defined above|0|||
125506493|NCT01159600|451483405|FG002|Overall Study|Other reason not defined above|4|||
125506494|NCT01159600|451483406|FG003|Overall Study|Other reason not defined above|2|||
125506495|NCT01159600|451483407|FG004|Overall Study|Other reason not defined above|5|||
125506496|NCT01159600|451483408|FG005|Overall Study|Other reason not defined above|7|||
125506497|NCT01159600|451483409|FG006|Overall Study|Other reason not defined above|3|||
125506498|NCT01159600|451483410|FG007|Overall Study|Other reason not defined above|3|||
125506499|NCT04433091|451483411|FG000|Overall Study|Lost to Follow-up|1|||
125506500|NCT04433091|451483412|FG001|Overall Study|Lost to Follow-up|0|||
125506501|NCT04433091|451483411|FG000|Overall Study|Withdrawn .|2|||
125506502|NCT04433091|451483412|FG001|Overall Study|Withdrawn .|4|||
125532347|NCT00588692|451580091|FG001|Overall Study|Withdrawal by Subject|2|||
125532348|NCT00588692|451580090|FG000|Overall Study|Hip Surgery|0|||
125532349|NCT00588692|451580091|FG001|Overall Study|Hip Surgery|1|||
125532350|NCT00588692|451580090|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
125532351|NCT00588692|451580091|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
125532352|NCT00588692|451580090|FG000|Overall Study|Cancer|1|||
125532353|NCT00588692|451580091|FG001|Overall Study|Cancer|0|||
125532354|NCT00588692|451580090|FG000|Overall Study|Death|1|||
125532355|NCT00588692|451580091|FG001|Overall Study|Death|0|||
125532356|NCT01374568|451580092|FG000|Overall Study|Lab unable to analyze BTM|0|||
125532357|NCT01374568|451580093|FG001|Overall Study|Lab unable to analyze BTM|2|||
125532358|NCT01912404|451580094|FG000|Overall Study|Due to personal reasons|1|||
125532359|NCT01912404|451580095|FG001|Overall Study|Due to personal reasons|0|||
125532360|NCT00604708|451580096|FG000|Overall Study|Withdrawal by Subject|9|||
125532361|NCT00604708|451580097|FG001|Overall Study|Withdrawal by Subject|10|||
125532362|NCT00604708|451580096|FG000|Overall Study|Protocol Violation|2|||
125532363|NCT00604708|451580097|FG001|Overall Study|Protocol Violation|8|||
125532364|NCT00604708|451580096|FG000|Overall Study|Lost to Follow-up|5|||
125532365|NCT00604708|451580097|FG001|Overall Study|Lost to Follow-up|5|||
125532366|NCT00604708|451580096|FG000|Overall Study|administrative reasons|9|||
125532367|NCT00604708|451580097|FG001|Overall Study|administrative reasons|11|||
125532368|NCT00604708|451580096|FG000|Overall Study|Adverse Event|6|||
125532369|NCT00604708|451580097|FG001|Overall Study|Adverse Event|6|||
125532370|NCT02817906|451580101|FG000|Overall Study|Adverse Event|3|||
125532371|NCT02817906|451580102|FG001|Overall Study|Adverse Event|0|||
125532372|NCT02817906|451580101|FG000|Overall Study|Lack of Efficacy|1|||
125532373|NCT02817906|451580102|FG001|Overall Study|Lack of Efficacy|0|||
125532374|NCT02817906|451580101|FG000|Overall Study|Protocol Violation|1|||
125532375|NCT02817906|451580102|FG001|Overall Study|Protocol Violation|1|||
125532376|NCT02817906|451580101|FG000|Overall Study|Study Terminated by Sponsor|2|||
125532377|NCT02817906|451580102|FG001|Overall Study|Study Terminated by Sponsor|2|||
125532378|NCT02817906|451580101|FG000|Overall Study|Withdrawal by Subject|7|||
125506503|NCT01562275|451485380|FG000|Stage 1|Adverse Event|0|||
125506504|NCT01562275|451485381|FG001|Stage 1|Adverse Event|0|||
125506505|NCT01562275|451485382|FG002|Stage 1|Adverse Event|0|||
125506506|NCT01562275|451485383|FG003|Stage 1|Adverse Event|1|||
125506507|NCT01562275|451485384|FG004|Stage 1|Adverse Event|1|||
125506508|NCT01562275|451485385|FG005|Stage 1|Adverse Event|0|||
125506509|NCT01562275|451485386|FG006|Stage 1|Adverse Event|0|||
125506510|NCT01562275|451485387|FG007|Stage 1|Adverse Event|0|||
125506511|NCT01562275|451485388|FG008|Stage 1|Adverse Event|0|||
125506512|NCT01562275|451485389|FG009|Stage 1|Adverse Event|1|||
125506513|NCT01562275|451485390|FG010|Stage 1|Adverse Event|0|||
125506514|NCT01562275|451485391|FG011|Stage 1|Adverse Event|0|||
125506515|NCT01562275|451485392|FG012|Stage 1|Adverse Event|0|||
125506516|NCT01562275|451485380|FG000|Stage 1|Death|1|||
125506517|NCT01562275|451485381|FG001|Stage 1|Death|0|||
125506518|NCT01562275|451485382|FG002|Stage 1|Death|0|||
125506519|NCT01562275|451485383|FG003|Stage 1|Death|0|||
125506520|NCT01562275|451485384|FG004|Stage 1|Death|0|||
125506521|NCT01562275|451485385|FG005|Stage 1|Death|0|||
125506522|NCT01562275|451485386|FG006|Stage 1|Death|0|||
125506523|NCT01562275|451485387|FG007|Stage 1|Death|0|||
125506524|NCT01562275|451485388|FG008|Stage 1|Death|0|||
125506525|NCT01562275|451485389|FG009|Stage 1|Death|0|||
125506526|NCT01562275|451485390|FG010|Stage 1|Death|0|||
125506527|NCT01562275|451485391|FG011|Stage 1|Death|0|||
125506528|NCT01562275|451485392|FG012|Stage 1|Death|0|||
125506529|NCT01562275|451485380|FG000|Stage 1|Non Compliance|0|||
125506530|NCT01562275|451485381|FG001|Stage 1|Non Compliance|0|||
125506531|NCT01562275|451485382|FG002|Stage 1|Non Compliance|1|||
125506532|NCT01562275|451485383|FG003|Stage 1|Non Compliance|0|||
125506533|NCT01562275|451485384|FG004|Stage 1|Non Compliance|0|||
125506534|NCT01562275|451485385|FG005|Stage 1|Non Compliance|0|||
125506535|NCT01562275|451485386|FG006|Stage 1|Non Compliance|0|||
125506536|NCT01562275|451485387|FG007|Stage 1|Non Compliance|0|||
125506537|NCT01562275|451485388|FG008|Stage 1|Non Compliance|0|||
125506538|NCT01562275|451485389|FG009|Stage 1|Non Compliance|0|||
125506539|NCT01562275|451485390|FG010|Stage 1|Non Compliance|0|||
125506540|NCT01562275|451485391|FG011|Stage 1|Non Compliance|0|||
125506541|NCT01562275|451485392|FG012|Stage 1|Non Compliance|0|||
125506542|NCT01562275|451485380|FG000|Stage 1|Physician Decision|0|||
125506543|NCT01562275|451485381|FG001|Stage 1|Physician Decision|0|||
125506544|NCT01562275|451485382|FG002|Stage 1|Physician Decision|0|||
125506545|NCT01562275|451485383|FG003|Stage 1|Physician Decision|0|||
125506546|NCT01562275|451485384|FG004|Stage 1|Physician Decision|1|||
125506547|NCT01562275|451485385|FG005|Stage 1|Physician Decision|0|||
125506548|NCT01562275|451485386|FG006|Stage 1|Physician Decision|1|||
125506549|NCT01562275|451485387|FG007|Stage 1|Physician Decision|0|||
125506550|NCT01562275|451485388|FG008|Stage 1|Physician Decision|1|||
125506551|NCT01562275|451485389|FG009|Stage 1|Physician Decision|0|||
125506552|NCT01562275|451485390|FG010|Stage 1|Physician Decision|0|||
125506553|NCT01562275|451485391|FG011|Stage 1|Physician Decision|0|||
125506554|NCT01562275|451485392|FG012|Stage 1|Physician Decision|0|||
125506555|NCT01562275|451485380|FG000|Stage 1|Progression of Disease|2|||
125506556|NCT01562275|451485381|FG001|Stage 1|Progression of Disease|6|||
125506557|NCT01562275|451485382|FG002|Stage 1|Progression of Disease|2|||
125506558|NCT01562275|451485383|FG003|Stage 1|Progression of Disease|1|||
125506559|NCT01562275|451485384|FG004|Stage 1|Progression of Disease|2|||
125506560|NCT01562275|451485385|FG005|Stage 1|Progression of Disease|4|||
125506561|NCT01562275|451485386|FG006|Stage 1|Progression of Disease|1|||
125506562|NCT01562275|451485387|FG007|Stage 1|Progression of Disease|7|||
125506563|NCT01562275|451485388|FG008|Stage 1|Progression of Disease|2|||
125506564|NCT01562275|451485389|FG009|Stage 1|Progression of Disease|5|||
125506565|NCT01562275|451485390|FG010|Stage 1|Progression of Disease|3|||
125506566|NCT01562275|451485391|FG011|Stage 1|Progression of Disease|0|||
125506567|NCT01562275|451485392|FG012|Stage 1|Progression of Disease|0|||
125506568|NCT01562275|451485380|FG000|Stage 1|Withdrawal by Subject|0|||
125506569|NCT01562275|451485381|FG001|Stage 1|Withdrawal by Subject|1|||
125506570|NCT01562275|451485382|FG002|Stage 1|Withdrawal by Subject|0|||
125506571|NCT01562275|451485383|FG003|Stage 1|Withdrawal by Subject|2|||
125506572|NCT01562275|451485384|FG004|Stage 1|Withdrawal by Subject|0|||
125506573|NCT01562275|451485385|FG005|Stage 1|Withdrawal by Subject|0|||
125506574|NCT01562275|451485386|FG006|Stage 1|Withdrawal by Subject|1|||
125506575|NCT01562275|451485387|FG007|Stage 1|Withdrawal by Subject|0|||
125506576|NCT01562275|451485388|FG008|Stage 1|Withdrawal by Subject|0|||
125506577|NCT01562275|451485389|FG009|Stage 1|Withdrawal by Subject|1|||
125506578|NCT01562275|451485390|FG010|Stage 1|Withdrawal by Subject|0|||
125506579|NCT01562275|451485391|FG011|Stage 1|Withdrawal by Subject|0|||
125506580|NCT01562275|451485392|FG012|Stage 1|Withdrawal by Subject|0|||
125506581|NCT01562275|451485380|FG000|Stage 2|Death|0|||
125506582|NCT01562275|451485381|FG001|Stage 2|Death|0|||
125506583|NCT01562275|451485382|FG002|Stage 2|Death|0|||
125506584|NCT01562275|451485383|FG003|Stage 2|Death|0|||
125506585|NCT01562275|451485384|FG004|Stage 2|Death|0|||
125506586|NCT01562275|451485385|FG005|Stage 2|Death|0|||
125506587|NCT01562275|451485386|FG006|Stage 2|Death|0|||
125506588|NCT01562275|451485387|FG007|Stage 2|Death|0|||
125506589|NCT01562275|451485388|FG008|Stage 2|Death|0|||
125506590|NCT01562275|451485389|FG009|Stage 2|Death|0|||
125506591|NCT01562275|451485390|FG010|Stage 2|Death|0|||
125506592|NCT01562275|451485391|FG011|Stage 2|Death|2|||
125506593|NCT01562275|451485392|FG012|Stage 2|Death|1|||
125506594|NCT01562275|451485380|FG000|Stage 2|Progression of Disease|0|||
125506595|NCT01562275|451485381|FG001|Stage 2|Progression of Disease|0|||
125506596|NCT01562275|451485382|FG002|Stage 2|Progression of Disease|0|||
125506597|NCT01562275|451485383|FG003|Stage 2|Progression of Disease|0|||
125506598|NCT01562275|451485384|FG004|Stage 2|Progression of Disease|0|||
125506599|NCT01562275|451485385|FG005|Stage 2|Progression of Disease|0|||
125506600|NCT01562275|451485386|FG006|Stage 2|Progression of Disease|0|||
125506601|NCT01562275|451485387|FG007|Stage 2|Progression of Disease|0|||
125506602|NCT01562275|451485388|FG008|Stage 2|Progression of Disease|0|||
125506603|NCT01562275|451485389|FG009|Stage 2|Progression of Disease|0|||
125506604|NCT01562275|451485390|FG010|Stage 2|Progression of Disease|0|||
125506605|NCT01562275|451485391|FG011|Stage 2|Progression of Disease|12|||
125506606|NCT01562275|451485392|FG012|Stage 2|Progression of Disease|4|||
125506607|NCT01863368|451485393|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
125506608|NCT01863368|451485394|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
125506609|NCT01863368|451485393|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
125506610|NCT01863368|451485394|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
125506611|NCT01863368|451485393|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
125506612|NCT01863368|451485394|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
125506613|NCT01863368|451485393|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
125506614|NCT01863368|451485394|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
125506615|NCT01863368|451485393|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
125506616|NCT01863368|451485394|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
125506617|NCT01863368|451485393|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
125506618|NCT01863368|451485394|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
125506619|NCT03761849|451485397|FG000|Overall Study|transferred to OpenLabelExtension|35|||
125506620|NCT03761849|451485398|FG001|Overall Study|transferred to OpenLabelExtension|34|||
125506621|NCT03761849|451485399|FG002|Overall Study|transferred to OpenLabelExtension|36|||
125506622|NCT03761849|451485400|FG003|Overall Study|transferred to OpenLabelExtension|0|||
125506623|NCT03761849|451485401|FG004|Overall Study|transferred to OpenLabelExtension|0|||
125506624|NCT03761849|451485402|FG005|Overall Study|transferred to OpenLabelExtension|0|||
125506625|NCT03761849|451485397|FG000|Overall Study|Adverse Event|1|||
125506626|NCT03761849|451485398|FG001|Overall Study|Adverse Event|0|||
125506627|NCT03761849|451485399|FG002|Overall Study|Adverse Event|0|||
125506628|NCT03761849|451485400|FG003|Overall Study|Adverse Event|0|||
125506629|NCT03761849|451485401|FG004|Overall Study|Adverse Event|2|||
125506630|NCT03761849|451485402|FG005|Overall Study|Adverse Event|3|||
125506631|NCT03761849|451485397|FG000|Overall Study|Withdrawal by Subject|0|||
125506632|NCT03761849|451485398|FG001|Overall Study|Withdrawal by Subject|0|||
125506633|NCT03761849|451485399|FG002|Overall Study|Withdrawal by Subject|0|||
125506634|NCT03761849|451485400|FG003|Overall Study|Withdrawal by Subject|41|||
125506635|NCT03761849|451485401|FG004|Overall Study|Withdrawal by Subject|43|||
125506636|NCT03761849|451485402|FG005|Overall Study|Withdrawal by Subject|35|||
125506637|NCT03761849|451485397|FG000|Overall Study|Lost to Follow-up|0|||
125506638|NCT03761849|451485398|FG001|Overall Study|Lost to Follow-up|1|||
125506639|NCT03761849|451485399|FG002|Overall Study|Lost to Follow-up|0|||
125506640|NCT03761849|451485400|FG003|Overall Study|Lost to Follow-up|2|||
125506641|NCT03761849|451485401|FG004|Overall Study|Lost to Follow-up|4|||
125506642|NCT03761849|451485402|FG005|Overall Study|Lost to Follow-up|5|||
125506643|NCT03761849|451485397|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
125506644|NCT03761849|451485398|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
125506645|NCT03761849|451485399|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
125506646|NCT03761849|451485400|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
125506647|NCT03761849|451485401|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
125506648|NCT03761849|451485402|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
125506649|NCT03761849|451485397|FG000|Overall Study|Physician Decision|0|||
125506650|NCT03761849|451485398|FG001|Overall Study|Physician Decision|0|||
125506651|NCT03761849|451485399|FG002|Overall Study|Physician Decision|0|||
125506652|NCT03761849|451485400|FG003|Overall Study|Physician Decision|1|||
125506653|NCT03761849|451485401|FG004|Overall Study|Physician Decision|4|||
125506654|NCT03761849|451485402|FG005|Overall Study|Physician Decision|4|||
125506655|NCT03761849|451485397|FG000|Overall Study|Death|0|||
125506656|NCT03761849|451485398|FG001|Overall Study|Death|0|||
125506657|NCT03761849|451485399|FG002|Overall Study|Death|0|||
125506658|NCT03761849|451485400|FG003|Overall Study|Death|1|||
125506659|NCT03761849|451485401|FG004|Overall Study|Death|1|||
125305472|NCT00483938|450745136|FG004|Overall Study|Death|0|||
125305473|NCT00483938|450745137|FG005|Overall Study|Death|0|||
125506660|NCT03761849|451485402|FG005|Overall Study|Death|3|||
125506661|NCT03761849|451485397|FG000|Overall Study|Protocol Violation|0|||
125506662|NCT03761849|451485398|FG001|Overall Study|Protocol Violation|0|||
125506663|NCT03761849|451485399|FG002|Overall Study|Protocol Violation|0|||
125506664|NCT03761849|451485400|FG003|Overall Study|Protocol Violation|2|||
125506665|NCT03761849|451485401|FG004|Overall Study|Protocol Violation|2|||
125506666|NCT03761849|451485402|FG005|Overall Study|Protocol Violation|1|||
125506667|NCT03761849|451485397|FG000|Overall Study|Participant could not come to site|0|||
125506668|NCT03761849|451485398|FG001|Overall Study|Participant could not come to site|0|||
125506669|NCT03761849|451485399|FG002|Overall Study|Participant could not come to site|0|||
125506670|NCT03761849|451485400|FG003|Overall Study|Participant could not come to site|0|||
125506671|NCT03761849|451485401|FG004|Overall Study|Participant could not come to site|1|||
125506672|NCT03761849|451485402|FG005|Overall Study|Participant could not come to site|0|||
125506673|NCT03761849|451485397|FG000|Overall Study|SF- safety Finding|0|||
125506674|NCT03761849|451485398|FG001|Overall Study|SF- safety Finding|0|||
125506675|NCT03761849|451485399|FG002|Overall Study|SF- safety Finding|0|||
125506676|NCT03761849|451485400|FG003|Overall Study|SF- safety Finding|0|||
125506677|NCT03761849|451485401|FG004|Overall Study|SF- safety Finding|0|||
125506678|NCT03761849|451485402|FG005|Overall Study|SF- safety Finding|1|||
125506679|NCT03761849|451485397|FG000|Overall Study|Patient did not attend visit|0|||
125506680|NCT03761849|451485398|FG001|Overall Study|Patient did not attend visit|0|||
125506681|NCT03761849|451485399|FG002|Overall Study|Patient did not attend visit|0|||
125506682|NCT03761849|451485400|FG003|Overall Study|Patient did not attend visit|0|||
125506683|NCT03761849|451485401|FG004|Overall Study|Patient did not attend visit|0|||
125506684|NCT03761849|451485402|FG005|Overall Study|Patient did not attend visit|1|||
125506685|NCT03344458|451485406|FG000|Overall Study|Physician Decision|1|||
125506686|NCT03344458|451485406|FG000|Overall Study|Withdrawal by Subject|16|||
125506687|NCT03344458|451485406|FG000|Overall Study|Other reasons|10|||
125506688|NCT03344458|451485406|FG000|Overall Study|Lost to Follow-up|9|||
125506689|NCT03344458|451485406|FG000|Overall Study|Protocol Violation|3|||
125506690|NCT03840993|451485407|FG000|Overall Study|Adverse Event|1|||
125506691|NCT03840993|451485408|FG001|Overall Study|Adverse Event|0|||
125506692|NCT03840993|451485407|FG000|Overall Study|Lost to Follow-up|4|||
125506693|NCT03840993|451485408|FG001|Overall Study|Lost to Follow-up|0|||
125506694|NCT03840993|451485407|FG000|Overall Study|Physician Decision|0|||
125506695|NCT03840993|451485408|FG001|Overall Study|Physician Decision|1|||
125506696|NCT03840993|451485407|FG000|Overall Study|Pregnancy|0|||
125506697|NCT03840993|451485408|FG001|Overall Study|Pregnancy|1|||
125506698|NCT03840993|451485407|FG000|Overall Study|Withdrawal by Subject|1|||
125506699|NCT03840993|451485408|FG001|Overall Study|Withdrawal by Subject|3|||
125506700|NCT03840993|451485407|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
125506701|NCT03840993|451485408|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
125506702|NCT00988429|451485409|FG000|Overall Study|Adverse Event|9|||
125506703|NCT00988429|451485410|FG001|Overall Study|Adverse Event|21|||
125506704|NCT00988429|451485411|FG002|Overall Study|Adverse Event|45|||
125506705|NCT00988429|451485409|FG000|Overall Study|Lack of Efficacy|0|||
125506706|NCT00988429|451485410|FG001|Overall Study|Lack of Efficacy|0|||
125506707|NCT00988429|451485411|FG002|Overall Study|Lack of Efficacy|1|||
125506708|NCT00988429|451485409|FG000|Overall Study|Non-Compliance with Study Drug|5|||
125506709|NCT00988429|451485410|FG001|Overall Study|Non-Compliance with Study Drug|1|||
125506710|NCT00988429|451485411|FG002|Overall Study|Non-Compliance with Study Drug|3|||
125506711|NCT00988429|451485409|FG000|Overall Study|Physician Decision|1|||
125506712|NCT00988429|451485410|FG001|Overall Study|Physician Decision|0|||
125506713|NCT00988429|451485411|FG002|Overall Study|Physician Decision|3|||
125506714|NCT00988429|451485409|FG000|Overall Study|Pregnancy|2|||
125506715|NCT00988429|451485410|FG001|Overall Study|Pregnancy|1|||
125506716|NCT00988429|451485411|FG002|Overall Study|Pregnancy|0|||
125506717|NCT00988429|451485409|FG000|Overall Study|Protocol Violation|4|||
125506718|NCT00988429|451485410|FG001|Overall Study|Protocol Violation|3|||
125506719|NCT00988429|451485411|FG002|Overall Study|Protocol Violation|3|||
125506720|NCT00988429|451485409|FG000|Overall Study|Withdrawal by Subject|7|||
125506721|NCT00988429|451485410|FG001|Overall Study|Withdrawal by Subject|7|||
125506722|NCT00988429|451485411|FG002|Overall Study|Withdrawal by Subject|12|||
125506723|NCT00988429|451485409|FG000|Overall Study|Administrative Reasons|1|||
125506724|NCT00988429|451485410|FG001|Overall Study|Administrative Reasons|2|||
125506725|NCT00988429|451485411|FG002|Overall Study|Administrative Reasons|1|||
125506726|NCT00988429|451485409|FG000|Overall Study|other reasons|8|||
125506727|NCT00988429|451485410|FG001|Overall Study|other reasons|8|||
125506728|NCT00988429|451485411|FG002|Overall Study|other reasons|1|||
125506729|NCT01074229|451485412|FG000|Overall Study|Lost to Follow-up|1|||
125506730|NCT01074229|451485413|FG001|Overall Study|Lost to Follow-up|0|||
125506731|NCT01074229|451485414|FG002|Overall Study|Lost to Follow-up|0|||
125506732|NCT01074229|451485412|FG000|Overall Study|Change to open surgical procedure|1|||
125506733|NCT01074229|451485413|FG001|Overall Study|Change to open surgical procedure|3|||
125506734|NCT01074229|451485414|FG002|Overall Study|Change to open surgical procedure|4|||
125506735|NCT02823574|451485420|FG000|Randomization|Disease Progression|0|||
125506736|NCT02823574|451485421|FG001|Randomization|Disease Progression|0|||
125506737|NCT02823574|451485422|FG002|Randomization|Disease Progression|1|||
125506738|NCT02823574|451485423|FG003|Randomization|Disease Progression|0|||
125506739|NCT02823574|451485420|FG000|Randomization|AE unrelated to Study Drug|1|||
125506740|NCT02823574|451485421|FG001|Randomization|AE unrelated to Study Drug|0|||
125506741|NCT02823574|451485422|FG002|Randomization|AE unrelated to Study Drug|0|||
125506742|NCT02823574|451485423|FG003|Randomization|AE unrelated to Study Drug|0|||
125506743|NCT02823574|451485420|FG000|Treatment Period|Poor/Non Compliance|1|||
125506744|NCT02823574|451485421|FG001|Treatment Period|Poor/Non Compliance|0|||
125506745|NCT02823574|451485422|FG002|Treatment Period|Poor/Non Compliance|0|||
125506746|NCT02823574|451485423|FG003|Treatment Period|Poor/Non Compliance|1|||
125506747|NCT02823574|451485420|FG000|Treatment Period|Maximum Clinical Benefit|8|||
125506748|NCT02823574|451485421|FG001|Treatment Period|Maximum Clinical Benefit|4|||
125506749|NCT02823574|451485422|FG002|Treatment Period|Maximum Clinical Benefit|7|||
125506750|NCT02823574|451485423|FG003|Treatment Period|Maximum Clinical Benefit|1|||
125506751|NCT02823574|451485420|FG000|Treatment Period|Lost to Follow-up|1|||
125506752|NCT02823574|451485421|FG001|Treatment Period|Lost to Follow-up|1|||
125506753|NCT02823574|451485422|FG002|Treatment Period|Lost to Follow-up|0|||
125506754|NCT02823574|451485423|FG003|Treatment Period|Lost to Follow-up|0|||
125506755|NCT02823574|451485420|FG000|Treatment Period|Participant withdrew consent|4|||
125506756|NCT02823574|451485421|FG001|Treatment Period|Participant withdrew consent|0|||
125506757|NCT02823574|451485422|FG002|Treatment Period|Participant withdrew consent|0|||
125506758|NCT02823574|451485423|FG003|Treatment Period|Participant withdrew consent|1|||
125506759|NCT02823574|451485420|FG000|Treatment Period|Participant request to discontinue|5|||
125506760|NCT02823574|451485421|FG001|Treatment Period|Participant request to discontinue|0|||
125506761|NCT02823574|451485422|FG002|Treatment Period|Participant request to discontinue|3|||
125506762|NCT02823574|451485423|FG003|Treatment Period|Participant request to discontinue|2|||
125506763|NCT02823574|451485420|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
125506764|NCT02823574|451485421|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
125506765|NCT02823574|451485422|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
125506766|NCT02823574|451485423|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
125506767|NCT02823574|451485420|FG000|Treatment Period|Study Drug Toxicity|11|||
125506768|NCT02823574|451485421|FG001|Treatment Period|Study Drug Toxicity|2|||
125506769|NCT02823574|451485422|FG002|Treatment Period|Study Drug Toxicity|14|||
125506770|NCT02823574|451485423|FG003|Treatment Period|Study Drug Toxicity|4|||
125506771|NCT02823574|451485420|FG000|Treatment Period|Disease Progression|113|||
125506772|NCT02823574|451485421|FG001|Treatment Period|Disease Progression|64|||
125506773|NCT02823574|451485422|FG002|Treatment Period|Disease Progression|82|||
125506774|NCT02823574|451485423|FG003|Treatment Period|Disease Progression|43|||
125506775|NCT02823574|451485420|FG000|Treatment Period|Other reasons|5|||
125506776|NCT02823574|451485421|FG001|Treatment Period|Other reasons|9|||
125506777|NCT02823574|451485422|FG002|Treatment Period|Other reasons|3|||
125506778|NCT02823574|451485423|FG003|Treatment Period|Other reasons|6|||
125506779|NCT02823574|451485420|FG000|Treatment Period|Participant no longer meets study criteria|0|||
125506780|NCT02823574|451485421|FG001|Treatment Period|Participant no longer meets study criteria|0|||
125506781|NCT02823574|451485422|FG002|Treatment Period|Participant no longer meets study criteria|1|||
125506782|NCT02823574|451485423|FG003|Treatment Period|Participant no longer meets study criteria|0|||
125506783|NCT02823574|451485420|FG000|Treatment Period|Death|0|||
125506784|NCT02823574|451485421|FG001|Treatment Period|Death|0|||
125506785|NCT02823574|451485422|FG002|Treatment Period|Death|3|||
125506786|NCT02823574|451485423|FG003|Treatment Period|Death|1|||
125506787|NCT00590759|451485424|FG000|Overall Study|Death|52|||
125506788|NCT00590759|451485424|FG000|Overall Study|Lost to Follow-up|28|||
125506789|NCT03845517|451485431|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
125506790|NCT03845517|451485432|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
125506791|NCT03845517|451485433|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
125506792|NCT03845517|451485434|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
125506793|NCT03845517|451485431|FG000|Treatment Period (52 Weeks)|Death|0|||
125506794|NCT03845517|451485432|FG001|Treatment Period (52 Weeks)|Death|0|||
125506795|NCT03845517|451485433|FG002|Treatment Period (52 Weeks)|Death|1|||
125506796|NCT03845517|451485434|FG003|Treatment Period (52 Weeks)|Death|0|||
125506797|NCT03845517|451485431|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
125506798|NCT03845517|451485432|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
125506799|NCT03845517|451485433|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
125506800|NCT03845517|451485434|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
125506801|NCT03845517|451485431|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
125506802|NCT03845517|451485432|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
125506803|NCT03845517|451485433|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
125506804|NCT03845517|451485434|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
125506805|NCT03845517|451485431|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
125506806|NCT03845517|451485432|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
125506807|NCT03845517|451485433|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
125506808|NCT03845517|451485434|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
125506809|NCT03845517|451485431|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
125506810|NCT03845517|451485432|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
125506811|NCT03845517|451485433|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
125506812|NCT03845517|451485434|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
125506813|NCT03845517|451485431|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
125506814|NCT03845517|451485432|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
125506815|NCT03845517|451485433|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
125506816|NCT03845517|451485434|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
125506817|NCT03845517|451485431|FG000|Treatment Period (52 Weeks)|Other|2|||
125506818|NCT03845517|451485432|FG001|Treatment Period (52 Weeks)|Other|0|||
125506819|NCT03845517|451485433|FG002|Treatment Period (52 Weeks)|Other|0|||
125506820|NCT03845517|451485434|FG003|Treatment Period (52 Weeks)|Other|0|||
125506821|NCT03845517|451485431|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
125506822|NCT03845517|451485432|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
125506823|NCT03845517|451485433|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
125506824|NCT03845517|451485434|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
125506825|NCT03845517|451485431|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
125506826|NCT03845517|451485432|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
125506827|NCT03845517|451485433|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
125506828|NCT03845517|451485434|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
125506829|NCT03845517|451485431|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
125506830|NCT03845517|451485432|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
125506831|NCT03845517|451485433|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
125506832|NCT03845517|451485434|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
125506833|NCT03845517|451485431|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
125506834|NCT03845517|451485432|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
125506835|NCT03845517|451485433|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
125506836|NCT03845517|451485434|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
125506837|NCT03845517|451485431|FG000|Follow-up Period (4 Weeks)|Death|0|||
125506838|NCT03845517|451485432|FG001|Follow-up Period (4 Weeks)|Death|0|||
125506839|NCT03845517|451485433|FG002|Follow-up Period (4 Weeks)|Death|1|||
125506840|NCT03845517|451485434|FG003|Follow-up Period (4 Weeks)|Death|1|||
125506841|NCT03845517|451485431|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
125506842|NCT03845517|451485432|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
125506843|NCT03845517|451485433|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
125506844|NCT03845517|451485434|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
125506845|NCT03845517|451485431|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
125506846|NCT03845517|451485432|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
125506847|NCT03845517|451485433|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
125506848|NCT03845517|451485434|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
125506849|NCT03845517|451485431|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
125506850|NCT03845517|451485432|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
125506851|NCT03845517|451485433|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
125506852|NCT03845517|451485434|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
125506853|NCT03845517|451485431|FG000|Follow-up Period (4 Weeks)|Other|1|||
125506854|NCT03845517|451485432|FG001|Follow-up Period (4 Weeks)|Other|0|||
125506855|NCT03845517|451485433|FG002|Follow-up Period (4 Weeks)|Other|1|||
125506856|NCT03845517|451485434|FG003|Follow-up Period (4 Weeks)|Other|0|||
125506857|NCT03845517|451485431|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
125506858|NCT03845517|451485432|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
125506859|NCT03845517|451485433|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
125506860|NCT03845517|451485434|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
125506861|NCT03845517|451485431|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
125506862|NCT03845517|451485432|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
125506863|NCT03845517|451485433|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
125506864|NCT03845517|451485434|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
125506865|NCT03845517|451485431|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
125506866|NCT03845517|451485432|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
125506867|NCT03845517|451485433|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
125506868|NCT03845517|451485434|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
125506869|NCT01494467|451485435|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
125506870|NCT01494467|451485436|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
125506871|NCT01494467|451485435|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
125506872|NCT01494467|451485436|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
125506873|NCT01494467|451485435|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
125506874|NCT01494467|451485436|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
125506875|NCT01494467|451485435|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
125506876|NCT01494467|451485436|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
125506877|NCT01494467|451485435|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
125506878|NCT01494467|451485436|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
125506879|NCT01494467|451485435|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
125506880|NCT01494467|451485436|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
125506881|NCT01494467|451485435|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
125506882|NCT01494467|451485436|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
125305474|NCT00483938|450745138|FG006|Overall Study|Death|0|||
125305475|NCT00483938|450745132|FG000|Overall Study|Other|3|||
125506883|NCT01494467|451485435|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
125506884|NCT01494467|451485436|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
125506885|NCT01494467|451485435|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
125506886|NCT01494467|451485436|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
125506887|NCT01494467|451485435|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
125506888|NCT01494467|451485436|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
125506889|NCT01494467|451485435|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
125506890|NCT01494467|451485436|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
125506891|NCT01494467|451485435|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
125506892|NCT01494467|451485436|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
125506893|NCT01494467|451485435|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
125506894|NCT01494467|451485436|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
125506895|NCT01494467|451485435|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
125506896|NCT01494467|451485436|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
125506897|NCT00417885|451485437|FG000|Overall Study|Adverse Event|1|||
125506898|NCT00417885|451485437|FG000|Overall Study|Objective Progression or Relapse|3|||
125506899|NCT00417885|451485437|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
125506900|NCT01190436|451485438|FG000|Overall Study|Lost to Follow-up|35|||
125506901|NCT01190436|451485438|FG000|Overall Study|Other|4|||
125506902|NCT02721147|451485439|FG000|Overall Study|Lost to Follow-up|2|||
125506903|NCT02721147|451485440|FG001|Overall Study|Lost to Follow-up|0|||
125506904|NCT02721147|451485441|FG002|Overall Study|Lost to Follow-up|0|||
125506905|NCT01722097|451485442|FG000|Overall Study|Patient sheets not returned|6|||
125506906|NCT01722097|451485443|FG001|Overall Study|Patient sheets not returned|5|||
125506907|NCT02009332|451485446|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
125506908|NCT02009332|451485447|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
125506909|NCT02009332|451485448|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
125506910|NCT02009332|451485449|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
125506911|NCT02009332|451485450|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
125506912|NCT02009332|451485451|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
125506913|NCT02009332|451485446|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
125506914|NCT02009332|451485447|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
125506915|NCT02009332|451485448|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
125506916|NCT02009332|451485449|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
125506917|NCT02009332|451485450|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
125506918|NCT02009332|451485451|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
125506919|NCT02009332|451485446|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
125506920|NCT02009332|451485447|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
125506921|NCT02009332|451485448|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
125506922|NCT02009332|451485449|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
125506923|NCT02009332|451485450|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
125506924|NCT02009332|451485451|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
125506925|NCT01912599|451485452|FG000|Overall Study|Withdrawal by Subject|0|||
125506926|NCT01912599|451485453|FG001|Overall Study|Withdrawal by Subject|1|||
125506927|NCT04739306|451485454|FG000|Main Study Period|Adverse Event|6|||
125506928|NCT04739306|451485455|FG001|Main Study Period|Adverse Event|7|||
125506929|NCT04739306|451485454|FG000|Main Study Period|Lost to Follow-up|4|||
125506930|NCT04739306|451485455|FG001|Main Study Period|Lost to Follow-up|6|||
125506931|NCT04739306|451485454|FG000|Main Study Period|Physician Decision|1|||
125506932|NCT04739306|451485455|FG001|Main Study Period|Physician Decision|1|||
125506933|NCT04739306|451485454|FG000|Main Study Period|Withdrawal by Subject|8|||
125506934|NCT04739306|451485455|FG001|Main Study Period|Withdrawal by Subject|6|||
125506935|NCT04739306|451485454|FG000|Main Study Period|Protocol Violation|0|||
125506936|NCT04739306|451485455|FG001|Main Study Period|Protocol Violation|1|||
125506937|NCT04739306|451485454|FG000|Main Study Period|War in Ukraine|1|||
125506938|NCT04739306|451485455|FG001|Main Study Period|War in Ukraine|1|||
125506939|NCT03386344|451485456|FG000|Overall Study|Adverse Event|6|||
125506940|NCT03386344|451485457|FG001|Overall Study|Adverse Event|3|||
125506941|NCT03386344|451485458|FG002|Overall Study|Adverse Event|1|||
125506942|NCT03386344|451485456|FG000|Overall Study|Poor Compliance to Protocol|0|||
125506943|NCT03386344|451485457|FG001|Overall Study|Poor Compliance to Protocol|1|||
125506944|NCT03386344|451485458|FG002|Overall Study|Poor Compliance to Protocol|0|||
125506945|NCT03386344|451485456|FG000|Overall Study|Study Terminated by Sponsor|101|||
125506946|NCT03386344|451485457|FG001|Overall Study|Study Terminated by Sponsor|102|||
125506947|NCT03386344|451485458|FG002|Overall Study|Study Terminated by Sponsor|106|||
125506948|NCT03386344|451485456|FG000|Overall Study|Lost to Follow-up|3|||
125506949|NCT03386344|451485457|FG001|Overall Study|Lost to Follow-up|2|||
125506950|NCT03386344|451485458|FG002|Overall Study|Lost to Follow-up|1|||
125506951|NCT03386344|451485456|FG000|Overall Study|At the Participant's own Request|7|||
125506952|NCT03386344|451485457|FG001|Overall Study|At the Participant's own Request|7|||
125506953|NCT03386344|451485458|FG002|Overall Study|At the Participant's own Request|8|||
125506954|NCT03386344|451485456|FG000|Overall Study|Reason not Specified|0|||
125305476|NCT00483938|450745133|FG001|Overall Study|Other|9|||
125506955|NCT03386344|451485457|FG001|Overall Study|Reason not Specified|1|||
125506956|NCT03386344|451485458|FG002|Overall Study|Reason not Specified|0|||
125506957|NCT01280721|451485459|FG000|Overall Study|Adverse Event|4|||
125506958|NCT01280721|451485459|FG000|Overall Study|Physician Decision|3|||
125506959|NCT01280721|451485459|FG000|Overall Study|Withdrawal by Subject|6|||
125506960|NCT01280721|451485459|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
125506961|NCT01280721|451485459|FG000|Overall Study|No tolerability for the lowest dose|2|||
125506962|NCT00248794|451485460|FG000|Overall Study|Lost to Follow-up|6|||
125506963|NCT00248794|451485461|FG001|Overall Study|Lost to Follow-up|8|||
125506964|NCT00248794|451485462|FG002|Overall Study|Lost to Follow-up|3|||
125506965|NCT02632747|451485463|FG000|Wash-out Period|Adverse Event|1|||
125506966|NCT02632747|451485464|FG001|Wash-out Period|Adverse Event|0|||
125506967|NCT03449979|451485465|FG000|Overall Study|Technical difficulty|0|||
125506968|NCT03449979|451485466|FG001|Overall Study|Technical difficulty|0|||
125506969|NCT03449979|451485467|FG002|Overall Study|Technical difficulty|0|||
125506970|NCT03449979|451485468|FG003|Overall Study|Technical difficulty|1|||
125506971|NCT02069379|451485469|FG000|Baseline Measurements|Lost to Follow-up|1|||
125506972|NCT02069379|451485470|FG001|Baseline Measurements|Lost to Follow-up|0|||
125506973|NCT02069379|451485471|FG002|Baseline Measurements|Lost to Follow-up|0|||
125506974|NCT02069379|451485472|FG003|Baseline Measurements|Lost to Follow-up|0|||
125506975|NCT02069379|451485469|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
125506976|NCT02069379|451485470|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
125506977|NCT02069379|451485471|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
125506978|NCT02069379|451485472|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
125506979|NCT02069379|451485469|FG000|First Treatment Arm|Lost to Follow-up|0|||
125506980|NCT02069379|451485470|FG001|First Treatment Arm|Lost to Follow-up|1|||
125506981|NCT02069379|451485471|FG002|First Treatment Arm|Lost to Follow-up|1|||
125506982|NCT02069379|451485472|FG003|First Treatment Arm|Lost to Follow-up|0|||
125506983|NCT02069379|451485469|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
125506984|NCT02069379|451485470|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
125506985|NCT02069379|451485471|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
125506986|NCT02069379|451485472|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
125506987|NCT02069379|451485469|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
125506988|NCT02069379|451485470|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
125506989|NCT02069379|451485471|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
125506990|NCT02069379|451485472|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
125506991|NCT02069379|451485469|FG000|Second Treatment Arm|Lost to Follow-up|0|||
125506992|NCT02069379|451485470|FG001|Second Treatment Arm|Lost to Follow-up|0|||
125506993|NCT02069379|451485471|FG002|Second Treatment Arm|Lost to Follow-up|1|||
125506994|NCT02069379|451485472|FG003|Second Treatment Arm|Lost to Follow-up|0|||
125506995|NCT00700999|451485473|FG000|Overall Study|Lost to Follow-up|7|||
125506996|NCT00700999|451485474|FG001|Overall Study|Lost to Follow-up|7|||
125506997|NCT00700999|451485473|FG000|Overall Study|Excluded - did not meet study criteria|0|||
125506998|NCT00700999|451485474|FG001|Overall Study|Excluded - did not meet study criteria|1|||
125506999|NCT00700999|451485473|FG000|Overall Study|Withdrawal by Subject|8|||
125507000|NCT00700999|451485474|FG001|Overall Study|Withdrawal by Subject|1|||
125507001|NCT03481725|451485475|FG000|Overall Study|Withdrawal by Subject|1|||
125507002|NCT03481725|451485476|FG001|Overall Study|Withdrawal by Subject|0|||
125507003|NCT03651271|451485479|FG000|Overall Study|Death|4|||
125507004|NCT03651271|451485480|FG001|Overall Study|Death|37|||
125507005|NCT03651271|451485481|FG002|Overall Study|Death|0|||
125507006|NCT03651271|451485482|FG003|Overall Study|Death|2|||
125507007|NCT03651271|451485483|FG004|Overall Study|Death|6|||
125507008|NCT03651271|451485479|FG000|Overall Study|Lost to Follow-up|1|||
125507009|NCT03651271|451485480|FG001|Overall Study|Lost to Follow-up|5|||
125507010|NCT03651271|451485481|FG002|Overall Study|Lost to Follow-up|0|||
125507011|NCT03651271|451485482|FG003|Overall Study|Lost to Follow-up|1|||
125507012|NCT03651271|451485483|FG004|Overall Study|Lost to Follow-up|0|||
125507013|NCT03651271|451485479|FG000|Overall Study|Physician Decision|0|||
125507014|NCT03651271|451485480|FG001|Overall Study|Physician Decision|2|||
125507015|NCT03651271|451485481|FG002|Overall Study|Physician Decision|0|||
125507016|NCT03651271|451485482|FG003|Overall Study|Physician Decision|0|||
125507017|NCT03651271|451485483|FG004|Overall Study|Physician Decision|0|||
125507018|NCT03651271|451485479|FG000|Overall Study|Withdrawal by Subject|1|||
125507019|NCT03651271|451485480|FG001|Overall Study|Withdrawal by Subject|15|||
125507020|NCT03651271|451485481|FG002|Overall Study|Withdrawal by Subject|0|||
125507021|NCT03651271|451485482|FG003|Overall Study|Withdrawal by Subject|0|||
125305477|NCT00483938|450745134|FG002|Overall Study|Other|0|||
125305478|NCT00483938|450745135|FG003|Overall Study|Other|4|||
125305479|NCT00483938|450745136|FG004|Overall Study|Other|0|||
125507022|NCT03651271|451485483|FG004|Overall Study|Withdrawal by Subject|1|||
125507023|NCT03651271|451485479|FG000|Overall Study|Patient medically unable to continue|0|||
125507024|NCT03651271|451485480|FG001|Overall Study|Patient medically unable to continue|0|||
125507025|NCT03651271|451485481|FG002|Overall Study|Patient medically unable to continue|0|||
125305480|NCT00483938|450745137|FG005|Overall Study|Other|4|||
125507026|NCT03651271|451485482|FG003|Overall Study|Patient medically unable to continue|1|||
125507027|NCT03651271|451485483|FG004|Overall Study|Patient medically unable to continue|0|||
125507028|NCT00821093|451485484|FG000|Overall Study|Adverse Event|20|||
125507029|NCT00821093|451485485|FG001|Overall Study|Adverse Event|12|||
125507030|NCT00821093|451485484|FG000|Overall Study|Withdrawal by Subject|9|||
125507031|NCT00821093|451485485|FG001|Overall Study|Withdrawal by Subject|13|||
125507032|NCT00821093|451485484|FG000|Overall Study|Lost to Follow-up|9|||
125507033|NCT00821093|451485485|FG001|Overall Study|Lost to Follow-up|3|||
125507034|NCT00821093|451485484|FG000|Overall Study|Protocol deviation|3|||
125507035|NCT00821093|451485485|FG001|Overall Study|Protocol deviation|6|||
125507036|NCT00821093|451485484|FG000|Overall Study|Abnormal laboratory value(s)|2|||
125507037|NCT00821093|451485485|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125507038|NCT00821093|451485484|FG000|Overall Study|Lack of Efficacy|2|||
125507039|NCT00821093|451485485|FG001|Overall Study|Lack of Efficacy|2|||
125507040|NCT00821093|451485484|FG000|Overall Study|Death|2|||
125507041|NCT00821093|451485485|FG001|Overall Study|Death|1|||
125507042|NCT00821093|451485484|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125507043|NCT00821093|451485485|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125507044|NCT00821093|451485484|FG000|Overall Study|Administrative problems|1|||
125507045|NCT00821093|451485485|FG001|Overall Study|Administrative problems|2|||
125507046|NCT03444155|451485486|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
125507047|NCT03444155|451485487|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
125507048|NCT01864200|451485494|FG000|Overall Study|Lost to Follow-up|1|||
125507049|NCT01864200|451485495|FG001|Overall Study|Lost to Follow-up|3|||
125507050|NCT01864200|451485494|FG000|Overall Study|Protocol Violation|1|||
125507051|NCT01864200|451485495|FG001|Overall Study|Protocol Violation|0|||
125507052|NCT02991118|451485496|FG000|Overall Study|Death|3|||
125507053|NCT02991118|451485497|FG001|Overall Study|Death|8|||
125507054|NCT02991118|451485496|FG000|Overall Study|Protocol Violation|0|||
125507055|NCT02991118|451485497|FG001|Overall Study|Protocol Violation|3|||
125507056|NCT02991118|451485496|FG000|Overall Study|Physician Decision|0|||
125507057|NCT02991118|451485497|FG001|Overall Study|Physician Decision|1|||
125507058|NCT02991118|451485496|FG000|Overall Study|Moved out of the country|0|||
125507059|NCT02991118|451485497|FG001|Overall Study|Moved out of the country|1|||
125507060|NCT02991118|451485496|FG000|Overall Study|Adverse Event|2|||
125507061|NCT02991118|451485497|FG001|Overall Study|Adverse Event|2|||
125507062|NCT02991118|451485496|FG000|Overall Study|Withdrawal by Subject|1|||
125507063|NCT02991118|451485497|FG001|Overall Study|Withdrawal by Subject|7|||
125507064|NCT02991118|451485496|FG000|Overall Study|Could not attend study visits|0|||
125507065|NCT02991118|451485497|FG001|Overall Study|Could not attend study visits|1|||
125507066|NCT02991118|451485496|FG000|Overall Study|Lost to Follow-up|1|||
125507067|NCT02991118|451485497|FG001|Overall Study|Lost to Follow-up|9|||
125507068|NCT00595959|451485498|FG000|Overall Study|Withdrawal by Subject|1|||
125507069|NCT00595959|451485498|FG000|Overall Study|Lost to Follow-up|1|||
125507070|NCT02077374|451485502|FG000|Overall Study|Withdrawal by Subject|0|||
125507071|NCT02077374|451485503|FG001|Overall Study|Withdrawal by Subject|1|||
125507072|NCT02077374|451485502|FG000|Overall Study|Protocol Violation|0|||
125507073|NCT02077374|451485503|FG001|Overall Study|Protocol Violation|1|||
125507074|NCT00446095|451485504|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
125507075|NCT00446095|451485505|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
125507076|NCT00446095|451485506|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
125507077|NCT00446095|451485507|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
125507078|NCT00446095|451485508|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
125507079|NCT00446095|451485504|FG000|Phase II (8 Weeks)|Adverse Event|0|||
125507080|NCT00446095|451485505|FG001|Phase II (8 Weeks)|Adverse Event|1|||
125507081|NCT00446095|451485506|FG002|Phase II (8 Weeks)|Adverse Event|1|||
125507082|NCT00446095|451485507|FG003|Phase II (8 Weeks)|Adverse Event|0|||
125507083|NCT00446095|451485508|FG004|Phase II (8 Weeks)|Adverse Event|0|||
125507084|NCT00446095|451485504|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
125507085|NCT00446095|451485505|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
125507086|NCT00446095|451485506|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
125507087|NCT00446095|451485507|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
125507088|NCT00446095|451485508|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
125507089|NCT00446095|451485504|FG000|Phase II (8 Weeks)|Physician Decision|1|||
125507090|NCT00446095|451485505|FG001|Phase II (8 Weeks)|Physician Decision|0|||
125507091|NCT00446095|451485506|FG002|Phase II (8 Weeks)|Physician Decision|0|||
125507092|NCT00446095|451485507|FG003|Phase II (8 Weeks)|Physician Decision|0|||
125507093|NCT00446095|451485508|FG004|Phase II (8 Weeks)|Physician Decision|0|||
125507094|NCT00446095|451485504|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
125507095|NCT00446095|451485505|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
125507096|NCT00446095|451485506|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
125507097|NCT00446095|451485507|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
125507098|NCT00446095|451485508|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
125507099|NCT00446095|451485504|FG000|Phase II (8 Weeks)|Ongoing|0|||
125507100|NCT00446095|451485505|FG001|Phase II (8 Weeks)|Ongoing|0|||
125507101|NCT00446095|451485506|FG002|Phase II (8 Weeks)|Ongoing|1|||
125507102|NCT00446095|451485507|FG003|Phase II (8 Weeks)|Ongoing|0|||
125507103|NCT00446095|451485508|FG004|Phase II (8 Weeks)|Ongoing|0|||
125507104|NCT00446095|451485504|FG000|Phase I (28 Days)|Adverse Event|0|||
125507105|NCT00446095|451485505|FG001|Phase I (28 Days)|Adverse Event|0|||
125507106|NCT00446095|451485506|FG002|Phase I (28 Days)|Adverse Event|0|||
125507107|NCT00446095|451485507|FG003|Phase I (28 Days)|Adverse Event|1|||
125507108|NCT00446095|451485508|FG004|Phase I (28 Days)|Adverse Event|0|||
125507109|NCT00446095|451485504|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
125507110|NCT00446095|451485505|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
125507111|NCT00446095|451485506|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
125507112|NCT00446095|451485507|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
125507113|NCT00446095|451485508|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
125507114|NCT00409747|451485509|FG000|Overall Study|Withdrawal by Subject|1|||
125507115|NCT01916109|451485512|FG000|Overall Study|Withdrawal by Subject|1|||
125507116|NCT00636168|451485515|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
125507117|NCT00636168|451485516|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
125507118|NCT00636168|451485515|FG000|Randomized to Study Drug|Adverse Event|1|||
125507119|NCT00636168|451485516|FG001|Randomized to Study Drug|Adverse Event|0|||
125507120|NCT00636168|451485515|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
125507121|NCT00636168|451485516|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
125507122|NCT00636168|451485515|FG000|Treated With Study Drug|Recurrence of disease|135|||
125507123|NCT00636168|451485516|FG001|Treated With Study Drug|Recurrence of disease|282|||
125507124|NCT00636168|451485515|FG000|Treated With Study Drug|Adverse Event|250|||
125507125|NCT00636168|451485516|FG001|Treated With Study Drug|Adverse Event|22|||
125507126|NCT00636168|451485515|FG000|Treated With Study Drug|Participant withdrew consent|16|||
125507127|NCT00636168|451485516|FG001|Treated With Study Drug|Participant withdrew consent|21|||
125507128|NCT00636168|451485515|FG000|Treated With Study Drug|Poor/non-compliance|1|||
125507129|NCT00636168|451485516|FG001|Treated With Study Drug|Poor/non-compliance|3|||
125507130|NCT00636168|451485515|FG000|Treated With Study Drug|Death|3|||
125507131|NCT00636168|451485516|FG001|Treated With Study Drug|Death|0|||
125507132|NCT00636168|451485515|FG000|Treated With Study Drug|Pregnancy|1|||
125507133|NCT00636168|451485516|FG001|Treated With Study Drug|Pregnancy|0|||
125507134|NCT00636168|451485515|FG000|Treated With Study Drug|No longer meets study criteria|1|||
125507135|NCT00636168|451485516|FG001|Treated With Study Drug|No longer meets study criteria|0|||
125507136|NCT00636168|451485515|FG000|Treated With Study Drug|Other reason|1|||
125507137|NCT00636168|451485516|FG001|Treated With Study Drug|Other reason|3|||
125507138|NCT00636168|451485515|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
125507139|NCT00636168|451485516|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
125507140|NCT00636168|451485515|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
125507141|NCT00636168|451485516|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
125507142|NCT00636168|451485515|FG000|Long Term Follow-Up|Death|8|||
125507143|NCT00636168|451485516|FG001|Long Term Follow-Up|Death|9|||
125507144|NCT02707952|451485519|FG000|Overall Study|Adverse Event|1|||
125507145|NCT02707952|451485520|FG001|Overall Study|Adverse Event|0|||
125507146|NCT02707952|451485521|FG002|Overall Study|Adverse Event|0|||
125507147|NCT02707952|451485522|FG003|Overall Study|Adverse Event|0|||
125507148|NCT02707952|451485519|FG000|Overall Study|Lost to Follow-up|1|||
125507149|NCT02707952|451485520|FG001|Overall Study|Lost to Follow-up|0|||
125507150|NCT02707952|451485521|FG002|Overall Study|Lost to Follow-up|0|||
125507151|NCT02707952|451485522|FG003|Overall Study|Lost to Follow-up|0|||
125507152|NCT02707952|451485519|FG000|Overall Study|Withdrawal by Subject|0|||
125507153|NCT02707952|451485520|FG001|Overall Study|Withdrawal by Subject|1|||
125507154|NCT02707952|451485521|FG002|Overall Study|Withdrawal by Subject|2|||
125507155|NCT02707952|451485522|FG003|Overall Study|Withdrawal by Subject|0|||
125507156|NCT02006641|451485523|FG000|Overall Study|Withdrawal before treatment|2|||
125507157|NCT02006641|451485524|FG001|Overall Study|Withdrawal before treatment|5|||
125507158|NCT02006641|451485525|FG002|Overall Study|Withdrawal before treatment|3|||
125507159|NCT02006641|451485523|FG000|Overall Study|Adverse Event|15|||
125507160|NCT02006641|451485524|FG001|Overall Study|Adverse Event|11|||
125507161|NCT02006641|451485525|FG002|Overall Study|Adverse Event|15|||
125507162|NCT02006641|451485523|FG000|Overall Study|Protocol Violation|0|||
125507163|NCT02006641|451485524|FG001|Overall Study|Protocol Violation|2|||
125507164|NCT02006641|451485525|FG002|Overall Study|Protocol Violation|2|||
125507165|NCT02006641|451485523|FG000|Overall Study|Lost to Follow-up|0|||
125507166|NCT02006641|451485524|FG001|Overall Study|Lost to Follow-up|1|||
125507167|NCT02006641|451485525|FG002|Overall Study|Lost to Follow-up|0|||
125507168|NCT02006641|451485523|FG000|Overall Study|Withdrawal by Subject|7|||
125507169|NCT02006641|451485524|FG001|Overall Study|Withdrawal by Subject|12|||
125507170|NCT02006641|451485525|FG002|Overall Study|Withdrawal by Subject|11|||
125507171|NCT02006641|451485523|FG000|Overall Study|Other reason: patient didn't show up|1|||
125507172|NCT02006641|451485524|FG001|Overall Study|Other reason: patient didn't show up|0|||
125507173|NCT02006641|451485525|FG002|Overall Study|Other reason: patient didn't show up|0|||
125507174|NCT02006641|451485523|FG000|Overall Study|Other reason:patient didn't want to come|0|||
125507175|NCT02006641|451485524|FG001|Overall Study|Other reason:patient didn't want to come|0|||
125507176|NCT02006641|451485525|FG002|Overall Study|Other reason:patient didn't want to come|1|||
125507177|NCT02006641|451485523|FG000|Overall Study|Other reason: patient has moved|1|||
125507178|NCT02006641|451485524|FG001|Overall Study|Other reason: patient has moved|0|||
125507179|NCT02006641|451485525|FG002|Overall Study|Other reason: patient has moved|1|||
125507180|NCT02006641|451485523|FG000|Overall Study|Other reason: caregiver in hospital|0|||
125507181|NCT02006641|451485524|FG001|Overall Study|Other reason: caregiver in hospital|1|||
125507182|NCT02006641|451485525|FG002|Overall Study|Other reason: caregiver in hospital|0|||
125507183|NCT02006641|451485523|FG000|Overall Study|Other reason: patient's wife has died|0|||
125507184|NCT02006641|451485524|FG001|Overall Study|Other reason: patient's wife has died|0|||
125507185|NCT02006641|451485525|FG002|Overall Study|Other reason: patient's wife has died|1|||
125507186|NCT02006641|451485523|FG000|Overall Study|Other reason: hospitalisation|0|||
125507187|NCT02006641|451485524|FG001|Overall Study|Other reason: hospitalisation|1|||
125507188|NCT02006641|451485525|FG002|Overall Study|Other reason: hospitalisation|0|||
125507189|NCT02006641|451485523|FG000|Overall Study|Other reason: caregiver impossibility|0|||
125507190|NCT02006641|451485524|FG001|Overall Study|Other reason: caregiver impossibility|0|||
125507191|NCT02006641|451485525|FG002|Overall Study|Other reason: caregiver impossibility|1|||
125507192|NCT02006641|451485523|FG000|Overall Study|Other reason: protocol non-compliance|0|||
125507193|NCT02006641|451485524|FG001|Overall Study|Other reason: protocol non-compliance|0|||
125507194|NCT02006641|451485525|FG002|Overall Study|Other reason: protocol non-compliance|1|||
125507195|NCT01287832|451485526|FG000|Overall Study|Adverse Event|1|||
125507196|NCT01287832|451485527|FG001|Overall Study|Adverse Event|0|||
125507197|NCT01287832|451485526|FG000|Overall Study|Death|0|||
125507198|NCT01287832|451485527|FG001|Overall Study|Death|1|||
125507199|NCT04749797|451485529|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
125507200|NCT04749797|451485530|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
125507201|NCT04749797|451485531|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
125507202|NCT00632736|451485532|FG000|Overall Study|Adverse Event|104|||
125507203|NCT00632736|451485532|FG000|Overall Study|Lost to Follow-up|15|||
125507204|NCT00632736|451485532|FG000|Overall Study|Protocol Violation|14|||
125507205|NCT00632736|451485532|FG000|Overall Study|Withdrawal by Subject|99|||
125507206|NCT00632736|451485532|FG000|Overall Study|Lack of Efficacy|5|||
125507207|NCT00632736|451485532|FG000|Overall Study|Sponsor terminated study|5|||
125507208|NCT00632736|451485532|FG000|Overall Study|Non-compliance|10|||
125507209|NCT00632736|451485532|FG000|Overall Study|Other|16|||
125507210|NCT01441596|451485533|FG000|Overall Study|Other reason not defined below|0|||
125507211|NCT01441596|451485534|FG001|Overall Study|Other reason not defined below|2|||
125507212|NCT01441596|451485535|FG002|Overall Study|Other reason not defined below|1|||
125507213|NCT01441596|451485533|FG000|Overall Study|Withdrawal by Subject|4|||
125507214|NCT01441596|451485534|FG001|Overall Study|Withdrawal by Subject|0|||
125507215|NCT01441596|451485535|FG002|Overall Study|Withdrawal by Subject|2|||
125507216|NCT01441596|451485533|FG000|Overall Study|Not treated|0|||
125507217|NCT01441596|451485534|FG001|Overall Study|Not treated|1|||
125507218|NCT01441596|451485535|FG002|Overall Study|Not treated|1|||
125507219|NCT01794689|451485536|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
125507220|NCT01794689|451485537|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
125507221|NCT01794689|451485538|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
125507222|NCT01794689|451485539|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
125507223|NCT01794689|451485536|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
125507224|NCT01794689|451485537|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
125507225|NCT01794689|451485538|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
125507226|NCT01794689|451485539|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
125507227|NCT01794689|451485536|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
125507228|NCT01794689|451485537|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
125507229|NCT01794689|451485538|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
125507230|NCT01794689|451485539|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
125507231|NCT01794689|451485536|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
125507232|NCT01794689|451485537|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
125507233|NCT01794689|451485538|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
125507234|NCT01794689|451485539|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
125507235|NCT01697956|451485540|FG000|Overall Study|Protocol Violation|1|||
125507236|NCT01697956|451485541|FG001|Overall Study|Protocol Violation|1|||
125507237|NCT00736502|451485552|FG000|Overall Study|Adverse Event|22|||
125507238|NCT00736502|451485552|FG000|Overall Study|Lack of Efficacy|16|||
125507239|NCT00736502|451485552|FG000|Overall Study|Lost to Follow-up|27|||
125507240|NCT00866619|451485553|FG000|Overall Study|Adverse Event|112|||
125507241|NCT00866619|451485554|FG001|Overall Study|Adverse Event|106|||
125305481|NCT00483938|450745138|FG006|Overall Study|Other|32|||
125305482|NCT02218008|450745139|FG000|Stage 1 (S1)|Adverse Event|6|||
125305483|NCT02218008|450745140|FG001|Stage 1 (S1)|Adverse Event|5|||
125507242|NCT00866619|451485555|FG002|Overall Study|Adverse Event|47|||
125507243|NCT00866619|451485556|FG003|Overall Study|Adverse Event|44|||
125507244|NCT00866619|451485553|FG000|Overall Study|Protocol Violation|2|||
125507245|NCT00866619|451485554|FG001|Overall Study|Protocol Violation|39|||
125507246|NCT00866619|451485555|FG002|Overall Study|Protocol Violation|2|||
125507247|NCT00866619|451485556|FG003|Overall Study|Protocol Violation|17|||
125305484|NCT02218008|450745141|FG002|Stage 1 (S1)|Adverse Event|11|||
125305485|NCT02218008|450745142|FG003|Stage 1 (S1)|Adverse Event|0|||
125305486|NCT02218008|450745143|FG004|Stage 1 (S1)|Adverse Event|0|||
125305487|NCT02218008|450745144|FG005|Stage 1 (S1)|Adverse Event|0|||
125507248|NCT00866619|451485553|FG000|Overall Study|Withdrawal by Subject|587|||
125507249|NCT00866619|451485554|FG001|Overall Study|Withdrawal by Subject|295|||
125507250|NCT00866619|451485555|FG002|Overall Study|Withdrawal by Subject|272|||
125507251|NCT00866619|451485556|FG003|Overall Study|Withdrawal by Subject|144|||
125507252|NCT00866619|451485553|FG000|Overall Study|Lost to Follow-up|1145|||
125507253|NCT00866619|451485554|FG001|Overall Study|Lost to Follow-up|830|||
125507254|NCT00866619|451485555|FG002|Overall Study|Lost to Follow-up|568|||
125507255|NCT00866619|451485556|FG003|Overall Study|Lost to Follow-up|425|||
125507256|NCT00645411|451485557|FG000|Overall Study|Adverse Event|0|||
125507257|NCT00645411|451485558|FG001|Overall Study|Adverse Event|0|||
125507258|NCT00645411|451485559|FG002|Overall Study|Adverse Event|0|||
125507259|NCT00645411|451485560|FG003|Overall Study|Adverse Event|2|||
125507260|NCT00645411|451485557|FG000|Overall Study|Withdrawal by Subject|2|||
125507261|NCT00645411|451485558|FG001|Overall Study|Withdrawal by Subject|1|||
125507262|NCT00645411|451485559|FG002|Overall Study|Withdrawal by Subject|19|||
125507263|NCT00645411|451485560|FG003|Overall Study|Withdrawal by Subject|21|||
125507264|NCT00645411|451485557|FG000|Overall Study|Lost to Follow-up|10|||
125507265|NCT00645411|451485558|FG001|Overall Study|Lost to Follow-up|5|||
125507266|NCT00645411|451485559|FG002|Overall Study|Lost to Follow-up|124|||
125507267|NCT00645411|451485560|FG003|Overall Study|Lost to Follow-up|75|||
125507268|NCT00645411|451485557|FG000|Overall Study|Protocol Violation|1|||
125507269|NCT00645411|451485558|FG001|Overall Study|Protocol Violation|0|||
125507270|NCT00645411|451485559|FG002|Overall Study|Protocol Violation|1|||
125507271|NCT00645411|451485560|FG003|Overall Study|Protocol Violation|0|||
125507272|NCT00645411|451485557|FG000|Overall Study|Inappropriate enrollment|0|||
125507273|NCT00645411|451485558|FG001|Overall Study|Inappropriate enrollment|0|||
125507274|NCT00645411|451485559|FG002|Overall Study|Inappropriate enrollment|4|||
125507275|NCT00645411|451485560|FG003|Overall Study|Inappropriate enrollment|1|||
125507276|NCT00645411|451485557|FG000|Overall Study|Unable to classify|0|||
125507277|NCT00645411|451485558|FG001|Overall Study|Unable to classify|0|||
125507278|NCT00645411|451485559|FG002|Overall Study|Unable to classify|3|||
125507279|NCT00645411|451485560|FG003|Overall Study|Unable to classify|4|||
125507280|NCT03987074|451485561|FG000|Overall Study|Withdrew Consent|1|||
125507281|NCT03987074|451485562|FG001|Overall Study|Withdrew Consent|1|||
125507282|NCT03987074|451485563|FG002|Overall Study|Withdrew Consent|0|||
125507283|NCT03987074|451485564|FG003|Overall Study|Withdrew Consent|2|||
125507284|NCT03987074|451485565|FG004|Overall Study|Withdrew Consent|1|||
125507285|NCT03987074|451485561|FG000|Overall Study|Adverse Event|2|||
125507286|NCT03987074|451485562|FG001|Overall Study|Adverse Event|1|||
125507287|NCT03987074|451485563|FG002|Overall Study|Adverse Event|0|||
125507288|NCT03987074|451485564|FG003|Overall Study|Adverse Event|0|||
125507289|NCT03987074|451485565|FG004|Overall Study|Adverse Event|1|||
125507290|NCT03987074|451485561|FG000|Overall Study|Lost to Follow-up|0|||
125507291|NCT03987074|451485562|FG001|Overall Study|Lost to Follow-up|0|||
125507292|NCT03987074|451485563|FG002|Overall Study|Lost to Follow-up|1|||
125507293|NCT03987074|451485564|FG003|Overall Study|Lost to Follow-up|1|||
125507294|NCT03987074|451485565|FG004|Overall Study|Lost to Follow-up|0|||
125507295|NCT03987074|451485561|FG000|Overall Study|Investigator's Discretion|0|||
125507296|NCT03987074|451485562|FG001|Overall Study|Investigator's Discretion|0|||
125507297|NCT03987074|451485563|FG002|Overall Study|Investigator's Discretion|0|||
125507298|NCT03987074|451485564|FG003|Overall Study|Investigator's Discretion|1|||
125507299|NCT03987074|451485565|FG004|Overall Study|Investigator's Discretion|0|||
125507300|NCT03100370|451485566|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
125507301|NCT03100370|451485567|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
125507302|NCT03100370|451485568|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
125507303|NCT03100370|451485569|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
125507304|NCT03100370|451485570|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
125507305|NCT03100370|451485571|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
125507306|NCT01020487|451487171|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
125507307|NCT01020487|451487172|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
125507308|NCT01020487|451487173|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
125507309|NCT01020487|451487171|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
125507310|NCT01020487|451487172|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
125507311|NCT01020487|451487173|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
125507312|NCT01020487|451487171|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
125507313|NCT01020487|451487172|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
125507314|NCT01020487|451487173|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
125507315|NCT01020487|451487171|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
125305488|NCT02218008|450745139|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
125507316|NCT01020487|451487172|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
125507317|NCT01020487|451487173|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
125507318|NCT01020487|451487171|FG000|Part 2 Open-label Period|Adverse Event|0|||
125507319|NCT01020487|451487172|FG001|Part 2 Open-label Period|Adverse Event|4|||
125507320|NCT01020487|451487173|FG002|Part 2 Open-label Period|Adverse Event|1|||
125507321|NCT04049578|451487174|FG000|Overall Study|Physician Decision|1|||
125507322|NCT02400749|451487175|FG000|Week 0 -16|Withdrawal by Subject|5|||
125507323|NCT02400749|451487176|FG001|Week 0 -16|Withdrawal by Subject|5|||
125507324|NCT02400749|451487175|FG000|Week 0 -16|Adverse Event|3|||
125507325|NCT02400749|451487176|FG001|Week 0 -16|Adverse Event|1|||
125507326|NCT02400749|451487175|FG000|Week 0 -16|Lost to Follow-up|2|||
125507327|NCT02400749|451487176|FG001|Week 0 -16|Lost to Follow-up|0|||
125507328|NCT02400749|451487175|FG000|Week 0 -16|Protocol Violation|1|||
125507329|NCT02400749|451487176|FG001|Week 0 -16|Protocol Violation|0|||
125507330|NCT02400749|451487175|FG000|Week 17 - 32|Withdrawal by Subject|3|||
125507331|NCT02400749|451487176|FG001|Week 17 - 32|Withdrawal by Subject|2|||
125507332|NCT02400749|451487175|FG000|Week 17 - 32|Adverse Event|2|||
125507333|NCT02400749|451487176|FG001|Week 17 - 32|Adverse Event|1|||
125507334|NCT00307489|451487179|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
125507335|NCT00307489|451487180|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
125507336|NCT00307489|451487179|FG000|Baseline Through Week 48|Physician Decision|1|||
125507337|NCT00307489|451487180|FG001|Baseline Through Week 48|Physician Decision|0|||
125507338|NCT00307489|451487179|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
125507339|NCT00307489|451487180|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
125507340|NCT00307489|451487179|FG000|Week 48 Through Week 168|Adverse Event|1|||
125507341|NCT00307489|451487180|FG001|Week 48 Through Week 168|Adverse Event|0|||
125507342|NCT00307489|451487179|FG000|Week 48 Through Week 168|Physician Decision|1|||
125507343|NCT00307489|451487180|FG001|Week 48 Through Week 168|Physician Decision|0|||
125507344|NCT00307489|451487179|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
125507345|NCT00307489|451487180|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
125507346|NCT00307489|451487179|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
125507347|NCT00307489|451487180|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
125507348|NCT00307489|451487179|FG000|Week 48 Through Week 168|Death|0|||
125507349|NCT00307489|451487180|FG001|Week 48 Through Week 168|Death|1|||
125507350|NCT00307489|451487179|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
125507351|NCT00307489|451487180|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
125507352|NCT00307489|451487179|FG000|Week 48 Through Week 168|Seroconversion|1|||
125507353|NCT00307489|451487180|FG001|Week 48 Through Week 168|Seroconversion|0|||
125507354|NCT04425252|451487181|FG000|Overall Study|Withdrawal by Subject|2|||
125507355|NCT04425252|451487182|FG001|Overall Study|Withdrawal by Subject|1|||
125507356|NCT04425252|451487181|FG000|Overall Study|Lost to Follow-up|1|||
125507357|NCT04425252|451487182|FG001|Overall Study|Lost to Follow-up|0|||
125507358|NCT04425252|451487181|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
125507359|NCT04425252|451487182|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
125507360|NCT01945593|451487186|FG000|Overall Study|Adverse Event|0|||
125507361|NCT01945593|451487187|FG001|Overall Study|Adverse Event|0|||
125507362|NCT01945593|451487188|FG002|Overall Study|Adverse Event|0|||
125507363|NCT01945593|451487189|FG003|Overall Study|Adverse Event|5|||
125507364|NCT01945593|451487186|FG000|Overall Study|Physician Decision|0|||
125507365|NCT01945593|451487187|FG001|Overall Study|Physician Decision|0|||
125507366|NCT01945593|451487188|FG002|Overall Study|Physician Decision|1|||
125507367|NCT01945593|451487189|FG003|Overall Study|Physician Decision|1|||
125507368|NCT01945593|451487186|FG000|Overall Study|Withdrawal by Subject|0|||
125507369|NCT01945593|451487187|FG001|Overall Study|Withdrawal by Subject|2|||
125507370|NCT01945593|451487188|FG002|Overall Study|Withdrawal by Subject|0|||
125507371|NCT01945593|451487189|FG003|Overall Study|Withdrawal by Subject|4|||
125507372|NCT01945593|451487186|FG000|Overall Study|Protocol Violation|0|||
125507373|NCT01945593|451487187|FG001|Overall Study|Protocol Violation|2|||
125507374|NCT01945593|451487188|FG002|Overall Study|Protocol Violation|1|||
125507375|NCT01945593|451487189|FG003|Overall Study|Protocol Violation|3|||
125507376|NCT01945593|451487186|FG000|Overall Study|Death|0|||
125507377|NCT01945593|451487187|FG001|Overall Study|Death|0|||
125507378|NCT01945593|451487188|FG002|Overall Study|Death|1|||
125507379|NCT01945593|451487189|FG003|Overall Study|Death|0|||
125507380|NCT01945593|451487186|FG000|Overall Study|Other: Terminated|0|||
125507381|NCT01945593|451487187|FG001|Overall Study|Other: Terminated|0|||
125507382|NCT01945593|451487188|FG002|Overall Study|Other: Terminated|0|||
125507383|NCT01945593|451487189|FG003|Overall Study|Other: Terminated|1|||
125507384|NCT01945593|451487186|FG000|Overall Study|Other: Surgical Procedure|0|||
125507385|NCT01945593|451487187|FG001|Overall Study|Other: Surgical Procedure|2|||
125507386|NCT01945593|451487188|FG002|Overall Study|Other: Surgical Procedure|0|||
125507387|NCT01945593|451487189|FG003|Overall Study|Other: Surgical Procedure|6|||
125507388|NCT01945593|451487186|FG000|Overall Study|Other: Screen Failure|0|||
125507389|NCT01945593|451487187|FG001|Overall Study|Other: Screen Failure|2|||
125507390|NCT01945593|451487188|FG002|Overall Study|Other: Screen Failure|0|||
125507391|NCT01945593|451487189|FG003|Overall Study|Other: Screen Failure|0|||
125507392|NCT02446015|451487190|FG000|Overall Study|Adverse Event|0|||
125507393|NCT02446015|451487191|FG001|Overall Study|Adverse Event|1|||
125507394|NCT02446015|451487190|FG000|Overall Study|Withdrawal by Subject|1|||
125507395|NCT02446015|451487191|FG001|Overall Study|Withdrawal by Subject|0|||
125507396|NCT02964234|451487193|FG000|Overall Study|Lost to Follow-up|22|||
125507397|NCT02964234|451487194|FG001|Overall Study|Lost to Follow-up|13|||
125507398|NCT02163499|451487197|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
125507399|NCT02163499|451487197|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
125507400|NCT02163499|451487197|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
125507401|NCT02163499|451487197|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
125507402|NCT02163499|451487197|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
125507403|NCT02163499|451487197|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
125507404|NCT02163499|451487197|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
125507405|NCT02163499|451487197|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
125507406|NCT02163499|451487197|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
125507407|NCT02163499|451487197|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
125507408|NCT02163499|451487197|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
125507409|NCT02163499|451487197|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
125507410|NCT02163499|451487197|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
125507411|NCT02163499|451487197|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
125507412|NCT02163499|451487197|FG000|Extended Dosing Phase: ZS|Death|8|||
125507413|NCT02163499|451487197|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
125507414|NCT02163499|451487197|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
125507415|NCT02163499|451487197|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
125507416|NCT01540474|451487198|FG000|Vaccination Period|Lost to Follow-up|0|||
125507417|NCT01540474|451487199|FG001|Vaccination Period|Lost to Follow-up|1|||
125507418|NCT01540474|451487200|FG002|Vaccination Period|Lost to Follow-up|0|||
125507419|NCT01540474|451487201|FG003|Vaccination Period|Lost to Follow-up|0|||
125507420|NCT04454125|451487202|FG000|Overall Study|Lost to Follow-up|0|||
125507421|NCT04454125|451487203|FG001|Overall Study|Lost to Follow-up|1|||
125507422|NCT00857311|451487204|FG000|Overall Study|Lost to Follow-up|1|||
125507423|NCT00857311|451487205|FG001|Overall Study|Lost to Follow-up|0|||
125507424|NCT00857311|451487206|FG002|Overall Study|Lost to Follow-up|0|||
125507425|NCT00857311|451487207|FG003|Overall Study|Lost to Follow-up|0|||
125507426|NCT01587703|451487212|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
125507427|NCT01587703|451487213|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507428|NCT01587703|451487214|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507429|NCT01587703|451487215|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507430|NCT01587703|451487216|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507431|NCT01587703|451487217|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507432|NCT01587703|451487218|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507433|NCT01587703|451487219|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507434|NCT01587703|451487220|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507435|NCT01587703|451487221|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507436|NCT01587703|451487222|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507437|NCT01587703|451487223|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507438|NCT01587703|451487224|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507439|NCT01587703|451487225|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507440|NCT01587703|451487226|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507441|NCT01587703|451487227|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507442|NCT01587703|451487228|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507443|NCT01587703|451487229|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507444|NCT01587703|451487230|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
125507445|NCT01587703|451487212|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507446|NCT01587703|451487213|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507447|NCT01587703|451487214|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507448|NCT01587703|451487215|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507449|NCT01587703|451487216|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507450|NCT01587703|451487217|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
125507451|NCT01587703|451487218|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507452|NCT01587703|451487219|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
125507453|NCT01587703|451487220|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507454|NCT01587703|451487221|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507455|NCT01587703|451487222|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507456|NCT01587703|451487223|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507457|NCT01587703|451487224|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507458|NCT01587703|451487225|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507459|NCT01587703|451487226|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507460|NCT01587703|451487227|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507461|NCT01587703|451487228|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507462|NCT01587703|451487229|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507463|NCT01587703|451487230|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
125507464|NCT01587703|451487212|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507465|NCT01587703|451487213|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507466|NCT01587703|451487214|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507467|NCT01587703|451487215|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507468|NCT01587703|451487216|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507469|NCT01587703|451487217|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507470|NCT01587703|451487218|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
125507471|NCT01587703|451487219|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507472|NCT01587703|451487220|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507473|NCT01587703|451487221|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507474|NCT01587703|451487222|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507475|NCT01587703|451487223|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507476|NCT01587703|451487224|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507477|NCT01587703|451487225|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507478|NCT01587703|451487226|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507479|NCT01587703|451487227|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507480|NCT01587703|451487228|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507481|NCT01587703|451487229|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125305489|NCT02218008|450745140|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
125305490|NCT02218008|450745141|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
125305491|NCT02218008|450745142|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
125305492|NCT02218008|450745143|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
125305493|NCT02218008|450745144|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
125305494|NCT02218008|450745139|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
125305495|NCT02218008|450745140|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
125305496|NCT02218008|450745141|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
125507482|NCT01587703|451487230|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
125507483|NCT01587703|451487212|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
125507484|NCT01587703|451487213|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
125507485|NCT01587703|451487214|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
125507486|NCT01587703|451487215|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
125507487|NCT01587703|451487216|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
125507488|NCT01587703|451487217|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
125507489|NCT01587703|451487218|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
125507490|NCT01587703|451487219|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
125507491|NCT01587703|451487220|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
125507492|NCT01587703|451487221|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
125507493|NCT01587703|451487222|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
125507494|NCT01587703|451487223|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
125507495|NCT01587703|451487224|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
125507496|NCT01587703|451487225|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
125507497|NCT01587703|451487226|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
125507498|NCT01587703|451487227|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
125507499|NCT01587703|451487228|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
125507500|NCT01587703|451487229|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
125507501|NCT01587703|451487230|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
125507502|NCT01587703|451487212|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507503|NCT01587703|451487213|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507504|NCT01587703|451487214|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507505|NCT01587703|451487215|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507506|NCT01587703|451487216|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507507|NCT01587703|451487217|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507508|NCT01587703|451487218|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507509|NCT01587703|451487219|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507510|NCT01587703|451487220|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
125507511|NCT01587703|451487221|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
125507512|NCT01587703|451487222|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
125507513|NCT01587703|451487223|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507514|NCT01587703|451487224|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507515|NCT01587703|451487225|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507516|NCT01587703|451487226|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507517|NCT01587703|451487227|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507518|NCT01587703|451487228|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507519|NCT01587703|451487229|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507520|NCT01587703|451487230|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
125507521|NCT01587703|451487212|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507522|NCT01587703|451487213|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507523|NCT01587703|451487214|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125305497|NCT02218008|450745142|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
125305498|NCT02218008|450745143|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
125305499|NCT02218008|450745144|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
125507524|NCT01587703|451487215|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507525|NCT01587703|451487216|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507526|NCT01587703|451487217|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507527|NCT01587703|451487218|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507528|NCT01587703|451487219|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507529|NCT01587703|451487220|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
125507530|NCT01587703|451487221|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507531|NCT01587703|451487222|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
125507532|NCT01587703|451487223|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507533|NCT01587703|451487224|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507534|NCT01587703|451487225|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507535|NCT01587703|451487226|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507536|NCT01587703|451487227|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507537|NCT01587703|451487228|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507538|NCT01587703|451487229|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507539|NCT01587703|451487230|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
125507540|NCT01587703|451487212|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507541|NCT01587703|451487213|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507542|NCT01587703|451487214|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507543|NCT01587703|451487215|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507544|NCT01587703|451487216|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507545|NCT01587703|451487217|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507546|NCT01587703|451487218|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507547|NCT01587703|451487219|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507548|NCT01587703|451487220|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507549|NCT01587703|451487221|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
125507550|NCT01587703|451487222|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
125507551|NCT01587703|451487223|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507552|NCT01587703|451487224|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507553|NCT01587703|451487225|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507554|NCT01587703|451487226|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507555|NCT01587703|451487227|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507556|NCT01587703|451487228|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507557|NCT01587703|451487229|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507558|NCT01587703|451487230|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
125507559|NCT01587703|451487212|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507560|NCT01587703|451487213|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507561|NCT01587703|451487214|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507562|NCT01587703|451487215|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507563|NCT01587703|451487216|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507564|NCT01587703|451487217|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507565|NCT01587703|451487218|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507566|NCT01587703|451487219|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507567|NCT01587703|451487220|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
125507568|NCT01587703|451487221|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507569|NCT01587703|451487222|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507570|NCT01587703|451487223|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507571|NCT01587703|451487224|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507572|NCT01587703|451487225|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507573|NCT01587703|451487226|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507574|NCT01587703|451487227|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507575|NCT01587703|451487228|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507576|NCT01587703|451487229|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507577|NCT01587703|451487230|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
125507578|NCT01587703|451487212|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507579|NCT01587703|451487213|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507580|NCT01587703|451487214|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507581|NCT01587703|451487215|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507582|NCT01587703|451487216|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507583|NCT01587703|451487217|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507584|NCT01587703|451487218|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507585|NCT01587703|451487219|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507586|NCT01587703|451487220|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507587|NCT01587703|451487221|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507588|NCT01587703|451487222|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507589|NCT01587703|451487223|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507590|NCT01587703|451487224|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507591|NCT01587703|451487225|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507592|NCT01587703|451487226|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507593|NCT01587703|451487227|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507594|NCT01587703|451487228|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507595|NCT01587703|451487229|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
125507596|NCT01587703|451487230|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
125507597|NCT01587703|451487212|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507598|NCT01587703|451487213|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507599|NCT01587703|451487214|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507600|NCT01587703|451487215|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507601|NCT01587703|451487216|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507602|NCT01587703|451487217|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507603|NCT01587703|451487218|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507604|NCT01587703|451487219|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507605|NCT01587703|451487220|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507606|NCT01587703|451487221|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507607|NCT01587703|451487222|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507608|NCT01587703|451487223|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507609|NCT01587703|451487224|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507610|NCT01587703|451487225|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507611|NCT01587703|451487226|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507612|NCT01587703|451487227|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507613|NCT01587703|451487228|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
125507614|NCT01587703|451487229|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
125507615|NCT01587703|451487230|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
125507616|NCT01587703|451487212|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507617|NCT01587703|451487213|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507618|NCT01587703|451487214|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507619|NCT01587703|451487215|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507620|NCT01587703|451487216|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507621|NCT01587703|451487217|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507622|NCT01587703|451487218|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507623|NCT01587703|451487219|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507624|NCT01587703|451487220|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507625|NCT01587703|451487221|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507626|NCT01587703|451487222|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507627|NCT01587703|451487223|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507628|NCT01587703|451487224|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507629|NCT01587703|451487225|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507630|NCT01587703|451487226|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507631|NCT01587703|451487227|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
125507632|NCT01587703|451487228|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507633|NCT01587703|451487229|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507634|NCT01587703|451487230|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
125507635|NCT01587703|451487212|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507636|NCT01587703|451487213|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507637|NCT01587703|451487214|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507638|NCT01587703|451487215|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507639|NCT01587703|451487216|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507640|NCT01587703|451487217|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507641|NCT01587703|451487218|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507642|NCT01587703|451487219|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507643|NCT01587703|451487220|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507644|NCT01587703|451487221|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507645|NCT01587703|451487222|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507646|NCT01587703|451487223|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
125507647|NCT01587703|451487224|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507648|NCT01587703|451487225|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507649|NCT01587703|451487226|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
125507650|NCT01587703|451487227|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507651|NCT01587703|451487228|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507652|NCT01587703|451487229|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507653|NCT01587703|451487230|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
125507654|NCT01587703|451487212|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125507655|NCT01587703|451487213|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125507656|NCT01587703|451487214|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125507657|NCT01587703|451487215|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125507658|NCT01587703|451487216|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125507659|NCT01587703|451487217|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125507660|NCT01587703|451487218|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125507661|NCT01587703|451487219|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125507662|NCT01587703|451487220|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125507663|NCT01587703|451487221|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125507664|NCT01587703|451487222|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125507665|NCT01587703|451487223|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
125507666|NCT01587703|451487224|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
125507667|NCT01587703|451487225|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
125507668|NCT01587703|451487226|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
125507669|NCT01587703|451487227|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
125507670|NCT01587703|451487228|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
125507671|NCT01587703|451487229|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125507672|NCT01587703|451487230|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
125507673|NCT01587703|451487212|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
125507674|NCT01587703|451487213|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
125507675|NCT01587703|451487214|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
125507676|NCT01587703|451487215|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
125507677|NCT01587703|451487216|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
125507678|NCT01587703|451487217|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
125507679|NCT01587703|451487218|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
125507680|NCT01587703|451487219|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
125507681|NCT01587703|451487220|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
125507682|NCT01587703|451487221|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
125507683|NCT01587703|451487222|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
125507684|NCT01587703|451487223|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
125507685|NCT01587703|451487224|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
125507686|NCT01587703|451487225|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
125507687|NCT01587703|451487226|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
125507688|NCT01587703|451487227|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
125507689|NCT01587703|451487228|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
125507690|NCT01587703|451487229|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
125507691|NCT01587703|451487230|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
125507692|NCT01587703|451487212|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507693|NCT01587703|451487213|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507694|NCT01587703|451487214|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507695|NCT01587703|451487215|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507696|NCT01587703|451487216|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507697|NCT01587703|451487217|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507698|NCT01587703|451487218|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507699|NCT01587703|451487219|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507700|NCT01587703|451487220|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507701|NCT01587703|451487221|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507702|NCT01587703|451487222|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507703|NCT01587703|451487223|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
125507704|NCT01587703|451487224|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507705|NCT01587703|451487225|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507706|NCT01587703|451487226|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507707|NCT01587703|451487227|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507708|NCT01587703|451487228|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507709|NCT01587703|451487229|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507710|NCT01587703|451487230|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
125507711|NCT00828139|451487231|FG000|Overall Study|Adverse Event|8|||
125507712|NCT00828139|451487232|FG001|Overall Study|Adverse Event|1|||
125507713|NCT00828139|451487233|FG002|Overall Study|Adverse Event|10|||
125507714|NCT00828139|451487234|FG003|Overall Study|Adverse Event|5|||
125507715|NCT00828139|451487231|FG000|Overall Study|Death|2|||
125507716|NCT00828139|451487232|FG001|Overall Study|Death|1|||
125507717|NCT00828139|451487233|FG002|Overall Study|Death|0|||
125507718|NCT00828139|451487234|FG003|Overall Study|Death|2|||
125507719|NCT00828139|451487231|FG000|Overall Study|Refusal unrelated to toxicity|3|||
125507720|NCT00828139|451487232|FG001|Overall Study|Refusal unrelated to toxicity|4|||
125507721|NCT00828139|451487233|FG002|Overall Study|Refusal unrelated to toxicity|5|||
125507722|NCT00828139|451487234|FG003|Overall Study|Refusal unrelated to toxicity|3|||
125507723|NCT00828139|451487231|FG000|Overall Study|Disease Progression|24|||
125507724|NCT00828139|451487232|FG001|Overall Study|Disease Progression|33|||
125507725|NCT00828139|451487233|FG002|Overall Study|Disease Progression|35|||
125507726|NCT00828139|451487234|FG003|Overall Study|Disease Progression|39|||
125507727|NCT00828139|451487231|FG000|Overall Study|Other|4|||
125507728|NCT00828139|451487232|FG001|Overall Study|Other|2|||
125507729|NCT00828139|451487233|FG002|Overall Study|Other|5|||
125507730|NCT00828139|451487234|FG003|Overall Study|Other|2|||
125507731|NCT01714947|451487235|FG000|Part B|Progressive Disease|3|||
125507732|NCT01922102|451487236|FG000|Overall Study|Withdrawal by Subject|7|||
125507733|NCT01922102|451487237|FG001|Overall Study|Withdrawal by Subject|3|||
125507734|NCT01922102|451487238|FG002|Overall Study|Withdrawal by Subject|7|||
125507735|NCT01922102|451487236|FG000|Overall Study|Physician Decision|0|||
125507736|NCT01922102|451487237|FG001|Overall Study|Physician Decision|2|||
125507737|NCT01922102|451487238|FG002|Overall Study|Physician Decision|1|||
125507738|NCT01922102|451487236|FG000|Overall Study|Adverse Event|1|||
125507739|NCT01922102|451487237|FG001|Overall Study|Adverse Event|2|||
125507740|NCT01922102|451487238|FG002|Overall Study|Adverse Event|0|||
125507741|NCT01922102|451487236|FG000|Overall Study|Lost to Follow-up|1|||
125507742|NCT01922102|451487237|FG001|Overall Study|Lost to Follow-up|0|||
125507743|NCT01922102|451487238|FG002|Overall Study|Lost to Follow-up|0|||
125507744|NCT01922102|451487236|FG000|Overall Study|Administrative problems|0|||
125507745|NCT01922102|451487237|FG001|Overall Study|Administrative problems|2|||
125507746|NCT01922102|451487238|FG002|Overall Study|Administrative problems|0|||
125507747|NCT01799993|451487242|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
125507748|NCT01799993|451487243|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
125507749|NCT01799993|451487242|FG000|Overall Study|Death|61|||
125507750|NCT01799993|451487243|FG001|Overall Study|Death|45|||
125507751|NCT01799993|451487242|FG000|Overall Study|Withdrawal by Subject|23|||
125507752|NCT01799993|451487243|FG001|Overall Study|Withdrawal by Subject|24|||
125507753|NCT01799993|451487242|FG000|Overall Study|Lost to Follow-up|5|||
125507754|NCT01799993|451487243|FG001|Overall Study|Lost to Follow-up|8|||
125507755|NCT01799993|451487242|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
125507756|NCT01799993|451487243|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
125507757|NCT01799993|451487242|FG000|Overall Study|Protocol driven decision point|0|||
125507758|NCT01799993|451487243|FG001|Overall Study|Protocol driven decision point|3|||
125507759|NCT01799993|451487242|FG000|Overall Study|Protocol Violation|1|||
125507760|NCT01799993|451487243|FG001|Overall Study|Protocol Violation|1|||
125507761|NCT01799993|451487242|FG000|Overall Study|Deterioration of general conditions|2|||
125507762|NCT01799993|451487243|FG001|Overall Study|Deterioration of general conditions|0|||
125507763|NCT01799993|451487242|FG000|Overall Study|Screen failure|0|||
125507764|NCT01799993|451487243|FG001|Overall Study|Screen failure|1|||
125507765|NCT01799993|451487242|FG000|Overall Study|Adverse Event|1|||
125507766|NCT01799993|451487243|FG001|Overall Study|Adverse Event|0|||
125507767|NCT01799993|451487242|FG000|Overall Study|Lack of Efficacy|1|||
125507768|NCT01799993|451487243|FG001|Overall Study|Lack of Efficacy|0|||
125507769|NCT01799993|451487242|FG000|Overall Study|Recovery|0|||
125507770|NCT01799993|451487243|FG001|Overall Study|Recovery|1|||
125507771|NCT01799993|451487242|FG000|Overall Study|Logistical difficulties|1|||
125507772|NCT01799993|451487243|FG001|Overall Study|Logistical difficulties|0|||
125507773|NCT01799993|451487242|FG000|Overall Study|Protocol deviation|1|||
125507774|NCT01799993|451487243|FG001|Overall Study|Protocol deviation|0|||
125507775|NCT01799993|451487242|FG000|Overall Study|Non-compliance with medical device|1|||
125507776|NCT01799993|451487243|FG001|Overall Study|Non-compliance with medical device|0|||
125507777|NCT01799993|451487242|FG000|Overall Study|Withdrawal by parent/guardian|0|||
125507778|NCT01799993|451487243|FG001|Overall Study|Withdrawal by parent/guardian|1|||
125507779|NCT01799993|451487242|FG000|Overall Study|Other|1|||
125507780|NCT01799993|451487243|FG001|Overall Study|Other|0|||
125507781|NCT01799993|451487242|FG000|Overall Study|Subject didn't return for follow-up|0|||
125507782|NCT01799993|451487243|FG001|Overall Study|Subject didn't return for follow-up|1|||
125507783|NCT04271254|451487244|FG000|Overall Study|Withdrawal by Subject|3|||
125507784|NCT04410445|451487245|FG000|Overall Study|Lost to Follow-up|3|||
125507785|NCT04410445|451487246|FG001|Overall Study|Lost to Follow-up|9|||
125507786|NCT04410445|451487245|FG000|Overall Study|Withdrawal by Subject|27|||
125507787|NCT04410445|451487246|FG001|Overall Study|Withdrawal by Subject|15|||
125507788|NCT01123356|451487247|FG000|Overall Study|Adverse Event|2|||
125507789|NCT01123356|451487247|FG000|Overall Study|Lack of Efficacy|4|||
125507790|NCT01123356|451487247|FG000|Overall Study|Withdrawal by Subject|1|||
125507791|NCT03262389|451487250|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
125507792|NCT03262389|451487250|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
125507793|NCT03262389|451487250|FG000|Overall Study|opted out of PET/MR|1|||
125507794|NCT01052272|451487251|FG000|Overall Study|Death|0|||
125507795|NCT01052272|451487252|FG001|Overall Study|Death|0|||
125507796|NCT01052272|451487253|FG002|Overall Study|Death|1|||
125507797|NCT01052272|451487254|FG003|Overall Study|Death|1|||
125507798|NCT01052272|451487251|FG000|Overall Study|Physician Decision|0|||
125507799|NCT01052272|451487252|FG001|Overall Study|Physician Decision|1|||
125507800|NCT01052272|451487253|FG002|Overall Study|Physician Decision|0|||
125507801|NCT01052272|451487254|FG003|Overall Study|Physician Decision|0|||
125507802|NCT01052272|451487251|FG000|Overall Study|patient refuses follow-up|5|||
125507803|NCT01052272|451487252|FG001|Overall Study|patient refuses follow-up|4|||
125507804|NCT01052272|451487253|FG002|Overall Study|patient refuses follow-up|2|||
125507805|NCT01052272|451487254|FG003|Overall Study|patient refuses follow-up|4|||
125507806|NCT01052272|451487251|FG000|Overall Study|Withdrawal by Subject|0|||
125507807|NCT01052272|451487252|FG001|Overall Study|Withdrawal by Subject|2|||
125507808|NCT01052272|451487253|FG002|Overall Study|Withdrawal by Subject|3|||
125507809|NCT01052272|451487254|FG003|Overall Study|Withdrawal by Subject|2|||
125507810|NCT01052272|451487251|FG000|Overall Study|placed in long-term care|0|||
125507811|NCT01052272|451487252|FG001|Overall Study|placed in long-term care|0|||
125507812|NCT01052272|451487253|FG002|Overall Study|placed in long-term care|1|||
125507813|NCT01052272|451487254|FG003|Overall Study|placed in long-term care|0|||
125507814|NCT01052272|451487251|FG000|Overall Study|decline in health|0|||
125507815|NCT01052272|451487252|FG001|Overall Study|decline in health|0|||
125507816|NCT01052272|451487253|FG002|Overall Study|decline in health|1|||
125507817|NCT01052272|451487254|FG003|Overall Study|decline in health|0|||
125507818|NCT01077284|451487256|FG000|Overall Study|Adverse Event|2|||
125507819|NCT01077284|451487257|FG001|Overall Study|Adverse Event|0|||
125507820|NCT01077284|451487258|FG002|Overall Study|Adverse Event|1|||
125507821|NCT01077284|451487256|FG000|Overall Study|Lost to Follow-up|1|||
125507822|NCT01077284|451487257|FG001|Overall Study|Lost to Follow-up|2|||
125507823|NCT01077284|451487258|FG002|Overall Study|Lost to Follow-up|0|||
125507824|NCT01077284|451487256|FG000|Overall Study|Withdrawal by Subject|2|||
125507825|NCT01077284|451487257|FG001|Overall Study|Withdrawal by Subject|3|||
125507826|NCT01077284|451487258|FG002|Overall Study|Withdrawal by Subject|1|||
125507827|NCT01077284|451487256|FG000|Overall Study|Other|0|||
125507828|NCT01077284|451487257|FG001|Overall Study|Other|0|||
125507829|NCT01077284|451487258|FG002|Overall Study|Other|1|||
125507830|NCT01180400|451487259|FG000|Overall Study|Withdrawal by Subject|5|||
125507831|NCT01180400|451487260|FG001|Overall Study|Withdrawal by Subject|6|||
125507832|NCT01180400|451487259|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
125507833|NCT01180400|451487260|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
125507834|NCT01180400|451487259|FG000|Overall Study|Adverse Event|12|||
125507835|NCT01180400|451487260|FG001|Overall Study|Adverse Event|10|||
125507836|NCT01180400|451487259|FG000|Overall Study|Severe non-compliance to protocol|1|||
125507837|NCT01180400|451487260|FG001|Overall Study|Severe non-compliance to protocol|2|||
125507838|NCT01180400|451487259|FG000|Overall Study|Condition under investigation worsened|2|||
125507839|NCT01180400|451487260|FG001|Overall Study|Condition under investigation worsened|1|||
125507840|NCT01180400|451487259|FG000|Overall Study|Lack of Efficacy|2|||
125507841|NCT01180400|451487260|FG001|Overall Study|Lack of Efficacy|0|||
125507842|NCT01180400|451487259|FG000|Overall Study|Study-specific withdrawal criteria|1|||
125507843|NCT01180400|451487260|FG001|Overall Study|Study-specific withdrawal criteria|2|||
125507844|NCT01180400|451487259|FG000|Overall Study|Lost to Follow-up|2|||
125507845|NCT01180400|451487260|FG001|Overall Study|Lost to Follow-up|3|||
125507846|NCT01180400|451487259|FG000|Overall Study|Other|0|||
125507847|NCT01180400|451487260|FG001|Overall Study|Other|1|||
125507848|NCT00096278|451487262|FG000|Overall Study|No follow-up data|15|||
125507849|NCT00096278|451487263|FG001|Overall Study|No follow-up data|18|||
125507850|NCT00096278|451487262|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
125507851|NCT00096278|451487263|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
125507852|NCT02877680|451487272|FG000|Overall Study|Lost to Follow-up|1|||
125507853|NCT02877680|451487273|FG001|Overall Study|Lost to Follow-up|1|||
125507854|NCT01133678|451487274|FG000|Overall Study|Death|1|||
125507855|NCT01133678|451487275|FG001|Overall Study|Death|1|||
125507856|NCT05104242|451487276|FG000|Overall Study|Withdrawal by Subject|1|||
125507857|NCT05104242|451487277|FG001|Overall Study|Withdrawal by Subject|5|||
125507858|NCT05104242|451487276|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
125507859|NCT05104242|451487277|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
125507860|NCT00424476|451487279|FG000|Overall Study|Withdrawal by Subject|7|||
125507861|NCT00424476|451487280|FG001|Overall Study|Withdrawal by Subject|6|||
125507862|NCT00424476|451487281|FG002|Overall Study|Withdrawal by Subject|3|||
125507863|NCT00424476|451487279|FG000|Overall Study|Adverse Event|19|||
125507864|NCT00424476|451487280|FG001|Overall Study|Adverse Event|16|||
125507865|NCT00424476|451487281|FG002|Overall Study|Adverse Event|15|||
125507866|NCT00424476|451487279|FG000|Overall Study|Lack of Efficacy|16|||
125507867|NCT00424476|451487280|FG001|Overall Study|Lack of Efficacy|12|||
125507868|NCT00424476|451487281|FG002|Overall Study|Lack of Efficacy|12|||
125507869|NCT00424476|451487279|FG000|Overall Study|Lack of Compliance|1|||
125507870|NCT00424476|451487280|FG001|Overall Study|Lack of Compliance|1|||
125507871|NCT00424476|451487281|FG002|Overall Study|Lack of Compliance|1|||
125507872|NCT00424476|451487279|FG000|Overall Study|Lost to Follow-up|4|||
125507873|NCT00424476|451487280|FG001|Overall Study|Lost to Follow-up|6|||
125507874|NCT00424476|451487281|FG002|Overall Study|Lost to Follow-up|3|||
125507875|NCT00424476|451487279|FG000|Overall Study|Protocol Violation|7|||
125507876|NCT00424476|451487280|FG001|Overall Study|Protocol Violation|2|||
125507877|NCT00424476|451487281|FG002|Overall Study|Protocol Violation|3|||
125507878|NCT00424476|451487279|FG000|Overall Study|Physician Decision|3|||
125507879|NCT00424476|451487280|FG001|Overall Study|Physician Decision|2|||
125507880|NCT00424476|451487281|FG002|Overall Study|Physician Decision|3|||
125507881|NCT00424476|451487279|FG000|Overall Study|Other|4|||
125507882|NCT00424476|451487280|FG001|Overall Study|Other|3|||
125507883|NCT00424476|451487281|FG002|Overall Study|Other|9|||
125507884|NCT02574286|451487282|FG000|Overall Study|Adverse Event|3|||
125507885|NCT02574286|451487282|FG000|Overall Study|Withdrawal by Subject|2|||
125507886|NCT01280656|451487283|FG000|Overall Study|Adverse Event|1|||
125507887|NCT01280656|451487284|FG001|Overall Study|Adverse Event|14|||
125507888|NCT01280656|451487285|FG002|Overall Study|Adverse Event|13|||
125507889|NCT01280656|451487283|FG000|Overall Study|Lack of Efficacy|1|||
125507890|NCT01280656|451487284|FG001|Overall Study|Lack of Efficacy|22|||
125507891|NCT01280656|451487285|FG002|Overall Study|Lack of Efficacy|38|||
125507892|NCT01280656|451487283|FG000|Overall Study|Treatment shortening (RGT)|0|||
125507893|NCT01280656|451487284|FG001|Overall Study|Treatment shortening (RGT)|4|||
125507894|NCT01280656|451487285|FG002|Overall Study|Treatment shortening (RGT)|5|||
125507895|NCT01280656|451487283|FG000|Overall Study|Other|1|||
125507896|NCT01280656|451487284|FG001|Overall Study|Other|7|||
125507897|NCT01280656|451487285|FG002|Overall Study|Other|7|||
125507898|NCT02138838|451487286|FG000|Overall Study|Study Closure|7|||
125507899|NCT02138838|451487287|FG001|Overall Study|Study Closure|6|||
125507900|NCT02138838|451487286|FG000|Overall Study|Withdrawal by Subject|1|||
125507901|NCT02138838|451487287|FG001|Overall Study|Withdrawal by Subject|5|||
125507902|NCT02993926|451487290|FG000|Enantone Treatment Phase|Adverse Event|1|||
125507903|NCT02993926|451487291|FG001|Enantone Treatment Phase|Adverse Event|0|||
125507904|NCT02993926|451487292|FG002|Enantone Treatment Phase|Adverse Event|0|||
125507905|NCT02993926|451487290|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
125507906|NCT02993926|451487291|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
125507907|NCT02993926|451487292|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
125507908|NCT02993926|451487290|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
125507909|NCT02993926|451487291|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
125507910|NCT02993926|451487292|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
125507911|NCT02993926|451487290|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
125507912|NCT02993926|451487291|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
125507913|NCT02993926|451487292|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
125507914|NCT01084772|451487294|FG000|Baseline|Withdrawal by Subject|7|||
125507915|NCT01084772|451487295|FG001|Baseline|Withdrawal by Subject|6|||
125507916|NCT01084772|451487294|FG000|3 Months|Death|1|||
125507917|NCT01084772|451487295|FG001|3 Months|Death|0|||
125507918|NCT01084772|451487294|FG000|3 Months|Study Termination|2|||
125507919|NCT01084772|451487295|FG001|3 Months|Study Termination|2|||
125507920|NCT01084772|451487294|FG000|1 Year|Withdrawal by Subject|0|||
125507921|NCT01084772|451487295|FG001|1 Year|Withdrawal by Subject|1|||
125507922|NCT01084772|451487294|FG000|1 Year|Lost to Follow-up|3|||
125507923|NCT01084772|451487295|FG001|1 Year|Lost to Follow-up|0|||
125507924|NCT01084772|451487294|FG000|1 Year|Study Termination|0|||
125507925|NCT01084772|451487295|FG001|1 Year|Study Termination|7|||
125507926|NCT01084772|451487294|FG000|2 Years|Withdrawal by Subject|1|||
125507927|NCT01084772|451487295|FG001|2 Years|Withdrawal by Subject|0|||
125507928|NCT01084772|451487294|FG000|2 Years|Lost to Follow-up|5|||
125507929|NCT01084772|451487295|FG001|2 Years|Lost to Follow-up|2|||
125507930|NCT01084772|451487294|FG000|2 Years|Study Termination|3|||
125507931|NCT01084772|451487295|FG001|2 Years|Study Termination|2|||
125507932|NCT01867307|451487296|FG000|Overall Study|Protocol Violation|2|||
125507933|NCT01867307|451487297|FG001|Overall Study|Protocol Violation|0|||
125507934|NCT01867307|451487296|FG000|Overall Study|Other Adverse Event|1|||
125507935|NCT01867307|451487297|FG001|Overall Study|Other Adverse Event|3|||
125507936|NCT00518206|451487298|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
125507937|NCT00518206|451487299|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
125507938|NCT00518206|451487298|FG000|Overall Study|Withdrawal by Subject|2|||
125507939|NCT00518206|451487299|FG001|Overall Study|Withdrawal by Subject|0|||
125507940|NCT00518206|451487298|FG000|Overall Study|Drug Supply Issue|1|||
125507941|NCT00518206|451487299|FG001|Overall Study|Drug Supply Issue|0|||
125507942|NCT00518206|451487298|FG000|Overall Study|Reason Unknown|1|||
125507943|NCT00518206|451487299|FG001|Overall Study|Reason Unknown|0|||
125507944|NCT00518206|451487298|FG000|Overall Study|Completion Status Unknown|1|||
125507945|NCT00518206|451487299|FG001|Overall Study|Completion Status Unknown|0|||
125507946|NCT01199302|451487302|FG000|Overall Study|Adverse Event|1|||
125507947|NCT01199302|451487303|FG001|Overall Study|Adverse Event|1|||
125507948|NCT01199302|451487304|FG002|Overall Study|Adverse Event|2|||
125507949|NCT01199302|451487305|FG003|Overall Study|Adverse Event|0|||
125507950|NCT01199302|451487302|FG000|Overall Study|Withdrawal by Subject|2|||
125507951|NCT01199302|451487303|FG001|Overall Study|Withdrawal by Subject|2|||
125507952|NCT01199302|451487304|FG002|Overall Study|Withdrawal by Subject|3|||
125507953|NCT01199302|451487305|FG003|Overall Study|Withdrawal by Subject|0|||
125507954|NCT01199302|451487302|FG000|Overall Study|Disease Progression|3|||
125507955|NCT01199302|451487303|FG001|Overall Study|Disease Progression|4|||
125507956|NCT01199302|451487304|FG002|Overall Study|Disease Progression|4|||
125507957|NCT01199302|451487305|FG003|Overall Study|Disease Progression|2|||
125507958|NCT01199302|451487302|FG000|Overall Study|Study Termination|13|||
125507959|NCT01199302|451487303|FG001|Overall Study|Study Termination|8|||
125507960|NCT01199302|451487304|FG002|Overall Study|Study Termination|11|||
125507961|NCT01199302|451487305|FG003|Overall Study|Study Termination|9|||
125507962|NCT01199302|451487302|FG000|Overall Study|Lost to Follow-up|0|||
125507963|NCT01199302|451487303|FG001|Overall Study|Lost to Follow-up|1|||
125507964|NCT01199302|451487304|FG002|Overall Study|Lost to Follow-up|0|||
125507965|NCT01199302|451487305|FG003|Overall Study|Lost to Follow-up|0|||
125507966|NCT01199302|451487302|FG000|Overall Study|Other|1|||
125507967|NCT01199302|451487303|FG001|Overall Study|Other|0|||
125507968|NCT01199302|451487304|FG002|Overall Study|Other|0|||
125507969|NCT01199302|451487305|FG003|Overall Study|Other|0|||
125507970|NCT03820024|451487308|FG000|Overall Study|Physician Decision|1|||
125507971|NCT03820024|451487309|FG001|Overall Study|Physician Decision|2|||
125507972|NCT00608959|451489072|FG000|Part 1|Did not meet eligibility criteria|1|||
125507973|NCT01005602|451489075|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
125507974|NCT01005602|451489076|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
125507975|NCT01248715|451489077|FG000|Overall Study|Not influenza positive|501|||
125507976|NCT01248715|451489078|FG001|Overall Study|Not influenza positive|510|||
125507977|NCT03409276|451489084|FG000|Overall Study|Withdrawal by Subject|0|||
125507978|NCT03409276|451489085|FG001|Overall Study|Withdrawal by Subject|0|||
125507979|NCT03409276|451489086|FG002|Overall Study|Withdrawal by Subject|0|||
125507980|NCT03409276|451489087|FG003|Overall Study|Withdrawal by Subject|0|||
125507981|NCT03409276|451489088|FG004|Overall Study|Withdrawal by Subject|1|||
125507982|NCT03409276|451489084|FG000|Overall Study|Lost to Follow-up|0|||
125507983|NCT03409276|451489085|FG001|Overall Study|Lost to Follow-up|0|||
125507984|NCT03409276|451489086|FG002|Overall Study|Lost to Follow-up|0|||
125507985|NCT03409276|451489087|FG003|Overall Study|Lost to Follow-up|2|||
125507986|NCT03409276|451489088|FG004|Overall Study|Lost to Follow-up|2|||
125507987|NCT03605745|451489089|FG000|Overall Study|Study was terminated for business reasons|47|||
125507988|NCT01279447|451489090|FG000|Overall Study|Lost to Follow-up|3|||
125507989|NCT01279447|451489091|FG001|Overall Study|Lost to Follow-up|1|||
125507990|NCT01215253|451489092|FG000|Overall Study|Withdrawal by Subject|57|||
125507991|NCT01215253|451489093|FG001|Overall Study|Withdrawal by Subject|35|||
125507992|NCT01215253|451489092|FG000|Overall Study|Physician Decision|9|||
125507993|NCT01215253|451489093|FG001|Overall Study|Physician Decision|12|||
125507994|NCT01215253|451489092|FG000|Overall Study|Lost to Follow-up|6|||
125507995|NCT01215253|451489093|FG001|Overall Study|Lost to Follow-up|4|||
125507996|NCT01215253|451489092|FG000|Overall Study|Other|14|||
125507997|NCT01215253|451489093|FG001|Overall Study|Other|12|||
125507998|NCT01320683|451489094|FG000|Overall Study|Positive antibody response|1|||
125507999|NCT00759681|451489095|FG000|Overall Study|Death|2|||
125508000|NCT00759681|451489096|FG001|Overall Study|Death|5|||
125508001|NCT00759681|451489095|FG000|Overall Study|Lost to Follow-up|8|||
125508002|NCT00759681|451489096|FG001|Overall Study|Lost to Follow-up|5|||
125508003|NCT00476151|451489097|FG000|Overall Study|Adverse Event|0|||
125508004|NCT00476151|451489098|FG001|Overall Study|Adverse Event|2|||
125508005|NCT00476151|451489097|FG000|Overall Study|Protocol Violation|1|||
125508006|NCT00476151|451489098|FG001|Overall Study|Protocol Violation|3|||
125508007|NCT00476151|451489097|FG000|Overall Study|Withdrawal by Subject|2|||
125508008|NCT00476151|451489098|FG001|Overall Study|Withdrawal by Subject|0|||
125508009|NCT00476151|451489097|FG000|Overall Study|Physician Decision|0|||
125508010|NCT00476151|451489098|FG001|Overall Study|Physician Decision|2|||
125508011|NCT01129011|451489106|FG000|Overall Study|Adverse Event|20|||
125508012|NCT01129011|451489107|FG001|Overall Study|Adverse Event|30|||
125508013|NCT01129011|451489106|FG000|Overall Study|Withdrawal by Subject|24|||
125508014|NCT01129011|451489107|FG001|Overall Study|Withdrawal by Subject|8|||
125508015|NCT01129011|451489106|FG000|Overall Study|Lost to Follow-up|6|||
125508016|NCT01129011|451489107|FG001|Overall Study|Lost to Follow-up|7|||
125508017|NCT01129011|451489106|FG000|Overall Study|Duodenal Ulcer|2|||
125508018|NCT01129011|451489107|FG001|Overall Study|Duodenal Ulcer|8|||
125508019|NCT01129011|451489106|FG000|Overall Study|misc|7|||
125508020|NCT01129011|451489107|FG001|Overall Study|misc|4|||
125508021|NCT02005484|451489108|FG000|Overall Study|Death|1|||
125508022|NCT02005484|451489108|FG000|Overall Study|Disease progression|1|||
125508023|NCT02005484|451489108|FG000|Overall Study|Changed to a Different Study|1|||
125508024|NCT02005484|451489108|FG000|Overall Study|Sponsor decision|1|||
125508025|NCT01767376|451489109|FG000|Overall Study|Lost to Follow-up|3|||
125508026|NCT01767376|451489110|FG001|Overall Study|Lost to Follow-up|2|||
125508027|NCT01767376|451489111|FG002|Overall Study|Lost to Follow-up|0|||
125508028|NCT01767376|451489109|FG000|Overall Study|Withdrawal by Subject|1|||
125508029|NCT01767376|451489110|FG001|Overall Study|Withdrawal by Subject|1|||
125508030|NCT01767376|451489111|FG002|Overall Study|Withdrawal by Subject|0|||
125508031|NCT01113541|451489115|FG000|Overall Study|Withdrawal by Subject|1|||
125508032|NCT01113541|451489115|FG000|Overall Study|Protocol Violation|1|||
125508033|NCT01113541|451489115|FG000|Overall Study|Study Terminated by Sponsor|7|||
125508034|NCT01113541|451489115|FG000|Overall Study|Adverse Event|4|||
125508035|NCT03745651|451489116|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
125508036|NCT03745651|451489117|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
125508037|NCT03745651|451489118|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125508038|NCT03745651|451489119|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125508039|NCT03745651|451489120|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125508040|NCT03745651|451489121|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125508041|NCT03745651|451489122|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
125508042|NCT03745651|451489116|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
125508043|NCT03745651|451489117|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
125508044|NCT03745651|451489118|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
125508045|NCT03745651|451489119|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125508046|NCT03745651|451489120|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125508047|NCT03745651|451489121|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125508048|NCT03745651|451489122|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
125508049|NCT03745651|451489116|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
125508050|NCT03745651|451489117|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125508051|NCT03745651|451489118|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
125508052|NCT03745651|451489119|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125508053|NCT03745651|451489120|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125508054|NCT03745651|451489121|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125508055|NCT03745651|451489122|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
125508056|NCT03745651|451489116|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125508057|NCT03745651|451489117|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
125508058|NCT03745651|451489118|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125508059|NCT03745651|451489119|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125508060|NCT03745651|451489120|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125508061|NCT03745651|451489121|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125508062|NCT03745651|451489122|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
125508063|NCT03745651|451489116|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
125508064|NCT03745651|451489117|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
125508065|NCT03745651|451489118|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
125508066|NCT03745651|451489119|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125508067|NCT03745651|451489120|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125508068|NCT03745651|451489121|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125508069|NCT03745651|451489122|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
125508070|NCT03745651|451489116|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
125508071|NCT03745651|451489117|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
125508072|NCT03745651|451489118|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
125508073|NCT03745651|451489119|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
125508074|NCT03745651|451489120|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
125508075|NCT03745651|451489121|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
125508076|NCT03745651|451489122|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
125508077|NCT03745651|451489116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125508078|NCT03745651|451489117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125508079|NCT03745651|451489118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125508080|NCT03745651|451489119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125508081|NCT03745651|451489120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125508082|NCT03745651|451489121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
125508083|NCT03745651|451489122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
125508084|NCT03745651|451489116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125508085|NCT03745651|451489117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125508086|NCT03745651|451489118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125508087|NCT03745651|451489119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
125508088|NCT03745651|451489120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
125508089|NCT03745651|451489121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
125508090|NCT03745651|451489122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
125508091|NCT03745651|451489116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125508092|NCT03745651|451489117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125508093|NCT03745651|451489118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
125508094|NCT03745651|451489119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
125508095|NCT03745651|451489120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
125508096|NCT03745651|451489121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
125508097|NCT03745651|451489122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
125508098|NCT03745651|451489116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125508099|NCT03745651|451489117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125508100|NCT03745651|451489118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125508101|NCT03745651|451489119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
125508102|NCT03745651|451489120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
125508103|NCT03745651|451489121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
125508104|NCT03745651|451489122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
125508105|NCT03745651|451489116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
125508106|NCT03745651|451489117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
125508107|NCT03745651|451489118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
125508108|NCT03745651|451489119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
125508109|NCT03745651|451489120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
125508110|NCT03745651|451489121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
125508111|NCT03745651|451489122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
125508112|NCT03745651|451489116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125508113|NCT03745651|451489117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125508114|NCT03745651|451489118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125508115|NCT03745651|451489119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125508116|NCT03745651|451489120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125508117|NCT03745651|451489121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
125508118|NCT03745651|451489122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
125508119|NCT03745651|451489116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125508120|NCT03745651|451489117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125305500|NCT02218008|450745139|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
125305501|NCT02218008|450745140|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
125305502|NCT02218008|450745141|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
125305503|NCT02218008|450745142|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
125305504|NCT02218008|450745143|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
125305505|NCT02218008|450745144|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
125508121|NCT03745651|451489118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
125508122|NCT03745651|451489119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
125508123|NCT03745651|451489120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
125508124|NCT03745651|451489121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
125508125|NCT03745651|451489122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
125508126|NCT03745651|451489116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
125508127|NCT03745651|451489117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
125508128|NCT03745651|451489118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
125508129|NCT03745651|451489119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
125508130|NCT03745651|451489120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
125508131|NCT03745651|451489121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
125508132|NCT03745651|451489122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
125508133|NCT00946088|451489123|FG000|Overall Study|Withdrawal by Subject|0|||
125508134|NCT00946088|451489124|FG001|Overall Study|Withdrawal by Subject|1|||
125508135|NCT04883541|451489125|FG000|Overall Study|Not attending regular yoga class|16|||
125508136|NCT04883541|451489126|FG001|Overall Study|Not attending regular yoga class|0|||
125508137|NCT04883541|451489125|FG000|Overall Study|Not attending the pregnancy school|0|||
125508138|NCT04883541|451489126|FG001|Overall Study|Not attending the pregnancy school|9|||
125508139|NCT02309892|451489131|FG000|Overall Study|Physician Decision|1|||
125508140|NCT02309892|451489132|FG001|Overall Study|Physician Decision|0|||
125508141|NCT02309892|451489133|FG002|Overall Study|Physician Decision|0|||
125508142|NCT02309892|451489134|FG003|Overall Study|Physician Decision|0|||
125508143|NCT02309892|451489135|FG004|Overall Study|Physician Decision|0|||
125508144|NCT02309892|451489136|FG005|Overall Study|Physician Decision|0|||
125508145|NCT02309892|451489137|FG006|Overall Study|Physician Decision|0|||
125508146|NCT02309892|451489131|FG000|Overall Study|Adverse Event|1|||
125508147|NCT02309892|451489132|FG001|Overall Study|Adverse Event|0|||
125508148|NCT02309892|451489133|FG002|Overall Study|Adverse Event|1|||
125508149|NCT02309892|451489134|FG003|Overall Study|Adverse Event|0|||
125508150|NCT02309892|451489135|FG004|Overall Study|Adverse Event|0|||
125508151|NCT02309892|451489136|FG005|Overall Study|Adverse Event|0|||
125508152|NCT02309892|451489137|FG006|Overall Study|Adverse Event|0|||
125305506|NCT02218008|450745139|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
125508153|NCT02309892|451489131|FG000|Overall Study|Progressive Disease|0|||
125508154|NCT02309892|451489132|FG001|Overall Study|Progressive Disease|1|||
125508155|NCT02309892|451489133|FG002|Overall Study|Progressive Disease|0|||
125508156|NCT02309892|451489134|FG003|Overall Study|Progressive Disease|0|||
125508157|NCT02309892|451489135|FG004|Overall Study|Progressive Disease|1|||
125508158|NCT02309892|451489136|FG005|Overall Study|Progressive Disease|0|||
125508159|NCT02309892|451489137|FG006|Overall Study|Progressive Disease|0|||
125508160|NCT02309892|451489131|FG000|Overall Study|Death|0|||
125508161|NCT02309892|451489132|FG001|Overall Study|Death|0|||
125508162|NCT02309892|451489133|FG002|Overall Study|Death|0|||
125508163|NCT02309892|451489134|FG003|Overall Study|Death|0|||
125508164|NCT02309892|451489135|FG004|Overall Study|Death|0|||
125508165|NCT02309892|451489136|FG005|Overall Study|Death|1|||
125508166|NCT02309892|451489137|FG006|Overall Study|Death|0|||
125508167|NCT01894620|451489141|FG000|Overall Study|Withdrawal by Subject|0|||
125508168|NCT01894620|451489142|FG001|Overall Study|Withdrawal by Subject|1|||
125508169|NCT01124916|451489143|FG000|Overall Study|Lost to Follow-up|3|||
125508170|NCT01124916|451489144|FG001|Overall Study|Lost to Follow-up|2|||
125508171|NCT01901302|451489145|FG000|Overall Study|Adverse Event|2|||
125508172|NCT01901302|451489146|FG001|Overall Study|Adverse Event|1|||
125508173|NCT01901302|451489145|FG000|Overall Study|Lack of Efficacy|0|||
125508174|NCT01901302|451489146|FG001|Overall Study|Lack of Efficacy|2|||
125508175|NCT01901302|451489145|FG000|Overall Study|Study Terminated by Sponsor|23|||
125508176|NCT01901302|451489146|FG001|Overall Study|Study Terminated by Sponsor|20|||
125508177|NCT01901302|451489145|FG000|Overall Study|Withdrawal by Subject|2|||
125508178|NCT01901302|451489146|FG001|Overall Study|Withdrawal by Subject|0|||
125508179|NCT00657709|451489152|FG000|Overall Study|AE or Death|7|||
125508180|NCT00657709|451489153|FG001|Overall Study|AE or Death|7|||
125508181|NCT00657709|451489154|FG002|Overall Study|AE or Death|6|||
125508182|NCT00657709|451489155|FG003|Overall Study|AE or Death|7|||
125508183|NCT00657709|451489156|FG004|Overall Study|AE or Death|1|||
125508184|NCT00657709|451489152|FG000|Overall Study|Withdrawal by Subject|7|||
125508185|NCT00657709|451489153|FG001|Overall Study|Withdrawal by Subject|15|||
125508186|NCT00657709|451489154|FG002|Overall Study|Withdrawal by Subject|15|||
125508187|NCT00657709|451489155|FG003|Overall Study|Withdrawal by Subject|5|||
125508188|NCT00657709|451489156|FG004|Overall Study|Withdrawal by Subject|9|||
125508189|NCT00657709|451489152|FG000|Overall Study|Lost to Follow-up|9|||
125508190|NCT00657709|451489153|FG001|Overall Study|Lost to Follow-up|9|||
125508191|NCT00657709|451489154|FG002|Overall Study|Lost to Follow-up|7|||
125508192|NCT00657709|451489155|FG003|Overall Study|Lost to Follow-up|1|||
125508193|NCT00657709|451489156|FG004|Overall Study|Lost to Follow-up|21|||
125508194|NCT00657709|451489152|FG000|Overall Study|Protocol Violation|0|||
125508195|NCT00657709|451489153|FG001|Overall Study|Protocol Violation|2|||
125508196|NCT00657709|451489154|FG002|Overall Study|Protocol Violation|0|||
125508197|NCT00657709|451489155|FG003|Overall Study|Protocol Violation|1|||
125508198|NCT00657709|451489156|FG004|Overall Study|Protocol Violation|2|||
125508199|NCT01029925|451489157|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
125508200|NCT01029925|451489157|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
125508201|NCT01029925|451489157|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
125508202|NCT05265247|451489158|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
125508203|NCT05265247|451489159|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
125508204|NCT05265247|451489158|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
125508205|NCT05265247|451489159|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
125508206|NCT05265247|451489158|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
125508207|NCT05265247|451489159|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
125508208|NCT00134056|451489169|FG000|Randomization|Not eligible for assigned treatment|22|||
125508209|NCT00134056|451489170|FG001|Randomization|Not eligible for assigned treatment|20|||
125508210|NCT00134056|451489169|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
125508211|NCT00134056|451489170|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
125508212|NCT00134056|451489169|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
125508213|NCT00134056|451489170|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
125508214|NCT00134056|451489169|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
125508215|NCT00134056|451489170|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
125508216|NCT00134056|451489169|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
125508217|NCT00134056|451489170|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
125508218|NCT02555397|451489174|FG000|Overall Study|Withdrawal by Subject|1|||
125508219|NCT02555397|451489175|FG001|Overall Study|Withdrawal by Subject|0|||
125508220|NCT02555397|451489176|FG002|Overall Study|Withdrawal by Subject|0|||
125508221|NCT02555397|451489177|FG003|Overall Study|Withdrawal by Subject|0|||
125508222|NCT02555397|451489178|FG004|Overall Study|Withdrawal by Subject|0|||
125508223|NCT00537914|451489182|FG000|Overall Study|Death|1|||
125508224|NCT00537914|451489182|FG000|Overall Study|Adverse Event|7|||
125508225|NCT00537914|451489182|FG000|Overall Study|Treatment failure|10|||
125508226|NCT00537914|451489182|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
125508227|NCT00537914|451489182|FG000|Overall Study|Lost to Follow-up|19|||
125508228|NCT00537914|451489182|FG000|Overall Study|Withdrawal of informed consent|59|||
125508229|NCT02312258|451489183|FG000|Overall Study|Lost to Follow-up|8|||
125508230|NCT02312258|451489184|FG001|Overall Study|Lost to Follow-up|8|||
125508231|NCT02312258|451489183|FG000|Overall Study|Withdrawal by Patient|49|||
125508232|NCT02312258|451489184|FG001|Overall Study|Withdrawal by Patient|76|||
125508233|NCT02312258|451489183|FG000|Overall Study|Reason not Specified|107|||
125508234|NCT02312258|451489184|FG001|Overall Study|Reason not Specified|159|||
125508235|NCT02312258|451489183|FG000|Overall Study|Missing|2|||
125508236|NCT02312258|451489184|FG001|Overall Study|Missing|1|||
125508237|NCT02312258|451489183|FG000|Overall Study|Death|115|||
125508238|NCT02312258|451489184|FG001|Overall Study|Death|181|||
125508239|NCT01468597|451489186|FG000|Overall Study|Found ineligible|17|||
125508240|NCT01468597|451489186|FG000|Overall Study|concomitant valves|12|||
125508241|NCT01468597|451489186|FG000|Overall Study|off-pump CABG|1|||
125508242|NCT01468597|451489186|FG000|Overall Study|no platelet function data|5|||
125508243|NCT02260154|451489187|FG000|Overall Study|Screening failure|2|||
125508244|NCT02561195|451489189|FG000|Vaccination 1 to 3|Adverse Event|4|||
125508245|NCT02561195|451489190|FG001|Vaccination 1 to 3|Adverse Event|5|||
125508246|NCT02561195|451489191|FG002|Vaccination 1 to 3|Adverse Event|0|||
125508247|NCT02561195|451489192|FG003|Vaccination 1 to 3|Adverse Event|3|||
125508248|NCT02561195|451489193|FG004|Vaccination 1 to 3|Adverse Event|4|||
125508249|NCT02561195|451489194|FG005|Vaccination 1 to 3|Adverse Event|0|||
125508250|NCT02561195|451489195|FG006|Vaccination 1 to 3|Adverse Event|0|||
125508251|NCT02561195|451489196|FG007|Vaccination 1 to 3|Adverse Event|0|||
125508252|NCT02561195|451489197|FG008|Vaccination 1 to 3|Adverse Event|0|||
125508253|NCT02561195|451489198|FG009|Vaccination 1 to 3|Adverse Event|0|||
125508254|NCT02561195|451489199|FG010|Vaccination 1 to 3|Adverse Event|0|||
125508255|NCT02561195|451489200|FG011|Vaccination 1 to 3|Adverse Event|0|||
125508256|NCT02561195|451489201|FG012|Vaccination 1 to 3|Adverse Event|0|||
125508257|NCT02561195|451489202|FG013|Vaccination 1 to 3|Adverse Event|0|||
125508258|NCT02561195|451489189|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
125508259|NCT02561195|451489190|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
125508260|NCT02561195|451489191|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
125508261|NCT02561195|451489192|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
125508262|NCT02561195|451489193|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
125508263|NCT02561195|451489194|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
125508264|NCT02561195|451489195|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
125508265|NCT02561195|451489196|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
125508266|NCT02561195|451489197|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
125508267|NCT02561195|451489198|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
125508268|NCT02561195|451489199|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
125508269|NCT02561195|451489200|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
125508270|NCT02561195|451489201|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
125508271|NCT02561195|451489202|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
125508272|NCT02561195|451489189|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
125508273|NCT02561195|451489190|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
125508274|NCT02561195|451489191|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
125508275|NCT02561195|451489192|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
125508276|NCT02561195|451489193|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
125508277|NCT02561195|451489194|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
125508278|NCT02561195|451489195|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
125508279|NCT02561195|451489196|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
125508280|NCT02561195|451489197|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
125508281|NCT02561195|451489198|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
125508282|NCT02561195|451489199|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
125508283|NCT02561195|451489200|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
125508284|NCT02561195|451489201|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
125508285|NCT02561195|451489202|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
125508286|NCT02561195|451489189|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
125508287|NCT02561195|451489190|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
125508288|NCT02561195|451489191|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
125508289|NCT02561195|451489192|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
125508290|NCT02561195|451489193|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
125508291|NCT02561195|451489194|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
125508292|NCT02561195|451489195|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
125508293|NCT02561195|451489196|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
125508294|NCT02561195|451489197|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
125508295|NCT02561195|451489198|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
125508296|NCT02561195|451489199|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
125508297|NCT02561195|451489200|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
125508298|NCT02561195|451489201|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
125508299|NCT02561195|451489202|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
125508300|NCT02561195|451489189|FG000|Vaccination 1 to 3|Other|7|||
125508301|NCT02561195|451489190|FG001|Vaccination 1 to 3|Other|3|||
125508302|NCT02561195|451489191|FG002|Vaccination 1 to 3|Other|1|||
125508303|NCT02561195|451489192|FG003|Vaccination 1 to 3|Other|7|||
125508304|NCT02561195|451489193|FG004|Vaccination 1 to 3|Other|5|||
125508305|NCT02561195|451489194|FG005|Vaccination 1 to 3|Other|1|||
125508306|NCT02561195|451489195|FG006|Vaccination 1 to 3|Other|0|||
125508307|NCT02561195|451489196|FG007|Vaccination 1 to 3|Other|0|||
125508308|NCT02561195|451489197|FG008|Vaccination 1 to 3|Other|0|||
125508309|NCT02561195|451489198|FG009|Vaccination 1 to 3|Other|0|||
125508310|NCT02561195|451489199|FG010|Vaccination 1 to 3|Other|0|||
125508311|NCT02561195|451489200|FG011|Vaccination 1 to 3|Other|0|||
125508312|NCT02561195|451489201|FG012|Vaccination 1 to 3|Other|0|||
125508313|NCT02561195|451489202|FG013|Vaccination 1 to 3|Other|0|||
125508314|NCT02561195|451489189|FG000|Vaccination 1 to 3|Protocol Violation|1|||
125508315|NCT02561195|451489190|FG001|Vaccination 1 to 3|Protocol Violation|0|||
125508316|NCT02561195|451489191|FG002|Vaccination 1 to 3|Protocol Violation|1|||
125508317|NCT02561195|451489192|FG003|Vaccination 1 to 3|Protocol Violation|2|||
125508318|NCT02561195|451489193|FG004|Vaccination 1 to 3|Protocol Violation|5|||
125508319|NCT02561195|451489194|FG005|Vaccination 1 to 3|Protocol Violation|2|||
125508320|NCT02561195|451489195|FG006|Vaccination 1 to 3|Protocol Violation|0|||
125508321|NCT02561195|451489196|FG007|Vaccination 1 to 3|Protocol Violation|0|||
125508322|NCT02561195|451489197|FG008|Vaccination 1 to 3|Protocol Violation|0|||
125508323|NCT02561195|451489198|FG009|Vaccination 1 to 3|Protocol Violation|0|||
125508324|NCT02561195|451489199|FG010|Vaccination 1 to 3|Protocol Violation|0|||
125508325|NCT02561195|451489200|FG011|Vaccination 1 to 3|Protocol Violation|0|||
125508326|NCT02561195|451489201|FG012|Vaccination 1 to 3|Protocol Violation|0|||
125508327|NCT02561195|451489202|FG013|Vaccination 1 to 3|Protocol Violation|0|||
125508328|NCT02561195|451489189|FG000|Vaccination 1 to 3|Death|2|||
125508329|NCT02561195|451489190|FG001|Vaccination 1 to 3|Death|1|||
125508330|NCT02561195|451489191|FG002|Vaccination 1 to 3|Death|0|||
125508331|NCT02561195|451489192|FG003|Vaccination 1 to 3|Death|2|||
125508332|NCT02561195|451489193|FG004|Vaccination 1 to 3|Death|0|||
125508333|NCT02561195|451489194|FG005|Vaccination 1 to 3|Death|0|||
125508334|NCT02561195|451489195|FG006|Vaccination 1 to 3|Death|0|||
125508335|NCT02561195|451489196|FG007|Vaccination 1 to 3|Death|0|||
125508336|NCT02561195|451489197|FG008|Vaccination 1 to 3|Death|0|||
125508337|NCT02561195|451489198|FG009|Vaccination 1 to 3|Death|0|||
125508338|NCT02561195|451489199|FG010|Vaccination 1 to 3|Death|0|||
125508339|NCT02561195|451489200|FG011|Vaccination 1 to 3|Death|0|||
125508340|NCT02561195|451489201|FG012|Vaccination 1 to 3|Death|0|||
125508341|NCT02561195|451489202|FG013|Vaccination 1 to 3|Death|0|||
125508342|NCT02561195|451489189|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
125508343|NCT02561195|451489190|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
125508344|NCT02561195|451489191|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
125508345|NCT02561195|451489192|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
125508346|NCT02561195|451489193|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
125508347|NCT02561195|451489194|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
125508348|NCT02561195|451489195|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
125508349|NCT02561195|451489196|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
125508350|NCT02561195|451489197|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
125508351|NCT02561195|451489198|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
125508352|NCT02561195|451489199|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
125508353|NCT02561195|451489200|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
125508354|NCT02561195|451489201|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
125508355|NCT02561195|451489202|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
125508356|NCT02561195|451489189|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
125508357|NCT02561195|451489190|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
125508358|NCT02561195|451489191|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
125508359|NCT02561195|451489192|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
125508360|NCT02561195|451489193|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
125508361|NCT02561195|451489194|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
125508362|NCT02561195|451489195|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
125508363|NCT02561195|451489196|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
125508364|NCT02561195|451489197|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
125508365|NCT02561195|451489198|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
125508366|NCT02561195|451489199|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
125508367|NCT02561195|451489200|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
125508368|NCT02561195|451489201|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
125508369|NCT02561195|451489202|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
125508370|NCT02561195|451489189|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
125508371|NCT02561195|451489190|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
125508372|NCT02561195|451489191|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
125508373|NCT02561195|451489192|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
125508374|NCT02561195|451489193|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
125508375|NCT02561195|451489194|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
125508376|NCT02561195|451489195|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
125508377|NCT02561195|451489196|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
125508378|NCT02561195|451489197|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
125508379|NCT02561195|451489198|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
125508380|NCT02561195|451489199|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
125508381|NCT02561195|451489200|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
125508382|NCT02561195|451489201|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
125508383|NCT02561195|451489202|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
125508384|NCT02561195|451489189|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
125508385|NCT02561195|451489190|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
125508386|NCT02561195|451489191|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
125508387|NCT02561195|451489192|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
125508388|NCT02561195|451489193|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
125508389|NCT02561195|451489194|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
125508390|NCT02561195|451489195|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
125508391|NCT02561195|451489196|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
125508392|NCT02561195|451489197|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
125508393|NCT02561195|451489198|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
125508394|NCT02561195|451489199|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
125508395|NCT02561195|451489200|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
125508396|NCT02561195|451489201|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
125508397|NCT02561195|451489202|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
125508398|NCT02561195|451489189|FG000|Extension Stage (Vaccination 4)|Death|0|||
125508399|NCT02561195|451489190|FG001|Extension Stage (Vaccination 4)|Death|0|||
125508400|NCT02561195|451489191|FG002|Extension Stage (Vaccination 4)|Death|0|||
125508401|NCT02561195|451489192|FG003|Extension Stage (Vaccination 4)|Death|0|||
125508402|NCT02561195|451489193|FG004|Extension Stage (Vaccination 4)|Death|0|||
125508403|NCT02561195|451489194|FG005|Extension Stage (Vaccination 4)|Death|0|||
125508404|NCT02561195|451489195|FG006|Extension Stage (Vaccination 4)|Death|0|||
125508405|NCT02561195|451489196|FG007|Extension Stage (Vaccination 4)|Death|0|||
125508406|NCT02561195|451489197|FG008|Extension Stage (Vaccination 4)|Death|0|||
125508407|NCT02561195|451489198|FG009|Extension Stage (Vaccination 4)|Death|1|||
125508408|NCT02561195|451489199|FG010|Extension Stage (Vaccination 4)|Death|0|||
125508409|NCT02561195|451489200|FG011|Extension Stage (Vaccination 4)|Death|0|||
125508410|NCT02561195|451489201|FG012|Extension Stage (Vaccination 4)|Death|0|||
125508411|NCT02561195|451489202|FG013|Extension Stage (Vaccination 4)|Death|0|||
125508412|NCT02561195|451489189|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
125508413|NCT02561195|451489190|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
125508414|NCT02561195|451489191|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
125508415|NCT02561195|451489192|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
125508416|NCT02561195|451489193|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
125508417|NCT02561195|451489194|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
125508418|NCT02561195|451489195|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
125508419|NCT02561195|451489196|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
125508420|NCT02561195|451489197|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
125508421|NCT02561195|451489198|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
125508422|NCT02561195|451489199|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
125508423|NCT02561195|451489200|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
125508424|NCT02561195|451489201|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
125508425|NCT02561195|451489202|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
125508426|NCT02561195|451489189|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
125508427|NCT02561195|451489190|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
125508428|NCT02561195|451489191|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
125508429|NCT02561195|451489192|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
125508430|NCT02561195|451489193|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
125508431|NCT02561195|451489194|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
125508432|NCT02561195|451489195|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
125508433|NCT02561195|451489196|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
125508434|NCT02561195|451489197|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
125508435|NCT02561195|451489198|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
125508436|NCT02561195|451489199|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
125508437|NCT02561195|451489200|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
125508438|NCT02561195|451489201|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
125508439|NCT02561195|451489202|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
125508440|NCT02561195|451489189|FG000|Extension Stage (Vaccination 4)|Other|0|||
125508441|NCT02561195|451489190|FG001|Extension Stage (Vaccination 4)|Other|0|||
125508442|NCT02561195|451489191|FG002|Extension Stage (Vaccination 4)|Other|0|||
125508443|NCT02561195|451489192|FG003|Extension Stage (Vaccination 4)|Other|0|||
125508444|NCT02561195|451489193|FG004|Extension Stage (Vaccination 4)|Other|0|||
125508445|NCT02561195|451489194|FG005|Extension Stage (Vaccination 4)|Other|0|||
125508446|NCT02561195|451489195|FG006|Extension Stage (Vaccination 4)|Other|0|||
125508447|NCT02561195|451489196|FG007|Extension Stage (Vaccination 4)|Other|0|||
125508448|NCT02561195|451489197|FG008|Extension Stage (Vaccination 4)|Other|0|||
125305507|NCT02218008|450745140|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
125305508|NCT02218008|450745141|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
125305509|NCT02218008|450745142|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
125305510|NCT02218008|450745143|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
125508449|NCT02561195|451489198|FG009|Extension Stage (Vaccination 4)|Other|0|||
125508450|NCT02561195|451489199|FG010|Extension Stage (Vaccination 4)|Other|2|||
125508451|NCT02561195|451489200|FG011|Extension Stage (Vaccination 4)|Other|2|||
125508452|NCT02561195|451489201|FG012|Extension Stage (Vaccination 4)|Other|1|||
125508453|NCT02561195|451489202|FG013|Extension Stage (Vaccination 4)|Other|0|||
125508454|NCT02561195|451489189|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
125508455|NCT02561195|451489190|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
125508456|NCT02561195|451489191|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
125508457|NCT02561195|451489192|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
125508458|NCT02561195|451489193|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
125508459|NCT02561195|451489194|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
125508460|NCT02561195|451489195|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
125508461|NCT02561195|451489196|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
125508462|NCT02561195|451489197|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
125508463|NCT02561195|451489198|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
125508464|NCT02561195|451489199|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
125508465|NCT02561195|451489200|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
125508466|NCT02561195|451489201|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
125508467|NCT02561195|451489202|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
125508468|NCT03905512|451489203|FG000|Overall Study|Withdrawal by Subject|9|||
125508469|NCT03905512|451489204|FG001|Overall Study|Withdrawal by Subject|8|||
125508470|NCT03905512|451489203|FG000|Overall Study|Adverse Event|1|||
125508471|NCT03905512|451489204|FG001|Overall Study|Adverse Event|2|||
125508472|NCT03905512|451489203|FG000|Overall Study|Lost to Follow-up|4|||
125508473|NCT03905512|451489204|FG001|Overall Study|Lost to Follow-up|3|||
125508474|NCT03905512|451489203|FG000|Overall Study|Other than Specified|7|||
125508475|NCT03905512|451489204|FG001|Overall Study|Other than Specified|4|||
125508476|NCT03560206|451489207|FG000|Overall Study|Lost to Follow-up|19|||
125508477|NCT03560206|451489208|FG001|Overall Study|Lost to Follow-up|11|||
125508478|NCT03560206|451489207|FG000|Overall Study|Withdrawal by Subject|2|||
125508479|NCT03560206|451489208|FG001|Overall Study|Withdrawal by Subject|4|||
125508480|NCT03560206|451489207|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
125508481|NCT03560206|451489208|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
125508482|NCT03560206|451489207|FG000|Overall Study|Busy schedule|14|||
125508483|NCT03560206|451489208|FG001|Overall Study|Busy schedule|2|||
125508484|NCT03560206|451489207|FG000|Overall Study|patients' new health condition such as cancer|10|||
125508485|NCT03560206|451489208|FG001|Overall Study|patients' new health condition such as cancer|1|||
125508486|NCT03138499|451489209|FG000|Overall Study|Lost to Follow-up|1|||
125508487|NCT03138499|451489210|FG001|Overall Study|Lost to Follow-up|0|||
125508488|NCT03138499|451489209|FG000|Overall Study|Participants withdrew consent|1|||
125508489|NCT03138499|451489210|FG001|Overall Study|Participants withdrew consent|0|||
125508490|NCT03138499|451489209|FG000|Overall Study|Participant discontinued study before treatment|0|||
125508491|NCT03138499|451489210|FG001|Overall Study|Participant discontinued study before treatment|1|||
125508492|NCT03138499|451489209|FG000|Overall Study|Disease Progression|2|||
125508493|NCT03138499|451489210|FG001|Overall Study|Disease Progression|6|||
125508494|NCT03138499|451489209|FG000|Overall Study|Study drug toxicity|2|||
125508495|NCT03138499|451489210|FG001|Overall Study|Study drug toxicity|2|||
125508496|NCT03138499|451489209|FG000|Overall Study|Participant request to discontinue study treatment|1|||
125508497|NCT03138499|451489210|FG001|Overall Study|Participant request to discontinue study treatment|1|||
125508498|NCT03138499|451489209|FG000|Overall Study|Other reasons|2|||
125508499|NCT03138499|451489210|FG001|Overall Study|Other reasons|0|||
125508500|NCT01334606|451489215|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
125508501|NCT02674399|451489216|FG000|Overall Study|Lost to Follow-up|2|||
125508502|NCT02674399|451489217|FG001|Overall Study|Lost to Follow-up|0|||
125508503|NCT01661972|451489218|FG000|Overall Study|Adverse Event|1|||
125508504|NCT01661972|451489219|FG001|Overall Study|Adverse Event|2|||
125508505|NCT01661972|451489218|FG000|Overall Study|Death during Treatment period|1|||
125508506|NCT01661972|451489219|FG001|Overall Study|Death during Treatment period|1|||
125508507|NCT01661972|451489218|FG000|Overall Study|Withdrawal by Subject|0|||
125508508|NCT01661972|451489219|FG001|Overall Study|Withdrawal by Subject|1|||
125508509|NCT01634165|451489231|FG000|Period 2|Adverse Event|0|||
125508510|NCT01634165|451489232|FG001|Period 2|Adverse Event|1|||
125508511|NCT01634165|451489233|FG002|Period 2|Adverse Event|0|||
125508512|NCT01634165|451489234|FG003|Period 2|Adverse Event|0|||
125508513|NCT05379400|451490497|FG000|Overall Study|Lost to Follow-up|1|||
125508514|NCT05379400|451490498|FG001|Overall Study|Lost to Follow-up|1|||
125508515|NCT03978130|451490500|FG000|Overall Study|Lost to Follow-up|13|||
125508516|NCT03978130|451490501|FG001|Overall Study|Lost to Follow-up|14|||
125508517|NCT03978130|451490500|FG000|Overall Study|Withdrawal by Subject|12|||
125508518|NCT03978130|451490501|FG001|Overall Study|Withdrawal by Subject|2|||
125508519|NCT03978130|451490500|FG000|Overall Study|Adverse Event|2|||
125508520|NCT03978130|451490501|FG001|Overall Study|Adverse Event|1|||
125508521|NCT00515112|451490502|FG000|Overall Study|Death|0|||
125508522|NCT00515112|451490503|FG001|Overall Study|Death|1|||
125508523|NCT00515112|451490502|FG000|Overall Study|The study was terminated|3|||
125508524|NCT00515112|451490503|FG001|Overall Study|The study was terminated|2|||
125508525|NCT00304278|451490505|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
125508526|NCT00304278|451490505|FG000|Overall Study|PT had medical condition preventing TX|1|||
125508527|NCT00409006|451490508|FG000|Overall Study|Death|15|||
125508528|NCT00409006|451490509|FG001|Overall Study|Death|6|||
125508529|NCT00409006|451490508|FG000|Overall Study|Lost to Follow-up|1|||
125508530|NCT00409006|451490509|FG001|Overall Study|Lost to Follow-up|2|||
125508531|NCT00409006|451490508|FG000|Overall Study|Withdrawal by Subject|3|||
125508532|NCT00409006|451490509|FG001|Overall Study|Withdrawal by Subject|2|||
125508533|NCT00409006|451490508|FG000|Overall Study|Physician Decision|1|||
125508534|NCT00409006|451490509|FG001|Overall Study|Physician Decision|2|||
125508535|NCT00228813|451490510|FG000|Overall Study|Death|4|||
125508536|NCT00507429|451490511|FG000|Treatment Phase|Disease Progression|12|||
125508537|NCT00507429|451490512|FG001|Treatment Phase|Disease Progression|5|||
125508538|NCT00507429|451490511|FG000|Treatment Phase|Adverse Event|12|||
125508539|NCT00507429|451490512|FG001|Treatment Phase|Adverse Event|5|||
125508540|NCT00507429|451490511|FG000|Treatment Phase|Withdrawal by Subject|3|||
125508541|NCT00507429|451490512|FG001|Treatment Phase|Withdrawal by Subject|3|||
125508542|NCT00507429|451490511|FG000|Treatment Phase|Physician Decision|4|||
125508543|NCT00507429|451490512|FG001|Treatment Phase|Physician Decision|2|||
125508544|NCT00507429|451490511|FG000|Treatment Phase|Other|6|||
125508545|NCT00507429|451490512|FG001|Treatment Phase|Other|3|||
125508546|NCT00507429|451490511|FG000|Maintenance Phase|Progressive Disease|14|||
125508547|NCT00507429|451490512|FG001|Maintenance Phase|Progressive Disease|0|||
125508548|NCT04025762|451490514|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
125508549|NCT04025762|451490515|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
125508550|NCT01131325|451490522|FG000|Overall Study|Adverse Event|1|||
125508551|NCT01131325|451490522|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
125508552|NCT03884478|451490523|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
125508553|NCT03884478|451490524|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
125508554|NCT03884478|451490525|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
125508555|NCT03884478|451490523|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
125508556|NCT03884478|451490524|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
125508557|NCT03884478|451490525|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
125508558|NCT03884478|451490523|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
125508559|NCT03884478|451490524|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
125508560|NCT03884478|451490525|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
125508561|NCT03884478|451490523|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
125508562|NCT03884478|451490524|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
125508563|NCT03884478|451490525|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
125508564|NCT02213094|451490528|FG000|Overall Study|Adverse Event|1|||
125508565|NCT02213094|451490529|FG001|Overall Study|Adverse Event|0|||
125508566|NCT01807234|451490530|FG000|Overall Study|Lost to Follow-up|2|||
125508567|NCT01807234|451490531|FG001|Overall Study|Lost to Follow-up|5|||
125508568|NCT01807234|451490532|FG002|Overall Study|Lost to Follow-up|1|||
125508569|NCT01807234|451490533|FG003|Overall Study|Lost to Follow-up|1|||
125508570|NCT01807234|451490534|FG004|Overall Study|Lost to Follow-up|1|||
125508571|NCT01807234|451490535|FG005|Overall Study|Lost to Follow-up|2|||
125508572|NCT01807234|451490530|FG000|Overall Study|Withdrawal by Subject|3|||
125508573|NCT01807234|451490531|FG001|Overall Study|Withdrawal by Subject|1|||
125508574|NCT01807234|451490532|FG002|Overall Study|Withdrawal by Subject|1|||
125508575|NCT01807234|451490533|FG003|Overall Study|Withdrawal by Subject|1|||
125508576|NCT01807234|451490534|FG004|Overall Study|Withdrawal by Subject|2|||
125508577|NCT01807234|451490535|FG005|Overall Study|Withdrawal by Subject|1|||
125508578|NCT01807234|451490530|FG000|Overall Study|Lack of Efficacy|0|||
125508579|NCT01807234|451490531|FG001|Overall Study|Lack of Efficacy|0|||
125508580|NCT01807234|451490532|FG002|Overall Study|Lack of Efficacy|0|||
125508581|NCT01807234|451490533|FG003|Overall Study|Lack of Efficacy|0|||
125508582|NCT01807234|451490534|FG004|Overall Study|Lack of Efficacy|1|||
125508583|NCT01807234|451490535|FG005|Overall Study|Lack of Efficacy|1|||
125508584|NCT00538629|451490536|FG000|Overall Study|At subject's request|1|||
125508585|NCT00538629|451490536|FG000|Overall Study|Adverse Event|2|||
125508586|NCT00538629|451490536|FG000|Overall Study|Lack of Efficacy|12|||
125508587|NCT00538629|451490536|FG000|Overall Study|Lost to Follow-up|6|||
125508588|NCT00538629|451490536|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
125508589|NCT00555620|451490538|FG000|Overall Study|Death|0|||
125508590|NCT00555620|451490539|FG001|Overall Study|Death|1|||
125508591|NCT00555620|451490540|FG002|Overall Study|Death|0|||
125508592|NCT00555620|451490541|FG003|Overall Study|Death|0|||
125508593|NCT00555620|451490542|FG004|Overall Study|Death|0|||
125508594|NCT00555620|451490543|FG005|Overall Study|Death|1|||
125508595|NCT00555620|451490538|FG000|Overall Study|Study terminated by sponsor|0|||
125508596|NCT00555620|451490539|FG001|Overall Study|Study terminated by sponsor|0|||
125305511|NCT02218008|450745144|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
125508597|NCT00555620|451490540|FG002|Overall Study|Study terminated by sponsor|1|||
125508598|NCT00555620|451490541|FG003|Overall Study|Study terminated by sponsor|0|||
125532454|NCT05511038|451580116|FG001|Treatment|Refuse by subject|0|||
125508599|NCT00555620|451490542|FG004|Overall Study|Study terminated by sponsor|0|||
125508600|NCT00555620|451490543|FG005|Overall Study|Study terminated by sponsor|0|||
125508601|NCT00555620|451490538|FG000|Overall Study|Adverse Event|0|||
125508602|NCT00555620|451490539|FG001|Overall Study|Adverse Event|0|||
125508603|NCT00555620|451490540|FG002|Overall Study|Adverse Event|1|||
125508604|NCT00555620|451490541|FG003|Overall Study|Adverse Event|5|||
125508605|NCT00555620|451490542|FG004|Overall Study|Adverse Event|0|||
125508606|NCT00555620|451490543|FG005|Overall Study|Adverse Event|1|||
125508607|NCT00555620|451490538|FG000|Overall Study|Objective progression or relapse|6|||
125508608|NCT00555620|451490539|FG001|Overall Study|Objective progression or relapse|5|||
125508609|NCT00555620|451490540|FG002|Overall Study|Objective progression or relapse|12|||
125508610|NCT00555620|451490541|FG003|Overall Study|Objective progression or relapse|17|||
125508611|NCT00555620|451490542|FG004|Overall Study|Objective progression or relapse|3|||
125508612|NCT00555620|451490543|FG005|Overall Study|Objective progression or relapse|16|||
125508613|NCT00555620|451490538|FG000|Overall Study|Participant refused treatment|0|||
125508614|NCT00555620|451490539|FG001|Overall Study|Participant refused treatment|1|||
125508615|NCT00555620|451490540|FG002|Overall Study|Participant refused treatment|1|||
125508616|NCT00555620|451490541|FG003|Overall Study|Participant refused treatment|0|||
125508617|NCT00555620|451490542|FG004|Overall Study|Participant refused treatment|0|||
125508618|NCT00555620|451490543|FG005|Overall Study|Participant refused treatment|1|||
125508619|NCT00555620|451490538|FG000|Overall Study|Other|0|||
125508620|NCT00555620|451490539|FG001|Overall Study|Other|0|||
125508621|NCT00555620|451490540|FG002|Overall Study|Other|0|||
125508622|NCT00555620|451490541|FG003|Overall Study|Other|1|||
125508623|NCT00555620|451490542|FG004|Overall Study|Other|0|||
125508624|NCT00555620|451490543|FG005|Overall Study|Other|3|||
125508625|NCT05203822|451490544|FG000|Overall Study|Adverse Event|1|||
125508626|NCT05203822|451490544|FG000|Overall Study|Withdrawal by Subject|1|||
125508627|NCT01345253|451490546|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
125508628|NCT01345253|451490547|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
125508629|NCT01345253|451490546|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
125508630|NCT01345253|451490547|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
125508631|NCT01345253|451490546|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
125508632|NCT01345253|451490547|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
125508633|NCT01345253|451490546|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
125508634|NCT01345253|451490547|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
125508635|NCT01345253|451490546|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
125508636|NCT01345253|451490547|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
125508637|NCT01345253|451490546|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
125508638|NCT01345253|451490547|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
125508639|NCT01345253|451490546|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
125508640|NCT01345253|451490547|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
125508641|NCT01345253|451490546|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
125508642|NCT01345253|451490547|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
125508643|NCT01345253|451490546|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
125508644|NCT01345253|451490547|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
125508645|NCT01345253|451490546|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
125508646|NCT01345253|451490547|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
125508647|NCT01345253|451490546|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
125508648|NCT01345253|451490547|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
125508649|NCT01345253|451490546|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
125508650|NCT01345253|451490547|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
125508651|NCT01345253|451490546|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
125508652|NCT01345253|451490547|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
125508653|NCT01345253|451490546|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
125508654|NCT01345253|451490547|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
125508655|NCT01345253|451490546|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
125508656|NCT01345253|451490547|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
125508657|NCT00648895|451490556|FG000|Overall Study|Lack of Efficacy|0|||
125508658|NCT00648895|451490557|FG001|Overall Study|Lack of Efficacy|1|||
125508659|NCT02865083|451490558|FG000|Overall Study|Early Termination|3|||
125508660|NCT02865083|451490559|FG001|Overall Study|Early Termination|1|||
125508661|NCT00841321|451490560|FG000|Overall Study|Lost to Follow-up|1|||
125508662|NCT00841321|451490561|FG001|Overall Study|Lost to Follow-up|1|||
125508663|NCT00841321|451490560|FG000|Overall Study|Adverse Event|0|||
125508664|NCT00841321|451490561|FG001|Overall Study|Adverse Event|2|||
125508665|NCT01358175|451490562|FG000|Overall Study|Death|1|||
125508666|NCT01358175|451490563|FG001|Overall Study|Death|0|||
125508667|NCT01358175|451490564|FG002|Overall Study|Death|1|||
125508668|NCT01358175|451490562|FG000|Overall Study|Withdrawal by Subject|9|||
125508669|NCT01358175|451490563|FG001|Overall Study|Withdrawal by Subject|5|||
125508670|NCT01358175|451490564|FG002|Overall Study|Withdrawal by Subject|10|||
125508671|NCT01358175|451490562|FG000|Overall Study|Technical issues|0|||
125508672|NCT01358175|451490563|FG001|Overall Study|Technical issues|1|||
125508673|NCT01358175|451490564|FG002|Overall Study|Technical issues|0|||
125508674|NCT01358175|451490562|FG000|Overall Study|Pregnancy|0|||
125508675|NCT01358175|451490563|FG001|Overall Study|Pregnancy|1|||
125508676|NCT01358175|451490564|FG002|Overall Study|Pregnancy|0|||
125508677|NCT01358175|451490562|FG000|Overall Study|Physician Decision|1|||
125508678|NCT01358175|451490563|FG001|Overall Study|Physician Decision|0|||
125508679|NCT01358175|451490564|FG002|Overall Study|Physician Decision|0|||
125508680|NCT01358175|451490562|FG000|Overall Study|Non Compliance with Study Treatment|0|||
125508681|NCT01358175|451490563|FG001|Overall Study|Non Compliance with Study Treatment|1|||
125508682|NCT01358175|451490564|FG002|Overall Study|Non Compliance with Study Treatment|1|||
125508683|NCT01358175|451490562|FG000|Overall Study|Lost to Follow-up|1|||
125508684|NCT01358175|451490563|FG001|Overall Study|Lost to Follow-up|1|||
125508685|NCT01358175|451490564|FG002|Overall Study|Lost to Follow-up|3|||
125508686|NCT01358175|451490562|FG000|Overall Study|Lack of Efficacy|3|||
125508687|NCT01358175|451490563|FG001|Overall Study|Lack of Efficacy|8|||
125508688|NCT01358175|451490564|FG002|Overall Study|Lack of Efficacy|6|||
125508689|NCT01358175|451490562|FG000|Overall Study|Adverse Event|6|||
125508690|NCT01358175|451490563|FG001|Overall Study|Adverse Event|11|||
125508691|NCT01358175|451490564|FG002|Overall Study|Adverse Event|11|||
125508692|NCT02379078|451490565|FG000|Overall Study|Lost to Follow-up|33|||
125508693|NCT02379078|451490566|FG001|Overall Study|Lost to Follow-up|30|||
125508694|NCT02379078|451490565|FG000|Overall Study|Withdrawal by Subject|6|||
125508695|NCT02379078|451490566|FG001|Overall Study|Withdrawal by Subject|5|||
125508696|NCT04908488|451490567|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
125508697|NCT04908488|451490568|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
125508698|NCT04908488|451490567|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
125508699|NCT04908488|451490568|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
125508700|NCT00901459|451490569|FG000|Overall Study|Withdrawal by Subject|6|||
125508701|NCT04765046|451490570|FG000|Overall Study|Screen Failure|2|||
125508702|NCT04765046|451490570|FG000|Overall Study|Withdrawal by Subject|4|||
125508703|NCT04765046|451490570|FG000|Overall Study|Physician Decision|4|||
125508704|NCT04765046|451490570|FG000|Overall Study|Surgery Cancelled|8|||
125508705|NCT02959866|451490572|FG000|Overall Study|Withdrawal by Subject|1|||
125508706|NCT00952523|451490573|FG000|Overall Study|Withdrawal by Subject|7|||
125508707|NCT00848198|451490574|FG000|Overall Study|Incomplete Case Report Forms|15|||
125508708|NCT03708744|451490578|FG000|Overall Study|Withdrawal by Subject|0|||
125508709|NCT03708744|451490579|FG001|Overall Study|Withdrawal by Subject|0|||
125508710|NCT03708744|451490580|FG002|Overall Study|Withdrawal by Subject|1|||
125508711|NCT03708744|451490581|FG003|Overall Study|Withdrawal by Subject|0|||
125508712|NCT04930263|451490582|FG000|Overall Study|Withdrawal by Subject|3|||
125508713|NCT04930263|451490583|FG001|Overall Study|Withdrawal by Subject|5|||
125508714|NCT03529942|451490584|FG000|Overall Study|Withdrawal by Subject|13|||
125508715|NCT03529942|451490584|FG000|Overall Study|Physician Decision|1|||
125508716|NCT03529942|451490584|FG000|Overall Study|Lost to Follow-up|7|||
125508717|NCT03529942|451490584|FG000|Overall Study|Needle inserted but no drug administered|1|||
125508718|NCT03529942|451490584|FG000|Overall Study|Personal reasons|1|||
125508719|NCT00850993|451490585|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
125508720|NCT00850993|451490586|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
125508721|NCT00850993|451490587|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
125508722|NCT00850993|451490588|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
125508723|NCT03839355|451490589|FG000|Overall Study|Withdrawal by Subject|1|||
125508724|NCT03839355|451490590|FG001|Overall Study|Withdrawal by Subject|0|||
125508725|NCT00658632|451490596|FG000|Overall Study|Adverse Event|13|||
125508726|NCT00658632|451490597|FG001|Overall Study|Adverse Event|11|||
125508727|NCT00658632|451490596|FG000|Overall Study|Lost to Follow-up|25|||
125305512|NCT02218008|450745139|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
125305513|NCT02218008|450745140|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
125305514|NCT02218008|450745141|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
125305515|NCT02218008|450745142|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
125305516|NCT02218008|450745143|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
125305517|NCT02218008|450745144|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
125305518|NCT02218008|450745139|FG000|Stage 1 (S1)|Pregnancy|0|||
125508728|NCT00658632|451490597|FG001|Overall Study|Lost to Follow-up|23|||
125508729|NCT00658632|451490596|FG000|Overall Study|Withdrawal by Subject|10|||
125508730|NCT00658632|451490597|FG001|Overall Study|Withdrawal by Subject|7|||
125508731|NCT00658632|451490596|FG000|Overall Study|Lack of Efficacy|0|||
125508732|NCT00658632|451490597|FG001|Overall Study|Lack of Efficacy|1|||
125508733|NCT00658632|451490596|FG000|Overall Study|Withdrawal of consent|8|||
125508734|NCT00658632|451490597|FG001|Overall Study|Withdrawal of consent|14|||
125508735|NCT00658632|451490596|FG000|Overall Study|Pregnancy|1|||
125508736|NCT00658632|451490597|FG001|Overall Study|Pregnancy|1|||
125508737|NCT00658632|451490596|FG000|Overall Study|Other|7|||
125508738|NCT00658632|451490597|FG001|Overall Study|Other|8|||
125508739|NCT01699178|451490598|FG000|Overall Study|Adverse Event|1|||
125508740|NCT01699178|451490599|FG001|Overall Study|Adverse Event|5|||
125508741|NCT01699178|451490598|FG000|Overall Study|Lost to Follow-up|1|||
125508742|NCT01699178|451490599|FG001|Overall Study|Lost to Follow-up|6|||
125508743|NCT01699178|451490598|FG000|Overall Study|Non-compliance with Study Drug|3|||
125508744|NCT01699178|451490599|FG001|Overall Study|Non-compliance with Study Drug|1|||
125508745|NCT01699178|451490598|FG000|Overall Study|Physician Decision|1|||
125508746|NCT01699178|451490599|FG001|Overall Study|Physician Decision|0|||
125508747|NCT01699178|451490598|FG000|Overall Study|Withdrawal by Subject|4|||
125508748|NCT01699178|451490599|FG001|Overall Study|Withdrawal by Subject|12|||
125508749|NCT01699178|451490598|FG000|Overall Study|Hematocrit >54%|1|||
125508750|NCT01699178|451490599|FG001|Overall Study|Hematocrit >54%|1|||
125508751|NCT01699178|451490598|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
125508752|NCT01699178|451490599|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
125508753|NCT01699178|451490598|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
125508754|NCT01699178|451490599|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
125508755|NCT03547167|451490600|FG000|Overall Study|Withdrawal by Subject|34|||
125508756|NCT03547167|451490601|FG001|Overall Study|Withdrawal by Subject|12|||
125508757|NCT03547167|451490600|FG000|Overall Study|Screen Failure|0|||
125508758|NCT03547167|451490601|FG001|Overall Study|Screen Failure|1|||
125508759|NCT03547167|451490600|FG000|Overall Study|Lost to Follow-up|59|||
125508760|NCT03547167|451490601|FG001|Overall Study|Lost to Follow-up|15|||
125508761|NCT03547167|451490600|FG000|Overall Study|Death|4|||
125508762|NCT03547167|451490601|FG001|Overall Study|Death|2|||
125508763|NCT02009865|451490605|FG000|Overall Study|Adverse Event|0|||
125508764|NCT02009865|451490606|FG001|Overall Study|Adverse Event|2|||
125508765|NCT02009865|451490605|FG000|Overall Study|Protocol Violation|0|||
125508766|NCT02009865|451490606|FG001|Overall Study|Protocol Violation|2|||
125508767|NCT02009865|451490605|FG000|Overall Study|Withdrawal by Subject|1|||
125508768|NCT02009865|451490606|FG001|Overall Study|Withdrawal by Subject|1|||
125508769|NCT01760876|451490607|FG000|Overall Study|Non-cardiac death (head injury)|1|||
125508770|NCT01760876|451490607|FG000|Overall Study|Carcinoma of prostate|1|||
125508771|NCT01760876|451490607|FG000|Overall Study|Impaired renal function|1|||
125508772|NCT01760876|451490607|FG000|Overall Study|Major depression|1|||
125508773|NCT01760876|451490607|FG000|Overall Study|Very poor baseline OCT quality|2|||
125508774|NCT01517282|451490610|FG000|Overall Study|Consent withdrawn|0|||
125508775|NCT01517282|451490611|FG001|Overall Study|Consent withdrawn|1|||
125508776|NCT01517282|451490612|FG002|Overall Study|Consent withdrawn|1|||
125508777|NCT01517282|451490613|FG003|Overall Study|Consent withdrawn|1|||
125508778|NCT01517282|451490610|FG000|Overall Study|Physician Decision|1|||
125508779|NCT01517282|451490611|FG001|Overall Study|Physician Decision|0|||
125508780|NCT01517282|451490612|FG002|Overall Study|Physician Decision|0|||
125508781|NCT01517282|451490613|FG003|Overall Study|Physician Decision|0|||
125508782|NCT00525915|451490614|FG000|Overall Study|Non-Compliance|0|||
125508783|NCT00525915|451490615|FG001|Overall Study|Non-Compliance|1|||
125508784|NCT00525915|451490614|FG000|Overall Study|Disease Progression|5|||
125508785|NCT00525915|451490615|FG001|Overall Study|Disease Progression|6|||
125508786|NCT00525915|451490614|FG000|Overall Study|Withdrawal by Subject|1|||
125508787|NCT00525915|451490615|FG001|Overall Study|Withdrawal by Subject|0|||
125508788|NCT00525915|451490614|FG000|Overall Study|Refused Surgery|1|||
125508789|NCT00525915|451490615|FG001|Overall Study|Refused Surgery|2|||
125508790|NCT00525915|451490614|FG000|Overall Study|Unrelated illness|1|||
125508791|NCT00525915|451490615|FG001|Overall Study|Unrelated illness|0|||
125508792|NCT00760877|451492144|FG000|Overall Study|Protocol Violation|1|||
125508793|NCT00760877|451492145|FG001|Overall Study|Protocol Violation|0|||
125508794|NCT00760877|451492144|FG000|Overall Study|Non-compliance with protocol treatment|2|||
125508795|NCT00760877|451492145|FG001|Overall Study|Non-compliance with protocol treatment|1|||
125508796|NCT00760877|451492144|FG000|Overall Study|Pregnancy|1|||
125508797|NCT00760877|451492145|FG001|Overall Study|Pregnancy|4|||
125508798|NCT00760877|451492144|FG000|Overall Study|Death|2|||
125508799|NCT00760877|451492145|FG001|Overall Study|Death|1|||
125508800|NCT00760877|451492144|FG000|Overall Study|Withdrawal by Subject|7|||
125508801|NCT00760877|451492145|FG001|Overall Study|Withdrawal by Subject|3|||
125508802|NCT00760877|451492144|FG000|Overall Study|Adverse Event|19|||
125508803|NCT00760877|451492145|FG001|Overall Study|Adverse Event|12|||
125508804|NCT00760877|451492144|FG000|Overall Study|Participant diagnosed with AML|0|||
125508805|NCT00760877|451492145|FG001|Overall Study|Participant diagnosed with AML|1|||
125508806|NCT00760877|451492144|FG000|Overall Study|Participant not eligible to cross-over|0|||
125508807|NCT00760877|451492145|FG001|Overall Study|Participant not eligible to cross-over|1|||
125508808|NCT00760877|451492144|FG000|Overall Study|Physician Decision|1|||
125305519|NCT02218008|450745140|FG001|Stage 1 (S1)|Pregnancy|0|||
125508809|NCT00760877|451492145|FG001|Overall Study|Physician Decision|2|||
125508810|NCT00760877|451492144|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
125508811|NCT00760877|451492145|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
125508812|NCT00760877|451492144|FG000|Overall Study|Treatment failure|1|||
125508813|NCT00760877|451492145|FG001|Overall Study|Treatment failure|0|||
125508814|NCT00711555|451492148|FG000|Overall Study|Adverse Event|3|||
125508815|NCT00946998|451492149|FG000|Overall Study|Exited prior to first outcome assessment|5|||
125532597|NCT00350727|451580161|FG000|Phase II|Disease Progression|0|||
125305520|NCT02218008|450745141|FG002|Stage 1 (S1)|Pregnancy|1|||
125508816|NCT00946998|451492150|FG001|Overall Study|Exited prior to first outcome assessment|3|||
125508817|NCT03020914|451492151|FG000|Overall Study|Surgery Cancelled|1|||
125508818|NCT03020914|451492152|FG001|Overall Study|Surgery Cancelled|0|||
125508819|NCT00668746|451492156|FG000|Overall Study|Lost to Follow-up|2|||
125508820|NCT00668746|451492157|FG001|Overall Study|Lost to Follow-up|1|||
125508821|NCT02109172|451492158|FG000|Overall Study|Withdrawal by Subject|1|||
125508822|NCT02109172|451492159|FG001|Overall Study|Withdrawal by Subject|0|||
125508823|NCT02109172|451492160|FG002|Overall Study|Withdrawal by Subject|0|||
125508824|NCT02109172|451492161|FG003|Overall Study|Withdrawal by Subject|1|||
125508825|NCT02109172|451492162|FG004|Overall Study|Withdrawal by Subject|0|||
125508826|NCT02109172|451492163|FG005|Overall Study|Withdrawal by Subject|0|||
125508827|NCT02109172|451492158|FG000|Overall Study|Adverse Event|0|||
125508828|NCT02109172|451492159|FG001|Overall Study|Adverse Event|0|||
125508829|NCT02109172|451492160|FG002|Overall Study|Adverse Event|1|||
125508830|NCT02109172|451492161|FG003|Overall Study|Adverse Event|0|||
125508831|NCT02109172|451492162|FG004|Overall Study|Adverse Event|0|||
125508832|NCT02109172|451492163|FG005|Overall Study|Adverse Event|1|||
125508833|NCT02109172|451492158|FG000|Overall Study|Death|0|||
125508834|NCT02109172|451492159|FG001|Overall Study|Death|0|||
125508835|NCT02109172|451492160|FG002|Overall Study|Death|0|||
125508836|NCT02109172|451492161|FG003|Overall Study|Death|0|||
125508837|NCT02109172|451492162|FG004|Overall Study|Death|1|||
125508838|NCT02109172|451492163|FG005|Overall Study|Death|0|||
125508839|NCT02011568|451492164|FG000|Overall Study|Withdrawal by Subject|8|||
125508840|NCT02011568|451492165|FG001|Overall Study|Withdrawal by Subject|10|||
125508841|NCT02011568|451492164|FG000|Overall Study|Physician Decision|1|||
125508842|NCT02011568|451492165|FG001|Overall Study|Physician Decision|3|||
125508843|NCT01816165|451492167|FG000|Overall Study|Adverse Event|1|||
125508844|NCT01816165|451492168|FG001|Overall Study|Adverse Event|0|||
125508845|NCT01816165|451492169|FG002|Overall Study|Adverse Event|0|||
125508846|NCT01816165|451492170|FG003|Overall Study|Adverse Event|0|||
125508847|NCT01263223|451492176|FG000|Period 2|Withdrawal by Subject|0|||
125508848|NCT01263223|451492177|FG001|Period 2|Withdrawal by Subject|1|||
125508849|NCT01263223|451492176|FG000|7-day Follow-up|Withdrawal by Subject|0|||
125508850|NCT01263223|451492177|FG001|7-day Follow-up|Withdrawal by Subject|1|||
125508851|NCT01263223|451492176|FG000|7-day Follow-up|Lost to Follow-up|1|||
125508852|NCT01263223|451492177|FG001|7-day Follow-up|Lost to Follow-up|0|||
125508853|NCT04175834|451492179|FG000|Overall Study|Withdrawal by Subject|1|||
125508854|NCT04175834|451492180|FG001|Overall Study|Withdrawal by Subject|0|||
125508855|NCT01322347|451492181|FG000|Overall Study|Adverse Event|7|||
125508856|NCT01322347|451492182|FG001|Overall Study|Adverse Event|2|||
125508857|NCT01322347|451492181|FG000|Overall Study|Death|5|||
125508858|NCT01322347|451492182|FG001|Overall Study|Death|3|||
125508859|NCT01322347|451492181|FG000|Overall Study|Physician Decision|2|||
125508860|NCT01322347|451492182|FG001|Overall Study|Physician Decision|1|||
125508861|NCT01322347|451492181|FG000|Overall Study|Protocol Violation|5|||
125508862|NCT01322347|451492182|FG001|Overall Study|Protocol Violation|2|||
125508863|NCT01322347|451492181|FG000|Overall Study|Withdrawal by Subject|1|||
125508864|NCT01322347|451492182|FG001|Overall Study|Withdrawal by Subject|4|||
125508865|NCT01322347|451492181|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
125508866|NCT01322347|451492182|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
125508867|NCT01322347|451492181|FG000|Overall Study|blood transfusion|5|||
125508868|NCT01322347|451492182|FG001|Overall Study|blood transfusion|5|||
125508869|NCT01322347|451492181|FG000|Overall Study|sponsor decision|1|||
125508870|NCT01322347|451492182|FG001|Overall Study|sponsor decision|3|||
125508871|NCT01322347|451492181|FG000|Overall Study|ineligible|6|||
125508872|NCT01322347|451492182|FG001|Overall Study|ineligible|3|||
125508873|NCT01322347|451492181|FG000|Overall Study|kidney transplant|3|||
125508874|NCT01322347|451492182|FG001|Overall Study|kidney transplant|1|||
125508875|NCT01322347|451492181|FG000|Overall Study|study drug withheld > 12 wks|0|||
125508876|NCT01322347|451492182|FG001|Overall Study|study drug withheld > 12 wks|1|||
125508877|NCT01322347|451492181|FG000|Overall Study|moved/changed dialysis|2|||
125508878|NCT01322347|451492182|FG001|Overall Study|moved/changed dialysis|4|||
125508879|NCT01369147|451492184|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
125508880|NCT01369147|451492185|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
125508881|NCT01369147|451492186|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
125305521|NCT02218008|450745142|FG003|Stage 1 (S1)|Pregnancy|0|||
125508882|NCT04239911|451492187|FG000|Overall Study|Lost to Follow-up|2|||
125508883|NCT04239911|451492188|FG001|Overall Study|Lost to Follow-up|1|||
125508884|NCT03345407|451492193|FG000|Overall Study|Withdrawal by Subject|11|||
125508885|NCT03345407|451492194|FG001|Overall Study|Withdrawal by Subject|1|||
125508886|NCT03345407|451492195|FG002|Overall Study|Withdrawal by Subject|5|||
125508887|NCT03345407|451492196|FG003|Overall Study|Withdrawal by Subject|6|||
125508888|NCT03345407|451492197|FG004|Overall Study|Withdrawal by Subject|3|||
125508889|NCT03345407|451492198|FG005|Overall Study|Withdrawal by Subject|6|||
125508890|NCT03345407|451492199|FG006|Overall Study|Withdrawal by Subject|16|||
125508891|NCT03345407|451492193|FG000|Overall Study|Physician Decision|3|||
125508892|NCT03345407|451492194|FG001|Overall Study|Physician Decision|1|||
125508893|NCT03345407|451492195|FG002|Overall Study|Physician Decision|0|||
125508894|NCT03345407|451492196|FG003|Overall Study|Physician Decision|0|||
125508895|NCT03345407|451492197|FG004|Overall Study|Physician Decision|1|||
125508896|NCT03345407|451492198|FG005|Overall Study|Physician Decision|2|||
125508897|NCT03345407|451492199|FG006|Overall Study|Physician Decision|3|||
125508898|NCT03345407|451492193|FG000|Overall Study|Lost to Follow-up|2|||
125508899|NCT03345407|451492194|FG001|Overall Study|Lost to Follow-up|0|||
125508900|NCT03345407|451492195|FG002|Overall Study|Lost to Follow-up|1|||
125508901|NCT03345407|451492196|FG003|Overall Study|Lost to Follow-up|0|||
125508902|NCT03345407|451492197|FG004|Overall Study|Lost to Follow-up|1|||
125508903|NCT03345407|451492198|FG005|Overall Study|Lost to Follow-up|2|||
125508904|NCT03345407|451492199|FG006|Overall Study|Lost to Follow-up|3|||
125508905|NCT03345407|451492193|FG000|Overall Study|Protocol-defined stopping criteria|9|||
125508906|NCT03345407|451492194|FG001|Overall Study|Protocol-defined stopping criteria|0|||
125508907|NCT03345407|451492195|FG002|Overall Study|Protocol-defined stopping criteria|0|||
125508908|NCT03345407|451492196|FG003|Overall Study|Protocol-defined stopping criteria|0|||
125508909|NCT03345407|451492197|FG004|Overall Study|Protocol-defined stopping criteria|2|||
125508910|NCT03345407|451492198|FG005|Overall Study|Protocol-defined stopping criteria|1|||
125508911|NCT03345407|451492199|FG006|Overall Study|Protocol-defined stopping criteria|1|||
125508912|NCT03345407|451492193|FG000|Overall Study|Protocol Violation|2|||
125508913|NCT03345407|451492194|FG001|Overall Study|Protocol Violation|0|||
125508914|NCT03345407|451492195|FG002|Overall Study|Protocol Violation|0|||
125508915|NCT03345407|451492196|FG003|Overall Study|Protocol Violation|0|||
125508916|NCT03345407|451492197|FG004|Overall Study|Protocol Violation|1|||
125508917|NCT03345407|451492198|FG005|Overall Study|Protocol Violation|0|||
125508918|NCT03345407|451492199|FG006|Overall Study|Protocol Violation|3|||
125508919|NCT03345407|451492193|FG000|Overall Study|Lack of Efficacy|1|||
125508920|NCT03345407|451492194|FG001|Overall Study|Lack of Efficacy|1|||
125508921|NCT03345407|451492195|FG002|Overall Study|Lack of Efficacy|1|||
125508922|NCT03345407|451492196|FG003|Overall Study|Lack of Efficacy|1|||
125508923|NCT03345407|451492197|FG004|Overall Study|Lack of Efficacy|1|||
125508924|NCT03345407|451492198|FG005|Overall Study|Lack of Efficacy|0|||
125508925|NCT03345407|451492199|FG006|Overall Study|Lack of Efficacy|3|||
125508926|NCT03345407|451492193|FG000|Overall Study|Adverse Event|4|||
125508927|NCT03345407|451492194|FG001|Overall Study|Adverse Event|0|||
125508928|NCT03345407|451492195|FG002|Overall Study|Adverse Event|5|||
125508929|NCT03345407|451492196|FG003|Overall Study|Adverse Event|4|||
125508930|NCT03345407|451492197|FG004|Overall Study|Adverse Event|6|||
125508931|NCT03345407|451492198|FG005|Overall Study|Adverse Event|5|||
125508932|NCT03345407|451492199|FG006|Overall Study|Adverse Event|16|||
125508933|NCT00379210|451492200|FG000|Overall Study|Withdrawal by Subject|10|||
125508934|NCT00379210|451492201|FG001|Overall Study|Withdrawal by Subject|7|||
125508935|NCT01762345|451492202|FG000|Overall Study|Adverse Event|5|||
125508936|NCT01762345|451492202|FG000|Overall Study|Protocol Violation|2|||
125508937|NCT01525875|451492203|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
125508938|NCT01525875|451492204|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
125508939|NCT01525875|451492203|FG000|Open-label Period|Lost to Follow-up|0|||
125508940|NCT01525875|451492204|FG001|Open-label Period|Lost to Follow-up|2|||
125508941|NCT05072795|451492205|FG000|Overall Study|Lost to Follow-up|5|||
125508942|NCT01107912|451492208|FG000|Period 1|Adverse Event|0|||
125508943|NCT01107912|451492209|FG001|Period 1|Adverse Event|0|||
125508944|NCT01107912|451492210|FG002|Period 1|Adverse Event|0|||
125508945|NCT01107912|451492211|FG003|Period 1|Adverse Event|0|||
125508946|NCT01107912|451492212|FG004|Period 1|Adverse Event|2|||
125508947|NCT01107912|451492213|FG005|Period 1|Adverse Event|0|||
125508948|NCT01107912|451492208|FG000|Period 1|Physician Decision|0|||
125508949|NCT01107912|451492209|FG001|Period 1|Physician Decision|0|||
125508950|NCT01107912|451492210|FG002|Period 1|Physician Decision|0|||
125508951|NCT01107912|451492211|FG003|Period 1|Physician Decision|0|||
125508952|NCT01107912|451492212|FG004|Period 1|Physician Decision|1|||
125508953|NCT01107912|451492213|FG005|Period 1|Physician Decision|0|||
125305522|NCT02218008|450745143|FG004|Stage 1 (S1)|Pregnancy|0|||
125305523|NCT02218008|450745144|FG005|Stage 1 (S1)|Pregnancy|0|||
125305524|NCT02218008|450745139|FG000|Stage 1 (S1)|Protocol Violation|0|||
125508954|NCT01107912|451492208|FG000|Period 1|Withdrawal by Subject|1|||
125508955|NCT01107912|451492209|FG001|Period 1|Withdrawal by Subject|0|||
125508956|NCT01107912|451492210|FG002|Period 1|Withdrawal by Subject|0|||
125508957|NCT01107912|451492211|FG003|Period 1|Withdrawal by Subject|0|||
125508958|NCT01107912|451492212|FG004|Period 1|Withdrawal by Subject|0|||
125508959|NCT01107912|451492213|FG005|Period 1|Withdrawal by Subject|0|||
125508960|NCT01107912|451492208|FG000|Period 2|Physician Decision|0|||
125508961|NCT01107912|451492209|FG001|Period 2|Physician Decision|0|||
125508962|NCT01107912|451492210|FG002|Period 2|Physician Decision|1|||
125508963|NCT01107912|451492211|FG003|Period 2|Physician Decision|0|||
125508964|NCT01107912|451492212|FG004|Period 2|Physician Decision|0|||
125508965|NCT01107912|451492213|FG005|Period 2|Physician Decision|0|||
125508966|NCT01107912|451492208|FG000|Period 3|Adverse Event|0|||
125508967|NCT01107912|451492209|FG001|Period 3|Adverse Event|1|||
125508968|NCT01107912|451492210|FG002|Period 3|Adverse Event|1|||
125508969|NCT01107912|451492211|FG003|Period 3|Adverse Event|0|||
125508970|NCT01107912|451492212|FG004|Period 3|Adverse Event|0|||
125508971|NCT01107912|451492213|FG005|Period 3|Adverse Event|0|||
125508972|NCT01107912|451492208|FG000|Period 3|Withdrawal by Subject|0|||
125508973|NCT01107912|451492209|FG001|Period 3|Withdrawal by Subject|0|||
125508974|NCT01107912|451492210|FG002|Period 3|Withdrawal by Subject|0|||
125508975|NCT01107912|451492211|FG003|Period 3|Withdrawal by Subject|1|||
125508976|NCT01107912|451492212|FG004|Period 3|Withdrawal by Subject|0|||
125508977|NCT01107912|451492213|FG005|Period 3|Withdrawal by Subject|0|||
125508978|NCT01601821|451492214|FG000|Overall Study|Death|2|||
125508979|NCT01601821|451492215|FG001|Overall Study|Death|5|||
125508980|NCT01601821|451492214|FG000|Overall Study|Protocol Violation|2|||
125508981|NCT01601821|451492215|FG001|Overall Study|Protocol Violation|2|||
125508982|NCT01601821|451492214|FG000|Overall Study|Lost to Follow-up|6|||
125508983|NCT01601821|451492215|FG001|Overall Study|Lost to Follow-up|14|||
125508984|NCT01601821|451492214|FG000|Overall Study|Withdrawal by Subject|1|||
125508985|NCT01601821|451492215|FG001|Overall Study|Withdrawal by Subject|0|||
125508986|NCT01601821|451492214|FG000|Overall Study|Graft Loss|6|||
125508987|NCT01601821|451492215|FG001|Overall Study|Graft Loss|6|||
125508988|NCT01601821|451492214|FG000|Overall Study|Study Events|7|||
125508989|NCT01601821|451492215|FG001|Overall Study|Study Events|1|||
125508990|NCT01601821|451492214|FG000|Overall Study|Other|5|||
125508991|NCT01601821|451492215|FG001|Overall Study|Other|1|||
125508992|NCT00442559|451492223|FG000|Overall Study|Lost to Follow-up|32|||
125508993|NCT00442559|451492224|FG001|Overall Study|Lost to Follow-up|34|||
125508994|NCT00442559|451492223|FG000|Overall Study|Protocol Violation|1|||
125508995|NCT00442559|451492224|FG001|Overall Study|Protocol Violation|1|||
125508996|NCT00442559|451492223|FG000|Overall Study|Withdrawal by Subject|1|||
125508997|NCT00442559|451492224|FG001|Overall Study|Withdrawal by Subject|0|||
125508998|NCT00753896|451492233|FG000|Overall Study|Adverse Event|4|||
125508999|NCT00753896|451492233|FG000|Overall Study|Death|1|||
125509000|NCT00753896|451492233|FG000|Overall Study|Lost to Follow-up|2|||
125509001|NCT00753896|451492233|FG000|Overall Study|Protocol Violation|1|||
125509002|NCT00753896|451492233|FG000|Overall Study|Withdrawal by Subject|4|||
125509003|NCT00753896|451492233|FG000|Overall Study|Entry Criteria Not Met|4|||
125509004|NCT01989156|451492234|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
125509005|NCT01989156|451492235|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
125509006|NCT01989156|451492236|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
125509007|NCT01989156|451492234|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
125509008|NCT01989156|451492235|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
125509009|NCT01989156|451492236|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
125509010|NCT01989156|451492234|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
125509011|NCT01989156|451492235|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
125509012|NCT01989156|451492236|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
125509013|NCT01989156|451492234|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
125509014|NCT01989156|451492235|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
125509015|NCT01989156|451492236|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
125509016|NCT01989156|451492234|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
125509017|NCT01989156|451492235|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
125509018|NCT01989156|451492236|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
125509019|NCT01989156|451492234|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
125509020|NCT01989156|451492235|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
125509021|NCT01989156|451492236|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
125509022|NCT01989156|451492234|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
125509023|NCT01989156|451492235|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
125509024|NCT01989156|451492236|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
125509025|NCT01989156|451492234|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
125509026|NCT01989156|451492235|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
125509027|NCT01989156|451492236|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
125509028|NCT01721109|451492240|FG000|Overall Study|Lack of Efficacy|1|||
125509029|NCT01721109|451492240|FG000|Overall Study|Non- Compliance with Study Drug|3|||
125509030|NCT01721109|451492240|FG000|Overall Study|Withdrew Consent|1|||
125509031|NCT01721109|451492240|FG000|Overall Study|Lost to Follow-up|2|||
125509032|NCT04362176|451492241|FG000|Overall Study|Lost to Follow-up|5|||
125509033|NCT04362176|451492242|FG001|Overall Study|Lost to Follow-up|8|||
125509034|NCT04362176|451492241|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
125509035|NCT04362176|451492242|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
125509036|NCT00742560|451492243|FG000|Overall Study|Adverse Event|0|||
125509037|NCT00742560|451492244|FG001|Overall Study|Adverse Event|0|||
125509038|NCT00742560|451492245|FG002|Overall Study|Adverse Event|1|||
125509039|NCT00742560|451492246|FG003|Overall Study|Adverse Event|1|||
125509040|NCT00742560|451492247|FG004|Overall Study|Adverse Event|1|||
125509041|NCT00742560|451492243|FG000|Overall Study|Death|0|||
125509042|NCT00742560|451492244|FG001|Overall Study|Death|2|||
125509043|NCT00742560|451492245|FG002|Overall Study|Death|0|||
125509044|NCT00742560|451492246|FG003|Overall Study|Death|2|||
125509045|NCT00742560|451492247|FG004|Overall Study|Death|3|||
125509046|NCT00742560|451492243|FG000|Overall Study|Subject's Decision|1|||
125509047|NCT00742560|451492244|FG001|Overall Study|Subject's Decision|0|||
125509048|NCT00742560|451492245|FG002|Overall Study|Subject's Decision|2|||
125509049|NCT00742560|451492246|FG003|Overall Study|Subject's Decision|3|||
125509050|NCT00742560|451492247|FG004|Overall Study|Subject's Decision|3|||
125509051|NCT00742560|451492243|FG000|Overall Study|Investigator's Decision|0|||
125509052|NCT00742560|451492244|FG001|Overall Study|Investigator's Decision|0|||
125509053|NCT00742560|451492245|FG002|Overall Study|Investigator's Decision|4|||
125509054|NCT00742560|451492246|FG003|Overall Study|Investigator's Decision|1|||
125509055|NCT00742560|451492247|FG004|Overall Study|Investigator's Decision|0|||
125509056|NCT00742560|451492243|FG000|Overall Study|Disease Progression|1|||
125509057|NCT00742560|451492244|FG001|Overall Study|Disease Progression|0|||
125509058|NCT00742560|451492245|FG002|Overall Study|Disease Progression|5|||
125509059|NCT00742560|451492246|FG003|Overall Study|Disease Progression|17|||
125509060|NCT00742560|451492247|FG004|Overall Study|Disease Progression|16|||
125509061|NCT00742560|451492243|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
125509062|NCT00742560|451492244|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
125509063|NCT00742560|451492245|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
125509064|NCT00742560|451492246|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
125509065|NCT00742560|451492247|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
125509066|NCT00742560|451492243|FG000|Overall Study|Other|0|||
125509067|NCT00742560|451492244|FG001|Overall Study|Other|1|||
125509068|NCT00742560|451492245|FG002|Overall Study|Other|8|||
125509069|NCT00742560|451492246|FG003|Overall Study|Other|9|||
125509070|NCT00742560|451492247|FG004|Overall Study|Other|9|||
125509071|NCT00742560|451492243|FG000|Overall Study|MIssing|0|||
125509072|NCT00742560|451492244|FG001|Overall Study|MIssing|0|||
125509073|NCT00742560|451492245|FG002|Overall Study|MIssing|0|||
125509074|NCT00742560|451492246|FG003|Overall Study|MIssing|0|||
125509075|NCT00742560|451492247|FG004|Overall Study|MIssing|1|||
125509076|NCT01426217|451492249|FG000|Overall Study|lost sample|8|||
125509077|NCT01426217|451492250|FG001|Overall Study|lost sample|14|||
125509078|NCT01536795|451492251|FG000|Overall Study|Lost to Follow-up|0|||
125509079|NCT01536795|451492252|FG001|Overall Study|Lost to Follow-up|2|||
125509080|NCT01536795|451492251|FG000|Overall Study|Lack of Efficacy|1|||
125509081|NCT01536795|451492252|FG001|Overall Study|Lack of Efficacy|0|||
125509082|NCT01812837|451492253|FG000|Overall Study|Lost to Follow-up|1|||
125509083|NCT01812837|451492254|FG001|Overall Study|Lost to Follow-up|1|||
125509084|NCT01812837|451492255|FG002|Overall Study|Lost to Follow-up|0|||
125509085|NCT01812837|451492253|FG000|Overall Study|Protocol Violation|1|||
125509086|NCT01812837|451492254|FG001|Overall Study|Protocol Violation|0|||
125509087|NCT01812837|451492255|FG002|Overall Study|Protocol Violation|0|||
125509088|NCT05008224|451492257|FG000|Overall Study|Death|3|||
125509089|NCT05008224|451492257|FG000|Overall Study|Lost to Follow-up|2|||
125509090|NCT05008224|451492257|FG000|Overall Study|Did Not Continue on Extension Study|39|||
125509091|NCT05008224|451492257|FG000|Overall Study|Transferred to Extension Study|100|||
125509092|NCT05008224|451492257|FG000|Overall Study|Withdrawal by Subject|2|||
125509093|NCT05234632|451492258|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
125509094|NCT05234632|451492259|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
125509095|NCT05234632|451492258|FG000|Overall Study|Withdrawal by Subject|2|||
125509096|NCT05234632|451492259|FG001|Overall Study|Withdrawal by Subject|0|||
125509097|NCT05234632|451492258|FG000|Overall Study|Adverse Event|0|||
125509098|NCT05234632|451492259|FG001|Overall Study|Adverse Event|4|||
125509099|NCT05234632|451492258|FG000|Overall Study|Physician Decision|1|||
125509100|NCT05234632|451492259|FG001|Overall Study|Physician Decision|1|||
125509101|NCT05234632|451492258|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
125509102|NCT05234632|451492259|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
125509103|NCT05234632|451492258|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
125509104|NCT05234632|451492259|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
125509105|NCT02991456|451492261|FG000|Overall Study|Adverse Event|2|||
125509106|NCT02991456|451492262|FG001|Overall Study|Adverse Event|0|||
125509107|NCT02991456|451492261|FG000|Overall Study|Lost to Follow-up|0|||
125509108|NCT02991456|451492262|FG001|Overall Study|Lost to Follow-up|2|||
125509109|NCT02991456|451492261|FG000|Overall Study|Withdrawal by Subject|1|||
125509110|NCT02991456|451492262|FG001|Overall Study|Withdrawal by Subject|0|||
125509111|NCT00321555|451492265|FG000|Overall Study|Developed antibodies|1|||
125509112|NCT00321555|451492265|FG000|Overall Study|Switched to alternative treatment|3|||
125509113|NCT00321555|451492265|FG000|Overall Study|Physician Decision|1|||
125509114|NCT00321555|451492265|FG000|Overall Study|Disease progression on study|1|||
125509115|NCT02066389|451492268|FG000|Overall Study|Adverse Event|1|||
125509116|NCT02066389|451492269|FG001|Overall Study|Adverse Event|1|||
125509117|NCT02066389|451492270|FG002|Overall Study|Adverse Event|1|||
125509118|NCT02066389|451492271|FG003|Overall Study|Adverse Event|1|||
125509119|NCT02066389|451492272|FG004|Overall Study|Adverse Event|5|||
125509120|NCT02066389|451492273|FG005|Overall Study|Adverse Event|1|||
125509121|NCT02066389|451492268|FG000|Overall Study|Withdrawal by Subject|4|||
125509122|NCT02066389|451492269|FG001|Overall Study|Withdrawal by Subject|0|||
125509123|NCT02066389|451492270|FG002|Overall Study|Withdrawal by Subject|5|||
125509124|NCT02066389|451492271|FG003|Overall Study|Withdrawal by Subject|1|||
125509125|NCT02066389|451492272|FG004|Overall Study|Withdrawal by Subject|1|||
125509126|NCT02066389|451492273|FG005|Overall Study|Withdrawal by Subject|2|||
125509127|NCT02066389|451492268|FG000|Overall Study|Lost to Follow-up|0|||
125509128|NCT02066389|451492269|FG001|Overall Study|Lost to Follow-up|0|||
125509129|NCT02066389|451492270|FG002|Overall Study|Lost to Follow-up|0|||
125509130|NCT02066389|451492271|FG003|Overall Study|Lost to Follow-up|1|||
125509131|NCT02066389|451492272|FG004|Overall Study|Lost to Follow-up|1|||
125509132|NCT02066389|451492273|FG005|Overall Study|Lost to Follow-up|1|||
125509133|NCT02066389|451492268|FG000|Overall Study|Randomized in Error|0|||
125509134|NCT02066389|451492269|FG001|Overall Study|Randomized in Error|0|||
125509135|NCT02066389|451492270|FG002|Overall Study|Randomized in Error|0|||
125509136|NCT02066389|451492271|FG003|Overall Study|Randomized in Error|0|||
125509137|NCT02066389|451492272|FG004|Overall Study|Randomized in Error|0|||
125509138|NCT02066389|451492273|FG005|Overall Study|Randomized in Error|1|||
125509139|NCT01755598|451492276|FG000|Overall Study|Other|109|||
125509140|NCT01755598|451492277|FG001|Overall Study|Other|109|||
125509141|NCT01755598|451492276|FG000|Overall Study|Lost to Follow-up|32|||
125509142|NCT01755598|451492277|FG001|Overall Study|Lost to Follow-up|43|||
125509143|NCT01755598|451492276|FG000|Overall Study|Migrated/moved from study area|76|||
125509144|NCT01755598|451492277|FG001|Overall Study|Migrated/moved from study area|65|||
125509145|NCT01755598|451492276|FG000|Overall Study|Withdrawal by Subject|22|||
125509146|NCT01755598|451492277|FG001|Overall Study|Withdrawal by Subject|31|||
125509147|NCT01755598|451492276|FG000|Overall Study|Protocol Violation|7|||
125509148|NCT01755598|451492277|FG001|Overall Study|Protocol Violation|7|||
125509149|NCT01755598|451492276|FG000|Overall Study|Adverse Event|19|||
125509150|NCT01755598|451492277|FG001|Overall Study|Adverse Event|28|||
125509151|NCT02924051|451492280|FG000|Overall Study|Withdrawal by Subject|1|||
125509152|NCT02924051|451492281|FG001|Overall Study|Withdrawal by Subject|9|||
125509153|NCT00738400|451492286|FG000|Overall Study|Adverse Event|3|||
125509154|NCT00738400|451492287|FG001|Overall Study|Adverse Event|1|||
125509155|NCT00738400|451492286|FG000|Overall Study|Withdrawal by Subject|0|||
125509156|NCT00738400|451492287|FG001|Overall Study|Withdrawal by Subject|1|||
125509157|NCT00738400|451492286|FG000|Overall Study|Lack of Efficacy|0|||
125509158|NCT00738400|451492287|FG001|Overall Study|Lack of Efficacy|1|||
125509159|NCT00738400|451492286|FG000|Overall Study|Lost to Follow-up|0|||
125509160|NCT00738400|451492287|FG001|Overall Study|Lost to Follow-up|3|||
125509161|NCT00738400|451492286|FG000|Overall Study|Protocol Violation|1|||
125509162|NCT00738400|451492287|FG001|Overall Study|Protocol Violation|0|||
125509163|NCT00738400|451492286|FG000|Overall Study|Non-compliant with study medication|0|||
125509164|NCT00738400|451492287|FG001|Overall Study|Non-compliant with study medication|1|||
125509165|NCT02312245|451492288|FG000|Overall Study|Death|0|||
125509166|NCT02312245|451492289|FG001|Overall Study|Death|0|||
125509167|NCT02312245|451492290|FG002|Overall Study|Death|0|||
125509168|NCT02312245|451492291|FG003|Overall Study|Death|1|||
125509169|NCT02312245|451492288|FG000|Overall Study|Withdrawal by Subject|1|||
125509170|NCT02312245|451492289|FG001|Overall Study|Withdrawal by Subject|1|||
125509171|NCT02312245|451492290|FG002|Overall Study|Withdrawal by Subject|0|||
125509172|NCT02312245|451492291|FG003|Overall Study|Withdrawal by Subject|2|||
125509173|NCT02312245|451492288|FG000|Overall Study|Alternative Therapy|1|||
125509174|NCT02312245|451492289|FG001|Overall Study|Alternative Therapy|0|||
125509175|NCT02312245|451492290|FG002|Overall Study|Alternative Therapy|0|||
125509176|NCT02312245|451492291|FG003|Overall Study|Alternative Therapy|0|||
125509177|NCT02312245|451492288|FG000|Overall Study|Progression|0|||
125509178|NCT02312245|451492289|FG001|Overall Study|Progression|0|||
125509179|NCT02312245|451492290|FG002|Overall Study|Progression|0|||
125509180|NCT02312245|451492291|FG003|Overall Study|Progression|5|||
125509181|NCT02312245|451492288|FG000|Overall Study|Patient went to hospice|0|||
125509182|NCT02312245|451492289|FG001|Overall Study|Patient went to hospice|0|||
125509183|NCT02312245|451492290|FG002|Overall Study|Patient went to hospice|0|||
125509184|NCT02312245|451492291|FG003|Overall Study|Patient went to hospice|1|||
125509185|NCT02312245|451492288|FG000|Overall Study|Ineligible|1|||
125509186|NCT02312245|451492289|FG001|Overall Study|Ineligible|0|||
125509187|NCT02312245|451492290|FG002|Overall Study|Ineligible|0|||
125509188|NCT02312245|451492291|FG003|Overall Study|Ineligible|0|||
125509189|NCT00508144|451492292|FG000|Overall Study|Not eligible|6|||
125509190|NCT00508144|451492292|FG000|Overall Study|Death|5|||
125509191|NCT03122548|451492297|FG000|Overall Study|Death|2|||
125509192|NCT03122548|451492297|FG000|Overall Study|Progression - subject went into hospice|1|||
125509193|NCT03122548|451492297|FG000|Overall Study|Study Terminated by Sponsor|2|||
125509194|NCT02332889|451492300|FG000|Overall Study|Physician Decision|1|||
125509195|NCT04448561|451492302|FG000|Overall Study|Noncompliance|1|||
125509196|NCT04448561|451492303|FG001|Overall Study|Noncompliance|0|||
125509197|NCT05356130|451493477|FG000|Overall Study|Withdrawal by Subject|0|||
125509198|NCT05356130|451493478|FG001|Overall Study|Withdrawal by Subject|0|||
125509199|NCT05356130|451493479|FG002|Overall Study|Withdrawal by Subject|3|||
125509200|NCT03141177|451493480|FG000|Overall Study|Death|62|||
125509201|NCT03141177|451493481|FG001|Overall Study|Death|13|||
125509202|NCT03141177|451493482|FG002|Overall Study|Death|84|||
125509203|NCT03141177|451493480|FG000|Overall Study|Participant withdrew consent|9|||
125509204|NCT03141177|451493481|FG001|Overall Study|Participant withdrew consent|2|||
125509205|NCT03141177|451493482|FG002|Overall Study|Participant withdrew consent|13|||
125509206|NCT03141177|451493480|FG000|Overall Study|Not reported|1|||
125509207|NCT03141177|451493481|FG001|Overall Study|Not reported|0|||
125509208|NCT03141177|451493482|FG002|Overall Study|Not reported|1|||
125509209|NCT03141177|451493480|FG000|Overall Study|Lost to Follow-up|2|||
125509210|NCT03141177|451493481|FG001|Overall Study|Lost to Follow-up|1|||
125509211|NCT03141177|451493482|FG002|Overall Study|Lost to Follow-up|1|||
125509212|NCT03141177|451493480|FG000|Overall Study|Other reasons|4|||
125509213|NCT03141177|451493481|FG001|Overall Study|Other reasons|0|||
125509214|NCT03141177|451493482|FG002|Overall Study|Other reasons|11|||
125509215|NCT03141177|451493480|FG000|Overall Study|Participants did not start treatment period|3|||
125509216|NCT03141177|451493481|FG001|Overall Study|Participants did not start treatment period|0|||
125509217|NCT03141177|451493482|FG002|Overall Study|Participants did not start treatment period|8|||
125509218|NCT03696342|451493491|FG000|Overall Study|Lost to Follow-up|1|||
125509219|NCT03696342|451493492|FG001|Overall Study|Lost to Follow-up|0|||
125509220|NCT05361304|451493495|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
125509221|NCT05361304|451493496|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
125509222|NCT05361304|451493495|FG000|Overall Study|COVID-19 Related|1|||
125509223|NCT05361304|451493496|FG001|Overall Study|COVID-19 Related|2|||
125509224|NCT05361304|451493495|FG000|Overall Study|Withdrawal by Subject|1|||
125509225|NCT05361304|451493496|FG001|Overall Study|Withdrawal by Subject|0|||
125509226|NCT02409732|451493497|FG000|Overall Study|Withdrawal by Subject|4|||
125509227|NCT02409732|451493497|FG000|Overall Study|Lost to Follow-up|2|||
125509228|NCT00376259|451493498|FG000|Overall Study|Sponsor request - study termination|21|||
125509229|NCT00376259|451493499|FG001|Overall Study|Sponsor request - study termination|21|||
125509230|NCT00376259|451493498|FG000|Overall Study|Patient request|1|||
125509231|NCT00376259|451493499|FG001|Overall Study|Patient request|0|||
125509232|NCT01877720|451493500|FG000|Overall Study|Adverse Event|1|||
125509233|NCT01877720|451493501|FG001|Overall Study|Adverse Event|0|||
125509234|NCT00447499|451493502|FG000|Overall Study|Adverse Event|1|||
125509235|NCT00447499|451493502|FG000|Overall Study|Patient Decision|4|||
125509236|NCT00447499|451493502|FG000|Overall Study|Sponsor Decision|1|||
125509237|NCT00447499|451493502|FG000|Overall Study|Physician Decision|1|||
125509238|NCT02068352|451493504|FG000|Overall Study|Lost to Follow-up|0|||
125509239|NCT02068352|451493505|FG001|Overall Study|Lost to Follow-up|2|||
125509240|NCT02068352|451493506|FG002|Overall Study|Lost to Follow-up|0|||
125509241|NCT02068352|451493504|FG000|Overall Study|Adverse Event|4|||
125509242|NCT02068352|451493505|FG001|Overall Study|Adverse Event|2|||
125509243|NCT02068352|451493506|FG002|Overall Study|Adverse Event|7|||
125509244|NCT02068352|451493504|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
125509245|NCT02068352|451493505|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
125509246|NCT02068352|451493506|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
125509247|NCT02068352|451493504|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
125509248|NCT02068352|451493505|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
125509249|NCT02068352|451493506|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
125509250|NCT02068352|451493504|FG000|Overall Study|Protocol Deviation|0|||
125509251|NCT02068352|451493505|FG001|Overall Study|Protocol Deviation|0|||
125509252|NCT02068352|451493506|FG002|Overall Study|Protocol Deviation|1|||
125509253|NCT03960437|451493509|FG000|Overall Study|Removed by PI|4|||
125509254|NCT03960437|451493509|FG000|Overall Study|Lost to Follow-up|2|||
125509255|NCT03960437|451493509|FG000|Overall Study|Withdrawal by Subject|1|||
125509256|NCT03960437|451493509|FG000|Overall Study|Death|2|||
125509257|NCT00473512|451493510|FG000|Period 1 (Phase 1)|Adverse Event|0|||
125509258|NCT00473512|451493511|FG001|Period 1 (Phase 1)|Adverse Event|0|||
125509259|NCT00473512|451493512|FG002|Period 1 (Phase 1)|Adverse Event|0|||
125305525|NCT02218008|450745140|FG001|Stage 1 (S1)|Protocol Violation|0|||
125305526|NCT02218008|450745141|FG002|Stage 1 (S1)|Protocol Violation|1|||
125509260|NCT00473512|451493513|FG003|Period 1 (Phase 1)|Adverse Event|5|||
125509261|NCT00473512|451493514|FG004|Period 1 (Phase 1)|Adverse Event|0|||
125509262|NCT00473512|451493510|FG000|Period 1 (Phase 1)|Death|0|||
125509263|NCT00473512|451493511|FG001|Period 1 (Phase 1)|Death|0|||
125509264|NCT00473512|451493512|FG002|Period 1 (Phase 1)|Death|0|||
125509265|NCT00473512|451493513|FG003|Period 1 (Phase 1)|Death|1|||
125509266|NCT00473512|451493514|FG004|Period 1 (Phase 1)|Death|0|||
125509267|NCT00473512|451493510|FG000|Period 1 (Phase 1)|Disease Progression|1|||
125509268|NCT00473512|451493511|FG001|Period 1 (Phase 1)|Disease Progression|1|||
125509269|NCT00473512|451493512|FG002|Period 1 (Phase 1)|Disease Progression|0|||
125509270|NCT00473512|451493513|FG003|Period 1 (Phase 1)|Disease Progression|10|||
125509271|NCT00473512|451493514|FG004|Period 1 (Phase 1)|Disease Progression|1|||
125509272|NCT00473512|451493510|FG000|Period 1 (Phase 1)|Other|0|||
125509273|NCT00473512|451493511|FG001|Period 1 (Phase 1)|Other|0|||
125509274|NCT00473512|451493512|FG002|Period 1 (Phase 1)|Other|0|||
125509275|NCT00473512|451493513|FG003|Period 1 (Phase 1)|Other|1|||
125509276|NCT00473512|451493514|FG004|Period 1 (Phase 1)|Other|0|||
125509277|NCT00473512|451493510|FG000|Period 2 (Phase 2)|Adverse Event|0|||
125509278|NCT00473512|451493511|FG001|Period 2 (Phase 2)|Adverse Event|0|||
125509279|NCT00473512|451493512|FG002|Period 2 (Phase 2)|Adverse Event|0|||
125509280|NCT00473512|451493513|FG003|Period 2 (Phase 2)|Adverse Event|1|||
125509281|NCT00473512|451493514|FG004|Period 2 (Phase 2)|Adverse Event|0|||
125509282|NCT00473512|451493510|FG000|Period 2 (Phase 2)|Death|0|||
125509283|NCT00473512|451493511|FG001|Period 2 (Phase 2)|Death|0|||
125509284|NCT00473512|451493512|FG002|Period 2 (Phase 2)|Death|0|||
125509285|NCT00473512|451493513|FG003|Period 2 (Phase 2)|Death|1|||
125509286|NCT00473512|451493514|FG004|Period 2 (Phase 2)|Death|1|||
125509287|NCT00473512|451493510|FG000|Period 2 (Phase 2)|Disease Progression|0|||
125509288|NCT00473512|451493511|FG001|Period 2 (Phase 2)|Disease Progression|2|||
125509289|NCT00473512|451493512|FG002|Period 2 (Phase 2)|Disease Progression|2|||
125509290|NCT00473512|451493513|FG003|Period 2 (Phase 2)|Disease Progression|17|||
125509291|NCT00473512|451493514|FG004|Period 2 (Phase 2)|Disease Progression|1|||
125509292|NCT00473512|451493510|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
125509293|NCT00473512|451493511|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
125509294|NCT00473512|451493512|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
125509295|NCT00473512|451493513|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
125509296|NCT00473512|451493514|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
125509297|NCT00473512|451493510|FG000|Period 2 (Phase 2)|Other|1|||
125509298|NCT00473512|451493511|FG001|Period 2 (Phase 2)|Other|0|||
125509299|NCT00473512|451493512|FG002|Period 2 (Phase 2)|Other|0|||
125509300|NCT00473512|451493513|FG003|Period 2 (Phase 2)|Other|3|||
125509301|NCT00473512|451493514|FG004|Period 2 (Phase 2)|Other|0|||
125509302|NCT00267956|451493515|FG000|Controlled Period|Adverse Event|4|||
125509303|NCT00267956|451493516|FG001|Controlled Period|Adverse Event|1|||
125509304|NCT00267956|451493517|FG002|Controlled Period|Adverse Event|0|||
125509305|NCT00267956|451493518|FG003|Controlled Period|Adverse Event|0|||
125509306|NCT00267956|451493515|FG000|Controlled Period|Lack of Efficacy|4|||
125509307|NCT00267956|451493516|FG001|Controlled Period|Lack of Efficacy|2|||
125509308|NCT00267956|451493517|FG002|Controlled Period|Lack of Efficacy|0|||
125509309|NCT00267956|451493518|FG003|Controlled Period|Lack of Efficacy|0|||
125509310|NCT00267956|451493515|FG000|Controlled Period|Lost to Follow-up|2|||
125509311|NCT00267956|451493516|FG001|Controlled Period|Lost to Follow-up|0|||
125509312|NCT00267956|451493517|FG002|Controlled Period|Lost to Follow-up|0|||
125509313|NCT00267956|451493518|FG003|Controlled Period|Lost to Follow-up|0|||
125509314|NCT00267956|451493515|FG000|Controlled Period|Withdrew consent|3|||
125509315|NCT00267956|451493516|FG001|Controlled Period|Withdrew consent|1|||
125509316|NCT00267956|451493517|FG002|Controlled Period|Withdrew consent|0|||
125509317|NCT00267956|451493518|FG003|Controlled Period|Withdrew consent|0|||
125509318|NCT00267956|451493515|FG000|After Controlled Period|Adverse Event|0|||
125509319|NCT00267956|451493516|FG001|After Controlled Period|Adverse Event|0|||
125509320|NCT00267956|451493517|FG002|After Controlled Period|Adverse Event|2|||
125509321|NCT00267956|451493518|FG003|After Controlled Period|Adverse Event|1|||
125509322|NCT00267956|451493515|FG000|After Controlled Period|Lack of Efficacy|0|||
125509323|NCT00267956|451493516|FG001|After Controlled Period|Lack of Efficacy|0|||
125509324|NCT00267956|451493517|FG002|After Controlled Period|Lack of Efficacy|1|||
125509325|NCT00267956|451493518|FG003|After Controlled Period|Lack of Efficacy|1|||
125509326|NCT00267956|451493515|FG000|After Controlled Period|Lost to Follow-up|0|||
125509327|NCT00267956|451493516|FG001|After Controlled Period|Lost to Follow-up|0|||
125509328|NCT00267956|451493517|FG002|After Controlled Period|Lost to Follow-up|1|||
125509329|NCT00267956|451493518|FG003|After Controlled Period|Lost to Follow-up|0|||
125509330|NCT00267956|451493515|FG000|After Controlled Period|Withdrew consent|0|||
125509331|NCT00267956|451493516|FG001|After Controlled Period|Withdrew consent|0|||
125509332|NCT00267956|451493517|FG002|After Controlled Period|Withdrew consent|1|||
125509333|NCT00267956|451493518|FG003|After Controlled Period|Withdrew consent|0|||
125509334|NCT02246647|451493519|FG000|Overall Study|Withdrawal by Subject|1|||
125509335|NCT02246647|451493520|FG001|Overall Study|Withdrawal by Subject|1|||
125509336|NCT01012999|451493521|FG000|Overall Study|Protocol Violation|1|||
125509337|NCT03557307|451493522|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
125509338|NCT03557307|451493522|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
125509339|NCT03557307|451493522|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
125509340|NCT03557307|451493522|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
125509341|NCT03557307|451493522|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
125509342|NCT03557307|451493522|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
125509343|NCT03557307|451493522|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
125509344|NCT03557307|451493522|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
125509345|NCT03557307|451493522|FG000|Period 2: Maintenance Phase|Death|3|||
125509346|NCT03557307|451493522|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
125509347|NCT03557307|451493522|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
125509348|NCT03557307|451493522|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
125509349|NCT03557307|451493522|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
125509350|NCT03557307|451493522|FG000|Period 2: Maintenance Phase|other|3|||
125509351|NCT03184519|451493523|FG000|Overall Study|Lost to Follow-up|6|||
125509352|NCT03184519|451493523|FG000|Overall Study|Physician Decision|21|||
125509353|NCT00584909|451493525|FG000|Overall Study|Adverse Event|4|||
125509354|NCT02256553|451493528|FG000|Period I|Adverse Event|5|||
125509355|NCT02256553|451493528|FG000|Period I|Protocol Violation|1|||
125509356|NCT02256553|451493528|FG000|Period II|Adverse Event|1|||
125509357|NCT02256553|451493528|FG000|Period II|Subject Moved|1|||
125509358|NCT02256553|451493528|FG000|Period III|Adverse Event|3|||
125509359|NCT02092909|451493529|FG000|Overall Study|Adverse Event|0|||
125509360|NCT02092909|451493530|FG001|Overall Study|Adverse Event|0|||
125509361|NCT02092909|451493531|FG002|Overall Study|Adverse Event|4|||
125509362|NCT02092909|451493532|FG003|Overall Study|Adverse Event|2|||
125509363|NCT02092909|451493529|FG000|Overall Study|Lack of Efficacy|0|||
125509364|NCT02092909|451493530|FG001|Overall Study|Lack of Efficacy|2|||
125509365|NCT02092909|451493531|FG002|Overall Study|Lack of Efficacy|1|||
125509366|NCT02092909|451493532|FG003|Overall Study|Lack of Efficacy|0|||
125509367|NCT02092909|451493529|FG000|Overall Study|Withdrawal by Subject|0|||
125509368|NCT02092909|451493530|FG001|Overall Study|Withdrawal by Subject|0|||
125509369|NCT02092909|451493531|FG002|Overall Study|Withdrawal by Subject|2|||
125509370|NCT02092909|451493532|FG003|Overall Study|Withdrawal by Subject|1|||
125509371|NCT02092909|451493529|FG000|Overall Study|Study terminated by Sponsor|0|||
125509372|NCT02092909|451493530|FG001|Overall Study|Study terminated by Sponsor|0|||
125509373|NCT02092909|451493531|FG002|Overall Study|Study terminated by Sponsor|0|||
125509374|NCT02092909|451493532|FG003|Overall Study|Study terminated by Sponsor|2|||
125509375|NCT02092909|451493529|FG000|Overall Study|Miscellaneous|1|||
125509376|NCT02092909|451493530|FG001|Overall Study|Miscellaneous|1|||
125509377|NCT02092909|451493531|FG002|Overall Study|Miscellaneous|2|||
125509378|NCT02092909|451493532|FG003|Overall Study|Miscellaneous|1|||
125509379|NCT03436797|451493533|FG000|Main Study|Withdrawal by Subject|2|||
125509380|NCT03436797|451493533|FG000|Main Study|Adverse Event|4|||
125509381|NCT03436797|451493533|FG000|Main Study|Lost to Follow-up|1|||
125509382|NCT03436797|451493533|FG000|Main Study|Death|1|||
125509383|NCT03436797|451493533|FG000|Main Study|Non-Specific|2|||
125509384|NCT03436797|451493533|FG000|Extended Dosing|Patient decision|1|||
125509385|NCT04626128|451493536|FG000|Overall Study|Withdrawal by Subject|0|||
125509386|NCT04626128|451493537|FG001|Overall Study|Withdrawal by Subject|1|||
125509387|NCT04626128|451493538|FG002|Overall Study|Withdrawal by Subject|0|||
125509388|NCT04626128|451493539|FG003|Overall Study|Withdrawal by Subject|0|||
125509389|NCT01182285|451493540|FG000|First Intervention Week 1-10|Disease progression|1|||
125509390|NCT01182285|451493541|FG001|First Intervention Week 1-10|Disease progression|0|||
125509391|NCT01182285|451493542|FG002|First Intervention Week 1-10|Disease progression|0|||
125509392|NCT01182285|451493540|FG000|First Intervention Week 1-10|Adverse Event|1|||
125509393|NCT01182285|451493541|FG001|First Intervention Week 1-10|Adverse Event|0|||
125509394|NCT01182285|451493542|FG002|First Intervention Week 1-10|Adverse Event|0|||
125509395|NCT01182285|451493540|FG000|First Intervention Week 1-10|Non-compliance|1|||
125509396|NCT01182285|451493541|FG001|First Intervention Week 1-10|Non-compliance|0|||
125509397|NCT01182285|451493542|FG002|First Intervention Week 1-10|Non-compliance|0|||
125509398|NCT01182285|451493540|FG000|Third Intervention Week 11-52|Disease Progression|0|||
125509399|NCT01182285|451493541|FG001|Third Intervention Week 11-52|Disease Progression|0|||
125509400|NCT01182285|451493542|FG002|Third Intervention Week 11-52|Disease Progression|6|||
125509401|NCT01182285|451493540|FG000|Third Intervention Week 11-52|Other|0|||
125509402|NCT01182285|451493541|FG001|Third Intervention Week 11-52|Other|0|||
125509403|NCT01182285|451493542|FG002|Third Intervention Week 11-52|Other|2|||
125509404|NCT01951105|451493545|FG000|Overall Study|Adverse Event|0|||
125509405|NCT01951105|451493546|FG001|Overall Study|Adverse Event|5|||
125509406|NCT01951105|451493547|FG002|Overall Study|Adverse Event|0|||
125509407|NCT01951105|451493545|FG000|Overall Study|Lost to Follow-up|0|||
125509408|NCT01951105|451493546|FG001|Overall Study|Lost to Follow-up|1|||
125509409|NCT01951105|451493547|FG002|Overall Study|Lost to Follow-up|0|||
125509410|NCT01951105|451493545|FG000|Overall Study|Protocol Violation|1|||
125509411|NCT01951105|451493546|FG001|Overall Study|Protocol Violation|1|||
125509412|NCT01951105|451493547|FG002|Overall Study|Protocol Violation|1|||
125509413|NCT01951105|451493545|FG000|Overall Study|Withdrawal by Subject|0|||
125509414|NCT01951105|451493546|FG001|Overall Study|Withdrawal by Subject|3|||
125509415|NCT01951105|451493547|FG002|Overall Study|Withdrawal by Subject|1|||
125509416|NCT03209492|451493548|FG000|Overall Study|Case Report Forms Uncollected|5|||
125509417|NCT02604199|451493553|FG000|Overall Study|Pregnancy|0|||
125509418|NCT02604199|451493554|FG001|Overall Study|Pregnancy|0|||
125509419|NCT02604199|451493555|FG002|Overall Study|Pregnancy|0|||
125509420|NCT02604199|451493556|FG003|Overall Study|Pregnancy|1|||
125509421|NCT02604199|451493553|FG000|Overall Study|Study terminated by sponsor|0|||
125509422|NCT02604199|451493554|FG001|Overall Study|Study terminated by sponsor|2|||
125509423|NCT02604199|451493555|FG002|Overall Study|Study terminated by sponsor|0|||
125509424|NCT02604199|451493556|FG003|Overall Study|Study terminated by sponsor|2|||
125509425|NCT02604199|451493553|FG000|Overall Study|Withdrawal by Subject|0|||
125509426|NCT02604199|451493554|FG001|Overall Study|Withdrawal by Subject|1|||
125509427|NCT02604199|451493555|FG002|Overall Study|Withdrawal by Subject|0|||
125509428|NCT02604199|451493556|FG003|Overall Study|Withdrawal by Subject|0|||
125509429|NCT02812706|451493557|FG000|Phase 1|Adverse Event|0|||
125509430|NCT02812706|451493558|FG001|Phase 1|Adverse Event|2|||
125509431|NCT02812706|451493559|FG002|Phase 1|Adverse Event|0|||
125509432|NCT02812706|451493557|FG000|Phase 1|Progressive disease|3|||
125509433|NCT02812706|451493558|FG001|Phase 1|Progressive disease|3|||
125509434|NCT02812706|451493559|FG002|Phase 1|Progressive disease|0|||
125509435|NCT02812706|451493557|FG000|Phase 2|Adverse Event|0|||
125509436|NCT02812706|451493558|FG001|Phase 2|Adverse Event|0|||
125509437|NCT02812706|451493559|FG002|Phase 2|Adverse Event|2|||
125509438|NCT02812706|451493557|FG000|Phase 2|Progressive disease|0|||
125509439|NCT02812706|451493558|FG001|Phase 2|Progressive disease|0|||
125509440|NCT02812706|451493559|FG002|Phase 2|Progressive disease|22|||
125509441|NCT02812706|451493557|FG000|Phase 2|Other-Unspecified|0|||
125509442|NCT02812706|451493558|FG001|Phase 2|Other-Unspecified|0|||
125509443|NCT02812706|451493559|FG002|Phase 2|Other-Unspecified|4|||
125509444|NCT03166215|451493565|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
125509445|NCT03166215|451493566|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
125509446|NCT03166215|451493567|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
125509447|NCT03166215|451493565|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
125509448|NCT03166215|451493566|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
125509449|NCT03166215|451493567|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
125509450|NCT02632045|451493568|FG000|Overall Study|Withdrawal by Subject|1|||
125509451|NCT02632045|451493569|FG001|Overall Study|Withdrawal by Subject|2|||
125509452|NCT05878522|451493570|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
125509453|NCT05878522|451493571|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
125509454|NCT05878522|451493572|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
125509455|NCT05878522|451493573|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
125509456|NCT05878522|451493574|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
125509457|NCT05878522|451493575|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
125509458|NCT05878522|451493576|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
125509459|NCT05878522|451493577|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
125509460|NCT05878522|451493578|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
125509461|NCT05878522|451493579|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
125509462|NCT05878522|451493580|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
125509463|NCT05878522|451493581|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
125509464|NCT05878522|451493570|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
125509465|NCT05878522|451493571|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
125509466|NCT05878522|451493572|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
125509467|NCT05878522|451493573|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
125509468|NCT05878522|451493574|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
125509469|NCT05878522|451493575|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
125509470|NCT05878522|451493576|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
125509471|NCT05878522|451493577|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
125509472|NCT05878522|451493578|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
125509473|NCT05878522|451493579|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
125509474|NCT05878522|451493580|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
125509475|NCT05878522|451493581|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
125509476|NCT05878522|451493570|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
125509477|NCT05878522|451493571|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
125509478|NCT05878522|451493572|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
125509479|NCT05878522|451493573|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
125509480|NCT05878522|451493574|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
125509481|NCT05878522|451493575|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
125509482|NCT05878522|451493576|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
125509483|NCT05878522|451493577|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
125509484|NCT05878522|451493578|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
125509485|NCT05878522|451493579|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
125509486|NCT05878522|451493580|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
125509487|NCT05878522|451493581|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
125509488|NCT05878522|451493570|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
125509489|NCT05878522|451493571|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
125509490|NCT05878522|451493572|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
125509491|NCT05878522|451493573|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
125509492|NCT05878522|451493574|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
125509493|NCT05878522|451493575|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
125509494|NCT05878522|451493576|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
125509495|NCT05878522|451493577|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
125509496|NCT05878522|451493578|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
125509497|NCT05878522|451493579|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
125509498|NCT05878522|451493580|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
125509499|NCT05878522|451493581|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
125509500|NCT02252172|451493582|FG000|Overall Study|Lost to Follow-up|3|||
125509501|NCT02252172|451493583|FG001|Overall Study|Lost to Follow-up|1|||
125509502|NCT02252172|451493582|FG000|Overall Study|Ongoing|276|||
125509503|NCT02252172|451493583|FG001|Overall Study|Ongoing|298|||
125509504|NCT05740371|451493584|FG000|Overall Study|Death|1|||
125509505|NCT01613599|451493586|FG000|Overall Study|Death|9|||
125509506|NCT01613599|451493586|FG000|Overall Study|Lost to Follow-up|5|||
125509507|NCT01613599|451493586|FG000|Overall Study|Withdrawal by Subject|8|||
125509508|NCT01613599|451493586|FG000|Overall Study|Reason not specified|3|||
125509509|NCT00617708|451493588|FG000|Overall Study|Adverse Event|0|||
125509510|NCT00617708|451493589|FG001|Overall Study|Adverse Event|6|||
125509511|NCT00617708|451493590|FG002|Overall Study|Adverse Event|9|||
125509512|NCT00617708|451493588|FG000|Overall Study|Withdrawal by Subject|1|||
125509513|NCT00617708|451493589|FG001|Overall Study|Withdrawal by Subject|1|||
125509514|NCT00617708|451493590|FG002|Overall Study|Withdrawal by Subject|7|||
125509515|NCT00617708|451493588|FG000|Overall Study|Death|0|||
125509516|NCT00617708|451493589|FG001|Overall Study|Death|6|||
125509517|NCT00617708|451493590|FG002|Overall Study|Death|5|||
125509518|NCT00617708|451493588|FG000|Overall Study|Progression/Relapse|7|||
125509519|NCT00617708|451493589|FG001|Overall Study|Progression/Relapse|40|||
125509520|NCT00617708|451493590|FG002|Overall Study|Progression/Relapse|36|||
125509521|NCT00617708|451493588|FG000|Overall Study|Not protocol specified|1|||
125509522|NCT00617708|451493589|FG001|Overall Study|Not protocol specified|4|||
125509523|NCT00617708|451493590|FG002|Overall Study|Not protocol specified|2|||
125509524|NCT00617708|451493588|FG000|Overall Study|Not eligible|1|||
125509525|NCT00617708|451493589|FG001|Overall Study|Not eligible|3|||
125509526|NCT00617708|451493590|FG002|Overall Study|Not eligible|5|||
125509527|NCT01075815|451493591|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
125509528|NCT01075815|451493592|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
125509529|NCT01075815|451493591|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
125509530|NCT01075815|451493592|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
125509531|NCT01075815|451493591|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
125509532|NCT01075815|451493592|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
125509533|NCT02058992|451493593|FG000|Overall Study|Lost to Follow-up|4|||
125509534|NCT02058992|451493593|FG000|Overall Study|Protocol Violation|92|||
125509535|NCT02058992|451493593|FG000|Overall Study|CRF Uncollected|20|||
125509536|NCT03503188|451493594|FG000|Overall Study|Non eligible in the sub study|0|||
125509537|NCT03503188|451493595|FG001|Overall Study|Non eligible in the sub study|1|||
125509538|NCT03747575|451493602|FG000|Overall Study|Withdrawal by Subject|6|||
125509539|NCT03747575|451493603|FG001|Overall Study|Withdrawal by Subject|3|||
125509540|NCT03747575|451493602|FG000|Overall Study|Lost to Follow-up|3|||
125509541|NCT03747575|451493603|FG001|Overall Study|Lost to Follow-up|3|||
125509542|NCT03747575|451493602|FG000|Overall Study|Adverse Event|0|||
125509543|NCT03747575|451493603|FG001|Overall Study|Adverse Event|1|||
125509544|NCT03005106|451493604|FG000|Overall Study|Lost to Follow-up|16|||
125509545|NCT03005106|451493604|FG000|Overall Study|Adverse Event|1|||
125509546|NCT03005106|451493604|FG000|Overall Study|Physician Decision|1|||
125509547|NCT03005106|451493604|FG000|Overall Study|Death|2|||
125509548|NCT00321672|451493605|FG000|Overall Study|Withdrawal by Subject|5|||
125509549|NCT00321672|451493606|FG001|Overall Study|Withdrawal by Subject|1|||
125509550|NCT00321672|451493607|FG002|Overall Study|Withdrawal by Subject|2|||
125509551|NCT00321672|451493608|FG003|Overall Study|Withdrawal by Subject|0|||
125509552|NCT00321672|451493605|FG000|Overall Study|Noncompliance|1|||
125509553|NCT00321672|451493606|FG001|Overall Study|Noncompliance|2|||
125509554|NCT00321672|451493607|FG002|Overall Study|Noncompliance|1|||
125509555|NCT00321672|451493608|FG003|Overall Study|Noncompliance|0|||
125509556|NCT00321672|451493605|FG000|Overall Study|Adverse Event|1|||
125509557|NCT00321672|451493606|FG001|Overall Study|Adverse Event|1|||
125509558|NCT00321672|451493607|FG002|Overall Study|Adverse Event|0|||
125509559|NCT00321672|451493608|FG003|Overall Study|Adverse Event|0|||
125509560|NCT00321672|451493605|FG000|Overall Study|Lack of Efficacy|1|||
125509561|NCT00321672|451493606|FG001|Overall Study|Lack of Efficacy|1|||
125509562|NCT00321672|451493607|FG002|Overall Study|Lack of Efficacy|0|||
125509563|NCT00321672|451493608|FG003|Overall Study|Lack of Efficacy|0|||
125509564|NCT00321672|451493605|FG000|Overall Study|Lost to Follow-up|2|||
125509565|NCT00321672|451493606|FG001|Overall Study|Lost to Follow-up|0|||
125509566|NCT00321672|451493607|FG002|Overall Study|Lost to Follow-up|4|||
125509567|NCT00321672|451493608|FG003|Overall Study|Lost to Follow-up|2|||
125509568|NCT00321672|451493605|FG000|Overall Study|Death|1|||
125509569|NCT00321672|451493606|FG001|Overall Study|Death|0|||
125305527|NCT02218008|450745142|FG003|Stage 1 (S1)|Protocol Violation|0|||
125509570|NCT00321672|451493607|FG002|Overall Study|Death|0|||
125509571|NCT00321672|451493608|FG003|Overall Study|Death|0|||
125509572|NCT00321672|451493605|FG000|Overall Study|Too far to travel for visits|1|||
125509573|NCT00321672|451493606|FG001|Overall Study|Too far to travel for visits|0|||
125509574|NCT00321672|451493607|FG002|Overall Study|Too far to travel for visits|0|||
125509575|NCT00321672|451493608|FG003|Overall Study|Too far to travel for visits|0|||
125509576|NCT00321672|451493605|FG000|Overall Study|Incarcerated|0|||
125509577|NCT00321672|451493606|FG001|Overall Study|Incarcerated|0|||
125305528|NCT02218008|450745143|FG004|Stage 1 (S1)|Protocol Violation|0|||
125509578|NCT00321672|451493607|FG002|Overall Study|Incarcerated|2|||
125509579|NCT00321672|451493608|FG003|Overall Study|Incarcerated|0|||
125509580|NCT00321672|451493605|FG000|Overall Study|Moved out of state|0|||
125509581|NCT00321672|451493606|FG001|Overall Study|Moved out of state|1|||
125509582|NCT00321672|451493607|FG002|Overall Study|Moved out of state|1|||
125509583|NCT00321672|451493608|FG003|Overall Study|Moved out of state|0|||
125509584|NCT00321672|451493605|FG000|Overall Study|Protocol Violation|0|||
125509585|NCT00321672|451493606|FG001|Overall Study|Protocol Violation|0|||
125509586|NCT00321672|451493607|FG002|Overall Study|Protocol Violation|1|||
125509587|NCT00321672|451493608|FG003|Overall Study|Protocol Violation|0|||
125509588|NCT00321672|451493605|FG000|Overall Study|Diagnosis of testicular cancer|0|||
125509589|NCT00321672|451493606|FG001|Overall Study|Diagnosis of testicular cancer|1|||
125509590|NCT00321672|451493607|FG002|Overall Study|Diagnosis of testicular cancer|0|||
125509591|NCT00321672|451493608|FG003|Overall Study|Diagnosis of testicular cancer|0|||
125509592|NCT00321672|451493605|FG000|Overall Study|Extensive travel required for new job|0|||
125509593|NCT00321672|451493606|FG001|Overall Study|Extensive travel required for new job|1|||
125509594|NCT00321672|451493607|FG002|Overall Study|Extensive travel required for new job|0|||
125509595|NCT00321672|451493608|FG003|Overall Study|Extensive travel required for new job|0|||
125509596|NCT00512902|451493611|FG000|Overall Study|Adverse Event|7|||
125509597|NCT00512902|451493611|FG000|Overall Study|Lost to Follow-up|1|||
125509598|NCT01549951|451493615|FG000|Overall Study|Adverse Event|15|||
125509599|NCT01549951|451493615|FG000|Overall Study|Withdrawal by Subject|2|||
125509600|NCT01549951|451493615|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
125509601|NCT01549951|451493615|FG000|Overall Study|Progressive disease|29|||
125509602|NCT01549951|451493615|FG000|Overall Study|Symptomatic deterioration|1|||
125509603|NCT01549951|451493615|FG000|Overall Study|Other|2|||
125509604|NCT03689452|451493618|FG000|Overall Study|Lost to Follow-up|1|||
125509605|NCT03689452|451493619|FG001|Overall Study|Lost to Follow-up|1|||
125509606|NCT02676778|451493621|FG000|Overall Study|Disease Progression|7|||
125509607|NCT02676778|451493622|FG001|Overall Study|Disease Progression|3|||
125509608|NCT02676778|451493623|FG002|Overall Study|Disease Progression|1|||
125509609|NCT02676778|451493621|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
125509610|NCT02676778|451493622|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
125509611|NCT02676778|451493623|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
125509612|NCT02676778|451493621|FG000|Overall Study|Withdrawal by Subject|3|||
125509613|NCT02676778|451493622|FG001|Overall Study|Withdrawal by Subject|2|||
125509614|NCT02676778|451493623|FG002|Overall Study|Withdrawal by Subject|0|||
125509615|NCT02676778|451493621|FG000|Overall Study|Other|4|||
125509616|NCT02676778|451493622|FG001|Overall Study|Other|3|||
125509617|NCT02676778|451493623|FG002|Overall Study|Other|0|||
125509618|NCT02676778|451493621|FG000|Overall Study|Adverse Event|2|||
125509619|NCT02676778|451493622|FG001|Overall Study|Adverse Event|3|||
125305529|NCT02218008|450745144|FG005|Stage 1 (S1)|Protocol Violation|0|||
125305530|NCT02218008|450745139|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
125305531|NCT02218008|450745140|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
125305532|NCT02218008|450745141|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
125305533|NCT02218008|450745142|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
125305534|NCT02218008|450745143|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
125305535|NCT02218008|450745144|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
125305536|NCT02218008|450745139|FG000|Stage 2 (S2)|Adverse Event|0|||
125305537|NCT02218008|450745140|FG001|Stage 2 (S2)|Adverse Event|0|||
125305538|NCT02218008|450745141|FG002|Stage 2 (S2)|Adverse Event|0|||
125305539|NCT02218008|450745142|FG003|Stage 2 (S2)|Adverse Event|2|||
125305540|NCT02218008|450745143|FG004|Stage 2 (S2)|Adverse Event|3|||
125305541|NCT02218008|450745144|FG005|Stage 2 (S2)|Adverse Event|3|||
125305542|NCT02218008|450745139|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
125305543|NCT02218008|450745140|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
125305544|NCT02218008|450745141|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
125305545|NCT02218008|450745142|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
125305546|NCT02218008|450745143|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
125305547|NCT02218008|450745144|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
125305548|NCT02218008|450745139|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
125305549|NCT02218008|450745140|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
125305550|NCT02218008|450745141|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
125305551|NCT02218008|450745142|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
125305552|NCT02218008|450745143|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
125305553|NCT02218008|450745144|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
125305554|NCT02218008|450745139|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
125305555|NCT02218008|450745140|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
125305556|NCT02218008|450745141|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
125305557|NCT02218008|450745142|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
125305558|NCT02218008|450745143|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
125305559|NCT02218008|450745144|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
125305560|NCT02218008|450745139|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
125509620|NCT02676778|451493623|FG002|Overall Study|Adverse Event|0|||
125509621|NCT00732498|451493627|FG000|Overall Study|Ineligible|1|||
125509622|NCT00732498|451493627|FG000|Overall Study|Adverse Event|2|||
125509623|NCT00732498|451493627|FG000|Overall Study|Physician Decision|3|||
125509624|NCT01288729|451493630|FG000|Overall Study|Withdrawal by Subject|1|||
125509625|NCT01288729|451493631|FG001|Overall Study|Withdrawal by Subject|0|||
125509626|NCT01730118|451494822|FG000|Dose Escalation|Death on study|5|||
125509627|NCT01730118|451494823|FG001|Dose Escalation|Death on study|7|||
125509628|NCT01730118|451494824|FG002|Dose Escalation|Death on study|2|||
125509629|NCT01730118|451494825|FG003|Dose Escalation|Death on study|6|||
125509630|NCT01730118|451494826|FG004|Dose Escalation|Death on study|0|||
125509631|NCT01730118|451494827|FG005|Dose Escalation|Death on study|0|||
125509632|NCT01730118|451494828|FG006|Dose Escalation|Death on study|0|||
125509633|NCT01730118|451494822|FG000|Dose Escalation|Died before treatment|0|||
125509634|NCT01730118|451494823|FG001|Dose Escalation|Died before treatment|0|||
125509635|NCT01730118|451494824|FG002|Dose Escalation|Died before treatment|0|||
125509636|NCT01730118|451494825|FG003|Dose Escalation|Died before treatment|0|||
125509637|NCT01730118|451494826|FG004|Dose Escalation|Died before treatment|0|||
125509638|NCT01730118|451494827|FG005|Dose Escalation|Died before treatment|0|||
125509639|NCT01730118|451494828|FG006|Dose Escalation|Died before treatment|1|||
125509640|NCT01730118|451494822|FG000|Dose Escalation|Chose to start a different treatment|1|||
125509641|NCT01730118|451494823|FG001|Dose Escalation|Chose to start a different treatment|0|||
125509642|NCT01730118|451494824|FG002|Dose Escalation|Chose to start a different treatment|0|||
125509643|NCT01730118|451494825|FG003|Dose Escalation|Chose to start a different treatment|0|||
125509644|NCT01730118|451494826|FG004|Dose Escalation|Chose to start a different treatment|0|||
125509645|NCT01730118|451494827|FG005|Dose Escalation|Chose to start a different treatment|0|||
125509646|NCT01730118|451494828|FG006|Dose Escalation|Chose to start a different treatment|0|||
125509647|NCT01730118|451494822|FG000|Dose Escalation|Withdrawal by Subject|0|||
125509648|NCT01730118|451494823|FG001|Dose Escalation|Withdrawal by Subject|0|||
125509649|NCT01730118|451494824|FG002|Dose Escalation|Withdrawal by Subject|1|||
125509650|NCT01730118|451494825|FG003|Dose Escalation|Withdrawal by Subject|0|||
125509651|NCT01730118|451494826|FG004|Dose Escalation|Withdrawal by Subject|0|||
125509652|NCT01730118|451494827|FG005|Dose Escalation|Withdrawal by Subject|0|||
125509653|NCT01730118|451494828|FG006|Dose Escalation|Withdrawal by Subject|0|||
125509654|NCT01730118|451494822|FG000|Dose Escalation|Disease progression prior to treatment|0|||
125509655|NCT01730118|451494823|FG001|Dose Escalation|Disease progression prior to treatment|0|||
125509656|NCT01730118|451494824|FG002|Dose Escalation|Disease progression prior to treatment|0|||
125509657|NCT01730118|451494825|FG003|Dose Escalation|Disease progression prior to treatment|0|||
125509658|NCT01730118|451494826|FG004|Dose Escalation|Disease progression prior to treatment|0|||
125509659|NCT01730118|451494827|FG005|Dose Escalation|Disease progression prior to treatment|0|||
125509660|NCT01730118|451494828|FG006|Dose Escalation|Disease progression prior to treatment|1|||
125509661|NCT01730118|451494822|FG000|Dose Expansion|Death|0|||
125509662|NCT01730118|451494823|FG001|Dose Expansion|Death|0|||
125509663|NCT01730118|451494824|FG002|Dose Expansion|Death|0|||
125509664|NCT01730118|451494825|FG003|Dose Expansion|Death|0|||
125509665|NCT01730118|451494826|FG004|Dose Expansion|Death|1|||
125509666|NCT01730118|451494827|FG005|Dose Expansion|Death|0|||
125509667|NCT01730118|451494828|FG006|Dose Expansion|Death|0|||
125509668|NCT01730118|451494822|FG000|Dose Expansion|Other medical condition|0|||
125509669|NCT01730118|451494823|FG001|Dose Expansion|Other medical condition|0|||
125509670|NCT01730118|451494824|FG002|Dose Expansion|Other medical condition|0|||
125509671|NCT01730118|451494825|FG003|Dose Expansion|Other medical condition|0|||
125509672|NCT01730118|451494826|FG004|Dose Expansion|Other medical condition|1|||
125509673|NCT01730118|451494827|FG005|Dose Expansion|Other medical condition|0|||
125509674|NCT01730118|451494828|FG006|Dose Expansion|Other medical condition|0|||
125509675|NCT01730118|451494822|FG000|Dose Expansion|Withdrawal by Subject|0|||
125509676|NCT01730118|451494823|FG001|Dose Expansion|Withdrawal by Subject|0|||
125509677|NCT01730118|451494824|FG002|Dose Expansion|Withdrawal by Subject|0|||
125509678|NCT01730118|451494825|FG003|Dose Expansion|Withdrawal by Subject|0|||
125509679|NCT01730118|451494826|FG004|Dose Expansion|Withdrawal by Subject|1|||
125509680|NCT01730118|451494827|FG005|Dose Expansion|Withdrawal by Subject|0|||
125509681|NCT01730118|451494828|FG006|Dose Expansion|Withdrawal by Subject|0|||
125509682|NCT01730118|451494822|FG000|Dose Expansion|Disease progression|0|||
125509683|NCT01730118|451494823|FG001|Dose Expansion|Disease progression|0|||
125509684|NCT01730118|451494824|FG002|Dose Expansion|Disease progression|0|||
125509685|NCT01730118|451494825|FG003|Dose Expansion|Disease progression|0|||
125509686|NCT01730118|451494826|FG004|Dose Expansion|Disease progression|0|||
125509687|NCT01730118|451494827|FG005|Dose Expansion|Disease progression|1|||
125509688|NCT01730118|451494828|FG006|Dose Expansion|Disease progression|0|||
125305561|NCT02218008|450745140|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
125305562|NCT02218008|450745141|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
125509689|NCT01730118|451494822|FG000|Dose Expansion|Inability to return|0|||
125305563|NCT02218008|450745142|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
125509690|NCT01730118|451494823|FG001|Dose Expansion|Inability to return|0|||
125509691|NCT01730118|451494824|FG002|Dose Expansion|Inability to return|0|||
125509692|NCT01730118|451494825|FG003|Dose Expansion|Inability to return|0|||
125509693|NCT01730118|451494826|FG004|Dose Expansion|Inability to return|0|||
125509694|NCT01730118|451494827|FG005|Dose Expansion|Inability to return|1|||
125509695|NCT01730118|451494828|FG006|Dose Expansion|Inability to return|0|||
125509696|NCT01730118|451494822|FG000|Dose Expansion|Physician Decision|0|||
125509697|NCT01730118|451494823|FG001|Dose Expansion|Physician Decision|0|||
125509698|NCT01730118|451494824|FG002|Dose Expansion|Physician Decision|0|||
125509699|NCT01730118|451494825|FG003|Dose Expansion|Physician Decision|0|||
125509700|NCT01730118|451494826|FG004|Dose Expansion|Physician Decision|0|||
125509701|NCT01730118|451494827|FG005|Dose Expansion|Physician Decision|1|||
125509702|NCT01730118|451494828|FG006|Dose Expansion|Physician Decision|0|||
125509703|NCT00489489|451494830|FG000|Overall Study|Not treated due to protocol violation|0|||
125509704|NCT00489489|451494831|FG001|Overall Study|Not treated due to protocol violation|1|||
125509705|NCT00489489|451494832|FG002|Overall Study|Not treated due to protocol violation|1|||
125509706|NCT00489489|451494830|FG000|Overall Study|Adverse Event|1|||
125509707|NCT00489489|451494831|FG001|Overall Study|Adverse Event|1|||
125509708|NCT00489489|451494832|FG002|Overall Study|Adverse Event|1|||
125509709|NCT00489489|451494830|FG000|Overall Study|Protocol Violation|1|||
125509710|NCT00489489|451494831|FG001|Overall Study|Protocol Violation|0|||
125509711|NCT00489489|451494832|FG002|Overall Study|Protocol Violation|1|||
125509712|NCT00489489|451494830|FG000|Overall Study|Progressive disease|0|||
125509713|NCT00489489|451494831|FG001|Overall Study|Progressive disease|1|||
125509714|NCT00489489|451494832|FG002|Overall Study|Progressive disease|0|||
125509715|NCT00489489|451494830|FG000|Overall Study|Participant did not wish to continue|1|||
125509716|NCT00489489|451494831|FG001|Overall Study|Participant did not wish to continue|1|||
125509717|NCT00489489|451494832|FG002|Overall Study|Participant did not wish to continue|0|||
125509718|NCT00489489|451494830|FG000|Overall Study|Other than above|0|||
125509719|NCT00489489|451494831|FG001|Overall Study|Other than above|1|||
125509720|NCT00489489|451494832|FG002|Overall Study|Other than above|0|||
125509721|NCT04851587|451494835|FG000|Overall Study|Lost to Follow-up|18|||
125509722|NCT02101554|451494839|FG000|Overall Study|Protocol Violation|0|||
125509723|NCT02101554|451494840|FG001|Overall Study|Protocol Violation|1|||
125509724|NCT02101554|451494841|FG002|Overall Study|Protocol Violation|0|||
125509725|NCT02101554|451494839|FG000|Overall Study|Insufficient Clinical Response|0|||
125509726|NCT02101554|451494840|FG001|Overall Study|Insufficient Clinical Response|2|||
125509727|NCT02101554|451494841|FG002|Overall Study|Insufficient Clinical Response|0|||
125509728|NCT02101554|451494839|FG000|Overall Study|Adverse Event|2|||
125509729|NCT02101554|451494840|FG001|Overall Study|Adverse Event|1|||
125509730|NCT02101554|451494841|FG002|Overall Study|Adverse Event|1|||
125509731|NCT02101554|451494839|FG000|Overall Study|Lost to Follow-up|0|||
125509732|NCT02101554|451494840|FG001|Overall Study|Lost to Follow-up|1|||
125509733|NCT02101554|451494841|FG002|Overall Study|Lost to Follow-up|0|||
125509734|NCT02101554|451494839|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
125509735|NCT02101554|451494840|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
125509736|NCT02101554|451494841|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
125509737|NCT01350102|451494842|FG000|Overall Study|Adverse Event|0|||
125509738|NCT01350102|451494843|FG001|Overall Study|Adverse Event|0|||
125509739|NCT01350102|451494844|FG002|Overall Study|Adverse Event|1|||
125509740|NCT01350102|451494845|FG003|Overall Study|Adverse Event|0|||
125509741|NCT02136797|451494848|FG000|Overall Study|Not Treated|8|||
125509742|NCT04523571|451494849|FG000|Received 2 Doses|Withdrawal by Subject|0|||
125509743|NCT04523571|451494850|FG001|Received 2 Doses|Withdrawal by Subject|0|||
125509744|NCT04523571|451494851|FG002|Received 2 Doses|Withdrawal by Subject|0|||
125509745|NCT04523571|451494852|FG003|Received 2 Doses|Withdrawal by Subject|1|||
125509746|NCT04523571|451494853|FG004|Received 2 Doses|Withdrawal by Subject|1|||
125509747|NCT04523571|451494854|FG005|Received 2 Doses|Withdrawal by Subject|0|||
125509748|NCT04523571|451494849|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
125509749|NCT04523571|451494850|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
125509750|NCT04523571|451494851|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
125509751|NCT04523571|451494852|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
125509752|NCT04523571|451494853|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
125509753|NCT04523571|451494854|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
125509754|NCT04523571|451494849|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
125509755|NCT04523571|451494850|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
125509756|NCT04523571|451494851|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
125509757|NCT04523571|451494852|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
125509758|NCT04523571|451494853|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
125509759|NCT04523571|451494854|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
125509760|NCT04523571|451494849|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
125509761|NCT04523571|451494850|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
125509762|NCT04523571|451494851|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
125509763|NCT04523571|451494852|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
125509764|NCT04523571|451494853|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
125509765|NCT04523571|451494854|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
125509766|NCT03694210|451494856|FG000|Overall Study|Death|1|||
125509767|NCT03694210|451494856|FG000|Overall Study|Screen Failure|7|||
125509768|NCT03050372|451494857|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
125509769|NCT03050372|451494858|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
125509770|NCT03050372|451494857|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
125509771|NCT03050372|451494858|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
125509772|NCT04385849|451494859|FG000|Overall Study|Lost to Follow-up|1|||
125509773|NCT04385849|451494860|FG001|Overall Study|Lost to Follow-up|0|||
125509774|NCT01375777|451494861|FG000|Overall Study|Withdrawal by Subject|0|||
125509775|NCT01375777|451494862|FG001|Overall Study|Withdrawal by Subject|2|||
125509776|NCT01375777|451494863|FG002|Overall Study|Withdrawal by Subject|1|||
125509777|NCT01375777|451494864|FG003|Overall Study|Withdrawal by Subject|0|||
125509778|NCT01375777|451494865|FG004|Overall Study|Withdrawal by Subject|1|||
125509779|NCT01375777|451494866|FG005|Overall Study|Withdrawal by Subject|1|||
125509780|NCT01375777|451494867|FG006|Overall Study|Withdrawal by Subject|1|||
125509781|NCT01375777|451494868|FG007|Overall Study|Withdrawal by Subject|2|||
125509782|NCT01375777|451494869|FG008|Overall Study|Withdrawal by Subject|1|||
125509783|NCT01375777|451494861|FG000|Overall Study|Lost to Follow-up|1|||
125509784|NCT01375777|451494862|FG001|Overall Study|Lost to Follow-up|0|||
125509785|NCT01375777|451494863|FG002|Overall Study|Lost to Follow-up|0|||
125509786|NCT01375777|451494864|FG003|Overall Study|Lost to Follow-up|0|||
125509787|NCT01375777|451494865|FG004|Overall Study|Lost to Follow-up|0|||
125509788|NCT01375777|451494866|FG005|Overall Study|Lost to Follow-up|0|||
125509789|NCT01375777|451494867|FG006|Overall Study|Lost to Follow-up|1|||
125509790|NCT01375777|451494868|FG007|Overall Study|Lost to Follow-up|0|||
125509791|NCT01375777|451494869|FG008|Overall Study|Lost to Follow-up|0|||
125509792|NCT01375777|451494861|FG000|Overall Study|Other|1|||
125509793|NCT01375777|451494862|FG001|Overall Study|Other|1|||
125509794|NCT01375777|451494863|FG002|Overall Study|Other|0|||
125509795|NCT01375777|451494864|FG003|Overall Study|Other|0|||
125509796|NCT01375777|451494865|FG004|Overall Study|Other|0|||
125509797|NCT01375777|451494866|FG005|Overall Study|Other|0|||
125509798|NCT01375777|451494867|FG006|Overall Study|Other|0|||
125509799|NCT01375777|451494868|FG007|Overall Study|Other|0|||
125509800|NCT01375777|451494869|FG008|Overall Study|Other|1|||
125509801|NCT05878990|451494870|FG000|Overall Study|Lost to Follow-up|7|||
125509802|NCT05878990|451494870|FG000|Overall Study|Withdrawal by Subject|1|||
125509803|NCT01838499|451494875|FG000|Overall Study|Protocol Violation|0|||
125509804|NCT01838499|451494876|FG001|Overall Study|Protocol Violation|1|||
125509805|NCT01838499|451494875|FG000|Overall Study|Lost to Follow-up|2|||
125509806|NCT01838499|451494876|FG001|Overall Study|Lost to Follow-up|4|||
125509807|NCT01838499|451494875|FG000|Overall Study|Lack of Efficacy|1|||
125509808|NCT01838499|451494876|FG001|Overall Study|Lack of Efficacy|2|||
125509809|NCT01838499|451494875|FG000|Overall Study|Adverse Event|2|||
125509810|NCT01838499|451494876|FG001|Overall Study|Adverse Event|1|||
125509811|NCT01838499|451494875|FG000|Overall Study|Withdrawal by Subject|19|||
125509812|NCT01838499|451494876|FG001|Overall Study|Withdrawal by Subject|9|||
125509813|NCT03614923|451494877|FG000|Overall Study|Withdrawal by Subject|2|||
125509814|NCT03614923|451494878|FG001|Overall Study|Withdrawal by Subject|1|||
125509815|NCT03614923|451494879|FG002|Overall Study|Withdrawal by Subject|1|||
125509816|NCT03614923|451494877|FG000|Overall Study|Adverse Event|0|||
125509817|NCT03614923|451494878|FG001|Overall Study|Adverse Event|2|||
125509818|NCT03614923|451494879|FG002|Overall Study|Adverse Event|1|||
125509819|NCT03614923|451494877|FG000|Overall Study|Lost to Follow-up|1|||
125509820|NCT03614923|451494878|FG001|Overall Study|Lost to Follow-up|0|||
125509821|NCT03614923|451494879|FG002|Overall Study|Lost to Follow-up|1|||
125509822|NCT03614923|451494877|FG000|Overall Study|Lack of Efficacy|2|||
125509823|NCT03614923|451494878|FG001|Overall Study|Lack of Efficacy|0|||
125509824|NCT03614923|451494879|FG002|Overall Study|Lack of Efficacy|1|||
125509825|NCT03614923|451494877|FG000|Overall Study|Non-compliance|0|||
125509826|NCT03614923|451494878|FG001|Overall Study|Non-compliance|1|||
125509827|NCT03614923|451494879|FG002|Overall Study|Non-compliance|0|||
125509828|NCT03614923|451494877|FG000|Overall Study|Other|0|||
125509829|NCT03614923|451494878|FG001|Overall Study|Other|1|||
125509830|NCT03614923|451494879|FG002|Overall Study|Other|1|||
125509831|NCT01107353|451494880|FG000|Overall Study|Positive Drug Screen|1|||
125509832|NCT01107353|451494881|FG001|Overall Study|Positive Drug Screen|0|||
125509833|NCT01136733|451494882|FG000|Phase 1b|Adverse Event|0|||
125509834|NCT01136733|451494883|FG001|Phase 1b|Adverse Event|3|||
125509835|NCT01136733|451494884|FG002|Phase 1b|Adverse Event|1|||
125509836|NCT01136733|451494885|FG003|Phase 1b|Adverse Event|0|||
125509837|NCT01136733|451494886|FG004|Phase 1b|Adverse Event|0|||
125509838|NCT01136733|451494887|FG005|Phase 1b|Adverse Event|0|||
125509839|NCT01136733|451494888|FG006|Phase 1b|Adverse Event|0|||
125509840|NCT01136733|451494882|FG000|Phase 1b|Participant Choice|0|||
125509841|NCT01136733|451494883|FG001|Phase 1b|Participant Choice|0|||
125509842|NCT01136733|451494884|FG002|Phase 1b|Participant Choice|1|||
125509843|NCT01136733|451494885|FG003|Phase 1b|Participant Choice|0|||
125509844|NCT01136733|451494886|FG004|Phase 1b|Participant Choice|0|||
125509845|NCT01136733|451494887|FG005|Phase 1b|Participant Choice|0|||
125509846|NCT01136733|451494888|FG006|Phase 1b|Participant Choice|0|||
125509847|NCT01136733|451494882|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
125509848|NCT01136733|451494883|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
125509849|NCT01136733|451494884|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
125509850|NCT01136733|451494885|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
125509851|NCT01136733|451494886|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
125509852|NCT01136733|451494887|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
125509853|NCT01136733|451494888|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
125509854|NCT01136733|451494882|FG000|Phase 1b|Clinical Progression|1|||
125509855|NCT01136733|451494883|FG001|Phase 1b|Clinical Progression|1|||
125509856|NCT01136733|451494884|FG002|Phase 1b|Clinical Progression|0|||
125509857|NCT01136733|451494885|FG003|Phase 1b|Clinical Progression|0|||
125509858|NCT01136733|451494886|FG004|Phase 1b|Clinical Progression|0|||
125509859|NCT01136733|451494887|FG005|Phase 1b|Clinical Progression|0|||
125509860|NCT01136733|451494888|FG006|Phase 1b|Clinical Progression|0|||
125509861|NCT01136733|451494882|FG000|Phase 2|Disease Progression|0|||
125509862|NCT01136733|451494883|FG001|Phase 2|Disease Progression|0|||
125509863|NCT01136733|451494884|FG002|Phase 2|Disease Progression|0|||
125509864|NCT01136733|451494885|FG003|Phase 2|Disease Progression|0|||
125509865|NCT01136733|451494886|FG004|Phase 2|Disease Progression|30|||
125509866|NCT01136733|451494887|FG005|Phase 2|Disease Progression|32|||
125509867|NCT01136733|451494888|FG006|Phase 2|Disease Progression|38|||
125509868|NCT01136733|451494882|FG000|Phase 2|Adverse Event|0|||
125509869|NCT01136733|451494883|FG001|Phase 2|Adverse Event|0|||
125509870|NCT01136733|451494884|FG002|Phase 2|Adverse Event|0|||
125509871|NCT01136733|451494885|FG003|Phase 2|Adverse Event|0|||
125509872|NCT01136733|451494886|FG004|Phase 2|Adverse Event|11|||
125509873|NCT01136733|451494887|FG005|Phase 2|Adverse Event|13|||
125509874|NCT01136733|451494888|FG006|Phase 2|Adverse Event|5|||
125509875|NCT01136733|451494882|FG000|Phase 2|Participant Choice|0|||
125509876|NCT01136733|451494883|FG001|Phase 2|Participant Choice|0|||
125509877|NCT01136733|451494884|FG002|Phase 2|Participant Choice|0|||
125509878|NCT01136733|451494885|FG003|Phase 2|Participant Choice|0|||
125509879|NCT01136733|451494886|FG004|Phase 2|Participant Choice|3|||
125509880|NCT01136733|451494887|FG005|Phase 2|Participant Choice|0|||
125509881|NCT01136733|451494888|FG006|Phase 2|Participant Choice|1|||
125509882|NCT01136733|451494882|FG000|Phase 2|Administrative-Withdrew Consent|0|||
125509883|NCT01136733|451494883|FG001|Phase 2|Administrative-Withdrew Consent|0|||
125509884|NCT01136733|451494884|FG002|Phase 2|Administrative-Withdrew Consent|0|||
125509885|NCT01136733|451494885|FG003|Phase 2|Administrative-Withdrew Consent|0|||
125509886|NCT01136733|451494886|FG004|Phase 2|Administrative-Withdrew Consent|1|||
125509887|NCT01136733|451494887|FG005|Phase 2|Administrative-Withdrew Consent|0|||
125509888|NCT01136733|451494888|FG006|Phase 2|Administrative-Withdrew Consent|0|||
125509889|NCT01136733|451494882|FG000|Phase 2|Other|0|||
125509890|NCT01136733|451494883|FG001|Phase 2|Other|0|||
125509891|NCT01136733|451494884|FG002|Phase 2|Other|0|||
125509892|NCT01136733|451494885|FG003|Phase 2|Other|0|||
125509893|NCT01136733|451494886|FG004|Phase 2|Other|6|||
125509894|NCT01136733|451494887|FG005|Phase 2|Other|7|||
125509895|NCT01136733|451494888|FG006|Phase 2|Other|6|||
125509896|NCT03360071|451494890|FG000|Overall Study|Lost to Follow-up|1|||
125509897|NCT03360071|451494891|FG001|Overall Study|Lost to Follow-up|0|||
125509898|NCT02368691|451494895|FG000|Overall Study|Death|13|||
125509899|NCT02368691|451494895|FG000|Overall Study|Lack of Efficacy|15|||
125509900|NCT02368691|451494895|FG000|Overall Study|Physician Decision|4|||
125509901|NCT03314233|451494898|FG000|Overall Study|No longer eligible at time of delivery|1|||
125509902|NCT01114217|451494900|FG000|Overall Study|Adverse Event|5|||
125509903|NCT01114217|451494901|FG001|Overall Study|Adverse Event|3|||
125509904|NCT01114217|451494900|FG000|Overall Study|Lost to Follow-up|17|||
125509905|NCT01114217|451494901|FG001|Overall Study|Lost to Follow-up|33|||
125509906|NCT01114217|451494900|FG000|Overall Study|Withdrawal by Subject|21|||
125509907|NCT01114217|451494901|FG001|Overall Study|Withdrawal by Subject|28|||
125509908|NCT01114217|451494900|FG000|Overall Study|Other-Clerical Error|3|||
125509909|NCT01114217|451494901|FG001|Overall Study|Other-Clerical Error|0|||
125509910|NCT01114217|451494900|FG000|Overall Study|Other-Early termination|6|||
125509911|NCT01114217|451494901|FG001|Overall Study|Other-Early termination|10|||
125509912|NCT01114217|451494900|FG000|Overall Study|Other-Procedure|1|||
125509913|NCT01114217|451494901|FG001|Overall Study|Other-Procedure|1|||
125509914|NCT01114217|451494900|FG000|Overall Study|Other-Pregnancy|2|||
125509915|NCT01114217|451494901|FG001|Overall Study|Other-Pregnancy|4|||
125509916|NCT01114217|451494900|FG000|Overall Study|Other-Protocol Violation|1|||
125509917|NCT01114217|451494901|FG001|Overall Study|Other-Protocol Violation|3|||
125509918|NCT01114217|451494900|FG000|Overall Study|Other-Lack of Efficacy|1|||
125509919|NCT01114217|451494901|FG001|Overall Study|Other-Lack of Efficacy|0|||
125509920|NCT01114217|451494900|FG000|Overall Study|Other-Non Compliance|2|||
125509921|NCT01114217|451494901|FG001|Overall Study|Other-Non Compliance|0|||
125509922|NCT01114217|451494900|FG000|Overall Study|Other-Physician Decision|1|||
125509923|NCT01114217|451494901|FG001|Overall Study|Other-Physician Decision|1|||
125509924|NCT01114217|451494900|FG000|Overall Study|Other-Sponsor Decision|10|||
125509925|NCT01114217|451494901|FG001|Overall Study|Other-Sponsor Decision|12|||
125509926|NCT01114217|451494900|FG000|Overall Study|Other-Study Termination|0|||
125509927|NCT01114217|451494901|FG001|Overall Study|Other-Study Termination|1|||
125509928|NCT01114217|451494900|FG000|Overall Study|Other-Study Withdrawn|1|||
125509929|NCT01114217|451494901|FG001|Overall Study|Other-Study Withdrawn|1|||
125509930|NCT01114217|451494900|FG000|Overall Study|Other-Site Stopped Communicating|2|||
125509931|NCT01114217|451494901|FG001|Overall Study|Other-Site Stopped Communicating|0|||
125509932|NCT01114217|451494900|FG000|Overall Study|Other-Lost to Follow-up|1|||
125509933|NCT01114217|451494901|FG001|Overall Study|Other-Lost to Follow-up|0|||
125509934|NCT01114217|451494900|FG000|Overall Study|Other-Withdrawal by Subject|1|||
125509935|NCT01114217|451494901|FG001|Overall Study|Other-Withdrawal by Subject|1|||
125509936|NCT01183013|451494902|FG000|Overall Study|Adverse Event|6|||
125509937|NCT01183013|451494903|FG001|Overall Study|Adverse Event|8|||
125509938|NCT01183013|451494904|FG002|Overall Study|Adverse Event|5|||
125509939|NCT01183013|451494905|FG003|Overall Study|Adverse Event|5|||
125509940|NCT01183013|451494906|FG004|Overall Study|Adverse Event|10|||
125509941|NCT01183013|451494907|FG005|Overall Study|Adverse Event|10|||
125509942|NCT01183013|451494908|FG006|Overall Study|Adverse Event|6|||
125509943|NCT01183013|451494902|FG000|Overall Study|Lack of Efficacy|3|||
125509944|NCT01183013|451494903|FG001|Overall Study|Lack of Efficacy|2|||
125509945|NCT01183013|451494904|FG002|Overall Study|Lack of Efficacy|1|||
125509946|NCT01183013|451494905|FG003|Overall Study|Lack of Efficacy|2|||
125509947|NCT01183013|451494906|FG004|Overall Study|Lack of Efficacy|1|||
125509948|NCT01183013|451494907|FG005|Overall Study|Lack of Efficacy|2|||
125509949|NCT01183013|451494908|FG006|Overall Study|Lack of Efficacy|0|||
125509950|NCT01183013|451494902|FG000|Overall Study|Protocol Violation|5|||
125509951|NCT01183013|451494903|FG001|Overall Study|Protocol Violation|2|||
125509952|NCT01183013|451494904|FG002|Overall Study|Protocol Violation|4|||
125509953|NCT01183013|451494905|FG003|Overall Study|Protocol Violation|0|||
125509954|NCT01183013|451494906|FG004|Overall Study|Protocol Violation|4|||
125509955|NCT01183013|451494907|FG005|Overall Study|Protocol Violation|3|||
125509956|NCT01183013|451494908|FG006|Overall Study|Protocol Violation|3|||
125509957|NCT01183013|451494902|FG000|Overall Study|Lost to Follow-up|7|||
125509958|NCT01183013|451494903|FG001|Overall Study|Lost to Follow-up|3|||
125509959|NCT01183013|451494904|FG002|Overall Study|Lost to Follow-up|4|||
125509960|NCT01183013|451494905|FG003|Overall Study|Lost to Follow-up|3|||
125509961|NCT01183013|451494906|FG004|Overall Study|Lost to Follow-up|2|||
125509962|NCT01183013|451494907|FG005|Overall Study|Lost to Follow-up|6|||
125509963|NCT01183013|451494908|FG006|Overall Study|Lost to Follow-up|5|||
125509964|NCT01183013|451494902|FG000|Overall Study|Withdrawal by Subject|9|||
125509965|NCT01183013|451494903|FG001|Overall Study|Withdrawal by Subject|13|||
125509966|NCT01183013|451494904|FG002|Overall Study|Withdrawal by Subject|10|||
125509967|NCT01183013|451494905|FG003|Overall Study|Withdrawal by Subject|8|||
125509968|NCT01183013|451494906|FG004|Overall Study|Withdrawal by Subject|7|||
125509969|NCT01183013|451494907|FG005|Overall Study|Withdrawal by Subject|9|||
125509970|NCT01183013|451494908|FG006|Overall Study|Withdrawal by Subject|10|||
125509971|NCT01183013|451494902|FG000|Overall Study|Reasons other than stated above|15|||
125509972|NCT01183013|451494903|FG001|Overall Study|Reasons other than stated above|11|||
125509973|NCT01183013|451494904|FG002|Overall Study|Reasons other than stated above|17|||
125509974|NCT01183013|451494905|FG003|Overall Study|Reasons other than stated above|12|||
125509975|NCT01183013|451494906|FG004|Overall Study|Reasons other than stated above|12|||
125509976|NCT01183013|451494907|FG005|Overall Study|Reasons other than stated above|15|||
125509977|NCT01183013|451494908|FG006|Overall Study|Reasons other than stated above|13|||
125509978|NCT02722278|451494911|FG000|Overall Study|Withdrawal by Subject|5|||
125509979|NCT02722278|451494912|FG001|Overall Study|Withdrawal by Subject|3|||
125509980|NCT02722278|451494911|FG000|Overall Study|Adverse Event|4|||
125509981|NCT02722278|451494912|FG001|Overall Study|Adverse Event|1|||
125509982|NCT02722278|451494911|FG000|Overall Study|Lost to Follow-up|2|||
125509983|NCT02722278|451494912|FG001|Overall Study|Lost to Follow-up|0|||
125509984|NCT02722278|451494911|FG000|Overall Study|Protocol Violation|1|||
125509985|NCT02722278|451494912|FG001|Overall Study|Protocol Violation|0|||
125509986|NCT02722278|451494911|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
125509987|NCT02722278|451494912|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
125509988|NCT02722278|451494911|FG000|Overall Study|Subject declined after tx assignment|0|||
125509989|NCT02722278|451494912|FG001|Overall Study|Subject declined after tx assignment|1|||
125509990|NCT02722278|451494911|FG000|Overall Study|Site closure not study related|0|||
125509991|NCT02722278|451494912|FG001|Overall Study|Site closure not study related|1|||
125509992|NCT04175392|451494913|FG000|Overall Study|Withdrawal by Subject|3|||
125509993|NCT04175392|451494914|FG001|Overall Study|Withdrawal by Subject|2|||
125509994|NCT02727998|451494915|FG000|Overall Study|Lost to Follow-up|3|||
125509995|NCT02727998|451494916|FG001|Overall Study|Lost to Follow-up|3|||
125509996|NCT02727998|451494915|FG000|Overall Study|Withdrawal by Subject|0|||
125509997|NCT02727998|451494916|FG001|Overall Study|Withdrawal by Subject|1|||
125509998|NCT02105688|451494917|FG000|Part A: Double-Blind|Adverse Event|1|||
125509999|NCT02105688|451494918|FG001|Part A: Double-Blind|Adverse Event|0|||
125510000|NCT02105688|451494917|FG000|Part A: Double-Blind|Death|0|||
125510001|NCT02105688|451494918|FG001|Part A: Double-Blind|Death|1|||
125510002|NCT02105688|451494917|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
125510003|NCT02105688|451494918|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
125510004|NCT02105688|451494917|FG000|Part A: Double-Blind|Physician Decision|0|||
125510005|NCT02105688|451494918|FG001|Part A: Double-Blind|Physician Decision|1|||
125510006|NCT02105688|451494917|FG000|Part A: Double-Blind|Status Unknown|0|||
125510007|NCT02105688|451494918|FG001|Part A: Double-Blind|Status Unknown|2|||
125510008|NCT02105688|451494917|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
125510009|NCT02105688|451494918|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
125510010|NCT02105688|451494917|FG000|Part B: Observational Follow-up|Death|2|||
125510011|NCT02105688|451494918|FG001|Part B: Observational Follow-up|Death|1|||
125510012|NCT02105688|451494917|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
125510013|NCT02105688|451494918|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
125510014|NCT02105688|451494917|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
125510015|NCT02105688|451494918|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
125510016|NCT02105688|451494917|FG000|Part B: Observational Follow-up|Physician Decision|3|||
125510017|NCT02105688|451494918|FG001|Part B: Observational Follow-up|Physician Decision|1|||
125510018|NCT01757171|451494922|FG000|Overall Study|Adverse Event|5|||
125510019|NCT01757171|451494923|FG001|Overall Study|Adverse Event|1|||
125510020|NCT01757171|451494922|FG000|Overall Study|Disease Progression|1|||
125510021|NCT01757171|451494923|FG001|Overall Study|Disease Progression|0|||
125510022|NCT01757171|451494922|FG000|Overall Study|Hospitalization|1|||
125510023|NCT01757171|451494923|FG001|Overall Study|Hospitalization|0|||
125510024|NCT01757171|451494922|FG000|Overall Study|ECOG decline|1|||
125510025|NCT01757171|451494923|FG001|Overall Study|ECOG decline|0|||
125510026|NCT03019289|451494927|FG000|Overall Study|Adverse Event|1|||
125510027|NCT03019289|451494928|FG001|Overall Study|Adverse Event|0|||
125510028|NCT03019289|451494929|FG002|Overall Study|Adverse Event|0|||
125510029|NCT03019289|451494930|FG003|Overall Study|Adverse Event|0|||
125510030|NCT03019289|451494931|FG004|Overall Study|Adverse Event|0|||
125510031|NCT03019289|451494932|FG005|Overall Study|Adverse Event|0|||
125510032|NCT03019289|451494933|FG006|Overall Study|Adverse Event|0|||
125510033|NCT03019289|451494934|FG007|Overall Study|Adverse Event|0|||
125510034|NCT03019289|451494935|FG008|Overall Study|Adverse Event|1|||
125510035|NCT03019289|451494927|FG000|Overall Study|Other|1|||
125510036|NCT03019289|451494928|FG001|Overall Study|Other|0|||
125510037|NCT03019289|451494929|FG002|Overall Study|Other|0|||
125510038|NCT03019289|451494930|FG003|Overall Study|Other|0|||
125510039|NCT03019289|451494931|FG004|Overall Study|Other|0|||
125510040|NCT03019289|451494932|FG005|Overall Study|Other|0|||
125510041|NCT03019289|451494933|FG006|Overall Study|Other|0|||
125510042|NCT03019289|451494934|FG007|Overall Study|Other|0|||
125510043|NCT03019289|451494935|FG008|Overall Study|Other|0|||
125510044|NCT02389894|451494936|FG000|Overall Study|Death|4|||
125510045|NCT02389894|451494937|FG001|Overall Study|Death|5|||
125510046|NCT02389894|451494938|FG002|Overall Study|Death|3|||
125510047|NCT02389894|451494936|FG000|Overall Study|Withdrawal by Subject|2|||
125510048|NCT02389894|451494937|FG001|Overall Study|Withdrawal by Subject|4|||
125510049|NCT02389894|451494938|FG002|Overall Study|Withdrawal by Subject|5|||
125510050|NCT02389894|451494936|FG000|Overall Study|Lost to Follow-up|2|||
125510051|NCT02389894|451494937|FG001|Overall Study|Lost to Follow-up|1|||
125510052|NCT02389894|451494938|FG002|Overall Study|Lost to Follow-up|1|||
125510053|NCT00145496|451494941|FG000|Overall Study|Adverse Event|42|||
125510054|NCT00145496|451494942|FG001|Overall Study|Adverse Event|30|||
125510055|NCT00145496|451494941|FG000|Overall Study|Lack of Efficacy|12|||
125510056|NCT00145496|451494942|FG001|Overall Study|Lack of Efficacy|7|||
125510057|NCT00145496|451494941|FG000|Overall Study|Withdrawal by Subject|32|||
125510058|NCT00145496|451494942|FG001|Overall Study|Withdrawal by Subject|26|||
125510059|NCT00145496|451494941|FG000|Overall Study|Lost to Follow-up|12|||
125305564|NCT02218008|450745143|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
125305565|NCT02218008|450745144|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
125305566|NCT00106353|450745145|FG000|Part 1|Disease progression|3|||
125305567|NCT00106353|450745146|FG001|Part 1|Disease progression|4|||
125305568|NCT00106353|450745147|FG002|Part 1|Disease progression|1|||
125305569|NCT00106353|450745148|FG003|Part 1|Disease progression|3|||
125305570|NCT00106353|450745149|FG004|Part 1|Disease progression|0|||
125510060|NCT00145496|451494942|FG001|Overall Study|Lost to Follow-up|5|||
125510061|NCT00145496|451494941|FG000|Overall Study|Other|25|||
125510062|NCT00145496|451494942|FG001|Overall Study|Other|13|||
125510063|NCT00070317|451494943|FG000|Overall Study|Inevaluable (Never Treated)|1|||
125510064|NCT00070317|451494943|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
125510065|NCT00070317|451494943|FG000|Overall Study|Ineligible required test not done|1|||
125510066|NCT00070317|451494943|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
125510067|NCT00070317|451494943|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
125510068|NCT01429285|451494944|FG000|Overall Study|Protocol Violation|9|||
125510069|NCT01429285|451494945|FG001|Overall Study|Protocol Violation|4|||
125510070|NCT01429285|451494944|FG000|Overall Study|Missing Data|5|||
125510071|NCT01429285|451494945|FG001|Overall Study|Missing Data|3|||
125510072|NCT01429285|451494944|FG000|Overall Study|Erroneously Enrolled Twice|8|||
125510073|NCT01429285|451494945|FG001|Overall Study|Erroneously Enrolled Twice|2|||
125510074|NCT01885559|451494946|FG000|Overall Study|Lost to Follow-up|15|||
125510075|NCT01885559|451494947|FG001|Overall Study|Lost to Follow-up|16|||
125510076|NCT01885559|451494946|FG000|Overall Study|Less than full participation|9|||
125510077|NCT01885559|451494947|FG001|Overall Study|Less than full participation|19|||
125510078|NCT01885559|451494946|FG000|Overall Study|Protocol Violation|0|||
125510079|NCT01885559|451494947|FG001|Overall Study|Protocol Violation|1|||
125510080|NCT01123200|451494949|FG000|Overall Study|Withdrawal by Subject|1|||
125510081|NCT03394508|451494954|FG000|Overall Study|Protocol Violation|0|||
125510082|NCT03394508|451494955|FG001|Overall Study|Protocol Violation|3|||
125510083|NCT03394508|451494954|FG000|Overall Study|Lost to Follow-up|1|||
125510084|NCT03394508|451494955|FG001|Overall Study|Lost to Follow-up|0|||
125510085|NCT03214198|451494956|FG000|Overall Study|Case Report Forms Uncollected|18|||
125510086|NCT03214198|451494956|FG000|Overall Study|Protocol Deviation|18|||
125510087|NCT04295499|451494957|FG000|Overall Study|moving out of state|1|||
125510088|NCT04295499|451494958|FG001|Overall Study|moving out of state|0|||
125510089|NCT04295499|451494957|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
125510090|NCT04295499|451494958|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
125510091|NCT02135445|451494959|FG000|Overall Study|Lost to Follow-up|1|||
125510092|NCT02135445|451494960|FG001|Overall Study|Lost to Follow-up|0|||
125510093|NCT02135445|451494959|FG000|Overall Study|Withdrawal by Subject|1|||
125510094|NCT02135445|451494960|FG001|Overall Study|Withdrawal by Subject|0|||
125510095|NCT03451292|451496262|FG000|Overall Study|Death|44|||
125510096|NCT03451292|451496263|FG001|Overall Study|Death|59|||
125510097|NCT03451292|451496262|FG000|Overall Study|Withdrawal by Subject|18|||
125510098|NCT03451292|451496263|FG001|Overall Study|Withdrawal by Subject|13|||
125510099|NCT03451292|451496262|FG000|Overall Study|Transplantation|18|||
125510100|NCT03451292|451496263|FG001|Overall Study|Transplantation|12|||
125510101|NCT03451292|451496262|FG000|Overall Study|Lost to Follow-up|4|||
125510102|NCT03451292|451496263|FG001|Overall Study|Lost to Follow-up|12|||
125510103|NCT03451292|451496262|FG000|Overall Study|Physician Decision|4|||
125510104|NCT03451292|451496263|FG001|Overall Study|Physician Decision|3|||
125510105|NCT03451292|451496262|FG000|Overall Study|Adverse Event|3|||
125510106|NCT03451292|451496263|FG001|Overall Study|Adverse Event|3|||
125510107|NCT03451292|451496262|FG000|Overall Study|Non-compliance with Study Drug|2|||
125510108|NCT03451292|451496263|FG001|Overall Study|Non-compliance with Study Drug|0|||
125510109|NCT02543294|451496266|FG000|Overall Study|Lost to Follow-up|3|||
125510110|NCT02543294|451496266|FG000|Overall Study|Physician Decision|2|||
125510111|NCT02543294|451496266|FG000|Overall Study|Withdrawal by Subject|7|||
125510112|NCT03672188|451496267|FG000|Overall Study|Withdrawal by Subject|0|||
125510113|NCT03672188|451496268|FG001|Overall Study|Withdrawal by Subject|0|||
125510114|NCT03672188|451496269|FG002|Overall Study|Withdrawal by Subject|0|||
125510115|NCT03672188|451496270|FG003|Overall Study|Withdrawal by Subject|3|||
125510116|NCT03672188|451496271|FG004|Overall Study|Withdrawal by Subject|0|||
125510117|NCT03672188|451496272|FG005|Overall Study|Withdrawal by Subject|0|||
125510118|NCT03672188|451496273|FG006|Overall Study|Withdrawal by Subject|0|||
125510119|NCT03672188|451496274|FG007|Overall Study|Withdrawal by Subject|0|||
125510120|NCT03672188|451496275|FG008|Overall Study|Withdrawal by Subject|0|||
125510121|NCT03672188|451496276|FG009|Overall Study|Withdrawal by Subject|0|||
125510122|NCT03672188|451496277|FG010|Overall Study|Withdrawal by Subject|0|||
125510123|NCT03672188|451496278|FG011|Overall Study|Withdrawal by Subject|0|||
125510124|NCT03672188|451496279|FG012|Overall Study|Withdrawal by Subject|0|||
125510125|NCT03672188|451496280|FG013|Overall Study|Withdrawal by Subject|0|||
125510126|NCT03672188|451496281|FG014|Overall Study|Withdrawal by Subject|0|||
125510127|NCT03672188|451496267|FG000|Overall Study|Death|0|||
125510128|NCT03672188|451496268|FG001|Overall Study|Death|0|||
125510129|NCT03672188|451496269|FG002|Overall Study|Death|0|||
125510130|NCT03672188|451496270|FG003|Overall Study|Death|0|||
125510131|NCT03672188|451496271|FG004|Overall Study|Death|0|||
125510132|NCT03672188|451496272|FG005|Overall Study|Death|0|||
125510133|NCT03672188|451496273|FG006|Overall Study|Death|0|||
125510134|NCT03672188|451496274|FG007|Overall Study|Death|0|||
125510135|NCT03672188|451496275|FG008|Overall Study|Death|0|||
125510136|NCT03672188|451496276|FG009|Overall Study|Death|0|||
125510137|NCT03672188|451496277|FG010|Overall Study|Death|0|||
125510138|NCT03672188|451496278|FG011|Overall Study|Death|0|||
125510139|NCT03672188|451496279|FG012|Overall Study|Death|1|||
125510140|NCT03672188|451496280|FG013|Overall Study|Death|0|||
125510141|NCT03672188|451496281|FG014|Overall Study|Death|0|||
125510142|NCT03672188|451496267|FG000|Overall Study|Lost to Follow-up|0|||
125510143|NCT03672188|451496268|FG001|Overall Study|Lost to Follow-up|0|||
125510144|NCT03672188|451496269|FG002|Overall Study|Lost to Follow-up|1|||
125510145|NCT03672188|451496270|FG003|Overall Study|Lost to Follow-up|0|||
125510146|NCT03672188|451496271|FG004|Overall Study|Lost to Follow-up|0|||
125510147|NCT03672188|451496272|FG005|Overall Study|Lost to Follow-up|0|||
125510148|NCT03672188|451496273|FG006|Overall Study|Lost to Follow-up|0|||
125510149|NCT03672188|451496274|FG007|Overall Study|Lost to Follow-up|0|||
125510150|NCT03672188|451496275|FG008|Overall Study|Lost to Follow-up|0|||
125510151|NCT03672188|451496276|FG009|Overall Study|Lost to Follow-up|0|||
125510152|NCT03672188|451496277|FG010|Overall Study|Lost to Follow-up|0|||
125510153|NCT03672188|451496278|FG011|Overall Study|Lost to Follow-up|0|||
125510154|NCT03672188|451496279|FG012|Overall Study|Lost to Follow-up|0|||
125510155|NCT03672188|451496280|FG013|Overall Study|Lost to Follow-up|0|||
125510156|NCT03672188|451496281|FG014|Overall Study|Lost to Follow-up|0|||
125510157|NCT00396409|451496287|FG000|Period 1 - 2007|Adverse Event|0|||
125510158|NCT00396409|451496288|FG001|Period 1 - 2007|Adverse Event|1|||
125510159|NCT00396409|451496287|FG000|Period 1 - 2007|Lack of Efficacy|0|||
125510160|NCT00396409|451496288|FG001|Period 1 - 2007|Lack of Efficacy|1|||
125510161|NCT00396409|451496287|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
125510162|NCT00396409|451496288|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
125510163|NCT00396409|451496287|FG000|Period 1 - 2007|Lost to Follow-up|2|||
125510164|NCT00396409|451496288|FG001|Period 1 - 2007|Lost to Follow-up|3|||
125510165|NCT00396409|451496287|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
125510166|NCT00396409|451496288|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
125510167|NCT00396409|451496287|FG000|Period 2 - 2008|Protocol Violation|1|||
125510168|NCT00396409|451496288|FG001|Period 2 - 2008|Protocol Violation|0|||
125510169|NCT00396409|451496287|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
125510170|NCT00396409|451496288|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
125510171|NCT00396409|451496287|FG000|Period 2 - 2008|Lost to Follow-up|3|||
125510172|NCT00396409|451496288|FG001|Period 2 - 2008|Lost to Follow-up|1|||
125510173|NCT04203199|451496291|FG000|First Intervention Period|Lost to Follow-up|0|||
125510174|NCT04203199|451496292|FG001|First Intervention Period|Lost to Follow-up|1|||
125510175|NCT04203199|451496291|FG000|Second Intervention Period|Medication change|1|||
125510176|NCT04203199|451496292|FG001|Second Intervention Period|Medication change|0|||
125510177|NCT03320941|451496293|FG000|Overall Study|subject/guardian decision|0|||
125510178|NCT03320941|451496294|FG001|Overall Study|subject/guardian decision|0|||
125510179|NCT03320941|451496295|FG002|Overall Study|subject/guardian decision|0|||
125510180|NCT03320941|451496296|FG003|Overall Study|subject/guardian decision|1|||
125510181|NCT03320941|451496297|FG004|Overall Study|subject/guardian decision|0|||
125510182|NCT00472199|451496298|FG000|Overall Study|Adverse Event|19|||
125510183|NCT00472199|451496299|FG001|Overall Study|Adverse Event|23|||
125510184|NCT00472199|451496298|FG000|Overall Study|Lack of Efficacy|4|||
125510185|NCT00472199|451496299|FG001|Overall Study|Lack of Efficacy|25|||
125510186|NCT00472199|451496298|FG000|Overall Study|Lost to Follow-up|2|||
125510187|NCT00472199|451496299|FG001|Overall Study|Lost to Follow-up|4|||
125510188|NCT00472199|451496298|FG000|Overall Study|Protocol Violation|3|||
125510189|NCT00472199|451496299|FG001|Overall Study|Protocol Violation|2|||
125510190|NCT00472199|451496298|FG000|Overall Study|Withdrawal by Subject|6|||
125510191|NCT00472199|451496299|FG001|Overall Study|Withdrawal by Subject|5|||
125510192|NCT00472199|451496298|FG000|Overall Study|personal reason|0|||
125510193|NCT00472199|451496299|FG001|Overall Study|personal reason|1|||
125510194|NCT00472199|451496298|FG000|Overall Study|patient was asymptomatic|1|||
125510195|NCT00472199|451496299|FG001|Overall Study|patient was asymptomatic|0|||
125510196|NCT02504502|451496300|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
125510197|NCT02504502|451496301|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
125510198|NCT02504502|451496300|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
125510199|NCT02504502|451496301|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
125510200|NCT01014013|451496302|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
125510201|NCT01014013|451496303|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
125510202|NCT01014013|451496302|FG000|Overall Study|Clinical adverse experience|4|||
125510203|NCT01014013|451496303|FG001|Overall Study|Clinical adverse experience|2|||
125510204|NCT01014013|451496302|FG000|Overall Study|Laboratory adverse experience|1|||
125510205|NCT01014013|451496303|FG001|Overall Study|Laboratory adverse experience|1|||
125510206|NCT01014013|451496302|FG000|Overall Study|Protocol Violation|1|||
125510207|NCT01014013|451496303|FG001|Overall Study|Protocol Violation|3|||
125510208|NCT01014013|451496302|FG000|Overall Study|Withdrawal by Subject|7|||
125510209|NCT01014013|451496303|FG001|Overall Study|Withdrawal by Subject|4|||
125510210|NCT01014013|451496302|FG000|Overall Study|Clinical/microbiologic failure|1|||
125510211|NCT01014013|451496303|FG001|Overall Study|Clinical/microbiologic failure|2|||
125510212|NCT01014013|451496302|FG000|Overall Study|Pathogen culture = no growth|26|||
125510213|NCT01014013|451496303|FG001|Overall Study|Pathogen culture = no growth|34|||
125510214|NCT01014013|451496302|FG000|Overall Study|Negative urine culture|2|||
125510215|NCT01014013|451496303|FG001|Overall Study|Negative urine culture|0|||
125510216|NCT01014013|451496302|FG000|Overall Study|Pathogen resistant|7|||
125510217|NCT01014013|451496303|FG001|Overall Study|Pathogen resistant|4|||
125510218|NCT01014013|451496302|FG000|Overall Study|Physician Decision|0|||
125510219|NCT01014013|451496303|FG001|Overall Study|Physician Decision|1|||
125510220|NCT01014013|451496302|FG000|Overall Study|Another antibiotic therapy required|0|||
125510221|NCT01014013|451496303|FG001|Overall Study|Another antibiotic therapy required|1|||
125510222|NCT01014013|451496302|FG000|Overall Study|Appendectomy|1|||
125510223|NCT01014013|451496303|FG001|Overall Study|Appendectomy|0|||
125510224|NCT01014013|451496302|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
125510225|NCT01014013|451496303|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
125510226|NCT00316121|451496304|FG000|Overall Study|Death|1|||
125510227|NCT00316121|451496305|FG001|Overall Study|Death|0|||
125510228|NCT00316121|451496304|FG000|Overall Study|Lost to Follow-up|14|||
125510229|NCT00316121|451496305|FG001|Overall Study|Lost to Follow-up|8|||
125532598|NCT00350727|451580162|FG001|Phase II|Disease Progression|15|||
125510230|NCT00316121|451496304|FG000|Overall Study|Withdrawal by Subject|2|||
125510231|NCT00316121|451496305|FG001|Overall Study|Withdrawal by Subject|0|||
125510232|NCT00316121|451496304|FG000|Overall Study|Reason is missing|1|||
125510233|NCT00316121|451496305|FG001|Overall Study|Reason is missing|0|||
125510234|NCT00316121|451496304|FG000|Overall Study|Subject relocated|1|||
125510235|NCT00316121|451496305|FG001|Overall Study|Subject relocated|1|||
125510236|NCT00316121|451496304|FG000|Overall Study|Subject refused to return|1|||
125510237|NCT00316121|451496305|FG001|Overall Study|Subject refused to return|0|||
125510238|NCT00316121|451496304|FG000|Overall Study|Subject no show for visit x 3|1|||
125510239|NCT00316121|451496305|FG001|Overall Study|Subject no show for visit x 3|0|||
125510240|NCT00316121|451496304|FG000|Overall Study|Subject did not have 24 month visit|1|||
125510241|NCT00316121|451496305|FG001|Overall Study|Subject did not have 24 month visit|0|||
125510242|NCT02305797|451496306|FG000|Overall Study|Adverse Event|11|||
125510243|NCT02305797|451496307|FG001|Overall Study|Adverse Event|2|||
125510244|NCT02305797|451496306|FG000|Overall Study|Withdrawal by Subject|9|||
125510245|NCT02305797|451496307|FG001|Overall Study|Withdrawal by Subject|10|||
125510246|NCT02305797|451496306|FG000|Overall Study|Lack of Efficacy|6|||
125510247|NCT02305797|451496307|FG001|Overall Study|Lack of Efficacy|0|||
125510248|NCT02305797|451496306|FG000|Overall Study|Lost to Follow-up|5|||
125510249|NCT02305797|451496307|FG001|Overall Study|Lost to Follow-up|11|||
125510250|NCT02305797|451496306|FG000|Overall Study|Pregnancy|0|||
125510251|NCT02305797|451496307|FG001|Overall Study|Pregnancy|2|||
125510252|NCT02305797|451496306|FG000|Overall Study|Noncompliance|14|||
125510253|NCT02305797|451496307|FG001|Overall Study|Noncompliance|12|||
125510254|NCT02305797|451496306|FG000|Overall Study|Reason not collected|0|||
125510255|NCT02305797|451496307|FG001|Overall Study|Reason not collected|1|||
125510256|NCT00460577|451496310|FG000|Overall Study|Protocol Violation|2|||
125510257|NCT00460577|451496311|FG001|Overall Study|Protocol Violation|6|||
125510258|NCT02213458|451496312|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
125510259|NCT02213458|451496313|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
125510260|NCT02213458|451496312|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
125510261|NCT02213458|451496313|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
125510262|NCT02213458|451496312|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
125510263|NCT02213458|451496313|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
125510264|NCT02213458|451496312|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
125510265|NCT02213458|451496313|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
125510266|NCT02213458|451496312|FG000|Overall Study|Refused re-consent|6|||
125510267|NCT02213458|451496313|FG001|Overall Study|Refused re-consent|0|||
125510268|NCT02213458|451496312|FG000|Overall Study|Lost to Follow-up|2|||
125510269|NCT02213458|451496313|FG001|Overall Study|Lost to Follow-up|2|||
125510270|NCT02213458|451496312|FG000|Overall Study|Withdrawal by Subject|26|||
125510271|NCT02213458|451496313|FG001|Overall Study|Withdrawal by Subject|8|||
125510272|NCT00910871|451496314|FG000|Overall Study|Adverse Event|5|||
125510273|NCT00910871|451496314|FG000|Overall Study|Death|12|||
125510274|NCT00910871|451496314|FG000|Overall Study|Lost to Follow-up|8|||
125510275|NCT00910871|451496314|FG000|Overall Study|Protocol Violation|11|||
125510276|NCT00910871|451496314|FG000|Overall Study|Withdrawal by Subject|12|||
125510277|NCT00910871|451496314|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
125510278|NCT00910871|451496314|FG000|Overall Study|Undefined|1|||
125510279|NCT01878253|451496315|FG000|Overall Study|Death|1|||
125510280|NCT01878253|451496315|FG000|Overall Study|SIdus System Removal|3|||
125510281|NCT01878253|451496315|FG000|Overall Study|Withdrawal by Subject|1|||
125510282|NCT01878253|451496315|FG000|Overall Study|Lost to Follow-up|2|||
125510283|NCT01878253|451496315|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
125510284|NCT04043806|451496316|FG000|Overall Study|Commercial drug is available for participants|13|||
125510285|NCT04043806|451496316|FG000|Overall Study|Physician Decision|2|||
125510286|NCT04043806|451496316|FG000|Overall Study|Other|12|||
125510287|NCT04043806|451496316|FG000|Overall Study|Adverse Event|2|||
125510288|NCT04043806|451496316|FG000|Overall Study|Lost to Follow-up|6|||
125510289|NCT04043806|451496316|FG000|Overall Study|Other non-compliance|2|||
125510290|NCT04043806|451496316|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
125510291|NCT04043806|451496316|FG000|Overall Study|Never Dosed|1|||
125510292|NCT01622088|451496317|FG000|Overall Study|Adverse Event|20|||
125510293|NCT01622088|451496317|FG000|Overall Study|Lost to Follow-up|1|||
125510294|NCT01622088|451496317|FG000|Overall Study|Withdrawal by Subject|20|||
125510295|NCT01622088|451496317|FG000|Overall Study|Investigator Decision|1|||
125510296|NCT01622088|451496317|FG000|Overall Study|Death|53|||
125510297|NCT01622088|451496317|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
125510298|NCT04799587|451496319|FG000|Overall Study|Withdrawal by Subject|0|||
125510299|NCT04799587|451496320|FG001|Overall Study|Withdrawal by Subject|1|||
125510300|NCT04598776|451496321|FG000|Overall Study|Protocol Violation|5|||
125510301|NCT04598776|451496321|FG000|Overall Study|Physician Decision|4|||
125510302|NCT06312566|451496328|FG000|Overall Study|Protocol Violation|0|||
125510303|NCT06312566|451496329|FG001|Overall Study|Protocol Violation|1|||
125510304|NCT04736472|451496330|FG000|Overall Study|Lost to Follow-up|1|||
125510305|NCT04736472|451496331|FG001|Overall Study|Lost to Follow-up|0|||
125510306|NCT04736472|451496332|FG002|Overall Study|Lost to Follow-up|0|||
125510307|NCT04736472|451496330|FG000|Overall Study|Withdrawal by Subject|2|||
125510308|NCT04736472|451496331|FG001|Overall Study|Withdrawal by Subject|0|||
125510309|NCT04736472|451496332|FG002|Overall Study|Withdrawal by Subject|0|||
125510310|NCT04736472|451496330|FG000|Overall Study|Protocol Violation|48|||
125510311|NCT04736472|451496331|FG001|Overall Study|Protocol Violation|0|||
125510312|NCT04736472|451496332|FG002|Overall Study|Protocol Violation|6|||
125510313|NCT02116582|451496333|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
125510314|NCT02116582|451496333|FG000|Overall Study|Adverse Event|22|||
125510315|NCT02116582|451496333|FG000|Overall Study|Death|9|||
125510316|NCT02116582|451496333|FG000|Overall Study|Progressive Disease|148|||
125510317|NCT02116582|451496333|FG000|Overall Study|Protocol Violation|3|||
125510318|NCT02116582|451496333|FG000|Overall Study|Withdrawal by Subject|8|||
125510319|NCT02116582|451496333|FG000|Overall Study|Other: Miscellaneous|11|||
125510320|NCT02116582|451496333|FG000|Overall Study|Lost to Follow-up|1|||
125510321|NCT02116582|451496333|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
125510322|NCT03861078|451496334|FG000|Overall Study|COVID-19 shut down|4|||
125510323|NCT03861078|451496334|FG000|Overall Study|Lost to Follow-up|1|||
125510324|NCT03861078|451496334|FG000|Overall Study|Protocol Violation|2|||
125510325|NCT03861078|451496334|FG000|Overall Study|lack of venous access|1|||
125510326|NCT02971683|451496335|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
125510327|NCT02971683|451496336|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
125510328|NCT02971683|451496335|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
125510329|NCT02971683|451496336|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
125510330|NCT02971683|451496335|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
125510331|NCT02971683|451496336|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
125510332|NCT02971683|451496335|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
125510333|NCT02971683|451496336|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
125510334|NCT02971683|451496335|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
125510335|NCT02971683|451496336|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
125510336|NCT02971683|451496335|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
125510337|NCT02971683|451496336|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
125510338|NCT02971683|451496335|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
125510339|NCT02971683|451496336|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
125510340|NCT02971683|451496335|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
125510341|NCT02971683|451496336|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
125510342|NCT02971683|451496335|FG000|Open-Label|Lost to Follow-up|1|||
125510343|NCT02971683|451496336|FG001|Open-Label|Lost to Follow-up|0|||
125510344|NCT02971683|451496335|FG000|Open-Label|Participants withdrew consent|0|||
125510345|NCT02971683|451496336|FG001|Open-Label|Participants withdrew consent|2|||
125510346|NCT02971683|451496335|FG000|Open-Label|Participant request to discontinue study treatment|1|||
125510347|NCT02971683|451496336|FG001|Open-Label|Participant request to discontinue study treatment|0|||
125510348|NCT02971683|451496335|FG000|Open-Label|Lack of Efficacy|2|||
125510349|NCT02971683|451496336|FG001|Open-Label|Lack of Efficacy|0|||
125510350|NCT02971683|451496335|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
125510351|NCT02971683|451496336|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
125510352|NCT02971683|451496335|FG000|Long-Term Open Label|Participant withdrew consent|1|||
125510353|NCT02971683|451496336|FG001|Long-Term Open Label|Participant withdrew consent|0|||
125510354|NCT02971683|451496335|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
125510355|NCT02971683|451496336|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
125510356|NCT02971683|451496335|FG000|Long-Term Open Label|Adverse Event|1|||
125510357|NCT02971683|451496336|FG001|Long-Term Open Label|Adverse Event|2|||
125510358|NCT02971683|451496335|FG000|Long-Term Open Label|Lack of Efficacy|1|||
125510359|NCT02971683|451496336|FG001|Long-Term Open Label|Lack of Efficacy|1|||
125510360|NCT02268526|451496339|FG000|Overall Study|Adverse Event|0|||
125510361|NCT02268526|451496340|FG001|Overall Study|Adverse Event|2|||
125510362|NCT02268526|451496341|FG002|Overall Study|Adverse Event|1|||
125510363|NCT02268526|451496339|FG000|Overall Study|Death|1|||
125510364|NCT02268526|451496340|FG001|Overall Study|Death|11|||
125510365|NCT02268526|451496341|FG002|Overall Study|Death|0|||
125510366|NCT02268526|451496339|FG000|Overall Study|protocol deviation|0|||
125510367|NCT02268526|451496340|FG001|Overall Study|protocol deviation|1|||
125510368|NCT02268526|451496341|FG002|Overall Study|protocol deviation|0|||
125510369|NCT02268526|451496339|FG000|Overall Study|Physician Decision|0|||
125510370|NCT02268526|451496340|FG001|Overall Study|Physician Decision|0|||
125510371|NCT02268526|451496341|FG002|Overall Study|Physician Decision|1|||
125510372|NCT02268526|451496339|FG000|Overall Study|Subject/guardian decision|0|||
125510373|NCT02268526|451496340|FG001|Overall Study|Subject/guardian decision|7|||
125510374|NCT02268526|451496341|FG002|Overall Study|Subject/guardian decision|3|||
125510375|NCT00596960|451496344|FG000|Overall Study|Death|1|||
125510376|NCT00596960|451496345|FG001|Overall Study|Death|2|||
125510377|NCT00596960|451496344|FG000|Overall Study|Lost to Follow-up|6|||
125510378|NCT00596960|451496345|FG001|Overall Study|Lost to Follow-up|5|||
125510379|NCT00596960|451496344|FG000|Overall Study|Withdrawal by Subject|1|||
125532599|NCT00350727|451580163|FG002|Phase II|Disease Progression|16|||
125510380|NCT00596960|451496345|FG001|Overall Study|Withdrawal by Subject|0|||
125510381|NCT00596960|451496344|FG000|Overall Study|Incarcerated|2|||
125510382|NCT00596960|451496345|FG001|Overall Study|Incarcerated|0|||
125510383|NCT00596960|451496344|FG000|Overall Study|Physician Decision|1|||
125510384|NCT00596960|451496345|FG001|Overall Study|Physician Decision|0|||
125510385|NCT00596960|451496344|FG000|Overall Study|Protocol Violation|0|||
125510386|NCT00596960|451496345|FG001|Overall Study|Protocol Violation|1|||
125510387|NCT00596960|451496344|FG000|Overall Study|No alcohol use data|0|||
125510388|NCT00596960|451496345|FG001|Overall Study|No alcohol use data|1|||
125510389|NCT02130401|451496349|FG000|Overall Study|Poor enrollment|6|||
125510390|NCT00936065|451496350|FG000|Overall Study|Adverse Event|1|||
125510391|NCT00936065|451496351|FG001|Overall Study|Adverse Event|0|||
125510392|NCT00936065|451496352|FG002|Overall Study|Adverse Event|1|||
125510393|NCT00936065|451496350|FG000|Overall Study|Lack of Efficacy|1|||
125510394|NCT00936065|451496351|FG001|Overall Study|Lack of Efficacy|0|||
125510395|NCT00936065|451496352|FG002|Overall Study|Lack of Efficacy|1|||
125510396|NCT00936065|451496350|FG000|Overall Study|Lost to Follow-up|1|||
125510397|NCT00936065|451496351|FG001|Overall Study|Lost to Follow-up|0|||
125510398|NCT00936065|451496352|FG002|Overall Study|Lost to Follow-up|0|||
125510399|NCT00936065|451496350|FG000|Overall Study|Protocol Violation|1|||
125510400|NCT00936065|451496351|FG001|Overall Study|Protocol Violation|2|||
125510401|NCT00936065|451496352|FG002|Overall Study|Protocol Violation|1|||
125510402|NCT00936065|451496350|FG000|Overall Study|Withdrawal by Subject|0|||
125510403|NCT00936065|451496351|FG001|Overall Study|Withdrawal by Subject|2|||
125510404|NCT00936065|451496352|FG002|Overall Study|Withdrawal by Subject|4|||
125510405|NCT01052714|451496353|FG000|Overall Study|Adverse Event|6|||
125510406|NCT01052714|451496354|FG001|Overall Study|Adverse Event|3|||
125510407|NCT01052714|451496355|FG002|Overall Study|Adverse Event|0|||
125510408|NCT01052714|451496353|FG000|Overall Study|Death|1|||
125510409|NCT01052714|451496354|FG001|Overall Study|Death|2|||
125510410|NCT01052714|451496355|FG002|Overall Study|Death|0|||
125510411|NCT01052714|451496353|FG000|Overall Study|Lost to Follow-up|2|||
125510412|NCT01052714|451496354|FG001|Overall Study|Lost to Follow-up|3|||
125510413|NCT01052714|451496355|FG002|Overall Study|Lost to Follow-up|0|||
125510414|NCT01052714|451496353|FG000|Overall Study|Physician Decision|9|||
125510415|NCT01052714|451496354|FG001|Overall Study|Physician Decision|9|||
125510416|NCT01052714|451496355|FG002|Overall Study|Physician Decision|1|||
125510417|NCT01052714|451496353|FG000|Overall Study|Withdrawal by Subject|7|||
125510418|NCT01052714|451496354|FG001|Overall Study|Withdrawal by Subject|12|||
125510419|NCT01052714|451496355|FG002|Overall Study|Withdrawal by Subject|1|||
125510420|NCT00267865|451496362|FG000|Induction Treatment|Died before completing.|2|||
125510421|NCT00267865|451496362|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
125510422|NCT03686176|451496363|FG000|Overall Study|Procedure cancelled|1|||
125510423|NCT03686176|451496364|FG001|Overall Study|Procedure cancelled|0|||
125510424|NCT03686176|451496365|FG002|Overall Study|Procedure cancelled|0|||
125510425|NCT03686176|451496363|FG000|Overall Study|VR Malfunction|1|||
125510426|NCT03686176|451496364|FG001|Overall Study|VR Malfunction|0|||
125510427|NCT03686176|451496365|FG002|Overall Study|VR Malfunction|0|||
125510428|NCT01636778|451496368|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
125510429|NCT01636778|451496369|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
125510430|NCT01636778|451496370|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
125510431|NCT01636778|451496368|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
125510432|NCT01636778|451496369|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
125510433|NCT01636778|451496370|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
125510434|NCT01636778|451496368|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
125510435|NCT01636778|451496369|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
125510436|NCT01636778|451496370|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
125510437|NCT01636778|451496368|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
125510438|NCT01636778|451496369|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
125510439|NCT01636778|451496370|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
125510440|NCT01636778|451496368|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
125510441|NCT01636778|451496369|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
125510442|NCT01636778|451496370|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
125510443|NCT01636778|451496368|FG000|Follow-up Period After Part 2|Other|0|||
125510444|NCT01636778|451496369|FG001|Follow-up Period After Part 2|Other|0|||
125510445|NCT01636778|451496370|FG002|Follow-up Period After Part 2|Other|1|||
125510446|NCT01636778|451496368|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
125510447|NCT01636778|451496369|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
125510448|NCT01636778|451496370|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
125510449|NCT01636778|451496368|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
125510450|NCT01636778|451496369|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
125510451|NCT01636778|451496370|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
125510452|NCT03530345|451496379|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
125532600|NCT00350727|451580161|FG000|Phase II|Clinical Deterioration|0|||
125510453|NCT03530345|451496380|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
125510454|NCT03530345|451496379|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
125510455|NCT03530345|451496380|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
125510456|NCT03530345|451496379|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
125510457|NCT03530345|451496380|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
125510458|NCT03530345|451496379|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
125305571|NCT00106353|450745150|FG005|Part 1|Disease progression|0|||
125305572|NCT00106353|450745151|FG006|Part 1|Disease progression|0|||
125305573|NCT00106353|450745145|FG000|Part 1|Withdrawal by Subject|0|||
125305574|NCT00106353|450745146|FG001|Part 1|Withdrawal by Subject|0|||
125305575|NCT00106353|450745147|FG002|Part 1|Withdrawal by Subject|1|||
125305576|NCT00106353|450745148|FG003|Part 1|Withdrawal by Subject|2|||
125305577|NCT00106353|450745149|FG004|Part 1|Withdrawal by Subject|0|||
125305578|NCT00106353|450745150|FG005|Part 1|Withdrawal by Subject|0|||
125305579|NCT00106353|450745151|FG006|Part 1|Withdrawal by Subject|0|||
125305580|NCT00106353|450745145|FG000|Part 1|Symptomatic deterioration|0|||
125305581|NCT00106353|450745146|FG001|Part 1|Symptomatic deterioration|0|||
125305582|NCT00106353|450745147|FG002|Part 1|Symptomatic deterioration|1|||
125305583|NCT00106353|450745148|FG003|Part 1|Symptomatic deterioration|0|||
125305584|NCT00106353|450745149|FG004|Part 1|Symptomatic deterioration|0|||
125305585|NCT00106353|450745150|FG005|Part 1|Symptomatic deterioration|0|||
125305586|NCT00106353|450745151|FG006|Part 1|Symptomatic deterioration|0|||
125305587|NCT00106353|450745145|FG000|Part 1|Entered follow-up phase|1|||
125305588|NCT00106353|450745146|FG001|Part 1|Entered follow-up phase|1|||
125305589|NCT00106353|450745147|FG002|Part 1|Entered follow-up phase|0|||
125305590|NCT00106353|450745148|FG003|Part 1|Entered follow-up phase|1|||
125305591|NCT00106353|450745149|FG004|Part 1|Entered follow-up phase|0|||
125305592|NCT00106353|450745150|FG005|Part 1|Entered follow-up phase|0|||
125305593|NCT00106353|450745151|FG006|Part 1|Entered follow-up phase|0|||
125305594|NCT00106353|450745145|FG000|Part 1|Adverse Event|0|||
125305595|NCT00106353|450745146|FG001|Part 1|Adverse Event|0|||
125305596|NCT00106353|450745147|FG002|Part 1|Adverse Event|0|||
125305597|NCT00106353|450745148|FG003|Part 1|Adverse Event|1|||
125305598|NCT00106353|450745149|FG004|Part 1|Adverse Event|0|||
125305599|NCT00106353|450745150|FG005|Part 1|Adverse Event|0|||
125305600|NCT00106353|450745151|FG006|Part 1|Adverse Event|0|||
125305601|NCT00106353|450745145|FG000|Part 2|Disease progression|0|||
125305602|NCT00106353|450745146|FG001|Part 2|Disease progression|0|||
125305603|NCT00106353|450745147|FG002|Part 2|Disease progression|0|||
125305604|NCT00106353|450745148|FG003|Part 2|Disease progression|0|||
125305605|NCT00106353|450745149|FG004|Part 2|Disease progression|8|||
125305606|NCT00106353|450745150|FG005|Part 2|Disease progression|14|||
125305607|NCT00106353|450745151|FG006|Part 2|Disease progression|13|||
125305608|NCT00106353|450745145|FG000|Part 2|Death|0|||
125305609|NCT00106353|450745146|FG001|Part 2|Death|0|||
125305610|NCT00106353|450745147|FG002|Part 2|Death|0|||
125305611|NCT00106353|450745148|FG003|Part 2|Death|0|||
125305612|NCT00106353|450745149|FG004|Part 2|Death|3|||
125305613|NCT00106353|450745150|FG005|Part 2|Death|0|||
125305614|NCT00106353|450745151|FG006|Part 2|Death|1|||
125305615|NCT00106353|450745145|FG000|Part 2|Symptomatic deterioration|0|||
125305616|NCT00106353|450745146|FG001|Part 2|Symptomatic deterioration|0|||
125305617|NCT00106353|450745147|FG002|Part 2|Symptomatic deterioration|0|||
125305618|NCT00106353|450745148|FG003|Part 2|Symptomatic deterioration|0|||
125305619|NCT00106353|450745149|FG004|Part 2|Symptomatic deterioration|3|||
125305620|NCT00106353|450745150|FG005|Part 2|Symptomatic deterioration|0|||
125305621|NCT00106353|450745151|FG006|Part 2|Symptomatic deterioration|0|||
125305622|NCT00106353|450745145|FG000|Part 2|Adverse Event|0|||
125305623|NCT00106353|450745146|FG001|Part 2|Adverse Event|0|||
125305624|NCT00106353|450745147|FG002|Part 2|Adverse Event|0|||
125305625|NCT00106353|450745148|FG003|Part 2|Adverse Event|0|||
125305626|NCT00106353|450745149|FG004|Part 2|Adverse Event|0|||
125305627|NCT00106353|450745150|FG005|Part 2|Adverse Event|2|||
125305628|NCT00106353|450745151|FG006|Part 2|Adverse Event|1|||
125305629|NCT00106353|450745145|FG000|Part 2|Other|0|||
125305630|NCT00106353|450745146|FG001|Part 2|Other|0|||
125305631|NCT00106353|450745147|FG002|Part 2|Other|0|||
125305632|NCT00106353|450745148|FG003|Part 2|Other|0|||
125305633|NCT00106353|450745149|FG004|Part 2|Other|1|||
125305634|NCT00106353|450745150|FG005|Part 2|Other|1|||
125305635|NCT00106353|450745151|FG006|Part 2|Other|1|||
125305636|NCT00106353|450745145|FG000|Part 2|Withdrawal by Subject|0|||
125305637|NCT00106353|450745146|FG001|Part 2|Withdrawal by Subject|0|||
125305638|NCT00106353|450745147|FG002|Part 2|Withdrawal by Subject|0|||
125305639|NCT00106353|450745148|FG003|Part 2|Withdrawal by Subject|0|||
125532601|NCT00350727|451580162|FG001|Phase II|Clinical Deterioration|1|||
125305640|NCT00106353|450745149|FG004|Part 2|Withdrawal by Subject|1|||
125305641|NCT00106353|450745150|FG005|Part 2|Withdrawal by Subject|0|||
125305642|NCT00106353|450745151|FG006|Part 2|Withdrawal by Subject|0|||
125305643|NCT00106353|450745145|FG000|Part 2|Physician Decision|0|||
125305644|NCT00106353|450745146|FG001|Part 2|Physician Decision|0|||
125305645|NCT00106353|450745147|FG002|Part 2|Physician Decision|0|||
125305646|NCT00106353|450745148|FG003|Part 2|Physician Decision|0|||
125510459|NCT03530345|451496380|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
125510460|NCT02661490|451498377|FG000|Overall Study|Lost to Follow-up|0|||
125510461|NCT02661490|451498378|FG001|Overall Study|Lost to Follow-up|1|||
125510462|NCT02661490|451498379|FG002|Overall Study|Lost to Follow-up|0|||
125510463|NCT02661490|451498380|FG003|Overall Study|Lost to Follow-up|0|||
125510464|NCT02661490|451498381|FG004|Overall Study|Lost to Follow-up|2|||
125510465|NCT02661490|451498377|FG000|Overall Study|Withdrawal by Subject|2|||
125510466|NCT02661490|451498378|FG001|Overall Study|Withdrawal by Subject|0|||
125510467|NCT02661490|451498379|FG002|Overall Study|Withdrawal by Subject|2|||
125510468|NCT02661490|451498380|FG003|Overall Study|Withdrawal by Subject|0|||
125510469|NCT02661490|451498381|FG004|Overall Study|Withdrawal by Subject|0|||
125510470|NCT02661490|451498377|FG000|Overall Study|Death|1|||
125510471|NCT02661490|451498378|FG001|Overall Study|Death|1|||
125510472|NCT02661490|451498379|FG002|Overall Study|Death|0|||
125510473|NCT02661490|451498380|FG003|Overall Study|Death|1|||
125510474|NCT02661490|451498381|FG004|Overall Study|Death|0|||
125510475|NCT02661490|451498377|FG000|Overall Study|Reason not Specified|0|||
125510476|NCT02661490|451498378|FG001|Overall Study|Reason not Specified|0|||
125510477|NCT02661490|451498379|FG002|Overall Study|Reason not Specified|0|||
125510478|NCT02661490|451498380|FG003|Overall Study|Reason not Specified|0|||
125510479|NCT02661490|451498381|FG004|Overall Study|Reason not Specified|1|||
125510480|NCT00644332|451498382|FG000|Overall Study|Adverse Event|11|||
125510481|NCT00644332|451498382|FG000|Overall Study|Withdrawal by Subject|6|||
125510482|NCT00644332|451498382|FG000|Overall Study|Completion Status Unknown|2|||
125510483|NCT00644332|451498382|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
125510484|NCT00644332|451498382|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
125305647|NCT00106353|450745149|FG004|Part 2|Physician Decision|0|||
125305648|NCT00106353|450745150|FG005|Part 2|Physician Decision|1|||
125305649|NCT00106353|450745151|FG006|Part 2|Physician Decision|0|||
125305650|NCT02038075|450745152|FG000|Overall Study|Withdrawal by Subject|3|||
125305651|NCT02038075|450745153|FG001|Overall Study|Withdrawal by Subject|0|||
125305652|NCT04000581|450745154|FG000|Overall Study|Withdrawal by Subject|0|||
125305653|NCT04000581|450745155|FG001|Overall Study|Withdrawal by Subject|1|||
125305654|NCT00588354|450745156|FG000|Baseline to 2 Weeks|Adverse Event|1|||
125305655|NCT00588354|450745157|FG001|Baseline to 2 Weeks|Adverse Event|0|||
125305656|NCT00588354|450745156|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
125305657|NCT00588354|450745157|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
125305658|NCT00588354|450745156|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
125305659|NCT00588354|450745157|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
125305660|NCT03477838|450745158|FG000|Overall Study|Lost to Follow-up|14|||
125305661|NCT02519595|450745159|FG000|Overall Study|Protocol Violation|8|||
125305662|NCT02519595|450745160|FG001|Overall Study|Protocol Violation|22|||
125305663|NCT02519595|450745161|FG002|Overall Study|Protocol Violation|16|||
125305664|NCT00850538|450745164|FG000|Overall Study|unable/unwilling to complete MRI|13|||
125305665|NCT00850538|450745164|FG000|Overall Study|specimen missed due to scheduling error|14|||
125305666|NCT00850538|450745164|FG000|Overall Study|specimen unusable|7|||
125305667|NCT00850538|450745164|FG000|Overall Study|Withdrawal by Subject|3|||
125305668|NCT00850538|450745164|FG000|Overall Study|radiology error|2|||
125305669|NCT00850538|450745164|FG000|Overall Study|Protocol Violation|2|||
125305670|NCT02328027|450745170|FG000|Overall Study|Withdrawal by Subject|0|||
125305671|NCT02328027|450745171|FG001|Overall Study|Withdrawal by Subject|1|||
125305672|NCT00999518|450745175|FG000|Overall Study|Adverse Event|1|||
125305673|NCT00999518|450745176|FG001|Overall Study|Adverse Event|6|||
125305674|NCT00999518|450745177|FG002|Overall Study|Adverse Event|3|||
125305675|NCT00999518|450745178|FG003|Overall Study|Adverse Event|1|||
125305676|NCT00999518|450745179|FG004|Overall Study|Adverse Event|2|||
125305677|NCT00999518|450745175|FG000|Overall Study|Lack of Efficacy|2|||
125305678|NCT00999518|450745176|FG001|Overall Study|Lack of Efficacy|0|||
125305679|NCT00999518|450745177|FG002|Overall Study|Lack of Efficacy|0|||
125305680|NCT00999518|450745178|FG003|Overall Study|Lack of Efficacy|2|||
125305681|NCT00999518|450745179|FG004|Overall Study|Lack of Efficacy|2|||
125305682|NCT00999518|450745175|FG000|Overall Study|Lost to Follow-up|0|||
125305683|NCT00999518|450745176|FG001|Overall Study|Lost to Follow-up|0|||
125305684|NCT00999518|450745177|FG002|Overall Study|Lost to Follow-up|0|||
125305685|NCT00999518|450745178|FG003|Overall Study|Lost to Follow-up|4|||
125305686|NCT00999518|450745179|FG004|Overall Study|Lost to Follow-up|1|||
125305687|NCT00999518|450745175|FG000|Overall Study|Did not meet entrance criteria|0|||
125305688|NCT00999518|450745176|FG001|Overall Study|Did not meet entrance criteria|0|||
125305689|NCT00999518|450745177|FG002|Overall Study|Did not meet entrance criteria|0|||
125305690|NCT00999518|450745178|FG003|Overall Study|Did not meet entrance criteria|0|||
125305691|NCT00999518|450745179|FG004|Overall Study|Did not meet entrance criteria|1|||
125305692|NCT00999518|450745175|FG000|Overall Study|Study terminated by sponsor|10|||
125305693|NCT00999518|450745176|FG001|Overall Study|Study terminated by sponsor|6|||
125510485|NCT02706834|451498385|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
125305694|NCT00999518|450745177|FG002|Overall Study|Study terminated by sponsor|5|||
125305695|NCT00999518|450745178|FG003|Overall Study|Study terminated by sponsor|5|||
125510486|NCT02706834|451498386|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
125510487|NCT02706834|451498387|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
125510488|NCT02706834|451498388|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
125510489|NCT02706834|451498389|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
125510490|NCT02706834|451498390|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
125510491|NCT02706834|451498391|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
125510492|NCT02706834|451498392|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
125510493|NCT02706834|451498393|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
125305696|NCT00999518|450745179|FG004|Overall Study|Study terminated by sponsor|9|||
125305697|NCT00999518|450745175|FG000|Overall Study|Pregnancy|0|||
125305698|NCT00999518|450745176|FG001|Overall Study|Pregnancy|0|||
125305699|NCT00999518|450745177|FG002|Overall Study|Pregnancy|1|||
125305700|NCT00999518|450745178|FG003|Overall Study|Pregnancy|0|||
125305701|NCT00999518|450745179|FG004|Overall Study|Pregnancy|0|||
125305702|NCT00999518|450745175|FG000|Overall Study|Protocol Violation|0|||
125305703|NCT00999518|450745176|FG001|Overall Study|Protocol Violation|1|||
125305704|NCT00999518|450745177|FG002|Overall Study|Protocol Violation|0|||
125305705|NCT00999518|450745178|FG003|Overall Study|Protocol Violation|0|||
125305706|NCT00999518|450745179|FG004|Overall Study|Protocol Violation|2|||
125305707|NCT00999518|450745175|FG000|Overall Study|Withdrawal by Subject|5|||
125305708|NCT00999518|450745176|FG001|Overall Study|Withdrawal by Subject|4|||
125305709|NCT00999518|450745177|FG002|Overall Study|Withdrawal by Subject|10|||
125305710|NCT00999518|450745178|FG003|Overall Study|Withdrawal by Subject|6|||
125305711|NCT00999518|450745179|FG004|Overall Study|Withdrawal by Subject|1|||
125305712|NCT00999518|450745175|FG000|Overall Study|Other|5|||
125305713|NCT00999518|450745176|FG001|Overall Study|Other|7|||
125305714|NCT00999518|450745177|FG002|Overall Study|Other|1|||
125305715|NCT00999518|450745178|FG003|Overall Study|Other|4|||
125305716|NCT00999518|450745179|FG004|Overall Study|Other|5|||
125305717|NCT00999518|450745175|FG000|Overall Study|Randomized but not Treated|1|||
125305718|NCT00999518|450745176|FG001|Overall Study|Randomized but not Treated|1|||
125305719|NCT00999518|450745177|FG002|Overall Study|Randomized but not Treated|2|||
125305720|NCT00999518|450745178|FG003|Overall Study|Randomized but not Treated|0|||
125305721|NCT00999518|450745179|FG004|Overall Study|Randomized but not Treated|1|||
125305722|NCT03319212|450745180|FG000|Overall Study|Discontinued as moving out of local area|0|||
125305723|NCT03319212|450745181|FG001|Overall Study|Discontinued as moving out of local area|1|||
125305724|NCT03319212|450745180|FG000|Overall Study|Adverse Event|2|||
125305725|NCT03319212|450745181|FG001|Overall Study|Adverse Event|2|||
125305726|NCT03319212|450745180|FG000|Overall Study|Withdrawal by Subject|0|||
125305727|NCT03319212|450745181|FG001|Overall Study|Withdrawal by Subject|1|||
125305728|NCT03319212|450745180|FG000|Overall Study|Lost to Follow-up|0|||
125305729|NCT03319212|450745181|FG001|Overall Study|Lost to Follow-up|1|||
125305730|NCT03319212|450745180|FG000|Overall Study|Physician Decision|1|||
125305731|NCT03319212|450745181|FG001|Overall Study|Physician Decision|0|||
125305732|NCT00250276|450745182|FG000|Overall Study|Serious Adverse Event|0|||
125305733|NCT00250276|450745183|FG001|Overall Study|Serious Adverse Event|0|||
125305734|NCT00250276|450745184|FG002|Overall Study|Serious Adverse Event|1|||
125305735|NCT00250276|450745185|FG003|Overall Study|Serious Adverse Event|0|||
125305736|NCT00250276|450745182|FG000|Overall Study|Non-serious Adverse Event|2|||
125305737|NCT00250276|450745183|FG001|Overall Study|Non-serious Adverse Event|0|||
125305738|NCT00250276|450745184|FG002|Overall Study|Non-serious Adverse Event|0|||
125305739|NCT00250276|450745185|FG003|Overall Study|Non-serious Adverse Event|2|||
125305740|NCT00250276|450745182|FG000|Overall Study|Protocol Violation|0|||
125305741|NCT00250276|450745183|FG001|Overall Study|Protocol Violation|1|||
125305742|NCT00250276|450745184|FG002|Overall Study|Protocol Violation|0|||
125305743|NCT00250276|450745185|FG003|Overall Study|Protocol Violation|0|||
125305744|NCT00250276|450745182|FG000|Overall Study|Withdrawal by Subject|1|||
125305745|NCT00250276|450745183|FG001|Overall Study|Withdrawal by Subject|2|||
125305746|NCT00250276|450745184|FG002|Overall Study|Withdrawal by Subject|3|||
125305747|NCT00250276|450745185|FG003|Overall Study|Withdrawal by Subject|2|||
125305748|NCT00250276|450745182|FG000|Overall Study|Migrated/moved from study area|3|||
125305749|NCT00250276|450745183|FG001|Overall Study|Migrated/moved from study area|0|||
125305750|NCT00250276|450745184|FG002|Overall Study|Migrated/moved from study area|2|||
125305751|NCT00250276|450745185|FG003|Overall Study|Migrated/moved from study area|7|||
125305752|NCT00250276|450745182|FG000|Overall Study|Lost to Follow-up|11|||
125305753|NCT00250276|450745183|FG001|Overall Study|Lost to Follow-up|18|||
125305754|NCT00250276|450745184|FG002|Overall Study|Lost to Follow-up|13|||
125305755|NCT00250276|450745185|FG003|Overall Study|Lost to Follow-up|8|||
125305756|NCT01088399|450745186|FG000|Overall Study|Adverse Event|211|||
125305757|NCT01088399|450745187|FG001|Overall Study|Adverse Event|16|||
125305758|NCT01088399|450745188|FG002|Overall Study|Adverse Event|0|||
125305759|NCT01088399|450745186|FG000|Overall Study|Death|204|||
125305760|NCT01088399|450745187|FG001|Overall Study|Death|45|||
125305761|NCT01088399|450745188|FG002|Overall Study|Death|0|||
125305762|NCT01088399|450745186|FG000|Overall Study|Lack of Efficacy|298|||
125305763|NCT01088399|450745187|FG001|Overall Study|Lack of Efficacy|7|||
125305764|NCT01088399|450745188|FG002|Overall Study|Lack of Efficacy|5|||
125305765|NCT01088399|450745186|FG000|Overall Study|Lost to Follow-up|1070|||
125305766|NCT01088399|450745187|FG001|Overall Study|Lost to Follow-up|278|||
125510494|NCT02706834|451498394|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
125510495|NCT02706834|451498395|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
125510496|NCT02706834|451498385|FG000|Overall Study|Lost to Follow-up|0|||
125510497|NCT02706834|451498386|FG001|Overall Study|Lost to Follow-up|0|||
125510498|NCT02706834|451498387|FG002|Overall Study|Lost to Follow-up|1|||
125510499|NCT02706834|451498388|FG003|Overall Study|Lost to Follow-up|0|||
125510500|NCT02706834|451498389|FG004|Overall Study|Lost to Follow-up|0|||
125510501|NCT02706834|451498390|FG005|Overall Study|Lost to Follow-up|0|||
125510502|NCT02706834|451498391|FG006|Overall Study|Lost to Follow-up|0|||
125510503|NCT02706834|451498392|FG007|Overall Study|Lost to Follow-up|0|||
125510504|NCT02706834|451498393|FG008|Overall Study|Lost to Follow-up|0|||
125510505|NCT02706834|451498394|FG009|Overall Study|Lost to Follow-up|0|||
125510506|NCT02706834|451498395|FG010|Overall Study|Lost to Follow-up|0|||
125510507|NCT02706834|451498385|FG000|Overall Study|Voluntary Withdrawal|1|||
125510508|NCT02706834|451498386|FG001|Overall Study|Voluntary Withdrawal|0|||
125510509|NCT02706834|451498387|FG002|Overall Study|Voluntary Withdrawal|0|||
125510510|NCT02706834|451498388|FG003|Overall Study|Voluntary Withdrawal|0|||
125510511|NCT02706834|451498389|FG004|Overall Study|Voluntary Withdrawal|0|||
125510512|NCT02706834|451498390|FG005|Overall Study|Voluntary Withdrawal|0|||
125510513|NCT02706834|451498391|FG006|Overall Study|Voluntary Withdrawal|0|||
125510514|NCT02706834|451498392|FG007|Overall Study|Voluntary Withdrawal|0|||
125510515|NCT02706834|451498393|FG008|Overall Study|Voluntary Withdrawal|0|||
125510516|NCT02706834|451498394|FG009|Overall Study|Voluntary Withdrawal|1|||
125510517|NCT02706834|451498395|FG010|Overall Study|Voluntary Withdrawal|0|||
125510518|NCT02706834|451498385|FG000|Overall Study|Other Reason Not Specified|1|||
125510519|NCT02706834|451498386|FG001|Overall Study|Other Reason Not Specified|0|||
125510520|NCT02706834|451498387|FG002|Overall Study|Other Reason Not Specified|0|||
125510521|NCT02706834|451498388|FG003|Overall Study|Other Reason Not Specified|0|||
125510522|NCT02706834|451498389|FG004|Overall Study|Other Reason Not Specified|1|||
125510523|NCT02706834|451498390|FG005|Overall Study|Other Reason Not Specified|0|||
125510524|NCT02706834|451498391|FG006|Overall Study|Other Reason Not Specified|0|||
125510525|NCT02706834|451498392|FG007|Overall Study|Other Reason Not Specified|0|||
125510526|NCT02706834|451498393|FG008|Overall Study|Other Reason Not Specified|0|||
125510527|NCT02706834|451498394|FG009|Overall Study|Other Reason Not Specified|0|||
125510528|NCT02706834|451498395|FG010|Overall Study|Other Reason Not Specified|0|||
125510529|NCT00627523|451498399|FG000|Overall Study|Lack of Efficacy|1|||
125510530|NCT00627523|451498400|FG001|Overall Study|Lack of Efficacy|0|||
125510531|NCT00627523|451498399|FG000|Overall Study|Withdrawal by Subject|0|||
125510532|NCT00627523|451498400|FG001|Overall Study|Withdrawal by Subject|2|||
125510533|NCT00627523|451498399|FG000|Overall Study|Other|1|||
125510534|NCT00627523|451498400|FG001|Overall Study|Other|0|||
125510535|NCT00355784|451498404|FG000|Overall Study|Withdrawal by Subject|0|||
125510536|NCT00355784|451498405|FG001|Overall Study|Withdrawal by Subject|0|||
125510537|NCT00355784|451498406|FG002|Overall Study|Withdrawal by Subject|2|||
125510538|NCT03602053|451498410|FG000|Overall Study|Withdrawal by Subject|7|||
125510539|NCT03602053|451498411|FG001|Overall Study|Withdrawal by Subject|9|||
125510540|NCT03602053|451498412|FG002|Overall Study|Withdrawal by Subject|7|||
125510541|NCT03602053|451498410|FG000|Overall Study|Lost to Follow-up|5|||
125510542|NCT03602053|451498411|FG001|Overall Study|Lost to Follow-up|6|||
125510543|NCT03602053|451498412|FG002|Overall Study|Lost to Follow-up|0|||
125510544|NCT03602053|451498410|FG000|Overall Study|Protocol Violation|3|||
125510545|NCT03602053|451498411|FG001|Overall Study|Protocol Violation|0|||
125510546|NCT03602053|451498412|FG002|Overall Study|Protocol Violation|4|||
125510547|NCT03602053|451498410|FG000|Overall Study|Physician Decision|1|||
125510548|NCT03602053|451498411|FG001|Overall Study|Physician Decision|0|||
125510549|NCT03602053|451498412|FG002|Overall Study|Physician Decision|0|||
125510550|NCT03602053|451498410|FG000|Overall Study|migration|2|||
125305767|NCT01088399|450745188|FG002|Overall Study|Lost to Follow-up|58|||
125305768|NCT01088399|450745186|FG000|Overall Study|Physician Decision|531|||
125510551|NCT03602053|451498411|FG001|Overall Study|migration|3|||
125510552|NCT03602053|451498412|FG002|Overall Study|migration|0|||
125510553|NCT03602053|451498410|FG000|Overall Study|Other|1|||
125510554|NCT03602053|451498411|FG001|Overall Study|Other|0|||
125510555|NCT03602053|451498412|FG002|Overall Study|Other|0|||
125510556|NCT01038128|451498413|FG000|Overall Study|Lack of Efficacy|1|||
125510557|NCT01038128|451498413|FG000|Overall Study|Lost to Follow-up|1|||
125510558|NCT01038128|451498413|FG000|Overall Study|Withdrawal by Subject|2|||
125510559|NCT01745380|451498423|FG000|Overall Study|Lost to Follow-up|1|||
125510560|NCT01745380|451498424|FG001|Overall Study|Lost to Follow-up|0|||
125510561|NCT01745380|451498423|FG000|Overall Study|Lack of Efficacy|0|||
125510562|NCT01745380|451498424|FG001|Overall Study|Lack of Efficacy|1|||
125510563|NCT01882088|451498425|FG000|Overall Study|Intolerance of esophageal manometry|1|||
125510564|NCT01882088|451498425|FG000|Overall Study|no possibility to place the catheter|1|||
125510565|NCT01882088|451498425|FG000|Overall Study|Protocol Violation|1|||
125510566|NCT01882088|451498425|FG000|Overall Study|inadequate pH-impedance tracings|2|||
125510567|NCT01193283|451498426|FG000|Overall Study|Death|1|||
125510568|NCT01838447|451498431|FG000|Overall Study|Change in surgical plan|1|||
125510569|NCT01838447|451498432|FG001|Overall Study|Change in surgical plan|2|||
125510570|NCT01838447|451498431|FG000|Overall Study|Withdrawal by Subject|1|||
125510571|NCT01838447|451498432|FG001|Overall Study|Withdrawal by Subject|1|||
125510572|NCT00168805|451498433|FG000|Overall Study|Adverse Event|7|||
125510573|NCT00168805|451498434|FG001|Overall Study|Adverse Event|11|||
125510574|NCT00168805|451498435|FG002|Overall Study|Adverse Event|16|||
125510575|NCT00168805|451498433|FG000|Overall Study|Protocol Violation|12|||
125510576|NCT00168805|451498434|FG001|Overall Study|Protocol Violation|11|||
125510577|NCT00168805|451498435|FG002|Overall Study|Protocol Violation|8|||
125510578|NCT00168805|451498433|FG000|Overall Study|Lost to Follow-up|12|||
125510579|NCT00168805|451498434|FG001|Overall Study|Lost to Follow-up|17|||
125510580|NCT00168805|451498435|FG002|Overall Study|Lost to Follow-up|11|||
125510581|NCT00168805|451498433|FG000|Overall Study|Withdrawal by Subject|16|||
125510582|NCT00168805|451498434|FG001|Overall Study|Withdrawal by Subject|18|||
125510583|NCT00168805|451498435|FG002|Overall Study|Withdrawal by Subject|21|||
125510584|NCT00168805|451498433|FG000|Overall Study|Other|24|||
125510585|NCT00168805|451498434|FG001|Overall Study|Other|21|||
125510586|NCT00168805|451498435|FG002|Overall Study|Other|22|||
125510587|NCT00168805|451498433|FG000|Treatment|Adverse Event|25|||
125510588|NCT00168805|451498434|FG001|Treatment|Adverse Event|26|||
125510589|NCT00168805|451498435|FG002|Treatment|Adverse Event|32|||
125510590|NCT00168805|451498433|FG000|Treatment|Protocol Violation|3|||
125510591|NCT00168805|451498434|FG001|Treatment|Protocol Violation|5|||
125510592|NCT00168805|451498435|FG002|Treatment|Protocol Violation|5|||
125510593|NCT00168805|451498433|FG000|Treatment|Withdrawal by Subject|3|||
125510594|NCT00168805|451498434|FG001|Treatment|Withdrawal by Subject|7|||
125510595|NCT00168805|451498435|FG002|Treatment|Withdrawal by Subject|8|||
125510596|NCT00168805|451498433|FG000|Treatment|Other|18|||
125510597|NCT00168805|451498434|FG001|Treatment|Other|18|||
125510598|NCT00168805|451498435|FG002|Treatment|Other|17|||
125510599|NCT04879823|451498436|FG000|Overall Study|Physician Decision|3|||
125510600|NCT04879823|451498437|FG001|Overall Study|Physician Decision|1|||
125510601|NCT04879823|451498436|FG000|Overall Study|Protocol Violation|2|||
125510602|NCT04879823|451498437|FG001|Overall Study|Protocol Violation|3|||
125510603|NCT04879823|451498436|FG000|Overall Study|Lost to Follow-up|43|||
125510604|NCT04879823|451498437|FG001|Overall Study|Lost to Follow-up|35|||
125510605|NCT04468633|451498440|FG000|Overall Study|Withdrawal by Subject|4|||
125510606|NCT04468633|451498441|FG001|Overall Study|Withdrawal by Subject|0|||
125510607|NCT00460434|451498444|FG000|Overall Study|Lost to Follow-up|3|||
125510608|NCT00460434|451498445|FG001|Overall Study|Lost to Follow-up|7|||
125510609|NCT02446912|451498469|FG000|Overall Study|Adverse Event|3|||
125510610|NCT02446912|451498470|FG001|Overall Study|Adverse Event|13|||
125510611|NCT02446912|451498471|FG002|Overall Study|Adverse Event|5|||
125510612|NCT02446912|451498469|FG000|Overall Study|Condition under investigation worsened|0|||
125510613|NCT02446912|451498470|FG001|Overall Study|Condition under investigation worsened|1|||
125510614|NCT02446912|451498471|FG002|Overall Study|Condition under investigation worsened|1|||
125510615|NCT02446912|451498469|FG000|Overall Study|Study-specific withdrawal criteria|1|||
125510616|NCT02446912|451498470|FG001|Overall Study|Study-specific withdrawal criteria|0|||
125510617|NCT02446912|451498471|FG002|Overall Study|Study-specific withdrawal criteria|0|||
125510618|NCT02446912|451498469|FG000|Overall Study|Lack of Efficacy|1|||
125510619|NCT02446912|451498470|FG001|Overall Study|Lack of Efficacy|4|||
125510620|NCT02446912|451498471|FG002|Overall Study|Lack of Efficacy|7|||
125510621|NCT02446912|451498469|FG000|Overall Study|Lost to Follow-up|0|||
125510622|NCT02446912|451498470|FG001|Overall Study|Lost to Follow-up|0|||
125510623|NCT02446912|451498471|FG002|Overall Study|Lost to Follow-up|2|||
125510624|NCT02446912|451498469|FG000|Overall Study|Severe non-compliance to protocol|1|||
125510625|NCT02446912|451498470|FG001|Overall Study|Severe non-compliance to protocol|0|||
125510626|NCT02446912|451498471|FG002|Overall Study|Severe non-compliance to protocol|1|||
125510627|NCT02446912|451498469|FG000|Overall Study|Withdrawal by Subject|10|||
125510628|NCT02446912|451498470|FG001|Overall Study|Withdrawal by Subject|15|||
125510629|NCT02446912|451498471|FG002|Overall Study|Withdrawal by Subject|15|||
125510630|NCT02446912|451498469|FG000|Overall Study|Miscellaneous|2|||
125510631|NCT02446912|451498470|FG001|Overall Study|Miscellaneous|2|||
125510632|NCT02446912|451498471|FG002|Overall Study|Miscellaneous|4|||
125510633|NCT01268488|451498472|FG000|Overall Study|Adverse Event|3|||
125510634|NCT01268488|451498472|FG000|Overall Study|Physician Decision|2|||
125510635|NCT00147745|451498475|FG000|Overall Study|Withdrawal by Subject|1|||
125510636|NCT00147745|451498476|FG001|Overall Study|Withdrawal by Subject|0|||
125510637|NCT00147745|451498477|FG002|Overall Study|Withdrawal by Subject|0|||
125510638|NCT00422162|451498481|FG000|Overall Study|Adverse Event|11|||
125305769|NCT01088399|450745187|FG001|Overall Study|Physician Decision|88|||
125510639|NCT00422162|451498482|FG001|Overall Study|Adverse Event|9|||
125510640|NCT00422162|451498481|FG000|Overall Study|Lack of Efficacy|4|||
125510641|NCT00422162|451498482|FG001|Overall Study|Lack of Efficacy|10|||
125510642|NCT00422162|451498481|FG000|Overall Study|Withdrawal by Subject|7|||
125510643|NCT00422162|451498482|FG001|Overall Study|Withdrawal by Subject|6|||
125510644|NCT00422162|451498481|FG000|Overall Study|Lost to Follow-up|1|||
125510645|NCT00422162|451498482|FG001|Overall Study|Lost to Follow-up|2|||
125510646|NCT00422162|451498481|FG000|Overall Study|Non-Compliant with Protocol|1|||
125510647|NCT00422162|451498482|FG001|Overall Study|Non-Compliant with Protocol|1|||
125305770|NCT01088399|450745188|FG002|Overall Study|Physician Decision|16|||
125305771|NCT01088399|450745186|FG000|Overall Study|Withdrawal by Subject|544|||
125305772|NCT01088399|450745187|FG001|Overall Study|Withdrawal by Subject|195|||
125305773|NCT01088399|450745188|FG002|Overall Study|Withdrawal by Subject|33|||
125305774|NCT01088399|450745186|FG000|Overall Study|Change to or start of somatropin therapy|234|||
125305775|NCT01088399|450745187|FG001|Overall Study|Change to or start of somatropin therapy|17|||
125305776|NCT01088399|450745188|FG002|Overall Study|Change to or start of somatropin therapy|12|||
125305777|NCT01088399|450745186|FG000|Overall Study|Sponsor decision|1573|||
125305778|NCT01088399|450745187|FG001|Overall Study|Sponsor decision|298|||
125305779|NCT01088399|450745188|FG002|Overall Study|Sponsor decision|7|||
125305780|NCT01088399|450745186|FG000|Overall Study|Protocol Violation|10|||
125305781|NCT01088399|450745187|FG001|Overall Study|Protocol Violation|1|||
125305782|NCT01088399|450745188|FG002|Overall Study|Protocol Violation|0|||
125305783|NCT01088399|450745186|FG000|Overall Study|Enrollment criteria not met|48|||
125305784|NCT01088399|450745187|FG001|Overall Study|Enrollment criteria not met|119|||
125305785|NCT01088399|450745188|FG002|Overall Study|Enrollment criteria not met|70|||
125305786|NCT01088399|450745186|FG000|Overall Study|Study summary visit not completed|2398|||
125305787|NCT01088399|450745187|FG001|Overall Study|Study summary visit not completed|283|||
125305788|NCT01088399|450745188|FG002|Overall Study|Study summary visit not completed|80|||
125305789|NCT00782483|450745189|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
125305790|NCT01811186|450745191|FG000|Overall Study|Adverse Event|54|||
125305791|NCT01811186|450745192|FG001|Overall Study|Adverse Event|38|||
125305792|NCT01811186|450745191|FG000|Overall Study|Protocol Violation|5|||
125305793|NCT01811186|450745192|FG001|Overall Study|Protocol Violation|6|||
125305794|NCT01811186|450745191|FG000|Overall Study|Withdrawal by Subject|5|||
125305795|NCT01811186|450745192|FG001|Overall Study|Withdrawal by Subject|10|||
125305796|NCT01811186|450745191|FG000|Overall Study|Lack of Efficacy|3|||
125305797|NCT01811186|450745192|FG001|Overall Study|Lack of Efficacy|6|||
125305798|NCT01811186|450745191|FG000|Overall Study|Lost to Follow-up|4|||
125305799|NCT01811186|450745192|FG001|Overall Study|Lost to Follow-up|2|||
125305800|NCT03369236|450745195|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
125305801|NCT03369236|450745196|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
125305802|NCT03369236|450745195|FG000|Open-label Extension Period|Lack of Efficacy|2|||
125305803|NCT03369236|450745196|FG001|Open-label Extension Period|Lack of Efficacy|1|||
125305804|NCT03369236|450745195|FG000|Open-label Extension Period|Adverse Event|0|||
125305805|NCT03369236|450745196|FG001|Open-label Extension Period|Adverse Event|1|||
125305806|NCT03369236|450745195|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
125305807|NCT03369236|450745196|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
125305808|NCT01865448|450746673|FG000|Overall Study|Adverse Event|1|||
125305809|NCT01865448|450746674|FG001|Overall Study|Adverse Event|1|||
125305810|NCT01865448|450746673|FG000|Overall Study|Pregnancy|0|||
125305811|NCT01865448|450746674|FG001|Overall Study|Pregnancy|1|||
125305812|NCT01865448|450746673|FG000|Overall Study|dropout unrelated to study|1|||
125305813|NCT01865448|450746674|FG001|Overall Study|dropout unrelated to study|1|||
125305814|NCT00872599|450746676|FG000|Second Washout Period|Adverse Event|1|||
125305815|NCT00872599|450746677|FG001|Second Washout Period|Adverse Event|1|||
125305816|NCT00801229|450746678|FG000|Signed Consent|Withdrawal by Subject|2|||
125305817|NCT00801229|450746679|FG001|Signed Consent|Withdrawal by Subject|2|||
125305818|NCT00801229|450746678|FG000|Signed Consent|Found Ineligible|1|||
125305819|NCT00801229|450746679|FG001|Signed Consent|Found Ineligible|1|||
125305820|NCT00801229|450746678|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
125305821|NCT00801229|450746679|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
125305822|NCT00801229|450746678|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
125305823|NCT00801229|450746679|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
125305824|NCT00801229|450746678|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
125305825|NCT00801229|450746679|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
125305826|NCT00801229|450746678|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
125305827|NCT00801229|450746679|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
125305828|NCT00801229|450746678|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
125305829|NCT00801229|450746679|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
125305830|NCT00801229|450746678|FG000|Received Study Drug/Placebo|Adverse Event|1|||
125305831|NCT00801229|450746679|FG001|Received Study Drug/Placebo|Adverse Event|1|||
125305832|NCT02255461|450746680|FG000|Overall Study|Adverse Event|0|||
125305833|NCT02255461|450746681|FG001|Overall Study|Adverse Event|1|||
125305834|NCT02255461|450746682|FG002|Overall Study|Adverse Event|0|||
125305835|NCT02255461|450746683|FG003|Overall Study|Adverse Event|0|||
125305836|NCT02255461|450746684|FG004|Overall Study|Adverse Event|1|||
125305837|NCT02255461|450746680|FG000|Overall Study|Withdrawal by Subject|0|||
125305838|NCT02255461|450746681|FG001|Overall Study|Withdrawal by Subject|0|||
125305839|NCT02255461|450746682|FG002|Overall Study|Withdrawal by Subject|1|||
125305840|NCT02255461|450746683|FG003|Overall Study|Withdrawal by Subject|0|||
125305841|NCT02255461|450746684|FG004|Overall Study|Withdrawal by Subject|1|||
125305842|NCT02255461|450746680|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
125510648|NCT00422162|451498481|FG000|Overall Study|Other|0|||
125510649|NCT00422162|451498482|FG001|Overall Study|Other|1|||
125510650|NCT00422162|451498481|FG000|Overall Study|Didn't Receive Treatment|0|||
125510651|NCT00422162|451498482|FG001|Overall Study|Didn't Receive Treatment|1|||
125510652|NCT05274906|451498483|FG000|Overall Study|Withdrawal by Subject|2|||
125510653|NCT05274906|451498484|FG001|Overall Study|Withdrawal by Subject|1|||
125510654|NCT03508830|451498485|FG000|Overall Study|Withdrawal by Subject|3|||
125510655|NCT03508830|451498486|FG001|Overall Study|Withdrawal by Subject|4|||
125510656|NCT03508830|451498485|FG000|Overall Study|Physician Decision|2|||
125510657|NCT03508830|451498486|FG001|Overall Study|Physician Decision|2|||
125510658|NCT02522299|451498487|FG000|Overall Study|Adverse Event|2|||
125510659|NCT02522299|451498488|FG001|Overall Study|Adverse Event|0|||
125510660|NCT02522299|451498487|FG000|Overall Study|Physician Decision|0|||
125510661|NCT02522299|451498488|FG001|Overall Study|Physician Decision|1|||
125510662|NCT02522299|451498487|FG000|Overall Study|Withdrawal by Subject|2|||
125510663|NCT02522299|451498488|FG001|Overall Study|Withdrawal by Subject|0|||
125510664|NCT04908800|451498491|FG000|Overall Study|Adverse Event|0|||
125510665|NCT04908800|451498492|FG001|Overall Study|Adverse Event|0|||
125510666|NCT04908800|451498493|FG002|Overall Study|Adverse Event|0|||
125510667|NCT04908800|451498494|FG003|Overall Study|Adverse Event|0|||
125510668|NCT04908800|451498495|FG004|Overall Study|Adverse Event|0|||
125510669|NCT04908800|451498496|FG005|Overall Study|Adverse Event|0|||
125510670|NCT04908800|451498497|FG006|Overall Study|Adverse Event|0|||
125510671|NCT04908800|451498498|FG007|Overall Study|Adverse Event|0|||
125510672|NCT04908800|451498499|FG008|Overall Study|Adverse Event|0|||
125510673|NCT04908800|451498500|FG009|Overall Study|Adverse Event|0|||
125510674|NCT04908800|451498501|FG010|Overall Study|Adverse Event|1|||
125510675|NCT04908800|451498502|FG011|Overall Study|Adverse Event|0|||
125510676|NCT04908800|451498503|FG012|Overall Study|Adverse Event|0|||
125510677|NCT02267746|451498504|FG000|Overall Study|Adverse Event|0|||
125510678|NCT02267746|451498505|FG001|Overall Study|Adverse Event|2|||
125510679|NCT02267746|451498506|FG002|Overall Study|Adverse Event|1|||
125510680|NCT02267746|451498504|FG000|Overall Study|Protocol Violation|8|||
125510681|NCT02267746|451498505|FG001|Overall Study|Protocol Violation|7|||
125510682|NCT02267746|451498506|FG002|Overall Study|Protocol Violation|3|||
125510683|NCT02267746|451498504|FG000|Overall Study|Lack of Efficacy|11|||
125510684|NCT02267746|451498505|FG001|Overall Study|Lack of Efficacy|11|||
125510685|NCT02267746|451498506|FG002|Overall Study|Lack of Efficacy|15|||
125510686|NCT02267746|451498504|FG000|Overall Study|Protocol Violation|1|||
125510687|NCT02267746|451498505|FG001|Overall Study|Protocol Violation|2|||
125510688|NCT02267746|451498506|FG002|Overall Study|Protocol Violation|1|||
125510689|NCT02267746|451498504|FG000|Overall Study|Miscellaneous|1|||
125510690|NCT02267746|451498505|FG001|Overall Study|Miscellaneous|0|||
125510691|NCT02267746|451498506|FG002|Overall Study|Miscellaneous|1|||
125510692|NCT00728884|451498511|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
125510693|NCT00728884|451498511|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
125510694|NCT00348283|451498512|FG000|Induction|Adverse Event|0|||
125510695|NCT00348283|451498513|FG001|Induction|Adverse Event|2|||
125510696|NCT00348283|451498512|FG000|Induction|Protocol Violation|0|||
125510697|NCT00348283|451498513|FG001|Induction|Protocol Violation|4|||
125510698|NCT00348283|451498512|FG000|Double Blind|Adverse Event|2|||
125510699|NCT00348283|451498513|FG001|Double Blind|Adverse Event|5|||
125510700|NCT00348283|451498512|FG000|Double Blind|Withdrawal by Subject|1|||
125510701|NCT00348283|451498513|FG001|Double Blind|Withdrawal by Subject|1|||
125510702|NCT00348283|451498512|FG000|Double Blind|Protocol Violation|0|||
125510703|NCT00348283|451498513|FG001|Double Blind|Protocol Violation|1|||
125510704|NCT00348283|451498512|FG000|Double Blind|Lack of Efficacy|2|||
125510705|NCT00348283|451498513|FG001|Double Blind|Lack of Efficacy|2|||
125510706|NCT00348283|451498512|FG000|Double Blind|Pregnancy|0|||
125510707|NCT00348283|451498513|FG001|Double Blind|Pregnancy|1|||
125510708|NCT00348283|451498512|FG000|Open Label|Adverse Event|0|||
125510709|NCT00348283|451498513|FG001|Open Label|Adverse Event|8|||
125510710|NCT00348283|451498512|FG000|Open Label|Withdrawal by Subject|0|||
125510711|NCT00348283|451498513|FG001|Open Label|Withdrawal by Subject|4|||
125510712|NCT00348283|451498512|FG000|Open Label|Lost to Follow-up|0|||
125510713|NCT00348283|451498513|FG001|Open Label|Lost to Follow-up|1|||
125510714|NCT00348283|451498512|FG000|Open Label|Lack of Efficacy|0|||
125510715|NCT00348283|451498513|FG001|Open Label|Lack of Efficacy|13|||
125510716|NCT00348283|451498512|FG000|Open Label|Administrative reasons|0|||
125510717|NCT00348283|451498513|FG001|Open Label|Administrative reasons|5|||
125510718|NCT00348283|451498512|FG000|Open Label|Subject moved to the United States|0|||
125510719|NCT00348283|451498513|FG001|Open Label|Subject moved to the United States|1|||
125510720|NCT00348283|451498512|FG000|Open Label|Pregnancy|0|||
125510721|NCT00348283|451498513|FG001|Open Label|Pregnancy|1|||
125510722|NCT00348283|451498512|FG000|Open Label|Sponsor decision|0|||
125510723|NCT00348283|451498513|FG001|Open Label|Sponsor decision|1|||
125510724|NCT04372186|451498517|FG000|Overall Study|Death|24|||
125510725|NCT04372186|451498518|FG001|Overall Study|Death|11|||
125510726|NCT04372186|451498517|FG000|Overall Study|Transferred to a different facility for care|0|||
125510727|NCT04372186|451498518|FG001|Overall Study|Transferred to a different facility for care|2|||
125510728|NCT02374476|451498520|FG000|VT Induced Ablation|Screening Failures|36|||
125510729|NCT02374476|451498521|FG001|VT Induced Ablation|Screening Failures|0|||
125510730|NCT02374476|451498522|FG002|VT Induced Ablation|Screening Failures|0|||
125510731|NCT02374476|451498520|FG000|Arm Assignment|Withdrawal by Subject|0|||
125510732|NCT02374476|451498521|FG001|Arm Assignment|Withdrawal by Subject|0|||
125510733|NCT02374476|451498522|FG002|Arm Assignment|Withdrawal by Subject|1|||
125510734|NCT03305458|451498523|FG000|Overall Study|Withdrawal by Subject|50|||
125510735|NCT03305458|451498524|FG001|Overall Study|Withdrawal by Subject|46|||
125510736|NCT03305458|451498525|FG002|Overall Study|Withdrawal by Subject|93|||
125510737|NCT03305458|451498523|FG000|Overall Study|Lost to Follow-up|85|||
125510738|NCT03305458|451498524|FG001|Overall Study|Lost to Follow-up|85|||
125510739|NCT03305458|451498525|FG002|Overall Study|Lost to Follow-up|35|||
125510740|NCT05431543|451498526|FG000|Overall Study|Medical History|1|||
125510741|NCT05431543|451498527|FG001|Overall Study|Medical History|0|||
125510742|NCT05431543|451498528|FG002|Overall Study|Medical History|0|||
125510743|NCT00440037|451498529|FG000|Overall Study|Withdrawal by Subject|6|||
125510744|NCT00440037|451498529|FG000|Overall Study|Administrative decision|3|||
125510745|NCT00498797|451498530|FG000|Overall Study|Withdrawal by Subject|4|||
125510746|NCT00498797|451498531|FG001|Overall Study|Withdrawal by Subject|2|||
125510747|NCT00498797|451498530|FG000|Overall Study|Adverse Event|12|||
125510748|NCT00498797|451498531|FG001|Overall Study|Adverse Event|5|||
125510749|NCT00498797|451498530|FG000|Overall Study|Condition under investigation worsened|19|||
125510750|NCT00498797|451498531|FG001|Overall Study|Condition under investigation worsened|21|||
125510751|NCT00498797|451498530|FG000|Overall Study|Other|3|||
125510752|NCT00498797|451498531|FG001|Overall Study|Other|1|||
125510753|NCT00914732|451498532|FG000|Overall Study|Lost to Follow-up|6|||
125510754|NCT00914732|451498533|FG001|Overall Study|Lost to Follow-up|7|||
125510755|NCT00914732|451498534|FG002|Overall Study|Lost to Follow-up|9|||
125510756|NCT00914732|451498532|FG000|Overall Study|Withdrawal by Subject|3|||
125510757|NCT00914732|451498533|FG001|Overall Study|Withdrawal by Subject|0|||
125510758|NCT00914732|451498534|FG002|Overall Study|Withdrawal by Subject|2|||
125510759|NCT00914732|451498532|FG000|Overall Study|Adverse Event|1|||
125510760|NCT00914732|451498533|FG001|Overall Study|Adverse Event|0|||
125510761|NCT00914732|451498534|FG002|Overall Study|Adverse Event|0|||
125510762|NCT01855399|451498537|FG000|6 Month|Lost to Follow-up|12|||
125510763|NCT01855399|451498538|FG001|6 Month|Lost to Follow-up|9|||
125510764|NCT01855399|451498537|FG000|6 Month|Withdrawal by Subject|8|||
125510765|NCT01855399|451498538|FG001|6 Month|Withdrawal by Subject|6|||
125510766|NCT01855399|451498537|FG000|12 Month|Lost to Follow-up|7|||
125510767|NCT01855399|451498538|FG001|12 Month|Lost to Follow-up|11|||
125510768|NCT03953079|451498539|FG000|Core Study|Withdrawal by Subject|1|||
125510769|NCT03953079|451498540|FG001|Core Study|Withdrawal by Subject|2|||
125510770|NCT03953079|451498541|FG002|Core Study|Withdrawal by Subject|1|||
125510771|NCT03953079|451498539|FG000|Core Study|COVID-19|0|||
125510772|NCT03953079|451498540|FG001|Core Study|COVID-19|1|||
125510773|NCT03953079|451498541|FG002|Core Study|COVID-19|0|||
125510774|NCT03953079|451498539|FG000|Core Study|Difficulties leaving the house|0|||
125510775|NCT03953079|451498540|FG001|Core Study|Difficulties leaving the house|1|||
125510776|NCT03953079|451498541|FG002|Core Study|Difficulties leaving the house|0|||
125510777|NCT03953079|451498539|FG000|Extension Study|Withdrawal by Subject|1|||
125510778|NCT03953079|451498540|FG001|Extension Study|Withdrawal by Subject|0|||
125510779|NCT03953079|451498541|FG002|Extension Study|Withdrawal by Subject|0|||
125510780|NCT03953079|451498539|FG000|Extension Study|Received Rescue Treatment|5|||
125510781|NCT03953079|451498540|FG001|Extension Study|Received Rescue Treatment|6|||
125510782|NCT03953079|451498541|FG002|Extension Study|Received Rescue Treatment|5|||
125510783|NCT04394624|451498542|FG000|Overall Study|Adverse Event|6|||
125510784|NCT04394624|451498543|FG001|Overall Study|Adverse Event|0|||
125510785|NCT04394624|451498542|FG000|Overall Study|Progressive disease|24|||
125510786|NCT04394624|451498543|FG001|Overall Study|Progressive disease|0|||
125510787|NCT04394624|451498542|FG000|Overall Study|Not related to COVID-19|1|||
125510788|NCT04394624|451498543|FG001|Overall Study|Not related to COVID-19|0|||
125510789|NCT00448344|451498549|FG000|Overall Study|Lost to Follow-up|20|||
125510790|NCT00448344|451498550|FG001|Overall Study|Lost to Follow-up|22|||
125510791|NCT00448344|451498549|FG000|Overall Study|Withdrawal by Subject|6|||
125510792|NCT00448344|451498550|FG001|Overall Study|Withdrawal by Subject|8|||
125510793|NCT00448344|451498549|FG000|Overall Study|Death|3|||
125510794|NCT00448344|451498550|FG001|Overall Study|Death|4|||
125510795|NCT00448344|451498549|FG000|Overall Study|Physician Decision|1|||
125510796|NCT00448344|451498550|FG001|Overall Study|Physician Decision|2|||
125510797|NCT00141271|451498553|FG000|Overall Study|Adverse Event|31|||
125510798|NCT00141271|451498554|FG001|Overall Study|Adverse Event|19|||
125510799|NCT00141271|451498555|FG002|Overall Study|Adverse Event|17|||
125510800|NCT00141271|451498553|FG000|Overall Study|Laboratory Abnormality|2|||
125510801|NCT00141271|451498554|FG001|Overall Study|Laboratory Abnormality|1|||
125510802|NCT00141271|451498555|FG002|Overall Study|Laboratory Abnormality|1|||
125510803|NCT00141271|451498553|FG000|Overall Study|Lack of Efficacy|7|||
125510804|NCT00141271|451498554|FG001|Overall Study|Lack of Efficacy|7|||
125510805|NCT00141271|451498555|FG002|Overall Study|Lack of Efficacy|3|||
125510806|NCT00141271|451498553|FG000|Overall Study|Lost to Follow-up|15|||
125510807|NCT00141271|451498554|FG001|Overall Study|Lost to Follow-up|15|||
125510808|NCT00141271|451498555|FG002|Overall Study|Lost to Follow-up|21|||
125510809|NCT00141271|451498553|FG000|Overall Study|Withdrawal by Subject|14|||
125510810|NCT00141271|451498554|FG001|Overall Study|Withdrawal by Subject|9|||
125510811|NCT00141271|451498555|FG002|Overall Study|Withdrawal by Subject|10|||
125510812|NCT00141271|451498553|FG000|Overall Study|Other|11|||
125510813|NCT00141271|451498554|FG001|Overall Study|Other|12|||
125510814|NCT00141271|451498555|FG002|Overall Study|Other|5|||
125510815|NCT00990314|451498559|FG000|Overall Study|Death|2|||
125510816|NCT00990314|451498559|FG000|Overall Study|Adverse Event|2|||
125510817|NCT00990314|451498559|FG000|Overall Study|Withdrawal by Subject|3|||
125510818|NCT00990314|451498559|FG000|Overall Study|Non-Compliance|1|||
125510819|NCT00990314|451498559|FG000|Overall Study|Physician Decision|3|||
125510820|NCT00990314|451498559|FG000|Overall Study|Lack of Efficacy|1|||
125510821|NCT04853394|451498563|FG000|Follow-up Interviews|Lost to Follow-up|22|||
125510822|NCT04853394|451498564|FG001|Follow-up Interviews|Lost to Follow-up|15|||
125510823|NCT04212299|451498565|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
125510824|NCT00705614|451500374|FG000|Initial Intervention|Adverse Event|40|||
125510825|NCT00705614|451500375|FG001|Initial Intervention|Adverse Event|21|||
125510826|NCT00705614|451500374|FG000|Initial Intervention|Lost to Follow-up|310|||
125510827|NCT00705614|451500375|FG001|Initial Intervention|Lost to Follow-up|191|||
125510828|NCT00705614|451500374|FG000|Initial Intervention|Withdrawal by Subject|114|||
125510829|NCT00705614|451500375|FG001|Initial Intervention|Withdrawal by Subject|71|||
125510830|NCT00705614|451500374|FG000|Initial Intervention|Administrative Reason|51|||
125510831|NCT00705614|451500375|FG001|Initial Intervention|Administrative Reason|38|||
125510832|NCT00705614|451500374|FG000|Initial Intervention|Status completion unknown|3|||
125510833|NCT00705614|451500375|FG001|Initial Intervention|Status completion unknown|0|||
125510834|NCT00705614|451500374|FG000|Switch to Remicade|Adverse Event|0|||
125510835|NCT00705614|451500375|FG001|Switch to Remicade|Adverse Event|5|||
125510836|NCT00705614|451500374|FG000|Switch to Remicade|Lost to Follow-up|0|||
125510837|NCT00705614|451500375|FG001|Switch to Remicade|Lost to Follow-up|23|||
125510838|NCT00705614|451500374|FG000|Switch to Remicade|Withdrawal by Subject|0|||
125510839|NCT00705614|451500375|FG001|Switch to Remicade|Withdrawal by Subject|12|||
125510840|NCT00705614|451500374|FG000|Switch to Remicade|Administrative Reason|0|||
125510841|NCT00705614|451500375|FG001|Switch to Remicade|Administrative Reason|9|||
125510842|NCT00676195|451500378|FG000|Overall Study|Lost to Follow-up|1|||
125510843|NCT00676195|451500378|FG000|Overall Study|Adverse Event|1|||
125510844|NCT00676195|451500378|FG000|Overall Study|Physician Decision|1|||
125510845|NCT02878590|451500379|FG000|Overall Study|Withdrawal by Subject|2|||
125510846|NCT03034772|451500390|FG000|Overall Study|Adverse Event|0|||
125510847|NCT03034772|451500391|FG001|Overall Study|Adverse Event|1|||
125510848|NCT03034772|451500390|FG000|Overall Study|Withdrawal by Subject|0|||
125510849|NCT03034772|451500391|FG001|Overall Study|Withdrawal by Subject|1|||
125510850|NCT00116584|451500394|FG000|Overall Study|Withdrawal by Subject|1|||
125510851|NCT00116584|451500395|FG001|Overall Study|Withdrawal by Subject|0|||
125510852|NCT00116584|451500394|FG000|Overall Study|Protocol Violation|1|||
125510853|NCT00116584|451500395|FG001|Overall Study|Protocol Violation|1|||
125510854|NCT02660034|451500396|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
125510855|NCT02660034|451500397|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
125510856|NCT02660034|451500398|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
125510857|NCT02660034|451500399|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
125510858|NCT02660034|451500400|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
125510859|NCT02660034|451500401|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
125510860|NCT02660034|451500402|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
125510861|NCT02660034|451500403|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
125510862|NCT02660034|451500404|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
125510863|NCT02660034|451500405|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
125510864|NCT02660034|451500406|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
125510865|NCT02660034|451500407|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
125510866|NCT02660034|451500408|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
125510867|NCT02660034|451500409|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
125510868|NCT02660034|451500396|FG000|Overall Study|Progressive Disease (Clinical)|7|||
125510869|NCT02660034|451500397|FG001|Overall Study|Progressive Disease (Clinical)|8|||
125510870|NCT02660034|451500398|FG002|Overall Study|Progressive Disease (Clinical)|3|||
125510871|NCT02660034|451500399|FG003|Overall Study|Progressive Disease (Clinical)|9|||
125510872|NCT02660034|451500400|FG004|Overall Study|Progressive Disease (Clinical)|3|||
125510873|NCT02660034|451500401|FG005|Overall Study|Progressive Disease (Clinical)|0|||
125510874|NCT02660034|451500402|FG006|Overall Study|Progressive Disease (Clinical)|0|||
125510875|NCT02660034|451500403|FG007|Overall Study|Progressive Disease (Clinical)|0|||
125510876|NCT02660034|451500404|FG008|Overall Study|Progressive Disease (Clinical)|0|||
125510877|NCT02660034|451500405|FG009|Overall Study|Progressive Disease (Clinical)|0|||
125510878|NCT02660034|451500406|FG010|Overall Study|Progressive Disease (Clinical)|0|||
125510879|NCT02660034|451500407|FG011|Overall Study|Progressive Disease (Clinical)|0|||
125510880|NCT02660034|451500408|FG012|Overall Study|Progressive Disease (Clinical)|0|||
125510881|NCT02660034|451500409|FG013|Overall Study|Progressive Disease (Clinical)|0|||
125305843|NCT02255461|450746681|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
125305844|NCT02255461|450746682|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
125305845|NCT02255461|450746683|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
125305846|NCT02255461|450746684|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
125305847|NCT04809285|450746687|FG000|Phase 1|Lost to Follow-up|6|||
125305848|NCT04809285|450746687|FG000|Phase 1|Protocol Violation|2|||
125305849|NCT04809285|450746687|FG000|Phase 1|Physician Decision|3|||
125305850|NCT04809285|450746687|FG000|Phase 1|Withdrawal by Subject|29|||
125305851|NCT04809285|450746687|FG000|Phase 2|Protocol Violation|3|||
125305852|NCT04809285|450746687|FG000|Phase 2|Withdrawal by Subject|4|||
125305853|NCT03350815|450746689|FG000|Period 1|Adverse Event|10|||
125305854|NCT03350815|450746690|FG001|Period 1|Adverse Event|0|||
125305855|NCT03350815|450746691|FG002|Period 1|Adverse Event|0|||
125305856|NCT03350815|450746692|FG003|Period 1|Adverse Event|0|||
125305857|NCT03350815|450746689|FG000|Period 1|Technical problems|1|||
125305858|NCT03350815|450746690|FG001|Period 1|Technical problems|0|||
125305859|NCT03350815|450746691|FG002|Period 1|Technical problems|0|||
125305860|NCT03350815|450746692|FG003|Period 1|Technical problems|0|||
125305861|NCT03350815|450746689|FG000|Period 1|Lost to Follow-up|3|||
125305862|NCT03350815|450746690|FG001|Period 1|Lost to Follow-up|0|||
125305863|NCT03350815|450746691|FG002|Period 1|Lost to Follow-up|0|||
125305864|NCT03350815|450746692|FG003|Period 1|Lost to Follow-up|0|||
125305865|NCT03350815|450746689|FG000|Period 1|Physician Decision|1|||
125305866|NCT03350815|450746690|FG001|Period 1|Physician Decision|0|||
125510882|NCT02660034|451500396|FG000|Overall Study|Lost to Follow-up|0|||
125510883|NCT02660034|451500397|FG001|Overall Study|Lost to Follow-up|0|||
125510884|NCT02660034|451500398|FG002|Overall Study|Lost to Follow-up|1|||
125510885|NCT02660034|451500399|FG003|Overall Study|Lost to Follow-up|1|||
125510886|NCT02660034|451500400|FG004|Overall Study|Lost to Follow-up|0|||
125510887|NCT02660034|451500401|FG005|Overall Study|Lost to Follow-up|0|||
125510888|NCT02660034|451500402|FG006|Overall Study|Lost to Follow-up|0|||
125510889|NCT02660034|451500403|FG007|Overall Study|Lost to Follow-up|0|||
125510890|NCT02660034|451500404|FG008|Overall Study|Lost to Follow-up|0|||
125510891|NCT02660034|451500405|FG009|Overall Study|Lost to Follow-up|1|||
125510892|NCT02660034|451500406|FG010|Overall Study|Lost to Follow-up|1|||
125510893|NCT02660034|451500407|FG011|Overall Study|Lost to Follow-up|1|||
125510894|NCT02660034|451500408|FG012|Overall Study|Lost to Follow-up|0|||
125510895|NCT02660034|451500409|FG013|Overall Study|Lost to Follow-up|0|||
125510896|NCT02660034|451500396|FG000|Overall Study|Participant moved into special access scheme|1|||
125510897|NCT02660034|451500397|FG001|Overall Study|Participant moved into special access scheme|2|||
125510898|NCT02660034|451500398|FG002|Overall Study|Participant moved into special access scheme|0|||
125510899|NCT02660034|451500399|FG003|Overall Study|Participant moved into special access scheme|0|||
125510900|NCT02660034|451500400|FG004|Overall Study|Participant moved into special access scheme|0|||
125510901|NCT02660034|451500401|FG005|Overall Study|Participant moved into special access scheme|0|||
125510902|NCT02660034|451500402|FG006|Overall Study|Participant moved into special access scheme|0|||
125510903|NCT02660034|451500403|FG007|Overall Study|Participant moved into special access scheme|0|||
125510904|NCT02660034|451500404|FG008|Overall Study|Participant moved into special access scheme|0|||
125510905|NCT02660034|451500405|FG009|Overall Study|Participant moved into special access scheme|0|||
125510906|NCT02660034|451500406|FG010|Overall Study|Participant moved into special access scheme|0|||
125510907|NCT02660034|451500407|FG011|Overall Study|Participant moved into special access scheme|0|||
125510908|NCT02660034|451500408|FG012|Overall Study|Participant moved into special access scheme|0|||
125510909|NCT02660034|451500409|FG013|Overall Study|Participant moved into special access scheme|0|||
125510910|NCT02660034|451500396|FG000|Overall Study|Adverse Event|1|||
125510911|NCT02660034|451500397|FG001|Overall Study|Adverse Event|0|||
125510912|NCT02660034|451500398|FG002|Overall Study|Adverse Event|0|||
125510913|NCT02660034|451500399|FG003|Overall Study|Adverse Event|0|||
125510914|NCT02660034|451500400|FG004|Overall Study|Adverse Event|0|||
125510915|NCT02660034|451500401|FG005|Overall Study|Adverse Event|0|||
125510916|NCT02660034|451500402|FG006|Overall Study|Adverse Event|0|||
125510917|NCT02660034|451500403|FG007|Overall Study|Adverse Event|0|||
125510918|NCT02660034|451500404|FG008|Overall Study|Adverse Event|0|||
125510919|NCT02660034|451500405|FG009|Overall Study|Adverse Event|0|||
125510920|NCT02660034|451500406|FG010|Overall Study|Adverse Event|0|||
125510921|NCT02660034|451500407|FG011|Overall Study|Adverse Event|0|||
125510922|NCT02660034|451500408|FG012|Overall Study|Adverse Event|0|||
125510923|NCT02660034|451500409|FG013|Overall Study|Adverse Event|0|||
125510924|NCT02660034|451500396|FG000|Overall Study|Sponsor Decision|0|||
125510925|NCT02660034|451500397|FG001|Overall Study|Sponsor Decision|1|||
125510926|NCT02660034|451500398|FG002|Overall Study|Sponsor Decision|2|||
125510927|NCT02660034|451500399|FG003|Overall Study|Sponsor Decision|2|||
125510928|NCT02660034|451500400|FG004|Overall Study|Sponsor Decision|3|||
125510929|NCT02660034|451500401|FG005|Overall Study|Sponsor Decision|0|||
125510930|NCT02660034|451500402|FG006|Overall Study|Sponsor Decision|0|||
125510931|NCT02660034|451500403|FG007|Overall Study|Sponsor Decision|0|||
125510932|NCT02660034|451500404|FG008|Overall Study|Sponsor Decision|0|||
125510933|NCT02660034|451500405|FG009|Overall Study|Sponsor Decision|0|||
125510934|NCT02660034|451500406|FG010|Overall Study|Sponsor Decision|0|||
125510935|NCT02660034|451500407|FG011|Overall Study|Sponsor Decision|0|||
125510936|NCT02660034|451500408|FG012|Overall Study|Sponsor Decision|0|||
125510937|NCT02660034|451500409|FG013|Overall Study|Sponsor Decision|1|||
125510938|NCT02660034|451500396|FG000|Overall Study|Withdrawal by Subject|0|||
125305867|NCT03350815|450746691|FG002|Period 1|Physician Decision|0|||
125305868|NCT03350815|450746692|FG003|Period 1|Physician Decision|0|||
125305869|NCT03350815|450746689|FG000|Period 1|Withdrawal by Subject|8|||
125305870|NCT03350815|450746690|FG001|Period 1|Withdrawal by Subject|0|||
125305871|NCT03350815|450746691|FG002|Period 1|Withdrawal by Subject|0|||
125305872|NCT03350815|450746692|FG003|Period 1|Withdrawal by Subject|0|||
125305873|NCT03350815|450746689|FG000|Period 1|Lack of Efficacy|15|||
125305874|NCT03350815|450746690|FG001|Period 1|Lack of Efficacy|0|||
125305875|NCT03350815|450746691|FG002|Period 1|Lack of Efficacy|0|||
125305876|NCT03350815|450746692|FG003|Period 1|Lack of Efficacy|0|||
125305877|NCT03350815|450746689|FG000|Period 1|Non-compliance with study treatment|2|||
125305878|NCT03350815|450746690|FG001|Period 1|Non-compliance with study treatment|0|||
125305879|NCT03350815|450746691|FG002|Period 1|Non-compliance with study treatment|0|||
125305880|NCT03350815|450746692|FG003|Period 1|Non-compliance with study treatment|0|||
125305881|NCT03350815|450746689|FG000|Period 1|Protocol Violation|3|||
125305882|NCT03350815|450746690|FG001|Period 1|Protocol Violation|0|||
125305883|NCT03350815|450746691|FG002|Period 1|Protocol Violation|0|||
125305884|NCT03350815|450746692|FG003|Period 1|Protocol Violation|0|||
125305885|NCT03350815|450746689|FG000|Period 2|Adverse Event|0|||
125305886|NCT03350815|450746690|FG001|Period 2|Adverse Event|3|||
125305887|NCT03350815|450746691|FG002|Period 2|Adverse Event|5|||
125510939|NCT02660034|451500397|FG001|Overall Study|Withdrawal by Subject|0|||
125510940|NCT02660034|451500398|FG002|Overall Study|Withdrawal by Subject|0|||
125510941|NCT02660034|451500399|FG003|Overall Study|Withdrawal by Subject|0|||
125510942|NCT02660034|451500400|FG004|Overall Study|Withdrawal by Subject|0|||
125510943|NCT02660034|451500401|FG005|Overall Study|Withdrawal by Subject|0|||
125510944|NCT02660034|451500402|FG006|Overall Study|Withdrawal by Subject|1|||
125510945|NCT02660034|451500403|FG007|Overall Study|Withdrawal by Subject|1|||
125510946|NCT02660034|451500404|FG008|Overall Study|Withdrawal by Subject|1|||
125510947|NCT02660034|451500405|FG009|Overall Study|Withdrawal by Subject|0|||
125510948|NCT02660034|451500406|FG010|Overall Study|Withdrawal by Subject|0|||
125510949|NCT02660034|451500407|FG011|Overall Study|Withdrawal by Subject|1|||
125510950|NCT02660034|451500408|FG012|Overall Study|Withdrawal by Subject|2|||
125510951|NCT02660034|451500409|FG013|Overall Study|Withdrawal by Subject|0|||
125510952|NCT02660034|451500396|FG000|Overall Study|Death|0|||
125510953|NCT02660034|451500397|FG001|Overall Study|Death|0|||
125510954|NCT02660034|451500398|FG002|Overall Study|Death|0|||
125510955|NCT02660034|451500399|FG003|Overall Study|Death|0|||
125305888|NCT03350815|450746692|FG003|Period 2|Adverse Event|0|||
125305889|NCT03350815|450746689|FG000|Period 2|Technical problem|0|||
125305890|NCT03350815|450746690|FG001|Period 2|Technical problem|1|||
125305891|NCT03350815|450746691|FG002|Period 2|Technical problem|0|||
125305892|NCT03350815|450746692|FG003|Period 2|Technical problem|0|||
125305893|NCT03350815|450746689|FG000|Period 2|Lost to Follow-up|0|||
125305894|NCT03350815|450746690|FG001|Period 2|Lost to Follow-up|3|||
125305895|NCT03350815|450746691|FG002|Period 2|Lost to Follow-up|3|||
125305896|NCT03350815|450746692|FG003|Period 2|Lost to Follow-up|0|||
125305897|NCT03350815|450746689|FG000|Period 2|Physician Decision|0|||
125305898|NCT03350815|450746690|FG001|Period 2|Physician Decision|0|||
125305899|NCT03350815|450746691|FG002|Period 2|Physician Decision|1|||
125305900|NCT03350815|450746692|FG003|Period 2|Physician Decision|0|||
125305901|NCT03350815|450746689|FG000|Period 2|Withdrawal by Subject|0|||
125305902|NCT03350815|450746690|FG001|Period 2|Withdrawal by Subject|3|||
125305903|NCT03350815|450746691|FG002|Period 2|Withdrawal by Subject|4|||
125305904|NCT03350815|450746692|FG003|Period 2|Withdrawal by Subject|0|||
125305905|NCT03350815|450746689|FG000|Period 2|Lack of Efficacy|0|||
125305906|NCT03350815|450746690|FG001|Period 2|Lack of Efficacy|6|||
125305907|NCT03350815|450746691|FG002|Period 2|Lack of Efficacy|2|||
125305908|NCT03350815|450746692|FG003|Period 2|Lack of Efficacy|0|||
125305909|NCT03350815|450746689|FG000|Period 2|Protocol Violation|0|||
125305910|NCT03350815|450746690|FG001|Period 2|Protocol Violation|0|||
125305911|NCT03350815|450746691|FG002|Period 2|Protocol Violation|1|||
125305912|NCT03350815|450746692|FG003|Period 2|Protocol Violation|0|||
125305913|NCT03350815|450746689|FG000|Period 2|New therapy for study indication|0|||
125305914|NCT03350815|450746690|FG001|Period 2|New therapy for study indication|0|||
125305915|NCT03350815|450746691|FG002|Period 2|New therapy for study indication|1|||
125305916|NCT03350815|450746692|FG003|Period 2|New therapy for study indication|0|||
125305917|NCT02630472|450746693|FG000|Overall Study|Physician Decision|10|||
125305918|NCT02630472|450746694|FG001|Overall Study|Physician Decision|0|||
125305919|NCT03040674|450746697|FG000|Overall Study|Lost to Follow-up|225|||
125305920|NCT03040674|450746697|FG000|Overall Study|Death|23|||
125305921|NCT02936843|450746698|FG000|Overall Study|Lost to Follow-up|3|||
125305922|NCT02936843|450746699|FG001|Overall Study|Lost to Follow-up|1|||
125305923|NCT02936843|450746698|FG000|Overall Study|Withdrawal by Subject|1|||
125305924|NCT02936843|450746699|FG001|Overall Study|Withdrawal by Subject|1|||
125305925|NCT03386487|450746700|FG000|Overall Study|Lost to Follow-up|5|||
125305926|NCT03386487|450746701|FG001|Overall Study|Lost to Follow-up|6|||
125305927|NCT03386487|450746700|FG000|Overall Study|Withdrawal by Subject|11|||
125305928|NCT03386487|450746701|FG001|Overall Study|Withdrawal by Subject|7|||
125305929|NCT03386487|450746700|FG000|Overall Study|Physician Decision|11|||
125305930|NCT03386487|450746701|FG001|Overall Study|Physician Decision|8|||
125305931|NCT02703324|450746702|FG000|Period Two|Withdrawal by Subject|0|||
125305932|NCT02703324|450746703|FG001|Period Two|Withdrawal by Subject|0|||
125305933|NCT02703324|450746704|FG002|Period Two|Withdrawal by Subject|1|||
125305934|NCT02703324|450746705|FG003|Period Two|Withdrawal by Subject|0|||
125305935|NCT02703324|450746706|FG004|Period Two|Withdrawal by Subject|0|||
125305936|NCT02703324|450746707|FG005|Period Two|Withdrawal by Subject|0|||
125305937|NCT04303572|450746708|FG000|Overall Study|Study closed due to poor enrollment|1|||
125305938|NCT06312592|450746709|FG000|Overall Study|Lost to Follow-up|29|||
125305939|NCT06312592|450746710|FG001|Overall Study|Lost to Follow-up|13|||
125305940|NCT01858766|450746711|FG000|Overall Study|Randomized but Never Treated|0|||
125305941|NCT01858766|450746712|FG001|Overall Study|Randomized but Never Treated|0|||
125305942|NCT01858766|450746713|FG002|Overall Study|Randomized but Never Treated|0|||
125305943|NCT01858766|450746714|FG003|Overall Study|Randomized but Never Treated|0|||
125305944|NCT01858766|450746715|FG004|Overall Study|Randomized but Never Treated|0|||
125305945|NCT01858766|450746716|FG005|Overall Study|Randomized but Never Treated|1|||
125305946|NCT01858766|450746717|FG006|Overall Study|Randomized but Never Treated|0|||
125305947|NCT01858766|450746718|FG007|Overall Study|Randomized but Never Treated|0|||
125305948|NCT01858766|450746719|FG008|Overall Study|Randomized but Never Treated|0|||
125305949|NCT01858766|450746720|FG009|Overall Study|Randomized but Never Treated|0|||
125305950|NCT01858766|450746721|FG010|Overall Study|Randomized but Never Treated|0|||
125305951|NCT01858766|450746722|FG011|Overall Study|Randomized but Never Treated|0|||
125305952|NCT01858766|450746723|FG012|Overall Study|Randomized but Never Treated|0|||
125305953|NCT01858766|450746724|FG013|Overall Study|Randomized but Never Treated|0|||
125305954|NCT01858766|450746725|FG014|Overall Study|Randomized but Never Treated|0|||
125305955|NCT01858766|450746726|FG015|Overall Study|Randomized but Never Treated|0|||
125305956|NCT01858766|450746727|FG016|Overall Study|Randomized but Never Treated|0|||
125305957|NCT01858766|450746728|FG017|Overall Study|Randomized but Never Treated|1|||
125305958|NCT01858766|450746729|FG018|Overall Study|Randomized but Never Treated|0|||
125305959|NCT01858766|450746711|FG000|Overall Study|Death|0|||
125305960|NCT01858766|450746712|FG001|Overall Study|Death|0|||
125305961|NCT01858766|450746713|FG002|Overall Study|Death|1|||
125305962|NCT01858766|450746714|FG003|Overall Study|Death|0|||
125305963|NCT01858766|450746715|FG004|Overall Study|Death|0|||
125305964|NCT01858766|450746716|FG005|Overall Study|Death|0|||
125305965|NCT01858766|450746717|FG006|Overall Study|Death|0|||
125305966|NCT01858766|450746718|FG007|Overall Study|Death|0|||
125305967|NCT01858766|450746719|FG008|Overall Study|Death|0|||
125305968|NCT01858766|450746720|FG009|Overall Study|Death|0|||
125305969|NCT01858766|450746721|FG010|Overall Study|Death|0|||
125305970|NCT01858766|450746722|FG011|Overall Study|Death|0|||
125305971|NCT01858766|450746723|FG012|Overall Study|Death|0|||
125305972|NCT01858766|450746724|FG013|Overall Study|Death|0|||
125305973|NCT01858766|450746725|FG014|Overall Study|Death|0|||
125305974|NCT01858766|450746726|FG015|Overall Study|Death|0|||
125305975|NCT01858766|450746727|FG016|Overall Study|Death|0|||
125305976|NCT01858766|450746728|FG017|Overall Study|Death|0|||
125305977|NCT01858766|450746729|FG018|Overall Study|Death|0|||
125305978|NCT01858766|450746711|FG000|Overall Study|Lack of Efficacy|1|||
125305979|NCT01858766|450746712|FG001|Overall Study|Lack of Efficacy|0|||
125305980|NCT01858766|450746713|FG002|Overall Study|Lack of Efficacy|0|||
125305981|NCT01858766|450746714|FG003|Overall Study|Lack of Efficacy|0|||
125305982|NCT01858766|450746715|FG004|Overall Study|Lack of Efficacy|1|||
125305983|NCT01858766|450746716|FG005|Overall Study|Lack of Efficacy|2|||
125305984|NCT01858766|450746717|FG006|Overall Study|Lack of Efficacy|0|||
125305985|NCT01858766|450746718|FG007|Overall Study|Lack of Efficacy|0|||
125305986|NCT01858766|450746719|FG008|Overall Study|Lack of Efficacy|0|||
125305987|NCT01858766|450746720|FG009|Overall Study|Lack of Efficacy|0|||
125305988|NCT01858766|450746721|FG010|Overall Study|Lack of Efficacy|0|||
125305989|NCT01858766|450746722|FG011|Overall Study|Lack of Efficacy|3|||
125510956|NCT02660034|451500400|FG004|Overall Study|Death|0|||
125305990|NCT01858766|450746723|FG012|Overall Study|Lack of Efficacy|5|||
125305991|NCT01858766|450746724|FG013|Overall Study|Lack of Efficacy|3|||
125305992|NCT01858766|450746725|FG014|Overall Study|Lack of Efficacy|5|||
125305993|NCT01858766|450746726|FG015|Overall Study|Lack of Efficacy|5|||
125305994|NCT01858766|450746727|FG016|Overall Study|Lack of Efficacy|2|||
125305995|NCT01858766|450746728|FG017|Overall Study|Lack of Efficacy|3|||
125305996|NCT01858766|450746729|FG018|Overall Study|Lack of Efficacy|3|||
125305997|NCT01858766|450746711|FG000|Overall Study|Lost to Follow-up|0|||
125305998|NCT01858766|450746712|FG001|Overall Study|Lost to Follow-up|0|||
125305999|NCT01858766|450746713|FG002|Overall Study|Lost to Follow-up|0|||
125306000|NCT01858766|450746714|FG003|Overall Study|Lost to Follow-up|0|||
125306001|NCT01858766|450746715|FG004|Overall Study|Lost to Follow-up|0|||
125306002|NCT01858766|450746716|FG005|Overall Study|Lost to Follow-up|1|||
125510957|NCT02660034|451500401|FG005|Overall Study|Death|13|||
125510958|NCT02660034|451500402|FG006|Overall Study|Death|14|||
125510959|NCT02660034|451500403|FG007|Overall Study|Death|10|||
125510960|NCT02660034|451500404|FG008|Overall Study|Death|9|||
125510961|NCT02660034|451500405|FG009|Overall Study|Death|21|||
125510962|NCT02660034|451500406|FG010|Overall Study|Death|17|||
125510963|NCT02660034|451500407|FG011|Overall Study|Death|15|||
125510964|NCT02660034|451500408|FG012|Overall Study|Death|18|||
125510965|NCT02660034|451500409|FG013|Overall Study|Death|7|||
125510966|NCT02660034|451500396|FG000|Overall Study|Physician Decision|0|||
125510967|NCT02660034|451500397|FG001|Overall Study|Physician Decision|0|||
125510968|NCT02660034|451500398|FG002|Overall Study|Physician Decision|0|||
125510969|NCT02660034|451500399|FG003|Overall Study|Physician Decision|0|||
125510970|NCT02660034|451500400|FG004|Overall Study|Physician Decision|0|||
125510971|NCT02660034|451500401|FG005|Overall Study|Physician Decision|0|||
125510972|NCT02660034|451500402|FG006|Overall Study|Physician Decision|0|||
125510973|NCT02660034|451500403|FG007|Overall Study|Physician Decision|0|||
125510974|NCT02660034|451500404|FG008|Overall Study|Physician Decision|0|||
125510975|NCT02660034|451500405|FG009|Overall Study|Physician Decision|0|||
125510976|NCT02660034|451500406|FG010|Overall Study|Physician Decision|0|||
125510977|NCT02660034|451500407|FG011|Overall Study|Physician Decision|0|||
125510978|NCT02660034|451500408|FG012|Overall Study|Physician Decision|0|||
125510979|NCT02660034|451500409|FG013|Overall Study|Physician Decision|1|||
125510980|NCT02660034|451500396|FG000|Overall Study|Participants transferred to LTE|0|||
125510981|NCT02660034|451500397|FG001|Overall Study|Participants transferred to LTE|0|||
125510982|NCT02660034|451500398|FG002|Overall Study|Participants transferred to LTE|0|||
125510983|NCT02660034|451500399|FG003|Overall Study|Participants transferred to LTE|0|||
125510984|NCT02660034|451500400|FG004|Overall Study|Participants transferred to LTE|0|||
125510985|NCT02660034|451500401|FG005|Overall Study|Participants transferred to LTE|10|||
125510986|NCT02660034|451500402|FG006|Overall Study|Participants transferred to LTE|8|||
125510987|NCT02660034|451500403|FG007|Overall Study|Participants transferred to LTE|8|||
125510988|NCT02660034|451500404|FG008|Overall Study|Participants transferred to LTE|10|||
125510989|NCT02660034|451500405|FG009|Overall Study|Participants transferred to LTE|1|||
125510990|NCT02660034|451500406|FG010|Overall Study|Participants transferred to LTE|2|||
125510991|NCT02660034|451500407|FG011|Overall Study|Participants transferred to LTE|4|||
125510992|NCT02660034|451500408|FG012|Overall Study|Participants transferred to LTE|1|||
125510993|NCT02660034|451500409|FG013|Overall Study|Participants transferred to LTE|1|||
125510994|NCT01797705|451500412|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
125510995|NCT01797705|451500412|FG000|Overall Study|Withdrawal by Subject|1|||
125510996|NCT01533181|451500415|FG000|Overall Study|Disease progression pre-active treatment|0|||
125510997|NCT01533181|451500416|FG001|Overall Study|Disease progression pre-active treatment|1|||
125510998|NCT01533181|451500415|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
125510999|NCT01533181|451500416|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
125511000|NCT02030847|451500417|FG000|Overall Study|Death|10|||
125511001|NCT02030847|451500417|FG000|Overall Study|Disease Progression|15|||
125511002|NCT02030847|451500417|FG000|Overall Study|New Cancer Therapy|8|||
125511003|NCT02030847|451500417|FG000|Overall Study|Physician Decision|3|||
125511004|NCT02030847|451500417|FG000|Overall Study|Withdrawal by Subject|1|||
125511005|NCT01837719|451500420|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
125511006|NCT01837719|451500420|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
125511007|NCT01703988|451500421|FG000|Overall Study|Investigator Judgment|0|||
125511008|NCT01703988|451500422|FG001|Overall Study|Investigator Judgment|0|||
125511009|NCT01703988|451500423|FG002|Overall Study|Investigator Judgment|0|||
125511010|NCT01703988|451500424|FG003|Overall Study|Investigator Judgment|1|||
125511011|NCT06247488|451500425|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
125511012|NCT06247488|451500426|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
125511013|NCT06247488|451500427|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
125511014|NCT06247488|451500428|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
125511015|NCT06247488|451500429|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
125511016|NCT06247488|451500430|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
125511017|NCT06247488|451500425|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
125511018|NCT06247488|451500426|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
125511019|NCT06247488|451500427|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
125511020|NCT06247488|451500428|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
125511021|NCT06247488|451500429|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
125511022|NCT06247488|451500430|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
125511023|NCT06247488|451500425|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
125511024|NCT06247488|451500426|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
125511025|NCT06247488|451500427|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
125511026|NCT06247488|451500428|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
125511027|NCT06247488|451500429|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
125511028|NCT06247488|451500430|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
125511029|NCT06247488|451500425|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
125306003|NCT01858766|450746717|FG006|Overall Study|Lost to Follow-up|0|||
125511030|NCT06247488|451500426|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
125511031|NCT06247488|451500427|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
125511032|NCT06247488|451500428|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
125511033|NCT06247488|451500429|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
125511034|NCT06247488|451500430|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
125511035|NCT06247488|451500425|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
125511036|NCT06247488|451500426|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
125511037|NCT06247488|451500427|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
125511038|NCT06247488|451500428|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
125511039|NCT06247488|451500429|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
125511040|NCT06247488|451500430|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
125511041|NCT06247488|451500425|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
125511042|NCT06247488|451500426|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
125511043|NCT06247488|451500427|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
125511044|NCT06247488|451500428|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
125511045|NCT06247488|451500429|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
125511046|NCT06247488|451500430|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
125511047|NCT06247488|451500425|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
125511048|NCT06247488|451500426|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
125511049|NCT06247488|451500427|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
125511050|NCT06247488|451500428|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
125511051|NCT06247488|451500429|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
125511052|NCT06247488|451500430|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
125511053|NCT02995733|451500431|FG000|Overall Study|Study site closed|9|||
125511054|NCT02995733|451500432|FG001|Overall Study|Study site closed|10|||
125511055|NCT02995733|451500431|FG000|Overall Study|Death|3|||
125511056|NCT02995733|451500432|FG001|Overall Study|Death|4|||
125511057|NCT02995733|451500431|FG000|Overall Study|Withdrawal by Subject|6|||
125511058|NCT02995733|451500432|FG001|Overall Study|Withdrawal by Subject|2|||
125511059|NCT02995733|451500431|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
125511060|NCT02995733|451500432|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
125511061|NCT02995733|451500431|FG000|Overall Study|Lost to Follow-up|48|||
125511062|NCT02995733|451500432|FG001|Overall Study|Lost to Follow-up|37|||
125511063|NCT02995733|451500431|FG000|Overall Study|Other|0|||
125511064|NCT02995733|451500432|FG001|Overall Study|Other|1|||
125511065|NCT03785210|451500435|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
125511066|NCT03785210|451500436|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
125511067|NCT02720198|451500440|FG000|Overall Study|Withdrawal by Subject|0|||
125511068|NCT02720198|451500441|FG001|Overall Study|Withdrawal by Subject|1|||
125511069|NCT02465866|451500444|FG000|Period 3|Withdrawal by Subject|0|||
125511070|NCT02465866|451500445|FG001|Period 3|Withdrawal by Subject|1|||
125511071|NCT02465866|451500446|FG002|Period 3|Withdrawal by Subject|0|||
125511072|NCT02465866|451500447|FG003|Period 3|Withdrawal by Subject|0|||
125511073|NCT00203502|451500448|FG000|Overall Study|Death|1|||
125511074|NCT02023099|451500449|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
125511075|NCT02023099|451500450|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
125511076|NCT02023099|451500451|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
125511077|NCT02023099|451500449|FG000|Overall Study|Withdrawn Consent|3|||
125511078|NCT02023099|451500450|FG001|Overall Study|Withdrawn Consent|0|||
125511079|NCT02023099|451500451|FG002|Overall Study|Withdrawn Consent|1|||
125511080|NCT02023099|451500449|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
125511081|NCT02023099|451500450|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
125511082|NCT02023099|451500451|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
125511083|NCT02592434|451500452|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
125511084|NCT02592434|451500453|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
125511085|NCT02592434|451500454|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
125511086|NCT02592434|451500452|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
125511087|NCT02592434|451500453|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
125511088|NCT02592434|451500454|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
125511089|NCT02592434|451500452|FG000|Open-Label Phase (18 Weeks)|Other|3|||
125511090|NCT02592434|451500453|FG001|Open-Label Phase (18 Weeks)|Other|0|||
125511091|NCT02592434|451500454|FG002|Open-Label Phase (18 Weeks)|Other|0|||
125511092|NCT02592434|451500452|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
125511093|NCT02592434|451500453|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
125511094|NCT02592434|451500454|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
125511095|NCT02592434|451500452|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
125511096|NCT02592434|451500453|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
125511097|NCT02592434|451500454|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
125511098|NCT02592434|451500452|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
125511099|NCT02592434|451500453|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
125511100|NCT02592434|451500454|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
125511101|NCT02592434|451500452|FG000|Double Blind Phase (26 Weeks)|Other|0|||
125511102|NCT02592434|451500453|FG001|Double Blind Phase (26 Weeks)|Other|1|||
125511103|NCT02592434|451500454|FG002|Double Blind Phase (26 Weeks)|Other|0|||
125511104|NCT02592434|451500452|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
125511105|NCT02592434|451500453|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
125511106|NCT02592434|451500454|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
125511107|NCT02592434|451500452|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
125511108|NCT02592434|451500453|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
125511109|NCT02592434|451500454|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
125511110|NCT02592434|451500452|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
125511111|NCT02592434|451500453|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
125511112|NCT02592434|451500454|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
125511113|NCT01469819|451500455|FG000|Overall Study|Withdrawal by Subject|1|||
125511114|NCT01469819|451500455|FG000|Overall Study|Did not meet inclusionary criteria|2|||
125511115|NCT01469819|451500455|FG000|Overall Study|Could not swallow SmartPill|2|||
125511116|NCT01469819|451500455|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
125511117|NCT01403805|451500456|FG000|Overall Study|Withdrawal by Subject|0|||
125511118|NCT01403805|451500457|FG001|Overall Study|Withdrawal by Subject|4|||
125511119|NCT01403805|451500456|FG000|Overall Study|Lost to Follow-up|0|||
125511120|NCT01403805|451500457|FG001|Overall Study|Lost to Follow-up|2|||
125511121|NCT01403805|451500456|FG000|Overall Study|Death|0|||
125511122|NCT01403805|451500457|FG001|Overall Study|Death|1|||
125511123|NCT01103141|451500460|FG000|Overall Study|Death|0|||
125511124|NCT01103141|451500461|FG001|Overall Study|Death|1|||
125511125|NCT01103141|451500460|FG000|Overall Study|Lost to Follow-up|2|||
125511126|NCT01103141|451500461|FG001|Overall Study|Lost to Follow-up|1|||
125511127|NCT01695993|451500462|FG000|Overall Study|Lost to Follow-up|2|||
125511128|NCT01695993|451500463|FG001|Overall Study|Lost to Follow-up|1|||
125511129|NCT01695993|451500464|FG002|Overall Study|Lost to Follow-up|3|||
125511130|NCT01695993|451500462|FG000|Overall Study|Withdrawal by Subject|2|||
125511131|NCT01695993|451500463|FG001|Overall Study|Withdrawal by Subject|2|||
125511132|NCT01695993|451500464|FG002|Overall Study|Withdrawal by Subject|2|||
125511133|NCT01695993|451500462|FG000|Overall Study|To ill to continue|1|||
125511134|NCT01695993|451500463|FG001|Overall Study|To ill to continue|2|||
125511135|NCT01695993|451500464|FG002|Overall Study|To ill to continue|0|||
125511136|NCT01695993|451500462|FG000|Overall Study|Changed Medical Facility|0|||
125511137|NCT01695993|451500463|FG001|Overall Study|Changed Medical Facility|0|||
125511138|NCT01695993|451500464|FG002|Overall Study|Changed Medical Facility|1|||
125511139|NCT04057937|451500465|FG000|Placebo-controlled Phase|Adverse Event|3|||
125511140|NCT04057937|451500466|FG001|Placebo-controlled Phase|Adverse Event|0|||
125511141|NCT04057937|451500465|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
125511142|NCT04057937|451500466|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
125511143|NCT04057937|451500465|FG000|Active-treatment Phase|Pregnancy|0|||
125511144|NCT04057937|451500466|FG001|Active-treatment Phase|Pregnancy|1|||
125511145|NCT04057937|451500465|FG000|Active-treatment Phase|Physician Decision|0|||
125511146|NCT04057937|451500466|FG001|Active-treatment Phase|Physician Decision|1|||
125511147|NCT02029521|451500467|FG000|Overall Study|Protocol Violation|1|||
125511148|NCT02029521|451500468|FG001|Overall Study|Protocol Violation|0|||
125511149|NCT02029521|451500467|FG000|Overall Study|Withdrawal by Subject|1|||
125511150|NCT02029521|451500468|FG001|Overall Study|Withdrawal by Subject|1|||
125511151|NCT00428441|451500472|FG000|Overall Study|Lost to Follow-up|1|||
125511152|NCT00510783|451500479|FG000|Overall Study|Lost to Follow-up|29|||
125511153|NCT00510783|451500480|FG001|Overall Study|Lost to Follow-up|25|||
125511154|NCT00510783|451500479|FG000|Overall Study|Withdrawal by Subject|2|||
125511155|NCT00510783|451500480|FG001|Overall Study|Withdrawal by Subject|3|||
125511156|NCT00510783|451500479|FG000|Overall Study|Protocol Violation|0|||
125511157|NCT00510783|451500480|FG001|Overall Study|Protocol Violation|1|||
125511158|NCT02744898|451500481|FG000|Overall Study|Progressive Disease|2|||
125511159|NCT02744898|451500481|FG000|Overall Study|Physician Decision|1|||
125511160|NCT02744898|451500481|FG000|Overall Study|Toxicity|1|||
125511161|NCT01047306|451500493|FG000|Overall Study|Withdrawal by Subject|2|||
125511162|NCT01047306|451500494|FG001|Overall Study|Withdrawal by Subject|0|||
125511163|NCT01047306|451500493|FG000|Overall Study|Lost to Follow-up|1|||
125511164|NCT01047306|451500494|FG001|Overall Study|Lost to Follow-up|0|||
125511165|NCT00274846|451500497|FG000|Overall Study|Did not receive adequate NK cells|1|||
125511166|NCT01648699|451500500|FG000|Overall Study|Death|1|||
125511167|NCT01648699|451500500|FG000|Overall Study|Lost to Follow-up|2|||
125511168|NCT01648699|451500500|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
125511169|NCT02038803|451500501|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
125511170|NCT02038803|451500501|FG000|Overall Study|Lost to Follow-up|1|||
125511171|NCT02588027|451500502|FG000|Overall Study|Withdrawal by Subject|1|||
125511172|NCT02588027|451500503|FG001|Overall Study|Withdrawal by Subject|3|||
125511173|NCT02588027|451500502|FG000|Overall Study|Protocol Violation|4|||
125511174|NCT02588027|451500503|FG001|Overall Study|Protocol Violation|1|||
125511175|NCT03219216|451500504|FG000|Overall Study|Lost to Follow-up|0|||
125511176|NCT03219216|451500505|FG001|Overall Study|Lost to Follow-up|1|||
125532602|NCT00350727|451580163|FG002|Phase II|Clinical Deterioration|0|||
125511177|NCT02332824|451500506|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
125511178|NCT02332824|451500507|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
125511179|NCT02332824|451500508|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
125511180|NCT02332824|451500509|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
125511181|NCT02332824|451500510|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
125511182|NCT02332824|451500511|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
125511183|NCT02332824|451500506|FG000|Overall Study|Voluntary Withdrawal|1|||
125511184|NCT02332824|451500507|FG001|Overall Study|Voluntary Withdrawal|0|||
125511185|NCT02332824|451500508|FG002|Overall Study|Voluntary Withdrawal|0|||
125511186|NCT02332824|451500509|FG003|Overall Study|Voluntary Withdrawal|0|||
125511187|NCT02332824|451500510|FG004|Overall Study|Voluntary Withdrawal|0|||
125511188|NCT02332824|451500511|FG005|Overall Study|Voluntary Withdrawal|0|||
125511189|NCT02332824|451500506|FG000|Overall Study|Inconvenient schedule|1|||
125511190|NCT02332824|451500507|FG001|Overall Study|Inconvenient schedule|1|||
125511191|NCT02332824|451500508|FG002|Overall Study|Inconvenient schedule|0|||
125511192|NCT02332824|451500509|FG003|Overall Study|Inconvenient schedule|0|||
125511193|NCT02332824|451500510|FG004|Overall Study|Inconvenient schedule|0|||
125511194|NCT02332824|451500511|FG005|Overall Study|Inconvenient schedule|0|||
125511195|NCT02332824|451500506|FG000|Overall Study|Transfer|0|||
125511196|NCT02332824|451500507|FG001|Overall Study|Transfer|0|||
125511197|NCT02332824|451500508|FG002|Overall Study|Transfer|1|||
125511198|NCT02332824|451500509|FG003|Overall Study|Transfer|1|||
125511199|NCT02332824|451500510|FG004|Overall Study|Transfer|0|||
125511200|NCT02332824|451500511|FG005|Overall Study|Transfer|0|||
125511201|NCT03840148|451500512|FG000|Study Drug Disposition|Adverse Event|13|||
125511202|NCT03840148|451500513|FG001|Study Drug Disposition|Adverse Event|2|||
125511203|NCT03840148|451500512|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
125511204|NCT03840148|451500513|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
125511205|NCT03840148|451500512|FG000|Study Drug Disposition|Lack of Efficacy|3|||
125511206|NCT03840148|451500513|FG001|Study Drug Disposition|Lack of Efficacy|0|||
125511207|NCT03840148|451500512|FG000|Study Drug Disposition|Physician Decision|2|||
125511208|NCT03840148|451500513|FG001|Study Drug Disposition|Physician Decision|0|||
125511209|NCT03840148|451500512|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
125511210|NCT03840148|451500513|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
125511211|NCT03840148|451500512|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
125511212|NCT03840148|451500513|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
125511213|NCT03840148|451500512|FG000|Study Completion Disposition|Physician Decision|2|||
125511214|NCT03840148|451500513|FG001|Study Completion Disposition|Physician Decision|0|||
125511215|NCT03840148|451500512|FG000|Study Completion Disposition|Covid-19 related|2|||
125511216|NCT03840148|451500513|FG001|Study Completion Disposition|Covid-19 related|0|||
125511217|NCT03840148|451500512|FG000|Study Completion Disposition|Lost to Follow-up|1|||
125511218|NCT03840148|451500513|FG001|Study Completion Disposition|Lost to Follow-up|1|||
125511219|NCT03840148|451500512|FG000|Study Completion Disposition|Death|1|||
125511220|NCT03840148|451500513|FG001|Study Completion Disposition|Death|0|||
125511221|NCT03840148|451500512|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
125511222|NCT03840148|451500513|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
125511223|NCT03615404|451500514|FG000|Overall Study|Death|1|||
125511224|NCT03615404|451500514|FG000|Overall Study|vaccine did not pass quality assurance|1|||
125511225|NCT01774929|451500515|FG000|Overall Study|Adverse Event|3|||
125511226|NCT02577315|451500517|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
125511227|NCT02577315|451500518|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
125511228|NCT01945086|451500519|FG000|Overall Study|Withdrawal by Subject|1|||
125511229|NCT01945086|451500520|FG001|Overall Study|Withdrawal by Subject|0|||
125511230|NCT01945086|451500521|FG002|Overall Study|Withdrawal by Subject|1|||
125511231|NCT01945086|451500519|FG000|Overall Study|Adverse Event|0|||
125511232|NCT01945086|451500520|FG001|Overall Study|Adverse Event|0|||
125511233|NCT01945086|451500521|FG002|Overall Study|Adverse Event|1|||
125511234|NCT04413149|451501837|FG000|Overall Study|Death|10|||
125511235|NCT04413149|451501838|FG001|Overall Study|Death|5|||
125511236|NCT04413149|451501837|FG000|Overall Study|Lung transplantation|1|||
125511237|NCT04413149|451501838|FG001|Overall Study|Lung transplantation|0|||
125511238|NCT05335005|451501842|FG000|Overall Study|Lost to Follow-up|1|||
125511239|NCT04050722|451501843|FG000|Overall Study|Withdrawal by Subject|1|||
125511240|NCT04050722|451501844|FG001|Overall Study|Withdrawal by Subject|0|||
125511241|NCT00443755|451501848|FG000|Overall Study|Withdrawal by Subject|2|||
125511242|NCT00443755|451501849|FG001|Overall Study|Withdrawal by Subject|1|||
125511243|NCT00678899|451501850|FG000|Overall Study|Adverse Event|1|||
125511244|NCT02339506|451501862|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
125511245|NCT02339506|451501863|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
125511246|NCT02339506|451501862|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
125511247|NCT02339506|451501863|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
125511248|NCT01572493|451501864|FG000|Overall Study|Physician Decision|1|||
125511249|NCT01572493|451501865|FG001|Overall Study|Physician Decision|0|||
125511250|NCT01572493|451501866|FG002|Overall Study|Physician Decision|0|||
125511251|NCT01572493|451501867|FG003|Overall Study|Physician Decision|0|||
125511252|NCT01572493|451501868|FG004|Overall Study|Physician Decision|0|||
125511253|NCT01572493|451501869|FG005|Overall Study|Physician Decision|0|||
125511254|NCT01572493|451501870|FG006|Overall Study|Physician Decision|0|||
125511255|NCT01572493|451501871|FG007|Overall Study|Physician Decision|0|||
125511256|NCT01572493|451501872|FG008|Overall Study|Physician Decision|0|||
125511257|NCT01572493|451501864|FG000|Overall Study|Switched to alternative treatment|0|||
125511258|NCT01572493|451501865|FG001|Overall Study|Switched to alternative treatment|1|||
125511259|NCT01572493|451501866|FG002|Overall Study|Switched to alternative treatment|2|||
125511260|NCT01572493|451501867|FG003|Overall Study|Switched to alternative treatment|1|||
125511261|NCT01572493|451501868|FG004|Overall Study|Switched to alternative treatment|2|||
125511262|NCT01572493|451501869|FG005|Overall Study|Switched to alternative treatment|0|||
125511263|NCT01572493|451501870|FG006|Overall Study|Switched to alternative treatment|2|||
125511264|NCT01572493|451501871|FG007|Overall Study|Switched to alternative treatment|0|||
125511265|NCT01572493|451501872|FG008|Overall Study|Switched to alternative treatment|2|||
125511266|NCT01572493|451501864|FG000|Overall Study|Death|0|||
125511267|NCT01572493|451501865|FG001|Overall Study|Death|0|||
125511268|NCT01572493|451501866|FG002|Overall Study|Death|0|||
125511269|NCT01572493|451501867|FG003|Overall Study|Death|1|||
125511270|NCT01572493|451501868|FG004|Overall Study|Death|0|||
125511271|NCT01572493|451501869|FG005|Overall Study|Death|1|||
125511272|NCT01572493|451501870|FG006|Overall Study|Death|0|||
125511273|NCT01572493|451501871|FG007|Overall Study|Death|0|||
125511274|NCT01572493|451501872|FG008|Overall Study|Death|0|||
125511275|NCT01572493|451501864|FG000|Overall Study|Adverse Event|0|||
125511276|NCT01572493|451501865|FG001|Overall Study|Adverse Event|0|||
125511277|NCT01572493|451501866|FG002|Overall Study|Adverse Event|0|||
125511278|NCT01572493|451501867|FG003|Overall Study|Adverse Event|0|||
125511279|NCT01572493|451501868|FG004|Overall Study|Adverse Event|0|||
125511280|NCT01572493|451501869|FG005|Overall Study|Adverse Event|0|||
125511281|NCT01572493|451501870|FG006|Overall Study|Adverse Event|1|||
125511282|NCT01572493|451501871|FG007|Overall Study|Adverse Event|0|||
125511283|NCT01572493|451501872|FG008|Overall Study|Adverse Event|0|||
125511284|NCT00609245|451501873|FG000|Overall Study|Adverse Event|1|||
125511285|NCT01234675|451501874|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
125511286|NCT01234675|451501875|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
125511287|NCT01234675|451501874|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
125511288|NCT01234675|451501875|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
125511289|NCT00331799|451501876|FG000|Overall Study|Withdrawal by Subject|2|||
125511290|NCT00331799|451501876|FG000|Overall Study|Sedation|1|||
125511291|NCT02889809|451501877|FG000|Overall Study|Withdrawal by Subject|30|||
125306004|NCT01858766|450746718|FG007|Overall Study|Lost to Follow-up|2|||
125306005|NCT01858766|450746719|FG008|Overall Study|Lost to Follow-up|0|||
125306006|NCT01858766|450746720|FG009|Overall Study|Lost to Follow-up|0|||
125306007|NCT01858766|450746721|FG010|Overall Study|Lost to Follow-up|0|||
125306008|NCT01858766|450746722|FG011|Overall Study|Lost to Follow-up|1|||
125306009|NCT01858766|450746723|FG012|Overall Study|Lost to Follow-up|0|||
125306010|NCT01858766|450746724|FG013|Overall Study|Lost to Follow-up|0|||
125306011|NCT01858766|450746725|FG014|Overall Study|Lost to Follow-up|3|||
125306012|NCT01858766|450746726|FG015|Overall Study|Lost to Follow-up|1|||
125306013|NCT01858766|450746727|FG016|Overall Study|Lost to Follow-up|1|||
125306014|NCT01858766|450746728|FG017|Overall Study|Lost to Follow-up|0|||
125306015|NCT01858766|450746729|FG018|Overall Study|Lost to Follow-up|1|||
125306016|NCT01858766|450746711|FG000|Overall Study|Withdrew Consent|0|||
125306017|NCT01858766|450746712|FG001|Overall Study|Withdrew Consent|0|||
125511292|NCT02889809|451501878|FG001|Overall Study|Withdrawal by Subject|21|||
125511293|NCT02889809|451501877|FG000|Overall Study|Lost to Follow-up|1|||
125511294|NCT02889809|451501878|FG001|Overall Study|Lost to Follow-up|1|||
125511295|NCT02889809|451501877|FG000|Overall Study|Site Closed|12|||
125511296|NCT02889809|451501878|FG001|Overall Study|Site Closed|11|||
125511297|NCT01090076|451501881|FG000|Overall Study|Death|1|||
125511298|NCT01090076|451501882|FG001|Overall Study|Death|1|||
125511299|NCT01090076|451501881|FG000|Overall Study|Withdrawal by Subject|0|||
125306018|NCT01858766|450746713|FG002|Overall Study|Withdrew Consent|0|||
125306019|NCT01858766|450746714|FG003|Overall Study|Withdrew Consent|0|||
125306020|NCT01858766|450746715|FG004|Overall Study|Withdrew Consent|0|||
125511300|NCT01090076|451501882|FG001|Overall Study|Withdrawal by Subject|1|||
125511301|NCT01116440|451501884|FG000|Treatment|Withdrawal by Subject|2|||
125511302|NCT01116440|451501885|FG001|Treatment|Withdrawal by Subject|2|||
125511303|NCT01116440|451501884|FG000|Treatment|Lost to Follow-up|1|||
125511304|NCT01116440|451501885|FG001|Treatment|Lost to Follow-up|1|||
125511305|NCT01116440|451501884|FG000|Treatment|Protocol Violation|0|||
125511306|NCT01116440|451501885|FG001|Treatment|Protocol Violation|2|||
125511307|NCT01116440|451501884|FG000|Treatment|Lack of Efficacy|0|||
125511308|NCT01116440|451501885|FG001|Treatment|Lack of Efficacy|1|||
125511309|NCT01116440|451501884|FG000|Treatment|Adverse Event|0|||
125511310|NCT01116440|451501885|FG001|Treatment|Adverse Event|1|||
125511311|NCT01116440|451501884|FG000|Withdrawal|Withdrawal by Subject|0|||
125511312|NCT01116440|451501885|FG001|Withdrawal|Withdrawal by Subject|1|||
125511313|NCT01116440|451501884|FG000|Withdrawal|Lost to Follow-up|0|||
125511314|NCT01116440|451501885|FG001|Withdrawal|Lost to Follow-up|1|||
125511315|NCT01116440|451501884|FG000|Follow-up|Lost to Follow-up|0|||
125511316|NCT01116440|451501885|FG001|Follow-up|Lost to Follow-up|1|||
125511317|NCT01116440|451501884|FG000|Follow-up|Withdrawal by Subject|0|||
125511318|NCT01116440|451501885|FG001|Follow-up|Withdrawal by Subject|1|||
125511319|NCT01870999|451501891|FG000|Overall Study|Adverse Event|0|||
125511320|NCT01870999|451501892|FG001|Overall Study|Adverse Event|4|||
125511321|NCT01870999|451501893|FG002|Overall Study|Adverse Event|1|||
125511322|NCT01870999|451501891|FG000|Overall Study|Subject met withdrawal criteria|3|||
125511323|NCT01870999|451501892|FG001|Overall Study|Subject met withdrawal criteria|2|||
125511324|NCT01870999|451501893|FG002|Overall Study|Subject met withdrawal criteria|0|||
125511325|NCT01870999|451501891|FG000|Overall Study|Subject withdrawn by Investigator|1|||
125511326|NCT01870999|451501892|FG001|Overall Study|Subject withdrawn by Investigator|0|||
125511327|NCT01870999|451501893|FG002|Overall Study|Subject withdrawn by Investigator|0|||
125511328|NCT01870999|451501891|FG000|Overall Study|Withdrawal by Subject|0|||
125511329|NCT01870999|451501892|FG001|Overall Study|Withdrawal by Subject|2|||
125511330|NCT01870999|451501893|FG002|Overall Study|Withdrawal by Subject|5|||
125511331|NCT01870999|451501891|FG000|Overall Study|Protocol Violation|0|||
125511332|NCT01870999|451501892|FG001|Overall Study|Protocol Violation|0|||
125511333|NCT01870999|451501893|FG002|Overall Study|Protocol Violation|1|||
125511334|NCT01636258|451501894|FG000|Overall Study|Lost to Follow-up|1|||
125511335|NCT01636258|451501895|FG001|Overall Study|Lost to Follow-up|0|||
125511336|NCT02798861|451501898|FG000|Overall Study|Lost to Follow-up|22|||
125511337|NCT02798861|451501898|FG000|Overall Study|Withdrawal by Subject|1|||
125511338|NCT02186015|451501899|FG000|Overall Study|Physician Decision|1|||
125511339|NCT02186015|451501900|FG001|Overall Study|Physician Decision|0|||
125511340|NCT00907517|451501901|FG000|Overall Study|Progressive Disease|3|||
125511341|NCT00907517|451501902|FG001|Overall Study|Progressive Disease|3|||
125511342|NCT00907517|451501903|FG002|Overall Study|Progressive Disease|4|||
125511343|NCT00907517|451501904|FG003|Overall Study|Progressive Disease|4|||
125511344|NCT00907517|451501905|FG004|Overall Study|Progressive Disease|4|||
125511345|NCT00907517|451501901|FG000|Overall Study|Symptomatic Deterioration|0|||
125511346|NCT00907517|451501902|FG001|Overall Study|Symptomatic Deterioration|0|||
125511347|NCT00907517|451501903|FG002|Overall Study|Symptomatic Deterioration|0|||
125511348|NCT00907517|451501904|FG003|Overall Study|Symptomatic Deterioration|0|||
125511349|NCT00907517|451501905|FG004|Overall Study|Symptomatic Deterioration|1|||
125306021|NCT01858766|450746716|FG005|Overall Study|Withdrew Consent|0|||
125306022|NCT01858766|450746717|FG006|Overall Study|Withdrew Consent|0|||
125306023|NCT01858766|450746718|FG007|Overall Study|Withdrew Consent|0|||
125306024|NCT01858766|450746719|FG008|Overall Study|Withdrew Consent|0|||
125306025|NCT01858766|450746720|FG009|Overall Study|Withdrew Consent|0|||
125306026|NCT01858766|450746721|FG010|Overall Study|Withdrew Consent|0|||
125306027|NCT01858766|450746722|FG011|Overall Study|Withdrew Consent|1|||
125306028|NCT01858766|450746723|FG012|Overall Study|Withdrew Consent|0|||
125306029|NCT01858766|450746724|FG013|Overall Study|Withdrew Consent|0|||
125306030|NCT01858766|450746725|FG014|Overall Study|Withdrew Consent|0|||
125306031|NCT01858766|450746726|FG015|Overall Study|Withdrew Consent|0|||
125306032|NCT01858766|450746727|FG016|Overall Study|Withdrew Consent|0|||
125306033|NCT01858766|450746728|FG017|Overall Study|Withdrew Consent|0|||
125306034|NCT01858766|450746729|FG018|Overall Study|Withdrew Consent|0|||
125306035|NCT03517228|450746730|FG000|Overall Study|Withdrawal by Subject|2|||
125306036|NCT03517228|450746730|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
125306037|NCT03517228|450746730|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
125306038|NCT03517228|450746730|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
125306039|NCT03517228|450746730|FG000|Overall Study|Canceled due to device being updated|1|||
125306040|NCT03517228|450746730|FG000|Overall Study|No V Cares in stock|1|||
125306041|NCT03517228|450746730|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
125306042|NCT00475709|450746738|FG000|Overall Study|Did not meet eligibility criteria|8|||
125306043|NCT00475709|450746738|FG000|Overall Study|Death|41|||
125306044|NCT00475709|450746738|FG000|Overall Study|Device Explant|6|||
125511350|NCT01348763|451501906|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
125511351|NCT01348763|451501906|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
125511352|NCT01078571|451501907|FG000|Overall Study|Adverse Event|36|||
125511353|NCT01078571|451501907|FG000|Overall Study|Lack of effectiveness|36|||
125511354|NCT01078571|451501907|FG000|Overall Study|Reason not reported|21|||
125511355|NCT01078571|451501907|FG000|Overall Study|Withdrawal by Subject|12|||
125511356|NCT01078571|451501907|FG000|Overall Study|Lost to Follow-up|8|||
125511357|NCT01078571|451501907|FG000|Overall Study|Protocol Violation|2|||
125511358|NCT03647709|451501909|FG000|Overall Study|Lost to Follow-up|5|||
125511359|NCT03647709|451501909|FG000|Overall Study|Physician Decision|6|||
125511360|NCT03647709|451501909|FG000|Overall Study|Withdrawal by Subject|3|||
125511361|NCT03802513|451501921|FG000|Overall Study|Lost to Follow-up|1|||
125511362|NCT03045302|451501927|FG000|Overall Study|Pre-treatment adverse event|1|||
125511363|NCT05287178|451501928|FG000|Overall Study|Lost to Follow-up|2|||
125511364|NCT00603278|451501929|FG000|Overall Study|Lack of Efficacy|35|||
125511365|NCT00603278|451501930|FG001|Overall Study|Lack of Efficacy|10|||
125511366|NCT00603278|451501931|FG002|Overall Study|Lack of Efficacy|11|||
125511367|NCT00603278|451501932|FG003|Overall Study|Lack of Efficacy|8|||
125511368|NCT00603278|451501933|FG004|Overall Study|Lack of Efficacy|7|||
125511369|NCT00603278|451501934|FG005|Overall Study|Lack of Efficacy|14|||
125511370|NCT00603278|451501929|FG000|Overall Study|Adverse Event|0|||
125511371|NCT00603278|451501930|FG001|Overall Study|Adverse Event|3|||
125511372|NCT00603278|451501931|FG002|Overall Study|Adverse Event|1|||
125511373|NCT00603278|451501932|FG003|Overall Study|Adverse Event|0|||
125511374|NCT00603278|451501933|FG004|Overall Study|Adverse Event|2|||
125511375|NCT00603278|451501934|FG005|Overall Study|Adverse Event|1|||
125511376|NCT00603278|451501929|FG000|Overall Study|Withdrawal by Subject|2|||
125511377|NCT00603278|451501930|FG001|Overall Study|Withdrawal by Subject|3|||
125511378|NCT00603278|451501931|FG002|Overall Study|Withdrawal by Subject|1|||
125511379|NCT00603278|451501932|FG003|Overall Study|Withdrawal by Subject|2|||
125511380|NCT00603278|451501933|FG004|Overall Study|Withdrawal by Subject|1|||
125511381|NCT00603278|451501934|FG005|Overall Study|Withdrawal by Subject|2|||
125511382|NCT00603278|451501929|FG000|Overall Study|Protocol Violation|3|||
125511383|NCT00603278|451501930|FG001|Overall Study|Protocol Violation|0|||
125511384|NCT00603278|451501931|FG002|Overall Study|Protocol Violation|1|||
125511385|NCT00603278|451501932|FG003|Overall Study|Protocol Violation|1|||
125511386|NCT00603278|451501933|FG004|Overall Study|Protocol Violation|0|||
125511387|NCT00603278|451501934|FG005|Overall Study|Protocol Violation|1|||
125511388|NCT00603278|451501929|FG000|Overall Study|Physician Decision|0|||
125511389|NCT00603278|451501930|FG001|Overall Study|Physician Decision|1|||
125511390|NCT00603278|451501931|FG002|Overall Study|Physician Decision|0|||
125511391|NCT00603278|451501932|FG003|Overall Study|Physician Decision|0|||
125511392|NCT00603278|451501933|FG004|Overall Study|Physician Decision|2|||
125511393|NCT00603278|451501934|FG005|Overall Study|Physician Decision|1|||
125511394|NCT00603278|451501929|FG000|Overall Study|Lost to Follow-up|1|||
125511395|NCT00603278|451501930|FG001|Overall Study|Lost to Follow-up|0|||
125511396|NCT00603278|451501931|FG002|Overall Study|Lost to Follow-up|0|||
125511397|NCT00603278|451501932|FG003|Overall Study|Lost to Follow-up|0|||
125511398|NCT00603278|451501933|FG004|Overall Study|Lost to Follow-up|1|||
125511399|NCT00603278|451501934|FG005|Overall Study|Lost to Follow-up|0|||
125511400|NCT04374253|451501938|FG000|Overall Study|Adverse Event|0|||
125511401|NCT04374253|451501939|FG001|Overall Study|Adverse Event|26|||
125511402|NCT04374253|451501940|FG002|Overall Study|Adverse Event|2|||
125511403|NCT04374253|451501941|FG003|Overall Study|Adverse Event|12|||
125511404|NCT04374253|451501938|FG000|Overall Study|Study terminated by sponsor|13|||
125511405|NCT04374253|451501939|FG001|Overall Study|Study terminated by sponsor|593|||
125511406|NCT04374253|451501940|FG002|Overall Study|Study terminated by sponsor|21|||
125511407|NCT04374253|451501941|FG003|Overall Study|Study terminated by sponsor|567|||
125511408|NCT04374253|451501938|FG000|Overall Study|Withdrawal by Subject|0|||
125511409|NCT04374253|451501939|FG001|Overall Study|Withdrawal by Subject|55|||
125511410|NCT04374253|451501940|FG002|Overall Study|Withdrawal by Subject|3|||
125511411|NCT04374253|451501941|FG003|Overall Study|Withdrawal by Subject|40|||
125511412|NCT04374253|451501938|FG000|Overall Study|Physician Decision|1|||
125511413|NCT04374253|451501939|FG001|Overall Study|Physician Decision|10|||
125511414|NCT04374253|451501940|FG002|Overall Study|Physician Decision|1|||
125511415|NCT04374253|451501941|FG003|Overall Study|Physician Decision|10|||
125511416|NCT04374253|451501938|FG000|Overall Study|Protocol Violation|0|||
125511417|NCT04374253|451501939|FG001|Overall Study|Protocol Violation|0|||
125511418|NCT04374253|451501940|FG002|Overall Study|Protocol Violation|0|||
125306045|NCT00475709|450746738|FG000|Overall Study|Lost to Follow-up|21|||
125306046|NCT01835158|450746741|FG000|Overall Study|Withdrawal by Subject|1|||
125306047|NCT01835158|450746742|FG001|Overall Study|Withdrawal by Subject|6|||
125306048|NCT01415401|450746743|FG000|Overall Study|Adverse Event|5|||
125306049|NCT01415401|450746743|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
125511419|NCT04374253|451501941|FG003|Overall Study|Protocol Violation|2|||
125511420|NCT04374253|451501938|FG000|Overall Study|Death|0|||
125511421|NCT04374253|451501939|FG001|Overall Study|Death|3|||
125511422|NCT04374253|451501940|FG002|Overall Study|Death|1|||
125306050|NCT01415401|450746743|FG000|Overall Study|Terminated by Sponsor|1|||
125306051|NCT00532298|450746754|FG000|Overall Study|Adverse Event|1|||
125511423|NCT04374253|451501941|FG003|Overall Study|Death|1|||
125511424|NCT04374253|451501938|FG000|Overall Study|Lack of Efficacy|0|||
125306052|NCT00532298|450746755|FG001|Overall Study|Adverse Event|0|||
125511425|NCT04374253|451501939|FG001|Overall Study|Lack of Efficacy|0|||
125511426|NCT04374253|451501940|FG002|Overall Study|Lack of Efficacy|0|||
125511427|NCT04374253|451501941|FG003|Overall Study|Lack of Efficacy|1|||
125511428|NCT04374253|451501938|FG000|Overall Study|Lost to Follow-up|1|||
125511429|NCT04374253|451501939|FG001|Overall Study|Lost to Follow-up|1|||
125511430|NCT04374253|451501940|FG002|Overall Study|Lost to Follow-up|0|||
125511431|NCT04374253|451501941|FG003|Overall Study|Lost to Follow-up|2|||
125511432|NCT04374253|451501938|FG000|Overall Study|Reason Not Specified|0|||
125511433|NCT04374253|451501939|FG001|Overall Study|Reason Not Specified|8|||
125511434|NCT04374253|451501940|FG002|Overall Study|Reason Not Specified|0|||
125511435|NCT04374253|451501941|FG003|Overall Study|Reason Not Specified|8|||
125511436|NCT01207453|451501942|FG000|First Intervention|Adverse Event|2|||
125511437|NCT01207453|451501943|FG001|First Intervention|Adverse Event|1|||
125511438|NCT01207453|451501942|FG000|Washout|Adverse Event|1|||
125511439|NCT01207453|451501943|FG001|Washout|Adverse Event|0|||
125511440|NCT01207453|451501942|FG000|Washout|Lost to Follow-up|1|||
125511441|NCT01207453|451501943|FG001|Washout|Lost to Follow-up|0|||
125511442|NCT01207453|451501942|FG000|2nd Intervention|Adverse Event|1|||
125511443|NCT01207453|451501943|FG001|2nd Intervention|Adverse Event|2|||
125511444|NCT01207453|451501942|FG000|2nd Intervention|Lost to Follow-up|1|||
125511445|NCT01207453|451501943|FG001|2nd Intervention|Lost to Follow-up|0|||
125511446|NCT00990821|451501946|FG000|Overall Study|Withdrawal by Subject|0|||
125511447|NCT00990821|451501947|FG001|Overall Study|Withdrawal by Subject|2|||
125511448|NCT00990821|451501948|FG002|Overall Study|Withdrawal by Subject|0|||
125511449|NCT00990821|451501949|FG003|Overall Study|Withdrawal by Subject|0|||
125511450|NCT00990821|451501950|FG004|Overall Study|Withdrawal by Subject|3|||
125511451|NCT00990821|451501951|FG005|Overall Study|Withdrawal by Subject|3|||
125511452|NCT00990821|451501952|FG006|Overall Study|Withdrawal by Subject|1|||
125511453|NCT00990821|451501953|FG007|Overall Study|Withdrawal by Subject|0|||
125511454|NCT00990821|451501954|FG008|Overall Study|Withdrawal by Subject|0|||
125511455|NCT00990821|451501955|FG009|Overall Study|Withdrawal by Subject|1|||
125511456|NCT00990821|451501956|FG010|Overall Study|Withdrawal by Subject|3|||
125511457|NCT00990821|451501957|FG011|Overall Study|Withdrawal by Subject|5|||
125511458|NCT00990821|451501958|FG012|Overall Study|Withdrawal by Subject|2|||
125511459|NCT00990821|451501959|FG013|Overall Study|Withdrawal by Subject|1|||
125511460|NCT04150250|451501960|FG000|Overall Study|Lost to Follow-up|0|||
125511461|NCT04150250|451501961|FG001|Overall Study|Lost to Follow-up|2|||
125511462|NCT01786551|451501962|FG000|Overall Study|Participant withdrew consent|2|||
125511463|NCT00308113|451501963|FG000|Overall Study|Protocol closure|0|||
125511464|NCT00308113|451501964|FG001|Overall Study|Protocol closure|0|||
125511465|NCT00308113|451501965|FG002|Overall Study|Protocol closure|0|||
125511466|NCT00308113|451501966|FG003|Overall Study|Protocol closure|1|||
125511467|NCT00170950|451501968|FG000|Overall Study|Death|236|||
125511468|NCT00170950|451501969|FG001|Overall Study|Death|274|||
125511469|NCT00170950|451501968|FG000|Overall Study|Withdrawal by Subject|496|||
125511470|NCT00170950|451501969|FG001|Overall Study|Withdrawal by Subject|498|||
125511471|NCT00170950|451501968|FG000|Overall Study|Lost to Follow-up|134|||
125511472|NCT00170950|451501969|FG001|Overall Study|Lost to Follow-up|115|||
125511473|NCT00170950|451501968|FG000|Overall Study|Missing|2|||
125511474|NCT00170950|451501969|FG001|Overall Study|Missing|1|||
125511475|NCT00170950|451501968|FG000|Overall Study|Termination Data Not Recorded|17|||
125511476|NCT00170950|451501969|FG001|Overall Study|Termination Data Not Recorded|22|||
125511477|NCT00748098|451501970|FG000|First Treatment Intervention Period|Adverse Event|1|||
125511478|NCT00748098|451501971|FG001|First Treatment Intervention Period|Adverse Event|1|||
125511479|NCT00748098|451501970|FG000|First Treatment Intervention Period|Protocol Violation|1|||
125511480|NCT00748098|451501971|FG001|First Treatment Intervention Period|Protocol Violation|0|||
125511481|NCT00748098|451501970|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
125511482|NCT00748098|451501971|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
125511483|NCT00748098|451501970|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
125511484|NCT00748098|451501971|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
125511485|NCT00748098|451501970|FG000|First Taper Period|Protocol Violation|1|||
125511486|NCT00748098|451501971|FG001|First Taper Period|Protocol Violation|0|||
125511487|NCT00748098|451501970|FG000|First Taper Period|Withdrawal by Subject|2|||
125511488|NCT00748098|451501971|FG001|First Taper Period|Withdrawal by Subject|0|||
125511489|NCT00748098|451501970|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
125511490|NCT00748098|451501971|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
125511491|NCT00748098|451501970|FG000|1-Week Washout Period|Adverse Event|0|||
125511492|NCT00748098|451501971|FG001|1-Week Washout Period|Adverse Event|1|||
125511493|NCT00748098|451501970|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
125511494|NCT00748098|451501971|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
125511495|NCT00748098|451501970|FG000|Second Treatment Intervention Period|Adverse Event|4|||
125511496|NCT00748098|451501971|FG001|Second Treatment Intervention Period|Adverse Event|1|||
125511497|NCT00748098|451501970|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
125511498|NCT00748098|451501971|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
125511499|NCT00748098|451501970|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
125511500|NCT00748098|451501971|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
125511501|NCT02442622|451501972|FG000|Overall Study|Withdrawal by Subject|3|||
125511502|NCT02442622|451501973|FG001|Overall Study|Withdrawal by Subject|1|||
125511503|NCT01123642|451503745|FG000|Overall Study|Lost to Follow-up|23|||
125511504|NCT01123642|451503745|FG000|Overall Study|Withdrawal by Subject|9|||
125511505|NCT01123642|451503745|FG000|Overall Study|ineligible at baseline assessment|36|||
125511506|NCT00925288|451503746|FG000|Overall Study|Lost to Follow-up|9|||
125511507|NCT00925288|451503747|FG001|Overall Study|Lost to Follow-up|7|||
125511508|NCT03322514|451503748|FG000|Overall Study|Withdrawal by Subject|1|||
125511509|NCT03322514|451503749|FG001|Overall Study|Withdrawal by Subject|1|||
125511510|NCT01184859|451503750|FG000|Period 1: Single Dose|Insufficient urine production|0|||
125511511|NCT01184859|451503751|FG001|Period 1: Single Dose|Insufficient urine production|1|||
125511512|NCT01184859|451503752|FG002|Period 1: Single Dose|Insufficient urine production|0|||
125511513|NCT01184859|451503753|FG003|Period 1: Single Dose|Insufficient urine production|0|||
125511514|NCT01184859|451503754|FG004|Period 1: Single Dose|Insufficient urine production|0|||
125511515|NCT01184859|451503750|FG000|Period 1: Single Dose|Protocol Violation|0|||
125511516|NCT01184859|451503751|FG001|Period 1: Single Dose|Protocol Violation|1|||
125511517|NCT01184859|451503752|FG002|Period 1: Single Dose|Protocol Violation|0|||
125511518|NCT01184859|451503753|FG003|Period 1: Single Dose|Protocol Violation|0|||
125511519|NCT01184859|451503754|FG004|Period 1: Single Dose|Protocol Violation|0|||
125511520|NCT01184859|451503750|FG000|Period 1: Single Dose|Adverse Event|0|||
125511521|NCT01184859|451503751|FG001|Period 1: Single Dose|Adverse Event|0|||
125511522|NCT01184859|451503752|FG002|Period 1: Single Dose|Adverse Event|0|||
125511523|NCT01184859|451503753|FG003|Period 1: Single Dose|Adverse Event|0|||
125511524|NCT01184859|451503754|FG004|Period 1: Single Dose|Adverse Event|1|||
125511525|NCT01184859|451503750|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
125511526|NCT01184859|451503751|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
125511527|NCT01184859|451503752|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
125511528|NCT01184859|451503753|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
125511529|NCT01184859|451503754|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
125511530|NCT01184859|451503750|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
125511531|NCT01184859|451503751|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
125511532|NCT01184859|451503752|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
125511533|NCT01184859|451503753|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
125511534|NCT01184859|451503754|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
125511535|NCT00961298|451503755|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
125511536|NCT00961298|451503755|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
125511537|NCT00961298|451503755|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
125511538|NCT01904019|451503757|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
125511539|NCT01904019|451503757|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
125511540|NCT01904019|451503757|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
125306053|NCT00532298|450746756|FG002|Overall Study|Adverse Event|0|||
125306054|NCT00532298|450746757|FG003|Overall Study|Adverse Event|0|||
125306055|NCT00532298|450746758|FG004|Overall Study|Adverse Event|1|||
125306056|NCT00532298|450746759|FG005|Overall Study|Adverse Event|1|||
125306057|NCT00532298|450746754|FG000|Overall Study|Lost to Follow-up|1|||
125306058|NCT00532298|450746755|FG001|Overall Study|Lost to Follow-up|1|||
125306059|NCT00532298|450746756|FG002|Overall Study|Lost to Follow-up|1|||
125306060|NCT00532298|450746757|FG003|Overall Study|Lost to Follow-up|0|||
125306061|NCT00532298|450746758|FG004|Overall Study|Lost to Follow-up|0|||
125306062|NCT00532298|450746759|FG005|Overall Study|Lost to Follow-up|1|||
125306063|NCT02023996|450746760|FG000|Overall Study|Protocol Violation|6|||
125306064|NCT00095173|450746764|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
125306065|NCT00095173|450746765|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
125306066|NCT00095173|450746766|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
125306067|NCT00095173|450746767|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
125306068|NCT00095173|450746768|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
125306069|NCT00095173|450746769|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
125306070|NCT00095173|450746764|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
125306071|NCT00095173|450746765|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
125306072|NCT00095173|450746766|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
125306073|NCT00095173|450746767|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
125306074|NCT00095173|450746768|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
125306075|NCT00095173|450746769|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
125306076|NCT00095173|450746764|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
125306077|NCT00095173|450746765|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
125306078|NCT00095173|450746766|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
125306079|NCT00095173|450746767|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
125306080|NCT00095173|450746768|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
125306081|NCT00095173|450746769|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
125306082|NCT00095173|450746764|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
125306083|NCT00095173|450746765|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
125306084|NCT00095173|450746766|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
125306085|NCT00095173|450746767|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
125306086|NCT00095173|450746768|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
125306087|NCT00095173|450746769|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
125306088|NCT00095173|450746764|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
125306089|NCT00095173|450746765|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
125306090|NCT00095173|450746766|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
125511541|NCT01904019|451503757|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
125511542|NCT01904019|451503757|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
125511543|NCT01904019|451503757|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
125511544|NCT01537120|451503758|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
125306091|NCT00095173|450746767|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
125306092|NCT00095173|450746768|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
125306093|NCT00095173|450746769|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
125306094|NCT00095173|450746764|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
125306095|NCT00095173|450746765|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
125306096|NCT00095173|450746766|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
125306097|NCT00095173|450746767|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
125306098|NCT00095173|450746768|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
125306099|NCT00095173|450746769|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
125306100|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Death|0|||
125306101|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Death|0|||
125306102|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Death|0|||
125306103|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Death|0|||
125306104|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Death|0|||
125306105|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Death|1|||
125306106|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
125306107|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
125306108|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
125306109|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
125306110|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
125306111|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
125306112|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
125306113|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
125306114|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
125306115|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
125306116|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
125306117|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
125306118|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
125306119|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
125306120|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
125306121|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
125306122|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
125306123|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
125306124|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
125306125|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
125306126|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
125306127|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
125306128|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
125306129|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
125306130|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
125306131|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
125306132|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
125306133|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
125306134|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
125306135|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
125306136|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
125306137|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
125306138|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
125306139|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
125306140|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
125306141|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
125306142|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
125306143|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
125306144|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
125306145|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
125306146|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
125306147|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
125306148|NCT00095173|450746764|FG000|Open-Label Extension Phase (Period C)|Other|0|||
125306149|NCT00095173|450746765|FG001|Open-Label Extension Phase (Period C)|Other|0|||
125306150|NCT00095173|450746766|FG002|Open-Label Extension Phase (Period C)|Other|0|||
125306151|NCT00095173|450746767|FG003|Open-Label Extension Phase (Period C)|Other|4|||
125306152|NCT00095173|450746768|FG004|Open-Label Extension Phase (Period C)|Other|6|||
125306153|NCT00095173|450746769|FG005|Open-Label Extension Phase (Period C)|Other|8|||
125306154|NCT02708355|450746772|FG000|Overall Study|Adverse Event|1|||
125306155|NCT02708355|450746773|FG001|Overall Study|Adverse Event|0|||
125306156|NCT02708355|450746774|FG002|Overall Study|Adverse Event|0|||
125511545|NCT01537120|451503758|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
125511546|NCT01503515|451503763|FG000|Overall Study|Adverse Event|4|||
125511547|NCT01503515|451503764|FG001|Overall Study|Adverse Event|5|||
125511548|NCT01503515|451503763|FG000|Overall Study|Death|0|||
125511549|NCT01503515|451503764|FG001|Overall Study|Death|1|||
125511550|NCT01503515|451503763|FG000|Overall Study|Physician Decision|14|||
125511551|NCT01503515|451503764|FG001|Overall Study|Physician Decision|23|||
125511552|NCT01503515|451503763|FG000|Overall Study|Withdrawal by Subject|0|||
125511553|NCT01503515|451503764|FG001|Overall Study|Withdrawal by Subject|1|||
125511554|NCT01503515|451503763|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
125511555|NCT01503515|451503764|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
125511556|NCT01503515|451503763|FG000|Overall Study|Ineligible|1|||
125511557|NCT01503515|451503764|FG001|Overall Study|Ineligible|1|||
125511558|NCT03087851|451503766|FG000|Overall Study|Withdraw on medical grounds|0|||
125511559|NCT03087851|451503767|FG001|Overall Study|Withdraw on medical grounds|1|||
125511560|NCT03087851|451503768|FG002|Overall Study|Withdraw on medical grounds|2|||
125511561|NCT02123797|451503771|FG000|Baseline Intervention|Death|9|||
125511562|NCT02123797|451503772|FG001|Baseline Intervention|Death|16|||
125511563|NCT02123797|451503773|FG002|Baseline Intervention|Death|0|||
125511564|NCT02123797|451503774|FG003|Baseline Intervention|Death|0|||
125511565|NCT02123797|451503775|FG004|Baseline Intervention|Death|0|||
125511566|NCT02123797|451503771|FG000|Baseline Intervention|Withdrawal by Subject|2|||
125511567|NCT02123797|451503772|FG001|Baseline Intervention|Withdrawal by Subject|8|||
125511568|NCT02123797|451503773|FG002|Baseline Intervention|Withdrawal by Subject|0|||
125511569|NCT02123797|451503774|FG003|Baseline Intervention|Withdrawal by Subject|0|||
125511570|NCT02123797|451503775|FG004|Baseline Intervention|Withdrawal by Subject|0|||
125511571|NCT02123797|451503771|FG000|Baseline Intervention|Relocation|2|||
125511572|NCT02123797|451503772|FG001|Baseline Intervention|Relocation|0|||
125511573|NCT02123797|451503773|FG002|Baseline Intervention|Relocation|0|||
125511574|NCT02123797|451503774|FG003|Baseline Intervention|Relocation|0|||
125511575|NCT02123797|451503775|FG004|Baseline Intervention|Relocation|0|||
125511576|NCT02123797|451503771|FG000|Baseline Intervention|Out of window for initial survey|6|||
125511577|NCT02123797|451503772|FG001|Baseline Intervention|Out of window for initial survey|13|||
125511578|NCT02123797|451503773|FG002|Baseline Intervention|Out of window for initial survey|0|||
125511579|NCT02123797|451503774|FG003|Baseline Intervention|Out of window for initial survey|0|||
125511580|NCT02123797|451503775|FG004|Baseline Intervention|Out of window for initial survey|0|||
125511581|NCT02123797|451503771|FG000|Baseline Intervention|Lost to Follow-up|0|||
125511582|NCT02123797|451503772|FG001|Baseline Intervention|Lost to Follow-up|5|||
125511583|NCT02123797|451503773|FG002|Baseline Intervention|Lost to Follow-up|0|||
125511584|NCT02123797|451503774|FG003|Baseline Intervention|Lost to Follow-up|0|||
125511585|NCT02123797|451503775|FG004|Baseline Intervention|Lost to Follow-up|0|||
125511586|NCT02123797|451503771|FG000|Baseline Intervention|Other Disease|3|||
125511587|NCT02123797|451503772|FG001|Baseline Intervention|Other Disease|0|||
125511588|NCT02123797|451503773|FG002|Baseline Intervention|Other Disease|0|||
125511589|NCT02123797|451503774|FG003|Baseline Intervention|Other Disease|0|||
125511590|NCT02123797|451503775|FG004|Baseline Intervention|Other Disease|0|||
125511591|NCT02123797|451503771|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
125511592|NCT02123797|451503772|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
125511593|NCT02123797|451503773|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
125511594|NCT02123797|451503774|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
125511595|NCT02123797|451503775|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
125511596|NCT02123797|451503771|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
125511597|NCT02123797|451503772|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
125511598|NCT02123797|451503773|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
125511599|NCT02123797|451503774|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
125511600|NCT02123797|451503775|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
125511601|NCT02123797|451503771|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
125511602|NCT02123797|451503772|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
125511603|NCT02123797|451503773|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
125511604|NCT02123797|451503774|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
125511605|NCT02123797|451503775|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
125511606|NCT02123797|451503771|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
125511607|NCT02123797|451503772|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
125511608|NCT02123797|451503773|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
125511609|NCT02123797|451503774|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
125511610|NCT02123797|451503775|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
125511611|NCT02123797|451503771|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
125511612|NCT02123797|451503772|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
125511613|NCT02123797|451503773|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
125511614|NCT02123797|451503774|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
125511615|NCT02123797|451503775|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
125511616|NCT02123797|451503771|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
125511617|NCT02123797|451503772|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
125511618|NCT02123797|451503773|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
125511619|NCT02123797|451503774|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
125511620|NCT02123797|451503775|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
125511621|NCT02123797|451503771|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
125511622|NCT02123797|451503772|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
125511623|NCT02123797|451503773|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
125511624|NCT02123797|451503774|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
125511625|NCT02123797|451503775|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
125511626|NCT02123797|451503771|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
125511627|NCT02123797|451503772|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
125511628|NCT02123797|451503773|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
125511629|NCT02123797|451503774|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
125511630|NCT02123797|451503775|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
125511631|NCT02123797|451503771|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
125511632|NCT02123797|451503772|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
125511633|NCT02123797|451503773|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
125511634|NCT02123797|451503774|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
125306157|NCT01019369|450746776|FG000|Overall Study|Lost to Follow-up|10|||
125306158|NCT01019369|450746777|FG001|Overall Study|Lost to Follow-up|6|||
125306159|NCT01019369|450746776|FG000|Overall Study|Withdrawal by Subject|0|||
125306160|NCT01019369|450746777|FG001|Overall Study|Withdrawal by Subject|1|||
125306161|NCT01380834|450746778|FG000|Overall Study|Physician Decision|1|||
125306162|NCT01380834|450746779|FG001|Overall Study|Physician Decision|0|||
125306163|NCT04310566|450746780|FG000|Period 1|Study Termination due to COVID-19|15|||
125306164|NCT04310566|450746781|FG001|Period 1|Study Termination due to COVID-19|17|||
125306165|NCT04310566|450746780|FG000|Period 1|Protocol Violation|0|||
125306166|NCT04310566|450746781|FG001|Period 1|Protocol Violation|1|||
125306167|NCT04310566|450746780|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
125306168|NCT04310566|450746781|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
125306169|NCT04310566|450746780|FG000|Period 1|Lost to Follow-up|1|||
125306170|NCT04310566|450746781|FG001|Period 1|Lost to Follow-up|0|||
125306171|NCT04310566|450746780|FG000|Period 1|Withdrawal by Subject|0|||
125306172|NCT04310566|450746781|FG001|Period 1|Withdrawal by Subject|1|||
125306173|NCT04310566|450746780|FG000|Period 2|Study Termination|7|||
125306174|NCT04310566|450746781|FG001|Period 2|Study Termination|5|||
125306175|NCT01711645|450746782|FG000|Overall Study|Withdrawal by Subject|8|||
125306176|NCT01711645|450746782|FG000|Overall Study|Lost to Follow-up|6|||
125306177|NCT01711645|450746782|FG000|Overall Study|Physician Decision|5|||
125306178|NCT01746173|450746788|FG000|Overall Study|Disease Progression|2|||
125306179|NCT01771250|450746790|FG000|Period 1|Met exclusion criteria|1|||
125306180|NCT01771250|450746791|FG001|Period 1|Met exclusion criteria|0|||
125306181|NCT01153724|450746797|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125306182|NCT01153724|450746797|FG000|Treatment Period 2|Adverse Event|1|||
125306183|NCT01153724|450746797|FG000|Treatment Period 2|Other reason not defined above|1|||
125306184|NCT04230213|450746803|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
125306185|NCT04230213|450746804|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
125306186|NCT04230213|450746805|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
125306187|NCT04230213|450746803|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
125306188|NCT04230213|450746804|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
125306189|NCT04230213|450746805|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
125306190|NCT04230213|450746803|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
125306191|NCT04230213|450746804|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
125306192|NCT04230213|450746805|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
125306193|NCT04230213|450746803|FG000|TP2: Week 10 to Week 16|Other|0|||
125306194|NCT04230213|450746804|FG001|TP2: Week 10 to Week 16|Other|2|||
125306195|NCT04230213|450746805|FG002|TP2: Week 10 to Week 16|Other|1|||
125306196|NCT04230213|450746803|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
125306197|NCT04230213|450746804|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
125306198|NCT04230213|450746805|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
125306199|NCT04230213|450746803|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
125306200|NCT04230213|450746804|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
125306201|NCT04230213|450746805|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
125306202|NCT04230213|450746803|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
125306203|NCT04230213|450746804|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
125306204|NCT04230213|450746805|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
125306205|NCT04230213|450746803|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
125511635|NCT02123797|451503775|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
125511636|NCT03997409|451503778|FG000|Overall Study|Protocol Violation|1|||
125511637|NCT03997409|451503779|FG001|Overall Study|Protocol Violation|1|||
125511638|NCT03997409|451503780|FG002|Overall Study|Protocol Violation|0|||
125511639|NCT03997409|451503778|FG000|Overall Study|Withdrawal by Subject|3|||
125511640|NCT03997409|451503779|FG001|Overall Study|Withdrawal by Subject|0|||
125511641|NCT03997409|451503780|FG002|Overall Study|Withdrawal by Subject|0|||
125511642|NCT03997409|451503778|FG000|Overall Study|Lost to Follow-up|0|||
125511643|NCT03997409|451503779|FG001|Overall Study|Lost to Follow-up|0|||
125511644|NCT03997409|451503780|FG002|Overall Study|Lost to Follow-up|1|||
125511645|NCT01753323|451503781|FG000|Overall Study|Lack of Efficacy|0|||
125511646|NCT01753323|451503782|FG001|Overall Study|Lack of Efficacy|0|||
125511647|NCT01753323|451503783|FG002|Overall Study|Lack of Efficacy|8|||
125511648|NCT01753323|451503781|FG000|Overall Study|Protocol deviation|1|||
125511649|NCT01753323|451503782|FG001|Overall Study|Protocol deviation|0|||
125511650|NCT01753323|451503783|FG002|Overall Study|Protocol deviation|0|||
125511651|NCT01753323|451503781|FG000|Overall Study|Adverse Event|0|||
125511652|NCT01753323|451503782|FG001|Overall Study|Adverse Event|0|||
125511653|NCT01753323|451503783|FG002|Overall Study|Adverse Event|1|||
125511654|NCT01498445|451503785|FG000|Overall Study|Lack of Efficacy|0|||
125511655|NCT01498445|451503786|FG001|Overall Study|Lack of Efficacy|0|||
125511656|NCT01498445|451503787|FG002|Overall Study|Lack of Efficacy|1|||
125511657|NCT01498445|451503788|FG003|Overall Study|Lack of Efficacy|2|||
125511658|NCT01498445|451503789|FG004|Overall Study|Lack of Efficacy|0|||
125511659|NCT01498445|451503790|FG005|Overall Study|Lack of Efficacy|0|||
125511660|NCT01498445|451503785|FG000|Overall Study|Screen Failure|0|||
125511661|NCT01498445|451503786|FG001|Overall Study|Screen Failure|0|||
125511662|NCT01498445|451503787|FG002|Overall Study|Screen Failure|0|||
125511663|NCT01498445|451503788|FG003|Overall Study|Screen Failure|0|||
125511664|NCT01498445|451503789|FG004|Overall Study|Screen Failure|1|||
125511665|NCT01498445|451503790|FG005|Overall Study|Screen Failure|1|||
125511666|NCT00730925|451503793|FG000|Overall Study|Progressive Disease|21|||
125511667|NCT00730925|451503793|FG000|Overall Study|Dose reducing Event|2|||
125511668|NCT00730925|451503793|FG000|Overall Study|Other Averse Event|7|||
125511669|NCT00730925|451503793|FG000|Overall Study|Protocol Violation|1|||
125511670|NCT00730925|451503793|FG000|Overall Study|Withdrawal by Subject|1|||
125511671|NCT00730925|451503793|FG000|Overall Study|Switch to combination therapy|8|||
125511672|NCT00730925|451503793|FG000|Overall Study|Other|1|||
125511673|NCT00561678|451503794|FG000|Overall Study|Withdrawal by Subject|4|||
125511674|NCT00561678|451503795|FG001|Overall Study|Withdrawal by Subject|3|||
125511675|NCT00561678|451503794|FG000|Overall Study|surgery cancelled|1|||
125511676|NCT00561678|451503795|FG001|Overall Study|surgery cancelled|1|||
125511677|NCT00561678|451503794|FG000|Overall Study|surgery rescheduled to different site|2|||
125511678|NCT00561678|451503795|FG001|Overall Study|surgery rescheduled to different site|2|||
125511679|NCT00561678|451503794|FG000|Overall Study|anesthesia provider refusal|1|||
125511680|NCT00561678|451503795|FG001|Overall Study|anesthesia provider refusal|0|||
125511681|NCT01732627|451503796|FG000|Overall Study|Withdrawal by Subject|1|||
125511682|NCT01732627|451503797|FG001|Overall Study|Withdrawal by Subject|0|||
125511683|NCT01072396|451503798|FG000|Period One|Adverse Event|1|||
125511684|NCT01072396|451503799|FG001|Period One|Adverse Event|1|||
125511685|NCT01072396|451503798|FG000|Period One|Protocol Violation|2|||
125511686|NCT01072396|451503799|FG001|Period One|Protocol Violation|1|||
125511687|NCT01072396|451503798|FG000|Period One|Withdrawal by Subject|2|||
125511688|NCT01072396|451503799|FG001|Period One|Withdrawal by Subject|0|||
125511689|NCT01072396|451503798|FG000|Washout Period|Missing termination information|0|||
125511690|NCT01072396|451503799|FG001|Washout Period|Missing termination information|1|||
125511691|NCT01072396|451503798|FG000|Period Two|Adverse Event|0|||
125511692|NCT01072396|451503799|FG001|Period Two|Adverse Event|3|||
125511693|NCT01072396|451503798|FG000|Period Two|Lost to Follow-up|1|||
125511694|NCT01072396|451503799|FG001|Period Two|Lost to Follow-up|0|||
125511695|NCT00005908|451503800|FG000|Overall Study|Withdrawal by Subject|1|||
125511696|NCT00005908|451503801|FG001|Overall Study|Withdrawal by Subject|0|||
125511697|NCT01106586|451503804|FG000|Overall Study|Adverse Event|9|||
125511698|NCT01106586|451503805|FG001|Overall Study|Adverse Event|15|||
125511699|NCT01106586|451503804|FG000|Overall Study|Death|1|||
125511700|NCT01106586|451503805|FG001|Overall Study|Death|3|||
125511701|NCT01106586|451503804|FG000|Overall Study|Pregnancy|2|||
125511702|NCT01106586|451503805|FG001|Overall Study|Pregnancy|2|||
125511703|NCT01106586|451503804|FG000|Overall Study|Lack of Efficacy|1|||
125511704|NCT01106586|451503805|FG001|Overall Study|Lack of Efficacy|0|||
125511705|NCT01106586|451503804|FG000|Overall Study|Investigator's Discretion|5|||
125511706|NCT01106586|451503805|FG001|Overall Study|Investigator's Discretion|8|||
125511707|NCT01106586|451503804|FG000|Overall Study|Withdrew Consent|18|||
125511708|NCT01106586|451503805|FG001|Overall Study|Withdrew Consent|30|||
125511709|NCT01106586|451503804|FG000|Overall Study|Lost to Follow-up|24|||
125511710|NCT01106586|451503805|FG001|Overall Study|Lost to Follow-up|20|||
125511711|NCT01106586|451503804|FG000|Overall Study|Participant Noncompliance|12|||
125511712|NCT01106586|451503805|FG001|Overall Study|Participant Noncompliance|10|||
125511713|NCT01106586|451503804|FG000|Overall Study|Protocol Violation|1|||
125306206|NCT04230213|450746804|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
125511714|NCT01106586|451503805|FG001|Overall Study|Protocol Violation|0|||
125511715|NCT01106586|451503804|FG000|Overall Study|Participant Transferred to Another Study|212|||
125511716|NCT01106586|451503805|FG001|Overall Study|Participant Transferred to Another Study|197|||
125511717|NCT01379521|451503806|FG000|Overall Study -Treatment Period|Adverse Event|3|||
125511718|NCT01379521|451503807|FG001|Overall Study -Treatment Period|Adverse Event|0|||
125511719|NCT01379521|451503806|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
125511720|NCT01379521|451503807|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
125511721|NCT01379521|451503806|FG000|Overall Study -Treatment Period|Disease Progression|23|||
125511722|NCT01379521|451503807|FG001|Overall Study -Treatment Period|Disease Progression|22|||
125511723|NCT01379521|451503806|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
125511724|NCT01379521|451503807|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
125511725|NCT01379521|451503806|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
125511726|NCT01379521|451503807|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
125511727|NCT01379521|451503806|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
125511728|NCT01379521|451503807|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
125511729|NCT01379521|451503806|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
125511730|NCT01379521|451503807|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
125511731|NCT01379521|451503806|FG000|Overall Study -Treatment Period|Death|2|||
125511732|NCT01379521|451503807|FG001|Overall Study -Treatment Period|Death|1|||
125511733|NCT01379521|451503806|FG000|Post-Treatment Evaluations|Disease Progression|22|||
125511734|NCT01379521|451503807|FG001|Post-Treatment Evaluations|Disease Progression|20|||
125511735|NCT01379521|451503806|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
125306207|NCT04230213|450746805|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
125306208|NCT04230213|450746803|FG000|TP3: Week 16 to Week 22|Other|0|||
125306209|NCT04230213|450746804|FG001|TP3: Week 16 to Week 22|Other|1|||
125306210|NCT04230213|450746805|FG002|TP3: Week 16 to Week 22|Other|3|||
125306211|NCT04230213|450746803|FG000|TP4: Week 22 to Week 32|Other|0|||
125306212|NCT04230213|450746804|FG001|TP4: Week 22 to Week 32|Other|5|||
125306213|NCT04230213|450746805|FG002|TP4: Week 22 to Week 32|Other|5|||
125306214|NCT04230213|450746803|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
125306215|NCT04230213|450746804|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
125306216|NCT04230213|450746805|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
125306217|NCT04230213|450746803|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
125306218|NCT04230213|450746804|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
125306219|NCT04230213|450746805|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
125306220|NCT04230213|450746803|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
125306221|NCT04230213|450746804|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
125306222|NCT04230213|450746805|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
125306223|NCT04230213|450746803|FG000|Follow up: Week 32 to Week 36|Other|0|||
125306224|NCT04230213|450746804|FG001|Follow up: Week 32 to Week 36|Other|1|||
125306225|NCT04230213|450746805|FG002|Follow up: Week 32 to Week 36|Other|1|||
125306226|NCT02508428|450746808|FG000|Overall Study|Death|32|||
125306227|NCT02508428|450746809|FG001|Overall Study|Death|33|||
125306228|NCT02508428|450746808|FG000|Overall Study|Liner revised|3|||
125306229|NCT02508428|450746809|FG001|Overall Study|Liner revised|19|||
125306230|NCT02508428|450746808|FG000|Overall Study|Incomplete follow-up|17|||
125306231|NCT02508428|450746809|FG001|Overall Study|Incomplete follow-up|15|||
125306232|NCT00534976|450746817|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
125306233|NCT00534976|450746818|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
125306234|NCT00534976|450746817|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
125306235|NCT00534976|450746818|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
125306236|NCT00534976|450746817|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
125306237|NCT00534976|450746818|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
125306238|NCT00861471|450746819|FG000|Overall Study|Withdrawal by Subject|1|||
125306239|NCT00861471|450746819|FG000|Overall Study|Adverse Event|2|||
125306240|NCT00861471|450746819|FG000|Overall Study|Lack of Efficacy|3|||
125306241|NCT00861471|450746819|FG000|Overall Study|treatment for lumbar laminectomy|1|||
125306242|NCT00861471|450746819|FG000|Overall Study|Physician Decision|2|||
125306243|NCT02834247|450746820|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
125306244|NCT02834247|450746821|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
125306245|NCT02834247|450746822|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
125306246|NCT02834247|450746823|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
125306247|NCT02834247|450746820|FG000|Dose Escalation Phase|Death|5|||
125306248|NCT02834247|450746821|FG001|Dose Escalation Phase|Death|6|||
125306249|NCT02834247|450746822|FG002|Dose Escalation Phase|Death|5|||
125306250|NCT02834247|450746823|FG003|Dose Escalation Phase|Death|0|||
125306251|NCT02834247|450746820|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
125306252|NCT02834247|450746821|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
125306253|NCT02834247|450746822|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
125306254|NCT02834247|450746823|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
125306255|NCT02834247|450746820|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
125306256|NCT02834247|450746821|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
125511736|NCT01379521|451503807|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
125511737|NCT01379521|451503806|FG000|Post-Treatment Evaluations|Death|1|||
125511738|NCT01379521|451503807|FG001|Post-Treatment Evaluations|Death|0|||
125511739|NCT00938041|451503808|FG000|Overall Study|Lost to Follow-up|6|||
125511740|NCT00938041|451503808|FG000|Overall Study|Received Alternative Therapy|1|||
125511741|NCT00938041|451503808|FG000|Overall Study|Progressive Disease|5|||
125511742|NCT00938041|451503808|FG000|Overall Study|Death|12|||
125511743|NCT00938041|451503808|FG000|Overall Study|Adrenal Insufficiency|3|||
125511744|NCT01026103|451503809|FG000|Overall Study|Physician Decision|1|||
125511745|NCT01026103|451503809|FG000|Overall Study|did not receive study device bc of error|1|||
125511746|NCT00105521|451503810|FG000|Overall Study|Other|1|||
125511747|NCT00105521|451503811|FG001|Overall Study|Other|1|||
125511748|NCT00105521|451503812|FG002|Overall Study|Other|2|||
125511749|NCT00105521|451503813|FG003|Overall Study|Other|0|||
125511750|NCT00105521|451503810|FG000|Overall Study|Adverse Event|10|||
125511751|NCT00105521|451503811|FG001|Overall Study|Adverse Event|4|||
125511752|NCT00105521|451503812|FG002|Overall Study|Adverse Event|10|||
125511753|NCT00105521|451503813|FG003|Overall Study|Adverse Event|8|||
125511754|NCT00105521|451503810|FG000|Overall Study|Withdrawal by Subject|1|||
125511755|NCT00105521|451503811|FG001|Overall Study|Withdrawal by Subject|0|||
125306257|NCT02834247|450746822|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
125306258|NCT02834247|450746823|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
125306259|NCT02834247|450746820|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
125306260|NCT02834247|450746821|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
125306261|NCT02834247|450746822|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
125306262|NCT02834247|450746823|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
125306263|NCT02834247|450746820|FG000|Dose Expansion Phase|Death|0|||
125306264|NCT02834247|450746821|FG001|Dose Expansion Phase|Death|0|||
125306265|NCT02834247|450746822|FG002|Dose Expansion Phase|Death|0|||
125306266|NCT02834247|450746823|FG003|Dose Expansion Phase|Death|8|||
125306267|NCT02834247|450746820|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
125306268|NCT02834247|450746821|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
125306269|NCT02834247|450746822|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
125306270|NCT02834247|450746823|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
125306271|NCT02834247|450746820|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
125306272|NCT02834247|450746821|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
125306273|NCT02834247|450746822|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
125306274|NCT02834247|450746823|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
125306275|NCT05111249|450748982|FG000|Overall Study|Lost to Follow-up|0|||
125306276|NCT05111249|450748983|FG001|Overall Study|Lost to Follow-up|2|||
125306277|NCT05111249|450748982|FG000|Overall Study|Physician Decision|0|||
125306278|NCT05111249|450748983|FG001|Overall Study|Physician Decision|1|||
125306279|NCT05111249|450748982|FG000|Overall Study|Participant decision|1|||
125306280|NCT05111249|450748983|FG001|Overall Study|Participant decision|5|||
125306281|NCT05128578|450748984|FG000|Overall Study|Withdrawal by Subject|9|||
125306282|NCT05128578|450748984|FG000|Overall Study|Lost to Follow-up|5|||
125306283|NCT01016600|450748987|FG000|Overall Study|Did not start treatment|1|||
125306284|NCT01016600|450748988|FG001|Overall Study|Did not start treatment|0|||
125306285|NCT01016600|450748989|FG002|Overall Study|Did not start treatment|0|||
125306286|NCT01016600|450748990|FG003|Overall Study|Did not start treatment|0|||
125306287|NCT02679755|450748991|FG000|Overall Study|Death|0|||
125306288|NCT02679755|450748992|FG001|Overall Study|Death|3|||
125306289|NCT02679755|450748991|FG000|Overall Study|Global deterioration of health status|1|||
125306290|NCT02679755|450748992|FG001|Overall Study|Global deterioration of health status|8|||
125306291|NCT02679755|450748991|FG000|Overall Study|Lost to Follow-up|1|||
125306292|NCT02679755|450748992|FG001|Overall Study|Lost to Follow-up|0|||
125306293|NCT02679755|450748991|FG000|Overall Study|Objective progression or relapse|24|||
125306294|NCT02679755|450748992|FG001|Overall Study|Objective progression or relapse|83|||
125306295|NCT02679755|450748991|FG000|Overall Study|Not defined|0|||
125306296|NCT02679755|450748992|FG001|Overall Study|Not defined|2|||
125306297|NCT02679755|450748991|FG000|Overall Study|Withdrawal by participant|6|||
125306298|NCT02679755|450748992|FG001|Overall Study|Withdrawal by participant|3|||
125306299|NCT02679755|450748991|FG000|Overall Study|Adverse Event|1|||
125306300|NCT02679755|450748992|FG001|Overall Study|Adverse Event|4|||
125306301|NCT02679755|450748991|FG000|Overall Study|Adverse events not related to study drug|1|||
125306302|NCT02679755|450748992|FG001|Overall Study|Adverse events not related to study drug|2|||
125306303|NCT02451917|450748995|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
125306304|NCT02451917|450748996|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
125306305|NCT02451917|450748995|FG000|First Intervention (24 Weeks)|Death|0|||
125306306|NCT02451917|450748996|FG001|First Intervention (24 Weeks)|Death|1|||
125306307|NCT02451917|450748995|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
125306308|NCT02451917|450748996|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
125306309|NCT02300259|450748999|FG000|Period 1|Adverse Event|0|||
125306310|NCT02300259|450749000|FG001|Period 1|Adverse Event|0|||
125306311|NCT02300259|450749001|FG002|Period 1|Adverse Event|1|||
125306312|NCT02300259|450748999|FG000|Period 1|Withdrawal by Subject|0|||
125511756|NCT00105521|451503812|FG002|Overall Study|Withdrawal by Subject|1|||
125511757|NCT00105521|451503813|FG003|Overall Study|Withdrawal by Subject|4|||
125511758|NCT00105521|451503810|FG000|Overall Study|Lack of Efficacy|0|||
125511759|NCT00105521|451503811|FG001|Overall Study|Lack of Efficacy|0|||
125511760|NCT00105521|451503812|FG002|Overall Study|Lack of Efficacy|0|||
125511761|NCT00105521|451503813|FG003|Overall Study|Lack of Efficacy|1|||
125511762|NCT00105521|451503810|FG000|Overall Study|Protocol Violation|3|||
125511763|NCT00105521|451503811|FG001|Overall Study|Protocol Violation|5|||
125306313|NCT02300259|450749000|FG001|Period 1|Withdrawal by Subject|0|||
125511764|NCT00105521|451503812|FG002|Overall Study|Protocol Violation|4|||
125511765|NCT00105521|451503813|FG003|Overall Study|Protocol Violation|4|||
125511766|NCT00105521|451503810|FG000|Overall Study|Lost to Follow-up|0|||
125511767|NCT00105521|451503811|FG001|Overall Study|Lost to Follow-up|1|||
125306314|NCT02300259|450749001|FG002|Period 1|Withdrawal by Subject|1|||
125306315|NCT02300259|450748999|FG000|Period 2|Adverse Event|1|||
125306316|NCT02300259|450749000|FG001|Period 2|Adverse Event|0|||
125306317|NCT02300259|450749001|FG002|Period 2|Adverse Event|0|||
125306318|NCT02300259|450748999|FG000|Period 2|Withdrawal by Subject|0|||
125306319|NCT02300259|450749000|FG001|Period 2|Withdrawal by Subject|0|||
125306320|NCT02300259|450749001|FG002|Period 2|Withdrawal by Subject|1|||
125306321|NCT04737278|450749002|FG000|Overall Study|Lost to Follow-up|1|||
125306322|NCT04737278|450749003|FG001|Overall Study|Lost to Follow-up|1|||
125306323|NCT04737278|450749002|FG000|Overall Study|Withdrawal by Subject|1|||
125306324|NCT04737278|450749003|FG001|Overall Study|Withdrawal by Subject|0|||
125306325|NCT04737278|450749002|FG000|Overall Study|Protocol Violation|1|||
125306326|NCT04737278|450749003|FG001|Overall Study|Protocol Violation|1|||
125306327|NCT04737278|450749002|FG000|Overall Study|failure to complete questionnaire|1|||
125306328|NCT04737278|450749003|FG001|Overall Study|failure to complete questionnaire|1|||
125306329|NCT02737475|450749004|FG000|Overall Study|Other reasons|0|||
125306330|NCT02737475|450749005|FG001|Overall Study|Other reasons|0|||
125306331|NCT02737475|450749006|FG002|Overall Study|Other reasons|0|||
125306332|NCT02737475|450749007|FG003|Overall Study|Other reasons|0|||
125306333|NCT02737475|450749008|FG004|Overall Study|Other reasons|1|||
125306334|NCT02737475|450749009|FG005|Overall Study|Other reasons|1|||
125306335|NCT02737475|450749010|FG006|Overall Study|Other reasons|0|||
125306336|NCT02737475|450749011|FG007|Overall Study|Other reasons|0|||
125306337|NCT02737475|450749012|FG008|Overall Study|Other reasons|1|||
125306338|NCT02737475|450749013|FG009|Overall Study|Other reasons|0|||
125306339|NCT02737475|450749014|FG010|Overall Study|Other reasons|1|||
125306340|NCT02737475|450749015|FG011|Overall Study|Other reasons|0|||
125306341|NCT02737475|450749016|FG012|Overall Study|Other reasons|0|||
125306342|NCT02737475|450749017|FG013|Overall Study|Other reasons|0|||
125306343|NCT02737475|450749018|FG014|Overall Study|Other reasons|0|||
125306344|NCT02737475|450749019|FG015|Overall Study|Other reasons|0|||
125306345|NCT02737475|450749020|FG016|Overall Study|Other reasons|0|||
125306346|NCT02737475|450749021|FG017|Overall Study|Other reasons|0|||
125306347|NCT02737475|450749022|FG018|Overall Study|Other reasons|0|||
125306348|NCT02737475|450749023|FG019|Overall Study|Other reasons|0|||
125306349|NCT02737475|450749024|FG020|Overall Study|Other reasons|0|||
125306350|NCT02737475|450749025|FG021|Overall Study|Other reasons|1|||
125306351|NCT02737475|450749026|FG022|Overall Study|Other reasons|0|||
125306352|NCT02737475|450749027|FG023|Overall Study|Other reasons|1|||
125306353|NCT02737475|450749028|FG024|Overall Study|Other reasons|1|||
125306354|NCT02737475|450749029|FG025|Overall Study|Other reasons|1|||
125306355|NCT02737475|450749030|FG026|Overall Study|Other reasons|0|||
125306356|NCT02737475|450749004|FG000|Overall Study|Death|1|||
125306357|NCT02737475|450749005|FG001|Overall Study|Death|0|||
125306358|NCT02737475|450749006|FG002|Overall Study|Death|0|||
125306359|NCT02737475|450749007|FG003|Overall Study|Death|1|||
125306360|NCT02737475|450749008|FG004|Overall Study|Death|0|||
125306361|NCT02737475|450749009|FG005|Overall Study|Death|0|||
125306362|NCT02737475|450749010|FG006|Overall Study|Death|0|||
125306363|NCT02737475|450749011|FG007|Overall Study|Death|2|||
125306364|NCT02737475|450749012|FG008|Overall Study|Death|0|||
125306365|NCT02737475|450749013|FG009|Overall Study|Death|0|||
125306366|NCT02737475|450749014|FG010|Overall Study|Death|0|||
125306367|NCT02737475|450749015|FG011|Overall Study|Death|4|||
125306368|NCT02737475|450749016|FG012|Overall Study|Death|2|||
125306369|NCT02737475|450749017|FG013|Overall Study|Death|2|||
125306370|NCT02737475|450749018|FG014|Overall Study|Death|0|||
125306371|NCT02737475|450749019|FG015|Overall Study|Death|2|||
125306372|NCT02737475|450749020|FG016|Overall Study|Death|2|||
125306373|NCT02737475|450749021|FG017|Overall Study|Death|2|||
125306374|NCT02737475|450749022|FG018|Overall Study|Death|1|||
125306375|NCT02737475|450749023|FG019|Overall Study|Death|0|||
125511768|NCT00105521|451503812|FG002|Overall Study|Lost to Follow-up|0|||
125511769|NCT00105521|451503813|FG003|Overall Study|Lost to Follow-up|0|||
125511770|NCT02475733|451503814|FG000|Overall Study|Withdrawal by Subject|1|||
125511771|NCT02475733|451503815|FG001|Overall Study|Withdrawal by Subject|0|||
125511772|NCT02475733|451503814|FG000|Overall Study|Physician Decision|1|||
125511773|NCT02475733|451503815|FG001|Overall Study|Physician Decision|0|||
125511774|NCT00404547|451503816|FG000|Overall Study|Adverse Event|39|||
125511775|NCT00404547|451503817|FG001|Overall Study|Adverse Event|6|||
125511776|NCT00404547|451503816|FG000|Overall Study|Withdrawal by Subject|19|||
125511777|NCT00404547|451503817|FG001|Overall Study|Withdrawal by Subject|2|||
125306376|NCT02737475|450749024|FG020|Overall Study|Death|0|||
125306377|NCT02737475|450749025|FG021|Overall Study|Death|0|||
125511778|NCT00404547|451503816|FG000|Overall Study|Protocol Violation|0|||
125511779|NCT00404547|451503817|FG001|Overall Study|Protocol Violation|1|||
125511780|NCT00404547|451503816|FG000|Overall Study|Lost to Follow-up|20|||
125511781|NCT00404547|451503817|FG001|Overall Study|Lost to Follow-up|9|||
125511782|NCT00404547|451503816|FG000|Overall Study|Lack of compliance|5|||
125511783|NCT00404547|451503817|FG001|Overall Study|Lack of compliance|1|||
125511784|NCT00404547|451503816|FG000|Overall Study|Other|4|||
125511785|NCT00404547|451503817|FG001|Overall Study|Other|0|||
125511786|NCT00404547|451503816|FG000|Overall Study|Reason not stated|3|||
125511787|NCT00404547|451503817|FG001|Overall Study|Reason not stated|6|||
125511788|NCT02131155|451503820|FG000|Overall Study|Adverse Event|1|||
125511789|NCT02131155|451503821|FG001|Overall Study|Adverse Event|0|||
125511790|NCT02131155|451503820|FG000|Overall Study|Treatment completed|1|||
125511791|NCT02131155|451503821|FG001|Overall Study|Treatment completed|0|||
125511792|NCT02131155|451503820|FG000|Overall Study|Primary tumour recurrence|2|||
125511793|NCT02131155|451503821|FG001|Overall Study|Primary tumour recurrence|1|||
125511794|NCT02131155|451503820|FG000|Overall Study|Refused to continue study medication|1|||
125511795|NCT02131155|451503821|FG001|Overall Study|Refused to continue study medication|0|||
125511796|NCT02131155|451503820|FG000|Overall Study|Study early termination|20|||
125511797|NCT02131155|451503821|FG001|Overall Study|Study early termination|10|||
125511798|NCT01887418|451503822|FG000|Overall Study|Travelling difficulties|0|||
125511799|NCT01887418|451503823|FG001|Overall Study|Travelling difficulties|0|||
125511800|NCT01887418|451503824|FG002|Overall Study|Travelling difficulties|1|||
125511801|NCT03132753|451503825|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
125511802|NCT03132753|451503826|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
125511803|NCT03132753|451503825|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
125511804|NCT03132753|451503826|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
125511805|NCT02350127|451503830|FG000|4-Month Assessment|Withdrawal by Subject|10|||
125511806|NCT02350127|451503831|FG001|4-Month Assessment|Withdrawal by Subject|9|||
125511807|NCT02350127|451503830|FG000|4-Month Assessment|Death|1|||
125511808|NCT02350127|451503831|FG001|4-Month Assessment|Death|0|||
125511809|NCT02350127|451503830|FG000|8-Month Assessment|Death|1|||
125511810|NCT02350127|451503831|FG001|8-Month Assessment|Death|1|||
125511811|NCT02350127|451503830|FG000|8-Month Assessment|Withdrawal by Subject|5|||
125511812|NCT02350127|451503831|FG001|8-Month Assessment|Withdrawal by Subject|8|||
125511813|NCT03906240|451503832|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
125511814|NCT03906240|451503833|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
125511815|NCT03906240|451503832|FG000|Overall Study|Lost to Follow-up|1|||
125511816|NCT03906240|451503833|FG001|Overall Study|Lost to Follow-up|0|||
125511817|NCT03906240|451503832|FG000|Overall Study|Withdrawal by Subject|0|||
125511818|NCT03906240|451503833|FG001|Overall Study|Withdrawal by Subject|1|||
125511819|NCT01446042|451503834|FG000|Overall Study|Withdrawal by Subject|12|||
125511820|NCT01446042|451503835|FG001|Overall Study|Withdrawal by Subject|2|||
125511821|NCT01446042|451503836|FG002|Overall Study|Withdrawal by Subject|4|||
125511822|NCT01446042|451503834|FG000|Overall Study|Adverse Event|1|||
125511823|NCT01446042|451503835|FG001|Overall Study|Adverse Event|0|||
125511824|NCT01446042|451503836|FG002|Overall Study|Adverse Event|4|||
125511825|NCT01446042|451503834|FG000|Overall Study|Lost to Follow-up|5|||
125511826|NCT01446042|451503835|FG001|Overall Study|Lost to Follow-up|0|||
125511827|NCT01446042|451503836|FG002|Overall Study|Lost to Follow-up|0|||
125511828|NCT01446042|451503834|FG000|Overall Study|Other reasons|2|||
125511829|NCT01446042|451503835|FG001|Overall Study|Other reasons|1|||
125511830|NCT01446042|451503836|FG002|Overall Study|Other reasons|1|||
125511831|NCT03751280|451503846|FG000|Overall Study|Adverse Event|0|||
125511832|NCT03751280|451503847|FG001|Overall Study|Adverse Event|1|||
125511833|NCT03751280|451503846|FG000|Overall Study|Lost to Follow-up|3|||
125511834|NCT03751280|451503847|FG001|Overall Study|Lost to Follow-up|5|||
125306378|NCT02737475|450749026|FG022|Overall Study|Death|0|||
125511835|NCT03751280|451503846|FG000|Overall Study|Physician Decision|0|||
125511836|NCT03751280|451503847|FG001|Overall Study|Physician Decision|2|||
125511837|NCT03751280|451503846|FG000|Overall Study|Protocol Violation|0|||
125511838|NCT03751280|451503847|FG001|Overall Study|Protocol Violation|2|||
125511839|NCT03751280|451503846|FG000|Overall Study|Withdrawal by Subject|5|||
125511840|NCT03751280|451503847|FG001|Overall Study|Withdrawal by Subject|2|||
125511841|NCT00296504|451503848|FG000|Interim Analysis|Withdrawal by Subject|8|||
125511842|NCT00296504|451503849|FG001|Interim Analysis|Withdrawal by Subject|0|||
125511843|NCT00296504|451503850|FG002|Interim Analysis|Withdrawal by Subject|12|||
125511844|NCT00296504|451503851|FG003|Interim Analysis|Withdrawal by Subject|0|||
125511845|NCT00296504|451503852|FG004|Interim Analysis|Withdrawal by Subject|5|||
125511846|NCT00296504|451503853|FG005|Interim Analysis|Withdrawal by Subject|5|||
125511847|NCT00296504|451503854|FG006|Interim Analysis|Withdrawal by Subject|9|||
125511848|NCT00296504|451503855|FG007|Interim Analysis|Withdrawal by Subject|3|||
125511849|NCT00296504|451503856|FG008|Interim Analysis|Withdrawal by Subject|0|||
125511850|NCT00296504|451503848|FG000|Interim Analysis|Lost to Follow-up|13|||
125511851|NCT00296504|451503849|FG001|Interim Analysis|Lost to Follow-up|3|||
125511852|NCT00296504|451503850|FG002|Interim Analysis|Lost to Follow-up|26|||
125511853|NCT00296504|451503851|FG003|Interim Analysis|Lost to Follow-up|8|||
125511854|NCT00296504|451503852|FG004|Interim Analysis|Lost to Follow-up|14|||
125511855|NCT00296504|451503853|FG005|Interim Analysis|Lost to Follow-up|4|||
125511856|NCT00296504|451503854|FG006|Interim Analysis|Lost to Follow-up|11|||
125511857|NCT00296504|451503855|FG007|Interim Analysis|Lost to Follow-up|4|||
125511858|NCT00296504|451503856|FG008|Interim Analysis|Lost to Follow-up|0|||
125511859|NCT00296504|451503848|FG000|Interim Analysis|Clinical Progression|1|||
125511860|NCT00296504|451503849|FG001|Interim Analysis|Clinical Progression|0|||
125511861|NCT00296504|451503850|FG002|Interim Analysis|Clinical Progression|1|||
125511862|NCT00296504|451503851|FG003|Interim Analysis|Clinical Progression|1|||
125511863|NCT00296504|451503852|FG004|Interim Analysis|Clinical Progression|0|||
125511864|NCT00296504|451503853|FG005|Interim Analysis|Clinical Progression|2|||
125511865|NCT00296504|451503854|FG006|Interim Analysis|Clinical Progression|1|||
125511866|NCT00296504|451503855|FG007|Interim Analysis|Clinical Progression|2|||
125511867|NCT00296504|451503856|FG008|Interim Analysis|Clinical Progression|0|||
125511868|NCT00296504|451503848|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
125511869|NCT00296504|451503849|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
125511870|NCT00296504|451503850|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
125511871|NCT00296504|451503851|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
125511872|NCT00296504|451503852|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
125511873|NCT00296504|451503853|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
125511874|NCT00296504|451503854|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
125511875|NCT00296504|451503855|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
125511876|NCT00296504|451503856|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
125511877|NCT00296504|451503848|FG000|Interim Analysis|Adverse Event|0|||
125511878|NCT00296504|451503849|FG001|Interim Analysis|Adverse Event|0|||
125511879|NCT00296504|451503850|FG002|Interim Analysis|Adverse Event|13|||
125511880|NCT00296504|451503851|FG003|Interim Analysis|Adverse Event|4|||
125511881|NCT00296504|451503852|FG004|Interim Analysis|Adverse Event|6|||
125511882|NCT00296504|451503853|FG005|Interim Analysis|Adverse Event|3|||
125511883|NCT00296504|451503854|FG006|Interim Analysis|Adverse Event|4|||
125511884|NCT00296504|451503855|FG007|Interim Analysis|Adverse Event|5|||
125511885|NCT00296504|451503856|FG008|Interim Analysis|Adverse Event|0|||
125511886|NCT00296504|451503848|FG000|Interim Analysis|Protocol Violation|0|||
125511887|NCT00296504|451503849|FG001|Interim Analysis|Protocol Violation|0|||
125511888|NCT00296504|451503850|FG002|Interim Analysis|Protocol Violation|2|||
125511889|NCT00296504|451503851|FG003|Interim Analysis|Protocol Violation|0|||
125511890|NCT00296504|451503852|FG004|Interim Analysis|Protocol Violation|1|||
125511891|NCT00296504|451503853|FG005|Interim Analysis|Protocol Violation|0|||
125511892|NCT00296504|451503854|FG006|Interim Analysis|Protocol Violation|0|||
125511893|NCT00296504|451503855|FG007|Interim Analysis|Protocol Violation|1|||
125511894|NCT00296504|451503856|FG008|Interim Analysis|Protocol Violation|0|||
125511895|NCT00296504|451503848|FG000|Interim Analysis|Insufficient CD4 Response|0|||
125511896|NCT00296504|451503849|FG001|Interim Analysis|Insufficient CD4 Response|0|||
125511897|NCT00296504|451503850|FG002|Interim Analysis|Insufficient CD4 Response|0|||
125511898|NCT00296504|451503851|FG003|Interim Analysis|Insufficient CD4 Response|0|||
125511899|NCT00296504|451503852|FG004|Interim Analysis|Insufficient CD4 Response|1|||
125511900|NCT00296504|451503853|FG005|Interim Analysis|Insufficient CD4 Response|1|||
125511901|NCT00296504|451503854|FG006|Interim Analysis|Insufficient CD4 Response|0|||
125511902|NCT00296504|451503855|FG007|Interim Analysis|Insufficient CD4 Response|0|||
125511903|NCT00296504|451503856|FG008|Interim Analysis|Insufficient CD4 Response|0|||
125511904|NCT00296504|451503848|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
125511905|NCT00296504|451503849|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
125511906|NCT00296504|451503850|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
125511907|NCT00296504|451503851|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
125511908|NCT00296504|451503852|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
125511909|NCT00296504|451503853|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
125511910|NCT00296504|451503854|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
125511911|NCT00296504|451503855|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
125511912|NCT00296504|451503856|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
125511913|NCT00296504|451503848|FG000|Interim Analysis|Pregnancy|4|||
125511914|NCT00296504|451503849|FG001|Interim Analysis|Pregnancy|1|||
125511915|NCT00296504|451503850|FG002|Interim Analysis|Pregnancy|4|||
125511916|NCT00296504|451503851|FG003|Interim Analysis|Pregnancy|2|||
125511917|NCT00296504|451503852|FG004|Interim Analysis|Pregnancy|0|||
125511918|NCT00296504|451503853|FG005|Interim Analysis|Pregnancy|1|||
125511919|NCT00296504|451503854|FG006|Interim Analysis|Pregnancy|1|||
125511920|NCT00296504|451503855|FG007|Interim Analysis|Pregnancy|1|||
125511921|NCT00296504|451503856|FG008|Interim Analysis|Pregnancy|0|||
125511922|NCT00296504|451503848|FG000|Interim Analysis|Death|1|||
125511923|NCT00296504|451503849|FG001|Interim Analysis|Death|0|||
125511924|NCT00296504|451503850|FG002|Interim Analysis|Death|3|||
125511925|NCT00296504|451503851|FG003|Interim Analysis|Death|0|||
125511926|NCT00296504|451503852|FG004|Interim Analysis|Death|0|||
125511927|NCT00296504|451503853|FG005|Interim Analysis|Death|0|||
125511928|NCT00296504|451503854|FG006|Interim Analysis|Death|0|||
125511929|NCT00296504|451503855|FG007|Interim Analysis|Death|0|||
125511930|NCT00296504|451503856|FG008|Interim Analysis|Death|0|||
125511931|NCT00296504|451503848|FG000|Interim Analysis|Participant Non-compliant|0|||
125511932|NCT00296504|451503849|FG001|Interim Analysis|Participant Non-compliant|1|||
125511933|NCT00296504|451503850|FG002|Interim Analysis|Participant Non-compliant|2|||
125511934|NCT00296504|451503851|FG003|Interim Analysis|Participant Non-compliant|1|||
125511935|NCT00296504|451503852|FG004|Interim Analysis|Participant Non-compliant|1|||
125511936|NCT00296504|451503853|FG005|Interim Analysis|Participant Non-compliant|3|||
125511937|NCT00296504|451503854|FG006|Interim Analysis|Participant Non-compliant|6|||
125511938|NCT00296504|451503855|FG007|Interim Analysis|Participant Non-compliant|2|||
125511939|NCT00296504|451503856|FG008|Interim Analysis|Participant Non-compliant|0|||
125511940|NCT00296504|451503848|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
125511941|NCT00296504|451503849|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
125511942|NCT00296504|451503850|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
125511943|NCT00296504|451503851|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
125511944|NCT00296504|451503852|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
125511945|NCT00296504|451503853|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
125511946|NCT00296504|451503854|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
125511947|NCT00296504|451503855|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
125511948|NCT00296504|451503856|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
125511949|NCT00296504|451503848|FG000|Interim Analysis|To Simplify Treatment|0|||
125511950|NCT00296504|451503849|FG001|Interim Analysis|To Simplify Treatment|0|||
125511951|NCT00296504|451503850|FG002|Interim Analysis|To Simplify Treatment|1|||
125511952|NCT00296504|451503851|FG003|Interim Analysis|To Simplify Treatment|0|||
125511953|NCT00296504|451503852|FG004|Interim Analysis|To Simplify Treatment|0|||
125511954|NCT00296504|451503853|FG005|Interim Analysis|To Simplify Treatment|0|||
125511955|NCT00296504|451503854|FG006|Interim Analysis|To Simplify Treatment|2|||
125511956|NCT00296504|451503855|FG007|Interim Analysis|To Simplify Treatment|0|||
125511957|NCT00296504|451503856|FG008|Interim Analysis|To Simplify Treatment|0|||
125511958|NCT00296504|451503848|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
125511959|NCT00296504|451503849|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
125511960|NCT00296504|451503850|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
125511961|NCT00296504|451503851|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
125511962|NCT00296504|451503852|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
125511963|NCT00296504|451503853|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
125511964|NCT00296504|451503854|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
125511965|NCT00296504|451503855|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
125511966|NCT00296504|451503856|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
125511967|NCT00296504|451503848|FG000|Interim Analysis|Participant Moved|1|||
125511968|NCT00296504|451503849|FG001|Interim Analysis|Participant Moved|0|||
125511969|NCT00296504|451503850|FG002|Interim Analysis|Participant Moved|1|||
125511970|NCT00296504|451503851|FG003|Interim Analysis|Participant Moved|0|||
125511971|NCT00296504|451503852|FG004|Interim Analysis|Participant Moved|0|||
125511972|NCT00296504|451503853|FG005|Interim Analysis|Participant Moved|1|||
125511973|NCT00296504|451503854|FG006|Interim Analysis|Participant Moved|1|||
125511974|NCT00296504|451503855|FG007|Interim Analysis|Participant Moved|0|||
125511975|NCT00296504|451503856|FG008|Interim Analysis|Participant Moved|0|||
125511976|NCT00296504|451503848|FG000|Interim Analysis|Participant Was Incarcerated|2|||
125511977|NCT00296504|451503849|FG001|Interim Analysis|Participant Was Incarcerated|0|||
125511978|NCT00296504|451503850|FG002|Interim Analysis|Participant Was Incarcerated|1|||
125511979|NCT00296504|451503851|FG003|Interim Analysis|Participant Was Incarcerated|0|||
125511980|NCT00296504|451503852|FG004|Interim Analysis|Participant Was Incarcerated|0|||
125511981|NCT00296504|451503853|FG005|Interim Analysis|Participant Was Incarcerated|0|||
125511982|NCT00296504|451503854|FG006|Interim Analysis|Participant Was Incarcerated|0|||
125511983|NCT00296504|451503855|FG007|Interim Analysis|Participant Was Incarcerated|0|||
125511984|NCT00296504|451503856|FG008|Interim Analysis|Participant Was Incarcerated|0|||
125511985|NCT00296504|451503848|FG000|Interim Analysis|Resistance to FPV|0|||
125306379|NCT02737475|450749027|FG023|Overall Study|Death|0|||
125511986|NCT00296504|451503849|FG001|Interim Analysis|Resistance to FPV|0|||
125511987|NCT00296504|451503850|FG002|Interim Analysis|Resistance to FPV|1|||
125511988|NCT00296504|451503851|FG003|Interim Analysis|Resistance to FPV|0|||
125306380|NCT02737475|450749028|FG024|Overall Study|Death|0|||
125306381|NCT02737475|450749029|FG025|Overall Study|Death|0|||
125306382|NCT02737475|450749030|FG026|Overall Study|Death|0|||
125306383|NCT02737475|450749004|FG000|Overall Study|Participant withdrew consent|0|||
125511989|NCT00296504|451503852|FG004|Interim Analysis|Resistance to FPV|0|||
125511990|NCT00296504|451503853|FG005|Interim Analysis|Resistance to FPV|0|||
125511991|NCT00296504|451503854|FG006|Interim Analysis|Resistance to FPV|0|||
125511992|NCT00296504|451503855|FG007|Interim Analysis|Resistance to FPV|0|||
125511993|NCT00296504|451503856|FG008|Interim Analysis|Resistance to FPV|0|||
125511994|NCT00296504|451503848|FG000|Interim Analysis|Physician Decision|0|||
125511995|NCT00296504|451503849|FG001|Interim Analysis|Physician Decision|0|||
125511996|NCT00296504|451503850|FG002|Interim Analysis|Physician Decision|1|||
125511997|NCT00296504|451503851|FG003|Interim Analysis|Physician Decision|0|||
125511998|NCT00296504|451503852|FG004|Interim Analysis|Physician Decision|0|||
125511999|NCT00296504|451503853|FG005|Interim Analysis|Physician Decision|0|||
125512000|NCT00296504|451503854|FG006|Interim Analysis|Physician Decision|0|||
125512001|NCT00296504|451503855|FG007|Interim Analysis|Physician Decision|0|||
125512002|NCT00296504|451503856|FG008|Interim Analysis|Physician Decision|0|||
125512003|NCT00296504|451503848|FG000|Interim Analysis|Principle Investigator Discretion|2|||
125512004|NCT00296504|451503849|FG001|Interim Analysis|Principle Investigator Discretion|0|||
125512005|NCT00296504|451503850|FG002|Interim Analysis|Principle Investigator Discretion|1|||
125512006|NCT00296504|451503851|FG003|Interim Analysis|Principle Investigator Discretion|1|||
125512007|NCT00296504|451503852|FG004|Interim Analysis|Principle Investigator Discretion|0|||
125512008|NCT00296504|451503853|FG005|Interim Analysis|Principle Investigator Discretion|0|||
125512009|NCT00296504|451503854|FG006|Interim Analysis|Principle Investigator Discretion|0|||
125512010|NCT00296504|451503855|FG007|Interim Analysis|Principle Investigator Discretion|0|||
125512011|NCT00296504|451503856|FG008|Interim Analysis|Principle Investigator Discretion|0|||
125512012|NCT00296504|451503848|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
125512013|NCT00296504|451503849|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
125512014|NCT00296504|451503850|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
125512015|NCT00296504|451503851|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
125512016|NCT00296504|451503852|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
125512017|NCT00296504|451503853|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
125512018|NCT00296504|451503854|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
125512019|NCT00296504|451503855|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
125512020|NCT00296504|451503856|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
125512021|NCT00296504|451503848|FG000|Interim Analysis|Non-adherence|2|||
125512022|NCT00296504|451503849|FG001|Interim Analysis|Non-adherence|0|||
125512023|NCT00296504|451503850|FG002|Interim Analysis|Non-adherence|0|||
125512024|NCT00296504|451503851|FG003|Interim Analysis|Non-adherence|0|||
125512025|NCT00296504|451503852|FG004|Interim Analysis|Non-adherence|1|||
125512026|NCT00296504|451503853|FG005|Interim Analysis|Non-adherence|0|||
125512027|NCT00296504|451503854|FG006|Interim Analysis|Non-adherence|0|||
125512028|NCT00296504|451503855|FG007|Interim Analysis|Non-adherence|1|||
125512029|NCT00296504|451503856|FG008|Interim Analysis|Non-adherence|0|||
125512030|NCT00296504|451503848|FG000|Interim Analysis|Site Closing|1|||
125512031|NCT00296504|451503849|FG001|Interim Analysis|Site Closing|0|||
125512032|NCT00296504|451503850|FG002|Interim Analysis|Site Closing|0|||
125512033|NCT00296504|451503851|FG003|Interim Analysis|Site Closing|0|||
125512034|NCT00296504|451503852|FG004|Interim Analysis|Site Closing|0|||
125512035|NCT00296504|451503853|FG005|Interim Analysis|Site Closing|1|||
125512036|NCT00296504|451503854|FG006|Interim Analysis|Site Closing|2|||
125512037|NCT00296504|451503855|FG007|Interim Analysis|Site Closing|0|||
125512038|NCT00296504|451503856|FG008|Interim Analysis|Site Closing|0|||
125512039|NCT00296504|451503848|FG000|Interim Analysis|Lack of Personnel at Site|1|||
125512040|NCT00296504|451503849|FG001|Interim Analysis|Lack of Personnel at Site|0|||
125512041|NCT00296504|451503850|FG002|Interim Analysis|Lack of Personnel at Site|0|||
125512042|NCT00296504|451503851|FG003|Interim Analysis|Lack of Personnel at Site|0|||
125512043|NCT00296504|451503852|FG004|Interim Analysis|Lack of Personnel at Site|0|||
125512044|NCT00296504|451503853|FG005|Interim Analysis|Lack of Personnel at Site|0|||
125512045|NCT00296504|451503854|FG006|Interim Analysis|Lack of Personnel at Site|0|||
125512046|NCT00296504|451503855|FG007|Interim Analysis|Lack of Personnel at Site|0|||
125512047|NCT00296504|451503856|FG008|Interim Analysis|Lack of Personnel at Site|0|||
125512048|NCT00296504|451503848|FG000|Interim Analysis|Missed Schedule Date|1|||
125512049|NCT00296504|451503849|FG001|Interim Analysis|Missed Schedule Date|0|||
125512050|NCT00296504|451503850|FG002|Interim Analysis|Missed Schedule Date|0|||
125512051|NCT00296504|451503851|FG003|Interim Analysis|Missed Schedule Date|0|||
125306384|NCT02737475|450749005|FG001|Overall Study|Participant withdrew consent|0|||
125512052|NCT00296504|451503852|FG004|Interim Analysis|Missed Schedule Date|0|||
125512053|NCT00296504|451503853|FG005|Interim Analysis|Missed Schedule Date|0|||
125512054|NCT00296504|451503854|FG006|Interim Analysis|Missed Schedule Date|0|||
125512055|NCT00296504|451503855|FG007|Interim Analysis|Missed Schedule Date|0|||
125306385|NCT02737475|450749006|FG002|Overall Study|Participant withdrew consent|0|||
125512056|NCT00296504|451503856|FG008|Interim Analysis|Missed Schedule Date|0|||
125512057|NCT00296504|451503848|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
125512058|NCT00296504|451503849|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
125512059|NCT00296504|451503850|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
125512060|NCT00296504|451503851|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
125512061|NCT00296504|451503852|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
125512062|NCT00296504|451503853|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
125512063|NCT00296504|451503854|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
125512064|NCT00296504|451503855|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
125512065|NCT00296504|451503856|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
125512066|NCT00296504|451503848|FG000|Interim Analysis|Participant Stopped|0|||
125512067|NCT00296504|451503849|FG001|Interim Analysis|Participant Stopped|0|||
125512068|NCT00296504|451503850|FG002|Interim Analysis|Participant Stopped|0|||
125512069|NCT00296504|451503851|FG003|Interim Analysis|Participant Stopped|0|||
125512070|NCT00296504|451503852|FG004|Interim Analysis|Participant Stopped|1|||
125512071|NCT00296504|451503853|FG005|Interim Analysis|Participant Stopped|0|||
125512072|NCT00296504|451503854|FG006|Interim Analysis|Participant Stopped|0|||
125512073|NCT00296504|451503855|FG007|Interim Analysis|Participant Stopped|0|||
125512074|NCT00296504|451503856|FG008|Interim Analysis|Participant Stopped|0|||
125512075|NCT00296504|451503848|FG000|Interim Analysis|Physician and Participant Decision|0|||
125512076|NCT00296504|451503849|FG001|Interim Analysis|Physician and Participant Decision|0|||
125512077|NCT00296504|451503850|FG002|Interim Analysis|Physician and Participant Decision|0|||
125512078|NCT00296504|451503851|FG003|Interim Analysis|Physician and Participant Decision|0|||
125512079|NCT00296504|451503852|FG004|Interim Analysis|Physician and Participant Decision|0|||
125512080|NCT00296504|451503853|FG005|Interim Analysis|Physician and Participant Decision|1|||
125512081|NCT00296504|451503854|FG006|Interim Analysis|Physician and Participant Decision|0|||
125512082|NCT00296504|451503855|FG007|Interim Analysis|Physician and Participant Decision|0|||
125512083|NCT00296504|451503856|FG008|Interim Analysis|Physician and Participant Decision|0|||
125512084|NCT00296504|451503848|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
125512085|NCT00296504|451503849|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
125512086|NCT00296504|451503850|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
125512087|NCT00296504|451503851|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
125512088|NCT00296504|451503852|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
125512089|NCT00296504|451503853|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
125512090|NCT00296504|451503854|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
125512091|NCT00296504|451503855|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
125512092|NCT00296504|451503856|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
125512093|NCT00296504|451503848|FG000|Interim Analysis|Study Ended|0|||
125512094|NCT00296504|451503849|FG001|Interim Analysis|Study Ended|0|||
125512095|NCT00296504|451503850|FG002|Interim Analysis|Study Ended|0|||
125512096|NCT00296504|451503851|FG003|Interim Analysis|Study Ended|0|||
125512097|NCT00296504|451503852|FG004|Interim Analysis|Study Ended|0|||
125512098|NCT00296504|451503853|FG005|Interim Analysis|Study Ended|0|||
125512099|NCT00296504|451503854|FG006|Interim Analysis|Study Ended|1|||
125512100|NCT00296504|451503855|FG007|Interim Analysis|Study Ended|0|||
125512101|NCT00296504|451503856|FG008|Interim Analysis|Study Ended|0|||
125512102|NCT00296504|451503848|FG000|Interim Analysis|Participant Needed Interferon|0|||
125512103|NCT00296504|451503849|FG001|Interim Analysis|Participant Needed Interferon|0|||
125512104|NCT00296504|451503850|FG002|Interim Analysis|Participant Needed Interferon|0|||
125512105|NCT00296504|451503851|FG003|Interim Analysis|Participant Needed Interferon|0|||
125512106|NCT00296504|451503852|FG004|Interim Analysis|Participant Needed Interferon|0|||
125512107|NCT00296504|451503853|FG005|Interim Analysis|Participant Needed Interferon|0|||
125512108|NCT00296504|451503854|FG006|Interim Analysis|Participant Needed Interferon|0|||
125512109|NCT00296504|451503855|FG007|Interim Analysis|Participant Needed Interferon|1|||
125512110|NCT00296504|451503856|FG008|Interim Analysis|Participant Needed Interferon|0|||
125512111|NCT00296504|451503848|FG000|Interim Analysis|Ongoing|32|||
125512112|NCT00296504|451503849|FG001|Interim Analysis|Ongoing|12|||
125512113|NCT00296504|451503850|FG002|Interim Analysis|Ongoing|16|||
125512114|NCT00296504|451503851|FG003|Interim Analysis|Ongoing|22|||
125512115|NCT00296504|451503852|FG004|Interim Analysis|Ongoing|0|||
125512116|NCT00296504|451503853|FG005|Interim Analysis|Ongoing|0|||
125512117|NCT00296504|451503854|FG006|Interim Analysis|Ongoing|30|||
125512118|NCT00296504|451503855|FG007|Interim Analysis|Ongoing|1|||
125512119|NCT00296504|451503856|FG008|Interim Analysis|Ongoing|0|||
125512120|NCT00296504|451503848|FG000|Final Analysis|Withdrawal by Subject|0|||
125306386|NCT02737475|450749007|FG003|Overall Study|Participant withdrew consent|0|||
125306387|NCT02737475|450749008|FG004|Overall Study|Participant withdrew consent|0|||
125512121|NCT00296504|451503849|FG001|Final Analysis|Withdrawal by Subject|0|||
125512122|NCT00296504|451503850|FG002|Final Analysis|Withdrawal by Subject|0|||
125512123|NCT00296504|451503851|FG003|Final Analysis|Withdrawal by Subject|0|||
125512124|NCT00296504|451503852|FG004|Final Analysis|Withdrawal by Subject|0|||
125512125|NCT00296504|451503853|FG005|Final Analysis|Withdrawal by Subject|0|||
125512126|NCT00296504|451503854|FG006|Final Analysis|Withdrawal by Subject|0|||
125512127|NCT00296504|451503855|FG007|Final Analysis|Withdrawal by Subject|0|||
125512128|NCT00296504|451503856|FG008|Final Analysis|Withdrawal by Subject|1|||
125512129|NCT00296504|451503848|FG000|Final Analysis|Lost to Follow-up|0|||
125512130|NCT00296504|451503849|FG001|Final Analysis|Lost to Follow-up|0|||
125512131|NCT00296504|451503850|FG002|Final Analysis|Lost to Follow-up|0|||
125306388|NCT02737475|450749009|FG005|Overall Study|Participant withdrew consent|2|||
125512132|NCT00296504|451503851|FG003|Final Analysis|Lost to Follow-up|0|||
125512133|NCT00296504|451503852|FG004|Final Analysis|Lost to Follow-up|0|||
125512134|NCT00296504|451503853|FG005|Final Analysis|Lost to Follow-up|0|||
125512135|NCT00296504|451503854|FG006|Final Analysis|Lost to Follow-up|0|||
125512136|NCT00296504|451503855|FG007|Final Analysis|Lost to Follow-up|0|||
125512137|NCT00296504|451503856|FG008|Final Analysis|Lost to Follow-up|5|||
125512138|NCT00296504|451503848|FG000|Final Analysis|Insufficient Viral Load Response|0|||
125512139|NCT00296504|451503849|FG001|Final Analysis|Insufficient Viral Load Response|0|||
125512140|NCT00296504|451503850|FG002|Final Analysis|Insufficient Viral Load Response|0|||
125512141|NCT00296504|451503851|FG003|Final Analysis|Insufficient Viral Load Response|0|||
125512142|NCT00296504|451503852|FG004|Final Analysis|Insufficient Viral Load Response|0|||
125512143|NCT00296504|451503853|FG005|Final Analysis|Insufficient Viral Load Response|0|||
125512144|NCT00296504|451503854|FG006|Final Analysis|Insufficient Viral Load Response|0|||
125512145|NCT00296504|451503855|FG007|Final Analysis|Insufficient Viral Load Response|0|||
125512146|NCT00296504|451503856|FG008|Final Analysis|Insufficient Viral Load Response|6|||
125512147|NCT00296504|451503848|FG000|Final Analysis|Adverse Event|0|||
125512148|NCT00296504|451503849|FG001|Final Analysis|Adverse Event|0|||
125512149|NCT00296504|451503850|FG002|Final Analysis|Adverse Event|0|||
125512150|NCT00296504|451503851|FG003|Final Analysis|Adverse Event|0|||
125512151|NCT00296504|451503852|FG004|Final Analysis|Adverse Event|0|||
125512152|NCT00296504|451503853|FG005|Final Analysis|Adverse Event|0|||
125512153|NCT00296504|451503854|FG006|Final Analysis|Adverse Event|0|||
125512154|NCT00296504|451503855|FG007|Final Analysis|Adverse Event|0|||
125512155|NCT00296504|451503856|FG008|Final Analysis|Adverse Event|2|||
125512156|NCT00296504|451503848|FG000|Final Analysis|Pregnancy|0|||
125512157|NCT00296504|451503849|FG001|Final Analysis|Pregnancy|0|||
125512158|NCT00296504|451503850|FG002|Final Analysis|Pregnancy|0|||
125512159|NCT00296504|451503851|FG003|Final Analysis|Pregnancy|0|||
125512160|NCT00296504|451503852|FG004|Final Analysis|Pregnancy|0|||
125512161|NCT00296504|451503853|FG005|Final Analysis|Pregnancy|0|||
125512162|NCT00296504|451503854|FG006|Final Analysis|Pregnancy|0|||
125512163|NCT00296504|451503855|FG007|Final Analysis|Pregnancy|0|||
125512164|NCT00296504|451503856|FG008|Final Analysis|Pregnancy|4|||
125512165|NCT00296504|451503848|FG000|Final Analysis|Tuberculosis|0|||
125512166|NCT00296504|451503849|FG001|Final Analysis|Tuberculosis|0|||
125512167|NCT00296504|451503850|FG002|Final Analysis|Tuberculosis|0|||
125512168|NCT00296504|451503851|FG003|Final Analysis|Tuberculosis|0|||
125512169|NCT00296504|451503852|FG004|Final Analysis|Tuberculosis|0|||
125512170|NCT00296504|451503853|FG005|Final Analysis|Tuberculosis|0|||
125512171|NCT00296504|451503854|FG006|Final Analysis|Tuberculosis|0|||
125512172|NCT00296504|451503855|FG007|Final Analysis|Tuberculosis|0|||
125512173|NCT00296504|451503856|FG008|Final Analysis|Tuberculosis|1|||
125512174|NCT00296504|451503848|FG000|Final Analysis|Participant Moved to Another Country|0|||
125512175|NCT00296504|451503849|FG001|Final Analysis|Participant Moved to Another Country|0|||
125512176|NCT00296504|451503850|FG002|Final Analysis|Participant Moved to Another Country|0|||
125512177|NCT00296504|451503851|FG003|Final Analysis|Participant Moved to Another Country|0|||
125512178|NCT00296504|451503852|FG004|Final Analysis|Participant Moved to Another Country|0|||
125512179|NCT00296504|451503853|FG005|Final Analysis|Participant Moved to Another Country|0|||
125512180|NCT00296504|451503854|FG006|Final Analysis|Participant Moved to Another Country|0|||
125512181|NCT00296504|451503855|FG007|Final Analysis|Participant Moved to Another Country|0|||
125512182|NCT00296504|451503856|FG008|Final Analysis|Participant Moved to Another Country|1|||
125512183|NCT00296504|451503848|FG000|Final Analysis|Poor Adherence|0|||
125512184|NCT00296504|451503849|FG001|Final Analysis|Poor Adherence|0|||
125512185|NCT00296504|451503850|FG002|Final Analysis|Poor Adherence|0|||
125512186|NCT00296504|451503851|FG003|Final Analysis|Poor Adherence|0|||
125512187|NCT00296504|451503852|FG004|Final Analysis|Poor Adherence|0|||
125512188|NCT00296504|451503853|FG005|Final Analysis|Poor Adherence|0|||
125512189|NCT00296504|451503854|FG006|Final Analysis|Poor Adherence|0|||
125512190|NCT00296504|451503855|FG007|Final Analysis|Poor Adherence|0|||
125512191|NCT00296504|451503856|FG008|Final Analysis|Poor Adherence|1|||
125512192|NCT02162771|451503863|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
125512193|NCT02162771|451503864|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
125512194|NCT02162771|451503863|FG000|Core Study Period (Part 2)|Adverse Event|4|||
125512195|NCT02162771|451503864|FG001|Core Study Period (Part 2)|Adverse Event|1|||
125512196|NCT02162771|451503863|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
125512197|NCT02162771|451503864|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
125512198|NCT02162771|451503863|FG000|Core Study Period (Part 2)|Physician Decision|0|||
125512199|NCT02162771|451503864|FG001|Core Study Period (Part 2)|Physician Decision|2|||
125306389|NCT02737475|450749010|FG006|Overall Study|Participant withdrew consent|0|||
125306390|NCT02737475|450749011|FG007|Overall Study|Participant withdrew consent|0|||
125512200|NCT02162771|451503863|FG000|Core Study Period (Part 2)|Death|1|||
125512201|NCT02162771|451503864|FG001|Core Study Period (Part 2)|Death|0|||
125512202|NCT02162771|451503863|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
125512203|NCT02162771|451503864|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
125512204|NCT02162771|451503863|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
125512205|NCT02162771|451503864|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
125512206|NCT02162771|451503863|FG000|Maintenance Study Period (Part 2)|Death|2|||
125512207|NCT02162771|451503864|FG001|Maintenance Study Period (Part 2)|Death|1|||
125512208|NCT02162771|451503863|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
125512209|NCT02162771|451503864|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
125512210|NCT02162771|451503863|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
125512211|NCT02162771|451503864|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
125512212|NCT02162771|451503863|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
125512213|NCT02162771|451503864|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
125512214|NCT00449033|451503881|FG000|Treatment Period|Adverse Event|117|||
125512215|NCT00449033|451503882|FG001|Treatment Period|Adverse Event|83|||
125512216|NCT00449033|451503881|FG000|Treatment Period|Death|21|||
125512217|NCT00449033|451503882|FG001|Treatment Period|Death|12|||
125512218|NCT00449033|451503881|FG000|Treatment Period|Lost to Follow-up|0|||
125512219|NCT00449033|451503882|FG001|Treatment Period|Lost to Follow-up|2|||
125512220|NCT00449033|451503881|FG000|Treatment Period|Physician Decision|4|||
125512221|NCT00449033|451503882|FG001|Treatment Period|Physician Decision|5|||
125512222|NCT00449033|451503881|FG000|Treatment Period|Protocol Violation|8|||
125512223|NCT00449033|451503882|FG001|Treatment Period|Protocol Violation|7|||
125512224|NCT00449033|451503881|FG000|Treatment Period|Disease Progression|231|||
125512225|NCT00449033|451503882|FG001|Treatment Period|Disease Progression|288|||
125512226|NCT00449033|451503881|FG000|Treatment Period|Consent Withdrawn|36|||
125512227|NCT00449033|451503882|FG001|Treatment Period|Consent Withdrawn|20|||
125512228|NCT00449033|451503881|FG000|Treatment Period|Amended Protocol Criteria|22|||
125512229|NCT00449033|451503882|FG001|Treatment Period|Amended Protocol Criteria|18|||
125512230|NCT00449033|451503881|FG000|Treatment Period|Non-compliance|7|||
125512231|NCT00449033|451503882|FG001|Treatment Period|Non-compliance|8|||
125512232|NCT00449033|451503881|FG000|Treatment Period|Second Malignancy|0|||
125512233|NCT00449033|451503882|FG001|Treatment Period|Second Malignancy|1|||
125512234|NCT00449033|451503881|FG000|Treatment Period|Reason Missing|0|||
125512235|NCT00449033|451503882|FG001|Treatment Period|Reason Missing|4|||
125512236|NCT00449033|451503881|FG000|Treatment Period|Treatment Ongoing|6|||
125512237|NCT00449033|451503882|FG001|Treatment Period|Treatment Ongoing|4|||
125512238|NCT00449033|451503881|FG000|Follow-up Period|Death|299|||
125512239|NCT00449033|451503882|FG001|Follow-up Period|Death|311|||
125512240|NCT00449033|451503881|FG000|Follow-up Period|Lost to Follow-up|6|||
125512241|NCT00449033|451503882|FG001|Follow-up Period|Lost to Follow-up|10|||
125512242|NCT00449033|451503881|FG000|Follow-up Period|Reason Missing|120|||
125512243|NCT00449033|451503882|FG001|Follow-up Period|Reason Missing|113|||
125512244|NCT01257698|451503885|FG000|Overall Study|Protocol Violation|4|||
125512245|NCT01257698|451503886|FG001|Overall Study|Protocol Violation|0|||
125512246|NCT04393779|451503887|FG000|Overall Study|Death|1|||
125512247|NCT04393779|451503887|FG000|Overall Study|Device reintervention or explant|4|||
125512248|NCT01190228|451503888|FG000|Overall Study|Protocol Violation|4|||
125306391|NCT02737475|450749012|FG008|Overall Study|Participant withdrew consent|0|||
125306392|NCT02737475|450749013|FG009|Overall Study|Participant withdrew consent|0|||
125306393|NCT02737475|450749014|FG010|Overall Study|Participant withdrew consent|0|||
125306394|NCT02737475|450749015|FG011|Overall Study|Participant withdrew consent|0|||
125306395|NCT02737475|450749016|FG012|Overall Study|Participant withdrew consent|0|||
125306396|NCT02737475|450749017|FG013|Overall Study|Participant withdrew consent|0|||
125512249|NCT01190228|451503889|FG001|Overall Study|Protocol Violation|0|||
125512250|NCT01190228|451503890|FG002|Overall Study|Protocol Violation|0|||
125512251|NCT01190228|451503888|FG000|Overall Study|Withdrawal by Subject|1|||
125512252|NCT01190228|451503889|FG001|Overall Study|Withdrawal by Subject|0|||
125512253|NCT01190228|451503890|FG002|Overall Study|Withdrawal by Subject|0|||
125512254|NCT03023878|451503893|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
125512255|NCT03023878|451503893|FG000|Pre-Study Run-In Period|Death|1|||
125512256|NCT03023878|451503893|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
125512257|NCT03023878|451503893|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
125512258|NCT03023878|451503893|FG000|Treatment Period|Disease Progression|1|||
125512259|NCT03023878|451503893|FG000|Treatment Period|Withdrawal by Subject|1|||
125512260|NCT03023878|451503893|FG000|Treatment Period|Adverse Event|1|||
125512261|NCT03023878|451503893|FG000|Long Term Follow-Up Period|Death|2|||
125512262|NCT01247922|451503895|FG000|Overall Study|Disease progression|4|||
125512263|NCT01876823|451503898|FG000|Overall Study|Withdrawal by Subject|5|||
125512264|NCT01876823|451503898|FG000|Overall Study|Physician Decision|2|||
125512265|NCT01876823|451503898|FG000|Overall Study|Patients moved|2|||
125512266|NCT01770509|451503899|FG000|Overall Study|Injury|0|||
125512267|NCT01770509|451503900|FG001|Overall Study|Injury|1|||
125512268|NCT01770509|451503899|FG000|Overall Study|Lost to Follow-up|1|||
125512269|NCT01770509|451503900|FG001|Overall Study|Lost to Follow-up|2|||
125512270|NCT00905255|451503905|FG000|Overall Study|Adverse Event|7|||
125512271|NCT00905255|451503906|FG001|Overall Study|Adverse Event|5|||
125512272|NCT00905255|451503905|FG000|Overall Study|Withdrawal by Subject|5|||
125512273|NCT00905255|451503906|FG001|Overall Study|Withdrawal by Subject|4|||
125512274|NCT00905255|451503905|FG000|Overall Study|Familial and Personal Reasons|1|||
125512275|NCT00905255|451503906|FG001|Overall Study|Familial and Personal Reasons|0|||
125512276|NCT00390806|451503909|FG000|Overall Study|Lost to Follow-up|7|||
125512277|NCT00390806|451503910|FG001|Overall Study|Lost to Follow-up|6|||
125512278|NCT00390806|451503909|FG000|Overall Study|Protocol Violation|2|||
125512279|NCT00390806|451503910|FG001|Overall Study|Protocol Violation|2|||
125532603|NCT00350727|451580161|FG000|Phase II|Withdrawal by Subject|0|||
125512280|NCT00390806|451503909|FG000|Overall Study|Withdrawal by Subject|12|||
125512281|NCT00390806|451503910|FG001|Overall Study|Withdrawal by Subject|15|||
125512282|NCT00390806|451503909|FG000|Overall Study|Investigator Decision|4|||
125512283|NCT00390806|451503910|FG001|Overall Study|Investigator Decision|6|||
125512284|NCT00390806|451503909|FG000|Overall Study|Death|1|||
125512285|NCT00390806|451503910|FG001|Overall Study|Death|0|||
125512286|NCT00390806|451503909|FG000|Overall Study|Physician Decision|0|||
125512287|NCT00390806|451503910|FG001|Overall Study|Physician Decision|1|||
125512288|NCT00390806|451503909|FG000|Overall Study|Ongoing|4|||
125512289|NCT00390806|451503910|FG001|Overall Study|Ongoing|2|||
125512290|NCT01232569|451505580|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
125512291|NCT01232569|451505581|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
125512292|NCT01232569|451505582|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
125512293|NCT01232569|451505583|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
125512294|NCT01232569|451505580|FG000|Double-blind Treatment Period|Escape|2|||
125512295|NCT01232569|451505581|FG001|Double-blind Treatment Period|Escape|2|||
125512296|NCT01232569|451505582|FG002|Double-blind Treatment Period|Escape|0|||
125512297|NCT01232569|451505583|FG003|Double-blind Treatment Period|Escape|0|||
125512298|NCT01232569|451505580|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
125512299|NCT01232569|451505581|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
125512300|NCT01232569|451505582|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
125512301|NCT01232569|451505583|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
125512302|NCT01232569|451505580|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
125512303|NCT01232569|451505581|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
125512304|NCT01232569|451505582|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
125512305|NCT01232569|451505583|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
125512306|NCT01232569|451505580|FG000|Double-blind Treatment Period|Physician Decision|1|||
125512307|NCT01232569|451505581|FG001|Double-blind Treatment Period|Physician Decision|0|||
125512308|NCT01232569|451505582|FG002|Double-blind Treatment Period|Physician Decision|0|||
125512309|NCT01232569|451505583|FG003|Double-blind Treatment Period|Physician Decision|0|||
125512310|NCT01232569|451505580|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
125512311|NCT01232569|451505581|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
125512312|NCT01232569|451505582|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
125512313|NCT01232569|451505583|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
125512314|NCT01232569|451505580|FG000|Double-blind Treatment Period|Death|2|||
125512315|NCT01232569|451505581|FG001|Double-blind Treatment Period|Death|0|||
125512316|NCT01232569|451505582|FG002|Double-blind Treatment Period|Death|0|||
125512317|NCT01232569|451505583|FG003|Double-blind Treatment Period|Death|0|||
125512318|NCT04044352|451505584|FG000|Overall Study|Lost to Follow-up|9|||
125512319|NCT04044352|451505584|FG000|Overall Study|Withdrawal by Subject|2|||
125512320|NCT00651937|451505585|FG000|Overall Study|Withdrawal by Subject|4|||
125512321|NCT00651937|451505586|FG001|Overall Study|Withdrawal by Subject|1|||
125512322|NCT00814632|451505587|FG000|Overall Study|Lack of Efficacy|2|||
125512323|NCT00635570|451505589|FG000|Overall Study|Lost to Follow-up|8|||
125512324|NCT00635570|451505590|FG001|Overall Study|Lost to Follow-up|8|||
125512325|NCT00635570|451505589|FG000|Overall Study|Withdrawal by Subject|1|||
125512326|NCT00635570|451505590|FG001|Overall Study|Withdrawal by Subject|1|||
125512327|NCT00635570|451505589|FG000|Overall Study|Adverse Event|2|||
125512328|NCT00635570|451505590|FG001|Overall Study|Adverse Event|0|||
125512329|NCT00635570|451505589|FG000|Overall Study|Physician Decision|1|||
125512330|NCT00635570|451505590|FG001|Overall Study|Physician Decision|0|||
125512331|NCT00635570|451505589|FG000|Overall Study|Did not complete survey|2|||
125512332|NCT00635570|451505590|FG001|Overall Study|Did not complete survey|1|||
125512333|NCT00635570|451505589|FG000|Overall Study|Early termination(No sexual activity)|1|||
125512334|NCT00635570|451505590|FG001|Overall Study|Early termination(No sexual activity)|1|||
125512335|NCT02514577|451505601|FG000|Overall Study|Lost to Follow-up|6|||
125512336|NCT02514577|451505602|FG001|Overall Study|Lost to Follow-up|6|||
125512337|NCT02514577|451505601|FG000|Overall Study|Protocol Violation|1|||
125512338|NCT02514577|451505602|FG001|Overall Study|Protocol Violation|0|||
125512339|NCT02514577|451505601|FG000|Overall Study|Withdrawal by Subject|6|||
125512340|NCT02514577|451505602|FG001|Overall Study|Withdrawal by Subject|6|||
125512341|NCT02514577|451505601|FG000|Overall Study|Adverse Event|1|||
125512342|NCT02514577|451505602|FG001|Overall Study|Adverse Event|1|||
125512343|NCT04816708|451505605|FG000|Overall Study|Lost to Follow-up|10|||
125512344|NCT04816708|451505606|FG001|Overall Study|Lost to Follow-up|4|||
125512345|NCT02388932|451505607|FG000|Overall Study|Death|1|||
125512346|NCT03568708|451505610|FG000|Overall Study|Withdrawal by Subject|1|||
125512347|NCT03568708|451505611|FG001|Overall Study|Withdrawal by Subject|1|||
125512348|NCT03568708|451505610|FG000|Overall Study|Lost to Follow-up|0|||
125512349|NCT03568708|451505611|FG001|Overall Study|Lost to Follow-up|1|||
125512350|NCT00511147|451505612|FG000|Overall Study|Withdrawal by Subject|1|||
125512351|NCT00511147|451505612|FG000|Overall Study|Disease progression|5|||
125512352|NCT00511147|451505612|FG000|Overall Study|Required platelet transfusion|1|||
125512353|NCT00809783|451505613|FG000|Overall Study|Death|1|||
125512354|NCT00809783|451505614|FG001|Overall Study|Death|0|||
125512355|NCT00809783|451505615|FG002|Overall Study|Death|0|||
125512356|NCT00809783|451505613|FG000|Overall Study|Adverse Event|34|||
125512357|NCT00809783|451505614|FG001|Overall Study|Adverse Event|52|||
125512358|NCT00809783|451505615|FG002|Overall Study|Adverse Event|71|||
125512359|NCT00809783|451505613|FG000|Overall Study|Lack of Efficacy|39|||
125512360|NCT00809783|451505614|FG001|Overall Study|Lack of Efficacy|52|||
125512361|NCT00809783|451505615|FG002|Overall Study|Lack of Efficacy|63|||
125512362|NCT00809783|451505613|FG000|Overall Study|Lost to Follow-up|0|||
125512363|NCT00809783|451505614|FG001|Overall Study|Lost to Follow-up|3|||
125512364|NCT00809783|451505615|FG002|Overall Study|Lost to Follow-up|4|||
125512365|NCT00809783|451505613|FG000|Overall Study|Withdrawal by Subject|47|||
125512366|NCT00809783|451505614|FG001|Overall Study|Withdrawal by Subject|72|||
125512367|NCT00809783|451505615|FG002|Overall Study|Withdrawal by Subject|64|||
125512368|NCT00809783|451505613|FG000|Overall Study|Protocol Violation|2|||
125512369|NCT00809783|451505614|FG001|Overall Study|Protocol Violation|6|||
125512370|NCT00809783|451505615|FG002|Overall Study|Protocol Violation|5|||
125512371|NCT00809783|451505613|FG000|Overall Study|Randomized, but not treated|3|||
125512372|NCT00809783|451505614|FG001|Overall Study|Randomized, but not treated|0|||
125512373|NCT00809783|451505615|FG002|Overall Study|Randomized, but not treated|2|||
125512374|NCT00809783|451505613|FG000|Overall Study|Study Terminated by Sponsor|378|||
125512375|NCT00809783|451505614|FG001|Overall Study|Study Terminated by Sponsor|626|||
125512376|NCT00809783|451505615|FG002|Overall Study|Study Terminated by Sponsor|565|||
125512377|NCT00809783|451505613|FG000|Overall Study|Other|21|||
125512378|NCT00809783|451505614|FG001|Overall Study|Other|21|||
125512379|NCT00809783|451505615|FG002|Overall Study|Other|16|||
125512380|NCT00126555|451505616|FG000|Overall Study|Withdrawal by Subject|1|||
125512381|NCT00126555|451505616|FG000|Overall Study|Adverse Event|2|||
125512382|NCT00126555|451505616|FG000|Overall Study|Progressive Disease|3|||
125512383|NCT00396097|451505620|FG000|Overall Study|Withdrawal by Subject|17|||
125512384|NCT00396097|451505621|FG001|Overall Study|Withdrawal by Subject|17|||
125512385|NCT00396097|451505620|FG000|Overall Study|Lost to Follow-up|4|||
125512386|NCT00396097|451505621|FG001|Overall Study|Lost to Follow-up|9|||
125512387|NCT00396097|451505620|FG000|Overall Study|Other|3|||
125512388|NCT00396097|451505621|FG001|Overall Study|Other|5|||
125512389|NCT00396097|451505620|FG000|Overall Study|Protocol Violation|0|||
125512390|NCT00396097|451505621|FG001|Overall Study|Protocol Violation|6|||
125512391|NCT00396097|451505620|FG000|Overall Study|Adverse Event|1|||
125512392|NCT00396097|451505621|FG001|Overall Study|Adverse Event|5|||
125512393|NCT00396097|451505620|FG000|Overall Study|Insufficient Clinical Response|1|||
125512394|NCT00396097|451505621|FG001|Overall Study|Insufficient Clinical Response|4|||
125512395|NCT03461211|451505622|FG000|Overall Study|Adverse Event|1|||
125512396|NCT03461211|451505623|FG001|Overall Study|Adverse Event|1|||
125512397|NCT03461211|451505622|FG000|Overall Study|Lack of Efficacy|0|||
125512398|NCT03461211|451505623|FG001|Overall Study|Lack of Efficacy|1|||
125512399|NCT04736602|451505630|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
125512400|NCT04736602|451505630|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
125512401|NCT00475735|451505632|FG000|Treatment Period 1|Adverse Event|2|||
125512402|NCT00475735|451505633|FG001|Treatment Period 1|Adverse Event|0|||
125512403|NCT00475735|451505634|FG002|Treatment Period 1|Adverse Event|0|||
125512404|NCT00475735|451505635|FG003|Treatment Period 1|Adverse Event|0|||
125512405|NCT00475735|451505636|FG004|Treatment Period 1|Adverse Event|0|||
125512406|NCT00475735|451505637|FG005|Treatment Period 1|Adverse Event|0|||
125512407|NCT00475735|451505632|FG000|Treatment Period 1|Lack of Efficacy|1|||
125512408|NCT00475735|451505633|FG001|Treatment Period 1|Lack of Efficacy|0|||
125512409|NCT00475735|451505634|FG002|Treatment Period 1|Lack of Efficacy|0|||
125512410|NCT00475735|451505635|FG003|Treatment Period 1|Lack of Efficacy|0|||
125512411|NCT00475735|451505636|FG004|Treatment Period 1|Lack of Efficacy|0|||
125512412|NCT00475735|451505637|FG005|Treatment Period 1|Lack of Efficacy|0|||
125512413|NCT00475735|451505632|FG000|Treatment Period 1|Lost to Follow-up|0|||
125512414|NCT00475735|451505633|FG001|Treatment Period 1|Lost to Follow-up|0|||
125512415|NCT00475735|451505634|FG002|Treatment Period 1|Lost to Follow-up|0|||
125512416|NCT00475735|451505635|FG003|Treatment Period 1|Lost to Follow-up|0|||
125512417|NCT00475735|451505636|FG004|Treatment Period 1|Lost to Follow-up|0|||
125512418|NCT00475735|451505637|FG005|Treatment Period 1|Lost to Follow-up|1|||
125512419|NCT00475735|451505632|FG000|Treatment Period 1|Protocol Violation|0|||
125512420|NCT00475735|451505633|FG001|Treatment Period 1|Protocol Violation|0|||
125512421|NCT00475735|451505634|FG002|Treatment Period 1|Protocol Violation|0|||
125512422|NCT00475735|451505635|FG003|Treatment Period 1|Protocol Violation|1|||
125512423|NCT00475735|451505636|FG004|Treatment Period 1|Protocol Violation|0|||
125512424|NCT00475735|451505637|FG005|Treatment Period 1|Protocol Violation|0|||
125512425|NCT00475735|451505632|FG000|Treatment Period 1|Withdrawal by Subject|1|||
125512426|NCT00475735|451505633|FG001|Treatment Period 1|Withdrawal by Subject|1|||
125512427|NCT00475735|451505634|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125512428|NCT00475735|451505635|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125512429|NCT00475735|451505636|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125512430|NCT00475735|451505637|FG005|Treatment Period 1|Withdrawal by Subject|0|||
125512431|NCT00475735|451505632|FG000|Treatment Period 1|DC due to AE but continuing|0|||
125512432|NCT00475735|451505633|FG001|Treatment Period 1|DC due to AE but continuing|0|||
125512433|NCT00475735|451505634|FG002|Treatment Period 1|DC due to AE but continuing|0|||
125512434|NCT00475735|451505635|FG003|Treatment Period 1|DC due to AE but continuing|1|||
125512435|NCT00475735|451505636|FG004|Treatment Period 1|DC due to AE but continuing|2|||
125512436|NCT00475735|451505637|FG005|Treatment Period 1|DC due to AE but continuing|2|||
125512437|NCT00475735|451505632|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
125512438|NCT00475735|451505633|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
125512439|NCT00475735|451505634|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
125512440|NCT00475735|451505635|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
125512441|NCT00475735|451505636|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
125512442|NCT00475735|451505637|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
125512443|NCT00475735|451505632|FG000|Treatment Washout|Lost to Follow-up|0|||
125512444|NCT00475735|451505633|FG001|Treatment Washout|Lost to Follow-up|1|||
125512445|NCT00475735|451505634|FG002|Treatment Washout|Lost to Follow-up|0|||
125512446|NCT00475735|451505635|FG003|Treatment Washout|Lost to Follow-up|0|||
125512447|NCT00475735|451505636|FG004|Treatment Washout|Lost to Follow-up|0|||
125512448|NCT00475735|451505637|FG005|Treatment Washout|Lost to Follow-up|0|||
125512449|NCT00475735|451505632|FG000|Treatment Washout|Protocol Violation|0|||
125512450|NCT00475735|451505633|FG001|Treatment Washout|Protocol Violation|1|||
125512451|NCT00475735|451505634|FG002|Treatment Washout|Protocol Violation|0|||
125512452|NCT00475735|451505635|FG003|Treatment Washout|Protocol Violation|0|||
125512453|NCT00475735|451505636|FG004|Treatment Washout|Protocol Violation|0|||
125512454|NCT00475735|451505637|FG005|Treatment Washout|Protocol Violation|0|||
125512455|NCT00475735|451505632|FG000|Treatment Period 2|Adverse Event|0|||
125512456|NCT00475735|451505633|FG001|Treatment Period 2|Adverse Event|1|||
125512457|NCT00475735|451505634|FG002|Treatment Period 2|Adverse Event|0|||
125512458|NCT00475735|451505635|FG003|Treatment Period 2|Adverse Event|2|||
125512459|NCT00475735|451505636|FG004|Treatment Period 2|Adverse Event|0|||
125512460|NCT00475735|451505637|FG005|Treatment Period 2|Adverse Event|0|||
125512461|NCT00475735|451505632|FG000|Treatment Period 2|Lack of Efficacy|0|||
125512462|NCT00475735|451505633|FG001|Treatment Period 2|Lack of Efficacy|0|||
125512463|NCT00475735|451505634|FG002|Treatment Period 2|Lack of Efficacy|0|||
125512464|NCT00475735|451505635|FG003|Treatment Period 2|Lack of Efficacy|0|||
125512465|NCT00475735|451505636|FG004|Treatment Period 2|Lack of Efficacy|0|||
125512466|NCT00475735|451505637|FG005|Treatment Period 2|Lack of Efficacy|1|||
125512467|NCT00475735|451505632|FG000|Treatment Period 2|Withdrawal by Subject|0|||
125512468|NCT00475735|451505633|FG001|Treatment Period 2|Withdrawal by Subject|0|||
125512469|NCT00475735|451505634|FG002|Treatment Period 2|Withdrawal by Subject|0|||
125512470|NCT00475735|451505635|FG003|Treatment Period 2|Withdrawal by Subject|0|||
125512471|NCT00475735|451505636|FG004|Treatment Period 2|Withdrawal by Subject|1|||
125512472|NCT00475735|451505637|FG005|Treatment Period 2|Withdrawal by Subject|0|||
125512473|NCT00125853|451505638|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
125512474|NCT00125853|451505639|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
125512475|NCT03575572|451505640|FG000|Overall Study|Withdrawal by Subject|2|||
125512476|NCT03575572|451505640|FG000|Overall Study|Physician Decision|2|||
125512477|NCT00157209|451505643|FG000|Overall Study|Ongoing at data cut-off|10|||
125512478|NCT00157209|451505644|FG001|Overall Study|Ongoing at data cut-off|0|||
125512479|NCT00577096|451505656|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
125512480|NCT00577096|451505657|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
125512481|NCT00577096|451505656|FG000|Short Term Participation|Withdrawal by Subject|3|||
125512482|NCT00577096|451505657|FG001|Short Term Participation|Withdrawal by Subject|5|||
125512483|NCT00577096|451505656|FG000|Short Term Participation|Death|1|||
125512484|NCT00577096|451505657|FG001|Short Term Participation|Death|1|||
125512485|NCT00794573|451505662|FG000|Overall Study|Death|3|||
125512486|NCT00794573|451505663|FG001|Overall Study|Death|0|||
125512487|NCT00794573|451505662|FG000|Overall Study|Withdrawal by Subject|9|||
125512488|NCT00794573|451505663|FG001|Overall Study|Withdrawal by Subject|12|||
125512489|NCT00794573|451505662|FG000|Overall Study|Lost to Follow-up|26|||
125512490|NCT00794573|451505663|FG001|Overall Study|Lost to Follow-up|33|||
125512491|NCT03928821|451505664|FG000|Overall Study|Death|0|||
125512492|NCT03928821|451505665|FG001|Overall Study|Death|1|||
125512493|NCT03928821|451505666|FG002|Overall Study|Death|0|||
125512494|NCT03928821|451505667|FG003|Overall Study|Death|0|||
125512495|NCT03928821|451505664|FG000|Overall Study|Lost to Follow-up|0|||
125512496|NCT03928821|451505665|FG001|Overall Study|Lost to Follow-up|2|||
125512497|NCT03928821|451505666|FG002|Overall Study|Lost to Follow-up|3|||
125512498|NCT03928821|451505667|FG003|Overall Study|Lost to Follow-up|0|||
125512499|NCT03928821|451505664|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
125512500|NCT03928821|451505665|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
125512501|NCT03928821|451505666|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
125512502|NCT03928821|451505667|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
125512503|NCT02784535|451505668|FG000|Overall Study|Adverse Event|1|||
125512504|NCT02784535|451505669|FG001|Overall Study|Adverse Event|0|||
125512505|NCT02784535|451505668|FG000|Overall Study|Withdrawal by Subject|0|||
125512506|NCT02784535|451505669|FG001|Overall Study|Withdrawal by Subject|1|||
125512507|NCT02784535|451505668|FG000|Overall Study|Physician Decision|0|||
125512508|NCT02784535|451505669|FG001|Overall Study|Physician Decision|1|||
125512509|NCT00985621|451505671|FG000|Overall Study|Adverse Event|2|||
125512510|NCT00985621|451505672|FG001|Overall Study|Adverse Event|3|||
125512511|NCT00985621|451505673|FG002|Overall Study|Adverse Event|4|||
125512512|NCT00985621|451505674|FG003|Overall Study|Adverse Event|16|||
125512513|NCT00985621|451505671|FG000|Overall Study|Lack of Efficacy|10|||
125512514|NCT00985621|451505672|FG001|Overall Study|Lack of Efficacy|6|||
125512515|NCT00985621|451505673|FG002|Overall Study|Lack of Efficacy|5|||
125512516|NCT00985621|451505674|FG003|Overall Study|Lack of Efficacy|12|||
125512517|NCT00985621|451505671|FG000|Overall Study|Lost to Follow-up|2|||
125512518|NCT00985621|451505672|FG001|Overall Study|Lost to Follow-up|3|||
125512519|NCT00985621|451505673|FG002|Overall Study|Lost to Follow-up|4|||
125512520|NCT00985621|451505674|FG003|Overall Study|Lost to Follow-up|4|||
125512521|NCT00985621|451505671|FG000|Overall Study|Study Terminated by Sponsor|89|||
125512522|NCT00985621|451505672|FG001|Overall Study|Study Terminated by Sponsor|108|||
125512523|NCT00985621|451505673|FG002|Overall Study|Study Terminated by Sponsor|99|||
125512524|NCT00985621|451505674|FG003|Overall Study|Study Terminated by Sponsor|92|||
125512525|NCT00985621|451505671|FG000|Overall Study|Protocol Violation|1|||
125512526|NCT00985621|451505672|FG001|Overall Study|Protocol Violation|1|||
125512527|NCT00985621|451505673|FG002|Overall Study|Protocol Violation|1|||
125512528|NCT00985621|451505674|FG003|Overall Study|Protocol Violation|0|||
125512529|NCT00985621|451505671|FG000|Overall Study|Withdrawal by Subject|8|||
125512530|NCT00985621|451505672|FG001|Overall Study|Withdrawal by Subject|10|||
125512531|NCT00985621|451505673|FG002|Overall Study|Withdrawal by Subject|8|||
125512532|NCT00985621|451505674|FG003|Overall Study|Withdrawal by Subject|12|||
125512533|NCT00985621|451505671|FG000|Overall Study|Other|1|||
125512534|NCT00985621|451505672|FG001|Overall Study|Other|0|||
125512535|NCT00985621|451505673|FG002|Overall Study|Other|0|||
125512536|NCT00985621|451505674|FG003|Overall Study|Other|0|||
125512537|NCT00985621|451505671|FG000|Overall Study|Randomized but not Treated|1|||
125512538|NCT00985621|451505672|FG001|Overall Study|Randomized but not Treated|0|||
125512539|NCT00985621|451505673|FG002|Overall Study|Randomized but not Treated|2|||
125512540|NCT00985621|451505674|FG003|Overall Study|Randomized but not Treated|1|||
125512541|NCT01911819|451505675|FG000|Overall Study|Adverse Event|0|||
125512542|NCT01911819|451505676|FG001|Overall Study|Adverse Event|1|||
125512543|NCT01911819|451505677|FG002|Overall Study|Adverse Event|0|||
125512544|NCT01911819|451505675|FG000|Overall Study|Withdrawal by Subject|1|||
125512545|NCT01911819|451505676|FG001|Overall Study|Withdrawal by Subject|1|||
125512546|NCT01911819|451505677|FG002|Overall Study|Withdrawal by Subject|0|||
125512547|NCT03849300|451505681|FG000|Overall Study|move out to different area|1|||
125512548|NCT03849300|451505682|FG001|Overall Study|move out to different area|3|||
125512549|NCT03849300|451505683|FG002|Overall Study|move out to different area|1|||
125512550|NCT03849300|451505684|FG003|Overall Study|move out to different area|4|||
125512551|NCT03849300|451505681|FG000|Overall Study|scheduling/transportation conflict|4|||
125512552|NCT03849300|451505682|FG001|Overall Study|scheduling/transportation conflict|4|||
125512553|NCT03849300|451505683|FG002|Overall Study|scheduling/transportation conflict|3|||
125512554|NCT03849300|451505684|FG003|Overall Study|scheduling/transportation conflict|2|||
125512555|NCT00464737|451505687|FG000|Overall Study|Adverse Event|12|||
125512556|NCT00464737|451505688|FG001|Overall Study|Adverse Event|17|||
125512557|NCT00464737|451505689|FG002|Overall Study|Adverse Event|33|||
125512558|NCT00464737|451505687|FG000|Overall Study|Lack of Efficacy|7|||
125512559|NCT00464737|451505688|FG001|Overall Study|Lack of Efficacy|7|||
125512560|NCT00464737|451505689|FG002|Overall Study|Lack of Efficacy|4|||
125512561|NCT00464737|451505687|FG000|Overall Study|Withdrawal by Subject|5|||
125512562|NCT00464737|451505688|FG001|Overall Study|Withdrawal by Subject|3|||
125512563|NCT00464737|451505689|FG002|Overall Study|Withdrawal by Subject|5|||
125512564|NCT00464737|451505687|FG000|Overall Study|Protocol Violation|1|||
125512565|NCT00464737|451505688|FG001|Overall Study|Protocol Violation|1|||
125512566|NCT00464737|451505689|FG002|Overall Study|Protocol Violation|5|||
125512567|NCT00464737|451505687|FG000|Overall Study|Non-compliance|0|||
125512568|NCT00464737|451505688|FG001|Overall Study|Non-compliance|1|||
125512569|NCT00464737|451505689|FG002|Overall Study|Non-compliance|1|||
125512570|NCT00464737|451505687|FG000|Overall Study|Lost to Follow-up|5|||
125512571|NCT00464737|451505688|FG001|Overall Study|Lost to Follow-up|2|||
125512572|NCT00464737|451505689|FG002|Overall Study|Lost to Follow-up|5|||
125512573|NCT00464737|451505687|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
125512574|NCT00464737|451505688|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
125512575|NCT00464737|451505689|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
125512576|NCT00464737|451505687|FG000|Overall Study|Other: Subject left town; family illness|1|||
125512577|NCT00464737|451505688|FG001|Overall Study|Other: Subject left town; family illness|0|||
125512578|NCT00464737|451505689|FG002|Overall Study|Other: Subject left town; family illness|0|||
125512579|NCT00464737|451505687|FG000|Overall Study|Other: Study demands too great|0|||
125512580|NCT00464737|451505688|FG001|Overall Study|Other: Study demands too great|1|||
125512581|NCT00464737|451505689|FG002|Overall Study|Other: Study demands too great|0|||
125512582|NCT00464737|451505687|FG000|Overall Study|Other: Personal family reasons|0|||
125512583|NCT00464737|451505688|FG001|Overall Study|Other: Personal family reasons|0|||
125512584|NCT00464737|451505689|FG002|Overall Study|Other: Personal family reasons|1|||
125512585|NCT00464737|451505687|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
125512586|NCT00464737|451505688|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
125512587|NCT00464737|451505689|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
125512588|NCT00676663|451505692|FG000|Overall Study|Death|43|||
125512589|NCT00676663|451505693|FG001|Overall Study|Death|27|||
125512590|NCT00676663|451505692|FG000|Overall Study|Withdrew Consent|1|||
125512591|NCT00676663|451505693|FG001|Overall Study|Withdrew Consent|8|||
125512592|NCT00676663|451505692|FG000|Overall Study|Lost to Follow-up|1|||
125512593|NCT00676663|451505693|FG001|Overall Study|Lost to Follow-up|3|||
125512594|NCT00580047|451505694|FG000|Overall Study|Lost to Follow-up|1|||
125512595|NCT00580047|451505695|FG001|Overall Study|Lost to Follow-up|1|||
125512596|NCT00580047|451505696|FG002|Overall Study|Lost to Follow-up|0|||
125512597|NCT00580047|451505694|FG000|Overall Study|Withdrawal by Subject|1|||
125512598|NCT00580047|451505695|FG001|Overall Study|Withdrawal by Subject|1|||
125512599|NCT00580047|451505696|FG002|Overall Study|Withdrawal by Subject|2|||
125512600|NCT00580047|451505694|FG000|Overall Study|Withdrawal by Subject|1|||
125512601|NCT00580047|451505695|FG001|Overall Study|Withdrawal by Subject|0|||
125512602|NCT00580047|451505696|FG002|Overall Study|Withdrawal by Subject|0|||
125512603|NCT04382053|451505702|FG000|Overall Study|Death|6|||
125512604|NCT04382053|451505703|FG001|Overall Study|Death|8|||
125512605|NCT04382053|451505702|FG000|Overall Study|Lost to Follow-up|0|||
125512606|NCT04382053|451505703|FG001|Overall Study|Lost to Follow-up|2|||
125512607|NCT04382053|451505702|FG000|Overall Study|Protocol Deviation|1|||
125512608|NCT04382053|451505703|FG001|Overall Study|Protocol Deviation|2|||
125512609|NCT04382053|451505702|FG000|Overall Study|Withdrawal by Subject|2|||
125512610|NCT04382053|451505703|FG001|Overall Study|Withdrawal by Subject|1|||
125512611|NCT00417989|451505709|FG000|Overall Study|Withdrawal by Subject|13|||
125512612|NCT00417989|451505710|FG001|Overall Study|Withdrawal by Subject|13|||
125512613|NCT00417989|451505709|FG000|Overall Study|Lost to Follow-up|1|||
125512614|NCT00417989|451505710|FG001|Overall Study|Lost to Follow-up|6|||
125512615|NCT00417989|451505709|FG000|Overall Study|Protocol Violation|1|||
125512616|NCT00417989|451505710|FG001|Overall Study|Protocol Violation|0|||
125512617|NCT00417989|451505709|FG000|Overall Study|Death|0|||
125512618|NCT00417989|451505710|FG001|Overall Study|Death|1|||
125512619|NCT00417989|451505709|FG000|Overall Study|Physician Decision|5|||
125512620|NCT00417989|451505710|FG001|Overall Study|Physician Decision|2|||
125512621|NCT00497198|451505718|FG000|Overall Study|Adverse Event|4|||
125512622|NCT00497198|451505719|FG001|Overall Study|Adverse Event|2|||
125512623|NCT00497198|451505718|FG000|Overall Study|Physician Decision|1|||
125512624|NCT00497198|451505719|FG001|Overall Study|Physician Decision|2|||
125512625|NCT00497198|451505718|FG000|Overall Study|Withdrawal by Subject|0|||
125512626|NCT00497198|451505719|FG001|Overall Study|Withdrawal by Subject|1|||
125512627|NCT02799745|451505720|FG000|Overall Study|Participant moved out of state|1|||
125512628|NCT02799745|451505721|FG001|Overall Study|Participant moved out of state|0|||
125512629|NCT02799745|451505720|FG000|Overall Study|Discontinued due to planned surgery|1|||
125512630|NCT02799745|451505721|FG001|Overall Study|Discontinued due to planned surgery|0|||
125512631|NCT02799745|451505720|FG000|Overall Study|Withdrawal by Subject|16|||
125512632|NCT02799745|451505721|FG001|Overall Study|Withdrawal by Subject|25|||
125512633|NCT02799745|451505720|FG000|Overall Study|Protocol Deviation|4|||
125512634|NCT02799745|451505721|FG001|Overall Study|Protocol Deviation|5|||
125512635|NCT02799745|451505720|FG000|Overall Study|Progressive Disease|28|||
125512636|NCT02799745|451505721|FG001|Overall Study|Progressive Disease|38|||
125512637|NCT02799745|451505720|FG000|Overall Study|Lost to Follow-up|3|||
125512638|NCT02799745|451505721|FG001|Overall Study|Lost to Follow-up|2|||
125512639|NCT02799745|451505720|FG000|Overall Study|Death|3|||
125512640|NCT02799745|451505721|FG001|Overall Study|Death|0|||
125512641|NCT02799745|451505720|FG000|Overall Study|Adverse Event|0|||
125512642|NCT02799745|451505721|FG001|Overall Study|Adverse Event|1|||
125512643|NCT01902381|451507182|FG000|Overall Study|Withdrawal by Subject|1|||
125512644|NCT00755716|451507183|FG000|Overall Study|Adverse Event|1|||
125512645|NCT00755716|451507184|FG001|Overall Study|Adverse Event|4|||
125512646|NCT00755716|451507185|FG002|Overall Study|Adverse Event|1|||
125512647|NCT00755716|451507183|FG000|Overall Study|Lack of Efficacy|2|||
125512648|NCT00755716|451507184|FG001|Overall Study|Lack of Efficacy|0|||
125512649|NCT00755716|451507185|FG002|Overall Study|Lack of Efficacy|0|||
125512650|NCT00755716|451507183|FG000|Overall Study|Lost to Follow-up|5|||
125512651|NCT00755716|451507184|FG001|Overall Study|Lost to Follow-up|3|||
125512652|NCT00755716|451507185|FG002|Overall Study|Lost to Follow-up|1|||
125512653|NCT00755716|451507183|FG000|Overall Study|work schedule issues|0|||
125512654|NCT00755716|451507184|FG001|Overall Study|work schedule issues|1|||
125512655|NCT00755716|451507185|FG002|Overall Study|work schedule issues|1|||
125512656|NCT01284634|451507195|FG000|Overall Study|Adverse Event|1|||
125512657|NCT01284634|451507196|FG001|Overall Study|Adverse Event|0|||
125512658|NCT01284634|451507197|FG002|Overall Study|Adverse Event|2|||
125512659|NCT01284634|451507198|FG003|Overall Study|Adverse Event|1|||
125512660|NCT01059526|451507199|FG000|Overall Study|Patient enrolled but not treated|20|||
125512661|NCT01059526|451507200|FG001|Overall Study|Patient enrolled but not treated|17|||
125512662|NCT01059526|451507199|FG000|Overall Study|Adverse Event|2|||
125512663|NCT01059526|451507200|FG001|Overall Study|Adverse Event|2|||
125512664|NCT01059526|451507199|FG000|Overall Study|Protocol Violation|0|||
125512665|NCT01059526|451507200|FG001|Overall Study|Protocol Violation|1|||
125512666|NCT01059526|451507199|FG000|Overall Study|Withdrawal by Subject|3|||
125512667|NCT01059526|451507200|FG001|Overall Study|Withdrawal by Subject|1|||
125512668|NCT01059526|451507199|FG000|Overall Study|Lost to Follow-up|4|||
125512669|NCT01059526|451507200|FG001|Overall Study|Lost to Follow-up|1|||
125512670|NCT01059526|451507199|FG000|Overall Study|Patient found to be dermatographic|1|||
125512671|NCT01059526|451507200|FG001|Overall Study|Patient found to be dermatographic|0|||
125512672|NCT01732588|451507201|FG000|First Intervention (7 Days)|Adverse Event|0|||
125512673|NCT01732588|451507202|FG001|First Intervention (7 Days)|Adverse Event|1|||
125512674|NCT01732588|451507203|FG002|First Intervention (7 Days)|Adverse Event|0|||
125512675|NCT02720081|451507204|FG000|Overall Study|Adverse Event|0|||
125512676|NCT02720081|451507205|FG001|Overall Study|Adverse Event|3|||
125512677|NCT02720081|451507204|FG000|Overall Study|Protocol Violation|4|||
125512678|NCT02720081|451507205|FG001|Overall Study|Protocol Violation|1|||
125512679|NCT05012397|451507209|FG000|Overall Study|Death|10|||
125512680|NCT05012397|451507209|FG000|Overall Study|Physician Decision|9|||
125512681|NCT05012397|451507209|FG000|Overall Study|Withdrawal by Subject|5|||
125512682|NCT05012397|451507209|FG000|Overall Study|Lost to Follow-up|2|||
125512683|NCT03334747|451507210|FG000|Treatment Phase|Technical problems|0|||
125512684|NCT03334747|451507211|FG001|Treatment Phase|Technical problems|0|||
125512685|NCT03334747|451507212|FG002|Treatment Phase|Technical problems|0|||
125512686|NCT03334747|451507213|FG003|Treatment Phase|Technical problems|0|||
125512687|NCT03334747|451507214|FG004|Treatment Phase|Technical problems|1|||
125512688|NCT03334747|451507215|FG005|Treatment Phase|Technical problems|0|||
125512689|NCT03334747|451507216|FG006|Treatment Phase|Technical problems|0|||
125512690|NCT03334747|451507217|FG007|Treatment Phase|Technical problems|0|||
125512691|NCT03334747|451507218|FG008|Treatment Phase|Technical problems|0|||
125512692|NCT03334747|451507210|FG000|Treatment Phase|Subject/guardian decision|1|||
125512693|NCT03334747|451507211|FG001|Treatment Phase|Subject/guardian decision|0|||
125512694|NCT03334747|451507212|FG002|Treatment Phase|Subject/guardian decision|0|||
125512695|NCT03334747|451507213|FG003|Treatment Phase|Subject/guardian decision|0|||
125512696|NCT03334747|451507214|FG004|Treatment Phase|Subject/guardian decision|0|||
125512697|NCT03334747|451507215|FG005|Treatment Phase|Subject/guardian decision|1|||
125512698|NCT03334747|451507216|FG006|Treatment Phase|Subject/guardian decision|0|||
125512699|NCT03334747|451507217|FG007|Treatment Phase|Subject/guardian decision|0|||
125512700|NCT03334747|451507218|FG008|Treatment Phase|Subject/guardian decision|0|||
125512701|NCT03334747|451507210|FG000|Follow-Up Phase|Subject/guardian decision|0|||
125512702|NCT03334747|451507211|FG001|Follow-Up Phase|Subject/guardian decision|0|||
125512703|NCT03334747|451507212|FG002|Follow-Up Phase|Subject/guardian decision|0|||
125512704|NCT03334747|451507213|FG003|Follow-Up Phase|Subject/guardian decision|0|||
125512705|NCT03334747|451507214|FG004|Follow-Up Phase|Subject/guardian decision|0|||
125512706|NCT03334747|451507215|FG005|Follow-Up Phase|Subject/guardian decision|0|||
125512707|NCT03334747|451507216|FG006|Follow-Up Phase|Subject/guardian decision|1|||
125512708|NCT03334747|451507217|FG007|Follow-Up Phase|Subject/guardian decision|0|||
125512709|NCT03334747|451507218|FG008|Follow-Up Phase|Subject/guardian decision|1|||
125512710|NCT02567227|451507219|FG000|9 Weeks|Adverse Event|5|||
125512711|NCT02567227|451507220|FG001|9 Weeks|Adverse Event|5|||
125512712|NCT02567227|451507219|FG000|9 Weeks|Withdrawal by Subject|18|||
125512713|NCT02567227|451507220|FG001|9 Weeks|Withdrawal by Subject|8|||
125512714|NCT02567227|451507219|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
125512715|NCT02567227|451507220|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
125512716|NCT02567227|451507219|FG000|6 Month|Death|2|||
125512717|NCT02567227|451507220|FG001|6 Month|Death|0|||
125512718|NCT02567227|451507219|FG000|6 Month|Lost to Follow-up|43|||
125512719|NCT02567227|451507220|FG001|6 Month|Lost to Follow-up|40|||
125512720|NCT02567227|451507219|FG000|12 Months|Lost to Follow-up|31|||
125512721|NCT02567227|451507220|FG001|12 Months|Lost to Follow-up|32|||
125512722|NCT02567227|451507219|FG000|12 Months|Death|0|||
125512723|NCT02567227|451507220|FG001|12 Months|Death|2|||
125512724|NCT04748445|451507221|FG000|Overall Study|No longer met eligibility criteria|12|||
125512725|NCT04748445|451507221|FG000|Overall Study|Other|36|||
125512726|NCT04748445|451507221|FG000|Overall Study|Withdrawal by Subject|553|||
125512727|NCT04748445|451507221|FG000|Overall Study|Lost to Follow-up|30|||
125512728|NCT02498418|451507225|FG000|Overall Study|Lack of Efficacy|0|||
125512729|NCT02498418|451507226|FG001|Overall Study|Lack of Efficacy|0|||
125512730|NCT02498418|451507227|FG002|Overall Study|Lack of Efficacy|1|||
125512731|NCT02498418|451507225|FG000|Overall Study|Withdrawal by Subject|2|||
125512732|NCT02498418|451507226|FG001|Overall Study|Withdrawal by Subject|0|||
125512733|NCT02498418|451507227|FG002|Overall Study|Withdrawal by Subject|3|||
125512734|NCT02498418|451507225|FG000|Overall Study|Lost to Follow-up|0|||
125512735|NCT02498418|451507226|FG001|Overall Study|Lost to Follow-up|1|||
125512736|NCT02498418|451507227|FG002|Overall Study|Lost to Follow-up|1|||
125512737|NCT02498418|451507225|FG000|Overall Study|Participant taken prohibited medication|0|||
125512738|NCT02498418|451507226|FG001|Overall Study|Participant taken prohibited medication|1|||
125512739|NCT02498418|451507227|FG002|Overall Study|Participant taken prohibited medication|1|||
125512740|NCT00762502|451507228|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
125512741|NCT00762502|451507229|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
125512742|NCT00762502|451507230|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
125512743|NCT00762502|451507228|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
125512744|NCT00762502|451507229|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
125512745|NCT00762502|451507230|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
125512746|NCT00762502|451507228|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
125512747|NCT00762502|451507229|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
125512748|NCT00762502|451507230|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
125512749|NCT03042559|451507231|FG000|Overall Study|drop out|1|||
125512750|NCT03042559|451507232|FG001|Overall Study|drop out|1|||
125512751|NCT01536535|451507235|FG000|Overall Study|Withdrawal by Subject|10|||
125512752|NCT01536535|451507236|FG001|Overall Study|Withdrawal by Subject|5|||
125512753|NCT01536535|451507235|FG000|Overall Study|Lost to Follow-up|4|||
125512754|NCT01536535|451507236|FG001|Overall Study|Lost to Follow-up|6|||
125512755|NCT01536535|451507235|FG000|Overall Study|Physician Decision|1|||
125512756|NCT01536535|451507236|FG001|Overall Study|Physician Decision|1|||
125512757|NCT01536535|451507235|FG000|Overall Study|Participant moved|0|||
125512758|NCT01536535|451507236|FG001|Overall Study|Participant moved|1|||
125512759|NCT00385697|451507239|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
125512760|NCT00385697|451507240|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
125512761|NCT00385697|451507241|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
125512762|NCT00385697|451507242|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
125512763|NCT00385697|451507243|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
125512764|NCT00385697|451507239|FG000|Open-label Segment 1|Lost to Follow-up|1|||
125512765|NCT00385697|451507240|FG001|Open-label Segment 1|Lost to Follow-up|0|||
125512766|NCT00385697|451507241|FG002|Open-label Segment 1|Lost to Follow-up|0|||
125512767|NCT00385697|451507242|FG003|Open-label Segment 1|Lost to Follow-up|0|||
125512768|NCT00385697|451507243|FG004|Open-label Segment 1|Lost to Follow-up|0|||
125512769|NCT00385697|451507239|FG000|Double-blind Segment 2|Adverse Event|0|||
125512770|NCT00385697|451507240|FG001|Double-blind Segment 2|Adverse Event|3|||
125512771|NCT00385697|451507241|FG002|Double-blind Segment 2|Adverse Event|1|||
125512772|NCT00385697|451507242|FG003|Double-blind Segment 2|Adverse Event|0|||
125512773|NCT00385697|451507243|FG004|Double-blind Segment 2|Adverse Event|0|||
125512774|NCT00385697|451507239|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
125512775|NCT00385697|451507240|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
125512776|NCT00385697|451507241|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
125512777|NCT00385697|451507242|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
125512778|NCT00385697|451507243|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
125512779|NCT00385697|451507239|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
125512780|NCT00385697|451507240|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
125512781|NCT00385697|451507241|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
125512782|NCT00385697|451507242|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
125512783|NCT00385697|451507243|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
125512784|NCT00385697|451507239|FG000|Double-blind Segment 2|Other|0|||
125512785|NCT00385697|451507240|FG001|Double-blind Segment 2|Other|2|||
125512786|NCT00385697|451507241|FG002|Double-blind Segment 2|Other|0|||
125512787|NCT00385697|451507242|FG003|Double-blind Segment 2|Other|0|||
125512788|NCT00385697|451507243|FG004|Double-blind Segment 2|Other|0|||
125512789|NCT01485991|451507244|FG000|Overall Study|Adverse Event|0|||
125512790|NCT01485991|451507245|FG001|Overall Study|Adverse Event|4|||
125512791|NCT01485991|451507244|FG000|Overall Study|Lost to Follow-up|13|||
125512792|NCT01485991|451507245|FG001|Overall Study|Lost to Follow-up|10|||
125512793|NCT01485991|451507244|FG000|Overall Study|Withdrawal by Subject|13|||
125512794|NCT01485991|451507245|FG001|Overall Study|Withdrawal by Subject|20|||
125512795|NCT01485991|451507244|FG000|Overall Study|randomized but not treated|6|||
125512796|NCT01485991|451507245|FG001|Overall Study|randomized but not treated|2|||
125512797|NCT01475370|451507247|FG000|Overall Study|Exacerbation of primary disease|2|||
125512798|NCT01475370|451507248|FG001|Overall Study|Exacerbation of primary disease|2|||
125512799|NCT01475370|451507249|FG002|Overall Study|Exacerbation of primary disease|2|||
125512800|NCT01475370|451507247|FG000|Overall Study|Study drug administration difficult|0|||
125512801|NCT01475370|451507248|FG001|Overall Study|Study drug administration difficult|1|||
125512802|NCT01475370|451507249|FG002|Overall Study|Study drug administration difficult|1|||
125512803|NCT01475370|451507247|FG000|Overall Study|Other than specified|1|||
125512804|NCT01475370|451507248|FG001|Overall Study|Other than specified|0|||
125512805|NCT01475370|451507249|FG002|Overall Study|Other than specified|0|||
125512806|NCT02538471|451507250|FG000|Overall Study|Progression of disease|2|||
125512807|NCT01675050|451507253|FG000|Period One Treatment|Withdrawal by Subject|1|||
125512808|NCT01675050|451507254|FG001|Period One Treatment|Withdrawal by Subject|0|||
125512809|NCT00084747|451507255|FG000|Overall Study|Relapsed|8|||
125512810|NCT00084747|451507255|FG000|Overall Study|Death|3|||
125512811|NCT00084747|451507255|FG000|Overall Study|Withdrawal by Subject|2|||
125512812|NCT02382406|451507260|FG000|Study Treatment|Disease Progression|8|||
125512813|NCT02382406|451507261|FG001|Study Treatment|Disease Progression|0|||
125512814|NCT02382406|451507262|FG002|Study Treatment|Disease Progression|20|||
125512815|NCT02382406|451507260|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
125512816|NCT02382406|451507261|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
125512817|NCT02382406|451507262|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
125512818|NCT02382406|451507260|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
125512819|NCT02382406|451507261|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
125512820|NCT02382406|451507262|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
125512821|NCT02382406|451507260|FG000|Study Treatment|symptomatic deterioration|1|||
125512822|NCT02382406|451507261|FG001|Study Treatment|symptomatic deterioration|0|||
125512823|NCT02382406|451507262|FG002|Study Treatment|symptomatic deterioration|1|||
125512824|NCT02382406|451507260|FG000|Study Treatment|Death|0|||
125512825|NCT02382406|451507261|FG001|Study Treatment|Death|0|||
125512826|NCT02382406|451507262|FG002|Study Treatment|Death|2|||
125512827|NCT02382406|451507260|FG000|Follow up|Death|11|||
125512828|NCT02382406|451507261|FG001|Follow up|Death|0|||
125512829|NCT02382406|451507262|FG002|Follow up|Death|19|||
125512830|NCT02382406|451507260|FG000|Follow up|Symptomatic deterioration|1|||
125512831|NCT02382406|451507261|FG001|Follow up|Symptomatic deterioration|0|||
125512832|NCT02382406|451507262|FG002|Follow up|Symptomatic deterioration|1|||
125512833|NCT02382406|451507260|FG000|Follow up|Patient Refused Follow-up|1|||
125512834|NCT02382406|451507261|FG001|Follow up|Patient Refused Follow-up|0|||
125512835|NCT02382406|451507262|FG002|Follow up|Patient Refused Follow-up|0|||
125512836|NCT02382406|451507260|FG000|Follow up|Study Terminated|1|||
125512837|NCT02382406|451507261|FG001|Follow up|Study Terminated|0|||
125512838|NCT02382406|451507262|FG002|Follow up|Study Terminated|8|||
125512839|NCT02382406|451507260|FG000|Follow up|Withdrawal by Subject|0|||
125512840|NCT02382406|451507261|FG001|Follow up|Withdrawal by Subject|0|||
125512841|NCT02382406|451507262|FG002|Follow up|Withdrawal by Subject|2|||
125512842|NCT03794609|451507265|FG000|Overall Study|Other|10|||
125512843|NCT03794609|451507265|FG000|Overall Study|Withdrawal by Subject|66|||
125512844|NCT03794609|451507265|FG000|Overall Study|The child is enrolled in an interventional study|70|||
125512845|NCT03794609|451507265|FG000|Overall Study|Inclusion/exclusion criteria|8|||
125512846|NCT03794609|451507265|FG000|Overall Study|At sponsor's request|151|||
125512847|NCT03794609|451507265|FG000|Overall Study|Physician Decision|1|||
125512848|NCT03794609|451507265|FG000|Overall Study|Lost to Follow-up|5|||
125512849|NCT04543942|451507266|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
125512850|NCT04543942|451507267|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
125512851|NCT04543942|451507266|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
125512852|NCT04543942|451507267|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
125512853|NCT02097056|451507272|FG000|Overall Study|Protocol Violation|2|||
125512854|NCT02097056|451507272|FG000|Overall Study|Withdrawal by Subject|15|||
125512855|NCT02097056|451507272|FG000|Overall Study|Lost to Follow-up|2|||
125512856|NCT02097056|451507272|FG000|Overall Study|Adverse Event|37|||
125512857|NCT02097056|451507272|FG000|Overall Study|Other|2|||
125512858|NCT04474691|451507273|FG000|Overall Study|Withdrawal by Subject|9|||
125512859|NCT01323309|451507274|FG000|Overall Study|Death|9|||
125512860|NCT01323309|451507275|FG001|Overall Study|Death|15|||
125512861|NCT01323309|451507276|FG002|Overall Study|Death|5|||
125512862|NCT01323309|451507274|FG000|Overall Study|Lost to Follow-up|11|||
125512863|NCT01323309|451507275|FG001|Overall Study|Lost to Follow-up|14|||
125512864|NCT01323309|451507276|FG002|Overall Study|Lost to Follow-up|24|||
125512865|NCT01323309|451507274|FG000|Overall Study|Withdrawal by Subject|14|||
125512866|NCT01323309|451507275|FG001|Overall Study|Withdrawal by Subject|14|||
125512867|NCT01323309|451507276|FG002|Overall Study|Withdrawal by Subject|18|||
125512868|NCT01323309|451507274|FG000|Overall Study|Disease progression|5|||
125306397|NCT02737475|450749018|FG014|Overall Study|Participant withdrew consent|1|||
125306398|NCT02737475|450749019|FG015|Overall Study|Participant withdrew consent|0|||
125512869|NCT01323309|451507275|FG001|Overall Study|Disease progression|11|||
125512870|NCT01323309|451507276|FG002|Overall Study|Disease progression|4|||
125512871|NCT02625922|451507277|FG000|Overall Study|Non-availability of IMP|1|||
125512872|NCT02625922|451507278|FG001|Overall Study|Non-availability of IMP|1|||
125512873|NCT02625922|451507277|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
125512874|NCT02625922|451507278|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
125512875|NCT01261793|451507289|FG000|Overall Study|Lack of Efficacy|44|||
125512876|NCT01261793|451507290|FG001|Overall Study|Lack of Efficacy|37|||
125512877|NCT01261793|451507291|FG002|Overall Study|Lack of Efficacy|32|||
125512878|NCT01261793|451507289|FG000|Overall Study|Protocol Violation|3|||
125512879|NCT01261793|451507290|FG001|Overall Study|Protocol Violation|5|||
125512880|NCT01261793|451507291|FG002|Overall Study|Protocol Violation|6|||
125512881|NCT01261793|451507289|FG000|Overall Study|Lost to Follow-up|10|||
125512882|NCT01261793|451507290|FG001|Overall Study|Lost to Follow-up|3|||
125512883|NCT01261793|451507291|FG002|Overall Study|Lost to Follow-up|7|||
125306399|NCT02737475|450749020|FG016|Overall Study|Participant withdrew consent|0|||
125512884|NCT01261793|451507289|FG000|Overall Study|Withdrawal by Subject|12|||
125512885|NCT01261793|451507290|FG001|Overall Study|Withdrawal by Subject|14|||
125512886|NCT01261793|451507291|FG002|Overall Study|Withdrawal by Subject|14|||
125512887|NCT01261793|451507289|FG000|Overall Study|Death|3|||
125512888|NCT01261793|451507290|FG001|Overall Study|Death|1|||
125512889|NCT01261793|451507291|FG002|Overall Study|Death|0|||
125512890|NCT01261793|451507289|FG000|Overall Study|Adverse Event|9|||
125512891|NCT01261793|451507290|FG001|Overall Study|Adverse Event|24|||
125512892|NCT01261793|451507291|FG002|Overall Study|Adverse Event|19|||
125512893|NCT01261793|451507289|FG000|Overall Study|Patient non-availability|1|||
125512894|NCT01261793|451507290|FG001|Overall Study|Patient non-availability|1|||
125512895|NCT01261793|451507291|FG002|Overall Study|Patient non-availability|1|||
125512896|NCT01261793|451507289|FG000|Overall Study|Suspected pregnancy|1|||
125512897|NCT01261793|451507290|FG001|Overall Study|Suspected pregnancy|1|||
125512898|NCT01261793|451507291|FG002|Overall Study|Suspected pregnancy|0|||
125512899|NCT01261793|451507289|FG000|Overall Study|Patient non-compliance|1|||
125512900|NCT01261793|451507290|FG001|Overall Study|Patient non-compliance|0|||
125512901|NCT01261793|451507291|FG002|Overall Study|Patient non-compliance|1|||
125512902|NCT01261793|451507289|FG000|Overall Study|Patient pregnant|1|||
125512903|NCT01261793|451507290|FG001|Overall Study|Patient pregnant|0|||
125512904|NCT01261793|451507291|FG002|Overall Study|Patient pregnant|0|||
125512905|NCT01261793|451507289|FG000|Overall Study|Outside the study area|0|||
125512906|NCT01261793|451507290|FG001|Overall Study|Outside the study area|2|||
125512907|NCT01261793|451507291|FG002|Overall Study|Outside the study area|1|||
125512908|NCT01261793|451507289|FG000|Overall Study|Lack of efficacy & patient not available|0|||
125512909|NCT01261793|451507290|FG001|Overall Study|Lack of efficacy & patient not available|1|||
125512910|NCT01261793|451507291|FG002|Overall Study|Lack of efficacy & patient not available|0|||
125512911|NCT01261793|451507289|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
125512912|NCT01261793|451507290|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
125512913|NCT01261793|451507291|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
125512914|NCT01261793|451507289|FG000|Overall Study|Randomization error|0|||
125512915|NCT01261793|451507290|FG001|Overall Study|Randomization error|1|||
125512916|NCT01261793|451507291|FG002|Overall Study|Randomization error|0|||
125512917|NCT01261793|451507289|FG000|Overall Study|Patient unable to start IV line|0|||
125512918|NCT01261793|451507290|FG001|Overall Study|Patient unable to start IV line|0|||
125512919|NCT01261793|451507291|FG002|Overall Study|Patient unable to start IV line|1|||
125512920|NCT00832650|451507295|FG000|Overall Study|Randomized but not treated|0|||
125512921|NCT00832650|451507296|FG001|Overall Study|Randomized but not treated|0|||
125512922|NCT00832650|451507297|FG002|Overall Study|Randomized but not treated|1|||
125512923|NCT02335242|451507301|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
125512924|NCT02335242|451507302|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
125512925|NCT02335242|451507301|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
125512926|NCT02335242|451507302|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
125512927|NCT02335242|451507301|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
125512928|NCT02335242|451507302|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
125512929|NCT00257556|451507305|FG000|Overall Study|Adverse Event|1|||
125512930|NCT00257556|451507306|FG001|Overall Study|Adverse Event|4|||
125512931|NCT00257556|451507305|FG000|Overall Study|Physician Decision|6|||
125512932|NCT00257556|451507306|FG001|Overall Study|Physician Decision|0|||
125512933|NCT00257556|451507305|FG000|Overall Study|Did not meet hCG criterion|3|||
125512934|NCT00257556|451507306|FG001|Overall Study|Did not meet hCG criterion|0|||
125512935|NCT00257556|451507305|FG000|Overall Study|other reason|4|||
125512936|NCT00257556|451507306|FG001|Overall Study|other reason|6|||
125512937|NCT04839289|451507307|FG000|Overall Study|Withdrawal by Subject|1|||
125512938|NCT04839289|451507308|FG001|Overall Study|Withdrawal by Subject|0|||
125512939|NCT02418819|451507310|FG000|Overall Study|Adverse Event|0|||
125512940|NCT02418819|451507311|FG001|Overall Study|Adverse Event|0|||
125512941|NCT02418819|451507312|FG002|Overall Study|Adverse Event|1|||
125512942|NCT02418819|451507313|FG003|Overall Study|Adverse Event|0|||
125512943|NCT02418819|451507310|FG000|Overall Study|Lost to Follow-up|1|||
125512944|NCT02418819|451507311|FG001|Overall Study|Lost to Follow-up|0|||
125512945|NCT02418819|451507312|FG002|Overall Study|Lost to Follow-up|0|||
125512946|NCT02418819|451507313|FG003|Overall Study|Lost to Follow-up|0|||
125512947|NCT02418819|451507310|FG000|Overall Study|No longer meets eligibility criteria|0|||
125512948|NCT02418819|451507311|FG001|Overall Study|No longer meets eligibility criteria|0|||
125512949|NCT02418819|451507312|FG002|Overall Study|No longer meets eligibility criteria|1|||
125512950|NCT02418819|451507313|FG003|Overall Study|No longer meets eligibility criteria|0|||
125512951|NCT02418819|451507310|FG000|Overall Study|No longer willing to participate|0|||
125512952|NCT02418819|451507311|FG001|Overall Study|No longer willing to participate|0|||
125512953|NCT02418819|451507312|FG002|Overall Study|No longer willing to participate|2|||
125512954|NCT02418819|451507313|FG003|Overall Study|No longer willing to participate|1|||
125512955|NCT04743999|451507314|FG000|3-month Questionnaire|Death|1|||
125512956|NCT04743999|451507314|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
125512957|NCT04743999|451507314|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
125512958|NCT04743999|451507314|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
125512959|NCT01721759|451507315|FG000|Treatment Period|Disease Progression|85|||
125512960|NCT01721759|451507315|FG000|Treatment Period|Study drug toxicity|14|||
125512961|NCT01721759|451507315|FG000|Treatment Period|Death|1|||
125512962|NCT01721759|451507315|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
125512963|NCT01721759|451507315|FG000|Treatment Period|Participant request to withdraw|3|||
125512964|NCT01721759|451507315|FG000|Treatment Period|Other Reasons|3|||
125512965|NCT01721759|451507315|FG000|End of Study Period|Participant Withdrew Consent|5|||
125512966|NCT01721759|451507315|FG000|End of Study Period|Death|101|||
125512967|NCT01721759|451507315|FG000|End of Study Period|Lost to Follow-up|1|||
125512968|NCT01721759|451507315|FG000|End of Study Period|Other Reasons|10|||
125512969|NCT01399905|451507316|FG000|Overall Study|Withdrawal by Subject|1|||
125512970|NCT01399905|451507317|FG001|Overall Study|Withdrawal by Subject|1|||
125512971|NCT01804140|451507323|FG000|Overall Study|No sampling or biopsy procedures done|114|||
125512972|NCT02785900|451507324|FG000|Overall Study|Study Termination by Sponsor|64|||
125512973|NCT02785900|451507325|FG001|Overall Study|Study Termination by Sponsor|81|||
125512974|NCT02785900|451507324|FG000|Overall Study|Death|46|||
125512975|NCT02785900|451507325|FG001|Overall Study|Death|32|||
125512976|NCT02785900|451507324|FG000|Overall Study|Withdrawal by Subject|4|||
125512977|NCT02785900|451507325|FG001|Overall Study|Withdrawal by Subject|8|||
125512978|NCT02785900|451507324|FG000|Overall Study|Physician Decision|3|||
125512979|NCT02785900|451507325|FG001|Overall Study|Physician Decision|2|||
125512980|NCT01808144|451507326|FG000|Overall Study|Death|1|||
125512981|NCT01808144|451507327|FG001|Overall Study|Death|0|||
125512982|NCT01808144|451507326|FG000|Overall Study|Withdrawal by Subject|16|||
125512983|NCT01808144|451507327|FG001|Overall Study|Withdrawal by Subject|23|||
125512984|NCT01808144|451507326|FG000|Overall Study|Lost to Follow-up|6|||
125512985|NCT01808144|451507327|FG001|Overall Study|Lost to Follow-up|3|||
125512986|NCT01808144|451507326|FG000|Overall Study|Protocol Violation|6|||
125512987|NCT01808144|451507327|FG001|Overall Study|Protocol Violation|6|||
125512988|NCT01808144|451507326|FG000|Overall Study|Gout flare|0|||
125512989|NCT01808144|451507327|FG001|Overall Study|Gout flare|1|||
125512990|NCT01808144|451507326|FG000|Overall Study|Adverse Event|11|||
125512991|NCT01808144|451507327|FG001|Overall Study|Adverse Event|15|||
125512992|NCT00383500|451507328|FG000|Overall Study|Withdrawal by Subject|8|||
125512993|NCT00383500|451507329|FG001|Overall Study|Withdrawal by Subject|3|||
125512994|NCT00383500|451507330|FG002|Overall Study|Withdrawal by Subject|0|||
125512995|NCT00383500|451507328|FG000|Overall Study|Lost to Follow-up|0|||
125512996|NCT00383500|451507329|FG001|Overall Study|Lost to Follow-up|0|||
125512997|NCT00383500|451507330|FG002|Overall Study|Lost to Follow-up|2|||
125512998|NCT04341584|451507334|FG000|Overall Study|Withdrew consent|0|||
125512999|NCT04341584|451507335|FG001|Overall Study|Withdrew consent|2|||
125513000|NCT04341584|451507336|FG002|Overall Study|Withdrew consent|2|||
125513001|NCT04341584|451507337|FG003|Overall Study|Withdrew consent|1|||
125513002|NCT04853238|451507339|FG000|Overall Study|Death|4|||
125513003|NCT04853238|451507340|FG001|Overall Study|Death|0|||
125513004|NCT04853238|451507341|FG002|Overall Study|Death|2|||
125513005|NCT04853238|451507339|FG000|Overall Study|Lost to Follow-up|16|||
125513006|NCT04853238|451507340|FG001|Overall Study|Lost to Follow-up|2|||
125513007|NCT04853238|451507341|FG002|Overall Study|Lost to Follow-up|37|||
125513008|NCT04853238|451507339|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
125513009|NCT04853238|451507340|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
125513010|NCT04853238|451507341|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
125513011|NCT04853238|451507339|FG000|Overall Study|Withdrawal by Subject|6|||
125513012|NCT04853238|451507340|FG001|Overall Study|Withdrawal by Subject|0|||
125513013|NCT04853238|451507341|FG002|Overall Study|Withdrawal by Subject|21|||
125513014|NCT04853238|451507339|FG000|Overall Study|Physician Decision|0|||
125513015|NCT04853238|451507340|FG001|Overall Study|Physician Decision|0|||
125513016|NCT04853238|451507341|FG002|Overall Study|Physician Decision|2|||
125513017|NCT04853238|451507339|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
125513018|NCT04853238|451507340|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
125513019|NCT04853238|451507341|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
125513020|NCT02176356|451508714|FG000|Overall Study|Screen Failure|14|||
125513021|NCT02176356|451508714|FG000|Overall Study|Lost to Follow-up|4|||
125513022|NCT02176356|451508714|FG000|Overall Study|Personal Reasons|3|||
125513023|NCT02176356|451508714|FG000|Overall Study|Other Miscellaneous Reasons|2|||
125306400|NCT02737475|450749021|FG017|Overall Study|Participant withdrew consent|2|||
125513024|NCT00332488|451508715|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
125513025|NCT00332488|451508716|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
125513026|NCT00332488|451508717|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
125513027|NCT00332488|451508715|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
125513028|NCT00332488|451508716|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
125513029|NCT00332488|451508717|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
125513030|NCT00332488|451508715|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
125513031|NCT00332488|451508716|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
125513032|NCT00332488|451508717|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
125513033|NCT00332488|451508715|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
125306401|NCT02737475|450749022|FG018|Overall Study|Participant withdrew consent|1|||
125513034|NCT00332488|451508716|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
125513035|NCT00332488|451508717|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
125513036|NCT00332488|451508715|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
125306402|NCT02737475|450749023|FG019|Overall Study|Participant withdrew consent|0|||
125513037|NCT00332488|451508716|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
125513038|NCT00332488|451508717|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
125513039|NCT00332488|451508715|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
125513040|NCT00332488|451508716|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
125513041|NCT00332488|451508717|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
125513042|NCT00332488|451508715|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
125513043|NCT00332488|451508716|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
125513044|NCT00332488|451508717|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
125513045|NCT00332488|451508715|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
125513046|NCT00332488|451508716|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
125513047|NCT00332488|451508717|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
125513048|NCT00332488|451508715|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
125513049|NCT00332488|451508716|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
125513050|NCT00332488|451508717|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
125513051|NCT00332488|451508715|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
125513052|NCT00332488|451508716|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
125513053|NCT00332488|451508717|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
125513054|NCT00332488|451508715|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
125513055|NCT00332488|451508716|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
125513056|NCT00332488|451508717|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
125513057|NCT00332488|451508715|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
125513058|NCT00332488|451508716|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
125513059|NCT00332488|451508717|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
125513060|NCT00792259|451508718|FG000|Overall Study|Poor Quality Scans|1|||
125513061|NCT00792259|451508719|FG001|Overall Study|Poor Quality Scans|0|||
125513062|NCT00792259|451508720|FG002|Overall Study|Poor Quality Scans|0|||
125513063|NCT00371462|451508721|FG000|Overall Study|Withdrawal by Subject|1|||
125513064|NCT00371462|451508722|FG001|Overall Study|Withdrawal by Subject|0|||
125513065|NCT00371462|451508721|FG000|Overall Study|Other|7|||
125513066|NCT00371462|451508722|FG001|Overall Study|Other|8|||
125513067|NCT03721978|451508724|FG000|Overall Study|Withdrawal by Subject|6|||
125513068|NCT03721978|451508725|FG001|Overall Study|Withdrawal by Subject|1|||
125513069|NCT03721978|451508724|FG000|Overall Study|Adverse Event|1|||
125513070|NCT03721978|451508725|FG001|Overall Study|Adverse Event|1|||
125513071|NCT03721978|451508724|FG000|Overall Study|Progressive Disease|1|||
125513072|NCT03721978|451508725|FG001|Overall Study|Progressive Disease|0|||
125513073|NCT03721978|451508724|FG000|Overall Study|Lost to Follow-up|5|||
125513074|NCT03721978|451508725|FG001|Overall Study|Lost to Follow-up|1|||
125513075|NCT03721978|451508724|FG000|Overall Study|Reason not Specified|0|||
125513076|NCT03721978|451508725|FG001|Overall Study|Reason not Specified|2|||
125513077|NCT05244226|451508726|FG000|Overall Study|Adverse Event|1|||
125513078|NCT05244226|451508727|FG001|Overall Study|Adverse Event|0|||
125513079|NCT05244226|451508728|FG002|Overall Study|Adverse Event|0|||
125513080|NCT05244226|451508726|FG000|Overall Study|Lost to Follow-up|0|||
125513081|NCT05244226|451508727|FG001|Overall Study|Lost to Follow-up|0|||
125513082|NCT05244226|451508728|FG002|Overall Study|Lost to Follow-up|1|||
125513083|NCT05244226|451508726|FG000|Overall Study|Protocol Violation|0|||
125513084|NCT05244226|451508727|FG001|Overall Study|Protocol Violation|2|||
125513085|NCT05244226|451508728|FG002|Overall Study|Protocol Violation|2|||
125513086|NCT00733226|451508729|FG000|Overall Study|Withdrawal by Subject|1|||
125513087|NCT00733226|451508730|FG001|Overall Study|Withdrawal by Subject|0|||
125513088|NCT00733226|451508729|FG000|Overall Study|Lost to Follow-up|2|||
125513089|NCT00733226|451508730|FG001|Overall Study|Lost to Follow-up|0|||
125513090|NCT00733226|451508729|FG000|Overall Study|moved to another place|2|||
125513091|NCT00733226|451508730|FG001|Overall Study|moved to another place|0|||
125513092|NCT03722485|451508731|FG000|Overall Study|Withdrawal by Subject|1|||
125513093|NCT03722485|451508732|FG001|Overall Study|Withdrawal by Subject|0|||
125513094|NCT03722485|451508731|FG000|Overall Study|Adverse Event|0|||
125513095|NCT03722485|451508732|FG001|Overall Study|Adverse Event|2|||
125513096|NCT03722485|451508731|FG000|Overall Study|subject discharged prior to study completion|1|||
125513097|NCT03722485|451508732|FG001|Overall Study|subject discharged prior to study completion|5|||
125513098|NCT03722485|451508731|FG000|Overall Study|eligibility criteria not met|2|||
125513099|NCT03722485|451508732|FG001|Overall Study|eligibility criteria not met|0|||
125513100|NCT00349622|451508733|FG000|Overall Study|Death|168|||
125513101|NCT00349622|451508734|FG001|Overall Study|Death|86|||
125513102|NCT00349622|451508733|FG000|Overall Study|Lost to Follow-up|5|||
125513103|NCT00349622|451508734|FG001|Overall Study|Lost to Follow-up|1|||
125513104|NCT00349622|451508733|FG000|Overall Study|Withdrawal by Subject|5|||
125513105|NCT00349622|451508734|FG001|Overall Study|Withdrawal by Subject|9|||
125513106|NCT02762500|451508735|FG000|Overall Study|Lack of Efficacy|1|||
125513107|NCT02762500|451508736|FG001|Overall Study|Lack of Efficacy|0|||
125513108|NCT02762500|451508735|FG000|Overall Study|Withdrawal by Subject|1|||
125513109|NCT02762500|451508736|FG001|Overall Study|Withdrawal by Subject|1|||
125513110|NCT02762500|451508735|FG000|Overall Study|Adverse Event|0|||
125513111|NCT02762500|451508736|FG001|Overall Study|Adverse Event|2|||
125513112|NCT02229396|451508737|FG000|Overall Study|Adverse Event|6|||
125513113|NCT02229396|451508738|FG001|Overall Study|Adverse Event|12|||
125513114|NCT02229396|451508739|FG002|Overall Study|Adverse Event|12|||
125513115|NCT02229396|451508737|FG000|Overall Study|Death|2|||
125513116|NCT02229396|451508738|FG001|Overall Study|Death|3|||
125513117|NCT02229396|451508739|FG002|Overall Study|Death|1|||
125513118|NCT02229396|451508737|FG000|Overall Study|Lost to Follow-up|14|||
125513119|NCT02229396|451508738|FG001|Overall Study|Lost to Follow-up|14|||
125513120|NCT02229396|451508739|FG002|Overall Study|Lost to Follow-up|21|||
125513121|NCT02229396|451508737|FG000|Overall Study|Protocol Violation|2|||
125513122|NCT02229396|451508738|FG001|Overall Study|Protocol Violation|1|||
125513123|NCT02229396|451508739|FG002|Overall Study|Protocol Violation|0|||
125513124|NCT02229396|451508737|FG000|Overall Study|Patient Incorrectly Randomized|0|||
125513125|NCT02229396|451508738|FG001|Overall Study|Patient Incorrectly Randomized|0|||
125513126|NCT02229396|451508739|FG002|Overall Study|Patient Incorrectly Randomized|1|||
125513127|NCT02229396|451508737|FG000|Overall Study|Other|10|||
125513128|NCT02229396|451508738|FG001|Overall Study|Other|18|||
125513129|NCT02229396|451508739|FG002|Overall Study|Other|15|||
125513130|NCT02229396|451508737|FG000|Overall Study|Withdrawal by Subject|42|||
125513131|NCT02229396|451508738|FG001|Overall Study|Withdrawal by Subject|28|||
125513132|NCT02229396|451508739|FG002|Overall Study|Withdrawal by Subject|41|||
125513133|NCT02229396|451508737|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
125513134|NCT02229396|451508738|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
125513135|NCT02229396|451508739|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
125513136|NCT02229396|451508737|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
125513137|NCT02229396|451508738|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
125513138|NCT02229396|451508739|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
125513139|NCT00377312|451508742|FG000|Overall Study|Adverse Event|1|||
125513140|NCT00377312|451508743|FG001|Overall Study|Adverse Event|1|||
125513141|NCT02775214|451508744|FG000|Overall Study|Withdrawal by Subject|2|||
125513142|NCT02775214|451508745|FG001|Overall Study|Withdrawal by Subject|0|||
125513143|NCT01145417|451508746|FG000|Overall Study|Death|1|||
125513144|NCT01145417|451508747|FG001|Overall Study|Death|0|||
125513145|NCT01145417|451508746|FG000|Overall Study|Lost to Follow-up|2|||
125513146|NCT01145417|451508747|FG001|Overall Study|Lost to Follow-up|1|||
125513147|NCT01145417|451508746|FG000|Overall Study|Withdrawal by Subject|1|||
125513148|NCT01145417|451508747|FG001|Overall Study|Withdrawal by Subject|2|||
125513149|NCT01145417|451508746|FG000|Overall Study|Pregnancy|1|||
125513150|NCT01145417|451508747|FG001|Overall Study|Pregnancy|0|||
125513151|NCT01145417|451508746|FG000|Overall Study|Adverse Event|0|||
125513152|NCT01145417|451508747|FG001|Overall Study|Adverse Event|1|||
125513153|NCT01145417|451508746|FG000|Overall Study|Study terminated by sponsor|35|||
125513154|NCT01145417|451508747|FG001|Overall Study|Study terminated by sponsor|43|||
125513155|NCT01145417|451508746|FG000|Overall Study|Other|1|||
125513156|NCT01145417|451508747|FG001|Overall Study|Other|0|||
125513157|NCT01191697|451508748|FG000|Overall Study|Death|1|||
125513158|NCT01191697|451508748|FG000|Overall Study|Physician Decision|2|||
125513159|NCT01191697|451508748|FG000|Overall Study|Pursue chemoradiation|2|||
125513160|NCT01191697|451508748|FG000|Overall Study|Break from chemotherapy|2|||
125513161|NCT01191697|451508748|FG000|Overall Study|Withdrawal by Subject|1|||
125513162|NCT01191697|451508748|FG000|Overall Study|Surveillance|1|||
125513163|NCT01191697|451508748|FG000|Overall Study|Adverse Event|2|||
125513164|NCT01191697|451508748|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
125513165|NCT01191697|451508748|FG000|Overall Study|Not completed but analyzed|25|||
125513166|NCT01066897|451508752|FG000|Overall Study|Withdrawal by Subject|1|||
125513167|NCT01066897|451508753|FG001|Overall Study|Withdrawal by Subject|0|||
125513168|NCT01066897|451508752|FG000|Overall Study|stopped study after developing the flu.|1|||
125513169|NCT01066897|451508753|FG001|Overall Study|stopped study after developing the flu.|0|||
125513170|NCT05372913|451508760|FG000|Overall Study|Withdrawal by Subject|0|||
125513171|NCT05372913|451508761|FG001|Overall Study|Withdrawal by Subject|2|||
125513172|NCT05372913|451508760|FG000|Overall Study|Protocol Violation|2|||
125513173|NCT05372913|451508761|FG001|Overall Study|Protocol Violation|2|||
125513174|NCT05372913|451508760|FG000|Overall Study|Adverse Event|0|||
125513175|NCT05372913|451508761|FG001|Overall Study|Adverse Event|1|||
125513176|NCT03275402|451508762|FG000|Overall Study|Death|17|||
125513177|NCT03275402|451508762|FG000|Overall Study|Study terminated by sponsor|21|||
125513178|NCT03275402|451508762|FG000|Overall Study|Withdrawal by Subject|1|||
125513179|NCT05135156|451508763|FG000|Overall Study|Lost to Follow-up|0|||
125513180|NCT05135156|451508764|FG001|Overall Study|Lost to Follow-up|0|||
125513181|NCT05135156|451508765|FG002|Overall Study|Lost to Follow-up|2|||
125513182|NCT02986659|451508769|FG000|First Intervention Period|Adverse Event|3|||
125513183|NCT02986659|451508770|FG001|First Intervention Period|Adverse Event|1|||
125513184|NCT02986659|451508769|FG000|First Intervention Period|Lost to Follow-up|1|||
125513185|NCT02986659|451508770|FG001|First Intervention Period|Lost to Follow-up|0|||
125513186|NCT02986659|451508769|FG000|First Intervention Period|Withdrawal by Subject|0|||
125532604|NCT00350727|451580162|FG001|Phase II|Withdrawal by Subject|2|||
125513187|NCT02986659|451508770|FG001|First Intervention Period|Withdrawal by Subject|1|||
125513188|NCT02986659|451508769|FG000|Second Intervention Period|Adverse Event|0|||
125513189|NCT02986659|451508770|FG001|Second Intervention Period|Adverse Event|6|||
125513190|NCT02402465|451508776|FG000|Overall Study|Withdrawal by Subject|0|||
125513191|NCT02402465|451508777|FG001|Overall Study|Withdrawal by Subject|0|||
125513192|NCT02402465|451508778|FG002|Overall Study|Withdrawal by Subject|0|||
125513193|NCT02402465|451508779|FG003|Overall Study|Withdrawal by Subject|0|||
125513194|NCT02402465|451508780|FG004|Overall Study|Withdrawal by Subject|0|||
125513195|NCT02402465|451508781|FG005|Overall Study|Withdrawal by Subject|1|||
125513196|NCT02402465|451508776|FG000|Overall Study|Lost to Follow-up|0|||
125513197|NCT02402465|451508777|FG001|Overall Study|Lost to Follow-up|1|||
125513198|NCT02402465|451508778|FG002|Overall Study|Lost to Follow-up|0|||
125513199|NCT02402465|451508779|FG003|Overall Study|Lost to Follow-up|0|||
125513200|NCT02402465|451508780|FG004|Overall Study|Lost to Follow-up|1|||
125513201|NCT02402465|451508781|FG005|Overall Study|Lost to Follow-up|0|||
125513202|NCT03807700|451508782|FG000|Overall Study|Withdrawal by Subject|2|||
125513203|NCT03807700|451508783|FG001|Overall Study|Withdrawal by Subject|1|||
125513204|NCT02005029|451508785|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
125513205|NCT02005029|451508786|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
125513206|NCT02316847|451508787|FG000|Overall Study|Adverse Event|0|||
125513207|NCT02316847|451508788|FG001|Overall Study|Adverse Event|3|||
125513208|NCT02316847|451508787|FG000|Overall Study|Lost to Follow-up|0|||
125513209|NCT02316847|451508788|FG001|Overall Study|Lost to Follow-up|2|||
125513210|NCT02316847|451508787|FG000|Overall Study|Physician Decision|0|||
125513211|NCT02316847|451508788|FG001|Overall Study|Physician Decision|1|||
125513212|NCT02316847|451508787|FG000|Overall Study|Pregnancy|0|||
125513213|NCT02316847|451508788|FG001|Overall Study|Pregnancy|1|||
125513214|NCT02316847|451508787|FG000|Overall Study|Withdrawal by Subject|2|||
125513215|NCT02316847|451508788|FG001|Overall Study|Withdrawal by Subject|9|||
125513216|NCT02316847|451508787|FG000|Overall Study|Noncompliance with study drug|0|||
125513217|NCT02316847|451508788|FG001|Overall Study|Noncompliance with study drug|3|||
125513218|NCT02316847|451508787|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
125513219|NCT02316847|451508788|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
125513220|NCT01370018|451508789|FG000|Overall Study|Did not meet criteria for analysis|1|||
125513221|NCT03772041|451508790|FG000|Overall Study|Adverse Event|8|||
125513222|NCT03772041|451508791|FG001|Overall Study|Adverse Event|3|||
125513223|NCT03772041|451508790|FG000|Overall Study|Withdrawal by Subject|0|||
125513224|NCT03772041|451508791|FG001|Overall Study|Withdrawal by Subject|2|||
125513225|NCT03772041|451508790|FG000|Overall Study|Protocol Violation|4|||
125513226|NCT03772041|451508791|FG001|Overall Study|Protocol Violation|2|||
125513227|NCT03772041|451508790|FG000|Overall Study|Physician Decision|2|||
125513228|NCT03772041|451508791|FG001|Overall Study|Physician Decision|3|||
125513229|NCT01525641|451508792|FG000|Overall Study|Case report form not collected|25|||
125513230|NCT01525641|451508792|FG000|Overall Study|No visit since the first visit|16|||
125513231|NCT01525641|451508792|FG000|Overall Study|Adverse Event|73|||
125513232|NCT01525641|451508792|FG000|Overall Study|Lack of Efficacy|24|||
125513233|NCT01525641|451508792|FG000|Overall Study|Improvement|5|||
125513234|NCT01525641|451508792|FG000|Overall Study|Lost to follow-up (relocation)|1|||
125513235|NCT01525641|451508792|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
125513236|NCT01525641|451508792|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
125513237|NCT01525641|451508792|FG000|Overall Study|Other than stated above|7|||
125513238|NCT00191984|451508808|FG000|Overall Study|Disease Progression|21|||
125513239|NCT00191984|451508808|FG000|Overall Study|Adverse Event|4|||
125513240|NCT00191984|451508808|FG000|Overall Study|Death|2|||
125513241|NCT00191984|451508808|FG000|Overall Study|Entry Criteria Exclusion|1|||
125513242|NCT00191984|451508808|FG000|Overall Study|Withdrawal by Subject|7|||
125513243|NCT00191984|451508808|FG000|Overall Study|Physician Decision|4|||
125513244|NCT02137239|451508809|FG000|Overall Study|Discontinued Study Treatment|0|||
125513245|NCT02137239|451508810|FG001|Overall Study|Discontinued Study Treatment|3|||
125513246|NCT02137239|451508809|FG000|Overall Study|Withdrew Consent|1|||
125513247|NCT02137239|451508810|FG001|Overall Study|Withdrew Consent|1|||
125513248|NCT02137239|451508809|FG000|Overall Study|Adverse Event|2|||
125513249|NCT02137239|451508810|FG001|Overall Study|Adverse Event|2|||
125513250|NCT03048058|451508812|FG000|Overall Study|Lost to Follow-up|4|||
125513251|NCT03048058|451508813|FG001|Overall Study|Lost to Follow-up|0|||
125513252|NCT03048058|451508812|FG000|Overall Study|Withdrawal by Subject|0|||
125513253|NCT03048058|451508813|FG001|Overall Study|Withdrawal by Subject|4|||
125513254|NCT02359552|451508815|FG000|Overall Study|Lost to Follow-up|3|||
125513255|NCT02359552|451508816|FG001|Overall Study|Lost to Follow-up|4|||
125513256|NCT02391116|451508817|FG000|Treatment|Withdrawal by Subject|1|||
125513257|NCT02391116|451508817|FG000|Treatment|Protocol Violation|1|||
125513258|NCT02391116|451508817|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
125513259|NCT02391116|451508817|FG000|Treatment|AE with Clinical PD|3|||
125513260|NCT02391116|451508817|FG000|Safety Follow-up|Adverse Event|1|||
125513261|NCT02391116|451508817|FG000|Safety Follow-up|Withdrawal by Subject|4|||
125513262|NCT02391116|451508817|FG000|Safety Follow-up|Switching to Other Therapy|4|||
125513263|NCT02391116|451508817|FG000|Safety Follow-up|No Follow Up|1|||
125513264|NCT02391116|451508817|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
125513265|NCT02391116|451508817|FG000|Active Follow-up|Withdrawal by Subject|1|||
125513266|NCT02391116|451508817|FG000|Active Follow-up|Switching to Other Therapy|2|||
125513267|NCT02391116|451508817|FG000|Survival Follow-up|Withdrawal by Subject|3|||
125513268|NCT02391116|451508817|FG000|Survival Follow-up|Switching to Other Therapy|1|||
125513269|NCT02133131|451508819|FG000|Overall Study|Adverse Event|0|||
125513270|NCT02133131|451508820|FG001|Overall Study|Adverse Event|0|||
125513271|NCT02133131|451508821|FG002|Overall Study|Adverse Event|0|||
125513272|NCT02133131|451508822|FG003|Overall Study|Adverse Event|1|||
125513273|NCT02133131|451508823|FG004|Overall Study|Adverse Event|0|||
125513274|NCT02133131|451508824|FG005|Overall Study|Adverse Event|0|||
125513275|NCT02133131|451508825|FG006|Overall Study|Adverse Event|0|||
125513276|NCT02133131|451508819|FG000|Overall Study|Lost to Follow-up|1|||
125513277|NCT02133131|451508820|FG001|Overall Study|Lost to Follow-up|0|||
125513278|NCT02133131|451508821|FG002|Overall Study|Lost to Follow-up|0|||
125513279|NCT02133131|451508822|FG003|Overall Study|Lost to Follow-up|1|||
125513280|NCT02133131|451508823|FG004|Overall Study|Lost to Follow-up|0|||
125513281|NCT02133131|451508824|FG005|Overall Study|Lost to Follow-up|0|||
125513282|NCT02133131|451508825|FG006|Overall Study|Lost to Follow-up|0|||
125513283|NCT02133131|451508819|FG000|Overall Study|Status not recorded|4|||
125513284|NCT02133131|451508820|FG001|Overall Study|Status not recorded|5|||
125513285|NCT02133131|451508821|FG002|Overall Study|Status not recorded|1|||
125513286|NCT02133131|451508822|FG003|Overall Study|Status not recorded|4|||
125513287|NCT02133131|451508823|FG004|Overall Study|Status not recorded|0|||
125513288|NCT02133131|451508824|FG005|Overall Study|Status not recorded|0|||
125513289|NCT02133131|451508825|FG006|Overall Study|Status not recorded|0|||
125513290|NCT02133131|451508819|FG000|Overall Study|Ongoing in study|0|||
125513291|NCT02133131|451508820|FG001|Overall Study|Ongoing in study|0|||
125513292|NCT02133131|451508821|FG002|Overall Study|Ongoing in study|0|||
125513293|NCT02133131|451508822|FG003|Overall Study|Ongoing in study|0|||
125513294|NCT02133131|451508823|FG004|Overall Study|Ongoing in study|15|||
125513295|NCT02133131|451508824|FG005|Overall Study|Ongoing in study|14|||
125513296|NCT02133131|451508825|FG006|Overall Study|Ongoing in study|11|||
125513297|NCT02133131|451508819|FG000|Overall Study|Protocol Violation|0|||
125513298|NCT02133131|451508820|FG001|Overall Study|Protocol Violation|0|||
125513299|NCT02133131|451508821|FG002|Overall Study|Protocol Violation|0|||
125513300|NCT02133131|451508822|FG003|Overall Study|Protocol Violation|0|||
125513301|NCT02133131|451508823|FG004|Overall Study|Protocol Violation|0|||
125513302|NCT02133131|451508824|FG005|Overall Study|Protocol Violation|0|||
125513303|NCT02133131|451508825|FG006|Overall Study|Protocol Violation|1|||
125513304|NCT01544153|451508826|FG000|Overall Study|Under 18|0|||
125513305|NCT01544153|451508827|FG001|Overall Study|Under 18|1|||
125513306|NCT01544153|451508828|FG002|Overall Study|Under 18|0|||
125513307|NCT01544153|451508829|FG003|Overall Study|Under 18|0|||
125513308|NCT01544153|451508826|FG000|Overall Study|Non-smoker|0|||
125513309|NCT01544153|451508827|FG001|Overall Study|Non-smoker|0|||
125513310|NCT01544153|451508828|FG002|Overall Study|Non-smoker|1|||
125513311|NCT01544153|451508829|FG003|Overall Study|Non-smoker|0|||
125513312|NCT03169530|451508834|FG000|Overall Study|Study ended by NIH|15|||
125513313|NCT03169530|451508835|FG001|Overall Study|Study ended by NIH|17|||
125513314|NCT00884793|451508836|FG000|Overall Study|Withdrawal by Subject|1|||
125513315|NCT01032200|451508837|FG000|Overall Study|Death|1|||
125513316|NCT01032200|451508838|FG001|Overall Study|Death|1|||
125513317|NCT01032200|451508837|FG000|Overall Study|Withdrawal by Subject|1|||
125513318|NCT01032200|451508838|FG001|Overall Study|Withdrawal by Subject|3|||
125513319|NCT01032200|451508837|FG000|Overall Study|Toxicity|0|||
125513320|NCT01032200|451508838|FG001|Overall Study|Toxicity|2|||
125513321|NCT01032200|451508837|FG000|Overall Study|Progression|1|||
125513322|NCT01032200|451508838|FG001|Overall Study|Progression|0|||
125513323|NCT01032200|451508837|FG000|Overall Study|Multiple|1|||
125513324|NCT01032200|451508838|FG001|Overall Study|Multiple|1|||
125513325|NCT00714688|451508842|FG000|Overall Study|Lack of Efficacy|14|||
125513326|NCT00714688|451508843|FG001|Overall Study|Lack of Efficacy|1|||
125513327|NCT00714688|451508844|FG002|Overall Study|Lack of Efficacy|4|||
125513328|NCT00714688|451508842|FG000|Overall Study|Withdrawal by Subject|4|||
125513329|NCT00714688|451508843|FG001|Overall Study|Withdrawal by Subject|3|||
125513330|NCT00714688|451508844|FG002|Overall Study|Withdrawal by Subject|3|||
125513331|NCT00714688|451508842|FG000|Overall Study|Lost to Follow-up|5|||
125513332|NCT00714688|451508843|FG001|Overall Study|Lost to Follow-up|2|||
125513333|NCT00714688|451508844|FG002|Overall Study|Lost to Follow-up|0|||
125513334|NCT00714688|451508842|FG000|Overall Study|Adverse Event|2|||
125513335|NCT00714688|451508843|FG001|Overall Study|Adverse Event|15|||
125513336|NCT00714688|451508844|FG002|Overall Study|Adverse Event|19|||
125513337|NCT00714688|451508842|FG000|Overall Study|Subject Non-compliant|3|||
125513338|NCT00714688|451508843|FG001|Overall Study|Subject Non-compliant|5|||
125513339|NCT00714688|451508844|FG002|Overall Study|Subject Non-compliant|5|||
125513340|NCT00714688|451508842|FG000|Overall Study|Ineligible to Continue the Study|0|||
125513341|NCT00714688|451508843|FG001|Overall Study|Ineligible to Continue the Study|1|||
125513342|NCT00714688|451508844|FG002|Overall Study|Ineligible to Continue the Study|1|||
125513343|NCT00714688|451508842|FG000|Overall Study|Sponsor's Decision|0|||
125513344|NCT00714688|451508843|FG001|Overall Study|Sponsor's Decision|2|||
125513345|NCT00714688|451508844|FG002|Overall Study|Sponsor's Decision|0|||
125513346|NCT00714688|451508842|FG000|Overall Study|Other|1|||
125513347|NCT00714688|451508843|FG001|Overall Study|Other|6|||
125513348|NCT00714688|451508844|FG002|Overall Study|Other|5|||
125513349|NCT00500539|451508845|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
125513350|NCT00500539|451508845|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
125513351|NCT00500539|451508845|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
125513352|NCT00500539|451508845|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
125513353|NCT00500539|451508845|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
125513354|NCT00500539|451508845|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
125513355|NCT00500539|451508845|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
125513356|NCT00500539|451508845|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
125513357|NCT00500539|451508845|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
125513358|NCT00500539|451508845|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
125513359|NCT00500539|451508845|FG000|Follow-up Period (16 Weeks)|Death|1|||
125513360|NCT00500539|451508845|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
125513361|NCT00500539|451508845|FG000|Follow-up Period (16 Weeks)|Missing|3|||
125513362|NCT02316171|451508846|FG000|Overall Study|difficulties with urinary catheter|1|||
125513363|NCT02316171|451508847|FG001|Overall Study|difficulties with urinary catheter|0|||
125513364|NCT02316171|451508848|FG002|Overall Study|difficulties with urinary catheter|0|||
125513365|NCT02316171|451508849|FG003|Overall Study|difficulties with urinary catheter|0|||
125513366|NCT01524887|451508851|FG000|Overall Study|Withdrawal by Subject|6|||
125513367|NCT01524887|451508852|FG001|Overall Study|Withdrawal by Subject|2|||
125513368|NCT01524887|451508853|FG002|Overall Study|Withdrawal by Subject|3|||
125513369|NCT01524887|451508851|FG000|Overall Study|Adverse Event|5|||
125513370|NCT01524887|451508852|FG001|Overall Study|Adverse Event|1|||
125513371|NCT01524887|451508853|FG002|Overall Study|Adverse Event|1|||
125513372|NCT01524887|451508851|FG000|Overall Study|Protocol Violation|0|||
125513373|NCT01524887|451508852|FG001|Overall Study|Protocol Violation|0|||
125513374|NCT01524887|451508853|FG002|Overall Study|Protocol Violation|1|||
125513375|NCT01524887|451508851|FG000|Overall Study|Study termination|73|||
125513376|NCT01524887|451508852|FG001|Overall Study|Study termination|87|||
125513377|NCT01524887|451508853|FG002|Overall Study|Study termination|79|||
125513378|NCT01524887|451508851|FG000|Overall Study|Withdrawal by Caregiver|0|||
125513379|NCT01524887|451508852|FG001|Overall Study|Withdrawal by Caregiver|0|||
125513380|NCT01524887|451508853|FG002|Overall Study|Withdrawal by Caregiver|2|||
125513381|NCT01524887|451508851|FG000|Overall Study|Use of prohibited medication|1|||
125513382|NCT01524887|451508852|FG001|Overall Study|Use of prohibited medication|0|||
125513383|NCT01524887|451508853|FG002|Overall Study|Use of prohibited medication|0|||
125513384|NCT00547300|451508854|FG000|Overall Study|Study was Administratively Terminated|25|||
125513385|NCT00547300|451508855|FG001|Overall Study|Study was Administratively Terminated|24|||
125513386|NCT00547300|451508854|FG000|Overall Study|Did not Meet Entry Criteria|0|||
125513387|NCT00547300|451508855|FG001|Overall Study|Did not Meet Entry Criteria|2|||
125513388|NCT04380688|451508858|FG000|Overall Study|Death|2|||
125513389|NCT04380688|451508859|FG001|Overall Study|Death|2|||
125513390|NCT04380688|451508858|FG000|Overall Study|Lost to Follow-up|2|||
125513391|NCT04380688|451508859|FG001|Overall Study|Lost to Follow-up|4|||
125513392|NCT04380688|451508858|FG000|Overall Study|Withdrawal by Subject|3|||
125513393|NCT04380688|451508859|FG001|Overall Study|Withdrawal by Subject|3|||
125513394|NCT03993054|451508860|FG000|Overall Study|PI Decision|1|||
125513395|NCT04267393|451508863|FG000|Randomization|Adverse Event|1|||
125513396|NCT04267393|451508864|FG001|Randomization|Adverse Event|0|||
125513397|NCT04267393|451508865|FG002|Randomization|Adverse Event|0|||
125513398|NCT04267393|451508863|FG000|Randomization|Administrative Reasons by Sponsor|0|||
125513399|NCT04267393|451508864|FG001|Randomization|Administrative Reasons by Sponsor|1|||
125513400|NCT04267393|451508865|FG002|Randomization|Administrative Reasons by Sponsor|0|||
125513401|NCT04267393|451508863|FG000|Treatment Period|Adverse Event|0|||
125513402|NCT04267393|451508864|FG001|Treatment Period|Adverse Event|2|||
125513403|NCT04267393|451508865|FG002|Treatment Period|Adverse Event|3|||
125513404|NCT04267393|451508863|FG000|Treatment Period|Participant Withdrew Consent|0|||
125513405|NCT04267393|451508864|FG001|Treatment Period|Participant Withdrew Consent|0|||
125513406|NCT04267393|451508865|FG002|Treatment Period|Participant Withdrew Consent|1|||
125513407|NCT04267393|451508863|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
125513408|NCT04267393|451508864|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
125513409|NCT04267393|451508865|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
125513410|NCT01002547|451510722|FG000|Overall Study|Withdrawal by Subject|4|||
125513411|NCT01002547|451510723|FG001|Overall Study|Withdrawal by Subject|0|||
125513412|NCT01002547|451510724|FG002|Overall Study|Withdrawal by Subject|5|||
125513413|NCT01002547|451510722|FG000|Overall Study|Lost to Follow-up|2|||
125513414|NCT01002547|451510723|FG001|Overall Study|Lost to Follow-up|1|||
125513415|NCT01002547|451510724|FG002|Overall Study|Lost to Follow-up|1|||
125513416|NCT01002547|451510722|FG000|Overall Study|Physician Decision|1|||
125513417|NCT01002547|451510723|FG001|Overall Study|Physician Decision|0|||
125513418|NCT01002547|451510724|FG002|Overall Study|Physician Decision|0|||
125513419|NCT01002547|451510722|FG000|Overall Study|Death|0|||
125513420|NCT01002547|451510723|FG001|Overall Study|Death|2|||
125513421|NCT01002547|451510724|FG002|Overall Study|Death|2|||
125513422|NCT01002547|451510722|FG000|Overall Study|Adverse Event|1|||
125513423|NCT01002547|451510723|FG001|Overall Study|Adverse Event|0|||
125513424|NCT01002547|451510724|FG002|Overall Study|Adverse Event|0|||
125513425|NCT02093897|451510729|FG000|Overall Study|Physician Decision|1|||
125513426|NCT02093897|451510729|FG000|Overall Study|Planned age group closure - no's reached|17|||
125513427|NCT02093897|451510729|FG000|Overall Study|Adverse event, non-fatal|1|||
125513428|NCT00088452|451510730|FG000|Overall Study|Did not receive intervention|1|||
125513429|NCT00088452|451510731|FG001|Overall Study|Did not receive intervention|0|||
125513430|NCT00088452|451510732|FG002|Overall Study|Did not receive intervention|1|||
125513431|NCT02081196|451510734|FG000|Overall Study|Lost to Follow-up|1|||
125513432|NCT03098797|451510737|FG000|Part 2 Open Label Extension|Adverse Event|2|||
125513433|NCT03098797|451510738|FG001|Part 2 Open Label Extension|Adverse Event|0|||
125513434|NCT00434577|451510741|FG000|Months 0-3|Serious Adverse Event|0|||
125513435|NCT00434577|451510742|FG001|Months 0-3|Serious Adverse Event|0|||
125513436|NCT00434577|451510743|FG002|Months 0-3|Serious Adverse Event|1|||
125513437|NCT00434577|451510744|FG003|Months 0-3|Serious Adverse Event|0|||
125513438|NCT00434577|451510745|FG004|Months 0-3|Serious Adverse Event|0|||
125513439|NCT00434577|451510741|FG000|Months 0-3|Adverse Event|0|||
125513440|NCT00434577|451510742|FG001|Months 0-3|Adverse Event|1|||
125513441|NCT00434577|451510743|FG002|Months 0-3|Adverse Event|1|||
125513442|NCT00434577|451510744|FG003|Months 0-3|Adverse Event|0|||
125513443|NCT00434577|451510745|FG004|Months 0-3|Adverse Event|0|||
125513444|NCT00434577|451510741|FG000|Months 0-3|Lost to Follow-up|0|||
125513445|NCT00434577|451510742|FG001|Months 0-3|Lost to Follow-up|0|||
125513446|NCT00434577|451510743|FG002|Months 0-3|Lost to Follow-up|0|||
125513447|NCT00434577|451510744|FG003|Months 0-3|Lost to Follow-up|0|||
125513448|NCT00434577|451510745|FG004|Months 0-3|Lost to Follow-up|2|||
125513449|NCT00434577|451510741|FG000|Months 0-3|Protocol Violation|1|||
125513450|NCT00434577|451510742|FG001|Months 0-3|Protocol Violation|0|||
125513451|NCT00434577|451510743|FG002|Months 0-3|Protocol Violation|1|||
125513452|NCT00434577|451510744|FG003|Months 0-3|Protocol Violation|0|||
125513453|NCT00434577|451510745|FG004|Months 0-3|Protocol Violation|0|||
125513454|NCT00434577|451510741|FG000|Months 0-3|Withdrawal by Subject|2|||
125513455|NCT00434577|451510742|FG001|Months 0-3|Withdrawal by Subject|1|||
125513456|NCT00434577|451510743|FG002|Months 0-3|Withdrawal by Subject|1|||
125513457|NCT00434577|451510744|FG003|Months 0-3|Withdrawal by Subject|1|||
125513458|NCT00434577|451510745|FG004|Months 0-3|Withdrawal by Subject|1|||
125513459|NCT01967719|451510746|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
125513460|NCT01967719|451510747|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
125513461|NCT01967719|451510748|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
125513462|NCT01967719|451510749|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
125513463|NCT01967719|451510746|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
125513464|NCT01967719|451510747|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
125513465|NCT01967719|451510748|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
125513466|NCT01967719|451510749|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
125513467|NCT02329223|451510750|FG000|Overall Study|Withdrawal by Subject|1|||
125513468|NCT02329223|451510751|FG001|Overall Study|Withdrawal by Subject|2|||
125513469|NCT02329223|451510752|FG002|Overall Study|Withdrawal by Subject|5|||
125513470|NCT02329223|451510750|FG000|Overall Study|Physician Decision|0|||
125513471|NCT02329223|451510751|FG001|Overall Study|Physician Decision|0|||
125513472|NCT02329223|451510752|FG002|Overall Study|Physician Decision|1|||
125513473|NCT02329223|451510750|FG000|Overall Study|Adverse Event|0|||
125513474|NCT02329223|451510751|FG001|Overall Study|Adverse Event|1|||
125513475|NCT02329223|451510752|FG002|Overall Study|Adverse Event|0|||
125513476|NCT00381888|451510760|FG000|Overall Study|Death|1|||
125513477|NCT00381888|451510760|FG000|Overall Study|Withdrawal by Subject|1|||
125513478|NCT00381888|451510760|FG000|Overall Study|Physician Decision|1|||
125513479|NCT00381888|451510760|FG000|Overall Study|Protocol Violation|9|||
125513480|NCT00381888|451510760|FG000|Overall Study|Had laparoscopic surgery|2|||
125513481|NCT00381888|451510760|FG000|Overall Study|Surgery was cancelled|2|||
125513482|NCT00381888|451510760|FG000|Overall Study|Adverse Event|1|||
125306403|NCT02737475|450749024|FG020|Overall Study|Participant withdrew consent|2|||
125513483|NCT01231464|451510761|FG000|Overall Study|Adverse Event|0|||
125513484|NCT01231464|451510762|FG001|Overall Study|Adverse Event|1|||
125513485|NCT01231464|451510761|FG000|Overall Study|Protocol Violation|1|||
125513486|NCT01231464|451510762|FG001|Overall Study|Protocol Violation|2|||
125513487|NCT01231464|451510761|FG000|Overall Study|Lost to Follow-up|1|||
125513488|NCT01231464|451510762|FG001|Overall Study|Lost to Follow-up|2|||
125513489|NCT01231464|451510761|FG000|Overall Study|Withdrawal by Subject|3|||
125513490|NCT01231464|451510762|FG001|Overall Study|Withdrawal by Subject|2|||
125513491|NCT01589523|451510771|FG000|Overall Study|Withdrawal by Subject|1|||
125513492|NCT00961896|451510772|FG000|Overall Study|Abnormal laboratory value|0|||
125513493|NCT00961896|451510773|FG001|Overall Study|Abnormal laboratory value|0|||
125513494|NCT00961896|451510774|FG002|Overall Study|Abnormal laboratory value|1|||
125513495|NCT00506922|451510775|FG000|Overall Study|Physician Decision|0|||
125513496|NCT00506922|451510776|FG001|Overall Study|Physician Decision|0|||
125513497|NCT00506922|451510777|FG002|Overall Study|Physician Decision|0|||
125306404|NCT02737475|450749025|FG021|Overall Study|Participant withdrew consent|0|||
125306405|NCT02737475|450749026|FG022|Overall Study|Participant withdrew consent|0|||
125306406|NCT02737475|450749027|FG023|Overall Study|Participant withdrew consent|0|||
125306407|NCT02737475|450749028|FG024|Overall Study|Participant withdrew consent|0|||
125306408|NCT02737475|450749029|FG025|Overall Study|Participant withdrew consent|0|||
125306409|NCT02737475|450749030|FG026|Overall Study|Participant withdrew consent|0|||
125306410|NCT02737475|450749004|FG000|Overall Study|Lost to Follow-up|0|||
125306411|NCT02737475|450749005|FG001|Overall Study|Lost to Follow-up|0|||
125306412|NCT02737475|450749006|FG002|Overall Study|Lost to Follow-up|0|||
125306413|NCT02737475|450749007|FG003|Overall Study|Lost to Follow-up|0|||
125306414|NCT02737475|450749008|FG004|Overall Study|Lost to Follow-up|0|||
125306415|NCT02737475|450749009|FG005|Overall Study|Lost to Follow-up|0|||
125306416|NCT02737475|450749010|FG006|Overall Study|Lost to Follow-up|0|||
125306417|NCT02737475|450749011|FG007|Overall Study|Lost to Follow-up|0|||
125306418|NCT02737475|450749012|FG008|Overall Study|Lost to Follow-up|0|||
125306419|NCT02737475|450749013|FG009|Overall Study|Lost to Follow-up|0|||
125306420|NCT02737475|450749014|FG010|Overall Study|Lost to Follow-up|0|||
125306421|NCT02737475|450749015|FG011|Overall Study|Lost to Follow-up|0|||
125306422|NCT02737475|450749016|FG012|Overall Study|Lost to Follow-up|0|||
125306423|NCT02737475|450749017|FG013|Overall Study|Lost to Follow-up|0|||
125306424|NCT02737475|450749018|FG014|Overall Study|Lost to Follow-up|0|||
125306425|NCT02737475|450749019|FG015|Overall Study|Lost to Follow-up|1|||
125306426|NCT02737475|450749020|FG016|Overall Study|Lost to Follow-up|0|||
125306427|NCT02737475|450749021|FG017|Overall Study|Lost to Follow-up|0|||
125306428|NCT02737475|450749022|FG018|Overall Study|Lost to Follow-up|0|||
125306429|NCT02737475|450749023|FG019|Overall Study|Lost to Follow-up|0|||
125306430|NCT02737475|450749024|FG020|Overall Study|Lost to Follow-up|0|||
125306431|NCT02737475|450749025|FG021|Overall Study|Lost to Follow-up|0|||
125306432|NCT02737475|450749026|FG022|Overall Study|Lost to Follow-up|0|||
125306433|NCT02737475|450749027|FG023|Overall Study|Lost to Follow-up|0|||
125306434|NCT02737475|450749028|FG024|Overall Study|Lost to Follow-up|0|||
125306435|NCT02737475|450749029|FG025|Overall Study|Lost to Follow-up|0|||
125306436|NCT02737475|450749030|FG026|Overall Study|Lost to Follow-up|0|||
125306437|NCT02737475|450749004|FG000|Overall Study|Disease Progression|0|||
125306438|NCT02737475|450749005|FG001|Overall Study|Disease Progression|0|||
125306439|NCT02737475|450749006|FG002|Overall Study|Disease Progression|0|||
125513498|NCT00506922|451510778|FG003|Overall Study|Physician Decision|2|||
125513499|NCT00506922|451510779|FG004|Overall Study|Physician Decision|0|||
125513500|NCT00506922|451510775|FG000|Overall Study|Withdrawal by Subject|0|||
125513501|NCT00506922|451510776|FG001|Overall Study|Withdrawal by Subject|0|||
125513502|NCT00506922|451510777|FG002|Overall Study|Withdrawal by Subject|0|||
125513503|NCT00506922|451510778|FG003|Overall Study|Withdrawal by Subject|0|||
125513504|NCT00506922|451510779|FG004|Overall Study|Withdrawal by Subject|1|||
125513505|NCT02507687|451510791|FG000|Overall Study|Adverse Event|3|||
125513506|NCT02507687|451510792|FG001|Overall Study|Adverse Event|2|||
125513507|NCT02507687|451510793|FG002|Overall Study|Adverse Event|2|||
125513508|NCT02507687|451510794|FG003|Overall Study|Adverse Event|2|||
125513509|NCT02507687|451510791|FG000|Overall Study|Withdrawal by Subject|1|||
125513510|NCT02507687|451510792|FG001|Overall Study|Withdrawal by Subject|4|||
125513511|NCT02507687|451510793|FG002|Overall Study|Withdrawal by Subject|6|||
125513512|NCT02507687|451510794|FG003|Overall Study|Withdrawal by Subject|6|||
125513513|NCT02507687|451510791|FG000|Overall Study|Protocol Violation|1|||
125513514|NCT02507687|451510792|FG001|Overall Study|Protocol Violation|0|||
125513515|NCT02507687|451510793|FG002|Overall Study|Protocol Violation|2|||
125513516|NCT02507687|451510794|FG003|Overall Study|Protocol Violation|0|||
125306440|NCT02737475|450749007|FG003|Overall Study|Disease Progression|0|||
125306441|NCT02737475|450749008|FG004|Overall Study|Disease Progression|0|||
125306442|NCT02737475|450749009|FG005|Overall Study|Disease Progression|0|||
125306443|NCT02737475|450749010|FG006|Overall Study|Disease Progression|0|||
125306444|NCT02737475|450749011|FG007|Overall Study|Disease Progression|0|||
125306445|NCT02737475|450749012|FG008|Overall Study|Disease Progression|0|||
125306446|NCT02737475|450749013|FG009|Overall Study|Disease Progression|0|||
125306447|NCT02737475|450749014|FG010|Overall Study|Disease Progression|0|||
125306448|NCT02737475|450749015|FG011|Overall Study|Disease Progression|0|||
125306449|NCT02737475|450749016|FG012|Overall Study|Disease Progression|0|||
125306450|NCT02737475|450749017|FG013|Overall Study|Disease Progression|0|||
125306451|NCT02737475|450749018|FG014|Overall Study|Disease Progression|0|||
125306452|NCT02737475|450749019|FG015|Overall Study|Disease Progression|0|||
125306453|NCT02737475|450749020|FG016|Overall Study|Disease Progression|0|||
125513517|NCT02507687|451510791|FG000|Overall Study|Lost to Follow-up|0|||
125513518|NCT02507687|451510792|FG001|Overall Study|Lost to Follow-up|0|||
125513519|NCT02507687|451510793|FG002|Overall Study|Lost to Follow-up|2|||
125306454|NCT02737475|450749021|FG017|Overall Study|Disease Progression|0|||
125513520|NCT02507687|451510794|FG003|Overall Study|Lost to Follow-up|1|||
125513521|NCT02507687|451510791|FG000|Overall Study|Screen Failure|0|||
125513522|NCT02507687|451510792|FG001|Overall Study|Screen Failure|0|||
125513523|NCT02507687|451510793|FG002|Overall Study|Screen Failure|1|||
125306455|NCT02737475|450749022|FG018|Overall Study|Disease Progression|0|||
125513524|NCT02507687|451510794|FG003|Overall Study|Screen Failure|0|||
125306456|NCT02737475|450749023|FG019|Overall Study|Disease Progression|0|||
125306457|NCT02737475|450749024|FG020|Overall Study|Disease Progression|0|||
125306458|NCT02737475|450749025|FG021|Overall Study|Disease Progression|0|||
125306459|NCT02737475|450749026|FG022|Overall Study|Disease Progression|0|||
125306460|NCT02737475|450749027|FG023|Overall Study|Disease Progression|0|||
125306461|NCT02737475|450749028|FG024|Overall Study|Disease Progression|0|||
125306462|NCT02737475|450749029|FG025|Overall Study|Disease Progression|0|||
125306463|NCT02737475|450749030|FG026|Overall Study|Disease Progression|1|||
125513525|NCT02507687|451510791|FG000|Overall Study|Other, Not Specified|0|||
125513526|NCT02507687|451510792|FG001|Overall Study|Other, Not Specified|0|||
125513527|NCT02507687|451510793|FG002|Overall Study|Other, Not Specified|2|||
125513528|NCT02507687|451510794|FG003|Overall Study|Other, Not Specified|4|||
125513529|NCT02675998|451510795|FG000|8-Week Treatment Period|Adverse Event|6|||
125513530|NCT02675998|451510796|FG001|8-Week Treatment Period|Adverse Event|5|||
125513531|NCT02675998|451510797|FG002|8-Week Treatment Period|Adverse Event|6|||
125513532|NCT02675998|451510798|FG003|8-Week Treatment Period|Adverse Event|0|||
125513533|NCT02675998|451510795|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
125513534|NCT02675998|451510796|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
125513535|NCT02675998|451510797|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
125513536|NCT02675998|451510798|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
125306464|NCT00546000|450749031|FG000|Overall Study|Adverse Event|1|||
125306465|NCT00546000|450749031|FG000|Overall Study|Lost to Follow-up|1|||
125513537|NCT02675998|451510795|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
125513538|NCT02675998|451510796|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
125513539|NCT02675998|451510797|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
125513540|NCT02675998|451510798|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
125513541|NCT02675998|451510795|FG000|8-Week Treatment Period|Physician Decision|1|||
125513542|NCT02675998|451510796|FG001|8-Week Treatment Period|Physician Decision|0|||
125513543|NCT02675998|451510797|FG002|8-Week Treatment Period|Physician Decision|2|||
125513544|NCT02675998|451510798|FG003|8-Week Treatment Period|Physician Decision|0|||
125513545|NCT02675998|451510795|FG000|8-Week Treatment Period|GI side Effects|1|||
125513546|NCT02675998|451510796|FG001|8-Week Treatment Period|GI side Effects|4|||
125513547|NCT02675998|451510797|FG002|8-Week Treatment Period|GI side Effects|2|||
125513548|NCT02675998|451510798|FG003|8-Week Treatment Period|GI side Effects|0|||
125513549|NCT02675998|451510795|FG000|8-Week Treatment Period|Protocol Violation|1|||
125513550|NCT02675998|451510796|FG001|8-Week Treatment Period|Protocol Violation|1|||
125306466|NCT00546000|450749031|FG000|Overall Study|Baseline HPA Axis Supression|2|||
125306467|NCT00660179|450749033|FG000|Overall Study|Death|44|||
125306468|NCT00660179|450749034|FG001|Overall Study|Death|47|||
125306469|NCT00660179|450749035|FG002|Overall Study|Death|34|||
125306470|NCT00660179|450749033|FG000|Overall Study|Withdrawal of consent|4|||
125306471|NCT00660179|450749034|FG001|Overall Study|Withdrawal of consent|6|||
125306472|NCT00660179|450749035|FG002|Overall Study|Withdrawal of consent|4|||
125306473|NCT00660179|450749033|FG000|Overall Study|Lost to Follow-up|7|||
125306474|NCT00660179|450749034|FG001|Overall Study|Lost to Follow-up|5|||
125306475|NCT00660179|450749035|FG002|Overall Study|Lost to Follow-up|2|||
125306476|NCT00660179|450749033|FG000|Overall Study|Administrative reason|0|||
125306477|NCT00660179|450749034|FG001|Overall Study|Administrative reason|0|||
125306478|NCT00660179|450749035|FG002|Overall Study|Administrative reason|1|||
125306479|NCT00660179|450749033|FG000|Overall Study|Incorrect randomization|1|||
125306480|NCT00660179|450749034|FG001|Overall Study|Incorrect randomization|0|||
125306481|NCT00660179|450749035|FG002|Overall Study|Incorrect randomization|0|||
125306482|NCT01504412|450749036|FG000|Overall Study|Adverse Event|1|||
125306483|NCT01504412|450749037|FG001|Overall Study|Adverse Event|8|||
125306484|NCT01504412|450749038|FG002|Overall Study|Adverse Event|1|||
125306485|NCT01504412|450749039|FG003|Overall Study|Adverse Event|7|||
125306486|NCT01504412|450749040|FG004|Overall Study|Adverse Event|10|||
125306487|NCT01504412|450749036|FG000|Overall Study|Withdrawal by Subject|2|||
125306488|NCT01504412|450749037|FG001|Overall Study|Withdrawal by Subject|1|||
125306489|NCT01504412|450749038|FG002|Overall Study|Withdrawal by Subject|1|||
125306490|NCT01504412|450749039|FG003|Overall Study|Withdrawal by Subject|5|||
125306491|NCT01504412|450749040|FG004|Overall Study|Withdrawal by Subject|1|||
125513551|NCT02675998|451510797|FG002|8-Week Treatment Period|Protocol Violation|1|||
125306492|NCT01504412|450749036|FG000|Overall Study|Other|2|||
125306493|NCT01504412|450749037|FG001|Overall Study|Other|1|||
125306494|NCT01504412|450749038|FG002|Overall Study|Other|1|||
125513552|NCT02675998|451510798|FG003|8-Week Treatment Period|Protocol Violation|0|||
125513553|NCT02675998|451510795|FG000|8-Week Treatment Period|Other|3|||
125513554|NCT02675998|451510796|FG001|8-Week Treatment Period|Other|1|||
125306495|NCT01504412|450749039|FG003|Overall Study|Other|6|||
125306496|NCT01504412|450749040|FG004|Overall Study|Other|1|||
125306497|NCT01504412|450749036|FG000|Overall Study|Lost to Follow-up|0|||
125306498|NCT01504412|450749037|FG001|Overall Study|Lost to Follow-up|2|||
125306499|NCT01504412|450749038|FG002|Overall Study|Lost to Follow-up|0|||
125306500|NCT01504412|450749039|FG003|Overall Study|Lost to Follow-up|0|||
125306501|NCT01504412|450749040|FG004|Overall Study|Lost to Follow-up|0|||
125306502|NCT01504412|450749036|FG000|Overall Study|Lack of Efficacy|0|||
125306503|NCT01504412|450749037|FG001|Overall Study|Lack of Efficacy|0|||
125306504|NCT01504412|450749038|FG002|Overall Study|Lack of Efficacy|1|||
125306505|NCT01504412|450749039|FG003|Overall Study|Lack of Efficacy|0|||
125306506|NCT01504412|450749040|FG004|Overall Study|Lack of Efficacy|1|||
125306507|NCT01504412|450749036|FG000|Overall Study|Death|0|||
125306508|NCT01504412|450749037|FG001|Overall Study|Death|0|||
125306509|NCT01504412|450749038|FG002|Overall Study|Death|0|||
125306510|NCT01504412|450749039|FG003|Overall Study|Death|1|||
125306511|NCT01504412|450749040|FG004|Overall Study|Death|0|||
125306512|NCT01449006|450749041|FG000|Overall Study|Lost to Follow-up|1|||
125306513|NCT01449006|450749042|FG001|Overall Study|Lost to Follow-up|0|||
125306514|NCT01449006|450749041|FG000|Overall Study|Withdrawal by Subject|1|||
125306515|NCT01449006|450749042|FG001|Overall Study|Withdrawal by Subject|0|||
125306516|NCT01449006|450749041|FG000|Overall Study|Protocol Violation|1|||
125306517|NCT01449006|450749042|FG001|Overall Study|Protocol Violation|0|||
125306518|NCT02221674|450749046|FG000|Overall Study|Lost to Follow-up|1|||
125306519|NCT02221674|450749047|FG001|Overall Study|Lost to Follow-up|0|||
125306520|NCT02221674|450749048|FG002|Overall Study|Lost to Follow-up|0|||
125306521|NCT05292131|450749049|FG000|Overall Study|Lost to Follow-up|1|||
125306522|NCT05292131|450749050|FG001|Overall Study|Lost to Follow-up|1|||
125306523|NCT05292131|450749049|FG000|Overall Study|Withdrawal by Subject|0|||
125306524|NCT05292131|450749050|FG001|Overall Study|Withdrawal by Subject|1|||
125306525|NCT04390880|450749052|FG000|Overall Study|Withdrawal by Subject|1|||
125306526|NCT02557542|450749053|FG000|Overall Study|Poor recruitment|3|||
125306527|NCT02557542|450749054|FG001|Overall Study|Poor recruitment|0|||
125306528|NCT06136897|450749055|FG000|Overall Study|Ineligible|3|||
125306529|NCT06136897|450749055|FG000|Overall Study|Mutation status not confirmed|7|||
125306530|NCT06136897|450749055|FG000|Overall Study|Adverse Event|2|||
125306531|NCT06136897|450749055|FG000|Overall Study|Death|1|||
125306532|NCT06136897|450749055|FG000|Overall Study|Disease progression|18|||
125306533|NCT06136897|450749055|FG000|Overall Study|Other complicating disease|1|||
125306534|NCT06136897|450749055|FG000|Overall Study|Withdrawal by Subject|1|||
125306535|NCT06136897|450749055|FG000|Overall Study|Still on treatment|1|||
125306536|NCT06136897|450749055|FG000|Overall Study|Lost to Follow-up|1|||
125306537|NCT03705559|450749056|FG000|Overall Study|COVID Shut down|1|||
125306538|NCT01979952|450749059|FG000|Overall Study|Adverse Event|4|||
125306539|NCT01979952|450749060|FG001|Overall Study|Adverse Event|5|||
125306540|NCT01979952|450749059|FG000|Overall Study|Protocol Violation|1|||
125306541|NCT01979952|450749060|FG001|Overall Study|Protocol Violation|0|||
125306542|NCT01979952|450749059|FG000|Overall Study|Withdrawal by Subject|2|||
125306543|NCT01979952|450749060|FG001|Overall Study|Withdrawal by Subject|1|||
125306544|NCT01979952|450749059|FG000|Overall Study|Other than specified above|1|||
125306545|NCT01979952|450749060|FG001|Overall Study|Other than specified above|0|||
125306546|NCT05438576|450749061|FG000|Overall Study|Death|1|||
125306547|NCT05438576|450749062|FG001|Overall Study|Death|1|||
125306548|NCT05438576|450749061|FG000|Overall Study|Withdrawal by Subject|4|||
125306549|NCT05438576|450749062|FG001|Overall Study|Withdrawal by Subject|2|||
125306550|NCT05438576|450749061|FG000|Overall Study|Not Eligible|2|||
125306551|NCT05438576|450749062|FG001|Overall Study|Not Eligible|1|||
125306552|NCT05438576|450749061|FG000|Overall Study|Did not complete baseline testing|22|||
125306553|NCT05438576|450749062|FG001|Overall Study|Did not complete baseline testing|4|||
125306554|NCT01067144|450749068|FG000|Treatment|Did not receive allocated intervention|4|||
125306555|NCT01067144|450749069|FG001|Treatment|Did not receive allocated intervention|7|||
125513555|NCT02675998|451510797|FG002|8-Week Treatment Period|Other|2|||
125513556|NCT02675998|451510798|FG003|8-Week Treatment Period|Other|0|||
125513557|NCT02675998|451510795|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
125513558|NCT02675998|451510796|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
125306556|NCT01067144|450749068|FG000|Follow-up|Lost to Follow-up|22|||
125306557|NCT01067144|450749069|FG001|Follow-up|Lost to Follow-up|12|||
125306558|NCT01067144|450749068|FG000|Follow-up|Censored owing to second surgery|19|||
125306559|NCT01067144|450749069|FG001|Follow-up|Censored owing to second surgery|28|||
125306560|NCT01067144|450749068|FG000|Follow-up|Withdrawal by Subject|18|||
125306561|NCT01067144|450749069|FG001|Follow-up|Withdrawal by Subject|14|||
125306562|NCT01067144|450749068|FG000|Follow-up|Surgery cancelled|0|||
125306563|NCT01067144|450749069|FG001|Follow-up|Surgery cancelled|1|||
125306564|NCT01067144|450749068|FG000|Follow-up|Death|0|||
125306565|NCT01067144|450749069|FG001|Follow-up|Death|1|||
125306566|NCT00203424|450749071|FG000|Treatment Period|Withdrawal by Subject|4|||
125306567|NCT00203424|450749071|FG000|Treatment Period|Adverse Event|5|||
125306568|NCT00203424|450749071|FG000|Treatment Period|progressive disease|2|||
125306569|NCT00203424|450749071|FG000|Follow-up Period|Withdrawal by Subject|1|||
125306570|NCT00203424|450749071|FG000|Follow-up Period|progressive disease|4|||
125306571|NCT00203424|450749071|FG000|Follow-up Period|Lost to Follow-up|1|||
125306572|NCT00555672|450749072|FG000|Overall Study|Death|0|||
125306573|NCT00555672|450749073|FG001|Overall Study|Death|2|||
125513559|NCT02675998|451510797|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
125306574|NCT00555672|450749072|FG000|Overall Study|Adverse Event|8|||
125306575|NCT00555672|450749073|FG001|Overall Study|Adverse Event|2|||
125306576|NCT00555672|450749072|FG000|Overall Study|Objective progression or relapse|11|||
125306577|NCT00555672|450749073|FG001|Overall Study|Objective progression or relapse|5|||
125306578|NCT00555672|450749072|FG000|Overall Study|Other|3|||
125306579|NCT00555672|450749073|FG001|Overall Study|Other|1|||
125306580|NCT00555672|450749072|FG000|Overall Study|Participant refused|2|||
125306581|NCT00555672|450749073|FG001|Overall Study|Participant refused|0|||
125306582|NCT01053988|450749074|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
125306583|NCT01053988|450749075|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125306584|NCT01053988|450749076|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125306585|NCT01053988|450749077|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125306586|NCT01053988|450749078|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125306587|NCT01053988|450749079|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
125306588|NCT01053988|450749074|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
125306589|NCT01053988|450749075|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125306590|NCT01053988|450749076|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125306591|NCT01053988|450749077|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125306592|NCT01053988|450749078|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125306593|NCT01053988|450749079|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
125306594|NCT01053988|450749074|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
125306595|NCT01053988|450749075|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125306596|NCT01053988|450749076|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125306597|NCT01053988|450749077|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125306598|NCT01053988|450749078|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125306599|NCT01053988|450749079|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
125306600|NCT01053988|450749074|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
125306601|NCT01053988|450749075|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
125306602|NCT01053988|450749076|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
125306603|NCT01053988|450749077|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
125306604|NCT01053988|450749078|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
125306605|NCT01053988|450749079|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
125306606|NCT01053988|450749074|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
125306607|NCT01053988|450749075|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
125306608|NCT01053988|450749076|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
125306609|NCT01053988|450749077|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
125306610|NCT01053988|450749078|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
125306611|NCT01053988|450749079|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
125306612|NCT01053988|450749074|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
125306613|NCT01053988|450749075|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125306614|NCT01053988|450749076|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125306615|NCT01053988|450749077|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125306616|NCT01053988|450749078|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125306617|NCT01053988|450749079|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
125306618|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
125306619|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
125306620|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
125513560|NCT02675998|451510798|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
125513561|NCT02675998|451510795|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
125513562|NCT02675998|451510796|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
125513563|NCT02675998|451510797|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
125513564|NCT02675998|451510798|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
125513565|NCT02675998|451510795|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
125513566|NCT02675998|451510796|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
125513567|NCT02675998|451510797|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
125513568|NCT02675998|451510798|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
125513569|NCT02675998|451510795|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
125513570|NCT02675998|451510796|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
125513571|NCT02675998|451510797|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
125513572|NCT02675998|451510798|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
125513573|NCT02675998|451510795|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
125513574|NCT02675998|451510796|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
125513575|NCT02675998|451510797|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
125306621|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
125306622|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
125306623|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
125306624|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125306625|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
125513576|NCT02675998|451510798|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
125513577|NCT02916706|451510799|FG000|Overall Study|Adverse Event|0|||
125513578|NCT02916706|451510800|FG001|Overall Study|Adverse Event|1|||
125513579|NCT02916706|451510799|FG000|Overall Study|Lost to Follow-up|0|||
125513580|NCT02916706|451510800|FG001|Overall Study|Lost to Follow-up|1|||
125513581|NCT02916706|451510799|FG000|Overall Study|Physician Decision|1|||
125513582|NCT02916706|451510800|FG001|Overall Study|Physician Decision|0|||
125513583|NCT02916706|451510799|FG000|Overall Study|Protocol Violation|3|||
125513584|NCT02916706|451510800|FG001|Overall Study|Protocol Violation|1|||
125513585|NCT02916706|451510799|FG000|Overall Study|Withdrawal by Subject|6|||
125513586|NCT02916706|451510800|FG001|Overall Study|Withdrawal by Subject|9|||
125513587|NCT02916706|451510799|FG000|Overall Study|Other|5|||
125513588|NCT02916706|451510800|FG001|Overall Study|Other|19|||
125513589|NCT04357964|451510801|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
125513590|NCT04357964|451510802|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
125513591|NCT04357964|451510801|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
125513592|NCT04357964|451510802|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
125513593|NCT04357964|451510801|FG000|Overall Study|Adipose sample was insufficient quality|0|||
125513594|NCT04357964|451510802|FG001|Overall Study|Adipose sample was insufficient quality|1|||
125513595|NCT00848393|451510807|FG000|Overall Study|Protocol Violation|0|||
125513596|NCT00848393|451510808|FG001|Overall Study|Protocol Violation|0|||
125513597|NCT00848393|451510809|FG002|Overall Study|Protocol Violation|1|||
125513598|NCT00848393|451510807|FG000|Overall Study|surgical complications unrelated to stud|0|||
125513599|NCT00848393|451510808|FG001|Overall Study|surgical complications unrelated to stud|0|||
125513600|NCT00848393|451510809|FG002|Overall Study|surgical complications unrelated to stud|2|||
125513601|NCT01194271|451510812|FG000|Overall Study|Withdrawal by Subject|1|||
125513602|NCT01194271|451510812|FG000|Overall Study|Ineligible, Screen Failure|1|||
125513603|NCT01194271|451510812|FG000|Overall Study|Death|1|||
125513604|NCT00381797|451510815|FG000|Overall Study|Withdrawal by Subject|1|||
125513605|NCT00381797|451510816|FG001|Overall Study|Withdrawal by Subject|1|||
125513606|NCT00381797|451510817|FG002|Overall Study|Withdrawal by Subject|0|||
125513607|NCT00381797|451510818|FG003|Overall Study|Withdrawal by Subject|0|||
125513608|NCT00381797|451510819|FG004|Overall Study|Withdrawal by Subject|2|||
125513609|NCT00381797|451510815|FG000|Overall Study|Ineligible|0|||
125513610|NCT00381797|451510816|FG001|Overall Study|Ineligible|0|||
125513611|NCT00381797|451510817|FG002|Overall Study|Ineligible|0|||
125513612|NCT00381797|451510818|FG003|Overall Study|Ineligible|1|||
125513613|NCT00381797|451510819|FG004|Overall Study|Ineligible|0|||
125513614|NCT00443898|451510822|FG000|Overall Study|Adverse Event|0|||
125513615|NCT00443898|451510823|FG001|Overall Study|Adverse Event|0|||
125513616|NCT00443898|451510824|FG002|Overall Study|Adverse Event|1|||
125513617|NCT00443898|451510825|FG003|Overall Study|Adverse Event|1|||
125513618|NCT00443898|451510822|FG000|Overall Study|Lack of Efficacy|2|||
125513619|NCT00443898|451510823|FG001|Overall Study|Lack of Efficacy|3|||
125513620|NCT00443898|451510824|FG002|Overall Study|Lack of Efficacy|3|||
125513621|NCT00443898|451510825|FG003|Overall Study|Lack of Efficacy|1|||
125513622|NCT00443898|451510822|FG000|Overall Study|Protocol Violation|1|||
125513623|NCT00443898|451510823|FG001|Overall Study|Protocol Violation|1|||
125513624|NCT00443898|451510824|FG002|Overall Study|Protocol Violation|1|||
125513625|NCT00443898|451510825|FG003|Overall Study|Protocol Violation|0|||
125513626|NCT00443898|451510822|FG000|Overall Study|Withdrawal by Subject|11|||
125513627|NCT00443898|451510823|FG001|Overall Study|Withdrawal by Subject|10|||
125513628|NCT00443898|451510824|FG002|Overall Study|Withdrawal by Subject|10|||
125513629|NCT00443898|451510825|FG003|Overall Study|Withdrawal by Subject|6|||
125513630|NCT00443898|451510822|FG000|Overall Study|Lost to Follow-up|10|||
125513631|NCT00443898|451510823|FG001|Overall Study|Lost to Follow-up|10|||
125513632|NCT00443898|451510824|FG002|Overall Study|Lost to Follow-up|14|||
125513633|NCT00443898|451510825|FG003|Overall Study|Lost to Follow-up|10|||
125513634|NCT00443898|451510822|FG000|Overall Study|Death|0|||
125513635|NCT00443898|451510823|FG001|Overall Study|Death|1|||
125513636|NCT00443898|451510824|FG002|Overall Study|Death|0|||
125513637|NCT00443898|451510825|FG003|Overall Study|Death|0|||
125513638|NCT00043186|451510826|FG000|Overall Study|Physician Decision|0|||
125513639|NCT00043186|451510827|FG001|Overall Study|Physician Decision|0|||
125513640|NCT00043186|451510828|FG002|Overall Study|Physician Decision|3|||
125513641|NCT00043186|451510829|FG003|Overall Study|Physician Decision|0|||
125513642|NCT00043186|451510830|FG004|Overall Study|Physician Decision|1|||
125513643|NCT00043186|451510831|FG005|Overall Study|Physician Decision|0|||
125513644|NCT00043186|451510832|FG006|Overall Study|Physician Decision|0|||
125513645|NCT00043186|451510833|FG007|Overall Study|Physician Decision|1|||
125513646|NCT00043186|451510834|FG008|Overall Study|Physician Decision|1|||
125513647|NCT00043186|451510826|FG000|Overall Study|Adverse Event|2|||
125513648|NCT00043186|451510827|FG001|Overall Study|Adverse Event|2|||
125513649|NCT00043186|451510828|FG002|Overall Study|Adverse Event|2|||
125513650|NCT00043186|451510829|FG003|Overall Study|Adverse Event|3|||
125513651|NCT00043186|451510830|FG004|Overall Study|Adverse Event|2|||
125513652|NCT00043186|451510831|FG005|Overall Study|Adverse Event|1|||
125513653|NCT00043186|451510832|FG006|Overall Study|Adverse Event|2|||
125306626|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
125306627|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
125306628|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
125306629|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
125306630|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
125306631|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
125306632|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
125306633|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
125306634|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
125306635|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
125306636|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
125306637|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
125306638|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
125306639|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
125306640|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
125306641|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
125306642|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
125306643|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
125306644|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
125306645|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
125306646|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
125306647|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
125306648|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125306649|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
125306650|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
125306651|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
125306652|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
125306653|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
125306654|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
125306655|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
125306656|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
125306657|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
125306658|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
125306659|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
125306660|NCT01053988|450749074|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
125306661|NCT01053988|450749075|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
125306662|NCT01053988|450749076|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
125306663|NCT01053988|450749077|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
125306664|NCT01053988|450749078|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
125306665|NCT01053988|450749079|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
125306666|NCT01824355|450749084|FG000|Overall Study|Adverse Event|2|||
125306667|NCT01824355|450749084|FG000|Overall Study|unevaluable reference method results per|1|||
125306668|NCT04427072|450749086|FG000|Randomized Treatment Phase|Progressive disease|9|||
125306669|NCT04427072|450749087|FG001|Randomized Treatment Phase|Progressive disease|4|||
125306670|NCT04427072|450749086|FG000|Randomized Treatment Phase|Adverse Event|3|||
125306671|NCT04427072|450749087|FG001|Randomized Treatment Phase|Adverse Event|1|||
125306672|NCT04427072|450749086|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
125306673|NCT04427072|450749087|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
125306674|NCT04427072|450749086|FG000|Randomized Treatment Phase|Death|0|||
125306675|NCT04427072|450749087|FG001|Randomized Treatment Phase|Death|1|||
125306676|NCT04427072|450749086|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
125306677|NCT04427072|450749087|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
125306678|NCT04427072|450749086|FG000|Extension Treatment Phase|Progressive disease|0|||
125306679|NCT04427072|450749087|FG001|Extension Treatment Phase|Progressive disease|5|||
125306680|NCT02104947|450749093|FG000|Overall Study|Withdrawal by Subject|10|||
125306681|NCT02104947|450749094|FG001|Overall Study|Withdrawal by Subject|3|||
125306682|NCT02104947|450749093|FG000|Overall Study|Lost to Follow-up|4|||
125306683|NCT02104947|450749094|FG001|Overall Study|Lost to Follow-up|4|||
125306684|NCT02104947|450749093|FG000|Overall Study|Protocol Violation|6|||
125306685|NCT02104947|450749094|FG001|Overall Study|Protocol Violation|8|||
125306686|NCT02104947|450749093|FG000|Overall Study|Adverse Event|57|||
125306687|NCT02104947|450749094|FG001|Overall Study|Adverse Event|38|||
125306688|NCT02104947|450749093|FG000|Overall Study|Other than stated above|2|||
125306689|NCT02104947|450749094|FG001|Overall Study|Other than stated above|3|||
125306690|NCT04698993|450749099|FG000|Overall Study|PCR results not accessible|2|||
125306691|NCT04698993|450749100|FG001|Overall Study|PCR results not accessible|7|||
125306692|NCT04698993|450749099|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
125306693|NCT04698993|450749100|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
125306694|NCT00145574|450749101|FG000|Double Blind|Adverse Event|0|||
125306695|NCT00145574|450749102|FG001|Double Blind|Adverse Event|3|||
125306696|NCT00145574|450749103|FG002|Double Blind|Adverse Event|1|||
125306697|NCT00145574|450749101|FG000|Double Blind|Withdrawal by Subject|1|||
125306698|NCT00145574|450749102|FG001|Double Blind|Withdrawal by Subject|1|||
125306699|NCT00145574|450749103|FG002|Double Blind|Withdrawal by Subject|1|||
125306700|NCT00145574|450749101|FG000|Double Blind|required restricted medicine|0|||
125306701|NCT00145574|450749102|FG001|Double Blind|required restricted medicine|1|||
125306702|NCT00145574|450749103|FG002|Double Blind|required restricted medicine|0|||
125306703|NCT00145574|450749101|FG000|Open Label Long-term Extension|Adverse Event|0|||
125306704|NCT00145574|450749102|FG001|Open Label Long-term Extension|Adverse Event|0|||
125306705|NCT00145574|450749103|FG002|Open Label Long-term Extension|Adverse Event|5|||
125306706|NCT00145574|450749101|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
125306707|NCT00145574|450749102|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
125306708|NCT00145574|450749103|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
125306709|NCT00145574|450749101|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
125306710|NCT00145574|450749102|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
125306711|NCT00145574|450749103|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
125306712|NCT00145574|450749101|FG000|Open Label Long-term Extension|required restricted medicine|0|||
125306713|NCT00145574|450749102|FG001|Open Label Long-term Extension|required restricted medicine|0|||
125306714|NCT00145574|450749103|FG002|Open Label Long-term Extension|required restricted medicine|1|||
125306715|NCT00527904|450749104|FG000|Overall Study|Adverse Event|45|||
125306716|NCT00527904|450749104|FG000|Overall Study|Withdrawal by Subject|21|||
125306717|NCT00527904|450749104|FG000|Overall Study|Lost to Follow-up|8|||
125306718|NCT00527904|450749104|FG000|Overall Study|misc|22|||
125306719|NCT01320202|450749108|FG000|Overall Study|Adverse Event|5|||
125306720|NCT01320202|450749109|FG001|Overall Study|Adverse Event|5|||
125306721|NCT01320202|450749108|FG000|Overall Study|Death|5|||
125306722|NCT01320202|450749109|FG001|Overall Study|Death|3|||
125306723|NCT01320202|450749108|FG000|Overall Study|Lost to Follow-up|1|||
125306724|NCT01320202|450749109|FG001|Overall Study|Lost to Follow-up|0|||
125306725|NCT01320202|450749108|FG000|Overall Study|Physician Decision|3|||
125306726|NCT01320202|450749109|FG001|Overall Study|Physician Decision|1|||
125306727|NCT01320202|450749108|FG000|Overall Study|Protocol Violation|2|||
125306728|NCT01320202|450749109|FG001|Overall Study|Protocol Violation|1|||
125306729|NCT01320202|450749108|FG000|Overall Study|Withdrawal by Subject|10|||
125306730|NCT01320202|450749109|FG001|Overall Study|Withdrawal by Subject|3|||
125306731|NCT01320202|450749108|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
125306732|NCT01320202|450749109|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
125306733|NCT01320202|450749108|FG000|Overall Study|kidney transplant|1|||
125513654|NCT00043186|451510833|FG007|Overall Study|Adverse Event|1|||
125513655|NCT00043186|451510834|FG008|Overall Study|Adverse Event|3|||
125513656|NCT00043186|451510826|FG000|Overall Study|Withdrawal by Subject|11|||
125513657|NCT00043186|451510827|FG001|Overall Study|Withdrawal by Subject|8|||
125513658|NCT00043186|451510828|FG002|Overall Study|Withdrawal by Subject|11|||
125513659|NCT00043186|451510829|FG003|Overall Study|Withdrawal by Subject|13|||
125513660|NCT00043186|451510830|FG004|Overall Study|Withdrawal by Subject|14|||
125513661|NCT00043186|451510831|FG005|Overall Study|Withdrawal by Subject|6|||
125513662|NCT00043186|451510832|FG006|Overall Study|Withdrawal by Subject|12|||
125513663|NCT00043186|451510833|FG007|Overall Study|Withdrawal by Subject|9|||
125306734|NCT01320202|450749109|FG001|Overall Study|kidney transplant|2|||
125306735|NCT01320202|450749108|FG000|Overall Study|blood transfusion|1|||
125306736|NCT01320202|450749109|FG001|Overall Study|blood transfusion|7|||
125306737|NCT01320202|450749108|FG000|Overall Study|moved/changed dialysis|5|||
125306738|NCT01320202|450749109|FG001|Overall Study|moved/changed dialysis|2|||
125306739|NCT01320202|450749108|FG000|Overall Study|sponsor request|2|||
125306740|NCT01320202|450749109|FG001|Overall Study|sponsor request|0|||
125306741|NCT01320202|450749108|FG000|Overall Study|ineligible|3|||
125306742|NCT01320202|450749109|FG001|Overall Study|ineligible|0|||
125306743|NCT01320202|450749108|FG000|Overall Study|regained renal function|1|||
125306744|NCT01320202|450749109|FG001|Overall Study|regained renal function|0|||
125513664|NCT00043186|451510834|FG008|Overall Study|Withdrawal by Subject|10|||
125306745|NCT00635882|450749110|FG000|Overall Study|Protocol Violation|1|||
125306746|NCT00635882|450749111|FG001|Overall Study|Protocol Violation|0|||
125306747|NCT00635882|450749112|FG002|Overall Study|Protocol Violation|0|||
125306748|NCT00635882|450749113|FG003|Overall Study|Protocol Violation|0|||
125513665|NCT00043186|451510826|FG000|Overall Study|Death|0|||
125306749|NCT00635882|450749114|FG004|Overall Study|Protocol Violation|0|||
125306750|NCT00635882|450749115|FG005|Overall Study|Protocol Violation|0|||
125306751|NCT00858637|450749116|FG000|Active Comparison Phase|Adverse Event|14|||
125306752|NCT00858637|450749117|FG001|Active Comparison Phase|Adverse Event|0|||
125306753|NCT00858637|450749118|FG002|Active Comparison Phase|Adverse Event|0|||
125513666|NCT00043186|451510827|FG001|Overall Study|Death|0|||
125306754|NCT00858637|450749119|FG003|Active Comparison Phase|Adverse Event|9|||
125306755|NCT00858637|450749120|FG004|Active Comparison Phase|Adverse Event|0|||
125306756|NCT00858637|450749121|FG005|Active Comparison Phase|Adverse Event|0|||
125306757|NCT00858637|450749116|FG000|Active Comparison Phase|Death|1|||
125306758|NCT00858637|450749117|FG001|Active Comparison Phase|Death|0|||
125306759|NCT00858637|450749118|FG002|Active Comparison Phase|Death|0|||
125306760|NCT00858637|450749119|FG003|Active Comparison Phase|Death|1|||
125306761|NCT00858637|450749120|FG004|Active Comparison Phase|Death|0|||
125306762|NCT00858637|450749121|FG005|Active Comparison Phase|Death|0|||
125306763|NCT00858637|450749116|FG000|Active Comparison Phase|Physician Decision|1|||
125306764|NCT00858637|450749117|FG001|Active Comparison Phase|Physician Decision|0|||
125306765|NCT00858637|450749118|FG002|Active Comparison Phase|Physician Decision|0|||
125306766|NCT00858637|450749119|FG003|Active Comparison Phase|Physician Decision|1|||
125306767|NCT00858637|450749120|FG004|Active Comparison Phase|Physician Decision|0|||
125306768|NCT00858637|450749121|FG005|Active Comparison Phase|Physician Decision|0|||
125306769|NCT00858637|450749116|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
125306770|NCT00858637|450749117|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
125306771|NCT00858637|450749118|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
125306772|NCT00858637|450749119|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
125306773|NCT00858637|450749120|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
125306774|NCT00858637|450749121|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
125306775|NCT00858637|450749116|FG000|Active Comparison Phase|Other Reasons|1|||
125306776|NCT00858637|450749117|FG001|Active Comparison Phase|Other Reasons|0|||
125306777|NCT00858637|450749118|FG002|Active Comparison Phase|Other Reasons|0|||
125306778|NCT00858637|450749119|FG003|Active Comparison Phase|Other Reasons|1|||
125306779|NCT00858637|450749120|FG004|Active Comparison Phase|Other Reasons|0|||
125306780|NCT00858637|450749121|FG005|Active Comparison Phase|Other Reasons|0|||
125306781|NCT00858637|450749116|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
125306782|NCT00858637|450749117|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
125306783|NCT00858637|450749118|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
125306784|NCT00858637|450749119|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
125306785|NCT00858637|450749120|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
125306786|NCT00858637|450749121|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
125306787|NCT00858637|450749116|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
125306788|NCT00858637|450749117|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
125306789|NCT00858637|450749118|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
125306790|NCT00858637|450749119|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
125306791|NCT00858637|450749120|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
125306792|NCT00858637|450749121|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
125306793|NCT00835341|450749122|FG000|Overall Study|Lost to Follow-up|3|||
125306794|NCT00835341|450749123|FG001|Overall Study|Lost to Follow-up|12|||
125306795|NCT02305238|450749124|FG000|Overall Study|Death|2|||
125306796|NCT02305238|450749125|FG001|Overall Study|Death|1|||
125306797|NCT02305238|450749126|FG002|Overall Study|Death|0|||
125306798|NCT02305238|450749124|FG000|Overall Study|Progressive disease|4|||
125306799|NCT02305238|450749125|FG001|Overall Study|Progressive disease|4|||
125306800|NCT02305238|450749126|FG002|Overall Study|Progressive disease|0|||
125306801|NCT02305238|450749124|FG000|Overall Study|Logistical difficulties|1|||
125306802|NCT02305238|450749125|FG001|Overall Study|Logistical difficulties|3|||
125306803|NCT02305238|450749126|FG002|Overall Study|Logistical difficulties|0|||
125306804|NCT02305238|450749124|FG000|Overall Study|Protocol Violation|0|||
125306805|NCT02305238|450749125|FG001|Overall Study|Protocol Violation|3|||
125306806|NCT02305238|450749126|FG002|Overall Study|Protocol Violation|0|||
125306807|NCT02305238|450749124|FG000|Overall Study|Physician Decision|2|||
125306808|NCT02305238|450749125|FG001|Overall Study|Physician Decision|1|||
125306809|NCT02305238|450749126|FG002|Overall Study|Physician Decision|0|||
125306810|NCT02305238|450749124|FG000|Overall Study|Adverse Event|4|||
125306811|NCT02305238|450749125|FG001|Overall Study|Adverse Event|2|||
125306812|NCT02305238|450749126|FG002|Overall Study|Adverse Event|0|||
125306813|NCT02305238|450749124|FG000|Overall Study|Withdrawal by Subject|3|||
125306814|NCT02305238|450749125|FG001|Overall Study|Withdrawal by Subject|4|||
125306815|NCT02305238|450749126|FG002|Overall Study|Withdrawal by Subject|0|||
125306816|NCT02305238|450749124|FG000|Overall Study|Randomized failure|0|||
125513667|NCT00043186|451510828|FG002|Overall Study|Death|1|||
125513668|NCT00043186|451510829|FG003|Overall Study|Death|0|||
125306817|NCT02305238|450749125|FG001|Overall Study|Randomized failure|0|||
125513669|NCT00043186|451510830|FG004|Overall Study|Death|0|||
125306818|NCT02305238|450749126|FG002|Overall Study|Randomized failure|8|||
125306819|NCT02305238|450749124|FG000|Overall Study|Required procedure failed|0|||
125306820|NCT02305238|450749125|FG001|Overall Study|Required procedure failed|1|||
125306821|NCT02305238|450749126|FG002|Overall Study|Required procedure failed|0|||
125306822|NCT02513472|450749127|FG000|Overall Study|Radiological Disease Progression|45|||
125306823|NCT02513472|450749128|FG001|Overall Study|Radiological Disease Progression|57|||
125306824|NCT02513472|450749127|FG000|Overall Study|Clinical Disease Progression|5|||
125306825|NCT02513472|450749128|FG001|Overall Study|Clinical Disease Progression|13|||
125513670|NCT00043186|451510831|FG005|Overall Study|Death|0|||
125306826|NCT02513472|450749127|FG000|Overall Study|Adverse Event|8|||
125306827|NCT02513472|450749128|FG001|Overall Study|Adverse Event|11|||
125306828|NCT02513472|450749127|FG000|Overall Study|Withdrawal by Subject|0|||
125306829|NCT02513472|450749128|FG001|Overall Study|Withdrawal by Subject|4|||
125306830|NCT02513472|450749127|FG000|Overall Study|Subject Choice|2|||
125306831|NCT02513472|450749128|FG001|Overall Study|Subject Choice|7|||
125306832|NCT02513472|450749127|FG000|Overall Study|Treatment Completed as per Protocol|3|||
125306833|NCT02513472|450749128|FG001|Overall Study|Treatment Completed as per Protocol|3|||
125306834|NCT02513472|450749127|FG000|Overall Study|Other|3|||
125306835|NCT02513472|450749128|FG001|Overall Study|Other|6|||
125306836|NCT04565951|450749134|FG000|Overall Study|Lost to Follow-up|66|||
125306837|NCT04565951|450749135|FG001|Overall Study|Lost to Follow-up|38|||
125306838|NCT04565951|450749134|FG000|Overall Study|Withdrawal by Subject|14|||
125306839|NCT04565951|450749135|FG001|Overall Study|Withdrawal by Subject|7|||
125306840|NCT04565951|450749134|FG000|Overall Study|Death|0|||
125306841|NCT04565951|450749135|FG001|Overall Study|Death|1|||
125306842|NCT04677504|450749136|FG000|Overall Study|Death|51|||
125306843|NCT04677504|450749137|FG001|Overall Study|Death|49|||
125306844|NCT04677504|450749136|FG000|Overall Study|Progressive Disease|1|||
125306845|NCT04677504|450749137|FG001|Overall Study|Progressive Disease|0|||
125306846|NCT04677504|450749136|FG000|Overall Study|Symptomatic Deterioration|1|||
125306847|NCT04677504|450749137|FG001|Overall Study|Symptomatic Deterioration|0|||
125306848|NCT04677504|450749136|FG000|Overall Study|Withdrawal by Subject|2|||
125306849|NCT04677504|450749137|FG001|Overall Study|Withdrawal by Subject|5|||
125306850|NCT04677504|450749136|FG000|Overall Study|Study Terminated By Sponsor|28|||
125306851|NCT04677504|450749137|FG001|Overall Study|Study Terminated By Sponsor|24|||
125306852|NCT04677504|450749136|FG000|Overall Study|Adverse Event|0|||
125306853|NCT04677504|450749137|FG001|Overall Study|Adverse Event|1|||
125306854|NCT00167310|450749148|FG000|Overall Study|Protocol Violation|5|||
125306855|NCT00167310|450749149|FG001|Overall Study|Protocol Violation|3|||
125306856|NCT00167310|450749148|FG000|Overall Study|Withdrawal by Subject|3|||
125306857|NCT00167310|450749149|FG001|Overall Study|Withdrawal by Subject|7|||
125306858|NCT03543137|450749150|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
125306859|NCT03543137|450749151|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
125306860|NCT03543137|450749150|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
125306861|NCT03543137|450749151|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
125306862|NCT03543137|450749150|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
125306863|NCT03543137|450749151|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
125306864|NCT00445770|450749152|FG000|Overall Study|Adverse Event|9|||
125306865|NCT00445770|450749153|FG001|Overall Study|Adverse Event|15|||
125306866|NCT00445770|450749154|FG002|Overall Study|Adverse Event|19|||
125306867|NCT00445770|450749152|FG000|Overall Study|Lack of Efficacy|38|||
125306868|NCT00445770|450749153|FG001|Overall Study|Lack of Efficacy|13|||
125306869|NCT00445770|450749154|FG002|Overall Study|Lack of Efficacy|6|||
125306870|NCT00445770|450749152|FG000|Overall Study|Lost to Follow-up|0|||
125306871|NCT00445770|450749153|FG001|Overall Study|Lost to Follow-up|2|||
125306872|NCT00445770|450749154|FG002|Overall Study|Lost to Follow-up|0|||
125306873|NCT00445770|450749152|FG000|Overall Study|Other|6|||
125306874|NCT00445770|450749153|FG001|Overall Study|Other|5|||
125306875|NCT00445770|450749154|FG002|Overall Study|Other|6|||
125306876|NCT03857542|450749155|FG000|Overall Study|Adverse Event|1|||
125306877|NCT03857542|450749156|FG001|Overall Study|Adverse Event|3|||
125306878|NCT03857542|450749155|FG000|Overall Study|Withdrawal by Subject|2|||
125306879|NCT03857542|450749156|FG001|Overall Study|Withdrawal by Subject|1|||
125306880|NCT03857542|450749155|FG000|Overall Study|Lost to Follow-up|2|||
125306881|NCT03857542|450749156|FG001|Overall Study|Lost to Follow-up|1|||
125306882|NCT03857542|450749155|FG000|Overall Study|Reason not Specified|1|||
125306883|NCT03857542|450749156|FG001|Overall Study|Reason not Specified|0|||
125306884|NCT00934128|450749157|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
125306885|NCT00934128|450749158|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
125306886|NCT00934128|450749157|FG000|First Intervention (2 Hours)|Adverse Event|4|||
125306887|NCT00934128|450749158|FG001|First Intervention (2 Hours)|Adverse Event|1|||
125306888|NCT00934128|450749157|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
125306889|NCT00934128|450749158|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
125306890|NCT00934128|450749157|FG000|Washout Period (1 Hour)|Patient preference|1|||
125306891|NCT00934128|450749158|FG001|Washout Period (1 Hour)|Patient preference|3|||
125306892|NCT00934128|450749157|FG000|Washout Period (1 Hour)|Pain|1|||
125306893|NCT00934128|450749158|FG001|Washout Period (1 Hour)|Pain|0|||
125306894|NCT00934128|450749157|FG000|Washout Period (1 Hour)|Too tired|1|||
125306895|NCT00934128|450749158|FG001|Washout Period (1 Hour)|Too tired|0|||
125306896|NCT00934128|450749157|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
125306897|NCT00934128|450749158|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
125306898|NCT00934128|450749157|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
125306899|NCT00934128|450749158|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
125306900|NCT01946152|450751236|FG000|Overall Study|Adverse Event|1|||
125306901|NCT01946152|450751237|FG001|Overall Study|Adverse Event|0|||
125306902|NCT01946152|450751238|FG002|Overall Study|Adverse Event|0|||
125306903|NCT01946152|450751239|FG003|Overall Study|Adverse Event|0|||
125306904|NCT01946152|450751236|FG000|Overall Study|Withdrawal by Subject|0|||
125306905|NCT01946152|450751237|FG001|Overall Study|Withdrawal by Subject|2|||
125306906|NCT01946152|450751238|FG002|Overall Study|Withdrawal by Subject|0|||
125306907|NCT01946152|450751239|FG003|Overall Study|Withdrawal by Subject|0|||
125306908|NCT01946152|450751236|FG000|Overall Study|Progression|0|||
125306909|NCT01946152|450751237|FG001|Overall Study|Progression|1|||
125306910|NCT01946152|450751238|FG002|Overall Study|Progression|4|||
125306911|NCT01946152|450751239|FG003|Overall Study|Progression|7|||
125306912|NCT01946152|450751236|FG000|Overall Study|Physician Decision|0|||
125306913|NCT01946152|450751237|FG001|Overall Study|Physician Decision|0|||
125306914|NCT01946152|450751238|FG002|Overall Study|Physician Decision|1|||
125306915|NCT01946152|450751239|FG003|Overall Study|Physician Decision|0|||
125306916|NCT01946152|450751236|FG000|Overall Study|Second malignancy|0|||
125306917|NCT01946152|450751237|FG001|Overall Study|Second malignancy|0|||
125306918|NCT01946152|450751238|FG002|Overall Study|Second malignancy|1|||
125306919|NCT01946152|450751239|FG003|Overall Study|Second malignancy|0|||
125306920|NCT01946152|450751236|FG000|Overall Study|Adverse Event|0|||
125306921|NCT01946152|450751237|FG001|Overall Study|Adverse Event|0|||
125306922|NCT01946152|450751238|FG002|Overall Study|Adverse Event|0|||
125306923|NCT01946152|450751239|FG003|Overall Study|Adverse Event|1|||
125306924|NCT01698814|450751240|FG000|Overall Study|Adverse Event|0|||
125306925|NCT01698814|450751241|FG001|Overall Study|Adverse Event|2|||
125306926|NCT01698814|450751240|FG000|Overall Study|Lost to Follow-up|0|||
125306927|NCT01698814|450751241|FG001|Overall Study|Lost to Follow-up|1|||
125306928|NCT01698814|450751240|FG000|Overall Study|Pregnancy|1|||
125306929|NCT01698814|450751241|FG001|Overall Study|Pregnancy|0|||
125306930|NCT01698814|450751240|FG000|Overall Study|Randomized in error|1|||
125306931|NCT01698814|450751241|FG001|Overall Study|Randomized in error|0|||
125306932|NCT01061359|450751246|FG000|Overall Study|Death|32|||
125306933|NCT01061359|450751246|FG000|Overall Study|Lost to Follow-up|1072|||
125306934|NCT01061359|450751246|FG000|Overall Study|Relapse|187|||
125306935|NCT01061359|450751246|FG000|Overall Study|Secondary neoplasm|11|||
125306936|NCT04014062|450751247|FG000|Period I: Dosing|Medical Grounds|4|||
125306937|NCT04014062|450751248|FG001|Period I: Dosing|Medical Grounds|5|||
125306938|NCT04014062|450751247|FG000|Period I: Dosing|Withdrawal by Subject|3|||
125306939|NCT04014062|450751248|FG001|Period I: Dosing|Withdrawal by Subject|1|||
125306940|NCT03038126|450751249|FG000|Overall Study|Death|1|||
125306941|NCT03038126|450751250|FG001|Overall Study|Death|1|||
125306942|NCT03038126|450751249|FG000|Overall Study|Withdrawal by Subject|5|||
125306943|NCT03038126|450751250|FG001|Overall Study|Withdrawal by Subject|0|||
125306944|NCT03038126|450751249|FG000|Overall Study|Lost to Follow-up|0|||
125306945|NCT03038126|450751250|FG001|Overall Study|Lost to Follow-up|1|||
125306946|NCT03038126|450751249|FG000|Overall Study|Long Term Hospitalization|2|||
125306947|NCT03038126|450751250|FG001|Overall Study|Long Term Hospitalization|0|||
125306948|NCT03038126|450751249|FG000|Overall Study|Too Ill to Participate|1|||
125306949|NCT03038126|450751250|FG001|Overall Study|Too Ill to Participate|2|||
125306950|NCT02610777|450751251|FG000|Overall Study|Lost to Follow-up|1|||
125306951|NCT02610777|450751252|FG001|Overall Study|Lost to Follow-up|0|||
125306952|NCT02610777|450751251|FG000|Overall Study|Site Terminated by Sponsor|9|||
125306953|NCT02610777|450751252|FG001|Overall Study|Site Terminated by Sponsor|8|||
125306954|NCT02610777|450751251|FG000|Overall Study|Withdrawal by Subject|2|||
125306955|NCT02610777|450751252|FG001|Overall Study|Withdrawal by Subject|2|||
125306956|NCT02610777|450751251|FG000|Overall Study|Reason not Specified|0|||
125306957|NCT02610777|450751252|FG001|Overall Study|Reason not Specified|1|||
125306958|NCT02610777|450751251|FG000|Overall Study|Death|50|||
125306959|NCT02610777|450751252|FG001|Overall Study|Death|47|||
125306960|NCT01724866|450751253|FG000|Overall Study|Adverse Event|0|||
125306961|NCT01724866|450751254|FG001|Overall Study|Adverse Event|0|||
125306962|NCT01724866|450751255|FG002|Overall Study|Adverse Event|1|||
125306963|NCT01724866|450751256|FG003|Overall Study|Adverse Event|1|||
125306964|NCT01724866|450751253|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
125306965|NCT01724866|450751254|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
125306966|NCT01724866|450751255|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
125306967|NCT01724866|450751256|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
125306968|NCT01724866|450751253|FG000|Overall Study|Investigator's Discretion|0|||
125306969|NCT01724866|450751254|FG001|Overall Study|Investigator's Discretion|1|||
125306970|NCT01724866|450751255|FG002|Overall Study|Investigator's Discretion|1|||
125306971|NCT01724866|450751256|FG003|Overall Study|Investigator's Discretion|0|||
125306972|NCT01724866|450751253|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
125306973|NCT01724866|450751254|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
125306974|NCT01724866|450751255|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
125306975|NCT01724866|450751256|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
125306976|NCT01724866|450751253|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
125306977|NCT01724866|450751254|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
125306978|NCT01724866|450751255|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
125306979|NCT01724866|450751256|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
125306980|NCT01424501|450751259|FG000|Overall Study|Withdrawal by Subject|1|||
125306981|NCT01424501|450751260|FG001|Overall Study|Withdrawal by Subject|0|||
125306982|NCT01424501|450751261|FG002|Overall Study|Withdrawal by Subject|1|||
125306983|NCT01424501|450751262|FG003|Overall Study|Withdrawal by Subject|0|||
125306984|NCT01424501|450751263|FG004|Overall Study|Withdrawal by Subject|0|||
125306985|NCT01424501|450751264|FG005|Overall Study|Withdrawal by Subject|0|||
125306986|NCT01424501|450751259|FG000|Overall Study|Lost to Follow-up|0|||
125306987|NCT01424501|450751260|FG001|Overall Study|Lost to Follow-up|1|||
125306988|NCT01424501|450751261|FG002|Overall Study|Lost to Follow-up|1|||
125306989|NCT01424501|450751262|FG003|Overall Study|Lost to Follow-up|0|||
125306990|NCT01424501|450751263|FG004|Overall Study|Lost to Follow-up|0|||
125306991|NCT01424501|450751264|FG005|Overall Study|Lost to Follow-up|0|||
125306992|NCT01980095|450751265|FG000|Overall Study|Lost to Follow-up|6|||
125306993|NCT01980095|450751266|FG001|Overall Study|Lost to Follow-up|7|||
125306994|NCT01980095|450751265|FG000|Overall Study|Withdrawal by Subject|2|||
125306995|NCT01980095|450751266|FG001|Overall Study|Withdrawal by Subject|3|||
125306996|NCT01980095|450751265|FG000|Overall Study|Poor compliance|5|||
125306997|NCT01980095|450751266|FG001|Overall Study|Poor compliance|0|||
125306998|NCT01980095|450751265|FG000|Overall Study|Safety issue|0|||
125306999|NCT01980095|450751266|FG001|Overall Study|Safety issue|1|||
125307000|NCT01980095|450751265|FG000|Overall Study|Study drug discontinued|1|||
125307001|NCT01980095|450751266|FG001|Overall Study|Study drug discontinued|0|||
125307002|NCT01980095|450751265|FG000|Overall Study|Randomized by mistake|1|||
125307003|NCT01980095|450751266|FG001|Overall Study|Randomized by mistake|0|||
125307004|NCT00398567|450751270|FG000|Overall Study|Disease Progression|3|||
125307005|NCT00398567|450751271|FG001|Overall Study|Disease Progression|4|||
125307006|NCT00398567|450751272|FG002|Overall Study|Disease Progression|27|||
125307007|NCT00398567|450751270|FG000|Overall Study|Withdrawal by Subject|1|||
125307008|NCT00398567|450751271|FG001|Overall Study|Withdrawal by Subject|0|||
125307009|NCT00398567|450751272|FG002|Overall Study|Withdrawal by Subject|4|||
125307010|NCT00398567|450751270|FG000|Overall Study|Adverse Event|0|||
125307011|NCT00398567|450751271|FG001|Overall Study|Adverse Event|0|||
125307012|NCT00398567|450751272|FG002|Overall Study|Adverse Event|2|||
125307013|NCT00398567|450751270|FG000|Overall Study|Protocol Violation|0|||
125307014|NCT00398567|450751271|FG001|Overall Study|Protocol Violation|0|||
125307015|NCT00398567|450751272|FG002|Overall Study|Protocol Violation|1|||
125307016|NCT02837029|450751273|FG000|Screening|Failed to meet screening requirements.|7|||
125307017|NCT02837029|450751274|FG001|Screening|Failed to meet screening requirements.|3|||
125307018|NCT02837029|450751275|FG002|Screening|Failed to meet screening requirements.|0|||
125307019|NCT02837029|450751273|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
125307020|NCT02837029|450751274|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
125307021|NCT02837029|450751275|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
125307022|NCT02837029|450751273|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
125307023|NCT02837029|450751274|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
125307024|NCT02837029|450751275|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
125307025|NCT02837029|450751273|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
125307026|NCT02837029|450751274|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
125307027|NCT02837029|450751275|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
125307028|NCT02837029|450751273|FG000|Cycle 2 and Beyond|Adverse Event|1|||
125307029|NCT02837029|450751274|FG001|Cycle 2 and Beyond|Adverse Event|0|||
125307030|NCT02837029|450751275|FG002|Cycle 2 and Beyond|Adverse Event|0|||
125307031|NCT02837029|450751273|FG000|2 Year Follow-up|Death|6|||
125307032|NCT02837029|450751274|FG001|2 Year Follow-up|Death|7|||
125307033|NCT02837029|450751275|FG002|2 Year Follow-up|Death|0|||
125307034|NCT02034877|450751276|FG000|Overall Study|Lost to Follow-up|0|||
125307035|NCT02034877|450751277|FG001|Overall Study|Lost to Follow-up|3|||
125307036|NCT02034877|450751276|FG000|Overall Study|No Longer Willing to Participate|0|||
125307037|NCT02034877|450751277|FG001|Overall Study|No Longer Willing to Participate|3|||
125307038|NCT04426318|450751280|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
125307039|NCT04426318|450751281|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
125307040|NCT01564732|450751292|FG000|Overall Study|Early termination by the study sponsor|6|||
125513671|NCT00043186|451510832|FG006|Overall Study|Death|2|||
125307041|NCT01564732|450751293|FG001|Overall Study|Early termination by the study sponsor|5|||
125307042|NCT01036321|450751296|FG000|Overall Study|Ineligible after randomization|0|||
125307043|NCT01036321|450751297|FG001|Overall Study|Ineligible after randomization|1|||
125307044|NCT01036321|450751296|FG000|Overall Study|Withdrawal by Subject|3|||
125513672|NCT00043186|451510833|FG007|Overall Study|Death|0|||
125307045|NCT01036321|450751297|FG001|Overall Study|Withdrawal by Subject|2|||
125307046|NCT01036321|450751296|FG000|Overall Study|Adverse Event|2|||
125307047|NCT01036321|450751297|FG001|Overall Study|Adverse Event|1|||
125307048|NCT01957202|450751298|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307049|NCT01957202|450751299|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
125307050|NCT01957202|450751300|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307051|NCT01957202|450751301|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307052|NCT01957202|450751302|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307053|NCT01957202|450751303|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307054|NCT01957202|450751304|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307055|NCT01957202|450751305|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307056|NCT01957202|450751306|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307057|NCT01957202|450751307|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307058|NCT01957202|450751308|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307059|NCT01957202|450751309|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307060|NCT01957202|450751310|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307061|NCT01957202|450751311|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307062|NCT01957202|450751312|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307063|NCT01957202|450751313|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307064|NCT01957202|450751314|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
125307065|NCT01957202|450751315|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
125307066|NCT01957202|450751298|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307067|NCT01957202|450751299|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307068|NCT01957202|450751300|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307069|NCT01957202|450751301|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307070|NCT01957202|450751302|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307071|NCT01957202|450751303|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307072|NCT01957202|450751304|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307073|NCT01957202|450751305|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307074|NCT01957202|450751306|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307075|NCT01957202|450751307|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307076|NCT01957202|450751308|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307077|NCT01957202|450751309|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307078|NCT01957202|450751310|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307079|NCT01957202|450751311|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307080|NCT01957202|450751312|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307081|NCT01957202|450751313|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307082|NCT01957202|450751314|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
125307083|NCT01957202|450751315|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
125307084|NCT00381693|450751318|FG000|Overall Study|Death|1|||
125307085|NCT00381693|450751318|FG000|Overall Study|Adverse Event|4|||
125307086|NCT00381693|450751318|FG000|Overall Study|Patient Choice|1|||
125307087|NCT00381693|450751318|FG000|Overall Study|Progression|2|||
125307088|NCT02506192|450751330|FG000|Overall Study|Withdrawal by Subject|1|||
125307089|NCT02506192|450751331|FG001|Overall Study|Withdrawal by Subject|1|||
125307090|NCT01922271|450751333|FG000|WASHOUT Period|Withdrawal by Subject|1|||
125307091|NCT01922271|450751334|FG001|WASHOUT Period|Withdrawal by Subject|0|||
125307092|NCT00836186|450751337|FG000|Overall Study|Blood could not be drawn|1|||
125307093|NCT04531241|450751339|FG000|Period 1|Withdrawal by Subject|2|||
125307094|NCT04531241|450751340|FG001|Period 1|Withdrawal by Subject|0|||
125307095|NCT04531241|450751339|FG000|Period 1|Dispesed incorrect lens power|1|||
125307096|NCT04531241|450751340|FG001|Period 1|Dispesed incorrect lens power|0|||
125307097|NCT04531241|450751339|FG000|Period 1|Protocol Violation|1|||
125307098|NCT04531241|450751340|FG001|Period 1|Protocol Violation|0|||
125307099|NCT04531241|450751339|FG000|Period 1|No longer eligible|0|||
125307100|NCT04531241|450751340|FG001|Period 1|No longer eligible|1|||
125307101|NCT04531241|450751339|FG000|Period 1|Lens Discomfort|0|||
125307102|NCT04531241|450751340|FG001|Period 1|Lens Discomfort|1|||
125307103|NCT04531241|450751339|FG000|Period 2|Covid-19 Related|1|||
125307104|NCT04531241|450751340|FG001|Period 2|Covid-19 Related|1|||
125307105|NCT02576795|450751341|FG000|Overall Study|Lost to Follow-up|0|||
125307106|NCT02576795|450751342|FG001|Overall Study|Lost to Follow-up|0|||
125307107|NCT02576795|450751343|FG002|Overall Study|Lost to Follow-up|1|||
125307108|NCT02576795|450751344|FG003|Overall Study|Lost to Follow-up|0|||
125307109|NCT05232864|450751346|FG000|Overall Study|Adverse Event|0|||
125307110|NCT05232864|450751347|FG001|Overall Study|Adverse Event|1|||
125307111|NCT05232864|450751346|FG000|Overall Study|Study terminated by sponsor|16|||
125513673|NCT00043186|451510834|FG008|Overall Study|Death|0|||
125513674|NCT00043186|451510826|FG000|Overall Study|Disease progression|1|||
125307112|NCT05232864|450751347|FG001|Overall Study|Study terminated by sponsor|14|||
125307113|NCT04765202|450751362|FG000|Overall Study|Lost to Follow-up|1|||
125307114|NCT04765202|450751363|FG001|Overall Study|Lost to Follow-up|1|||
125307115|NCT04765202|450751364|FG002|Overall Study|Lost to Follow-up|2|||
125307116|NCT04765202|450751365|FG003|Overall Study|Lost to Follow-up|2|||
125307117|NCT04765202|450751362|FG000|Overall Study|Physician Decision|0|||
125307118|NCT04765202|450751363|FG001|Overall Study|Physician Decision|0|||
125307119|NCT04765202|450751364|FG002|Overall Study|Physician Decision|1|||
125307120|NCT04765202|450751365|FG003|Overall Study|Physician Decision|1|||
125307121|NCT00465452|450751366|FG000|Overall Study|Adverse Event|1|||
125307122|NCT01635855|450751368|FG000|Overall Study|Withdrawal by Subject|4|||
125513675|NCT00043186|451510827|FG001|Overall Study|Disease progression|0|||
125307123|NCT03828019|450751369|FG000|Overall Study|Withdrawal by Subject|3|||
125307124|NCT03828019|450751370|FG001|Overall Study|Withdrawal by Subject|8|||
125307125|NCT03828019|450751369|FG000|Overall Study|Lost to Follow-up|1|||
125307126|NCT03828019|450751370|FG001|Overall Study|Lost to Follow-up|6|||
125307127|NCT03828019|450751369|FG000|Overall Study|Incarcerated|1|||
125307128|NCT03828019|450751370|FG001|Overall Study|Incarcerated|0|||
125307129|NCT03828019|450751369|FG000|Overall Study|Adverse Event|0|||
125307130|NCT03828019|450751370|FG001|Overall Study|Adverse Event|1|||
125307131|NCT03400176|450751371|FG000|Dose Escalation|Progressive disease|1|||
125307132|NCT03400176|450751372|FG001|Dose Escalation|Progressive disease|1|||
125307133|NCT03400176|450751373|FG002|Dose Escalation|Progressive disease|0|||
125307134|NCT03400176|450751374|FG003|Dose Escalation|Progressive disease|0|||
125307135|NCT03400176|450751375|FG004|Dose Escalation|Progressive disease|1|||
125307136|NCT03400176|450751371|FG000|Dose Escalation|Patient decision|0|||
125307137|NCT03400176|450751372|FG001|Dose Escalation|Patient decision|0|||
125307138|NCT03400176|450751373|FG002|Dose Escalation|Patient decision|0|||
125307139|NCT03400176|450751374|FG003|Dose Escalation|Patient decision|0|||
125307140|NCT03400176|450751375|FG004|Dose Escalation|Patient decision|1|||
125307141|NCT03400176|450751371|FG000|Dose Expansion|Patient decision|0|||
125307142|NCT03400176|450751372|FG001|Dose Expansion|Patient decision|0|||
125307143|NCT03400176|450751373|FG002|Dose Expansion|Patient decision|0|||
125307144|NCT03400176|450751374|FG003|Dose Expansion|Patient decision|1|||
125307145|NCT03400176|450751375|FG004|Dose Expansion|Patient decision|0|||
125307146|NCT03400176|450751371|FG000|Dose Expansion|Adverse Event|0|||
125307147|NCT03400176|450751372|FG001|Dose Expansion|Adverse Event|0|||
125307148|NCT03400176|450751373|FG002|Dose Expansion|Adverse Event|0|||
125307149|NCT03400176|450751374|FG003|Dose Expansion|Adverse Event|1|||
125307150|NCT03400176|450751375|FG004|Dose Expansion|Adverse Event|0|||
125307151|NCT03400176|450751371|FG000|Dose Expansion|Physician Decision|0|||
125307152|NCT03400176|450751372|FG001|Dose Expansion|Physician Decision|0|||
125307153|NCT03400176|450751373|FG002|Dose Expansion|Physician Decision|0|||
125307154|NCT03400176|450751374|FG003|Dose Expansion|Physician Decision|1|||
125307155|NCT03400176|450751375|FG004|Dose Expansion|Physician Decision|0|||
125307156|NCT03400176|450751371|FG000|Dose Expansion|Progressive disease|0|||
125307157|NCT03400176|450751372|FG001|Dose Expansion|Progressive disease|0|||
125307158|NCT03400176|450751373|FG002|Dose Expansion|Progressive disease|1|||
125307159|NCT03400176|450751374|FG003|Dose Expansion|Progressive disease|1|||
125307160|NCT03400176|450751375|FG004|Dose Expansion|Progressive disease|0|||
125307161|NCT00206440|450751376|FG000|Overall Study|Protocol Violation|1|||
125307162|NCT00206440|450751377|FG001|Overall Study|Protocol Violation|2|||
125307163|NCT00206440|450751376|FG000|Overall Study|Adverse Event|4|||
125307164|NCT00206440|450751377|FG001|Overall Study|Adverse Event|2|||
125307165|NCT01298765|450751378|FG000|Titration Period|Adverse Event|26|||
125307166|NCT01298765|450751378|FG000|Titration Period|Death|1|||
125307167|NCT01298765|450751378|FG000|Titration Period|Lack of Efficacy|21|||
125307168|NCT01298765|450751378|FG000|Titration Period|Lost to Follow-up|9|||
125307169|NCT01298765|450751378|FG000|Titration Period|Physician Decision|1|||
125307170|NCT01298765|450751378|FG000|Titration Period|Withdrawal by Subject|10|||
125307171|NCT01298765|450751378|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
125307172|NCT01298765|450751378|FG000|Long-Term Treatment Period|Adverse Event|19|||
125307173|NCT01298765|450751378|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
125307174|NCT01298765|450751378|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
125307175|NCT01298765|450751378|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
125307176|NCT01298765|450751378|FG000|Long-Term Treatment Period|Physician Decision|1|||
125307177|NCT01298765|450751378|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
125307178|NCT03302247|450751381|FG000|Overall Study|the study has closed prematurely|2|||
125307179|NCT03302247|450751381|FG000|Overall Study|Death|1|||
125307180|NCT04090242|450751382|FG000|Overall Study|Withdrawal by Subject|1|||
125307181|NCT04090242|450751383|FG001|Overall Study|Withdrawal by Subject|0|||
125307182|NCT03214406|450751384|FG000|Overall Study|did not meet enrollment criteria|9|||
125307183|NCT03214406|450751385|FG001|Overall Study|did not meet enrollment criteria|13|||
125307184|NCT03214406|450751384|FG000|Overall Study|Withdrawal by Subject|1|||
125307185|NCT03214406|450751385|FG001|Overall Study|Withdrawal by Subject|0|||
125307186|NCT03214406|450751384|FG000|Overall Study|Lost to Follow-up|0|||
125307187|NCT03214406|450751385|FG001|Overall Study|Lost to Follow-up|2|||
125307188|NCT01098305|450751389|FG000|Overall Study|Lost to Follow-up|31|||
125307189|NCT01098305|450751390|FG001|Overall Study|Lost to Follow-up|33|||
125307190|NCT03182907|450751391|FG000|Overall Study|Death|3|||
125307191|NCT03182907|450751392|FG001|Overall Study|Death|0|||
125307192|NCT03182907|450751391|FG000|Overall Study|Protocol Violation|4|||
125307193|NCT03182907|450751392|FG001|Overall Study|Protocol Violation|0|||
125307194|NCT03182907|450751391|FG000|Overall Study|Lost to Follow-up|1|||
125307195|NCT03182907|450751392|FG001|Overall Study|Lost to Follow-up|0|||
125307196|NCT03182907|450751391|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125307197|NCT03182907|450751392|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
125307198|NCT00429169|450751393|FG000|Overall Study|Lost to Follow-up|0|||
125307199|NCT00429169|450751394|FG001|Overall Study|Lost to Follow-up|1|||
125307200|NCT00429169|450751393|FG000|Overall Study|Ineligibility discovered after entry|2|||
125307201|NCT00429169|450751394|FG001|Overall Study|Ineligibility discovered after entry|1|||
125307202|NCT01180296|450751399|FG000|Overall Study|Protocol Violation|1|||
125307203|NCT01180296|450751400|FG001|Overall Study|Protocol Violation|2|||
125307204|NCT01371552|450751405|FG000|Part 1, First 3 Days|Inconvenience|0|||
125307205|NCT01371552|450751406|FG001|Part 1, First 3 Days|Inconvenience|0|||
125307206|NCT01371552|450751407|FG002|Part 1, First 3 Days|Inconvenience|1|||
125307207|NCT01371552|450751408|FG003|Part 1, First 3 Days|Inconvenience|0|||
125307208|NCT01371552|450751409|FG004|Part 1, First 3 Days|Inconvenience|0|||
125307209|NCT01371552|450751410|FG005|Part 1, First 3 Days|Inconvenience|0|||
125307210|NCT03364309|450751411|FG000|Induction Period|Adverse Event|4|||
125307211|NCT03364309|450751412|FG001|Induction Period|Adverse Event|0|||
125307212|NCT03364309|450751413|FG002|Induction Period|Adverse Event|1|||
125307213|NCT03364309|450751414|FG003|Induction Period|Adverse Event|0|||
125307214|NCT03364309|450751415|FG004|Induction Period|Adverse Event|0|||
125307215|NCT03364309|450751416|FG005|Induction Period|Adverse Event|0|||
125307216|NCT03364309|450751417|FG006|Induction Period|Adverse Event|0|||
125307217|NCT03364309|450751418|FG007|Induction Period|Adverse Event|0|||
125307218|NCT03364309|450751419|FG008|Induction Period|Adverse Event|0|||
125307219|NCT03364309|450751420|FG009|Induction Period|Adverse Event|0|||
125307220|NCT03364309|450751421|FG010|Induction Period|Adverse Event|0|||
125307221|NCT03364309|450751422|FG011|Induction Period|Adverse Event|0|||
125307222|NCT03364309|450751423|FG012|Induction Period|Adverse Event|0|||
125307223|NCT03364309|450751424|FG013|Induction Period|Adverse Event|0|||
125307224|NCT03364309|450751425|FG014|Induction Period|Adverse Event|0|||
125307225|NCT03364309|450751426|FG015|Induction Period|Adverse Event|0|||
125307226|NCT03364309|450751427|FG016|Induction Period|Adverse Event|0|||
125307227|NCT03364309|450751428|FG017|Induction Period|Adverse Event|0|||
125307228|NCT03364309|450751429|FG018|Induction Period|Adverse Event|0|||
125307229|NCT03364309|450751411|FG000|Induction Period|Withdrawal by Subject|1|||
125307230|NCT03364309|450751412|FG001|Induction Period|Withdrawal by Subject|3|||
125307231|NCT03364309|450751413|FG002|Induction Period|Withdrawal by Subject|0|||
125307232|NCT03364309|450751414|FG003|Induction Period|Withdrawal by Subject|0|||
125307233|NCT03364309|450751415|FG004|Induction Period|Withdrawal by Subject|0|||
125307234|NCT03364309|450751416|FG005|Induction Period|Withdrawal by Subject|0|||
125307235|NCT03364309|450751417|FG006|Induction Period|Withdrawal by Subject|0|||
125307236|NCT03364309|450751418|FG007|Induction Period|Withdrawal by Subject|0|||
125307237|NCT03364309|450751419|FG008|Induction Period|Withdrawal by Subject|0|||
125307238|NCT03364309|450751420|FG009|Induction Period|Withdrawal by Subject|0|||
125307239|NCT03364309|450751421|FG010|Induction Period|Withdrawal by Subject|0|||
125307240|NCT03364309|450751422|FG011|Induction Period|Withdrawal by Subject|0|||
125307241|NCT03364309|450751423|FG012|Induction Period|Withdrawal by Subject|0|||
125307242|NCT03364309|450751424|FG013|Induction Period|Withdrawal by Subject|0|||
125307243|NCT03364309|450751425|FG014|Induction Period|Withdrawal by Subject|0|||
125307244|NCT03364309|450751426|FG015|Induction Period|Withdrawal by Subject|0|||
125307245|NCT03364309|450751427|FG016|Induction Period|Withdrawal by Subject|0|||
125307246|NCT03364309|450751428|FG017|Induction Period|Withdrawal by Subject|0|||
125307247|NCT03364309|450751429|FG018|Induction Period|Withdrawal by Subject|0|||
125307248|NCT03364309|450751411|FG000|Induction Period|Lost to Follow-up|1|||
125307249|NCT03364309|450751412|FG001|Induction Period|Lost to Follow-up|0|||
125307250|NCT03364309|450751413|FG002|Induction Period|Lost to Follow-up|0|||
125307251|NCT03364309|450751414|FG003|Induction Period|Lost to Follow-up|0|||
125307252|NCT03364309|450751415|FG004|Induction Period|Lost to Follow-up|0|||
125307253|NCT03364309|450751416|FG005|Induction Period|Lost to Follow-up|0|||
125307254|NCT03364309|450751417|FG006|Induction Period|Lost to Follow-up|0|||
125307255|NCT03364309|450751418|FG007|Induction Period|Lost to Follow-up|0|||
125307256|NCT03364309|450751419|FG008|Induction Period|Lost to Follow-up|0|||
125307257|NCT03364309|450751420|FG009|Induction Period|Lost to Follow-up|0|||
125307258|NCT03364309|450751421|FG010|Induction Period|Lost to Follow-up|0|||
125307259|NCT03364309|450751422|FG011|Induction Period|Lost to Follow-up|0|||
125307260|NCT03364309|450751423|FG012|Induction Period|Lost to Follow-up|0|||
125307261|NCT03364309|450751424|FG013|Induction Period|Lost to Follow-up|0|||
125307262|NCT03364309|450751425|FG014|Induction Period|Lost to Follow-up|0|||
125307263|NCT03364309|450751426|FG015|Induction Period|Lost to Follow-up|0|||
125307264|NCT03364309|450751427|FG016|Induction Period|Lost to Follow-up|0|||
125307265|NCT03364309|450751428|FG017|Induction Period|Lost to Follow-up|0|||
125307266|NCT03364309|450751429|FG018|Induction Period|Lost to Follow-up|0|||
125307267|NCT03364309|450751411|FG000|Induction Period|Physician Decision|0|||
125307268|NCT03364309|450751412|FG001|Induction Period|Physician Decision|1|||
125307269|NCT03364309|450751413|FG002|Induction Period|Physician Decision|0|||
125307270|NCT03364309|450751414|FG003|Induction Period|Physician Decision|0|||
125307271|NCT03364309|450751415|FG004|Induction Period|Physician Decision|0|||
125307272|NCT03364309|450751416|FG005|Induction Period|Physician Decision|0|||
125307273|NCT03364309|450751417|FG006|Induction Period|Physician Decision|0|||
125307274|NCT03364309|450751418|FG007|Induction Period|Physician Decision|0|||
125307275|NCT03364309|450751419|FG008|Induction Period|Physician Decision|0|||
125307276|NCT03364309|450751420|FG009|Induction Period|Physician Decision|0|||
125307277|NCT03364309|450751421|FG010|Induction Period|Physician Decision|0|||
125307278|NCT03364309|450751422|FG011|Induction Period|Physician Decision|0|||
125307279|NCT03364309|450751423|FG012|Induction Period|Physician Decision|0|||
125307280|NCT03364309|450751424|FG013|Induction Period|Physician Decision|0|||
125307281|NCT03364309|450751425|FG014|Induction Period|Physician Decision|0|||
125307282|NCT03364309|450751426|FG015|Induction Period|Physician Decision|0|||
125307283|NCT03364309|450751427|FG016|Induction Period|Physician Decision|0|||
125307284|NCT03364309|450751428|FG017|Induction Period|Physician Decision|0|||
125307285|NCT03364309|450751429|FG018|Induction Period|Physician Decision|0|||
125307286|NCT03364309|450751411|FG000|Maintenance Period|Withdrawal by Subject|0|||
125307287|NCT03364309|450751412|FG001|Maintenance Period|Withdrawal by Subject|0|||
125307288|NCT03364309|450751413|FG002|Maintenance Period|Withdrawal by Subject|0|||
125307289|NCT03364309|450751414|FG003|Maintenance Period|Withdrawal by Subject|1|||
125307290|NCT03364309|450751415|FG004|Maintenance Period|Withdrawal by Subject|3|||
125307291|NCT03364309|450751416|FG005|Maintenance Period|Withdrawal by Subject|1|||
125307292|NCT03364309|450751417|FG006|Maintenance Period|Withdrawal by Subject|3|||
125307293|NCT03364309|450751418|FG007|Maintenance Period|Withdrawal by Subject|0|||
125307294|NCT03364309|450751419|FG008|Maintenance Period|Withdrawal by Subject|1|||
125307295|NCT03364309|450751420|FG009|Maintenance Period|Withdrawal by Subject|1|||
125307296|NCT03364309|450751421|FG010|Maintenance Period|Withdrawal by Subject|2|||
125307297|NCT03364309|450751422|FG011|Maintenance Period|Withdrawal by Subject|0|||
125307298|NCT03364309|450751423|FG012|Maintenance Period|Withdrawal by Subject|0|||
125307299|NCT03364309|450751424|FG013|Maintenance Period|Withdrawal by Subject|0|||
125307300|NCT03364309|450751425|FG014|Maintenance Period|Withdrawal by Subject|0|||
125307301|NCT03364309|450751426|FG015|Maintenance Period|Withdrawal by Subject|0|||
125307302|NCT03364309|450751427|FG016|Maintenance Period|Withdrawal by Subject|0|||
125307303|NCT03364309|450751428|FG017|Maintenance Period|Withdrawal by Subject|0|||
125307304|NCT03364309|450751429|FG018|Maintenance Period|Withdrawal by Subject|0|||
125307305|NCT03364309|450751411|FG000|Maintenance Period|Adverse Event|0|||
125307306|NCT03364309|450751412|FG001|Maintenance Period|Adverse Event|0|||
125307307|NCT03364309|450751413|FG002|Maintenance Period|Adverse Event|0|||
125307308|NCT03364309|450751414|FG003|Maintenance Period|Adverse Event|0|||
125307309|NCT03364309|450751415|FG004|Maintenance Period|Adverse Event|2|||
125307310|NCT03364309|450751416|FG005|Maintenance Period|Adverse Event|0|||
125307311|NCT03364309|450751417|FG006|Maintenance Period|Adverse Event|3|||
125307312|NCT03364309|450751418|FG007|Maintenance Period|Adverse Event|0|||
125307313|NCT03364309|450751419|FG008|Maintenance Period|Adverse Event|1|||
125307314|NCT03364309|450751420|FG009|Maintenance Period|Adverse Event|0|||
125307315|NCT03364309|450751421|FG010|Maintenance Period|Adverse Event|2|||
125307316|NCT03364309|450751422|FG011|Maintenance Period|Adverse Event|0|||
125307317|NCT03364309|450751423|FG012|Maintenance Period|Adverse Event|0|||
125307318|NCT03364309|450751424|FG013|Maintenance Period|Adverse Event|0|||
125307319|NCT03364309|450751425|FG014|Maintenance Period|Adverse Event|0|||
125307320|NCT03364309|450751426|FG015|Maintenance Period|Adverse Event|0|||
125307321|NCT03364309|450751427|FG016|Maintenance Period|Adverse Event|0|||
125307322|NCT03364309|450751428|FG017|Maintenance Period|Adverse Event|0|||
125307323|NCT03364309|450751429|FG018|Maintenance Period|Adverse Event|0|||
125307324|NCT03364309|450751411|FG000|Maintenance Period|Relapsed|0|||
125307325|NCT03364309|450751412|FG001|Maintenance Period|Relapsed|0|||
125307326|NCT03364309|450751413|FG002|Maintenance Period|Relapsed|0|||
125307327|NCT03364309|450751414|FG003|Maintenance Period|Relapsed|43|||
125307328|NCT03364309|450751415|FG004|Maintenance Period|Relapsed|7|||
125307329|NCT03364309|450751416|FG005|Maintenance Period|Relapsed|45|||
125307330|NCT03364309|450751417|FG006|Maintenance Period|Relapsed|10|||
125307331|NCT03364309|450751418|FG007|Maintenance Period|Relapsed|2|||
125307332|NCT03364309|450751419|FG008|Maintenance Period|Relapsed|0|||
125307333|NCT03364309|450751420|FG009|Maintenance Period|Relapsed|0|||
125307334|NCT03364309|450751421|FG010|Maintenance Period|Relapsed|0|||
125307335|NCT03364309|450751422|FG011|Maintenance Period|Relapsed|0|||
125307336|NCT03364309|450751423|FG012|Maintenance Period|Relapsed|0|||
125307337|NCT03364309|450751424|FG013|Maintenance Period|Relapsed|0|||
125513676|NCT00043186|451510828|FG002|Overall Study|Disease progression|0|||
125513677|NCT00043186|451510829|FG003|Overall Study|Disease progression|3|||
125513678|NCT00043186|451510830|FG004|Overall Study|Disease progression|0|||
125307338|NCT03364309|450751425|FG014|Maintenance Period|Relapsed|0|||
125307339|NCT03364309|450751426|FG015|Maintenance Period|Relapsed|0|||
125307340|NCT03364309|450751427|FG016|Maintenance Period|Relapsed|0|||
125307341|NCT03364309|450751428|FG017|Maintenance Period|Relapsed|0|||
125307342|NCT03364309|450751429|FG018|Maintenance Period|Relapsed|0|||
125307343|NCT03364309|450751411|FG000|Maintenance Period|Lack of Efficacy|0|||
125307344|NCT03364309|450751412|FG001|Maintenance Period|Lack of Efficacy|0|||
125307345|NCT03364309|450751413|FG002|Maintenance Period|Lack of Efficacy|0|||
125307346|NCT03364309|450751414|FG003|Maintenance Period|Lack of Efficacy|0|||
125307347|NCT03364309|450751415|FG004|Maintenance Period|Lack of Efficacy|0|||
125307348|NCT03364309|450751416|FG005|Maintenance Period|Lack of Efficacy|0|||
125307349|NCT03364309|450751417|FG006|Maintenance Period|Lack of Efficacy|0|||
125307350|NCT03364309|450751418|FG007|Maintenance Period|Lack of Efficacy|0|||
125307351|NCT03364309|450751419|FG008|Maintenance Period|Lack of Efficacy|1|||
125307352|NCT03364309|450751420|FG009|Maintenance Period|Lack of Efficacy|3|||
125307353|NCT03364309|450751421|FG010|Maintenance Period|Lack of Efficacy|2|||
125307354|NCT03364309|450751422|FG011|Maintenance Period|Lack of Efficacy|0|||
125307355|NCT03364309|450751423|FG012|Maintenance Period|Lack of Efficacy|0|||
125307356|NCT03364309|450751424|FG013|Maintenance Period|Lack of Efficacy|0|||
125307357|NCT03364309|450751425|FG014|Maintenance Period|Lack of Efficacy|0|||
125307358|NCT03364309|450751426|FG015|Maintenance Period|Lack of Efficacy|0|||
125307359|NCT03364309|450751427|FG016|Maintenance Period|Lack of Efficacy|0|||
125307360|NCT03364309|450751428|FG017|Maintenance Period|Lack of Efficacy|0|||
125307361|NCT03364309|450751429|FG018|Maintenance Period|Lack of Efficacy|0|||
125307362|NCT03364309|450751411|FG000|Maintenance Period|Death|0|||
125307363|NCT03364309|450751412|FG001|Maintenance Period|Death|0|||
125307364|NCT03364309|450751413|FG002|Maintenance Period|Death|0|||
125307365|NCT03364309|450751414|FG003|Maintenance Period|Death|0|||
125307366|NCT03364309|450751415|FG004|Maintenance Period|Death|0|||
125307367|NCT03364309|450751416|FG005|Maintenance Period|Death|0|||
125307368|NCT03364309|450751417|FG006|Maintenance Period|Death|0|||
125307369|NCT03364309|450751418|FG007|Maintenance Period|Death|0|||
125307370|NCT03364309|450751419|FG008|Maintenance Period|Death|1|||
125307371|NCT03364309|450751420|FG009|Maintenance Period|Death|0|||
125307372|NCT03364309|450751421|FG010|Maintenance Period|Death|0|||
125307373|NCT03364309|450751422|FG011|Maintenance Period|Death|0|||
125307374|NCT03364309|450751423|FG012|Maintenance Period|Death|0|||
125307375|NCT03364309|450751424|FG013|Maintenance Period|Death|0|||
125307376|NCT03364309|450751425|FG014|Maintenance Period|Death|0|||
125307377|NCT03364309|450751426|FG015|Maintenance Period|Death|0|||
125307378|NCT03364309|450751427|FG016|Maintenance Period|Death|0|||
125307379|NCT03364309|450751428|FG017|Maintenance Period|Death|0|||
125307380|NCT03364309|450751429|FG018|Maintenance Period|Death|0|||
125307381|NCT03364309|450751411|FG000|Maintenance Period|Lost to Follow-up|0|||
125307382|NCT03364309|450751412|FG001|Maintenance Period|Lost to Follow-up|0|||
125307383|NCT03364309|450751413|FG002|Maintenance Period|Lost to Follow-up|0|||
125307384|NCT03364309|450751414|FG003|Maintenance Period|Lost to Follow-up|0|||
125307385|NCT03364309|450751415|FG004|Maintenance Period|Lost to Follow-up|0|||
125307386|NCT03364309|450751416|FG005|Maintenance Period|Lost to Follow-up|0|||
125307387|NCT03364309|450751417|FG006|Maintenance Period|Lost to Follow-up|0|||
125307388|NCT03364309|450751418|FG007|Maintenance Period|Lost to Follow-up|0|||
125307389|NCT03364309|450751419|FG008|Maintenance Period|Lost to Follow-up|1|||
125307390|NCT03364309|450751420|FG009|Maintenance Period|Lost to Follow-up|0|||
125307391|NCT03364309|450751421|FG010|Maintenance Period|Lost to Follow-up|0|||
125307392|NCT03364309|450751422|FG011|Maintenance Period|Lost to Follow-up|0|||
125307393|NCT03364309|450751423|FG012|Maintenance Period|Lost to Follow-up|0|||
125307394|NCT03364309|450751424|FG013|Maintenance Period|Lost to Follow-up|0|||
125307395|NCT03364309|450751425|FG014|Maintenance Period|Lost to Follow-up|0|||
125307396|NCT03364309|450751426|FG015|Maintenance Period|Lost to Follow-up|0|||
125307397|NCT03364309|450751427|FG016|Maintenance Period|Lost to Follow-up|0|||
125307398|NCT03364309|450751428|FG017|Maintenance Period|Lost to Follow-up|0|||
125307399|NCT03364309|450751429|FG018|Maintenance Period|Lost to Follow-up|0|||
125307400|NCT03364309|450751411|FG000|Maintenance Period|Miscellaneous|0|||
125307401|NCT03364309|450751412|FG001|Maintenance Period|Miscellaneous|0|||
125307402|NCT03364309|450751413|FG002|Maintenance Period|Miscellaneous|0|||
125307403|NCT03364309|450751414|FG003|Maintenance Period|Miscellaneous|0|||
125307404|NCT03364309|450751415|FG004|Maintenance Period|Miscellaneous|0|||
125307405|NCT03364309|450751416|FG005|Maintenance Period|Miscellaneous|0|||
125307406|NCT03364309|450751417|FG006|Maintenance Period|Miscellaneous|0|||
125307407|NCT03364309|450751418|FG007|Maintenance Period|Miscellaneous|0|||
125307408|NCT03364309|450751419|FG008|Maintenance Period|Miscellaneous|1|||
125307409|NCT03364309|450751420|FG009|Maintenance Period|Miscellaneous|0|||
125307410|NCT03364309|450751421|FG010|Maintenance Period|Miscellaneous|0|||
125307411|NCT03364309|450751422|FG011|Maintenance Period|Miscellaneous|0|||
125307412|NCT03364309|450751423|FG012|Maintenance Period|Miscellaneous|0|||
125513679|NCT00043186|451510831|FG005|Overall Study|Disease progression|0|||
125513680|NCT00043186|451510832|FG006|Overall Study|Disease progression|0|||
125307413|NCT03364309|450751424|FG013|Maintenance Period|Miscellaneous|0|||
125307414|NCT03364309|450751425|FG014|Maintenance Period|Miscellaneous|0|||
125307415|NCT03364309|450751426|FG015|Maintenance Period|Miscellaneous|0|||
125307416|NCT03364309|450751427|FG016|Maintenance Period|Miscellaneous|0|||
125307417|NCT03364309|450751428|FG017|Maintenance Period|Miscellaneous|0|||
125307418|NCT03364309|450751429|FG018|Maintenance Period|Miscellaneous|0|||
125307419|NCT03364309|450751411|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307420|NCT03364309|450751412|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307421|NCT03364309|450751413|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307422|NCT03364309|450751414|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307423|NCT03364309|450751415|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307424|NCT03364309|450751416|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307425|NCT03364309|450751417|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307426|NCT03364309|450751418|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307427|NCT03364309|450751419|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125513681|NCT00043186|451510833|FG007|Overall Study|Disease progression|4|||
125307428|NCT03364309|450751420|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307429|NCT03364309|450751421|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307430|NCT03364309|450751422|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307431|NCT03364309|450751423|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307432|NCT03364309|450751424|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
125307433|NCT03364309|450751425|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
125307434|NCT03364309|450751426|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
125307435|NCT03364309|450751427|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307436|NCT03364309|450751428|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307437|NCT03364309|450751429|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
125307438|NCT03364309|450751411|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307439|NCT03364309|450751412|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307440|NCT03364309|450751413|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307441|NCT03364309|450751414|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307442|NCT03364309|450751415|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307443|NCT03364309|450751416|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307444|NCT03364309|450751417|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307445|NCT03364309|450751418|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307446|NCT03364309|450751419|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307447|NCT03364309|450751420|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307448|NCT03364309|450751421|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307449|NCT03364309|450751422|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307450|NCT03364309|450751423|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307451|NCT03364309|450751424|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307452|NCT03364309|450751425|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
125307453|NCT03364309|450751426|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307454|NCT03364309|450751427|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307455|NCT03364309|450751428|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307456|NCT03364309|450751429|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
125307457|NCT03364309|450751411|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
125307458|NCT03364309|450751412|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
125307459|NCT03364309|450751413|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
125307460|NCT03364309|450751414|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
125307461|NCT03364309|450751415|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
125307462|NCT03364309|450751416|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
125307463|NCT03364309|450751417|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
125307464|NCT03364309|450751418|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
125307465|NCT03364309|450751419|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
125307466|NCT03364309|450751420|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
125307467|NCT03364309|450751421|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
125307468|NCT03364309|450751422|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
125307469|NCT03364309|450751423|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
125307470|NCT03364309|450751424|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
125307471|NCT03364309|450751425|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
125307472|NCT03364309|450751426|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
125307473|NCT03364309|450751427|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
125307474|NCT03364309|450751428|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
125307475|NCT03364309|450751429|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
125307476|NCT03364309|450751411|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307477|NCT03364309|450751412|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307478|NCT03364309|450751413|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307479|NCT03364309|450751414|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307480|NCT03364309|450751415|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307481|NCT03364309|450751416|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307482|NCT03364309|450751417|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307483|NCT03364309|450751418|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307484|NCT03364309|450751419|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307485|NCT03364309|450751420|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307486|NCT03364309|450751421|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307487|NCT03364309|450751422|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307488|NCT03364309|450751423|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307489|NCT03364309|450751424|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307490|NCT03364309|450751425|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307491|NCT03364309|450751426|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
125307492|NCT03364309|450751427|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
125307493|NCT03364309|450751428|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
125307494|NCT03364309|450751429|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
125307495|NCT03364309|450751411|FG000|Post-Treatment Followup Period|Adverse Event|0|||
125513682|NCT00043186|451510834|FG008|Overall Study|Disease progression|0|||
125532605|NCT00350727|451580163|FG002|Phase II|Withdrawal by Subject|1|||
125307496|NCT03364309|450751412|FG001|Post-Treatment Followup Period|Adverse Event|0|||
125307497|NCT03364309|450751413|FG002|Post-Treatment Followup Period|Adverse Event|0|||
125307498|NCT03364309|450751414|FG003|Post-Treatment Followup Period|Adverse Event|0|||
125307499|NCT03364309|450751415|FG004|Post-Treatment Followup Period|Adverse Event|0|||
125307500|NCT03364309|450751416|FG005|Post-Treatment Followup Period|Adverse Event|0|||
125307501|NCT03364309|450751417|FG006|Post-Treatment Followup Period|Adverse Event|0|||
125307502|NCT03364309|450751418|FG007|Post-Treatment Followup Period|Adverse Event|0|||
125307503|NCT03364309|450751419|FG008|Post-Treatment Followup Period|Adverse Event|0|||
125307504|NCT03364309|450751420|FG009|Post-Treatment Followup Period|Adverse Event|0|||
125307505|NCT03364309|450751421|FG010|Post-Treatment Followup Period|Adverse Event|0|||
125307506|NCT03364309|450751422|FG011|Post-Treatment Followup Period|Adverse Event|0|||
125307507|NCT03364309|450751423|FG012|Post-Treatment Followup Period|Adverse Event|0|||
125307508|NCT03364309|450751424|FG013|Post-Treatment Followup Period|Adverse Event|0|||
125307509|NCT03364309|450751425|FG014|Post-Treatment Followup Period|Adverse Event|0|||
125307510|NCT03364309|450751426|FG015|Post-Treatment Followup Period|Adverse Event|0|||
125307511|NCT03364309|450751427|FG016|Post-Treatment Followup Period|Adverse Event|2|||
125307512|NCT03364309|450751428|FG017|Post-Treatment Followup Period|Adverse Event|6|||
125307513|NCT03364309|450751429|FG018|Post-Treatment Followup Period|Adverse Event|1|||
125307514|NCT03364309|450751411|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307515|NCT03364309|450751412|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307516|NCT03364309|450751413|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307517|NCT03364309|450751414|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307518|NCT03364309|450751415|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307519|NCT03364309|450751416|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307520|NCT03364309|450751417|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307521|NCT03364309|450751418|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307522|NCT03364309|450751419|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307523|NCT03364309|450751420|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307524|NCT03364309|450751421|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307525|NCT03364309|450751422|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307526|NCT03364309|450751423|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307527|NCT03364309|450751424|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307528|NCT03364309|450751425|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307529|NCT03364309|450751426|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307530|NCT03364309|450751427|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307531|NCT03364309|450751428|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
125307532|NCT03364309|450751429|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
125307533|NCT03364309|450751411|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
125307534|NCT03364309|450751412|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
125307535|NCT03364309|450751413|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
125307536|NCT03364309|450751414|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
125307537|NCT03364309|450751415|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
125307538|NCT03364309|450751416|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
125307539|NCT03364309|450751417|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
125307540|NCT03364309|450751418|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
125307541|NCT03364309|450751419|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
125307542|NCT03364309|450751420|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
125307543|NCT03364309|450751421|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
125307544|NCT03364309|450751422|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
125307545|NCT03364309|450751423|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
125307546|NCT03364309|450751424|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
125307547|NCT03364309|450751425|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
125307548|NCT03364309|450751426|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
125307549|NCT03364309|450751427|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
125307550|NCT03364309|450751428|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
125307551|NCT03364309|450751429|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
125513683|NCT00043186|451510826|FG000|Overall Study|Ineligibility determined|0|||
125307552|NCT03304873|450751430|FG000|Overall Study|Lost to Follow-up|1|||
125307553|NCT03304873|450751431|FG001|Overall Study|Lost to Follow-up|8|||
125307554|NCT01546688|450751432|FG000|Overall Study|Adverse Event|0|||
125307555|NCT01546688|450751433|FG001|Overall Study|Adverse Event|4|||
125307556|NCT01546688|450751432|FG000|Overall Study|Withdrawal by Subject|2|||
125307557|NCT01546688|450751433|FG001|Overall Study|Withdrawal by Subject|1|||
125307558|NCT01546688|450751432|FG000|Overall Study|Lack of Efficacy|1|||
125307559|NCT01546688|450751433|FG001|Overall Study|Lack of Efficacy|0|||
125513684|NCT00043186|451510827|FG001|Overall Study|Ineligibility determined|0|||
125513685|NCT00043186|451510828|FG002|Overall Study|Ineligibility determined|0|||
125513686|NCT00043186|451510829|FG003|Overall Study|Ineligibility determined|0|||
125307560|NCT01052077|450751437|FG000|Phase A|Lost to Follow-up|22|||
125307561|NCT01052077|450751438|FG001|Phase A|Lost to Follow-up|0|||
125307562|NCT01052077|450751439|FG002|Phase A|Lost to Follow-up|0|||
125513687|NCT00043186|451510830|FG004|Overall Study|Ineligibility determined|0|||
125307563|NCT01052077|450751440|FG003|Phase A|Lost to Follow-up|0|||
125307564|NCT01052077|450751437|FG000|Phase A|Adverse Event|32|||
125307565|NCT01052077|450751438|FG001|Phase A|Adverse Event|0|||
125307566|NCT01052077|450751439|FG002|Phase A|Adverse Event|0|||
125307567|NCT01052077|450751440|FG003|Phase A|Adverse Event|0|||
125307568|NCT01052077|450751437|FG000|Phase A|Met Withdrawal Criteria|26|||
125307569|NCT01052077|450751438|FG001|Phase A|Met Withdrawal Criteria|0|||
125307570|NCT01052077|450751439|FG002|Phase A|Met Withdrawal Criteria|0|||
125307571|NCT01052077|450751440|FG003|Phase A|Met Withdrawal Criteria|0|||
125307572|NCT01052077|450751437|FG000|Phase A|Physician Decision|10|||
125307573|NCT01052077|450751438|FG001|Phase A|Physician Decision|0|||
125307574|NCT01052077|450751439|FG002|Phase A|Physician Decision|0|||
125307575|NCT01052077|450751440|FG003|Phase A|Physician Decision|0|||
125307576|NCT01052077|450751437|FG000|Phase A|Withdrawal by Subject|29|||
125307577|NCT01052077|450751438|FG001|Phase A|Withdrawal by Subject|0|||
125307578|NCT01052077|450751439|FG002|Phase A|Withdrawal by Subject|0|||
125307579|NCT01052077|450751440|FG003|Phase A|Withdrawal by Subject|0|||
125307580|NCT01052077|450751437|FG000|Phase A|Protocol Deviation|27|||
125307581|NCT01052077|450751438|FG001|Phase A|Protocol Deviation|0|||
125307582|NCT01052077|450751439|FG002|Phase A|Protocol Deviation|0|||
125307583|NCT01052077|450751440|FG003|Phase A|Protocol Deviation|0|||
125307584|NCT01052077|450751437|FG000|Phase B|Lost to Follow-up|0|||
125307585|NCT01052077|450751438|FG001|Phase B|Lost to Follow-up|2|||
125307586|NCT01052077|450751439|FG002|Phase B|Lost to Follow-up|3|||
125307587|NCT01052077|450751440|FG003|Phase B|Lost to Follow-up|0|||
125307588|NCT01052077|450751437|FG000|Phase B|Adverse Event|0|||
125307589|NCT01052077|450751438|FG001|Phase B|Adverse Event|9|||
125307590|NCT01052077|450751439|FG002|Phase B|Adverse Event|2|||
125307591|NCT01052077|450751440|FG003|Phase B|Adverse Event|0|||
125307592|NCT01052077|450751437|FG000|Phase B|Met Withdrawal Criteria|0|||
125307593|NCT01052077|450751438|FG001|Phase B|Met Withdrawal Criteria|2|||
125307594|NCT01052077|450751439|FG002|Phase B|Met Withdrawal Criteria|1|||
125307595|NCT01052077|450751440|FG003|Phase B|Met Withdrawal Criteria|0|||
125307596|NCT01052077|450751437|FG000|Phase B|Physician Decision|0|||
125307597|NCT01052077|450751438|FG001|Phase B|Physician Decision|1|||
125307598|NCT01052077|450751439|FG002|Phase B|Physician Decision|1|||
125307599|NCT01052077|450751440|FG003|Phase B|Physician Decision|0|||
125307600|NCT01052077|450751437|FG000|Phase B|Withdrawal by Subject|0|||
125307601|NCT01052077|450751438|FG001|Phase B|Withdrawal by Subject|0|||
125307602|NCT01052077|450751439|FG002|Phase B|Withdrawal by Subject|5|||
125307603|NCT01052077|450751440|FG003|Phase B|Withdrawal by Subject|0|||
125307604|NCT01052077|450751437|FG000|Phase B|Protocol Deviation|0|||
125307605|NCT01052077|450751438|FG001|Phase B|Protocol Deviation|3|||
125307606|NCT01052077|450751439|FG002|Phase B|Protocol Deviation|4|||
125307607|NCT01052077|450751440|FG003|Phase B|Protocol Deviation|0|||
125307608|NCT01052077|450751437|FG000|Phase B|Lack of Efficacy|0|||
125307609|NCT01052077|450751438|FG001|Phase B|Lack of Efficacy|1|||
125307610|NCT01052077|450751439|FG002|Phase B|Lack of Efficacy|0|||
125307611|NCT01052077|450751440|FG003|Phase B|Lack of Efficacy|0|||
125307612|NCT01052077|450751437|FG000|Phase A+|Lost to Follow-up|0|||
125307613|NCT01052077|450751438|FG001|Phase A+|Lost to Follow-up|0|||
125307614|NCT01052077|450751439|FG002|Phase A+|Lost to Follow-up|0|||
125307615|NCT01052077|450751440|FG003|Phase A+|Lost to Follow-up|8|||
125307616|NCT01052077|450751437|FG000|Phase A+|Adverse Event|0|||
125307617|NCT01052077|450751438|FG001|Phase A+|Adverse Event|0|||
125307618|NCT01052077|450751439|FG002|Phase A+|Adverse Event|0|||
125307619|NCT01052077|450751440|FG003|Phase A+|Adverse Event|4|||
125307620|NCT01052077|450751437|FG000|Phase A+|Met Withdrawal Criteria|0|||
125307621|NCT01052077|450751438|FG001|Phase A+|Met Withdrawal Criteria|0|||
125307622|NCT01052077|450751439|FG002|Phase A+|Met Withdrawal Criteria|0|||
125307623|NCT01052077|450751440|FG003|Phase A+|Met Withdrawal Criteria|2|||
125307624|NCT01052077|450751437|FG000|Phase A+|Withdrawal by Subject|0|||
125307625|NCT01052077|450751438|FG001|Phase A+|Withdrawal by Subject|0|||
125307626|NCT01052077|450751439|FG002|Phase A+|Withdrawal by Subject|0|||
125307627|NCT01052077|450751440|FG003|Phase A+|Withdrawal by Subject|7|||
125307628|NCT02465203|450751441|FG000|Overall Study|Protocol Violation|1|||
125307629|NCT02465203|450751442|FG001|Overall Study|Protocol Violation|1|||
125307630|NCT02465203|450751443|FG002|Overall Study|Protocol Violation|1|||
125307631|NCT02465203|450751441|FG000|Overall Study|Study terminated by sponsor|50|||
125307632|NCT02465203|450751442|FG001|Overall Study|Study terminated by sponsor|34|||
125307633|NCT02465203|450751443|FG002|Overall Study|Study terminated by sponsor|11|||
125307634|NCT02465203|450751441|FG000|Overall Study|New therapy for study indication|4|||
125307635|NCT02465203|450751442|FG001|Overall Study|New therapy for study indication|0|||
125307636|NCT02465203|450751443|FG002|Overall Study|New therapy for study indication|0|||
125307637|NCT02465203|450751441|FG000|Overall Study|Patient/guardian decision|1|||
125307638|NCT02465203|450751442|FG001|Overall Study|Patient/guardian decision|1|||
125307639|NCT02465203|450751443|FG002|Overall Study|Patient/guardian decision|1|||
125307640|NCT00042991|450751444|FG000|Overall Study|Adverse Event|1|||
125307641|NCT00042991|450751445|FG001|Overall Study|Adverse Event|4|||
125307642|NCT00042991|450751446|FG002|Overall Study|Adverse Event|2|||
125307643|NCT00042991|450751447|FG003|Overall Study|Adverse Event|0|||
125307644|NCT00042991|450751448|FG004|Overall Study|Adverse Event|0|||
125307645|NCT00042991|450751449|FG005|Overall Study|Adverse Event|1|||
125307646|NCT00042991|450751450|FG006|Overall Study|Adverse Event|0|||
125307647|NCT00042991|450751444|FG000|Overall Study|Withdrawal by Subject|0|||
125307648|NCT00042991|450751445|FG001|Overall Study|Withdrawal by Subject|7|||
125307649|NCT00042991|450751446|FG002|Overall Study|Withdrawal by Subject|2|||
125307650|NCT00042991|450751447|FG003|Overall Study|Withdrawal by Subject|0|||
125307651|NCT00042991|450751448|FG004|Overall Study|Withdrawal by Subject|1|||
125307652|NCT00042991|450751449|FG005|Overall Study|Withdrawal by Subject|0|||
125307653|NCT00042991|450751450|FG006|Overall Study|Withdrawal by Subject|0|||
125307654|NCT00042991|450751444|FG000|Overall Study|Disease Progression|5|||
125307655|NCT00042991|450751445|FG001|Overall Study|Disease Progression|29|||
125307656|NCT00042991|450751446|FG002|Overall Study|Disease Progression|2|||
125307657|NCT00042991|450751447|FG003|Overall Study|Disease Progression|2|||
125307658|NCT00042991|450751448|FG004|Overall Study|Disease Progression|1|||
125307659|NCT00042991|450751449|FG005|Overall Study|Disease Progression|4|||
125307660|NCT00042991|450751450|FG006|Overall Study|Disease Progression|2|||
125307661|NCT00042991|450751444|FG000|Overall Study|Alternative Therapy|0|||
125307662|NCT00042991|450751445|FG001|Overall Study|Alternative Therapy|0|||
125307663|NCT00042991|450751446|FG002|Overall Study|Alternative Therapy|0|||
125307664|NCT00042991|450751447|FG003|Overall Study|Alternative Therapy|0|||
125307665|NCT00042991|450751448|FG004|Overall Study|Alternative Therapy|1|||
125307666|NCT00042991|450751449|FG005|Overall Study|Alternative Therapy|0|||
125307667|NCT00042991|450751450|FG006|Overall Study|Alternative Therapy|0|||
125307668|NCT04072887|450751451|FG000|Overall Study|Withdrawal by Subject|3|||
125307669|NCT04072887|450751452|FG001|Overall Study|Withdrawal by Subject|8|||
125307670|NCT04072887|450751453|FG002|Overall Study|Withdrawal by Subject|1|||
125307671|NCT04072887|450751454|FG003|Overall Study|Withdrawal by Subject|3|||
125307672|NCT04072887|450751455|FG004|Overall Study|Withdrawal by Subject|3|||
125307673|NCT04072887|450751456|FG005|Overall Study|Withdrawal by Subject|13|||
125307674|NCT04072887|450751451|FG000|Overall Study|Adverse Event|2|||
125307675|NCT04072887|450751452|FG001|Overall Study|Adverse Event|4|||
125307676|NCT04072887|450751453|FG002|Overall Study|Adverse Event|1|||
125307677|NCT04072887|450751454|FG003|Overall Study|Adverse Event|4|||
125307678|NCT04072887|450751455|FG004|Overall Study|Adverse Event|0|||
125307679|NCT04072887|450751456|FG005|Overall Study|Adverse Event|1|||
125307680|NCT04072887|450751451|FG000|Overall Study|Physician Decision|2|||
125307681|NCT04072887|450751452|FG001|Overall Study|Physician Decision|0|||
125307682|NCT04072887|450751453|FG002|Overall Study|Physician Decision|0|||
125307683|NCT04072887|450751454|FG003|Overall Study|Physician Decision|0|||
125307684|NCT04072887|450751455|FG004|Overall Study|Physician Decision|0|||
125307685|NCT04072887|450751456|FG005|Overall Study|Physician Decision|1|||
125307686|NCT04072887|450751451|FG000|Overall Study|Lost to Follow-up|1|||
125307687|NCT04072887|450751452|FG001|Overall Study|Lost to Follow-up|3|||
125307688|NCT04072887|450751453|FG002|Overall Study|Lost to Follow-up|0|||
125307689|NCT04072887|450751454|FG003|Overall Study|Lost to Follow-up|0|||
125307690|NCT04072887|450751455|FG004|Overall Study|Lost to Follow-up|0|||
125307691|NCT04072887|450751456|FG005|Overall Study|Lost to Follow-up|0|||
125307692|NCT04072887|450751451|FG000|Overall Study|Death|0|||
125307693|NCT04072887|450751452|FG001|Overall Study|Death|2|||
125307694|NCT04072887|450751453|FG002|Overall Study|Death|0|||
125307695|NCT04072887|450751454|FG003|Overall Study|Death|2|||
125307696|NCT04072887|450751455|FG004|Overall Study|Death|3|||
125307697|NCT04072887|450751456|FG005|Overall Study|Death|0|||
125307698|NCT03193736|450751457|FG000|Overall Study|Death|2|||
125307699|NCT03193736|450751457|FG000|Overall Study|Withdrawal by Subject|1|||
125307700|NCT03193736|450751457|FG000|Overall Study|Lost to Follow-up|1|||
125307701|NCT03193736|450751457|FG000|Overall Study|implant not received|1|||
125307702|NCT00423449|450751458|FG000|Overall Study|Clinical Adverse Event|1|||
125307703|NCT00423449|450751459|FG001|Overall Study|Clinical Adverse Event|0|||
125307704|NCT00423449|450751460|FG002|Overall Study|Clinical Adverse Event|1|||
125307705|NCT00423449|450751461|FG003|Overall Study|Clinical Adverse Event|8|||
125307706|NCT00423449|450751462|FG004|Overall Study|Clinical Adverse Event|2|||
125307707|NCT00423449|450751458|FG000|Overall Study|Death|1|||
125307708|NCT00423449|450751459|FG001|Overall Study|Death|0|||
125307709|NCT00423449|450751460|FG002|Overall Study|Death|2|||
125307710|NCT00423449|450751461|FG003|Overall Study|Death|1|||
125307711|NCT00423449|450751462|FG004|Overall Study|Death|1|||
125307712|NCT00423449|450751458|FG000|Overall Study|Progressive Disease|1|||
125307713|NCT00423449|450751459|FG001|Overall Study|Progressive Disease|3|||
125307714|NCT00423449|450751460|FG002|Overall Study|Progressive Disease|8|||
125307715|NCT00423449|450751461|FG003|Overall Study|Progressive Disease|11|||
125307716|NCT00423449|450751462|FG004|Overall Study|Progressive Disease|4|||
125307717|NCT00423449|450751458|FG000|Overall Study|Laboratory Adverse Event|0|||
125307718|NCT00423449|450751459|FG001|Overall Study|Laboratory Adverse Event|1|||
125307719|NCT00423449|450751460|FG002|Overall Study|Laboratory Adverse Event|2|||
125307720|NCT00423449|450751461|FG003|Overall Study|Laboratory Adverse Event|0|||
125307721|NCT00423449|450751462|FG004|Overall Study|Laboratory Adverse Event|0|||
125307722|NCT00423449|450751458|FG000|Overall Study|Other|0|||
125307723|NCT00423449|450751459|FG001|Overall Study|Other|0|||
125307724|NCT00423449|450751460|FG002|Overall Study|Other|0|||
125307725|NCT00423449|450751461|FG003|Overall Study|Other|1|||
125307726|NCT00423449|450751462|FG004|Overall Study|Other|0|||
125307727|NCT00423449|450751458|FG000|Overall Study|Protocol Violation|0|||
125307728|NCT00423449|450751459|FG001|Overall Study|Protocol Violation|0|||
125307729|NCT00423449|450751460|FG002|Overall Study|Protocol Violation|2|||
125307730|NCT00423449|450751461|FG003|Overall Study|Protocol Violation|1|||
125307731|NCT00423449|450751462|FG004|Overall Study|Protocol Violation|0|||
125307732|NCT02697435|450751463|FG000|Overall Study|Withdrawal by Subject|1|||
125307733|NCT02697435|450751464|FG001|Overall Study|Withdrawal by Subject|0|||
125307734|NCT02697435|450751463|FG000|Overall Study|Physician Decision|0|||
125307735|NCT02697435|450751464|FG001|Overall Study|Physician Decision|4|||
125307736|NCT04371666|450751465|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
125307737|NCT04371666|450751466|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
125307738|NCT04371666|450751465|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
125307739|NCT04371666|450751466|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
125307740|NCT04371666|450751465|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
125307741|NCT04371666|450751466|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
125307742|NCT04371666|450751465|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
125307743|NCT04371666|450751466|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
125307744|NCT04371666|450751465|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
125307745|NCT04371666|450751466|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
125307746|NCT04371666|450751465|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
125307747|NCT04371666|450751466|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
125307748|NCT01445080|450751473|FG000|Overall Study|Adverse Event|5|||
125307749|NCT01445080|450751474|FG001|Overall Study|Adverse Event|3|||
125307750|NCT01445080|450751475|FG002|Overall Study|Adverse Event|11|||
125307751|NCT01445080|450751476|FG003|Overall Study|Adverse Event|6|||
125307752|NCT01445080|450751477|FG004|Overall Study|Adverse Event|2|||
125307753|NCT01445080|450751478|FG005|Overall Study|Adverse Event|3|||
125307754|NCT01445080|450751479|FG006|Overall Study|Adverse Event|0|||
125307755|NCT01445080|450751480|FG007|Overall Study|Adverse Event|3|||
125307756|NCT01445080|450751481|FG008|Overall Study|Adverse Event|10|||
125307757|NCT01445080|450751473|FG000|Overall Study|Physician Decision|0|||
125307758|NCT01445080|450751474|FG001|Overall Study|Physician Decision|0|||
125307759|NCT01445080|450751475|FG002|Overall Study|Physician Decision|1|||
125307760|NCT01445080|450751476|FG003|Overall Study|Physician Decision|0|||
125307761|NCT01445080|450751477|FG004|Overall Study|Physician Decision|0|||
125307762|NCT01445080|450751478|FG005|Overall Study|Physician Decision|3|||
125307763|NCT01445080|450751479|FG006|Overall Study|Physician Decision|2|||
125307764|NCT01445080|450751480|FG007|Overall Study|Physician Decision|2|||
125307765|NCT01445080|450751481|FG008|Overall Study|Physician Decision|0|||
125307766|NCT01445080|450751473|FG000|Overall Study|Withdrawal by Subject|1|||
125307767|NCT01445080|450751474|FG001|Overall Study|Withdrawal by Subject|0|||
125307768|NCT01445080|450751475|FG002|Overall Study|Withdrawal by Subject|0|||
125307769|NCT01445080|450751476|FG003|Overall Study|Withdrawal by Subject|1|||
125307770|NCT01445080|450751477|FG004|Overall Study|Withdrawal by Subject|0|||
125307771|NCT01445080|450751478|FG005|Overall Study|Withdrawal by Subject|0|||
125307772|NCT01445080|450751479|FG006|Overall Study|Withdrawal by Subject|0|||
125307773|NCT01445080|450751480|FG007|Overall Study|Withdrawal by Subject|0|||
125307774|NCT01445080|450751481|FG008|Overall Study|Withdrawal by Subject|2|||
125307775|NCT01445080|450751473|FG000|Overall Study|Ineligible/Inevaluable|1|||
125307776|NCT01445080|450751474|FG001|Overall Study|Ineligible/Inevaluable|2|||
125307777|NCT01445080|450751475|FG002|Overall Study|Ineligible/Inevaluable|0|||
125307778|NCT01445080|450751476|FG003|Overall Study|Ineligible/Inevaluable|1|||
125307779|NCT01445080|450751477|FG004|Overall Study|Ineligible/Inevaluable|2|||
125307780|NCT01445080|450751478|FG005|Overall Study|Ineligible/Inevaluable|3|||
125307781|NCT01445080|450751479|FG006|Overall Study|Ineligible/Inevaluable|0|||
125307782|NCT01445080|450751480|FG007|Overall Study|Ineligible/Inevaluable|0|||
125307783|NCT01445080|450751481|FG008|Overall Study|Ineligible/Inevaluable|6|||
125307784|NCT02123576|450751482|FG000|Overall Study|Adverse Event|1|||
125513688|NCT00043186|451510831|FG005|Overall Study|Ineligibility determined|0|||
125513689|NCT00043186|451510832|FG006|Overall Study|Ineligibility determined|0|||
125307785|NCT02123576|450751483|FG001|Overall Study|Adverse Event|0|||
125307786|NCT02974257|450753308|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
125307787|NCT02974257|450753309|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
125307788|NCT02974257|450753308|FG000|Overall Study|Clinical indication for thiamine|1|||
125307789|NCT02974257|450753309|FG001|Overall Study|Clinical indication for thiamine|0|||
125307790|NCT02974257|450753308|FG000|Overall Study|Already on thiamine|1|||
125307791|NCT02974257|450753309|FG001|Overall Study|Already on thiamine|0|||
125307792|NCT02974257|450753308|FG000|Overall Study|Extubated prior to study drug|0|||
125307793|NCT02974257|450753309|FG001|Overall Study|Extubated prior to study drug|1|||
125307794|NCT02974257|450753308|FG000|Overall Study|Death|0|||
125307795|NCT02974257|450753309|FG001|Overall Study|Death|1|||
125513690|NCT00043186|451510833|FG007|Overall Study|Ineligibility determined|0|||
125307796|NCT02828436|450753312|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
125307797|NCT02828436|450753313|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
125307798|NCT02828436|450753312|FG000|Period 1|Lost to Follow-up|0|||
125307799|NCT02828436|450753313|FG001|Period 1|Lost to Follow-up|1|||
125307800|NCT02828436|450753312|FG000|Period 2|Withdrawal by Subject|4|||
125307801|NCT02828436|450753313|FG001|Period 2|Withdrawal by Subject|0|||
125307802|NCT02828436|450753312|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
125307803|NCT02828436|450753313|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
125307804|NCT02828436|450753312|FG000|Period 2|Lost to Follow-up|1|||
125307805|NCT02828436|450753313|FG001|Period 2|Lost to Follow-up|0|||
125307806|NCT01136408|450753314|FG000|Overall Study|Adverse Event|4|||
125307807|NCT01136408|450753315|FG001|Overall Study|Adverse Event|8|||
125307808|NCT01136408|450753316|FG002|Overall Study|Adverse Event|4|||
125307809|NCT01136408|450753314|FG000|Overall Study|Protocol Violation|1|||
125307810|NCT01136408|450753315|FG001|Overall Study|Protocol Violation|1|||
125307811|NCT01136408|450753316|FG002|Overall Study|Protocol Violation|1|||
125307812|NCT04421482|450753320|FG000|Overall Study|Physician Decision|1|||
125307813|NCT02128724|450753323|FG000|Overall Study|Death|1|||
125307814|NCT02128724|450753324|FG001|Overall Study|Death|0|||
125307815|NCT02128724|450753325|FG002|Overall Study|Death|0|||
125307816|NCT02128724|450753326|FG003|Overall Study|Death|0|||
125307817|NCT02128724|450753323|FG000|Overall Study|Adverse Event|0|||
125307818|NCT02128724|450753324|FG001|Overall Study|Adverse Event|1|||
125307819|NCT02128724|450753325|FG002|Overall Study|Adverse Event|0|||
125307820|NCT02128724|450753326|FG003|Overall Study|Adverse Event|0|||
125307821|NCT02128724|450753323|FG000|Overall Study|Physician Decision|0|||
125307822|NCT02128724|450753324|FG001|Overall Study|Physician Decision|0|||
125307823|NCT02128724|450753325|FG002|Overall Study|Physician Decision|0|||
125307824|NCT02128724|450753326|FG003|Overall Study|Physician Decision|2|||
125307825|NCT02128724|450753323|FG000|Overall Study|Withdrawal by Subject|0|||
125307826|NCT02128724|450753324|FG001|Overall Study|Withdrawal by Subject|0|||
125307827|NCT02128724|450753325|FG002|Overall Study|Withdrawal by Subject|0|||
125307828|NCT02128724|450753326|FG003|Overall Study|Withdrawal by Subject|1|||
125307829|NCT03329092|450753327|FG000|Overall Study|Other|2|||
125307830|NCT03329092|450753328|FG001|Overall Study|Other|2|||
125307831|NCT03329092|450753327|FG000|Overall Study|Withdrawal by Subject|16|||
125307832|NCT03329092|450753328|FG001|Overall Study|Withdrawal by Subject|3|||
125307833|NCT03329092|450753327|FG000|Overall Study|Physician Decision|1|||
125307834|NCT03329092|450753328|FG001|Overall Study|Physician Decision|0|||
125307835|NCT03329092|450753327|FG000|Overall Study|Death|17|||
125307836|NCT03329092|450753328|FG001|Overall Study|Death|11|||
125307837|NCT03329092|450753327|FG000|Overall Study|Adverse Event|3|||
125307838|NCT03329092|450753328|FG001|Overall Study|Adverse Event|1|||
125307839|NCT03329092|450753327|FG000|Overall Study|Lost to Follow-up|1|||
125307840|NCT03329092|450753328|FG001|Overall Study|Lost to Follow-up|1|||
125307841|NCT05786508|450753329|FG000|Overall Study|Withdrawal by Subject|2|||
125307842|NCT05786508|450753330|FG001|Overall Study|Withdrawal by Subject|0|||
125307843|NCT04273893|450753331|FG000|Overall Study|Withdrawal by Subject|0|||
125307844|NCT04273893|450753332|FG001|Overall Study|Withdrawal by Subject|2|||
125307845|NCT04273893|450753331|FG000|Overall Study|Treatment of Disease Progression|0|||
125307846|NCT04273893|450753332|FG001|Overall Study|Treatment of Disease Progression|2|||
125307847|NCT04273893|450753331|FG000|Overall Study|Death|1|||
125307848|NCT04273893|450753332|FG001|Overall Study|Death|2|||
125307849|NCT04273893|450753331|FG000|Overall Study|Lost to Follow-up|0|||
125307850|NCT04273893|450753332|FG001|Overall Study|Lost to Follow-up|2|||
125307851|NCT04273893|450753331|FG000|Overall Study|Physician Decision|1|||
125513691|NCT00043186|451510834|FG008|Overall Study|Ineligibility determined|1|||
125513692|NCT00043186|451510826|FG000|Overall Study|Lost to Follow-up|3|||
125513693|NCT00043186|451510827|FG001|Overall Study|Lost to Follow-up|5|||
125307852|NCT04273893|450753332|FG001|Overall Study|Physician Decision|0|||
125307853|NCT03906071|450753333|FG000|Overall Study|Death|180|||
125307854|NCT03906071|450753334|FG001|Overall Study|Death|185|||
125307855|NCT03906071|450753333|FG000|Overall Study|Lost to Follow-up|3|||
125307856|NCT03906071|450753334|FG001|Overall Study|Lost to Follow-up|3|||
125307857|NCT03906071|450753333|FG000|Overall Study|Withdrawal by Subject|15|||
125307858|NCT03906071|450753334|FG001|Overall Study|Withdrawal by Subject|27|||
125307859|NCT03906071|450753333|FG000|Overall Study|Other|2|||
125307860|NCT03906071|450753334|FG001|Overall Study|Other|1|||
125307861|NCT01456169|450753338|FG000|Overall Study|Adverse Event|1|||
125307862|NCT01456169|450753339|FG001|Overall Study|Adverse Event|2|||
125307863|NCT01456169|450753340|FG002|Overall Study|Adverse Event|7|||
125307864|NCT01456169|450753338|FG000|Overall Study|Major Protocol Deviation|3|||
125307865|NCT01456169|450753339|FG001|Overall Study|Major Protocol Deviation|2|||
125307866|NCT01456169|450753340|FG002|Overall Study|Major Protocol Deviation|3|||
125307867|NCT01456169|450753338|FG000|Overall Study|Voluntary Withdrawal|3|||
125307868|NCT01456169|450753339|FG001|Overall Study|Voluntary Withdrawal|0|||
125307869|NCT01456169|450753340|FG002|Overall Study|Voluntary Withdrawal|2|||
125307870|NCT01456169|450753338|FG000|Overall Study|Lack of Efficacy|2|||
125307871|NCT01456169|450753339|FG001|Overall Study|Lack of Efficacy|0|||
125513694|NCT00043186|451510828|FG002|Overall Study|Lost to Follow-up|1|||
125307872|NCT01456169|450753340|FG002|Overall Study|Lack of Efficacy|0|||
125307873|NCT01456169|450753338|FG000|Overall Study|Other|1|||
125307874|NCT01456169|450753339|FG001|Overall Study|Other|1|||
125307875|NCT01456169|450753340|FG002|Overall Study|Other|0|||
125307876|NCT02598297|450753341|FG000|Overall Study|Study terminated by Sponsor|21|||
125307877|NCT02598297|450753342|FG001|Overall Study|Study terminated by Sponsor|23|||
125307878|NCT02598297|450753341|FG000|Overall Study|Adverse Event|1|||
125307879|NCT02598297|450753342|FG001|Overall Study|Adverse Event|1|||
125307880|NCT02598297|450753341|FG000|Overall Study|Physician Decision|1|||
125307881|NCT02598297|450753342|FG001|Overall Study|Physician Decision|0|||
125307882|NCT02598297|450753341|FG000|Overall Study|Subject/guardian decision|1|||
125307883|NCT02598297|450753342|FG001|Overall Study|Subject/guardian decision|0|||
125307884|NCT02598297|450753341|FG000|Overall Study|Followed for survival|1|||
125307885|NCT02598297|450753342|FG001|Overall Study|Followed for survival|0|||
125307886|NCT00394706|450753348|FG000|Overall Study|Withdrawal by Subject|2|||
125307887|NCT00394706|450753349|FG001|Overall Study|Withdrawal by Subject|0|||
125307888|NCT00394706|450753350|FG002|Overall Study|Withdrawal by Subject|1|||
125307889|NCT00394706|450753351|FG003|Overall Study|Withdrawal by Subject|0|||
125307890|NCT00394706|450753352|FG004|Overall Study|Withdrawal by Subject|0|||
125307891|NCT00394706|450753353|FG005|Overall Study|Withdrawal by Subject|2|||
125307892|NCT00394706|450753354|FG006|Overall Study|Withdrawal by Subject|1|||
125307893|NCT00394706|450753355|FG007|Overall Study|Withdrawal by Subject|0|||
125307894|NCT00394706|450753348|FG000|Overall Study|Lost to Follow-up|2|||
125307895|NCT00394706|450753349|FG001|Overall Study|Lost to Follow-up|2|||
125307896|NCT00394706|450753350|FG002|Overall Study|Lost to Follow-up|8|||
125307897|NCT00394706|450753351|FG003|Overall Study|Lost to Follow-up|1|||
125307898|NCT00394706|450753352|FG004|Overall Study|Lost to Follow-up|2|||
125307899|NCT00394706|450753353|FG005|Overall Study|Lost to Follow-up|5|||
125307900|NCT00394706|450753354|FG006|Overall Study|Lost to Follow-up|2|||
125307901|NCT00394706|450753355|FG007|Overall Study|Lost to Follow-up|0|||
125307902|NCT02003534|450753359|FG000|Overall Study|Lost to Follow-up|47|||
125307903|NCT02652156|450753360|FG000|Overall Study|Physician Decision|1|||
125307904|NCT02652156|450753361|FG001|Overall Study|Physician Decision|0|||
125307905|NCT02652156|450753362|FG002|Overall Study|Physician Decision|0|||
125307906|NCT02342223|450753364|FG000|Overall Study|Lost to Follow-up|1|||
125307907|NCT00496080|450753367|FG000|Overall Study|Lost to Follow-up|9|||
125307908|NCT00496080|450753367|FG000|Overall Study|Surgical re-intervention|7|||
125307909|NCT00496080|450753367|FG000|Overall Study|Withdrawal by Subject|5|||
125307910|NCT00496080|450753367|FG000|Overall Study|Physician Decision|6|||
125307911|NCT01200368|450753372|FG000|Infant Series|Adverse Event|2|||
125307912|NCT01200368|450753373|FG001|Infant Series|Adverse Event|2|||
125307913|NCT01200368|450753374|FG002|Infant Series|Adverse Event|3|||
125307914|NCT01200368|450753372|FG000|Infant Series|Withdrawal by Subject|0|||
125307915|NCT01200368|450753373|FG001|Infant Series|Withdrawal by Subject|2|||
125307916|NCT01200368|450753374|FG002|Infant Series|Withdrawal by Subject|2|||
125307917|NCT01200368|450753372|FG000|Infant Series|Did not meet entrance criteria|0|||
125307918|NCT01200368|450753373|FG001|Infant Series|Did not meet entrance criteria|1|||
125307919|NCT01200368|450753374|FG002|Infant Series|Did not meet entrance criteria|0|||
125307920|NCT01200368|450753372|FG000|Infant Series|Randomized, not vaccinated|0|||
125307921|NCT01200368|450753373|FG001|Infant Series|Randomized, not vaccinated|1|||
125307922|NCT01200368|450753374|FG002|Infant Series|Randomized, not vaccinated|1|||
125307923|NCT01200368|450753372|FG000|Infant Series|Other|1|||
125307924|NCT01200368|450753373|FG001|Infant Series|Other|0|||
125307925|NCT01200368|450753374|FG002|Infant Series|Other|0|||
125307926|NCT01200368|450753372|FG000|After Infant Series|Adverse Event|6|||
125307927|NCT01200368|450753373|FG001|After Infant Series|Adverse Event|6|||
125307928|NCT01200368|450753374|FG002|After Infant Series|Adverse Event|3|||
125307929|NCT01200368|450753372|FG000|After Infant Series|Withdrawal by Subject|10|||
125307930|NCT01200368|450753373|FG001|After Infant Series|Withdrawal by Subject|8|||
125307931|NCT01200368|450753374|FG002|After Infant Series|Withdrawal by Subject|4|||
125307932|NCT01200368|450753372|FG000|After Infant Series|Lost to Follow-up|1|||
125307933|NCT01200368|450753373|FG001|After Infant Series|Lost to Follow-up|0|||
125307934|NCT01200368|450753374|FG002|After Infant Series|Lost to Follow-up|0|||
125307935|NCT01200368|450753372|FG000|After Infant Series|Other|1|||
125307936|NCT01200368|450753373|FG001|After Infant Series|Other|2|||
125307937|NCT01200368|450753374|FG002|After Infant Series|Other|2|||
125307938|NCT01200368|450753372|FG000|Toddler Dose|Adverse Event|0|||
125307939|NCT01200368|450753373|FG001|Toddler Dose|Adverse Event|3|||
125307940|NCT01200368|450753374|FG002|Toddler Dose|Adverse Event|1|||
125307941|NCT00570310|450753375|FG000|Overall Study|Adverse Event|1|||
125307942|NCT00570310|450753376|FG001|Overall Study|Adverse Event|2|||
125307943|NCT00570310|450753375|FG000|Overall Study|Lack of Efficacy|1|||
125307944|NCT00570310|450753376|FG001|Overall Study|Lack of Efficacy|4|||
125307945|NCT00108862|450753377|FG000|Overall Study|Death|31|||
125307946|NCT00108862|450753378|FG001|Overall Study|Death|37|||
125307947|NCT00108862|450753377|FG000|Overall Study|Withdrawal by Subject|10|||
125307948|NCT00108862|450753378|FG001|Overall Study|Withdrawal by Subject|6|||
125307949|NCT00108862|450753377|FG000|Overall Study|Lost to Follow-up|27|||
125307950|NCT00108862|450753378|FG001|Overall Study|Lost to Follow-up|19|||
125513695|NCT00043186|451510829|FG003|Overall Study|Lost to Follow-up|1|||
125513696|NCT00043186|451510830|FG004|Overall Study|Lost to Follow-up|1|||
125513697|NCT00043186|451510831|FG005|Overall Study|Lost to Follow-up|1|||
125513698|NCT00043186|451510832|FG006|Overall Study|Lost to Follow-up|1|||
125513699|NCT00043186|451510833|FG007|Overall Study|Lost to Follow-up|1|||
125513700|NCT00043186|451510834|FG008|Overall Study|Lost to Follow-up|2|||
125513701|NCT00043186|451510826|FG000|Overall Study|Noncompliance|0|||
125513702|NCT00043186|451510827|FG001|Overall Study|Noncompliance|0|||
125513703|NCT00043186|451510828|FG002|Overall Study|Noncompliance|1|||
125513704|NCT00043186|451510829|FG003|Overall Study|Noncompliance|1|||
125513705|NCT00043186|451510830|FG004|Overall Study|Noncompliance|0|||
125513706|NCT00043186|451510831|FG005|Overall Study|Noncompliance|0|||
125513707|NCT00043186|451510832|FG006|Overall Study|Noncompliance|0|||
125513708|NCT00043186|451510833|FG007|Overall Study|Noncompliance|0|||
125513709|NCT00043186|451510834|FG008|Overall Study|Noncompliance|0|||
125513710|NCT00043186|451510826|FG000|Overall Study|Other|0|||
125513711|NCT00043186|451510827|FG001|Overall Study|Other|0|||
125513712|NCT00043186|451510828|FG002|Overall Study|Other|1|||
125513713|NCT00043186|451510829|FG003|Overall Study|Other|1|||
125513714|NCT00043186|451510830|FG004|Overall Study|Other|0|||
125513715|NCT00043186|451510831|FG005|Overall Study|Other|0|||
125513716|NCT00043186|451510832|FG006|Overall Study|Other|0|||
125513717|NCT00043186|451510833|FG007|Overall Study|Other|0|||
125513718|NCT00043186|451510834|FG008|Overall Study|Other|0|||
125513719|NCT00958711|451510835|FG000|Overall Study|Withdrawal by Subject|0|||
125513720|NCT00958711|451510836|FG001|Overall Study|Withdrawal by Subject|4|||
125513721|NCT00958711|451510835|FG000|Overall Study|Physician Decision|5|||
125513722|NCT00958711|451510836|FG001|Overall Study|Physician Decision|7|||
125307951|NCT03534141|450753379|FG000|Overall Study|Enrolled in other clinical trial|1|||
125307952|NCT03534141|450753380|FG001|Overall Study|Enrolled in other clinical trial|0|||
125307953|NCT03534141|450753379|FG000|Overall Study|Liver transplant aborted after randomization|0|||
125307954|NCT03534141|450753380|FG001|Overall Study|Liver transplant aborted after randomization|2|||
125307955|NCT03534141|450753379|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
125307956|NCT03534141|450753380|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
125307957|NCT03785405|450753383|FG000|Overall Study|Adverse Event|16|||
125307958|NCT03785405|450753384|FG001|Overall Study|Adverse Event|1|||
125307959|NCT03785405|450753383|FG000|Overall Study|Death|6|||
125307960|NCT03785405|450753384|FG001|Overall Study|Death|4|||
125307961|NCT03785405|450753383|FG000|Overall Study|Guardian decision|4|||
125307962|NCT03785405|450753384|FG001|Overall Study|Guardian decision|1|||
125307963|NCT03785405|450753383|FG000|Overall Study|Lost to Follow-up|1|||
125307964|NCT03785405|450753384|FG001|Overall Study|Lost to Follow-up|0|||
125307965|NCT03785405|450753383|FG000|Overall Study|Physician Decision|8|||
125307966|NCT03785405|450753384|FG001|Overall Study|Physician Decision|5|||
125307967|NCT03785405|450753383|FG000|Overall Study|Participant decision|2|||
125307968|NCT03785405|450753384|FG001|Overall Study|Participant decision|0|||
125307969|NCT03785405|450753383|FG000|Overall Study|Other|1|||
125307970|NCT03785405|450753384|FG001|Overall Study|Other|0|||
125307971|NCT03785405|450753383|FG000|Overall Study|No treatment was received|0|||
125307972|NCT03785405|450753384|FG001|Overall Study|No treatment was received|1|||
125307973|NCT02881762|450753387|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
125307974|NCT02881762|450753388|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
125307975|NCT04137731|450753391|FG000|Overall Study|Surgery Cancellation|1|||
125307976|NCT04137731|450753392|FG001|Overall Study|Surgery Cancellation|2|||
125307977|NCT04137731|450753391|FG000|Overall Study|Withdrawal by Subject|2|||
125307978|NCT04137731|450753392|FG001|Overall Study|Withdrawal by Subject|0|||
125307979|NCT04137731|450753391|FG000|Overall Study|Protocol Violation|0|||
125307980|NCT04137731|450753392|FG001|Overall Study|Protocol Violation|1|||
125307981|NCT03983304|450753396|FG000|Overall Study|Withdrawal by Subject|5|||
125307982|NCT03983304|450753396|FG000|Overall Study|Lost to Follow-up|2|||
125307983|NCT00310817|450753397|FG000|Overall Study|AE or Death|3|||
125307984|NCT00310817|450753398|FG001|Overall Study|AE or Death|1|||
125307985|NCT00310817|450753399|FG002|Overall Study|AE or Death|0|||
125307986|NCT00310817|450753400|FG003|Overall Study|AE or Death|0|||
125307987|NCT00310817|450753397|FG000|Overall Study|Withdrawal by Subject|1|||
125307988|NCT00310817|450753398|FG001|Overall Study|Withdrawal by Subject|4|||
125307989|NCT00310817|450753399|FG002|Overall Study|Withdrawal by Subject|6|||
125307990|NCT00310817|450753400|FG003|Overall Study|Withdrawal by Subject|7|||
125307991|NCT00310817|450753397|FG000|Overall Study|Lost to Follow-up|2|||
125307992|NCT00310817|450753398|FG001|Overall Study|Lost to Follow-up|1|||
125307993|NCT00310817|450753399|FG002|Overall Study|Lost to Follow-up|0|||
125307994|NCT00310817|450753400|FG003|Overall Study|Lost to Follow-up|0|||
125307995|NCT00310817|450753397|FG000|Overall Study|Inappropriate Enrollment|1|||
125513723|NCT00958711|451510835|FG000|Overall Study|Lost to Follow-up|4|||
125513724|NCT00958711|451510836|FG001|Overall Study|Lost to Follow-up|1|||
125513725|NCT00958711|451510835|FG000|Overall Study|Other|2|||
125513726|NCT00958711|451510836|FG001|Overall Study|Other|5|||
125513727|NCT00958711|451510835|FG000|Overall Study|Death|1|||
125513728|NCT00958711|451510836|FG001|Overall Study|Death|2|||
125513729|NCT00958711|451510835|FG000|Overall Study|Adverse Event|1|||
125307996|NCT00310817|450753398|FG001|Overall Study|Inappropriate Enrollment|0|||
125307997|NCT00310817|450753399|FG002|Overall Study|Inappropriate Enrollment|1|||
125307998|NCT00310817|450753400|FG003|Overall Study|Inappropriate Enrollment|0|||
125307999|NCT00310817|450753397|FG000|Overall Study|Protocol Violation|1|||
125308000|NCT00310817|450753398|FG001|Overall Study|Protocol Violation|1|||
125308001|NCT00310817|450753399|FG002|Overall Study|Protocol Violation|1|||
125308002|NCT00310817|450753400|FG003|Overall Study|Protocol Violation|1|||
125308003|NCT00310817|450753397|FG000|Overall Study|Unable to classify|3|||
125308004|NCT00310817|450753398|FG001|Overall Study|Unable to classify|1|||
125308005|NCT00310817|450753399|FG002|Overall Study|Unable to classify|0|||
125308006|NCT00310817|450753400|FG003|Overall Study|Unable to classify|0|||
125308007|NCT01702246|450753401|FG000|Overall Study|Lost to Follow-up|2|||
125308008|NCT01702246|450753401|FG000|Overall Study|Withdrawal by Subject|2|||
125308009|NCT01702246|450753401|FG000|Overall Study|Physician Decision|1|||
125308010|NCT01587040|450753402|FG000|Overall Study|Protocol Violation|0|||
125308011|NCT01587040|450753403|FG001|Overall Study|Protocol Violation|0|||
125308012|NCT01587040|450753404|FG002|Overall Study|Protocol Violation|1|||
125308013|NCT01587040|450753405|FG003|Overall Study|Protocol Violation|0|||
125308014|NCT01587040|450753402|FG000|Overall Study|Adverse Event|0|||
125308015|NCT01587040|450753403|FG001|Overall Study|Adverse Event|1|||
125308016|NCT01587040|450753404|FG002|Overall Study|Adverse Event|10|||
125308017|NCT01587040|450753405|FG003|Overall Study|Adverse Event|0|||
125308018|NCT01587040|450753402|FG000|Overall Study|Disease progression|12|||
125308019|NCT01587040|450753403|FG001|Overall Study|Disease progression|1|||
125308020|NCT01587040|450753404|FG002|Overall Study|Disease progression|15|||
125308021|NCT01587040|450753405|FG003|Overall Study|Disease progression|3|||
125308022|NCT01587040|450753402|FG000|Overall Study|Other than specified|5|||
125308023|NCT01587040|450753403|FG001|Overall Study|Other than specified|1|||
125308024|NCT01587040|450753404|FG002|Overall Study|Other than specified|11|||
125308025|NCT01587040|450753405|FG003|Overall Study|Other than specified|1|||
125308026|NCT01518374|450753408|FG000|Overall Study|Withdrawal by Subject|2|||
125308027|NCT01518374|450753408|FG000|Overall Study|Protocol Violation|3|||
125308028|NCT01518374|450753408|FG000|Overall Study|Lost to Follow-up|2|||
125308029|NCT04300309|450753409|FG000|Overall Study|Lost to Follow-up|1|||
125308030|NCT04300309|450753410|FG001|Overall Study|Lost to Follow-up|0|||
125308031|NCT03724890|450753413|FG000|Overall Study|Death|2|||
125308032|NCT03724890|450753414|FG001|Overall Study|Death|6|||
125308033|NCT03724890|450753415|FG002|Overall Study|Death|3|||
125308034|NCT03724890|450753416|FG003|Overall Study|Death|5|||
125308035|NCT03724890|450753417|FG004|Overall Study|Death|2|||
125308036|NCT03724890|450753418|FG005|Overall Study|Death|0|||
125308037|NCT03724890|450753419|FG006|Overall Study|Death|2|||
125308038|NCT03724890|450753420|FG007|Overall Study|Death|3|||
125308039|NCT03724890|450753421|FG008|Overall Study|Death|4|||
125308040|NCT03724890|450753422|FG009|Overall Study|Death|2|||
125308041|NCT03724890|450753423|FG010|Overall Study|Death|2|||
125308042|NCT03724890|450753413|FG000|Overall Study|Lost to Follow-up|0|||
125308043|NCT03724890|450753414|FG001|Overall Study|Lost to Follow-up|3|||
125308044|NCT03724890|450753415|FG002|Overall Study|Lost to Follow-up|0|||
125308045|NCT03724890|450753416|FG003|Overall Study|Lost to Follow-up|1|||
125308046|NCT03724890|450753417|FG004|Overall Study|Lost to Follow-up|2|||
125308047|NCT03724890|450753418|FG005|Overall Study|Lost to Follow-up|2|||
125308048|NCT03724890|450753419|FG006|Overall Study|Lost to Follow-up|1|||
125308049|NCT03724890|450753420|FG007|Overall Study|Lost to Follow-up|0|||
125308050|NCT03724890|450753421|FG008|Overall Study|Lost to Follow-up|2|||
125308051|NCT03724890|450753422|FG009|Overall Study|Lost to Follow-up|0|||
125308052|NCT03724890|450753423|FG010|Overall Study|Lost to Follow-up|0|||
125308053|NCT03724890|450753413|FG000|Overall Study|Withdrawal by Subject|1|||
125513730|NCT00958711|451510836|FG001|Overall Study|Adverse Event|2|||
125308054|NCT03724890|450753414|FG001|Overall Study|Withdrawal by Subject|2|||
125308055|NCT03724890|450753415|FG002|Overall Study|Withdrawal by Subject|1|||
125308056|NCT03724890|450753416|FG003|Overall Study|Withdrawal by Subject|0|||
125308057|NCT03724890|450753417|FG004|Overall Study|Withdrawal by Subject|0|||
125308058|NCT03724890|450753418|FG005|Overall Study|Withdrawal by Subject|1|||
125308059|NCT03724890|450753419|FG006|Overall Study|Withdrawal by Subject|0|||
125308060|NCT03724890|450753420|FG007|Overall Study|Withdrawal by Subject|0|||
125308061|NCT03724890|450753421|FG008|Overall Study|Withdrawal by Subject|2|||
125308062|NCT03724890|450753422|FG009|Overall Study|Withdrawal by Subject|2|||
125308063|NCT03724890|450753423|FG010|Overall Study|Withdrawal by Subject|1|||
125308064|NCT03724890|450753413|FG000|Overall Study|Other|1|||
125308065|NCT03724890|450753414|FG001|Overall Study|Other|0|||
125308066|NCT03724890|450753415|FG002|Overall Study|Other|0|||
125513731|NCT00550771|451510843|FG000|Overall Study|Adverse Event|11|||
125513732|NCT00550771|451510844|FG001|Overall Study|Adverse Event|3|||
125308067|NCT03724890|450753416|FG003|Overall Study|Other|0|||
125308068|NCT03724890|450753417|FG004|Overall Study|Other|0|||
125308069|NCT03724890|450753418|FG005|Overall Study|Other|0|||
125308070|NCT03724890|450753419|FG006|Overall Study|Other|0|||
125308071|NCT03724890|450753420|FG007|Overall Study|Other|1|||
125308072|NCT03724890|450753421|FG008|Overall Study|Other|1|||
125308073|NCT03724890|450753422|FG009|Overall Study|Other|0|||
125308074|NCT03724890|450753423|FG010|Overall Study|Other|2|||
125308075|NCT04607837|450753426|FG000|Overall Study|Adverse Event|8|||
125308076|NCT04607837|450753427|FG001|Overall Study|Adverse Event|2|||
125308077|NCT04607837|450753426|FG000|Overall Study|Withdrawal by Subject|8|||
125308078|NCT04607837|450753427|FG001|Overall Study|Withdrawal by Subject|7|||
125308079|NCT04607837|450753426|FG000|Overall Study|Physician Decision|2|||
125308080|NCT04607837|450753427|FG001|Overall Study|Physician Decision|0|||
125308081|NCT04607837|450753426|FG000|Overall Study|Lack of Efficacy|2|||
125308082|NCT04607837|450753427|FG001|Overall Study|Lack of Efficacy|0|||
125308083|NCT04607837|450753426|FG000|Overall Study|Participant terminated by sponsor|1|||
125308084|NCT04607837|450753427|FG001|Overall Study|Participant terminated by sponsor|0|||
125308085|NCT04607837|450753426|FG000|Overall Study|Disease worsening|36|||
125308086|NCT04607837|450753427|FG001|Overall Study|Disease worsening|36|||
125308087|NCT04607837|450753426|FG000|Overall Study|Other|1|||
125308088|NCT04607837|450753427|FG001|Overall Study|Other|0|||
125308089|NCT02362464|450753428|FG000|Overall Study|Switched to alternative therapy|1|||
125308090|NCT02362464|450753428|FG000|Overall Study|Refused further treatment|1|||
125308091|NCT02362464|450753428|FG000|Overall Study|Physician Decision|4|||
125308092|NCT04346654|450753429|FG000|Overall Study|Adverse Event|2|||
125308093|NCT04346654|450753430|FG001|Overall Study|Adverse Event|0|||
125308094|NCT04346654|450753429|FG000|Overall Study|Non-response|1|||
125308095|NCT04346654|450753430|FG001|Overall Study|Non-response|1|||
125308096|NCT04346654|450753429|FG000|Overall Study|Withdrawal by Subject|2|||
125308097|NCT04346654|450753430|FG001|Overall Study|Withdrawal by Subject|0|||
125308098|NCT04346654|450753429|FG000|Overall Study|Lost to Follow-up|0|||
125308099|NCT04346654|450753430|FG001|Overall Study|Lost to Follow-up|1|||
125308100|NCT04346654|450753429|FG000|Overall Study|Pregnancy|0|||
125308101|NCT04346654|450753430|FG001|Overall Study|Pregnancy|1|||
125308102|NCT05715242|450753431|FG000|Overall Study|Lost to Follow-up|0|||
125308103|NCT05715242|450753432|FG001|Overall Study|Lost to Follow-up|0|||
125308104|NCT05715242|450753433|FG002|Overall Study|Lost to Follow-up|1|||
125308105|NCT05715242|450753434|FG003|Overall Study|Lost to Follow-up|0|||
125308106|NCT05715242|450753435|FG004|Overall Study|Lost to Follow-up|0|||
125308107|NCT05715242|450753436|FG005|Overall Study|Lost to Follow-up|1|||
125308108|NCT05715242|450753437|FG006|Overall Study|Lost to Follow-up|0|||
125308109|NCT05715242|450753438|FG007|Overall Study|Lost to Follow-up|0|||
125308110|NCT05715242|450753439|FG008|Overall Study|Lost to Follow-up|0|||
125308111|NCT05715242|450753440|FG009|Overall Study|Lost to Follow-up|0|||
125308112|NCT05715242|450753441|FG010|Overall Study|Lost to Follow-up|0|||
125308113|NCT05715242|450753442|FG011|Overall Study|Lost to Follow-up|0|||
125308114|NCT05715242|450753443|FG012|Overall Study|Lost to Follow-up|0|||
125308115|NCT05715242|450753444|FG013|Overall Study|Lost to Follow-up|0|||
125308116|NCT05715242|450753445|FG014|Overall Study|Lost to Follow-up|0|||
125308117|NCT05715242|450753446|FG015|Overall Study|Lost to Follow-up|0|||
125308118|NCT02915978|450753447|FG000|Overall Study|Adverse Event|2|||
125308119|NCT02915978|450753448|FG001|Overall Study|Adverse Event|1|||
125308120|NCT02915978|450753449|FG002|Overall Study|Adverse Event|0|||
125308121|NCT02343406|450753455|FG000|Overall Study|Progressive disease|72|||
125308122|NCT02343406|450753456|FG001|Overall Study|Progressive disease|70|||
125308123|NCT02343406|450753457|FG002|Overall Study|Progressive disease|43|||
125308124|NCT02343406|450753458|FG003|Overall Study|Progressive disease|15|||
125308125|NCT02343406|450753459|FG004|Overall Study|Progressive disease|5|||
125308126|NCT02343406|450753455|FG000|Overall Study|Adverse Event|6|||
125308127|NCT02343406|450753456|FG001|Overall Study|Adverse Event|8|||
125308128|NCT02343406|450753457|FG002|Overall Study|Adverse Event|6|||
125308129|NCT02343406|450753458|FG003|Overall Study|Adverse Event|3|||
125308130|NCT02343406|450753459|FG004|Overall Study|Adverse Event|0|||
125308131|NCT02343406|450753455|FG000|Overall Study|Withdrawal by Subject|6|||
125308132|NCT02343406|450753456|FG001|Overall Study|Withdrawal by Subject|4|||
125308133|NCT02343406|450753457|FG002|Overall Study|Withdrawal by Subject|8|||
125308134|NCT02343406|450753458|FG003|Overall Study|Withdrawal by Subject|3|||
125308135|NCT02343406|450753459|FG004|Overall Study|Withdrawal by Subject|0|||
125308136|NCT02343406|450753455|FG000|Overall Study|Death|2|||
125308137|NCT02343406|450753456|FG001|Overall Study|Death|1|||
125308138|NCT02343406|450753457|FG002|Overall Study|Death|0|||
125308139|NCT02343406|450753458|FG003|Overall Study|Death|0|||
125308140|NCT02343406|450753459|FG004|Overall Study|Death|0|||
125308141|NCT02343406|450753455|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
125308142|NCT02343406|450753456|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
125308143|NCT02343406|450753457|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
125308144|NCT02343406|450753458|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
125308145|NCT02343406|450753459|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
125308146|NCT02343406|450753455|FG000|Overall Study|Other primary malignancy|0|||
125308147|NCT02343406|450753456|FG001|Overall Study|Other primary malignancy|1|||
125308148|NCT02343406|450753457|FG002|Overall Study|Other primary malignancy|0|||
125308149|NCT02343406|450753458|FG003|Overall Study|Other primary malignancy|0|||
125308150|NCT02343406|450753459|FG004|Overall Study|Other primary malignancy|0|||
125308151|NCT02343406|450753455|FG000|Overall Study|Other, not specified|2|||
125308152|NCT02343406|450753456|FG001|Overall Study|Other, not specified|1|||
125308153|NCT02343406|450753457|FG002|Overall Study|Other, not specified|1|||
125308154|NCT02343406|450753458|FG003|Overall Study|Other, not specified|4|||
125308155|NCT02343406|450753459|FG004|Overall Study|Other, not specified|0|||
125308156|NCT02451124|450753460|FG000|Overall Study|Withdrawal by Subject|1|||
125308157|NCT00766051|450753461|FG000|Overall Study|Withdrawal by Subject|2|||
125308158|NCT00766051|450753462|FG001|Overall Study|Withdrawal by Subject|0|||
125308159|NCT03058692|450755063|FG000|Overall Study|Lost to Follow-up|2|||
125308160|NCT03058692|450755064|FG001|Overall Study|Lost to Follow-up|1|||
125308161|NCT03058692|450755063|FG000|Overall Study|Withdrawal by Subject|1|||
125308162|NCT03058692|450755064|FG001|Overall Study|Withdrawal by Subject|1|||
125308163|NCT01392547|450755065|FG000|Overall Study|Adverse Event|2|||
125308164|NCT01392547|450755065|FG000|Overall Study|Non-compliance|2|||
125308165|NCT01392547|450755065|FG000|Overall Study|Withdrawal criteria|3|||
125308166|NCT01392547|450755065|FG000|Overall Study|Unclassified|1|||
125308167|NCT00799266|450755070|FG000|Overall Study|Adverse Event|0|||
125308168|NCT00799266|450755071|FG001|Overall Study|Adverse Event|1|||
125308169|NCT00799266|450755070|FG000|Overall Study|Subject withdrew consent|3|||
125308170|NCT00799266|450755071|FG001|Overall Study|Subject withdrew consent|0|||
125308171|NCT01362608|450755083|FG000|Overall Study|Protocol Violation|0|||
125308172|NCT01362608|450755084|FG001|Overall Study|Protocol Violation|1|||
125308173|NCT01362608|450755083|FG000|Overall Study|Lost to Follow-up|3|||
125308174|NCT01362608|450755084|FG001|Overall Study|Lost to Follow-up|1|||
125308175|NCT01362608|450755083|FG000|Overall Study|Withdrawal by Subject|1|||
125308176|NCT01362608|450755084|FG001|Overall Study|Withdrawal by Subject|2|||
125308177|NCT01362608|450755083|FG000|Overall Study|Lack of Efficacy|0|||
125308178|NCT01362608|450755084|FG001|Overall Study|Lack of Efficacy|2|||
125308179|NCT01362608|450755083|FG000|Overall Study|Adverse Event|0|||
125308180|NCT01362608|450755084|FG001|Overall Study|Adverse Event|2|||
125308181|NCT04506502|450755089|FG000|Overall Study|Withdrawal by Subject|1|||
125308182|NCT04506502|450755089|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
125308183|NCT00699608|450755090|FG000|First Intervention|Withdrawal by Subject|0|||
125308184|NCT00699608|450755091|FG001|First Intervention|Withdrawal by Subject|0|||
125308185|NCT00699608|450755092|FG002|First Intervention|Withdrawal by Subject|1|||
125308186|NCT00699608|450755093|FG003|First Intervention|Withdrawal by Subject|0|||
125308187|NCT00699608|450755094|FG004|First Intervention|Withdrawal by Subject|0|||
125308188|NCT00699608|450755095|FG005|First Intervention|Withdrawal by Subject|0|||
125308189|NCT00699608|450755090|FG000|First Intervention|Protocol Violation|0|||
125308190|NCT00699608|450755091|FG001|First Intervention|Protocol Violation|0|||
125308191|NCT00699608|450755092|FG002|First Intervention|Protocol Violation|0|||
125308192|NCT00699608|450755093|FG003|First Intervention|Protocol Violation|0|||
125308193|NCT00699608|450755094|FG004|First Intervention|Protocol Violation|1|||
125308194|NCT00699608|450755095|FG005|First Intervention|Protocol Violation|0|||
125308195|NCT00699608|450755090|FG000|Second Intervention|Adverse Event|0|||
125308196|NCT00699608|450755091|FG001|Second Intervention|Adverse Event|0|||
125308197|NCT00699608|450755092|FG002|Second Intervention|Adverse Event|1|||
125308198|NCT00699608|450755093|FG003|Second Intervention|Adverse Event|0|||
125308199|NCT00699608|450755094|FG004|Second Intervention|Adverse Event|0|||
125308200|NCT00699608|450755095|FG005|Second Intervention|Adverse Event|0|||
125308201|NCT00699608|450755090|FG000|Second Intervention|Withdrawal by Subject|0|||
125308202|NCT00699608|450755091|FG001|Second Intervention|Withdrawal by Subject|0|||
125308203|NCT00699608|450755092|FG002|Second Intervention|Withdrawal by Subject|0|||
125308204|NCT00699608|450755093|FG003|Second Intervention|Withdrawal by Subject|1|||
125308205|NCT00699608|450755094|FG004|Second Intervention|Withdrawal by Subject|0|||
125308206|NCT00699608|450755095|FG005|Second Intervention|Withdrawal by Subject|0|||
125308207|NCT03010319|450755098|FG000|Overall Study|Adverse Event|15|||
125308208|NCT03010319|450755099|FG001|Overall Study|Adverse Event|9|||
125308209|NCT03010319|450755098|FG000|Overall Study|Withdrawal by Subject|1|||
125308210|NCT03010319|450755099|FG001|Overall Study|Withdrawal by Subject|6|||
125308211|NCT03010319|450755098|FG000|Overall Study|Physician Decision|2|||
125308212|NCT03010319|450755099|FG001|Overall Study|Physician Decision|4|||
125308213|NCT03010319|450755098|FG000|Overall Study|Sponsor requested withdrawal|2|||
125308214|NCT03010319|450755099|FG001|Overall Study|Sponsor requested withdrawal|2|||
125308215|NCT03010319|450755098|FG000|Overall Study|Death|1|||
125308216|NCT03010319|450755099|FG001|Overall Study|Death|0|||
125308217|NCT03010319|450755098|FG000|Overall Study|Lost to Follow-up|0|||
125308218|NCT03010319|450755099|FG001|Overall Study|Lost to Follow-up|1|||
125308219|NCT03010319|450755098|FG000|Overall Study|Other Reason|5|||
125513733|NCT00550771|451510843|FG000|Overall Study|Discontinued for study-related reasons|0|||
125308220|NCT03010319|450755099|FG001|Overall Study|Other Reason|7|||
125308221|NCT04720417|450755100|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
125308222|NCT02588261|450755103|FG000|Overall Study|Study Terminated by Sponsor|157|||
125308223|NCT02588261|450755104|FG001|Overall Study|Study Terminated by Sponsor|142|||
125308224|NCT02588261|450755103|FG000|Overall Study|Protocol Deviation|1|||
125308225|NCT02588261|450755104|FG001|Overall Study|Protocol Deviation|0|||
125308226|NCT02588261|450755103|FG000|Overall Study|Death|1|||
125308227|NCT02588261|450755104|FG001|Overall Study|Death|2|||
125308228|NCT02588261|450755103|FG000|Overall Study|Withdrawal by Subject|12|||
125308229|NCT02588261|450755104|FG001|Overall Study|Withdrawal by Subject|8|||
125308230|NCT02588261|450755103|FG000|Overall Study|Noncompliance with Study Drug|0|||
125308231|NCT02588261|450755104|FG001|Overall Study|Noncompliance with Study Drug|1|||
125308232|NCT02588261|450755103|FG000|Overall Study|Miscellaneous|5|||
125308233|NCT02588261|450755104|FG001|Overall Study|Miscellaneous|4|||
125308234|NCT02588261|450755103|FG000|Overall Study|Progressive Disease|61|||
125308235|NCT02588261|450755104|FG001|Overall Study|Progressive Disease|82|||
125308236|NCT02588261|450755103|FG000|Overall Study|Adverse Event|29|||
125308237|NCT02588261|450755104|FG001|Overall Study|Adverse Event|24|||
125308238|NCT02588261|450755103|FG000|Overall Study|Lost to Follow-up|1|||
125308239|NCT02588261|450755104|FG001|Overall Study|Lost to Follow-up|0|||
125308240|NCT03781778|450755105|FG000|Overall Study|Withdrawal by Subject|2|||
125308241|NCT03781778|450755106|FG001|Overall Study|Withdrawal by Subject|2|||
125308242|NCT02287467|450755107|FG000|Overall Study|Protocol Violation|12|||
125308243|NCT02287467|450755108|FG001|Overall Study|Protocol Violation|9|||
125308244|NCT03472950|450755111|FG000|Overall Study|Lost to Follow-up|0|||
125308245|NCT03472950|450755112|FG001|Overall Study|Lost to Follow-up|1|||
125308246|NCT03472950|450755111|FG000|Overall Study|Adverse Event|0|||
125308247|NCT03472950|450755112|FG001|Overall Study|Adverse Event|3|||
125308248|NCT00517361|450755117|FG000|Overall Study|Death|6|||
125308249|NCT00517361|450755117|FG000|Overall Study|The study was terminated|5|||
125308250|NCT00195091|450755118|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
125308251|NCT00245037|450755124|FG000|Overall Study|Death|17|||
125308252|NCT06964165|450755129|FG000|Overall Study|Withdrawal by Subject|0|||
125308253|NCT06964165|450755130|FG001|Overall Study|Withdrawal by Subject|1|||
125308254|NCT06964165|450755129|FG000|Overall Study|Ongoing at the time of analysis|15|||
125308255|NCT06964165|450755130|FG001|Overall Study|Ongoing at the time of analysis|14|||
125308256|NCT06964165|450755129|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
125308257|NCT06964165|450755130|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
125308258|NCT06964165|450755129|FG000|Overall Study|Participant removed due to non-compliance|0|||
125308259|NCT06964165|450755130|FG001|Overall Study|Participant removed due to non-compliance|1|||
125308260|NCT01514201|450755144|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
125308261|NCT01514201|450755145|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
125308262|NCT01514201|450755146|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
125308263|NCT01514201|450755147|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
125308264|NCT01514201|450755144|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
125308265|NCT01514201|450755145|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
125308266|NCT01514201|450755146|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
125308267|NCT01514201|450755147|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
125308268|NCT01514201|450755144|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
125308269|NCT01514201|450755145|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
125308270|NCT01514201|450755146|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
125308271|NCT01514201|450755147|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
125308272|NCT01514201|450755144|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
125308273|NCT01514201|450755145|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
125308274|NCT01514201|450755146|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
125308275|NCT01514201|450755147|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
125308276|NCT01514201|450755144|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
125308277|NCT01514201|450755145|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
125308278|NCT01514201|450755146|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
125308279|NCT01514201|450755147|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
125308280|NCT01514201|450755144|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
125308281|NCT01514201|450755145|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
125308282|NCT01514201|450755146|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
125308283|NCT01514201|450755147|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
125308284|NCT01514201|450755144|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
125308285|NCT01514201|450755145|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
125308286|NCT01514201|450755146|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
125308287|NCT01514201|450755147|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
125308288|NCT01514201|450755144|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
125308289|NCT01514201|450755145|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
125308290|NCT01514201|450755146|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
125308291|NCT01514201|450755147|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
125308292|NCT01514201|450755144|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
125308293|NCT01514201|450755145|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
125308294|NCT01514201|450755146|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
125308295|NCT01514201|450755147|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
125308296|NCT01514201|450755144|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
125308297|NCT01514201|450755145|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
125308298|NCT01514201|450755146|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
125308299|NCT01514201|450755147|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
125308300|NCT01514201|450755144|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
125308301|NCT01514201|450755145|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
125308302|NCT01514201|450755146|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
125308303|NCT01514201|450755147|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
125308304|NCT01514201|450755144|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
125308305|NCT01514201|450755145|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
125308306|NCT01514201|450755146|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
125308307|NCT01514201|450755147|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
125308308|NCT05888181|450755148|FG000|Overall Study|Lost to Follow-up|1|||
125308309|NCT05888181|450755149|FG001|Overall Study|Lost to Follow-up|1|||
125308310|NCT05888181|450755150|FG002|Overall Study|Lost to Follow-up|0|||
125308311|NCT02735343|450755154|FG000|Overall Study|screen fail|0|||
125308312|NCT02735343|450755155|FG001|Overall Study|screen fail|2|||
125308313|NCT00637416|450755156|FG000|Overall Study|Lost to Follow-up|1|||
125308314|NCT00637416|450755157|FG001|Overall Study|Lost to Follow-up|1|||
125308315|NCT00637416|450755156|FG000|Overall Study|Unable to take study drug|0|||
125308316|NCT00637416|450755157|FG001|Overall Study|Unable to take study drug|1|||
125308317|NCT02534909|450755161|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
125308318|NCT01625000|450755164|FG000|Overall Study|Physician Decision|15|||
125308319|NCT01625000|450755165|FG001|Overall Study|Physician Decision|7|||
125308320|NCT01625000|450755166|FG002|Overall Study|Physician Decision|7|||
125308321|NCT01625000|450755167|FG003|Overall Study|Physician Decision|2|||
125308322|NCT01625000|450755168|FG004|Overall Study|Physician Decision|15|||
125308323|NCT01625000|450755164|FG000|Overall Study|Protocol Violation|3|||
125308324|NCT01625000|450755165|FG001|Overall Study|Protocol Violation|10|||
125308325|NCT01625000|450755166|FG002|Overall Study|Protocol Violation|4|||
125308326|NCT01625000|450755167|FG003|Overall Study|Protocol Violation|1|||
125308327|NCT01625000|450755168|FG004|Overall Study|Protocol Violation|2|||
125308328|NCT01625000|450755164|FG000|Overall Study|Withdrawal by Subject|19|||
125308329|NCT01625000|450755165|FG001|Overall Study|Withdrawal by Subject|16|||
125308330|NCT01625000|450755166|FG002|Overall Study|Withdrawal by Subject|11|||
125308331|NCT01625000|450755167|FG003|Overall Study|Withdrawal by Subject|9|||
125308332|NCT01625000|450755168|FG004|Overall Study|Withdrawal by Subject|17|||
125308333|NCT01625000|450755164|FG000|Overall Study|Adverse Event (including Death)|15|||
125308334|NCT01625000|450755165|FG001|Overall Study|Adverse Event (including Death)|19|||
125308335|NCT01625000|450755166|FG002|Overall Study|Adverse Event (including Death)|11|||
125308336|NCT01625000|450755167|FG003|Overall Study|Adverse Event (including Death)|7|||
125308337|NCT01625000|450755168|FG004|Overall Study|Adverse Event (including Death)|21|||
125308338|NCT00566852|450755169|FG000|Overall Study|Protocol Violation|22|||
125308339|NCT00566852|450755170|FG001|Overall Study|Protocol Violation|24|||
125308340|NCT00566852|450755169|FG000|Overall Study|Death|95|||
125308341|NCT00566852|450755170|FG001|Overall Study|Death|78|||
125308342|NCT00566852|450755169|FG000|Overall Study|Withdrawal by Subject|30|||
125308343|NCT00566852|450755170|FG001|Overall Study|Withdrawal by Subject|25|||
125308344|NCT00566852|450755169|FG000|Overall Study|Patient refusal|37|||
125308345|NCT00566852|450755170|FG001|Overall Study|Patient refusal|37|||
125308346|NCT00566852|450755169|FG000|Overall Study|Not tested due to disability|6|||
125308347|NCT00566852|450755170|FG001|Overall Study|Not tested due to disability|12|||
125308348|NCT00566852|450755169|FG000|Overall Study|Missing reason not specified|1|||
125308349|NCT00566852|450755170|FG001|Overall Study|Missing reason not specified|2|||
125308350|NCT00566852|450755169|FG000|Overall Study|Missing reason not reported|16|||
125308351|NCT00566852|450755170|FG001|Overall Study|Missing reason not reported|20|||
125308352|NCT00577824|450755173|FG000|Overall Study|Adverse Event|6|||
125308353|NCT00577824|450755174|FG001|Overall Study|Adverse Event|18|||
125308354|NCT00577824|450755175|FG002|Overall Study|Adverse Event|1|||
125308355|NCT00577824|450755173|FG000|Overall Study|Patient decision|0|||
125308356|NCT00577824|450755174|FG001|Overall Study|Patient decision|1|||
125308357|NCT00577824|450755175|FG002|Overall Study|Patient decision|1|||
125308358|NCT00577824|450755173|FG000|Overall Study|Protocol Violation|1|||
125308359|NCT00577824|450755174|FG001|Overall Study|Protocol Violation|1|||
125308360|NCT00577824|450755175|FG002|Overall Study|Protocol Violation|0|||
125308361|NCT04079816|450755176|FG000|Overall Study|Request of Subject|2|||
125308362|NCT04079816|450755176|FG000|Overall Study|Unable to draw samples|1|||
125308363|NCT00362648|450755177|FG000|Overall Study|Adverse Event|12|||
125308364|NCT00362648|450755178|FG001|Overall Study|Adverse Event|21|||
125308365|NCT00362648|450755179|FG002|Overall Study|Adverse Event|1|||
125308366|NCT00362648|450755180|FG003|Overall Study|Adverse Event|0|||
125308367|NCT00362648|450755177|FG000|Overall Study|Lost to Follow-up|62|||
125308368|NCT00362648|450755178|FG001|Overall Study|Lost to Follow-up|69|||
125308369|NCT00362648|450755179|FG002|Overall Study|Lost to Follow-up|4|||
125308370|NCT00362648|450755180|FG003|Overall Study|Lost to Follow-up|3|||
125308371|NCT00362648|450755177|FG000|Overall Study|Protocol Violation|4|||
125308372|NCT00362648|450755178|FG001|Overall Study|Protocol Violation|2|||
125308373|NCT00362648|450755179|FG002|Overall Study|Protocol Violation|2|||
125308374|NCT00362648|450755180|FG003|Overall Study|Protocol Violation|2|||
125308375|NCT00362648|450755177|FG000|Overall Study|Withdrawal by Subject|48|||
125308376|NCT00362648|450755178|FG001|Overall Study|Withdrawal by Subject|42|||
125308377|NCT00362648|450755179|FG002|Overall Study|Withdrawal by Subject|2|||
125308378|NCT00362648|450755180|FG003|Overall Study|Withdrawal by Subject|6|||
125308379|NCT02123823|450755182|FG000|Overall Study|Lack of Efficacy|0|||
125308380|NCT02123823|450755183|FG001|Overall Study|Lack of Efficacy|2|||
125308381|NCT02123823|450755184|FG002|Overall Study|Lack of Efficacy|8|||
125308382|NCT02123823|450755185|FG003|Overall Study|Lack of Efficacy|10|||
125308383|NCT02123823|450755182|FG000|Overall Study|Progressive disease|3|||
125308384|NCT02123823|450755183|FG001|Overall Study|Progressive disease|19|||
125308385|NCT02123823|450755184|FG002|Overall Study|Progressive disease|52|||
125308386|NCT02123823|450755185|FG003|Overall Study|Progressive disease|53|||
125308387|NCT02123823|450755182|FG000|Overall Study|Withdrawal by Subject|0|||
125308388|NCT02123823|450755183|FG001|Overall Study|Withdrawal by Subject|0|||
125308389|NCT02123823|450755184|FG002|Overall Study|Withdrawal by Subject|7|||
125308390|NCT02123823|450755185|FG003|Overall Study|Withdrawal by Subject|2|||
125308391|NCT02123823|450755182|FG000|Overall Study|Adverse Event|0|||
125308392|NCT02123823|450755183|FG001|Overall Study|Adverse Event|0|||
125308393|NCT02123823|450755184|FG002|Overall Study|Adverse Event|3|||
125308394|NCT02123823|450755185|FG003|Overall Study|Adverse Event|5|||
125308395|NCT05870865|450755191|FG000|Randomized|Did not receive study treatment|2|||
125308396|NCT05870865|450755192|FG001|Randomized|Did not receive study treatment|4|||
125308397|NCT05870865|450755193|FG002|Randomized|Did not receive study treatment|4|||
125308398|NCT05870865|450755194|FG003|Randomized|Did not receive study treatment|3|||
125308399|NCT05870865|450755191|FG000|Treatment Period|Adverse Event|1|||
125308400|NCT05870865|450755192|FG001|Treatment Period|Adverse Event|1|||
125308401|NCT05870865|450755193|FG002|Treatment Period|Adverse Event|1|||
125308402|NCT05870865|450755194|FG003|Treatment Period|Adverse Event|1|||
125308403|NCT05870865|450755191|FG000|Treatment Period|Lost to Follow-up|0|||
125308404|NCT05870865|450755192|FG001|Treatment Period|Lost to Follow-up|1|||
125308405|NCT05870865|450755193|FG002|Treatment Period|Lost to Follow-up|2|||
125308406|NCT05870865|450755194|FG003|Treatment Period|Lost to Follow-up|0|||
125308407|NCT05870865|450755191|FG000|Treatment Period|Protocol Violation|0|||
125308408|NCT05870865|450755192|FG001|Treatment Period|Protocol Violation|0|||
125308409|NCT05870865|450755193|FG002|Treatment Period|Protocol Violation|0|||
125308410|NCT05870865|450755194|FG003|Treatment Period|Protocol Violation|1|||
125308411|NCT05870865|450755191|FG000|Treatment Period|Withdrawal by Subject|0|||
125308412|NCT05870865|450755192|FG001|Treatment Period|Withdrawal by Subject|1|||
125308413|NCT05870865|450755193|FG002|Treatment Period|Withdrawal by Subject|1|||
125308414|NCT05870865|450755194|FG003|Treatment Period|Withdrawal by Subject|1|||
125308415|NCT04752332|450755195|FG000|Overall Study|Adverse Event|3|||
125308416|NCT04752332|450755196|FG001|Overall Study|Adverse Event|1|||
125308417|NCT04752332|450755195|FG000|Overall Study|Disease Relapse|1|||
125308418|NCT04752332|450755196|FG001|Overall Study|Disease Relapse|0|||
125308419|NCT04752332|450755195|FG000|Overall Study|Non-compliance With Study Drug|2|||
125308420|NCT04752332|450755196|FG001|Overall Study|Non-compliance With Study Drug|0|||
125308421|NCT04752332|450755195|FG000|Overall Study|Physician Decision|2|||
125308422|NCT04752332|450755196|FG001|Overall Study|Physician Decision|1|||
125308423|NCT04752332|450755195|FG000|Overall Study|Protocol Violation|1|||
125308424|NCT04752332|450755196|FG001|Overall Study|Protocol Violation|1|||
125308425|NCT04752332|450755195|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
125308426|NCT04752332|450755196|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
125308427|NCT04752332|450755195|FG000|Overall Study|Study Terminated by Sponsor|10|||
125308428|NCT04752332|450755196|FG001|Overall Study|Study Terminated by Sponsor|48|||
125308429|NCT04752332|450755195|FG000|Overall Study|Withdrawal by Subject|11|||
125308430|NCT04752332|450755196|FG001|Overall Study|Withdrawal by Subject|3|||
125308431|NCT01868477|450755198|FG000|Overall Study|Adverse Event|2|||
125308432|NCT01868477|450755199|FG001|Overall Study|Adverse Event|4|||
125308433|NCT01868477|450755198|FG000|Overall Study|Disease progression|1|||
125308434|NCT01868477|450755199|FG001|Overall Study|Disease progression|1|||
125513734|NCT00550771|451510844|FG001|Overall Study|Discontinued for study-related reasons|1|||
125513735|NCT00550771|451510843|FG000|Overall Study|Physician Decision|2|||
125513736|NCT00550771|451510844|FG001|Overall Study|Physician Decision|0|||
125308435|NCT01868477|450755198|FG000|Overall Study|Withdrawal by Subject|1|||
125308436|NCT01868477|450755199|FG001|Overall Study|Withdrawal by Subject|0|||
125308437|NCT00856297|450755205|FG000|Overall Study|Unable to classify|2|||
125308438|NCT00856297|450755206|FG001|Overall Study|Unable to classify|0|||
125308439|NCT00856297|450755207|FG002|Overall Study|Unable to classify|0|||
125308440|NCT00856297|450755208|FG003|Overall Study|Unable to classify|0|||
125308441|NCT00856297|450755209|FG004|Overall Study|Unable to classify|0|||
125308442|NCT03526146|450756463|FG000|Overall Study|Lost to Follow-up|5|||
125308443|NCT03526146|450756463|FG000|Overall Study|Withdrawal by Subject|6|||
125308444|NCT03526146|450756463|FG000|Overall Study|class canceled due to COVID-19|4|||
125308445|NCT02517541|450756468|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
125308446|NCT02517541|450756468|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
125308447|NCT02517541|450756468|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
125308448|NCT02517541|450756468|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
125308449|NCT02517541|450756468|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
125308450|NCT02517541|450756468|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
125308451|NCT01510158|450756469|FG000|Overall Study|Adverse Event|7|||
125308452|NCT01510158|450756470|FG001|Overall Study|Adverse Event|8|||
125308453|NCT01510158|450756471|FG002|Overall Study|Adverse Event|5|||
125308454|NCT01510158|450756469|FG000|Overall Study|Gout flare|1|||
125308455|NCT01510158|450756470|FG001|Overall Study|Gout flare|0|||
125308456|NCT01510158|450756471|FG002|Overall Study|Gout flare|0|||
125308457|NCT01510158|450756469|FG000|Overall Study|Protocol Violation|17|||
125308458|NCT01510158|450756470|FG001|Overall Study|Protocol Violation|16|||
125308459|NCT01510158|450756471|FG002|Overall Study|Protocol Violation|24|||
125308460|NCT01510158|450756469|FG000|Overall Study|Sponsor terminated study.|2|||
125308461|NCT01510158|450756470|FG001|Overall Study|Sponsor terminated study.|0|||
125308462|NCT01510158|450756471|FG002|Overall Study|Sponsor terminated study.|2|||
125308463|NCT01510158|450756469|FG000|Overall Study|Lost to Follow-up|13|||
125308464|NCT01510158|450756470|FG001|Overall Study|Lost to Follow-up|16|||
125308465|NCT01510158|450756471|FG002|Overall Study|Lost to Follow-up|9|||
125308466|NCT01510158|450756469|FG000|Overall Study|Withdrawal by Subject|10|||
125308467|NCT01510158|450756470|FG001|Overall Study|Withdrawal by Subject|13|||
125308468|NCT01510158|450756471|FG002|Overall Study|Withdrawal by Subject|10|||
125308469|NCT01510158|450756469|FG000|Overall Study|Death|1|||
125308470|NCT01510158|450756470|FG001|Overall Study|Death|0|||
125308471|NCT01510158|450756471|FG002|Overall Study|Death|0|||
125308472|NCT03078556|450756472|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
125308473|NCT03078556|450756473|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
125308474|NCT03078556|450756474|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
125308475|NCT03078556|450756475|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
125308476|NCT03078556|450756472|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
125308477|NCT03078556|450756473|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
125308478|NCT03078556|450756474|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
125308479|NCT03078556|450756475|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
125308480|NCT03078556|450756472|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
125308481|NCT03078556|450756473|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
125308482|NCT03078556|450756474|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
125308483|NCT03078556|450756475|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
125308484|NCT03078556|450756472|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
125308485|NCT03078556|450756473|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
125308486|NCT03078556|450756474|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
125308487|NCT03078556|450756475|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
125308488|NCT03314987|450756476|FG000|Overall Study|Lost to Follow-up|13|||
125308489|NCT03314987|450756477|FG001|Overall Study|Lost to Follow-up|13|||
125308490|NCT03574779|450756478|FG000|Overall Study|Screening failure|13|||
125308491|NCT03574779|450756479|FG001|Overall Study|Screening failure|83|||
125308492|NCT02751580|450756480|FG000|Overall Study|Lost to Follow-up|4|||
125308493|NCT02751580|450756480|FG000|Overall Study|Death|2|||
125308494|NCT02152761|450756487|FG000|Epoch: Treatment Epoch|Technical problems|0|||
125308495|NCT02152761|450756488|FG001|Epoch: Treatment Epoch|Technical problems|0|||
125308496|NCT02152761|450756489|FG002|Epoch: Treatment Epoch|Technical problems|0|||
125308497|NCT02152761|450756490|FG003|Epoch: Treatment Epoch|Technical problems|1|||
125308498|NCT02152761|450756487|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
125308499|NCT02152761|450756488|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
125308500|NCT02152761|450756489|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
125308501|NCT02152761|450756490|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
125308502|NCT02152761|450756487|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
125308503|NCT02152761|450756488|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
125308504|NCT02152761|450756489|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
125308505|NCT02152761|450756490|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
125308506|NCT02152761|450756487|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
125308507|NCT02152761|450756488|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
125308508|NCT02152761|450756489|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
125308509|NCT02152761|450756490|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
125308510|NCT02152761|450756487|FG000|Epoch: Treatment Epoch|Death|0|||
125308511|NCT02152761|450756488|FG001|Epoch: Treatment Epoch|Death|3|||
125308512|NCT02152761|450756489|FG002|Epoch: Treatment Epoch|Death|1|||
125308513|NCT02152761|450756490|FG003|Epoch: Treatment Epoch|Death|0|||
125308514|NCT02152761|450756487|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
125308515|NCT02152761|450756488|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
125308516|NCT02152761|450756489|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
125513737|NCT00550771|451510843|FG000|Overall Study|Withdrawal by Subject|0|||
125308517|NCT02152761|450756490|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
125308518|NCT02152761|450756487|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
125308519|NCT02152761|450756488|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
125308520|NCT02152761|450756489|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
125513738|NCT00550771|451510844|FG001|Overall Study|Withdrawal by Subject|1|||
125308521|NCT02152761|450756490|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
125308522|NCT02152761|450756487|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
125308523|NCT02152761|450756488|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
125308524|NCT02152761|450756489|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
125308525|NCT02152761|450756490|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
125308526|NCT02152761|450756487|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
125308527|NCT02152761|450756488|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
125308528|NCT02152761|450756489|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
125308529|NCT02152761|450756490|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
125308530|NCT02152761|450756487|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
125308531|NCT02152761|450756488|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
125308532|NCT02152761|450756489|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
125308533|NCT02152761|450756490|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
125308534|NCT03755882|450756491|FG000|Period 1|Protocol Violation|1|||
125308535|NCT03755882|450756492|FG001|Period 1|Protocol Violation|0|||
125308536|NCT03755882|450756491|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
125308537|NCT03755882|450756492|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
125308538|NCT02292446|450756493|FG000|Overall Study|Adverse Event|12|||
125308539|NCT02292446|450756493|FG000|Overall Study|Death|1|||
125308540|NCT02292446|450756493|FG000|Overall Study|Disease progression|2|||
125308541|NCT02292446|450756493|FG000|Overall Study|Subject/guardian decision|2|||
125308542|NCT02292446|450756493|FG000|Overall Study|Withdrawal by Subject|3|||
125308543|NCT03329846|450756497|FG000|Overall Study|Disease progression|4|||
125308544|NCT03329846|450756498|FG001|Overall Study|Disease progression|6|||
125308545|NCT03329846|450756497|FG000|Overall Study|Study drug toxicity|1|||
125308546|NCT03329846|450756498|FG001|Overall Study|Study drug toxicity|0|||
125308547|NCT03329846|450756497|FG000|Overall Study|Participant request to discontinue treatment|0|||
125308548|NCT03329846|450756498|FG001|Overall Study|Participant request to discontinue treatment|1|||
125308549|NCT03329846|450756497|FG000|Overall Study|Participant withdrew consent|1|||
125308550|NCT03329846|450756498|FG001|Overall Study|Participant withdrew consent|0|||
125308551|NCT03329846|450756497|FG000|Overall Study|Other reasons|2|||
125308552|NCT03329846|450756498|FG001|Overall Study|Other reasons|2|||
125308553|NCT03066193|450756499|FG000|Overall Study|Withdrawal by Subject|1|||
125308554|NCT02631551|450756500|FG000|Overall Study|Adverse Event|1|||
125308555|NCT02631551|450756501|FG001|Overall Study|Adverse Event|2|||
125308556|NCT02631551|450756502|FG002|Overall Study|Adverse Event|4|||
125308557|NCT02631551|450756503|FG003|Overall Study|Adverse Event|0|||
125308558|NCT02631551|450756500|FG000|Overall Study|Lack of Efficacy|0|||
125308559|NCT02631551|450756501|FG001|Overall Study|Lack of Efficacy|0|||
125308560|NCT02631551|450756502|FG002|Overall Study|Lack of Efficacy|1|||
125308561|NCT02631551|450756503|FG003|Overall Study|Lack of Efficacy|0|||
125308562|NCT02631551|450756500|FG000|Overall Study|Lost to Follow-up|1|||
125308563|NCT02631551|450756501|FG001|Overall Study|Lost to Follow-up|2|||
125308564|NCT02631551|450756502|FG002|Overall Study|Lost to Follow-up|0|||
125308565|NCT02631551|450756503|FG003|Overall Study|Lost to Follow-up|3|||
125308566|NCT02631551|450756500|FG000|Overall Study|Withdrawal by Subject|2|||
125308567|NCT02631551|450756501|FG001|Overall Study|Withdrawal by Subject|2|||
125308568|NCT02631551|450756502|FG002|Overall Study|Withdrawal by Subject|0|||
125308569|NCT02631551|450756503|FG003|Overall Study|Withdrawal by Subject|5|||
125308570|NCT02631551|450756500|FG000|Overall Study|Protocol deviation|3|||
125308571|NCT02631551|450756501|FG001|Overall Study|Protocol deviation|6|||
125308572|NCT02631551|450756502|FG002|Overall Study|Protocol deviation|3|||
125308573|NCT02631551|450756503|FG003|Overall Study|Protocol deviation|0|||
125308574|NCT02631551|450756500|FG000|Overall Study|Non-compliance with study procedures|0|||
125308575|NCT02631551|450756501|FG001|Overall Study|Non-compliance with study procedures|0|||
125308576|NCT02631551|450756502|FG002|Overall Study|Non-compliance with study procedures|1|||
125308577|NCT02631551|450756503|FG003|Overall Study|Non-compliance with study procedures|1|||
125308578|NCT02631551|450756500|FG000|Overall Study|Non-compliance with study drug|1|||
125308579|NCT02631551|450756501|FG001|Overall Study|Non-compliance with study drug|0|||
125308580|NCT02631551|450756502|FG002|Overall Study|Non-compliance with study drug|0|||
125308581|NCT02631551|450756503|FG003|Overall Study|Non-compliance with study drug|0|||
125308582|NCT02631551|450756500|FG000|Overall Study|Other, specific reasons not collected|5|||
125308583|NCT02631551|450756501|FG001|Overall Study|Other, specific reasons not collected|7|||
125308584|NCT02631551|450756502|FG002|Overall Study|Other, specific reasons not collected|2|||
125308585|NCT02631551|450756503|FG003|Overall Study|Other, specific reasons not collected|2|||
125308586|NCT05636852|450756512|FG000|Overall Study|Withdrawal by Subject|1|||
125308587|NCT05636852|450756512|FG000|Overall Study|Other than specified|1|||
125308588|NCT00377858|450756513|FG000|Overall Study|Withdrawal by Subject|12|||
125308589|NCT00377858|450756514|FG001|Overall Study|Withdrawal by Subject|11|||
125308590|NCT00377858|450756513|FG000|Overall Study|Lost to Follow-up|6|||
125308591|NCT00377858|450756514|FG001|Overall Study|Lost to Follow-up|1|||
125308592|NCT00377858|450756513|FG000|Overall Study|Physician Decision|5|||
125308593|NCT00377858|450756514|FG001|Overall Study|Physician Decision|5|||
125308594|NCT00377858|450756513|FG000|Overall Study|Protocol Violation|3|||
125308595|NCT00377858|450756514|FG001|Overall Study|Protocol Violation|4|||
125308596|NCT00377858|450756513|FG000|Overall Study|Adverse Event|2|||
125308597|NCT00377858|450756514|FG001|Overall Study|Adverse Event|1|||
125308598|NCT00377858|450756513|FG000|Overall Study|Entry Criteria Not Met|2|||
125308599|NCT00377858|450756514|FG001|Overall Study|Entry Criteria Not Met|0|||
125308600|NCT00377858|450756513|FG000|Overall Study|Sponsor Decision|1|||
125308601|NCT00377858|450756514|FG001|Overall Study|Sponsor Decision|2|||
125308602|NCT00377858|450756513|FG000|Overall Study|Death|0|||
125308603|NCT00377858|450756514|FG001|Overall Study|Death|3|||
125308604|NCT01685697|450756515|FG000|Overall Study|Protocol Violation|3|||
125308605|NCT01685697|450756516|FG001|Overall Study|Protocol Violation|3|||
125308606|NCT01076036|450756517|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
125308607|NCT04034004|450756522|FG000|Overall Study|Withdrawal by Subject|1|||
125308608|NCT04034004|450756523|FG001|Overall Study|Withdrawal by Subject|2|||
125308609|NCT04034004|450756524|FG002|Overall Study|Withdrawal by Subject|2|||
125308610|NCT04034004|450756525|FG003|Overall Study|Withdrawal by Subject|3|||
125308611|NCT04034004|450756522|FG000|Overall Study|could not find vein to administer IV|2|||
125308612|NCT04034004|450756523|FG001|Overall Study|could not find vein to administer IV|1|||
125308613|NCT04034004|450756524|FG002|Overall Study|could not find vein to administer IV|0|||
125308614|NCT04034004|450756525|FG003|Overall Study|could not find vein to administer IV|0|||
125308615|NCT04034004|450756522|FG000|Overall Study|nurse accidentally unblinded subject|0|||
125308616|NCT04034004|450756523|FG001|Overall Study|nurse accidentally unblinded subject|0|||
125308617|NCT04034004|450756524|FG002|Overall Study|nurse accidentally unblinded subject|0|||
125308618|NCT04034004|450756525|FG003|Overall Study|nurse accidentally unblinded subject|1|||
125308619|NCT01345188|450756526|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
125308620|NCT01345188|450756526|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
125308621|NCT01397461|450756527|FG000|Overall Study|Withdrawal by Subject|2|||
125308622|NCT01397461|450756528|FG001|Overall Study|Withdrawal by Subject|1|||
125308623|NCT01397461|450756529|FG002|Overall Study|Withdrawal by Subject|0|||
125308624|NCT01397461|450756527|FG000|Overall Study|Lost to Follow-up|0|||
125308625|NCT01397461|450756528|FG001|Overall Study|Lost to Follow-up|2|||
125308626|NCT01397461|450756529|FG002|Overall Study|Lost to Follow-up|1|||
125308627|NCT01397461|450756527|FG000|Overall Study|Lack of Efficacy|0|||
125308628|NCT01397461|450756528|FG001|Overall Study|Lack of Efficacy|3|||
125308629|NCT01397461|450756529|FG002|Overall Study|Lack of Efficacy|0|||
125308630|NCT01397461|450756527|FG000|Overall Study|Not treated|0|||
125308631|NCT01397461|450756528|FG001|Overall Study|Not treated|0|||
125308632|NCT01397461|450756529|FG002|Overall Study|Not treated|1|||
125308633|NCT05729568|450756546|FG000|Overall Study|Still on Study|52|||
125308634|NCT05729568|450756547|FG001|Overall Study|Still on Study|26|||
125308635|NCT05729568|450756546|FG000|Overall Study|Randomized but Never Treated|3|||
125308636|NCT05729568|450756547|FG001|Overall Study|Randomized but Never Treated|0|||
125308637|NCT05729568|450756546|FG000|Overall Study|Adverse Event|0|||
125308638|NCT05729568|450756547|FG001|Overall Study|Adverse Event|1|||
125308639|NCT05729568|450756546|FG000|Overall Study|Investigator's Discretion|1|||
125308640|NCT05729568|450756547|FG001|Overall Study|Investigator's Discretion|0|||
125308641|NCT04181762|450756548|FG000|Overall Study|Adverse Event|1|||
125308642|NCT04181762|450756549|FG001|Overall Study|Adverse Event|3|||
125308643|NCT04181762|450756548|FG000|Overall Study|Lost to Follow-up|1|||
125308644|NCT04181762|450756549|FG001|Overall Study|Lost to Follow-up|1|||
125308645|NCT04181762|450756548|FG000|Overall Study|Physician Decision|1|||
125308646|NCT04181762|450756549|FG001|Overall Study|Physician Decision|3|||
125308647|NCT04181762|450756548|FG000|Overall Study|Pregnancy|0|||
125308648|NCT04181762|450756549|FG001|Overall Study|Pregnancy|1|||
125308649|NCT04181762|450756548|FG000|Overall Study|Lack of Efficacy|2|||
125308650|NCT04181762|450756549|FG001|Overall Study|Lack of Efficacy|2|||
125308651|NCT04181762|450756548|FG000|Overall Study|Study terminated by sponsor|95|||
125308652|NCT04181762|450756549|FG001|Overall Study|Study terminated by sponsor|97|||
125308653|NCT04181762|450756548|FG000|Overall Study|Subject decision|11|||
125308654|NCT04181762|450756549|FG001|Overall Study|Subject decision|4|||
125308655|NCT04181762|450756548|FG000|Overall Study|Death|1|||
125308656|NCT04181762|450756549|FG001|Overall Study|Death|1|||
125308657|NCT04181762|450756548|FG000|Overall Study|Protocol deviation|1|||
125308658|NCT04181762|450756549|FG001|Overall Study|Protocol deviation|0|||
125308659|NCT04181762|450756548|FG000|Overall Study|Withdrawal of informed consent|1|||
125308660|NCT04181762|450756549|FG001|Overall Study|Withdrawal of informed consent|3|||
125308661|NCT04526145|450756550|FG000|Overall Study|Withdrawal by Subject|5|||
125308662|NCT00048347|450756559|FG000|Overall Study|Screen failure|2|||
125308663|NCT00958165|450756560|FG000|Overall Study|Lost to Follow-up|5|||
125308664|NCT00958165|450756560|FG000|Overall Study|Not eligible|9|||
125308665|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
125308666|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
125308667|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
125308668|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Death|0|||
125308669|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Death|2|||
125513739|NCT00550771|451510843|FG000|Overall Study|Protocol Violation|4|||
125308670|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Death|0|||
125308671|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
125308672|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
125308673|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
125308674|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
125308675|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
125308676|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
125308677|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
125308678|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
125308679|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
125308680|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
125308681|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
125308682|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
125308683|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
125308684|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
125308685|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
125308686|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Recovery|1|||
125308687|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Recovery|0|||
125308688|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Recovery|1|||
125308689|NCT00195663|450756561|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
125308690|NCT00195663|450756562|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
125308691|NCT00195663|450756563|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
125308692|NCT00195663|450756561|FG000|Open-Label Extension Period|Adverse Event|21|||
125308693|NCT00195663|450756562|FG001|Open-Label Extension Period|Adverse Event|32|||
125308694|NCT00195663|450756563|FG002|Open-Label Extension Period|Adverse Event|36|||
125308695|NCT00195663|450756561|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
125308696|NCT00195663|450756562|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
125308697|NCT00195663|450756563|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
125308698|NCT00195663|450756561|FG000|Open-Label Extension Period|Recovery|0|||
125308699|NCT00195663|450756562|FG001|Open-Label Extension Period|Recovery|2|||
125308700|NCT00195663|450756563|FG002|Open-Label Extension Period|Recovery|2|||
125308701|NCT00195663|450756561|FG000|Open-Label Extension Period|Protocol Violation|3|||
125308702|NCT00195663|450756562|FG001|Open-Label Extension Period|Protocol Violation|4|||
125308703|NCT00195663|450756563|FG002|Open-Label Extension Period|Protocol Violation|4|||
125308704|NCT00195663|450756561|FG000|Open-Label Extension Period|Death|2|||
125308705|NCT00195663|450756562|FG001|Open-Label Extension Period|Death|2|||
125308706|NCT00195663|450756563|FG002|Open-Label Extension Period|Death|2|||
125308707|NCT00195663|450756561|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
125308708|NCT00195663|450756562|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
125308709|NCT00195663|450756563|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
125308710|NCT00195663|450756561|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
125308711|NCT00195663|450756562|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
125308712|NCT00195663|450756563|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
125308713|NCT00195663|450756561|FG000|Open-Label Extension Period|Administrative reasons|11|||
125308714|NCT00195663|450756562|FG001|Open-Label Extension Period|Administrative reasons|11|||
125308715|NCT00195663|450756563|FG002|Open-Label Extension Period|Administrative reasons|13|||
125308716|NCT00604695|450756564|FG000|Overall Study|Did not receive first bolus.|0|||
125308717|NCT00604695|450756565|FG001|Overall Study|Did not receive first bolus.|4|||
125308718|NCT02058563|450756569|FG000|Overall Study|Lost to Follow-up|26|||
125308719|NCT02058563|450756570|FG001|Overall Study|Lost to Follow-up|22|||
125308720|NCT02058563|450756569|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
125308721|NCT02058563|450756570|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
125308722|NCT02058563|450756569|FG000|Overall Study|Consent Withdrawal|1|||
125308723|NCT02058563|450756570|FG001|Overall Study|Consent Withdrawal|1|||
125308724|NCT02058563|450756569|FG000|Overall Study|Other (patient incarcerated)|0|||
125308725|NCT02058563|450756570|FG001|Overall Study|Other (patient incarcerated)|1|||
125308726|NCT00166439|450756571|FG000|Overall Study|Ineligible|5|||
125308727|NCT04039217|450756572|FG000|Overall Study|Lost to Follow-up|1|||
125308728|NCT00615992|450756573|FG000|Overall Study|Protocol Violation|67|||
125308729|NCT04522141|450756574|FG000|Overall Study|Withdrawal by Subject|1|||
125308730|NCT04522141|450756575|FG001|Overall Study|Withdrawal by Subject|0|||
125308731|NCT03508609|450756576|FG000|Overall Study|Withdrawal by Subject|1|||
125308732|NCT00555217|450756577|FG000|Overall Study|Withdrawal by Subject|35|||
125308733|NCT00555217|450756578|FG001|Overall Study|Withdrawal by Subject|31|||
125308734|NCT00555217|450756577|FG000|Overall Study|Lost to Follow-up|19|||
125308735|NCT00555217|450756578|FG001|Overall Study|Lost to Follow-up|20|||
125308736|NCT00555217|450756577|FG000|Overall Study|close out sites|21|||
125308737|NCT00555217|450756578|FG001|Overall Study|close out sites|17|||
125308738|NCT00367835|450756580|FG000|Overall Study|Adverse Event|14|||
125308739|NCT00367835|450756581|FG001|Overall Study|Adverse Event|1|||
125308740|NCT00367835|450756580|FG000|Overall Study|Protocol Violation|1|||
125308741|NCT00367835|450756581|FG001|Overall Study|Protocol Violation|7|||
125308742|NCT00367835|450756580|FG000|Overall Study|Withdrawal by Subject|7|||
125308743|NCT00367835|450756581|FG001|Overall Study|Withdrawal by Subject|6|||
125308744|NCT00367835|450756580|FG000|Overall Study|Lost to Follow-up|1|||
125308745|NCT00367835|450756581|FG001|Overall Study|Lost to Follow-up|4|||
125308746|NCT00367835|450756580|FG000|Overall Study|Lack of Efficacy|3|||
125308747|NCT00367835|450756581|FG001|Overall Study|Lack of Efficacy|12|||
125308748|NCT00367835|450756580|FG000|Overall Study|Subject in juvenile detention center|1|||
125308749|NCT00367835|450756581|FG001|Overall Study|Subject in juvenile detention center|0|||
125308750|NCT00367835|450756580|FG000|Overall Study|refused blood collection|1|||
125308751|NCT00367835|450756581|FG001|Overall Study|refused blood collection|0|||
125308752|NCT00367835|450756580|FG000|Overall Study|Did not respond to calls|1|||
125308753|NCT00367835|450756581|FG001|Overall Study|Did not respond to calls|0|||
125308754|NCT00367835|450756580|FG000|Overall Study|History of lead poisoning|0|||
125308755|NCT00367835|450756581|FG001|Overall Study|History of lead poisoning|1|||
125308756|NCT03761810|450756585|FG000|Overall Study|Adverse Event|12|||
125308757|NCT03761810|450756586|FG001|Overall Study|Adverse Event|0|||
125308758|NCT03761810|450756585|FG000|Overall Study|Lost to Follow-up|15|||
125308759|NCT03761810|450756586|FG001|Overall Study|Lost to Follow-up|7|||
125308760|NCT03761810|450756585|FG000|Overall Study|Pregnancy|1|||
125308761|NCT03761810|450756586|FG001|Overall Study|Pregnancy|0|||
125308762|NCT03761810|450756585|FG000|Overall Study|Withdrawal by Subject|14|||
125308763|NCT03761810|450756586|FG001|Overall Study|Withdrawal by Subject|5|||
125308764|NCT03761810|450756585|FG000|Overall Study|Physician Decision|1|||
125308765|NCT03761810|450756586|FG001|Overall Study|Physician Decision|0|||
125308766|NCT03761810|450756585|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
125308767|NCT03761810|450756586|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
125308768|NCT03761810|450756585|FG000|Overall Study|Other Than Specified|1|||
125308769|NCT03761810|450756586|FG001|Overall Study|Other Than Specified|0|||
125308770|NCT01574651|450756587|FG000|Overall Study|Lost to Follow-up|2|||
125308771|NCT01574651|450756588|FG001|Overall Study|Lost to Follow-up|4|||
125308772|NCT01574651|450756587|FG000|Overall Study|Administrative problems|0|||
125308773|NCT01574651|450756588|FG001|Overall Study|Administrative problems|1|||
125308774|NCT01574651|450756587|FG000|Overall Study|Death|3|||
125308775|NCT01574651|450756588|FG001|Overall Study|Death|3|||
125308776|NCT01574651|450756587|FG000|Overall Study|Patient's inability to use the device|0|||
125308777|NCT01574651|450756588|FG001|Overall Study|Patient's inability to use the device|1|||
125308778|NCT01574651|450756587|FG000|Overall Study|Adverse Event|36|||
125308779|NCT01574651|450756588|FG001|Overall Study|Adverse Event|27|||
125308780|NCT01574651|450756587|FG000|Overall Study|Abnormal laboratory value(s)|1|||
125308781|NCT01574651|450756588|FG001|Overall Study|Abnormal laboratory value(s)|0|||
125308782|NCT01574651|450756587|FG000|Overall Study|Abnormal test procedure result(s)|1|||
125308783|NCT01574651|450756588|FG001|Overall Study|Abnormal test procedure result(s)|1|||
125308784|NCT01574651|450756587|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
125308785|NCT01574651|450756588|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
125308786|NCT01574651|450756587|FG000|Overall Study|Protocol Violation|3|||
125308787|NCT01574651|450756588|FG001|Overall Study|Protocol Violation|5|||
125308788|NCT01574651|450756587|FG000|Overall Study|Withdrawal by Subject|9|||
125308789|NCT01574651|450756588|FG001|Overall Study|Withdrawal by Subject|10|||
125308790|NCT03887221|450756589|FG000|Overall Study|Protocol Violation|1|||
125308791|NCT03887221|450756590|FG001|Overall Study|Protocol Violation|0|||
125308792|NCT02487030|450756591|FG000|Overall Study|Lack of Efficacy|2|||
125308793|NCT02487030|450756592|FG001|Overall Study|Lack of Efficacy|4|||
125308794|NCT02487030|450756593|FG002|Overall Study|Lack of Efficacy|1|||
125308795|NCT02487030|450756594|FG003|Overall Study|Lack of Efficacy|0|||
125308796|NCT02487030|450756595|FG004|Overall Study|Lack of Efficacy|1|||
125308797|NCT02487030|450756596|FG005|Overall Study|Lack of Efficacy|0|||
125308798|NCT02487030|450756597|FG006|Overall Study|Lack of Efficacy|0|||
125308799|NCT02487030|450756591|FG000|Overall Study|Lost to Follow-up|0|||
125308800|NCT02487030|450756592|FG001|Overall Study|Lost to Follow-up|0|||
125308801|NCT02487030|450756593|FG002|Overall Study|Lost to Follow-up|1|||
125308802|NCT02487030|450756594|FG003|Overall Study|Lost to Follow-up|1|||
125308803|NCT02487030|450756595|FG004|Overall Study|Lost to Follow-up|0|||
125308804|NCT02487030|450756596|FG005|Overall Study|Lost to Follow-up|1|||
125308805|NCT02487030|450756597|FG006|Overall Study|Lost to Follow-up|0|||
125308806|NCT02487030|450756591|FG000|Overall Study|Adverse Event|0|||
125308807|NCT02487030|450756592|FG001|Overall Study|Adverse Event|0|||
125308808|NCT02487030|450756593|FG002|Overall Study|Adverse Event|0|||
125308809|NCT02487030|450756594|FG003|Overall Study|Adverse Event|1|||
125308810|NCT02487030|450756595|FG004|Overall Study|Adverse Event|0|||
125308811|NCT02487030|450756596|FG005|Overall Study|Adverse Event|0|||
125308812|NCT02487030|450756597|FG006|Overall Study|Adverse Event|0|||
125308813|NCT02487030|450756591|FG000|Overall Study|Death|0|||
125308814|NCT02487030|450756592|FG001|Overall Study|Death|0|||
125308815|NCT02487030|450756593|FG002|Overall Study|Death|0|||
125308816|NCT02487030|450756594|FG003|Overall Study|Death|0|||
125308817|NCT02487030|450756595|FG004|Overall Study|Death|1|||
125308818|NCT02487030|450756596|FG005|Overall Study|Death|0|||
125308819|NCT02487030|450756597|FG006|Overall Study|Death|0|||
125308820|NCT02092025|450756598|FG000|Overall Study|Case Report Forms Uncollected|44|||
125308821|NCT02092025|450756598|FG000|Overall Study|Protocol Deviation|24|||
125308822|NCT00264537|450756599|FG000|Overall Study|Death|0|||
125308823|NCT00264537|450756600|FG001|Overall Study|Death|3|||
125308824|NCT00264537|450756601|FG002|Overall Study|Death|3|||
125308825|NCT00264537|450756602|FG003|Overall Study|Death|2|||
125308826|NCT00264537|450756599|FG000|Overall Study|Lost to Follow-up|3|||
125308827|NCT00264537|450756600|FG001|Overall Study|Lost to Follow-up|4|||
125308828|NCT00264537|450756601|FG002|Overall Study|Lost to Follow-up|7|||
125308829|NCT00264537|450756602|FG003|Overall Study|Lost to Follow-up|6|||
125308830|NCT00264537|450756599|FG000|Overall Study|Adverse Event|21|||
125308831|NCT00264537|450756600|FG001|Overall Study|Adverse Event|32|||
125308832|NCT00264537|450756601|FG002|Overall Study|Adverse Event|24|||
125308833|NCT00264537|450756602|FG003|Overall Study|Adverse Event|34|||
125308834|NCT00264537|450756599|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
125308835|NCT00264537|450756600|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
125308836|NCT00264537|450756601|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
125308837|NCT00264537|450756602|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
125308838|NCT00264537|450756599|FG000|Overall Study|Other|21|||
125308839|NCT00264537|450756600|FG001|Overall Study|Other|11|||
125308840|NCT00264537|450756601|FG002|Overall Study|Other|10|||
125308841|NCT00264537|450756602|FG003|Overall Study|Other|11|||
125308842|NCT00264537|450756599|FG000|Overall Study|Not treated|0|||
125308843|NCT00264537|450756600|FG001|Overall Study|Not treated|2|||
125308844|NCT00264537|450756601|FG002|Overall Study|Not treated|1|||
125308845|NCT00264537|450756602|FG003|Overall Study|Not treated|0|||
125308846|NCT03228212|450756604|FG000|Period 1|Adverse Event|1|||
125308847|NCT03228212|450756605|FG001|Period 1|Adverse Event|0|||
125308848|NCT03228212|450756604|FG000|Period 1|no longer meets eligibility criteria|0|||
125308849|NCT03228212|450756605|FG001|Period 1|no longer meets eligibility criteria|1|||
125308850|NCT03228212|450756604|FG000|Period 2|Lost to Follow-up|1|||
125308851|NCT03228212|450756605|FG001|Period 2|Lost to Follow-up|0|||
125308852|NCT01807299|450756606|FG000|Overall Study|Protocol Violation|3|||
125308853|NCT01807299|450756607|FG001|Overall Study|Protocol Violation|1|||
125308854|NCT01807299|450756608|FG002|Overall Study|Protocol Violation|0|||
125308855|NCT01807299|450756609|FG003|Overall Study|Protocol Violation|2|||
125308856|NCT00811174|450756610|FG000|Overall Study|Protocol Violation|2|||
125308857|NCT00811174|450756610|FG000|Overall Study|Sponsors Decision|1|||
125308858|NCT00999544|450758036|FG000|Overall Study|Withdrawal by Subject|1|||
125308859|NCT02407223|450758038|FG000|Overall Study|Adverse Event|1|||
125308860|NCT02407223|450758039|FG001|Overall Study|Adverse Event|0|||
125308861|NCT02407223|450758040|FG002|Overall Study|Adverse Event|1|||
125308862|NCT02407223|450758038|FG000|Overall Study|Lack of Efficacy|6|||
125308863|NCT02407223|450758039|FG001|Overall Study|Lack of Efficacy|6|||
125308864|NCT02407223|450758040|FG002|Overall Study|Lack of Efficacy|4|||
125308865|NCT02407223|450758038|FG000|Overall Study|Lost to Follow-up|1|||
125308866|NCT02407223|450758039|FG001|Overall Study|Lost to Follow-up|0|||
125308867|NCT02407223|450758040|FG002|Overall Study|Lost to Follow-up|2|||
125308868|NCT02407223|450758038|FG000|Overall Study|Withdrawal by Subject|2|||
125308869|NCT02407223|450758039|FG001|Overall Study|Withdrawal by Subject|4|||
125308870|NCT02407223|450758040|FG002|Overall Study|Withdrawal by Subject|4|||
125308871|NCT02407223|450758038|FG000|Overall Study|Study Terminated by Sponsor|77|||
125308872|NCT02407223|450758039|FG001|Overall Study|Study Terminated by Sponsor|80|||
125308873|NCT02407223|450758040|FG002|Overall Study|Study Terminated by Sponsor|86|||
125308874|NCT02407223|450758038|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
125308875|NCT02407223|450758039|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
125308876|NCT02407223|450758040|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
125308877|NCT02407223|450758038|FG000|Overall Study|Other|29|||
125308878|NCT02407223|450758039|FG001|Overall Study|Other|27|||
125308879|NCT02407223|450758040|FG002|Overall Study|Other|25|||
125308880|NCT04864639|450758041|FG000|Overall Study|Death|1|||
125308881|NCT04864639|450758041|FG000|Overall Study|Lost to Follow-up|1|||
125308882|NCT00615017|450758042|FG000|Overall Study|Adverse Event|0|||
125308883|NCT00615017|450758043|FG001|Overall Study|Adverse Event|1|||
125308884|NCT00615017|450758044|FG002|Overall Study|Adverse Event|2|||
125308885|NCT00615017|450758045|FG003|Overall Study|Adverse Event|0|||
125308886|NCT00615017|450758046|FG004|Overall Study|Adverse Event|0|||
125308887|NCT00615017|450758047|FG005|Overall Study|Adverse Event|1|||
125308888|NCT00615017|450758042|FG000|Overall Study|Death|0|||
125308889|NCT00615017|450758043|FG001|Overall Study|Death|0|||
125308890|NCT00615017|450758044|FG002|Overall Study|Death|2|||
125308891|NCT00615017|450758045|FG003|Overall Study|Death|0|||
125308892|NCT00615017|450758046|FG004|Overall Study|Death|1|||
125308893|NCT00615017|450758047|FG005|Overall Study|Death|1|||
125308894|NCT00615017|450758042|FG000|Overall Study|Sepsis resolved|0|||
125308895|NCT00615017|450758043|FG001|Overall Study|Sepsis resolved|0|||
125308896|NCT00615017|450758044|FG002|Overall Study|Sepsis resolved|1|||
125308897|NCT00615017|450758045|FG003|Overall Study|Sepsis resolved|0|||
125308898|NCT00615017|450758046|FG004|Overall Study|Sepsis resolved|0|||
125308899|NCT00615017|450758047|FG005|Overall Study|Sepsis resolved|0|||
125513740|NCT00550771|451510844|FG001|Overall Study|Protocol Violation|5|||
125308900|NCT00615017|450758042|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
125308901|NCT00615017|450758043|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
125308902|NCT00615017|450758044|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
125308903|NCT00615017|450758045|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
125308904|NCT00615017|450758046|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
125308905|NCT00615017|450758047|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
125308906|NCT00615017|450758042|FG000|Overall Study|Physician discontinued drug|0|||
125308907|NCT00615017|450758043|FG001|Overall Study|Physician discontinued drug|0|||
125308908|NCT00615017|450758044|FG002|Overall Study|Physician discontinued drug|0|||
125308909|NCT00615017|450758045|FG003|Overall Study|Physician discontinued drug|0|||
125308910|NCT00615017|450758046|FG004|Overall Study|Physician discontinued drug|0|||
125308911|NCT00615017|450758047|FG005|Overall Study|Physician discontinued drug|1|||
125308912|NCT00806988|450758048|FG000|Overall Study|Death|15|||
125308913|NCT00806988|450758049|FG001|Overall Study|Death|16|||
125308914|NCT00806988|450758048|FG000|Overall Study|Withdrawal by Subject|8|||
125308915|NCT00806988|450758049|FG001|Overall Study|Withdrawal by Subject|8|||
125308916|NCT00806988|450758048|FG000|Overall Study|Lost to Follow-up|4|||
125308917|NCT00806988|450758049|FG001|Overall Study|Lost to Follow-up|19|||
125308918|NCT01478971|450758050|FG000|Standard of Care Period|Adverse Event|1|||
125308919|NCT01478971|450758050|FG000|Standard of Care Period|Withdrawal by Subject|3|||
125308920|NCT01478971|450758050|FG000|Standard of Care Period|Death|8|||
125308921|NCT01478971|450758050|FG000|Standard of Care Period|Lost to Follow-up|9|||
125308922|NCT01478971|450758050|FG000|Standard of Care Period|Other|4|||
125308923|NCT01478971|450758050|FG000|Peginesatide Treatment Period|Adverse Event|1|||
125308924|NCT01478971|450758050|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
125308925|NCT01478971|450758050|FG000|Peginesatide Treatment Period|Death|4|||
125308926|NCT01478971|450758050|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
125308927|NCT01478971|450758050|FG000|Peginesatide Treatment Period|Other|4|||
125308928|NCT00584012|450758051|FG000|Overall Study|Withdrawal by Subject|1|||
125308929|NCT01525615|450758052|FG000|Overall Study|Adverse Event|11|||
125308930|NCT01525615|450758053|FG001|Overall Study|Adverse Event|7|||
125308931|NCT01525615|450758054|FG002|Overall Study|Adverse Event|5|||
125308932|NCT01525615|450758052|FG000|Overall Study|Lost to Follow-up|1|||
125308933|NCT01525615|450758053|FG001|Overall Study|Lost to Follow-up|0|||
125308934|NCT01525615|450758054|FG002|Overall Study|Lost to Follow-up|0|||
125308935|NCT01525615|450758052|FG000|Overall Study|Withdrawal by Subject|1|||
125308936|NCT01525615|450758053|FG001|Overall Study|Withdrawal by Subject|0|||
125308937|NCT01525615|450758054|FG002|Overall Study|Withdrawal by Subject|0|||
125308938|NCT01525615|450758052|FG000|Overall Study|Other reason not described above|1|||
125308939|NCT01525615|450758053|FG001|Overall Study|Other reason not described above|0|||
125308940|NCT01525615|450758054|FG002|Overall Study|Other reason not described above|1|||
125308941|NCT04050618|450758055|FG000|First Intervention|Withdrawal by Subject|2|||
125308942|NCT04050618|450758056|FG001|First Intervention|Withdrawal by Subject|0|||
125308943|NCT04050618|450758055|FG000|Second Intervention|Withdrawal by Subject|1|||
125308944|NCT04050618|450758056|FG001|Second Intervention|Withdrawal by Subject|0|||
125308945|NCT04404556|450758057|FG000|Intervention|Withdrawal by Subject|15|||
125308946|NCT04404556|450758058|FG001|Intervention|Withdrawal by Subject|3|||
125308947|NCT04404556|450758057|FG000|Intervention|Did not complete all intervention sessions|2|||
125308948|NCT04404556|450758058|FG001|Intervention|Did not complete all intervention sessions|1|||
125308949|NCT04404556|450758057|FG000|Post-Intervention|Missing Data|1|||
125308950|NCT04404556|450758058|FG001|Post-Intervention|Missing Data|2|||
125308951|NCT04404556|450758057|FG000|Follow-up 1|Withdrawal by Subject|5|||
125308952|NCT04404556|450758058|FG001|Follow-up 1|Withdrawal by Subject|1|||
125308953|NCT04404556|450758057|FG000|Follow-up 1|Missing Data|4|||
125308954|NCT04404556|450758058|FG001|Follow-up 1|Missing Data|7|||
125308955|NCT04404556|450758057|FG000|Follow-up 2|Withdrawal by Subject|1|||
125308956|NCT04404556|450758058|FG001|Follow-up 2|Withdrawal by Subject|1|||
125308957|NCT04404556|450758057|FG000|Follow-up 2|Missing Data|6|||
125308958|NCT04404556|450758058|FG001|Follow-up 2|Missing Data|5|||
125308959|NCT04775953|450758059|FG000|Overall Study|Lost to Follow-up|6|||
125308960|NCT04775953|450758060|FG001|Overall Study|Lost to Follow-up|11|||
125308961|NCT04775953|450758059|FG000|Overall Study|Death|5|||
125308962|NCT04775953|450758060|FG001|Overall Study|Death|4|||
125308963|NCT04775953|450758059|FG000|Overall Study|Withdrawal by Subject|3|||
125308964|NCT04775953|450758060|FG001|Overall Study|Withdrawal by Subject|3|||
125308965|NCT04775953|450758059|FG000|Overall Study|Protocol Violation|2|||
125308966|NCT04775953|450758060|FG001|Overall Study|Protocol Violation|0|||
125513741|NCT00730847|451510845|FG000|Overall Study|Adverse Event|1|||
125308967|NCT04775953|450758059|FG000|Overall Study|Participant non-compliance|0|||
125308968|NCT04775953|450758060|FG001|Overall Study|Participant non-compliance|1|||
125308969|NCT00855959|450758061|FG000|Overall Study|Adverse Event|2|||
125308970|NCT00855959|450758061|FG000|Overall Study|Lost to Follow-up|2|||
125308971|NCT00855959|450758061|FG000|Overall Study|Withdrawal by Subject|3|||
125308972|NCT00855959|450758061|FG000|Overall Study|Pregnancy|1|||
125308973|NCT00855959|450758061|FG000|Overall Study|Incorrect enrolment|1|||
125308974|NCT02451943|450758062|FG000|Overall Study|Withdrawal by Subject|13|||
125513742|NCT00730847|451510845|FG000|Overall Study|Protocol Violation|2|||
125308975|NCT02451943|450758063|FG001|Overall Study|Withdrawal by Subject|16|||
125308976|NCT02451943|450758062|FG000|Overall Study|Lost to Follow-up|3|||
125308977|NCT02451943|450758063|FG001|Overall Study|Lost to Follow-up|4|||
125308978|NCT02451943|450758062|FG000|Overall Study|Sponsor Decision|0|||
125308979|NCT02451943|450758063|FG001|Overall Study|Sponsor Decision|4|||
125308980|NCT00368641|450758064|FG000|Overall Study|Adverse Event|2|||
125308981|NCT00368641|450758065|FG001|Overall Study|Adverse Event|1|||
125308982|NCT00368641|450758064|FG000|Overall Study|Death|1|||
125308983|NCT00368641|450758065|FG001|Overall Study|Death|0|||
125308984|NCT00368641|450758064|FG000|Overall Study|Withdrawal by Subject|1|||
125308985|NCT00368641|450758065|FG001|Overall Study|Withdrawal by Subject|0|||
125308986|NCT00368641|450758064|FG000|Overall Study|Sponsor decision to terminate study|2|||
125308987|NCT00368641|450758065|FG001|Overall Study|Sponsor decision to terminate study|5|||
125308988|NCT00763386|450758067|FG000|Overall Study|Adverse Event|43|||
125308989|NCT00763386|450758068|FG001|Overall Study|Adverse Event|33|||
125308990|NCT00763386|450758067|FG000|Overall Study|Death|1|||
125308991|NCT00763386|450758068|FG001|Overall Study|Death|2|||
125308992|NCT00763386|450758067|FG000|Overall Study|Lost to Follow-up|3|||
125308993|NCT00763386|450758068|FG001|Overall Study|Lost to Follow-up|3|||
125308994|NCT00763386|450758067|FG000|Overall Study|Withdrawal by Subject|0|||
125308995|NCT00763386|450758068|FG001|Overall Study|Withdrawal by Subject|1|||
125308996|NCT00763386|450758067|FG000|Overall Study|CRF missing|0|||
125308997|NCT00763386|450758068|FG001|Overall Study|CRF missing|1|||
125308998|NCT00763386|450758067|FG000|Overall Study|Study Prosthesis Removed|1|||
125308999|NCT00763386|450758068|FG001|Overall Study|Study Prosthesis Removed|0|||
125309000|NCT01290757|450758071|FG000|Overall Study|Adverse Event|1|||
125309001|NCT01290757|450758072|FG001|Overall Study|Adverse Event|0|||
125309002|NCT01290757|450758071|FG000|Overall Study|Protocol Violation|1|||
125309003|NCT01290757|450758072|FG001|Overall Study|Protocol Violation|1|||
125309004|NCT01290757|450758071|FG000|Overall Study|Other|0|||
125309005|NCT01290757|450758072|FG001|Overall Study|Other|1|||
125309006|NCT00887549|450758073|FG000|Induction Therapy|Adverse Event|8|||
125309007|NCT00887549|450758073|FG000|Induction Therapy|Physician Decision|1|||
125309008|NCT00887549|450758073|FG000|Induction Therapy|Progressive Disease|13|||
125309009|NCT00887549|450758073|FG000|Induction Therapy|Death due to Study Disease|4|||
125309010|NCT00887549|450758073|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
125309011|NCT00887549|450758073|FG000|Maintenance Therapy|Adverse Event|16|||
125309012|NCT00887549|450758073|FG000|Maintenance Therapy|Physician Decision|1|||
125309013|NCT00887549|450758073|FG000|Maintenance Therapy|Progressive Disease|25|||
125309014|NCT00887549|450758073|FG000|Maintenance Therapy|Death due to adverse event|1|||
125309015|NCT00479336|450758075|FG000|Overall Study|Adverse Event|1|||
125309016|NCT00479336|450758076|FG001|Overall Study|Adverse Event|1|||
125309017|NCT00479336|450758077|FG002|Overall Study|Adverse Event|1|||
125309018|NCT00479336|450758078|FG003|Overall Study|Adverse Event|3|||
125309019|NCT00479336|450758075|FG000|Overall Study|Lack of Efficacy|1|||
125309020|NCT00479336|450758076|FG001|Overall Study|Lack of Efficacy|0|||
125309021|NCT00479336|450758077|FG002|Overall Study|Lack of Efficacy|0|||
125309022|NCT00479336|450758078|FG003|Overall Study|Lack of Efficacy|0|||
125309023|NCT00479336|450758075|FG000|Overall Study|Protocol Violation|0|||
125309024|NCT00479336|450758076|FG001|Overall Study|Protocol Violation|1|||
125309025|NCT00479336|450758077|FG002|Overall Study|Protocol Violation|0|||
125309026|NCT00479336|450758078|FG003|Overall Study|Protocol Violation|0|||
125309027|NCT00479336|450758075|FG000|Overall Study|Withdrawal by Subject|1|||
125309028|NCT00479336|450758076|FG001|Overall Study|Withdrawal by Subject|2|||
125309029|NCT00479336|450758077|FG002|Overall Study|Withdrawal by Subject|0|||
125309030|NCT00479336|450758078|FG003|Overall Study|Withdrawal by Subject|0|||
125309031|NCT00479336|450758075|FG000|Overall Study|Physician Decision|0|||
125309032|NCT00479336|450758076|FG001|Overall Study|Physician Decision|1|||
125309033|NCT00479336|450758077|FG002|Overall Study|Physician Decision|0|||
125309034|NCT00479336|450758078|FG003|Overall Study|Physician Decision|2|||
125513743|NCT00730847|451510845|FG000|Overall Study|Withdrawal by Subject|16|||
125513744|NCT00730847|451510845|FG000|Overall Study|Lost to Follow-up|67|||
125309035|NCT00479336|450758075|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
125309036|NCT00479336|450758076|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
125309037|NCT00479336|450758077|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
125309038|NCT00479336|450758078|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
125513745|NCT00730847|451510845|FG000|Overall Study|Unknown completion status|21|||
125309039|NCT02021643|450758079|FG000|Overall Study|Enrolled but Never Treated|1|||
125309040|NCT02021643|450758080|FG001|Overall Study|Enrolled but Never Treated|0|||
125309041|NCT02021643|450758081|FG002|Overall Study|Enrolled but Never Treated|0|||
125309042|NCT02021643|450758082|FG003|Overall Study|Enrolled but Never Treated|0|||
125309043|NCT02021643|450758079|FG000|Overall Study|Adverse Event|0|||
125513746|NCT00730847|451510845|FG000|Overall Study|Other|24|||
125309044|NCT02021643|450758080|FG001|Overall Study|Adverse Event|1|||
125309045|NCT02021643|450758081|FG002|Overall Study|Adverse Event|0|||
125309046|NCT02021643|450758082|FG003|Overall Study|Adverse Event|0|||
125309047|NCT02021643|450758079|FG000|Overall Study|Death|0|||
125309048|NCT02021643|450758080|FG001|Overall Study|Death|1|||
125513747|NCT03022578|451510846|FG000|Overall Study|Adverse Event|1|||
125309049|NCT02021643|450758081|FG002|Overall Study|Death|0|||
125309050|NCT02021643|450758082|FG003|Overall Study|Death|0|||
125309051|NCT02021643|450758079|FG000|Overall Study|Investigator's Discretion|1|||
125309052|NCT02021643|450758080|FG001|Overall Study|Investigator's Discretion|0|||
125309053|NCT02021643|450758081|FG002|Overall Study|Investigator's Discretion|0|||
125309054|NCT02021643|450758082|FG003|Overall Study|Investigator's Discretion|0|||
125309055|NCT02021643|450758079|FG000|Overall Study|Lack of Efficacy|7|||
125309056|NCT02021643|450758080|FG001|Overall Study|Lack of Efficacy|6|||
125309057|NCT02021643|450758081|FG002|Overall Study|Lack of Efficacy|0|||
125309058|NCT02021643|450758082|FG003|Overall Study|Lack of Efficacy|12|||
125309059|NCT02021643|450758079|FG000|Overall Study|Lost to Follow-up|0|||
125309060|NCT02021643|450758080|FG001|Overall Study|Lost to Follow-up|1|||
125309061|NCT02021643|450758081|FG002|Overall Study|Lost to Follow-up|0|||
125309062|NCT02021643|450758082|FG003|Overall Study|Lost to Follow-up|0|||
125309063|NCT02021643|450758079|FG000|Overall Study|Withdrew Consent|0|||
125309064|NCT02021643|450758080|FG001|Overall Study|Withdrew Consent|1|||
125309065|NCT02021643|450758081|FG002|Overall Study|Withdrew Consent|0|||
125309066|NCT02021643|450758082|FG003|Overall Study|Withdrew Consent|0|||
125309067|NCT04854551|450758085|FG000|Overall Study|Withdrawal by Subject|1|||
125309068|NCT04854551|450758086|FG001|Overall Study|Withdrawal by Subject|1|||
125309069|NCT04112303|450758087|FG000|Overall Study|Death|1|||
125309070|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Death|0|||
125309071|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Death|0|||
125309072|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Death|0|||
125309073|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Death|0|||
125309074|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Death|1|||
125309075|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Death|0|||
125309076|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Death|0|||
125309077|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Death|0|||
125309078|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
125309079|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
125309080|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
125309081|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
125309082|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
125309083|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
125309084|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
125309085|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
125309086|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
125309087|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
125309088|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
125309089|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
125309090|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
125309091|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
125309092|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
125309093|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
125309094|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
125309095|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
125309096|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
125309097|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
125309098|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
125309099|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
125309100|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
125309101|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
125309102|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
125309103|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
125309104|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
125309105|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
125309106|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
125309107|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
125309108|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
125309109|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
125309110|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
125309111|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
125513748|NCT03022578|451510846|FG000|Overall Study|Lack of Efficacy|2|||
125309112|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
125309113|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
125309114|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
125309115|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
125309116|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
125309117|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
125513749|NCT03022578|451510846|FG000|Overall Study|Withdrawal by Subject|1|||
125309118|NCT00726232|450758088|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
125309119|NCT00726232|450758089|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309120|NCT00726232|450758090|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309121|NCT00726232|450758091|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309122|NCT00726232|450758092|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309123|NCT00726232|450758093|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309124|NCT00726232|450758094|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309125|NCT00726232|450758095|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
125309126|NCT00726232|450758088|FG000|Expansion Phase|Death|0|||
125309127|NCT00726232|450758089|FG001|Expansion Phase|Death|0|||
125309128|NCT00726232|450758090|FG002|Expansion Phase|Death|0|||
125309129|NCT00726232|450758091|FG003|Expansion Phase|Death|0|||
125309130|NCT00726232|450758092|FG004|Expansion Phase|Death|0|||
125309131|NCT00726232|450758093|FG005|Expansion Phase|Death|0|||
125309132|NCT00726232|450758094|FG006|Expansion Phase|Death|0|||
125309133|NCT00726232|450758095|FG007|Expansion Phase|Death|1|||
125309134|NCT00726232|450758088|FG000|Expansion Phase|Adverse Event|0|||
125309135|NCT00726232|450758089|FG001|Expansion Phase|Adverse Event|0|||
125309136|NCT00726232|450758090|FG002|Expansion Phase|Adverse Event|0|||
125309137|NCT00726232|450758091|FG003|Expansion Phase|Adverse Event|0|||
125309138|NCT00726232|450758092|FG004|Expansion Phase|Adverse Event|0|||
125309139|NCT00726232|450758093|FG005|Expansion Phase|Adverse Event|0|||
125309140|NCT00726232|450758094|FG006|Expansion Phase|Adverse Event|6|||
125309141|NCT00726232|450758095|FG007|Expansion Phase|Adverse Event|11|||
125309142|NCT00726232|450758088|FG000|Expansion Phase|Withdrawal by Subject|0|||
125309143|NCT00726232|450758089|FG001|Expansion Phase|Withdrawal by Subject|0|||
125309144|NCT00726232|450758090|FG002|Expansion Phase|Withdrawal by Subject|0|||
125309145|NCT00726232|450758091|FG003|Expansion Phase|Withdrawal by Subject|0|||
125309146|NCT00726232|450758092|FG004|Expansion Phase|Withdrawal by Subject|0|||
125309147|NCT00726232|450758093|FG005|Expansion Phase|Withdrawal by Subject|0|||
125309148|NCT00726232|450758094|FG006|Expansion Phase|Withdrawal by Subject|2|||
125309149|NCT00726232|450758095|FG007|Expansion Phase|Withdrawal by Subject|3|||
125309150|NCT00726232|450758088|FG000|Expansion Phase|Disease progression|0|||
125309151|NCT00726232|450758089|FG001|Expansion Phase|Disease progression|0|||
125309152|NCT00726232|450758090|FG002|Expansion Phase|Disease progression|0|||
125309153|NCT00726232|450758091|FG003|Expansion Phase|Disease progression|0|||
125309154|NCT00726232|450758092|FG004|Expansion Phase|Disease progression|0|||
125309155|NCT00726232|450758093|FG005|Expansion Phase|Disease progression|0|||
125309156|NCT00726232|450758094|FG006|Expansion Phase|Disease progression|4|||
125309157|NCT00726232|450758095|FG007|Expansion Phase|Disease progression|0|||
125309158|NCT00726232|450758088|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
125309159|NCT00726232|450758089|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
125309160|NCT00726232|450758090|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
125309161|NCT00726232|450758091|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
125309162|NCT00726232|450758092|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
125309163|NCT00726232|450758093|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
125309164|NCT00726232|450758094|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
125309165|NCT00726232|450758095|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
125309166|NCT00726232|450758088|FG000|Expansion Phase|Per Investigator: lack of response|0|||
125309167|NCT00726232|450758089|FG001|Expansion Phase|Per Investigator: lack of response|0|||
125309168|NCT00726232|450758090|FG002|Expansion Phase|Per Investigator: lack of response|0|||
125309169|NCT00726232|450758091|FG003|Expansion Phase|Per Investigator: lack of response|0|||
125309170|NCT00726232|450758092|FG004|Expansion Phase|Per Investigator: lack of response|0|||
125309171|NCT00726232|450758093|FG005|Expansion Phase|Per Investigator: lack of response|0|||
125309172|NCT00726232|450758094|FG006|Expansion Phase|Per Investigator: lack of response|1|||
125309173|NCT00726232|450758095|FG007|Expansion Phase|Per Investigator: lack of response|7|||
125309174|NCT00726232|450758088|FG000|Expansion Phase|Unspecified reason|0|||
125309175|NCT00726232|450758089|FG001|Expansion Phase|Unspecified reason|0|||
125309176|NCT00726232|450758090|FG002|Expansion Phase|Unspecified reason|0|||
125309177|NCT00726232|450758091|FG003|Expansion Phase|Unspecified reason|0|||
125309178|NCT00726232|450758092|FG004|Expansion Phase|Unspecified reason|0|||
125309179|NCT00726232|450758093|FG005|Expansion Phase|Unspecified reason|0|||
125309180|NCT00726232|450758094|FG006|Expansion Phase|Unspecified reason|1|||
125513750|NCT03681353|451510852|FG000|Overall Study|Lost to Follow-up|2|||
125513751|NCT03681353|451510852|FG000|Overall Study|Withdrawal by Subject|3|||
125513752|NCT03681353|451510852|FG000|Overall Study|withdrawn by PI|2|||
125309181|NCT00726232|450758095|FG007|Expansion Phase|Unspecified reason|0|||
125309182|NCT03088917|450758096|FG000|Overall Study|In care/cured elsewhere|15|||
125309183|NCT03088917|450758096|FG000|Overall Study|Refuse re-evaluation|13|||
125309184|NCT03088917|450758096|FG000|Overall Study|Contact not established|13|||
125309185|NCT03088917|450758096|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
125309186|NCT03088917|450758096|FG000|Overall Study|Moved outside study region|50|||
125309187|NCT05447663|450758098|FG000|Overall Study|Study terminated by Sponsor|5|||
125309188|NCT05447663|450758098|FG000|Overall Study|Death|2|||
125309189|NCT05447663|450758098|FG000|Overall Study|Withdrawal by Subject|1|||
125309190|NCT06041919|450758099|FG000|Overall Study|Lost to Follow-up|1|||
125309191|NCT06041919|450758100|FG001|Overall Study|Lost to Follow-up|0|||
125309192|NCT06041919|450758101|FG002|Overall Study|Lost to Follow-up|0|||
125309193|NCT06041919|450758102|FG003|Overall Study|Lost to Follow-up|0|||
125309194|NCT06041919|450758103|FG004|Overall Study|Lost to Follow-up|0|||
125309195|NCT06041919|450758099|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
125309196|NCT06041919|450758100|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
125309197|NCT06041919|450758101|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
125309198|NCT06041919|450758102|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
125309199|NCT06041919|450758103|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
125309200|NCT01502228|450758104|FG000|Overall Study|Death|1|||
125309201|NCT01221350|450758111|FG000|Overall Study|Discontinued intervention (GERD)|1|||
125309202|NCT01221350|450758112|FG001|Overall Study|Discontinued intervention (GERD)|0|||
125309203|NCT01221350|450758111|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
125309204|NCT01221350|450758112|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
125309205|NCT01221350|450758111|FG000|Overall Study|Withdrawal by Subject|4|||
125309206|NCT01221350|450758112|FG001|Overall Study|Withdrawal by Subject|2|||
125309207|NCT04209205|450758118|FG000|Overall Study|Adverse Event|2|||
125309208|NCT04209205|450758119|FG001|Overall Study|Adverse Event|3|||
125309209|NCT04209205|450758118|FG000|Overall Study|Lost to Follow-up|3|||
125309210|NCT04209205|450758119|FG001|Overall Study|Lost to Follow-up|1|||
125309211|NCT04209205|450758118|FG000|Overall Study|Physician Decision|1|||
125309212|NCT04209205|450758119|FG001|Overall Study|Physician Decision|1|||
125309213|NCT04209205|450758118|FG000|Overall Study|Subject decision|10|||
125309214|NCT04209205|450758119|FG001|Overall Study|Subject decision|10|||
125309215|NCT04209205|450758118|FG000|Overall Study|Progressive disease|1|||
125309216|NCT04209205|450758119|FG001|Overall Study|Progressive disease|0|||
125309217|NCT04209205|450758118|FG000|Overall Study|Protocol deviation|0|||
125309218|NCT04209205|450758119|FG001|Overall Study|Protocol deviation|1|||
125309219|NCT04209205|450758118|FG000|Overall Study|New therapy for study indication|1|||
125309220|NCT04209205|450758119|FG001|Overall Study|New therapy for study indication|0|||
125309221|NCT04209205|450758118|FG000|Overall Study|Adverse event - placebo not switched|0|||
125309222|NCT04209205|450758119|FG001|Overall Study|Adverse event - placebo not switched|1|||
125309223|NCT04209205|450758118|FG000|Overall Study|Subject decision - placebo not switched|0|||
125309224|NCT04209205|450758119|FG001|Overall Study|Subject decision - placebo not switched|5|||
125309225|NCT04209205|450758118|FG000|Overall Study|Death - placebo not switched|0|||
125309226|NCT04209205|450758119|FG001|Overall Study|Death - placebo not switched|1|||
125309227|NCT05236257|450758152|FG000|Overall Study|Ongoing with study treatment|29|||
125309228|NCT05236257|450758153|FG001|Overall Study|Ongoing with study treatment|1|||
125309229|NCT05236257|450758152|FG000|Overall Study|Discontinued study treatment|22|||
125309230|NCT05236257|450758153|FG001|Overall Study|Discontinued study treatment|41|||
125309231|NCT00924443|450758157|FG000|Overall Study|Physician Decision|2|||
125309232|NCT00924443|450758157|FG000|Overall Study|Protocol Violation|1|||
125309233|NCT01746225|450758159|FG000|Overall Study|Death|1|||
125309234|NCT01746225|450758160|FG001|Overall Study|Death|0|||
125309235|NCT01746225|450758161|FG002|Overall Study|Death|1|||
125309236|NCT01746225|450758159|FG000|Overall Study|Withdrawal by Subject|5|||
125309237|NCT01746225|450758160|FG001|Overall Study|Withdrawal by Subject|15|||
125309238|NCT01746225|450758161|FG002|Overall Study|Withdrawal by Subject|19|||
125309239|NCT01746225|450758159|FG000|Overall Study|Physician Decision|14|||
125309240|NCT01746225|450758160|FG001|Overall Study|Physician Decision|11|||
125309241|NCT01746225|450758161|FG002|Overall Study|Physician Decision|3|||
125309242|NCT01746225|450758159|FG000|Overall Study|Adverse Event|15|||
125309243|NCT01746225|450758160|FG001|Overall Study|Adverse Event|12|||
125309244|NCT01746225|450758161|FG002|Overall Study|Adverse Event|17|||
125309245|NCT01746225|450758159|FG000|Overall Study|Continuing Treatment|5|||
125309246|NCT01746225|450758160|FG001|Overall Study|Continuing Treatment|8|||
125309247|NCT01746225|450758161|FG002|Overall Study|Continuing Treatment|3|||
125309248|NCT03405818|450758162|FG000|Overall Study|Withdrawal by Subject|4|||
125309249|NCT03405818|450758162|FG000|Overall Study|Lost to Follow-up|4|||
125309250|NCT03197376|450758166|FG000|Primary and Booster Phase|Adverse Event|0|||
125513753|NCT00726388|451510858|FG000|Overall Study|Withdrawal by Subject|5|||
125513754|NCT00726388|451510858|FG000|Overall Study|Adverse Event|3|||
125513755|NCT00726388|451510858|FG000|Overall Study|Lost to Follow-up|10|||
125513756|NCT00726388|451510858|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
125513757|NCT00726388|451510858|FG000|Overall Study|Other|5|||
125513758|NCT00726388|451510858|FG000|Overall Study|Enrolled, Not Treated|79|||
125513759|NCT00111839|451510859|FG000|Overall Study|Disease Progression|30|||
125513760|NCT00111839|451510860|FG001|Overall Study|Disease Progression|33|||
125513761|NCT00111839|451510861|FG002|Overall Study|Disease Progression|33|||
125513762|NCT00111839|451510859|FG000|Overall Study|Adverse Event|5|||
125513763|NCT00111839|451510860|FG001|Overall Study|Adverse Event|3|||
125513764|NCT00111839|451510861|FG002|Overall Study|Adverse Event|1|||
125513765|NCT00111839|451510859|FG000|Overall Study|Protocol Violation|2|||
125513766|NCT00111839|451510860|FG001|Overall Study|Protocol Violation|4|||
125513767|NCT00111839|451510861|FG002|Overall Study|Protocol Violation|2|||
125513768|NCT00111839|451510859|FG000|Overall Study|Death|1|||
125513769|NCT00111839|451510860|FG001|Overall Study|Death|1|||
125513770|NCT00111839|451510861|FG002|Overall Study|Death|6|||
125513771|NCT00111839|451510859|FG000|Overall Study|Withdrawal by Subject|2|||
125513772|NCT00111839|451510860|FG001|Overall Study|Withdrawal by Subject|2|||
125513773|NCT00111839|451510861|FG002|Overall Study|Withdrawal by Subject|2|||
125513774|NCT00111839|451510859|FG000|Overall Study|Lost to Follow-up|1|||
125513775|NCT00111839|451510860|FG001|Overall Study|Lost to Follow-up|0|||
125513776|NCT00111839|451510861|FG002|Overall Study|Lost to Follow-up|0|||
125513777|NCT00111839|451510859|FG000|Overall Study|Logistical Constraint|1|||
125513778|NCT00111839|451510860|FG001|Overall Study|Logistical Constraint|0|||
125513779|NCT00111839|451510861|FG002|Overall Study|Logistical Constraint|0|||
125513780|NCT00111839|451510859|FG000|Overall Study|Other|6|||
125513781|NCT00111839|451510860|FG001|Overall Study|Other|3|||
125513782|NCT00111839|451510861|FG002|Overall Study|Other|3|||
125513783|NCT00111839|451510859|FG000|Overall Study|Randomized but Not Treated|0|||
125513784|NCT00111839|451510860|FG001|Overall Study|Randomized but Not Treated|0|||
125513785|NCT00111839|451510861|FG002|Overall Study|Randomized but Not Treated|2|||
125513786|NCT00382408|451510862|FG000|Overall Study|Did not meet protocol requirement|3|||
125513787|NCT00382408|451510863|FG001|Overall Study|Did not meet protocol requirement|3|||
125513788|NCT00382408|451510862|FG000|Overall Study|Protocol Violation|2|||
125513789|NCT00382408|451510863|FG001|Overall Study|Protocol Violation|2|||
125513790|NCT00382408|451510862|FG000|Overall Study|Physician Decision|1|||
125513791|NCT00382408|451510863|FG001|Overall Study|Physician Decision|0|||
125513792|NCT00382408|451510862|FG000|Overall Study|Withdrawal by Subject|17|||
125513793|NCT00382408|451510863|FG001|Overall Study|Withdrawal by Subject|6|||
125513794|NCT00382408|451510862|FG000|Overall Study|Pregnancy|2|||
125513795|NCT00382408|451510863|FG001|Overall Study|Pregnancy|0|||
125513796|NCT00382408|451510862|FG000|Overall Study|Lost to Follow-up|19|||
125513797|NCT00382408|451510863|FG001|Overall Study|Lost to Follow-up|8|||
125513798|NCT00382408|451510862|FG000|Overall Study|Other|100|||
125513799|NCT00382408|451510863|FG001|Overall Study|Other|35|||
125513800|NCT00762723|451510864|FG000|Overall Study|Study Terminated slow enrollement|5|||
125513801|NCT00762723|451510865|FG001|Overall Study|Study Terminated slow enrollement|5|||
125513802|NCT00762723|451510866|FG002|Overall Study|Study Terminated slow enrollement|3|||
125513803|NCT02435381|451510867|FG000|Overall Study|Lost to Follow-up|2|||
125513804|NCT02435381|451510868|FG001|Overall Study|Lost to Follow-up|1|||
125513805|NCT00139659|451510869|FG000|Overall Study|Adverse Event|12|||
125513806|NCT00139659|451510870|FG001|Overall Study|Adverse Event|1|||
125513807|NCT00139659|451510869|FG000|Overall Study|Lack of Efficacy|1|||
125513808|NCT00139659|451510870|FG001|Overall Study|Lack of Efficacy|1|||
125513809|NCT00139659|451510869|FG000|Overall Study|Lost to Follow-up|7|||
125513810|NCT00139659|451510870|FG001|Overall Study|Lost to Follow-up|3|||
125513811|NCT00139659|451510869|FG000|Overall Study|Reason not Specified|6|||
125513812|NCT00139659|451510870|FG001|Overall Study|Reason not Specified|3|||
125513813|NCT00139659|451510869|FG000|Overall Study|Withdrawal by Subject|14|||
125513814|NCT00139659|451510870|FG001|Overall Study|Withdrawal by Subject|10|||
125513815|NCT02282917|451510871|FG000|Overall Study|Withdrawal by Subject|1|||
125513816|NCT02282917|451510871|FG000|Overall Study|Screen Failure/Not Eligible|1|||
125513817|NCT01747629|451510872|FG000|Overall Study|Adverse Event|1|||
125513818|NCT01747629|451510873|FG001|Overall Study|Adverse Event|2|||
125513819|NCT01747629|451510872|FG000|Overall Study|Withdrawal by Subject|2|||
125513820|NCT01747629|451510873|FG001|Overall Study|Withdrawal by Subject|2|||
125513821|NCT01747629|451510872|FG000|Overall Study|Noncompliance|1|||
125513822|NCT01747629|451510873|FG001|Overall Study|Noncompliance|1|||
125513823|NCT01747629|451510872|FG000|Overall Study|Inclusion criteria not met|1|||
125513824|NCT01747629|451510873|FG001|Overall Study|Inclusion criteria not met|0|||
125513825|NCT01747629|451510872|FG000|Overall Study|Not treated|1|||
125513826|NCT01747629|451510873|FG001|Overall Study|Not treated|0|||
125513827|NCT01747629|451510872|FG000|Overall Study|Other|2|||
125513828|NCT01747629|451510873|FG001|Overall Study|Other|1|||
125513829|NCT01395914|451510874|FG000|Overall Study|Unrelated to study drug AE|6|||
125513830|NCT01395914|451510875|FG001|Overall Study|Unrelated to study drug AE|1|||
125513831|NCT01395914|451510874|FG000|Overall Study|Death|23|||
125513832|NCT01395914|451510875|FG001|Overall Study|Death|17|||
125513833|NCT01395914|451510874|FG000|Overall Study|Other|9|||
125513834|NCT01395914|451510875|FG001|Overall Study|Other|3|||
125513835|NCT01395914|451510874|FG000|Overall Study|Withdrawal by patient|27|||
125513836|NCT01395914|451510875|FG001|Overall Study|Withdrawal by patient|14|||
125513837|NCT01395914|451510874|FG000|Overall Study|Study drug-related AE|1|||
125513838|NCT01395914|451510875|FG001|Overall Study|Study drug-related AE|0|||
125513839|NCT01395914|451510874|FG000|Overall Study|Lost to Follow-up|6|||
125513840|NCT01395914|451510875|FG001|Overall Study|Lost to Follow-up|2|||
125513841|NCT04414397|451510876|FG000|Control Period|Withdrawal by Subject|2|||
125513842|NCT04414397|451510877|FG001|Control Period|Withdrawal by Subject|2|||
125513843|NCT04414397|451510876|FG000|Control Period|Lost to Follow-up|0|||
125513844|NCT04414397|451510877|FG001|Control Period|Lost to Follow-up|4|||
125513845|NCT04414397|451510876|FG000|Control Period|Protocol deviation|0|||
125513846|NCT04414397|451510877|FG001|Control Period|Protocol deviation|1|||
125513847|NCT04414397|451510876|FG000|Post-Control Period|Withdrawal by Subject|3|||
125513848|NCT04414397|451510877|FG001|Post-Control Period|Withdrawal by Subject|6|||
125513849|NCT04414397|451510876|FG000|Post-Control Period|Lost to Follow-up|4|||
125513850|NCT04414397|451510877|FG001|Post-Control Period|Lost to Follow-up|9|||
125513851|NCT04414397|451510876|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
125513852|NCT04414397|451510877|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
125513853|NCT04414397|451510876|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
125513854|NCT04414397|451510877|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
125513855|NCT01920178|451510882|FG000|Overall Study|Lost to Follow-up|2|||
125513856|NCT01920178|451510883|FG001|Overall Study|Lost to Follow-up|1|||
125513857|NCT02391545|451510884|FG000|Overall Study|Death|0|||
125513858|NCT02391545|451510885|FG001|Overall Study|Death|2|||
125513859|NCT02391545|451510884|FG000|Overall Study|Lost to Follow-up|0|||
125513860|NCT02391545|451510885|FG001|Overall Study|Lost to Follow-up|1|||
125513861|NCT02391545|451510884|FG000|Overall Study|Termination of study by sponsor|20|||
125513862|NCT02391545|451510885|FG001|Overall Study|Termination of study by sponsor|20|||
125513863|NCT02391545|451510884|FG000|Overall Study|Withdrawal by Subject|0|||
125513864|NCT02391545|451510885|FG001|Overall Study|Withdrawal by Subject|1|||
125513865|NCT02391545|451510884|FG000|Overall Study|Other Reasons|6|||
125513866|NCT02391545|451510885|FG001|Overall Study|Other Reasons|4|||
125513867|NCT04754594|451510889|FG000|Blinded Period|Withdrawal by Subject|4|||
125513868|NCT04754594|451510890|FG001|Blinded Period|Withdrawal by Subject|9|||
125513869|NCT04754594|451510891|FG002|Blinded Period|Withdrawal by Subject|0|||
125513870|NCT04754594|451510892|FG003|Blinded Period|Withdrawal by Subject|0|||
125513871|NCT04754594|451510889|FG000|Blinded Period|Protocol Violation|2|||
125513872|NCT04754594|451510890|FG001|Blinded Period|Protocol Violation|2|||
125513873|NCT04754594|451510891|FG002|Blinded Period|Protocol Violation|0|||
125513874|NCT04754594|451510892|FG003|Blinded Period|Protocol Violation|0|||
125513875|NCT04754594|451510889|FG000|Blinded Period|Lost to Follow-up|1|||
125513876|NCT04754594|451510890|FG001|Blinded Period|Lost to Follow-up|1|||
125513877|NCT04754594|451510891|FG002|Blinded Period|Lost to Follow-up|0|||
125513878|NCT04754594|451510892|FG003|Blinded Period|Lost to Follow-up|0|||
125513879|NCT04754594|451510889|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
125513880|NCT04754594|451510890|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
125513881|NCT04754594|451510891|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
125513882|NCT04754594|451510892|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
125513883|NCT04754594|451510889|FG000|Unblinded Period|Withdrawal by Subject|6|||
125513884|NCT04754594|451510890|FG001|Unblinded Period|Withdrawal by Subject|8|||
125513885|NCT04754594|451510891|FG002|Unblinded Period|Withdrawal by Subject|0|||
125513886|NCT04754594|451510892|FG003|Unblinded Period|Withdrawal by Subject|0|||
125513887|NCT04754594|451510889|FG000|Unblinded Period|Lost to Follow-up|5|||
125513888|NCT04754594|451510890|FG001|Unblinded Period|Lost to Follow-up|3|||
125513889|NCT04754594|451510891|FG002|Unblinded Period|Lost to Follow-up|0|||
125513890|NCT04754594|451510892|FG003|Unblinded Period|Lost to Follow-up|0|||
125513891|NCT04754594|451510889|FG000|Unblinded Period|Protocol Violation|2|||
125513892|NCT04754594|451510890|FG001|Unblinded Period|Protocol Violation|4|||
125513893|NCT04754594|451510891|FG002|Unblinded Period|Protocol Violation|0|||
125513894|NCT04754594|451510892|FG003|Unblinded Period|Protocol Violation|0|||
125513895|NCT04754594|451510889|FG000|Unblinded Period|Other|3|||
125513896|NCT04754594|451510890|FG001|Unblinded Period|Other|0|||
125513897|NCT04754594|451510891|FG002|Unblinded Period|Other|0|||
125513898|NCT04754594|451510892|FG003|Unblinded Period|Other|0|||
125513899|NCT04754594|451510889|FG000|Infant Participants|Withdrawal by Subject|0|||
125513900|NCT04754594|451510890|FG001|Infant Participants|Withdrawal by Subject|0|||
125513901|NCT04754594|451510891|FG002|Infant Participants|Withdrawal by Subject|9|||
125513902|NCT04754594|451510892|FG003|Infant Participants|Withdrawal by Subject|17|||
125513903|NCT04754594|451510889|FG000|Infant Participants|Lost to Follow-up|0|||
125513904|NCT04754594|451510890|FG001|Infant Participants|Lost to Follow-up|0|||
125513905|NCT04754594|451510891|FG002|Infant Participants|Lost to Follow-up|4|||
125513906|NCT04754594|451510892|FG003|Infant Participants|Lost to Follow-up|10|||
125513907|NCT04754594|451510889|FG000|Infant Participants|Death|0|||
125513908|NCT04754594|451510890|FG001|Infant Participants|Death|0|||
125513909|NCT04754594|451510891|FG002|Infant Participants|Death|1|||
125513910|NCT04754594|451510892|FG003|Infant Participants|Death|1|||
125513911|NCT04754594|451510889|FG000|Infant Participants|Other|0|||
125513912|NCT04754594|451510890|FG001|Infant Participants|Other|0|||
125513913|NCT04754594|451510891|FG002|Infant Participants|Other|1|||
125513914|NCT04754594|451510892|FG003|Infant Participants|Other|1|||
125513915|NCT03340766|451510895|FG000|Overall Study|Withdrawal by Subject|2|||
125513916|NCT03340766|451510896|FG001|Overall Study|Withdrawal by Subject|1|||
125513917|NCT03340766|451510897|FG002|Overall Study|Withdrawal by Subject|3|||
125513918|NCT03340766|451510895|FG000|Overall Study|Lost to Follow-up|0|||
125513919|NCT03340766|451510896|FG001|Overall Study|Lost to Follow-up|0|||
125513920|NCT03340766|451510897|FG002|Overall Study|Lost to Follow-up|1|||
125513921|NCT03340766|451510895|FG000|Overall Study|Death|6|||
125513922|NCT03340766|451510896|FG001|Overall Study|Death|7|||
125513923|NCT03340766|451510897|FG002|Overall Study|Death|4|||
125532606|NCT00350727|451580161|FG000|Phase II|Adverse Event|0|||
125513924|NCT02849509|451510900|FG000|Overall Study|Worsening of disease under study|1|||
125513925|NCT02849509|451510901|FG001|Overall Study|Worsening of disease under study|1|||
125513926|NCT02849509|451510902|FG002|Overall Study|Worsening of disease under study|1|||
125513927|NCT02849509|451510900|FG000|Overall Study|Worsening of other pre-existing disease|0|||
125513928|NCT02849509|451510901|FG001|Overall Study|Worsening of other pre-existing disease|1|||
125513929|NCT02849509|451510902|FG002|Overall Study|Worsening of other pre-existing disease|2|||
125513930|NCT02849509|451510900|FG000|Overall Study|Other adverse event|36|||
125513931|NCT02849509|451510901|FG001|Overall Study|Other adverse event|41|||
125513932|NCT02849509|451510902|FG002|Overall Study|Other adverse event|8|||
125513933|NCT02849509|451510900|FG000|Overall Study|Withdrawal by Subject|6|||
125513934|NCT02849509|451510901|FG001|Overall Study|Withdrawal by Subject|17|||
125513935|NCT02849509|451510902|FG002|Overall Study|Withdrawal by Subject|12|||
125513936|NCT02849509|451510900|FG000|Overall Study|Lost to Follow-up|27|||
125513937|NCT02849509|451510901|FG001|Overall Study|Lost to Follow-up|67|||
125513938|NCT02849509|451510902|FG002|Overall Study|Lost to Follow-up|36|||
125513939|NCT02849509|451510900|FG000|Overall Study|Other, reason not specified|14|||
125513940|NCT02849509|451510901|FG001|Overall Study|Other, reason not specified|29|||
125513941|NCT02849509|451510902|FG002|Overall Study|Other, reason not specified|25|||
125513942|NCT02849509|451510900|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
125513943|NCT02849509|451510901|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
125513944|NCT02849509|451510902|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
125513945|NCT02256488|451510903|FG000|Overall Study|Lost to Follow-up|6|||
125513946|NCT02256488|451510904|FG001|Overall Study|Lost to Follow-up|6|||
125513947|NCT02256488|451510905|FG002|Overall Study|Lost to Follow-up|9|||
125513948|NCT02256488|451510906|FG003|Overall Study|Lost to Follow-up|3|||
125513949|NCT02256488|451510903|FG000|Overall Study|OTHER|1|||
125513950|NCT02256488|451510904|FG001|Overall Study|OTHER|0|||
125513951|NCT02256488|451510905|FG002|Overall Study|OTHER|1|||
125513952|NCT02256488|451510906|FG003|Overall Study|OTHER|1|||
125513953|NCT02256488|451510903|FG000|Overall Study|Withdrawal by Subject|1|||
125513954|NCT02256488|451510904|FG001|Overall Study|Withdrawal by Subject|0|||
125513955|NCT02256488|451510905|FG002|Overall Study|Withdrawal by Subject|0|||
125513956|NCT02256488|451510906|FG003|Overall Study|Withdrawal by Subject|2|||
125513957|NCT01011049|451513251|FG000|Overall Study|Protocol Violation|0|||
125513958|NCT01011049|451513252|FG001|Overall Study|Protocol Violation|0|||
125513959|NCT01011049|451513253|FG002|Overall Study|Protocol Violation|2|||
125513960|NCT01011049|451513254|FG003|Overall Study|Protocol Violation|0|||
125513961|NCT01011049|451513251|FG000|Overall Study|Lost to Follow-up|1|||
125513962|NCT01011049|451513252|FG001|Overall Study|Lost to Follow-up|2|||
125513963|NCT01011049|451513253|FG002|Overall Study|Lost to Follow-up|1|||
125513964|NCT01011049|451513254|FG003|Overall Study|Lost to Follow-up|0|||
125513965|NCT01011049|451513251|FG000|Overall Study|Withdrawal by Subject|0|||
125513966|NCT01011049|451513252|FG001|Overall Study|Withdrawal by Subject|0|||
125513967|NCT01011049|451513253|FG002|Overall Study|Withdrawal by Subject|1|||
125513968|NCT01011049|451513254|FG003|Overall Study|Withdrawal by Subject|0|||
125513969|NCT00520403|451513260|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
125513970|NCT00520403|451513260|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
125513971|NCT00520403|451513260|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
125513972|NCT00520403|451513260|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
125513973|NCT00520403|451513260|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
125513974|NCT00520403|451513260|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
125513975|NCT00520403|451513260|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
125513976|NCT00520403|451513260|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
125513977|NCT00352053|451513261|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
125513978|NCT00352053|451513262|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
125513979|NCT00352053|451513261|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
125513980|NCT00352053|451513262|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
125513981|NCT00352053|451513261|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
125513982|NCT00352053|451513262|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
125513983|NCT00352053|451513261|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
125513984|NCT00352053|451513262|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
125513985|NCT00352053|451513261|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
125513986|NCT00352053|451513262|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
125513987|NCT00352053|451513261|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
125513988|NCT00352053|451513262|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
125513989|NCT00352053|451513261|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
125513990|NCT00352053|451513262|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
125513991|NCT00352053|451513261|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
125513992|NCT00352053|451513262|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
125513993|NCT00352053|451513261|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
125513994|NCT00352053|451513262|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
125532607|NCT00350727|451580162|FG001|Phase II|Adverse Event|1|||
125513995|NCT00352053|451513261|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
125513996|NCT00352053|451513262|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
125513997|NCT00352053|451513261|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
125513998|NCT00352053|451513262|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
125513999|NCT00352053|451513261|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
125514000|NCT00352053|451513262|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
125514001|NCT00352053|451513261|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
125514002|NCT00352053|451513262|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
125514003|NCT00405912|451513265|FG000|Overall Study|Withdrawal by Subject|12|||
125514004|NCT00405912|451513266|FG001|Overall Study|Withdrawal by Subject|11|||
125514005|NCT00405912|451513267|FG002|Overall Study|Withdrawal by Subject|12|||
125514006|NCT00405912|451513265|FG000|Overall Study|Lost to Follow-up|4|||
125514007|NCT00405912|451513266|FG001|Overall Study|Lost to Follow-up|8|||
125514008|NCT00405912|451513267|FG002|Overall Study|Lost to Follow-up|4|||
125514009|NCT01797562|451513268|FG000|Overall Study|Protocol Violation|5|||
125514010|NCT03730662|451513269|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
125514011|NCT03730662|451513270|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
125514012|NCT03730662|451513271|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
125514013|NCT03730662|451513272|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
125514014|NCT03730662|451513269|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
125514015|NCT03730662|451513270|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
125514016|NCT03730662|451513271|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
125514017|NCT03730662|451513272|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
125514018|NCT03730662|451513269|FG000|Treatment Period (52 Weeks)|Death|6|||
125514019|NCT03730662|451513270|FG001|Treatment Period (52 Weeks)|Death|2|||
125514020|NCT03730662|451513271|FG002|Treatment Period (52 Weeks)|Death|2|||
125514021|NCT03730662|451513272|FG003|Treatment Period (52 Weeks)|Death|9|||
125514022|NCT03730662|451513269|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
125514023|NCT03730662|451513270|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
125514024|NCT03730662|451513271|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
125514025|NCT03730662|451513272|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
125514026|NCT03730662|451513269|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
125514027|NCT03730662|451513270|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
125514028|NCT03730662|451513271|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
125514029|NCT03730662|451513272|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
125514030|NCT03730662|451513269|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
125514031|NCT03730662|451513270|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
125514032|NCT03730662|451513271|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
125514033|NCT03730662|451513272|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
125514034|NCT03730662|451513269|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
125514035|NCT03730662|451513270|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
125514036|NCT03730662|451513271|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
125514037|NCT03730662|451513272|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
125514038|NCT03730662|451513269|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
125514039|NCT03730662|451513270|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
125514040|NCT03730662|451513271|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
125514041|NCT03730662|451513272|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
125514042|NCT03730662|451513269|FG000|Variable Treatment Period|Adverse Event|1|||
125514043|NCT03730662|451513270|FG001|Variable Treatment Period|Adverse Event|2|||
125514044|NCT03730662|451513271|FG002|Variable Treatment Period|Adverse Event|0|||
125514045|NCT03730662|451513272|FG003|Variable Treatment Period|Adverse Event|7|||
125514046|NCT03730662|451513269|FG000|Variable Treatment Period|Death|9|||
125514047|NCT03730662|451513270|FG001|Variable Treatment Period|Death|0|||
125514048|NCT03730662|451513271|FG002|Variable Treatment Period|Death|6|||
125514049|NCT03730662|451513272|FG003|Variable Treatment Period|Death|26|||
125514050|NCT03730662|451513269|FG000|Variable Treatment Period|Lost to Follow-up|2|||
125514051|NCT03730662|451513270|FG001|Variable Treatment Period|Lost to Follow-up|1|||
125514052|NCT03730662|451513271|FG002|Variable Treatment Period|Lost to Follow-up|4|||
125514053|NCT03730662|451513272|FG003|Variable Treatment Period|Lost to Follow-up|11|||
125514054|NCT03730662|451513269|FG000|Variable Treatment Period|Personal Reason|0|||
125514055|NCT03730662|451513270|FG001|Variable Treatment Period|Personal Reason|2|||
125514056|NCT03730662|451513271|FG002|Variable Treatment Period|Personal Reason|1|||
125514057|NCT03730662|451513272|FG003|Variable Treatment Period|Personal Reason|6|||
125514058|NCT03730662|451513269|FG000|Variable Treatment Period|Physician Decision|0|||
125514059|NCT03730662|451513270|FG001|Variable Treatment Period|Physician Decision|0|||
125514060|NCT03730662|451513271|FG002|Variable Treatment Period|Physician Decision|0|||
125514061|NCT03730662|451513272|FG003|Variable Treatment Period|Physician Decision|3|||
125514062|NCT03730662|451513269|FG000|Variable Treatment Period|Protocol Violation|0|||
125514063|NCT03730662|451513270|FG001|Variable Treatment Period|Protocol Violation|1|||
125514064|NCT03730662|451513271|FG002|Variable Treatment Period|Protocol Violation|1|||
125514065|NCT03730662|451513272|FG003|Variable Treatment Period|Protocol Violation|1|||
125514066|NCT03730662|451513269|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
125514067|NCT03730662|451513270|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
125514068|NCT03730662|451513271|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
125514069|NCT03730662|451513272|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
125514070|NCT01309243|451513273|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
125514071|NCT01309243|451513274|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
125514072|NCT01309243|451513273|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
125514073|NCT01309243|451513274|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
125514074|NCT01309243|451513273|FG000|Randomized Phase Through Week 96|Death|0|||
125514075|NCT01309243|451513274|FG001|Randomized Phase Through Week 96|Death|1|||
125514076|NCT01309243|451513273|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
125514077|NCT01309243|451513274|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
125514078|NCT01309243|451513273|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
125514079|NCT01309243|451513274|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
125514080|NCT01309243|451513273|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
125514081|NCT01309243|451513274|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
125514082|NCT01309243|451513273|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
125514083|NCT01309243|451513274|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
125514084|NCT01309243|451513273|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
125514085|NCT01309243|451513274|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
125514086|NCT01309243|451513273|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
125514087|NCT01309243|451513274|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
125514088|NCT01309243|451513273|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
125514089|NCT01309243|451513274|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
125514090|NCT01309243|451513273|FG000|Extension Phase|Lost to Follow-up|6|||
125514091|NCT01309243|451513274|FG001|Extension Phase|Lost to Follow-up|0|||
125514092|NCT00632931|451513277|FG000|Part 1, Period 1|Protocol Violation|1|||
125514093|NCT00632931|451513278|FG001|Part 1, Period 1|Protocol Violation|0|||
125514094|NCT00632931|451513279|FG002|Part 1, Period 1|Protocol Violation|0|||
125514095|NCT00632931|451513277|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
125514096|NCT00632931|451513278|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
125514097|NCT00632931|451513279|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
125514098|NCT00632931|451513277|FG000|Part 2|Adverse Event|0|||
125514099|NCT00632931|451513278|FG001|Part 2|Adverse Event|0|||
125514100|NCT00632931|451513279|FG002|Part 2|Adverse Event|3|||
125514101|NCT00632931|451513277|FG000|Part 2|Death|0|||
125514102|NCT00632931|451513278|FG001|Part 2|Death|0|||
125514103|NCT00632931|451513279|FG002|Part 2|Death|1|||
125514104|NCT00632931|451513277|FG000|Part 2|Lack of Efficacy|0|||
125514105|NCT00632931|451513278|FG001|Part 2|Lack of Efficacy|0|||
125514106|NCT00632931|451513279|FG002|Part 2|Lack of Efficacy|17|||
125514107|NCT00632931|451513277|FG000|Part 2|Withdrawal by Subject|0|||
125514108|NCT00632931|451513278|FG001|Part 2|Withdrawal by Subject|0|||
125514109|NCT00632931|451513279|FG002|Part 2|Withdrawal by Subject|3|||
125514110|NCT01441583|451513282|FG000|Overall Study|Withdrawal by Subject|1|||
125514111|NCT01441583|451513283|FG001|Overall Study|Withdrawal by Subject|1|||
125514112|NCT01441583|451513284|FG002|Overall Study|Withdrawal by Subject|1|||
125514113|NCT01441583|451513282|FG000|Overall Study|Death|1|||
125514114|NCT01441583|451513283|FG001|Overall Study|Death|0|||
125514115|NCT01441583|451513284|FG002|Overall Study|Death|4|||
125514116|NCT01441583|451513282|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
125514117|NCT01441583|451513283|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
125514118|NCT01441583|451513284|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
125514119|NCT03341312|451513285|FG000|Period 1|Withdrawal by Subject|0|||
125514120|NCT03341312|451513286|FG001|Period 1|Withdrawal by Subject|1|||
125514121|NCT03341312|451513287|FG002|Period 1|Withdrawal by Subject|0|||
125514122|NCT03341312|451513288|FG003|Period 1|Withdrawal by Subject|0|||
125514123|NCT00839306|451513289|FG000|Overall Study|Adverse Event|3|||
125514124|NCT00839306|451513290|FG001|Overall Study|Adverse Event|5|||
125514125|NCT00839306|451513289|FG000|Overall Study|Lost to Follow-up|6|||
125514126|NCT00839306|451513290|FG001|Overall Study|Lost to Follow-up|9|||
125514127|NCT00839306|451513289|FG000|Overall Study|Withdrawal by Subject|5|||
125514128|NCT00839306|451513290|FG001|Overall Study|Withdrawal by Subject|7|||
125514129|NCT00839306|451513289|FG000|Overall Study|Lack of Efficacy|5|||
125514130|NCT00839306|451513290|FG001|Overall Study|Lack of Efficacy|4|||
125514131|NCT00839306|451513289|FG000|Overall Study|Other|6|||
125514132|NCT00839306|451513290|FG001|Overall Study|Other|18|||
125514133|NCT01812707|451513291|FG000|Overall Study|Adverse Event|0|||
125514134|NCT01812707|451513292|FG001|Overall Study|Adverse Event|0|||
125514135|NCT01812707|451513293|FG002|Overall Study|Adverse Event|0|||
125514136|NCT01812707|451513294|FG003|Overall Study|Adverse Event|2|||
125514137|NCT01812707|451513291|FG000|Overall Study|Poor compliance to protocol|1|||
125514138|NCT01812707|451513292|FG001|Overall Study|Poor compliance to protocol|0|||
125514139|NCT01812707|451513293|FG002|Overall Study|Poor compliance to protocol|0|||
125514140|NCT01812707|451513294|FG003|Overall Study|Poor compliance to protocol|0|||
125514141|NCT01812707|451513291|FG000|Overall Study|Consent withdrawn by participant|1|||
125514142|NCT01812707|451513292|FG001|Overall Study|Consent withdrawn by participant|0|||
125514143|NCT01812707|451513293|FG002|Overall Study|Consent withdrawn by participant|0|||
125514144|NCT01812707|451513294|FG003|Overall Study|Consent withdrawn by participant|0|||
125514145|NCT05060237|451513295|FG000|Overall Study|Withdrawal by Subject|4|||
125514146|NCT05060237|451513295|FG000|Overall Study|Screening failure|8|||
125514147|NCT01697592|451513296|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
125514148|NCT01697592|451513297|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
125514149|NCT01697592|451513298|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
125514150|NCT01697592|451513299|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
125514151|NCT01697592|451513300|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
125514152|NCT01697592|451513301|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
125514153|NCT01697592|451513302|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
125514154|NCT01697592|451513303|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
125514155|NCT01697592|451513304|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
125514156|NCT01697592|451513305|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
125514157|NCT01697592|451513296|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125514158|NCT01697592|451513297|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125514159|NCT01697592|451513298|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125514160|NCT01697592|451513299|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125514161|NCT01697592|451513300|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125514162|NCT01697592|451513301|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
125514163|NCT01697592|451513302|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125514164|NCT01697592|451513303|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125514165|NCT01697592|451513304|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125514166|NCT01697592|451513305|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
125514167|NCT01697592|451513296|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
125514168|NCT01697592|451513297|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
125514169|NCT01697592|451513298|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
125514170|NCT01697592|451513299|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
125514171|NCT01697592|451513300|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
125514172|NCT01697592|451513301|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
125514173|NCT01697592|451513302|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
125514174|NCT01697592|451513303|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
125514175|NCT01697592|451513304|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
125514176|NCT01697592|451513305|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
125514177|NCT01697592|451513296|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
125514178|NCT01697592|451513297|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
125514179|NCT01697592|451513298|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
125514180|NCT01697592|451513299|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
125514181|NCT01697592|451513300|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
125514182|NCT01697592|451513301|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
125514183|NCT01697592|451513302|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
125514184|NCT01697592|451513303|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
125514185|NCT01697592|451513304|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
125514186|NCT01697592|451513305|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
125514187|NCT01697592|451513296|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
125514188|NCT01697592|451513297|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
125514189|NCT01697592|451513298|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
125514190|NCT01697592|451513299|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
125514191|NCT01697592|451513300|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
125514192|NCT01697592|451513301|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
125514193|NCT01697592|451513302|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
125514194|NCT01697592|451513303|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
125514195|NCT01697592|451513304|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
125514196|NCT01697592|451513305|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
125514197|NCT01697592|451513296|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
125514198|NCT01697592|451513297|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
125514199|NCT01697592|451513298|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
125514200|NCT01697592|451513299|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
125514201|NCT01697592|451513300|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
125514202|NCT01697592|451513301|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
125514203|NCT01697592|451513302|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
125514204|NCT01697592|451513303|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
125514205|NCT01697592|451513304|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
125514206|NCT01697592|451513305|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
125514207|NCT01697592|451513296|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
125514208|NCT01697592|451513297|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
125514209|NCT01697592|451513298|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
125514210|NCT01697592|451513299|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
125514211|NCT01697592|451513300|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
125514212|NCT01697592|451513301|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
125532608|NCT00350727|451580163|FG002|Phase II|Adverse Event|1|||
125514213|NCT01697592|451513302|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
125514214|NCT01697592|451513303|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
125514215|NCT01697592|451513304|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
125514216|NCT01697592|451513305|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
125514217|NCT01697592|451513296|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
125514218|NCT01697592|451513297|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
125514219|NCT01697592|451513298|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
125514220|NCT01697592|451513299|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
125514221|NCT01697592|451513300|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
125514222|NCT01697592|451513301|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
125514223|NCT01697592|451513302|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
125514224|NCT01697592|451513303|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
125514225|NCT01697592|451513304|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
125514226|NCT01697592|451513305|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
125514227|NCT02396758|451513306|FG000|Overall Study|Withdrawal by Subject|2|||
125514228|NCT02396758|451513307|FG001|Overall Study|Withdrawal by Subject|0|||
125514229|NCT02396758|451513308|FG002|Overall Study|Withdrawal by Subject|0|||
125514230|NCT02396758|451513309|FG003|Overall Study|Withdrawal by Subject|1|||
125514231|NCT02396758|451513306|FG000|Overall Study|Lost to Follow-up|8|||
125514232|NCT02396758|451513307|FG001|Overall Study|Lost to Follow-up|5|||
125514233|NCT02396758|451513308|FG002|Overall Study|Lost to Follow-up|3|||
125514234|NCT02396758|451513309|FG003|Overall Study|Lost to Follow-up|3|||
125514235|NCT02396758|451513306|FG000|Overall Study|Death|1|||
125514236|NCT02396758|451513307|FG001|Overall Study|Death|1|||
125514237|NCT02396758|451513308|FG002|Overall Study|Death|0|||
125514238|NCT02396758|451513309|FG003|Overall Study|Death|1|||
125514239|NCT02396758|451513306|FG000|Overall Study|Randomized but not treated|1|||
125514240|NCT02396758|451513307|FG001|Overall Study|Randomized but not treated|0|||
125514241|NCT02396758|451513308|FG002|Overall Study|Randomized but not treated|1|||
125514242|NCT02396758|451513309|FG003|Overall Study|Randomized but not treated|0|||
125514243|NCT00265096|451513310|FG000|Overall Study|Adverse Event|14|||
125514244|NCT00265096|451513311|FG001|Overall Study|Adverse Event|18|||
125514245|NCT00265096|451513312|FG002|Overall Study|Adverse Event|18|||
125514246|NCT00265096|451513310|FG000|Overall Study|Lost to Follow-up|2|||
125514247|NCT00265096|451513311|FG001|Overall Study|Lost to Follow-up|5|||
125514248|NCT00265096|451513312|FG002|Overall Study|Lost to Follow-up|3|||
125514249|NCT00265096|451513310|FG000|Overall Study|Death|0|||
125514250|NCT00265096|451513311|FG001|Overall Study|Death|1|||
125514251|NCT00265096|451513312|FG002|Overall Study|Death|2|||
125514252|NCT00265096|451513310|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
125514253|NCT00265096|451513311|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
125514254|NCT00265096|451513312|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
125514255|NCT00265096|451513310|FG000|Overall Study|Other|11|||
125514256|NCT00265096|451513311|FG001|Overall Study|Other|19|||
125514257|NCT00265096|451513312|FG002|Overall Study|Other|10|||
125514258|NCT00774306|451513313|FG000|Overall Study|Adverse Event|3|||
125514259|NCT00774306|451513314|FG001|Overall Study|Adverse Event|0|||
125514260|NCT00774306|451513315|FG002|Overall Study|Adverse Event|0|||
125514261|NCT00774306|451513316|FG003|Overall Study|Adverse Event|0|||
125514262|NCT00774306|451513313|FG000|Overall Study|Protocol Violation|2|||
125514263|NCT00774306|451513314|FG001|Overall Study|Protocol Violation|0|||
125514264|NCT00774306|451513315|FG002|Overall Study|Protocol Violation|3|||
125514265|NCT00774306|451513316|FG003|Overall Study|Protocol Violation|0|||
125514266|NCT00774306|451513313|FG000|Overall Study|Withdrawal by Subject|6|||
125514267|NCT00774306|451513314|FG001|Overall Study|Withdrawal by Subject|1|||
125514268|NCT00774306|451513315|FG002|Overall Study|Withdrawal by Subject|1|||
125514269|NCT00774306|451513316|FG003|Overall Study|Withdrawal by Subject|0|||
125514270|NCT00774306|451513313|FG000|Overall Study|Lost to Follow-up|6|||
125514271|NCT00774306|451513314|FG001|Overall Study|Lost to Follow-up|0|||
125514272|NCT00774306|451513315|FG002|Overall Study|Lost to Follow-up|4|||
125514273|NCT00774306|451513316|FG003|Overall Study|Lost to Follow-up|5|||
125514274|NCT00774306|451513313|FG000|Overall Study|Death|1|||
125514275|NCT00774306|451513314|FG001|Overall Study|Death|1|||
125514276|NCT00774306|451513315|FG002|Overall Study|Death|0|||
125514277|NCT00774306|451513316|FG003|Overall Study|Death|0|||
125514278|NCT00666835|451513319|FG000|Overall Study|Withdrawal by Subject|5|||
125514279|NCT00666835|451513320|FG001|Overall Study|Withdrawal by Subject|2|||
125514280|NCT00666835|451513319|FG000|Overall Study|Lack of Efficacy|0|||
125514281|NCT00666835|451513320|FG001|Overall Study|Lack of Efficacy|1|||
125514282|NCT00666835|451513319|FG000|Overall Study|Incl./excl. not fulfilled|7|||
125514283|NCT00666835|451513320|FG001|Overall Study|Incl./excl. not fulfilled|2|||
125514284|NCT00666835|451513319|FG000|Overall Study|Adverse Event|7|||
125514285|NCT00666835|451513320|FG001|Overall Study|Adverse Event|6|||
125514286|NCT00666835|451513319|FG000|Overall Study|Protocol Violation|2|||
125514287|NCT00666835|451513320|FG001|Overall Study|Protocol Violation|0|||
125514288|NCT00666835|451513319|FG000|Overall Study|Death|15|||
125514289|NCT00666835|451513320|FG001|Overall Study|Death|4|||
125514290|NCT00666835|451513319|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
125514291|NCT00666835|451513320|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
125514292|NCT00666835|451513319|FG000|Overall Study|Hemoglobulin concentration|4|||
125514293|NCT00666835|451513320|FG001|Overall Study|Hemoglobulin concentration|3|||
125514294|NCT00666835|451513319|FG000|Overall Study|Planned operation|2|||
125514295|NCT00666835|451513320|FG001|Overall Study|Planned operation|0|||
125514296|NCT00666835|451513319|FG000|Overall Study|Physician Decision|1|||
125514297|NCT00666835|451513320|FG001|Overall Study|Physician Decision|2|||
125514298|NCT01126879|451513321|FG000|Overall Study|Progressive Disease|3|||
125514299|NCT01126879|451513322|FG001|Overall Study|Progressive Disease|1|||
125514300|NCT01126879|451513321|FG000|Overall Study|Withdrawal by Subject|1|||
125514301|NCT01126879|451513322|FG001|Overall Study|Withdrawal by Subject|0|||
125514302|NCT01126879|451513321|FG000|Overall Study|Adverse Event|0|||
125514303|NCT01126879|451513322|FG001|Overall Study|Adverse Event|1|||
125514304|NCT01126879|451513321|FG000|Overall Study|Physician Decision|1|||
125514305|NCT01126879|451513322|FG001|Overall Study|Physician Decision|0|||
125514306|NCT03319719|451513323|FG000|Overall Study|Lost to Follow-up|1|||
125514307|NCT03193216|451513327|FG000|Overall Study|Lost to Follow-up|1|||
125514308|NCT03193216|451513328|FG001|Overall Study|Lost to Follow-up|0|||
125514309|NCT03193216|451513327|FG000|Overall Study|Withdrawal by Subject|5|||
125514310|NCT03193216|451513328|FG001|Overall Study|Withdrawal by Subject|0|||
125514311|NCT03193216|451513327|FG000|Overall Study|Physician Decision|4|||
125514312|NCT03193216|451513328|FG001|Overall Study|Physician Decision|0|||
125514313|NCT02236598|451513332|FG000|Overall Study|Adverse Event|0|||
125514314|NCT02236598|451513333|FG001|Overall Study|Adverse Event|1|||
125514315|NCT02236598|451513332|FG000|Overall Study|Withdrawal by Subject|0|||
125514316|NCT02236598|451513333|FG001|Overall Study|Withdrawal by Subject|1|||
125514317|NCT01264887|451513335|FG000|Overall Study|Adverse Event|5|||
125514318|NCT01264887|451513335|FG000|Overall Study|Death|7|||
125514319|NCT01264887|451513335|FG000|Overall Study|Lack of Efficacy|5|||
125514320|NCT01264887|451513335|FG000|Overall Study|Physician Decision|4|||
125514321|NCT01264887|451513335|FG000|Overall Study|Withdrawal by Subject|6|||
125514322|NCT01264887|451513335|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
125514323|NCT01264887|451513335|FG000|Overall Study|Other|2|||
125514324|NCT02959177|451513336|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
125514325|NCT02959177|451513337|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
125514326|NCT02959177|451513338|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
125514327|NCT02959177|451513336|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
125514328|NCT02959177|451513337|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
125514329|NCT02959177|451513338|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
125514330|NCT02959177|451513336|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
125514331|NCT02959177|451513337|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
125514332|NCT02959177|451513338|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
125514333|NCT02959177|451513336|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
125514334|NCT02959177|451513337|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
125514335|NCT02959177|451513338|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
125514336|NCT02959177|451513336|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
125514337|NCT02959177|451513337|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
125514338|NCT02959177|451513338|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
125514339|NCT02959177|451513336|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
125514340|NCT02959177|451513337|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
125514341|NCT02959177|451513338|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
125514342|NCT02959177|451513336|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
125514343|NCT02959177|451513337|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
125514344|NCT02959177|451513338|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
125514345|NCT01061775|451513341|FG000|Overall Study|Physician Decision|2|||
125514346|NCT01061775|451513341|FG000|Overall Study|Lost to Follow-up|1|||
125514347|NCT01313299|451513346|FG000|Overall Study|Adverse Event|3|||
125514348|NCT01313299|451513347|FG001|Overall Study|Adverse Event|1|||
125514349|NCT01313299|451513348|FG002|Overall Study|Adverse Event|1|||
125514350|NCT01313299|451513346|FG000|Overall Study|Lost to Follow-up|1|||
125514351|NCT01313299|451513347|FG001|Overall Study|Lost to Follow-up|0|||
125514352|NCT01313299|451513348|FG002|Overall Study|Lost to Follow-up|0|||
125514353|NCT01313299|451513346|FG000|Overall Study|Protocol Violation|2|||
125514354|NCT01313299|451513347|FG001|Overall Study|Protocol Violation|0|||
125514355|NCT01313299|451513348|FG002|Overall Study|Protocol Violation|0|||
125514356|NCT01313299|451513346|FG000|Overall Study|Withdrawal by Subject|1|||
125514357|NCT01313299|451513347|FG001|Overall Study|Withdrawal by Subject|0|||
125514358|NCT01313299|451513348|FG002|Overall Study|Withdrawal by Subject|2|||
125514359|NCT01313299|451513346|FG000|Overall Study|Family reason and moved out of state|0|||
125514360|NCT01313299|451513347|FG001|Overall Study|Family reason and moved out of state|2|||
125514361|NCT01313299|451513348|FG002|Overall Study|Family reason and moved out of state|0|||
125514362|NCT01313299|451513346|FG000|Overall Study|Lack of subject compliance|0|||
125514363|NCT01313299|451513347|FG001|Overall Study|Lack of subject compliance|0|||
125514364|NCT01313299|451513348|FG002|Overall Study|Lack of subject compliance|1|||
125514365|NCT04089332|451513352|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
125514366|NCT04089332|451513352|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
125514367|NCT04089332|451513352|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
125514368|NCT00050167|451513353|FG000|Overall Study|not eligible not invasive|1|||
125514369|NCT00050167|451513354|FG001|Overall Study|not eligible not invasive|1|||
125514370|NCT02864147|451513358|FG000|Overall Study|Withdrawal by Subject|3|||
125514371|NCT02864147|451513359|FG001|Overall Study|Withdrawal by Subject|2|||
125514372|NCT02864147|451513360|FG002|Overall Study|Withdrawal by Subject|1|||
125514373|NCT02864147|451513358|FG000|Overall Study|Lost to Follow-up|0|||
125514374|NCT02864147|451513359|FG001|Overall Study|Lost to Follow-up|4|||
125514375|NCT02864147|451513360|FG002|Overall Study|Lost to Follow-up|0|||
125514376|NCT02864147|451513358|FG000|Overall Study|Adverse Event|0|||
125514377|NCT02864147|451513359|FG001|Overall Study|Adverse Event|1|||
125514378|NCT02864147|451513360|FG002|Overall Study|Adverse Event|0|||
125514379|NCT02864147|451513358|FG000|Overall Study|Pregnancy|4|||
125514380|NCT02864147|451513359|FG001|Overall Study|Pregnancy|0|||
125514381|NCT02864147|451513360|FG002|Overall Study|Pregnancy|0|||
125514382|NCT02864147|451513358|FG000|Overall Study|Physician Decision|0|||
125514383|NCT02864147|451513359|FG001|Overall Study|Physician Decision|0|||
125514384|NCT02864147|451513360|FG002|Overall Study|Physician Decision|1|||
125514385|NCT02864147|451513358|FG000|Overall Study|Opted for excisional procedures|0|||
125514386|NCT02864147|451513359|FG001|Overall Study|Opted for excisional procedures|0|||
125514387|NCT02864147|451513360|FG002|Overall Study|Opted for excisional procedures|3|||
125514388|NCT00975130|451513361|FG000|Study Part 1|Adverse Event|150|||
125514389|NCT00975130|451513362|FG001|Study Part 1|Adverse Event|0|||
125514390|NCT00975130|451513363|FG002|Study Part 1|Adverse Event|0|||
125514391|NCT00975130|451513361|FG000|Study Part 1|Lost to Follow-up|19|||
125514392|NCT00975130|451513362|FG001|Study Part 1|Lost to Follow-up|0|||
125514393|NCT00975130|451513363|FG002|Study Part 1|Lost to Follow-up|0|||
125514394|NCT00975130|451513361|FG000|Study Part 1|Withdrawal by Subject|61|||
125514395|NCT00975130|451513362|FG001|Study Part 1|Withdrawal by Subject|0|||
125514396|NCT00975130|451513363|FG002|Study Part 1|Withdrawal by Subject|0|||
125514397|NCT00975130|451513361|FG000|Study Part 1|Protocol Violation|13|||
125514398|NCT00975130|451513362|FG001|Study Part 1|Protocol Violation|0|||
125514399|NCT00975130|451513363|FG002|Study Part 1|Protocol Violation|0|||
125514400|NCT00975130|451513361|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
125514401|NCT00975130|451513362|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
125514402|NCT00975130|451513363|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
125514403|NCT00975130|451513361|FG000|Study Part 1|Administrative|4|||
125514404|NCT00975130|451513362|FG001|Study Part 1|Administrative|0|||
125514405|NCT00975130|451513363|FG002|Study Part 1|Administrative|0|||
125514406|NCT00975130|451513361|FG000|Study Part 1|Withdrew Consent|24|||
125514407|NCT00975130|451513362|FG001|Study Part 1|Withdrew Consent|0|||
125514408|NCT00975130|451513363|FG002|Study Part 1|Withdrew Consent|0|||
125514409|NCT00975130|451513361|FG000|Study Part 2|Adverse Event|0|||
125514410|NCT00975130|451513362|FG001|Study Part 2|Adverse Event|14|||
125514411|NCT00975130|451513363|FG002|Study Part 2|Adverse Event|7|||
125514412|NCT00975130|451513361|FG000|Study Part 2|Lost to Follow-up|0|||
125514413|NCT00975130|451513362|FG001|Study Part 2|Lost to Follow-up|0|||
125514414|NCT00975130|451513363|FG002|Study Part 2|Lost to Follow-up|1|||
125514415|NCT00975130|451513361|FG000|Study Part 2|Withdrawal by Subject|0|||
125514416|NCT00975130|451513362|FG001|Study Part 2|Withdrawal by Subject|13|||
125514417|NCT00975130|451513363|FG002|Study Part 2|Withdrawal by Subject|5|||
125514418|NCT00975130|451513361|FG000|Study Part 2|Withdrew Consent|0|||
125514419|NCT00975130|451513362|FG001|Study Part 2|Withdrew Consent|6|||
125514420|NCT00975130|451513363|FG002|Study Part 2|Withdrew Consent|2|||
125514421|NCT00975130|451513361|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
125514422|NCT00975130|451513362|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
125514423|NCT00975130|451513363|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
125514424|NCT00975130|451513361|FG000|Study Part 2|Administrative|0|||
125514425|NCT00975130|451513362|FG001|Study Part 2|Administrative|1|||
125514426|NCT00975130|451513363|FG002|Study Part 2|Administrative|0|||
125514427|NCT00975130|451513361|FG000|Study Part 2|Protocol Violation|0|||
125514428|NCT00975130|451513362|FG001|Study Part 2|Protocol Violation|0|||
125514429|NCT00975130|451513363|FG002|Study Part 2|Protocol Violation|1|||
125514430|NCT00240097|451513364|FG000|Part I|Adverse Event|1|||
125514431|NCT00240097|451513364|FG000|Part I|Death|1|||
125514432|NCT00240097|451513364|FG000|Part I|histology|1|||
125514433|NCT00240097|451513364|FG000|Part I|unevaluable|1|||
125514434|NCT00240097|451513364|FG000|Part II|did not continue from Part I|23|||
125514435|NCT02383927|451513365|FG000|Overall Study|Disease Progression|8|||
125514436|NCT02383927|451513366|FG001|Overall Study|Disease Progression|8|||
125514437|NCT02383927|451513367|FG002|Overall Study|Disease Progression|15|||
125514438|NCT02383927|451513368|FG003|Overall Study|Disease Progression|4|||
125514439|NCT02383927|451513365|FG000|Overall Study|Physician Decision|0|||
125514440|NCT02383927|451513366|FG001|Overall Study|Physician Decision|0|||
125514441|NCT02383927|451513367|FG002|Overall Study|Physician Decision|2|||
125514442|NCT02383927|451513368|FG003|Overall Study|Physician Decision|0|||
125514443|NCT02383927|451513365|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
125514444|NCT02383927|451513366|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
125514445|NCT02383927|451513367|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
125514446|NCT02383927|451513368|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
125514447|NCT02383927|451513365|FG000|Overall Study|Adverse Event|4|||
125514448|NCT02383927|451513366|FG001|Overall Study|Adverse Event|1|||
125514449|NCT02383927|451513367|FG002|Overall Study|Adverse Event|3|||
125514450|NCT02383927|451513368|FG003|Overall Study|Adverse Event|5|||
125514451|NCT02383927|451513365|FG000|Overall Study|Miscellaneous|1|||
125514452|NCT02383927|451513366|FG001|Overall Study|Miscellaneous|0|||
125514453|NCT02383927|451513367|FG002|Overall Study|Miscellaneous|0|||
125514454|NCT02383927|451513368|FG003|Overall Study|Miscellaneous|1|||
125514455|NCT02383927|451513365|FG000|Overall Study|Withdrawal by Subject|0|||
125514456|NCT02383927|451513366|FG001|Overall Study|Withdrawal by Subject|1|||
125514457|NCT02383927|451513367|FG002|Overall Study|Withdrawal by Subject|4|||
125514458|NCT02383927|451513368|FG003|Overall Study|Withdrawal by Subject|0|||
125514459|NCT00734851|451513369|FG000|Overall Study|Withdrawal by Subject|2|||
125514460|NCT00734851|451513369|FG000|Overall Study|Lost to Follow-up|1|||
125514461|NCT00734851|451513369|FG000|Overall Study|Physician Decision|18|||
125514462|NCT00818519|451513370|FG000|Overall Study|Adverse Event|2|||
125514463|NCT00818519|451513371|FG001|Overall Study|Adverse Event|2|||
125514464|NCT00818519|451513370|FG000|Overall Study|Lost to Follow-up|4|||
125514465|NCT00818519|451513371|FG001|Overall Study|Lost to Follow-up|6|||
125514466|NCT00818519|451513370|FG000|Overall Study|Protocol Violation|2|||
125514467|NCT00818519|451513371|FG001|Overall Study|Protocol Violation|1|||
125514468|NCT00818519|451513370|FG000|Overall Study|Pregnancy|0|||
125514469|NCT00818519|451513371|FG001|Overall Study|Pregnancy|1|||
125514470|NCT00818519|451513370|FG000|Overall Study|Withdrawal by Subject|4|||
125514471|NCT00818519|451513371|FG001|Overall Study|Withdrawal by Subject|9|||
125514472|NCT00818519|451513370|FG000|Overall Study|participant recovered completely|1|||
125514473|NCT00818519|451513371|FG001|Overall Study|participant recovered completely|0|||
125514474|NCT00818519|451513370|FG000|Overall Study|participant will leave for long tme|1|||
125514475|NCT00818519|451513371|FG001|Overall Study|participant will leave for long tme|0|||
125514476|NCT03562117|451513374|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
125514477|NCT03562117|451513375|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
125514478|NCT03562117|451513376|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
125514479|NCT01294358|451513377|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
125514480|NCT01294358|451513378|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
125514481|NCT01294358|451513379|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
125514482|NCT01294358|451513380|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
125514483|NCT01294358|451513381|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
125514484|NCT01294358|451513377|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
125514485|NCT01294358|451513378|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
125514486|NCT01294358|451513379|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
125514487|NCT01294358|451513380|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
125514488|NCT01294358|451513381|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
125514489|NCT01294358|451513377|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
125514490|NCT01294358|451513378|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
125514491|NCT01294358|451513379|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
125514492|NCT01294358|451513380|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
125514493|NCT01294358|451513381|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
125514494|NCT01294358|451513377|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
125514495|NCT01294358|451513378|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
125514496|NCT01294358|451513379|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
125514497|NCT01294358|451513380|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
125514498|NCT01294358|451513381|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
125514499|NCT03613454|451513382|FG000|Overall Study|Protocol Violation|1|||
125514500|NCT03613454|451513383|FG001|Overall Study|Protocol Violation|0|||
125514501|NCT03613454|451513382|FG000|Overall Study|Protocol Violation|0|||
125514502|NCT03613454|451513383|FG001|Overall Study|Protocol Violation|1|||
125514503|NCT03356145|451513384|FG000|Overall Study|Withdrawal by Subject|2|||
125514504|NCT03356145|451513385|FG001|Overall Study|Withdrawal by Subject|1|||
125514505|NCT03356145|451513384|FG000|Overall Study|Did not meet inclusion criteria|1|||
125514506|NCT03356145|451513385|FG001|Overall Study|Did not meet inclusion criteria|0|||
125514507|NCT02963922|451513386|FG000|Overall Study|Adverse Event|15|||
125514508|NCT02963922|451513387|FG001|Overall Study|Adverse Event|6|||
125514509|NCT02963922|451513386|FG000|Overall Study|Protocol deviation|6|||
125514510|NCT02963922|451513387|FG001|Overall Study|Protocol deviation|6|||
125514511|NCT02963922|451513386|FG000|Overall Study|Lack of Efficacy|1|||
125514512|NCT02963922|451513387|FG001|Overall Study|Lack of Efficacy|1|||
125514513|NCT02963922|451513386|FG000|Overall Study|Lost to Follow-up|2|||
125514514|NCT02963922|451513387|FG001|Overall Study|Lost to Follow-up|3|||
125514515|NCT02963922|451513386|FG000|Overall Study|Other|8|||
125514516|NCT02963922|451513387|FG001|Overall Study|Other|14|||
125514517|NCT00655668|451513401|FG000|Overall Study|Adverse Event|6|||
125514518|NCT00655668|451513401|FG000|Overall Study|Death|5|||
125514519|NCT00655668|451513401|FG000|Overall Study|Disease Progression|27|||
125514520|NCT00655668|451513401|FG000|Overall Study|Study Terminated|9|||
125514521|NCT00655668|451513401|FG000|Overall Study|Other|1|||
125514522|NCT00655668|451513401|FG000|Overall Study|New Lymphoma Treatment Started|4|||
125514523|NCT00655668|451513401|FG000|Overall Study|Withdrawal by Subject|2|||
125514524|NCT03740919|451513402|FG000|Lead-in Period|Lost to Follow-up|1|||
125514525|NCT03740919|451513403|FG001|Lead-in Period|Lost to Follow-up|0|||
125514526|NCT03740919|451513404|FG002|Lead-in Period|Lost to Follow-up|0|||
125514527|NCT03740919|451513405|FG003|Lead-in Period|Lost to Follow-up|0|||
125514528|NCT03740919|451513402|FG000|Lead-in Period|Physician Decision|2|||
125514529|NCT03740919|451513403|FG001|Lead-in Period|Physician Decision|0|||
125514530|NCT03740919|451513404|FG002|Lead-in Period|Physician Decision|0|||
125514531|NCT03740919|451513405|FG003|Lead-in Period|Physician Decision|0|||
125514532|NCT03740919|451513402|FG000|Lead-in Period|Protocol Violation|1|||
125514533|NCT03740919|451513403|FG001|Lead-in Period|Protocol Violation|0|||
125514534|NCT03740919|451513404|FG002|Lead-in Period|Protocol Violation|0|||
125514535|NCT03740919|451513405|FG003|Lead-in Period|Protocol Violation|0|||
125514536|NCT03740919|451513402|FG000|Lead-in Period|Withdrawal by Subject|10|||
125514537|NCT03740919|451513403|FG001|Lead-in Period|Withdrawal by Subject|0|||
125514538|NCT03740919|451513404|FG002|Lead-in Period|Withdrawal by Subject|0|||
125514539|NCT03740919|451513405|FG003|Lead-in Period|Withdrawal by Subject|0|||
125514540|NCT03740919|451513402|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
125514541|NCT03740919|451513403|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
125514542|NCT03740919|451513404|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
125514543|NCT03740919|451513405|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
125514544|NCT03740919|451513402|FG000|Lead-in Period|Study Task Too Burdensome|1|||
125514545|NCT03740919|451513403|FG001|Lead-in Period|Study Task Too Burdensome|0|||
125514546|NCT03740919|451513404|FG002|Lead-in Period|Study Task Too Burdensome|0|||
125514547|NCT03740919|451513405|FG003|Lead-in Period|Study Task Too Burdensome|0|||
125514548|NCT03740919|451513402|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
125514549|NCT03740919|451513403|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
125514550|NCT03740919|451513404|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
125514551|NCT03740919|451513405|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
125514552|NCT03740919|451513402|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
125514553|NCT03740919|451513403|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
125514554|NCT03740919|451513404|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
125514555|NCT03740919|451513405|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
125514556|NCT03740919|451513402|FG000|Treatment Period|Adverse Event|0|||
125514557|NCT03740919|451513403|FG001|Treatment Period|Adverse Event|0|||
125514558|NCT03740919|451513404|FG002|Treatment Period|Adverse Event|2|||
125514559|NCT03740919|451513405|FG003|Treatment Period|Adverse Event|0|||
125514560|NCT03740919|451513402|FG000|Treatment Period|Protocol Violation|0|||
125514561|NCT03740919|451513403|FG001|Treatment Period|Protocol Violation|1|||
125514562|NCT03740919|451513404|FG002|Treatment Period|Protocol Violation|0|||
125514563|NCT03740919|451513405|FG003|Treatment Period|Protocol Violation|0|||
125514564|NCT03740919|451513402|FG000|Treatment Period|Withdrawal by Subject|0|||
125514565|NCT03740919|451513403|FG001|Treatment Period|Withdrawal by Subject|7|||
125514566|NCT03740919|451513404|FG002|Treatment Period|Withdrawal by Subject|6|||
125514567|NCT03740919|451513405|FG003|Treatment Period|Withdrawal by Subject|2|||
125514568|NCT03740919|451513402|FG000|Treatment Period|Terminated by Sponsor|0|||
125514569|NCT03740919|451513403|FG001|Treatment Period|Terminated by Sponsor|1|||
125514570|NCT03740919|451513404|FG002|Treatment Period|Terminated by Sponsor|0|||
125514571|NCT03740919|451513405|FG003|Treatment Period|Terminated by Sponsor|0|||
125514572|NCT03740919|451513402|FG000|Treatment Period|Issue with Insulin Pump|0|||
125514573|NCT03740919|451513403|FG001|Treatment Period|Issue with Insulin Pump|1|||
125514574|NCT03740919|451513404|FG002|Treatment Period|Issue with Insulin Pump|0|||
125514575|NCT03740919|451513405|FG003|Treatment Period|Issue with Insulin Pump|0|||
125514576|NCT03740919|451513402|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
125514577|NCT03740919|451513403|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
125514578|NCT03740919|451513404|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
125514579|NCT03740919|451513405|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
125514580|NCT03740919|451513402|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
125514581|NCT03740919|451513403|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
125514582|NCT03740919|451513404|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
125514583|NCT03740919|451513405|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
125514584|NCT03740919|451513402|FG000|Treatment Period|Not Completing Diary|0|||
125514585|NCT03740919|451513403|FG001|Treatment Period|Not Completing Diary|0|||
125514586|NCT03740919|451513404|FG002|Treatment Period|Not Completing Diary|1|||
125514587|NCT03740919|451513405|FG003|Treatment Period|Not Completing Diary|0|||
125514588|NCT03740919|451513402|FG000|Treatment Period|Insulin Painful to Participant|0|||
125514589|NCT03740919|451513403|FG001|Treatment Period|Insulin Painful to Participant|0|||
125514590|NCT03740919|451513404|FG002|Treatment Period|Insulin Painful to Participant|1|||
125514591|NCT03740919|451513405|FG003|Treatment Period|Insulin Painful to Participant|0|||
125514592|NCT03873038|451513408|FG000|Part 2|Withdrawal by Subject|0|||
125514593|NCT03873038|451513409|FG001|Part 2|Withdrawal by Subject|0|||
125514594|NCT03873038|451513410|FG002|Part 2|Withdrawal by Subject|0|||
125514595|NCT03873038|451513411|FG003|Part 2|Withdrawal by Subject|0|||
125514596|NCT03873038|451513412|FG004|Part 2|Withdrawal by Subject|0|||
125514597|NCT03873038|451513413|FG005|Part 2|Withdrawal by Subject|1|||
125514598|NCT03873038|451513408|FG000|Part 2|Unknon|0|||
125514599|NCT03873038|451513409|FG001|Part 2|Unknon|0|||
125514600|NCT03873038|451513410|FG002|Part 2|Unknon|0|||
125514601|NCT03873038|451513411|FG003|Part 2|Unknon|0|||
125514602|NCT03873038|451513412|FG004|Part 2|Unknon|1|||
125514603|NCT03873038|451513413|FG005|Part 2|Unknon|0|||
125514604|NCT00595764|451513415|FG000|Overall Study|Protocol Violation|24|||
125514605|NCT00595764|451513416|FG001|Overall Study|Protocol Violation|19|||
125514606|NCT00595764|451513415|FG000|Overall Study|Missed Medication >1 week|10|||
125514607|NCT00595764|451513416|FG001|Overall Study|Missed Medication >1 week|17|||
125514608|NCT00595764|451513415|FG000|Overall Study|Missed 3 PM visits|1|||
125514609|NCT00595764|451513416|FG001|Overall Study|Missed 3 PM visits|7|||
125514610|NCT00595764|451513415|FG000|Overall Study|Withdrawal by Subject|4|||
125514611|NCT00595764|451513416|FG001|Overall Study|Withdrawal by Subject|0|||
125514612|NCT04222088|451513417|FG000|Overall Study|Lost to Follow-up|5|||
125514613|NCT04222088|451513418|FG001|Overall Study|Lost to Follow-up|1|||
125514614|NCT04222088|451513417|FG000|Overall Study|Withdrawal by Subject|4|||
125514615|NCT04222088|451513418|FG001|Overall Study|Withdrawal by Subject|0|||
125514616|NCT01071317|451513419|FG000|Overall Study|Lost to Follow-up|2|||
125514617|NCT01071317|451513420|FG001|Overall Study|Lost to Follow-up|2|||
125514618|NCT01332318|451513422|FG000|Overall Study|Adverse Event|0|||
125514619|NCT01332318|451513423|FG001|Overall Study|Adverse Event|3|||
125514620|NCT01332318|451513424|FG002|Overall Study|Adverse Event|0|||
125514621|NCT01332318|451513425|FG003|Overall Study|Adverse Event|0|||
125514622|NCT01332318|451513422|FG000|Overall Study|Withdrawal by Subject|1|||
125514623|NCT01332318|451513423|FG001|Overall Study|Withdrawal by Subject|1|||
125514624|NCT01332318|451513424|FG002|Overall Study|Withdrawal by Subject|0|||
125514625|NCT01332318|451513425|FG003|Overall Study|Withdrawal by Subject|1|||
125514626|NCT01332318|451513422|FG000|Overall Study|Protocol Violation|1|||
125514627|NCT01332318|451513423|FG001|Overall Study|Protocol Violation|0|||
125514628|NCT01332318|451513424|FG002|Overall Study|Protocol Violation|1|||
125514629|NCT01332318|451513425|FG003|Overall Study|Protocol Violation|1|||
125514630|NCT02040532|451513426|FG000|Overall Study|Lost to Follow-up|1|||
125514631|NCT02040532|451513426|FG000|Overall Study|Physician Decision|4|||
125514632|NCT02040532|451513426|FG000|Overall Study|Adverse Event|4|||
125514633|NCT02040532|451513426|FG000|Overall Study|Withdrawal by Subject|3|||
125514634|NCT02820298|451513431|FG000|Overall Study|Withdrawal by Subject|0|||
125514635|NCT02820298|451513432|FG001|Overall Study|Withdrawal by Subject|1|||
125514636|NCT02820298|451513431|FG000|Overall Study|Physician Decision|1|||
125514637|NCT02820298|451513432|FG001|Overall Study|Physician Decision|0|||
125514638|NCT02820298|451513431|FG000|Overall Study|Protocol Violation|0|||
125514639|NCT02820298|451513432|FG001|Overall Study|Protocol Violation|1|||
125514640|NCT01894256|451513433|FG000|Part A|Adverse Event|0|||
125514641|NCT01894256|451513434|FG001|Part A|Adverse Event|1|||
125514642|NCT01894256|451513435|FG002|Part A|Adverse Event|0|||
125514643|NCT01894256|451513433|FG000|Part B|Death|0|||
125514644|NCT01894256|451513434|FG001|Part B|Death|1|||
125514645|NCT01894256|451513435|FG002|Part B|Death|1|||
125514646|NCT01894256|451513433|FG000|Part B|Withdrawal by Subject|0|||
125514647|NCT01894256|451513434|FG001|Part B|Withdrawal by Subject|1|||
125514648|NCT01894256|451513435|FG002|Part B|Withdrawal by Subject|0|||
125514649|NCT01894256|451513433|FG000|Part B|Lack of Efficacy|15|||
125514650|NCT01894256|451513434|FG001|Part B|Lack of Efficacy|12|||
125514651|NCT01894256|451513435|FG002|Part B|Lack of Efficacy|13|||
125514652|NCT01780584|451513436|FG000|Overall Study|Death|1|||
125514653|NCT01780584|451513437|FG001|Overall Study|Death|0|||
125514654|NCT01780584|451513438|FG002|Overall Study|Death|1|||
125514655|NCT01780584|451513436|FG000|Overall Study|Adverse Event|0|||
125514656|NCT01780584|451513437|FG001|Overall Study|Adverse Event|1|||
125514657|NCT01780584|451513438|FG002|Overall Study|Adverse Event|0|||
125514658|NCT01780584|451513436|FG000|Overall Study|Protocol Violation|0|||
125514659|NCT01780584|451513437|FG001|Overall Study|Protocol Violation|0|||
125514660|NCT01780584|451513438|FG002|Overall Study|Protocol Violation|1|||
125514661|NCT01679613|451513444|FG000|Overall Study|other than stated above|0|||
125514662|NCT01679613|451513445|FG001|Overall Study|other than stated above|1|||
125514663|NCT01679613|451513446|FG002|Overall Study|other than stated above|2|||
125514664|NCT01679613|451513447|FG003|Overall Study|other than stated above|2|||
125514665|NCT04783519|451513448|FG000|Overall Study|Withdrawal by Subject|2|||
125514666|NCT04783519|451513449|FG001|Overall Study|Withdrawal by Subject|7|||
125514667|NCT04783519|451513450|FG002|Overall Study|Withdrawal by Subject|3|||
125514668|NCT04783519|451513448|FG000|Overall Study|Lost to Follow-up|9|||
125514669|NCT04783519|451513449|FG001|Overall Study|Lost to Follow-up|7|||
125514670|NCT04783519|451513450|FG002|Overall Study|Lost to Follow-up|6|||
125514671|NCT00727259|451513451|FG000|Overall Study|Not all questionnaires completed|1055|||
125514672|NCT01021683|451513452|FG000|Overall Study|Lack of Efficacy|12|||
125514673|NCT01021683|451513452|FG000|Overall Study|Recovery of neutrophil count|51|||
125514674|NCT01021683|451513452|FG000|Overall Study|Other|8|||
125514675|NCT00645099|451513453|FG000|Overall Study|Lack of Efficacy|15|||
125514676|NCT00645099|451513454|FG001|Overall Study|Lack of Efficacy|6|||
125514677|NCT00645099|451513453|FG000|Overall Study|Withdrawal by Subject|30|||
125514678|NCT00645099|451513454|FG001|Overall Study|Withdrawal by Subject|22|||
125514679|NCT00645099|451513453|FG000|Overall Study|Lost to Follow-up|6|||
125514680|NCT00645099|451513454|FG001|Overall Study|Lost to Follow-up|4|||
125514681|NCT00645099|451513453|FG000|Overall Study|Adverse Event|11|||
125514682|NCT00645099|451513454|FG001|Overall Study|Adverse Event|5|||
125514683|NCT00645099|451513453|FG000|Overall Study|Other|9|||
125514684|NCT00645099|451513454|FG001|Overall Study|Other|5|||
125514685|NCT01201915|451513455|FG000|Overall Study|Adverse Event|2|||
125514686|NCT01201915|451513456|FG001|Overall Study|Adverse Event|1|||
125514687|NCT01201915|451513457|FG002|Overall Study|Adverse Event|1|||
125514688|NCT01201915|451513455|FG000|Overall Study|Lost to Follow-up|0|||
125514689|NCT01201915|451513456|FG001|Overall Study|Lost to Follow-up|4|||
125514690|NCT01201915|451513457|FG002|Overall Study|Lost to Follow-up|0|||
125514691|NCT01201915|451513455|FG000|Overall Study|Physician Decision|3|||
125514692|NCT01201915|451513456|FG001|Overall Study|Physician Decision|0|||
125514693|NCT01201915|451513457|FG002|Overall Study|Physician Decision|0|||
125514694|NCT01201915|451513455|FG000|Overall Study|Subject Decision|3|||
125514695|NCT01201915|451513456|FG001|Overall Study|Subject Decision|3|||
125514696|NCT01201915|451513457|FG002|Overall Study|Subject Decision|5|||
125514697|NCT01201915|451513455|FG000|Overall Study|Target Lesion Progression|0|||
125514698|NCT01201915|451513456|FG001|Overall Study|Target Lesion Progression|3|||
125514699|NCT01201915|451513457|FG002|Overall Study|Target Lesion Progression|0|||
125514700|NCT01772147|451514869|FG000|Overall Study|Adverse Event|13|||
125514701|NCT01772147|451514870|FG001|Overall Study|Adverse Event|10|||
125514702|NCT01772147|451514871|FG002|Overall Study|Adverse Event|6|||
125514703|NCT01772147|451514869|FG000|Overall Study|Withdrew Consent|7|||
125514704|NCT01772147|451514870|FG001|Overall Study|Withdrew Consent|8|||
125514705|NCT01772147|451514871|FG002|Overall Study|Withdrew Consent|4|||
125514706|NCT01772147|451514869|FG000|Overall Study|Lost to Follow-up|1|||
125514707|NCT01772147|451514870|FG001|Overall Study|Lost to Follow-up|0|||
125514708|NCT01772147|451514871|FG002|Overall Study|Lost to Follow-up|1|||
125514709|NCT01772147|451514869|FG000|Overall Study|Protocol Deviation|2|||
125514710|NCT01772147|451514870|FG001|Overall Study|Protocol Deviation|1|||
125514711|NCT01772147|451514871|FG002|Overall Study|Protocol Deviation|1|||
125514712|NCT01772147|451514869|FG000|Overall Study|Lack of Efficacy|8|||
125514713|NCT01772147|451514870|FG001|Overall Study|Lack of Efficacy|6|||
125514714|NCT01772147|451514871|FG002|Overall Study|Lack of Efficacy|6|||
125514715|NCT00796614|451514876|FG000|Overall Study|Adverse Event|1|||
125514716|NCT00796614|451514877|FG001|Overall Study|Adverse Event|2|||
125514717|NCT00796614|451514878|FG002|Overall Study|Adverse Event|0|||
125514718|NCT00796614|451514879|FG003|Overall Study|Adverse Event|0|||
125514719|NCT00796614|451514876|FG000|Overall Study|Protocol Violation|0|||
125514720|NCT00796614|451514877|FG001|Overall Study|Protocol Violation|0|||
125514721|NCT00796614|451514878|FG002|Overall Study|Protocol Violation|2|||
125514722|NCT00796614|451514879|FG003|Overall Study|Protocol Violation|0|||
125514723|NCT00796614|451514876|FG000|Overall Study|Lost to Follow-up|2|||
125514724|NCT00796614|451514877|FG001|Overall Study|Lost to Follow-up|2|||
125514725|NCT00796614|451514878|FG002|Overall Study|Lost to Follow-up|1|||
125514726|NCT00796614|451514879|FG003|Overall Study|Lost to Follow-up|0|||
125514727|NCT00796614|451514876|FG000|Overall Study|Withdrawal by Subject|1|||
125514728|NCT00796614|451514877|FG001|Overall Study|Withdrawal by Subject|0|||
125514729|NCT00796614|451514878|FG002|Overall Study|Withdrawal by Subject|0|||
125514730|NCT00796614|451514879|FG003|Overall Study|Withdrawal by Subject|1|||
125514731|NCT00796614|451514876|FG000|Overall Study|Other than stated|1|||
125514732|NCT00796614|451514877|FG001|Overall Study|Other than stated|0|||
125514733|NCT00796614|451514878|FG002|Overall Study|Other than stated|0|||
125514734|NCT00796614|451514879|FG003|Overall Study|Other than stated|0|||
125514735|NCT00509821|451514880|FG000|Study Period 1 (Induction)|Death|0|||
125514736|NCT00509821|451514881|FG001|Study Period 1 (Induction)|Death|1|||
125514737|NCT00509821|451514880|FG000|Study Period 1 (Induction)|Adverse Event|0|||
125514738|NCT00509821|451514881|FG001|Study Period 1 (Induction)|Adverse Event|2|||
125514739|NCT00509821|451514880|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
125514740|NCT00509821|451514881|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
125514741|NCT01816685|451514882|FG000|Overall Study|Lost to Follow-up|7|||
125514742|NCT01816685|451514883|FG001|Overall Study|Lost to Follow-up|9|||
125514743|NCT01816685|451514882|FG000|Overall Study|Surgery Cancelled|3|||
125514744|NCT01816685|451514883|FG001|Overall Study|Surgery Cancelled|2|||
125514745|NCT03449134|451514884|FG000|52-Week Treatment Period|Death|2|||
125514746|NCT03449134|451514885|FG001|52-Week Treatment Period|Death|1|||
125514747|NCT03449134|451514886|FG002|52-Week Treatment Period|Death|0|||
125514748|NCT03449134|451514884|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
125514749|NCT03449134|451514885|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
125514750|NCT03449134|451514886|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
125514751|NCT03449134|451514884|FG000|52-Week Treatment Period|Physician Decision|2|||
125514752|NCT03449134|451514885|FG001|52-Week Treatment Period|Physician Decision|3|||
125514753|NCT03449134|451514886|FG002|52-Week Treatment Period|Physician Decision|3|||
125514754|NCT03449134|451514884|FG000|52-Week Treatment Period|Screen Failure|1|||
125514755|NCT03449134|451514885|FG001|52-Week Treatment Period|Screen Failure|0|||
125514756|NCT03449134|451514886|FG002|52-Week Treatment Period|Screen Failure|1|||
125514757|NCT03449134|451514884|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
125514758|NCT03449134|451514885|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
125514759|NCT03449134|451514886|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
125514760|NCT03449134|451514884|FG000|52-Week Treatment Period|Site Closure|1|||
125514761|NCT03449134|451514885|FG001|52-Week Treatment Period|Site Closure|0|||
125514762|NCT03449134|451514886|FG002|52-Week Treatment Period|Site Closure|0|||
125514763|NCT00957996|451514887|FG000|Overall Study|Death|4|||
125514764|NCT00957996|451514888|FG001|Overall Study|Death|10|||
125514765|NCT00957996|451514887|FG000|Overall Study|Lost to Follow-up|4|||
125514766|NCT00957996|451514888|FG001|Overall Study|Lost to Follow-up|7|||
125514767|NCT00957996|451514887|FG000|Overall Study|Withdrawal by Subject|9|||
125514768|NCT00957996|451514888|FG001|Overall Study|Withdrawal by Subject|2|||
125514769|NCT00957996|451514887|FG000|Overall Study|Adverse Event|2|||
125514770|NCT00957996|451514888|FG001|Overall Study|Adverse Event|1|||
125514771|NCT00957996|451514887|FG000|Overall Study|Physician Decision|1|||
125514772|NCT00957996|451514888|FG001|Overall Study|Physician Decision|1|||
125514773|NCT00957996|451514887|FG000|Overall Study|Influenza-related complication|0|||
125514774|NCT00957996|451514888|FG001|Overall Study|Influenza-related complication|1|||
125514775|NCT00957996|451514887|FG000|Overall Study|Missing|1|||
125514776|NCT00957996|451514888|FG001|Overall Study|Missing|0|||
125514777|NCT00957996|451514887|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
125514778|NCT00957996|451514888|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
125514779|NCT01960348|451514891|FG000|Overall Study|Adverse event, not serious|2|||
125514780|NCT01960348|451514892|FG001|Overall Study|Adverse event, not serious|2|||
125514781|NCT01960348|451514891|FG000|Overall Study|Adverse event, serious fatal|6|||
125514782|NCT01960348|451514892|FG001|Overall Study|Adverse event, serious fatal|5|||
125514783|NCT01960348|451514891|FG000|Overall Study|Adverse event, serious non-fatal|0|||
125514784|NCT01960348|451514892|FG001|Overall Study|Adverse event, serious non-fatal|3|||
125514785|NCT01960348|451514891|FG000|Overall Study|Withdrawal by Subject|1|||
125514786|NCT01960348|451514892|FG001|Overall Study|Withdrawal by Subject|11|||
125514787|NCT01960348|451514891|FG000|Overall Study|Physician Decision|0|||
125514788|NCT01960348|451514892|FG001|Overall Study|Physician Decision|1|||
125514789|NCT01960348|451514891|FG000|Overall Study|Protocol Violation|1|||
125514790|NCT01960348|451514892|FG001|Overall Study|Protocol Violation|0|||
125514791|NCT01580995|451514893|FG000|Overall Study|Lost to Follow-up|2|||
125514792|NCT01580995|451514894|FG001|Overall Study|Lost to Follow-up|2|||
125514793|NCT00275301|451514895|FG000|Overall Study|Adverse Event|5|||
125514794|NCT02561078|451514898|FG000|Overall Study|Adverse Event|5|||
125514795|NCT02561078|451514899|FG001|Overall Study|Adverse Event|2|||
125514796|NCT02561078|451514898|FG000|Overall Study|Death|2|||
125514797|NCT02561078|451514899|FG001|Overall Study|Death|1|||
125514798|NCT02561078|451514898|FG000|Overall Study|Lost to Follow-up|2|||
125514799|NCT02561078|451514899|FG001|Overall Study|Lost to Follow-up|6|||
125514800|NCT02561078|451514898|FG000|Overall Study|Non-Compliance with Study Drug|6|||
125514801|NCT02561078|451514899|FG001|Overall Study|Non-Compliance with Study Drug|3|||
125514802|NCT02561078|451514898|FG000|Overall Study|Physician Decision|2|||
125514803|NCT02561078|451514899|FG001|Overall Study|Physician Decision|3|||
125514804|NCT02561078|451514898|FG000|Overall Study|Withdrawal by Subject|13|||
125514805|NCT02561078|451514899|FG001|Overall Study|Withdrawal by Subject|10|||
125514806|NCT01983462|451514900|FG000|Overall Study|Adverse Event|1|||
125514807|NCT01983462|451514901|FG001|Overall Study|Adverse Event|0|||
125514808|NCT01983462|451514902|FG002|Overall Study|Adverse Event|0|||
125514809|NCT00684203|451514903|FG000|Overall Study|Adverse Event|6|||
125514810|NCT00684203|451514904|FG001|Overall Study|Adverse Event|4|||
125514811|NCT00684203|451514905|FG002|Overall Study|Adverse Event|8|||
125514812|NCT00684203|451514906|FG003|Overall Study|Adverse Event|0|||
125514813|NCT00684203|451514907|FG004|Overall Study|Adverse Event|0|||
125514814|NCT00684203|451514908|FG005|Overall Study|Adverse Event|0|||
125514815|NCT00684203|451514903|FG000|Overall Study|Protocol-defined clinical event|3|||
125514816|NCT00684203|451514904|FG001|Overall Study|Protocol-defined clinical event|1|||
125514817|NCT00684203|451514905|FG002|Overall Study|Protocol-defined clinical event|0|||
125514818|NCT00684203|451514906|FG003|Overall Study|Protocol-defined clinical event|0|||
125514819|NCT00684203|451514907|FG004|Overall Study|Protocol-defined clinical event|0|||
125514820|NCT00684203|451514908|FG005|Overall Study|Protocol-defined clinical event|0|||
125514821|NCT00684203|451514903|FG000|Overall Study|Withdrawal by Subject|0|||
125514822|NCT00684203|451514904|FG001|Overall Study|Withdrawal by Subject|2|||
125514823|NCT00684203|451514905|FG002|Overall Study|Withdrawal by Subject|1|||
125514824|NCT00684203|451514906|FG003|Overall Study|Withdrawal by Subject|0|||
125514825|NCT00684203|451514907|FG004|Overall Study|Withdrawal by Subject|0|||
125514826|NCT00684203|451514908|FG005|Overall Study|Withdrawal by Subject|0|||
125514827|NCT00684203|451514903|FG000|Overall Study|Did not meet protocol eligibility|0|||
125514828|NCT00684203|451514904|FG001|Overall Study|Did not meet protocol eligibility|1|||
125514829|NCT00684203|451514905|FG002|Overall Study|Did not meet protocol eligibility|0|||
125532609|NCT00350727|451580161|FG000|Phase II|Death|0|||
125514830|NCT00684203|451514906|FG003|Overall Study|Did not meet protocol eligibility|0|||
125514831|NCT00684203|451514907|FG004|Overall Study|Did not meet protocol eligibility|0|||
125514832|NCT00684203|451514908|FG005|Overall Study|Did not meet protocol eligibility|0|||
125514833|NCT00719212|451514909|FG000|Overall Study|Death|41|||
125514834|NCT00719212|451514909|FG000|Overall Study|Lost to Follow-up|2|||
125514835|NCT00719212|451514909|FG000|Overall Study|Withdrawal by Subject|1|||
125514836|NCT00508274|451514910|FG000|Overall Study|Adverse Event|5|||
125514837|NCT00508274|451514910|FG000|Overall Study|Death|7|||
125514838|NCT00508274|451514910|FG000|Overall Study|Disease progression|32|||
125514839|NCT00508274|451514910|FG000|Overall Study|Withdrawal by Subject|1|||
125514840|NCT00508274|451514910|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
125514841|NCT00508274|451514910|FG000|Overall Study|Missing|3|||
125514842|NCT03296566|451514911|FG000|Overall Study|Lost to Follow-up|19|||
125514843|NCT03296566|451514912|FG001|Overall Study|Lost to Follow-up|46|||
125514844|NCT03296566|451514911|FG000|Overall Study|Withdrawal by Subject|0|||
125514845|NCT03296566|451514912|FG001|Overall Study|Withdrawal by Subject|3|||
125514846|NCT03924947|451514917|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
125514847|NCT03924947|451514918|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
125514848|NCT03924947|451514919|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
125514849|NCT03924947|451514920|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
125514850|NCT03924947|451514921|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
125514851|NCT03924947|451514922|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
125514852|NCT01631825|451514923|FG000|Overall Study|Adverse Event|42|||
125514853|NCT01631825|451514923|FG000|Overall Study|Lack of Efficacy|7|||
125514854|NCT01631825|451514923|FG000|Overall Study|Withdrawal by Subject|9|||
125514855|NCT01631825|451514923|FG000|Overall Study|Protocol Violation|4|||
125514856|NCT01631825|451514923|FG000|Overall Study|Discontinuation criteria|1|||
125514857|NCT01631825|451514923|FG000|Overall Study|Physician Decision|2|||
125514858|NCT02499835|451514924|FG000|Overall Study|Withdrawal by Subject|1|||
125514859|NCT02499835|451514925|FG001|Overall Study|Withdrawal by Subject|0|||
125514860|NCT02499835|451514926|FG002|Overall Study|Withdrawal by Subject|0|||
125514861|NCT02499835|451514927|FG003|Overall Study|Withdrawal by Subject|1|||
125514862|NCT02499835|451514924|FG000|Overall Study|Physician Decision|0|||
125514863|NCT02499835|451514925|FG001|Overall Study|Physician Decision|3|||
125514864|NCT02499835|451514926|FG002|Overall Study|Physician Decision|18|||
125514865|NCT02499835|451514927|FG003|Overall Study|Physician Decision|7|||
125514866|NCT02499835|451514924|FG000|Overall Study|Adverse Event|0|||
125514867|NCT02499835|451514925|FG001|Overall Study|Adverse Event|0|||
125514868|NCT02499835|451514926|FG002|Overall Study|Adverse Event|0|||
125514869|NCT02499835|451514927|FG003|Overall Study|Adverse Event|1|||
125514870|NCT02499835|451514924|FG000|Overall Study|Disease progression|2|||
125514871|NCT02499835|451514925|FG001|Overall Study|Disease progression|1|||
125514872|NCT02499835|451514926|FG002|Overall Study|Disease progression|0|||
125514873|NCT02499835|451514927|FG003|Overall Study|Disease progression|7|||
125514874|NCT05109117|451514928|FG000|Overall Study|Lost to Follow-up|1|||
125514875|NCT05109117|451514928|FG000|Overall Study|Discontinued for non-compliance|1|||
125514876|NCT03226353|451514929|FG000|Overall Study|Withdrawal by Subject|1|||
125514877|NCT03226353|451514929|FG000|Overall Study|Screen Failure|5|||
125514878|NCT04491006|451514931|FG000|Overall Study|Adverse Event|0|||
125514879|NCT04491006|451514932|FG001|Overall Study|Adverse Event|3|||
125514880|NCT04491006|451514933|FG002|Overall Study|Adverse Event|5|||
125514881|NCT04491006|451514931|FG000|Overall Study|Withdrawal by Subject|1|||
125514882|NCT04491006|451514932|FG001|Overall Study|Withdrawal by Subject|0|||
125514883|NCT04491006|451514933|FG002|Overall Study|Withdrawal by Subject|2|||
125514884|NCT00498433|451514934|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
125514885|NCT00498433|451514935|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
125514886|NCT00498433|451514936|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
125514887|NCT00498433|451514934|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
125514888|NCT00498433|451514935|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
125514889|NCT00498433|451514936|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
125514890|NCT00498433|451514934|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
125514891|NCT00498433|451514935|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
125514892|NCT00498433|451514936|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
125514893|NCT00498433|451514934|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
125514894|NCT00498433|451514935|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
125514895|NCT00498433|451514936|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
125514896|NCT00744796|451514938|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
125514897|NCT02581189|451514943|FG000|Overall Study|Failure to return|36|||
125514898|NCT02581189|451514943|FG000|Overall Study|Withdrew consent|5|||
125514899|NCT02581189|451514943|FG000|Overall Study|Death|3|||
125514900|NCT02581189|451514943|FG000|Overall Study|Insufficient virological response|2|||
125514901|NCT02581189|451514943|FG000|Overall Study|Other, not specified|7|||
125514902|NCT01514864|451514944|FG000|Overall Study|Disease progression|7|||
125514903|NCT01514864|451514945|FG001|Overall Study|Disease progression|5|||
125514904|NCT01514864|451514944|FG000|Overall Study|Study drug toxicity|2|||
125514905|NCT01514864|451514945|FG001|Overall Study|Study drug toxicity|0|||
125514906|NCT02253147|451514947|FG000|Overall Study|Protocol Violation|30|||
125514907|NCT02253147|451514947|FG000|Overall Study|Did not consent to study extension|9|||
125514908|NCT02253147|451514947|FG000|Overall Study|Conditional re-treatment at W52|5|||
125514909|NCT02253147|451514947|FG000|Overall Study|Lost to Follow-up|2|||
125514910|NCT02253147|451514947|FG000|Overall Study|Withdrawal by Subject|1|||
125514911|NCT02254681|451514948|FG000|Overall Study|Lack of Efficacy|6|||
125514912|NCT00797511|451514949|FG000|Overall Study|Withdrawal by Subject|1|||
125514913|NCT00843115|451514950|FG000|Overall Study|Death|4|||
125514914|NCT00843115|451514950|FG000|Overall Study|Adverse Event|30|||
125514915|NCT00843115|451514950|FG000|Overall Study|Lost to Follow-up|4|||
125514916|NCT00843115|451514950|FG000|Overall Study|Withdrawal by Subject|17|||
125514917|NCT00843115|451514950|FG000|Overall Study|Family wanted meds stopped|1|||
125514918|NCT00843115|451514950|FG000|Overall Study|Family does not want continuation|1|||
125514919|NCT00843115|451514950|FG000|Overall Study|Patient forgot to take meds|1|||
125514920|NCT00843115|451514950|FG000|Overall Study|Does not meet entrance criteria|1|||
125514921|NCT00843115|451514950|FG000|Overall Study|Physician Decision|1|||
125514922|NCT00843115|451514950|FG000|Overall Study|Family discontinued meds|1|||
125514923|NCT00843115|451514950|FG000|Overall Study|patient took for 2 days then stopped|1|||
125514924|NCT00843115|451514950|FG000|Overall Study|patient never took the medication|1|||
125514925|NCT00843115|451514950|FG000|Overall Study|hospitalized due to deterioration|1|||
125514926|NCT00843115|451514950|FG000|Overall Study|week 12 not done|1|||
125514927|NCT00843115|451514950|FG000|Overall Study|Syndrome De Glissement|1|||
125514928|NCT02621047|451514951|FG000|Overall Study|Adverse Event|0|||
125514929|NCT02621047|451514952|FG001|Overall Study|Adverse Event|0|||
125514930|NCT02621047|451514953|FG002|Overall Study|Adverse Event|1|||
125514931|NCT01951261|451514954|FG000|Overall Study|Death|1|||
125514932|NCT01951261|451514955|FG001|Overall Study|Death|0|||
125514933|NCT01951261|451514954|FG000|Overall Study|Lost to Follow-up|4|||
125514934|NCT01951261|451514955|FG001|Overall Study|Lost to Follow-up|3|||
125514935|NCT01951261|451514954|FG000|Overall Study|Protocol Violation|4|||
125514936|NCT01951261|451514955|FG001|Overall Study|Protocol Violation|3|||
125514937|NCT01924806|451514956|FG000|Overall Study|Physician Decision|2|||
125514938|NCT01924806|451514957|FG001|Overall Study|Physician Decision|1|||
125514939|NCT01954771|451514958|FG000|Overall Study|Missing HbA1c of end-point|1|||
125514940|NCT01954771|451514959|FG001|Overall Study|Missing HbA1c of end-point|1|||
125514941|NCT01954771|451514960|FG002|Overall Study|Missing HbA1c of end-point|0|||
125514942|NCT01954771|451514958|FG000|Overall Study|Missing CGMS of end-point|1|||
125514943|NCT01954771|451514959|FG001|Overall Study|Missing CGMS of end-point|1|||
125514944|NCT01954771|451514960|FG002|Overall Study|Missing CGMS of end-point|0|||
125514945|NCT01954771|451514958|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
125514946|NCT01954771|451514959|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
125514947|NCT01954771|451514960|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
125514948|NCT03635775|451514963|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
125514949|NCT03635775|451514964|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
125514950|NCT03635775|451514965|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
125514951|NCT03635775|451514966|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
125514952|NCT00495612|451514969|FG000|Overall Study|Lost to Follow-up|1|||
125514953|NCT00495612|451514970|FG001|Overall Study|Lost to Follow-up|0|||
125514954|NCT00495612|451514969|FG000|Overall Study|Subject's Decision to Withdraw|3|||
125514955|NCT00495612|451514970|FG001|Overall Study|Subject's Decision to Withdraw|0|||
125514956|NCT03640754|451514973|FG000|Overall Study|Withdrawal by Subject|1|||
125514957|NCT03640754|451514974|FG001|Overall Study|Withdrawal by Subject|0|||
125514958|NCT03640754|451514973|FG000|Overall Study|Lost to Follow-up|0|||
125514959|NCT03640754|451514974|FG001|Overall Study|Lost to Follow-up|1|||
125514960|NCT02154516|451514975|FG000|Overall Study|Withdrawal by Subject|0|||
125514961|NCT02154516|451514976|FG001|Overall Study|Withdrawal by Subject|1|||
125514962|NCT02154516|451514975|FG000|Overall Study|Lost to Follow-up|1|||
125514963|NCT02154516|451514976|FG001|Overall Study|Lost to Follow-up|0|||
125514964|NCT02154516|451514975|FG000|Overall Study|Removal/revision of device|1|||
125514965|NCT02154516|451514976|FG001|Overall Study|Removal/revision of device|0|||
125514966|NCT02154516|451514975|FG000|Overall Study|Death|2|||
125514967|NCT02154516|451514976|FG001|Overall Study|Death|1|||
125514968|NCT03406507|451514977|FG000|Extension Period|Lack of Efficacy|0|||
125514969|NCT03406507|451514978|FG001|Extension Period|Lack of Efficacy|1|||
125514970|NCT00663923|451514979|FG000|Overall Study|Lost to Follow-up|2|||
125514971|NCT02965599|451514980|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
125514972|NCT02965599|451514981|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
125514973|NCT00230971|451514982|FG000|Randomization|No study drug administered|3|||
125514974|NCT00230971|451514983|FG001|Randomization|No study drug administered|3|||
125514975|NCT00230971|451514982|FG000|Baseline Participants|Lost to Follow-up|5|||
125514976|NCT00230971|451514983|FG001|Baseline Participants|Lost to Follow-up|12|||
125514977|NCT00230971|451514982|FG000|Baseline Participants|Death|6|||
125514978|NCT00230971|451514983|FG001|Baseline Participants|Death|5|||
125514979|NCT00230971|451514982|FG000|Baseline Participants|Withdrawal by Subject|7|||
125514980|NCT00230971|451514983|FG001|Baseline Participants|Withdrawal by Subject|1|||
125514981|NCT00230971|451514982|FG000|Baseline Participants|Adverse Event|1|||
125514982|NCT00230971|451514983|FG001|Baseline Participants|Adverse Event|0|||
125514983|NCT00230971|451514982|FG000|Baseline Participants|No bacteria observed|1|||
125514984|NCT00230971|451514983|FG001|Baseline Participants|No bacteria observed|0|||
125514985|NCT00230971|451514982|FG000|Baseline Participants|Failure to return|1|||
125514986|NCT00230971|451514983|FG001|Baseline Participants|Failure to return|1|||
125514987|NCT00230971|451514982|FG000|Baseline Participants|Reintervention|1|||
125514988|NCT00230971|451514983|FG001|Baseline Participants|Reintervention|0|||
125514989|NCT00598871|451516386|FG000|Overall Study|Adverse Event|0|||
125514990|NCT00598871|451516387|FG001|Overall Study|Adverse Event|1|||
125514991|NCT02151643|451516392|FG000|Overall Study|Adverse Event|2|||
125514992|NCT02151643|451516393|FG001|Overall Study|Adverse Event|0|||
125514993|NCT02151643|451516394|FG002|Overall Study|Adverse Event|1|||
125514994|NCT02151643|451516395|FG003|Overall Study|Adverse Event|4|||
125514995|NCT02151643|451516396|FG004|Overall Study|Adverse Event|0|||
125514996|NCT02151643|451516392|FG000|Overall Study|Withdrawal by Subject|0|||
125514997|NCT02151643|451516393|FG001|Overall Study|Withdrawal by Subject|1|||
125514998|NCT02151643|451516394|FG002|Overall Study|Withdrawal by Subject|1|||
125514999|NCT02151643|451516395|FG003|Overall Study|Withdrawal by Subject|1|||
125515000|NCT02151643|451516396|FG004|Overall Study|Withdrawal by Subject|1|||
125515001|NCT02151643|451516392|FG000|Overall Study|Hyperphosphataemia|1|||
125515002|NCT02151643|451516393|FG001|Overall Study|Hyperphosphataemia|0|||
125515003|NCT02151643|451516394|FG002|Overall Study|Hyperphosphataemia|0|||
125515004|NCT02151643|451516395|FG003|Overall Study|Hyperphosphataemia|0|||
125515005|NCT02151643|451516396|FG004|Overall Study|Hyperphosphataemia|1|||
125515006|NCT02151643|451516392|FG000|Overall Study|High Ferritin levels|3|||
125515007|NCT02151643|451516393|FG001|Overall Study|High Ferritin levels|3|||
125515008|NCT02151643|451516394|FG002|Overall Study|High Ferritin levels|2|||
125515009|NCT02151643|451516395|FG003|Overall Study|High Ferritin levels|2|||
125515010|NCT02151643|451516396|FG004|Overall Study|High Ferritin levels|1|||
125515011|NCT01084239|451516401|FG000|28-Day Follow-up|Lost to Follow-up|4|||
125515012|NCT01084239|451516402|FG001|28-Day Follow-up|Lost to Follow-up|9|||
125515013|NCT02396953|451516403|FG000|Overall Study|Withdrawal by Subject|0|||
125515014|NCT02396953|451516404|FG001|Overall Study|Withdrawal by Subject|0|||
125515015|NCT02396953|451516405|FG002|Overall Study|Withdrawal by Subject|1|||
125515016|NCT02396953|451516403|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
125515017|NCT02396953|451516404|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
125515018|NCT02396953|451516405|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
125515019|NCT02396953|451516403|FG000|Overall Study|Personal Reasons|1|||
125515020|NCT02396953|451516404|FG001|Overall Study|Personal Reasons|1|||
125515021|NCT02396953|451516405|FG002|Overall Study|Personal Reasons|0|||
125515022|NCT03371485|451516415|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
125515023|NCT03371485|451516415|FG000|2-year Follow-up|Death|5|||
125515024|NCT02204319|451516416|FG000|Overall Study|Pregnancy|1|||
125515025|NCT02204319|451516416|FG000|Overall Study|Withdrawal by Subject|2|||
125515026|NCT04531813|451516421|FG000|Overall Study|Protocol Violation|1|||
125515027|NCT04531813|451516421|FG000|Overall Study|Withdrawal by Subject|1|||
125515028|NCT02171130|451516422|FG000|Overall Study|Death|1|||
125515029|NCT02171130|451516422|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
125515030|NCT02171130|451516422|FG000|Overall Study|Discontinued; Site Termination|5|||
125515031|NCT02171130|451516422|FG000|Overall Study|Withdrawal by Subject|3|||
125515032|NCT02171130|451516422|FG000|Overall Study|Physician Decision|1|||
125515033|NCT02171130|451516422|FG000|Overall Study|Lost to Follow-up|1|||
125515034|NCT02171130|451516422|FG000|Overall Study|Met Exclusion Criteria|1|||
125515035|NCT02853305|451516423|FG000|Overall Study|Death|287|||
125515036|NCT02853305|451516424|FG001|Overall Study|Death|249|||
125515037|NCT02853305|451516425|FG002|Overall Study|Death|300|||
125515038|NCT02853305|451516423|FG000|Overall Study|Withdrawal by Subject|2|||
125515039|NCT02853305|451516424|FG001|Overall Study|Withdrawal by Subject|8|||
125515040|NCT02853305|451516425|FG002|Overall Study|Withdrawal by Subject|3|||
125515041|NCT02853305|451516423|FG000|Overall Study|Transferred to Extension Study|46|||
125515042|NCT02853305|451516424|FG001|Overall Study|Transferred to Extension Study|30|||
125515043|NCT02853305|451516425|FG002|Overall Study|Transferred to Extension Study|25|||
125515044|NCT02853305|451516423|FG000|Overall Study|Did Not Continue on Extension Study|16|||
125515045|NCT02853305|451516424|FG001|Overall Study|Did Not Continue on Extension Study|20|||
125515046|NCT02853305|451516425|FG002|Overall Study|Did Not Continue on Extension Study|24|||
125515047|NCT02381652|451516430|FG000|Overall Study|Withdrawal by Subject|0|||
125515048|NCT02381652|451516431|FG001|Overall Study|Withdrawal by Subject|0|||
125515049|NCT02381652|451516432|FG002|Overall Study|Withdrawal by Subject|1|||
125515050|NCT01340300|451516433|FG000|Overall Study|Lost to Follow-up|3|||
125515051|NCT01340300|451516434|FG001|Overall Study|Lost to Follow-up|0|||
125515052|NCT01340300|451516435|FG002|Overall Study|Lost to Follow-up|5|||
125515053|NCT01340300|451516436|FG003|Overall Study|Lost to Follow-up|10|||
125515054|NCT01340300|451516433|FG000|Overall Study|Withdrawal by Subject|5|||
125515055|NCT01340300|451516434|FG001|Overall Study|Withdrawal by Subject|6|||
125515056|NCT01340300|451516435|FG002|Overall Study|Withdrawal by Subject|6|||
125515057|NCT01340300|451516436|FG003|Overall Study|Withdrawal by Subject|3|||
125515058|NCT01340300|451516433|FG000|Overall Study|Adverse Event|1|||
125515059|NCT01340300|451516434|FG001|Overall Study|Adverse Event|0|||
125515060|NCT01340300|451516435|FG002|Overall Study|Adverse Event|4|||
125515061|NCT01340300|451516436|FG003|Overall Study|Adverse Event|0|||
125515062|NCT01340300|451516433|FG000|Overall Study|Physician Decision|0|||
125515063|NCT01340300|451516434|FG001|Overall Study|Physician Decision|1|||
125515064|NCT01340300|451516435|FG002|Overall Study|Physician Decision|0|||
125515065|NCT01340300|451516436|FG003|Overall Study|Physician Decision|0|||
125515066|NCT01340300|451516433|FG000|Overall Study|Unrelated sickness|0|||
125515067|NCT01340300|451516434|FG001|Overall Study|Unrelated sickness|2|||
125515068|NCT01340300|451516435|FG002|Overall Study|Unrelated sickness|0|||
125515069|NCT01340300|451516436|FG003|Overall Study|Unrelated sickness|1|||
125515070|NCT03544229|451516437|FG000|Overall Study|Adverse Event|1|||
125515071|NCT03544229|451516438|FG001|Overall Study|Adverse Event|0|||
125515072|NCT03544229|451516439|FG002|Overall Study|Adverse Event|1|||
125515073|NCT03544229|451516440|FG003|Overall Study|Adverse Event|0|||
125515074|NCT03544229|451516437|FG000|Overall Study|Protocol Deviation|0|||
125515075|NCT03544229|451516438|FG001|Overall Study|Protocol Deviation|0|||
125515076|NCT03544229|451516439|FG002|Overall Study|Protocol Deviation|1|||
125515077|NCT03544229|451516440|FG003|Overall Study|Protocol Deviation|0|||
125515078|NCT03544229|451516437|FG000|Overall Study|Lost to Follow-up|3|||
125515079|NCT03544229|451516438|FG001|Overall Study|Lost to Follow-up|0|||
125515080|NCT03544229|451516439|FG002|Overall Study|Lost to Follow-up|0|||
125515081|NCT03544229|451516440|FG003|Overall Study|Lost to Follow-up|2|||
125515082|NCT03544229|451516437|FG000|Overall Study|Voluntary Withdrawal|2|||
125515083|NCT03544229|451516438|FG001|Overall Study|Voluntary Withdrawal|1|||
125515084|NCT03544229|451516439|FG002|Overall Study|Voluntary Withdrawal|3|||
125515085|NCT03544229|451516440|FG003|Overall Study|Voluntary Withdrawal|0|||
125515086|NCT03544229|451516437|FG000|Overall Study|Lack of Efficacy|0|||
125515087|NCT03544229|451516438|FG001|Overall Study|Lack of Efficacy|1|||
125515088|NCT03544229|451516439|FG002|Overall Study|Lack of Efficacy|0|||
125515089|NCT03544229|451516440|FG003|Overall Study|Lack of Efficacy|0|||
125515090|NCT04772313|451516441|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
125515091|NCT04772313|451516441|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
125515092|NCT01836198|451516443|FG000|Part A, Period 2|Protocol Violation|0|||
125515093|NCT01836198|451516444|FG001|Part A, Period 2|Protocol Violation|1|||
125515094|NCT01836198|451516445|FG002|Part A, Period 2|Protocol Violation|0|||
125515095|NCT03187353|451516446|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
125515096|NCT03187353|451516447|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
125515097|NCT03187353|451516446|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
125515098|NCT03187353|451516447|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
125515099|NCT03187353|451516446|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
125515100|NCT03187353|451516447|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
125515101|NCT03187353|451516446|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
125515102|NCT03187353|451516447|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
125515103|NCT03187353|451516446|FG000|Washout (2 Weeks)|Adverse Event|2|||
125515104|NCT03187353|451516447|FG001|Washout (2 Weeks)|Adverse Event|0|||
125515105|NCT03187353|451516446|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
125515106|NCT03187353|451516447|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
125515107|NCT02215954|451516448|FG000|Overall Study|Adverse Event|0|||
125515108|NCT02215954|451516449|FG001|Overall Study|Adverse Event|0|||
125515109|NCT02215954|451516450|FG002|Overall Study|Adverse Event|1|||
125515110|NCT02215954|451516448|FG000|Overall Study|Withdrawal by Subject|0|||
125515111|NCT02215954|451516449|FG001|Overall Study|Withdrawal by Subject|0|||
125515112|NCT02215954|451516450|FG002|Overall Study|Withdrawal by Subject|2|||
125515113|NCT02215954|451516448|FG000|Overall Study|Not exposed|1|||
125515114|NCT02215954|451516449|FG001|Overall Study|Not exposed|1|||
125515115|NCT02215954|451516450|FG002|Overall Study|Not exposed|3|||
125515116|NCT02460562|451516452|FG000|Overall Study|Lost to Follow-up|15|||
125515117|NCT02460562|451516453|FG001|Overall Study|Lost to Follow-up|16|||
125515118|NCT03303521|451516454|FG000|Overall Study|Withdrawal by Subject|2|||
125515119|NCT03303521|451516455|FG001|Overall Study|Withdrawal by Subject|0|||
125515120|NCT03303521|451516454|FG000|Overall Study|Death|1|||
125515121|NCT03303521|451516455|FG001|Overall Study|Death|0|||
125515122|NCT03303521|451516454|FG000|Overall Study|Kidney transplantation|0|||
125515123|NCT03303521|451516455|FG001|Overall Study|Kidney transplantation|1|||
125515124|NCT03303521|451516454|FG000|Overall Study|Investigational product discontinuation|0|||
125515125|NCT03303521|451516455|FG001|Overall Study|Investigational product discontinuation|1|||
125515126|NCT03303521|451516454|FG000|Overall Study|Transferred to non-study dialysis center|1|||
125515127|NCT03303521|451516455|FG001|Overall Study|Transferred to non-study dialysis center|0|||
125515128|NCT03303521|451516454|FG000|Overall Study|Non-comliance to study protocol|0|||
125515129|NCT03303521|451516455|FG001|Overall Study|Non-comliance to study protocol|1|||
125515130|NCT03303521|451516454|FG000|Overall Study|Adverse Event|1|||
125515131|NCT03303521|451516455|FG001|Overall Study|Adverse Event|0|||
125515132|NCT01654289|451516456|FG000|Overall Study|Withdrawal by Subject|10|||
125515133|NCT01654289|451516457|FG001|Overall Study|Withdrawal by Subject|8|||
125515134|NCT01654289|451516458|FG002|Overall Study|Withdrawal by Subject|5|||
125515135|NCT01654289|451516456|FG000|Overall Study|Withdrew from intervention only|17|||
125515136|NCT01654289|451516457|FG001|Overall Study|Withdrew from intervention only|20|||
125515137|NCT01654289|451516458|FG002|Overall Study|Withdrew from intervention only|0|||
125515138|NCT04194541|451516459|FG000|Day 1 Through 13|Lost to Follow-up|3|||
125515139|NCT04194541|451516459|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
125515140|NCT04194541|451516459|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
125515141|NCT02642159|451516460|FG000|Overall Study|Randomized but not treated|1|||
125515142|NCT02642159|451516461|FG001|Overall Study|Randomized but not treated|0|||
125515143|NCT02642159|451516460|FG000|Overall Study|Adverse Event|10|||
125515144|NCT02642159|451516461|FG001|Overall Study|Adverse Event|4|||
125515145|NCT02642159|451516460|FG000|Overall Study|Withdrawal by Subject|9|||
125515146|NCT02642159|451516461|FG001|Overall Study|Withdrawal by Subject|1|||
125515147|NCT02642159|451516460|FG000|Overall Study|Poor compliance to study protocol|1|||
125515148|NCT02642159|451516461|FG001|Overall Study|Poor compliance to study protocol|0|||
125515149|NCT02642159|451516460|FG000|Overall Study|Other than specified above|10|||
125515150|NCT02642159|451516461|FG001|Overall Study|Other than specified above|3|||
125515151|NCT03746483|451516462|FG000|Overall Study|Adverse Event|0|||
125515152|NCT03746483|451516463|FG001|Overall Study|Adverse Event|1|||
125515153|NCT03746483|451516462|FG000|Overall Study|Lack of Efficacy|3|||
125515154|NCT03746483|451516463|FG001|Overall Study|Lack of Efficacy|2|||
125515155|NCT03746483|451516462|FG000|Overall Study|Lost to Follow-up|1|||
125515156|NCT03746483|451516463|FG001|Overall Study|Lost to Follow-up|0|||
125515157|NCT03746483|451516462|FG000|Overall Study|Protocol Violation|2|||
125515158|NCT03746483|451516463|FG001|Overall Study|Protocol Violation|0|||
125515159|NCT00187135|451516464|FG000|Visit One|Withdrawal by Subject|1|||
125515160|NCT00187135|451516465|FG001|Visit One|Withdrawal by Subject|0|||
125515161|NCT00187135|451516466|FG002|Visit One|Withdrawal by Subject|0|||
125515162|NCT00187135|451516467|FG003|Visit One|Withdrawal by Subject|0|||
125515163|NCT00187135|451516468|FG004|Visit One|Withdrawal by Subject|0|||
125515164|NCT00187135|451516469|FG005|Visit One|Withdrawal by Subject|1|||
125515165|NCT00187135|451516464|FG000|Visit One|Physician Decision|3|||
125515166|NCT00187135|451516465|FG001|Visit One|Physician Decision|1|||
125515167|NCT00187135|451516466|FG002|Visit One|Physician Decision|0|||
125515168|NCT00187135|451516467|FG003|Visit One|Physician Decision|0|||
125515169|NCT00187135|451516468|FG004|Visit One|Physician Decision|0|||
125515170|NCT00187135|451516469|FG005|Visit One|Physician Decision|1|||
125515171|NCT00187135|451516464|FG000|Visit Two|Death|0|||
125515172|NCT00187135|451516465|FG001|Visit Two|Death|0|||
125515173|NCT00187135|451516466|FG002|Visit Two|Death|0|||
125515174|NCT00187135|451516467|FG003|Visit Two|Death|1|||
125515175|NCT00187135|451516468|FG004|Visit Two|Death|0|||
125515176|NCT00187135|451516469|FG005|Visit Two|Death|1|||
125515177|NCT00187135|451516464|FG000|Visit Two|Physician Decision|1|||
125515178|NCT00187135|451516465|FG001|Visit Two|Physician Decision|0|||
125515179|NCT00187135|451516466|FG002|Visit Two|Physician Decision|0|||
125515180|NCT00187135|451516467|FG003|Visit Two|Physician Decision|0|||
125515181|NCT00187135|451516468|FG004|Visit Two|Physician Decision|0|||
125515182|NCT00187135|451516469|FG005|Visit Two|Physician Decision|0|||
125515183|NCT00187135|451516464|FG000|Visit Two|Withdrawal by Subject|1|||
125515184|NCT00187135|451516465|FG001|Visit Two|Withdrawal by Subject|1|||
125515185|NCT00187135|451516466|FG002|Visit Two|Withdrawal by Subject|1|||
125515186|NCT00187135|451516467|FG003|Visit Two|Withdrawal by Subject|0|||
125515187|NCT00187135|451516468|FG004|Visit Two|Withdrawal by Subject|1|||
125515188|NCT00187135|451516469|FG005|Visit Two|Withdrawal by Subject|1|||
125515189|NCT00187135|451516464|FG000|Visit Two|Study Discontinued|3|||
125515190|NCT00187135|451516465|FG001|Visit Two|Study Discontinued|2|||
125515191|NCT00187135|451516466|FG002|Visit Two|Study Discontinued|1|||
125515192|NCT00187135|451516467|FG003|Visit Two|Study Discontinued|7|||
125515193|NCT00187135|451516468|FG004|Visit Two|Study Discontinued|5|||
125515194|NCT00187135|451516469|FG005|Visit Two|Study Discontinued|6|||
125515195|NCT00187135|451516464|FG000|Visit Three|Death|0|||
125515196|NCT00187135|451516465|FG001|Visit Three|Death|0|||
125515197|NCT00187135|451516466|FG002|Visit Three|Death|1|||
125515198|NCT00187135|451516467|FG003|Visit Three|Death|0|||
125515199|NCT00187135|451516468|FG004|Visit Three|Death|1|||
125515200|NCT00187135|451516469|FG005|Visit Three|Death|0|||
125515201|NCT00187135|451516464|FG000|Visit Three|Withdrawal by Subject|0|||
125515202|NCT00187135|451516465|FG001|Visit Three|Withdrawal by Subject|1|||
125515203|NCT00187135|451516466|FG002|Visit Three|Withdrawal by Subject|1|||
125515204|NCT00187135|451516467|FG003|Visit Three|Withdrawal by Subject|2|||
125515205|NCT00187135|451516468|FG004|Visit Three|Withdrawal by Subject|0|||
125515206|NCT00187135|451516469|FG005|Visit Three|Withdrawal by Subject|0|||
125515207|NCT00187135|451516464|FG000|Visit Three|Study Discontinued|7|||
125515208|NCT00187135|451516465|FG001|Visit Three|Study Discontinued|6|||
125515209|NCT00187135|451516466|FG002|Visit Three|Study Discontinued|7|||
125515210|NCT00187135|451516467|FG003|Visit Three|Study Discontinued|7|||
125515211|NCT00187135|451516468|FG004|Visit Three|Study Discontinued|7|||
125515212|NCT00187135|451516469|FG005|Visit Three|Study Discontinued|6|||
125515213|NCT00297778|451516470|FG000|Overall Study|Adverse Event|16|||
125515214|NCT00297778|451516471|FG001|Overall Study|Adverse Event|10|||
125515215|NCT00297778|451516470|FG000|Overall Study|Withdrawal by Subject|1|||
125515216|NCT00297778|451516471|FG001|Overall Study|Withdrawal by Subject|5|||
125515217|NCT00297778|451516470|FG000|Overall Study|Lack of Efficacy|2|||
125515218|NCT00297778|451516471|FG001|Overall Study|Lack of Efficacy|1|||
125515219|NCT00297778|451516470|FG000|Overall Study|Non-compliant with trial protocol|0|||
125515220|NCT00297778|451516471|FG001|Overall Study|Non-compliant with trial protocol|3|||
125515221|NCT00297778|451516470|FG000|Overall Study|Other|0|||
125515222|NCT00297778|451516471|FG001|Overall Study|Other|1|||
125515223|NCT00679549|451516472|FG000|Overall Study|dropout|2|||
125515224|NCT00679549|451516473|FG001|Overall Study|dropout|4|||
125515225|NCT00679549|451516472|FG000|Overall Study|missing outcome echocardiograms|4|||
125515226|NCT00679549|451516473|FG001|Overall Study|missing outcome echocardiograms|5|||
125515227|NCT03280108|451516474|FG000|Overall Study|Lost to Follow-up|2|||
125515228|NCT03280108|451516475|FG001|Overall Study|Lost to Follow-up|0|||
125515229|NCT02996097|451516476|FG000|Overall Study|Lost to Follow-up|11|||
125515230|NCT02996097|451516477|FG001|Overall Study|Lost to Follow-up|11|||
125515231|NCT02201771|451516478|FG000|Overall Study|Death|3|||
125515232|NCT02201771|451516479|FG001|Overall Study|Death|2|||
125515233|NCT02201771|451516480|FG002|Overall Study|Death|0|||
125515234|NCT02201771|451516478|FG000|Overall Study|Protocol Violation|10|||
125515235|NCT02201771|451516479|FG001|Overall Study|Protocol Violation|8|||
125515236|NCT02201771|451516480|FG002|Overall Study|Protocol Violation|10|||
125515237|NCT01820637|451516481|FG000|Overall Study|Death|2|||
125515238|NCT01820637|451516481|FG000|Overall Study|Withdrawal by Subject|1|||
125515239|NCT00264498|451516482|FG000|Randomized Treatment|Death|0|||
125515240|NCT00264498|451516483|FG001|Randomized Treatment|Death|3|||
125515241|NCT00264498|451516482|FG000|Randomized Treatment|Withdrawal by Subject|0|||
125515242|NCT00264498|451516483|FG001|Randomized Treatment|Withdrawal by Subject|1|||
125515243|NCT00264498|451516482|FG000|Randomized Treatment|Objective disease Progression|13|||
125515244|NCT00264498|451516483|FG001|Randomized Treatment|Objective disease Progression|14|||
125515245|NCT00264498|451516482|FG000|Randomized Treatment|Physician Decision|1|||
125515246|NCT00264498|451516483|FG001|Randomized Treatment|Physician Decision|0|||
125515247|NCT00264498|451516482|FG000|Randomized Treatment|Incorrectly randomized|1|||
125515248|NCT00264498|451516483|FG001|Randomized Treatment|Incorrectly randomized|0|||
125515249|NCT00264498|451516482|FG000|Randomized Treatment|Study Closure|1|||
125515250|NCT00264498|451516483|FG001|Randomized Treatment|Study Closure|0|||
125515251|NCT00264498|451516482|FG000|Randomized Treatment|Protocol Violation|1|||
125515252|NCT00264498|451516483|FG001|Randomized Treatment|Protocol Violation|0|||
125515253|NCT00264498|451516482|FG000|Crossover Treatment|Death|1|||
125515254|NCT00264498|451516483|FG001|Crossover Treatment|Death|3|||
125515255|NCT00264498|451516482|FG000|Crossover Treatment|Objective disease progression|4|||
125515256|NCT00264498|451516483|FG001|Crossover Treatment|Objective disease progression|5|||
125515257|NCT00264498|451516482|FG000|Crossover Treatment|Study closure|0|||
125515258|NCT00264498|451516483|FG001|Crossover Treatment|Study closure|1|||
125515259|NCT00264498|451516482|FG000|Crossover Treatment|Withdrawal by Subject|1|||
125515260|NCT00264498|451516483|FG001|Crossover Treatment|Withdrawal by Subject|0|||
125515261|NCT00583115|451516484|FG000|Overall Study|Death|1|||
125515262|NCT02205476|451516485|FG000|Overall Study|Study termination by Sponsor|7|||
125515263|NCT02205476|451516486|FG001|Overall Study|Study termination by Sponsor|3|||
125515264|NCT02109107|451516487|FG000|Overall Study|Lost to Follow-up|2|||
125515265|NCT00607789|451516493|FG000|Overall Study|Adverse Event|3|||
125515266|NCT00607789|451516494|FG001|Overall Study|Adverse Event|0|||
125515267|NCT00607789|451516493|FG000|Overall Study|Lack of Efficacy|0|||
125515268|NCT00607789|451516494|FG001|Overall Study|Lack of Efficacy|1|||
125515269|NCT00607789|451516493|FG000|Overall Study|Inadequate adherence|3|||
125515270|NCT00607789|451516494|FG001|Overall Study|Inadequate adherence|0|||
125515271|NCT00607789|451516493|FG000|Overall Study|Lost to Follow-up|0|||
125515272|NCT00607789|451516494|FG001|Overall Study|Lost to Follow-up|5|||
125515273|NCT00607789|451516493|FG000|Overall Study|Withdrawal by Subject|1|||
125515274|NCT00607789|451516494|FG001|Overall Study|Withdrawal by Subject|0|||
125515275|NCT01919398|451516495|FG000|Overall Study|Progressive Disease|0|||
125515276|NCT01919398|451516496|FG001|Overall Study|Progressive Disease|0|||
125515277|NCT01919398|451516497|FG002|Overall Study|Progressive Disease|4|||
125515278|NCT02016690|451516499|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
125515279|NCT02016690|451516499|FG000|Overall Study|Excluded from SAS: Duplication|2|||
125515280|NCT02016690|451516499|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
125515281|NCT02016690|451516499|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
125515282|NCT02016690|451516499|FG000|Overall Study|Did not meet inclusion criteria|13|||
125515283|NCT02016690|451516499|FG000|Overall Study|Hospitalized for RSV at study start|3|||
125515284|NCT02515097|451516500|FG000|Overall Study|Lost to Follow-up|4|||
125515285|NCT02515097|451516501|FG001|Overall Study|Lost to Follow-up|2|||
125515286|NCT02515097|451516500|FG000|Overall Study|Withdrawal by Subject|1|||
125515287|NCT02515097|451516501|FG001|Overall Study|Withdrawal by Subject|3|||
125515288|NCT02515097|451516500|FG000|Overall Study|Adverse Event|2|||
125515289|NCT02515097|451516501|FG001|Overall Study|Adverse Event|1|||
125515290|NCT06016127|451516506|FG000|Overall Study|Withdrawal by Subject|4|||
125515291|NCT06016127|451516507|FG001|Overall Study|Withdrawal by Subject|3|||
125515292|NCT03915951|451516510|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
125515293|NCT03915951|451516511|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
125515294|NCT03915951|451516510|FG000|Overall Study|Adverse Event|12|||
125515295|NCT03915951|451516511|FG001|Overall Study|Adverse Event|6|||
125515296|NCT03915951|451516510|FG000|Overall Study|Disease progression (radiological)|17|||
125515297|NCT03915951|451516511|FG001|Overall Study|Disease progression (radiological)|15|||
125515298|NCT03915951|451516510|FG000|Overall Study|Disease progression (clinical)|4|||
125515299|NCT03915951|451516511|FG001|Overall Study|Disease progression (clinical)|1|||
125515300|NCT03915951|451516510|FG000|Overall Study|Patient decision|0|||
125515301|NCT03915951|451516511|FG001|Overall Study|Patient decision|4|||
125515302|NCT03915951|451516510|FG000|Overall Study|Investigator decision|0|||
125515303|NCT03915951|451516511|FG001|Overall Study|Investigator decision|1|||
125515304|NCT03915951|451516510|FG000|Overall Study|Consent withdrawn|1|||
125515305|NCT03915951|451516511|FG001|Overall Study|Consent withdrawn|1|||
125515306|NCT03915951|451516510|FG000|Overall Study|Death|0|||
125515307|NCT03915951|451516511|FG001|Overall Study|Death|3|||
125515308|NCT02269917|451516513|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
125515309|NCT02269917|451516514|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
125515310|NCT02269917|451516515|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
125515311|NCT02269917|451516513|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
125515312|NCT02269917|451516514|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
125515313|NCT02269917|451516515|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
125515314|NCT02269917|451516513|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
125515315|NCT02269917|451516514|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
125515316|NCT02269917|451516515|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
125515317|NCT02269917|451516513|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
125515318|NCT02269917|451516514|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
125515319|NCT02269917|451516515|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
125515320|NCT02269917|451516513|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
125515321|NCT02269917|451516514|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
125515322|NCT02269917|451516515|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
125515323|NCT02269917|451516513|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
125515324|NCT02269917|451516514|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
125515325|NCT02269917|451516515|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
125515326|NCT02269917|451516513|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
125515327|NCT02269917|451516514|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
125515328|NCT02269917|451516515|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
125515329|NCT02269917|451516513|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
125515330|NCT02269917|451516514|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
125515331|NCT02269917|451516515|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
125515332|NCT02269917|451516513|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
125515333|NCT02269917|451516514|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
125515334|NCT02269917|451516515|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
125515335|NCT02269917|451516513|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
125515336|NCT02269917|451516514|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
125515337|NCT02269917|451516515|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
125515338|NCT02269917|451516513|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
125515339|NCT02269917|451516514|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
125515340|NCT02269917|451516515|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
125515341|NCT02269917|451516513|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
125515342|NCT02269917|451516514|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
125515343|NCT02269917|451516515|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
125515344|NCT02269917|451516513|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
125515345|NCT02269917|451516514|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
125515346|NCT02269917|451516515|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
125515347|NCT02269917|451516513|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
125515348|NCT02269917|451516514|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
125515349|NCT02269917|451516515|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
125515350|NCT02269917|451516513|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
125515351|NCT02269917|451516514|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
125515352|NCT02269917|451516515|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
125515353|NCT02269917|451516513|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
125515354|NCT02269917|451516514|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
125515355|NCT02269917|451516515|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
125515356|NCT02865135|451516519|FG000|Overall Study|Death|0|||
125515357|NCT02865135|451516520|FG001|Overall Study|Death|1|||
125515358|NCT02865135|451516521|FG002|Overall Study|Death|0|||
125515359|NCT02865135|451516519|FG000|Overall Study|Progression|6|||
125515360|NCT02865135|451516520|FG001|Overall Study|Progression|2|||
125515361|NCT02865135|451516521|FG002|Overall Study|Progression|2|||
125515362|NCT01121185|451516525|FG000|Overall Study|Not infused|0|||
125515363|NCT01121185|451516526|FG001|Overall Study|Not infused|1|||
125515364|NCT01121185|451516525|FG000|Overall Study|Not transplanted|1|||
125515365|NCT01121185|451516526|FG001|Overall Study|Not transplanted|0|||
125515366|NCT01196741|451516529|FG000|Overall Study|Disease progression|34|||
125515367|NCT01196741|451516530|FG001|Overall Study|Disease progression|14|||
125515368|NCT01196741|451516529|FG000|Overall Study|Adverse Event|10|||
125515369|NCT01196741|451516530|FG001|Overall Study|Adverse Event|6|||
125515370|NCT01196741|451516529|FG000|Overall Study|Serious Adverse Event|3|||
125515371|NCT01196741|451516530|FG001|Overall Study|Serious Adverse Event|1|||
125515372|NCT01196741|451516529|FG000|Overall Study|Dose limiting Adverse Event|2|||
125515373|NCT01196741|451516530|FG001|Overall Study|Dose limiting Adverse Event|1|||
125515374|NCT01196741|451516529|FG000|Overall Study|Withdrawal by Subject|3|||
125515375|NCT01196741|451516530|FG001|Overall Study|Withdrawal by Subject|0|||
125515376|NCT01196741|451516529|FG000|Overall Study|Other reason|3|||
125515377|NCT01196741|451516530|FG001|Overall Study|Other reason|3|||
125515378|NCT01196741|451516529|FG000|Overall Study|Other|3|||
125515379|NCT01196741|451516530|FG001|Overall Study|Other|2|||
125515380|NCT01196741|451516529|FG000|Overall Study|Protocol Violation|2|||
125515381|NCT01196741|451516530|FG001|Overall Study|Protocol Violation|1|||
125515382|NCT02273180|451516531|FG000|Overall Study|Adverse Event|2|||
125515383|NCT02273180|451516532|FG001|Overall Study|Adverse Event|2|||
125515384|NCT02273180|451516531|FG000|Overall Study|Lack of Efficacy|1|||
125515385|NCT02273180|451516532|FG001|Overall Study|Lack of Efficacy|0|||
125515386|NCT02273180|451516531|FG000|Overall Study|Protocol Violation|1|||
125515387|NCT02273180|451516532|FG001|Overall Study|Protocol Violation|7|||
125515388|NCT02273180|451516531|FG000|Overall Study|Randomized but not treated|1|||
125515389|NCT02273180|451516532|FG001|Overall Study|Randomized but not treated|0|||
125515390|NCT02273180|451516531|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
125515391|NCT02273180|451516532|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
125515392|NCT02273180|451516531|FG000|Overall Study|Other than specified above|21|||
125515393|NCT02273180|451516532|FG001|Overall Study|Other than specified above|10|||
125515394|NCT00509925|451516533|FG000|Overall Study|Personal reasons|0|||
125515395|NCT00509925|451516534|FG001|Overall Study|Personal reasons|1|||
125515396|NCT03302559|451516537|FG000|Overall Study|Adverse Event|2|||
125515397|NCT03302559|451516537|FG000|Overall Study|Lost to Follow-up|1|||
125515398|NCT03302559|451516537|FG000|Overall Study|Withdrew Consent|3|||
125515399|NCT02972242|451518737|FG000|Overall Study|Withdrawal by Subject|1|||
125515400|NCT02972242|451518738|FG001|Overall Study|Withdrawal by Subject|0|||
125515401|NCT04572997|451518739|FG000|Overall Study|Adverse Event|1|||
125515402|NCT02956278|451518740|FG000|Overall Study|Withdrawal by Subject|6|||
125515403|NCT02956278|451518741|FG001|Overall Study|Withdrawal by Subject|2|||
125515404|NCT02956278|451518742|FG002|Overall Study|Withdrawal by Subject|0|||
125515405|NCT00740597|451518751|FG000|Overall Study|insurance would not cover treatment|1|||
125515406|NCT00552513|451518755|FG000|Overall Study|Lost to Follow-up|5|||
125515407|NCT00552513|451518756|FG001|Overall Study|Lost to Follow-up|1|||
125515408|NCT02720185|451518757|FG000|Overall Study|Lost to Follow-up|1|||
125515409|NCT01157351|451518758|FG000|Overall Study|Adverse Event|5|||
125515410|NCT01157351|451518759|FG001|Overall Study|Adverse Event|4|||
125515411|NCT01157351|451518758|FG000|Overall Study|Death|1|||
125515412|NCT01157351|451518759|FG001|Overall Study|Death|0|||
125515413|NCT01157351|451518758|FG000|Overall Study|Lost to Follow-up|53|||
125515414|NCT01157351|451518759|FG001|Overall Study|Lost to Follow-up|55|||
125515415|NCT01157351|451518758|FG000|Overall Study|Withdrawal by Subject|37|||
125515416|NCT01157351|451518759|FG001|Overall Study|Withdrawal by Subject|27|||
125515417|NCT01157351|451518758|FG000|Overall Study|Physician Decision|5|||
125515418|NCT01157351|451518759|FG001|Overall Study|Physician Decision|4|||
125515419|NCT01157351|451518758|FG000|Overall Study|Protocol Violation|0|||
125515420|NCT01157351|451518759|FG001|Overall Study|Protocol Violation|1|||
125515421|NCT01157351|451518758|FG000|Overall Study|Other|32|||
125515422|NCT01157351|451518759|FG001|Overall Study|Other|36|||
125515423|NCT01157351|451518758|FG000|Overall Study|Noncompliance with Study Drug|0|||
125515424|NCT01157351|451518759|FG001|Overall Study|Noncompliance with Study Drug|3|||
125515425|NCT01157351|451518758|FG000|Overall Study|Randomized but not Treated|4|||
125515426|NCT01157351|451518759|FG001|Overall Study|Randomized but not Treated|2|||
125515427|NCT03418493|451518760|FG000|Overall Study|Adverse Event|1|||
125515428|NCT03418493|451518761|FG001|Overall Study|Adverse Event|0|||
125515429|NCT03418493|451518762|FG002|Overall Study|Adverse Event|0|||
125515430|NCT03418493|451518763|FG003|Overall Study|Adverse Event|0|||
125515431|NCT03418493|451518764|FG004|Overall Study|Adverse Event|0|||
125515432|NCT03418493|451518765|FG005|Overall Study|Adverse Event|0|||
125515433|NCT03418493|451518766|FG006|Overall Study|Adverse Event|0|||
125515434|NCT03418493|451518767|FG007|Overall Study|Adverse Event|0|||
125515435|NCT03418493|451518768|FG008|Overall Study|Adverse Event|0|||
125515436|NCT03418493|451518769|FG009|Overall Study|Adverse Event|0|||
125515437|NCT03418493|451518770|FG010|Overall Study|Adverse Event|0|||
125515438|NCT03418493|451518760|FG000|Overall Study|Protocol Violation|0|||
125515439|NCT03418493|451518761|FG001|Overall Study|Protocol Violation|0|||
125515440|NCT03418493|451518762|FG002|Overall Study|Protocol Violation|0|||
125515441|NCT03418493|451518763|FG003|Overall Study|Protocol Violation|0|||
125515442|NCT03418493|451518764|FG004|Overall Study|Protocol Violation|0|||
125515443|NCT03418493|451518765|FG005|Overall Study|Protocol Violation|0|||
125515444|NCT03418493|451518766|FG006|Overall Study|Protocol Violation|0|||
125515445|NCT03418493|451518767|FG007|Overall Study|Protocol Violation|0|||
125515446|NCT03418493|451518768|FG008|Overall Study|Protocol Violation|0|||
125515447|NCT03418493|451518769|FG009|Overall Study|Protocol Violation|1|||
125515448|NCT03418493|451518770|FG010|Overall Study|Protocol Violation|0|||
125515449|NCT05446714|451518774|FG000|Overall Study|Lost to Follow-up|1|||
125515450|NCT05446714|451518775|FG001|Overall Study|Lost to Follow-up|3|||
125515451|NCT05446714|451518776|FG002|Overall Study|Lost to Follow-up|2|||
125515452|NCT05446714|451518774|FG000|Overall Study|Protocol Violation|2|||
125515453|NCT05446714|451518775|FG001|Overall Study|Protocol Violation|0|||
125515454|NCT05446714|451518776|FG002|Overall Study|Protocol Violation|0|||
125515455|NCT00197106|451518779|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
125515456|NCT00197106|451518780|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
125515457|NCT00197106|451518781|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
125515458|NCT00197106|451518779|FG000|Overall Treatment Period|Lack of Efficacy|0|||
125515459|NCT00197106|451518780|FG001|Overall Treatment Period|Lack of Efficacy|1|||
125515460|NCT00197106|451518781|FG002|Overall Treatment Period|Lack of Efficacy|0|||
125515461|NCT00197106|451518779|FG000|Overall Treatment Period|Lost to Follow-up|0|||
125515462|NCT00197106|451518780|FG001|Overall Treatment Period|Lost to Follow-up|0|||
125515463|NCT00197106|451518781|FG002|Overall Treatment Period|Lost to Follow-up|2|||
125515464|NCT00197106|451518779|FG000|Overall Treatment Period|Protocol Violation|0|||
125515465|NCT00197106|451518780|FG001|Overall Treatment Period|Protocol Violation|0|||
125515466|NCT00197106|451518781|FG002|Overall Treatment Period|Protocol Violation|2|||
125515467|NCT00197106|451518779|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
125515468|NCT00197106|451518780|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
125515469|NCT00197106|451518781|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
125515470|NCT00329550|451518784|FG000|Overall Study|Adverse Event|3|||
125515471|NCT00329550|451518785|FG001|Overall Study|Adverse Event|4|||
125515472|NCT00329550|451518786|FG002|Overall Study|Adverse Event|2|||
125515473|NCT00329550|451518784|FG000|Overall Study|Withdrawal of Consent|1|||
125515474|NCT00329550|451518785|FG001|Overall Study|Withdrawal of Consent|0|||
125515475|NCT00329550|451518786|FG002|Overall Study|Withdrawal of Consent|1|||
125515476|NCT00329550|451518784|FG000|Overall Study|Due to Relocation|0|||
125515477|NCT00329550|451518785|FG001|Overall Study|Due to Relocation|0|||
125515478|NCT00329550|451518786|FG002|Overall Study|Due to Relocation|1|||
125515479|NCT02679079|451518787|FG000|Overall Study|Adverse Event|2|||
125515480|NCT02679079|451518788|FG001|Overall Study|Adverse Event|0|||
125515481|NCT02679079|451518789|FG002|Overall Study|Adverse Event|2|||
125515482|NCT02679079|451518787|FG000|Overall Study|Protocol Violation|0|||
125515483|NCT02679079|451518788|FG001|Overall Study|Protocol Violation|1|||
125515484|NCT02679079|451518789|FG002|Overall Study|Protocol Violation|0|||
125515485|NCT02679079|451518787|FG000|Overall Study|Withdrawal by Subject|2|||
125515486|NCT02679079|451518788|FG001|Overall Study|Withdrawal by Subject|1|||
125515487|NCT02679079|451518789|FG002|Overall Study|Withdrawal by Subject|0|||
125515488|NCT04150341|451518790|FG000|Overall Study|Physician Decision|0|||
125515489|NCT04150341|451518791|FG001|Overall Study|Physician Decision|0|||
125515490|NCT04150341|451518792|FG002|Overall Study|Physician Decision|1|||
125515491|NCT04150341|451518793|FG003|Overall Study|Physician Decision|0|||
125515492|NCT04150341|451518794|FG004|Overall Study|Physician Decision|0|||
125515493|NCT04150341|451518795|FG005|Overall Study|Physician Decision|0|||
125515494|NCT04150341|451518790|FG000|Overall Study|Adverse Event|0|||
125515495|NCT04150341|451518791|FG001|Overall Study|Adverse Event|0|||
125515496|NCT04150341|451518792|FG002|Overall Study|Adverse Event|0|||
125515497|NCT04150341|451518793|FG003|Overall Study|Adverse Event|0|||
125515498|NCT04150341|451518794|FG004|Overall Study|Adverse Event|1|||
125515499|NCT04150341|451518795|FG005|Overall Study|Adverse Event|0|||
125515500|NCT00833898|451518802|FG000|Overall Study|Withdrawal by Subject|33|||
125515501|NCT00833898|451518803|FG001|Overall Study|Withdrawal by Subject|27|||
125515502|NCT00833898|451518802|FG000|Overall Study|Lost to Follow-up|7|||
125515503|NCT00833898|451518803|FG001|Overall Study|Lost to Follow-up|7|||
125515504|NCT00833898|451518802|FG000|Overall Study|Patient did not receive transplant|0|||
125515505|NCT00833898|451518803|FG001|Overall Study|Patient did not receive transplant|2|||
125515506|NCT00805285|451518804|FG000|Overall Study|Lack of Efficacy|1|||
125515507|NCT00917462|451518805|FG000|Overall Study|Clinical Deterioration|1|||
125515508|NCT01402063|451518806|FG000|Overall Study|Withdrawal by Subject|3|||
125515509|NCT01402063|451518807|FG001|Overall Study|Withdrawal by Subject|3|||
125515510|NCT02110225|451518811|FG000|Overall Study|Lost to Follow-up|0|||
125515511|NCT02110225|451518812|FG001|Overall Study|Lost to Follow-up|1|||
125515512|NCT02110225|451518813|FG002|Overall Study|Lost to Follow-up|0|||
125515513|NCT02176018|451518814|FG000|Overall Study|Adverse Event|0|||
125515514|NCT02176018|451518815|FG001|Overall Study|Adverse Event|2|||
125515515|NCT02176018|451518814|FG000|Overall Study|Lost to Follow-up|3|||
125515516|NCT02176018|451518815|FG001|Overall Study|Lost to Follow-up|1|||
125515517|NCT02176018|451518814|FG000|Overall Study|Protocol Violation|1|||
125515518|NCT02176018|451518815|FG001|Overall Study|Protocol Violation|1|||
125515519|NCT02176018|451518814|FG000|Overall Study|Withdrawal by Subject|1|||
125515520|NCT02176018|451518815|FG001|Overall Study|Withdrawal by Subject|2|||
125515521|NCT03022045|451518816|FG000|Overall Study|Adverse Event|0|||
125515522|NCT03022045|451518817|FG001|Overall Study|Adverse Event|1|||
125515523|NCT03022045|451518816|FG000|Overall Study|Withdrawal by Subject|1|||
125515524|NCT03022045|451518817|FG001|Overall Study|Withdrawal by Subject|1|||
125515525|NCT03972137|451518824|FG000|Overall Study|Lost to Follow-up|2|||
125515526|NCT03972137|451518824|FG000|Overall Study|Withdrawal by Subject|4|||
125515527|NCT00899379|451518825|FG000|Overall Study|Adverse Event|2|||
125515528|NCT00899379|451518826|FG001|Overall Study|Adverse Event|2|||
125515529|NCT00899379|451518827|FG002|Overall Study|Adverse Event|1|||
125515530|NCT00899379|451518828|FG003|Overall Study|Adverse Event|1|||
125515531|NCT00899379|451518829|FG004|Overall Study|Adverse Event|2|||
125515532|NCT00899379|451518825|FG000|Overall Study|Lack of Efficacy|0|||
125515533|NCT00899379|451518826|FG001|Overall Study|Lack of Efficacy|4|||
125515534|NCT00899379|451518827|FG002|Overall Study|Lack of Efficacy|3|||
125515535|NCT00899379|451518828|FG003|Overall Study|Lack of Efficacy|0|||
125515536|NCT00899379|451518829|FG004|Overall Study|Lack of Efficacy|1|||
125515537|NCT00899379|451518825|FG000|Overall Study|Lost to Follow-up|9|||
125515538|NCT00899379|451518826|FG001|Overall Study|Lost to Follow-up|3|||
125515539|NCT00899379|451518827|FG002|Overall Study|Lost to Follow-up|0|||
125515540|NCT00899379|451518828|FG003|Overall Study|Lost to Follow-up|6|||
125515541|NCT00899379|451518829|FG004|Overall Study|Lost to Follow-up|2|||
125515542|NCT00899379|451518825|FG000|Overall Study|Protocol Violation|0|||
125515543|NCT00899379|451518826|FG001|Overall Study|Protocol Violation|0|||
125515544|NCT00899379|451518827|FG002|Overall Study|Protocol Violation|1|||
125515545|NCT00899379|451518828|FG003|Overall Study|Protocol Violation|1|||
125515546|NCT00899379|451518829|FG004|Overall Study|Protocol Violation|0|||
125515547|NCT00899379|451518825|FG000|Overall Study|Withdrawal by Subject|2|||
125515548|NCT00899379|451518826|FG001|Overall Study|Withdrawal by Subject|4|||
125515549|NCT00899379|451518827|FG002|Overall Study|Withdrawal by Subject|2|||
125515550|NCT00899379|451518828|FG003|Overall Study|Withdrawal by Subject|3|||
125515551|NCT00899379|451518829|FG004|Overall Study|Withdrawal by Subject|6|||
125515552|NCT00899379|451518825|FG000|Overall Study|Pregnancy|0|||
125515553|NCT00899379|451518826|FG001|Overall Study|Pregnancy|0|||
125515554|NCT00899379|451518827|FG002|Overall Study|Pregnancy|1|||
125515555|NCT00899379|451518828|FG003|Overall Study|Pregnancy|0|||
125515556|NCT00899379|451518829|FG004|Overall Study|Pregnancy|1|||
125515557|NCT00899379|451518825|FG000|Overall Study|Patient Uncooperative|0|||
125515558|NCT00899379|451518826|FG001|Overall Study|Patient Uncooperative|1|||
125515559|NCT00899379|451518827|FG002|Overall Study|Patient Uncooperative|0|||
125515560|NCT00899379|451518828|FG003|Overall Study|Patient Uncooperative|1|||
125515561|NCT00899379|451518829|FG004|Overall Study|Patient Uncooperative|2|||
125515562|NCT00899379|451518825|FG000|Overall Study|Abnormal Baseline ECG|0|||
125515563|NCT00899379|451518826|FG001|Overall Study|Abnormal Baseline ECG|0|||
125515564|NCT00899379|451518827|FG002|Overall Study|Abnormal Baseline ECG|0|||
125515565|NCT00899379|451518828|FG003|Overall Study|Abnormal Baseline ECG|1|||
125515566|NCT00899379|451518829|FG004|Overall Study|Abnormal Baseline ECG|0|||
125515567|NCT00899379|451518825|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
125515568|NCT00899379|451518826|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
125515569|NCT00899379|451518827|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
125515570|NCT00899379|451518828|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
125515571|NCT00899379|451518829|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
125515572|NCT00899379|451518825|FG000|Overall Study|Not Completed/Entered Extn|5|||
125515573|NCT00899379|451518826|FG001|Overall Study|Not Completed/Entered Extn|1|||
125515574|NCT00899379|451518827|FG002|Overall Study|Not Completed/Entered Extn|6|||
125515575|NCT00899379|451518828|FG003|Overall Study|Not Completed/Entered Extn|4|||
125515576|NCT00899379|451518829|FG004|Overall Study|Not Completed/Entered Extn|3|||
125515577|NCT00899379|451518825|FG000|Overall Study|Study Terminated|3|||
125515578|NCT00899379|451518826|FG001|Overall Study|Study Terminated|0|||
125515579|NCT00899379|451518827|FG002|Overall Study|Study Terminated|3|||
125515580|NCT00899379|451518828|FG003|Overall Study|Study Terminated|3|||
125515581|NCT00899379|451518829|FG004|Overall Study|Study Terminated|1|||
125515582|NCT00899379|451518825|FG000|Overall Study|Lost to Follow-up|3|||
125515583|NCT00899379|451518826|FG001|Overall Study|Lost to Follow-up|1|||
125515584|NCT00899379|451518827|FG002|Overall Study|Lost to Follow-up|0|||
125515585|NCT00899379|451518828|FG003|Overall Study|Lost to Follow-up|2|||
125515586|NCT00899379|451518829|FG004|Overall Study|Lost to Follow-up|5|||
125515587|NCT00899379|451518825|FG000|Overall Study|Withdrawal by Subject|4|||
125515588|NCT00899379|451518826|FG001|Overall Study|Withdrawal by Subject|7|||
125515589|NCT00899379|451518827|FG002|Overall Study|Withdrawal by Subject|4|||
125515590|NCT00899379|451518828|FG003|Overall Study|Withdrawal by Subject|7|||
125515591|NCT00899379|451518829|FG004|Overall Study|Withdrawal by Subject|2|||
125515592|NCT00899379|451518825|FG000|Overall Study|Pregnancy|1|||
125515593|NCT00899379|451518826|FG001|Overall Study|Pregnancy|0|||
125515594|NCT00899379|451518827|FG002|Overall Study|Pregnancy|0|||
125515595|NCT00899379|451518828|FG003|Overall Study|Pregnancy|0|||
125515596|NCT00899379|451518829|FG004|Overall Study|Pregnancy|0|||
125515597|NCT00899379|451518825|FG000|Overall Study|Patient Uncooperative|0|||
125515598|NCT00899379|451518826|FG001|Overall Study|Patient Uncooperative|0|||
125515599|NCT00899379|451518827|FG002|Overall Study|Patient Uncooperative|0|||
125515600|NCT00899379|451518828|FG003|Overall Study|Patient Uncooperative|1|||
125515601|NCT00899379|451518829|FG004|Overall Study|Patient Uncooperative|0|||
125515602|NCT00899379|451518825|FG000|Overall Study|Abnormal Prestudy Labs|0|||
125515603|NCT00899379|451518826|FG001|Overall Study|Abnormal Prestudy Labs|0|||
125515604|NCT00899379|451518827|FG002|Overall Study|Abnormal Prestudy Labs|0|||
125515605|NCT00899379|451518828|FG003|Overall Study|Abnormal Prestudy Labs|0|||
125515606|NCT00899379|451518829|FG004|Overall Study|Abnormal Prestudy Labs|2|||
125515607|NCT00899379|451518825|FG000|Overall Study|Abnormal Baseline ECG|0|||
125515608|NCT00899379|451518826|FG001|Overall Study|Abnormal Baseline ECG|0|||
125515609|NCT00899379|451518827|FG002|Overall Study|Abnormal Baseline ECG|1|||
125515610|NCT00899379|451518828|FG003|Overall Study|Abnormal Baseline ECG|1|||
125515611|NCT00899379|451518829|FG004|Overall Study|Abnormal Baseline ECG|0|||
125515612|NCT00899379|451518825|FG000|Overall Study|No Attack Pretreatment|3|||
125515613|NCT00899379|451518826|FG001|Overall Study|No Attack Pretreatment|5|||
125515614|NCT00899379|451518827|FG002|Overall Study|No Attack Pretreatment|5|||
125515615|NCT00899379|451518828|FG003|Overall Study|No Attack Pretreatment|6|||
125515616|NCT00899379|451518829|FG004|Overall Study|No Attack Pretreatment|4|||
125515617|NCT00899379|451518825|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
125515618|NCT00899379|451518826|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
125515619|NCT00899379|451518827|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
125515620|NCT00899379|451518828|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
125515621|NCT00899379|451518829|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
125515622|NCT00899379|451518825|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
125515623|NCT00899379|451518826|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
125515624|NCT00899379|451518827|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
125515625|NCT00899379|451518828|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
125515626|NCT00899379|451518829|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
125515627|NCT03220776|451518834|FG000|Overall Study|Claustrophobia|0|||
125515628|NCT03220776|451518835|FG001|Overall Study|Claustrophobia|1|||
125515629|NCT03220776|451518836|FG002|Overall Study|Claustrophobia|1|||
125515630|NCT03220776|451518837|FG003|Overall Study|Claustrophobia|0|||
125515631|NCT03220776|451518838|FG004|Overall Study|Claustrophobia|1|||
125515632|NCT03220776|451518839|FG005|Overall Study|Claustrophobia|0|||
125515633|NCT03220776|451518834|FG000|Overall Study|MRI Equipment Failure|1|||
125515634|NCT03220776|451518835|FG001|Overall Study|MRI Equipment Failure|0|||
125515635|NCT03220776|451518836|FG002|Overall Study|MRI Equipment Failure|0|||
125515636|NCT03220776|451518837|FG003|Overall Study|MRI Equipment Failure|0|||
125515637|NCT03220776|451518838|FG004|Overall Study|MRI Equipment Failure|0|||
125515638|NCT03220776|451518839|FG005|Overall Study|MRI Equipment Failure|0|||
125515639|NCT03220776|451518834|FG000|Overall Study|Inclimate Weather|0|||
125515640|NCT03220776|451518835|FG001|Overall Study|Inclimate Weather|0|||
125515641|NCT03220776|451518836|FG002|Overall Study|Inclimate Weather|0|||
125515642|NCT03220776|451518837|FG003|Overall Study|Inclimate Weather|0|||
125515643|NCT03220776|451518838|FG004|Overall Study|Inclimate Weather|0|||
125515644|NCT03220776|451518839|FG005|Overall Study|Inclimate Weather|1|||
125515645|NCT03220776|451518834|FG000|Overall Study|Physician Decision|0|||
125515646|NCT03220776|451518835|FG001|Overall Study|Physician Decision|0|||
125515647|NCT03220776|451518836|FG002|Overall Study|Physician Decision|0|||
125515648|NCT03220776|451518837|FG003|Overall Study|Physician Decision|1|||
125515649|NCT03220776|451518838|FG004|Overall Study|Physician Decision|0|||
125515650|NCT03220776|451518839|FG005|Overall Study|Physician Decision|0|||
125515651|NCT03220776|451518834|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
125515652|NCT03220776|451518835|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
125515653|NCT03220776|451518836|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
125515654|NCT03220776|451518837|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
125515655|NCT03220776|451518838|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
125515656|NCT03220776|451518839|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
125515657|NCT03220776|451518834|FG000|Overall Study|Protocol Violation|0|||
125515658|NCT03220776|451518835|FG001|Overall Study|Protocol Violation|0|||
125515659|NCT03220776|451518836|FG002|Overall Study|Protocol Violation|0|||
125515660|NCT03220776|451518837|FG003|Overall Study|Protocol Violation|2|||
125515661|NCT03220776|451518838|FG004|Overall Study|Protocol Violation|0|||
125515662|NCT03220776|451518839|FG005|Overall Study|Protocol Violation|1|||
125515663|NCT03220776|451518834|FG000|Overall Study|Withdrawal by Subject|1|||
125515664|NCT03220776|451518835|FG001|Overall Study|Withdrawal by Subject|0|||
125515665|NCT03220776|451518836|FG002|Overall Study|Withdrawal by Subject|0|||
125515666|NCT03220776|451518837|FG003|Overall Study|Withdrawal by Subject|0|||
125515667|NCT03220776|451518838|FG004|Overall Study|Withdrawal by Subject|0|||
125515668|NCT03220776|451518839|FG005|Overall Study|Withdrawal by Subject|0|||
125515669|NCT01780545|451518840|FG000|Overall Study|Withdrawal by Subject|3|||
125515670|NCT01780545|451518841|FG001|Overall Study|Withdrawal by Subject|1|||
125515671|NCT01780545|451518840|FG000|Overall Study|Lost to Follow-up|1|||
125515672|NCT01780545|451518841|FG001|Overall Study|Lost to Follow-up|1|||
125515673|NCT03441789|451518842|FG000|Overall Study|Withdrawal by Subject|1|||
125515674|NCT03441789|451518843|FG001|Overall Study|Withdrawal by Subject|1|||
125515675|NCT03441789|451518842|FG000|Overall Study|Adverse Event|0|||
125515676|NCT03441789|451518843|FG001|Overall Study|Adverse Event|1|||
125515677|NCT03441789|451518842|FG000|Overall Study|Protocol Violation|0|||
125515678|NCT03441789|451518843|FG001|Overall Study|Protocol Violation|1|||
125515679|NCT03441789|451518842|FG000|Overall Study|Lost to Follow-up|0|||
125515680|NCT03441789|451518843|FG001|Overall Study|Lost to Follow-up|1|||
125515681|NCT03168425|451518844|FG000|Overall Study|Lost to Follow-up|5|||
125515682|NCT03168425|451518845|FG001|Overall Study|Lost to Follow-up|8|||
125515683|NCT03168425|451518844|FG000|Overall Study|unable to confirm post op opioids|2|||
125515684|NCT03168425|451518845|FG001|Overall Study|unable to confirm post op opioids|3|||
125515685|NCT03029234|451518848|FG000|Overall Study|Sponsor Decision|1|||
125515686|NCT03029234|451518848|FG000|Overall Study|Withdrawal by Subject|5|||
125515687|NCT03029234|451518848|FG000|Overall Study|Death|91|||
125515688|NCT03029234|451518848|FG000|Overall Study|Lost to Follow-up|2|||
125515689|NCT02166047|451518852|FG000|Overall Study|Withdrawal by Participant|0|||
125515690|NCT02166047|451518853|FG001|Overall Study|Withdrawal by Participant|1|||
125515691|NCT02166047|451518854|FG002|Overall Study|Withdrawal by Participant|2|||
125515692|NCT02166047|451518855|FG003|Overall Study|Withdrawal by Participant|0|||
125515693|NCT02166047|451518856|FG004|Overall Study|Withdrawal by Participant|0|||
125515694|NCT02166047|451518857|FG005|Overall Study|Withdrawal by Participant|0|||
125515695|NCT02166047|451518858|FG006|Overall Study|Withdrawal by Participant|1|||
125515696|NCT02166047|451518859|FG007|Overall Study|Withdrawal by Participant|0|||
125515697|NCT02166047|451518860|FG008|Overall Study|Withdrawal by Participant|0|||
125515698|NCT02166047|451518861|FG009|Overall Study|Withdrawal by Participant|0|||
125515699|NCT02166047|451518862|FG010|Overall Study|Withdrawal by Participant|0|||
125515700|NCT02166047|451518863|FG011|Overall Study|Withdrawal by Participant|0|||
125515701|NCT02166047|451518852|FG000|Overall Study|Adverse Event|0|||
125515702|NCT02166047|451518853|FG001|Overall Study|Adverse Event|0|||
125515703|NCT02166047|451518854|FG002|Overall Study|Adverse Event|0|||
125515704|NCT02166047|451518855|FG003|Overall Study|Adverse Event|0|||
125515705|NCT02166047|451518856|FG004|Overall Study|Adverse Event|1|||
125515706|NCT02166047|451518857|FG005|Overall Study|Adverse Event|0|||
125515707|NCT02166047|451518858|FG006|Overall Study|Adverse Event|1|||
125515708|NCT02166047|451518859|FG007|Overall Study|Adverse Event|0|||
125515709|NCT02166047|451518860|FG008|Overall Study|Adverse Event|0|||
125515710|NCT02166047|451518861|FG009|Overall Study|Adverse Event|0|||
125515711|NCT02166047|451518862|FG010|Overall Study|Adverse Event|2|||
125515712|NCT02166047|451518863|FG011|Overall Study|Adverse Event|0|||
125515713|NCT01960114|451518864|FG000|Overall Study|Adverse Event|1|||
125515714|NCT01960114|451518865|FG001|Overall Study|Adverse Event|0|||
125515715|NCT01960114|451518864|FG000|Overall Study|Could not swallow study medication|0|||
125515716|NCT01960114|451518865|FG001|Overall Study|Could not swallow study medication|1|||
125515717|NCT02469077|451518866|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
125515718|NCT02469077|451518867|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
125515719|NCT02469077|451518866|FG000|Post Randomization/Intervention Period|Relocated|1|||
125515720|NCT02469077|451518867|FG001|Post Randomization/Intervention Period|Relocated|1|||
125515721|NCT02469077|451518866|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
125515722|NCT02469077|451518867|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
125515723|NCT02469077|451518866|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
125515724|NCT02469077|451518867|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
125515725|NCT00053352|451518873|FG000|Overall Study|Lost to Follow-up|0|||
125515726|NCT00053352|451518874|FG001|Overall Study|Lost to Follow-up|1|||
125515727|NCT00053352|451518873|FG000|Overall Study|Physician Decision|11|||
125515728|NCT00053352|451518874|FG001|Overall Study|Physician Decision|1|||
125515729|NCT00053352|451518873|FG000|Overall Study|Withdrawal by Subject|1|||
125515730|NCT00053352|451518874|FG001|Overall Study|Withdrawal by Subject|0|||
125515731|NCT00053352|451518873|FG000|Overall Study|Ineligible|8|||
125515732|NCT00053352|451518874|FG001|Overall Study|Ineligible|8|||
125515733|NCT00053352|451518873|FG000|Overall Study|Disease at new site|1|||
125515734|NCT00053352|451518874|FG001|Overall Study|Disease at new site|0|||
125515735|NCT00439647|451518875|FG000|Overall Study|Withdrawal by Subject|25|||
125515736|NCT00439647|451518876|FG001|Overall Study|Withdrawal by Subject|22|||
125515737|NCT00439647|451518875|FG000|Overall Study|Death|15|||
125515738|NCT00439647|451518876|FG001|Overall Study|Death|18|||
125515739|NCT00439647|451518875|FG000|Overall Study|Adverse Event|11|||
125515740|NCT00439647|451518876|FG001|Overall Study|Adverse Event|11|||
125515741|NCT00439647|451518875|FG000|Overall Study|Lost to Follow-up|4|||
125515742|NCT00439647|451518876|FG001|Overall Study|Lost to Follow-up|12|||
125515743|NCT00439647|451518875|FG000|Overall Study|Protocol Violation|3|||
125515744|NCT00439647|451518876|FG001|Overall Study|Protocol Violation|4|||
125515745|NCT00439647|451518875|FG000|Overall Study|Lack of Efficacy|0|||
125515746|NCT00439647|451518876|FG001|Overall Study|Lack of Efficacy|4|||
125515747|NCT02845375|451518877|FG000|Overall Study|upper airway obstruction|1|||
125515748|NCT02845375|451518878|FG001|Overall Study|upper airway obstruction|2|||
125515749|NCT02845375|451518879|FG002|Overall Study|upper airway obstruction|1|||
125515750|NCT01177137|451518883|FG000|Overall Study|Withdrawal by Subject|10|||
125515751|NCT01177137|451518884|FG001|Overall Study|Withdrawal by Subject|10|||
125515752|NCT01177137|451518885|FG002|Overall Study|Withdrawal by Subject|2|||
125515753|NCT02025985|451518887|FG000|Overall Study|Consent withdrawn|0|||
125515754|NCT02025985|451518888|FG001|Overall Study|Consent withdrawn|0|||
125515755|NCT02025985|451518889|FG002|Overall Study|Consent withdrawn|1|||
125515756|NCT02025985|451518890|FG003|Overall Study|Consent withdrawn|0|||
125515757|NCT02025985|451518891|FG004|Overall Study|Consent withdrawn|0|||
125515758|NCT02025985|451518887|FG000|Overall Study|Termination of study by Sponsor|4|||
125515759|NCT02025985|451518888|FG001|Overall Study|Termination of study by Sponsor|3|||
125515760|NCT02025985|451518889|FG002|Overall Study|Termination of study by Sponsor|1|||
125515761|NCT02025985|451518890|FG003|Overall Study|Termination of study by Sponsor|1|||
125515762|NCT02025985|451518891|FG004|Overall Study|Termination of study by Sponsor|3|||
125515763|NCT02025985|451518887|FG000|Overall Study|Death|21|||
125515764|NCT02025985|451518888|FG001|Overall Study|Death|20|||
125515765|NCT02025985|451518889|FG002|Overall Study|Death|23|||
125515766|NCT02025985|451518890|FG003|Overall Study|Death|20|||
125515767|NCT02025985|451518891|FG004|Overall Study|Death|17|||
125515768|NCT03041701|451518892|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
125515769|NCT03041701|451518893|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
125515770|NCT03041701|451518894|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
125515771|NCT03041701|451518892|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
125515772|NCT03041701|451518893|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
125515773|NCT03041701|451518894|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
125515774|NCT01287416|451518895|FG000|Pre-post Training|Withdrawal by Subject|17|||
125515775|NCT01287416|451518896|FG001|Pre-post Training|Withdrawal by Subject|24|||
125515776|NCT01287416|451518895|FG000|Pre-post Training|Lost to Follow-up|5|||
125515777|NCT01287416|451518896|FG001|Pre-post Training|Lost to Follow-up|1|||
125515778|NCT01287416|451518895|FG000|6 Month Follow-up|Lost to Follow-up|3|||
125515779|NCT01287416|451518896|FG001|6 Month Follow-up|Lost to Follow-up|2|||
125515780|NCT02506881|451518897|FG000|First Intervention (Day 1)|Protocol Violation|0|||
125515781|NCT02506881|451518898|FG001|First Intervention (Day 1)|Protocol Violation|0|||
125515782|NCT02506881|451518899|FG002|First Intervention (Day 1)|Protocol Violation|1|||
125515783|NCT02506881|451518900|FG003|First Intervention (Day 1)|Protocol Violation|0|||
125515784|NCT02506881|451518897|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
125515785|NCT02506881|451518898|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
125515786|NCT02506881|451518899|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
125515787|NCT02506881|451518900|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
125515788|NCT02506881|451518897|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
125515789|NCT02506881|451518898|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
125515790|NCT02506881|451518899|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
125515791|NCT02506881|451518900|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
125515792|NCT01363297|451518905|FG000|Overall Study|Other|0|||
125515793|NCT01363297|451518906|FG001|Overall Study|Other|0|||
125515794|NCT01363297|451518907|FG002|Overall Study|Other|0|||
125515795|NCT01363297|451518908|FG003|Overall Study|Other|0|||
125515796|NCT01363297|451518909|FG004|Overall Study|Other|1|||
125515797|NCT01363297|451518905|FG000|Overall Study|Death|3|||
125515798|NCT01363297|451518906|FG001|Overall Study|Death|6|||
125515799|NCT01363297|451518907|FG002|Overall Study|Death|6|||
125515800|NCT01363297|451518908|FG003|Overall Study|Death|10|||
125515801|NCT01363297|451518909|FG004|Overall Study|Death|30|||
125515802|NCT03015181|451518910|FG000|Overall Study|Enrolled, but product never administered|1|||
125515803|NCT03015181|451518911|FG001|Overall Study|Enrolled, but product never administered|0|||
125515804|NCT03015181|451518912|FG002|Overall Study|Enrolled, but product never administered|0|||
125515805|NCT03015181|451518913|FG003|Overall Study|Enrolled, but product never administered|0|||
125515806|NCT03015181|451518914|FG004|Overall Study|Enrolled, but product never administered|0|||
125515807|NCT03015181|451518915|FG005|Overall Study|Enrolled, but product never administered|0|||
125515808|NCT03015181|451518916|FG006|Overall Study|Enrolled, but product never administered|0|||
125515809|NCT03015181|451518910|FG000|Overall Study|Withdrawal by Subject|0|||
125515810|NCT03015181|451518911|FG001|Overall Study|Withdrawal by Subject|0|||
125515811|NCT03015181|451518912|FG002|Overall Study|Withdrawal by Subject|0|||
125515812|NCT03015181|451518913|FG003|Overall Study|Withdrawal by Subject|0|||
125515813|NCT03015181|451518914|FG004|Overall Study|Withdrawal by Subject|0|||
125515814|NCT03015181|451518915|FG005|Overall Study|Withdrawal by Subject|1|||
125515815|NCT03015181|451518916|FG006|Overall Study|Withdrawal by Subject|0|||
125515816|NCT03015181|451518910|FG000|Overall Study|Physician Decision|0|||
125515817|NCT03015181|451518911|FG001|Overall Study|Physician Decision|0|||
125515818|NCT03015181|451518912|FG002|Overall Study|Physician Decision|0|||
125515819|NCT03015181|451518913|FG003|Overall Study|Physician Decision|0|||
125515820|NCT03015181|451518914|FG004|Overall Study|Physician Decision|0|||
125515821|NCT03015181|451518915|FG005|Overall Study|Physician Decision|0|||
125515822|NCT03015181|451518916|FG006|Overall Study|Physician Decision|1|||
125515823|NCT01064856|451518922|FG000|Double-blind (DB) Period|Adverse Event|1|||
125515824|NCT01064856|451518923|FG001|Double-blind (DB) Period|Adverse Event|0|||
125515825|NCT01064856|451518924|FG002|Double-blind (DB) Period|Adverse Event|0|||
125515826|NCT01064856|451518925|FG003|Double-blind (DB) Period|Adverse Event|0|||
125515827|NCT01064856|451518922|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
125515828|NCT01064856|451518923|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
125515829|NCT01064856|451518924|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
125515830|NCT01064856|451518925|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
125515831|NCT01064856|451518922|FG000|Open-label (OL) Period|Adverse Event|0|||
125515832|NCT01064856|451518923|FG001|Open-label (OL) Period|Adverse Event|0|||
125515833|NCT01064856|451518924|FG002|Open-label (OL) Period|Adverse Event|12|||
125515834|NCT01064856|451518925|FG003|Open-label (OL) Period|Adverse Event|6|||
125515835|NCT01064856|451518922|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
125515836|NCT01064856|451518923|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
125515837|NCT01064856|451518924|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
125515838|NCT01064856|451518925|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
125515839|NCT01064856|451518922|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
125515840|NCT01064856|451518923|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
125515841|NCT01064856|451518924|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
125515842|NCT01064856|451518925|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
125515843|NCT01064856|451518922|FG000|Open-label (OL) Period|Other|0|||
125515844|NCT01064856|451518923|FG001|Open-label (OL) Period|Other|0|||
125515845|NCT01064856|451518924|FG002|Open-label (OL) Period|Other|7|||
125515846|NCT01064856|451518925|FG003|Open-label (OL) Period|Other|7|||
125515847|NCT01204775|451518928|FG000|Overall Study|Poor/non-compliance|0|||
125515848|NCT01204775|451518929|FG001|Overall Study|Poor/non-compliance|1|||
125515849|NCT01204775|451518928|FG000|Overall Study|Withdrawal by Subject|1|||
125515850|NCT01204775|451518929|FG001|Overall Study|Withdrawal by Subject|0|||
125515851|NCT01374971|451518930|FG000|Overall Study|Withdrawal by Subject|1|||
125515852|NCT03749616|451518933|FG000|Overall Study|Lost to Follow-up|4|||
125515853|NCT03749616|451518934|FG001|Overall Study|Lost to Follow-up|7|||
125515854|NCT03749616|451518933|FG000|Overall Study|Screen Failure|1|||
125515855|NCT03749616|451518934|FG001|Overall Study|Screen Failure|1|||
125515856|NCT03749616|451518933|FG000|Overall Study|Withdrawal by Subject|2|||
125515857|NCT03749616|451518934|FG001|Overall Study|Withdrawal by Subject|0|||
125515858|NCT04435522|451518935|FG000|Overall Study|Withdrawal by Subject|2|||
125515859|NCT00951171|451518936|FG000|Overall Study|Adverse Event|2|||
125515860|NCT00951171|451518937|FG001|Overall Study|Adverse Event|0|||
125515861|NCT00919061|451518938|FG000|Overall Study|Adverse Event|1|||
125515862|NCT00919061|451518938|FG000|Overall Study|Withdrawal by Subject|1|||
125515863|NCT05294328|451518947|FG000|Overall Study|Adverse Event|1|||
125515864|NCT05294328|451518948|FG001|Overall Study|Adverse Event|0|||
125515865|NCT05294328|451518949|FG002|Overall Study|Adverse Event|0|||
125515866|NCT05294328|451518947|FG000|Overall Study|Physician Decision|1|||
125515867|NCT05294328|451518948|FG001|Overall Study|Physician Decision|1|||
125515868|NCT05294328|451518949|FG002|Overall Study|Physician Decision|0|||
125515869|NCT05294328|451518947|FG000|Overall Study|Withdrawal by Subject|0|||
125515870|NCT05294328|451518948|FG001|Overall Study|Withdrawal by Subject|2|||
125515871|NCT05294328|451518949|FG002|Overall Study|Withdrawal by Subject|1|||
125515872|NCT05294328|451518947|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
125515873|NCT05294328|451518948|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
125515874|NCT05294328|451518949|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
125515875|NCT02056873|451518950|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
125515876|NCT01990313|451520924|FG000|Overall Study|Lost to Follow-up|1|||
125515877|NCT03511378|451520925|FG000|Overall Study|Withdrawal by Subject|2|||
125515878|NCT03511378|451520926|FG001|Overall Study|Withdrawal by Subject|2|||
125515879|NCT03511378|451520925|FG000|Overall Study|Patient not coming or schedule visit|1|||
125515880|NCT03511378|451520926|FG001|Overall Study|Patient not coming or schedule visit|0|||
125515881|NCT00837096|451520927|FG000|Overall Study|Physician Decision|1|||
125515882|NCT00837096|451520928|FG001|Overall Study|Physician Decision|1|||
125515883|NCT00837096|451520927|FG000|Overall Study|Not reported|9|||
125515884|NCT00837096|451520928|FG001|Overall Study|Not reported|8|||
125515885|NCT05006417|451520929|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
125515886|NCT00280683|451520930|FG000|Overall Study|Withdrawal by Subject|1|||
125515887|NCT00280683|451520931|FG001|Overall Study|Withdrawal by Subject|2|||
125515888|NCT00280683|451520930|FG000|Overall Study|Adverse Event|1|||
125515889|NCT00280683|451520931|FG001|Overall Study|Adverse Event|1|||
125515890|NCT01243411|451520932|FG000|Overall Study|Withdrawal by Subject|18|||
125515891|NCT01243411|451520932|FG000|Overall Study|Lost to Follow-up|10|||
125515892|NCT01243411|451520932|FG000|Overall Study|Adverse Event|5|||
125515893|NCT01243411|451520932|FG000|Overall Study|Other|8|||
125515894|NCT00510198|451520935|FG000|Overall Study|Withdrawal by Subject|5|||
125515895|NCT00510198|451520936|FG001|Overall Study|Withdrawal by Subject|4|||
125515896|NCT01649557|451520944|FG000|Overall Study|Lost to Follow-up|5|||
125515897|NCT01649557|451520945|FG001|Overall Study|Lost to Follow-up|0|||
125515898|NCT01649557|451520946|FG002|Overall Study|Lost to Follow-up|3|||
125515899|NCT01649557|451520944|FG000|Overall Study|Adverse Event|7|||
125515900|NCT01649557|451520945|FG001|Overall Study|Adverse Event|5|||
125515901|NCT01649557|451520946|FG002|Overall Study|Adverse Event|1|||
125515902|NCT01649557|451520944|FG000|Overall Study|Met withdrawal criteria|4|||
125515903|NCT01649557|451520945|FG001|Overall Study|Met withdrawal criteria|0|||
125515904|NCT01649557|451520946|FG002|Overall Study|Met withdrawal criteria|0|||
125515905|NCT01649557|451520944|FG000|Overall Study|Physician Decision|8|||
125515906|NCT01649557|451520945|FG001|Overall Study|Physician Decision|2|||
125515907|NCT01649557|451520946|FG002|Overall Study|Physician Decision|1|||
125515908|NCT01649557|451520944|FG000|Overall Study|Withdrawal by Subject|15|||
125515909|NCT01649557|451520945|FG001|Overall Study|Withdrawal by Subject|5|||
125515910|NCT01649557|451520946|FG002|Overall Study|Withdrawal by Subject|4|||
125515911|NCT01649557|451520944|FG000|Overall Study|Protocol deviation|0|||
125515912|NCT01649557|451520945|FG001|Overall Study|Protocol deviation|2|||
125515913|NCT01649557|451520946|FG002|Overall Study|Protocol deviation|0|||
125515914|NCT01649557|451520944|FG000|Overall Study|Lack of Efficacy|5|||
125515915|NCT01649557|451520945|FG001|Overall Study|Lack of Efficacy|0|||
125515916|NCT01649557|451520946|FG002|Overall Study|Lack of Efficacy|0|||
125515917|NCT03712449|451520952|FG000|Overall Study|Withdraw Consent|0|||
125515918|NCT03712449|451520953|FG001|Overall Study|Withdraw Consent|1|||
125515919|NCT00666198|451520959|FG000|Overall Study|Protocol Violation|10|||
125515920|NCT00666198|451520959|FG000|Overall Study|No Visit After First Day of Treatment|13|||
125515921|NCT00666198|451520959|FG000|Overall Study|Safety Not Assessable|6|||
125515922|NCT00666198|451520959|FG000|Overall Study|No Drug Administration|4|||
125515923|NCT05153499|451520960|FG000|Overall Study|Withdrawal by Subject|1|||
125515924|NCT05153499|451520961|FG001|Overall Study|Withdrawal by Subject|0|||
125515925|NCT05153499|451520960|FG000|Overall Study|Clinical Hold|1|||
125515926|NCT05153499|451520961|FG001|Overall Study|Clinical Hold|0|||
125515927|NCT05153499|451520960|FG000|Overall Study|Study Termination|6|||
125515928|NCT05153499|451520961|FG001|Overall Study|Study Termination|5|||
125515929|NCT01649297|451520963|FG000|Overall Study|Adverse Event|5|||
125515930|NCT01649297|451520964|FG001|Overall Study|Adverse Event|5|||
125515931|NCT01649297|451520965|FG002|Overall Study|Adverse Event|4|||
125515932|NCT01649297|451520966|FG003|Overall Study|Adverse Event|13|||
125515933|NCT01649297|451520967|FG004|Overall Study|Adverse Event|1|||
125515934|NCT01649297|451520963|FG000|Overall Study|Lack of Efficacy|0|||
125515935|NCT01649297|451520964|FG001|Overall Study|Lack of Efficacy|0|||
125515936|NCT01649297|451520965|FG002|Overall Study|Lack of Efficacy|0|||
125515937|NCT01649297|451520966|FG003|Overall Study|Lack of Efficacy|0|||
125515938|NCT01649297|451520967|FG004|Overall Study|Lack of Efficacy|1|||
125515939|NCT01649297|451520963|FG000|Overall Study|Non compliant with Protocol|1|||
125515940|NCT01649297|451520964|FG001|Overall Study|Non compliant with Protocol|0|||
125515941|NCT01649297|451520965|FG002|Overall Study|Non compliant with Protocol|3|||
125515942|NCT01649297|451520966|FG003|Overall Study|Non compliant with Protocol|2|||
125515943|NCT01649297|451520967|FG004|Overall Study|Non compliant with Protocol|1|||
125515944|NCT01649297|451520963|FG000|Overall Study|Lost to Follow-up|1|||
125515945|NCT01649297|451520964|FG001|Overall Study|Lost to Follow-up|1|||
125515946|NCT01649297|451520965|FG002|Overall Study|Lost to Follow-up|4|||
125515947|NCT01649297|451520966|FG003|Overall Study|Lost to Follow-up|3|||
125515948|NCT01649297|451520967|FG004|Overall Study|Lost to Follow-up|0|||
125515949|NCT01649297|451520963|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
125515950|NCT01649297|451520964|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
125515951|NCT01649297|451520965|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
125515952|NCT01649297|451520966|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
125515953|NCT01649297|451520967|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
125515954|NCT01649297|451520963|FG000|Overall Study|For other reason|4|||
125515955|NCT01649297|451520964|FG001|Overall Study|For other reason|1|||
125515956|NCT01649297|451520965|FG002|Overall Study|For other reason|2|||
125515957|NCT01649297|451520966|FG003|Overall Study|For other reason|0|||
125515958|NCT01649297|451520967|FG004|Overall Study|For other reason|0|||
125515959|NCT01685047|451520968|FG000|Overall Study|Withdrawal by Subject|20|||
125515960|NCT01685047|451520968|FG000|Overall Study|Death|26|||
125515961|NCT01685047|451520968|FG000|Overall Study|Lost to Follow-up|8|||
125515962|NCT01685047|451520968|FG000|Overall Study|Physician Decision|25|||
125515963|NCT01685047|451520968|FG000|Overall Study|Adverse Event|5|||
125515964|NCT01685047|451520968|FG000|Overall Study|patient withdrawn by sponsor|1|||
125515965|NCT00922441|451520972|FG000|Overall Study|Protocol Violation|0|||
125515966|NCT00922441|451520973|FG001|Overall Study|Protocol Violation|0|||
125515967|NCT00922441|451520974|FG002|Overall Study|Protocol Violation|2|||
125515968|NCT00922441|451520972|FG000|Overall Study|Withdrawal by Subject|0|||
125515969|NCT00922441|451520973|FG001|Overall Study|Withdrawal by Subject|0|||
125515970|NCT00922441|451520974|FG002|Overall Study|Withdrawal by Subject|1|||
125515971|NCT01040403|451520977|FG000|Overall Study|Adverse Event|10|||
125515972|NCT01040403|451520977|FG000|Overall Study|Protocol Violation|2|||
125515973|NCT01040403|451520977|FG000|Overall Study|Lost to Follow-up|1|||
125515974|NCT01040403|451520977|FG000|Overall Study|Not treated|1|||
125515975|NCT01040403|451520977|FG000|Overall Study|Other reason not defined above|6|||
125515976|NCT02973477|451520978|FG000|First Intervention|Lost to Follow-up|0|||
125515977|NCT02973477|451520979|FG001|First Intervention|Lost to Follow-up|2|||
125515978|NCT02973477|451520978|FG000|Washout|Withdrawal by Subject|1|||
125515979|NCT02973477|451520979|FG001|Washout|Withdrawal by Subject|0|||
125515980|NCT02973477|451520978|FG000|Second Intervention|Lost to Follow-up|1|||
125515981|NCT02973477|451520979|FG001|Second Intervention|Lost to Follow-up|0|||
125515982|NCT01885936|451520980|FG000|Overall Study|Withdrawal by Subject|1|||
125515983|NCT01885936|451520981|FG001|Overall Study|Withdrawal by Subject|0|||
125515984|NCT03036150|451520982|FG000|Overall Study|Withdrawal by Subject|8|||
125515985|NCT03036150|451520983|FG001|Overall Study|Withdrawal by Subject|3|||
125515986|NCT03036150|451520982|FG000|Overall Study|Lost to Follow-up|2|||
125515987|NCT03036150|451520983|FG001|Overall Study|Lost to Follow-up|2|||
125515988|NCT00317603|451520984|FG000|Overall Study|Progressive Disease|3|||
125515989|NCT00523549|451520985|FG000|Overall Study|Adverse Event|6|||
125515990|NCT00523549|451520986|FG001|Overall Study|Adverse Event|3|||
125515991|NCT00523549|451520985|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
125515992|NCT00523549|451520986|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
125515993|NCT00523549|451520985|FG000|Overall Study|Protocol Deviation|3|||
125515994|NCT00523549|451520986|FG001|Overall Study|Protocol Deviation|1|||
125515995|NCT00523549|451520985|FG000|Overall Study|Patient withdrew consent|7|||
125515996|NCT00523549|451520986|FG001|Overall Study|Patient withdrew consent|6|||
125515997|NCT00523549|451520985|FG000|Overall Study|Lost to Follow-up|3|||
125515998|NCT00523549|451520986|FG001|Overall Study|Lost to Follow-up|5|||
125515999|NCT00427778|451520991|FG000|First Intervention (4 Weeks)|no longer interested|1|||
125516000|NCT00427778|451520992|FG001|First Intervention (4 Weeks)|no longer interested|0|||
125516001|NCT00427778|451520991|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
125516002|NCT00427778|451520992|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
125516003|NCT00427778|451520991|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
125516004|NCT00427778|451520992|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
125516005|NCT00427778|451520991|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
125516006|NCT00427778|451520992|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
125516007|NCT01388478|451520993|FG000|Overall Study|Adverse Event|4|||
125516008|NCT01388478|451520993|FG000|Overall Study|Withdrawal by Subject|1|||
125516009|NCT01990664|451520994|FG000|Overall Study|Lost to Follow-up|2|||
125516010|NCT01990664|451520995|FG001|Overall Study|Lost to Follow-up|6|||
125516011|NCT01990664|451520994|FG000|Overall Study|Withdrawal by Subject|2|||
125516012|NCT01990664|451520995|FG001|Overall Study|Withdrawal by Subject|3|||
125516013|NCT01990664|451520994|FG000|Overall Study|Protocol Violation|1|||
125516014|NCT01990664|451520995|FG001|Overall Study|Protocol Violation|0|||
125516015|NCT01990664|451520994|FG000|Overall Study|Lens Discomfort|1|||
125516016|NCT01990664|451520995|FG001|Overall Study|Lens Discomfort|1|||
125516017|NCT01990664|451520994|FG000|Overall Study|Lens Handling Difficulties|1|||
125516018|NCT01990664|451520995|FG001|Overall Study|Lens Handling Difficulties|0|||
125516019|NCT01990664|451520994|FG000|Overall Study|Unsatisfactory Visual Response|0|||
125516020|NCT01990664|451520995|FG001|Overall Study|Unsatisfactory Visual Response|1|||
125516021|NCT01037413|451520996|FG000|Part A: Skin Testing|Adverse Event|1|||
125516022|NCT01037413|451520997|FG001|Part A: Skin Testing|Adverse Event|0|||
125516023|NCT01037413|451520996|FG000|Part A: Skin Testing|Protocol Violation|1|||
125516024|NCT01037413|451520997|FG001|Part A: Skin Testing|Protocol Violation|0|||
125516025|NCT01037413|451520996|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
125516026|NCT01037413|451520997|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
125516027|NCT01037413|451520996|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
125516028|NCT01037413|451520997|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
125516029|NCT00619983|451520998|FG000|Test Drug Alone|Withdrawal by Subject|1|||
125516030|NCT00619983|451520999|FG001|Test Drug Alone|Withdrawal by Subject|0|||
125516031|NCT00619983|451521000|FG002|Test Drug Alone|Withdrawal by Subject|0|||
125516032|NCT00619983|451521001|FG003|Test Drug Alone|Withdrawal by Subject|1|||
125516033|NCT00619983|451520998|FG000|Test Drug Alone|Failure of daily diary device|1|||
125516034|NCT00619983|451520999|FG001|Test Drug Alone|Failure of daily diary device|1|||
125516035|NCT00619983|451521000|FG002|Test Drug Alone|Failure of daily diary device|2|||
125516036|NCT00619983|451521001|FG003|Test Drug Alone|Failure of daily diary device|2|||
125516037|NCT00931918|451521002|FG000|Overall Study|Adverse Event|4|||
125516038|NCT00931918|451521003|FG001|Overall Study|Adverse Event|6|||
125516039|NCT00931918|451521002|FG000|Overall Study|Progressive Disease|2|||
125516040|NCT00931918|451521003|FG001|Overall Study|Progressive Disease|1|||
125516041|NCT00931918|451521002|FG000|Overall Study|Symptomatic Deterioration|1|||
125516042|NCT00931918|451521003|FG001|Overall Study|Symptomatic Deterioration|0|||
125516043|NCT00931918|451521002|FG000|Overall Study|Withdrawal by Patient|3|||
125516044|NCT00931918|451521003|FG001|Overall Study|Withdrawal by Patient|4|||
125516045|NCT00931918|451521002|FG000|Overall Study|Other Reason not Specified|4|||
125516046|NCT00931918|451521003|FG001|Overall Study|Other Reason not Specified|4|||
125516047|NCT00931918|451521002|FG000|Overall Study|Did not receive study drug|3|||
125516048|NCT00931918|451521003|FG001|Overall Study|Did not receive study drug|2|||
125516049|NCT00570921|451521004|FG000|Overall Study|Protocol Violation|1|||
125516050|NCT00570921|451521004|FG000|Overall Study|Physician Decision|1|||
125516051|NCT00784277|451521006|FG000|IR Treatment|Adverse Event|4|||
125516052|NCT00784277|451521007|FG001|IR Treatment|Adverse Event|8|||
125516053|NCT00784277|451521008|FG002|IR Treatment|Adverse Event|19|||
125516054|NCT00784277|451521009|FG003|IR Treatment|Adverse Event|35|||
125516055|NCT00784277|451521010|FG004|IR Treatment|Adverse Event|0|||
125516056|NCT00784277|451521011|FG005|IR Treatment|Adverse Event|0|||
125516057|NCT00784277|451521012|FG006|IR Treatment|Adverse Event|0|||
125516058|NCT00784277|451521006|FG000|IR Treatment|Lack of Efficacy|4|||
125516059|NCT00784277|451521007|FG001|IR Treatment|Lack of Efficacy|4|||
125516060|NCT00784277|451521008|FG002|IR Treatment|Lack of Efficacy|1|||
125516061|NCT00784277|451521009|FG003|IR Treatment|Lack of Efficacy|0|||
125516062|NCT00784277|451521010|FG004|IR Treatment|Lack of Efficacy|0|||
125516063|NCT00784277|451521011|FG005|IR Treatment|Lack of Efficacy|0|||
125516064|NCT00784277|451521012|FG006|IR Treatment|Lack of Efficacy|0|||
125516065|NCT00784277|451521006|FG000|IR Treatment|Lost to Follow-up|1|||
125516066|NCT00784277|451521007|FG001|IR Treatment|Lost to Follow-up|0|||
125516067|NCT00784277|451521008|FG002|IR Treatment|Lost to Follow-up|1|||
125516068|NCT00784277|451521009|FG003|IR Treatment|Lost to Follow-up|0|||
125516069|NCT00784277|451521010|FG004|IR Treatment|Lost to Follow-up|0|||
125516070|NCT00784277|451521011|FG005|IR Treatment|Lost to Follow-up|0|||
125516071|NCT00784277|451521012|FG006|IR Treatment|Lost to Follow-up|0|||
125516072|NCT00784277|451521006|FG000|IR Treatment|Withdrawal by Subject|5|||
125516073|NCT00784277|451521007|FG001|IR Treatment|Withdrawal by Subject|1|||
125516074|NCT00784277|451521008|FG002|IR Treatment|Withdrawal by Subject|4|||
125516075|NCT00784277|451521009|FG003|IR Treatment|Withdrawal by Subject|6|||
125516076|NCT00784277|451521010|FG004|IR Treatment|Withdrawal by Subject|0|||
125516077|NCT00784277|451521011|FG005|IR Treatment|Withdrawal by Subject|0|||
125516078|NCT00784277|451521012|FG006|IR Treatment|Withdrawal by Subject|0|||
125516079|NCT00784277|451521006|FG000|IR Treatment|Resolution Of Pain|0|||
125516080|NCT00784277|451521007|FG001|IR Treatment|Resolution Of Pain|1|||
125516081|NCT00784277|451521008|FG002|IR Treatment|Resolution Of Pain|0|||
125516082|NCT00784277|451521009|FG003|IR Treatment|Resolution Of Pain|0|||
125516083|NCT00784277|451521010|FG004|IR Treatment|Resolution Of Pain|0|||
125516084|NCT00784277|451521011|FG005|IR Treatment|Resolution Of Pain|0|||
125516085|NCT00784277|451521012|FG006|IR Treatment|Resolution Of Pain|0|||
125516086|NCT00784277|451521006|FG000|IR Treatment|Other|2|||
125516087|NCT00784277|451521007|FG001|IR Treatment|Other|3|||
125516088|NCT00784277|451521008|FG002|IR Treatment|Other|3|||
125516089|NCT00784277|451521009|FG003|IR Treatment|Other|2|||
125516090|NCT00784277|451521010|FG004|IR Treatment|Other|0|||
125516091|NCT00784277|451521011|FG005|IR Treatment|Other|0|||
125516092|NCT00784277|451521012|FG006|IR Treatment|Other|0|||
125516093|NCT00784277|451521006|FG000|ER Treatment|Adverse Event|0|||
125516094|NCT00784277|451521007|FG001|ER Treatment|Adverse Event|0|||
125516095|NCT00784277|451521008|FG002|ER Treatment|Adverse Event|0|||
125516096|NCT00784277|451521009|FG003|ER Treatment|Adverse Event|0|||
125516097|NCT00784277|451521010|FG004|ER Treatment|Adverse Event|1|||
125516098|NCT00784277|451521011|FG005|ER Treatment|Adverse Event|7|||
125516099|NCT00784277|451521012|FG006|ER Treatment|Adverse Event|7|||
125516100|NCT00784277|451521006|FG000|ER Treatment|Lack of Efficacy|0|||
125516101|NCT00784277|451521007|FG001|ER Treatment|Lack of Efficacy|0|||
125516102|NCT00784277|451521008|FG002|ER Treatment|Lack of Efficacy|0|||
125516103|NCT00784277|451521009|FG003|ER Treatment|Lack of Efficacy|0|||
125516104|NCT00784277|451521010|FG004|ER Treatment|Lack of Efficacy|3|||
125516105|NCT00784277|451521011|FG005|ER Treatment|Lack of Efficacy|4|||
125516106|NCT00784277|451521012|FG006|ER Treatment|Lack of Efficacy|0|||
125516107|NCT00784277|451521006|FG000|ER Treatment|Lost to Follow-up|0|||
125516108|NCT00784277|451521007|FG001|ER Treatment|Lost to Follow-up|0|||
125516109|NCT00784277|451521008|FG002|ER Treatment|Lost to Follow-up|0|||
125516110|NCT00784277|451521009|FG003|ER Treatment|Lost to Follow-up|0|||
125516111|NCT00784277|451521010|FG004|ER Treatment|Lost to Follow-up|0|||
125516112|NCT00784277|451521011|FG005|ER Treatment|Lost to Follow-up|2|||
125516113|NCT00784277|451521012|FG006|ER Treatment|Lost to Follow-up|0|||
125516114|NCT00784277|451521006|FG000|ER Treatment|Withdrawal by Subject|0|||
125516115|NCT00784277|451521007|FG001|ER Treatment|Withdrawal by Subject|0|||
125516116|NCT00784277|451521008|FG002|ER Treatment|Withdrawal by Subject|0|||
125516117|NCT00784277|451521009|FG003|ER Treatment|Withdrawal by Subject|0|||
125516118|NCT00784277|451521010|FG004|ER Treatment|Withdrawal by Subject|2|||
125516119|NCT00784277|451521011|FG005|ER Treatment|Withdrawal by Subject|5|||
125516120|NCT00784277|451521012|FG006|ER Treatment|Withdrawal by Subject|3|||
125516121|NCT00784277|451521006|FG000|ER Treatment|Study Medication Non-Compliant|0|||
125516122|NCT00784277|451521007|FG001|ER Treatment|Study Medication Non-Compliant|0|||
125516123|NCT00784277|451521008|FG002|ER Treatment|Study Medication Non-Compliant|0|||
125516124|NCT00784277|451521009|FG003|ER Treatment|Study Medication Non-Compliant|0|||
125516125|NCT00784277|451521010|FG004|ER Treatment|Study Medication Non-Compliant|2|||
125516126|NCT00784277|451521011|FG005|ER Treatment|Study Medication Non-Compliant|3|||
125516127|NCT00784277|451521012|FG006|ER Treatment|Study Medication Non-Compliant|3|||
125516128|NCT00784277|451521006|FG000|ER Treatment|Other|0|||
125516129|NCT00784277|451521007|FG001|ER Treatment|Other|0|||
125516130|NCT00784277|451521008|FG002|ER Treatment|Other|0|||
125516131|NCT00784277|451521009|FG003|ER Treatment|Other|0|||
125516132|NCT00784277|451521010|FG004|ER Treatment|Other|1|||
125516133|NCT00784277|451521011|FG005|ER Treatment|Other|3|||
125516134|NCT00784277|451521012|FG006|ER Treatment|Other|2|||
125516135|NCT00745121|451521020|FG000|Overall Study|Death|3|||
125516136|NCT00745121|451521021|FG001|Overall Study|Death|0|||
125516137|NCT00745121|451521020|FG000|Overall Study|Adverse Event|1|||
125516138|NCT00745121|451521021|FG001|Overall Study|Adverse Event|0|||
125516139|NCT00745121|451521020|FG000|Overall Study|Lost to Follow-up|1|||
125516140|NCT00745121|451521021|FG001|Overall Study|Lost to Follow-up|0|||
125516141|NCT00745121|451521020|FG000|Overall Study|Withdrawal by Subject|4|||
125516142|NCT00745121|451521021|FG001|Overall Study|Withdrawal by Subject|2|||
125516143|NCT01713998|451521022|FG000|Overall Study|Lost to Follow-up|2|||
125516144|NCT01713998|451521023|FG001|Overall Study|Lost to Follow-up|0|||
125516145|NCT01713998|451521024|FG002|Overall Study|Lost to Follow-up|2|||
125516146|NCT01713998|451521022|FG000|Overall Study|Withdrawal by Subject|1|||
125516147|NCT01713998|451521023|FG001|Overall Study|Withdrawal by Subject|0|||
125516148|NCT01713998|451521024|FG002|Overall Study|Withdrawal by Subject|0|||
125516149|NCT02101268|451521025|FG000|Randomized Treatment Phase|Subject Decision|8|||
125516150|NCT02101268|451521026|FG001|Randomized Treatment Phase|Subject Decision|4|||
125516151|NCT02101268|451521027|FG002|Randomized Treatment Phase|Subject Decision|0|||
125516152|NCT02101268|451521028|FG003|Randomized Treatment Phase|Subject Decision|0|||
125516153|NCT02101268|451521025|FG000|Randomized Treatment Phase|Physician Decision|4|||
125516154|NCT02101268|451521026|FG001|Randomized Treatment Phase|Physician Decision|1|||
125516155|NCT02101268|451521027|FG002|Randomized Treatment Phase|Physician Decision|0|||
125516156|NCT02101268|451521028|FG003|Randomized Treatment Phase|Physician Decision|0|||
125516157|NCT02101268|451521025|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
125516158|NCT02101268|451521026|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
125516159|NCT02101268|451521027|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
125516160|NCT02101268|451521028|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
125516161|NCT02101268|451521025|FG000|Randomized Treatment Phase|Adverse Event|6|||
125516162|NCT02101268|451521026|FG001|Randomized Treatment Phase|Adverse Event|0|||
125516163|NCT02101268|451521027|FG002|Randomized Treatment Phase|Adverse Event|0|||
125516164|NCT02101268|451521028|FG003|Randomized Treatment Phase|Adverse Event|0|||
125516165|NCT02101268|451521025|FG000|Randomized Treatment Phase|Death|5|||
125516166|NCT02101268|451521026|FG001|Randomized Treatment Phase|Death|4|||
125516167|NCT02101268|451521027|FG002|Randomized Treatment Phase|Death|0|||
125516168|NCT02101268|451521028|FG003|Randomized Treatment Phase|Death|0|||
125516169|NCT02101268|451521025|FG000|Randomized Treatment Phase|Disease Progression|4|||
125516170|NCT02101268|451521026|FG001|Randomized Treatment Phase|Disease Progression|1|||
125516171|NCT02101268|451521027|FG002|Randomized Treatment Phase|Disease Progression|0|||
125516172|NCT02101268|451521028|FG003|Randomized Treatment Phase|Disease Progression|0|||
125516173|NCT02101268|451521025|FG000|Extended Treatment Phase|Subject Decision|0|||
125516174|NCT02101268|451521026|FG001|Extended Treatment Phase|Subject Decision|0|||
125516175|NCT02101268|451521027|FG002|Extended Treatment Phase|Subject Decision|3|||
125516176|NCT02101268|451521028|FG003|Extended Treatment Phase|Subject Decision|2|||
125516177|NCT02101268|451521025|FG000|Extended Treatment Phase|Physician Decision|0|||
125516178|NCT02101268|451521026|FG001|Extended Treatment Phase|Physician Decision|0|||
125516179|NCT02101268|451521027|FG002|Extended Treatment Phase|Physician Decision|5|||
125516180|NCT02101268|451521028|FG003|Extended Treatment Phase|Physician Decision|2|||
125516181|NCT02101268|451521025|FG000|Extended Treatment Phase|Adverse Event|0|||
125516182|NCT02101268|451521026|FG001|Extended Treatment Phase|Adverse Event|0|||
125516183|NCT02101268|451521027|FG002|Extended Treatment Phase|Adverse Event|14|||
125516184|NCT02101268|451521028|FG003|Extended Treatment Phase|Adverse Event|18|||
125516185|NCT02101268|451521025|FG000|Extended Treatment Phase|Death|0|||
125516186|NCT02101268|451521026|FG001|Extended Treatment Phase|Death|0|||
125516187|NCT02101268|451521027|FG002|Extended Treatment Phase|Death|5|||
125516188|NCT02101268|451521028|FG003|Extended Treatment Phase|Death|1|||
125516189|NCT02101268|451521025|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
125516190|NCT02101268|451521026|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
125516191|NCT02101268|451521027|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
125516192|NCT02101268|451521028|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
125516193|NCT02101268|451521025|FG000|Extended Treatment Phase|Disease Progression|0|||
125516194|NCT02101268|451521026|FG001|Extended Treatment Phase|Disease Progression|0|||
125516195|NCT02101268|451521027|FG002|Extended Treatment Phase|Disease Progression|13|||
125516196|NCT02101268|451521028|FG003|Extended Treatment Phase|Disease Progression|6|||
125516197|NCT02101268|451521025|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
125516198|NCT02101268|451521026|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
125516199|NCT02101268|451521027|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
125516200|NCT02101268|451521028|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
125516201|NCT00740870|451521029|FG000|Overall Study|Not Catheterized|4|||
125516202|NCT00740870|451521029|FG000|Overall Study|Further testing contraindicated implant|17|||
125516203|NCT00839332|451521031|FG000|Phase 1|Disease Progression|38|||
125516204|NCT00839332|451521032|FG001|Phase 1|Disease Progression|0|||
125516205|NCT00839332|451521033|FG002|Phase 1|Disease Progression|0|||
125516206|NCT00839332|451521031|FG000|Phase 1|Adverse Event|6|||
125516207|NCT00839332|451521032|FG001|Phase 1|Adverse Event|0|||
125516208|NCT00839332|451521033|FG002|Phase 1|Adverse Event|0|||
125516209|NCT00839332|451521031|FG000|Phase 1|Withdrawal by Subject|4|||
125516210|NCT00839332|451521032|FG001|Phase 1|Withdrawal by Subject|0|||
125516211|NCT00839332|451521033|FG002|Phase 1|Withdrawal by Subject|0|||
125516212|NCT00839332|451521031|FG000|Phase 1|Physician Decision|2|||
125516213|NCT00839332|451521032|FG001|Phase 1|Physician Decision|0|||
125516214|NCT00839332|451521033|FG002|Phase 1|Physician Decision|0|||
125516215|NCT00839332|451521031|FG000|Phase 2|Protocol Violation|0|||
125516216|NCT00839332|451521032|FG001|Phase 2|Protocol Violation|1|||
125516217|NCT00839332|451521033|FG002|Phase 2|Protocol Violation|0|||
125516218|NCT00839332|451521031|FG000|Phase 2|Disease Progression|0|||
125516219|NCT00839332|451521032|FG001|Phase 2|Disease Progression|46|||
125516220|NCT00839332|451521033|FG002|Phase 2|Disease Progression|21|||
125516221|NCT00839332|451521031|FG000|Phase 2|Adverse Event|0|||
125516222|NCT00839332|451521032|FG001|Phase 2|Adverse Event|8|||
125516223|NCT00839332|451521033|FG002|Phase 2|Adverse Event|6|||
125516224|NCT00839332|451521031|FG000|Phase 2|Death|0|||
125516225|NCT00839332|451521032|FG001|Phase 2|Death|4|||
125516226|NCT00839332|451521033|FG002|Phase 2|Death|2|||
125516227|NCT00839332|451521031|FG000|Phase 2|Withdrawal by Subject|0|||
125516228|NCT00839332|451521032|FG001|Phase 2|Withdrawal by Subject|5|||
125516229|NCT00839332|451521033|FG002|Phase 2|Withdrawal by Subject|8|||
125516230|NCT00839332|451521031|FG000|Phase 2|Physician Decision|0|||
125516231|NCT00839332|451521032|FG001|Phase 2|Physician Decision|4|||
125516232|NCT00839332|451521033|FG002|Phase 2|Physician Decision|1|||
125516233|NCT00839332|451521031|FG000|Phase 2|Lost to Follow-up|0|||
125516234|NCT00839332|451521032|FG001|Phase 2|Lost to Follow-up|0|||
125516235|NCT00839332|451521033|FG002|Phase 2|Lost to Follow-up|1|||
125516236|NCT01200485|451521034|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
125516237|NCT01200485|451521035|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
125516238|NCT01200485|451521036|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
125516239|NCT01200485|451521034|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
125516240|NCT01200485|451521035|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
125516241|NCT01200485|451521036|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
125516242|NCT06080438|451521037|FG000|Overall Study|Lost to Follow-up|2|||
125516243|NCT03569475|451521038|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
125516244|NCT03569475|451521039|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
125516245|NCT03569475|451521040|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
125516246|NCT03569475|451521038|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
125516247|NCT03569475|451521039|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
125516248|NCT03569475|451521040|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
125516249|NCT03569475|451521038|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
125516250|NCT03569475|451521039|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
125516251|NCT03569475|451521040|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
125516252|NCT03569475|451521038|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
125516253|NCT03569475|451521039|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
125516254|NCT03569475|451521040|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
125516255|NCT03569475|451521038|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
125516256|NCT03569475|451521039|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
125516257|NCT03569475|451521040|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
125516258|NCT03569475|451521038|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
125516259|NCT03569475|451521039|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
125516260|NCT03569475|451521040|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
125516261|NCT03569475|451521038|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
125516262|NCT03569475|451521039|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
125516263|NCT03569475|451521040|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
125516264|NCT03569475|451521038|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
125516265|NCT03569475|451521039|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
125516266|NCT03569475|451521040|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
125516267|NCT03569475|451521038|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
125516268|NCT03569475|451521039|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
125516269|NCT03569475|451521040|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
125516270|NCT03638258|451521042|FG000|Overall Study|Adverse Event|1|||
125516271|NCT03638258|451521043|FG001|Overall Study|Adverse Event|0|||
125516272|NCT03638258|451521044|FG002|Overall Study|Adverse Event|2|||
125516273|NCT03638258|451521042|FG000|Overall Study|Lost to Follow-up|2|||
125516274|NCT03638258|451521043|FG001|Overall Study|Lost to Follow-up|4|||
125516275|NCT03638258|451521044|FG002|Overall Study|Lost to Follow-up|5|||
125516276|NCT03638258|451521042|FG000|Overall Study|Pregnancy|0|||
125516277|NCT03638258|451521043|FG001|Overall Study|Pregnancy|0|||
125516278|NCT03638258|451521044|FG002|Overall Study|Pregnancy|1|||
125516279|NCT03638258|451521042|FG000|Overall Study|Protocol Violation|0|||
125516280|NCT03638258|451521043|FG001|Overall Study|Protocol Violation|0|||
125516281|NCT03638258|451521044|FG002|Overall Study|Protocol Violation|1|||
125516282|NCT03638258|451521042|FG000|Overall Study|Withdrawal by Subject|4|||
125516283|NCT03638258|451521043|FG001|Overall Study|Withdrawal by Subject|5|||
125516284|NCT03638258|451521044|FG002|Overall Study|Withdrawal by Subject|12|||
125516285|NCT03638258|451521042|FG000|Overall Study|Lack of Efficacy|0|||
125516286|NCT03638258|451521043|FG001|Overall Study|Lack of Efficacy|0|||
125516287|NCT03638258|451521044|FG002|Overall Study|Lack of Efficacy|2|||
125516288|NCT02630706|451521045|FG000|Overall Study|Adverse Event|2|||
125516289|NCT02630706|451521046|FG001|Overall Study|Adverse Event|1|||
125516290|NCT02630706|451521047|FG002|Overall Study|Adverse Event|1|||
125516291|NCT02630706|451521045|FG000|Overall Study|Lost to Follow-up|0|||
125516292|NCT02630706|451521046|FG001|Overall Study|Lost to Follow-up|1|||
125516293|NCT02630706|451521047|FG002|Overall Study|Lost to Follow-up|2|||
125516294|NCT02630706|451521045|FG000|Overall Study|Physician Decision|1|||
125516295|NCT02630706|451521046|FG001|Overall Study|Physician Decision|1|||
125516296|NCT02630706|451521047|FG002|Overall Study|Physician Decision|0|||
125516297|NCT02630706|451521045|FG000|Overall Study|Pregnancy|0|||
125516298|NCT02630706|451521046|FG001|Overall Study|Pregnancy|1|||
125516299|NCT02630706|451521047|FG002|Overall Study|Pregnancy|0|||
125516300|NCT02630706|451521045|FG000|Overall Study|Withdrawal by Subject|4|||
125516301|NCT02630706|451521046|FG001|Overall Study|Withdrawal by Subject|5|||
125516302|NCT02630706|451521047|FG002|Overall Study|Withdrawal by Subject|7|||
125516303|NCT01678898|451521048|FG000|PB-102-F01|Adverse Event|0|||
125516304|NCT01678898|451521049|FG001|PB-102-F01|Adverse Event|1|||
125516305|NCT01678898|451521050|FG002|PB-102-F01|Adverse Event|0|||
125516306|NCT01678898|451521048|FG000|PB-102-F01|Physician Decision|0|||
125516307|NCT01678898|451521049|FG001|PB-102-F01|Physician Decision|1|||
125516308|NCT01678898|451521050|FG002|PB-102-F01|Physician Decision|0|||
125516309|NCT01527500|451521053|FG000|Part A|Administrative|11|||
125516310|NCT01527500|451521054|FG001|Part A|Administrative|7|||
125516311|NCT01527500|451521053|FG000|Part A|Adverse Event|4|||
125516312|NCT01527500|451521054|FG001|Part A|Adverse Event|2|||
125516313|NCT01527500|451521053|FG000|Part A|Death|4|||
125516314|NCT01527500|451521054|FG001|Part A|Death|1|||
125516315|NCT01527500|451521053|FG000|Part A|Lost to Follow-up|0|||
125516316|NCT01527500|451521054|FG001|Part A|Lost to Follow-up|1|||
125516317|NCT01527500|451521053|FG000|Part A|Protocol Deviation|9|||
125516318|NCT01527500|451521054|FG001|Part A|Protocol Deviation|2|||
125516319|NCT01527500|451521053|FG000|Part A|Withdrawal by Subject|2|||
125516320|NCT01527500|451521054|FG001|Part A|Withdrawal by Subject|0|||
125516321|NCT01527500|451521053|FG000|Part B|Adverse Event|1|||
125516322|NCT01527500|451521054|FG001|Part B|Adverse Event|0|||
125516323|NCT03078751|451521062|FG000|Overall Study|Adverse Event|4|||
125516324|NCT03078751|451521063|FG001|Overall Study|Adverse Event|0|||
125516325|NCT03078751|451521062|FG000|Overall Study|Physician Decision|1|||
125516326|NCT03078751|451521063|FG001|Overall Study|Physician Decision|0|||
125516327|NCT03078751|451521062|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
125516328|NCT03078751|451521063|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
125516329|NCT03078751|451521062|FG000|Overall Study|Subject/guardian decision|8|||
125516330|NCT03078751|451521063|FG001|Overall Study|Subject/guardian decision|1|||
125516331|NCT03078751|451521062|FG000|Overall Study|Untreated|0|||
125516332|NCT03078751|451521063|FG001|Overall Study|Untreated|4|||
125516333|NCT01209286|451521064|FG000|Overall Study|Adverse Event|4|||
125516334|NCT01209286|451521065|FG001|Overall Study|Adverse Event|3|||
125516335|NCT01209286|451521066|FG002|Overall Study|Adverse Event|1|||
125516336|NCT01209286|451521064|FG000|Overall Study|Hematological Relapse After Remission|0|||
125516337|NCT01209286|451521065|FG001|Overall Study|Hematological Relapse After Remission|1|||
125516338|NCT01209286|451521066|FG002|Overall Study|Hematological Relapse After Remission|1|||
125516339|NCT01209286|451521064|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
125516340|NCT01209286|451521065|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
125516341|NCT01209286|451521066|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
125516342|NCT01209286|451521064|FG000|Overall Study|Physician Decision|0|||
125516343|NCT01209286|451521065|FG001|Overall Study|Physician Decision|2|||
125516344|NCT01209286|451521066|FG002|Overall Study|Physician Decision|0|||
125516345|NCT01209286|451521064|FG000|Overall Study|Other|0|||
125516346|NCT01209286|451521065|FG001|Overall Study|Other|1|||
125516347|NCT01209286|451521066|FG002|Overall Study|Other|0|||
125516348|NCT00981578|451521067|FG000|Overall Study|Death|1|||
125516349|NCT00981578|451521067|FG000|Overall Study|Withdrawal by Subject|2|||
125516350|NCT03030599|451521068|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
125516351|NCT03030599|451521069|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
125516352|NCT03030599|451521070|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
125516353|NCT03030599|451521068|FG000|Open Label Treatment and Titration|Other|1|||
125516354|NCT03030599|451521069|FG001|Open Label Treatment and Titration|Other|0|||
125516355|NCT03030599|451521070|FG002|Open Label Treatment and Titration|Other|0|||
125516356|NCT03030599|451521068|FG000|Open Label Treatment and Titration|Physician Decision|3|||
125516357|NCT03030599|451521069|FG001|Open Label Treatment and Titration|Physician Decision|0|||
125516358|NCT03030599|451521070|FG002|Open Label Treatment and Titration|Physician Decision|0|||
125516359|NCT03030599|451521068|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
125516360|NCT03030599|451521069|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
125516361|NCT03030599|451521070|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
125516362|NCT03030599|451521068|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
125516363|NCT03030599|451521069|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
125516364|NCT03030599|451521070|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
125516365|NCT03030599|451521068|FG000|Open Label Treatment and Titration|Adverse Event|18|||
125516366|NCT03030599|451521069|FG001|Open Label Treatment and Titration|Adverse Event|0|||
125516367|NCT03030599|451521070|FG002|Open Label Treatment and Titration|Adverse Event|0|||
125516368|NCT03030599|451521068|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
125516369|NCT03030599|451521069|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
125516370|NCT03030599|451521070|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
125516371|NCT03030599|451521068|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
125516372|NCT03030599|451521069|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
125516373|NCT03030599|451521070|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
125516374|NCT03030599|451521068|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
125516375|NCT03030599|451521069|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
125516376|NCT03030599|451521070|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
125516377|NCT03030599|451521068|FG000|Stable Dose|Protocol deviation|3|||
125516378|NCT03030599|451521069|FG001|Stable Dose|Protocol deviation|0|||
125516379|NCT03030599|451521070|FG002|Stable Dose|Protocol deviation|0|||
125516380|NCT03030599|451521068|FG000|Stable Dose|Adverse Event|1|||
125516381|NCT03030599|451521069|FG001|Stable Dose|Adverse Event|0|||
125516382|NCT03030599|451521070|FG002|Stable Dose|Adverse Event|0|||
125516383|NCT03030599|451521068|FG000|Stable Dose|Lost to Follow-up|1|||
125516384|NCT03030599|451521069|FG001|Stable Dose|Lost to Follow-up|0|||
125516385|NCT03030599|451521070|FG002|Stable Dose|Lost to Follow-up|0|||
125516386|NCT03030599|451521068|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
125516387|NCT03030599|451521069|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
125516388|NCT03030599|451521070|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
125516389|NCT03030599|451521068|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
125516390|NCT03030599|451521069|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
125516391|NCT03030599|451521070|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
125516392|NCT03030599|451521068|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
125516393|NCT03030599|451521069|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
125516394|NCT03030599|451521070|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
125516395|NCT03030599|451521068|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
125516396|NCT03030599|451521069|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
125516397|NCT03030599|451521070|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
125516398|NCT03030599|451521068|FG000|Open-label Extension|Adverse Event|3|||
125516399|NCT03030599|451521069|FG001|Open-label Extension|Adverse Event|0|||
125516400|NCT03030599|451521070|FG002|Open-label Extension|Adverse Event|0|||
125516401|NCT03030599|451521068|FG000|Open-label Extension|Lost to Follow-up|2|||
125516402|NCT03030599|451521069|FG001|Open-label Extension|Lost to Follow-up|0|||
125516403|NCT03030599|451521070|FG002|Open-label Extension|Lost to Follow-up|0|||
125516404|NCT03030599|451521068|FG000|Open-label Extension|Lack of Efficacy|1|||
125516405|NCT03030599|451521069|FG001|Open-label Extension|Lack of Efficacy|0|||
125516406|NCT03030599|451521070|FG002|Open-label Extension|Lack of Efficacy|0|||
125516407|NCT03030599|451521068|FG000|Open-label Extension|Other Reason|1|||
125516408|NCT03030599|451521069|FG001|Open-label Extension|Other Reason|0|||
125516409|NCT03030599|451521070|FG002|Open-label Extension|Other Reason|0|||
125516410|NCT01180790|451521071|FG000|Overall Study|Adverse Event|1|||
125516411|NCT01180790|451521072|FG001|Overall Study|Adverse Event|1|||
125516412|NCT01180790|451521073|FG002|Overall Study|Adverse Event|2|||
125516413|NCT01180790|451521074|FG003|Overall Study|Adverse Event|0|||
125516414|NCT01180790|451521075|FG004|Overall Study|Adverse Event|1|||
125516415|NCT01180790|451521076|FG005|Overall Study|Adverse Event|3|||
125516416|NCT01180790|451521077|FG006|Overall Study|Adverse Event|0|||
125516417|NCT01180790|451521071|FG000|Overall Study|Withdrawal by Subject|3|||
125516418|NCT01180790|451521072|FG001|Overall Study|Withdrawal by Subject|0|||
125516419|NCT01180790|451521073|FG002|Overall Study|Withdrawal by Subject|5|||
125516420|NCT01180790|451521074|FG003|Overall Study|Withdrawal by Subject|0|||
125516421|NCT01180790|451521075|FG004|Overall Study|Withdrawal by Subject|2|||
125516422|NCT01180790|451521076|FG005|Overall Study|Withdrawal by Subject|1|||
125516423|NCT01180790|451521077|FG006|Overall Study|Withdrawal by Subject|0|||
125516424|NCT01180790|451521071|FG000|Overall Study|Lost to Follow-up|3|||
125516425|NCT01180790|451521072|FG001|Overall Study|Lost to Follow-up|1|||
125516426|NCT01180790|451521073|FG002|Overall Study|Lost to Follow-up|0|||
125516427|NCT01180790|451521074|FG003|Overall Study|Lost to Follow-up|2|||
125516428|NCT01180790|451521075|FG004|Overall Study|Lost to Follow-up|1|||
125516429|NCT01180790|451521076|FG005|Overall Study|Lost to Follow-up|0|||
125516430|NCT01180790|451521077|FG006|Overall Study|Lost to Follow-up|1|||
125516431|NCT01180790|451521071|FG000|Overall Study|Physician Decision|1|||
125516432|NCT01180790|451521072|FG001|Overall Study|Physician Decision|0|||
125516433|NCT01180790|451521073|FG002|Overall Study|Physician Decision|0|||
125516434|NCT01180790|451521074|FG003|Overall Study|Physician Decision|1|||
125516435|NCT01180790|451521075|FG004|Overall Study|Physician Decision|0|||
125516436|NCT01180790|451521076|FG005|Overall Study|Physician Decision|0|||
125516437|NCT01180790|451521077|FG006|Overall Study|Physician Decision|0|||
125516438|NCT01180790|451521071|FG000|Overall Study|Lack of Efficacy|1|||
125516439|NCT01180790|451521072|FG001|Overall Study|Lack of Efficacy|2|||
125516440|NCT01180790|451521073|FG002|Overall Study|Lack of Efficacy|5|||
125516441|NCT01180790|451521074|FG003|Overall Study|Lack of Efficacy|6|||
125516442|NCT01180790|451521075|FG004|Overall Study|Lack of Efficacy|1|||
125516443|NCT01180790|451521076|FG005|Overall Study|Lack of Efficacy|3|||
125516444|NCT01180790|451521077|FG006|Overall Study|Lack of Efficacy|0|||
125516445|NCT01180790|451521071|FG000|Overall Study|compliance|0|||
125516446|NCT01180790|451521072|FG001|Overall Study|compliance|1|||
125516447|NCT01180790|451521073|FG002|Overall Study|compliance|0|||
125516448|NCT01180790|451521074|FG003|Overall Study|compliance|0|||
125516449|NCT01180790|451521075|FG004|Overall Study|compliance|0|||
125516450|NCT01180790|451521076|FG005|Overall Study|compliance|0|||
125516451|NCT01180790|451521077|FG006|Overall Study|compliance|0|||
125516452|NCT01180790|451521071|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
125516453|NCT01180790|451521072|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
125516454|NCT01180790|451521073|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
125516455|NCT01180790|451521074|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
125516456|NCT01180790|451521075|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
125516457|NCT01180790|451521076|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
125516458|NCT01180790|451521077|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
125516459|NCT04582864|451521078|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
125516460|NCT04582864|451521078|FG000|Overall Study|Death|1|||
125516461|NCT00316589|451521079|FG000|Overall Study|Withdrawal by Subject|0|||
125516462|NCT00316589|451521080|FG001|Overall Study|Withdrawal by Subject|5|||
125516463|NCT00316589|451521081|FG002|Overall Study|Withdrawal by Subject|0|||
125516464|NCT00316589|451521082|FG003|Overall Study|Withdrawal by Subject|1|||
125516465|NCT00316589|451521079|FG000|Overall Study|Subject unwilling/unable to comply|0|||
125516466|NCT00316589|451521080|FG001|Overall Study|Subject unwilling/unable to comply|6|||
125516467|NCT00316589|451521081|FG002|Overall Study|Subject unwilling/unable to comply|0|||
125516468|NCT00316589|451521082|FG003|Overall Study|Subject unwilling/unable to comply|2|||
125516469|NCT00316589|451521079|FG000|Overall Study|Adverse Event|1|||
125516470|NCT00316589|451521080|FG001|Overall Study|Adverse Event|0|||
125516471|NCT00316589|451521081|FG002|Overall Study|Adverse Event|0|||
125516472|NCT00316589|451521082|FG003|Overall Study|Adverse Event|1|||
125516473|NCT00316589|451521079|FG000|Overall Study|Physician Decision|0|||
125516474|NCT00316589|451521080|FG001|Overall Study|Physician Decision|1|||
125516475|NCT00316589|451521081|FG002|Overall Study|Physician Decision|0|||
125516476|NCT00316589|451521082|FG003|Overall Study|Physician Decision|0|||
125516477|NCT00316589|451521079|FG000|Overall Study|Other reason|0|||
125516478|NCT00316589|451521080|FG001|Overall Study|Other reason|12|||
125516479|NCT00316589|451521081|FG002|Overall Study|Other reason|1|||
125516480|NCT00316589|451521082|FG003|Overall Study|Other reason|1|||
125516481|NCT01482819|451521083|FG000|Overall Study|Lost to Follow-up|2|||
125516482|NCT00562484|451521084|FG000|Overall Study|Adverse Event|6|||
125516483|NCT00562484|451521085|FG001|Overall Study|Adverse Event|1|||
125516484|NCT00562484|451521084|FG000|Overall Study|Protocol Violation|11|||
125516485|NCT00562484|451521085|FG001|Overall Study|Protocol Violation|2|||
125516486|NCT00562484|451521084|FG000|Overall Study|Withdrawal by Subject|12|||
125516487|NCT00562484|451521085|FG001|Overall Study|Withdrawal by Subject|9|||
125516488|NCT00562484|451521084|FG000|Overall Study|Moved away from the study area|20|||
125516489|NCT00562484|451521085|FG001|Overall Study|Moved away from the study area|9|||
125516490|NCT00562484|451521084|FG000|Overall Study|Lost to Follow-up|132|||
125516491|NCT00562484|451521085|FG001|Overall Study|Lost to Follow-up|71|||
125516492|NCT00562484|451521084|FG000|Overall Study|Reason not provided or not specified|25|||
125516493|NCT00562484|451521085|FG001|Overall Study|Reason not provided or not specified|12|||
125516494|NCT00702520|451521087|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
125516495|NCT00702520|451521088|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
125516496|NCT00702520|451521089|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
125516497|NCT00702520|451521090|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
125516498|NCT00702520|451521087|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
125516499|NCT00702520|451521088|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
125516500|NCT00702520|451521089|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
125516501|NCT00702520|451521090|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
125516502|NCT00702520|451521087|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
125516503|NCT00702520|451521088|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
125516504|NCT00702520|451521089|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
125516505|NCT00702520|451521090|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
125516506|NCT02481934|451521091|FG000|Overall Study|Death|2|||
125516507|NCT04130061|451521099|FG000|Overall Study|OR team forgot to request membrane|1|||
125516508|NCT04130061|451521100|FG001|Overall Study|OR team forgot to request membrane|0|||
125516509|NCT01568112|451521101|FG000|Overall Study|Randomized But Not Treated|0|||
125516510|NCT01568112|451521102|FG001|Overall Study|Randomized But Not Treated|1|||
125516511|NCT01568112|451521103|FG002|Overall Study|Randomized But Not Treated|0|||
125516512|NCT01568112|451521104|FG003|Overall Study|Randomized But Not Treated|0|||
125516513|NCT01568112|451521101|FG000|Overall Study|Withdrew due to Adverse Event|2|||
125516514|NCT01568112|451521102|FG001|Overall Study|Withdrew due to Adverse Event|4|||
125516515|NCT01568112|451521103|FG002|Overall Study|Withdrew due to Adverse Event|6|||
125516516|NCT01568112|451521104|FG003|Overall Study|Withdrew due to Adverse Event|3|||
125516517|NCT01568112|451521101|FG000|Overall Study|Lost to Follow-up|0|||
125516518|NCT01568112|451521102|FG001|Overall Study|Lost to Follow-up|0|||
125516519|NCT01568112|451521103|FG002|Overall Study|Lost to Follow-up|0|||
125516520|NCT01568112|451521104|FG003|Overall Study|Lost to Follow-up|1|||
125516521|NCT01568112|451521101|FG000|Overall Study|Withdrawal by Subject|2|||
125516522|NCT01568112|451521102|FG001|Overall Study|Withdrawal by Subject|3|||
125516523|NCT01568112|451521103|FG002|Overall Study|Withdrawal by Subject|0|||
125516524|NCT01568112|451521104|FG003|Overall Study|Withdrawal by Subject|7|||
125516525|NCT01568112|451521101|FG000|Overall Study|Withdrawal by Physician|1|||
125516526|NCT01568112|451521102|FG001|Overall Study|Withdrawal by Physician|0|||
125516527|NCT01568112|451521103|FG002|Overall Study|Withdrawal by Physician|1|||
125516528|NCT01568112|451521104|FG003|Overall Study|Withdrawal by Physician|1|||
125516529|NCT00560313|451522556|FG000|Overall Study|Adverse Events or Death|2|||
125516530|NCT00560313|451522556|FG000|Overall Study|Withdrawal by Subject|2|||
125516531|NCT00560313|451522556|FG000|Overall Study|Lost to Follow-up|1|||
125516532|NCT00560313|451522556|FG000|Overall Study|Protocol Violation|1|||
125516533|NCT00746785|451522557|FG000|Overall Study|Lost to Follow-up|29|||
125516534|NCT00746785|451522558|FG001|Overall Study|Lost to Follow-up|25|||
125516535|NCT00746785|451522559|FG002|Overall Study|Lost to Follow-up|27|||
125516536|NCT00113269|451522560|FG000|Overall Study|Not transplanted, donor issues|4|||
125516537|NCT00113269|451522561|FG001|Overall Study|Not transplanted, donor issues|0|||
125516538|NCT00113269|451522562|FG002|Overall Study|Not transplanted, donor issues|2|||
125516539|NCT00113269|451522563|FG003|Overall Study|Not transplanted, donor issues|2|||
125516540|NCT00113269|451522560|FG000|Overall Study|Not transplanted, recipient issues|2|||
125516541|NCT00113269|451522561|FG001|Overall Study|Not transplanted, recipient issues|1|||
125516542|NCT00113269|451522562|FG002|Overall Study|Not transplanted, recipient issues|7|||
125516543|NCT00113269|451522563|FG003|Overall Study|Not transplanted, recipient issues|4|||
125516544|NCT00113269|451522560|FG000|Overall Study|Early graft loss, technical|0|||
125516545|NCT00113269|451522561|FG001|Overall Study|Early graft loss, technical|0|||
125516546|NCT00113269|451522562|FG002|Overall Study|Early graft loss, technical|2|||
125516547|NCT00113269|451522563|FG003|Overall Study|Early graft loss, technical|0|||
125516548|NCT00113269|451522560|FG000|Overall Study|Death in operating room|0|||
125516549|NCT00113269|451522561|FG001|Overall Study|Death in operating room|0|||
125516550|NCT00113269|451522562|FG002|Overall Study|Death in operating room|0|||
125516551|NCT00113269|451522563|FG003|Overall Study|Death in operating room|1|||
125516552|NCT00113269|451522560|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
125516553|NCT00113269|451522561|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
125516554|NCT00113269|451522562|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
125516555|NCT00113269|451522563|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
125516556|NCT00113269|451522560|FG000|Overall Study|Adverse Event|2|||
125516557|NCT00113269|451522561|FG001|Overall Study|Adverse Event|7|||
125516558|NCT00113269|451522562|FG002|Overall Study|Adverse Event|11|||
125516559|NCT00113269|451522563|FG003|Overall Study|Adverse Event|7|||
125516560|NCT00113269|451522560|FG000|Overall Study|Withdrawal by Subject|4|||
125516561|NCT00113269|451522561|FG001|Overall Study|Withdrawal by Subject|3|||
125516562|NCT00113269|451522562|FG002|Overall Study|Withdrawal by Subject|4|||
125516563|NCT00113269|451522563|FG003|Overall Study|Withdrawal by Subject|2|||
125516564|NCT00113269|451522560|FG000|Overall Study|Graft loss|6|||
125516565|NCT00113269|451522561|FG001|Overall Study|Graft loss|6|||
125516566|NCT00113269|451522562|FG002|Overall Study|Graft loss|4|||
125516567|NCT00113269|451522563|FG003|Overall Study|Graft loss|9|||
125516568|NCT00113269|451522560|FG000|Overall Study|Protocol Violation|1|||
125516569|NCT00113269|451522561|FG001|Overall Study|Protocol Violation|0|||
125516570|NCT00113269|451522562|FG002|Overall Study|Protocol Violation|4|||
125516571|NCT00113269|451522563|FG003|Overall Study|Protocol Violation|2|||
125516572|NCT00113269|451522560|FG000|Overall Study|Lost to Follow-up|2|||
125516573|NCT00113269|451522561|FG001|Overall Study|Lost to Follow-up|3|||
125516574|NCT00113269|451522562|FG002|Overall Study|Lost to Follow-up|6|||
125516575|NCT00113269|451522563|FG003|Overall Study|Lost to Follow-up|3|||
125516576|NCT00113269|451522560|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
125516577|NCT00113269|451522561|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
125516578|NCT00113269|451522562|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
125516579|NCT00113269|451522563|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
125516580|NCT00113269|451522560|FG000|Overall Study|Discontinued due to rejection|0|||
125516581|NCT00113269|451522561|FG001|Overall Study|Discontinued due to rejection|0|||
125516582|NCT00113269|451522562|FG002|Overall Study|Discontinued due to rejection|1|||
125516583|NCT00113269|451522563|FG003|Overall Study|Discontinued due to rejection|0|||
125516584|NCT00113269|451522560|FG000|Overall Study|Moved|0|||
125516585|NCT00113269|451522561|FG001|Overall Study|Moved|1|||
125516586|NCT00113269|451522562|FG002|Overall Study|Moved|0|||
125516587|NCT00113269|451522563|FG003|Overall Study|Moved|3|||
125516588|NCT00113269|451522560|FG000|Overall Study|Received pancreas transplant|0|||
125516589|NCT00113269|451522561|FG001|Overall Study|Received pancreas transplant|0|||
125516590|NCT00113269|451522562|FG002|Overall Study|Received pancreas transplant|0|||
125516591|NCT00113269|451522563|FG003|Overall Study|Received pancreas transplant|2|||
125516592|NCT00113269|451522560|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
125516593|NCT00113269|451522561|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
125516594|NCT00113269|451522562|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
125516595|NCT00113269|451522563|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
125516596|NCT00113269|451522560|FG000|Overall Study|Did not meet eligibility criteria|1|||
125516597|NCT00113269|451522561|FG001|Overall Study|Did not meet eligibility criteria|0|||
125516598|NCT00113269|451522562|FG002|Overall Study|Did not meet eligibility criteria|0|||
125516599|NCT00113269|451522563|FG003|Overall Study|Did not meet eligibility criteria|1|||
125516600|NCT00113269|451522560|FG000|Overall Study|Unable to return for follow up|2|||
125516601|NCT00113269|451522561|FG001|Overall Study|Unable to return for follow up|1|||
125516602|NCT00113269|451522562|FG002|Overall Study|Unable to return for follow up|0|||
125516603|NCT00113269|451522563|FG003|Overall Study|Unable to return for follow up|0|||
125516604|NCT00966979|451522567|FG000|Overall Study|Death|1|||
125516605|NCT00966979|451522567|FG000|Overall Study|Lost to Follow-up|6|||
125516606|NCT00966979|451522567|FG000|Overall Study|Withdrawal by Subject|14|||
125516607|NCT00966979|451522567|FG000|Overall Study|Adverse Event|5|||
125516608|NCT00966979|451522567|FG000|Overall Study|Sponsor terminated early|49|||
125516609|NCT00966979|451522567|FG000|Overall Study|Censored because surgery not done|2|||
125516610|NCT00966979|451522567|FG000|Overall Study|Censored because study device was not implanted|14|||
125516611|NCT00966979|451522567|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
125516612|NCT04140266|451522568|FG000|Overall Study|Physician Decision|2|||
125516613|NCT04140266|451522569|FG001|Overall Study|Physician Decision|0|||
125516614|NCT04140266|451522568|FG000|Overall Study|Withdrawal by Subject|4|||
125516615|NCT04140266|451522569|FG001|Overall Study|Withdrawal by Subject|2|||
125516616|NCT03119688|451522573|FG000|Overall Study|Adverse Event|4|||
125516617|NCT03226106|451522574|FG000|Overall Study|Withdrawal by Subject|2|||
125516618|NCT03226106|451522575|FG001|Overall Study|Withdrawal by Subject|0|||
125516619|NCT03226106|451522574|FG000|Overall Study|Adverse Event|1|||
125516620|NCT03226106|451522575|FG001|Overall Study|Adverse Event|0|||
125516621|NCT03226106|451522574|FG000|Overall Study|Lost to Follow-up|2|||
125516622|NCT03226106|451522575|FG001|Overall Study|Lost to Follow-up|0|||
125516623|NCT00721214|451522576|FG000|Overall Study|Chose another center for transplant|1|||
125516624|NCT00721214|451522576|FG000|Overall Study|Death|3|||
125516625|NCT00488319|451522579|FG000|Overall Study|Adverse Event|1|||
125516626|NCT00488319|451522580|FG001|Overall Study|Adverse Event|2|||
125516627|NCT00488319|451522581|FG002|Overall Study|Adverse Event|23|||
125516628|NCT00488319|451522579|FG000|Overall Study|Lack of Efficacy|6|||
125516629|NCT00488319|451522580|FG001|Overall Study|Lack of Efficacy|12|||
125516630|NCT00488319|451522581|FG002|Overall Study|Lack of Efficacy|27|||
125516631|NCT00488319|451522579|FG000|Overall Study|Lost to Follow-up|3|||
125516632|NCT00488319|451522580|FG001|Overall Study|Lost to Follow-up|5|||
125516633|NCT00488319|451522581|FG002|Overall Study|Lost to Follow-up|16|||
125516634|NCT00488319|451522579|FG000|Overall Study|Withdrawal by Subject|5|||
125516635|NCT00488319|451522580|FG001|Overall Study|Withdrawal by Subject|20|||
125516636|NCT00488319|451522581|FG002|Overall Study|Withdrawal by Subject|44|||
125516637|NCT00488319|451522579|FG000|Overall Study|Other reasons for withdrawal|0|||
125516638|NCT00488319|451522580|FG001|Overall Study|Other reasons for withdrawal|4|||
125516639|NCT00488319|451522581|FG002|Overall Study|Other reasons for withdrawal|12|||
125516640|NCT02158247|451522582|FG000|Overall Study|Invisible vocal cords|5|||
125516641|NCT00875615|451522589|FG000|Overall Study|Withdrawal by Subject|1|||
125516642|NCT01772823|451522590|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
125516643|NCT01772823|451522591|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
125516644|NCT01772823|451522590|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
125516645|NCT01772823|451522591|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
125516646|NCT01772823|451522590|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
125516647|NCT01772823|451522591|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
125516648|NCT01772823|451522590|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
125516649|NCT01772823|451522591|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
125516650|NCT01772823|451522590|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
125516651|NCT01772823|451522591|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
125516652|NCT01772823|451522590|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
125516653|NCT01772823|451522591|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
125516654|NCT01772823|451522590|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
125516655|NCT01772823|451522591|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
125516656|NCT01772823|451522590|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
125516657|NCT01772823|451522591|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
125516658|NCT01772823|451522590|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
125516659|NCT01772823|451522591|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
125516660|NCT01772823|451522590|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
125516661|NCT01772823|451522591|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
125516662|NCT01772823|451522590|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
125516663|NCT01772823|451522591|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
125516664|NCT01772823|451522590|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
125516665|NCT01772823|451522591|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
125516666|NCT01772823|451522590|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
125516667|NCT01772823|451522591|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
125516668|NCT01772823|451522590|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
125516669|NCT01772823|451522591|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
125516670|NCT01772823|451522590|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
125516671|NCT01772823|451522591|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
125516672|NCT01772823|451522590|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
125516673|NCT01772823|451522591|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
125516674|NCT02490878|451522595|FG000|Overall Study|deemed ineligible|0|||
125516675|NCT02490878|451522596|FG001|Overall Study|deemed ineligible|1|||
125516676|NCT02490878|451522595|FG000|Overall Study|progression prior to treatment|0|||
125516677|NCT02490878|451522596|FG001|Overall Study|progression prior to treatment|1|||
125516678|NCT02490878|451522595|FG000|Overall Study|only submitted baseline QOL|0|||
125516679|NCT02490878|451522596|FG001|Overall Study|only submitted baseline QOL|1|||
125516680|NCT02544113|451522597|FG000|Overall Study|Death|3|||
125516681|NCT02544113|451522598|FG001|Overall Study|Death|4|||
125516682|NCT00451555|451522599|FG000|Overall Study|Protocol Violation|2|||
125516683|NCT00451555|451522600|FG001|Overall Study|Protocol Violation|2|||
125516684|NCT00451555|451522599|FG000|Overall Study|Adverse Event|3|||
125516685|NCT00451555|451522600|FG001|Overall Study|Adverse Event|1|||
125516686|NCT00451555|451522599|FG000|Overall Study|Withdrawal by Subject|6|||
125516687|NCT00451555|451522600|FG001|Overall Study|Withdrawal by Subject|0|||
125516688|NCT00451555|451522599|FG000|Overall Study|Physician Decision|2|||
125516689|NCT00451555|451522600|FG001|Overall Study|Physician Decision|1|||
125516690|NCT02847637|451522601|FG000|Overall Study|Withdrawal by Subject|0|||
125516691|NCT02847637|451522602|FG001|Overall Study|Withdrawal by Subject|1|||
125516692|NCT02847637|451522603|FG002|Overall Study|Withdrawal by Subject|1|||
125516693|NCT02847637|451522604|FG003|Overall Study|Withdrawal by Subject|0|||
125516694|NCT02847637|451522601|FG000|Overall Study|Lost to Follow-up|1|||
125516695|NCT02847637|451522602|FG001|Overall Study|Lost to Follow-up|1|||
125516696|NCT02847637|451522603|FG002|Overall Study|Lost to Follow-up|0|||
125516697|NCT02847637|451522604|FG003|Overall Study|Lost to Follow-up|0|||
125516698|NCT02741713|451522612|FG000|Overall Study|Surgery type changed intra-operatively|2|||
125516699|NCT02741713|451522613|FG001|Overall Study|Surgery type changed intra-operatively|1|||
125516700|NCT01093222|451522614|FG000|Overall Study|Ineligible|6|||
125516701|NCT01093222|451522614|FG000|Overall Study|Adverse Event|7|||
125516702|NCT01093222|451522614|FG000|Overall Study|Progression/relapse|24|||
125516703|NCT01093222|451522614|FG000|Overall Study|Death|2|||
125516704|NCT01093222|451522614|FG000|Overall Study|Not protocol specified|1|||
125516705|NCT00588341|451522615|FG000|Overall Study|Withdrawal by Subject|3|||
125516706|NCT00588341|451522615|FG000|Overall Study|Not treated due to metastatic disease|1|||
125516707|NCT00588341|451522615|FG000|Overall Study|Patient ineligible|1|||
125516708|NCT01670188|451522616|FG000|Overall Study|Death|0|||
125516709|NCT01670188|451522617|FG001|Overall Study|Death|1|||
125516710|NCT01281917|451522625|FG000|Overall Study|Withdrawal by Subject|1|||
125516711|NCT01187407|451522627|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
125516712|NCT01187407|451522628|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125516713|NCT01187407|451522629|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125516714|NCT01187407|451522630|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125516715|NCT01187407|451522631|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125516716|NCT01187407|451522627|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
125516717|NCT01187407|451522628|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125516718|NCT01187407|451522629|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125516719|NCT01187407|451522630|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125516720|NCT01187407|451522631|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125516721|NCT01187407|451522627|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
125516722|NCT01187407|451522628|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125516723|NCT01187407|451522629|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125516724|NCT01187407|451522630|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125516725|NCT01187407|451522631|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125516726|NCT01187407|451522627|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
125516727|NCT01187407|451522628|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125516728|NCT01187407|451522629|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125516729|NCT01187407|451522630|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125516730|NCT01187407|451522631|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125516731|NCT01187407|451522627|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
125516732|NCT01187407|451522628|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125516733|NCT01187407|451522629|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125516734|NCT01187407|451522630|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125516735|NCT01187407|451522631|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125516736|NCT01187407|451522627|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
125516737|NCT01187407|451522628|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125516738|NCT01187407|451522629|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125516739|NCT01187407|451522630|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125516740|NCT01187407|451522631|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125516741|NCT01187407|451522627|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
125516742|NCT01187407|451522628|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125516743|NCT01187407|451522629|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125516744|NCT01187407|451522630|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125516745|NCT01187407|451522631|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125516746|NCT01187407|451522627|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
125516747|NCT01187407|451522628|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
125516748|NCT01187407|451522629|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
125516749|NCT01187407|451522630|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
125516750|NCT01187407|451522631|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
125516751|NCT01187407|451522627|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
125516752|NCT01187407|451522628|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
125516753|NCT01187407|451522629|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
125516754|NCT01187407|451522630|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
125516755|NCT01187407|451522631|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
125516756|NCT01187407|451522627|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
125516757|NCT01187407|451522628|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
125516758|NCT01187407|451522629|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
125516759|NCT01187407|451522630|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
125516760|NCT01187407|451522631|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
125516761|NCT01187407|451522627|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
125516762|NCT01187407|451522628|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
125516763|NCT01187407|451522629|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
125516764|NCT01187407|451522630|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
125516765|NCT01187407|451522631|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
125516766|NCT01187407|451522627|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
125516767|NCT01187407|451522628|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
125516768|NCT01187407|451522629|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
125516769|NCT01187407|451522630|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
125516770|NCT01187407|451522631|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
125516771|NCT01187407|451522627|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
125516772|NCT01187407|451522628|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
125516773|NCT01187407|451522629|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
125516774|NCT01187407|451522630|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
125516775|NCT01187407|451522631|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
125516776|NCT01187407|451522627|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
125516777|NCT01187407|451522628|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
125516778|NCT01187407|451522629|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
125516779|NCT01187407|451522630|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
125516780|NCT01187407|451522631|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
125516781|NCT00776984|451522634|FG000|Overall Study|Adverse Event|8|||
125516782|NCT00776984|451522635|FG001|Overall Study|Adverse Event|2|||
125516783|NCT00776984|451522634|FG000|Overall Study|Protocol Violation|4|||
125516784|NCT00776984|451522635|FG001|Overall Study|Protocol Violation|2|||
125516785|NCT00776984|451522634|FG000|Overall Study|Lost to Follow-up|2|||
125516786|NCT00776984|451522635|FG001|Overall Study|Lost to Follow-up|0|||
125516787|NCT00776984|451522634|FG000|Overall Study|Withdrawal by Subject|12|||
125516788|NCT00776984|451522635|FG001|Overall Study|Withdrawal by Subject|7|||
125516789|NCT00776984|451522634|FG000|Overall Study|Lack of Efficacy|0|||
125516790|NCT00776984|451522635|FG001|Overall Study|Lack of Efficacy|1|||
125516791|NCT00776984|451522634|FG000|Overall Study|Other|5|||
125516792|NCT00776984|451522635|FG001|Overall Study|Other|9|||
125516793|NCT02573883|451522643|FG000|Six Month Follow Up|Lost to Follow-up|1|||
125516794|NCT02573883|451522644|FG001|Six Month Follow Up|Lost to Follow-up|0|||
125516795|NCT02573883|451522645|FG002|Six Month Follow Up|Lost to Follow-up|0|||
125516796|NCT02573883|451522646|FG003|Six Month Follow Up|Lost to Follow-up|0|||
125516797|NCT02573883|451522643|FG000|One Year Follow Up|Lost to Follow-up|2|||
125516798|NCT02573883|451522644|FG001|One Year Follow Up|Lost to Follow-up|1|||
125516799|NCT02573883|451522645|FG002|One Year Follow Up|Lost to Follow-up|0|||
125516800|NCT02573883|451522646|FG003|One Year Follow Up|Lost to Follow-up|0|||
125516801|NCT01544309|451522647|FG000|Overall Study|Withdrawal by Subject|12|||
125516802|NCT01544309|451522648|FG001|Overall Study|Withdrawal by Subject|7|||
125516803|NCT01544309|451522647|FG000|Overall Study|Protocol Violation|2|||
125516804|NCT01544309|451522648|FG001|Overall Study|Protocol Violation|1|||
125516805|NCT01544309|451522647|FG000|Overall Study|Physician Decision|4|||
125516806|NCT01544309|451522648|FG001|Overall Study|Physician Decision|1|||
125516807|NCT01544309|451522647|FG000|Overall Study|Not performed pre-dose examination|1|||
125516808|NCT01544309|451522648|FG001|Overall Study|Not performed pre-dose examination|2|||
125516809|NCT01544309|451522647|FG000|Overall Study|Administered prohibit prior medication|1|||
125516810|NCT01544309|451522648|FG001|Overall Study|Administered prohibit prior medication|0|||
125516811|NCT00118703|451522649|FG000|Overall Study|Protocol Violation|1|||
125516812|NCT00118703|451522650|FG001|Overall Study|Protocol Violation|0|||
125516813|NCT00118703|451522649|FG000|Overall Study|Adverse Event|1|||
125516814|NCT00118703|451522650|FG001|Overall Study|Adverse Event|1|||
125516815|NCT00118703|451522649|FG000|Overall Study|Participant took two different treatment|0|||
125516816|NCT00118703|451522650|FG001|Overall Study|Participant took two different treatment|1|||
125516817|NCT00118703|451522649|FG000|Overall Study|Withdrawal by Subject|2|||
125516818|NCT00118703|451522650|FG001|Overall Study|Withdrawal by Subject|5|||
125516819|NCT00118703|451522649|FG000|Overall Study|Lost to Follow-up|1|||
125516820|NCT00118703|451522650|FG001|Overall Study|Lost to Follow-up|2|||
125516821|NCT03796208|451522655|FG000|Overall Study|Withdrawal by Subject|3|||
125516822|NCT03796208|451522656|FG001|Overall Study|Withdrawal by Subject|0|||
125516823|NCT03796208|451522655|FG000|Overall Study|Loss of pregnancy|1|||
125516824|NCT03796208|451522656|FG001|Overall Study|Loss of pregnancy|1|||
125516825|NCT03796208|451522655|FG000|Overall Study|Changed prenatal clinics|0|||
125516826|NCT03796208|451522656|FG001|Overall Study|Changed prenatal clinics|5|||
125516827|NCT03796208|451522655|FG000|Overall Study|Lost to Follow-up|20|||
125516828|NCT03796208|451522656|FG001|Overall Study|Lost to Follow-up|16|||
125516829|NCT01560585|451522657|FG000|Overall Study|Physician Decision|3|||
125516830|NCT02725008|451522658|FG000|Overall Study|Lost to Follow-up|7|||
125516831|NCT02725008|451522659|FG001|Overall Study|Lost to Follow-up|9|||
125516832|NCT02725008|451522658|FG000|Overall Study|Withdrawal by Subject|2|||
125516833|NCT02725008|451522659|FG001|Overall Study|Withdrawal by Subject|2|||
125516834|NCT02725008|451522658|FG000|Overall Study|Admitted to hospital|0|||
125516835|NCT02725008|451522659|FG001|Overall Study|Admitted to hospital|1|||
125516836|NCT02175745|451522664|FG000|Overall Study|Not Eligible|1|||
125516837|NCT04688086|451522665|FG000|Overall Study|Lost to Follow-up|164|||
125516838|NCT04688086|451522665|FG000|Overall Study|Imaging error;|64|||
125516839|NCT04206384|451522668|FG000|Overall Study|Withdrawal by Subject|8|||
125516840|NCT04206384|451522668|FG000|Overall Study|Adverse Event|2|||
125516841|NCT00006436|451522669|FG000|Overall Study|Refused further treatment|2|||
125516842|NCT00006436|451522669|FG000|Overall Study|Declined to participate (before treatment started)|1|||
125516843|NCT00942188|451522672|FG000|Overall Study|Adverse Event|0|||
125516844|NCT00942188|451522673|FG001|Overall Study|Adverse Event|3|||
125516845|NCT00942188|451522674|FG002|Overall Study|Adverse Event|2|||
125516846|NCT00942188|451522675|FG003|Overall Study|Adverse Event|0|||
125516847|NCT00942188|451522672|FG000|Overall Study|Lack of Efficacy|0|||
125516848|NCT00942188|451522673|FG001|Overall Study|Lack of Efficacy|0|||
125516849|NCT00942188|451522674|FG002|Overall Study|Lack of Efficacy|0|||
125516850|NCT00942188|451522675|FG003|Overall Study|Lack of Efficacy|1|||
125516851|NCT00942188|451522672|FG000|Overall Study|Protocol Violation|1|||
125516852|NCT00942188|451522673|FG001|Overall Study|Protocol Violation|1|||
125516853|NCT00942188|451522674|FG002|Overall Study|Protocol Violation|0|||
125516854|NCT00942188|451522675|FG003|Overall Study|Protocol Violation|0|||
125516855|NCT00942188|451522672|FG000|Overall Study|Lost to Follow-up|2|||
125516856|NCT00942188|451522673|FG001|Overall Study|Lost to Follow-up|1|||
125516857|NCT00942188|451522674|FG002|Overall Study|Lost to Follow-up|2|||
125516858|NCT00942188|451522675|FG003|Overall Study|Lost to Follow-up|0|||
125516859|NCT00942188|451522672|FG000|Overall Study|Withdrawal by Subject|1|||
125516860|NCT00942188|451522673|FG001|Overall Study|Withdrawal by Subject|3|||
125516861|NCT00942188|451522674|FG002|Overall Study|Withdrawal by Subject|4|||
125516862|NCT00942188|451522675|FG003|Overall Study|Withdrawal by Subject|2|||
125516863|NCT00942188|451522672|FG000|Overall Study|Physician Decision|0|||
125516864|NCT00942188|451522673|FG001|Overall Study|Physician Decision|0|||
125516865|NCT00942188|451522674|FG002|Overall Study|Physician Decision|1|||
125516866|NCT00942188|451522675|FG003|Overall Study|Physician Decision|0|||
125516867|NCT00942188|451522672|FG000|Overall Study|Sponsor Decision|0|||
125516868|NCT00942188|451522673|FG001|Overall Study|Sponsor Decision|2|||
125516869|NCT00942188|451522674|FG002|Overall Study|Sponsor Decision|0|||
125516870|NCT00942188|451522675|FG003|Overall Study|Sponsor Decision|1|||
125516871|NCT00276016|451522676|FG000|Intervention 1|Withdrawal by Subject|0|||
125516872|NCT00276016|451522677|FG001|Intervention 1|Withdrawal by Subject|1|||
125516873|NCT00276016|451522678|FG002|Intervention 1|Withdrawal by Subject|0|||
125516874|NCT00276016|451522679|FG003|Intervention 1|Withdrawal by Subject|0|||
125516875|NCT00276016|451522680|FG004|Intervention 1|Withdrawal by Subject|0|||
125516876|NCT00276016|451522681|FG005|Intervention 1|Withdrawal by Subject|0|||
125516877|NCT05041439|451522682|FG000|Overall Study|Withdrawal by Subject|1|||
125516878|NCT05041439|451522683|FG001|Overall Study|Withdrawal by Subject|1|||
125516879|NCT05041439|451522682|FG000|Overall Study|Death|1|||
125516880|NCT05041439|451522683|FG001|Overall Study|Death|0|||
125516881|NCT01821729|451523935|FG000|Overall Study|Withdrawal by Subject|1|||
125516882|NCT02517528|451523936|FG000|Overall Study|Withdrawal by Subject|1|||
125516883|NCT01732926|451523938|FG000|Overall Study|Study Terminated by Sponsor|168|||
125516884|NCT01732926|451523939|FG001|Overall Study|Study Terminated by Sponsor|80|||
125516885|NCT01732926|451523938|FG000|Overall Study|Withdrawal by Subject|46|||
125516886|NCT01732926|451523939|FG001|Overall Study|Withdrawal by Subject|8|||
125516887|NCT01732926|451523938|FG000|Overall Study|Physician Decision|24|||
125516888|NCT01732926|451523939|FG001|Overall Study|Physician Decision|11|||
125516889|NCT01732926|451523938|FG000|Overall Study|Other Reason|21|||
125516890|NCT01732926|451523939|FG001|Overall Study|Other Reason|4|||
125516891|NCT01732926|451523938|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
125516892|NCT01732926|451523939|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
125516893|NCT01732926|451523938|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
125516894|NCT01732926|451523939|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
125516895|NCT02262364|451523943|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
125516896|NCT01049984|451523945|FG000|Overall Study|Withdrawal by Subject|1|||
125516897|NCT01049984|451523946|FG001|Overall Study|Withdrawal by Subject|5|||
125516898|NCT01049984|451523945|FG000|Overall Study|Protocol Violation|3|||
125516899|NCT01049984|451523946|FG001|Overall Study|Protocol Violation|4|||
125516900|NCT01049984|451523945|FG000|Overall Study|Lost to Follow-up|2|||
125516901|NCT01049984|451523946|FG001|Overall Study|Lost to Follow-up|1|||
125516902|NCT01049984|451523945|FG000|Overall Study|Adverse Event|13|||
125516903|NCT01049984|451523946|FG001|Overall Study|Adverse Event|7|||
125516904|NCT01049984|451523945|FG000|Overall Study|Treatment failure|0|||
125516905|NCT01049984|451523946|FG001|Overall Study|Treatment failure|2|||
125516906|NCT03503162|451523952|FG000|Overall Study|did not meet eligibility|1|||
125516907|NCT02246218|451523953|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
125516908|NCT02246218|451523954|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
125516909|NCT02246218|451523953|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
125516910|NCT02246218|451523954|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
125516911|NCT02246218|451523953|FG000|Overall Study|Adverse Event|1|||
125516912|NCT02246218|451523954|FG001|Overall Study|Adverse Event|1|||
125516913|NCT02246218|451523953|FG000|Overall Study|Lost to Follow-up|1|||
125516914|NCT02246218|451523954|FG001|Overall Study|Lost to Follow-up|0|||
125516915|NCT03891641|451523957|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
125516916|NCT03891641|451523958|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
125516917|NCT02212301|451523959|FG000|Period 1|Lost to Follow-up|0|||
125516918|NCT02212301|451523960|FG001|Period 1|Lost to Follow-up|1|||
125516919|NCT00866918|451523965|FG000|Overall Study|Death|1|||
125516920|NCT00866918|451523966|FG001|Overall Study|Death|5|||
125516921|NCT00866918|451523965|FG000|Overall Study|Lack of Efficacy|1|||
125516922|NCT00866918|451523966|FG001|Overall Study|Lack of Efficacy|1|||
125516923|NCT00866918|451523965|FG000|Overall Study|Physician Decision|10|||
125516924|NCT00866918|451523966|FG001|Overall Study|Physician Decision|2|||
125516925|NCT00866918|451523965|FG000|Overall Study|Ineligible|2|||
125516926|NCT00866918|451523966|FG001|Overall Study|Ineligible|4|||
125516927|NCT00866918|451523965|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
125516928|NCT00866918|451523966|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
125516929|NCT00866918|451523965|FG000|Overall Study|Secondary malignancy|1|||
125516930|NCT00866918|451523966|FG001|Overall Study|Secondary malignancy|0|||
125516931|NCT00527514|451523967|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
125516932|NCT00527514|451523967|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
125516933|NCT00527514|451523967|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
125516934|NCT00527514|451523967|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
125516935|NCT00527514|451523967|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
125516936|NCT00527514|451523967|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
125516937|NCT00527514|451523967|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
125516938|NCT00920699|451523972|FG000|Overall Study|Withdrawal by Subject|2|||
125516939|NCT00920699|451523973|FG001|Overall Study|Withdrawal by Subject|0|||
125516940|NCT00920699|451523974|FG002|Overall Study|Withdrawal by Subject|2|||
125516941|NCT00920699|451523972|FG000|Overall Study|no longer met eligibility|0|||
125516942|NCT00920699|451523973|FG001|Overall Study|no longer met eligibility|1|||
125516943|NCT00920699|451523974|FG002|Overall Study|no longer met eligibility|0|||
125516944|NCT00920699|451523972|FG000|Overall Study|Lost to Follow-up|0|||
125516945|NCT00920699|451523973|FG001|Overall Study|Lost to Follow-up|0|||
125516946|NCT00920699|451523974|FG002|Overall Study|Lost to Follow-up|2|||
125516947|NCT03723915|451523976|FG000|Screening|Failed to meet screening requirements.|2|||
125516948|NCT03723915|451523976|FG000|On Treatment|Failed to meet treatment requirements|2|||
125516949|NCT01978236|451523979|FG000|Overall Study|Discontinued due to study close|2|||
125516950|NCT00634920|451523981|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
125516951|NCT00634920|451523982|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
125516952|NCT00634920|451523983|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
125516953|NCT00634920|451523981|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
125516954|NCT00634920|451523982|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
125516955|NCT00634920|451523983|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
125516956|NCT00634920|451523981|FG000|Period 1 - Pre-Randomization|Rejections|0|||
125516957|NCT00634920|451523982|FG001|Period 1 - Pre-Randomization|Rejections|0|||
125516958|NCT00634920|451523983|FG002|Period 1 - Pre-Randomization|Rejections|55|||
125516959|NCT00634920|451523981|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
125516960|NCT00634920|451523982|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
125516961|NCT00634920|451523983|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
125516962|NCT00634920|451523981|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
125516963|NCT00634920|451523982|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
125516964|NCT00634920|451523983|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
125516965|NCT00634920|451523981|FG000|Period 1 - Pre-Randomization|Other issues|0|||
125516966|NCT00634920|451523982|FG001|Period 1 - Pre-Randomization|Other issues|0|||
125516967|NCT00634920|451523983|FG002|Period 1 - Pre-Randomization|Other issues|6|||
125516968|NCT00634920|451523981|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
125516969|NCT00634920|451523982|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
125516970|NCT00634920|451523983|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
125516971|NCT00634920|451523981|FG000|Period 2 - Post-Randomization|Rejection|11|||
125516972|NCT00634920|451523982|FG001|Period 2 - Post-Randomization|Rejection|5|||
125516973|NCT00634920|451523983|FG002|Period 2 - Post-Randomization|Rejection|0|||
125516974|NCT00634920|451523981|FG000|Period 2 - Post-Randomization|Death|2|||
125516975|NCT00634920|451523982|FG001|Period 2 - Post-Randomization|Death|5|||
125516976|NCT00634920|451523983|FG002|Period 2 - Post-Randomization|Death|0|||
125516977|NCT00634920|451523981|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
125516978|NCT00634920|451523982|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
125516979|NCT00634920|451523983|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
125516980|NCT00634920|451523981|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
125516981|NCT00634920|451523982|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
125516982|NCT00634920|451523983|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
125516983|NCT00819013|451523984|FG000|Overall Study|Not meeting continuing study eligibility|2|||
125516984|NCT00819013|451523985|FG001|Overall Study|Not meeting continuing study eligibility|1|||
125516985|NCT00819013|451523986|FG002|Overall Study|Not meeting continuing study eligibility|2|||
125516986|NCT00819013|451523987|FG003|Overall Study|Not meeting continuing study eligibility|1|||
125516987|NCT00819013|451523984|FG000|Overall Study|Adverse Event|0|||
125516988|NCT00819013|451523985|FG001|Overall Study|Adverse Event|0|||
125516989|NCT00819013|451523986|FG002|Overall Study|Adverse Event|1|||
125516990|NCT00819013|451523987|FG003|Overall Study|Adverse Event|0|||
125516991|NCT00819013|451523984|FG000|Overall Study|Withdrawal by Subject|1|||
125516992|NCT00819013|451523985|FG001|Overall Study|Withdrawal by Subject|0|||
125516993|NCT00819013|451523986|FG002|Overall Study|Withdrawal by Subject|1|||
125516994|NCT00819013|451523987|FG003|Overall Study|Withdrawal by Subject|0|||
125516995|NCT00819013|451523984|FG000|Overall Study|Lost to Follow-up|0|||
125516996|NCT00819013|451523985|FG001|Overall Study|Lost to Follow-up|0|||
125516997|NCT00819013|451523986|FG002|Overall Study|Lost to Follow-up|1|||
125516998|NCT00819013|451523987|FG003|Overall Study|Lost to Follow-up|2|||
125516999|NCT00819013|451523984|FG000|Overall Study|Death|0|||
125517000|NCT00819013|451523985|FG001|Overall Study|Death|0|||
125517001|NCT00819013|451523986|FG002|Overall Study|Death|0|||
125517002|NCT00819013|451523987|FG003|Overall Study|Death|1|||
125517003|NCT00363649|451523988|FG000|Overall Study|Withdrawal by Subject|1|||
125517004|NCT00363649|451523989|FG001|Overall Study|Withdrawal by Subject|1|||
125517005|NCT00363649|451523988|FG000|Overall Study|Adverse Event|6|||
125517006|NCT00363649|451523989|FG001|Overall Study|Adverse Event|0|||
125517007|NCT00607997|451523992|FG000|Overall Study|Lack of Efficacy|6|||
125517008|NCT00607997|451523993|FG001|Overall Study|Lack of Efficacy|20|||
125517009|NCT00607997|451523994|FG002|Overall Study|Lack of Efficacy|14|||
125517010|NCT00607997|451523995|FG003|Overall Study|Lack of Efficacy|10|||
125517011|NCT00607997|451523992|FG000|Overall Study|Death|8|||
125517012|NCT00607997|451523993|FG001|Overall Study|Death|5|||
125517013|NCT00607997|451523994|FG002|Overall Study|Death|2|||
125517014|NCT00607997|451523995|FG003|Overall Study|Death|5|||
125517015|NCT00607997|451523992|FG000|Overall Study|Adverse Event|3|||
125517016|NCT00607997|451523993|FG001|Overall Study|Adverse Event|1|||
125517017|NCT00607997|451523994|FG002|Overall Study|Adverse Event|2|||
125517018|NCT00607997|451523995|FG003|Overall Study|Adverse Event|0|||
125517019|NCT00607997|451523992|FG000|Overall Study|Physician Decision|4|||
125517020|NCT00607997|451523993|FG001|Overall Study|Physician Decision|1|||
125517021|NCT00607997|451523994|FG002|Overall Study|Physician Decision|0|||
125517022|NCT00607997|451523995|FG003|Overall Study|Physician Decision|0|||
125517023|NCT00607997|451523992|FG000|Overall Study|Relapse, recurrent illness|4|||
125517024|NCT00607997|451523993|FG001|Overall Study|Relapse, recurrent illness|0|||
125517025|NCT00607997|451523994|FG002|Overall Study|Relapse, recurrent illness|2|||
125517026|NCT00607997|451523995|FG003|Overall Study|Relapse, recurrent illness|0|||
125517027|NCT00607997|451523992|FG000|Overall Study|Other without explanation|2|||
125517028|NCT00607997|451523993|FG001|Overall Study|Other without explanation|0|||
125517029|NCT00607997|451523994|FG002|Overall Study|Other without explanation|4|||
125517030|NCT00607997|451523995|FG003|Overall Study|Other without explanation|1|||
125517031|NCT00576823|451523999|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
125517032|NCT00576823|451524000|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
125517033|NCT00576823|451524001|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
125517034|NCT00576823|451523999|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
125517035|NCT00576823|451524000|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
125517036|NCT00576823|451524001|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
125517037|NCT00510146|451524004|FG000|Double-Blind Treatment|Adverse Event|30|||
125517038|NCT00510146|451524005|FG001|Double-Blind Treatment|Adverse Event|13|||
125517039|NCT00510146|451524004|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
125517040|NCT00510146|451524005|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
125517041|NCT00510146|451524004|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
125517042|NCT00510146|451524005|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
125517043|NCT00510146|451524004|FG000|Double-Blind Treatment|Physician Decision|6|||
125517044|NCT00510146|451524005|FG001|Double-Blind Treatment|Physician Decision|0|||
125517045|NCT00510146|451524004|FG000|Double-Blind Treatment|Protocol Violation|1|||
125517046|NCT00510146|451524005|FG001|Double-Blind Treatment|Protocol Violation|2|||
125517047|NCT00510146|451524004|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
125517048|NCT00510146|451524005|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
125517049|NCT00510146|451524004|FG000|Double-Blind Treatment|Clinical Relapse|0|||
125517050|NCT00510146|451524005|FG001|Double-Blind Treatment|Clinical Relapse|1|||
125517051|NCT00510146|451524004|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
125517052|NCT00510146|451524005|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
125517053|NCT00510146|451524004|FG000|Open-Label Treatment|Adverse Event|22|||
125517054|NCT00510146|451524005|FG001|Open-Label Treatment|Adverse Event|8|||
125517055|NCT00510146|451524004|FG000|Open-Label Treatment|Death|1|||
125517056|NCT00510146|451524005|FG001|Open-Label Treatment|Death|1|||
125517057|NCT00510146|451524004|FG000|Open-Label Treatment|Lack of Efficacy|4|||
125517058|NCT00510146|451524005|FG001|Open-Label Treatment|Lack of Efficacy|0|||
125517059|NCT00510146|451524004|FG000|Open-Label Treatment|Lost to Follow-up|10|||
125517060|NCT00510146|451524005|FG001|Open-Label Treatment|Lost to Follow-up|1|||
125517061|NCT00510146|451524004|FG000|Open-Label Treatment|Physician Decision|3|||
125517062|NCT00510146|451524005|FG001|Open-Label Treatment|Physician Decision|1|||
125517063|NCT00510146|451524004|FG000|Open-Label Treatment|Protocol Violation|4|||
125517064|NCT00510146|451524005|FG001|Open-Label Treatment|Protocol Violation|2|||
125517065|NCT00510146|451524004|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
125517066|NCT00510146|451524005|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
125517067|NCT00510146|451524004|FG000|Open-Label Treatment|Clinical Relapse|1|||
125517068|NCT00510146|451524005|FG001|Open-Label Treatment|Clinical Relapse|1|||
125517069|NCT00510146|451524004|FG000|Open-Label Treatment|Sponsor Decision|2|||
125517070|NCT00510146|451524005|FG001|Open-Label Treatment|Sponsor Decision|0|||
125517071|NCT01930214|451524007|FG000|Overall Study|Death|4|||
125517072|NCT01930214|451524008|FG001|Overall Study|Death|4|||
125517073|NCT01930214|451524009|FG002|Overall Study|Death|11|||
125517074|NCT01930214|451524007|FG000|Overall Study|Lost to Follow-up|12|||
125517075|NCT01930214|451524008|FG001|Overall Study|Lost to Follow-up|13|||
125517076|NCT01930214|451524009|FG002|Overall Study|Lost to Follow-up|12|||
125517077|NCT01930214|451524007|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
125517078|NCT01930214|451524008|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
125517079|NCT01930214|451524009|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
125517080|NCT01930214|451524007|FG000|Overall Study|Physician Decision|2|||
125517081|NCT01930214|451524008|FG001|Overall Study|Physician Decision|0|||
125517082|NCT01930214|451524009|FG002|Overall Study|Physician Decision|0|||
125517083|NCT02132117|451524010|FG000|Overall Study|Adverse Event|6|||
125517084|NCT02132117|451524011|FG001|Overall Study|Adverse Event|1|||
125517085|NCT02132117|451524010|FG000|Overall Study|Lost to Follow-up|2|||
125517086|NCT02132117|451524011|FG001|Overall Study|Lost to Follow-up|2|||
125517087|NCT02132117|451524010|FG000|Overall Study|Personal Reasons|1|||
125517088|NCT02132117|451524011|FG001|Overall Study|Personal Reasons|2|||
125517089|NCT02132117|451524010|FG000|Overall Study|Other Miscellaneous Reasons|2|||
125517090|NCT02132117|451524011|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125517091|NCT03589300|451524012|FG000|Overall Study|Adverse Event|2|||
125517092|NCT03589300|451524012|FG000|Overall Study|Death|4|||
125517093|NCT03589300|451524012|FG000|Overall Study|Lost to Follow-up|12|||
125517094|NCT03589300|451524012|FG000|Overall Study|Withdrawal by Subject|5|||
125517095|NCT00640042|451524018|FG000|Enrollment|Did not receive study drug|83|||
125517096|NCT02864342|451524019|FG000|Overall Study|Eligibility Criteria Deviation|2|||
125517097|NCT02864342|451524020|FG001|Overall Study|Eligibility Criteria Deviation|3|||
125517098|NCT02864342|451524019|FG000|Overall Study|Withdrawal by Subject|4|||
125517099|NCT02864342|451524020|FG001|Overall Study|Withdrawal by Subject|2|||
125517100|NCT02864342|451524019|FG000|Overall Study|Device Technology Issue|6|||
125517101|NCT02864342|451524020|FG001|Overall Study|Device Technology Issue|7|||
125517102|NCT02864342|451524019|FG000|Overall Study|Death|0|||
125517103|NCT02864342|451524020|FG001|Overall Study|Death|1|||
125517104|NCT02864342|451524019|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
125517105|NCT02864342|451524020|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
125517106|NCT02864342|451524019|FG000|Overall Study|Lost to Follow-up|1|||
125517107|NCT02864342|451524020|FG001|Overall Study|Lost to Follow-up|5|||
125517108|NCT02864342|451524019|FG000|Overall Study|Lost Device|1|||
125517109|NCT02864342|451524020|FG001|Overall Study|Lost Device|0|||
125517110|NCT02864342|451524019|FG000|Overall Study|Adverse Event|1|||
125517111|NCT02864342|451524020|FG001|Overall Study|Adverse Event|0|||
125517112|NCT00519285|451524025|FG000|Overall Study|Adverse Event|127|||
125517113|NCT00519285|451524026|FG001|Overall Study|Adverse Event|266|||
125517114|NCT00519285|451524025|FG000|Overall Study|Disease progression|334|||
125517115|NCT00519285|451524026|FG001|Overall Study|Disease progression|186|||
125517116|NCT00519285|451524025|FG000|Overall Study|Physician Decision|75|||
125517117|NCT00519285|451524026|FG001|Overall Study|Physician Decision|47|||
125517118|NCT00519285|451524025|FG000|Overall Study|Participant's request|53|||
125517119|NCT00519285|451524026|FG001|Overall Study|Participant's request|84|||
125517120|NCT00519285|451524025|FG000|Overall Study|Consent withdrawn|4|||
125517121|NCT00519285|451524026|FG001|Overall Study|Consent withdrawn|5|||
125517122|NCT00519285|451524025|FG000|Overall Study|Poor compliance to protocol|5|||
125517123|NCT00519285|451524026|FG001|Overall Study|Poor compliance to protocol|7|||
125517124|NCT00519285|451524025|FG000|Overall Study|Reason unspecified|5|||
125517125|NCT00519285|451524026|FG001|Overall Study|Reason unspecified|8|||
125517126|NCT00519285|451524025|FG000|Overall Study|Not treated|8|||
125517127|NCT00519285|451524026|FG001|Overall Study|Not treated|7|||
125517128|NCT00519285|451524025|FG000|Overall Study|Treatment ongoing|1|||
125517129|NCT00519285|451524026|FG001|Overall Study|Treatment ongoing|2|||
125517130|NCT00853021|451524027|FG000|Overall Study|Adverse Event|2|||
125517131|NCT00853021|451524027|FG000|Overall Study|Withdrawal by Subject|2|||
125517132|NCT00853021|451524027|FG000|Overall Study|Death|1|||
125517133|NCT01329419|451524028|FG000|Overall Study|Protocol Violation|235|||
125517134|NCT02212197|451524034|FG000|Overall Study|Need for radiotherapy|1|||
125517135|NCT02212197|451524035|FG001|Overall Study|Need for radiotherapy|0|||
125517136|NCT02212197|451524036|FG002|Overall Study|Need for radiotherapy|0|||
125517137|NCT02551692|451524038|FG000|Overall Study|Lost to Follow-up|0|||
125517138|NCT02551692|451524039|FG001|Overall Study|Lost to Follow-up|1|||
125517139|NCT02551692|451524040|FG002|Overall Study|Lost to Follow-up|4|||
125517140|NCT02551692|451524038|FG000|Overall Study|Withdrawal by Subject|1|||
125517141|NCT02551692|451524039|FG001|Overall Study|Withdrawal by Subject|0|||
125517142|NCT02551692|451524040|FG002|Overall Study|Withdrawal by Subject|1|||
125517143|NCT01091519|451524041|FG000|Overall Study|Adverse Event|12|||
125517144|NCT01091519|451524042|FG001|Overall Study|Adverse Event|16|||
125517145|NCT01091519|451524041|FG000|Overall Study|Death|1|||
125517146|NCT01091519|451524042|FG001|Overall Study|Death|0|||
125517147|NCT01091519|451524041|FG000|Overall Study|Lack of Efficacy|16|||
125517148|NCT01091519|451524042|FG001|Overall Study|Lack of Efficacy|19|||
125517149|NCT01091519|451524041|FG000|Overall Study|Lost to Follow-up|14|||
125517150|NCT01091519|451524042|FG001|Overall Study|Lost to Follow-up|24|||
125517151|NCT01091519|451524041|FG000|Overall Study|Withdrawal by Subject|2|||
125517152|NCT01091519|451524042|FG001|Overall Study|Withdrawal by Subject|2|||
125517153|NCT01091519|451524041|FG000|Overall Study|Other|6|||
125517154|NCT01091519|451524042|FG001|Overall Study|Other|8|||
125517155|NCT01091519|451524041|FG000|Overall Study|Randomized not treated|4|||
125517156|NCT01091519|451524042|FG001|Overall Study|Randomized not treated|4|||
125517157|NCT01177228|451524045|FG000|Overall Study|Positive tuberculosis test|0|||
125517158|NCT01177228|451524046|FG001|Overall Study|Positive tuberculosis test|1|||
125517159|NCT01177228|451524047|FG002|Overall Study|Positive tuberculosis test|0|||
125517160|NCT01177228|451524048|FG003|Overall Study|Positive tuberculosis test|0|||
125517161|NCT01177228|451524045|FG000|Overall Study|Worsening disease activity|1|||
125517162|NCT01177228|451524046|FG001|Overall Study|Worsening disease activity|0|||
125517163|NCT01177228|451524047|FG002|Overall Study|Worsening disease activity|0|||
125517164|NCT01177228|451524048|FG003|Overall Study|Worsening disease activity|0|||
125517165|NCT01177228|451524045|FG000|Overall Study|Withdrawal by Subject|0|||
125517166|NCT01177228|451524046|FG001|Overall Study|Withdrawal by Subject|1|||
125517167|NCT01177228|451524047|FG002|Overall Study|Withdrawal by Subject|0|||
125517168|NCT01177228|451524048|FG003|Overall Study|Withdrawal by Subject|0|||
125517169|NCT01592383|451524049|FG000|Overall Study|Adverse Event|1|||
125517170|NCT04159805|451524050|FG000|Overall Study|Withdrawal by Subject|0|||
125517171|NCT04159805|451524051|FG001|Overall Study|Withdrawal by Subject|2|||
125517172|NCT04159805|451524052|FG002|Overall Study|Withdrawal by Subject|2|||
125517173|NCT04167085|451524053|FG000|Baseline|Withdrawal by Subject|2|||
125517174|NCT04167085|451524054|FG001|Baseline|Withdrawal by Subject|1|||
125517175|NCT04167085|451524053|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
125517176|NCT04167085|451524054|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
125517177|NCT01171183|451526063|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
125517178|NCT01171183|451526064|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
125517179|NCT01171183|451526063|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
125517180|NCT01171183|451526064|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
125517181|NCT01171183|451526063|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
125517182|NCT01171183|451526064|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
125517183|NCT01171183|451526063|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
125517184|NCT01171183|451526064|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
125517185|NCT01171183|451526063|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
125517186|NCT01171183|451526064|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
125517187|NCT01171183|451526063|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
125517188|NCT01171183|451526064|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
125517189|NCT01904136|451526068|FG000|Overall Study|Physician Decision|0|||
125517190|NCT01904136|451526069|FG001|Overall Study|Physician Decision|0|||
125517191|NCT01904136|451526070|FG002|Overall Study|Physician Decision|0|||
125517192|NCT01904136|451526071|FG003|Overall Study|Physician Decision|0|||
125517193|NCT01904136|451526072|FG004|Overall Study|Physician Decision|0|||
125517194|NCT01904136|451526073|FG005|Overall Study|Physician Decision|1|||
125517195|NCT01904136|451526074|FG006|Overall Study|Physician Decision|0|||
125517196|NCT01904136|451526075|FG007|Overall Study|Physician Decision|0|||
125517197|NCT01904136|451526076|FG008|Overall Study|Physician Decision|0|||
125517198|NCT00853372|451526077|FG000|Overall Study|Death|30|||
125517199|NCT00853372|451526078|FG001|Overall Study|Death|26|||
125517200|NCT00853372|451526077|FG000|Overall Study|Lost to Follow-up|1|||
125517201|NCT00853372|451526078|FG001|Overall Study|Lost to Follow-up|2|||
125517202|NCT00853372|451526077|FG000|Overall Study|Full Consent Withdrawn|1|||
125517203|NCT00853372|451526078|FG001|Overall Study|Full Consent Withdrawn|1|||
125517204|NCT01093599|451526086|FG000|Overall Study|Lost to Follow-up|32|||
125517205|NCT01093599|451526087|FG001|Overall Study|Lost to Follow-up|46|||
125517206|NCT01703845|451526088|FG000|Overall Study|Adverse Event|1|||
125517207|NCT01703845|451526089|FG001|Overall Study|Adverse Event|0|||
125517208|NCT01703845|451526088|FG000|Overall Study|Protocol Violation|1|||
125517209|NCT01703845|451526089|FG001|Overall Study|Protocol Violation|0|||
125517210|NCT01703845|451526088|FG000|Overall Study|other than stated above|1|||
125517211|NCT01703845|451526089|FG001|Overall Study|other than stated above|0|||
125517212|NCT01644188|451526090|FG000|Overall Study|Adverse Event|44|||
125517213|NCT01644188|451526091|FG001|Overall Study|Adverse Event|20|||
125517214|NCT01644188|451526090|FG000|Overall Study|Poor compliance to protocol|26|||
125517215|NCT01644188|451526091|FG001|Overall Study|Poor compliance to protocol|14|||
125517216|NCT01644188|451526090|FG000|Overall Study|Physician Decision|1|||
125517217|NCT01644188|451526091|FG001|Overall Study|Physician Decision|3|||
125517218|NCT01644188|451526090|FG000|Overall Study|Participant moved|7|||
125517219|NCT01644188|451526091|FG001|Overall Study|Participant moved|2|||
125517220|NCT01644188|451526090|FG000|Overall Study|Related to auto-injector administration|2|||
125517221|NCT01644188|451526091|FG001|Overall Study|Related to auto-injector administration|2|||
125517222|NCT01644188|451526090|FG000|Overall Study|Consent withdrawn by participant|14|||
125517223|NCT01644188|451526091|FG001|Overall Study|Consent withdrawn by participant|7|||
125517224|NCT01644188|451526090|FG000|Overall Study|Selection criteria finally not met|2|||
125517225|NCT01644188|451526091|FG001|Overall Study|Selection criteria finally not met|0|||
125517226|NCT01644188|451526090|FG000|Overall Study|Lost to Follow-up|1|||
125517227|NCT01644188|451526091|FG001|Overall Study|Lost to Follow-up|0|||
125517228|NCT01644188|451526090|FG000|Overall Study|Death|4|||
125517229|NCT01644188|451526091|FG001|Overall Study|Death|3|||
125517230|NCT01644188|451526090|FG000|Overall Study|Last visit outside protocol visit window|14|||
125517231|NCT01644188|451526091|FG001|Overall Study|Last visit outside protocol visit window|16|||
125517232|NCT01644188|451526090|FG000|Overall Study|Site closure|1|||
125517233|NCT01644188|451526091|FG001|Overall Study|Site closure|1|||
125517234|NCT01644188|451526090|FG000|Overall Study|Other than specified above|6|||
125517235|NCT01644188|451526091|FG001|Overall Study|Other than specified above|7|||
125517236|NCT03713281|451526095|FG000|Overall Study|Lens handling difficuluties|2|||
125517237|NCT03713281|451526095|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
125517238|NCT00320398|451526096|FG000|Overall Study|Adverse Event|1|||
125517239|NCT00320398|451526097|FG001|Overall Study|Adverse Event|4|||
125517240|NCT00320398|451526096|FG000|Overall Study|Other|1|||
125517241|NCT00320398|451526097|FG001|Overall Study|Other|0|||
125517242|NCT01114139|451526100|FG000|Overall Study|Adverse Event|3|||
125517243|NCT01114139|451526101|FG001|Overall Study|Adverse Event|2|||
125517244|NCT01114139|451526100|FG000|Overall Study|Lost to Follow-up|15|||
125517245|NCT01114139|451526101|FG001|Overall Study|Lost to Follow-up|3|||
125517246|NCT01114139|451526100|FG000|Overall Study|Withdrawal by Subject|17|||
125517247|NCT01114139|451526101|FG001|Overall Study|Withdrawal by Subject|6|||
125517248|NCT01114139|451526100|FG000|Overall Study|Other-Missed 1 visit|1|||
125517249|NCT01114139|451526101|FG001|Overall Study|Other-Missed 1 visit|0|||
125517250|NCT01114139|451526100|FG000|Overall Study|Other-Protocol Violation|1|||
125517251|NCT01114139|451526101|FG001|Overall Study|Other-Protocol Violation|0|||
125517252|NCT01114139|451526100|FG000|Overall Study|Other-Out of window for study drug dose|1|||
125517253|NCT01114139|451526101|FG001|Overall Study|Other-Out of window for study drug dose|0|||
125517254|NCT01114139|451526100|FG000|Overall Study|Other-Participant falsified records|0|||
125517255|NCT01114139|451526101|FG001|Overall Study|Other-Participant falsified records|1|||
125517256|NCT01114139|451526100|FG000|Overall Study|Other-Participant went on hospice|0|||
125517257|NCT01114139|451526101|FG001|Overall Study|Other-Participant went on hospice|1|||
125517258|NCT01114139|451526100|FG000|Overall Study|Other-Physician changed treatment|1|||
125517259|NCT01114139|451526101|FG001|Overall Study|Other-Physician changed treatment|0|||
125517260|NCT01114139|451526100|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
125517261|NCT01114139|451526101|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
125517262|NCT02705625|451526102|FG000|Overall Study|Protocol Violation|1|||
125517263|NCT02705625|451526103|FG001|Overall Study|Protocol Violation|0|||
125517264|NCT02705625|451526104|FG002|Overall Study|Protocol Violation|0|||
125517265|NCT02705625|451526102|FG000|Overall Study|Adverse Event|6|||
125517266|NCT02705625|451526103|FG001|Overall Study|Adverse Event|5|||
125517267|NCT02705625|451526104|FG002|Overall Study|Adverse Event|2|||
125517268|NCT02705625|451526102|FG000|Overall Study|Death|0|||
125517269|NCT02705625|451526103|FG001|Overall Study|Death|0|||
125517270|NCT02705625|451526104|FG002|Overall Study|Death|1|||
125517271|NCT02705625|451526102|FG000|Overall Study|Withdrawal by Subject|1|||
125517272|NCT02705625|451526103|FG001|Overall Study|Withdrawal by Subject|4|||
125517273|NCT02705625|451526104|FG002|Overall Study|Withdrawal by Subject|5|||
125517274|NCT02705625|451526102|FG000|Overall Study|Lost to Follow-up|0|||
125517275|NCT02705625|451526103|FG001|Overall Study|Lost to Follow-up|0|||
125517276|NCT02705625|451526104|FG002|Overall Study|Lost to Follow-up|1|||
125517277|NCT02705625|451526102|FG000|Overall Study|Non-compliance|0|||
125517278|NCT02705625|451526103|FG001|Overall Study|Non-compliance|1|||
125517279|NCT02705625|451526104|FG002|Overall Study|Non-compliance|1|||
125517280|NCT02705625|451526102|FG000|Overall Study|Overdosing|0|||
125517281|NCT02705625|451526103|FG001|Overall Study|Overdosing|0|||
125517282|NCT02705625|451526104|FG002|Overall Study|Overdosing|1|||
125517283|NCT00494026|451526105|FG000|Overall Study|Sponsor Decision|4|||
125517284|NCT02637856|451526107|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
125517285|NCT02637856|451526108|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
125517286|NCT02637856|451526107|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
125517287|NCT02637856|451526108|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
125517288|NCT02637856|451526107|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
125517289|NCT02637856|451526108|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
125517290|NCT02637856|451526107|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
125517291|NCT02637856|451526108|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
125517292|NCT02637856|451526107|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
125517293|NCT02637856|451526108|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
125517294|NCT02637856|451526107|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
125517295|NCT02637856|451526108|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
125517296|NCT02637856|451526107|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
125517297|NCT02637856|451526108|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
125517298|NCT02637856|451526107|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
125517299|NCT02637856|451526108|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
125517300|NCT02637856|451526107|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
125517301|NCT02637856|451526108|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
125517302|NCT02637856|451526107|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
125517303|NCT02637856|451526108|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
125517304|NCT02637856|451526107|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
125517305|NCT02637856|451526108|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
125517306|NCT02637856|451526107|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
125517307|NCT02637856|451526108|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
125517308|NCT02637856|451526107|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
125517309|NCT02637856|451526108|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
125517310|NCT01057251|451526109|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
125517311|NCT01057251|451526110|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
125517312|NCT01057251|451526109|FG000|Overall Study|Adverse Event|4|||
125517313|NCT01057251|451526110|FG001|Overall Study|Adverse Event|2|||
125517314|NCT01057251|451526109|FG000|Overall Study|Lack of Efficacy|2|||
125517315|NCT01057251|451526110|FG001|Overall Study|Lack of Efficacy|11|||
125517316|NCT01057251|451526109|FG000|Overall Study|Protocol Violation|6|||
125517317|NCT01057251|451526110|FG001|Overall Study|Protocol Violation|2|||
125517318|NCT01057251|451526109|FG000|Overall Study|Withdrawal by Subject|4|||
125517319|NCT01057251|451526110|FG001|Overall Study|Withdrawal by Subject|5|||
125517320|NCT01057251|451526109|FG000|Overall Study|Lost to Follow-up|7|||
125517321|NCT01057251|451526110|FG001|Overall Study|Lost to Follow-up|6|||
125517322|NCT01057251|451526109|FG000|Overall Study|Other Reason|1|||
125517323|NCT01057251|451526110|FG001|Overall Study|Other Reason|1|||
125517324|NCT00784147|451526111|FG000|Overall Study|Lost to Follow-up|2|||
125517325|NCT00784147|451526112|FG001|Overall Study|Lost to Follow-up|4|||
125517326|NCT00784147|451526111|FG000|Overall Study|Withdrawal by Subject|1|||
125517327|NCT00784147|451526112|FG001|Overall Study|Withdrawal by Subject|3|||
125517328|NCT00784147|451526111|FG000|Overall Study|Physician Decision|2|||
125517329|NCT00784147|451526112|FG001|Overall Study|Physician Decision|1|||
125517330|NCT00784147|451526111|FG000|Overall Study|Protocol Violation|1|||
125517331|NCT00784147|451526112|FG001|Overall Study|Protocol Violation|1|||
125517332|NCT00784147|451526111|FG000|Overall Study|Death|2|||
125517333|NCT00784147|451526112|FG001|Overall Study|Death|0|||
125517334|NCT04544865|451526116|FG000|Overall Study|Death|0|||
125517335|NCT04544865|451526117|FG001|Overall Study|Death|2|||
125517336|NCT04544865|451526116|FG000|Overall Study|Lost to Follow-up|11|||
125517337|NCT04544865|451526117|FG001|Overall Study|Lost to Follow-up|7|||
125517338|NCT04544865|451526116|FG000|Overall Study|Withdrawal by Subject|0|||
125517339|NCT04544865|451526117|FG001|Overall Study|Withdrawal by Subject|1|||
125517340|NCT04544865|451526116|FG000|Overall Study|Other|0|||
125517341|NCT04544865|451526117|FG001|Overall Study|Other|1|||
125517342|NCT02815735|451526118|FG000|First Intervention (4 Weeks)|Discomfort|1|||
125517343|NCT02815735|451526119|FG001|First Intervention (4 Weeks)|Discomfort|0|||
125517344|NCT02815735|451526118|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
125517345|NCT02815735|451526119|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
125517346|NCT02815735|451526118|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
125517347|NCT02815735|451526119|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
125517348|NCT02815735|451526118|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
125517349|NCT02815735|451526119|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
125517350|NCT01746108|451526122|FG000|Overall Study|Migrated /moved from study area|0|||
125517351|NCT01746108|451526123|FG001|Overall Study|Migrated /moved from study area|1|||
125517352|NCT01746108|451526124|FG002|Overall Study|Migrated /moved from study area|0|||
125517353|NCT01746108|451526122|FG000|Overall Study|Adverse event, non-fatal|0|||
125517354|NCT01746108|451526123|FG001|Overall Study|Adverse event, non-fatal|1|||
125517355|NCT01746108|451526124|FG002|Overall Study|Adverse event, non-fatal|0|||
125517356|NCT01746108|451526122|FG000|Overall Study|Withdrawal by Subject|0|||
125517357|NCT01746108|451526123|FG001|Overall Study|Withdrawal by Subject|1|||
125517358|NCT01746108|451526124|FG002|Overall Study|Withdrawal by Subject|0|||
125517359|NCT01746108|451526122|FG000|Overall Study|Lost to Follow-up|0|||
125517360|NCT01746108|451526123|FG001|Overall Study|Lost to Follow-up|1|||
125517361|NCT01746108|451526124|FG002|Overall Study|Lost to Follow-up|0|||
125517362|NCT00468858|451526126|FG000|Overall Study|Adverse Event|0|||
125517363|NCT00468858|451526127|FG001|Overall Study|Adverse Event|1|||
125517364|NCT00468858|451526128|FG002|Overall Study|Adverse Event|0|||
125517365|NCT00468858|451526126|FG000|Overall Study|Withdrawal by Subject|7|||
125517366|NCT00468858|451526127|FG001|Overall Study|Withdrawal by Subject|4|||
125517367|NCT00468858|451526128|FG002|Overall Study|Withdrawal by Subject|5|||
125517368|NCT00468858|451526126|FG000|Overall Study|Relocation|1|||
125517369|NCT00468858|451526127|FG001|Overall Study|Relocation|3|||
125517370|NCT00468858|451526128|FG002|Overall Study|Relocation|3|||
125517371|NCT00468858|451526126|FG000|Overall Study|Lost to Follow-up|1|||
125517372|NCT00468858|451526127|FG001|Overall Study|Lost to Follow-up|2|||
125517373|NCT00468858|451526128|FG002|Overall Study|Lost to Follow-up|5|||
125517374|NCT00468858|451526126|FG000|Overall Study|Other|0|||
125517375|NCT00468858|451526127|FG001|Overall Study|Other|0|||
125517376|NCT00468858|451526128|FG002|Overall Study|Other|1|||
125517377|NCT00809341|451526131|FG000|Overall Study|Physician Decision|0|||
125517378|NCT00809341|451526132|FG001|Overall Study|Physician Decision|1|||
125517379|NCT00225277|451526140|FG000|Overall Study|Adverse Event|30|||
125517380|NCT00225277|451526141|FG001|Overall Study|Adverse Event|34|||
125517381|NCT00225277|451526140|FG000|Overall Study|Lack of Efficacy|4|||
125517382|NCT00225277|451526141|FG001|Overall Study|Lack of Efficacy|1|||
125517383|NCT00225277|451526140|FG000|Overall Study|Lost to Follow-up|4|||
125517384|NCT00225277|451526141|FG001|Overall Study|Lost to Follow-up|6|||
125517385|NCT00225277|451526140|FG000|Overall Study|Physician Decision|6|||
125517386|NCT00225277|451526141|FG001|Overall Study|Physician Decision|8|||
125517387|NCT00225277|451526140|FG000|Overall Study|Protocol Violation|6|||
125517388|NCT00225277|451526141|FG001|Overall Study|Protocol Violation|3|||
125517389|NCT00225277|451526140|FG000|Overall Study|Withdrawal by Subject|40|||
125517390|NCT00225277|451526141|FG001|Overall Study|Withdrawal by Subject|34|||
125517391|NCT00225277|451526140|FG000|Overall Study|Other|7|||
125517392|NCT00225277|451526141|FG001|Overall Study|Other|9|||
125517393|NCT04582669|451526148|FG000|Overall Study|Subject missed appointment(s).|1|||
125517394|NCT04582669|451526149|FG001|Overall Study|Subject missed appointment(s).|0|||
125517395|NCT04582669|451526150|FG002|Overall Study|Subject missed appointment(s).|1|||
125517396|NCT04582669|451526151|FG003|Overall Study|Subject missed appointment(s).|2|||
125517397|NCT04582669|451526148|FG000|Overall Study|Protocol Violation|0|||
125517398|NCT04582669|451526149|FG001|Overall Study|Protocol Violation|1|||
125517399|NCT04582669|451526150|FG002|Overall Study|Protocol Violation|1|||
125517400|NCT04582669|451526151|FG003|Overall Study|Protocol Violation|0|||
125517401|NCT00591409|451526152|FG000|Overall Study|Not Treated|0|||
125517402|NCT00591409|451526153|FG001|Overall Study|Not Treated|0|||
125517403|NCT00591409|451526154|FG002|Overall Study|Not Treated|0|||
125517404|NCT00591409|451526155|FG003|Overall Study|Not Treated|0|||
125517405|NCT00591409|451526156|FG004|Overall Study|Not Treated|1|||
125517406|NCT00591409|451526157|FG005|Overall Study|Not Treated|0|||
125517407|NCT00591409|451526158|FG006|Overall Study|Not Treated|0|||
125517408|NCT00591409|451526159|FG007|Overall Study|Not Treated|0|||
125517409|NCT00591409|451526160|FG008|Overall Study|Not Treated|0|||
125517410|NCT00591409|451526161|FG009|Overall Study|Not Treated|1|||
125517411|NCT00677092|451526162|FG000|Overall Study|Adverse Event|1|||
125517412|NCT00677092|451526162|FG000|Overall Study|Lost to Follow-up|1|||
125517413|NCT00677092|451526162|FG000|Overall Study|Withdrawal by Subject|3|||
125517414|NCT00677092|451526162|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
125517415|NCT00550446|451526163|FG000|Up To Week 12|Adverse Event|2|||
125517416|NCT00550446|451526164|FG001|Up To Week 12|Adverse Event|2|||
125517417|NCT00550446|451526165|FG002|Up To Week 12|Adverse Event|0|||
125517418|NCT00550446|451526166|FG003|Up To Week 12|Adverse Event|0|||
125517419|NCT00550446|451526167|FG004|Up To Week 12|Adverse Event|2|||
125517420|NCT00550446|451526168|FG005|Up To Week 12|Adverse Event|2|||
125517421|NCT00550446|451526169|FG006|Up To Week 12|Adverse Event|1|||
125517422|NCT00550446|451526170|FG007|Up To Week 12|Adverse Event|0|||
125517423|NCT00550446|451526171|FG008|Up To Week 12|Adverse Event|0|||
125517424|NCT00550446|451526172|FG009|Up To Week 12|Adverse Event|0|||
125517425|NCT00550446|451526173|FG010|Up To Week 12|Adverse Event|0|||
125517426|NCT00550446|451526163|FG000|Up To Week 12|Lack of Efficacy|3|||
125517427|NCT00550446|451526164|FG001|Up To Week 12|Lack of Efficacy|1|||
125517428|NCT00550446|451526165|FG002|Up To Week 12|Lack of Efficacy|0|||
125517429|NCT00550446|451526166|FG003|Up To Week 12|Lack of Efficacy|1|||
125517430|NCT00550446|451526167|FG004|Up To Week 12|Lack of Efficacy|0|||
125517431|NCT00550446|451526168|FG005|Up To Week 12|Lack of Efficacy|3|||
125517432|NCT00550446|451526169|FG006|Up To Week 12|Lack of Efficacy|3|||
125517433|NCT00550446|451526170|FG007|Up To Week 12|Lack of Efficacy|0|||
125517434|NCT00550446|451526171|FG008|Up To Week 12|Lack of Efficacy|0|||
125517435|NCT00550446|451526172|FG009|Up To Week 12|Lack of Efficacy|0|||
125517436|NCT00550446|451526173|FG010|Up To Week 12|Lack of Efficacy|0|||
125517437|NCT00550446|451526163|FG000|Up To Week 12|Lost to Follow-up|0|||
125517438|NCT00550446|451526164|FG001|Up To Week 12|Lost to Follow-up|1|||
125517439|NCT00550446|451526165|FG002|Up To Week 12|Lost to Follow-up|0|||
125517440|NCT00550446|451526166|FG003|Up To Week 12|Lost to Follow-up|0|||
125517441|NCT00550446|451526167|FG004|Up To Week 12|Lost to Follow-up|1|||
125517442|NCT00550446|451526168|FG005|Up To Week 12|Lost to Follow-up|1|||
125517443|NCT00550446|451526169|FG006|Up To Week 12|Lost to Follow-up|2|||
125517444|NCT00550446|451526170|FG007|Up To Week 12|Lost to Follow-up|0|||
125517445|NCT00550446|451526171|FG008|Up To Week 12|Lost to Follow-up|0|||
125517446|NCT00550446|451526172|FG009|Up To Week 12|Lost to Follow-up|0|||
125517447|NCT00550446|451526173|FG010|Up To Week 12|Lost to Follow-up|0|||
125517448|NCT00550446|451526163|FG000|Up To Week 12|Withdrawal by Subject|2|||
125517449|NCT00550446|451526164|FG001|Up To Week 12|Withdrawal by Subject|0|||
125517450|NCT00550446|451526165|FG002|Up To Week 12|Withdrawal by Subject|3|||
125517451|NCT00550446|451526166|FG003|Up To Week 12|Withdrawal by Subject|2|||
125517452|NCT00550446|451526167|FG004|Up To Week 12|Withdrawal by Subject|0|||
125517453|NCT00550446|451526168|FG005|Up To Week 12|Withdrawal by Subject|1|||
125517454|NCT00550446|451526169|FG006|Up To Week 12|Withdrawal by Subject|3|||
125517455|NCT00550446|451526170|FG007|Up To Week 12|Withdrawal by Subject|0|||
125517456|NCT00550446|451526171|FG008|Up To Week 12|Withdrawal by Subject|0|||
125517457|NCT00550446|451526172|FG009|Up To Week 12|Withdrawal by Subject|0|||
125517458|NCT00550446|451526173|FG010|Up To Week 12|Withdrawal by Subject|0|||
125517459|NCT00550446|451526163|FG000|Up To Week 12|Other|3|||
125517460|NCT00550446|451526164|FG001|Up To Week 12|Other|0|||
125517461|NCT00550446|451526165|FG002|Up To Week 12|Other|0|||
125517462|NCT00550446|451526166|FG003|Up To Week 12|Other|0|||
125517463|NCT00550446|451526167|FG004|Up To Week 12|Other|0|||
125517464|NCT00550446|451526168|FG005|Up To Week 12|Other|1|||
125517465|NCT00550446|451526169|FG006|Up To Week 12|Other|4|||
125517466|NCT00550446|451526170|FG007|Up To Week 12|Other|0|||
125517467|NCT00550446|451526171|FG008|Up To Week 12|Other|0|||
125517468|NCT00550446|451526172|FG009|Up To Week 12|Other|0|||
125517469|NCT00550446|451526173|FG010|Up To Week 12|Other|0|||
125517470|NCT00550446|451526163|FG000|Up To Week 12|Randomized not treated|0|||
125517471|NCT00550446|451526164|FG001|Up To Week 12|Randomized not treated|1|||
125517472|NCT00550446|451526165|FG002|Up To Week 12|Randomized not treated|1|||
125517473|NCT00550446|451526166|FG003|Up To Week 12|Randomized not treated|0|||
125517474|NCT00550446|451526167|FG004|Up To Week 12|Randomized not treated|0|||
125517475|NCT00550446|451526168|FG005|Up To Week 12|Randomized not treated|0|||
125517476|NCT00550446|451526169|FG006|Up To Week 12|Randomized not treated|0|||
125517477|NCT00550446|451526170|FG007|Up To Week 12|Randomized not treated|0|||
125517478|NCT00550446|451526171|FG008|Up To Week 12|Randomized not treated|0|||
125517479|NCT00550446|451526172|FG009|Up To Week 12|Randomized not treated|0|||
125517480|NCT00550446|451526173|FG010|Up To Week 12|Randomized not treated|0|||
125517481|NCT00550446|451526163|FG000|Post Week 12|Adverse Event|2|||
125517482|NCT00550446|451526164|FG001|Post Week 12|Adverse Event|1|||
125517483|NCT00550446|451526165|FG002|Post Week 12|Adverse Event|1|||
125517484|NCT00550446|451526166|FG003|Post Week 12|Adverse Event|1|||
125517485|NCT00550446|451526167|FG004|Post Week 12|Adverse Event|1|||
125517486|NCT00550446|451526168|FG005|Post Week 12|Adverse Event|1|||
125517487|NCT00550446|451526169|FG006|Post Week 12|Adverse Event|0|||
125517488|NCT00550446|451526170|FG007|Post Week 12|Adverse Event|0|||
125517489|NCT00550446|451526171|FG008|Post Week 12|Adverse Event|0|||
125517490|NCT00550446|451526172|FG009|Post Week 12|Adverse Event|4|||
125517491|NCT00550446|451526173|FG010|Post Week 12|Adverse Event|0|||
125517492|NCT00550446|451526163|FG000|Post Week 12|Lack of Efficacy|0|||
125517493|NCT00550446|451526164|FG001|Post Week 12|Lack of Efficacy|0|||
125517494|NCT00550446|451526165|FG002|Post Week 12|Lack of Efficacy|1|||
125517495|NCT00550446|451526166|FG003|Post Week 12|Lack of Efficacy|0|||
125517496|NCT00550446|451526167|FG004|Post Week 12|Lack of Efficacy|0|||
125517497|NCT00550446|451526168|FG005|Post Week 12|Lack of Efficacy|0|||
125517498|NCT00550446|451526169|FG006|Post Week 12|Lack of Efficacy|0|||
125517499|NCT00550446|451526170|FG007|Post Week 12|Lack of Efficacy|1|||
125517500|NCT00550446|451526171|FG008|Post Week 12|Lack of Efficacy|1|||
125517501|NCT00550446|451526172|FG009|Post Week 12|Lack of Efficacy|2|||
125517502|NCT00550446|451526173|FG010|Post Week 12|Lack of Efficacy|1|||
125517503|NCT00550446|451526163|FG000|Post Week 12|Lost to Follow-up|0|||
125517504|NCT00550446|451526164|FG001|Post Week 12|Lost to Follow-up|0|||
125517505|NCT00550446|451526165|FG002|Post Week 12|Lost to Follow-up|1|||
125517506|NCT00550446|451526166|FG003|Post Week 12|Lost to Follow-up|1|||
125517507|NCT00550446|451526167|FG004|Post Week 12|Lost to Follow-up|0|||
125517508|NCT00550446|451526168|FG005|Post Week 12|Lost to Follow-up|0|||
125517509|NCT00550446|451526169|FG006|Post Week 12|Lost to Follow-up|1|||
125517510|NCT00550446|451526170|FG007|Post Week 12|Lost to Follow-up|0|||
125517511|NCT00550446|451526171|FG008|Post Week 12|Lost to Follow-up|0|||
125517512|NCT00550446|451526172|FG009|Post Week 12|Lost to Follow-up|0|||
125517513|NCT00550446|451526173|FG010|Post Week 12|Lost to Follow-up|0|||
125517514|NCT00550446|451526163|FG000|Post Week 12|Withdrawal by Subject|0|||
125517515|NCT00550446|451526164|FG001|Post Week 12|Withdrawal by Subject|0|||
125517516|NCT00550446|451526165|FG002|Post Week 12|Withdrawal by Subject|0|||
125517517|NCT00550446|451526166|FG003|Post Week 12|Withdrawal by Subject|0|||
125517518|NCT00550446|451526167|FG004|Post Week 12|Withdrawal by Subject|1|||
125517519|NCT00550446|451526168|FG005|Post Week 12|Withdrawal by Subject|0|||
125517520|NCT00550446|451526169|FG006|Post Week 12|Withdrawal by Subject|0|||
125517521|NCT00550446|451526170|FG007|Post Week 12|Withdrawal by Subject|0|||
125517522|NCT00550446|451526171|FG008|Post Week 12|Withdrawal by Subject|0|||
125517523|NCT00550446|451526172|FG009|Post Week 12|Withdrawal by Subject|0|||
125517524|NCT00550446|451526173|FG010|Post Week 12|Withdrawal by Subject|0|||
125517525|NCT00550446|451526163|FG000|Post Week 12|Other|1|||
125517526|NCT00550446|451526164|FG001|Post Week 12|Other|1|||
125517527|NCT00550446|451526165|FG002|Post Week 12|Other|0|||
125517528|NCT00550446|451526166|FG003|Post Week 12|Other|1|||
125517529|NCT00550446|451526167|FG004|Post Week 12|Other|0|||
125517530|NCT00550446|451526168|FG005|Post Week 12|Other|0|||
125517531|NCT00550446|451526169|FG006|Post Week 12|Other|1|||
125517532|NCT00550446|451526170|FG007|Post Week 12|Other|0|||
125517533|NCT00550446|451526171|FG008|Post Week 12|Other|1|||
125517534|NCT00550446|451526172|FG009|Post Week 12|Other|1|||
125517535|NCT00550446|451526173|FG010|Post Week 12|Other|0|||
125517536|NCT02716298|451526174|FG000|First Intervention (1 Month)|Lens discomfort|1|||
125517537|NCT02716298|451526175|FG001|First Intervention (1 Month)|Lens discomfort|1|||
125517538|NCT04952701|451526176|FG000|Control Lens|Physician Decision|4|||
125517539|NCT04952701|451526176|FG000|Test Lens|Physician Decision|1|||
125517540|NCT03927222|451526177|FG000|Overall Study|Progression|3|||
125517541|NCT03927222|451526177|FG000|Overall Study|CMV testing results inconclusive|1|||
125517542|NCT03927222|451526177|FG000|Overall Study|Unable to generate enough vaccines|1|||
125517543|NCT03927222|451526177|FG000|Overall Study|Early study termination|1|||
125517544|NCT00578318|451526178|FG000|Overall Study|Lost to Follow-up|2|||
125517545|NCT00578318|451526179|FG001|Overall Study|Lost to Follow-up|0|||
125517546|NCT00578318|451526178|FG000|Overall Study|Physician Decision|1|||
125517547|NCT00578318|451526179|FG001|Overall Study|Physician Decision|0|||
125517548|NCT00001941|451526186|FG000|Overall Study|not treated- rapidly progressing disease|0|||
125517549|NCT00001941|451526187|FG001|Overall Study|not treated- rapidly progressing disease|0|||
125517550|NCT00001941|451526188|FG002|Overall Study|not treated- rapidly progressing disease|0|||
125517551|NCT00001941|451526189|FG003|Overall Study|not treated- rapidly progressing disease|0|||
125517552|NCT00001941|451526190|FG004|Overall Study|not treated- rapidly progressing disease|1|||
125517553|NCT01020747|451526204|FG000|Overall Study|Withdrawal by Subject|1|||
125517554|NCT01222078|451526205|FG000|Overall Study|Early termination of the study|1|||
125517555|NCT02970305|451526206|FG000|Overall Study|Adverse Event|10|||
125517556|NCT02970305|451526207|FG001|Overall Study|Adverse Event|6|||
125517557|NCT02970305|451526206|FG000|Overall Study|Lack of Efficacy|1|||
125517558|NCT02970305|451526207|FG001|Overall Study|Lack of Efficacy|1|||
125517559|NCT02970305|451526206|FG000|Overall Study|Noncompliance with study drug|2|||
125517560|NCT02970305|451526207|FG001|Overall Study|Noncompliance with study drug|4|||
125517561|NCT02970305|451526206|FG000|Overall Study|Protocol Violation|2|||
125517562|NCT02970305|451526207|FG001|Overall Study|Protocol Violation|2|||
125517563|NCT02970305|451526206|FG000|Overall Study|Withdrawal by Subject|12|||
125517564|NCT02970305|451526207|FG001|Overall Study|Withdrawal by Subject|11|||
125517565|NCT02970305|451526206|FG000|Overall Study|Not further specified|1|||
125517566|NCT02970305|451526207|FG001|Overall Study|Not further specified|2|||
125517567|NCT02970305|451526206|FG000|Overall Study|Lost to Follow-up|1|||
125517568|NCT02970305|451526207|FG001|Overall Study|Lost to Follow-up|2|||
125517569|NCT00983892|451526208|FG000|Overall Study|Withdrawal by Subject|10|||
125517570|NCT00983892|451526209|FG001|Overall Study|Withdrawal by Subject|12|||
125517571|NCT00808899|451526211|FG000|Overall Study|Death|1|||
125517572|NCT00808899|451526211|FG000|Overall Study|Physician Decision|3|||
125517573|NCT03120949|451526216|FG000|Overall Study|randomized in error|1|||
125517574|NCT03120949|451526217|FG001|Overall Study|randomized in error|0|||
125517575|NCT03120949|451526216|FG000|Overall Study|Death|13|||
125517576|NCT03120949|451526217|FG001|Overall Study|Death|13|||
125517577|NCT03120949|451526216|FG000|Overall Study|Lost to Follow-up|23|||
125517578|NCT03120949|451526217|FG001|Overall Study|Lost to Follow-up|13|||
125517579|NCT03120949|451526216|FG000|Overall Study|Withdrawal by Subject|139|||
125517580|NCT03120949|451526217|FG001|Overall Study|Withdrawal by Subject|124|||
125517581|NCT03120949|451526216|FG000|Overall Study|Covid-19|43|||
125517582|NCT03120949|451526217|FG001|Overall Study|Covid-19|34|||
125517583|NCT03120949|451526216|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
125517584|NCT03120949|451526217|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
125517585|NCT03120949|451526216|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
125517586|NCT03120949|451526217|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
125517587|NCT03120949|451526216|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
125517588|NCT03120949|451526217|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
125517589|NCT03120949|451526216|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
125517590|NCT03120949|451526217|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
125517591|NCT03120949|451526216|FG000|Overall Study|Site was closed|2|||
125517592|NCT03120949|451526217|FG001|Overall Study|Site was closed|3|||
125517593|NCT03120949|451526216|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
125517594|NCT03120949|451526217|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
125517595|NCT03120949|451526216|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
125517596|NCT03120949|451526217|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
125517597|NCT03120949|451526216|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
125517598|NCT03120949|451526217|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
125517599|NCT03120949|451526216|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
125517600|NCT03120949|451526217|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
125517601|NCT03120949|451526216|FG000|Overall Study|Other: Adverse Event|0|||
125517602|NCT03120949|451526217|FG001|Overall Study|Other: Adverse Event|1|||
125517603|NCT03120949|451526216|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
125517604|NCT03120949|451526217|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
125517605|NCT03120949|451526216|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
125517606|NCT03120949|451526217|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
125517607|NCT03120949|451526216|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
125517608|NCT03120949|451526217|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
125517609|NCT03120949|451526216|FG000|Overall Study|Personal Reasons|0|||
125517610|NCT03120949|451526217|FG001|Overall Study|Personal Reasons|1|||
125517611|NCT03120949|451526216|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
125517612|NCT03120949|451526217|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
125517613|NCT03120949|451526216|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
125517614|NCT03120949|451526217|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
125517615|NCT03120949|451526216|FG000|Overall Study|Compliance With Medication|0|||
125517616|NCT03120949|451526217|FG001|Overall Study|Compliance With Medication|1|||
125517617|NCT03120949|451526216|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
125517618|NCT03120949|451526217|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
125517619|NCT03120949|451526216|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
125532610|NCT00350727|451580162|FG001|Phase II|Death|0|||
125517620|NCT03120949|451526217|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
125517621|NCT03120949|451526216|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
125517622|NCT03120949|451526217|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
125517623|NCT00988117|451526218|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
125517624|NCT00988117|451526218|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
125517625|NCT04522778|451526221|FG000|Overall Study|Patient did not want to wear the device|1|||
125517626|NCT04522778|451526222|FG001|Overall Study|Patient did not want to wear the device|0|||
125517627|NCT04522778|451526221|FG000|Overall Study|Lost to Follow-up|0|||
125517628|NCT04522778|451526222|FG001|Overall Study|Lost to Follow-up|1|||
125517629|NCT01225159|451526223|FG000|Overall Study|Change operation|1|||
125517630|NCT01225159|451526224|FG001|Overall Study|Change operation|0|||
125517631|NCT00312845|451526225|FG000|Overall Study|Adverse Event|19|||
125517632|NCT00312845|451526226|FG001|Overall Study|Adverse Event|5|||
125517633|NCT00312845|451526225|FG000|Overall Study|Death|2|||
125517634|NCT00312845|451526226|FG001|Overall Study|Death|2|||
125517635|NCT00312845|451526225|FG000|Overall Study|Withdrawal by Subject|14|||
125517636|NCT00312845|451526226|FG001|Overall Study|Withdrawal by Subject|6|||
125517637|NCT00312845|451526225|FG000|Overall Study|Disease Progression|56|||
125517638|NCT00312845|451526226|FG001|Overall Study|Disease Progression|77|||
125517639|NCT00312845|451526225|FG000|Overall Study|Lost to Follow-up|2|||
125517640|NCT00312845|451526226|FG001|Overall Study|Lost to Follow-up|0|||
125517641|NCT00312845|451526225|FG000|Overall Study|Other|6|||
125517642|NCT00312845|451526226|FG001|Overall Study|Other|5|||
125517643|NCT01220856|451526227|FG000|Overall Study|graft loss|3|||
125517644|NCT01220856|451526228|FG001|Overall Study|graft loss|3|||
125517645|NCT01220856|451526227|FG000|Overall Study|Lost to Follow-up|1|||
125517646|NCT01220856|451526228|FG001|Overall Study|Lost to Follow-up|0|||
125517647|NCT04088500|451526229|FG000|Overall Study|Reason unknown|1|||
125517648|NCT04088500|451526229|FG000|Overall Study|Participant withdrew consent|1|||
125517649|NCT04088500|451526229|FG000|Overall Study|Disease progression|3|||
125517650|NCT03821064|451526230|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
125517651|NCT03325608|451526239|FG000|Overall Study|Lost to Follow-up|23|||
125517652|NCT03325608|451526240|FG001|Overall Study|Lost to Follow-up|23|||
125517653|NCT03325608|451526241|FG002|Overall Study|Lost to Follow-up|30|||
125517654|NCT03325608|451526242|FG003|Overall Study|Lost to Follow-up|30|||
125517655|NCT03325608|451526239|FG000|Overall Study|Death of Caregiver|0|||
125517656|NCT03325608|451526240|FG001|Overall Study|Death of Caregiver|0|||
125517657|NCT03325608|451526241|FG002|Overall Study|Death of Caregiver|2|||
125517658|NCT03325608|451526242|FG003|Overall Study|Death of Caregiver|2|||
125517659|NCT03325608|451526239|FG000|Overall Study|Death of Care Recipient|34|||
125517660|NCT03325608|451526240|FG001|Overall Study|Death of Care Recipient|34|||
125517661|NCT03325608|451526241|FG002|Overall Study|Death of Care Recipient|28|||
125517662|NCT03325608|451526242|FG003|Overall Study|Death of Care Recipient|28|||
125517663|NCT03325608|451526239|FG000|Overall Study|Withdrawal by Subject|49|||
125517664|NCT03325608|451526240|FG001|Overall Study|Withdrawal by Subject|49|||
125517665|NCT03325608|451526241|FG002|Overall Study|Withdrawal by Subject|35|||
125517666|NCT03325608|451526242|FG003|Overall Study|Withdrawal by Subject|35|||
125517667|NCT03325608|451526239|FG000|Overall Study|Ineligible|7|||
125517668|NCT03325608|451526240|FG001|Overall Study|Ineligible|7|||
125517669|NCT03325608|451526241|FG002|Overall Study|Ineligible|5|||
125517670|NCT03325608|451526242|FG003|Overall Study|Ineligible|5|||
125517671|NCT02188784|451526243|FG000|Overall Study|Death|3|||
125517672|NCT02188784|451526244|FG001|Overall Study|Death|1|||
125517673|NCT02188784|451526243|FG000|Overall Study|Lost to Follow-up|1|||
125517674|NCT02188784|451526244|FG001|Overall Study|Lost to Follow-up|0|||
125517675|NCT02188784|451526243|FG000|Overall Study|Withdrawal by Subject|3|||
125517676|NCT02188784|451526244|FG001|Overall Study|Withdrawal by Subject|9|||
125517677|NCT02188784|451526243|FG000|Overall Study|Physician Decision|2|||
125517678|NCT02188784|451526244|FG001|Overall Study|Physician Decision|3|||
125517679|NCT01190449|451526245|FG000|Overall Study|Ineligible|0|||
125517680|NCT01190449|451526246|FG001|Overall Study|Ineligible|4|||
125517681|NCT01268098|451527950|FG000|Overall Study|Adverse Event|1|||
125517682|NCT01268098|451527951|FG001|Overall Study|Adverse Event|0|||
125517683|NCT01929876|451527953|FG000|Period 2|Non-Compliance|1|||
125517684|NCT01845649|451527954|FG000|Overall Study|Adverse Event|7|||
125517685|NCT01845649|451527955|FG001|Overall Study|Adverse Event|10|||
125517686|NCT01845649|451527954|FG000|Overall Study|Lack of Efficacy|1|||
125517687|NCT01845649|451527955|FG001|Overall Study|Lack of Efficacy|1|||
125517688|NCT01845649|451527954|FG000|Overall Study|Lost to Follow-up|2|||
125517689|NCT01845649|451527955|FG001|Overall Study|Lost to Follow-up|2|||
125517690|NCT01845649|451527954|FG000|Overall Study|Withdrew Consent|12|||
125517691|NCT01845649|451527955|FG001|Overall Study|Withdrew Consent|4|||
125517692|NCT01845649|451527954|FG000|Overall Study|Protocol Deviation|7|||
125517693|NCT01845649|451527955|FG001|Overall Study|Protocol Deviation|4|||
125517694|NCT01845649|451527954|FG000|Overall Study|Reason not Specified|2|||
125517695|NCT01845649|451527955|FG001|Overall Study|Reason not Specified|1|||
125517696|NCT03991988|451527956|FG000|Overall Study|Withdrawal by Subject|2|||
125517697|NCT03991988|451527957|FG001|Overall Study|Withdrawal by Subject|2|||
125517698|NCT01222533|451527959|FG000|Overall Study|Adverse Event|5|||
125517699|NCT01222533|451527959|FG000|Overall Study|Withdrawal by Subject|5|||
125517700|NCT01222533|451527959|FG000|Overall Study|Other|4|||
125517701|NCT01947517|451527960|FG000|Overall Study|Withdrawal by Subject|1|||
125517702|NCT01947517|451527961|FG001|Overall Study|Withdrawal by Subject|1|||
125517703|NCT02418845|451527965|FG000|Overall Study|Lost to Follow-up|7|||
125517704|NCT02418845|451527966|FG001|Overall Study|Lost to Follow-up|2|||
125517705|NCT02418845|451527965|FG000|Overall Study|Lack of Efficacy|0|||
125517706|NCT02418845|451527966|FG001|Overall Study|Lack of Efficacy|3|||
125517707|NCT02418845|451527965|FG000|Overall Study|Physician Decision|5|||
125517708|NCT02418845|451527966|FG001|Overall Study|Physician Decision|5|||
125517709|NCT02418845|451527965|FG000|Overall Study|Protocol Violation|1|||
125517710|NCT02418845|451527966|FG001|Overall Study|Protocol Violation|0|||
125517711|NCT02418845|451527965|FG000|Overall Study|Withdrawal by Subject|3|||
125517712|NCT02418845|451527966|FG001|Overall Study|Withdrawal by Subject|2|||
125517713|NCT00526097|451527967|FG000|Overall Study|Adverse Event|6|||
125517714|NCT00526097|451527968|FG001|Overall Study|Adverse Event|44|||
125517715|NCT00526097|451527967|FG000|Overall Study|Protocol Violation|4|||
125517716|NCT00526097|451527968|FG001|Overall Study|Protocol Violation|10|||
125517717|NCT00526097|451527967|FG000|Overall Study|Withdrawal by Subject|3|||
125517718|NCT00526097|451527968|FG001|Overall Study|Withdrawal by Subject|1|||
125517719|NCT00526097|451527967|FG000|Overall Study|Other|2|||
125517720|NCT00526097|451527968|FG001|Overall Study|Other|1|||
125517721|NCT00460564|451527969|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
125517722|NCT00460564|451527970|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
125517723|NCT00460564|451527971|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
125517724|NCT00460564|451527972|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
125517725|NCT00460564|451527973|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
125517726|NCT00460564|451527974|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
125517727|NCT00460564|451527975|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
125517728|NCT00460564|451527976|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
125517729|NCT00460564|451527969|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
125517730|NCT00460564|451527970|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125517731|NCT00460564|451527971|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125517732|NCT00460564|451527972|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125517733|NCT00460564|451527973|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125517734|NCT00460564|451527974|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125517735|NCT00460564|451527975|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125517736|NCT00460564|451527976|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
125517737|NCT00460564|451527969|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
125517738|NCT00460564|451527970|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
125517739|NCT00460564|451527971|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
125517740|NCT00460564|451527972|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
125517741|NCT00460564|451527973|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
125517742|NCT00460564|451527974|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
125517743|NCT00460564|451527975|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
125517744|NCT00460564|451527976|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
125517745|NCT00460564|451527969|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
125517746|NCT00460564|451527970|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
125517747|NCT00460564|451527971|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
125517748|NCT00460564|451527972|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
125517749|NCT00460564|451527973|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
125517750|NCT00460564|451527974|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
125517751|NCT00460564|451527975|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
125517752|NCT00460564|451527976|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
125517753|NCT00460564|451527969|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
125517754|NCT00460564|451527970|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
125517755|NCT00460564|451527971|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
125517756|NCT00460564|451527972|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
125517757|NCT00460564|451527973|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
125517758|NCT00460564|451527974|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
125517759|NCT00460564|451527975|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
125517760|NCT00460564|451527976|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
125517761|NCT00511836|451527977|FG000|Double-blind Period|Lost to Follow-up|1|||
125517762|NCT00511836|451527978|FG001|Double-blind Period|Lost to Follow-up|0|||
125517763|NCT00943618|451527982|FG000|Overall Study|Lost to Follow-up|38|||
125517764|NCT00943618|451527983|FG001|Overall Study|Lost to Follow-up|48|||
125517765|NCT00943618|451527984|FG002|Overall Study|Lost to Follow-up|20|||
125517766|NCT00943618|451527982|FG000|Overall Study|Discontinued Medication|17|||
125517767|NCT00943618|451527983|FG001|Overall Study|Discontinued Medication|29|||
125517768|NCT00943618|451527984|FG002|Overall Study|Discontinued Medication|11|||
125517769|NCT00487552|451527999|FG000|Overall Study|Unsuccessful magnet placements|3|||
125532611|NCT00350727|451580163|FG002|Phase II|Death|2|||
125517770|NCT00487552|451527999|FG000|Overall Study|Death due to progressive malignancy|2|||
125517771|NCT00487552|451527999|FG000|Overall Study|Stent not placed|1|||
125517772|NCT02412111|451528000|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
125517773|NCT02412111|451528001|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
125517774|NCT02412111|451528002|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
125517775|NCT02412111|451528000|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
125517776|NCT02412111|451528001|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
125517777|NCT02412111|451528002|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
125517778|NCT02412111|451528000|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
125517779|NCT02412111|451528001|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
125517780|NCT02412111|451528002|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
125517781|NCT02412111|451528000|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
125517782|NCT02412111|451528001|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
125517783|NCT02412111|451528002|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
125517784|NCT02412111|451528000|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
125517785|NCT02412111|451528001|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
125517786|NCT02412111|451528002|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
125517787|NCT02412111|451528000|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
125517788|NCT02412111|451528001|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
125517789|NCT02412111|451528002|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
125517790|NCT02412111|451528000|FG000|Active Comparator Period (8 Weeks)|Other|0|||
125517791|NCT02412111|451528001|FG001|Active Comparator Period (8 Weeks)|Other|0|||
125517792|NCT02412111|451528002|FG002|Active Comparator Period (8 Weeks)|Other|2|||
125517793|NCT00630552|451528003|FG000|Overall Study|Adverse Event|0|||
125517794|NCT00630552|451528004|FG001|Overall Study|Adverse Event|1|||
125517795|NCT00630552|451528005|FG002|Overall Study|Adverse Event|5|||
125517796|NCT00630552|451528006|FG003|Overall Study|Adverse Event|4|||
125517797|NCT00630552|451528007|FG004|Overall Study|Adverse Event|2|||
125517798|NCT00630552|451528003|FG000|Overall Study|Disease progression|5|||
125517799|NCT00630552|451528004|FG001|Overall Study|Disease progression|6|||
125517800|NCT00630552|451528005|FG002|Overall Study|Disease progression|27|||
125517801|NCT00630552|451528006|FG003|Overall Study|Disease progression|22|||
125517802|NCT00630552|451528007|FG004|Overall Study|Disease progression|31|||
125517803|NCT00630552|451528003|FG000|Overall Study|Never received IP|0|||
125517804|NCT00630552|451528004|FG001|Overall Study|Never received IP|0|||
125517805|NCT00630552|451528005|FG002|Overall Study|Never received IP|0|||
125517806|NCT00630552|451528006|FG003|Overall Study|Never received IP|2|||
125517807|NCT00630552|451528007|FG004|Overall Study|Never received IP|2|||
125517808|NCT00630552|451528003|FG000|Overall Study|Ineligibility determined|0|||
125517809|NCT00630552|451528004|FG001|Overall Study|Ineligibility determined|0|||
125517810|NCT00630552|451528005|FG002|Overall Study|Ineligibility determined|0|||
125517811|NCT00630552|451528006|FG003|Overall Study|Ineligibility determined|0|||
125517812|NCT00630552|451528007|FG004|Overall Study|Ineligibility determined|1|||
125517813|NCT00630552|451528003|FG000|Overall Study|Protocol Violation|0|||
125517814|NCT00630552|451528004|FG001|Overall Study|Protocol Violation|0|||
125517815|NCT00630552|451528005|FG002|Overall Study|Protocol Violation|0|||
125517816|NCT00630552|451528006|FG003|Overall Study|Protocol Violation|1|||
125517817|NCT00630552|451528007|FG004|Overall Study|Protocol Violation|0|||
125517818|NCT00630552|451528003|FG000|Overall Study|Physician Decision|0|||
125517819|NCT00630552|451528004|FG001|Overall Study|Physician Decision|0|||
125517820|NCT00630552|451528005|FG002|Overall Study|Physician Decision|0|||
125517821|NCT00630552|451528006|FG003|Overall Study|Physician Decision|0|||
125517822|NCT00630552|451528007|FG004|Overall Study|Physician Decision|1|||
125517823|NCT00630552|451528003|FG000|Overall Study|Death|0|||
125517824|NCT00630552|451528004|FG001|Overall Study|Death|0|||
125517825|NCT00630552|451528005|FG002|Overall Study|Death|1|||
125517826|NCT00630552|451528006|FG003|Overall Study|Death|2|||
125517827|NCT00630552|451528007|FG004|Overall Study|Death|2|||
125517828|NCT00630552|451528003|FG000|Overall Study|Withdrawal by Subject|0|||
125517829|NCT00630552|451528004|FG001|Overall Study|Withdrawal by Subject|0|||
125517830|NCT00630552|451528005|FG002|Overall Study|Withdrawal by Subject|0|||
125517831|NCT00630552|451528006|FG003|Overall Study|Withdrawal by Subject|1|||
125517832|NCT00630552|451528007|FG004|Overall Study|Withdrawal by Subject|0|||
125517833|NCT00630552|451528003|FG000|Overall Study|Other|0|||
125517834|NCT00630552|451528004|FG001|Overall Study|Other|0|||
125517835|NCT00630552|451528005|FG002|Overall Study|Other|4|||
125517836|NCT00630552|451528006|FG003|Overall Study|Other|2|||
125517837|NCT00630552|451528007|FG004|Overall Study|Other|0|||
125517838|NCT04349644|451528008|FG000|Allocation/Pretest|Lost to pretest|0|||
125517839|NCT04349644|451528009|FG001|Allocation/Pretest|Lost to pretest|3|||
125517840|NCT04349644|451528008|FG000|Posttest|Lost to posttest|0|||
125517841|NCT04349644|451528009|FG001|Posttest|Lost to posttest|8|||
125517842|NCT04349644|451528008|FG000|Posttest|Discontinued intervention|6|||
125517843|NCT04349644|451528009|FG001|Posttest|Discontinued intervention|0|||
125517844|NCT04349644|451528008|FG000|Follow-up|Lost to Follow-up|0|||
125517845|NCT04349644|451528009|FG001|Follow-up|Lost to Follow-up|2|||
125517846|NCT00983905|451528010|FG000|Theophylline Alone|Adverse Event|1|||
125517847|NCT00983905|451528010|FG000|Colchicine Alone|Adverse Event|2|||
125517848|NCT01169636|451528011|FG000|Overall Study|Adverse Event|0|||
125517849|NCT01169636|451528012|FG001|Overall Study|Adverse Event|0|||
125517850|NCT01169636|451528013|FG002|Overall Study|Adverse Event|1|||
125517851|NCT01169636|451528014|FG003|Overall Study|Adverse Event|1|||
125517852|NCT01169636|451528015|FG004|Overall Study|Adverse Event|0|||
125517853|NCT01169636|451528011|FG000|Overall Study|Screen failure|0|||
125517854|NCT01169636|451528012|FG001|Overall Study|Screen failure|0|||
125517855|NCT01169636|451528013|FG002|Overall Study|Screen failure|2|||
125517856|NCT01169636|451528014|FG003|Overall Study|Screen failure|0|||
125517857|NCT01169636|451528015|FG004|Overall Study|Screen failure|0|||
125517858|NCT01169636|451528011|FG000|Overall Study|Withdrawal by Subject|0|||
125517859|NCT01169636|451528012|FG001|Overall Study|Withdrawal by Subject|0|||
125517860|NCT01169636|451528013|FG002|Overall Study|Withdrawal by Subject|0|||
125517861|NCT01169636|451528014|FG003|Overall Study|Withdrawal by Subject|0|||
125517862|NCT01169636|451528015|FG004|Overall Study|Withdrawal by Subject|3|||
125517863|NCT02287883|451528016|FG000|Overall Study|Death|8|||
125517864|NCT02287883|451528017|FG001|Overall Study|Death|7|||
125517865|NCT02287883|451528016|FG000|Overall Study|No longer eligible|222|||
125517866|NCT02287883|451528017|FG001|Overall Study|No longer eligible|182|||
125517867|NCT02287883|451528016|FG000|Overall Study|Non-response to survey|229|||
125517868|NCT02287883|451528017|FG001|Overall Study|Non-response to survey|237|||
125517869|NCT00802438|451528018|FG000|Overall Study|Screen Failure|20|||
125517870|NCT00802438|451528018|FG000|Overall Study|Withdrawal by Subject|7|||
125517871|NCT00802438|451528018|FG000|Overall Study|Physician Decision|1|||
125517872|NCT04016805|451528019|FG000|Overall Study|Sponsor's Discretion|30|||
125517873|NCT04016805|451528020|FG001|Overall Study|Sponsor's Discretion|6|||
125517874|NCT04016805|451528021|FG002|Overall Study|Sponsor's Discretion|5|||
125517875|NCT03175198|451528022|FG000|Overall Study|Adverse Event|480|||
125517876|NCT03175198|451528022|FG000|Overall Study|No actual visit|120|||
125517877|NCT03175198|451528022|FG000|Overall Study|Registration rule not followed|4|||
125517878|NCT03175198|451528022|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
125517879|NCT03175198|451528022|FG000|Overall Study|Other personal reason|509|||
125517880|NCT03175198|451528022|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
125517881|NCT03175198|451528022|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
125517882|NCT03175198|451528022|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
125517883|NCT03175198|451528022|FG000|Overall Study|To conduct invasive treatment of operation|53|||
125517884|NCT03175198|451528022|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
125517885|NCT01193218|451528024|FG000|0-12 Weeks|Adverse Event|6|||
125517886|NCT01193218|451528025|FG001|0-12 Weeks|Adverse Event|0|||
125517887|NCT01193218|451528026|FG002|0-12 Weeks|Adverse Event|1|||
125517888|NCT01193218|451528027|FG003|0-12 Weeks|Adverse Event|0|||
125517889|NCT01193218|451528028|FG004|0-12 Weeks|Adverse Event|0|||
125517890|NCT01193218|451528029|FG005|0-12 Weeks|Adverse Event|2|||
125517891|NCT01193218|451528030|FG006|0-12 Weeks|Adverse Event|2|||
125517892|NCT01193218|451528031|FG007|0-12 Weeks|Adverse Event|0|||
125517893|NCT01193218|451528024|FG000|0-12 Weeks|Protocol Violation|0|||
125517894|NCT01193218|451528025|FG001|0-12 Weeks|Protocol Violation|0|||
125517895|NCT01193218|451528026|FG002|0-12 Weeks|Protocol Violation|0|||
125517896|NCT01193218|451528027|FG003|0-12 Weeks|Protocol Violation|0|||
125517897|NCT01193218|451528028|FG004|0-12 Weeks|Protocol Violation|1|||
125517898|NCT01193218|451528029|FG005|0-12 Weeks|Protocol Violation|1|||
125517899|NCT01193218|451528030|FG006|0-12 Weeks|Protocol Violation|0|||
125517900|NCT01193218|451528031|FG007|0-12 Weeks|Protocol Violation|0|||
125517901|NCT01193218|451528024|FG000|0-12 Weeks|Withdrawal by Subject|3|||
125517902|NCT01193218|451528025|FG001|0-12 Weeks|Withdrawal by Subject|0|||
125517903|NCT01193218|451528026|FG002|0-12 Weeks|Withdrawal by Subject|2|||
125517904|NCT01193218|451528027|FG003|0-12 Weeks|Withdrawal by Subject|0|||
125517905|NCT01193218|451528028|FG004|0-12 Weeks|Withdrawal by Subject|0|||
125517906|NCT01193218|451528029|FG005|0-12 Weeks|Withdrawal by Subject|0|||
125517907|NCT01193218|451528030|FG006|0-12 Weeks|Withdrawal by Subject|1|||
125517908|NCT01193218|451528031|FG007|0-12 Weeks|Withdrawal by Subject|0|||
125517909|NCT01193218|451528024|FG000|12-52 Weeks|Adverse Event|1|||
125517910|NCT01193218|451528025|FG001|12-52 Weeks|Adverse Event|0|||
125517911|NCT01193218|451528026|FG002|12-52 Weeks|Adverse Event|1|||
125517912|NCT01193218|451528027|FG003|12-52 Weeks|Adverse Event|2|||
125517913|NCT01193218|451528028|FG004|12-52 Weeks|Adverse Event|3|||
125517914|NCT01193218|451528029|FG005|12-52 Weeks|Adverse Event|3|||
125517915|NCT01193218|451528030|FG006|12-52 Weeks|Adverse Event|1|||
125517916|NCT01193218|451528031|FG007|12-52 Weeks|Adverse Event|2|||
125517917|NCT01193218|451528024|FG000|12-52 Weeks|Lack of Efficacy|0|||
125517918|NCT01193218|451528025|FG001|12-52 Weeks|Lack of Efficacy|0|||
125517919|NCT01193218|451528026|FG002|12-52 Weeks|Lack of Efficacy|0|||
125517920|NCT01193218|451528027|FG003|12-52 Weeks|Lack of Efficacy|0|||
125517921|NCT01193218|451528028|FG004|12-52 Weeks|Lack of Efficacy|0|||
125517922|NCT01193218|451528029|FG005|12-52 Weeks|Lack of Efficacy|0|||
125517923|NCT01193218|451528030|FG006|12-52 Weeks|Lack of Efficacy|1|||
125517924|NCT01193218|451528031|FG007|12-52 Weeks|Lack of Efficacy|0|||
125517925|NCT01193218|451528024|FG000|12-52 Weeks|Withdrawal by Subject|3|||
125517926|NCT01193218|451528025|FG001|12-52 Weeks|Withdrawal by Subject|0|||
125517927|NCT01193218|451528026|FG002|12-52 Weeks|Withdrawal by Subject|3|||
125517928|NCT01193218|451528027|FG003|12-52 Weeks|Withdrawal by Subject|0|||
125517929|NCT01193218|451528028|FG004|12-52 Weeks|Withdrawal by Subject|0|||
125517930|NCT01193218|451528029|FG005|12-52 Weeks|Withdrawal by Subject|2|||
125517931|NCT01193218|451528030|FG006|12-52 Weeks|Withdrawal by Subject|1|||
125517932|NCT01193218|451528031|FG007|12-52 Weeks|Withdrawal by Subject|2|||
125517933|NCT01193218|451528024|FG000|12-52 Weeks|Other reason than above|1|||
125517934|NCT01193218|451528025|FG001|12-52 Weeks|Other reason than above|0|||
125517935|NCT01193218|451528026|FG002|12-52 Weeks|Other reason than above|0|||
125517936|NCT01193218|451528027|FG003|12-52 Weeks|Other reason than above|1|||
125517937|NCT01193218|451528028|FG004|12-52 Weeks|Other reason than above|1|||
125517938|NCT01193218|451528029|FG005|12-52 Weeks|Other reason than above|0|||
125517939|NCT01193218|451528030|FG006|12-52 Weeks|Other reason than above|0|||
125517940|NCT01193218|451528031|FG007|12-52 Weeks|Other reason than above|0|||
125517941|NCT03811834|451528032|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
125517942|NCT01242371|451528033|FG000|Overall Study|Withdrawal by Subject|2|||
125517943|NCT01242371|451528034|FG001|Overall Study|Withdrawal by Subject|2|||
125517944|NCT01242371|451528033|FG000|Overall Study|Protocol Violation|0|||
125517945|NCT01242371|451528034|FG001|Overall Study|Protocol Violation|3|||
125517946|NCT03188536|451528035|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
125517947|NCT03188536|451528035|FG000|Overall Study|Not participated/met inclusion criteria|1|||
125517948|NCT04947436|451528038|FG000|Overall Study|Lost to Follow-up|3|||
125517949|NCT04947436|451528039|FG001|Overall Study|Lost to Follow-up|7|||
125517950|NCT04947436|451528040|FG002|Overall Study|Lost to Follow-up|5|||
125517951|NCT04947436|451528038|FG000|Overall Study|Death|1|||
125517952|NCT04947436|451528039|FG001|Overall Study|Death|1|||
125517953|NCT04947436|451528040|FG002|Overall Study|Death|1|||
125517954|NCT02161185|451528044|FG000|Treatment Phase|Administrative/Other|7|||
125517955|NCT00372255|451528045|FG000|Overall Study|Withdrawn for other reasons|2|||
125517956|NCT00372255|451528046|FG001|Overall Study|Withdrawn for other reasons|1|||
125517957|NCT01215032|451528052|FG000|Overall Study|Adverse Event|3|||
125517958|NCT01215032|451528052|FG000|Overall Study|Lack of Efficacy|17|||
125517959|NCT01424189|451528053|FG000|Overall Study|Adverse Event|1|||
125517960|NCT01424189|451528054|FG001|Overall Study|Adverse Event|0|||
125517961|NCT01424189|451528053|FG000|Overall Study|Lost to Follow-up|4|||
125517962|NCT01424189|451528054|FG001|Overall Study|Lost to Follow-up|1|||
125517963|NCT01424189|451528053|FG000|Overall Study|Withdrawal by Subject|4|||
125517964|NCT01424189|451528054|FG001|Overall Study|Withdrawal by Subject|4|||
125517965|NCT01424189|451528053|FG000|Overall Study|Subject moved|1|||
125517966|NCT01424189|451528054|FG001|Overall Study|Subject moved|0|||
125517967|NCT01424189|451528053|FG000|Overall Study|Death|3|||
125517968|NCT01424189|451528054|FG001|Overall Study|Death|1|||
125517969|NCT00361842|451528059|FG000|Overall Study|Withdrawal by Subject|2|||
125517970|NCT00361842|451528060|FG001|Overall Study|Withdrawal by Subject|3|||
125517971|NCT00361842|451528059|FG000|Overall Study|Death|2|||
125517972|NCT00361842|451528060|FG001|Overall Study|Death|1|||
125517973|NCT00361842|451528059|FG000|Overall Study|Disease progression|19|||
125517974|NCT00361842|451528060|FG001|Overall Study|Disease progression|20|||
125517975|NCT00361842|451528059|FG000|Overall Study|Adverse Event|2|||
125517976|NCT00361842|451528060|FG001|Overall Study|Adverse Event|3|||
125517977|NCT00361842|451528059|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
125517978|NCT00361842|451528060|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
125517979|NCT00361842|451528059|FG000|Overall Study|Other|1|||
125517980|NCT00361842|451528060|FG001|Overall Study|Other|0|||
125517981|NCT00361842|451528059|FG000|Overall Study|Other|0|||
125517982|NCT00361842|451528060|FG001|Overall Study|Other|2|||
125517983|NCT04814992|451528061|FG000|Overall Study|Withdrawal by Subject|6|||
125517984|NCT04814992|451528062|FG001|Overall Study|Withdrawal by Subject|3|||
125517985|NCT04814992|451528061|FG000|Overall Study|Lost to Follow-up|1|||
125517986|NCT04814992|451528062|FG001|Overall Study|Lost to Follow-up|4|||
125517987|NCT01078584|451528063|FG000|Overall Study|Final Status Unknown|1073|||
125517988|NCT01078584|451528063|FG000|Overall Study|Lost to Follow-up|670|||
125517989|NCT01078584|451528063|FG000|Overall Study|Non-serious Adverse Event|577|||
125517990|NCT01078584|451528063|FG000|Overall Study|Withdrawal of Consent|244|||
125517991|NCT01078584|451528063|FG000|Overall Study|Physician Withdrew from Study|90|||
125517992|NCT01078584|451528063|FG000|Overall Study|Non-compliance|67|||
125517993|NCT01078584|451528063|FG000|Overall Study|Blood Pressure Controlled|49|||
125517994|NCT01078584|451528063|FG000|Overall Study|Physician Switched Medication|26|||
125517995|NCT01078584|451528063|FG000|Overall Study|Physician Discontinued Patient|12|||
125517996|NCT01078584|451528063|FG000|Overall Study|Lack of Efficacy|98|||
125517997|NCT01078584|451528063|FG000|Overall Study|Protocol Violation|75|||
125517998|NCT01078584|451528063|FG000|Overall Study|Serious Adverse Event|27|||
125517999|NCT01078584|451528063|FG000|Overall Study|Multiple Reasons|2|||
125518000|NCT01208870|451528066|FG000|Overall Study|Lost to Follow-up|2|||
125518001|NCT01208870|451528067|FG001|Overall Study|Lost to Follow-up|8|||
125518002|NCT01077622|451528068|FG000|Overall Study|Physician Decision|2|||
125518003|NCT01077622|451528068|FG000|Overall Study|Withdrawal by Subject|1|||
125518004|NCT01260142|451528069|FG000|Treatment Period 1|Study on hold|1|||
125518005|NCT01260142|451528070|FG001|Treatment Period 1|Study on hold|1|||
125518006|NCT01260142|451528071|FG002|Treatment Period 1|Study on hold|0|||
125518007|NCT01260142|451528072|FG003|Treatment Period 1|Study on hold|0|||
125518008|NCT01260142|451528073|FG004|Treatment Period 1|Study on hold|1|||
125518009|NCT01260142|451528074|FG005|Treatment Period 1|Study on hold|2|||
125518010|NCT01260142|451528069|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
125518011|NCT01260142|451528070|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
125518012|NCT01260142|451528071|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
125518013|NCT01260142|451528072|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
125518014|NCT01260142|451528073|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
125518015|NCT01260142|451528074|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
125518016|NCT01260142|451528069|FG000|Treatment Period 1|Withdrawal by Subject|0|||
125518017|NCT01260142|451528070|FG001|Treatment Period 1|Withdrawal by Subject|0|||
125518018|NCT01260142|451528071|FG002|Treatment Period 1|Withdrawal by Subject|0|||
125518019|NCT01260142|451528072|FG003|Treatment Period 1|Withdrawal by Subject|0|||
125518020|NCT01260142|451528073|FG004|Treatment Period 1|Withdrawal by Subject|0|||
125518021|NCT01260142|451528074|FG005|Treatment Period 1|Withdrawal by Subject|1|||
125518022|NCT00424177|451528075|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
125518023|NCT00424177|451528075|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
125518024|NCT00424177|451528075|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
125518025|NCT00424177|451528075|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
125518026|NCT00424177|451528075|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
125518027|NCT00424177|451528075|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
125518028|NCT00424177|451528075|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
125518029|NCT00424177|451528075|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
125518030|NCT00424177|451528075|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
125518031|NCT00424177|451528075|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
125518032|NCT00691678|451528081|FG000|Overall Study|Adverse Event|5|||
125518033|NCT00691678|451528081|FG000|Overall Study|life events, pain|11|||
125518034|NCT00496834|451528082|FG000|Overall Study|Withdrawal by Subject|4|||
125518035|NCT00496834|451528083|FG001|Overall Study|Withdrawal by Subject|6|||
125518036|NCT00496834|451528082|FG000|Overall Study|Contraindicated medication administered|0|||
125518037|NCT00496834|451528083|FG001|Overall Study|Contraindicated medication administered|1|||
125518038|NCT00496834|451528082|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
125518039|NCT00496834|451528083|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
125518040|NCT00496834|451528082|FG000|Overall Study|Adverse Event|5|||
125518041|NCT00496834|451528083|FG001|Overall Study|Adverse Event|3|||
125518042|NCT00496834|451528082|FG000|Overall Study|IP administration violation|2|||
125518043|NCT00496834|451528083|FG001|Overall Study|IP administration violation|0|||
125518044|NCT00496834|451528082|FG000|Overall Study|Lost to Follow-up|2|||
125518045|NCT00496834|451528083|FG001|Overall Study|Lost to Follow-up|0|||
125518046|NCT00496834|451528082|FG000|Overall Study|Blood Pressure control failure|2|||
125518047|NCT00496834|451528083|FG001|Overall Study|Blood Pressure control failure|1|||
125518048|NCT01227928|451528084|FG000|Overall Study|Lost to Follow-up|4|||
125518049|NCT01227928|451528085|FG001|Overall Study|Lost to Follow-up|2|||
125518050|NCT01227928|451528084|FG000|Overall Study|Withdrawal by Subject|4|||
125518051|NCT01227928|451528085|FG001|Overall Study|Withdrawal by Subject|3|||
125518052|NCT01227928|451528084|FG000|Overall Study|Death|14|||
125518053|NCT01227928|451528085|FG001|Overall Study|Death|12|||
125518054|NCT01494298|451528086|FG000|Overall Study|Protocol Violation|2|||
125518055|NCT01494298|451528087|FG001|Overall Study|Protocol Violation|8|||
125518056|NCT02930837|451528088|FG000|Overall Study|Adverse Event|6|||
125518057|NCT02930837|451528088|FG000|Overall Study|Lost to Follow-up|5|||
125518058|NCT02930837|451528088|FG000|Overall Study|Withdrawal by Subject|1|||
125518059|NCT01393613|451528089|FG000|Overall Study|Adverse Event|11|||
125518060|NCT01393613|451528090|FG001|Overall Study|Adverse Event|11|||
125518061|NCT01393613|451528091|FG002|Overall Study|Adverse Event|13|||
125518062|NCT01393613|451528092|FG003|Overall Study|Adverse Event|22|||
125518063|NCT01393613|451528089|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
125518064|NCT01393613|451528090|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
125518065|NCT01393613|451528091|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
125518066|NCT01393613|451528092|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
125518067|NCT01393613|451528089|FG000|Overall Study|Physician Decision|2|||
125518068|NCT01393613|451528090|FG001|Overall Study|Physician Decision|0|||
125518069|NCT01393613|451528091|FG002|Overall Study|Physician Decision|0|||
125518070|NCT01393613|451528092|FG003|Overall Study|Physician Decision|1|||
125518071|NCT01393613|451528089|FG000|Overall Study|Withdrawal by Subject|15|||
125518072|NCT01393613|451528090|FG001|Overall Study|Withdrawal by Subject|25|||
125518073|NCT01393613|451528091|FG002|Overall Study|Withdrawal by Subject|23|||
125518074|NCT01393613|451528092|FG003|Overall Study|Withdrawal by Subject|21|||
125518075|NCT01393613|451528089|FG000|Overall Study|Protocol Deviation|2|||
125518076|NCT01393613|451528090|FG001|Overall Study|Protocol Deviation|1|||
125518077|NCT01393613|451528091|FG002|Overall Study|Protocol Deviation|0|||
125518078|NCT01393613|451528092|FG003|Overall Study|Protocol Deviation|0|||
125518079|NCT01393613|451528089|FG000|Overall Study|Lack of Efficacy|9|||
125518080|NCT01393613|451528090|FG001|Overall Study|Lack of Efficacy|20|||
125518081|NCT01393613|451528091|FG002|Overall Study|Lack of Efficacy|16|||
125518082|NCT01393613|451528092|FG003|Overall Study|Lack of Efficacy|21|||
125518083|NCT02598934|451528093|FG000|Overall Study|Adverse Event|11|||
125518084|NCT02598934|451528094|FG001|Overall Study|Adverse Event|13|||
125518085|NCT02598934|451528093|FG000|Overall Study|Failure to Return|3|||
125518086|NCT02598934|451528094|FG001|Overall Study|Failure to Return|3|||
125518087|NCT02598934|451528093|FG000|Overall Study|Withdrawal by Subject|2|||
125518088|NCT02598934|451528094|FG001|Overall Study|Withdrawal by Subject|3|||
125518089|NCT02598934|451528093|FG000|Overall Study|Administrative|2|||
125518090|NCT02598934|451528094|FG001|Overall Study|Administrative|1|||
125518091|NCT02598934|451528093|FG000|Overall Study|Protocol Violation|1|||
125518092|NCT02598934|451528094|FG001|Overall Study|Protocol Violation|2|||
125518093|NCT04944784|451528099|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
125518094|NCT04944784|451528100|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
125518095|NCT04944784|451528101|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
125518096|NCT04944784|451528102|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
125518097|NCT04944784|451528099|FG000|Double-blind Period|Adverse Event|20|||
125518098|NCT04944784|451528100|FG001|Double-blind Period|Adverse Event|4|||
125518099|NCT04944784|451528101|FG002|Double-blind Period|Adverse Event|0|||
125518100|NCT04944784|451528102|FG003|Double-blind Period|Adverse Event|0|||
125518101|NCT04944784|451528099|FG000|Double-blind Period|Withdrawal by Subject|15|||
125518102|NCT04944784|451528100|FG001|Double-blind Period|Withdrawal by Subject|4|||
125518103|NCT04944784|451528101|FG002|Double-blind Period|Withdrawal by Subject|0|||
125518104|NCT04944784|451528102|FG003|Double-blind Period|Withdrawal by Subject|0|||
125518105|NCT04944784|451528099|FG000|Double-blind Period|Death|7|||
125518106|NCT04944784|451528100|FG001|Double-blind Period|Death|2|||
125518107|NCT04944784|451528101|FG002|Double-blind Period|Death|0|||
125518108|NCT04944784|451528102|FG003|Double-blind Period|Death|0|||
125518109|NCT04944784|451528099|FG000|Double-blind Period|Physician Decision|2|||
125518110|NCT04944784|451528100|FG001|Double-blind Period|Physician Decision|1|||
125518111|NCT04944784|451528101|FG002|Double-blind Period|Physician Decision|0|||
125518112|NCT04944784|451528102|FG003|Double-blind Period|Physician Decision|0|||
125518113|NCT04944784|451528099|FG000|Double-blind Period|Lack of Efficacy|0|||
125518114|NCT04944784|451528100|FG001|Double-blind Period|Lack of Efficacy|1|||
125518115|NCT04944784|451528101|FG002|Double-blind Period|Lack of Efficacy|0|||
125518116|NCT04944784|451528102|FG003|Double-blind Period|Lack of Efficacy|0|||
125518117|NCT04944784|451528099|FG000|Double-blind Period|Sponsor Request|2|||
125518118|NCT04944784|451528100|FG001|Double-blind Period|Sponsor Request|1|||
125518119|NCT04944784|451528101|FG002|Double-blind Period|Sponsor Request|0|||
125518120|NCT04944784|451528102|FG003|Double-blind Period|Sponsor Request|0|||
125518121|NCT04944784|451528099|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
125518122|NCT04944784|451528100|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
125518123|NCT04944784|451528101|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
125518124|NCT04944784|451528102|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
125518125|NCT04944784|451528099|FG000|Double-blind Period|Participant Choice|1|||
125518126|NCT04944784|451528100|FG001|Double-blind Period|Participant Choice|1|||
125518127|NCT04944784|451528101|FG002|Double-blind Period|Participant Choice|0|||
125518128|NCT04944784|451528102|FG003|Double-blind Period|Participant Choice|0|||
125518129|NCT04944784|451528099|FG000|Double-blind Period|Progressive Disease|2|||
125518130|NCT04944784|451528100|FG001|Double-blind Period|Progressive Disease|2|||
125518131|NCT04944784|451528101|FG002|Double-blind Period|Progressive Disease|0|||
125518132|NCT04944784|451528102|FG003|Double-blind Period|Progressive Disease|0|||
125518133|NCT04944784|451528099|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
125518134|NCT04944784|451528100|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
125518135|NCT04944784|451528101|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
125518136|NCT04944784|451528102|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
125518137|NCT04944784|451528099|FG000|Active Drug Period|Adverse Event|0|||
125518138|NCT04944784|451528100|FG001|Active Drug Period|Adverse Event|0|||
125518139|NCT04944784|451528101|FG002|Active Drug Period|Adverse Event|3|||
125518140|NCT04944784|451528102|FG003|Active Drug Period|Adverse Event|6|||
125518141|NCT04944784|451528099|FG000|Active Drug Period|Withdrawal by Subject|0|||
125518142|NCT04944784|451528100|FG001|Active Drug Period|Withdrawal by Subject|0|||
125518143|NCT04944784|451528101|FG002|Active Drug Period|Withdrawal by Subject|4|||
125518144|NCT04944784|451528102|FG003|Active Drug Period|Withdrawal by Subject|7|||
125518145|NCT04944784|451528099|FG000|Active Drug Period|Death|0|||
125518146|NCT04944784|451528100|FG001|Active Drug Period|Death|0|||
125518147|NCT04944784|451528101|FG002|Active Drug Period|Death|3|||
125518148|NCT04944784|451528102|FG003|Active Drug Period|Death|4|||
125518149|NCT04944784|451528099|FG000|Active Drug Period|Lack of Efficacy|0|||
125518150|NCT04944784|451528100|FG001|Active Drug Period|Lack of Efficacy|0|||
125518151|NCT04944784|451528101|FG002|Active Drug Period|Lack of Efficacy|2|||
125518152|NCT04944784|451528102|FG003|Active Drug Period|Lack of Efficacy|2|||
125518153|NCT04944784|451528099|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
125518154|NCT04944784|451528100|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
125518155|NCT04944784|451528101|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
125518156|NCT04944784|451528102|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
125518157|NCT04944784|451528099|FG000|Active Drug Period|Participant Choice|0|||
125518158|NCT04944784|451528100|FG001|Active Drug Period|Participant Choice|0|||
125518159|NCT04944784|451528101|FG002|Active Drug Period|Participant Choice|0|||
125518160|NCT04944784|451528102|FG003|Active Drug Period|Participant Choice|1|||
125518161|NCT04944784|451528099|FG000|Active Drug Period|Progressive Disease|0|||
125518162|NCT04944784|451528100|FG001|Active Drug Period|Progressive Disease|0|||
125518163|NCT04944784|451528101|FG002|Active Drug Period|Progressive Disease|4|||
125518164|NCT04944784|451528102|FG003|Active Drug Period|Progressive Disease|4|||
125518165|NCT04944784|451528099|FG000|Active Drug Period|Lost to Follow-up|0|||
125518166|NCT04944784|451528100|FG001|Active Drug Period|Lost to Follow-up|0|||
125518167|NCT04944784|451528101|FG002|Active Drug Period|Lost to Follow-up|0|||
125518168|NCT04944784|451528102|FG003|Active Drug Period|Lost to Follow-up|1|||
125518169|NCT02210208|451529954|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
125518170|NCT02210208|451529954|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
125518171|NCT02210208|451529954|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
125518172|NCT01066936|451529955|FG000|Overall Study|Death|2|||
125518173|NCT01066936|451529955|FG000|Overall Study|Device revised/removed|1|||
125518174|NCT01066936|451529955|FG000|Overall Study|Lost to Follow-up|3|||
125518175|NCT01066936|451529955|FG000|Overall Study|Withdrawal by Subject|4|||
125518176|NCT04984239|451529958|FG000|Overall Study|Lost to Follow-up|1|||
125518177|NCT04190225|451529959|FG000|Overall Study|Lost to Follow-up|2|||
125518178|NCT04190225|451529960|FG001|Overall Study|Lost to Follow-up|3|||
125518179|NCT04190225|451529959|FG000|Overall Study|Withdrawal by Subject|3|||
125518180|NCT04190225|451529960|FG001|Overall Study|Withdrawal by Subject|2|||
125518181|NCT04190225|451529959|FG000|Overall Study|Unrelated health condition|2|||
125518182|NCT04190225|451529960|FG001|Overall Study|Unrelated health condition|0|||
125518183|NCT02994784|451529961|FG000|6 Months Follow-up|Lost to Follow-up|3|||
125518184|NCT02466243|451529963|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
125518185|NCT02466243|451529964|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
125518186|NCT02466243|451529963|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
125518187|NCT02466243|451529964|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
125518188|NCT02466243|451529963|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
125518189|NCT02466243|451529964|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
125518190|NCT02466243|451529963|FG000|Part B Open-label Treatment Period|Missing|2|||
125518191|NCT02466243|451529964|FG001|Part B Open-label Treatment Period|Missing|2|||
125518192|NCT00477464|451529965|FG000|Overall Study|Lost to Follow-up|1|||
125518193|NCT00477464|451529965|FG000|Overall Study|Death|36|||
125518194|NCT00477464|451529965|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
125518195|NCT00639769|451529966|FG000|Overall Study|Death|2|||
125518196|NCT00639769|451529966|FG000|Overall Study|Adverse Event|7|||
125518197|NCT00639769|451529966|FG000|Overall Study|Lack of Efficacy|1|||
125518198|NCT00639769|451529966|FG000|Overall Study|Disease progression|26|||
125518199|NCT00639769|451529966|FG000|Overall Study|Withdrawal by Subject|4|||
125518200|NCT00863798|451529967|FG000|Overall Study|Adverse Event|5|||
125518201|NCT00863798|451529968|FG001|Overall Study|Adverse Event|2|||
125518202|NCT00863798|451529969|FG002|Overall Study|Adverse Event|4|||
125518203|NCT00863798|451529967|FG000|Overall Study|Participant failed to return|2|||
125518204|NCT00863798|451529968|FG001|Overall Study|Participant failed to return|1|||
125518205|NCT00863798|451529969|FG002|Overall Study|Participant failed to return|0|||
125518206|NCT00863798|451529967|FG000|Overall Study|Investigator request|1|||
125518207|NCT00863798|451529968|FG001|Overall Study|Investigator request|2|||
125518208|NCT00863798|451529969|FG002|Overall Study|Investigator request|1|||
125518209|NCT00863798|451529967|FG000|Overall Study|Lack of Efficacy|4|||
125518210|NCT00863798|451529968|FG001|Overall Study|Lack of Efficacy|3|||
125518211|NCT00863798|451529969|FG002|Overall Study|Lack of Efficacy|6|||
125518212|NCT00863798|451529967|FG000|Overall Study|Lost to Follow-up|6|||
125518213|NCT00863798|451529968|FG001|Overall Study|Lost to Follow-up|9|||
125518214|NCT00863798|451529969|FG002|Overall Study|Lost to Follow-up|5|||
125518215|NCT00863798|451529967|FG000|Overall Study|Other|2|||
125518216|NCT00863798|451529968|FG001|Overall Study|Other|3|||
125518217|NCT00863798|451529969|FG002|Overall Study|Other|1|||
125518218|NCT00863798|451529967|FG000|Overall Study|Protocol Violation|0|||
125518219|NCT00863798|451529968|FG001|Overall Study|Protocol Violation|1|||
125518220|NCT00863798|451529969|FG002|Overall Study|Protocol Violation|1|||
125518221|NCT00863798|451529967|FG000|Overall Study|Withdrawal by Subject|8|||
125518222|NCT00863798|451529968|FG001|Overall Study|Withdrawal by Subject|7|||
125518223|NCT00863798|451529969|FG002|Overall Study|Withdrawal by Subject|4|||
125518224|NCT00863798|451529967|FG000|Overall Study|Randomized not treated|4|||
125518225|NCT00863798|451529968|FG001|Overall Study|Randomized not treated|2|||
125518226|NCT00863798|451529969|FG002|Overall Study|Randomized not treated|3|||
125518227|NCT04238520|451529970|FG000|Overall Study|Withdrawal by Subject|1|||
125518228|NCT04238520|451529971|FG001|Overall Study|Withdrawal by Subject|1|||
125518229|NCT04238520|451529970|FG000|Overall Study|Lost to Follow-up|1|||
125518230|NCT04238520|451529971|FG001|Overall Study|Lost to Follow-up|2|||
125518231|NCT04238520|451529970|FG000|Overall Study|Death|0|||
125518232|NCT04238520|451529971|FG001|Overall Study|Death|2|||
125518233|NCT04238520|451529970|FG000|Overall Study|Unsafe home environment for research staff|0|||
125518234|NCT04238520|451529971|FG001|Overall Study|Unsafe home environment for research staff|1|||
125518235|NCT01470599|451529972|FG000|Overall Study|Did not meet entrance criteria|1|||
125518236|NCT01470599|451529973|FG001|Overall Study|Did not meet entrance criteria|0|||
125518237|NCT01470599|451529972|FG000|Overall Study|Lost to Follow-up|2|||
125518238|NCT01470599|451529973|FG001|Overall Study|Lost to Follow-up|1|||
125518239|NCT01470599|451529972|FG000|Overall Study|Withdrawal by Subject|3|||
125518240|NCT01470599|451529973|FG001|Overall Study|Withdrawal by Subject|4|||
125518241|NCT01470599|451529972|FG000|Overall Study|Other|1|||
125518242|NCT01470599|451529973|FG001|Overall Study|Other|0|||
125518243|NCT01470599|451529972|FG000|Overall Study|Protocol Violation|3|||
125518244|NCT01470599|451529973|FG001|Overall Study|Protocol Violation|1|||
125518245|NCT01470599|451529972|FG000|Overall Study|Adverse event related to study drug|2|||
125518246|NCT01470599|451529973|FG001|Overall Study|Adverse event related to study drug|5|||
125518247|NCT01470599|451529972|FG000|Overall Study|Insufficient clinical response|6|||
125518248|NCT01470599|451529973|FG001|Overall Study|Insufficient clinical response|27|||
125518249|NCT01470599|451529972|FG000|Overall Study|Adverse event not related to study drug|1|||
125518250|NCT01470599|451529973|FG001|Overall Study|Adverse event not related to study drug|5|||
125518251|NCT00195442|451529974|FG000|Overall Study|Less than expected therapeutic effect|38|||
125518252|NCT00195442|451529974|FG000|Overall Study|Lost to Follow-up|27|||
125518253|NCT00195442|451529974|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
125518254|NCT00195442|451529974|FG000|Overall Study|Intermittent product shortage|21|||
125518255|NCT00195442|451529974|FG000|Overall Study|Death|7|||
125518256|NCT00195442|451529974|FG000|Overall Study|No reason specified|4|||
125518257|NCT00195442|451529974|FG000|Overall Study|Poor cooperation|2|||
125518258|NCT00195442|451529974|FG000|Overall Study|Other|14|||
125518259|NCT01917006|451529975|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
125518260|NCT01917006|451529976|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
125518261|NCT01917006|451529977|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
125518262|NCT01917006|451529978|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
125518263|NCT01917006|451529979|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
125518264|NCT01917006|451529980|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
125518265|NCT01917006|451529981|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
125518266|NCT01917006|451529982|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
125518267|NCT01917006|451529975|FG000|Randomized-treatment Period|Personal Reasons|0|||
125518268|NCT01917006|451529976|FG001|Randomized-treatment Period|Personal Reasons|0|||
125518269|NCT01917006|451529977|FG002|Randomized-treatment Period|Personal Reasons|0|||
125518270|NCT01917006|451529978|FG003|Randomized-treatment Period|Personal Reasons|0|||
125518271|NCT01917006|451529979|FG004|Randomized-treatment Period|Personal Reasons|0|||
125518272|NCT01917006|451529980|FG005|Randomized-treatment Period|Personal Reasons|1|||
125518273|NCT01917006|451529981|FG006|Randomized-treatment Period|Personal Reasons|0|||
125518274|NCT01917006|451529982|FG007|Randomized-treatment Period|Personal Reasons|0|||
125518275|NCT01917006|451529975|FG000|Randomized-treatment Period|Protocol Violation|1|||
125518276|NCT01917006|451529976|FG001|Randomized-treatment Period|Protocol Violation|0|||
125518277|NCT01917006|451529977|FG002|Randomized-treatment Period|Protocol Violation|0|||
125518278|NCT01917006|451529978|FG003|Randomized-treatment Period|Protocol Violation|0|||
125518279|NCT01917006|451529979|FG004|Randomized-treatment Period|Protocol Violation|0|||
125518280|NCT01917006|451529980|FG005|Randomized-treatment Period|Protocol Violation|0|||
125518281|NCT01917006|451529981|FG006|Randomized-treatment Period|Protocol Violation|0|||
125518282|NCT01917006|451529982|FG007|Randomized-treatment Period|Protocol Violation|0|||
125518283|NCT01917006|451529975|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
125518284|NCT01917006|451529976|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
125518285|NCT01917006|451529977|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
125518286|NCT01917006|451529978|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
125518287|NCT01917006|451529979|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
125518288|NCT01917006|451529980|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
125518289|NCT01917006|451529981|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
125518290|NCT01917006|451529982|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
125518291|NCT01917006|451529975|FG000|Open-label Period|Adverse Event|0|||
125518292|NCT01917006|451529976|FG001|Open-label Period|Adverse Event|0|||
125518293|NCT01917006|451529977|FG002|Open-label Period|Adverse Event|0|||
125518294|NCT01917006|451529978|FG003|Open-label Period|Adverse Event|0|||
125518295|NCT01917006|451529979|FG004|Open-label Period|Adverse Event|0|||
125518296|NCT01917006|451529980|FG005|Open-label Period|Adverse Event|0|||
125518297|NCT01917006|451529981|FG006|Open-label Period|Adverse Event|0|||
125518298|NCT01917006|451529982|FG007|Open-label Period|Adverse Event|1|||
125518299|NCT01917006|451529975|FG000|Open-label Period|Lost to Follow-up|0|||
125518300|NCT01917006|451529976|FG001|Open-label Period|Lost to Follow-up|0|||
125518301|NCT01917006|451529977|FG002|Open-label Period|Lost to Follow-up|0|||
125518302|NCT01917006|451529978|FG003|Open-label Period|Lost to Follow-up|0|||
125518303|NCT01917006|451529979|FG004|Open-label Period|Lost to Follow-up|0|||
125518304|NCT01917006|451529980|FG005|Open-label Period|Lost to Follow-up|0|||
125518305|NCT01917006|451529981|FG006|Open-label Period|Lost to Follow-up|0|||
125518306|NCT01917006|451529982|FG007|Open-label Period|Lost to Follow-up|1|||
125518307|NCT00847132|451529985|FG000|Overall Study|Death|1|||
125518308|NCT00847132|451529986|FG001|Overall Study|Death|1|||
125518309|NCT02973802|451529992|FG000|Overall Study|Lost to Follow-up|1|||
125518310|NCT02973802|451529992|FG000|Overall Study|Withdrawal by Subject|1|||
125518311|NCT03357471|451529993|FG000|Overall Study|Adverse Event|1|||
125518312|NCT03357471|451529994|FG001|Overall Study|Adverse Event|0|||
125518313|NCT03357471|451529993|FG000|Overall Study|Lost to Follow-up|1|||
125518314|NCT03357471|451529994|FG001|Overall Study|Lost to Follow-up|0|||
125518315|NCT00706914|451529995|FG000|Overall Study|Lack of Efficacy|0|||
125518316|NCT00706914|451529996|FG001|Overall Study|Lack of Efficacy|1|||
125518317|NCT00706914|451529997|FG002|Overall Study|Lack of Efficacy|0|||
125518318|NCT00706914|451529995|FG000|Overall Study|Lost to Follow-up|1|||
125518319|NCT00706914|451529996|FG001|Overall Study|Lost to Follow-up|0|||
125518320|NCT00706914|451529997|FG002|Overall Study|Lost to Follow-up|0|||
125518321|NCT00706914|451529995|FG000|Overall Study|Adverse Event|2|||
125518322|NCT00706914|451529996|FG001|Overall Study|Adverse Event|2|||
125518323|NCT00706914|451529997|FG002|Overall Study|Adverse Event|0|||
125518324|NCT00706914|451529995|FG000|Overall Study|Protocol Violation|3|||
125518325|NCT00706914|451529996|FG001|Overall Study|Protocol Violation|1|||
125518326|NCT00706914|451529997|FG002|Overall Study|Protocol Violation|1|||
125518327|NCT03927690|451530002|FG000|Overall Study|Withdrawal by Subject|3|||
125518328|NCT03927690|451530003|FG001|Overall Study|Withdrawal by Subject|1|||
125518329|NCT03927690|451530004|FG002|Overall Study|Withdrawal by Subject|1|||
125518330|NCT03927690|451530002|FG000|Overall Study|Adverse Event|1|||
125518331|NCT03927690|451530003|FG001|Overall Study|Adverse Event|0|||
125518332|NCT03927690|451530004|FG002|Overall Study|Adverse Event|0|||
125518333|NCT03927690|451530002|FG000|Overall Study|Death|1|||
125518334|NCT03927690|451530003|FG001|Overall Study|Death|0|||
125518335|NCT03927690|451530004|FG002|Overall Study|Death|0|||
125518336|NCT03927690|451530002|FG000|Overall Study|Lost to Follow-up|2|||
125518337|NCT03927690|451530003|FG001|Overall Study|Lost to Follow-up|2|||
125518338|NCT03927690|451530004|FG002|Overall Study|Lost to Follow-up|1|||
125518339|NCT01850823|451530005|FG000|Overall Study|Early Visit Window|0|||
125518340|NCT01850823|451530006|FG001|Overall Study|Early Visit Window|1|||
125518341|NCT01850823|451530007|FG002|Overall Study|Early Visit Window|4|||
125518342|NCT01850823|451530005|FG000|Overall Study|Enrolled in Error|0|||
125518343|NCT01850823|451530006|FG001|Overall Study|Enrolled in Error|1|||
125518344|NCT01850823|451530007|FG002|Overall Study|Enrolled in Error|2|||
125518345|NCT01850823|451530005|FG000|Overall Study|Lack of Efficacy|1|||
125518346|NCT01850823|451530006|FG001|Overall Study|Lack of Efficacy|0|||
125518347|NCT01850823|451530007|FG002|Overall Study|Lack of Efficacy|0|||
125518348|NCT01850823|451530005|FG000|Overall Study|Lost to Follow-up|0|||
125518349|NCT01850823|451530006|FG001|Overall Study|Lost to Follow-up|0|||
125518350|NCT01850823|451530007|FG002|Overall Study|Lost to Follow-up|1|||
125518351|NCT01850823|451530005|FG000|Overall Study|Restricted Medication|0|||
125518352|NCT01850823|451530006|FG001|Overall Study|Restricted Medication|0|||
125518353|NCT01850823|451530007|FG002|Overall Study|Restricted Medication|2|||
125518354|NCT01850823|451530005|FG000|Overall Study|Significant worstening of SAR|0|||
125518355|NCT01850823|451530006|FG001|Overall Study|Significant worstening of SAR|1|||
125518356|NCT01850823|451530007|FG002|Overall Study|Significant worstening of SAR|0|||
125518357|NCT01850823|451530005|FG000|Overall Study|Withdrawal by Subject|2|||
125518358|NCT01850823|451530006|FG001|Overall Study|Withdrawal by Subject|0|||
125518359|NCT01850823|451530007|FG002|Overall Study|Withdrawal by Subject|1|||
125518360|NCT01751165|451530008|FG000|Overall Study|Adverse event, serious fatal|1|||
125518361|NCT01751165|451530009|FG001|Overall Study|Adverse event, serious fatal|0|||
125518362|NCT01751165|451530010|FG002|Overall Study|Adverse event, serious fatal|1|||
125518363|NCT01751165|451530008|FG000|Overall Study|Withdrawal by Subject|0|||
125518364|NCT01751165|451530009|FG001|Overall Study|Withdrawal by Subject|0|||
125518365|NCT01751165|451530010|FG002|Overall Study|Withdrawal by Subject|1|||
125518366|NCT01751165|451530008|FG000|Overall Study|Serious adverse event|0|||
125518367|NCT01751165|451530009|FG001|Overall Study|Serious adverse event|2|||
125518368|NCT01751165|451530010|FG002|Overall Study|Serious adverse event|0|||
125518369|NCT01751165|451530008|FG000|Overall Study|Lost to Follow-up|1|||
125518370|NCT01751165|451530009|FG001|Overall Study|Lost to Follow-up|1|||
125518371|NCT01751165|451530010|FG002|Overall Study|Lost to Follow-up|1|||
125518372|NCT00988533|451530017|FG000|Overall Study|Lost to Follow-up|3|||
125518373|NCT00943722|451530021|FG000|Base Study|Adverse Event|0|||
125518374|NCT00943722|451530022|FG001|Base Study|Adverse Event|0|||
125518375|NCT00943722|451530023|FG002|Base Study|Adverse Event|0|||
125518376|NCT00943722|451530024|FG003|Base Study|Adverse Event|1|||
125518377|NCT00943722|451530025|FG004|Base Study|Adverse Event|0|||
125518378|NCT00943722|451530026|FG005|Base Study|Adverse Event|0|||
125518379|NCT00943722|451530027|FG006|Base Study|Adverse Event|0|||
125518380|NCT00943722|451530021|FG000|Base Study|Lost to Follow-up|12|||
125518381|NCT00943722|451530022|FG001|Base Study|Lost to Follow-up|8|||
125518382|NCT00943722|451530023|FG002|Base Study|Lost to Follow-up|10|||
125518383|NCT00943722|451530024|FG003|Base Study|Lost to Follow-up|8|||
125518384|NCT00943722|451530025|FG004|Base Study|Lost to Follow-up|11|||
125518385|NCT00943722|451530026|FG005|Base Study|Lost to Follow-up|0|||
125518386|NCT00943722|451530027|FG006|Base Study|Lost to Follow-up|0|||
125518387|NCT00943722|451530021|FG000|Base Study|Physician Decision|1|||
125518388|NCT00943722|451530022|FG001|Base Study|Physician Decision|0|||
125518389|NCT00943722|451530023|FG002|Base Study|Physician Decision|0|||
125518390|NCT00943722|451530024|FG003|Base Study|Physician Decision|0|||
125518391|NCT00943722|451530025|FG004|Base Study|Physician Decision|1|||
125518392|NCT00943722|451530026|FG005|Base Study|Physician Decision|0|||
125518393|NCT00943722|451530027|FG006|Base Study|Physician Decision|0|||
125518394|NCT00943722|451530021|FG000|Base Study|Pregnancy|0|||
125518395|NCT00943722|451530022|FG001|Base Study|Pregnancy|0|||
125518396|NCT00943722|451530023|FG002|Base Study|Pregnancy|1|||
125518397|NCT00943722|451530024|FG003|Base Study|Pregnancy|0|||
125518398|NCT00943722|451530025|FG004|Base Study|Pregnancy|2|||
125518399|NCT00943722|451530026|FG005|Base Study|Pregnancy|0|||
125518400|NCT00943722|451530027|FG006|Base Study|Pregnancy|0|||
125518401|NCT00943722|451530021|FG000|Base Study|Protocol Violation|0|||
125518402|NCT00943722|451530022|FG001|Base Study|Protocol Violation|1|||
125518403|NCT00943722|451530023|FG002|Base Study|Protocol Violation|0|||
125518404|NCT00943722|451530024|FG003|Base Study|Protocol Violation|0|||
125518405|NCT00943722|451530025|FG004|Base Study|Protocol Violation|2|||
125518406|NCT00943722|451530026|FG005|Base Study|Protocol Violation|0|||
125518407|NCT00943722|451530027|FG006|Base Study|Protocol Violation|0|||
125518408|NCT00943722|451530021|FG000|Base Study|Withdrawal by Subject|12|||
125518409|NCT00943722|451530022|FG001|Base Study|Withdrawal by Subject|13|||
125518410|NCT00943722|451530023|FG002|Base Study|Withdrawal by Subject|2|||
125518411|NCT00943722|451530024|FG003|Base Study|Withdrawal by Subject|13|||
125518412|NCT00943722|451530025|FG004|Base Study|Withdrawal by Subject|8|||
125518413|NCT00943722|451530026|FG005|Base Study|Withdrawal by Subject|0|||
125518414|NCT00943722|451530027|FG006|Base Study|Withdrawal by Subject|0|||
125518415|NCT00943722|451530021|FG000|Base Study|Month 12 visit not completed|0|||
125518416|NCT00943722|451530022|FG001|Base Study|Month 12 visit not completed|0|||
125518417|NCT00943722|451530023|FG002|Base Study|Month 12 visit not completed|0|||
125518418|NCT00943722|451530024|FG003|Base Study|Month 12 visit not completed|0|||
125518419|NCT00943722|451530025|FG004|Base Study|Month 12 visit not completed|2|||
125518420|NCT00943722|451530026|FG005|Base Study|Month 12 visit not completed|0|||
125518421|NCT00943722|451530027|FG006|Base Study|Month 12 visit not completed|0|||
125518422|NCT00943722|451530021|FG000|First Extension Study: EXT 1|Adverse Event|0|||
125518423|NCT00943722|451530022|FG001|First Extension Study: EXT 1|Adverse Event|0|||
125518424|NCT00943722|451530023|FG002|First Extension Study: EXT 1|Adverse Event|0|||
125518425|NCT00943722|451530024|FG003|First Extension Study: EXT 1|Adverse Event|0|||
125518426|NCT00943722|451530025|FG004|First Extension Study: EXT 1|Adverse Event|0|||
125518427|NCT00943722|451530026|FG005|First Extension Study: EXT 1|Adverse Event|1|||
125518428|NCT00943722|451530027|FG006|First Extension Study: EXT 1|Adverse Event|0|||
125518429|NCT00943722|451530021|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
125518430|NCT00943722|451530022|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
125518431|NCT00943722|451530023|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
125518432|NCT00943722|451530024|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
125518433|NCT00943722|451530025|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
125518434|NCT00943722|451530026|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
125518435|NCT00943722|451530027|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
125518436|NCT00943722|451530021|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
125518437|NCT00943722|451530022|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
125518438|NCT00943722|451530023|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
125518439|NCT00943722|451530024|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
125518440|NCT00943722|451530025|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
125518441|NCT00943722|451530026|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
125518442|NCT00943722|451530027|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
125518443|NCT00943722|451530021|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
125518444|NCT00943722|451530022|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
125518445|NCT00943722|451530023|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
125518446|NCT00943722|451530024|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
125518447|NCT00943722|451530025|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
125518448|NCT00943722|451530026|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
125518449|NCT00943722|451530027|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
125518450|NCT00943722|451530021|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
125518451|NCT00943722|451530022|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
125518452|NCT00943722|451530023|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
125518453|NCT00943722|451530024|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
125518454|NCT00943722|451530025|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
125518455|NCT00943722|451530026|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
125518456|NCT00943722|451530027|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
125518457|NCT00943722|451530021|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
125518458|NCT00943722|451530022|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
125518459|NCT00943722|451530023|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
125518460|NCT00943722|451530024|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
125518461|NCT00943722|451530025|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
125518462|NCT00943722|451530026|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
125518463|NCT00943722|451530027|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
125518464|NCT00943722|451530021|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
125518465|NCT00943722|451530022|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
125518466|NCT00943722|451530023|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
125518467|NCT00943722|451530024|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
125518468|NCT00943722|451530025|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
125518469|NCT00943722|451530026|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
125518470|NCT00943722|451530027|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
125518471|NCT00943722|451530021|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
125518472|NCT00943722|451530022|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
125518473|NCT00943722|451530023|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
125518474|NCT00943722|451530024|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
125518475|NCT00943722|451530025|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
125518476|NCT00943722|451530026|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
125518477|NCT00943722|451530027|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
125518478|NCT00943722|451530021|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
125518479|NCT00943722|451530022|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
125518480|NCT00943722|451530023|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
125518481|NCT00943722|451530024|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
125518482|NCT00943722|451530025|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
125518483|NCT00943722|451530026|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
125518484|NCT00943722|451530027|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
125518485|NCT01036165|451530028|FG000|Overall Study|Adverse Event|6|||
125518486|NCT01036165|451530028|FG000|Overall Study|Lost to Follow-up|2|||
125518487|NCT01036165|451530028|FG000|Overall Study|Withdrawal by Subject|3|||
125518488|NCT01036165|451530028|FG000|Overall Study|Device Related Issues|3|||
125518489|NCT01036165|451530028|FG000|Overall Study|Problems finding proper area to inject|1|||
125518490|NCT00913523|451530034|FG000|Overall Study|Withdrawal by Subject|3|||
125518491|NCT00913523|451530035|FG001|Overall Study|Withdrawal by Subject|2|||
125518492|NCT00913523|451530036|FG002|Overall Study|Withdrawal by Subject|2|||
125518493|NCT00913523|451530034|FG000|Overall Study|Lost to Follow-up|1|||
125518494|NCT00913523|451530035|FG001|Overall Study|Lost to Follow-up|1|||
125518495|NCT00913523|451530036|FG002|Overall Study|Lost to Follow-up|1|||
125518496|NCT00913523|451530034|FG000|Overall Study|Adverse Event|1|||
125518497|NCT00913523|451530035|FG001|Overall Study|Adverse Event|0|||
125518498|NCT00913523|451530036|FG002|Overall Study|Adverse Event|0|||
125518499|NCT00913523|451530034|FG000|Overall Study|Protocol Violation|5|||
125518500|NCT00913523|451530035|FG001|Overall Study|Protocol Violation|8|||
125518501|NCT00913523|451530036|FG002|Overall Study|Protocol Violation|8|||
125518502|NCT00913523|451530034|FG000|Overall Study|Pregnancy|1|||
125518503|NCT00913523|451530035|FG001|Overall Study|Pregnancy|3|||
125518504|NCT00913523|451530036|FG002|Overall Study|Pregnancy|0|||
125518505|NCT00913523|451530034|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
125518506|NCT00913523|451530035|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
125518507|NCT00913523|451530036|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
125518508|NCT02895360|451530037|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
125518509|NCT02895360|451530038|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
125518510|NCT02895360|451530039|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
125518511|NCT02895360|451530040|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
125518512|NCT02895360|451530041|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
125518513|NCT02895360|451530042|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
125518514|NCT02895360|451530037|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
125518515|NCT02895360|451530038|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
125518516|NCT02895360|451530039|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
125518517|NCT02895360|451530040|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
125518518|NCT02895360|451530041|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
125518519|NCT02895360|451530042|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
125518520|NCT02895360|451530037|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
125518521|NCT02895360|451530038|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
125518522|NCT02895360|451530039|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
125518523|NCT02895360|451530040|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
125518524|NCT02895360|451530041|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
125518525|NCT02895360|451530042|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
125518526|NCT02895360|451530037|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
125518527|NCT02895360|451530038|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
125518528|NCT02895360|451530039|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
125518529|NCT02895360|451530040|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
125518530|NCT02895360|451530041|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
125518531|NCT02895360|451530042|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
125518532|NCT02895360|451530037|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
125518533|NCT02895360|451530038|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
125518534|NCT02895360|451530039|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
125518535|NCT02895360|451530040|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
125518536|NCT02895360|451530041|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
125518537|NCT02895360|451530042|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
125518538|NCT02895360|451530037|FG000|Phase 2a|Adverse Event|0|||
125518539|NCT02895360|451530038|FG001|Phase 2a|Adverse Event|0|||
125518540|NCT02895360|451530039|FG002|Phase 2a|Adverse Event|0|||
125518541|NCT02895360|451530040|FG003|Phase 2a|Adverse Event|0|||
125518542|NCT02895360|451530041|FG004|Phase 2a|Adverse Event|0|||
125518543|NCT02895360|451530042|FG005|Phase 2a|Adverse Event|1|||
125518544|NCT02895360|451530037|FG000|Phase 2a|Progressive disease|0|||
125518545|NCT02895360|451530038|FG001|Phase 2a|Progressive disease|0|||
125518546|NCT02895360|451530039|FG002|Phase 2a|Progressive disease|0|||
125518547|NCT02895360|451530040|FG003|Phase 2a|Progressive disease|0|||
125518548|NCT02895360|451530041|FG004|Phase 2a|Progressive disease|11|||
125518549|NCT02895360|451530042|FG005|Phase 2a|Progressive disease|11|||
125518550|NCT00916305|451530043|FG000|Overall Study|Lost to Follow-up|21|||
125518551|NCT00916305|451530044|FG001|Overall Study|Lost to Follow-up|27|||
125518552|NCT00916305|451530043|FG000|Overall Study|Withdrawal by Subject|0|||
125518553|NCT00916305|451530044|FG001|Overall Study|Withdrawal by Subject|1|||
125518554|NCT01844726|451530045|FG000|Overall Study|Withdrawal by Subject|0|||
125518555|NCT01844726|451530046|FG001|Overall Study|Withdrawal by Subject|1|||
125518556|NCT01844726|451530045|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
125518557|NCT01844726|451530046|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
125518558|NCT00307164|451530049|FG000|Overall Study|Death|1|||
125518559|NCT00307164|451530050|FG001|Overall Study|Death|0|||
125518560|NCT00307164|451530049|FG000|Overall Study|Severe debilitation, unable to continue|1|||
125518561|NCT00307164|451530050|FG001|Overall Study|Severe debilitation, unable to continue|0|||
125518562|NCT00307164|451530049|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
125518563|NCT00307164|451530050|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
125518564|NCT00307164|451530049|FG000|Overall Study|Withdrawal by Subject|1|||
125518565|NCT00307164|451530050|FG001|Overall Study|Withdrawal by Subject|8|||
125518566|NCT00307164|451530049|FG000|Overall Study|Not compliant with requirements|4|||
125518567|NCT00307164|451530050|FG001|Overall Study|Not compliant with requirements|4|||
125518568|NCT00307164|451530049|FG000|Overall Study|Lost to Follow-up|6|||
125518569|NCT00307164|451530050|FG001|Overall Study|Lost to Follow-up|1|||
125518570|NCT04191148|451530056|FG000|Overall Study|Withdrawal by Subject|1|||
125518571|NCT04191148|451530057|FG001|Overall Study|Withdrawal by Subject|0|||
125518572|NCT04191148|451530056|FG000|Overall Study|Adverse Event|1|||
125518573|NCT04191148|451530057|FG001|Overall Study|Adverse Event|0|||
125518574|NCT01274559|451530060|FG000|Overall Study|Adverse Event|57|||
125518575|NCT01274559|451530061|FG001|Overall Study|Adverse Event|13|||
125518576|NCT01274559|451530060|FG000|Overall Study|Death|1|||
125518577|NCT01274559|451530061|FG001|Overall Study|Death|1|||
125518578|NCT01274559|451530060|FG000|Overall Study|Lost to Follow-up|3|||
125518579|NCT01274559|451530061|FG001|Overall Study|Lost to Follow-up|3|||
125518580|NCT01274559|451530060|FG000|Overall Study|Non-compliance with Study Drug|2|||
125518581|NCT01274559|451530061|FG001|Overall Study|Non-compliance with Study Drug|4|||
125518582|NCT01274559|451530060|FG000|Overall Study|Physician Decision|2|||
125518583|NCT01274559|451530061|FG001|Overall Study|Physician Decision|1|||
125518584|NCT01274559|451530060|FG000|Overall Study|Protocol Violation|28|||
125518585|NCT01274559|451530061|FG001|Overall Study|Protocol Violation|23|||
125518586|NCT01274559|451530060|FG000|Overall Study|Study Terminated by Sponsor|79|||
125518587|NCT01274559|451530061|FG001|Overall Study|Study Terminated by Sponsor|87|||
125518588|NCT01274559|451530060|FG000|Overall Study|Withdrawal by Subject|25|||
125518589|NCT01274559|451530061|FG001|Overall Study|Withdrawal by Subject|13|||
125518590|NCT02971228|451530062|FG000|Overall Study|Withdrawal by Subject|1|||
125518591|NCT02971228|451530063|FG001|Overall Study|Withdrawal by Subject|1|||
125518592|NCT02971228|451530064|FG002|Overall Study|Withdrawal by Subject|0|||
125518593|NCT02971228|451530065|FG003|Overall Study|Withdrawal by Subject|0|||
125518594|NCT02971228|451530066|FG004|Overall Study|Withdrawal by Subject|0|||
125518595|NCT02971228|451530062|FG000|Overall Study|Logistical challenges|0|||
125518596|NCT02971228|451530063|FG001|Overall Study|Logistical challenges|1|||
125518597|NCT02971228|451530064|FG002|Overall Study|Logistical challenges|0|||
125518598|NCT02971228|451530065|FG003|Overall Study|Logistical challenges|0|||
125518599|NCT02971228|451530066|FG004|Overall Study|Logistical challenges|0|||
125518600|NCT01167192|451530067|FG000|Overall Study|Adverse Event|1|||
125518601|NCT01167192|451530067|FG000|Overall Study|Death|1|||
125518602|NCT01167192|451530067|FG000|Overall Study|Withdrawal by Subject|1|||
125518603|NCT01167192|451530067|FG000|Overall Study|Insurance denial|1|||
125518604|NCT02560389|451530068|FG000|Overall Study|Lost to Follow-up|1|||
125518605|NCT02560389|451530069|FG001|Overall Study|Lost to Follow-up|2|||
125518606|NCT02560389|451530070|FG002|Overall Study|Lost to Follow-up|2|||
125518607|NCT02560389|451530068|FG000|Overall Study|Tested positive for illicit substance|0|||
125532612|NCT00350727|451580161|FG000|Phase II|Sponsor Terminated Study|0|||
125518608|NCT02560389|451530069|FG001|Overall Study|Tested positive for illicit substance|1|||
125518609|NCT02560389|451530070|FG002|Overall Study|Tested positive for illicit substance|0|||
125518610|NCT03409731|451530081|FG000|Overall Study|Withdrawal by Subject|17|||
125518611|NCT03409731|451530081|FG000|Overall Study|Death|4|||
125518612|NCT00827775|451530087|FG000|Overall Study|Withdrawal by Subject|0|||
125518613|NCT00827775|451530088|FG001|Overall Study|Withdrawal by Subject|5|||
125518614|NCT03410108|451530091|FG000|Overall Study|Ongoing|41|||
125518615|NCT03410108|451530091|FG000|Overall Study|Adverse Event|4|||
125518616|NCT03410108|451530091|FG000|Overall Study|Progressive Disease|58|||
125518617|NCT03410108|451530091|FG000|Overall Study|Withdrawal by Subject|1|||
125518618|NCT00338949|451530092|FG000|Subject Screening|Screen failures|11|||
125518619|NCT00338949|451530093|FG001|Subject Screening|Screen failures|11|||
125518620|NCT00338949|451530092|FG000|Randomization|Withdrawal by Subject|1|||
125518621|NCT00338949|451530093|FG001|Randomization|Withdrawal by Subject|0|||
125518622|NCT00338949|451530092|FG000|Randomization|Adverse Event|0|||
125518623|NCT00338949|451530093|FG001|Randomization|Adverse Event|5|||
125518624|NCT01203956|451530095|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
125518625|NCT01203956|451530096|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
125518626|NCT00069277|451530097|FG000|Overall Study|Adverse Event|3|||
125518627|NCT00069277|451530097|FG000|Overall Study|Withdrawal by Subject|1|||
125518628|NCT00069277|451530097|FG000|Overall Study|Progressive Disease|15|||
125518629|NCT00069277|451530097|FG000|Overall Study|Physician Decision|2|||
125518630|NCT02230306|451530098|FG000|Overall Study|Did not receive study treatment|1|||
125518631|NCT03512288|451530103|FG000|Overall Study|Adverse Event|1|||
125518632|NCT03512288|451530104|FG001|Overall Study|Adverse Event|0|||
125518633|NCT03512288|451530103|FG000|Overall Study|Lost to Follow-up|12|||
125518634|NCT03512288|451530104|FG001|Overall Study|Lost to Follow-up|15|||
125518635|NCT03512288|451530103|FG000|Overall Study|Physician Decision|0|||
125518636|NCT03512288|451530104|FG001|Overall Study|Physician Decision|2|||
125518637|NCT03512288|451530103|FG000|Overall Study|Protocol Violation|6|||
125518638|NCT03512288|451530104|FG001|Overall Study|Protocol Violation|4|||
125518639|NCT03512288|451530103|FG000|Overall Study|Medication error without associated adverse event|1|||
125518640|NCT03512288|451530104|FG001|Overall Study|Medication error without associated adverse event|0|||
125518641|NCT03512288|451530103|FG000|Overall Study|No longer met eligibility criteria|5|||
125518642|NCT03512288|451530104|FG001|Overall Study|No longer met eligibility criteria|2|||
125518643|NCT03512288|451530103|FG000|Overall Study|Withdrawal by parent/guardian|14|||
125518644|NCT03512288|451530104|FG001|Overall Study|Withdrawal by parent/guardian|18|||
125518645|NCT03512288|451530103|FG000|Overall Study|Other|1|||
125518646|NCT03512288|451530104|FG001|Overall Study|Other|1|||
125518647|NCT03512288|451530103|FG000|Overall Study|Randomized but not treated|1|||
125518648|NCT03512288|451530104|FG001|Overall Study|Randomized but not treated|1|||
125518649|NCT00934700|451530107|FG000|Overall Study|missing scan|5|||
125518650|NCT00934700|451530108|FG001|Overall Study|missing scan|9|||
125518651|NCT00934700|451530107|FG000|Overall Study|Death|8|||
125518652|NCT00934700|451530108|FG001|Overall Study|Death|3|||
125518653|NCT01831726|451530111|FG000|Overall Study|Adverse Event|16|||
125518654|NCT01831726|451530111|FG000|Overall Study|Death|7|||
125518655|NCT01831726|451530111|FG000|Overall Study|Disease Progression|49|||
125518656|NCT01831726|451530111|FG000|Overall Study|Physician Decision|1|||
125518657|NCT01831726|451530111|FG000|Overall Study|Subject/guardian decision|7|||
125518658|NCT01283971|451530118|FG000|Overall Study|Adverse Event|3|||
125518659|NCT01283971|451530119|FG001|Overall Study|Adverse Event|5|||
125518660|NCT01283971|451530118|FG000|Overall Study|Insufficient therapeutic responses|3|||
125518661|NCT01283971|451530119|FG001|Overall Study|Insufficient therapeutic responses|3|||
125518662|NCT01283971|451530118|FG000|Overall Study|Protocol Violation|5|||
125518663|NCT01283971|451530119|FG001|Overall Study|Protocol Violation|1|||
125518664|NCT01283971|451530118|FG000|Overall Study|Refused treatment|3|||
125518665|NCT01283971|451530119|FG001|Overall Study|Refused treatment|1|||
125518666|NCT01283971|451530118|FG000|Overall Study|Failure to return|0|||
125518667|NCT01283971|451530119|FG001|Overall Study|Failure to return|1|||
125518668|NCT01283971|451530118|FG000|Overall Study|Administrative reasons|1|||
125518669|NCT01283971|451530119|FG001|Overall Study|Administrative reasons|1|||
125518670|NCT01502371|451530120|FG000|Overall Study|Withdrawal by Subject|1|||
125518671|NCT01502371|451530121|FG001|Overall Study|Withdrawal by Subject|2|||
125518672|NCT01502371|451530122|FG002|Overall Study|Withdrawal by Subject|1|||
125518673|NCT01502371|451530123|FG003|Overall Study|Withdrawal by Subject|1|||
125518674|NCT01502371|451530124|FG004|Overall Study|Withdrawal by Subject|1|||
125518675|NCT01502371|451530120|FG000|Overall Study|Adverse Event|2|||
125518676|NCT01502371|451530121|FG001|Overall Study|Adverse Event|1|||
125518677|NCT01502371|451530122|FG002|Overall Study|Adverse Event|0|||
125518678|NCT01502371|451530123|FG003|Overall Study|Adverse Event|4|||
125518679|NCT01502371|451530124|FG004|Overall Study|Adverse Event|3|||
125518680|NCT01502371|451530120|FG000|Overall Study|Treatment Failure|22|||
125518681|NCT01502371|451530121|FG001|Overall Study|Treatment Failure|20|||
125518682|NCT01502371|451530122|FG002|Overall Study|Treatment Failure|12|||
125518683|NCT01502371|451530123|FG003|Overall Study|Treatment Failure|19|||
125518684|NCT01502371|451530124|FG004|Overall Study|Treatment Failure|30|||
125518685|NCT01502371|451530120|FG000|Overall Study|Lack of Efficacy|3|||
125518686|NCT01502371|451530121|FG001|Overall Study|Lack of Efficacy|3|||
125518687|NCT01502371|451530122|FG002|Overall Study|Lack of Efficacy|2|||
125518688|NCT01502371|451530123|FG003|Overall Study|Lack of Efficacy|2|||
125518689|NCT01502371|451530124|FG004|Overall Study|Lack of Efficacy|4|||
125518690|NCT01502371|451530120|FG000|Overall Study|Physician Decision|3|||
125518691|NCT01502371|451530121|FG001|Overall Study|Physician Decision|0|||
125518692|NCT01502371|451530122|FG002|Overall Study|Physician Decision|0|||
125518693|NCT01502371|451530123|FG003|Overall Study|Physician Decision|0|||
125518694|NCT01502371|451530124|FG004|Overall Study|Physician Decision|1|||
125518695|NCT01502371|451530120|FG000|Overall Study|Noncompliance with Study Drug|0|||
125518696|NCT01502371|451530121|FG001|Overall Study|Noncompliance with Study Drug|0|||
125518697|NCT01502371|451530122|FG002|Overall Study|Noncompliance with Study Drug|1|||
125518698|NCT01502371|451530123|FG003|Overall Study|Noncompliance with Study Drug|2|||
125518699|NCT01502371|451530124|FG004|Overall Study|Noncompliance with Study Drug|1|||
125518700|NCT01502371|451530120|FG000|Overall Study|Technical Problems|1|||
125518701|NCT01502371|451530121|FG001|Overall Study|Technical Problems|0|||
125518702|NCT01502371|451530122|FG002|Overall Study|Technical Problems|2|||
125518703|NCT01502371|451530123|FG003|Overall Study|Technical Problems|4|||
125518704|NCT01502371|451530124|FG004|Overall Study|Technical Problems|1|||
125518705|NCT01502371|451530120|FG000|Overall Study|Protocol Violation|9|||
125518706|NCT01502371|451530121|FG001|Overall Study|Protocol Violation|5|||
125518707|NCT01502371|451530122|FG002|Overall Study|Protocol Violation|6|||
125518708|NCT01502371|451530123|FG003|Overall Study|Protocol Violation|5|||
125518709|NCT01502371|451530124|FG004|Overall Study|Protocol Violation|10|||
125518710|NCT01502371|451530120|FG000|Overall Study|Excluded Medication|0|||
125518711|NCT01502371|451530121|FG001|Overall Study|Excluded Medication|1|||
125518712|NCT01502371|451530122|FG002|Overall Study|Excluded Medication|1|||
125518713|NCT01502371|451530123|FG003|Overall Study|Excluded Medication|0|||
125518714|NCT01502371|451530124|FG004|Overall Study|Excluded Medication|1|||
125518715|NCT03049306|451530125|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
125518716|NCT03049306|451530126|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
125518717|NCT02154347|451530127|FG000|Double-blind Period|Adverse Event|1|||
125518718|NCT02154347|451530128|FG001|Double-blind Period|Adverse Event|2|||
125518719|NCT02154347|451530127|FG000|Double-blind Period|Lack of Efficacy|1|||
125518720|NCT02154347|451530128|FG001|Double-blind Period|Lack of Efficacy|0|||
125518721|NCT02154347|451530127|FG000|Double-blind Period|Physician Decision|0|||
125518722|NCT02154347|451530128|FG001|Double-blind Period|Physician Decision|1|||
125518723|NCT02154347|451530127|FG000|Double-blind Period|Withdrawal by Subject|1|||
125518724|NCT02154347|451530128|FG001|Double-blind Period|Withdrawal by Subject|1|||
125518725|NCT02154347|451530127|FG000|Open-label Period|Adverse Event|3|||
125518726|NCT02154347|451530128|FG001|Open-label Period|Adverse Event|4|||
125518727|NCT02154347|451530127|FG000|Open-label Period|Lack of Efficacy|4|||
125518728|NCT02154347|451530128|FG001|Open-label Period|Lack of Efficacy|19|||
125518729|NCT02154347|451530127|FG000|Open-label Period|Protocol Violation|0|||
125518730|NCT02154347|451530128|FG001|Open-label Period|Protocol Violation|1|||
125518731|NCT02154347|451530127|FG000|Open-label Period|Withdrawal by Subject|0|||
125518732|NCT02154347|451530128|FG001|Open-label Period|Withdrawal by Subject|1|||
125518733|NCT02473913|451530130|FG000|Overall Study|Lost to Follow-up|3|||
125518734|NCT02473913|451530131|FG001|Overall Study|Lost to Follow-up|3|||
125518735|NCT00605566|451531760|FG000|Overall Study|Adverse Event|1|||
125518736|NCT00605566|451531760|FG000|Overall Study|Clinical deterioration|1|||
125518737|NCT00605566|451531760|FG000|Overall Study|Poor compliance in run-in period|1|||
125518738|NCT04156399|451531761|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
125518739|NCT04156399|451531761|FG000|Overall Study|study suspension due to COVID pandemic|3|||
125518740|NCT03440047|451531762|FG000|Overall Study|Withdrawal by Subject|2|||
125518741|NCT01181609|451531763|FG000|Overall Study|Adverse Event|1|||
125518742|NCT01181609|451531763|FG000|Overall Study|Withdrawal by Subject|1|||
125518743|NCT01181609|451531763|FG000|Overall Study|Lost to Follow-up|1|||
125518744|NCT01181609|451531763|FG000|Overall Study|Death|50|||
125518745|NCT01333111|451531764|FG000|Overall Study|patient undergoing major surgery|0|||
125518746|NCT01333111|451531765|FG001|Overall Study|patient undergoing major surgery|2|||
125518747|NCT01333111|451531766|FG002|Overall Study|patient undergoing major surgery|0|||
125518748|NCT01333111|451531764|FG000|Overall Study|personal reasons|0|||
125518749|NCT01333111|451531765|FG001|Overall Study|personal reasons|0|||
125518750|NCT01333111|451531766|FG002|Overall Study|personal reasons|1|||
125518751|NCT01333111|451531764|FG000|Overall Study|unclassified|1|||
125518752|NCT01333111|451531765|FG001|Overall Study|unclassified|0|||
125518753|NCT01333111|451531766|FG002|Overall Study|unclassified|0|||
125518754|NCT01333111|451531764|FG000|Overall Study|withdrawal criteria|0|||
125518755|NCT01333111|451531765|FG001|Overall Study|withdrawal criteria|1|||
125518756|NCT01333111|451531766|FG002|Overall Study|withdrawal criteria|0|||
125518757|NCT01333111|451531764|FG000|Overall Study|Non-compliance|1|||
125518758|NCT01333111|451531765|FG001|Overall Study|Non-compliance|0|||
125518759|NCT01333111|451531766|FG002|Overall Study|Non-compliance|0|||
125518760|NCT01333111|451531764|FG000|Overall Study|Ineffective therapy|0|||
125518761|NCT01333111|451531765|FG001|Overall Study|Ineffective therapy|0|||
125518762|NCT01333111|451531766|FG002|Overall Study|Ineffective therapy|1|||
125518763|NCT04732871|451531767|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
125518764|NCT04732871|451531768|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
125518765|NCT04732871|451531769|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
125518766|NCT04732871|451531767|FG000|Overall Study|Lost to Follow-up|7|||
125518767|NCT04732871|451531768|FG001|Overall Study|Lost to Follow-up|4|||
125518768|NCT04732871|451531769|FG002|Overall Study|Lost to Follow-up|3|||
125518769|NCT04732871|451531767|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
125518770|NCT04732871|451531768|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
125518771|NCT04732871|451531769|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
125518772|NCT04732871|451531767|FG000|Overall Study|Migrated / moved from the study area|5|||
125518773|NCT04732871|451531768|FG001|Overall Study|Migrated / moved from the study area|0|||
125518774|NCT04732871|451531769|FG002|Overall Study|Migrated / moved from the study area|0|||
125518775|NCT04732871|451531767|FG000|Overall Study|Other|1|||
125518776|NCT04732871|451531768|FG001|Overall Study|Other|0|||
125518777|NCT04732871|451531769|FG002|Overall Study|Other|1|||
125518778|NCT04732871|451531767|FG000|Overall Study|Ongoing|6|||
125518779|NCT04732871|451531768|FG001|Overall Study|Ongoing|0|||
125518780|NCT04732871|451531769|FG002|Overall Study|Ongoing|1|||
125518781|NCT04732871|451531767|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
125518782|NCT04732871|451531768|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
125518783|NCT04732871|451531769|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
125518784|NCT00478647|451531774|FG000|Overall Study|Adverse Event|1|||
125518785|NCT00478647|451531774|FG000|Overall Study|Withdrawal by Subject|1|||
125518786|NCT03596242|451531779|FG000|Overall Study|Lost to Follow-up|2|||
125518787|NCT03596242|451531780|FG001|Overall Study|Lost to Follow-up|2|||
125518788|NCT02509312|451531781|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
125518789|NCT02509312|451531782|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
125518790|NCT02509312|451531781|FG000|Overall Study|Obstetrician refusal|0|||
125518791|NCT02509312|451531782|FG001|Overall Study|Obstetrician refusal|1|||
125518792|NCT02509312|451531781|FG000|Overall Study|Patient elected for TOLAC|1|||
125518793|NCT02509312|451531782|FG001|Overall Study|Patient elected for TOLAC|0|||
125518794|NCT02509312|451531781|FG000|Overall Study|Cesarean deemed stat|1|||
125518795|NCT02509312|451531782|FG001|Overall Study|Cesarean deemed stat|0|||
125518796|NCT02509312|451531781|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
125518797|NCT02509312|451531782|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
125518798|NCT03294941|451531783|FG000|Overall Study|Withdrawal by Subject|0|||
125518799|NCT03294941|451531784|FG001|Overall Study|Withdrawal by Subject|2|||
125518800|NCT00702650|451531785|FG000|Overall Study|Withdrawal by Subject|9|||
125518801|NCT00702650|451531785|FG000|Overall Study|Non-Compliance of Study Drug|3|||
125518802|NCT00702650|451531785|FG000|Overall Study|Lost to Follow-up|2|||
125518803|NCT00702650|451531785|FG000|Overall Study|Non-Compliance with Site Directives|1|||
125518804|NCT00702650|451531785|FG000|Overall Study|Sponsor Request|1|||
125518805|NCT00702650|451531785|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
125518806|NCT00702650|451531785|FG000|Overall Study|Adverse Event|3|||
125518807|NCT01475461|451531791|FG000|Run-in Period|Not meet eligibility criteria|16|||
125518808|NCT01475461|451531792|FG001|Run-in Period|Not meet eligibility criteria|0|||
125518809|NCT01475461|451531793|FG002|Run-in Period|Not meet eligibility criteria|0|||
125518810|NCT01475461|451531794|FG003|Run-in Period|Not meet eligibility criteria|0|||
125518811|NCT01475461|451531795|FG004|Run-in Period|Not meet eligibility criteria|0|||
125518812|NCT01475461|451531796|FG005|Run-in Period|Not meet eligibility criteria|0|||
125518813|NCT01475461|451531797|FG006|Run-in Period|Not meet eligibility criteria|0|||
125518814|NCT01475461|451531791|FG000|Run-in Period|Lost to Follow-up|7|||
125518815|NCT01475461|451531792|FG001|Run-in Period|Lost to Follow-up|0|||
125518816|NCT01475461|451531793|FG002|Run-in Period|Lost to Follow-up|0|||
125518817|NCT01475461|451531794|FG003|Run-in Period|Lost to Follow-up|0|||
125518818|NCT01475461|451531795|FG004|Run-in Period|Lost to Follow-up|0|||
125518819|NCT01475461|451531796|FG005|Run-in Period|Lost to Follow-up|0|||
125518820|NCT01475461|451531797|FG006|Run-in Period|Lost to Follow-up|0|||
125518821|NCT01475461|451531791|FG000|Run-in Period|Withdrawal by Subject|11|||
125518822|NCT01475461|451531792|FG001|Run-in Period|Withdrawal by Subject|0|||
125518823|NCT01475461|451531793|FG002|Run-in Period|Withdrawal by Subject|0|||
125518824|NCT01475461|451531794|FG003|Run-in Period|Withdrawal by Subject|0|||
125518825|NCT01475461|451531795|FG004|Run-in Period|Withdrawal by Subject|0|||
125518826|NCT01475461|451531796|FG005|Run-in Period|Withdrawal by Subject|0|||
125518827|NCT01475461|451531797|FG006|Run-in Period|Withdrawal by Subject|0|||
125518828|NCT01475461|451531791|FG000|Run-in Period|Other|3|||
125518829|NCT01475461|451531792|FG001|Run-in Period|Other|0|||
125518830|NCT01475461|451531793|FG002|Run-in Period|Other|0|||
125518831|NCT01475461|451531794|FG003|Run-in Period|Other|0|||
125518832|NCT01475461|451531795|FG004|Run-in Period|Other|0|||
125518833|NCT01475461|451531796|FG005|Run-in Period|Other|0|||
125518834|NCT01475461|451531797|FG006|Run-in Period|Other|0|||
125518835|NCT01475461|451531791|FG000|Run-in Period|Protocol Violation|4|||
125518836|NCT01475461|451531792|FG001|Run-in Period|Protocol Violation|0|||
125518837|NCT01475461|451531793|FG002|Run-in Period|Protocol Violation|0|||
125518838|NCT01475461|451531794|FG003|Run-in Period|Protocol Violation|0|||
125518839|NCT01475461|451531795|FG004|Run-in Period|Protocol Violation|0|||
125518840|NCT01475461|451531796|FG005|Run-in Period|Protocol Violation|0|||
125518841|NCT01475461|451531797|FG006|Run-in Period|Protocol Violation|0|||
125518842|NCT01475461|451531791|FG000|Treatment Period|Death|0|||
125518843|NCT01475461|451531792|FG001|Treatment Period|Death|0|||
125518844|NCT01475461|451531793|FG002|Treatment Period|Death|0|||
125518845|NCT01475461|451531794|FG003|Treatment Period|Death|1|||
125518846|NCT01475461|451531795|FG004|Treatment Period|Death|0|||
125518847|NCT01475461|451531796|FG005|Treatment Period|Death|0|||
125518848|NCT01475461|451531797|FG006|Treatment Period|Death|0|||
125518849|NCT01475461|451531791|FG000|Treatment Period|Lost to Follow-up|0|||
125518850|NCT01475461|451531792|FG001|Treatment Period|Lost to Follow-up|3|||
125518851|NCT01475461|451531793|FG002|Treatment Period|Lost to Follow-up|2|||
125518852|NCT01475461|451531794|FG003|Treatment Period|Lost to Follow-up|3|||
125518853|NCT01475461|451531795|FG004|Treatment Period|Lost to Follow-up|1|||
125518854|NCT01475461|451531796|FG005|Treatment Period|Lost to Follow-up|2|||
125518855|NCT01475461|451531797|FG006|Treatment Period|Lost to Follow-up|1|||
125518856|NCT01475461|451531791|FG000|Treatment Period|Withdrawal by Subject|0|||
125518857|NCT01475461|451531792|FG001|Treatment Period|Withdrawal by Subject|2|||
125518858|NCT01475461|451531793|FG002|Treatment Period|Withdrawal by Subject|2|||
125518859|NCT01475461|451531794|FG003|Treatment Period|Withdrawal by Subject|0|||
125518860|NCT01475461|451531795|FG004|Treatment Period|Withdrawal by Subject|2|||
125518861|NCT01475461|451531796|FG005|Treatment Period|Withdrawal by Subject|2|||
125518862|NCT01475461|451531797|FG006|Treatment Period|Withdrawal by Subject|0|||
125518863|NCT01475461|451531791|FG000|Treatment Period|Other|0|||
125518864|NCT01475461|451531792|FG001|Treatment Period|Other|1|||
125518865|NCT01475461|451531793|FG002|Treatment Period|Other|0|||
125518866|NCT01475461|451531794|FG003|Treatment Period|Other|0|||
125518867|NCT01475461|451531795|FG004|Treatment Period|Other|0|||
125518868|NCT01475461|451531796|FG005|Treatment Period|Other|0|||
125518869|NCT01475461|451531797|FG006|Treatment Period|Other|0|||
125518870|NCT01475461|451531791|FG000|Treatment Period|Protocol Violation|0|||
125518871|NCT01475461|451531792|FG001|Treatment Period|Protocol Violation|1|||
125518872|NCT01475461|451531793|FG002|Treatment Period|Protocol Violation|0|||
125518873|NCT01475461|451531794|FG003|Treatment Period|Protocol Violation|0|||
125518874|NCT01475461|451531795|FG004|Treatment Period|Protocol Violation|0|||
125518875|NCT01475461|451531796|FG005|Treatment Period|Protocol Violation|0|||
125518876|NCT01475461|451531797|FG006|Treatment Period|Protocol Violation|1|||
125518877|NCT01475461|451531791|FG000|Treatment Period|Lack of Efficacy|0|||
125518878|NCT01475461|451531792|FG001|Treatment Period|Lack of Efficacy|2|||
125518879|NCT01475461|451531793|FG002|Treatment Period|Lack of Efficacy|0|||
125518880|NCT01475461|451531794|FG003|Treatment Period|Lack of Efficacy|2|||
125518881|NCT01475461|451531795|FG004|Treatment Period|Lack of Efficacy|1|||
125518882|NCT01475461|451531796|FG005|Treatment Period|Lack of Efficacy|1|||
125518883|NCT01475461|451531797|FG006|Treatment Period|Lack of Efficacy|0|||
125518884|NCT01475461|451531791|FG000|Treatment Period|Medication Error|0|||
125518885|NCT01475461|451531792|FG001|Treatment Period|Medication Error|0|||
125518886|NCT01475461|451531793|FG002|Treatment Period|Medication Error|0|||
125518887|NCT01475461|451531794|FG003|Treatment Period|Medication Error|1|||
125518888|NCT01475461|451531795|FG004|Treatment Period|Medication Error|0|||
125518889|NCT01475461|451531796|FG005|Treatment Period|Medication Error|0|||
125518890|NCT01475461|451531797|FG006|Treatment Period|Medication Error|0|||
125518891|NCT01475461|451531791|FG000|Treatment Period|Adverse Event|0|||
125518892|NCT01475461|451531792|FG001|Treatment Period|Adverse Event|0|||
125518893|NCT01475461|451531793|FG002|Treatment Period|Adverse Event|0|||
125518894|NCT01475461|451531794|FG003|Treatment Period|Adverse Event|1|||
125518895|NCT01475461|451531795|FG004|Treatment Period|Adverse Event|0|||
125518896|NCT01475461|451531796|FG005|Treatment Period|Adverse Event|0|||
125518897|NCT01475461|451531797|FG006|Treatment Period|Adverse Event|0|||
125518898|NCT02512861|451531800|FG000|Overall Study|Protocol Violation|3|||
125518899|NCT02512861|451531801|FG001|Overall Study|Protocol Violation|7|||
125518900|NCT02512861|451531800|FG000|Overall Study|Physician Decision|3|||
125518901|NCT02512861|451531801|FG001|Overall Study|Physician Decision|1|||
125518902|NCT02512861|451531800|FG000|Overall Study|Withdrawal by Subject|0|||
125518903|NCT02512861|451531801|FG001|Overall Study|Withdrawal by Subject|1|||
125518904|NCT01774019|451531802|FG000|Overall Study|No longer meets protocol criteria|2|||
125518905|NCT01774019|451531803|FG001|Overall Study|No longer meets protocol criteria|0|||
125518906|NCT01774019|451531802|FG000|Overall Study|Withdrawal by Subject|1|||
125518907|NCT01774019|451531803|FG001|Overall Study|Withdrawal by Subject|0|||
125518908|NCT01774019|451531802|FG000|Overall Study|Surgery delayed > 120 days|1|||
125518909|NCT01774019|451531803|FG001|Overall Study|Surgery delayed > 120 days|0|||
125518910|NCT01774019|451531802|FG000|Overall Study|Patient refused surgery|1|||
125518911|NCT01774019|451531803|FG001|Overall Study|Patient refused surgery|1|||
125518912|NCT01774019|451531802|FG000|Overall Study|Unable to implant study device|1|||
125518913|NCT01774019|451531803|FG001|Overall Study|Unable to implant study device|0|||
125518914|NCT01774019|451531802|FG000|Overall Study|Lost to Follow-up|0|||
125518915|NCT01774019|451531803|FG001|Overall Study|Lost to Follow-up|3|||
125518916|NCT03214250|451531806|FG000|Overall Study|Death|5|||
125518917|NCT03214250|451531807|FG001|Overall Study|Death|5|||
125518918|NCT03214250|451531808|FG002|Overall Study|Death|7|||
125518919|NCT03214250|451531809|FG003|Overall Study|Death|4|||
125518920|NCT03214250|451531810|FG004|Overall Study|Death|23|||
125518921|NCT03214250|451531811|FG005|Overall Study|Death|23|||
125518922|NCT03214250|451531812|FG006|Overall Study|Death|24|||
125518923|NCT03214250|451531806|FG000|Overall Study|Lost to Follow-up|0|||
125518924|NCT03214250|451531807|FG001|Overall Study|Lost to Follow-up|0|||
125518925|NCT03214250|451531808|FG002|Overall Study|Lost to Follow-up|0|||
125518926|NCT03214250|451531809|FG003|Overall Study|Lost to Follow-up|1|||
125518927|NCT03214250|451531810|FG004|Overall Study|Lost to Follow-up|1|||
125518928|NCT03214250|451531811|FG005|Overall Study|Lost to Follow-up|2|||
125518929|NCT03214250|451531812|FG006|Overall Study|Lost to Follow-up|0|||
125518930|NCT03214250|451531806|FG000|Overall Study|Other|0|||
125518931|NCT03214250|451531807|FG001|Overall Study|Other|0|||
125518932|NCT03214250|451531808|FG002|Overall Study|Other|0|||
125518933|NCT03214250|451531809|FG003|Overall Study|Other|0|||
125518934|NCT03214250|451531810|FG004|Overall Study|Other|1|||
125518935|NCT03214250|451531811|FG005|Overall Study|Other|1|||
125518936|NCT03214250|451531812|FG006|Overall Study|Other|2|||
125518937|NCT03214250|451531806|FG000|Overall Study|Remains on Study|2|||
125518938|NCT03214250|451531807|FG001|Overall Study|Remains on Study|2|||
125518939|NCT03214250|451531808|FG002|Overall Study|Remains on Study|0|||
125518940|NCT03214250|451531809|FG003|Overall Study|Remains on Study|1|||
125518941|NCT03214250|451531810|FG004|Overall Study|Remains on Study|7|||
125518942|NCT03214250|451531811|FG005|Overall Study|Remains on Study|5|||
125518943|NCT03214250|451531812|FG006|Overall Study|Remains on Study|3|||
125518944|NCT03214250|451531806|FG000|Overall Study|Withdrawal by Subject|0|||
125518945|NCT03214250|451531807|FG001|Overall Study|Withdrawal by Subject|0|||
125518946|NCT03214250|451531808|FG002|Overall Study|Withdrawal by Subject|1|||
125518947|NCT03214250|451531809|FG003|Overall Study|Withdrawal by Subject|2|||
125518948|NCT03214250|451531810|FG004|Overall Study|Withdrawal by Subject|5|||
125518949|NCT03214250|451531811|FG005|Overall Study|Withdrawal by Subject|0|||
125518950|NCT03214250|451531812|FG006|Overall Study|Withdrawal by Subject|2|||
125518951|NCT03463577|451531818|FG000|Overall Study|Lost to Follow-up|238|||
125518952|NCT03463577|451531819|FG001|Overall Study|Lost to Follow-up|435|||
125518953|NCT03463577|451531820|FG002|Overall Study|Lost to Follow-up|0|||
125518954|NCT03463577|451531821|FG003|Overall Study|Lost to Follow-up|0|||
125518955|NCT03463577|451531822|FG004|Overall Study|Lost to Follow-up|0|||
125518956|NCT03463577|451531823|FG005|Overall Study|Lost to Follow-up|0|||
125518957|NCT03463577|451531818|FG000|Overall Study|With unknown pregnancy outcome|0|||
125518958|NCT03463577|451531819|FG001|Overall Study|With unknown pregnancy outcome|5|||
125518959|NCT03463577|451531820|FG002|Overall Study|With unknown pregnancy outcome|0|||
125518960|NCT03463577|451531821|FG003|Overall Study|With unknown pregnancy outcome|0|||
125518961|NCT03463577|451531822|FG004|Overall Study|With unknown pregnancy outcome|0|||
125518962|NCT03463577|451531823|FG005|Overall Study|With unknown pregnancy outcome|0|||
125518963|NCT03463577|451531818|FG000|Overall Study|Maternal death|2|||
125518964|NCT03463577|451531819|FG001|Overall Study|Maternal death|0|||
125518965|NCT03463577|451531820|FG002|Overall Study|Maternal death|0|||
125518966|NCT03463577|451531821|FG003|Overall Study|Maternal death|0|||
125518967|NCT03463577|451531822|FG004|Overall Study|Maternal death|0|||
125518968|NCT03463577|451531823|FG005|Overall Study|Maternal death|0|||
125518969|NCT03463577|451531818|FG000|Overall Study|Neonatal death|0|||
125518970|NCT03463577|451531819|FG001|Overall Study|Neonatal death|0|||
125518971|NCT03463577|451531820|FG002|Overall Study|Neonatal death|0|||
125518972|NCT03463577|451531821|FG003|Overall Study|Neonatal death|15|||
125518973|NCT03463577|451531822|FG004|Overall Study|Neonatal death|17|||
125518974|NCT03463577|451531823|FG005|Overall Study|Neonatal death|0|||
125518975|NCT00292981|451531825|FG000|Overall Study|Adverse Event|1|||
125518976|NCT00292981|451531825|FG000|Overall Study|Lost to Follow-up|13|||
125518977|NCT00292981|451531825|FG000|Overall Study|Withdrawal by Subject|22|||
125518978|NCT00292981|451531825|FG000|Overall Study|Other|3|||
125518979|NCT00594178|451531826|FG000|Overall Study|Physician Decision|5|||
125518980|NCT02172950|451531827|FG000|Overall Study|Physician Decision|3|||
125518981|NCT02172950|451531828|FG001|Overall Study|Physician Decision|3|||
125518982|NCT02172950|451531827|FG000|Overall Study|Lack of Efficacy|1|||
125518983|NCT02172950|451531828|FG001|Overall Study|Lack of Efficacy|0|||
125518984|NCT02172950|451531827|FG000|Overall Study|Adverse Event|4|||
125518985|NCT02172950|451531828|FG001|Overall Study|Adverse Event|1|||
125518986|NCT02172950|451531827|FG000|Overall Study|Withdrawal by Subject|10|||
125518987|NCT02172950|451531828|FG001|Overall Study|Withdrawal by Subject|0|||
125518988|NCT02172950|451531827|FG000|Overall Study|Protocol Violation|1|||
125518989|NCT02172950|451531828|FG001|Overall Study|Protocol Violation|0|||
125518990|NCT02172950|451531827|FG000|Overall Study|Lost to Follow-up|1|||
125518991|NCT02172950|451531828|FG001|Overall Study|Lost to Follow-up|0|||
125518992|NCT02172950|451531827|FG000|Overall Study|Death|1|||
125518993|NCT02172950|451531828|FG001|Overall Study|Death|0|||
125518994|NCT02172950|451531827|FG000|Overall Study|Patient traveling|1|||
125518995|NCT02172950|451531828|FG001|Overall Study|Patient traveling|0|||
125518996|NCT02172950|451531827|FG000|Overall Study|Patient went to other country|1|||
125518997|NCT02172950|451531828|FG001|Overall Study|Patient went to other country|0|||
125518998|NCT02172950|451531827|FG000|Overall Study|Patient relocated overseas|1|||
125518999|NCT02172950|451531828|FG001|Overall Study|Patient relocated overseas|1|||
125519000|NCT02172950|451531827|FG000|Overall Study|Patient moving|1|||
125519001|NCT02172950|451531828|FG001|Overall Study|Patient moving|0|||
125519002|NCT00496626|451531829|FG000|Overall Study|Lost to Follow-up|0|||
125519003|NCT00496626|451531830|FG001|Overall Study|Lost to Follow-up|1|||
125519004|NCT00496626|451531829|FG000|Overall Study|Protocol Violation|1|||
125519005|NCT00496626|451531830|FG001|Overall Study|Protocol Violation|0|||
125519006|NCT00496626|451531829|FG000|Overall Study|Withdrawal by Subject|5|||
125519007|NCT00496626|451531830|FG001|Overall Study|Withdrawal by Subject|4|||
125519008|NCT00496626|451531829|FG000|Overall Study|Relocated|0|||
125519009|NCT00496626|451531830|FG001|Overall Study|Relocated|1|||
125519010|NCT00611715|451531831|FG000|Overall Study|Disease Progression|24|||
125519011|NCT00611715|451531832|FG001|Overall Study|Disease Progression|4|||
125519012|NCT00611715|451531831|FG000|Overall Study|Withdrawal by Subject|5|||
125519013|NCT00611715|451531832|FG001|Overall Study|Withdrawal by Subject|1|||
125519014|NCT00611715|451531831|FG000|Overall Study|Adverse Event|9|||
125519015|NCT00611715|451531832|FG001|Overall Study|Adverse Event|1|||
125519016|NCT00611715|451531831|FG000|Overall Study|Death|1|||
125519017|NCT00611715|451531832|FG001|Overall Study|Death|0|||
125519018|NCT00611715|451531831|FG000|Overall Study|two patients are still on treatment|2|||
125519019|NCT00611715|451531832|FG001|Overall Study|two patients are still on treatment|0|||
125519020|NCT00107978|451531833|FG000|Overall Study|Adverse Event|1|||
125519021|NCT00107978|451531834|FG001|Overall Study|Adverse Event|5|||
125519022|NCT00107978|451531833|FG000|Overall Study|Death|3|||
125519023|NCT00107978|451531834|FG001|Overall Study|Death|3|||
125519024|NCT00107978|451531833|FG000|Overall Study|Lost to Follow-up|20|||
125519025|NCT00107978|451531834|FG001|Overall Study|Lost to Follow-up|28|||
125519026|NCT00107978|451531833|FG000|Overall Study|Withdrawal by Subject|4|||
125519027|NCT00107978|451531834|FG001|Overall Study|Withdrawal by Subject|9|||
125519028|NCT00107978|451531833|FG000|Overall Study|Protocol Violation|0|||
125519029|NCT00107978|451531834|FG001|Overall Study|Protocol Violation|1|||
125519030|NCT00107978|451531833|FG000|Overall Study|Other|5|||
125519031|NCT00107978|451531834|FG001|Overall Study|Other|4|||
125519032|NCT00727415|451531835|FG000|Phase I|Dose Limiting Toxicity|2|||
125519033|NCT01664923|451531839|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
125519034|NCT01664923|451531840|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
125519035|NCT01664923|451531839|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
125519036|NCT01664923|451531840|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
125519037|NCT01664923|451531839|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
125519038|NCT01664923|451531840|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
125519039|NCT01664923|451531839|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
125519040|NCT01664923|451531840|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
125519041|NCT01664923|451531839|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
125519042|NCT01664923|451531840|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
125519043|NCT01664923|451531839|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
125519044|NCT01664923|451531840|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
125519045|NCT01664923|451531839|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
125519046|NCT01664923|451531840|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
125519047|NCT01664923|451531839|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
125519048|NCT01664923|451531840|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
125519049|NCT01664923|451531839|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
125519050|NCT01664923|451531840|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
125519051|NCT01664923|451531839|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
125519052|NCT01664923|451531840|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
125519053|NCT01664923|451531839|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
125519054|NCT01664923|451531840|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
125519055|NCT01664923|451531839|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
125519056|NCT01664923|451531840|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
125519057|NCT01664923|451531839|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
125519058|NCT01664923|451531840|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
125519059|NCT01664923|451531839|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
125519060|NCT01664923|451531840|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
125519061|NCT02427958|451531841|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
125519062|NCT02427958|451531841|FG000|Overall Study|Lost to Follow-up|6|||
125519063|NCT02427958|451531841|FG000|Overall Study|Withdrawal by Subject|14|||
125519064|NCT02427958|451531841|FG000|Overall Study|Lack of Efficacy|1|||
125519065|NCT03974100|451531842|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
125519066|NCT03974100|451531843|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
125519067|NCT03974100|451531844|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
125519068|NCT03974100|451531845|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
125519069|NCT03974100|451531846|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
125519070|NCT03974100|451531842|FG000|TP1 - Day 1 to Week 52|Death|1|||
125519071|NCT03974100|451531843|FG001|TP1 - Day 1 to Week 52|Death|0|||
125519072|NCT03974100|451531844|FG002|TP1 - Day 1 to Week 52|Death|0|||
125519073|NCT03974100|451531845|FG003|TP1 - Day 1 to Week 52|Death|0|||
125519074|NCT03974100|451531846|FG004|TP1 - Day 1 to Week 52|Death|0|||
125519075|NCT03974100|451531842|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
125519076|NCT03974100|451531843|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
125519077|NCT03974100|451531844|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
125519078|NCT03974100|451531845|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
125519079|NCT03974100|451531846|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
125519080|NCT03974100|451531842|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
125519081|NCT03974100|451531843|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
125519082|NCT03974100|451531844|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
125519083|NCT03974100|451531845|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
125519084|NCT03974100|451531846|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
125519085|NCT03974100|451531842|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
125519086|NCT03974100|451531843|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
125519087|NCT03974100|451531844|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
125519088|NCT03974100|451531845|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
125519089|NCT03974100|451531846|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
125519090|NCT03974100|451531842|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
125519091|NCT03974100|451531843|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
125519092|NCT03974100|451531844|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
125519093|NCT03974100|451531845|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
125519094|NCT03974100|451531846|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
125519095|NCT03974100|451531842|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
125519096|NCT03974100|451531843|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
125519097|NCT03974100|451531844|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
125519098|NCT03974100|451531845|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
125519099|NCT03974100|451531846|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
125519100|NCT00545571|451531849|FG000|Overall Study|Administrative Reasons|1|||
125519101|NCT00545571|451531849|FG000|Overall Study|Adverse Event|2|||
125519102|NCT00545571|451531849|FG000|Overall Study|Death|5|||
125519103|NCT00545571|451531849|FG000|Overall Study|Lack of Efficacy|1|||
125519104|NCT00545571|451531849|FG000|Overall Study|Protocol Violation|2|||
125519105|NCT00545571|451531849|FG000|Overall Study|Refused Treatment|1|||
125519106|NCT00545571|451531849|FG000|Overall Study|Screen Failure|16|||
125519107|NCT00545571|451531849|FG000|Overall Study|Transfusion|12|||
125519108|NCT00545571|451531849|FG000|Overall Study|Early Termination of Study|24|||
125519109|NCT00545571|451531849|FG000|Overall Study|Kidney Transplantation|3|||
125519110|NCT03269695|451531850|FG000|Overall Study|Adverse Event|2|||
125519111|NCT03269695|451531851|FG001|Overall Study|Adverse Event|1|||
125519112|NCT03269695|451531850|FG000|Overall Study|Lack of Efficacy|0|||
125519113|NCT03269695|451531851|FG001|Overall Study|Lack of Efficacy|1|||
125519114|NCT03269695|451531850|FG000|Overall Study|Withdrawal by Subject|0|||
125519115|NCT03269695|451531851|FG001|Overall Study|Withdrawal by Subject|1|||
125519116|NCT01013740|451531852|FG000|Overall Study|Lost to Follow-up|3|||
125519117|NCT01013740|451531853|FG001|Overall Study|Lost to Follow-up|5|||
125519118|NCT01013740|451531852|FG000|Overall Study|Physician Decision|2|||
125519119|NCT01013740|451531853|FG001|Overall Study|Physician Decision|0|||
125519120|NCT01013740|451531852|FG000|Overall Study|Withdrawal by Subject|2|||
125519121|NCT01013740|451531853|FG001|Overall Study|Withdrawal by Subject|10|||
125519122|NCT01013740|451531852|FG000|Overall Study|study close / terminated : done in error|2|||
125519123|NCT01013740|451531853|FG001|Overall Study|study close / terminated : done in error|1|||
125519124|NCT01013740|451531852|FG000|Overall Study|Missing|2|||
125519125|NCT01013740|451531853|FG001|Overall Study|Missing|1|||
125519126|NCT01013740|451531852|FG000|Overall Study|Ongoing: Study records not completed|0|||
125519127|NCT01013740|451531853|FG001|Overall Study|Ongoing: Study records not completed|2|||
125519128|NCT00025662|451531854|FG000|Overall Study|Withdrawal by Subject|2|||
125519129|NCT00025662|451531854|FG000|Overall Study|Technical failure of manipulation|1|||
125519130|NCT00582114|451531855|FG000|Overall Study|Death|4|||
125519131|NCT00582114|451531856|FG001|Overall Study|Death|4|||
125519132|NCT00582114|451531855|FG000|Overall Study|Kidney Transplant|3|||
125519133|NCT00582114|451531856|FG001|Overall Study|Kidney Transplant|1|||
125519134|NCT00582114|451531855|FG000|Overall Study|Lost to Follow-up|7|||
125519135|NCT00582114|451531856|FG001|Overall Study|Lost to Follow-up|6|||
125519136|NCT00582114|451531855|FG000|Overall Study|Withdrawal by Subject|8|||
125519137|NCT00582114|451531856|FG001|Overall Study|Withdrawal by Subject|16|||
125519138|NCT00582114|451531855|FG000|Overall Study|Adverse Event|1|||
125519139|NCT00582114|451531856|FG001|Overall Study|Adverse Event|1|||
125519140|NCT00582114|451531855|FG000|Overall Study|Physician Decision|0|||
125519141|NCT00582114|451531856|FG001|Overall Study|Physician Decision|6|||
125519142|NCT00582114|451531855|FG000|Overall Study|Stopped by data safety monitoring board|19|||
125519143|NCT00582114|451531856|FG001|Overall Study|Stopped by data safety monitoring board|20|||
125519144|NCT02604342|451531857|FG000|Overall Study|Death|32|||
125519145|NCT02604342|451531858|FG001|Overall Study|Death|16|||
125519146|NCT02604342|451531857|FG000|Overall Study|Progression of disease|1|||
125519147|NCT02604342|451531858|FG001|Overall Study|Progression of disease|0|||
125519148|NCT02604342|451531857|FG000|Overall Study|Withdrawal by Subject|5|||
125519149|NCT02604342|451531858|FG001|Overall Study|Withdrawal by Subject|6|||
125519150|NCT02604342|451531857|FG000|Overall Study|Other|1|||
125519151|NCT02604342|451531858|FG001|Overall Study|Other|0|||
125519152|NCT02604342|451531857|FG000|Overall Study|Study Termination by Sponsor|1|||
125519153|NCT02604342|451531858|FG001|Overall Study|Study Termination by Sponsor|0|||
125519154|NCT02604342|451531857|FG000|Overall Study|Lost to Follow-up|1|||
125519155|NCT02604342|451531858|FG001|Overall Study|Lost to Follow-up|1|||
125519156|NCT02604342|451531857|FG000|Overall Study|Physician Decision|2|||
125519157|NCT02604342|451531858|FG001|Overall Study|Physician Decision|0|||
125519158|NCT02024750|451531859|FG000|Overall Study|Withdrawal by Subject|2|||
125519159|NCT02024750|451531860|FG001|Overall Study|Withdrawal by Subject|1|||
125519160|NCT00130728|451531861|FG000|Overall Study|Death|258|||
125519161|NCT00130728|451531862|FG001|Overall Study|Death|258|||
125519162|NCT00130728|451531861|FG000|Overall Study|Lost to Follow-up|4|||
125519163|NCT00130728|451531862|FG001|Overall Study|Lost to Follow-up|0|||
125519164|NCT00130728|451531861|FG000|Overall Study|Withdrawal by Subject|0|||
125519165|NCT00130728|451531862|FG001|Overall Study|Withdrawal by Subject|2|||
125519166|NCT01349036|451531863|FG000|Overall Study|Disease progression|13|||
125519167|NCT01349036|451531864|FG001|Overall Study|Disease progression|22|||
125519168|NCT01349036|451531863|FG000|Overall Study|Other|1|||
125519169|NCT01349036|451531864|FG001|Overall Study|Other|0|||
125519170|NCT01349036|451531863|FG000|Overall Study|Withdrawal by Subject|0|||
125519171|NCT01349036|451531864|FG001|Overall Study|Withdrawal by Subject|2|||
125519172|NCT00746356|451531865|FG000|Overall Study|Withdrawal by Subject|2|||
125519173|NCT00746356|451531866|FG001|Overall Study|Withdrawal by Subject|3|||
125519174|NCT00746356|451531865|FG000|Overall Study|Death|7|||
125519175|NCT00746356|451531866|FG001|Overall Study|Death|3|||
125519176|NCT00746356|451531865|FG000|Overall Study|Lost to Follow-up|1|||
125519177|NCT00746356|451531866|FG001|Overall Study|Lost to Follow-up|0|||
125519178|NCT00746356|451531865|FG000|Overall Study|Removal of Device|0|||
125519179|NCT00746356|451531866|FG001|Overall Study|Removal of Device|1|||
125519180|NCT00746356|451531865|FG000|Overall Study|Patient relocated|1|||
125519181|NCT00746356|451531866|FG001|Overall Study|Patient relocated|0|||
125519182|NCT01125566|451531871|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
125519183|NCT01125566|451531872|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
125519184|NCT01125566|451531873|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
125519185|NCT01125566|451531871|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
125519186|NCT01125566|451531872|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
125519187|NCT01125566|451531873|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
125519188|NCT01125566|451531871|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
125519189|NCT01125566|451531872|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
125519190|NCT01125566|451531873|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
125519191|NCT01125566|451531871|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
125519192|NCT01125566|451531872|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
125519193|NCT01125566|451531873|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
125519194|NCT01125566|451531871|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
125519195|NCT01125566|451531872|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
125519196|NCT01125566|451531873|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
125519197|NCT01125566|451531871|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
125519198|NCT01125566|451531872|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
125519199|NCT01125566|451531873|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
125519200|NCT01125566|451531871|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
125519201|NCT01125566|451531872|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
125519202|NCT01125566|451531873|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
125519203|NCT01125566|451531871|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
125519204|NCT01125566|451531872|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
125519205|NCT01125566|451531873|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
125519206|NCT01125566|451531871|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
125519207|NCT01125566|451531872|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
125519208|NCT01125566|451531873|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
125519209|NCT01125566|451531871|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
125519210|NCT01125566|451531872|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
125519211|NCT01125566|451531873|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
125519212|NCT01125566|451531871|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
125519213|NCT01125566|451531872|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
125519214|NCT01125566|451531873|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
125519215|NCT01125566|451531871|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
125519216|NCT01125566|451531872|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
125519217|NCT01125566|451531873|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
125519218|NCT02881047|451531874|FG000|Overall Study|Adverse Event|1|||
125519219|NCT02881047|451531874|FG000|Overall Study|Withdrawal by Subject|1|||
125519220|NCT03028012|451531875|FG000|Overall Study|Lost to Follow-up|2|||
125519221|NCT03028012|451531876|FG001|Overall Study|Lost to Follow-up|3|||
125519222|NCT03028012|451531877|FG002|Overall Study|Lost to Follow-up|3|||
125519223|NCT02484547|451531886|FG000|Placebo-Controlled Period|Adverse Event|10|||
125519224|NCT02484547|451531887|FG001|Placebo-Controlled Period|Adverse Event|13|||
125519225|NCT02484547|451531888|FG002|Placebo-Controlled Period|Adverse Event|20|||
125519226|NCT02484547|451531889|FG003|Placebo-Controlled Period|Adverse Event|0|||
125519227|NCT02484547|451531890|FG004|Placebo-Controlled Period|Adverse Event|0|||
125519228|NCT02484547|451531891|FG005|Placebo-Controlled Period|Adverse Event|0|||
125519229|NCT02484547|451531892|FG006|Placebo-Controlled Period|Adverse Event|0|||
125519230|NCT02484547|451531886|FG000|Placebo-Controlled Period|Change of Treatment|0|||
125519231|NCT02484547|451531887|FG001|Placebo-Controlled Period|Change of Treatment|0|||
125519232|NCT02484547|451531888|FG002|Placebo-Controlled Period|Change of Treatment|1|||
125519233|NCT02484547|451531889|FG003|Placebo-Controlled Period|Change of Treatment|0|||
125519234|NCT02484547|451531890|FG004|Placebo-Controlled Period|Change of Treatment|0|||
125519235|NCT02484547|451531891|FG005|Placebo-Controlled Period|Change of Treatment|0|||
125519236|NCT02484547|451531892|FG006|Placebo-Controlled Period|Change of Treatment|0|||
125519237|NCT02484547|451531886|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
125519238|NCT02484547|451531887|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
125519239|NCT02484547|451531888|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
125519240|NCT02484547|451531889|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
125519241|NCT02484547|451531890|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
125519242|NCT02484547|451531891|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
125519243|NCT02484547|451531892|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
125519244|NCT02484547|451531886|FG000|Placebo-Controlled Period|Death|5|||
125519245|NCT02484547|451531887|FG001|Placebo-Controlled Period|Death|0|||
125519246|NCT02484547|451531888|FG002|Placebo-Controlled Period|Death|6|||
125519247|NCT02484547|451531889|FG003|Placebo-Controlled Period|Death|0|||
125519248|NCT02484547|451531890|FG004|Placebo-Controlled Period|Death|0|||
125519249|NCT02484547|451531891|FG005|Placebo-Controlled Period|Death|0|||
125519250|NCT02484547|451531892|FG006|Placebo-Controlled Period|Death|0|||
125519251|NCT02484547|451531886|FG000|Placebo-Controlled Period|Disease Progression|2|||
125519252|NCT02484547|451531887|FG001|Placebo-Controlled Period|Disease Progression|0|||
125519253|NCT02484547|451531888|FG002|Placebo-Controlled Period|Disease Progression|1|||
125519254|NCT02484547|451531889|FG003|Placebo-Controlled Period|Disease Progression|0|||
125519255|NCT02484547|451531890|FG004|Placebo-Controlled Period|Disease Progression|0|||
125519256|NCT02484547|451531891|FG005|Placebo-Controlled Period|Disease Progression|0|||
125519257|NCT02484547|451531892|FG006|Placebo-Controlled Period|Disease Progression|0|||
125519258|NCT02484547|451531886|FG000|Placebo-Controlled Period|Investigator Decision|2|||
125519259|NCT02484547|451531887|FG001|Placebo-Controlled Period|Investigator Decision|2|||
125519260|NCT02484547|451531888|FG002|Placebo-Controlled Period|Investigator Decision|5|||
125519261|NCT02484547|451531889|FG003|Placebo-Controlled Period|Investigator Decision|0|||
125519262|NCT02484547|451531890|FG004|Placebo-Controlled Period|Investigator Decision|0|||
125519263|NCT02484547|451531891|FG005|Placebo-Controlled Period|Investigator Decision|0|||
125519264|NCT02484547|451531892|FG006|Placebo-Controlled Period|Investigator Decision|0|||
125519265|NCT02484547|451531886|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
125519266|NCT02484547|451531887|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
125519267|NCT02484547|451531888|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
125519268|NCT02484547|451531889|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
125519269|NCT02484547|451531890|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
125519270|NCT02484547|451531891|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
125519271|NCT02484547|451531892|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
125519272|NCT02484547|451531886|FG000|Placebo-Controlled Period|Relocation|1|||
125519273|NCT02484547|451531887|FG001|Placebo-Controlled Period|Relocation|1|||
125519274|NCT02484547|451531888|FG002|Placebo-Controlled Period|Relocation|1|||
125519275|NCT02484547|451531889|FG003|Placebo-Controlled Period|Relocation|0|||
125519276|NCT02484547|451531890|FG004|Placebo-Controlled Period|Relocation|0|||
125519277|NCT02484547|451531891|FG005|Placebo-Controlled Period|Relocation|0|||
125519278|NCT02484547|451531892|FG006|Placebo-Controlled Period|Relocation|0|||
125519279|NCT02484547|451531886|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
125519280|NCT02484547|451531887|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
125519281|NCT02484547|451531888|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
125519282|NCT02484547|451531889|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
125519283|NCT02484547|451531890|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
125519284|NCT02484547|451531891|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
125519285|NCT02484547|451531892|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
125519286|NCT02484547|451531886|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
125519287|NCT02484547|451531887|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
125519288|NCT02484547|451531888|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
125519289|NCT02484547|451531889|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125519290|NCT02484547|451531890|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125519291|NCT02484547|451531891|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125519292|NCT02484547|451531892|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
125519293|NCT02484547|451531886|FG000|Placebo-Controlled Period|Reason not Specified|216|||
125519294|NCT02484547|451531887|FG001|Placebo-Controlled Period|Reason not Specified|194|||
125519295|NCT02484547|451531888|FG002|Placebo-Controlled Period|Reason not Specified|183|||
125519296|NCT02484547|451531889|FG003|Placebo-Controlled Period|Reason not Specified|0|||
125519297|NCT02484547|451531890|FG004|Placebo-Controlled Period|Reason not Specified|0|||
125519298|NCT02484547|451531891|FG005|Placebo-Controlled Period|Reason not Specified|0|||
125519299|NCT02484547|451531892|FG006|Placebo-Controlled Period|Reason not Specified|0|||
125519300|NCT02484547|451531886|FG000|Long-Term Extension Period|Adverse Event|0|||
125519301|NCT02484547|451531887|FG001|Long-Term Extension Period|Adverse Event|0|||
125519302|NCT02484547|451531888|FG002|Long-Term Extension Period|Adverse Event|0|||
125519303|NCT02484547|451531889|FG003|Long-Term Extension Period|Adverse Event|0|||
125519304|NCT02484547|451531890|FG004|Long-Term Extension Period|Adverse Event|1|||
125519305|NCT02484547|451531891|FG005|Long-Term Extension Period|Adverse Event|3|||
125519306|NCT02484547|451531892|FG006|Long-Term Extension Period|Adverse Event|2|||
125519307|NCT02484547|451531886|FG000|Long-Term Extension Period|Death|0|||
125519308|NCT02484547|451531887|FG001|Long-Term Extension Period|Death|0|||
125519309|NCT02484547|451531888|FG002|Long-Term Extension Period|Death|0|||
125519310|NCT02484547|451531889|FG003|Long-Term Extension Period|Death|0|||
125519311|NCT02484547|451531890|FG004|Long-Term Extension Period|Death|0|||
125519312|NCT02484547|451531891|FG005|Long-Term Extension Period|Death|3|||
125519313|NCT02484547|451531892|FG006|Long-Term Extension Period|Death|0|||
125519314|NCT02484547|451531886|FG000|Long-Term Extension Period|Disease Progression|0|||
125519315|NCT02484547|451531887|FG001|Long-Term Extension Period|Disease Progression|0|||
125519316|NCT02484547|451531888|FG002|Long-Term Extension Period|Disease Progression|0|||
125519317|NCT02484547|451531889|FG003|Long-Term Extension Period|Disease Progression|0|||
125519318|NCT02484547|451531890|FG004|Long-Term Extension Period|Disease Progression|2|||
125519319|NCT02484547|451531891|FG005|Long-Term Extension Period|Disease Progression|4|||
125519320|NCT02484547|451531892|FG006|Long-Term Extension Period|Disease Progression|0|||
125519321|NCT02484547|451531886|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
125519322|NCT02484547|451531887|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
125519323|NCT02484547|451531888|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
125519324|NCT02484547|451531889|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
125519325|NCT02484547|451531890|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
125519326|NCT02484547|451531891|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
125519327|NCT02484547|451531892|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
125519328|NCT02484547|451531886|FG000|Long-Term Extension Period|Loss of Capacity|0|||
125519329|NCT02484547|451531887|FG001|Long-Term Extension Period|Loss of Capacity|0|||
125519330|NCT02484547|451531888|FG002|Long-Term Extension Period|Loss of Capacity|0|||
125519331|NCT02484547|451531889|FG003|Long-Term Extension Period|Loss of Capacity|0|||
125519332|NCT02484547|451531890|FG004|Long-Term Extension Period|Loss of Capacity|1|||
125519333|NCT02484547|451531891|FG005|Long-Term Extension Period|Loss of Capacity|0|||
125519334|NCT02484547|451531892|FG006|Long-Term Extension Period|Loss of Capacity|0|||
125519335|NCT02484547|451531886|FG000|Long-Term Extension Period|Change of Treatment|0|||
125519336|NCT02484547|451531887|FG001|Long-Term Extension Period|Change of Treatment|0|||
125519337|NCT02484547|451531888|FG002|Long-Term Extension Period|Change of Treatment|0|||
125519338|NCT02484547|451531889|FG003|Long-Term Extension Period|Change of Treatment|0|||
125519339|NCT02484547|451531890|FG004|Long-Term Extension Period|Change of Treatment|0|||
125519340|NCT02484547|451531891|FG005|Long-Term Extension Period|Change of Treatment|0|||
125519341|NCT02484547|451531892|FG006|Long-Term Extension Period|Change of Treatment|1|||
125519342|NCT02484547|451531886|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
125519343|NCT02484547|451531887|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
125519344|NCT02484547|451531888|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
125519345|NCT02484547|451531889|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
125519346|NCT02484547|451531890|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
125519347|NCT02484547|451531891|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
125519348|NCT02484547|451531892|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
125519349|NCT02484547|451531886|FG000|Long-Term Extension Period|Investigator Decision|0|||
125519350|NCT02484547|451531887|FG001|Long-Term Extension Period|Investigator Decision|0|||
125519351|NCT02484547|451531888|FG002|Long-Term Extension Period|Investigator Decision|0|||
125519352|NCT02484547|451531889|FG003|Long-Term Extension Period|Investigator Decision|2|||
125519353|NCT02484547|451531890|FG004|Long-Term Extension Period|Investigator Decision|1|||
125519354|NCT02484547|451531891|FG005|Long-Term Extension Period|Investigator Decision|0|||
125519355|NCT02484547|451531892|FG006|Long-Term Extension Period|Investigator Decision|1|||
125519356|NCT02484547|451531886|FG000|Long-Term Extension Period|Relocation|0|||
125519357|NCT02484547|451531887|FG001|Long-Term Extension Period|Relocation|0|||
125519358|NCT02484547|451531888|FG002|Long-Term Extension Period|Relocation|0|||
125519359|NCT02484547|451531889|FG003|Long-Term Extension Period|Relocation|1|||
125532613|NCT00350727|451580162|FG001|Phase II|Sponsor Terminated Study|0|||
125519360|NCT02484547|451531890|FG004|Long-Term Extension Period|Relocation|1|||
125519361|NCT02484547|451531891|FG005|Long-Term Extension Period|Relocation|0|||
125519362|NCT02484547|451531892|FG006|Long-Term Extension Period|Relocation|0|||
125519363|NCT02484547|451531886|FG000|Long-Term Extension Period|Study Visit Burden|0|||
125519364|NCT02484547|451531887|FG001|Long-Term Extension Period|Study Visit Burden|0|||
125519365|NCT02484547|451531888|FG002|Long-Term Extension Period|Study Visit Burden|0|||
125519366|NCT02484547|451531889|FG003|Long-Term Extension Period|Study Visit Burden|2|||
125519367|NCT02484547|451531890|FG004|Long-Term Extension Period|Study Visit Burden|0|||
125519368|NCT02484547|451531891|FG005|Long-Term Extension Period|Study Visit Burden|0|||
125519369|NCT02484547|451531892|FG006|Long-Term Extension Period|Study Visit Burden|3|||
125519370|NCT02484547|451531886|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
125519371|NCT02484547|451531887|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
125519372|NCT02484547|451531888|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
125519373|NCT02484547|451531889|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
125519374|NCT02484547|451531890|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
125519375|NCT02484547|451531891|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
125519376|NCT02484547|451531892|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
125519377|NCT02484547|451531886|FG000|Long-Term Extension Period|Reason not Specified|0|||
125519378|NCT02484547|451531887|FG001|Long-Term Extension Period|Reason not Specified|0|||
125519379|NCT02484547|451531888|FG002|Long-Term Extension Period|Reason not Specified|0|||
125519380|NCT02484547|451531889|FG003|Long-Term Extension Period|Reason not Specified|119|||
125519381|NCT02484547|451531890|FG004|Long-Term Extension Period|Reason not Specified|117|||
125519382|NCT02484547|451531891|FG005|Long-Term Extension Period|Reason not Specified|223|||
125519383|NCT02484547|451531892|FG006|Long-Term Extension Period|Reason not Specified|231|||
125519384|NCT01813305|451531893|FG000|Overall Study|Withdrawal by Subject|12|||
125519385|NCT01813305|451531894|FG001|Overall Study|Withdrawal by Subject|5|||
125519386|NCT01813305|451531893|FG000|Overall Study|Safety Concern|4|||
125519387|NCT01813305|451531894|FG001|Overall Study|Safety Concern|0|||
125519388|NCT01813305|451531893|FG000|Overall Study|Ulcer became worse|4|||
125519389|NCT01813305|451531894|FG001|Overall Study|Ulcer became worse|0|||
125519390|NCT01813305|451531893|FG000|Overall Study|Physician Decision|4|||
125519391|NCT01813305|451531894|FG001|Overall Study|Physician Decision|0|||
125519392|NCT01813305|451531893|FG000|Overall Study|Lost to Follow-up|3|||
125519393|NCT01813305|451531894|FG001|Overall Study|Lost to Follow-up|1|||
125519394|NCT01813305|451531893|FG000|Overall Study|Protocol Violation|1|||
125519395|NCT01813305|451531894|FG001|Overall Study|Protocol Violation|0|||
125519396|NCT01813305|451531893|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
125519397|NCT01813305|451531894|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
125519398|NCT01665599|451531898|FG000|Overall Study|Adverse Event|1|||
125519399|NCT01665599|451531898|FG000|Overall Study|Consent Withdrawn|1|||
125519400|NCT01665599|451531898|FG000|Overall Study|Investigator/Sponsor decision|1|||
125519401|NCT01665599|451531898|FG000|Overall Study|Death|1|||
125519402|NCT01665599|451531898|FG000|Overall Study|Lost to Follow-up|2|||
125519403|NCT01665599|451531898|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
125519404|NCT01665599|451531898|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
125519405|NCT01837797|451531899|FG000|Period 1|Adverse Event|9|||
125519406|NCT01837797|451531900|FG001|Period 1|Adverse Event|0|||
125519407|NCT01837797|451531901|FG002|Period 1|Adverse Event|0|||
125519408|NCT01837797|451531902|FG003|Period 1|Adverse Event|0|||
125519409|NCT01837797|451531903|FG004|Period 1|Adverse Event|0|||
125519410|NCT01837797|451531899|FG000|Period 1|Withdrawal by Subject|6|||
125519411|NCT01837797|451531900|FG001|Period 1|Withdrawal by Subject|0|||
125519412|NCT01837797|451531901|FG002|Period 1|Withdrawal by Subject|0|||
125519413|NCT01837797|451531902|FG003|Period 1|Withdrawal by Subject|0|||
125519414|NCT01837797|451531903|FG004|Period 1|Withdrawal by Subject|0|||
125519415|NCT01837797|451531899|FG000|Period 1|Administrative reasons|76|||
125519416|NCT01837797|451531900|FG001|Period 1|Administrative reasons|0|||
125519417|NCT01837797|451531901|FG002|Period 1|Administrative reasons|0|||
125519418|NCT01837797|451531902|FG003|Period 1|Administrative reasons|0|||
125519419|NCT01837797|451531903|FG004|Period 1|Administrative reasons|0|||
125519420|NCT01837797|451531899|FG000|Period 1|Withdrawal of consent before treatment|1|||
125519421|NCT01837797|451531900|FG001|Period 1|Withdrawal of consent before treatment|0|||
125519422|NCT01837797|451531901|FG002|Period 1|Withdrawal of consent before treatment|0|||
125519423|NCT01837797|451531902|FG003|Period 1|Withdrawal of consent before treatment|0|||
125519424|NCT01837797|451531903|FG004|Period 1|Withdrawal of consent before treatment|0|||
125519425|NCT01837797|451531899|FG000|Period 1|Other|10|||
125519426|NCT01837797|451531900|FG001|Period 1|Other|0|||
125519427|NCT01837797|451531901|FG002|Period 1|Other|0|||
125519428|NCT01837797|451531902|FG003|Period 1|Other|0|||
125519429|NCT01837797|451531903|FG004|Period 1|Other|0|||
125519430|NCT01837797|451531899|FG000|Period 2|Administrative or other reasons|0|||
125519431|NCT01837797|451531900|FG001|Period 2|Administrative or other reasons|5|||
125519432|NCT01837797|451531901|FG002|Period 2|Administrative or other reasons|2|||
125519433|NCT01837797|451531902|FG003|Period 2|Administrative or other reasons|4|||
125519434|NCT01837797|451531903|FG004|Period 2|Administrative or other reasons|0|||
125519435|NCT01837797|451531899|FG000|Period 2|Adverse Event|0|||
125519436|NCT01837797|451531900|FG001|Period 2|Adverse Event|0|||
125519437|NCT01837797|451531901|FG002|Period 2|Adverse Event|0|||
125519438|NCT01837797|451531902|FG003|Period 2|Adverse Event|1|||
125519439|NCT01837797|451531903|FG004|Period 2|Adverse Event|0|||
125519440|NCT01837797|451531899|FG000|Period 3|Adverse Event|0|||
125519441|NCT01837797|451531900|FG001|Period 3|Adverse Event|0|||
125519442|NCT01837797|451531901|FG002|Period 3|Adverse Event|0|||
125519443|NCT01837797|451531902|FG003|Period 3|Adverse Event|0|||
125519444|NCT01837797|451531903|FG004|Period 3|Adverse Event|1|||
125519445|NCT01837797|451531899|FG000|Period 3|Administrative reasons|0|||
125519446|NCT01837797|451531900|FG001|Period 3|Administrative reasons|0|||
125519447|NCT01837797|451531901|FG002|Period 3|Administrative reasons|0|||
125519448|NCT01837797|451531902|FG003|Period 3|Administrative reasons|0|||
125519449|NCT01837797|451531903|FG004|Period 3|Administrative reasons|20|||
125519450|NCT01837797|451531899|FG000|Period 3|Other|0|||
125519451|NCT01837797|451531900|FG001|Period 3|Other|0|||
125519452|NCT01837797|451531901|FG002|Period 3|Other|0|||
125519453|NCT01837797|451531902|FG003|Period 3|Other|0|||
125519454|NCT01837797|451531903|FG004|Period 3|Other|2|||
125519455|NCT01705145|451531904|FG000|Part B|Adverse Event|1|||
125519456|NCT01503164|451531913|FG000|Overall Study|Withdrawal by Subject|2|||
125519457|NCT01503164|451531914|FG001|Overall Study|Withdrawal by Subject|1|||
125519458|NCT04088136|451531915|FG000|Overall Study|Withdrawal by Subject|5|||
125519459|NCT04088136|451531916|FG001|Overall Study|Withdrawal by Subject|0|||
125519460|NCT04088136|451531915|FG000|Overall Study|Lack of Efficacy|0|||
125519461|NCT04088136|451531916|FG001|Overall Study|Lack of Efficacy|1|||
125519462|NCT03151551|451531917|FG000|Open-Label Treatment Period|Adverse Event|0|||
125519463|NCT03151551|451531918|FG001|Open-Label Treatment Period|Adverse Event|2|||
125519464|NCT03151551|451531917|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
125519465|NCT03151551|451531918|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
125519466|NCT03151551|451531917|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
125519467|NCT03151551|451531918|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
125519468|NCT03151551|451531917|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
125519469|NCT03151551|451531918|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
125519470|NCT03151551|451531917|FG000|Open-Label Treatment Period|Physician Decision|3|||
125519471|NCT03151551|451531918|FG001|Open-Label Treatment Period|Physician Decision|0|||
125519472|NCT03151551|451531917|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
125519473|NCT03151551|451531918|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
125519474|NCT03151551|451531917|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
125519475|NCT03151551|451531918|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
125519476|NCT03151551|451531917|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
125519477|NCT03151551|451531918|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
125519478|NCT03151551|451531917|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
125519479|NCT03151551|451531918|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
125519480|NCT03151551|451531917|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
125519481|NCT03151551|451531918|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
125519482|NCT03282799|451531925|FG000|Overall Study|Pregnancy|1|||
125519483|NCT03282799|451531926|FG001|Overall Study|Pregnancy|0|||
125519484|NCT03282799|451531925|FG000|Overall Study|Physician Decision|1|||
125519485|NCT03282799|451531926|FG001|Overall Study|Physician Decision|0|||
125519486|NCT00143598|451531931|FG000|Overall Study|Lost to Follow-up|23|||
125519487|NCT00143598|451531932|FG001|Overall Study|Lost to Follow-up|21|||
125519488|NCT00143598|451531931|FG000|Overall Study|Withdrawal by Subject|33|||
125519489|NCT00143598|451531932|FG001|Overall Study|Withdrawal by Subject|37|||
125519490|NCT00143598|451531931|FG000|Overall Study|Death|36|||
125519491|NCT00143598|451531932|FG001|Overall Study|Death|36|||
125519492|NCT03900715|451531935|FG000|Overall Study|Protocol Deviation|1|||
125519493|NCT03900715|451531935|FG000|Overall Study|Lack of Efficacy|1|||
125519494|NCT03900715|451531935|FG000|Overall Study|Progressive Disease|6|||
125519495|NCT03900715|451531935|FG000|Overall Study|Adverse Event|2|||
125519496|NCT03900715|451531935|FG000|Overall Study|Other reasons|11|||
125519497|NCT01878383|451533445|FG000|Overall Study|Lost to Follow-up|0|||
125519498|NCT01878383|451533446|FG001|Overall Study|Lost to Follow-up|1499|||
125519499|NCT03464383|451533447|FG000|Overall Study|Lost to Follow-up|1|||
125519500|NCT03464383|451533448|FG001|Overall Study|Lost to Follow-up|0|||
125519501|NCT03464383|451533449|FG002|Overall Study|Lost to Follow-up|0|||
125519502|NCT03464383|451533447|FG000|Overall Study|Withdrawal by Subject|0|||
125519503|NCT03464383|451533448|FG001|Overall Study|Withdrawal by Subject|1|||
125519504|NCT03464383|451533449|FG002|Overall Study|Withdrawal by Subject|0|||
125519505|NCT00695136|451533454|FG000|Overall Study|Withdrawal by Subject|1|||
125519506|NCT00695136|451533454|FG000|Overall Study|unrelated adverse event|1|||
125519507|NCT01726049|451533456|FG000|Overall Study|Death|1|||
125519508|NCT01726049|451533457|FG001|Overall Study|Death|1|||
125519509|NCT01726049|451533456|FG000|Overall Study|Adverse Event|4|||
125519510|NCT01726049|451533457|FG001|Overall Study|Adverse Event|1|||
125519511|NCT01726049|451533456|FG000|Overall Study|refused second HC|0|||
125519512|NCT01726049|451533457|FG001|Overall Study|refused second HC|2|||
125519513|NCT02806505|451533459|FG000|Overall Study|Adverse event/intercurrent illness|1|||
125519514|NCT02806505|451533460|FG001|Overall Study|Adverse event/intercurrent illness|3|||
125519515|NCT02806505|451533459|FG000|Overall Study|Death|4|||
125519516|NCT02806505|451533460|FG001|Overall Study|Death|0|||
125519517|NCT02806505|451533459|FG000|Overall Study|Did not cooperate/refused treatment|3|||
125519518|NCT02806505|451533460|FG001|Overall Study|Did not cooperate/refused treatment|3|||
125519519|NCT02806505|451533459|FG000|Overall Study|Failure to return|0|||
125519520|NCT02806505|451533460|FG001|Overall Study|Failure to return|1|||
125519521|NCT02806505|451533459|FG000|Overall Study|Insufficient therapeutic response|2|||
125519522|NCT02806505|451533460|FG001|Overall Study|Insufficient therapeutic response|4|||
125519523|NCT01722045|451533467|FG000|Overall Study|Adverse Event|8|||
125519524|NCT01722045|451533467|FG000|Overall Study|Death|3|||
125519525|NCT01722045|451533467|FG000|Overall Study|Withdrawal by Subject|8|||
125519526|NCT01722045|451533467|FG000|Overall Study|Lost to Follow-up|4|||
125519527|NCT01722045|451533467|FG000|Overall Study|Protocol Deviation|1|||
125519528|NCT01722045|451533467|FG000|Overall Study|Physician Decision|3|||
125519529|NCT01722045|451533467|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
125519530|NCT00263211|451533472|FG000|Overall Study|Death|1|||
125519531|NCT00263211|451533473|FG001|Overall Study|Death|0|||
125519532|NCT00263211|451533472|FG000|Overall Study|Withdrawal by Subject|3|||
125519533|NCT00263211|451533473|FG001|Overall Study|Withdrawal by Subject|0|||
125519534|NCT00263211|451533472|FG000|Overall Study|Protocol Violation|1|||
125519535|NCT00263211|451533473|FG001|Overall Study|Protocol Violation|0|||
125519536|NCT00263211|451533472|FG000|Overall Study|Disease Progression|0|||
125519537|NCT00263211|451533473|FG001|Overall Study|Disease Progression|1|||
125519538|NCT00760513|451533474|FG000|Overall Study|Withdrawal by Subject|5|||
125519539|NCT00760513|451533475|FG001|Overall Study|Withdrawal by Subject|7|||
125519540|NCT00908349|451533478|FG000|Overall Study|Adverse Event|10|||
125519541|NCT00908349|451533478|FG000|Overall Study|Withdrawal by Subject|9|||
125519542|NCT00908349|451533478|FG000|Overall Study|Physician Decision|5|||
125519543|NCT00908349|451533478|FG000|Overall Study|Lost to Follow-up|5|||
125519544|NCT00908349|451533478|FG000|Overall Study|Various|6|||
125519545|NCT03834623|451533482|FG000|Overall Study|Progression|0|||
125519546|NCT03834623|451533483|FG001|Overall Study|Progression|1|||
125519547|NCT01755546|451533484|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
125519548|NCT01755546|451533484|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
125519549|NCT01755546|451533484|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
125519550|NCT01755546|451533484|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
125519551|NCT01755546|451533484|FG000|Titration Phase|Adverse Event|11|||
125519552|NCT01755546|451533484|FG000|Titration Phase|Lack of Efficacy|18|||
125519553|NCT01755546|451533484|FG000|Titration Phase|Protocol Violation|9|||
125519554|NCT01755546|451533484|FG000|Titration Phase|Lost to Follow-up|2|||
125519555|NCT01755546|451533484|FG000|Titration Phase|Other and Continuing|22|||
125519556|NCT01755546|451533484|FG000|Titration Phase|Withdrawal by Subject|8|||
125519557|NCT01755546|451533484|FG000|Long Term Treatment|Adverse Event|12|||
125519558|NCT01755546|451533484|FG000|Long Term Treatment|Lack of Efficacy|6|||
125519559|NCT01755546|451533484|FG000|Long Term Treatment|Protocol Violation|10|||
125519560|NCT01755546|451533484|FG000|Long Term Treatment|Withdrawal by Subject|35|||
125519561|NCT01755546|451533484|FG000|Long Term Treatment|Lost to Follow-up|17|||
125519562|NCT01755546|451533484|FG000|Long Term Treatment|other and ongoing|41|||
125519563|NCT00362375|451533485|FG000|Overall Study|Lost to Follow-up|40|||
125519564|NCT00362375|451533486|FG001|Overall Study|Lost to Follow-up|35|||
125519565|NCT04606199|451533487|FG000|Overall Study|Withdrawal by Subject|2|||
125519566|NCT02624869|451533491|FG000|Overall Study|Lost to Follow-up|0|||
125519567|NCT02624869|451533492|FG001|Overall Study|Lost to Follow-up|0|||
125519568|NCT02624869|451533493|FG002|Overall Study|Lost to Follow-up|1|||
125519569|NCT02624869|451533491|FG000|Overall Study|Withdrawal by Subject|1|||
125519570|NCT02624869|451533492|FG001|Overall Study|Withdrawal by Subject|3|||
125519571|NCT02624869|451533493|FG002|Overall Study|Withdrawal by Subject|1|||
125519572|NCT04051242|451533497|FG000|Overall Study|Withdrawal by Subject|1|||
125519573|NCT04051242|451533497|FG000|Overall Study|Physician Decision|1|||
125519574|NCT00704171|451533498|FG000|Overall Study|Withdrawal by Subject|1|||
125519575|NCT00704171|451533499|FG001|Overall Study|Withdrawal by Subject|0|||
125519576|NCT01874665|451533500|FG000|Overall Study|Adverse Event|6|||
125519577|NCT01874665|451533501|FG001|Overall Study|Adverse Event|2|||
125519578|NCT01874665|451533500|FG000|Overall Study|Withdrawal by Subject|4|||
125519579|NCT01874665|451533501|FG001|Overall Study|Withdrawal by Subject|1|||
125519580|NCT01874665|451533500|FG000|Overall Study|Physician Decision|3|||
125519581|NCT01874665|451533501|FG001|Overall Study|Physician Decision|0|||
125519582|NCT01874665|451533500|FG000|Overall Study|Clinical Progressive Disease|4|||
125519583|NCT01874665|451533501|FG001|Overall Study|Clinical Progressive Disease|3|||
125519584|NCT01874665|451533500|FG000|Overall Study|Study Terminated by Sponsor|0|||
125519585|NCT01874665|451533501|FG001|Overall Study|Study Terminated by Sponsor|2|||
125519586|NCT01874665|451533500|FG000|Overall Study|Documented Progressive Disease|11|||
125519587|NCT01874665|451533501|FG001|Overall Study|Documented Progressive Disease|7|||
125519588|NCT01874665|451533500|FG000|Overall Study|Other|2|||
125519589|NCT01874665|451533501|FG001|Overall Study|Other|0|||
125519590|NCT04962698|451533506|FG000|Motor Imagery|Technical difficulty|1|||
125519591|NCT04962698|451533507|FG001|Motor Imagery|Technical difficulty|0|||
125519592|NCT04962698|451533506|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
125519593|NCT04962698|451533507|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
125519594|NCT04962698|451533506|FG000|Kinesthetic MI|Technical difficulty|1|||
125519595|NCT04962698|451533507|FG001|Kinesthetic MI|Technical difficulty|0|||
125519596|NCT04962698|451533506|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
125519597|NCT04962698|451533507|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
125519598|NCT04962698|451533506|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
125519599|NCT04962698|451533507|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
125519600|NCT04962698|451533506|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
125519601|NCT04962698|451533507|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
125519602|NCT04962698|451533506|FG000|Virtual-hand Interaction|Technical difficulty|1|||
125519603|NCT04962698|451533507|FG001|Virtual-hand Interaction|Technical difficulty|0|||
125519604|NCT04962698|451533506|FG000|Robotic Action Observation|Technical difficulty|1|||
125519605|NCT04962698|451533507|FG001|Robotic Action Observation|Technical difficulty|0|||
125519606|NCT04962698|451533506|FG000|Rest|Technical difficulty|1|||
125519607|NCT04962698|451533507|FG001|Rest|Technical difficulty|0|||
125519608|NCT04962698|451533506|FG000|Rest|Exclusion criteria met after enrollment|0|||
125519609|NCT04962698|451533507|FG001|Rest|Exclusion criteria met after enrollment|2|||
125519610|NCT00853229|451533508|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
125519611|NCT00853229|451533509|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
125519612|NCT03201900|451533510|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
125519613|NCT03201900|451533510|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
125519614|NCT03201900|451533510|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
125519615|NCT03201900|451533510|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
125519616|NCT03201900|451533510|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
125519617|NCT03201900|451533510|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
125519618|NCT03201900|451533510|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
125519619|NCT03201900|451533510|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
125519620|NCT03201900|451533510|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
125519621|NCT03201900|451533510|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
125519622|NCT03201900|451533510|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
125519623|NCT03201900|451533510|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
125519624|NCT03201900|451533510|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
125519625|NCT00776659|451533532|FG000|Overall Study|Lost to Follow-up|15|||
125519626|NCT00776659|451533532|FG000|Overall Study|Withdrawal by Subject|10|||
125519627|NCT00776659|451533532|FG000|Overall Study|Study Terminated by Sponsor|1|||
125519628|NCT01233999|451533533|FG000|Overall Study|Withdrawal by Subject|1|||
125519629|NCT01233999|451533533|FG000|Overall Study|Lost to Follow-up|1|||
125519630|NCT00129649|451533543|FG000|Overall Study|Withdrawal by Subject|76|||
125519631|NCT00129649|451533544|FG001|Overall Study|Withdrawal by Subject|65|||
125519632|NCT02835092|451533545|FG000|Overall Study|Withdrawal by Subject|3|||
125519633|NCT02835092|451533546|FG001|Overall Study|Withdrawal by Subject|6|||
125519634|NCT02835092|451533547|FG002|Overall Study|Withdrawal by Subject|3|||
125519635|NCT02835092|451533545|FG000|Overall Study|Lost to Follow-up|0|||
125519636|NCT02835092|451533546|FG001|Overall Study|Lost to Follow-up|2|||
125519637|NCT02835092|451533547|FG002|Overall Study|Lost to Follow-up|0|||
125519638|NCT00025506|451533549|FG000|Overall Study|Ineligible: clerical error|1|||
125519639|NCT00025506|451533549|FG000|Overall Study|Ineligible: wrong cell type|5|||
125519640|NCT00025506|451533549|FG000|Overall Study|Ineligible: inadequate pathology|2|||
125519641|NCT00025506|451533549|FG000|Overall Study|Never Treated|2|||
125519642|NCT01321723|451533550|FG000|Overall Study|Adverse Event|3|||
125519643|NCT01321723|451533551|FG001|Overall Study|Adverse Event|5|||
125519644|NCT01321723|451533552|FG002|Overall Study|Adverse Event|2|||
125519645|NCT01321723|451533550|FG000|Overall Study|Withdrawal by Subject|2|||
125519646|NCT01321723|451533551|FG001|Overall Study|Withdrawal by Subject|0|||
125519647|NCT01321723|451533552|FG002|Overall Study|Withdrawal by Subject|2|||
125519648|NCT00713206|451533553|FG000|Overall Study|Lost to Follow-up|4|||
125519649|NCT00713206|451533554|FG001|Overall Study|Lost to Follow-up|4|||
125519650|NCT00713206|451533553|FG000|Overall Study|Death|1|||
125519651|NCT00713206|451533554|FG001|Overall Study|Death|0|||
125519652|NCT02561806|451533555|FG000|Induction Period|Adverse Event|0|||
125519653|NCT02561806|451533556|FG001|Induction Period|Adverse Event|2|||
125519654|NCT02561806|451533555|FG000|Induction Period|Lack of Efficacy|1|||
125519655|NCT02561806|451533556|FG001|Induction Period|Lack of Efficacy|0|||
125519656|NCT02561806|451533555|FG000|Induction Period|Withdrawal by Subject|0|||
125519657|NCT02561806|451533556|FG001|Induction Period|Withdrawal by Subject|2|||
125519658|NCT02561806|451533555|FG000|Induction Period|Site staff became unblinded|1|||
125519659|NCT02561806|451533556|FG001|Induction Period|Site staff became unblinded|0|||
125519660|NCT02561806|451533555|FG000|Induction Period|Randomized but not treated|0|||
125519661|NCT02561806|451533556|FG001|Induction Period|Randomized but not treated|1|||
125519662|NCT02561806|451533555|FG000|Maintenance Period|Adverse Event|2|||
125519663|NCT02561806|451533556|FG001|Maintenance Period|Adverse Event|1|||
125519664|NCT02561806|451533555|FG000|Maintenance Period|Lack of Efficacy|3|||
125519665|NCT02561806|451533556|FG001|Maintenance Period|Lack of Efficacy|1|||
125519666|NCT02561806|451533555|FG000|Maintenance Period|Lost to Follow-up|2|||
125519667|NCT02561806|451533556|FG001|Maintenance Period|Lost to Follow-up|2|||
125519668|NCT02561806|451533555|FG000|Maintenance Period|Protocol Violation|1|||
125519669|NCT02561806|451533556|FG001|Maintenance Period|Protocol Violation|0|||
125519670|NCT02561806|451533555|FG000|Maintenance Period|Withdrawal by Subject|5|||
125519671|NCT02561806|451533556|FG001|Maintenance Period|Withdrawal by Subject|3|||
125519672|NCT02561806|451533555|FG000|Maintenance Period|Site staff became unblinded|0|||
125519673|NCT02561806|451533556|FG001|Maintenance Period|Site staff became unblinded|1|||
125519674|NCT02561806|451533555|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
125519675|NCT02561806|451533556|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
125519676|NCT02561806|451533555|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
125519677|NCT02561806|451533556|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
125519678|NCT02547441|451533557|FG000|Double-Blind Study Period|Adverse Event|4|||
125519679|NCT02547441|451533558|FG001|Double-Blind Study Period|Adverse Event|9|||
125519680|NCT02547441|451533557|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
125519681|NCT02547441|451533558|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
125519682|NCT02547441|451533557|FG000|Double-Blind Study Period|Physician Decision|1|||
125519683|NCT02547441|451533558|FG001|Double-Blind Study Period|Physician Decision|0|||
125519684|NCT02547441|451533557|FG000|Double-Blind Study Period|Protocol Violation|1|||
125519685|NCT02547441|451533558|FG001|Double-Blind Study Period|Protocol Violation|2|||
125519686|NCT02547441|451533557|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
125519687|NCT02547441|451533558|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
125519688|NCT02547441|451533557|FG000|Double-Blind Study Period|Sponsor Decision|1|||
125519689|NCT02547441|451533558|FG001|Double-Blind Study Period|Sponsor Decision|0|||
125519690|NCT02547441|451533557|FG000|Open-Label Study Period|Adverse Event|10|||
125519691|NCT02547441|451533558|FG001|Open-Label Study Period|Adverse Event|11|||
125519692|NCT02547441|451533557|FG000|Open-Label Study Period|Lack of Efficacy|3|||
125519693|NCT02547441|451533558|FG001|Open-Label Study Period|Lack of Efficacy|2|||
125519694|NCT02547441|451533557|FG000|Open-Label Study Period|Lost to Follow-up|7|||
125519695|NCT02547441|451533558|FG001|Open-Label Study Period|Lost to Follow-up|8|||
125519696|NCT02547441|451533557|FG000|Open-Label Study Period|Physician Decision|1|||
125519697|NCT02547441|451533558|FG001|Open-Label Study Period|Physician Decision|0|||
125519698|NCT02547441|451533557|FG000|Open-Label Study Period|Protocol Violation|2|||
125519699|NCT02547441|451533558|FG001|Open-Label Study Period|Protocol Violation|0|||
125519700|NCT02547441|451533557|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
125519701|NCT02547441|451533558|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
125519702|NCT02547441|451533557|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
125519703|NCT02547441|451533558|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
125519704|NCT01322009|451533560|FG000|Overall Study|Death|0|||
125519705|NCT01322009|451533561|FG001|Overall Study|Death|1|||
125519706|NCT01322009|451533560|FG000|Overall Study|Adverse Event|0|||
125519707|NCT01322009|451533561|FG001|Overall Study|Adverse Event|1|||
125519708|NCT01322009|451533560|FG000|Overall Study|ng tube discontinued|0|||
125519709|NCT01322009|451533561|FG001|Overall Study|ng tube discontinued|1|||
125519710|NCT01657877|451533562|FG000|Overall Study|Withdrawal by Subject|4|||
125519711|NCT01657877|451533562|FG000|Overall Study|Protocol Violation|6|||
125519712|NCT01657877|451533562|FG000|Overall Study|Adverse Event|2|||
125519713|NCT01657877|451533562|FG000|Overall Study|Other Reason|2|||
125519714|NCT00905034|451533563|FG000|Overall Study|Withdrawal by Subject|1|||
125519715|NCT00394589|451533564|FG000|Overall Study|Adverse Event|2|||
125519716|NCT00394589|451533565|FG001|Overall Study|Adverse Event|1|||
125519717|NCT00394589|451533566|FG002|Overall Study|Adverse Event|2|||
125519718|NCT00394589|451533564|FG000|Overall Study|Lack of Efficacy|2|||
125519719|NCT00394589|451533565|FG001|Overall Study|Lack of Efficacy|2|||
125519720|NCT00394589|451533566|FG002|Overall Study|Lack of Efficacy|3|||
125519721|NCT00394589|451533564|FG000|Overall Study|Protocol Violation|4|||
125519722|NCT00394589|451533565|FG001|Overall Study|Protocol Violation|0|||
125519723|NCT00394589|451533566|FG002|Overall Study|Protocol Violation|2|||
125519724|NCT04081389|451533567|FG000|Overall Study|Withdrawal by Subject|0|||
125519725|NCT04081389|451533568|FG001|Overall Study|Withdrawal by Subject|0|||
125519726|NCT04081389|451533569|FG002|Overall Study|Withdrawal by Subject|1|||
125519727|NCT04081389|451533570|FG003|Overall Study|Withdrawal by Subject|0|||
125519728|NCT01710800|451533571|FG000|Overall Study|Withdrawal by Subject|21|||
125519729|NCT01710800|451533571|FG000|Overall Study|Protocol Violation|1|||
125519730|NCT02872311|451533575|FG000|Overall Study|Death|2|||
125519731|NCT02872311|451533576|FG001|Overall Study|Death|0|||
125519732|NCT02872311|451533577|FG002|Overall Study|Death|0|||
125519733|NCT02872311|451533578|FG003|Overall Study|Death|0|||
125519734|NCT02872311|451533579|FG004|Overall Study|Death|0|||
125519735|NCT02872311|451533575|FG000|Overall Study|Lost to Follow-up|2|||
125519736|NCT02872311|451533576|FG001|Overall Study|Lost to Follow-up|0|||
125519737|NCT02872311|451533577|FG002|Overall Study|Lost to Follow-up|0|||
125519738|NCT02872311|451533578|FG003|Overall Study|Lost to Follow-up|0|||
125519739|NCT02872311|451533579|FG004|Overall Study|Lost to Follow-up|0|||
125519740|NCT02872311|451533575|FG000|Overall Study|Protocol Violation|0|||
125519741|NCT02872311|451533576|FG001|Overall Study|Protocol Violation|2|||
125519742|NCT02872311|451533577|FG002|Overall Study|Protocol Violation|1|||
125519743|NCT02872311|451533578|FG003|Overall Study|Protocol Violation|0|||
125519744|NCT02872311|451533579|FG004|Overall Study|Protocol Violation|0|||
125519745|NCT00511797|451533580|FG000|Overall Study|Adverse Event|1|||
125519746|NCT00511797|451533581|FG001|Overall Study|Adverse Event|2|||
125519747|NCT00511797|451533582|FG002|Overall Study|Adverse Event|2|||
125519748|NCT00511797|451533583|FG003|Overall Study|Adverse Event|2|||
125519749|NCT00511797|451533580|FG000|Overall Study|Lost to Follow-up|1|||
125519750|NCT00511797|451533581|FG001|Overall Study|Lost to Follow-up|0|||
125519751|NCT00511797|451533582|FG002|Overall Study|Lost to Follow-up|0|||
125519752|NCT00511797|451533583|FG003|Overall Study|Lost to Follow-up|1|||
125519753|NCT00511797|451533580|FG000|Overall Study|Pregnancy|0|||
125519754|NCT00511797|451533581|FG001|Overall Study|Pregnancy|0|||
125519755|NCT00511797|451533582|FG002|Overall Study|Pregnancy|0|||
125519756|NCT00511797|451533583|FG003|Overall Study|Pregnancy|1|||
125519757|NCT00511797|451533580|FG000|Overall Study|Protocol Violation|0|||
125519758|NCT00511797|451533581|FG001|Overall Study|Protocol Violation|2|||
125519759|NCT00511797|451533582|FG002|Overall Study|Protocol Violation|2|||
125519760|NCT00511797|451533583|FG003|Overall Study|Protocol Violation|3|||
125519761|NCT00511797|451533580|FG000|Overall Study|Withdrawal by Subject|3|||
125519762|NCT00511797|451533581|FG001|Overall Study|Withdrawal by Subject|3|||
125519763|NCT00511797|451533582|FG002|Overall Study|Withdrawal by Subject|4|||
125519764|NCT00511797|451533583|FG003|Overall Study|Withdrawal by Subject|2|||
125519765|NCT00511797|451533580|FG000|Overall Study|Never dispensed|1|||
125519766|NCT00511797|451533581|FG001|Overall Study|Never dispensed|0|||
125519767|NCT00511797|451533582|FG002|Overall Study|Never dispensed|1|||
125519768|NCT00511797|451533583|FG003|Overall Study|Never dispensed|3|||
125519769|NCT00511797|451533580|FG000|Overall Study|Study drug not taken|0|||
125519770|NCT00511797|451533581|FG001|Overall Study|Study drug not taken|1|||
125519771|NCT00511797|451533582|FG002|Overall Study|Study drug not taken|0|||
125519772|NCT00511797|451533583|FG003|Overall Study|Study drug not taken|1|||
125519773|NCT00511797|451533580|FG000|Overall Study|Partially missing diary|0|||
125519774|NCT00511797|451533581|FG001|Overall Study|Partially missing diary|0|||
125519775|NCT00511797|451533582|FG002|Overall Study|Partially missing diary|1|||
125519776|NCT00511797|451533583|FG003|Overall Study|Partially missing diary|0|||
125519777|NCT00511797|451533580|FG000|Overall Study|Other (moving etc)|1|||
125519778|NCT00511797|451533581|FG001|Overall Study|Other (moving etc)|0|||
125519779|NCT00511797|451533582|FG002|Overall Study|Other (moving etc)|1|||
125519780|NCT00511797|451533583|FG003|Overall Study|Other (moving etc)|2|||
125519781|NCT02019641|451533584|FG000|10-Week Follow up|Withdrawal by investigator|2|||
125519782|NCT02019641|451533585|FG001|10-Week Follow up|Withdrawal by investigator|0|||
125519783|NCT02019641|451533586|FG002|10-Week Follow up|Withdrawal by investigator|0|||
125519784|NCT02019641|451533584|FG000|10-Week Follow up|Withdrawal by Subject|1|||
125519785|NCT02019641|451533585|FG001|10-Week Follow up|Withdrawal by Subject|1|||
125519786|NCT02019641|451533586|FG002|10-Week Follow up|Withdrawal by Subject|0|||
125519787|NCT02019641|451533584|FG000|20-Week Follow up|Withdrawal by investigator|0|||
125519788|NCT02019641|451533585|FG001|20-Week Follow up|Withdrawal by investigator|0|||
125519789|NCT02019641|451533586|FG002|20-Week Follow up|Withdrawal by investigator|1|||
125519790|NCT01560871|451533589|FG000|Overall Study|transportation issues|2|||
125519791|NCT01560871|451533590|FG001|Overall Study|transportation issues|1|||
125519792|NCT01560871|451533589|FG000|Overall Study|relocation|1|||
125519793|NCT01560871|451533590|FG001|Overall Study|relocation|0|||
125519794|NCT01560871|451533589|FG000|Overall Study|readmission to a hospital|2|||
125519795|NCT01560871|451533590|FG001|Overall Study|readmission to a hospital|1|||
125519796|NCT01560871|451533589|FG000|Overall Study|Lost to Follow-up|1|||
125519797|NCT01560871|451533590|FG001|Overall Study|Lost to Follow-up|0|||
125519798|NCT00591591|451533593|FG000|Overall Study|Withdrawal by Subject|1|||
125519799|NCT00591591|451533594|FG001|Overall Study|Withdrawal by Subject|37|||
125519800|NCT00591591|451533593|FG000|Overall Study|Lack of Efficacy|10|||
125519801|NCT00591591|451533594|FG001|Overall Study|Lack of Efficacy|2|||
125519802|NCT00461123|451533598|FG000|Overall Study|Adverse Event|1|||
125519803|NCT00461123|451533599|FG001|Overall Study|Adverse Event|0|||
125519804|NCT00461123|451533598|FG000|Overall Study|Lost to Follow-up|1|||
125519805|NCT00461123|451533599|FG001|Overall Study|Lost to Follow-up|1|||
125519806|NCT00461123|451533598|FG000|Overall Study|Protocol Violation|3|||
125519807|NCT00461123|451533599|FG001|Overall Study|Protocol Violation|2|||
125519808|NCT00461123|451533598|FG000|Overall Study|Withdrawal by Subject|1|||
125519809|NCT00461123|451533599|FG001|Overall Study|Withdrawal by Subject|3|||
125519810|NCT03605368|451533600|FG000|Overall Study|Lost to Follow-up|2|||
125519811|NCT03605368|451533601|FG001|Overall Study|Lost to Follow-up|1|||
125519812|NCT03605368|451533602|FG002|Overall Study|Lost to Follow-up|3|||
125519813|NCT03605368|451533603|FG003|Overall Study|Lost to Follow-up|2|||
125519814|NCT03605368|451533600|FG000|Overall Study|Withdrawal by Subject|0|||
125519815|NCT03605368|451533601|FG001|Overall Study|Withdrawal by Subject|0|||
125519816|NCT03605368|451533602|FG002|Overall Study|Withdrawal by Subject|4|||
125519817|NCT03605368|451533603|FG003|Overall Study|Withdrawal by Subject|3|||
125519818|NCT00514813|451533606|FG000|Overall Study|Study terminated|14|||
125519819|NCT00514813|451533607|FG001|Overall Study|Study terminated|74|||
125519820|NCT00514813|451533608|FG002|Overall Study|Study terminated|40|||
125519821|NCT00514813|451533609|FG003|Overall Study|Study terminated|2|||
125519822|NCT00514813|451533606|FG000|Overall Study|Adverse Event|0|||
125519823|NCT00514813|451533607|FG001|Overall Study|Adverse Event|2|||
125519824|NCT00514813|451533608|FG002|Overall Study|Adverse Event|2|||
125519825|NCT00514813|451533609|FG003|Overall Study|Adverse Event|0|||
125519826|NCT00514813|451533606|FG000|Overall Study|Protocol Violation|1|||
125519827|NCT00514813|451533607|FG001|Overall Study|Protocol Violation|0|||
125519828|NCT00514813|451533608|FG002|Overall Study|Protocol Violation|0|||
125519829|NCT00514813|451533609|FG003|Overall Study|Protocol Violation|0|||
125519830|NCT00514813|451533606|FG000|Overall Study|Withdrawal by Subject|0|||
125519831|NCT00514813|451533607|FG001|Overall Study|Withdrawal by Subject|1|||
125519832|NCT00514813|451533608|FG002|Overall Study|Withdrawal by Subject|0|||
125519833|NCT00514813|451533609|FG003|Overall Study|Withdrawal by Subject|0|||
125519834|NCT00514813|451533606|FG000|Overall Study|Lack of Efficacy|0|||
125519835|NCT00514813|451533607|FG001|Overall Study|Lack of Efficacy|1|||
125519836|NCT00514813|451533608|FG002|Overall Study|Lack of Efficacy|0|||
125519837|NCT00514813|451533609|FG003|Overall Study|Lack of Efficacy|0|||
125519838|NCT00514813|451533606|FG000|Overall Study|Kidney transplant|0|||
125519839|NCT00514813|451533607|FG001|Overall Study|Kidney transplant|6|||
125519840|NCT00514813|451533608|FG002|Overall Study|Kidney transplant|2|||
125519841|NCT00514813|451533609|FG003|Overall Study|Kidney transplant|0|||
125519842|NCT00514813|451533606|FG000|Overall Study|Death|0|||
125519843|NCT00514813|451533607|FG001|Overall Study|Death|2|||
125519844|NCT00514813|451533608|FG002|Overall Study|Death|3|||
125519845|NCT00514813|451533609|FG003|Overall Study|Death|2|||
125519846|NCT02979613|451533610|FG000|Double-Blind Phase|Withdrew Consent|2|||
125519847|NCT02979613|451533611|FG001|Double-Blind Phase|Withdrew Consent|4|||
125519848|NCT02979613|451533610|FG000|Double-Blind Phase|Pregnancy|2|||
125519849|NCT02979613|451533611|FG001|Double-Blind Phase|Pregnancy|2|||
125519850|NCT02979613|451533610|FG000|Double-Blind Phase|Adverse Event|2|||
125519851|NCT02979613|451533611|FG001|Double-Blind Phase|Adverse Event|0|||
125519852|NCT02979613|451533610|FG000|Double-Blind Phase|Lost to Follow-up|1|||
125519853|NCT02979613|451533611|FG001|Double-Blind Phase|Lost to Follow-up|1|||
125519854|NCT02979613|451533610|FG000|Double-Blind Phase|Protocol Violation|1|||
125519855|NCT02979613|451533611|FG001|Double-Blind Phase|Protocol Violation|1|||
125519856|NCT02979613|451533610|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
125519857|NCT02979613|451533611|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
125519858|NCT02979613|451533610|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
125519859|NCT02979613|451533611|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
125519860|NCT02979613|451533610|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
125519861|NCT02979613|451533611|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
125519862|NCT02979613|451533610|FG000|Open-Label Extension (OLE) Phase|Death|0|||
125519863|NCT02979613|451533611|FG001|Open-Label Extension (OLE) Phase|Death|1|||
125519864|NCT02979613|451533610|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
125519865|NCT02979613|451533611|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
125519866|NCT01075100|451533612|FG000|Overall Study|Adverse Event|15|||
125519867|NCT01075100|451533613|FG001|Overall Study|Adverse Event|18|||
125519868|NCT01075100|451533612|FG000|Overall Study|Patient Request|4|||
125519869|NCT01075100|451533613|FG001|Overall Study|Patient Request|4|||
125519870|NCT01075100|451533612|FG000|Overall Study|Investigator Request|2|||
125519871|NCT01075100|451533613|FG001|Overall Study|Investigator Request|1|||
125519872|NCT01075100|451533612|FG000|Overall Study|Disease Progression|25|||
125519873|NCT01075100|451533613|FG001|Overall Study|Disease Progression|29|||
125519874|NCT01075100|451533612|FG000|Overall Study|Other|3|||
125519875|NCT01075100|451533613|FG001|Overall Study|Other|1|||
125519876|NCT02250183|451533614|FG000|Overall Study|Withdrawal by Subject|2|||
125519877|NCT02250183|451533614|FG000|Overall Study|Adverse Event|5|||
125519878|NCT02250183|451533614|FG000|Overall Study|Lost to Follow-up|1|||
125519879|NCT00092521|451535349|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
125519880|NCT00092521|451535350|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
125519881|NCT00092521|451535351|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
125519882|NCT00092521|451535352|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
125519883|NCT00092521|451535349|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
125519884|NCT00092521|451535350|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
125519885|NCT00092521|451535351|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
125519886|NCT00092521|451535352|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
125519887|NCT00092521|451535349|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
125519888|NCT00092521|451535350|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
125519889|NCT00092521|451535351|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
125519890|NCT00092521|451535352|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
125519891|NCT00092521|451535349|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
125519892|NCT00092521|451535350|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
125519893|NCT00092521|451535351|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
125519894|NCT00092521|451535352|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
125519895|NCT00092521|451535349|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
125519896|NCT00092521|451535350|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
125519897|NCT00092521|451535351|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
125519898|NCT00092521|451535352|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
125519899|NCT00092521|451535349|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
125519900|NCT00092521|451535350|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
125519901|NCT00092521|451535351|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
125519902|NCT00092521|451535352|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
125519903|NCT00092521|451535349|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
125519904|NCT00092521|451535350|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
125519905|NCT00092521|451535351|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
125519906|NCT00092521|451535352|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
125519907|NCT00092521|451535349|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
125519908|NCT00092521|451535350|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
125519909|NCT00092521|451535351|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
125519910|NCT00092521|451535352|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
125519911|NCT00092521|451535349|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
125519912|NCT00092521|451535350|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
125519913|NCT00092521|451535351|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
125519914|NCT00092521|451535352|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
125519915|NCT00092521|451535349|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
125519916|NCT00092521|451535350|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
125519917|NCT00092521|451535351|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
125519918|NCT00092521|451535352|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
125519919|NCT00092521|451535349|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
125519920|NCT00092521|451535350|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
125519921|NCT00092521|451535351|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
125519922|NCT00092521|451535352|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
125519923|NCT00092521|451535349|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
125519924|NCT00092521|451535350|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
125519925|NCT00092521|451535351|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
125519926|NCT00092521|451535352|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
125519927|NCT00092521|451535349|FG000|Follow-Up (After Month 7)|Death|2|||
125519928|NCT00092521|451535350|FG001|Follow-Up (After Month 7)|Death|0|||
125519929|NCT00092521|451535351|FG002|Follow-Up (After Month 7)|Death|1|||
125519930|NCT00092521|451535352|FG003|Follow-Up (After Month 7)|Death|0|||
125519931|NCT00092521|451535349|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
125519932|NCT00092521|451535350|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
125519933|NCT00092521|451535351|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
125519934|NCT00092521|451535352|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
125519935|NCT00092521|451535349|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
125519936|NCT00092521|451535350|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
125519937|NCT00092521|451535351|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
125519938|NCT00092521|451535352|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
125519939|NCT00092521|451535349|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
125519940|NCT00092521|451535350|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
125519941|NCT00092521|451535351|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
125519942|NCT00092521|451535352|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
125519943|NCT00092521|451535349|FG000|Follow-Up (After Month 7)|Moved|32|||
125519944|NCT00092521|451535350|FG001|Follow-Up (After Month 7)|Moved|2|||
125519945|NCT00092521|451535351|FG002|Follow-Up (After Month 7)|Moved|28|||
125519946|NCT00092521|451535352|FG003|Follow-Up (After Month 7)|Moved|0|||
125519947|NCT00092521|451535349|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
125519948|NCT00092521|451535350|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
125519949|NCT00092521|451535351|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
125519950|NCT00092521|451535352|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
125519951|NCT00092521|451535349|FG000|Follow-Up (After Month 7)|Travel|2|||
125519952|NCT00092521|451535350|FG001|Follow-Up (After Month 7)|Travel|0|||
125519953|NCT00092521|451535351|FG002|Follow-Up (After Month 7)|Travel|0|||
125519954|NCT00092521|451535352|FG003|Follow-Up (After Month 7)|Travel|0|||
125519955|NCT00092521|451535349|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
125519956|NCT00092521|451535350|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
125519957|NCT00092521|451535351|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
125519958|NCT00092521|451535352|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
125519959|NCT00092521|451535349|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
125519960|NCT00092521|451535350|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
125519961|NCT00092521|451535351|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
125519962|NCT00092521|451535352|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
125519963|NCT00092521|451535349|FG000|Extension Study (Group 4)|Adverse Event|0|||
125519964|NCT00092521|451535350|FG001|Extension Study (Group 4)|Adverse Event|0|||
125519965|NCT00092521|451535351|FG002|Extension Study (Group 4)|Adverse Event|0|||
125519966|NCT00092521|451535352|FG003|Extension Study (Group 4)|Adverse Event|2|||
125519967|NCT00092521|451535349|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
125519968|NCT00092521|451535350|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
125519969|NCT00092521|451535351|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
125519970|NCT00092521|451535352|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
125519971|NCT00092521|451535349|FG000|Extension Study (Group 4)|Pregnancy|0|||
125519972|NCT00092521|451535350|FG001|Extension Study (Group 4)|Pregnancy|0|||
125519973|NCT00092521|451535351|FG002|Extension Study (Group 4)|Pregnancy|0|||
125519974|NCT00092521|451535352|FG003|Extension Study (Group 4)|Pregnancy|4|||
125519975|NCT00092521|451535349|FG000|Extension Study (Group 4)|Protocol Violation|0|||
125519976|NCT00092521|451535350|FG001|Extension Study (Group 4)|Protocol Violation|0|||
125519977|NCT00092521|451535351|FG002|Extension Study (Group 4)|Protocol Violation|0|||
125519978|NCT00092521|451535352|FG003|Extension Study (Group 4)|Protocol Violation|2|||
125519979|NCT00092521|451535349|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
125519980|NCT00092521|451535350|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
125519981|NCT00092521|451535351|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
125519982|NCT00092521|451535352|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
125519983|NCT00092521|451535349|FG000|Extension Study (Group 4)|Moved|0|||
125519984|NCT00092521|451535350|FG001|Extension Study (Group 4)|Moved|0|||
125519985|NCT00092521|451535351|FG002|Extension Study (Group 4)|Moved|0|||
125519986|NCT00092521|451535352|FG003|Extension Study (Group 4)|Moved|16|||
125519987|NCT00092521|451535349|FG000|Extension Study (Group 4)|Site Terminated|0|||
125519988|NCT00092521|451535350|FG001|Extension Study (Group 4)|Site Terminated|0|||
125519989|NCT00092521|451535351|FG002|Extension Study (Group 4)|Site Terminated|0|||
125519990|NCT00092521|451535352|FG003|Extension Study (Group 4)|Site Terminated|4|||
125519991|NCT00092521|451535349|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
125519992|NCT00092521|451535350|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
125519993|NCT00092521|451535351|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
125519994|NCT00092521|451535352|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
125519995|NCT03475056|451535353|FG000|Overall Study|Lost to Follow-up|0|||
125519996|NCT03475056|451535354|FG001|Overall Study|Lost to Follow-up|1|||
125519997|NCT03475056|451535353|FG000|Overall Study|Moved from Area|0|||
125519998|NCT03475056|451535354|FG001|Overall Study|Moved from Area|2|||
125519999|NCT01932762|451535355|FG000|Overall Study|Withdrawal by Subject|1|||
125520000|NCT01932762|451535356|FG001|Overall Study|Withdrawal by Subject|2|||
125520001|NCT01932762|451535357|FG002|Overall Study|Withdrawal by Subject|0|||
125520002|NCT01932762|451535358|FG003|Overall Study|Withdrawal by Subject|0|||
125520003|NCT01932762|451535355|FG000|Overall Study|Lost to Follow-up|4|||
125520004|NCT01932762|451535356|FG001|Overall Study|Lost to Follow-up|0|||
125520005|NCT01932762|451535357|FG002|Overall Study|Lost to Follow-up|0|||
125520006|NCT01932762|451535358|FG003|Overall Study|Lost to Follow-up|1|||
125520007|NCT01932762|451535355|FG000|Overall Study|Physician Decision|1|||
125520008|NCT01932762|451535356|FG001|Overall Study|Physician Decision|0|||
125520009|NCT01932762|451535357|FG002|Overall Study|Physician Decision|0|||
125520010|NCT01932762|451535358|FG003|Overall Study|Physician Decision|0|||
125520011|NCT01101334|451535362|FG000|Overall Study|Adverse Event|9|||
125520012|NCT01101334|451535363|FG001|Overall Study|Adverse Event|4|||
125520013|NCT01101334|451535362|FG000|Overall Study|Death|7|||
125520014|NCT01101334|451535363|FG001|Overall Study|Death|1|||
125520015|NCT01101334|451535362|FG000|Overall Study|Withdrawal by Subject|4|||
125520016|NCT01101334|451535363|FG001|Overall Study|Withdrawal by Subject|3|||
125520017|NCT01101334|451535362|FG000|Overall Study|Withdrawal by Sponsor|1|||
125520018|NCT01101334|451535363|FG001|Overall Study|Withdrawal by Sponsor|1|||
125520019|NCT01101334|451535362|FG000|Overall Study|Progressive Disease|22|||
125520020|NCT01101334|451535363|FG001|Overall Study|Progressive Disease|35|||
125520021|NCT01101334|451535362|FG000|Overall Study|Other|2|||
125520022|NCT01101334|451535363|FG001|Overall Study|Other|1|||
125520023|NCT03864341|451535366|FG000|Overall Study|Withdrawal by Subject|1|||
125520024|NCT02826798|451535368|FG000|Overall Study|Withdrawal by Subject|0|||
125520025|NCT02826798|451535369|FG001|Overall Study|Withdrawal by Subject|1|||
125520026|NCT02826798|451535370|FG002|Overall Study|Withdrawal by Subject|0|||
125520027|NCT02826798|451535371|FG003|Overall Study|Withdrawal by Subject|1|||
125520028|NCT02826798|451535372|FG004|Overall Study|Withdrawal by Subject|0|||
125520029|NCT00612352|451535375|FG000|Overall Study|Adverse Event|1|||
125520030|NCT00612352|451535376|FG001|Overall Study|Adverse Event|0|||
125520031|NCT00612352|451535375|FG000|Overall Study|Withdrawal by Subject|3|||
125520032|NCT00612352|451535376|FG001|Overall Study|Withdrawal by Subject|5|||
125520033|NCT00612352|451535375|FG000|Overall Study|moved out of state|1|||
125520034|NCT00612352|451535376|FG001|Overall Study|moved out of state|0|||
125520035|NCT00612352|451535375|FG000|Overall Study|didn't return calls/show up on test date|4|||
125520036|NCT00612352|451535376|FG001|Overall Study|didn't return calls/show up on test date|1|||
125520037|NCT02161406|451535377|FG000|Overall Study|Death|2|||
125520038|NCT02161406|451535378|FG001|Overall Study|Death|1|||
125520039|NCT02161406|451535377|FG000|Overall Study|Lost to Follow-up|2|||
125520040|NCT02161406|451535378|FG001|Overall Study|Lost to Follow-up|1|||
125520041|NCT02161406|451535377|FG000|Overall Study|Withdrawal by Subject|2|||
125520042|NCT02161406|451535378|FG001|Overall Study|Withdrawal by Subject|4|||
125520043|NCT02161406|451535377|FG000|Overall Study|investigator withdrew subject|3|||
125520044|NCT02161406|451535378|FG001|Overall Study|investigator withdrew subject|1|||
125520045|NCT02161406|451535377|FG000|Overall Study|Lack of Efficacy|1|||
125520046|NCT02161406|451535378|FG001|Overall Study|Lack of Efficacy|1|||
125520047|NCT02161406|451535377|FG000|Overall Study|relocation|0|||
125520048|NCT02161406|451535378|FG001|Overall Study|relocation|1|||
125520049|NCT02034162|451535379|FG000|Double-blind|Lost to Follow-up|3|||
125520050|NCT02034162|451535380|FG001|Double-blind|Lost to Follow-up|0|||
125520051|NCT02034162|451535381|FG002|Double-blind|Lost to Follow-up|0|||
125520052|NCT02034162|451535379|FG000|Double-blind|Physician Decision|1|||
125520053|NCT02034162|451535380|FG001|Double-blind|Physician Decision|0|||
125520054|NCT02034162|451535381|FG002|Double-blind|Physician Decision|0|||
125520055|NCT02034162|451535379|FG000|Double-blind|Protocol Violation|0|||
125520056|NCT02034162|451535380|FG001|Double-blind|Protocol Violation|1|||
125520057|NCT02034162|451535381|FG002|Double-blind|Protocol Violation|0|||
125520058|NCT02034162|451535379|FG000|Double-blind|Withdrawal by Subject|5|||
125520059|NCT02034162|451535380|FG001|Double-blind|Withdrawal by Subject|7|||
125520060|NCT02034162|451535381|FG002|Double-blind|Withdrawal by Subject|0|||
125520061|NCT03458728|451535383|FG000|Overall Study|Adverse Event|1|||
125520062|NCT03458728|451535384|FG001|Overall Study|Adverse Event|0|||
125520063|NCT03458728|451535383|FG000|Overall Study|Physician Decision|1|||
125520064|NCT03458728|451535384|FG001|Overall Study|Physician Decision|0|||
125520065|NCT03458728|451535383|FG000|Overall Study|Progressive disease - clinical assessment|1|||
125520066|NCT03458728|451535384|FG001|Overall Study|Progressive disease - clinical assessment|0|||
125520067|NCT03458728|451535383|FG000|Overall Study|Progressive disease - radiological progression|21|||
125520068|NCT03458728|451535384|FG001|Overall Study|Progressive disease - radiological progression|6|||
125520069|NCT03458728|451535383|FG000|Overall Study|Withdrawal by Subject|0|||
125520070|NCT03458728|451535384|FG001|Overall Study|Withdrawal by Subject|1|||
125520071|NCT01951378|451535385|FG000|Overall Study|Study Terminated-Not completed|23|||
125520072|NCT01951378|451535386|FG001|Overall Study|Study Terminated-Not completed|17|||
125520073|NCT01660256|451535388|FG000|Overall Study|Adverse Event|4|||
125520074|NCT01660256|451535389|FG001|Overall Study|Adverse Event|0|||
125520075|NCT01660256|451535390|FG002|Overall Study|Adverse Event|2|||
125520076|NCT01660256|451535388|FG000|Overall Study|Withdrawal by Subject|1|||
125520077|NCT01660256|451535389|FG001|Overall Study|Withdrawal by Subject|0|||
125520078|NCT01660256|451535390|FG002|Overall Study|Withdrawal by Subject|2|||
125520079|NCT03491215|451535391|FG000|Overall Study|Death|6|||
125520080|NCT03491215|451535392|FG001|Overall Study|Death|2|||
125520081|NCT03491215|451535393|FG002|Overall Study|Death|1|||
125520082|NCT03491215|451535394|FG003|Overall Study|Death|0|||
125520083|NCT03491215|451535391|FG000|Overall Study|Physician Decision|1|||
125520084|NCT03491215|451535392|FG001|Overall Study|Physician Decision|0|||
125520085|NCT03491215|451535393|FG002|Overall Study|Physician Decision|0|||
125520086|NCT03491215|451535394|FG003|Overall Study|Physician Decision|0|||
125520087|NCT00551135|451535400|FG000|Overall Study|Adverse Event|1|||
125520088|NCT00551135|451535401|FG001|Overall Study|Adverse Event|0|||
125520089|NCT00551135|451535402|FG002|Overall Study|Adverse Event|1|||
125520090|NCT00551135|451535403|FG003|Overall Study|Adverse Event|1|||
125520091|NCT00551135|451535400|FG000|Overall Study|Lost to Follow-up|0|||
125520092|NCT00551135|451535401|FG001|Overall Study|Lost to Follow-up|0|||
125520093|NCT00551135|451535402|FG002|Overall Study|Lost to Follow-up|0|||
125520094|NCT00551135|451535403|FG003|Overall Study|Lost to Follow-up|1|||
125520095|NCT00551135|451535400|FG000|Overall Study|Other|3|||
125520096|NCT00551135|451535401|FG001|Overall Study|Other|2|||
125520097|NCT00551135|451535402|FG002|Overall Study|Other|1|||
125520098|NCT00551135|451535403|FG003|Overall Study|Other|2|||
125520099|NCT00551135|451535400|FG000|Overall Study|Withdrawal by Subject|1|||
125520100|NCT00551135|451535401|FG001|Overall Study|Withdrawal by Subject|0|||
125520101|NCT00551135|451535402|FG002|Overall Study|Withdrawal by Subject|3|||
125520102|NCT00551135|451535403|FG003|Overall Study|Withdrawal by Subject|1|||
125520103|NCT01202409|451535404|FG000|Overall Study|Adverse Event|1|||
125520104|NCT01202409|451535404|FG000|Overall Study|Ineligible - KRAS mutants|7|||
125520105|NCT00858247|451535405|FG000|Baseline Assessment|Withdrawal by Subject|1|||
125520106|NCT00858247|451535406|FG001|Baseline Assessment|Withdrawal by Subject|1|||
125520107|NCT00858247|451535405|FG000|Baseline Assessment|Poor IV access|1|||
125520108|NCT00858247|451535406|FG001|Baseline Assessment|Poor IV access|0|||
125520109|NCT00858247|451535405|FG000|Baseline Assessment|Protocol Violation|0|||
125520110|NCT00858247|451535406|FG001|Baseline Assessment|Protocol Violation|1|||
125520111|NCT00858247|451535405|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
125520112|NCT00858247|451535406|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
125520113|NCT00337285|451535407|FG000|Overall Study|Withdrawal by Subject|42|||
125520114|NCT00337285|451535407|FG000|Overall Study|Lost to Follow-up|41|||
125520115|NCT00337285|451535407|FG000|Overall Study|Adverse Event|28|||
125520116|NCT00337285|451535407|FG000|Overall Study|Protocol Violation|27|||
125520117|NCT00337285|451535407|FG000|Overall Study|Lack of Efficacy|11|||
125520118|NCT00337285|451535407|FG000|Overall Study|Death|1|||
125520119|NCT00337285|451535407|FG000|Overall Study|Physician Decision|1|||
125520120|NCT00337285|451535407|FG000|Overall Study|Lack of protocol compliance|7|||
125520121|NCT00553605|451535408|FG000|Overall Study|Did not meet entrance criteria|1|||
125520122|NCT00553605|451535409|FG001|Overall Study|Did not meet entrance criteria|3|||
125520123|NCT00553605|451535408|FG000|Overall Study|Did not receive full dose|1|||
125520124|NCT00553605|451535409|FG001|Overall Study|Did not receive full dose|0|||
125520125|NCT00553605|451535408|FG000|Overall Study|Randomized but not treated|2|||
125520126|NCT00553605|451535409|FG001|Overall Study|Randomized but not treated|0|||
125520127|NCT01004185|451535410|FG000|Overall Study|Adverse Event|1|||
125520128|NCT01004185|451535411|FG001|Overall Study|Adverse Event|1|||
125520129|NCT01004185|451535410|FG000|Overall Study|Lost to Follow-up|0|||
125520130|NCT01004185|451535411|FG001|Overall Study|Lost to Follow-up|1|||
125520131|NCT01004185|451535410|FG000|Overall Study|Lack of Efficacy|2|||
125520132|NCT01004185|451535411|FG001|Overall Study|Lack of Efficacy|1|||
125520133|NCT01004185|451535410|FG000|Overall Study|Sponsor Terminated Study|4|||
125520134|NCT01004185|451535411|FG001|Overall Study|Sponsor Terminated Study|5|||
125520135|NCT01004185|451535410|FG000|Overall Study|Withdrawal by Subject|2|||
125520136|NCT01004185|451535411|FG001|Overall Study|Withdrawal by Subject|1|||
125520137|NCT03481556|451535414|FG000|Overall Study|Adverse Event|1|||
125520138|NCT03481556|451535415|FG001|Overall Study|Adverse Event|0|||
125520139|NCT03481556|451535416|FG002|Overall Study|Adverse Event|0|||
125520140|NCT03481556|451535417|FG003|Overall Study|Adverse Event|0|||
125520141|NCT03481556|451535414|FG000|Overall Study|Death|4|||
125520142|NCT03481556|451535415|FG001|Overall Study|Death|2|||
125520143|NCT03481556|451535416|FG002|Overall Study|Death|3|||
125520144|NCT03481556|451535417|FG003|Overall Study|Death|16|||
125520145|NCT03481556|451535414|FG000|Overall Study|Study Terminated by Sponsor|10|||
125520146|NCT03481556|451535415|FG001|Overall Study|Study Terminated by Sponsor|5|||
125520147|NCT03481556|451535416|FG002|Overall Study|Study Terminated by Sponsor|2|||
125520148|NCT03481556|451535417|FG003|Overall Study|Study Terminated by Sponsor|9|||
125520149|NCT01085812|451535418|FG000|Open-Label Period|Adverse Event|0|||
125520150|NCT01085812|451535419|FG001|Open-Label Period|Adverse Event|80|||
125520151|NCT01085812|451535418|FG000|Open-Label Period|Lack of Efficacy|0|||
125520152|NCT01085812|451535419|FG001|Open-Label Period|Lack of Efficacy|26|||
125520153|NCT01085812|451535418|FG000|Open-Label Period|Protocol Violation|0|||
125520154|NCT01085812|451535419|FG001|Open-Label Period|Protocol Violation|39|||
125520155|NCT01085812|451535418|FG000|Open-Label Period|Withdrawal by Subject|0|||
125520156|NCT01085812|451535419|FG001|Open-Label Period|Withdrawal by Subject|53|||
125520157|NCT01085812|451535418|FG000|Open-Label Period|Lost to Follow-up|0|||
125520158|NCT01085812|451535419|FG001|Open-Label Period|Lost to Follow-up|42|||
125520159|NCT01085812|451535418|FG000|Double-Blind Period|Adverse Event|3|||
125520160|NCT01085812|451535419|FG001|Double-Blind Period|Adverse Event|8|||
125520161|NCT01085812|451535418|FG000|Double-Blind Period|Protocol Violation|2|||
125520162|NCT01085812|451535419|FG001|Double-Blind Period|Protocol Violation|7|||
125520163|NCT01085812|451535418|FG000|Double-Blind Period|Withdrawal by Subject|11|||
125520164|NCT01085812|451535419|FG001|Double-Blind Period|Withdrawal by Subject|24|||
125520165|NCT01085812|451535418|FG000|Double-Blind Period|Lost to Follow-up|5|||
125520166|NCT01085812|451535419|FG001|Double-Blind Period|Lost to Follow-up|17|||
125520167|NCT01085812|451535418|FG000|Double-Blind Period|Other Reasons|0|||
125520168|NCT01085812|451535419|FG001|Double-Blind Period|Other Reasons|2|||
125520169|NCT01085812|451535418|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
125520170|NCT01085812|451535419|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
125520171|NCT01085812|451535418|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
125520172|NCT01085812|451535419|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
125520173|NCT01085812|451535418|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
125520174|NCT01085812|451535419|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
125520175|NCT01085812|451535418|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
125520176|NCT01085812|451535419|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
125520177|NCT01085812|451535418|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
125520178|NCT01085812|451535419|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
125520179|NCT01101997|451535420|FG000|Overall Study|Withdrawal by Subject|2|||
125520180|NCT01172639|451535423|FG000|Overall Study|Death|1|||
125520181|NCT01172639|451535424|FG001|Overall Study|Death|1|||
125520182|NCT01172639|451535425|FG002|Overall Study|Death|0|||
125520183|NCT01172639|451535426|FG003|Overall Study|Death|0|||
125520184|NCT01172639|451535427|FG004|Overall Study|Death|0|||
125520185|NCT01172639|451535423|FG000|Overall Study|Lost to Follow-up|9|||
125520186|NCT01172639|451535424|FG001|Overall Study|Lost to Follow-up|7|||
125520187|NCT01172639|451535425|FG002|Overall Study|Lost to Follow-up|11|||
125520188|NCT01172639|451535426|FG003|Overall Study|Lost to Follow-up|6|||
125520189|NCT01172639|451535427|FG004|Overall Study|Lost to Follow-up|6|||
125520190|NCT01172639|451535423|FG000|Overall Study|Withdrawal by Subject|3|||
125520191|NCT01172639|451535424|FG001|Overall Study|Withdrawal by Subject|3|||
125520192|NCT01172639|451535425|FG002|Overall Study|Withdrawal by Subject|5|||
125520193|NCT01172639|451535426|FG003|Overall Study|Withdrawal by Subject|5|||
125520194|NCT01172639|451535427|FG004|Overall Study|Withdrawal by Subject|0|||
125520195|NCT00469456|451535428|FG000|Overall Study|Adverse Event|4|||
125520196|NCT00469456|451535429|FG001|Overall Study|Adverse Event|3|||
125520197|NCT00469456|451535428|FG000|Overall Study|Protocol Violation|1|||
125520198|NCT00469456|451535429|FG001|Overall Study|Protocol Violation|0|||
125520199|NCT00469456|451535428|FG000|Overall Study|Withdrawal by Subject|4|||
125520200|NCT00469456|451535429|FG001|Overall Study|Withdrawal by Subject|1|||
125520201|NCT02669407|451535434|FG000|Overall Study|Physician Decision|3|||
125520202|NCT03634839|451535435|FG000|First Intervention (2 Hours)|Adverse Event|0|||
125520203|NCT03634839|451535436|FG001|First Intervention (2 Hours)|Adverse Event|2|||
125520204|NCT00350298|451535437|FG000|Overall Study|Death|7|||
125520205|NCT00350298|451535438|FG001|Overall Study|Death|8|||
125520206|NCT00350298|451535437|FG000|Overall Study|Lost to Follow-up|1|||
125520207|NCT00350298|451535438|FG001|Overall Study|Lost to Follow-up|2|||
125520208|NCT00350298|451535437|FG000|Overall Study|Withdrawal by Subject|1|||
125520209|NCT00350298|451535438|FG001|Overall Study|Withdrawal by Subject|3|||
125520210|NCT02447432|451535439|FG000|Epoch 001|Adverse Event|1|||
125520211|NCT02447432|451535440|FG001|Epoch 001|Adverse Event|1|||
125520212|NCT02447432|451535439|FG000|Epoch 001|Withdrawal by Subject|0|||
125520213|NCT02447432|451535440|FG001|Epoch 001|Withdrawal by Subject|4|||
125520214|NCT02447432|451535439|FG000|Epoch 001|Migrated/moved from study area|3|||
125520215|NCT02447432|451535440|FG001|Epoch 001|Migrated/moved from study area|5|||
125520216|NCT02447432|451535439|FG000|Epoch 001|Lost to Follow-up|1|||
125520217|NCT02447432|451535440|FG001|Epoch 001|Lost to Follow-up|3|||
125520218|NCT02647788|451535443|FG000|Overall Study|Lost to Follow-up|13|||
125520219|NCT02647788|451535444|FG001|Overall Study|Lost to Follow-up|11|||
125520220|NCT02647788|451535443|FG000|Overall Study|Did not want opiate|0|||
125520221|NCT02647788|451535444|FG001|Overall Study|Did not want opiate|1|||
125520222|NCT02647788|451535443|FG000|Overall Study|Withdrawal by Subject|1|||
125520223|NCT02647788|451535444|FG001|Overall Study|Withdrawal by Subject|0|||
125520224|NCT02647788|451535443|FG000|Overall Study|Felt itchy with assigned medication|1|||
125520225|NCT02647788|451535444|FG001|Overall Study|Felt itchy with assigned medication|0|||
125520226|NCT02647788|451535443|FG000|Overall Study|Felt nauseous with assigned medication|1|||
125520227|NCT02647788|451535444|FG001|Overall Study|Felt nauseous with assigned medication|1|||
125520228|NCT00233389|451535445|FG000|Overall Study|Adverse Event|5|||
125520229|NCT00233389|451535446|FG001|Overall Study|Adverse Event|5|||
125520230|NCT00233389|451535445|FG000|Overall Study|Lack of Efficacy|11|||
125520231|NCT00233389|451535446|FG001|Overall Study|Lack of Efficacy|8|||
125520232|NCT00233389|451535445|FG000|Overall Study|Lost to Follow-up|1|||
125520233|NCT00233389|451535446|FG001|Overall Study|Lost to Follow-up|1|||
125520234|NCT00233389|451535445|FG000|Overall Study|Physician Decision|1|||
125520235|NCT00233389|451535446|FG001|Overall Study|Physician Decision|0|||
125520236|NCT00233389|451535445|FG000|Overall Study|Protocol Violation|0|||
125520237|NCT00233389|451535446|FG001|Overall Study|Protocol Violation|1|||
125520238|NCT00233389|451535445|FG000|Overall Study|Withdrawal by Subject|0|||
125520239|NCT00233389|451535446|FG001|Overall Study|Withdrawal by Subject|1|||
125520240|NCT00302159|451535449|FG000|Overall Study|pt declined before treatment started|1|||
125520241|NCT00302159|451535449|FG000|Overall Study|pt started Avastin|1|||
125520242|NCT01114672|451535455|FG000|Overall Study|Death|0|||
125520243|NCT01114672|451535456|FG001|Overall Study|Death|1|||
125520244|NCT01114672|451535455|FG000|Overall Study|Withdrawal by Subject|2|||
125520245|NCT01114672|451535456|FG001|Overall Study|Withdrawal by Subject|1|||
125520246|NCT01114672|451535455|FG000|Overall Study|Lost to Follow-up|1|||
125520247|NCT01114672|451535456|FG001|Overall Study|Lost to Follow-up|0|||
125520248|NCT01114672|451535455|FG000|Overall Study|transplanted|1|||
125520249|NCT01114672|451535456|FG001|Overall Study|transplanted|0|||
125520250|NCT02586415|451535459|FG000|Overall Study|Death|13|||
125520251|NCT02586415|451535460|FG001|Overall Study|Death|23|||
125520252|NCT02586415|451535459|FG000|Overall Study|Lost to Follow-up|1|||
125520253|NCT02586415|451535460|FG001|Overall Study|Lost to Follow-up|2|||
125520254|NCT01585298|451535461|FG000|Overall Study|Study completion was not documented.|1|||
125520255|NCT01585298|451535461|FG000|Overall Study|Protocol deviation|1|||
125520256|NCT01585298|451535461|FG000|Overall Study|Administrative problems|4|||
125520257|NCT01585298|451535461|FG000|Overall Study|Lost to Follow-up|2|||
125520258|NCT01585298|451535461|FG000|Overall Study|Withdrawal by Subject|4|||
125520259|NCT01585298|451535461|FG000|Overall Study|Abnormal test procedure results|1|||
125520260|NCT01585298|451535461|FG000|Overall Study|Adverse Event|24|||
125520261|NCT04545476|451535462|FG000|Overall Study|Lost to Follow-up|1|||
125520262|NCT04545476|451535463|FG001|Overall Study|Lost to Follow-up|1|||
125520263|NCT04545476|451535464|FG002|Overall Study|Lost to Follow-up|0|||
125520264|NCT04545476|451535465|FG003|Overall Study|Lost to Follow-up|0|||
125520265|NCT03318783|451535468|FG000|Overall Study|Withdrawal by Subject|0|||
125520266|NCT03318783|451535469|FG001|Overall Study|Withdrawal by Subject|1|||
125520267|NCT03318783|451535468|FG000|Overall Study|Death|0|||
125520268|NCT03318783|451535469|FG001|Overall Study|Death|1|||
125520269|NCT04035577|451535472|FG000|Overall Study|Lost to Follow-up|1|||
125520270|NCT04035577|451535472|FG000|Overall Study|Withdrawal by Subject|1|||
125520271|NCT00104637|451535474|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
125520272|NCT00104637|451535475|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
125520273|NCT01313624|451535476|FG000|Double-Blind Phase|Adverse Event|27|||
125520274|NCT01313624|451535477|FG001|Double-Blind Phase|Adverse Event|4|||
125520275|NCT01313624|451535476|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
125520276|NCT01313624|451535477|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
125520277|NCT01313624|451535476|FG000|Double-Blind Phase|Lost to Follow-up|0|||
125520278|NCT01313624|451535477|FG001|Double-Blind Phase|Lost to Follow-up|2|||
125520279|NCT01313624|451535476|FG000|Double-Blind Phase|Physician Decision|1|||
125520280|NCT01313624|451535477|FG001|Double-Blind Phase|Physician Decision|0|||
125520281|NCT01313624|451535476|FG000|Double-Blind Phase|Lack of Efficacy|1|||
125520282|NCT01313624|451535477|FG001|Double-Blind Phase|Lack of Efficacy|0|||
125520283|NCT01313624|451535476|FG000|Open-Label Phase|Adverse Event|1|||
125520284|NCT01313624|451535477|FG001|Open-Label Phase|Adverse Event|10|||
125520285|NCT01313624|451535476|FG000|Open-Label Phase|Withdrawal by Subject|2|||
125520286|NCT01313624|451535477|FG001|Open-Label Phase|Withdrawal by Subject|2|||
125520287|NCT01313624|451535476|FG000|Open-Label Phase|Lost to Follow-up|1|||
125520288|NCT01313624|451535477|FG001|Open-Label Phase|Lost to Follow-up|1|||
125520289|NCT00505414|451535478|FG000|Titration Phase|Adverse Event|0|||
125520290|NCT00505414|451535479|FG001|Titration Phase|Adverse Event|0|||
125520291|NCT00505414|451535480|FG002|Titration Phase|Adverse Event|0|||
125520292|NCT00505414|451535481|FG003|Titration Phase|Adverse Event|8|||
125520293|NCT00505414|451535482|FG004|Titration Phase|Adverse Event|3|||
125520294|NCT00505414|451535478|FG000|Titration Phase|Death|0|||
125520295|NCT00505414|451535479|FG001|Titration Phase|Death|0|||
125520296|NCT00505414|451535480|FG002|Titration Phase|Death|0|||
125520297|NCT00505414|451535481|FG003|Titration Phase|Death|2|||
125520298|NCT00505414|451535482|FG004|Titration Phase|Death|0|||
125520299|NCT00505414|451535478|FG000|Titration Phase|Lack of Efficacy|0|||
125520300|NCT00505414|451535479|FG001|Titration Phase|Lack of Efficacy|0|||
125520301|NCT00505414|451535480|FG002|Titration Phase|Lack of Efficacy|0|||
125520302|NCT00505414|451535481|FG003|Titration Phase|Lack of Efficacy|10|||
125520303|NCT00505414|451535482|FG004|Titration Phase|Lack of Efficacy|1|||
125520304|NCT00505414|451535478|FG000|Titration Phase|Protocol Violation|0|||
125520305|NCT00505414|451535479|FG001|Titration Phase|Protocol Violation|0|||
125520306|NCT00505414|451535480|FG002|Titration Phase|Protocol Violation|0|||
125520307|NCT00505414|451535481|FG003|Titration Phase|Protocol Violation|0|||
125520308|NCT00505414|451535482|FG004|Titration Phase|Protocol Violation|1|||
125520309|NCT00505414|451535478|FG000|Titration Phase|Withdrawal by Subject|0|||
125520310|NCT00505414|451535479|FG001|Titration Phase|Withdrawal by Subject|0|||
125520311|NCT00505414|451535480|FG002|Titration Phase|Withdrawal by Subject|0|||
125520312|NCT00505414|451535481|FG003|Titration Phase|Withdrawal by Subject|3|||
125520313|NCT00505414|451535482|FG004|Titration Phase|Withdrawal by Subject|4|||
125520314|NCT00505414|451535478|FG000|Titration Phase|Underlying disease and therapy required|0|||
125520315|NCT00505414|451535479|FG001|Titration Phase|Underlying disease and therapy required|0|||
125520316|NCT00505414|451535480|FG002|Titration Phase|Underlying disease and therapy required|0|||
125520317|NCT00505414|451535481|FG003|Titration Phase|Underlying disease and therapy required|7|||
125520318|NCT00505414|451535482|FG004|Titration Phase|Underlying disease and therapy required|3|||
125520319|NCT00505414|451535478|FG000|Maintenance Phase|Adverse Event|2|||
125520320|NCT00505414|451535479|FG001|Maintenance Phase|Adverse Event|2|||
125520321|NCT00505414|451535480|FG002|Maintenance Phase|Adverse Event|3|||
125520322|NCT00505414|451535481|FG003|Maintenance Phase|Adverse Event|0|||
125520323|NCT00505414|451535482|FG004|Maintenance Phase|Adverse Event|0|||
125520324|NCT00505414|451535478|FG000|Maintenance Phase|Death|2|||
125520325|NCT00505414|451535479|FG001|Maintenance Phase|Death|0|||
125520326|NCT00505414|451535480|FG002|Maintenance Phase|Death|1|||
125520327|NCT00505414|451535481|FG003|Maintenance Phase|Death|0|||
125520328|NCT00505414|451535482|FG004|Maintenance Phase|Death|0|||
125520329|NCT00505414|451535478|FG000|Maintenance Phase|Lack of Efficacy|2|||
125520330|NCT00505414|451535479|FG001|Maintenance Phase|Lack of Efficacy|1|||
125520331|NCT00505414|451535480|FG002|Maintenance Phase|Lack of Efficacy|1|||
125520332|NCT00505414|451535481|FG003|Maintenance Phase|Lack of Efficacy|0|||
125520333|NCT00505414|451535482|FG004|Maintenance Phase|Lack of Efficacy|0|||
125520334|NCT00505414|451535478|FG000|Maintenance Phase|Withdrawal by Subject|0|||
125520335|NCT00505414|451535479|FG001|Maintenance Phase|Withdrawal by Subject|0|||
125520336|NCT00505414|451535480|FG002|Maintenance Phase|Withdrawal by Subject|1|||
125520337|NCT00505414|451535481|FG003|Maintenance Phase|Withdrawal by Subject|0|||
125520338|NCT00505414|451535482|FG004|Maintenance Phase|Withdrawal by Subject|0|||
125520339|NCT00505414|451535478|FG000|Maintenance Phase|underlying disease and therapy required|0|||
125520340|NCT00505414|451535479|FG001|Maintenance Phase|underlying disease and therapy required|2|||
125520341|NCT00505414|451535480|FG002|Maintenance Phase|underlying disease and therapy required|2|||
125520342|NCT00505414|451535481|FG003|Maintenance Phase|underlying disease and therapy required|0|||
125520343|NCT00505414|451535482|FG004|Maintenance Phase|underlying disease and therapy required|0|||
125520344|NCT00644878|451535483|FG000|Overall Study|Adverse Event|2|||
125520345|NCT00644878|451535483|FG000|Overall Study|Abnormal laboratory value|3|||
125520346|NCT00644878|451535483|FG000|Overall Study|Protocol deviation|2|||
125520347|NCT00644878|451535483|FG000|Overall Study|Treatment duration completed as per protocol|11|||
125520348|NCT01841112|451535486|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
125520349|NCT01841112|451535487|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
125520350|NCT01841112|451535488|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
125520351|NCT01841112|451535489|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
125520352|NCT01841112|451535490|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
125520353|NCT00878553|451535491|FG000|Sleep Study|Withdrawal by Subject|2|||
125520354|NCT00878553|451535492|FG001|Sleep Study|Withdrawal by Subject|0|||
125520355|NCT00878553|451535493|FG002|Sleep Study|Withdrawal by Subject|0|||
125520356|NCT00878553|451535494|FG003|Sleep Study|Withdrawal by Subject|0|||
125520357|NCT00878553|451535495|FG004|Sleep Study|Withdrawal by Subject|0|||
125520358|NCT00878553|451535491|FG000|Sleep Study|Lost to Follow-up|1|||
125520359|NCT00878553|451535492|FG001|Sleep Study|Lost to Follow-up|0|||
125520360|NCT00878553|451535493|FG002|Sleep Study|Lost to Follow-up|0|||
125520361|NCT00878553|451535494|FG003|Sleep Study|Lost to Follow-up|0|||
125520362|NCT00878553|451535495|FG004|Sleep Study|Lost to Follow-up|0|||
125520363|NCT00878553|451535491|FG000|Sleep Study|car accident|1|||
125520364|NCT00878553|451535492|FG001|Sleep Study|car accident|0|||
125520365|NCT00878553|451535493|FG002|Sleep Study|car accident|0|||
125520366|NCT00878553|451535494|FG003|Sleep Study|car accident|0|||
125520367|NCT00878553|451535495|FG004|Sleep Study|car accident|0|||
125520368|NCT00878553|451535491|FG000|Sleep Study|family emergency|1|||
125520369|NCT00878553|451535492|FG001|Sleep Study|family emergency|0|||
125520370|NCT00878553|451535493|FG002|Sleep Study|family emergency|0|||
125520371|NCT00878553|451535494|FG003|Sleep Study|family emergency|0|||
125520372|NCT00878553|451535495|FG004|Sleep Study|family emergency|0|||
125520373|NCT00878553|451535491|FG000|PK Study|Withdrawal by Subject|0|||
125520374|NCT00878553|451535492|FG001|PK Study|Withdrawal by Subject|0|||
125520375|NCT00878553|451535493|FG002|PK Study|Withdrawal by Subject|0|||
125520376|NCT00878553|451535494|FG003|PK Study|Withdrawal by Subject|1|||
125520377|NCT00878553|451535495|FG004|PK Study|Withdrawal by Subject|0|||
125520378|NCT05896696|451535498|FG000|Overall Study|Screening Failure|7|||
125520379|NCT05896696|451535498|FG000|Overall Study|Withdrawal by Subject|2|||
125520380|NCT02080403|451537646|FG000|Overall Study|Adverse Event|5|||
125520381|NCT02080403|451537647|FG001|Overall Study|Adverse Event|1|||
125520382|NCT02080403|451537646|FG000|Overall Study|Death|0|||
125520383|NCT02080403|451537647|FG001|Overall Study|Death|2|||
125520384|NCT02080403|451537646|FG000|Overall Study|Lost to Follow-up|2|||
125520385|NCT02080403|451537647|FG001|Overall Study|Lost to Follow-up|0|||
125520386|NCT02080403|451537646|FG000|Overall Study|Pregnancy|0|||
125520387|NCT02080403|451537647|FG001|Overall Study|Pregnancy|1|||
125520388|NCT02080403|451537646|FG000|Overall Study|Protocol Violation|3|||
125520389|NCT02080403|451537647|FG001|Overall Study|Protocol Violation|7|||
125520390|NCT02080403|451537646|FG000|Overall Study|Withdrawal by Subject|5|||
125520391|NCT02080403|451537647|FG001|Overall Study|Withdrawal by Subject|1|||
125520392|NCT01999972|451537648|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
125520393|NCT01999972|451537649|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
125520394|NCT01999972|451537650|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
125520395|NCT01999972|451537651|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
125520396|NCT01999972|451537652|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
125520397|NCT01999972|451537653|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
125520398|NCT01999972|451537648|FG000|Dose Escalation Part|Death|0|||
125520399|NCT01999972|451537649|FG001|Dose Escalation Part|Death|1|||
125520400|NCT01999972|451537650|FG002|Dose Escalation Part|Death|0|||
125520401|NCT01999972|451537651|FG003|Dose Escalation Part|Death|0|||
125520402|NCT01999972|451537652|FG004|Dose Escalation Part|Death|0|||
125520403|NCT01999972|451537653|FG005|Dose Escalation Part|Death|0|||
125520404|NCT01999972|451537648|FG000|Dose Escalation Part|Enrolled but not treated|0|||
125520405|NCT01999972|451537649|FG001|Dose Escalation Part|Enrolled but not treated|0|||
125520406|NCT01999972|451537650|FG002|Dose Escalation Part|Enrolled but not treated|1|||
125520407|NCT01999972|451537651|FG003|Dose Escalation Part|Enrolled but not treated|1|||
125520408|NCT01999972|451537652|FG004|Dose Escalation Part|Enrolled but not treated|0|||
125520409|NCT01999972|451537653|FG005|Dose Escalation Part|Enrolled but not treated|0|||
125520410|NCT01999972|451537648|FG000|Dose Escalation Part|Disease progression|3|||
125520411|NCT01999972|451537649|FG001|Dose Escalation Part|Disease progression|2|||
125520412|NCT01999972|451537650|FG002|Dose Escalation Part|Disease progression|3|||
125520413|NCT01999972|451537651|FG003|Dose Escalation Part|Disease progression|6|||
125520414|NCT01999972|451537652|FG004|Dose Escalation Part|Disease progression|0|||
125520415|NCT01999972|451537653|FG005|Dose Escalation Part|Disease progression|0|||
125520416|NCT01999972|451537648|FG000|Dose Escalation Part|Adverse Event|0|||
125520417|NCT01999972|451537649|FG001|Dose Escalation Part|Adverse Event|0|||
125520418|NCT01999972|451537650|FG002|Dose Escalation Part|Adverse Event|0|||
125520419|NCT01999972|451537651|FG003|Dose Escalation Part|Adverse Event|2|||
125520420|NCT01999972|451537652|FG004|Dose Escalation Part|Adverse Event|0|||
125520421|NCT01999972|451537653|FG005|Dose Escalation Part|Adverse Event|0|||
125520422|NCT01999972|451537648|FG000|Dose Escalation Part|Global deterioration of health status|1|||
125520423|NCT01999972|451537649|FG001|Dose Escalation Part|Global deterioration of health status|0|||
125520424|NCT01999972|451537650|FG002|Dose Escalation Part|Global deterioration of health status|0|||
125520425|NCT01999972|451537651|FG003|Dose Escalation Part|Global deterioration of health status|1|||
125520426|NCT01999972|451537652|FG004|Dose Escalation Part|Global deterioration of health status|0|||
125520427|NCT01999972|451537653|FG005|Dose Escalation Part|Global deterioration of health status|0|||
125520428|NCT01999972|451537648|FG000|Dose Expansion Part|Death|0|||
125520429|NCT01999972|451537649|FG001|Dose Expansion Part|Death|0|||
125520430|NCT01999972|451537650|FG002|Dose Expansion Part|Death|0|||
125520431|NCT01999972|451537651|FG003|Dose Expansion Part|Death|0|||
125520432|NCT01999972|451537652|FG004|Dose Expansion Part|Death|2|||
125520433|NCT01999972|451537653|FG005|Dose Expansion Part|Death|1|||
125520434|NCT01999972|451537648|FG000|Dose Expansion Part|Disease progression|0|||
125520435|NCT01999972|451537649|FG001|Dose Expansion Part|Disease progression|0|||
125520436|NCT01999972|451537650|FG002|Dose Expansion Part|Disease progression|0|||
125520437|NCT01999972|451537651|FG003|Dose Expansion Part|Disease progression|0|||
125520438|NCT01999972|451537652|FG004|Dose Expansion Part|Disease progression|9|||
125520439|NCT01999972|451537653|FG005|Dose Expansion Part|Disease progression|3|||
125520440|NCT01999972|451537648|FG000|Dose Expansion Part|Sponsor decision|0|||
125520441|NCT01999972|451537649|FG001|Dose Expansion Part|Sponsor decision|0|||
125520442|NCT01999972|451537650|FG002|Dose Expansion Part|Sponsor decision|0|||
125520443|NCT01999972|451537651|FG003|Dose Expansion Part|Sponsor decision|0|||
125520444|NCT01999972|451537652|FG004|Dose Expansion Part|Sponsor decision|1|||
125520445|NCT01999972|451537653|FG005|Dose Expansion Part|Sponsor decision|0|||
125520446|NCT01999972|451537648|FG000|Dose Expansion Part|Adverse Event|0|||
125520447|NCT01999972|451537649|FG001|Dose Expansion Part|Adverse Event|0|||
125520448|NCT01999972|451537650|FG002|Dose Expansion Part|Adverse Event|0|||
125520449|NCT01999972|451537651|FG003|Dose Expansion Part|Adverse Event|0|||
125520450|NCT01999972|451537652|FG004|Dose Expansion Part|Adverse Event|4|||
125520451|NCT01999972|451537653|FG005|Dose Expansion Part|Adverse Event|2|||
125520452|NCT01999972|451537648|FG000|Dose Expansion Part|Participant's non-compliance|0|||
125520453|NCT01999972|451537649|FG001|Dose Expansion Part|Participant's non-compliance|0|||
125520454|NCT01999972|451537650|FG002|Dose Expansion Part|Participant's non-compliance|0|||
125520455|NCT01999972|451537651|FG003|Dose Expansion Part|Participant's non-compliance|0|||
125520456|NCT01999972|451537652|FG004|Dose Expansion Part|Participant's non-compliance|0|||
125520457|NCT01999972|451537653|FG005|Dose Expansion Part|Participant's non-compliance|1|||
125520458|NCT01999972|451537648|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
125520459|NCT01999972|451537649|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
125520460|NCT01999972|451537650|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
125520461|NCT01999972|451537651|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
125520462|NCT01999972|451537652|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
125520463|NCT01999972|451537653|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
125520464|NCT01999972|451537648|FG000|Dose Expansion Part|Changed to standard of care|0|||
125520465|NCT01999972|451537649|FG001|Dose Expansion Part|Changed to standard of care|0|||
125520466|NCT01999972|451537650|FG002|Dose Expansion Part|Changed to standard of care|0|||
125520467|NCT01999972|451537651|FG003|Dose Expansion Part|Changed to standard of care|0|||
125520468|NCT01999972|451537652|FG004|Dose Expansion Part|Changed to standard of care|1|||
125520469|NCT01999972|451537653|FG005|Dose Expansion Part|Changed to standard of care|0|||
125520470|NCT02202109|451537654|FG000|Overall Study|Lost to Follow-up|88|||
125520471|NCT02202109|451537655|FG001|Overall Study|Lost to Follow-up|87|||
125520472|NCT02202109|451537654|FG000|Overall Study|Withdrawal by Subject|2|||
125520473|NCT02202109|451537655|FG001|Overall Study|Withdrawal by Subject|0|||
125520474|NCT01256671|451537660|FG000|Overall Study|Adverse Event|29|||
125520475|NCT01256671|451537660|FG000|Overall Study|Lost to Follow-up|16|||
125520476|NCT01256671|451537660|FG000|Overall Study|Withdrawal by Subject|31|||
125520477|NCT01256671|451537660|FG000|Overall Study|Physician Decision|3|||
125520478|NCT01256671|451537660|FG000|Overall Study|Lack of Efficacy|4|||
125520479|NCT01256671|451537660|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
125520480|NCT01986114|451537661|FG000|Overall Study|Adverse Event|59|||
125520481|NCT01986114|451537661|FG000|Overall Study|Lack of Efficacy|23|||
125520482|NCT01986114|451537661|FG000|Overall Study|Withdrawal by Subject|58|||
125520483|NCT01986114|451537661|FG000|Overall Study|Noncompliance|3|||
125520484|NCT01986114|451537661|FG000|Overall Study|Protocol Violation|1|||
125520485|NCT01986114|451537661|FG000|Overall Study|Lost to Follow-up|5|||
125520486|NCT01986114|451537661|FG000|Overall Study|Other reason|7|||
125520487|NCT00664105|451537662|FG000|Overall Study|Death|3|||
125520488|NCT00664105|451537662|FG000|Overall Study|Withdrawal by Subject|5|||
125520489|NCT00664105|451537662|FG000|Overall Study|Adverse Event|9|||
125520490|NCT00664105|451537662|FG000|Overall Study|Disease progression|7|||
125520491|NCT01468077|451537669|FG000|Overall Study|Adverse Event|2|||
125520492|NCT01468077|451537670|FG001|Overall Study|Adverse Event|2|||
125520493|NCT01468077|451537669|FG000|Overall Study|Lack of Efficacy|1|||
125520494|NCT01468077|451537670|FG001|Overall Study|Lack of Efficacy|1|||
125520495|NCT01468077|451537669|FG000|Overall Study|Physician Decision|1|||
125520496|NCT01468077|451537670|FG001|Overall Study|Physician Decision|0|||
125520497|NCT00761956|451537671|FG000|Overall Study|Lost to Follow-up|6|||
125520498|NCT00761956|451537672|FG001|Overall Study|Lost to Follow-up|11|||
125520499|NCT00761956|451537671|FG000|Overall Study|Withdrawal by Subject|3|||
125520500|NCT00761956|451537672|FG001|Overall Study|Withdrawal by Subject|8|||
125520501|NCT00761956|451537671|FG000|Overall Study|Death|0|||
125520502|NCT00761956|451537672|FG001|Overall Study|Death|1|||
125520503|NCT00761956|451537671|FG000|Overall Study|Adverse Event|26|||
125520504|NCT00761956|451537672|FG001|Overall Study|Adverse Event|34|||
125520505|NCT03024996|451537673|FG000|Overall Study|Death|57|||
125520506|NCT03024996|451537674|FG001|Overall Study|Death|55|||
125520507|NCT03024996|451537673|FG000|Overall Study|Disease relapse|1|||
125520508|NCT03024996|451537674|FG001|Overall Study|Disease relapse|0|||
125520509|NCT03024996|451537673|FG000|Overall Study|Lost to Follow-up|5|||
125520510|NCT03024996|451537674|FG001|Overall Study|Lost to Follow-up|10|||
125520511|NCT03024996|451537673|FG000|Overall Study|Other|3|||
125520512|NCT03024996|451537674|FG001|Overall Study|Other|3|||
125520513|NCT03024996|451537673|FG000|Overall Study|Physician Decision|0|||
125520514|NCT03024996|451537674|FG001|Overall Study|Physician Decision|1|||
125520515|NCT03024996|451537673|FG000|Overall Study|Study terminated by sponsor|303|||
125520516|NCT03024996|451537674|FG001|Overall Study|Study terminated by sponsor|283|||
125520517|NCT03024996|451537673|FG000|Overall Study|Withdrawal by Subject|21|||
125520518|NCT03024996|451537674|FG001|Overall Study|Withdrawal by Subject|36|||
125520519|NCT02106195|451537679|FG000|Overall Study|Adverse Event|2|||
125520520|NCT02106195|451537679|FG000|Overall Study|Protocol Violation|1|||
125520521|NCT04702893|451537680|FG000|Overall Study|Other reasons than listed|11|||
125520522|NCT04702893|451537680|FG000|Overall Study|Withdrawal by Subject|3|||
125520523|NCT04702893|451537680|FG000|Overall Study|Lost to Follow-up|7|||
125520524|NCT04702893|451537680|FG000|Overall Study|Death|10|||
125520525|NCT04702893|451537680|FG000|Overall Study|Not treated|6|||
125520526|NCT04469465|451537681|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
125520527|NCT04469465|451537682|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
125520528|NCT04469465|451537681|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
125520529|NCT04469465|451537682|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
125520530|NCT04469465|451537681|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
125520531|NCT04469465|451537682|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
125520532|NCT04469465|451537681|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
125520533|NCT04469465|451537682|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
125520534|NCT04469465|451537681|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
125520535|NCT04469465|451537682|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
125520536|NCT04469465|451537681|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
125520537|NCT04469465|451537682|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
125520538|NCT04469465|451537681|FG000|Long-Term Extension (LTE)|Death|0|||
125520539|NCT04469465|451537682|FG001|Long-Term Extension (LTE)|Death|1|||
125520540|NCT04469465|451537681|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
125520541|NCT04469465|451537682|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
125520542|NCT01588366|451537695|FG000|Overall Study|Adverse Event|0|||
125520543|NCT01588366|451537696|FG001|Overall Study|Adverse Event|1|||
125520544|NCT01588366|451537697|FG002|Overall Study|Adverse Event|0|||
125520545|NCT01588366|451537698|FG003|Overall Study|Adverse Event|1|||
125520546|NCT01588366|451537699|FG004|Overall Study|Adverse Event|0|||
125520547|NCT01588366|451537700|FG005|Overall Study|Adverse Event|2|||
125520548|NCT00719043|451537701|FG000|Overall Study|Adverse Event|5|||
125520549|NCT00719043|451537702|FG001|Overall Study|Adverse Event|1|||
125520550|NCT00719043|451537703|FG002|Overall Study|Adverse Event|2|||
125520551|NCT00719043|451537704|FG003|Overall Study|Adverse Event|2|||
125520552|NCT00719043|451537705|FG004|Overall Study|Adverse Event|1|||
125520553|NCT00719043|451537706|FG005|Overall Study|Adverse Event|4|||
125520554|NCT00719043|451537707|FG006|Overall Study|Adverse Event|4|||
125520555|NCT00719043|451537701|FG000|Overall Study|Lost to Follow-up|14|||
125520556|NCT00719043|451537702|FG001|Overall Study|Lost to Follow-up|10|||
125520557|NCT00719043|451537703|FG002|Overall Study|Lost to Follow-up|8|||
125520558|NCT00719043|451537704|FG003|Overall Study|Lost to Follow-up|9|||
125520559|NCT00719043|451537705|FG004|Overall Study|Lost to Follow-up|10|||
125520560|NCT00719043|451537706|FG005|Overall Study|Lost to Follow-up|9|||
125520561|NCT00719043|451537707|FG006|Overall Study|Lost to Follow-up|9|||
125520562|NCT00719043|451537701|FG000|Overall Study|Protocol Violation|0|||
125520563|NCT00719043|451537702|FG001|Overall Study|Protocol Violation|0|||
125520564|NCT00719043|451537703|FG002|Overall Study|Protocol Violation|0|||
125520565|NCT00719043|451537704|FG003|Overall Study|Protocol Violation|0|||
125520566|NCT00719043|451537705|FG004|Overall Study|Protocol Violation|0|||
125520567|NCT00719043|451537706|FG005|Overall Study|Protocol Violation|1|||
125520568|NCT00719043|451537707|FG006|Overall Study|Protocol Violation|0|||
125520569|NCT00719043|451537701|FG000|Overall Study|Other|1|||
125520570|NCT00719043|451537702|FG001|Overall Study|Other|0|||
125520571|NCT00719043|451537703|FG002|Overall Study|Other|1|||
125520572|NCT00719043|451537704|FG003|Overall Study|Other|2|||
125520573|NCT00719043|451537705|FG004|Overall Study|Other|0|||
125520574|NCT00719043|451537706|FG005|Overall Study|Other|2|||
125520575|NCT00719043|451537707|FG006|Overall Study|Other|1|||
125520576|NCT00719043|451537701|FG000|Overall Study|Withdrawal by Subject|12|||
125520577|NCT00719043|451537702|FG001|Overall Study|Withdrawal by Subject|14|||
125520578|NCT00719043|451537703|FG002|Overall Study|Withdrawal by Subject|9|||
125520579|NCT00719043|451537704|FG003|Overall Study|Withdrawal by Subject|10|||
125520580|NCT00719043|451537705|FG004|Overall Study|Withdrawal by Subject|16|||
125520581|NCT00719043|451537706|FG005|Overall Study|Withdrawal by Subject|18|||
125520582|NCT00719043|451537707|FG006|Overall Study|Withdrawal by Subject|14|||
125520583|NCT03245619|451537708|FG000|Part A (Up to Day 22)|Physician Decision|4|||
125520584|NCT03245619|451537709|FG001|Part A (Up to Day 22)|Physician Decision|6|||
125520585|NCT03245619|451537710|FG002|Part A (Up to Day 22)|Physician Decision|6|||
125520586|NCT03245619|451537711|FG003|Part A (Up to Day 22)|Physician Decision|0|||
125520587|NCT03245619|451537712|FG004|Part A (Up to Day 22)|Physician Decision|0|||
125520588|NCT03245619|451537713|FG005|Part A (Up to Day 22)|Physician Decision|0|||
125520589|NCT03245619|451537714|FG006|Part A (Up to Day 22)|Physician Decision|0|||
125520590|NCT03245619|451537715|FG007|Part A (Up to Day 22)|Physician Decision|0|||
125520591|NCT03245619|451537716|FG008|Part A (Up to Day 22)|Physician Decision|0|||
125520592|NCT03245619|451537717|FG009|Part A (Up to Day 22)|Physician Decision|0|||
125520593|NCT03245619|451537718|FG010|Part A (Up to Day 22)|Physician Decision|0|||
125520594|NCT03245619|451537719|FG011|Part A (Up to Day 22)|Physician Decision|0|||
125520595|NCT03245619|451537720|FG012|Part A (Up to Day 22)|Physician Decision|0|||
125520596|NCT03245619|451537721|FG013|Part A (Up to Day 22)|Physician Decision|0|||
125520597|NCT03245619|451537722|FG014|Part A (Up to Day 22)|Physician Decision|0|||
125520598|NCT03245619|451537723|FG015|Part A (Up to Day 22)|Physician Decision|0|||
125520599|NCT03245619|451537724|FG016|Part A (Up to Day 22)|Physician Decision|0|||
125520600|NCT01704547|451537725|FG000|Overall Study|Physician Decision|4|||
125520601|NCT01704547|451537725|FG000|Overall Study|Withdrawal by Subject|1|||
125520602|NCT00690378|451537732|FG000|Overall Study|Adverse Event|1|||
125520603|NCT00690378|451537733|FG001|Overall Study|Adverse Event|0|||
125520604|NCT00690378|451537732|FG000|Overall Study|Withdrawal by Subject|2|||
125520605|NCT00690378|451537733|FG001|Overall Study|Withdrawal by Subject|0|||
125520606|NCT00690378|451537732|FG000|Overall Study|Protocol Violation|1|||
125520607|NCT00690378|451537733|FG001|Overall Study|Protocol Violation|0|||
125520608|NCT00690378|451537732|FG000|Overall Study|Lost to Follow-up|2|||
125520609|NCT00690378|451537733|FG001|Overall Study|Lost to Follow-up|3|||
125520610|NCT00690378|451537732|FG000|Overall Study|Did not meet inc/exc criteria|13|||
125520611|NCT00690378|451537733|FG001|Overall Study|Did not meet inc/exc criteria|11|||
125520612|NCT00690378|451537732|FG000|Overall Study|Social problem|1|||
125520613|NCT00690378|451537733|FG001|Overall Study|Social problem|0|||
125520614|NCT00846768|451537735|FG000|Overall Study|Adverse Event|0|||
125520615|NCT00846768|451537736|FG001|Overall Study|Adverse Event|1|||
125520616|NCT00846768|451537737|FG002|Overall Study|Adverse Event|0|||
125520617|NCT00846768|451537738|FG003|Overall Study|Adverse Event|0|||
125520618|NCT00912223|451537743|FG000|Overall Study|Withdrawal by Subject|1|||
125520619|NCT00912223|451537743|FG000|Overall Study|Not transplanted|1|||
125520620|NCT00912223|451537743|FG000|Overall Study|Transformed disease|1|||
125520621|NCT01099579|451537744|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
125520622|NCT01099579|451537745|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
125520623|NCT01099579|451537746|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
125520624|NCT01099579|451537744|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
125520625|NCT01099579|451537745|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
125520626|NCT01099579|451537746|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
125520627|NCT01099579|451537744|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
125520628|NCT01099579|451537745|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
125520629|NCT01099579|451537746|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
125520630|NCT01099579|451537744|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
125520631|NCT01099579|451537745|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
125520632|NCT01099579|451537746|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
125520633|NCT01099579|451537744|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
125520634|NCT01099579|451537745|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
125520635|NCT01099579|451537746|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
125520636|NCT01099579|451537744|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
125520637|NCT01099579|451537745|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
125520638|NCT01099579|451537746|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
125520639|NCT01099579|451537744|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
125520640|NCT01099579|451537745|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
125520641|NCT01099579|451537746|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
125520642|NCT01099579|451537744|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
125520643|NCT01099579|451537745|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
125520644|NCT01099579|451537746|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
125520645|NCT01099579|451537744|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
125520646|NCT01099579|451537745|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
125520647|NCT01099579|451537746|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
125520648|NCT01099579|451537744|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
125520649|NCT01099579|451537745|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
125520650|NCT01099579|451537746|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
125520651|NCT00909532|451537747|FG000|Overall Study|Adverse Event|4|||
125520652|NCT00909532|451537748|FG001|Overall Study|Adverse Event|1|||
125520653|NCT00909532|451537747|FG000|Overall Study|Pregnancy|0|||
125520654|NCT00909532|451537748|FG001|Overall Study|Pregnancy|1|||
125520655|NCT00909532|451537747|FG000|Overall Study|Prohibited Medication|2|||
125520656|NCT00909532|451537748|FG001|Overall Study|Prohibited Medication|1|||
125520657|NCT00909532|451537747|FG000|Overall Study|Withdrawal of Consent|1|||
125520658|NCT00909532|451537748|FG001|Overall Study|Withdrawal of Consent|1|||
125520659|NCT00909532|451537747|FG000|Overall Study|Noncompliance with Study Requirements|0|||
125520660|NCT00909532|451537748|FG001|Overall Study|Noncompliance with Study Requirements|2|||
125520661|NCT00909532|451537747|FG000|Overall Study|Physician Decision|1|||
125520662|NCT00909532|451537748|FG001|Overall Study|Physician Decision|0|||
125520663|NCT00909532|451537747|FG000|Overall Study|Wrong Genotype|1|||
125520664|NCT00909532|451537748|FG001|Overall Study|Wrong Genotype|0|||
125520665|NCT00909532|451537747|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
125520666|NCT00909532|451537748|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
125520667|NCT01157377|451537751|FG000|Overall Study|Lost to Follow-up|0|||
125520668|NCT01157377|451537752|FG001|Overall Study|Lost to Follow-up|0|||
125520669|NCT01157377|451537753|FG002|Overall Study|Lost to Follow-up|1|||
125520670|NCT01157377|451537754|FG003|Overall Study|Lost to Follow-up|0|||
125520671|NCT01157377|451537755|FG004|Overall Study|Lost to Follow-up|1|||
125520672|NCT01157377|451537756|FG005|Overall Study|Lost to Follow-up|1|||
125520673|NCT01157377|451537757|FG006|Overall Study|Lost to Follow-up|0|||
125520674|NCT01157377|451537751|FG000|Overall Study|Personal Reasons|2|||
125520675|NCT01157377|451537752|FG001|Overall Study|Personal Reasons|1|||
125520676|NCT01157377|451537753|FG002|Overall Study|Personal Reasons|0|||
125520677|NCT01157377|451537754|FG003|Overall Study|Personal Reasons|1|||
125520678|NCT01157377|451537755|FG004|Overall Study|Personal Reasons|0|||
125520679|NCT01157377|451537756|FG005|Overall Study|Personal Reasons|0|||
125520680|NCT01157377|451537757|FG006|Overall Study|Personal Reasons|0|||
125520681|NCT01157377|451537751|FG000|Overall Study|Protocol Violation|0|||
125520682|NCT01157377|451537752|FG001|Overall Study|Protocol Violation|0|||
125520683|NCT01157377|451537753|FG002|Overall Study|Protocol Violation|0|||
125520684|NCT01157377|451537754|FG003|Overall Study|Protocol Violation|0|||
125520685|NCT01157377|451537755|FG004|Overall Study|Protocol Violation|0|||
125520686|NCT01157377|451537756|FG005|Overall Study|Protocol Violation|1|||
125520687|NCT01157377|451537757|FG006|Overall Study|Protocol Violation|0|||
125520688|NCT01157377|451537751|FG000|Overall Study|Lack of Efficacy|0|||
125520689|NCT01157377|451537752|FG001|Overall Study|Lack of Efficacy|0|||
125520690|NCT01157377|451537753|FG002|Overall Study|Lack of Efficacy|0|||
125520691|NCT01157377|451537754|FG003|Overall Study|Lack of Efficacy|0|||
125520692|NCT01157377|451537755|FG004|Overall Study|Lack of Efficacy|0|||
125520693|NCT01157377|451537756|FG005|Overall Study|Lack of Efficacy|0|||
125520694|NCT01157377|451537757|FG006|Overall Study|Lack of Efficacy|1|||
125520695|NCT01157377|451537751|FG000|Overall Study|Other Miscellaneous Reasons|0|||
125520696|NCT01157377|451537752|FG001|Overall Study|Other Miscellaneous Reasons|2|||
125520697|NCT01157377|451537753|FG002|Overall Study|Other Miscellaneous Reasons|0|||
125520698|NCT01157377|451537754|FG003|Overall Study|Other Miscellaneous Reasons|0|||
125520699|NCT01157377|451537755|FG004|Overall Study|Other Miscellaneous Reasons|1|||
125520700|NCT01157377|451537756|FG005|Overall Study|Other Miscellaneous Reasons|1|||
125520701|NCT01157377|451537757|FG006|Overall Study|Other Miscellaneous Reasons|1|||
125520702|NCT00927901|451537758|FG000|Treatment Period 1|Subject withdrew consent|0|||
125520703|NCT00927901|451537759|FG001|Treatment Period 1|Subject withdrew consent|0|||
125520704|NCT00927901|451537760|FG002|Treatment Period 1|Subject withdrew consent|1|||
125520705|NCT00927901|451537761|FG003|Treatment Period 1|Subject withdrew consent|0|||
125520706|NCT00927901|451537758|FG000|Treatment Period 4|Adverse Event|0|||
125520707|NCT00927901|451537759|FG001|Treatment Period 4|Adverse Event|0|||
125520708|NCT00927901|451537760|FG002|Treatment Period 4|Adverse Event|0|||
125520709|NCT00927901|451537761|FG003|Treatment Period 4|Adverse Event|1|||
125520710|NCT00927901|451537758|FG000|Treatment Period 4|Subject withdrew consent|0|||
125520711|NCT00927901|451537759|FG001|Treatment Period 4|Subject withdrew consent|0|||
125520712|NCT00927901|451537760|FG002|Treatment Period 4|Subject withdrew consent|1|||
125520713|NCT00927901|451537761|FG003|Treatment Period 4|Subject withdrew consent|0|||
125520714|NCT01263925|451537766|FG000|Overall Study|Protocol Violation|1|||
125520715|NCT01263925|451537767|FG001|Overall Study|Protocol Violation|0|||
125520716|NCT01263925|451537766|FG000|Overall Study|Lack of Efficacy|0|||
125520717|NCT01263925|451537767|FG001|Overall Study|Lack of Efficacy|1|||
125520718|NCT01263925|451537766|FG000|Overall Study|Adverse Event|23|||
125520719|NCT01263925|451537767|FG001|Overall Study|Adverse Event|22|||
125520720|NCT01263925|451537766|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
125520721|NCT01263925|451537767|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
125520722|NCT01263925|451537766|FG000|Overall Study|Withdrawal by Subject|6|||
125520723|NCT01263925|451537767|FG001|Overall Study|Withdrawal by Subject|8|||
125520724|NCT01263925|451537766|FG000|Overall Study|Other|4|||
125520725|NCT01263925|451537767|FG001|Overall Study|Other|4|||
125520726|NCT01263925|451537766|FG000|Overall Study|Lost to Follow-up|3|||
125520727|NCT01263925|451537767|FG001|Overall Study|Lost to Follow-up|1|||
125520728|NCT01263925|451537766|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
125520729|NCT01263925|451537767|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
125520730|NCT01263925|451537766|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
125520731|NCT01263925|451537767|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
125520732|NCT01263925|451537766|FG000|Overall Study|AE/ Withdrawal|1|||
125520733|NCT01263925|451537767|FG001|Overall Study|AE/ Withdrawal|4|||
125520734|NCT01263925|451537766|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
125520735|NCT01263925|451537767|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
125520736|NCT01263925|451537766|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
125520737|NCT01263925|451537767|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
125520738|NCT01263925|451537766|FG000|Overall Study|Withdrawal/ Not specified|0|||
125520739|NCT01263925|451537767|FG001|Overall Study|Withdrawal/ Not specified|1|||
125520740|NCT03029819|451537768|FG000|Overall Study|Lost to Follow-up|3|||
125520741|NCT03029819|451537769|FG001|Overall Study|Lost to Follow-up|5|||
125520742|NCT03029819|451537768|FG000|Overall Study|Removed due to disruptive behavior|0|||
125520743|NCT03029819|451537769|FG001|Overall Study|Removed due to disruptive behavior|1|||
125520744|NCT02650466|451537776|FG000|Overall Study|Physician Decision|1|||
125520745|NCT02650466|451537776|FG000|Overall Study|Withdrawal by Subject|5|||
125520746|NCT02650466|451537776|FG000|Overall Study|Lost to Follow-up|1|||
125520747|NCT01726517|451537777|FG000|Overall Study|Withdrawal by Subject|0|||
125520748|NCT01726517|451537778|FG001|Overall Study|Withdrawal by Subject|0|||
125520749|NCT01726517|451537779|FG002|Overall Study|Withdrawal by Subject|1|||
125520750|NCT01726517|451537780|FG003|Overall Study|Withdrawal by Subject|0|||
125520751|NCT01726517|451537781|FG004|Overall Study|Withdrawal by Subject|0|||
125520752|NCT00573651|451537782|FG000|Overall Study|Lost to Follow-up|3|||
125520753|NCT00573651|451537782|FG000|Overall Study|Withdrawal by Subject|1|||
125520754|NCT03765164|451537783|FG000|Pre-intervention|Withdrawal by Subject|5|||
125520755|NCT03765164|451537784|FG001|Pre-intervention|Withdrawal by Subject|6|||
125520756|NCT03797989|451537806|FG000|VAC069A|Withdrawal by Subject|0|||
125520757|NCT03797989|451537807|FG001|VAC069A|Withdrawal by Subject|0|||
125520758|NCT03797989|451537808|FG002|VAC069A|Withdrawal by Subject|1|||
125520759|NCT03797989|451537809|FG003|VAC069A|Withdrawal by Subject|0|||
125520760|NCT03797989|451537810|FG004|VAC069A|Withdrawal by Subject|0|||
125520761|NCT03797989|451537811|FG005|VAC069A|Withdrawal by Subject|0|||
125520762|NCT03797989|451537812|FG006|VAC069A|Withdrawal by Subject|0|||
125520763|NCT03797989|451537813|FG007|VAC069A|Withdrawal by Subject|0|||
125520764|NCT03797989|451537814|FG008|VAC069A|Withdrawal by Subject|0|||
125520765|NCT03797989|451537815|FG009|VAC069A|Withdrawal by Subject|0|||
125520766|NCT03797989|451537816|FG010|VAC069A|Withdrawal by Subject|0|||
125520767|NCT03797989|451537817|FG011|VAC069A|Withdrawal by Subject|0|||
125520768|NCT04052997|451537818|FG000|Overall Study|Withdrawal by Subject|17|||
125520769|NCT04052997|451537818|FG000|Overall Study|Physician Decision|50|||
125520770|NCT04052997|451537818|FG000|Overall Study|Death|43|||
125520771|NCT04052997|451537818|FG000|Overall Study|Lost to Follow-up|5|||
125520772|NCT04052997|451537818|FG000|Overall Study|Progression of Disease|1|||
125520773|NCT01024036|451537819|FG000|Blinded Treatment|Adverse Event|1|||
125520774|NCT01024036|451537820|FG001|Blinded Treatment|Adverse Event|1|||
125520775|NCT01024036|451537819|FG000|Blinded Treatment|Lack of Efficacy|16|||
125520776|NCT01024036|451537820|FG001|Blinded Treatment|Lack of Efficacy|14|||
125520777|NCT01024036|451537819|FG000|Blinded Treatment|Physician Decision|1|||
125520778|NCT01024036|451537820|FG001|Blinded Treatment|Physician Decision|0|||
125520779|NCT01024036|451537819|FG000|Blinded Treatment|Death|0|||
125520780|NCT01024036|451537820|FG001|Blinded Treatment|Death|2|||
125520781|NCT01024036|451537819|FG000|Blinded Treatment|Withdrawal by Subject|4|||
125520782|NCT01024036|451537820|FG001|Blinded Treatment|Withdrawal by Subject|3|||
125520783|NCT01024036|451537819|FG000|Unblinded Treatment|Adverse Event|0|||
125520784|NCT01024036|451537820|FG001|Unblinded Treatment|Adverse Event|1|||
125520785|NCT01024036|451537819|FG000|Unblinded Treatment|Lack of Efficacy|0|||
125520786|NCT01024036|451537820|FG001|Unblinded Treatment|Lack of Efficacy|2|||
125520787|NCT01024036|451537819|FG000|Follow-Up Period|Lost to Follow-up|1|||
125520788|NCT01024036|451537820|FG001|Follow-Up Period|Lost to Follow-up|1|||
125520789|NCT01024036|451537819|FG000|Follow-Up Period|Withdrawal by Subject|0|||
125520790|NCT01024036|451537820|FG001|Follow-Up Period|Withdrawal by Subject|1|||
125520791|NCT01024036|451537819|FG000|Follow-Up Period|Adverse Event|4|||
125520792|NCT01024036|451537820|FG001|Follow-Up Period|Adverse Event|1|||
125520793|NCT00604188|451537825|FG000|Overall Study|Adverse Event|1|||
125520794|NCT00604188|451537826|FG001|Overall Study|Adverse Event|4|||
125520795|NCT00604188|451537825|FG000|Overall Study|Lost to Follow-up|17|||
125520796|NCT00604188|451537826|FG001|Overall Study|Lost to Follow-up|15|||
125520797|NCT00604188|451537825|FG000|Overall Study|Withdrawal by Subject|5|||
125520798|NCT00604188|451537826|FG001|Overall Study|Withdrawal by Subject|1|||
125520799|NCT00604188|451537825|FG000|Overall Study|Non-compliance with protocol|4|||
125520800|NCT00604188|451537826|FG001|Overall Study|Non-compliance with protocol|4|||
125520801|NCT00604188|451537825|FG000|Overall Study|Did not receive study drug|0|||
125520802|NCT00604188|451537826|FG001|Overall Study|Did not receive study drug|1|||
125520803|NCT00356759|451537831|FG000|Overall Study|Death|5|||
125520804|NCT00356759|451537832|FG001|Overall Study|Death|2|||
125520805|NCT00356759|451537831|FG000|Overall Study|Withdrawal by Subject|2|||
125520806|NCT00356759|451537832|FG001|Overall Study|Withdrawal by Subject|2|||
125520807|NCT00356759|451537831|FG000|Overall Study|Adverse Event|1|||
125520808|NCT00356759|451537832|FG001|Overall Study|Adverse Event|3|||
125520809|NCT00356759|451537831|FG000|Overall Study|Lost to Follow-up|1|||
125520810|NCT00356759|451537832|FG001|Overall Study|Lost to Follow-up|1|||
125520811|NCT00356759|451537831|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
125520812|NCT00356759|451537832|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
125520813|NCT00474383|451537834|FG000|Main Study|Adverse Event|11|||
125520814|NCT00474383|451537835|FG001|Main Study|Adverse Event|0|||
125520815|NCT00474383|451537834|FG000|Main Study|Symptomatic Deterioration|1|||
125520816|NCT00474383|451537835|FG001|Main Study|Symptomatic Deterioration|0|||
125520817|NCT00474383|451537834|FG000|Main Study|Progressive Disease|23|||
125520818|NCT00474383|451537835|FG001|Main Study|Progressive Disease|0|||
125520819|NCT00474383|451537834|FG000|Main Study|Other|1|||
125520820|NCT00474383|451537835|FG001|Main Study|Other|0|||
125520821|NCT00474383|451537834|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
125520822|NCT00474383|451537835|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
125520823|NCT00474383|451537834|FG000|Extension|Progressive Disease|0|||
125520824|NCT00474383|451537835|FG001|Extension|Progressive Disease|5|||
125520825|NCT02998918|451537836|FG000|Overall Study|Withdrawal by Subject|1|||
125520826|NCT02998918|451537837|FG001|Overall Study|Withdrawal by Subject|0|||
125520827|NCT00443599|451537843|FG000|Overall Study|Physician Decision|2|||
125520828|NCT00443599|451537844|FG001|Overall Study|Physician Decision|1|||
125520829|NCT00443599|451537843|FG000|Overall Study|Death|1|||
125520830|NCT00443599|451537844|FG001|Overall Study|Death|1|||
125520831|NCT00443599|451537843|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
125520832|NCT00443599|451537844|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
125520833|NCT00030823|451539776|FG000|Overall Study|Withdrawal by Subject|1|||
125520834|NCT04333147|451539778|FG000|Overall Study|Adverse Event|43|||
125520835|NCT04333147|451539779|FG001|Overall Study|Adverse Event|40|||
125520836|NCT04333147|451539778|FG000|Overall Study|Lack of Efficacy|49|||
125520837|NCT04333147|451539779|FG001|Overall Study|Lack of Efficacy|48|||
125520838|NCT04333147|451539778|FG000|Overall Study|Lost to Follow-up|19|||
125520839|NCT04333147|451539779|FG001|Overall Study|Lost to Follow-up|16|||
125520840|NCT04333147|451539778|FG000|Overall Study|Physician Decision|17|||
125520841|NCT04333147|451539779|FG001|Overall Study|Physician Decision|20|||
125520842|NCT04333147|451539778|FG000|Overall Study|Withdrawal by Subject|65|||
125520843|NCT04333147|451539779|FG001|Overall Study|Withdrawal by Subject|68|||
125520844|NCT04333147|451539778|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
125520845|NCT04333147|451539779|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
125520846|NCT04333147|451539778|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
125520847|NCT04333147|451539779|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
125520848|NCT04333147|451539778|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
125520849|NCT04333147|451539779|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
125520850|NCT00408928|451539780|FG000|Overall Study|Withdrawal by Subject|1|||
125520851|NCT00408928|451539780|FG000|Overall Study|Death|1|||
125520852|NCT00408928|451539780|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
125520853|NCT03194867|451539781|FG000|Overall Study|Incorrect completion of end of study form|0|||
125520854|NCT03194867|451539782|FG001|Overall Study|Incorrect completion of end of study form|0|||
125520855|NCT03194867|451539783|FG002|Overall Study|Incorrect completion of end of study form|1|||
125520856|NCT03194867|451539784|FG003|Overall Study|Incorrect completion of end of study form|0|||
125520857|NCT00464945|451539785|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
125520858|NCT00464945|451539786|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
125520859|NCT00464945|451539785|FG000|Infant Series|Protocol Violation|1|||
125520860|NCT00464945|451539786|FG001|Infant Series|Protocol Violation|0|||
125520861|NCT00464945|451539785|FG000|Infant Series|Lost to Follow-up|1|||
125520862|NCT00464945|451539786|FG001|Infant Series|Lost to Follow-up|0|||
125520863|NCT00464945|451539785|FG000|After Infant Series|Withdrawal by Subject|0|||
125520864|NCT00464945|451539786|FG001|After Infant Series|Withdrawal by Subject|2|||
125520865|NCT00464945|451539785|FG000|Toddler Dose|Lost to Follow-up|0|||
125520866|NCT00464945|451539786|FG001|Toddler Dose|Lost to Follow-up|1|||
125520867|NCT03305809|451539789|FG000|Overall Study|Adverse Event|2|||
125520868|NCT03305809|451539790|FG001|Overall Study|Adverse Event|2|||
125520869|NCT03305809|451539791|FG002|Overall Study|Adverse Event|6|||
125520870|NCT03305809|451539792|FG003|Overall Study|Adverse Event|6|||
125520871|NCT03305809|451539789|FG000|Overall Study|Death|0|||
125520872|NCT03305809|451539790|FG001|Overall Study|Death|0|||
125520873|NCT03305809|451539791|FG002|Overall Study|Death|1|||
125520874|NCT03305809|451539792|FG003|Overall Study|Death|1|||
125520875|NCT03305809|451539789|FG000|Overall Study|Lost to Follow-up|1|||
125520876|NCT03305809|451539790|FG001|Overall Study|Lost to Follow-up|2|||
125520877|NCT03305809|451539791|FG002|Overall Study|Lost to Follow-up|0|||
125520878|NCT03305809|451539792|FG003|Overall Study|Lost to Follow-up|0|||
125520879|NCT03305809|451539789|FG000|Overall Study|Sponsor Decision|1|||
125520880|NCT03305809|451539790|FG001|Overall Study|Sponsor Decision|0|||
125520881|NCT03305809|451539791|FG002|Overall Study|Sponsor Decision|1|||
125520882|NCT03305809|451539792|FG003|Overall Study|Sponsor Decision|8|||
125520883|NCT03305809|451539789|FG000|Overall Study|Physician Decision|0|||
125520884|NCT03305809|451539790|FG001|Overall Study|Physician Decision|0|||
125520885|NCT03305809|451539791|FG002|Overall Study|Physician Decision|2|||
125520886|NCT03305809|451539792|FG003|Overall Study|Physician Decision|4|||
125520887|NCT03305809|451539789|FG000|Overall Study|Progressive Disease|0|||
125520888|NCT03305809|451539790|FG001|Overall Study|Progressive Disease|0|||
125520889|NCT03305809|451539791|FG002|Overall Study|Progressive Disease|1|||
125520890|NCT03305809|451539792|FG003|Overall Study|Progressive Disease|0|||
125520891|NCT03305809|451539789|FG000|Overall Study|Protocol Violation|1|||
125520892|NCT03305809|451539790|FG001|Overall Study|Protocol Violation|0|||
125520893|NCT03305809|451539791|FG002|Overall Study|Protocol Violation|2|||
125520894|NCT03305809|451539792|FG003|Overall Study|Protocol Violation|3|||
125520895|NCT03305809|451539789|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
125520896|NCT03305809|451539790|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
125520897|NCT03305809|451539791|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
125520898|NCT03305809|451539792|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
125520899|NCT03305809|451539789|FG000|Overall Study|Withdrawal by Subject|2|||
125520900|NCT03305809|451539790|FG001|Overall Study|Withdrawal by Subject|4|||
125520901|NCT03305809|451539791|FG002|Overall Study|Withdrawal by Subject|5|||
125520902|NCT03305809|451539792|FG003|Overall Study|Withdrawal by Subject|2|||
125520903|NCT03305809|451539789|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
125520904|NCT03305809|451539790|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
125520905|NCT03305809|451539791|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
125520906|NCT03305809|451539792|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
125520907|NCT00816556|451539793|FG000|Overall Study|Adverse Event|1|||
125520908|NCT00816556|451539794|FG001|Overall Study|Adverse Event|1|||
125520909|NCT00816556|451539795|FG002|Overall Study|Adverse Event|1|||
125520910|NCT00816556|451539793|FG000|Overall Study|Withdrawal by Subject|1|||
125520911|NCT00816556|451539794|FG001|Overall Study|Withdrawal by Subject|1|||
125520912|NCT00816556|451539795|FG002|Overall Study|Withdrawal by Subject|1|||
125520913|NCT00816556|451539793|FG000|Overall Study|Lost to Follow-up|0|||
125520914|NCT00816556|451539794|FG001|Overall Study|Lost to Follow-up|0|||
125520915|NCT00816556|451539795|FG002|Overall Study|Lost to Follow-up|1|||
125520916|NCT03546816|451539796|FG000|Overall Study|Adverse Event|5|||
125520917|NCT03546816|451539797|FG001|Overall Study|Adverse Event|3|||
125520918|NCT03546816|451539796|FG000|Overall Study|Lack of Efficacy|2|||
125520919|NCT03546816|451539797|FG001|Overall Study|Lack of Efficacy|4|||
125520920|NCT03546816|451539796|FG000|Overall Study|Pregnancy|1|||
125520921|NCT03546816|451539797|FG001|Overall Study|Pregnancy|0|||
125520922|NCT03546816|451539796|FG000|Overall Study|Physician Decision|2|||
125520923|NCT03546816|451539797|FG001|Overall Study|Physician Decision|0|||
125520924|NCT03546816|451539796|FG000|Overall Study|Withdrawal by Subject|8|||
125520925|NCT03546816|451539797|FG001|Overall Study|Withdrawal by Subject|10|||
125520926|NCT03546816|451539796|FG000|Overall Study|Lost to Follow-up|3|||
125520927|NCT03546816|451539797|FG001|Overall Study|Lost to Follow-up|2|||
125520928|NCT02438371|451539798|FG000|Overall Study|Lost to Follow-up|3|||
125520929|NCT02438371|451539799|FG001|Overall Study|Lost to Follow-up|2|||
125520930|NCT02438371|451539798|FG000|Overall Study|Withdrawal by Subject|1|||
125520931|NCT02438371|451539799|FG001|Overall Study|Withdrawal by Subject|1|||
125520932|NCT01161446|451539800|FG000|Overall Study|Lost to Follow-up|18|||
125520933|NCT01161446|451539801|FG001|Overall Study|Lost to Follow-up|14|||
125520934|NCT01161446|451539800|FG000|Overall Study|Withdrawal by Subject|0|||
125520935|NCT01161446|451539801|FG001|Overall Study|Withdrawal by Subject|1|||
125520936|NCT03065933|451539802|FG000|Overall Study|study terminated|5|||
125520937|NCT02330562|451539803|FG000|Overall Study|Adverse Event|0|||
125520938|NCT02330562|451539804|FG001|Overall Study|Adverse Event|0|||
125520939|NCT02330562|451539805|FG002|Overall Study|Adverse Event|3|||
125520940|NCT02330562|451539806|FG003|Overall Study|Adverse Event|0|||
125520941|NCT02330562|451539807|FG004|Overall Study|Adverse Event|3|||
125520942|NCT02330562|451539808|FG005|Overall Study|Adverse Event|1|||
125520943|NCT02330562|451539809|FG006|Overall Study|Adverse Event|0|||
125520944|NCT02330562|451539810|FG007|Overall Study|Adverse Event|0|||
125520945|NCT02330562|451539811|FG008|Overall Study|Adverse Event|0|||
125520946|NCT02330562|451539812|FG009|Overall Study|Adverse Event|1|||
125520947|NCT02330562|451539813|FG010|Overall Study|Adverse Event|1|||
125520948|NCT02330562|451539803|FG000|Overall Study|Participant decision|1|||
125520949|NCT02330562|451539804|FG001|Overall Study|Participant decision|0|||
125520950|NCT02330562|451539805|FG002|Overall Study|Participant decision|4|||
125520951|NCT02330562|451539806|FG003|Overall Study|Participant decision|1|||
125520952|NCT02330562|451539807|FG004|Overall Study|Participant decision|5|||
125520953|NCT02330562|451539808|FG005|Overall Study|Participant decision|2|||
125520954|NCT02330562|451539809|FG006|Overall Study|Participant decision|0|||
125520955|NCT02330562|451539810|FG007|Overall Study|Participant decision|0|||
125520956|NCT02330562|451539811|FG008|Overall Study|Participant decision|0|||
125520957|NCT02330562|451539812|FG009|Overall Study|Participant decision|3|||
125520958|NCT02330562|451539813|FG010|Overall Study|Participant decision|0|||
125520959|NCT02330562|451539803|FG000|Overall Study|Disease progression|5|||
125520960|NCT02330562|451539804|FG001|Overall Study|Disease progression|3|||
125520961|NCT02330562|451539805|FG002|Overall Study|Disease progression|20|||
125520962|NCT02330562|451539806|FG003|Overall Study|Disease progression|28|||
125520963|NCT02330562|451539807|FG004|Overall Study|Disease progression|23|||
125520964|NCT02330562|451539808|FG005|Overall Study|Disease progression|7|||
125520965|NCT02330562|451539809|FG006|Overall Study|Disease progression|1|||
125520966|NCT02330562|451539810|FG007|Overall Study|Disease progression|1|||
125520967|NCT02330562|451539811|FG008|Overall Study|Disease progression|1|||
125520968|NCT02330562|451539812|FG009|Overall Study|Disease progression|0|||
125520969|NCT02330562|451539813|FG010|Overall Study|Disease progression|5|||
125520970|NCT02330562|451539803|FG000|Overall Study|Other reasons|0|||
125520971|NCT02330562|451539804|FG001|Overall Study|Other reasons|0|||
125520972|NCT02330562|451539805|FG002|Overall Study|Other reasons|0|||
125520973|NCT02330562|451539806|FG003|Overall Study|Other reasons|1|||
125520974|NCT02330562|451539807|FG004|Overall Study|Other reasons|0|||
125520975|NCT02330562|451539808|FG005|Overall Study|Other reasons|0|||
125520976|NCT02330562|451539809|FG006|Overall Study|Other reasons|0|||
125520977|NCT02330562|451539810|FG007|Overall Study|Other reasons|0|||
125520978|NCT02330562|451539811|FG008|Overall Study|Other reasons|0|||
125520979|NCT02330562|451539812|FG009|Overall Study|Other reasons|0|||
125520980|NCT02330562|451539813|FG010|Overall Study|Other reasons|0|||
125520981|NCT02330562|451539803|FG000|Overall Study|Withdrawal by Subject|0|||
125520982|NCT02330562|451539804|FG001|Overall Study|Withdrawal by Subject|0|||
125520983|NCT02330562|451539805|FG002|Overall Study|Withdrawal by Subject|0|||
125520984|NCT02330562|451539806|FG003|Overall Study|Withdrawal by Subject|0|||
125520985|NCT02330562|451539807|FG004|Overall Study|Withdrawal by Subject|0|||
125520986|NCT02330562|451539808|FG005|Overall Study|Withdrawal by Subject|0|||
125520987|NCT02330562|451539809|FG006|Overall Study|Withdrawal by Subject|0|||
125520988|NCT02330562|451539810|FG007|Overall Study|Withdrawal by Subject|0|||
125520989|NCT02330562|451539811|FG008|Overall Study|Withdrawal by Subject|0|||
125520990|NCT02330562|451539812|FG009|Overall Study|Withdrawal by Subject|1|||
125520991|NCT02330562|451539813|FG010|Overall Study|Withdrawal by Subject|0|||
125520992|NCT01162135|451539817|FG000|Overall Study|Withdrawal by Subject|1|||
125520993|NCT01162135|451539817|FG000|Overall Study|Severe back pain|1|||
125520994|NCT01162135|451539817|FG000|Overall Study|Ineligible|1|||
125520995|NCT01379703|451539818|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
125520996|NCT01379703|451539819|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
125520997|NCT01379703|451539820|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
125520998|NCT01379703|451539818|FG000|Study Start Through 9 Months|Adverse Event|0|||
125520999|NCT01379703|451539819|FG001|Study Start Through 9 Months|Adverse Event|14|||
125521000|NCT01379703|451539820|FG002|Study Start Through 9 Months|Adverse Event|10|||
125521001|NCT01379703|451539818|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
125521002|NCT01379703|451539819|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
125521003|NCT01379703|451539820|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
125521004|NCT01379703|451539818|FG000|Study Start Through 9 Months|Treatment Failure|0|||
125521005|NCT01379703|451539819|FG001|Study Start Through 9 Months|Treatment Failure|2|||
125521006|NCT01379703|451539820|FG002|Study Start Through 9 Months|Treatment Failure|2|||
125521007|NCT01379703|451539818|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
125521008|NCT01379703|451539819|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
125521009|NCT01379703|451539820|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
125521010|NCT01379703|451539818|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
125521011|NCT01379703|451539819|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
125521012|NCT01379703|451539820|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
125521013|NCT01379703|451539818|FG000|Study Start Through 9 Months|Medication not available|0|||
125521014|NCT01379703|451539819|FG001|Study Start Through 9 Months|Medication not available|2|||
125521015|NCT01379703|451539820|FG002|Study Start Through 9 Months|Medication not available|1|||
125521016|NCT01379703|451539818|FG000|Study Start Through 9 Months|Poor general condition|0|||
125521017|NCT01379703|451539819|FG001|Study Start Through 9 Months|Poor general condition|1|||
125521018|NCT01379703|451539820|FG002|Study Start Through 9 Months|Poor general condition|0|||
125521019|NCT01379703|451539818|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
125521020|NCT01379703|451539819|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
125521021|NCT01379703|451539820|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
125521022|NCT01379703|451539818|FG000|Study Start Through 9 Months|Reason unknown|2|||
125521023|NCT01379703|451539819|FG001|Study Start Through 9 Months|Reason unknown|31|||
125521024|NCT01379703|451539820|FG002|Study Start Through 9 Months|Reason unknown|24|||
125521025|NCT01379703|451539818|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
125521026|NCT01379703|451539819|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
125521027|NCT01379703|451539820|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
125521028|NCT01379703|451539818|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
125521029|NCT01379703|451539819|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
125521030|NCT01379703|451539820|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
125521031|NCT01379703|451539818|FG000|9 Months Through 18 Months|Adverse Event|0|||
125521032|NCT01379703|451539819|FG001|9 Months Through 18 Months|Adverse Event|6|||
125521033|NCT01379703|451539820|FG002|9 Months Through 18 Months|Adverse Event|0|||
125521034|NCT01379703|451539818|FG000|9 Months Through 18 Months|Treatment failure|0|||
125521035|NCT01379703|451539819|FG001|9 Months Through 18 Months|Treatment failure|5|||
125521036|NCT01379703|451539820|FG002|9 Months Through 18 Months|Treatment failure|0|||
125521037|NCT01379703|451539818|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
125521038|NCT01379703|451539819|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
125521039|NCT01379703|451539820|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
125521040|NCT01379703|451539818|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
125521041|NCT01379703|451539819|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
125521042|NCT01379703|451539820|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
125521043|NCT01379703|451539818|FG000|9 Months Through 18 Months|Fatigue|0|||
125521044|NCT01379703|451539819|FG001|9 Months Through 18 Months|Fatigue|1|||
125521045|NCT01379703|451539820|FG002|9 Months Through 18 Months|Fatigue|0|||
125521046|NCT01379703|451539818|FG000|9 Months Through 18 Months|Reason Unknown|0|||
125521047|NCT01379703|451539819|FG001|9 Months Through 18 Months|Reason Unknown|23|||
125521048|NCT01379703|451539820|FG002|9 Months Through 18 Months|Reason Unknown|0|||
125521049|NCT01316887|451539821|FG000|Overall Study|Adverse Event|13|||
125521050|NCT01316887|451539822|FG001|Overall Study|Adverse Event|21|||
125521051|NCT01316887|451539823|FG002|Overall Study|Adverse Event|17|||
125521052|NCT01316887|451539821|FG000|Overall Study|Lack of Efficacy|9|||
125521053|NCT01316887|451539822|FG001|Overall Study|Lack of Efficacy|3|||
125521054|NCT01316887|451539823|FG002|Overall Study|Lack of Efficacy|1|||
125521055|NCT01316887|451539821|FG000|Overall Study|Protocol Violation|2|||
125521056|NCT01316887|451539822|FG001|Overall Study|Protocol Violation|6|||
125521057|NCT01316887|451539823|FG002|Overall Study|Protocol Violation|6|||
125521058|NCT01316887|451539821|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
125521059|NCT01316887|451539822|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
125521060|NCT01316887|451539823|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
125521061|NCT01316887|451539821|FG000|Overall Study|Study Closed/Terminated|2|||
125521062|NCT01316887|451539822|FG001|Overall Study|Study Closed/Terminated|4|||
125521063|NCT01316887|451539823|FG002|Overall Study|Study Closed/Terminated|3|||
125521064|NCT01316887|451539821|FG000|Overall Study|Lost to Follow-up|1|||
125521065|NCT01316887|451539822|FG001|Overall Study|Lost to Follow-up|7|||
125521066|NCT01316887|451539823|FG002|Overall Study|Lost to Follow-up|5|||
125521067|NCT01316887|451539821|FG000|Overall Study|Withdrawal by Subject|8|||
125521068|NCT01316887|451539822|FG001|Overall Study|Withdrawal by Subject|16|||
125521069|NCT01316887|451539823|FG002|Overall Study|Withdrawal by Subject|15|||
125521070|NCT00813098|451539824|FG000|Overall Study|Adverse Event|2|||
125521071|NCT00813098|451539825|FG001|Overall Study|Adverse Event|4|||
125521072|NCT00813098|451539826|FG002|Overall Study|Adverse Event|1|||
125521073|NCT00813098|451539824|FG000|Overall Study|Withdrawal by Subject|0|||
125521074|NCT00813098|451539825|FG001|Overall Study|Withdrawal by Subject|1|||
125521075|NCT00813098|451539826|FG002|Overall Study|Withdrawal by Subject|0|||
125521076|NCT00813098|451539824|FG000|Overall Study|Inability to complete study procedures|1|||
125521077|NCT00813098|451539825|FG001|Overall Study|Inability to complete study procedures|0|||
125521078|NCT00813098|451539826|FG002|Overall Study|Inability to complete study procedures|0|||
125521079|NCT00813098|451539824|FG000|Overall Study|Lost to Follow-up|0|||
125521080|NCT00813098|451539825|FG001|Overall Study|Lost to Follow-up|1|||
125521081|NCT00813098|451539826|FG002|Overall Study|Lost to Follow-up|0|||
125521082|NCT00813098|451539824|FG000|Overall Study|Protocol Violation|0|||
125521083|NCT00813098|451539825|FG001|Overall Study|Protocol Violation|0|||
125521084|NCT00813098|451539826|FG002|Overall Study|Protocol Violation|1|||
125521085|NCT00813098|451539824|FG000|Overall Study|Principal Investigator decision|0|||
125521086|NCT00813098|451539825|FG001|Overall Study|Principal Investigator decision|1|||
125521087|NCT00813098|451539826|FG002|Overall Study|Principal Investigator decision|0|||
125521088|NCT00813098|451539824|FG000|Overall Study|Withdrew Consent|0|||
125521089|NCT00813098|451539825|FG001|Overall Study|Withdrew Consent|1|||
125521090|NCT00813098|451539826|FG002|Overall Study|Withdrew Consent|0|||
125521091|NCT03470545|451539829|FG000|Overall Study|Death|0|||
125521092|NCT03470545|451539830|FG001|Overall Study|Death|1|||
125521093|NCT03470545|451539829|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
125521094|NCT03470545|451539830|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
125521095|NCT03470545|451539829|FG000|Overall Study|Adverse Event|2|||
125521096|NCT03470545|451539830|FG001|Overall Study|Adverse Event|0|||
125521097|NCT03470545|451539829|FG000|Overall Study|Withdrawal by Subject|1|||
125521098|NCT03470545|451539830|FG001|Overall Study|Withdrawal by Subject|1|||
125521099|NCT03470545|451539829|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
125521100|NCT03470545|451539830|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
125521101|NCT02312206|451539831|FG000|Overall Study|Adverse Event|3|||
125521102|NCT02312206|451539832|FG001|Overall Study|Adverse Event|6|||
125521103|NCT02312206|451539831|FG000|Overall Study|Withdrawal by Subject|6|||
125521104|NCT02312206|451539832|FG001|Overall Study|Withdrawal by Subject|6|||
125521105|NCT02312206|451539831|FG000|Overall Study|Physician Decision|7|||
125521106|NCT02312206|451539832|FG001|Overall Study|Physician Decision|6|||
125521107|NCT02312206|451539831|FG000|Overall Study|Death|31|||
125521108|NCT02312206|451539832|FG001|Overall Study|Death|36|||
125521109|NCT02312206|451539831|FG000|Overall Study|Study Terminated by Sponsor|81|||
125521110|NCT02312206|451539832|FG001|Overall Study|Study Terminated by Sponsor|74|||
125521111|NCT02312206|451539831|FG000|Overall Study|Patient transferred to hospice|0|||
125521112|NCT02312206|451539832|FG001|Overall Study|Patient transferred to hospice|1|||
125521113|NCT02312206|451539831|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
125521114|NCT02312206|451539832|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
125521115|NCT02312206|451539831|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
125521116|NCT02312206|451539832|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
125521117|NCT02312206|451539831|FG000|Overall Study|Disease Progression|1|||
125521118|NCT02312206|451539832|FG001|Overall Study|Disease Progression|0|||
125521119|NCT00585975|451539833|FG000|Overall Study|Withdrawal by Subject|3|||
125521120|NCT00585975|451539834|FG001|Overall Study|Withdrawal by Subject|3|||
125521121|NCT00585975|451539833|FG000|Overall Study|Lost to Follow-up|2|||
125521122|NCT00585975|451539834|FG001|Overall Study|Lost to Follow-up|1|||
125521123|NCT00585975|451539833|FG000|Overall Study|Enrollment met/over-enrolled|10|||
125521124|NCT00585975|451539834|FG001|Overall Study|Enrollment met/over-enrolled|9|||
125521125|NCT03082612|451539835|FG000|Overall Study|Lost to Follow-up|2|||
125521126|NCT03082612|451539836|FG001|Overall Study|Lost to Follow-up|0|||
125521127|NCT01336205|451539837|FG000|Overall Study|Other|22|||
125521128|NCT01336205|451539838|FG001|Overall Study|Other|9|||
125521129|NCT01336205|451539837|FG000|Overall Study|Lost to Follow-up|40|||
125521130|NCT01336205|451539838|FG001|Overall Study|Lost to Follow-up|20|||
125521131|NCT01336205|451539837|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
125521132|NCT01336205|451539838|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
125521133|NCT01336205|451539837|FG000|Overall Study|Lack of Efficacy|4|||
125521134|NCT01336205|451539838|FG001|Overall Study|Lack of Efficacy|0|||
125521135|NCT01336205|451539837|FG000|Overall Study|Severe noncompliance with protocol|9|||
125521136|NCT01336205|451539838|FG001|Overall Study|Severe noncompliance with protocol|2|||
125521137|NCT01336205|451539837|FG000|Overall Study|Adverse Event|56|||
125521138|NCT01336205|451539838|FG001|Overall Study|Adverse Event|6|||
125521139|NCT01336205|451539837|FG000|Overall Study|Death|1|||
125521140|NCT01336205|451539838|FG001|Overall Study|Death|1|||
125521141|NCT01336205|451539837|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
125521142|NCT01336205|451539838|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
125521143|NCT01336205|451539837|FG000|Overall Study|Withdrawal by Subject|72|||
125521144|NCT01336205|451539838|FG001|Overall Study|Withdrawal by Subject|38|||
125521145|NCT01336205|451539837|FG000|Overall Study|Did not receive treatment|4|||
125521146|NCT01336205|451539838|FG001|Overall Study|Did not receive treatment|0|||
125521147|NCT01006616|451539839|FG000|Period 1 (6 Months)|Adverse Event|10|||
125521148|NCT01006616|451539840|FG001|Period 1 (6 Months)|Adverse Event|31|||
125521149|NCT01006616|451539841|FG002|Period 1 (6 Months)|Adverse Event|37|||
125521150|NCT01006616|451539842|FG003|Period 1 (6 Months)|Adverse Event|9|||
125521151|NCT01006616|451539839|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
125521152|NCT01006616|451539840|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
125521153|NCT01006616|451539841|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
125521154|NCT01006616|451539842|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
125521155|NCT01006616|451539839|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
125521156|NCT01006616|451539840|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
125521157|NCT01006616|451539841|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
125521158|NCT01006616|451539842|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
125521159|NCT01006616|451539839|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
125521160|NCT01006616|451539840|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
125521161|NCT01006616|451539841|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
125521162|NCT01006616|451539842|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
125521163|NCT01006616|451539839|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
125521164|NCT01006616|451539840|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
125521165|NCT01006616|451539841|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
125521166|NCT01006616|451539842|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
125521167|NCT01006616|451539839|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
125521168|NCT01006616|451539840|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
125521169|NCT01006616|451539841|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
125521170|NCT01006616|451539842|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
125521171|NCT01006616|451539839|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
125521172|NCT01006616|451539840|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
125521173|NCT01006616|451539841|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
125521174|NCT01006616|451539842|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
125521175|NCT01006616|451539839|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
125521176|NCT01006616|451539840|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
125521177|NCT01006616|451539841|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
125521178|NCT01006616|451539842|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
125521179|NCT01006616|451539839|FG000|Period 1 (6 Months)|Not Treated|0|||
125521180|NCT01006616|451539840|FG001|Period 1 (6 Months)|Not Treated|0|||
125521181|NCT01006616|451539841|FG002|Period 1 (6 Months)|Not Treated|1|||
125521182|NCT01006616|451539842|FG003|Period 1 (6 Months)|Not Treated|1|||
125521183|NCT01006616|451539839|FG000|Period 2 (18 Months)|Adverse Event|6|||
125521184|NCT01006616|451539840|FG001|Period 2 (18 Months)|Adverse Event|6|||
125521185|NCT01006616|451539841|FG002|Period 2 (18 Months)|Adverse Event|6|||
125521186|NCT01006616|451539842|FG003|Period 2 (18 Months)|Adverse Event|4|||
125521187|NCT01006616|451539839|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
125521188|NCT01006616|451539840|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
125521189|NCT01006616|451539841|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
125521190|NCT01006616|451539842|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
125521191|NCT01006616|451539839|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
125521192|NCT01006616|451539840|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
125521193|NCT01006616|451539841|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
125521194|NCT01006616|451539842|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
125521195|NCT01006616|451539839|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
125521196|NCT01006616|451539840|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
125521197|NCT01006616|451539841|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
125521198|NCT01006616|451539842|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
125521199|NCT01006616|451539839|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
125521200|NCT01006616|451539840|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
125521201|NCT01006616|451539841|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
125521202|NCT01006616|451539842|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
125521203|NCT01006616|451539839|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
125521204|NCT01006616|451539840|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
125521205|NCT01006616|451539841|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
125521206|NCT01006616|451539842|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
125521207|NCT01006616|451539839|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
125521208|NCT01006616|451539840|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
125521209|NCT01006616|451539841|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
125521210|NCT01006616|451539842|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
125521211|NCT01006616|451539839|FG000|Period 2 (18 Months)|Study Terminated|63|||
125521212|NCT01006616|451539840|FG001|Period 2 (18 Months)|Study Terminated|46|||
125521213|NCT01006616|451539841|FG002|Period 2 (18 Months)|Study Terminated|44|||
125521214|NCT01006616|451539842|FG003|Period 2 (18 Months)|Study Terminated|70|||
125521215|NCT03672175|451539843|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
125521216|NCT03672175|451539844|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
125521217|NCT03672175|451539845|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
125521218|NCT03672175|451539843|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
125521219|NCT03672175|451539844|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
125521220|NCT03672175|451539845|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
125521221|NCT03672175|451539843|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
125521222|NCT03672175|451539844|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
125521223|NCT03672175|451539845|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
125521224|NCT03672175|451539843|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
125521225|NCT03672175|451539844|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
125521226|NCT03672175|451539845|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
125521227|NCT03672175|451539843|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
125521228|NCT03672175|451539844|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
125521229|NCT03672175|451539845|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
125521230|NCT03672175|451539843|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
125521231|NCT03672175|451539844|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
125521232|NCT03672175|451539845|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
125521233|NCT03672175|451539843|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
125521234|NCT03672175|451539844|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
125521235|NCT03672175|451539845|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
125521236|NCT03672175|451539843|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
125521237|NCT03672175|451539844|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
125521238|NCT03672175|451539845|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
125521239|NCT03672175|451539843|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
125521240|NCT03672175|451539844|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
125521241|NCT03672175|451539845|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
125521242|NCT03672175|451539843|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
125521243|NCT03672175|451539844|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
125521244|NCT03672175|451539845|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
125521245|NCT03672175|451539843|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
125521246|NCT03672175|451539844|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
125521247|NCT03672175|451539845|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
125521248|NCT03672175|451539843|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
125521249|NCT03672175|451539844|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
125521250|NCT03672175|451539845|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
125521251|NCT02482935|451539848|FG000|Period 1|Withdrawal by Subject|1|||
125521252|NCT02482935|451539849|FG001|Period 1|Withdrawal by Subject|0|||
125521253|NCT03414047|451539850|FG000|Overall Study|Adverse Event|0|||
125521254|NCT03414047|451539851|FG001|Overall Study|Adverse Event|0|||
125521255|NCT03414047|451539852|FG002|Overall Study|Adverse Event|1|||
125521256|NCT03414047|451539853|FG003|Overall Study|Adverse Event|1|||
125521257|NCT03414047|451539850|FG000|Overall Study|Physician Decision|1|||
125521258|NCT03414047|451539851|FG001|Overall Study|Physician Decision|0|||
125521259|NCT03414047|451539852|FG002|Overall Study|Physician Decision|0|||
125521260|NCT03414047|451539853|FG003|Overall Study|Physician Decision|1|||
125521261|NCT03414047|451539850|FG000|Overall Study|Withdrawal by Subject|1|||
125521262|NCT03414047|451539851|FG001|Overall Study|Withdrawal by Subject|0|||
125521263|NCT03414047|451539852|FG002|Overall Study|Withdrawal by Subject|2|||
125521264|NCT03414047|451539853|FG003|Overall Study|Withdrawal by Subject|0|||
125521265|NCT00217022|451539861|FG000|Overall Study|Withdrawal by Subject|1|||
125521266|NCT00217022|451539862|FG001|Overall Study|Withdrawal by Subject|1|||
125521267|NCT02777242|451539866|FG000|Overall Study|Other|2|||
125521268|NCT02777242|451539866|FG000|Overall Study|Lost to Follow-up|1|||
125521269|NCT02777242|451539866|FG000|Overall Study|Multiple|1|||
125521270|NCT02777242|451539866|FG000|Overall Study|Sponsor's request|1|||
125521271|NCT02777242|451539866|FG000|Overall Study|Withdrawal by Subject|1|||
125521272|NCT01898442|451539867|FG000|Overall Study|Hemolysis/technical problems|1|||
125521273|NCT01898442|451539868|FG001|Overall Study|Hemolysis/technical problems|2|||
125521274|NCT01898442|451539869|FG002|Overall Study|Hemolysis/technical problems|2|||
125521275|NCT01898442|451539867|FG000|Overall Study|Patient vomited pills|0|||
125521276|NCT01898442|451539868|FG001|Overall Study|Patient vomited pills|0|||
125521277|NCT01898442|451539869|FG002|Overall Study|Patient vomited pills|1|||
125521278|NCT05178979|451539870|FG000|Overall Study|Death|0|||
125521279|NCT05178979|451539871|FG001|Overall Study|Death|5|||
125521280|NCT05178979|451539872|FG002|Overall Study|Death|0|||
125521281|NCT05178979|451539873|FG003|Overall Study|Death|3|||
125521282|NCT05178979|451539870|FG000|Overall Study|Adverse Event|0|||
125521283|NCT05178979|451539871|FG001|Overall Study|Adverse Event|1|||
125521284|NCT05178979|451539872|FG002|Overall Study|Adverse Event|0|||
125521285|NCT05178979|451539873|FG003|Overall Study|Adverse Event|0|||
125521286|NCT05178979|451539870|FG000|Overall Study|Lost to Follow-up|1|||
125521287|NCT05178979|451539871|FG001|Overall Study|Lost to Follow-up|8|||
125521288|NCT05178979|451539872|FG002|Overall Study|Lost to Follow-up|3|||
125521289|NCT05178979|451539873|FG003|Overall Study|Lost to Follow-up|8|||
125521290|NCT01747837|451539875|FG000|Overall Study|Lost to Follow-up|5|||
125521291|NCT01747837|451539876|FG001|Overall Study|Lost to Follow-up|2|||
125521292|NCT01747837|451539875|FG000|Overall Study|Death|4|||
125521293|NCT01747837|451539876|FG001|Overall Study|Death|4|||
125521294|NCT01435798|451539877|FG000|Overall Study|Withdrawal by Subject|1|||
125521295|NCT01253447|451539878|FG000|Overall Study|Adverse Event|2|||
125521296|NCT02299427|451539879|FG000|Overall Study|Withdrawal by Subject|1|||
125521297|NCT02299427|451539880|FG001|Overall Study|Withdrawal by Subject|0|||
125521298|NCT02299427|451539879|FG000|Overall Study|Lost to Follow-up|1|||
125521299|NCT02299427|451539880|FG001|Overall Study|Lost to Follow-up|3|||
125521300|NCT02299427|451539879|FG000|Overall Study|not adherent to dog website use|21|||
125521301|NCT02299427|451539880|FG001|Overall Study|not adherent to dog website use|0|||
125521302|NCT00937521|451539889|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
125521303|NCT00937521|451539890|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
125521304|NCT00937521|451539891|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
125521305|NCT00937521|451539892|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
125521306|NCT00937521|451539893|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
125521307|NCT00937521|451539894|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
125521308|NCT00937521|451539895|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
125521309|NCT00937521|451539896|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
125521310|NCT00937521|451539889|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
125521311|NCT00937521|451539890|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
125521312|NCT00937521|451539891|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
125521313|NCT00937521|451539892|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
125521314|NCT00937521|451539893|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
125521315|NCT00937521|451539894|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
125521316|NCT00937521|451539895|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
125521317|NCT00937521|451539896|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
125521318|NCT00937521|451539889|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
125521319|NCT00937521|451539890|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
125521320|NCT00937521|451539891|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
125521321|NCT00937521|451539892|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
125521322|NCT00937521|451539893|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
125521323|NCT00937521|451539894|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
125521324|NCT00937521|451539895|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
125521325|NCT00937521|451539896|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
125532614|NCT00350727|451580163|FG002|Phase II|Sponsor Terminated Study|1|||
125521326|NCT00937521|451539889|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
125521327|NCT00937521|451539890|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
125521328|NCT00937521|451539891|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
125521329|NCT00937521|451539892|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
125521330|NCT00937521|451539893|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
125521331|NCT00937521|451539894|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
125521332|NCT00937521|451539895|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
125521333|NCT00937521|451539896|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
125521334|NCT00937521|451539889|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
125521335|NCT00937521|451539890|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
125521336|NCT00937521|451539891|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
125521337|NCT00937521|451539892|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
125521338|NCT00937521|451539893|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
125521339|NCT00937521|451539894|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
125521340|NCT00937521|451539895|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
125521341|NCT00937521|451539896|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
125521342|NCT00937521|451539889|FG000|Booster Phase|Adverse Event|0|||
125521343|NCT00937521|451539890|FG001|Booster Phase|Adverse Event|0|||
125521344|NCT00937521|451539891|FG002|Booster Phase|Adverse Event|0|||
125521345|NCT00937521|451539892|FG003|Booster Phase|Adverse Event|0|||
125521346|NCT00937521|451539893|FG004|Booster Phase|Adverse Event|0|||
125521347|NCT00937521|451539894|FG005|Booster Phase|Adverse Event|0|||
125521348|NCT00937521|451539895|FG006|Booster Phase|Adverse Event|1|||
125521349|NCT00937521|451539896|FG007|Booster Phase|Adverse Event|0|||
125521350|NCT00937521|451539889|FG000|Booster Phase|Withdrawal by Subject|1|||
125521351|NCT00937521|451539890|FG001|Booster Phase|Withdrawal by Subject|0|||
125521352|NCT00937521|451539891|FG002|Booster Phase|Withdrawal by Subject|0|||
125521353|NCT00937521|451539892|FG003|Booster Phase|Withdrawal by Subject|1|||
125521354|NCT00937521|451539893|FG004|Booster Phase|Withdrawal by Subject|0|||
125521355|NCT00937521|451539894|FG005|Booster Phase|Withdrawal by Subject|0|||
125521356|NCT00937521|451539895|FG006|Booster Phase|Withdrawal by Subject|0|||
125521357|NCT00937521|451539896|FG007|Booster Phase|Withdrawal by Subject|2|||
125521358|NCT00937521|451539889|FG000|Booster Phase|Lost to Follow-up|2|||
125521359|NCT00937521|451539890|FG001|Booster Phase|Lost to Follow-up|2|||
125521360|NCT00937521|451539891|FG002|Booster Phase|Lost to Follow-up|4|||
125521361|NCT00937521|451539892|FG003|Booster Phase|Lost to Follow-up|2|||
125521362|NCT00937521|451539893|FG004|Booster Phase|Lost to Follow-up|4|||
125521363|NCT00937521|451539894|FG005|Booster Phase|Lost to Follow-up|4|||
125521364|NCT00937521|451539895|FG006|Booster Phase|Lost to Follow-up|3|||
125521365|NCT00937521|451539896|FG007|Booster Phase|Lost to Follow-up|0|||
125521366|NCT00937521|451539889|FG000|Booster Phase|Administrative Reason|0|||
125521367|NCT00937521|451539890|FG001|Booster Phase|Administrative Reason|0|||
125521368|NCT00937521|451539891|FG002|Booster Phase|Administrative Reason|1|||
125521369|NCT00937521|451539892|FG003|Booster Phase|Administrative Reason|0|||
125521370|NCT00937521|451539893|FG004|Booster Phase|Administrative Reason|1|||
125521371|NCT00937521|451539894|FG005|Booster Phase|Administrative Reason|1|||
125521372|NCT00937521|451539895|FG006|Booster Phase|Administrative Reason|0|||
125521373|NCT00937521|451539896|FG007|Booster Phase|Administrative Reason|0|||
125521374|NCT00937521|451539889|FG000|Booster Phase|Protocol Deviation|0|||
125521375|NCT00937521|451539890|FG001|Booster Phase|Protocol Deviation|0|||
125521376|NCT00937521|451539891|FG002|Booster Phase|Protocol Deviation|0|||
125521377|NCT00937521|451539892|FG003|Booster Phase|Protocol Deviation|0|||
125521378|NCT00937521|451539893|FG004|Booster Phase|Protocol Deviation|0|||
125521379|NCT00937521|451539894|FG005|Booster Phase|Protocol Deviation|0|||
125521380|NCT00937521|451539895|FG006|Booster Phase|Protocol Deviation|1|||
125521381|NCT00937521|451539896|FG007|Booster Phase|Protocol Deviation|0|||
125521382|NCT02980705|451539897|FG000|Overall Study|Adverse Event|0|||
125521383|NCT02980705|451539898|FG001|Overall Study|Adverse Event|1|||
125521384|NCT02980705|451539897|FG000|Overall Study|Withdrawal by Subject|6|||
125521385|NCT02980705|451539898|FG001|Overall Study|Withdrawal by Subject|9|||
125521386|NCT02980705|451539897|FG000|Overall Study|withdrew participation|0|||
125521387|NCT02980705|451539898|FG001|Overall Study|withdrew participation|1|||
125521388|NCT02980705|451539897|FG000|Overall Study|Lost to Follow-up|2|||
125521389|NCT02980705|451539898|FG001|Overall Study|Lost to Follow-up|0|||
125521390|NCT01721746|451539899|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
125521391|NCT01721746|451539900|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
125521392|NCT01721746|451539899|FG000|Pre-Treatment|Withdrawal by Subject|1|||
125521393|NCT01721746|451539900|FG001|Pre-Treatment|Withdrawal by Subject|16|||
125521394|NCT01721746|451539899|FG000|Pre-Treatment|Poor/Non-compliance|1|||
125521395|NCT01721746|451539900|FG001|Pre-Treatment|Poor/Non-compliance|0|||
125521396|NCT01721746|451539899|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
125521397|NCT01721746|451539900|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
125521398|NCT01721746|451539899|FG000|Treatment|Disease Progression|192|||
125521399|NCT01721746|451539900|FG001|Treatment|Disease Progression|74|||
125521400|NCT01721746|451539899|FG000|Treatment|Study Drug Toxicity|19|||
125521401|NCT01721746|451539900|FG001|Treatment|Study Drug Toxicity|11|||
125521402|NCT01721746|451539899|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
125521403|NCT01721746|451539900|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
125521404|NCT01721746|451539899|FG000|Treatment|Participant request to discontinue Study treatment|26|||
125521405|NCT01721746|451539900|FG001|Treatment|Participant request to discontinue Study treatment|7|||
125521406|NCT01721746|451539899|FG000|Treatment|Participant withdrew consent|4|||
125521407|NCT01721746|451539900|FG001|Treatment|Participant withdrew consent|2|||
125521408|NCT01721746|451539899|FG000|Treatment|Maximum Clinical Benefit|9|||
125521409|NCT01721746|451539900|FG001|Treatment|Maximum Clinical Benefit|3|||
125521410|NCT01721746|451539899|FG000|Treatment|Poor/Non-compliance|2|||
125521411|NCT01721746|451539900|FG001|Treatment|Poor/Non-compliance|0|||
125521412|NCT01721746|451539899|FG000|Treatment|Participant no longer met Study criteria|4|||
125521413|NCT01721746|451539900|FG001|Treatment|Participant no longer met Study criteria|0|||
125521414|NCT01721746|451539899|FG000|Treatment|Other reasons|6|||
125521415|NCT01721746|451539900|FG001|Treatment|Other reasons|2|||
125521416|NCT04353817|451539901|FG000|Overall Study|Adverse Event|0|||
125521417|NCT04353817|451539902|FG001|Overall Study|Adverse Event|1|||
125521418|NCT04358068|451539903|FG000|Overall Study|Did not initiate study treatment|2|||
125521419|NCT04358068|451539904|FG001|Overall Study|Did not initiate study treatment|2|||
125521420|NCT00239681|451539905|FG000|Overall Study|Adverse Event|100|||
125521421|NCT00239681|451539906|FG001|Overall Study|Adverse Event|99|||
125521422|NCT00239681|451539905|FG000|Overall Study|Withdrawal by Subject|458|||
125521423|NCT00239681|451539906|FG001|Overall Study|Withdrawal by Subject|489|||
125521424|NCT00239681|451539905|FG000|Overall Study|Lost to Follow-up|28|||
125521425|NCT00239681|451539906|FG001|Overall Study|Lost to Follow-up|22|||
125521426|NCT00239681|451539905|FG000|Overall Study|Protocol Violation|4|||
125521427|NCT00239681|451539906|FG001|Overall Study|Protocol Violation|4|||
125521428|NCT00239681|451539905|FG000|Overall Study|Physician Decision|13|||
125521429|NCT00239681|451539906|FG001|Overall Study|Physician Decision|17|||
125521430|NCT00239681|451539905|FG000|Overall Study|No information chacked on CaseReportForm|90|||
125521431|NCT00239681|451539906|FG001|Overall Study|No information chacked on CaseReportForm|84|||
125521432|NCT02447718|451539907|FG000|Overall Study|Lost to Follow-up|8|||
125521433|NCT02447718|451539908|FG001|Overall Study|Lost to Follow-up|0|||
125521434|NCT02447718|451539907|FG000|Overall Study|Withdrawal by Subject|3|||
125521435|NCT02447718|451539908|FG001|Overall Study|Withdrawal by Subject|0|||
125521436|NCT02447718|451539907|FG000|Overall Study|Screen Failure|1|||
125521437|NCT02447718|451539908|FG001|Overall Study|Screen Failure|0|||
125521438|NCT03599622|451539909|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
125521439|NCT03599622|451539910|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
125521440|NCT03599622|451539911|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
125521441|NCT03599622|451539912|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
125521442|NCT03599622|451539909|FG000|Pre-Treatment Period|Other reasons|1|||
125521443|NCT03599622|451539910|FG001|Pre-Treatment Period|Other reasons|1|||
125521444|NCT03599622|451539911|FG002|Pre-Treatment Period|Other reasons|1|||
125521445|NCT03599622|451539912|FG003|Pre-Treatment Period|Other reasons|0|||
125521446|NCT03599622|451539909|FG000|Treatment Period|Adverse Event|11|||
125521447|NCT03599622|451539910|FG001|Treatment Period|Adverse Event|20|||
125521448|NCT03599622|451539911|FG002|Treatment Period|Adverse Event|18|||
125521449|NCT03599622|451539912|FG003|Treatment Period|Adverse Event|2|||
125521450|NCT03599622|451539909|FG000|Treatment Period|Lack of Efficacy|18|||
125521451|NCT03599622|451539910|FG001|Treatment Period|Lack of Efficacy|12|||
125521452|NCT03599622|451539911|FG002|Treatment Period|Lack of Efficacy|13|||
125521453|NCT03599622|451539912|FG003|Treatment Period|Lack of Efficacy|2|||
125521454|NCT03599622|451539909|FG000|Treatment Period|Withdrawal by Subject|5|||
125521455|NCT03599622|451539910|FG001|Treatment Period|Withdrawal by Subject|11|||
125521456|NCT03599622|451539911|FG002|Treatment Period|Withdrawal by Subject|16|||
125521457|NCT03599622|451539912|FG003|Treatment Period|Withdrawal by Subject|1|||
125521458|NCT03599622|451539909|FG000|Treatment Period|Other reasons|4|||
125521459|NCT03599622|451539910|FG001|Treatment Period|Other reasons|6|||
125521460|NCT03599622|451539911|FG002|Treatment Period|Other reasons|7|||
125521461|NCT03599622|451539912|FG003|Treatment Period|Other reasons|0|||
125521462|NCT03599622|451539909|FG000|Treatment Period|Lost to Follow-up|1|||
125521463|NCT03599622|451539910|FG001|Treatment Period|Lost to Follow-up|0|||
125521464|NCT03599622|451539911|FG002|Treatment Period|Lost to Follow-up|0|||
125521465|NCT03599622|451539912|FG003|Treatment Period|Lost to Follow-up|0|||
125521466|NCT03599622|451539909|FG000|Treatment Period|Study terminated by sponsor|7|||
125521467|NCT03599622|451539910|FG001|Treatment Period|Study terminated by sponsor|20|||
125521468|NCT03599622|451539911|FG002|Treatment Period|Study terminated by sponsor|15|||
125521469|NCT03599622|451539912|FG003|Treatment Period|Study terminated by sponsor|0|||
125521470|NCT03599622|451539909|FG000|Treatment Period|Site terminated by sponsor|0|||
125521471|NCT03599622|451539910|FG001|Treatment Period|Site terminated by sponsor|1|||
125521472|NCT03599622|451539911|FG002|Treatment Period|Site terminated by sponsor|0|||
125521473|NCT03599622|451539912|FG003|Treatment Period|Site terminated by sponsor|0|||
125521474|NCT00770588|451539913|FG000|Overall Study|Adverse Event|9|||
125521475|NCT00770588|451539914|FG001|Overall Study|Adverse Event|2|||
125521476|NCT00770588|451539913|FG000|Overall Study|Death caused by progression of disease|70|||
125521477|NCT00770588|451539914|FG001|Overall Study|Death caused by progression of disease|91|||
125521478|NCT00770588|451539913|FG000|Overall Study|Lost to Follow-up|1|||
125521479|NCT00770588|451539914|FG001|Overall Study|Lost to Follow-up|1|||
125521480|NCT00770588|451539913|FG000|Overall Study|Withdrawal by Subject|1|||
125521481|NCT00770588|451539914|FG001|Overall Study|Withdrawal by Subject|1|||
125521482|NCT00468130|451539916|FG000|Overall Study|Adverse Event|2|||
125521483|NCT00468130|451539917|FG001|Overall Study|Adverse Event|1|||
125521484|NCT00468130|451539916|FG000|Overall Study|Withdrawal by Subject|0|||
125521485|NCT00468130|451539917|FG001|Overall Study|Withdrawal by Subject|1|||
125521486|NCT00436956|451539918|FG000|Overall Study|Not evaluable|1|||
125521487|NCT00436956|451539919|FG001|Overall Study|Not evaluable|0|||
125521488|NCT01006889|451539920|FG000|Overall Study|Withdrawal by Subject|3|||
125521489|NCT02143063|451539921|FG000|Overall Study|Lost to Follow-up|16|||
125521490|NCT02143063|451539922|FG001|Overall Study|Lost to Follow-up|28|||
125521491|NCT02143063|451539923|FG002|Overall Study|Lost to Follow-up|29|||
125521492|NCT02143063|451539921|FG000|Overall Study|Withdrawal by Subject|0|||
125521493|NCT02143063|451539922|FG001|Overall Study|Withdrawal by Subject|1|||
125521494|NCT02143063|451539923|FG002|Overall Study|Withdrawal by Subject|0|||
125521495|NCT02143063|451539921|FG000|Overall Study|Death|0|||
125521496|NCT02143063|451539922|FG001|Overall Study|Death|1|||
125521497|NCT02143063|451539923|FG002|Overall Study|Death|1|||
125521498|NCT00623363|451539926|FG000|Overall Study|Adverse Event|2|||
125521499|NCT00623363|451539927|FG001|Overall Study|Adverse Event|2|||
125521500|NCT01130168|451539929|FG000|Period 1|Withdrawal by Subject|0|||
125521501|NCT01130168|451539930|FG001|Period 1|Withdrawal by Subject|1|||
125521502|NCT01130168|451539931|FG002|Period 1|Withdrawal by Subject|0|||
125521503|NCT01130168|451539932|FG003|Period 1|Withdrawal by Subject|1|||
125521504|NCT01130168|451539933|FG004|Period 1|Withdrawal by Subject|0|||
125521505|NCT01130168|451539934|FG005|Period 1|Withdrawal by Subject|0|||
125521506|NCT01130168|451539929|FG000|Period 1|Discontinued For Other Reason|0|||
125521507|NCT01130168|451539930|FG001|Period 1|Discontinued For Other Reason|0|||
125521508|NCT01130168|451539931|FG002|Period 1|Discontinued For Other Reason|1|||
125521509|NCT01130168|451539932|FG003|Period 1|Discontinued For Other Reason|1|||
125521510|NCT01130168|451539933|FG004|Period 1|Discontinued For Other Reason|0|||
125521511|NCT01130168|451539934|FG005|Period 1|Discontinued For Other Reason|0|||
125521512|NCT01130168|451539929|FG000|Period 1|Adverse Event|0|||
125521513|NCT01130168|451539930|FG001|Period 1|Adverse Event|0|||
125521514|NCT01130168|451539931|FG002|Period 1|Adverse Event|0|||
125521515|NCT01130168|451539932|FG003|Period 1|Adverse Event|1|||
125521516|NCT01130168|451539933|FG004|Period 1|Adverse Event|0|||
125521517|NCT01130168|451539934|FG005|Period 1|Adverse Event|0|||
125521518|NCT01702519|451539935|FG000|Washout Period|Lost to Follow-up|1|||
125521519|NCT01702519|451539936|FG001|Washout Period|Lost to Follow-up|0|||
125521520|NCT01702519|451539935|FG000|Washout Period|Withdrawal by Subject|0|||
125521521|NCT01702519|451539936|FG001|Washout Period|Withdrawal by Subject|2|||
125521522|NCT03738397|451539937|FG000|Overall Study|Adverse Event|3|||
125521523|NCT03738397|451539938|FG001|Overall Study|Adverse Event|7|||
125521524|NCT03738397|451539937|FG000|Overall Study|Withdrawal by Subject|8|||
125521525|NCT03738397|451539938|FG001|Overall Study|Withdrawal by Subject|11|||
125521526|NCT03738397|451539937|FG000|Overall Study|Lost to Follow-up|7|||
125521527|NCT03738397|451539938|FG001|Overall Study|Lost to Follow-up|5|||
125521528|NCT03738397|451539937|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
125521529|NCT03738397|451539938|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
125521530|NCT03738397|451539937|FG000|Overall Study|Other|4|||
125521531|NCT03738397|451539938|FG001|Overall Study|Other|6|||
125521532|NCT00904722|451539941|FG000|Overall Study|Physician Decision|1|||
125521533|NCT01891890|451539942|FG000|Overall Study|Lost to Follow-up|0|||
125521534|NCT01891890|451539943|FG001|Overall Study|Lost to Follow-up|0|||
125521535|NCT01891890|451539944|FG002|Overall Study|Lost to Follow-up|1|||
125521536|NCT01891890|451539942|FG000|Overall Study|Study ended before endpoint reached|7|||
125521537|NCT01891890|451539943|FG001|Overall Study|Study ended before endpoint reached|3|||
125521538|NCT01891890|451539944|FG002|Overall Study|Study ended before endpoint reached|6|||
125521539|NCT03448536|451539951|FG000|Overall Study|Protocol Violation|2|||
125521540|NCT03448536|451539952|FG001|Overall Study|Protocol Violation|0|||
125521541|NCT03448536|451539951|FG000|Overall Study|Pregnancy|1|||
125521542|NCT03448536|451539952|FG001|Overall Study|Pregnancy|0|||
125521543|NCT03448536|451539951|FG000|Overall Study|Withdrawal by Subject|1|||
125521544|NCT03448536|451539952|FG001|Overall Study|Withdrawal by Subject|2|||
125521545|NCT03448536|451539951|FG000|Overall Study|Lost to Follow-up|3|||
125521546|NCT03448536|451539952|FG001|Overall Study|Lost to Follow-up|2|||
125521547|NCT03448536|451539951|FG000|Overall Study|Inadequate pain reporter|1|||
125521548|NCT03448536|451539952|FG001|Overall Study|Inadequate pain reporter|0|||
125521549|NCT03448536|451539951|FG000|Overall Study|Other|3|||
125521550|NCT03448536|451539952|FG001|Overall Study|Other|0|||
125521551|NCT03448536|451539951|FG000|Overall Study|Physician Decision|1|||
125521552|NCT03448536|451539952|FG001|Overall Study|Physician Decision|0|||
125521553|NCT04811339|451539957|FG000|Overall Study|lack of transportation not wanting to return|4|||
125521554|NCT04811339|451539958|FG001|Overall Study|lack of transportation not wanting to return|8|||
125521555|NCT04811339|451539959|FG002|Overall Study|lack of transportation not wanting to return|0|||
125521556|NCT04811339|451539957|FG000|Overall Study|Adverse Event|3|||
125521557|NCT04811339|451539958|FG001|Overall Study|Adverse Event|0|||
125521558|NCT04811339|451539959|FG002|Overall Study|Adverse Event|0|||
125521559|NCT04811339|451539957|FG000|Overall Study|Lost to Follow-up|1|||
125521560|NCT04811339|451539958|FG001|Overall Study|Lost to Follow-up|0|||
125521561|NCT04811339|451539959|FG002|Overall Study|Lost to Follow-up|0|||
125521562|NCT04811339|451539957|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
125521563|NCT04811339|451539958|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
125521564|NCT04811339|451539959|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
125521565|NCT04811339|451539957|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
125521566|NCT04811339|451539958|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
125521567|NCT04811339|451539959|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
125521568|NCT04811339|451539957|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
125521569|NCT04811339|451539958|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
125521570|NCT04811339|451539959|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
125521571|NCT04811339|451539957|FG000|Overall Study|Withdrawal by Subject|0|||
125521572|NCT04811339|451539958|FG001|Overall Study|Withdrawal by Subject|3|||
125521573|NCT04811339|451539959|FG002|Overall Study|Withdrawal by Subject|0|||
125521574|NCT04811339|451539957|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
125521575|NCT04811339|451539958|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
125521576|NCT04811339|451539959|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
125521577|NCT04811339|451539957|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
125521578|NCT04811339|451539958|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
125521579|NCT04811339|451539959|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
125521580|NCT00497874|451541593|FG000|Overall Study|Withdrawal by Subject|48|||
125521581|NCT00497874|451541594|FG001|Overall Study|Withdrawal by Subject|17|||
125521582|NCT00497874|451541593|FG000|Overall Study|Illness|8|||
125521583|NCT00497874|451541594|FG001|Overall Study|Illness|4|||
125521584|NCT00497874|451541593|FG000|Overall Study|Death|2|||
125521585|NCT00497874|451541594|FG001|Overall Study|Death|4|||
125521586|NCT00497874|451541593|FG000|Overall Study|Unable to contact|52|||
125521587|NCT00497874|451541594|FG001|Overall Study|Unable to contact|67|||
125521588|NCT00497874|451541593|FG000|Overall Study|Unable to schedule|37|||
125521589|NCT00497874|451541594|FG001|Overall Study|Unable to schedule|24|||
125521590|NCT04843579|451541598|FG000|Overall Study|Adverse Event|1|||
125521591|NCT04843579|451541598|FG000|Overall Study|Disease Progression|1|||
125521592|NCT04009629|451541599|FG000|Overall Study|Withdrawal by Subject|2|||
125521593|NCT04009629|451541600|FG001|Overall Study|Withdrawal by Subject|0|||
125521594|NCT04398368|451541601|FG000|Overall Study|Withdrawal by Subject|2|||
125521595|NCT02808975|451541603|FG000|Overall Study|Adverse Event|3|||
125521596|NCT02808975|451541604|FG001|Overall Study|Adverse Event|4|||
125521597|NCT02808975|451541603|FG000|Overall Study|Withdrew consent|9|||
125521598|NCT02808975|451541604|FG001|Overall Study|Withdrew consent|8|||
125521599|NCT02808975|451541603|FG000|Overall Study|Lost to Follow-up|4|||
125521600|NCT02808975|451541604|FG001|Overall Study|Lost to Follow-up|6|||
125521601|NCT02808975|451541603|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
125521602|NCT02808975|451541604|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
125521603|NCT02808975|451541603|FG000|Overall Study|Other, not specified|5|||
125521604|NCT02808975|451541604|FG001|Overall Study|Other, not specified|1|||
125521605|NCT03602586|451541605|FG000|Overall Study|Withdrawal by Subject|3|||
125521606|NCT03062449|451541606|FG000|Overall Study|Withdrawal by Subject|7|||
125521607|NCT03062449|451541607|FG001|Overall Study|Withdrawal by Subject|1|||
125521608|NCT03568812|451541609|FG000|Overall Study|Physician Decision|0|||
125521609|NCT03568812|451541610|FG001|Overall Study|Physician Decision|1|||
125521610|NCT04014790|451541611|FG000|Overall Study|Death|4|||
125521611|NCT04014790|451541611|FG000|Overall Study|Adverse Event|1|||
125521612|NCT04014790|451541611|FG000|Overall Study|Withdrawal by Subject|1|||
125521613|NCT02536742|451541612|FG000|Overall Study|Did not start protocol therapy|1|||
125521614|NCT02536742|451541612|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
125521615|NCT04629443|451541613|FG000|Overall Study|Adverse Event|2|||
125521616|NCT04629443|451541614|FG001|Overall Study|Adverse Event|1|||
125521617|NCT04629443|451541615|FG002|Overall Study|Adverse Event|2|||
125521618|NCT04629443|451541613|FG000|Overall Study|Progressive Disease|2|||
125521619|NCT04629443|451541614|FG001|Overall Study|Progressive Disease|3|||
125521620|NCT04629443|451541615|FG002|Overall Study|Progressive Disease|3|||
125521621|NCT04629443|451541613|FG000|Overall Study|Physician Decision|1|||
125521622|NCT04629443|451541614|FG001|Overall Study|Physician Decision|3|||
125521623|NCT04629443|451541615|FG002|Overall Study|Physician Decision|0|||
125521624|NCT01547117|451541616|FG000|Overall Study|Physician Decision|0|||
125521625|NCT01547117|451541617|FG001|Overall Study|Physician Decision|1|||
125521626|NCT01547117|451541618|FG002|Overall Study|Physician Decision|1|||
125521627|NCT01547117|451541619|FG003|Overall Study|Physician Decision|3|||
125521628|NCT01547117|451541616|FG000|Overall Study|Withdrawal by Subject|1|||
125521629|NCT01547117|451541617|FG001|Overall Study|Withdrawal by Subject|2|||
125521630|NCT01547117|451541618|FG002|Overall Study|Withdrawal by Subject|1|||
125521631|NCT01547117|451541619|FG003|Overall Study|Withdrawal by Subject|2|||
125521632|NCT03021551|451541620|FG000|Overall Study|Equipment Issues|2|||
125521633|NCT03021551|451541620|FG000|Overall Study|Protocol Violation|1|||
125521634|NCT02088554|451541624|FG000|Overall Study|Exited before procedure|130|||
125521635|NCT02088554|451541624|FG000|Overall Study|Attempted but not implanted|31|||
125521636|NCT02088554|451541624|FG000|Overall Study|Implant not attempted|19|||
125521637|NCT02088554|451541624|FG000|Overall Study|Pending next visit|532|||
125521638|NCT02088554|451541624|FG000|Overall Study|Death|170|||
125521639|NCT02088554|451541624|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
125521640|NCT02088554|451541624|FG000|Overall Study|Lost to Follow-up|23|||
125521641|NCT02088554|451541624|FG000|Overall Study|Explanted|32|||
125521642|NCT02088554|451541624|FG000|Overall Study|Any other reason not covered by previous categories|11|||
125521643|NCT03898960|451541627|FG000|Overall Study|Death|10|||
125521644|NCT00548847|451541628|FG000|Overall Study|Disease progression|7|||
125521645|NCT01086384|451541631|FG000|2-week Run-in Period|Adverse Event|1|||
125521646|NCT01086384|451541632|FG001|2-week Run-in Period|Adverse Event|0|||
125521647|NCT01086384|451541633|FG002|2-week Run-in Period|Adverse Event|0|||
125521648|NCT01086384|451541631|FG000|2-week Run-in Period|Protocol Violation|1|||
125521649|NCT01086384|451541632|FG001|2-week Run-in Period|Protocol Violation|0|||
125521650|NCT01086384|451541633|FG002|2-week Run-in Period|Protocol Violation|0|||
125521651|NCT01086384|451541631|FG000|2-week Run-in Period|Lost to Follow-up|1|||
125521652|NCT01086384|451541632|FG001|2-week Run-in Period|Lost to Follow-up|0|||
125521653|NCT01086384|451541633|FG002|2-week Run-in Period|Lost to Follow-up|0|||
125521654|NCT01086384|451541631|FG000|2-week Run-in Period|Physician Decision|6|||
125521655|NCT01086384|451541632|FG001|2-week Run-in Period|Physician Decision|0|||
125521656|NCT01086384|451541633|FG002|2-week Run-in Period|Physician Decision|0|||
125521657|NCT01086384|451541631|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
125521658|NCT01086384|451541632|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
125521659|NCT01086384|451541633|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
125521660|NCT01086384|451541631|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
125521661|NCT01086384|451541632|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
125521662|NCT01086384|451541633|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
125521663|NCT01086384|451541631|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
125521664|NCT01086384|451541632|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
125521665|NCT01086384|451541633|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
125521666|NCT01086384|451541631|FG000|2-week Run-in Period|Randomized in Error|1|||
125521667|NCT01086384|451541632|FG001|2-week Run-in Period|Randomized in Error|0|||
125521668|NCT01086384|451541633|FG002|2-week Run-in Period|Randomized in Error|0|||
125521669|NCT01086384|451541631|FG000|Treatment Period|Withdrawal by Subject|0|||
125521670|NCT01086384|451541632|FG001|Treatment Period|Withdrawal by Subject|53|||
125521671|NCT01086384|451541633|FG002|Treatment Period|Withdrawal by Subject|55|||
125521672|NCT01086384|451541631|FG000|Treatment Period|Protocol Violation|0|||
125521673|NCT01086384|451541632|FG001|Treatment Period|Protocol Violation|26|||
125521674|NCT01086384|451541633|FG002|Treatment Period|Protocol Violation|17|||
125521675|NCT01086384|451541631|FG000|Treatment Period|Lack of Efficacy|0|||
125521676|NCT01086384|451541632|FG001|Treatment Period|Lack of Efficacy|22|||
125521677|NCT01086384|451541633|FG002|Treatment Period|Lack of Efficacy|13|||
125521678|NCT01086384|451541631|FG000|Treatment Period|Adverse Event|0|||
125521679|NCT01086384|451541632|FG001|Treatment Period|Adverse Event|19|||
125521680|NCT01086384|451541633|FG002|Treatment Period|Adverse Event|15|||
125521681|NCT01086384|451541631|FG000|Treatment Period|Lost to Follow-up|0|||
125521682|NCT01086384|451541632|FG001|Treatment Period|Lost to Follow-up|11|||
125521683|NCT01086384|451541633|FG002|Treatment Period|Lost to Follow-up|9|||
125521684|NCT01086384|451541631|FG000|Treatment Period|Physician Decision|0|||
125521685|NCT01086384|451541632|FG001|Treatment Period|Physician Decision|9|||
125521686|NCT01086384|451541633|FG002|Treatment Period|Physician Decision|6|||
125521687|NCT01086384|451541631|FG000|Treatment Period|Study Closed/Terminated|0|||
125521688|NCT01086384|451541632|FG001|Treatment Period|Study Closed/Terminated|7|||
125521689|NCT01086384|451541633|FG002|Treatment Period|Study Closed/Terminated|8|||
125521690|NCT01086384|451541631|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
125521691|NCT01086384|451541632|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
125521692|NCT01086384|451541633|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
125521693|NCT01086384|451541631|FG000|Treatment Period|Received Treatment in Error|0|||
125521694|NCT01086384|451541632|FG001|Treatment Period|Received Treatment in Error|1|||
125521695|NCT01086384|451541633|FG002|Treatment Period|Received Treatment in Error|0|||
125521696|NCT00992992|451541634|FG000|Overall Study|Lost to Follow-up|3|||
125521697|NCT00992992|451541634|FG000|Overall Study|Death|16|||
125521698|NCT00992992|451541634|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
125521699|NCT00992992|451541634|FG000|Overall Study|Sponsor Closed the Study|4|||
125521700|NCT02250534|451541635|FG000|Overall Study|Lost to Follow-up|18|||
125521701|NCT02250534|451541636|FG001|Overall Study|Lost to Follow-up|28|||
125521702|NCT02250534|451541637|FG002|Overall Study|Lost to Follow-up|33|||
125521703|NCT02250534|451541635|FG000|Overall Study|Personal reasons|7|||
125521704|NCT02250534|451541636|FG001|Overall Study|Personal reasons|8|||
125521705|NCT02250534|451541637|FG002|Overall Study|Personal reasons|14|||
125521706|NCT02250534|451541635|FG000|Overall Study|Adverse Event|6|||
125521707|NCT02250534|451541636|FG001|Overall Study|Adverse Event|3|||
125521708|NCT02250534|451541637|FG002|Overall Study|Adverse Event|8|||
125521709|NCT02250534|451541635|FG000|Overall Study|incarcerated|2|||
125521710|NCT02250534|451541636|FG001|Overall Study|incarcerated|1|||
125521711|NCT02250534|451541637|FG002|Overall Study|incarcerated|2|||
125521712|NCT02250534|451541635|FG000|Overall Study|Withdrawal by Subject|0|||
125521713|NCT02250534|451541636|FG001|Overall Study|Withdrawal by Subject|1|||
125521714|NCT02250534|451541637|FG002|Overall Study|Withdrawal by Subject|2|||
125521715|NCT02250534|451541635|FG000|Overall Study|Death|0|||
125521716|NCT02250534|451541636|FG001|Overall Study|Death|1|||
125521717|NCT02250534|451541637|FG002|Overall Study|Death|1|||
125521718|NCT02250534|451541635|FG000|Overall Study|Physician Decision|1|||
125521719|NCT02250534|451541636|FG001|Overall Study|Physician Decision|3|||
125521720|NCT02250534|451541637|FG002|Overall Study|Physician Decision|1|||
125521721|NCT02250534|451541635|FG000|Overall Study|Protocol Violation|1|||
125521722|NCT02250534|451541636|FG001|Overall Study|Protocol Violation|0|||
125521723|NCT02250534|451541637|FG002|Overall Study|Protocol Violation|1|||
125521724|NCT02250534|451541635|FG000|Overall Study|Reason unknown|1|||
125521725|NCT02250534|451541636|FG001|Overall Study|Reason unknown|0|||
125521726|NCT02250534|451541637|FG002|Overall Study|Reason unknown|0|||
125521727|NCT02725567|451541639|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
125521728|NCT02725567|451541640|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
125521729|NCT02725567|451541639|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
125521730|NCT02725567|451541640|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
125521731|NCT02725567|451541639|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
125521732|NCT02725567|451541640|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
125521733|NCT00255944|451541641|FG000|Overall Study|Lost to Follow-up|797|||
125521734|NCT00255944|451541642|FG001|Overall Study|Lost to Follow-up|834|||
125521735|NCT01129115|451541643|FG000|Overall Study|Adverse Event|1|||
125521736|NCT01129115|451541644|FG001|Overall Study|Adverse Event|2|||
125521737|NCT01129115|451541645|FG002|Overall Study|Adverse Event|3|||
125521738|NCT01129115|451541646|FG003|Overall Study|Adverse Event|3|||
125521739|NCT01129115|451541643|FG000|Overall Study|Withdrawal by Subject|1|||
125521740|NCT01129115|451541644|FG001|Overall Study|Withdrawal by Subject|3|||
125521741|NCT01129115|451541645|FG002|Overall Study|Withdrawal by Subject|1|||
125521742|NCT01129115|451541646|FG003|Overall Study|Withdrawal by Subject|4|||
125521743|NCT01129115|451541643|FG000|Overall Study|Protocol Violation|0|||
125521744|NCT01129115|451541644|FG001|Overall Study|Protocol Violation|2|||
125521745|NCT01129115|451541645|FG002|Overall Study|Protocol Violation|2|||
125521746|NCT01129115|451541646|FG003|Overall Study|Protocol Violation|2|||
125521747|NCT00817336|451541649|FG000|Overall Study|Withdrawal by Subject|1|||
125521748|NCT00817336|451541650|FG001|Overall Study|Withdrawal by Subject|1|||
125521749|NCT02108652|451541651|FG000|Overall Study|Death|253|||
125521750|NCT02108652|451541651|FG000|Overall Study|Lost to Follow-up|2|||
125521751|NCT02108652|451541651|FG000|Overall Study|Withdrawal by Subject|16|||
125521752|NCT02108652|451541651|FG000|Overall Study|Study Terminated By Sponsor|31|||
125521753|NCT02108652|451541651|FG000|Overall Study|Non-Compliance|1|||
125521754|NCT02108652|451541651|FG000|Overall Study|Physician Decision|6|||
125521755|NCT02108652|451541651|FG000|Overall Study|Progression Of Disease|1|||
125521756|NCT01182181|451541652|FG000|First Intervention|Adverse Event|1|||
125521757|NCT01182181|451541653|FG001|First Intervention|Adverse Event|0|||
125521758|NCT01182181|451541652|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
125521759|NCT01182181|451541653|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
125521760|NCT01121913|451541654|FG000|First Intervention Period|Adverse Event|0|||
125521761|NCT01121913|451541655|FG001|First Intervention Period|Adverse Event|0|||
125521762|NCT01121913|451541656|FG002|First Intervention Period|Adverse Event|1|||
125521763|NCT01121913|451541657|FG003|First Intervention Period|Adverse Event|0|||
125521764|NCT01121913|451541654|FG000|First Washout Period|Withdrawal by Subject|1|||
125521765|NCT01121913|451541655|FG001|First Washout Period|Withdrawal by Subject|0|||
125521766|NCT01121913|451541656|FG002|First Washout Period|Withdrawal by Subject|0|||
125521767|NCT01121913|451541657|FG003|First Washout Period|Withdrawal by Subject|0|||
125521768|NCT01121913|451541654|FG000|Second Intervention Period|Adverse Event|0|||
125521769|NCT01121913|451541655|FG001|Second Intervention Period|Adverse Event|0|||
125521770|NCT01121913|451541656|FG002|Second Intervention Period|Adverse Event|1|||
125521771|NCT01121913|451541657|FG003|Second Intervention Period|Adverse Event|0|||
125521772|NCT01121913|451541654|FG000|Second Washout Period|Withdrawal by Subject|0|||
125521773|NCT01121913|451541655|FG001|Second Washout Period|Withdrawal by Subject|0|||
125521774|NCT01121913|451541656|FG002|Second Washout Period|Withdrawal by Subject|1|||
125521775|NCT01121913|451541657|FG003|Second Washout Period|Withdrawal by Subject|0|||
125521776|NCT01121913|451541654|FG000|Third Washout Period|Adverse Event|1|||
125521777|NCT01121913|451541655|FG001|Third Washout Period|Adverse Event|0|||
125521778|NCT01121913|451541656|FG002|Third Washout Period|Adverse Event|0|||
125521779|NCT01121913|451541657|FG003|Third Washout Period|Adverse Event|0|||
125521780|NCT02564718|451541660|FG000|Overall Study|Withdrew from treatment|0|||
125521781|NCT02564718|451541661|FG001|Overall Study|Withdrew from treatment|1|||
125521782|NCT01017263|451541662|FG000|Overall Study|not eligible|12|||
125521783|NCT00002597|451541663|FG000|Overall Study|Protocol Violation|19|||
125521784|NCT00002597|451541664|FG001|Overall Study|Protocol Violation|17|||
125521785|NCT00002597|451541663|FG000|Overall Study|Withdrawal by Subject|7|||
125521786|NCT00002597|451541664|FG001|Overall Study|Withdrawal by Subject|6|||
125521787|NCT02654132|451541665|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
125521788|NCT02654132|451541666|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
125521789|NCT02654132|451541665|FG000|Treatment Period|Disease progression|43|||
125521790|NCT02654132|451541666|FG001|Treatment Period|Disease progression|38|||
125521791|NCT02654132|451541665|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
125521792|NCT02654132|451541666|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
125521793|NCT02654132|451541665|FG000|Treatment Period|Other reasons|4|||
125521794|NCT02654132|451541666|FG001|Treatment Period|Other reasons|2|||
125521795|NCT02654132|451541665|FG000|Treatment Period|Study drug toxicity|2|||
125521796|NCT02654132|451541666|FG001|Treatment Period|Study drug toxicity|2|||
125521797|NCT02654132|451541665|FG000|Treatment Period|Withdrawal by Subject|2|||
125521798|NCT02654132|451541666|FG001|Treatment Period|Withdrawal by Subject|1|||
125521799|NCT02654132|451541665|FG000|Treatment Period|Maximum Clinical Benefit|0|||
125521800|NCT02654132|451541666|FG001|Treatment Period|Maximum Clinical Benefit|2|||
125521801|NCT02654132|451541665|FG000|Treatment Period|Participant request to discontinue|2|||
125521802|NCT02654132|451541666|FG001|Treatment Period|Participant request to discontinue|0|||
125521803|NCT02654132|451541665|FG000|Treatment Period|Administrative reasons by sponsor|0|||
125521804|NCT02654132|451541666|FG001|Treatment Period|Administrative reasons by sponsor|1|||
125521805|NCT02654132|451541665|FG000|Treatment Period|Death|1|||
125521806|NCT02654132|451541666|FG001|Treatment Period|Death|0|||
125521807|NCT02485899|451541668|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
125521808|NCT02485899|451541669|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125521809|NCT02485899|451541668|FG000|Overall Study|Withdrawal by Subject|1|||
125521810|NCT02485899|451541669|FG001|Overall Study|Withdrawal by Subject|0|||
125521811|NCT02485899|451541668|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
125521812|NCT02485899|451541669|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
125521813|NCT01918371|451541670|FG000|Overall Study|Missing Data|1|||
125521814|NCT01918371|451541671|FG001|Overall Study|Missing Data|1|||
125521815|NCT01880437|451541672|FG000|Overall Study|Death|12|||
125521816|NCT01880437|451541673|FG001|Overall Study|Death|4|||
125521817|NCT01880437|451541674|FG002|Overall Study|Death|17|||
125521818|NCT01880437|451541672|FG000|Overall Study|Study terminated by Sponsor|3|||
125521819|NCT01880437|451541673|FG001|Overall Study|Study terminated by Sponsor|0|||
125521820|NCT01880437|451541674|FG002|Overall Study|Study terminated by Sponsor|2|||
125521821|NCT00823836|451541675|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
125521822|NCT00823836|451541676|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
125521823|NCT00823836|451541675|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
125521824|NCT00823836|451541676|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
125521825|NCT00823836|451541675|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
125521826|NCT00823836|451541676|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
125521827|NCT00823836|451541675|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
125521828|NCT00823836|451541676|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
125521829|NCT00823836|451541675|FG000|Long-term Phase|Adverse Event|3|||
125521830|NCT00823836|451541676|FG001|Long-term Phase|Adverse Event|2|||
125521831|NCT00823836|451541675|FG000|Long-term Phase|Physician Decision|1|||
125521832|NCT00823836|451541676|FG001|Long-term Phase|Physician Decision|2|||
125521833|NCT00823836|451541675|FG000|Long-term Phase|Withdrawal by Subject|1|||
125521834|NCT00823836|451541676|FG001|Long-term Phase|Withdrawal by Subject|1|||
125521835|NCT03713320|451541677|FG000|Randomized Period|Adverse Event|1|||
125521836|NCT03713320|451541678|FG001|Randomized Period|Adverse Event|5|||
125521837|NCT03713320|451541679|FG002|Randomized Period|Adverse Event|0|||
125521838|NCT03713320|451541677|FG000|Randomized Period|Physician Decision|1|||
125521839|NCT03713320|451541678|FG001|Randomized Period|Physician Decision|1|||
125521840|NCT03713320|451541679|FG002|Randomized Period|Physician Decision|0|||
125521841|NCT03713320|451541677|FG000|Randomized Period|Withdrawal by Subject|4|||
125521842|NCT03713320|451541678|FG001|Randomized Period|Withdrawal by Subject|0|||
125521843|NCT03713320|451541679|FG002|Randomized Period|Withdrawal by Subject|0|||
125521844|NCT03713320|451541677|FG000|Randomized Period|Participant decision|3|||
125521845|NCT03713320|451541678|FG001|Randomized Period|Participant decision|1|||
125521846|NCT03713320|451541679|FG002|Randomized Period|Participant decision|0|||
125521847|NCT03713320|451541677|FG000|Randomized Period|Study terminated by sponsor|6|||
125521848|NCT03713320|451541678|FG001|Randomized Period|Study terminated by sponsor|3|||
125521849|NCT03713320|451541679|FG002|Randomized Period|Study terminated by sponsor|0|||
125521850|NCT03713320|451541677|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
125521851|NCT03713320|451541678|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
125521852|NCT03713320|451541679|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
125521853|NCT03713320|451541677|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
125521854|NCT03713320|451541678|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
125521855|NCT03713320|451541679|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
125521856|NCT04354168|451541684|FG000|Overall Study|Lost to Follow-up|22|||
125521857|NCT01438840|451541687|FG000|Core Study|Adverse Event|0|||
125521858|NCT01438840|451541688|FG001|Core Study|Adverse Event|3|||
125521859|NCT01438840|451541689|FG002|Core Study|Adverse Event|0|||
125521860|NCT01438840|451541687|FG000|Core Study|Lack of Efficacy|15|||
125521861|NCT01438840|451541688|FG001|Core Study|Lack of Efficacy|7|||
125521862|NCT01438840|451541689|FG002|Core Study|Lack of Efficacy|0|||
125521863|NCT01438840|451541687|FG000|Core Study|Withdrawal of consent|1|||
125521864|NCT01438840|451541688|FG001|Core Study|Withdrawal of consent|0|||
125521865|NCT01438840|451541689|FG002|Core Study|Withdrawal of consent|0|||
125521866|NCT01438840|451541687|FG000|Extension Phase|Adverse Event|0|||
125521867|NCT01438840|451541688|FG001|Extension Phase|Adverse Event|0|||
125521868|NCT01438840|451541689|FG002|Extension Phase|Adverse Event|3|||
125521869|NCT01438840|451541687|FG000|Extension Phase|Lost to Follow-up|0|||
125521870|NCT01438840|451541688|FG001|Extension Phase|Lost to Follow-up|0|||
125521871|NCT01438840|451541689|FG002|Extension Phase|Lost to Follow-up|1|||
125521872|NCT01438840|451541687|FG000|Extension Phase|Withdrawal by Subject|0|||
125521873|NCT01438840|451541688|FG001|Extension Phase|Withdrawal by Subject|0|||
125521874|NCT01438840|451541689|FG002|Extension Phase|Withdrawal by Subject|3|||
125521875|NCT01438840|451541687|FG000|Extension Phase|Lack of Efficacy|0|||
125521876|NCT01438840|451541688|FG001|Extension Phase|Lack of Efficacy|0|||
125521877|NCT01438840|451541689|FG002|Extension Phase|Lack of Efficacy|2|||
125521878|NCT01438840|451541687|FG000|Extension Phase|Other|0|||
125521879|NCT01438840|451541688|FG001|Extension Phase|Other|0|||
125521880|NCT01438840|451541689|FG002|Extension Phase|Other|1|||
125521881|NCT02062645|451541692|FG000|Overall Study|Adverse Event|2|||
125521882|NCT02062645|451541692|FG000|Overall Study|Protocol Violation|8|||
125521883|NCT02062645|451541692|FG000|Overall Study|Lost to Follow-up|5|||
125521884|NCT02804399|451541693|FG000|Period 2|Adverse Event|0|||
125521885|NCT02804399|451541694|FG001|Period 2|Adverse Event|1|||
125521886|NCT01774305|451541695|FG000|Overall Study|Physician Decision|1|||
125521887|NCT01774305|451541696|FG001|Overall Study|Physician Decision|0|||
125521888|NCT04211389|451541697|FG000|Overall Study|Adverse Event|1|||
125521889|NCT04211389|451541698|FG001|Overall Study|Adverse Event|2|||
125521890|NCT04211389|451541697|FG000|Overall Study|Lost to Follow-up|15|||
125521891|NCT04211389|451541698|FG001|Overall Study|Lost to Follow-up|7|||
125521892|NCT04211389|451541697|FG000|Overall Study|Protocol Violation|0|||
125521893|NCT04211389|451541698|FG001|Overall Study|Protocol Violation|1|||
125521894|NCT04211389|451541697|FG000|Overall Study|Withdrawal by Subject|10|||
125521895|NCT04211389|451541698|FG001|Overall Study|Withdrawal by Subject|11|||
125521896|NCT00087555|451541702|FG000|Overall Study|Adverse Event|3|||
125521897|NCT00087555|451541703|FG001|Overall Study|Adverse Event|6|||
125521898|NCT00087555|451541704|FG002|Overall Study|Adverse Event|14|||
125521899|NCT00087555|451541702|FG000|Overall Study|Lost to Follow-up|0|||
125521900|NCT00087555|451541703|FG001|Overall Study|Lost to Follow-up|1|||
125521901|NCT00087555|451541704|FG002|Overall Study|Lost to Follow-up|1|||
125521902|NCT00087555|451541702|FG000|Overall Study|Non - Compliance|1|||
125521903|NCT00087555|451541703|FG001|Overall Study|Non - Compliance|0|||
125521904|NCT00087555|451541704|FG002|Overall Study|Non - Compliance|0|||
125521905|NCT00087555|451541702|FG000|Overall Study|Protocol Violation|0|||
125521906|NCT00087555|451541703|FG001|Overall Study|Protocol Violation|0|||
125521907|NCT00087555|451541704|FG002|Overall Study|Protocol Violation|2|||
125521908|NCT00087555|451541702|FG000|Overall Study|Screen Failure|1|||
125521909|NCT00087555|451541703|FG001|Overall Study|Screen Failure|1|||
125521910|NCT00087555|451541704|FG002|Overall Study|Screen Failure|0|||
125521911|NCT00087555|451541702|FG000|Overall Study|Pregnancy|0|||
125521912|NCT00087555|451541703|FG001|Overall Study|Pregnancy|1|||
125521913|NCT00087555|451541704|FG002|Overall Study|Pregnancy|1|||
125521914|NCT00087555|451541702|FG000|Overall Study|Withdrawal by Subject|3|||
125521915|NCT00087555|451541703|FG001|Overall Study|Withdrawal by Subject|2|||
125521916|NCT00087555|451541704|FG002|Overall Study|Withdrawal by Subject|1|||
125521917|NCT00087555|451541702|FG000|Overall Study|Lack of Efficacy|2|||
125521918|NCT00087555|451541703|FG001|Overall Study|Lack of Efficacy|0|||
125521919|NCT00087555|451541704|FG002|Overall Study|Lack of Efficacy|1|||
125521920|NCT00087555|451541702|FG000|Overall Study|Non Compliance|0|||
125521921|NCT00087555|451541703|FG001|Overall Study|Non Compliance|0|||
125521922|NCT00087555|451541704|FG002|Overall Study|Non Compliance|1|||
125521923|NCT00087555|451541702|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
125521924|NCT00087555|451541703|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
125521925|NCT00087555|451541704|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
125521926|NCT00087555|451541702|FG000|Overall Study|Patient wanted to go back on Med|1|||
125521927|NCT00087555|451541703|FG001|Overall Study|Patient wanted to go back on Med|0|||
125521928|NCT00087555|451541704|FG002|Overall Study|Patient wanted to go back on Med|0|||
125521929|NCT01062971|451541707|FG000|Overall Study|Protocol Violation|1|||
125521930|NCT01062971|451541708|FG001|Overall Study|Protocol Violation|3|||
125521931|NCT01062971|451541707|FG000|Overall Study|Lost to Follow-up|3|||
125521932|NCT01062971|451541708|FG001|Overall Study|Lost to Follow-up|4|||
125521933|NCT01530087|451541709|FG000|Overall Study|Physician Decision|2|||
125521934|NCT05523219|451541710|FG000|Overall Study|Wrong inclusion|1|||
125521935|NCT05523219|451541710|FG000|Overall Study|Lost to Follow-up|7|||
125521936|NCT02261285|451541711|FG000|Overall Study|Disease progression|0|||
125521937|NCT02261285|451541712|FG001|Overall Study|Disease progression|0|||
125521938|NCT02261285|451541713|FG002|Overall Study|Disease progression|1|||
125521939|NCT02760485|451541714|FG000|Phase 1|Death|3|||
125521940|NCT02760485|451541715|FG001|Phase 1|Death|6|||
125521941|NCT02760485|451541716|FG002|Phase 1|Death|0|||
125521942|NCT02760485|451541714|FG000|Phase 1|Withdrawal by Subject|2|||
125521943|NCT02760485|451541715|FG001|Phase 1|Withdrawal by Subject|0|||
125521944|NCT02760485|451541716|FG002|Phase 1|Withdrawal by Subject|0|||
125521945|NCT02760485|451541714|FG000|Phase 1|Progressive Disease|1|||
125521946|NCT02760485|451541715|FG001|Phase 1|Progressive Disease|0|||
125521947|NCT02760485|451541716|FG002|Phase 1|Progressive Disease|0|||
125521948|NCT02760485|451541714|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
125521949|NCT02760485|451541715|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
125521950|NCT02760485|451541716|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
125521951|NCT02760485|451541714|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
125521952|NCT02760485|451541715|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
125521953|NCT02760485|451541716|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
125521954|NCT02760485|451541714|FG000|Phase 2|Death|0|||
125521955|NCT02760485|451541715|FG001|Phase 2|Death|0|||
125521956|NCT02760485|451541716|FG002|Phase 2|Death|12|||
125521957|NCT02760485|451541714|FG000|Phase 2|Withdrawal by Subject|0|||
125521958|NCT02760485|451541715|FG001|Phase 2|Withdrawal by Subject|0|||
125521959|NCT02760485|451541716|FG002|Phase 2|Withdrawal by Subject|3|||
125521960|NCT02760485|451541714|FG000|Phase 2|Progressive Disease|0|||
125521961|NCT02760485|451541715|FG001|Phase 2|Progressive Disease|0|||
125521962|NCT02760485|451541716|FG002|Phase 2|Progressive Disease|1|||
125521963|NCT02760485|451541714|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
125521964|NCT02760485|451541715|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
125521965|NCT02760485|451541716|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
125521966|NCT01182207|451541717|FG000|First Intervention|Positive Hepatitis Results|0|||
125521967|NCT01182207|451541718|FG001|First Intervention|Positive Hepatitis Results|1|||
125521968|NCT01182207|451541717|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
125521969|NCT01182207|451541718|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
125521970|NCT01087814|451541719|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
125521971|NCT01087814|451541720|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
125521972|NCT01087814|451541719|FG000|Second Intervention (5 Days)|Physician Decision|1|||
125521973|NCT01087814|451541720|FG001|Second Intervention (5 Days)|Physician Decision|0|||
125521974|NCT00661713|451541721|FG000|Overall Study|Death|1|||
125521975|NCT00661713|451541722|FG001|Overall Study|Death|0|||
125521976|NCT00661713|451541723|FG002|Overall Study|Death|0|||
125521977|NCT00661713|451541724|FG003|Overall Study|Death|0|||
125521978|NCT00661713|451541725|FG004|Overall Study|Death|1|||
125521979|NCT00661713|451541726|FG005|Overall Study|Death|0|||
125521980|NCT00661713|451541727|FG006|Overall Study|Death|0|||
125521981|NCT00661713|451541728|FG007|Overall Study|Death|0|||
125521982|NCT00661713|451541721|FG000|Overall Study|Unable to Classify|1|||
125521983|NCT00661713|451541722|FG001|Overall Study|Unable to Classify|0|||
125521984|NCT00661713|451541723|FG002|Overall Study|Unable to Classify|0|||
125521985|NCT00661713|451541724|FG003|Overall Study|Unable to Classify|0|||
125521986|NCT00661713|451541725|FG004|Overall Study|Unable to Classify|0|||
125521987|NCT00661713|451541726|FG005|Overall Study|Unable to Classify|0|||
125521988|NCT00661713|451541727|FG006|Overall Study|Unable to Classify|0|||
125521989|NCT00661713|451541728|FG007|Overall Study|Unable to Classify|0|||
125521990|NCT00661713|451541721|FG000|Overall Study|Protocol Violation|1|||
125521991|NCT00661713|451541722|FG001|Overall Study|Protocol Violation|6|||
125521992|NCT00661713|451541723|FG002|Overall Study|Protocol Violation|3|||
125521993|NCT00661713|451541724|FG003|Overall Study|Protocol Violation|3|||
125521994|NCT00661713|451541725|FG004|Overall Study|Protocol Violation|0|||
125521995|NCT00661713|451541726|FG005|Overall Study|Protocol Violation|2|||
125521996|NCT00661713|451541727|FG006|Overall Study|Protocol Violation|2|||
125521997|NCT00661713|451541728|FG007|Overall Study|Protocol Violation|1|||
125521998|NCT00661713|451541721|FG000|Overall Study|Withdrawal by Subject|11|||
125521999|NCT00661713|451541722|FG001|Overall Study|Withdrawal by Subject|25|||
125522000|NCT00661713|451541723|FG002|Overall Study|Withdrawal by Subject|12|||
125522001|NCT00661713|451541724|FG003|Overall Study|Withdrawal by Subject|21|||
125522002|NCT00661713|451541725|FG004|Overall Study|Withdrawal by Subject|12|||
125522003|NCT00661713|451541726|FG005|Overall Study|Withdrawal by Subject|26|||
125522004|NCT00661713|451541727|FG006|Overall Study|Withdrawal by Subject|45|||
125522005|NCT00661713|451541728|FG007|Overall Study|Withdrawal by Subject|9|||
125522006|NCT00661713|451541721|FG000|Overall Study|Lost to Follow-up|2|||
125522007|NCT00661713|451541722|FG001|Overall Study|Lost to Follow-up|7|||
125522008|NCT00661713|451541723|FG002|Overall Study|Lost to Follow-up|2|||
125522009|NCT00661713|451541724|FG003|Overall Study|Lost to Follow-up|2|||
125522010|NCT00661713|451541725|FG004|Overall Study|Lost to Follow-up|5|||
125522011|NCT00661713|451541726|FG005|Overall Study|Lost to Follow-up|7|||
125522012|NCT00661713|451541727|FG006|Overall Study|Lost to Follow-up|14|||
125522013|NCT00661713|451541728|FG007|Overall Study|Lost to Follow-up|1|||
125522014|NCT00661713|451541721|FG000|Overall Study|Administrative Reason|0|||
125522015|NCT00661713|451541722|FG001|Overall Study|Administrative Reason|1|||
125522016|NCT00661713|451541723|FG002|Overall Study|Administrative Reason|0|||
125522017|NCT00661713|451541724|FG003|Overall Study|Administrative Reason|2|||
125522018|NCT00661713|451541725|FG004|Overall Study|Administrative Reason|2|||
125522019|NCT00661713|451541726|FG005|Overall Study|Administrative Reason|2|||
125522020|NCT00661713|451541727|FG006|Overall Study|Administrative Reason|1|||
125522021|NCT00661713|451541728|FG007|Overall Study|Administrative Reason|0|||
125522022|NCT00661713|451541721|FG000|Overall Study|Adverse Event|0|||
125522023|NCT00661713|451541722|FG001|Overall Study|Adverse Event|0|||
125522024|NCT00661713|451541723|FG002|Overall Study|Adverse Event|0|||
125522025|NCT00661713|451541724|FG003|Overall Study|Adverse Event|0|||
125522026|NCT00661713|451541725|FG004|Overall Study|Adverse Event|0|||
125522027|NCT00661713|451541726|FG005|Overall Study|Adverse Event|0|||
125522028|NCT00661713|451541727|FG006|Overall Study|Adverse Event|1|||
125522029|NCT00661713|451541728|FG007|Overall Study|Adverse Event|0|||
125522030|NCT00661713|451541721|FG000|Overall Study|Inappropriate Enrollment|0|||
125522031|NCT00661713|451541722|FG001|Overall Study|Inappropriate Enrollment|0|||
125522032|NCT00661713|451541723|FG002|Overall Study|Inappropriate Enrollment|0|||
125522033|NCT00661713|451541724|FG003|Overall Study|Inappropriate Enrollment|0|||
125522034|NCT00661713|451541725|FG004|Overall Study|Inappropriate Enrollment|0|||
125522035|NCT00661713|451541726|FG005|Overall Study|Inappropriate Enrollment|0|||
125522036|NCT00661713|451541727|FG006|Overall Study|Inappropriate Enrollment|1|||
125522037|NCT00661713|451541728|FG007|Overall Study|Inappropriate Enrollment|0|||
125522038|NCT01161628|451541729|FG000|Overall Study|Death|6|||
125522039|NCT01161628|451541729|FG000|Overall Study|Lack of Efficacy|2|||
125522040|NCT00715117|451541730|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
125522041|NCT00715117|451541731|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
125522042|NCT01482429|451541732|FG000|Care Usual|Protocol Violation|0|||
125522043|NCT01482429|451541733|FG001|Care Usual|Protocol Violation|172|||
125522044|NCT01482429|451541732|FG000|Care Usual|Lost to Follow-up|0|||
125522045|NCT01482429|451541733|FG001|Care Usual|Lost to Follow-up|1|||
125522046|NCT01482429|451541732|FG000|Protocol|Protocol Violation|275|||
125522047|NCT01482429|451541733|FG001|Protocol|Protocol Violation|0|||
125522048|NCT04680637|451541734|FG000|Overall Study|Lost to Follow-up|0|||
125522049|NCT04680637|451541735|FG001|Overall Study|Lost to Follow-up|1|||
125522050|NCT04680637|451541736|FG002|Overall Study|Lost to Follow-up|0|||
125522051|NCT04680637|451541737|FG003|Overall Study|Lost to Follow-up|1|||
125522052|NCT04680637|451541734|FG000|Overall Study|Death|1|||
125522053|NCT04680637|451541735|FG001|Overall Study|Death|0|||
125522054|NCT04680637|451541736|FG002|Overall Study|Death|0|||
125522055|NCT04680637|451541737|FG003|Overall Study|Death|0|||
125522056|NCT04680637|451541734|FG000|Overall Study|Withdrawal by Subject|7|||
125522057|NCT04680637|451541735|FG001|Overall Study|Withdrawal by Subject|10|||
125522058|NCT04680637|451541736|FG002|Overall Study|Withdrawal by Subject|17|||
125522059|NCT04680637|451541737|FG003|Overall Study|Withdrawal by Subject|15|||
125522060|NCT04680637|451541734|FG000|Overall Study|Decision by Sponsor|21|||
125522061|NCT04680637|451541735|FG001|Overall Study|Decision by Sponsor|15|||
125522062|NCT04680637|451541736|FG002|Overall Study|Decision by Sponsor|7|||
125522063|NCT04680637|451541737|FG003|Overall Study|Decision by Sponsor|32|||
125522064|NCT02037256|451541738|FG000|Overall Study|Protocol Violation|0|||
125522065|NCT02037256|451541739|FG001|Overall Study|Protocol Violation|1|||
125522066|NCT02037256|451541738|FG000|Overall Study|Withdrawn prior to Velcade|0|||
125522067|NCT02037256|451541739|FG001|Overall Study|Withdrawn prior to Velcade|2|||
125522068|NCT00891046|451543348|FG000|Overall Study|Protocol Violation|1|||
125522069|NCT00891046|451543349|FG001|Overall Study|Protocol Violation|1|||
125522070|NCT00891046|451543350|FG002|Overall Study|Protocol Violation|0|||
125522071|NCT00891046|451543351|FG003|Overall Study|Protocol Violation|0|||
125522072|NCT00891046|451543352|FG004|Overall Study|Protocol Violation|1|||
125522073|NCT00891046|451543348|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
125522074|NCT00891046|451543349|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
125522075|NCT00891046|451543350|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
125522076|NCT00891046|451543351|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
125522077|NCT00891046|451543352|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
125522078|NCT00891046|451543348|FG000|Overall Study|Administrative problems|0|||
125522079|NCT00891046|451543349|FG001|Overall Study|Administrative problems|0|||
125522080|NCT00891046|451543350|FG002|Overall Study|Administrative problems|0|||
125522081|NCT00891046|451543351|FG003|Overall Study|Administrative problems|0|||
125522082|NCT00891046|451543352|FG004|Overall Study|Administrative problems|1|||
125522083|NCT00891046|451543348|FG000|Overall Study|Participant no longer required drug|0|||
125522084|NCT00891046|451543349|FG001|Overall Study|Participant no longer required drug|2|||
125522085|NCT00891046|451543350|FG002|Overall Study|Participant no longer required drug|0|||
125522086|NCT00891046|451543351|FG003|Overall Study|Participant no longer required drug|0|||
125532918|NCT04266795|451581421|FG001|Overall Study|Adverse Event|19|||
125522087|NCT00891046|451543352|FG004|Overall Study|Participant no longer required drug|1|||
125522088|NCT00891046|451543348|FG000|Overall Study|Adverse Event|4|||
125522089|NCT00891046|451543349|FG001|Overall Study|Adverse Event|3|||
125522090|NCT00891046|451543350|FG002|Overall Study|Adverse Event|2|||
125522091|NCT00891046|451543351|FG003|Overall Study|Adverse Event|0|||
125522092|NCT00891046|451543352|FG004|Overall Study|Adverse Event|14|||
125522093|NCT00891046|451543348|FG000|Overall Study|Withdrawal by Subject|2|||
125522094|NCT00891046|451543349|FG001|Overall Study|Withdrawal by Subject|1|||
125522095|NCT00891046|451543350|FG002|Overall Study|Withdrawal by Subject|2|||
125522096|NCT00891046|451543351|FG003|Overall Study|Withdrawal by Subject|1|||
125522097|NCT00891046|451543352|FG004|Overall Study|Withdrawal by Subject|1|||
125522098|NCT00891046|451543348|FG000|Overall Study|Lost to Follow-up|0|||
125522099|NCT00891046|451543349|FG001|Overall Study|Lost to Follow-up|0|||
125522100|NCT00891046|451543350|FG002|Overall Study|Lost to Follow-up|0|||
125522101|NCT00891046|451543351|FG003|Overall Study|Lost to Follow-up|0|||
125522102|NCT00891046|451543352|FG004|Overall Study|Lost to Follow-up|1|||
125522103|NCT02166476|451543353|FG000|Overall Study|Withdrawal by Subject|5|||
125522104|NCT02166476|451543354|FG001|Overall Study|Withdrawal by Subject|7|||
125522105|NCT02166476|451543353|FG000|Overall Study|Adverse Event|3|||
125522106|NCT02166476|451543354|FG001|Overall Study|Adverse Event|3|||
125522107|NCT02166476|451543353|FG000|Overall Study|Lost to Follow-up|5|||
125522108|NCT02166476|451543354|FG001|Overall Study|Lost to Follow-up|10|||
125522109|NCT02166476|451543353|FG000|Overall Study|Physician Decision|1|||
125522110|NCT02166476|451543354|FG001|Overall Study|Physician Decision|0|||
125522111|NCT02166476|451543353|FG000|Overall Study|Unable to Come for Visit|0|||
125522112|NCT02166476|451543354|FG001|Overall Study|Unable to Come for Visit|3|||
125522113|NCT04523207|451543358|FG000|Overall Study|Adverse Event|5|||
125522114|NCT04523207|451543359|FG001|Overall Study|Adverse Event|1|||
125522115|NCT04523207|451543358|FG000|Overall Study|Lost to Follow-up|2|||
125522116|NCT04523207|451543359|FG001|Overall Study|Lost to Follow-up|0|||
125522117|NCT04523207|451543358|FG000|Overall Study|Withdrawal by Subject|2|||
125522118|NCT04523207|451543359|FG001|Overall Study|Withdrawal by Subject|0|||
125522119|NCT04523207|451543358|FG000|Overall Study|Progressive Disease|2|||
125522120|NCT04523207|451543359|FG001|Overall Study|Progressive Disease|1|||
125522121|NCT04523207|451543358|FG000|Overall Study|Other|7|||
125522122|NCT04523207|451543359|FG001|Overall Study|Other|1|||
125522123|NCT03113383|451543360|FG000|Overall Study|Death|4|||
125522124|NCT03113383|451543361|FG001|Overall Study|Death|0|||
125522125|NCT02053610|451543363|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
125522126|NCT02053610|451543364|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
125522127|NCT02053610|451543363|FG000|Overall Study|Withdrew Consent|2|||
125522128|NCT02053610|451543364|FG001|Overall Study|Withdrew Consent|9|||
125522129|NCT02053610|451543363|FG000|Overall Study|Death|5|||
125522130|NCT02053610|451543364|FG001|Overall Study|Death|5|||
125522131|NCT02053610|451543363|FG000|Overall Study|Administrative/Other|1|||
125522132|NCT02053610|451543364|FG001|Overall Study|Administrative/Other|1|||
125522133|NCT02053610|451543363|FG000|Overall Study|Disease Progression|2|||
125522134|NCT02053610|451543364|FG001|Overall Study|Disease Progression|3|||
125522135|NCT02053610|451543363|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
125522136|NCT02053610|451543364|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
125522137|NCT02053610|451543363|FG000|Overall Study|Did not Receive Treatment|4|||
125522138|NCT02053610|451543364|FG001|Overall Study|Did not Receive Treatment|2|||
125522139|NCT02053610|451543363|FG000|Overall Study|Insufficient Therapeutic Response|1|||
125522140|NCT02053610|451543364|FG001|Overall Study|Insufficient Therapeutic Response|1|||
125522141|NCT02053610|451543363|FG000|Overall Study|Violation of Selection Criteria|1|||
125522142|NCT02053610|451543364|FG001|Overall Study|Violation of Selection Criteria|0|||
125522143|NCT00543062|451543368|FG000|Overall Study|Withdrawal by Subject|1|||
125522144|NCT00543062|451543369|FG001|Overall Study|Withdrawal by Subject|0|||
125522145|NCT00543062|451543370|FG002|Overall Study|Withdrawal by Subject|2|||
125522146|NCT00543062|451543371|FG003|Overall Study|Withdrawal by Subject|0|||
125522147|NCT00543062|451543368|FG000|Overall Study|Adverse Event|0|||
125522148|NCT00543062|451543369|FG001|Overall Study|Adverse Event|1|||
125522149|NCT00543062|451543370|FG002|Overall Study|Adverse Event|1|||
125522150|NCT00543062|451543371|FG003|Overall Study|Adverse Event|1|||
125522151|NCT00543062|451543368|FG000|Overall Study|Protocol Violation|1|||
125522152|NCT00543062|451543369|FG001|Overall Study|Protocol Violation|0|||
125522153|NCT00543062|451543370|FG002|Overall Study|Protocol Violation|0|||
125522154|NCT00543062|451543371|FG003|Overall Study|Protocol Violation|0|||
125522155|NCT00328562|451543374|FG000|Overall Study|Disease progression|1|||
125522156|NCT01010204|451543377|FG000|Overall Study|Lost to Follow-up|2|||
125522157|NCT01010204|451543378|FG001|Overall Study|Lost to Follow-up|2|||
125522158|NCT01010204|451543377|FG000|Overall Study|Adverse Event|1|||
125522159|NCT01010204|451543378|FG001|Overall Study|Adverse Event|3|||
125522160|NCT01010204|451543377|FG000|Overall Study|Withdrawal by Subject|2|||
125522161|NCT01010204|451543378|FG001|Overall Study|Withdrawal by Subject|3|||
125522162|NCT01010204|451543377|FG000|Overall Study|psychiatric hospitalization|2|||
125522163|NCT01010204|451543378|FG001|Overall Study|psychiatric hospitalization|1|||
125522164|NCT01513330|451543379|FG000|SenSura Mio First,|Adverse Event|2|||
125522165|NCT01513330|451543380|FG001|SenSura Mio First,|Adverse Event|0|||
125522166|NCT01513330|451543379|FG000|SenSura Mio First,|Lack of Efficacy|0|||
125522167|NCT01513330|451543380|FG001|SenSura Mio First,|Lack of Efficacy|1|||
125522168|NCT01513330|451543379|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
125522169|NCT01513330|451543380|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
125522170|NCT01513330|451543379|FG000|SenSura Mio First,|Other|1|||
125522171|NCT01513330|451543380|FG001|SenSura Mio First,|Other|0|||
125522172|NCT01513330|451543379|FG000|Standard Care First,|Lack of Efficacy|2|||
125522173|NCT01513330|451543380|FG001|Standard Care First,|Lack of Efficacy|2|||
125522174|NCT01513330|451543379|FG000|Standard Care First,|Withdrawal by Subject|1|||
125522175|NCT01513330|451543380|FG001|Standard Care First,|Withdrawal by Subject|2|||
125522176|NCT01513330|451543379|FG000|Standard Care First,|Other|1|||
125522177|NCT01513330|451543380|FG001|Standard Care First,|Other|0|||
125522178|NCT01519778|451543381|FG000|Overall Study|Withdrawal by Subject|3|||
125522179|NCT01519778|451543381|FG000|Overall Study|Lost to Follow-up|10|||
125522180|NCT01519778|451543381|FG000|Overall Study|Physician Decision|1|||
125522181|NCT04486313|451543382|FG000|Overall Study|Lost to Follow-up|7|||
125522182|NCT04486313|451543383|FG001|Overall Study|Lost to Follow-up|9|||
125522183|NCT04486313|451543382|FG000|Overall Study|Withdrawal by Subject|8|||
125522184|NCT04486313|451543383|FG001|Overall Study|Withdrawal by Subject|6|||
125522185|NCT04486313|451543382|FG000|Overall Study|Physician Decision|1|||
125522186|NCT04486313|451543383|FG001|Overall Study|Physician Decision|1|||
125522187|NCT04486313|451543382|FG000|Overall Study|Death|2|||
125522188|NCT04486313|451543383|FG001|Overall Study|Death|0|||
125522189|NCT04486313|451543382|FG000|Overall Study|Protocol Violation|1|||
125522190|NCT04486313|451543383|FG001|Overall Study|Protocol Violation|1|||
125522191|NCT01657799|451543384|FG000|Overall Study|Adverse Event Related to progression|6|||
125522192|NCT01657799|451543385|FG001|Overall Study|Adverse Event Related to progression|8|||
125522193|NCT01657799|451543386|FG002|Overall Study|Adverse Event Related to progression|12|||
125522194|NCT01657799|451543384|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
125522195|NCT01657799|451543385|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
125522196|NCT01657799|451543386|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
125522197|NCT01657799|451543384|FG000|Overall Study|Withdrawal by Subject|13|||
125522198|NCT01657799|451543385|FG001|Overall Study|Withdrawal by Subject|10|||
125522199|NCT01657799|451543386|FG002|Overall Study|Withdrawal by Subject|10|||
125522200|NCT01657799|451543384|FG000|Overall Study|Lost to Follow-up|1|||
125522201|NCT01657799|451543385|FG001|Overall Study|Lost to Follow-up|0|||
125522202|NCT01657799|451543386|FG002|Overall Study|Lost to Follow-up|1|||
125522203|NCT01657799|451543384|FG000|Overall Study|Disease Progression|2|||
125522204|NCT01657799|451543385|FG001|Overall Study|Disease Progression|4|||
125522205|NCT01657799|451543386|FG002|Overall Study|Disease Progression|4|||
125522206|NCT01657799|451543384|FG000|Overall Study|Progressive Disease Clinical|7|||
125522207|NCT01657799|451543385|FG001|Overall Study|Progressive Disease Clinical|4|||
125522208|NCT01657799|451543386|FG002|Overall Study|Progressive Disease Clinical|7|||
125522209|NCT01657799|451543384|FG000|Overall Study|Radiographic & Clinical Progression|16|||
125522210|NCT01657799|451543385|FG001|Overall Study|Radiographic & Clinical Progression|11|||
125522211|NCT01657799|451543386|FG002|Overall Study|Radiographic & Clinical Progression|15|||
125522212|NCT01657799|451543384|FG000|Overall Study|Other|52|||
125522213|NCT01657799|451543385|FG001|Overall Study|Other|62|||
125522214|NCT01657799|451543386|FG002|Overall Study|Other|49|||
125522215|NCT00412880|451543387|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
125522216|NCT00412880|451543387|FG000|Overall Study|Consent withdrawn|1|||
125522217|NCT00412880|451543387|FG000|Overall Study|Adverse Event|1|||
125522218|NCT00412880|451543387|FG000|Overall Study|Progressive disease|20|||
125522219|NCT01843777|451543389|FG000|Overall Study|Withdrawal by Subject|1|||
125522220|NCT01843777|451543390|FG001|Overall Study|Withdrawal by Subject|0|||
125522221|NCT04599855|451543401|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
125522222|NCT04599855|451543402|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
125522223|NCT04599855|451543403|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
125522224|NCT04599855|451543401|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
125522225|NCT04599855|451543402|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
125522226|NCT04599855|451543403|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
125522227|NCT04599855|451543401|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
125522228|NCT04599855|451543402|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
125522229|NCT04599855|451543403|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
125522230|NCT04599855|451543401|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
125522231|NCT04599855|451543402|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
125522232|NCT04599855|451543403|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
125522233|NCT04599855|451543401|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
125522234|NCT04599855|451543402|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
125522235|NCT04599855|451543403|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
125522236|NCT04599855|451543401|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
125522237|NCT04599855|451543402|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
125532919|NCT04266795|451581420|FG000|Overall Study|Death|7|||
125522238|NCT04599855|451543403|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
125522239|NCT04599855|451543401|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
125522240|NCT04599855|451543402|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
125522241|NCT04599855|451543403|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
125522242|NCT04599855|451543401|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
125522243|NCT04599855|451543402|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
125522244|NCT04599855|451543403|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
125522245|NCT04599855|451543401|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
125522246|NCT04599855|451543402|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
125522247|NCT04599855|451543403|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
125522248|NCT04599855|451543401|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
125522249|NCT04599855|451543402|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
125522250|NCT04599855|451543403|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
125522251|NCT04599855|451543401|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
125522252|NCT04599855|451543402|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
125522253|NCT04599855|451543403|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
125522254|NCT04599855|451543401|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
125522255|NCT04599855|451543402|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
125522256|NCT04599855|451543403|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
125522257|NCT04599855|451543401|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
125522258|NCT04599855|451543402|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
125522259|NCT04599855|451543403|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
125522260|NCT04599855|451543401|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
125522261|NCT04599855|451543402|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
125522262|NCT04599855|451543403|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
125522263|NCT02165397|451543404|FG000|Overall Study|Death|7|||
125522264|NCT02165397|451543405|FG001|Overall Study|Death|10|||
125522265|NCT02165397|451543406|FG002|Overall Study|Death|8|||
125522266|NCT02165397|451543404|FG000|Overall Study|Lost to Follow-up|1|||
125522267|NCT02165397|451543405|FG001|Overall Study|Lost to Follow-up|3|||
125522268|NCT02165397|451543406|FG002|Overall Study|Lost to Follow-up|0|||
125522269|NCT02165397|451543404|FG000|Overall Study|Withdrawal by Subject|6|||
125522270|NCT02165397|451543405|FG001|Overall Study|Withdrawal by Subject|6|||
125522271|NCT02165397|451543406|FG002|Overall Study|Withdrawal by Subject|1|||
125522272|NCT02165397|451543404|FG000|Overall Study|Other, Not Specified|0|||
125522273|NCT02165397|451543405|FG001|Overall Study|Other, Not Specified|0|||
125522274|NCT02165397|451543406|FG002|Overall Study|Other, Not Specified|1|||
125522275|NCT03297398|451543407|FG000|Overall Study|Sponsor's decision|6|||
125522276|NCT03297398|451543408|FG001|Overall Study|Sponsor's decision|9|||
125522277|NCT03297398|451543409|FG002|Overall Study|Sponsor's decision|7|||
125522278|NCT03297398|451543407|FG000|Overall Study|Adverse Event|1|||
125522279|NCT03297398|451543408|FG001|Overall Study|Adverse Event|4|||
125522280|NCT03297398|451543409|FG002|Overall Study|Adverse Event|4|||
125522281|NCT03297398|451543407|FG000|Overall Study|Withdrawal by Subject|1|||
125522282|NCT03297398|451543408|FG001|Overall Study|Withdrawal by Subject|2|||
125522283|NCT03297398|451543409|FG002|Overall Study|Withdrawal by Subject|2|||
125522284|NCT03297398|451543407|FG000|Overall Study|Protocol Violation|0|||
125522285|NCT03297398|451543408|FG001|Overall Study|Protocol Violation|2|||
125522286|NCT03297398|451543409|FG002|Overall Study|Protocol Violation|0|||
125522287|NCT03297398|451543407|FG000|Overall Study|Physician Decision|0|||
125522288|NCT03297398|451543408|FG001|Overall Study|Physician Decision|0|||
125522289|NCT03297398|451543409|FG002|Overall Study|Physician Decision|1|||
125522290|NCT03297398|451543407|FG000|Overall Study|Lost to Follow-up|0|||
125522291|NCT03297398|451543408|FG001|Overall Study|Lost to Follow-up|0|||
125522292|NCT03297398|451543409|FG002|Overall Study|Lost to Follow-up|1|||
125522293|NCT00236184|451543414|FG000|Overall Study|Adverse Event|5|||
125522294|NCT00236184|451543415|FG001|Overall Study|Adverse Event|2|||
125522295|NCT00236184|451543414|FG000|Overall Study|Lack of Efficacy|0|||
125522296|NCT00236184|451543415|FG001|Overall Study|Lack of Efficacy|1|||
125522297|NCT00236184|451543414|FG000|Overall Study|Lost to Follow-up|3|||
125522298|NCT00236184|451543415|FG001|Overall Study|Lost to Follow-up|4|||
125522299|NCT00236184|451543414|FG000|Overall Study|Physician Decision|1|||
125522300|NCT00236184|451543415|FG001|Overall Study|Physician Decision|1|||
125522301|NCT00236184|451543414|FG000|Overall Study|Withdrawal by Subject|3|||
125522302|NCT00236184|451543415|FG001|Overall Study|Withdrawal by Subject|0|||
125522303|NCT00236184|451543414|FG000|Overall Study|Protocol Violation|3|||
125522304|NCT00236184|451543415|FG001|Overall Study|Protocol Violation|0|||
125522305|NCT00236184|451543414|FG000|Overall Study|non-compliance with study drug|2|||
125522306|NCT00236184|451543415|FG001|Overall Study|non-compliance with study drug|1|||
125522307|NCT00236184|451543414|FG000|Overall Study|other|1|||
125522308|NCT00236184|451543415|FG001|Overall Study|other|2|||
125522309|NCT01772563|451543416|FG000|Cycle 1|Dose limiting toxicity|2|||
125522310|NCT01772563|451543416|FG000|Cycle 1|Progressive disease|2|||
125522311|NCT01772563|451543416|FG000|Cycle 2 and Beyond|Progressive disease|17|||
125522312|NCT01772563|451543416|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
125522313|NCT01772563|451543416|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
125522314|NCT01192776|451543418|FG000|Overall Study|Death|8|||
125522315|NCT01192776|451543419|FG001|Overall Study|Death|15|||
125522316|NCT01192776|451543420|FG002|Overall Study|Death|18|||
125522317|NCT01192776|451543421|FG003|Overall Study|Death|15|||
125522318|NCT01192776|451543418|FG000|Overall Study|Lost to Follow-up|3|||
125522319|NCT01192776|451543419|FG001|Overall Study|Lost to Follow-up|6|||
125522320|NCT01192776|451543420|FG002|Overall Study|Lost to Follow-up|3|||
125522321|NCT01192776|451543421|FG003|Overall Study|Lost to Follow-up|5|||
125522322|NCT03732820|451543429|FG000|Overall Study|Death|168|||
125522323|NCT03732820|451543430|FG001|Overall Study|Death|203|||
125522324|NCT03732820|451543429|FG000|Overall Study|Other|2|||
125522325|NCT03732820|451543430|FG001|Overall Study|Other|2|||
125522326|NCT03732820|451543429|FG000|Overall Study|Failure to meet randomisation criteria|1|||
125522327|NCT03732820|451543430|FG001|Overall Study|Failure to meet randomisation criteria|1|||
125522328|NCT03732820|451543429|FG000|Overall Study|Patient decision|14|||
125522329|NCT03732820|451543430|FG001|Overall Study|Patient decision|10|||
125522330|NCT03732820|451543429|FG000|Overall Study|Screen failure|0|||
125522331|NCT03732820|451543430|FG001|Overall Study|Screen failure|1|||
125522332|NCT03732820|451543429|FG000|Overall Study|Patients ongoing study at data cut off|210|||
125522333|NCT03732820|451543430|FG001|Overall Study|Patients ongoing study at data cut off|178|||
125522334|NCT03732820|451543429|FG000|Overall Study|Lost to Follow-up|4|||
125522335|NCT03732820|451543430|FG001|Overall Study|Lost to Follow-up|2|||
125522336|NCT00832000|451543431|FG000|Overall Study|Adverse Event|2|||
125522337|NCT00832000|451543432|FG001|Overall Study|Adverse Event|0|||
125522338|NCT00832000|451543431|FG000|Overall Study|Withdrawal by Subject|1|||
125522339|NCT00832000|451543432|FG001|Overall Study|Withdrawal by Subject|0|||
125522340|NCT00832000|451543431|FG000|Overall Study|No calls to IVR in either period|1|||
125522341|NCT00832000|451543432|FG001|Overall Study|No calls to IVR in either period|1|||
125522342|NCT00832000|451543431|FG000|Overall Study|No calls to IVR in period 2|2|||
125522343|NCT00832000|451543432|FG001|Overall Study|No calls to IVR in period 2|0|||
125522344|NCT03845075|451543433|FG000|Part 1 - DB|Withdrawal by Subject|1|||
125522345|NCT03845075|451543434|FG001|Part 1 - DB|Withdrawal by Subject|1|||
125522346|NCT03845075|451543435|FG002|Part 1 - DB|Withdrawal by Subject|0|||
125522347|NCT03845075|451543436|FG003|Part 1 - DB|Withdrawal by Subject|0|||
125522348|NCT03845075|451543433|FG000|Part 1 - DB|Adverse Event|0|||
125522349|NCT03845075|451543434|FG001|Part 1 - DB|Adverse Event|1|||
125522350|NCT03845075|451543435|FG002|Part 1 - DB|Adverse Event|0|||
125522351|NCT03845075|451543436|FG003|Part 1 - DB|Adverse Event|0|||
125522352|NCT03845075|451543433|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
125522353|NCT03845075|451543434|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
125522354|NCT03845075|451543435|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
125522355|NCT03845075|451543436|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
125522356|NCT00935259|451543437|FG000|Period 1|Administrative (scheduling conflict)|1|||
125522357|NCT00935259|451543438|FG001|Period 1|Administrative (scheduling conflict)|1|||
125522358|NCT03856047|451543439|FG000|Overall Study|Withdrawal by Subject|0|||
125522359|NCT03856047|451543440|FG001|Overall Study|Withdrawal by Subject|1|||
125522360|NCT03856047|451543441|FG002|Overall Study|Withdrawal by Subject|1|||
125522361|NCT03856047|451543442|FG003|Overall Study|Withdrawal by Subject|0|||
125522362|NCT03856047|451543443|FG004|Overall Study|Withdrawal by Subject|3|||
125522363|NCT03856047|451543444|FG005|Overall Study|Withdrawal by Subject|0|||
125522364|NCT03856047|451543445|FG006|Overall Study|Withdrawal by Subject|2|||
125522365|NCT03856047|451543439|FG000|Overall Study|Lost to Follow-up|4|||
125522366|NCT03856047|451543440|FG001|Overall Study|Lost to Follow-up|2|||
125522367|NCT03856047|451543441|FG002|Overall Study|Lost to Follow-up|3|||
125522368|NCT03856047|451543442|FG003|Overall Study|Lost to Follow-up|1|||
125522369|NCT03856047|451543443|FG004|Overall Study|Lost to Follow-up|4|||
125522370|NCT03856047|451543444|FG005|Overall Study|Lost to Follow-up|4|||
125522371|NCT03856047|451543445|FG006|Overall Study|Lost to Follow-up|4|||
125522372|NCT00874497|451543449|FG000|Overall Study|Lost to Follow-up|2|||
125522373|NCT00874497|451543450|FG001|Overall Study|Lost to Follow-up|4|||
125522374|NCT00874497|451543449|FG000|Overall Study|Adverse Event|9|||
125522375|NCT00874497|451543450|FG001|Overall Study|Adverse Event|4|||
125522376|NCT00874497|451543449|FG000|Overall Study|Sponsor Discontinued Trial|7|||
125522377|NCT00874497|451543450|FG001|Overall Study|Sponsor Discontinued Trial|3|||
125522378|NCT00874497|451543449|FG000|Overall Study|Met Withdrawal Criteria|4|||
125522379|NCT00874497|451543450|FG001|Overall Study|Met Withdrawal Criteria|2|||
125522380|NCT00874497|451543449|FG000|Overall Study|Physician Decision|1|||
125522381|NCT00874497|451543450|FG001|Overall Study|Physician Decision|1|||
125522382|NCT00874497|451543449|FG000|Overall Study|Withdrawal by Subject|5|||
125522383|NCT00874497|451543450|FG001|Overall Study|Withdrawal by Subject|4|||
125522384|NCT01278615|451543455|FG000|Overall Study|Withdrawal by Subject|2|||
125522385|NCT00665223|451543456|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
125522386|NCT00665223|451543457|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
125522387|NCT00665223|451543458|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
125522388|NCT00665223|451543456|FG000|Randomized Phase (26 Weeks)|Death|0|||
125522389|NCT00665223|451543457|FG001|Randomized Phase (26 Weeks)|Death|0|||
125522390|NCT00665223|451543458|FG002|Randomized Phase (26 Weeks)|Death|1|||
125522391|NCT00665223|451543456|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
125522392|NCT00665223|451543457|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
125522393|NCT00665223|451543458|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
125522394|NCT00665223|451543456|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
125522395|NCT00665223|451543457|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
125522396|NCT00665223|451543458|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
125522397|NCT00665223|451543456|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
125522398|NCT00665223|451543457|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
125522399|NCT00665223|451543458|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
125522400|NCT00665223|451543456|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
125522401|NCT00665223|451543457|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
125522402|NCT00665223|451543458|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
125522403|NCT00665223|451543456|FG000|Open-Label Period (26 Weeks)|Death|0|||
125522404|NCT00665223|451543457|FG001|Open-Label Period (26 Weeks)|Death|1|||
125522405|NCT00665223|451543458|FG002|Open-Label Period (26 Weeks)|Death|0|||
125522406|NCT00665223|451543456|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
125522407|NCT00665223|451543457|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
125522408|NCT00665223|451543458|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
125522409|NCT00665223|451543456|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
125522410|NCT00665223|451543457|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
125522411|NCT00665223|451543458|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
125522412|NCT00665223|451543456|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
125522413|NCT00665223|451543457|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
125522414|NCT00665223|451543458|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
125522415|NCT00665223|451543456|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
125522416|NCT00665223|451543457|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
125522417|NCT00665223|451543458|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
125522418|NCT00905359|451543459|FG000|Overall Study|Lost to Follow-up|17|||
125522419|NCT00905359|451543460|FG001|Overall Study|Lost to Follow-up|10|||
125522420|NCT00905359|451543459|FG000|Overall Study|Death|2|||
125522421|NCT00905359|451543460|FG001|Overall Study|Death|0|||
125522422|NCT00905359|451543459|FG000|Overall Study|Withdrawal consent|5|||
125522423|NCT00905359|451543460|FG001|Overall Study|Withdrawal consent|6|||
125522424|NCT00243022|451543461|FG000|Overall Study|Withdrawal by Subject|1|||
125522425|NCT00243022|451543462|FG001|Overall Study|Withdrawal by Subject|0|||
125522426|NCT00243022|451543461|FG000|Overall Study|Death|1|||
125522427|NCT00243022|451543462|FG001|Overall Study|Death|0|||
125522428|NCT00243022|451543461|FG000|Overall Study|Difficult Travel Distance|0|||
125522429|NCT00243022|451543462|FG001|Overall Study|Difficult Travel Distance|1|||
125522430|NCT03517111|451543463|FG000|Enrolled|Withdrawal by Subject|0|||
125522431|NCT03517111|451543464|FG001|Enrolled|Withdrawal by Subject|1|||
125522432|NCT03517111|451543465|FG002|Enrolled|Withdrawal by Subject|0|||
125522433|NCT03517111|451543463|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
125522434|NCT03517111|451543464|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
125522435|NCT03517111|451543465|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
125522436|NCT03517111|451543463|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
125522437|NCT03517111|451543464|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
125522438|NCT03517111|451543465|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
125522439|NCT03517111|451543463|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
125522440|NCT03517111|451543464|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
125522441|NCT03517111|451543465|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
125522442|NCT03517111|451543463|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
125522443|NCT03517111|451543464|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
125522444|NCT03517111|451543465|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
125522445|NCT00621192|451543466|FG000|Overall Study|Withdrawal by Subject|0|||
125522446|NCT00621192|451543467|FG001|Overall Study|Withdrawal by Subject|0|||
125522447|NCT00621192|451543468|FG002|Overall Study|Withdrawal by Subject|2|||
125522448|NCT00621192|451543469|FG003|Overall Study|Withdrawal by Subject|0|||
125522449|NCT00621192|451543466|FG000|Overall Study|Physician Decision|1|||
125522450|NCT00621192|451543467|FG001|Overall Study|Physician Decision|3|||
125522451|NCT00621192|451543468|FG002|Overall Study|Physician Decision|0|||
125522452|NCT00621192|451543469|FG003|Overall Study|Physician Decision|0|||
125522453|NCT00621192|451543466|FG000|Overall Study|Protocol Violation|1|||
125522454|NCT00621192|451543467|FG001|Overall Study|Protocol Violation|0|||
125522455|NCT00621192|451543468|FG002|Overall Study|Protocol Violation|0|||
125522456|NCT00621192|451543469|FG003|Overall Study|Protocol Violation|1|||
125522457|NCT00621192|451543466|FG000|Overall Study|Adverse Event|0|||
125522458|NCT00621192|451543467|FG001|Overall Study|Adverse Event|1|||
125522459|NCT00621192|451543468|FG002|Overall Study|Adverse Event|0|||
125522460|NCT00621192|451543469|FG003|Overall Study|Adverse Event|1|||
125522461|NCT00621192|451543466|FG000|Overall Study|Death|2|||
125522462|NCT00621192|451543467|FG001|Overall Study|Death|5|||
125522463|NCT00621192|451543468|FG002|Overall Study|Death|0|||
125522464|NCT00621192|451543469|FG003|Overall Study|Death|0|||
125522465|NCT00621192|451543466|FG000|Overall Study|Final Assessments not Completed|0|||
125522466|NCT00621192|451543467|FG001|Overall Study|Final Assessments not Completed|0|||
125522467|NCT00621192|451543468|FG002|Overall Study|Final Assessments not Completed|3|||
125522468|NCT00621192|451543469|FG003|Overall Study|Final Assessments not Completed|1|||
125522469|NCT04706793|451543470|FG000|Treatment|Disease worsening|10|||
125522470|NCT04706793|451543471|FG001|Treatment|Disease worsening|10|||
125522471|NCT04706793|451543470|FG000|Follow-up|Lack of Efficacy|1|||
125522472|NCT04706793|451543471|FG001|Follow-up|Lack of Efficacy|0|||
125522473|NCT04706793|451543470|FG000|Follow-up|Disease worsening|8|||
125522474|NCT04706793|451543471|FG001|Follow-up|Disease worsening|10|||
125522475|NCT04706793|451543470|FG000|Follow-up|Adverse Event|1|||
125522476|NCT04706793|451543471|FG001|Follow-up|Adverse Event|0|||
125522477|NCT01781832|451543475|FG000|Overall Study|Withdrawal by Subject|1|||
125522478|NCT02601209|451543476|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
125522479|NCT02601209|451543477|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
125522480|NCT02601209|451543478|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
125522481|NCT02601209|451543479|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
125522482|NCT02601209|451543480|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
125522483|NCT02601209|451543481|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
125522484|NCT02601209|451543482|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
125522485|NCT02601209|451543483|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
125522486|NCT02601209|451543484|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
125522487|NCT02601209|451543476|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
125522488|NCT02601209|451543477|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
125522489|NCT02601209|451543478|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
125522490|NCT02601209|451543479|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
125522491|NCT02601209|451543480|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
125522492|NCT02601209|451543481|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
125522493|NCT02601209|451543482|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
125522494|NCT02601209|451543483|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
125522495|NCT02601209|451543484|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
125522496|NCT03636373|451543485|FG000|Overall Study|Study closure due to Covid-19|1|||
125522497|NCT03636373|451543486|FG001|Overall Study|Study closure due to Covid-19|0|||
125522498|NCT00572533|451543487|FG000|Overall Study|Death|4|||
125522499|NCT00572533|451543488|FG001|Overall Study|Death|1|||
125522500|NCT00572533|451543487|FG000|Overall Study|Received Kidney Transplant|2|||
125522501|NCT00572533|451543488|FG001|Overall Study|Received Kidney Transplant|1|||
125522502|NCT00572533|451543487|FG000|Overall Study|Social Issues|1|||
125522503|NCT00572533|451543488|FG001|Overall Study|Social Issues|0|||
125522504|NCT00572533|451543487|FG000|Overall Study|Transfer out of Facility|0|||
125522505|NCT00572533|451543488|FG001|Overall Study|Transfer out of Facility|1|||
125522506|NCT00798304|451543492|FG000|Overall Study|Adverse Event|0|||
125522507|NCT00798304|451543493|FG001|Overall Study|Adverse Event|1|||
125522508|NCT00798304|451543494|FG002|Overall Study|Adverse Event|1|||
125522509|NCT00798304|451543492|FG000|Overall Study|Discontinuation by Sponsor|14|||
125522510|NCT00798304|451543493|FG001|Overall Study|Discontinuation by Sponsor|21|||
125522511|NCT00798304|451543494|FG002|Overall Study|Discontinuation by Sponsor|9|||
125522512|NCT02344173|451543499|FG000|Procedure|Ablation Procedure Not Performed|7|||
125522513|NCT02344173|451543499|FG000|12-month Visit|Death|8|||
125522514|NCT02344173|451543499|FG000|12-month Visit|Withdrawal by Subject|30|||
125522515|NCT02344173|451543499|FG000|12-month Visit|Lost to Follow-up|58|||
125522516|NCT00416598|451545751|FG000|Induction & Intensification|Adverse Event|38|||
125522517|NCT00416598|451545751|FG000|Induction & Intensification|Death|32|||
125522518|NCT00416598|451545751|FG000|Induction & Intensification|Withdrawal by Subject|46|||
125522519|NCT00416598|451545751|FG000|Induction & Intensification|Alternative Treatment|135|||
125522520|NCT00416598|451545751|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
125522521|NCT00416598|451545751|FG000|Induction & Intensification|Relapse/progression|29|||
125522522|NCT00416598|451545751|FG000|Induction & Intensification|Failed induction|87|||
125522523|NCT00416598|451545751|FG000|Decitabine Maintenance|Adverse Event|5|||
125522524|NCT00416598|451545751|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
125522525|NCT00416598|451545751|FG000|Decitabine Maintenance|Progression/relapse|38|||
125522526|NCT00416598|451545751|FG000|Decitabine Maintenance|Alternative treatment|2|||
125522527|NCT00416598|451545751|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
125522528|NCT00810342|451545756|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
125522529|NCT00810342|451545757|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
125522530|NCT00810342|451545756|FG000|Month 1 Follow-up|Pregnancy|1|||
125522531|NCT00810342|451545757|FG001|Month 1 Follow-up|Pregnancy|0|||
125522532|NCT00810342|451545756|FG000|6-month Follow-up|Lost to Follow-up|18|||
125522533|NCT00810342|451545757|FG001|6-month Follow-up|Lost to Follow-up|6|||
125522534|NCT00810342|451545756|FG000|6-month Follow-up|Pregnancy|6|||
125522535|NCT00810342|451545757|FG001|6-month Follow-up|Pregnancy|2|||
125522536|NCT00810342|451545756|FG000|12-month Followup|Pregnancy|9|||
125522537|NCT00810342|451545757|FG001|12-month Followup|Pregnancy|10|||
125522538|NCT00810342|451545756|FG000|12-month Followup|Lost to Follow-up|3|||
125522539|NCT00810342|451545757|FG001|12-month Followup|Lost to Follow-up|1|||
125522540|NCT04504630|451545758|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
125522541|NCT04504630|451545759|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
125522542|NCT04504630|451545758|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
125522543|NCT04504630|451545759|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
125522544|NCT01496365|451545760|FG000|Overall Study|Adverse Event|2|||
125522545|NCT01496365|451545761|FG001|Overall Study|Adverse Event|3|||
125522546|NCT01496365|451545762|FG002|Overall Study|Adverse Event|3|||
125522547|NCT01496365|451545763|FG003|Overall Study|Adverse Event|2|||
125522548|NCT01496365|451545764|FG004|Overall Study|Adverse Event|5|||
125522549|NCT01496365|451545765|FG005|Overall Study|Adverse Event|6|||
125522550|NCT01496365|451545766|FG006|Overall Study|Adverse Event|4|||
125522551|NCT01496365|451545760|FG000|Overall Study|Withdrawal by Subject|6|||
125522552|NCT01496365|451545761|FG001|Overall Study|Withdrawal by Subject|6|||
125522553|NCT01496365|451545762|FG002|Overall Study|Withdrawal by Subject|0|||
125522554|NCT01496365|451545763|FG003|Overall Study|Withdrawal by Subject|1|||
125522555|NCT01496365|451545764|FG004|Overall Study|Withdrawal by Subject|3|||
125522556|NCT01496365|451545765|FG005|Overall Study|Withdrawal by Subject|2|||
125522557|NCT01496365|451545766|FG006|Overall Study|Withdrawal by Subject|1|||
125522558|NCT01496365|451545760|FG000|Overall Study|Protocol Violation|2|||
125522559|NCT01496365|451545761|FG001|Overall Study|Protocol Violation|1|||
125522560|NCT01496365|451545762|FG002|Overall Study|Protocol Violation|1|||
125522561|NCT01496365|451545763|FG003|Overall Study|Protocol Violation|0|||
125522562|NCT01496365|451545764|FG004|Overall Study|Protocol Violation|0|||
125522563|NCT01496365|451545765|FG005|Overall Study|Protocol Violation|1|||
125522564|NCT01496365|451545766|FG006|Overall Study|Protocol Violation|0|||
125522565|NCT01496365|451545760|FG000|Overall Study|Lack of Efficacy|1|||
125522566|NCT01496365|451545761|FG001|Overall Study|Lack of Efficacy|0|||
125522567|NCT01496365|451545762|FG002|Overall Study|Lack of Efficacy|0|||
125522568|NCT01496365|451545763|FG003|Overall Study|Lack of Efficacy|0|||
125522569|NCT01496365|451545764|FG004|Overall Study|Lack of Efficacy|0|||
125522570|NCT01496365|451545765|FG005|Overall Study|Lack of Efficacy|1|||
125522571|NCT01496365|451545766|FG006|Overall Study|Lack of Efficacy|0|||
125522572|NCT01496365|451545760|FG000|Overall Study|Lost to Follow-up|0|||
125522573|NCT01496365|451545761|FG001|Overall Study|Lost to Follow-up|1|||
125522574|NCT01496365|451545762|FG002|Overall Study|Lost to Follow-up|0|||
125522575|NCT01496365|451545763|FG003|Overall Study|Lost to Follow-up|0|||
125522576|NCT01496365|451545764|FG004|Overall Study|Lost to Follow-up|2|||
125522577|NCT01496365|451545765|FG005|Overall Study|Lost to Follow-up|0|||
125522578|NCT01496365|451545766|FG006|Overall Study|Lost to Follow-up|0|||
125522579|NCT01496365|451545760|FG000|Overall Study|Other|4|||
125522580|NCT01496365|451545761|FG001|Overall Study|Other|4|||
125522581|NCT01496365|451545762|FG002|Overall Study|Other|2|||
125522582|NCT01496365|451545763|FG003|Overall Study|Other|1|||
125522583|NCT01496365|451545764|FG004|Overall Study|Other|3|||
125522584|NCT01496365|451545765|FG005|Overall Study|Other|0|||
125522585|NCT01496365|451545766|FG006|Overall Study|Other|1|||
125522586|NCT02706951|451545767|FG000|Period 1|Adverse Event|1|||
125522587|NCT02706951|451545768|FG001|Period 1|Adverse Event|5|||
125522588|NCT02706951|451545769|FG002|Period 1|Adverse Event|3|||
125522589|NCT02706951|451545770|FG003|Period 1|Adverse Event|0|||
125522590|NCT02706951|451545771|FG004|Period 1|Adverse Event|0|||
125522591|NCT02706951|451545767|FG000|Period 1|Withdrawal by Subject|10|||
125522592|NCT02706951|451545768|FG001|Period 1|Withdrawal by Subject|6|||
125522593|NCT02706951|451545769|FG002|Period 1|Withdrawal by Subject|6|||
125522594|NCT02706951|451545770|FG003|Period 1|Withdrawal by Subject|0|||
125522595|NCT02706951|451545771|FG004|Period 1|Withdrawal by Subject|0|||
125522596|NCT02706951|451545767|FG000|Period 1|Lost to Follow-up|0|||
125522597|NCT02706951|451545768|FG001|Period 1|Lost to Follow-up|4|||
125522598|NCT02706951|451545769|FG002|Period 1|Lost to Follow-up|1|||
125522599|NCT02706951|451545770|FG003|Period 1|Lost to Follow-up|0|||
125522600|NCT02706951|451545771|FG004|Period 1|Lost to Follow-up|0|||
125522601|NCT02706951|451545767|FG000|Period 1|Other|2|||
125522602|NCT02706951|451545768|FG001|Period 1|Other|1|||
125522603|NCT02706951|451545769|FG002|Period 1|Other|0|||
125522604|NCT02706951|451545770|FG003|Period 1|Other|0|||
125522605|NCT02706951|451545771|FG004|Period 1|Other|0|||
125522606|NCT02706951|451545767|FG000|Period 2|Adverse Event|0|||
125522607|NCT02706951|451545768|FG001|Period 2|Adverse Event|0|||
125522608|NCT02706951|451545769|FG002|Period 2|Adverse Event|0|||
125522609|NCT02706951|451545770|FG003|Period 2|Adverse Event|25|||
125522610|NCT02706951|451545771|FG004|Period 2|Adverse Event|34|||
125522611|NCT02706951|451545767|FG000|Period 2|Withdrawal by Subject|0|||
125522612|NCT02706951|451545768|FG001|Period 2|Withdrawal by Subject|0|||
125522613|NCT02706951|451545769|FG002|Period 2|Withdrawal by Subject|0|||
125522614|NCT02706951|451545770|FG003|Period 2|Withdrawal by Subject|38|||
125522615|NCT02706951|451545771|FG004|Period 2|Withdrawal by Subject|44|||
125522616|NCT02706951|451545767|FG000|Period 2|Lost to Follow-up|0|||
125522617|NCT02706951|451545768|FG001|Period 2|Lost to Follow-up|0|||
125522618|NCT02706951|451545769|FG002|Period 2|Lost to Follow-up|0|||
125522619|NCT02706951|451545770|FG003|Period 2|Lost to Follow-up|17|||
125522620|NCT02706951|451545771|FG004|Period 2|Lost to Follow-up|9|||
125522621|NCT02706951|451545767|FG000|Period 2|COVID-19 Related|0|||
125522622|NCT02706951|451545768|FG001|Period 2|COVID-19 Related|0|||
125522623|NCT02706951|451545769|FG002|Period 2|COVID-19 Related|0|||
125522624|NCT02706951|451545770|FG003|Period 2|COVID-19 Related|1|||
125522625|NCT02706951|451545771|FG004|Period 2|COVID-19 Related|2|||
125522626|NCT02706951|451545767|FG000|Period 2|Other|0|||
125522627|NCT02706951|451545768|FG001|Period 2|Other|0|||
125522628|NCT02706951|451545769|FG002|Period 2|Other|0|||
125522629|NCT02706951|451545770|FG003|Period 2|Other|37|||
125522630|NCT02706951|451545771|FG004|Period 2|Other|31|||
125522631|NCT01777334|451545772|FG000|Overall Study|Adverse Event|18|||
125522632|NCT01777334|451545773|FG001|Overall Study|Adverse Event|14|||
125522633|NCT01777334|451545772|FG000|Overall Study|Lack of Efficacy|15|||
125522634|NCT01777334|451545773|FG001|Overall Study|Lack of Efficacy|29|||
125522635|NCT01777334|451545772|FG000|Overall Study|Protocol Violation|3|||
125522636|NCT01777334|451545773|FG001|Overall Study|Protocol Violation|7|||
125522637|NCT01777334|451545772|FG000|Overall Study|Lost to Follow-up|3|||
125522638|NCT01777334|451545773|FG001|Overall Study|Lost to Follow-up|2|||
125522639|NCT01777334|451545772|FG000|Overall Study|Withdrawal by Subject|14|||
125522640|NCT01777334|451545773|FG001|Overall Study|Withdrawal by Subject|11|||
125522641|NCT04294667|451545774|FG000|Overall Study|Lack of Efficacy|4|||
125522642|NCT04294667|451545775|FG001|Overall Study|Lack of Efficacy|4|||
125522643|NCT04294667|451545774|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
125522644|NCT04294667|451545775|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
125522645|NCT04294667|451545774|FG000|Overall Study|Patient has a Renal Flare|1|||
125522646|NCT04294667|451545775|FG001|Overall Study|Patient has a Renal Flare|0|||
125522647|NCT04294667|451545774|FG000|Overall Study|SLE Worsening|0|||
125522648|NCT04294667|451545775|FG001|Overall Study|SLE Worsening|1|||
125522649|NCT04294667|451545774|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
125522650|NCT04294667|451545775|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
125522651|NCT04294667|451545774|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
125522652|NCT04294667|451545775|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
125522653|NCT04294667|451545774|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
125522654|NCT04294667|451545775|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
125522655|NCT04294667|451545774|FG000|Overall Study|Subject Moved to Another State|0|||
125522656|NCT04294667|451545775|FG001|Overall Study|Subject Moved to Another State|1|||
125522657|NCT04294667|451545774|FG000|Overall Study|Adverse event, serious fatal|0|||
125522658|NCT04294667|451545775|FG001|Overall Study|Adverse event, serious fatal|1|||
125522659|NCT04294667|451545774|FG000|Overall Study|Adverse event, non-fatal|3|||
125522660|NCT04294667|451545775|FG001|Overall Study|Adverse event, non-fatal|4|||
125522661|NCT04799418|451545776|FG000|Overall Study|Death|1|||
125522662|NCT04799418|451545777|FG001|Overall Study|Death|1|||
125522663|NCT04799418|451545776|FG000|Overall Study|Lack of Efficacy|14|||
125522664|NCT04799418|451545777|FG001|Overall Study|Lack of Efficacy|14|||
125522665|NCT04799418|451545776|FG000|Overall Study|Withdrawal by Subject|10|||
125522666|NCT04799418|451545777|FG001|Overall Study|Withdrawal by Subject|7|||
125522667|NCT04799418|451545776|FG000|Overall Study|Adverse Event|3|||
125522668|NCT04799418|451545777|FG001|Overall Study|Adverse Event|2|||
125522669|NCT02599688|451545778|FG000|Overall Study|Lack of Efficacy|1|||
125522670|NCT02599688|451545778|FG000|Overall Study|Withdrawal by Subject|1|||
125522671|NCT02599688|451545778|FG000|Overall Study|Termination by Sponsor|2|||
125522672|NCT01841697|451545779|FG000|Overall Study|Death|0|||
125522673|NCT01841697|451545780|FG001|Overall Study|Death|1|||
125522674|NCT01841697|451545779|FG000|Overall Study|Lost to Follow-up|4|||
125522675|NCT01841697|451545780|FG001|Overall Study|Lost to Follow-up|1|||
125522676|NCT01841697|451545779|FG000|Overall Study|Withdrawal by Subject|16|||
125522677|NCT01841697|451545780|FG001|Overall Study|Withdrawal by Subject|16|||
125522678|NCT00756457|451545781|FG000|Overall Study|Lost to Follow-up|1|||
125522679|NCT00756457|451545782|FG001|Overall Study|Lost to Follow-up|2|||
125522680|NCT01777490|451545786|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
125522681|NCT01777490|451545787|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
125522682|NCT01777490|451545788|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
125522683|NCT01777490|451545789|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
125522684|NCT00822770|451545794|FG000|Overall Study|Not treated|1|||
125522685|NCT00822770|451545795|FG001|Overall Study|Not treated|0|||
125522686|NCT00822770|451545794|FG000|Overall Study|Complication/Incomplete treatment|1|||
125522687|NCT00822770|451545795|FG001|Overall Study|Complication/Incomplete treatment|0|||
125522688|NCT00822770|451545794|FG000|Overall Study|Death|1|||
125522689|NCT00822770|451545795|FG001|Overall Study|Death|1|||
125522690|NCT02818998|451545796|FG000|Overall Study|Adverse Event|3|||
125522691|NCT02818998|451545797|FG001|Overall Study|Adverse Event|2|||
125522692|NCT02818998|451545798|FG002|Overall Study|Adverse Event|1|||
125522693|NCT02818998|451545796|FG000|Overall Study|Lost to Follow-up|4|||
125522694|NCT02818998|451545797|FG001|Overall Study|Lost to Follow-up|1|||
125522695|NCT02818998|451545798|FG002|Overall Study|Lost to Follow-up|2|||
125522696|NCT02818998|451545796|FG000|Overall Study|Withdrawal by sponsor|0|||
125522697|NCT02818998|451545797|FG001|Overall Study|Withdrawal by sponsor|1|||
125522698|NCT02818998|451545798|FG002|Overall Study|Withdrawal by sponsor|1|||
125522699|NCT02818998|451545796|FG000|Overall Study|Death|3|||
125522700|NCT02818998|451545797|FG001|Overall Study|Death|6|||
125522701|NCT02818998|451545798|FG002|Overall Study|Death|8|||
125522702|NCT02818998|451545796|FG000|Overall Study|Withdrawal by Subject|7|||
125522703|NCT02818998|451545797|FG001|Overall Study|Withdrawal by Subject|6|||
125522704|NCT02818998|451545798|FG002|Overall Study|Withdrawal by Subject|6|||
125522705|NCT02818998|451545796|FG000|Overall Study|Physician Decision|1|||
125522706|NCT02818998|451545797|FG001|Overall Study|Physician Decision|0|||
125522707|NCT02818998|451545798|FG002|Overall Study|Physician Decision|0|||
125522708|NCT00632021|451545802|FG000|Overall Study|Withdrawal/death|4|||
125522709|NCT00632021|451545803|FG001|Overall Study|Withdrawal/death|7|||
125522710|NCT00952848|451545806|FG000|Overall Study|Withdrawal by Subject|4|||
125522711|NCT00458393|451545807|FG000|Overall Study|Withdrawal by Subject|67|||
125522712|NCT00458393|451545808|FG001|Overall Study|Withdrawal by Subject|80|||
125522713|NCT00458393|451545807|FG000|Overall Study|Physician Decision|31|||
125522714|NCT00458393|451545808|FG001|Overall Study|Physician Decision|22|||
125522715|NCT00458393|451545807|FG000|Overall Study|Relocated|77|||
125522716|NCT00458393|451545808|FG001|Overall Study|Relocated|81|||
125522717|NCT00458393|451545807|FG000|Overall Study|Lost to Follow-up|115|||
125522718|NCT00458393|451545808|FG001|Overall Study|Lost to Follow-up|92|||
125522719|NCT00458393|451545807|FG000|Overall Study|Sites marked other on the form.|19|||
125522720|NCT00458393|451545808|FG001|Overall Study|Sites marked other on the form.|20|||
125522721|NCT01101061|451545811|FG000|Overall Study|Adverse Event|0|||
125522722|NCT01101061|451545812|FG001|Overall Study|Adverse Event|0|||
125522723|NCT01101061|451545813|FG002|Overall Study|Adverse Event|1|||
125522724|NCT01101061|451545814|FG003|Overall Study|Adverse Event|0|||
125522725|NCT01101061|451545815|FG004|Overall Study|Adverse Event|0|||
125522726|NCT01101061|451545816|FG005|Overall Study|Adverse Event|0|||
125522727|NCT00857233|451545817|FG000|Overall Study|Adverse Event|24|||
125522728|NCT00857233|451545817|FG000|Overall Study|Lack of Efficacy|1|||
125522729|NCT00857233|451545817|FG000|Overall Study|Non-compliance|1|||
125522730|NCT00857233|451545817|FG000|Overall Study|Withdrawal of Consent|9|||
125522731|NCT00857233|451545817|FG000|Overall Study|Lost to Follow-up|4|||
125522732|NCT00857233|451545817|FG000|Overall Study|Nursing Home Placement|14|||
125522733|NCT00857233|451545817|FG000|Overall Study|Other Reasons|2|||
125522734|NCT05043883|451545818|FG000|Overall Study|Minimum required measurements could not be taken|4|||
125522735|NCT01587118|451545819|FG000|Overall Study|Adverse Event|3|||
125522736|NCT01587118|451545819|FG000|Overall Study|Lost to Follow-up|2|||
125522737|NCT01587118|451545819|FG000|Overall Study|Relocation|1|||
125522738|NCT01587118|451545819|FG000|Overall Study|nonresponse|1|||
125522739|NCT00263575|451545820|FG000|Titration Period|Adverse Event|14|||
125522740|NCT00263575|451545820|FG000|Titration Period|Withdrawal by Subject|10|||
125522741|NCT00263575|451545820|FG000|Titration Period|Protocol Violation|9|||
125522742|NCT00263575|451545820|FG000|Titration Period|Sponsor Decision|2|||
125522743|NCT00263575|451545820|FG000|Titration Period|Other|2|||
125522744|NCT00263575|451545820|FG000|Titration Period|Lack of Efficacy|6|||
125522745|NCT00263575|451545820|FG000|Maintence Period|Adverse Event|23|||
125522746|NCT00263575|451545820|FG000|Maintence Period|Withdrawal by Subject|8|||
125522747|NCT00263575|451545820|FG000|Maintence Period|Protocol Violation|4|||
125522748|NCT00263575|451545820|FG000|Maintence Period|Lack of Efficacy|4|||
125522749|NCT00263575|451545820|FG000|Maintence Period|Physician Decision|6|||
125522750|NCT00263575|451545820|FG000|Maintence Period|Lost to Follow-up|1|||
125522751|NCT00263575|451545820|FG000|Maintence Period|Sponsor Decision|24|||
125522752|NCT00263575|451545820|FG000|Maintence Period|Other|7|||
125522753|NCT00537329|451545821|FG000|Overall Study|Death|10|||
125522754|NCT00537329|451545821|FG000|Overall Study|Adverse Event|3|||
125522755|NCT00537329|451545821|FG000|Overall Study|Lack of Efficacy|2|||
125522756|NCT00537329|451545821|FG000|Overall Study|Lost to Follow-up|6|||
125522757|NCT00537329|451545821|FG000|Overall Study|Withdrawal by Subject|4|||
125522758|NCT00537329|451545821|FG000|Overall Study|Other|1|||
125522759|NCT02049515|451545822|FG000|Overall Study|Adverse Event|46|||
125522760|NCT02049515|451545823|FG001|Overall Study|Adverse Event|2|||
125522761|NCT02049515|451545822|FG000|Overall Study|Protocol-specified Disease Progression|23|||
125522762|NCT02049515|451545823|FG001|Overall Study|Protocol-specified Disease Progression|2|||
125522763|NCT02049515|451545822|FG000|Overall Study|Death|6|||
125522764|NCT02049515|451545823|FG001|Overall Study|Death|0|||
125522765|NCT02049515|451545822|FG000|Overall Study|Physician Decision|5|||
125522766|NCT02049515|451545823|FG001|Overall Study|Physician Decision|1|||
125522767|NCT02049515|451545822|FG000|Overall Study|Withdrawal by Subject|3|||
125522768|NCT02049515|451545823|FG001|Overall Study|Withdrawal by Subject|0|||
125522769|NCT02049515|451545822|FG000|Overall Study|Termination of the Study by Sponsor|2|||
125522770|NCT02049515|451545823|FG001|Overall Study|Termination of the Study by Sponsor|0|||
125522771|NCT02049515|451545822|FG000|Overall Study|Protocol Violation|1|||
125522772|NCT02049515|451545823|FG001|Overall Study|Protocol Violation|1|||
125522773|NCT02049515|451545822|FG000|Overall Study|Clinical Deterioration|1|||
125522774|NCT02049515|451545823|FG001|Overall Study|Clinical Deterioration|0|||
125522775|NCT02049515|451545822|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
125522776|NCT02049515|451545823|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
125522777|NCT02049515|451545822|FG000|Overall Study|Treatment Interruption >42 Days|1|||
125522778|NCT02049515|451545823|FG001|Overall Study|Treatment Interruption >42 Days|0|||
125522779|NCT02049515|451545822|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
125522780|NCT02049515|451545823|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
125522781|NCT02138253|451545828|FG000|Overall Study|Adverse Event|3|||
125522782|NCT02138253|451545829|FG001|Overall Study|Adverse Event|3|||
125522783|NCT02138253|451545828|FG000|Overall Study|Lost to Follow-up|2|||
125522784|NCT02138253|451545829|FG001|Overall Study|Lost to Follow-up|1|||
125522785|NCT02138253|451545828|FG000|Overall Study|Physician Decision|2|||
125522786|NCT02138253|451545829|FG001|Overall Study|Physician Decision|0|||
125522787|NCT02138253|451545828|FG000|Overall Study|Non compliance|1|||
125522788|NCT02138253|451545829|FG001|Overall Study|Non compliance|0|||
125522789|NCT02138253|451545828|FG000|Overall Study|Withdrawal by Subject|1|||
125522790|NCT02138253|451545829|FG001|Overall Study|Withdrawal by Subject|0|||
125522791|NCT01426113|451545830|FG000|Overall Study|Study Discontinued|1|||
125522792|NCT01426113|451545831|FG001|Overall Study|Study Discontinued|1|||
125522793|NCT01426113|451545830|FG000|Overall Study|Adverse Event|0|||
125522794|NCT01426113|451545831|FG001|Overall Study|Adverse Event|1|||
125522795|NCT02872012|451545832|FG000|Overall Study|Withdrawal by Subject|1|||
125522796|NCT02872012|451545833|FG001|Overall Study|Withdrawal by Subject|0|||
125522797|NCT02872012|451545834|FG002|Overall Study|Withdrawal by Subject|0|||
125522798|NCT02872012|451545835|FG003|Overall Study|Withdrawal by Subject|0|||
125522799|NCT02872012|451545836|FG004|Overall Study|Withdrawal by Subject|0|||
125522800|NCT01728623|451545837|FG000|Overall Study|Disease progression|26|||
125522801|NCT01728623|451545837|FG000|Overall Study|Adverse Event|1|||
125522802|NCT01728623|451545837|FG000|Overall Study|Withdrawal by Subject|1|||
125522803|NCT01390441|451545838|FG000|Treatment Period|Protocol Violation|0|||
125522804|NCT01390441|451545839|FG001|Treatment Period|Protocol Violation|1|||
125522805|NCT01390441|451545840|FG002|Treatment Period|Protocol Violation|0|||
125522806|NCT01390441|451545841|FG003|Treatment Period|Protocol Violation|0|||
125522807|NCT01390441|451545842|FG004|Treatment Period|Protocol Violation|0|||
125522808|NCT01390441|451545838|FG000|Treatment Period|Physician Decision|0|||
125522809|NCT01390441|451545839|FG001|Treatment Period|Physician Decision|0|||
125522810|NCT01390441|451545840|FG002|Treatment Period|Physician Decision|0|||
125522811|NCT01390441|451545841|FG003|Treatment Period|Physician Decision|1|||
125522812|NCT01390441|451545842|FG004|Treatment Period|Physician Decision|0|||
125522813|NCT01390441|451545838|FG000|Treatment Period|Lack of Efficacy|0|||
125522814|NCT01390441|451545839|FG001|Treatment Period|Lack of Efficacy|0|||
125522815|NCT01390441|451545840|FG002|Treatment Period|Lack of Efficacy|0|||
125522816|NCT01390441|451545841|FG003|Treatment Period|Lack of Efficacy|0|||
125522817|NCT01390441|451545842|FG004|Treatment Period|Lack of Efficacy|1|||
125522818|NCT01390441|451545838|FG000|Treatment Period|Unknown due to early stopping of study|0|||
125522819|NCT01390441|451545839|FG001|Treatment Period|Unknown due to early stopping of study|0|||
125522820|NCT01390441|451545840|FG002|Treatment Period|Unknown due to early stopping of study|8|||
125522821|NCT01390441|451545841|FG003|Treatment Period|Unknown due to early stopping of study|11|||
125522822|NCT01390441|451545842|FG004|Treatment Period|Unknown due to early stopping of study|7|||
125522823|NCT01390441|451545838|FG000|Treatment Period|Adverse Event|0|||
125522824|NCT01390441|451545839|FG001|Treatment Period|Adverse Event|0|||
125522825|NCT01390441|451545840|FG002|Treatment Period|Adverse Event|1|||
125522826|NCT01390441|451545841|FG003|Treatment Period|Adverse Event|1|||
125522827|NCT01390441|451545842|FG004|Treatment Period|Adverse Event|2|||
125522828|NCT01390441|451545838|FG000|Treatment Period|Withdrawal by Subject|0|||
125522829|NCT01390441|451545839|FG001|Treatment Period|Withdrawal by Subject|0|||
125522830|NCT01390441|451545840|FG002|Treatment Period|Withdrawal by Subject|1|||
125522831|NCT01390441|451545841|FG003|Treatment Period|Withdrawal by Subject|0|||
125522832|NCT01390441|451545842|FG004|Treatment Period|Withdrawal by Subject|1|||
125522833|NCT01390441|451545838|FG000|Treatment Period|Lost to Follow-up|1|||
125522834|NCT01390441|451545839|FG001|Treatment Period|Lost to Follow-up|0|||
125522835|NCT01390441|451545840|FG002|Treatment Period|Lost to Follow-up|0|||
125522836|NCT01390441|451545841|FG003|Treatment Period|Lost to Follow-up|0|||
125522837|NCT01390441|451545842|FG004|Treatment Period|Lost to Follow-up|0|||
125522838|NCT01390441|451545838|FG000|Extension Period|Protocol Violation|3|||
125522839|NCT01390441|451545839|FG001|Extension Period|Protocol Violation|1|||
125522840|NCT01390441|451545840|FG002|Extension Period|Protocol Violation|0|||
125522841|NCT01390441|451545841|FG003|Extension Period|Protocol Violation|1|||
125522842|NCT01390441|451545842|FG004|Extension Period|Protocol Violation|0|||
125522843|NCT02725528|451545844|FG000|Overall Study|Lost to Follow-up|1|||
125522844|NCT02725528|451545845|FG001|Overall Study|Lost to Follow-up|4|||
125522845|NCT02725528|451545844|FG000|Overall Study|Withdrawal by Subject|0|||
125522846|NCT02725528|451545845|FG001|Overall Study|Withdrawal by Subject|1|||
125522847|NCT02569957|451545847|FG000|Overall Study|Withdrawal by Subject|0|||
125522848|NCT02569957|451545848|FG001|Overall Study|Withdrawal by Subject|1|||
125522849|NCT02635386|451545849|FG000|Overall Study|Pregnancy|2|||
125522850|NCT02635386|451545850|FG001|Overall Study|Pregnancy|0|||
125522851|NCT02635386|451545851|FG002|Overall Study|Pregnancy|0|||
125522852|NCT02635386|451545852|FG003|Overall Study|Pregnancy|0|||
125522853|NCT02635386|451545853|FG004|Overall Study|Pregnancy|2|||
125522854|NCT02635386|451545849|FG000|Overall Study|Withdrawal by Subject|1|||
125522855|NCT02635386|451545850|FG001|Overall Study|Withdrawal by Subject|1|||
125522856|NCT02635386|451545851|FG002|Overall Study|Withdrawal by Subject|0|||
125522857|NCT02635386|451545852|FG003|Overall Study|Withdrawal by Subject|1|||
125522858|NCT02635386|451545853|FG004|Overall Study|Withdrawal by Subject|0|||
125522859|NCT02635386|451545849|FG000|Overall Study|Physician Decision|0|||
125522860|NCT02635386|451545850|FG001|Overall Study|Physician Decision|1|||
125522861|NCT02635386|451545851|FG002|Overall Study|Physician Decision|0|||
125522862|NCT02635386|451545852|FG003|Overall Study|Physician Decision|0|||
125522863|NCT02635386|451545853|FG004|Overall Study|Physician Decision|0|||
125522864|NCT02635386|451545849|FG000|Overall Study|Moved Out of State|0|||
125522865|NCT02635386|451545850|FG001|Overall Study|Moved Out of State|1|||
125522866|NCT02635386|451545851|FG002|Overall Study|Moved Out of State|0|||
125522867|NCT02635386|451545852|FG003|Overall Study|Moved Out of State|0|||
125522868|NCT02635386|451545853|FG004|Overall Study|Moved Out of State|0|||
125522869|NCT02635386|451545849|FG000|Overall Study|Noncompliant|0|||
125522870|NCT02635386|451545850|FG001|Overall Study|Noncompliant|2|||
125522871|NCT02635386|451545851|FG002|Overall Study|Noncompliant|1|||
125522872|NCT02635386|451545852|FG003|Overall Study|Noncompliant|1|||
125522873|NCT02635386|451545853|FG004|Overall Study|Noncompliant|1|||
125522874|NCT02635386|451545849|FG000|Overall Study|side effects|0|||
125522875|NCT02635386|451545850|FG001|Overall Study|side effects|0|||
125522876|NCT02635386|451545851|FG002|Overall Study|side effects|1|||
125522877|NCT02635386|451545852|FG003|Overall Study|side effects|4|||
125522878|NCT02635386|451545853|FG004|Overall Study|side effects|6|||
125522879|NCT02635386|451545849|FG000|Overall Study|needed other major surgery|0|||
125522880|NCT02635386|451545850|FG001|Overall Study|needed other major surgery|1|||
125522881|NCT02635386|451545851|FG002|Overall Study|needed other major surgery|0|||
125522882|NCT02635386|451545852|FG003|Overall Study|needed other major surgery|0|||
125522883|NCT02635386|451545853|FG004|Overall Study|needed other major surgery|0|||
125522884|NCT02635386|451545849|FG000|Overall Study|Other medical problems not drug related|0|||
125522885|NCT02635386|451545850|FG001|Overall Study|Other medical problems not drug related|0|||
125522886|NCT02635386|451545851|FG002|Overall Study|Other medical problems not drug related|0|||
125522887|NCT02635386|451545852|FG003|Overall Study|Other medical problems not drug related|1|||
125522888|NCT02635386|451545853|FG004|Overall Study|Other medical problems not drug related|0|||
125522889|NCT01209598|451545854|FG000|Overall Study|Withdrawal by Subject|1|||
125522890|NCT01209598|451545855|FG001|Overall Study|Withdrawal by Subject|0|||
125522891|NCT02719743|451545856|FG000|Overall Study|Consent withdrawal|0|||
125522892|NCT02719743|451545857|FG001|Overall Study|Consent withdrawal|2|||
125522893|NCT02719743|451545858|FG002|Overall Study|Consent withdrawal|0|||
125522894|NCT02719743|451545859|FG003|Overall Study|Consent withdrawal|1|||
125522895|NCT02719743|451545860|FG004|Overall Study|Consent withdrawal|0|||
125522896|NCT02719743|451545856|FG000|Overall Study|Migrated/moved from study area|0|||
125522897|NCT02719743|451545857|FG001|Overall Study|Migrated/moved from study area|0|||
125522898|NCT02719743|451545858|FG002|Overall Study|Migrated/moved from study area|0|||
125522899|NCT02719743|451545859|FG003|Overall Study|Migrated/moved from study area|0|||
125522900|NCT02719743|451545860|FG004|Overall Study|Migrated/moved from study area|2|||
125522901|NCT02719743|451545856|FG000|Overall Study|Lost to Follow-up|1|||
125522902|NCT02719743|451545857|FG001|Overall Study|Lost to Follow-up|1|||
125522903|NCT02719743|451545858|FG002|Overall Study|Lost to Follow-up|0|||
125522904|NCT02719743|451545859|FG003|Overall Study|Lost to Follow-up|0|||
125522905|NCT02719743|451545860|FG004|Overall Study|Lost to Follow-up|0|||
125522906|NCT02287233|451545861|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
125522907|NCT02287233|451545862|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
125522908|NCT02287233|451545863|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
125522909|NCT02287233|451545861|FG000|Overall Study|Adverse Event Related to Progression|0|||
125522910|NCT02287233|451545862|FG001|Overall Study|Adverse Event Related to Progression|2|||
125522911|NCT02287233|451545863|FG002|Overall Study|Adverse Event Related to Progression|8|||
125522912|NCT02287233|451545861|FG000|Overall Study|Physician Decision|1|||
125522913|NCT02287233|451545862|FG001|Overall Study|Physician Decision|2|||
125522914|NCT02287233|451545863|FG002|Overall Study|Physician Decision|4|||
125522915|NCT02287233|451545861|FG000|Overall Study|Progressive Disease with Death|0|||
125522916|NCT02287233|451545862|FG001|Overall Study|Progressive Disease with Death|0|||
125522917|NCT02287233|451545863|FG002|Overall Study|Progressive Disease with Death|10|||
125522918|NCT02287233|451545861|FG000|Overall Study|Progressive Disease Without Death|2|||
125522919|NCT02287233|451545862|FG001|Overall Study|Progressive Disease Without Death|3|||
125522920|NCT02287233|451545863|FG002|Overall Study|Progressive Disease Without Death|20|||
125522921|NCT02287233|451545861|FG000|Overall Study|Withdrawal by Subject|1|||
125522922|NCT02287233|451545862|FG001|Overall Study|Withdrawal by Subject|1|||
125522923|NCT02287233|451545863|FG002|Overall Study|Withdrawal by Subject|7|||
125522924|NCT02287233|451545861|FG000|Overall Study|Other|3|||
125522925|NCT02287233|451545862|FG001|Overall Study|Other|0|||
125522926|NCT02287233|451545863|FG002|Overall Study|Other|15|||
125522927|NCT02287233|451545861|FG000|Overall Study|Did Not Receive Treatment|0|||
125522928|NCT02287233|451545862|FG001|Overall Study|Did Not Receive Treatment|0|||
125522929|NCT02287233|451545863|FG002|Overall Study|Did Not Receive Treatment|2|||
125522930|NCT01163474|451545864|FG000|Overall Study|Withdrawal by Subject|1|||
125522931|NCT01163474|451545864|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
125522932|NCT01163474|451545864|FG000|Overall Study|Lost to Follow-up|3|||
125522933|NCT03432390|451545867|FG000|Apnea Period|Protocol Violation|2|||
125522934|NCT03432390|451545868|FG001|Apnea Period|Protocol Violation|2|||
125522935|NCT02689453|451545881|FG000|Overall Study|Progressive disease|0|||
125522936|NCT02689453|451545882|FG001|Overall Study|Progressive disease|1|||
125522937|NCT02689453|451545883|FG002|Overall Study|Progressive disease|1|||
125522938|NCT04206085|451545884|FG000|Overall Study|Lost to Follow-up|0|||
125522939|NCT04206085|451545885|FG001|Overall Study|Lost to Follow-up|1|||
125522940|NCT04206085|451545886|FG002|Overall Study|Lost to Follow-up|0|||
125522941|NCT04206085|451545884|FG000|Overall Study|Lost to Follow-up|0|||
125522942|NCT04206085|451545885|FG001|Overall Study|Lost to Follow-up|0|||
125522943|NCT04206085|451545886|FG002|Overall Study|Lost to Follow-up|1|||
125522944|NCT00763451|451545887|FG000|Overall Study|Adverse Event|4|||
125522945|NCT00763451|451545888|FG001|Overall Study|Adverse Event|6|||
125522946|NCT00763451|451545889|FG002|Overall Study|Adverse Event|19|||
125522947|NCT00763451|451545890|FG003|Overall Study|Adverse Event|14|||
125522948|NCT00763451|451545887|FG000|Overall Study|Lack of Efficacy|1|||
125522949|NCT00763451|451545888|FG001|Overall Study|Lack of Efficacy|4|||
125522950|NCT00763451|451545889|FG002|Overall Study|Lack of Efficacy|3|||
125522951|NCT00763451|451545890|FG003|Overall Study|Lack of Efficacy|2|||
125522952|NCT00763451|451545887|FG000|Overall Study|Withdrawal by Subject|1|||
125522953|NCT00763451|451545888|FG001|Overall Study|Withdrawal by Subject|6|||
125522954|NCT00763451|451545889|FG002|Overall Study|Withdrawal by Subject|9|||
125522955|NCT00763451|451545890|FG003|Overall Study|Withdrawal by Subject|7|||
125522956|NCT00763451|451545887|FG000|Overall Study|Protocol Violation|0|||
125522957|NCT00763451|451545888|FG001|Overall Study|Protocol Violation|0|||
125522958|NCT00763451|451545889|FG002|Overall Study|Protocol Violation|1|||
125522959|NCT00763451|451545890|FG003|Overall Study|Protocol Violation|0|||
125522960|NCT00763451|451545887|FG000|Overall Study|Poor Compliance to Protocol|1|||
125522961|NCT00763451|451545888|FG001|Overall Study|Poor Compliance to Protocol|1|||
125522962|NCT00763451|451545889|FG002|Overall Study|Poor Compliance to Protocol|2|||
125522963|NCT00763451|451545890|FG003|Overall Study|Poor Compliance to Protocol|2|||
125522964|NCT00763451|451545887|FG000|Overall Study|Familial and Personal Reasons|5|||
125522965|NCT00763451|451545888|FG001|Overall Study|Familial and Personal Reasons|3|||
125522966|NCT00763451|451545889|FG002|Overall Study|Familial and Personal Reasons|5|||
125522967|NCT00763451|451545890|FG003|Overall Study|Familial and Personal Reasons|4|||
125522968|NCT00763451|451545887|FG000|Overall Study|Randomized but not Treated|1|||
125522969|NCT00763451|451545888|FG001|Overall Study|Randomized but not Treated|1|||
125522970|NCT00763451|451545889|FG002|Overall Study|Randomized but not Treated|0|||
125522971|NCT00763451|451545890|FG003|Overall Study|Randomized but not Treated|0|||
125522972|NCT00763451|451545887|FG000|Overall Study|Study Site Reason|0|||
125522973|NCT00763451|451545888|FG001|Overall Study|Study Site Reason|1|||
125522974|NCT00763451|451545889|FG002|Overall Study|Study Site Reason|1|||
125522975|NCT00763451|451545890|FG003|Overall Study|Study Site Reason|1|||
125522976|NCT00725543|451545894|FG000|Overall Study|Adverse Event|10|||
125522977|NCT00725543|451545894|FG000|Overall Study|Lack of Efficacy|3|||
125522978|NCT00725543|451545894|FG000|Overall Study|Withdrawal by Subject|10|||
125522979|NCT00725543|451545894|FG000|Overall Study|Physician Decision|5|||
125522980|NCT00725543|451545894|FG000|Overall Study|Lost to Follow-up|4|||
125522981|NCT00725543|451545894|FG000|Overall Study|Non-compliance|2|||
125522982|NCT00725543|451545894|FG000|Overall Study|Other|119|||
125522983|NCT05594589|451545895|FG000|Overall Study|Other|0|||
125522984|NCT05594589|451545896|FG001|Overall Study|Other|1|||
125522985|NCT05594589|451545897|FG002|Overall Study|Other|0|||
125522986|NCT02168478|451545904|FG000|Overall Study|Withdrawal by Subject|1|||
125522987|NCT02168478|451545904|FG000|Overall Study|Did Not Consent to Participation|2|||
125522988|NCT02168478|451545904|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
125522989|NCT03845023|451545909|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
125522990|NCT03845023|451545910|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
125522991|NCT03845023|451545911|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
125522992|NCT03845023|451545912|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
125522993|NCT03845023|451545909|FG000|Follow-Up (14 Days)|Adverse Event|0|||
125522994|NCT03845023|451545910|FG001|Follow-Up (14 Days)|Adverse Event|0|||
125522995|NCT03845023|451545911|FG002|Follow-Up (14 Days)|Adverse Event|1|||
125522996|NCT03845023|451545912|FG003|Follow-Up (14 Days)|Adverse Event|1|||
125522997|NCT03772613|451545913|FG000|Overall Study|Lost to Follow-up|0|||
125522998|NCT03772613|451545914|FG001|Overall Study|Lost to Follow-up|1|||
125522999|NCT03772613|451545915|FG002|Overall Study|Lost to Follow-up|1|||
125523000|NCT02554383|451545919|FG000|Overall Study|Ineligible|3|||
125523001|NCT02554383|451545920|FG001|Overall Study|Ineligible|2|||
125523002|NCT02554383|451545919|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
125523003|NCT02554383|451545920|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
125523004|NCT02554383|451545919|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
125523005|NCT02554383|451545920|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
125523006|NCT02554383|451545919|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
125523007|NCT02554383|451545920|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
125523008|NCT02918292|451545921|FG000|Study Enrollment Prior to Transplant|Death|1|||
125523009|NCT02918292|451545921|FG000|Study Follow up After Transplant|Death|6|||
125523010|NCT01801982|451545924|FG000|Overall Study|Lost to Follow-up|1|||
125523011|NCT01185171|451545925|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
125523012|NCT01185171|451545925|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
125523013|NCT01185171|451545925|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
125523014|NCT01185171|451545925|FG000|Maintenance|Elevated liver transaminases|3|||
125523015|NCT01185171|451545925|FG000|Maintenance|Rush|2|||
125523016|NCT01185171|451545925|FG000|Maintenance|Diarrhea|1|||
125523017|NCT01185171|451545925|FG000|Maintenance|Xerostomia|1|||
125523018|NCT01185171|451545925|FG000|Maintenance|Nausea|1|||
125523019|NCT01185171|451545925|FG000|Maintenance|Comorbid Illness|2|||
125523020|NCT01185171|451545925|FG000|Maintenance|Withdrawal by Subject|1|||
125523021|NCT01185171|451545925|FG000|Maintenance|Disease Recurrence|1|||
125523022|NCT00727506|451545926|FG000|Overall Study|Adverse Event|0|||
125523023|NCT00727506|451545927|FG001|Overall Study|Adverse Event|0|||
125523024|NCT00727506|451545928|FG002|Overall Study|Adverse Event|4|||
125523025|NCT00727506|451545929|FG003|Overall Study|Adverse Event|4|||
125523026|NCT00727506|451545930|FG004|Overall Study|Adverse Event|1|||
125523027|NCT00727506|451545931|FG005|Overall Study|Adverse Event|8|||
125523028|NCT00727506|451545926|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
125523029|NCT00727506|451545927|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125523030|NCT00727506|451545928|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
125523031|NCT00727506|451545929|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125523032|NCT00727506|451545930|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125523033|NCT00727506|451545931|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
125523034|NCT00727506|451545926|FG000|Overall Study|Progressive disease|4|||
125523035|NCT00727506|451545927|FG001|Overall Study|Progressive disease|7|||
125523036|NCT00727506|451545928|FG002|Overall Study|Progressive disease|9|||
125523037|NCT00727506|451545929|FG003|Overall Study|Progressive disease|28|||
125523038|NCT00727506|451545930|FG004|Overall Study|Progressive disease|38|||
125523039|NCT00727506|451545931|FG005|Overall Study|Progressive disease|28|||
125523040|NCT00727506|451545926|FG000|Overall Study|Refused to continue medication|0|||
125523041|NCT00727506|451545927|FG001|Overall Study|Refused to continue medication|1|||
125523042|NCT00727506|451545928|FG002|Overall Study|Refused to continue medication|2|||
125523043|NCT00727506|451545929|FG003|Overall Study|Refused to continue medication|3|||
125523044|NCT00727506|451545930|FG004|Overall Study|Refused to continue medication|1|||
125523045|NCT00727506|451545931|FG005|Overall Study|Refused to continue medication|2|||
125523046|NCT00727506|451545926|FG000|Overall Study|Other reason not described above|0|||
125523047|NCT00727506|451545927|FG001|Overall Study|Other reason not described above|0|||
125523048|NCT00727506|451545928|FG002|Overall Study|Other reason not described above|1|||
125523049|NCT00727506|451545929|FG003|Overall Study|Other reason not described above|4|||
125523050|NCT00727506|451545930|FG004|Overall Study|Other reason not described above|1|||
125523051|NCT00727506|451545931|FG005|Overall Study|Other reason not described above|1|||
125523052|NCT03561597|451545932|FG000|Overall Study|Lost to Follow-up|20|||
125523053|NCT03783689|451545934|FG000|Overall Study|Adverse Event|2|||
125523054|NCT03783689|451545935|FG001|Overall Study|Adverse Event|0|||
125523055|NCT03783689|451545934|FG000|Overall Study|Lost to Follow-up|2|||
125523056|NCT03783689|451545935|FG001|Overall Study|Lost to Follow-up|1|||
125523057|NCT03783689|451545934|FG000|Overall Study|Physician Decision|2|||
125523058|NCT03783689|451545935|FG001|Overall Study|Physician Decision|1|||
125523059|NCT03783689|451545934|FG000|Overall Study|Withdrawal by Subject|3|||
125523060|NCT03783689|451545935|FG001|Overall Study|Withdrawal by Subject|3|||
125523061|NCT01255761|451545938|FG000|Overall Study|Adverse Event|29|||
125523062|NCT01255761|451545939|FG001|Overall Study|Adverse Event|43|||
125523063|NCT01255761|451545938|FG000|Overall Study|Lack of Efficacy|86|||
125523064|NCT01255761|451545939|FG001|Overall Study|Lack of Efficacy|74|||
125523065|NCT01255761|451545938|FG000|Overall Study|Protocol Violation|9|||
125523066|NCT01255761|451545939|FG001|Overall Study|Protocol Violation|5|||
125523067|NCT01255761|451545938|FG000|Overall Study|Lost to Follow-up|10|||
125523068|NCT01255761|451545939|FG001|Overall Study|Lost to Follow-up|8|||
125523069|NCT01255761|451545938|FG000|Overall Study|Withdrawal by Subject|11|||
125523070|NCT01255761|451545939|FG001|Overall Study|Withdrawal by Subject|27|||
125523071|NCT01255761|451545938|FG000|Overall Study|Other Reasons|37|||
125523072|NCT01255761|451545939|FG001|Overall Study|Other Reasons|18|||
125523073|NCT03783871|451545945|FG000|Overall Study|Withdrawal by Subject|15|||
125523074|NCT03783871|451545945|FG000|Overall Study|Death|13|||
125523075|NCT03783871|451545945|FG000|Overall Study|Lost to Follow-up|2|||
125523076|NCT04594733|451545947|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
125523077|NCT04594733|451545948|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
125523078|NCT04594733|451545947|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
125523079|NCT04594733|451545948|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
125523080|NCT04594733|451545947|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
125523081|NCT04594733|451545948|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
125523082|NCT02647645|451545951|FG000|Overall Study|Lost to Follow-up|2|||
125523083|NCT02647645|451545952|FG001|Overall Study|Lost to Follow-up|1|||
125523084|NCT00356811|451545953|FG000|Overall Study|Death|35|||
125523085|NCT00356811|451545953|FG000|Overall Study|Lost to Follow-up|2|||
125523086|NCT00356811|451545953|FG000|Overall Study|Withdrawal by Subject|6|||
125523087|NCT00356811|451545953|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
125523088|NCT00356811|451545953|FG000|Overall Study|Study Is Terminating|3|||
125523089|NCT00356811|451545953|FG000|Overall Study|Site Closed during Follow-up|2|||
125523090|NCT02386839|451545954|FG000|Overall Study|Death|1|||
125523091|NCT02386839|451545955|FG001|Overall Study|Death|0|||
125523092|NCT02386839|451545954|FG000|Overall Study|Withdrawal by Subject|9|||
125523093|NCT02386839|451545955|FG001|Overall Study|Withdrawal by Subject|10|||
125523094|NCT02386839|451545954|FG000|Overall Study|Lost to Follow-up|4|||
125523095|NCT02386839|451545955|FG001|Overall Study|Lost to Follow-up|4|||
125523096|NCT02386839|451545954|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
125523097|NCT02386839|451545955|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
125523098|NCT02386839|451545954|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
125523099|NCT02386839|451545955|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
125523100|NCT02386839|451545954|FG000|Overall Study|Other (unspecified)|1|||
125523101|NCT02386839|451545955|FG001|Overall Study|Other (unspecified)|0|||
125523102|NCT02101983|451545956|FG000|Overall Study|Physician Decision|1|||
125523103|NCT02101983|451545957|FG001|Overall Study|Physician Decision|0|||
125523104|NCT00826228|451547199|FG000|Overall Study|Withdrawal by Subject|1|||
125523105|NCT00903760|451547200|FG000|Overall Study|Disease Progression/Death|8|||
125523106|NCT00903760|451547201|FG001|Overall Study|Disease Progression/Death|6|||
125523107|NCT00903760|451547200|FG000|Overall Study|Stem Cell Transplant|8|||
125523108|NCT00903760|451547201|FG001|Overall Study|Stem Cell Transplant|4|||
125523109|NCT00903760|451547200|FG000|Overall Study|Physician Decision|1|||
125523110|NCT00903760|451547201|FG001|Overall Study|Physician Decision|2|||
125523111|NCT00903760|451547200|FG000|Overall Study|Death|0|||
125523112|NCT00903760|451547201|FG001|Overall Study|Death|1|||
125523113|NCT00903760|451547200|FG000|Overall Study|Lost to Follow-up|1|||
125523114|NCT00903760|451547201|FG001|Overall Study|Lost to Follow-up|0|||
125523115|NCT00903760|451547200|FG000|Overall Study|Withdrawal by Subject|1|||
125523116|NCT00903760|451547201|FG001|Overall Study|Withdrawal by Subject|2|||
125523117|NCT00903760|451547200|FG000|Overall Study|Off treatment for long period|0|||
125523118|NCT00903760|451547201|FG001|Overall Study|Off treatment for long period|1|||
125523119|NCT01845805|451547203|FG000|Overall Study|Withdrawal by Subject|1|||
125523120|NCT01845805|451547204|FG001|Overall Study|Withdrawal by Subject|2|||
125523121|NCT01845805|451547203|FG000|Overall Study|Disease Progression|13|||
125523122|NCT01845805|451547204|FG001|Overall Study|Disease Progression|14|||
125523123|NCT01845805|451547203|FG000|Overall Study|Drug-related Toxicity|4|||
125523124|NCT01845805|451547204|FG001|Overall Study|Drug-related Toxicity|0|||
125523125|NCT04795336|451547205|FG000|Overall Study|Withdrawal by Subject|3|||
125523126|NCT04795336|451547206|FG001|Overall Study|Withdrawal by Subject|4|||
125523127|NCT04795336|451547207|FG002|Overall Study|Withdrawal by Subject|3|||
125523128|NCT04795336|451547208|FG003|Overall Study|Withdrawal by Subject|12|||
125523129|NCT04795336|451547205|FG000|Overall Study|Lost study logs|0|||
125523130|NCT04795336|451547206|FG001|Overall Study|Lost study logs|1|||
125523131|NCT04795336|451547207|FG002|Overall Study|Lost study logs|0|||
125523132|NCT04795336|451547208|FG003|Overall Study|Lost study logs|2|||
125523133|NCT04795336|451547205|FG000|Overall Study|Did not take study medication|2|||
125523134|NCT04795336|451547206|FG001|Overall Study|Did not take study medication|0|||
125523135|NCT04795336|451547207|FG002|Overall Study|Did not take study medication|0|||
125523136|NCT04795336|451547208|FG003|Overall Study|Did not take study medication|0|||
125523137|NCT03898700|451547209|FG000|Overall Study|Withdrawal by Subject|2|||
125523138|NCT00589303|451547216|FG000|Overall Study|Withdrawal by Subject|2|||
125523139|NCT00589303|451547217|FG001|Overall Study|Withdrawal by Subject|1|||
125523140|NCT04367480|451547218|FG000|Overall Study|Adverse Event|1|||
125523141|NCT04367480|451547219|FG001|Overall Study|Adverse Event|1|||
125523142|NCT04367480|451547218|FG000|Overall Study|Death|1|||
125523143|NCT04367480|451547219|FG001|Overall Study|Death|0|||
125523144|NCT04367480|451547218|FG000|Overall Study|Lost to Follow-up|1|||
125523145|NCT04367480|451547219|FG001|Overall Study|Lost to Follow-up|1|||
125523146|NCT04367480|451547218|FG000|Overall Study|Withdrawal by Subject|0|||
125523147|NCT04367480|451547219|FG001|Overall Study|Withdrawal by Subject|3|||
125523148|NCT04367480|451547218|FG000|Overall Study|App glitch during the study|1|||
125523149|NCT04367480|451547219|FG001|Overall Study|App glitch during the study|0|||
125523150|NCT04367480|451547218|FG000|Overall Study|Device Distribution Error|0|||
125523151|NCT04367480|451547219|FG001|Overall Study|Device Distribution Error|2|||
125523152|NCT04367480|451547218|FG000|Overall Study|Ineligible after Randomization|0|||
125523153|NCT04367480|451547219|FG001|Overall Study|Ineligible after Randomization|1|||
125523154|NCT04367480|451547218|FG000|Overall Study|Other Medical Reasons|0|||
125523155|NCT04367480|451547219|FG001|Overall Study|Other Medical Reasons|2|||
125523156|NCT00730015|451547221|FG000|Overall Study|Adverse Event|11|||
125523157|NCT00730015|451547222|FG001|Overall Study|Adverse Event|10|||
125523158|NCT00730015|451547223|FG002|Overall Study|Adverse Event|8|||
125523159|NCT00730015|451547221|FG000|Overall Study|Protocol Violation|2|||
125523160|NCT00730015|451547222|FG001|Overall Study|Protocol Violation|6|||
125523161|NCT00730015|451547223|FG002|Overall Study|Protocol Violation|4|||
125523162|NCT00730015|451547221|FG000|Overall Study|Withdrawal by Subject|12|||
125523163|NCT00730015|451547222|FG001|Overall Study|Withdrawal by Subject|12|||
125523164|NCT00730015|451547223|FG002|Overall Study|Withdrawal by Subject|8|||
125523165|NCT00730015|451547221|FG000|Overall Study|Lost to Follow-up|4|||
125523166|NCT00730015|451547222|FG001|Overall Study|Lost to Follow-up|10|||
125523167|NCT00730015|451547223|FG002|Overall Study|Lost to Follow-up|3|||
125523168|NCT00730015|451547221|FG000|Overall Study|Lack of Efficacy|1|||
125523169|NCT00730015|451547222|FG001|Overall Study|Lack of Efficacy|2|||
125523170|NCT00730015|451547223|FG002|Overall Study|Lack of Efficacy|8|||
125523171|NCT00730015|451547221|FG000|Overall Study|Other Reason|1|||
125523172|NCT00730015|451547222|FG001|Overall Study|Other Reason|0|||
125523173|NCT00730015|451547223|FG002|Overall Study|Other Reason|1|||
125523174|NCT04120376|451547224|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
125523175|NCT04120376|451547225|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
125523176|NCT00634842|451547226|FG000|Overall Study|Adverse Event|2|||
125523177|NCT00634842|451547227|FG001|Overall Study|Adverse Event|3|||
125523178|NCT00634842|451547226|FG000|Overall Study|Protocol Violation|8|||
125523179|NCT00634842|451547227|FG001|Overall Study|Protocol Violation|4|||
125523180|NCT00634842|451547226|FG000|Overall Study|Move to another state|1|||
125523181|NCT00634842|451547227|FG001|Overall Study|Move to another state|0|||
125523182|NCT00634842|451547226|FG000|Overall Study|Inclusion criteria were not met|1|||
125523183|NCT00634842|451547227|FG001|Overall Study|Inclusion criteria were not met|0|||
125523184|NCT00634842|451547226|FG000|Overall Study|Lost to Follow-up|1|||
125523185|NCT00634842|451547227|FG001|Overall Study|Lost to Follow-up|2|||
125523186|NCT00634842|451547226|FG000|Overall Study|Physician Decision|1|||
125523187|NCT00634842|451547227|FG001|Overall Study|Physician Decision|0|||
125523188|NCT00634842|451547226|FG000|Overall Study|Withdrawal by Subject|1|||
125523189|NCT00634842|451547227|FG001|Overall Study|Withdrawal by Subject|3|||
125523190|NCT00634842|451547226|FG000|Overall Study|Lack of time and intolerance to drug|0|||
125523191|NCT00634842|451547227|FG001|Overall Study|Lack of time and intolerance to drug|1|||
125523192|NCT00634842|451547226|FG000|Overall Study|Discontinued due to injection|0|||
125523193|NCT00634842|451547227|FG001|Overall Study|Discontinued due to injection|2|||
125523194|NCT00634842|451547226|FG000|Overall Study|No need of study drug to treat diabetes|0|||
125523195|NCT00634842|451547227|FG001|Overall Study|No need of study drug to treat diabetes|1|||
125523196|NCT00634842|451547226|FG000|Overall Study|No wish to keep taking Avandia|0|||
125523197|NCT00634842|451547227|FG001|Overall Study|No wish to keep taking Avandia|1|||
125523198|NCT00634842|451547226|FG000|Overall Study|Subject off study drug for too long|0|||
125523199|NCT00634842|451547227|FG001|Overall Study|Subject off study drug for too long|1|||
125523200|NCT02229578|451547251|FG000|Overall Study|Withdrawal by Subject|1|||
125523201|NCT02229578|451547252|FG001|Overall Study|Withdrawal by Subject|3|||
125523202|NCT02229578|451547251|FG000|Overall Study|Protocol Violation|2|||
125523203|NCT02229578|451547252|FG001|Overall Study|Protocol Violation|0|||
125523204|NCT00943787|451547253|FG000|Overall Study|Physician Decision|4|||
125523205|NCT00943787|451547253|FG000|Overall Study|Withdrawal by Subject|3|||
125523206|NCT01288209|451547255|FG000|Overall Study|Withdrawal by Subject|1|||
125523207|NCT01288209|451547256|FG001|Overall Study|Withdrawal by Subject|3|||
125523208|NCT01288209|451547255|FG000|Overall Study|Other|1|||
125523209|NCT01288209|451547256|FG001|Overall Study|Other|0|||
125523210|NCT01015677|451547257|FG000|Overall Study|Adverse Event|0|||
125523211|NCT01015677|451547258|FG001|Overall Study|Adverse Event|1|||
125523212|NCT01015677|451547259|FG002|Overall Study|Adverse Event|0|||
125523213|NCT01015677|451547257|FG000|Overall Study|Lack of Efficacy|0|||
125523214|NCT01015677|451547258|FG001|Overall Study|Lack of Efficacy|1|||
125523215|NCT01015677|451547259|FG002|Overall Study|Lack of Efficacy|0|||
125523216|NCT01015677|451547257|FG000|Overall Study|Protocol Violation|0|||
125523217|NCT01015677|451547258|FG001|Overall Study|Protocol Violation|1|||
125523218|NCT01015677|451547259|FG002|Overall Study|Protocol Violation|0|||
125523219|NCT01015677|451547257|FG000|Overall Study|Withdrawal by Subject|1|||
125523220|NCT01015677|451547258|FG001|Overall Study|Withdrawal by Subject|1|||
125523221|NCT01015677|451547259|FG002|Overall Study|Withdrawal by Subject|0|||
125523222|NCT02232399|451547260|FG000|Overall Study|Adverse Event|1|||
125523223|NCT02232399|451547261|FG001|Overall Study|Adverse Event|0|||
125523224|NCT02232399|451547260|FG000|Overall Study|Withdrawal by Subject|0|||
125523225|NCT02232399|451547261|FG001|Overall Study|Withdrawal by Subject|1|||
125523226|NCT01646385|451547264|FG000|Overall Study|Death|202|||
125523227|NCT01646385|451547265|FG001|Overall Study|Death|222|||
125523228|NCT01646385|451547264|FG000|Overall Study|Switched to alternate biologic|636|||
125523229|NCT01646385|451547265|FG001|Overall Study|Switched to alternate biologic|649|||
125523230|NCT01216072|451547266|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
125523231|NCT01216072|451547267|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
125523232|NCT01216072|451547266|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
125523233|NCT01216072|451547267|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
125523234|NCT01216072|451547266|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
125523235|NCT01216072|451547267|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
125523236|NCT01216072|451547266|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
125523237|NCT01216072|451547267|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
125523238|NCT01216072|451547266|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
125523239|NCT01216072|451547267|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
125523240|NCT01216072|451547266|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
125523241|NCT01216072|451547267|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
125523242|NCT01216072|451547266|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
125523243|NCT01216072|451547267|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
125523244|NCT01216072|451547266|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
125523245|NCT01216072|451547267|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
125523246|NCT01216072|451547266|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
125523247|NCT01216072|451547267|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
125523248|NCT01216072|451547266|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
125523249|NCT01216072|451547267|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
125523250|NCT00224029|451547271|FG000|Overall Study|Lost to Follow-up|1|||
125523251|NCT00224029|451547271|FG000|Overall Study|Withdrawal by Subject|4|||
125523252|NCT00224029|451547271|FG000|Overall Study|Other|1|||
125523253|NCT00085566|451547279|FG000|Overall Study|Adverse Event|0|||
125523254|NCT00085566|451547280|FG001|Overall Study|Adverse Event|0|||
125523255|NCT00085566|451547281|FG002|Overall Study|Adverse Event|10|||
125523256|NCT00085566|451547279|FG000|Overall Study|Patient Not treated|0|||
125523257|NCT00085566|451547280|FG001|Overall Study|Patient Not treated|0|||
125523258|NCT00085566|451547281|FG002|Overall Study|Patient Not treated|3|||
125523259|NCT00085566|451547279|FG000|Overall Study|Clinical progression|0|||
125523260|NCT00085566|451547280|FG001|Overall Study|Clinical progression|0|||
125523261|NCT00085566|451547281|FG002|Overall Study|Clinical progression|1|||
125523262|NCT03174782|451547282|FG000|Overall Study|Protocol Violation|1|||
125523263|NCT03174782|451547283|FG001|Overall Study|Protocol Violation|0|||
125523264|NCT03174782|451547282|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
125523265|NCT03174782|451547283|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
125523266|NCT00778921|451547284|FG000|Overall Study|Adverse Event|9|||
125523267|NCT00778921|451547285|FG001|Overall Study|Adverse Event|10|||
125523268|NCT00778921|451547286|FG002|Overall Study|Adverse Event|14|||
125523269|NCT00778921|451547284|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
125523270|NCT00778921|451547285|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
125523271|NCT00778921|451547286|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
125523272|NCT00778921|451547284|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
125523273|NCT00778921|451547285|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
125523274|NCT00778921|451547286|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
125523275|NCT00778921|451547284|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
125523276|NCT00778921|451547285|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
125523277|NCT00778921|451547286|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
125523278|NCT00778921|451547284|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
125523279|NCT00778921|451547285|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
125523280|NCT00778921|451547286|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
125523281|NCT00778921|451547284|FG000|Overall Study|Patient withdrew request|3|||
125523282|NCT00778921|451547285|FG001|Overall Study|Patient withdrew request|1|||
125523283|NCT00778921|451547286|FG002|Overall Study|Patient withdrew request|6|||
125523284|NCT00778921|451547284|FG000|Overall Study|Lost to Follow-up|0|||
125523285|NCT00778921|451547285|FG001|Overall Study|Lost to Follow-up|2|||
125523286|NCT00778921|451547286|FG002|Overall Study|Lost to Follow-up|1|||
125523287|NCT00778921|451547284|FG000|Overall Study|Administrative Problems|1|||
125523288|NCT00778921|451547285|FG001|Overall Study|Administrative Problems|2|||
125523289|NCT00778921|451547286|FG002|Overall Study|Administrative Problems|0|||
125523290|NCT00778921|451547284|FG000|Overall Study|Protocol Violation|3|||
125523291|NCT00778921|451547285|FG001|Overall Study|Protocol Violation|0|||
125523292|NCT00778921|451547286|FG002|Overall Study|Protocol Violation|2|||
125523293|NCT00778921|451547284|FG000|Overall Study|Not treated|0|||
125523294|NCT00778921|451547285|FG001|Overall Study|Not treated|2|||
125523295|NCT00778921|451547286|FG002|Overall Study|Not treated|2|||
125523296|NCT03178045|451547287|FG000|Overall Study|Withdrawal by Subject|5|||
125523297|NCT03178045|451547288|FG001|Overall Study|Withdrawal by Subject|7|||
125523298|NCT03178045|451547287|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
125523299|NCT03178045|451547288|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
125523300|NCT03178045|451547287|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
125523301|NCT03178045|451547288|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
125523302|NCT01078922|451547289|FG000|Overall Study|Adverse Event|1|||
125523303|NCT02706847|451547290|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
125523304|NCT02706847|451547291|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
125523305|NCT02706847|451547292|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
125523306|NCT02706847|451547293|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
125523307|NCT02706847|451547290|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
125523308|NCT02706847|451547291|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
125523309|NCT02706847|451547292|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
125523310|NCT02706847|451547293|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
125523311|NCT02706847|451547290|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
125523312|NCT02706847|451547291|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
125523313|NCT02706847|451547292|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
125523314|NCT02706847|451547293|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
125523315|NCT02706847|451547290|FG000|Period 1: Day 1 to Week 12|Other|4|||
125523316|NCT02706847|451547291|FG001|Period 1: Day 1 to Week 12|Other|4|||
125523317|NCT02706847|451547292|FG002|Period 1: Day 1 to Week 12|Other|2|||
125523318|NCT02706847|451547293|FG003|Period 1: Day 1 to Week 12|Other|2|||
125523319|NCT02706847|451547290|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
125523320|NCT02706847|451547291|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
125523321|NCT02706847|451547292|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
125523322|NCT02706847|451547293|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
125523323|NCT02706847|451547290|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
125523324|NCT02706847|451547291|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
125523325|NCT02706847|451547292|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
125523326|NCT02706847|451547293|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
125523327|NCT02706847|451547290|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
125523328|NCT02706847|451547291|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
125523329|NCT02706847|451547292|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
125523330|NCT02706847|451547293|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
125523331|NCT02706847|451547290|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
125523332|NCT02706847|451547291|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
125523333|NCT02706847|451547292|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
125523334|NCT02706847|451547293|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
125523335|NCT02706847|451547290|FG000|Period 1: Week 12 to Week 24|Other|1|||
125523336|NCT02706847|451547291|FG001|Period 1: Week 12 to Week 24|Other|0|||
125523337|NCT02706847|451547292|FG002|Period 1: Week 12 to Week 24|Other|1|||
125523338|NCT02706847|451547293|FG003|Period 1: Week 12 to Week 24|Other|4|||
125523339|NCT02706847|451547290|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
125523340|NCT02706847|451547291|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
125523341|NCT02706847|451547292|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
125523342|NCT02706847|451547293|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
125523343|NCT02706847|451547290|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
125523344|NCT02706847|451547291|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
125523345|NCT02706847|451547292|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
125523346|NCT02706847|451547293|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
125523347|NCT02706847|451547290|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
125523348|NCT02706847|451547291|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
125523349|NCT02706847|451547292|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
125523350|NCT02706847|451547293|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
125523351|NCT02706847|451547290|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
125523352|NCT02706847|451547291|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
125523353|NCT02706847|451547292|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
125523354|NCT02706847|451547293|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
125523355|NCT02706847|451547290|FG000|Period 2: Week 24 to Week 260|Other|8|||
125523356|NCT02706847|451547291|FG001|Period 2: Week 24 to Week 260|Other|5|||
125523357|NCT02706847|451547292|FG002|Period 2: Week 24 to Week 260|Other|15|||
125523358|NCT02706847|451547293|FG003|Period 2: Week 24 to Week 260|Other|15|||
125523359|NCT01174264|451547296|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
125523360|NCT01174264|451547297|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
125523361|NCT01174264|451547298|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
125523362|NCT01174264|451547296|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
125523363|NCT01174264|451547297|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
125523364|NCT01174264|451547298|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
125523365|NCT01174264|451547296|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
125523366|NCT01174264|451547297|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
125523367|NCT01174264|451547298|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
125523368|NCT01427738|451547299|FG000|Overall Study|Death|12|||
125523369|NCT01427738|451547300|FG001|Overall Study|Death|9|||
125523370|NCT01427738|451547299|FG000|Overall Study|Severe debilitation, unable to continue|0|||
125523371|NCT01427738|451547300|FG001|Overall Study|Severe debilitation, unable to continue|1|||
125523372|NCT01427738|451547299|FG000|Overall Study|Subject unable to get to clinic|5|||
125523373|NCT01427738|451547300|FG001|Overall Study|Subject unable to get to clinic|2|||
125523374|NCT01427738|451547299|FG000|Overall Study|Withdrawal by Subject|0|||
125523375|NCT01427738|451547300|FG001|Overall Study|Withdrawal by Subject|2|||
125523376|NCT01427738|451547299|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
125523377|NCT01427738|451547300|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
125523378|NCT01427738|451547299|FG000|Overall Study|Lost to Follow-up|1|||
125523379|NCT01427738|451547300|FG001|Overall Study|Lost to Follow-up|5|||
125523380|NCT05314374|451547301|FG000|Overall Study|Adverse Event|2|||
125523381|NCT05314374|451547302|FG001|Overall Study|Adverse Event|2|||
125523382|NCT02658175|451547303|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
125523383|NCT02658175|451547304|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
125523384|NCT02658175|451547305|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
125523385|NCT02658175|451547303|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
125523386|NCT02658175|451547304|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
125523387|NCT02658175|451547305|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
125523388|NCT02658175|451547303|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
125523389|NCT02658175|451547304|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
125523390|NCT02658175|451547305|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
125523391|NCT02658175|451547303|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
125523392|NCT02658175|451547304|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
125523393|NCT02658175|451547305|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
125523394|NCT02658175|451547303|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
125523395|NCT02658175|451547304|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
125523396|NCT02658175|451547305|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
125523397|NCT02658175|451547303|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
125523398|NCT02658175|451547304|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
125523399|NCT02658175|451547305|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
125523400|NCT02658175|451547303|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
125523401|NCT02658175|451547304|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
125523402|NCT02658175|451547305|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
125523403|NCT02658175|451547303|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
125523404|NCT02658175|451547304|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
125523405|NCT02658175|451547305|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
125523406|NCT02658175|451547303|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
125523407|NCT02658175|451547304|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
125523408|NCT02658175|451547305|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
125523409|NCT02658175|451547303|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
125523410|NCT02658175|451547304|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
125523411|NCT02658175|451547305|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
125523412|NCT01214421|451547306|FG000|Overall Study|Lost to Follow-up|7|||
125523413|NCT01214421|451547307|FG001|Overall Study|Lost to Follow-up|3|||
125523414|NCT01214421|451547308|FG002|Overall Study|Lost to Follow-up|7|||
125523415|NCT01214421|451547309|FG003|Overall Study|Lost to Follow-up|3|||
125523416|NCT01214421|451547306|FG000|Overall Study|Adverse Event|16|||
125523417|NCT01214421|451547307|FG001|Overall Study|Adverse Event|35|||
125523418|NCT01214421|451547308|FG002|Overall Study|Adverse Event|14|||
125523419|NCT01214421|451547309|FG003|Overall Study|Adverse Event|3|||
125523420|NCT01214421|451547306|FG000|Overall Study|Sponsor Discontinued Site|1|||
125523421|NCT01214421|451547307|FG001|Overall Study|Sponsor Discontinued Site|2|||
125523422|NCT01214421|451547308|FG002|Overall Study|Sponsor Discontinued Site|0|||
125523423|NCT01214421|451547309|FG003|Overall Study|Sponsor Discontinued Site|0|||
125523424|NCT01214421|451547306|FG000|Overall Study|Withdrawal Criteria Met|3|||
125523425|NCT01214421|451547307|FG001|Overall Study|Withdrawal Criteria Met|0|||
125523426|NCT01214421|451547308|FG002|Overall Study|Withdrawal Criteria Met|2|||
125523427|NCT01214421|451547309|FG003|Overall Study|Withdrawal Criteria Met|1|||
125523428|NCT01214421|451547306|FG000|Overall Study|Physician Decision|2|||
125523429|NCT01214421|451547307|FG001|Overall Study|Physician Decision|0|||
125523430|NCT01214421|451547308|FG002|Overall Study|Physician Decision|4|||
125523431|NCT01214421|451547309|FG003|Overall Study|Physician Decision|0|||
125523432|NCT01214421|451547306|FG000|Overall Study|Withdrawal by Subject|21|||
125523433|NCT01214421|451547307|FG001|Overall Study|Withdrawal by Subject|18|||
125523434|NCT01214421|451547308|FG002|Overall Study|Withdrawal by Subject|11|||
125523435|NCT01214421|451547309|FG003|Overall Study|Withdrawal by Subject|2|||
125523436|NCT02581059|451547314|FG000|Study Treatment|Disease Progression|1|||
125523437|NCT02581059|451547315|FG001|Study Treatment|Disease Progression|1|||
125523438|NCT02581059|451547314|FG000|Study Treatment|Adverse Event|2|||
125523439|NCT02581059|451547315|FG001|Study Treatment|Adverse Event|1|||
125523440|NCT02581059|451547314|FG000|Study Treatment|Death|1|||
125523441|NCT02581059|451547315|FG001|Study Treatment|Death|1|||
125523442|NCT02581059|451547314|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
125523443|NCT02581059|451547315|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
125523444|NCT02581059|451547314|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
125523445|NCT02581059|451547315|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
125523446|NCT02581059|451547314|FG000|Follow up|Death|1|||
125523447|NCT02581059|451547315|FG001|Follow up|Death|3|||
125523448|NCT02581059|451547314|FG000|Follow up|study terminated|1|||
125523449|NCT02581059|451547315|FG001|Follow up|study terminated|1|||
125523450|NCT02581059|451547314|FG000|Follow up|screen failure|0|||
125523451|NCT02581059|451547315|FG001|Follow up|screen failure|1|||
125523452|NCT02581059|451547314|FG000|Follow up|Patient started new clinical trial|1|||
125523453|NCT02581059|451547315|FG001|Follow up|Patient started new clinical trial|0|||
125523454|NCT02392104|451547316|FG000|Overall Study|discontinuation of warfarin|3|||
125523455|NCT02392104|451547316|FG000|Overall Study|bleeding event|1|||
125523456|NCT02392104|451547316|FG000|Overall Study|transferred care to another doctor|2|||
125523457|NCT02392104|451547316|FG000|Overall Study|INR goal range changed|1|||
125523458|NCT02392104|451547316|FG000|Overall Study|admitted to skilled nursing facility|3|||
125523459|NCT02392104|451547316|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
125523460|NCT04887506|451547317|FG000|Overall Study|Death|1|||
125523461|NCT04887506|451547318|FG001|Overall Study|Death|1|||
125523462|NCT04887506|451547317|FG000|Overall Study|Withdrawal by Subject|0|||
125523463|NCT04887506|451547318|FG001|Overall Study|Withdrawal by Subject|3|||
125523464|NCT04887506|451547317|FG000|Overall Study|Adverse Event|4|||
125523465|NCT04887506|451547318|FG001|Overall Study|Adverse Event|3|||
125523466|NCT04887506|451547317|FG000|Overall Study|Other - Not Reported|1|||
125523467|NCT04887506|451547318|FG001|Overall Study|Other - Not Reported|1|||
125523468|NCT02394665|451547321|FG000|Overall Study|Physician Decision|1|||
125523469|NCT02394665|451547322|FG001|Overall Study|Physician Decision|0|||
125523470|NCT02394665|451547323|FG002|Overall Study|Physician Decision|0|||
125523471|NCT02636608|451547324|FG000|Overall Study|Failure to Return|4|||
125523472|NCT02636608|451547324|FG000|Overall Study|Insufficient Virological Response|1|||
125523473|NCT02636608|451547324|FG000|Overall Study|Death|3|||
125523474|NCT02636608|451547324|FG000|Overall Study|Other|2|||
125523475|NCT02636608|451547324|FG000|Overall Study|Did Not Receive Treatment|1|||
125523476|NCT05613088|451547327|FG000|Treatment|Ongoing Study Treatment|9|||
125523477|NCT05613088|451547328|FG001|Treatment|Ongoing Study Treatment|2|||
125523478|NCT05613088|451547327|FG000|Treatment|Adverse Event|3|||
125523479|NCT05613088|451547328|FG001|Treatment|Adverse Event|1|||
125523480|NCT05613088|451547327|FG000|Treatment|Other Reasons|0|||
125523481|NCT05613088|451547328|FG001|Treatment|Other Reasons|1|||
125523482|NCT05613088|451547327|FG000|Treatment|Progressive Disease|58|||
125523483|NCT05613088|451547328|FG001|Treatment|Progressive Disease|26|||
125523484|NCT05613088|451547327|FG000|Treatment|Withdrawal by Subject|0|||
125523485|NCT05613088|451547328|FG001|Treatment|Withdrawal by Subject|4|||
125523486|NCT03912532|451547329|FG000|Overall Study|Adverse Event|3|||
125523487|NCT03912532|451547330|FG001|Overall Study|Adverse Event|3|||
125523488|NCT03912532|451547331|FG002|Overall Study|Adverse Event|2|||
125523489|NCT03912532|451547332|FG003|Overall Study|Adverse Event|2|||
125523490|NCT03912532|451547329|FG000|Overall Study|Lost to Follow-up|3|||
125523491|NCT03912532|451547330|FG001|Overall Study|Lost to Follow-up|2|||
125523492|NCT03912532|451547331|FG002|Overall Study|Lost to Follow-up|1|||
125523493|NCT03912532|451547332|FG003|Overall Study|Lost to Follow-up|2|||
125523494|NCT03912532|451547329|FG000|Overall Study|Withdrawal by Subject|1|||
125523495|NCT03912532|451547330|FG001|Overall Study|Withdrawal by Subject|1|||
125523496|NCT03912532|451547331|FG002|Overall Study|Withdrawal by Subject|2|||
125523497|NCT03912532|451547332|FG003|Overall Study|Withdrawal by Subject|0|||
125523498|NCT03912532|451547329|FG000|Overall Study|Physician Decision|1|||
125523499|NCT03912532|451547330|FG001|Overall Study|Physician Decision|0|||
125523500|NCT03912532|451547331|FG002|Overall Study|Physician Decision|0|||
125523501|NCT03912532|451547332|FG003|Overall Study|Physician Decision|3|||
125523502|NCT03912532|451547329|FG000|Overall Study|Other|0|||
125523503|NCT03912532|451547330|FG001|Overall Study|Other|1|||
125523504|NCT03912532|451547331|FG002|Overall Study|Other|1|||
125523505|NCT03912532|451547332|FG003|Overall Study|Other|0|||
125523506|NCT04199052|451547335|FG000|Overall Study|Lost to Follow-up|11|||
125523507|NCT04199052|451547336|FG001|Overall Study|Lost to Follow-up|18|||
125523508|NCT03569891|451547337|FG000|Lead-in|Ineligible during lead-in|8|||
125523509|NCT03569891|451547337|FG000|Lead-in|Withdrawal by Subject|3|||
125523510|NCT03569891|451547337|FG000|Lead-in|Risks related to COVID-19|2|||
125523511|NCT03569891|451547337|FG000|AMT-061|Adverse Event|1|||
125523512|NCT00815919|451547338|FG000|Overall Study|Unrelated Fungal Infection|1|||
125523513|NCT00815919|451547338|FG000|Overall Study|AML Relapse|1|||
125523514|NCT00815919|451547338|FG000|Overall Study|Lack of Efficacy|2|||
125523515|NCT03614676|451549312|FG000|Overall Study|Delivery before planned visit|2|||
125523516|NCT03614676|451549313|FG001|Overall Study|Delivery before planned visit|0|||
125523517|NCT03614676|451549312|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
125523518|NCT03614676|451549313|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
125523519|NCT03614676|451549312|FG000|Overall Study|Migrated / moved from the study area|30|||
125532920|NCT04266795|451581421|FG001|Overall Study|Death|8|||
125523520|NCT03614676|451549313|FG001|Overall Study|Migrated / moved from the study area|22|||
125523521|NCT03614676|451549312|FG000|Overall Study|Lost to Follow-up|17|||
125523522|NCT03614676|451549313|FG001|Overall Study|Lost to Follow-up|42|||
125523523|NCT03614676|451549312|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
125523524|NCT03614676|451549313|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
125523525|NCT03614676|451549312|FG000|Overall Study|Other|16|||
125523526|NCT03614676|451549313|FG001|Overall Study|Other|47|||
125523527|NCT03614676|451549312|FG000|Overall Study|Protocol Violation|0|||
125523528|NCT03614676|451549313|FG001|Overall Study|Protocol Violation|2|||
125523529|NCT03614676|451549312|FG000|Overall Study|Neonatal event of interest|0|||
125523530|NCT03614676|451549313|FG001|Overall Study|Neonatal event of interest|6|||
125523531|NCT03614676|451549312|FG000|Overall Study|Death in infant greater than 28 days old|0|||
125523532|NCT03614676|451549313|FG001|Overall Study|Death in infant greater than 28 days old|12|||
125523533|NCT03614676|451549312|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
125523534|NCT03614676|451549313|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
125523535|NCT02388347|451549314|FG000|Overall Study|Withdrawal by Subject|0|||
125523536|NCT02388347|451549315|FG001|Overall Study|Withdrawal by Subject|0|||
125523537|NCT02388347|451549316|FG002|Overall Study|Withdrawal by Subject|1|||
125523538|NCT02388347|451549317|FG003|Overall Study|Withdrawal by Subject|0|||
125523539|NCT02388347|451549318|FG004|Overall Study|Withdrawal by Subject|0|||
125523540|NCT02825251|451549322|FG000|Overall Study|Adverse Event|0|||
125523541|NCT02825251|451549323|FG001|Overall Study|Adverse Event|1|||
125523542|NCT02825251|451549322|FG000|Overall Study|Lost to Follow-up|0|||
125523543|NCT02825251|451549323|FG001|Overall Study|Lost to Follow-up|1|||
125523544|NCT02825251|451549322|FG000|Overall Study|Withdrawal by Subject|1|||
125523545|NCT02825251|451549323|FG001|Overall Study|Withdrawal by Subject|4|||
125523546|NCT02825251|451549322|FG000|Overall Study|Unclassified|2|||
125523547|NCT02825251|451549323|FG001|Overall Study|Unclassified|0|||
125523548|NCT00487825|451549324|FG000|Overall Study|Adverse Event|2|||
125523549|NCT00487825|451549325|FG001|Overall Study|Adverse Event|2|||
125523550|NCT00487825|451549324|FG000|Overall Study|Lack of Efficacy|1|||
125523551|NCT00487825|451549325|FG001|Overall Study|Lack of Efficacy|1|||
125523552|NCT00487825|451549324|FG000|Overall Study|Other|3|||
125523553|NCT00487825|451549325|FG001|Overall Study|Other|2|||
125523554|NCT01639742|451549328|FG000|Overall Study|Study Ongoing|17|||
125523555|NCT01639742|451549328|FG000|Overall Study|Lost to Follow-up|1|||
125523556|NCT01190644|451549330|FG000|Overall Study|Death|2|||
125523557|NCT01190644|451549330|FG000|Overall Study|Disease progression|1|||
125523558|NCT02366143|451549331|FG000|Overall Study|Death|307|||
125523559|NCT02366143|451549332|FG001|Overall Study|Death|278|||
125523560|NCT02366143|451549333|FG002|Overall Study|Death|280|||
125523561|NCT02366143|451549331|FG000|Overall Study|Lost to Follow-up|2|||
125523562|NCT02366143|451549332|FG001|Overall Study|Lost to Follow-up|4|||
125523563|NCT02366143|451549333|FG002|Overall Study|Lost to Follow-up|2|||
125523564|NCT02366143|451549331|FG000|Overall Study|Physician Decision|1|||
125523565|NCT02366143|451549332|FG001|Overall Study|Physician Decision|2|||
125523566|NCT02366143|451549333|FG002|Overall Study|Physician Decision|1|||
125523567|NCT02366143|451549331|FG000|Overall Study|Protocol Violation|0|||
125523568|NCT02366143|451549332|FG001|Overall Study|Protocol Violation|0|||
125523569|NCT02366143|451549333|FG002|Overall Study|Protocol Violation|2|||
125523570|NCT02366143|451549331|FG000|Overall Study|Withdrawal by Subject|16|||
125523571|NCT02366143|451549332|FG001|Overall Study|Withdrawal by Subject|17|||
125523572|NCT02366143|451549333|FG002|Overall Study|Withdrawal by Subject|22|||
125523573|NCT02366143|451549331|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
125523574|NCT02366143|451549332|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
125523575|NCT02366143|451549333|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
125523576|NCT02366143|451549331|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
125523577|NCT02366143|451549332|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
125523578|NCT02366143|451549333|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
125523579|NCT02366143|451549331|FG000|Overall Study|Randomization Error|1|||
125523580|NCT02366143|451549332|FG001|Overall Study|Randomization Error|0|||
125523581|NCT02366143|451549333|FG002|Overall Study|Randomization Error|0|||
125523582|NCT02366143|451549331|FG000|Overall Study|PI Move and Site Closure|1|||
125523583|NCT02366143|451549332|FG001|Overall Study|PI Move and Site Closure|0|||
125523584|NCT02366143|451549333|FG002|Overall Study|PI Move and Site Closure|1|||
125523585|NCT02366143|451549331|FG000|Overall Study|Study Terminated By Sponsor|0|||
125523586|NCT02366143|451549332|FG001|Overall Study|Study Terminated By Sponsor|0|||
125523587|NCT02366143|451549333|FG002|Overall Study|Study Terminated By Sponsor|2|||
125523588|NCT02366143|451549331|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
125523589|NCT02366143|451549332|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
125523590|NCT02366143|451549333|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
125523591|NCT02366143|451549331|FG000|Overall Study|Patient moved to roll-over study|1|||
125523592|NCT02366143|451549332|FG001|Overall Study|Patient moved to roll-over study|19|||
125523593|NCT02366143|451549333|FG002|Overall Study|Patient moved to roll-over study|28|||
125523594|NCT02366143|451549331|FG000|Overall Study|Patient moved to commercial stock|0|||
125523595|NCT02366143|451549332|FG001|Overall Study|Patient moved to commercial stock|0|||
125523596|NCT02366143|451549333|FG002|Overall Study|Patient moved to commercial stock|1|||
125523597|NCT02366143|451549331|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
125523598|NCT02366143|451549332|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
125523599|NCT02366143|451549333|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
125523600|NCT02366143|451549331|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
125523601|NCT02366143|451549332|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
125523602|NCT02366143|451549333|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
125523603|NCT02366143|451549331|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
125523604|NCT02366143|451549332|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
125523605|NCT02366143|451549333|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
125523606|NCT02366143|451549331|FG000|Overall Study|Requester's instructions|1|||
125523607|NCT02366143|451549332|FG001|Overall Study|Requester's instructions|1|||
125523608|NCT02366143|451549333|FG002|Overall Study|Requester's instructions|1|||
125523609|NCT02366143|451549331|FG000|Overall Study|Uneligible|0|||
125523610|NCT02366143|451549332|FG001|Overall Study|Uneligible|1|||
125523611|NCT02366143|451549333|FG002|Overall Study|Uneligible|0|||
125523612|NCT02366143|451549331|FG000|Overall Study|Post Trial Migration|0|||
125523613|NCT02366143|451549332|FG001|Overall Study|Post Trial Migration|1|||
125523614|NCT02366143|451549333|FG002|Overall Study|Post Trial Migration|0|||
125523615|NCT02366143|451549331|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
125523616|NCT02366143|451549332|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
125523617|NCT02366143|451549333|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
125523618|NCT02366143|451549331|FG000|Overall Study|Patient switched to PTAP|0|||
125523619|NCT02366143|451549332|FG001|Overall Study|Patient switched to PTAP|1|||
125523620|NCT02366143|451549333|FG002|Overall Study|Patient switched to PTAP|0|||
125523621|NCT02366143|451549331|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
125523622|NCT02366143|451549332|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
125523623|NCT02366143|451549333|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
125523624|NCT04411186|451549334|FG000|Overall Study|Withdrawn due to protocol violation|0|||
125523625|NCT04411186|451549335|FG001|Overall Study|Withdrawn due to protocol violation|1|||
125523626|NCT02820597|451549336|FG000|Overall Study|Lost to Follow-up|12|||
125523627|NCT00575042|451549337|FG000|Overall Study|Adverse Event|2|||
125523628|NCT00575042|451549337|FG000|Overall Study|Lost to Follow-up|1|||
125523629|NCT01053247|451549338|FG000|Overall Study|Withdrawal by Subject|9|||
125523630|NCT01053247|451549339|FG001|Overall Study|Withdrawal by Subject|4|||
125523631|NCT01053247|451549340|FG002|Overall Study|Withdrawal by Subject|15|||
125523632|NCT01053247|451549338|FG000|Overall Study|Lack of Efficacy|1|||
125523633|NCT01053247|451549339|FG001|Overall Study|Lack of Efficacy|0|||
125523634|NCT01053247|451549340|FG002|Overall Study|Lack of Efficacy|1|||
125523635|NCT01053247|451549338|FG000|Overall Study|Protocol Violation|2|||
125523636|NCT01053247|451549339|FG001|Overall Study|Protocol Violation|1|||
125523637|NCT01053247|451549340|FG002|Overall Study|Protocol Violation|2|||
125523638|NCT01053247|451549338|FG000|Overall Study|Lost to Follow-up|8|||
125523639|NCT01053247|451549339|FG001|Overall Study|Lost to Follow-up|5|||
125523640|NCT01053247|451549340|FG002|Overall Study|Lost to Follow-up|7|||
125523641|NCT01053247|451549338|FG000|Overall Study|Adverse Event|0|||
125523642|NCT01053247|451549339|FG001|Overall Study|Adverse Event|9|||
125523643|NCT01053247|451549340|FG002|Overall Study|Adverse Event|3|||
125523644|NCT00701909|451549343|FG000|Overall Study|Withdrawal by Subject|0|||
125523645|NCT00701909|451549344|FG001|Overall Study|Withdrawal by Subject|1|||
125523646|NCT03023722|451549349|FG000|Overall Study|No follow-up assessment|4|||
125523647|NCT03616964|451549350|FG000|Overall Study|Adverse Event|15|||
125523648|NCT03616964|451549351|FG001|Overall Study|Adverse Event|10|||
125523649|NCT03616964|451549352|FG002|Overall Study|Adverse Event|16|||
125523650|NCT03616964|451549350|FG000|Overall Study|Death|3|||
125523651|NCT03616964|451549351|FG001|Overall Study|Death|0|||
125523652|NCT03616964|451549352|FG002|Overall Study|Death|4|||
125523653|NCT03616964|451549350|FG000|Overall Study|Lack of Efficacy|4|||
125523654|NCT03616964|451549351|FG001|Overall Study|Lack of Efficacy|8|||
125523655|NCT03616964|451549352|FG002|Overall Study|Lack of Efficacy|8|||
125523656|NCT03616964|451549350|FG000|Overall Study|Lost to Follow-up|2|||
125523657|NCT03616964|451549351|FG001|Overall Study|Lost to Follow-up|1|||
125523658|NCT03616964|451549352|FG002|Overall Study|Lost to Follow-up|3|||
125523659|NCT03616964|451549350|FG000|Overall Study|Withdrawal by Subject|18|||
125523660|NCT03616964|451549351|FG001|Overall Study|Withdrawal by Subject|14|||
125523661|NCT03616964|451549352|FG002|Overall Study|Withdrawal by Subject|21|||
125523662|NCT03616964|451549350|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
125523663|NCT03616964|451549351|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
125523664|NCT03616964|451549352|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
125523665|NCT03616964|451549350|FG000|Overall Study|Sponsor's Decision|1|||
125523666|NCT03616964|451549351|FG001|Overall Study|Sponsor's Decision|0|||
125523667|NCT03616964|451549352|FG002|Overall Study|Sponsor's Decision|0|||
125523668|NCT03616964|451549350|FG000|Overall Study|Physician Decision|0|||
125523669|NCT03616964|451549351|FG001|Overall Study|Physician Decision|2|||
125523670|NCT03616964|451549352|FG002|Overall Study|Physician Decision|0|||
125523671|NCT03616964|451549350|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
125523672|NCT03616964|451549351|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
125523673|NCT03616964|451549352|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
125523674|NCT03616964|451549350|FG000|Overall Study|Protocol Violation|0|||
125523675|NCT03616964|451549351|FG001|Overall Study|Protocol Violation|1|||
125523676|NCT03616964|451549352|FG002|Overall Study|Protocol Violation|0|||
125523677|NCT03616964|451549350|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
125523678|NCT03616964|451549351|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
125523679|NCT03616964|451549352|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
125523680|NCT03616964|451549350|FG000|Overall Study|Randomized but Never Treated|1|||
125523681|NCT03616964|451549351|FG001|Overall Study|Randomized but Never Treated|1|||
125523682|NCT03616964|451549352|FG002|Overall Study|Randomized but Never Treated|1|||
125523683|NCT01266018|451549360|FG000|Overall Study|Physician Decision|1|||
125523684|NCT01266018|451549361|FG001|Overall Study|Physician Decision|0|||
125523685|NCT01266018|451549360|FG000|Overall Study|Progressive disease|0|||
125523686|NCT01266018|451549361|FG001|Overall Study|Progressive disease|1|||
125523687|NCT03167151|451549362|FG000|Overall Study|Withdrawal by Subject|1|||
125523688|NCT03167151|451549363|FG001|Overall Study|Withdrawal by Subject|0|||
125523689|NCT03167151|451549364|FG002|Overall Study|Withdrawal by Subject|0|||
125523690|NCT03167151|451549362|FG000|Overall Study|No evidence of tumour at surgery|0|||
125523691|NCT03167151|451549363|FG001|Overall Study|No evidence of tumour at surgery|1|||
125523692|NCT03167151|451549364|FG002|Overall Study|No evidence of tumour at surgery|1|||
125523693|NCT02641587|451549369|FG000|Confinement Period|Adverse Event|1|||
125523694|NCT02641587|451549370|FG001|Confinement Period|Adverse Event|0|||
125523695|NCT02641587|451549369|FG000|Confinement Period|Withdrawal by Subject|2|||
125523696|NCT02641587|451549370|FG001|Confinement Period|Withdrawal by Subject|1|||
125523697|NCT02641587|451549369|FG000|Ambulatory Period|Withdrawal by Subject|1|||
125523698|NCT02641587|451549370|FG001|Ambulatory Period|Withdrawal by Subject|0|||
125523699|NCT01165177|451549371|FG000|Overall Study|Serious Adverse Event|227|||
125523700|NCT01165177|451549372|FG001|Overall Study|Serious Adverse Event|235|||
125523701|NCT01165177|451549371|FG000|Overall Study|Withdrawal by Subject|368|||
125523702|NCT01165177|451549372|FG001|Overall Study|Withdrawal by Subject|354|||
125523703|NCT01165177|451549371|FG000|Overall Study|Protocol Violation|19|||
125523704|NCT01165177|451549372|FG001|Overall Study|Protocol Violation|21|||
125523705|NCT01165177|451549371|FG000|Overall Study|Non-serious adverse event|30|||
125523706|NCT01165177|451549372|FG001|Overall Study|Non-serious adverse event|18|||
125523707|NCT01165177|451549371|FG000|Overall Study|Other unspecified reasons|47|||
125523708|NCT01165177|451549372|FG001|Overall Study|Other unspecified reasons|35|||
125523709|NCT01165177|451549371|FG000|Overall Study|Suspected HZ episode|0|||
125523710|NCT01165177|451549372|FG001|Overall Study|Suspected HZ episode|2|||
125523711|NCT01165177|451549371|FG000|Overall Study|Lost to Follow-up|183|||
125523712|NCT01165177|451549372|FG001|Overall Study|Lost to Follow-up|194|||
125523713|NCT01165177|451549371|FG000|Overall Study|Migrated/ moved from study area|48|||
125523714|NCT01165177|451549372|FG001|Overall Study|Migrated/ moved from study area|43|||
125523715|NCT01663506|451549373|FG000|Overall Study|Lack of Efficacy|3|||
125523716|NCT01663506|451549373|FG000|Overall Study|Consent Withdrawal by Subject|1|||
125523717|NCT01663506|451549373|FG000|Overall Study|Lost to Follow-up|1|||
125523718|NCT01663506|451549373|FG000|Overall Study|Adverse Event|1|||
125523719|NCT01663506|451549373|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
125523720|NCT04351269|451549377|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
125523721|NCT04351269|451549378|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
125523722|NCT04351269|451549379|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
125523723|NCT04351269|451549377|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
125523724|NCT04351269|451549378|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
125523725|NCT04351269|451549379|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
125523726|NCT04351269|451549377|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
125523727|NCT04351269|451549378|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
125523728|NCT04351269|451549379|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
125523729|NCT04351269|451549377|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
125523730|NCT04351269|451549378|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
125523731|NCT04351269|451549379|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
125523732|NCT04351269|451549377|FG000|Overall Study|Lost to Follow-up|1|||
125523733|NCT04351269|451549378|FG001|Overall Study|Lost to Follow-up|3|||
125523734|NCT04351269|451549379|FG002|Overall Study|Lost to Follow-up|0|||
125523735|NCT03210519|451549380|FG000|Overall Study|Adverse Event|2|||
125523736|NCT03210519|451549381|FG001|Overall Study|Adverse Event|0|||
125523737|NCT01407276|451549386|FG000|Overall Study|Withdrawal by Subject|0|||
125523738|NCT01407276|451549387|FG001|Overall Study|Withdrawal by Subject|0|||
125523739|NCT01407276|451549388|FG002|Overall Study|Withdrawal by Subject|0|||
125523740|NCT01407276|451549389|FG003|Overall Study|Withdrawal by Subject|0|||
125523741|NCT01407276|451549390|FG004|Overall Study|Withdrawal by Subject|0|||
125523742|NCT01407276|451549391|FG005|Overall Study|Withdrawal by Subject|0|||
125523743|NCT01407276|451549392|FG006|Overall Study|Withdrawal by Subject|0|||
125523744|NCT01407276|451549393|FG007|Overall Study|Withdrawal by Subject|1|||
125523745|NCT00745498|451549394|FG000|Overall Study|Lost to Follow-up|1|||
125523746|NCT00745498|451549395|FG001|Overall Study|Lost to Follow-up|1|||
125523747|NCT00745498|451549396|FG002|Overall Study|Lost to Follow-up|3|||
125523748|NCT00745498|451549394|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
125523749|NCT00745498|451549395|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
125523750|NCT00745498|451549396|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
125523751|NCT00745498|451549394|FG000|Overall Study|Non-PDR related VH|0|||
125523752|NCT00745498|451549395|FG001|Overall Study|Non-PDR related VH|1|||
125523753|NCT00745498|451549396|FG002|Overall Study|Non-PDR related VH|1|||
125523754|NCT00745498|451549394|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
125523755|NCT00745498|451549395|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
125523756|NCT00745498|451549396|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
125523757|NCT04805073|451549397|FG000|Overall Study|study personnel not available|2|||
125523758|NCT04805073|451549398|FG001|Overall Study|study personnel not available|0|||
125523759|NCT04805073|451549397|FG000|Overall Study|spinal anesthesia failure|0|||
125523760|NCT04805073|451549398|FG001|Overall Study|spinal anesthesia failure|1|||
125523761|NCT04805073|451549397|FG000|Overall Study|Lost to Follow-up|0|||
125523762|NCT04805073|451549398|FG001|Overall Study|Lost to Follow-up|2|||
125523763|NCT02058836|451549407|FG000|Overall Study|Withdrawal by Subject|1|||
125523764|NCT02058836|451549408|FG001|Overall Study|Withdrawal by Subject|1|||
125523765|NCT00267098|451549409|FG000|Overall Study|Death|0|||
125523766|NCT00267098|451549410|FG001|Overall Study|Death|0|||
125523767|NCT00267098|451549411|FG002|Overall Study|Death|57|||
125523768|NCT00267098|451549412|FG003|Overall Study|Death|66|||
125523769|NCT00267098|451549413|FG004|Overall Study|Death|14|||
125523770|NCT00267098|451549414|FG005|Overall Study|Death|23|||
125523771|NCT00267098|451549415|FG006|Overall Study|Death|28|||
125523772|NCT00267098|451549416|FG007|Overall Study|Death|9|||
125523773|NCT00267098|451549409|FG000|Overall Study|Lost to Follow-up|0|||
125523774|NCT00267098|451549410|FG001|Overall Study|Lost to Follow-up|0|||
125523775|NCT00267098|451549411|FG002|Overall Study|Lost to Follow-up|6|||
125523776|NCT00267098|451549412|FG003|Overall Study|Lost to Follow-up|5|||
125523777|NCT00267098|451549413|FG004|Overall Study|Lost to Follow-up|2|||
125523778|NCT00267098|451549414|FG005|Overall Study|Lost to Follow-up|3|||
125523779|NCT00267098|451549415|FG006|Overall Study|Lost to Follow-up|1|||
125523780|NCT00267098|451549416|FG007|Overall Study|Lost to Follow-up|1|||
125523781|NCT00267098|451549409|FG000|Overall Study|Withdrawal by Subject|8|||
125523782|NCT00267098|451549410|FG001|Overall Study|Withdrawal by Subject|0|||
125523783|NCT00267098|451549411|FG002|Overall Study|Withdrawal by Subject|24|||
125523784|NCT00267098|451549412|FG003|Overall Study|Withdrawal by Subject|21|||
125523785|NCT00267098|451549413|FG004|Overall Study|Withdrawal by Subject|12|||
125523786|NCT00267098|451549414|FG005|Overall Study|Withdrawal by Subject|9|||
125523787|NCT00267098|451549415|FG006|Overall Study|Withdrawal by Subject|12|||
125523788|NCT00267098|451549416|FG007|Overall Study|Withdrawal by Subject|5|||
125523789|NCT00267098|451549409|FG000|Overall Study|Physician Decision|5|||
125523790|NCT00267098|451549410|FG001|Overall Study|Physician Decision|0|||
125523791|NCT00267098|451549411|FG002|Overall Study|Physician Decision|7|||
125523792|NCT00267098|451549412|FG003|Overall Study|Physician Decision|11|||
125523793|NCT00267098|451549413|FG004|Overall Study|Physician Decision|5|||
125523794|NCT00267098|451549414|FG005|Overall Study|Physician Decision|4|||
125523795|NCT00267098|451549415|FG006|Overall Study|Physician Decision|3|||
125523796|NCT00267098|451549416|FG007|Overall Study|Physician Decision|0|||
125523797|NCT00267098|451549409|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
125523798|NCT00267098|451549410|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125523799|NCT00267098|451549411|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125523800|NCT00267098|451549412|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125523801|NCT00267098|451549413|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
125523802|NCT00267098|451549414|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125523803|NCT00267098|451549415|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125523804|NCT00267098|451549416|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
125523805|NCT00267098|451549409|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
125523806|NCT00267098|451549410|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
125523807|NCT00267098|451549411|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
125523808|NCT00267098|451549412|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
125523809|NCT00267098|451549413|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
125523810|NCT00267098|451549414|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
125523811|NCT00267098|451549415|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
125523812|NCT00267098|451549416|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
125523813|NCT00267098|451549409|FG000|Overall Study|Site closure|0|||
125523814|NCT00267098|451549410|FG001|Overall Study|Site closure|0|||
125523815|NCT00267098|451549411|FG002|Overall Study|Site closure|0|||
125523816|NCT00267098|451549412|FG003|Overall Study|Site closure|1|||
125523817|NCT00267098|451549413|FG004|Overall Study|Site closure|0|||
125523818|NCT00267098|451549414|FG005|Overall Study|Site closure|1|||
125523819|NCT00267098|451549415|FG006|Overall Study|Site closure|1|||
125523820|NCT00267098|451549416|FG007|Overall Study|Site closure|0|||
125523821|NCT00267098|451549409|FG000|Overall Study|Explanted Medtronic device|0|||
125523822|NCT00267098|451549410|FG001|Overall Study|Explanted Medtronic device|0|||
125523823|NCT00267098|451549411|FG002|Overall Study|Explanted Medtronic device|0|||
125523824|NCT00267098|451549412|FG003|Overall Study|Explanted Medtronic device|1|||
125523825|NCT00267098|451549413|FG004|Overall Study|Explanted Medtronic device|0|||
125523826|NCT00267098|451549414|FG005|Overall Study|Explanted Medtronic device|0|||
125523827|NCT00267098|451549415|FG006|Overall Study|Explanted Medtronic device|0|||
125523828|NCT00267098|451549416|FG007|Overall Study|Explanted Medtronic device|0|||
125523829|NCT00267098|451549409|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
125523830|NCT00267098|451549410|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
125523831|NCT00267098|451549411|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
125523832|NCT00267098|451549412|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
125523833|NCT00267098|451549413|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
125523834|NCT00267098|451549414|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
125523835|NCT00267098|451549415|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
125523836|NCT00267098|451549416|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
125523837|NCT00267098|451549409|FG000|Overall Study|Subject listed for heart transplant|0|||
125523838|NCT00267098|451549410|FG001|Overall Study|Subject listed for heart transplant|0|||
125523839|NCT00267098|451549411|FG002|Overall Study|Subject listed for heart transplant|0|||
125523840|NCT00267098|451549412|FG003|Overall Study|Subject listed for heart transplant|0|||
125523841|NCT00267098|451549413|FG004|Overall Study|Subject listed for heart transplant|0|||
125523842|NCT00267098|451549414|FG005|Overall Study|Subject listed for heart transplant|0|||
125523843|NCT00267098|451549415|FG006|Overall Study|Subject listed for heart transplant|1|||
125523844|NCT00267098|451549416|FG007|Overall Study|Subject listed for heart transplant|0|||
125523845|NCT00267098|451549409|FG000|Overall Study|Sponsor withdrew subject|0|||
125523846|NCT00267098|451549410|FG001|Overall Study|Sponsor withdrew subject|0|||
125523847|NCT00267098|451549411|FG002|Overall Study|Sponsor withdrew subject|0|||
125523848|NCT00267098|451549412|FG003|Overall Study|Sponsor withdrew subject|1|||
125523849|NCT00267098|451549413|FG004|Overall Study|Sponsor withdrew subject|0|||
125523850|NCT00267098|451549414|FG005|Overall Study|Sponsor withdrew subject|0|||
125523851|NCT00267098|451549415|FG006|Overall Study|Sponsor withdrew subject|0|||
125523852|NCT00267098|451549416|FG007|Overall Study|Sponsor withdrew subject|0|||
125523853|NCT00547534|451549417|FG000|Overall Study|Adverse Event|7|||
125523854|NCT00547534|451549417|FG000|Overall Study|Disease Progression|4|||
125523855|NCT02688530|451549419|FG000|Overall Study|Withdrawal by Subject|0|||
125523856|NCT02688530|451549420|FG001|Overall Study|Withdrawal by Subject|1|||
125523857|NCT02688530|451549421|FG002|Overall Study|Withdrawal by Subject|0|||
125523858|NCT02688530|451549422|FG003|Overall Study|Withdrawal by Subject|0|||
125523859|NCT02688530|451549419|FG000|Overall Study|Lost to Follow-up|0|||
125523860|NCT02688530|451549420|FG001|Overall Study|Lost to Follow-up|0|||
125523861|NCT02688530|451549421|FG002|Overall Study|Lost to Follow-up|2|||
125523862|NCT02688530|451549422|FG003|Overall Study|Lost to Follow-up|0|||
125523863|NCT01658020|451549423|FG000|Overall Study|Adverse Event|3|||
125523864|NCT01658020|451549424|FG001|Overall Study|Adverse Event|3|||
125523865|NCT01658020|451549423|FG000|Overall Study|Lost to Follow-up|1|||
125523866|NCT01658020|451549424|FG001|Overall Study|Lost to Follow-up|0|||
125523867|NCT01658020|451549423|FG000|Overall Study|Withdrawal by Subject|4|||
125523868|NCT01658020|451549424|FG001|Overall Study|Withdrawal by Subject|5|||
125523869|NCT01658020|451549423|FG000|Overall Study|Protocol Violation|0|||
125523870|NCT01658020|451549424|FG001|Overall Study|Protocol Violation|1|||
125523871|NCT02353871|451549425|FG000|Overall Study|Protocol deviation|0|||
125523872|NCT02353871|451549426|FG001|Overall Study|Protocol deviation|1|||
125523873|NCT02353871|451549425|FG000|Overall Study|Consent withdrawn|1|||
125523874|NCT02353871|451549426|FG001|Overall Study|Consent withdrawn|8|||
125523875|NCT02353871|451549425|FG000|Overall Study|Lost to Follow-up|2|||
125523876|NCT02353871|451549426|FG001|Overall Study|Lost to Follow-up|0|||
125523877|NCT00115336|451549427|FG000|Overall Study|Hospital discharge before study drug|0|||
125523878|NCT00115336|451549428|FG001|Overall Study|Hospital discharge before study drug|1|||
125523879|NCT04599907|451549435|FG000|Overall Study|Withdrawal by Subject|1|||
125523880|NCT04599907|451549436|FG001|Overall Study|Withdrawal by Subject|7|||
125523881|NCT04599907|451549437|FG002|Overall Study|Withdrawal by Subject|6|||
125523882|NCT04599907|451549435|FG000|Overall Study|Lost to Follow-up|0|||
125523883|NCT04599907|451549436|FG001|Overall Study|Lost to Follow-up|1|||
125523884|NCT04599907|451549437|FG002|Overall Study|Lost to Follow-up|0|||
125523885|NCT01466790|451549441|FG000|Overall Study|Adverse Event|1|||
125523886|NCT01466790|451549442|FG001|Overall Study|Adverse Event|0|||
125523887|NCT01466790|451549443|FG002|Overall Study|Adverse Event|0|||
125523888|NCT01466790|451549444|FG003|Overall Study|Adverse Event|0|||
125523889|NCT01466790|451549445|FG004|Overall Study|Adverse Event|2|||
125523890|NCT01466790|451549446|FG005|Overall Study|Adverse Event|0|||
125523891|NCT01466790|451549447|FG006|Overall Study|Adverse Event|0|||
125523892|NCT01466790|451549448|FG007|Overall Study|Adverse Event|0|||
125523893|NCT01466790|451549441|FG000|Overall Study|Lost to Follow-up|2|||
125523894|NCT01466790|451549442|FG001|Overall Study|Lost to Follow-up|0|||
125523895|NCT01466790|451549443|FG002|Overall Study|Lost to Follow-up|0|||
125523896|NCT01466790|451549444|FG003|Overall Study|Lost to Follow-up|0|||
125523897|NCT01466790|451549445|FG004|Overall Study|Lost to Follow-up|0|||
125523898|NCT01466790|451549446|FG005|Overall Study|Lost to Follow-up|0|||
125523899|NCT01466790|451549447|FG006|Overall Study|Lost to Follow-up|0|||
125523900|NCT01466790|451549448|FG007|Overall Study|Lost to Follow-up|0|||
125523901|NCT01466790|451549441|FG000|Overall Study|Withdrawal by Subject|1|||
125523902|NCT01466790|451549442|FG001|Overall Study|Withdrawal by Subject|1|||
125523903|NCT01466790|451549443|FG002|Overall Study|Withdrawal by Subject|0|||
125523904|NCT01466790|451549444|FG003|Overall Study|Withdrawal by Subject|0|||
125523905|NCT01466790|451549445|FG004|Overall Study|Withdrawal by Subject|1|||
125523906|NCT01466790|451549446|FG005|Overall Study|Withdrawal by Subject|0|||
125523907|NCT01466790|451549447|FG006|Overall Study|Withdrawal by Subject|1|||
125523908|NCT01466790|451549448|FG007|Overall Study|Withdrawal by Subject|1|||
125523909|NCT02242643|451549449|FG000|Overall Study|Protocol Violation|1|||
125523910|NCT02242643|451549450|FG001|Overall Study|Protocol Violation|2|||
125523911|NCT02242643|451549449|FG000|Overall Study|Withdrawal by Subject|15|||
125523912|NCT02242643|451549450|FG001|Overall Study|Withdrawal by Subject|10|||
125523913|NCT02242643|451549449|FG000|Overall Study|Migrated/moved from study area|1|||
125523914|NCT02242643|451549450|FG001|Overall Study|Migrated/moved from study area|3|||
125523915|NCT02242643|451549449|FG000|Overall Study|Lost to Follow-up|54|||
125523916|NCT02242643|451549450|FG001|Overall Study|Lost to Follow-up|61|||
125523917|NCT02242643|451549449|FG000|Overall Study|Child placed in foster care by family|0|||
125523918|NCT02242643|451549450|FG001|Overall Study|Child placed in foster care by family|1|||
125523919|NCT02242643|451549449|FG000|Overall Study|Non-compliance|1|||
125523920|NCT02242643|451549450|FG001|Overall Study|Non-compliance|0|||
125523921|NCT02242643|451549449|FG000|Overall Study|Consent withdrawal by parent|1|||
125523922|NCT02242643|451549450|FG001|Overall Study|Consent withdrawal by parent|0|||
125523923|NCT02242643|451549449|FG000|Overall Study|Protocol requirements not followed|1|||
125523924|NCT02242643|451549450|FG001|Overall Study|Protocol requirements not followed|0|||
125523925|NCT02242643|451549449|FG000|Overall Study|Language barrier|1|||
125523926|NCT02242643|451549450|FG001|Overall Study|Language barrier|0|||
125523927|NCT02242643|451549449|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
125523928|NCT02242643|451549450|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
125523929|NCT01251887|451549451|FG000|Overall Study|Scheduling conflict|1|||
125523930|NCT01251887|451549452|FG001|Overall Study|Scheduling conflict|2|||
125523931|NCT01251887|451549453|FG002|Overall Study|Scheduling conflict|2|||
125523932|NCT01251887|451549451|FG000|Overall Study|Physician Decision|0|||
125523933|NCT01251887|451549452|FG001|Overall Study|Physician Decision|1|||
125523934|NCT01251887|451549453|FG002|Overall Study|Physician Decision|0|||
125523935|NCT02633397|451549454|FG000|Overall Study|Adverse Event|8|||
125523936|NCT02633397|451549455|FG001|Overall Study|Adverse Event|8|||
125523937|NCT02633397|451549454|FG000|Overall Study|Study Burden|4|||
125523938|NCT02633397|451549455|FG001|Overall Study|Study Burden|1|||
125523939|NCT02633397|451549454|FG000|Overall Study|Treatment interruption|2|||
125523940|NCT02633397|451549455|FG001|Overall Study|Treatment interruption|5|||
125523941|NCT02633397|451549454|FG000|Overall Study|Death|2|||
125523942|NCT02633397|451549455|FG001|Overall Study|Death|2|||
125523943|NCT02633397|451549454|FG000|Overall Study|Physician Decision|0|||
125523944|NCT02633397|451549455|FG001|Overall Study|Physician Decision|1|||
125523945|NCT03595878|451549456|FG000|Overall Study|Death|2|||
125523946|NCT03595878|451549457|FG001|Overall Study|Death|1|||
125523947|NCT03595878|451549458|FG002|Overall Study|Death|0|||
125523948|NCT03595878|451549456|FG000|Overall Study|Disease progression|2|||
125523949|NCT03595878|451549457|FG001|Overall Study|Disease progression|1|||
125523950|NCT03595878|451549458|FG002|Overall Study|Disease progression|2|||
125523951|NCT03668223|451549459|FG000|Overall Study|Death|10|||
125523952|NCT03668223|451549460|FG001|Overall Study|Death|5|||
125523953|NCT03668223|451549459|FG000|Overall Study|Lost to Follow-up|12|||
125523954|NCT03668223|451549460|FG001|Overall Study|Lost to Follow-up|12|||
125523955|NCT03668223|451549459|FG000|Overall Study|Withdrawal by Subject|8|||
125523956|NCT03668223|451549460|FG001|Overall Study|Withdrawal by Subject|3|||
125523957|NCT01103232|451549461|FG000|Overall Study|Withdrawal by Subject|1|||
125523958|NCT01103232|451549462|FG001|Overall Study|Withdrawal by Subject|1|||
125523959|NCT01103232|451549461|FG000|Overall Study|Protocol Violation|0|||
125523960|NCT01103232|451549462|FG001|Overall Study|Protocol Violation|1|||
125523961|NCT03036124|451549463|FG000|Overall Study|Lost to Follow-up|0|||
125523962|NCT03036124|451549464|FG001|Overall Study|Lost to Follow-up|2|||
125523963|NCT03036124|451549463|FG000|Overall Study|Withdrawal by Subject|5|||
125523964|NCT03036124|451549464|FG001|Overall Study|Withdrawal by Subject|4|||
125523965|NCT02282059|451549465|FG000|Overall Study|Other|15|||
125523966|NCT02282059|451549466|FG001|Overall Study|Other|3|||
125523967|NCT02282059|451549465|FG000|Overall Study|Participant refused further follow-up|8|||
125523968|NCT02282059|451549466|FG001|Overall Study|Participant refused further follow-up|4|||
125523969|NCT02282059|451549465|FG000|Overall Study|Lost to Follow-up|19|||
125523970|NCT02282059|451549466|FG001|Overall Study|Lost to Follow-up|3|||
125523971|NCT02282059|451549465|FG000|Overall Study|Death|40|||
125523972|NCT02282059|451549466|FG001|Overall Study|Death|8|||
125523973|NCT05093504|451549467|FG000|Overall Study|Death|0|||
125523974|NCT05093504|451549468|FG001|Overall Study|Death|1|||
125523975|NCT02394925|451549469|FG000|Overall Study|Adverse Event|1|||
125523976|NCT02394925|451549469|FG000|Overall Study|Lens Discomfort|3|||
125523977|NCT02394925|451549469|FG000|Overall Study|Lens handling difficulities|5|||
125523978|NCT02394925|451549469|FG000|Overall Study|Lost to Follow-up|9|||
125523979|NCT02394925|451549469|FG000|Overall Study|Protocol Violation|5|||
125523980|NCT02394925|451549469|FG000|Overall Study|No longer meet eligibility criteria|1|||
125523981|NCT02394925|451549469|FG000|Overall Study|Unsatisfactory Visual Response|5|||
125523982|NCT05347485|451549477|FG000|Overall Study|Death|14|||
125523983|NCT05347485|451549477|FG000|Overall Study|Lost to Follow-up|2|||
125523984|NCT05347485|451549477|FG000|Overall Study|Withdrawal by Subject|13|||
125523985|NCT05347485|451549477|FG000|Overall Study|Progressive Disease|1|||
125523986|NCT05347485|451549477|FG000|Overall Study|Study Terminated by Sponsor|49|||
125523987|NCT05347485|451549477|FG000|Overall Study|Other|1|||
125523988|NCT05347485|451549477|FG000|Overall Study|Enrolled (consented) but not treated|4|||
125523989|NCT05347485|451549477|FG000|Overall Study|Disease Relapse|2|||
125523990|NCT04886518|451549478|FG000|Overall Study|Noncompliance with study drug|1|||
125523991|NCT04886518|451549479|FG001|Overall Study|Noncompliance with study drug|0|||
125523992|NCT04886518|451549480|FG002|Overall Study|Noncompliance with study drug|0|||
125523993|NCT04886518|451549478|FG000|Overall Study|Adverse Event|0|||
125523994|NCT04886518|451549479|FG001|Overall Study|Adverse Event|1|||
125523995|NCT04886518|451549480|FG002|Overall Study|Adverse Event|0|||
125523996|NCT04886518|451549478|FG000|Overall Study|Withdrawal by Subject|1|||
125523997|NCT04886518|451549479|FG001|Overall Study|Withdrawal by Subject|0|||
125523998|NCT04886518|451549480|FG002|Overall Study|Withdrawal by Subject|0|||
125523999|NCT03733899|451549481|FG000|Period 1|Protocol Violation|0|||
125524000|NCT03733899|451549482|FG001|Period 1|Protocol Violation|0|||
125524001|NCT03733899|451549483|FG002|Period 1|Protocol Violation|0|||
125524002|NCT03733899|451549484|FG003|Period 1|Protocol Violation|0|||
125524003|NCT03733899|451549485|FG004|Period 1|Protocol Violation|0|||
125524004|NCT03733899|451549486|FG005|Period 1|Protocol Violation|1|||
125524005|NCT03733899|451549481|FG000|Period 2|Unscuccessful Treatment|0|||
125524006|NCT03733899|451549482|FG001|Period 2|Unscuccessful Treatment|1|||
125524007|NCT03733899|451549483|FG002|Period 2|Unscuccessful Treatment|0|||
125524008|NCT03733899|451549484|FG003|Period 2|Unscuccessful Treatment|0|||
125524009|NCT03733899|451549485|FG004|Period 2|Unscuccessful Treatment|0|||
125524010|NCT03733899|451549486|FG005|Period 2|Unscuccessful Treatment|0|||
125524011|NCT03733899|451549481|FG000|Period 3|Withdrawal by Subject|1|||
125524012|NCT03733899|451549482|FG001|Period 3|Withdrawal by Subject|0|||
125524013|NCT03733899|451549483|FG002|Period 3|Withdrawal by Subject|0|||
125524014|NCT03733899|451549484|FG003|Period 3|Withdrawal by Subject|0|||
125524015|NCT03733899|451549485|FG004|Period 3|Withdrawal by Subject|0|||
125524016|NCT03733899|451549486|FG005|Period 3|Withdrawal by Subject|0|||
125524017|NCT04650698|451551384|FG000|Overall Study|Protocol Violation|2|||
125524018|NCT04650698|451551385|FG001|Overall Study|Protocol Violation|1|||
125524019|NCT04650698|451551384|FG000|Overall Study|Withdrawal by Subject|0|||
125524020|NCT04650698|451551385|FG001|Overall Study|Withdrawal by Subject|1|||
125524021|NCT01090011|451551386|FG000|Overall Study|Progressive disease|128|||
125524022|NCT01090011|451551386|FG000|Overall Study|Adverse Event|32|||
125524023|NCT01090011|451551386|FG000|Overall Study|Protocol Violation|1|||
125524024|NCT01090011|451551386|FG000|Overall Study|Refusal to start/continue medication|5|||
125524025|NCT01090011|451551386|FG000|Overall Study|Other reason not defined above|5|||
125524026|NCT00307047|451551387|FG000|Overall Study|Lost to Follow-up|35|||
125524027|NCT00307047|451551388|FG001|Overall Study|Lost to Follow-up|24|||
125524028|NCT00307047|451551387|FG000|Overall Study|Withdrawal by Subject|6|||
125524029|NCT00307047|451551388|FG001|Overall Study|Withdrawal by Subject|6|||
125524030|NCT00307047|451551387|FG000|Overall Study|Physician Decision|1|||
125524031|NCT00307047|451551388|FG001|Overall Study|Physician Decision|2|||
125524032|NCT00307047|451551387|FG000|Overall Study|Lost to follow-up for other reasons|0|||
125524033|NCT00307047|451551388|FG001|Overall Study|Lost to follow-up for other reasons|1|||
125524034|NCT00307047|451551387|FG000|Overall Study|All death, all MI, all Revascularization|27|||
125524035|NCT00307047|451551388|FG001|Overall Study|All death, all MI, all Revascularization|16|||
125524036|NCT00379769|451551389|FG000|Main Study|Death|57|||
125524037|NCT00379769|451551390|FG001|Main Study|Death|67|||
125524038|NCT00379769|451551391|FG002|Main Study|Death|54|||
125524039|NCT00379769|451551392|FG003|Main Study|Death|72|||
125524040|NCT00379769|451551393|FG004|Main Study|Death|0|||
125524041|NCT00379769|451551394|FG005|Main Study|Death|0|||
125524042|NCT00379769|451551389|FG000|Main Study|Adverse Event|5|||
125524043|NCT00379769|451551390|FG001|Main Study|Adverse Event|8|||
125524044|NCT00379769|451551391|FG002|Main Study|Adverse Event|10|||
125524045|NCT00379769|451551392|FG003|Main Study|Adverse Event|11|||
125524046|NCT00379769|451551393|FG004|Main Study|Adverse Event|0|||
125524047|NCT00379769|451551394|FG005|Main Study|Adverse Event|0|||
125524048|NCT00379769|451551389|FG000|Main Study|Lost to Follow-up|29|||
125524049|NCT00379769|451551390|FG001|Main Study|Lost to Follow-up|29|||
125524050|NCT00379769|451551391|FG002|Main Study|Lost to Follow-up|25|||
125524051|NCT00379769|451551392|FG003|Main Study|Lost to Follow-up|26|||
125524052|NCT00379769|451551393|FG004|Main Study|Lost to Follow-up|0|||
125524053|NCT00379769|451551394|FG005|Main Study|Lost to Follow-up|0|||
125524054|NCT00379769|451551389|FG000|Main Study|Withdrawal by Subject|46|||
125524055|NCT00379769|451551390|FG001|Main Study|Withdrawal by Subject|56|||
125524056|NCT00379769|451551391|FG002|Main Study|Withdrawal by Subject|72|||
125524057|NCT00379769|451551392|FG003|Main Study|Withdrawal by Subject|70|||
125524058|NCT00379769|451551393|FG004|Main Study|Withdrawal by Subject|0|||
125524059|NCT00379769|451551394|FG005|Main Study|Withdrawal by Subject|0|||
125524060|NCT00379769|451551389|FG000|Main Study|Moved to survival status follow-up only|27|||
125524061|NCT00379769|451551390|FG001|Main Study|Moved to survival status follow-up only|25|||
125524062|NCT00379769|451551391|FG002|Main Study|Moved to survival status follow-up only|32|||
125524063|NCT00379769|451551392|FG003|Main Study|Moved to survival status follow-up only|36|||
125524064|NCT00379769|451551393|FG004|Main Study|Moved to survival status follow-up only|0|||
125524065|NCT00379769|451551394|FG005|Main Study|Moved to survival status follow-up only|0|||
125524066|NCT00379769|451551389|FG000|Main Study|Participant moved|3|||
125524067|NCT00379769|451551390|FG001|Main Study|Participant moved|2|||
125524068|NCT00379769|451551391|FG002|Main Study|Participant moved|3|||
125524069|NCT00379769|451551392|FG003|Main Study|Participant moved|3|||
125524070|NCT00379769|451551393|FG004|Main Study|Participant moved|0|||
125524071|NCT00379769|451551394|FG005|Main Study|Participant moved|0|||
125524072|NCT00379769|451551389|FG000|Main Study|Poor compliance|3|||
125524073|NCT00379769|451551390|FG001|Main Study|Poor compliance|2|||
125524074|NCT00379769|451551391|FG002|Main Study|Poor compliance|2|||
125524075|NCT00379769|451551392|FG003|Main Study|Poor compliance|1|||
125524076|NCT00379769|451551393|FG004|Main Study|Poor compliance|0|||
125524077|NCT00379769|451551394|FG005|Main Study|Poor compliance|0|||
125524078|NCT00379769|451551389|FG000|Main Study|Prohibited glucose lowering medication|0|||
125524079|NCT00379769|451551390|FG001|Main Study|Prohibited glucose lowering medication|3|||
125524080|NCT00379769|451551391|FG002|Main Study|Prohibited glucose lowering medication|0|||
125524081|NCT00379769|451551392|FG003|Main Study|Prohibited glucose lowering medication|1|||
125524082|NCT00379769|451551393|FG004|Main Study|Prohibited glucose lowering medication|0|||
125524083|NCT00379769|451551394|FG005|Main Study|Prohibited glucose lowering medication|0|||
125524084|NCT00379769|451551389|FG000|Main Study|Site closed|4|||
125524085|NCT00379769|451551390|FG001|Main Study|Site closed|4|||
125524086|NCT00379769|451551391|FG002|Main Study|Site closed|4|||
125524087|NCT00379769|451551392|FG003|Main Study|Site closed|8|||
125524088|NCT00379769|451551393|FG004|Main Study|Site closed|0|||
125524089|NCT00379769|451551394|FG005|Main Study|Site closed|0|||
125524090|NCT00379769|451551389|FG000|Main Study|Entry criteria violation|0|||
125524091|NCT00379769|451551390|FG001|Main Study|Entry criteria violation|0|||
125524092|NCT00379769|451551391|FG002|Main Study|Entry criteria violation|1|||
125524093|NCT00379769|451551392|FG003|Main Study|Entry criteria violation|1|||
125524094|NCT00379769|451551393|FG004|Main Study|Entry criteria violation|0|||
125524095|NCT00379769|451551394|FG005|Main Study|Entry criteria violation|0|||
125524096|NCT00379769|451551389|FG000|Main Study|Participant did not take study drug|0|||
125524097|NCT00379769|451551390|FG001|Main Study|Participant did not take study drug|0|||
125524098|NCT00379769|451551391|FG002|Main Study|Participant did not take study drug|1|||
125524099|NCT00379769|451551392|FG003|Main Study|Participant did not take study drug|0|||
125524100|NCT00379769|451551393|FG004|Main Study|Participant did not take study drug|0|||
125524101|NCT00379769|451551394|FG005|Main Study|Participant did not take study drug|0|||
125524102|NCT00379769|451551389|FG000|Main Study|Physician Decision|2|||
125524103|NCT00379769|451551390|FG001|Main Study|Physician Decision|2|||
125524104|NCT00379769|451551391|FG002|Main Study|Physician Decision|1|||
125524105|NCT00379769|451551392|FG003|Main Study|Physician Decision|1|||
125524106|NCT00379769|451551393|FG004|Main Study|Physician Decision|0|||
125524107|NCT00379769|451551394|FG005|Main Study|Physician Decision|0|||
125524108|NCT00379769|451551389|FG000|Main Study|Participant completed study at visit 27|1|||
125524109|NCT00379769|451551390|FG001|Main Study|Participant completed study at visit 27|0|||
125524110|NCT00379769|451551391|FG002|Main Study|Participant completed study at visit 27|0|||
125524111|NCT00379769|451551392|FG003|Main Study|Participant completed study at visit 27|0|||
125524112|NCT00379769|451551393|FG004|Main Study|Participant completed study at visit 27|0|||
125524113|NCT00379769|451551394|FG005|Main Study|Participant completed study at visit 27|0|||
125524114|NCT00379769|451551389|FG000|Main Study|Personal reasons|1|||
125524115|NCT00379769|451551390|FG001|Main Study|Personal reasons|0|||
125524116|NCT00379769|451551391|FG002|Main Study|Personal reasons|0|||
125524117|NCT00379769|451551392|FG003|Main Study|Personal reasons|0|||
125524118|NCT00379769|451551393|FG004|Main Study|Personal reasons|0|||
125524119|NCT00379769|451551394|FG005|Main Study|Personal reasons|0|||
125524120|NCT00379769|451551389|FG000|Main Study|Risk of heart failure|0|||
125524121|NCT00379769|451551390|FG001|Main Study|Risk of heart failure|1|||
125524122|NCT00379769|451551391|FG002|Main Study|Risk of heart failure|0|||
125524123|NCT00379769|451551392|FG003|Main Study|Risk of heart failure|0|||
125524124|NCT00379769|451551393|FG004|Main Study|Risk of heart failure|0|||
125524125|NCT00379769|451551394|FG005|Main Study|Risk of heart failure|0|||
125524126|NCT00379769|451551389|FG000|Main Study|Investigator refused to log temperature|0|||
125524127|NCT00379769|451551390|FG001|Main Study|Investigator refused to log temperature|0|||
125524128|NCT00379769|451551391|FG002|Main Study|Investigator refused to log temperature|1|||
125524129|NCT00379769|451551392|FG003|Main Study|Investigator refused to log temperature|0|||
125524130|NCT00379769|451551393|FG004|Main Study|Investigator refused to log temperature|0|||
125524131|NCT00379769|451551394|FG005|Main Study|Investigator refused to log temperature|0|||
125524132|NCT00379769|451551389|FG000|Main Study|Reason unspecified|0|||
125524133|NCT00379769|451551390|FG001|Main Study|Reason unspecified|0|||
125524134|NCT00379769|451551391|FG002|Main Study|Reason unspecified|1|||
125524135|NCT00379769|451551392|FG003|Main Study|Reason unspecified|0|||
125524136|NCT00379769|451551393|FG004|Main Study|Reason unspecified|0|||
125524137|NCT00379769|451551394|FG005|Main Study|Reason unspecified|0|||
125524138|NCT00379769|451551389|FG000|Observational Follow-up|Death|0|||
125524139|NCT00379769|451551390|FG001|Observational Follow-up|Death|0|||
125524140|NCT00379769|451551391|FG002|Observational Follow-up|Death|0|||
125524141|NCT00379769|451551392|FG003|Observational Follow-up|Death|0|||
125524142|NCT00379769|451551393|FG004|Observational Follow-up|Death|78|||
125524143|NCT00379769|451551394|FG005|Observational Follow-up|Death|70|||
125524144|NCT00379769|451551389|FG000|Observational Follow-up|Adverse Event|0|||
125524145|NCT00379769|451551390|FG001|Observational Follow-up|Adverse Event|0|||
125524146|NCT00379769|451551391|FG002|Observational Follow-up|Adverse Event|0|||
125524147|NCT00379769|451551392|FG003|Observational Follow-up|Adverse Event|0|||
125524148|NCT00379769|451551393|FG004|Observational Follow-up|Adverse Event|1|||
125524149|NCT00379769|451551394|FG005|Observational Follow-up|Adverse Event|0|||
125524150|NCT00379769|451551389|FG000|Observational Follow-up|Lost to Follow-up|0|||
125524151|NCT00379769|451551390|FG001|Observational Follow-up|Lost to Follow-up|0|||
125524152|NCT00379769|451551391|FG002|Observational Follow-up|Lost to Follow-up|0|||
125524153|NCT00379769|451551392|FG003|Observational Follow-up|Lost to Follow-up|0|||
125524154|NCT00379769|451551393|FG004|Observational Follow-up|Lost to Follow-up|25|||
125524155|NCT00379769|451551394|FG005|Observational Follow-up|Lost to Follow-up|27|||
125524156|NCT00379769|451551389|FG000|Observational Follow-up|Withdrawal by Subject|0|||
125524157|NCT00379769|451551390|FG001|Observational Follow-up|Withdrawal by Subject|0|||
125524158|NCT00379769|451551391|FG002|Observational Follow-up|Withdrawal by Subject|0|||
125524159|NCT00379769|451551392|FG003|Observational Follow-up|Withdrawal by Subject|0|||
125524160|NCT00379769|451551393|FG004|Observational Follow-up|Withdrawal by Subject|12|||
125524161|NCT00379769|451551394|FG005|Observational Follow-up|Withdrawal by Subject|12|||
125524162|NCT00379769|451551389|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
125524163|NCT00379769|451551390|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
125524164|NCT00379769|451551391|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
125524165|NCT00379769|451551392|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
125524166|NCT00379769|451551393|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
125524167|NCT00379769|451551394|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
125524168|NCT00379769|451551389|FG000|Observational Follow-up|Physician Decision|0|||
125524169|NCT00379769|451551390|FG001|Observational Follow-up|Physician Decision|0|||
125524170|NCT00379769|451551391|FG002|Observational Follow-up|Physician Decision|0|||
125524171|NCT00379769|451551392|FG003|Observational Follow-up|Physician Decision|0|||
125524172|NCT00379769|451551393|FG004|Observational Follow-up|Physician Decision|8|||
125524173|NCT00379769|451551394|FG005|Observational Follow-up|Physician Decision|8|||
125524174|NCT00379769|451551389|FG000|Observational Follow-up|Site Closed Early|0|||
125524175|NCT00379769|451551390|FG001|Observational Follow-up|Site Closed Early|0|||
125524176|NCT00379769|451551391|FG002|Observational Follow-up|Site Closed Early|0|||
125524177|NCT00379769|451551392|FG003|Observational Follow-up|Site Closed Early|0|||
125524178|NCT00379769|451551393|FG004|Observational Follow-up|Site Closed Early|6|||
125524179|NCT00379769|451551394|FG005|Observational Follow-up|Site Closed Early|7|||
125524180|NCT00379769|451551389|FG000|Observational Follow-up|Participant Moved|0|||
125524181|NCT00379769|451551390|FG001|Observational Follow-up|Participant Moved|0|||
125524182|NCT00379769|451551391|FG002|Observational Follow-up|Participant Moved|0|||
125524183|NCT00379769|451551392|FG003|Observational Follow-up|Participant Moved|0|||
125524184|NCT00379769|451551393|FG004|Observational Follow-up|Participant Moved|0|||
125524185|NCT00379769|451551394|FG005|Observational Follow-up|Participant Moved|1|||
125524186|NCT00379769|451551389|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
125524187|NCT00379769|451551390|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
125524188|NCT00379769|451551391|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
125524189|NCT00379769|451551392|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
125524190|NCT00379769|451551393|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
125524191|NCT00379769|451551394|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
125524192|NCT03778294|451551395|FG000|Overall Study|Death|1|||
125524193|NCT03778294|451551395|FG000|Overall Study|Issues with insurance|1|||
125524194|NCT03778294|451551395|FG000|Overall Study|disease progression before treatment|2|||
125524195|NCT02666664|451551398|FG000|Overall Study|Physician Decision|0|||
125524196|NCT02666664|451551399|FG001|Overall Study|Physician Decision|1|||
125524197|NCT02666664|451551398|FG000|Overall Study|Protocol Violation|0|||
125524198|NCT02666664|451551399|FG001|Overall Study|Protocol Violation|2|||
125524199|NCT02666664|451551398|FG000|Overall Study|Other|0|||
125524200|NCT02666664|451551399|FG001|Overall Study|Other|1|||
125524201|NCT02666664|451551398|FG000|Overall Study|Adverse Event|12|||
125524202|NCT02666664|451551399|FG001|Overall Study|Adverse Event|37|||
125524203|NCT02666664|451551398|FG000|Overall Study|Withdrawal by participant|23|||
125524204|NCT02666664|451551399|FG001|Overall Study|Withdrawal by participant|40|||
125524205|NCT02666664|451551398|FG000|Overall Study|Sponsor decision|0|||
125524206|NCT02666664|451551399|FG001|Overall Study|Sponsor decision|1|||
125524207|NCT02666664|451551398|FG000|Overall Study|Lost to Follow-up|1|||
125524208|NCT02666664|451551399|FG001|Overall Study|Lost to Follow-up|2|||
125524209|NCT00971997|451551400|FG000|Overall Study|Adverse Event|2|||
125524210|NCT00971997|451551400|FG000|Overall Study|Death|1|||
125524211|NCT00971997|451551400|FG000|Overall Study|Protocol Violation|4|||
125524212|NCT00971997|451551400|FG000|Overall Study|Withdrawal by Subject|5|||
125524213|NCT00971997|451551400|FG000|Overall Study|Physician Decision|7|||
125524214|NCT01385748|451551401|FG000|Overall Study|Withdrawal by Subject|7|||
125524215|NCT01385748|451551402|FG001|Overall Study|Withdrawal by Subject|4|||
125524216|NCT01385748|451551403|FG002|Overall Study|Withdrawal by Subject|5|||
125524217|NCT01385748|451551401|FG000|Overall Study|Noncompliance|3|||
125524218|NCT01385748|451551402|FG001|Overall Study|Noncompliance|1|||
125524219|NCT01385748|451551403|FG002|Overall Study|Noncompliance|6|||
125524220|NCT01385748|451551401|FG000|Overall Study|Other|1|||
125524221|NCT01385748|451551402|FG001|Overall Study|Other|7|||
125524222|NCT01385748|451551403|FG002|Overall Study|Other|1|||
125524223|NCT01385748|451551401|FG000|Overall Study|Adverse Event|4|||
125524224|NCT01385748|451551402|FG001|Overall Study|Adverse Event|2|||
125524225|NCT01385748|451551403|FG002|Overall Study|Adverse Event|1|||
125524226|NCT01458522|451551404|FG000|Overall Study|Withdrawal by Subject|2|||
125524227|NCT01458522|451551405|FG001|Overall Study|Withdrawal by Subject|2|||
125524228|NCT01458522|451551404|FG000|Overall Study|Physician Decision|1|||
125524229|NCT01458522|451551405|FG001|Overall Study|Physician Decision|9|||
125524230|NCT02684123|451551406|FG000|Phase 1|Lack of Efficacy|5|||
125524231|NCT02684123|451551407|FG001|Phase 1|Lack of Efficacy|0|||
125524232|NCT02684123|451551406|FG000|Phase 1|Adverse Event|3|||
125524233|NCT02684123|451551407|FG001|Phase 1|Adverse Event|0|||
125524234|NCT02684123|451551406|FG000|Phase 1|Lost to Follow-up|0|||
125524235|NCT02684123|451551407|FG001|Phase 1|Lost to Follow-up|1|||
125524236|NCT02684123|451551406|FG000|Phase 2|Lack of Efficacy|1|||
125524237|NCT02684123|451551407|FG001|Phase 2|Lack of Efficacy|8|||
125524238|NCT00516139|451551408|FG000|Overall Study|Adverse Event|27|||
125524239|NCT00516139|451551408|FG000|Overall Study|Lost to Follow-up|1|||
125524240|NCT00516139|451551408|FG000|Overall Study|Protocol Violation|1|||
125524241|NCT00516139|451551408|FG000|Overall Study|Withdrawal by Subject|8|||
125524242|NCT00516139|451551408|FG000|Overall Study|Lack of Efficacy|1|||
125524243|NCT03382561|451551409|FG000|Overall Study|Disease progression|47|||
125524244|NCT03382561|451551410|FG001|Overall Study|Disease progression|6|||
125524245|NCT03382561|451551409|FG000|Overall Study|Adverse Event|10|||
125524246|NCT03382561|451551410|FG001|Overall Study|Adverse Event|2|||
125524247|NCT03382561|451551409|FG000|Overall Study|Death|8|||
125524248|NCT03382561|451551410|FG001|Overall Study|Death|3|||
125524249|NCT03382561|451551409|FG000|Overall Study|Withdrawal by Subject|6|||
125524250|NCT03382561|451551410|FG001|Overall Study|Withdrawal by Subject|5|||
125524251|NCT03382561|451551409|FG000|Overall Study|Alternative therapy|2|||
125524252|NCT03382561|451551410|FG001|Overall Study|Alternative therapy|8|||
125524253|NCT03382561|451551409|FG000|Overall Study|Never started treatment|3|||
125524254|NCT03382561|451551410|FG001|Overall Study|Never started treatment|6|||
125524255|NCT03382561|451551409|FG000|Overall Study|Lack of Efficacy|0|||
125524256|NCT03382561|451551410|FG001|Overall Study|Lack of Efficacy|1|||
125524257|NCT03382561|451551409|FG000|Overall Study|Physician Decision|0|||
125524258|NCT03382561|451551410|FG001|Overall Study|Physician Decision|1|||
125524259|NCT03382561|451551409|FG000|Overall Study|Other complicating disease|0|||
125524260|NCT03382561|451551410|FG001|Overall Study|Other complicating disease|1|||
125524261|NCT01131104|451551411|FG000|Overall Study|Withdrawal by Subject|3|||
125524262|NCT01131104|451551411|FG000|Overall Study|Physician Decision|4|||
125524263|NCT01131104|451551411|FG000|Overall Study|Information Not Available|5|||
125524264|NCT01131104|451551411|FG000|Overall Study|No Information on Index Date of Onset|1|||
125524265|NCT02370251|451551414|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
125524266|NCT02370251|451551414|FG000|Overall Study|Death|4|||
125524267|NCT02270671|451551415|FG000|Overall Study|Withdrawal by Subject|1|||
125524268|NCT02270671|451551416|FG001|Overall Study|Withdrawal by Subject|1|||
125524269|NCT02270671|451551415|FG000|Overall Study|Protocol Violation|0|||
125524270|NCT02270671|451551416|FG001|Overall Study|Protocol Violation|1|||
125524271|NCT02270671|451551415|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
125524272|NCT02270671|451551416|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
125524273|NCT02270671|451551415|FG000|Overall Study|Lost to Follow-up|2|||
125524274|NCT02270671|451551416|FG001|Overall Study|Lost to Follow-up|1|||
125524275|NCT02367352|451551428|FG000|Overall Study|Progressive disease|7|||
125524276|NCT02367352|451551429|FG001|Overall Study|Progressive disease|0|||
125524277|NCT02367352|451551430|FG002|Overall Study|Progressive disease|0|||
125524278|NCT02367352|451551428|FG000|Overall Study|Participant Received Alternative Therapy|1|||
125524279|NCT02367352|451551429|FG001|Overall Study|Participant Received Alternative Therapy|0|||
125524280|NCT02367352|451551430|FG002|Overall Study|Participant Received Alternative Therapy|0|||
125524281|NCT02367352|451551428|FG000|Overall Study|Adverse Event|1|||
125524282|NCT02367352|451551429|FG001|Overall Study|Adverse Event|0|||
125524283|NCT02367352|451551430|FG002|Overall Study|Adverse Event|0|||
125524284|NCT00174447|451551431|FG000|Overall Study|Adverse Event|19|||
125524285|NCT00174447|451551431|FG000|Overall Study|Withdrawal by Subject|15|||
125524286|NCT00174447|451551431|FG000|Overall Study|Protocol Violation|1|||
125524287|NCT00174447|451551431|FG000|Overall Study|Lack of Efficacy|1|||
125524288|NCT00174447|451551431|FG000|Overall Study|Administrative reason/Other|2|||
125524289|NCT01437423|451551432|FG000|Overall Study|Lost to Follow-up|12|||
125524290|NCT01437423|451551432|FG000|Overall Study|Off label usage|3|||
125524291|NCT05878873|451551433|FG000|Overall Study|Lost to Follow-up|2|||
125524292|NCT05878873|451551434|FG001|Overall Study|Lost to Follow-up|0|||
125524293|NCT00633945|451551436|FG000|Overall Study|Physician Decision|2|||
125524294|NCT03865953|451551437|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
125524295|NCT03865953|451551438|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
125524296|NCT03865953|451551437|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
125524297|NCT03865953|451551438|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
125524298|NCT03865953|451551437|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
125524299|NCT03865953|451551438|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
125524300|NCT01271504|451551439|FG000|Overall Study|Death|7|||
125524301|NCT01271504|451551440|FG001|Overall Study|Death|6|||
125524302|NCT01271504|451551441|FG002|Overall Study|Death|32|||
125524303|NCT01271504|451551442|FG003|Overall Study|Death|32|||
125524304|NCT01271504|451551439|FG000|Overall Study|Lost to Follow-up|0|||
125524305|NCT01271504|451551440|FG001|Overall Study|Lost to Follow-up|1|||
125524306|NCT01271504|451551441|FG002|Overall Study|Lost to Follow-up|3|||
125524307|NCT01271504|451551442|FG003|Overall Study|Lost to Follow-up|1|||
125524308|NCT01271504|451551439|FG000|Overall Study|Protocol Violation|0|||
125524309|NCT01271504|451551440|FG001|Overall Study|Protocol Violation|0|||
125524310|NCT01271504|451551441|FG002|Overall Study|Protocol Violation|0|||
125524311|NCT01271504|451551442|FG003|Overall Study|Protocol Violation|2|||
125524312|NCT01271504|451551439|FG000|Overall Study|Administrative Reasons|0|||
125524313|NCT01271504|451551440|FG001|Overall Study|Administrative Reasons|0|||
125524314|NCT01271504|451551441|FG002|Overall Study|Administrative Reasons|6|||
125524315|NCT01271504|451551442|FG003|Overall Study|Administrative Reasons|5|||
125524316|NCT01271504|451551439|FG000|Overall Study|Withdrawal by Subject|0|||
125524317|NCT01271504|451551440|FG001|Overall Study|Withdrawal by Subject|0|||
125524318|NCT01271504|451551441|FG002|Overall Study|Withdrawal by Subject|1|||
125524319|NCT01271504|451551442|FG003|Overall Study|Withdrawal by Subject|3|||
125524320|NCT01271504|451551439|FG000|Overall Study|Other|0|||
125524321|NCT01271504|451551440|FG001|Overall Study|Other|1|||
125524322|NCT01271504|451551441|FG002|Overall Study|Other|2|||
125524323|NCT01271504|451551442|FG003|Overall Study|Other|0|||
125524324|NCT00882115|451551443|FG000|Overall Study|Withdrawal by Subject|3|||
125524325|NCT00882115|451551443|FG000|Overall Study|did not respond to DEP challe|6|||
125524326|NCT02375347|451551444|FG000|Overall Study|Protocol Violation|1|||
125524327|NCT02552147|451551445|FG000|First Intervention (7 Days)|Protocol Violation|1|||
125524328|NCT02552147|451551446|FG001|First Intervention (7 Days)|Protocol Violation|0|||
125524329|NCT02552147|451551445|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
125524330|NCT02552147|451551446|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
125524331|NCT02472145|451551447|FG000|Overall Study|Death|10|||
125524332|NCT02472145|451551448|FG001|Overall Study|Death|101|||
125524333|NCT02472145|451551449|FG002|Overall Study|Death|99|||
125524334|NCT02472145|451551447|FG000|Overall Study|Lost to Follow-up|0|||
125524335|NCT02472145|451551448|FG001|Overall Study|Lost to Follow-up|1|||
125524336|NCT02472145|451551449|FG002|Overall Study|Lost to Follow-up|0|||
125524337|NCT02472145|451551447|FG000|Overall Study|Withdrawal by Subject|0|||
125524338|NCT02472145|451551448|FG001|Overall Study|Withdrawal by Subject|9|||
125524339|NCT02472145|451551449|FG002|Overall Study|Withdrawal by Subject|13|||
125524340|NCT02472145|451551447|FG000|Overall Study|Sponsor decision|0|||
125524341|NCT02472145|451551448|FG001|Overall Study|Sponsor decision|3|||
125524342|NCT02472145|451551449|FG002|Overall Study|Sponsor decision|2|||
125524343|NCT02472145|451551447|FG000|Overall Study|Other|0|||
125524344|NCT02472145|451551448|FG001|Overall Study|Other|45|||
125524345|NCT02472145|451551449|FG002|Overall Study|Other|43|||
125524346|NCT01080326|451551450|FG000|Overall Study|Patient deterioration prior to procedure|3|||
125524347|NCT01080326|451551450|FG000|Overall Study|Surgeon decision|1|||
125524348|NCT01296555|451551451|FG000|Overall Study|Adverse Event|0|||
125524349|NCT01296555|451551452|FG001|Overall Study|Adverse Event|0|||
125524350|NCT01296555|451551453|FG002|Overall Study|Adverse Event|1|||
125524351|NCT01296555|451551454|FG003|Overall Study|Adverse Event|1|||
125524352|NCT01296555|451551455|FG004|Overall Study|Adverse Event|2|||
125524353|NCT01296555|451551456|FG005|Overall Study|Adverse Event|4|||
125524354|NCT01296555|451551457|FG006|Overall Study|Adverse Event|1|||
125524355|NCT01296555|451551458|FG007|Overall Study|Adverse Event|4|||
125524356|NCT01296555|451551459|FG008|Overall Study|Adverse Event|3|||
125524357|NCT01296555|451551460|FG009|Overall Study|Adverse Event|1|||
125524358|NCT01296555|451551461|FG010|Overall Study|Adverse Event|0|||
125524359|NCT01296555|451551462|FG011|Overall Study|Adverse Event|4|||
125524360|NCT01296555|451551463|FG012|Overall Study|Adverse Event|1|||
125524361|NCT01296555|451551464|FG013|Overall Study|Adverse Event|4|||
125524362|NCT01296555|451551465|FG014|Overall Study|Adverse Event|0|||
125524363|NCT01296555|451551466|FG015|Overall Study|Adverse Event|0|||
125524364|NCT01296555|451551467|FG016|Overall Study|Adverse Event|0|||
125524365|NCT01296555|451551468|FG017|Overall Study|Adverse Event|0|||
125524366|NCT01296555|451551469|FG018|Overall Study|Adverse Event|0|||
125524367|NCT01296555|451551470|FG019|Overall Study|Adverse Event|1|||
125524368|NCT01296555|451551471|FG020|Overall Study|Adverse Event|0|||
125524369|NCT01296555|451551472|FG021|Overall Study|Adverse Event|0|||
125524370|NCT01296555|451551473|FG022|Overall Study|Adverse Event|0|||
125524371|NCT01296555|451551474|FG023|Overall Study|Adverse Event|0|||
125524372|NCT01296555|451551475|FG024|Overall Study|Adverse Event|0|||
125524373|NCT01296555|451551476|FG025|Overall Study|Adverse Event|0|||
125524374|NCT01296555|451551477|FG026|Overall Study|Adverse Event|0|||
125524375|NCT01296555|451551478|FG027|Overall Study|Adverse Event|0|||
125524376|NCT01296555|451551479|FG028|Overall Study|Adverse Event|0|||
125524377|NCT01296555|451551451|FG000|Overall Study|Reason Not Specified|0|||
125524378|NCT01296555|451551452|FG001|Overall Study|Reason Not Specified|0|||
125524379|NCT01296555|451551453|FG002|Overall Study|Reason Not Specified|0|||
125524380|NCT01296555|451551454|FG003|Overall Study|Reason Not Specified|0|||
125524381|NCT01296555|451551455|FG004|Overall Study|Reason Not Specified|0|||
125524382|NCT01296555|451551456|FG005|Overall Study|Reason Not Specified|0|||
125524383|NCT01296555|451551457|FG006|Overall Study|Reason Not Specified|0|||
125524384|NCT01296555|451551458|FG007|Overall Study|Reason Not Specified|0|||
125524385|NCT01296555|451551459|FG008|Overall Study|Reason Not Specified|0|||
125524386|NCT01296555|451551460|FG009|Overall Study|Reason Not Specified|0|||
125524387|NCT01296555|451551461|FG010|Overall Study|Reason Not Specified|0|||
125524388|NCT01296555|451551462|FG011|Overall Study|Reason Not Specified|0|||
125524389|NCT01296555|451551463|FG012|Overall Study|Reason Not Specified|0|||
125524390|NCT01296555|451551464|FG013|Overall Study|Reason Not Specified|1|||
125524391|NCT01296555|451551465|FG014|Overall Study|Reason Not Specified|2|||
125524392|NCT01296555|451551466|FG015|Overall Study|Reason Not Specified|3|||
125524393|NCT01296555|451551467|FG016|Overall Study|Reason Not Specified|7|||
125524394|NCT01296555|451551468|FG017|Overall Study|Reason Not Specified|4|||
125524395|NCT01296555|451551469|FG018|Overall Study|Reason Not Specified|3|||
125524396|NCT01296555|451551470|FG019|Overall Study|Reason Not Specified|7|||
125524397|NCT01296555|451551471|FG020|Overall Study|Reason Not Specified|11|||
125524398|NCT01296555|451551472|FG021|Overall Study|Reason Not Specified|5|||
125524399|NCT01296555|451551473|FG022|Overall Study|Reason Not Specified|5|||
125524400|NCT01296555|451551474|FG023|Overall Study|Reason Not Specified|7|||
125524401|NCT01296555|451551475|FG024|Overall Study|Reason Not Specified|2|||
125524402|NCT01296555|451551476|FG025|Overall Study|Reason Not Specified|2|||
125524403|NCT01296555|451551477|FG026|Overall Study|Reason Not Specified|19|||
125524404|NCT01296555|451551478|FG027|Overall Study|Reason Not Specified|11|||
125524405|NCT01296555|451551479|FG028|Overall Study|Reason Not Specified|9|||
125524406|NCT01296555|451551451|FG000|Overall Study|Physician Decision|0|||
125524407|NCT01296555|451551452|FG001|Overall Study|Physician Decision|0|||
125524408|NCT01296555|451551453|FG002|Overall Study|Physician Decision|0|||
125524409|NCT01296555|451551454|FG003|Overall Study|Physician Decision|0|||
125524410|NCT01296555|451551455|FG004|Overall Study|Physician Decision|1|||
125524411|NCT01296555|451551456|FG005|Overall Study|Physician Decision|0|||
125524412|NCT01296555|451551457|FG006|Overall Study|Physician Decision|0|||
125524413|NCT01296555|451551458|FG007|Overall Study|Physician Decision|0|||
125524414|NCT01296555|451551459|FG008|Overall Study|Physician Decision|0|||
125524415|NCT01296555|451551460|FG009|Overall Study|Physician Decision|0|||
125524416|NCT01296555|451551461|FG010|Overall Study|Physician Decision|0|||
125524417|NCT01296555|451551462|FG011|Overall Study|Physician Decision|0|||
125524418|NCT01296555|451551463|FG012|Overall Study|Physician Decision|0|||
125524419|NCT01296555|451551464|FG013|Overall Study|Physician Decision|1|||
125524420|NCT01296555|451551465|FG014|Overall Study|Physician Decision|0|||
125524421|NCT01296555|451551466|FG015|Overall Study|Physician Decision|0|||
125524422|NCT01296555|451551467|FG016|Overall Study|Physician Decision|0|||
125524423|NCT01296555|451551468|FG017|Overall Study|Physician Decision|0|||
125524424|NCT01296555|451551469|FG018|Overall Study|Physician Decision|0|||
125524425|NCT01296555|451551470|FG019|Overall Study|Physician Decision|1|||
125524426|NCT01296555|451551471|FG020|Overall Study|Physician Decision|0|||
125524427|NCT01296555|451551472|FG021|Overall Study|Physician Decision|0|||
125524428|NCT01296555|451551473|FG022|Overall Study|Physician Decision|0|||
125524429|NCT01296555|451551474|FG023|Overall Study|Physician Decision|0|||
125524430|NCT01296555|451551475|FG024|Overall Study|Physician Decision|0|||
125524431|NCT01296555|451551476|FG025|Overall Study|Physician Decision|0|||
125524432|NCT01296555|451551477|FG026|Overall Study|Physician Decision|0|||
125524433|NCT01296555|451551478|FG027|Overall Study|Physician Decision|0|||
125524434|NCT01296555|451551479|FG028|Overall Study|Physician Decision|0|||
125524435|NCT01296555|451551451|FG000|Overall Study|Progressive Disease|6|||
125524436|NCT01296555|451551452|FG001|Overall Study|Progressive Disease|3|||
125524437|NCT01296555|451551453|FG002|Overall Study|Progressive Disease|3|||
125524438|NCT01296555|451551454|FG003|Overall Study|Progressive Disease|7|||
125524439|NCT01296555|451551455|FG004|Overall Study|Progressive Disease|6|||
125524440|NCT01296555|451551456|FG005|Overall Study|Progressive Disease|16|||
125524441|NCT01296555|451551457|FG006|Overall Study|Progressive Disease|16|||
125524442|NCT01296555|451551458|FG007|Overall Study|Progressive Disease|8|||
125524443|NCT01296555|451551459|FG008|Overall Study|Progressive Disease|7|||
125524444|NCT01296555|451551460|FG009|Overall Study|Progressive Disease|18|||
125524445|NCT01296555|451551461|FG010|Overall Study|Progressive Disease|7|||
125524446|NCT01296555|451551462|FG011|Overall Study|Progressive Disease|14|||
125524447|NCT01296555|451551463|FG012|Overall Study|Progressive Disease|5|||
125524448|NCT01296555|451551464|FG013|Overall Study|Progressive Disease|12|||
125524449|NCT01296555|451551465|FG014|Overall Study|Progressive Disease|1|||
125524450|NCT01296555|451551466|FG015|Overall Study|Progressive Disease|1|||
125524451|NCT01296555|451551467|FG016|Overall Study|Progressive Disease|0|||
125524452|NCT01296555|451551468|FG017|Overall Study|Progressive Disease|0|||
125524453|NCT01296555|451551469|FG018|Overall Study|Progressive Disease|0|||
125524454|NCT01296555|451551470|FG019|Overall Study|Progressive Disease|1|||
125524455|NCT01296555|451551471|FG020|Overall Study|Progressive Disease|0|||
125524456|NCT01296555|451551472|FG021|Overall Study|Progressive Disease|0|||
125524457|NCT01296555|451551473|FG022|Overall Study|Progressive Disease|0|||
125524458|NCT01296555|451551474|FG023|Overall Study|Progressive Disease|0|||
125524459|NCT01296555|451551475|FG024|Overall Study|Progressive Disease|1|||
125524460|NCT01296555|451551476|FG025|Overall Study|Progressive Disease|0|||
125524461|NCT01296555|451551477|FG026|Overall Study|Progressive Disease|5|||
125524462|NCT01296555|451551478|FG027|Overall Study|Progressive Disease|1|||
125524463|NCT01296555|451551479|FG028|Overall Study|Progressive Disease|0|||
125524464|NCT01296555|451551451|FG000|Overall Study|Protocol Violation|0|||
125524465|NCT01296555|451551452|FG001|Overall Study|Protocol Violation|0|||
125524466|NCT01296555|451551453|FG002|Overall Study|Protocol Violation|0|||
125524467|NCT01296555|451551454|FG003|Overall Study|Protocol Violation|0|||
125524468|NCT01296555|451551455|FG004|Overall Study|Protocol Violation|0|||
125524469|NCT01296555|451551456|FG005|Overall Study|Protocol Violation|0|||
125524470|NCT01296555|451551457|FG006|Overall Study|Protocol Violation|0|||
125524471|NCT01296555|451551458|FG007|Overall Study|Protocol Violation|0|||
125524472|NCT01296555|451551459|FG008|Overall Study|Protocol Violation|0|||
125524473|NCT01296555|451551460|FG009|Overall Study|Protocol Violation|0|||
125524474|NCT01296555|451551461|FG010|Overall Study|Protocol Violation|0|||
125524475|NCT01296555|451551462|FG011|Overall Study|Protocol Violation|0|||
125524476|NCT01296555|451551463|FG012|Overall Study|Protocol Violation|0|||
125524477|NCT01296555|451551464|FG013|Overall Study|Protocol Violation|1|||
125524478|NCT01296555|451551465|FG014|Overall Study|Protocol Violation|0|||
125524479|NCT01296555|451551466|FG015|Overall Study|Protocol Violation|0|||
125524480|NCT01296555|451551467|FG016|Overall Study|Protocol Violation|0|||
125524481|NCT01296555|451551468|FG017|Overall Study|Protocol Violation|0|||
125524482|NCT01296555|451551469|FG018|Overall Study|Protocol Violation|0|||
125524483|NCT01296555|451551470|FG019|Overall Study|Protocol Violation|0|||
125524484|NCT01296555|451551471|FG020|Overall Study|Protocol Violation|0|||
125524485|NCT01296555|451551472|FG021|Overall Study|Protocol Violation|0|||
125524486|NCT01296555|451551473|FG022|Overall Study|Protocol Violation|0|||
125524487|NCT01296555|451551474|FG023|Overall Study|Protocol Violation|0|||
125524488|NCT01296555|451551475|FG024|Overall Study|Protocol Violation|0|||
125524489|NCT01296555|451551476|FG025|Overall Study|Protocol Violation|0|||
125524490|NCT01296555|451551477|FG026|Overall Study|Protocol Violation|0|||
125524491|NCT01296555|451551478|FG027|Overall Study|Protocol Violation|0|||
125524492|NCT01296555|451551479|FG028|Overall Study|Protocol Violation|0|||
125524493|NCT01296555|451551451|FG000|Overall Study|Study Terminated By Sponsor|0|||
125524494|NCT01296555|451551452|FG001|Overall Study|Study Terminated By Sponsor|0|||
125524495|NCT01296555|451551453|FG002|Overall Study|Study Terminated By Sponsor|0|||
125524496|NCT01296555|451551454|FG003|Overall Study|Study Terminated By Sponsor|0|||
125524497|NCT01296555|451551455|FG004|Overall Study|Study Terminated By Sponsor|0|||
125524498|NCT01296555|451551456|FG005|Overall Study|Study Terminated By Sponsor|0|||
125524499|NCT01296555|451551457|FG006|Overall Study|Study Terminated By Sponsor|0|||
125524500|NCT01296555|451551458|FG007|Overall Study|Study Terminated By Sponsor|0|||
125524501|NCT01296555|451551459|FG008|Overall Study|Study Terminated By Sponsor|0|||
125524502|NCT01296555|451551460|FG009|Overall Study|Study Terminated By Sponsor|0|||
125524503|NCT01296555|451551461|FG010|Overall Study|Study Terminated By Sponsor|0|||
125524504|NCT01296555|451551462|FG011|Overall Study|Study Terminated By Sponsor|0|||
125524505|NCT01296555|451551463|FG012|Overall Study|Study Terminated By Sponsor|0|||
125524506|NCT01296555|451551464|FG013|Overall Study|Study Terminated By Sponsor|0|||
125524507|NCT01296555|451551465|FG014|Overall Study|Study Terminated By Sponsor|0|||
125524508|NCT01296555|451551466|FG015|Overall Study|Study Terminated By Sponsor|0|||
125524509|NCT01296555|451551467|FG016|Overall Study|Study Terminated By Sponsor|0|||
125524510|NCT01296555|451551468|FG017|Overall Study|Study Terminated By Sponsor|0|||
125524511|NCT01296555|451551469|FG018|Overall Study|Study Terminated By Sponsor|0|||
125524512|NCT01296555|451551470|FG019|Overall Study|Study Terminated By Sponsor|0|||
125524513|NCT01296555|451551471|FG020|Overall Study|Study Terminated By Sponsor|0|||
125524514|NCT01296555|451551472|FG021|Overall Study|Study Terminated By Sponsor|0|||
125524515|NCT01296555|451551473|FG022|Overall Study|Study Terminated By Sponsor|0|||
125524516|NCT01296555|451551474|FG023|Overall Study|Study Terminated By Sponsor|0|||
125524517|NCT01296555|451551475|FG024|Overall Study|Study Terminated By Sponsor|0|||
125524518|NCT01296555|451551476|FG025|Overall Study|Study Terminated By Sponsor|1|||
125524519|NCT01296555|451551477|FG026|Overall Study|Study Terminated By Sponsor|0|||
125524520|NCT01296555|451551478|FG027|Overall Study|Study Terminated By Sponsor|0|||
125524521|NCT01296555|451551479|FG028|Overall Study|Study Terminated By Sponsor|0|||
125524522|NCT01296555|451551451|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524523|NCT01296555|451551452|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524524|NCT01296555|451551453|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524525|NCT01296555|451551454|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524526|NCT01296555|451551455|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524527|NCT01296555|451551456|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524528|NCT01296555|451551457|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524529|NCT01296555|451551458|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524530|NCT01296555|451551459|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524531|NCT01296555|451551460|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524532|NCT01296555|451551461|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524533|NCT01296555|451551462|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524534|NCT01296555|451551463|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524535|NCT01296555|451551464|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524536|NCT01296555|451551465|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524537|NCT01296555|451551466|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524538|NCT01296555|451551467|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524539|NCT01296555|451551468|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524540|NCT01296555|451551469|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524541|NCT01296555|451551470|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
125524542|NCT01296555|451551471|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524543|NCT01296555|451551472|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524544|NCT01296555|451551473|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524545|NCT01296555|451551474|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524546|NCT01296555|451551475|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524547|NCT01296555|451551476|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524548|NCT01296555|451551477|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524549|NCT01296555|451551478|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524550|NCT01296555|451551479|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
125524551|NCT01296555|451551451|FG000|Overall Study|Death|0|||
125524552|NCT01296555|451551452|FG001|Overall Study|Death|0|||
125524553|NCT01296555|451551453|FG002|Overall Study|Death|0|||
125524554|NCT01296555|451551454|FG003|Overall Study|Death|2|||
125524555|NCT01296555|451551455|FG004|Overall Study|Death|1|||
125524556|NCT01296555|451551456|FG005|Overall Study|Death|0|||
125524557|NCT01296555|451551457|FG006|Overall Study|Death|2|||
125524558|NCT01296555|451551458|FG007|Overall Study|Death|0|||
125524559|NCT01296555|451551459|FG008|Overall Study|Death|0|||
125524560|NCT01296555|451551460|FG009|Overall Study|Death|1|||
125524561|NCT01296555|451551461|FG010|Overall Study|Death|0|||
125524562|NCT01296555|451551462|FG011|Overall Study|Death|1|||
125524563|NCT01296555|451551463|FG012|Overall Study|Death|0|||
125524564|NCT01296555|451551464|FG013|Overall Study|Death|2|||
125524565|NCT01296555|451551465|FG014|Overall Study|Death|27|||
125524566|NCT01296555|451551466|FG015|Overall Study|Death|15|||
125524567|NCT01296555|451551467|FG016|Overall Study|Death|11|||
125524568|NCT01296555|451551468|FG017|Overall Study|Death|11|||
125524569|NCT01296555|451551469|FG018|Overall Study|Death|17|||
125524570|NCT01296555|451551470|FG019|Overall Study|Death|12|||
125524571|NCT01296555|451551471|FG020|Overall Study|Death|13|||
125524572|NCT01296555|451551472|FG021|Overall Study|Death|12|||
125524573|NCT01296555|451551473|FG022|Overall Study|Death|12|||
125524574|NCT01296555|451551474|FG023|Overall Study|Death|13|||
125524575|NCT01296555|451551475|FG024|Overall Study|Death|7|||
125524576|NCT01296555|451551476|FG025|Overall Study|Death|7|||
125524577|NCT01296555|451551477|FG026|Overall Study|Death|35|||
125524578|NCT01296555|451551478|FG027|Overall Study|Death|92|||
125524579|NCT01296555|451551479|FG028|Overall Study|Death|44|||
125524580|NCT01296555|451551451|FG000|Overall Study|Lost to Follow-up|0|||
125524581|NCT01296555|451551452|FG001|Overall Study|Lost to Follow-up|0|||
125524582|NCT01296555|451551453|FG002|Overall Study|Lost to Follow-up|0|||
125524583|NCT01296555|451551454|FG003|Overall Study|Lost to Follow-up|0|||
125524584|NCT01296555|451551455|FG004|Overall Study|Lost to Follow-up|0|||
125524585|NCT01296555|451551456|FG005|Overall Study|Lost to Follow-up|0|||
125524586|NCT01296555|451551457|FG006|Overall Study|Lost to Follow-up|0|||
125524587|NCT01296555|451551458|FG007|Overall Study|Lost to Follow-up|0|||
125524588|NCT01296555|451551459|FG008|Overall Study|Lost to Follow-up|0|||
125524589|NCT01296555|451551460|FG009|Overall Study|Lost to Follow-up|0|||
125524590|NCT01296555|451551461|FG010|Overall Study|Lost to Follow-up|0|||
125524591|NCT01296555|451551462|FG011|Overall Study|Lost to Follow-up|0|||
125524592|NCT01296555|451551463|FG012|Overall Study|Lost to Follow-up|0|||
125524593|NCT01296555|451551464|FG013|Overall Study|Lost to Follow-up|0|||
125524594|NCT01296555|451551465|FG014|Overall Study|Lost to Follow-up|2|||
125524595|NCT01296555|451551466|FG015|Overall Study|Lost to Follow-up|1|||
125524596|NCT01296555|451551467|FG016|Overall Study|Lost to Follow-up|0|||
125524597|NCT01296555|451551468|FG017|Overall Study|Lost to Follow-up|2|||
125524598|NCT01296555|451551469|FG018|Overall Study|Lost to Follow-up|0|||
125524599|NCT01296555|451551470|FG019|Overall Study|Lost to Follow-up|2|||
125524600|NCT01296555|451551471|FG020|Overall Study|Lost to Follow-up|3|||
125524601|NCT01296555|451551472|FG021|Overall Study|Lost to Follow-up|2|||
125524602|NCT01296555|451551473|FG022|Overall Study|Lost to Follow-up|0|||
125524603|NCT01296555|451551474|FG023|Overall Study|Lost to Follow-up|0|||
125524604|NCT01296555|451551475|FG024|Overall Study|Lost to Follow-up|0|||
125524605|NCT01296555|451551476|FG025|Overall Study|Lost to Follow-up|0|||
125524606|NCT01296555|451551477|FG026|Overall Study|Lost to Follow-up|3|||
125524607|NCT01296555|451551478|FG027|Overall Study|Lost to Follow-up|13|||
125524608|NCT01296555|451551479|FG028|Overall Study|Lost to Follow-up|5|||
125524609|NCT01296555|451551451|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125524610|NCT01296555|451551452|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125524611|NCT01296555|451551453|FG002|Overall Study|Non-Compliance With Study Drug|0|||
125524612|NCT01296555|451551454|FG003|Overall Study|Non-Compliance With Study Drug|0|||
125524613|NCT01296555|451551455|FG004|Overall Study|Non-Compliance With Study Drug|0|||
125524614|NCT01296555|451551456|FG005|Overall Study|Non-Compliance With Study Drug|0|||
125524615|NCT01296555|451551457|FG006|Overall Study|Non-Compliance With Study Drug|0|||
125524616|NCT01296555|451551458|FG007|Overall Study|Non-Compliance With Study Drug|1|||
125524617|NCT01296555|451551459|FG008|Overall Study|Non-Compliance With Study Drug|0|||
125524618|NCT01296555|451551460|FG009|Overall Study|Non-Compliance With Study Drug|0|||
125524619|NCT01296555|451551461|FG010|Overall Study|Non-Compliance With Study Drug|0|||
125524620|NCT01296555|451551462|FG011|Overall Study|Non-Compliance With Study Drug|0|||
125524621|NCT01296555|451551463|FG012|Overall Study|Non-Compliance With Study Drug|0|||
125524622|NCT01296555|451551464|FG013|Overall Study|Non-Compliance With Study Drug|0|||
125524623|NCT01296555|451551465|FG014|Overall Study|Non-Compliance With Study Drug|0|||
125524624|NCT01296555|451551466|FG015|Overall Study|Non-Compliance With Study Drug|0|||
125524625|NCT01296555|451551467|FG016|Overall Study|Non-Compliance With Study Drug|0|||
125524626|NCT01296555|451551468|FG017|Overall Study|Non-Compliance With Study Drug|0|||
125524627|NCT01296555|451551469|FG018|Overall Study|Non-Compliance With Study Drug|0|||
125524628|NCT01296555|451551470|FG019|Overall Study|Non-Compliance With Study Drug|0|||
125524629|NCT01296555|451551471|FG020|Overall Study|Non-Compliance With Study Drug|0|||
125524630|NCT01296555|451551472|FG021|Overall Study|Non-Compliance With Study Drug|0|||
125524631|NCT01296555|451551473|FG022|Overall Study|Non-Compliance With Study Drug|0|||
125524632|NCT01296555|451551474|FG023|Overall Study|Non-Compliance With Study Drug|0|||
125524633|NCT01296555|451551475|FG024|Overall Study|Non-Compliance With Study Drug|0|||
125524634|NCT01296555|451551476|FG025|Overall Study|Non-Compliance With Study Drug|0|||
125524635|NCT01296555|451551477|FG026|Overall Study|Non-Compliance With Study Drug|0|||
125524636|NCT01296555|451551478|FG027|Overall Study|Non-Compliance With Study Drug|0|||
125524637|NCT01296555|451551479|FG028|Overall Study|Non-Compliance With Study Drug|0|||
125524638|NCT01296555|451551451|FG000|Overall Study|Withdrawal by Subject|0|||
125524639|NCT01296555|451551452|FG001|Overall Study|Withdrawal by Subject|0|||
125524640|NCT01296555|451551453|FG002|Overall Study|Withdrawal by Subject|0|||
125524641|NCT01296555|451551454|FG003|Overall Study|Withdrawal by Subject|0|||
125524642|NCT01296555|451551455|FG004|Overall Study|Withdrawal by Subject|1|||
125524643|NCT01296555|451551456|FG005|Overall Study|Withdrawal by Subject|0|||
125524644|NCT01296555|451551457|FG006|Overall Study|Withdrawal by Subject|1|||
125524645|NCT01296555|451551458|FG007|Overall Study|Withdrawal by Subject|0|||
125524646|NCT01296555|451551459|FG008|Overall Study|Withdrawal by Subject|0|||
125524647|NCT01296555|451551460|FG009|Overall Study|Withdrawal by Subject|0|||
125524648|NCT01296555|451551461|FG010|Overall Study|Withdrawal by Subject|1|||
125524649|NCT01296555|451551462|FG011|Overall Study|Withdrawal by Subject|1|||
125524650|NCT01296555|451551463|FG012|Overall Study|Withdrawal by Subject|0|||
125524651|NCT01296555|451551464|FG013|Overall Study|Withdrawal by Subject|0|||
125524652|NCT01296555|451551465|FG014|Overall Study|Withdrawal by Subject|3|||
125524653|NCT01296555|451551466|FG015|Overall Study|Withdrawal by Subject|0|||
125524654|NCT01296555|451551467|FG016|Overall Study|Withdrawal by Subject|2|||
125524655|NCT01296555|451551468|FG017|Overall Study|Withdrawal by Subject|1|||
125524656|NCT01296555|451551469|FG018|Overall Study|Withdrawal by Subject|0|||
125524657|NCT01296555|451551470|FG019|Overall Study|Withdrawal by Subject|1|||
125524658|NCT01296555|451551471|FG020|Overall Study|Withdrawal by Subject|1|||
125524659|NCT01296555|451551472|FG021|Overall Study|Withdrawal by Subject|1|||
125524660|NCT01296555|451551473|FG022|Overall Study|Withdrawal by Subject|3|||
125524661|NCT01296555|451551474|FG023|Overall Study|Withdrawal by Subject|0|||
125524662|NCT01296555|451551475|FG024|Overall Study|Withdrawal by Subject|0|||
125524663|NCT01296555|451551476|FG025|Overall Study|Withdrawal by Subject|0|||
125524664|NCT01296555|451551477|FG026|Overall Study|Withdrawal by Subject|8|||
125524665|NCT01296555|451551478|FG027|Overall Study|Withdrawal by Subject|4|||
125524666|NCT01296555|451551479|FG028|Overall Study|Withdrawal by Subject|2|||
125524667|NCT00409409|451551480|FG000|Overall Study|Adverse Event|7|||
125524668|NCT00409409|451551481|FG001|Overall Study|Adverse Event|2|||
125524669|NCT00409409|451551480|FG000|Overall Study|Withdrawal by Subject|1|||
125524670|NCT00409409|451551481|FG001|Overall Study|Withdrawal by Subject|1|||
125524671|NCT00409409|451551480|FG000|Overall Study|Any other reason not above-mentioned|0|||
125524672|NCT00409409|451551481|FG001|Overall Study|Any other reason not above-mentioned|1|||
125524673|NCT03000348|451551483|FG000|Overall Study|Adverse Event|1|||
125524674|NCT03000348|451551484|FG001|Overall Study|Adverse Event|1|||
125524675|NCT03000348|451551485|FG002|Overall Study|Adverse Event|1|||
125524676|NCT03000348|451551486|FG003|Overall Study|Adverse Event|1|||
125524677|NCT03000348|451551487|FG004|Overall Study|Adverse Event|1|||
125524678|NCT03000348|451551488|FG005|Overall Study|Adverse Event|1|||
125524679|NCT03000348|451551483|FG000|Overall Study|Lost to Follow-up|0|||
125524680|NCT03000348|451551484|FG001|Overall Study|Lost to Follow-up|0|||
125524681|NCT03000348|451551485|FG002|Overall Study|Lost to Follow-up|1|||
125524682|NCT03000348|451551486|FG003|Overall Study|Lost to Follow-up|0|||
125524683|NCT03000348|451551487|FG004|Overall Study|Lost to Follow-up|0|||
125524684|NCT03000348|451551488|FG005|Overall Study|Lost to Follow-up|0|||
125524685|NCT03000348|451551483|FG000|Overall Study|Withdrawal by Subject|0|||
125524686|NCT03000348|451551484|FG001|Overall Study|Withdrawal by Subject|1|||
125524687|NCT03000348|451551485|FG002|Overall Study|Withdrawal by Subject|0|||
125524688|NCT03000348|451551486|FG003|Overall Study|Withdrawal by Subject|0|||
125524689|NCT03000348|451551487|FG004|Overall Study|Withdrawal by Subject|0|||
125524690|NCT03000348|451551488|FG005|Overall Study|Withdrawal by Subject|0|||
125524691|NCT03000348|451551483|FG000|Overall Study|Consent|0|||
125524692|NCT03000348|451551484|FG001|Overall Study|Consent|0|||
125524693|NCT03000348|451551485|FG002|Overall Study|Consent|0|||
125524694|NCT03000348|451551486|FG003|Overall Study|Consent|0|||
125524695|NCT03000348|451551487|FG004|Overall Study|Consent|1|||
125524696|NCT03000348|451551488|FG005|Overall Study|Consent|0|||
125524697|NCT03000348|451551483|FG000|Overall Study|Failure to expectorate sputum|1|||
125524698|NCT03000348|451551484|FG001|Overall Study|Failure to expectorate sputum|0|||
125524699|NCT03000348|451551485|FG002|Overall Study|Failure to expectorate sputum|1|||
125524700|NCT03000348|451551486|FG003|Overall Study|Failure to expectorate sputum|0|||
125524701|NCT03000348|451551487|FG004|Overall Study|Failure to expectorate sputum|1|||
125524702|NCT03000348|451551488|FG005|Overall Study|Failure to expectorate sputum|0|||
125524703|NCT03000348|451551483|FG000|Overall Study|No gram negative|1|||
125524704|NCT03000348|451551484|FG001|Overall Study|No gram negative|2|||
125524705|NCT03000348|451551485|FG002|Overall Study|No gram negative|1|||
125524706|NCT03000348|451551486|FG003|Overall Study|No gram negative|1|||
125524707|NCT03000348|451551487|FG004|Overall Study|No gram negative|1|||
125524708|NCT03000348|451551488|FG005|Overall Study|No gram negative|1|||
125524709|NCT03000348|451551483|FG000|Overall Study|Patient had no transport|0|||
125524710|NCT03000348|451551484|FG001|Overall Study|Patient had no transport|0|||
125524711|NCT03000348|451551485|FG002|Overall Study|Patient had no transport|0|||
125524712|NCT03000348|451551486|FG003|Overall Study|Patient had no transport|1|||
125524713|NCT03000348|451551487|FG004|Overall Study|Patient had no transport|0|||
125524714|NCT03000348|451551488|FG005|Overall Study|Patient had no transport|0|||
125524715|NCT03000348|451551483|FG000|Overall Study|Dosing|0|||
125524716|NCT03000348|451551484|FG001|Overall Study|Dosing|0|||
125524717|NCT03000348|451551485|FG002|Overall Study|Dosing|0|||
125524718|NCT03000348|451551486|FG003|Overall Study|Dosing|0|||
125524719|NCT03000348|451551487|FG004|Overall Study|Dosing|1|||
125524720|NCT03000348|451551488|FG005|Overall Study|Dosing|0|||
125524721|NCT04042077|451551489|FG000|Overall Study|Adverse Event|0|||
125524722|NCT04042077|451551490|FG001|Overall Study|Adverse Event|1|||
125524723|NCT04042077|451551489|FG000|Overall Study|Death|2|||
125524724|NCT04042077|451551490|FG001|Overall Study|Death|1|||
125524725|NCT04042077|451551489|FG000|Overall Study|Physician Decision|2|||
125524726|NCT04042077|451551490|FG001|Overall Study|Physician Decision|0|||
125524727|NCT04042077|451551489|FG000|Overall Study|Withdrawal by Subject|3|||
125524728|NCT04042077|451551490|FG001|Overall Study|Withdrawal by Subject|2|||
125524729|NCT04042077|451551489|FG000|Overall Study|Lack of Efficacy|0|||
125524730|NCT04042077|451551490|FG001|Overall Study|Lack of Efficacy|1|||
125524731|NCT01236352|451551495|FG000|Overall Study|Death|0|||
125524732|NCT01236352|451551496|FG001|Overall Study|Death|0|||
125524733|NCT01236352|451551497|FG002|Overall Study|Death|0|||
125524734|NCT01236352|451551498|FG003|Overall Study|Death|0|||
125524735|NCT01236352|451551499|FG004|Overall Study|Death|0|||
125524736|NCT01236352|451551500|FG005|Overall Study|Death|0|||
125524737|NCT01236352|451551501|FG006|Overall Study|Death|0|||
125524738|NCT01236352|451551502|FG007|Overall Study|Death|1|||
125524739|NCT01236352|451551503|FG008|Overall Study|Death|0|||
125524740|NCT01236352|451551504|FG009|Overall Study|Death|0|||
125524741|NCT01236352|451551505|FG010|Overall Study|Death|0|||
125524742|NCT01236352|451551495|FG000|Overall Study|Withdrawal by Subject|0|||
125524743|NCT01236352|451551496|FG001|Overall Study|Withdrawal by Subject|0|||
125524744|NCT01236352|451551497|FG002|Overall Study|Withdrawal by Subject|0|||
125524745|NCT01236352|451551498|FG003|Overall Study|Withdrawal by Subject|0|||
125524746|NCT01236352|451551499|FG004|Overall Study|Withdrawal by Subject|0|||
125524747|NCT01236352|451551500|FG005|Overall Study|Withdrawal by Subject|0|||
125524748|NCT01236352|451551501|FG006|Overall Study|Withdrawal by Subject|0|||
125524749|NCT01236352|451551502|FG007|Overall Study|Withdrawal by Subject|0|||
125524750|NCT01236352|451551503|FG008|Overall Study|Withdrawal by Subject|0|||
125524751|NCT01236352|451551504|FG009|Overall Study|Withdrawal by Subject|2|||
125524752|NCT01236352|451551505|FG010|Overall Study|Withdrawal by Subject|1|||
125524753|NCT01236352|451551495|FG000|Overall Study|Adverse Event|0|||
125524754|NCT01236352|451551496|FG001|Overall Study|Adverse Event|0|||
125524755|NCT01236352|451551497|FG002|Overall Study|Adverse Event|0|||
125524756|NCT01236352|451551498|FG003|Overall Study|Adverse Event|0|||
125524757|NCT01236352|451551499|FG004|Overall Study|Adverse Event|0|||
125524758|NCT01236352|451551500|FG005|Overall Study|Adverse Event|0|||
125524759|NCT01236352|451551501|FG006|Overall Study|Adverse Event|2|||
125524760|NCT01236352|451551502|FG007|Overall Study|Adverse Event|0|||
125524761|NCT01236352|451551503|FG008|Overall Study|Adverse Event|0|||
125524762|NCT01236352|451551504|FG009|Overall Study|Adverse Event|4|||
125524763|NCT01236352|451551505|FG010|Overall Study|Adverse Event|1|||
125524764|NCT01236352|451551495|FG000|Overall Study|Study drug toxicity|0|||
125524765|NCT01236352|451551496|FG001|Overall Study|Study drug toxicity|0|||
125524766|NCT01236352|451551497|FG002|Overall Study|Study drug toxicity|0|||
125524767|NCT01236352|451551498|FG003|Overall Study|Study drug toxicity|0|||
125524768|NCT01236352|451551499|FG004|Overall Study|Study drug toxicity|0|||
125524769|NCT01236352|451551500|FG005|Overall Study|Study drug toxicity|1|||
125524770|NCT01236352|451551501|FG006|Overall Study|Study drug toxicity|1|||
125524771|NCT01236352|451551502|FG007|Overall Study|Study drug toxicity|0|||
125524772|NCT01236352|451551503|FG008|Overall Study|Study drug toxicity|0|||
125524773|NCT01236352|451551504|FG009|Overall Study|Study drug toxicity|2|||
125524774|NCT01236352|451551505|FG010|Overall Study|Study drug toxicity|2|||
125524775|NCT01236352|451551495|FG000|Overall Study|Disease progression|1|||
125524776|NCT01236352|451551496|FG001|Overall Study|Disease progression|2|||
125524777|NCT01236352|451551497|FG002|Overall Study|Disease progression|1|||
125524778|NCT01236352|451551498|FG003|Overall Study|Disease progression|2|||
125524779|NCT01236352|451551499|FG004|Overall Study|Disease progression|2|||
125524780|NCT01236352|451551500|FG005|Overall Study|Disease progression|2|||
125524781|NCT01236352|451551501|FG006|Overall Study|Disease progression|1|||
125524782|NCT01236352|451551502|FG007|Overall Study|Disease progression|3|||
125524783|NCT01236352|451551503|FG008|Overall Study|Disease progression|2|||
125524784|NCT01236352|451551504|FG009|Overall Study|Disease progression|2|||
125524785|NCT01236352|451551505|FG010|Overall Study|Disease progression|2|||
125524786|NCT01236352|451551495|FG000|Overall Study|Poor/Non-compliance|1|||
125524787|NCT01236352|451551496|FG001|Overall Study|Poor/Non-compliance|0|||
125524788|NCT01236352|451551497|FG002|Overall Study|Poor/Non-compliance|0|||
125524789|NCT01236352|451551498|FG003|Overall Study|Poor/Non-compliance|0|||
125524790|NCT01236352|451551499|FG004|Overall Study|Poor/Non-compliance|0|||
125524791|NCT01236352|451551500|FG005|Overall Study|Poor/Non-compliance|0|||
125524792|NCT01236352|451551501|FG006|Overall Study|Poor/Non-compliance|0|||
125524793|NCT01236352|451551502|FG007|Overall Study|Poor/Non-compliance|0|||
125524794|NCT01236352|451551503|FG008|Overall Study|Poor/Non-compliance|0|||
125524795|NCT01236352|451551504|FG009|Overall Study|Poor/Non-compliance|0|||
125524796|NCT01236352|451551505|FG010|Overall Study|Poor/Non-compliance|0|||
125524797|NCT01236352|451551495|FG000|Overall Study|Maximum clinical benefit|1|||
125524798|NCT01236352|451551496|FG001|Overall Study|Maximum clinical benefit|1|||
125524799|NCT01236352|451551497|FG002|Overall Study|Maximum clinical benefit|1|||
125524800|NCT01236352|451551498|FG003|Overall Study|Maximum clinical benefit|0|||
125524801|NCT01236352|451551499|FG004|Overall Study|Maximum clinical benefit|2|||
125524802|NCT01236352|451551500|FG005|Overall Study|Maximum clinical benefit|0|||
125524803|NCT01236352|451551501|FG006|Overall Study|Maximum clinical benefit|3|||
125524804|NCT01236352|451551502|FG007|Overall Study|Maximum clinical benefit|1|||
125524805|NCT01236352|451551503|FG008|Overall Study|Maximum clinical benefit|1|||
125524806|NCT01236352|451551504|FG009|Overall Study|Maximum clinical benefit|4|||
125524807|NCT01236352|451551505|FG010|Overall Study|Maximum clinical benefit|2|||
125524808|NCT01236352|451551495|FG000|Overall Study|Subject request to discontinue treatment|0|||
125524809|NCT01236352|451551496|FG001|Overall Study|Subject request to discontinue treatment|0|||
125524810|NCT01236352|451551497|FG002|Overall Study|Subject request to discontinue treatment|1|||
125524811|NCT01236352|451551498|FG003|Overall Study|Subject request to discontinue treatment|1|||
125524812|NCT01236352|451551499|FG004|Overall Study|Subject request to discontinue treatment|0|||
125524813|NCT01236352|451551500|FG005|Overall Study|Subject request to discontinue treatment|1|||
125524814|NCT01236352|451551501|FG006|Overall Study|Subject request to discontinue treatment|0|||
125524815|NCT01236352|451551502|FG007|Overall Study|Subject request to discontinue treatment|0|||
125524816|NCT01236352|451551503|FG008|Overall Study|Subject request to discontinue treatment|0|||
125524817|NCT01236352|451551504|FG009|Overall Study|Subject request to discontinue treatment|1|||
125524818|NCT01236352|451551505|FG010|Overall Study|Subject request to discontinue treatment|4|||
125524819|NCT01236352|451551495|FG000|Overall Study|Subject to receive drug via EAP|1|||
125524820|NCT01236352|451551496|FG001|Overall Study|Subject to receive drug via EAP|1|||
125524821|NCT01236352|451551497|FG002|Overall Study|Subject to receive drug via EAP|1|||
125524822|NCT01236352|451551498|FG003|Overall Study|Subject to receive drug via EAP|0|||
125524823|NCT01236352|451551499|FG004|Overall Study|Subject to receive drug via EAP|0|||
125524824|NCT01236352|451551500|FG005|Overall Study|Subject to receive drug via EAP|0|||
125524825|NCT01236352|451551501|FG006|Overall Study|Subject to receive drug via EAP|0|||
125524826|NCT01236352|451551502|FG007|Overall Study|Subject to receive drug via EAP|2|||
125524827|NCT01236352|451551503|FG008|Overall Study|Subject to receive drug via EAP|0|||
125524828|NCT01236352|451551504|FG009|Overall Study|Subject to receive drug via EAP|4|||
125524829|NCT01236352|451551505|FG010|Overall Study|Subject to receive drug via EAP|0|||
125524830|NCT01236352|451551495|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
125524831|NCT01236352|451551496|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
125524832|NCT01236352|451551497|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
125524833|NCT01236352|451551498|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
125524834|NCT01236352|451551499|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
125524835|NCT01236352|451551500|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
125524836|NCT01236352|451551501|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
125524837|NCT01236352|451551502|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
125524838|NCT01236352|451551503|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
125524839|NCT01236352|451551504|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
125524840|NCT01236352|451551505|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
125524841|NCT01236352|451551495|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
125524842|NCT01236352|451551496|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
125524843|NCT01236352|451551497|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
125524844|NCT01236352|451551498|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
125524845|NCT01236352|451551499|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
125524846|NCT01236352|451551500|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
125524847|NCT01236352|451551501|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
125524848|NCT01236352|451551502|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
125524849|NCT01236352|451551503|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
125524850|NCT01236352|451551504|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
125524851|NCT01236352|451551505|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
125524852|NCT01236352|451551495|FG000|Overall Study|Lack of response to drug|0|||
125524853|NCT01236352|451551496|FG001|Overall Study|Lack of response to drug|0|||
125524854|NCT01236352|451551497|FG002|Overall Study|Lack of response to drug|0|||
125524855|NCT01236352|451551498|FG003|Overall Study|Lack of response to drug|0|||
125524856|NCT01236352|451551499|FG004|Overall Study|Lack of response to drug|0|||
125524857|NCT01236352|451551500|FG005|Overall Study|Lack of response to drug|0|||
125524858|NCT01236352|451551501|FG006|Overall Study|Lack of response to drug|0|||
125524859|NCT01236352|451551502|FG007|Overall Study|Lack of response to drug|0|||
125524860|NCT01236352|451551503|FG008|Overall Study|Lack of response to drug|0|||
125524861|NCT01236352|451551504|FG009|Overall Study|Lack of response to drug|1|||
125524862|NCT01236352|451551505|FG010|Overall Study|Lack of response to drug|1|||
125524863|NCT01236352|451551495|FG000|Overall Study|Patient transferred to IST|0|||
125524864|NCT01236352|451551496|FG001|Overall Study|Patient transferred to IST|0|||
125524865|NCT01236352|451551497|FG002|Overall Study|Patient transferred to IST|0|||
125524866|NCT01236352|451551498|FG003|Overall Study|Patient transferred to IST|0|||
125524867|NCT01236352|451551499|FG004|Overall Study|Patient transferred to IST|0|||
125524868|NCT01236352|451551500|FG005|Overall Study|Patient transferred to IST|0|||
125524869|NCT01236352|451551501|FG006|Overall Study|Patient transferred to IST|0|||
125524870|NCT01236352|451551502|FG007|Overall Study|Patient transferred to IST|0|||
125524871|NCT01236352|451551503|FG008|Overall Study|Patient transferred to IST|0|||
125524872|NCT01236352|451551504|FG009|Overall Study|Patient transferred to IST|2|||
125524873|NCT01236352|451551505|FG010|Overall Study|Patient transferred to IST|6|||
125524874|NCT02031536|451551506|FG000|Overall Study|ineligible|1|||
125524875|NCT02031536|451551507|FG001|Overall Study|ineligible|0|||
125524876|NCT04147858|451551522|FG000|Overall Study|Adverse Event|6|||
125524877|NCT04147858|451551523|FG001|Overall Study|Adverse Event|6|||
125524878|NCT04147858|451551524|FG002|Overall Study|Adverse Event|6|||
125524879|NCT04147858|451551522|FG000|Overall Study|Lack of Efficacy|3|||
125524880|NCT04147858|451551523|FG001|Overall Study|Lack of Efficacy|3|||
125524881|NCT04147858|451551524|FG002|Overall Study|Lack of Efficacy|1|||
125524882|NCT04147858|451551522|FG000|Overall Study|Lost to Follow-up|1|||
125524883|NCT04147858|451551523|FG001|Overall Study|Lost to Follow-up|6|||
125524884|NCT04147858|451551524|FG002|Overall Study|Lost to Follow-up|2|||
125524885|NCT04147858|451551522|FG000|Overall Study|Withdrawal by Subject|3|||
125524886|NCT04147858|451551523|FG001|Overall Study|Withdrawal by Subject|4|||
125524887|NCT04147858|451551524|FG002|Overall Study|Withdrawal by Subject|10|||
125524888|NCT04147858|451551522|FG000|Overall Study|Subject Noncompliance, Other|4|||
125524889|NCT04147858|451551523|FG001|Overall Study|Subject Noncompliance, Other|3|||
125524890|NCT04147858|451551524|FG002|Overall Study|Subject Noncompliance, Other|1|||
125524891|NCT01191008|451551525|FG000|Overall Study|Protocol Violation|7|||
125524892|NCT01191008|451551525|FG000|Overall Study|Lost to Follow-up|8|||
125524893|NCT04905849|451551528|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
125524894|NCT04905849|451551529|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
125524895|NCT00838929|451551534|FG000|Overall Study|Protocol Violation|0|||
125524896|NCT00838929|451551535|FG001|Overall Study|Protocol Violation|1|||
125524897|NCT00838929|451551536|FG002|Overall Study|Protocol Violation|0|||
125524898|NCT00838929|451551534|FG000|Overall Study|Disease progression|0|||
125524899|NCT00838929|451551535|FG001|Overall Study|Disease progression|2|||
125524900|NCT00838929|451551536|FG002|Overall Study|Disease progression|1|||
125524901|NCT04913948|451551542|FG000|Overall Study|Withdrawal by Subject|2|||
125524902|NCT04913948|451551542|FG000|Overall Study|Sample processing issues|1|||
125524903|NCT04913948|451551542|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
125524904|NCT01068210|451551545|FG000|Overall Study|Lost to Follow-up|1|||
125524905|NCT01068210|451551546|FG001|Overall Study|Lost to Follow-up|2|||
125524906|NCT01068210|451551547|FG002|Overall Study|Lost to Follow-up|2|||
125524907|NCT01068210|451551548|FG003|Overall Study|Lost to Follow-up|1|||
125524908|NCT01068210|451551545|FG000|Overall Study|Second cancer|0|||
125524909|NCT01068210|451551546|FG001|Overall Study|Second cancer|1|||
125524910|NCT01068210|451551547|FG002|Overall Study|Second cancer|0|||
125524911|NCT01068210|451551548|FG003|Overall Study|Second cancer|0|||
125524912|NCT01068210|451551545|FG000|Overall Study|Disease progression|0|||
125524913|NCT01068210|451551546|FG001|Overall Study|Disease progression|0|||
125524914|NCT01068210|451551547|FG002|Overall Study|Disease progression|0|||
125524915|NCT01068210|451551548|FG003|Overall Study|Disease progression|2|||
125524916|NCT03522389|451551549|FG000|Overall Study|Lost to Follow-up|1|||
125524917|NCT03522389|451551550|FG001|Overall Study|Lost to Follow-up|1|||
125524918|NCT03522389|451551551|FG002|Overall Study|Lost to Follow-up|2|||
125524919|NCT03522389|451551549|FG000|Overall Study|had herniated nucleus pulposus|0|||
125524920|NCT03522389|451551550|FG001|Overall Study|had herniated nucleus pulposus|1|||
125524921|NCT03522389|451551551|FG002|Overall Study|had herniated nucleus pulposus|0|||
125524922|NCT03522389|451551549|FG000|Overall Study|go to work in other province|1|||
125524923|NCT03522389|451551550|FG001|Overall Study|go to work in other province|0|||
125524924|NCT03522389|451551551|FG002|Overall Study|go to work in other province|0|||
125524925|NCT02257918|451551552|FG000|Overall Study|Lost to Follow-up|4|||
125524926|NCT02257918|451551553|FG001|Overall Study|Lost to Follow-up|1|||
125524927|NCT02257918|451551554|FG002|Overall Study|Lost to Follow-up|0|||
125524928|NCT02257918|451551552|FG000|Overall Study|Withdrawal by Subject|0|||
125524929|NCT02257918|451551553|FG001|Overall Study|Withdrawal by Subject|0|||
125524930|NCT02257918|451551554|FG002|Overall Study|Withdrawal by Subject|1|||
125524931|NCT02257918|451551552|FG000|Overall Study|Pregnancy|0|||
125524932|NCT02257918|451551553|FG001|Overall Study|Pregnancy|0|||
125524933|NCT02257918|451551554|FG002|Overall Study|Pregnancy|1|||
125524934|NCT01263054|451551559|FG000|Overall Study|Death|1|||
125524935|NCT01263054|451551560|FG001|Overall Study|Death|0|||
125524936|NCT01263054|451551559|FG000|Overall Study|Lost to Follow-up|2|||
125524937|NCT01263054|451551560|FG001|Overall Study|Lost to Follow-up|2|||
125524938|NCT01263054|451551559|FG000|Overall Study|Withdrawal by Subject|1|||
125524939|NCT01263054|451551560|FG001|Overall Study|Withdrawal by Subject|3|||
125524940|NCT01263054|451551559|FG000|Overall Study|Qualification Violation|1|||
125524941|NCT01263054|451551560|FG001|Overall Study|Qualification Violation|0|||
125524942|NCT01263054|451551559|FG000|Overall Study|Other|0|||
125524943|NCT01263054|451551560|FG001|Overall Study|Other|1|||
125524944|NCT03494985|451551568|FG000|Overall Study|Adverse Event|3|||
125524945|NCT03494985|451551569|FG001|Overall Study|Adverse Event|2|||
125524946|NCT03494985|451551570|FG002|Overall Study|Adverse Event|3|||
125524947|NCT03494985|451551571|FG003|Overall Study|Adverse Event|0|||
125524948|NCT03494985|451551568|FG000|Overall Study|Other (Withdrawal of consent)|2|||
125524949|NCT03494985|451551569|FG001|Overall Study|Other (Withdrawal of consent)|3|||
125524950|NCT03494985|451551570|FG002|Overall Study|Other (Withdrawal of consent)|2|||
125524951|NCT03494985|451551571|FG003|Overall Study|Other (Withdrawal of consent)|5|||
125524952|NCT03494985|451551568|FG000|Overall Study|Other (Not specified)|0|||
125524953|NCT03494985|451551569|FG001|Overall Study|Other (Not specified)|1|||
125524954|NCT03494985|451551570|FG002|Overall Study|Other (Not specified)|1|||
125524955|NCT03494985|451551571|FG003|Overall Study|Other (Not specified)|0|||
125524956|NCT01689363|451553434|FG000|Overall Study|Protocol Violation|0|||
125524957|NCT01689363|451553435|FG001|Overall Study|Protocol Violation|1|||
125524958|NCT01689363|451553436|FG002|Overall Study|Protocol Violation|0|||
125524959|NCT01689363|451553437|FG003|Overall Study|Protocol Violation|0|||
125524960|NCT01689363|451553438|FG004|Overall Study|Protocol Violation|0|||
125524961|NCT01689363|451553439|FG005|Overall Study|Protocol Violation|0|||
125524962|NCT01689363|451553440|FG006|Overall Study|Protocol Violation|0|||
125524963|NCT01689363|451553441|FG007|Overall Study|Protocol Violation|0|||
125524964|NCT02104505|451553442|FG000|First Intervention (14 Days)|Adverse Event|2|||
125524965|NCT02104505|451553443|FG001|First Intervention (14 Days)|Adverse Event|0|||
125524966|NCT02104505|451553442|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
125524967|NCT02104505|451553443|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
125524968|NCT02104505|451553442|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
125524969|NCT02104505|451553443|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
125524970|NCT02104505|451553442|FG000|First Intervention (14 Days)|exclusionary condition|0|||
125524971|NCT02104505|451553443|FG001|First Intervention (14 Days)|exclusionary condition|1|||
125524972|NCT02104505|451553442|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
125524973|NCT02104505|451553443|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
125524974|NCT02104505|451553442|FG000|Second Intervention (14 Days)|Adverse Event|2|||
125524975|NCT02104505|451553443|FG001|Second Intervention (14 Days)|Adverse Event|0|||
125524976|NCT02859064|451553444|FG000|Overall Study|Progressive Disease|3|||
125524977|NCT02859064|451553444|FG000|Overall Study|Physician Decision|1|||
125524978|NCT02859064|451553444|FG000|Overall Study|Withdrawal by Subject|1|||
125524979|NCT02859064|451553444|FG000|Overall Study|Death|1|||
125524980|NCT00321685|451553445|FG000|Overall Study|Adverse Event|18|||
125524981|NCT00321685|451553445|FG000|Overall Study|Death|2|||
125524982|NCT00321685|451553445|FG000|Overall Study|Withdrawal by Subject|8|||
125524983|NCT00321685|451553445|FG000|Overall Study|Alternative therapy|1|||
125524984|NCT00321685|451553445|FG000|Overall Study|Complicating disese|1|||
125524985|NCT00321685|451553445|FG000|Overall Study|Other|5|||
125524986|NCT00321685|451553445|FG000|Overall Study|Not start protocol therapy|2|||
125524987|NCT00321685|451553445|FG000|Overall Study|Ineligible|2|||
125524988|NCT00127842|451553446|FG000|Overall Study|Adverse Event|15|||
125524989|NCT00127842|451553446|FG000|Overall Study|Withdrawal by Subject|3|||
125524990|NCT00127842|451553446|FG000|Overall Study|Lost to Follow-up|1|||
125524991|NCT00127842|451553446|FG000|Overall Study|Lack of Efficacy|12|||
125524992|NCT00127842|451553446|FG000|Overall Study|Noncompliance|2|||
125524993|NCT00127842|451553446|FG000|Overall Study|Protocol Violation|1|||
125524994|NCT00127842|451553446|FG000|Overall Study|Other|5|||
125524995|NCT01638390|451553449|FG000|Overall Study|screening failures|21|||
125524996|NCT01377389|451553450|FG000|Overall Study|Withdrawal by Subject|1|||
125524997|NCT01377389|451553450|FG000|Overall Study|Screen failure|2|||
125524998|NCT01439867|451553451|FG000|Overall Study|Non-compliance|0|||
125524999|NCT01439867|451553452|FG001|Overall Study|Non-compliance|1|||
125525000|NCT01439867|451553451|FG000|Overall Study|Withdrawal by Subject|1|||
125525001|NCT01439867|451553452|FG001|Overall Study|Withdrawal by Subject|2|||
125525002|NCT01439867|451553451|FG000|Overall Study|Administrative Decision|4|||
125525003|NCT01439867|451553452|FG001|Overall Study|Administrative Decision|5|||
125525004|NCT01439867|451553451|FG000|Overall Study|Protocol-specified Criteria|1|||
125525005|NCT01439867|451553452|FG001|Overall Study|Protocol-specified Criteria|0|||
125525006|NCT00334542|451553453|FG000|Overall Study|Adverse Event|3|||
125525007|NCT00334542|451553453|FG000|Overall Study|Withdrawal by Subject|1|||
125525008|NCT00334542|451553453|FG000|Overall Study|New cancer diagnosis|1|||
125525009|NCT04698915|451553457|FG000|Overall Study|Adverse Event|2|||
125525010|NCT04698915|451553458|FG001|Overall Study|Adverse Event|0|||
125525011|NCT04698915|451553457|FG000|Overall Study|Death|23|||
125525012|NCT04698915|451553458|FG001|Overall Study|Death|20|||
125525013|NCT04698915|451553457|FG000|Overall Study|Physician Decision|1|||
125525014|NCT04698915|451553458|FG001|Overall Study|Physician Decision|1|||
125525015|NCT04698915|451553457|FG000|Overall Study|Lost to Follow-up|1|||
125525016|NCT04698915|451553458|FG001|Overall Study|Lost to Follow-up|0|||
125525017|NCT04698915|451553457|FG000|Overall Study|Study Terminated by Sponsor|55|||
125525018|NCT04698915|451553458|FG001|Overall Study|Study Terminated by Sponsor|60|||
125525019|NCT04698915|451553457|FG000|Overall Study|Withdrawal by Subject|2|||
125525020|NCT04698915|451553458|FG001|Overall Study|Withdrawal by Subject|3|||
125525021|NCT00013611|451553459|FG000|Overall Study|Lost to Follow-up|91|||
125525022|NCT00013611|451553460|FG001|Overall Study|Lost to Follow-up|100|||
125525023|NCT01150045|451553461|FG000|Overall Study|Protocol Violation|0|||
125525024|NCT01150045|451553462|FG001|Overall Study|Protocol Violation|1|||
125525025|NCT01150045|451553463|FG002|Overall Study|Protocol Violation|0|||
125525026|NCT01150045|451553464|FG003|Overall Study|Protocol Violation|1|||
125525027|NCT02094898|451553471|FG000|Overall Study|Clinical Worsening|2|||
125525028|NCT02094898|451553471|FG000|Overall Study|Adverse Event|2|||
125525029|NCT02094898|451553471|FG000|Overall Study|Lack of Efficacy|1|||
125525030|NCT03520075|451553472|FG000|Phase 1 (Dose Escalation)|Death|2|||
125525031|NCT03520075|451553473|FG001|Phase 1 (Dose Escalation)|Death|2|||
125525032|NCT03520075|451553474|FG002|Phase 1 (Dose Escalation)|Death|3|||
125525033|NCT03520075|451553475|FG003|Phase 1 (Dose Escalation)|Death|2|||
125525034|NCT03520075|451553476|FG004|Phase 1 (Dose Escalation)|Death|6|||
125525035|NCT03520075|451553477|FG005|Phase 1 (Dose Escalation)|Death|5|||
125525036|NCT03520075|451553478|FG006|Phase 1 (Dose Escalation)|Death|3|||
125525037|NCT03520075|451553479|FG007|Phase 1 (Dose Escalation)|Death|2|||
125525038|NCT03520075|451553480|FG008|Phase 1 (Dose Escalation)|Death|3|||
125525039|NCT03520075|451553481|FG009|Phase 1 (Dose Escalation)|Death|1|||
125525040|NCT03520075|451553482|FG010|Phase 1 (Dose Escalation)|Death|5|||
125525041|NCT03520075|451553483|FG011|Phase 1 (Dose Escalation)|Death|7|||
125525042|NCT03520075|451553484|FG012|Phase 1 (Dose Escalation)|Death|11|||
125525043|NCT03520075|451553485|FG013|Phase 1 (Dose Escalation)|Death|0|||
125525044|NCT03520075|451553486|FG014|Phase 1 (Dose Escalation)|Death|0|||
125525045|NCT03520075|451553487|FG015|Phase 1 (Dose Escalation)|Death|0|||
125525046|NCT03520075|451553488|FG016|Phase 1 (Dose Escalation)|Death|0|||
125525047|NCT03520075|451553489|FG017|Phase 1 (Dose Escalation)|Death|0|||
125525048|NCT03520075|451553490|FG018|Phase 1 (Dose Escalation)|Death|0|||
125525049|NCT03520075|451553472|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
125525050|NCT03520075|451553473|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125525051|NCT03520075|451553474|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125525052|NCT03520075|451553475|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
125525053|NCT03520075|451553476|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
125525054|NCT03520075|451553477|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
125525055|NCT03520075|451553478|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125525056|NCT03520075|451553479|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
125525057|NCT03520075|451553480|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125525058|NCT03520075|451553481|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
125525059|NCT03520075|451553482|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125525060|NCT03520075|451553483|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125525061|NCT03520075|451553484|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
125525062|NCT03520075|451553485|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125525063|NCT03520075|451553486|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125525064|NCT03520075|451553487|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125525065|NCT03520075|451553488|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125525066|NCT03520075|451553489|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125525067|NCT03520075|451553490|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
125525068|NCT03520075|451553472|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525069|NCT03520075|451553473|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
125525070|NCT03520075|451553474|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525071|NCT03520075|451553475|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
125525072|NCT03520075|451553476|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
125525073|NCT03520075|451553477|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525074|NCT03520075|451553478|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525075|NCT03520075|451553479|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525076|NCT03520075|451553480|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525077|NCT03520075|451553481|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525078|NCT03520075|451553482|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
125525079|NCT03520075|451553483|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525080|NCT03520075|451553484|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
125525081|NCT03520075|451553485|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525082|NCT03520075|451553486|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525083|NCT03520075|451553487|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525084|NCT03520075|451553488|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525085|NCT03520075|451553489|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525086|NCT03520075|451553490|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
125525087|NCT03520075|451553472|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525088|NCT03520075|451553473|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525089|NCT03520075|451553474|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525090|NCT03520075|451553475|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525091|NCT03520075|451553476|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525092|NCT03520075|451553477|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525093|NCT03520075|451553478|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525094|NCT03520075|451553479|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525095|NCT03520075|451553480|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525096|NCT03520075|451553481|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
125525097|NCT03520075|451553482|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525098|NCT03520075|451553483|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525099|NCT03520075|451553484|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
125525100|NCT03520075|451553485|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525101|NCT03520075|451553486|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525102|NCT03520075|451553487|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525103|NCT03520075|451553488|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525104|NCT03520075|451553489|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525105|NCT03520075|451553490|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
125525106|NCT03520075|451553472|FG000|Phase 2 (Dose Expansion)|Death|0|||
125525107|NCT03520075|451553473|FG001|Phase 2 (Dose Expansion)|Death|0|||
125525108|NCT03520075|451553474|FG002|Phase 2 (Dose Expansion)|Death|0|||
125525109|NCT03520075|451553475|FG003|Phase 2 (Dose Expansion)|Death|0|||
125525110|NCT03520075|451553476|FG004|Phase 2 (Dose Expansion)|Death|0|||
125525111|NCT03520075|451553477|FG005|Phase 2 (Dose Expansion)|Death|0|||
125525112|NCT03520075|451553478|FG006|Phase 2 (Dose Expansion)|Death|0|||
125525113|NCT03520075|451553479|FG007|Phase 2 (Dose Expansion)|Death|0|||
125525114|NCT03520075|451553480|FG008|Phase 2 (Dose Expansion)|Death|0|||
125525115|NCT03520075|451553481|FG009|Phase 2 (Dose Expansion)|Death|0|||
125525116|NCT03520075|451553482|FG010|Phase 2 (Dose Expansion)|Death|0|||
125525117|NCT03520075|451553483|FG011|Phase 2 (Dose Expansion)|Death|0|||
125525118|NCT03520075|451553484|FG012|Phase 2 (Dose Expansion)|Death|0|||
125525119|NCT03520075|451553485|FG013|Phase 2 (Dose Expansion)|Death|20|||
125525120|NCT03520075|451553486|FG014|Phase 2 (Dose Expansion)|Death|13|||
125525121|NCT03520075|451553487|FG015|Phase 2 (Dose Expansion)|Death|9|||
125525122|NCT03520075|451553488|FG016|Phase 2 (Dose Expansion)|Death|5|||
125525123|NCT03520075|451553489|FG017|Phase 2 (Dose Expansion)|Death|14|||
125525124|NCT03520075|451553490|FG018|Phase 2 (Dose Expansion)|Death|12|||
125525125|NCT03520075|451553472|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525126|NCT03520075|451553473|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525127|NCT03520075|451553474|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525128|NCT03520075|451553475|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525129|NCT03520075|451553476|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525130|NCT03520075|451553477|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525131|NCT03520075|451553478|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525132|NCT03520075|451553479|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525133|NCT03520075|451553480|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525134|NCT03520075|451553481|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525135|NCT03520075|451553482|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525136|NCT03520075|451553483|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525137|NCT03520075|451553484|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525138|NCT03520075|451553485|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
125525139|NCT03520075|451553486|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
125525140|NCT03520075|451553487|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
125525141|NCT03520075|451553488|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
125525142|NCT03520075|451553489|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
125525143|NCT03520075|451553490|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
125525144|NCT03520075|451553472|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525145|NCT03520075|451553473|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525146|NCT03520075|451553474|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525147|NCT03520075|451553475|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525148|NCT03520075|451553476|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525149|NCT03520075|451553477|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525150|NCT03520075|451553478|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525151|NCT03520075|451553479|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525152|NCT03520075|451553480|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525153|NCT03520075|451553481|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525154|NCT03520075|451553482|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525155|NCT03520075|451553483|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525156|NCT03520075|451553484|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525157|NCT03520075|451553485|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525158|NCT03520075|451553486|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
125525159|NCT03520075|451553487|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
125525160|NCT03520075|451553488|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525161|NCT03520075|451553489|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
125525162|NCT03520075|451553490|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
125525163|NCT03520075|451553472|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525164|NCT03520075|451553473|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525165|NCT03520075|451553474|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525166|NCT03520075|451553475|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525167|NCT03520075|451553476|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525168|NCT03520075|451553477|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525169|NCT03520075|451553478|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525170|NCT03520075|451553479|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525171|NCT03520075|451553480|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525172|NCT03520075|451553481|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525173|NCT03520075|451553482|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525174|NCT03520075|451553483|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525175|NCT03520075|451553484|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525176|NCT03520075|451553485|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
125525177|NCT03520075|451553486|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525178|NCT03520075|451553487|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525179|NCT03520075|451553488|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
125525180|NCT03520075|451553489|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
125525181|NCT03520075|451553490|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
125525182|NCT05382039|451553491|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
125525183|NCT05382039|451553492|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
125533000|NCT04047862|451581430|FG008|Overall Study|Physician Decision|0|||
125525184|NCT05382039|451553493|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
125525185|NCT05382039|451553491|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
125525186|NCT05382039|451553492|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
125525187|NCT05382039|451553493|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
125525188|NCT05382039|451553491|FG000|Overall Study|waiting for confirmation|0|||
125525189|NCT05382039|451553492|FG001|Overall Study|waiting for confirmation|0|||
125525190|NCT05382039|451553493|FG002|Overall Study|waiting for confirmation|1|||
125525191|NCT01432626|451553494|FG000|Overall Study|LV function recovered|2|||
125525192|NCT01432626|451553494|FG000|Overall Study|Withdrawal by Subject|2|||
125525193|NCT01432626|451553494|FG000|Overall Study|Only 1 image competed|2|||
125525194|NCT01432626|451553494|FG000|Overall Study|Imaging agent not available|1|||
125525195|NCT01234883|451553495|FG000|Overall Study|Early treatment release|8|||
125525196|NCT01234883|451553496|FG001|Overall Study|Early treatment release|10|||
125525197|NCT01234883|451553495|FG000|Overall Study|Parent/guardian withdrew consent|1|||
125525198|NCT01234883|451553496|FG001|Overall Study|Parent/guardian withdrew consent|2|||
125525199|NCT01234883|451553495|FG000|Overall Study|Technical difficulties with IV infusion|0|||
125525200|NCT01234883|451553496|FG001|Overall Study|Technical difficulties with IV infusion|1|||
125525201|NCT01234883|451553495|FG000|Overall Study|Inclusion/exclusion failure|1|||
125525202|NCT01234883|451553496|FG001|Overall Study|Inclusion/exclusion failure|0|||
125525203|NCT00126659|451553502|FG000|Overall Study|Adverse Event|0|||
125525204|NCT00126659|451553503|FG001|Overall Study|Adverse Event|0|||
125525205|NCT00126659|451553504|FG002|Overall Study|Adverse Event|2|||
125525206|NCT01013961|451553505|FG000|Overall Study|Adverse Event|2|||
125525207|NCT01013961|451553506|FG001|Overall Study|Adverse Event|2|||
125525208|NCT01013961|451553505|FG000|Overall Study|Withdrawal by Subject|1|||
125525209|NCT01013961|451553506|FG001|Overall Study|Withdrawal by Subject|0|||
125525210|NCT01013961|451553505|FG000|Overall Study|Physician Decision|0|||
125525211|NCT01013961|451553506|FG001|Overall Study|Physician Decision|1|||
125525212|NCT01375751|451553511|FG000|Overall Study|Other|0|||
125525213|NCT01375751|451553512|FG001|Overall Study|Other|1|||
125525214|NCT01375751|451553513|FG002|Overall Study|Other|0|||
125525215|NCT02980523|451553514|FG000|Overall Study|Lost to Follow-up|1|||
125525216|NCT02980523|451553515|FG001|Overall Study|Lost to Follow-up|4|||
125525217|NCT02980523|451553516|FG002|Overall Study|Lost to Follow-up|1|||
125525218|NCT02980523|451553517|FG003|Overall Study|Lost to Follow-up|2|||
125525219|NCT02980523|451553518|FG004|Overall Study|Lost to Follow-up|1|||
125525220|NCT02980523|451553514|FG000|Overall Study|Excluded from analysis|1|||
125525221|NCT02980523|451553515|FG001|Overall Study|Excluded from analysis|3|||
125525222|NCT02980523|451553516|FG002|Overall Study|Excluded from analysis|1|||
125525223|NCT02980523|451553517|FG003|Overall Study|Excluded from analysis|1|||
125525224|NCT02980523|451553518|FG004|Overall Study|Excluded from analysis|1|||
125525225|NCT02980523|451553514|FG000|Overall Study|Lack of Efficacy|1|||
125525226|NCT02980523|451553515|FG001|Overall Study|Lack of Efficacy|4|||
125525227|NCT02980523|451553516|FG002|Overall Study|Lack of Efficacy|4|||
125525228|NCT02980523|451553517|FG003|Overall Study|Lack of Efficacy|5|||
125525229|NCT02980523|451553518|FG004|Overall Study|Lack of Efficacy|8|||
125525230|NCT02980523|451553514|FG000|Overall Study|Did not receive intervention|0|||
125525231|NCT02980523|451553515|FG001|Overall Study|Did not receive intervention|0|||
125525232|NCT02980523|451553516|FG002|Overall Study|Did not receive intervention|0|||
125525233|NCT02980523|451553517|FG003|Overall Study|Did not receive intervention|1|||
125525234|NCT02980523|451553518|FG004|Overall Study|Did not receive intervention|0|||
125525235|NCT01547598|451553522|FG000|Overall Study|Withdrew consent|1|||
125525236|NCT01547598|451553523|FG001|Overall Study|Withdrew consent|1|||
125525237|NCT01547598|451553522|FG000|Overall Study|Lost to Follow-up|1|||
125525238|NCT01547598|451553523|FG001|Overall Study|Lost to Follow-up|1|||
125525239|NCT01547598|451553522|FG000|Overall Study|Adverse Event|1|||
125525240|NCT01547598|451553523|FG001|Overall Study|Adverse Event|1|||
125525241|NCT01547598|451553522|FG000|Overall Study|Protocol Violation|1|||
125525242|NCT01547598|451553523|FG001|Overall Study|Protocol Violation|1|||
125525243|NCT01547598|451553522|FG000|Overall Study|Other Miscellaneous Reasons|2|||
125525244|NCT01547598|451553523|FG001|Overall Study|Other Miscellaneous Reasons|1|||
125525245|NCT02229227|451553529|FG000|Overall Study|Adverse Event|14|||
125525246|NCT02229227|451553530|FG001|Overall Study|Adverse Event|9|||
125525247|NCT02229227|451553529|FG000|Overall Study|Lack of Efficacy|3|||
125525248|NCT02229227|451553530|FG001|Overall Study|Lack of Efficacy|3|||
125525249|NCT02229227|451553529|FG000|Overall Study|Protocol Violation|6|||
125525250|NCT02229227|451553530|FG001|Overall Study|Protocol Violation|8|||
125525251|NCT02229227|451553529|FG000|Overall Study|Protocol defined stopping criteria|1|||
125525252|NCT02229227|451553530|FG001|Overall Study|Protocol defined stopping criteria|3|||
125525253|NCT02229227|451553529|FG000|Overall Study|Lost to Follow-up|3|||
125525254|NCT02229227|451553530|FG001|Overall Study|Lost to Follow-up|3|||
125525255|NCT02229227|451553529|FG000|Overall Study|Study terminated by sponsor|11|||
125525256|NCT02229227|451553530|FG001|Overall Study|Study terminated by sponsor|11|||
125525257|NCT02229227|451553529|FG000|Overall Study|Withdrawal by Subject|8|||
125525258|NCT02229227|451553530|FG001|Overall Study|Withdrawal by Subject|12|||
125525259|NCT02229227|451553529|FG000|Overall Study|Other|0|||
125525260|NCT02229227|451553530|FG001|Overall Study|Other|1|||
125525261|NCT02229227|451553529|FG000|Overall Study|Physician Decision|5|||
125525262|NCT02229227|451553530|FG001|Overall Study|Physician Decision|12|||
125525263|NCT04071301|451553531|FG000|Overall Study|Withdrawal by Subject|6|||
125525264|NCT04071301|451553531|FG000|Overall Study|Death|1|||
125525265|NCT05186311|451553532|FG000|Part A: Serum|Withdrawal by Subject|1|||
125525266|NCT02125279|451553533|FG000|Overall Study|Lack of Efficacy|2|||
125525267|NCT02125279|451553533|FG000|Overall Study|Withdrawal by Subject|6|||
125525268|NCT02125279|451553533|FG000|Overall Study|Protocol Violation|1|||
125525269|NCT02125279|451553533|FG000|Overall Study|Lost to Follow-up|4|||
125525270|NCT01850589|451553541|FG000|Overall Study|Withdrawal by Subject|8|||
125525271|NCT01850589|451553542|FG001|Overall Study|Withdrawal by Subject|0|||
125525272|NCT04468230|451553546|FG000|Overall Study|Adverse Event|2|||
125525273|NCT03721705|451553550|FG000|Overall Study|Adverse Event|2|||
125525274|NCT03721705|451553551|FG001|Overall Study|Adverse Event|0|||
125525275|NCT03721705|451553550|FG000|Overall Study|Withdrawal by Subject|4|||
125525276|NCT03721705|451553551|FG001|Overall Study|Withdrawal by Subject|10|||
125525277|NCT03721705|451553550|FG000|Overall Study|No Suitable Study Partner|1|||
125525278|NCT03721705|451553551|FG001|Overall Study|No Suitable Study Partner|0|||
125525279|NCT03721705|451553550|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
125525280|NCT03721705|451553551|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
125525281|NCT03721705|451553550|FG000|Overall Study|Death|0|||
125525282|NCT03721705|451553551|FG001|Overall Study|Death|1|||
125525283|NCT01790295|451553552|FG000|Overall Study|Adverse Event|1|||
125525284|NCT01790295|451553552|FG000|Overall Study|Death|4|||
125525285|NCT01790295|451553552|FG000|Overall Study|Lack of Efficacy|2|||
125525286|NCT01790295|451553552|FG000|Overall Study|Study closure|4|||
125525287|NCT03721172|451553555|FG000|Placebo-controlled Phase|Adverse Event|7|||
125525288|NCT03721172|451553556|FG001|Placebo-controlled Phase|Adverse Event|7|||
125525289|NCT03721172|451553557|FG002|Placebo-controlled Phase|Adverse Event|0|||
125525290|NCT03721172|451553555|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
125525291|NCT03721172|451553556|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
125525292|NCT03721172|451553557|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
125525293|NCT03721172|451553555|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
125525294|NCT03721172|451553556|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
125525295|NCT03721172|451553557|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
125525296|NCT03721172|451553555|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
125525297|NCT03721172|451553556|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
125525298|NCT03721172|451553557|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
125525299|NCT03721172|451553555|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
125525300|NCT03721172|451553556|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
125525301|NCT03721172|451553557|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
125525302|NCT03721172|451553555|FG000|Placebo-controlled Phase|Other|3|||
125525303|NCT03721172|451553556|FG001|Placebo-controlled Phase|Other|0|||
125525304|NCT03721172|451553557|FG002|Placebo-controlled Phase|Other|0|||
125525305|NCT03721172|451553555|FG000|Apremilast Extension Phase|Adverse Event|0|||
125525306|NCT03721172|451553556|FG001|Apremilast Extension Phase|Adverse Event|0|||
125525307|NCT03721172|451553557|FG002|Apremilast Extension Phase|Adverse Event|10|||
125525308|NCT03721172|451553555|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
125525309|NCT03721172|451553556|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
125525310|NCT03721172|451553557|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
125525311|NCT03721172|451553555|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
125525312|NCT03721172|451553556|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
125525313|NCT03721172|451553557|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
125525314|NCT03721172|451553555|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
125525315|NCT03721172|451553556|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
125525316|NCT03721172|451553557|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
125525317|NCT03721172|451553555|FG000|Apremilast Extension Phase|Protocol Violation|0|||
125525318|NCT03721172|451553556|FG001|Apremilast Extension Phase|Protocol Violation|0|||
125525319|NCT03721172|451553557|FG002|Apremilast Extension Phase|Protocol Violation|1|||
125525320|NCT03721172|451553555|FG000|Apremilast Extension Phase|Physician Decision|0|||
125525321|NCT03721172|451553556|FG001|Apremilast Extension Phase|Physician Decision|0|||
125525322|NCT03721172|451553557|FG002|Apremilast Extension Phase|Physician Decision|1|||
125525323|NCT03721172|451553555|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
125525324|NCT03721172|451553556|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
125525325|NCT03721172|451553557|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
125525326|NCT03721172|451553555|FG000|Apremilast Extension Phase|Other|0|||
125525327|NCT03721172|451553556|FG001|Apremilast Extension Phase|Other|0|||
125525328|NCT03721172|451553557|FG002|Apremilast Extension Phase|Other|3|||
125525329|NCT03721172|451553555|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
125525330|NCT03721172|451553556|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
125525331|NCT03721172|451553557|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
125525332|NCT00420784|451553558|FG000|Overall Study|Adverse Event|11|||
125525333|NCT00420784|451553559|FG001|Overall Study|Adverse Event|29|||
125525334|NCT00420784|451553560|FG002|Overall Study|Adverse Event|10|||
125525335|NCT00420784|451553561|FG003|Overall Study|Adverse Event|5|||
125525336|NCT00420784|451553558|FG000|Overall Study|Withdrawal by Subject|0|||
125525337|NCT00420784|451553559|FG001|Overall Study|Withdrawal by Subject|1|||
125525338|NCT00420784|451553560|FG002|Overall Study|Withdrawal by Subject|0|||
125525339|NCT00420784|451553561|FG003|Overall Study|Withdrawal by Subject|0|||
125525340|NCT00420784|451553558|FG000|Overall Study|Lost to Follow-up|0|||
125525341|NCT00420784|451553559|FG001|Overall Study|Lost to Follow-up|0|||
125525342|NCT00420784|451553560|FG002|Overall Study|Lost to Follow-up|2|||
125525343|NCT00420784|451553561|FG003|Overall Study|Lost to Follow-up|1|||
125525344|NCT00420784|451553558|FG000|Overall Study|Virologic Stopping Rule|17|||
125525345|NCT00420784|451553559|FG001|Overall Study|Virologic Stopping Rule|26|||
125525346|NCT00420784|451553560|FG002|Overall Study|Virologic Stopping Rule|41|||
125525347|NCT00420784|451553561|FG003|Overall Study|Virologic Stopping Rule|67|||
125525348|NCT00420784|451553558|FG000|Overall Study|Other|1|||
125525349|NCT00420784|451553559|FG001|Overall Study|Other|2|||
125525350|NCT00420784|451553560|FG002|Overall Study|Other|0|||
125525351|NCT00420784|451553561|FG003|Overall Study|Other|5|||
125525352|NCT02417441|451553564|FG000|Overall Study|Inconclusive due to missing data|52|||
125525353|NCT02417441|451553565|FG001|Overall Study|Inconclusive due to missing data|19|||
125525354|NCT00983853|451553570|FG000|Overall Study|Lost to Follow-up|1|||
125525355|NCT00983853|451553571|FG001|Overall Study|Lost to Follow-up|1|||
125525356|NCT00983853|451553572|FG002|Overall Study|Lost to Follow-up|2|||
125525357|NCT00983853|451553573|FG003|Overall Study|Lost to Follow-up|2|||
125525358|NCT00983853|451553574|FG004|Overall Study|Lost to Follow-up|2|||
125525359|NCT00983853|451553575|FG005|Overall Study|Lost to Follow-up|1|||
125525360|NCT00983853|451553570|FG000|Overall Study|Withdrawal by Subject|0|||
125525361|NCT00983853|451553571|FG001|Overall Study|Withdrawal by Subject|0|||
125525362|NCT00983853|451553572|FG002|Overall Study|Withdrawal by Subject|1|||
125525363|NCT00983853|451553573|FG003|Overall Study|Withdrawal by Subject|0|||
125525364|NCT00983853|451553574|FG004|Overall Study|Withdrawal by Subject|1|||
125525365|NCT00983853|451553575|FG005|Overall Study|Withdrawal by Subject|0|||
125525366|NCT00983853|451553570|FG000|Overall Study|Unable to come to study follow-up visits|0|||
125525367|NCT00983853|451553571|FG001|Overall Study|Unable to come to study follow-up visits|1|||
125525368|NCT00983853|451553572|FG002|Overall Study|Unable to come to study follow-up visits|0|||
125525369|NCT00983853|451553573|FG003|Overall Study|Unable to come to study follow-up visits|0|||
125525370|NCT00983853|451553574|FG004|Overall Study|Unable to come to study follow-up visits|0|||
125525371|NCT00983853|451553575|FG005|Overall Study|Unable to come to study follow-up visits|0|||
125525372|NCT03603639|451553576|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
125525373|NCT03603639|451553577|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
125525374|NCT03603639|451553578|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
125525375|NCT03603639|451553579|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
125525376|NCT03603639|451553580|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
125525377|NCT03603639|451553581|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
125525378|NCT03603639|451553576|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
125525379|NCT03603639|451553577|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
125525380|NCT03603639|451553578|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
125525381|NCT03603639|451553579|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
125525382|NCT03603639|451553580|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
125525383|NCT03603639|451553581|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
125525384|NCT02947100|451553589|FG000|Overall Study|study terminated early|3|||
125525385|NCT02947100|451553589|FG000|Overall Study|did not meet inclusion criteria|1|||
125525386|NCT02402322|451553590|FG000|Pretreatment|Withdrawal by Subject|3|||
125525387|NCT02402322|451553591|FG001|Pretreatment|Withdrawal by Subject|1|||
125525388|NCT02402322|451553592|FG002|Pretreatment|Withdrawal by Subject|1|||
125525389|NCT02402322|451553590|FG000|Follow-up|Withdrawal by Subject|6|||
125525390|NCT02402322|451553591|FG001|Follow-up|Withdrawal by Subject|3|||
125525391|NCT02402322|451553592|FG002|Follow-up|Withdrawal by Subject|24|||
125525392|NCT00742326|451553595|FG000|Overall Study|Physician Decision|0|||
125525393|NCT00742326|451553596|FG001|Overall Study|Physician Decision|1|||
125525394|NCT01318876|451553598|FG000|Day 8 Survey|email address invalid|96|||
125525395|NCT01318876|451553598|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
125525396|NCT01318876|451553598|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
125525397|NCT03635086|451553602|FG000|Overall Study|Withdrawal of consent|0|||
125525398|NCT03635086|451553603|FG001|Overall Study|Withdrawal of consent|0|||
125525399|NCT03635086|451553604|FG002|Overall Study|Withdrawal of consent|1|||
125525400|NCT03635086|451553605|FG003|Overall Study|Withdrawal of consent|0|||
125525401|NCT03635086|451553606|FG004|Overall Study|Withdrawal of consent|0|||
125525402|NCT03635086|451553602|FG000|Overall Study|Adverse Event|0|||
125525403|NCT03635086|451553603|FG001|Overall Study|Adverse Event|1|||
125525404|NCT03635086|451553604|FG002|Overall Study|Adverse Event|0|||
125525405|NCT03635086|451553605|FG003|Overall Study|Adverse Event|0|||
125525406|NCT03635086|451553606|FG004|Overall Study|Adverse Event|0|||
125525407|NCT03635086|451553602|FG000|Overall Study|Lost to Follow-up|1|||
125525408|NCT03635086|451553603|FG001|Overall Study|Lost to Follow-up|0|||
125525409|NCT03635086|451553604|FG002|Overall Study|Lost to Follow-up|0|||
125525410|NCT03635086|451553605|FG003|Overall Study|Lost to Follow-up|0|||
125525411|NCT03635086|451553606|FG004|Overall Study|Lost to Follow-up|0|||
125525412|NCT01056263|451553617|FG000|Overall Study|Adverse Event|12|||
125525413|NCT01056263|451553617|FG000|Overall Study|Death|1|||
125525414|NCT01056263|451553617|FG000|Overall Study|Withdrawal by Subject|1|||
125525415|NCT01056263|451553617|FG000|Overall Study|Lack of Efficacy|29|||
125525416|NCT01056263|451553617|FG000|Overall Study|Progressive disease|2|||
125525417|NCT01056263|451553617|FG000|Overall Study|Neoplasm progression|1|||
125525418|NCT01056263|451553617|FG000|Overall Study|Objective progression or relapse|1|||
125525419|NCT01056263|451553617|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
125525420|NCT01262092|451553618|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
125525421|NCT01262092|451553619|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
125525422|NCT01262092|451553618|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
125525423|NCT01262092|451553619|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
125525424|NCT01262092|451553618|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
125525425|NCT01262092|451553619|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
125525426|NCT01262092|451553618|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
125525427|NCT01262092|451553619|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
125525428|NCT00699842|451553622|FG000|Overall Study|Death|0|||
125525429|NCT00699842|451553623|FG001|Overall Study|Death|1|||
125525430|NCT00699842|451553624|FG002|Overall Study|Death|0|||
125525431|NCT05990387|451553625|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
125525432|NCT05990387|451553626|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
125525433|NCT04750577|451553627|FG000|Overall Study|Adverse Event|2|||
125525434|NCT04750577|451553628|FG001|Overall Study|Adverse Event|10|||
125525435|NCT04750577|451553629|FG002|Overall Study|Adverse Event|8|||
125525436|NCT04750577|451553630|FG003|Overall Study|Adverse Event|1|||
125525437|NCT04750577|451553627|FG000|Overall Study|Change of residence|0|||
125525438|NCT04750577|451553628|FG001|Overall Study|Change of residence|0|||
125525439|NCT04750577|451553629|FG002|Overall Study|Change of residence|1|||
125525440|NCT04750577|451553630|FG003|Overall Study|Change of residence|0|||
125525441|NCT04750577|451553627|FG000|Overall Study|Burden of study procedures|0|||
125525442|NCT04750577|451553628|FG001|Overall Study|Burden of study procedures|2|||
125525443|NCT04750577|451553629|FG002|Overall Study|Burden of study procedures|2|||
125525444|NCT04750577|451553630|FG003|Overall Study|Burden of study procedures|0|||
125525445|NCT04750577|451553627|FG000|Overall Study|Prematurely discontinued|0|||
125525446|NCT04750577|451553628|FG001|Overall Study|Prematurely discontinued|0|||
125525447|NCT04750577|451553629|FG002|Overall Study|Prematurely discontinued|0|||
125525448|NCT04750577|451553630|FG003|Overall Study|Prematurely discontinued|2|||
125525449|NCT04750577|451553627|FG000|Overall Study|Protocol deviation|1|||
125525450|NCT04750577|451553628|FG001|Overall Study|Protocol deviation|1|||
125525451|NCT04750577|451553629|FG002|Overall Study|Protocol deviation|1|||
125525452|NCT04750577|451553630|FG003|Overall Study|Protocol deviation|1|||
125525453|NCT04750577|451553627|FG000|Overall Study|Other than listed|3|||
125525454|NCT04750577|451553628|FG001|Overall Study|Other than listed|2|||
125525455|NCT04750577|451553629|FG002|Overall Study|Other than listed|2|||
125525456|NCT04750577|451553630|FG003|Overall Study|Other than listed|1|||
125525457|NCT04750577|451553627|FG000|Overall Study|Not treated|0|||
125525458|NCT04750577|451553628|FG001|Overall Study|Not treated|0|||
125525459|NCT04750577|451553629|FG002|Overall Study|Not treated|0|||
125525460|NCT04750577|451553630|FG003|Overall Study|Not treated|2|||
125525461|NCT01806389|451553633|FG000|Overall Study|Withdrawal by Subject|4|||
125525462|NCT03371823|451553636|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
125525463|NCT03371823|451553637|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
125525464|NCT00936598|451553638|FG000|Overall Study|Withdrawal by Subject|1|||
125525465|NCT00936598|451553639|FG001|Overall Study|Withdrawal by Subject|0|||
125525466|NCT00936598|451553638|FG000|Overall Study|Ineligible after consent|1|||
125525467|NCT00936598|451553639|FG001|Overall Study|Ineligible after consent|0|||
125525468|NCT01310699|451553640|FG000|Overall Study|Patients did not complete tandem.|4|||
125525469|NCT01310699|451553641|FG001|Overall Study|Patients did not complete tandem.|6|||
125525470|NCT00926575|451553642|FG000|Overall Study|Adverse Event|1|||
125525471|NCT00926575|451553643|FG001|Overall Study|Adverse Event|1|||
125525472|NCT00926575|451553642|FG000|Overall Study|Death|4|||
125525473|NCT00926575|451553643|FG001|Overall Study|Death|4|||
125525474|NCT00926575|451553642|FG000|Overall Study|Lost to Follow-up|1|||
125525475|NCT00926575|451553643|FG001|Overall Study|Lost to Follow-up|1|||
125525476|NCT00926575|451553642|FG000|Overall Study|Physician Decision|1|||
125525477|NCT00926575|451553643|FG001|Overall Study|Physician Decision|2|||
125525478|NCT00926575|451553642|FG000|Overall Study|Protocol Violation|1|||
125525479|NCT00926575|451553643|FG001|Overall Study|Protocol Violation|0|||
125525480|NCT00926575|451553642|FG000|Overall Study|Withdrawal by Subject|8|||
125525481|NCT00926575|451553643|FG001|Overall Study|Withdrawal by Subject|9|||
125525482|NCT02035696|451555546|FG000|Overall Study|Lost to Follow-up|0|||
125525483|NCT02035696|451555547|FG001|Overall Study|Lost to Follow-up|3|||
125525484|NCT02035696|451555548|FG002|Overall Study|Lost to Follow-up|1|||
125525485|NCT02035696|451555549|FG003|Overall Study|Lost to Follow-up|2|||
125525486|NCT02035696|451555546|FG000|Overall Study|Withdrawal by Subject|3|||
125525487|NCT02035696|451555547|FG001|Overall Study|Withdrawal by Subject|0|||
125525488|NCT02035696|451555548|FG002|Overall Study|Withdrawal by Subject|2|||
125525489|NCT02035696|451555549|FG003|Overall Study|Withdrawal by Subject|1|||
125525490|NCT00966264|451555550|FG000|Overall Study|Lost to Follow-up|4|||
125525491|NCT00966264|451555551|FG001|Overall Study|Lost to Follow-up|3|||
125525492|NCT01246999|451555552|FG000|Overall Study|Lost to Follow-up|0|||
125525493|NCT01246999|451555553|FG001|Overall Study|Lost to Follow-up|1|||
125525494|NCT01246999|451555554|FG002|Overall Study|Lost to Follow-up|0|||
125525495|NCT01246999|451555555|FG003|Overall Study|Lost to Follow-up|0|||
125525496|NCT01246999|451555552|FG000|Overall Study|Withdrawal by Subject|0|||
125525497|NCT01246999|451555553|FG001|Overall Study|Withdrawal by Subject|0|||
125525498|NCT01246999|451555554|FG002|Overall Study|Withdrawal by Subject|0|||
125525499|NCT01246999|451555555|FG003|Overall Study|Withdrawal by Subject|2|||
125525500|NCT01867047|451555556|FG000|Overall Study|Lost to Follow-up|3|||
125525501|NCT01867047|451555557|FG001|Overall Study|Lost to Follow-up|3|||
125525502|NCT01867047|451555556|FG000|Overall Study|Withdrawal by Subject|2|||
125525503|NCT01867047|451555557|FG001|Overall Study|Withdrawal by Subject|0|||
125525504|NCT01867047|451555556|FG000|Overall Study|Physician Decision|2|||
125525505|NCT01867047|451555557|FG001|Overall Study|Physician Decision|0|||
125525506|NCT01867047|451555556|FG000|Overall Study|surgery not indicated in protocol|1|||
125525507|NCT01867047|451555557|FG001|Overall Study|surgery not indicated in protocol|2|||
125525508|NCT01536587|451555560|FG000|Overall Study|Adverse Event|2|||
125525509|NCT02354651|451555561|FG000|Overall Study|Withdrawal by Subject|2|||
125525510|NCT02354651|451555561|FG000|Overall Study|Physician Decision|1|||
125525511|NCT01245140|451555568|FG000|Overall Study|Adverse Event|1|||
125525512|NCT01245140|451555569|FG001|Overall Study|Adverse Event|3|||
125525513|NCT01245140|451555568|FG000|Overall Study|Lack of Efficacy|2|||
125525514|NCT01245140|451555569|FG001|Overall Study|Lack of Efficacy|4|||
125525515|NCT01245140|451555568|FG000|Overall Study|Protocol Violation|0|||
125525516|NCT01245140|451555569|FG001|Overall Study|Protocol Violation|1|||
125525517|NCT01245140|451555568|FG000|Overall Study|Withdrawal by Subject|0|||
125525518|NCT01245140|451555569|FG001|Overall Study|Withdrawal by Subject|1|||
125525519|NCT01245140|451555568|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
125525520|NCT01245140|451555569|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
125525521|NCT04836559|451555570|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
125525522|NCT04836559|451555571|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
125525523|NCT04836559|451555572|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
125525524|NCT04836559|451555573|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
125525525|NCT04836559|451555574|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
125525526|NCT04836559|451555575|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
125525527|NCT04836559|451555576|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
125525528|NCT04836559|451555577|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
125525529|NCT04836559|451555570|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
125525530|NCT04836559|451555571|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
125525531|NCT04836559|451555572|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
125525532|NCT04836559|451555573|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
125525533|NCT04836559|451555574|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
125525534|NCT04836559|451555575|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
125525535|NCT04836559|451555576|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
125525536|NCT04836559|451555577|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
125525537|NCT04836559|451555570|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
125525538|NCT04836559|451555571|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
125525539|NCT04836559|451555572|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
125525540|NCT04836559|451555573|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
125525541|NCT04836559|451555574|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
125525542|NCT04836559|451555575|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
125525543|NCT04836559|451555576|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
125525544|NCT04836559|451555577|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
125525545|NCT04836559|451555570|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
125525546|NCT04836559|451555571|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
125525547|NCT04836559|451555572|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
125525548|NCT04836559|451555573|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
125525549|NCT04836559|451555574|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
125525550|NCT04836559|451555575|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
125525551|NCT04836559|451555576|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
125525552|NCT04836559|451555577|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
125525553|NCT04836559|451555570|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
125525554|NCT04836559|451555571|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
125525555|NCT04836559|451555572|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
125525556|NCT04836559|451555573|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
125525557|NCT04836559|451555574|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
125525558|NCT04836559|451555575|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
125525559|NCT04836559|451555576|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
125525560|NCT04836559|451555577|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
125525561|NCT04836559|451555570|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
125525562|NCT04836559|451555571|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
125525563|NCT04836559|451555572|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
125525564|NCT04836559|451555573|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
125525565|NCT04836559|451555574|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
125525566|NCT04836559|451555575|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
125525567|NCT04836559|451555576|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
125525568|NCT04836559|451555577|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
125525569|NCT04836559|451555570|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
125525570|NCT04836559|451555571|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
125525571|NCT04836559|451555572|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
125525572|NCT04836559|451555573|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
125525573|NCT04836559|451555574|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
125525574|NCT04836559|451555575|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
125525575|NCT04836559|451555576|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
125525576|NCT04836559|451555577|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
125525577|NCT04836559|451555570|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
125525578|NCT04836559|451555571|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
125525579|NCT04836559|451555572|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
125525580|NCT04836559|451555573|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
125525581|NCT04836559|451555574|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
125525582|NCT04836559|451555575|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
125525583|NCT04836559|451555576|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
125525584|NCT04836559|451555577|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
125525585|NCT04836559|451555570|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
125525586|NCT04836559|451555571|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
125525587|NCT04836559|451555572|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
125525588|NCT04836559|451555573|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
125525589|NCT04836559|451555574|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
125525590|NCT04836559|451555575|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
125525591|NCT04836559|451555576|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
125525592|NCT04836559|451555577|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
125525593|NCT02635360|451555578|FG000|Overall Study|Adverse Event|0|||
125525594|NCT02635360|451555579|FG001|Overall Study|Adverse Event|3|||
125525595|NCT02635360|451555578|FG000|Overall Study|Withdrawal by Subject|2|||
125525596|NCT02635360|451555579|FG001|Overall Study|Withdrawal by Subject|0|||
125525597|NCT02635360|451555578|FG000|Overall Study|Non-Compliance|3|||
125525598|NCT02635360|451555579|FG001|Overall Study|Non-Compliance|1|||
125525599|NCT02635360|451555578|FG000|Overall Study|Disease Progression|0|||
125525600|NCT02635360|451555579|FG001|Overall Study|Disease Progression|2|||
125525601|NCT02635360|451555578|FG000|Overall Study|Lost to Follow-up|1|||
125525602|NCT02635360|451555579|FG001|Overall Study|Lost to Follow-up|1|||
125525603|NCT04978350|451555580|FG000|Overall Study|Lost to Follow-up|6|||
125525604|NCT05765435|451555583|FG000|Overall Study|Lost to Follow-up|0|||
125525605|NCT05765435|451555584|FG001|Overall Study|Lost to Follow-up|1|||
125525606|NCT05765435|451555585|FG002|Overall Study|Lost to Follow-up|0|||
125525607|NCT05765435|451555583|FG000|Overall Study|Withdrawal by Subject|0|||
125525608|NCT05765435|451555584|FG001|Overall Study|Withdrawal by Subject|0|||
125525609|NCT05765435|451555585|FG002|Overall Study|Withdrawal by Subject|1|||
125525610|NCT00781937|451555591|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
125525611|NCT00781937|451555592|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
125525612|NCT00781937|451555591|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
125525613|NCT00781937|451555592|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
125525614|NCT00781937|451555591|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
125525615|NCT00781937|451555592|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
125525616|NCT00781937|451555591|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
125525617|NCT00781937|451555592|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
125525618|NCT00781937|451555591|FG000|Main Trial Period Through Week 56|Unclassified|10|||
125525619|NCT00781937|451555592|FG001|Main Trial Period Through Week 56|Unclassified|15|||
125533001|NCT04047862|451581431|FG009|Overall Study|Physician Decision|0|||
125525620|NCT00781937|451555591|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
125525621|NCT00781937|451555592|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
125525622|NCT00781937|451555591|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
125525623|NCT00781937|451555592|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
125525624|NCT03016598|451555597|FG000|Overall Study|Lost to Follow-up|0|||
125525625|NCT03016598|451555598|FG001|Overall Study|Lost to Follow-up|2|||
125525626|NCT04593823|451555600|FG000|Overall Study|Withdrawal by Subject|1|||
125525627|NCT04593823|451555601|FG001|Overall Study|Withdrawal by Subject|1|||
125525628|NCT04593823|451555600|FG000|Overall Study|Lost to Follow-up|0|||
125525629|NCT04593823|451555601|FG001|Overall Study|Lost to Follow-up|1|||
125525630|NCT00443209|451555602|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
125525631|NCT00443209|451555603|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
125525632|NCT00443209|451555602|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
125525633|NCT00443209|451555603|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
125525634|NCT00443209|451555602|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
125525635|NCT00443209|451555603|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
125525636|NCT00443209|451555602|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
125525637|NCT00443209|451555603|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
125525638|NCT00443209|451555602|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
125525639|NCT00443209|451555603|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
125525640|NCT00443209|451555602|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
125525641|NCT00443209|451555603|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
125525642|NCT00443209|451555602|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
125525643|NCT00443209|451555603|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
125525644|NCT00443209|451555602|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
125525645|NCT00443209|451555603|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
125525646|NCT00443209|451555602|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
125525647|NCT00443209|451555603|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
125525648|NCT00443209|451555602|FG000|Months 1 to 12 Treatment Period|Missing|2|||
125525649|NCT00443209|451555603|FG001|Months 1 to 12 Treatment Period|Missing|1|||
125525650|NCT00443209|451555602|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
125525651|NCT00443209|451555603|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
125525652|NCT00443209|451555602|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
125525653|NCT00443209|451555603|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
125525654|NCT00443209|451555602|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
125525655|NCT00443209|451555603|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
125525656|NCT00443209|451555602|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
125525657|NCT00443209|451555603|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
125525658|NCT00443209|451555602|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
125525659|NCT00443209|451555603|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
125525660|NCT00443209|451555602|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
125525661|NCT00443209|451555603|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
125525662|NCT00443209|451555602|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
125525663|NCT00443209|451555603|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
125525664|NCT01628692|451555604|FG000|Overall Study|Lack of Efficacy|4|||
125525665|NCT01628692|451555605|FG001|Overall Study|Lack of Efficacy|4|||
125525666|NCT01628692|451555606|FG002|Overall Study|Lack of Efficacy|5|||
125525667|NCT01628692|451555607|FG003|Overall Study|Lack of Efficacy|1|||
125525668|NCT01628692|451555608|FG004|Overall Study|Lack of Efficacy|4|||
125525669|NCT01628692|451555609|FG005|Overall Study|Lack of Efficacy|7|||
125525670|NCT01628692|451555604|FG000|Overall Study|Adverse Event|2|||
125525671|NCT01628692|451555605|FG001|Overall Study|Adverse Event|0|||
125525672|NCT01628692|451555606|FG002|Overall Study|Adverse Event|2|||
125525673|NCT01628692|451555607|FG003|Overall Study|Adverse Event|0|||
125525674|NCT01628692|451555608|FG004|Overall Study|Adverse Event|0|||
125525675|NCT01628692|451555609|FG005|Overall Study|Adverse Event|0|||
125525676|NCT01628692|451555604|FG000|Overall Study|Withdrawal by Subject|0|||
125525677|NCT01628692|451555605|FG001|Overall Study|Withdrawal by Subject|1|||
125525678|NCT01628692|451555606|FG002|Overall Study|Withdrawal by Subject|1|||
125525679|NCT01628692|451555607|FG003|Overall Study|Withdrawal by Subject|0|||
125525680|NCT01628692|451555608|FG004|Overall Study|Withdrawal by Subject|0|||
125525681|NCT01628692|451555609|FG005|Overall Study|Withdrawal by Subject|0|||
125525682|NCT01628692|451555604|FG000|Overall Study|Death|0|||
125525683|NCT01628692|451555605|FG001|Overall Study|Death|1|||
125525684|NCT01628692|451555606|FG002|Overall Study|Death|0|||
125525685|NCT01628692|451555607|FG003|Overall Study|Death|0|||
125525686|NCT01628692|451555608|FG004|Overall Study|Death|0|||
125525687|NCT01628692|451555609|FG005|Overall Study|Death|0|||
125525688|NCT01628692|451555604|FG000|Overall Study|Poor compliance/noncompliance|1|||
125525689|NCT01628692|451555605|FG001|Overall Study|Poor compliance/noncompliance|0|||
125525690|NCT01628692|451555606|FG002|Overall Study|Poor compliance/noncompliance|0|||
125525691|NCT01628692|451555607|FG003|Overall Study|Poor compliance/noncompliance|0|||
125525692|NCT01628692|451555608|FG004|Overall Study|Poor compliance/noncompliance|0|||
125525693|NCT01628692|451555609|FG005|Overall Study|Poor compliance/noncompliance|0|||
125525694|NCT01628692|451555604|FG000|Overall Study|Administrative reason by sponsor|0|||
125525695|NCT01628692|451555605|FG001|Overall Study|Administrative reason by sponsor|0|||
125525696|NCT01628692|451555606|FG002|Overall Study|Administrative reason by sponsor|0|||
125525697|NCT01628692|451555607|FG003|Overall Study|Administrative reason by sponsor|0|||
125525698|NCT01628692|451555608|FG004|Overall Study|Administrative reason by sponsor|0|||
125525699|NCT01628692|451555609|FG005|Overall Study|Administrative reason by sponsor|1|||
125525700|NCT01628692|451555604|FG000|Overall Study|Completed 12 Week only|0|||
125525701|NCT01628692|451555605|FG001|Overall Study|Completed 12 Week only|0|||
125525702|NCT01628692|451555606|FG002|Overall Study|Completed 12 Week only|0|||
125525703|NCT01628692|451555607|FG003|Overall Study|Completed 12 Week only|0|||
125525704|NCT01628692|451555608|FG004|Overall Study|Completed 12 Week only|0|||
125525705|NCT01628692|451555609|FG005|Overall Study|Completed 12 Week only|1|||
125525706|NCT02196077|451555611|FG000|Overall Study|Adverse Event|4|||
125525707|NCT02196077|451555611|FG000|Overall Study|Lack of Efficacy|1|||
125525708|NCT02196077|451555611|FG000|Overall Study|Withdrawal by Subject|14|||
125525709|NCT02196077|451555611|FG000|Overall Study|Physician Decision|1|||
125525710|NCT02196077|451555611|FG000|Overall Study|Lost to Follow-up|3|||
125525711|NCT02196077|451555611|FG000|Overall Study|Protocol Violation|24|||
125525712|NCT02638103|451555616|FG000|Overall Study|Adverse Event|13|||
125525713|NCT02638103|451555617|FG001|Overall Study|Adverse Event|12|||
125525714|NCT02638103|451555618|FG002|Overall Study|Adverse Event|19|||
125525715|NCT02638103|451555619|FG003|Overall Study|Adverse Event|12|||
125525716|NCT02638103|451555616|FG000|Overall Study|Withdrawal by Subject|43|||
125525717|NCT02638103|451555617|FG001|Overall Study|Withdrawal by Subject|53|||
125525718|NCT02638103|451555618|FG002|Overall Study|Withdrawal by Subject|30|||
125525719|NCT02638103|451555619|FG003|Overall Study|Withdrawal by Subject|61|||
125525720|NCT02638103|451555616|FG000|Overall Study|Protocol Violation|1|||
125525721|NCT02638103|451555617|FG001|Overall Study|Protocol Violation|2|||
125525722|NCT02638103|451555618|FG002|Overall Study|Protocol Violation|1|||
125525723|NCT02638103|451555619|FG003|Overall Study|Protocol Violation|4|||
125525724|NCT02638103|451555616|FG000|Overall Study|Pregnancy|2|||
125525725|NCT02638103|451555617|FG001|Overall Study|Pregnancy|3|||
125525726|NCT02638103|451555618|FG002|Overall Study|Pregnancy|0|||
125525727|NCT02638103|451555619|FG003|Overall Study|Pregnancy|1|||
125525728|NCT02638103|451555616|FG000|Overall Study|Non-compliance to Study Procedures|2|||
125525729|NCT02638103|451555617|FG001|Overall Study|Non-compliance to Study Procedures|1|||
125525730|NCT02638103|451555618|FG002|Overall Study|Non-compliance to Study Procedures|1|||
125525731|NCT02638103|451555619|FG003|Overall Study|Non-compliance to Study Procedures|1|||
125525732|NCT02638103|451555616|FG000|Overall Study|Lost to Follow-up|26|||
125525733|NCT02638103|451555617|FG001|Overall Study|Lost to Follow-up|33|||
125525734|NCT02638103|451555618|FG002|Overall Study|Lost to Follow-up|20|||
125525735|NCT02638103|451555619|FG003|Overall Study|Lost to Follow-up|37|||
125525736|NCT02638103|451555616|FG000|Overall Study|Lack of Efficacy|14|||
125525737|NCT02638103|451555617|FG001|Overall Study|Lack of Efficacy|10|||
125525738|NCT02638103|451555618|FG002|Overall Study|Lack of Efficacy|12|||
125525739|NCT02638103|451555619|FG003|Overall Study|Lack of Efficacy|22|||
125525740|NCT02638103|451555616|FG000|Overall Study|Other than specified|5|||
125525741|NCT02638103|451555617|FG001|Overall Study|Other than specified|4|||
125525742|NCT02638103|451555618|FG002|Overall Study|Other than specified|2|||
125525743|NCT02638103|451555619|FG003|Overall Study|Other than specified|4|||
125525744|NCT01827046|451555625|FG000|Overall Study|Lost to Follow-up|1|||
125525745|NCT01827046|451555626|FG001|Overall Study|Lost to Follow-up|5|||
125525746|NCT01827046|451555625|FG000|Overall Study|Withdrawal by Subject|0|||
125525747|NCT01827046|451555626|FG001|Overall Study|Withdrawal by Subject|4|||
125525748|NCT02734004|451555627|FG000|Overall Study|Death|36|||
125525749|NCT02734004|451555628|FG001|Overall Study|Death|24|||
125525750|NCT02734004|451555629|FG002|Overall Study|Death|26|||
125525751|NCT02734004|451555630|FG003|Overall Study|Death|35|||
125525752|NCT02734004|451555631|FG004|Overall Study|Death|13|||
125525753|NCT02734004|451555632|FG005|Overall Study|Death|17|||
125525754|NCT02734004|451555633|FG006|Overall Study|Death|20|||
125525755|NCT02734004|451555627|FG000|Overall Study|Lost to Follow-up|1|||
125525756|NCT02734004|451555628|FG001|Overall Study|Lost to Follow-up|1|||
125525757|NCT02734004|451555629|FG002|Overall Study|Lost to Follow-up|0|||
125525758|NCT02734004|451555630|FG003|Overall Study|Lost to Follow-up|0|||
125525759|NCT02734004|451555631|FG004|Overall Study|Lost to Follow-up|1|||
125525760|NCT02734004|451555632|FG005|Overall Study|Lost to Follow-up|0|||
125525761|NCT02734004|451555633|FG006|Overall Study|Lost to Follow-up|0|||
125525762|NCT02734004|451555627|FG000|Overall Study|Withdrawal by Subject|3|||
125525763|NCT02734004|451555628|FG001|Overall Study|Withdrawal by Subject|1|||
125525764|NCT02734004|451555629|FG002|Overall Study|Withdrawal by Subject|1|||
125525765|NCT02734004|451555630|FG003|Overall Study|Withdrawal by Subject|1|||
125525766|NCT02734004|451555631|FG004|Overall Study|Withdrawal by Subject|3|||
125525767|NCT02734004|451555632|FG005|Overall Study|Withdrawal by Subject|0|||
125525768|NCT02734004|451555633|FG006|Overall Study|Withdrawal by Subject|2|||
125525769|NCT02734004|451555627|FG000|Overall Study|Other|0|||
125525770|NCT02734004|451555628|FG001|Overall Study|Other|8|||
125525771|NCT02734004|451555629|FG002|Overall Study|Other|7|||
125525772|NCT02734004|451555630|FG003|Overall Study|Other|4|||
125525773|NCT02734004|451555631|FG004|Overall Study|Other|34|||
125525774|NCT02734004|451555632|FG005|Overall Study|Other|14|||
125525775|NCT02734004|451555633|FG006|Overall Study|Other|10|||
125525776|NCT01294436|451555634|FG000|Overall Study|Adverse Event|10|||
125525777|NCT01294436|451555635|FG001|Overall Study|Adverse Event|17|||
125525778|NCT01294436|451555634|FG000|Overall Study|Withdrawal by Subject|11|||
125525779|NCT01294436|451555635|FG001|Overall Study|Withdrawal by Subject|28|||
125525780|NCT01294436|451555634|FG000|Overall Study|subject no longer meets study criteria|5|||
125525781|NCT01294436|451555635|FG001|Overall Study|subject no longer meets study criteria|20|||
125525782|NCT01294436|451555634|FG000|Overall Study|poor/non-compliance|2|||
125525783|NCT01294436|451555635|FG001|Overall Study|poor/non-compliance|5|||
125525784|NCT02296892|451555636|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
125525785|NCT02296892|451555637|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
125525786|NCT02296892|451555638|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
125525787|NCT02296892|451555636|FG000|Overall Study|Lost to Follow-up|5|||
125525788|NCT02296892|451555637|FG001|Overall Study|Lost to Follow-up|0|||
125525789|NCT02296892|451555638|FG002|Overall Study|Lost to Follow-up|1|||
125525790|NCT01018732|451555639|FG000|Overall Study|Lost to Follow-up|0|||
125525791|NCT01018732|451555640|FG001|Overall Study|Lost to Follow-up|0|||
125525792|NCT01018732|451555641|FG002|Overall Study|Lost to Follow-up|3|||
125525793|NCT01018732|451555639|FG000|Overall Study|Protocol Violation|1|||
125525794|NCT01018732|451555640|FG001|Overall Study|Protocol Violation|1|||
125525795|NCT01018732|451555641|FG002|Overall Study|Protocol Violation|0|||
125525796|NCT01018732|451555639|FG000|Overall Study|Inappropriate Enrollment|0|||
125525797|NCT01018732|451555640|FG001|Overall Study|Inappropriate Enrollment|1|||
125525798|NCT01018732|451555641|FG002|Overall Study|Inappropriate Enrollment|0|||
125525799|NCT01018732|451555639|FG000|Overall Study|Unable to Classify|0|||
125525800|NCT01018732|451555640|FG001|Overall Study|Unable to Classify|0|||
125525801|NCT01018732|451555641|FG002|Overall Study|Unable to Classify|1|||
125525802|NCT00585078|451555642|FG000|Overall Study|Withdrawal by Subject|4|||
125525803|NCT00585078|451555642|FG000|Overall Study|Poor performance status|1|||
125525804|NCT00585078|451555642|FG000|Overall Study|Disease Progression|24|||
125525805|NCT00585078|451555642|FG000|Overall Study|Adverse Event|10|||
125525806|NCT00585078|451555642|FG000|Overall Study|Death|1|||
125525807|NCT01536171|451555643|FG000|Overall Study|Withdrawal by Subject|1|||
125525808|NCT02781311|451555646|FG000|Overall Study|Adverse Event|2|||
125525809|NCT02781311|451555647|FG001|Overall Study|Adverse Event|6|||
125525810|NCT02781311|451555648|FG002|Overall Study|Adverse Event|1|||
125525811|NCT02781311|451555646|FG000|Overall Study|Withdrawal of Consent|11|||
125525812|NCT02781311|451555647|FG001|Overall Study|Withdrawal of Consent|12|||
125525813|NCT02781311|451555648|FG002|Overall Study|Withdrawal of Consent|2|||
125525814|NCT02781311|451555646|FG000|Overall Study|Lost to Follow-up|11|||
125525815|NCT02781311|451555647|FG001|Overall Study|Lost to Follow-up|8|||
125525816|NCT02781311|451555648|FG002|Overall Study|Lost to Follow-up|1|||
125525817|NCT02781311|451555646|FG000|Overall Study|Non-Compliance with Study Drug|2|||
125525818|NCT02781311|451555647|FG001|Overall Study|Non-Compliance with Study Drug|0|||
125525819|NCT02781311|451555648|FG002|Overall Study|Non-Compliance with Study Drug|0|||
125525820|NCT02165826|451555650|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
125525821|NCT02165826|451555651|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
125525822|NCT02165826|451555652|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
125525823|NCT02165826|451555650|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
125525824|NCT02165826|451555651|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
125525825|NCT02165826|451555652|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
125525826|NCT02165826|451555650|FG000|Main Treatment Period|Lost to Follow-up|4|||
125525827|NCT02165826|451555651|FG001|Main Treatment Period|Lost to Follow-up|2|||
125525828|NCT02165826|451555652|FG002|Main Treatment Period|Lost to Follow-up|1|||
125525829|NCT02165826|451555650|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
125525830|NCT02165826|451555651|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
125525831|NCT02165826|451555652|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
125525832|NCT02165826|451555650|FG000|Main Treatment Period|Lack of Efficacy|2|||
125525833|NCT02165826|451555651|FG001|Main Treatment Period|Lack of Efficacy|0|||
125525834|NCT02165826|451555652|FG002|Main Treatment Period|Lack of Efficacy|0|||
125525835|NCT02165826|451555650|FG000|Main Treatment Period|Reason Not Specified|8|||
125525836|NCT02165826|451555651|FG001|Main Treatment Period|Reason Not Specified|5|||
125525837|NCT02165826|451555652|FG002|Main Treatment Period|Reason Not Specified|16|||
125525838|NCT02165826|451555650|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
125525839|NCT02165826|451555651|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
125525840|NCT02165826|451555652|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
125525841|NCT02165826|451555650|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
125525842|NCT02165826|451555651|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
125525843|NCT02165826|451555652|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
125525844|NCT02165826|451555650|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
125525845|NCT02165826|451555651|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
125525846|NCT02165826|451555652|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
125525847|NCT02165826|451555650|FG000|Down-Titration Period|Reason Not Specified|1|||
125525848|NCT02165826|451555651|FG001|Down-Titration Period|Reason Not Specified|0|||
125525849|NCT02165826|451555652|FG002|Down-Titration Period|Reason Not Specified|2|||
125525850|NCT00250432|451555657|FG000|Overall Study|Adverse Event|25|||
125525851|NCT00250432|451555658|FG001|Overall Study|Adverse Event|29|||
125525852|NCT00250432|451555657|FG000|Overall Study|Lack of Efficacy|2|||
125525853|NCT00250432|451555658|FG001|Overall Study|Lack of Efficacy|1|||
125525854|NCT00250432|451555657|FG000|Overall Study|Lost to Follow-up|6|||
125525855|NCT00250432|451555658|FG001|Overall Study|Lost to Follow-up|5|||
125525856|NCT00250432|451555657|FG000|Overall Study|Patient Moved|0|||
125525857|NCT00250432|451555658|FG001|Overall Study|Patient Moved|1|||
125525858|NCT00250432|451555657|FG000|Overall Study|Protocol Violation|0|||
125525859|NCT00250432|451555658|FG001|Overall Study|Protocol Violation|3|||
125525860|NCT00250432|451555657|FG000|Overall Study|Withdrawal by Subject|6|||
125525861|NCT00250432|451555658|FG001|Overall Study|Withdrawal by Subject|2|||
125525862|NCT00250432|451555657|FG000|Overall Study|Pt died out of posttherapy report period|6|||
125525863|NCT00250432|451555658|FG001|Overall Study|Pt died out of posttherapy report period|5|||
125525864|NCT00250432|451555657|FG000|Overall Study|Pt was considered untreatable|0|||
125525865|NCT00250432|451555658|FG001|Overall Study|Pt was considered untreatable|1|||
125525866|NCT00658606|451555661|FG000|Overall Study|Adverse Event|2|||
125525867|NCT00658606|451555662|FG001|Overall Study|Adverse Event|1|||
125525868|NCT00658606|451555661|FG000|Overall Study|Lack of Efficacy|6|||
125525869|NCT00658606|451555662|FG001|Overall Study|Lack of Efficacy|3|||
125525870|NCT00658606|451555661|FG000|Overall Study|Lost to Follow-up|1|||
125525871|NCT00658606|451555662|FG001|Overall Study|Lost to Follow-up|0|||
125525872|NCT00658606|451555661|FG000|Overall Study|Withdrawal by Subject|7|||
125525873|NCT00658606|451555662|FG001|Overall Study|Withdrawal by Subject|16|||
125525874|NCT00658606|451555661|FG000|Overall Study|Lack of Compliance|0|||
125525875|NCT00658606|451555662|FG001|Overall Study|Lack of Compliance|3|||
125525876|NCT00365547|451555665|FG000|Overall Study|Insurance did not cover Avastin|1|||
125525877|NCT00365547|451555665|FG000|Overall Study|Screen failure|1|||
125525878|NCT00365547|451555665|FG000|Overall Study|Withdrawal by Subject|1|||
125525879|NCT03023423|451555666|FG000|Overall Study|Death|5|||
125525880|NCT03023423|451555667|FG001|Overall Study|Death|12|||
125525881|NCT03023423|451555668|FG002|Overall Study|Death|20|||
125525882|NCT03023423|451555666|FG000|Overall Study|Other|0|||
125525883|NCT03023423|451555667|FG001|Overall Study|Other|2|||
125525884|NCT03023423|451555668|FG002|Overall Study|Other|2|||
125525885|NCT03023423|451555666|FG000|Overall Study|Ongoing|2|||
125525886|NCT03023423|451555667|FG001|Overall Study|Ongoing|32|||
125525887|NCT03023423|451555668|FG002|Overall Study|Ongoing|24|||
125525888|NCT03512197|451555669|FG000|Overall Study|Guardian decision|1|||
125525889|NCT03512197|451555670|FG001|Overall Study|Guardian decision|1|||
125525890|NCT03512197|451555669|FG000|Overall Study|Lack of Efficacy|19|||
125525891|NCT03512197|451555670|FG001|Overall Study|Lack of Efficacy|11|||
125525892|NCT03512197|451555669|FG000|Overall Study|New Therapy for Study Indication|16|||
125525893|NCT03512197|451555670|FG001|Overall Study|New Therapy for Study Indication|16|||
125525894|NCT03512197|451555669|FG000|Overall Study|Physician Decision|60|||
125525895|NCT03512197|451555670|FG001|Overall Study|Physician Decision|60|||
125525896|NCT03512197|451555669|FG000|Overall Study|Protocol Violation|0|||
125525897|NCT03512197|451555670|FG001|Overall Study|Protocol Violation|2|||
125525898|NCT03512197|451555669|FG000|Overall Study|Terminated by Sponsored|46|||
125525899|NCT03512197|451555670|FG001|Overall Study|Terminated by Sponsored|50|||
125525900|NCT03512197|451555669|FG000|Overall Study|Subject Decision|15|||
125525901|NCT03512197|451555670|FG001|Overall Study|Subject Decision|12|||
125525902|NCT03512197|451555669|FG000|Overall Study|Withdrawal of informed consent|20|||
125525903|NCT03512197|451555670|FG001|Overall Study|Withdrawal of informed consent|14|||
125525904|NCT03512197|451555669|FG000|Overall Study|Adverse Event|30|||
125525905|NCT03512197|451555670|FG001|Overall Study|Adverse Event|34|||
125525906|NCT03512197|451555669|FG000|Overall Study|Death|14|||
125525907|NCT03512197|451555670|FG001|Overall Study|Death|9|||
125525908|NCT03512197|451555669|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
125525909|NCT03512197|451555670|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
125525910|NCT03512197|451555669|FG000|Overall Study|Missing|3|||
125525911|NCT03512197|451555670|FG001|Overall Study|Missing|13|||
125525912|NCT03842436|451555671|FG000|Overall Study|Lost to Follow-up|1|||
125525913|NCT02201901|451555674|FG000|Overall Study|Randomized but never treated|0|||
125525914|NCT02201901|451555675|FG001|Overall Study|Randomized but never treated|1|||
125525915|NCT02201901|451555676|FG002|Overall Study|Randomized but never treated|0|||
125525916|NCT02201901|451555674|FG000|Overall Study|Lack of Efficacy|7|||
125525917|NCT02201901|451555675|FG001|Overall Study|Lack of Efficacy|1|||
125525918|NCT02201901|451555676|FG002|Overall Study|Lack of Efficacy|6|||
125525919|NCT02201901|451555674|FG000|Overall Study|Death|3|||
125525920|NCT02201901|451555675|FG001|Overall Study|Death|3|||
125525921|NCT02201901|451555676|FG002|Overall Study|Death|3|||
125525922|NCT02201901|451555674|FG000|Overall Study|Lost to Follow-up|2|||
125525923|NCT02201901|451555675|FG001|Overall Study|Lost to Follow-up|3|||
125525924|NCT02201901|451555676|FG002|Overall Study|Lost to Follow-up|2|||
125525925|NCT02201901|451555674|FG000|Overall Study|Withdrew Consent|2|||
125525926|NCT02201901|451555675|FG001|Overall Study|Withdrew Consent|0|||
125525927|NCT02201901|451555676|FG002|Overall Study|Withdrew Consent|2|||
125525928|NCT02201901|451555674|FG000|Overall Study|Adverse Event|1|||
125525929|NCT02201901|451555675|FG001|Overall Study|Adverse Event|1|||
125525930|NCT02201901|451555676|FG002|Overall Study|Adverse Event|0|||
125525931|NCT00490698|451555679|FG000|Overall Study|Withdrawal by Subject|1|||
125525932|NCT00490698|451555679|FG000|Overall Study|Disease Progression|7|||
125525933|NCT00490698|451555679|FG000|Overall Study|Physician Decision|2|||
125525934|NCT03358238|451555683|FG000|Overall Study|Withdrawal by Subject|0|||
125525935|NCT03358238|451555684|FG001|Overall Study|Withdrawal by Subject|1|||
125525936|NCT04277507|451555685|FG000|Overall Study|Lost to Follow-up|17|||
125525937|NCT04277507|451555685|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
125525938|NCT04277507|451555685|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
125525939|NCT04277507|451555685|FG000|Overall Study|Withdrawal by Subject|3|||
125525940|NCT04277507|451555685|FG000|Overall Study|Death due to COVID-19|1|||
125525941|NCT04277507|451555685|FG000|Overall Study|Data missing for full evaluation|5|||
125525942|NCT01431950|451555686|FG000|Overall Study|Study Site Closed/Terminated|7|||
125525943|NCT01431950|451555687|FG001|Overall Study|Study Site Closed/Terminated|3|||
125525944|NCT01431950|451555686|FG000|Overall Study|Withdrawal by Subject|4|||
125525945|NCT01431950|451555687|FG001|Overall Study|Withdrawal by Subject|3|||
125525946|NCT01431950|451555686|FG000|Overall Study|Protocol Violation|2|||
125525947|NCT01431950|451555687|FG001|Overall Study|Protocol Violation|3|||
125525948|NCT01431950|451555686|FG000|Overall Study|Adverse Event|2|||
125525949|NCT01431950|451555687|FG001|Overall Study|Adverse Event|2|||
125525950|NCT01431950|451555686|FG000|Overall Study|Physician Decision|2|||
125525951|NCT01431950|451555687|FG001|Overall Study|Physician Decision|1|||
125525952|NCT01431950|451555686|FG000|Overall Study|Lack of Efficacy|2|||
125525953|NCT01431950|451555687|FG001|Overall Study|Lack of Efficacy|1|||
125525954|NCT01431950|451555686|FG000|Overall Study|Lost to Follow-up|0|||
125525955|NCT01431950|451555687|FG001|Overall Study|Lost to Follow-up|1|||
125525956|NCT01431950|451555686|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
125525957|NCT01431950|451555687|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
125525958|NCT04577573|451555690|FG000|Overall Study|Technical - invalid protocol|0|||
125525959|NCT04577573|451555691|FG001|Overall Study|Technical - invalid protocol|2|||
125525960|NCT04577573|451555692|FG002|Overall Study|Technical - invalid protocol|0|||
125525961|NCT06719986|451555693|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
125525962|NCT06719986|451555694|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
125525963|NCT06719986|451555695|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
125525964|NCT06719986|451555693|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
125525965|NCT06719986|451555694|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
125525966|NCT06719986|451555695|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
125525967|NCT05992922|451555697|FG000|Overall Study|Adverse Event|6|||
125525968|NCT05992922|451555698|FG001|Overall Study|Adverse Event|0|||
125525969|NCT05992922|451555697|FG000|Overall Study|Sponsor Termination of Study|14|||
125525970|NCT05992922|451555698|FG001|Overall Study|Sponsor Termination of Study|20|||
125525971|NCT04596995|451557018|FG000|Overall Study|Lack of Efficacy|8|||
125525972|NCT04596995|451557018|FG000|Overall Study|Lost to Follow-up|3|||
125525973|NCT04596995|451557018|FG000|Overall Study|Withdrawal by Subject|12|||
125525974|NCT04596995|451557018|FG000|Overall Study|Sponsor decision|3|||
125525975|NCT04596995|451557018|FG000|Overall Study|Enrolled in managed access program|3|||
125525976|NCT00590564|451557020|FG000|Overall Study|Withdrawal by Subject|4|||
125525977|NCT00590564|451557020|FG000|Overall Study|Lost to Follow-up|6|||
125525978|NCT00590564|451557020|FG000|Overall Study|Protocol Violation|1|||
125525979|NCT00590564|451557020|FG000|Overall Study|Patient Found to be Ineligible|1|||
125525980|NCT00590564|451557020|FG000|Overall Study|Patient Non-compliance|6|||
125525981|NCT01434680|451557021|FG000|Overall Study|Withdrawal by Subject|1|||
125525982|NCT01434680|451557022|FG001|Overall Study|Withdrawal by Subject|0|||
125525983|NCT01434680|451557023|FG002|Overall Study|Withdrawal by Subject|2|||
125525984|NCT01434680|451557024|FG003|Overall Study|Withdrawal by Subject|0|||
125525985|NCT01434680|451557021|FG000|Overall Study|Lost to Follow-up|1|||
125525986|NCT01434680|451557022|FG001|Overall Study|Lost to Follow-up|1|||
125525987|NCT01434680|451557023|FG002|Overall Study|Lost to Follow-up|0|||
125525988|NCT01434680|451557024|FG003|Overall Study|Lost to Follow-up|0|||
125525989|NCT01434680|451557021|FG000|Overall Study|Protocol Violation|1|||
125525990|NCT01434680|451557022|FG001|Overall Study|Protocol Violation|1|||
125525991|NCT01434680|451557023|FG002|Overall Study|Protocol Violation|0|||
125525992|NCT01434680|451557024|FG003|Overall Study|Protocol Violation|0|||
125525993|NCT00983749|451557027|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
125525994|NCT00983749|451557028|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
125525995|NCT01952847|451557029|FG000|Overall Study|Ineligible|1|||
125525996|NCT01952847|451557030|FG001|Overall Study|Ineligible|0|||
125525997|NCT01952847|451557031|FG002|Overall Study|Ineligible|0|||
125525998|NCT01952847|451557032|FG003|Overall Study|Ineligible|0|||
125525999|NCT01952847|451557029|FG000|Overall Study|Lack of Insurance Coverage|0|||
125526000|NCT01952847|451557030|FG001|Overall Study|Lack of Insurance Coverage|1|||
125526001|NCT01952847|451557031|FG002|Overall Study|Lack of Insurance Coverage|0|||
125526002|NCT01952847|451557032|FG003|Overall Study|Lack of Insurance Coverage|0|||
125526003|NCT01952847|451557029|FG000|Overall Study|Withdrawal by Subject|1|||
125526004|NCT01952847|451557030|FG001|Overall Study|Withdrawal by Subject|1|||
125526005|NCT01952847|451557031|FG002|Overall Study|Withdrawal by Subject|0|||
125526006|NCT01952847|451557032|FG003|Overall Study|Withdrawal by Subject|1|||
125526007|NCT01907906|451557033|FG000|Overall Study|Withdrawal by Subject|1|||
125526008|NCT01907906|451557034|FG001|Overall Study|Withdrawal by Subject|0|||
125526009|NCT01907906|451557033|FG000|Overall Study|Physician Decision|3|||
125526010|NCT01907906|451557034|FG001|Overall Study|Physician Decision|1|||
125526011|NCT00490945|451557036|FG000|Overall Study|Adverse Event|0|||
125526012|NCT00490945|451557037|FG001|Overall Study|Adverse Event|1|||
125526013|NCT00490945|451557038|FG002|Overall Study|Adverse Event|0|||
125526014|NCT00490945|451557039|FG003|Overall Study|Adverse Event|0|||
125526015|NCT00490945|451557040|FG004|Overall Study|Adverse Event|0|||
125526016|NCT03334253|451557041|FG000|Overall Study|Withdrawal by Subject|1|||
125526017|NCT03334253|451557042|FG001|Overall Study|Withdrawal by Subject|0|||
125526018|NCT03334253|451557041|FG000|Overall Study|Lost to Follow-up|4|||
125526019|NCT03334253|451557042|FG001|Overall Study|Lost to Follow-up|3|||
125526020|NCT03334253|451557041|FG000|Overall Study|Moved residence|2|||
125526021|NCT03334253|451557042|FG001|Overall Study|Moved residence|2|||
125526022|NCT00203047|451557043|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
125526023|NCT00203047|451557044|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
125526024|NCT00203047|451557043|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
125526025|NCT00203047|451557044|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
125526026|NCT00203047|451557043|FG000|Overall Study|Withdrawal by Subject|13|||
125526027|NCT00203047|451557044|FG001|Overall Study|Withdrawal by Subject|47|||
125526028|NCT00203047|451557043|FG000|Overall Study|Teva requested participant withdrawal|1|||
125526029|NCT00203047|451557044|FG001|Overall Study|Teva requested participant withdrawal|1|||
125526030|NCT00203047|451557043|FG000|Overall Study|Physician Decision|8|||
125526031|NCT00203047|451557044|FG001|Overall Study|Physician Decision|7|||
125526032|NCT00203047|451557043|FG000|Overall Study|Non-compliance|4|||
125526033|NCT00203047|451557044|FG001|Overall Study|Non-compliance|8|||
125526034|NCT00203047|451557043|FG000|Overall Study|Protocol Violation|1|||
125526035|NCT00203047|451557044|FG001|Overall Study|Protocol Violation|0|||
125526036|NCT00203047|451557043|FG000|Overall Study|Lost to Follow-up|11|||
125526037|NCT00203047|451557044|FG001|Overall Study|Lost to Follow-up|5|||
125526038|NCT00203047|451557043|FG000|Overall Study|Adverse Event|8|||
125526039|NCT00203047|451557044|FG001|Overall Study|Adverse Event|18|||
125526040|NCT00203047|451557043|FG000|Overall Study|Death|1|||
125526041|NCT00203047|451557044|FG001|Overall Study|Death|2|||
125526042|NCT00203047|451557043|FG000|Overall Study|Pregnancy|3|||
125526043|NCT00203047|451557044|FG001|Overall Study|Pregnancy|0|||
125526044|NCT00203047|451557043|FG000|Overall Study|Other|5|||
125526045|NCT00203047|451557044|FG001|Overall Study|Other|5|||
125526046|NCT00340704|451557047|FG000|PK Study|Adverse Event|0|||
125526047|NCT00340704|451557048|FG001|PK Study|Adverse Event|1|||
125526048|NCT00340704|451557049|FG002|PK Study|Adverse Event|0|||
125526049|NCT00340704|451557050|FG003|PK Study|Adverse Event|0|||
125526050|NCT00340704|451557051|FG004|PK Study|Adverse Event|0|||
125526051|NCT00340704|451557052|FG005|PK Study|Adverse Event|0|||
125526052|NCT00340704|451557053|FG006|PK Study|Adverse Event|0|||
125526053|NCT00340704|451557054|FG007|PK Study|Adverse Event|0|||
125526054|NCT00340704|451557055|FG008|PK Study|Adverse Event|0|||
125526055|NCT00340704|451557047|FG000|PK Study|Not treated|0|||
125526056|NCT00340704|451557048|FG001|PK Study|Not treated|0|||
125526057|NCT00340704|451557049|FG002|PK Study|Not treated|1|||
125526058|NCT00340704|451557050|FG003|PK Study|Not treated|0|||
125526059|NCT00340704|451557051|FG004|PK Study|Not treated|0|||
125526060|NCT00340704|451557052|FG005|PK Study|Not treated|0|||
125526061|NCT00340704|451557053|FG006|PK Study|Not treated|0|||
125526062|NCT00340704|451557054|FG007|PK Study|Not treated|0|||
125526063|NCT00340704|451557055|FG008|PK Study|Not treated|0|||
125526064|NCT00340704|451557047|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
125526065|NCT00340704|451557048|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
125526066|NCT00340704|451557049|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
125526067|NCT00340704|451557050|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
125526068|NCT00340704|451557051|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
125526069|NCT00340704|451557052|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
125526070|NCT00340704|451557053|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
125526071|NCT00340704|451557054|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
125526072|NCT00340704|451557055|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
125526073|NCT00340704|451557047|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
125526074|NCT00340704|451557048|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
125526075|NCT00340704|451557049|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
125526076|NCT00340704|451557050|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
125526077|NCT00340704|451557051|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
125526078|NCT00340704|451557052|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
125526079|NCT00340704|451557053|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
125526080|NCT00340704|451557054|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
125526081|NCT00340704|451557055|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
125526082|NCT00340704|451557047|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
125526083|NCT00340704|451557048|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
125526084|NCT00340704|451557049|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
125526085|NCT00340704|451557050|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
125526086|NCT00340704|451557051|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
125526087|NCT00340704|451557052|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
125526088|NCT00340704|451557053|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
125526089|NCT00340704|451557054|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
125526090|NCT00340704|451557055|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
125526091|NCT00340704|451557047|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
125526092|NCT00340704|451557048|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
125526093|NCT00340704|451557049|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
125526094|NCT00340704|451557050|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
125526095|NCT00340704|451557051|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
125526096|NCT00340704|451557052|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
125526097|NCT00340704|451557053|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
125526098|NCT00340704|451557054|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
125526099|NCT00340704|451557055|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
125526100|NCT00121667|451557056|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
125526101|NCT00121667|451557057|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
125526102|NCT00121667|451557058|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
125526103|NCT00121667|451557059|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
125526104|NCT00121667|451557056|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
125526105|NCT00121667|451557057|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
125526106|NCT00121667|451557058|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
125526107|NCT00121667|451557059|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
125526108|NCT00121667|451557056|FG000|Short Term (ST) Period|Adverse Event|5|||
125526109|NCT00121667|451557057|FG001|Short Term (ST) Period|Adverse Event|6|||
125526110|NCT00121667|451557058|FG002|Short Term (ST) Period|Adverse Event|5|||
125526111|NCT00121667|451557059|FG003|Short Term (ST) Period|Adverse Event|3|||
125526112|NCT00121667|451557056|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
125526113|NCT00121667|451557057|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
125526114|NCT00121667|451557058|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
125526115|NCT00121667|451557059|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
125526116|NCT00121667|451557056|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
125526117|NCT00121667|451557057|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
125526118|NCT00121667|451557058|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
125526119|NCT00121667|451557059|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
125526120|NCT00121667|451557056|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
125526121|NCT00121667|451557057|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
125526122|NCT00121667|451557058|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
125526123|NCT00121667|451557059|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
125526124|NCT00121667|451557056|FG000|Short Term (ST) Period|Other Reason|3|||
125526125|NCT00121667|451557057|FG001|Short Term (ST) Period|Other Reason|0|||
125526126|NCT00121667|451557058|FG002|Short Term (ST) Period|Other Reason|0|||
125526127|NCT00121667|451557059|FG003|Short Term (ST) Period|Other Reason|0|||
125526128|NCT00121667|451557056|FG000|Short Term (ST) Period|Death|0|||
125526129|NCT00121667|451557057|FG001|Short Term (ST) Period|Death|0|||
125526130|NCT00121667|451557058|FG002|Short Term (ST) Period|Death|0|||
125526131|NCT00121667|451557059|FG003|Short Term (ST) Period|Death|1|||
125526132|NCT00121667|451557056|FG000|Short Term (ST) Period|Pregnancy|0|||
125526133|NCT00121667|451557057|FG001|Short Term (ST) Period|Pregnancy|0|||
125526134|NCT00121667|451557058|FG002|Short Term (ST) Period|Pregnancy|0|||
125526135|NCT00121667|451557059|FG003|Short Term (ST) Period|Pregnancy|1|||
125526136|NCT00121667|451557056|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
125526137|NCT00121667|451557057|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
125526138|NCT00121667|451557058|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
125526139|NCT00121667|451557059|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
125526140|NCT00121667|451557056|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
125526141|NCT00121667|451557057|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
125526142|NCT00121667|451557058|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
125526143|NCT00121667|451557059|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
125526144|NCT00121667|451557056|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
125526145|NCT00121667|451557057|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
125526146|NCT00121667|451557058|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
125526147|NCT00121667|451557059|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
125526148|NCT00121667|451557056|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
125526149|NCT00121667|451557057|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
125526150|NCT00121667|451557058|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
125526151|NCT00121667|451557059|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
125526152|NCT00121667|451557056|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
125526153|NCT00121667|451557057|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
125526154|NCT00121667|451557058|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
125526155|NCT00121667|451557059|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
125526156|NCT00121667|451557056|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
125526157|NCT00121667|451557057|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
125526158|NCT00121667|451557058|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
125526159|NCT00121667|451557059|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
125526160|NCT00121667|451557056|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
125526161|NCT00121667|451557057|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
125526162|NCT00121667|451557058|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
125526163|NCT00121667|451557059|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
125526164|NCT00121667|451557056|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
125526165|NCT00121667|451557057|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
125526166|NCT00121667|451557058|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
125526167|NCT00121667|451557059|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
125526168|NCT00121667|451557056|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
125526169|NCT00121667|451557057|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
125526170|NCT00121667|451557058|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
125526171|NCT00121667|451557059|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
125526172|NCT01453023|451557060|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
125526173|NCT01453023|451557061|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
125526174|NCT01453023|451557060|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
125526175|NCT01453023|451557061|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
125526176|NCT01453023|451557060|FG000|Treatment Period 2|Protocol Violation|0|||
125526177|NCT01453023|451557061|FG001|Treatment Period 2|Protocol Violation|1|||
125526178|NCT02879383|451557062|FG000|First 24 Weeks|Physician Decision|0|||
125526179|NCT02879383|451557063|FG001|First 24 Weeks|Physician Decision|1|||
125526180|NCT02879383|451557064|FG002|First 24 Weeks|Physician Decision|0|||
125526181|NCT02879383|451557065|FG003|First 24 Weeks|Physician Decision|0|||
125526182|NCT02413593|451557079|FG000|Overall Study|Lost to Follow-up|3|||
125526183|NCT02413593|451557079|FG000|Overall Study|Adverse Event|1|||
125526184|NCT00723125|451557080|FG000|Overall Study|Met Dx|1|||
125526185|NCT00723125|451557081|FG001|Overall Study|Met Dx|0|||
125526186|NCT00723125|451557080|FG000|Overall Study|Withdrawal by Subject|15|||
125526187|NCT00723125|451557081|FG001|Overall Study|Withdrawal by Subject|6|||
125526188|NCT00723125|451557080|FG000|Overall Study|Adverse Event|2|||
125526189|NCT00723125|451557081|FG001|Overall Study|Adverse Event|0|||
125526190|NCT03482752|451557085|FG000|Overall Study|Withdrawal by Subject|2|||
125526191|NCT03482752|451557085|FG000|Overall Study|Lost to Follow-up|1|||
125526192|NCT03482752|451557085|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
125526193|NCT01080300|451557087|FG000|Overall Study|Adverse Event|49|||
125526194|NCT01080300|451557088|FG001|Overall Study|Adverse Event|35|||
125526195|NCT01080300|451557087|FG000|Overall Study|Lack of Efficacy|12|||
125526196|NCT01080300|451557088|FG001|Overall Study|Lack of Efficacy|15|||
125526197|NCT01080300|451557087|FG000|Overall Study|Protocol Violation|7|||
125526198|NCT01080300|451557088|FG001|Overall Study|Protocol Violation|13|||
125526199|NCT01080300|451557087|FG000|Overall Study|Lost to Follow-up|10|||
125526200|NCT01080300|451557088|FG001|Overall Study|Lost to Follow-up|6|||
125526201|NCT01080300|451557087|FG000|Overall Study|Death|0|||
125526202|NCT01080300|451557088|FG001|Overall Study|Death|1|||
125526203|NCT01080300|451557087|FG000|Overall Study|Withdrawal by Subject|12|||
125526204|NCT01080300|451557088|FG001|Overall Study|Withdrawal by Subject|28|||
125526205|NCT01080300|451557087|FG000|Overall Study|Reasons not specified|4|||
125526206|NCT01080300|451557088|FG001|Overall Study|Reasons not specified|6|||
125526207|NCT01807182|451557089|FG000|Overall Study|Death|1|||
125526208|NCT01807182|451557089|FG000|Overall Study|New therapy|1|||
125526209|NCT01807182|451557089|FG000|Overall Study|Moved to hospice care|1|||
125526210|NCT01776008|451557091|FG000|Overall Study|ineligible|2|||
125526211|NCT00478205|451557093|FG000|Overall Study|Adverse Event|182|||
125526212|NCT00478205|451557094|FG001|Overall Study|Adverse Event|39|||
125526213|NCT00478205|451557093|FG000|Overall Study|Medication Non-compliance|9|||
125526214|NCT00478205|451557094|FG001|Overall Study|Medication Non-compliance|4|||
125526215|NCT00478205|451557093|FG000|Overall Study|Protocol Violation|15|||
125526216|NCT00478205|451557094|FG001|Overall Study|Protocol Violation|5|||
125526217|NCT00478205|451557093|FG000|Overall Study|Request of Investigator or Sponsor|4|||
125526218|NCT00478205|451557094|FG001|Overall Study|Request of Investigator or Sponsor|5|||
125526219|NCT00478205|451557093|FG000|Overall Study|Withdrawal by Subject|61|||
125526220|NCT00478205|451557094|FG001|Overall Study|Withdrawal by Subject|22|||
125526221|NCT00478205|451557093|FG000|Overall Study|Lack of Efficacy|1|||
125526222|NCT00478205|451557094|FG001|Overall Study|Lack of Efficacy|0|||
125526223|NCT00478205|451557093|FG000|Overall Study|Other|24|||
125526224|NCT00478205|451557094|FG001|Overall Study|Other|12|||
125526225|NCT03513068|451557095|FG000|Overall Study|Death|1|||
125526226|NCT03513068|451557096|FG001|Overall Study|Death|0|||
125526227|NCT03513068|451557095|FG000|Overall Study|Withdrawal by Subject|4|||
125526228|NCT03513068|451557096|FG001|Overall Study|Withdrawal by Subject|6|||
125526229|NCT00003477|451557099|FG000|Overall Study|Not evalauable|4|||
125526230|NCT01575873|451557100|FG000|Overall Study|Withdrawal by Subject|15|||
125526231|NCT01575873|451557101|FG001|Overall Study|Withdrawal by Subject|20|||
125526232|NCT01575873|451557102|FG002|Overall Study|Withdrawal by Subject|34|||
125526233|NCT01575873|451557103|FG003|Overall Study|Withdrawal by Subject|34|||
125526234|NCT01575873|451557100|FG000|Overall Study|Adverse Event|7|||
125526235|NCT01575873|451557101|FG001|Overall Study|Adverse Event|7|||
125526236|NCT01575873|451557102|FG002|Overall Study|Adverse Event|9|||
125526237|NCT01575873|451557103|FG003|Overall Study|Adverse Event|12|||
125526238|NCT01575873|451557100|FG000|Overall Study|Lost to Follow-up|1|||
125526239|NCT01575873|451557101|FG001|Overall Study|Lost to Follow-up|3|||
125526240|NCT01575873|451557102|FG002|Overall Study|Lost to Follow-up|13|||
125526241|NCT01575873|451557103|FG003|Overall Study|Lost to Follow-up|5|||
125526242|NCT01575873|451557100|FG000|Overall Study|Death|3|||
125526243|NCT01575873|451557101|FG001|Overall Study|Death|2|||
125526244|NCT01575873|451557102|FG002|Overall Study|Death|8|||
125526245|NCT01575873|451557103|FG003|Overall Study|Death|9|||
125526246|NCT01575873|451557100|FG000|Overall Study|Noncompliance|1|||
125526247|NCT01575873|451557101|FG001|Overall Study|Noncompliance|2|||
125526248|NCT01575873|451557102|FG002|Overall Study|Noncompliance|4|||
125526249|NCT01575873|451557103|FG003|Overall Study|Noncompliance|3|||
125526250|NCT01575873|451557100|FG000|Overall Study|Administrative decision|1|||
125526251|NCT01575873|451557101|FG001|Overall Study|Administrative decision|1|||
125526252|NCT01575873|451557102|FG002|Overall Study|Administrative decision|1|||
125526253|NCT01575873|451557103|FG003|Overall Study|Administrative decision|0|||
125526254|NCT01575873|451557100|FG000|Overall Study|Protocol deviation|0|||
125526255|NCT01575873|451557101|FG001|Overall Study|Protocol deviation|1|||
125526256|NCT01575873|451557102|FG002|Overall Study|Protocol deviation|0|||
125526257|NCT01575873|451557103|FG003|Overall Study|Protocol deviation|1|||
125526258|NCT01575873|451557100|FG000|Overall Study|Requirement for Alternative Therapy|0|||
125526259|NCT01575873|451557101|FG001|Overall Study|Requirement for Alternative Therapy|0|||
125526260|NCT01575873|451557102|FG002|Overall Study|Requirement for Alternative Therapy|1|||
125526261|NCT01575873|451557103|FG003|Overall Study|Requirement for Alternative Therapy|1|||
125526262|NCT01575873|451557100|FG000|Overall Study|Other|0|||
125526263|NCT01575873|451557101|FG001|Overall Study|Other|0|||
125526264|NCT01575873|451557102|FG002|Overall Study|Other|4|||
125526265|NCT01575873|451557103|FG003|Overall Study|Other|2|||
125526266|NCT01850030|451557104|FG000|Overall Study|Adverse Event|64|||
125526267|NCT01850030|451557105|FG001|Overall Study|Adverse Event|82|||
125526268|NCT01850030|451557104|FG000|Overall Study|Lack of Efficacy|3|||
125526269|NCT01850030|451557105|FG001|Overall Study|Lack of Efficacy|1|||
125526270|NCT01850030|451557104|FG000|Overall Study|Lost to Follow-up|5|||
125526271|NCT01850030|451557105|FG001|Overall Study|Lost to Follow-up|5|||
125526272|NCT01850030|451557104|FG000|Overall Study|Withdrawal by Subject|3|||
125526273|NCT01850030|451557105|FG001|Overall Study|Withdrawal by Subject|4|||
125526274|NCT01850030|451557104|FG000|Overall Study|Protocol Violation|24|||
125526275|NCT01850030|451557105|FG001|Overall Study|Protocol Violation|28|||
125526276|NCT01850030|451557104|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
125526277|NCT01850030|451557105|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
125526278|NCT00762476|451557106|FG000|Overall Study|Adverse Event|7|||
125526279|NCT00762476|451557107|FG001|Overall Study|Adverse Event|1|||
125526280|NCT00762476|451557106|FG000|Overall Study|Lost to Follow-up|2|||
125526281|NCT00762476|451557107|FG001|Overall Study|Lost to Follow-up|0|||
125526282|NCT00762476|451557106|FG000|Overall Study|Protocol Violation|5|||
125526283|NCT00762476|451557107|FG001|Overall Study|Protocol Violation|6|||
125526284|NCT00762476|451557106|FG000|Overall Study|Physician Decision|2|||
125526285|NCT00762476|451557107|FG001|Overall Study|Physician Decision|14|||
125526286|NCT00762476|451557106|FG000|Overall Study|Withdrawal by Subject|6|||
125526287|NCT00762476|451557107|FG001|Overall Study|Withdrawal by Subject|12|||
125526288|NCT00762476|451557106|FG000|Overall Study|antibiotic use|0|||
125526289|NCT00762476|451557107|FG001|Overall Study|antibiotic use|1|||
125526290|NCT00762476|451557106|FG000|Overall Study|non-compliance with study visits|0|||
125526291|NCT00762476|451557107|FG001|Overall Study|non-compliance with study visits|2|||
125526292|NCT00762476|451557106|FG000|Overall Study|Seasonal allergies|1|||
125526293|NCT00762476|451557107|FG001|Overall Study|Seasonal allergies|0|||
125526294|NCT00965497|451557108|FG000|Overall Study|Physician Decision|1|||
125526295|NCT00953615|451557110|FG000|Overall Study|Adverse Event|1|||
125526296|NCT01299480|451557111|FG000|Overall Study|No longer willing to participate|19|||
125526297|NCT01299480|451557112|FG001|Overall Study|No longer willing to participate|17|||
125526298|NCT01299480|451557113|FG002|Overall Study|No longer willing to participate|14|||
125526299|NCT01299480|451557114|FG003|Overall Study|No longer willing to participate|13|||
125526300|NCT01299480|451557115|FG004|Overall Study|No longer willing to participate|10|||
125526301|NCT01299480|451557111|FG000|Overall Study|Protocol Violation|7|||
125526302|NCT01299480|451557112|FG001|Overall Study|Protocol Violation|5|||
125526303|NCT01299480|451557113|FG002|Overall Study|Protocol Violation|8|||
125526304|NCT01299480|451557114|FG003|Overall Study|Protocol Violation|1|||
125526305|NCT01299480|451557115|FG004|Overall Study|Protocol Violation|1|||
125526306|NCT01299480|451557111|FG000|Overall Study|Withdrawal by Subject|3|||
125526307|NCT01299480|451557112|FG001|Overall Study|Withdrawal by Subject|4|||
125526308|NCT01299480|451557113|FG002|Overall Study|Withdrawal by Subject|7|||
125526309|NCT01299480|451557114|FG003|Overall Study|Withdrawal by Subject|3|||
125526310|NCT01299480|451557115|FG004|Overall Study|Withdrawal by Subject|4|||
125526311|NCT01299480|451557111|FG000|Overall Study|Adverse Event|6|||
125526312|NCT01299480|451557112|FG001|Overall Study|Adverse Event|4|||
125526313|NCT01299480|451557113|FG002|Overall Study|Adverse Event|5|||
125526314|NCT01299480|451557114|FG003|Overall Study|Adverse Event|4|||
125526315|NCT01299480|451557115|FG004|Overall Study|Adverse Event|0|||
125526316|NCT01299480|451557111|FG000|Overall Study|Withdrawal due to pregnancy|0|||
125526317|NCT01299480|451557112|FG001|Overall Study|Withdrawal due to pregnancy|1|||
125526318|NCT01299480|451557113|FG002|Overall Study|Withdrawal due to pregnancy|1|||
125526319|NCT01299480|451557114|FG003|Overall Study|Withdrawal due to pregnancy|0|||
125526320|NCT01299480|451557115|FG004|Overall Study|Withdrawal due to pregnancy|0|||
125526321|NCT01299480|451557111|FG000|Overall Study|Physician Decision|1|||
125526322|NCT01299480|451557112|FG001|Overall Study|Physician Decision|1|||
125526323|NCT01299480|451557113|FG002|Overall Study|Physician Decision|0|||
125526324|NCT01299480|451557114|FG003|Overall Study|Physician Decision|2|||
125526325|NCT01299480|451557115|FG004|Overall Study|Physician Decision|0|||
125526326|NCT01299480|451557111|FG000|Overall Study|Lost to Follow-up|3|||
125526327|NCT01299480|451557112|FG001|Overall Study|Lost to Follow-up|1|||
125526328|NCT01299480|451557113|FG002|Overall Study|Lost to Follow-up|2|||
125526329|NCT01299480|451557114|FG003|Overall Study|Lost to Follow-up|1|||
125526330|NCT01299480|451557115|FG004|Overall Study|Lost to Follow-up|2|||
125526331|NCT01299480|451557111|FG000|Overall Study|Other|3|||
125526332|NCT01299480|451557112|FG001|Overall Study|Other|2|||
125526333|NCT01299480|451557113|FG002|Overall Study|Other|3|||
125526334|NCT01299480|451557114|FG003|Overall Study|Other|0|||
125526335|NCT01299480|451557115|FG004|Overall Study|Other|3|||
125526336|NCT01299480|451557111|FG000|Overall Study|Started, but not vaccinated|0|||
125526337|NCT01299480|451557112|FG001|Overall Study|Started, but not vaccinated|0|||
125526338|NCT01299480|451557113|FG002|Overall Study|Started, but not vaccinated|1|||
125526339|NCT01299480|451557114|FG003|Overall Study|Started, but not vaccinated|1|||
125526340|NCT01299480|451557115|FG004|Overall Study|Started, but not vaccinated|0|||
125526341|NCT04547023|451557124|FG000|Overall Study|Did Not Receive Intervention|3|||
125526342|NCT04547023|451557125|FG001|Overall Study|Did Not Receive Intervention|2|||
125526343|NCT04547023|451557124|FG000|Overall Study|Lost to Follow-up|1|||
125526344|NCT04547023|451557125|FG001|Overall Study|Lost to Follow-up|1|||
125526345|NCT01011868|451557126|FG000|After Week 18 Follow-up|Adverse Event|8|||
125526346|NCT01011868|451557127|FG001|After Week 18 Follow-up|Adverse Event|6|||
125526347|NCT01011868|451557128|FG002|After Week 18 Follow-up|Adverse Event|13|||
125526348|NCT01011868|451557126|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
125526349|NCT01011868|451557127|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
125526350|NCT01011868|451557128|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
125526351|NCT01011868|451557126|FG000|After Week 18 Follow-up|Protocol Violation|1|||
125526352|NCT01011868|451557127|FG001|After Week 18 Follow-up|Protocol Violation|1|||
125526353|NCT01011868|451557128|FG002|After Week 18 Follow-up|Protocol Violation|1|||
125526354|NCT01011868|451557126|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
125526355|NCT01011868|451557127|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
125526356|NCT01011868|451557128|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
125526357|NCT01011868|451557126|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
125526358|NCT01011868|451557127|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
125526359|NCT01011868|451557128|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
125526360|NCT01011868|451557126|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
125526361|NCT01011868|451557127|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
125526362|NCT01011868|451557128|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
125526363|NCT01011868|451557126|FG000|After Week 78 Follow-up|Adverse Event|14|||
125526364|NCT01011868|451557127|FG001|After Week 78 Follow-up|Adverse Event|18|||
125526365|NCT01011868|451557128|FG002|After Week 78 Follow-up|Adverse Event|21|||
125526366|NCT01011868|451557126|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
125526367|NCT01011868|451557127|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
125526368|NCT01011868|451557128|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
125526369|NCT01011868|451557126|FG000|After Week 78 Follow-up|Protocol Violation|9|||
125526370|NCT01011868|451557127|FG001|After Week 78 Follow-up|Protocol Violation|1|||
125526371|NCT01011868|451557128|FG002|After Week 78 Follow-up|Protocol Violation|2|||
125526372|NCT01011868|451557126|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
125526373|NCT01011868|451557127|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
125526374|NCT01011868|451557128|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
125526375|NCT01011868|451557126|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
125526376|NCT01011868|451557127|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
125526377|NCT01011868|451557128|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
125526378|NCT01011868|451557126|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
125526379|NCT01011868|451557127|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
125526380|NCT01011868|451557128|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
125526381|NCT03784820|451557129|FG000|Overall Study|Lost to Follow-up|5|||
125526382|NCT03784820|451557130|FG001|Overall Study|Lost to Follow-up|5|||
125526383|NCT03784820|451557131|FG002|Overall Study|Lost to Follow-up|3|||
125526384|NCT03784820|451557132|FG003|Overall Study|Lost to Follow-up|3|||
125526385|NCT03170518|451557133|FG000|Overall Study|Lost to Follow-up|4|||
125526386|NCT03170518|451557134|FG001|Overall Study|Lost to Follow-up|1|||
125526387|NCT03170518|451557135|FG002|Overall Study|Lost to Follow-up|0|||
125526388|NCT03170518|451557133|FG000|Overall Study|Physician Decision|1|||
125526389|NCT03170518|451557134|FG001|Overall Study|Physician Decision|0|||
125526390|NCT03170518|451557135|FG002|Overall Study|Physician Decision|0|||
125526391|NCT03170518|451557133|FG000|Overall Study|Withdrawal by Subject|4|||
125526392|NCT03170518|451557134|FG001|Overall Study|Withdrawal by Subject|5|||
125526393|NCT03170518|451557135|FG002|Overall Study|Withdrawal by Subject|2|||
125526394|NCT03170518|451557133|FG000|Overall Study|Site terminated by sponsor|0|||
125526395|NCT03170518|451557134|FG001|Overall Study|Site terminated by sponsor|1|||
125526396|NCT03170518|451557135|FG002|Overall Study|Site terminated by sponsor|0|||
125526397|NCT03170518|451557133|FG000|Overall Study|Non-compliance with study drug|1|||
125526398|NCT03170518|451557134|FG001|Overall Study|Non-compliance with study drug|0|||
125526399|NCT03170518|451557135|FG002|Overall Study|Non-compliance with study drug|1|||
125526400|NCT03170518|451557133|FG000|Overall Study|Withdrawal by parent/guardian|2|||
125526401|NCT03170518|451557134|FG001|Overall Study|Withdrawal by parent/guardian|0|||
125526402|NCT03170518|451557135|FG002|Overall Study|Withdrawal by parent/guardian|0|||
125526403|NCT04428476|451557136|FG000|Overall Study|Withdrawal by Subject|1|||
125526404|NCT04428476|451557136|FG000|Overall Study|Still on treatment|12|||
125526405|NCT00546078|451557137|FG000|Overall Study|Lost to Follow-up|1|||
125526406|NCT00546078|451557138|FG001|Overall Study|Lost to Follow-up|3|||
125526407|NCT00546078|451557137|FG000|Overall Study|Withdrawal by Subject|2|||
125526408|NCT00546078|451557138|FG001|Overall Study|Withdrawal by Subject|3|||
125526409|NCT00546078|451557137|FG000|Overall Study|Other reason|1|||
125526410|NCT00546078|451557138|FG001|Overall Study|Other reason|1|||
125526411|NCT01261247|451557142|FG000|Overall Study|Ineligible|2|||
125526412|NCT02559310|451557143|FG000|Overall Study|Death|4|||
125526413|NCT02559310|451557144|FG001|Overall Study|Death|3|||
125526414|NCT02559310|451557143|FG000|Overall Study|Lost to Follow-up|5|||
125526415|NCT02559310|451557144|FG001|Overall Study|Lost to Follow-up|3|||
125526416|NCT02559310|451557143|FG000|Overall Study|Physician Decision|2|||
125526417|NCT02559310|451557144|FG001|Overall Study|Physician Decision|1|||
125526418|NCT02559310|451557143|FG000|Overall Study|Withdrawal by Subject|13|||
125526419|NCT02559310|451557144|FG001|Overall Study|Withdrawal by Subject|9|||
125526420|NCT02559310|451557143|FG000|Overall Study|Sponsor Decision|0|||
125526421|NCT02559310|451557144|FG001|Overall Study|Sponsor Decision|1|||
125526422|NCT02559310|451557143|FG000|Overall Study|Randomized but not treated|3|||
125526423|NCT02559310|451557144|FG001|Overall Study|Randomized but not treated|2|||
125526424|NCT01740154|451557145|FG000|Overall Study|Adverse Event|1|||
125526425|NCT02726945|451557147|FG000|Overall Study|Withdrawal by Subject|0|||
125526426|NCT02726945|451557148|FG001|Overall Study|Withdrawal by Subject|0|||
125526427|NCT02726945|451557149|FG002|Overall Study|Withdrawal by Subject|1|||
125526428|NCT02726945|451557147|FG000|Overall Study|Elected to have total knee replacement|0|||
125526429|NCT02726945|451557148|FG001|Overall Study|Elected to have total knee replacement|1|||
125526430|NCT02726945|451557149|FG002|Overall Study|Elected to have total knee replacement|0|||
125526431|NCT02737826|451559441|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
125526432|NCT02737826|451559442|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
125526433|NCT02737826|451559443|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
125526434|NCT00129935|451559444|FG000|Overall Study|Adverse Event|18|||
125526435|NCT00129935|451559445|FG001|Overall Study|Adverse Event|56|||
125526436|NCT00129935|451559444|FG000|Overall Study|Death|1|||
125526437|NCT00129935|451559445|FG001|Overall Study|Death|1|||
125526438|NCT00129935|451559444|FG000|Overall Study|Withdrawal by Subject|7|||
125526439|NCT00129935|451559445|FG001|Overall Study|Withdrawal by Subject|20|||
125526440|NCT00129935|451559444|FG000|Overall Study|Protocol Violation|0|||
125526441|NCT00129935|451559445|FG001|Overall Study|Protocol Violation|4|||
125526442|NCT00129935|451559444|FG000|Overall Study|Physician Decision|3|||
125526443|NCT00129935|451559445|FG001|Overall Study|Physician Decision|4|||
125526444|NCT00129935|451559444|FG000|Overall Study|Recurrence|1|||
125526445|NCT00129935|451559445|FG001|Overall Study|Recurrence|3|||
125526446|NCT00129935|451559444|FG000|Overall Study|Second primary|0|||
125526447|NCT00129935|451559445|FG001|Overall Study|Second primary|1|||
125526448|NCT00129935|451559444|FG000|Overall Study|Other|3|||
125526449|NCT00129935|451559445|FG001|Overall Study|Other|2|||
125526450|NCT00129935|451559444|FG000|Overall Study|Crossed to the other arm|2|||
125526451|NCT00129935|451559445|FG001|Overall Study|Crossed to the other arm|1|||
125526452|NCT00129935|451559444|FG000|Overall Study|Incorrect study treatment|1|||
125526453|NCT00129935|451559445|FG001|Overall Study|Incorrect study treatment|0|||
125526454|NCT02783573|451559446|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
125526455|NCT02783573|451559447|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
125526456|NCT02783573|451559448|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
125526457|NCT02783573|451559446|FG000|Placebo-Controlled Treatment Period|Death|4|||
125526458|NCT02783573|451559447|FG001|Placebo-Controlled Treatment Period|Death|2|||
125526459|NCT02783573|451559448|FG002|Placebo-Controlled Treatment Period|Death|3|||
125526460|NCT02783573|451559446|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
125526461|NCT02783573|451559447|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
125526462|NCT02783573|451559448|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
125526463|NCT02783573|451559446|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
125526464|NCT02783573|451559447|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
125526465|NCT02783573|451559448|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
125526466|NCT02783573|451559446|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
125526467|NCT02783573|451559447|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
125526468|NCT02783573|451559448|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
125526469|NCT02783573|451559446|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
125526470|NCT02783573|451559447|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
125526471|NCT02783573|451559448|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
125526472|NCT02783573|451559446|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
125526473|NCT02783573|451559447|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
125526474|NCT02783573|451559448|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
125526475|NCT02783573|451559446|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
125526476|NCT02783573|451559447|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
125526477|NCT02783573|451559448|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
125526478|NCT02783573|451559446|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
125526479|NCT02783573|451559447|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
125526480|NCT02783573|451559448|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
125526481|NCT02783573|451559446|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
125526482|NCT02783573|451559447|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
125526483|NCT02783573|451559448|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
125526484|NCT02783573|451559446|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
125526485|NCT02783573|451559447|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
125526486|NCT02783573|451559448|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
125526487|NCT02783573|451559446|FG000|Delayed-Start Period|Sponsor Decision|0|||
125526488|NCT02783573|451559447|FG001|Delayed-Start Period|Sponsor Decision|17|||
125526489|NCT02783573|451559448|FG002|Delayed-Start Period|Sponsor Decision|12|||
125526490|NCT02797522|451559456|FG000|Overall Study|Study Terminated by Sponsor|0|||
125526491|NCT02797522|451559457|FG001|Overall Study|Study Terminated by Sponsor|0|||
125526492|NCT02797522|451559458|FG002|Overall Study|Study Terminated by Sponsor|0|||
125526493|NCT02797522|451559459|FG003|Overall Study|Study Terminated by Sponsor|0|||
125526494|NCT02797522|451559460|FG004|Overall Study|Study Terminated by Sponsor|0|||
125526495|NCT02797522|451559461|FG005|Overall Study|Study Terminated by Sponsor|0|||
125526496|NCT02797522|451559462|FG006|Overall Study|Study Terminated by Sponsor|0|||
125526497|NCT02797522|451559463|FG007|Overall Study|Study Terminated by Sponsor|4|||
125526498|NCT02797522|451559464|FG008|Overall Study|Study Terminated by Sponsor|2|||
125526499|NCT02797522|451559465|FG009|Overall Study|Study Terminated by Sponsor|4|||
125526500|NCT02797522|451559466|FG010|Overall Study|Study Terminated by Sponsor|1|||
125526501|NCT00725712|451559467|FG000|Overall Study|Withdrawal by Subject|2|||
125526502|NCT00725712|451559468|FG001|Overall Study|Withdrawal by Subject|1|||
125526503|NCT00725712|451559467|FG000|Overall Study|Protocol Violation|1|||
125526504|NCT00725712|451559468|FG001|Overall Study|Protocol Violation|0|||
125526505|NCT00725712|451559467|FG000|Overall Study|Progressive disease|37|||
125526506|NCT00725712|451559468|FG001|Overall Study|Progressive disease|16|||
125526507|NCT00725712|451559467|FG000|Overall Study|Clinical progression not based on RECIST|0|||
125526508|NCT00725712|451559468|FG001|Overall Study|Clinical progression not based on RECIST|3|||
125526509|NCT00725712|451559467|FG000|Overall Study|Adverse Event|5|||
125526510|NCT00725712|451559468|FG001|Overall Study|Adverse Event|5|||
125526511|NCT00725712|451559467|FG000|Overall Study|Death|2|||
125526512|NCT00725712|451559468|FG001|Overall Study|Death|0|||
125526513|NCT00725712|451559467|FG000|Overall Study|Other: Death|1|||
125526514|NCT00725712|451559468|FG001|Overall Study|Other: Death|0|||
125526515|NCT00725712|451559467|FG000|Overall Study|Hospitalized, unable to continue|0|||
125526516|NCT00725712|451559468|FG001|Overall Study|Hospitalized, unable to continue|1|||
125526517|NCT03020069|451559469|FG000|Overall Study|Lost to Follow-up|0|||
125526518|NCT03020069|451559470|FG001|Overall Study|Lost to Follow-up|1|||
125533002|NCT04047862|451581432|FG010|Overall Study|Physician Decision|0|||
125526519|NCT00132678|451559473|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
125526520|NCT00132678|451559474|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
125526521|NCT00132678|451559475|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
125526522|NCT00132678|451559473|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
125526523|NCT00132678|451559474|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
125526524|NCT00132678|451559475|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
125526525|NCT00132678|451559473|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
125526526|NCT00132678|451559474|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
125526527|NCT00132678|451559475|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
125526528|NCT00132678|451559473|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
125526529|NCT00132678|451559474|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
125526530|NCT00132678|451559475|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
125526531|NCT00132678|451559473|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
125526532|NCT00132678|451559474|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
125526533|NCT00132678|451559475|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
125526534|NCT00132678|451559473|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
125526535|NCT00132678|451559474|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
125526536|NCT00132678|451559475|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
125526537|NCT00132678|451559473|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
125526538|NCT00132678|451559474|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
125526539|NCT00132678|451559475|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
125526540|NCT00132678|451559473|FG000|Period III (Open-Label Stabilization)|Death|2|||
125526541|NCT00132678|451559474|FG001|Period III (Open-Label Stabilization)|Death|0|||
125526542|NCT00132678|451559475|FG002|Period III (Open-Label Stabilization)|Death|0|||
125526543|NCT00132678|451559473|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
125526544|NCT00132678|451559474|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
125526545|NCT00132678|451559475|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
125526546|NCT00132678|451559473|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
125526547|NCT00132678|451559474|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
125526548|NCT00132678|451559475|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
125526549|NCT00132678|451559473|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
125526550|NCT00132678|451559474|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
125526551|NCT00132678|451559475|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
125526552|NCT00132678|451559473|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
125526553|NCT00132678|451559474|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
125526554|NCT00132678|451559475|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
125526555|NCT00132678|451559473|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
125526556|NCT00132678|451559474|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
125526557|NCT00132678|451559475|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
125526558|NCT00132678|451559473|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
125526559|NCT00132678|451559474|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
125526560|NCT00132678|451559475|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
125526561|NCT00132678|451559473|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
125526562|NCT00132678|451559474|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
125526563|NCT00132678|451559475|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
125526564|NCT00132678|451559473|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
125526565|NCT00132678|451559474|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
125526566|NCT00132678|451559475|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
125526567|NCT00132678|451559473|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
125526568|NCT00132678|451559474|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
125526569|NCT00132678|451559475|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
125526570|NCT00132678|451559473|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
125526571|NCT00132678|451559474|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
125526572|NCT00132678|451559475|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
125526573|NCT00132678|451559473|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
125526574|NCT00132678|451559474|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
125526575|NCT00132678|451559475|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
125526576|NCT00132678|451559473|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
125526577|NCT00132678|451559474|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
125526578|NCT00132678|451559475|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
125526579|NCT00132678|451559473|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
125526580|NCT00132678|451559474|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
125526581|NCT00132678|451559475|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
125526582|NCT00132678|451559473|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
125526583|NCT00132678|451559474|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
125526584|NCT00132678|451559475|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
125526585|NCT00132678|451559473|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
125526586|NCT00132678|451559474|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
125526587|NCT00132678|451559475|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
125526588|NCT00953147|451559476|FG000|Overall Study|Adverse Event|8|||
125526589|NCT00953147|451559477|FG001|Overall Study|Adverse Event|16|||
125526590|NCT00953147|451559478|FG002|Overall Study|Adverse Event|6|||
125526591|NCT00953147|451559476|FG000|Overall Study|Protocol Violation|2|||
125526592|NCT00953147|451559477|FG001|Overall Study|Protocol Violation|8|||
125526593|NCT00953147|451559478|FG002|Overall Study|Protocol Violation|4|||
125526594|NCT00953147|451559476|FG000|Overall Study|Withdrawal by Subject|13|||
125526595|NCT00953147|451559477|FG001|Overall Study|Withdrawal by Subject|15|||
125526596|NCT00953147|451559478|FG002|Overall Study|Withdrawal by Subject|12|||
125526597|NCT00953147|451559476|FG000|Overall Study|Lost to Follow-up|8|||
125526598|NCT00953147|451559477|FG001|Overall Study|Lost to Follow-up|9|||
125526599|NCT00953147|451559478|FG002|Overall Study|Lost to Follow-up|4|||
125526600|NCT00953147|451559476|FG000|Overall Study|Physician Decision|2|||
125526601|NCT00953147|451559477|FG001|Overall Study|Physician Decision|7|||
125526602|NCT00953147|451559478|FG002|Overall Study|Physician Decision|3|||
125526603|NCT00953147|451559476|FG000|Overall Study|Other|4|||
125526604|NCT00953147|451559477|FG001|Overall Study|Other|11|||
125526605|NCT00953147|451559478|FG002|Overall Study|Other|13|||
125526606|NCT01367847|451559479|FG000|Overall Study|Withdrawal by Subject|2|||
125526607|NCT01367847|451559480|FG001|Overall Study|Withdrawal by Subject|2|||
125526608|NCT02056626|451559481|FG000|Overall Study|patient did not follow directions|3|||
125526609|NCT02056626|451559482|FG001|Overall Study|patient did not follow directions|1|||
125526610|NCT02056626|451559483|FG002|Overall Study|patient did not follow directions|0|||
125526611|NCT02056626|451559484|FG003|Overall Study|patient did not follow directions|0|||
125526612|NCT00863512|451559485|FG000|Overall Study|Adverse Event|2|||
125526613|NCT00863512|451559486|FG001|Overall Study|Adverse Event|0|||
125526614|NCT00863512|451559485|FG000|Overall Study|Withdrawal by Subject|11|||
125526615|NCT00863512|451559486|FG001|Overall Study|Withdrawal by Subject|0|||
125526616|NCT00863512|451559485|FG000|Overall Study|Physician Decision|1|||
125526617|NCT00863512|451559486|FG001|Overall Study|Physician Decision|0|||
125526618|NCT00078338|451559487|FG000|Overall Study|Adverse Event|31|||
125526619|NCT00078338|451559488|FG001|Overall Study|Adverse Event|24|||
125526620|NCT00078338|451559487|FG000|Overall Study|Lost to Follow-up|17|||
125526621|NCT00078338|451559488|FG001|Overall Study|Lost to Follow-up|2|||
125526622|NCT00078338|451559487|FG000|Overall Study|Protocol Violation|2|||
125526623|NCT00078338|451559488|FG001|Overall Study|Protocol Violation|2|||
125526624|NCT00078338|451559487|FG000|Overall Study|Disease Progression|4|||
125526625|NCT00078338|451559488|FG001|Overall Study|Disease Progression|7|||
125526626|NCT00078338|451559487|FG000|Overall Study|Other|28|||
125526627|NCT00078338|451559488|FG001|Overall Study|Other|16|||
125526628|NCT00078338|451559487|FG000|Overall Study|Subjects randomized, but not treated|3|||
125526629|NCT00078338|451559488|FG001|Overall Study|Subjects randomized, but not treated|3|||
125526630|NCT02037477|451559489|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
125526631|NCT02037477|451559490|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
125526632|NCT02037477|451559491|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
125526633|NCT02037477|451559492|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
125526634|NCT01454739|451559493|FG000|Overall Study|Protocol Violation|2|||
125526635|NCT01454739|451559494|FG001|Overall Study|Protocol Violation|3|||
125526636|NCT01454739|451559493|FG000|Overall Study|Withdrawal by Subject|2|||
125526637|NCT01454739|451559494|FG001|Overall Study|Withdrawal by Subject|6|||
125526638|NCT01454739|451559493|FG000|Overall Study|Other|3|||
125526639|NCT01454739|451559494|FG001|Overall Study|Other|5|||
125526640|NCT01454739|451559493|FG000|Overall Study|Physician Decision|0|||
125526641|NCT01454739|451559494|FG001|Overall Study|Physician Decision|5|||
125526642|NCT01454739|451559493|FG000|Overall Study|Lost to Follow-up|0|||
125526643|NCT01454739|451559494|FG001|Overall Study|Lost to Follow-up|1|||
125526644|NCT01454739|451559493|FG000|Overall Study|Adverse Event|0|||
125526645|NCT01454739|451559494|FG001|Overall Study|Adverse Event|1|||
125526646|NCT01784523|451559495|FG000|Overall Study|Study closed early|7|||
125526647|NCT01784523|451559496|FG001|Overall Study|Study closed early|4|||
125526648|NCT02577003|451559499|FG000|Overall Study|Adverse Event|2|||
125526649|NCT02577003|451559500|FG001|Overall Study|Adverse Event|4|||
125526650|NCT02577003|451559499|FG000|Overall Study|Withdrawal by Subject|0|||
125526651|NCT02577003|451559500|FG001|Overall Study|Withdrawal by Subject|1|||
125526652|NCT02786004|451559501|FG000|Overall Study|Withdrawal by Subject|0|||
125526653|NCT02786004|451559502|FG001|Overall Study|Withdrawal by Subject|1|||
125526654|NCT01677299|451559503|FG000|Overall Study|Adverse Event|0|||
125526655|NCT01677299|451559504|FG001|Overall Study|Adverse Event|2|||
125526656|NCT01677299|451559505|FG002|Overall Study|Adverse Event|1|||
125526657|NCT01677299|451559506|FG003|Overall Study|Adverse Event|0|||
125526658|NCT01677299|451559503|FG000|Overall Study|Withdrawal by Subject|0|||
125526659|NCT01677299|451559504|FG001|Overall Study|Withdrawal by Subject|1|||
125533003|NCT04047862|451581433|FG011|Overall Study|Physician Decision|0|||
125526660|NCT01677299|451559505|FG002|Overall Study|Withdrawal by Subject|0|||
125526661|NCT01677299|451559506|FG003|Overall Study|Withdrawal by Subject|1|||
125526662|NCT00559377|451559508|FG000|Overall Study|Withdrawal by Subject|9|||
125526663|NCT00940875|451559509|FG000|Treatment Phase|Adverse Event|9|||
125526664|NCT00940875|451559510|FG001|Treatment Phase|Adverse Event|3|||
125526665|NCT00940875|451559509|FG000|Treatment Phase|Death|3|||
125526666|NCT00940875|451559510|FG001|Treatment Phase|Death|5|||
125526667|NCT00940875|451559509|FG000|Treatment Phase|Lack of Efficacy|1|||
125526668|NCT00940875|451559510|FG001|Treatment Phase|Lack of Efficacy|0|||
125526669|NCT00940875|451559509|FG000|Treatment Phase|Withdrawal by Subject|3|||
125526670|NCT00940875|451559510|FG001|Treatment Phase|Withdrawal by Subject|0|||
125526671|NCT00940875|451559509|FG000|Treatment Phase|Disease progression|9|||
125526672|NCT00940875|451559510|FG001|Treatment Phase|Disease progression|11|||
125526673|NCT00940875|451559509|FG000|Treatment Phase|Physician Decision|1|||
125526674|NCT00940875|451559510|FG001|Treatment Phase|Physician Decision|0|||
125526675|NCT00940875|451559509|FG000|Post-Study Treatment|Death|0|||
125526676|NCT00940875|451559510|FG001|Post-Study Treatment|Death|1|||
125526677|NCT00940875|451559509|FG000|Post-Study Treatment|Disease Progression|0|||
125526678|NCT00940875|451559510|FG001|Post-Study Treatment|Disease Progression|2|||
125526679|NCT00872001|451559511|FG000|Overall Study|Adverse Event|34|||
125526680|NCT00872001|451559512|FG001|Overall Study|Adverse Event|23|||
125526681|NCT00872001|451559511|FG000|Overall Study|Protocol Defined Clinical Event|5|||
125526682|NCT00872001|451559512|FG001|Overall Study|Protocol Defined Clinical Event|7|||
125526683|NCT00872001|451559511|FG000|Overall Study|Lost to Follow-up|13|||
125526684|NCT00872001|451559512|FG001|Overall Study|Lost to Follow-up|12|||
125526685|NCT00872001|451559511|FG000|Overall Study|Withdrawal by Subject|18|||
125526686|NCT00872001|451559512|FG001|Overall Study|Withdrawal by Subject|30|||
125526687|NCT00872001|451559511|FG000|Overall Study|Protocol Violation|5|||
125526688|NCT00872001|451559512|FG001|Overall Study|Protocol Violation|8|||
125526689|NCT00872001|451559511|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
125526690|NCT00872001|451559512|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
125526691|NCT00872001|451559511|FG000|Overall Study|Administrative|23|||
125526692|NCT00872001|451559512|FG001|Overall Study|Administrative|15|||
125526693|NCT04674189|451559517|FG000|Overall Study|Adverse Event|0|||
125526694|NCT04674189|451559518|FG001|Overall Study|Adverse Event|0|||
125526695|NCT04674189|451559519|FG002|Overall Study|Adverse Event|1|||
125526696|NCT04674189|451559517|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
125526697|NCT04674189|451559518|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
125526698|NCT04674189|451559519|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
125526699|NCT04674189|451559517|FG000|Overall Study|Physician Decision|1|||
125526700|NCT04674189|451559518|FG001|Overall Study|Physician Decision|0|||
125526701|NCT04674189|451559519|FG002|Overall Study|Physician Decision|0|||
125526702|NCT04674189|451559517|FG000|Overall Study|Withdrawal by Participant|83|||
125526703|NCT04674189|451559518|FG001|Overall Study|Withdrawal by Participant|71|||
125526704|NCT04674189|451559519|FG002|Overall Study|Withdrawal by Participant|142|||
125526705|NCT04674189|451559517|FG000|Overall Study|Lost to Follow-up|55|||
125526706|NCT04674189|451559518|FG001|Overall Study|Lost to Follow-up|53|||
125526707|NCT04674189|451559519|FG002|Overall Study|Lost to Follow-up|44|||
125526708|NCT04674189|451559517|FG000|Overall Study|Miscellaneous|27|||
125526709|NCT04674189|451559518|FG001|Overall Study|Miscellaneous|23|||
125526710|NCT04674189|451559519|FG002|Overall Study|Miscellaneous|207|||
125526711|NCT04674189|451559517|FG000|Overall Study|Did Not Receive Treatment|3|||
125526712|NCT04674189|451559518|FG001|Overall Study|Did Not Receive Treatment|1|||
125526713|NCT04674189|451559519|FG002|Overall Study|Did Not Receive Treatment|2|||
125526714|NCT02838134|451559520|FG000|Overall Study|Lost to Follow-up|1|||
125526715|NCT02838134|451559521|FG001|Overall Study|Lost to Follow-up|2|||
125526716|NCT02838134|451559520|FG000|Overall Study|logistic problems|1|||
125526717|NCT02838134|451559521|FG001|Overall Study|logistic problems|1|||
125526718|NCT01564277|451559522|FG000|Overall Study|Protocol Violation|0|||
125526719|NCT01564277|451559523|FG001|Overall Study|Protocol Violation|1|||
125526720|NCT01564277|451559522|FG000|Overall Study|Physician Decision|1|||
125526721|NCT01564277|451559523|FG001|Overall Study|Physician Decision|0|||
125526722|NCT01637077|451559527|FG000|Overall Study|Cancel|1|||
125526723|NCT01637077|451559528|FG001|Overall Study|Cancel|1|||
125526724|NCT01637077|451559527|FG000|Overall Study|Withdrawal by Subject|1|||
125526725|NCT01637077|451559528|FG001|Overall Study|Withdrawal by Subject|0|||
125526726|NCT01637077|451559527|FG000|Overall Study|No cycle 1 questionnaire data|2|||
125526727|NCT01637077|451559528|FG001|Overall Study|No cycle 1 questionnaire data|0|||
125526728|NCT00246090|451559529|FG000|Overall Study|Adverse Event|25|||
125526729|NCT00246090|451559529|FG000|Overall Study|Withdrawal by Subject|7|||
125526730|NCT00246090|451559529|FG000|Overall Study|Progressive Disease|212|||
125526731|NCT00246090|451559529|FG000|Overall Study|Clinical Progression|30|||
125526732|NCT00246090|451559529|FG000|Overall Study|Physician Decision|11|||
125526733|NCT00246090|451559529|FG000|Overall Study|Not Otherwise Specified|10|||
125526734|NCT02595372|451559530|FG000|Overall Study|Adverse Event|6|||
125526735|NCT02595372|451559530|FG000|Overall Study|Physician Decision|2|||
125526736|NCT02595372|451559530|FG000|Overall Study|Disease Progression|1|||
125526737|NCT00794924|451559531|FG000|Overall Study|Lost to Follow-up|6|||
125526738|NCT00794924|451559532|FG001|Overall Study|Lost to Follow-up|8|||
125526739|NCT00794924|451559531|FG000|Overall Study|Withdrawal by Subject|48|||
125526740|NCT00794924|451559532|FG001|Overall Study|Withdrawal by Subject|60|||
125526741|NCT00794924|451559531|FG000|Overall Study|Adverse Event|6|||
125526742|NCT00794924|451559532|FG001|Overall Study|Adverse Event|2|||
125526743|NCT01594970|451559533|FG000|Overall Study|Non-Adverse Event Related|4|||
125526744|NCT01594970|451559534|FG001|Overall Study|Non-Adverse Event Related|5|||
125526745|NCT01594970|451559535|FG002|Overall Study|Non-Adverse Event Related|6|||
125526746|NCT01594970|451559533|FG000|Overall Study|Adverse Event|17|||
125526747|NCT01594970|451559534|FG001|Overall Study|Adverse Event|23|||
125526748|NCT01594970|451559535|FG002|Overall Study|Adverse Event|23|||
125526749|NCT01594970|451559533|FG000|Overall Study|Lost to Follow-up|54|||
125526750|NCT01594970|451559534|FG001|Overall Study|Lost to Follow-up|54|||
125526751|NCT01594970|451559535|FG002|Overall Study|Lost to Follow-up|37|||
125526752|NCT02389764|451559536|FG000|Overall Study|Lack of Efficacy|9|||
125526753|NCT00583947|451559537|FG000|Cross-over Period|Adverse Event|2|||
125526754|NCT00583947|451559538|FG001|Cross-over Period|Adverse Event|0|||
125526755|NCT00583947|451559537|FG000|Cross-over Period|Withdrawal by Subject|2|||
125526756|NCT00583947|451559538|FG001|Cross-over Period|Withdrawal by Subject|0|||
125526757|NCT00583947|451559537|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
125526758|NCT00583947|451559538|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
125526759|NCT00583947|451559537|FG000|Cross-over Period|Other|1|||
125526760|NCT00583947|451559538|FG001|Cross-over Period|Other|1|||
125526761|NCT00738283|451559539|FG000|Overall Study|Death|1|||
125526762|NCT00738283|451559539|FG000|Overall Study|Transfer to another facility|2|||
125526763|NCT00738283|451559539|FG000|Overall Study|Discharge home prior to end of study|1|||
125526764|NCT00486252|451559542|FG000|Overall Study|Adverse Event|7|||
125526765|NCT00486252|451559542|FG000|Overall Study|Lack of Efficacy|9|||
125526766|NCT00486252|451559542|FG000|Overall Study|Lost to Follow-up|24|||
125526767|NCT00486252|451559542|FG000|Overall Study|Other|18|||
125526768|NCT01210651|451559543|FG000|Overall Study|Lost to Follow-up|1|||
125526769|NCT01210651|451559544|FG001|Overall Study|Lost to Follow-up|1|||
125526770|NCT01210651|451559543|FG000|Overall Study|schedule conflicts|1|||
125526771|NCT01210651|451559544|FG001|Overall Study|schedule conflicts|5|||
125526772|NCT01210651|451559543|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
125526773|NCT01210651|451559544|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
125526774|NCT01210651|451559543|FG000|Overall Study|Withdrawal by Subject|1|||
125526775|NCT01210651|451559544|FG001|Overall Study|Withdrawal by Subject|1|||
125526776|NCT01210651|451559543|FG000|Overall Study|Injury outside study|2|||
125526777|NCT01210651|451559544|FG001|Overall Study|Injury outside study|0|||
125526778|NCT02592707|451559548|FG000|Overall Study|Consent Withdrawn|0|||
125526779|NCT02592707|451559549|FG001|Overall Study|Consent Withdrawn|1|||
125526780|NCT02592707|451559550|FG002|Overall Study|Consent Withdrawn|2|||
125526781|NCT02592707|451559551|FG003|Overall Study|Consent Withdrawn|0|||
125526782|NCT02592707|451559548|FG000|Overall Study|Death|1|||
125526783|NCT02592707|451559549|FG001|Overall Study|Death|0|||
125526784|NCT02592707|451559550|FG002|Overall Study|Death|0|||
125526785|NCT02592707|451559551|FG003|Overall Study|Death|0|||
125526786|NCT02592707|451559548|FG000|Overall Study|Progressive Disease|4|||
125526787|NCT02592707|451559549|FG001|Overall Study|Progressive Disease|4|||
125526788|NCT02592707|451559550|FG002|Overall Study|Progressive Disease|3|||
125526789|NCT02592707|451559551|FG003|Overall Study|Progressive Disease|3|||
125526790|NCT02592707|451559548|FG000|Overall Study|Other|0|||
125526791|NCT02592707|451559549|FG001|Overall Study|Other|0|||
125526792|NCT02592707|451559550|FG002|Overall Study|Other|1|||
125526793|NCT02592707|451559551|FG003|Overall Study|Other|2|||
125526794|NCT02592707|451559548|FG000|Overall Study|Never entered LTFU period|1|||
125526795|NCT02592707|451559549|FG001|Overall Study|Never entered LTFU period|0|||
125526796|NCT02592707|451559550|FG002|Overall Study|Never entered LTFU period|0|||
125526797|NCT02592707|451559551|FG003|Overall Study|Never entered LTFU period|2|||
125526798|NCT00469859|451559552|FG000|Overall Study|Inevaluable|0|||
125526799|NCT00469859|451559553|FG001|Overall Study|Inevaluable|2|||
125526800|NCT04124471|451559554|FG000|Overall Study|screen failure|1|||
125526801|NCT05226130|451559555|FG000|Overall Study|Lost to Follow-up|0|||
125526802|NCT05226130|451559556|FG001|Overall Study|Lost to Follow-up|1|||
125526803|NCT05226130|451559555|FG000|Overall Study|Not treatment adherent|0|||
125526804|NCT05226130|451559556|FG001|Overall Study|Not treatment adherent|2|||
125526805|NCT04855734|451559557|FG000|Overall Study|Lost to Follow-up|2|||
125526806|NCT04855734|451559558|FG001|Overall Study|Lost to Follow-up|2|||
125526807|NCT03358472|451559559|FG000|Overall Study|Death|6|||
125526808|NCT03358472|451559560|FG001|Overall Study|Death|3|||
125526809|NCT03358472|451559561|FG002|Overall Study|Death|10|||
125526810|NCT03358472|451559559|FG000|Overall Study|Physician Decision|0|||
125526811|NCT03358472|451559560|FG001|Overall Study|Physician Decision|1|||
125526812|NCT03358472|451559561|FG002|Overall Study|Physician Decision|0|||
125526813|NCT03358472|451559559|FG000|Overall Study|Withdrawal by Subject|0|||
125526814|NCT03358472|451559560|FG001|Overall Study|Withdrawal by Subject|0|||
125526815|NCT03358472|451559561|FG002|Overall Study|Withdrawal by Subject|1|||
125526816|NCT03358472|451559559|FG000|Overall Study|On-going at clinical cut off date|9|||
125526817|NCT03358472|451559560|FG001|Overall Study|On-going at clinical cut off date|6|||
125526818|NCT03358472|451559561|FG002|Overall Study|On-going at clinical cut off date|5|||
125526819|NCT03732677|451559562|FG000|Overall Study|Terminated the study|154|||
125526820|NCT03732677|451559563|FG001|Overall Study|Terminated the study|197|||
125526821|NCT03732677|451559562|FG000|Overall Study|Continuing study off treatment|379|||
125526822|NCT03732677|451559563|FG001|Overall Study|Continuing study off treatment|333|||
125526823|NCT04013971|451559564|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
125526824|NCT04013971|451559565|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
125526825|NCT04013971|451559564|FG000|Overall Study|Missing biomechanical data|0|||
125526826|NCT04013971|451559565|FG001|Overall Study|Missing biomechanical data|1|||
125526827|NCT02520310|451559568|FG000|At 6 Months Clinical Follow-up|Death|1|||
125526828|NCT02520310|451559568|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
125526829|NCT02520310|451559568|FG000|AT 3 Year Clinical Follow-up|Death|2|||
125526830|NCT02520310|451559568|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
125526831|NCT02520310|451559568|FG000|AT 4 Year Clinical Follow-up|Death|1|||
125526832|NCT02520310|451559568|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
125526833|NCT01340014|451559569|FG000|Period 1, First 7 Days|Adverse Event|1|||
125526834|NCT01340014|451559570|FG001|Period 1, First 7 Days|Adverse Event|0|||
125526835|NCT01340014|451559569|FG000|Period 1, First 7 Days|Personal Reasons|1|||
125526836|NCT01340014|451559570|FG001|Period 1, First 7 Days|Personal Reasons|0|||
125526837|NCT01340014|451559569|FG000|Period 2, Second 7 Days|Adverse Event|0|||
125526838|NCT01340014|451559570|FG001|Period 2, Second 7 Days|Adverse Event|1|||
125526839|NCT04535544|451559573|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
125526840|NCT04535544|451559574|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
125526841|NCT04535544|451559575|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
125526842|NCT04535544|451559576|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
125526843|NCT04535544|451559573|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
125526844|NCT04535544|451559574|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
125526845|NCT04535544|451559575|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
125526846|NCT04535544|451559576|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
125526847|NCT04535544|451559573|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
125526848|NCT04535544|451559574|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
125526849|NCT04535544|451559575|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
125526850|NCT04535544|451559576|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
125526851|NCT04535544|451559573|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
125526852|NCT04535544|451559574|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
125526853|NCT04535544|451559575|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
125526854|NCT04535544|451559576|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
125526855|NCT04535544|451559573|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
125526856|NCT04535544|451559574|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
125526857|NCT04535544|451559575|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
125526858|NCT04535544|451559576|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
125526859|NCT04535544|451559573|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
125526860|NCT04535544|451559574|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
125526861|NCT04535544|451559575|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
125526862|NCT04535544|451559576|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
125526863|NCT04535544|451559573|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
125526864|NCT04535544|451559574|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
125526865|NCT04535544|451559575|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
125526866|NCT04535544|451559576|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
125526867|NCT04535544|451559573|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
125526868|NCT04535544|451559574|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
125526869|NCT04535544|451559575|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
125526870|NCT04535544|451559576|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
125526871|NCT05131477|451559583|FG000|PART 1|Withdrawal by Subject|2|||
125526872|NCT05131477|451559584|FG001|PART 1|Withdrawal by Subject|9|||
125526873|NCT05131477|451559585|FG002|PART 1|Withdrawal by Subject|6|||
125526874|NCT05131477|451559586|FG003|PART 1|Withdrawal by Subject|2|||
125526875|NCT05131477|451559587|FG004|PART 1|Withdrawal by Subject|8|||
125526876|NCT05131477|451559588|FG005|PART 1|Withdrawal by Subject|0|||
125526877|NCT05131477|451559589|FG006|PART 1|Withdrawal by Subject|0|||
125526878|NCT05131477|451559590|FG007|PART 1|Withdrawal by Subject|0|||
125526879|NCT05131477|451559591|FG008|PART 1|Withdrawal by Subject|0|||
125526880|NCT05131477|451559592|FG009|PART 1|Withdrawal by Subject|0|||
125526881|NCT05131477|451559593|FG010|PART 1|Withdrawal by Subject|0|||
125526882|NCT05131477|451559594|FG011|PART 1|Withdrawal by Subject|0|||
125526883|NCT05131477|451559595|FG012|PART 1|Withdrawal by Subject|0|||
125526884|NCT05131477|451559596|FG013|PART 1|Withdrawal by Subject|0|||
125526885|NCT05131477|451559583|FG000|PART 1|Physician Decision|1|||
125526886|NCT05131477|451559584|FG001|PART 1|Physician Decision|0|||
125526887|NCT05131477|451559585|FG002|PART 1|Physician Decision|0|||
125526888|NCT05131477|451559586|FG003|PART 1|Physician Decision|0|||
125526889|NCT05131477|451559587|FG004|PART 1|Physician Decision|0|||
125526890|NCT05131477|451559588|FG005|PART 1|Physician Decision|0|||
125526891|NCT05131477|451559589|FG006|PART 1|Physician Decision|0|||
125526892|NCT05131477|451559590|FG007|PART 1|Physician Decision|0|||
125526893|NCT05131477|451559591|FG008|PART 1|Physician Decision|0|||
125526894|NCT05131477|451559592|FG009|PART 1|Physician Decision|0|||
125526895|NCT05131477|451559593|FG010|PART 1|Physician Decision|0|||
125526896|NCT05131477|451559594|FG011|PART 1|Physician Decision|0|||
125526897|NCT05131477|451559595|FG012|PART 1|Physician Decision|0|||
125526898|NCT05131477|451559596|FG013|PART 1|Physician Decision|0|||
125526899|NCT05131477|451559583|FG000|PART 1|Adverse Event|3|||
125526900|NCT05131477|451559584|FG001|PART 1|Adverse Event|5|||
125526901|NCT05131477|451559585|FG002|PART 1|Adverse Event|1|||
125526902|NCT05131477|451559586|FG003|PART 1|Adverse Event|6|||
125526903|NCT05131477|451559587|FG004|PART 1|Adverse Event|4|||
125526904|NCT05131477|451559588|FG005|PART 1|Adverse Event|0|||
125526905|NCT05131477|451559589|FG006|PART 1|Adverse Event|0|||
125526906|NCT05131477|451559590|FG007|PART 1|Adverse Event|0|||
125526907|NCT05131477|451559591|FG008|PART 1|Adverse Event|0|||
125526908|NCT05131477|451559592|FG009|PART 1|Adverse Event|0|||
125526909|NCT05131477|451559593|FG010|PART 1|Adverse Event|0|||
125526910|NCT05131477|451559594|FG011|PART 1|Adverse Event|0|||
125526911|NCT05131477|451559595|FG012|PART 1|Adverse Event|0|||
125526912|NCT05131477|451559596|FG013|PART 1|Adverse Event|0|||
125526913|NCT05131477|451559583|FG000|PART 1|unclassified|1|||
125526914|NCT05131477|451559584|FG001|PART 1|unclassified|1|||
125526915|NCT05131477|451559585|FG002|PART 1|unclassified|0|||
125526916|NCT05131477|451559586|FG003|PART 1|unclassified|0|||
125526917|NCT05131477|451559587|FG004|PART 1|unclassified|4|||
125526918|NCT05131477|451559588|FG005|PART 1|unclassified|0|||
125526919|NCT05131477|451559589|FG006|PART 1|unclassified|0|||
125526920|NCT05131477|451559590|FG007|PART 1|unclassified|0|||
125526921|NCT05131477|451559591|FG008|PART 1|unclassified|0|||
125526922|NCT05131477|451559592|FG009|PART 1|unclassified|0|||
125526923|NCT05131477|451559593|FG010|PART 1|unclassified|0|||
125526924|NCT05131477|451559594|FG011|PART 1|unclassified|0|||
125526925|NCT05131477|451559595|FG012|PART 1|unclassified|0|||
125526926|NCT05131477|451559596|FG013|PART 1|unclassified|0|||
125526927|NCT05131477|451559583|FG000|PART 1|Randomized and not treated|0|||
125526928|NCT05131477|451559584|FG001|PART 1|Randomized and not treated|0|||
125526929|NCT05131477|451559585|FG002|PART 1|Randomized and not treated|0|||
125526930|NCT05131477|451559586|FG003|PART 1|Randomized and not treated|1|||
125526931|NCT05131477|451559587|FG004|PART 1|Randomized and not treated|1|||
125526932|NCT05131477|451559588|FG005|PART 1|Randomized and not treated|0|||
125526933|NCT05131477|451559589|FG006|PART 1|Randomized and not treated|0|||
125526934|NCT05131477|451559590|FG007|PART 1|Randomized and not treated|0|||
125526935|NCT05131477|451559591|FG008|PART 1|Randomized and not treated|0|||
125526936|NCT05131477|451559592|FG009|PART 1|Randomized and not treated|0|||
125526937|NCT05131477|451559593|FG010|PART 1|Randomized and not treated|0|||
125526938|NCT05131477|451559594|FG011|PART 1|Randomized and not treated|0|||
125526939|NCT05131477|451559595|FG012|PART 1|Randomized and not treated|0|||
125526940|NCT05131477|451559596|FG013|PART 1|Randomized and not treated|0|||
125526941|NCT05131477|451559583|FG000|PART 1|Protocol Violation|2|||
125526942|NCT05131477|451559584|FG001|PART 1|Protocol Violation|0|||
125526943|NCT05131477|451559585|FG002|PART 1|Protocol Violation|0|||
125526944|NCT05131477|451559586|FG003|PART 1|Protocol Violation|1|||
125526945|NCT05131477|451559587|FG004|PART 1|Protocol Violation|0|||
125526946|NCT05131477|451559588|FG005|PART 1|Protocol Violation|0|||
125526947|NCT05131477|451559589|FG006|PART 1|Protocol Violation|0|||
125526948|NCT05131477|451559590|FG007|PART 1|Protocol Violation|0|||
125526949|NCT05131477|451559591|FG008|PART 1|Protocol Violation|0|||
125526950|NCT05131477|451559592|FG009|PART 1|Protocol Violation|0|||
125526951|NCT05131477|451559593|FG010|PART 1|Protocol Violation|0|||
125526952|NCT05131477|451559594|FG011|PART 1|Protocol Violation|0|||
125526953|NCT05131477|451559595|FG012|PART 1|Protocol Violation|0|||
125526954|NCT05131477|451559596|FG013|PART 1|Protocol Violation|0|||
125526955|NCT05131477|451559583|FG000|PART 1|Lack of Efficacy|0|||
125526956|NCT05131477|451559584|FG001|PART 1|Lack of Efficacy|1|||
125526957|NCT05131477|451559585|FG002|PART 1|Lack of Efficacy|1|||
125526958|NCT05131477|451559586|FG003|PART 1|Lack of Efficacy|2|||
125526959|NCT05131477|451559587|FG004|PART 1|Lack of Efficacy|5|||
125526960|NCT05131477|451559588|FG005|PART 1|Lack of Efficacy|0|||
125526961|NCT05131477|451559589|FG006|PART 1|Lack of Efficacy|0|||
125526962|NCT05131477|451559590|FG007|PART 1|Lack of Efficacy|0|||
125526963|NCT05131477|451559591|FG008|PART 1|Lack of Efficacy|0|||
125526964|NCT05131477|451559592|FG009|PART 1|Lack of Efficacy|0|||
125526965|NCT05131477|451559593|FG010|PART 1|Lack of Efficacy|0|||
125526966|NCT05131477|451559594|FG011|PART 1|Lack of Efficacy|0|||
125526967|NCT05131477|451559595|FG012|PART 1|Lack of Efficacy|0|||
125526968|NCT05131477|451559596|FG013|PART 1|Lack of Efficacy|0|||
125526969|NCT05131477|451559583|FG000|PART 2|Withdrawal by Subject|0|||
125526970|NCT05131477|451559584|FG001|PART 2|Withdrawal by Subject|0|||
125526971|NCT05131477|451559585|FG002|PART 2|Withdrawal by Subject|0|||
125526972|NCT05131477|451559586|FG003|PART 2|Withdrawal by Subject|0|||
125526973|NCT05131477|451559587|FG004|PART 2|Withdrawal by Subject|0|||
125526974|NCT05131477|451559588|FG005|PART 2|Withdrawal by Subject|0|||
125526975|NCT05131477|451559589|FG006|PART 2|Withdrawal by Subject|2|||
125526976|NCT05131477|451559590|FG007|PART 2|Withdrawal by Subject|0|||
125526977|NCT05131477|451559591|FG008|PART 2|Withdrawal by Subject|0|||
125526978|NCT05131477|451559592|FG009|PART 2|Withdrawal by Subject|0|||
125526979|NCT05131477|451559593|FG010|PART 2|Withdrawal by Subject|2|||
125526980|NCT05131477|451559594|FG011|PART 2|Withdrawal by Subject|0|||
125526981|NCT05131477|451559595|FG012|PART 2|Withdrawal by Subject|2|||
125526982|NCT05131477|451559596|FG013|PART 2|Withdrawal by Subject|2|||
125526983|NCT05131477|451559583|FG000|PART 2|Other|0|||
125526984|NCT05131477|451559584|FG001|PART 2|Other|0|||
125526985|NCT05131477|451559585|FG002|PART 2|Other|0|||
125526986|NCT05131477|451559586|FG003|PART 2|Other|0|||
125526987|NCT05131477|451559587|FG004|PART 2|Other|0|||
125526988|NCT05131477|451559588|FG005|PART 2|Other|0|||
125526989|NCT05131477|451559589|FG006|PART 2|Other|0|||
125526990|NCT05131477|451559590|FG007|PART 2|Other|0|||
125526991|NCT05131477|451559591|FG008|PART 2|Other|1|||
125526992|NCT05131477|451559592|FG009|PART 2|Other|1|||
125526993|NCT05131477|451559593|FG010|PART 2|Other|0|||
125526994|NCT05131477|451559594|FG011|PART 2|Other|0|||
125526995|NCT05131477|451559595|FG012|PART 2|Other|1|||
125526996|NCT05131477|451559596|FG013|PART 2|Other|0|||
125526997|NCT05131477|451559583|FG000|PART 2|Lack of Efficacy|0|||
125526998|NCT05131477|451559584|FG001|PART 2|Lack of Efficacy|0|||
125526999|NCT05131477|451559585|FG002|PART 2|Lack of Efficacy|0|||
125527000|NCT05131477|451559586|FG003|PART 2|Lack of Efficacy|0|||
125527001|NCT05131477|451559587|FG004|PART 2|Lack of Efficacy|0|||
125527002|NCT05131477|451559588|FG005|PART 2|Lack of Efficacy|1|||
125527003|NCT05131477|451559589|FG006|PART 2|Lack of Efficacy|1|||
125527004|NCT05131477|451559590|FG007|PART 2|Lack of Efficacy|0|||
125527005|NCT05131477|451559591|FG008|PART 2|Lack of Efficacy|3|||
125527006|NCT05131477|451559592|FG009|PART 2|Lack of Efficacy|0|||
125527007|NCT05131477|451559593|FG010|PART 2|Lack of Efficacy|1|||
125527008|NCT05131477|451559594|FG011|PART 2|Lack of Efficacy|0|||
125527009|NCT05131477|451559595|FG012|PART 2|Lack of Efficacy|2|||
125527010|NCT05131477|451559596|FG013|PART 2|Lack of Efficacy|0|||
125527011|NCT05131477|451559583|FG000|PART 2|Unclassified|0|||
125527012|NCT05131477|451559584|FG001|PART 2|Unclassified|0|||
125527013|NCT05131477|451559585|FG002|PART 2|Unclassified|0|||
125527014|NCT05131477|451559586|FG003|PART 2|Unclassified|0|||
125527015|NCT05131477|451559587|FG004|PART 2|Unclassified|0|||
125527016|NCT05131477|451559588|FG005|PART 2|Unclassified|0|||
125527017|NCT05131477|451559589|FG006|PART 2|Unclassified|0|||
125527018|NCT05131477|451559590|FG007|PART 2|Unclassified|0|||
125527019|NCT05131477|451559591|FG008|PART 2|Unclassified|0|||
125527020|NCT05131477|451559592|FG009|PART 2|Unclassified|0|||
125527021|NCT05131477|451559593|FG010|PART 2|Unclassified|1|||
125527022|NCT05131477|451559594|FG011|PART 2|Unclassified|0|||
125527023|NCT05131477|451559595|FG012|PART 2|Unclassified|0|||
125527024|NCT05131477|451559596|FG013|PART 2|Unclassified|0|||
125527025|NCT05131477|451559583|FG000|PART 2|Re-randomized and not treated|0|||
125527026|NCT05131477|451559584|FG001|PART 2|Re-randomized and not treated|0|||
125527027|NCT05131477|451559585|FG002|PART 2|Re-randomized and not treated|0|||
125527028|NCT05131477|451559586|FG003|PART 2|Re-randomized and not treated|0|||
125527029|NCT05131477|451559587|FG004|PART 2|Re-randomized and not treated|0|||
125527030|NCT05131477|451559588|FG005|PART 2|Re-randomized and not treated|0|||
125527031|NCT05131477|451559589|FG006|PART 2|Re-randomized and not treated|0|||
125527032|NCT05131477|451559590|FG007|PART 2|Re-randomized and not treated|1|||
125527033|NCT05131477|451559591|FG008|PART 2|Re-randomized and not treated|0|||
125527034|NCT05131477|451559592|FG009|PART 2|Re-randomized and not treated|0|||
125527035|NCT05131477|451559593|FG010|PART 2|Re-randomized and not treated|1|||
125527036|NCT05131477|451559594|FG011|PART 2|Re-randomized and not treated|0|||
125527037|NCT05131477|451559595|FG012|PART 2|Re-randomized and not treated|1|||
125527038|NCT05131477|451559596|FG013|PART 2|Re-randomized and not treated|1|||
125527039|NCT02194829|451559597|FG000|Overall Study|Adverse Event|2|||
125527040|NCT02194829|451559598|FG001|Overall Study|Adverse Event|2|||
125527041|NCT02194829|451559597|FG000|Overall Study|Death|0|||
125527042|NCT02194829|451559598|FG001|Overall Study|Death|1|||
125527043|NCT02194829|451559597|FG000|Overall Study|Disease progression|0|||
125527044|NCT02194829|451559598|FG001|Overall Study|Disease progression|1|||
125527045|NCT02194829|451559597|FG000|Overall Study|Withdrawal by Subject|0|||
125527046|NCT02194829|451559598|FG001|Overall Study|Withdrawal by Subject|1|||
125527047|NCT02194829|451559597|FG000|Overall Study|Never started protocol therapy|0|||
125527048|NCT02194829|451559598|FG001|Overall Study|Never started protocol therapy|1|||
125527049|NCT05101993|451559601|FG000|Overall Study|Withdrawal by Subject|1|||
125527050|NCT01124838|451559602|FG000|Overall Study|Miscellaneous|4|||
125527051|NCT01124838|451559603|FG001|Overall Study|Miscellaneous|2|||
125527052|NCT01124838|451559602|FG000|Overall Study|Adverse Event|7|||
125527053|NCT01124838|451559603|FG001|Overall Study|Adverse Event|11|||
125527054|NCT01124838|451559602|FG000|Overall Study|Lack of Efficacy|2|||
125527055|NCT01124838|451559603|FG001|Overall Study|Lack of Efficacy|0|||
125527056|NCT01124838|451559602|FG000|Overall Study|Withdrawal by Subject|3|||
125527057|NCT01124838|451559603|FG001|Overall Study|Withdrawal by Subject|2|||
125527058|NCT01124838|451559602|FG000|Overall Study|Lost to Follow-up|2|||
125527059|NCT01124838|451559603|FG001|Overall Study|Lost to Follow-up|0|||
125527060|NCT04297618|451559604|FG000|Overall Study|Adverse Event|1|||
125527061|NCT04297618|451559604|FG000|Overall Study|Withdrawal by Subject|1|||
125527062|NCT02600897|451559605|FG000|Overall Study|Death|1|||
125527063|NCT02600897|451559606|FG001|Overall Study|Death|2|||
125527064|NCT02600897|451559607|FG002|Overall Study|Death|1|||
125527065|NCT02600897|451559608|FG003|Overall Study|Death|2|||
125527066|NCT02600897|451559609|FG004|Overall Study|Death|3|||
125527067|NCT02600897|451559610|FG005|Overall Study|Death|2|||
125527068|NCT02600897|451559611|FG006|Overall Study|Death|10|||
125527069|NCT02600897|451559612|FG007|Overall Study|Death|7|||
125527070|NCT02600897|451559613|FG008|Overall Study|Death|20|||
125527071|NCT02600897|451559605|FG000|Overall Study|Lost to Follow-up|1|||
125527072|NCT02600897|451559606|FG001|Overall Study|Lost to Follow-up|0|||
125527073|NCT02600897|451559607|FG002|Overall Study|Lost to Follow-up|0|||
125527074|NCT02600897|451559608|FG003|Overall Study|Lost to Follow-up|0|||
125527075|NCT02600897|451559609|FG004|Overall Study|Lost to Follow-up|0|||
125527076|NCT02600897|451559610|FG005|Overall Study|Lost to Follow-up|0|||
125527077|NCT02600897|451559611|FG006|Overall Study|Lost to Follow-up|0|||
125527078|NCT02600897|451559612|FG007|Overall Study|Lost to Follow-up|1|||
125527079|NCT02600897|451559613|FG008|Overall Study|Lost to Follow-up|0|||
125527080|NCT02600897|451559605|FG000|Overall Study|Withdrawal by Subject|0|||
125527081|NCT02600897|451559606|FG001|Overall Study|Withdrawal by Subject|0|||
125527082|NCT02600897|451559607|FG002|Overall Study|Withdrawal by Subject|0|||
125527083|NCT02600897|451559608|FG003|Overall Study|Withdrawal by Subject|0|||
125527084|NCT02600897|451559609|FG004|Overall Study|Withdrawal by Subject|0|||
125527085|NCT02600897|451559610|FG005|Overall Study|Withdrawal by Subject|0|||
125527086|NCT02600897|451559611|FG006|Overall Study|Withdrawal by Subject|0|||
125527087|NCT02600897|451559612|FG007|Overall Study|Withdrawal by Subject|4|||
125527088|NCT02600897|451559613|FG008|Overall Study|Withdrawal by Subject|2|||
125527089|NCT02600897|451559605|FG000|Overall Study|Reason Not Specified|0|||
125527090|NCT02600897|451559606|FG001|Overall Study|Reason Not Specified|0|||
125527091|NCT02600897|451559607|FG002|Overall Study|Reason Not Specified|0|||
125527092|NCT02600897|451559608|FG003|Overall Study|Reason Not Specified|0|||
125527093|NCT02600897|451559609|FG004|Overall Study|Reason Not Specified|0|||
125527094|NCT02600897|451559610|FG005|Overall Study|Reason Not Specified|0|||
125527095|NCT02600897|451559611|FG006|Overall Study|Reason Not Specified|0|||
125527096|NCT02600897|451559612|FG007|Overall Study|Reason Not Specified|0|||
125527097|NCT02600897|451559613|FG008|Overall Study|Reason Not Specified|1|||
125527098|NCT06840769|451559614|FG000|Overall Study|Withdrawal by Subject|1|||
125527099|NCT06840769|451559615|FG001|Overall Study|Withdrawal by Subject|0|||
125527100|NCT06840769|451559616|FG002|Overall Study|Withdrawal by Subject|0|||
125527101|NCT06840769|451559617|FG003|Overall Study|Withdrawal by Subject|0|||
125527102|NCT06840769|451559618|FG004|Overall Study|Withdrawal by Subject|0|||
125527103|NCT02172911|451561273|FG000|Overall Study|Serious Adverse Event|0|||
125527104|NCT02172911|451561274|FG001|Overall Study|Serious Adverse Event|1|||
125527105|NCT02172911|451561273|FG000|Overall Study|Progression of Disease|0|||
125527106|NCT02172911|451561274|FG001|Overall Study|Progression of Disease|1|||
125527107|NCT02172911|451561273|FG000|Overall Study|Loss of insurance coverage|1|||
125527108|NCT02172911|451561274|FG001|Overall Study|Loss of insurance coverage|0|||
125527109|NCT03258723|451561275|FG000|Overall Study|COVID Interruption of study|54|||
125527110|NCT03258723|451561275|FG000|Overall Study|Lost to Follow-up|8|||
125527111|NCT00592293|451561279|FG000|Overall Study|Withdrawal by Subject|1|||
125527112|NCT01606319|451561280|FG000|Overall Study|Lost to Follow-up|17|||
125527113|NCT01606319|451561281|FG001|Overall Study|Lost to Follow-up|14|||
125527114|NCT01606319|451561280|FG000|Overall Study|Withdrawal by Subject|9|||
125527115|NCT01606319|451561281|FG001|Overall Study|Withdrawal by Subject|12|||
125527116|NCT01606319|451561280|FG000|Overall Study|Physician Decision|1|||
125527117|NCT01606319|451561281|FG001|Overall Study|Physician Decision|2|||
125527118|NCT01606319|451561280|FG000|Overall Study|Lack of Efficacy|6|||
125527119|NCT01606319|451561281|FG001|Overall Study|Lack of Efficacy|8|||
125527120|NCT01606319|451561280|FG000|Overall Study|Adverse Event|1|||
125527121|NCT01606319|451561281|FG001|Overall Study|Adverse Event|4|||
125527122|NCT04340947|451561284|FG000|7-day Washout Period|Lost to Follow-up|5|||
125527123|NCT04340947|451561285|FG001|7-day Washout Period|Lost to Follow-up|4|||
125527124|NCT01124097|451561290|FG000|Overall Study|Withdrawal by Subject|4|||
125527125|NCT01124097|451561291|FG001|Overall Study|Withdrawal by Subject|3|||
125527126|NCT01124097|451561292|FG002|Overall Study|Withdrawal by Subject|2|||
125527127|NCT01124097|451561293|FG003|Overall Study|Withdrawal by Subject|3|||
125527128|NCT01124097|451561290|FG000|Overall Study|Lack of Efficacy|2|||
125527129|NCT01124097|451561291|FG001|Overall Study|Lack of Efficacy|3|||
125527130|NCT01124097|451561292|FG002|Overall Study|Lack of Efficacy|1|||
125527131|NCT01124097|451561293|FG003|Overall Study|Lack of Efficacy|3|||
125527132|NCT01124097|451561290|FG000|Overall Study|Adverse Event|24|||
125527133|NCT01124097|451561291|FG001|Overall Study|Adverse Event|15|||
125527134|NCT01124097|451561292|FG002|Overall Study|Adverse Event|15|||
125527135|NCT01124097|451561293|FG003|Overall Study|Adverse Event|7|||
125527136|NCT01124097|451561290|FG000|Overall Study|Protocol Violation|2|||
125527137|NCT01124097|451561291|FG001|Overall Study|Protocol Violation|0|||
125527138|NCT01124097|451561292|FG002|Overall Study|Protocol Violation|2|||
125527139|NCT01124097|451561293|FG003|Overall Study|Protocol Violation|1|||
125527140|NCT01124097|451561290|FG000|Overall Study|Physician Decision|2|||
125527141|NCT01124097|451561291|FG001|Overall Study|Physician Decision|1|||
125527142|NCT01124097|451561292|FG002|Overall Study|Physician Decision|0|||
125527143|NCT01124097|451561293|FG003|Overall Study|Physician Decision|0|||
125527144|NCT01821937|451561294|FG000|Overall Study|Adverse Event|0|||
125527145|NCT01821937|451561295|FG001|Overall Study|Adverse Event|3|||
125527146|NCT02153905|451561296|FG000|Overall Study|Death|1|||
125527147|NCT02153905|451561297|FG001|Overall Study|Death|0|||
125527148|NCT00193479|451561298|FG000|Induction Chemotherapy|Adverse Event|2|||
125527149|NCT00193479|451561298|FG000|Induction Chemotherapy|Disease Progression|1|||
125527150|NCT00193479|451561298|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
125527151|NCT00193479|451561298|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
125527152|NCT02030002|451561299|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
125527153|NCT02030002|451561299|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
125527154|NCT02030002|451561299|FG000|Follow-up|Lost to Follow-up|2|||
125527155|NCT00609947|451561300|FG000|Overall Study|Death|1|||
125527156|NCT01304498|451561301|FG000|Overall Study|Adverse Event|1|||
125527157|NCT01304498|451561302|FG001|Overall Study|Adverse Event|1|||
125527158|NCT01304498|451561301|FG000|Overall Study|Withdrawal by Subject|2|||
125527159|NCT01304498|451561302|FG001|Overall Study|Withdrawal by Subject|3|||
125527160|NCT01304498|451561301|FG000|Overall Study|Protocol Violation|1|||
125527161|NCT01304498|451561302|FG001|Overall Study|Protocol Violation|0|||
125527162|NCT01304498|451561301|FG000|Overall Study|Lost to Follow-up|2|||
125527163|NCT01304498|451561302|FG001|Overall Study|Lost to Follow-up|1|||
125527164|NCT01834586|451561304|FG000|Overall Study|Adverse Event|1|||
125527165|NCT01667549|451561305|FG000|Overall Study|Withdrawal by Subject|3|||
125527166|NCT01667549|451561306|FG001|Overall Study|Withdrawal by Subject|5|||
125527167|NCT01667549|451561307|FG002|Overall Study|Withdrawal by Subject|7|||
125527168|NCT01667549|451561308|FG003|Overall Study|Withdrawal by Subject|6|||
125527169|NCT01667549|451561309|FG004|Overall Study|Withdrawal by Subject|1|||
125527170|NCT04210843|451561310|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
125527171|NCT04210843|451561311|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
125527172|NCT04210843|451561310|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
125527173|NCT04210843|451561311|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
125527174|NCT04210843|451561310|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
125527175|NCT04210843|451561311|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
125527176|NCT04210843|451561310|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
125527177|NCT04210843|451561311|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
125527178|NCT04210843|451561310|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
125527179|NCT04210843|451561311|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
125527180|NCT04210843|451561310|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
125527181|NCT04210843|451561311|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
125527182|NCT04210843|451561310|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
125527183|NCT04210843|451561311|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
125527184|NCT04210843|451561310|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
125527185|NCT04210843|451561311|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
125527186|NCT04210843|451561310|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
125527187|NCT04210843|451561311|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
125527188|NCT04210843|451561310|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
125527189|NCT04210843|451561311|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
125527190|NCT04210843|451561310|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
125527191|NCT04210843|451561311|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
125527192|NCT04210843|451561310|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
125527193|NCT04210843|451561311|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
125527194|NCT04210843|451561310|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
125527195|NCT04210843|451561311|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
125527196|NCT04210843|451561310|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
125527197|NCT04210843|451561311|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
125527198|NCT04210843|451561310|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
125527199|NCT04210843|451561311|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
125527200|NCT04210843|451561310|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
125527201|NCT04210843|451561311|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
125527202|NCT04210843|451561310|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
125527203|NCT04210843|451561311|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
125527204|NCT04210843|451561310|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
125527205|NCT04210843|451561311|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
125527206|NCT04210843|451561310|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
125527207|NCT04210843|451561311|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
125527208|NCT04210843|451561310|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
125527209|NCT04210843|451561311|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
125527210|NCT04210843|451561310|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
125527211|NCT04210843|451561311|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
125527212|NCT04210843|451561310|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
125527213|NCT04210843|451561311|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
125527214|NCT04210843|451561310|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
125527215|NCT04210843|451561311|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
125527216|NCT04210843|451561310|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
125527217|NCT04210843|451561311|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
125527218|NCT02844777|451561312|FG000|Overall Study|Withdrawal by Subject|2|||
125527219|NCT02844777|451561313|FG001|Overall Study|Withdrawal by Subject|0|||
125527220|NCT02844777|451561314|FG002|Overall Study|Withdrawal by Subject|0|||
125527221|NCT00150618|451561315|FG000|Overall Study|Adverse Event|2|||
125527222|NCT00150618|451561316|FG001|Overall Study|Adverse Event|2|||
125527223|NCT00150618|451561317|FG002|Overall Study|Adverse Event|6|||
125527224|NCT00150618|451561318|FG003|Overall Study|Adverse Event|9|||
125527225|NCT00150618|451561319|FG004|Overall Study|Adverse Event|5|||
125527226|NCT00150618|451561315|FG000|Overall Study|Withdrawal by Subject|6|||
125527227|NCT00150618|451561316|FG001|Overall Study|Withdrawal by Subject|8|||
125527228|NCT00150618|451561317|FG002|Overall Study|Withdrawal by Subject|8|||
125527229|NCT00150618|451561318|FG003|Overall Study|Withdrawal by Subject|4|||
125527230|NCT00150618|451561319|FG004|Overall Study|Withdrawal by Subject|5|||
125527231|NCT00150618|451561315|FG000|Overall Study|Lost to Follow-up|4|||
125527232|NCT00150618|451561316|FG001|Overall Study|Lost to Follow-up|1|||
125527233|NCT00150618|451561317|FG002|Overall Study|Lost to Follow-up|5|||
125527234|NCT00150618|451561318|FG003|Overall Study|Lost to Follow-up|8|||
125527235|NCT00150618|451561319|FG004|Overall Study|Lost to Follow-up|4|||
125527236|NCT00150618|451561315|FG000|Overall Study|Protocol Violation|1|||
125527237|NCT00150618|451561316|FG001|Overall Study|Protocol Violation|0|||
125527238|NCT00150618|451561317|FG002|Overall Study|Protocol Violation|0|||
125527239|NCT00150618|451561318|FG003|Overall Study|Protocol Violation|0|||
125527240|NCT00150618|451561319|FG004|Overall Study|Protocol Violation|1|||
125527241|NCT00150618|451561315|FG000|Overall Study|Lack of Efficacy|1|||
125527242|NCT00150618|451561316|FG001|Overall Study|Lack of Efficacy|4|||
125527243|NCT00150618|451561317|FG002|Overall Study|Lack of Efficacy|7|||
125527244|NCT00150618|451561318|FG003|Overall Study|Lack of Efficacy|4|||
125527245|NCT00150618|451561319|FG004|Overall Study|Lack of Efficacy|6|||
125527246|NCT00150618|451561315|FG000|Overall Study|No study meds|0|||
125527247|NCT00150618|451561316|FG001|Overall Study|No study meds|0|||
125527248|NCT00150618|451561317|FG002|Overall Study|No study meds|0|||
125527249|NCT00150618|451561318|FG003|Overall Study|No study meds|0|||
125527250|NCT00150618|451561319|FG004|Overall Study|No study meds|2|||
125527251|NCT00150618|451561315|FG000|Overall Study|Physician Decision|0|||
125527252|NCT00150618|451561316|FG001|Overall Study|Physician Decision|2|||
125527253|NCT00150618|451561317|FG002|Overall Study|Physician Decision|0|||
125527254|NCT00150618|451561318|FG003|Overall Study|Physician Decision|0|||
125527255|NCT00150618|451561319|FG004|Overall Study|Physician Decision|1|||
125527256|NCT00150618|451561315|FG000|Overall Study|Lack of compliance|2|||
125527257|NCT00150618|451561316|FG001|Overall Study|Lack of compliance|1|||
125527258|NCT00150618|451561317|FG002|Overall Study|Lack of compliance|1|||
125527259|NCT00150618|451561318|FG003|Overall Study|Lack of compliance|0|||
125527260|NCT00150618|451561319|FG004|Overall Study|Lack of compliance|1|||
125527261|NCT00150618|451561315|FG000|Overall Study|Abnormal ECG|1|||
125527262|NCT00150618|451561316|FG001|Overall Study|Abnormal ECG|0|||
125527263|NCT00150618|451561317|FG002|Overall Study|Abnormal ECG|0|||
125527264|NCT00150618|451561318|FG003|Overall Study|Abnormal ECG|0|||
125527265|NCT00150618|451561319|FG004|Overall Study|Abnormal ECG|0|||
125527266|NCT00150618|451561315|FG000|Overall Study|Sponsor's decision|0|||
125527267|NCT00150618|451561316|FG001|Overall Study|Sponsor's decision|0|||
125527268|NCT00150618|451561317|FG002|Overall Study|Sponsor's decision|0|||
125527269|NCT00150618|451561318|FG003|Overall Study|Sponsor's decision|1|||
125527270|NCT00150618|451561319|FG004|Overall Study|Sponsor's decision|0|||
125527271|NCT01012947|451561320|FG000|Overall Study|Lost to Follow-up|131|||
125527272|NCT01012947|451561321|FG001|Overall Study|Lost to Follow-up|135|||
125527273|NCT01012947|451561322|FG002|Overall Study|Lost to Follow-up|130|||
125527274|NCT01012947|451561323|FG003|Overall Study|Lost to Follow-up|118|||
125527275|NCT01012947|451561324|FG004|Overall Study|Lost to Follow-up|142|||
125527276|NCT01791413|451561325|FG000|Overall Study|Lost to Follow-up|5|||
125527277|NCT01791413|451561326|FG001|Overall Study|Lost to Follow-up|1|||
125527278|NCT00825305|451561327|FG000|Overall Study|Adverse Event|1|||
125527279|NCT00825305|451561328|FG001|Overall Study|Adverse Event|1|||
125527280|NCT00825305|451561327|FG000|Overall Study|Withdrawal by Subject|6|||
125527281|NCT00825305|451561328|FG001|Overall Study|Withdrawal by Subject|12|||
125527282|NCT00825305|451561327|FG000|Overall Study|Inappropriate inclusion|1|||
125527283|NCT00825305|451561328|FG001|Overall Study|Inappropriate inclusion|0|||
125527284|NCT00825305|451561327|FG000|Overall Study|Protocol Violation|9|||
125527285|NCT00825305|451561328|FG001|Overall Study|Protocol Violation|9|||
125527286|NCT00825305|451561327|FG000|Overall Study|Can not be classified|0|||
125527287|NCT00825305|451561328|FG001|Overall Study|Can not be classified|1|||
125527288|NCT04016272|451561329|FG000|Overall Study|Withdrawal by Subject|1|||
125527289|NCT04016272|451561330|FG001|Overall Study|Withdrawal by Subject|2|||
125527290|NCT02493946|451561334|FG000|DB Period|Withdrawal by Subject|8|||
125527291|NCT02493946|451561335|FG001|DB Period|Withdrawal by Subject|5|||
125527292|NCT02493946|451561336|FG002|DB Period|Withdrawal by Subject|0|||
125527293|NCT02493946|451561334|FG000|Open Label Period|Withdrawal by Subject|0|||
125527294|NCT02493946|451561335|FG001|Open Label Period|Withdrawal by Subject|0|||
125527295|NCT02493946|451561336|FG002|Open Label Period|Withdrawal by Subject|74|||
125527296|NCT02493946|451561334|FG000|Open Label Period|Adverse Event|0|||
125527297|NCT02493946|451561335|FG001|Open Label Period|Adverse Event|0|||
125527298|NCT02493946|451561336|FG002|Open Label Period|Adverse Event|4|||
125527299|NCT02493946|451561334|FG000|Open Label Period|Lost to Follow-up|0|||
125527300|NCT02493946|451561335|FG001|Open Label Period|Lost to Follow-up|0|||
125527301|NCT02493946|451561336|FG002|Open Label Period|Lost to Follow-up|1|||
125527302|NCT02493946|451561334|FG000|Open Label Period|Investigator decision, non-compliance|0|||
125527303|NCT02493946|451561335|FG001|Open Label Period|Investigator decision, non-compliance|0|||
125527304|NCT02493946|451561336|FG002|Open Label Period|Investigator decision, non-compliance|2|||
125527305|NCT02493946|451561334|FG000|Open Label Period|Investigator decision, non-availability|0|||
125527306|NCT02493946|451561335|FG001|Open Label Period|Investigator decision, non-availability|0|||
125527307|NCT02493946|451561336|FG002|Open Label Period|Investigator decision, non-availability|1|||
125527308|NCT02493946|451561334|FG000|Open Label Period|Pregnancy|0|||
125527309|NCT02493946|451561335|FG001|Open Label Period|Pregnancy|0|||
125527310|NCT02493946|451561336|FG002|Open Label Period|Pregnancy|3|||
125527311|NCT02493946|451561334|FG000|Open Label Period|Site error|0|||
125527312|NCT02493946|451561335|FG001|Open Label Period|Site error|0|||
125527313|NCT02493946|451561336|FG002|Open Label Period|Site error|1|||
125527314|NCT03355209|451561337|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
125527315|NCT03355209|451561338|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
125527316|NCT03355209|451561339|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
125527317|NCT03355209|451561340|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
125527318|NCT03355209|451561341|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
125527319|NCT03355209|451561342|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
125527320|NCT03355209|451561337|FG000|Part 1: Double-Blind Period|Death|0|||
125527321|NCT03355209|451561338|FG001|Part 1: Double-Blind Period|Death|0|||
125527322|NCT03355209|451561339|FG002|Part 1: Double-Blind Period|Death|1|||
125527323|NCT03355209|451561340|FG003|Part 1: Double-Blind Period|Death|0|||
125527324|NCT03355209|451561341|FG004|Part 1: Double-Blind Period|Death|0|||
125527325|NCT03355209|451561342|FG005|Part 1: Double-Blind Period|Death|0|||
125527326|NCT03355209|451561337|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
125527327|NCT03355209|451561338|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
125527328|NCT03355209|451561339|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
125527329|NCT03355209|451561340|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
125527330|NCT03355209|451561341|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
125527331|NCT03355209|451561342|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
125527332|NCT03355209|451561337|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
125527333|NCT03355209|451561338|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
125527334|NCT03355209|451561339|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
125527335|NCT03355209|451561340|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
125527336|NCT03355209|451561341|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
125527337|NCT03355209|451561342|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
125527338|NCT03355209|451561337|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
125527339|NCT03355209|451561338|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
125527340|NCT03355209|451561339|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
125527341|NCT03355209|451561340|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
125527342|NCT03355209|451561341|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
125527343|NCT03355209|451561342|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
125527344|NCT03355209|451561337|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
125527345|NCT03355209|451561338|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
125527346|NCT03355209|451561339|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
125527347|NCT03355209|451561340|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
125527348|NCT03355209|451561341|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
125527349|NCT03355209|451561342|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
125527350|NCT03355209|451561337|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
125527351|NCT03355209|451561338|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
125527352|NCT03355209|451561339|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
125527353|NCT03355209|451561340|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
125527354|NCT03355209|451561341|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
125527355|NCT03355209|451561342|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
125533004|NCT04047862|451581434|FG012|Overall Study|Physician Decision|0|||
125527356|NCT03355209|451561337|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
125527357|NCT03355209|451561338|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
125527358|NCT03355209|451561339|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
125527359|NCT03355209|451561340|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
125527360|NCT03355209|451561341|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
125527361|NCT03355209|451561342|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
125527362|NCT03355209|451561337|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
125527363|NCT03355209|451561338|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
125527364|NCT03355209|451561339|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
125527365|NCT03355209|451561340|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125527366|NCT03355209|451561341|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
125527367|NCT03355209|451561342|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
125527368|NCT03355209|451561337|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
125527369|NCT03355209|451561338|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
125527370|NCT03355209|451561339|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
125527371|NCT03355209|451561340|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
125527372|NCT03355209|451561341|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
125527373|NCT03355209|451561342|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
125527374|NCT03355209|451561337|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
125527375|NCT03355209|451561338|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
125527376|NCT03355209|451561339|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
125527377|NCT03355209|451561340|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
125527378|NCT03355209|451561341|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
125527379|NCT03355209|451561342|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
125527380|NCT01727505|451561344|FG000|First 24 Hours|Adverse Event|0|||
125527381|NCT01727505|451561345|FG001|First 24 Hours|Adverse Event|1|||
125527382|NCT01727505|451561344|FG000|Second 24 Hours|Missing data|0|||
125527383|NCT01727505|451561345|FG001|Second 24 Hours|Missing data|1|||
125527384|NCT02878603|451561346|FG000|Overall Study|Lost to Follow-up|4|||
125527385|NCT02878603|451561347|FG001|Overall Study|Lost to Follow-up|1|||
125527386|NCT02878603|451561346|FG000|Overall Study|Withdrawal by Subject|1|||
125527387|NCT02878603|451561347|FG001|Overall Study|Withdrawal by Subject|1|||
125527388|NCT02878603|451561346|FG000|Overall Study|Death|1|||
125527389|NCT02878603|451561347|FG001|Overall Study|Death|0|||
125527390|NCT02878603|451561346|FG000|Overall Study|Physician Decision|0|||
125527391|NCT02878603|451561347|FG001|Overall Study|Physician Decision|3|||
125527424|NCT00358644|451561352|FG000|Overall Study|Progressive Disease|21|||
125527425|NCT00358644|451561352|FG000|Overall Study|Adverse Event|7|||
125527426|NCT00358644|451561352|FG000|Overall Study|Death|11|||
125527427|NCT00358644|451561352|FG000|Overall Study|Withdrawal by Subject|4|||
125527428|NCT00358644|451561352|FG000|Overall Study|Physician Decision|6|||
125527429|NCT00358644|451561352|FG000|Overall Study|Patient not eligible for study|1|||
125527430|NCT03327831|451561353|FG000|Overall Study|Lost to Follow-up|2|||
125527431|NCT03332784|451561356|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527432|NCT03332784|451561357|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
125527433|NCT03332784|451561358|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527434|NCT03332784|451561359|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527435|NCT03332784|451561360|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527436|NCT03332784|451561361|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527437|NCT03332784|451561362|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527438|NCT03332784|451561363|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527439|NCT03332784|451561364|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527440|NCT03332784|451561365|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527441|NCT03332784|451561366|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527442|NCT03332784|451561367|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527443|NCT03332784|451561368|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527444|NCT03332784|451561369|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527445|NCT03332784|451561370|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
125527446|NCT03332784|451561371|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527447|NCT03332784|451561372|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527448|NCT03332784|451561373|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527449|NCT03332784|451561374|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527450|NCT03332784|451561375|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
125527451|NCT02498236|451561381|FG000|Overall Study|Did not show for testing|1|||
125527452|NCT02498236|451561382|FG001|Overall Study|Did not show for testing|0|||
125527453|NCT02498236|451561383|FG002|Overall Study|Did not show for testing|0|||
125527454|NCT02498236|451561384|FG003|Overall Study|Did not show for testing|0|||
125527455|NCT02498236|451561385|FG004|Overall Study|Did not show for testing|0|||
125527456|NCT02498236|451561386|FG005|Overall Study|Did not show for testing|0|||
125527457|NCT02498236|451561387|FG006|Overall Study|Did not show for testing|0|||
125527458|NCT02498236|451561388|FG007|Overall Study|Did not show for testing|1|||
125527459|NCT02498236|451561381|FG000|Overall Study|Equipment failure|0|||
125527460|NCT02498236|451561382|FG001|Overall Study|Equipment failure|0|||
125527461|NCT02498236|451561383|FG002|Overall Study|Equipment failure|0|||
125527462|NCT02498236|451561384|FG003|Overall Study|Equipment failure|0|||
125527463|NCT02498236|451561385|FG004|Overall Study|Equipment failure|0|||
125527464|NCT02498236|451561386|FG005|Overall Study|Equipment failure|0|||
125527465|NCT02498236|451561387|FG006|Overall Study|Equipment failure|1|||
125527466|NCT02498236|451561388|FG007|Overall Study|Equipment failure|0|||
125527467|NCT02498236|451561381|FG000|Overall Study|Withdrawal by Subject|0|||
125527468|NCT02498236|451561382|FG001|Overall Study|Withdrawal by Subject|0|||
125527469|NCT02498236|451561383|FG002|Overall Study|Withdrawal by Subject|0|||
125527470|NCT02498236|451561384|FG003|Overall Study|Withdrawal by Subject|0|||
125527471|NCT02498236|451561385|FG004|Overall Study|Withdrawal by Subject|1|||
125527472|NCT02498236|451561386|FG005|Overall Study|Withdrawal by Subject|0|||
125527473|NCT02498236|451561387|FG006|Overall Study|Withdrawal by Subject|0|||
125527474|NCT02498236|451561388|FG007|Overall Study|Withdrawal by Subject|0|||
125527475|NCT00383123|451561389|FG000|Overall Study|Adverse Event|1|||
125527476|NCT00383123|451561390|FG001|Overall Study|Adverse Event|0|||
125527477|NCT00383123|451561389|FG000|Overall Study|Lost to Follow-up|68|||
125527478|NCT00383123|451561390|FG001|Overall Study|Lost to Follow-up|61|||
125527479|NCT00383123|451561389|FG000|Overall Study|Protocol Violation|5|||
125527480|NCT00383123|451561390|FG001|Overall Study|Protocol Violation|1|||
125527481|NCT00383123|451561389|FG000|Overall Study|Withdrawal by Subject|27|||
125527482|NCT00383123|451561390|FG001|Overall Study|Withdrawal by Subject|18|||
125527483|NCT00383123|451561389|FG000|Overall Study|Other reason|10|||
125527484|NCT00383123|451561390|FG001|Overall Study|Other reason|6|||
125527485|NCT01814072|451561391|FG000|Overall Study|Lost to Follow-up|2|||
125527486|NCT01814072|451561392|FG001|Overall Study|Lost to Follow-up|2|||
125527487|NCT01814072|451561393|FG002|Overall Study|Lost to Follow-up|2|||
125527488|NCT01814072|451561394|FG003|Overall Study|Lost to Follow-up|0|||
125527489|NCT01814072|451561395|FG004|Overall Study|Lost to Follow-up|2|||
125527490|NCT01814072|451561396|FG005|Overall Study|Lost to Follow-up|3|||
125527491|NCT01814072|451561397|FG006|Overall Study|Lost to Follow-up|3|||
125527492|NCT01814072|451561398|FG007|Overall Study|Lost to Follow-up|1|||
125527493|NCT01814072|451561399|FG008|Overall Study|Lost to Follow-up|2|||
125527494|NCT01814072|451561400|FG009|Overall Study|Lost to Follow-up|3|||
125527495|NCT01814072|451561401|FG010|Overall Study|Lost to Follow-up|1|||
125527496|NCT01814072|451561402|FG011|Overall Study|Lost to Follow-up|2|||
125527497|NCT01814072|451561403|FG012|Overall Study|Lost to Follow-up|2|||
125527498|NCT01814072|451561404|FG013|Overall Study|Lost to Follow-up|1|||
125527499|NCT01814072|451561405|FG014|Overall Study|Lost to Follow-up|2|||
125527500|NCT01814072|451561406|FG015|Overall Study|Lost to Follow-up|1|||
125527501|NCT01814072|451561407|FG016|Overall Study|Lost to Follow-up|3|||
125527502|NCT01814072|451561408|FG017|Overall Study|Lost to Follow-up|1|||
125527503|NCT01814072|451561409|FG018|Overall Study|Lost to Follow-up|3|||
125527504|NCT01814072|451561410|FG019|Overall Study|Lost to Follow-up|3|||
125527505|NCT01814072|451561411|FG020|Overall Study|Lost to Follow-up|2|||
125527506|NCT01814072|451561412|FG021|Overall Study|Lost to Follow-up|1|||
125527507|NCT01814072|451561413|FG022|Overall Study|Lost to Follow-up|3|||
125527508|NCT01814072|451561414|FG023|Overall Study|Lost to Follow-up|1|||
125527509|NCT01814072|451561415|FG024|Overall Study|Lost to Follow-up|4|||
125527510|NCT01814072|451561416|FG025|Overall Study|Lost to Follow-up|1|||
125527511|NCT01814072|451561417|FG026|Overall Study|Lost to Follow-up|1|||
125527512|NCT01814072|451561418|FG027|Overall Study|Lost to Follow-up|2|||
125527513|NCT01814072|451561419|FG028|Overall Study|Lost to Follow-up|3|||
125527514|NCT01814072|451561420|FG029|Overall Study|Lost to Follow-up|3|||
125527515|NCT01814072|451561421|FG030|Overall Study|Lost to Follow-up|2|||
125527516|NCT01814072|451561422|FG031|Overall Study|Lost to Follow-up|0|||
125527517|NCT01814072|451561391|FG000|Overall Study|Withdrawal by Subject|2|||
125527518|NCT01814072|451561392|FG001|Overall Study|Withdrawal by Subject|0|||
125527519|NCT01814072|451561393|FG002|Overall Study|Withdrawal by Subject|1|||
125527520|NCT01814072|451561394|FG003|Overall Study|Withdrawal by Subject|0|||
125527521|NCT01814072|451561395|FG004|Overall Study|Withdrawal by Subject|2|||
125527522|NCT01814072|451561396|FG005|Overall Study|Withdrawal by Subject|3|||
125527523|NCT01814072|451561397|FG006|Overall Study|Withdrawal by Subject|1|||
125527524|NCT01814072|451561398|FG007|Overall Study|Withdrawal by Subject|0|||
125527525|NCT01814072|451561399|FG008|Overall Study|Withdrawal by Subject|1|||
125527526|NCT01814072|451561400|FG009|Overall Study|Withdrawal by Subject|2|||
125527527|NCT01814072|451561401|FG010|Overall Study|Withdrawal by Subject|0|||
125527528|NCT01814072|451561402|FG011|Overall Study|Withdrawal by Subject|0|||
125527529|NCT01814072|451561403|FG012|Overall Study|Withdrawal by Subject|1|||
125527530|NCT01814072|451561404|FG013|Overall Study|Withdrawal by Subject|1|||
125527531|NCT01814072|451561405|FG014|Overall Study|Withdrawal by Subject|1|||
125527532|NCT01814072|451561406|FG015|Overall Study|Withdrawal by Subject|1|||
125527533|NCT01814072|451561407|FG016|Overall Study|Withdrawal by Subject|0|||
125527534|NCT01814072|451561408|FG017|Overall Study|Withdrawal by Subject|0|||
125527535|NCT01814072|451561409|FG018|Overall Study|Withdrawal by Subject|0|||
125527536|NCT01814072|451561410|FG019|Overall Study|Withdrawal by Subject|2|||
125527537|NCT01814072|451561411|FG020|Overall Study|Withdrawal by Subject|0|||
125527538|NCT01814072|451561412|FG021|Overall Study|Withdrawal by Subject|0|||
125527539|NCT01814072|451561413|FG022|Overall Study|Withdrawal by Subject|1|||
125527540|NCT01814072|451561414|FG023|Overall Study|Withdrawal by Subject|0|||
125527541|NCT01814072|451561415|FG024|Overall Study|Withdrawal by Subject|2|||
125527542|NCT01814072|451561416|FG025|Overall Study|Withdrawal by Subject|1|||
125527543|NCT01814072|451561417|FG026|Overall Study|Withdrawal by Subject|1|||
125527544|NCT01814072|451561418|FG027|Overall Study|Withdrawal by Subject|2|||
125527545|NCT01814072|451561419|FG028|Overall Study|Withdrawal by Subject|1|||
125527546|NCT01814072|451561420|FG029|Overall Study|Withdrawal by Subject|0|||
125527547|NCT01814072|451561421|FG030|Overall Study|Withdrawal by Subject|0|||
125527548|NCT01814072|451561422|FG031|Overall Study|Withdrawal by Subject|0|||
125527549|NCT02336425|451561423|FG000|Overall Study|Study terminated.|2|||
125527550|NCT02336425|451561424|FG001|Overall Study|Study terminated.|2|||
125527551|NCT02336425|451561425|FG002|Overall Study|Study terminated.|3|||
125527552|NCT02336425|451561426|FG003|Overall Study|Study terminated.|3|||
125527553|NCT00978562|451561427|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
125527554|NCT01782690|451561428|FG000|Overall Study|Not reported|7|||
125527555|NCT01782690|451561428|FG000|Overall Study|Toxicity of gemcitabine|1|||
125527556|NCT01782690|451561428|FG000|Overall Study|Toxicity of erlotinib|1|||
125527557|NCT01782690|451561428|FG000|Overall Study|Lost to Follow-up|31|||
125527558|NCT01782690|451561428|FG000|Overall Study|Withdrawal of informed consent|2|||
125527559|NCT01782690|451561428|FG000|Overall Study|Absent rash|9|||
125527560|NCT01782690|451561428|FG000|Overall Study|Physician Decision|13|||
125527561|NCT01782690|451561428|FG000|Overall Study|Patient's wish|21|||
125527562|NCT01782690|451561428|FG000|Overall Study|Tumor progression|74|||
125527563|NCT01782690|451561428|FG000|Overall Study|Death|133|||
125527564|NCT01782690|451561428|FG000|Overall Study|Study completion unknown|7|||
125527565|NCT04946942|451561430|FG000|Overall Study|Lost to Follow-up|6|||
125527566|NCT04946942|451561431|FG001|Overall Study|Lost to Follow-up|2|||
125527567|NCT04946942|451561432|FG002|Overall Study|Lost to Follow-up|0|||
125527568|NCT04907357|451561433|FG000|Overall Study|Death|0|||
125527569|NCT04907357|451561434|FG001|Overall Study|Death|1|||
125527570|NCT04907357|451561433|FG000|Overall Study|Lost to Follow-up|9|||
125527571|NCT04907357|451561434|FG001|Overall Study|Lost to Follow-up|18|||
125527572|NCT04907357|451561433|FG000|Overall Study|Physician Decision|1|||
125527573|NCT04907357|451561434|FG001|Overall Study|Physician Decision|0|||
125527574|NCT04907357|451561433|FG000|Overall Study|Withdrawal by Subject|0|||
125527575|NCT04907357|451561434|FG001|Overall Study|Withdrawal by Subject|1|||
125527576|NCT04907357|451561433|FG000|Overall Study|Unable to attend visits|1|||
125527577|NCT04907357|451561434|FG001|Overall Study|Unable to attend visits|0|||
125527578|NCT04907357|451561433|FG000|Overall Study|Incarcerated|1|||
125527579|NCT04907357|451561434|FG001|Overall Study|Incarcerated|1|||
125527580|NCT01948076|451561435|FG000|Overall Study|Withdrawal by Subject|0|||
125527581|NCT01948076|451561436|FG001|Overall Study|Withdrawal by Subject|1|||
125527582|NCT00344032|451561445|FG000|Overall Study|Adverse Event|0|||
125527583|NCT00344032|451561446|FG001|Overall Study|Adverse Event|1|||
125527584|NCT00344032|451561445|FG000|Overall Study|Withdrawal by Subject|6|||
125527585|NCT00344032|451561446|FG001|Overall Study|Withdrawal by Subject|2|||
125527586|NCT00344032|451561445|FG000|Overall Study|Lost to Follow-up|4|||
125527587|NCT00344032|451561446|FG001|Overall Study|Lost to Follow-up|6|||
125527588|NCT00344032|451561445|FG000|Overall Study|Physician Decision|4|||
125527589|NCT00344032|451561446|FG001|Overall Study|Physician Decision|1|||
125527590|NCT02065882|451561447|FG000|Part I: PK/PD|Screening failure|5|||
125527591|NCT02065882|451561447|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
125527592|NCT02065882|451561447|FG000|Part I: PK/PD|Adverse Event|1|||
125527593|NCT02065882|451561447|FG000|Part II: Clinical Efficacy|Screening failure|7|||
125527594|NCT02065882|451561447|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
125527595|NCT02065882|451561447|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
125527596|NCT02065882|451561447|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
125527597|NCT02065882|451561447|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
125527598|NCT02065882|451561447|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
125527599|NCT03192462|451563442|FG000|Overall Study|Death|13|||
125527600|NCT03192462|451563443|FG001|Overall Study|Death|11|||
125527601|NCT03192462|451563444|FG002|Overall Study|Death|9|||
125527602|NCT03192462|451563442|FG000|Overall Study|Lost to Follow-up|0|||
125527603|NCT03192462|451563443|FG001|Overall Study|Lost to Follow-up|1|||
125527604|NCT03192462|451563444|FG002|Overall Study|Lost to Follow-up|0|||
125527605|NCT03192462|451563442|FG000|Overall Study|On follow up|0|||
125527606|NCT03192462|451563443|FG001|Overall Study|On follow up|0|||
125527607|NCT03192462|451563444|FG002|Overall Study|On follow up|3|||
125527608|NCT02419417|451563445|FG000|Overall Study|Disease progression|5|||
125527609|NCT02419417|451563446|FG001|Overall Study|Disease progression|4|||
125527610|NCT02419417|451563447|FG002|Overall Study|Disease progression|13|||
125527611|NCT02419417|451563448|FG003|Overall Study|Disease progression|10|||
125527612|NCT02419417|451563449|FG004|Overall Study|Disease progression|10|||
125527613|NCT02419417|451563450|FG005|Overall Study|Disease progression|3|||
125527614|NCT02419417|451563451|FG006|Overall Study|Disease progression|4|||
125527615|NCT02419417|451563452|FG007|Overall Study|Disease progression|5|||
125527616|NCT02419417|451563453|FG008|Overall Study|Disease progression|13|||
125527617|NCT02419417|451563454|FG009|Overall Study|Disease progression|9|||
125527618|NCT02419417|451563455|FG010|Overall Study|Disease progression|0|||
125527619|NCT02419417|451563445|FG000|Overall Study|Study drug toxicity|0|||
125527620|NCT02419417|451563446|FG001|Overall Study|Study drug toxicity|0|||
125527621|NCT02419417|451563447|FG002|Overall Study|Study drug toxicity|0|||
125527622|NCT02419417|451563448|FG003|Overall Study|Study drug toxicity|0|||
125527623|NCT02419417|451563449|FG004|Overall Study|Study drug toxicity|1|||
125527624|NCT02419417|451563450|FG005|Overall Study|Study drug toxicity|0|||
125527625|NCT02419417|451563451|FG006|Overall Study|Study drug toxicity|0|||
125527626|NCT02419417|451563452|FG007|Overall Study|Study drug toxicity|0|||
125527627|NCT02419417|451563453|FG008|Overall Study|Study drug toxicity|0|||
125527628|NCT02419417|451563454|FG009|Overall Study|Study drug toxicity|0|||
125527629|NCT02419417|451563455|FG010|Overall Study|Study drug toxicity|0|||
125527630|NCT02419417|451563445|FG000|Overall Study|Adverse event unrelated to study drug|0|||
125527631|NCT02419417|451563446|FG001|Overall Study|Adverse event unrelated to study drug|0|||
125527632|NCT02419417|451563447|FG002|Overall Study|Adverse event unrelated to study drug|0|||
125527633|NCT02419417|451563448|FG003|Overall Study|Adverse event unrelated to study drug|0|||
125527634|NCT02419417|451563449|FG004|Overall Study|Adverse event unrelated to study drug|2|||
125527635|NCT02419417|451563450|FG005|Overall Study|Adverse event unrelated to study drug|1|||
125527636|NCT02419417|451563451|FG006|Overall Study|Adverse event unrelated to study drug|0|||
125527637|NCT02419417|451563452|FG007|Overall Study|Adverse event unrelated to study drug|1|||
125527638|NCT02419417|451563453|FG008|Overall Study|Adverse event unrelated to study drug|0|||
125527639|NCT02419417|451563454|FG009|Overall Study|Adverse event unrelated to study drug|0|||
125527640|NCT02419417|451563455|FG010|Overall Study|Adverse event unrelated to study drug|0|||
125527641|NCT02419417|451563445|FG000|Overall Study|Participant request to discontinue|0|||
125527642|NCT02419417|451563446|FG001|Overall Study|Participant request to discontinue|0|||
125527643|NCT02419417|451563447|FG002|Overall Study|Participant request to discontinue|0|||
125527644|NCT02419417|451563448|FG003|Overall Study|Participant request to discontinue|0|||
125527645|NCT02419417|451563449|FG004|Overall Study|Participant request to discontinue|0|||
125527646|NCT02419417|451563450|FG005|Overall Study|Participant request to discontinue|0|||
125527647|NCT02419417|451563451|FG006|Overall Study|Participant request to discontinue|0|||
125527648|NCT02419417|451563452|FG007|Overall Study|Participant request to discontinue|0|||
125527649|NCT02419417|451563453|FG008|Overall Study|Participant request to discontinue|0|||
125527650|NCT02419417|451563454|FG009|Overall Study|Participant request to discontinue|1|||
125527651|NCT02419417|451563455|FG010|Overall Study|Participant request to discontinue|0|||
125527652|NCT02419417|451563445|FG000|Overall Study|Withdrawal by Subject|0|||
125527653|NCT02419417|451563446|FG001|Overall Study|Withdrawal by Subject|0|||
125527654|NCT02419417|451563447|FG002|Overall Study|Withdrawal by Subject|0|||
125527655|NCT02419417|451563448|FG003|Overall Study|Withdrawal by Subject|0|||
125527656|NCT02419417|451563449|FG004|Overall Study|Withdrawal by Subject|0|||
125527657|NCT02419417|451563450|FG005|Overall Study|Withdrawal by Subject|0|||
125527658|NCT02419417|451563451|FG006|Overall Study|Withdrawal by Subject|0|||
125527659|NCT02419417|451563452|FG007|Overall Study|Withdrawal by Subject|0|||
125527660|NCT02419417|451563453|FG008|Overall Study|Withdrawal by Subject|0|||
125527661|NCT02419417|451563454|FG009|Overall Study|Withdrawal by Subject|0|||
125527662|NCT02419417|451563455|FG010|Overall Study|Withdrawal by Subject|1|||
125527663|NCT00078377|451563456|FG000|Overall Study|Adverse Event|2|||
125527664|NCT00078377|451563457|FG001|Overall Study|Adverse Event|5|||
125527665|NCT00078377|451563458|FG002|Overall Study|Adverse Event|1|||
125527666|NCT00078377|451563456|FG000|Overall Study|Lack of Efficacy|2|||
125527667|NCT00078377|451563457|FG001|Overall Study|Lack of Efficacy|0|||
125527668|NCT00078377|451563458|FG002|Overall Study|Lack of Efficacy|2|||
125527669|NCT00078377|451563456|FG000|Overall Study|Lost to Follow-up|0|||
125527670|NCT00078377|451563457|FG001|Overall Study|Lost to Follow-up|1|||
125527671|NCT00078377|451563458|FG002|Overall Study|Lost to Follow-up|1|||
125527672|NCT00078377|451563456|FG000|Overall Study|Physician Decision|2|||
125527673|NCT00078377|451563457|FG001|Overall Study|Physician Decision|0|||
125527674|NCT00078377|451563458|FG002|Overall Study|Physician Decision|0|||
125527675|NCT00078377|451563456|FG000|Overall Study|Withdrawal by Subject|3|||
125527676|NCT00078377|451563457|FG001|Overall Study|Withdrawal by Subject|4|||
125527677|NCT00078377|451563458|FG002|Overall Study|Withdrawal by Subject|4|||
125527678|NCT00078377|451563456|FG000|Overall Study|Miscellaneous|2|||
125527679|NCT00078377|451563457|FG001|Overall Study|Miscellaneous|6|||
125527680|NCT00078377|451563458|FG002|Overall Study|Miscellaneous|1|||
125527681|NCT00581893|451563459|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
125527682|NCT00581893|451563460|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
125527683|NCT00233480|451563461|FG000|Overall Study|Underwent status II heart transplant|0|||
125527684|NCT00233480|451563462|FG001|Overall Study|Underwent status II heart transplant|1|||
125527685|NCT00790400|451563465|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
125527686|NCT00790400|451563466|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
125527687|NCT00790400|451563465|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
125527688|NCT00790400|451563466|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
125527689|NCT00790400|451563465|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
125527690|NCT00790400|451563466|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
125527691|NCT00790400|451563465|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
125527692|NCT00790400|451563466|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
125527693|NCT00790400|451563465|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
125527694|NCT00790400|451563466|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
125527695|NCT00790400|451563465|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
125527696|NCT00790400|451563466|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
125527697|NCT00790400|451563465|FG000|Double-blind Period (Core Phase)|Death|1|||
125527698|NCT00790400|451563466|FG001|Double-blind Period (Core Phase)|Death|0|||
125527699|NCT00790400|451563465|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
125527700|NCT00790400|451563466|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
125527701|NCT00790400|451563465|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
125527702|NCT00790400|451563466|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
125527703|NCT00790400|451563465|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
125527704|NCT00790400|451563466|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
125527705|NCT00790400|451563465|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
125527706|NCT00790400|451563466|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
125527707|NCT00790400|451563465|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
125527708|NCT00790400|451563466|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
125527709|NCT00790400|451563465|FG000|Everolimus Period (Core or Extension)|Death|1|||
125527710|NCT00790400|451563466|FG001|Everolimus Period (Core or Extension)|Death|0|||
125527711|NCT00790400|451563465|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
125527712|NCT00790400|451563466|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
125527713|NCT00790400|451563465|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
125527714|NCT00790400|451563466|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
125527715|NCT00790400|451563465|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
125527716|NCT00790400|451563466|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
125527717|NCT00944229|451563469|FG000|Overall Study|Withdrawal by Subject|11|||
125527718|NCT00944229|451563469|FG000|Overall Study|Physician Decision|14|||
125527719|NCT04292470|451563470|FG000|Overall Study|Withdrawal by Subject|0|||
125527720|NCT04292470|451563471|FG001|Overall Study|Withdrawal by Subject|1|||
125527721|NCT02906020|451563472|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
125527722|NCT02906020|451563473|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
125527723|NCT02906020|451563474|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
125527724|NCT02906020|451563475|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
125527725|NCT02906020|451563476|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
125527726|NCT02906020|451563477|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
125527727|NCT02906020|451563478|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
125527728|NCT02906020|451563479|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
125527729|NCT02906020|451563480|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
125527730|NCT02906020|451563481|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
125527731|NCT02906020|451563482|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
125527732|NCT02906020|451563483|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
125527733|NCT02906020|451563484|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
125527734|NCT02906020|451563485|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
125527735|NCT02906020|451563486|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
125527736|NCT02906020|451563487|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
125527737|NCT02906020|451563472|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527738|NCT02906020|451563473|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527739|NCT02906020|451563474|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527740|NCT02906020|451563475|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527741|NCT02906020|451563476|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527742|NCT02906020|451563477|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527743|NCT02906020|451563478|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527744|NCT02906020|451563479|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527745|NCT02906020|451563480|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
125527746|NCT02906020|451563481|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
125527747|NCT02906020|451563482|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527748|NCT02906020|451563483|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527749|NCT02906020|451563484|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527750|NCT02906020|451563485|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527751|NCT02906020|451563486|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527752|NCT02906020|451563487|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
125527753|NCT02906020|451563472|FG000|Part 2: Double-blind Treatment Period|Other|0|||
125527754|NCT02906020|451563473|FG001|Part 2: Double-blind Treatment Period|Other|0|||
125527755|NCT02906020|451563474|FG002|Part 2: Double-blind Treatment Period|Other|0|||
125527756|NCT02906020|451563475|FG003|Part 2: Double-blind Treatment Period|Other|0|||
125527757|NCT02906020|451563476|FG004|Part 2: Double-blind Treatment Period|Other|0|||
125527758|NCT02906020|451563477|FG005|Part 2: Double-blind Treatment Period|Other|0|||
125527759|NCT02906020|451563478|FG006|Part 2: Double-blind Treatment Period|Other|0|||
125527760|NCT02906020|451563479|FG007|Part 2: Double-blind Treatment Period|Other|0|||
125527761|NCT02906020|451563480|FG008|Part 2: Double-blind Treatment Period|Other|6|||
125527762|NCT02906020|451563481|FG009|Part 2: Double-blind Treatment Period|Other|10|||
125527763|NCT02906020|451563482|FG010|Part 2: Double-blind Treatment Period|Other|0|||
125527764|NCT02906020|451563483|FG011|Part 2: Double-blind Treatment Period|Other|0|||
125527765|NCT02906020|451563484|FG012|Part 2: Double-blind Treatment Period|Other|0|||
125527766|NCT02906020|451563485|FG013|Part 2: Double-blind Treatment Period|Other|0|||
125527767|NCT02906020|451563486|FG014|Part 2: Double-blind Treatment Period|Other|0|||
125527768|NCT02906020|451563487|FG015|Part 2: Double-blind Treatment Period|Other|0|||
125527769|NCT02906020|451563472|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527770|NCT02906020|451563473|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527771|NCT02906020|451563474|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527772|NCT02906020|451563475|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527773|NCT02906020|451563476|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527774|NCT02906020|451563477|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527775|NCT02906020|451563478|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527776|NCT02906020|451563479|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527777|NCT02906020|451563480|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527778|NCT02906020|451563481|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527779|NCT02906020|451563482|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527780|NCT02906020|451563483|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527781|NCT02906020|451563484|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
125527782|NCT02906020|451563485|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
125527783|NCT02906020|451563486|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527784|NCT02906020|451563487|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
125527785|NCT02906020|451563472|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
125527786|NCT02906020|451563473|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
125527787|NCT02906020|451563474|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
125527788|NCT02906020|451563475|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
125527789|NCT02906020|451563476|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
125527790|NCT02906020|451563477|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
125527791|NCT02906020|451563478|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
125527792|NCT02906020|451563479|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
125527793|NCT02906020|451563480|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
125527794|NCT02906020|451563481|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
125527795|NCT02906020|451563482|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
125527796|NCT02906020|451563483|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
125527797|NCT02906020|451563484|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
125527798|NCT02906020|451563485|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
125527799|NCT02906020|451563486|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
125527800|NCT02906020|451563487|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
125527801|NCT02906020|451563472|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527802|NCT02906020|451563473|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527803|NCT02906020|451563474|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527804|NCT02906020|451563475|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527805|NCT02906020|451563476|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527806|NCT02906020|451563477|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527807|NCT02906020|451563478|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527808|NCT02906020|451563479|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527809|NCT02906020|451563480|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527810|NCT02906020|451563481|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527811|NCT02906020|451563482|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527812|NCT02906020|451563483|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527813|NCT02906020|451563484|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
125527814|NCT02906020|451563485|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
125527815|NCT02906020|451563486|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527816|NCT02906020|451563487|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
125527817|NCT02906020|451563472|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527818|NCT02906020|451563473|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527819|NCT02906020|451563474|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527820|NCT02906020|451563475|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527821|NCT02906020|451563476|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527822|NCT02906020|451563477|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527823|NCT02906020|451563478|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527824|NCT02906020|451563479|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527825|NCT02906020|451563480|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527826|NCT02906020|451563481|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527827|NCT02906020|451563482|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527828|NCT02906020|451563483|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527829|NCT02906020|451563484|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
125527830|NCT02906020|451563485|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
125527831|NCT02906020|451563486|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527832|NCT02906020|451563487|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
125527833|NCT02906020|451563472|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
125527834|NCT02906020|451563473|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
125527835|NCT02906020|451563474|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
125527836|NCT02906020|451563475|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
125527837|NCT02906020|451563476|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
125527838|NCT02906020|451563477|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
125527839|NCT02906020|451563478|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
125527840|NCT02906020|451563479|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
125527841|NCT02906020|451563480|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
125527842|NCT02906020|451563481|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
125527843|NCT02906020|451563482|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
125527844|NCT02906020|451563483|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
125527845|NCT02906020|451563484|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
125527846|NCT02906020|451563485|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
125527847|NCT02906020|451563486|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
125527848|NCT02906020|451563487|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
125527849|NCT02906020|451563472|FG000|Part 2: Long-term Follow-up Period|Other|0|||
125527850|NCT02906020|451563473|FG001|Part 2: Long-term Follow-up Period|Other|0|||
125527851|NCT02906020|451563474|FG002|Part 2: Long-term Follow-up Period|Other|0|||
125527852|NCT02906020|451563475|FG003|Part 2: Long-term Follow-up Period|Other|0|||
125527853|NCT02906020|451563476|FG004|Part 2: Long-term Follow-up Period|Other|0|||
125527854|NCT02906020|451563477|FG005|Part 2: Long-term Follow-up Period|Other|0|||
125527855|NCT02906020|451563478|FG006|Part 2: Long-term Follow-up Period|Other|0|||
125527856|NCT02906020|451563479|FG007|Part 2: Long-term Follow-up Period|Other|0|||
125527857|NCT02906020|451563480|FG008|Part 2: Long-term Follow-up Period|Other|0|||
125527858|NCT02906020|451563481|FG009|Part 2: Long-term Follow-up Period|Other|0|||
125527859|NCT02906020|451563482|FG010|Part 2: Long-term Follow-up Period|Other|0|||
125527860|NCT02906020|451563483|FG011|Part 2: Long-term Follow-up Period|Other|0|||
125527861|NCT02906020|451563484|FG012|Part 2: Long-term Follow-up Period|Other|13|||
125527862|NCT02906020|451563485|FG013|Part 2: Long-term Follow-up Period|Other|8|||
125527863|NCT02906020|451563486|FG014|Part 2: Long-term Follow-up Period|Other|3|||
125527864|NCT02906020|451563487|FG015|Part 2: Long-term Follow-up Period|Other|2|||
125527865|NCT00884650|451563489|FG000|Overall Study|Did not return complete pain diaries|7|||
125527866|NCT00884650|451563490|FG001|Overall Study|Did not return complete pain diaries|7|||
125527867|NCT00884650|451563489|FG000|Overall Study|Admitted Post-Op|1|||
125527868|NCT00884650|451563490|FG001|Overall Study|Admitted Post-Op|0|||
125527869|NCT00884650|451563489|FG000|Overall Study|Femoral Stress Fracture|1|||
125527870|NCT00884650|451563490|FG001|Overall Study|Femoral Stress Fracture|0|||
125527871|NCT00884650|451563489|FG000|Overall Study|Pain Pump Complication|0|||
125527872|NCT00884650|451563490|FG001|Overall Study|Pain Pump Complication|1|||
125527873|NCT01594827|451563496|FG000|Overall Study|Adverse Event|1|||
125527874|NCT01594827|451563497|FG001|Overall Study|Adverse Event|0|||
125527875|NCT01594827|451563496|FG000|Overall Study|Physician Decision|3|||
125527876|NCT01594827|451563497|FG001|Overall Study|Physician Decision|0|||
125527877|NCT01607879|451563502|FG000|Overall Study|Death|1|||
125527878|NCT01607879|451563503|FG001|Overall Study|Death|0|||
125527879|NCT01592045|451563504|FG000|Overall Study|Disease Progression|1|||
125527880|NCT01592045|451563505|FG001|Overall Study|Disease Progression|1|||
125527881|NCT01592045|451563504|FG000|Overall Study|Adverse Event|1|||
125527882|NCT01592045|451563505|FG001|Overall Study|Adverse Event|1|||
125527883|NCT01592045|451563504|FG000|Overall Study|Withdrawal by Subject|1|||
125527884|NCT01592045|451563505|FG001|Overall Study|Withdrawal by Subject|0|||
125527885|NCT01592045|451563504|FG000|Overall Study|Moved out of country|2|||
125527886|NCT01592045|451563505|FG001|Overall Study|Moved out of country|0|||
125527887|NCT03994731|451563506|FG000|Pegloticase + IMM Period|Death|2|||
125527888|NCT03994731|451563507|FG001|Pegloticase + IMM Period|Death|0|||
125527889|NCT03994731|451563506|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
125527890|NCT03994731|451563507|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
125527891|NCT03994731|451563506|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
125527892|NCT03994731|451563507|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
125527893|NCT02406248|451563510|FG000|Overall Study|Death|7|||
125527894|NCT02406248|451563510|FG000|Overall Study|Withdrawal by Subject|2|||
125527895|NCT03812029|451563516|FG000|Overall Study|Protocol Violation|1|||
125527896|NCT03812029|451563517|FG001|Overall Study|Protocol Violation|0|||
125527897|NCT03812029|451563518|FG002|Overall Study|Protocol Violation|0|||
125527898|NCT03812029|451563519|FG003|Overall Study|Protocol Violation|1|||
125527899|NCT03812029|451563520|FG004|Overall Study|Protocol Violation|0|||
125527900|NCT03812029|451563516|FG000|Overall Study|Withdrawal by Subject|1|||
125527901|NCT03812029|451563517|FG001|Overall Study|Withdrawal by Subject|0|||
125527902|NCT03812029|451563518|FG002|Overall Study|Withdrawal by Subject|0|||
125527903|NCT03812029|451563519|FG003|Overall Study|Withdrawal by Subject|2|||
125527904|NCT03812029|451563520|FG004|Overall Study|Withdrawal by Subject|2|||
125527905|NCT03812029|451563516|FG000|Overall Study|Stopping rules|0|||
125527906|NCT03812029|451563517|FG001|Overall Study|Stopping rules|1|||
125527907|NCT03812029|451563518|FG002|Overall Study|Stopping rules|0|||
125527908|NCT03812029|451563519|FG003|Overall Study|Stopping rules|0|||
125527909|NCT03812029|451563520|FG004|Overall Study|Stopping rules|0|||
125527910|NCT03812029|451563516|FG000|Overall Study|Adverse Event|0|||
125527911|NCT03812029|451563517|FG001|Overall Study|Adverse Event|9|||
125527912|NCT03812029|451563518|FG002|Overall Study|Adverse Event|0|||
125527913|NCT03812029|451563519|FG003|Overall Study|Adverse Event|3|||
125527914|NCT03812029|451563520|FG004|Overall Study|Adverse Event|5|||
125527915|NCT03812029|451563516|FG000|Overall Study|Lost to Follow-up|0|||
125527916|NCT03812029|451563517|FG001|Overall Study|Lost to Follow-up|0|||
125527917|NCT03812029|451563518|FG002|Overall Study|Lost to Follow-up|0|||
125527918|NCT03812029|451563519|FG003|Overall Study|Lost to Follow-up|0|||
125527919|NCT03812029|451563520|FG004|Overall Study|Lost to Follow-up|3|||
125527920|NCT03149042|451563521|FG000|Overall Study|Invasive FFR not performed|21|||
125527921|NCT03149042|451563521|FG000|Overall Study|Poor CT Image Quality|1|||
125527922|NCT03149042|451563521|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
125527923|NCT00790205|451563522|FG000|Overall Study|Lost to Follow-up|61|||
125527924|NCT00790205|451563523|FG001|Overall Study|Lost to Follow-up|71|||
125527925|NCT00790205|451563522|FG000|Overall Study|Withdrawal by Subject|299|||
125527926|NCT00790205|451563523|FG001|Overall Study|Withdrawal by Subject|363|||
125527927|NCT04092452|451563539|FG000|Overall Study|Adverse Event|1|||
125527928|NCT04092452|451563540|FG001|Overall Study|Adverse Event|3|||
125527929|NCT04092452|451563541|FG002|Overall Study|Adverse Event|3|||
125527930|NCT04092452|451563542|FG003|Overall Study|Adverse Event|7|||
125527931|NCT04092452|451563539|FG000|Overall Study|Lack of Efficacy|1|||
125527932|NCT04092452|451563540|FG001|Overall Study|Lack of Efficacy|1|||
125527933|NCT04092452|451563541|FG002|Overall Study|Lack of Efficacy|1|||
125527934|NCT04092452|451563542|FG003|Overall Study|Lack of Efficacy|0|||
125527935|NCT04092452|451563539|FG000|Overall Study|Lost to Follow-up|4|||
125527936|NCT04092452|451563540|FG001|Overall Study|Lost to Follow-up|3|||
125527937|NCT04092452|451563541|FG002|Overall Study|Lost to Follow-up|5|||
125527938|NCT04092452|451563542|FG003|Overall Study|Lost to Follow-up|1|||
125527939|NCT04092452|451563539|FG000|Overall Study|Non-Compliance With Study Drug|0|||
125527940|NCT04092452|451563540|FG001|Overall Study|Non-Compliance With Study Drug|0|||
125527941|NCT04092452|451563541|FG002|Overall Study|Non-Compliance With Study Drug|1|||
125527942|NCT04092452|451563542|FG003|Overall Study|Non-Compliance With Study Drug|1|||
125527943|NCT04092452|451563539|FG000|Overall Study|Physician Decision|1|||
125527944|NCT04092452|451563540|FG001|Overall Study|Physician Decision|0|||
125527945|NCT04092452|451563541|FG002|Overall Study|Physician Decision|1|||
125527946|NCT04092452|451563542|FG003|Overall Study|Physician Decision|0|||
125527947|NCT04092452|451563539|FG000|Overall Study|Pregnancy|2|||
125527948|NCT04092452|451563540|FG001|Overall Study|Pregnancy|0|||
125527949|NCT04092452|451563541|FG002|Overall Study|Pregnancy|0|||
125527950|NCT04092452|451563542|FG003|Overall Study|Pregnancy|0|||
125527951|NCT04092452|451563539|FG000|Overall Study|Protocol Deviation|1|||
125527952|NCT04092452|451563540|FG001|Overall Study|Protocol Deviation|0|||
125527953|NCT04092452|451563541|FG002|Overall Study|Protocol Deviation|0|||
125527954|NCT04092452|451563542|FG003|Overall Study|Protocol Deviation|0|||
125527955|NCT04092452|451563539|FG000|Overall Study|Withdrawal by Subject|3|||
125527956|NCT04092452|451563540|FG001|Overall Study|Withdrawal by Subject|10|||
125527957|NCT04092452|451563541|FG002|Overall Study|Withdrawal by Subject|3|||
125527958|NCT04092452|451563542|FG003|Overall Study|Withdrawal by Subject|5|||
125527959|NCT04092452|451563539|FG000|Overall Study|Other|0|||
125527960|NCT04092452|451563540|FG001|Overall Study|Other|0|||
125527961|NCT04092452|451563541|FG002|Overall Study|Other|1|||
125527962|NCT04092452|451563542|FG003|Overall Study|Other|2|||
125527963|NCT02127125|451563543|FG000|Overall Study|Lost to Follow-up|0|||
125527964|NCT02127125|451563544|FG001|Overall Study|Lost to Follow-up|0|||
125527965|NCT02127125|451563545|FG002|Overall Study|Lost to Follow-up|0|||
125527966|NCT02127125|451563546|FG003|Overall Study|Lost to Follow-up|0|||
125527967|NCT02127125|451563547|FG004|Overall Study|Lost to Follow-up|2|||
125527968|NCT02127125|451563548|FG005|Overall Study|Lost to Follow-up|1|||
125527969|NCT02127125|451563549|FG006|Overall Study|Lost to Follow-up|0|||
125527970|NCT02127125|451563550|FG007|Overall Study|Lost to Follow-up|0|||
125527971|NCT02127125|451563551|FG008|Overall Study|Lost to Follow-up|0|||
125527972|NCT02127125|451563543|FG000|Overall Study|Withdrawal by Subject|0|||
125527973|NCT02127125|451563544|FG001|Overall Study|Withdrawal by Subject|0|||
125527974|NCT02127125|451563545|FG002|Overall Study|Withdrawal by Subject|0|||
125527975|NCT02127125|451563546|FG003|Overall Study|Withdrawal by Subject|1|||
125527976|NCT02127125|451563547|FG004|Overall Study|Withdrawal by Subject|0|||
125527977|NCT02127125|451563548|FG005|Overall Study|Withdrawal by Subject|0|||
125527978|NCT02127125|451563549|FG006|Overall Study|Withdrawal by Subject|0|||
125527979|NCT02127125|451563550|FG007|Overall Study|Withdrawal by Subject|0|||
125527980|NCT02127125|451563551|FG008|Overall Study|Withdrawal by Subject|0|||
125527981|NCT02127125|451563543|FG000|Overall Study|Physician Decision|0|||
125527982|NCT02127125|451563544|FG001|Overall Study|Physician Decision|0|||
125527983|NCT02127125|451563545|FG002|Overall Study|Physician Decision|1|||
125527984|NCT02127125|451563546|FG003|Overall Study|Physician Decision|0|||
125527985|NCT02127125|451563547|FG004|Overall Study|Physician Decision|1|||
125527986|NCT02127125|451563548|FG005|Overall Study|Physician Decision|2|||
125527987|NCT02127125|451563549|FG006|Overall Study|Physician Decision|0|||
125527988|NCT02127125|451563550|FG007|Overall Study|Physician Decision|0|||
125527989|NCT02127125|451563551|FG008|Overall Study|Physician Decision|0|||
125527990|NCT02353468|451563552|FG000|Overall Study|Study terminated|3|||
125527991|NCT02344342|451563553|FG000|Overall Study|Industry partner dropped out|11|||
125527992|NCT02344342|451563554|FG001|Overall Study|Industry partner dropped out|9|||
125527993|NCT02344342|451563555|FG002|Overall Study|Industry partner dropped out|14|||
125527994|NCT02344342|451563556|FG003|Overall Study|Industry partner dropped out|10|||
125527995|NCT00848484|451563557|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
125527996|NCT00848484|451563558|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
125527997|NCT00848484|451563557|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
125527998|NCT00848484|451563558|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
125527999|NCT00848484|451563557|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
125528000|NCT00848484|451563558|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
125528001|NCT00848484|451563557|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
125528002|NCT00848484|451563558|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
125528003|NCT00848484|451563557|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
125528004|NCT00848484|451563558|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
125528005|NCT03017742|451563566|FG000|Overall Study|Protocol Violation|36|||
125528006|NCT03017742|451563566|FG000|Overall Study|Withdrawal by Subject|37|||
125528007|NCT02975102|451563567|FG000|Overall Study|Adverse Event|2|||
125528008|NCT02975102|451563568|FG001|Overall Study|Adverse Event|1|||
125528009|NCT01441635|451563573|FG000|Overall Study|Adverse Event|4|||
125528010|NCT01441635|451563574|FG001|Overall Study|Adverse Event|3|||
125528011|NCT01441635|451563575|FG002|Overall Study|Adverse Event|1|||
125528012|NCT01441635|451563576|FG003|Overall Study|Adverse Event|5|||
125528013|NCT01441635|451563577|FG004|Overall Study|Adverse Event|1|||
125528014|NCT01441635|451563578|FG005|Overall Study|Adverse Event|2|||
125528015|NCT01441635|451563579|FG006|Overall Study|Adverse Event|2|||
125528016|NCT01441635|451563580|FG007|Overall Study|Adverse Event|2|||
125528017|NCT01441635|451563581|FG008|Overall Study|Adverse Event|1|||
125528018|NCT01441635|451563582|FG009|Overall Study|Adverse Event|0|||
125528019|NCT01441635|451563573|FG000|Overall Study|Withdrawal by Subject|1|||
125528020|NCT01441635|451563574|FG001|Overall Study|Withdrawal by Subject|1|||
125528021|NCT01441635|451563575|FG002|Overall Study|Withdrawal by Subject|0|||
125528022|NCT01441635|451563576|FG003|Overall Study|Withdrawal by Subject|1|||
125528023|NCT01441635|451563577|FG004|Overall Study|Withdrawal by Subject|0|||
125528024|NCT01441635|451563578|FG005|Overall Study|Withdrawal by Subject|0|||
125528025|NCT01441635|451563579|FG006|Overall Study|Withdrawal by Subject|2|||
125528026|NCT01441635|451563580|FG007|Overall Study|Withdrawal by Subject|0|||
125528027|NCT01441635|451563581|FG008|Overall Study|Withdrawal by Subject|1|||
125528028|NCT01441635|451563582|FG009|Overall Study|Withdrawal by Subject|1|||
125528029|NCT01441635|451563573|FG000|Overall Study|Lost to Follow-up|0|||
125528030|NCT01441635|451563574|FG001|Overall Study|Lost to Follow-up|1|||
125528031|NCT01441635|451563575|FG002|Overall Study|Lost to Follow-up|1|||
125528032|NCT01441635|451563576|FG003|Overall Study|Lost to Follow-up|1|||
125528033|NCT01441635|451563577|FG004|Overall Study|Lost to Follow-up|1|||
125528034|NCT01441635|451563578|FG005|Overall Study|Lost to Follow-up|3|||
125528035|NCT01441635|451563579|FG006|Overall Study|Lost to Follow-up|1|||
125528036|NCT01441635|451563580|FG007|Overall Study|Lost to Follow-up|1|||
125528037|NCT01441635|451563581|FG008|Overall Study|Lost to Follow-up|0|||
125528038|NCT01441635|451563582|FG009|Overall Study|Lost to Follow-up|1|||
125528039|NCT01441635|451563573|FG000|Overall Study|Noncompliance|0|||
125528040|NCT01441635|451563574|FG001|Overall Study|Noncompliance|1|||
125528041|NCT01441635|451563575|FG002|Overall Study|Noncompliance|0|||
125528042|NCT01441635|451563576|FG003|Overall Study|Noncompliance|0|||
125528043|NCT01441635|451563577|FG004|Overall Study|Noncompliance|0|||
125528044|NCT01441635|451563578|FG005|Overall Study|Noncompliance|0|||
125528045|NCT01441635|451563579|FG006|Overall Study|Noncompliance|1|||
125528046|NCT01441635|451563580|FG007|Overall Study|Noncompliance|0|||
125528047|NCT01441635|451563581|FG008|Overall Study|Noncompliance|0|||
125528048|NCT01441635|451563582|FG009|Overall Study|Noncompliance|0|||
125528049|NCT01441635|451563573|FG000|Overall Study|Surgery or Invasive Intervention|0|||
125528050|NCT01441635|451563574|FG001|Overall Study|Surgery or Invasive Intervention|0|||
125528051|NCT01441635|451563575|FG002|Overall Study|Surgery or Invasive Intervention|1|||
125528052|NCT01441635|451563576|FG003|Overall Study|Surgery or Invasive Intervention|0|||
125528053|NCT01441635|451563577|FG004|Overall Study|Surgery or Invasive Intervention|0|||
125528054|NCT01441635|451563578|FG005|Overall Study|Surgery or Invasive Intervention|0|||
125528055|NCT01441635|451563579|FG006|Overall Study|Surgery or Invasive Intervention|0|||
125528056|NCT01441635|451563580|FG007|Overall Study|Surgery or Invasive Intervention|0|||
125528057|NCT01441635|451563581|FG008|Overall Study|Surgery or Invasive Intervention|0|||
125528058|NCT01441635|451563582|FG009|Overall Study|Surgery or Invasive Intervention|0|||
125528059|NCT01441635|451563573|FG000|Overall Study|Received Exclusionary Medication|1|||
125528060|NCT01441635|451563574|FG001|Overall Study|Received Exclusionary Medication|0|||
125528061|NCT01441635|451563575|FG002|Overall Study|Received Exclusionary Medication|0|||
125528062|NCT01441635|451563576|FG003|Overall Study|Received Exclusionary Medication|0|||
125528063|NCT01441635|451563577|FG004|Overall Study|Received Exclusionary Medication|0|||
125528064|NCT01441635|451563578|FG005|Overall Study|Received Exclusionary Medication|0|||
125528065|NCT01441635|451563579|FG006|Overall Study|Received Exclusionary Medication|0|||
125528066|NCT01441635|451563580|FG007|Overall Study|Received Exclusionary Medication|0|||
125528067|NCT01441635|451563581|FG008|Overall Study|Received Exclusionary Medication|0|||
125528068|NCT01441635|451563582|FG009|Overall Study|Received Exclusionary Medication|0|||
125528069|NCT01441635|451563573|FG000|Overall Study|Other|0|||
125528070|NCT01441635|451563574|FG001|Overall Study|Other|0|||
125528071|NCT01441635|451563575|FG002|Overall Study|Other|0|||
125528072|NCT01441635|451563576|FG003|Overall Study|Other|0|||
125528073|NCT01441635|451563577|FG004|Overall Study|Other|0|||
125528074|NCT01441635|451563578|FG005|Overall Study|Other|0|||
125528075|NCT01441635|451563579|FG006|Overall Study|Other|0|||
125528076|NCT01441635|451563580|FG007|Overall Study|Other|1|||
125528077|NCT01441635|451563581|FG008|Overall Study|Other|0|||
125528078|NCT01441635|451563582|FG009|Overall Study|Other|0|||
125528079|NCT01825577|451563583|FG000|Overall Study|Physician Decision|2|||
125528080|NCT01825577|451563583|FG000|Overall Study|Withdrawal by Subject|1|||
125528081|NCT01825577|451563583|FG000|Overall Study|Withdrawn by family members|2|||
125528082|NCT01825577|451563583|FG000|Overall Study|Lack of Efficacy|3|||
125528083|NCT01358331|451563584|FG000|Overall Study|Lost to Follow-up|0|||
125528084|NCT01358331|451563585|FG001|Overall Study|Lost to Follow-up|0|||
125528085|NCT01358331|451563586|FG002|Overall Study|Lost to Follow-up|0|||
125528086|NCT01358331|451563587|FG003|Overall Study|Lost to Follow-up|1|||
125528087|NCT01358331|451563588|FG004|Overall Study|Lost to Follow-up|0|||
125528088|NCT01358331|451563589|FG005|Overall Study|Lost to Follow-up|0|||
125528089|NCT01358331|451563584|FG000|Overall Study|Withdrawal by Subject|0|||
125528090|NCT01358331|451563585|FG001|Overall Study|Withdrawal by Subject|0|||
125528091|NCT01358331|451563586|FG002|Overall Study|Withdrawal by Subject|0|||
125528092|NCT01358331|451563587|FG003|Overall Study|Withdrawal by Subject|1|||
125528093|NCT01358331|451563588|FG004|Overall Study|Withdrawal by Subject|1|||
125528094|NCT01358331|451563589|FG005|Overall Study|Withdrawal by Subject|1|||
125528095|NCT01358331|451563584|FG000|Overall Study|Adverse Events|1|||
125528096|NCT01358331|451563585|FG001|Overall Study|Adverse Events|1|||
125528097|NCT01358331|451563586|FG002|Overall Study|Adverse Events|1|||
125528098|NCT01358331|451563587|FG003|Overall Study|Adverse Events|0|||
125528099|NCT01358331|451563588|FG004|Overall Study|Adverse Events|1|||
125528100|NCT01358331|451563589|FG005|Overall Study|Adverse Events|5|||
125528101|NCT01358331|451563584|FG000|Overall Study|Symptomatic Deterioration|0|||
125528102|NCT01358331|451563585|FG001|Overall Study|Symptomatic Deterioration|0|||
125528103|NCT01358331|451563586|FG002|Overall Study|Symptomatic Deterioration|0|||
125528104|NCT01358331|451563587|FG003|Overall Study|Symptomatic Deterioration|0|||
125528105|NCT01358331|451563588|FG004|Overall Study|Symptomatic Deterioration|1|||
125528106|NCT01358331|451563589|FG005|Overall Study|Symptomatic Deterioration|0|||
125528107|NCT01358331|451563584|FG000|Overall Study|Participants did not wish to continue|0|||
125528108|NCT01358331|451563585|FG001|Overall Study|Participants did not wish to continue|0|||
125528109|NCT01358331|451563586|FG002|Overall Study|Participants did not wish to continue|0|||
125528110|NCT01358331|451563587|FG003|Overall Study|Participants did not wish to continue|0|||
125528111|NCT01358331|451563588|FG004|Overall Study|Participants did not wish to continue|1|||
125528112|NCT01358331|451563589|FG005|Overall Study|Participants did not wish to continue|0|||
125528113|NCT01358331|451563584|FG000|Overall Study|Progress of disease under investigation|1|||
125528114|NCT01358331|451563585|FG001|Overall Study|Progress of disease under investigation|2|||
125528115|NCT01358331|451563586|FG002|Overall Study|Progress of disease under investigation|3|||
125528116|NCT01358331|451563587|FG003|Overall Study|Progress of disease under investigation|1|||
125528117|NCT01358331|451563588|FG004|Overall Study|Progress of disease under investigation|3|||
125528118|NCT01358331|451563589|FG005|Overall Study|Progress of disease under investigation|0|||
125528119|NCT01969851|451563590|FG000|Overall Study|Adverse Event|0|||
125528120|NCT01969851|451563591|FG001|Overall Study|Adverse Event|0|||
125528121|NCT01969851|451563592|FG002|Overall Study|Adverse Event|3|||
125528122|NCT01969851|451563590|FG000|Overall Study|Lack of Efficacy|0|||
125528123|NCT01969851|451563591|FG001|Overall Study|Lack of Efficacy|3|||
125528124|NCT01969851|451563592|FG002|Overall Study|Lack of Efficacy|1|||
125528125|NCT01969851|451563590|FG000|Overall Study|Withdrawal by Subject|1|||
125528126|NCT01969851|451563591|FG001|Overall Study|Withdrawal by Subject|0|||
125528127|NCT01969851|451563592|FG002|Overall Study|Withdrawal by Subject|1|||
125528128|NCT01969851|451563590|FG000|Overall Study|No effective dose in Titration period|0|||
125528129|NCT01969851|451563591|FG001|Overall Study|No effective dose in Titration period|0|||
125528130|NCT01969851|451563592|FG002|Overall Study|No effective dose in Titration period|1|||
125528131|NCT01969851|451563590|FG000|Overall Study|Sponsor decision|0|||
125528132|NCT01969851|451563591|FG001|Overall Study|Sponsor decision|0|||
125528133|NCT01969851|451563592|FG002|Overall Study|Sponsor decision|1|||
125528134|NCT01430468|451563605|FG000|Overall Study|Physician Decision|2|||
125528135|NCT01430468|451563606|FG001|Overall Study|Physician Decision|1|||
125528136|NCT01430468|451563605|FG000|Overall Study|Withdrawal by Subject|5|||
125528137|NCT01430468|451563606|FG001|Overall Study|Withdrawal by Subject|5|||
125528138|NCT00617929|451563609|FG000|Overall Study|Physician Decision|1|||
125528139|NCT01426347|451563610|FG000|Overall Study|Lost to Follow-up|0|||
125528140|NCT01426347|451563611|FG001|Overall Study|Lost to Follow-up|3|||
125528141|NCT01426347|451563610|FG000|Overall Study|Protocol Violation|2|||
125528142|NCT01426347|451563611|FG001|Overall Study|Protocol Violation|0|||
125528143|NCT01426347|451563610|FG000|Overall Study|Withdrawal by Subject|5|||
125528144|NCT01426347|451563611|FG001|Overall Study|Withdrawal by Subject|0|||
125528145|NCT01151423|451563613|FG000|Overall Study|Study terminated by Sponsor|9|||
125528146|NCT01151423|451563614|FG001|Overall Study|Study terminated by Sponsor|10|||
125528147|NCT01151423|451563613|FG000|Overall Study|Protocol Violation|0|||
125528148|NCT01151423|451563614|FG001|Overall Study|Protocol Violation|1|||
125528149|NCT01151423|451563613|FG000|Overall Study|Physician Decision|1|||
125528150|NCT01151423|451563614|FG001|Overall Study|Physician Decision|1|||
125528151|NCT01151423|451563613|FG000|Overall Study|Pregnancy|0|||
125528152|NCT01151423|451563614|FG001|Overall Study|Pregnancy|1|||
125528153|NCT01151423|451563613|FG000|Overall Study|Death|0|||
125528154|NCT01151423|451563614|FG001|Overall Study|Death|1|||
125528155|NCT01151423|451563613|FG000|Overall Study|Adverse Event|3|||
125528156|NCT01151423|451563614|FG001|Overall Study|Adverse Event|0|||
125528157|NCT01151423|451563613|FG000|Overall Study|Withdrawal by Subject|1|||
125528158|NCT01151423|451563614|FG001|Overall Study|Withdrawal by Subject|3|||
125528159|NCT01151423|451563613|FG000|Overall Study|Lost to Follow-up|1|||
125528160|NCT01151423|451563614|FG001|Overall Study|Lost to Follow-up|0|||
125528161|NCT01151423|451563613|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
125528162|NCT01151423|451563614|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
125528163|NCT01151423|451563613|FG000|Overall Study|Participated in other clinical trial|1|||
125528164|NCT01151423|451563614|FG001|Overall Study|Participated in other clinical trial|0|||
125528165|NCT02763215|451565404|FG000|Overall Study|Participants withdrew from study|3|||
125528166|NCT02763215|451565404|FG000|Overall Study|Missed visit|1|||
125528167|NCT02763215|451565404|FG000|Overall Study|Visit outside visit-window|1|||
125528168|NCT02763215|451565404|FG000|Overall Study|Death|1|||
125528169|NCT02763215|451565404|FG000|Overall Study|Lost to Follow-up|1|||
125528170|NCT00475644|451565406|FG000|Overall Study|Protocol Violation|13|||
125528171|NCT01411241|451565407|FG000|Overall Study|Protocol Violation|0|||
125528172|NCT01411241|451565408|FG001|Overall Study|Protocol Violation|5|||
125528173|NCT01411241|451565407|FG000|Overall Study|Withdrawal by Subject|9|||
125528174|NCT01411241|451565408|FG001|Overall Study|Withdrawal by Subject|10|||
125528175|NCT01411241|451565407|FG000|Overall Study|Serious Adverse Event|0|||
125528176|NCT01411241|451565408|FG001|Overall Study|Serious Adverse Event|3|||
125528177|NCT01411241|451565407|FG000|Overall Study|Lost to Follow-up|2|||
125528178|NCT01411241|451565408|FG001|Overall Study|Lost to Follow-up|4|||
125528179|NCT01107899|451565414|FG000|Overall Study|Physician Decision|5|||
125528180|NCT01107899|451565415|FG001|Overall Study|Physician Decision|0|||
125528181|NCT01107899|451565416|FG002|Overall Study|Physician Decision|3|||
125528182|NCT01107899|451565414|FG000|Overall Study|Withdrawal by Subject|0|||
125528183|NCT01107899|451565415|FG001|Overall Study|Withdrawal by Subject|0|||
125528184|NCT01107899|451565416|FG002|Overall Study|Withdrawal by Subject|1|||
125528185|NCT00974259|451565417|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
125528186|NCT00974259|451565418|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
125528187|NCT01810939|451565438|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
125528188|NCT01810939|451565439|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
125528189|NCT01810939|451565440|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
125528190|NCT01810939|451565438|FG000|Part A Treatment Period|Protocol Violation|2|||
125528191|NCT01810939|451565439|FG001|Part A Treatment Period|Protocol Violation|0|||
125528192|NCT01810939|451565440|FG002|Part A Treatment Period|Protocol Violation|0|||
125528193|NCT01810939|451565438|FG000|Part A Treatment Period|Adverse Event|10|||
125528194|NCT01810939|451565439|FG001|Part A Treatment Period|Adverse Event|0|||
125528195|NCT01810939|451565440|FG002|Part A Treatment Period|Adverse Event|0|||
125528196|NCT01810939|451565438|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
125528197|NCT01810939|451565439|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
125528198|NCT01810939|451565440|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
125528199|NCT01810939|451565438|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
125528200|NCT01810939|451565439|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
125528201|NCT01810939|451565440|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
125528202|NCT01810939|451565438|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
125528203|NCT01810939|451565439|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
125528204|NCT01810939|451565440|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
125528205|NCT01810939|451565438|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
125528206|NCT01810939|451565439|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
125528207|NCT01810939|451565440|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
125528208|NCT01810939|451565438|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
125528209|NCT01810939|451565439|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
125528210|NCT01810939|451565440|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
125528211|NCT01810939|451565438|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
125528212|NCT01810939|451565439|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
125528213|NCT01810939|451565440|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
125528214|NCT01810939|451565438|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
125528215|NCT01810939|451565439|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
125528216|NCT01810939|451565440|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
125528217|NCT01810939|451565438|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
125528218|NCT01810939|451565439|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
125528219|NCT01810939|451565440|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
125528220|NCT01810939|451565438|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
125528221|NCT01810939|451565439|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
125528222|NCT01810939|451565440|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
125528223|NCT01810939|451565438|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
125528224|NCT01810939|451565439|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
125528225|NCT01810939|451565440|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
125528226|NCT01810939|451565438|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
125528227|NCT01810939|451565439|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
125528228|NCT01810939|451565440|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
125528229|NCT01810939|451565438|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
125528230|NCT01810939|451565439|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
125528231|NCT01810939|451565440|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
125528232|NCT01810939|451565438|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
125528233|NCT01810939|451565439|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
125528234|NCT01810939|451565440|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
125528235|NCT01810939|451565438|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
125528236|NCT01810939|451565439|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
125533005|NCT04047862|451581435|FG013|Overall Study|Physician Decision|0|||
125528237|NCT01810939|451565440|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
125528238|NCT02963090|451565441|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
125528239|NCT02963090|451565442|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
125528240|NCT01375673|451565443|FG000|Overall Study|Withdrawal by Subject|0|||
125528241|NCT01375673|451565444|FG001|Overall Study|Withdrawal by Subject|1|||
125528242|NCT00979953|451565447|FG000|Overall Study|Adverse Event|5|||
125528243|NCT00979953|451565448|FG001|Overall Study|Adverse Event|2|||
125528244|NCT00979953|451565449|FG002|Overall Study|Adverse Event|17|||
125528245|NCT00979953|451565450|FG003|Overall Study|Adverse Event|4|||
125528246|NCT00979953|451565447|FG000|Overall Study|Lack of Efficacy|1|||
125528247|NCT00979953|451565448|FG001|Overall Study|Lack of Efficacy|2|||
125528248|NCT00979953|451565449|FG002|Overall Study|Lack of Efficacy|0|||
125528249|NCT00979953|451565450|FG003|Overall Study|Lack of Efficacy|0|||
125528250|NCT00979953|451565447|FG000|Overall Study|Lost to Follow-up|1|||
125528251|NCT00979953|451565448|FG001|Overall Study|Lost to Follow-up|1|||
125528252|NCT00979953|451565449|FG002|Overall Study|Lost to Follow-up|1|||
125528253|NCT00979953|451565450|FG003|Overall Study|Lost to Follow-up|0|||
125528254|NCT00979953|451565447|FG000|Overall Study|Withdrawal by Subject|0|||
125528255|NCT00979953|451565448|FG001|Overall Study|Withdrawal by Subject|0|||
125528256|NCT00979953|451565449|FG002|Overall Study|Withdrawal by Subject|2|||
125528257|NCT00979953|451565450|FG003|Overall Study|Withdrawal by Subject|1|||
125528258|NCT00979953|451565447|FG000|Overall Study|Protocol Violation|1|||
125528259|NCT00979953|451565448|FG001|Overall Study|Protocol Violation|0|||
125528260|NCT00979953|451565449|FG002|Overall Study|Protocol Violation|2|||
125528261|NCT00979953|451565450|FG003|Overall Study|Protocol Violation|2|||
125528262|NCT03054337|451565453|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
125528263|NCT03054337|451565454|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
125528264|NCT03054337|451565455|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
125528265|NCT03054337|451565456|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
125528266|NCT03054337|451565457|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
125528267|NCT03054337|451565458|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
125528268|NCT01681992|451565461|FG000|Overall Study|Adverse Event|3|||
125528269|NCT01681992|451565462|FG001|Overall Study|Adverse Event|2|||
125528270|NCT01681992|451565463|FG002|Overall Study|Adverse Event|3|||
125528271|NCT01681992|451565461|FG000|Overall Study|Lost to Follow-up|36|||
125528272|NCT01681992|451565462|FG001|Overall Study|Lost to Follow-up|38|||
125528273|NCT01681992|451565463|FG002|Overall Study|Lost to Follow-up|53|||
125528274|NCT01681992|451565461|FG000|Overall Study|As Per Sponsor Decision|0|||
125528275|NCT01681992|451565462|FG001|Overall Study|As Per Sponsor Decision|0|||
125528276|NCT01681992|451565463|FG002|Overall Study|As Per Sponsor Decision|1|||
125528277|NCT01681992|451565461|FG000|Overall Study|Protocol Violation|0|||
125528278|NCT01681992|451565462|FG001|Overall Study|Protocol Violation|0|||
125528279|NCT01681992|451565463|FG002|Overall Study|Protocol Violation|1|||
125528280|NCT01681992|451565461|FG000|Overall Study|Withdrawal by Subject|27|||
125528281|NCT01681992|451565462|FG001|Overall Study|Withdrawal by Subject|30|||
125528282|NCT01681992|451565463|FG002|Overall Study|Withdrawal by Subject|25|||
125528283|NCT01327612|451565464|FG000|Overall Study|Withdrawal by Subject|0|||
125528284|NCT01327612|451565465|FG001|Overall Study|Withdrawal by Subject|0|||
125528285|NCT01327612|451565466|FG002|Overall Study|Withdrawal by Subject|0|||
125528286|NCT01327612|451565467|FG003|Overall Study|Withdrawal by Subject|0|||
125528287|NCT01327612|451565468|FG004|Overall Study|Withdrawal by Subject|0|||
125528288|NCT01327612|451565469|FG005|Overall Study|Withdrawal by Subject|1|||
125528289|NCT01327612|451565470|FG006|Overall Study|Withdrawal by Subject|0|||
125528290|NCT01327612|451565464|FG000|Overall Study|Disease Progression|1|||
125528291|NCT01327612|451565465|FG001|Overall Study|Disease Progression|1|||
125528292|NCT01327612|451565466|FG002|Overall Study|Disease Progression|1|||
125528293|NCT01327612|451565467|FG003|Overall Study|Disease Progression|0|||
125528294|NCT01327612|451565468|FG004|Overall Study|Disease Progression|1|||
125528295|NCT01327612|451565469|FG005|Overall Study|Disease Progression|2|||
125528296|NCT01327612|451565470|FG006|Overall Study|Disease Progression|2|||
125528297|NCT01327612|451565464|FG000|Overall Study|Administrative Decision|0|||
125528298|NCT01327612|451565465|FG001|Overall Study|Administrative Decision|0|||
125528299|NCT01327612|451565466|FG002|Overall Study|Administrative Decision|0|||
125528300|NCT01327612|451565467|FG003|Overall Study|Administrative Decision|1|||
125528301|NCT01327612|451565468|FG004|Overall Study|Administrative Decision|0|||
125528302|NCT01327612|451565469|FG005|Overall Study|Administrative Decision|0|||
125528303|NCT01327612|451565470|FG006|Overall Study|Administrative Decision|0|||
125528304|NCT01327612|451565464|FG000|Overall Study|Death|0|||
125528305|NCT01327612|451565465|FG001|Overall Study|Death|0|||
125528306|NCT01327612|451565466|FG002|Overall Study|Death|0|||
125528307|NCT01327612|451565467|FG003|Overall Study|Death|0|||
125528308|NCT01327612|451565468|FG004|Overall Study|Death|1|||
125528309|NCT01327612|451565469|FG005|Overall Study|Death|0|||
125528310|NCT01327612|451565470|FG006|Overall Study|Death|0|||
125528311|NCT01967069|451565476|FG000|Overall Study|Adverse Event|2|||
125528312|NCT01967069|451565477|FG001|Overall Study|Adverse Event|2|||
125528313|NCT01967069|451565476|FG000|Overall Study|Lost to Follow-up|5|||
125528314|NCT01967069|451565477|FG001|Overall Study|Lost to Follow-up|2|||
125528315|NCT01967069|451565476|FG000|Overall Study|Withdrawal by Subject|1|||
125528316|NCT01967069|451565477|FG001|Overall Study|Withdrawal by Subject|3|||
125528317|NCT01967069|451565476|FG000|Overall Study|Lack of Efficacy|0|||
125528318|NCT01967069|451565477|FG001|Overall Study|Lack of Efficacy|1|||
125528319|NCT02643628|451565482|FG000|Overall Study|Lost to Follow-up|1|||
125528320|NCT02643628|451565483|FG001|Overall Study|Lost to Follow-up|4|||
125528321|NCT02643628|451565482|FG000|Overall Study|Withdrawal by Subject|0|||
125528322|NCT02643628|451565483|FG001|Overall Study|Withdrawal by Subject|1|||
125528323|NCT02643628|451565482|FG000|Overall Study|Relocated out of state|0|||
125528324|NCT02643628|451565483|FG001|Overall Study|Relocated out of state|1|||
125528325|NCT04245345|451565484|FG000|Overall Study|Death|1|||
125528326|NCT04245345|451565484|FG000|Overall Study|Exited prior to implant|5|||
125528327|NCT04245345|451565484|FG000|Overall Study|Exited prior to 1-month|9|||
125528328|NCT04245345|451565484|FG000|Overall Study|Missed 1-month visit|3|||
125528329|NCT04245345|451565484|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
125528330|NCT04245345|451565484|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
125528331|NCT00706654|451565485|FG000|Conversion Phase|Lost to Follow-up|4|||
125528332|NCT00706654|451565486|FG001|Conversion Phase|Lost to Follow-up|0|||
125528333|NCT00706654|451565487|FG002|Conversion Phase|Lost to Follow-up|0|||
125528334|NCT00706654|451565488|FG003|Conversion Phase|Lost to Follow-up|0|||
125528335|NCT00706654|451565485|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
125528336|NCT00706654|451565486|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
125528337|NCT00706654|451565487|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
125528338|NCT00706654|451565488|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
125528339|NCT00706654|451565485|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
125528340|NCT00706654|451565486|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
125528341|NCT00706654|451565487|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
125528342|NCT00706654|451565488|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
125528343|NCT00706654|451565485|FG000|Conversion Phase|Withdrawn by Investigator|14|||
125528344|NCT00706654|451565486|FG001|Conversion Phase|Withdrawn by Investigator|0|||
125528345|NCT00706654|451565487|FG002|Conversion Phase|Withdrawn by Investigator|0|||
125528346|NCT00706654|451565488|FG003|Conversion Phase|Withdrawn by Investigator|0|||
125528347|NCT00706654|451565485|FG000|Conversion Phase|Withdrew Consent|38|||
125528348|NCT00706654|451565486|FG001|Conversion Phase|Withdrew Consent|0|||
125528349|NCT00706654|451565487|FG002|Conversion Phase|Withdrew Consent|0|||
125528350|NCT00706654|451565488|FG003|Conversion Phase|Withdrew Consent|0|||
125528351|NCT00706654|451565485|FG000|Conversion Phase|Adverse Event|18|||
125528352|NCT00706654|451565486|FG001|Conversion Phase|Adverse Event|0|||
125528353|NCT00706654|451565487|FG002|Conversion Phase|Adverse Event|0|||
125528354|NCT00706654|451565488|FG003|Conversion Phase|Adverse Event|0|||
125528355|NCT00706654|451565485|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
125528356|NCT00706654|451565486|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
125528357|NCT00706654|451565487|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
125528358|NCT00706654|451565488|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
125528359|NCT00706654|451565485|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
125528360|NCT00706654|451565486|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
125528361|NCT00706654|451565487|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
125528362|NCT00706654|451565488|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
125528363|NCT00706654|451565485|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
125528364|NCT00706654|451565486|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
125528365|NCT00706654|451565487|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
125528366|NCT00706654|451565488|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
125528367|NCT00706654|451565485|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
125528368|NCT00706654|451565486|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
125528369|NCT00706654|451565487|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
125528370|NCT00706654|451565488|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
125528371|NCT00706654|451565485|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
125528372|NCT00706654|451565486|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
125528373|NCT00706654|451565487|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
125528374|NCT00706654|451565488|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
125528375|NCT00706654|451565485|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
125528376|NCT00706654|451565486|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
125528377|NCT00706654|451565487|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
125528378|NCT00706654|451565488|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
125528379|NCT00706654|451565485|FG000|Oral Stabilization Phase|Withdrew consent|55|||
125528380|NCT00706654|451565486|FG001|Oral Stabilization Phase|Withdrew consent|0|||
125528381|NCT00706654|451565487|FG002|Oral Stabilization Phase|Withdrew consent|0|||
125528382|NCT00706654|451565488|FG003|Oral Stabilization Phase|Withdrew consent|0|||
125528383|NCT00706654|451565485|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
125528384|NCT00706654|451565486|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
125528385|NCT00706654|451565487|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
125528386|NCT00706654|451565488|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
125528387|NCT00706654|451565485|FG000|Oral Stabilization Phase|Adverse Event|21|||
125528388|NCT00706654|451565486|FG001|Oral Stabilization Phase|Adverse Event|0|||
125528389|NCT00706654|451565487|FG002|Oral Stabilization Phase|Adverse Event|0|||
125528390|NCT00706654|451565488|FG003|Oral Stabilization Phase|Adverse Event|0|||
125528391|NCT00706654|451565485|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
125528392|NCT00706654|451565486|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
125528393|NCT00706654|451565487|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
125528394|NCT00706654|451565488|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
125528395|NCT00706654|451565485|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
125528396|NCT00706654|451565486|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
125528397|NCT00706654|451565487|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
125528398|NCT00706654|451565488|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
125528399|NCT00706654|451565485|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
125528400|NCT00706654|451565486|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
125528401|NCT00706654|451565487|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
125528402|NCT00706654|451565488|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
125528403|NCT00706654|451565485|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
125528404|NCT00706654|451565486|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
125528405|NCT00706654|451565487|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
125528406|NCT00706654|451565488|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
125528407|NCT00706654|451565485|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
125528408|NCT00706654|451565486|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
125528409|NCT00706654|451565487|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
125528410|NCT00706654|451565488|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
125528411|NCT00706654|451565485|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
125528412|NCT00706654|451565486|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
125528413|NCT00706654|451565487|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
125528414|NCT00706654|451565488|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
125528415|NCT00706654|451565485|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
125528416|NCT00706654|451565486|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
125528417|NCT00706654|451565487|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
125528418|NCT00706654|451565488|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
125528419|NCT00706654|451565485|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
125528420|NCT00706654|451565486|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
125528421|NCT00706654|451565487|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
125528422|NCT00706654|451565488|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
125528423|NCT00706654|451565485|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
125528424|NCT00706654|451565486|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
125528425|NCT00706654|451565487|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
125528426|NCT00706654|451565488|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
125528427|NCT00706654|451565485|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
125528428|NCT00706654|451565486|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
125528429|NCT00706654|451565487|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
125528430|NCT00706654|451565488|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
125528431|NCT01001390|451565494|FG000|Overall Study|Failure to wear AFO device|2|||
125528432|NCT01001390|451565495|FG001|Overall Study|Failure to wear AFO device|0|||
125528433|NCT03690427|451565496|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
125528434|NCT03690427|451565497|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
125528435|NCT01151215|451565501|FG000|Overall Study|Worsening of condition under study|1|||
125528436|NCT01151215|451565502|FG001|Overall Study|Worsening of condition under study|1|||
125528437|NCT01151215|451565503|FG002|Overall Study|Worsening of condition under study|1|||
125528438|NCT01151215|451565501|FG000|Overall Study|Death|16|||
125528439|NCT01151215|451565502|FG001|Overall Study|Death|20|||
125528440|NCT01151215|451565503|FG002|Overall Study|Death|11|||
125528441|NCT01151215|451565501|FG000|Overall Study|Lost to Follow-up|0|||
125528442|NCT01151215|451565502|FG001|Overall Study|Lost to Follow-up|0|||
125528443|NCT01151215|451565503|FG002|Overall Study|Lost to Follow-up|3|||
125528444|NCT01151215|451565501|FG000|Overall Study|Withdrawal by Subject|3|||
125528445|NCT01151215|451565502|FG001|Overall Study|Withdrawal by Subject|1|||
125528446|NCT01151215|451565503|FG002|Overall Study|Withdrawal by Subject|2|||
125528447|NCT01151215|451565501|FG000|Overall Study|Disease progression|0|||
125528448|NCT01151215|451565502|FG001|Overall Study|Disease progression|1|||
125528449|NCT01151215|451565503|FG002|Overall Study|Disease progression|1|||
125528450|NCT01151215|451565501|FG000|Overall Study|Safety as judged by the investigator|0|||
125528451|NCT01151215|451565502|FG001|Overall Study|Safety as judged by the investigator|0|||
125528452|NCT01151215|451565503|FG002|Overall Study|Safety as judged by the investigator|1|||
125528453|NCT01721954|451565505|FG000|Overall Study|Death|58|||
125528454|NCT01721954|451565506|FG001|Overall Study|Death|64|||
125528455|NCT01721954|451565505|FG000|Overall Study|Withdrawal by Subject|8|||
125528456|NCT01721954|451565506|FG001|Overall Study|Withdrawal by Subject|4|||
125528457|NCT01721954|451565505|FG000|Overall Study|Adverse Event|2|||
125528458|NCT01721954|451565506|FG001|Overall Study|Adverse Event|0|||
125528459|NCT01721954|451565505|FG000|Overall Study|Lost to Follow-up|2|||
125528460|NCT01721954|451565506|FG001|Overall Study|Lost to Follow-up|1|||
125528461|NCT03392168|451565507|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
125528462|NCT03392168|451565508|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
125528463|NCT03392168|451565509|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
125528464|NCT03392168|451565510|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
125528465|NCT03392168|451565507|FG000|Period 2: Cohort 2|Other|0|||
125528466|NCT03392168|451565508|FG001|Period 2: Cohort 2|Other|1|||
125528467|NCT03392168|451565509|FG002|Period 2: Cohort 2|Other|0|||
125528468|NCT03392168|451565510|FG003|Period 2: Cohort 2|Other|0|||
125528469|NCT02609672|451565513|FG000|Overall Study|Lost to Follow-up|3|||
125528470|NCT02609672|451565514|FG001|Overall Study|Lost to Follow-up|1|||
125528471|NCT02956837|451565515|FG000|Overall Study|Serious Adverse Events|0|||
125528472|NCT02956837|451565516|FG001|Overall Study|Serious Adverse Events|1|||
125528473|NCT02956837|451565517|FG002|Overall Study|Serious Adverse Events|0|||
125528474|NCT02956837|451565518|FG003|Overall Study|Serious Adverse Events|0|||
125528475|NCT02956837|451565515|FG000|Overall Study|Withdrawal by Subject|0|||
125528476|NCT02956837|451565516|FG001|Overall Study|Withdrawal by Subject|1|||
125528477|NCT02956837|451565517|FG002|Overall Study|Withdrawal by Subject|0|||
125528478|NCT02956837|451565518|FG003|Overall Study|Withdrawal by Subject|3|||
125528479|NCT02956837|451565515|FG000|Overall Study|Lost to Follow-up|0|||
125528480|NCT02956837|451565516|FG001|Overall Study|Lost to Follow-up|1|||
125528481|NCT02956837|451565517|FG002|Overall Study|Lost to Follow-up|2|||
125528482|NCT02956837|451565518|FG003|Overall Study|Lost to Follow-up|0|||
125528483|NCT02597712|451565519|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
125528484|NCT02597712|451565520|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
125528485|NCT02597712|451565519|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
125528486|NCT02597712|451565520|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
125528487|NCT02597712|451565519|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
125528488|NCT02597712|451565520|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
125528489|NCT02637323|451565521|FG000|Overall Study|Lost to Follow-up|2|||
125528490|NCT02637323|451565522|FG001|Overall Study|Lost to Follow-up|0|||
125528491|NCT02637323|451565521|FG000|Overall Study|Protocol Violation|0|||
125528492|NCT02637323|451565522|FG001|Overall Study|Protocol Violation|1|||
125528493|NCT00513708|451565523|FG000|Overall Study|Lost to Follow-up|4|||
125528494|NCT00513708|451565524|FG001|Overall Study|Lost to Follow-up|4|||
125528495|NCT00513708|451565525|FG002|Overall Study|Lost to Follow-up|4|||
125528496|NCT01162486|451565526|FG000|Overall Study|low ANC|1|||
125528497|NCT01162486|451565527|FG001|Overall Study|low ANC|0|||
125528498|NCT01162486|451565528|FG002|Overall Study|low ANC|0|||
125528499|NCT01162486|451565529|FG003|Overall Study|low ANC|0|||
125528500|NCT01162486|451565530|FG004|Overall Study|low ANC|0|||
125528501|NCT01162486|451565526|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
125528502|NCT01162486|451565527|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
125528503|NCT01162486|451565528|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
125528504|NCT01162486|451565529|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
125528505|NCT01162486|451565530|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
125528506|NCT01162486|451565526|FG000|Overall Study|elevated LFTs|0|||
125528507|NCT01162486|451565527|FG001|Overall Study|elevated LFTs|0|||
125528508|NCT01162486|451565528|FG002|Overall Study|elevated LFTs|1|||
125528509|NCT01162486|451565529|FG003|Overall Study|elevated LFTs|0|||
125528510|NCT01162486|451565530|FG004|Overall Study|elevated LFTs|0|||
125528511|NCT01162486|451565526|FG000|Overall Study|Pregnancy|0|||
125528512|NCT01162486|451565527|FG001|Overall Study|Pregnancy|0|||
125528513|NCT01162486|451565528|FG002|Overall Study|Pregnancy|0|||
125528514|NCT01162486|451565529|FG003|Overall Study|Pregnancy|1|||
125528515|NCT01162486|451565530|FG004|Overall Study|Pregnancy|0|||
125528516|NCT03274895|451565536|FG000|Overall Study|Lack of Efficacy|1|||
125528517|NCT03274895|451565537|FG001|Overall Study|Lack of Efficacy|0|||
125528518|NCT03274895|451565536|FG000|Overall Study|Adverse Event|8|||
125528519|NCT03274895|451565537|FG001|Overall Study|Adverse Event|7|||
125528520|NCT03274895|451565536|FG000|Overall Study|Lost to Follow-up|1|||
125528521|NCT03274895|451565537|FG001|Overall Study|Lost to Follow-up|0|||
125528522|NCT03274895|451565536|FG000|Overall Study|Diagnosis not confirmed|3|||
125528523|NCT03274895|451565537|FG001|Overall Study|Diagnosis not confirmed|4|||
125528524|NCT00401258|451565538|FG000|Overall Study|Adverse Event|7|||
125528525|NCT03229486|451565544|FG000|Overall Study|Protocol Violation|0|||
125528526|NCT03229486|451565545|FG001|Overall Study|Protocol Violation|1|||
125528527|NCT01461005|451565546|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
125528528|NCT00760747|451565551|FG000|Study Period II|Adverse Event|3|||
125528529|NCT00760747|451565552|FG001|Study Period II|Adverse Event|4|||
125528530|NCT00760747|451565551|FG000|Study Period II|Lack of Efficacy|0|||
125528531|NCT00760747|451565552|FG001|Study Period II|Lack of Efficacy|6|||
125528532|NCT00760747|451565551|FG000|Study Period II|Parent/Caregiver Decision|3|||
125528533|NCT00760747|451565552|FG001|Study Period II|Parent/Caregiver Decision|0|||
125528534|NCT00760747|451565551|FG000|Study Period II|Protocol Violation|6|||
125528535|NCT00760747|451565552|FG001|Study Period II|Protocol Violation|3|||
125528536|NCT00760747|451565551|FG000|Study Period II|Withdrawal by Subject|1|||
125528537|NCT00760747|451565552|FG001|Study Period II|Withdrawal by Subject|0|||
125528538|NCT00760747|451565551|FG000|Study Period II|No drug administered|0|||
125528539|NCT00760747|451565552|FG001|Study Period II|No drug administered|1|||
125528540|NCT00760747|451565551|FG000|Study Period III|Adverse Event|1|||
125528541|NCT00760747|451565552|FG001|Study Period III|Adverse Event|0|||
125528542|NCT00760747|451565551|FG000|Study Period III|Lack of Efficacy|1|||
125528543|NCT00760747|451565552|FG001|Study Period III|Lack of Efficacy|0|||
125528544|NCT00760747|451565551|FG000|Study Period III|Parent/Caregiver Decision|0|||
125528545|NCT00760747|451565552|FG001|Study Period III|Parent/Caregiver Decision|1|||
125528546|NCT00760747|451565551|FG000|Study Period III|Protocol Violation|1|||
125528547|NCT00760747|451565552|FG001|Study Period III|Protocol Violation|1|||
125528548|NCT00760747|451565551|FG000|Study Period III|Physician Decision|0|||
125528549|NCT00760747|451565552|FG001|Study Period III|Physician Decision|1|||
125528550|NCT01443923|451565553|FG000|Overall Study|Adverse Event|1|||
125528551|NCT01443923|451565554|FG001|Overall Study|Adverse Event|0|||
125528552|NCT03566979|451565557|FG000|Overall Study|Withdrawal by Subject|2|||
125528553|NCT03566979|451565558|FG001|Overall Study|Withdrawal by Subject|0|||
125528554|NCT03566979|451565559|FG002|Overall Study|Withdrawal by Subject|1|||
125528555|NCT03566979|451565560|FG003|Overall Study|Withdrawal by Subject|1|||
125528556|NCT03566979|451565557|FG000|Overall Study|Lost to Follow-up|2|||
125528557|NCT03566979|451565558|FG001|Overall Study|Lost to Follow-up|7|||
125528558|NCT03566979|451565559|FG002|Overall Study|Lost to Follow-up|9|||
125528559|NCT03566979|451565560|FG003|Overall Study|Lost to Follow-up|5|||
125528560|NCT03566979|451565557|FG000|Overall Study|Adverse Event|1|||
125528561|NCT03566979|451565558|FG001|Overall Study|Adverse Event|0|||
125528562|NCT03566979|451565559|FG002|Overall Study|Adverse Event|0|||
125528563|NCT03566979|451565560|FG003|Overall Study|Adverse Event|0|||
125528564|NCT01228175|451565565|FG000|Overall Study|Lost to Follow-up|64|||
125528565|NCT01228175|451565566|FG001|Overall Study|Lost to Follow-up|50|||
125528566|NCT01228175|451565565|FG000|Overall Study|Withdrawal by Subject|1|||
125528567|NCT01228175|451565566|FG001|Overall Study|Withdrawal by Subject|2|||
125528568|NCT01228175|451565565|FG000|Overall Study|Physician Decision|1|||
125528569|NCT01228175|451565566|FG001|Overall Study|Physician Decision|1|||
125528570|NCT01889069|451565567|FG000|Overall Study|Death|18|||
125528571|NCT01889069|451565567|FG000|Overall Study|Progression of Disease|14|||
125528572|NCT01889069|451565567|FG000|Overall Study|Lost to Follow-up|6|||
125528573|NCT01889069|451565567|FG000|Overall Study|Other|4|||
125528574|NCT01889069|451565567|FG000|Overall Study|Consent Withdrawal|3|||
125528575|NCT00108745|451565568|FG000|Overall Study|Withdrawal by Subject|19|||
125528576|NCT00108745|451565569|FG001|Overall Study|Withdrawal by Subject|12|||
125528577|NCT00108745|451565570|FG002|Overall Study|Withdrawal by Subject|12|||
125528578|NCT00108745|451565568|FG000|Overall Study|Never Treated|8|||
125528579|NCT00108745|451565569|FG001|Overall Study|Never Treated|10|||
125528580|NCT00108745|451565570|FG002|Overall Study|Never Treated|12|||
125528581|NCT00108745|451565568|FG000|Overall Study|Ineligible|7|||
125528582|NCT00108745|451565569|FG001|Overall Study|Ineligible|13|||
125528583|NCT00108745|451565570|FG002|Overall Study|Ineligible|13|||
125528584|NCT00455741|451565572|FG000|Overall Study|Physician Decision|0|||
125528585|NCT00455741|451565573|FG001|Overall Study|Physician Decision|1|||
125528586|NCT01245374|451565577|FG000|Overall Study|Protocol Violation|1|||
125528587|NCT01245374|451565577|FG000|Overall Study|Withdrawal by Subject|3|||
125528588|NCT02227992|451565580|FG000|Overall Study|Lost to Follow-up|1|||
125528589|NCT02227992|451565581|FG001|Overall Study|Lost to Follow-up|1|||
125528590|NCT00935532|451565582|FG000|Overall Study|Adverse Event|11|||
125528591|NCT00935532|451565583|FG001|Overall Study|Adverse Event|6|||
125528592|NCT00935532|451565582|FG000|Overall Study|Death|1|||
125528593|NCT00935532|451565583|FG001|Overall Study|Death|0|||
125528594|NCT00935532|451565582|FG000|Overall Study|Lost to Follow-up|1|||
125528595|NCT00935532|451565583|FG001|Overall Study|Lost to Follow-up|0|||
125528596|NCT00935532|451565582|FG000|Overall Study|Physician Decision|1|||
125528597|NCT00935532|451565583|FG001|Overall Study|Physician Decision|2|||
125528598|NCT00935532|451565582|FG000|Overall Study|Protocol Violation|2|||
125528599|NCT00935532|451565583|FG001|Overall Study|Protocol Violation|1|||
125528600|NCT00935532|451565582|FG000|Overall Study|Subject Decision|2|||
125528601|NCT00935532|451565583|FG001|Overall Study|Subject Decision|1|||
125528602|NCT00935532|451565582|FG000|Overall Study|Sponsor Decision|0|||
125528603|NCT00935532|451565583|FG001|Overall Study|Sponsor Decision|1|||
125528604|NCT00935532|451565582|FG000|Overall Study|Loss Glucose Control|4|||
125528605|NCT00935532|451565583|FG001|Overall Study|Loss Glucose Control|0|||
125528606|NCT04954326|451565584|FG000|Overall Study|Protocol Violation|0|||
125528607|NCT04954326|451565585|FG001|Overall Study|Protocol Violation|1|||
125528608|NCT04954326|451565584|FG000|Overall Study|Death|0|||
125528609|NCT04954326|451565585|FG001|Overall Study|Death|2|||
125528610|NCT04954326|451565584|FG000|Overall Study|Physician Decision|0|||
125528611|NCT04954326|451565585|FG001|Overall Study|Physician Decision|1|||
125528612|NCT04982575|451565586|FG000|Overall Study|Withdrawal by Subject|2|||
125528613|NCT04982575|451565587|FG001|Overall Study|Withdrawal by Subject|0|||
125528614|NCT04982575|451565588|FG002|Overall Study|Withdrawal by Subject|2|||
125528615|NCT00475228|451565589|FG000|Overall Study|Lost to Follow-up|17|||
125528616|NCT00475228|451565590|FG001|Overall Study|Lost to Follow-up|17|||
125528617|NCT04949802|451567758|FG000|Overall Study|Lost to Follow-up|3|||
125528618|NCT02473965|451567759|FG000|Overall Study|Adverse Event|6|||
125528619|NCT02473965|451567760|FG001|Overall Study|Adverse Event|4|||
125528620|NCT02473965|451567759|FG000|Overall Study|MG worsening|4|||
125528621|NCT02473965|451567760|FG001|Overall Study|MG worsening|1|||
125528622|NCT02473965|451567759|FG000|Overall Study|Withdrawal by Subject|2|||
125528623|NCT02473965|451567760|FG001|Overall Study|Withdrawal by Subject|3|||
125528624|NCT02473965|451567759|FG000|Overall Study|Physician Decision|0|||
125528625|NCT02473965|451567760|FG001|Overall Study|Physician Decision|2|||
125528626|NCT01183390|451567761|FG000|First Intervention|Adverse Event|0|||
125528627|NCT01183390|451567762|FG001|First Intervention|Adverse Event|1|||
125528628|NCT03816761|451567763|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
125528629|NCT03816761|451567764|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
125528630|NCT03816761|451567765|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
125528631|NCT03816761|451567766|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
125528632|NCT03816761|451567767|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
125528633|NCT03816761|451567768|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
125528634|NCT03816761|451567763|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
125528635|NCT03816761|451567764|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
125528636|NCT03816761|451567765|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
125528637|NCT03816761|451567766|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
125528638|NCT03816761|451567767|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
125528639|NCT03816761|451567768|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
125528640|NCT01240551|451567769|FG000|Overall Study|Refused further treatment|3|||
125528641|NCT01240551|451567770|FG001|Overall Study|Refused further treatment|2|||
125528642|NCT01240551|451567769|FG000|Overall Study|Lost to Follow-up|1|||
125528643|NCT01240551|451567770|FG001|Overall Study|Lost to Follow-up|1|||
125528644|NCT01730950|451567776|FG000|Overall Study|Protocol Violation|6|||
125528645|NCT01730950|451567777|FG001|Overall Study|Protocol Violation|6|||
125528646|NCT00667459|451567778|FG000|Overall Study|Death|0|||
125528647|NCT00667459|451567779|FG001|Overall Study|Death|2|||
125528648|NCT00667459|451567778|FG000|Overall Study|Lost to Follow-up|8|||
125528649|NCT00667459|451567779|FG001|Overall Study|Lost to Follow-up|43|||
125528650|NCT02568397|451567780|FG000|Period 2|Withdrawal by Subject|0|||
125528651|NCT02568397|451567781|FG001|Period 2|Withdrawal by Subject|1|||
125528652|NCT02568397|451567780|FG000|Period 2|Physician Decision|0|||
125528653|NCT02568397|451567781|FG001|Period 2|Physician Decision|1|||
125528654|NCT01200342|451567782|FG000|Overall Study|Disease Progression|1|||
125528655|NCT04546217|451567785|FG000|Overall Study|Withdrawal by Subject|2|||
125528656|NCT04546217|451567786|FG001|Overall Study|Withdrawal by Subject|0|||
125528657|NCT04546217|451567785|FG000|Overall Study|Uncontrolled hypertension|1|||
125528658|NCT04546217|451567786|FG001|Overall Study|Uncontrolled hypertension|0|||
125528659|NCT02550938|451567787|FG000|Overall Study|Lost to Follow-up|8|||
125528660|NCT02550938|451567788|FG001|Overall Study|Lost to Follow-up|7|||
125528661|NCT02550938|451567789|FG002|Overall Study|Lost to Follow-up|12|||
125528662|NCT02550938|451567790|FG003|Overall Study|Lost to Follow-up|11|||
125528663|NCT01484431|451567791|FG000|Period 1: High Dose|Physician Decision|0|||
125528664|NCT01484431|451567792|FG001|Period 1: High Dose|Physician Decision|1|||
125528665|NCT01484431|451567793|FG002|Period 1: High Dose|Physician Decision|0|||
125528666|NCT01484431|451567791|FG000|Period 2|Death|0|||
125528667|NCT01484431|451567792|FG001|Period 2|Death|1|||
125528668|NCT01484431|451567793|FG002|Period 2|Death|1|||
125528669|NCT01484431|451567791|FG000|Period 2|Physician Decision|0|||
125528670|NCT01484431|451567792|FG001|Period 2|Physician Decision|0|||
125528671|NCT01484431|451567793|FG002|Period 2|Physician Decision|1|||
125528672|NCT01484431|451567791|FG000|Period 2|Non-Compliance with Study Drug|1|||
125528673|NCT01484431|451567792|FG001|Period 2|Non-Compliance with Study Drug|0|||
125528674|NCT01484431|451567793|FG002|Period 2|Non-Compliance with Study Drug|0|||
125528675|NCT01888874|451567797|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
125528676|NCT01888874|451567798|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
125528677|NCT01888874|451567799|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
125528678|NCT01888874|451567800|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
125528679|NCT01888874|451567801|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
125528680|NCT01888874|451567802|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
125528681|NCT01888874|451567803|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
125528682|NCT01888874|451567797|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
125528683|NCT01888874|451567798|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
125528684|NCT01888874|451567799|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
125528685|NCT01888874|451567800|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
125528686|NCT01888874|451567801|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
125528687|NCT01888874|451567802|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
125528688|NCT01888874|451567803|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
125528689|NCT01888874|451567797|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
125528690|NCT01888874|451567798|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
125528691|NCT01888874|451567799|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
125528692|NCT01888874|451567800|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
125528693|NCT01888874|451567801|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
125528694|NCT01888874|451567802|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
125528695|NCT01888874|451567803|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
125528696|NCT01888874|451567797|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
125528697|NCT01888874|451567798|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
125528698|NCT01888874|451567799|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
125528699|NCT01888874|451567800|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
125528700|NCT01888874|451567801|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
125528701|NCT01888874|451567802|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
125528702|NCT01888874|451567803|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
125528703|NCT01888874|451567797|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
125528704|NCT01888874|451567798|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
125528705|NCT01888874|451567799|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
125528706|NCT01888874|451567800|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
125528707|NCT01888874|451567801|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
125528708|NCT01888874|451567802|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
125528709|NCT01888874|451567803|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
125528710|NCT01888874|451567797|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
125528711|NCT01888874|451567798|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
125528712|NCT01888874|451567799|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
125528713|NCT01888874|451567800|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
125528714|NCT01888874|451567801|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
125528715|NCT01888874|451567802|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
125528716|NCT01888874|451567803|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
125528717|NCT01888874|451567797|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
125528718|NCT01888874|451567798|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
125528719|NCT01888874|451567799|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
125528720|NCT01888874|451567800|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
125528721|NCT01888874|451567801|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
125528722|NCT01888874|451567802|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
125528723|NCT01888874|451567803|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
125528724|NCT01888874|451567797|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
125528725|NCT01888874|451567798|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
125528726|NCT01888874|451567799|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
125528727|NCT01888874|451567800|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
125528728|NCT01888874|451567801|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
125528729|NCT01888874|451567802|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
125528730|NCT01888874|451567803|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
125528731|NCT01888874|451567797|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
125528732|NCT01888874|451567798|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
125528733|NCT01888874|451567799|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
125528734|NCT01888874|451567800|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
125528735|NCT01888874|451567801|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
125528736|NCT01888874|451567802|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
125528737|NCT01888874|451567803|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
125528738|NCT01888874|451567797|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
125528739|NCT01888874|451567798|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
125528740|NCT01888874|451567799|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
125528741|NCT01888874|451567800|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
125528742|NCT01888874|451567801|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
125528743|NCT01888874|451567802|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
125528744|NCT01888874|451567803|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
125528745|NCT01888874|451567797|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
125528746|NCT01888874|451567798|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
125528747|NCT01888874|451567799|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
125528748|NCT01888874|451567800|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
125528749|NCT01888874|451567801|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
125528750|NCT01888874|451567802|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
125528751|NCT01888874|451567803|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
125528752|NCT01888874|451567797|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
125528753|NCT01888874|451567798|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
125528754|NCT01888874|451567799|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
125528755|NCT01888874|451567800|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
125528756|NCT01888874|451567801|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
125528757|NCT01888874|451567802|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
125528758|NCT01888874|451567803|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
125528759|NCT01888874|451567797|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
125528760|NCT01888874|451567798|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
125528761|NCT01888874|451567799|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
125528762|NCT01888874|451567800|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
125528763|NCT01888874|451567801|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
125528764|NCT01888874|451567802|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
125528765|NCT01888874|451567803|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
125528766|NCT02980042|451567804|FG000|Overall Study|Lost to Follow-up|5|||
125528767|NCT02980042|451567805|FG001|Overall Study|Lost to Follow-up|0|||
125528768|NCT02980042|451567804|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
125528769|NCT02980042|451567805|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
125528770|NCT01483144|451567813|FG000|Overall Study|Adverse Event|9|||
125528771|NCT01483144|451567814|FG001|Overall Study|Adverse Event|4|||
125528772|NCT01483144|451567815|FG002|Overall Study|Adverse Event|6|||
125528773|NCT01483144|451567813|FG000|Overall Study|Withdrawal by Subject|0|||
125528774|NCT01483144|451567814|FG001|Overall Study|Withdrawal by Subject|2|||
125528775|NCT01483144|451567815|FG002|Overall Study|Withdrawal by Subject|5|||
125528776|NCT01483144|451567813|FG000|Overall Study|Physician Decision|1|||
125528777|NCT01483144|451567814|FG001|Overall Study|Physician Decision|0|||
125528778|NCT01483144|451567815|FG002|Overall Study|Physician Decision|0|||
125528779|NCT01483144|451567813|FG000|Overall Study|Lost to Follow-up|2|||
125528780|NCT01483144|451567814|FG001|Overall Study|Lost to Follow-up|4|||
125528781|NCT01483144|451567815|FG002|Overall Study|Lost to Follow-up|1|||
125528782|NCT01483144|451567813|FG000|Overall Study|Protocol Violation|3|||
125528783|NCT01483144|451567814|FG001|Overall Study|Protocol Violation|3|||
125528784|NCT01483144|451567815|FG002|Overall Study|Protocol Violation|3|||
125528785|NCT02460575|451567816|FG000|Overall Study|Lost to Follow-up|1|||
125528786|NCT02460575|451567817|FG001|Overall Study|Lost to Follow-up|0|||
125528787|NCT02870972|451567818|FG000|Overall Study|Adverse Event|1|||
125528788|NCT02870972|451567819|FG001|Overall Study|Adverse Event|0|||
125528789|NCT02870972|451567820|FG002|Overall Study|Adverse Event|0|||
125528790|NCT02870972|451567821|FG003|Overall Study|Adverse Event|0|||
125528791|NCT02870972|451567822|FG004|Overall Study|Adverse Event|0|||
125528792|NCT02179177|451567823|FG000|Overall Study|Lost to Follow-up|1|||
125528793|NCT02179177|451567824|FG001|Overall Study|Lost to Follow-up|1|||
125528794|NCT02179177|451567823|FG000|Overall Study|Withdrawal by Subject|1|||
125528795|NCT02179177|451567824|FG001|Overall Study|Withdrawal by Subject|1|||
125528796|NCT04497389|451567825|FG000|Overall Study|Withdrawal by Subject|1|||
125528797|NCT04497389|451567826|FG001|Overall Study|Withdrawal by Subject|0|||
125528798|NCT04052425|451567827|FG000|24-Week Double-blind Period|Adverse Event|0|||
125528799|NCT04052425|451567828|FG001|24-Week Double-blind Period|Adverse Event|1|||
125528800|NCT04052425|451567829|FG002|24-Week Double-blind Period|Adverse Event|0|||
125528801|NCT04052425|451567830|FG003|24-Week Double-blind Period|Adverse Event|0|||
125528802|NCT04052425|451567827|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
125528803|NCT04052425|451567828|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
125528804|NCT04052425|451567829|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
125528805|NCT04052425|451567830|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
125528806|NCT04052425|451567827|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
125528807|NCT04052425|451567828|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
125528808|NCT04052425|451567829|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
125528809|NCT04052425|451567830|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
125528810|NCT04052425|451567827|FG000|24-Week Double-blind Period|Physician Decision|1|||
125528811|NCT04052425|451567828|FG001|24-Week Double-blind Period|Physician Decision|0|||
125528812|NCT04052425|451567829|FG002|24-Week Double-blind Period|Physician Decision|0|||
125528813|NCT04052425|451567830|FG003|24-Week Double-blind Period|Physician Decision|0|||
125528814|NCT04052425|451567827|FG000|24-Week Double-blind Period|Protocol Violation|1|||
125528815|NCT04052425|451567828|FG001|24-Week Double-blind Period|Protocol Violation|0|||
125528816|NCT04052425|451567829|FG002|24-Week Double-blind Period|Protocol Violation|0|||
125528817|NCT04052425|451567830|FG003|24-Week Double-blind Period|Protocol Violation|0|||
125528818|NCT04052425|451567827|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
125528819|NCT04052425|451567828|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
125528820|NCT04052425|451567829|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
125528821|NCT04052425|451567830|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
125528822|NCT04052425|451567827|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
125528823|NCT04052425|451567828|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
125528824|NCT04052425|451567829|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
125528825|NCT04052425|451567830|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
125528826|NCT04052425|451567827|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
125528827|NCT04052425|451567828|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
125528828|NCT04052425|451567829|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
125528829|NCT04052425|451567830|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
125528830|NCT04052425|451567827|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
125528831|NCT04052425|451567828|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
125528832|NCT04052425|451567829|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
125528833|NCT04052425|451567830|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
125528834|NCT04052425|451567827|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
125528835|NCT04052425|451567828|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
125528836|NCT04052425|451567829|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
125528837|NCT04052425|451567830|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
125528838|NCT04052425|451567827|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
125528839|NCT04052425|451567828|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
125528840|NCT04052425|451567829|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
125528841|NCT04052425|451567830|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
125528842|NCT04052425|451567827|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
125528843|NCT04052425|451567828|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
125528844|NCT04052425|451567829|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
125528845|NCT04052425|451567830|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
125528846|NCT04052425|451567827|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
125528847|NCT04052425|451567828|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
125528848|NCT04052425|451567829|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
125528849|NCT04052425|451567830|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
125528850|NCT04052425|451567827|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
125528851|NCT04052425|451567828|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
125528852|NCT04052425|451567829|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
125528853|NCT04052425|451567830|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
125528854|NCT04829747|451567833|FG000|Overall Study|Protocol Violation|1|||
125528855|NCT03445533|451567836|FG000|Overall Study|Progressive Disease|48|||
125528856|NCT03445533|451567837|FG001|Overall Study|Progressive Disease|81|||
125528857|NCT03445533|451567836|FG000|Overall Study|Adverse Event|60|||
125528858|NCT03445533|451567837|FG001|Overall Study|Adverse Event|64|||
125528859|NCT03445533|451567836|FG000|Overall Study|Death|9|||
125528860|NCT03445533|451567837|FG001|Overall Study|Death|19|||
125528861|NCT03445533|451567836|FG000|Overall Study|Miscellaneous|0|||
125528862|NCT03445533|451567837|FG001|Overall Study|Miscellaneous|16|||
125528863|NCT03445533|451567836|FG000|Overall Study|Withdrawal by Subject|3|||
125528864|NCT03445533|451567837|FG001|Overall Study|Withdrawal by Subject|4|||
125528865|NCT03445533|451567836|FG000|Overall Study|Physician Decision|1|||
125528866|NCT03445533|451567837|FG001|Overall Study|Physician Decision|3|||
125528867|NCT03445533|451567836|FG000|Overall Study|Sponsor Decision|0|||
125528868|NCT03445533|451567837|FG001|Overall Study|Sponsor Decision|1|||
125528869|NCT03445533|451567836|FG000|Overall Study|Lost to Follow-up|0|||
125528870|NCT03445533|451567837|FG001|Overall Study|Lost to Follow-up|1|||
125528871|NCT03445533|451567836|FG000|Overall Study|Never Received any Study Treatment|7|||
125528872|NCT03445533|451567837|FG001|Overall Study|Never Received any Study Treatment|4|||
125528873|NCT02615509|451567838|FG000|Overall Study|Lost to Follow-up|134|||
125528874|NCT02615509|451567838|FG000|Overall Study|Death|4|||
125528875|NCT02615509|451567838|FG000|Overall Study|Withdrawal by Subject|8|||
125528876|NCT00425607|451567839|FG000|Overall Study|Death|1|||
125528877|NCT00425607|451567839|FG000|Overall Study|Withdrawal by Subject|1|||
125528878|NCT00079339|451567840|FG000|Overall Study|Adverse Event|1|||
125528879|NCT00079339|451567841|FG001|Overall Study|Adverse Event|7|||
125528880|NCT00079339|451567842|FG002|Overall Study|Adverse Event|2|||
125528881|NCT00079339|451567840|FG000|Overall Study|Death|1|||
125528882|NCT00079339|451567841|FG001|Overall Study|Death|0|||
125528883|NCT00079339|451567842|FG002|Overall Study|Death|0|||
125528884|NCT00079339|451567840|FG000|Overall Study|Non-compliance|0|||
125528885|NCT00079339|451567841|FG001|Overall Study|Non-compliance|0|||
125528886|NCT00079339|451567842|FG002|Overall Study|Non-compliance|1|||
125528887|NCT00079339|451567840|FG000|Overall Study|Withdrawal by Subject|0|||
125528888|NCT00079339|451567841|FG001|Overall Study|Withdrawal by Subject|4|||
125528889|NCT00079339|451567842|FG002|Overall Study|Withdrawal by Subject|1|||
125528890|NCT00079339|451567840|FG000|Overall Study|Disease progression|3|||
125528891|NCT00079339|451567841|FG001|Overall Study|Disease progression|28|||
125528892|NCT00079339|451567842|FG002|Overall Study|Disease progression|2|||
125528893|NCT02563548|451567843|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
125528894|NCT02563548|451567844|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
125528895|NCT02563548|451567845|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
125528896|NCT02563548|451567846|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
125528897|NCT02563548|451567847|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
125528898|NCT02563548|451567848|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
125528899|NCT02563548|451567843|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
125528900|NCT02563548|451567844|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
125528901|NCT02563548|451567845|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
125528902|NCT02563548|451567846|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
125528903|NCT02563548|451567847|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
125528904|NCT02563548|451567848|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
125528905|NCT02563548|451567843|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
125528906|NCT02563548|451567844|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
125528907|NCT02563548|451567845|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
125528908|NCT02563548|451567846|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
125528909|NCT02563548|451567847|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
125528910|NCT02563548|451567848|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
125528911|NCT02563548|451567843|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
125528912|NCT02563548|451567844|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
125528913|NCT02563548|451567845|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
125528914|NCT02563548|451567846|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
125528915|NCT02563548|451567847|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
125528916|NCT02563548|451567848|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
125528917|NCT02563548|451567843|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
125528918|NCT02563548|451567844|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
125528919|NCT02563548|451567845|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
125528920|NCT02563548|451567846|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
125528921|NCT02563548|451567847|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
125528922|NCT02563548|451567848|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
125528923|NCT02563548|451567843|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
125528924|NCT02563548|451567844|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
125528925|NCT02563548|451567845|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
125528926|NCT02563548|451567846|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
125528927|NCT02563548|451567847|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
125528928|NCT02563548|451567848|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
125528929|NCT02563548|451567843|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
125528930|NCT02563548|451567844|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
125528931|NCT02563548|451567845|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
125528932|NCT02563548|451567846|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
125528933|NCT02563548|451567847|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
125528934|NCT02563548|451567848|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
125528935|NCT02563548|451567843|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
125528936|NCT02563548|451567844|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
125528937|NCT02563548|451567845|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
125528938|NCT02563548|451567846|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
125528939|NCT02563548|451567847|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
125528940|NCT02563548|451567848|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
125528941|NCT02563548|451567843|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
125528942|NCT02563548|451567844|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
125528943|NCT02563548|451567845|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
125528944|NCT02563548|451567846|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
125528945|NCT02563548|451567847|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
125528946|NCT02563548|451567848|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
125528947|NCT02563548|451567843|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
125528948|NCT02563548|451567844|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
125528949|NCT02563548|451567845|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
125528950|NCT02563548|451567846|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
125528951|NCT02563548|451567847|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
125528952|NCT02563548|451567848|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
125528953|NCT02563548|451567843|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
125528954|NCT02563548|451567844|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
125528955|NCT02563548|451567845|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
125528956|NCT02563548|451567846|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
125528957|NCT02563548|451567847|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
125528958|NCT02563548|451567848|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
125528959|NCT02563548|451567843|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
125528960|NCT02563548|451567844|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
125528961|NCT02563548|451567845|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
125528962|NCT02563548|451567846|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
125528963|NCT02563548|451567847|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
125533006|NCT04047862|451581436|FG014|Overall Study|Physician Decision|1|||
125528964|NCT02563548|451567848|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
125528965|NCT00520845|451567849|FG000|Overall Study|Death|3|||
125528966|NCT00520845|451567849|FG000|Overall Study|Adverse Event|4|||
125528967|NCT00520845|451567849|FG000|Overall Study|Disease Progression, relapse|13|||
125528968|NCT00520845|451567849|FG000|Overall Study|Withdrawal by Subject|1|||
125528969|NCT00520845|451567849|FG000|Overall Study|Alternative Therapy|1|||
125528970|NCT03274453|451567852|FG000|Overall Study|Lost to Follow-up|2|||
125528971|NCT03274453|451567853|FG001|Overall Study|Lost to Follow-up|5|||
125528972|NCT03274453|451567854|FG002|Overall Study|Lost to Follow-up|4|||
125528973|NCT03274453|451567855|FG003|Overall Study|Lost to Follow-up|1|||
125528974|NCT03274453|451567852|FG000|Overall Study|Physician Decision|2|||
125528975|NCT03274453|451567853|FG001|Overall Study|Physician Decision|0|||
125528976|NCT03274453|451567854|FG002|Overall Study|Physician Decision|0|||
125528977|NCT03274453|451567855|FG003|Overall Study|Physician Decision|3|||
125528978|NCT03274453|451567852|FG000|Overall Study|Surgery Cancelled|0|||
125528979|NCT03274453|451567853|FG001|Overall Study|Surgery Cancelled|1|||
125528980|NCT03274453|451567854|FG002|Overall Study|Surgery Cancelled|0|||
125528981|NCT03274453|451567855|FG003|Overall Study|Surgery Cancelled|0|||
125528982|NCT01516749|451567857|FG000|Active Therapy|Lost to Follow-up|1|||
125528983|NCT01516749|451567857|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
125528984|NCT01732549|451567858|FG000|Overall Study|Adverse Event|13|||
125528985|NCT01732549|451567859|FG001|Overall Study|Adverse Event|3|||
125528986|NCT01732549|451567858|FG000|Overall Study|Consent withdrawn|13|||
125528987|NCT01732549|451567859|FG001|Overall Study|Consent withdrawn|6|||
125528988|NCT01732549|451567858|FG000|Overall Study|Disease progression|37|||
125528989|NCT01732549|451567859|FG001|Overall Study|Disease progression|50|||
125528990|NCT01732549|451567858|FG000|Overall Study|Other|8|||
125528991|NCT01732549|451567859|FG001|Overall Study|Other|14|||
125528992|NCT00351377|451567860|FG000|Overall Study|Adverse Event|5|||
125528993|NCT00351377|451567860|FG000|Overall Study|Death|1|||
125528994|NCT00351377|451567860|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
125528995|NCT02493062|451567865|FG000|Overall Study|Physician Decision|12|||
125528996|NCT03845140|451567866|FG000|Overall Study|Participant travelled outside study area|0|||
125528997|NCT03845140|451567867|FG001|Overall Study|Participant travelled outside study area|1|||
125528998|NCT03845140|451567868|FG002|Overall Study|Participant travelled outside study area|0|||
125528999|NCT03845140|451567869|FG003|Overall Study|Participant travelled outside study area|0|||
125529000|NCT03845140|451567870|FG004|Overall Study|Participant travelled outside study area|0|||
125529001|NCT03845140|451567871|FG005|Overall Study|Participant travelled outside study area|0|||
125529002|NCT00447590|451567877|FG000|Overall Study|Withdrawal by Subject|26|||
125529003|NCT00447590|451567877|FG000|Overall Study|Lost to Follow-up|24|||
125529004|NCT00447590|451567877|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
125529005|NCT01661205|451567878|FG000|Overall Study|Physician Decision|2|||
125529006|NCT05569421|451567883|FG000|Overall Study|Withdrawal by Subject|1|||
125529007|NCT05569421|451567884|FG001|Overall Study|Withdrawal by Subject|0|||
125529008|NCT05569421|451567885|FG002|Overall Study|Withdrawal by Subject|0|||
125529009|NCT03111095|451567886|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
125529010|NCT03111095|451567887|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
125529011|NCT03111095|451567886|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
125529012|NCT03111095|451567887|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
125529013|NCT00504075|451567888|FG000|Overall Study|Adverse Event|1|||
125529014|NCT00504075|451567888|FG000|Overall Study|Lost to Follow-up|5|||
125529015|NCT00504075|451567888|FG000|Overall Study|Withdrawal by Subject|1|||
125529016|NCT00504075|451567888|FG000|Overall Study|Required other therapeutic intervention|1|||
125529017|NCT01689857|451567890|FG000|Overall Study|Lost to Follow-up|5|||
125529018|NCT01689857|451567891|FG001|Overall Study|Lost to Follow-up|2|||
125529019|NCT05105087|451567892|FG000|Overall Study|Withdrawal by Subject|2|||
125529020|NCT05105087|451567892|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
125529021|NCT03106753|451567895|FG000|Overall Study|Withdrawal by Subject|0|||
125529022|NCT03106753|451567896|FG001|Overall Study|Withdrawal by Subject|1|||
125529023|NCT00368875|451567901|FG000|Overall Study|Adverse Event|0|||
125529024|NCT00368875|451567902|FG001|Overall Study|Adverse Event|12|||
125529025|NCT00368875|451567901|FG000|Overall Study|Progressive disease|3|||
125529026|NCT00368875|451567902|FG001|Overall Study|Progressive disease|27|||
125529027|NCT00368875|451567901|FG000|Overall Study|Withdrawal by Subject|2|||
125529028|NCT00368875|451567902|FG001|Overall Study|Withdrawal by Subject|6|||
125529029|NCT00368875|451567901|FG000|Overall Study|Other Reason|0|||
125529030|NCT00368875|451567902|FG001|Overall Study|Other Reason|2|||
125529031|NCT00368875|451567901|FG000|Overall Study|Alternative Therapy|1|||
125529032|NCT00368875|451567902|FG001|Overall Study|Alternative Therapy|1|||
125529033|NCT00844597|451567903|FG000|Overall Study|Adverse Event|0|||
125529034|NCT00844597|451567904|FG001|Overall Study|Adverse Event|0|||
125529035|NCT00844597|451567905|FG002|Overall Study|Adverse Event|0|||
125529036|NCT00844597|451567906|FG003|Overall Study|Adverse Event|1|||
125529037|NCT00844597|451567907|FG004|Overall Study|Adverse Event|0|||
125529038|NCT00844597|451567908|FG005|Overall Study|Adverse Event|0|||
125529039|NCT04160988|451567909|FG000|Overall Study|poor image quality|28|||
125529040|NCT02670122|451567910|FG000|Overall Study|Lost to Follow-up|4|||
125529041|NCT02762903|451567912|FG000|Overall Study|Lost to Follow-up|0|||
125529042|NCT02762903|451567913|FG001|Overall Study|Lost to Follow-up|1|||
125529043|NCT00243074|451567914|FG000|Overall Study|Ineligible|6|||
125529044|NCT00243074|451567914|FG000|Overall Study|Adverse Event|6|||
125529045|NCT00243074|451567914|FG000|Overall Study|Withdrawal by Subject|2|||
125529046|NCT00243074|451567914|FG000|Overall Study|Lack of Efficacy|36|||
125529047|NCT00243074|451567914|FG000|Overall Study|Death|2|||
125529048|NCT00243074|451567914|FG000|Overall Study|not protocol specified|1|||
125529049|NCT00243074|451567914|FG000|Overall Study|Did not receive any treatment|1|||
125529050|NCT00664534|451567915|FG000|Overall Study|Adverse Event|2|||
125529051|NCT00664534|451567916|FG001|Overall Study|Adverse Event|3|||
125529052|NCT00664534|451567915|FG000|Overall Study|Lost to Follow-up|6|||
125529053|NCT00664534|451567916|FG001|Overall Study|Lost to Follow-up|10|||
125529054|NCT00664534|451567915|FG000|Overall Study|Protocol Violation|10|||
125529055|NCT00664534|451567916|FG001|Overall Study|Protocol Violation|8|||
125529056|NCT00664534|451567915|FG000|Overall Study|Withdrawal by Subject|7|||
125529057|NCT00664534|451567916|FG001|Overall Study|Withdrawal by Subject|6|||
125529058|NCT00664534|451567915|FG000|Overall Study|Physician Decision|8|||
125529059|NCT00664534|451567916|FG001|Overall Study|Physician Decision|0|||
125529060|NCT00664534|451567915|FG000|Overall Study|Sponsor decision|8|||
125529061|NCT00664534|451567916|FG001|Overall Study|Sponsor decision|6|||
125529062|NCT03041792|451567917|FG000|Overall Study|Adverse Event|4|||
125529063|NCT03041792|451567918|FG001|Overall Study|Adverse Event|0|||
125529064|NCT03041792|451567917|FG000|Overall Study|Death in the family|0|||
125529065|NCT03041792|451567918|FG001|Overall Study|Death in the family|2|||
125529066|NCT03041792|451567917|FG000|Overall Study|Randomized but not treated|0|||
125529067|NCT03041792|451567918|FG001|Overall Study|Randomized but not treated|1|||
125529068|NCT04978090|451567919|FG000|Overall Study|unable to adequately fit device|2|||
125529069|NCT00632502|451567922|FG000|Overall Study|Adverse Event|0|||
125529070|NCT00632502|451567923|FG001|Overall Study|Adverse Event|1|||
125529071|NCT00632502|451567922|FG000|Overall Study|Randomized not treated|3|||
125529072|NCT00632502|451567923|FG001|Overall Study|Randomized not treated|0|||
125529073|NCT03075527|451567924|FG000|Overall Study|Death|1|||
125529074|NCT03075527|451567924|FG000|Overall Study|Withdrawal by Subject|1|||
125529075|NCT03075527|451567924|FG000|Overall Study|Physician Decision|3|||
125529076|NCT03075527|451567924|FG000|Overall Study|Progression/Relapse|14|||
125529077|NCT00681668|451567925|FG000|Overall Study|Protocol Violation|1|||
125529078|NCT00681668|451567925|FG000|Overall Study|Withdrawal by Subject|1|||
125529079|NCT02209181|451567926|FG000|Overall Study|Adverse Event|1|||
125529080|NCT02209181|451567927|FG001|Overall Study|Adverse Event|0|||
125529081|NCT02209181|451567928|FG002|Overall Study|Adverse Event|1|||
125529082|NCT02209181|451567929|FG003|Overall Study|Adverse Event|0|||
125529083|NCT02209181|451567926|FG000|Overall Study|Withdrawal by Subject|0|||
125529084|NCT02209181|451567927|FG001|Overall Study|Withdrawal by Subject|1|||
125529085|NCT02209181|451567928|FG002|Overall Study|Withdrawal by Subject|0|||
125529086|NCT02209181|451567929|FG003|Overall Study|Withdrawal by Subject|0|||
125529087|NCT06926673|451567930|FG000|Overall Study|Lost to Follow-up|0|||
125529088|NCT06926673|451567931|FG001|Overall Study|Lost to Follow-up|0|||
125529089|NCT06926673|451567932|FG002|Overall Study|Lost to Follow-up|0|||
125529090|NCT06926673|451567933|FG003|Overall Study|Lost to Follow-up|1|||
125529091|NCT06926673|451567934|FG004|Overall Study|Lost to Follow-up|0|||
125529092|NCT06926673|451567935|FG005|Overall Study|Lost to Follow-up|0|||
125529093|NCT06926673|451567936|FG006|Overall Study|Lost to Follow-up|0|||
125529094|NCT06926673|451567930|FG000|Overall Study|Physician Decision|0|||
125529095|NCT06926673|451567931|FG001|Overall Study|Physician Decision|0|||
125529096|NCT06926673|451567932|FG002|Overall Study|Physician Decision|0|||
125529097|NCT06926673|451567933|FG003|Overall Study|Physician Decision|0|||
125529098|NCT06926673|451567934|FG004|Overall Study|Physician Decision|0|||
125529099|NCT06926673|451567935|FG005|Overall Study|Physician Decision|0|||
125529100|NCT06926673|451567936|FG006|Overall Study|Physician Decision|1|||
125529101|NCT06926673|451567930|FG000|Overall Study|Withdrawal by Subject|0|||
125529102|NCT06926673|451567931|FG001|Overall Study|Withdrawal by Subject|3|||
125529103|NCT06926673|451567932|FG002|Overall Study|Withdrawal by Subject|2|||
125529104|NCT06926673|451567933|FG003|Overall Study|Withdrawal by Subject|1|||
125529105|NCT06926673|451567934|FG004|Overall Study|Withdrawal by Subject|0|||
125529106|NCT06926673|451567935|FG005|Overall Study|Withdrawal by Subject|2|||
125529107|NCT06926673|451567936|FG006|Overall Study|Withdrawal by Subject|0|||
125529108|NCT02358668|451570744|FG000|Overall Study|Adverse Event|2|||
125529109|NCT02358668|451570745|FG001|Overall Study|Adverse Event|0|||
125529110|NCT02358668|451570746|FG002|Overall Study|Adverse Event|0|||
125529111|NCT02358668|451570744|FG000|Overall Study|Withdrawal by Subject|0|||
125529112|NCT02358668|451570745|FG001|Overall Study|Withdrawal by Subject|1|||
125529113|NCT02358668|451570746|FG002|Overall Study|Withdrawal by Subject|0|||
125529114|NCT04057573|451570747|FG000|24-Week Double-Blind Period|Adverse Event|2|||
125529115|NCT04057573|451570748|FG001|24-Week Double-Blind Period|Adverse Event|0|||
125529116|NCT04057573|451570749|FG002|24-Week Double-Blind Period|Adverse Event|0|||
125529117|NCT04057573|451570750|FG003|24-Week Double-Blind Period|Adverse Event|0|||
125529118|NCT04057573|451570747|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
125529119|NCT04057573|451570748|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
125529120|NCT04057573|451570749|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
125529121|NCT04057573|451570750|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
125529122|NCT04057573|451570747|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
125529123|NCT04057573|451570748|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
125529124|NCT04057573|451570749|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
125529125|NCT04057573|451570750|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
125529126|NCT04057573|451570747|FG000|24-Week Double-Blind Period|Physician Decision|1|||
125529127|NCT04057573|451570748|FG001|24-Week Double-Blind Period|Physician Decision|0|||
125529128|NCT04057573|451570749|FG002|24-Week Double-Blind Period|Physician Decision|0|||
125529129|NCT04057573|451570750|FG003|24-Week Double-Blind Period|Physician Decision|0|||
125529130|NCT04057573|451570747|FG000|24-Week Double-Blind Period|Pregnancy|1|||
125529131|NCT04057573|451570748|FG001|24-Week Double-Blind Period|Pregnancy|0|||
125529132|NCT04057573|451570749|FG002|24-Week Double-Blind Period|Pregnancy|0|||
125529133|NCT04057573|451570750|FG003|24-Week Double-Blind Period|Pregnancy|0|||
125529134|NCT04057573|451570747|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
125529135|NCT04057573|451570748|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
125529136|NCT04057573|451570749|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
125529137|NCT04057573|451570750|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
125529138|NCT04057573|451570747|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
125529139|NCT04057573|451570748|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
125529140|NCT04057573|451570749|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
125529141|NCT04057573|451570750|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
125529142|NCT04057573|451570747|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
125529143|NCT04057573|451570748|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
125529144|NCT04057573|451570749|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
125529145|NCT04057573|451570750|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
125529146|NCT04057573|451570747|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
125529147|NCT04057573|451570748|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
125529148|NCT04057573|451570749|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
125529149|NCT04057573|451570750|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
125529150|NCT04057573|451570747|FG000|24-Week Double-Blind Period|Not Treated|1|||
125529151|NCT04057573|451570748|FG001|24-Week Double-Blind Period|Not Treated|0|||
125529152|NCT04057573|451570749|FG002|24-Week Double-Blind Period|Not Treated|0|||
125529153|NCT04057573|451570750|FG003|24-Week Double-Blind Period|Not Treated|0|||
125529154|NCT04057573|451570747|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
125529155|NCT04057573|451570748|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
125529156|NCT04057573|451570749|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
125529157|NCT04057573|451570750|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
125529158|NCT04057573|451570747|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
125529159|NCT04057573|451570748|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
125529160|NCT04057573|451570749|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
125529161|NCT04057573|451570750|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
125529162|NCT04057573|451570747|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
125529163|NCT04057573|451570748|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
125529164|NCT04057573|451570749|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
125529165|NCT04057573|451570750|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
125529166|NCT04057573|451570747|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
125529167|NCT04057573|451570748|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
125529168|NCT04057573|451570749|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
125529169|NCT04057573|451570750|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
125529170|NCT04057573|451570747|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
125529171|NCT04057573|451570748|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
125529172|NCT04057573|451570749|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
125529173|NCT04057573|451570750|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
125529174|NCT01317875|451570753|FG000|Overall Study|Other|0|||
125529175|NCT01317875|451570754|FG001|Overall Study|Other|0|||
125529176|NCT01317875|451570755|FG002|Overall Study|Other|1|||
125529177|NCT01317875|451570756|FG003|Overall Study|Other|0|||
125529178|NCT01317875|451570757|FG004|Overall Study|Other|0|||
125529179|NCT01317875|451570758|FG005|Overall Study|Other|0|||
125529180|NCT01317875|451570759|FG006|Overall Study|Other|0|||
125529181|NCT01317875|451570760|FG007|Overall Study|Other|0|||
125529182|NCT01317875|451570761|FG008|Overall Study|Other|0|||
125529183|NCT01317875|451570762|FG009|Overall Study|Other|0|||
125529184|NCT01317875|451570753|FG000|Overall Study|Noncompliance with study drug|0|||
125529185|NCT01317875|451570754|FG001|Overall Study|Noncompliance with study drug|0|||
125529186|NCT01317875|451570755|FG002|Overall Study|Noncompliance with study drug|1|||
125529187|NCT01317875|451570756|FG003|Overall Study|Noncompliance with study drug|0|||
125529188|NCT01317875|451570757|FG004|Overall Study|Noncompliance with study drug|0|||
125529189|NCT01317875|451570758|FG005|Overall Study|Noncompliance with study drug|0|||
125529190|NCT01317875|451570759|FG006|Overall Study|Noncompliance with study drug|0|||
125529191|NCT01317875|451570760|FG007|Overall Study|Noncompliance with study drug|0|||
125529192|NCT01317875|451570761|FG008|Overall Study|Noncompliance with study drug|0|||
125529193|NCT01317875|451570762|FG009|Overall Study|Noncompliance with study drug|0|||
125529194|NCT01317875|451570753|FG000|Overall Study|Progressive Disease|1|||
125529195|NCT01317875|451570754|FG001|Overall Study|Progressive Disease|0|||
125529196|NCT01317875|451570755|FG002|Overall Study|Progressive Disease|2|||
125529197|NCT01317875|451570756|FG003|Overall Study|Progressive Disease|0|||
125529198|NCT01317875|451570757|FG004|Overall Study|Progressive Disease|1|||
125529199|NCT01317875|451570758|FG005|Overall Study|Progressive Disease|0|||
125529200|NCT01317875|451570759|FG006|Overall Study|Progressive Disease|0|||
125529201|NCT01317875|451570760|FG007|Overall Study|Progressive Disease|1|||
125529202|NCT01317875|451570761|FG008|Overall Study|Progressive Disease|0|||
125529203|NCT01317875|451570762|FG009|Overall Study|Progressive Disease|0|||
125529204|NCT01317875|451570753|FG000|Overall Study|Withdrawal by Subject|0|||
125529205|NCT01317875|451570754|FG001|Overall Study|Withdrawal by Subject|0|||
125529206|NCT01317875|451570755|FG002|Overall Study|Withdrawal by Subject|0|||
125529207|NCT01317875|451570756|FG003|Overall Study|Withdrawal by Subject|0|||
125529208|NCT01317875|451570757|FG004|Overall Study|Withdrawal by Subject|1|||
125529209|NCT01317875|451570758|FG005|Overall Study|Withdrawal by Subject|0|||
125529210|NCT01317875|451570759|FG006|Overall Study|Withdrawal by Subject|0|||
125529211|NCT01317875|451570760|FG007|Overall Study|Withdrawal by Subject|3|||
125529212|NCT01317875|451570761|FG008|Overall Study|Withdrawal by Subject|0|||
125529213|NCT01317875|451570762|FG009|Overall Study|Withdrawal by Subject|0|||
125529214|NCT01317875|451570753|FG000|Overall Study|Physician Decision|0|||
125529215|NCT01317875|451570754|FG001|Overall Study|Physician Decision|1|||
125529216|NCT01317875|451570755|FG002|Overall Study|Physician Decision|1|||
125529217|NCT01317875|451570756|FG003|Overall Study|Physician Decision|0|||
125529218|NCT01317875|451570757|FG004|Overall Study|Physician Decision|2|||
125529219|NCT01317875|451570758|FG005|Overall Study|Physician Decision|0|||
125529220|NCT01317875|451570759|FG006|Overall Study|Physician Decision|0|||
125529221|NCT01317875|451570760|FG007|Overall Study|Physician Decision|2|||
125529222|NCT01317875|451570761|FG008|Overall Study|Physician Decision|0|||
125529223|NCT01317875|451570762|FG009|Overall Study|Physician Decision|0|||
125529224|NCT01317875|451570753|FG000|Overall Study|Death|0|||
125529225|NCT01317875|451570754|FG001|Overall Study|Death|0|||
125529226|NCT01317875|451570755|FG002|Overall Study|Death|2|||
125529227|NCT01317875|451570756|FG003|Overall Study|Death|1|||
125529228|NCT01317875|451570757|FG004|Overall Study|Death|0|||
125529229|NCT01317875|451570758|FG005|Overall Study|Death|1|||
125529230|NCT01317875|451570759|FG006|Overall Study|Death|0|||
125529231|NCT01317875|451570760|FG007|Overall Study|Death|4|||
125529232|NCT01317875|451570761|FG008|Overall Study|Death|0|||
125529233|NCT01317875|451570762|FG009|Overall Study|Death|0|||
125529234|NCT01317875|451570753|FG000|Overall Study|Adverse Event|2|||
125529235|NCT01317875|451570754|FG001|Overall Study|Adverse Event|1|||
125529236|NCT01317875|451570755|FG002|Overall Study|Adverse Event|2|||
125529237|NCT01317875|451570756|FG003|Overall Study|Adverse Event|1|||
125529238|NCT01317875|451570757|FG004|Overall Study|Adverse Event|5|||
125529239|NCT01317875|451570758|FG005|Overall Study|Adverse Event|1|||
125529240|NCT01317875|451570759|FG006|Overall Study|Adverse Event|2|||
125529241|NCT01317875|451570760|FG007|Overall Study|Adverse Event|5|||
125529242|NCT01317875|451570761|FG008|Overall Study|Adverse Event|0|||
125529243|NCT01317875|451570762|FG009|Overall Study|Adverse Event|0|||
125529244|NCT01381575|451570763|FG000|Overall Study|Serious Adverse Event|1|||
125529245|NCT01381575|451570764|FG001|Overall Study|Serious Adverse Event|0|||
125529246|NCT01381575|451570765|FG002|Overall Study|Serious Adverse Event|0|||
125529247|NCT01381575|451570763|FG000|Overall Study|Non-Serious Adverse Event|0|||
125529248|NCT01381575|451570764|FG001|Overall Study|Non-Serious Adverse Event|0|||
125529249|NCT01381575|451570765|FG002|Overall Study|Non-Serious Adverse Event|1|||
125529250|NCT01381575|451570763|FG000|Overall Study|Protocol Violation|0|||
125529251|NCT01381575|451570764|FG001|Overall Study|Protocol Violation|1|||
125529252|NCT01381575|451570765|FG002|Overall Study|Protocol Violation|1|||
125529253|NCT01381575|451570763|FG000|Overall Study|Withdrawal by Subject|15|||
125529254|NCT01381575|451570764|FG001|Overall Study|Withdrawal by Subject|9|||
125529255|NCT01381575|451570765|FG002|Overall Study|Withdrawal by Subject|7|||
125529256|NCT01381575|451570763|FG000|Overall Study|Migrated/moved from study area|2|||
125529257|NCT01381575|451570764|FG001|Overall Study|Migrated/moved from study area|12|||
125529258|NCT01381575|451570765|FG002|Overall Study|Migrated/moved from study area|2|||
125529259|NCT01381575|451570763|FG000|Overall Study|Lost to Follow-up|8|||
125529260|NCT01381575|451570764|FG001|Overall Study|Lost to Follow-up|17|||
125529261|NCT01381575|451570765|FG002|Overall Study|Lost to Follow-up|9|||
125529262|NCT01920477|451570766|FG000|Overall Study|Adverse Event|0|||
125529263|NCT01920477|451570767|FG001|Overall Study|Adverse Event|1|||
125529264|NCT01920477|451570766|FG000|Overall Study|Lack of Efficacy|1|||
125529265|NCT01920477|451570767|FG001|Overall Study|Lack of Efficacy|0|||
125529266|NCT01920477|451570766|FG000|Overall Study|Study closed/terminated|14|||
125529267|NCT01920477|451570767|FG001|Overall Study|Study closed/terminated|15|||
125529268|NCT01920477|451570766|FG000|Overall Study|Withdrawal by Subject|0|||
125529269|NCT01920477|451570767|FG001|Overall Study|Withdrawal by Subject|1|||
125529270|NCT01443403|451570768|FG000|Overall Study|Adverse Event|1|||
125529271|NCT01443403|451570769|FG001|Overall Study|Adverse Event|1|||
125529272|NCT01443403|451570770|FG002|Overall Study|Adverse Event|4|||
125529273|NCT01443403|451570771|FG003|Overall Study|Adverse Event|5|||
125529274|NCT01443403|451570768|FG000|Overall Study|Withdrawal by Subject|0|||
125529275|NCT01443403|451570769|FG001|Overall Study|Withdrawal by Subject|1|||
125529276|NCT01443403|451570770|FG002|Overall Study|Withdrawal by Subject|2|||
125529277|NCT01443403|451570771|FG003|Overall Study|Withdrawal by Subject|1|||
125529278|NCT01443403|451570768|FG000|Overall Study|Lost to Follow-up|0|||
125529279|NCT01443403|451570769|FG001|Overall Study|Lost to Follow-up|0|||
125529280|NCT01443403|451570770|FG002|Overall Study|Lost to Follow-up|0|||
125529281|NCT01443403|451570771|FG003|Overall Study|Lost to Follow-up|1|||
125529282|NCT01443403|451570768|FG000|Overall Study|Protocol Violation|2|||
125529283|NCT01443403|451570769|FG001|Overall Study|Protocol Violation|1|||
125529284|NCT01443403|451570770|FG002|Overall Study|Protocol Violation|1|||
125529285|NCT01443403|451570771|FG003|Overall Study|Protocol Violation|1|||
125529286|NCT01443403|451570768|FG000|Overall Study|Use of Prohibited Treatment|2|||
125529287|NCT01443403|451570769|FG001|Overall Study|Use of Prohibited Treatment|3|||
125529288|NCT01443403|451570770|FG002|Overall Study|Use of Prohibited Treatment|0|||
125529289|NCT01443403|451570771|FG003|Overall Study|Use of Prohibited Treatment|0|||
125529290|NCT01443403|451570768|FG000|Overall Study|Other - Miscellaneous|1|||
125529291|NCT01443403|451570769|FG001|Overall Study|Other - Miscellaneous|0|||
125529292|NCT01443403|451570770|FG002|Overall Study|Other - Miscellaneous|0|||
125529293|NCT01443403|451570771|FG003|Overall Study|Other - Miscellaneous|1|||
125529294|NCT01681277|451570772|FG000|Overall Study|Adverse Event|1|||
125529295|NCT01681277|451570773|FG001|Overall Study|Adverse Event|0|||
125529296|NCT01681277|451570774|FG002|Overall Study|Adverse Event|0|||
125529297|NCT01681277|451570775|FG003|Overall Study|Adverse Event|0|||
125529298|NCT01681277|451570776|FG004|Overall Study|Adverse Event|0|||
125529299|NCT00474526|451570777|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
125529300|NCT00474526|451570778|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
125529301|NCT00474526|451570779|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
125529302|NCT00474526|451570780|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
125529303|NCT00474526|451570781|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
125529304|NCT00474526|451570782|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
125529305|NCT00474526|451570783|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
125529306|NCT00474526|451570784|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
125529307|NCT00474526|451570785|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
125529308|NCT00474526|451570786|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
125529309|NCT00474526|451570787|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
125529310|NCT00474526|451570788|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
125529311|NCT00474526|451570789|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
125529312|NCT00474526|451570790|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
125529313|NCT00474526|451570791|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
125529314|NCT00474526|451570792|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
125529315|NCT00474526|451570793|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
125529316|NCT00474526|451570777|FG000|Overall Study|Adverse Event|2|||
125529317|NCT00474526|451570778|FG001|Overall Study|Adverse Event|0|||
125529318|NCT00474526|451570779|FG002|Overall Study|Adverse Event|2|||
125529319|NCT00474526|451570780|FG003|Overall Study|Adverse Event|4|||
125529320|NCT00474526|451570781|FG004|Overall Study|Adverse Event|2|||
125529321|NCT00474526|451570782|FG005|Overall Study|Adverse Event|1|||
125529322|NCT00474526|451570783|FG006|Overall Study|Adverse Event|1|||
125529323|NCT00474526|451570784|FG007|Overall Study|Adverse Event|0|||
125529324|NCT00474526|451570785|FG008|Overall Study|Adverse Event|0|||
125529325|NCT00474526|451570786|FG009|Overall Study|Adverse Event|0|||
125529326|NCT00474526|451570787|FG010|Overall Study|Adverse Event|0|||
125529327|NCT00474526|451570788|FG011|Overall Study|Adverse Event|0|||
125529328|NCT00474526|451570789|FG012|Overall Study|Adverse Event|0|||
125529329|NCT00474526|451570790|FG013|Overall Study|Adverse Event|0|||
125529330|NCT00474526|451570791|FG014|Overall Study|Adverse Event|1|||
125529331|NCT00474526|451570792|FG015|Overall Study|Adverse Event|1|||
125529332|NCT00474526|451570793|FG016|Overall Study|Adverse Event|0|||
125529333|NCT00474526|451570777|FG000|Overall Study|Death|0|||
125529334|NCT00474526|451570778|FG001|Overall Study|Death|0|||
125529335|NCT00474526|451570779|FG002|Overall Study|Death|0|||
125529336|NCT00474526|451570780|FG003|Overall Study|Death|0|||
125529337|NCT00474526|451570781|FG004|Overall Study|Death|0|||
125529338|NCT00474526|451570782|FG005|Overall Study|Death|0|||
125529339|NCT00474526|451570783|FG006|Overall Study|Death|0|||
125529340|NCT00474526|451570784|FG007|Overall Study|Death|0|||
125529341|NCT00474526|451570785|FG008|Overall Study|Death|0|||
125529342|NCT00474526|451570786|FG009|Overall Study|Death|0|||
125529343|NCT00474526|451570787|FG010|Overall Study|Death|0|||
125529344|NCT00474526|451570788|FG011|Overall Study|Death|0|||
125529345|NCT00474526|451570789|FG012|Overall Study|Death|0|||
125529346|NCT00474526|451570790|FG013|Overall Study|Death|3|||
125529347|NCT00474526|451570791|FG014|Overall Study|Death|0|||
125529348|NCT00474526|451570792|FG015|Overall Study|Death|0|||
125529349|NCT00474526|451570793|FG016|Overall Study|Death|0|||
125529350|NCT00474526|451570777|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
125529351|NCT00474526|451570778|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
125529352|NCT00474526|451570779|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
125529353|NCT00474526|451570780|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
125529354|NCT00474526|451570781|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
125529355|NCT00474526|451570782|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
125529356|NCT00474526|451570783|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
125529357|NCT00474526|451570784|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
125529358|NCT00474526|451570785|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
125529359|NCT00474526|451570786|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
125529360|NCT00474526|451570787|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
125529361|NCT00474526|451570788|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
125529362|NCT00474526|451570789|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
125529363|NCT00474526|451570790|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
125529364|NCT00474526|451570791|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
125529365|NCT00474526|451570792|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
125529366|NCT00474526|451570793|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
125529367|NCT00474526|451570777|FG000|Overall Study|Lost to Follow-up|8|||
125529368|NCT00474526|451570778|FG001|Overall Study|Lost to Follow-up|6|||
125529369|NCT00474526|451570779|FG002|Overall Study|Lost to Follow-up|13|||
125529370|NCT00474526|451570780|FG003|Overall Study|Lost to Follow-up|29|||
125529371|NCT00474526|451570781|FG004|Overall Study|Lost to Follow-up|11|||
125529372|NCT00474526|451570782|FG005|Overall Study|Lost to Follow-up|5|||
125529373|NCT00474526|451570783|FG006|Overall Study|Lost to Follow-up|8|||
125529374|NCT00474526|451570784|FG007|Overall Study|Lost to Follow-up|1|||
125529375|NCT00474526|451570785|FG008|Overall Study|Lost to Follow-up|0|||
125529376|NCT00474526|451570786|FG009|Overall Study|Lost to Follow-up|6|||
125529377|NCT00474526|451570787|FG010|Overall Study|Lost to Follow-up|2|||
125529378|NCT00474526|451570788|FG011|Overall Study|Lost to Follow-up|4|||
125529379|NCT00474526|451570789|FG012|Overall Study|Lost to Follow-up|6|||
125529380|NCT00474526|451570790|FG013|Overall Study|Lost to Follow-up|74|||
125529381|NCT00474526|451570791|FG014|Overall Study|Lost to Follow-up|29|||
125529382|NCT00474526|451570792|FG015|Overall Study|Lost to Follow-up|4|||
125529383|NCT00474526|451570793|FG016|Overall Study|Lost to Follow-up|5|||
125529384|NCT00474526|451570777|FG000|Overall Study|Protocol Violation|2|||
125529385|NCT00474526|451570778|FG001|Overall Study|Protocol Violation|6|||
125529386|NCT00474526|451570779|FG002|Overall Study|Protocol Violation|4|||
125529387|NCT00474526|451570780|FG003|Overall Study|Protocol Violation|12|||
125529388|NCT00474526|451570781|FG004|Overall Study|Protocol Violation|3|||
125529389|NCT00474526|451570782|FG005|Overall Study|Protocol Violation|1|||
125529390|NCT00474526|451570783|FG006|Overall Study|Protocol Violation|3|||
125529391|NCT00474526|451570784|FG007|Overall Study|Protocol Violation|0|||
125529392|NCT00474526|451570785|FG008|Overall Study|Protocol Violation|0|||
125529393|NCT00474526|451570786|FG009|Overall Study|Protocol Violation|4|||
125529394|NCT00474526|451570787|FG010|Overall Study|Protocol Violation|2|||
125529395|NCT00474526|451570788|FG011|Overall Study|Protocol Violation|2|||
125529396|NCT00474526|451570789|FG012|Overall Study|Protocol Violation|4|||
125529397|NCT00474526|451570790|FG013|Overall Study|Protocol Violation|19|||
125529398|NCT00474526|451570791|FG014|Overall Study|Protocol Violation|9|||
125529399|NCT00474526|451570792|FG015|Overall Study|Protocol Violation|6|||
125529400|NCT00474526|451570793|FG016|Overall Study|Protocol Violation|2|||
125529401|NCT00474526|451570777|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
125529402|NCT00474526|451570778|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
125529403|NCT00474526|451570779|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
125529404|NCT00474526|451570780|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
125529405|NCT00474526|451570781|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
125529406|NCT00474526|451570782|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
125529407|NCT00474526|451570783|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
125529408|NCT00474526|451570784|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
125529409|NCT00474526|451570785|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
125529410|NCT00474526|451570786|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
125529411|NCT00474526|451570787|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
125529412|NCT00474526|451570788|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
125529413|NCT00474526|451570789|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
125529414|NCT00474526|451570790|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
125529415|NCT00474526|451570791|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
125529416|NCT00474526|451570792|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
125529417|NCT00474526|451570793|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
125529418|NCT00474526|451570777|FG000|Overall Study|Withdrawal by Subject|9|||
125529419|NCT00474526|451570778|FG001|Overall Study|Withdrawal by Subject|24|||
125529420|NCT00474526|451570779|FG002|Overall Study|Withdrawal by Subject|21|||
125529421|NCT00474526|451570780|FG003|Overall Study|Withdrawal by Subject|52|||
125529422|NCT00474526|451570781|FG004|Overall Study|Withdrawal by Subject|38|||
125529423|NCT00474526|451570782|FG005|Overall Study|Withdrawal by Subject|6|||
125529424|NCT00474526|451570783|FG006|Overall Study|Withdrawal by Subject|12|||
125529425|NCT00474526|451570784|FG007|Overall Study|Withdrawal by Subject|4|||
125529426|NCT00474526|451570785|FG008|Overall Study|Withdrawal by Subject|4|||
125529427|NCT00474526|451570786|FG009|Overall Study|Withdrawal by Subject|13|||
125529428|NCT00474526|451570787|FG010|Overall Study|Withdrawal by Subject|5|||
125529429|NCT00474526|451570788|FG011|Overall Study|Withdrawal by Subject|4|||
125529430|NCT00474526|451570789|FG012|Overall Study|Withdrawal by Subject|4|||
125529431|NCT00474526|451570790|FG013|Overall Study|Withdrawal by Subject|37|||
125529432|NCT00474526|451570791|FG014|Overall Study|Withdrawal by Subject|22|||
125529433|NCT00474526|451570792|FG015|Overall Study|Withdrawal by Subject|1|||
125529434|NCT00474526|451570793|FG016|Overall Study|Withdrawal by Subject|1|||
125529435|NCT01251770|451570797|FG000|Overall Study|Protocol Violation|13|||
125529436|NCT01251770|451570798|FG001|Overall Study|Protocol Violation|7|||
125529437|NCT02113124|451570799|FG000|Overall Study|Unable to retrieve blood sample|1|||
125529438|NCT02113124|451570800|FG001|Overall Study|Unable to retrieve blood sample|1|||
125529439|NCT02514239|451570801|FG000|Overall Study|Refused to continue trial medication|0|||
125529440|NCT02514239|451570802|FG001|Overall Study|Refused to continue trial medication|0|||
125529441|NCT02514239|451570803|FG002|Overall Study|Refused to continue trial medication|0|||
125529442|NCT02514239|451570804|FG003|Overall Study|Refused to continue trial medication|0|||
125529443|NCT02514239|451570805|FG004|Overall Study|Refused to continue trial medication|0|||
125529444|NCT02514239|451570806|FG005|Overall Study|Refused to continue trial medication|0|||
125529445|NCT02514239|451570807|FG006|Overall Study|Refused to continue trial medication|0|||
125529446|NCT02514239|451570808|FG007|Overall Study|Refused to continue trial medication|0|||
125529447|NCT02514239|451570809|FG008|Overall Study|Refused to continue trial medication|0|||
125529448|NCT02514239|451570810|FG009|Overall Study|Refused to continue trial medication|1|||
125529449|NCT02514239|451570801|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
125529450|NCT02514239|451570802|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
125529451|NCT02514239|451570803|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
125529452|NCT02514239|451570804|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
125529453|NCT02514239|451570805|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
125529454|NCT02514239|451570806|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
125529455|NCT02514239|451570807|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
125529456|NCT02514239|451570808|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
125529457|NCT02514239|451570809|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
125529458|NCT02514239|451570810|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
125529459|NCT02514239|451570801|FG000|Overall Study|Not treated|0|||
125529460|NCT02514239|451570802|FG001|Overall Study|Not treated|1|||
125529461|NCT02514239|451570803|FG002|Overall Study|Not treated|0|||
125529462|NCT02514239|451570804|FG003|Overall Study|Not treated|0|||
125529463|NCT02514239|451570805|FG004|Overall Study|Not treated|0|||
125529464|NCT02514239|451570806|FG005|Overall Study|Not treated|0|||
125529465|NCT02514239|451570807|FG006|Overall Study|Not treated|0|||
125529466|NCT02514239|451570808|FG007|Overall Study|Not treated|0|||
125529467|NCT02514239|451570809|FG008|Overall Study|Not treated|0|||
125529468|NCT02514239|451570810|FG009|Overall Study|Not treated|0|||
125529469|NCT02514239|451570801|FG000|Overall Study|Other Adverse Events|2|||
125529470|NCT02514239|451570802|FG001|Overall Study|Other Adverse Events|0|||
125529471|NCT02514239|451570803|FG002|Overall Study|Other Adverse Events|0|||
125529472|NCT02514239|451570804|FG003|Overall Study|Other Adverse Events|1|||
125529473|NCT02514239|451570805|FG004|Overall Study|Other Adverse Events|0|||
125529474|NCT02514239|451570806|FG005|Overall Study|Other Adverse Events|1|||
125529475|NCT02514239|451570807|FG006|Overall Study|Other Adverse Events|0|||
125529476|NCT02514239|451570808|FG007|Overall Study|Other Adverse Events|1|||
125529477|NCT02514239|451570809|FG008|Overall Study|Other Adverse Events|2|||
125529478|NCT02514239|451570810|FG009|Overall Study|Other Adverse Events|0|||
125529479|NCT02514239|451570801|FG000|Overall Study|Progressive disease|3|||
125529480|NCT02514239|451570802|FG001|Overall Study|Progressive disease|3|||
125529481|NCT02514239|451570803|FG002|Overall Study|Progressive disease|2|||
125529482|NCT02514239|451570804|FG003|Overall Study|Progressive disease|2|||
125529483|NCT02514239|451570805|FG004|Overall Study|Progressive disease|3|||
125529484|NCT02514239|451570806|FG005|Overall Study|Progressive disease|3|||
125529485|NCT02514239|451570807|FG006|Overall Study|Progressive disease|4|||
125529486|NCT02514239|451570808|FG007|Overall Study|Progressive disease|2|||
125529487|NCT02514239|451570809|FG008|Overall Study|Progressive disease|5|||
125529488|NCT02514239|451570810|FG009|Overall Study|Progressive disease|0|||
125529489|NCT02271984|451570815|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
125529490|NCT02271984|451570816|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
125529491|NCT02271984|451570817|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
125529492|NCT02271984|451570818|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
125529493|NCT02271984|451570819|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
125529494|NCT02271984|451570820|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
125529495|NCT02271984|451570821|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
125529496|NCT02271984|451570822|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
125529497|NCT02271984|451570823|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
125529498|NCT02271984|451570824|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
125529499|NCT02271984|451570825|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
125529500|NCT02271984|451570826|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
125529501|NCT01020877|451570827|FG000|Second Intervention|Withdrawal by Subject|1|||
125529502|NCT01020877|451570828|FG001|Second Intervention|Withdrawal by Subject|0|||
125529503|NCT04307940|451570829|FG000|Overall Study|Adverse Event|1|||
125529504|NCT04307940|451570830|FG001|Overall Study|Adverse Event|0|||
125529505|NCT04307940|451570831|FG002|Overall Study|Adverse Event|0|||
125529506|NCT04307940|451570829|FG000|Overall Study|Withdrawal by Subject|2|||
125529507|NCT04307940|451570830|FG001|Overall Study|Withdrawal by Subject|3|||
125529508|NCT04307940|451570831|FG002|Overall Study|Withdrawal by Subject|1|||
125529509|NCT04307940|451570829|FG000|Overall Study|Lost to Follow-up|2|||
125529510|NCT04307940|451570830|FG001|Overall Study|Lost to Follow-up|0|||
125529511|NCT04307940|451570831|FG002|Overall Study|Lost to Follow-up|1|||
125529512|NCT04624243|451570832|FG000|Overall Study|Death|0|||
125529513|NCT04624243|451570833|FG001|Overall Study|Death|1|||
125529514|NCT04624243|451570834|FG002|Overall Study|Death|0|||
125529515|NCT04624243|451570835|FG003|Overall Study|Death|0|||
125529516|NCT04624243|451570836|FG004|Overall Study|Death|0|||
125529517|NCT04624243|451570832|FG000|Overall Study|Lost to Follow-up|2|||
125529518|NCT04624243|451570833|FG001|Overall Study|Lost to Follow-up|3|||
125529519|NCT04624243|451570834|FG002|Overall Study|Lost to Follow-up|7|||
125529520|NCT04624243|451570835|FG003|Overall Study|Lost to Follow-up|1|||
125529521|NCT04624243|451570836|FG004|Overall Study|Lost to Follow-up|3|||
125529522|NCT04624243|451570832|FG000|Overall Study|Physician Decision|3|||
125529523|NCT04624243|451570833|FG001|Overall Study|Physician Decision|8|||
125529524|NCT04624243|451570834|FG002|Overall Study|Physician Decision|15|||
125529525|NCT04624243|451570835|FG003|Overall Study|Physician Decision|2|||
125529526|NCT04624243|451570836|FG004|Overall Study|Physician Decision|11|||
125529527|NCT04624243|451570832|FG000|Overall Study|Withdrawal by Subject|19|||
125529528|NCT04624243|451570833|FG001|Overall Study|Withdrawal by Subject|44|||
125529529|NCT04624243|451570834|FG002|Overall Study|Withdrawal by Subject|40|||
125529530|NCT04624243|451570835|FG003|Overall Study|Withdrawal by Subject|21|||
125529531|NCT04624243|451570836|FG004|Overall Study|Withdrawal by Subject|39|||
125529532|NCT04624243|451570832|FG000|Overall Study|Miscellaneous|3|||
125529533|NCT04624243|451570833|FG001|Overall Study|Miscellaneous|12|||
125529534|NCT04624243|451570834|FG002|Overall Study|Miscellaneous|9|||
125529535|NCT04624243|451570835|FG003|Overall Study|Miscellaneous|4|||
125529536|NCT04624243|451570836|FG004|Overall Study|Miscellaneous|6|||
125529537|NCT05543174|451570837|FG000|Overall Study|Ongoing|7|||
125529538|NCT00953771|451570838|FG000|Overall Study|Death|1|||
125529539|NCT00953771|451570839|FG001|Overall Study|Death|0|||
125529540|NCT04896008|451570840|FG000|Overall Study|Ongoing|70|||
125529541|NCT04896008|451570841|FG001|Overall Study|Ongoing|38|||
125529542|NCT04896008|451570840|FG000|Overall Study|Adverse Event|0|||
125529543|NCT04896008|451570841|FG001|Overall Study|Adverse Event|2|||
125529544|NCT04896008|451570840|FG000|Overall Study|Death|5|||
125529545|NCT04896008|451570841|FG001|Overall Study|Death|10|||
125529546|NCT04896008|451570840|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
125529547|NCT04896008|451570841|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
125529548|NCT04896008|451570840|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
125529549|NCT04896008|451570841|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
125529550|NCT04896008|451570840|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
125529551|NCT04896008|451570841|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
125529552|NCT04896008|451570840|FG000|Overall Study|Withdrawal by Subject|1|||
125529553|NCT04896008|451570841|FG001|Overall Study|Withdrawal by Subject|4|||
125529554|NCT04896008|451570840|FG000|Overall Study|Investigator Decision|2|||
125529555|NCT04896008|451570841|FG001|Overall Study|Investigator Decision|0|||
125529556|NCT04896008|451570840|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
125529557|NCT04896008|451570841|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
125529558|NCT01270828|451570846|FG000|Pregabalin CR SB|Reason Unspecified|0|||
125529559|NCT01270828|451570847|FG001|Pregabalin CR SB|Reason Unspecified|0|||
125529560|NCT01270828|451570848|FG002|Pregabalin CR SB|Reason Unspecified|8|||
125529561|NCT01270828|451570846|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
125529562|NCT01270828|451570847|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
125529563|NCT01270828|451570848|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
125529564|NCT01270828|451570846|FG000|Pregabalin CR SB|Related adverse event|0|||
125529565|NCT01270828|451570847|FG001|Pregabalin CR SB|Related adverse event|0|||
125529566|NCT01270828|451570848|FG002|Pregabalin CR SB|Related adverse event|46|||
125529567|NCT01270828|451570846|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
125529568|NCT01270828|451570847|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
125529569|NCT01270828|451570848|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
125529570|NCT01270828|451570846|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
125529571|NCT01270828|451570847|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
125529572|NCT01270828|451570848|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
125529573|NCT01270828|451570846|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
125529574|NCT01270828|451570847|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
125529575|NCT01270828|451570848|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
125529576|NCT01270828|451570846|FG000|Pregabalin CR SB|Unrelated AE|0|||
125529577|NCT01270828|451570847|FG001|Pregabalin CR SB|Unrelated AE|0|||
125529578|NCT01270828|451570848|FG002|Pregabalin CR SB|Unrelated AE|8|||
125529579|NCT01270828|451570846|FG000|Pregabalin CR SB|Protocol Violation|0|||
125529580|NCT01270828|451570847|FG001|Pregabalin CR SB|Protocol Violation|0|||
125529581|NCT01270828|451570848|FG002|Pregabalin CR SB|Protocol Violation|8|||
125529582|NCT01270828|451570846|FG000|Double Blind Phase|Death|0|||
125529583|NCT01270828|451570847|FG001|Double Blind Phase|Death|1|||
125529584|NCT01270828|451570848|FG002|Double Blind Phase|Death|0|||
125529585|NCT01270828|451570846|FG000|Double Blind Phase|Protocol Violation|0|||
125529586|NCT01270828|451570847|FG001|Double Blind Phase|Protocol Violation|1|||
125529587|NCT01270828|451570848|FG002|Double Blind Phase|Protocol Violation|0|||
125529588|NCT01270828|451570846|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
125529589|NCT01270828|451570847|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
125529590|NCT01270828|451570848|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
125529591|NCT01270828|451570846|FG000|Double Blind Phase|Reason Unspecified|7|||
125529592|NCT01270828|451570847|FG001|Double Blind Phase|Reason Unspecified|4|||
125529593|NCT01270828|451570848|FG002|Double Blind Phase|Reason Unspecified|0|||
125529594|NCT01270828|451570846|FG000|Double Blind Phase|Withdrawal by Subject|6|||
125529595|NCT01270828|451570847|FG001|Double Blind Phase|Withdrawal by Subject|15|||
125529596|NCT01270828|451570848|FG002|Double Blind Phase|Withdrawal by Subject|0|||
125529597|NCT01270828|451570846|FG000|Double Blind Phase|Lost to Follow-up|1|||
125529598|NCT01270828|451570847|FG001|Double Blind Phase|Lost to Follow-up|2|||
125529599|NCT01270828|451570848|FG002|Double Blind Phase|Lost to Follow-up|0|||
125529600|NCT01270828|451570846|FG000|Double Blind Phase|Lack of Efficacy|2|||
125529601|NCT01270828|451570847|FG001|Double Blind Phase|Lack of Efficacy|11|||
125529602|NCT01270828|451570848|FG002|Double Blind Phase|Lack of Efficacy|0|||
125529603|NCT01270828|451570846|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
125529604|NCT01270828|451570847|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
125529605|NCT01270828|451570848|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
125529606|NCT01270828|451570846|FG000|Double Blind Phase|Adverse event related to study drug|5|||
125529607|NCT01270828|451570847|FG001|Double Blind Phase|Adverse event related to study drug|7|||
125529608|NCT01270828|451570848|FG002|Double Blind Phase|Adverse event related to study drug|0|||
125529609|NCT00709228|451570856|FG000|Overall Study|Not treated|14|||
125529610|NCT00709228|451570856|FG000|Overall Study|Eligibility criteria not met|281|||
125529611|NCT00709228|451570856|FG000|Overall Study|Adverse events|2|||
125529612|NCT00709228|451570856|FG000|Overall Study|Discontinued treatment|14|||
125529613|NCT00709228|451570856|FG000|Overall Study|Did not enter follow-up|4|||
125529614|NCT00709228|451570856|FG000|Overall Study|Discontinued follow-up|5|||
125529615|NCT00709228|451570856|FG000|Overall Study|Disease progression|1|||
125529616|NCT00709228|451570856|FG000|Overall Study|Lost to Follow-up|6|||
125529617|NCT00709228|451570856|FG000|Overall Study|Non-compliance|5|||
125529618|NCT03322540|451570859|FG000|Overall Study|Death|21|||
125529619|NCT03322540|451570860|FG001|Overall Study|Death|28|||
125529620|NCT03322540|451570859|FG000|Overall Study|Lost to Follow-up|0|||
125529621|NCT03322540|451570860|FG001|Overall Study|Lost to Follow-up|1|||
125529622|NCT03322540|451570859|FG000|Overall Study|Physician Decision|7|||
125529623|NCT03322540|451570860|FG001|Overall Study|Physician Decision|6|||
125529624|NCT03322540|451570859|FG000|Overall Study|Withdrawal by Subject|3|||
125529625|NCT03322540|451570860|FG001|Overall Study|Withdrawal by Subject|1|||
125529626|NCT03322540|451570859|FG000|Overall Study|Study terminated by sponsor|0|||
125529627|NCT03322540|451570860|FG001|Overall Study|Study terminated by sponsor|1|||
125529628|NCT04334278|451570861|FG000|Overall Study|Lost to Follow-up|0|||
125529629|NCT04334278|451570862|FG001|Overall Study|Lost to Follow-up|3|||
125529630|NCT04334278|451570861|FG000|Overall Study|Withdrawal by Subject|4|||
125529631|NCT04334278|451570862|FG001|Overall Study|Withdrawal by Subject|2|||
125529632|NCT00945672|451570864|FG000|Overall Study|Withdrawal by Subject|0|||
125529633|NCT00945672|451570865|FG001|Overall Study|Withdrawal by Subject|0|||
125529634|NCT00945672|451570866|FG002|Overall Study|Withdrawal by Subject|0|||
125529635|NCT00945672|451570867|FG003|Overall Study|Withdrawal by Subject|1|||
125529636|NCT00968526|451570868|FG000|Overall Study|Adverse Event|2|||
125529637|NCT00968526|451570869|FG001|Overall Study|Adverse Event|0|||
125529638|NCT00968526|451570868|FG000|Overall Study|Migrated/moved from study area|1|||
125529639|NCT00968526|451570869|FG001|Overall Study|Migrated/moved from study area|0|||
125529640|NCT03926195|451570871|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
125529641|NCT03926195|451570872|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
125529642|NCT03926195|451570871|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
125529643|NCT03926195|451570872|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
125529644|NCT03926195|451570871|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
125529645|NCT03926195|451570872|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
125529646|NCT03926195|451570871|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
125529647|NCT03926195|451570872|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
125529648|NCT03926195|451570871|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
125529649|NCT03926195|451570872|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
125529650|NCT03926195|451570871|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
125529651|NCT03926195|451570872|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
125529652|NCT01736540|451570874|FG000|Overall Study|Did not complete scan within 45 days|2|||
125529653|NCT01736540|451570874|FG000|Overall Study|Death|1|||
125529654|NCT01736540|451570874|FG000|Overall Study|Abnormal test procedure|1|||
125529655|NCT01736540|451570874|FG000|Overall Study|Withdrawal by Subject|5|||
125529656|NCT01736540|451570874|FG000|Overall Study|Protocol Violation|1|||
125529657|NCT01736540|451570874|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
125529658|NCT01736540|451570874|FG000|Overall Study|No show for MRI appointment|1|||
125529659|NCT01736540|451570874|FG000|Overall Study|Unable to make MRI appointment|3|||
125529660|NCT00479882|451570875|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
125529661|NCT00479882|451570876|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
125529662|NCT00479882|451570877|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
125529663|NCT00479882|451570878|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
125529664|NCT00479882|451570875|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
125529665|NCT00479882|451570876|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
125529666|NCT00479882|451570877|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
125529667|NCT00479882|451570878|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
125529668|NCT00479882|451570875|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
125529669|NCT00479882|451570876|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
125529670|NCT00479882|451570877|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
125529671|NCT00479882|451570878|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
125529672|NCT00479882|451570875|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
125529673|NCT00479882|451570876|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
125529674|NCT00479882|451570877|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
125529675|NCT00479882|451570878|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
125529676|NCT00479882|451570875|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
125529677|NCT00479882|451570876|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
125529678|NCT00479882|451570877|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
125529679|NCT00479882|451570878|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
125529680|NCT00479882|451570875|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
125529681|NCT00479882|451570876|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
125529682|NCT00479882|451570877|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
125529683|NCT00479882|451570878|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
125529684|NCT00479882|451570875|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
125529685|NCT00479882|451570876|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
125529686|NCT00479882|451570877|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
125529687|NCT00479882|451570878|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
125529688|NCT00479882|451570875|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
125529689|NCT00479882|451570876|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
125529690|NCT00479882|451570877|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
125529691|NCT00479882|451570878|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
125529692|NCT00479882|451570875|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
125529693|NCT00479882|451570876|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
125529694|NCT00479882|451570877|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
125529695|NCT00479882|451570878|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
125529696|NCT00479882|451570875|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
125529697|NCT00479882|451570876|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
125529698|NCT00479882|451570877|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
125529699|NCT00479882|451570878|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
125529700|NCT00479882|451570875|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
125529701|NCT00479882|451570876|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
125529702|NCT00479882|451570877|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
125529703|NCT00479882|451570878|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
125529704|NCT00479882|451570875|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
125529705|NCT00479882|451570876|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
125529706|NCT00479882|451570877|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
125529707|NCT00479882|451570878|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
125529708|NCT00479882|451570875|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
125529709|NCT00479882|451570876|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
125529710|NCT00479882|451570877|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
125529711|NCT00479882|451570878|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
125529712|NCT00479882|451570875|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
125529713|NCT00479882|451570876|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
125529714|NCT00479882|451570877|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
125529715|NCT00479882|451570878|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
125529716|NCT03738475|451570879|FG000|Overall Study|Participant Non-Compliance|1|||
125529717|NCT03738475|451570880|FG001|Overall Study|Participant Non-Compliance|0|||
125529718|NCT00737477|451570881|FG000|Overall Study|Adverse Event|9|||
125529719|NCT00737477|451570881|FG000|Overall Study|Death|9|||
125529720|NCT00737477|451570881|FG000|Overall Study|Treatment Refusal|1|||
125529721|NCT00737477|451570881|FG000|Overall Study|Withdrawal by Subject|1|||
125529722|NCT00737477|451570881|FG000|Overall Study|Renal Transplantation|10|||
125529723|NCT00737477|451570881|FG000|Overall Study|Other|4|||
125529724|NCT01370655|451570882|FG000|Period 1|Adverse Event|2|||
125529725|NCT01370655|451570883|FG001|Period 1|Adverse Event|0|||
125529726|NCT01370655|451570884|FG002|Period 1|Adverse Event|0|||
125529727|NCT01370655|451570885|FG003|Period 1|Adverse Event|0|||
125529728|NCT01370655|451570886|FG004|Period 1|Adverse Event|0|||
125529729|NCT01370655|451570887|FG005|Period 1|Adverse Event|0|||
125529730|NCT01370655|451570888|FG006|Period 1|Adverse Event|1|||
125529731|NCT01370655|451570889|FG007|Period 1|Adverse Event|0|||
125529732|NCT01370655|451570890|FG008|Period 1|Adverse Event|0|||
125529733|NCT01370655|451570891|FG009|Period 1|Adverse Event|0|||
125529734|NCT01370655|451570892|FG010|Period 1|Adverse Event|0|||
125529735|NCT01370655|451570893|FG011|Period 1|Adverse Event|0|||
125529736|NCT01370655|451570882|FG000|Period 2|Adverse Event|0|||
125529737|NCT01370655|451570883|FG001|Period 2|Adverse Event|0|||
125529738|NCT01370655|451570884|FG002|Period 2|Adverse Event|1|||
125529739|NCT01370655|451570885|FG003|Period 2|Adverse Event|0|||
125529740|NCT01370655|451570886|FG004|Period 2|Adverse Event|1|||
125529741|NCT01370655|451570887|FG005|Period 2|Adverse Event|0|||
125529742|NCT01370655|451570888|FG006|Period 2|Adverse Event|0|||
125529743|NCT01370655|451570889|FG007|Period 2|Adverse Event|1|||
125529744|NCT01370655|451570890|FG008|Period 2|Adverse Event|0|||
125529745|NCT01370655|451570891|FG009|Period 2|Adverse Event|0|||
125529746|NCT01370655|451570892|FG010|Period 2|Adverse Event|0|||
125529747|NCT01370655|451570893|FG011|Period 2|Adverse Event|0|||
125529748|NCT01370655|451570882|FG000|Period 2|met protocol specified stopping criteria|0|||
125529749|NCT01370655|451570883|FG001|Period 2|met protocol specified stopping criteria|0|||
125529750|NCT01370655|451570884|FG002|Period 2|met protocol specified stopping criteria|1|||
125529751|NCT01370655|451570885|FG003|Period 2|met protocol specified stopping criteria|0|||
125529752|NCT01370655|451570886|FG004|Period 2|met protocol specified stopping criteria|0|||
125529753|NCT01370655|451570887|FG005|Period 2|met protocol specified stopping criteria|0|||
125529754|NCT01370655|451570888|FG006|Period 2|met protocol specified stopping criteria|1|||
125529755|NCT01370655|451570889|FG007|Period 2|met protocol specified stopping criteria|0|||
125529756|NCT01370655|451570890|FG008|Period 2|met protocol specified stopping criteria|1|||
125529757|NCT01370655|451570891|FG009|Period 2|met protocol specified stopping criteria|0|||
125529758|NCT01370655|451570892|FG010|Period 2|met protocol specified stopping criteria|1|||
125529759|NCT01370655|451570893|FG011|Period 2|met protocol specified stopping criteria|0|||
125529760|NCT01370655|451570882|FG000|Period 2|Withdrawal by Subject|0|||
125529761|NCT01370655|451570883|FG001|Period 2|Withdrawal by Subject|0|||
125529762|NCT01370655|451570884|FG002|Period 2|Withdrawal by Subject|0|||
125529763|NCT01370655|451570885|FG003|Period 2|Withdrawal by Subject|0|||
125529764|NCT01370655|451570886|FG004|Period 2|Withdrawal by Subject|0|||
125529765|NCT01370655|451570887|FG005|Period 2|Withdrawal by Subject|0|||
125529766|NCT01370655|451570888|FG006|Period 2|Withdrawal by Subject|0|||
125529767|NCT01370655|451570889|FG007|Period 2|Withdrawal by Subject|0|||
125529768|NCT01370655|451570890|FG008|Period 2|Withdrawal by Subject|1|||
125529769|NCT01370655|451570891|FG009|Period 2|Withdrawal by Subject|0|||
125529770|NCT01370655|451570892|FG010|Period 2|Withdrawal by Subject|0|||
125529771|NCT01370655|451570893|FG011|Period 2|Withdrawal by Subject|0|||
125529772|NCT00581477|451570894|FG000|Overall Study|Physician Decision|2|||
125529791|NCT02159040|451570903|FG000|Overall Study|Death|1|||
125529792|NCT02362503|451570906|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
125529793|NCT02362503|451570907|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
125529794|NCT02362503|451570908|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
125529795|NCT02362503|451570906|FG000|Double-blind Period-Up to 8 Days|Death|1|||
125529796|NCT02362503|451570907|FG001|Double-blind Period-Up to 8 Days|Death|0|||
125529797|NCT02362503|451570908|FG002|Double-blind Period-Up to 8 Days|Death|0|||
125529798|NCT02362503|451570906|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
125529799|NCT02362503|451570907|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
125529800|NCT02362503|451570908|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
125529801|NCT02362503|451570906|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
125529802|NCT02362503|451570907|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
125529803|NCT02362503|451570908|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
125529804|NCT02362503|451570906|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
125529805|NCT02362503|451570907|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
125529806|NCT02362503|451570908|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
125529807|NCT02362503|451570906|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
125529808|NCT02362503|451570907|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
125529809|NCT02362503|451570908|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
125529810|NCT02362503|451570906|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
125529811|NCT02362503|451570907|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
125529812|NCT02362503|451570908|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
125529813|NCT02362503|451570906|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
125529814|NCT02362503|451570907|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
125529815|NCT02362503|451570908|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
125529816|NCT02362503|451570906|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
125529817|NCT02362503|451570907|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
125529818|NCT02362503|451570908|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
125529819|NCT02362503|451570906|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
125529820|NCT02362503|451570907|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
125529821|NCT02362503|451570908|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
125529822|NCT02362503|451570906|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
125529823|NCT02362503|451570907|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
125529824|NCT02362503|451570908|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
125529825|NCT02362503|451570906|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
125529826|NCT02362503|451570907|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
125529827|NCT02362503|451570908|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
125529828|NCT02362503|451570906|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
125529829|NCT02362503|451570907|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
125529830|NCT02362503|451570908|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
125529831|NCT02362503|451570906|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
125529832|NCT02362503|451570907|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
125529833|NCT02362503|451570908|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
125529834|NCT02803593|451570909|FG000|Overall Study|Lost to Follow-up|17|||
125529835|NCT02803593|451570910|FG001|Overall Study|Lost to Follow-up|35|||
125529836|NCT05143138|451570911|FG000|Overall Study|Death|5|||
125529837|NCT05143138|451570912|FG001|Overall Study|Death|35|||
125529838|NCT05143138|451570913|FG002|Overall Study|Death|1|||
125529839|NCT05143138|451570911|FG000|Overall Study|Lost to Follow-up|2|||
125529840|NCT05143138|451570912|FG001|Overall Study|Lost to Follow-up|4|||
125529841|NCT05143138|451570913|FG002|Overall Study|Lost to Follow-up|0|||
125529842|NCT05143138|451570911|FG000|Overall Study|withdrawal|1|||
125529843|NCT05143138|451570912|FG001|Overall Study|withdrawal|1|||
125529844|NCT05143138|451570913|FG002|Overall Study|withdrawal|0|||
125529845|NCT03443414|451570916|FG000|Overall Study|Adverse Event|6|||
125529846|NCT03443414|451570917|FG001|Overall Study|Adverse Event|0|||
125529847|NCT03443414|451570918|FG002|Overall Study|Adverse Event|4|||
125529848|NCT03443414|451570919|FG003|Overall Study|Adverse Event|2|||
125529849|NCT03443414|451570920|FG004|Overall Study|Adverse Event|3|||
125529850|NCT03443414|451570916|FG000|Overall Study|Withdrawal by Subject|3|||
125529851|NCT03443414|451570917|FG001|Overall Study|Withdrawal by Subject|2|||
125529852|NCT03443414|451570918|FG002|Overall Study|Withdrawal by Subject|2|||
125529853|NCT03443414|451570919|FG003|Overall Study|Withdrawal by Subject|2|||
125529854|NCT03443414|451570920|FG004|Overall Study|Withdrawal by Subject|1|||
125529855|NCT03443414|451570916|FG000|Overall Study|Death|0|||
125529856|NCT03443414|451570917|FG001|Overall Study|Death|1|||
125529857|NCT03443414|451570918|FG002|Overall Study|Death|0|||
125529858|NCT03443414|451570919|FG003|Overall Study|Death|1|||
125529859|NCT03443414|451570920|FG004|Overall Study|Death|0|||
125529860|NCT03443414|451570916|FG000|Overall Study|Reason not specified|2|||
125529861|NCT03443414|451570917|FG001|Overall Study|Reason not specified|0|||
125529862|NCT03443414|451570918|FG002|Overall Study|Reason not specified|0|||
125529863|NCT03443414|451570919|FG003|Overall Study|Reason not specified|0|||
125529864|NCT03443414|451570920|FG004|Overall Study|Reason not specified|1|||
125529865|NCT00732992|451570921|FG000|Overall Study|Adverse Event|1|||
125529866|NCT00732992|451570922|FG001|Overall Study|Adverse Event|1|||
125529867|NCT00732992|451570921|FG000|Overall Study|Objective Progression or Relapse|3|||
125529868|NCT00732992|451570922|FG001|Overall Study|Objective Progression or Relapse|5|||
125529869|NCT00732992|451570921|FG000|Overall Study|Global Deterioration of Health Status|1|||
125529870|NCT00732992|451570922|FG001|Overall Study|Global Deterioration of Health Status|0|||
125529871|NCT00732992|451570921|FG000|Overall Study|Withdrawal by Subject|1|||
125529872|NCT00732992|451570922|FG001|Overall Study|Withdrawal by Subject|0|||
125529873|NCT03933462|451570925|FG000|Overall Study|Adverse Event|2|||
125529874|NCT03933462|451570926|FG001|Overall Study|Adverse Event|0|||
125529875|NCT00422734|451570932|FG000|Overall Study|Physician Decision|1|||
125529876|NCT00422734|451570933|FG001|Overall Study|Physician Decision|1|||
125529877|NCT00422734|451570932|FG000|Overall Study|Protocol Violation|1|||
125529878|NCT00422734|451570933|FG001|Overall Study|Protocol Violation|6|||
125529879|NCT00422734|451570932|FG000|Overall Study|Withdrawal by Subject|12|||
125529880|NCT00422734|451570933|FG001|Overall Study|Withdrawal by Subject|8|||
125529881|NCT00422734|451570932|FG000|Overall Study|Adverse Event|0|||
125529882|NCT00422734|451570933|FG001|Overall Study|Adverse Event|3|||
125529883|NCT00422734|451570932|FG000|Overall Study|Partner Decision|0|||
125529884|NCT00422734|451570933|FG001|Overall Study|Partner Decision|3|||
125529885|NCT00996606|451570944|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
125529886|NCT00996606|451570944|FG000|Overall Study|Insufficient Therapeutic Response|2|||
125529887|NCT00996606|451570944|FG000|Overall Study|Protocol Violation|1|||
125529888|NCT00996606|451570944|FG000|Overall Study|Withdrawal by Subject|3|||
125529889|NCT02548078|451570949|FG000|Overall Study|Serious adverse event/Adverse event|1|||
125529890|NCT02548078|451570950|FG001|Overall Study|Serious adverse event/Adverse event|0|||
125529891|NCT02548078|451570949|FG000|Overall Study|Moved from study area|3|||
125529892|NCT02548078|451570950|FG001|Overall Study|Moved from study area|3|||
125529893|NCT02548078|451570949|FG000|Overall Study|Lost to Follow-up|1|||
125529894|NCT02548078|451570950|FG001|Overall Study|Lost to Follow-up|3|||
125529895|NCT03128671|451570955|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
125529896|NCT03128671|451570956|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
125529897|NCT03128671|451570955|FG000|Allocation|Death|1|||
125529898|NCT03128671|451570956|FG001|Allocation|Death|0|||
125529899|NCT03128671|451570955|FG000|Allocation|Withdrawal by Subject|4|||
125529900|NCT03128671|451570956|FG001|Allocation|Withdrawal by Subject|0|||
125529901|NCT03128671|451570955|FG000|Intervention|Withdrawal by Subject|11|||
125529902|NCT03128671|451570956|FG001|Intervention|Withdrawal by Subject|10|||
125529903|NCT03128671|451570955|FG000|Intervention|Palliative/hospice care initiated|9|||
125529904|NCT03128671|451570956|FG001|Intervention|Palliative/hospice care initiated|10|||
125529905|NCT03128671|451570955|FG000|Intervention|Death|13|||
125529906|NCT03128671|451570956|FG001|Intervention|Death|11|||
125529907|NCT03128671|451570955|FG000|Intervention|Interrupted by hurricane|1|||
125529908|NCT03128671|451570956|FG001|Intervention|Interrupted by hurricane|0|||
125529909|NCT03128671|451570955|FG000|Intervention|Physician Decision|2|||
125529910|NCT03128671|451570956|FG001|Intervention|Physician Decision|3|||
125529911|NCT04641962|451570958|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
125529912|NCT04641962|451570959|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
125529913|NCT04641962|451570960|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
125529914|NCT04641962|451570961|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
125529915|NCT04641962|451570962|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
125529916|NCT04641962|451570958|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
125529917|NCT04641962|451570959|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
125529918|NCT04641962|451570960|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
125529919|NCT04641962|451570961|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
125529920|NCT04641962|451570962|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
125529921|NCT04641962|451570958|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
125529922|NCT04641962|451570959|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
125529923|NCT04641962|451570960|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
125529924|NCT04641962|451570961|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
125529925|NCT04641962|451570962|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
125529926|NCT04641962|451570958|FG000|DBT Period: Up to 52 Weeks|Death|1|||
125529927|NCT04641962|451570959|FG001|DBT Period: Up to 52 Weeks|Death|0|||
125529928|NCT04641962|451570960|FG002|DBT Period: Up to 52 Weeks|Death|0|||
125529929|NCT04641962|451570961|FG003|DBT Period: Up to 52 Weeks|Death|0|||
125529930|NCT04641962|451570962|FG004|DBT Period: Up to 52 Weeks|Death|0|||
125529931|NCT04641962|451570958|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
125529932|NCT04641962|451570959|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
125529933|NCT04641962|451570960|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
125529934|NCT04641962|451570961|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
125529935|NCT04641962|451570962|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
125529936|NCT04641962|451570958|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
125529937|NCT04641962|451570959|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
125529938|NCT04641962|451570960|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
125529939|NCT04641962|451570961|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
125529940|NCT04641962|451570962|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
125529941|NCT04641962|451570958|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
125529942|NCT04641962|451570959|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
125529943|NCT04641962|451570960|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
125529944|NCT04641962|451570961|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
125529945|NCT04641962|451570962|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
125529946|NCT00862836|451570964|FG000|Overall Study|Withdrawal by Subject|1|||
125529947|NCT04463680|451570965|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
125529948|NCT04463680|451570965|FG000|Overall Study|Not eligible due to implant duration of use|1|||
125529949|NCT04463680|451570965|FG000|Overall Study|Withdrawal by Subject|3|||
125529950|NCT05239598|451570968|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
125529951|NCT05239598|451570969|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
125529952|NCT05239598|451570968|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
125529953|NCT05239598|451570969|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
125529954|NCT05823012|451570972|FG000|Titration Period|Adverse Event|1|||
125529955|NCT05823012|451570972|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
125529956|NCT05823012|451570972|FG000|Maintenance Period|Adverse Event|1|||
125529957|NCT05823012|451570972|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
125529958|NCT05823012|451570972|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
125529959|NCT03104075|451572584|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
125529960|NCT03104075|451572585|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
125529961|NCT04024462|451572586|FG000|Overall Study|Withdrawal by Subject|6|||
125529962|NCT04024462|451572587|FG001|Overall Study|Withdrawal by Subject|7|||
125529963|NCT04024462|451572586|FG000|Overall Study|Progressive Disease|0|||
125529964|NCT04024462|451572587|FG001|Overall Study|Progressive Disease|1|||
125529965|NCT04024462|451572586|FG000|Overall Study|Adverse Event|0|||
125529966|NCT04024462|451572587|FG001|Overall Study|Adverse Event|1|||
125529967|NCT04024462|451572586|FG000|Overall Study|Death|0|||
125529968|NCT04024462|451572587|FG001|Overall Study|Death|1|||
125529969|NCT04024462|451572586|FG000|Overall Study|Lost to Follow-up|1|||
125529970|NCT04024462|451572587|FG001|Overall Study|Lost to Follow-up|0|||
125529971|NCT04024462|451572586|FG000|Overall Study|Ongoing in the Study|94|||
125529972|NCT04024462|451572587|FG001|Overall Study|Ongoing in the Study|89|||
125529973|NCT00789360|451572590|FG000|Overall Study|Protocol Violation|3|||
125529974|NCT00789360|451572591|FG001|Overall Study|Protocol Violation|1|||
125529975|NCT04400487|451572592|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
125529976|NCT04400487|451572592|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
125529977|NCT04400487|451572592|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
125529978|NCT00022659|451572593|FG000|Overall Study|Ineligible: wrong primary|1|||
125529979|NCT00022659|451572593|FG000|Overall Study|Never treated|1|||
125529980|NCT03559062|451572594|FG000|Overall Study|Other|0|||
125529981|NCT03559062|451572595|FG001|Overall Study|Other|1|||
125529982|NCT03559062|451572596|FG002|Overall Study|Other|0|||
125529983|NCT00426127|451572597|FG000|Overall Study|Adverse Event|1|||
125529984|NCT00426127|451572597|FG000|Overall Study|Removed due to disease progression|1|||
125529985|NCT05048238|451572600|FG000|Overall Study|Withdrawal by Subject|1|||
125529986|NCT01730378|451572601|FG000|Overall Study|Lost to Follow-up|1|||
125529987|NCT01730378|451572602|FG001|Overall Study|Lost to Follow-up|0|||
125529988|NCT00955708|451572603|FG000|Overall Study|Death|269|||
125529989|NCT00955708|451572603|FG000|Overall Study|Lost to Follow-up|72|||
125529990|NCT00955708|451572603|FG000|Overall Study|Physician Decision|36|||
125529991|NCT00955708|451572603|FG000|Overall Study|Protocol Violation|134|||
125529992|NCT00955708|451572603|FG000|Overall Study|Registry Conclusion|186|||
125529993|NCT00955708|451572603|FG000|Overall Study|Product removed from service|94|||
125529994|NCT00955708|451572603|FG000|Overall Study|Patient Refused to participate further|116|||
125529995|NCT00955708|451572603|FG000|Overall Study|Closure of study location|60|||
125529996|NCT00955708|451572603|FG000|Overall Study|Patient changed care provider/moved|91|||
125529997|NCT01016262|451572604|FG000|Double-blind Phase|Adverse Event|0|||
125529998|NCT01016262|451572605|FG001|Double-blind Phase|Adverse Event|0|||
125529999|NCT01016262|451572606|FG002|Double-blind Phase|Adverse Event|1|||
125530000|NCT01016262|451572607|FG003|Double-blind Phase|Adverse Event|0|||
125530001|NCT01016262|451572608|FG004|Double-blind Phase|Adverse Event|0|||
125530002|NCT01016262|451572609|FG005|Double-blind Phase|Adverse Event|0|||
125530003|NCT01016262|451572604|FG000|Double-blind Phase|Lack of Efficacy|1|||
125530004|NCT01016262|451572605|FG001|Double-blind Phase|Lack of Efficacy|0|||
125530005|NCT01016262|451572606|FG002|Double-blind Phase|Lack of Efficacy|5|||
125530006|NCT01016262|451572607|FG003|Double-blind Phase|Lack of Efficacy|0|||
125530007|NCT01016262|451572608|FG004|Double-blind Phase|Lack of Efficacy|0|||
125530008|NCT01016262|451572609|FG005|Double-blind Phase|Lack of Efficacy|0|||
125530009|NCT01016262|451572604|FG000|Double-blind Phase|Disease Progression|0|||
125530010|NCT01016262|451572605|FG001|Double-blind Phase|Disease Progression|1|||
125530011|NCT01016262|451572606|FG002|Double-blind Phase|Disease Progression|2|||
125530012|NCT01016262|451572607|FG003|Double-blind Phase|Disease Progression|0|||
125530013|NCT01016262|451572608|FG004|Double-blind Phase|Disease Progression|0|||
125530014|NCT01016262|451572609|FG005|Double-blind Phase|Disease Progression|0|||
125530015|NCT01016262|451572604|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
125530016|NCT01016262|451572605|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
125530017|NCT01016262|451572606|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
125530018|NCT01016262|451572607|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
125530019|NCT01016262|451572608|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
125530020|NCT01016262|451572609|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
125530021|NCT01016262|451572604|FG000|Open-Label Phase|Adverse Event|0|||
125530022|NCT01016262|451572605|FG001|Open-Label Phase|Adverse Event|0|||
125530023|NCT01016262|451572606|FG002|Open-Label Phase|Adverse Event|0|||
125530024|NCT01016262|451572607|FG003|Open-Label Phase|Adverse Event|1|||
125530025|NCT01016262|451572608|FG004|Open-Label Phase|Adverse Event|0|||
125530026|NCT01016262|451572609|FG005|Open-Label Phase|Adverse Event|0|||
125530027|NCT01016262|451572604|FG000|Open-Label Phase|Lost to Follow-up|0|||
125530028|NCT01016262|451572605|FG001|Open-Label Phase|Lost to Follow-up|0|||
125530029|NCT01016262|451572606|FG002|Open-Label Phase|Lost to Follow-up|0|||
125530030|NCT01016262|451572607|FG003|Open-Label Phase|Lost to Follow-up|0|||
125530031|NCT01016262|451572608|FG004|Open-Label Phase|Lost to Follow-up|1|||
125530032|NCT01016262|451572609|FG005|Open-Label Phase|Lost to Follow-up|0|||
125530033|NCT01016262|451572604|FG000|Open-Label Phase|Lack of Efficacy|0|||
125530034|NCT01016262|451572605|FG001|Open-Label Phase|Lack of Efficacy|0|||
125530035|NCT01016262|451572606|FG002|Open-Label Phase|Lack of Efficacy|0|||
125530036|NCT01016262|451572607|FG003|Open-Label Phase|Lack of Efficacy|1|||
125530037|NCT01016262|451572608|FG004|Open-Label Phase|Lack of Efficacy|0|||
125530038|NCT01016262|451572609|FG005|Open-Label Phase|Lack of Efficacy|0|||
125530039|NCT01016262|451572604|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
125530040|NCT01016262|451572605|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
125530041|NCT01016262|451572606|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
125530042|NCT01016262|451572607|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
125530043|NCT01016262|451572608|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
125530044|NCT01016262|451572609|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
125530045|NCT02057575|451572614|FG000|Overall Study|Adverse Event|0|||
125530046|NCT02057575|451572615|FG001|Overall Study|Adverse Event|2|||
125530047|NCT02057575|451572616|FG002|Overall Study|Adverse Event|0|||
125530048|NCT02057575|451572617|FG003|Overall Study|Adverse Event|1|||
125530049|NCT02057575|451572614|FG000|Overall Study|Withdrawal by Subject|1|||
125530050|NCT02057575|451572615|FG001|Overall Study|Withdrawal by Subject|0|||
125530051|NCT02057575|451572616|FG002|Overall Study|Withdrawal by Subject|0|||
125530052|NCT02057575|451572617|FG003|Overall Study|Withdrawal by Subject|0|||
125530053|NCT02057575|451572614|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
125530054|NCT02057575|451572615|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
125530055|NCT02057575|451572616|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
125530056|NCT02057575|451572617|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
125530057|NCT02057575|451572614|FG000|Overall Study|Protocol Violation|0|||
125530058|NCT02057575|451572615|FG001|Overall Study|Protocol Violation|1|||
125530059|NCT02057575|451572616|FG002|Overall Study|Protocol Violation|0|||
125530060|NCT02057575|451572617|FG003|Overall Study|Protocol Violation|0|||
125530061|NCT00332462|451572618|FG000|Overall Study|Adverse Event|5|||
125530062|NCT00332462|451572618|FG000|Overall Study|Abnormal Lab Value|1|||
125530063|NCT00332462|451572618|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
125530064|NCT00332462|451572618|FG000|Overall Study|no longer requires study drug|1|||
125530065|NCT00332462|451572618|FG000|Overall Study|Death|3|||
125530066|NCT00332462|451572618|FG000|Overall Study|Graft Loss|2|||
125530067|NCT01643044|451572619|FG000|Overall Study|Lost to Follow-up|1|||
125530068|NCT01643044|451572620|FG001|Overall Study|Lost to Follow-up|1|||
125530069|NCT01643044|451572619|FG000|Overall Study|Miscarried baby|2|||
125530070|NCT01643044|451572620|FG001|Overall Study|Miscarried baby|2|||
125530071|NCT01643044|451572619|FG000|Overall Study|Delivered outside of hospital|1|||
125530072|NCT01643044|451572620|FG001|Overall Study|Delivered outside of hospital|2|||
125530073|NCT01735175|451572624|FG000|Overall Study|Withdrawal by Subject|9|||
125530074|NCT01735175|451572625|FG001|Overall Study|Withdrawal by Subject|2|||
125530075|NCT01735175|451572624|FG000|Overall Study|Lost to Follow-up|4|||
125530076|NCT01735175|451572625|FG001|Overall Study|Lost to Follow-up|2|||
125530077|NCT01735175|451572624|FG000|Overall Study|Death|3|||
125530078|NCT01735175|451572625|FG001|Overall Study|Death|2|||
125530079|NCT01735175|451572624|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
125530080|NCT01735175|451572625|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
125530081|NCT01853475|451572626|FG000|Overall Study|Withdrawal by Subject|0|||
125530082|NCT01853475|451572627|FG001|Overall Study|Withdrawal by Subject|1|||
125530083|NCT01853475|451572628|FG002|Overall Study|Withdrawal by Subject|0|||
125530084|NCT01023958|451572631|FG000|Overall Study|Progressive disease|48|||
125530085|NCT01023958|451572631|FG000|Overall Study|Other adverse event|1|||
125530086|NCT01023958|451572631|FG000|Overall Study|Refused to continue medication|1|||
125530087|NCT03080493|451572632|FG000|Overall Study|Did not provide NRS pain results|1|||
125530088|NCT03080493|451572633|FG001|Overall Study|Did not provide NRS pain results|0|||
125530089|NCT03080493|451572632|FG000|Overall Study|Adverse Event|0|||
125530090|NCT03080493|451572633|FG001|Overall Study|Adverse Event|1|||
125530091|NCT03080493|451572632|FG000|Overall Study|Randomization error (parity group)|0|||
125530092|NCT03080493|451572633|FG001|Overall Study|Randomization error (parity group)|1|||
125530093|NCT00755417|451572634|FG000|Overall Study|Adverse Event|28|||
125530094|NCT00755417|451572635|FG001|Overall Study|Adverse Event|20|||
125530095|NCT00755417|451572636|FG002|Overall Study|Adverse Event|7|||
125530096|NCT00755417|451572634|FG000|Overall Study|Lack of Efficacy|8|||
125530097|NCT00755417|451572635|FG001|Overall Study|Lack of Efficacy|4|||
125530098|NCT00755417|451572636|FG002|Overall Study|Lack of Efficacy|9|||
125530099|NCT00755417|451572634|FG000|Overall Study|Protocol Violation|2|||
125530100|NCT00755417|451572635|FG001|Overall Study|Protocol Violation|1|||
125530101|NCT00755417|451572636|FG002|Overall Study|Protocol Violation|1|||
125530102|NCT00755417|451572634|FG000|Overall Study|Lost to Follow-up|3|||
125530103|NCT00755417|451572635|FG001|Overall Study|Lost to Follow-up|0|||
125530104|NCT00755417|451572636|FG002|Overall Study|Lost to Follow-up|1|||
125530105|NCT00755417|451572634|FG000|Overall Study|Withdrawal by Subject|12|||
125530106|NCT00755417|451572635|FG001|Overall Study|Withdrawal by Subject|12|||
125530107|NCT00755417|451572636|FG002|Overall Study|Withdrawal by Subject|12|||
125530108|NCT00755417|451572634|FG000|Overall Study|Not specified or missing data|9|||
125530109|NCT00755417|451572635|FG001|Overall Study|Not specified or missing data|18|||
125530110|NCT00755417|451572636|FG002|Overall Study|Not specified or missing data|12|||
125530111|NCT02195479|451572637|FG000|Overall Study|Lost to Follow-up|18|||
125530112|NCT02195479|451572638|FG001|Overall Study|Lost to Follow-up|15|||
125530113|NCT02195479|451572637|FG000|Overall Study|Death|217|||
125530114|NCT02195479|451572638|FG001|Overall Study|Death|171|||
125530115|NCT02195479|451572637|FG000|Overall Study|Physician Decision|1|||
125530116|NCT02195479|451572638|FG001|Overall Study|Physician Decision|0|||
125530117|NCT02195479|451572637|FG000|Overall Study|Withdrawal by Subject|30|||
125530118|NCT02195479|451572638|FG001|Overall Study|Withdrawal by Subject|30|||
125530119|NCT02195479|451572637|FG000|Overall Study|Other|3|||
125530120|NCT02195479|451572638|FG001|Overall Study|Other|4|||
125530121|NCT02195479|451572637|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
125530122|NCT02195479|451572638|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
125530123|NCT03325777|451572643|FG000|Overall Study|Lost to Follow-up|9|||
125530124|NCT03325777|451572644|FG001|Overall Study|Lost to Follow-up|12|||
125530125|NCT03004404|451572647|FG000|Period 2|Adverse Event|0|||
125530126|NCT03004404|451572648|FG001|Period 2|Adverse Event|0|||
125530127|NCT03004404|451572649|FG002|Period 2|Adverse Event|0|||
125530128|NCT03004404|451572650|FG003|Period 2|Adverse Event|0|||
125530129|NCT03004404|451572651|FG004|Period 2|Adverse Event|0|||
125530130|NCT03004404|451572652|FG005|Period 2|Adverse Event|0|||
125530131|NCT03004404|451572653|FG006|Period 2|Adverse Event|0|||
125530132|NCT03004404|451572654|FG007|Period 2|Adverse Event|0|||
125530133|NCT03004404|451572655|FG008|Period 2|Adverse Event|1|||
125530134|NCT03004404|451572656|FG009|Period 2|Adverse Event|0|||
125530135|NCT03004404|451572657|FG010|Period 2|Adverse Event|0|||
125530136|NCT03004404|451572658|FG011|Period 2|Adverse Event|0|||
125530137|NCT03004404|451572659|FG012|Period 2|Adverse Event|0|||
125530138|NCT03004404|451572660|FG013|Period 2|Adverse Event|0|||
125530139|NCT03004404|451572661|FG014|Period 2|Adverse Event|0|||
125530140|NCT03004404|451572662|FG015|Period 2|Adverse Event|1|||
125530141|NCT02522728|451572667|FG000|Overall Study|Withdrawal by Subject|6|||
125530142|NCT02522728|451572668|FG001|Overall Study|Withdrawal by Subject|6|||
125530143|NCT02522728|451572667|FG000|Overall Study|Death|4|||
125530144|NCT02522728|451572668|FG001|Overall Study|Death|3|||
125530145|NCT02522728|451572667|FG000|Overall Study|Adverse Event|2|||
125530146|NCT02522728|451572668|FG001|Overall Study|Adverse Event|1|||
125530147|NCT02522728|451572667|FG000|Overall Study|Did not receive randomized study device|0|||
125530148|NCT02522728|451572668|FG001|Overall Study|Did not receive randomized study device|1|||
125530149|NCT01099917|451572669|FG000|Overall Study|Adverse Event|3|||
125530150|NCT01099917|451572669|FG000|Overall Study|Not Treated|24|||
125530151|NCT01266161|451572676|FG000|Overall Study|Ineligible|1|||
125530152|NCT01266161|451572677|FG001|Overall Study|Ineligible|0|||
125530153|NCT01266161|451572676|FG000|Overall Study|Lack of Efficacy|0|||
125530154|NCT01266161|451572677|FG001|Overall Study|Lack of Efficacy|1|||
125530155|NCT01266161|451572676|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
125530156|NCT01266161|451572677|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
125530157|NCT02990468|451572678|FG000|Phase 2: MTD|Change in treatment|0|||
125530158|NCT02990468|451572679|FG001|Phase 2: MTD|Change in treatment|0|||
125530159|NCT02990468|451572680|FG002|Phase 2: MTD|Change in treatment|1|||
125530160|NCT01436305|451572682|FG000|Overall Study|Death|1|||
125530161|NCT01436305|451572683|FG001|Overall Study|Death|0|||
125530162|NCT01436305|451572684|FG002|Overall Study|Death|0|||
125530163|NCT01436305|451572682|FG000|Overall Study|Lost to Follow-up|0|||
125530164|NCT01436305|451572683|FG001|Overall Study|Lost to Follow-up|1|||
125530165|NCT01436305|451572684|FG002|Overall Study|Lost to Follow-up|0|||
125530166|NCT01436305|451572682|FG000|Overall Study|Withdrawal by Subject|1|||
125530167|NCT01436305|451572683|FG001|Overall Study|Withdrawal by Subject|3|||
125530168|NCT01436305|451572684|FG002|Overall Study|Withdrawal by Subject|0|||
125530169|NCT01485120|451572687|FG000|Overall Study|Withdrawal by Subject|2|||
125530170|NCT05071053|451572688|FG000|Overall Study|Progressive disease|30|||
125530171|NCT05071053|451572688|FG000|Overall Study|Adverse Event|5|||
125530172|NCT01081886|451572689|FG000|Overall Study|Study termination|11|||
125530173|NCT01081886|451572690|FG001|Overall Study|Study termination|13|||
125530174|NCT02567708|451572691|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
125530175|NCT02567708|451572692|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
125530176|NCT02567708|451572691|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
125530177|NCT02567708|451572692|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
125530178|NCT02567708|451572691|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
125530179|NCT02567708|451572692|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
125530180|NCT02567708|451572691|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
125530181|NCT02567708|451572692|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
125530182|NCT04148651|451572697|FG000|Overall Study|Lost to Follow-up|2|||
125530183|NCT01602510|451572698|FG000|Open Label Phase|Adverse Event|46|||
125530184|NCT01602510|451572699|FG001|Open Label Phase|Adverse Event|0|||
125530185|NCT01602510|451572700|FG002|Open Label Phase|Adverse Event|0|||
125530186|NCT01602510|451572698|FG000|Open Label Phase|Lack of Efficacy|22|||
125530187|NCT01602510|451572699|FG001|Open Label Phase|Lack of Efficacy|0|||
125530188|NCT01602510|451572700|FG002|Open Label Phase|Lack of Efficacy|0|||
125530189|NCT01602510|451572698|FG000|Open Label Phase|Protocol Violation|15|||
125530190|NCT01602510|451572699|FG001|Open Label Phase|Protocol Violation|0|||
125530191|NCT01602510|451572700|FG002|Open Label Phase|Protocol Violation|0|||
125530192|NCT01602510|451572698|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
125530193|NCT01602510|451572699|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
125530194|NCT01602510|451572700|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
125530195|NCT01602510|451572698|FG000|Open Label Phase|Lost to Follow-up|22|||
125530196|NCT01602510|451572699|FG001|Open Label Phase|Lost to Follow-up|0|||
125530197|NCT01602510|451572700|FG002|Open Label Phase|Lost to Follow-up|0|||
125530198|NCT01602510|451572698|FG000|Open Label Phase|Physician Decision|19|||
125530199|NCT01602510|451572699|FG001|Open Label Phase|Physician Decision|0|||
125530200|NCT01602510|451572700|FG002|Open Label Phase|Physician Decision|0|||
125530201|NCT01602510|451572698|FG000|Open Label Phase|Withdrawal by Subject|57|||
125530202|NCT01602510|451572699|FG001|Open Label Phase|Withdrawal by Subject|0|||
125530203|NCT01602510|451572700|FG002|Open Label Phase|Withdrawal by Subject|0|||
125530204|NCT01602510|451572698|FG000|Randomized Phase|Adverse Event|0|||
125530205|NCT01602510|451572699|FG001|Randomized Phase|Adverse Event|2|||
125530206|NCT01602510|451572700|FG002|Randomized Phase|Adverse Event|6|||
125530207|NCT01602510|451572698|FG000|Randomized Phase|Lack of Efficacy|0|||
125530208|NCT01602510|451572699|FG001|Randomized Phase|Lack of Efficacy|4|||
125530209|NCT01602510|451572700|FG002|Randomized Phase|Lack of Efficacy|4|||
125530210|NCT01602510|451572698|FG000|Randomized Phase|Protocol Violation|0|||
125530211|NCT01602510|451572699|FG001|Randomized Phase|Protocol Violation|3|||
125530212|NCT01602510|451572700|FG002|Randomized Phase|Protocol Violation|3|||
125530213|NCT01602510|451572698|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
125530214|NCT01602510|451572699|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
125530215|NCT01602510|451572700|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
125530216|NCT01602510|451572698|FG000|Randomized Phase|Lost to Follow-up|0|||
125530217|NCT01602510|451572699|FG001|Randomized Phase|Lost to Follow-up|1|||
125530218|NCT01602510|451572700|FG002|Randomized Phase|Lost to Follow-up|3|||
125530219|NCT01602510|451572698|FG000|Randomized Phase|Physician Decision|0|||
125530220|NCT01602510|451572699|FG001|Randomized Phase|Physician Decision|0|||
125530221|NCT01602510|451572700|FG002|Randomized Phase|Physician Decision|2|||
125530222|NCT01602510|451572698|FG000|Randomized Phase|Withdrawal by Subject|0|||
125530223|NCT01602510|451572699|FG001|Randomized Phase|Withdrawal by Subject|6|||
125530224|NCT01602510|451572700|FG002|Randomized Phase|Withdrawal by Subject|7|||
125530225|NCT05262751|451572701|FG000|Washout Period 2|Adverse Event|1|||
125530226|NCT05262751|451572702|FG001|Washout Period 2|Adverse Event|0|||
125530227|NCT05262751|451572703|FG002|Washout Period 2|Adverse Event|0|||
125530228|NCT05262751|451572704|FG003|Washout Period 2|Adverse Event|0|||
125530229|NCT05262751|451572705|FG004|Washout Period 2|Adverse Event|0|||
125530230|NCT05262751|451572706|FG005|Washout Period 2|Adverse Event|0|||
125530231|NCT05262751|451572701|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
125530232|NCT05262751|451572702|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
125530233|NCT05262751|451572703|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
125530234|NCT05262751|451572704|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
125530235|NCT05262751|451572705|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
125530236|NCT05262751|451572706|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
125530237|NCT03519204|451572707|FG000|Overall Study|Lost to Follow-up|3|||
125530238|NCT03519204|451572708|FG001|Overall Study|Lost to Follow-up|8|||
125530239|NCT03519204|451572707|FG000|Overall Study|Withdrawal by Subject|9|||
125530240|NCT03519204|451572708|FG001|Overall Study|Withdrawal by Subject|7|||
125530241|NCT03519204|451572707|FG000|Overall Study|Other Miscellaneous Reasons|1|||
125530242|NCT03519204|451572708|FG001|Overall Study|Other Miscellaneous Reasons|0|||
125530243|NCT01154140|451572709|FG000|Overall Study|Death|71|||
125530244|NCT01154140|451572710|FG001|Overall Study|Death|81|||
125530245|NCT01154140|451572709|FG000|Overall Study|Lost to Follow-up|4|||
125530246|NCT01154140|451572710|FG001|Overall Study|Lost to Follow-up|5|||
125530247|NCT01154140|451572709|FG000|Overall Study|Withdrawal by Subject|12|||
125530248|NCT01154140|451572710|FG001|Overall Study|Withdrawal by Subject|13|||
125530249|NCT01154140|451572709|FG000|Overall Study|Other|3|||
125530250|NCT01154140|451572710|FG001|Overall Study|Other|1|||
125530251|NCT01154140|451572709|FG000|Overall Study|Randomized but not treated|1|||
125530252|NCT01154140|451572710|FG001|Overall Study|Randomized but not treated|2|||
125530253|NCT01818531|451572714|FG000|Overall Study|Withdrawn for case delay after block|1|||
125530254|NCT01818531|451572715|FG001|Overall Study|Withdrawn for case delay after block|0|||
125530255|NCT01818531|451572714|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
125530256|NCT01818531|451572715|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
125530257|NCT01818531|451572714|FG000|Overall Study|Withdrawn for failure to place block|0|||
125530258|NCT01818531|451572715|FG001|Overall Study|Withdrawn for failure to place block|1|||
125530259|NCT00477490|451572716|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
125530260|NCT00477490|451572717|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
125530261|NCT00477490|451572718|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
125530262|NCT00477490|451572719|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
125530263|NCT00477490|451572720|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
125530264|NCT00477490|451572721|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
125530265|NCT00477490|451572722|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
125530266|NCT00477490|451572723|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
125530267|NCT00477490|451572724|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
125530268|NCT00477490|451572716|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
125530269|NCT00477490|451572717|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
125530270|NCT00477490|451572718|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
125530271|NCT00477490|451572719|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
125530272|NCT00477490|451572720|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
125530273|NCT00477490|451572721|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
125530274|NCT00477490|451572722|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
125530275|NCT00477490|451572723|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
125530276|NCT00477490|451572724|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
125530277|NCT00477490|451572716|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
125530278|NCT00477490|451572717|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
125530279|NCT00477490|451572718|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
125530280|NCT00477490|451572719|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
125530281|NCT00477490|451572720|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
125530282|NCT00477490|451572721|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
125530283|NCT00477490|451572722|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
125530284|NCT00477490|451572723|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
125530285|NCT00477490|451572724|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
125530286|NCT00477490|451572716|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
125530287|NCT00477490|451572717|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
125530288|NCT00477490|451572718|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
125530289|NCT00477490|451572719|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
125530290|NCT00477490|451572720|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
125530291|NCT00477490|451572721|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
125530292|NCT00477490|451572722|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
125530293|NCT00477490|451572723|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
125530294|NCT00477490|451572724|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
125530295|NCT00477490|451572716|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
125530296|NCT00477490|451572717|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
125530297|NCT00477490|451572718|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
125530298|NCT00477490|451572719|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
125530299|NCT00477490|451572720|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
125530300|NCT00477490|451572721|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
125530301|NCT00477490|451572722|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
125530302|NCT00477490|451572723|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
125530303|NCT00477490|451572724|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
125530304|NCT00477490|451572716|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
125530305|NCT00477490|451572717|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
125530306|NCT00477490|451572718|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
125530307|NCT00477490|451572719|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
125530308|NCT00477490|451572720|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
125530309|NCT00477490|451572721|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
125530310|NCT00477490|451572722|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
125530311|NCT00477490|451572723|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
125530312|NCT00477490|451572724|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
125530313|NCT00477490|451572716|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
125530314|NCT00477490|451572717|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
125530315|NCT00477490|451572718|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
125530316|NCT00477490|451572719|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
125530317|NCT00477490|451572720|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
125530318|NCT00477490|451572721|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
125530319|NCT00477490|451572722|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
125530320|NCT00477490|451572723|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
125530321|NCT00477490|451572724|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
125530322|NCT00477490|451572716|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
125530323|NCT00477490|451572717|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
125530324|NCT00477490|451572718|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
125530325|NCT00477490|451572719|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
125530326|NCT00477490|451572720|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
125530327|NCT00477490|451572721|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
125530328|NCT00477490|451572722|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
125530329|NCT00477490|451572723|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
125530330|NCT00477490|451572724|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
125530331|NCT00477490|451572716|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
125530332|NCT00477490|451572717|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
125530333|NCT00477490|451572718|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
125530334|NCT00477490|451572719|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
125530335|NCT00477490|451572720|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
125530336|NCT00477490|451572721|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
125530337|NCT00477490|451572722|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
125530338|NCT00477490|451572723|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
125530339|NCT00477490|451572724|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
125530340|NCT00477490|451572716|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
125530341|NCT00477490|451572717|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
125530342|NCT00477490|451572718|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
125530343|NCT00477490|451572719|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
125530344|NCT00477490|451572720|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
125530345|NCT00477490|451572721|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
125530346|NCT00477490|451572722|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
125530347|NCT00477490|451572723|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
125530348|NCT00477490|451572724|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
125530349|NCT00477490|451572716|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
125530350|NCT00477490|451572717|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
125530351|NCT00477490|451572718|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
125530352|NCT00477490|451572719|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
125530353|NCT00477490|451572720|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
125530354|NCT00477490|451572721|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
125530355|NCT00477490|451572722|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
125530356|NCT00477490|451572723|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
125530357|NCT00477490|451572724|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
125530358|NCT00477490|451572716|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
125530359|NCT00477490|451572717|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
125530360|NCT00477490|451572718|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
125530361|NCT00477490|451572719|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
125530362|NCT00477490|451572720|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
125530363|NCT00477490|451572721|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
125530364|NCT00477490|451572722|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
125530365|NCT00477490|451572723|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
125530366|NCT00477490|451572724|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
125530367|NCT00477490|451572716|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
125530368|NCT00477490|451572717|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
125530369|NCT00477490|451572718|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
125530370|NCT00477490|451572719|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
125530371|NCT00477490|451572720|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
125530372|NCT00477490|451572721|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
125530373|NCT00477490|451572722|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
125530374|NCT00477490|451572723|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
125530375|NCT00477490|451572724|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
125530376|NCT00477490|451572716|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
125530377|NCT00477490|451572717|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
125530378|NCT00477490|451572718|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
125530379|NCT00477490|451572719|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
125530380|NCT00477490|451572720|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
125530381|NCT00477490|451572721|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
125530382|NCT00477490|451572722|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
125530383|NCT00477490|451572723|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
125530384|NCT00477490|451572724|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
125530385|NCT01646177|451572725|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
125530386|NCT01646177|451572726|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
125530387|NCT01646177|451572727|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
125530388|NCT01646177|451572728|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
125530389|NCT01646177|451572729|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
125530390|NCT01646177|451572730|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
125530391|NCT01646177|451572731|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
125530392|NCT01646177|451572732|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
125530393|NCT01646177|451572733|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
125530394|NCT01646177|451572734|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
125530395|NCT01646177|451572735|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
125530396|NCT01646177|451572736|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
125530397|NCT01646177|451572725|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
125530398|NCT01646177|451572726|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
125530399|NCT01646177|451572727|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
125530400|NCT01646177|451572728|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
125530401|NCT01646177|451572729|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
125530402|NCT01646177|451572730|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
125530403|NCT01646177|451572731|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
125530404|NCT01646177|451572732|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
125530405|NCT01646177|451572733|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
125530406|NCT01646177|451572734|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
125530407|NCT01646177|451572735|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
125530408|NCT01646177|451572736|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
125530409|NCT01646177|451572725|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
125530410|NCT01646177|451572726|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
125530411|NCT01646177|451572727|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
125530412|NCT01646177|451572728|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
125530413|NCT01646177|451572729|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
125530414|NCT01646177|451572730|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
125530415|NCT01646177|451572731|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
125530416|NCT01646177|451572732|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
125530417|NCT01646177|451572733|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
125530418|NCT01646177|451572734|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
125530419|NCT01646177|451572735|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
125530420|NCT01646177|451572736|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
125530421|NCT01646177|451572725|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
125530422|NCT01646177|451572726|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
125530423|NCT01646177|451572727|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
125530424|NCT01646177|451572728|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
125530425|NCT01646177|451572729|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
125530426|NCT01646177|451572730|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
125530427|NCT01646177|451572731|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
125530428|NCT01646177|451572732|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
125530429|NCT01646177|451572733|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
125530430|NCT01646177|451572734|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
125530431|NCT01646177|451572735|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
125530432|NCT01646177|451572736|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
125530433|NCT01646177|451572725|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
125530434|NCT01646177|451572726|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
125530435|NCT01646177|451572727|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
125530436|NCT01646177|451572728|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
125530437|NCT01646177|451572729|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
125530438|NCT01646177|451572730|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
125530439|NCT01646177|451572731|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
125530440|NCT01646177|451572732|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
125530441|NCT01646177|451572733|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
125530442|NCT01646177|451572734|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
125530443|NCT01646177|451572735|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
125530444|NCT01646177|451572736|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
125530445|NCT01646177|451572725|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
125530446|NCT01646177|451572726|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
125530447|NCT01646177|451572727|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
125530448|NCT01646177|451572728|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
125530449|NCT01646177|451572729|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
125530450|NCT01646177|451572730|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
125530451|NCT01646177|451572731|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
125530452|NCT01646177|451572732|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
125530453|NCT01646177|451572733|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
125530454|NCT01646177|451572734|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
125530455|NCT01646177|451572735|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
125530456|NCT01646177|451572736|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
125530457|NCT01646177|451572725|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
125530458|NCT01646177|451572726|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
125530459|NCT01646177|451572727|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
125530460|NCT01646177|451572728|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
125530461|NCT01646177|451572729|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
125530462|NCT01646177|451572730|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
125530463|NCT01646177|451572731|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
125530464|NCT01646177|451572732|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
125530465|NCT01646177|451572733|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
125530466|NCT01646177|451572734|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
125530467|NCT01646177|451572735|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
125530468|NCT01646177|451572736|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
125530469|NCT01646177|451572725|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
125530470|NCT01646177|451572726|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
125530471|NCT01646177|451572727|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
125530472|NCT01646177|451572728|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
125530473|NCT01646177|451572729|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
125530474|NCT01646177|451572730|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
125530475|NCT01646177|451572731|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
125530476|NCT01646177|451572732|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
125530477|NCT01646177|451572733|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
125530478|NCT01646177|451572734|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
125530479|NCT01646177|451572735|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
125530480|NCT01646177|451572736|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
125530481|NCT01646177|451572725|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
125530482|NCT01646177|451572726|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
125530483|NCT01646177|451572727|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
125530484|NCT01646177|451572728|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
125530485|NCT01646177|451572729|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
125530486|NCT01646177|451572730|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
125530487|NCT01646177|451572731|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
125530488|NCT01646177|451572732|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
125530489|NCT01646177|451572733|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
125530490|NCT01646177|451572734|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
125530491|NCT01646177|451572735|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
125530492|NCT01646177|451572736|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
125530493|NCT01646177|451572725|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
125530494|NCT01646177|451572726|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
125530495|NCT01646177|451572727|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
125530496|NCT01646177|451572728|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
125530497|NCT01646177|451572729|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
125530498|NCT01646177|451572730|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
125530499|NCT01646177|451572731|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
125530500|NCT01646177|451572732|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
125530501|NCT01646177|451572733|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
125530502|NCT01646177|451572734|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
125530503|NCT01646177|451572735|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
125530504|NCT01646177|451572736|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
125530505|NCT01646177|451572725|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
125530506|NCT01646177|451572726|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
125530507|NCT01646177|451572727|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
125530508|NCT01646177|451572728|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
125530509|NCT01646177|451572729|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
125530510|NCT01646177|451572730|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
125530511|NCT01646177|451572731|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
125533007|NCT04047862|451581437|FG015|Overall Study|Physician Decision|0|||
125530512|NCT01646177|451572732|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
125530513|NCT01646177|451572733|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
125530514|NCT01646177|451572734|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
125530515|NCT01646177|451572735|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
125530516|NCT01646177|451572736|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
125530517|NCT01646177|451572725|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
125530518|NCT01646177|451572726|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
125530519|NCT01646177|451572727|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
125530520|NCT01646177|451572728|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
125530521|NCT01646177|451572729|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
125530522|NCT01646177|451572730|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
125530523|NCT01646177|451572731|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
125530524|NCT01646177|451572732|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
125530525|NCT01646177|451572733|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
125530526|NCT01646177|451572734|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
125530527|NCT01646177|451572735|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
125530528|NCT01646177|451572736|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
125530529|NCT01646177|451572725|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
125530530|NCT01646177|451572726|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
125530531|NCT01646177|451572727|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
125530532|NCT01646177|451572728|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
125530533|NCT01646177|451572729|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
125530534|NCT01646177|451572730|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
125530535|NCT01646177|451572731|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
125530536|NCT01646177|451572732|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
125530537|NCT01646177|451572733|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
125530538|NCT01646177|451572734|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
125530539|NCT01646177|451572735|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
125530540|NCT01646177|451572736|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
125530541|NCT01646177|451572725|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
125530542|NCT01646177|451572726|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
125530543|NCT01646177|451572727|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
125530544|NCT01646177|451572728|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
125530545|NCT01646177|451572729|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
125530546|NCT01646177|451572730|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
125530547|NCT01646177|451572731|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
125530548|NCT01646177|451572732|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
125530549|NCT01646177|451572733|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
125530550|NCT01646177|451572734|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
125530551|NCT01646177|451572735|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
125530552|NCT01646177|451572736|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
125530553|NCT01646177|451572725|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
125530554|NCT01646177|451572726|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
125530555|NCT01646177|451572727|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
125530556|NCT01646177|451572728|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
125530557|NCT01646177|451572729|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
125530558|NCT01646177|451572730|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
125530559|NCT01646177|451572731|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
125530560|NCT01646177|451572732|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
125530561|NCT01646177|451572733|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
125530562|NCT01646177|451572734|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
125530563|NCT01646177|451572735|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
125530564|NCT01646177|451572736|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
125530565|NCT01646177|451572725|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
125530566|NCT01646177|451572726|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
125530567|NCT01646177|451572727|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
125530568|NCT01646177|451572728|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
125530569|NCT01646177|451572729|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
125530570|NCT01646177|451572730|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
125530571|NCT01646177|451572731|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
125530572|NCT01646177|451572732|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
125530573|NCT01646177|451572733|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
125530574|NCT01646177|451572734|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
125530575|NCT01646177|451572735|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
125530576|NCT01646177|451572736|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
125530577|NCT01646177|451572725|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
125530578|NCT01646177|451572726|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
125530579|NCT01646177|451572727|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
125530580|NCT01646177|451572728|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
125530581|NCT01646177|451572729|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
125530582|NCT01646177|451572730|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
125530583|NCT01646177|451572731|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
125530584|NCT01646177|451572732|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
125530585|NCT01646177|451572733|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
125530586|NCT01646177|451572734|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
125530587|NCT01646177|451572735|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
125530588|NCT01646177|451572736|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
125530589|NCT01646177|451572725|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
125530590|NCT01646177|451572726|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
125530591|NCT01646177|451572727|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
125530592|NCT01646177|451572728|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
125530593|NCT01646177|451572729|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
125530594|NCT01646177|451572730|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
125530595|NCT01646177|451572731|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
125530596|NCT01646177|451572732|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
125530597|NCT01646177|451572733|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
125530598|NCT01646177|451572734|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
125530599|NCT01646177|451572735|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
125530600|NCT01646177|451572736|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
125530601|NCT01646177|451572725|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
125530602|NCT01646177|451572726|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
125530603|NCT01646177|451572727|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
125530604|NCT01646177|451572728|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
125530605|NCT01646177|451572729|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
125530606|NCT01646177|451572730|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
125530607|NCT01646177|451572731|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
125530608|NCT01646177|451572732|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
125530609|NCT01646177|451572733|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
125530610|NCT01646177|451572734|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
125530611|NCT01646177|451572735|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
125530612|NCT01646177|451572736|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
125530613|NCT01646177|451572725|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
125530614|NCT01646177|451572726|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
125530615|NCT01646177|451572727|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
125530616|NCT01646177|451572728|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
125530617|NCT01646177|451572729|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
125530618|NCT01646177|451572730|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
125530619|NCT01646177|451572731|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
125530620|NCT01646177|451572732|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
125530621|NCT01646177|451572733|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
125530622|NCT01646177|451572734|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
125530623|NCT01646177|451572735|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
125530624|NCT01646177|451572736|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
125530625|NCT01646177|451572725|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
125530626|NCT01646177|451572726|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
125530627|NCT01646177|451572727|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
125530628|NCT01646177|451572728|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
125530629|NCT01646177|451572729|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
125530630|NCT01646177|451572730|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
125530631|NCT01646177|451572731|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
125530632|NCT01646177|451572732|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
125530633|NCT01646177|451572733|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
125530634|NCT01646177|451572734|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
125530635|NCT01646177|451572735|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
125530636|NCT01646177|451572736|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
125530637|NCT01646177|451572725|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
125530638|NCT01646177|451572726|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
125530639|NCT01646177|451572727|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
125530640|NCT01646177|451572728|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
125530641|NCT01646177|451572729|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
125530642|NCT01646177|451572730|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
125530643|NCT01646177|451572731|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
125530644|NCT01646177|451572732|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
125530645|NCT01646177|451572733|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
125530646|NCT01646177|451572734|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
125530647|NCT01646177|451572735|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
125530648|NCT01646177|451572736|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
125530649|NCT01646177|451572725|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
125530650|NCT01646177|451572726|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
125530651|NCT01646177|451572727|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
125530652|NCT01646177|451572728|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
125530653|NCT01646177|451572729|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
125530654|NCT01646177|451572730|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
125530655|NCT01646177|451572731|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
125530656|NCT01646177|451572732|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
125530657|NCT01646177|451572733|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
125530658|NCT01646177|451572734|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
125530659|NCT01646177|451572735|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
125530660|NCT01646177|451572736|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
125530661|NCT01646177|451572725|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
125530662|NCT01646177|451572726|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
125530663|NCT01646177|451572727|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
125530664|NCT01646177|451572728|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
125530665|NCT01646177|451572729|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
125530666|NCT01646177|451572730|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
125530667|NCT01646177|451572731|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
125530668|NCT01646177|451572732|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
125530669|NCT01646177|451572733|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
125530670|NCT01646177|451572734|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
125530671|NCT01646177|451572735|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
125530672|NCT01646177|451572736|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
125530673|NCT01646177|451572725|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
125530674|NCT01646177|451572726|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
125530675|NCT01646177|451572727|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
125530676|NCT01646177|451572728|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
125530677|NCT01646177|451572729|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
125530678|NCT01646177|451572730|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
125530679|NCT01646177|451572731|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
125530680|NCT01646177|451572732|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
125530681|NCT01646177|451572733|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
125530682|NCT01646177|451572734|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
125530683|NCT01646177|451572735|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
125530684|NCT01646177|451572736|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
125530685|NCT01646177|451572725|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
125530686|NCT01646177|451572726|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
125530687|NCT01646177|451572727|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
125530688|NCT01646177|451572728|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
125530689|NCT01646177|451572729|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
125530690|NCT01646177|451572730|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
125530691|NCT01646177|451572731|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
125530692|NCT01646177|451572732|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
125530693|NCT01646177|451572733|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
125530694|NCT01646177|451572734|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
125530695|NCT01646177|451572735|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
125530696|NCT01646177|451572736|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
125530697|NCT01646177|451572725|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
125530698|NCT01646177|451572726|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
125530699|NCT01646177|451572727|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
125530700|NCT01646177|451572728|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
125530701|NCT01646177|451572729|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
125530702|NCT01646177|451572730|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
125530703|NCT01646177|451572731|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
125530704|NCT01646177|451572732|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
125530705|NCT01646177|451572733|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
125530706|NCT01646177|451572734|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
125530707|NCT01646177|451572735|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
125530708|NCT01646177|451572736|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
125530709|NCT01305239|451572740|FG000|Overall Study|Adverse Event|22|||
125530710|NCT01305239|451572740|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
125530711|NCT00402051|451572743|FG000|Overall Study|Progressive Disease|13|||
125530712|NCT00402051|451572744|FG001|Overall Study|Progressive Disease|20|||
125530713|NCT00402051|451572743|FG000|Overall Study|Adverse Event|11|||
125530714|NCT00402051|451572744|FG001|Overall Study|Adverse Event|4|||
125530715|NCT00402051|451572743|FG000|Overall Study|Physician Decision|7|||
125530716|NCT00402051|451572744|FG001|Overall Study|Physician Decision|3|||
125530717|NCT00402051|451572743|FG000|Overall Study|Withdrawal by Subject|3|||
125530718|NCT00402051|451572744|FG001|Overall Study|Withdrawal by Subject|3|||
125530719|NCT00402051|451572743|FG000|Overall Study|Death - Related to Study Drug|1|||
125530720|NCT00402051|451572744|FG001|Overall Study|Death - Related to Study Drug|2|||
125530721|NCT00402051|451572743|FG000|Overall Study|Death Due to Study Disease|2|||
125530722|NCT00402051|451572744|FG001|Overall Study|Death Due to Study Disease|1|||
125530723|NCT00402051|451572743|FG000|Overall Study|Death Due to Adverse Event|0|||
125530724|NCT00402051|451572744|FG001|Overall Study|Death Due to Adverse Event|2|||
125530725|NCT00402051|451572743|FG000|Overall Study|Lost to Follow-up|1|||
125530726|NCT00402051|451572744|FG001|Overall Study|Lost to Follow-up|0|||
125530727|NCT00570908|451572758|FG000|Overall Study|Adverse Event|5|||
125530728|NCT00570908|451572758|FG000|Overall Study|Withdrawal by Subject|2|||
125530729|NCT01213524|451572759|FG000|Baseline|Withdrawal by Subject|5|||
125530730|NCT01213524|451572759|FG000|Baseline|high breath alcohol levels|1|||
125530731|NCT01213524|451572759|FG000|Baseline|Physician Decision|1|||
125530732|NCT01213524|451572759|FG000|Session 2|Withdrawal by Subject|5|||
125530733|NCT01213524|451572759|FG000|Session 3|Withdrawal by Subject|4|||
125530734|NCT01213524|451572759|FG000|Session 4|Physician Decision|1|||
125530735|NCT01213524|451572759|FG000|Session 4|Withdrawal by Subject|2|||
125530736|NCT06152224|451572765|FG000|Overall Study|Withdrawal by Subject|1|||
125530737|NCT06152224|451572766|FG001|Overall Study|Withdrawal by Subject|0|||
125530738|NCT06152224|451572765|FG000|Overall Study|Lost to Follow-up|0|||
125530739|NCT06152224|451572766|FG001|Overall Study|Lost to Follow-up|1|||
125530740|NCT06152224|451572765|FG000|Overall Study|On Follow Up|18|||
125530741|NCT06152224|451572766|FG001|Overall Study|On Follow Up|18|||
125530742|NCT00281320|451572767|FG000|Overall Study|Adverse Event|12|||
125530743|NCT00281320|451572768|FG001|Overall Study|Adverse Event|9|||
125530744|NCT00281320|451572767|FG000|Overall Study|Lack of Efficacy|4|||
125530745|NCT00281320|451572768|FG001|Overall Study|Lack of Efficacy|3|||
125530746|NCT00281320|451572767|FG000|Overall Study|Withdrawal by Subject|5|||
125530747|NCT00281320|451572768|FG001|Overall Study|Withdrawal by Subject|6|||
125530748|NCT00281320|451572767|FG000|Overall Study|Lost to Follow-up|1|||
125530749|NCT00281320|451572768|FG001|Overall Study|Lost to Follow-up|2|||
125530750|NCT00281320|451572767|FG000|Overall Study|Other|3|||
125530751|NCT00281320|451572768|FG001|Overall Study|Other|1|||
125530752|NCT01447576|451572777|FG000|Overall Study|Lost to Follow-up|52|||
125530753|NCT01447576|451572777|FG000|Overall Study|Adverse Event|127|||
125530754|NCT01447576|451572777|FG000|Overall Study|Participant met withdrawal criteria|40|||
125530755|NCT01447576|451572777|FG000|Overall Study|Withdrawal by Subject|100|||
125530756|NCT01447576|451572777|FG000|Overall Study|Protocol deviation|83|||
125530757|NCT01447576|451572777|FG000|Overall Study|Lack of Efficacy|68|||
125530758|NCT01447576|451572777|FG000|Overall Study|Physician Decision|6|||
125530759|NCT00975676|451572778|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
125530760|NCT00975676|451572779|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
125530761|NCT02579772|451572780|FG000|Overall Study|Withdrawal by Subject|0|||
125530762|NCT02579772|451572781|FG001|Overall Study|Withdrawal by Subject|1|||
125530763|NCT02579772|451572780|FG000|Overall Study|Usage of additional antioxidants|1|||
125530764|NCT02579772|451572781|FG001|Overall Study|Usage of additional antioxidants|0|||
125530765|NCT02579772|451572780|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
125530766|NCT02579772|451572781|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
125530767|NCT04991753|451574303|FG000|Overall Study|Withdrawal by Subject|0|||
125530768|NCT04991753|451574304|FG001|Overall Study|Withdrawal by Subject|1|||
125530769|NCT03299049|451574307|FG000|Overall Study|On-going|486|||
125530770|NCT03299049|451574308|FG001|Overall Study|On-going|481|||
125530771|NCT03299049|451574307|FG000|Overall Study|Withdrawal by Subject|6|||
125530772|NCT03299049|451574308|FG001|Overall Study|Withdrawal by Subject|21|||
125530773|NCT03299049|451574307|FG000|Overall Study|Physician Decision|5|||
125530774|NCT03299049|451574308|FG001|Overall Study|Physician Decision|1|||
125530775|NCT03299049|451574307|FG000|Overall Study|Lost to Follow-up|2|||
125530776|NCT03299049|451574308|FG001|Overall Study|Lost to Follow-up|0|||
125530777|NCT03299049|451574307|FG000|Overall Study|Pregnancy|1|||
125530778|NCT03299049|451574308|FG001|Overall Study|Pregnancy|3|||
125530779|NCT03299049|451574307|FG000|Overall Study|Protocol Violation|1|||
125530780|NCT03299049|451574308|FG001|Overall Study|Protocol Violation|1|||
125530781|NCT03299049|451574307|FG000|Overall Study|Lack of Efficacy|9|||
125530782|NCT03299049|451574308|FG001|Overall Study|Lack of Efficacy|3|||
125530783|NCT03299049|451574307|FG000|Overall Study|Adverse Event|12|||
125530784|NCT03299049|451574308|FG001|Overall Study|Adverse Event|13|||
125530785|NCT01901419|451574309|FG000|Overall Study|Protocol Violation|2|||
125530786|NCT01901419|451574310|FG001|Overall Study|Protocol Violation|6|||
125530787|NCT01901419|451574309|FG000|Overall Study|unavailable researchers|6|||
125530788|NCT01901419|451574310|FG001|Overall Study|unavailable researchers|3|||
125530789|NCT01667926|451574315|FG000|Overall Study|Withdrawal by Subject|1|||
125530790|NCT01667926|451574316|FG001|Overall Study|Withdrawal by Subject|2|||
125530791|NCT01667926|451574317|FG002|Overall Study|Withdrawal by Subject|2|||
125530792|NCT01667926|451574315|FG000|Overall Study|Physician Decision|0|||
125530793|NCT01667926|451574316|FG001|Overall Study|Physician Decision|0|||
125530794|NCT01667926|451574317|FG002|Overall Study|Physician Decision|1|||
125530795|NCT01667926|451574315|FG000|Overall Study|Time committment|0|||
125530796|NCT01667926|451574316|FG001|Overall Study|Time committment|0|||
125530797|NCT01667926|451574317|FG002|Overall Study|Time committment|2|||
125530798|NCT01667926|451574315|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
125530799|NCT01667926|451574316|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
125530800|NCT01667926|451574317|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
125530801|NCT01667926|451574315|FG000|Overall Study|Lost to Follow-up|1|||
125530802|NCT01667926|451574316|FG001|Overall Study|Lost to Follow-up|2|||
125530803|NCT01667926|451574317|FG002|Overall Study|Lost to Follow-up|1|||
125530804|NCT01667926|451574315|FG000|Overall Study|Side effects|3|||
125530805|NCT01667926|451574316|FG001|Overall Study|Side effects|0|||
125530806|NCT01667926|451574317|FG002|Overall Study|Side effects|0|||
125530807|NCT01088984|451574322|FG000|Phase 1|Death|2|||
125530808|NCT01088984|451574323|FG001|Phase 1|Death|1|||
125530809|NCT01088984|451574322|FG000|Phase 1|Disease Progression|2|||
125530810|NCT01088984|451574323|FG001|Phase 1|Disease Progression|4|||
125530811|NCT01088984|451574322|FG000|Phase 1|Other|1|||
125530812|NCT01088984|451574323|FG001|Phase 1|Other|1|||
125530813|NCT01088984|451574322|FG000|Phase 2|Death|0|||
125530814|NCT01088984|451574323|FG001|Phase 2|Death|5|||
125530815|NCT01088984|451574322|FG000|Phase 2|Withdrawal by Subject|0|||
125530816|NCT01088984|451574323|FG001|Phase 2|Withdrawal by Subject|1|||
125530817|NCT01088984|451574322|FG000|Phase 2|DIsease Progression|0|||
125530818|NCT01088984|451574323|FG001|Phase 2|DIsease Progression|25|||
125530819|NCT01088984|451574322|FG000|Phase 2|Other|0|||
125530820|NCT01088984|451574323|FG001|Phase 2|Other|1|||
125530821|NCT04707664|451574324|FG000|Overall Study|Adverse Event|2|||
125530822|NCT04707664|451574325|FG001|Overall Study|Adverse Event|0|||
125530823|NCT04707664|451574324|FG000|Overall Study|Death|1|||
125530824|NCT04707664|451574325|FG001|Overall Study|Death|2|||
125530825|NCT04707664|451574324|FG000|Overall Study|Withdrawal by Subject|13|||
125530826|NCT04707664|451574325|FG001|Overall Study|Withdrawal by Subject|21|||
125530827|NCT04707664|451574324|FG000|Overall Study|Lost to Follow-up|11|||
125530828|NCT04707664|451574325|FG001|Overall Study|Lost to Follow-up|13|||
125530829|NCT04707664|451574324|FG000|Overall Study|Not treated|2|||
125530830|NCT04707664|451574325|FG001|Overall Study|Not treated|0|||
125530831|NCT00699153|451574326|FG000|Overall Study|Lost to Follow-up|1|||
125530832|NCT00699153|451574327|FG001|Overall Study|Lost to Follow-up|0|||
125530833|NCT00699153|451574326|FG000|Overall Study|Adverse Event|0|||
125530834|NCT00699153|451574327|FG001|Overall Study|Adverse Event|2|||
125530835|NCT00699153|451574326|FG000|Overall Study|Protocol Violation|1|||
125530836|NCT00699153|451574327|FG001|Overall Study|Protocol Violation|0|||
125530837|NCT00699153|451574326|FG000|Overall Study|Travel Problem|1|||
125530838|NCT00699153|451574327|FG001|Overall Study|Travel Problem|0|||
125530839|NCT02412735|451574330|FG000|Overall Study|Adverse Event|0|||
125530840|NCT02412735|451574331|FG001|Overall Study|Adverse Event|1|||
125530841|NCT02412735|451574332|FG002|Overall Study|Adverse Event|2|||
125530842|NCT02412735|451574330|FG000|Overall Study|Withdrawal by Subject|23|||
125530843|NCT02412735|451574331|FG001|Overall Study|Withdrawal by Subject|27|||
125530844|NCT02412735|451574332|FG002|Overall Study|Withdrawal by Subject|22|||
125530845|NCT02412735|451574330|FG000|Overall Study|Investigator Decision|3|||
125530846|NCT02412735|451574331|FG001|Overall Study|Investigator Decision|3|||
125530847|NCT02412735|451574332|FG002|Overall Study|Investigator Decision|2|||
125530848|NCT02412735|451574330|FG000|Overall Study|Lost to Follow-up|17|||
125530849|NCT02412735|451574331|FG001|Overall Study|Lost to Follow-up|11|||
125530850|NCT02412735|451574332|FG002|Overall Study|Lost to Follow-up|18|||
125530851|NCT02412735|451574330|FG000|Overall Study|Reason not Specified|3|||
125530852|NCT02412735|451574331|FG001|Overall Study|Reason not Specified|2|||
125530853|NCT02412735|451574332|FG002|Overall Study|Reason not Specified|2|||
125530854|NCT01228318|451574333|FG000|Overall Study|Clinic no show to receive intervention|1|||
125530855|NCT01228318|451574334|FG001|Overall Study|Clinic no show to receive intervention|0|||
125530856|NCT01228318|451574333|FG000|Overall Study|Unable to contact|2|||
125530857|NCT01228318|451574334|FG001|Overall Study|Unable to contact|5|||
125530858|NCT01228318|451574333|FG000|Overall Study|Moved|0|||
125530859|NCT01228318|451574334|FG001|Overall Study|Moved|2|||
125530860|NCT01228318|451574333|FG000|Overall Study|Incarcerated|1|||
125530861|NCT01228318|451574334|FG001|Overall Study|Incarcerated|0|||
125530862|NCT04043143|451574335|FG000|Overall Study|Lost to Follow-up|5|||
125530863|NCT04043143|451574336|FG001|Overall Study|Lost to Follow-up|5|||
125530864|NCT04043143|451574335|FG000|Overall Study|screen failure|1|||
125530865|NCT04043143|451574336|FG001|Overall Study|screen failure|0|||
125530866|NCT02521363|451574337|FG000|Overall Study|Withdrawal by Subject|1|||
125530867|NCT02521363|451574338|FG001|Overall Study|Withdrawal by Subject|2|||
125530868|NCT03374488|451574339|FG000|Overall Study|Death|13|||
125530869|NCT03374488|451574340|FG001|Overall Study|Death|13|||
125530870|NCT03374488|451574339|FG000|Overall Study|Withdrawal by Subject|3|||
125530871|NCT03374488|451574340|FG001|Overall Study|Withdrawal by Subject|1|||
125530872|NCT03374488|451574339|FG000|Overall Study|Physician Decision|3|||
125530873|NCT03374488|451574340|FG001|Overall Study|Physician Decision|0|||
125530874|NCT01757197|451574341|FG000|Overall Study|Death|2|||
125530875|NCT01077128|451574344|FG000|Overall Study|Adverse Event|8|||
125530876|NCT01077128|451574344|FG000|Overall Study|Lack of Efficacy|1|||
125530877|NCT01077128|451574344|FG000|Overall Study|Disease exacerbation|1|||
125530878|NCT01077128|451574344|FG000|Overall Study|Adverse event and consent withdrawal|1|||
125530879|NCT01077128|451574344|FG000|Overall Study|Adverse event and disease exacerbation|1|||
125530880|NCT01077128|451574344|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
125530881|NCT01077128|451574344|FG000|Overall Study|Other|54|||
125530882|NCT01706705|451574345|FG000|Overall Study|Death|1|||
125530883|NCT01706705|451574345|FG000|Overall Study|Lack of Efficacy|13|||
125530884|NCT01706705|451574345|FG000|Overall Study|Non-clinical|6|||
125530885|NCT04703192|451574346|FG000|Overall Study|Withdrawal by Subject|2|||
125530886|NCT04703192|451574347|FG001|Overall Study|Withdrawal by Subject|0|||
125530887|NCT04703192|451574346|FG000|Overall Study|Death|3|||
125530888|NCT04703192|451574347|FG001|Overall Study|Death|1|||
125530889|NCT04703192|451574346|FG000|Overall Study|Adverse Event|13|||
125530890|NCT04703192|451574347|FG001|Overall Study|Adverse Event|2|||
125530891|NCT04703192|451574346|FG000|Overall Study|Progressive or Relapsed Disease|46|||
125530892|NCT04703192|451574347|FG001|Overall Study|Progressive or Relapsed Disease|7|||
125530893|NCT04703192|451574346|FG000|Overall Study|Clinical Progression|19|||
125530894|NCT04703192|451574347|FG001|Overall Study|Clinical Progression|8|||
125530895|NCT04703192|451574346|FG000|Overall Study|Lost to Follow-up|1|||
125530896|NCT04703192|451574347|FG001|Overall Study|Lost to Follow-up|0|||
125530897|NCT04703192|451574346|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
125530898|NCT04703192|451574347|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
125530899|NCT04703192|451574346|FG000|Overall Study|Other|5|||
125530900|NCT04703192|451574347|FG001|Overall Study|Other|1|||
125530901|NCT02088957|451574348|FG000|Overall Study|Lack of Efficacy|1|||
125530902|NCT02088957|451574349|FG001|Overall Study|Lack of Efficacy|0|||
125530903|NCT01939353|451574350|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
125530904|NCT01939353|451574350|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
125530905|NCT01939353|451574350|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
125530906|NCT01939353|451574350|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
125530907|NCT01939353|451574350|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
125530908|NCT00874731|451574358|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
125530909|NCT00874731|451574359|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
125530910|NCT00874731|451574360|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
125530911|NCT00874731|451574358|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
125530912|NCT00874731|451574359|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
125530913|NCT00874731|451574360|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
125530914|NCT00874731|451574358|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
125530915|NCT00874731|451574359|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
125530916|NCT00874731|451574360|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
125530917|NCT01132820|451574365|FG000|Overall Study|Ineligible: wrong cell type|1|||
125530918|NCT01132820|451574365|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
125530919|NCT01132820|451574365|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
125530920|NCT01132820|451574365|FG000|Overall Study|Never treated|1|||
125530921|NCT01132820|451574365|FG000|Overall Study|Inadequate data|1|||
125530922|NCT00667394|451574369|FG000|Overall Study|Adverse Event|3|||
125530923|NCT00667394|451574370|FG001|Overall Study|Adverse Event|0|||
125530924|NCT00667394|451574369|FG000|Overall Study|Progressive disease|1|||
125530925|NCT00667394|451574370|FG001|Overall Study|Progressive disease|0|||
125530926|NCT05000216|451574371|FG000|Stage 1|Lost to Follow-up|0|||
125530927|NCT05000216|451574372|FG001|Stage 1|Lost to Follow-up|0|||
125530928|NCT05000216|451574373|FG002|Stage 1|Lost to Follow-up|0|||
125530929|NCT05000216|451574374|FG003|Stage 1|Lost to Follow-up|0|||
125530930|NCT05000216|451574375|FG004|Stage 1|Lost to Follow-up|0|||
125530931|NCT05000216|451574376|FG005|Stage 1|Lost to Follow-up|0|||
125530932|NCT05000216|451574377|FG006|Stage 1|Lost to Follow-up|1|||
125530933|NCT05000216|451574378|FG007|Stage 1|Lost to Follow-up|1|||
125530934|NCT05000216|451574379|FG008|Stage 1|Lost to Follow-up|0|||
125530935|NCT05000216|451574380|FG009|Stage 1|Lost to Follow-up|2|||
125530936|NCT05000216|451574381|FG010|Stage 1|Lost to Follow-up|3|||
125530937|NCT05000216|451574382|FG011|Stage 1|Lost to Follow-up|0|||
125530938|NCT05000216|451574383|FG012|Stage 1|Lost to Follow-up|0|||
125530939|NCT05000216|451574384|FG013|Stage 1|Lost to Follow-up|0|||
125530940|NCT05000216|451574385|FG014|Stage 1|Lost to Follow-up|0|||
125530941|NCT05000216|451574386|FG015|Stage 1|Lost to Follow-up|0|||
125530942|NCT05000216|451574387|FG016|Stage 1|Lost to Follow-up|0|||
125530943|NCT05000216|451574388|FG017|Stage 1|Lost to Follow-up|0|||
125530944|NCT05000216|451574389|FG018|Stage 1|Lost to Follow-up|0|||
125530945|NCT05000216|451574390|FG019|Stage 1|Lost to Follow-up|0|||
125530946|NCT05000216|451574391|FG020|Stage 1|Lost to Follow-up|0|||
125530947|NCT05000216|451574392|FG021|Stage 1|Lost to Follow-up|0|||
125530948|NCT05000216|451574371|FG000|Stage 1|Physician Decision|0|||
125530949|NCT05000216|451574372|FG001|Stage 1|Physician Decision|0|||
125530950|NCT05000216|451574373|FG002|Stage 1|Physician Decision|0|||
125530951|NCT05000216|451574374|FG003|Stage 1|Physician Decision|0|||
125530952|NCT05000216|451574375|FG004|Stage 1|Physician Decision|0|||
125530953|NCT05000216|451574376|FG005|Stage 1|Physician Decision|0|||
125530954|NCT05000216|451574377|FG006|Stage 1|Physician Decision|0|||
125530955|NCT05000216|451574378|FG007|Stage 1|Physician Decision|1|||
125530956|NCT05000216|451574379|FG008|Stage 1|Physician Decision|1|||
125530957|NCT05000216|451574380|FG009|Stage 1|Physician Decision|0|||
125530958|NCT05000216|451574381|FG010|Stage 1|Physician Decision|0|||
125530959|NCT05000216|451574382|FG011|Stage 1|Physician Decision|0|||
125530960|NCT05000216|451574383|FG012|Stage 1|Physician Decision|0|||
125530961|NCT05000216|451574384|FG013|Stage 1|Physician Decision|0|||
125530962|NCT05000216|451574385|FG014|Stage 1|Physician Decision|0|||
125530963|NCT05000216|451574386|FG015|Stage 1|Physician Decision|0|||
125530964|NCT05000216|451574387|FG016|Stage 1|Physician Decision|0|||
125530965|NCT05000216|451574388|FG017|Stage 1|Physician Decision|0|||
125530966|NCT05000216|451574389|FG018|Stage 1|Physician Decision|0|||
125530967|NCT05000216|451574390|FG019|Stage 1|Physician Decision|0|||
125530968|NCT05000216|451574391|FG020|Stage 1|Physician Decision|0|||
125530969|NCT05000216|451574392|FG021|Stage 1|Physician Decision|0|||
125530970|NCT05000216|451574371|FG000|Stage 1|Withdrawal by Subject|0|||
125530971|NCT05000216|451574372|FG001|Stage 1|Withdrawal by Subject|1|||
125530972|NCT05000216|451574373|FG002|Stage 1|Withdrawal by Subject|0|||
125530973|NCT05000216|451574374|FG003|Stage 1|Withdrawal by Subject|0|||
125530974|NCT05000216|451574375|FG004|Stage 1|Withdrawal by Subject|0|||
125530975|NCT05000216|451574376|FG005|Stage 1|Withdrawal by Subject|0|||
125530976|NCT05000216|451574377|FG006|Stage 1|Withdrawal by Subject|0|||
125530977|NCT05000216|451574378|FG007|Stage 1|Withdrawal by Subject|0|||
125530978|NCT05000216|451574379|FG008|Stage 1|Withdrawal by Subject|0|||
125530979|NCT05000216|451574380|FG009|Stage 1|Withdrawal by Subject|3|||
125530980|NCT05000216|451574381|FG010|Stage 1|Withdrawal by Subject|10|||
125530981|NCT05000216|451574382|FG011|Stage 1|Withdrawal by Subject|0|||
125530982|NCT05000216|451574383|FG012|Stage 1|Withdrawal by Subject|0|||
125530983|NCT05000216|451574384|FG013|Stage 1|Withdrawal by Subject|0|||
125530984|NCT05000216|451574385|FG014|Stage 1|Withdrawal by Subject|0|||
125530985|NCT05000216|451574386|FG015|Stage 1|Withdrawal by Subject|0|||
125530986|NCT05000216|451574387|FG016|Stage 1|Withdrawal by Subject|0|||
125530987|NCT05000216|451574388|FG017|Stage 1|Withdrawal by Subject|0|||
125530988|NCT05000216|451574389|FG018|Stage 1|Withdrawal by Subject|0|||
125530989|NCT05000216|451574390|FG019|Stage 1|Withdrawal by Subject|0|||
125530990|NCT05000216|451574391|FG020|Stage 1|Withdrawal by Subject|0|||
125530991|NCT05000216|451574392|FG021|Stage 1|Withdrawal by Subject|0|||
125530992|NCT05000216|451574371|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
125530993|NCT05000216|451574372|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
125530994|NCT05000216|451574373|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
125530995|NCT05000216|451574374|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
125530996|NCT05000216|451574375|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
125530997|NCT05000216|451574376|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
125530998|NCT05000216|451574377|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
125530999|NCT05000216|451574378|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
125531000|NCT05000216|451574379|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
125531001|NCT05000216|451574380|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
125531002|NCT05000216|451574381|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
125531003|NCT05000216|451574382|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
125531004|NCT05000216|451574383|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
125531005|NCT05000216|451574384|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
125531006|NCT05000216|451574385|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
125531007|NCT05000216|451574386|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
125531008|NCT05000216|451574387|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
125531009|NCT05000216|451574388|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
125531010|NCT05000216|451574389|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
125531011|NCT05000216|451574390|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
125531012|NCT05000216|451574391|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
125531013|NCT05000216|451574392|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
125531014|NCT05000216|451574371|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531015|NCT05000216|451574372|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531016|NCT05000216|451574373|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531017|NCT05000216|451574374|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531018|NCT05000216|451574375|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531019|NCT05000216|451574376|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531020|NCT05000216|451574377|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531021|NCT05000216|451574378|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531022|NCT05000216|451574379|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
125531023|NCT05000216|451574380|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531024|NCT05000216|451574381|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531025|NCT05000216|451574382|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531026|NCT05000216|451574383|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531027|NCT05000216|451574384|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531028|NCT05000216|451574385|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531029|NCT05000216|451574386|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531030|NCT05000216|451574387|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531031|NCT05000216|451574388|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531032|NCT05000216|451574389|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531033|NCT05000216|451574390|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531034|NCT05000216|451574391|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531035|NCT05000216|451574392|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
125531036|NCT05000216|451574371|FG000|Stage 1|Other|0|||
125531037|NCT05000216|451574372|FG001|Stage 1|Other|0|||
125531038|NCT05000216|451574373|FG002|Stage 1|Other|0|||
125531039|NCT05000216|451574374|FG003|Stage 1|Other|0|||
125531040|NCT05000216|451574375|FG004|Stage 1|Other|1|||
125531041|NCT05000216|451574376|FG005|Stage 1|Other|0|||
125531042|NCT05000216|451574377|FG006|Stage 1|Other|0|||
125531043|NCT05000216|451574378|FG007|Stage 1|Other|2|||
125531044|NCT05000216|451574379|FG008|Stage 1|Other|0|||
125531045|NCT05000216|451574380|FG009|Stage 1|Other|0|||
125531046|NCT05000216|451574381|FG010|Stage 1|Other|1|||
125531047|NCT05000216|451574382|FG011|Stage 1|Other|1|||
125531048|NCT05000216|451574383|FG012|Stage 1|Other|0|||
125531049|NCT05000216|451574384|FG013|Stage 1|Other|0|||
125531050|NCT05000216|451574385|FG014|Stage 1|Other|0|||
125531051|NCT05000216|451574386|FG015|Stage 1|Other|0|||
125531052|NCT05000216|451574387|FG016|Stage 1|Other|0|||
125531053|NCT05000216|451574388|FG017|Stage 1|Other|0|||
125531054|NCT05000216|451574389|FG018|Stage 1|Other|0|||
125531055|NCT05000216|451574390|FG019|Stage 1|Other|0|||
125531056|NCT05000216|451574391|FG020|Stage 1|Other|0|||
125531057|NCT05000216|451574392|FG021|Stage 1|Other|0|||
125531058|NCT05000216|451574371|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
125531059|NCT05000216|451574372|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
125531060|NCT05000216|451574373|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
125531061|NCT05000216|451574374|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
125531062|NCT05000216|451574375|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
125531063|NCT05000216|451574376|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
125531064|NCT05000216|451574377|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
125531065|NCT05000216|451574378|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
125531066|NCT05000216|451574379|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
125531067|NCT05000216|451574380|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
125531068|NCT05000216|451574381|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
125531069|NCT05000216|451574382|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
125531070|NCT05000216|451574383|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
125531071|NCT05000216|451574384|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
125531072|NCT05000216|451574385|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
125531073|NCT05000216|451574386|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
125531074|NCT05000216|451574387|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
125531075|NCT05000216|451574388|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
125531076|NCT05000216|451574389|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
125531077|NCT05000216|451574390|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
125531078|NCT05000216|451574391|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
125531079|NCT05000216|451574392|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
125531080|NCT05000216|451574371|FG000|Stage 2|Lost to Follow-up|0|||
125531081|NCT05000216|451574372|FG001|Stage 2|Lost to Follow-up|0|||
125531082|NCT05000216|451574373|FG002|Stage 2|Lost to Follow-up|0|||
125531083|NCT05000216|451574374|FG003|Stage 2|Lost to Follow-up|0|||
125531084|NCT05000216|451574375|FG004|Stage 2|Lost to Follow-up|0|||
125531085|NCT05000216|451574376|FG005|Stage 2|Lost to Follow-up|0|||
125531086|NCT05000216|451574377|FG006|Stage 2|Lost to Follow-up|0|||
125531087|NCT05000216|451574378|FG007|Stage 2|Lost to Follow-up|0|||
125531088|NCT05000216|451574379|FG008|Stage 2|Lost to Follow-up|0|||
125531089|NCT05000216|451574380|FG009|Stage 2|Lost to Follow-up|0|||
125531090|NCT05000216|451574381|FG010|Stage 2|Lost to Follow-up|0|||
125531091|NCT05000216|451574382|FG011|Stage 2|Lost to Follow-up|0|||
125531092|NCT05000216|451574383|FG012|Stage 2|Lost to Follow-up|0|||
125531093|NCT05000216|451574384|FG013|Stage 2|Lost to Follow-up|0|||
125531094|NCT05000216|451574385|FG014|Stage 2|Lost to Follow-up|0|||
125531095|NCT05000216|451574386|FG015|Stage 2|Lost to Follow-up|0|||
125531096|NCT05000216|451574387|FG016|Stage 2|Lost to Follow-up|4|||
125531097|NCT05000216|451574388|FG017|Stage 2|Lost to Follow-up|0|||
125531098|NCT05000216|451574389|FG018|Stage 2|Lost to Follow-up|0|||
125531099|NCT05000216|451574390|FG019|Stage 2|Lost to Follow-up|0|||
125531100|NCT05000216|451574391|FG020|Stage 2|Lost to Follow-up|0|||
125531101|NCT05000216|451574392|FG021|Stage 2|Lost to Follow-up|0|||
125531102|NCT05000216|451574371|FG000|Stage 2|Physician Decision|0|||
125531103|NCT05000216|451574372|FG001|Stage 2|Physician Decision|0|||
125531104|NCT05000216|451574373|FG002|Stage 2|Physician Decision|0|||
125531105|NCT05000216|451574374|FG003|Stage 2|Physician Decision|0|||
125531106|NCT05000216|451574375|FG004|Stage 2|Physician Decision|0|||
125531107|NCT05000216|451574376|FG005|Stage 2|Physician Decision|0|||
125531108|NCT05000216|451574377|FG006|Stage 2|Physician Decision|0|||
125531109|NCT05000216|451574378|FG007|Stage 2|Physician Decision|0|||
125531110|NCT05000216|451574379|FG008|Stage 2|Physician Decision|0|||
125531111|NCT05000216|451574380|FG009|Stage 2|Physician Decision|0|||
125531112|NCT05000216|451574381|FG010|Stage 2|Physician Decision|0|||
125531113|NCT05000216|451574382|FG011|Stage 2|Physician Decision|0|||
125531114|NCT05000216|451574383|FG012|Stage 2|Physician Decision|1|||
125531115|NCT05000216|451574384|FG013|Stage 2|Physician Decision|0|||
125531116|NCT05000216|451574385|FG014|Stage 2|Physician Decision|0|||
125531117|NCT05000216|451574386|FG015|Stage 2|Physician Decision|0|||
125531118|NCT05000216|451574387|FG016|Stage 2|Physician Decision|0|||
125531119|NCT05000216|451574388|FG017|Stage 2|Physician Decision|0|||
125531120|NCT05000216|451574389|FG018|Stage 2|Physician Decision|0|||
125531121|NCT05000216|451574390|FG019|Stage 2|Physician Decision|0|||
125531122|NCT05000216|451574391|FG020|Stage 2|Physician Decision|0|||
125531123|NCT05000216|451574392|FG021|Stage 2|Physician Decision|0|||
125531124|NCT05000216|451574371|FG000|Stage 2|Withdrawal by Subject|0|||
125531125|NCT05000216|451574372|FG001|Stage 2|Withdrawal by Subject|0|||
125531126|NCT05000216|451574373|FG002|Stage 2|Withdrawal by Subject|0|||
125531127|NCT05000216|451574374|FG003|Stage 2|Withdrawal by Subject|0|||
125531128|NCT05000216|451574375|FG004|Stage 2|Withdrawal by Subject|0|||
125531129|NCT05000216|451574376|FG005|Stage 2|Withdrawal by Subject|0|||
125531130|NCT05000216|451574377|FG006|Stage 2|Withdrawal by Subject|0|||
125531131|NCT05000216|451574378|FG007|Stage 2|Withdrawal by Subject|0|||
125531132|NCT05000216|451574379|FG008|Stage 2|Withdrawal by Subject|0|||
125531133|NCT05000216|451574380|FG009|Stage 2|Withdrawal by Subject|0|||
125531134|NCT05000216|451574381|FG010|Stage 2|Withdrawal by Subject|0|||
125531135|NCT05000216|451574382|FG011|Stage 2|Withdrawal by Subject|0|||
125531136|NCT05000216|451574383|FG012|Stage 2|Withdrawal by Subject|0|||
125531137|NCT05000216|451574384|FG013|Stage 2|Withdrawal by Subject|0|||
125531138|NCT05000216|451574385|FG014|Stage 2|Withdrawal by Subject|2|||
125531139|NCT05000216|451574386|FG015|Stage 2|Withdrawal by Subject|0|||
125531140|NCT05000216|451574387|FG016|Stage 2|Withdrawal by Subject|9|||
125531141|NCT05000216|451574388|FG017|Stage 2|Withdrawal by Subject|0|||
125531142|NCT05000216|451574389|FG018|Stage 2|Withdrawal by Subject|0|||
125531143|NCT05000216|451574390|FG019|Stage 2|Withdrawal by Subject|0|||
125531144|NCT05000216|451574391|FG020|Stage 2|Withdrawal by Subject|0|||
125531145|NCT05000216|451574392|FG021|Stage 2|Withdrawal by Subject|0|||
125531146|NCT05000216|451574371|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
125531147|NCT05000216|451574372|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
125531148|NCT05000216|451574373|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
125531149|NCT05000216|451574374|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
125531150|NCT05000216|451574375|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
125531151|NCT05000216|451574376|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
125531152|NCT05000216|451574377|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
125531153|NCT05000216|451574378|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
125531154|NCT05000216|451574379|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
125531155|NCT05000216|451574380|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
125531156|NCT05000216|451574381|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
125531157|NCT05000216|451574382|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
125531158|NCT05000216|451574383|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
125531159|NCT05000216|451574384|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
125531160|NCT05000216|451574385|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
125531161|NCT05000216|451574386|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
125531162|NCT05000216|451574387|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
125531163|NCT05000216|451574388|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
125531164|NCT05000216|451574389|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
125531165|NCT05000216|451574390|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
125531166|NCT05000216|451574391|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
125531167|NCT05000216|451574392|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
125531168|NCT05000216|451574371|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531169|NCT05000216|451574372|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531170|NCT05000216|451574373|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531171|NCT05000216|451574374|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531172|NCT05000216|451574375|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531173|NCT05000216|451574376|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531174|NCT05000216|451574377|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531175|NCT05000216|451574378|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531176|NCT05000216|451574379|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531177|NCT05000216|451574380|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531178|NCT05000216|451574381|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531179|NCT05000216|451574382|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531180|NCT05000216|451574383|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531181|NCT05000216|451574384|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531182|NCT05000216|451574385|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
125531183|NCT05000216|451574386|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531184|NCT05000216|451574387|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
125531185|NCT05000216|451574388|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531186|NCT05000216|451574389|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531187|NCT05000216|451574390|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531188|NCT05000216|451574391|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531189|NCT05000216|451574392|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
125531190|NCT05000216|451574371|FG000|Stage 2|Other reason|0|||
125531191|NCT05000216|451574372|FG001|Stage 2|Other reason|0|||
125531192|NCT05000216|451574373|FG002|Stage 2|Other reason|0|||
125531193|NCT05000216|451574374|FG003|Stage 2|Other reason|0|||
125531194|NCT05000216|451574375|FG004|Stage 2|Other reason|0|||
125531195|NCT05000216|451574376|FG005|Stage 2|Other reason|0|||
125531196|NCT05000216|451574377|FG006|Stage 2|Other reason|0|||
125531197|NCT05000216|451574378|FG007|Stage 2|Other reason|0|||
125531198|NCT05000216|451574379|FG008|Stage 2|Other reason|0|||
125531199|NCT05000216|451574380|FG009|Stage 2|Other reason|0|||
125531200|NCT05000216|451574381|FG010|Stage 2|Other reason|0|||
125531201|NCT05000216|451574382|FG011|Stage 2|Other reason|0|||
125531202|NCT05000216|451574383|FG012|Stage 2|Other reason|0|||
125531203|NCT05000216|451574384|FG013|Stage 2|Other reason|0|||
125531204|NCT05000216|451574385|FG014|Stage 2|Other reason|0|||
125531205|NCT05000216|451574386|FG015|Stage 2|Other reason|0|||
125531206|NCT05000216|451574387|FG016|Stage 2|Other reason|1|||
125531207|NCT05000216|451574388|FG017|Stage 2|Other reason|0|||
125531208|NCT05000216|451574389|FG018|Stage 2|Other reason|0|||
125531209|NCT05000216|451574390|FG019|Stage 2|Other reason|0|||
125531210|NCT05000216|451574391|FG020|Stage 2|Other reason|0|||
125531211|NCT05000216|451574392|FG021|Stage 2|Other reason|0|||
125531212|NCT05000216|451574371|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
125531213|NCT05000216|451574372|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
125531214|NCT05000216|451574373|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
125531215|NCT05000216|451574374|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
125531216|NCT05000216|451574375|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
125531217|NCT05000216|451574376|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
125531218|NCT05000216|451574377|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
125531219|NCT05000216|451574378|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
125531220|NCT05000216|451574379|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
125531221|NCT05000216|451574380|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
125531222|NCT05000216|451574381|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
125531223|NCT05000216|451574382|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
125531224|NCT05000216|451574383|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
125531225|NCT05000216|451574384|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
125531226|NCT05000216|451574385|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
125531227|NCT05000216|451574386|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
125531228|NCT05000216|451574387|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
125531229|NCT05000216|451574388|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
125531230|NCT05000216|451574389|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
125531231|NCT05000216|451574390|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
125531232|NCT05000216|451574391|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
125531233|NCT05000216|451574392|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
125531234|NCT05000216|451574371|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531235|NCT05000216|451574372|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531236|NCT05000216|451574373|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531237|NCT05000216|451574374|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531238|NCT05000216|451574375|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531239|NCT05000216|451574376|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531240|NCT05000216|451574377|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531241|NCT05000216|451574378|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531242|NCT05000216|451574379|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531243|NCT05000216|451574380|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531244|NCT05000216|451574381|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531245|NCT05000216|451574382|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531246|NCT05000216|451574383|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531247|NCT05000216|451574384|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531248|NCT05000216|451574385|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531249|NCT05000216|451574386|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
125531250|NCT05000216|451574387|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531251|NCT05000216|451574388|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531252|NCT05000216|451574389|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531253|NCT05000216|451574390|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531254|NCT05000216|451574391|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531255|NCT05000216|451574392|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
125531256|NCT05000216|451574371|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531257|NCT05000216|451574372|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531258|NCT05000216|451574373|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531259|NCT05000216|451574374|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531260|NCT05000216|451574375|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531261|NCT05000216|451574376|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531262|NCT05000216|451574377|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531263|NCT05000216|451574378|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531264|NCT05000216|451574379|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531265|NCT05000216|451574380|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531266|NCT05000216|451574381|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531267|NCT05000216|451574382|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531268|NCT05000216|451574383|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531269|NCT05000216|451574384|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
125531270|NCT05000216|451574385|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531271|NCT05000216|451574386|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
125531272|NCT05000216|451574387|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531273|NCT05000216|451574388|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531274|NCT05000216|451574389|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
125531275|NCT05000216|451574390|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531276|NCT05000216|451574391|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531277|NCT05000216|451574392|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
125531278|NCT01572740|451574394|FG000|Overall Study|Adverse Event|1|||
125531279|NCT01572740|451574395|FG001|Overall Study|Adverse Event|1|||
125531280|NCT01572740|451574394|FG000|Overall Study|Withdrawal by Subject|1|||
125531281|NCT01572740|451574395|FG001|Overall Study|Withdrawal by Subject|1|||
125531282|NCT01572740|451574394|FG000|Overall Study|unclassified|4|||
125531283|NCT01572740|451574395|FG001|Overall Study|unclassified|3|||
125531284|NCT01289210|451574396|FG000|Overall Study|Adverse Event|1|||
125531285|NCT01110408|451574399|FG000|Overall Study|Protocol Violation|1|||
125531286|NCT01110408|451574400|FG001|Overall Study|Protocol Violation|0|||
125531287|NCT02269423|451574401|FG000|Overall Study|Discontinued due to change in residence|0|||
125531288|NCT02269423|451574402|FG001|Overall Study|Discontinued due to change in residence|1|||
125531289|NCT02269423|451574403|FG002|Overall Study|Discontinued due to change in residence|0|||
125531290|NCT02269423|451574404|FG003|Overall Study|Discontinued due to change in residence|1|||
125531291|NCT00839956|451574405|FG000|Overall Study|Adverse Event|2|||
125531292|NCT00839956|451574405|FG000|Overall Study|Lack of Efficacy|6|||
125531293|NCT00839956|451574405|FG000|Overall Study|Physician Decision|1|||
125531294|NCT00839956|451574405|FG000|Overall Study|Withdrawal by Subject|3|||
125531295|NCT01509547|451574406|FG000|Overall Study|Lost to Follow-up|24|||
125531296|NCT01509547|451574407|FG001|Overall Study|Lost to Follow-up|14|||
125531297|NCT01509547|451574406|FG000|Overall Study|Withdrawal by Subject|11|||
125531298|NCT01509547|451574407|FG001|Overall Study|Withdrawal by Subject|24|||
125531299|NCT01509547|451574406|FG000|Overall Study|Physician Decision|0|||
125531300|NCT01509547|451574407|FG001|Overall Study|Physician Decision|1|||
125531301|NCT00277095|451574408|FG000|Overall Study|Death|2|||
125531302|NCT00277095|451574408|FG000|Overall Study|Explanted|7|||
125531303|NCT00277095|451574408|FG000|Overall Study|Lost to Follow-up|2|||
125531304|NCT00277095|451574408|FG000|Overall Study|Missed Follow-up|9|||
125531305|NCT00277095|451574408|FG000|Overall Study|Physician Decision|1|||
125531306|NCT04147195|451574411|FG000|Overall Study|Adverse Event|0|||
125531307|NCT04147195|451574412|FG001|Overall Study|Adverse Event|3|||
125531308|NCT04147195|451574411|FG000|Overall Study|Study Terminated by Sponsor|4|||
125531309|NCT04147195|451574412|FG001|Overall Study|Study Terminated by Sponsor|2|||
125531310|NCT04147195|451574411|FG000|Overall Study|Withdrawal by Subject|0|||
125531311|NCT04147195|451574412|FG001|Overall Study|Withdrawal by Subject|1|||
125531312|NCT01424813|451574413|FG000|Overall Study|Withdrawal by Subject|3|||
125531313|NCT01424813|451574414|FG001|Overall Study|Withdrawal by Subject|0|||
125531314|NCT01424813|451574413|FG000|Overall Study|Protocol Violation|1|||
125531315|NCT01424813|451574414|FG001|Overall Study|Protocol Violation|0|||
125531316|NCT01424813|451574413|FG000|Overall Study|Other|1|||
125531317|NCT01424813|451574414|FG001|Overall Study|Other|2|||
125531318|NCT02614183|451574415|FG000|Double Blind Treatment Phase|Adverse Event|10|||
125531319|NCT02614183|451574416|FG001|Double Blind Treatment Phase|Adverse Event|9|||
125531320|NCT02614183|451574417|FG002|Double Blind Treatment Phase|Adverse Event|7|||
125531321|NCT02614183|451574415|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
125531322|NCT02614183|451574416|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
125531323|NCT02614183|451574417|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
125531324|NCT02614183|451574415|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
125531325|NCT02614183|451574416|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
125531326|NCT02614183|451574417|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
125531327|NCT02614183|451574415|FG000|Double Blind Treatment Phase|Physician Decision|7|||
125531328|NCT02614183|451574416|FG001|Double Blind Treatment Phase|Physician Decision|3|||
125531329|NCT02614183|451574417|FG002|Double Blind Treatment Phase|Physician Decision|2|||
125531330|NCT02614183|451574415|FG000|Double Blind Treatment Phase|Pregnancy|2|||
125531331|NCT02614183|451574416|FG001|Double Blind Treatment Phase|Pregnancy|1|||
125531332|NCT02614183|451574417|FG002|Double Blind Treatment Phase|Pregnancy|3|||
125531333|NCT02614183|451574415|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
125531334|NCT02614183|451574416|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
125531335|NCT02614183|451574417|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
125531336|NCT02614183|451574415|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
125531337|NCT02614183|451574416|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
125531338|NCT02614183|451574417|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
125531339|NCT02614183|451574415|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
125531340|NCT02614183|451574416|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
125531341|NCT02614183|451574417|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
125531342|NCT02614183|451574415|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
125531343|NCT02614183|451574416|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
125531344|NCT02614183|451574417|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
125531345|NCT02614183|451574415|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
125531346|NCT02614183|451574416|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
125531347|NCT02614183|451574417|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
125531348|NCT02614183|451574415|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
125531349|NCT02614183|451574416|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
125531350|NCT02614183|451574417|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
125531351|NCT02614183|451574415|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
125531352|NCT02614183|451574416|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
125531353|NCT02614183|451574417|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
125531354|NCT01006980|451576124|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
125531355|NCT01006980|451576125|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
125531356|NCT01006980|451576124|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
125531357|NCT01006980|451576125|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
125531358|NCT01006980|451576124|FG000|Vemurafenib and Dacarbazine|Death|13|||
125531359|NCT01006980|451576125|FG001|Vemurafenib and Dacarbazine|Death|12|||
125531360|NCT01006980|451576124|FG000|Vemurafenib and Dacarbazine|Progression|257|||
125531361|NCT01006980|451576125|FG001|Vemurafenib and Dacarbazine|Progression|218|||
125531362|NCT01006980|451576124|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
125531363|NCT01006980|451576125|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
125531364|NCT01006980|451576124|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
125531365|NCT01006980|451576125|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
125531366|NCT01006980|451576124|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
125531367|NCT01006980|451576125|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
125531368|NCT01006980|451576124|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
125531369|NCT01006980|451576125|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
125531370|NCT01006980|451576124|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
125531371|NCT01006980|451576125|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
125531372|NCT01006980|451576124|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
125531373|NCT01006980|451576125|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
125531374|NCT01006980|451576124|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
125531375|NCT01006980|451576125|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
125531376|NCT01006980|451576124|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
125531377|NCT01006980|451576125|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
125531378|NCT01006980|451576124|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
125531379|NCT01006980|451576125|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
125531380|NCT02706405|451576130|FG000|Overall Study|Death|3|||
125531381|NCT02706405|451576131|FG001|Overall Study|Death|2|||
125531382|NCT02706405|451576132|FG002|Overall Study|Death|0|||
125531383|NCT02706405|451576133|FG003|Overall Study|Death|1|||
125531384|NCT02706405|451576134|FG004|Overall Study|Death|0|||
125531385|NCT02706405|451576135|FG005|Overall Study|Death|0|||
125531386|NCT02706405|451576136|FG006|Overall Study|Death|3|||
125531387|NCT02706405|451576137|FG007|Overall Study|Death|4|||
125531388|NCT02706405|451576130|FG000|Overall Study|Disease progression|0|||
125531389|NCT02706405|451576131|FG001|Overall Study|Disease progression|0|||
125531390|NCT02706405|451576132|FG002|Overall Study|Disease progression|0|||
125531391|NCT02706405|451576133|FG003|Overall Study|Disease progression|0|||
125531392|NCT02706405|451576134|FG004|Overall Study|Disease progression|0|||
125531393|NCT02706405|451576135|FG005|Overall Study|Disease progression|0|||
125531394|NCT02706405|451576136|FG006|Overall Study|Disease progression|0|||
125531395|NCT02706405|451576137|FG007|Overall Study|Disease progression|1|||
125531396|NCT02706405|451576130|FG000|Overall Study|Pt moved to new therapy|0|||
125531397|NCT02706405|451576131|FG001|Overall Study|Pt moved to new therapy|0|||
125531398|NCT02706405|451576132|FG002|Overall Study|Pt moved to new therapy|0|||
125531399|NCT02706405|451576133|FG003|Overall Study|Pt moved to new therapy|0|||
125531400|NCT02706405|451576134|FG004|Overall Study|Pt moved to new therapy|0|||
125531401|NCT02706405|451576135|FG005|Overall Study|Pt moved to new therapy|1|||
125531402|NCT02706405|451576136|FG006|Overall Study|Pt moved to new therapy|0|||
125531403|NCT02706405|451576137|FG007|Overall Study|Pt moved to new therapy|1|||
125531404|NCT02706405|451576130|FG000|Overall Study|Physician Decision|1|||
125531405|NCT02706405|451576131|FG001|Overall Study|Physician Decision|0|||
125531406|NCT02706405|451576132|FG002|Overall Study|Physician Decision|0|||
125531407|NCT02706405|451576133|FG003|Overall Study|Physician Decision|0|||
125531408|NCT02706405|451576134|FG004|Overall Study|Physician Decision|0|||
125531409|NCT02706405|451576135|FG005|Overall Study|Physician Decision|0|||
125531410|NCT02706405|451576136|FG006|Overall Study|Physician Decision|0|||
125531411|NCT02706405|451576137|FG007|Overall Study|Physician Decision|0|||
125531412|NCT01182441|451576142|FG000|Overall Study|Patient Still in Follow-up|152|||
125531413|NCT01182441|451576143|FG001|Overall Study|Patient Still in Follow-up|72|||
125531414|NCT01182441|451576142|FG000|Overall Study|Death|37|||
125531415|NCT01182441|451576143|FG001|Overall Study|Death|25|||
125531416|NCT01182441|451576142|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
125531417|NCT01182441|451576143|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
125531418|NCT01182441|451576142|FG000|Overall Study|Lost to Follow-up|5|||
125531419|NCT01182441|451576143|FG001|Overall Study|Lost to Follow-up|8|||
125531420|NCT01182441|451576142|FG000|Overall Study|Withdrawal by Subject|6|||
125531421|NCT01182441|451576143|FG001|Overall Study|Withdrawal by Subject|13|||
125531422|NCT01182441|451576142|FG000|Overall Study|Implant Not Attempted|4|||
125531423|NCT01182441|451576143|FG001|Overall Study|Implant Not Attempted|0|||
125531424|NCT01182441|451576142|FG000|Overall Study|Adverse Event|2|||
125531425|NCT01182441|451576143|FG001|Overall Study|Adverse Event|0|||
125531426|NCT01182441|451576142|FG000|Overall Study|Physician Decision|1|||
125531427|NCT01182441|451576143|FG001|Overall Study|Physician Decision|1|||
125531428|NCT00603525|451576144|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
125531429|NCT00603525|451576145|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
125531430|NCT00603525|451576146|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
125531431|NCT00603525|451576144|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
125531432|NCT00603525|451576145|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
125531433|NCT00603525|451576146|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
125531434|NCT00603525|451576144|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
125531435|NCT00603525|451576145|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
125531436|NCT00603525|451576146|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
125531437|NCT00603525|451576144|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
125531438|NCT00603525|451576145|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
125531439|NCT00603525|451576146|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
125531440|NCT00603525|451576144|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
125531441|NCT00603525|451576145|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
125531442|NCT00603525|451576146|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
125531443|NCT00603525|451576144|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
125531444|NCT00603525|451576145|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
125531445|NCT00603525|451576146|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
125531446|NCT00603525|451576144|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
125531447|NCT00603525|451576145|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
125531448|NCT00603525|451576146|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
125531449|NCT00603525|451576144|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
125531450|NCT00603525|451576145|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
125531451|NCT00603525|451576146|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
125531452|NCT00603525|451576144|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
125531453|NCT00603525|451576145|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
125531454|NCT00603525|451576146|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
125531455|NCT00603525|451576144|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
125531456|NCT00603525|451576145|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
125531457|NCT00603525|451576146|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
125531458|NCT00603525|451576144|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
125531459|NCT00603525|451576145|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
125531460|NCT00603525|451576146|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
125531461|NCT00603525|451576144|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
125531462|NCT00603525|451576145|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
125531463|NCT00603525|451576146|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
125531464|NCT00603525|451576144|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
125531465|NCT00603525|451576145|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
125531466|NCT00603525|451576146|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
125531467|NCT00603525|451576144|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
125531468|NCT00603525|451576145|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
125531469|NCT00603525|451576146|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
125531470|NCT00603525|451576144|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
125531471|NCT00603525|451576145|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
125531472|NCT00603525|451576146|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
125531473|NCT02304705|451576147|FG000|Overall Study|Withdrawal by Subject|2|||
125531474|NCT02304705|451576148|FG001|Overall Study|Withdrawal by Subject|0|||
125531475|NCT02304705|451576147|FG000|Overall Study|Physician Decision|2|||
125531476|NCT02304705|451576148|FG001|Overall Study|Physician Decision|4|||
125531477|NCT02304705|451576147|FG000|Overall Study|Death|0|||
125531478|NCT02304705|451576148|FG001|Overall Study|Death|1|||
125531479|NCT02304705|451576147|FG000|Overall Study|Lost to Follow-up|0|||
125531480|NCT02304705|451576148|FG001|Overall Study|Lost to Follow-up|2|||
125531481|NCT02124811|451576149|FG000|Overall Study|Early termination|2|||
125531482|NCT02124811|451576150|FG001|Overall Study|Early termination|2|||
125531483|NCT02124811|451576149|FG000|Overall Study|Withdrawal by Subject|1|||
125531484|NCT02124811|451576150|FG001|Overall Study|Withdrawal by Subject|0|||
125531485|NCT03480932|451576151|FG000|Overall Study|Death|1|||
125531486|NCT03480932|451576152|FG001|Overall Study|Death|1|||
125531487|NCT03480932|451576153|FG002|Overall Study|Death|0|||
125531488|NCT03480932|451576151|FG000|Overall Study|Lost to Follow-up|0|||
125531489|NCT03480932|451576152|FG001|Overall Study|Lost to Follow-up|2|||
125531490|NCT03480932|451576153|FG002|Overall Study|Lost to Follow-up|3|||
125531491|NCT03480932|451576151|FG000|Overall Study|Incarcerated|2|||
125531492|NCT03480932|451576152|FG001|Overall Study|Incarcerated|2|||
125531493|NCT03480932|451576153|FG002|Overall Study|Incarcerated|2|||
125531494|NCT01174446|451576160|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
125531495|NCT01174446|451576161|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
125531496|NCT01174446|451576162|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
125531497|NCT01174446|451576163|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
125531498|NCT01174446|451576160|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
125531499|NCT01174446|451576161|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
125531500|NCT01174446|451576162|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
125531501|NCT01174446|451576163|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
125531502|NCT01174446|451576160|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
125531503|NCT01174446|451576161|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
125531504|NCT01174446|451576162|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
125531505|NCT01174446|451576163|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
125531506|NCT01174446|451576160|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
125531507|NCT01174446|451576161|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
125531508|NCT01174446|451576162|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
125531509|NCT01174446|451576163|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
125531510|NCT00847626|451576166|FG000|Overall Study|Adverse Event|10|||
125531511|NCT00847626|451576167|FG001|Overall Study|Adverse Event|10|||
125531512|NCT00847626|451576168|FG002|Overall Study|Adverse Event|6|||
125531513|NCT00847626|451576169|FG003|Overall Study|Adverse Event|19|||
125531514|NCT00847626|451576170|FG004|Overall Study|Adverse Event|11|||
125531515|NCT00847626|451576171|FG005|Overall Study|Adverse Event|22|||
125531516|NCT00847626|451576172|FG006|Overall Study|Adverse Event|4|||
125531517|NCT00847626|451576173|FG007|Overall Study|Adverse Event|6|||
125531518|NCT00847626|451576174|FG008|Overall Study|Adverse Event|3|||
125531519|NCT00847626|451576175|FG009|Overall Study|Adverse Event|6|||
125531520|NCT00847626|451576176|FG010|Overall Study|Adverse Event|6|||
125531521|NCT00847626|451576166|FG000|Overall Study|Protocol Violation|2|||
125531522|NCT00847626|451576167|FG001|Overall Study|Protocol Violation|1|||
125531523|NCT00847626|451576168|FG002|Overall Study|Protocol Violation|2|||
125531524|NCT00847626|451576169|FG003|Overall Study|Protocol Violation|1|||
125531525|NCT00847626|451576170|FG004|Overall Study|Protocol Violation|1|||
125531526|NCT00847626|451576171|FG005|Overall Study|Protocol Violation|1|||
125531527|NCT00847626|451576172|FG006|Overall Study|Protocol Violation|1|||
125531528|NCT00847626|451576173|FG007|Overall Study|Protocol Violation|1|||
125531529|NCT00847626|451576174|FG008|Overall Study|Protocol Violation|0|||
125531530|NCT00847626|451576175|FG009|Overall Study|Protocol Violation|1|||
125531531|NCT00847626|451576176|FG010|Overall Study|Protocol Violation|1|||
125531532|NCT00847626|451576166|FG000|Overall Study|Lost to Follow-up|0|||
125531533|NCT00847626|451576167|FG001|Overall Study|Lost to Follow-up|1|||
125531534|NCT00847626|451576168|FG002|Overall Study|Lost to Follow-up|1|||
125531535|NCT00847626|451576169|FG003|Overall Study|Lost to Follow-up|1|||
125531536|NCT00847626|451576170|FG004|Overall Study|Lost to Follow-up|0|||
125531537|NCT00847626|451576171|FG005|Overall Study|Lost to Follow-up|3|||
125531538|NCT00847626|451576172|FG006|Overall Study|Lost to Follow-up|1|||
125531539|NCT00847626|451576173|FG007|Overall Study|Lost to Follow-up|3|||
125531540|NCT00847626|451576174|FG008|Overall Study|Lost to Follow-up|1|||
125531541|NCT00847626|451576175|FG009|Overall Study|Lost to Follow-up|0|||
125531542|NCT00847626|451576176|FG010|Overall Study|Lost to Follow-up|1|||
125531543|NCT00847626|451576166|FG000|Overall Study|Withdrawal by Subject|5|||
125531544|NCT00847626|451576167|FG001|Overall Study|Withdrawal by Subject|5|||
125531545|NCT00847626|451576168|FG002|Overall Study|Withdrawal by Subject|3|||
125531546|NCT00847626|451576169|FG003|Overall Study|Withdrawal by Subject|8|||
125531547|NCT00847626|451576170|FG004|Overall Study|Withdrawal by Subject|12|||
125531548|NCT00847626|451576171|FG005|Overall Study|Withdrawal by Subject|9|||
125531549|NCT00847626|451576172|FG006|Overall Study|Withdrawal by Subject|8|||
125531550|NCT00847626|451576173|FG007|Overall Study|Withdrawal by Subject|4|||
125531551|NCT00847626|451576174|FG008|Overall Study|Withdrawal by Subject|4|||
125531552|NCT00847626|451576175|FG009|Overall Study|Withdrawal by Subject|5|||
125531553|NCT00847626|451576176|FG010|Overall Study|Withdrawal by Subject|2|||
125531554|NCT00847626|451576166|FG000|Overall Study|Lack of Efficacy|3|||
125531555|NCT00847626|451576167|FG001|Overall Study|Lack of Efficacy|1|||
125531556|NCT00847626|451576168|FG002|Overall Study|Lack of Efficacy|0|||
125531557|NCT00847626|451576169|FG003|Overall Study|Lack of Efficacy|1|||
125531558|NCT00847626|451576170|FG004|Overall Study|Lack of Efficacy|2|||
125531559|NCT00847626|451576171|FG005|Overall Study|Lack of Efficacy|0|||
125531560|NCT00847626|451576172|FG006|Overall Study|Lack of Efficacy|6|||
125531561|NCT00847626|451576173|FG007|Overall Study|Lack of Efficacy|2|||
125531562|NCT00847626|451576174|FG008|Overall Study|Lack of Efficacy|5|||
125531563|NCT00847626|451576175|FG009|Overall Study|Lack of Efficacy|1|||
125531564|NCT00847626|451576176|FG010|Overall Study|Lack of Efficacy|7|||
125531565|NCT00847626|451576166|FG000|Overall Study|Other|1|||
125531566|NCT00847626|451576167|FG001|Overall Study|Other|5|||
125531567|NCT00847626|451576168|FG002|Overall Study|Other|4|||
125531568|NCT00847626|451576169|FG003|Overall Study|Other|1|||
125531569|NCT00847626|451576170|FG004|Overall Study|Other|2|||
125531570|NCT00847626|451576171|FG005|Overall Study|Other|2|||
125531571|NCT00847626|451576172|FG006|Overall Study|Other|2|||
125531572|NCT00847626|451576173|FG007|Overall Study|Other|3|||
125531573|NCT00847626|451576174|FG008|Overall Study|Other|1|||
125531574|NCT00847626|451576175|FG009|Overall Study|Other|1|||
125531575|NCT00847626|451576176|FG010|Overall Study|Other|3|||
125531576|NCT03057847|451576177|FG000|Overall Study|Lost to Follow-up|16|||
125531577|NCT02138786|451576178|FG000|Overall Study|Adverse Event|0|||
125531578|NCT02138786|451576179|FG001|Overall Study|Adverse Event|2|||
125531579|NCT02138786|451576180|FG002|Overall Study|Adverse Event|1|||
125531580|NCT02138786|451576178|FG000|Overall Study|Death|1|||
125531581|NCT02138786|451576179|FG001|Overall Study|Death|7|||
125531582|NCT02138786|451576180|FG002|Overall Study|Death|2|||
125531583|NCT02138786|451576178|FG000|Overall Study|Disease Progression|1|||
125531584|NCT02138786|451576179|FG001|Overall Study|Disease Progression|1|||
125531585|NCT02138786|451576180|FG002|Overall Study|Disease Progression|3|||
125531586|NCT02138786|451576178|FG000|Overall Study|Withdrawal by Subject|1|||
125531587|NCT02138786|451576179|FG001|Overall Study|Withdrawal by Subject|2|||
125531588|NCT02138786|451576180|FG002|Overall Study|Withdrawal by Subject|0|||
125531589|NCT02138786|451576178|FG000|Overall Study|Patient's Wish|0|||
125531590|NCT02138786|451576179|FG001|Overall Study|Patient's Wish|2|||
125531591|NCT02138786|451576180|FG002|Overall Study|Patient's Wish|0|||
125531592|NCT02138786|451576178|FG000|Overall Study|Sponsor Terminated Study|0|||
125531593|NCT02138786|451576179|FG001|Overall Study|Sponsor Terminated Study|1|||
125531594|NCT02138786|451576180|FG002|Overall Study|Sponsor Terminated Study|1|||
125531595|NCT02138786|451576178|FG000|Overall Study|Non-Compliance|0|||
125531596|NCT02138786|451576179|FG001|Overall Study|Non-Compliance|0|||
125531597|NCT02138786|451576180|FG002|Overall Study|Non-Compliance|1|||
125531598|NCT01923662|451576181|FG000|Overall Study|Withdrawal by Subject|1|||
125531599|NCT00659880|451576182|FG000|Overall Study|Lost to Follow-up|5|||
125531600|NCT00669877|451576189|FG000|Overall Study|Disease Progression/Death|4|||
125531601|NCT01465763|451576190|FG000|Overall Study|Withdrawal by Subject|4|||
125531602|NCT01465763|451576191|FG001|Overall Study|Withdrawal by Subject|0|||
125531603|NCT01465763|451576192|FG002|Overall Study|Withdrawal by Subject|1|||
125531604|NCT01465763|451576190|FG000|Overall Study|Insufficient Clinical Response|11|||
125531605|NCT01465763|451576191|FG001|Overall Study|Insufficient Clinical Response|0|||
125531606|NCT01465763|451576192|FG002|Overall Study|Insufficient Clinical Response|1|||
125531607|NCT01465763|451576190|FG000|Overall Study|Adverse Event|9|||
125531608|NCT01465763|451576191|FG001|Overall Study|Adverse Event|0|||
125531609|NCT01465763|451576192|FG002|Overall Study|Adverse Event|1|||
125531610|NCT01465763|451576190|FG000|Overall Study|Other|2|||
125531611|NCT01465763|451576191|FG001|Overall Study|Other|0|||
125531612|NCT01465763|451576192|FG002|Overall Study|Other|0|||
125531613|NCT01465763|451576190|FG000|Overall Study|Protocol Violation|4|||
125531614|NCT01465763|451576191|FG001|Overall Study|Protocol Violation|1|||
125531615|NCT01465763|451576192|FG002|Overall Study|Protocol Violation|1|||
125531616|NCT01465763|451576190|FG000|Overall Study|Death|1|||
125531617|NCT01465763|451576191|FG001|Overall Study|Death|0|||
125531618|NCT01465763|451576192|FG002|Overall Study|Death|0|||
125531619|NCT02920970|451576193|FG000|First Intervention|Protocol Violation|0|||
125531620|NCT02920970|451576194|FG001|First Intervention|Protocol Violation|1|||
125531621|NCT02920970|451576193|FG000|First Intervention|Adverse Event|0|||
125531622|NCT02920970|451576194|FG001|First Intervention|Adverse Event|1|||
125531623|NCT02920970|451576193|FG000|Second Intervention|Poor Lens Fit|1|||
125531624|NCT02920970|451576194|FG001|Second Intervention|Poor Lens Fit|0|||
125531625|NCT01711853|451576196|FG000|Overall Study|Not treated|3|||
125531626|NCT02992691|451576201|FG000|Overall Study|Adverse Event|2|||
125531627|NCT02992691|451576201|FG000|Overall Study|Withdrawal by Subject|1|||
125531628|NCT01427725|451576202|FG000|Overall Study|Lost to Follow-up|17|||
125531629|NCT01427725|451576202|FG000|Overall Study|Protocol Violation|1|||
125531630|NCT01427725|451576202|FG000|Overall Study|Drug not administered|1|||
125531631|NCT01427725|451576202|FG000|Overall Study|Failure to visit|7|||
125531632|NCT01427725|451576202|FG000|Overall Study|Adverse Event|46|||
125531633|NCT01427725|451576202|FG000|Overall Study|Failure to visit after administration|40|||
125531634|NCT01427725|451576202|FG000|Overall Study|Patient's rejection|27|||
125531635|NCT01427725|451576202|FG000|Overall Study|Transfer to a different hospital|17|||
125531636|NCT01427725|451576202|FG000|Overall Study|Lack of Efficacy|8|||
125531637|NCT01427725|451576202|FG000|Overall Study|Death|7|||
125531638|NCT01427725|451576202|FG000|Overall Study|Symptom improvement|6|||
125531639|NCT01427725|451576202|FG000|Overall Study|AE and Patient's rejection|5|||
125531640|NCT01427725|451576202|FG000|Overall Study|Physician Decision|5|||
125531641|NCT01427725|451576202|FG000|Overall Study|Exacerbation of underlying disease|5|||
125531642|NCT01427725|451576202|FG000|Overall Study|Oral feeding difficulty|5|||
125531643|NCT01427725|451576202|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
125531644|NCT01427725|451576202|FG000|Overall Study|Forgetting prescription|1|||
125531645|NCT01427725|451576202|FG000|Overall Study|Other|2|||
125531646|NCT04276051|451576204|FG000|Overall Study|Lost to Follow-up|0|||
125531647|NCT04276051|451576205|FG001|Overall Study|Lost to Follow-up|1|||
125531648|NCT04276051|451576204|FG000|Overall Study|Physician Decision|0|||
125531649|NCT04276051|451576205|FG001|Overall Study|Physician Decision|1|||
125531650|NCT04276051|451576204|FG000|Overall Study|Withdrawal by Subject|1|||
125531651|NCT04276051|451576205|FG001|Overall Study|Withdrawal by Subject|1|||
125531652|NCT00392925|451576206|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
125531653|NCT00392925|451576207|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
125531654|NCT00392925|451576208|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
125531655|NCT00392925|451576209|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
125531656|NCT00392925|451576206|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
125531657|NCT00392925|451576207|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
125531658|NCT00392925|451576208|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
125531659|NCT00392925|451576209|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
125531660|NCT00392925|451576206|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
125531661|NCT00392925|451576207|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
125531662|NCT00392925|451576208|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
125531663|NCT00392925|451576209|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
125531664|NCT00392925|451576206|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
125531665|NCT00392925|451576207|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
125531666|NCT00392925|451576208|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
125531667|NCT00392925|451576209|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
125531668|NCT00392925|451576206|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
125531669|NCT00392925|451576207|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
125531670|NCT00392925|451576208|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
125531671|NCT00392925|451576209|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
125531672|NCT00392925|451576206|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
125531673|NCT00392925|451576207|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
125531674|NCT00392925|451576208|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
125531675|NCT00392925|451576209|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
125531676|NCT00392925|451576206|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
125531677|NCT00392925|451576207|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
125531678|NCT00392925|451576208|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
125531679|NCT00392925|451576209|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
125531680|NCT00392925|451576206|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
125531681|NCT00392925|451576207|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
125531682|NCT00392925|451576208|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
125531683|NCT00392925|451576209|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
125531684|NCT00392925|451576206|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
125531685|NCT00392925|451576207|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
125531686|NCT00392925|451576208|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
125531687|NCT00392925|451576209|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
125531688|NCT00755105|451576215|FG000|Overall Study|Withdrawal by Subject|9|||
125531689|NCT00755105|451576216|FG001|Overall Study|Withdrawal by Subject|11|||
125531690|NCT00755105|451576217|FG002|Overall Study|Withdrawal by Subject|4|||
125531691|NCT01281839|451576219|FG000|Overall Study|Lost to Follow-up|6|||
125531692|NCT01281839|451576220|FG001|Overall Study|Lost to Follow-up|3|||
125531693|NCT01281839|451576219|FG000|Overall Study|Withdrawal by Subject|4|||
125531694|NCT01281839|451576220|FG001|Overall Study|Withdrawal by Subject|10|||
125531695|NCT01281839|451576219|FG000|Overall Study|Reason not specified|0|||
125531696|NCT01281839|451576220|FG001|Overall Study|Reason not specified|1|||
125531697|NCT01277887|451576221|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
125531698|NCT01277887|451576222|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
125531699|NCT01277887|451576221|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
125533008|NCT04047862|451581438|FG016|Overall Study|Physician Decision|1|||
125531700|NCT01277887|451576222|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
125531701|NCT01277887|451576221|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
125531702|NCT01277887|451576222|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
125531703|NCT00415051|451576224|FG000|Overall Study|Protocol Violation|1|||
125531704|NCT00780559|451576227|FG000|Overall Study|Lost to Follow-up|2|||
125531705|NCT00780559|451576228|FG001|Overall Study|Lost to Follow-up|7|||
125531706|NCT00780559|451576227|FG000|Overall Study|Death|1|||
125531707|NCT00780559|451576228|FG001|Overall Study|Death|0|||
125531708|NCT04462289|451576231|FG000|Overall Study|Lost to Follow-up|4|||
125531709|NCT04462289|451576232|FG001|Overall Study|Lost to Follow-up|5|||
125531710|NCT04462289|451576231|FG000|Overall Study|Death|0|||
125531711|NCT04462289|451576232|FG001|Overall Study|Death|3|||
125531712|NCT04462289|451576231|FG000|Overall Study|Withdrawal by Subject|1|||
125531713|NCT04462289|451576232|FG001|Overall Study|Withdrawal by Subject|3|||
125531714|NCT01518153|451576233|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
125531715|NCT01518153|451576234|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
125531716|NCT01518153|451576235|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
125531717|NCT01518153|451576233|FG000|Stem Cell Transplant|Death|2|||
125531718|NCT01518153|451576234|FG001|Stem Cell Transplant|Death|0|||
125531719|NCT01518153|451576235|FG002|Stem Cell Transplant|Death|0|||
125531720|NCT01518153|451576233|FG000|Stem Cell Transplant|Secondary graft failure|1|||
125531721|NCT01518153|451576234|FG001|Stem Cell Transplant|Secondary graft failure|0|||
125531722|NCT01518153|451576235|FG002|Stem Cell Transplant|Secondary graft failure|0|||
125531723|NCT01518153|451576233|FG000|Stem Cell Transplant|Adverse Event|1|||
125531724|NCT01518153|451576234|FG001|Stem Cell Transplant|Adverse Event|0|||
125531725|NCT01518153|451576235|FG002|Stem Cell Transplant|Adverse Event|0|||
125531726|NCT01518153|451576233|FG000|Donor Lymphocyte Infusion|Death|0|||
125531727|NCT01518153|451576234|FG001|Donor Lymphocyte Infusion|Death|2|||
125531728|NCT01518153|451576235|FG002|Donor Lymphocyte Infusion|Death|1|||
125531729|NCT00856245|451576236|FG000|Overall Study|Was not transplanted|5|||
125531730|NCT01250509|451576237|FG000|Overall Study|Lost to Follow-up|5|||
125531731|NCT01250509|451576238|FG001|Overall Study|Lost to Follow-up|2|||
125531732|NCT00203268|451576247|FG000|Early Treatment|only treated one headache|2|||
125531733|NCT00203268|451576247|FG000|Early Treatment|Lost to Follow-up|1|||
125531734|NCT00203268|451576247|FG000|Early Treatment|Withdrawal by Subject|1|||
125531735|NCT00600613|451576248|FG000|Overall Study|Protocol Deviation|1|||
125531736|NCT02807883|451576250|FG000|Overall Study|Withdrawal by Subject|2|||
125531737|NCT02514551|451576253|FG000|Overall Study|Lost to Follow-up|0|||
125531738|NCT02514551|451576254|FG001|Overall Study|Lost to Follow-up|1|||
125531739|NCT02514551|451576253|FG000|Overall Study|Participant Never Treated|0|||
125531740|NCT02514551|451576254|FG001|Overall Study|Participant Never Treated|2|||
125531741|NCT02998476|451576275|FG000|Overall Study|Lost to Follow-up|1|||
125531742|NCT02998476|451576276|FG001|Overall Study|Lost to Follow-up|0|||
125531743|NCT02998476|451576275|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
125531744|NCT02998476|451576276|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
125531745|NCT02998476|451576275|FG000|Overall Study|Withdrawal by Subject|1|||
125531746|NCT02998476|451576276|FG001|Overall Study|Withdrawal by Subject|2|||
125531747|NCT02998476|451576275|FG000|Overall Study|Death|45|||
125531748|NCT02998476|451576276|FG001|Overall Study|Death|2|||
125531749|NCT02998476|451576275|FG000|Overall Study|Other|6|||
125531750|NCT02998476|451576276|FG001|Overall Study|Other|1|||
125531751|NCT03832595|451576277|FG000|Overall Study|Death|142|||
125531752|NCT03832595|451576278|FG001|Overall Study|Death|130|||
125531753|NCT03832595|451576277|FG000|Overall Study|Medical management without dialysis|37|||
125531754|NCT03832595|451576278|FG001|Overall Study|Medical management without dialysis|1|||
125531755|NCT03277352|451576279|FG000|Overall Study|Study Terminated By Sponsor|2|||
125531756|NCT03277352|451576279|FG000|Overall Study|Withdrawal by Subject|4|||
125531757|NCT03277352|451576279|FG000|Overall Study|Death|4|||
125531758|NCT02397447|451576280|FG000|Overall Study|Lost to Follow-up|2|||
125531759|NCT02397447|451576281|FG001|Overall Study|Lost to Follow-up|2|||
125531760|NCT01435772|451576282|FG000|Overall Study|Adverse Event|1|||
125531761|NCT01435772|451576283|FG001|Overall Study|Adverse Event|0|||
125531762|NCT01435772|451576284|FG002|Overall Study|Adverse Event|2|||
125531763|NCT01435772|451576282|FG000|Overall Study|Withdrawal by Subject|0|||
125531764|NCT01435772|451576283|FG001|Overall Study|Withdrawal by Subject|1|||
125531765|NCT01435772|451576284|FG002|Overall Study|Withdrawal by Subject|3|||
125531766|NCT01435772|451576282|FG000|Overall Study|Other - study termination|2|||
125531767|NCT01435772|451576283|FG001|Overall Study|Other - study termination|2|||
125531768|NCT01435772|451576284|FG002|Overall Study|Other - study termination|10|||
125531769|NCT03238963|451576285|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
125531770|NCT03238963|451576286|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
125531771|NCT03238963|451576285|FG000|Overall Study|Withdrawal by Subject|1|||
125531772|NCT03238963|451576286|FG001|Overall Study|Withdrawal by Subject|1|||
125531773|NCT03238963|451576285|FG000|Overall Study|Lost to Follow-up|1|||
125531774|NCT03238963|451576286|FG001|Overall Study|Lost to Follow-up|0|||
125531775|NCT03238963|451576285|FG000|Overall Study|Protocol Violation|1|||
125531776|NCT03238963|451576286|FG001|Overall Study|Protocol Violation|1|||
125531777|NCT03238963|451576285|FG000|Overall Study|Adverse Event|1|||
125531778|NCT03238963|451576286|FG001|Overall Study|Adverse Event|0|||
125531779|NCT03838731|451578342|FG000|Overall Study|Pregnancy|0|||
125531780|NCT03838731|451578343|FG001|Overall Study|Pregnancy|1|||
125531781|NCT03838731|451578342|FG000|Overall Study|Withdrawal of consent|1|||
125531782|NCT03838731|451578343|FG001|Overall Study|Withdrawal of consent|0|||
125531783|NCT01195948|451578349|FG000|Overall Study|Lost to Follow-up|0|||
125531784|NCT01195948|451578350|FG001|Overall Study|Lost to Follow-up|1|||
125531785|NCT01195948|451578351|FG002|Overall Study|Lost to Follow-up|2|||
125531786|NCT00770029|451578352|FG000|Overall Study|Lost to Follow-up|2|||
125531787|NCT00770029|451578353|FG001|Overall Study|Lost to Follow-up|0|||
125531788|NCT00770029|451578352|FG000|Overall Study|Withdrawal by Subject|3|||
125531789|NCT00770029|451578353|FG001|Overall Study|Withdrawal by Subject|3|||
125531790|NCT00770029|451578352|FG000|Overall Study|Adverse Event|1|||
125531791|NCT00770029|451578353|FG001|Overall Study|Adverse Event|0|||
125531792|NCT03809039|451578356|FG000|Part 1|Withdrawal by Subject|1|||
125531793|NCT03809039|451578357|FG001|Part 1|Withdrawal by Subject|0|||
125531794|NCT03809039|451578358|FG002|Part 1|Withdrawal by Subject|0|||
125531795|NCT03809039|451578359|FG003|Part 1|Withdrawal by Subject|1|||
125531796|NCT03809039|451578360|FG004|Part 1|Withdrawal by Subject|0|||
125531797|NCT03809039|451578361|FG005|Part 1|Withdrawal by Subject|0|||
125531798|NCT03809039|451578362|FG006|Part 1|Withdrawal by Subject|0|||
125531799|NCT03809039|451578363|FG007|Part 1|Withdrawal by Subject|0|||
125531800|NCT03809039|451578364|FG008|Part 1|Withdrawal by Subject|0|||
125531801|NCT03809039|451578356|FG000|Part 3|Withdrawn by study termination|0|||
125531802|NCT03809039|451578357|FG001|Part 3|Withdrawn by study termination|0|||
125531803|NCT03809039|451578358|FG002|Part 3|Withdrawn by study termination|0|||
125531804|NCT03809039|451578359|FG003|Part 3|Withdrawn by study termination|0|||
125531805|NCT03809039|451578360|FG004|Part 3|Withdrawn by study termination|0|||
125531806|NCT03809039|451578361|FG005|Part 3|Withdrawn by study termination|0|||
125531807|NCT03809039|451578362|FG006|Part 3|Withdrawn by study termination|0|||
125531808|NCT03809039|451578363|FG007|Part 3|Withdrawn by study termination|2|||
125531809|NCT03809039|451578364|FG008|Part 3|Withdrawn by study termination|6|||
125531810|NCT05627258|451578365|FG000|Overall Study|Lost to Follow-up|1|||
125531811|NCT05627258|451578366|FG001|Overall Study|Lost to Follow-up|0|||
125531812|NCT05627258|451578367|FG002|Overall Study|Lost to Follow-up|0|||
125531813|NCT05627258|451578368|FG003|Overall Study|Lost to Follow-up|0|||
125531814|NCT05627258|451578369|FG004|Overall Study|Lost to Follow-up|0|||
125531815|NCT05627258|451578370|FG005|Overall Study|Lost to Follow-up|0|||
125531816|NCT05627258|451578365|FG000|Overall Study|Withdrawal by Subject|0|||
125531817|NCT05627258|451578366|FG001|Overall Study|Withdrawal by Subject|0|||
125531818|NCT05627258|451578367|FG002|Overall Study|Withdrawal by Subject|0|||
125531819|NCT05627258|451578368|FG003|Overall Study|Withdrawal by Subject|0|||
125531820|NCT05627258|451578369|FG004|Overall Study|Withdrawal by Subject|2|||
125531821|NCT05627258|451578370|FG005|Overall Study|Withdrawal by Subject|0|||
125531822|NCT05627258|451578365|FG000|Overall Study|Enrolled, but product not administered|1|||
125531823|NCT05627258|451578366|FG001|Overall Study|Enrolled, but product not administered|0|||
125531824|NCT05627258|451578367|FG002|Overall Study|Enrolled, but product not administered|0|||
125531825|NCT05627258|451578368|FG003|Overall Study|Enrolled, but product not administered|0|||
125531826|NCT05627258|451578369|FG004|Overall Study|Enrolled, but product not administered|0|||
125531827|NCT05627258|451578370|FG005|Overall Study|Enrolled, but product not administered|0|||
125531828|NCT05627258|451578365|FG000|Overall Study|Other subject illness/injury|1|||
125531829|NCT05627258|451578366|FG001|Overall Study|Other subject illness/injury|0|||
125531830|NCT05627258|451578367|FG002|Overall Study|Other subject illness/injury|0|||
125531831|NCT05627258|451578368|FG003|Overall Study|Other subject illness/injury|0|||
125531832|NCT05627258|451578369|FG004|Overall Study|Other subject illness/injury|0|||
125531833|NCT05627258|451578370|FG005|Overall Study|Other subject illness/injury|0|||
125531834|NCT05627258|451578365|FG000|Overall Study|Subject moved from area|0|||
125531835|NCT05627258|451578366|FG001|Overall Study|Subject moved from area|0|||
125531836|NCT05627258|451578367|FG002|Overall Study|Subject moved from area|1|||
125531837|NCT05627258|451578368|FG003|Overall Study|Subject moved from area|0|||
125531838|NCT05627258|451578369|FG004|Overall Study|Subject moved from area|0|||
125531839|NCT05627258|451578370|FG005|Overall Study|Subject moved from area|0|||
125531840|NCT01199068|451578373|FG000|Overall Study|Unacceptable toxicity|0|||
125531841|NCT01199068|451578374|FG001|Overall Study|Unacceptable toxicity|0|||
125531842|NCT01199068|451578375|FG002|Overall Study|Unacceptable toxicity|2|||
125531843|NCT01199068|451578373|FG000|Overall Study|Progressive disease|3|||
125531844|NCT01199068|451578374|FG001|Overall Study|Progressive disease|3|||
125531845|NCT01199068|451578375|FG002|Overall Study|Progressive disease|6|||
125531846|NCT01199068|451578373|FG000|Overall Study|Withdrawal by Subject|0|||
125531847|NCT01199068|451578374|FG001|Overall Study|Withdrawal by Subject|0|||
125531848|NCT01199068|451578375|FG002|Overall Study|Withdrawal by Subject|1|||
125531849|NCT01294397|451578376|FG000|Overall Study|Withdrawal by Subject|1|||
125531850|NCT01294397|451578376|FG000|Overall Study|Administrative Decision|1|||
125531851|NCT01250925|451578377|FG000|Overall Study|Lost to Follow-up|1|||
125531852|NCT01250925|451578378|FG001|Overall Study|Lost to Follow-up|1|||
125531853|NCT01250925|451578379|FG002|Overall Study|Lost to Follow-up|0|||
125531854|NCT01250925|451578377|FG000|Overall Study|Withdrawal by Subject|2|||
125531855|NCT01250925|451578378|FG001|Overall Study|Withdrawal by Subject|0|||
125531856|NCT01250925|451578379|FG002|Overall Study|Withdrawal by Subject|0|||
125531857|NCT01250925|451578377|FG000|Overall Study|Protocol Violation|2|||
125531858|NCT01250925|451578378|FG001|Overall Study|Protocol Violation|0|||
125531859|NCT01250925|451578379|FG002|Overall Study|Protocol Violation|0|||
125531860|NCT01250925|451578377|FG000|Overall Study|Physician Decision|0|||
125531861|NCT01250925|451578378|FG001|Overall Study|Physician Decision|2|||
125531862|NCT01250925|451578379|FG002|Overall Study|Physician Decision|1|||
125531863|NCT01250925|451578377|FG000|Overall Study|Adverse Event|0|||
125531864|NCT01250925|451578378|FG001|Overall Study|Adverse Event|0|||
125531865|NCT01250925|451578379|FG002|Overall Study|Adverse Event|1|||
125531866|NCT00678301|451578380|FG000|Overall Study|Non-compliance with study procedures|0|||
125531867|NCT00678301|451578381|FG001|Overall Study|Non-compliance with study procedures|1|||
125531868|NCT00678301|451578380|FG000|Overall Study|Adverse Event|1|||
125531869|NCT00678301|451578381|FG001|Overall Study|Adverse Event|0|||
125531870|NCT00678301|451578380|FG000|Overall Study|Withdrawal by Subject|4|||
125531871|NCT00678301|451578381|FG001|Overall Study|Withdrawal by Subject|0|||
125531872|NCT00678301|451578380|FG000|Overall Study|Lost to Follow-up|3|||
125531873|NCT00678301|451578381|FG001|Overall Study|Lost to Follow-up|1|||
125531874|NCT03338296|451578382|FG000|Overall Study|Adverse Event|0|||
125531875|NCT03338296|451578383|FG001|Overall Study|Adverse Event|1|||
125531876|NCT03338296|451578382|FG000|Overall Study|Withdrawal by Subject|14|||
125531877|NCT03338296|451578383|FG001|Overall Study|Withdrawal by Subject|13|||
125531878|NCT03338296|451578382|FG000|Overall Study|Lost to Follow-up|10|||
125531879|NCT03338296|451578383|FG001|Overall Study|Lost to Follow-up|10|||
125531880|NCT03338296|451578382|FG000|Overall Study|Study Terminated by Sponsor|77|||
125531881|NCT03338296|451578383|FG001|Overall Study|Study Terminated by Sponsor|76|||
125531882|NCT03338296|451578382|FG000|Overall Study|Other|2|||
125531883|NCT03338296|451578383|FG001|Overall Study|Other|7|||
125531884|NCT03338296|451578382|FG000|Overall Study|Missing|0|||
125531885|NCT03338296|451578383|FG001|Overall Study|Missing|1|||
125531886|NCT04421950|451578384|FG000|Overall Study|Dropped or lost to follow up|4|||
125531887|NCT04421950|451578385|FG001|Overall Study|Dropped or lost to follow up|2|||
125531888|NCT01252355|451578387|FG000|Overall Study|Adverse Event|9|||
125531889|NCT01252355|451578388|FG001|Overall Study|Adverse Event|17|||
125531890|NCT01252355|451578389|FG002|Overall Study|Adverse Event|22|||
125531891|NCT01252355|451578387|FG000|Overall Study|Lack of Efficacy|6|||
125531892|NCT01252355|451578388|FG001|Overall Study|Lack of Efficacy|4|||
125531893|NCT01252355|451578389|FG002|Overall Study|Lack of Efficacy|2|||
125531894|NCT01252355|451578387|FG000|Overall Study|Lost to Follow-up|0|||
125531895|NCT01252355|451578388|FG001|Overall Study|Lost to Follow-up|0|||
125531896|NCT01252355|451578389|FG002|Overall Study|Lost to Follow-up|1|||
125531897|NCT01252355|451578387|FG000|Overall Study|Poor Compliance to Protocol|1|||
125531898|NCT01252355|451578388|FG001|Overall Study|Poor Compliance to Protocol|1|||
125531899|NCT01252355|451578389|FG002|Overall Study|Poor Compliance to Protocol|1|||
125531900|NCT01252355|451578387|FG000|Overall Study|Progressive Disease|2|||
125531901|NCT01252355|451578388|FG001|Overall Study|Progressive Disease|0|||
125531902|NCT01252355|451578389|FG002|Overall Study|Progressive Disease|0|||
125531903|NCT01252355|451578387|FG000|Overall Study|Sponsor Early Termination of Study|149|||
125531904|NCT01252355|451578388|FG001|Overall Study|Sponsor Early Termination of Study|149|||
125531905|NCT01252355|451578389|FG002|Overall Study|Sponsor Early Termination of Study|146|||
125531906|NCT01252355|451578387|FG000|Overall Study|Randomized but not Treated|2|||
125531907|NCT01252355|451578388|FG001|Overall Study|Randomized but not Treated|0|||
125531908|NCT01252355|451578389|FG002|Overall Study|Randomized but not Treated|0|||
125531909|NCT01252355|451578387|FG000|Overall Study|Other Than Above|8|||
125531910|NCT01252355|451578388|FG001|Overall Study|Other Than Above|7|||
125531911|NCT01252355|451578389|FG002|Overall Study|Other Than Above|7|||
125531912|NCT01725126|451578390|FG000|Overall Study|Protocol Violation|0|||
125531913|NCT01725126|451578391|FG001|Overall Study|Protocol Violation|1|||
125531914|NCT01725126|451578392|FG002|Overall Study|Protocol Violation|0|||
125531915|NCT01725126|451578393|FG003|Overall Study|Protocol Violation|0|||
125531916|NCT01725126|451578394|FG004|Overall Study|Protocol Violation|0|||
125531917|NCT01725126|451578395|FG005|Overall Study|Protocol Violation|0|||
125531918|NCT01725126|451578390|FG000|Overall Study|Withdrawal by Subject|0|||
125531919|NCT01725126|451578391|FG001|Overall Study|Withdrawal by Subject|0|||
125531920|NCT01725126|451578392|FG002|Overall Study|Withdrawal by Subject|0|||
125531921|NCT01725126|451578393|FG003|Overall Study|Withdrawal by Subject|1|||
125531922|NCT01725126|451578394|FG004|Overall Study|Withdrawal by Subject|0|||
125531923|NCT01725126|451578395|FG005|Overall Study|Withdrawal by Subject|0|||
125531924|NCT00677534|451578400|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
125531925|NCT00677534|451578400|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
125531926|NCT00677534|451578400|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
125531927|NCT02687035|451578401|FG000|Overall Study|Withdrawal by Subject|1|||
125531928|NCT02687035|451578401|FG000|Overall Study|Death|87|||
125531929|NCT02687035|451578401|FG000|Overall Study|Lost to Follow-up|1|||
125531930|NCT02687035|451578401|FG000|Overall Study|Missed Visit|87|||
125531931|NCT02687035|451578401|FG000|Overall Study|Did not receive Study Device|8|||
125531932|NCT04076943|451578410|FG000|Overall Study|Withdrawal by Subject|12|||
125531933|NCT04076943|451578410|FG000|Overall Study|Adverse Event|1|||
125531934|NCT04076943|451578410|FG000|Overall Study|Progressive Disease|2|||
125531935|NCT04076943|451578410|FG000|Overall Study|Death|13|||
125531936|NCT04076943|451578410|FG000|Overall Study|Other than specified|6|||
125531937|NCT02224703|451578416|FG000|Overall Study|Adverse Event|0|||
125531938|NCT02224703|451578417|FG001|Overall Study|Adverse Event|5|||
125531939|NCT02224703|451578418|FG002|Overall Study|Adverse Event|0|||
125531940|NCT02224703|451578416|FG000|Overall Study|Withdrawn by investigator|1|||
125531941|NCT02224703|451578417|FG001|Overall Study|Withdrawn by investigator|0|||
125531942|NCT02224703|451578418|FG002|Overall Study|Withdrawn by investigator|0|||
125531943|NCT02224703|451578416|FG000|Overall Study|Advised by medical monitor|1|||
125531944|NCT02224703|451578417|FG001|Overall Study|Advised by medical monitor|0|||
125531945|NCT02224703|451578418|FG002|Overall Study|Advised by medical monitor|0|||
125531946|NCT02224703|451578416|FG000|Overall Study|Withdrawn by parent/guardian|0|||
125531947|NCT02224703|451578417|FG001|Overall Study|Withdrawn by parent/guardian|1|||
125531948|NCT02224703|451578418|FG002|Overall Study|Withdrawn by parent/guardian|0|||
125531949|NCT02224703|451578416|FG000|Overall Study|Lack of Efficacy|1|||
125531950|NCT02224703|451578417|FG001|Overall Study|Lack of Efficacy|0|||
125531951|NCT02224703|451578418|FG002|Overall Study|Lack of Efficacy|0|||
125531952|NCT02922023|451578419|FG000|Overall Study|Lost to Follow-up|2|||
125531953|NCT02922023|451578420|FG001|Overall Study|Lost to Follow-up|0|||
125531954|NCT00863681|451578421|FG000|Overall Study|Other|2|||
125531955|NCT00863681|451578422|FG001|Overall Study|Other|0|||
125531956|NCT00863681|451578423|FG002|Overall Study|Other|0|||
125531957|NCT00863681|451578421|FG000|Overall Study|Missing|1|||
125531958|NCT00863681|451578422|FG001|Overall Study|Missing|0|||
125531959|NCT00863681|451578423|FG002|Overall Study|Missing|0|||
125531960|NCT00863681|451578421|FG000|Overall Study|Death|40|||
125531961|NCT00863681|451578422|FG001|Overall Study|Death|23|||
125531962|NCT00863681|451578423|FG002|Overall Study|Death|6|||
125531963|NCT00863681|451578421|FG000|Overall Study|Withdrawal by Subject|12|||
125531964|NCT00863681|451578422|FG001|Overall Study|Withdrawal by Subject|5|||
125531965|NCT00863681|451578423|FG002|Overall Study|Withdrawal by Subject|2|||
125531966|NCT00863681|451578421|FG000|Overall Study|Protocol Violation|2|||
125531967|NCT00863681|451578422|FG001|Overall Study|Protocol Violation|0|||
125531968|NCT00863681|451578423|FG002|Overall Study|Protocol Violation|0|||
125531969|NCT00863681|451578421|FG000|Overall Study|Lost to Follow-up|3|||
125531970|NCT00863681|451578422|FG001|Overall Study|Lost to Follow-up|0|||
125531971|NCT00863681|451578423|FG002|Overall Study|Lost to Follow-up|3|||
125531972|NCT00863681|451578421|FG000|Overall Study|Adverse Event|28|||
125531973|NCT00863681|451578422|FG001|Overall Study|Adverse Event|10|||
125531974|NCT00863681|451578423|FG002|Overall Study|Adverse Event|6|||
125531975|NCT00863681|451578421|FG000|Overall Study|Lack of Efficacy|2|||
125531976|NCT00863681|451578422|FG001|Overall Study|Lack of Efficacy|2|||
125531977|NCT00863681|451578423|FG002|Overall Study|Lack of Efficacy|1|||
125531978|NCT00863681|451578421|FG000|Overall Study|Non-compliance with study drug|1|||
125531979|NCT00863681|451578422|FG001|Overall Study|Non-compliance with study drug|3|||
125531980|NCT00863681|451578423|FG002|Overall Study|Non-compliance with study drug|0|||
125531981|NCT03031496|451578424|FG000|Period 1|Adverse Event|2|||
125531982|NCT03031496|451578425|FG001|Period 1|Adverse Event|0|||
125531983|NCT03031496|451578424|FG000|Period 1|Withdrawal by Subject|0|||
125531984|NCT03031496|451578425|FG001|Period 1|Withdrawal by Subject|2|||
125531985|NCT02766777|451578431|FG000|Overall Study|Adverse Event|12|||
125531986|NCT02766777|451578431|FG000|Overall Study|Lost to Follow-up|16|||
125531987|NCT02766777|451578431|FG000|Overall Study|Non-Compliance With Study Drug|1|||
125531988|NCT02766777|451578431|FG000|Overall Study|Protocol Violation|1|||
125531989|NCT02766777|451578431|FG000|Overall Study|Withdrawal by Subject|4|||
125531990|NCT01886287|451578432|FG000|Overall Study|Radiographic disease progression|1|||
125531991|NCT01886287|451578432|FG000|Overall Study|Clinical progression due to disease|1|||
125531992|NCT03596762|451578433|FG000|Overall Study|Protocol Violation|0|||
125531993|NCT03596762|451578434|FG001|Overall Study|Protocol Violation|0|||
125531994|NCT03596762|451578435|FG002|Overall Study|Protocol Violation|0|||
125531995|NCT03596762|451578436|FG003|Overall Study|Protocol Violation|0|||
125531996|NCT03596762|451578437|FG004|Overall Study|Protocol Violation|1|||
125531997|NCT03596762|451578433|FG000|Overall Study|Adverse Event|2|||
125531998|NCT03596762|451578434|FG001|Overall Study|Adverse Event|0|||
125531999|NCT03596762|451578435|FG002|Overall Study|Adverse Event|1|||
125532000|NCT03596762|451578436|FG003|Overall Study|Adverse Event|0|||
125532001|NCT03596762|451578437|FG004|Overall Study|Adverse Event|5|||
125532002|NCT03596762|451578433|FG000|Overall Study|Withdrawal by Subject|2|||
125532003|NCT03596762|451578434|FG001|Overall Study|Withdrawal by Subject|1|||
125532004|NCT03596762|451578435|FG002|Overall Study|Withdrawal by Subject|0|||
125532005|NCT03596762|451578436|FG003|Overall Study|Withdrawal by Subject|1|||
125532006|NCT03596762|451578437|FG004|Overall Study|Withdrawal by Subject|1|||
125532007|NCT01031628|451578438|FG000|Overall Study|Study terminated early|0|||
125532008|NCT01031628|451578439|FG001|Overall Study|Study terminated early|1|||
125532009|NCT01031628|451578440|FG002|Overall Study|Study terminated early|3|||
125532010|NCT01031628|451578441|FG003|Overall Study|Study terminated early|0|||
125532011|NCT00967005|451578444|FG000|Overall Study|Lost to Follow-up|7|||
125532012|NCT00967005|451578445|FG001|Overall Study|Lost to Follow-up|10|||
125532013|NCT01371825|451578448|FG000|Overall Study|Death|4|||
125532014|NCT00895895|451578449|FG000|Period 1|Adverse Event|7|||
125532015|NCT00895895|451578450|FG001|Period 1|Adverse Event|6|||
125532016|NCT00895895|451578451|FG002|Period 1|Adverse Event|4|||
125532017|NCT00895895|451578452|FG003|Period 1|Adverse Event|6|||
125532018|NCT00895895|451578453|FG004|Period 1|Adverse Event|7|||
125532019|NCT00895895|451578449|FG000|Period 1|Death|0|||
125532020|NCT00895895|451578450|FG001|Period 1|Death|0|||
125532021|NCT00895895|451578451|FG002|Period 1|Death|0|||
125532022|NCT00895895|451578452|FG003|Period 1|Death|0|||
125532023|NCT00895895|451578453|FG004|Period 1|Death|1|||
125532024|NCT00895895|451578449|FG000|Period 1|discontinued by sponsor|2|||
125532025|NCT00895895|451578450|FG001|Period 1|discontinued by sponsor|1|||
125532026|NCT00895895|451578451|FG002|Period 1|discontinued by sponsor|2|||
125532027|NCT00895895|451578452|FG003|Period 1|discontinued by sponsor|1|||
125532028|NCT00895895|451578453|FG004|Period 1|discontinued by sponsor|1|||
125532029|NCT00895895|451578449|FG000|Period 1|failed to return|0|||
125532030|NCT00895895|451578450|FG001|Period 1|failed to return|0|||
125532031|NCT00895895|451578451|FG002|Period 1|failed to return|1|||
125532032|NCT00895895|451578452|FG003|Period 1|failed to return|0|||
125532033|NCT00895895|451578453|FG004|Period 1|failed to return|1|||
125532034|NCT00895895|451578449|FG000|Period 1|investigator request|0|||
125532035|NCT00895895|451578450|FG001|Period 1|investigator request|1|||
125532036|NCT00895895|451578451|FG002|Period 1|investigator request|0|||
125532037|NCT00895895|451578452|FG003|Period 1|investigator request|0|||
125532038|NCT00895895|451578453|FG004|Period 1|investigator request|0|||
125532039|NCT00895895|451578449|FG000|Period 1|Lost to Follow-up|2|||
125532040|NCT00895895|451578450|FG001|Period 1|Lost to Follow-up|1|||
125532041|NCT00895895|451578451|FG002|Period 1|Lost to Follow-up|3|||
125532042|NCT00895895|451578452|FG003|Period 1|Lost to Follow-up|2|||
125532043|NCT00895895|451578453|FG004|Period 1|Lost to Follow-up|3|||
125532044|NCT00895895|451578449|FG000|Period 1|Other|1|||
125532045|NCT00895895|451578450|FG001|Period 1|Other|2|||
125532046|NCT00895895|451578451|FG002|Period 1|Other|1|||
125532047|NCT00895895|451578452|FG003|Period 1|Other|1|||
125532048|NCT00895895|451578453|FG004|Period 1|Other|1|||
125532049|NCT00895895|451578449|FG000|Period 1|Protocol Violation|0|||
125532050|NCT00895895|451578450|FG001|Period 1|Protocol Violation|1|||
125532051|NCT00895895|451578451|FG002|Period 1|Protocol Violation|0|||
125532052|NCT00895895|451578452|FG003|Period 1|Protocol Violation|0|||
125532053|NCT00895895|451578453|FG004|Period 1|Protocol Violation|0|||
125532054|NCT00895895|451578449|FG000|Period 1|Withdrawal by Subject|6|||
125532055|NCT00895895|451578450|FG001|Period 1|Withdrawal by Subject|6|||
125532056|NCT00895895|451578451|FG002|Period 1|Withdrawal by Subject|8|||
125532057|NCT00895895|451578452|FG003|Period 1|Withdrawal by Subject|2|||
125532058|NCT00895895|451578453|FG004|Period 1|Withdrawal by Subject|4|||
125532059|NCT00895895|451578449|FG000|Period 1|unsatisfactory response-efficacy|2|||
125532060|NCT00895895|451578450|FG001|Period 1|unsatisfactory response-efficacy|0|||
125532061|NCT00895895|451578451|FG002|Period 1|unsatisfactory response-efficacy|0|||
125532062|NCT00895895|451578452|FG003|Period 1|unsatisfactory response-efficacy|0|||
125532063|NCT00895895|451578453|FG004|Period 1|unsatisfactory response-efficacy|0|||
125532064|NCT00895895|451578449|FG000|Period 1|randomized and not treated|1|||
125532065|NCT00895895|451578450|FG001|Period 1|randomized and not treated|3|||
125532066|NCT00895895|451578451|FG002|Period 1|randomized and not treated|1|||
125532067|NCT00895895|451578452|FG003|Period 1|randomized and not treated|1|||
125532068|NCT00895895|451578453|FG004|Period 1|randomized and not treated|2|||
125532069|NCT00895895|451578449|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
125532070|NCT00895895|451578450|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
125532071|NCT00895895|451578451|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
125532072|NCT00895895|451578452|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
125532073|NCT00895895|451578453|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
125532074|NCT00895895|451578449|FG000|After Period 1, Prior to Period 2|Other|0|||
125532075|NCT00895895|451578450|FG001|After Period 1, Prior to Period 2|Other|0|||
125532076|NCT00895895|451578451|FG002|After Period 1, Prior to Period 2|Other|1|||
125532077|NCT00895895|451578452|FG003|After Period 1, Prior to Period 2|Other|0|||
125532078|NCT00895895|451578453|FG004|After Period 1, Prior to Period 2|Other|0|||
125532079|NCT00895895|451578449|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
125532080|NCT00895895|451578450|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
125532081|NCT00895895|451578451|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
125532082|NCT00895895|451578452|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
125532083|NCT00895895|451578453|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
125532084|NCT00895895|451578449|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
125532085|NCT00895895|451578450|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
125532086|NCT00895895|451578451|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
125532087|NCT00895895|451578452|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
125532088|NCT00895895|451578453|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
125532089|NCT00895895|451578449|FG000|Period 2|Adverse Event|3|||
125532090|NCT00895895|451578450|FG001|Period 2|Adverse Event|3|||
125532091|NCT00895895|451578451|FG002|Period 2|Adverse Event|5|||
125532092|NCT00895895|451578452|FG003|Period 2|Adverse Event|2|||
125532093|NCT00895895|451578453|FG004|Period 2|Adverse Event|5|||
125532094|NCT00895895|451578449|FG000|Period 2|Death|0|||
125532095|NCT00895895|451578450|FG001|Period 2|Death|0|||
125532096|NCT00895895|451578451|FG002|Period 2|Death|1|||
125532097|NCT00895895|451578452|FG003|Period 2|Death|0|||
125532098|NCT00895895|451578453|FG004|Period 2|Death|0|||
125532099|NCT00895895|451578449|FG000|Period 2|discontinued by sponsor|44|||
125532100|NCT00895895|451578450|FG001|Period 2|discontinued by sponsor|44|||
125532101|NCT00895895|451578451|FG002|Period 2|discontinued by sponsor|38|||
125532102|NCT00895895|451578452|FG003|Period 2|discontinued by sponsor|46|||
125532103|NCT00895895|451578453|FG004|Period 2|discontinued by sponsor|37|||
125532104|NCT00895895|451578449|FG000|Period 2|failed to return|2|||
125532105|NCT00895895|451578450|FG001|Period 2|failed to return|0|||
125532106|NCT00895895|451578451|FG002|Period 2|failed to return|0|||
125532107|NCT00895895|451578452|FG003|Period 2|failed to return|0|||
125532108|NCT00895895|451578453|FG004|Period 2|failed to return|0|||
125532109|NCT00895895|451578449|FG000|Period 2|investigator request|2|||
125532110|NCT00895895|451578450|FG001|Period 2|investigator request|0|||
125532111|NCT00895895|451578451|FG002|Period 2|investigator request|0|||
125532112|NCT00895895|451578452|FG003|Period 2|investigator request|0|||
125532113|NCT00895895|451578453|FG004|Period 2|investigator request|0|||
125532114|NCT00895895|451578449|FG000|Period 2|Lost to Follow-up|1|||
125532115|NCT00895895|451578450|FG001|Period 2|Lost to Follow-up|2|||
125532116|NCT00895895|451578451|FG002|Period 2|Lost to Follow-up|1|||
125532117|NCT00895895|451578452|FG003|Period 2|Lost to Follow-up|1|||
125532118|NCT00895895|451578453|FG004|Period 2|Lost to Follow-up|0|||
125532119|NCT00895895|451578449|FG000|Period 2|Other|1|||
125532120|NCT00895895|451578450|FG001|Period 2|Other|1|||
125532121|NCT00895895|451578451|FG002|Period 2|Other|3|||
125532122|NCT00895895|451578452|FG003|Period 2|Other|1|||
125532123|NCT00895895|451578453|FG004|Period 2|Other|1|||
125532124|NCT00895895|451578449|FG000|Period 2|Protocol Violation|1|||
125532125|NCT00895895|451578450|FG001|Period 2|Protocol Violation|0|||
125532126|NCT00895895|451578451|FG002|Period 2|Protocol Violation|1|||
125532127|NCT00895895|451578452|FG003|Period 2|Protocol Violation|1|||
125532128|NCT00895895|451578453|FG004|Period 2|Protocol Violation|1|||
125532129|NCT00895895|451578449|FG000|Period 2|Withdrawal by Subject|0|||
125532130|NCT00895895|451578450|FG001|Period 2|Withdrawal by Subject|2|||
125532131|NCT00895895|451578451|FG002|Period 2|Withdrawal by Subject|0|||
125532132|NCT00895895|451578452|FG003|Period 2|Withdrawal by Subject|3|||
125532133|NCT00895895|451578453|FG004|Period 2|Withdrawal by Subject|5|||
125532134|NCT00895895|451578449|FG000|Period 2|unsatisfactory response-efficacy|2|||
125532135|NCT00895895|451578450|FG001|Period 2|unsatisfactory response-efficacy|1|||
125532136|NCT00895895|451578451|FG002|Period 2|unsatisfactory response-efficacy|0|||
125532137|NCT00895895|451578452|FG003|Period 2|unsatisfactory response-efficacy|0|||
125532138|NCT00895895|451578453|FG004|Period 2|unsatisfactory response-efficacy|0|||
125532139|NCT01261000|451578454|FG000|Overall Study|Screen failure|1|||
125532140|NCT00504777|451578455|FG000|Overall Study|Adverse Event|1|||
125532141|NCT00820170|451578460|FG000|Overall Study|Adverse Event|0|||
125532142|NCT00820170|451578461|FG001|Overall Study|Adverse Event|0|||
125532143|NCT00820170|451578462|FG002|Overall Study|Adverse Event|0|||
125532144|NCT00820170|451578463|FG003|Overall Study|Adverse Event|0|||
125532145|NCT00820170|451578464|FG004|Overall Study|Adverse Event|2|||
125532146|NCT00820170|451578460|FG000|Overall Study|Progressive Disease|0|||
125532147|NCT00820170|451578461|FG001|Overall Study|Progressive Disease|0|||
125532148|NCT00820170|451578462|FG002|Overall Study|Progressive Disease|0|||
125532149|NCT00820170|451578463|FG003|Overall Study|Progressive Disease|0|||
125532150|NCT00820170|451578464|FG004|Overall Study|Progressive Disease|2|||
125532151|NCT03552523|451578465|FG000|Overall Study|Withdrawal by Subject|1|||
125532152|NCT03552523|451578466|FG001|Overall Study|Withdrawal by Subject|1|||
125532153|NCT03538938|451578467|FG000|Overall Study|Death|0|||
125532154|NCT03538938|451578468|FG001|Overall Study|Death|0|||
125532155|NCT03538938|451578469|FG002|Overall Study|Death|2|||
125532156|NCT03538938|451578470|FG003|Overall Study|Death|0|||
125532157|NCT03538938|451578471|FG004|Overall Study|Death|0|||
125532158|NCT03538938|451578472|FG005|Overall Study|Death|1|||
125532159|NCT03538938|451578473|FG006|Overall Study|Death|0|||
125532160|NCT03538938|451578474|FG007|Overall Study|Death|1|||
125532161|NCT03538938|451578475|FG008|Overall Study|Death|1|||
125532162|NCT03538938|451578476|FG009|Overall Study|Death|1|||
125532163|NCT03538938|451578477|FG010|Overall Study|Death|0|||
125532164|NCT03538938|451578478|FG011|Overall Study|Death|0|||
125532165|NCT03538938|451578479|FG012|Overall Study|Death|1|||
125532166|NCT03538938|451578480|FG013|Overall Study|Death|1|||
125532167|NCT03538938|451578481|FG014|Overall Study|Death|0|||
125532168|NCT03538938|451578482|FG015|Overall Study|Death|1|||
125532169|NCT03538938|451578467|FG000|Overall Study|Withdrawal by Subject|4|||
125532170|NCT03538938|451578468|FG001|Overall Study|Withdrawal by Subject|6|||
125532171|NCT03538938|451578469|FG002|Overall Study|Withdrawal by Subject|5|||
125532172|NCT03538938|451578470|FG003|Overall Study|Withdrawal by Subject|3|||
125532173|NCT03538938|451578471|FG004|Overall Study|Withdrawal by Subject|0|||
125532174|NCT03538938|451578472|FG005|Overall Study|Withdrawal by Subject|0|||
125532175|NCT03538938|451578473|FG006|Overall Study|Withdrawal by Subject|3|||
125532176|NCT03538938|451578474|FG007|Overall Study|Withdrawal by Subject|1|||
125532177|NCT03538938|451578475|FG008|Overall Study|Withdrawal by Subject|5|||
125532178|NCT03538938|451578476|FG009|Overall Study|Withdrawal by Subject|1|||
125532179|NCT03538938|451578477|FG010|Overall Study|Withdrawal by Subject|2|||
125532180|NCT03538938|451578478|FG011|Overall Study|Withdrawal by Subject|1|||
125532181|NCT03538938|451578479|FG012|Overall Study|Withdrawal by Subject|3|||
125532182|NCT03538938|451578480|FG013|Overall Study|Withdrawal by Subject|0|||
125532183|NCT03538938|451578481|FG014|Overall Study|Withdrawal by Subject|2|||
125532184|NCT03538938|451578482|FG015|Overall Study|Withdrawal by Subject|4|||
125532185|NCT03538938|451578467|FG000|Overall Study|Incarcerated|0|||
125532186|NCT03538938|451578468|FG001|Overall Study|Incarcerated|0|||
125532187|NCT03538938|451578469|FG002|Overall Study|Incarcerated|0|||
125532188|NCT03538938|451578470|FG003|Overall Study|Incarcerated|0|||
125532189|NCT03538938|451578471|FG004|Overall Study|Incarcerated|0|||
125532190|NCT03538938|451578472|FG005|Overall Study|Incarcerated|0|||
125532191|NCT03538938|451578473|FG006|Overall Study|Incarcerated|0|||
125532192|NCT03538938|451578474|FG007|Overall Study|Incarcerated|0|||
125532193|NCT03538938|451578475|FG008|Overall Study|Incarcerated|0|||
125532194|NCT03538938|451578476|FG009|Overall Study|Incarcerated|0|||
125532195|NCT03538938|451578477|FG010|Overall Study|Incarcerated|0|||
125532196|NCT03538938|451578478|FG011|Overall Study|Incarcerated|1|||
125532197|NCT03538938|451578479|FG012|Overall Study|Incarcerated|0|||
125532198|NCT03538938|451578480|FG013|Overall Study|Incarcerated|0|||
125532199|NCT03538938|451578481|FG014|Overall Study|Incarcerated|0|||
125532200|NCT03538938|451578482|FG015|Overall Study|Incarcerated|0|||
125532201|NCT03995316|451578483|FG000|Overall Study|Lost to Follow-up|10|||
125532202|NCT03995316|451578484|FG001|Overall Study|Lost to Follow-up|3|||
125532203|NCT01361594|451578485|FG000|Overall Study|Withdrawal by Subject|1|||
125532204|NCT01361594|451578486|FG001|Overall Study|Withdrawal by Subject|2|||
125532205|NCT01754753|451578487|FG000|Overall Study|Study close|43|||
125532206|NCT01754753|451578488|FG001|Overall Study|Study close|44|||
125532207|NCT01754753|451578487|FG000|Overall Study|Lost to Follow-up|9|||
125532208|NCT01754753|451578488|FG001|Overall Study|Lost to Follow-up|5|||
125532209|NCT01399918|451578493|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
125532210|NCT03197766|451578494|FG000|Overall Study|Withdrawal by Subject|2|||
125532211|NCT03197766|451578495|FG001|Overall Study|Withdrawal by Subject|0|||
125532212|NCT05415748|451578500|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
125532213|NCT05415748|451578501|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
125532214|NCT05415748|451578502|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
125532215|NCT05415748|451578503|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
125532216|NCT05415748|451578500|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
125532217|NCT05415748|451578501|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
125532218|NCT05415748|451578502|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
125532219|NCT05415748|451578503|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
125532220|NCT04520659|451578504|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
125532221|NCT04520659|451578505|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
125532222|NCT04520659|451578506|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
125532223|NCT04520659|451578507|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
125532224|NCT03361865|451578508|FG000|Overall Study|Death|17|||
125532225|NCT03361865|451578509|FG001|Overall Study|Death|18|||
125532226|NCT03361865|451578508|FG000|Overall Study|Physician Decision|1|||
125532227|NCT03361865|451578509|FG001|Overall Study|Physician Decision|9|||
125532228|NCT03361865|451578508|FG000|Overall Study|Withdrawal by Subject|1|||
125532229|NCT03361865|451578509|FG001|Overall Study|Withdrawal by Subject|0|||
125532230|NCT03852719|451578510|FG000|Overall Study|Withdrawal of consent|8|||
125532231|NCT03852719|451578511|FG001|Overall Study|Withdrawal of consent|8|||
125532232|NCT03852719|451578512|FG002|Overall Study|Withdrawal of consent|9|||
125532233|NCT03852719|451578510|FG000|Overall Study|Physician Decision|5|||
125532234|NCT03852719|451578511|FG001|Overall Study|Physician Decision|4|||
125532235|NCT03852719|451578512|FG002|Overall Study|Physician Decision|1|||
125532236|NCT03852719|451578510|FG000|Overall Study|Pregnancy|2|||
125532237|NCT03852719|451578511|FG001|Overall Study|Pregnancy|1|||
125532238|NCT03852719|451578512|FG002|Overall Study|Pregnancy|0|||
125532239|NCT03852719|451578510|FG000|Overall Study|Death|1|||
125532240|NCT03852719|451578511|FG001|Overall Study|Death|0|||
125532241|NCT03852719|451578512|FG002|Overall Study|Death|0|||
125532242|NCT03852719|451578510|FG000|Overall Study|Reason not Specified|3|||
125532243|NCT03852719|451578511|FG001|Overall Study|Reason not Specified|3|||
125532244|NCT03852719|451578512|FG002|Overall Study|Reason not Specified|5|||
125532245|NCT03852719|451578510|FG000|Overall Study|Adverse Event|2|||
125532246|NCT03852719|451578511|FG001|Overall Study|Adverse Event|1|||
125532247|NCT03852719|451578512|FG002|Overall Study|Adverse Event|4|||
125532248|NCT03852719|451578510|FG000|Overall Study|Progressive disease|1|||
125532249|NCT03852719|451578511|FG001|Overall Study|Progressive disease|4|||
125532250|NCT03852719|451578512|FG002|Overall Study|Progressive disease|1|||
125532251|NCT03852719|451578510|FG000|Overall Study|Lost to Follow-up|1|||
125532252|NCT03852719|451578511|FG001|Overall Study|Lost to Follow-up|0|||
125532253|NCT03852719|451578512|FG002|Overall Study|Lost to Follow-up|0|||
125532254|NCT05543187|451578513|FG000|Overall Study|Ongoing|3|||
125532255|NCT05543187|451578514|FG001|Overall Study|Ongoing|2|||
125532256|NCT02819024|451578516|FG000|Overall Study|Withdrawal by Subject|1|||
125532257|NCT00792948|451578517|FG000|Overall Study|Adverse Event|6|||
125532258|NCT00792948|451578517|FG000|Overall Study|Death|4|||
125532259|NCT00792948|451578517|FG000|Overall Study|Withdrawal by Subject|3|||
125532260|NCT00792948|451578517|FG000|Overall Study|Ineligible|2|||
125532261|NCT00792948|451578517|FG000|Overall Study|Insurance denial - not treated|1|||
125532262|NCT00792948|451578517|FG000|Overall Study|Physician Decision|11|||
125532263|NCT00792948|451578517|FG000|Overall Study|Protocol Violation|1|||
125532264|NCT01263509|451580070|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
125532265|NCT01263509|451580071|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
125309251|NCT03197376|450758167|FG001|Primary and Booster Phase|Adverse Event|0|||
125309252|NCT03197376|450758168|FG002|Primary and Booster Phase|Adverse Event|0|||
125309253|NCT03197376|450758169|FG003|Primary and Booster Phase|Adverse Event|1|||
125309254|NCT03197376|450758166|FG000|Primary and Booster Phase|Death|1|||
125309255|NCT03197376|450758167|FG001|Primary and Booster Phase|Death|0|||
125309256|NCT03197376|450758168|FG002|Primary and Booster Phase|Death|0|||
125309257|NCT03197376|450758169|FG003|Primary and Booster Phase|Death|2|||
125309258|NCT03197376|450758166|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
125309259|NCT03197376|450758167|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
125309260|NCT03197376|450758168|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
125309261|NCT03197376|450758169|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
125309262|NCT03197376|450758166|FG000|Primary and Booster Phase|Physician Decision|1|||
125309263|NCT03197376|450758167|FG001|Primary and Booster Phase|Physician Decision|0|||
125309264|NCT03197376|450758168|FG002|Primary and Booster Phase|Physician Decision|1|||
125309265|NCT03197376|450758169|FG003|Primary and Booster Phase|Physician Decision|3|||
125309266|NCT03197376|450758166|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
125309267|NCT03197376|450758167|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
125309268|NCT03197376|450758168|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
125309269|NCT03197376|450758169|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
125309270|NCT03197376|450758166|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
125309271|NCT03197376|450758167|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
125309272|NCT03197376|450758168|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
125309273|NCT03197376|450758169|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
125309274|NCT03197376|450758166|FG000|Primary and Booster Phase|Not vaccine related|1|||
125309275|NCT03197376|450758167|FG001|Primary and Booster Phase|Not vaccine related|2|||
125309276|NCT03197376|450758168|FG002|Primary and Booster Phase|Not vaccine related|0|||
125309277|NCT03197376|450758169|FG003|Primary and Booster Phase|Not vaccine related|6|||
125309278|NCT03197376|450758166|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
125309279|NCT03197376|450758167|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
125309280|NCT03197376|450758168|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
125309281|NCT03197376|450758169|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
125309282|NCT03197376|450758166|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
125309283|NCT03197376|450758167|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
125309284|NCT03197376|450758168|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
125309285|NCT03197376|450758169|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
125309286|NCT03197376|450758166|FG000|Immune Persistence Phase|Not vaccine related|1|||
125309287|NCT03197376|450758167|FG001|Immune Persistence Phase|Not vaccine related|0|||
125309288|NCT03197376|450758168|FG002|Immune Persistence Phase|Not vaccine related|1|||
125309289|NCT03197376|450758169|FG003|Immune Persistence Phase|Not vaccine related|1|||
125309290|NCT00003199|450758170|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
125309291|NCT00003199|450758170|FG000|Overall Study|Lack of insurance clearance|2|||
125309292|NCT00003199|450758170|FG000|Overall Study|Screen fail|15|||
125309293|NCT01223183|450758172|FG000|Imaging Day 1|Physician Decision|0|||
125309294|NCT01223183|450758173|FG001|Imaging Day 1|Physician Decision|1|||
125309295|NCT01223183|450758172|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
125532266|NCT01263509|451580072|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
125532267|NCT01263509|451580073|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
125532268|NCT01263509|451580070|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
125532269|NCT01263509|451580071|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
125532270|NCT01263509|451580072|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
125532271|NCT01263509|451580073|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
125532272|NCT01263509|451580070|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
125532273|NCT01263509|451580071|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
125532274|NCT01263509|451580072|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
125532275|NCT01263509|451580073|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
125309296|NCT01223183|450758173|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
125309297|NCT01223183|450758172|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
125309298|NCT01223183|450758173|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
125309299|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
125309300|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
125309301|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
125309302|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
125309303|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
125309304|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
125309305|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
125309306|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
125309307|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
125309308|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
125309309|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
125309310|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
125309311|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
125309312|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
125309313|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
125309314|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
125309315|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
125309316|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
125309317|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
125309318|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
125309319|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
125309320|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
125309321|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
125309322|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
125309323|NCT03777059|450760015|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
125309324|NCT03777059|450760016|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
125309325|NCT03777059|450760017|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
125309326|NCT03777059|450760018|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
125309327|NCT03777059|450760015|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
125309328|NCT03777059|450760016|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
125309329|NCT03777059|450760017|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
125309330|NCT03777059|450760018|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
125309331|NCT03777059|450760015|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
125309332|NCT03777059|450760016|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
125309333|NCT03777059|450760017|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
125309334|NCT03777059|450760018|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
125309335|NCT03777059|450760015|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
125309336|NCT03777059|450760016|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
125309337|NCT03777059|450760017|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
125309338|NCT03777059|450760018|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
125309339|NCT03777059|450760015|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
125309340|NCT03777059|450760016|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
125309341|NCT03777059|450760017|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
125309342|NCT03777059|450760018|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
125309343|NCT02813889|450760019|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
125309344|NCT02813889|450760020|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
125309345|NCT01101035|450760027|FG000|Overall Study|Adverse Event|191|||
125309346|NCT01101035|450760028|FG001|Overall Study|Adverse Event|172|||
125309347|NCT01101035|450760027|FG000|Overall Study|Major Protocol Deviation|52|||
125309348|NCT01101035|450760028|FG001|Overall Study|Major Protocol Deviation|46|||
125309349|NCT01101035|450760027|FG000|Overall Study|Lost to Follow-up|226|||
125309350|NCT01101035|450760028|FG001|Overall Study|Lost to Follow-up|223|||
125309351|NCT01101035|450760027|FG000|Overall Study|Voluntary Withdrawal|595|||
125309352|NCT01101035|450760028|FG001|Overall Study|Voluntary Withdrawal|587|||
125309353|NCT01101035|450760027|FG000|Overall Study|Reason not Specified|333|||
125309354|NCT01101035|450760028|FG001|Overall Study|Reason not Specified|363|||
125309355|NCT00681629|450760029|FG000|Overall Study|Study termination|4|||
125309356|NCT00681629|450760030|FG001|Overall Study|Study termination|2|||
125309357|NCT00681629|450760029|FG000|Overall Study|Adverse Event|1|||
125309358|NCT00681629|450760030|FG001|Overall Study|Adverse Event|0|||
125309359|NCT00411671|450760031|FG000|Overall Study|Adverse Event|15|||
125309360|NCT00411671|450760031|FG000|Overall Study|Death|2|||
125309361|NCT00411671|450760031|FG000|Overall Study|Lost to Follow-up|3|||
125309362|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
125309363|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125309364|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125309365|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125309366|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
125309367|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
125309368|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125309369|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125309370|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125309371|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
125309372|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
125309373|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125309374|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125309375|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125309376|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
125309377|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
125309378|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125309379|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125309380|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125309381|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
125309382|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
125309383|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125309384|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125309385|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125309386|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
125309387|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
125309388|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125309389|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125309390|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125309391|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
125309392|NCT01173601|450760035|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
125309393|NCT01173601|450760036|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125309394|NCT01173601|450760037|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125309395|NCT01173601|450760038|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125309396|NCT01173601|450760039|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
125309397|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
125309398|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
125309399|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
125309400|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
125309401|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
125309402|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
125309403|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
125309404|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
125309405|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
125309406|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
125309407|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
125309408|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
125309409|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
125309410|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
125309411|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
125309412|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
125309413|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
125309414|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
125309415|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
125309416|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
125309417|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
125309418|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
125309419|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
125309420|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
125309421|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
125309422|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
125309423|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
125309424|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
125309425|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
125309426|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
125309427|NCT01173601|450760035|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
125309428|NCT01173601|450760036|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
125309429|NCT01173601|450760037|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
125309430|NCT01173601|450760038|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
125309431|NCT01173601|450760039|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
125309432|NCT03951077|450760040|FG000|Overall Study|Adverse Event|1|||
125309433|NCT03951077|450760041|FG001|Overall Study|Adverse Event|0|||
125309434|NCT03951077|450760042|FG002|Overall Study|Adverse Event|0|||
125309435|NCT03951077|450760043|FG003|Overall Study|Adverse Event|0|||
125309436|NCT03951077|450760044|FG004|Overall Study|Adverse Event|0|||
125309437|NCT03951077|450760045|FG005|Overall Study|Adverse Event|0|||
125309438|NCT03951077|450760040|FG000|Overall Study|Withdrawal by Subject|3|||
125309439|NCT03951077|450760041|FG001|Overall Study|Withdrawal by Subject|3|||
125309440|NCT03951077|450760042|FG002|Overall Study|Withdrawal by Subject|0|||
125309441|NCT03951077|450760043|FG003|Overall Study|Withdrawal by Subject|3|||
125309442|NCT03951077|450760044|FG004|Overall Study|Withdrawal by Subject|3|||
125309443|NCT03951077|450760045|FG005|Overall Study|Withdrawal by Subject|2|||
125309444|NCT03951077|450760040|FG000|Overall Study|Lost to Follow-up|1|||
125309445|NCT03951077|450760041|FG001|Overall Study|Lost to Follow-up|1|||
125309446|NCT03951077|450760042|FG002|Overall Study|Lost to Follow-up|2|||
125309447|NCT03951077|450760043|FG003|Overall Study|Lost to Follow-up|3|||
125309448|NCT03951077|450760044|FG004|Overall Study|Lost to Follow-up|2|||
125309449|NCT03951077|450760045|FG005|Overall Study|Lost to Follow-up|3|||
125309450|NCT03951077|450760040|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
125309451|NCT03951077|450760041|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
125309452|NCT03951077|450760042|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
125309453|NCT03951077|450760043|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
125309454|NCT03951077|450760044|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
125309455|NCT03951077|450760045|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
125309456|NCT03951077|450760040|FG000|Overall Study|Other, Not Specified|12|||
125309457|NCT03951077|450760041|FG001|Overall Study|Other, Not Specified|10|||
125309458|NCT03951077|450760042|FG002|Overall Study|Other, Not Specified|10|||
125309459|NCT03951077|450760043|FG003|Overall Study|Other, Not Specified|5|||
125309460|NCT03951077|450760044|FG004|Overall Study|Other, Not Specified|9|||
125309461|NCT03951077|450760045|FG005|Overall Study|Other, Not Specified|6|||
125309462|NCT03951077|450760040|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
125309463|NCT03951077|450760041|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
125309464|NCT03951077|450760042|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
125309465|NCT03951077|450760043|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
125309466|NCT03951077|450760044|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
125309467|NCT03951077|450760045|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
125309468|NCT01395901|450760048|FG000|Overall Study|Lost to Follow-up|4|||
125309469|NCT01395901|450760049|FG001|Overall Study|Lost to Follow-up|0|||
125309470|NCT01395901|450760048|FG000|Overall Study|Randomized but not received study drug|5|||
125309471|NCT01395901|450760049|FG001|Overall Study|Randomized but not received study drug|4|||
125309472|NCT01395901|450760048|FG000|Overall Study|Adverse Event|0|||
125309473|NCT01395901|450760049|FG001|Overall Study|Adverse Event|1|||
125309474|NCT01395901|450760048|FG000|Overall Study|Withdrawal of consent|1|||
125309475|NCT01395901|450760049|FG001|Overall Study|Withdrawal of consent|0|||
125309476|NCT00713544|450760055|FG000|Overall Study|Adverse Event|5|||
125309477|NCT00713544|450760056|FG001|Overall Study|Adverse Event|3|||
125309478|NCT00713544|450760057|FG002|Overall Study|Adverse Event|7|||
125309479|NCT00713544|450760058|FG003|Overall Study|Adverse Event|7|||
125309480|NCT00713544|450760059|FG004|Overall Study|Adverse Event|3|||
125309481|NCT00713544|450760060|FG005|Overall Study|Adverse Event|5|||
125309482|NCT00713544|450760055|FG000|Overall Study|Withdrawal by Subject|2|||
125309483|NCT00713544|450760056|FG001|Overall Study|Withdrawal by Subject|0|||
125309484|NCT00713544|450760057|FG002|Overall Study|Withdrawal by Subject|3|||
125309485|NCT00713544|450760058|FG003|Overall Study|Withdrawal by Subject|2|||
125309486|NCT00713544|450760059|FG004|Overall Study|Withdrawal by Subject|3|||
125309487|NCT00713544|450760060|FG005|Overall Study|Withdrawal by Subject|1|||
125309488|NCT00713544|450760055|FG000|Overall Study|Protocol Violation|0|||
125309489|NCT00713544|450760056|FG001|Overall Study|Protocol Violation|0|||
125309490|NCT00713544|450760057|FG002|Overall Study|Protocol Violation|0|||
125309491|NCT00713544|450760058|FG003|Overall Study|Protocol Violation|0|||
125309492|NCT00713544|450760059|FG004|Overall Study|Protocol Violation|0|||
125309493|NCT00713544|450760060|FG005|Overall Study|Protocol Violation|1|||
125309494|NCT00713544|450760055|FG000|Overall Study|Physician Decision|0|||
125309495|NCT00713544|450760056|FG001|Overall Study|Physician Decision|0|||
125309496|NCT00713544|450760057|FG002|Overall Study|Physician Decision|0|||
125309497|NCT00713544|450760058|FG003|Overall Study|Physician Decision|0|||
125309498|NCT00713544|450760059|FG004|Overall Study|Physician Decision|0|||
125309499|NCT00713544|450760060|FG005|Overall Study|Physician Decision|2|||
125309500|NCT00713544|450760055|FG000|Overall Study|Lack of Efficacy|0|||
125309501|NCT00713544|450760056|FG001|Overall Study|Lack of Efficacy|1|||
125309502|NCT00713544|450760057|FG002|Overall Study|Lack of Efficacy|0|||
125309503|NCT00713544|450760058|FG003|Overall Study|Lack of Efficacy|1|||
125309504|NCT00713544|450760059|FG004|Overall Study|Lack of Efficacy|1|||
125309505|NCT00713544|450760060|FG005|Overall Study|Lack of Efficacy|0|||
125309506|NCT00713544|450760055|FG000|Overall Study|Lost to Follow-up|0|||
125309507|NCT00713544|450760056|FG001|Overall Study|Lost to Follow-up|0|||
125309508|NCT00713544|450760057|FG002|Overall Study|Lost to Follow-up|1|||
125309509|NCT00713544|450760058|FG003|Overall Study|Lost to Follow-up|0|||
125309510|NCT00713544|450760059|FG004|Overall Study|Lost to Follow-up|0|||
125309511|NCT00713544|450760060|FG005|Overall Study|Lost to Follow-up|0|||
125309512|NCT00713544|450760055|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
125309513|NCT00713544|450760056|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
125309514|NCT00713544|450760057|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
125309515|NCT00713544|450760058|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
125309516|NCT00713544|450760059|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
125309517|NCT00713544|450760060|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
125309518|NCT00713544|450760055|FG000|Overall Study|Incorrect enrollment|0|||
125309519|NCT00713544|450760056|FG001|Overall Study|Incorrect enrollment|1|||
125309520|NCT00713544|450760057|FG002|Overall Study|Incorrect enrollment|0|||
125309521|NCT00713544|450760058|FG003|Overall Study|Incorrect enrollment|0|||
125309522|NCT00713544|450760059|FG004|Overall Study|Incorrect enrollment|0|||
125309523|NCT00713544|450760060|FG005|Overall Study|Incorrect enrollment|0|||
125309524|NCT00713544|450760055|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
125309525|NCT00713544|450760056|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
125309526|NCT00713544|450760057|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
125309527|NCT00713544|450760058|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
125309528|NCT00713544|450760059|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
125309529|NCT00713544|450760060|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
125309530|NCT02380287|450760061|FG000|Overall Study|Adverse Event|0|||
125309531|NCT02380287|450760062|FG001|Overall Study|Adverse Event|0|||
125309532|NCT02380287|450760063|FG002|Overall Study|Adverse Event|1|||
125309533|NCT02380287|450760064|FG003|Overall Study|Adverse Event|0|||
125309534|NCT02380287|450760065|FG004|Overall Study|Adverse Event|0|||
125309535|NCT02380287|450760066|FG005|Overall Study|Adverse Event|0|||
125309536|NCT02380287|450760067|FG006|Overall Study|Adverse Event|0|||
125309537|NCT02380287|450760068|FG007|Overall Study|Adverse Event|0|||
125309538|NCT01641601|450760069|FG000|Overall Study|Study discontinued.|3|||
125309539|NCT01641601|450760070|FG001|Overall Study|Study discontinued.|5|||
125309540|NCT00950846|450760074|FG000|Overall Study|Death|6|||
125309541|NCT00950846|450760074|FG000|Overall Study|Lost to Follow-up|3|||
125309542|NCT00950846|450760074|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
125309543|NCT02178995|450760075|FG000|Double Blind|Adverse Event|0|||
125309544|NCT02178995|450760076|FG001|Double Blind|Adverse Event|0|||
125309545|NCT02178995|450760077|FG002|Double Blind|Adverse Event|0|||
125309546|NCT02178995|450760078|FG003|Double Blind|Adverse Event|0|||
125309547|NCT02178995|450760079|FG004|Double Blind|Adverse Event|0|||
125309548|NCT02178995|450760080|FG005|Double Blind|Adverse Event|1|||
125309549|NCT02178995|450760081|FG006|Double Blind|Adverse Event|0|||
125309550|NCT02178995|450760082|FG007|Double Blind|Adverse Event|1|||
125309551|NCT02178995|450760083|FG008|Double Blind|Adverse Event|1|||
125309552|NCT02178995|450760075|FG000|Double Blind|Lost to Follow-up|0|||
125309553|NCT02178995|450760076|FG001|Double Blind|Lost to Follow-up|1|||
125309554|NCT02178995|450760077|FG002|Double Blind|Lost to Follow-up|0|||
125309555|NCT02178995|450760078|FG003|Double Blind|Lost to Follow-up|0|||
125309556|NCT02178995|450760079|FG004|Double Blind|Lost to Follow-up|0|||
125309557|NCT02178995|450760080|FG005|Double Blind|Lost to Follow-up|0|||
125309558|NCT02178995|450760081|FG006|Double Blind|Lost to Follow-up|0|||
125309559|NCT02178995|450760082|FG007|Double Blind|Lost to Follow-up|1|||
125309560|NCT02178995|450760083|FG008|Double Blind|Lost to Follow-up|0|||
125309561|NCT02178995|450760075|FG000|Open Label|Adverse Event|2|||
125309562|NCT02178995|450760076|FG001|Open Label|Adverse Event|0|||
125309563|NCT02178995|450760077|FG002|Open Label|Adverse Event|0|||
125309564|NCT02178995|450760078|FG003|Open Label|Adverse Event|0|||
125309565|NCT02178995|450760079|FG004|Open Label|Adverse Event|0|||
125309566|NCT02178995|450760080|FG005|Open Label|Adverse Event|0|||
125309567|NCT02178995|450760081|FG006|Open Label|Adverse Event|0|||
125309568|NCT02178995|450760082|FG007|Open Label|Adverse Event|0|||
125309569|NCT02178995|450760083|FG008|Open Label|Adverse Event|0|||
125309570|NCT00587158|450760084|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
125309571|NCT00587158|450760085|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
125309572|NCT00587158|450760084|FG000|Overall Study|Physician Decision|0|||
125309573|NCT00587158|450760085|FG001|Overall Study|Physician Decision|1|||
125309574|NCT00587158|450760084|FG000|Overall Study|Lost to Follow-up|1|||
125309575|NCT00587158|450760085|FG001|Overall Study|Lost to Follow-up|2|||
125309576|NCT00587158|450760084|FG000|Overall Study|Death|0|||
125309577|NCT00587158|450760085|FG001|Overall Study|Death|1|||
125309578|NCT00587158|450760084|FG000|Overall Study|Subject did not want to take study med|0|||
125309579|NCT00587158|450760085|FG001|Overall Study|Subject did not want to take study med|1|||
125309580|NCT05258149|450760086|FG000|Period 1|Protocol Deviation|1|||
125309581|NCT05258149|450760087|FG001|Period 1|Protocol Deviation|0|||
125309582|NCT05258149|450760086|FG000|Period 1|Adverse Event|0|||
125309583|NCT05258149|450760087|FG001|Period 1|Adverse Event|1|||
125309584|NCT05258149|450760086|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
125309585|NCT05258149|450760087|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
125309586|NCT05258149|450760086|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
125309587|NCT05258149|450760087|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
125309588|NCT05258149|450760086|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
125309589|NCT05258149|450760087|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
125309590|NCT00832416|450760088|FG000|Overall Study|Lack of Efficacy|17|||
125309591|NCT00832416|450760089|FG001|Overall Study|Lack of Efficacy|15|||
125309592|NCT00832416|450760090|FG002|Overall Study|Lack of Efficacy|13|||
125309593|NCT00832416|450760091|FG003|Overall Study|Lack of Efficacy|52|||
125309594|NCT00832416|450760088|FG000|Overall Study|Withdrawal by Subject|5|||
125309595|NCT00832416|450760089|FG001|Overall Study|Withdrawal by Subject|7|||
125309596|NCT00832416|450760090|FG002|Overall Study|Withdrawal by Subject|2|||
125309597|NCT00832416|450760091|FG003|Overall Study|Withdrawal by Subject|10|||
125309598|NCT00832416|450760088|FG000|Overall Study|Physician Decision|2|||
125309599|NCT00832416|450760089|FG001|Overall Study|Physician Decision|12|||
125309600|NCT00832416|450760090|FG002|Overall Study|Physician Decision|5|||
125309601|NCT00832416|450760091|FG003|Overall Study|Physician Decision|10|||
125309602|NCT00832416|450760088|FG000|Overall Study|Administrative|0|||
125309603|NCT00832416|450760089|FG001|Overall Study|Administrative|0|||
125309604|NCT00832416|450760090|FG002|Overall Study|Administrative|0|||
125309605|NCT00832416|450760091|FG003|Overall Study|Administrative|1|||
125309606|NCT00832416|450760088|FG000|Overall Study|Adverse Event|21|||
125309607|NCT00832416|450760089|FG001|Overall Study|Adverse Event|19|||
125309608|NCT00832416|450760090|FG002|Overall Study|Adverse Event|41|||
125309609|NCT00832416|450760091|FG003|Overall Study|Adverse Event|10|||
125309610|NCT00832416|450760088|FG000|Overall Study|Death|1|||
125309611|NCT00832416|450760089|FG001|Overall Study|Death|0|||
125309612|NCT00832416|450760090|FG002|Overall Study|Death|0|||
125309613|NCT00832416|450760091|FG003|Overall Study|Death|0|||
125309614|NCT02114606|450760092|FG000|Overall Study|Unable to swallow Cytosponge|6|||
125309615|NCT00981461|450760093|FG000|Overall Study|Lost to Follow-up|5|||
125309616|NCT00981461|450760094|FG001|Overall Study|Lost to Follow-up|2|||
125309617|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
125309618|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
125309619|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
125309620|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
125309621|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
125309622|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
125309623|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
125309624|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
125309625|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
125309626|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
125309627|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
125309628|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
125309629|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
125309630|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
125309631|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
125309632|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
125309633|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
125309634|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
125309635|NCT01910402|450760105|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
125309636|NCT01910402|450760106|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
125309637|NCT01910402|450760107|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
125309638|NCT01910402|450760105|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
125309639|NCT01910402|450760106|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
125309640|NCT01910402|450760107|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
125309641|NCT01910402|450760105|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
125309642|NCT01910402|450760106|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
125309643|NCT01910402|450760107|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
125309644|NCT01910402|450760105|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
125309645|NCT01910402|450760106|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
125309646|NCT01910402|450760107|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
125309647|NCT01910402|450760105|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
125309648|NCT01910402|450760106|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
125309649|NCT01910402|450760107|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
125309650|NCT01910402|450760105|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
125309651|NCT01910402|450760106|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
125309652|NCT01910402|450760107|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
125533009|NCT04047862|451581439|FG017|Overall Study|Physician Decision|0|||
125309653|NCT01910402|450760105|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
125309654|NCT01910402|450760106|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
125309655|NCT01910402|450760107|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
125309656|NCT00483405|450760108|FG000|Overall Study|Adverse Event|8|||
125309657|NCT00483405|450760108|FG000|Overall Study|Lack of Efficacy|14|||
125309658|NCT00483405|450760108|FG000|Overall Study|Death|3|||
125309659|NCT00483405|450760108|FG000|Overall Study|Withdrawal by Subject|2|||
125309660|NCT00483405|450760108|FG000|Overall Study|Other complicating disease|1|||
125309661|NCT00571038|450760109|FG000|Overall Study|Lost to Follow-up|1|||
125309662|NCT00571038|450760110|FG001|Overall Study|Lost to Follow-up|4|||
125309663|NCT00571038|450760109|FG000|Overall Study|Death|7|||
125309664|NCT00571038|450760110|FG001|Overall Study|Death|5|||
125309665|NCT00571038|450760109|FG000|Overall Study|Withdrawal by Subject|1|||
125309666|NCT00571038|450760110|FG001|Overall Study|Withdrawal by Subject|3|||
125309667|NCT00571038|450760109|FG000|Overall Study|Moved out of state|2|||
125309668|NCT00571038|450760110|FG001|Overall Study|Moved out of state|2|||
125309669|NCT01442714|450760111|FG000|Overall Study|Death|11|||
125309670|NCT01442714|450760111|FG000|Overall Study|Withdrawal by Subject|1|||
125309671|NCT04306510|450760112|FG000|Overall Study|Voluntarily withdrawal|1|||
125309672|NCT04306510|450760112|FG000|Overall Study|Enrolled but Not Treated|1|||
125309673|NCT04829916|450760119|FG000|Overall Study|Withdrawal by Subject|1|||
125309674|NCT04829916|450760120|FG001|Overall Study|Withdrawal by Subject|0|||
125309675|NCT04343755|450760121|FG000|Overall Study|Death|11|||
125309676|NCT04343755|450760121|FG000|Overall Study|Screen Failure|1|||
125309677|NCT00193206|450760122|FG000|Preoperative Therapy|Lack of Efficacy|2|||
125309678|NCT00193206|450760122|FG000|Preoperative Therapy|Adverse Event|2|||
125309679|NCT00193206|450760122|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
125309680|NCT00193206|450760122|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
125309681|NCT00193206|450760122|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
125309682|NCT00193206|450760122|FG000|Postoperative Therapy|Physician Decision|3|||
125309683|NCT00193206|450760122|FG000|Postoperative Therapy|Intercurrent Illness|2|||
125309684|NCT00193206|450760122|FG000|Postoperative Therapy|Lack of Efficacy|1|||
125309685|NCT00193206|450760122|FG000|Postoperative Therapy|Protocol Violation|1|||
125309686|NCT02940496|450760123|FG000|Overall Study|Adverse Event|1|||
125309687|NCT02940496|450760124|FG001|Overall Study|Adverse Event|0|||
125309688|NCT02940496|450760123|FG000|Overall Study|Death|2|||
125309689|NCT02940496|450760124|FG001|Overall Study|Death|0|||
125309690|NCT02940496|450760123|FG000|Overall Study|Hospice Care|1|||
125309691|NCT02940496|450760124|FG001|Overall Study|Hospice Care|0|||
125309692|NCT02940496|450760123|FG000|Overall Study|No MRE Done|1|||
125309693|NCT02940496|450760124|FG001|Overall Study|No MRE Done|0|||
125309694|NCT02940496|450760123|FG000|Overall Study|MRE Failure|1|||
125309695|NCT02940496|450760124|FG001|Overall Study|MRE Failure|0|||
125309696|NCT01147055|450760132|FG000|First Intervention Period|Lost to Follow-up|1|||
125309697|NCT01147055|450760133|FG001|First Intervention Period|Lost to Follow-up|0|||
125309698|NCT00132808|450760134|FG000|Stratum I|Adverse Event|2|||
125309699|NCT00132808|450760135|FG001|Stratum I|Adverse Event|1|||
125309700|NCT00132808|450760136|FG002|Stratum I|Adverse Event|0|||
125309701|NCT00132808|450760134|FG000|Stratum I|Lost to Follow-up|3|||
125309702|NCT00132808|450760135|FG001|Stratum I|Lost to Follow-up|4|||
125309703|NCT00132808|450760136|FG002|Stratum I|Lost to Follow-up|1|||
125309704|NCT00132808|450760134|FG000|Stratum I|Withdrawal by Subject|4|||
125309705|NCT00132808|450760135|FG001|Stratum I|Withdrawal by Subject|7|||
125309706|NCT00132808|450760136|FG002|Stratum I|Withdrawal by Subject|3|||
125309707|NCT00132808|450760134|FG000|Stratum I|Abnormal test procedure result (s)|0|||
125309708|NCT00132808|450760135|FG001|Stratum I|Abnormal test procedure result (s)|0|||
125309709|NCT00132808|450760136|FG002|Stratum I|Abnormal test procedure result (s)|1|||
125309710|NCT00132808|450760134|FG000|Stratum II|Adverse Event|1|||
125309711|NCT00132808|450760135|FG001|Stratum II|Adverse Event|2|||
125309712|NCT00132808|450760136|FG002|Stratum II|Adverse Event|1|||
125309713|NCT00132808|450760134|FG000|Stratum II|Death|1|||
125309714|NCT00132808|450760135|FG001|Stratum II|Death|0|||
125309715|NCT00132808|450760136|FG002|Stratum II|Death|0|||
125309716|NCT00132808|450760134|FG000|Stratum II|Lost to Follow-up|2|||
125309717|NCT00132808|450760135|FG001|Stratum II|Lost to Follow-up|2|||
125309718|NCT00132808|450760136|FG002|Stratum II|Lost to Follow-up|1|||
125309719|NCT00132808|450760134|FG000|Stratum II|Protocol Violation|0|||
125309720|NCT00132808|450760135|FG001|Stratum II|Protocol Violation|2|||
125309721|NCT00132808|450760136|FG002|Stratum II|Protocol Violation|1|||
125309722|NCT00132808|450760134|FG000|Stratum II|Withdrawal by Subject|4|||
125309723|NCT00132808|450760135|FG001|Stratum II|Withdrawal by Subject|9|||
125309724|NCT00132808|450760136|FG002|Stratum II|Withdrawal by Subject|6|||
125309725|NCT02204072|450760143|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
125309726|NCT02204072|450760144|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
125309727|NCT02204072|450760145|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
125309728|NCT02204072|450760146|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
125309729|NCT02204072|450760147|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
125309730|NCT02204072|450760143|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
125309731|NCT02204072|450760144|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
125309732|NCT02204072|450760145|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
125309733|NCT02204072|450760146|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
125309734|NCT02204072|450760147|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
125309735|NCT02204072|450760143|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
125309736|NCT02204072|450760144|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
125309737|NCT02204072|450760145|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
125309738|NCT02204072|450760146|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
125309739|NCT02204072|450760147|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
125309740|NCT02204072|450760143|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
125309741|NCT02204072|450760144|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
125309742|NCT02204072|450760145|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
125309743|NCT02204072|450760146|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
125309744|NCT02204072|450760147|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
125309745|NCT00874848|450760154|FG000|Overall Study|Adverse Event|13|||
125309746|NCT00874848|450760155|FG001|Overall Study|Adverse Event|2|||
125309747|NCT00874848|450760154|FG000|Overall Study|Progressive neoplastic disease|38|||
125309748|NCT00874848|450760155|FG001|Overall Study|Progressive neoplastic disease|18|||
125309749|NCT00874848|450760154|FG000|Overall Study|Withdrawal by Subject|7|||
125309750|NCT00874848|450760155|FG001|Overall Study|Withdrawal by Subject|4|||
125309751|NCT00874848|450760154|FG000|Overall Study|Noncompliance|1|||
125309752|NCT00874848|450760155|FG001|Overall Study|Noncompliance|1|||
125309753|NCT00874848|450760154|FG000|Overall Study|Failure to comply with protocol|0|||
125309754|NCT00874848|450760155|FG001|Overall Study|Failure to comply with protocol|1|||
125309755|NCT00874848|450760154|FG000|Overall Study|Physician Decision|0|||
125309756|NCT00874848|450760155|FG001|Overall Study|Physician Decision|2|||
125309757|NCT01870726|450760160|FG000|Overall Study|Withdrawal of informed consent|0|||
125309758|NCT01870726|450760161|FG001|Overall Study|Withdrawal of informed consent|0|||
125309759|NCT01870726|450760162|FG002|Overall Study|Withdrawal of informed consent|0|||
125309760|NCT01870726|450760163|FG003|Overall Study|Withdrawal of informed consent|1|||
125309761|NCT01870726|450760164|FG004|Overall Study|Withdrawal of informed consent|0|||
125309762|NCT01870726|450760165|FG005|Overall Study|Withdrawal of informed consent|0|||
125309763|NCT01870726|450760166|FG006|Overall Study|Withdrawal of informed consent|0|||
125309764|NCT01870726|450760160|FG000|Overall Study|Withdrawal by Subject|0|||
125309765|NCT01870726|450760161|FG001|Overall Study|Withdrawal by Subject|1|||
125309766|NCT01870726|450760162|FG002|Overall Study|Withdrawal by Subject|0|||
125309767|NCT01870726|450760163|FG003|Overall Study|Withdrawal by Subject|0|||
125309768|NCT01870726|450760164|FG004|Overall Study|Withdrawal by Subject|0|||
125309769|NCT01870726|450760165|FG005|Overall Study|Withdrawal by Subject|0|||
125309770|NCT01870726|450760166|FG006|Overall Study|Withdrawal by Subject|0|||
125309771|NCT01870726|450760160|FG000|Overall Study|Adverse Event|0|||
125309772|NCT01870726|450760161|FG001|Overall Study|Adverse Event|0|||
125309773|NCT01870726|450760162|FG002|Overall Study|Adverse Event|0|||
125309774|NCT01870726|450760163|FG003|Overall Study|Adverse Event|0|||
125309775|NCT01870726|450760164|FG004|Overall Study|Adverse Event|1|||
125309776|NCT01870726|450760165|FG005|Overall Study|Adverse Event|1|||
125309777|NCT01870726|450760166|FG006|Overall Study|Adverse Event|0|||
125309778|NCT01870726|450760160|FG000|Overall Study|Progressive disease|5|||
125309779|NCT01870726|450760161|FG001|Overall Study|Progressive disease|5|||
125309780|NCT01870726|450760162|FG002|Overall Study|Progressive disease|4|||
125309781|NCT01870726|450760163|FG003|Overall Study|Progressive disease|5|||
125309782|NCT01870726|450760164|FG004|Overall Study|Progressive disease|6|||
125309783|NCT01870726|450760165|FG005|Overall Study|Progressive disease|4|||
125309784|NCT01870726|450760166|FG006|Overall Study|Progressive disease|10|||
125309785|NCT00286429|450760167|FG000|Overall Study|Adverse Event|4|||
125309786|NCT00286429|450760168|FG001|Overall Study|Adverse Event|1|||
125309787|NCT00286429|450760169|FG002|Overall Study|Adverse Event|6|||
125309788|NCT00286429|450760167|FG000|Overall Study|Lack of Efficacy|52|||
125309789|NCT00286429|450760168|FG001|Overall Study|Lack of Efficacy|27|||
125309790|NCT00286429|450760169|FG002|Overall Study|Lack of Efficacy|25|||
125309791|NCT00286429|450760167|FG000|Overall Study|Lost to Follow-up|2|||
125309792|NCT00286429|450760168|FG001|Overall Study|Lost to Follow-up|4|||
125309793|NCT00286429|450760169|FG002|Overall Study|Lost to Follow-up|3|||
125309794|NCT00286429|450760167|FG000|Overall Study|Physician Decision|10|||
125309795|NCT00286429|450760168|FG001|Overall Study|Physician Decision|7|||
125309796|NCT00286429|450760169|FG002|Overall Study|Physician Decision|7|||
125309797|NCT00286429|450760167|FG000|Overall Study|Protocol Violation|3|||
125309798|NCT00286429|450760168|FG001|Overall Study|Protocol Violation|5|||
125309799|NCT00286429|450760169|FG002|Overall Study|Protocol Violation|4|||
125309800|NCT00286429|450760167|FG000|Overall Study|Withdrawal by Subject|3|||
125309801|NCT00286429|450760168|FG001|Overall Study|Withdrawal by Subject|2|||
125309802|NCT00286429|450760169|FG002|Overall Study|Withdrawal by Subject|6|||
125309803|NCT00286429|450760167|FG000|Overall Study|Administrative Error|1|||
125309804|NCT00286429|450760168|FG001|Overall Study|Administrative Error|1|||
125309805|NCT00286429|450760169|FG002|Overall Study|Administrative Error|1|||
125309806|NCT00286429|450760167|FG000|Overall Study|Administrative Decision|0|||
125309807|NCT00286429|450760168|FG001|Overall Study|Administrative Decision|1|||
125309808|NCT00286429|450760169|FG002|Overall Study|Administrative Decision|0|||
125309809|NCT00595478|450760172|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
125309810|NCT00595478|450760173|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
125309811|NCT00595478|450760172|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
125309812|NCT00595478|450760173|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
125309813|NCT01123395|450760175|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
125309814|NCT01123395|450760176|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
125309815|NCT03691571|450760177|FG000|Overall Study|Withdrawal by Subject|9|||
125309816|NCT03691571|450760178|FG001|Overall Study|Withdrawal by Subject|2|||
125309817|NCT00186901|450760180|FG000|Overall Study|Pregnancy|6|||
125309818|NCT00186901|450760181|FG001|Overall Study|Pregnancy|3|||
125309819|NCT00186901|450760182|FG002|Overall Study|Pregnancy|0|||
125309820|NCT00186901|450760180|FG000|Overall Study|Lost to Follow-up|6|||
125309821|NCT00186901|450760181|FG001|Overall Study|Lost to Follow-up|3|||
125309822|NCT00186901|450760182|FG002|Overall Study|Lost to Follow-up|0|||
125309823|NCT00186901|450760180|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
125309824|NCT00186901|450760181|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
125309825|NCT00186901|450760182|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
125309826|NCT00186901|450760180|FG000|Overall Study|ALL relapse or second malignancy|1|||
125309827|NCT00186901|450760181|FG001|Overall Study|ALL relapse or second malignancy|2|||
125309828|NCT00186901|450760182|FG002|Overall Study|ALL relapse or second malignancy|0|||
125309829|NCT00186901|450760180|FG000|Overall Study|Withdrawal by Subject|4|||
125309830|NCT00186901|450760181|FG001|Overall Study|Withdrawal by Subject|5|||
125309831|NCT00186901|450760182|FG002|Overall Study|Withdrawal by Subject|0|||
125309832|NCT00186901|450760180|FG000|Overall Study|Open label|3|||
125309833|NCT00186901|450760181|FG001|Overall Study|Open label|2|||
125309834|NCT00186901|450760182|FG002|Overall Study|Open label|0|||
125309835|NCT00186901|450760180|FG000|Overall Study|Limited adherence to study requirements|20|||
125309836|NCT00186901|450760181|FG001|Overall Study|Limited adherence to study requirements|23|||
125309837|NCT00186901|450760182|FG002|Overall Study|Limited adherence to study requirements|0|||
125309838|NCT00186901|450760180|FG000|Overall Study|Bone Mineral Density > 0|0|||
125309839|NCT00186901|450760181|FG001|Overall Study|Bone Mineral Density > 0|0|||
125309840|NCT00186901|450760182|FG002|Overall Study|Bone Mineral Density > 0|149|||
125309841|NCT02363959|450760187|FG000|Overall Study|Medical instability|1|||
125309842|NCT02363959|450760188|FG001|Overall Study|Medical instability|0|||
125309843|NCT00950248|450760191|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
125309844|NCT00950248|450760192|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
125309845|NCT00950248|450760193|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
125309846|NCT00950248|450760191|FG000|Year 1: Baseline|worsening of symptoms|2|||
125309847|NCT00950248|450760192|FG001|Year 1: Baseline|worsening of symptoms|0|||
125309848|NCT00950248|450760193|FG002|Year 1: Baseline|worsening of symptoms|0|||
125309849|NCT00950248|450760191|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
125309850|NCT00950248|450760192|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
125309851|NCT00950248|450760193|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
125309852|NCT00950248|450760191|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
125309853|NCT00950248|450760192|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
125309854|NCT00950248|450760193|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
125309855|NCT00950248|450760191|FG000|Year 2&3 Treatment Randomization|Death|0|||
125309856|NCT00950248|450760192|FG001|Year 2&3 Treatment Randomization|Death|0|||
125309857|NCT00950248|450760193|FG002|Year 2&3 Treatment Randomization|Death|1|||
125309858|NCT00950248|450760191|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
125309859|NCT00950248|450760192|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
125309860|NCT00950248|450760193|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
125309861|NCT00869518|450760197|FG000|Overall Study|Lost to Follow-up|1|||
125309862|NCT00869518|450760198|FG001|Overall Study|Lost to Follow-up|1|||
125309863|NCT00947115|450760199|FG000|Overall Study|Missed reporting interval|3|||
125309864|NCT00947115|450760200|FG001|Overall Study|Missed reporting interval|4|||
125309865|NCT00947115|450760201|FG002|Overall Study|Missed reporting interval|2|||
125309866|NCT00947115|450760199|FG000|Overall Study|Physician Decision|0|||
125309867|NCT00947115|450760200|FG001|Overall Study|Physician Decision|2|||
125309868|NCT00947115|450760201|FG002|Overall Study|Physician Decision|0|||
125309869|NCT00947115|450760199|FG000|Overall Study|Death|0|||
125309870|NCT00947115|450760200|FG001|Overall Study|Death|1|||
125309871|NCT00947115|450760201|FG002|Overall Study|Death|1|||
125309872|NCT00947115|450760199|FG000|Overall Study|Migrated from study area|2|||
125309873|NCT00947115|450760200|FG001|Overall Study|Migrated from study area|0|||
125309874|NCT00947115|450760201|FG002|Overall Study|Migrated from study area|0|||
125309875|NCT00947115|450760199|FG000|Overall Study|Withdrawal by Subject|1|||
125309876|NCT00947115|450760200|FG001|Overall Study|Withdrawal by Subject|3|||
125309877|NCT00947115|450760201|FG002|Overall Study|Withdrawal by Subject|4|||
125309883|NCT00511238|450760204|FG000|Overall Study|Withdrawal by Subject|2|||
125309884|NCT00511238|450760205|FG001|Overall Study|Withdrawal by Subject|22|||
125309885|NCT00511238|450760204|FG000|Overall Study|Progressive Disease|23|||
125309886|NCT00511238|450760205|FG001|Overall Study|Progressive Disease|157|||
125309887|NCT00511238|450760204|FG000|Overall Study|various reasons|4|||
125309888|NCT00511238|450760205|FG001|Overall Study|various reasons|14|||
125309889|NCT02587819|450760206|FG000|Overall Study|Adverse Event|1|||
125309890|NCT02587819|450760206|FG000|Overall Study|Lost to Follow-up|1|||
125309891|NCT03772665|450760207|FG000|Overall Study|Protocol Violation|1|||
125309892|NCT03772665|450760208|FG001|Overall Study|Protocol Violation|0|||
125532276|NCT01263509|451580070|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
125532277|NCT01263509|451580071|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
125532278|NCT01263509|451580072|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
125532279|NCT01263509|451580073|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
125532280|NCT01263509|451580070|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
125532281|NCT01263509|451580071|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
125532282|NCT01263509|451580072|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
125532283|NCT01263509|451580073|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
125532284|NCT02593123|451580074|FG000|Overall Study|Physician Decision|2|||
125532285|NCT02593123|451580075|FG001|Overall Study|Physician Decision|1|||
125532286|NCT02593123|451580074|FG000|Overall Study|Relapse|1|||
125532287|NCT02593123|451580075|FG001|Overall Study|Relapse|1|||
125532288|NCT02440425|451580076|FG000|Overall Study|Death likely due to disease progression|1|||
125532289|NCT02440425|451580076|FG000|Overall Study|Withdrawal by Subject|2|||
125532290|NCT02440425|451580076|FG000|Overall Study|Adverse Event|1|||
125532291|NCT02440425|451580076|FG000|Overall Study|Adverse Event/Ineligible|1|||
125532292|NCT02807272|451580079|FG000|Overall Study|Death|9|||
125532293|NCT02807272|451580080|FG001|Overall Study|Death|5|||
125532294|NCT02807272|451580081|FG002|Overall Study|Death|2|||
125532295|NCT02807272|451580082|FG003|Overall Study|Death|0|||
125532296|NCT02807272|451580083|FG004|Overall Study|Death|1|||
125532297|NCT02807272|451580079|FG000|Overall Study|Lost to Follow-up|1|||
125532298|NCT02807272|451580080|FG001|Overall Study|Lost to Follow-up|0|||
125532299|NCT02807272|451580081|FG002|Overall Study|Lost to Follow-up|0|||
125532300|NCT02807272|451580082|FG003|Overall Study|Lost to Follow-up|0|||
125532301|NCT02807272|451580083|FG004|Overall Study|Lost to Follow-up|0|||
125532302|NCT02807272|451580079|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
125532303|NCT02807272|451580080|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
125532304|NCT02807272|451580081|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
125532305|NCT02807272|451580082|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
125532306|NCT02807272|451580083|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
125532307|NCT02807272|451580079|FG000|Overall Study|Protocol-defined Disease Progression|0|||
125532308|NCT02807272|451580080|FG001|Overall Study|Protocol-defined Disease Progression|1|||
125532309|NCT02807272|451580081|FG002|Overall Study|Protocol-defined Disease Progression|0|||
125532310|NCT02807272|451580082|FG003|Overall Study|Protocol-defined Disease Progression|0|||
125532311|NCT02807272|451580083|FG004|Overall Study|Protocol-defined Disease Progression|1|||
125532312|NCT02807272|451580079|FG000|Overall Study|Study Terminated by Sponsor|1|||
125532313|NCT02807272|451580080|FG001|Overall Study|Study Terminated by Sponsor|0|||
125532314|NCT02807272|451580081|FG002|Overall Study|Study Terminated by Sponsor|0|||
125532315|NCT02807272|451580082|FG003|Overall Study|Study Terminated by Sponsor|1|||
125532316|NCT02807272|451580083|FG004|Overall Study|Study Terminated by Sponsor|0|||
125532317|NCT02807272|451580079|FG000|Overall Study|Other|1|||
125532318|NCT02807272|451580080|FG001|Overall Study|Other|0|||
125532319|NCT02807272|451580081|FG002|Overall Study|Other|0|||
125532320|NCT02807272|451580082|FG003|Overall Study|Other|0|||
125532321|NCT02807272|451580083|FG004|Overall Study|Other|1|||
125532322|NCT01038427|451580084|FG000|Overall Study|Lost to follow up|1|||
125532323|NCT01038427|451580085|FG001|Overall Study|Lost to follow up|1|||
125532324|NCT01038427|451580086|FG002|Overall Study|Lost to follow up|0|||
125532325|NCT01038427|451580084|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
125532326|NCT01038427|451580085|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
125532327|NCT01038427|451580086|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
125532328|NCT01038427|451580084|FG000|Overall Study|Withdrew consent|0|||
125532329|NCT01038427|451580085|FG001|Overall Study|Withdrew consent|0|||
125532330|NCT01038427|451580086|FG002|Overall Study|Withdrew consent|1|||
125532331|NCT01038427|451580084|FG000|Overall Study|Adverse Event|2|||
125532332|NCT01038427|451580085|FG001|Overall Study|Adverse Event|2|||
125532333|NCT01038427|451580086|FG002|Overall Study|Adverse Event|1|||
125532334|NCT01038427|451580084|FG000|Overall Study|Enrolled in error|0|||
125532335|NCT01038427|451580085|FG001|Overall Study|Enrolled in error|1|||
125532336|NCT01038427|451580086|FG002|Overall Study|Enrolled in error|1|||
125532337|NCT01038427|451580084|FG000|Overall Study|Other|0|||
125532338|NCT01038427|451580085|FG001|Overall Study|Other|2|||
125532339|NCT01038427|451580086|FG002|Overall Study|Other|0|||
125532340|NCT01162863|451580087|FG000|Overall Study|Lack of Efficacy|1|||
125532379|NCT02817906|451580102|FG001|Overall Study|Withdrawal by Subject|0|||
125532380|NCT02817906|451580101|FG000|Overall Study|Other|2|||
125532381|NCT02817906|451580102|FG001|Overall Study|Other|2|||
125532382|NCT03686423|451580103|FG000|Overall Study|Withdrawal by Subject|9|||
125532383|NCT03686423|451580103|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
125532384|NCT02833077|451580104|FG000|Overall Study|Adverse Event|1|||
125532385|NCT02833077|451580105|FG001|Overall Study|Adverse Event|2|||
125532386|NCT02833077|451580104|FG000|Overall Study|Lost to Follow-up|10|||
125532387|NCT02833077|451580105|FG001|Overall Study|Lost to Follow-up|1|||
125532388|NCT02833077|451580104|FG000|Overall Study|Personal Reasons|6|||
125532389|NCT02833077|451580105|FG001|Overall Study|Personal Reasons|4|||
125532390|NCT02833077|451580104|FG000|Overall Study|Protocol Deviation|0|||
125532391|NCT02833077|451580105|FG001|Overall Study|Protocol Deviation|1|||
125532392|NCT01077518|451580106|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
125532393|NCT01077518|451580107|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
125532394|NCT01077518|451580108|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
125532395|NCT01077518|451580106|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
125532396|NCT01077518|451580107|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
125532397|NCT01077518|451580108|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
125532398|NCT01077518|451580106|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
125532399|NCT01077518|451580107|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
125532400|NCT01077518|451580108|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
125532401|NCT01077518|451580106|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
125532402|NCT01077518|451580107|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
125532403|NCT01077518|451580108|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
125532404|NCT01077518|451580106|FG000|Optional Ofa Phase|Physician Decision|0|||
125532405|NCT01077518|451580107|FG001|Optional Ofa Phase|Physician Decision|0|||
125532406|NCT01077518|451580108|FG002|Optional Ofa Phase|Physician Decision|1|||
125532407|NCT01077518|451580106|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
125532408|NCT01077518|451580107|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
125532409|NCT01077518|451580108|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
125532410|NCT01077518|451580106|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
125532411|NCT01077518|451580107|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
125532412|NCT01077518|451580108|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
125532413|NCT00972322|451580109|FG000|Overall Study|Adverse Event|2|||
125532414|NCT00972322|451580110|FG001|Overall Study|Adverse Event|1|||
125532415|NCT00972322|451580109|FG000|Overall Study|Positive drug screen|0|||
125532416|NCT00972322|451580110|FG001|Overall Study|Positive drug screen|1|||
125532417|NCT00972322|451580109|FG000|Overall Study|Lost to Follow-up|0|||
125532418|NCT00972322|451580110|FG001|Overall Study|Lost to Follow-up|1|||
125532419|NCT00972322|451580109|FG000|Overall Study|Consistently high glucose values|1|||
125532420|NCT00972322|451580110|FG001|Overall Study|Consistently high glucose values|0|||
125532421|NCT01495598|451580111|FG000|Overall Study|Death during follow up period|2|||
125532422|NCT01495598|451580111|FG000|Overall Study|Death on study|1|||
125532423|NCT01495598|451580111|FG000|Overall Study|Lost to Follow-up|3|||
125532424|NCT01495598|451580111|FG000|Overall Study|Physician Decision|8|||
125532425|NCT05511038|451580115|FG000|Overall|Withdrawal by Subject|5|||
125532426|NCT05511038|451580116|FG001|Overall|Withdrawal by Subject|3|||
125532427|NCT05511038|451580115|FG000|Overall|Screen Failure|20|||
125532428|NCT05511038|451580116|FG001|Overall|Screen Failure|1|||
125532429|NCT05511038|451580115|FG000|Overall|Physician Decision|3|||
125532430|NCT05511038|451580116|FG001|Overall|Physician Decision|0|||
125532431|NCT05511038|451580115|FG000|Overall|Lost to Follow-up|3|||
125532432|NCT05511038|451580116|FG001|Overall|Lost to Follow-up|0|||
125532433|NCT05511038|451580115|FG000|Overall|Death|1|||
125532434|NCT05511038|451580116|FG001|Overall|Death|0|||
125532435|NCT05511038|451580115|FG000|Screening|Withdrawal by Subject|1|||
125532436|NCT05511038|451580116|FG001|Screening|Withdrawal by Subject|0|||
125532437|NCT05511038|451580115|FG000|Screening|Lost to Follow Up (1 participant)|1|||
125532438|NCT05511038|451580116|FG001|Screening|Lost to Follow Up (1 participant)|0|||
125532439|NCT05511038|451580115|FG000|Screening|Screen Failure|3|||
125532440|NCT05511038|451580116|FG001|Screening|Screen Failure|0|||
125532441|NCT05511038|451580115|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
125532442|NCT05511038|451580116|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
125532443|NCT05511038|451580115|FG000|Treatment|Withdrawal by Subject|5|||
125532444|NCT05511038|451580116|FG001|Treatment|Withdrawal by Subject|3|||
125532445|NCT05511038|451580115|FG000|Treatment|Physician Decision|4|||
125532446|NCT05511038|451580116|FG001|Treatment|Physician Decision|0|||
125532447|NCT05511038|451580115|FG000|Treatment|Lost to Follow-up|2|||
125532448|NCT05511038|451580116|FG001|Treatment|Lost to Follow-up|0|||
125532449|NCT05511038|451580115|FG000|Treatment|Death|1|||
125532450|NCT05511038|451580116|FG001|Treatment|Death|0|||
125532451|NCT05511038|451580115|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
125532452|NCT05511038|451580116|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
125532453|NCT05511038|451580115|FG000|Treatment|Refuse by subject|1|||
125532455|NCT05511038|451580115|FG000|Treatment|Subject did not go to the site for visit|1|||
125532456|NCT05511038|451580116|FG001|Treatment|Subject did not go to the site for visit|0|||
125532457|NCT05140915|451580117|FG000|Overall Study|Lost to Follow-up|2|||
125532458|NCT05140915|451580118|FG001|Overall Study|Lost to Follow-up|1|||
125532459|NCT04485611|451580119|FG000|Prehabilitation|Physician Decision|1|||
125532460|NCT04879849|451580120|FG000|Overall Study|Lost to Follow-up|0|||
125532461|NCT04879849|451580121|FG001|Overall Study|Lost to Follow-up|0|||
125532462|NCT04879849|451580122|FG002|Overall Study|Lost to Follow-up|0|||
125532463|NCT04879849|451580123|FG003|Overall Study|Lost to Follow-up|1|||
125532464|NCT04879849|451580124|FG004|Overall Study|Lost to Follow-up|0|||
125532465|NCT04879849|451580125|FG005|Overall Study|Lost to Follow-up|0|||
125532466|NCT04879849|451580126|FG006|Overall Study|Lost to Follow-up|0|||
125532467|NCT04879849|451580127|FG007|Overall Study|Lost to Follow-up|0|||
125532468|NCT04879849|451580120|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
125532469|NCT04879849|451580121|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
125532470|NCT04879849|451580122|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
125532471|NCT04879849|451580123|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
125532472|NCT04879849|451580124|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
125532473|NCT04879849|451580125|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
125532474|NCT04879849|451580126|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
125532475|NCT04879849|451580127|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
125532476|NCT04879849|451580120|FG000|Overall Study|Withdrawal by Subject|0|||
125532477|NCT04879849|451580121|FG001|Overall Study|Withdrawal by Subject|0|||
125532478|NCT04879849|451580122|FG002|Overall Study|Withdrawal by Subject|0|||
125532479|NCT04879849|451580123|FG003|Overall Study|Withdrawal by Subject|0|||
125532480|NCT04879849|451580124|FG004|Overall Study|Withdrawal by Subject|2|||
125532481|NCT04879849|451580125|FG005|Overall Study|Withdrawal by Subject|0|||
125532482|NCT04879849|451580126|FG006|Overall Study|Withdrawal by Subject|1|||
125532483|NCT04879849|451580127|FG007|Overall Study|Withdrawal by Subject|0|||
125532484|NCT04879849|451580120|FG000|Overall Study|Progressive Disease|0|||
125532485|NCT04879849|451580121|FG001|Overall Study|Progressive Disease|0|||
125532486|NCT04879849|451580122|FG002|Overall Study|Progressive Disease|1|||
125532487|NCT04879849|451580123|FG003|Overall Study|Progressive Disease|0|||
125532488|NCT04879849|451580124|FG004|Overall Study|Progressive Disease|0|||
125532489|NCT04879849|451580125|FG005|Overall Study|Progressive Disease|0|||
125532490|NCT04879849|451580126|FG006|Overall Study|Progressive Disease|0|||
125532491|NCT04879849|451580127|FG007|Overall Study|Progressive Disease|0|||
125532492|NCT04879849|451580120|FG000|Overall Study|Death|0|||
125532493|NCT04879849|451580121|FG001|Overall Study|Death|0|||
125532494|NCT04879849|451580122|FG002|Overall Study|Death|1|||
125532495|NCT04879849|451580123|FG003|Overall Study|Death|1|||
125532496|NCT04879849|451580124|FG004|Overall Study|Death|1|||
125532497|NCT04879849|451580125|FG005|Overall Study|Death|2|||
125532498|NCT04879849|451580126|FG006|Overall Study|Death|1|||
125532499|NCT04879849|451580127|FG007|Overall Study|Death|2|||
125532500|NCT04879849|451580120|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
125532501|NCT04879849|451580121|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
125532502|NCT04879849|451580122|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
125532503|NCT04879849|451580123|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
125532504|NCT04879849|451580124|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
125532505|NCT04879849|451580125|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
125532506|NCT04879849|451580126|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
125532507|NCT04879849|451580127|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
125532508|NCT04879849|451580120|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
125532509|NCT04879849|451580121|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
125532510|NCT04879849|451580122|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
125532511|NCT04879849|451580123|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
125532512|NCT04879849|451580124|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
125532513|NCT04879849|451580125|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
125532514|NCT04879849|451580126|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
125532515|NCT04879849|451580127|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
125532516|NCT04879849|451580120|FG000|Overall Study|Reason Not Specified|1|||
125532517|NCT04879849|451580121|FG001|Overall Study|Reason Not Specified|0|||
125532518|NCT04879849|451580122|FG002|Overall Study|Reason Not Specified|0|||
125532519|NCT04879849|451580123|FG003|Overall Study|Reason Not Specified|0|||
125532520|NCT04879849|451580124|FG004|Overall Study|Reason Not Specified|0|||
125532521|NCT04879849|451580125|FG005|Overall Study|Reason Not Specified|0|||
125532522|NCT04879849|451580126|FG006|Overall Study|Reason Not Specified|0|||
125533010|NCT04047862|451581440|FG018|Overall Study|Physician Decision|0|||
125532523|NCT04879849|451580127|FG007|Overall Study|Reason Not Specified|0|||
125532524|NCT03810235|451580130|FG000|Overall Study|Withdrawal by Subject|2|||
125532525|NCT03810235|451580131|FG001|Overall Study|Withdrawal by Subject|0|||
125532526|NCT04777864|451580132|FG000|Overall Study|Lost to Follow-up|8|||
125532527|NCT04777864|451580133|FG001|Overall Study|Lost to Follow-up|19|||
125532528|NCT01647542|451580134|FG000|Overall Study|Major Protocol Deviation|1|||
125532529|NCT01647542|451580135|FG001|Overall Study|Major Protocol Deviation|0|||
125532530|NCT01647542|451580136|FG002|Overall Study|Major Protocol Deviation|0|||
125532531|NCT01647542|451580134|FG000|Overall Study|Adverse Event|4|||
125532532|NCT01647542|451580135|FG001|Overall Study|Adverse Event|5|||
125532533|NCT01647542|451580136|FG002|Overall Study|Adverse Event|4|||
125532534|NCT01647542|451580134|FG000|Overall Study|Lost to Follow-up|0|||
125532535|NCT01647542|451580135|FG001|Overall Study|Lost to Follow-up|2|||
125532536|NCT01647542|451580136|FG002|Overall Study|Lost to Follow-up|2|||
125532537|NCT01647542|451580134|FG000|Overall Study|Withdrawal by Subject|6|||
125532538|NCT01647542|451580135|FG001|Overall Study|Withdrawal by Subject|4|||
125532539|NCT01647542|451580136|FG002|Overall Study|Withdrawal by Subject|0|||
125532540|NCT01647542|451580134|FG000|Overall Study|Study Termination|64|||
125532541|NCT01647542|451580135|FG001|Overall Study|Study Termination|61|||
125532542|NCT01647542|451580136|FG002|Overall Study|Study Termination|65|||
125532543|NCT01647542|451580134|FG000|Overall Study|Lack of Efficacy|1|||
125532544|NCT01647542|451580135|FG001|Overall Study|Lack of Efficacy|1|||
125532545|NCT01647542|451580136|FG002|Overall Study|Lack of Efficacy|0|||
125532546|NCT01647542|451580134|FG000|Overall Study|Death|0|||
125532547|NCT01647542|451580135|FG001|Overall Study|Death|0|||
125532548|NCT01647542|451580136|FG002|Overall Study|Death|1|||
125532549|NCT03086655|451580137|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
125532550|NCT03086655|451580138|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
125532551|NCT03086655|451580137|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
125532552|NCT03086655|451580138|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
125532553|NCT03086655|451580137|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
125532554|NCT03086655|451580138|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
125532555|NCT03086655|451580137|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
125532556|NCT03086655|451580138|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
125532557|NCT03086655|451580137|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
125532558|NCT03086655|451580138|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
125532559|NCT03086655|451580137|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
125532560|NCT03086655|451580138|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
125532561|NCT03086655|451580137|FG000|12 Month Follow-up = Final Assessment|Death|0|||
125532562|NCT03086655|451580138|FG001|12 Month Follow-up = Final Assessment|Death|1|||
125532563|NCT05576662|451580139|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
125532564|NCT05576662|451580140|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
125532565|NCT05576662|451580139|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
125532566|NCT05576662|451580140|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
125532567|NCT05576662|451580139|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
125532568|NCT05576662|451580140|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
125532569|NCT05576662|451580139|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
125532570|NCT05576662|451580140|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
125532571|NCT03008005|451580141|FG000|Overall Study|Physician Decision|1|||
125532572|NCT03008005|451580142|FG001|Overall Study|Physician Decision|0|||
125532573|NCT03008005|451580143|FG002|Overall Study|Physician Decision|0|||
125532574|NCT03008005|451580141|FG000|Overall Study|Withdrawal by Subject|1|||
125532575|NCT03008005|451580142|FG001|Overall Study|Withdrawal by Subject|0|||
125532576|NCT03008005|451580143|FG002|Overall Study|Withdrawal by Subject|0|||
125532577|NCT03008005|451580141|FG000|Overall Study|Ineligible|0|||
125532578|NCT03008005|451580142|FG001|Overall Study|Ineligible|1|||
125532579|NCT03008005|451580143|FG002|Overall Study|Ineligible|0|||
125532580|NCT01040169|451580159|FG000|Overall Study|Lost to Follow-up|3|||
125532581|NCT01040169|451580160|FG001|Overall Study|Lost to Follow-up|8|||
125532582|NCT00350727|451580161|FG000|Phase I: Dose Escalation|Adverse Event|4|||
125532583|NCT00350727|451580162|FG001|Phase I: Dose Escalation|Adverse Event|0|||
125532584|NCT00350727|451580163|FG002|Phase I: Dose Escalation|Adverse Event|0|||
125532585|NCT00350727|451580161|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
125532586|NCT00350727|451580162|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
125532587|NCT00350727|451580163|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
125532588|NCT00350727|451580161|FG000|Phase I: Dose Escalation|Death|1|||
125532589|NCT00350727|451580162|FG001|Phase I: Dose Escalation|Death|0|||
125532590|NCT00350727|451580163|FG002|Phase I: Dose Escalation|Death|0|||
125532591|NCT00350727|451580161|FG000|Phase I: Dose Escalation|Physician Decision|1|||
125532592|NCT00350727|451580162|FG001|Phase I: Dose Escalation|Physician Decision|0|||
125532593|NCT00350727|451580163|FG002|Phase I: Dose Escalation|Physician Decision|0|||
125532594|NCT00350727|451580161|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
125532595|NCT00350727|451580162|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
125532596|NCT00350727|451580163|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
125532615|NCT00350727|451580161|FG000|Phase II|Enrolled in Rollover Study|0|||
125532616|NCT00350727|451580162|FG001|Phase II|Enrolled in Rollover Study|0|||
125532617|NCT00350727|451580163|FG002|Phase II|Enrolled in Rollover Study|1|||
125532618|NCT03633799|451580168|FG000|Overall Study|Adverse Event|349|||
125532619|NCT03633799|451580168|FG000|Overall Study|Withdrawal by Subject|288|||
125532620|NCT03633799|451580168|FG000|Overall Study|Lost to Follow-up|97|||
125532621|NCT03633799|451580168|FG000|Overall Study|Physician Decision|9|||
125532622|NCT03633799|451580168|FG000|Overall Study|Protocol Violation|4|||
125532623|NCT03633799|451580168|FG000|Overall Study|Pregnancy|20|||
125532624|NCT03633799|451580168|FG000|Overall Study|other|39|||
125532625|NCT03633799|451580168|FG000|Overall Study|ongoing within third year of study|106|||
125532626|NCT03633799|451580168|FG000|Overall Study|unsuccessful study drug placement|19|||
125532627|NCT03551691|451580169|FG000|Overall Study|Withdrawal by Subject|3|||
125532628|NCT03551691|451580170|FG001|Overall Study|Withdrawal by Subject|3|||
125532629|NCT03520712|451580171|FG000|Overall Study|Early termination of the study by Sponsor|2|||
125532630|NCT05855967|451580172|FG000|Overall Study|Withdrawal by Subject|7|||
125532631|NCT05855967|451580173|FG001|Overall Study|Withdrawal by Subject|5|||
125532632|NCT05855967|451580172|FG000|Overall Study|Lost to Follow-up|2|||
125532633|NCT05855967|451580173|FG001|Overall Study|Lost to Follow-up|1|||
125532634|NCT02446821|451580174|FG000|Overall Study|Adverse Event|28|||
125532635|NCT02446821|451580174|FG000|Overall Study|Withdrawal by Subject|6|||
125532636|NCT02446821|451580174|FG000|Overall Study|Lost to Follow-up|22|||
125532637|NCT02446821|451580174|FG000|Overall Study|other|9|||
125532638|NCT02446821|451580174|FG000|Overall Study|insertion failure|3|||
125532639|NCT02284009|451580176|FG000|Overall Study|Adverse Event|3|||
125532640|NCT02284009|451580177|FG001|Overall Study|Adverse Event|0|||
125532641|NCT02284009|451580176|FG000|Overall Study|Lost to Follow-up|1|||
125532642|NCT02284009|451580177|FG001|Overall Study|Lost to Follow-up|3|||
125532643|NCT02284009|451580176|FG000|Overall Study|Physician Decision|0|||
125532644|NCT02284009|451580177|FG001|Overall Study|Physician Decision|2|||
125532645|NCT02284009|451580176|FG000|Overall Study|Withdrawal by Subject|2|||
125532646|NCT02284009|451580177|FG001|Overall Study|Withdrawal by Subject|5|||
125532647|NCT04942366|451581320|FG000|Overall Study|Withdrawal by Subject|5|||
125532648|NCT04942366|451581321|FG001|Overall Study|Withdrawal by Subject|5|||
125532649|NCT01736189|451581322|FG000|Overall Study|Violation of registration criteria|41|||
125532650|NCT01736189|451581322|FG000|Overall Study|Protocol Violation|4|||
125532651|NCT01736189|451581322|FG000|Overall Study|Criteria and protocol violations|1|||
125532652|NCT03301155|451581324|FG000|Overall Study|Сompliance with exclusion criteria|8|||
125532653|NCT03301155|451581325|FG001|Overall Study|Сompliance with exclusion criteria|7|||
125532654|NCT00384189|451581326|FG000|Overall Study|Reason Not Specified|50|||
125532655|NCT00384189|451581327|FG001|Overall Study|Reason Not Specified|57|||
125532656|NCT00384189|451581328|FG002|Overall Study|Reason Not Specified|58|||
125532657|NCT00384189|451581329|FG003|Overall Study|Reason Not Specified|40|||
125532658|NCT00608868|451581330|FG000|Overall Study|Withdrawal by Subject|7|||
125532659|NCT00608868|451581330|FG000|Overall Study|Protocol Violation|3|||
125532660|NCT00608868|451581330|FG000|Overall Study|Lost to Follow-up|2|||
125532661|NCT00608868|451581330|FG000|Overall Study|Adverse Event|1|||
125532662|NCT00608868|451581330|FG000|Overall Study|Physician Decision|2|||
125532663|NCT00335140|451581333|FG000|Overall Study|Ineligible|1|||
125532664|NCT04546425|451581334|FG000|Overall Study|Protocol Violation|1|||
125532665|NCT04546425|451581335|FG001|Overall Study|Protocol Violation|1|||
125532666|NCT04546425|451581336|FG002|Overall Study|Protocol Violation|0|||
125532667|NCT04546425|451581337|FG003|Overall Study|Protocol Violation|0|||
125532668|NCT04546425|451581334|FG000|Overall Study|Adverse Event|3|||
125532669|NCT04546425|451581335|FG001|Overall Study|Adverse Event|0|||
125532670|NCT04546425|451581336|FG002|Overall Study|Adverse Event|0|||
125532671|NCT04546425|451581337|FG003|Overall Study|Adverse Event|0|||
125532672|NCT04546425|451581334|FG000|Overall Study|Lost to Follow-up|5|||
125532673|NCT04546425|451581335|FG001|Overall Study|Lost to Follow-up|4|||
125532674|NCT04546425|451581336|FG002|Overall Study|Lost to Follow-up|0|||
125532675|NCT04546425|451581337|FG003|Overall Study|Lost to Follow-up|0|||
125532676|NCT04546425|451581334|FG000|Overall Study|No Longer met eligibility criteria|3|||
125532677|NCT04546425|451581335|FG001|Overall Study|No Longer met eligibility criteria|3|||
125532678|NCT04546425|451581336|FG002|Overall Study|No Longer met eligibility criteria|1|||
125532679|NCT04546425|451581337|FG003|Overall Study|No Longer met eligibility criteria|1|||
125532680|NCT04546425|451581334|FG000|Overall Study|Withdrawal by parent/guardian|6|||
125532681|NCT04546425|451581335|FG001|Overall Study|Withdrawal by parent/guardian|5|||
125532682|NCT04546425|451581336|FG002|Overall Study|Withdrawal by parent/guardian|1|||
125532683|NCT04546425|451581337|FG003|Overall Study|Withdrawal by parent/guardian|1|||
125532684|NCT02979249|451581340|FG000|Overall Study|Lost to Follow-up|2|||
125532685|NCT02979249|451581340|FG000|Overall Study|Withdrawal by Subject|4|||
125532686|NCT01125046|451581341|FG000|First 6 Months of Treatment|Death|1|||
125532687|NCT01125046|451581341|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
125532688|NCT01125046|451581341|FG000|First 6 Months of Treatment|Non-compliance|1|||
125532689|NCT01125046|451581341|FG000|First 6 Months of Treatment|Surgery|1|||
125532690|NCT01125046|451581341|FG000|First 6 Months of Treatment|Progressive Disease|7|||
125532691|NCT01125046|451581341|FG000|First 6 Months of Treatment|Adverse Event|2|||
125532692|NCT01125046|451581341|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
125532693|NCT01125046|451581341|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
125532694|NCT01125046|451581341|FG000|Follow-up/Data Cut Off Point|Death|29|||
125532695|NCT01125046|451581341|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
125532696|NCT01685229|451581343|FG000|Overall Study|Subjects missing Study Exit form|3|||
125532697|NCT01685229|451581344|FG001|Overall Study|Subjects missing Study Exit form|1|||
125532698|NCT01685229|451581343|FG000|Overall Study|Lost to Follow-up|16|||
125532699|NCT01685229|451581344|FG001|Overall Study|Lost to Follow-up|10|||
125532700|NCT01685229|451581343|FG000|Overall Study|Withdrawal by Subject|6|||
125532701|NCT01685229|451581344|FG001|Overall Study|Withdrawal by Subject|5|||
125532702|NCT01685229|451581343|FG000|Overall Study|Death|1|||
125532703|NCT01685229|451581344|FG001|Overall Study|Death|0|||
125532704|NCT03868787|451581345|FG000|Overall Study|Withdrawal by Subject|2|||
125532705|NCT03868787|451581346|FG001|Overall Study|Withdrawal by Subject|1|||
125532706|NCT01399697|451581359|FG000|Overall Study|Adverse Event|13|||
125532707|NCT01399697|451581360|FG001|Overall Study|Adverse Event|3|||
125532708|NCT01399697|451581361|FG002|Overall Study|Adverse Event|1|||
125532709|NCT01399697|451581359|FG000|Overall Study|Lost to Follow-up|2|||
125532710|NCT01399697|451581360|FG001|Overall Study|Lost to Follow-up|0|||
125532711|NCT01399697|451581361|FG002|Overall Study|Lost to Follow-up|0|||
125532712|NCT01399697|451581359|FG000|Overall Study|Withdrawal by Subject|8|||
125532713|NCT01399697|451581360|FG001|Overall Study|Withdrawal by Subject|0|||
125532714|NCT01399697|451581361|FG002|Overall Study|Withdrawal by Subject|0|||
125532715|NCT01399697|451581359|FG000|Overall Study|Investigator Decisión|1|||
125532716|NCT01399697|451581360|FG001|Overall Study|Investigator Decisión|0|||
125532717|NCT01399697|451581361|FG002|Overall Study|Investigator Decisión|2|||
125532718|NCT01399697|451581359|FG000|Overall Study|Lack of Efficacy|9|||
125532719|NCT01399697|451581360|FG001|Overall Study|Lack of Efficacy|0|||
125532720|NCT01399697|451581361|FG002|Overall Study|Lack of Efficacy|1|||
125532721|NCT01399697|451581359|FG000|Overall Study|Protocol Violation|2|||
125532722|NCT01399697|451581360|FG001|Overall Study|Protocol Violation|0|||
125532723|NCT01399697|451581361|FG002|Overall Study|Protocol Violation|0|||
125532724|NCT01399697|451581359|FG000|Overall Study|Non-Compliant|1|||
125532725|NCT01399697|451581360|FG001|Overall Study|Non-Compliant|0|||
125532726|NCT01399697|451581361|FG002|Overall Study|Non-Compliant|0|||
125532727|NCT01399697|451581359|FG000|Overall Study|Inclusion Error|2|||
125532728|NCT01399697|451581360|FG001|Overall Study|Inclusion Error|0|||
125532729|NCT01399697|451581361|FG002|Overall Study|Inclusion Error|0|||
125532730|NCT01399697|451581359|FG000|Overall Study|Positive result for hepatitis B|1|||
125532731|NCT01399697|451581360|FG001|Overall Study|Positive result for hepatitis B|0|||
125532732|NCT01399697|451581361|FG002|Overall Study|Positive result for hepatitis B|0|||
125532733|NCT01399697|451581359|FG000|Overall Study|Clinical RA remission|1|||
125532734|NCT01399697|451581360|FG001|Overall Study|Clinical RA remission|0|||
125532735|NCT01399697|451581361|FG002|Overall Study|Clinical RA remission|0|||
125532736|NCT01399697|451581359|FG000|Overall Study|Sponsor Decision|1|||
125532737|NCT01399697|451581360|FG001|Overall Study|Sponsor Decision|0|||
125532738|NCT01399697|451581361|FG002|Overall Study|Sponsor Decision|0|||
125532739|NCT04313608|451581362|FG000|Overall Study|Death|12|||
125532740|NCT04313608|451581363|FG001|Overall Study|Death|3|||
125532741|NCT03019640|451581365|FG000|Overall Study|Screen Failures|4|||
125532742|NCT03019640|451581365|FG000|Overall Study|Adverse Event|3|||
125532743|NCT03019640|451581365|FG000|Overall Study|Participant Relapsed|1|||
125532744|NCT01327846|451581368|FG000|Core Phase|Subject decision (vital status: missing)|1|||
125532745|NCT01327846|451581369|FG001|Core Phase|Subject decision (vital status: missing)|2|||
125532746|NCT01327846|451581370|FG002|Core Phase|Subject decision (vital status: missing)|2|||
125532747|NCT01327846|451581371|FG003|Core Phase|Subject decision (vital status: missing)|1|||
125532748|NCT01327846|451581368|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
125532749|NCT01327846|451581369|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
125532750|NCT01327846|451581370|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
125532751|NCT01327846|451581371|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
125532752|NCT01327846|451581368|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
125532753|NCT01327846|451581369|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
125532754|NCT01327846|451581370|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
125532755|NCT01327846|451581371|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
125532756|NCT01327846|451581368|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
125532757|NCT01327846|451581369|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
125532758|NCT01327846|451581370|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
125532759|NCT01327846|451581371|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
125532760|NCT01327846|451581368|FG000|Core Phase|Lost to Follow-up|3|||
125532761|NCT01327846|451581369|FG001|Core Phase|Lost to Follow-up|3|||
125532762|NCT01327846|451581370|FG002|Core Phase|Lost to Follow-up|4|||
125532763|NCT01327846|451581371|FG003|Core Phase|Lost to Follow-up|5|||
125532764|NCT01327846|451581368|FG000|Extension Phase|Study terminated by sponsor|1073|||
125532765|NCT01327846|451581369|FG001|Extension Phase|Study terminated by sponsor|1124|||
125532766|NCT01327846|451581370|FG002|Extension Phase|Study terminated by sponsor|1067|||
125532767|NCT01327846|451581371|FG003|Extension Phase|Study terminated by sponsor|1660|||
125532768|NCT01327846|451581368|FG000|Extension Phase|Withdrawal by Subject|20|||
125532769|NCT01327846|451581369|FG001|Extension Phase|Withdrawal by Subject|13|||
125532770|NCT01327846|451581370|FG002|Extension Phase|Withdrawal by Subject|19|||
125532771|NCT01327846|451581371|FG003|Extension Phase|Withdrawal by Subject|37|||
125532772|NCT01327846|451581368|FG000|Extension Phase|Lost to Follow-up|4|||
125532773|NCT01327846|451581369|FG001|Extension Phase|Lost to Follow-up|3|||
125532774|NCT01327846|451581370|FG002|Extension Phase|Lost to Follow-up|4|||
125532775|NCT01327846|451581371|FG003|Extension Phase|Lost to Follow-up|7|||
125532776|NCT01327846|451581368|FG000|Extension Phase|Technical Problems|2|||
125532777|NCT01327846|451581369|FG001|Extension Phase|Technical Problems|4|||
125532778|NCT01327846|451581370|FG002|Extension Phase|Technical Problems|2|||
125532779|NCT01327846|451581371|FG003|Extension Phase|Technical Problems|2|||
125532780|NCT04343976|451581372|FG000|Overall Study|Withdrawal by Subject|0|||
125532781|NCT04343976|451581373|FG001|Overall Study|Withdrawal by Subject|1|||
125532782|NCT00594880|451581374|FG000|Overall Study|Withdrawal by Subject|1|||
125532783|NCT00594880|451581375|FG001|Overall Study|Withdrawal by Subject|1|||
125532784|NCT00594880|451581374|FG000|Overall Study|Lost to Follow-up|1|||
125532785|NCT00594880|451581375|FG001|Overall Study|Lost to Follow-up|0|||
125532786|NCT01371708|451581376|FG000|Overall Study|Insufficient clinical response|3|||
125532787|NCT01371708|451581377|FG001|Overall Study|Insufficient clinical response|2|||
125532788|NCT01371708|451581378|FG002|Overall Study|Insufficient clinical response|0|||
125532789|NCT01371708|451581376|FG000|Overall Study|Lost to Follow-up|5|||
125532790|NCT01371708|451581377|FG001|Overall Study|Lost to Follow-up|9|||
125532791|NCT01371708|451581378|FG002|Overall Study|Lost to Follow-up|7|||
125532792|NCT01371708|451581376|FG000|Overall Study|Protocol Violation|2|||
125532793|NCT01371708|451581377|FG001|Overall Study|Protocol Violation|1|||
125532794|NCT01371708|451581378|FG002|Overall Study|Protocol Violation|2|||
125532795|NCT01371708|451581376|FG000|Overall Study|No longer willing to participate|7|||
125532796|NCT01371708|451581377|FG001|Overall Study|No longer willing to participate|7|||
125532797|NCT01371708|451581378|FG002|Overall Study|No longer willing to participate|13|||
125532798|NCT01371708|451581376|FG000|Overall Study|Medication error/not related to AE|0|||
125532799|NCT01371708|451581377|FG001|Overall Study|Medication error/not related to AE|1|||
125532800|NCT01371708|451581378|FG002|Overall Study|Medication error/not related to AE|0|||
125532801|NCT01371708|451581376|FG000|Overall Study|Other|3|||
125532802|NCT01371708|451581377|FG001|Overall Study|Other|2|||
125532803|NCT01371708|451581378|FG002|Overall Study|Other|4|||
125532804|NCT01371708|451581376|FG000|Overall Study|Adverse Event|5|||
125532805|NCT01371708|451581377|FG001|Overall Study|Adverse Event|8|||
125532806|NCT01371708|451581378|FG002|Overall Study|Adverse Event|12|||
125532807|NCT01371708|451581376|FG000|Overall Study|Started but did not receive treatment|1|||
125532808|NCT01371708|451581377|FG001|Overall Study|Started but did not receive treatment|0|||
125532809|NCT01371708|451581378|FG002|Overall Study|Started but did not receive treatment|1|||
125532810|NCT00694109|451581379|FG000|Overall Study|Physician Decision|3|||
125532811|NCT00694109|451581379|FG000|Overall Study|Adverse Event|74|||
125532812|NCT00694109|451581379|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
125532813|NCT00694109|451581379|FG000|Overall Study|Lack of Efficacy|2|||
125532814|NCT00694109|451581379|FG000|Overall Study|Withdrawal by Subject|13|||
125532815|NCT00694109|451581379|FG000|Overall Study|Pregnancy|1|||
125532816|NCT00694109|451581379|FG000|Overall Study|Enrolled but not treated|1|||
125532817|NCT00694109|451581379|FG000|Overall Study|Other|2|||
125532818|NCT00694109|451581379|FG000|Overall Study|Consented but no additional treatment|3|||
125532819|NCT00846807|451581380|FG000|Overall Study|Adverse Event|270|||
125532820|NCT00846807|451581380|FG000|Overall Study|Lost to Follow-up|94|||
125532821|NCT00846807|451581380|FG000|Overall Study|Withdrawal by Subject|56|||
125532822|NCT00846807|451581380|FG000|Overall Study|Non compliant with European label|7|||
125532823|NCT00846807|451581380|FG000|Overall Study|Switch to other anticoagulants|89|||
125532824|NCT00846807|451581380|FG000|Overall Study|No prescription after hospital discharge|56|||
125532825|NCT00846807|451581380|FG000|Overall Study|Other|60|||
125532826|NCT00737698|451581381|FG000|Overall Study|Withdrawal by Subject|6|||
125532827|NCT00737698|451581382|FG001|Overall Study|Withdrawal by Subject|5|||
125532828|NCT00737698|451581383|FG002|Overall Study|Withdrawal by Subject|3|||
125532829|NCT00737698|451581381|FG000|Overall Study|Death|0|||
125532830|NCT00737698|451581382|FG001|Overall Study|Death|0|||
125532831|NCT00737698|451581383|FG002|Overall Study|Death|1|||
125532832|NCT01067846|451581388|FG000|Overall Study|Lost to Follow-up|17|||
125532833|NCT01067846|451581389|FG001|Overall Study|Lost to Follow-up|19|||
125532834|NCT01067846|451581388|FG000|Overall Study|Withdrawal by Subject|1|||
125532835|NCT01067846|451581389|FG001|Overall Study|Withdrawal by Subject|0|||
125532836|NCT01067846|451581388|FG000|Overall Study|participation in other tx study|1|||
125532837|NCT01067846|451581389|FG001|Overall Study|participation in other tx study|0|||
125532838|NCT04608773|451581390|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
125532839|NCT04608773|451581391|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
125532840|NCT04608773|451581390|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
125532841|NCT04608773|451581391|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
125532842|NCT04608773|451581390|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
125532843|NCT04608773|451581391|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
125532844|NCT04608773|451581390|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
125532845|NCT04608773|451581391|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
125532846|NCT04608773|451581390|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
125532847|NCT04608773|451581391|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
125532848|NCT02387970|451581392|FG000|Overall Study|Did not complete 1-year follow up|1|||
125532849|NCT02387970|451581393|FG001|Overall Study|Did not complete 1-year follow up|2|||
125532850|NCT01436253|451581398|FG000|Overall Study|Lost to Follow-up|182|||
125532851|NCT01436253|451581398|FG000|Overall Study|Not meeting all eligibility criteria|117|||
125532852|NCT01217437|451581399|FG000|Overall Study|Adverse Event|0|||
125532853|NCT01217437|451581400|FG001|Overall Study|Adverse Event|8|||
125532854|NCT01217437|451581399|FG000|Overall Study|Death|5|||
125532855|NCT01217437|451581400|FG001|Overall Study|Death|0|||
125532856|NCT01217437|451581399|FG000|Overall Study|Lack of Efficacy|29|||
125532857|NCT01217437|451581400|FG001|Overall Study|Lack of Efficacy|25|||
125532858|NCT01217437|451581399|FG000|Overall Study|Physician Decision|8|||
125532859|NCT01217437|451581400|FG001|Overall Study|Physician Decision|5|||
125532860|NCT01217437|451581399|FG000|Overall Study|Withdrawal by Subject|0|||
125532861|NCT01217437|451581400|FG001|Overall Study|Withdrawal by Subject|2|||
125532862|NCT01217437|451581399|FG000|Overall Study|Ineligible|1|||
125532863|NCT01217437|451581400|FG001|Overall Study|Ineligible|1|||
125532864|NCT03682185|451581403|FG000|Overall Study|Lost to Follow-up|4|||
125532865|NCT03682185|451581404|FG001|Overall Study|Lost to Follow-up|7|||
125532866|NCT03682185|451581405|FG002|Overall Study|Lost to Follow-up|4|||
125532867|NCT03682185|451581406|FG003|Overall Study|Lost to Follow-up|7|||
125532868|NCT03682185|451581407|FG004|Overall Study|Lost to Follow-up|1|||
125532869|NCT03682185|451581403|FG000|Overall Study|Withdrawal by Subject|7|||
125532870|NCT03682185|451581404|FG001|Overall Study|Withdrawal by Subject|3|||
125532871|NCT03682185|451581405|FG002|Overall Study|Withdrawal by Subject|7|||
125532872|NCT03682185|451581406|FG003|Overall Study|Withdrawal by Subject|3|||
125532873|NCT03682185|451581407|FG004|Overall Study|Withdrawal by Subject|0|||
125532874|NCT04908631|451581408|FG000|Overall Study|Lost to Follow-up|1|||
125532875|NCT04908631|451581408|FG000|Overall Study|Physician Decision|1|||
125532876|NCT04908631|451581408|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
125532877|NCT04531982|451581409|FG000|Overall Study|Withdrawal by Subject|10|||
125532878|NCT04531982|451581410|FG001|Overall Study|Withdrawal by Subject|11|||
125532879|NCT04531982|451581409|FG000|Overall Study|Adverse Event|6|||
125532880|NCT04531982|451581410|FG001|Overall Study|Adverse Event|14|||
125532881|NCT04531982|451581409|FG000|Overall Study|Protocol Violation|6|||
125532882|NCT04531982|451581410|FG001|Overall Study|Protocol Violation|9|||
125532883|NCT04531982|451581409|FG000|Overall Study|Non-compliance with study drug|3|||
125532884|NCT04531982|451581410|FG001|Overall Study|Non-compliance with study drug|2|||
125532885|NCT04531982|451581409|FG000|Overall Study|Use of prohibited medication|2|||
125532886|NCT04531982|451581410|FG001|Overall Study|Use of prohibited medication|0|||
125532887|NCT04531982|451581409|FG000|Overall Study|Lost to Follow-up|0|||
125532888|NCT04531982|451581410|FG001|Overall Study|Lost to Follow-up|1|||
125532889|NCT04531982|451581409|FG000|Overall Study|Geopolitical conflict|2|||
125532890|NCT04531982|451581410|FG001|Overall Study|Geopolitical conflict|0|||
125532891|NCT04531982|451581409|FG000|Overall Study|Lack of Efficacy|3|||
125532892|NCT04531982|451581410|FG001|Overall Study|Lack of Efficacy|1|||
125532893|NCT03841526|451581414|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
125532894|NCT03841526|451581415|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
125532895|NCT03841526|451581416|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
125532896|NCT03841526|451581417|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
125532897|NCT03841526|451581418|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
125532898|NCT03841526|451581419|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
125532899|NCT03841526|451581414|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
125532900|NCT03841526|451581415|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
125532901|NCT03841526|451581416|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
125532902|NCT03841526|451581417|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
125532903|NCT03841526|451581418|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
125532904|NCT03841526|451581419|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
125532905|NCT03841526|451581414|FG000|Outpatient Phase Treatment|Physician Decision|0|||
125532906|NCT03841526|451581415|FG001|Outpatient Phase Treatment|Physician Decision|1|||
125532907|NCT03841526|451581416|FG002|Outpatient Phase Treatment|Physician Decision|0|||
125532908|NCT03841526|451581417|FG003|Outpatient Phase Treatment|Physician Decision|0|||
125532909|NCT03841526|451581418|FG004|Outpatient Phase Treatment|Physician Decision|0|||
125532910|NCT03841526|451581419|FG005|Outpatient Phase Treatment|Physician Decision|0|||
125532911|NCT03841526|451581414|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
125532912|NCT03841526|451581415|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
125532913|NCT03841526|451581416|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
125532914|NCT03841526|451581417|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
125532915|NCT03841526|451581418|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
125532916|NCT03841526|451581419|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
125532917|NCT04266795|451581420|FG000|Overall Study|Adverse Event|10|||
125532921|NCT04266795|451581420|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
125532922|NCT04266795|451581421|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
125532923|NCT04266795|451581420|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
125532924|NCT04266795|451581421|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
125532925|NCT04266795|451581420|FG000|Overall Study|Progressive Disease|12|||
125532926|NCT04266795|451581421|FG001|Overall Study|Progressive Disease|9|||
125532927|NCT04266795|451581420|FG000|Overall Study|Withdrawal by Patient|5|||
125532928|NCT04266795|451581421|FG001|Overall Study|Withdrawal by Patient|6|||
125532929|NCT04266795|451581420|FG000|Overall Study|Disease Relapse|3|||
125532930|NCT04266795|451581421|FG001|Overall Study|Disease Relapse|6|||
125532931|NCT04266795|451581420|FG000|Overall Study|Reason not Specified|12|||
125532932|NCT04266795|451581421|FG001|Overall Study|Reason not Specified|10|||
125532933|NCT04266795|451581420|FG000|Overall Study|Participants Ongoing on Treatment|25|||
125532934|NCT04266795|451581421|FG001|Overall Study|Participants Ongoing on Treatment|23|||
125532935|NCT04047862|451581422|FG000|Overall Study|Death|0|||
125532936|NCT04047862|451581423|FG001|Overall Study|Death|0|||
125532937|NCT04047862|451581424|FG002|Overall Study|Death|4|||
125532938|NCT04047862|451581425|FG003|Overall Study|Death|7|||
125532939|NCT04047862|451581426|FG004|Overall Study|Death|2|||
125532940|NCT04047862|451581427|FG005|Overall Study|Death|4|||
125532941|NCT04047862|451581428|FG006|Overall Study|Death|3|||
125532942|NCT04047862|451581429|FG007|Overall Study|Death|24|||
125532943|NCT04047862|451581430|FG008|Overall Study|Death|24|||
125532944|NCT04047862|451581431|FG009|Overall Study|Death|22|||
125532945|NCT04047862|451581432|FG010|Overall Study|Death|35|||
125532946|NCT04047862|451581433|FG011|Overall Study|Death|18|||
125532947|NCT04047862|451581434|FG012|Overall Study|Death|14|||
125532948|NCT04047862|451581435|FG013|Overall Study|Death|6|||
125532949|NCT04047862|451581436|FG014|Overall Study|Death|19|||
125532950|NCT04047862|451581437|FG015|Overall Study|Death|42|||
125532951|NCT04047862|451581438|FG016|Overall Study|Death|9|||
125532952|NCT04047862|451581439|FG017|Overall Study|Death|8|||
125532953|NCT04047862|451581440|FG018|Overall Study|Death|10|||
125532954|NCT04047862|451581422|FG000|Overall Study|Withdrawal by Subject|0|||
125532955|NCT04047862|451581423|FG001|Overall Study|Withdrawal by Subject|0|||
125532956|NCT04047862|451581424|FG002|Overall Study|Withdrawal by Subject|0|||
125532957|NCT04047862|451581425|FG003|Overall Study|Withdrawal by Subject|5|||
125532958|NCT04047862|451581426|FG004|Overall Study|Withdrawal by Subject|2|||
125532959|NCT04047862|451581427|FG005|Overall Study|Withdrawal by Subject|0|||
125532960|NCT04047862|451581428|FG006|Overall Study|Withdrawal by Subject|1|||
125532961|NCT04047862|451581429|FG007|Overall Study|Withdrawal by Subject|0|||
125532962|NCT04047862|451581430|FG008|Overall Study|Withdrawal by Subject|4|||
125532963|NCT04047862|451581431|FG009|Overall Study|Withdrawal by Subject|4|||
125532964|NCT04047862|451581432|FG010|Overall Study|Withdrawal by Subject|4|||
125532965|NCT04047862|451581433|FG011|Overall Study|Withdrawal by Subject|2|||
125532966|NCT04047862|451581434|FG012|Overall Study|Withdrawal by Subject|3|||
125532967|NCT04047862|451581435|FG013|Overall Study|Withdrawal by Subject|0|||
125532968|NCT04047862|451581436|FG014|Overall Study|Withdrawal by Subject|9|||
125532969|NCT04047862|451581437|FG015|Overall Study|Withdrawal by Subject|5|||
125532970|NCT04047862|451581438|FG016|Overall Study|Withdrawal by Subject|1|||
125532971|NCT04047862|451581439|FG017|Overall Study|Withdrawal by Subject|3|||
125532972|NCT04047862|451581440|FG018|Overall Study|Withdrawal by Subject|1|||
125532973|NCT04047862|451581422|FG000|Overall Study|Lost to Follow-up|0|||
125532974|NCT04047862|451581423|FG001|Overall Study|Lost to Follow-up|0|||
125532975|NCT04047862|451581424|FG002|Overall Study|Lost to Follow-up|1|||
125532976|NCT04047862|451581425|FG003|Overall Study|Lost to Follow-up|0|||
125532977|NCT04047862|451581426|FG004|Overall Study|Lost to Follow-up|0|||
125532978|NCT04047862|451581427|FG005|Overall Study|Lost to Follow-up|0|||
125532979|NCT04047862|451581428|FG006|Overall Study|Lost to Follow-up|0|||
125532980|NCT04047862|451581429|FG007|Overall Study|Lost to Follow-up|1|||
125532981|NCT04047862|451581430|FG008|Overall Study|Lost to Follow-up|0|||
125532982|NCT04047862|451581431|FG009|Overall Study|Lost to Follow-up|1|||
125532983|NCT04047862|451581432|FG010|Overall Study|Lost to Follow-up|0|||
125532984|NCT04047862|451581433|FG011|Overall Study|Lost to Follow-up|3|||
125532985|NCT04047862|451581434|FG012|Overall Study|Lost to Follow-up|0|||
125532986|NCT04047862|451581435|FG013|Overall Study|Lost to Follow-up|0|||
125532987|NCT04047862|451581436|FG014|Overall Study|Lost to Follow-up|2|||
125532988|NCT04047862|451581437|FG015|Overall Study|Lost to Follow-up|2|||
125532989|NCT04047862|451581438|FG016|Overall Study|Lost to Follow-up|1|||
125532990|NCT04047862|451581439|FG017|Overall Study|Lost to Follow-up|0|||
125532991|NCT04047862|451581440|FG018|Overall Study|Lost to Follow-up|0|||
125532992|NCT04047862|451581422|FG000|Overall Study|Physician Decision|0|||
125532993|NCT04047862|451581423|FG001|Overall Study|Physician Decision|0|||
125532994|NCT04047862|451581424|FG002|Overall Study|Physician Decision|0|||
125532995|NCT04047862|451581425|FG003|Overall Study|Physician Decision|1|||
125532996|NCT04047862|451581426|FG004|Overall Study|Physician Decision|0|||
125532997|NCT04047862|451581427|FG005|Overall Study|Physician Decision|0|||
125532998|NCT04047862|451581428|FG006|Overall Study|Physician Decision|0|||
125532999|NCT04047862|451581429|FG007|Overall Study|Physician Decision|0|||
125533011|NCT04047862|451581422|FG000|Overall Study|Completed all Assessments|1|||
125533012|NCT04047862|451581423|FG001|Overall Study|Completed all Assessments|3|||
125533013|NCT04047862|451581424|FG002|Overall Study|Completed all Assessments|1|||
125533014|NCT04047862|451581425|FG003|Overall Study|Completed all Assessments|3|||
125533015|NCT04047862|451581426|FG004|Overall Study|Completed all Assessments|2|||
125533016|NCT04047862|451581427|FG005|Overall Study|Completed all Assessments|5|||
125533017|NCT04047862|451581428|FG006|Overall Study|Completed all Assessments|7|||
125533018|NCT04047862|451581429|FG007|Overall Study|Completed all Assessments|0|||
125533019|NCT04047862|451581430|FG008|Overall Study|Completed all Assessments|0|||
125533020|NCT04047862|451581431|FG009|Overall Study|Completed all Assessments|0|||
125533021|NCT04047862|451581432|FG010|Overall Study|Completed all Assessments|0|||
125533022|NCT04047862|451581433|FG011|Overall Study|Completed all Assessments|0|||
125533023|NCT04047862|451581434|FG012|Overall Study|Completed all Assessments|0|||
125533024|NCT04047862|451581435|FG013|Overall Study|Completed all Assessments|0|||
125533025|NCT04047862|451581436|FG014|Overall Study|Completed all Assessments|0|||
125533026|NCT04047862|451581437|FG015|Overall Study|Completed all Assessments|0|||
125533027|NCT04047862|451581438|FG016|Overall Study|Completed all Assessments|0|||
125533028|NCT04047862|451581439|FG017|Overall Study|Completed all Assessments|0|||
125533029|NCT04047862|451581440|FG018|Overall Study|Completed all Assessments|0|||
125533030|NCT04047862|451581422|FG000|Overall Study|Sponsor Decision|0|||
125533031|NCT04047862|451581423|FG001|Overall Study|Sponsor Decision|0|||
125533032|NCT04047862|451581424|FG002|Overall Study|Sponsor Decision|0|||
125533033|NCT04047862|451581425|FG003|Overall Study|Sponsor Decision|0|||
125533034|NCT04047862|451581426|FG004|Overall Study|Sponsor Decision|0|||
125533035|NCT04047862|451581427|FG005|Overall Study|Sponsor Decision|0|||
125533036|NCT04047862|451581428|FG006|Overall Study|Sponsor Decision|0|||
125533037|NCT04047862|451581429|FG007|Overall Study|Sponsor Decision|13|||
125533038|NCT04047862|451581430|FG008|Overall Study|Sponsor Decision|10|||
125533039|NCT04047862|451581431|FG009|Overall Study|Sponsor Decision|18|||
125533040|NCT04047862|451581432|FG010|Overall Study|Sponsor Decision|3|||
125533041|NCT04047862|451581433|FG011|Overall Study|Sponsor Decision|3|||
125533042|NCT04047862|451581434|FG012|Overall Study|Sponsor Decision|4|||
125533043|NCT04047862|451581435|FG013|Overall Study|Sponsor Decision|0|||
125533044|NCT04047862|451581436|FG014|Overall Study|Sponsor Decision|7|||
125533045|NCT04047862|451581437|FG015|Overall Study|Sponsor Decision|8|||
125533046|NCT04047862|451581438|FG016|Overall Study|Sponsor Decision|9|||
125533047|NCT04047862|451581439|FG017|Overall Study|Sponsor Decision|7|||
125533048|NCT04047862|451581440|FG018|Overall Study|Sponsor Decision|8|||
125533049|NCT04047862|451581422|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
125533050|NCT04047862|451581423|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
125533051|NCT04047862|451581424|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
125533052|NCT04047862|451581425|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
125533053|NCT04047862|451581426|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
125533054|NCT04047862|451581427|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
125533055|NCT04047862|451581428|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
125533056|NCT04047862|451581429|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
125533057|NCT04047862|451581430|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
125533058|NCT04047862|451581431|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
125533059|NCT04047862|451581432|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
125533060|NCT04047862|451581433|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
125533061|NCT04047862|451581434|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
125533062|NCT04047862|451581435|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
125533063|NCT04047862|451581436|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
125533064|NCT04047862|451581437|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
125533065|NCT04047862|451581438|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
125533066|NCT04047862|451581439|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
125533067|NCT04047862|451581440|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
125533068|NCT04047862|451581422|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533069|NCT04047862|451581423|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533070|NCT04047862|451581424|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533071|NCT04047862|451581425|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533072|NCT04047862|451581426|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533073|NCT04047862|451581427|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533074|NCT04047862|451581428|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533075|NCT04047862|451581429|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533076|NCT04047862|451581430|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533077|NCT04047862|451581431|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533078|NCT04047862|451581432|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533079|NCT04047862|451581433|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533080|NCT04047862|451581434|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533081|NCT04047862|451581435|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533082|NCT04047862|451581436|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533083|NCT04047862|451581437|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
125533084|NCT04047862|451581438|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533085|NCT04047862|451581439|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
125533086|NCT04047862|451581440|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
125533087|NCT04047862|451581422|FG000|Overall Study|Other|0|||
125533088|NCT04047862|451581423|FG001|Overall Study|Other|0|||
125533089|NCT04047862|451581424|FG002|Overall Study|Other|0|||
125533090|NCT04047862|451581425|FG003|Overall Study|Other|0|||
125533091|NCT04047862|451581426|FG004|Overall Study|Other|0|||
125533092|NCT04047862|451581427|FG005|Overall Study|Other|0|||
125533093|NCT04047862|451581428|FG006|Overall Study|Other|0|||
125533094|NCT04047862|451581429|FG007|Overall Study|Other|0|||
125533095|NCT04047862|451581430|FG008|Overall Study|Other|0|||
125533096|NCT04047862|451581431|FG009|Overall Study|Other|0|||
125533097|NCT04047862|451581432|FG010|Overall Study|Other|0|||
125533098|NCT04047862|451581433|FG011|Overall Study|Other|0|||
125533099|NCT04047862|451581434|FG012|Overall Study|Other|0|||
125533100|NCT04047862|451581435|FG013|Overall Study|Other|0|||
125533101|NCT04047862|451581436|FG014|Overall Study|Other|2|||
125533102|NCT04047862|451581437|FG015|Overall Study|Other|1|||
125533103|NCT04047862|451581438|FG016|Overall Study|Other|1|||
125533104|NCT04047862|451581439|FG017|Overall Study|Other|1|||
125533105|NCT04047862|451581440|FG018|Overall Study|Other|0|||
